{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import asyncio , re , httpx\n",
    "from bs4 import BeautifulSoup\n",
    "from typing import Optional , AsyncIterator , List\n",
    "import urllib.parse\n",
    "import requests\n",
    "from dotenv import load_dotenv\n",
    "import os, sys\n",
    "from tenacity import retry, stop_after_attempt,wait_exponential\n",
    "import certifi\n",
    "from playwright.async_api import async_playwright\n",
    "import asyncio\n",
    "import os\n",
    "from typing import Optional\n",
    "from urllib.parse import quote , urlparse , urljoin\n",
    "import httpx\n",
    "import random"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/longlab/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/certifi/cacert.pem\n"
     ]
    }
   ],
   "source": [
    "print(certifi.where())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-22 17:31:16.229827: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:467] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
      "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
      "E0000 00:00:1750635076.291227    5590 cuda_dnn.cc:8579] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
      "E0000 00:00:1750635076.307815    5590 cuda_blas.cc:1407] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
      "W0000 00:00:1750635076.432555    5590 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
      "W0000 00:00:1750635076.432584    5590 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
      "W0000 00:00:1750635076.432586    5590 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
      "W0000 00:00:1750635076.432588    5590 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
      "2025-06-22 17:31:16.446665: I tensorflow/core/platform/cpu_feature_guard.cc:210] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
      "To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n"
     ]
    }
   ],
   "source": [
    "\n",
    "cwd = os.getcwd()\n",
    "parent_folder = os.path.abspath(os.path.join(cwd, \"..\"))\n",
    "if parent_folder not in sys.path:\n",
    "    sys.path.append(parent_folder)\n",
    "from functions.paper_to_doi import get_info_from_doi\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# class Easy_Publisher_PDF_Resolver:\n",
    "#     \"\"\"\n",
    "#     Resolve a DOI to a direct PDF URL for Springer, OUP, Hindawi, F1000, etc.\n",
    "#     Raises NeedsBrowser when the easy path fails.\n",
    "#     \"\"\"\n",
    "    \n",
    "#     _SPRINGER_HOST     = \"link.springer.com\"\n",
    "#     _OUP_HOST_RE       = re.compile(r\"^https?://academic\\.oup\\.com/\")\n",
    "#     _F1000_HOST_RE     = re.compile(r\"^https?://(?:f1000research|wellcomeopenresearch|gatesopenresearch)\\.org/\")\n",
    "#     _HINDAWI_DOWNLOAD  = re.compile(r\"^https?://downloads\\.hindawi\\.com/\")\n",
    "#     _HINDAWI_LANDING   = re.compile(r\"^https?://(?:www\\.)?hindawi\\.com/\")\n",
    "\n",
    "    \n",
    "#     _ANCHOR_PDF_CLASS_RE = re.compile(r\"pdf|download\", re.I)  # class / id hints\n",
    "\n",
    "\n",
    "#     class NeedsBrowser(RuntimeError):\n",
    "#         \"\"\"Raised when the resolver needs a browser to resolve the URL.\"\"\"\n",
    "#         pass\n",
    "    \n",
    "    \n",
    "#     def __init__(self,*,\n",
    "#                  headers: Optional[dict] = None,\n",
    "#                  timeout: int = 30):\n",
    "#         self.headers = headers or {\n",
    "#             \"User-Agent\": \"Mozilla/5.0 (easy-pdf-resolver/0.2)\"\n",
    "#         }\n",
    "#         self.timeout = timeout\n",
    "#         self._client : Optional[httpx.AsyncClient] = None\n",
    "      \n",
    "#     async def __aenter__(self): \n",
    "#         self._client = httpx.AsyncClient(\n",
    "#             headers=self.headers,\n",
    "#             follow_redirects=True, \n",
    "#             timeout=self.timeout\n",
    "#         )\n",
    "        \n",
    "#         return self\n",
    "    \n",
    "#     async def __aexit__(self, exc_type, exc, traceback):\n",
    "#         await self._client.aclose()\n",
    "#         self._client = None\n",
    "        \n",
    "#     def _require_client(self) -> httpx.AsyncClient:\n",
    "#         if self._client is None:\n",
    "#             # allow use without 'async with' by lazily creating a client\n",
    "#             self._client = httpx.AsyncClient(\n",
    "#                 headers=self.headers,\n",
    "#                 follow_redirects=True,\n",
    "#                 timeout=self.timeout\n",
    "#             )\n",
    "#         return self._client\n",
    "\n",
    "    \n",
    "#     async def _is_pdf(self, url: str) -> bool:\n",
    "#         client = self._require_client()\n",
    "#         r = await client.head(url)\n",
    "#         return (\n",
    "#             r.status_code == 200 and\n",
    "#             r.headers.get(\"content-type\", \"\").startswith(\"application/pdf\")\n",
    "#         )\n",
    "    \n",
    "#     @staticmethod\n",
    "#     def _extract_meta_pdf(html: str) -> Optional[str]:\n",
    "#         \"\"\"\n",
    "#         Extract the PDF URL advertised in a page’s ``<meta>`` tag.\n",
    "\n",
    "#         Many scholarly-publisher landing pages include\n",
    "#         ``<meta name=\"citation_pdf_url\" content=\"https://…/article.pdf\">``  \n",
    "#         inside their ``<head>`` section.  This helper pulls that value out\n",
    "#         so the scraper can download the PDF without further heuristics.\n",
    "\n",
    "#         Args:\n",
    "#         html (str):\n",
    "#             Raw HTML source of the article landing page\n",
    "#             (typically obtained via ``await http_client.get(url).text``).\n",
    "\n",
    "#         Returns:\n",
    "#             Optional[str]:\n",
    "#                 • The PDF URL found in the ``content`` attribute of the first\n",
    "#                 ``<meta name=\"citation_pdf_url\">`` tag, **or**  \n",
    "#                 • ``None`` if no such tag exists (caller should try another\n",
    "#                 strategy, e.g. Playwright).\n",
    "\n",
    "#         Example:\n",
    "#             >>> landing_html = client.get(\"https://academic.oup.com/jn/article/...\", timeout=30).text\n",
    "#             >>> pdf_url = _extract_meta_pdf(landing_html)\n",
    "#             >>> print(pdf_url)\n",
    "#             https://academic.oup.com/jn/article-pdf/123/4/1234/9876543/jn.123.4.1234.pdf\n",
    "\n",
    "#         Notes:\n",
    "#             * Uses BeautifulSoup’s default parser (``html.parser``) to avoid\n",
    "#             external dependencies.  Switch to ``\"lxml\"`` if you already have\n",
    "#             lxml installed and want a performance boost.\n",
    "#             * Only the **first** matching tag is returned; this is sufficient\n",
    "#             for OUP, Wiley HTML, and most CrossRef-compliant publishers.\n",
    "\n",
    "#         \"\"\"\n",
    "#         soup = BeautifulSoup(html, \"html.parser\")\n",
    "#         tag  = soup.find(\"meta\", attrs={\"name\": \"citation_pdf_url\"})\n",
    "#         return tag[\"content\"] if tag else None\n",
    "    \n",
    "    \n",
    "#     @classmethod\n",
    "#     def _extract_anchor_pdf(cls, html: str, base_url: str) -> Optional[str]:\n",
    "#         \"\"\"Return absolute URL from the *best* `<a>` that seems to be a PDF link.\n",
    "\n",
    "#         Heuristics (checked in order):\n",
    "#         1. `href` ends with `.pdf` (common for Springer / OUP).\n",
    "#         2. `href` contains `/pdf` *and* anchor text or class‑attribute mentions\n",
    "#            \"pdf\" or \"download\" (F1000 style: `/pdf?article_uuid=…`).\n",
    "#         3. Anchor `class` / `id` matches /pdf|download/ even if `href` is just\n",
    "#            a relative `/content/pdf/…` path.\n",
    "#         \"\"\"\n",
    "#         soup = BeautifulSoup(html, \"html.parser\")\n",
    "\n",
    "#         def make_abs(href: str) -> str:\n",
    "#             return urllib.parse.urljoin(base_url, href)\n",
    "\n",
    "#         # Pass 0 – explicit OUP pattern /article-pdf/ ---------------------------\n",
    "#         for a in soup.find_all(\"a\", href=True):\n",
    "#             href = a[\"href\"].strip()\n",
    "#             if \"/article-pdf/\" in href.lower():\n",
    "#                 return make_abs(href)\n",
    "\n",
    "#         # Pass 1 – href ends with .pdf -----------------------------------------\n",
    "#         for a in soup.find_all(\"a\", href=True):\n",
    "#             href = a[\"href\"].strip()\n",
    "#             if href.lower().endswith(\".pdf\"):\n",
    "#                 return make_abs(href)\n",
    "\n",
    "#         # Pass 2 – href contains \"pdf\" + textual or class cues -----------------\n",
    "#         for a in soup.find_all(\"a\", href=True):\n",
    "#             href = a[\"href\"].strip()\n",
    "#             href_lower = href.lower()\n",
    "#             if \"pdf\" in href_lower:\n",
    "#                 text = a.get_text(\" \", strip=True).lower()\n",
    "#                 classes = \" \".join(a.get(\"class\", [])).lower()\n",
    "#                 ident   = a.get(\"id\", \"\").lower()\n",
    "#                 if (\"pdf\" in text or \"download\" in text or cls._ANCHOR_HINT_RE.search(classes) or cls._ANCHOR_HINT_RE.search(ident)):\n",
    "#                     return make_abs(href)\n",
    "\n",
    "#         # Pass 3 – only class/id hints -----------------------------------------\n",
    "#         for a in soup.find_all(\"a\", href=True):\n",
    "#             classes = \" \".join(a.get(\"class\", []))\n",
    "#             ident   = a.get(\"id\", \"\")\n",
    "#             if cls._ANCHOR_HINT_RE.search(classes) or cls._ANCHOR_HINT_RE.search(ident):\n",
    "#                 return make_abs(a[\"href\"].strip())\n",
    "\n",
    "#         return None\n",
    "\n",
    "        \n",
    "       \n",
    "        \n",
    "#     async def get_pdf(self, doi: str) -> str:\n",
    "        \n",
    "#         \"\"\"\n",
    "#         Return a direct PDF URL for the given DOI.\n",
    "#         Raises EasyPDFResolver.NeedsBrowser if the easy strategies fail.\n",
    "#         \"\"\"\n",
    "#         client = self._client or httpx.AsyncClient(headers=self.headers, follow_redirects=True, timeout=self.timeout)\n",
    "#         landing = str((await client.get(f\"https://doi.org/{doi}\")).url)\n",
    "        \n",
    "#         if self._SPRINGER_HOST in landing:\n",
    "#             candidates = [\n",
    "#                 f\"https://{self._SPRINGER_HOST}/content/pdf/{doi}.pdf\",\n",
    "#             ]\n",
    "#             # /fulltext.html → .pdf\n",
    "#             if landing.endswith(\"fulltext.html\") or landing.endswith(\"fulltext.htm\"):\n",
    "#                 candidates.append(landing.rsplit(\"/\", 1)[0] + \".pdf\")\n",
    "#             # article path without extension → add .pdf\n",
    "#             elif landing.endswith(\".html\"):\n",
    "#                 candidates.append(landing[:-5] + \".pdf\")\n",
    "#             else:\n",
    "#                 if \"/article/\" in landing and not landing.endswith(\".pdf\"):\n",
    "#                     candidates.append(landing + \".pdf\")\n",
    "\n",
    "#             for pdf_url in candidates:\n",
    "#                 if await self._is_pdf(pdf_url):\n",
    "#                     return pdf_url\n",
    "\n",
    "#             # 🚀 NEW: scrape the Download‑PDF button\n",
    "\n",
    "#         # ------------------------------------------------------------------\n",
    "#         # Hindawi – DOI redirect or downloads.hindawi.com\n",
    "#         # ------------------------------------------------------------------\n",
    "#         if self._HINDAWI_DOWNLOAD.match(landing) or self._HINDAWI_LANDING.match(landing):\n",
    "#             for cand in {landing, f\"https://doi.org/{doi}\"}:\n",
    "#                 if await self._is_pdf(cand):\n",
    "#                     return cand\n",
    "#             # try landing→html parse as last resort\n",
    "#             html = (await client.get(landing)).text\n",
    "#             meta = self._extract_meta_pdf(html)\n",
    "#             if meta and await self._is_pdf(meta):\n",
    "#                 return meta\n",
    "\n",
    "#         # ------------------------------------------------------------------\n",
    "#         # F1000Research family – JSON API\n",
    "#         # ------------------------------------------------------------------\n",
    "#         if self._F1000_HOST_RE.match(landing):\n",
    "#             article_id = doi.split(\"/\")[-1]\n",
    "#             host = urllib.parse.urlparse(landing).hostname\n",
    "#             api_url = f\"https://api.{host}/article/{article_id}\"\n",
    "#             try:\n",
    "#                 pdf_url = (await client.get(api_url)).json()[\"data\"][\"pdf_url\"]\n",
    "#                 if await self._is_pdf(pdf_url):\n",
    "#                     return pdf_url\n",
    "#             except Exception:\n",
    "#                 pass\n",
    "\n",
    "#         # ------------------------------------------------------------------\n",
    "#         # OUP – meta tag only\n",
    "#         # ------------------------------------------------------------------\n",
    "#         if self._OUP_HOST_RE.match(landing):\n",
    "#             html = (await client.get(landing)).text\n",
    "#             meta_link = self._extract_meta_pdf(html)\n",
    "#             if meta_link and await self._is_pdf(meta_link):\n",
    "#                 return meta_link\n",
    "#         try:\n",
    "#             html = (await client.get(landing)).text\n",
    "#             anchor_link = self._extract_anchor_pdf(html, landing)\n",
    "#             if anchor_link and await self._is_pdf(anchor_link):\n",
    "#                 return anchor_link\n",
    "#         except httpx.HTTPError:\n",
    "#             pass \n",
    "#         # ------------------------------------------------------------------\n",
    "#         # Escalate\n",
    "#         # ------------------------------------------------------------------\n",
    "#         raise self.NeedsBrowser(f\"Browser required for {doi} → {landing}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "class PDFResolver:\n",
    "    _SPRINGER_HOST = \"link.springer.com\"\n",
    "    _OUP_HOST_RE = re.compile(r\"^https?://academic\\.oup\\.com/\")\n",
    "    _F1000_HOST_RE = re.compile(r\"^https?://(?:f1000research|wellcomeopenresearch|gatesopenresearch)\\.org/\")\n",
    "    _HINDAWI_DOWNLOAD_RE = re.compile(r\"^https?://downloads\\.hindawi\\.com/\")\n",
    "    _HINDAWI_LANDING_RE = re.compile(r\"^https?://(?:www\\.)?hindawi\\.com/\")\n",
    "    _ANCHOR_HINT_RE = re.compile(r\"\"\"(?x)                         # verbose mode for clarity\n",
    "    (\n",
    "        pdf\n",
    "        | full[\\s_-]*text\n",
    "        | full[\\s_-]*article\n",
    "        | view[\\s_-]*article\n",
    "        | view[\\s_-]*pdf\n",
    "        | read[\\s_-]*(this[\\s_-]*)?article\n",
    "        | article[\\s_-]*as[\\s_-]*pdf\n",
    "        | open[\\s_-]*access\n",
    "        | download\n",
    "        | dl[\\s_-]*(pdf|article)?\n",
    "        | link[\\s_-]*to[\\s_-]*pdf\n",
    "        | show[\\s_-]*pdf\n",
    "        | get[\\s_-]*pdf\n",
    "        | pdf[\\s_-]*download\n",
    "        | primary[\\s_-]*document\n",
    "        | main[\\s_-]*article\n",
    "        | publication[\\s_-]*file\n",
    "        | document[\\s_-]*view\n",
    "        | article[\\s_-]*file\n",
    "        | content[\\s_-]*pdf\n",
    "        | view[\\s_-]*full[\\s_-]*text\n",
    "        | citation[\\s_-]*pdf[\\s_-]*url\n",
    "    )\n",
    "    \"\"\",\n",
    "    re.I\n",
    ")\n",
    "    wiley_token = os.getenv(\"wiley_api_token\")\n",
    "\n",
    "    class CantDownload(RuntimeError):\n",
    "        pass\n",
    "\n",
    "    def __init__(self, *, headers: Optional[dict] = None, timeout: int = 30):\n",
    "        self.headers = headers or {\"User-Agent\": \"Mozilla/5.0 (easy-pdf-resolver/1.2)\"}\n",
    "        self.timeout = timeout\n",
    "        self._client: Optional[httpx.AsyncClient] = None\n",
    "\n",
    "    async def __aenter__(self):\n",
    "        self._client = httpx.AsyncClient(headers=self.headers, follow_redirects=True, timeout=self.timeout)\n",
    "        return self\n",
    "\n",
    "    async def __aexit__(self, exc_type, exc, tb):\n",
    "        if self._client:\n",
    "            await self._client.aclose()\n",
    "            self._client = None\n",
    "\n",
    "    def _client_required(self) -> httpx.AsyncClient:\n",
    "        if self._client is None:\n",
    "            self._client = httpx.AsyncClient(headers=self.headers, follow_redirects=True, timeout=self.timeout)\n",
    "        return self._client\n",
    "\n",
    "    async def get_pdf(self, doi: str) -> str:\n",
    "        client = self._client_required()\n",
    "        landing = str((await client.get(f\"https://doi.org/{doi}\")).url)\n",
    "\n",
    "        if self._SPRINGER_HOST in landing:\n",
    "            for url in self._springer_candidates(landing, doi):\n",
    "                if await self._is_pdf(url):\n",
    "                    return url\n",
    "\n",
    "        if self._HINDAWI_DOWNLOAD_RE.match(landing) or self._HINDAWI_LANDING_RE.match(landing):\n",
    "            for url in (landing, f\"https://doi.org/{doi}\"):\n",
    "                if await self._is_pdf(url):\n",
    "                    return url\n",
    "\n",
    "        if self._F1000_HOST_RE.match(landing):\n",
    "            api_pdf = await self._f1000_pdf(landing, doi)\n",
    "            if api_pdf and await self._is_pdf(api_pdf):\n",
    "                return api_pdf\n",
    "\n",
    "        if self._OUP_HOST_RE.match(landing):\n",
    "            oup_pdf = await self._oup_pdf(landing)\n",
    "            if oup_pdf:\n",
    "                return oup_pdf\n",
    "            \n",
    "        if \"onlinelibrary.wiley.com\" in landing:\n",
    "            wiley_pdf = await self._wiley_pdf(landing, doi)\n",
    "            if wiley_pdf:\n",
    "                return wiley_pdf\n",
    "        \n",
    "        html = (await client.get(landing)).text\n",
    "        anchor = self._extract_anchor_pdf_score(html, landing)\n",
    "        if anchor:\n",
    "            return anchor\n",
    "\n",
    "        cr_pdf = self._crossref_fallback(doi)\n",
    "        if cr_pdf:\n",
    "            return cr_pdf\n",
    "        \n",
    "        browser_pdf = await self.fetch_pdf_with_browser(doi)\n",
    "        if browser_pdf:\n",
    "            return browser_pdf\n",
    "        \n",
    "\n",
    "        raise self.CantDownload(f\"Cant Downlaod  {doi} → {landing}\")\n",
    "\n",
    "    async def _springer_candidates(self, landing: str, doi: str) -> List[str]:\n",
    "        base = f\"https://{self._SPRINGER_HOST}\"\n",
    "        candidates = [f\"{base}/content/pdf/{doi}.pdf\"]\n",
    "        if landing.endswith((\"fulltext.html\", \"fulltext.htm\")):\n",
    "            candidates.append(landing.rsplit(\"/\", 1)[0] + \".pdf\")\n",
    "        elif landing.endswith(\".html\"):\n",
    "            candidates.append(landing[:-5] + \".pdf\")\n",
    "        elif \"/article/\" in landing and not landing.endswith(\".pdf\"):\n",
    "            candidates.append(landing + \".pdf\")\n",
    "        return candidates\n",
    "\n",
    "    async def _f1000_pdf(self, landing: str, doi: str) -> Optional[str]:\n",
    "        client = self._client_required()\n",
    "        article_id = doi.split(\"/\")[-1]\n",
    "        host = urllib.parse.urlparse(landing).hostname\n",
    "        api_url = f\"https://api.{host}/article/{article_id}\"\n",
    "        try:\n",
    "            r = await client.get(api_url)\n",
    "            r.raise_for_status()\n",
    "            return r.json()[\"data\"][\"pdf_url\"]\n",
    "        except Exception:\n",
    "            return None\n",
    "\n",
    "    async def _oup_pdf(self, landing: str) -> Optional[str]:\n",
    "        client = self._client_required()\n",
    "        html = (await client.get(landing)).text\n",
    "        meta = self._extract_meta_pdf(html)\n",
    "        if meta:\n",
    "            return meta\n",
    "        anchor = self._extract_anchor_pdf(html, landing)\n",
    "        return anchor\n",
    "\n",
    "    async def _wiley_pdf(self , landing:str , doi:str) -> Optional[str]:\n",
    "        client = self._client_required()\n",
    "        \n",
    "        #1 TDM Api\n",
    "        api_url = f\"https://api.wiley.com/tdm/v1/articles?{doi}/pdf\"\n",
    "        r = await client.get(\n",
    "            api_url,\n",
    "            headers= {\"Authorization\": f\"Bearer {self.wiley_token}\"})\n",
    "        print(f\"[Wiley] API status: {r.status_code}, content-type: {r.headers.get('content-type')}\")\n",
    "        print(f\"[Wiley] Token present? {'yes' if self.wiley_token else 'no'}\")\n",
    "        \n",
    "        if r.status_code == 200 and r.headers.get(\"content-type\", \"\").startswith(\"application/pdf\"):\n",
    "            return api_url\n",
    "        \n",
    "        #pdfdirect \n",
    "        \n",
    "        pdf_url = f\"https://onlinelibrary.wiley.com/doi/pdfdirect/{doi}\"\n",
    "        r2 = await client.get(pdf_url)\n",
    "        if r2.status_code == 200 and r2.headers.get(\"content-type\", \"\").startswith(\"application/pdf\"):\n",
    "            return pdf_url\n",
    "        \n",
    "        #htmlparse \n",
    "        \n",
    "        html = (await client.get(landing)).text\n",
    "        soup = BeautifulSoup(html, \"html.parser\")\n",
    "        btn = soup.find(\"a\", class_=\"pdf-download-link\", href=True)\n",
    "        if btn:\n",
    "            return urllib.parse.urljoin(landing, btn[\"href\"])\n",
    "        return None \n",
    "    \n",
    "    async def _tand_pdf(self , landing:str , doi:str) -> Optional[str]:\n",
    "        client = self._client_required()\n",
    "        \n",
    "        #direct pdf endpoint \n",
    "        \n",
    "        pdf_endpoint = f\"https://www.tandfonline.com/doi/pdf/{doi}\"\n",
    "        resp = await client.get(pdf_endpoint)\n",
    "        if resp.status_code == 200 and resp.headers.get(\"content-type\", \"\").startswith(\"application/pdf\"):\n",
    "            return pdf_endpoint\n",
    "        \n",
    "        #meta tag\n",
    "        html = (await client.get(landing)).text\n",
    "        if (meta:= self._extract_meta_pdf(html)):\n",
    "            return urllib.parse.urljoin(landing, meta)\n",
    "        \n",
    "        if (anchor := self._extract_anchor_pdf(html, landing)):\n",
    "            return anchor\n",
    "        return None\n",
    "        \n",
    "    async def _sage_pdf(self, landing: str, doi: str) -> Optional[str]:\n",
    "        client = self._client_required()\n",
    "        \n",
    "        #pdf endpoint\n",
    "        \n",
    "        pdf_url = f\"https://journals.sagepub.com/doi/pdf/{doi}\"\n",
    "        r = await client.get(pdf_url)\n",
    "        if r.status_code == 200 and r.headers.get(\"content-type\", \"\").startswith(\"application/pdf\"):\n",
    "            return pdf_url\n",
    "        \n",
    "        html = (await client.get(landing)).text\n",
    "        if (meta:= self._extract_meta_pdf(html)):\n",
    "            return urllib.parse.urljoin(landing, meta)\n",
    "        \n",
    "        if (anchor := self._extract_anchor_pdf(html, landing)):\n",
    "            return anchor\n",
    "        return None\n",
    "        \n",
    "        \n",
    "    async def _karger_pdf(self, landing: str, doi: str) -> Optional[str]:\n",
    "        clinet = self._client_required()\n",
    "        \n",
    "        #must get article id \n",
    "        \n",
    "        html = (await clinet.get(landing)).text\n",
    "        soup = BeautifulSoup(html, \"html.parser\")\n",
    "        tag = soup.find(\"meta\", attrs={\"name\": \"dc.identifier\"})\n",
    "        if not tag or not tag.get(\"data-article-id\"):\n",
    "            return None\n",
    "        article_id = tag[\"data-article-id\"]\n",
    "        return f\"https://www.karger.com/Article/Pdf/{article_id}\"\n",
    "       \n",
    "    async def _is_pdf(self, url: str) -> bool:\n",
    "        client = self._client_required()\n",
    "        try:\n",
    "            r = await client.head(url)\n",
    "            if r.status_code in (403, 405):\n",
    "                r = await client.get(url, headers={\"Range\": \"bytes=0-0\"})\n",
    "            return r.status_code == 200 and r.headers.get(\"content-type\", \"\").startswith(\"application/pdf\")\n",
    "        except Exception:\n",
    "            return False\n",
    "\n",
    "    @staticmethod\n",
    "    def _extract_meta_pdf(html: str) -> Optional[str]:\n",
    "        tag = BeautifulSoup(html, \"html.parser\").find(\"meta\", attrs={\"name\": \"citation_pdf_url\"})\n",
    "        return tag[\"content\"].strip() if tag and tag.get(\"content\") else None\n",
    "\n",
    "    def _extract_anchor_pdf(self, html: str, base_url: str) -> Optional[str]:\n",
    "        soup = BeautifulSoup(html, \"html.parser\")\n",
    "        join = lambda h: urllib.parse.urljoin(base_url, h)\n",
    "        for a in soup.find_all(\"a\", href=True):\n",
    "            href = a[\"href\"].strip()\n",
    "            lower = href.lower()\n",
    "            full_url = join(href)\n",
    "            if lower.endswith(\".pdf\") or \"/article-pdf/\" in lower or \"/advance-article-pdf/\" in lower:\n",
    "                return full_url\n",
    "            text = a.get_text(\" \").lower()\n",
    "            cls = \" \".join(a.get(\"class\", [])).lower()\n",
    "            ident = a.get(\"id\", \"\").lower()\n",
    "            if \"download pdf\" in text or self._ANCHOR_HINT_RE.search(cls) or self._ANCHOR_HINT_RE.search(ident):\n",
    "                return full_url\n",
    "        return None\n",
    "    \n",
    "    def _extract_anchor_pdf_score(self, html: str, base_url: str) -> Optional[str]:\n",
    "        soup = BeautifulSoup(html, \"html.parser\")\n",
    "        join = lambda h: urllib.parse.urljoin(base_url, h)\n",
    "        best = None\n",
    "\n",
    "        for a in soup.find_all(\"a\", href=True):\n",
    "            href = a[\"href\"].strip()\n",
    "            lower = href.lower()\n",
    "            full_url = join(href)\n",
    "\n",
    "            text = a.get_text(\" \").lower()\n",
    "            cls = \" \".join(a.get(\"class\", [])).lower()\n",
    "            ident = a.get(\"id\", \"\").lower()\n",
    "            title = a.get(\"title\", \"\").lower()\n",
    "            aria = a.get(\"aria-label\", \"\").lower()\n",
    "\n",
    "            score = 0\n",
    "            if lower.endswith(\".pdf\"):\n",
    "                score += 3\n",
    "            if \"/article-pdf/\" in lower or \"/advance-article-pdf/\" in lower:\n",
    "                score += 2\n",
    "            if \"pdf\" in text:\n",
    "                score += 2\n",
    "            if re.search(self._ANCHOR_HINT_RE, cls) or re.search(self._ANCHOR_HINT_RE, ident):\n",
    "                score += 1\n",
    "            if \"full text\" in text or \"read article\" in text:\n",
    "                score += 1\n",
    "            if \"pdf\" in title or \"pdf\" in aria:\n",
    "                score += 1\n",
    "\n",
    "            if score >= 3:  # only consider fairly confident ones\n",
    "                return full_url\n",
    "            elif not best and score > 0:\n",
    "                best = full_url\n",
    "\n",
    "        return best\n",
    "    @staticmethod\n",
    "    def _crossref_fallback(doi: str) -> Optional[str]:\n",
    "        try:\n",
    "            r = requests.get(f\"https://api.crossref.org/works/{doi}\", timeout=15)\n",
    "            r.raise_for_status()\n",
    "            data = r.json()\n",
    "        except Exception:\n",
    "            return None\n",
    "        links = data.get(\"message\", {}).get(\"link\", [])\n",
    "        best = None\n",
    "        for link in links:\n",
    "            ct = link.get(\"content-type\")\n",
    "            url = link.get(\"URL\")\n",
    "            if ct == \"text/html\":\n",
    "                return url\n",
    "            if ct == \"application/pdf\" and best is None:\n",
    "                best = url\n",
    "            if url and url.endswith(\".pdf\") and best is None:\n",
    "                best = url\n",
    "        return best\n",
    "    \n",
    "    async def fetch_pdf_with_browser(self ,doi: str) -> Optional[str]:\n",
    "        EZPROXY_PREFIX = \"https://ezproxy.lib.ucalgary.ca/login?url=\"\n",
    "        JOURNAL_PDF_SELECTORS = {\n",
    "        \"bmj.com\": 'a[title=\"Download this article as a PDF\"]',\n",
    "        \"thelancet.com\": 'a.download-pdf-link',\n",
    "        \"nejm.org\": 'a[href*=\"pdf\"]',\n",
    "        \"sciencedirect.com\": 'a.pdf-download',\n",
    "        \"jamanetwork.com\": 'a[href*=\"/pdf\"]',\n",
    "        \"nature.com\": 'a[data-track-action=\"download pdf\"]',\n",
    "        \"springer.com\": 'a[href$=\".pdf\"]',\n",
    "        \"oup.com\": 'a[href$=\".pdf\"]',\n",
    "        \"frontiersin.org\": 'a.article-pdf-download',\n",
    "        \"tandfonline.com\": 'a[href*=\"/pdf\"]',\n",
    "        \"sagepub.com\": 'a.article-tools-download',\n",
    "        \"karger.com\": 'a[href$=\".pdf\"]',\n",
    "        # Add more as needed...\n",
    "    }\n",
    "        USER_AGENTS = [\n",
    "    \"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0 Safari/537.36\",\n",
    "    \"Mozilla/5.0 (Macintosh; Intel Mac OS X 13_4) AppleWebKit/605.1.15 (KHTML, like Gecko) Version/17.4 Safari/605.1.15\",\n",
    "    \"Mozilla/5.0 (X11; Linux x86_64) Gecko/20100101 Firefox/125.0\",\n",
    "]\n",
    "        client = self._client_required()\n",
    "        landing_url = str((await client.get(f\"https://doi.org/{doi}\")).url)\n",
    "        proxied_url = EZPROXY_PREFIX + quote(landing_url, safe=\"\")\n",
    "        domain = urlparse(landing_url).netloc\n",
    "\n",
    "        username = os.getenv(\"uni_username\")\n",
    "        password = os.getenv(\"uni_password\")\n",
    "        if not username or not password:\n",
    "            raise RuntimeError(\"Missing EZProxy credentials.\")\n",
    "\n",
    "        async with async_playwright() as p:\n",
    "            browser = await p.chromium.launch(\n",
    "                headless=True, \n",
    "                args=[ \"--disable-blink-features=AutomationControlled\",\n",
    "                    \"--disable-web-security\",\n",
    "                    \"--no-sandbox\",\n",
    "                    \"--disable-gpu\"\n",
    "                ])\n",
    "            context = await browser.new_context(user_agent=random.choice(USER_AGENTS))\n",
    "            page = await context.new_page()\n",
    "\n",
    "            # EZProxy login page\n",
    "            if \"login\" in page.url.lower():\n",
    "                await page.goto(proxied_url)\n",
    "                await page.fill('input[name=\"user\"]', username)\n",
    "                await page.fill('input[name=\"pass\"]', password)\n",
    "                await page.click('input[type=\"submit\"]')\n",
    "                await page.wait_for_load_state(\"networkidle\")\n",
    "\n",
    "            # Journal-specific selector\n",
    "            selector = JOURNAL_PDF_SELECTORS.get(domain)\n",
    "            if selector:\n",
    "                try:\n",
    "                    await page.wait_for_selector(selector, timeout=5000)\n",
    "                    pdf_link = await page.locator(selector).get_attribute(\"href\")\n",
    "                    if pdf_link:\n",
    "                        return urljoin(page.url, pdf_link)\n",
    "                except Exception:\n",
    "                    pass  # fallback to anchor hint matching\n",
    "\n",
    "            # Fallback using _ANCHOR_HINT_RE\n",
    "            html = await page.content()\n",
    "            soup = BeautifulSoup(html, \"html.parser\")\n",
    "            for a in soup.find_all(\"a\", href=True):\n",
    "                href = a[\"href\"].strip()\n",
    "                text = a.get_text(\" \").lower()\n",
    "                cls = \" \".join(a.get(\"class\", [])).lower()\n",
    "                id_ = a.get(\"id\", \"\").lower()\n",
    "                title = a.get(\"title\", \"\").lower()\n",
    "                aria = a.get(\"aria-label\", \"\").lower()\n",
    "\n",
    "                if (\n",
    "                    href.lower().endswith(\".pdf\") or\n",
    "                    _ANCHOR_HINT_RE.search(text) or\n",
    "                    _ANCHOR_HINT_RE.search(href) or\n",
    "                    _ANCHOR_HINT_RE.search(cls) or\n",
    "                    _ANCHOR_HINT_RE.search(id_) or\n",
    "                    _ANCHOR_HINT_RE.search(title) or\n",
    "                    _ANCHOR_HINT_RE.search(aria)\n",
    "                ):\n",
    "                    return urljoin(page.url, href)\n",
    "\n",
    "            return None\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "def resolve_pmcid_from_doi(doi: str, email: str = \"you@example.com\") -> Optional[str]:\n",
    "    \"\"\"Convert DOI to PMCID using NCBI ID Converter API.\"\"\"\n",
    "    url = f\"https://www.ncbi.nlm.nih.gov/pmc/utils/idconv/v1.0/?tool=biorxiv-utils&email={email}&ids={doi}\"\n",
    "    try:\n",
    "        resp = requests.get(url, timeout=15)\n",
    "        resp.raise_for_status()\n",
    "        match = re.search(r'pmcid=\"(PMC[0-9]+)\"', resp.text)\n",
    "        return match.group(1) if match else None\n",
    "    except Exception as e:\n",
    "        print(f\"❌ DOI to PMCID resolution failed: {e}\")\n",
    "        return None\n",
    "\n",
    "def fetch_pmc_pdf(pmcid: str) -> Optional[bytes]:\n",
    "    # url = f\"https://www.ncbi.nlm.nih.gov/pmc/articles/{pmcid}/pdf\"\n",
    "    # url = f\"https://pmc.ncbi.nlm.nih.gov/articles/{pmcid}/pdf\"\n",
    "    # url = f\"https://www-ncbi-nlm-nih-gov.ezproxy.lib.ucalgary.ca/research/bionlp/RESTful/pmcoa.cgi/BioC_json/{pmcid}/unicode\"\n",
    "    url = f\"https://www-ncbi-nlm-nih-gov.ezproxy.lib.ucalgary.ca/pmc/articles/{pmcid}/pdf\"\n",
    "\n",
    "    \n",
    "\n",
    "    try:\n",
    "        with httpx.Client( verify= False, timeout=60,follow_redirects=True) as client:\n",
    "            response = client.get(url.strip())\n",
    "            response.raise_for_status()\n",
    "            return response.content\n",
    "    except Exception as e:\n",
    "        print(f\"❌ Failed to fetch PMC PDF: {e}\")\n",
    "        return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "import httpx\n",
    "import xml.etree.ElementTree as ET\n",
    "from typing import Optional\n",
    "\n",
    "def extract_isrctn_from_doi(doi: str) -> Optional[str]:\n",
    "    \"\"\"\n",
    "    Extract the ISRCTN number from a DOI like \"10.1186/isrctn04296019\".\n",
    "    \"\"\"\n",
    "    if \"isrctn\" in doi.lower():\n",
    "        return doi.lower().split(\"isrctn\")[-1]\n",
    "    return None\n",
    "\n",
    "def fetch_isrctn_trial_data(doi: str, format_: str = \"who\") -> Optional[dict]:\n",
    "    \"\"\"\n",
    "    Fetch ISRCTN trial data given a DOI containing an ISRCTN number.\n",
    "\n",
    "    Args:\n",
    "        doi: The DOI containing the ISRCTN, e.g. \"10.1186/isrctn04296019\"\n",
    "        format_: One of \"default\", \"ukctg\", or \"who\"\n",
    "\n",
    "    Returns:\n",
    "        A dictionary of parsed trial data, or None if not found or failed.\n",
    "    \"\"\"\n",
    "    isrctn = extract_isrctn_from_doi(doi)\n",
    "    if not isrctn:\n",
    "        print(\"❌ ISRCTN not found in DOI\")\n",
    "        return None\n",
    "\n",
    "    url = f\"https://www.isrctn.com/api/trial/{isrctn}/format/{format_}\"\n",
    "    try:\n",
    "        r = httpx.get(url, timeout=15)\n",
    "        r.raise_for_status()\n",
    "    except httpx.RequestError as e:\n",
    "        print(f\"❌ HTTP error: {e}\")\n",
    "        return None\n",
    "\n",
    "    try:\n",
    "        root = ET.fromstring(r.text)\n",
    "        return {elem.tag: elem.text for elem in root.iter() if elem.text}\n",
    "    except ET.ParseError:\n",
    "        print(\"❌ Failed to parse XML\")\n",
    "        return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_dois = [\n",
    "    \"10.3390/jcm8081218\" # Hindawi OA\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "trial_info = fetch_isrctn_trial_data(test_dois[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "ename": "CantDownload",
     "evalue": "Cant Downlaod  10.3390/jcm8081218 → https://www.mdpi.com/2077-0383/8/8/1218",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mCantDownload\u001b[39m                              Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[20]\u001b[39m\u001b[32m, line 3\u001b[39m\n\u001b[32m      1\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpprint\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m pprint\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m EasyPDFResolver() \u001b[38;5;28;01mas\u001b[39;00m r:\n\u001b[32m----> \u001b[39m\u001b[32m3\u001b[39m     pdf_url = \u001b[38;5;28;01mawait\u001b[39;00m r.get_pdf(test_dois[\u001b[32m0\u001b[39m])\n\u001b[32m      4\u001b[39m     pprint(pdf_url)\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[7]\u001b[39m\u001b[32m, line 102\u001b[39m, in \u001b[36mEasyPDFResolver.get_pdf\u001b[39m\u001b[34m(self, doi)\u001b[39m\n\u001b[32m     98\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m browser_pdf:\n\u001b[32m     99\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m browser_pdf\n\u001b[32m--> \u001b[39m\u001b[32m102\u001b[39m \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;28mself\u001b[39m.CantDownload(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mCant Downlaod  \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mdoi\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m → \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mlanding\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m)\n",
      "\u001b[31mCantDownload\u001b[39m: Cant Downlaod  10.3390/jcm8081218 → https://www.mdpi.com/2077-0383/8/8/1218"
     ]
    }
   ],
   "source": [
    "from pprint import pprint\n",
    "async with EasyPDFResolver() as r:\n",
    "    pdf_url = await r.get_pdf(test_dois[0])\n",
    "    pprint(pdf_url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "paper_info = get_info_from_doi(\"10.1093/rheumatology/keab153\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'doi': '10.1093/rheumatology/keab153',\n",
       " 'title': 'Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)',\n",
       " 'document_link': 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab153/36643438/keab153.pdf'}"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "paper_info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from playwright.async_api import async_playwright\n",
    "import asyncio\n",
    "import os\n",
    "from typing import Optional\n",
    "from urllib.parse import quote , urlparse , urljoin\n",
    "import httpx \n",
    "\n",
    "\n",
    "\n",
    "async def fetch_pdf_with_browser(doi: str) -> Optional[str]:\n",
    "    EZPROXY_PREFIX = \"https://ezproxy.lib.ucalgary.ca/login?url=\"\n",
    "    JOURNAL_PDF_SELECTORS = {\n",
    "    \"bmj.com\": 'a[title=\"Download this article as a PDF\"]',\n",
    "    \"thelancet.com\": 'a.download-pdf-link',\n",
    "    \"nejm.org\": 'a[href*=\"pdf\"]',\n",
    "    \"sciencedirect.com\": 'a.pdf-download',\n",
    "    \"jamanetwork.com\": 'a[href*=\"/pdf\"]',\n",
    "    \"nature.com\": 'a[data-track-action=\"download pdf\"]',\n",
    "    \"springer.com\": 'a[href$=\".pdf\"]',\n",
    "    \"oup.com\": 'a[href$=\".pdf\"]',\n",
    "    \"frontiersin.org\": 'a.article-pdf-download',\n",
    "    \"tandfonline.com\": 'a[href*=\"/pdf\"]',\n",
    "    \"sagepub.com\": 'a.article-tools-download',\n",
    "    \"karger.com\": 'a[href$=\".pdf\"]',\n",
    "    # Add more as needed...\n",
    "}\n",
    "\n",
    "    client = self._client_required()\n",
    "    landing_url = str((await client.get(f\"https://doi.org/{doi}\")).url)\n",
    "    proxied_url = EZPROXY_PREFIX + quote(landing_url, safe=\"\")\n",
    "    domain = urlparse(landing_url).netloc\n",
    "\n",
    "    username = os.getenv(\"uni_username\")\n",
    "    password = os.getenv(\"uni_password\")\n",
    "    if not username or not password:\n",
    "        raise RuntimeError(\"Missing EZProxy credentials.\")\n",
    "\n",
    "    async with async_playwright() as p:\n",
    "        browser = await p.chromium.launch(headless=True)\n",
    "        context = await browser.new_context()\n",
    "        page = await context.new_page()\n",
    "\n",
    "        # EZProxy login page\n",
    "        if \"login\" in page.url.lower():\n",
    "            await page.goto(proxied_url)\n",
    "            await page.fill('input[name=\"user\"]', username)\n",
    "            await page.fill('input[name=\"pass\"]', password)\n",
    "            await page.click('input[type=\"submit\"]')\n",
    "            await page.wait_for_load_state(\"networkidle\")\n",
    "\n",
    "        # Journal-specific selector\n",
    "        selector = JOURNAL_PDF_SELECTORS.get(domain)\n",
    "        if selector:\n",
    "            try:\n",
    "                await page.wait_for_selector(selector, timeout=5000)\n",
    "                pdf_link = await page.locator(selector).get_attribute(\"href\")\n",
    "                if pdf_link:\n",
    "                    return urljoin(page.url, pdf_link)\n",
    "            except Exception:\n",
    "                pass  # fallback to anchor hint matching\n",
    "\n",
    "        # Fallback using _ANCHOR_HINT_RE\n",
    "        html = await page.content()\n",
    "        soup = BeautifulSoup(html, \"html.parser\")\n",
    "        for a in soup.find_all(\"a\", href=True):\n",
    "            href = a[\"href\"].strip()\n",
    "            text = a.get_text(\" \").lower()\n",
    "            cls = \" \".join(a.get(\"class\", [])).lower()\n",
    "            id_ = a.get(\"id\", \"\").lower()\n",
    "            title = a.get(\"title\", \"\").lower()\n",
    "            aria = a.get(\"aria-label\", \"\").lower()\n",
    "\n",
    "            if (\n",
    "                href.lower().endswith(\".pdf\") or\n",
    "                ANCHOR_HINT_RE.search(text) or\n",
    "                ANCHOR_HINT_RE.search(href) or\n",
    "                ANCHOR_HINT_RE.search(cls) or\n",
    "                ANCHOR_HINT_RE.search(id_) or\n",
    "                ANCHOR_HINT_RE.search(title) or\n",
    "                ANCHOR_HINT_RE.search(aria)\n",
    "            ):\n",
    "                return urljoin(page.url, href)\n",
    "\n",
    "        return None\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "ename": "TimeoutError",
     "evalue": "Page.fill: Timeout 30000ms exceeded.\nCall log:\n  - waiting for locator(\"input[name=\\\"user\\\"]\")\n",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mTimeoutError\u001b[39m                              Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[70]\u001b[39m\u001b[32m, line 3\u001b[39m\n\u001b[32m      1\u001b[39m doi = \u001b[33m\"\u001b[39m\u001b[33m10.1038/srep40473\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m      2\u001b[39m landing = \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mhttps://doi.org/\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mdoi\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m3\u001b[39m pdf_link = \u001b[38;5;28;01mawait\u001b[39;00m fetch_pdf_with_browser(landing)\n\u001b[32m      4\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33mPDF Link:\u001b[39m\u001b[33m\"\u001b[39m, pdf_link)\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[65]\u001b[39m\u001b[32m, line 43\u001b[39m, in \u001b[36mfetch_pdf_with_browser\u001b[39m\u001b[34m(landing_url)\u001b[39m\n\u001b[32m     41\u001b[39m \u001b[38;5;66;03m# Login if prompted\u001b[39;00m\n\u001b[32m     42\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[33m\"\u001b[39m\u001b[33mlogin\u001b[39m\u001b[33m\"\u001b[39m \u001b[38;5;129;01min\u001b[39;00m page.url.lower():\n\u001b[32m---> \u001b[39m\u001b[32m43\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m page.fill(\u001b[33m'\u001b[39m\u001b[33minput[name=\u001b[39m\u001b[33m\"\u001b[39m\u001b[33muser\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m]\u001b[39m\u001b[33m'\u001b[39m, username)\n\u001b[32m     44\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m page.fill(\u001b[33m'\u001b[39m\u001b[33minput[name=\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mpass\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m]\u001b[39m\u001b[33m'\u001b[39m, password)\n\u001b[32m     45\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m page.click(\u001b[33m'\u001b[39m\u001b[33minput[type=\u001b[39m\u001b[33m\"\u001b[39m\u001b[33msubmit\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m]\u001b[39m\u001b[33m'\u001b[39m)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/playwright/async_api/_generated.py:10075\u001b[39m, in \u001b[36mPage.fill\u001b[39m\u001b[34m(self, selector, value, timeout, no_wait_after, strict, force)\u001b[39m\n\u001b[32m  10031\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mfill\u001b[39m(\n\u001b[32m  10032\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m  10033\u001b[39m     selector: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m  10039\u001b[39m     force: typing.Optional[\u001b[38;5;28mbool\u001b[39m] = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m  10040\u001b[39m ) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m  10041\u001b[39m \u001b[38;5;250m    \u001b[39m\u001b[33;03m\"\"\"Page.fill\u001b[39;00m\n\u001b[32m  10042\u001b[39m \n\u001b[32m  10043\u001b[39m \u001b[33;03m    This method waits for an element matching `selector`, waits for [actionability](https://playwright.dev/python/docs/actionability) checks,\u001b[39;00m\n\u001b[32m   (...)\u001b[39m\u001b[32m  10071\u001b[39m \u001b[33;03m        Whether to bypass the [actionability](../actionability.md) checks. Defaults to `false`.\u001b[39;00m\n\u001b[32m  10072\u001b[39m \u001b[33;03m    \"\"\"\u001b[39;00m\n\u001b[32m  10074\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m mapping.from_maybe_impl(\n\u001b[32m> \u001b[39m\u001b[32m10075\u001b[39m         \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._impl_obj.fill(\n\u001b[32m  10076\u001b[39m             selector=selector,\n\u001b[32m  10077\u001b[39m             value=value,\n\u001b[32m  10078\u001b[39m             timeout=timeout,\n\u001b[32m  10079\u001b[39m             noWaitAfter=no_wait_after,\n\u001b[32m  10080\u001b[39m             strict=strict,\n\u001b[32m  10081\u001b[39m             force=force,\n\u001b[32m  10082\u001b[39m         )\n\u001b[32m  10083\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/playwright/_impl/_page.py:866\u001b[39m, in \u001b[36mPage.fill\u001b[39m\u001b[34m(self, selector, value, timeout, noWaitAfter, strict, force)\u001b[39m\n\u001b[32m    857\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mfill\u001b[39m(\n\u001b[32m    858\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m    859\u001b[39m     selector: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m    864\u001b[39m     force: \u001b[38;5;28mbool\u001b[39m = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m    865\u001b[39m ) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m866\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._main_frame.fill(**locals_to_params(\u001b[38;5;28mlocals\u001b[39m()))\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/playwright/_impl/_frame.py:527\u001b[39m, in \u001b[36mFrame.fill\u001b[39m\u001b[34m(self, selector, value, timeout, noWaitAfter, strict, force)\u001b[39m\n\u001b[32m    518\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mfill\u001b[39m(\n\u001b[32m    519\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m    520\u001b[39m     selector: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m    525\u001b[39m     force: \u001b[38;5;28mbool\u001b[39m = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m    526\u001b[39m ) -> \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m527\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._channel.send(\u001b[33m\"\u001b[39m\u001b[33mfill\u001b[39m\u001b[33m\"\u001b[39m, locals_to_params(\u001b[38;5;28mlocals\u001b[39m()))\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/playwright/_impl/_connection.py:61\u001b[39m, in \u001b[36mChannel.send\u001b[39m\u001b[34m(self, method, params)\u001b[39m\n\u001b[32m     60\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34msend\u001b[39m(\u001b[38;5;28mself\u001b[39m, method: \u001b[38;5;28mstr\u001b[39m, params: Dict = \u001b[38;5;28;01mNone\u001b[39;00m) -> Any:\n\u001b[32m---> \u001b[39m\u001b[32m61\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._connection.wrap_api_call(\n\u001b[32m     62\u001b[39m         \u001b[38;5;28;01mlambda\u001b[39;00m: \u001b[38;5;28mself\u001b[39m._inner_send(method, params, \u001b[38;5;28;01mFalse\u001b[39;00m),\n\u001b[32m     63\u001b[39m         \u001b[38;5;28mself\u001b[39m._is_internal_type,\n\u001b[32m     64\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/Research_Projects/rheumatology_llm/rheum_project/robust_py311/lib/python3.11/site-packages/playwright/_impl/_connection.py:528\u001b[39m, in \u001b[36mConnection.wrap_api_call\u001b[39m\u001b[34m(self, cb, is_internal)\u001b[39m\n\u001b[32m    526\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m cb()\n\u001b[32m    527\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mException\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m error:\n\u001b[32m--> \u001b[39m\u001b[32m528\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m rewrite_error(error, \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mparsed_st[\u001b[33m'\u001b[39m\u001b[33mapiName\u001b[39m\u001b[33m'\u001b[39m]\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00merror\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m    529\u001b[39m \u001b[38;5;28;01mfinally\u001b[39;00m:\n\u001b[32m    530\u001b[39m     \u001b[38;5;28mself\u001b[39m._api_zone.set(\u001b[38;5;28;01mNone\u001b[39;00m)\n",
      "\u001b[31mTimeoutError\u001b[39m: Page.fill: Timeout 30000ms exceeded.\nCall log:\n  - waiting for locator(\"input[name=\\\"user\\\"]\")\n"
     ]
    }
   ],
   "source": [
    "doi = \"10.1038/srep40473\"\n",
    "landing = f\"https://doi.org/{doi}\"\n",
    "# pdf_link = await fetch_pdf_with_browser(landing)\n",
    "# print(\"PDF Link:\", pdf_link)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "@retry(stop=stop_after_attempt(5), wait=wait_exponential(multiplier=1, min=2, max=20))\n",
    "async def get_biorxiv_pdf_link(article_url: str) -> Optional[str]:\n",
    "    pdf_url = article_url if article_url.endswith(\".full.pdf\") else f\"{article_url}.full.pdf\"\n",
    "    last_exc: Optional[Exception] = None\n",
    "\n",
    "    for hdr in _HEADERS_SETS:\n",
    "        try:\n",
    "            async with httpx.AsyncClient(headers=hdr, timeout=60, follow_redirects=True) as client:\n",
    "                resp = await client.get(pdf_url.strip())\n",
    "                resp.raise_for_status()\n",
    "\n",
    "                if resp.headers.get(\"Content-Type\", \"\").lower().startswith(\"application/pdf\"):\n",
    "                    return extract_pdf(resp.content)  # type: ignore[name-defined]\n",
    "\n",
    "                print(\"⚠️  Not a PDF response (content‑type:\", resp.headers.get(\"Content-Type\"), \")\")\n",
    "                return None\n",
    "\n",
    "        except httpx.HTTPStatusError as exc:\n",
    "            last_exc = exc\n",
    "            if exc.response.status_code in {403, 429}:\n",
    "                continue\n",
    "            raise\n",
    "        except Exception as exc:\n",
    "            last_exc = exc\n",
    "            raise\n",
    "\n",
    "    if last_exc:\n",
    "        raise last_exc\n",
    "\n",
    "    return None\n",
    "\n",
    "async def search_pubmed_by_abstract(abstract_text: str) -> Optional[str]:\n",
    "    search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "    params = {\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": abstract_text,\n",
    "        \"retmode\": \"json\",\n",
    "        \"retmax\": 1\n",
    "    }\n",
    "    async with httpx.AsyncClient(timeout=30) as client:\n",
    "        response = await client.get(search_url, params=params)\n",
    "        if response.status_code == 200:\n",
    "            data = response.json()\n",
    "            id_list = data.get(\"esearchresult\", {}).get(\"idlist\", [])\n",
    "            if id_list:\n",
    "                return id_list[0]  # return first PubMed ID\n",
    "    return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "paper_journal_info = \"../research_paper_database/paper_journal_info.csv\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['9263431', 'Tak PP; Balanescu A; Tseluyko V; Bojin S; Drescher E; Dairaghi D; Miao S; Marchesin V; Jaen J; Schall TJ; Bekker P. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Annals of the rheumatic diseases. (2013) 72 3 pp337-344', '10.1136/annrheumdis-2011-201605', '']\n",
      "['9262389', 'Fettner S; Mela C; Wildenhahn F; Tavanti M; Wells C; Mallalieu NL. Evaluation of a tocilizumab autoinjector: results of healthy volunteer bioequivalence and rheumatoid patient human factors studies. Clinical pharmacology and therapeutics. Conference: 119th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2018. United states. (2018) 103 Supplement 1 ppS78-S79', '10.1080/17425247.2019.1604678', 'https://tandfonline.com/doi/pdf/10.1080/17425247.2019.1604678']\n",
      "['11083831', 'Tanaka Yoshiya; Millson David; Iwata Shigeru; Nakayamada Shingo. Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study. Rheumatology (Oxford, England). (2021) 60 6 pp2884-2895', '10.1093/rheumatology/keaa732', 'http://academic.oup.com/rheumatology/article-pdf/60/6/2884/38695178/keaa732.pdf']\n",
      "['9736908', 'NCT00966875. A Study in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00966875. (2009)   pp', '10.1016/b978-032305475-1.50053-7', '']\n",
      "['9257373', \"Prior Y; Sutton C; Cotterill S; Adams J; Camacho E; Arafin N; Firth J; O'Neill T; Hough Y; Jones W; Hammond A. The effects of arthritis gloves on people with Rheumatoid Arthritis or Inflammatory Arthritis with hand pain: a study protocol for a multi-centre randomised controlled trial (the A-GLOVES trial). BMC musculoskeletal disorders. (2017) 18 1 pp224\", '10.1186/s12891-017-1583-4', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1583-4.pdf']\n",
      "['9261008', 'Sonomoto K; Yamaoka K; Kubo S; Hirata S; Fukuyo S; Maeshima K; Suzuki K; Saito K; Tanaka Y. Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events. Rheumatology (Oxford, England). (2014) 53 5 pp914-918', '10.1093/rheumatology/ket466', 'http://academic.oup.com/rheumatology/article-pdf/53/5/914/17388663/ket466.pdf']\n",
      "['11086181', 'Conaghan PG; Ostergaard M; Troum O; Xie Z; Brett A; Snyder M; Ebrahim A; Chapman D; Sawyerr G; Andrews J. Exploring novel tenosynovitis and combined inflammation imaging outcomes: results from a randomised controlled trial in early rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp450-451', '10.1136/annrheumdis-2021-eular.364', '']\n",
      "['9257590', 'Winthrop KL; Wouters A; Choy EH; Nduaka C; Abramsky S; Biswas P; Wang L; Hodge J; Lazariciu I; Soma K; Mojcik CF; Rigby WFC. The effectiveness of zoster vaccine in RA patients subsequently treated up to 19 months with tofacitinib. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3529-3531', '10.1136/annrheumdis-2017-eular.2437', '']\n",
      "['9261800', 'Winthrop IV K; Wouters A; Choy EH; Soma K; Hodge J; Nduaka C; Biswas P; McNeil LK; Passador S; Mojcik CF; Rigby WFC. Assessment of immunogenicity of live zoster vaccination (zostavax) in rheumatoid arthritis patients on background methotrexate before and after initiating tofacitinib or placebo. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1332', '']\n",
      "['9262391', 'Winthrop KL; Wouters A; Choy EH; Nduaka CI; Biswas P; Wang L; Hodge JA; Lazariciu I; Soma K; Mojcik CF; Rigby WFC. The effectiveness of zoster vaccine in patients subsequently treated with tofacitinib. American journal of gastroenterology. Conference: 82nd annual scientific meeting of the american college of gastroenterology. United states. (2017) 112 Supplement 1 ppS416-S417', '10.14309/00000434-201710001-00748', '']\n",
      "['9736957', 'Winthrop K; Wouters A; Choy E; Soma K; Hodge J; Nduaka C; Biswas P; McNeil L; Passador S; Mojcik C; Rigby W. Assessment of immunogenicity of live zoster vaccination in rheumatoid arthritis patients on background methotrexate before and after initiating tofacitinib or placebo. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp468', '10.1136/annrheumdis-2016-eular.1332', '']\n",
      "['9739459', 'Winthrop K; Wouters A; Choy E; Soma K; Hodge J; Nduaka C; Biswas P; McNeil L; Passador S; Mojcik C; Rigby W. Assessment of immunogenicity of live zoster vaccination in rheumatoid arthritis patients on background methotrexate before and after initiating tofacitinib or placebo. Annals of the rheumatic diseases. (2016) 75  pp468-', '10.1136/annrheumdis-2016-eular.1332', '']\n",
      "['11088719', '. AORTA - ABATON for RheumaToid Arthritis. . (2021)   pp', '10.53347/rid-89980', '']\n",
      "['9258302', 'Abe T; Takeuchi T; Miyasaka N; Hashimoto H; Kondo H; Ichikawa Y; Nagaya I. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. Journal of rheumatology. (2006) 33 1 pp37-44', '10.3109/9780203214237-61', '']\n",
      "['9257342', 'Naredo E; M√∂ller I; Acebes C; Batlle-Gualda E; Brito E; de Agust√≠n JJ; de Miguel E; Mart√≠nez A; Mayordomo L; Moragues C; Rej√≥n E; Rodr√≠guez A; Uson J; Garrido J. Three-dimensional volumetric ultrasonography. Does it improve reliabililty of musculoskeletal ultrasound?. Clinical and experimental rheumatology. (2010) 28 1 pp79-82', '10.3899/jrheum.121103', '']\n",
      "['9738406', 'EUCTR2018-004539-54-DE. Capability of Tofacitinib or Etanercept to accelerate clinical relevant dose reduction of non-steroidal anti-inflammatory drugs and treat-to-target guided minimization of intake of corticosteroids in patients with active Rheumatoid Arthrtis and an inadequate response to previous csDMARD therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-004539-54-DE. (2019)   pp', '10.1007/978-3-0348-7720-6_5', 'http://link.springer.com/content/pdf/10.1007/978-3-0348-7720-6_5.pdf']\n",
      "['9737803', 'NCT00774852. Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis. https://clinicaltrials.gov/show/NCT00774852. (2008)   pp', '10.1002/art.38790', '']\n",
      "['9256947', 'Genovese MC; Pacheco-Tena C; Covarrubias A; Leon G; Mysler E; Keiserman M; Valente RM; Nash P; Simon-Campos JA; Box J; Legerton CW; Nasonov E; Durez P; Elegbe A; Wong R; Li X; Banerjee S; Alten R. Longterm safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial. Journal of rheumatology. (2018) 45 8 pp1085-1092', '10.3899/jrheum.170344', '']\n",
      "['9257552', \"D'Agostino MA; Alten R; Mysler E; Le Bars M; Ye J; Murthy B; Heitzmann J; Vadanici R; Ferraccioli G. Body mass index does not affect response to subcutaneous or intravenous abatacept in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1960-1962\", '10.1093/rheumatology/kex062.215', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.215/19705854/kex062.215.pdf']\n",
      "['9260696', 'Genovese MC; Covarrubias A; Leon G; Mysler E; Keiserman M; Valente R; Nash P; Simon-Campos JA; Porawska W; Box J; Legerton C; Nasonov E; Durez P; Aranda R; Pappu R; Delaet I; Teng J; Alten R. Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate. Arthritis and rheumatism. (2011) 63 10 pp2854-2864', '10.1002/art.30463', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.30463']\n",
      "['9261015', 'Genovese MC; Tena CP; Covarrubias A; Leon G; Mysler E; Keiserman M; Valente R; Nash P; Simon-Campos JA; Box J; Legerton CW; Nasonov E; Durez P; Delaet I; Teng J; Alten R. Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial. Journal of rheumatology. (2014) 41 4 pp629-639', '10.3899/jrheum.130112', '']\n",
      "['9261159', 'Genovese MC; Cobos AC; Leon G; Mysler EF; Keiserman MW; Valente RM; Nash PT; Campos JAS; Porawska W; Box JH; Legerton III CW; Nasonov EL; Durez P; Pappu R; Delaet I; Teng J; Alten R. Subcutaneous abatacept versus intravenous abatacept in patients with rheumatoid arthritis: Long-term data from the acquire trial. Rheumatology (United Kingdom). (2012) 51  ppiii128-iii129', '10.1002/art.30463', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.30463']\n",
      "['9261206', 'Genovese MC; Cobos AC; Leon G; Mysler EF; Keiserman MW; Valente RM; Nash PT. Subcutaneous (SC) abatacept (ABA) versus intravenous (IV) ABA in patients (PTS) with rheumatoid arthritis: Long-term data from the acquire (abatacept comparison of subqucutaneous versus intravenous in inadequate responders to methotrexate) trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.30463', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.30463']\n",
      "['9263633', \"D'Agostino MA; Alten R; Mysler E; Le Bars M; Ye J; Murthy B; Heitzmann J; Vadanici R; Ferraccioli G. Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis. Clinical rheumatology. (2017) 36 12 pp2655-2665\", '10.1007/s10067-017-3788-1', 'http://link.springer.com/article/10.1007/s10067-017-3788-1/fulltext.html']\n",
      "['9738603', \"D'Agostino MA; Alten R; Mysler E; Le Bars M; Ye J; Murthy B; Heitzmann J; Vadanici R; Ferraccioli G. Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis. Clinical rheumatology. (2017) 36 12 pp2655-2665\", '10.1007/s10067-017-3788-1', 'http://link.springer.com/article/10.1007/s10067-017-3788-1/fulltext.html']\n",
      "['9738687', 'Genovese Mark C; Pacheco-Tena Cesar; Covarrubias Arturo; Leon Gustavo; Mysler Eduardo; Keiserman Mauro; Valente Robert M; Nash Peter; Simon-Campos J Abraham; Box Jane; Legerton Clarence W 3rd; Nasonov Evgeny; Durez Patrick; Elegbe Ayanbola; Wong Robert; Li Xiaohui; Banerjee Subhashis; Alten Rieke. Longterm safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial. Journal of rheumatology. (2018) 45 8 pp1085-1092', '10.3899/jrheum.170344', '']\n",
      "['9740037', 'EUCTR2007-005434-37-AT. A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects with Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate. (Short title: mTX-IR Study)  Revised Protocol 02 incorporating Protocol amendment 02 (v2.0 date 19-dec-2007), Protocol amendment 03 (v1.0, date 25-Apr-2008), and Protocol Amendment 06 (v1.0, date 25-Sep-2008). And Anti-TNF failure Substudy Protocol Amendment 05-Site Specific (v2.0, date 02-Oct-2008). - MTX-IR Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005434-37-AT. (2008)   pp', '10.3410/f.1097731.553845', '']\n",
      "['9741207', 'NCT00559585. Methotrexate-Inadequate Response Study. https://clinicaltrials.gov/show/NCT00559585. (2007)   pp', '10.31525/ct1-nct04038970', '']\n",
      "['9257220', 'Conaghan PG; Peterfy CG; Di Carlo J; Olech E; Alberts AR; Alper JA; Devenport J; Anisfeld AM; Troum OM. Tocilizumab as monotherapy or in combination with methotrexate associated with early reductions in tissue inflammation: 12 week results from a magnetic resonance imaging substudy of a randomized controlled trial. Rheumatology (United Kingdom). (2012) 51  ppiii24', '10.1136/annrheumdis-2013-204762', '']\n",
      "['9258712', 'Huizinga TW; Conaghan PG; Martin-Mola E; Schett G; Amital H; Xavier RM; Troum O; Aassi M; Bernasconi C; Dougados M. Clinical and radiographic outcomes at 2‚ÄÖyears and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. Annals of the rheumatic diseases. (2015) 74 1 pp35-43', '10.1136/annrheumdis-2014-205752', '']\n",
      "['9260748', 'Dougados M; Kissel K; Sheeran T; Tak PP; Conaghan PG; Mola EM; Schett G; Amital H; Navarro-Sarabia F; Hou A; Bernasconi C; Huizinga TW. Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Annals of the rheumatic diseases. (2013) 72 1 pp43-50', '10.1136/annrheumdis-2011-201282', '']\n",
      "['9261012', 'Conaghan PG; Peterfy C; Olech E; Kaine J; Ridley D; Dicarlo J; Friedman J; Devenport J; Troum O. The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Annals of the rheumatic diseases. (2014) 73 5 pp810-816', '10.1136/annrheumdis-2013-204762', '']\n",
      "['9261013', 'Dougados M; Kissel K; Conaghan PG; Mola EM; Schett G; Gerli R; Hansen MS; Amital H; Xavier RM; Troum O; Bernasconi C; Huizinga TW. Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study. Annals of the rheumatic diseases. (2014) 73 5 pp803-809', '10.1136/annrheumdis-2013-204761', '']\n",
      "['9261107', 'Dougados M; Kissel K; Conaghan PG; Martin-Mola E; Schett GA; Amital H; Xavier RM; Troum OM; Bernasconi C; Huizinga TWJ. Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab-based treatment strategy with and without methotrexate in rheumatoid arthritis: The ACT-RAY study. Arthritis and rheumatism. (2012) 64  ppS1077-S1078', '10.1136/annrheumdis-2012-eular.2058', '']\n",
      "['9261164', 'Dougados M; Kissel K; Amital H; Conaghan P; Martin-Mola E; Nasonov E; Schett G; Troum O; Veldi T; Bernasconi C; Huizinga T. Double-blind study of tocilizumab+ methotrexate versus tocilizumab+placebo in patients with active rheumatoid arthritis despite prior methotrexate: Progression of structural damage, quality of life and physical function at 24 weeks. Rheumatology (United Kingdom). (2012) 51  ppiii28-iii29', '10.1136/annrheumdis-2012-eular.2058', '']\n",
      "['9261221', 'Dougados M; Kissel K; Amital H; Conaghan PG; Martin-Mola E; Nasonov EL; Schett G. Double-blind study of tocilizumab plus methotrexate vs tocilizumab plus placebo in patients with active rheumatoid arthritis despite prior methotrexate: Progression of structural damage, quality of life, and physical function at 24 weeks. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.30158', '']\n",
      "['9262463', 'Moller B; Scholz G; Dougados M; Huizinga T; Villiger PM; Finckh A. Anemia is a better predictor for radiographic damage in rheumatoid arthritis than DAS28 when determined before start of tocilizumab-treatment-a secondary analysis from the ACT-ray trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp569', '10.1136/annrheumdis-2017-eular.6685', '']\n",
      "['9263476', 'Conaghan PG; Peterfy CG; DiCarlo J; Olech E; Alberts AR; Alper JA; Devenport J. Early reductions in tissue inflammation with tocilizumab as either monotherapy or in combination with methotrexate: 12-week unblinded results from a magnetic resonance imaging substudy of a randomized controlled trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2013-204762', '']\n",
      "['9740995', 'NCT00810199. A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment. https://clinicaltrials.gov/show/NCT00810199. (2008)   pp', '10.23937/2469-5726/1510074', '']\n",
      "['9742751', 'EUCTR2008-001847-20-GR. Randomized placebo-controlled study to evaluate the safety and efficacy of adding tocilizumab (TCZ) to methotrexate (MTX) versus switching to TCZ (placebo controlled), with possible addition of other disease-modifying anti-rheumatic drugs (DMARDs), in patients with active rheumatoid arthritis who have inadequately responded to prior MTX treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-001847-20-GR. (2009)   pp', '10.1136/annrheumdis-2014-eular.2178', '']\n",
      "['9261202', 'Weinblatt ME; Kremer JM; Cush JJ; Rigby W; Teng L; Singh N; Malamet RL. Tocilizumab monotherapy and tocilizumab plus disease-modifying antirheumatic drugs in a US rheumatoid arthritis population with inadequate response to anti-tumor necrosis factor agents. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/acr.21847', '']\n",
      "['9740942', 'NCT00891020. A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs). https://clinicaltrials.gov/show/NCT00891020. (2009)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9736981', 'Edwards C J; Kiely P; Ostor A; Naisbett-Groet B. Tapering MTX versus steady-state MTX in combination with tocilizumab for treatment of rheumatoid arthritis (ACT-TAPER): a randomised, double-blind, controlled phase 4 trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp508', '10.1136/annrheumdis-2016-eular.1694', '']\n",
      "['9737779', 'Edwards CJ; Kiely P; Ostor A; Naisbett-Groet B. Tapering MTX versus steady-state MTX in combination with tocilizumab for treatment of rheumatoid arthritis (ACT-TAPER): a randomised, double-blind, controlled phase 4 trial. Annals of the rheumatic diseases. (2016) 75  pp508-', '10.1136/annrheumdis-2016-eular.1694', '']\n",
      "['9740064', 'EUCTR2011-005260-20-GB. RoActemra¬Æ (tocilizumab) plus methotrexate (MTX) in stable dosage in comparison with RoActemra¬Æ plus reducing (tapering) MTX dosages in patients with severe rheumatoid arthritis (RA) that have inadequate responded to a trial of two disease modifying anti-rheumatic drugs (DMARDs), including MTX and have not been previously treated with a biologic agent, such as a TNF inhibitor. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005260-20-GB. (2012)   pp', '10.1136/annrheumdis-2017-eular.4914', '']\n",
      "['9260526', 'Genovese MC; Kaine JL; Lowenstein MB; Del Giudice J; Baldassare A; Schechtman J; Fudman E; Kohen M; Gujrathi S; Trapp RG; Sweiss NJ; Spaniolo G; Dummer W; ACTION Study Group. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study. Arthritis and rheumatism. (2008) 58 9 pp2652-2661', '10.1002/art.23732', '']\n",
      "['9258552', 'Mori S; Yoshitama T; Hidaka T; Hirakata N; Ueki Y. Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: A real-life registry study in Japan (the ACTRA-RI study). Annals of the rheumatic diseases. (2015) 74  3 pp627-630', '10.1136/annrheumdis-2014-206695', '']\n",
      "['9257189', 'Best JH; Pei J. Comparative cost per response for four clinical outcomes of tocilizumab monotherapy versus adalimumab monotherapy in a head-to-head randomized double-blind superiority trial (ADACTA) in patients with rheumatoid arthritis. Value in health. Conference: 23rd annual meeting of the international society for pharmacoeconomics and outcomes research, ISPOR 2018. United states. (2018) 21 Supplement 1 ppS194', '10.1016/j.jval.2018.04.1323', '']\n",
      "['9261114', 'Navarro Sarabia F; Blanco FJ; Alvaro Gracia JM; Meijide JAG; Poveda JL. Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS919-S920', '10.1016/j.jval.2012.08.1385', '']\n",
      "['9261433', 'Gabay C; Emery P; Van Vollenhoven R; Dikranian A; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Kavanaugh A. Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 adacta trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1963', '']\n",
      "['9262015', 'Ravera S; Batticciotto A; Riva M; Donati C; Sarzi-Puttini P. Economic evaluation of tocilizumab monotherapy vs adalimumab monotherapy in patients with rheumatoid arthritis in italy. Value in health. (2015) 18 7 ppA640', '10.1016/j.jval.2015.09.2283', '']\n",
      "['9262176', 'Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 10 pp1806-1812', '10.1136/annrheumdis-2015-207872', '']\n",
      "['9262711', 'Best J; Pei J. Comparative cost per response for four clinical outcomes of tocilizumab monotherapy versus adalimumab monotherapy in a head-to-head randomised double-blind superiority trial (ADACTA) in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp521', '10.1136/annrheumdis-2018-eular.2009', '']\n",
      "['9263391', 'Gabay C; Emery P; van Vollenhoven R; Dikranian A; Alten R; Pavelka K; Klearman M; Musselman D; Agarwal S; Green J; Kavanaugh A; ADACTA Study Investigators. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet (London, England). (2013) 381 9877 pp1541-1550', '10.1016/s0140-6736(13)60250-0', '']\n",
      "['9736994', 'Best Jennie H; Vlad Steven C; Pei Jinglan. Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis. Rheumatology and therapy. (2020) 7 1 pp165-171', '10.1007/s40744-019-00191-6', 'https://link.springer.com/article/10.1007/s40744-019-00191-6/fulltext.html']\n",
      "['9737012', 'Kavanaugh A; Emery P; Van Vollenhoven; R F; Dikranian A H; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Gabay C. Tocilizumab monotherapy compared with adalimumab monotherapy in patients with rheumatoid arthritis: uesults of a 24-week study. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS333-S334', '10.1136/annrheumdis-2012-eular.1963', '']\n",
      "['9737352', 'Gabay C; Emery P; Van Vollenhoven. Erratum: tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (The Lancet (2013) 381 (1541-1550)). Lancet. (2013) 381 9877 pp1540', '10.1016/s0140-6736(13)60250-0', '']\n",
      "['9738752', 'Best JH; Pei J. Comparative cost per response for four clinical outcomes of tocilizumab monotherapy versus adalimumab monotherapy in a head-to-head randomized double-blind superiority trial (ADACTA) in patients with rheumatoid arthritis. Value in health. (2018) Conference: 23rd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2018. United States. 21 Supplement 1 ppS194', '10.1016/j.jval.2018.04.1323', '']\n",
      "['9738766', 'Best J; Pei J. Comparative cost per response for four clinical outcomes of tocilizumab monotherapy versus adalimumab monotherapy in a head-to-head randomised double-blind superiority trial (ADACTA) in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp521', '10.1136/annrheumdis-2018-eular.2009', '']\n",
      "['9743078', 'Koehm Michaela; McIntosh Matthew J; Hofmann Michael W; Abraham Varghese; Gabay Cem; Choy Ernest H; Kavanaugh Arthur; Burkhardt Harald; Behrens Frank. Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies. Rheumatology international. (2020) 40 5 pp747-755', '10.1007/s00296-020-04514-7', 'http://link.springer.com/article/10.1007/s00296-020-04514-7/fulltext.html']\n",
      "['11083611', 'Anonymous. Erratum: department of Error (Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (2013) 381(9877) (1541-1550), (S0140673613602500), (10.1016/S0140-6736(13)60250-0)). Lancet. (2013) 381 9877 pp1540', '10.1016/s0140-6736(13)60250-0', '']\n",
      "['11085234', 'Best JH; Vlad SC; Pei J. Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis. . (2020) 7 1 pp165', '10.1007/s40744-019-00191-6', 'https://link.springer.com/article/10.1007/s40744-019-00191-6/fulltext.html']\n",
      "['9740251', 'EUCTR2009-015845-21-SE. A multi-center, randomized, blinded, parallel-group study of the reduction of signs and symptoms during monotherapy treatment with tocilizumab 8 mg/kg intravenously versus adalimumab 40 mg subcutaneously in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015845-21-SE. (2010)   pp', '10.1016/j.jval.2018.04.1323', '']\n",
      "['9741265', 'Koehm M; McIntosh MJ; Hofmann MW; Abraham V; Gabay C; Choy EH; Kavanaugh A; Burkhardt H; Behrens F. Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies. Rheumatology international. (2020)   pp', '10.1007/s00296-020-04514-7', 'http://link.springer.com/article/10.1007/s00296-020-04514-7/fulltext.html']\n",
      "['9742993', 'NCT01119859. A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01119859. (2010)   pp', '10.1016/s0140-6736(13)60634-0', '']\n",
      "['9739072', 'Gabay C; McInnes I; Kavanaugh A; Tuckwell K; Collinson N; Klearman M; Green J; Sattar N. Changes in lipoprotein(A) after treatment with tocilizumab (TCZ), adalimumab (ADA), and methotrexate (MTX) in patients with Rheumatoid Arthritis (RA). Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.3030', '']\n",
      "['9739997', 'UMIN000021157. Clinical trial for efficacy and safety related to weekly dosage regimens of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021157. (2016)   pp', '10.1186/isrctn59733193', '']\n",
      "['9741194', 'EUCTR2019-001554-25-NL. Adalimumab dose optimization in rheumatoid arthritis using drug                 concentration in blood (ADDORA): multi-center open label randomized                 controlled trail. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-001554-25-NL. (2019)   pp', '10.1186/isrctn95861172', '']\n",
      "['9741209', 'NL8208. Adalimumab drug optimisation in rheumatoid arthritis using therapeutic drug monitoring (ADDORA): multi-centre open label randomised controlled trail. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NL8208. (2019)   pp', '10.31525/ct1-nct04194827', '']\n",
      "['9741195', 'EUCTR2019-001793-28-NL. Adalimumab dose reduction aiming low drug levels with control of disease activity (ADDORA-LOW). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-001793-28-NL. (2019)   pp', '10.31525/ct1-nct04222920', '']\n",
      "['9741247', 'NCT04251741. Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment. https://clinicaltrials.gov/show/NCT04251741. (2020)   pp', '10.31525/ct1-nct04251741', '']\n",
      "['11087917', 'Wientjes Maike H M; Atiqi Sadaf; Wolbink Gerrit Jan; Nurmohamed Michael T; Boers Maarten; Rispens Theo; de Vries Annick; van Vollenhoven Ronald F; van den Bemt Bart J F; den Broeder Alfons A. Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial. Trials. (2021) 22 1 pp406', '10.1186/s13063-021-05358-7', 'https://link.springer.com/article/10.1186/s13063-021-05358-7/fulltext.html']\n",
      "['9262490', 'Mease PJ; Chen S; Ganz F; Tillett W. Correlation of the routine assessment of patient index data (rapid-3) with other psoriatic arthritis composite disease activity measures in patients receiving adalimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp682-683', '10.1136/annrheumdis-2017-eular.1952', '']\n",
      "['9738268', 'Landewe R B M; Ritchlin C T; Coates L C; Aletaha D; Guerette B; Zhang Y; Ganz F; Hojnik M. Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1093/rheumatology/key417', 'http://academic.oup.com/rheumatology/article-pdf/58/6/1025/28697361/key417.pdf']\n",
      "['11083572', 'Vadell Anna K E; Barebring Linnea; Hulander Erik; Gjertsson Inger; Lindqvist Helen M; Winkvist Anna. Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. American journal of clinical nutrition. (2020) 111 6 pp1203-1213', '10.1093/ajcn/nqaa019', 'http://academic.oup.com/ajcn/article-pdf/111/6/1203/33325182/nqaa019.pdf']\n",
      "['11083821', 'Lindqvist HM; Barebring L; Gjertsson I; Jylha A; Laaksonen R; Winkvist A; Hilvo M. A randomized controlled dietary intervention improved the serum lipid signature towards a less atherogenic profile in patients with rheumatoid arthritis. Metabolites. (2021) 11 9 pp', '10.3390/metabo11090632', '']\n",
      "['9258420', 'Emery P; Durez P; Dougados M; Legerton CW; Becker JC; Vratsanos G; Genant HK; Peterfy C; Mitra P; Overfield S; Qi K; Westhovens R. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Annals of the rheumatic diseases. (2010) 69 3 pp510-516', '10.1136/ard.2009.119016', '']\n",
      "['9261142', 'Chatzidionysiou K; Turesson C; Teleman A; Knight A; Lindqvist E; Larsson P; Coster L; Rydberg B; Van Vollenhoven RF; Heimburger M. A multicenter, randomized, controlled, open-label pilot study of the feasibility of discontinuation of adalimumab in rheumatoid arthritis patients in stable clinical remission. Arthritis and rheumatism. (2012) 64  ppS336', '10.1136/rmdopen-2015-000133', '']\n",
      "['9740217', 'EUCTR2008-004398-16-SE. A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable RA Patients in Clinical remission - ADMIRE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-004398-16-SE. (2008)   pp', '10.1136/rmdopen-2015-000133', '']\n",
      "['9737316', 'Wiland P; Jeka S; Dokoupilova E; Limon JMM; Jauch-Lembach J; Thakur A; Haliduola H; Gaylis NB. A randomized, double-blind, parallel-group, multicenter study to compare the efficacy, safety and immunogenicity of a proposed adalimumab biosimilar (GP2017) with reference adalimumab in patients with moderateto-severe active rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2162-2163', '10.1136/annrheumdis-2019-eular.960', '']\n",
      "['9739966', 'EUCTR2015-003433-10-HU. ADMYRA Trial: clinical trial to compare treatment with GP2017 and Humira¬¨√Ü in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003433-10-HU. (2016)   pp', '10.1186/isrctn25142273', '']\n",
      "['11088095', 'Wiland Piotr; Jeka Slawomir; Dokoupilova Eva; Brandt-Jurgens Jan; Miranda Limon Juan Manuel; Cantalejo Moreira Miguel; Cabello Raul Veiga; Jauch-Lembach Julia; Thakur Anjali; Haliduola Halimuniyazi; Brueckmann Ines; Gaylis Norman B. Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study. BioDrugs. (2020) 34 6 pp809-823', '10.1007/s40259-020-00447-6', 'http://link.springer.com/article/10.1007/s40259-020-00447-6/fulltext.html']\n",
      "['9260180', 'van Riel PL; Taggart AJ; Sany J; Gaubitz M; Nab HW; Pedersen R; Freundlich B; MacPeek D; Add Enbrel or Replace Methotrexate Study Investigators. Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study. Annals of the rheumatic diseases. (2006) 65 11 pp1478-1483', '10.1136/ard.2005.043299', '']\n",
      "['9260300', 'Van Riel PLCM; Taggart AJ; Sany J; Gaubitz M; Nab HW; Pedersen R; Freundlich B; MacPeek D. Efficacy and safely of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: The ADORE study. Annals of the rheumatic diseases. (2006) 65 11 pp1478-1483', '10.1136/ard.2005.043299', '']\n",
      "['9260304', 'van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A; ADORE Study Investigators. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. Annals of the rheumatic diseases. (2008) 67 8 pp1104-1110', '10.1136/ard.2006.068585', '']\n",
      "['9260373', 'Sennels H; S‚àö‚àèrensen S; Ostergaard M; Knudsen L; Hansen M; Skj‚àö‚àèdt H; Peters N; Colic A; Grau K; Jacobsen S. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scandinavian journal of rheumatology. (2008) 37 4 pp241-247', '10.1080/03009740801910320', '']\n",
      "['9261447', 'Kass A; Hollan I; Torjesen P; Gulseth HC; Forre OT. Cetrorelix, a gonadotropin-releasing hormone antagonist, demonstrates efficacy and significantly reduces proinflammatory cytokines in patients with active longstanding rheumatoid arthritis with high gonadotropin levels: A proof-of-concept, double-blind, randomized trial. Arthritis and rheumatism. (2013) 65  12 pp3324-3325', '10.1136/annrheumdis-2012-eular.1885', '']\n",
      "['9263527', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; Van Der Heijde D; Miyasaka N; Koike T. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Annals of the rheumatic diseases. (2016) 75  1 pp75-83', '10.1136/annrheumdis-2015-207511', '']\n",
      "['9261079', 'Westhovens R; Durez P; Genant H; Robles M; Becker J-C; Covucci A; Bathon J. Disease remission, normalized physical function and radiographic non-progression are achieved by the majority of patients with early rheumatoid arthritis treated with abatacept + methotrexate: Results from the 2-year agree trial. Rheumatology. (2011) 50  ppiii122', '10.1136/ard.2010.145268', '']\n",
      "['9261226', 'Yazici Y; Wollenhaupt J; Durez P; Gomez-Reino JJ; Grassi W; Le Bars M; Gaillez C. Clinical response at months 16 can predict likelihood of achieving remission in abatacept plus methotrexate-treated patients with early rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1186/s13075-015-0671-9', 'https://link.springer.com/article/10.1186/s13075-015-0671-9/fulltext.html']\n",
      "['9262475', 'Jansen D; Emery P; Smolen J; Westhovens R; Le Bars M; Connolly S; Ye J; Toes R; Huizinga T. Association between conversion to ACPA/RF seronegative status and clinical outcomes following treatment with abatacept in combination with methotrexate compared with methotrexate alone in patients with early rheumatoid arthritis and poor prognostic indicators. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp566', '10.1136/annrheumdis-2017-eular.1716', '']\n",
      "['9263346', 'Bathon J; Robles M; Ximenes AC; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Covucci A; Moniz Reed D; Helfrick R; Westhovens R. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes. Annals of the rheumatic diseases. (2011) 70 11 pp1949-1956', '10.1136/ard.2010.145268', '']\n",
      "['9263381', 'Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression. Journal of rheumatology. (2011) 38 11 pp2362-2368', '10.3899/jrheum.110054', '']\n",
      "['9736634', 'Westhovens R; Wollenhaupt J; Haraoui B; Becker J C; Covucci A; Rosenblatt L; Bathon J. Sustained and clinically meaningful improvements in physical function and fatigue and Reductions in activity limitation are observed in MTX-nave patients with early rheumatoid arthritis (RA) treated with abatacept over 2 years of the AGREE trial. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1837', '10.1016/s0973-3698(09)60080-7', '']\n",
      "['9737438', 'Bathon J; Genant H; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W. Reduced radiographic progression in patients with early rheumatoid arthritis (RA) treated with abatacept methotrexate compared to methotrexate alone: 24 month outcomes. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp639', '10.1136/ard.2010.145268', '']\n",
      "['9738276', 'Jansen DTSL; Emery P; Smolen JS; Westhovens R; Le Bars M; Connolly SE; Ye J; Toes REM; Huizinga TWJ. Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study. RMD open. (2018) 4 1 pp', '10.1136/rmdopen-2017-000564', '']\n",
      "['9738818', 'Bathon J; Genant H; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park S H; Robles M; Peterfy C; Becker J C; Westhovens R. Reduced radiographic progression in patients with early rheumatoid arthritis (RA) treated with abatacept + methotrexate compared to methotrexate alone: 24 month outcomes. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp102', '10.1136/ard.2008.101121', '']\n",
      "['9738897', 'Haraoui B; Westhovens R; Robles M; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Shergy W; Park S; Genant H; Peterfy C; Becker J C; Covucci A; Helfrick R; Bathon J. The efficacy and safety of abatacept in methotrexate-naive patients with early erosive rheumatoid arthritis and poor prognostic factors. Journal of rheumatology. (2009) 36 11 pp2593', '10.1136/ard.2008.101121', '']\n",
      "['9739012', 'Westhovens R; Durez P; Genant H; Robles M; Becker J; Covucci A; Bathon J. Disease remission, normalized physical function and radiographic non-progression are achieved by the majority of patients with early Rheumatoid Arthritis (Ra) treated with Abatacept (Aba) + Methotrexate (Mtx): results from the 2-year agree trial. Zeitschrift fur Rheumatologie. (2010) 69 SUPPL. 1 pp49-50', '10.1136/ard.2010.145268', '']\n",
      "['9739013', 'Westhovens R; Durez P; Genant H; Robles M; Becker J C; Covucci A; Bathon J. Disease remission, normalized physical function and radiographic non-progression are achieved by the majority of patients with early rheumatoid arthritis (RA) treated with abatacept (ABA) + methotrexate (MTX): results from the 2-year agree trial. Journal of rheumatology. (2011) 38 6 pp1197-1198', '10.1136/ard.2010.145268', '']\n",
      "['9739015', 'Westhovens R; Robles M; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W. Disease remission is achieved within two years in over half of methotrexate naive patients with early erosive rheumatoid arthritis (RA) treated with abatacept plus MTX: results from the AGREE trial. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp638', '10.1186/s13075-015-0671-9', 'https://link.springer.com/article/10.1186/s13075-015-0671-9/fulltext.html']\n",
      "['9739616', 'EUCTR2005-000784-26-ES. A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated with Abatacept plus Methotrexate Compared with Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-000784-26-ES. (2005)   pp', '10.1186/s13075-015-0671-9', 'https://link.springer.com/article/10.1186/s13075-015-0671-9/fulltext.html']\n",
      "['9740163', 'ACTRN12605000784617. A Phase IIIB Multi-Center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12605000784617. (2005)   pp', '10.1186/s13075-015-0671-9', 'https://link.springer.com/article/10.1186/s13075-015-0671-9/fulltext.html']\n",
      "['9741031', 'NCT00122382. Remission and Joint Damage Progression in Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00122382. (2005)   pp', '10.1186/s13075-015-0671-9', 'https://link.springer.com/article/10.1186/s13075-015-0671-9/fulltext.html']\n",
      "['9742591', 'Westhovens R; Robles M; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park S H; Genant H; Peterfy C; Becker J C; Bathon J. Disease remission is achieved within two years in over half of methotrexate naive patients with early erosive rheumatoid arthritis (RA) treated with abatacept plus MTX: results from the AGREE trial. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp102', '10.1136/ard.2008.101121', '']\n",
      "['9258151', 'Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechi‚âà√ëski J; Li T; Teng J; Becker JC; Westhovens R. Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis and rheumatism. (2008) 58 4 pp953-963', '10.1002/art.23397', '']\n",
      "['9260148', 'Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Ge Z; Becker JC; Westhovens R. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Annals of internal medicine. (2006) 144 12 pp865-876', '10.7326/0003-4819-144-12-200606200-00003', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-144-12-200606200-00003']\n",
      "['9260311', 'Genant HK; Peterfy CG; Westhovens R; Becker JC; Aranda R; Vratsanos G; Teng J; Kremer JM. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial. Annals of the rheumatic diseases. (2008) 67 8 pp1084-1089', '10.1136/ard.2007.085084', '']\n",
      "['9260368', 'Li T; Gignac M; Wells G; Shen S; Westhovens R. Decreased external home help use with improved clinical status in rheumatoid arthritis: an exploratory analysis of the Abatacept in Inadequate responders to Methotrexate (AIM) trial. Clinical therapeutics. (2008) 30 4 pp734-748', '10.1016/j.clinthera.2008.03.015', '']\n",
      "['9260603', 'Vecchio P; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Zhao C; Becker JC; Westhovens R; Kremer JM. The AIM trial: four-year safety and efficacy of abatacept in rheumatoid arthritis patients with inadequate response to methotrexate [Abstract]. Internal medicine journal. (2009) 39 S2 ppA73', '10.1136/ard.2010.139345', '']\n",
      "['9260685', 'Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Westhovens R; Li T; Zhou X; Becker JC; Aranda R; Peterfy C; Genant HK. Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial. Annals of the rheumatic diseases. (2011) 70 10 pp1826-1830', '10.1136/ard.2010.139345', '']\n",
      "['9261160', 'Sibilia J; Flipo RM; Combe B; Gaillez C; Le Bars M; Poncet C; Elegbe A; Westhovens R. Abatacept confers clinical efficacy regardless of baseline CRP status in patients with rheumatoid arthritis and inadequate response to methotrexate in the aim trial. Rheumatology (United Kingdom). (2012) 51  ppiii124-iii125', '10.1136/annrheumdis-2012-eular.2656', '']\n",
      "['9261187', 'Russell A; Dougados M; Khraishi M; Flipo RM; Le Loet X; Smolen J; Gaillez C; Le Bars M; Poncet C; Elegbe A; Yazici Y. Efficacy with abatacept in patients with earlier versus more longstanding disease: Insights from the AIM trial. Journal of rheumatology. (2012) 39  8 pp1714', '10.1136/annrheumdis-2012-eular.543', '']\n",
      "['9261656', 'Kremer JM; Peterfy C; Russell AS; Emery P; Abud-Mendoza C; Sibilia J; Becker JC; Westhovens R; Genant HK. Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial. Journal of rheumatology. (2014) 41 6 pp1077-1087', '10.3899/jrheum.130263', '']\n",
      "['9263168', 'Russell AS; Wallenstein GV; Li T; Martin MC; Maclean R; Blaisdell B; Gajria K; Cole JC; Becker JC; Emery P. Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment. Annals of the rheumatic diseases. (2007) 66 2 pp189-194', '10.1136/ard.2006.057018', '']\n",
      "['9737055', 'NCT00048568. A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate. https://clinicaltrials.gov/show/NCT00048568. (2002)   pp', '10.1007/s10165-012-0798-3', '']\n",
      "['9737376', 'Russell A S; Kremer J M; Emery P; Abud-Mendoza C; Szechinski J; Zhao C; Becker J C; Westhovens R. Safety and efficacy of abatacept over 4 years of treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate in the AIM trial. Journal of rheumatology. (2009) 36 11 pp2608-2609', '10.3899/jrheum.130263', '']\n",
      "['9738926', 'Kremer J M; Russell A S; Emery P; Abud-Mendoza C; Szechinski J; Becker J C; Wu G; Westhovens R. Abatacept demonstrates consistent safety and sustained improvements in efficacy through 5 years of treatment in biologic-naive patients with rheumatoid arthritis. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1016/s0973-3698(09)60050-9', '']\n",
      "['9739010', 'Wells G; Dougados M; Schmidely N; Lafosse C; Le Bars; Van Riel. Achievement of sustained Low disease activity state predicts the absence of structural damage progression in patients with rheumatoid arthritis: insights from the abatacept database. Journal of rheumatology. (2009) 36 11 pp2593-2594', '10.1136/ard.2008.092577', '']\n",
      "['9739082', 'Haraoui P; Genant H K; Peterfy C; Westhovens R; Becker J C; Vratsanos G; Tsai K; Zhou X; Kremer J. Abatacept provides an increasing degree of inhibition of structural damage progression through 3 years in patients with rheumatoid arthritis and an inadequate response to methotrexate who remain on treatment. Journal of rheumatology. (2009) 36 11 pp2569', '10.1016/s0973-3698(09)60049-2', '']\n",
      "['9260333', 'Cole JC; Li T; Lin P; MacLean R; Wallenstein GV. Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept. Rheumatology (Oxford, England). (2008) 47 7 pp1044-1050', '10.1093/rheumatology/ken141', 'http://academic.oup.com/rheumatology/article-pdf/47/7/1044/5064532/ken141.pdf']\n",
      "['9260626', 'Wells G; Li T; Tugwell P. Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale. Annals of the rheumatic diseases. (2010) 69 10 pp1768-1773', '10.1136/ard.2009.119727', '']\n",
      "['9260663', 'Li T; Wells G; Westhovens R; Emery P; Becker JC; Tugwell P. Improvements in participation in usual daily activities in patients with rheumatoid arthritis treated with abatacept. Value in health. (2011) 14 2 pp361-370', '10.1016/j.jval.2010.10.008', '']\n",
      "['9738493', 'Wells G; Li T; Maxwell L; MacLean R; Tugwell P.. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. Journal of rheumatology. (2007) 34 2 pp280-289', '10.1136/ard.2007.069690', '']\n",
      "['9739077', 'Gossec L; Ahdjoudj S; Alemao E; Strand V. Does fatigue improve in a similar manner to pain in patients with rheumatoid arthritis (RA) treated with a biologic? a reanalysis of randomized controlled trials of abatacept in 1536 patients with active ra. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1249-1250', '10.1136/annrheumdis-2016-eular.1451', '']\n",
      "['9261070', 'Huizinga T; Nigrovic P; Ruderman E; Schulze-Koops H. Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: A post hoc analysis of randomized clinical trial data - Commentary. International Journal of Advances in Rheumatology. (2011) 9  4 pp150-151', '10.1093/rheumatology/kew144.014', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i97/5079008/kew144.014.pdf']\n",
      "['9742611', 'Keystone E; Genovese M; Hochberg M; Cohen R; Weinblatt M; Kaine J; Nash P; Delaet I; Alten R. Prolonged exposure to subcutaneous and intravenous abatacept in patients with rheumatoid arthritis does not affect rates of infection, malignancy and autoimmune events: results from pooled clinical trial data. Journal of rheumatology. (2013) 40 6 pp995', '10.1136/annrheumdis-2013-eular.1854', '']\n",
      "['9260811', 'Alam MK; Sutradhar SR; Pandit H; Ahmed S; Bhattacharjee M; Miah AH; Bari MA; Islam MZ; Khan NA; Zannat KF; Akhter S. Comparative study on methotrexate and hydroxychloroquine in the treatment of rheumatoid arthritis. Mymensingh medical journal : MMJ. (2012) 21 3 pp391-398', '10.3329/mmj.v15i2.46', '']\n",
      "['9739861', 'UMIN000024025. The clinical impact of methotrexate dose reduction at combination therapy with adalimumab plus methotrexate in rheumatoid arthritis; ALIBABA study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000024025. (2016)   pp', '10.3410/f.14174.471676', '']\n",
      "['11085300', 'Winthrop Kevin L; Harigai Masayoshi; Genovese Mark C; Lindsey Stephen; Takeuchi Tsutomu; Fleischmann Roy; Bradley John D; Byers Nicole L; Hyslop David L; Issa Maher; Nishikawa Atsushi; Rooney Terence P; Witt Sarah; Dickson Christina L; Smolen Josef S; Dougados Maxime. Infections in baricitinib clinical trials for patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2020) 79 10 pp1290-1297', '10.1136/annrheumdis-2019-216852', '']\n",
      "['11086206', 'Bird P; Winthrop K; Takeuchi T; Burmester G; Durez P; Deberdt W; Schlichting D; Beattie S; Mo D; Walls C; Smolen J. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 8.4 years: an updated integrated safety analysis. Internal medicine journal. (2021) 51 SUPPL 2 pp24', '10.1093/rheumatology/keab246.008', 'http://academic.oup.com/rheumatology/article-pdf/60/Supplement_1/keab246.008/37398124/keab246.008.pdf']\n",
      "['11086650', 'Hall S; Genovese MC; Smolen JS; Takeuchi T; Burmester G; Brinker D; Rooney TP; Zhong J; Mo D; Saifan C; Cardoso A; Issa M; Wu W-S; Winthrop KL. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 7 years: an updated integrated safety analysis. Internal medicine journal. (2020) 50 SUPPL 2 pp16', '10.1136/annrheumdis-2019-eular.691', '']\n",
      "['9261208', 'Kaine JL; Gladstein GS; Strusberg I; Robles M; Pappu R; Delaet I; Pans M. SC abatacept is effective and well tolerated with low immunogenicity following temporary withdrawal and reintroduction in the allow lte (evaluation of aba administered subcutaneously in adults with active rheumatoid arthritis: Impact of withdrawal and reintroduction). Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2011-200344', '']\n",
      "['9261233', 'Kaine J; Gladstein G; Strusberg I; Robles M; Pappu R; Delaet I; Pans M; Ludivico C. Subcutaneous (SC) abatacept is well tolerated, demonstrates clinical efficacy and is associated with low immunogenicity following withdrawal and re-introduction: Phase III evaluation in rheumatoid arthritis (RA) patients responding to abatacept. Zeitschrift fur Rheumatologie. (2011) 70  pp87-88', '10.1136/annrheumdis-2011-200344', '']\n",
      "['9263333', 'Kaine J; Gladstein G; Strusberg I; Robles M; Louw I; Gujrathi S; Pappu R; Delaet I; Pans M; Ludivico C. Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the rheumatic diseases. (2012) 71 1 pp38-44', '10.1136/annrheumdis-2011-200344', '']\n",
      "['9741019', 'NCT00533897. Phase IIIB Subcutaneous Missed Dose Study. https://clinicaltrials.gov/show/NCT00533897. (2007)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9261341', 'Kennedy W; Horn P; Su Z; Basu K; Herman A; Song A; Townsend M; Xiao J; Grogan J; Derby M; Simon-Campos JA; Davis Jr J. Efficacy and safety of pateclizumab (anti-lymphotoxin-alpha) in DMARD-IR patients: Results of a randomized, double-blind, placebo-controlled head-to-head phase 2 study with adalimumab. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1836', '']\n",
      "['9741066', 'NCT01225393. A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01225393. (2010)   pp', '10.1007/978-3-211-79280-3_256', 'http://link.springer.com/content/pdf/10.1007/978-3-211-79280-3_256.pdf']\n",
      "['9262660', 'Mazurov V; Denisov L; Gordeev I; Nesmeyanova O; Plaksina T; Ilivanova E; Krechikova D; Zonova E; Knyazeva L; Artemeva A; Dokukina E; Chernyaeva E; Ivanov R. Results of the alterra clinical trial-the efficacy of the alternative dosing regimen for rituximab biosimilar in bDMARDS naive patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp963', '10.1136/annrheumdis-2018-eular.2300', '']\n",
      "['9737415', 'Mazurov V; Denisov L; Gordeev I; Nesmeyanova O; Plaksina T; Ilivanova E; Krechikova D; Zonova E; Knyazeva L; Artemeva A; Dokukina E; Chernyaeva E; Ivanov R. Results of the alterra clinical trial-the efficacy of the alternative dosing regimen for rituximab biosimilar in bDMARDS naive patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp963', '10.1136/annrheumdis-2018-eular.2300', '']\n",
      "['9258384', 'Behrens F; Rossmanith T; Koehm M; Alten R; Aringer M; Burmester GR; Feist E; Kruger K; Muller-Ladner U; Rubbert-Roth A; Wassenberg S; Tony H-P; Kellner H; Backhaus M; Burkhardt H. Effectiveness of different dosages of retreatment of rituximab in combination with leflunomide: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (amara-study). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1262-1263', '10.1093/rheumatology/keab153', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab153/36643438/keab153.pdf']\n",
      "['9262476', 'Kohm M; Rossmanith T; Dauth S; Alten R; Aringer M; Backhaus M; Burmester G; Feist E; Kellner H; Kruger K; Muller-Ladner U; Rubbert-Roth A; Tony H-P; Wassenberg S; Burkhardt H; Behrens F. Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (amara-study). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp565', '10.1136/annrheumdis-2017-eular.6238', '']\n",
      "['9262672', 'Kohm M; Rossmanith T; Alten R; Aringer M; Backhaus M; Burmester G; Feist E; Herrmann E; Kellner H; Lehn A; Muller-Ladner U; Rubbert-Roth A; Tony H-P; Wassenberg S; Burkhardt H; Behrens F. Treatment response to rituximab in combination with leflunomide is influenced by anti-CCP status in active rheumatoid arthritis: results from a multicenter randomised placebo-controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-study). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1315', '10.1136/annrheumdis-2018-eular.6671', '']\n",
      "['9737502', 'Behrens F; Rossmanith T; Kohm M; Alten R; Aringer M; Backhaus M; Baerwald C; Burmester G; Feist E; Kellner H; Kruger K; Muller-Ladner U; Rubbert-Roth A; Tony H-P; Wassenberg S; Burkhardt H. Rituximab in combination with leflunomide: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-study). Annals of the rheumatic diseases. (2016) 75  pp502-', '10.1136/annrheumdis-2016-eular.5684', '']\n",
      "['9738722', 'Kohm M; Rossmanith T; Alten R; Aringer M; Backhaus M; Burmester G; Feist E; Herrmann E; Kellner H; Lehn A; Muller-Ladner U; Rubbert-Roth A; Tony H-P; Wassenberg S; Burkhardt H; Behrens F. Treatment response to rituximab in combination with leflunomide is influenced by anti-CCP status in active rheumatoid arthritis: results from a multicenter randomised placebo-controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-study). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1315', '10.1136/annrheumdis-2018-eular.6671', '']\n",
      "['9738820', 'Behrens F; Rossmanith T; Kohm M; Alten R; Aringer M; Backhaus M; Baerwald C; Burmester G; Feist E; Kellner H; Kruger K; Muller-Ladner U; Rubbert-Roth A; Tony H P; Wassenberg S; Burkhardt H. Rituximab in combination with leflunomide: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-study). Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp502', '10.1136/annrheumdis-2016-eular.5684', '']\n",
      "['9740156', 'EUCTR2009-015950-39-DE. Rituximab-Treatment in Addition to Leflunomide in Patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015950-39-DE. (2009)   pp', '10.1007/s00296-009-1302-z', 'http://link.springer.com/article/10.1007/s00296-009-1302-z/fulltext.html']\n",
      "['11085150', 'Koehm M; Foldenauer AC; Rossmanith T; Alten R; Aringer M; Backhaus M; Burmester GR; Feist E; Kellner H; Krueger K; Muller-Ladner U; Rubbert-Roth A; Tony H-P; Wassenberg S; Burkhardt H; Behrens F. Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine. (2022) 11 24 pp', '10.3390/jcm11247316', '']\n",
      "['11085593', 'Behrens F; Koehm M; Rossmanith T; Alten R; Aringer M; Backhaus M; Burmester GR; Feist E; Herrmann E; Kellner H; Krueger K; Lehn A; M√ºller-Ladner U; Rubbert-Roth A; Tony HP; Wassenberg S; Burkhardt H. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). Rheumatology (Oxford, England). (2021) 60 11 pp5318-5328', '10.1093/rheumatology/keab153', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab153/36643438/keab153.pdf']\n",
      "['9256880', 'Jones G; Wallace T; McIntosh MJ; Brockwell L; Gomez-Reino JJ; Sebba A. Five-year Efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexate-And biologic-naive or free of methotrexate for 6 months: the ambition study. Journal of rheumatology. (2017) 44 2 pp142-146', '10.3899/jrheum.160287', '']\n",
      "['9258318', 'Jones G. The AMBITION trial: tocilizumab monotherapy for rheumatoid arthritis. Expert review of clinical immunology. (2010) 6 2 pp189-195', '10.1586/eci.10.2', '']\n",
      "['9259790', 'Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Genovese MC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Finck BK. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New England journal of medicine. (2000) 343 22 pp1586-1593', '10.1056/nejm200011303432201', '']\n",
      "['9261100', 'Jones G; Taylor A; Sebba A; Anisfeld A; Devenport J; Bernasconi C; Smart D; Galindez D; Mpofu C; Gomez-Reino J. Long-term efficacy of tocilizumab (TCZ) monotherapy in patients with rheumatoid arthritis (RA) previously methotrexate (MTX) naive or MTX free for 6 months. Internal medicine journal. (2013) 43  pp12', '10.1136/annrheumdis-2013-eular.1375', '']\n",
      "['9261288', 'Khraishi M; Sebba A; Anisfeld A; Devenport J; Bernasconi C; Smart D; Galindez D; Mpofu C; Gomez-Reino J; Jones G. Long-term efficacy and safety of tocilizumab (TCZ) monotherapy in patients (PTS) with rheumatoid arthritis (RA) previously methotrexate (MTX) naive or MTX free for 6 months prior to study start. Journal of rheumatology. (2014) 41  7 pp1468', '10.1136/annrheumdis-2013-eular.1375', '']\n",
      "['9738350', 'NCT00109408. A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00109408. (2005)   pp', '10.1007/s10165-011-0419-6', '']\n",
      "['9738371', 'EUCTR2005-001138-33-DK. A randomized, double-blind, double-dummy, parallel group study of the safety and efficacy of MRA monotherapy, versus methotrexate (MTX) monotherapy, in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001138-33-DK. (2005)   pp', '10.3410/f.732763351.793564277', '']\n",
      "['9742233', 'Bay-Jensen AC; Siebuhr AS; Thudium CS; Karsdal MA. Tissues are differently modulated by tocilizumab and methotrexate; assessment of connective tissue metabolites in the ambition study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp551', '10.1136/annrheumdis-2018-eular.6945', '']\n",
      "['11085724', 'Drobinski PJ; Nissen NI; Sinkeviciute D; Willumsen N; Karsdal MA; Bay-Jensen AC. In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker. International journal of molecular sciences. (2022) 24 1 pp', '10.3390/ijms24010321', '']\n",
      "['9737014', 'Safy M; Jacobs JWG; Edwardes M; De Hair MJH; Teitsma XM; Welsing PMJ; Borm MEA; Luder Y; Van Laar J; Petho-Schramm A; Bijlsma JWJ. No effect of concomitant glucocorticoid therapy on efficacy and safety of tocilizumab monotherapy found in rheumatoid arthritis clinical trials. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp1719-1720', '10.1136/annrheumdis-2018-eular.6327', '']\n",
      "['9262652', 'Safy M; Jacobs JWG; Edwardes M; Pei J; De Hair M; Teitsma X; Welsing P; Borm M; Luder Y; Van Laar J; Petho-Schramm A; Bijlsma JWJ. No evidence that concomitant glucocorticoid therapy affects efficacy and safety of tocilizumab monotherapy in rheumatoid arthritis clinical trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp945', '10.1136/annrheumdis-2018-eular.6327', '']\n",
      "['9738711', 'Safy M; Jacobs JWG; Edwardes M; Pei J; De Hair M; Teitsma X; Welsing P; Borm M; Luder Y; Van Laar J; Petho-Schramm A; Bijlsma JWJ. No evidence that concomitant glucocorticoid therapy affects efficacy and safety of tocilizumab monotherapy in rheumatoid arthritis clinical trials. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp945', '10.1136/annrheumdis-2018-eular.6327', '']\n",
      "['9740666', '. No effect of concomitant glucocorticoid therapy on efficacy and safety of tocilizumab monotherapy found in rheumatoid arthritis clinical trials. Arthritis and rheumatology. (2018) 70  pp1719-1720', '10.1136/annrheumdis-2018-eular.6327', '']\n",
      "['9741219', 'Collins JE; Johansson FD; Gale S; Kim S; Shrestha S; Sontag D; Stratton J; Trinh H; Xu C; Losina E; Solomon DH. Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: model Derivation and Remission Score Development. ACR open rheumatology. (2020)   pp', '10.1002/acr2.11101', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11101']\n",
      "['9741360', 'Safy-Khan M; Jacobs JWG; De Hair MJH; Welsing PMJ; Edwardes MD; Teitsma XM; Luder Y; Devenport J; Van Laar JM; Pethoe-Schramm A; Bijlsma JWJ. Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2019-216537', '']\n",
      "['9741603', 'Collins Jamie E; Johansson Fredrik D; Gale Sara; Kim Seoyoung; Shrestha Swastina; Sontag David; Stratton Jacklyn; Trinh Huong; Xu Chang; Losina Elena; Solomon Daniel H. Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: model Derivation and Remission Score Development. ACR open rheumatology. (2020) 2 2 pp65-73', '10.1002/acr2.11101', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11101']\n",
      "['9741639', 'Safy-Khan Mary; Jacobs Johannes W G; de Hair Maria J H; Welsing Paco M J; Edwardes Michael D; Teitsma Xavier M; Luder Yves; Devenport Jenny; van Laar Jacob M; Pethoe-Schramm Attila; Bijlsma Johannes W J. Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy. Annals of the rheumatic diseases. (2020) 79 4 pp460-463', '10.1136/annrheumdis-2019-216537', '']\n",
      "['9742353', 'Collins J; Johansson F; Gale S; Kim S; Shrestha S; Sontag D; Stratton J; Huong T; Xu C; Losina E; Solomon D. Predicting remission among patients with rheumatoid arthritis starting tocilizumab monotherapy: model derivation and validation using conventional regression and machine learning. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp727', '10.1136/annrheumdis-2019-eular.4305', '']\n",
      "['11084046', 'Safy-Khan M; Jacobs JWG; De Hair MJH; Welsing PMJ; Edwardes MD; Teitsma XM; Luder Y; Devenport J; Van Laar JM; Pethoe-Schramm A; Bijlsma JWJ. Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy. . (2020) 79 4 pp460', '10.1136/annrheumdis-2019-216537', '']\n",
      "['9257684', 'Strand V; Lampl K; Birchwood C; Pei J; Tuckwell K; Finch R; Gabay C; Kavanaugh A; Jones G. Patient-reported outcomes in two randomized, controlled trials (RCTS) in patients with rheumatoid arthritis (RA) treated with tocilizumab (TCZ) monotherapy compared with methotrexate (MTX) or adalimumab (ADA). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3356-3359', '10.1136/rmdopen-2017-000496', '']\n",
      "['9262678', 'Fautrel B; Zhu B; Taylor PC; Van De Laar M; Emery P; De Leonardis F; Gaich C; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R. Comparative effectiveness in pain and HAQ-DI improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in cSDMARD-naive rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp973-974', '10.1136/annrheumdis-2018-eular.1997', '']\n",
      "['9736488', 'Fautrel B; Zhu B; Taylor PC; Van De Laar M; Emery P; De Leonardis F; Gaich C; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R. Comparative effectiveness in pain and HAQ-DI improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in cSDMARD-naive rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp973-974', '10.1136/annrheumdis-2018-eular.1997', '']\n",
      "['9261118', 'Genovese MC; Sebba A; Andrea R-R; Scali JJ; Alten R; Kremer JM; Pitts L; Vernon E; Van Vollenhoven RF. Long-term safety of tocilizumab in patients with rheumatoid arthritis and a mean treatment duration of 3.7 years. Arthritis and rheumatism. (2012) 64  ppS700-S701', '10.1136/annrheumdis-2013-eular.1383', '']\n",
      "['9261714', 'Genovese MC; Rubbert-Roth A; Smolen JS; Kremer J; Khraishi M; G‚àö‚â•mez-Reino J; Sebba A; Pilson R; Williams S; Van Vollenhoven R. Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure. Journal of rheumatology. (2013) 40 6 pp768-780', '10.3899/jrheum.120687', '']\n",
      "['9261386', 'Genovese MC; Kremer JM; Van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Rowell L; Pitts L. Transaminase levels and hepatic events observed during tocilizumab treatment: Pooled analysis of long-term clinical trial safety data in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS201', '10.1002/art.40176', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40176']\n",
      "['9260783', 'Levi M; Grange S; Frey N. Exposure-response relationship of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in a large population of patients with rheumatoid arthritis. Journal of clinical pharmacology. (2013) 53 2 pp151-159', '10.1177/0091270012437585', '']\n",
      "['9739081', 'Haraoui B; Van Vollenhoven; R F; Smolen J S. Safety of tocilizumab in patients with rheumatoid arthritis: an interim analysis of long-term extension trials with a mean treatment duration of 1.5 years. Journal of rheumatology. (2009) 36 11 pp2596', '10.1136/annrheumdis-2013-eular.1383', '']\n",
      "['9739332', 'NCT03619876. Effects of Abatacept on Myocarditis in Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03619876. (2018)   pp', '10.1111/j.1742-1241.2007.01289.x', '']\n",
      "['9260757', 'Weinblatt ME; Schiff M; Valente R; van der Heijde D; Citera G; Zhao C; Maldonado M; Fleischmann R. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study. Arthritis and rheumatism. (2013) 65 1 pp28-38', '10.1002/art.37711', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.37711']\n",
      "['9260937', 'Schiff M; Weinblatt ME; Valente R; van der Heijde D; Citera G; Elegbe A; Maldonado M; Fleischmann R. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Annals of the rheumatic diseases. (2014) 73 1 pp86-94', '10.1136/annrheumdis-2013-203843', '']\n",
      "['9261112', 'Weinblatt ME; Schiff MH; Fleischmann R; Valente R; Van Der Heijde D; Citera G; Zhao C; Maldonado MA. Head to head comparison of subcutaneous abatacept versus adalimumab in the treatment of rheumatoid arthritis: Key efficacy and safety results from the ample (abatacept versus adalimumab comparison in biologic-naive RA subjects with background methotrexate) trial. Arthritis and rheumatism. (2012) 64  ppS1031', '10.1093/rheumatology/keu101.007', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i88/9578452/keu101.007.pdf']\n",
      "['9261120', 'Fleischmann R; Weinblatt ME; Schiff MH; Khanna D; Furst D; Maldonado MA. Changes in patient reported outcomes in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis: Results from the ample (abatacept versus adalimumab comparison in biologic naive RA subjects with background methotrexate) trial. Arthritis and rheumatism. (2012) 64  ppS578', '10.1136/annrheumdis-2014-eular.2113', '']\n",
      "['9261121', 'Fleischmann R; Schiff MH; Weinblatt ME; Maldonado MA; Massarotti EM; Yazici Y. Effects of subcutaneous abatacept or adalimumab on remission and associated changes in physical function and radiographic outcomes: One year results from the ample (abatacept versus adalimumab comparison in biologic-naive ra subjects with background methotrexate) trial. Arthritis and rheumatism. (2012) 64  ppS577', '10.1136/annrheumdis-2013-eular.1858', '']\n",
      "['9261287', 'Fleischmann R; Weinblatt M; Schiff M; Khanna D; Maldonado M; Nadkarni A; Furst D. 2-year results from the ample (abatacept versus adalimumab comparison in biologic-naive RA patients with background methotrexate) trial: Changes in patient-reported outcomes in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis. Journal of rheumatology. (2014) 41  7 pp1474-1475', '10.1136/annrheumdis-2014-eular.2113', '']\n",
      "['9261289', 'Maldonado M; Fleischmann R; Weinblatt M; Schiff M; Khanna D; Furst D. Changes in patient-reported outcomes in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis: Results from the ample (abatacept versus adalimumab comparison in biologic-naive ra subjects with background methotrexate) trial. Journal of rheumatology. (2013) 40  6 pp1006', '10.1136/annrheumdis-2014-eular.2113', '']\n",
      "['9261290', 'Maldonado M; Weinblatt M; Schiff M; Fleischmann R; Valente R; Van Der Heijde D; Citera G; Zhao C. Head-to-head comparison of subcutaneous abatacept versus adalimumab in the treatment of rheumatoid arthritis: Key efficacy and safety results from the ample (abatacept versus adalimumab comparison in biologic-naive RA subjects with background methotrexate) trial. Journal of rheumatology. (2013) 40  6 pp1005-1006', '10.1093/rheumatology/keu101.007', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i88/9578452/keu101.007.pdf']\n",
      "['9261306', 'Weinblatt ME; Schiff MH; Valente R; Van Der Heijde D; Citera G; Elegbe A; Maldonado MA; Fleischmann R. Head-to-head comparison of subcutaneous abatacept versus adalimumab on background methotrexate in rheumatoid arthritis: Blinded two-year results from the ample study. Rheumatology (United Kingdom). (2014) 53  ppi88', '10.1093/rheumatology/keu101.007', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i88/9578452/keu101.007.pdf']\n",
      "['9261311', 'Fleischmann R; Weinblatt M; Schiff M; Khanna D; Rosenblatt L; Maldonado M; Furst D. Improved quality of life, work productivity, general activity and independence in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis: Results from the AMPLE trial. Zeitschrift fur Rheumatologie. (2013) 72  2 SUPPL. 1 pp109-110', '10.1136/annrheumdis-2013-eular.1855', '']\n",
      "['9261313', 'Fleischmann R; Weinblatt M; Schiff M; Khanna D; Rosenblatt L; Maldonado M; Furst D. Improved quality of life, work productivity, general activity and independence in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis: Results from the ample trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1855', '']\n",
      "['9261339', 'Fleischmann R; Schiff M; Weinblatt M; Maldonado M; Massarotti E; Yazici Y. Remission, low disease activity, and associated changes in physical function and radiographic outcomes with subcutaneous abatacept or adalimumab: Results from the ample trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1858', '']\n",
      "['9261392', 'Fleischmann R; Weinblatt ME; Schiff M; Khanna D; Maldonado MA; Nadkarni A; Furst DE. 2-Year results from the ample (abatacept versus adalimumab comparison in biologic-naive RA patients with background methotrexate) trial: Changes in patient-reported outcomes in response to subcutaneous abatacept or adalimumab in rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS183', '10.1136/annrheumdis-2014-eular.2113', '']\n",
      "['9261520', 'Fleischmann R; Weinblatt M; Schiff M; Khanna D; Rosenblatt L; Maldonado M; Furst D; Roy S. Improved quality of life, work productivity, general activity and independence in response to subcutaneous Abatacept or Adalimumab in rheumatoid Arthritis: Results from the AMPLE trial. Indian Journal of Rheumatology. (2013) 8  ppS18', '10.1136/annrheumdis-2013-eular.1855', '']\n",
      "['9261886', 'Charles-Schoeman C; Gugiu GB; Ge H; Shahbazian A; Lee YY; Wang X; Furst DE; Ranganath VK; Maldonado M; Reddy ST. Proteomic profiling following immunoaffinity capture of high-density lipoprotein (HDL) identifies changes in multiple hdl-associated proteins following treatment with abatacept or adalimumab in the ample study of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp443', '10.1136/annrheumdis-2015-eular.2330', '']\n",
      "['9262014', 'Gaultney J; Nappi C; Benucci M; Iannazzo S; Sion K; Alemao E; Sabater J. Cost-effectiveness of abatacept compared to adalimumab in italy based on a head-to-head outcomes study in rheumatoid arthritis. Value in health. (2015) 18 7 ppA644', '10.1016/j.jval.2015.09.2302', '']\n",
      "['9262238', 'Weijers L; Baerwald C; Mennini FS; Rodriguez-Heredia JM; Bergman MJ; Choquette D; Herrmann KH; Attina G; Nappi C; Merino SJ; Patel C; Mtibaa M; Foo J. Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada. Rheumatology international. (2017) 37 7 pp1111-1123', '10.1007/s00296-017-3739-9', 'http://link.springer.com/article/10.1007/s00296-017-3739-9/fulltext.html']\n",
      "['9262605', 'Charles-Schoeman C; Gugiu GB; Ge H; Shahbazian A; Lee YY; Wang X; Furst DE; Ranganath VK; Maldonado M; Lee T; Reddy ST. Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis. Atherosclerosis. (2018) 275  pp107-114', '10.1016/j.atherosclerosis.2018.04.003', '']\n",
      "['9263547', 'Walsem AV; Patel C; Johnston S; Alemao E; Gaultney J. Anti-CCP2 quartile comparison of the cost per response for abatacept compared to adalimumab based on ample in the United States. Value in health. Conference: ISPOR 21st annual international meeting research. Washington, DC united states. Conference start: 20160521. Conference end: 20160525. Conference publication: (var.pagings). (2016) 19 3 ppA233', '10.1016/j.jval.2016.03.1146', '']\n",
      "['9738599', 'Foo J; Rodriguez-Heredia JMR; Sanchez CP; Mtibaa M; Herrmann KH; Alemao E; Postema R; Baerwald C. Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, DEU, ESP and CAN. Rheumatology (united kingdom). (2018) Conference: 2018 Annual Conference of the British Society for Rheumatology. United Kingdom. 57 Supplement 3 ppiii136-iii137', '10.1093/rheumatology/key075.444', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.444/24768364/key075.444.pdf']\n",
      "['9740826', '. Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada. Rheumatology international. (2019) 39 9 pp1621-1630', '10.1007/s00296-019-04352-2', 'http://link.springer.com/article/10.1007/s00296-019-04352-2/fulltext.html']\n",
      "['9740855', 'Fleischmann Roy; Weinblatt Michael; Ahmad Harris; Maldonado Michael A; Alemao Evo; Ye June; Schiff Michael. Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE). Rheumatology and therapy. (2019) 6 4 pp559-571', '10.1007/s40744-019-00174-7', 'https://link.springer.com/article/10.1007/s40744-019-00174-7/fulltext.html']\n",
      "['9741101', 'NCT00929864. Abatacept Versus Adalimumab Head-to-Head. https://clinicaltrials.gov/show/NCT00929864. (2009)   pp', '10.3410/f.718078250.793492818', '']\n",
      "['9742497', 'Charles-Schoeman C; Gugiu G B; Ge H; Shahbazian A; Lee Y Y; Wang X; Furst D E; Ranganath V K; Maldonado M; Lee Terry; Reddy S T. Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis. Atherosclerosis. (2018) 275  pp107-114', '10.1016/j.atherosclerosis.2018.04.003', '']\n",
      "['9742651', 'Schiff Michael; Weinblatt Michael E; Valente Robert; Citera Gustavo; Maldonado Michael; Massarotti Elena; Yazici Yusuf; Fleischmann Roy. Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration. RMD open. (2016) 2 1 ppe000210', '10.1136/rmdopen-2015-000210', '']\n",
      "['11085449', 'Jabado O; Maldonado MA; Schiff M; Weinblatt ME; Fleischmann R; Robinson WH; He A; Patel V; Greenfield A; Saini J; Galbraith D; Connolly SE. Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis. . (2021)   pp', '10.1007/s40744-021-00404-x', 'https://link.springer.com/article/10.1007/s40744-021-00404-x/fulltext.html']\n",
      "['11085578', 'Degboe Y; Schiff M; Weinblatt M; Fleischmann R; Ahmad HA; Constantin A. Background glucocorticoid therapy has no impact on efficacy and safety of abatacept or adalimumab in patients with rheumatoid arthritis. Journal of clinical medicine. (2020) 9 6 pp1-9', '10.3390/jcm9062017', '']\n",
      "['11085846', 'Jabado Omar; Maldonado Michael A; Schiff Michael; Weinblatt Michael E; Fleischmann Roy; Robinson William H; He Aiqing; Patel Vishal; Greenfield Alex; Saini Jasmine; Galbraith David; Connolly Sean E. Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis. Rheumatology and therapy. (2022) 9 2 pp391-409', '10.1007/s40744-021-00404-x', 'https://link.springer.com/article/10.1007/s40744-021-00404-x/fulltext.html']\n",
      "['11086233', 'Degboe Y; Schiff M; Weinblatt M; Fleischmann R; Ahmad HA; Constantin A. Background glucocorticoid therapy has no impact on efficacy and safety of abatacept or adalimumab in patients with rheumatoid arthritis. Journal of clinical medicine. (2020) 9 6 pp1-9', '10.3390/jcm9062017', '']\n",
      "['11086593', 'Klink A; Han X; Lobo F; Szymialis R; Lam J; Feinberg B. Clinical benefits reported in ample trial observed in a real-world (RW) cohort of us rheumatoid arthritis (RA) patients. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp626-627', '10.1136/annrheumdis-2020-eular.1453', '']\n",
      "['9261384', 'Christensen R; Tarp S; Furst DE; Kristensen LE; Bliddal H. Efficacy and safety of infliximab or adalimumab vs abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Attest-ample network randomized trial. Arthritis and rheumatism. (2013) 65  ppS219', '10.2217/ijr.13.62', '']\n",
      "['9740616', '. Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/ double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials. Clinical and experimental rheumatology. (2019) 37 1 pp127-132', '10.1093/rheumatology/kew144.015', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i98/5079020/kew144.015.pdf']\n",
      "['9741768', 'Buch Maya H; Johnsen Alyssa; Schiff Michael. Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials. Clinical and experimental rheumatology. (2019) 37 1 pp127-132', '10.1093/rheumatology/kew144.015', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i98/5079020/kew144.015.pdf']\n",
      "['9259003', \"Andersen PA; West SG; O'Dell JR; Via CS; Claypool RG; Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Annals of internal medicine. (1985) 103 4 pp489-496\", '10.7326/0003-4819-103-4-489', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-103-4-489']\n",
      "['9737930', 'Morimoto A; Rae J; Chinn L; Ramamoorthi N; Hwang O; Ward A; Haddon DJ; Looney C; Desai R; Toth B; Tuckwell K; Townsend MJ. The BTK inhibitor, fenebrutinib, effectively modulates b and myeloid cell biology in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp733-734', '10.1136/annrheumdis-2019-eular.5162', '']\n",
      "['9739757', 'EUCTR2016-000335-40-BG. A Study examining the treatment effect and Safety of GDC-0853 when compared With Placebo and a biologic therapy (Adalimumab) in Rheumatoid Arthritis Patients who have not responded or intolerance to Previous therapies. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000335-40-BG. (2016)   pp', '10.1186/isrctn63375144', '']\n",
      "['9740884', 'Cohen S; Tuckwell K; Katsumoto TR; Zhao R; Lee C; Berman A; Damjanov N; Fedkov D; Jeka S; Genovese MC. Fenebrutinib compared to placebo and adalimumab in patients with inadequate response to either methotrexate therapy or prior tnf therapy: phase 2 study. Annals of the rheumatic diseases. (2019) 78  pp80-81', '10.1136/annrheumdis-2019-eular.4469', '']\n",
      "['11084444', 'Cohen S; Tuckwell K; Katsumoto TR; Zhao R; Galanter J; Lee C; Rae J; Toth B; Ramamoorthi N; Hackney JA; Berman A; Damjanov N; Fedkov D; Jeka S; Chinn LW; Townsend MJ; Morimoto AM; Genovese MC. Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: a Randomized, Double-Blind, Phase II Trial (ANDES Study). . (2020)   pp', '10.1002/art.41275', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.41275']\n",
      "['9739597', 'ISRCTN46017566. Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with Abatacept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN46017566. (2014)   pp', '10.1186/isrctn46017566', '']\n",
      "['9740736', \"Al-Laith M; Jasenecova M; Abraham S; Bosworth A; Bruce IN; Buckley CD; Ciurtin C; D'Agostino M-A; Emery P; Gaston H; Isaacs JD; Filer A; Fisher BA; Huizinga TWJ; Ho P; Jacklin C; Lempp H; McInnes IB; Pratt AG; Ostor A; Raza K; Taylor PC; Van Schaardenburg D; Shivapatham D; Wright AJ; Vasconcelos JC; Kelly J; Murphy C; Prevost AT; Cope AP. Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials. (2019) 20 1 pp\", '10.1186/s13063-019-3403-7', 'http://link.springer.com/article/10.1186/s13063-019-3403-7/fulltext.html']\n",
      "['9741677', \"Al-Laith Mariam; Jasenecova Marianna; Abraham Sonya; Bosworth Aisla; Bruce Ian N; Buckley Christopher D; Ciurtin Coziana; D'Agostino Maria-Antonietta; Emery Paul; Gaston Hill; Isaacs John D; Filer Andrew; Fisher Benjamin A; Huizinga Thomas W J; Ho Pauline; Jacklin Clare; Lempp Heidi; McInnes Iain B; Pratt Arthur G; Ostor Andrew; Raza Karim; Taylor Peter C; van Schaardenburg Dirkjan; Shivapatham Dharshene; Wright Alison J; Vasconcelos Joana C; Kelly Joanna; Murphy Caroline; Prevost A Toby; Cope Andrew P. Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials. (2019) 20 1 pp429\", '10.1186/s13063-019-3403-7', 'http://link.springer.com/article/10.1186/s13063-019-3403-7/fulltext.html']\n",
      "['9256811', 'Bae SC; Gun SC; Mok CC; Khandker R; Nab HW; Koenig AS; Vlahos B; Pedersen R; Singh A. Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. BMC musculoskeletal disorders. (2013) 14  pp13', '10.1186/1471-2474-14-13', 'http://link.springer.com/article/10.1186/1471-2474-14-13/fulltext.html']\n",
      "['9260828', 'Kim HY; Hsu PN; Barba M; Sulaiman W; Robertson D; Vlahos B; Khandker R; Nab H; Freundlich B; Koenig A. Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial. International journal of rheumatic diseases. (2012) 15 2 pp188-196', '10.1111/j.1756-185x.2011.01680.x', '']\n",
      "['9739095', 'Kim H Y; Hsu P N; Barba M; Sulaiman W; Robertson D; Vlahos B; Khandker R; Nab H; Freundlich B; Koenig A. Efficacy comparison of etanercept with usual DMARD therapy in an Asia-Pacific population. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp88', '10.1111/j.1756-185x.2011.01680.x', '']\n",
      "['9740911', 'NCT00422227. Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region. https://clinicaltrials.gov/show/NCT00422227. (2007)   pp', '10.1186/ar2084', 'https://link.springer.com/article/10.1186/ar2084/fulltext.html']\n",
      "['9261652', 'Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis. Rheumatology (Oxford, England). (2014) 53 11 pp1984-1993', '10.1093/rheumatology/keu235', 'http://academic.oup.com/rheumatology/article-pdf/53/11/1984/17388453/keu235.pdf']\n",
      "['11088763', '. A study of MSB11456 compared to RoActemra in patients with moderately to severely active rheumatoid arthritis (APTURA I). . (2020)   pp', '10.2165/00128413-200615440-00065', '']\n",
      "['9739576', 'EUCTR2014-000109-11-BG. Study to assess the efficacy and safety of FKB327 compared with Humira¬¨√Ü, when each is administered in combination with Methotrexate in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-000109-11-BG. (2014)   pp', '10.31525/ct1-nct04230213', '']\n",
      "['9262310', 'Jonsson MK; Sundlis√¶ter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 12 pp2031-2037', '10.1136/annrheumdis-2017-211695', '']\n",
      "['9737692', 'Nordberg Lena Bugge; Lillegraven Siri; Aga Anna-Birgitte; Sexton Joseph; Olsen Inge Christoffer; Lie Elisabeth; Berner Hammer Hilde; Uhlig Till; van der Heijde Desiree; Kvien Tore K; Haavardsholm Espen A. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. RMD open. (2018) 4 2 ppe000752', '10.1136/rmdopen-2018-000752', '']\n",
      "['9738611', 'Paulshus Sundlisaeter N; Aga A-B; Olsen IC; Hammer HB; Uhlig T; Van Der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Annals of the rheumatic diseases. (2018) (no pagination)  pp', '10.1136/annrheumdis-2017-212830', '']\n",
      "['9741017', 'NCT01205854. Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial. https://clinicaltrials.gov/show/NCT01205854. (2010)   pp', '10.1007/bf03318142', 'http://link.springer.com/article/10.1007/BF03318142/fulltext.html']\n",
      "['9742009', 'Holten Karen; Sexton Joseph; Kvien Tore K; Aga Anna-Birgitte; Haavardsholm Espen A. Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study. RMD open. (2018) 4 2 ppe000754', '10.1136/rmdopen-2018-000754', '']\n",
      "['9742136', 'Holten K; Sexton J; Kvien TK; Haavardsholm EA; Aga A-B. Comparative analyses of responsiveness between the rheumatoid arthritis impact of disease (RAID) score, other patient reported outcomes and disease activity measures: secondary analyses from the arctic study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1824', '10.1136/annrheumdis-2018-eular.2889', '']\n",
      "['9742428', 'Norvang V; Brinkmann GH; Yoshida K; Lillegraven S; Aga A-B; Sexton J; Tedeschi SK; Lyu H; Norli ES; Uhlig T; Kvien TK; Mjaavatten MD; Solomon DH; Haavardsholm EA; Fremstad H; Madland TM; Lexberg AS; Haukeland H; Rodevand E; Hoili C; Stray H; Bendvold AN; Widding-Hansen IJ; Bakland G; Thunem C; Kverneggen Ovreas H. Achievement of Remission in Two Early Rheumatoid Arthritis Cohorts Implementing Different Treat-to-Target Strategies. Arthritis and rheumatology. (2020)   pp', '10.1002/art.41232', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.41232']\n",
      "['9743066', 'Sundin Ulf; Aga Anna-Birgitte; Skare Oivind; Nordberg Lena B; Uhlig Till; Hammer Hilde B; van der Heijde Desiree; Kvien Tore K; Lillegraven Siri; Haavardsholm Espen A; ARCTIC study group. Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/kez674', 'http://academic.oup.com/rheumatology/article-pdf/59/9/2550/33686414/kez674.pdf']\n",
      "['11085031', 'Holten K; Paulshus Sundlisater N; Lillegraven S; Sexton J; Nordberg LB; Moholt E; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Aga A-B. Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment. . (2021)   pp', '10.1136/annrheumdis-2021-220750', '']\n",
      "['11085077', 'Paulshus Sundlis√¶ter N; Sundin U; Aga AB; Sexton J; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Lillegraven S. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study. . (2022) 8 1 pp', '10.1136/rmdopen-2021-002013', '']\n",
      "['11085649', 'Paulshus Sundlis√¶ter N; Sundin U; Aga AB; Sexton J; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Lillegraven S. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study. RMD open. (2022) 8 1 pp', '10.1136/rmdopen-2021-002013', '']\n",
      "['11085658', 'Holten K; Paulshus Sundlisater N; Lillegraven S; Sexton J; Nordberg LB; Moholt E; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Aga AB. Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment. Annals of the rheumatic diseases. (2022) 81 3 pp344-350', '10.1136/annrheumdis-2021-220750', '']\n",
      "['11086594', 'Lillegraven S; Sundlisater NP; Aga AB; Sexton J; Olsen I; Fremstad H; Spada C; Madland TM; Hoili CA; Bakland G; Lexberg A; Widding Hansen IJ; Hansen IM; Haukeland H; Ljosa MKA; Moholt E; Uhlig T; Solomon D; Van Der Heijde D; Kvien TK; Haavardsholm EA. Tapering of conventional synthetic disease modifying anti-rheumatic drugs in sustained rheumatoid arthritis remission: results from a randomized controlled trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1012-1013', '10.1136/annrheumdis-2020-eular.3090', '']\n",
      "['11086603', 'Lillegraven S; Sundlisaeter NP; Aga AB; Sexton J; Olsen I; Lexberg A; Madland TM; Fremstad H; Hoili CA; Bakland G; Spada C; Haukeland H; Hansen IM; Moholt E; Uhlig T; Solomon D; Van Der Heijde D; Kvien TK; Haavardsholm EA. Stable versus tapered and withdrawn treatment with tumor necrosis factor inhibitor in rheumatoid arthritis remission (Arctic Rewind): a randomised, open-label, phase 4, non-inferiority trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp14-15', '10.1136/annrheumdis-2020-eular.1955', '']\n",
      "['9259907', 'Weinblatt ME; Keystone EC; Furst DE; Moreland LW; Weisman MH; Birbara CA; Teoh LA; Fischkoff SA; Chartash EK. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis and rheumatism. (2003) 48 1 pp35-45', '10.1002/art.546', '']\n",
      "['9260171', 'Weinblatt ME; Keystone EC; Furst DE; Kavanaugh AF; Chartash EK; Segurado OG. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Annals of the rheumatic diseases. (2006) 65 6 pp753-759', '10.1136/ard.2005.044404', '']\n",
      "['9738999', 'Torrance G W; Tugwell P; Amorosi S; Chartash E; Sengupta N. Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate. Rheumatology. (2004) 43 6 pp712-718', '10.1093/rheumatology/keh153', 'http://academic.oup.com/rheumatology/article-pdf/43/6/712/9445317/keh153.pdf']\n",
      "['9740499', '. Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate. Rheumatology. (2004) 43 6 pp712-718', '10.1093/rheumatology/keh153', 'http://academic.oup.com/rheumatology/article-pdf/43/6/712/9445317/keh153.pdf']\n",
      "['9740773', 'Aletaha Daniel; Maa Jen-Fue; Chen Su; Park Sung-Hwan; Nicholls Dave; Florentinus Stefan; Furtner Daniel; Smolen Josef S. Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 12 pp1609-1615', '10.1136/annrheumdis-2018-214918', '']\n",
      "['9257732', 'Yount S; Sorensen MV; Cella D; Sengupta N; Grober J; Chartash EK. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clinical and experimental rheumatology. (2007) 25 6 pp838-846', '10.1093/rheumatology/keh153', 'http://academic.oup.com/rheumatology/article-pdf/43/6/712/9445317/keh153.pdf']\n",
      "['9259126', \"Arnold MH; O'Callaghan J; McCredie M; Beller EM; Kelly DE; Brooks PM. Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study. British journal of rheumatology. (1990) 29 2 pp120-125\", '10.1093/rheumatology/29.2.120', 'http://academic.oup.com/rheumatology/article-pdf/29/2/120/5028988/29-2-120.pdf']\n",
      "['9257967', 'Alheresh R; Allaire SH; Lavalley MP; Vaughan M; Emmetts R; Keysor JJ. \"Work it\" recruitment: Lessons learned from an arthritis work disability prevention randomized trial. Arthritis and rheumatism. (2013) 65  ppS1220', '10.1016/j.conctc.2021.100862', '']\n",
      "['9740406', 'EUCTR2017-002878-38-NL. Abatacept to Silence anti-Citrullinated protein Antibody-expressing B cells in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-002878-38-NL. (2017)   pp', '10.1136/annrheumdis-2023-eular.4607', '']\n",
      "['9256861', 'Smolen JS; Han C; van der Heijde DM; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Aletaha D; Baker D; Han J; Bala M; St Clair EW; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Annals of the rheumatic diseases. (2009) 68 6 pp823-827', '10.1136/ard.2008.090019', '']\n",
      "['9256910', 'Visvanathan S; Marini JC; Smolen JS; Clair EW; Pritchard C; Shergy W; Pendley C; Baker D; Bala M; Gathany T; Han J; Wagner C. Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis. Journal of rheumatology. (2007) 34 7 pp1465-1474', '10.1002/art.22054', '']\n",
      "['9258557', 'Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis and rheumatism. (2006) 54 3 pp702-710', '10.1002/art.21678', '']\n",
      "['9258570', 'Smolen JS; Han C; van der Heijde D; Emery P; Bathon JM; Keystone E; Kalden JR; Schiff M; Bala M; Baker D; Han J; Maini RN; St Clair EW. Infliximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 3 pp716-722', '10.1002/art.21661', '']\n",
      "['9260380', 'Bejarano V; Quinn M; Conaghan PG; Reece R; Keenan AM; Walker D; Gough A; Green M; McGonagle D; Adebajo A; Jarrett S; Doherty S; Hordon L; Melsom R; Unnebrink K; Kupper H; Emery P; Yorkshire Early Arthritis Register Consortium. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2008) 59 10 pp1467-1474', '10.1002/art.24106', '']\n",
      "['9260298', 'Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 9 pp2840-2844', '10.1002/art.22054', '']\n",
      "['9260494', 'Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. Annals of the rheumatic diseases. (2009) 68 10 pp1535-1540', '10.1136/ard.2008.094128', '']\n",
      "['9260547', 'Haugeberg G; Conaghan PG; Quinn M; Emery P. Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases. (2009) 68 12 pp1898-1901', '10.1136/ard.2008.106484', '']\n",
      "['9263423', 'Moreland L. Efficacy of costimulation blockade with abatacept in rheumatoid arthritis patients refractory to tumor necrosis factor-alpha inhibition. Current rheumatology reports. (2006) 8  5 pp367', '10.1007/s11926-006-0066-7', 'http://link.springer.com/article/10.1007/s11926-006-0066-7/fulltext.html']\n",
      "['9258152', 'Han C; Smolen J; Kavanaugh A; St Clair EW; Baker D; Bala M. Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis. Arthritis and rheumatism. (2008) 59 4 pp510-514', '10.1002/art.23541', '']\n",
      "['9263258', 'Han C; Rahman MU; Doyle MK; Bathon JM; Smolen J; Kavanaugh A; Westhovens R; St Clair EW; Baker D; Bala M. Association of anemia and physical disability among patients with rheumatoid arthritis. Journal of rheumatology. (2007) 34 11 pp2177-2182', '10.1186/ar2306', 'https://link.springer.com/article/10.1186/ar2306/fulltext.html']\n",
      "['9738463', 'Strand V; Purcaru O; Kavanaugh A. Work productivity measures as treatment goals beyond signs and symptoms. Arthritis and rheumatism. (2009) 60  pp64-', '10.1002/art.24828', '']\n",
      "['9736746', 'Koller MD; Aletaha D; Funovits J; Pangan A; Baker D; Smolen JS. Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients. Rheumatology. (2009) 48 12 pp1575-1580', '10.1093/rheumatology/kep291', 'http://academic.oup.com/rheumatology/article-pdf/48/12/1575/5053796/kep291.pdf']\n",
      "['9260808', 'Conaghan PG; Durez P; Alten RE; Burmester GR; Tak PP; Klareskog L; Catrina AI; DiCarlo J; Gaillez C; Le Bars M; Zhou X; Peterfy C. Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial. Annals of the rheumatic diseases. (2013) 72 8 pp1287-1294', '10.1136/annrheumdis-2012-201611', '']\n",
      "['9261234', 'Conaghan P; Durez P; Alten RH-E; Burmester G-R; Tak P; Catrina A; Gaillez C; Le Bars M; Zhou X; Peterfy C. Persistent beneficial effect of Abatacept on magnetic resonance imaging(MRI)-assessed synovitis and structural damage through 12 months in Methotrexate (MTX)-inadequate responders with active rheumatoid arthritis (RA). Zeitschrift fur Rheumatologie. (2011) 70  pp81', '10.1136/annrheumdis-2012-201611', '']\n",
      "['9737286', 'EUCTR2006-003768-67-SE. A Phase III Multicenter, Randomized, Double-Blind, placebo-controlled Study to Assess short-term changes in synovitis and structural damage outcomes in subjects with active Rheumatoid Arthritis and inadequate response to Methotrexate, Treated with Abatacept versus Placebo on a Background Therapy with Methotrexate  Revised Protocol 03, incorporating Protocol Amendment 01 (Version 1.0, Date 16-May-2007), Protocol Amendment 03 (Version 1.0, Date 19-Mar-2008), Protocol Amendment 04 (Version 1.0, Date 05-Dec-2008), and Administrative Letter dated 13-Jun-2007. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003768-67-SE. (2007)   pp', '10.3410/f.1097731.553845', '']\n",
      "['9741001', 'NCT00420199. A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate. https://clinicaltrials.gov/show/NCT00420199. (2007)   pp', '10.31525/ct1-nct04204603', '']\n",
      "['9739801', 'EUCTR2012-003876-38-PL. Clinical study to find out if the biologically similar medicine GP2013 is safe in patients with rheumatoid arthritis who have been treated with Rituxan¬¨√Ü or MabThera¬¨√Ü in the past. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003876-38-PL. (2015)   pp', '10.1111/1756-185x.15055', '']\n",
      "['9260217', 'Weinblatt M; Combe B; Covucci A; Aranda R; Becker JC; Keystone E. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis and rheumatism. (2006) 54 9 pp2807-2816', '10.1002/art.22070', '']\n",
      "['9257458', 'Genovese MC; Schiff M; Luggen M; Becker JC; Aranda R; Teng J; Li T; Schmidely N; Le Bars M; Dougados M. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Annals of the rheumatic diseases. (2008) 67 4 pp547-554', '10.1136/ard.2007.074773', '']\n",
      "['9260125', 'Genovese MC; Becker JC; Schiff M; Luggen M; Sherrer Y; Kremer J; Birbara C; Box J; Natarajan K; Nuamah I; Li T; Aranda R; Hagerty DT; Dougados M. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. New England journal of medicine. (2005) 353 11 pp1114-1123', '10.1056/nejmoa050524', '']\n",
      "['9260230', 'Westhovens R; Cole JC; Li T; Martin M; Maclean R; Lin P; Blaisdell B; Wallenstein GV; Aranda R; Sherrer Y. Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial. Rheumatology (Oxford, England). (2006) 45 10 pp1238-1246', '10.1093/rheumatology/kel066', 'http://academic.oup.com/rheumatology/article-pdf/45/10/1238/6698111/kel066.pdf']\n",
      "['9260322', 'Hassett AL; Li T; Buyske S; Savage SV; Gignac MA. The multi-faceted assessment of independence in patients with rheumatoid arthritis: preliminary validation from the ATTAIN study. Current medical research and opinion. (2008) 24 5 pp1443-1453', '10.1185/030079908x297376', '']\n",
      "['9260347', 'Fernandez-Lopez C; Blanco FJ. ATTAIN study: Efficacy of abatacept in patients with rheumatoid arthritis and inadequate response to anti-TNF-alpha. [Spanish]. Reumatologia Clinica Suplementos. (2006) 1 2 pp34-43', '10.1093/rheumatology/kes115', 'http://academic.oup.com/rheumatology/article-pdf/51/suppl_5/v22/5055090/kes115.pdf']\n",
      "['9263201', 'Wells G; Li T; Maxwell L; Maclean R; Tugwell P. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Annals of the rheumatic diseases. (2008) 67 2 pp260-265', '10.1136/ard.2007.069690', '']\n",
      "['9263366', 'Genovese MC; Schiff M; Luggen M; Le Bars M; Aranda R; Elegbe A; Dougados M. Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy. Journal of rheumatology. (2012) 39 8 pp1546-1554', '10.3899/jrheum.111531', '']\n",
      "['9256934', 'Atteritano M; Mazzaferro S; Mantuano S; Bagnato GL; Bagnato GF. Effects of infliximab on sister chromatid exchanges and chromosomal aberration in patients with rheumatoid arthritis. Cytotechnology. (2016) 68  2 pp313-318', '10.1007/s10616-014-9782-4', 'http://link.springer.com/article/10.1007/s10616-014-9782-4/fulltext.html']\n",
      "['9260308', 'Schiff M; Keiserman M; Codding C; Songcharoen S; Berman A; Nayiager S; Saldate C; Li T; Aranda R; Becker JC; Lin C; Cornet PL; Dougados M. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Annals of the rheumatic diseases. (2008) 67 8 pp1096-1103', '10.1136/ard.2007.080002', '']\n",
      "['9260771', 'Benucci M; Stam WB; Gilloteau I; Sennf‚àö¬ßlt K; Leclerc A; Maetzel A; Lucioni C. Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis. Clinical and experimental rheumatology. (2013) 31 4 pp575-583', '10.1016/j.jval.2011.08.415', '']\n",
      "['9263335', 'Schiff M; Keiserman M; Codding C; Songcharoen S; Berman A; Nayiager S; Saldate C; Aranda R; Becker JC; Nys M; le Bars M; Reed DM; Poncet C; Dougados M. Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study. Annals of the rheumatic diseases. (2011) 70 11 pp2003-2007', '10.1136/annrheumdis-2011-200316', '']\n",
      "['9737050', 'EUCTR2004-000922-59-SE. A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination with Methotrexate in Controlling Disease Activity in Subjects with Rheumatoid Arthritis Having an Inadequate Clinical Response to Methotrexate.  Revised Protocol 1 , incorporating Amendment 02 (v5.0).  Pharmacogenomic Amendment 01.  Protocol Amendment 03 - Long-Term Extension.  Protocol Amendment 05 - Long Term Extension Site Specific (V2.0, Date 23-Dec-2006). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000922-59-SE. (2004)   pp', '10.3410/f.1097731.553845', '']\n",
      "['9738973', 'Schiff M; Keiserman M; Codding C; Songcharoen S; Berman A; Nayiager S; Saldate C; Aranda R; Becker J C; Zhao C; Le Bars; Dougados M. 2-year efficacy and safety in abatacepttreated patients with rheumatoid arthritis who received continuous therapy or switched from infliximab to abatacept: the attest trial. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1136/annrheumdis-2011-200316', '']\n",
      "['9741012', 'NCT00095147. Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00095147. (2004)   pp', '10.1093/rheumatology/kev080.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i28/5179183/kev080.006.pdf']\n",
      "['9256954', 'Breedveld FC; Emery P; Keystone E; Patel K; Furst DE; Kalden JR; St Clair EW; Weisman M; Smolen J; Lipsky PE; Maini RN. Infliximab in active early rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 2 pp149-155', '10.1136/ard.2003.013961', '']\n",
      "['9257449', 'Lipsky PE; Van Der Heijde DMFM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN. Infliximab and methotrexate in the treatment of rheumatoid arthritis. New England journal of medicine. (2000) 343 22 pp1594-1602', '10.1056/nejm200011303432202', '']\n",
      "['9257984', 'Breedveld FC; Han C; Bala M; van der Heijde D; Baker D; Kavanaugh AF; Maini RN; Lipsky PE. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 1 pp52-55', '10.1136/ard.2003.017160', '']\n",
      "['9258511', 'St Clair EW; Wagner CL; Fasanmade AA; Wang B; Schaible T; Kavanaugh A; Keystone EC. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2002) 46 6 pp1451-1459', '10.1002/art.10302', '']\n",
      "['9258695', 'Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis and rheumatism. (2004) 50 4 pp1051-1065', '10.1002/art.20159', '']\n",
      "['9260069', 'Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE; ATTRACT Study Group. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis and rheumatism. (2005) 52 4 pp1020-1030', '10.1002/art.20982', '']\n",
      "['9263115', 'Maini R; St Clair EW; Breedveld F; Furst D; Kalden J; Weisman M; Smolen J; Emery P; Harriman G; Feldmann M; Lipsky P. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. Lancet. (1999) 354 9194 pp1932-1939', '10.1016/s0140-6736(99)05246-0', '']\n",
      "['9737564', 'Wong J B; Singh G; Kavanaugh A. Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. American journal of medicine. (2002) 113 5 pp400-408', '10.1016/s0002-9343(02)01243-3', '']\n",
      "['9739283', 'Keystone E C; Haraoui B; Bykerk V P. Role of infliximab in the treatment of early rheumatoid arthritis. Clinical and experimental rheumatology. (2003) 21 5 Suppl 31 ppS200-S202', '10.1016/j.berh.2004.08.011', '']\n",
      "['9739356', 'Alten R; Nitschmann S. Janus kinase inhibitor baricitinib for rheumatoid arthritis : randomized, double-blind, placebo- and active-controlled, phase¬†3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy (RA-BEAM). Der Internist. (2017) 58 12 pp1341-1344', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739793', 'ISRCTN51200229. Randomised double blind trial of safety of anti-tumour necrosis factor (anti-TNF) chimeric monoclonal antibody (infliximab) in combination with methatrexate compared to methatrexate alone in patients with rheumatoid arthritis on standard disease modifying anti-rheumatic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN51200229. (2003)   pp', '10.1186/isrctn51200229', '']\n",
      "['9260703', 'Genovese MC; Kinnman N; de La Bourdonnaye G; Pena Rossi C; Tak PP. Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial. Arthritis and rheumatism. (2011) 63 7 pp1793-1803', '10.1002/art.30373', '']\n",
      "['9741042', 'NCT00430495. A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I). https://clinicaltrials.gov/show/NCT00430495. (2007)   pp', '10.1002/art.23178', '']\n",
      "['9739154', 'Van Vollenhoven; Tak P P; Bathon J; Genovese M; Vincent E C; Kinnman N. Atacicept reduces immunoglobulin and B-cell levels in patients with rheumatoid arthritis. Lupus. (2010) 19 SUPPL. 1 pp122', '10.1002/art.30372', '']\n",
      "['9260702', 'van Vollenhoven RF; Kinnman N; Vincent E; Wax S; Bathon J. Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial. Arthritis and rheumatism. (2011) 63 7 pp1782-1792', '10.1002/art.30372', '']\n",
      "['9740302', 'EUCTR2007-002536-29-DE. A randomised, double-blind, placebo controlled, multi-centre phase II study of atacicept in anti- TNF alfa-na‚àö√òve patients with moderate to severely active rheumatoid arthritis and an inadequate response to methotrexate - Atacicept in anti-TNF alfa-na‚àö√òve subjects with RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-002536-29-DE. (2007)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9742955', 'Mazurov V; Zotkin E; Ilivanova E; Kropotina T; Plaksina T; Nesmeyanova O; Soroka N; Kundzer A; Lutskii A; Dokukina E; Chernyaeva E; Ivanov R. Short-term efficacy of BCD-089, novel monoclonal anti-IL-6 receptor antibody, in combination with methotrexate in patients with rheumatoid arthritis: 12-week results of phase 2 Aurora study. Annals of the rheumatic diseases. (2019) 78  pp721-', '10.1136/annrheumdis-2019-eular.7220', '']\n",
      "['11085520', 'Mazurov V; Zotkin E; Ilivanova E; Kropotina T; Plaksina T; Nesmeyanova O; Soroka N; Kundzer A; Lutskii A; Dokukina E; Eremeeva A; Zinkina-Orihan A. Efficacy of levilimab, novel monoclonal anti-IL-6 receptor antibody, in combination with methotrexate in patients with rheumatoid arthritis: 1-year results of phase 2 aurora study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp637-638', '10.1136/annrheumdis-2020-eular.5465', '']\n",
      "['9258194', 'Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Wong DA; Emery P. On drug and drug-free remission by baseline disease duration: abatacept versus methotrexate comparison in patients with early rheumatoid arthritis. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp42', '10.1136/annrheumdis-2015-eular.2071', '']\n",
      "['9261842', 'Furst DE; Bykerk VP; Burmester GR; Combe BG; Huizinga TWJ; Alemao E; Wong DA; Emery P. Treatment effects and minimal clinically important differences in patient-reported outcomes following treatment and withdrawal of abatacept, methotrexate or combination therapy in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp1044', '10.1136/annrheumdis-2015-eular.1463', '']\n",
      "['9261881', 'Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Wong DA; Emery P. On drug and drug-free remission by baseline disease duration in the avert trial: abatacept versus methotrexate comparison in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp477-478', '10.1136/annrheumdis-2015-eular.2071', '']\n",
      "['9262220', 'Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TW; Wong DA; Conaghan PG; Emery P. Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 8 pp1501-1505', '10.1136/annrheumdis-2015-208258', '']\n",
      "['9262479', 'Ahmad H; Baker J; Ostergaard M; Emery P; Durez P; Ye J; Banerjee S; Conaghan P. Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-naive RA: data from the avert trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp174', '10.1136/annrheumdis-2017-eular.1723', '']\n",
      "['9261955', 'Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Peth‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (u-act-early): a multicentre, randomised, double-blind, double-dummy, strategy trial. Lancet (london, england). (2016) 388 10042 pp343-355', '10.1016/s0140-6736(16)30363-4', '']\n",
      "['9736725', 'Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Karyekar CS; Wong DA; Huizinga TWJ. Predictors of drug-free remission following treatment with abatacept (in combination with methotrexate or as monotherapy) in early rheumatoid arthritis. Rheumatology (united kingdom). (2015) 54 Supplement 1 ppi28-i29', '10.1093/rheumatology/kev080.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i28/5179183/kev080.006.pdf']\n",
      "['9736943', 'Ahmad HA; Baker JF; Ostergaard M; Ye J; Emery P; Conaghan PG. Validating MRI-detected inflammation thresholds predictive of structural damage progression in patients with rheumatoid arthritis in a randomized placebo-controlled trial. Annals of the rheumatic diseases. (2016) 75  pp624-', '10.1136/annrheumdis-2016-eular.1374', '']\n",
      "['9737206', 'Emery P; Burmester G; Bykerk V P; Combe B; Furst D E; Barre E; Karyekar C S; Wong D; Huizinga T W J. Predictors of drug-free remission following treatment with abatacept (in combination with methotrexate or as monotherapy) in early rheumatoid arthritis. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1084', '10.1093/rheumatology/kev080.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i28/5179183/kev080.006.pdf']\n",
      "['9739060', 'Emery P; Burmester G; Bykerk V; Combe B; Furst D E; Maldonado M A; Huizinga T W. Abatacept plus methotrexate can effectively and safely regain the target of remission following re-treatment for flares after drug-free withdrawal in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp720-721', '10.1136/annrheumdis-2016-eular.2054', '']\n",
      "['9739610', 'Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Maldonado MA; Huizinga TWJ. Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD open. (2019) 5 1 pp', '10.1136/rmdopen-2018-000840', '']\n",
      "['9740088', 'PER-041-15. A PHASE 3B, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT SC IN COMBINATION WITH METHOTREXATE COMPARED TO METHOTREXATE MONOTHERAPY IN ACHIEVING CLINICAL REMISSION IN ADULTS WITH EARLY RHEUMATOID ARTHRITIS WHO ARE METHOTREXATE NAIVE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-041-15. (2016)   pp', '10.3410/f.14174.471676', '']\n",
      "['9740110', 'EUCTR2010-018674-20-SE. Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-018674-20-SE. (2010)   pp', '10.1186/isrctn32484878', '']\n",
      "['9740663', 'Ahmad Harris A; Baker Joshua F; Ostergaard Mikkel; Ye June; Emery Paul; Conaghan Philip G. Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: results of a Randomized, Placebo-Controlled Trial. Advances in therapy. (2019) 36 9 pp2384-2393', '10.1007/s12325-019-01020-6', 'http://link.springer.com/article/10.1007/s12325-019-01020-6/fulltext.html']\n",
      "['9741038', 'NCT01142726. Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01142726. (2010)   pp', '10.1186/isrctn49682259', '']\n",
      "['9742965', 'Bykerk Vivian P; Burmester Gerd R; Combe Bernard G; Furst Daniel E; Huizinga Tom W J; Ahmad Harris A; Emery Paul. On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology international. (2018) 38 12 pp2225-2231', '10.1007/s00296-018-4173-3', 'http://link.springer.com/article/10.1007/s00296-018-4173-3/fulltext.html']\n",
      "['11086582', 'Gandhi Y; Connolly S; Huang KHG; Wong R; Chilewski S; Murthy B. The relationship between abatacept exposure and efficacy measures in early MTX-naive anti-citrullinated protein antibody-positive patients with RA during the de-escalation period of a phase IIIB study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp593-594', '10.1136/annrheumdis-2020-eular.6017', '']\n",
      "['9737594', 'Keystone Edward C; Ahmad Harris A; Yazici Yusuf; Bergman Martin J. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England). (2019)   pp', '10.1093/rheumatology/kez455', 'http://academic.oup.com/rheumatology/article-pdf/59/8/2090/33532505/kez455.pdf']\n",
      "['9741007', 'Keystone EC; Ahmad HA; Yazici Y; Bergman MJ. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England). (2019)   pp', '10.1093/rheumatology/kez455', 'http://academic.oup.com/rheumatology/article-pdf/59/8/2090/33532505/kez455.pdf']\n",
      "['9742406', 'Keystone EC; Ahmad HA; Yazici Y; Bergman MJ. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England). (2019)   pp', '10.1093/rheumatology/kez455', 'http://academic.oup.com/rheumatology/article-pdf/59/8/2090/33532505/kez455.pdf']\n",
      "['9742406', 'Keystone EC; Ahmad HA; Yazici Y; Bergman MJ. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England). (2019)   pp', '10.1093/rheumatology/kez455', 'http://academic.oup.com/rheumatology/article-pdf/59/8/2090/33532505/kez455.pdf']\n",
      "['11084953', 'Keystone Edward C; Ahmad Harris A; Yazici Yusuf; Bergman Martin J. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. Rheumatology (Oxford, England). (2020) 59 8 pp2090-2098', '10.1093/rheumatology/kez455', 'http://academic.oup.com/rheumatology/article-pdf/59/8/2090/33532505/kez455.pdf']\n",
      "['9739781', 'EUCTR2015-001275-50-AT. Effects of abatacept in patients who have recently been diagnosed with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-001275-50-AT. (2015)   pp', '10.1186/isrctn89222125', '']\n",
      "['9742882', 'EUCTR2015-001275-50-SE. Effects of abatacept in patients who have recently been diagnosed with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-001275-50-SE. (2015)   pp', '10.1186/isrctn89222125', '']\n",
      "['11085093', 'Emery P; Fleischmann R; Wong R; Lozenski K; Tanaka Y; Bykerk V; Bingham C; Huizinga T; Citera G; Elbez Y; Perera V; Murthy B; Maxwell K; Passarell J; Hedrich W; Williams D. ABSENCE of ASSOCIATION between ABATACEPT EXPOSURE LEVELS and INITIAL INFECTION in PATIENTS with RA: a POST HOC ANALYSIS of the RANDOMIZED, PLACEBO-CONTROLLED AVERT-2 STUDY. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp556-557', '10.1136/annrheumdis-2022-eular.44', '']\n",
      "['11085777', 'Wu C; Hu Y; Schafer P; Connolly SE; Wong R; Nielsen SH; Bay-Jensen AC; Emery P; Tanaka Y; Bykerk VP; Bingham CO; Huizinga TW; Fleischmann R; Liu J. Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open. (2022) 8 2 pp', '10.1136/rmdopen-2022-002683', '']\n",
      "['9261137', 'Axelsen MB; Hetland ML; Horslev-Petersen K; Stengaard-Pedersen K; Junker P; Podenphant J; Moller JM; Bliddal H; Kubassova O; Boesen M; Ostergaard M. Dynamic contrast-enhanced magnetic resonance imaging of the wrist in rheumatoid arthritis patients treated with methotrexate, intra-articular glucocorticoid and adalimumab/placebo. Arthritis and rheumatism. (2012) 64  ppS452-S453', '10.3109/03009742.2013.824022', '']\n",
      "['11084612', '. Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH). . (2021)   pp', '10.1007/s15002-021-3390-4', 'https://link.springer.com/article/10.1007/s15002-021-3390-4/fulltext.html']\n",
      "['9261320', 'Lim MJ; Park SH; Shim S-C; Baek HJ; Yoo D-H; Kim HA; Lee SK; Lee YJ; Park YE; Cha H-S; Park W; Song Y-W. A double-blind, placebo-controlled, multicenter trial of tocilizumab in moderate to severe active RA patients with inadequate response to methotrexate in Korean population. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.562', '']\n",
      "['9736855', 'Baek Han Joo; Lim Mie Jin; Park Won; Park Sung Hwan; Shim Seung-Cheol; Yoo Dae-Hyun; Kim Hyun Ah; Lee Soo Kon; Lee Yun Jong; Park Young Eun; Cha Hoon-Suk; Song Yeong-Wook. Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis. The Korean journal of internal medicine. (2019) 34 4 pp917-931', '10.1111/pai.13772/v2/response1', '']\n",
      "['9261799', 'Kremer JM; Keystone EC; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Jungerwirth S. Safety and efficacy of ABT-494, a novel selective JAK1 inhibitor, in patients with active rheumatoid arthritis and inadequate response or intolerance to anti-tnf biologic therapy. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1448', '']\n",
      "['9262152', 'Kremer JM; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Pangan AL; Jungerwirth S; Keystone EC. A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy. Arthritis and rheumatology. (2016) 68 12 pp2867-2877', '10.1002/art.39801', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39801']\n",
      "['9739983', 'EUCTR2013-002358-57-HU. A Study to investigate the Safety and Efficacy of ABT-494 Given with Methotrexate (MTX) in Subjects with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Failed Anti-TNF Biologic Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-002358-57-HU. (2013)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9738416', 'Genovese MC; Smolen JS; Weinblatt ME; Meerwein S; Camp HS; Wang L; Othman AA; Khan N; Jungerwirth S. Safety and efficacy of ABT-494, a novel selective JAK1 inhibitor, in patients with active rheumatoid arthritis with an inadequate response to methotrexate. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp141-142', '10.1136/annrheumdis-2016-eular.3698', '']\n",
      "['9740031', 'EUCTR2013-003984-72-ES. A Study Investigating the Efficacy and Safety of ABT-494 given with Methotrexate in Subjects with Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003984-72-ES. (2014)   pp', '10.1080/14656566.2017.1370453', '']\n",
      "['9741160', 'NCT02066389. A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone. https://clinicaltrials.gov/show/NCT02066389. (2014)   pp', '10.1002/cca.2942', '']\n",
      "['9256843', 'Strand V; Tundia N; Friedman A. Patient-reported outcomes of long-term upadacitinib use in patients with rheumatoid arthritis: interim analysis results of a phase 2, open-label extension study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40321', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40321']\n",
      "['9262446', 'Strand V; Tundia N; Song IH; Meerwein S; Lin J; Chen N; Friedman A. Early patient-reported outcomes and clinical outcomes with ABT-494 in patients with active rheumatoid arthritis who are inadequate responders to methotrexate or tumor necrosis factor inhibitors: post-hoc analysis of phase 2 randomized controlled trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp855', '10.1136/annrheumdis-2017-eular.1143', '']\n",
      "['9262517', 'Nurmohamed M; Zhang Y; Lin J; Camp H. Changes in c-reactive protein and lipid levels in patients with rheumatoid arthritis treated with ABT-494 a selective JAK-1 inhibitor. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp280', '10.1136/annrheumdis-2017-eular.2807', '']\n",
      "['9262547', 'Strand V; Genovese M; Kremer J; Schiff M; Li Y; Sokolove J. Changes in hemoglobin levels upon treatment with ABT-494, a selective JAK-1 inhibitor, and relation to baseline levels of c-reactive protein. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp283', '10.1136/annrheumdis-2017-eular.3216', '']\n",
      "['9262555', 'Genovese MC; Kremer J; Zhong S; Friedman A. Long-term safetyand efficacyof upadacitinib (ABT-494), an oral JAK-1 inhibitor in patients with rheumatoid arthritis in an open-label extension study. Journal of clinical rheumatology. (2018) 24 (3 Supplement 1) 3 Supplement 1 ppS85', '10.1136/annrheumdis-2018-eular.7021', '']\n",
      "['9262671', 'Genovese MC; Kremer J; Zhong S; Friedman A. Long-term safety and efficacy of upadacitinib (ABT-494), an oral JAK-1 inhibitor in patients with rheumatoid arthritis in an open label extension study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp979', '10.1136/annrheumdis-2018-eular.7021', '']\n",
      "['9737754', 'Nurmohamed M; Zhang Y; Lin JH; Camp HS. Changes in C-reactive protein and lipid levels in patients with rheumatoid arthritis treated with upadacitinib (ABT-494), a selective JAK-1 inhibitor. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp100', '10.1136/annrheumdis-2017-eular.2807', '']\n",
      "['9737920', 'Genovese MC; Kremer J; Zhong S; Friedman A. Long-term safety and efficacy of upadacitinib (ABT-494), an oral JAK-1 inhibitor in patients with rheumatoid arthritis in an open label extension study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp979', '10.1136/annrheumdis-2018-eular.7021', '']\n",
      "['9738557', 'Strand V; Genovese M; Kremer J; Schiff M; Li Y; Sokolove J. Changes in hemoglobin levels upon treatment with ABT-494, a selective JAK-1 inhibitor, and relation to baseline levels of c-reactive protein. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp283', '10.1136/annrheumdis-2017-eular.3216', '']\n",
      "['9738564', 'Genovese MC; Kremer J; Zhong S; Friedman A. Long-term safetyand efficacyof upadacitinib (ABT-494), an oral JAK-1 inhibitor in patients with rheumatoid arthritis in an open-label extension study. Journal of clinical rheumatology. (2018) 24 (3 Supplement 1) 3 Supplement 1 ppS85', '10.1136/annrheumdis-2018-eular.7021', '']\n",
      "['9742801', 'EUCTR2013-003530-33-BG. Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) with ABT-494. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003530-33-BG. (2014)   pp', '10.1186/isrctn87762302', '']\n",
      "['9260007', 'Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Chinese medical journal. (2003) 116 8 pp1228-1234', '10.1002/art.24643', '']\n",
      "['9257651', 'Bao J; Yue T; Li T; He DY; Bao YX. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist. International journal of rheumatic diseases. (2016) 19 4 pp370-376', '10.1111/1756-185x.12387', '']\n",
      "['9261642', 'Hafstr√∂m I; Engvall IL; R√∂nnelid J; Boonen A; van der Heijde D; Svensson B; BARFOT study group. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study. BMJ open. (2014) 4 7 ppe005246', '10.1136/bmjopen-2014-005246', '']\n",
      "['9258762', 'Barnes CG; Currey HL; Dunne JF; Hazleman B; Mason RM; Strickland ID. Azathioprine: a controlled, double-blind trial in rheumatoid arthritis. Annals of the rheumatic diseases. (1969) 28 3 pp327-328', '10.1136/ard.28.3.327-e', '']\n",
      "['9257809', 'Buvanendran A; Barkin R. Lumiracoxib. Drugs of today (Barcelona, Spain : 1998). (2007) 43  3 pp137-147', '10.1358/dot.2007.43.3.1062673', '']\n",
      "['9259447', 'Bendix G; Bjelle A. Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo-controlled study. British journal of rheumatology. (1996) 35 11 pp1142-1149', '10.1093/rheumatology/35.11.1142', 'http://academic.oup.com/rheumatology/article-pdf/35/11/1142/18094933/35-11-1142.pdf']\n",
      "['9736731', 'ISRCTN62900439. Leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha (TNF-alpha) blocking agents in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN62900439. (2010)   pp', '10.1186/isrctn62900439', '']\n",
      "['9739365', 'Benucci M; Saviola G; Baiardi P; Manfredi M; Sarzi-Puttini P; Atzeni F. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis. International journal of immunopathology and pharmacology. (2011) 24 1 pp269-274', '10.1177/039463201102400136', 'https://journals.sagepub.com/doi/pdf/10.1177/039463201102400136']\n",
      "['9256777', 'van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis. Arthritis and rheumatism. (2009) 61 1 pp4-12', '10.1002/art.24367', '']\n",
      "['9257102', 'van der Kooij SM; le Cessie S; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Zeben D; Kerstens PJ; Hazes JM; van Schaardenburg D; Breedveld FC; Dijkmans BA; Allaart CF. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2009) 68 7 pp1153-1158', '10.1136/ard.2008.093294', '']\n",
      "['9257496', 'Markusse IM; Akdemir G; Dirven L; Goekoop-Ruiterman YP; van Groenendael JH; Han KH; Molenaar TH; Le Cessie S; Lems WF; van der Lubbe PA; Kerstens PJ; Peeters AJ; Ronday HK; de Sonnaville PB; Speyer I; Stijnen T; Ten Wolde S; Huizinga TW; Allaart CF. Long-term outcomes of patients with recent-onset rheumatoid arthritis after 10 years of tight controlled treatment: a randomized trial. Annals of internal medicine. (2016) 164 8 pp523-531', '10.7326/m15-0919', 'https://www.acpjournals.org/doi/pdf/10.7326/M15-0919']\n",
      "['9257841', 'Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis and rheumatism. (2008) 58 2 Suppl ppS126-35', '10.1002/art.21405', '']\n",
      "['9257938', 'Van Den Broek M; Dirven L; Kroon H; Westedt M; Gerards A; Kerstens P; Huizinga T; Lems W; Allaart C. Large joint damage after 8 years of das-steered treatment in early rheumatoid arthritis (RA) patients. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2540', '']\n",
      "['9258042', 'Klarenbeek NB; G‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√†¬¥ler-Y‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√†¬¥ksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab. Annals of the rheumatic diseases. (2010) 69 12 pp2107-2113', '10.1136/ard.2010.131201', '']\n",
      "['9258306', 'Klarenbeek NB; van der Kooij SM; Huizinga TJ; Goekoop-Ruiterman YP; Hulsmans HM; van Krugten MV; Speyer I; de Vries-Bouwstra JK; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial. Annals of the rheumatic diseases. (2010) 69 7 pp1342-1345', '10.1136/ard.2009.124180', '']\n",
      "['9258497', 'Visser K; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Seys PE; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Annals of the rheumatic diseases. (2010) 69 7 pp1333-1337', '10.1136/ard.2009.121160', '']\n",
      "['9260266', 'van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; van Zeben D; Kerstens PJ; Gerards AH; van Groenendael JH; Hazes JM; Breedveld FC; Allaart CF; Dijkmans BA. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the rheumatic diseases. (2007) 66 10 pp1356-1362', '10.1136/ard.2006.066662', '']\n",
      "['9260269', 'Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; Kerstens PJ; Grillet BA; de Jager MH; Han KH; Speyer I; van der Lubbe PA; Seys PE; Breedveld FC; Dijkmans BA. Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial). Annals of the rheumatic diseases. (2007) 66 9 pp1227-1232', '10.1136/ard.2006.068296', '']\n",
      "['9260324', 'de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis and rheumatism. (2008) 58 5 pp1293-1298', '10.1002/art.23439', '']\n",
      "['9260647', 'Klarenbeek NB; van der Kooij SM; G‚Äö√†√∂¬¨‚à´ler-Y‚Äö√†√∂¬¨‚à´ksel M; van Groenendael JH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Annals of the rheumatic diseases. (2011) 70 2 pp315-319', '10.1136/ard.2010.136556', '']\n",
      "['9260650', 'Klarenbeek NB; G‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†¬¨¬•ler-Y‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†¬¨¬•ksel M; van der Kooij SM; Han KH; Ronday HK; Kerstens PJ; Seys PE; Huizinga TW; Dijkmans BA; Allaart CF. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Annals of the rheumatic diseases. (2011) 70 6 pp1039-1046', '10.1136/ard.2010.141234', '']\n",
      "['9260687', 'Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Annals of the rheumatic diseases. (2011) 70 10 pp1815-1821', '10.1136/ard.2010.149260', '']\n",
      "['9260945', 'Allaart CF; Lems WF; Huizinga TW. The BeSt way of withdrawing biologic agents. Clinical and experimental rheumatology. (2013) 31 4 Suppl 78 ppS14-8', '10.1093/rheumatology/kes362', 'http://academic.oup.com/rheumatology/article-pdf/52/7/1202/17387911/kes362.pdf']\n",
      "['9260964', 'van den Broek M; Dirven L; Kroon HM; Kloppenburg M; Ronday HK; Peeters AJ; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis. Journal of rheumatology. (2013) 40 5 pp624-629', '10.3899/jrheum.121248', '']\n",
      "['9260982', 'Dirven L; Klarenbeek NB; van den Broek M; van Groenendael JH; de Sonnaville PB; Kerstens PJ; Huizinga TW; Dijkmans BA; Lems WF; Allaart CF. Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. Clinical rheumatology. (2013) 32 5 pp585-590', '10.1007/s10067-012-2136-8', 'http://link.springer.com/article/10.1007/s10067-012-2136-8/fulltext.html']\n",
      "['9261492', 'Markusse IM; Akdemir G; Van Den Broek M; Dirven L; Goekoop RJ; Han KH; Van Oosterhout M; Kerstens PJSM; Lems WF; Huizinga TWJ; Allaart CF. 10 years of treat-to-target therapy in rheumatoid arthritis patients (the best study): Clinical and radiological outcomes. Arthritis and rheumatism. (2013) 65  ppS620', '10.1136/annrheumdis-2014-eular.2015', '']\n",
      "['9261507', 'Markusse IM; Han KH; Peeters AJ; Ronday HK; Kerstens PJSM; Huizinga TWJ; Lems WF; Allaart CF. Initial combination therapy in early rheumatoid arthritis: Which patients benefit?. Arthritis and rheumatism. (2013) 65  ppS570', '10.1136/annrheumdis-2015-eular.1638', '']\n",
      "['9262013', 'Markusse I; Dirven L; Han H; Ronday K; Speyer I; Kerstens P; Lems W; Huizinga T; Allaart C. Survival in early rheumatoid arthritis patients after 10 years of targeted treatment. Annals of the rheumatic diseases. (2015) 74  pp84-85', '10.1136/annrheumdis-2015-eular.1638', '']\n",
      "['9262275', 'Bergstra SA; Landew‚àö¬© RBM; Huizinga TWJ; Allaart CF. Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy. Rheumatology (oxford, england). (2017) 56 10 pp1721-1728', '10.1093/rheumatology/kex236', 'http://academic.oup.com/rheumatology/article-pdf/56/10/1721/20118595/kex236.pdf']\n",
      "['9262435', 'Loef M; Kroon FP; Bergstra SA; Van Der Pol JA; Lems WF; Kerstens PJ; Allaart CF; Kloppenburg M. Prolonged TNF-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp976', '10.1136/annrheumdis-2017-eular.2337', '']\n",
      "['9262525', 'Akdemir G; Markusse IM; Goekoop-Ruiterman YP; Harbers JB; Van Oosterhout M; Kerstens PJSM; Lems WF; Huizinga TWJ; Allaart CF. Assessment of two different DAS treatment targets in early active rheumatoid arthritis patients. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp4297-4299', '10.1007/s10067-016-3405-8', 'http://link.springer.com/article/10.1007/s10067-016-3405-8/fulltext.html']\n",
      "['9262968', 'Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (London, England). (1997) 350 9074 pp309-318', '10.1016/s0140-6736(97)01300-7', '']\n",
      "['9263188', 'Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Peeters AJ; de Jonge-Bok JM; Mall‚Äö√†√∂¬¨¬©e C; de Beus WM; de Sonnaville PB; Ewals JA; Breedveld FC; Dijkmans BA. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Annals of internal medicine. (2007) 146 6 pp406-415', '10.7326/0003-4819-146-6-200703200-00005', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-146-6-200703200-00005']\n",
      "['9263210', 'Allaart CF; Breedveld FC; Dijkmans BA. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study. Journal of rheumatology. Supplement. (2007) 80 SUPPL. 80 pp25-33', '10.1097/bor.0b013e3282fa13db', '']\n",
      "['9263250', 'van den Hout WB; Goekoop-Ruiterman YP; Allaart CF; de Vries-Bouwstra JK; Hazes JM; Kerstens PJ; van Zeben D; Hulsmans HM; de Jonge-Bok JM; de Sonnaville PB; Dijkmans BA; Breedveld FC. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis. Arthritis and rheumatism. (2009) 61 3 pp291-299', '10.1002/art.24169', '']\n",
      "['9263253', 'van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Peeters AJ; van Krugten MV; Breedveld FC; Dijkmans BA; Allaart CF. Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the rheumatic diseases. (2008) 67 2 pp266-269', '10.1136/ard.2007.079368', '']\n",
      "['9263264', 'van der Bijl AE; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ten Wolde S; Han KH; van Krugten MV; Allaart CF; Breedveld FC; Dijkmans BA. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2007) 56 7 pp2129-2134', '10.1002/art.22718', '']\n",
      "['9263266', 'van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; G‚àö¬∫ler-Y‚àö¬∫ksel M; Zwinderman AH; Kerstens PJ; van der Lubbe PA; de Beus WM; Grillet BA; Ronday HK; Huizinga TW; Breedveld FC; Dijkmans BA; Allaart CF. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Annals of the rheumatic diseases. (2009) 68 6 pp914-921', '10.1136/ard.2008.092254', '']\n",
      "['9263323', 'van den Broek M; Dirven L; Klarenbeek NB; Molenaar TH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Annals of the rheumatic diseases. (2012) 71 2 pp245-248', '10.1136/annrheumdis-2011-200379', '']\n",
      "['9263358', 'van den Broek M; Klarenbeek NB; Dirven L; van Schaardenburg D; Hulsmans HM; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the rheumatic diseases. (2011) 70 8 pp1389-1394', '10.1136/ard.2010.147751', '']\n",
      "['9263413', 'Dirven L; Visser K; Klarenbeek NB; Ewals JAPM; Han KH; Peeters AJ; Kerstens PJSM; Huizinga TWJ; Dijkmans BAC; Allaart CF. Towards personalized treatment: Predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression. Scandinavian journal of rheumatology. (2012) 41  1 pp15-19', '10.3109/03009742.2011.594964', '']\n",
      "['9263425', 'Van Den Broek M; Lems WF; Allaart CF. BeSt practice: The success of early-targeted treatment in rheumatoid arthritis. Clinical and experimental rheumatology. (2012) 30  4 SUPPL.73 ppS35-S38', '10.1093/rheumatology/kes228', 'http://academic.oup.com/rheumatology/article-pdf/51/12/2262/5105069/kes228.pdf']\n",
      "['9263429', \"Koevoets R; Dirven L; Klarenbeek NB; van Krugten MV; Ronday HK; van der Heijde DM; Huizinga TW; Kerstens PS; Lems WF; Allaart CF. 'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'. Annals of the rheumatic diseases. (2013) 72 6 pp870-874\", '10.1136/annrheumdis-2011-201191', '']\n",
      "['9263471', 'Van Den Broek M; Dirven L; Kroon HM; Van Oosterhout M; Han KH; Kerstens PJSM; Huizinga TWJ. Local swelling and prolonged local pain in a large joint are independent predictors of damage in that joint in recent onset rheumatoid arthritis patients. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3899/jrheum.121248', '']\n",
      "['9263623', 'Van Der Pol JA; Akdemir G; Van Den Broek M; Dirven L; Kerstens P; Lems WF; Markusse IM; Huizinga TW; Allaart CF. Repair of joint damage in newly diagnosed rheumatoid arthritis patients occurs but does not relate to previous suppression of inflammation; an 8-years sub analysis in the best-cohort. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp516', '10.1136/annrheumdis-2017-eular.2270', '']\n",
      "['9263626', 'Loef M; Kroon FP; Bergstra SA; Van Der Pol JA; Lems WF; Kerstens PJ; Allaart CF; Kloppenburg M. Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. Osteoarthritis and cartilage. (2018) Conference: 2018 Osteoarthritis Research Society International, OARSI World Congress. United Kingdom. 26 Supplement 1 ppS300-S301', '10.1016/j.joca.2018.02.604', '']\n",
      "['9738508', 'Goekoop-Ruiterman Y P; de Vries-Bouwstra; J K; Allaart C F; van Zeben; Kerstens P J; Hazes J M; Zwinderman A H; Ronday H K; Han K H; Westedt M L; Gerards A H; van Groenendael; J H; Lems W F; van Krugten; M V; Breedveld F C; Dijkmans B A. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis and rheumatism. (2008) 58 2 Suppl ppS126-135', '10.1002/art.21405', '']\n",
      "['9739099', 'Koevoets R; Klarenbeek N B; Van Der Heijde; D M F M; Van Krugten; M V; Van Schaardenburg; Dijkmans B; Huizinga T W J. Being in remission or in low disease activity in rheumatoid arthritis: different meaning with the use of different composite scores. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp957', '10.1002/art.24661', '']\n",
      "['9739253', 'Akdemir G; Markusse I M; Dirven L; Riyazi N; Steup-Beekman G M; Kerstens Pjsm; Lems W F; Huizinga Twj; Allaart C F. Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial. RMD open. (2016) 2 1 ppe000143', '10.1136/rmdopen-2015-000143', '']\n",
      "['9739444', 'Koevoets R; Klarenbeek NB; Van Der Heijde DMFM; Van Krugten MV; Van Schaardenburg D; Dijkmans B; Huizinga TWJ. Being in remission or in low disease activity in rheumatoid arthritis: different meaning with the use of different composite scores. Arthritis and rheumatism. (2009) 60  pp957-', '10.1002/art.24661', '']\n",
      "['9739648', 'Akdemir G; Markusse IM; Schouffoer AA; De Sonnaville PB; Grillet BA; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF. Low disease activity or DAS-remission as treatment target in early rheumatoid arthritis patients. Annals of the rheumatic diseases. (2016) 75  pp454-', '10.1136/annrheumdis-2016-eular.2715', '']\n",
      "['9740040', 'ISRCTN32675862. Treatment strategies for Rheumatoid Arthritis (BeSt - BehandelStrategie‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®‚Äö√Ñ¬¢n in Reumato‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßde Artritis). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN32675862. (2005)   pp', '10.4324/9780203187838.bmatt3', '']\n",
      "['9741417', 'Allaart CF; Breedveld FC; Dijkmans BAC. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt Study. Journal of rheumatology. (2007) 34  pp25-33', '10.1097/bor.0b013e3282fa13db', '']\n",
      "['11087242', 'Van Der Pol J; Bergstra SA; Huizinga T; Allaart C. PREDNISONE USE and the INCIDENCE of HYPERGLYCEMIA or DIABETES in PATIENTS with RHEUMATOID ARTHRITIS; A 10-YEAR SUB ANALYSIS of the BEST STUDY. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp181', '10.1136/annrheumdis-2022-eular.4474', '']\n",
      "['9257182', 'Hissink Muller PCE; Brederije I; Brinkman DMC; Allaart CF; Van Suijlekom-Smit LWA; Van Rossum MAJ; Ten Cate R. Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial). Pediatric Rheumatology. (2011) 9  pp', '10.1186/1546-0096-9-s1-p184', 'http://link.springer.com/article/10.1186/1546-0096-9-S1-P184/fulltext.html']\n",
      "['9738723', 'Van Der Pol JA; Bergstra SA; Riyazi N; Goekoop-Ruiterman YP; Chopra A; Kerstens P; Lems WF; Tsonaka R; Huizinga TW; Allaart CF. Window or no window: earlier is better when treating rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp910-911', '10.1136/annrheumdis-2018-eular.1743', '']\n",
      "['9743074', 'Bergstra Sytske Anne; Van Der Pol Joy A; Riyazi Naghmeh; Goekoop-Ruiterman Yvonne P M; Kerstens Pit J S M; Lems Willem; Huizinga Tom W J; Allaart Cornelia F. Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?. RMD open. (2020) 6 1 pp', '10.1136/rmdopen-2020-001242', '']\n",
      "['9262018', 'Bhatt K; Girish K; Pundarikaksha HP; Tamboli T. Cost-effectiveness of methotrexate and sulfasalazine in rheumatoid arthritis: a comparative study. Indian journal of pharmacology. (2014) 46 7 SUPPL. 1 ppS54', '10.4103/0253-7613.135947', '']\n",
      "['9737262', 'UMIN000030760. A pilot study of a simple navigation system for artificial hip joint surgery using augmented reality technology. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000030760. (2018)   pp', '10.1016/j.jjoisr.2024.06.002', '']\n",
      "['9738323', 'Studenic P; Bond G; Kerschbaumer A; Becede M; Pavelka K; Karateev D; Stieger J; Puchner R; Muller R; Puchhammer-Stockl E; Durechova M; Loiskandl M; Perkmann T; Olejarova M; Luchikhina E; Steiner C-W; Bonelli M; Smolen JS; Aletaha D. Torque Teno viral load for monitoring of biological therapies in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp322', '10.1136/annrheumdis-2019-eular.5080', '']\n",
      "['9740192', 'EUCTR2015-000581-58-CZ. A Randomized,Biomarker Trial to Predict Therapeutic Responses of Patients with Rheumatoid Arthritis to a Specific Biologic Mode of Action. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-000581-58-CZ. (2015)   pp', '10.1186/isrctn43336433', '']\n",
      "['9740731', 'Studenic P; Bond G; Kerschbaumer A; Becede M; Pavelka K; Karateev D; Stieger J; Puchner R; Muller R; Puchhammer-Stockl E; Durechova M; Loiskandl M; Perkmann T; Olejarova M; Luchikhina E; Steiner C-W; Bonelli M; Smolen JS; Aletaha D. Torque Teno viral load for monitoring of biological therapies in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp322-', '10.1136/annrheumdis-2019-eular.5080', '']\n",
      "['11083927', 'Studenic P; Bond G; Kerschbaumer A; Becede M; Pavelka K; Karateev D; Stieger J; Puchner R; Mueller RB; Puchhammer-Stockl E; Durechova M; Loiskandl M; Perkmann T; Olejarova M; Luchikhina E; Steiner C-W; Bonelli M; Smolen JS; Aletaha D. Torque Teno Virus Quantification for Monitoring of Immunomodulation with Biological Compounds in the Treatment of Rheumatoid Arthritis. Rheumatology (Oxford, England). (2021) 61 7 pp2815-2825', '10.1093/rheumatology/keab839', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab839/42378011/keab839.pdf']\n",
      "['9740740', 'Uhrenholt L; Schlemmer A; Hauge E-M; Christensen R; Dreyer L; Suarez-Almazor ME; Kristensen S. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ open. (2019) 9 7 pp', '10.1136/bmjopen-2018-028517', '']\n",
      "['9741586', 'Uhrenholt Line; Schlemmer Annette; Hauge Ellen-Margrethe; Christensen Robin; Dreyer Lene; Suarez-Almazor Maria E; Kristensen Salome. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ open. (2019) 9 7 ppe028517', '10.1136/bmjopen-2018-028517', '']\n",
      "['11084671', 'Uhrenholt L; Christensen R; Dreyer L; Hauge EM; Schlemmer A; Loft AG; Nyhuus Bendix Rasch M; Horn HC; Gade K; Taylor PC; Kristensen S. DISEASE ACTIVITY-GUIDED TAPERING of BIOLOGICS in PATIENTS with INFLAMMATORY ARTHRITIS: a RANDOMISED, OPEN-LABEL, EQUIVALENCE TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp15-16', '10.1136/annrheumdis-2022-eular.1061', '']\n",
      "['9257681', 'Nasonov E; Mazurov V; Plaksina T; Nesmeyanova O; Knyazeva L; Eremeeva A; Chernyaeva E; Ivanov R. Interchangeability of innovator rituximab and its biosimilar: results from international controlled comparative 1-year study in patients with active rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2046-2047', '10.1002/art.39977', '']\n",
      "['9737258', '. Comparison of efficacy and safety of rituximab biosimilar, BCD-020, and innovator rituximab in patients with active rheumatoid arthritis refractory to TNFa inhibitors. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp513-514', '10.1136/annrheumdis-2016-eular.1715', '']\n",
      "['9742604', 'Eremeeva A; Chernyaeva E; Ivanov R; Nasonov E; Knyazeva L. Comparison of efficacy and safety of rituximab biosimilar, BCD-020, and innovator rituximab in patients with active rheumatoid arthritis refractory to TNFa inhibitors. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp513-514', '10.1136/annrheumdis-2016-eular.1715', '']\n",
      "['11083984', '. Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN). . (2020)   pp', '10.31525/ct1-nct04255134', '']\n",
      "['9261496', 'Kivitz A; Olech E; Borofsky MA; Zazueta BM; Navarro-Sarabia F; Radominski SC; Merrill JT; Wells C; Wimalasundera S; Douglass W; Pope JE. The safety and efficacy of tocilizumab subcutaneous in combination with traditional DMARDS in patients with moderate to severe rheumatoid arthritis up to 48 weeks (BREVACTA). Arthritis and rheumatism. (2013) 65 var.pagings ppS604-S605', '10.1002/acr.22384', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.22384']\n",
      "['9261527', 'Kivitz AJ; Olech E; Borofsky MA; Zazueta BM; Navarro-Sarabia F; Rowell L; Nasmyth-Miller C; Pope JE. A Randomized, double-blind, parallel-group study of the safety and efficacy of tocilizumab subcutaneous versus placebo in combination with traditional dmards in patients with moderate to severe rheumatoid arthritis (BREVACTA). Arthritis and rheumatism. (2012) 64  12 pp4170', '10.1002/acr.22384', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.22384']\n",
      "['9737343', 'EUCTR2010-019912-18-ES. A randomized, double-blind, parallel-group study of safety and the effect on clinical outcome of tocilizumab SC versus placebo SC in combination with traditional disease modifying anti-rheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis. Estudio randomizado, doble ciego, con grupos de tratamiento paralelos, para evaluar la seguridad y el efecto sobre el resultado cl‚àö‚â†nico de tocilizumab SC frente a placebo SC en combinaci‚àö‚â•n con f‚àö¬∞rmacos antirreum‚àö¬∞ticos modificadores de la enfermedad (FAMEs) tradicionales, en pacientes con artritis reumatoide activa moderada a severa. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019912-18-ES. (2011)   pp', '10.1016/j.acuro.2024.05.005', '']\n",
      "['9743011', 'NCT01232569. A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01232569. (2010)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9262262', 'Abdallah H; Hsu JC; Lu P; Fettner S; Zhang X; Douglass W; Bao M; Rowell L; Burmester GR; Kivitz A. Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA. Journal of clinical pharmacology. (2017) 57 4 pp459-468', '10.1002/jcph.826', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.826']\n",
      "['9742587', 'Strand V; Lampl K; Birchwood C; Pei J; Tuckwell K; Finch R; Kivitz A; Burmester G. Patient-reported outcomes in patients with rheumatoid arthritis treated with subcutaneous tocilizumab compared with placebo or intravenous tocilizumab in combination with csDMARDs. Annals of the rheumatic diseases. (2017) 76 Supplement 2 pp581-582', '10.1136/annrheumdis-2017-eular.3312', '']\n",
      "['9738583', 'Harrison M; Boonen A; Tugwell P; Symmons D. Same question, different answer: a comparison of global health assessments using vas scales. Rheumatology.. (2009) 48  ppi110', '10.1007/s11136-009-9546-3', 'http://link.springer.com/article/10.1007/s11136-009-9546-3/fulltext.html']\n",
      "['9260938', 'Sieper J; Porter-Brown B; Thompson L; Harari O; Dougados M. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Annals of the rheumatic diseases. (2014) 73 1 pp95-100', '10.1136/annrheumdis-2013-203559', '']\n",
      "['9257165', 'Kameda H; Kurasawa T; Nagasawa H; Amano K; Takeuchi T. The addition of another disease-modifying anti-rheumatic drug to methotrexate in place of infliximab reduces the flare rate during 2 years after infliximab discontinuation in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS206', '10.3109/14397595.2013.844886', '']\n",
      "['9736655', 'Kameda H; Kurasawa T; Nagasawa H; Amano K; Takeuchi T. The addition of another disease-modifying anti-rheumatic drug, bucillamine, to methotrexate in place of infliximab improves the rate of infliximab-free sustained remission. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp107', '10.1136/annrheumdis-2012-eular.2120', '']\n",
      "['9258391', \"Glintborg B; Sorensen IJ; Jensen DV; Krogh NS; Loft AG; Espesen J; Olsen J; Hendricks O; Grydehoj J; Hansen IMJ; Sorensen MV; Chrysidis S; Andersen BL; Manilo N; Klarlund M; Andersen LS; Nordin H; Kristensen S; Norregaard J; Hetland ML. A nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Eleven months' clinical outcomes from the Danbio registry. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1255-1258\", '10.1136/annrheumdis-2016-eular.1785', '']\n",
      "['9258398', \"Bingham C; Emery P; Weinblatt M; Burmester G-R; Furst DE; Mariette X; Van Vollenhoven R; VanLunen B; Purcaru O; Bykerk VP. Maintenance of improvements in patients' physical function, workplace and household productivity, and reduction in caregiver burden with 2 years of certolizumab pegol treatment in DMARD-naive, early RA patients with severe progressive disease. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp772-774\", '10.1136/annrheumdis-2016-eular.3232', '']\n",
      "['9258402', 'Bykerk VP; Emery P; Weinblatt M; Burmester G-R; Furst DE; Mariette X; Van Vollenhoven R; Purcaru O; Ralston P; Bingham C. Cinical responses and improvements in patient-reported outcomes are associated with increased productivity in the workplace and at home in rheumatoid arthritis patients treated with certolizumab pegol. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp775-776', '10.1016/j.jval.2016.09.1150', '']\n",
      "['9261822', 'Weinblatt M; Bingham C; Burmester G; Bykerk V; Furst DE; Mariette X; Van Der Heijde D; Tatla D; Arendt C; Mountian I; VanLunen B; Emery P. Early response AS a predictor of long-term remission in dmard-naive patients with severe, active and progressive rheumatoid arthritis treated with certolizumab pegol in combination with methotrexate. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.1493', '']\n",
      "['9261831', 'Weinblatt M; Bingham C; Burmester G; Bykerk VP; Furst DE; Mariette X; Van Der Heijde D; Tatla D; Arendt C; Mountian I; Van Lunen B; Emery P. Certolizumab pegol in combination with methotrexate in dmard-naive patients with active, severe, progressive rheumatoid arthritis: results from a randomized, double-blind, controlled phase 3 study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.1493', '']\n",
      "['9261865', 'Emery P; Bingham CO; Burmester G-R; Bykerk VP; Furst DE; Mariette X; Purcaru O; Coteur G; Van Lunen B; Weinblatt M. Improvements in patient-reported outcomes and workplace and household productivity following 52 weeks of treatment with certolizumab pegol in combination with methotrexate in dmard-naive early rheumatoid arthritis patients: results from the c-early randomized, double-blind, controlled phase 3 study. Annals of the rheumatic diseases. (2015) 74  pp712-713', '10.1136/annrheumdis-2015-eular.1499', '']\n",
      "['9261866', 'Emery P; Bingham CO; Burmester G-R; Bykerk VP; Furst DE; Mariette X; Van Der Heijde D; Tatla D; Arendt C; Mountian I; Van Lunen B; Weinblatt M. The first study of certolizumab pegol in combination with methotrexate in dmard-naive early rheumatoid arthritis patients led to sustained clinical response and inhibition of radiographic progression at 52 weeks: the c-early randomized, double-blind, controlled phase 3 study. Annals of the rheumatic diseases. (2015) 74  pp712', '10.1136/annrheumdis-2015-eular.1493', '']\n",
      "['9261922', 'Emery P; Bingham C; Burmester GR; Bykerk VP; Furst D; Mariette X; Purcaru O; VanLunen B; Weinblatt M. Improvements in workplace and household productivity following 52 weeks of treatment with certolizumab pegol in combination with methotrexate in dmard-naive patients with severe, active and progressive rheumatoid arthritis: results from the c-early randomized, double-blind, controlled phase 3 study. Value in health. (2015) 18 7 ppA710', '10.1016/j.jval.2015.09.2671', '']\n",
      "['9261923', 'Emery P; Bingham C; Burmester G; Bykerk V; Furst D; Mariette X; Purcaru O; Coteur G; Vanlunen B; Weinblatt M. Improvements in patient-reported outcomes following 52 weeks of treatment with certolizumab pegol in combination with methotrexate in dmard-naive patients with severe, active and progressive rheumatoid arthritis: results from the c-early randomized, double-blind, controlled phase 3 study. Value in health. (2015) 18 7 ppA707-A708', '10.1016/j.jval.2015.09.2660', '']\n",
      "['9262049', 'Hall S; Weinblatt M; Burmester GR; Bykerk V; Furst D; Mariette X; Van Der Heijde D; Nash P; Bagga H; Cook N; Rischmueller M; Romas E; Arendt C; Van Lunen B; Emery P. Certolizumab pegol and methotrexate in dmard-naive patients with active, severe, rheumatoid arthritis: results from C-EARLY period 1 including australian patients. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp170-171', '10.1136/annrheumdis-2016-eular.1471', '']\n",
      "['9262077', 'Bykerk VP; Emery P; Weinblatt ME; Burmester G; Furst DE; Mariette X; Van Vollenhoven R; Ralston P; Purcaru O; Bingham C. Clinical responses and improvements in patient-reported outcomes are associated with increased productivity in the workplace and at home in rheumatoid arthritis patients treated with certolizumab pegol. Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA545', '10.1016/j.jval.2016.09.1150', '']\n",
      "['9258291', 'Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis and rheumatism. (2006) 54 1 pp26-37', '10.1002/art.21519', '']\n",
      "['9740280', 'EUCTR2011-001729-25-GB. Study designed to demonstrate the efficacy and safety of Certolizumab pegol in combination with Methotrexate in the treatment of subjects suffering from early, progressive active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001729-25-GB. (2012)   pp', '10.1007/s00393-016-0133-z', 'http://link.springer.com/article/10.1007/s00393-016-0133-z/fulltext.html']\n",
      "['9741120', 'NCT01519791. A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-na‚àö√òve Adults With Early Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01519791. (2012)   pp', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9741121', 'NCT01521923. A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-na√Øve Adults With Early Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01521923. (2012)   pp', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9257052', 'Atsumi T; Tanaka Y; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Togo O; Okada T; van der Heijde D; Miyasaka N; Koike T. Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial. Annals of the rheumatic diseases. (2017) 76 8 pp1348-1356', '10.1136/annrheumdis-2016-210246', '']\n",
      "['9258378', 'Tanaka Y; Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Shoji T; Ralston P; Van Der Heijde D; Miyasaka N; Koike T. Maintenance of clinical remission and radiographic non-progression with mtx after completion of 1 year initial treatment with certolizumab pegol in Japanese patients with early rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4315-4317', '10.3109/14397595.2014.904475', '']\n",
      "['9261543', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Okada T; Van Der Heijde D; Miyasaka N; Koike T. The first early rheumatoid arthritis, certolizumab pegol, multicenter, double-blind, randomized, parallel-group study: C-Opera, in patients fulfilling the 2010 ACR/EULAR classification criteria, demonstrates inhibition of joint damage progression. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1448', '']\n",
      "['9261864', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Togo O; Okada T; Van Der Heijde D; Miyasaka N; Koike T. Baseline parameters identified in early, methotrexate-naive rheumatoid arthritis patients with better outcomes with certolizumab pegol+methotrexate compared to placebo+methotrexate: post-hoc analyses of c-opera, a randomized, controlled, phase 3 study. Annals of the Rheumatic Diseases.Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2015 Rome Italy.Conference Start: 20150610 Conference End: 20150613.Conference Publication: (var.pagings). (2015) 74  pp716-717', '10.1136/annrheumdis-2015-eular.1501', '']\n",
      "['9262053', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Yoshida K; Miyasaka N; Koike T. Clinical and patient-reported benefits of certolizumab pegol treatment in mtx-naive, early RA patients are maintained 1-year after discontinuation in C-OPERA. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp168', '10.1136/annrheumdis-2016-eular.1249', '']\n",
      "['9261584', 'Burmester GR; Kivitz AJ; Kupper H; Arulmani U; Florentinus S; Goss SL; Rathmann SS; Fleischmann RM. Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial. Annals of the rheumatic diseases. (2015) 74 6 pp1037-1044', '10.1136/annrheumdis-2013-204769', '']\n",
      "['9737357', 'NCT01451203. Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01451203. (2011)   pp', '10.1002/cca.48', '']\n",
      "['9737980', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Togo O; Okada T; Van Der Heijde; D M; Miyasaka N; Koike T. The first, multicenter, double-blind, randomized, parallel-group study of certolizumab pegol in early rheumatoid arthritis demonstrates inhibition of joint damage progression. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1078-S1079', '10.1136/annrheumdis-2014-eular.1448', '']\n",
      "['9739391', 'Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Togo O; Okada T; Van Der Heijde D; Miyasaka N; Koike T. Clinical outcomes at week 104 and analysis of associated baseline factors after an initial 1 year of certolizumab pegol and MTX treatment in MTX-na‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßve patients with early RA: results from the second year of the c-opera study. Annals of the rheumatic diseases. (2016) 75  pp239-', '10.1136/annrheumdis-2016-eular.1249', '']\n",
      "['9741317', 'Tanaka Yoshiya; Atsumi Tatsuya; Yamamoto Kazuhiko; Takeuchi Tsutomu; Yamanaka Hisashi; Ishiguro Naoki; Eguchi Katsumi; Watanabe Akira; Origasa Hideki; Shoji Toshiharu; Miyasaka Nobuyuki; Koike Takao. Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis. International journal of rheumatic diseases. (2020) 23 3 pp316-324', '10.1111/1756-185x.13780', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13780']\n",
      "['11083789', 'Tanaka Y; Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Shoji T; Miyasaka N; Koike T. Certolizumab Pegol in Japanese patients with early rheumatoid arthritis: disease activity and radiographic progression across rheumatoid factor quartiles (C-OPERA Study). International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp254-255', '10.1111/1756-185x.13780', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13780']\n",
      "['11088227', 'Tanaka Yoshiya; Atsumi Tatsuya; Yamamoto Kazuhiko; Takeuchi Tsutomu; Yamanaka Hisashi; Ishiguro Naoki; Eguchi Katsumi; Watanabe Akira; Origasa Hideki; Shoji Toshiharu; Miyasaka Nobuyuki; Koike Takao. Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis. International journal of rheumatic diseases. (2020) 23 3 pp316-324', '10.1111/1756-185x.13780', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13780']\n",
      "['9258021', 'Pope J; Keystone E; Thorne C; Poulin-Costello M; Phan-Chronis K; Haraoui B. Study completion and etanercept retention in patients with rheumatoid arthritis treated with etanercept or etanercept and methotrexate in the Canadian methotrexate and etanercept outcome (CAMEO) study. Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1239-1240', '10.1136/annrheumdis-2014-eular.1054', '']\n",
      "['9261282', 'Haraoui B; Thorne C; Keystone E; Poulin-Costello M; Trottier E; Vieira A; Pope J. Clinical and radiographic outcomes in patients with rheumatoid arthritis treated with etanercept or etanercept + methotrexate: Two-year results from the canadian methotrexate and etanercept outcome study (CAMEO). Journal of rheumatology. (2014) 41  7 pp1506-1507', '10.1136/annrheumdis-2014-eular.1054', '']\n",
      "['9261291', 'Pope J; Haraoui B; Thorne C; Poulin-Costello M; Vieira A; Keystone E. One-year results from the canadian methotrexate and etanercept outcome (cameo) study: A randomized trial of etanercept and methotrexate versus etanercept alone in active rheumatoid arthritis. Journal of rheumatology. (2013) 40  6 pp998-999', '10.1136/annrheumdis-2013-203684', '']\n",
      "['9261491', 'Haraoui B; Thorne JC; Keystone EC; Poulin-Costello M; Trottier E; Vieira A; Pope JE. Clinical and radiographic outcomes with etanercept and etanercept and methotrexate in patients with rheumatoid arthritis: Two-year results from the Canadian methotrexate and etanercept outcome study (CAMEO). Arthritis and rheumatism. (2013) 65  ppS622', '10.1093/rheumatology/kev338', 'http://academic.oup.com/rheumatology/article-pdf/55/2/327/5159107/kev338.pdf']\n",
      "['9261550', 'Pope JE; Haraoui B; Thorne JC; Phan-Chronis K; Poulin-Costello M; Vieira A; Keystone E. Achievement and maintenance of remission/low disease activity over 24 months in patients with rheumatoid arthritis treated with etanercept or etanercept + methotrexate in the Canadian methotrexate and etanercept outcome (CAMEO) study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1054', '']\n",
      "['9261809', 'Pope JE; Keystone EC; Thorne JC; Poulin-Costello M; Phan-Chronis K; Haraoui B. Study completion and etanercept retention in patients with rheumatoid arthritis treated with etanercept monotherapy versus etanercept and methotrexate combination therapy. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2014-eular.1054', '']\n",
      "['9261966', 'Keystone EC; Pope JE; Thorne JC; Poulin-Costello M; Phan-Chronis K; Vieira A; Haraoui B; CAMEO Investigators. Two-year radiographic and clinical outcomes from the canadian methotrexate and etanercept outcome study in patients with rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 2 pp327-334', '10.1093/rheumatology/kev338', 'http://academic.oup.com/rheumatology/article-pdf/55/2/327/5159107/kev338.pdf']\n",
      "['9736948', 'Pope J; Keystone E; Haraoui B; Thorne J C; Poulin-Costello M. Number of cardiovascular risk factors may be associated with higher disease activity severity. Exploratory analysis of baseline data from the canadian methotrexate and etanercept outcome study: a randomized trial of etanercept and methotrexate vs etanercept alone in rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.389', '']\n",
      "['9738954', 'Pope J E; Haraoui B; Thorne J C; Poulin-Costello M; Vieira A; Keystone E. One-year results from the Canadian methotrexate and etanercept outcome study: a randomized trial of etanercept and methotrexate versus etanercept alone in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS566', '10.1136/annrheumdis-2013-203684', '']\n",
      "['9738955', 'Pope J E; Keystone E; Haraoui B; Thorne C; Poulin-Costello M. Number of cardiovascular risk factors may be associated with higher disease activity severity. Exploratory analysis of baseline data from the canadian MTX and etanercept outcome study: a randomized trial of etanercept and MTX vs etanercept alone in RA. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.389', '']\n",
      "['9740993', 'NCT00654368. CAMEO: canadian Methotrexate and Etanercept Outcome Study. https://clinicaltrials.gov/show/NCT00654368. (2008)   pp', '10.1136/annrheumdis-2014-eular.1054', '']\n",
      "['9741329', 'Keystone EC; Pope JE; Thorne JC; Poulin-Costello M; Phan-Chronis K; Vieira A; Haraoui B. Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis. Rheumatology. (2016) 55 2 pp327-334', '10.1093/rheumatology/kev338', 'http://academic.oup.com/rheumatology/article-pdf/55/2/327/5159107/kev338.pdf']\n",
      "['9260276', 'Verstappen SM; Jacobs JW; van der Veen MJ; Heurkens AH; Schenk Y; ter Borg EJ; Blaauw AA; Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Annals of the rheumatic diseases. (2007) 66 11 pp1443-1449', '10.1136/ard.2007.071092', '']\n",
      "['9260613', 'Bakker MF; Jacobs JW; Welsing PM; van der Werf JH; Linn-Rasker SP; van der Veen MJ; Lafeber FP; Bijlsma JW; Utrecht Arthritis Cohort Study Group. Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study. Annals of the rheumatic diseases. (2010) 69 10 pp1849-1852', '10.1136/ard.2009.124065', '']\n",
      "['9261018', 'Jurgens MS; Welsing PM; Geenen R; Bakker MF; Schenk Y; de Man YA; Bijlsma JW; Lafeber FP; Jacobs JW. The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials. Clinical and experimental rheumatology. (2014) 32 3 pp369-376', '10.1136/annrheumdis-2013-eular.1786', '']\n",
      "['9261969', 'Nair SC; Welsing PM; Jacobs JW; van Laar JM; Rensen WH; Ardine de Wit G; Bijlsma JW; Lafeber FP. Economic evaluation of a tight-control treatment strategy using an imaging device (handscan) for monitoring joint inflammation in early rheumatoid arthritis. Clinical and experimental rheumatology. (2015) 33 6 pp831-838', '10.1136/annrheumdis-2014-eular.2890', '']\n",
      "['9262230', 'Safy M; Jacobs JWG; Ijff ND; Bijlsma JWJ; Van Laar JM; De Hair MJH. Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial. Annals of the rheumatic diseases. (2017) 76 8 pp1432-1435', '10.1136/annrheumdis-2016-210647', '']\n",
      "['9261222', 'Bakker MF; Jacobs JWG; Welsing PMJ; Verstappen SMM; Tekstra J; Ton E; Geurts MAW. Double-blind randomized CAMERA-II trial: Better control of disease and erosive joint damage with inclusion of low-dose prednisone into a MTX-based tight control strategy for early rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.7326/0003-4819-156-5-201203060-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-156-5-201203060-00004']\n",
      "['9736650', 'Bijlsma J W J; Jacobs J W G; Buttgereit F. Glucocorticoids in the treatment of rheumatoid arthritis. Clinical and experimental rheumatology. (2015) 33 Supplement92 pp34-36', '10.1093/oso/9780198566304.003.0023', 'https://academic.oup.com/book/chapter-pdf/52405289/isbn-9780198566304-book-part-23.pdf']\n",
      "['9258294', 'Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Annals of internal medicine. (2012) 156 5 pp329-339', '10.7326/0003-4819-156-5-201203060-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-156-5-201203060-00004']\n",
      "['9258727', 'De Hair MJ; Safy M; Ijff N; Jacobs JW; Van Laar JM. Comorbidities after daily concomitant treatment with 10mg prednisone or placebo in the 2-year computer assisted management in early rheumatoid arthritis trial-ii. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp710-711', '10.1136/annrheumdis-2016-eular.3859', '']\n",
      "['9260804', 'van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?. Osteoporosis international. (2013) 24 4 pp1429-1436', '10.1007/s00198-012-2073-z', '']\n",
      "['9261405', 'Van Der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; Welsing PM; Bijlsma JW. No decrease in bone mineral density when prednisone is added to a methotrexate-based tight control strategy for early rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.405', '']\n",
      "['9261898', 'De Hair M; Jurgens M; Lafeber F; Jacobs J; Van Laar J. Is a high contribution of tender joint count and vas general health to the DAS28 associated with poor clinical response to treatment in early dmard-naive RA patients?. Annals of the rheumatic diseases. (2015) 74  pp238', '10.1136/annrheumdis-2015-eular.4613', '']\n",
      "['9262684', 'Safy M; De Hair M; Welsing P; Van Laar J; Jacobs J. Smoking is negatively associated with clinical response to concomitant prednisone use in early rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp281-282', '10.1136/annrheumdis-2018-eular.6494', '']\n",
      "['9738730', 'Safy M; De Hair M; Welsing P; Van Laar J; Jacobs J. Smoking is negatively associated with clinical response to concomitant prednisone use in early rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp281-282', '10.1136/annrheumdis-2018-eular.6494', '']\n",
      "['11084724', 'Safy-Khan Mary; de Hair Maria J H; Welsing Paco M J; van Laar Jacob M; Jacobs Johannes W G; Society for Rheumatology Research Utrecht (SRU). Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use. Journal of rheumatology. (2021) 48 10 pp1504-1507', '10.3899/jrheum.200213', '']\n",
      "['9262949', 'Porter DR; McInnes I; Hunter J; Capell HA. Outcome of second line therapy in rheumatoid arthritis. Annals of the rheumatic diseases. (1994) 53 12 pp812-815', '10.1136/ard.53.12.812', '']\n",
      "['9260584', 'Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Annals of the rheumatic diseases. (2010) 69 7 pp1275-1280', '10.1136/ard.2009.126888', '']\n",
      "['9261472', 'Alten R; Holt R; Grahn A; Rice P; Kent J; Buttgereit F; Gibofsky A. Switching from immediate release (IR) prednisone to delayed release (DR) prednisone improves patient reported outcomes in rheumatoid arthritis (RA) patients on conventional disease-modifying antirheumatic drugs (DMARDS). Arthritis and rheumatism. (2013) 65  ppS963-S964', '10.1136/annrheumdis-2014-eular.1467', '']\n",
      "['9256817', 'Buttgereit F; Kent JD; Holt RJ; Grahn AY; Rice P; Alten R; Yazici Y. Improvement thresholds for morning stiffness duration in patients receiving delayed- versus immediate-release prednisone for rheumatoid arthritis. Bulletin of the Hospital for Joint Diseases. (2015) 73  3 pp168-177', '10.1136/annrheumdis-2014-eular.1467', '']\n",
      "['9738855', 'Dejaco C; Duftner C. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Journal fur mineralstoffwechsel. (2008) 15 2 pp101', '10.3410/f.1099142.555355', '']\n",
      "['9260749', 'Buttgereit F; Mehta D; Kirwan J; Szechinski J; Boers M; Alten RE; Supronik J; Szombati I; Romer U; Witte S; Saag KG. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Annals of the rheumatic diseases. (2013) 72 2 pp204-210', '10.1136/annrheumdis-2011-201067', '']\n",
      "['9742538', 'Buttgereit F; Mehta D; Kirwan J; Szechinski J; Boers M; Alten R E; Supronik J; Szombati I; Romer U; Witte S; Witte K G. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Annals of the rheumatic diseases. (2012)   pp', '10.1136/annrheumdis-2011-201067', '']\n",
      "['9738491', 'EUCTR2013-004604-19-DE. Effect of Adalimumab plus Methortrexat (MTX) versus Placebo plus MTX on cartilage in early RA patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-004604-19-DE. (2014)   pp', '10.31525/ct1-nct04247815', '']\n",
      "['9739596', 'UMIN000004412. Corticosteroid-sparing effect of Actemra in patients with Rheumatoid Arthritis refractory to anti-TNF agents, methotrexate and corticosteroid. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004412. (2010)   pp', '10.1186/isrctn62900439', '']\n",
      "['9738038', 'EUCTR2010-019964-36-DE. A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy - CARAT-2. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019964-36-DE. (2010)   pp', '10.1186/isrctn67054656', '']\n",
      "['9257468', 'Scott IC; Walker J; Quist J; Spain S; Tan R; Okada Y; Raychaudhuri S; Steer S; Cope AP; Lewis CM. Genetic susceptibility variants for rheumatoid arthritis do not associate with radiological progression in early active disease. Rheumatology (United Kingdom). (2014) 53  ppi158', '10.1093/rheumatology/keu122.002', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i158/9578854/keu122.002.pdf']\n",
      "['9258103', 'Scott IC; Seegobin SD; Ma MHY; Dahanayake C; Cope AP; Scott DL; Lewis CM. Assessment of combination therapy responses in early rheumatoid arthritis defined by presence or absence of anti-citrullinated protein antibodies. Lancet. (2014) 383  ppS95', '10.1016/s0140-6736(14)60358-5', '']\n",
      "['9257018', 'Burmester GR; Rigby WF; van Vollenhoven RF; Kay J; Rubbert-Roth A; Blanco R; Kadva A; Dimonaco S. Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial. Annals of the rheumatic diseases. (2017) 76 7 pp1279-1284', '10.1136/annrheumdis-2016-210561', '']\n",
      "['9261030', 'Ma MHY; Scott IC; Dahanayake C; Cope AP; Scott DL. Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen. Journal of rheumatology. (2014) 41  7 pp1298-1303', '10.3899/jrheum.131401', '']\n",
      "['9736841', 'Ma M H; Dahanayake C; Scott I C; Kingsley G; Cope A; Scott D L. Serological status: a role in personalized medicine for rheumatoid arthritis. Rheumatology (united kingdom). (2013) 52 SUPPL. 1 pp', '10.1016/s0140-6736(13)60508-5', '']\n",
      "['9737322', 'Ma M H Y; Dahanayake C; Scott I C; Kingsley G H; Cope A P; Scott D L. Serological status: a predictor of response to intensive therapy in rheumatoid arthritis. Lancet. (2013) 381 SUPPL. 1 ppS67', '10.1016/s0140-6736(13)60508-5', '']\n",
      "['9737581', 'Ma MHY; Dahanayake C; C Scott I; Kingsley GH; Cope AP; Scott DL. Serological status: a predictor of response to intensive therapy in rheumatoid arthritis. Lancet. (2013) 381  ppS68-', '10.1016/s0140-6736(13)60508-5', '']\n",
      "['9737727', 'Seegobin SD; Ma MHY; Dahanayake C; Cope AP; Scott DL; Lewis CM; Scott IC. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids. Rheumatology (united kingdom). (2014) 53  ppi92-i93', '10.1093/rheumatology/keu101.017', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i92/9578475/keu101.017.pdf']\n",
      "['9737821', 'Matcham F; Norton S; Scott DL; Steer S; Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (oxford, england). (2016) 55 2 pp268-278', '10.1093/rheumatology/kev306', 'http://academic.oup.com/rheumatology/article-pdf/55/2/268/5158105/kev306.pdf']\n",
      "['9738525', 'Wailoo A; Alava MH; Scott IC; Ibrahim F; Scott DL. Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis. Rheumatology (united kingdom). (2014) 53 10 pp1773-1777', '10.1093/rheumatology/keu039', 'http://academic.oup.com/rheumatology/article-pdf/53/10/1773/17388298/keu039.pdf']\n",
      "['9739109', 'Ma M H Y; Dahanayake C; Scott I C; Kingsley G H; Cope A P; Scott D L. Serological status: a predictor of response to intensive therapy in rheumatoid arthritis. Lancet. (2013) 381 SUPPL. 1 ppS68', '10.1016/s0140-6736(13)60508-5', '']\n",
      "['9739128', 'Seegobin S D; Ma M H Y; Dahanayake C; Cope A P; Scott D L; Lewis C M; Scott I C. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids. Rheumatology (united kingdom). (2014) 53 SUPPL. 1 pp', '10.1093/rheumatology/keu101.017', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i92/9578475/keu101.017.pdf']\n",
      "['9742687', 'Eusden J; Matcham F; Steer S; Cope AP; Lewis CM; Scott IC. Reduced mental health in early rheumatoid arthritis is associated with genetic susceptibility for depression, disease severity and pain levels. Rheumatology (united kingdom). (2015) 54  ppi49-', '10.1093/rheumatology/kev087.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i49/5179483/kev087.006.pdf']\n",
      "['9263546', 'Scott IC; Ibrahim F; Scott DL; Lewis CM. The impact of intensive treatment and remission on health-related quality of life in rheumatoid arthritis. The lancet. Conference: spring meeting for clinician scientists in training 2016. London united kingdom. Conference start: 20160225. Conference end: 20160225. Conference publication: (var.pagings). (2016) 387  pp90', '10.1016/s0140-6736(16)00477-3', '']\n",
      "['9260359', 'Choy EH; Smith CM; Farewell V; Walker D; Hassell A; Chau L; Scott DL; CARDERA (Combination Anti-Rheumatic Drugs in Early Rheumatoid Arhritis) Trial Group. Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Annals of the rheumatic diseases. (2008) 67 5 pp656-663', '10.1136/ard.2007.076299', '']\n",
      "['11085840', 'Weiner Joan; Lui Geyanne; Brown Mackenzie; Paez Yuliana Dominguez; Fritz Shelley; Sydnor-Campbell Tien; Allen Aberdeen Jr; Jabri Assem; Venkatachalam Shilpa; Gavigan Kelly; Nowell William Benjamin; Curtis Jeffrey R; Fraenkel Liana; Safford Monika; Navarro-Millan Iris. Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention. Pilot and feasibility studies. (2022) 8 1 pp84', '10.1186/s40814-022-01041-z', 'https://link.springer.com/article/10.1186/s40814-022-01041-z/fulltext.html']\n",
      "['11088886', 'Weiner J; Lui G; Brown M; Paez YD; Fritz S; Sydnor-Campbell T; Allen A; Jabri A; Venkatachalam S; Gavigan K; Nowell WB; Curtis JR; Fraenkel L; Safford M; Navarro-Millan I. Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention. . (2022) 8 1 pp', '10.1186/s40814-022-01041-z', 'https://link.springer.com/article/10.1186/s40814-022-01041-z/fulltext.html']\n",
      "['9257640', 'Decock D; Westhovens R; Stouten V; Van Der Elst K; Joly J; Verschueren P. Patient characteristics predicting remission using intensive treatment strategies in early rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3377-3378', '10.1002/art.39977', '']\n",
      "['9257739', 'Decock D; Westhovens R; Stouten V; Van Der Elst K; Joly J; Verschueren P. Glucocorticoids in early rheumatoid arthritis management, friend or foe?. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2915-2916', '10.1002/art.39977', '']\n",
      "['9259249', 'Clark P; Casas E; Tugwell P; Medina C; Gheno C; Tenorio G; Orozco JA. Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial. Annals of internal medicine. (1993) 119 11 pp1067-1071', '10.7326/0003-4819-119-11-199312010-00002', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-119-11-199312010-00002']\n",
      "['9261446', 'De Cock D; Meyfroidt S; Joly J; Van Der Elst K; Westhovens R; Verschueren P. For remission induction with glucocorticoid bridging, methotrexate monotherapy is as effective as a combination with other dmards, with fewer reported side effects: 4 month primary outcome of carera, a randomized induction strategy and treat to target trial in early rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  12 pp3325-3326', '10.1136/annrheumdis-2014-eular.2137', '']\n",
      "['9261559', 'De Cock D; Westhovens R; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van Der Elst K; Verschueren P. Comparison of MTX therapy with or without a moderate dose glucocorticoid bridging scheme in early rheumatoid arthritis patients lacking classical poor prognostic markers: Week 16 results from the randomized multicenter carera trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2144', '']\n",
      "['9261908', 'Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravilingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Van Der Elst K; Meyfroidt S; Westhovens R. Remission induction with DMARD combinations and glucocorticoids is not superior to remission induction with mtx monotherapy and glucocorticoids: week 52 results of the high-risk group from the carera trial. Annals of the rheumatic diseases. (2015) 74  pp139', '10.1136/annrheumdis-2015-eular.4018', '']\n",
      "['9262429', 'Pazmino S; Westhovens R; Stouten V; Joly J; Van Der Elst K; Verschueren P. Long term use of analgesics and NSAIDS in early RA: lessons from the carera study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp765-766', '10.1136/annrheumdis-2017-eular.3399', '']\n",
      "['9262457', 'Stouten V; Joly J; De Cock D; Pazmino S; Van Der Elst K; Westhovens R; Verschueren P. Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to-target setting: 2-year results of the carera trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp147', '10.1136/annrheumdis-2017-eular.6472', '']\n",
      "['9262650', 'Stouten V; Michiels S; Belba A; Westhovens R; Verschueren P. Effectiveness of a randomized step-down to methotrexate or leflunomide maintenance therapy in patients with low disease activity, 40 weeks after starting combined methotrexate-leflunomide remission induction therapy in early rheumatoid arthritis: results from the carera trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp967-968', '10.1136/annrheumdis-2018-eular.3036', '']\n",
      "['9262718', 'Pazmino SS; Westhovens R; Joly J; Stouten V; De Cock D; Van der Elst K; Verschueren P. Two year cost-effectiveness analysis of the carera trial in early RA: a piggy back study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp197', '10.1136/annrheumdis-2018-eular.7296', '']\n",
      "['9262725', 'Stouten V; Joly J; Pazmino S; Van Der Elst K; DeCock D; Westhovens R; Verschueren P. Long-term effectiveness of the cobra slim remission induction and treat to target strategy in patients with early rheumatoid arthritis lacking classical markers of poor prognosis: 2 year results of the carera trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp67', '10.1136/annrheumdis-2018-eular.2535', '']\n",
      "['9263540', 'Lunzer R. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.. Journal fur mineralstoffwechsel. (2016) 23 3 pp109-110', '10.1136/annrheumdis-2016-209212', '']\n",
      "['9263571', 'Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van Der Elst K; Westhovens R. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial. Annals of the rheumatic diseases. (2017) 76 3 pp511-520', '10.1136/annrheumdis-2016-209212', '']\n",
      "['9737015', 'De Cock; De Saedeleer; Van Der Elst; Stouten V; Joly J; Westhovens R; Verschueren P. A cost-effectiveness analysis of different intensive combination therapies for early rheumatoid arthritis: 1 year results of the carera trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp121', '10.1136/annrheumdis-2016-eular.4139', '']\n",
      "['9737469', 'Verschueren P; De Cock; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen; Van Essche; Sileghem A; De Brabanter; Joly J; Meyfroidt S; Van Der Elst; Westhovens R. Associated with a glucocorticoid bridging scheme, methotrexate is as effective alone as in combination with other DMARDs for early rheumatoid arthritis, with fewer reported side effects: 16 weeks remission induction data from the carera trial. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.2137', '']\n",
      "['9738376', 'Stouten V; Joly J; De Cock; Pazmino S; Van Der Elst; Westhovens R; Verschueren P. Sustained effectiveness after remission induction with methotrexate and step-down glucocorticoids in patients with early rheumatoid arthritis following a treat-to-target strategy after 2 years. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.6472', '']\n",
      "['9738396', 'De Cock; Westhovens R; Stouten V; Van Der Elst; Joly J; Verschueren P. Does BMI increase in patients with early rheumatoid arthritis when treated with short-term glucocorticoid remission induction schemes?. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1241-1242', '10.1136/annrheumdis-2016-eular.4076', '']\n",
      "['9738710', 'Stouten V; Michiels S; Belba A; Westhovens R; Verschueren P. Effectiveness of a randomized step-down to methotrexate or leflunomide maintenance therapy in patients with low disease activity, 40 weeks after starting combined methotrexate-leflunomide remission induction therapy in early rheumatoid arthritis: results from the carera trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp967-968', '10.1136/annrheumdis-2018-eular.3036', '']\n",
      "['9738771', 'Pazmino SS; Westhovens R; Joly J; Stouten V; De Cock D; Van der Elst K; Verschueren P. Two year cost-effectiveness analysis of the carera trial in early RA: a piggy back study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp197', '10.1136/annrheumdis-2018-eular.7296', '']\n",
      "['9738774', 'Stouten V; Joly J; Pazmino S; Van Der Elst K; DeCock D; Westhovens R; Verschueren P. Long-term effectiveness of the cobra slim remission induction and treat to target strategy in patients with early rheumatoid arthritis lacking classical markers of poor prognosis: 2 year results of the carera trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp67', '10.1136/annrheumdis-2018-eular.2535', '']\n",
      "['9739488', 'Van Der Elst K; De Cock D; Stouten V; Joly J; Moons P; Verschueren P; Westhovens R. Patients with early rheumatoid arthritis treated with remission induction treat-to-target regimens report important early and lasting health improvement: results from the carera trial. Annals of the rheumatic diseases. (2016) 75  pp690-', '10.1136/annrheumdis-2016-eular.5971', '']\n",
      "['9739547', 'Pazmino S; Westhovens R; Stouten V; Joly J; Van Der Elst K; De Cock D; Verschueren P. Step-down-bridge versus tight-step-up therapy in patients with early rheumatoid arthritis lacking poor prognostic factors: an economic point of view. Arthritis and rheumatology. (2018) 70  pp679-', '10.1136/annrheumdis-2018-eular.2535', '']\n",
      "['9740087', 'EUCTR2008-007225-39-BE. A 2 year follow up to assess the effectiveness in daily practice of different treatment strategies for early Rheumatoid Arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-007225-39-BE. (2009)   pp', '10.1093/rheumatology/39.4.407', 'http://academic.oup.com/rheumatology/article-pdf/39/4/407/9532685/390407.pdf']\n",
      "['9740278', 'NTR4524. COBRA treat-to-target trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4524. (2014)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9740723', \"Stouten V; De Cock D; Pazmino S; Van Der Elst K; Joly J; Bertrand D; Westhovens R; Verschueren P. Rheumatologists' adherence to the treat-totarget principle in early RA patients within the pragmatic carera trial: room for improvement?. Annals of the rheumatic diseases. (2019) 78  pp342-\", '10.1136/annrheumdis-2019-eular.7239', '']\n",
      "['9740738', 'Stouten V; Westhovens R; Pazmino S; De Cock D; Van Der Elst K; Joly J; Verschueren P; Maeyaert B; De Brabanter G; Devinck M; Langenaken C; Lenaerts J; Corluy L; Remans J; Vander Cruyssen B; Ravelingien I; Van Essche E; Vandevyvere K; Durnez A; Verbruggen A; Geens E; Raeman F; Joos R; De Vlam K; Taelman V; Vanhoof J; Coppens M; Geusens P; Sileghem A; Volders P; Van Den Bosch F. Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA. Rheumatology (Oxford, England). (2019) 58 12 pp2284-2294', '10.1093/rheumatology/kez213', 'http://academic.oup.com/rheumatology/article-pdf/58/12/2284/31145275/kez213.pdf']\n",
      "['9740777', 'Pazmino S; Boonen A; Stouten V; De Cock D; Bertrand D; Van Der Elst K; Joly J; Westhovens R; Verschueren P; Group CS. Seronegative rheumatoid arthritis: mild no more. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp317-318', '10.1136/annrheumdis-2019-eular.1940', '']\n",
      "['9741309', 'Pazmino S; Boonen A; Stouten V; De Cock D; Joly J; Van Der Elst K; Westhovens R; Verschueren P. Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2019-216874', '']\n",
      "['9741315', 'Stouten V; Michiels S; Westhovens R; De Cock D; Belba A; Pazmino S; Van der Elst K; Joly J; Verschueren P. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05008-4', 'http://link.springer.com/article/10.1007/s10067-020-05008-4/fulltext.html']\n",
      "['9741484', 'Pazmino Sofia; Boonen Annelies; Stouten Veerle; De Cock Diederik; Joly Johan; Van der Elst Kristien; Westhovens Rene; Verschueren Patrick. Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the rheumatic diseases. (2020) 79 5 pp556-565', '10.1136/annrheumdis-2019-216874', '']\n",
      "['9742219', 'Van Der Elst K; Verschueren P; Stouten V; Pazmino S; De Cock D; Joly J; Moons P; Westhovens R. Rapid and sustained remission contributes to improved psychosocial outcomes after 1 year of treatment in patients with early rheumatoid arthritis: data from the carera trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp557-558', '10.1136/annrheumdis-2018-eular.6310', '']\n",
      "['9742358', \"Stouten V; De Cock D; Pazmino S; Van Der Elst K; Joly J; Bertrand D; Westhovens R; Verschueren P. Rheumatologists' adherence to the treat-totarget principle in early RA patients within the pragmatic carera trial: room for improvement?. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp342\", '10.1136/annrheumdis-2019-eular.7239', '']\n",
      "['9742393', 'Lucio SP; Boonen A; Westhovens R; Stouten V; Joly J; De Cock D; Van Der Elst K; Verschueren P. Two-year cost-utilityand cost-effectiveness analysis of different cobra like intensive remission induction strategies for early rheumatoid arthritis: a piggy back studyon the pragmatic randomized controlled careratrial. Journal of clinical rheumatology. (2019) Conference: 21st Pan American Rheumatology Congress, PANLAR 2019. Ecuador. 25 3 Supplement ppS49', '10.1136/annrheumdis-2019-216874', '']\n",
      "['9742450', 'Pazmino S; Boonen A; Stouten V; De Cock D; Joly J; Van Der Elst K; Westhovens R; Verschueren P. Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the rheumatic diseases. (2020)  no pagination pp', '10.1136/annrheumdis-2019-216874', '']\n",
      "['9742465', 'Stouten V; Michiels S; Westhovens R; De Cock D; Belba A; Pazmino S; Van der Elst K; Joly J; Verschueren P. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05008-4', 'http://link.springer.com/article/10.1007/s10067-020-05008-4/fulltext.html']\n",
      "['9742677', 'De Cock D; De Saedeleer A; Van Der Elst K; Stouten V; Joly J; Westhovens R; Verschueren P. A cost-effectiveness analysis of different intensive combination therapies for early rheumatoid arthritis: 1 year results of the carera trial. Annals of the rheumatic diseases. (2016) 75  pp121-', '10.1136/annrheumdis-2016-eular.4139', '']\n",
      "['9742912', 'Lucio SP; Boonen A; Westhovens R; Stouten V; Joly J; De Cock D; Van Der Elst K; Verschueren P. Two-year cost-utilityand cost-effectiveness analysis of different cobra like intensive remission induction strategies for early rheumatoid arthritis: a piggy back studyon the pragmatic randomized controlled careratrial. Journal of clinical rheumatology. (2019) 25 3 ppS49-', '10.1136/annrheumdis-2019-216874', '']\n",
      "['9743065', 'Stouten Veerle; Michiels Stijn; Westhovens Rene; De Cock Diederik; Belba Amy; Pazmino Sofia; Van der Elst Kristien; Joly Johan; Verschueren Patrick. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05008-4', 'http://link.springer.com/article/10.1007/s10067-020-05008-4/fulltext.html']\n",
      "['11084051', 'De Cock D; Nooyens A; Pazmino S; Bertrand D; Stouten V; Joly J; Westhovens R; Verschueren P. Treating early and intensively is associated with lower fatigue levels on the long term, even in patients with early rheumatoid arthritis considered to have a favourable risk profile. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp583-584', '10.1136/annrheumdis-2020-eular.3160', '']\n",
      "['11084300', 'Stouten Veerle; Westhovens Rene; Pazmino Sofia; De Cock Diederik; Van der Elst Kristien; Joly Johan; Bertrand Delphine; Verschueren Patrick. Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial. Annals of the rheumatic diseases. (2021) 80 8 pp965-973', '10.1136/annrheumdis-2020-219825', '']\n",
      "['11084739', 'Doumen M; De Cock D; Pazmino S; Bertrand D; Joly J; Westhovens R; Verschueren P. Psychosocial burden predicts sustained remission in early rheumatoid arthritis: unraveling the complex interplay of wellbeing and disease activity. . (2021)   pp', '10.1002/acr.24847', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24847']\n",
      "['11084847', 'Pazmino Sofia; Boonen Annelies; Stouten Veerle; De Cock Diederik; Joly Johan; Van der Elst Kristien; Westhovens Rene; Verschueren Patrick. Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the rheumatic diseases. (2020) 79 5 pp556-565', '10.1136/annrheumdis-2019-216874', '']\n",
      "['11085370', 'Pazmino Sofia; Boonen Annelies; De Cock Diederik; Stouten Veerle; Joly Johan; Bertrand Delphine; Westhovens Rene; Verschueren Patrick. Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial. RMD open. (2021) 7 2 pp', '10.1136/rmdopen-2021-001615', '']\n",
      "['11086047', \"Jain S; Dhir V. Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'. Annals of the rheumatic diseases. (2021)   pp\", '10.1136/annrheumdis-2021-220816', '']\n",
      "['11086492', 'Pazmino S; Boonen A; Stouten V; De Cock D; Bertrand D; Van Der Elst K; Joly J; Wethovens R; Verschueren P. Seronegative rheumatoidarthritis: mild nomore. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS135', '10.1136/annrheumdis-2019-eular.1940', '']\n",
      "['11086643', 'Pazmino S; Lovik A; Boonen A; De Cock D; Stouten V; Joly J; Bertrand D; Westhovens R; Verschueren P. Clinical treatment response still does not match patient reported improvement, even in early rheumatoid arthritis. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp582', '10.1136/annrheumdis-2020-eular.2116', '']\n",
      "['11088012', 'Stouten Veerle; Westhovens Rene; De Cock Diederik; Van der Elst Kristien; Pazmino Sofia; Bertrand Delphine; Joly Johan; Verschueren Patrick. Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial. Rheumatology (Oxford, England). (2021) 60 8 pp3699-3708', '10.1093/rheumatology/keaa841', 'http://academic.oup.com/rheumatology/article-pdf/60/8/3699/39543579/keaa841.pdf']\n",
      "['11088204', 'Stouten Veerle; Michiels Stijn; Westhovens Rene; De Cock Diederik; Belba Amy; Pazmino Sofia; Van der Elst Kristien; Joly Johan; Verschueren Patrick. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT. Clinical rheumatology. (2020) 39 9 pp2593-2601', '10.1007/s10067-020-05008-4', 'http://link.springer.com/article/10.1007/s10067-020-05008-4/fulltext.html']\n",
      "['9740525', 'EUCTR2017-004054-41-BE. COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-004054-41-BE. (2018)   pp', '10.1186/isrctn75505683', '']\n",
      "['9742657', 'NCT03649061. COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA. Https://clinicaltrials.gov/show/nct03649061. (2018)   pp', '10.1186/isrctn75505683', '']\n",
      "['9258631', 'Schiff MH; von Kempis J; Goldblum R; Tesser JR; Mueller RB. Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Annals of the rheumatic diseases. (2014) 73 12 pp2174-2177', '10.1136/annrheumdis-2014-205325', '']\n",
      "['9261408', 'Schiff M; Goldblum R; Tesser J. Can rheumatoid arthritis (RA) incomplete secondary responders to TNF-alpha attain an efficacious and safe response by switching to certolizumab pegol?. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.3091', '']\n",
      "['9261158', 'Emery P; Smolen JS; Samborski W; Berenbaum F; Davies O; Ambrugeat J; Bennett B; Burkhardt H. Efficacy and safety of certolizumab pegol after incomplete response to dmards in rheumatoid arthritis patients with low moderate disease activity: Results from certain, a phase IIIB study. Rheumatology (United Kingdom). (2012) 51  ppiii134', '10.1136/annrheumdis-2012-eular.2607', '']\n",
      "['9263506', 'Smolen JS; Emery P; Ferraccioli GF; Samborski W; Berenbaum F; Davies OR; Koetse W; Purcaru O; Bennett B; Burkhardt H. Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial. Annals of the rheumatic diseases. (2015) 74 5 pp843-850', '10.1136/annrheumdis-2013-204632', '']\n",
      "['9737864', 'EUCTR2007-000830-38-AT. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of   certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000830-38-AT. (2008)   pp', '10.1186/isrctn27093749', '']\n",
      "['9740051', \"EUCTR2007-000828-40-AT. A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFa Fab'fragment, certolizumab pegol, administered concomitantly with stable-dose DMARDs in patients with moderate to low disease activity rheumatoid arthritis. - C87076. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000828-40-AT. (2008)   pp\", '10.1186/isrctn61635363', '']\n",
      "['9738013', 'NCT00674362. Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study. https://clinicaltrials.gov/show/NCT00674362. (2008)   pp', '10.1093/rheumatology/keq406', 'http://academic.oup.com/rheumatology/article-pdf/50/5/926/5023635/keq406.pdf']\n",
      "['9738981', 'Smolen J S; Emery P; Ferraccioli G F; Samborski W; Berenbaum F; Davies O R; Koetse W; Purcaru O; Bennett B; Burkhardt H. Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204632', '']\n",
      "['9739704', 'UMIN000002340. Comparison of effects between higher dosages of infliximab and switching to other biologics for rheumatoid arthritis patients with less responsiveness to infliximab therapy (cHAMLET). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002340. (2009)   pp', '10.2147/btt.s3189', '']\n",
      "['9263238', 'Miyasaka N; CHANGE Study Investigators. Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study. Modern rheumatology. (2008) 18 3 pp252-262', '10.3109/s10165-008-0045-0', '']\n",
      "['9260219', 'Maini RN; Taylor PC; Szechinski J; Pavelka K; Br‚àö‚àÇll J; Balint G; Emery P; Raemen F; Petersen J; Smolen J; Thomson D; Kishimoto T; CHARISMA Study Group. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis and rheumatism. (2006) 54 9 pp2817-2829', '10.1002/art.22033', '']\n",
      "['9256965', 'Chen DY; Chou SJ; Hsieh TY; Chen YH; Chen HH; Hsieh CW; Lan JL. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis. Journal of the Formosan Medical Association / Taiwan yi zhi. (2009) 108 4 pp310-319', '10.1016/s0929-6646(09)60071-1', '']\n",
      "['9742539', 'Chen R L; Tao Y; Lin Z Y; Huang C H; Huang W H. Efficacy and safety of adalimumab in patients with rheumatoid arthritis. Chinese journal of new drugs. (2011) 20 2 pp152', '10.1517/14740338.2011.581661', '']\n",
      "['11085697', 'Chen F; Wang Y; Wang L; Du H; He S. Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis. Computational and mathematical methods in medicine. (2022) 2022  pp6829358', '10.1155/2022/6829358', 'http://downloads.hindawi.com/journals/cmmm/2022/6829358.pdf']\n",
      "['9738243', 'ChiCTR-INR-16009546. The Efficacy and Safety of Low Dose IL-2 Conbined IL-6 Antagonist  Therapy in Chinese Over-treated Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16009546. (2016)   pp', '10.3030/633413', '']\n",
      "['11088120', 'Kang Bing-Xin; Xu Hui; Gao Chen-Xin; Zhong Sheng; Zhang Jing; Xie Jun; Sun Song-Tao; Ma Ying-Hui; Zhai Wei-Tao; Xiao Lian-Bo. Multiple-dose tranexamic acid for perioperative blood loss in total knee arthroplasty in patients with rheumatoid arthritis: a single-blinded, randomised, parallel-controlled study protocol in China. BMJ open. (2020) 10 8 ppe034431', '10.1136/bmjopen-2019-034431', '']\n",
      "['9263371', 'Choy E; McKenna F; Vencovsky J; Valente R; Goel N; Vanlunen B; Davies O; Stahl HD; Alten R. Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX. Rheumatology (Oxford, England). (2012) 51 7 pp1226-1234', '10.1093/rheumatology/ker519', 'http://academic.oup.com/rheumatology/article-pdf/51/7/1226/5089893/ker519.pdf']\n",
      "['9258246', 'Moller-Bisgaard S; Ejbjerg B; Eshed I; Horslev-Petersen K; Hetland M; Jurik AG; Thomsen H; Torfing T; Stengaard-Pedersen K; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Skjodt H; Svendsen A; Tarp U; Hansen I; Podenphant J; Pedersen JK; Lindegaard H; Vestergaard A; Glinatsi D; Ostergaard M. Magnetic resonance imaging joint space narrowing is an independent predictor of radiographic and MRI damage progression in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp638', '10.1136/annrheumdis-2016-eular.3452', '']\n",
      "['9262933', 'Davis MJ; Dawes PT; Fowler PD; Clarke S; Fisher J; Shadforth MF. Should disease-modifying agents be used in mild rheumatoid arthritis?. British journal of rheumatology. (1991) 30 6 pp451-454', '10.1093/rheumatology/30.6.451', 'http://academic.oup.com/rheumatology/article-pdf/30/6/451/5030150/30-6-451.pdf']\n",
      "['9260305', 'Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skj‚Äö√†√∂‚Äö√†√®dt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; ‚Äö√†√∂‚àö‚â§stergaard M; H‚Äö√†√∂‚Äö√†√®rslev-Petersen K; CIMESTRA study group. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Annals of the rheumatic diseases. (2008) 67 6 pp815-822', '10.1136/ard.2007.076307', '']\n",
      "['9260438', 'Hetland ML; Ejbjerg B; H‚àö‚àèrslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skj‚àö‚àèdt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vall‚àö‚àè J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M; CIMESTRA study group. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Annals of the rheumatic diseases. (2009) 68 3 pp384-390', '10.1136/ard.2008.088245', '']\n",
      "['9260582', 'Christensen AF; H‚àö‚àèrslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skj‚àö‚àèdt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; P‚àö‚àèdenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. Journal of rheumatology. (2010) 37 6 pp1113-1120', '10.3899/jrheum.091265', '']\n",
      "['9260619', 'Hetland ML; Stengaard-Pedersen K; Junker P; ‚àö√≤stergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; P‚àö‚àèdenphant J; Vestergaard A; Jurik AG; H‚àö‚àèrslev-Petersen K; CIMESTRA study group. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Annals of the rheumatic diseases. (2010) 69 10 pp1789-1795', '10.1136/ard.2009.125534', '']\n",
      "['9260799', 'Hetland ML; H‚àö‚àèrslev-Petersen K. The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis. Clinical and experimental rheumatology. (2012) 30 4 Suppl 73 ppS44-9', '10.1186/isrctn97686858', '']\n",
      "['9260836', 'Ellingsen T; Hansen I; Thorsen J; Kuno M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; H‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürslev-Petersen K; Stengaard-Pedersen K. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis. Clinical and experimental rheumatology. (2012) 30 1 pp58-63', '10.4324/9780203187838.bmatt3', '']\n",
      "['9261420', 'Hetland ML; Junker P; Poodenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Joorgensen A; Krintel SB; Raun J; Ammitzbooll CG; Johansen JS; Ostergaard M; Stengaard-Pedersen K. Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis-1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA)K. Hoorslev-Petersen1. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2605', '']\n",
      "['9261737', \"Moller-Bisgaard S; Ejbjerg BJ; Eshed I; Horslev-Petersen K; Hetland ML; Jurik AG; Vallo J; Thomsen H; Torfing T; Stengaard-Pedersen K; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjodt H; Svendsen A; Tarp U; Podenphant J; Pedersen JK; Lindegaard H; Ostergaard M. Effect of a non biologic treat-to-target strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis'results from a 2-year investigator-initiated double-blind randomized controlled clinical trial. Arthritis and Rheumatology. (2015) 67 no pagination pp\", '10.1136/annrheumdis-2015-eular.2808', '']\n",
      "['9261874', \"Moller-Bisgaard S; Ejbjerg BJ; Eshed I; Horslev-Petersen K; Jurik AG; Vallo J; Thomsen H; Torfing T; Stengaard-Pedersen K; Hetland ML; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjodt H; Svendsen AJ; Tarp U; Podenphant J; Pedersen JK; Lindegaard H; Ostergaard M. Effect of methotrexate and intra-articular betamethasone with or without additional cyclosporine on magnetic resonance imaging (mri)-determined inflammatory and destructive changes in very early rheumatoid arthritis-results from a 24-months' randomised double blind placebo controlled trial. Annals of the rheumatic diseases. (2015) 74  pp648\", '10.1136/annrheumdis-2015-eular.2808', '']\n",
      "['9262296', 'Moller-Bisgaard S; Ejbjerg BJ; Eshed I; Horslev-Petersen K; Hetland ML; Jurik AG; Thomsen H; Torfing T; Stengaard-Pedersen K; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Skjodt H; Svendsen AJ; Tarp U; Hansen IT; Podenphant J; Pedersen JK; Lindegaard H; Hanson LG; Vestergaard A; Glinatsi D; Ostergaard M. Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). Scandinavian journal of rheumatology. (2017) 46 5 pp335-345', '10.1080/03009742.2016.1209550', '']\n",
      "['9262333', 'Herly M; Stengaard-Pedersen K; H√∏rslev-Petersen K; Hetland ML; √òstergaard M; Christensen R; L√∏gstrup BB; Vestergaard P; P√∏denphant J; Junker P; Ellingsen T. Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes. BMJ open. (2017) 7 4 ppe014816', '10.1136/bmjopen-2016-014816', '']\n",
      "['9262343', \"Hetland ML; Stengaard-Pedersen K; Junker P; Lindegaard H; Ellingsen T; Podenphant J; Skjodt H; Vestergaard A; Ejbjerg BJ; Jacobsen S; Krogh NS; Ostergaard M; Horslev-Petersen K. 10+ years' follow-up of a Danish 2-year treat-to-target rct in patients with early rheumatoid arthritis: baseline predictors of functional and radiographic outcomes. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp4292-4294\", '10.1136/annrheumdis-2017-eular.1720', '']\n",
      "['9262344', 'Moller-Bisgaard S; Ejbjerg BJ; Eshed I; Horslev-Petersen K; Hetland ML; Jurik AG; Thomsen HS; Torfing T; Stengaard-Pedersen K; Junker P; Krogh NS; Lottenburger T; Ellingsen T; Andersen LS; Skjodt H; Svendsen A; Tarp U; Hansen IT; Podenphant J; Pedersen JK; Lindegaard H; Vestergaard A; Glinatsi D; Ostergaard M. Magnetic resonance imaging (MRI) joint space narrowing is an independent predictor of radiographic and MRI damage progression in patients with early rheumatoid arthritis. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp1229-1230', '10.1136/annrheumdis-2016-eular.3452', '']\n",
      "['9262426', \"Hetland ML; Stengaard-Petersen K; Junker P; Lindegaard H; Ellingsen T; Podenphant J; Skjodt H; Vestergaard A; Ejbjerg B; Jacobsen S; Krogh NS; Ostergaard M; Horslev-Petersen K. 11 years' follow-up of a Danish 2-year treat-totarget randomized controlled trial in patients with early rheumatoid arthritis: baseline predictors of functional and radiographic outcomes. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp784\", '10.1136/annrheumdis-2017-eular.1720', '']\n",
      "['9739053', 'David T W J; Hansen M S; Horslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Podenphant J; Stengaard-Pedersen K; Junker P; Ostergaard M; Lottenburger T; Ellingsen T; Smedegaard Andersen; Hansen I; Skjodt H; Pedersen J K; Lauridsen U B; Svendsen A; Tarp U; Hansen G; Lindegaard H; Carvalho A; Hetland M. Periarticular and generalised bone loss in patients with early rheumatoid arthritis (ERA). Influence of alendronate (AL) and glucocorticoid treatment, and disease activity. Bone. (2011) 48 SUPPL. 2 ppS211', '10.1016/j.bone.2011.03.485', '']\n",
      "['9739278', \"Hetland M L; Ostergaard M; Stengaard-Pedersen K; Junker P; Ejbjerg B; Jacobsen S; Ellingsen T; Lindegaard H; Podenphant J; Vestergaard A; Jurik A G; Krogh N S; Horslev-Petersen K; and The; Cimestra Study Group. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis. Scandinavian journal of rheumatology. (2018) 48 1 pp1-8\", '10.1080/03009742.2018.1466362', '']\n",
      "['9740713', 'Herly M; Stengaard-Pedersen K; Vestergaard P; Christensen R; Stergaard M; Junker P; Hetland ML; Horslev-Petersen K; Ellingsen T. Low serum level of vitamin d at time of diagnosis is associated with higher one-year remission rate in patients with newly diagnosed RA, treated aggressively during follow-up: post-hoc analyses of the cimestra trial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1112', '10.1136/annrheumdis-2019-eular.1569', '']\n",
      "['9741221', 'Odderskov C; Stengaard-Pedersen K; Ellingsen T; Hornung N. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial. Scandinavian journal of clinical and laboratory investigation. (2019)   pp', '10.1080/00365513.2019.1706190', '']\n",
      "['9743085', 'Odderskov Caroline; Stengaard-Pedersen Kristian; Ellingsen Torkell; Hornung Nete. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial. Scandinavian journal of clinical and laboratory investigation. (2020) 80 3 pp185-190', '10.1080/00365513.2019.1706190', '']\n",
      "['11084385', 'Odderskov Caroline; Stengaard-Pedersen Kristian; Ellingsen Torkell; Hornung Nete. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial. Scandinavian journal of clinical and laboratory investigation. (2020) 80 3 pp185-190', '10.1080/00365513.2019.1706190', '']\n",
      "['11086649', 'Christensen GL; Jensen TW; Hansen MS; Horslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Podenphanth J; Stengaard-Petersen K; Junker P; Ostergaard M; Lottenburger T; Ellingsen TJ; Andersen LS; Hansen IT; Skjodt H; Pedersen JK; Svendsen AJ; Tarp U; Lindegaard HM; Hetland ML; Jorgensen NR. Rheumatoid arthritis treatment associated changes in circulating bone-turnover markers. Bone reports. (2020) 13 Supplement pp100364', '10.1016/j.bonr.2020.100364', '']\n",
      "['11088730', 'Christensen GL; Jensen TW; Hansen MS; Horslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Podenphanth J; Stengaard-Petersen K; Junker P; Ostergaard M; Lottenburger T; Ellingsen TJ; Andersen LS; Hansen IT; Skjodt H; Pedersen JK; Svendsen AJ; Tarp U; Lindegaard HM; Hetland ML; Jorgensen NR. Rheumatoid arthritis treatment associated changes in circulating bone-turnover markers. . (2020) 13  pp', '10.1016/j.bonr.2020.100364', '']\n",
      "['9738689', \"Hetland ML; Ostergaard M; Stengaard-Pedersen K; Junker P; Ejbjerg B; Jacobsen S; Ellingsen T; Lindegaard H; Podenphant J; Vestergaard A; Jurik AG; Krogh NS; Horslev-Petersen K. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis. Scandinavian journal of rheumatology. (2018) (no pagination)  pp\", '10.1080/03009742.2018.1466362', '']\n",
      "['9740891', 'NCT00209859. Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00209859. (2005)   pp', '10.1211/pj.2020.20208165', '']\n",
      "['9262280', 'Glinatsi D; Baker JF; Hetland ML; H‚àö‚àèrslev-Petersen K; Ejbjerg BJ; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard HM; Hansen I; Lottenburger T; M‚àö‚àèller JM; ‚àö√≤rnbjerg L; Vestergaard A; Jurik AG; Thomsen HS; Torfing T; M‚àö‚àèller-Bisgaard S; Axelsen MB; ‚àö√≤stergaard M. Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials. Annals of the rheumatic diseases. (2017) 76 10 pp1707-1715', '10.1136/annrheumdis-2017-211315', '']\n",
      "['9262469', 'Glinatsi D; Baker JF; Hetland ML; Horslev-Petersen K; Ejbjerg BJ; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard HM; Hansen I; Lottenburger T; Moller JM; Ornbjerg L; Vestergaard A; Jurik AG; Thomsen HS; Torfing T; Bisgaard SM; Axelsen MB; Ostergaard M. Wrist inflammation as assessed by magnetic resonance imaging is associated with patientreported physical impairment, global disease activity and pain in early rheumatoid arthritis: long-term results from two randomized controlled trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp732', '10.1136/annrheumdis-2017-eular.1555', '']\n",
      "['9260819', 'de Jong PH; Hazes JM; Barendregt PJ; Huisman M; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PB; Grillet BA; Luime JJ; Weel AE. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. Annals of the rheumatic diseases. (2013) 72 1 pp72-78', '10.1136/annrheumdis-2011-201162', '']\n",
      "['9258046', 'Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. (2000) 284 10 pp1247-1255', '10.1001/jama.284.10.1247', '']\n",
      "['9739723', 'EUCTR2014-002374-36-SE. A study with dose de-escalation of coventional or biologic treatments in early rheeumatoid arthritis in patients with low disease activity. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-002374-36-SE. (2014)   pp', '10.1186/isrctn20612367', '']\n",
      "['9257118', 'Trampisch US; Krause D; Trampisch HJ; Klaassen-Mielke R; Baraliakos X; Braun J. Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial. Trials. (2014) 15  pp344', '10.1186/1745-6215-15-344', 'http://link.springer.com/article/10.1186/1745-6215-15-344/fulltext.html']\n",
      "['9258054', 'Boers M; Verhoeven AC; van der Linden S. American College of Rheumatology criteria for improvement in rheumatoid arthritis should only be calculated from scores that decrease on improvement. Arthritis and rheumatism. (2001) 44 5 pp1052-1055', '10.1002/1529-0131(200105)44:5<1052::aid-anr185>3.0.co;2-8', '']\n",
      "['9258175', 'Verhoeven AC; Bibo JC; Boers M; Engel GL; van der Linden S. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumato√Øde Artritis. British journal of rheumatology. (1998) 37 10 pp1102-1109', '10.1093/rheumatology/37.10.1102', 'http://academic.oup.com/rheumatology/article-pdf/37/10/1102/18105803/371102.pdf']\n",
      "['9258427', 'Landew‚àö¬© R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis and rheumatism. (2004) 50 5 pp1390-1399', '10.1002/art.20222', '']\n",
      "['9258490', 'van Tuyl LH; Boers M; Lems WF; Landew‚àö¬© RB; Han H; van der Linden S; van de Laar M; Westhovens R; van Denderen JC; Westedt ML; Peeters AJ; Jacobs P; Huizinga TW; van de Brink H; Dijkmans BA; Voskuyl AE. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis. Annals of the rheumatic diseases. (2010) 69 5 pp807-812', '10.1136/ard.2009.108027', '']\n",
      "['9259506', 'Lassere M; Boers M; van der Heijde D; Boonen A; Edmonds J; Saudan A; Verhoeven AC. Smallest detectable difference in radiological progression. Journal of rheumatology. (1999) 26 3 pp731-739', '10.1002/art.10190', '']\n",
      "['9259776', 'Verhoeven AC; Boers M; van Der Linden S. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Annals of the rheumatic diseases. (2000) 59 12 pp966-974', '10.1136/ard.59.12.966', '']\n",
      "['9259851', 'Boers M; Kostense PJ; Verhoeven AC; van der Linden S; COBRA Trial Group Combinatietherapie Bij Reumatoide Artritis. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2001) 44 10 pp2242-2246', '10.1002/1529-0131(200110)44:10<2242::aid-art386>3.0.co;2-f', '']\n",
      "['9259894', 'Bruynesteyn K; Van Der Heijde D; Boers M; Verhoeven A; Boonen A; Van Der Linden S; COBRA Trial Group. Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example. Arthritis and rheumatism. (2002) 47 5 pp532-536', '10.1002/art.10654', '']\n",
      "['9260052', 'Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Ad‚àö¬Ær HJ; Bibo J; Boonen A; Van Der Linden S. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. Journal of rheumatology. (2004) 31 9 pp1709-1716', '10.1016/s0140-6736(97)01300-7', '']\n",
      "['9260139', 'Landew‚àö¬© RB; Geusens P; van der Heijde DM; Boers M; van der Linden SJ; Garnero P. Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis. Annals of the rheumatic diseases. (2006) 65 1 pp40-44', '10.1136/ard.2004.035196', '']\n",
      "['9260625', 'van Tuyl LH; Voskuyl AE; Boers M; Geusens P; Landew‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬© RB; Dijkmans BA; Lems WF. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Annals of the rheumatic diseases. (2010) 69 9 pp1623-1628', '10.1136/ard.2009.121764', '']\n",
      "['9739363', \"den Uyl D; ter Wee M; Boers M; Kerstens P; Voskuyl A; Nurmohamed M; Raterman H; van Schaardenburg D; van Dillen N; Dijkmans B; Lems W. A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks. Annals of the rheumatic diseases. (2014) 73 6 pp1071-1078\", '10.1136/annrheumdis-2012-202818', '']\n",
      "['9263088', 'Verhoeven AC; Boers M; te Koppele JM; van der Laan WH; Markusse HM; Geusens P; van der Linden S. Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone. Rheumatology (Oxford, England). (2001) 40 11 pp1231-1237', '10.1093/rheumatology/40.11.1231', 'http://academic.oup.com/rheumatology/article-pdf/40/11/1231/18094767/401231.pdf']\n",
      "['9263100', 'Landew‚àö¬© RB; Boers M; Verhoeven AC; Westhovens R; van de Laar MA; Markusse HM; van Denderen JC; Westedt ML; Peeters AJ; Dijkmans BA; Jacobs P; Boonen A; van der Heijde DM; van der Linden S. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis and rheumatism. (2002) 46 2 pp347-356', '10.1002/art.10083', '']\n",
      "['9263108', 'Lard LR; Boers M; Verhoeven A; Vos K; Visser H; Hazes JM; Zwinderman AH; Schreuder GM; Breedveld FC; De Vries RR; van der Linden S; Zanelli E; Huizinga TW. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis and rheumatism. (2002) 46 4 pp899-905', '10.1002/art.10151', '']\n",
      "['9737083', 'NTR4524. COBRA treat-to-target trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4524. (2014)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9737929', 'Poppelaars PB; Van Tuyl LHD; Boers M. Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up. Annals of the rheumatic diseases. (2019)   pp', '10.1136/annrheumdis-2018-214618', '']\n",
      "['9738060', 'Boers M. Erratum. Randomised comparison of combined step-down prednisolone, methotrexate; and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis (The Lancet (1997) Aug 2 (309)). Lancet. (1998) 351 9097 pp220', '10.1016/s0140-6736(97)01300-7', '']\n",
      "['9741140', 'NCT01172639. Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01172639. (2010)   pp', '10.1093/rheumatology/kem288', 'http://academic.oup.com/rheumatology/article-pdf/47/1/59/5062184/kem288.pdf']\n",
      "['9258163', 'Konijn NP; van Tuyl LH; Boers M; van de Ven PM; den Uyl D; Ter Wee MM; Kerstens P; Voskuyl AE; van Schaardenburg D; Lems WF; Nurmohamed MT. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 9 pp1615-1622', '10.1093/rheumatology/kew221', 'http://academic.oup.com/rheumatology/article-pdf/55/9/1615/18097941/kew221.pdf']\n",
      "['9261007', \"den Uyl D; ter Wee M; Boers M; Kerstens P; Voskuyl A; Nurmohamed M; Raterman H; van Schaardenburg D; van Dillen N; Dijkmans B; Lems W. A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks. Annals of the rheumatic diseases. (2014) 73 6 pp1071-1078\", '10.1136/annrheumdis-2012-202818', '']\n",
      "['9261154', \"Den Uyl D; Ter Wee MM; Boers M; Voskuyl A; Kerstens PJSM; Nurmohamed MT; Raterman HG; Van Schaardenburg D; Van Dillen N; Dijkmans BAC; Lems WF. Six months of an attenuated cobra regimen ('cobra-light') is clinically noninferior to the original cobra regimen: An open-label randomized trial in early rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS155\", '10.1136/annrheumdis-2012-eular.1834', '']\n",
      "['9261155', 'Van Den Oever IAM; Stuijver DJF; Den Uyl D; Van Zaane B; Ter Wee MM; Lems WF; Van Schaardenburg D; Meijers JCM; Gerdes VEA; Nurmohamed MT. The effect of combination therapy and prednisolone on haemostatic markers in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS153', '10.1136/annrheumdis-2012-eular.2571', '']\n",
      "['9261393', 'Konijn NPC; Britsemmer K; Wee MMT; Den Uyl D; Blomjous BS; Boers M; Van Schaardenburg D; Lems WF; Nurmohamed MT. Changes in body composition on two different glucocorticoid regimens in early RA: Experience from the cobra-light trial. Arthritis and rheumatism. (2013) 65  ppS179', '10.1136/rmdopen-2017-000502', '']\n",
      "['9261583', 'ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial. Annals of the rheumatic diseases. (2015) 74 6 pp1233-1240', '10.1136/annrheumdis-2013-205143', '']\n",
      "['9261850', 'Rasch LA; Konijn NPC; Krul-Poel YHM; Van Tuyl LHD; Raterman HG; Ter Wee MM; Den Uyl D; Simsek S; Nurmohamed M; Lems WF. High levels of 25(OH)D are associated with lower disease activity in patients with newly diagnosed rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp989', '10.1136/annrheumdis-2015-eular.3746', '']\n",
      "['9261897', 'Konijn N; Van Tuyl L; Den Uijl D; Ter Wee M; Kerstens P; Voskuyl A; Van Schaardenburg D; Lems W; Nurmohamed M. Prednisolone causes dose related unfavourable effects on body composition in early rheumatoid arthritis patients during the first year of treatment. Annals of the rheumatic diseases. (2015) 74  pp239', '10.1136/annrheumdis-2015-eular.1943', '']\n",
      "['9262667', 'Folmo HD; TerWee MM; Den Uyl D; Konijn NP; Kerstens PJ; Voskuyl AE; Van Schaardenburg D; Nurmohamed MT; Boers M; Lems WF. Decline in anti-CCP and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1297', '10.1136/annrheumdis-2018-eular.5167', '']\n",
      "['9262719', 'Lucassen MJ; Ter Wee MM; DenUyl D; Konijn NP; Nurmohamed MT; Van Schaardenburg D; Kerstens PJ; Bultink IE; Van Tuyl LH; Boers M; Lems WF. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobralight trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp290-291', '10.1136/annrheumdis-2018-eular.2826', '']\n",
      "['9736505', 'Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; van der Wijden LKM; Bultink IEM; Kerstens PJSM; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial. Rheumatology (oxford, england). (2017) 56 9 pp1586-1596', '10.1093/rheumatology/kex223', 'http://academic.oup.com/rheumatology/article-pdf/56/9/1586/19540076/kex223.pdf']\n",
      "['9736588', 'Konijn N; Van Tuyl L; Boers M; Den Uijl D; Ter Wee M; Van Der Wijden L; Kerstens P; Voskuyl A; Van Schaardenburg D; Nurmohamed M; Lems W. Limited safety signals, but no advantage of cobra-light over cobra combination therapy 4 years after initiation of the cobra-light trial in early rheumatoid arthritis. Annals of the rheumatic diseases. (2016) Conference  pp217', '10.1136/annrheumdis-2016-eular.1730', '']\n",
      "['9736859', 'Lucassen MJJ; Ter Wee MM; Konijn NPC; Den Uyl D; Boers M; Lems WF. Negligible long-term effects on bone density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light Trial. Journal of bone and mineral research. (2017) 32  ppS23-', '10.1136/annrheumdis-2018-eular.2826', '']\n",
      "['9738145', 'Rasch L; Van Tuyl L; Kremer M; Bultink I; Boers M; Lems W. One-year changes in bone mineral density with high-dose prednisone in patients with rheumatoid arthritis. Journal of bone and mineral research. (2017) 32  ppS375-', '10.1530/boneabs.5.p463', '']\n",
      "['9738392', 'Konijn NPC; van Tuyl LHD; Boers M; van de Ven PM; den Uyl D; ter Wee MM; Kerstens P; Voskuyl AE; van Schaardenburg D; Lems WF; Nurmohamed MT. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis. Rheumatology (united kingdom). (2016) 55 9 pp1615-1622', '10.1093/rheumatology/kew221', 'http://academic.oup.com/rheumatology/article-pdf/55/9/1615/18097941/kew221.pdf']\n",
      "['9738772', 'Lucassen MJ; Ter Wee MM; DenUyl D; Konijn NP; Nurmohamed MT; Van Schaardenburg D; Kerstens PJ; Bultink IE; Van Tuyl LH; Boers M; Lems WF. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobralight trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp290-291', '10.1136/annrheumdis-2018-eular.2826', '']\n",
      "['9260817', 'Detert J; Bastian H; Listing J; Wei‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√†¬¥ A; Wassenberg S; Liebhaber A; Rockwitz K; Alten R; Kr‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†¬¨¬•ger K; Rau R; Simon C; Gremmelsbacher E; Braun T; Marsmann B; H‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞hne-Zimmer V; Egerer K; Buttgereit F; Burmester GR. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study. Annals of the rheumatic diseases. (2013) 72 6 pp844-850', '10.1136/annrheumdis-2012-201612', '']\n",
      "['9739846', 'NTR1213. COBRA-light study, an open randomised trial comparing a modified COBRA therapy with the COBRA therapy according to BeSt in early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1213. (2008)   pp', '10.1186/isrctn55552928', '']\n",
      "['9742510', 'Lucassen MJJ; Ter Wee MM; Den Uyl D; Konijn NPC; Nurmohamed MT; Van Schaardenburg D; Kerstens PJS; Bultink IEM; Van Tuyl LHD; Boers M; Lems WF. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritis patients: the cobra-light trial. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS72', '10.1136/annrheumdis-2018-eular.2826', '']\n",
      "['9742601', 'Den Uyl; Ter Wee; M M; Boers M; Voskuyl A E; Kerstens P J; Nurmohamed M T; Raterman H G; Van Schaardenburg; Van Dillen; Dijkmans B A; Lems W F. Cobra-light therapy is clinically non-inferior to original cobra therapy in the treatment of early rheumatoid arthritis. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.1834', '']\n",
      "['9742676', 'Konijn N; Van Tuyl L; Boers M; Den Uijl D; Ter Wee M; Kerstens P; Voskuyl A; Van Schaardenburg D; Nurmohamed M; Lems W. Similar clinical and radiological outcome in the cobra and cobra-light treatment group 4 years after initiation of the cobra-light trial. Annals of the rheumatic diseases. (2016) 75  pp157-', '10.1136/annrheumdis-2016-eular.1987', '']\n",
      "['11088009', 'Lucassen M J J; Ter Wee M M; den Uyl D; Konijn N P C; Nurmohamed M T; Voskuyl A E; van Schaardenburg D; Kerstens P J S M; Bultink I E M; Boers M; Lems W F. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial. Osteoporosis international. (2021) 32 7 pp1441-1449', '10.1007/s00198-020-05781-7', 'https://link.springer.com/article/10.1007/s00198-020-05781-7/fulltext.html']\n",
      "['9262625', 'Lucassen MJJ; Ter Wee MM; Den Uyl D; Konijn NPC; Nurmohamed MT; Van Schaardenburg D; Kerstens PJS; Bultink IEM; Van Tuyl LHD; Boers M; Lems WF. Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritis patients: the cobra-light trial. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS72', '10.1136/annrheumdis-2018-eular.2826', '']\n",
      "['9262268', 'Rasch LA; Van Tuyl LHD; Kremer M; Bultink IEM; Boers M; Lems WF. One-year changesin bone mineral density with high-dose prednisone in patients with rheumatoid arthritis. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2017. Italy. (2017) 28  ppS458', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9260022', 'Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB; 990145 Study Group. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Annals of the rheumatic diseases. (2004) 63 9 pp1062-1068', '10.1136/ard.2003.016014', '']\n",
      "['9737641', \"Colia R; Corrado A; Maruotti N; Carriero A; D'Onofrio F; Cantatore FP. Effects of different anti TNF alpha treatments on lipid and carbohydrate metabolism in patients with rheumatoid arthritis and psoriatic arthritis. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp594-595\", '10.1136/annrheumdis-2016-eular.4675', '']\n",
      "['9257919', 'Combe B; Dougados M; Logeart I; Lukas C; Mariette X; Puechal X; Saraux A; Schaeverbeke T. An open-label randomized controlled study to evaluate the efficacy of etanercept (ETN) versus rituximab (RTX), in patients with active rheumatoid arthritis previously treated with RTX and TNF blockers. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.516', '']\n",
      "['9262518', 'Gossec L; Foissac F; Soubrier M; Fayet F; Bardin T; Beauvais C; Chales G; Chary-Valckenaere I; Dernis E; Euller-Ziegler L; Flipo R-M; Gaudin P; Guis S; Marhadour T; Mariette X; Mouterde G; Pouplin S; Richette P; Ruyssen-Witrand A; Schaeverbeke T; Sibilia J; Dougados M. Who are the patients with rheumatoid arthritis (RA) who are getting comorbidity screening procedures in accordance with guidelines? A study of 769 established RA patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp258', '10.1136/annrheumdis-2017-eular.2991', '']\n",
      "['9737455', 'Dougados M; Soubrier M; Perrodeau E; Gossec L; Fayet F; Gilson M; Cerato M-H; Pouplin S; Flipo R-M; Chabrefy L; Mouterde G; Euller-Ziegler L; Schaeverbeke T; Fautrel B; Saraux A; Chary-Valckenaere I; Chales G; Dernis E; Richette P; Mariette X; Berenbaum F; Sibilia J; Ravaud P. Impact of a nurse-led programme on comorbidity management and impact of a patient selfassessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204733', '']\n",
      "['9741053', 'NCT01315652. Interest of a Standardized Monitoring of Rheumatoid Arthritis: the COMEDRA Trial. https://clinicaltrials.gov/show/NCT01315652. (2011)   pp', '10.1016/j.homp.2011.06.004', '']\n",
      "['9259524', 'Dougados M; Combe B; Cantagrel A; Goupille P; Olive P; Schattenkirchner M; Meusser S; Paimela L; Rau R; Zeidler H; Leirisalo-Repo M; Peldan K. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Annals of the rheumatic diseases. (1999) 58 4 pp220-225', '10.1136/ard.58.4.220', '']\n",
      "['9260483', 'Anis A; Zhang W; Emery P; Sun H; Singh A; Freundlich B; Sato R. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study. Rheumatology (Oxford, England). (2009) 48 10 pp1283-1289', '10.1093/rheumatology/kep239', 'http://academic.oup.com/rheumatology/article-pdf/48/10/1283/5055409/kep239.pdf']\n",
      "['9260539', 'Kekow J; Moots RJ; Emery P; Durez P; Koenig A; Singh A; Pedersen R; Robertson D; Freundlich B; Sato R. Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Annals of the rheumatic diseases. (2010) 69 1 pp222-225', '10.1136/ard.2008.102509', '']\n",
      "['9261190', 'Fleischmann R; Koenig A; Pederson R; Ferdousi T; Bananis E. Treatment outcomes based on methotrexate dose range in patients with rheumatoid arthritis receiving etanercept plus methotrexate versus methotrexate alone. Internal medicine journal. (2012) 42  pp13', '10.1093/rheumatology/keu235', 'http://academic.oup.com/rheumatology/article-pdf/53/11/1984/17388453/keu235.pdf']\n",
      "['9261194', 'Fleischmann R; Koenig AS; Pedersen R; Ferdousi T; Bananis E. Treatment outcomes based on methotrexate dose range in patients with rheumatoid arthritis receiving etanercept plus methotrexate versus methotrexate alone. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1093/rheumatology/keu235', 'http://academic.oup.com/rheumatology/article-pdf/53/11/1984/17388453/keu235.pdf']\n",
      "['9261640', 'Dougados MR; van der Heijde DM; Brault Y; Koenig AS; Logeart IS. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET). Journal of rheumatology. (2014) 41 10 pp1922-1934', '10.3899/jrheum.131238', '']\n",
      "['9736635', 'NCT00195494. Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00195494. (2005)   pp', '10.1186/ar3661', 'http://link.springer.com/article/10.1186/ar3661/fulltext.html']\n",
      "['9738862', 'Emery P; Durez P; Kvien T K; Manolios N; Pedersen R; Robertson D H; Foehl J. Sustainability of clinical remission with etanercept and methotrexate, in combination or as monotherapy, in early active rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1656', '10.1002/art.27268', '']\n",
      "['9739169', 'Zhang W; Sun H; Sato R; Singh A; Freundlich B; Emery P; Chou C T. Predicting absence or work stoppage among patients with early rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1385', '10.1093/rheumatology/ker189', 'http://academic.oup.com/rheumatology/article-pdf/51/2/270/5024036/ker189.pdf']\n",
      "['9740168', 'EUCTR2004-000563-96-SE. A 24-MONTH, RANDOMIZED, DOUBLE-BLIND, TWO PERIOD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF ETANERCEPT AND METHOTREXATE AND METHOTREXATE ALONE IN SUBJECTS WITH ACTIVE EARLY RHEUMATOID ARTHRITIS: COMBINATION OF METHOTREXATE AND ETANERCEPT IN ACTIVE EARLY RHEUMATOID ARTHRITIS (COMET)  - COMET. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000563-96-SE. (2004)   pp', '10.1016/s0084-3873(09)79342-3', '']\n",
      "['9742575', 'Nash P; Breedveld F C; Robertson D; Foehl J; Ferdousi T; Freundlich B; Koenig A. Etanercept plus methotrexate combination therapy is efficacious in moderate as well as severe early rheumatoid arthritis. Rheumatology (united kingdom). (2011) 50 SUPPL. 2 pp', '10.1016/s0140-6736(08)61000-4', '']\n",
      "['11084549', 'Emery P; Breedveld F; Campos-Alberto E; Szumski AE; Hirose T. Clinical, radiologic, and functional outcomes following methotrexate withdrawal in etanercept-treated patients with active early rheumatoid arthritis: a subanalysis of comet year 2 by week 52 das28 status. Open rheumatology journal. (2021) 15 1 pp31-38', '10.2174/1874312902115010031', 'https://openrheumatologyjournal.com/contents/volumes/V15/TORJ-15-31/TORJ-15-31.pdf']\n",
      "['9256830', 'Peterfy C; Kremer J; Rigby WFC; Singer N; Birchwood C; Gill D; Reiss W; Pei J; Michalska M. MRI results following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40493', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40493']\n",
      "['9256873', 'Kremer J; Rigby WFC; Singer N; Birchwood C; Gill D; Reiss W; Best J; Pei J; Michalska M. Patient-reported outcomes following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40493', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40493']\n",
      "['9736630', 'Peterfy Charles; Kremer Joel; Rigby William; Singer Nora; Birchwood Christine; Gill Darcy; Reiss William; Pei Jinglan; Michalska Margaret. Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: the COMP-ACT MRI Substudy. Journal of rheumatology. (2020) 47 3 pp325-332', '10.3899/jrheum.180953', '']\n",
      "['9737348', 'Kremer J; Rigby W F C; Singer N; Birchwood C; Gill D; Reiss W; Pei J; Michalska M. Sustained response following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1002/art.40493', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40493']\n",
      "['9738922', 'Kremer J; Rigby W; Singer N; Birchwood C; Gill D; Reiss W; Best J; Pei J; Michalska M. Patient-reported outcomes following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomised controlled trial. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp1386-1387', '10.1136/annrheumdis-2018-eular.1838', '']\n",
      "['9738953', 'Peterfy C; Kremer J; Rigby W; Singer N; Birchwood C; Gill D; Reiss W; Pei J; Michalska M. Mri results following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp944-945', '10.1136/annrheumdis-2018-eular.1741', '']\n",
      "['9740757', 'Haddon DJ; Sornasse T; Townsend MJ; Pei J; Michalska M. Evaluation of CXCL13, sICAM-1, MMP-3 and S100A8/A9 as serum biomarkers in patients with rheumatoid arthritis treated with subcutaneous tocilizumab. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1593-1594', '10.1136/annrheumdis-2019-eular.831', '']\n",
      "['9743023', 'NCT01855789. A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX. https://clinicaltrials.gov/show/NCT01855789. (2013)   pp', '10.1136/annrheumdis-2013-eular.1375', '']\n",
      "['11088278', 'Peterfy Charles; Kremer Joel; Rigby William; Singer Nora; Birchwood Christine; Gill Darcy; Reiss William; Pei Jinglan; Michalska Margaret. Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: the COMP-ACT MRI Substudy. Journal of rheumatology. (2020) 47 3 pp325-332', '10.3899/jrheum.180953', '']\n",
      "['9261217', 'Sierakowski S; Dietrich B; Hentsch B; Ammendola A. Efficacy, safety and pharmacokinetics of vidofludimus, a novel oral immunomodulator, in patients with active rheumatoid arthritis on methotrexate background therapy: The component study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1007/s40268-019-00286-z', 'https://link.springer.com/article/10.1007/s40268-019-00286-z/fulltext.html']\n",
      "['9261314', 'Fleischmann RM; Kivitz A; Van Vollenhoven RF; Shaw JW; Florentinus S; Karunaratne M; Kupper H; Dougados M; Burmester G-R. No differences in patient-reported outcomes by methotrexate dose among early rheumatoid arthritis patients treated concomitantly with adalimumab: Results from the concerto trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1732', '']\n",
      "['9261318', 'Burmester G; Kivitz AJ; Van Vollenhoven RF; Florentinus S; Karunaratne PM; Kupper H; Dougados M; Fleischmann RM. Methotrexate dose has minimal effects on methotrexate-related toxicity in patients with early rheumatoid arthritis treated in combination with adalimumab-results of concerto trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.767', '']\n",
      "['9261319', 'Burmester G; Kivitz A; Kupper H; Arulmani U; Florentinus S; Goss S; Rathmann S; Fleischmann R. Efficacy, pharmacokinetics, and safety of different doses of methotrexate in combination with adalimumab: Results from the concerto trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.272', '']\n",
      "['9261385', 'Goss SL; Klein CE; Kupper H; Burmester GR; Awni W. Adalimumab and methotrexate pharmacokinetics following combination therapy with different methotrexate doses in methotrexate and biologic-naive rheumatoid arthritis patients: Concerto study. Arthritis and rheumatism. (2013) 65  ppS212', '10.1016/j.clinthera.2018.01.002', '']\n",
      "['9261391', 'Burmester GR; Kivitz AJ; Kupper H; Arulmani U; Florentinus S; Goss S; Rathmann SS; Fleischmann R. Efficacy, pharmacokinetics, and safety of different doses of methotrexate in combination with adalimumab: Results from the concerto trial. Arthritis and rheumatism. (2013) 65  ppS183-S184', '10.1093/rheumatology/keu091.003', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i43/9578163/keu091.003.pdf']\n",
      "['9261459', 'Burmester GR; Kivitz AJ; Van Vollenhoven RF; Florentinus S; Karunaratne PM; Kupper H; Dougados M; Fleischmann RM. Methotrexate dose has minimal effects on methotrexate-related toxicity in patients with early rheumatoid arthritis treated in combination with adalimumab-results of concerto trial. Arthritis and rheumatism. (2013) 65  ppS1148-S1149', '10.1136/annrheumdis-2013-eular.767', '']\n",
      "['9261505', 'Fleischmann RM; Kivitz A; Van Vollenhoven RF; Shaw JW; Florentinus S; Karunaratne PM; Kupper H; Dougados M; Burmester GR. No differences in patient-reported outcomes by methotrexate dose among early rheumatoid arthritis patients treated concomitantly with adalimumab: Results from the concerto trial. Arthritis and rheumatism. (2013) 65  ppS574-S575', '10.1136/annrheumdis-2013-eular.1732', '']\n",
      "['9258287', 'Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clinical and experimental rheumatology. (1998) 16 6 pp695-701', '10.1007/s002960050113', 'http://link.springer.com/article/10.1007/s002960050113/fulltext.html']\n",
      "['9262380', 'Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester G-R; Awni WM. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial. Clinical therapeutics. (2018) 40 2 pp309-319', '10.1016/j.clinthera.2018.01.002', '']\n",
      "['9738180', 'Goss Sandra L; Klein Cheri E; Jin Ziyi; Locke Charles S; Rodila Ramona C; Kupper Hartmut; Burmester Gerd-Rudiger; Awni Walid M. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial. Clinical therapeutics. (2018) 40 2 pp309-319', '10.1016/j.clinthera.2018.01.002', '']\n",
      "['9738224', 'Burmester G R; Kivitz A J; Kupper H; Arulmani U; Florentinus S; Goss S L; Rathmann S S; Fleischmann R M. Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204769', '']\n",
      "['9738647', '. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial. Clinical therapeutics. (2018) 40 2 pp309-319', '10.1016/j.clinthera.2018.01.002', '']\n",
      "['9740975', 'NCT01185301. Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT01185301. (2010)   pp', '10.1016/s1098-3015(10)67228-2', '']\n",
      "['9742752', 'EUCTR2010-019514-24-ES. Estudio multic‚àö¬©ntrico, doble ciego, aleatorizado, de brazos paralelos para determinar la respuesta a la dosis de metotrexato (MTX) en combinaci‚àö‚â•n con adalimumab en sujetos con artritis reumatoide temprana (CONCERTO). A Double-Blind, Randomized, Parallel-Arm, Multi-Center Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy with Adalimumab in Subjects with Early Rheumatoid Arthritis. - CONCERTO. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019514-24-ES. (2010)   pp', '10.1016/j.rcreu.2018.10.001', '']\n",
      "['9260593', 'Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet (London, England). (2010) 376 9736 pp173-179', '10.1016/s0140-6736(10)60673-3', '']\n",
      "['9261060', 'Chan FKL; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL. Erratum: Celecoxib versusomeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial (The Lancet (2010) 376 (173-179)). Lancet. (2011) 378  9787 pp228', '10.1016/s0140-6736(10)60673-3', '']\n",
      "['9740619', 'NCT03980483. Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate. Https://clinicaltrials.gov/show/nct03980483. (2019)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9741191', 'EUCTR2019-000797-39-HU. Efficacy and safety of GSK3196165 versus placebo and tofacitinib in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-000797-39-HU. (2019)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9743045', 'NCT04333147. Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT04333147. (2020)   pp', '10.31525/ct1-nct04134728', '']\n",
      "['11085131', '. Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA). . (2020)   pp', '10.31525/ct1-nct04134728', '']\n",
      "['9738431', 'NCT03970837. Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs). Https://clinicaltrials.gov/show/nct03970837. (2019)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9741192', 'EUCTR2019-000867-26-EE. Efficacy and safety study, comparing GSK3196165 (study drug) with placebo and with tofacitinib in combination with conventional synthetic antirheumatic drugs, in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to conventional synthetic/biologic antirheumatic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-000867-26-EE. (2019)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9742968', 'NCT04134728. Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors. https://clinicaltrials.gov/show/NCT04134728. (2019)   pp', '10.31525/ct1-nct04134728', '']\n",
      "['9742774', 'EUCTR2012-004074-25-DE. Comparison of the effectiveness and safety of two different starting dosages of cortisone, compared to each other and to placebo, in early active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-004074-25-DE. (2013)   pp', '10.1186/1745-6215-15-344', 'http://link.springer.com/article/10.1186/1745-6215-15-344/fulltext.html']\n",
      "['9739925', 'EUCTR2015-005307-83-CZ. Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-005307-83-CZ. (2016)   pp', '10.1136/annrheumdis-2020-eular.1688', '']\n",
      "['11085709', 'Smolen JS; Feist E; Fatenejad S; Grishin SA; Korneva EV; Nasonov EL; Samsonov MY; Fleischmann RM; CREDO2 Group. Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis. New England journal of medicine. (2022) 387 8 pp715-726', '10.1056/nejmoa2201302', '']\n",
      "['11087251', 'Strand V; Choy E; Nasonov E; Lisitsyna T; Lila A; Kuzkina S; Samsonov M; Feist E. OLOKIZUMAB IMPROVES PATIENT REPORTED OUTCOMES in MODERATE to SEVERELY ACTIVE RHEUMATOID ARTHRITIS PATIENTS INADEQUATELY CONTROLLED by METHOTREXATE (MTX-IR): RESULTS from the PHASE 3 RANDOMIZED CONTROLLED TRIAL, CREDO 2. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp43-44', '10.1136/annrheumdis-2022-eular.1977', '']\n",
      "['11087219', 'Feist E; Nasonov E; Luggen M; Fatenejad S; Grishin S; Samsonov M; Fleischmann RM. LONG-TERM SAFETY and EFFICACY of OLOKIZUMAB in PATIENTS with RHEUMATOID ARTHRITIS-RESULT of AN OPEN-LABEL EXTENSION STUDY, CREDO4. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp593', '10.1136/annrheumdis-2022-eular.1743', '']\n",
      "['9739690', \"EUCTR2006-003843-22-IT. prospeCtive study on  intensive early rheumatoid arthritis treatment with adalimUmab: induction of REmission and maintenance - 'CURE' A Phase IV multicenter, randomized, double-blind study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003843-22-IT. (2006)   pp\", '10.3410/f.14174.471676', '']\n",
      "['9262777', 'Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. British medical journal. (1974) 3 5934 pp763-766', '10.1136/bmj.3.5934.763', '']\n",
      "['9262780', 'Woodland J; Mason RM; Harris J; Dixon AS; Currey HL; Brownjohn AM; Davies J; Owen-Smith BD. Proceedings: Trial of azathioprine, cyclophosphamide, and gold in rheumatoid arthritis. Annals of the rheumatic diseases. (1974) 33 4 pp399-401', '10.1136/ard.33.4.399-b', '']\n",
      "['9741813', 'Sarzi-Puttini Piercarlo; Filippucci Emilio; Adami Silvano; Meroni Pier Luigi; Batticciotto Alberto; Idolazzi Luca; De Lucia Orazio; Talavera Pablo; Kumke Thomas; Grassi Walter. Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study. Advances in therapy. (2018) 35 8 pp1153-1168', '10.1007/s12325-018-0751-8', 'https://link.springer.com/article/10.1007/s12325-018-0751-8/fulltext.html']\n",
      "['9260728', 'Keystone EC; Wang MM; Layton M; Hollis S; McInnes IB; D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Annals of the rheumatic diseases. (2012) 71 10 pp1630-1635', '10.1136/annrheumdis-2011-143578', '']\n",
      "['9739633', 'EUCTR2007-001420-12-BE. A Randomised, Double-Blind (with Open Comparator Etanercept Limb), Placebo-Controlled, Phase IIb, Multicentre Study to Evaluate the Efficacy of 4 Doses of AZD9056 Administered for 6 Months on the Signs and Symptoms of Rheumatoid Arthritis in Patients with Active Disease Receiving Background Methotrexate or Sulphasalazine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001420-12-BE. (2007)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9742828', 'EUCTR2011-006040-79-DK. A clinical trial with the aim to explore the efficacy and safety of adding tocilizumab to standard of care in patients withearly rheumatoid arth. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-006040-79-DK. (2012)   pp', '10.1186/isrctn21216199', '']\n",
      "['9257531', 'Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial. Journal of rheumatology. (2008) 35 1 pp20-30', '10.1007/s100670050088', 'http://link.springer.com/article/10.1007/s100670050088/fulltext.html']\n",
      "['9260195', 'Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM; DANCER Study Group. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis and rheumatism. (2006) 54 5 pp1390-1400', '10.1002/art.21778', '']\n",
      "['9258236', 'Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Annals of the rheumatic diseases. (1992) 51 8 pp946-950', '10.1136/ard.51.8.946', '']\n",
      "['9261825', 'Westhovens R; Alten R; Pavlova D; Enriquez-Sosa F; Mazur M; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634), an oral JAK1 selective inhibitor is effective in combination with methotrexate in patients with active rheumatoid arthritis: results from a phase 2b dose ranging study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1954', '']\n",
      "['9262528', 'Taylor PC; Westhovens R; Meuleners L; Meuleman B; Pan Y; Vyncke V; Van Der Aa A; Harrison P; Tasset C; Galien R. The JAK1-selective inhibitor filgotinib displays an anti-inflammatory biomarker signature in rheumatoid arthritis patients. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp3539-3540', '10.1093/rheumatology/kex061.002', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.002/19705330/kex061.002.pdf']\n",
      "['9736786', 'Taylor P C; Westhovens R; Vyncke V; Meuleners L; Van Der Aa; Harrison P; Tasset C. Filgotinib, an oral JAK1 selective inhibitor with a rapid onset of action: results from the darwin 1 study in methotrexate inadequate response rheumatoid arthritis patients. Rheumatology (united kingdom). (2017) 56 Supplement 2 pp', '10.1093/rheumatology/kex061.002', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.002/19705330/kex061.002.pdf']\n",
      "['9262186', 'Westhovens R; Taylor PC; Alten R; Pavlova D; Enriquez-Sosa F; Mazur M; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1). Annals of the rheumatic diseases. (2017) 76 6 pp998-1008', '10.1136/annrheumdis-2016-210104', '']\n",
      "['9258578', 'Westhovens R; Kavanaugh A; Jamoul C; Tasset C; Harrison P; Van Der Aa A. Effect of baseline serum CRP levels on clinical efficacy in rheumatoid arthritis patients treated with filgotinib: post-hoc analysis from two phase 2b studies. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp148', '10.1136/annrheumdis-2017-eular.5428', '']\n",
      "['11085547', 'Tarrant JM; Galien R; Li W; Goyal L; Pan Y; Hawtin R; Zhang W; Van der Aa A; Taylor PC. Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: results from Two Randomized, Controlled Phase 2b Trials. . (2020) 7 1 pp173', '10.1007/s40744-019-00192-5', 'https://link.springer.com/article/10.1007/s40744-019-00192-5/fulltext.html']\n",
      "['9738877', 'Genovese M; Westhovens R; Kavanaugh A; Meuleners L; Van Der Aa; Harrison P; Tasset C. The effect of filgotinib (GLPG0634), an oral JAK1 selective inhibitor on patient-reported outcomes: results from two 24-week phase 2B dose ranging studies. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp244', '10.1136/annrheumdis-2016-eular.3894', '']\n",
      "['9738883', 'Genovese M C; Van Der Aa; Jamoul C; Tasset C; Harrison P; Westhovens R; Kavanaugh A. Association between clinical response and normalization of patient-reported outcome measures in rheumatoid arthritis: post-hoc analysis from two phase 2B filgotinib studies. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.5428', '']\n",
      "['9738907', 'Kavanaugh A; Van Der Aa; Jamoul C; Tasset C; Harrison P; Westhovens R. No effect of baseline serum CRP levels on clinical efficacy parameters in rheumatoid arthritis patients treated with filgotinib: post hoc analysis from two phase 2B studies. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.5428', '']\n",
      "['9739386', 'Genovese M; Westhovens R; Kavanaugh A; Meuleners L; Van Der Aa A; Harrison P; Tasset C. The effect of filgotinib (GLPG0634), an oral JAK1 selective inhibitor on patient-reported outcomes: results from two 24-week phase 2B dose ranging studies. Annals of the rheumatic diseases. (2016) 75  pp244-', '10.1136/annrheumdis-2016-eular.3894', '']\n",
      "['9741237', '. The JAK1-selective inhibitor filgotinib reverses the disease-associated transcriptional profile in the blood of patients with active rheumatoid arthritis. Rheumatology (united kingdom). (2019) 58  ppiii24-', '10.1093/rheumatology/kez105.001', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez105.001/28710338/kez105.001.pdf']\n",
      "['9742487', 'Alten R; Westhovens R; Kavanaugh A; Genovese M; Winthrop K; Greenwald M; Ponce L; Enriquez F; Stanislavchuk M; Mazur M; Spindler A; Cseuz R; Nikulenkova N; Glowacka-Kulesz M; Szombati I; Dudek A; Meuleners L; Tasset C; Harrison P; Van Der Aa A. Long term safety and efficacy of filgotinib in a phase 2b open label extension study in patients with rheumatoid arthritis: results up to 144 weeks. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp267', '10.1136/annrheumdis-2017-eular.5460', '']\n",
      "['9262545', 'Alten R; Westhovens R; Kavanaugh A; Genovese M; Winthrop K; Greenwald M; Ponce L; Enriquez F; Stanislavchuk M; Mazur M; Spindler A; Cseuz R; Nikulenkova N; Glowacka-Kulesz M; Szombati I; Dudek A; Meuleners L; Tasset C; Harrison P; Van Der Aa A. Long term safety and efficacy of filgotinib in a phase 2b open label extension study in patients with rheumatoid arthritis: results up to 144 weeks. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp267', '10.1136/annrheumdis-2017-eular.5460', '']\n",
      "['9258390', 'Genovese MC; Westhovens R; Kavanaugh A; Meuleners L; Van Der Aa A; Harrison P; Tasset C. The effect of filgotinib (GLPG0634), an oral JAK1 selective inhibitor on patient-reported outcomes: results from two 24-week phase 2b dose ranging studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4040-4041', '10.1136/annrheumdis-2016-eular.3894', '']\n",
      "['9737215', 'NCT01888874. Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Patients (DARWIN1). https://clinicaltrials.gov/show/NCT01888874. (2013)   pp', '10.1007/bf03296932', 'http://link.springer.com/article/10.1007/BF03296932/fulltext.html']\n",
      "['9736984', 'Tarrant Jacqueline M; Galien Rene; Li Wanying; Goyal Lovely; Pan Yang; Hawtin Rachael; Zhang Wangshu; Van der Aa Annegret; Taylor Peter C. Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: results from Two Randomized, Controlled Phase 2b Trials. Rheumatology and therapy. (2020) 7 1 pp173-190', '10.1007/s40744-019-00192-5', 'https://link.springer.com/article/10.1007/s40744-019-00192-5/fulltext.html']\n",
      "['9741047', 'NCT01894516. Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (DARWIN2). https://clinicaltrials.gov/show/NCT01894516. (2013)   pp', '10.21019/ale.2000.95', '']\n",
      "['9260449', 'Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience. Current medical research and opinion. (2007) 23 9 pp2227-2234', '10.1185/030079907x219634', '']\n",
      "['9737728', 'ISRCTN44880063. Differentiating the mechanism of action of anti-TNF alpha agents. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44880063. (2008)   pp', '10.1186/isrctn44880063', '']\n",
      "['9262063', 'Dumitru RB; Horton S; Hodgson R; Wakefield RJ; Hensor EMA; Emery P; Buch MH. A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed etanercept in patients with rheumatoid arthritis (VEDERA). BMC musculoskeletal disorders. (2016) 17  pp61', '10.1186/s12891-016-0915-0', 'http://link.springer.com/article/10.1186/s12891-016-0915-0/fulltext.html']\n",
      "['9260237', 'De Filippis L; Caliri A; Anghelone S; Scibilia G; Lo Gullo R; Bagnato G. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis. Panminerva medica. (2006) 48 2 pp129-135', '10.1136/ard.62.suppl_2.ii13', '']\n",
      "['9260627', 'De Stefano R; Frati E; Nargi F; Baldi C; Menza L; Hammoud M; Galeazzi M. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha. Clinical rheumatology. (2010) 29 5 pp517-524', '10.1007/s10067-009-1349-y', 'http://link.springer.com/article/10.1007/s10067-009-1349-y/fulltext.html']\n",
      "['9257222', 'Keystone EC; Van Der Heijde D; Weinblatt ME; Mozaffarian N; Guerette B; Kupper H; Liu S; Kavanaugh A. Initial combination therapy with adalimumab plus methotrexate leads to better long-term outcomes in patients with advanced rheumatoid arthritis: Analysis of the final 10-year results of an open-label extension of a phase 3 trail. Rheumatology (United Kingdom). (2012) 51  ppiii115', '10.1136/annrheumdis-2012-eular.3074', '']\n",
      "['9257916', 'Mozaffarian N; Liu S. Routine preventative vaccinations in patients with long-standing rheumatoid arthritis receiving adalimumab. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1792', '']\n",
      "['9258425', 'Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis and rheumatism. (2004) 50 5 pp1400-1411', '10.1002/art.20217', '']\n",
      "['9259992', 'Keystone EC; Haraoui B; Bykerk VP. Role of adalimumab in the treatment of early rheumatoid arthritis. Clinical and experimental rheumatology. (2003) 21 5 Suppl 31 ppS198-9', '10.1016/j.berh.2004.08.011', '']\n",
      "['9260507', 'Jamal S; Patra K; Keystone EC. Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis. Clinical rheumatology. (2009) 28 4 pp413-419', '10.1007/s10067-008-1064-0', 'http://link.springer.com/article/10.1007/s10067-008-1064-0/fulltext.html']\n",
      "['9260707', 'Keystone EC; Kavanaugh A; Weinblatt ME; Patra K; Pangan AL. Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritis. Journal of rheumatology. (2011) 38 5 pp855-862', '10.3899/jrheum.100752', '']\n",
      "['9260910', 'Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Gu‚àö¬©rette B; Mozaffarian N. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis. Journal of rheumatology. (2013) 40 9 pp1487-1497', '10.3899/jrheum.120964', '']\n",
      "['9261937', 'Keystone EC; Van Der Heijde D; Weinblatt ME; Kavanaugh A; Kupper H; Liu S; Mozaffarian N. Effective disease control following up to 10 years of treatment with adalimumab in patients with long-standing rheumatoid arthritis and an inadequate response to methotrexate: final 10-year results of the DE019 trial. Annals of the rheumatic disease. (2013) 71 no pagination pp', '10.1136/annrheumdis-2012-eular.3074', '']\n",
      "['9263474', 'Keystone E; Van Der Heijde D; Weinblatt ME; Mozaffarian N; Guerette B; Kupper H; Liu S. Initial combination therapy with adalimumab plus methotrexate leads to better long-term outcomes in patients with advanced rheumatoid arthritis: Analysis of the final 10-year results of an open-label extension of a phase 1-7 trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.3074', '']\n",
      "['9738913', 'Keystone E; Van Der Heijde; Kavanaugh A; Kupper H; Liu S; Mozaffarian N. Effective disease control following up to 10 years of treatment with adalimumab in patients with long-standing rheumatoid arthritis and an inadequate response to methotrexate: final 10-year results of the de019 trial. Journal of rheumatology. (2013) 40 6 pp996', '10.1136/annrheumdis-2012-eular.3074', '']\n",
      "['9739092', 'Keystone E; Kavanaugh A; Van Der Heijde; Sinisi S; Guerette B. Improvements in radiographic, clinical, and functional outcomes for patients with rheumatoid arthritis treated with adalimumab plus methotrexate through 8 years. Journal of rheumatology. (2010) 37 6 SUPPL. 2 pp1293', '10.3899/jrheum.120964', '']\n",
      "['9739094', 'Keystone E C; Kavanaugh A; Van Der Heijde; Sinisi S; Guerette B. Long-term efficacy of adalimumab plus methotrexate for patients with rheumatoid arthritis: impact on radiographic, clinical and functional outcomes. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.3899/jrheum.120964', '']\n",
      "['9739504', 'Keystone E; Van Der Heijde D; Kavanaugh A; Kupper H; Liu S; Mozaffarian N. Effective disease control following up to 10 years of treatment with adalimumab in patients with long-standing rheumatoid arthritis and an inadequate response to methotrexate: final 10-year results of the de019 trial. Journal of rheumatology. (2013) 40 6 pp996-', '10.1136/annrheumdis-2012-eular.3074', '']\n",
      "['9740991', 'NCT00195702. Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. https://clinicaltrials.gov/show/NCT00195702. (2005)   pp', '10.1007/s10067-018-4002-9', 'http://link.springer.com/article/10.1007/s10067-018-4002-9/fulltext.html']\n",
      "['9742266', 'Smolen J; Mostafa N; Huang X; Noertersheuser P; Kluender B; Chen K; Kalabic J; Sainsbury I; Oerlemans R; Florentinus S; Burmester G. The value of adalimumab trough levels and clinical assessments in predicting clinical response in patients with established rheumatoid arthritis and an inadequate response to methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp311', '10.1136/annrheumdis-2018-eular.2721', '']\n",
      "['9262477', 'Scoville C; Suboticki J; Zhong S; Keystone E. The relevance of elevated CRP as an inclusion criterion in clinical trials in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp230-231', '10.1136/annrheumdis-2017-eular.2316', '']\n",
      "['9257505', 'Deodhar AA; Bitman B; Yang Y; Collier D. Etanercept treatment does not adversely affect traditional cardiovascular risk factors in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3472-3473', '10.1136/annrheumdis-2016-eular.1130', '']\n",
      "['9261533', 'Hobbs K; Chung J; Bitman B; Wang B; Nussbaum J; Collier DH. Efficacy and safety of etanercept (ETN) in patients with moderately active rheumatoid arthritis (RA) despite disease-modifying antirheumatic drug (DMARD) therapy. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1253', '']\n",
      "['9262138', 'Deodhar A; Bitman B; Yang Y; Collier DH. The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis. Clinical rheumatology. (2016) 35 12 pp3045-3052', '10.1007/s10067-016-3422-7', 'http://link.springer.com/article/10.1007/s10067-016-3422-7/fulltext.html']\n",
      "['9737528', 'Hobbs Kathryn; Deodhar Atul; Wang Brian; Bitman Bojena; Nussbaum Joyce; Chung James; Collier David H. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy. Springerplus. (2015) 4  pp113', '10.1186/s40064-015-0895-9', 'http://link.springer.com/article/10.1186/s40064-015-0895-9/fulltext.html']\n",
      "['9738856', 'Deodhar A; Bitman B; Yang Y; Collier D. Etanercept treatment does not adversely affect traditional cardiovascular risk factors in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp224', '10.1136/annrheumdis-2016-eular.1130', '']\n",
      "['9739408', 'Deodhar A; Bitman B; Yang Y; Collier D. Etanercept treatment does not adversely affect traditional cardiovascular risk factors in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp224-', '10.1136/annrheumdis-2016-eular.1130', '']\n",
      "['9262430', 'Takeuchi T; Tanaka Y; Soen S; Yamanaka H; Yoneda T; Tanaka S; Nitta T; Okubo N; Genant HK; Van Der Heijde D. Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in Japanese patients with rheumatoid arthritis treated with csDMARDs: results from the 12-month double blind phase 3, desirable study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp841-842', '10.1136/annrheumdis-2017-eular.1081', '']\n",
      "['9262683', 'Takeuchi T; Tanaka Y; Soen S; Yamanaka H; Yoneda T; Tanaka S; Nitta T; Okubo N; Genant H; Van Der Heijde D. Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csDMARDS: result from the long-term treatment of phase 3, desirable study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp947-948', '10.1136/annrheumdis-2018-eular.2290', '']\n",
      "['9737761', 'Takeuchi Tsutomu; Tanaka Yoshiya; Soen Satoshi; Yamanaka Hisashi; Yoneda Toshiyuki; Tanaka Sakae; Nitta Takaya; Okubo Naoki; Genant Harry K; van der Heijde Desiree. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Annals of the rheumatic diseases. (2019) 78 7 pp899-907', '10.1136/annrheumdis-2018-214827', '']\n",
      "['9738729', 'Takeuchi T; Tanaka Y; Soen S; Yamanaka H; Yoneda T; Tanaka S; Nitta T; Okubo N; Genant H; Van Der Heijde D. Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csDMARDS: result from the long-term treatment of phase 3, desirable study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp947-948', '10.1136/annrheumdis-2018-eular.2290', '']\n",
      "['9263215', 'Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis and rheumatism. (2007) 56 12 pp3919-3927', '10.1002/art.23055', '']\n",
      "['9262492', 'Stamm TA; Machold K; Aletaha D; Alasti F; Lipsky P; Pisetsky D; Landewe R; Van Der Heijde D; Sepriano A; Aringer M; Boumpas D; Burmester G; Cutolo M; Ebener W; Graninger W; Huizinga T; Schett G; Schulze-Koops H; Tak PP; Breedveld F; Smolen J. Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate, methotrexate alone or placebo: the dinora trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp560', '10.1136/annrheumdis-2017-eular.3743', '']\n",
      "['9261128', 'Furst D; Shaikh SA; Greenwald MW; Schiff MH; Bennett B; Davies O; Staelens F; Koetse W; Bertin P. Certolizumab pegol plus methotrexate is similarly effective in active rheumatoid arthritis secondary non-responders to anti-TNF inhibitors: Post-hoc analysis of a phase IIIB trial. Arthritis and rheumatism. (2012) 64  ppS567', '10.1136/annrheumdis-2012-eular.480', '']\n",
      "['9261402', 'Schiff M; Davies O; Bennett B; Luijtens K; Furst DE. Certolizumab pegol plus methotrexate is similarly effective in active rheumatoid arthritis regardless of prior TNF inhibitor use: Analysis of the doseflex PHASE IIIB study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.480', '']\n",
      "['9261409', 'Furst DE; Shaikh SA; Greenwald M; Bennett B; Staelens F; Koetse W; Bertin P. Evaluation of two dosing regimens of certolizumab pegol for maintenance of clinical response in patients with active rheumatoid arthritis: Primary results from doseflex, a phase IIIB study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.3073', '']\n",
      "['9737003', 'NCT00580840. Dosing Flexibility Study in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00580840. (2007)   pp', '10.1186/isrctn28793839', '']\n",
      "['9739734', 'EUCTR2007-005288-86-FR. A Phase IIIb, open-label, run-in and double-blind, placebo-controlled, randomized study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with stable-dose methotrexate in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005288-86-FR. (2008)   pp', '10.1186/isrctn49455679', '']\n",
      "['9261460', 'Ostergaard M; Leirisalo-Repo M; Uhlig T; Jansson M; Larsson E; Brock F; Van Vollenhoven RF. In rheumatoid arthritis patients with stable low disease activity on methotrexate plus etanercept, continuation of etanercept is superior both clinically and radiographically to discontinuation: Results from a randomized, 3-armed, double-blind clinical trial. Arthritis and rheumatism. (2013) 65  ppS1017-S1018', '10.1136/annrheumdis-2013-eular.1312', '']\n",
      "['9736643', 'EUCTR2007-006657-63-FI. Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006657-63-FI. (2009)   pp', '10.3899/jrheum.080663', '']\n",
      "['9737188', 'NCT00858780. Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA. https://clinicaltrials.gov/show/NCT00858780. (2009)   pp', '10.3899/jrheum.080663', '']\n",
      "['9257844', 'Dougados M; Awada H; Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Annals of the rheumatic diseases. (1988) 47 2 pp127-133', '10.1136/ard.47.2.127', '']\n",
      "['9262200', 'Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the rheumatic diseases. (2017) 76 1 pp96-104', '10.1136/annrheumdis-2015-209057', '']\n",
      "['9259964', 'Maillefert JF; Combe B; Goupille P; Cantagrel A; Dougados M. Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Annals of the rheumatic diseases. (2003) 62 8 pp764-766', '10.1136/ard.62.8.764', '']\n",
      "['9257977', 'Manders SHM; Kievit W; Brus HLM; Bernelot Moens HJ; Hartkamp A; Bos R; Brouwer E; Visser H; Vonkeman HE; Westhovens R; Van De Laar MAFJ; Van Riel PLCM. Mode of action change not necessary after failing the first tumornecrosisfactor inhibitor: Preliminary results of a randomized controlled trial. Arthritis and rheumatism. (2013) 65  ppS600', '10.1136/annrheumdis-2014-eular.1635', '']\n",
      "['9739940', 'EUCTR2008-005450-20-BE. The cost-effectiveness of abatacept, rituximab or anti-TNF alpha for patients with rheumatoid artritis. - Dutch Rheumatoid Arthritis Monitoring (DREAM) Targetted Immune Modulator Evaluation (TIME). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-005450-20-BE. (2009)   pp', '10.1186/isrctn89222125', '']\n",
      "['9257426', 'Van Der Maas A; Van Herwaarden N; Woodworth T; Minten M; Furst D; Christensen R; Den Broeder A; Choy E. Validity of omeract preliminary flare questions in a randomized controlled trial, that assesses impact of disease activity guided down-titration of anti-TNF treatment in rheumatoid arthritis patients in low disease activity. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2337', '']\n",
      "['9257463', 'Kievit W; Van Herwaarden N; Van Den Hoogen FH; Van Vollenhoven RF; Bijlsma JW; Van Den Bemt BJ; Van Der Maas A; Den Broeder AA. Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-Tapering tight control rheumatoid arthritis care: analyses of the DRESS study. Annals of the rheumatic diseases. (2016) 75 11 pp1939-1944', '10.1136/annrheumdis-2015-208317', '']\n",
      "['9257520', 'Den Broeder AA; Bouman CAM; Van Den Hoogen FHJ; Fransen J; Van Vollenhoven RF; Bijlsma JWJ; Van Der Maas A; Van Herwaarden N. Long-term outcomes after disease activity guided tapering of tumor necrosis factor inhibition in rheumatoid arthritis: 3 year data of a randomised controlled pragmatic non inferiority strategy study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4016-4019', '10.1136/annrheumdis-2017-211169', '']\n",
      "['9257869', 'van Herwaarden N; van der Maas A; Minten MJ; van den Hoogen FH; Kievit W; van Vollenhoven RF; Bijlsma JW; van den Bemt BJ; den Broeder AA. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ (Clinical research ed.). (2015) 350  pph1389', '10.1136/bmj.h1389', '']\n",
      "['9261255', 'Van Herwaarden N; Bouman C; Van Der Maas A; Van Vollenhoven RF; Bijlsma JWJ; Van Den Hoogen FHJ; Den Broeder AA; Van Den Bemt B. Prediction of successful dose reduction or discontinuation of adalimumab or etanercept using serum drug levels and antidrug antibody measurement. Arthritis and Rheumatology. (2014) 66  ppS216', '10.1080/17425255.2017.1320390', '']\n",
      "['9261687', 'den Broeder AA; van Herwaarden N; van der Maas A; van den Hoogen FH; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ. Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study. BMC musculoskeletal disorders. (2013) 14  pp299', '10.1186/1471-2474-14-299', 'http://link.springer.com/article/10.1186/1471-2474-14-299/fulltext.html']\n",
      "['9261750', 'Bouman C; Van Der Maas A; Segurado OG; Sasso EH; Van Den Hoogen F; Den Broeder A. Associations of a multi-biomarker disease activity score with clinical and radiographic parameters in rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp974', '10.1136/annrheumdis-2015-eular.1932', '']\n",
      "['9261852', 'Bouman C; Van Der Maas A; Van Herwaarden N; Segurado OG; Sasso EH; Van Den Hoogen F; Den Broeder A. Predictive value of a multi-biomarker disease activity score for successful dose reduction of TNF inhibitors in rheumatoid arthritis: results of the dress study. Annals of the rheumatic diseases. (2015) 74  pp973-974', '10.1136/annrheumdis-2015-eular.2972', '']\n",
      "['9261925', 'Kievit W; Van Herwaarden N; Van Den Hoogen F; Van Vollenhoven R; Bijlsma H; Van Den Bemt B; Van Der Maas A; Den Broeder A. Controlling the cost spent on expensive biologic agents: an example of net monetary savings by dose optimisation of tumor necrosis factor inhibitors in rheumatoid arthritis patients. Value in health. (2015) 18 7 ppA647-A648', '10.1016/j.jval.2015.09.2324', '']\n",
      "['9262239', 'Bouman CAM; van der Maas A; van Herwaarden N; Sasso EH; van den Hoogen FHJ; den Broeder AA. A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes. Rheumatology (oxford, england). (2017) 56 6 pp973-980', '10.1093/rheumatology/kex003', 'http://academic.oup.com/rheumatology/article-pdf/56/6/973/17572683/kex003.pdf']\n",
      "['9262281', 'Bouman CA; van Herwaarden N; van den Hoogen FH; Fransen J; van Vollenhoven RF; Bijlsma JW; Maas AV; den Broeder AA. Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial. Annals of the rheumatic diseases. (2017) 76 10 pp1716-1722', '10.1136/annrheumdis-2017-211169', '']\n",
      "['9736791', 'Bouman C A M; Den Broeder; A A; Van Der Maas; Van Den Hoogen; F H J; Landewe R B M; Van Herwaarden. What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?. RMD open. (2017) 3 1 ppe000327', '10.1136/rmdopen-2016-000327', '']\n",
      "['9739647', 'Bouman C; Den Broeder AA; Van Der Maas A; Van Den Hoogen FH; Landewe R; Van Herwaarden N. Radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors is primarily driven by mean disease activity over time, not so much by flaring or lower TNF inhibitor exposition. Annals of the rheumatic diseases. (2016) 75  pp122-', '10.1136/annrheumdis-2016-eular.2075', '']\n",
      "['9741368', 'van Herwaarden N; van der Maas A; Minten MJM; van den Hoogen FHJ; Kievit W; van Vollenhoven RF; Bijlsma JWJ; van den Bemt BJF; den Broeder AA. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ: british medical journal. (2015) 350 8007 pp12-12', '10.1136/bmj.h1389', '']\n",
      "['9258679', 'Takeuchi T; Tanaka Y; Ishiguro N; Yamanaka H; Yoneda T; Ohira T; Okubo N; Genant HK; Van Der Heijde D. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Annals of the rheumatic diseases. (2016) 75 6 pp983-990', '10.1136/annrheumdis-2015-208052', '']\n",
      "['9742981', 'Takeuchi T; Soen S; Ishiguro N; Yamanaka H; Tanaka S; Kobayashi M; Okubo N; Nitta T; Tanaka Y. Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: analysis of data from the DRIVE and DESIRABLE studies. Modern rheumatology. (2019)   pp1-20', '10.1080/14397595.2019.1703484', '']\n",
      "['11088664', 'Tanaka Y; Soen S; Ishiguro N; Yamanaka H; Yoneda T; Tanaka S; Ohira T; Nitta T; Okubo N; Genant H; van der Heijde D; Takeuchi T. Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. . (2020) 6 2 pp', '10.1136/rmdopen-2020-001249', '']\n",
      "['9738295', 'Takeuchi T; Soen S; Ishiguro N; Yamanaka H; Tanaka S; Kobayashi M; Okubo N; Nitta T; Tanaka Y. Predictors of new bone erosion in rheumatoid arthritis patients receiving csDMARDs: analysis of data from the drive and desirable studies. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1605-1606', '10.1136/annrheumdis-2019-eular.4562', '']\n",
      "['9737922', 'DRKS00009749. Early effects of TNF-alpha blocking on pain scores and quantitative sensory testing in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00009749. (2016)   pp', '10.1186/isrctn89222125', '']\n",
      "['9740415', 'DRKS00012590. Comparison of risk and patient-related benefit of treatment with etanercept in elderly patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00012590. (2018)   pp', '10.2165/00002512-200724030-00005', '']\n",
      "['9260344', 'Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Robertson D; Singh A; Pedersen RD; Koenig AS; Freundlich B. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet (London, England). (2008) 372 9636 pp375-382', '10.1016/s0140-6736(08)61000-4', '']\n",
      "['9259745', 'Drosos AA; Voulgari PV; Katsaraki A; Zikou AK. Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study. Rheumatology international. (2000) 19 3 pp113-118', '10.1007/s002960050113', 'http://link.springer.com/article/10.1007/s002960050113/fulltext.html']\n",
      "['9263488', 'Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Barre E; Karyekar CS; Wong DA; Huizinga TWJ. Evaluating drug-free remission with abatacept in early rheumatoid arthritis: Results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period. Annals of the rheumatic diseases. (2015) 74  1 // () *Pfizer* pp19-26', '10.1136/annrheumdis-2014-206106', '']\n",
      "['9742983', 'NCT00396747. A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: a Magnetic Resonance Imaging Study. https://clinicaltrials.gov/show/NCT00396747. (2006)   pp', '10.1002/art.23055', '']\n",
      "['9256867', 'Dwosh IL; Stein HB; Urowitz MB; Smythe HA; Hunter T; Ogryzlo MA. Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine. Arthritis and rheumatism. (1977) 20 2 pp685-692', '10.1002/art.1780200208', '']\n",
      "['9260793', 'Burmester GR; Weinblatt ME; McInnes IB; Porter D; Barbarash O; Vatutin M; Szombati I; Esfandiari E; Sleeman MA; Kane CD; Cavet G; Wang B; Godwood A; Magrini F; EARTH Study Group. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 9 pp1445-1452', '10.1136/annrheumdis-2012-202450', '']\n",
      "['9261345', 'Burmester G; Takeuchi T; Barbarash O; Ranganna G; Close D; Godwood A; Saurigny D. Consistent efficacy and safety outcomes between european and Japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1359', '']\n",
      "['9261753', 'Guo X; Sinibaldi D; Kuziora M; Brohawn P; Ryan PC; Bay-Jensen AC; Karsdal MA; Roskos LK; White WI. Sustained response to mavrilimumab in rheumatoid arthritis patients via suppression of macrophage and T cells. Annals of the rheumatic diseases. (2015) 74  pp734', '10.1136/annrheumdis-2015-eular.4254', '']\n",
      "['9261913', 'Burmester GR; McInnes IB; Kremer JM; Miranda P; Korkosz M; Vencovsky J; Rubbert-Roth A; Mysler E; Sleeman MA; Godwood A; Albulescu M; Close D; Weinblatt M. Efficacy and safety of mavrilimumab, a fully human gm-csfr-alpha monoclonal antibody in patients with rheumatoid arthritis: primary results from the earth explorer 1 study. Annals of the rheumatic diseases. (2015) 74  pp78', '10.1136/annrheumdis-2015-eular.1945', '']\n",
      "['9262259', 'Burmester GR; McInnes IB; Kremer J; Miranda P; Korkosz M; Vencovsky J; Rubbert-Roth A; Mysler E; Sleeman MA; Godwood A; Sinibaldi D; Guo X; White WI; Wang B; Wu CY; Ryan PC; Close D; Weinblatt ME; EARTH EXPLORER 1 study investigators. A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 6 pp1020-1030', '10.1136/annrheumdis-2016-210624', '']\n",
      "['9257525', 'Guo X; Wang S; Bay-Jensen AC; Karsdal MA; Godwood A; Albulescu M; Close D; Ryan PC; Roskos L; White W. Sustained suppression of peripheral biomarkers by mavrilimumab but not golimumab in anti-tumor necrosis factor-inadequate responders: an exploratory analysis in the phase IIB earth explorer 2 clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3542-3543', '10.1136/annrheumdis-2016-eular.4475', '']\n",
      "['9257761', 'Weinblatt M; McInnes IB; Kremer JM; Miranda P; Vencovsky J; Godwood A; Albulescu M; Close D; Burmester GR. Earth explorer 2, a phase IIb exploratory study evaluating efficacy and safety of mavrilimumab, a fully human granulocyte-macrophage colony-stimulating factor receptor-alpha monoclonal antibody, and the tumor necrosis factor antagonist golimumab in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2015-2017', '10.1136/annrheumdis-2016-eular.3453', '']\n",
      "['9262376', 'Weinblatt M; McInnes I; Kremer J; Miranda P; Vencovsky J; Godwood A; Albulescu M; Close D; Burmester G. Earth explorer 2, a phase IIB exploratory study evaluating efficacy and safety of mavrilimumab, a fully human granulocyte-macrophage colony-stimulating factor receptor-alpha monoclonal antibody, and the tumor necrosis factor antagonist golimumab in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp717-718', '10.1136/annrheumdis-2016-eular.3453', '']\n",
      "['9740810', 'Guo Xiang; Wang Shiliang; Godwood Alex; Close David; Ryan Patricia C; Roskos Lorin K; White Wendy I. Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis. International journal of rheumatic diseases. (2019) 22 4 pp646-653', '10.1111/1756-185x.13395', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13395']\n",
      "['9262474', 'Araujo EG; Englbrecht M; Hoepken S; Finzel S; Hueber A; Rech J; Schett G. Ustekinumab is superior to TNF inhibitor treatment in resolving enthesitis in PSA patients with active enthesitis-results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp142', '10.1136/annrheumdis-2017-eular.5398', '']\n",
      "['9258355', 'Edwards JC; Szczepanski L; Szechinski J; Filipowicz-Sosnowska A; Emery P; Close DR; Stevens RM; Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. New England journal of medicine. (2004) 350 25 pp2572-2581', '10.1056/nejmoa032534', '']\n",
      "['9260246', 'Strand V; Balbir-Gurman A; Pavelka K; Emery P; Li N; Yin M; Lehane PB; Agarwal S. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years. Rheumatology (Oxford, England). (2006) 45 12 pp1505-1513', '10.1093/rheumatology/kel358', 'http://academic.oup.com/rheumatology/article-pdf/45/12/1505/6700211/kel358.pdf']\n",
      "['9263200', 'Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response. Journal of clinical pharmacology. (2007) 47 9 pp1119-1128', '10.1177/0091270007305297', '']\n",
      "['11087495', 'Anonymous. Correction to: social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study (Scandinavian Journal of Rheumatology, (2021), 50, 3, (178-182), 10.1080/03009742.2020.1813325). Scandinavian journal of rheumatology. (2022) 51 4 pp344', '10.1080/03009742.2020.1813325', '']\n",
      "['9260403', 'Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis and rheumatism. (1998) 41 7 pp1258-1265', '10.1002/1529-0131(199807)41:7<1258::aid-art17>3.0.co;2-1', '']\n",
      "['9740598', 'Elmedany Samah Hamdy; Mohamed Aly Elsayed; Galil Sahar Mahfouz Abdel. Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis. Clinical rheumatology. (2019) 38 8 pp2109-2117', '10.1007/s10067-019-04508-2', 'http://link.springer.com/article/10.1007/s10067-019-04508-2/fulltext.html']\n",
      "['9742665', 'Elmuntaser K. Efficacy of leflunomide 100mg weekly compared to 10mg methotrexate weekly in patients with active rheumatoid arthritis. Clinical and experimental rheumatology. (2014) 32 4 ppS43-', '10.2165/00128413-200414480-00036', '']\n",
      "['9257785', 'Emery P; Breedveld FC; Lemmel EM; Kaltwasser JP; Dawes PT; G‚àö‚àÇm‚àö‚àÇr B; Van Den Bosch F; Nordstr‚àö‚àÇm D; Bjorneboe O; Dahl R; Horslev-Petersen K; Rodriguez De La Serna A; Molloy M; Tikly M; Oed C; Rosenburg R; Loew-Friedrich I. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 6 pp655-665', '10.1093/rheumatology/39.6.655', 'http://academic.oup.com/rheumatology/article-pdf/39/6/655/18108912/390655.pdf']\n",
      "['9263202', 'Tchetverikov I; Kraan MC; van El B; Hanemaaijer R; DeGroot J; Huizinga TW. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients. Annals of the rheumatic diseases. (2008) 67 1 pp128-130', '10.1136/ard.2006.067827', '']\n",
      "['9261023', 'Nam JL; Villeneuve E; Hensor EM; Wakefield RJ; Conaghan PG; Green MJ; Gough A; Quinn M; Reece R; Cox SR; Buch MH; van der Heijde DM; Emery P. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Annals of the rheumatic diseases. (2014) 73 6 pp1027-1036', '10.1136/annrheumdis-2013-204882', '']\n",
      "['9263469', 'Villeneuve E; Nam JL; Hensor E; Wakefield RJ; Conaghan PG; Green MJ; Gough AK. Preliminary results of a multicentre randomised controlled trial of etanercept and methotrexate to induce remission in patients with newly diagnosed inflammatory arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2013-204882', '']\n",
      "['9257424', 'Yamanaka H; Seto Y; Nagaoka S; Bae S-C; Kasama T; Lee S-K; Kobayashi H; Nishioka Y; Tanaka Y; Takeuchi T. Discontinuation of etanercept in early rheumatoid arthritis patients who have achieved sustained remission: Results of the randomized controlled trial in period 2 of the encourage study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2429', '']\n",
      "['9262175', 'Yamanaka H; Nagaoka S; Lee SK; Bae SC; Kasama T; Kobayashi H; Nishioka Y; Ueki Y; Seto Y; Nishinarita M; Tamura N; Kimura N; Saito K; Tomita T; Nawata Y; Suzuki S; Ishigatsubo Y; Munakata Y; Makino Y; Inoue E; Tanaka Y; Takeuchi T; ENCOURAGE study group. Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study. Modern rheumatology. (2016) 26 5 pp651-661', '10.3109/14397595.2015.1123349', '']\n",
      "['9739710', 'UMIN000002687. ENBREL Clinical Outcome in RA patients for Growing Evidence. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002687. (2009)   pp', '10.1186/isrctn36516369', '']\n",
      "['9262294', '. Correction: edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis (Journal of the American College of Cardiology (2016) 68(11) (1169-1178) (S0735109716344369)(10.1016/j.jacc.2016.06.034)). Journal of the american college of cardiology. (2017) 70 4 pp512-513', '10.1016/j.jacc.2016.06.034', '']\n",
      "['9257563', 'Giles JT; Sattar N; Gabriel SE; Ridker PM; Gay S; Warne C; Musselman D; Brockwell L; Shittu E; Klearman M; Fleming T. Comparative cardiovascular safety of tocilizumab vs etanercept in rheumatoid arthritis: results of a randomized, parallel-group, multicenter, noninferiority, phase 4 clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4357-4359', '10.1002/art.41095', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41095']\n",
      "['9742780', 'EUCTR2010-020065-24-NL. A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020065-24-NL. (2011)   pp', '10.2174/1381612828666220527141532', 'https://www.eurekaselect.com/205352/article']\n",
      "['11088683', 'Giles JT; Sattar N; Gabriel S; Ridker PM; Gay S; Warne C; Musselman D; Brockwell L; Shittu E; Klearman M; Fleming TR. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: a Randomized Controlled Trial. . (2020) 72 1 pp31', '10.1002/art.41095', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41095']\n",
      "['9262973', 'Glenn‚àö‚Ä¢s A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis. British journal of rheumatology. (1997) 36 8 pp870-877', '10.1093/rheumatology/36.8.870', 'http://academic.oup.com/rheumatology/article-pdf/36/8/870/18105462/360870.pdf']\n",
      "['9256828', 'Kavanaugh A; Allanore Y; Kucharz EJ; Babic G. Etanercept biosimilar GP2015 has equivalent efficacy and safety to etanercept originator in patients with moderate to severe rheumatoid arthritis: the phase 3 equira study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2018-eular.1368', '']\n",
      "['9740230', 'EUCTR2012-002009-23-LV. Clinical trial to demonstrate that treatments with GP2015 and Enbrel¬¨√Ü are comparable in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002009-23-LV. (2015)   pp', '10.1186/s13075-020-02399-2', 'http://link.springer.com/article/10.1186/s13075-020-02399-2/fulltext.html']\n",
      "['9742008', 'Matucci-Cerinic Marco; Allanore Yannick; Kavanaugh Arthur; Buch Maya H; Schulze-Koops Hendrik; Kucharz Eugeniusz J; Woehling Heike; Babic Goran; Poetzl Johann; Davis Adanna; Schwebig Arnd. Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study. RMD open. (2018) 4 2 ppe000757', '10.1136/rmdopen-2018-000757', '']\n",
      "['9258262', 'Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. American journal of managed care. (2002) 8 3 pp231-240', '10.1016/s1098-3015(11)70442-9', '']\n",
      "['9258512', 'Genovese MC; Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Cannon GW; Spencer-Green G; Finck BK. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis and rheumatism. (2002) 46 6 pp1443-1450', '10.1002/art.10308', '']\n",
      "['9260049', 'Baumgartner SW; Fleischmann RM; Moreland LW; Schiff MH; Markenson J; Whitmore JB. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. Journal of rheumatology. (2004) 31 8 pp1532-1537', '10.1136/annrheumdis-2001.1210', '']\n",
      "['9260095', 'Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges Jr SL. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis and rheumatism. (2004) 50 9 pp2750-2756', '10.1002/art.20469', '']\n",
      "['9260120', 'Genovese MC; Bathon JM; Fleischmann RM; Moreland LW; Martin RW; Whitmore JB; Tsuji WH; Leff JA. Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. Journal of rheumatology. (2005) 32 7 pp1232-1242', '10.1002/art.10308', '']\n",
      "['9263097', 'Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2002) 46 1 pp21-30', '10.1002/1529-0131(200201)46:1<21::aid-art10061>3.0.co;2-q', '']\n",
      "['9737539', 'NCT00356590. Open-Label Extension Treatment With Etanercept (TNFR: fc) for Participating Patients in Etanercept (TNFR: fc) Clinical Trial 016.0012. https://clinicaltrials.gov/show/NCT00356590. (2006)   pp', '10.2165/00126839-199901010-00025', '']\n",
      "['11088117', 'Plein Sven; Erhayiem Bara; Fent Graham; Horton Sarah; Dumitru Raluca Bianca; Andrews Jacqueline; Greenwood John P; Emery Paul; Hensor Elizabeth Ma; Baxter Paul; Pavitt Sue; Buch Maya H. Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis. Annals of the rheumatic diseases. (2020) 79 11 pp1414-1422', '10.1136/annrheumdis-2020-217653', '']\n",
      "['9260186', 'Moreland LW; Genovese MC; Sato R; Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis and rheumatism. (2006) 55 2 pp287-293', '10.1002/art.21838', '']\n",
      "['9260249', 'Goldman JA; Xia HA; White B; Paulus H. Evaluation of a modified ACR20 scoring system in patients with rheumatoid arthritis receiving treatment with etanercept. Annals of the rheumatic diseases. (2006) 65 12 pp1649-1652', '10.1136/ard.2005.047266', '']\n",
      "['9262462', 'Kruger K; Eder R; Muller C; Hecker R. Optimizing comorbidity risk management in ra by translating a nurse-led interview into an easily interpretable traffic light system. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp257-258', '10.1136/annrheumdis-2017-eular.3395', '']\n",
      "['9738328', 'Krueger K; Eder R; Mueller C; Rietzler K. Assessing the risk of RA patients for comorbid conditions through a structured nurse-led interview-the eriko study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp119', '10.1136/annrheumdis-2018-eular.1268', '']\n",
      "['9739631', 'UMIN000012073. Effects of Subcutaneous Actemura and MTX Blending in RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012073. (2013)   pp', '10.1136/annrheumdis-2013-eular.1376', '']\n",
      "['9257207', 'Combe B; Codreanu C; Fiocco U; Gaubitz M; Geusens PP; Kvien TK; Pavelka K; Sambrook PN; Smolen JS; Khandker R; Singh A; Wajdula J; Fatenejad S; Etanercept European Investigators Network. Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study. Annals of the rheumatic diseases. (2009) 68 7 pp1146-1152', '10.1136/ard.2007.087106', '']\n",
      "['9260231', 'Combe B; Codreanu C; Fiocco U; Gaubitz M; Geusens PP; Kvien TK; Pavelka K; Sambrook PN; Smolen JS; Wajdula J; Fatenejad S; Etanercept European Investigators Network (Etanercept Study 309 Investigators). Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Annals of the rheumatic diseases. (2006) 65 10 pp1357-1362', '10.1136/ard.2005.049650', '']\n",
      "['9736930', 'EUCTR2012-000139-21-AT. Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients with Rheumatoid Arthritis  to a Specific Biologic Mode of Action. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-000139-21-AT. (2012)   pp', '10.55776/kli72', '']\n",
      "['9742742', 'EUCTR2012-003644-71-NL. Randomized, Double-Blind, Placebo-Controlled Trial of etanercept plus methotrexate in monoclonal antibody (mAb) anti-TNF failure. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003644-71-NL. (2013)   pp', '10.1186/isrctn21272423', '']\n",
      "['9737553', 'EUCTR2013-004808-19-DE. Study in patients with primary Sj√∂gren‚Äôs syndrome with the aim to assess safety, tolerability, pharmacokinetics (way the body absorbs, distributes, and gets rid of the drug) and preliminary efficacy of CFZ533. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-004808-19-DE. (2015)   pp', '10.31525/ct1-nct04069026', '']\n",
      "['9737379', 'EUCTR2014-003529-16-GB. Stratification of biologic Therapies for Rheumatoid Arthritis by Pathobiology. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-003529-16-GB. (2015)   pp', '10.1186/isrctn10618686', '']\n",
      "['9741188', 'EUCTR2018-004558-30-ES. Synovial ultrasound as primary outcome in a 3-arm, randomized, open-label, parallel active controlled, multicenter international study comparing baricitinib, alone and combined with MTX versus TNF-alfa inhibitor in rheumatoid arthritis patients: searching for synovium predictors of response. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-004558-30-ES. (2019)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739896', 'EUCTR2007-001625-10-IT. An Open-Label, Randomized Study to Evaluate the Radiographic Efficacy and Safety of Enbrel‚Ñ¢ (Etanercept) added to Methotrexate in Comparison with Usual Treatment in Subjects with Moderate Rheumatoid Arthritis Disease Activity. - EXTRA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001625-10-IT. (2009)   pp', '10.1186/isrctn95861172', '']\n",
      "['9257131', 'Chua A; Lee E; Ralston P; Senecal M; Stark J; Liu R; Yassine M; Low R; Sun Y. Cost per response of certolizumab pegol versus adalimumab among biologic-naive patients with moderate or severe rheumatoid arthritis from the US payer perspective. Value in health. Conference: 23rd annual meeting of the international society for pharmacoeconomics and outcomes research, ISPOR 2018. United states. (2018) 21 Supplement 1 ppS194', '10.1016/j.jval.2018.04.1321', '']\n",
      "['9262160', 'Anonymous. Erratum: head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study (The Lancet (2016) 388(10061) (2763-2774)(S0140673616316518)(10.1016/S0140-6736(16)31651-8)). Lancet. (2017) 389 10068 ppe2', '10.1016/s0140-6736(16)31651-8', '']\n",
      "['9263561', 'Anonymous. Erratum: head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study (The Lancet (2016) 388(10061) (2763-2774) (S0140673616316518) (10.1016/S0140-6736(16)31651-8)). Lancet. (2016) 388 10061 pp2742', '10.1016/s0140-6736(16)31651-8', '']\n",
      "['9263562', 'Smolen JS; Burmester GR; Combe B; Curtis JR; Hall S; Haraoui B; van Vollenhoven R; Cioffi C; Ecoffet C; Gervitz L; Ionescu L; Peterson L; Fleischmann R. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study. Lancet (london, england). (2016) 388 10061 pp2763-2774', '10.1016/s0140-6736(16)31651-8', '']\n",
      "['9738045', 'NCT01500278. Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate. https://clinicaltrials.gov/show/NCT01500278. (2011)   pp', '10.1016/j.jval.2011.08.431', '']\n",
      "['9738753', 'Chua A; Lee E; Ralston P; Senecal M; Stark J; Liu R; Yassine M; Low R; Sun Y. Cost per response of certolizumab pegol versus adalimumab among biologic-naive patients with moderate or severe rheumatoid arthritis from the US payer perspective. Value in health. (2018) Conference: 23rd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2018. United States. 21 Supplement 1 ppS194', '10.1016/j.jval.2018.04.1321', '']\n",
      "['9739802', 'EUCTR2011-002067-20-AT. Study designed to assess the short- and long-term efficacy of CZP compared with Adalimumab, both when used with methotrexate (MTX) in the treatment of subjects suffering from rheumatoid arthritis that are not responding adequately to MTX. Adalimumab is a recombinant human IgG1 monoclonal antibody specific for human TNF that has been approved for the treatment of moderate to severe active RA in the USA, the European Union, and a number of other countries worldwide. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002067-20-AT. (2012)   pp', '10.1136/annrheumdis-2001.1212', '']\n",
      "['9261576', 'Vital EM; Dass S; Buch MH; Rawstron AC; Emery P. An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Annals of the rheumatic diseases. (2015) 74 6 pp1195-1201', '10.1136/annrheumdis-2013-204544', '']\n",
      "['9737828', 'EUCTR2006-005640-81-GB. A PLACEBO CONTROLLED STUDY OF THE EFFECT OF EXTENDED TREATMENT WITH RITUXIMAB ON RESISTANT RHEUMATOID ARTHRITIS: - EXXTRA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005640-81-GB. (2007)   pp', '10.1186/isrctn23348591', '']\n",
      "['9259256', 'Faarvang KL; Egsmose C; Kryger P; P‚àö‚àèdenphant J; Ingeman-Nielsen M; Hansen TM. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Annals of the rheumatic diseases. (1993) 52 10 pp711-715', '10.1136/ard.52.10.711', '']\n",
      "['9260893', 'Fallahi S; Rostamian A; Khalvat A; Khazaeipour Z; Shahbazi F. Depicting and comparing the time to normalize \"erythrocyte sedimentation rate\" following two combination therapies in rheumatoid arthritis patients: A randomized clinical trial. Caspian Journal of Internal Medicine. (2012) 4  1 pp564-568', '10.1016/j.ctim.2025.103189', '']\n",
      "['9739888', 'IRCT2012110611383N1. Effect of two different combination drug therapies  on control of joints inflammation in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012110611383N1. (2012)   pp', '10.1186/isrctn18445519', '']\n",
      "['9258347', 'Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis. Clinical rheumatology. (1995) 14 5 pp531-536', '10.1007/bf02208150', 'http://link.springer.com/article/10.1007/BF02208150/fulltext.html']\n",
      "['9737309', 'EUCTR2011-001883-23-SE. Febuxoststat versus Allopurinol Steamlined Trial (FAST). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001883-23-SE. (2016)   pp', '10.1186/isrctn72443728', '']\n",
      "['9256886', 'Fleischmann R; Vencovsky J; van Vollenhoven RF; Borenstein D; Box J; Coteur G; Goel N; Brezinschek HP; Innes A; Strand V. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Annals of the rheumatic diseases. (2009) 68 6 pp805-811', '10.1136/ard.2008.099291', '']\n",
      "['9738872', 'Fleischmann R M; Van Vollenhoven; R F; Vencovsky J; Alten R; Davies O; Stach C; De Longueville; Van Lunen; Choy E. Long-term safety and efficacy of 4-weekly certolizumab pegol combination and monotherapy in rheumatoid arthritis: 5 year results from an open label extension study. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS565-S566', '10.1136/annrheumdis-2012-eular.3098', '']\n",
      "['9740973', 'NCT00548834. Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00548834. (2007)   pp', '10.1093/rheumatology/41.9.1008', 'http://academic.oup.com/rheumatology/article-pdf/41/9/1008/9533205/411008.pdf']\n",
      "['9260884', 'Huffstutter JE; Taylor J; Schechtman J; Leszczynski P; Brzosko M; Sedarati F; Moawad D; Kapp AV; Sudlow R; Dummer W. Single-versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: Results from the phase III FEATURE trial. International journal of clinical rheumatology. (2011) 6  6 pp689-696', '10.2217/ijr.11.55', '']\n",
      "['9739994', 'EUCTR2007-005759-41-DE. A Randomized, Double-Blind, Parallel-Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Given as a Single Infusion or Dual Infusion Compared with Placebo in Patients with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy - FEATURE: ocrelizumab in MTX-IR RA-patients; mono- vs. dual infusion. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005759-41-DE. (2008)   pp', '10.3899/jrheum.110994', '']\n",
      "['9258059', 'Fedorenko E; Lukina G; Sigidin Y. Remission as the main target of therapy in early rheumatoid arthritis (RA) patients: Comparative efficacy of four treatment regimens. Annals of the rheumatic diseases. (2015) 74  ppA82', '10.1136/annrheumdis-2015-207259.188', '']\n",
      "['9261096', 'Fedorenko E; Lukina G; Sigidin Y. Remission as the main therapeutic target: Comparative efficacy of four treatment regimens in early rheumatoid arthritis (RA) patients (PTS). Annals of the rheumatic diseases. (2013) 72  ppA70', '10.1136/annrheumdis-2013-203223.15', '']\n",
      "['9261175', 'Fedorenko E; Lukina G; Sigidin Y. Pain as the main index of treatment effectiveness in early rheumatoid arthritis patients: Comparative efficacy of four treatment regimens. International journal of rheumatic diseases. (2012) 15  pp69', '10.1136/annrheumdis-2016-211055.33', '']\n",
      "['9261238', 'Fedorenko EV; Lukina GV; Sigidin YA. Four different treatment regimens in early rheumatoid arthritis (comparative efficacy). European journal of clinical investigation. (2012) 42  pp65-66', '10.1136/annrheumdis-2016-211055.33', '']\n",
      "['9261528', 'Fedorenko E; Lukina G; Sigidin Y; Karateev D. Comparative analysis of safety data of four treatment regimens in early rheumatoid arthritis patients. European journal of clinical investigation. (2014) 44  pp65-66', '10.1136/annrheumdis-2012-eular.597', '']\n",
      "['9261786', 'Fedorenko EV; Lukina GV; Sigidin YA. Safety data of four treatment regimens in early rheumatoid arthritis patients. Annals of the rheumatic diseases. (2016) Conference: 36th European Workshop for Rheumatology Research York United Kingdom. Conference Start: 20160225 Conference End: 20160227. Conference Publication: var.pagings ppA76', '10.1136/annrheumdis-2016-209124.181', '']\n",
      "['9262471', 'Fedorenko E; Lukina G; Sigidin Y; Karateev D. Safety of four treatment regimens in early rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp273-274', '10.1136/annrheumdis-2017-eular.6717', '']\n",
      "['9263480', 'Fedorenko E; Lukina G; Sigidin Y. The best strategy of treatment in early rheumatoid arthritis patients: Comparative efficacy of four regimens. Rheumatology. (2012) 51  ppi40', '10.1136/annrheumdis-2016-211055.33', '']\n",
      "['9263548', 'Fedorenko E. Pain -the main index of treatment effectiveness in early rheumatoid arthritis (RA) patients: comparative efficacy of four treatment regimens. Annals of the rheumatic diseases. Conference: 36th european workshop for rheumatology research. York united kingdom. Conference start: 20160225. Conference end: 20160227. Conference publication: (var.pagings). (2016) 75  ppA76-A77', '10.1136/annrheumdis-2016-209124.182', '']\n",
      "['9258598', 'Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years. Rheumatology (Oxford, England). (2002) 41 8 pp892-898', '10.1093/rheumatology/41.8.892', 'http://academic.oup.com/rheumatology/article-pdf/41/8/892/5034037/410892.pdf']\n",
      "['9259331', 'Ferraz MB; Pinheiro GR; Helfenstein M; Albuquerque E; Rezende C; Roimicher L; Brandao L; Silva SC; Pinheiro GC; Atra E. Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial. Scandinavian journal of rheumatology. (1994) 23 5 pp231-236', '10.3109/03009749409103721', '']\n",
      "['9260737', 'Stohl W; Gomez-Reino J; Olech E; Dudler J; Fleischmann RM; Zerbini CA; Ashrafzadeh A; Grzeschik S; Bieraugel R; Green J; Francom S; Dummer W. Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial. Annals of the rheumatic diseases. (2012) 71 8 pp1289-1296', '10.1136/annrheumdis-2011-200706', '']\n",
      "['9256971', 'Puolakka K; Kautiainen H; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Bl‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´¬¨¬®¬¨¬¢field H; Hakala M; Leirisalo-Repo M. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis and rheumatism. (2004) 50 1 pp55-62', '10.4324/9780203187838.bmatt3', '']\n",
      "['9257417', 'Karstila KL; Rantalaiho VM; Mustonen JT; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen TT; Hannonen PJ; Leirisalo-Repo M; Kaipiainen-Sepp‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫nen OA; Karjalainen AH; Korpela MM; FIN-RACo Trial Group. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial. Clinical and experimental rheumatology. (2010) 28 1 pp73-78', '10.4324/9780203187838.bmatt3', '']\n",
      "['9257632', 'Puolakka K; Kautiainen H; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Hakala M; Korpela M; Ilva K; Yli-Kerttula U; Piirainen H; Leirisalo-Repo M; FIN-RACo Trial Troup. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Annals of the rheumatic diseases. (2005) 64 1 pp130-133', '10.4324/9780203187838.bmatt3', '']\n",
      "['9258165', 'Puolakka K; Kautiainen H; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Korpela M; Hakala M; J‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫rvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M; FIN-RACo Trial Group. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis and rheumatism. (2005) 52 1 pp36-41', '10.4324/9780203187838.bmatt3', '']\n",
      "['9259932', 'Gerards AH; Landew‚Äö√†√∂¬¨¬© RB; Prins AP; Bruyn GA; Goei Th‚Äö√†√∂¬¨¬© HS; Laan RF; Dijkmans BA; Bruijn GA. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Annals of the rheumatic diseases. (2003) 62 4 pp291-296', '10.1136/ard.62.4.291', '']\n",
      "['9259833', 'Neva MH; Kauppi MJ; Kautiainen H; Luukkainen R; Hannonen P; Leirisalo-Repo M; Nissil‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫ M; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; FIN-RACo Trail Group. Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis and rheumatism. (2000) 43 11 pp2397-2401', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260035', 'Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Bl‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´¬¨¬®¬¨¬¢field H; Puolakka K; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; FIN-RACo Trial Group. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis and rheumatism. (2004) 50 7 pp2072-2081', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260078', 'Kuuliala A; Leirisalo-Repo M; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Nissil‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫ M; Kautiainen H; Korpela M; Julkunen H; Hakola M; Repo H; FIN-RACo Trial Group. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. Clinical and experimental rheumatology. (2005) 23 2 pp243-246', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260256', 'Laivoranta-Nyman S; M‚àö‚àÇtt‚àö‚àÇnen T; Hannonen P; Korpela M; Kautiainen H; Leirisalo-Repo M; Julkunen H; Luukkainen R; Hakala M; Vuori K; Laine AP; Toivanen A; Ilonen J; FIN-RACo Trial Group. Association of tumour necrosis factor a, b and c microsatellite polymorphisms with clinical disease activity and induction of remission in early rheumatoid arthritis. Clinical and experimental rheumatology. (2006) 24 6 pp636-642', '10.1080/03009740902756515', '']\n",
      "['9260286', 'Puolakka K; Kautiainen H; M√∂tt√∂nen T; Hannonen P; Pohjolainen T; Korpela M; Vuori K; Ilva K; Yli-Kerttula U; J√§rvinen P; Leirisalo-Repo M. Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial. Scandinavian journal of rheumatology. (2007) 36 4 pp270-277', '10.1080/03009740701286847', '']\n",
      "['9260323', 'Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Fin-Raco Trial Group. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression. Scandinavian journal of rheumatology. (2008) 37 2 pp90-93', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260358', 'M‚àö¬ßkinen H; Kautiainen H; Hannonen P; M‚àö‚àÇtt‚àö‚àÇnen T; Leirisalo-Repo M; Laasonen L; Korpela M; Bl‚àö‚Ä¢field H; Hakola M; Sokka T. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. Journal of rheumatology. (2007) 34 2 pp316-321', '10.1002/art.10135', '']\n",
      "['9260392', 'Kauppi MJ; Neva MH; Laiho K; Kautiainen H; Luukkainen R; Karjalainen A; Hannonen PJ; Leirisalo-Repo M; Korpela M; Ilva K; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; FIN-RACo Trial Group. Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs. Journal of rheumatology. (2009) 36 2 pp273-278', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260691', 'Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Leirisalo-Repo M; Ilonen J; J‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫rvenp‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫ S; Luukkainen R; Hannonen P. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Clinical and experimental rheumatology. (2011) 29 3 pp500-505', '10.4324/9780203187838.bmatt3', '']\n",
      "['9260788', 'Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; M‚àö‚àÇtt‚àö‚àÇnen T; FIN-RACo Trial Group. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial. Annals of the rheumatic diseases. (2013) 72 5 pp786-788', '10.1136/annrheumdis-2012-202737', '']\n",
      "['9261676', \"Rantalaiho V; Kautiainen H; Korpela M; Puolakka K; Bl√•field H; Ilva K; Hannonen P; Leirisalo-Repo M; M√∂tt√∂nen T; FIN-RACo Study Group. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. Annals of the rheumatic diseases. (2014) 73 4 pp788-790\", '10.1136/annrheumdis-2013-204271', '']\n",
      "['9261833', 'Levitsky A; Wick MC; Mottonen T; Leirisalo-Repo M; Laasonen L; Kautiainen H; Korpela M; Van Vollenhoven RF; Rantalaiho V. Early intensification of treatment induces superior outcomes in two randomized trials according to predicted vs. Observed radiographic progression in rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.3109/03009742.2015.1019560', '']\n",
      "['9263107', 'M‚àö‚àÇtt‚àö‚àÇnen T; Hannonen P; Korpela M; Nissil‚àö¬ß M; Kautiainen H; Ilonen J; Laasonen L; Kaipiainen-Sepp‚àö¬ßnen O; Franzen P; Helve T; Koski J; Gripenberg-Gahmberg M; Myllykangas-Luosuj‚àö¬ßrvi R; Leirisalo-Repo M; FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis and rheumatism. (2002) 46 4 pp894-898', '10.1002/art.10135', '']\n",
      "['9263155', 'Sokka T. Rheumatoid arthritis databases in Finland. Clinical and experimental rheumatology. (2005) 23 5 Suppl 39 ppS201-4', '10.1016/j.berh.2008.08.003', '']\n",
      "['9263303', 'Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; J√§rvenp√§√§ S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosuj√§rvi R; M√∂tt√∂nen T; FIN-RACo Trial Group. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Arthritis and rheumatism. (2009) 60 5 pp1222-1231', '10.1002/art.24447', '']\n",
      "['9258110', 'Levitsky A; Wick MC; M‚àö‚àÇtt‚àö‚àÇnen T; Leirisalo-Repo M; Laasonen L; Korpela M; van Vollenhoven RF; Rantalaiho V. Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials. Clinical and experimental rheumatology. (2016) 34 6 pp1065-1071', '10.3109/03009742.2015.1043142', '']\n",
      "['11083709', 'Tanaka Yoshiya; Atsumi Tatsuya; Aletaha Daniel; Bartok Beatrix; Pechonkina Alena; Han Ling; Emoto Kahaku; Kano Shungo; Rajendran Vijay; Takeuchi Tsutomu. Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: post Hoc Analysis of Two Trials. Rheumatology and therapy. (2022)   pp', '10.1007/s40744-022-00503-3', 'https://link.springer.com/article/10.1007/s40744-022-00503-3/fulltext.html']\n",
      "['11083788', 'Galloway J; Buch MH; Yamaoka K; Leatherwood C; Pechonkina A; Tiamiyu I; Jiang D; Ye L; Besuyen R; Aletaha D; Winthrop K. Infections and serious infections in the filgotinib rheumatoid arthritis program. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp70-71', '10.1136/annrheumdis-2021-eular.1416', '']\n",
      "['11084000', 'Tanaka Y; Matsubara T; Atsumi T; Amano K; Ishiguro N; Sugiyama E; Yamaoka K; Combe BG; Kivitz AJ; Bae S-C; Keystone EC; Nash P; Matzkies F; Bartok B; Pechonkina A; Kondo A; Ye L; Guo Y; Tasset C; Sundy JS; Takeuchi T. Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). Modern rheumatology. (2022) 32 2 pp263-272', '10.1093/mr/roab030', 'https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roab030/41927077/roab030.pdf']\n",
      "['11084208', 'Taylor PC; Elboudwarej E; Downie B; Liu J; Hawtin RE; Mirza AM. Peripheral protein biomarker changes following selective inhibition of janus kinase 1 (JAK1) by filgotinib in adults with moderately-to-severely active rheumatoid arthritis with prior inadequate response to methotrexate (FINCH1). Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp650-651', '10.1136/annrheumdis-2020-eular.4704', '']\n",
      "['11084389', 'Combe B; Tanaka Y; Buch MH; Bur Mester GR; Bar Tok B; Pechonkina A; Han L; Emoto K; Kano S; Hendrikx T; Aletaha D. EFFICACY and SAFETY of FILGOTINIB in PATIENTS with INADEQUATE RESPONSE to METHOTREXATE, with 4 or <4 POOR PROGNOSTIC FACTORS: a POST HOC ANALYSIS of the FINCH 1 STUDY. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp632', '10.1136/annrheumdis-2022-eular.5051', '']\n",
      "['11084996', 'Kivitz A; Tanaka Y; Lee S; Ye L; Hu H; Besuyen R; Combe B. Filgotinib provided rapid and sustained improvements in functional status, pain, health-related quality of life, and fatigue in patients with rheumatoid arthritis and inadequate response to methotrexate: results from the finch 1 study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp645-646', '10.1136/annrheumdis-2020-eular.2882', '']\n",
      "['11084997', 'Walker D; Combe BG; Kivitiz AJ; Tanaka Y; Van Der Heijde D; Matzkies F; Bartok B; Ye L; Guo Y; Tasset C; Sundy JS; Mozaffarian N; Landewe RBM; Bae S-C; Keystone EC; Nash P. Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: finch1 primary outcome results. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii96', '10.1093/rheumatology/keaa111.205', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.205/33102308/keaa111.205.pdf']\n",
      "['11085028', 'Combe B; Kivitz A; Tanaka Y; Van Der Heijde D; Simon-Campos JA; Baraf HSB; Kumar U; Matzkies F; Bartok B; Ye L; Guo Y; Tasset C; Sundy J; Jahreis A; Mozaffarian N; Landewe RBM; Bae SC; Keystone E; Nash P. Efficacy and safety of filgotinib for patients with rheumatoid arthritis with inadequate response to methotrexate: finch 1 52-week results. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp320-321', '10.1136/annrheumdis-2020-eular.276', '']\n",
      "['11085061', 'Combe B; Tanaka Y; Emery P; Pechonkina A; Kuo A; Gong Q; Van Beneden K; Rajendran V; Schulze-Koops H. CLINICAL OUTCOMES UP to WEEK (W) 48 in the ONGOING FILGOTINIB (FIL) LONG-TERM EXTENSION (LTE) TRIAL of RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) with INADEQUATE RESPONSE (IR) to METHOTREXATE (MTX) INITIALLY TREATED with FIL or ADALIMUMAB (ADA) during the PHASE 3 PARENT STUDY (PS). Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp615-616', '10.1136/annrheumdis-2022-eular.1641', '']\n",
      "['11086215', 'Buch MH; Walker D; Kiely PDW; Edwards CJ; Barry J; McCaughey G; Akroyd L; Tiamiyu I; Ye L; Chen K; Taylor PC. A subgroup analysis of the e}cacy offilgotinib for patients with moderately active RAfollowing an inadequate response to methotrexate. Rheumatology (united kingdom). (2021) 60 SUPPL 1 ppi70-i71', '10.1093/rheumatology/keab247.123', 'http://academic.oup.com/rheumatology/article-pdf/60/Supplement_1/keab247.123/37399829/keab247.123.pdf']\n",
      "['11086454', 'Loftus EV; Genovese M; Winthrop K; Tanaka Y; Takeuchi T; Kivitz A; Matzkies F; Ye L; Jiang D; Guo Y; Bartok B; Besuyen R; Burmester GR; Gottenberg JE. Integrated safety analysis of filgotinib treatment for rheumatoid arthritis from 7 clinical trials. United European gastroenterology journal. (2020) 8 8 SUPPL pp438-439', '10.1136/annrheumdis-2020-eular.267', '']\n",
      "['11086473', 'Westhovens R; Burmester GR; Aletaha D; Pope J; Tanaka Y; Durez P; Gomez-Centeno A; Pechonkina A; Bartok B; Matzkies F; Ye L; Yin Z; Besuyen R; Rigby W; Combe B. Characterisation of depth of response, including 50% improve-ment in acr components at week 12 and remission at week 24, following treatment with filgotinib compared with methotrexate or adalimumab in patients with rheumatoid arthritis. Swiss medical weekly. (2020) 150 SUPPL 245 pp10S-11S', '10.1136/annrheumdis-2020-eular.2236', '']\n",
      "['11086480', 'Valenzuela G; Keystone E; Winthrop K; Genovese M; Combe B; Tanaka Y; Kivitz A; Matzkies F; Bartok B; Ye L; Guo Y; Sundy J; Tasset C; Westhovens R; Rigby W; Burmester G. Pooled safetyanalyses from phase 3 studies of filgotinib in patients with rheumatoid arthritis. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS127', '10.1016/s0016-5085(20)32389-1', '']\n",
      "['11086541', 'Taylor PC; Downie B; Elboudwarej E; Kim S; Hertz A; Mirza AM; Siegel J; Hawtin RE; Liu J. Whole blood transcriptional changes following selective inhibition of janus kinase 1 (JAK1) by filgotinib in adults with moderately-to-severely active rheumatoid arthritis with prior inadequate response to methotrexate (finch1). Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp333', '10.1136/annrheumdis-2020-eular.2996', '']\n",
      "['11086596', 'Genovese MC; Winthrop K; Tanaka Y; Takeuchi T; Kivitz A; Matzkies F; Ye L; Jiang D; Guo Y; Bartok B; Besuyen R; Burmester GR; Gottenberg JE. Integrated safety analysis of filgotinib treatment for rheumatoid arthritis from 7 clinical trials. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp324-325', '10.1136/annrheumdis-2020-eular.267', '']\n",
      "['11086620', 'Burmester GR; Aletaha D; Pope J; Tanaka Y; Durez P; Gomez-Centeno A; Pechonkina A; Bartok B; Matzkies F; Ye L; Yin Z; Besuyen R; Rigby W; Combe B. Characterisation of depth of response, including 50% improvement in acr components at week 12 and remission at week 24, following treatment with filgotinib compared with methotrexate or adalimumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp316-317', '10.1136/annrheumdis-2020-eular.2236', '']\n",
      "['11087233', 'Tanaka Y; Atsumi T; Aletaha D; Landewe RBM; Bartok B; Pechonkina A; Yin Z; Han L; Emoto K; Kano S; Rajendran V; Takeuchi T. RADIOGRAPHIC CHANGE in PATIENTS with RHEUMATOID ARTHRITIS and ESTIMATED BASELINE YEARLY PROGRESSION >=5 or <5: POST HOC ANALYSIS of TWO PHASE 3 TRIALS of FILGOTINIB. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp604-605', '10.1136/annrheumdis-2022-eular.198', '']\n",
      "['11087248', 'Balsa A; Wassenberg S; Tournadre A; Orzechowski HD; Van Beneden K; Rajendran V; Lendl U; Stiers PJ; Watson C; Caporali R; Verschueren P. EFFECT of FILGOTINIB (FIL) on BODY WEIGHT (BW) and BODY MASS INDEX (BMI) and EFFECT of BASELINE BMI on the EFFICACY and SAFETY of FIL in RHEUMATOID ARTHRITIS (RA). Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp516-517', '10.1136/annrheumdis-2022-eular.1088', '']\n",
      "['11087425', 'Tanaka Y; Matsubara T; Atsumi T; Amano K; Ishiguro N; Sugiyama E; Yamaoka K; Combe BG; Kivitz AJ; Bae S-C; Keystone EC; Nash P; Genovese M; Matzkies F; Bartok B; Pechonkina A; Kondo A; Ye L; Gong Q; Tasset C; Takeuchi T. Safety and Efficacy of Filgotinib for Japanese Patients with RA and Inadequate Response to MTX: FINCH 1 52-Week Results and FINCH 4 48-Week Results. Modern rheumatology. (2022)   pp', '10.1093/mr/roac084', 'https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roac084/45612285/roac084.pdf']\n",
      "['11087535', 'Emery P; Downie B; Liu J; Hawtin RE; Curtis JR; Burmester GR. FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: a POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS. Rheumatology (united kingdom). (2022) 61 SUPPL 1 ppi115-i116', '10.1093/rheumatology/keac133.203', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac133.203/43436786/keac133.203.pdf']\n",
      "['11088004', 'Combe Bernard; Kivitz Alan; Tanaka Yoshiya; van der Heijde Desiree; Simon J Abraham; Baraf Herbert S B; Kumar Uma; Matzkies Franziska; Bartok Beatrix; Ye Lei; Guo Ying; Tasset Chantal; Sundy John S; Jahreis Angelika; Genovese Mark C; Mozaffarian Neelufar; Landewe Robert B M; Bae Sang-Cheol; Keystone Edward C; Nash Peter. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. Annals of the rheumatic diseases. (2021) 80 7 pp848-858', '10.1136/annrheumdis-2020-219214', '']\n",
      "['11088328', 'Combe BG; Tanaka Y; Buch MH; Nash P; Burmester GR; Kivitz AJ; Bartok B; Pechonkina A; Xia K; Emoto K; Kano S; Hendrikx TK; Landewe RBM; Aletaha D. Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: a Post Hoc Analysis of the FINCH 1 Study. . (2022)   pp', '10.1007/s40744-022-00498-x', 'https://link.springer.com/article/10.1007/s40744-022-00498-x/fulltext.html']\n",
      "['11085083', 'Bartok B; Winthrop KL; Genovese M; Combe BG; Tanaka Y; Kivitz A; Matzkies F; Ye L; Guo Y; Tasset CT; Sundy JS; Keystone E; Westhovens R; Rigby W; Burmester GR; Walker DR. POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS. . (2020) 158 6 ppS', '10.1016/s0016-5085(20)32389-1', '']\n",
      "['11086158', 'Perez-Garcia LF; Micu M; Gheyle L; Yin Z; Tan Y; Chen K; Papazian P; Van Beneden K; Dolhain R; Westhovens R. Sexual function in male and female patients with rheumatoid arthritis: a post-hoc analysis of the finch studies. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp496-497', '10.1136/annrheumdis-2021-eular.1774', '']\n",
      "['11088726', 'Bingham CO; Walker D; Nash P; Lee SJ; Ye L; Hu H; Khalid JM; Combe B. The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies. . (2022) 24 1 pp', '10.1186/s13075-021-02677-7', 'https://link.springer.com/article/10.1186/s13075-021-02677-7/fulltext.html']\n",
      "['11083971', 'Tanaka Y; Curtis J; Wassenberg S; Kiely P; Ye L; Yin Z; Downie B; Enomoto H; Strengholt S; Akhdar A; Watson C; Atsumi T. EFFICACY OF FILGOTINIB IN RHEUMATOID ARTHRITIS BY AGE, BODY WEIGHT, BODY MASS INDEX: POST HOC SUBGROUP ANALYSIS OF TWO PHASE 3 TRIALS. Rheumatology (united kingdom). (2022) 61 SUPPL 1 ppi109-i110', '10.1093/rheumatology/keac133.191', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac133.191/43436419/keac133.191.pdf']\n",
      "['11086076', 'Tanaka Y; Curtis J; Wassenberg S; Kiely P; Ye L; Yin Z; Downie B; Enomoto H; Strengholt S; Akhdar A; Watson C; Atsumi T. Efficacy of filgotinib in rheumatoid arthritis by age, body weight, BMI: post hoc subgroup analysis of two Phase 3 trials. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp234-237', '10.1093/rheumatology/keac133.191', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac133.191/43436419/keac133.191.pdf']\n",
      "['9737833', 'Genovese Mark C; Kalunian Kenneth; Gottenberg Jacques-Eric; Mozaffarian Neelufar; Bartok Beatrix; Matzkies Franziska; Gao Jie; Guo Ying; Tasset Chantal; Sundy John S; de Vlam Kurt; Walker David; Takeuchi Tsutomu. Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: the FINCH 2 Randomized Clinical Trial. JAMA. (2019) 322 4 pp315-325', '10.1001/jama.2019.9055', 'https://jamanetwork.com/journals/jama/article-pdf/322/4/315/17730608/jama_genovese_2019_oi_190069.pdf']\n",
      "['9742472', 'Anonymous. Erratum: effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid ArthritisRefractory to Disease-Modifying Antirheumatic DrugTherapy: theFINCH2RandomizedClinicalTrial (JAMA (2019) 322: 4 (315-325) DOI: 10.1001/jama.2019.9055). JAMA - journal of the american medical association. (2020) 323 5 pp480', '10.1001/jama.2019.9055', 'https://jamanetwork.com/journals/jama/article-pdf/322/4/315/17730608/jama_genovese_2019_oi_190069.pdf']\n",
      "['11083816', 'Walker D; Genovese MC; Kalunian K; Gottenberg J-E; Bartok B; Tan YM; Guo Y; Tasset C; Sundy JS; De Vlam K; Takeuchi T. Effects of filgotinib on anaemia, thrombocytopoenia and leukopoenia: results from a phase 3 study in patients with active Ra and prior inadequate response or intolerance to bdmards. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii99', '10.1093/rheumatology/keaa111.211', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.211/33102414/keaa111.211.pdf']\n",
      "['11086586', 'Gottenberg JE; Buch MH; Caporali R; Wright GC; Takeuchi T; Kalunian K; Pechonkina A; Guo Y; Rao S; Tan Y; Besuyen R; Genovese MC. A subgroup analysis of low disease activity and remission from phase 3 study of filgotinib in patients with inadequate response to biologic DMARDs. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp326-327', '10.1136/annrheumdis-2020-eular.2237', '']\n",
      "['11086662', 'Taylor PC; Elboudwarej E; Li W; Hawtin RE; Liu J; Mirza AM. Filgotinib, a janus kinase 1 selective inhibitor, modulates disease-associated cytokines in patients with active Ra. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii99', '10.1093/rheumatology/keaa111.210', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.210/33102396/keaa111.210.pdf']\n",
      "['11083824', 'Alten R; Rigby W; Pechonkina A; Yin Z; Hasegawa K; Hendrikx T; Atsumi T; Westhovens R. Filgotinib provided rapid and sustained improvements in functional status, pain, and health-related quality of life, and reduced fatigue over time in patients with rheumatoid arthritis who are methotrexate-naive: results from the finch 3 study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp638-639', '10.1136/annrheumdis-2020-eular.2927', '']\n",
      "['11083825', 'Westhovens R; Rigby W; Van Der Heijde D; Ching D; Stohl W; Kay J; Chopra A; Bartok B; Matzkies F; Yin Z; Guo Y; Tasset C; Sundy J; Jahreis A; Mozaffarian N; Messina O; Landewe RBM; Atsumi T; Burmester GR. Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis: finch 3 52-week results. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1019-1020', '10.1136/annrheumdis-2020-eular.277', '']\n",
      "['11085488', 'Taylor PC; Mirza AM; Downie B; Liu J; Hawtin RE; Elboudwarej E. Peripheral protein biomarker changes following selective inhibition of janus kinase 1 (JAK1) by filgotinib in methotrexate naive adults with moderately-to-severely active rheumatoid arthritis (FINCH3). Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp333-334', '10.1136/annrheumdis-2020-eular.4725', '']\n",
      "['11085698', 'Atsumi T; Tanaka Y; Matsubara T; Amano K; Ishiguro N; Sugiyama E; Yamaoka K; Westhovens R; Ching DWT; Messina OD; Burmester GR; Bartok B; Pechonkina A; Kondo A; Yin Z; Guo Y; Tasset C; Sundy JS; Takeuchi T. Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3). Modern rheumatology. (2022) 32 2 pp273-283', '10.1093/mr/roab021', 'https://academic.oup.com/mr/article-pdf/32/2/273/42644862/roab021.pdf']\n",
      "['11086343', 'Atsumi T; Shin K; Bartok B; Pechonkina A; Tasset C; Yin Z; Yip CSM; Cheng-Chung Wei J. Efficacy and safety of filgotinib for asian patients with rheumatoid arthritis who are naive to methotrexate: FINCH3 subgroup analysis. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp234-235', '10.1136/annrheumdis-2019-eular.8678', '']\n",
      "['11086358', 'Atsumi T; Aletaha D; Westhovens R; Gaujoux-Viala C; Adami G; Matsumoto A; Bird P; Daniel Messina O; Buch MH; Bartok B; Yin Z; Guo Y; Hendrikx T; Rudiger Burmester G. Efficacy of filgotinib in patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp8', '10.1136/annrheumdis-2020-eular.288', '']\n",
      "['11086474', 'Westhovens R; Aletaha D; Gaujoux-Viala C; Adami G; Matsumoto A; Bird P; Messina O; Buch M; Bartok B; Yin Z; Guo Y; Hendrikx T; Burmester G. Efficacy of filgotinib in patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of finch 3. Swiss medical weekly. (2020) 150 SUPPL 245 pp9S-10S', '10.1136/annrheumdis-2020-eular.288', '']\n",
      "['11086479', 'Valenzuela G; Van Der Heijde D; Westhovens R; Rigby W; Ching D; Bartok B; Matzkies F; Yin Z; Guo Y; Tasset C; Sundy J; Mozaffarian N; Messina O; Landewe R; Atsumi T; Burmester G. Efficacyand safetyof filgotinib for patients with rheumatoid arthritis naive to methotrexate therapy: finch 3 primaryoutcome results. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS128', '10.1136/annrheumdis-2020-eular.277', '']\n",
      "['11086513', 'Aletaha D; Westhovens R; Gaujoux-Viala C; Adami G; Matsumoto A; Bird P; Messina O; Buch MH; Bartok B; Yin Z; Guo Y; Hendrikx T; Burmester GR. Efficacy of filgotinib in patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of finch 3. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp312-313', '10.1136/annrheumdis-2020-eular.288', '']\n",
      "['11086576', 'Taylor PC; Downie B; Elboudwarej E; Kim S; Hertz A; Mirza AM; Siegel J; Hawtin RE; Liu J. Whole blood transcriptional changes following selective inhibition of janus kinase 1 (JAK1) by filgotinib in MTX-naive adults with moderately-to-severely active rheumatoid arthritis (RA) (FINCH3). Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1017-1018', '10.1136/annrheumdis-2020-eular.3949', '']\n",
      "['11086661', 'McKay N; Van Der Heijde D; Westhovens R; Rigby WFC; Ching DWT; Bartok B; Matzkies F; Yin Z; Guo Y; Tasset C; Sundy JS; Mozaffarian N; Messina OD; Landewe RBM; Atsumi T; Burmester GR. Efficacy and safety of filgotinib for patients with Ra naive to MTX therapy: finch3 primary outcome results. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii99-ii101', '10.1093/rheumatology/keaa111.212', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.212/33102430/keaa111.212.pdf']\n",
      "['11087867', 'Aletaha Daniel; Westhovens Rene; Gaujoux-Viala Cecile; Adami Giovanni; Matsumoto Alan; Bird Paul; Messina Osvaldo Daniel; Buch Maya H; Bartok Beatrix; Yin Zhaoyu; Guo Ying; Hendrikx Thijs; Burmester Gerd R. Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. RMD open. (2021) 7 2 pp', '10.1136/rmdopen-2021-001621', '']\n",
      "['9258058', 'Fisher BA; Donatien P; Filer A; Winlove CP; McInnes IB; Buckley CD; Taylor PC. Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis. Clinical and experimental rheumatology. (2016) 34 6 pp1072-1076', '10.3899/jrheum.161068', '']\n",
      "['9739550', 'Jeffery LE; Calder P; Filer A; Raza K; Buckley C; McInnes I; Taylor P; Fisher B. Plasma levels of polyunsaturated omega 3 eicosapentaenoic acid are associated with anti-TNF response in rheumatoid arthritis, and inhibit the etanercept driven rise in Th17 cell differentiation in vitro. Rheumatology (united kingdom). (2015) 54  ppi42-', '10.1093/rheumatology/kev085.004', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i42/5179391/kev085.004.pdf']\n",
      "['9257145', 'Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis and rheumatism. (2003) 48 4 pp927-934', '10.1002/art.10870', '']\n",
      "['9258271', 'Schiff MH; DiVittorio G; Tesser J; Fleischmann R; Schechtman J; Hartman S; Liu T; Solinger AM. The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions. Arthritis and rheumatism. (2004) 50 6 pp1752-1760', '10.1002/art.20277', '']\n",
      "['9258498', 'Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J; 990757 Study Group. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis. Journal of rheumatology. (2004) 31 4 pp649-654', '10.1002/art.10870', '']\n",
      "['9260173', 'Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B. Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2006) 65 8 pp1006-1012', '10.1136/ard.2005.048371', '']\n",
      "['9260743', 'Fleischmann R; Cutolo M; Genovese MC; Lee EB; Kanik KS; Sadis S; Connell CA; Gruben D; Krishnaswami S; Wallenstein G; Wilkinson BE; Zwillich SH. Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs. Arthritis and rheumatism. (2012) 64 3 pp617-629', '10.1002/art.33383', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.33383']\n",
      "['9737301', '. RNA profiling of healthy and rheumatoid arthritis subjects treated with tofacitinib monotherapy. Annals of the rheumatic diseases. (2019) 78  pp284-', '10.1136/annrheumdis-2019-eular.1928', '']\n",
      "['9738924', 'Kremer J; Zerbini C; Lee E B; Gruben D; Krishnaswami S; Zwillich S H; Koncz T; Bradley J; Mebus C A. Tofacitinib (CP-690,550), an oral janus kinase inhibitor: analyses of efficacy endpoints by subgroups in a pooled phase 2 and 3 rheumatoid arthritis study population. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.2108', '']\n",
      "['9740109', 'EUCTR2007-002066-35-DE. A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED ACTIVE COMPARATOR, MULTICENTER STUDY TO COMPARE 5 DOSE REGIMENS OF CP-690,550 AND ADALIMUMAB VERSUS PLACEBO, ADMINISTERED FOR 6 MONTHS IN THE TREATMENT OF SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS - not applicable. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-002066-35-DE. (2009)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9740947', \"NCT00550446. A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00550446. (2007)   pp\", '10.1016/j.cpha.2020.08.004', '']\n",
      "['9742339', 'Hadjipanayis A; Chen X; Lee J; Zhao S; Zhang W; Martin D; Maciejewski M; Ziemek D; Fitz L; Hyde C; Von Schack D. RNA profiling of healthy and rheumatoid arthritis subjects treated with tofacitinib monotherapy. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp284', '10.1136/annrheumdis-2019-eular.1928', '']\n",
      "['9737897', 'Suzuki Misaki; Shoji Satoshi; Miyoshi So; Krishnaswami Sriram. Model-Based Comparison of Dose-Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients. Journal of clinical pharmacology. (2020) 60 2 pp198-208', '10.1002/jcph.1514', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1514']\n",
      "['9740633', 'EUCTR2018-000666-10-HU. A Phase 2 study to investigate the safety and efficacy of ABBV-105 given alone or in combination with ABT-494 (Upadacitinib) in patients with active rheumatoid arthritis who have failed prior treatment with biologic therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-000666-10-HU. (2018)   pp', '10.31525/ct1-nct03978520', '']\n",
      "['11087445', 'Fleischmann R; Friedman A; Drescher E; Singhal A; Cortes-Maisonet G; Doan T; Lu W; Wang Z; Nader A; Housley W; Cohen S; Taylor PC; Blanco R. Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial. The lancet rheumatology. (2022) 4 6 ppe395-e406', '10.1016/s2665-9913(22)00092-3', '']\n",
      "['9261612', 'Genovese MC; Silverman GJ; Emery P; Gupta RC; Gill A; Veenhuizen M; Xie L; Komocsar WJ; Berclaz PY; Lee C. Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in a heterogeneous rheumatoid arthritis population: Results from a randomized, placebo-controlled, phase 3 trial (FLEX-O). Journal of clinical rheumatology. (2015) 21  5 pp231-238', '10.1097/rhu.0000000000000276', '']\n",
      "['9262887', 'F‚àö‚àèrre O; Bjerkhoel F; Salvesen CF; Berg KJ; Rugstad HE; Saelid G; Mellbye OJ; K‚àö‚Ä¢ss E. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis and rheumatism. (1987) 30 1 pp88-92', '10.1002/art.1780300112', '']\n",
      "['9259326', 'Forre O; Bjerkhoel F; Kjeldsen-Kragh J; Ostensen H; Astor T; Boe E; Lekven C; Utne Sorensen J; Karoliussen O; Dehli O; Glennas A; Kvien TK; Solbu D; Haaland K; Straume S; Haavik T; Loland Jacobsen K; Vinje O. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Arthritis and rheumatism. (1994) 37 10 pp1506-1512', '10.1002/art.1780371015', '']\n",
      "['9738634', 'Burggraaf B; van Breukelen - van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn G-JM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome. Atherosclerosis. (2018) 271 pp 84-91 pp', '10.1016/j.atherosclerosis.2018.02.019', '']\n",
      "['9736528', 'FREEDMAN A; STEINBERG VL. Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year. Annals of the rheumatic diseases. (1960) 19 pp 243-250 pp', '10.1136/ard.19.3.243', '']\n",
      "['9740534', '. Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year. Annals of the rheumatic diseases. (1960) 19  pp243-250', '10.1136/ard.19.3.243', '']\n",
      "['9260520', 'Froebel KS; Lewis D; Dickson R; Sturrock RD. Spontaneous lymphocyte activity in rheumatoid arthritis in a longitudinal study in relation to gold therapy. Clinical rheumatology. (1985) 4 3 pp301-307', '10.1007/bf02031612', 'http://link.springer.com/article/10.1007/BF02031612/fulltext.html']\n",
      "['9257487', 'Ghosh B; Halder S; Ghosh A; Dhar S. Early rheumatoid arthritis: clinical and therapeutic evaluation in a tertiary care centre in India. Indian Journal of Rheumatology. (2008) 3 2 pp48-51', '10.1016/s0973-3698(10)60110-0', '']\n",
      "['9261371', 'Burmester G; Rigby W; Van Vollenhoven R; Kay J; Rubbert-Roth A; Kelman A; Dimonaco S; Mitchell N. Tocilizumab (TCZ) in combination and monotherapy versus methotrexate (MTX) in MTX-naive patients (pts) with early rheumatoid arthritis (RA): Clinical and radiographic outcomes from a randomised, placebo-controlled trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.246', '']\n",
      "['9261455', 'Burmester GR; Rigby W; Van Vollenhoven RF; Kay J; Rubbert-Roth A; Kelman A; Dimonaco S; Mitchell N. Tocilizumab in combination therapy and monotherapy versus methotrexate in methotrexate-naive patients with early rheumatoid arthritis: Clinical and radiographic outcomes from a randomized, placebo-controlled trial. Arthritis and rheumatism. (2013) 65  ppS1182-S1183', '10.1136/annrheumdis-2013-eular.246', '']\n",
      "['9261537', 'Burmester G; Blanco R; Keiserman M; Rigby W; Van Vollenhoven RF; Dimonaco SM; Grzeschik SM; Mitchell N. Tocilizumab (TCZ) as combination therapy and as monotherapy vs methotrexate (MTX) in MTX-naive patients with early rheumatoid arthritis: Patient-reported outcomes (PROS) from a randomized, placebo-controlled trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2178', '']\n",
      "['9261953', 'Burmester GR; Rigby WF; Van Vollenhoven RF; Kay J; Rubbert-Roth A; Kelman A; Dimonaco S; Mitchell N. Tocilizumab in early progressive rheumatoid arthritis: fUNCTION, a randomised controlled trial. Annals of the rheumatic diseases. (2016) 75 6 pp1081-1091', '10.1136/annrheumdis-2015-207628', '']\n",
      "['9740157', 'EUCTR2009-012759-12-GR. A multi-center, randomized, double-blind, parallel group study of the safety, disease remission and prevention of structural joint damage during treatment with tocilizumab (TCZ), as a monotherapy and in combination with methotrexate (MTX), versus methotrexate in patients with early, moderate to severe rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012759-12-GR. (2009)   pp', '10.1016/s0084-3873(09)79342-3', '']\n",
      "['9741089', 'NCT01007435. A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01007435. (2009)   pp', '10.1016/s0084-3873(09)79342-3', '']\n",
      "['9736685', '. Levels of CXCL13 and SICAM1 correlate with disease activity score in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ). Arthritis and rheumatology. (2018) 70  pp612-613', '10.1136/annrheumdis-2018-eular.1846', '']\n",
      "['9742268', 'Sornasse T; Gabay C; Townsend M; Laubender R; Wang J; Tuckwell K. Levels of CXCL13 and sicam1 correlate with disease activity score in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp286-287', '10.1136/annrheumdis-2018-eular.1846', '']\n",
      "['9743175', 'Tuckwell K; Gabay C; Sornasse T; Laubender R; Wang J; Townsend M. Levels of CXCL13 and SICAM1 correlate with disease activity score in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ). Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp612-613', '10.1136/annrheumdis-2018-eular.1846', '']\n",
      "['9258237', 'Garmish I; Cherkasova G; Kuryata A. Influence of ossein hydroxyapatite complex on clinical manifestations of osteoporosis in patients with rheumatoid arthritis. Osteoporosis international. Conference: IOF regionals 3rd middle east and africa osteoporosis meeting. United arab emirates. (2015) 26 2 Supplement ppS483', '10.1007/s00198-015-3361-1', 'http://link.springer.com/article/10.1007/s00198-015-3361-1/fulltext.html']\n",
      "['9261019', 'Gashi AA; Rexhepi S; Berisha I; Kryeziu A; Ismaili J; Krasniqi G. Treatment of rheumatoid arthritis with biologic DMARDS (Rituximab and Etanercept). Medical archives (Sarajevo, Bosnia and Herzegovina). (2014) 68 1 pp51-53', '10.5455/medarh.2014.68.51-53', 'https://ejmanager.com/mnstemps/10/10-1392927029.pdf']\n",
      "['9259878', 'Giacomelli R; Cipriani P; Matucci Cerinic M; Fulminis A; Barattelli G; Pingiotti E; Di Franco M; Trotta A; Perricone R; Zazzeroni F; Alesse E; Tonietti G. Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study. Clinical and experimental rheumatology. (2002) 20 3 pp365-372', '10.1046/j.1365-2249.2001.01603.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2249.2001.01603.x']\n",
      "['9738537', '. Erratum: cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial (Annals of the Rheumatic Diseases (2003) 62 (291-296)). Annals of the rheumatic diseases. (2003) 62 11 pp1126', '10.1136/ard.62.4.291', '']\n",
      "['9258315', 'Ghauri M; Sualeh Muhammad J; Hameed K; A Mirza. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients [Abstract]. Internal medicine journal. (2011) 41 S1 pp20', '10.3109/s10165-010-0405-4', '']\n",
      "['9263151', 'Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis and rheumatism. (2005) 52 11 pp3381-3390', '10.1002/art.21405', '']\n",
      "['9260371', \"Gubar' EE; Bochkova AG; Bunchuk NV. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Terapevticheskii‚Äö√†√∂‚àö√¢‚Äö√†√∂‚àö‚à´ arkhiv. (2008) 80 5 pp25-30\", '10.14412/1995-4484-2011-599', '']\n",
      "['11083820', 'Hartman L; El Alili M; Cutolo M; Opris-Belinski D; Da Silva JAP; Szekanecz Z; Buttgereit F; Masaryk P; Bos R; Kok MR; Paolino S; Coupe VMH; Lems W; Boers M; Middelink LM; Dekker V; Es-Sbai H; Doerwald L; Prinsen K; Scholte-Voshaar M; Redol J; Pinto R; Griep EN; Klaasen R; Allaart CF; Bruyn GAW; Raterman HG; Jansen TLTA; Codreanu C; Van Woerkom JM; Molenaar E; Van Laar JM; Ruiterman YPM; Boonen AERCH; Micaelo M; Costa J; Sieburg M; Spoorenberg JPL; Prothmann U; Saavedra MJ; Silva I; Nurmohamed MT; Jacobs JWG; Tas SW; Bijlsma JWJ; Christensen R; Smulders YM; Ralston SH. COST-EFFECTIVENESS and COST-UTILITY of ADD-ON, LOW-DOSE PREDNISOLONE in RA PATIENTS AGED 65+: the PRAGMATIC, MULTICENTER, PLACEBO-CONTROLLED GLORIA TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1041-1042', '10.1136/annrheumdis-2021-221957', '']\n",
      "['11085773', 'Hartman L; El Alili M; Cutolo M; Opris D; Da Silva J; Szekanecz Z; Buttgereit F; Masaryk P; Bos R; Kok MR; Paolino S; Coup√© V; Lems WF; Boers M; GLORIA consortium. Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic, multicenter, placebo-controlled GLORIA trial. Seminars in arthritis and rheumatism. (2022) 57  pp152109', '10.1016/j.semarthrit.2022.152109', '']\n",
      "['11085782', 'Hartman Linda; da Silva Jose A P; Buttgereit Frank; Cutolo Maurizio; Opris-Belinski Daniela; Szekanecz Zoltan; Masaryk Pavol; Voshaar Marieke J H; Heymans Martijn W; Lems Willem F; van der Heijde Desiree M F M; Boers Maarten. Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids. Rheumatology (Oxford, England). (2022)   pp', '10.1093/rheumatology/keac547', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac547/46608244/keac547.pdf']\n",
      "['11086116', 'Boers M; Hartman L; Opris-Belinski D; Bos R; Kok MR; Da Silva JAP; Griep EN; Klaasen R; Allaart C; Baudoin P; Raterman H; Szekanecz Z; Buttgereit F; Masaryk P; Klausch T; Paolino S; Schilder A; Lems W; Cutolo M. High number of concomitant medications and comorbidities at baseline in the glucocorticoid low-dose outcome in rheumatoid arthritis (GLORIA) study: an older population with rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp1107', '10.1136/annrheumdis-2021-eular.2013', '']\n",
      "['11087243', 'Almayali A; Boers M; Hartman L; Opris-Belinski D; Bos R; Kok MR; Da Silva JAP; Griep EN; Klaasen R; Allaart C; Baudoin P; Raterman H; Szekanecz Z; Buttgereit F; Masaryk P; Lems W; Cutolo M; Ter Wee M. TAPERING of LONG-TERM, LOW-DOSE GLUCOCORTICOIDS in SENIOR RHEUMATOID ARTHRITIS PATIENTS: FOLLOW-UP of the PRAGMATIC, MULTICENTRE, PLACEBO-CONTROLLED GLORIA TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp180', '10.1136/annrheumdis-2022-eular.663', '']\n",
      "['11087370', 'Hartman L; Da Silva JAP; Buttgereit F; Cutolo M; Opris-Belinski D; Szekanecz Z; Masaryk P; Voshaar M; Heijmans MW; Lems W; Van Der Heijde D; Boers M. DEVELOPMENT of PREDICTION MODELS for SENIOR PATIENTS with RHEUMATOID ARTHRITIS and COMORBIDITIES TREATED with CHRONIC LOW-DOSE GLUCOCORTICOIDS in the GLORIA TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1047', '10.1136/annrheumdis-2022-eular.770', '']\n",
      "['11083785', 'Dejaco C; Mueller T; Zamani O; Kurtz U; Egger S; Resch-Passini J; Totzauer A; Yazdani-Biuki B; Schwingenschloegl T; Peichl P; Kraus A; Naerr GW. A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study. Frontiers in medicine. (2022) 9  pp881943', '10.3389/fmed.2022.881943', '']\n",
      "['9257008', 'Smolen JS; Kay J; Doyle MK; Landew‚Äö√†√∂¬¨¬© R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU; GO-AFTER study investigators. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Lancet (London, England). (2009) 374 9685 pp210-221', '10.1016/s0140-6736(09)60506-7', '']\n",
      "['9260602', 'Hall S; Smolen J; Kay J; Doyle MK; Landewe R; Matteson EL; Zhou Y; Hsia EC; Rahman MU. Golimumab, a human TNF-alpha monoclonal antibody, in rheumatoid arthritis patients previously treated with anti-TNF-a agents (GO-AFTER study) [Abstract]. Internal medicine journal. (2009) 39 S2 ppA71', '10.1093/rheumatology/ker094', 'http://academic.oup.com/rheumatology/article-pdf/50/suppl_2/ii3/5061169/ker094.pdf']\n",
      "['9261216', 'Smolen J; Kay J; Landewe R; Matteson EL; Gaylis NB; Wollenhaupt JJ; Murphy FT. Golimumab use and sustained clinical response in patients with active rheumatoid arthritis previously treated with anti-tumor necrosis factor alpha agents. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1093/rheumatology/keu101.006', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i87/9578450/keu101.006.pdf']\n",
      "['9261307', 'Smolen JS; Kay J; Landewe R; Matteson EK; Gaylis N; Wollenhaupt J; Murphy FT; Han C; Gathany T; Xu S; Zhou Y; Hsia EC; Doyle MK. Final 5-year safety and efficacy results of a phase 3, randomized, placebo-controlled trial of golimumab in patients with active rheumatoid arthritis despite previous anti-tumor necrosis factor therapy. Rheumatology (United Kingdom). (2014) 53  ppi87-i88', '10.1093/rheumatology/keu101.006', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i87/9578450/keu101.006.pdf']\n",
      "['9261364', 'Smolen JS; Kay J; Landewe R; Matteson EL; Gaylis N; Wollenhaupt J; Murphy FT; Han C; Gathany T; Xu S; Zhou Y; Hsia EC; Doyle MK. Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite previous anti-tumor necrosis factor therapy: Final study results of the phase 3, randomized, placebo-controlled go-after trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.730', '']\n",
      "['9261470', 'Smolen JS; Kay J; Landewe R; Matteson EL; Gaylis NB; Wollenhaupt J; Murphy FT; Han C; Gathany TA; Xu S; Zhou Y; Hsia EC; Doyle MK. Final 5-year safety and efficacy results of a phase 3, randomized, placebo-controlled trial of golimumab in patients with active rheumatoid arthritis despite previous anti-tumor necrosis factor therapy. Arthritis and rheumatism. (2013) 65 var.pagings ppS991', '10.1093/rheumatology/keu101.006', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i87/9578450/keu101.006.pdf']\n",
      "['9261703', 'Smolen JS; Kay J; Matteson EL; Landew‚Äö√†√∂¬¨¬© R; Hsia EC; Xu S; Zhou Y; Doyle MK. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study. Annals of the rheumatic diseases. (2014) 73 10 pp1811-1818', '10.1136/annrheumdis-2013-203435', '']\n",
      "['9736817', 'Smolen J; Hsia E; Matteson E; Murphy F; Kay J; Wollenhaupt J; Doyle M; Gaylis N; Zamani O; Landewe R; Zhou Y. Golimumab in patients with active rheumatoid arthritis previously treated with anti-tumor necrosis factor alpha agents: sustained clinical response in go-after through week 100. International journal of rheumatic diseases. (2012) 15 SUPPL. 1 pp59', '10.1136/annrheumdis-2011-200956', '']\n",
      "['9737090', 'Smolen J S; Kay J; Doyle M K; Landewe R; Matteson E; Wollenhaupt J; Gaylis N; Murphy F T; Zhou Y; Visvanathan S; Hsia E C; Rahman M U. Golimumab in rheumatoid arthritis patients previously treated with anti-TNF alpha agents: 2 year results from go-after study. Rheumatology (united kingdom). (2011) 50 SUPPL. 2 pp', '10.1093/rheumatology/ker094', 'http://academic.oup.com/rheumatology/article-pdf/50/suppl_2/ii3/5061169/ker094.pdf']\n",
      "['9740002', 'EUCTR2005-001742-16-DE. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis and Previously Treated with Biologic Anti-TNFalfa Agent(s) - GO-AFTER. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001742-16-DE. (2006)   pp', '10.3410/f.718325312.793492806', '']\n",
      "['9740984', 'NCT00299546. A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s). https://clinicaltrials.gov/show/NCT00299546. (2006)   pp', '10.3899/jrheum.110570', '']\n",
      "['11085561', 'Kerschbaumer A; Rivai ZI; Smolen JS; Aletaha D. Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis. Annals of the rheumatic diseases. (2022) 81 10 pp1374-1378', '10.1136/annrheumdis-2021-221807', '']\n",
      "['11088611', 'Kerschbaumer A; Rivai ZI; Smolen JS; Aletaha D. Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis. . (2022)   pp', '10.1136/annrheumdis-2021-221807', '']\n",
      "['9256960', 'Smolen JS; Kay J; Landew‚àö¬© RB; Matteson EL; Gaylis N; Wollenhaupt J; Murphy FT; Zhou Y; Hsia EC; Doyle MK. Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160. Annals of the rheumatic diseases. (2012) 71 10 pp1671-1679', '10.1136/annrheumdis-2011-200956', '']\n",
      "['11085770', 'Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision. Annals of the rheumatic diseases. (2023) 82 1 pp74-80', '10.1136/ard-2022-223413', '']\n",
      "['9257290', 'Emery P; Fleischmann RM; Hsia EC; Xu S; Zhou Y; Baker D. Efficacy of golimumab plus methotrexate in methotrexate-na‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßve patients with severe active rheumatoid arthritis. Clinical rheumatology. (2014) 33 9 pp1239-1246', '10.1007/s10067-014-2731-y', 'http://link.springer.com/article/10.1007/s10067-014-2731-y/fulltext.html']\n",
      "['9258610', 'Baker JF; Conaghan PG; Emery P; Baker DG; Ostergaard M. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 6 pp1114-1119', '10.1136/annrheumdis-2014-206934', '']\n",
      "['9260511', 'Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 8 pp2272-2283', '10.1002/art.24638', '']\n",
      "['9260601', 'Nash P; Emery P; Fleischmann RM; Moreland LW; Hsia EC; Xu W. Golumumab, a new human anti-TNF-alpha monoclonal antibody, in methotrexate-naive active rheumatoid arthritis (GO-BEFORE study) [Abstract]. Internal medicine journal. (2009) 39 S2 ppA71', '10.1002/art.24638', '']\n",
      "['9260720', '‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢¬¨√üstergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients. Arthritis and rheumatism. (2011) 63 12 pp3712-3722', '10.1002/art.30592', '']\n",
      "['9260814', 'Baker JF; Baker DG; Toedter G; Shults J; Von Feldt JM; Leonard MB. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clinical and experimental rheumatology. (2012) 30 5 pp658-664', '10.1093/rheumatology/ker294', 'http://academic.oup.com/rheumatology/article-pdf/50/11/2100/5056161/ker294.pdf']\n",
      "['9261001', 'H‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ærslev-Petersen K; Hetland ML; Junker P; P‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ædenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzb‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Æll CG; J‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ærgensen A; Krintel SB; Raun J; Johansen JS; ‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßstergaard M; Stengaard-Pedersen K; OPERA Study-Group. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Annals of the rheumatic diseases. (2014) 73 4 pp654-661', '10.1136/annrheumdis-2012-202735', '']\n",
      "['9260968', 'Wagner C; Chen D; Fan H; Hsia EC; Mack M; Emery P; Fleischmann RM. Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naive rheumatoid arthritis patients treated with methotrexate or golimumab. Journal of rheumatology. (2013) 40 5 pp590-598', '10.3899/jrheum.120889', '']\n",
      "['9261162', 'Emery P; Fleischmann R; Han C; Van Der Heijde D; Conaghan P; Xu W; Hsia E. Predictors of radiographic progression in methotrexate-naive patients with rheumatoid arthritis based on one-year radiographic data from the go-before golimumab clinical trial. Rheumatology (United Kingdom). (2012) 51  ppiii68-iii69', '10.1002/art.34460', '']\n",
      "['9261181', \"Emery P; Baker D; Hsia E; Fleischmann R; Xu S; Xu W. Golimumab's efficacy in patients with very active disease in methotrexate-naive rheumatoid arthritis. International journal of rheumatic diseases. (2012) 15  pp58\", '10.1136/annrheumdis-2012-eular.485', '']\n",
      "['9261303', 'Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Han C; Gathany T; Zhou Y; Xu S; Hsia EC. Final 5-year safety and efficacy results of a phase 3, randomized, placebo-controlled trial of golimumab in methotrexate-naive patients with rheumatoid arthritis. Rheumatology (United Kingdom). (2014) 53  ppi93', '10.1093/rheumatology/keu101.018', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i93/9578477/keu101.018.pdf']\n",
      "['9261350', 'Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Han C; Gathany T; Zhou Y; Xu S; Hsia EC. Five-year safety and efficacy of golimumab in methotrexate-naive patients with rheumatoid arthritis: Final study results of the phase 3, randomized, placebo-controlled go-before trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1305', '']\n",
      "['9261390', 'Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill MA; Park W; Pons-Estel B; Han C; Gathany TA; Zhou Y; Xu S; Hsia EC. Final 5-year safety and efficacy results of a phase 3, randomized, placebo-controlled trial of golimumab in methotrexate-naive patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 var.pagings ppS188-S189', '10.1093/rheumatology/keu101.018', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i93/9578477/keu101.018.pdf']\n",
      "['9261534', 'Karpouzas GA; Emery P; Fleischmann R; Xu S; Hsia EC. DAS28(CRP) <3.2 achieved with or without a TNF inhibitor: Differences in radiographic, clinical, and biomarker outcomes between placebo + MTX and golimumab + MTX treatment among MTX-naive patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3794', '']\n",
      "['9261702', 'Baker JF; Ostergaard M; Emery P; Hsia EC; Lu J; Baker DG; Conaghan PG. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial. Annals of the rheumatic diseases. (2014) 73 11 pp1968-1974', '10.1136/annrheumdis-2013-203444', '']\n",
      "['9261867', 'Emery P; Fleischmann R; Xu S; Hsia EC. Treatment target status at 6 months and long-term outcomes at 5 years: analysis of methotrexate-naive patients with rheumatoid arthritis in the go-before trial. Annals of the rheumatic diseases. (2015) 74  pp711', '10.1136/annrheumdis-2015-eular.3647', '']\n",
      "['9737043', \"Emery P; Fleischmann R M; Hsia E C; Xu S; Xu W; Baker D G. Golimumab's efficacy in patients with very active disease in methotrexate-nave rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp\", '10.1007/s10067-014-2731-y', 'http://link.springer.com/article/10.1007/s10067-014-2731-y/fulltext.html']\n",
      "['9738863', 'Emery P; Fleischmann R M; Moreland L W; Hsia E C; Xu W; Rahman M U. Golimumab, a new human anti-TNF-alpha monoclonal antibody, in methotrexate-naive active rheumatoid arthritis (go-before study). Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1002/art.24638', '']\n",
      "['9740481', '. Golimumab and cardiovascular disease: carotid artery ultrasound evaluation and cardiovascular adverse events. Arthritis and rheumatism.. (2010) 62 SUPPL. 10 pp386', '10.1002/art.27551', '']\n",
      "['9740488', '. Golimumab and cardiovascular disease: carotid artery ultrasound evaluation and cardiovascular adverse events. Arthritis and rheumatism.. (2010) 62 SUPPL. 10 pp386', '10.1002/art.27551', '']\n",
      "['9740998', 'NCT00264537. A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive. https://clinicaltrials.gov/show/NCT00264537. (2005)   pp', '10.3410/f.718325312.793492806', '']\n",
      "['9742602', 'Emery P; Fleischmann R; Xu S; Hsia E C. Treatment target status at 6 months and long-term outcomes at 5 years: analysis of methotrexate-naive patients with rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1136/annrheumdis-2015-eular.3647', '']\n",
      "['9742856', 'EUCTR2004-003295-10-IT. A Multicenter, Randomized, Double-blind,  Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNF  945; Monoclonal Antibody, Administered Subcutaneously, in Methotrexatena ve Subjects with Active Rheumatoid Arthritis - CNTO148 T05. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003295-10-IT. (2006)   pp', '10.3410/f.718325312.793492806', '']\n",
      "['9260666', 'Emery P; Fleischmann R; van der Heijde D; Keystone EC; Genovese MC; Conaghan PG; Hsia EC; Xu W; Baratelle A; Beutler A; Rahman MU. The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy. Arthritis and rheumatism. (2011) 63 5 pp1200-1210', '10.1002/art.30263', '']\n",
      "['9261085', 'Strusberg I; Pons-Estel BA; Miranda P; Genovese M; Fleischmann RM; Puig A; Han C; Hsia E. Improvements in physical function, health related quality of life and work productivity in patients with rheumatoid arthritis treated with golimumab: Sub-analysis of latin america n patients enrolled in mulitcentre phase III clinical trials. Value in health. (2013) 16  7 ppA718', '10.1016/j.jval.2013.08.2230', '']\n",
      "['9261180', 'Emery P; Han C; Keystone E; Hsia E; Klares Kog L; Genovese M; Fleischmann R; Xu S. New, Provisional American College of Rheumatology and European League against rheumatism remission criteria: Results from 2 randomized, controlled golimumab trials in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2012) 15  pp59', '10.1136/annrheumdis-2012-eular.486', '']\n",
      "['9261716', 'Kirkham BW; Wasko MC; Hsia EC; Fleischmann RM; Genovese MC; Matteson EL; Liu H; Rahman MU. Effects of golimumab, an anti-tumour necrosis factor-≈í¬± human monoclonal antibody, on lipids and markers of inflammation. Annals of the rheumatic diseases. (2014) 73 1 pp161-169', '10.1136/annrheumdis-2012-202089', '']\n",
      "['9263331', 'Emery P; van der Heijde D; Ostergaard M; Conaghan PG; Genovese MC; Keystone EC; Fleischmann R; Hsia EC; Xu W; Xu S; Rahman MU. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2011) 70 12 pp2126-2130', '10.1136/ard.2011.154500', '']\n",
      "['9739063', 'Emery P; Van Der Heijde; D M; Ostergaard M; Conaghan P G; Genovese M C; Keystone E C; Fleischmann R M. Magnetic resonance imaging assessments of patients with RA and their association with clinical and radiographic outcomes. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1114', '10.1002/art.34367', '']\n",
      "['9742608', 'Han C; Keystone E C; Fleischmann R; Smolen J S; Matteson E L; Emery P; Genovese M C; Gathany T A; Hsia E C. Impact of golimumab on physical function and employability of patients with rheumatoid arthritis: 5-year data from 3 phase III clinical trials. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1090', '10.1136/annrheumdis-2014-eular.2535', '']\n",
      "['9262139', 'Kay J; Fleischmann R; Keystone E; Hsia EC; Hsu B; Zhou Y; Goldstein N; Braun J. Five-year safety data from 5 clinical trials of subcutaneous golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Journal of rheumatology. (2016) 43 12 pp2120-2130', '10.3899/jrheum.160420', '']\n",
      "['9736754', 'Hall S; Buchanan J; Fleischmann R; Genovese M; Kay J; Hsia E; Doyle M; Rahman M; Han C; Parasuraman S. Golimumab significantly improves self-reported productivity in patients with rheumatoid arthritis. Internal medicine journal. (2010) 40 SUPPL. 3 pp14', '10.1016/s1098-3015(10)66835-0', '']\n",
      "['9738833', 'Buchanan J; Emery P; Keystone E C; Smolen J; Doyle M K; Hsia E C; Rahman M U; Gathany T; Han C; Parasuraman S. Golimumab significantly reduces time lost from work for patients with rheumatoid arthritis: pooled results from three phase 3 studies. Value in health. (2009) 12 3 ppA69', '10.1016/s1098-3015(10)73405-7', '']\n",
      "['9738834', 'Buchanan J; Fleischmann R; Genovese M C; Kay J; Hsia E C; Doyle M K; Rahman M U; Han C; Parasuraman S. Golimumab, a human anti-TNF-alpha monoclonal antibody, significantly improves self-reported productivity in patients with rheumatoid arthritis: results from three phase 3 studies. Value in health. (2009) 12 3 ppA72', '10.1016/s1098-3015(10)73423-9', '']\n",
      "['9738864', 'Emery P; Genovese M C; Fleischmann R M; Matteson E L; Hsia E C; Xu S; Doyle M K. Efficacy of golimumab, a human anti-TNF antibody, by baseline CRP level in patients with rheumatoid arthritis: results from three phase 3, randomized, double-blind, placebo-controlled studies. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1696', '10.1002/art.24638', '']\n",
      "['9738865', 'Emery P; Genovese M C; Fleischmann R M; Matteson E L; Hsia E C; Xu S; Doyle M K; Rahman M U. Efficacy of Golimumab, a human anti-TNFalpha antibody, by baseline CRP level in patients with rheumatoid arthritis: results from three phase 3, randomized, double-blind, placebo-controlled studies. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1016/s1098-3015(10)73423-9', '']\n",
      "['9738945', 'Nash P; Buchanan J; Emery P; Keystone E C; Smolen J; Doyle M K; Hsia E C; Rahman M U; Gathany T; Han C; Parasuraman S. Golimumab significantly reduces time lost from work for patients with rheumatoid arthritis: pooled results from three phase 3 studies. Internal medicine journal. (2009) 39 SUPPL. 2 ppA70', '10.1016/s1098-3015(10)73405-7', '']\n",
      "['11087280', 'Weinstein C; Govoni M; Lin J; Meehan A; Qureshi Z. LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED from FIVE PHASE III CLINICAL TRIALS in PATIENTS with RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, and ANKYLOSING SPONDYLITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp777-778', '10.1136/annrheumdis-2022-eular.4385', '']\n",
      "['9260742', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Miyasaka N; Koike T; Kanazawa M; Oba T; Yoshinari T; Baker D; GO-FORTH Study Group. Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study. Annals of the rheumatic diseases. (2012) 71 6 pp817-824', '10.1136/ard.2011.200317', '']\n",
      "['9261125', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Ishii Y; Baker D; Miyasaka N; Koike T. Prevention of joint destruction in patients with high disease activity or high C-reactive protein. Arthritis and rheumatism. (2012) 64  ppS570-S571', '10.3109/14397595.2015.1086041', '']\n",
      "['9261347', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Murakami Y; Yoshinari T; Baker D; Miyasaka N; Koike T. Golimumab administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy: Long-term clinical, radiographic and safety results, including evaluation of remission using the new ACR/EULAR criteria. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1332', '']\n",
      "['9261414', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Kanazawa M; Murakami Y; Yoshinari T; Baker D; Miyasaka N; Koike T. 52-week results of clinical, radiographic and pharmacokinetic assessments: Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2634', '']\n",
      "['9261944', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Miyasaka N; Koike T; Baker D; Ishii Y; Yoshinari T; GO-FORTH study group. Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial. Modern rheumatology. (2016) 26 4 pp481-490', '10.3109/14397595.2015.1109762', '']\n",
      "['9738988', 'Takeuchi T; Ishii Y; Tanaka K; Ukyo Y; Sekine H. Analysis on predictors for long-term clinical efficacies of golimumab in patients with rheumatoid arthritis. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1102', '10.1007/s40744-023-00539-z', 'https://link.springer.com/article/10.1007/s40744-023-00539-z/fulltext.html']\n",
      "['9738994', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Oba T. Golimumab, a human anti-TNF monoclonal antibody administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy: 24-week results of clinical and radiographic assessments. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1815', '10.1136/annrheumdis-2012-eular.2634', '']\n",
      "['9740961', 'NCT00727987. A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00727987. (2008)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9256968', 'Hayashi M; Kobayakawa T; Takanashi T; Yamazaki H; Ishikawa H; Kanamono T. Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies. Clinical rheumatology. (2013) 32 7 pp961-967', '10.1007/s10067-013-2210-x', 'http://link.springer.com/article/10.1007/s10067-013-2210-x/fulltext.html']\n",
      "['9256832', 'Hu C; Xu Z; Zhang Y; Rahman MU; Davis HM; Zhou H. Population approach for exposure-response modeling of golimumab in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2011) 51 5 pp639-648', '10.1177/0091270010372520', '']\n",
      "['9258332', 'Keystone E; Genovese MC; Klareskog L; Hsia EC; Hall S; Miranda PC; Pazdur J; Bae SC; Palmer W; Xu S; Rahman MU. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study. Annals of the rheumatic diseases. (2010) 69 6 pp1129-1135', '10.1136/ard.2009.116319', '']\n",
      "['9260825', 'Genovese MC; Han C; Keystone EC; Hsia EC; Buchanan J; Gathany T; Murphy FT; Wu Z; Parasuraman S; Rahman MU. Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study. Journal of rheumatology. (2012) 39 6 pp1185-1191', '10.3899/jrheum.111195', '']\n",
      "['9260924', 'Keystone EC; Genovese MC; Hall S; Miranda PC; Bae SC; Palmer W; Wu Z; Xu S; Hsia EC. Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extension. Journal of rheumatology. (2013) 40 7 pp1097-1103', '10.3899/jrheum.120584', '']\n",
      "['9261302', 'Keystone E; Genovese MC; Hall S; Miranda PC; Bae S-C; Han C; Gathany T; Zhou Y; Xu S; Hsia EC. Final 5-year safety and efficacy results of a phase 3, randomized placebo-controlled trial of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate. Rheumatology (United Kingdom). (2014) 53  ppi99', '10.1093/rheumatology/keu101.031', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i99/9578503/keu101.031.pdf']\n",
      "['9261309', 'Han C; Kavanaugh A; Genovese MC; Deodhar A; Hsu B; Hsia E. Sustained improvement in health-related quality of life, work productivity, employability and reduced healthcare resource utilization of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with golimumab: 5-year results from three phase III studies. Rheumatology (United Kingdom). (2014) 53  ppi74', '10.1093/rheumatology/keu098.005', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i74/9578360/keu098.005.pdf']\n",
      "['9261317', 'Han C; Kavanaugh A; Genovese MC; Deodhar A; Hsu B; Hsia E. Sustained improvement in health related quality of life, work productivity, employability, and reduced healthcare resource utilization of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with golimumab:5yr results. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1041', '']\n",
      "['9261335', 'Keystone E; Genovese MC; Hall S; Miranda PC; Bae S-C; Han C; Gathany T; Zhou Y; Xu S; Hsia EC. Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: Final study results of the phase 3, randomized placebo-controlled go-forward trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2589', '']\n",
      "['9261394', 'Han C; Kavanaugh A; Genovese MC; Hsu B; Deodhar AA; Hsia EC. Sustained improvement in health-related quality of life, work productivity, employability, and reduced healthcare resource utilization of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with golimumab: 5-year results from 3 phase iii studies. Arthritis and rheumatism. (2013) 65  ppS137', '10.1093/rheumatology/keu098.005', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i74/9578360/keu098.005.pdf']\n",
      "['9261500', 'Keystone E; Genovese MC; Hall S; Miranda P; Bae S-C; Han C; Gathany TA; Zhou Y; Xu S; Hsia EC. Final 5-year safety and efficacy results of a phase 3, randomized placebo-controlled trial of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate. Arthritis and rheumatism. (2013) 65 var.pagings ppS597-S598', '10.1093/rheumatology/keu101.031', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i99/9578503/keu101.031.pdf']\n",
      "['9263304', 'Keystone EC; Genovese MC; Klareskog L; Hsia EC; Hall ST; Miranda PC; Pazdur J; Bae SC; Palmer W; Zrubek J; Wiekowski M; Visvanathan S; Wu Z; Rahman MU; GO-FORWARD Study. Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Annals of the rheumatic diseases. (2009) 68 6 pp789-796', '10.1136/ard.2008.099010', '']\n",
      "['9263350', 'Conaghan PG; Emery P; ‚àö√≤stergaard M; Keystone EC; Genovese MC; Hsia EC; Xu W; Rahman MU. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Annals of the rheumatic diseases. (2011) 70 11 pp1968-1974', '10.1136/ard.2010.146068', '']\n",
      "['9263518', 'Keystone EC; Genovese MC; Hall S; Bae SC; Han C; Gathany TA; Xu S; Zhou Y; Leu JH; Hsia EC. Safety and efficacy of subcutaneous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: Final 5-year results of the GO-FORWARD trial. Journal of rheumatology. (2016) 43  2 pp298-306', '10.3899/jrheum.150712', '']\n",
      "['9738204', 'EUCTR2004-003296-36-DE. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy - NA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003296-36-DE. (2005)   pp', '10.3410/f.718325312.793492806', '']\n",
      "['9738882', 'Genovese M C; Keystone E C; Hsia E C; Buchanan J; Klareskog L; Murphy F T; Wu Z; Parasuraman S; Rahman M U. Impact of golimumab on physical function, health-related quality of life, productivity and employment in rheumatoid arthritis patients: week 52 results from the GO-FORWARD study. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp88', '10.1136/ard.2009.116319', '']\n",
      "['9738966', 'Rubbert A; Keystone Ed; Genovese M; Klareskog L; Hsia E C; Zrubek J; Wu Z; Rahman M U. Golimumab administered subcutaneously every 4 weeks in active rheumatoid arthritis despite methotrexate: week 24 results of go-forward study. Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1136/ard.2009.116319', '']\n",
      "['9739080', 'Han C; Gathany T; Tandon N; Hsia E. Employability-adjusted-life-years in patients with rheumatoidarthritis treated with golimumab plus methotrexate ormethotrexate alone. Value in health. (2011) 14 3 ppA131-A132', '10.1016/j.jval.2011.02.732', '']\n",
      "['9741036', 'NCT00264550. An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00264550. (2005)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9742544', 'Genovese M C; Keystone E C; Hsia E C; Buchanan J; Klareskog L; Murphy F T; Wu Z. Impact of golimumab on physical function, health-related quality of life, productivity and employment in rheumatoid arthritis patients: week 52 results from GO-FORWARD. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1670', '10.1186/ar3188', 'https://link.springer.com/article/10.1186/ar3188/fulltext.html']\n",
      "['11083957', 'Tsai WC; Mu R; Suh CH; Furtner D; Lo KH; Zhou Y; Hsia EC. Improvements in patient-reported outcomes in rheumatoid arthritis patients treated with golimumab: sub-analysis of asian patients enrolled in phase-3 clinical trials. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp447-448', '10.1136/annrheumdis-2021-eular.205', '']\n",
      "['9258711', 'Westhovens R; Keystone E; Bingham CO; Hsia EC; Kim L; Zhou Y; Mendelsohn A; Weinblatt M. Long term safety of intravenous golimumab and comparison with subcutaneous golimumab in rheumatoid arthritis: results through 2 years. International journal of rheumatic diseases. (2015) 18  pp91', '10.1136/annrheumdis-2015-eular.3155', '']\n",
      "['11086353', 'Tsai W; Mu R; Suh C; Furtner D; Hung Lo K; Zhou Y; Hsia E. Improvements in patient-reported outcomes in RA patients treated with golimumab: sub-analysis of asian patients enrolled in phase III clinical trials. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp220-221', '10.1136/annrheumdis-2021-eular.205', '']\n",
      "['9257730', 'Tesser J; Kafka S; DeHoratius RJ; Xu S; Tang KL; Hsia EC; Turkiewicz A. Efficacy and safety of intravenous golimumab plus methotrexate in patients 65 years and younger and those greater than 65 years of age-a post-hoc analysis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp819-820', '10.1186/s13075-019-1968-x', 'http://link.springer.com/article/10.1186/s13075-019-1968-x/fulltext.html']\n",
      "['9257924', 'Westhovens R; Weinblatt ME; Han C; Gathany T; Kim L; Mack M; Lu J; Baker D; Mendelsohn AM; Bingham III CO. Fatigue is an independent variable predicting physical function and DAS-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: Results from phase 3, placebo controlled clinical trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.491', '']\n",
      "['9260820', 'Weinblatt ME; Bingham CO; Mendelsohn AM; Kim L; Mack M; Lu J; Baker D; Westhovens R. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Annals of the rheumatic diseases. (2013) 72 3 pp381-389', '10.1136/annrheumdis-2012-201411', '']\n",
      "['9261017', 'Bingham CO; Weinblatt M; Han C; Gathany TA; Kim L; Lo KH; Baker D; Mendelsohn A; Westhovens R. The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial. Journal of rheumatology. (2014) 41 6 pp1067-1076', '10.3899/jrheum.130864', '']\n",
      "['9261141', 'Weinblatt M; Bingham III CO; Mendelsohn A; Noonan L; Sheng S; Kim L; Hung K; Lu J; Baker D; Westhovens R. Intravenous golimumab inhibits radiographic progression and maintains clinical efficacy and safety in patients with active rheumatoid arthritis despite methotrexate therapy: 1-year results of a phase 3 trial. Arthritis and rheumatism. (2012) 64  ppS353-S354', '10.1136/annrheumdis-2013-eular.746', '']\n",
      "['9261377', 'Bingham III CO; Westhovens R; Mendelsohn AM; Kim L; Hung Lo K; Weinblatt ME. Sustained and consistent clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: Results through 1-year of a phase 3, randomized, multicenter, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2013) 65  ppS374', '10.1136/annrheumdis-2012-eular.2626', '']\n",
      "['9261416', 'Weinblatt ME; Bingham III CO; Mendelsohn AM; Kim L; Mack M; Lu J; Baker D; Westhovens R. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with results observed by 2 weeks: Results of the phase 3, multicenter, double-blind, placebo-controlled trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2626', '']\n",
      "['9261454', 'Weinblatt ME; Bingham III CO; Mendelsohn AM; Kim L; Lo KH; Noonan L; Baker D; Westhovens R. Intravenous golimumab inhibits radiographic progression and maintains clinical efficacy and safety in patients with active rheumatoid arthritis despite methotrexate therapy: 2-year results of a phase 3 trial of intravenous golimumab. Arthritis and rheumatism. (2013) 65  ppS1183-S1184', '10.1136/annrheumdis-2014-eular.2049', '']\n",
      "['9261532', 'Weinblatt ME; Bingham III CO; Mendelsohn AM; Kim L; Lo KH; Noonan L; Baker D; Westhovens R. Intravenous golimumab inhibits radiographic progression and maintains clinical efficacy and safety in patients with active rheumatoid arthritis despite methotrexate therapy: 2-year results of a phase 3 trial of intravenous golimumab. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2049', '']\n",
      "['9261544', 'Westhovens R; Weinblatt ME; Han C; Kim L; Mack M; Lu J; Baker D; Mendelsohn A; Bingham III CO. Health-related quality of life of patients with rheumatoid arthritis achieving DAS28 remission, improvement in physical function and no radiographic progression after treatment with intravenous golimumab. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3819', '']\n",
      "['9261692', 'Weinblatt ME; Westhovens R; Mendelsohn AM; Kim L; Lo KH; Sheng S; Noonan L; Lu J; Xu Z; Leu J; Baker D; Bingham CO; GO-FURTHER investigators. Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial. Annals of the rheumatic diseases. (2014) 73 12 pp2152-2159', '10.1136/annrheumdis-2013-203742', '']\n",
      "['9261846', 'Han C; Bingham CO; Westhovens R; Weinblatt ME; Kim L; Baker D; Peterson S; Hsia E. Clinical meaningfulness of radiographic joint damage on physical function, employability and work productivity in patients with rheumatoid arthritis: results from the intravenous golimumab study, GO-FURTHER. Annals of the rheumatic diseases. (2015) 74  pp1031', '10.1136/annrheumdis-2015-eular.3170', '']\n",
      "['9261901', 'Han C; Bingham CO; Westhovens R; Weinblatt ME; Kim L; Baker D; Peterson S; Hsia E. A comparison of EQ5D index from the UK, US, and japan preference weights model, and mapping algorithm from clinical outcomes in patients with rheumatoid arthritis: results of from simponi aria study. Annals of the rheumatic diseases. (2015) 74  pp225-226', '10.1136/annrheumdis-2015-eular.3147', '']\n",
      "['9262728', 'Husni ME; Schwartzman S; Deodhar A; Kafka S; Chakravarty SD; Hsia EC; Harrison DD; Leu JH; Zhou Y; Lo KH; Kavanaugh A. Integrated safety data analysis across phase 3 clinical studies for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp608-609', '10.1136/annrheumdis-2018-eular.5425', '']\n",
      "['9736690', 'Bingham C O; Weinblatt M E; Mendelsohn A; Kim L; Mack M; Lu J; Baker D; Westhovens R. Predictors of significant disease activity score-28 (using c-reactive protein) remission achieved with intravenous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results of the phase iii, multicentre, double-blind, placebo-controlled trial. Rheumatology (united kingdom). (2013) 52 SUPPL. 1 pp', '10.1136/annrheumdis-2012-201411', '']\n",
      "['9737079', 'EUCTR2008-006064-11-LT. An Efficacy and Safety Study of intravenous Golimumab in patients with Active Rheumatoid Arthritis (RA) despite treatment with methotrexate, non steroidal pain medications and/or corticosteroids. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006064-11-LT. (2009)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9737321', 'Westhovens R; Weinblatt M; Han C; Gathany T; Kim L; Mack M; Lu J; Baker D; Mendelsohn A; Bingham Iii C O. Intravenously administered golimumab significantly improves health related quality of life and work productivity in patients with rheumatoid arthritis: results of a phase III, placebo controlled trial. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS776-S777', '10.1016/j.jval.2012.03.237', '']\n",
      "['9737646', 'Kavanaugh A; Deodhar A; Schwartzman S; Kafka S; Chakravarty S; Hsia E; Zazzetti F; Leu J; Lo KH; Elaine Husni M. Integrated safety analysis across phase 3 clinical studies including the controlled and uncontrolled periods for intravenous golimumab in rheumatoidarthritis, psoriatic arthritis, and ankylosing spondylitis. Journal of clinical rheumatology. (2019) 25 3 Supplement ppS66-S67', '10.1136/annrheumdis-2019-eular.179', '']\n",
      "['9738091', 'Han C; Bingham Iii C O; Westhovens R; Weinblatt M; Kim L; Baker D; Peterson S; Hsia E C. A comparison of EQ5D index from the UK, US, and Japan preference weights model, and mapping algorithm from clinical outcomes in patients with rheumatoid arthritis: results from golimumab intravenous study. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1136/annrheumdis-2015-eular.3147', '']\n",
      "['9738141', 'Westhovens R; Weinblatt M E; Han C; Gathany T; Kim L; Mack M; Lu J; Baker D; Mendelsohn A; Bingham C. Fatigue is an independent variable predicting physical function and DAS-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: results from a phase 3, placebo controlled clinical trial. Value in health. (2012) 15 4 ppA42', '10.1016/j.jval.2012.03.238', '']\n",
      "['9738151', 'Kavanaugh A; Deodhar AA; Schwartzman S; Kafka S; Chakravarty SD; Hsia EC; Harrison DD; Leu J; Zhou Y; Lo KH; Husni ME. Integrated safety analysis across phase 3 clinical studies including the controlled and uncontrolled periods for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1674-1676', '10.1136/annrheumdis-2019-eular.179', '']\n",
      "['9738776', 'Husni ME; Schwartzman S; Deodhar A; Kafka S; Chakravarty SD; Hsia EC; Harrison DD; Leu JH; Zhou Y; Lo KH; Kavanaugh A. Integrated safety data analysis across phase 3 clinical studies for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp608-609', '10.1136/annrheumdis-2018-eular.5425', '']\n",
      "['9738827', 'Bingham Iii C O; Weinblatt M; Mendelsohn A; Kim L; Mack M; Lu J; Baker D; Westhovens R. Predictors of significant disease activity score-28 (using C-reactive protein) remission achieved with intravenous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results of the phase 3, multicenter, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS558', '10.1136/annrheumdis-2012-eular.2626', '']\n",
      "['9739014', 'Westhovens R; Han C; Weinblatt M E; Kim L; Hsia E C; Parenti D; Kafka S; Bingham C O. Hemoglobin is a better predictor for radiographic progression than DAS28 in patients with moderate to severe rheumatoid arthritis-analysis from intravenously administered golimumab go-further study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp237-238', '10.1136/annrheumdis-2016-eular.2015', '']\n",
      "['9739017', 'Westhovens R; Weinblatt M; Han C; Gathany T; Kim L; Mack M; Lu J; Baker D; Mendelsohn A; Bingham C O. Fatigue is an independent variable predicting physical function and disease activity score-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: results from phase 3, placebo controlled clinical trial. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS554', '10.1136/annrheumdis-2012-eular.491', '']\n",
      "['9739018', 'Westhovens R; Weinblatt M E; Han C; Gathany T; Kim L; Mack M; Lu J; Baker D; Mendelsohn A; Bingham C. Intravenously administered golimumab significantly improves health related quality of life and work productivity in patients with rheumatoid arthritis: results of a phase III, placebocontrolled trial. Value in health. (2012) 15 4 ppA42', '10.1016/j.jval.2012.03.237', '']\n",
      "['9739389', 'Han C; Weinblatt ME; Westhovens R; Kim L; Hsia EC; Parenti D; Kafka S; Bingham CO. Intravenous golimumab therapy improves hemoglobin, resulting in reduced anemia, improved physical function and fatigue in patients with moderate to severe rheumatoid arthritis: results from go-further phase Iii clinical trial. Annals of the rheumatic diseases. (2016) 75  pp226-', '10.1136/annrheumdis-2016-eular.2012', '']\n",
      "['9740500', '. Hemoglobin is a better predictor for radiographic progression than DAS28 in patients with moderate to severe rheumatoid arthritis-analysis from intravenously administered golimumab go-further study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp237-238', '10.1136/annrheumdis-2016-eular.2015', '']\n",
      "['9740718', 'Deodhar A; Husni ME; Schwartzman S; Kafka S; Chakravarty SD; Hsia EC; Harrison DD; Leu JH; Zhou Y; Hung Lo K; Kavanaugh A. Integrated safety analysis across phase 3 clinical studies including the controlled and uncontrolled periods for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1653-1654', '10.1136/annrheumdis-2019-eular.179', '']\n",
      "['9741078', 'NCT00973479. An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00973479. (2009)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['11084129', 'Husni ME; Deodhar A; Schwartzman S; Chakravarty SD; Hsia EC; Leu JH; Zhou Y; Lo KH; Kavanaugh A. Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. . (2022) 24 1 pp', '10.1186/s13075-022-02753-6', 'https://link.springer.com/article/10.1186/s13075-022-02753-6/fulltext.html']\n",
      "['9258532', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Miyasaka N; Koike T; Ukyo Y; Ishii Y; Yoshinari T; Baker D. Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: final results of the GO-MONO trial through week 120. Modern rheumatology. (2018) 28 5 pp770-779', '10.1080/14397595.2017.1404731', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1404731']\n",
      "['9260991', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Miyasaka N; Koike T; Kanazawa M; Oba T; Yoshinari T; Baker D; GO-MONO study group. Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks. Annals of the rheumatic diseases. (2013) 72 9 pp1488-1495', '10.1136/annrheumdis-2012-201796', '']\n",
      "['9261126', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Kanazawa M; Murakami Y; Yoshinari T; Baker D; Miyasaka N; Koike T. Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite disease modifying antirheumatic drug therapy: Week 104 results of clinical, radiographic and safety assessments. Arthritis and rheumatism. (2012) 64  ppS570', '10.1136/annrheumdis-2012-eular.2634', '']\n",
      "['9261215', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Kanazawa M. Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite DMARD therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.2633', '']\n",
      "['9261348', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Murakami Y; Yoshinari T; Baker D; Miyasaka N; Koike T. Golimumab monotherapy in patients with active rheumatoid arthritis despite DMARD therapy: Week 104 results of clinical, radiographic and safety assessments including evaluation of remission using the new ACR/EULAR criteria. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1324', '']\n",
      "['9261415', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Kanazawa M; Murakami Y; Yoshinari T; Baker D; Miyasaka N; Koike T. Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite dmard therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2633', '']\n",
      "['9736561', 'Takeuchi T; Harigai M; Tanaka Y; Yamanaka H; Ishiguro N; Yamamoto K; Oba T. Golimumab, a human anti-TNF monoclonal antibody administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite DMARD therapy: 24-week results of clinical and radiographic assessments. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1814', '10.1136/annrheumdis-2012-eular.2633', '']\n",
      "['9738699', 'Takeuchi Tsutomu; Harigai Masayoshi; Tanaka Yoshiya; Yamanaka Hisashi; Ishiguro Naoki; Yamamoto Kazuhiko; Miyasaka Nobuyuki; Koike Takao; Ukyo Yoshifumi; Ishii Yutaka; Yoshinari Toru; Baker Daniel; GO-MONO study group. Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: final results of the GO-MONO trial through week 120. Modern rheumatology. (2018) 28 5 pp770-779', '10.1080/14397595.2017.1404731', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1404731']\n",
      "['9263510', 'Combe B; Dasgupta B; Louw I; Pal S; Wollenhaupt J; Zerbini CA; Beaulieu AD; Schulze-Koops H; Durez P; Yao R; Vastesaeger N; Weng HH; GO-MORE Investigators. Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study. Annals of the rheumatic diseases. (2014) 73 8 pp1477-1486', '10.1136/annrheumdis-2013-203229', '']\n",
      "['9263625', 'Durez P; Pavelka K; Lazaro MA; Garcia-Kutzbach A; Moots RJ; Amital H; Govoni M; Vastesaeger N. Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. Clinical rheumatology. (2018) 37 5 pp1417-1420', '10.1007/s10067-018-4074-6', 'http://link.springer.com/article/10.1007/s10067-018-4074-6/fulltext.html']\n",
      "['9738099', 'EUCTR2009-011137-26-NL. An open-label study assessing the addition of subcutaneous golimumab (GLM) to conventional disease-modifying antirheumatic drug (DMARD) therapy in biologic-na‚àö√òve subjects with rheumatoid arthritis (Part 1), followed by a randomized study assessing the value of combined intravenous and subcutaneous GLM administration aimed at inducing and maintaining remission (Part 2). - GO-MORE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011137-26-NL. (2009)   pp', '10.1016/j.jval.2023.09.916', '']\n",
      "['9741076', 'NCT00975130. Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2). https://clinicaltrials.gov/show/NCT00975130. (2009)   pp', '10.1002/art.38478', '']\n",
      "['9743082', 'Kruger Klaus; Burmester Gerd Rudiger; Wassenberg Siegfried; Thomas Matthias H. Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: post Hoc Analysis of a Noninterventional Study in Germany. Rheumatology and therapy. (2020) 7 2 pp371-382', '10.1007/s40744-020-00204-9', 'https://link.springer.com/article/10.1007/s40744-020-00204-9/fulltext.html']\n",
      "['9257098', 'Huffstutter JE; Kafka S; Brent LH; Matucci-Cerinic M; Tang KL; Chevrier M; Sprabery T; DeHoratius RJ. Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study. Current medical research and opinion. (2017) 33 4 pp657-666', '10.1080/03007995.2016.1277195', '']\n",
      "['9262580', 'Dehoratius RJ; Brent LH; Curtis JR; Ellis LA; Tang KL. Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept. Patient. (2018) 11 3 pp361-369', '10.1007/s40271-018-0297-5', 'http://link.springer.com/article/10.1007/s40271-018-0297-5/fulltext.html']\n",
      "['9738580', 'Dehoratius Raphael J; Brent Lawrence H; Curtis Jeffrey R; Ellis Lorie A; Tang Kezhen L. Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept. Patient. (2018) 11 3 pp361-369', '10.1007/s40271-018-0297-5', 'http://link.springer.com/article/10.1007/s40271-018-0297-5/fulltext.html']\n",
      "['9739349', 'NCT01004432. Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA). Https://clinicaltrials.gov/show/nct01004432. (2009)   pp', '10.2165/00151234-200905920-00030', 'http://link.springer.com/article/10.2165/00151234-200905920-00030/fulltext.html']\n",
      "['9740267', 'EUCTR2009-010582-23-SE. A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept (ENBREL¬¨¬®‚àö√ú) or Adalimumab (HUMIRA¬¨¬®‚àö√ú). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-010582-23-SE. (2009)   pp', '10.1007/s40271-018-0297-5', 'http://link.springer.com/article/10.1007/s40271-018-0297-5/fulltext.html']\n",
      "['9262841', 'GOEBEL KM; Janzen R; Joseph K; B‚àö‚àÇrngen U. Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis. European journal of clinical pharmacology. (1976) 09 5-6 pp405-410', '10.1007/bf00606556', 'http://link.springer.com/article/10.1007/BF00606556/fulltext.html']\n",
      "['9742547', 'Greenwald M W; Fidelus-Gort R; Levy R; Liang J; Vaddi K; Williams W V; Newton R. A randomized dose-ranging, placebo-controlled study of INCB028050, a selective JAK1 and JAK2 inhibitor in subjects with active rheumatoid arthritis. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp2172', '10.3410/f.13827957.15267059', '']\n",
      "['9259368', 'Pasero G; Priolo F; Marubini E; Fantini F; Ferraccioli G; Magaro M; Marcolongo R; Oriente P; Pipitone V; Portioli I; Tirri G; Trotta F; Della Casa-Alberighi O. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis and rheumatism. (1996) 39 6 pp1006-1015', '10.1002/art.1780390618', '']\n",
      "['9259408', 'Ferraccioli GF; Della Casa-Alberighi O; Marubini E; Priolo F; Mathieu A; Fantini F; Cutolo M; Pasero G. Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide). British journal of rheumatology. (1996) 35 Suppl 2  pp8-13', '10.1093/rheumatology/35.suppl_2.8', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_2/8/5043314/35-suppl_2-8.pdf']\n",
      "['9262440', 'Groppa L; Russu E; Chislari L; Bujor O. The efficacy of the triple combination therapy with methotrexate, leflunomide and methylprednisolone in rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1199', '10.1136/annrheumdis-2017-eular.6317', '']\n",
      "['9262993', 'Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. British journal of rheumatology. (1997) 36 10 pp1082-1088', '10.1093/rheumatology/36.10.1082', 'http://academic.oup.com/rheumatology/article-pdf/36/10/1082/18104838/361082.pdf']\n",
      "['9259250', 'Hannonen P; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hakola M; Oka M. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. Arthritis and rheumatism. (1993) 36 11 pp1501-1509', '10.4324/9780203187838.bmatt3', '']\n",
      "['9258495', 'Haagsma CJ; van Riel PL; van de Putte LB. Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions. British journal of rheumatology. (1995) 34 Suppl 2 suppl 2 pp104-108', '10.1093/rheumatology/xxxiv.suppl_4.104', 'http://academic.oup.com/rheumatology/article-pdf/XXXIV/suppl_4/104/5067391/XXXIV-suppl_4-104.pdf']\n",
      "['9259340', \"Haagsma CJ; van Riel PL; de Rooij DJ; Vree TB; Russel FJ; van't Hof MA; van de Putte LB. Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. British journal of rheumatology. (1994) 33 11 pp1049-1055\", '10.1093/rheumatology/33.11.1049', 'http://academic.oup.com/rheumatology/article-pdf/33/11/1049/5030180/33-11-1049.pdf']\n",
      "['9257883', 'van Gestel AM; Haagsma CJ; van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis and rheumatism. (1998) 41 10 pp1845-1850', '10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k', '']\n",
      "['9259520', \"Haagsma CJ; Blom HJ; van Riel PL; van't Hof MA; Giesendorf BA; van Oppenraaij-Emmerzaal D; van de Putte LB. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1999) 58 2 pp79-84\", '10.1136/ard.58.2.79', '']\n",
      "['11088086', 'Hetland Merete Lund; Haavardsholm Espen A; Rudin Anna; Nordstrom Dan; Nurmohamed Michael; Gudbjornsson Bjorn; Lampa Jon; Horslev-Petersen Kim; Uhlig Till; Grondal Gerdur; Ostergaard Mikkel; Heiberg Marte S; Twisk Jos; Lend Kristina; Krabbe Simon; Hyldstrup Lise Hejl; Lindqvist Joakim; Hultgard Ekwall Anna-Karin; Gron Kathrine Lederballe; Kapetanovic Meliha; Faustini Francesca; Tuompo Riitta; Lorenzen Tove; Cagnotto Giovanni; Baecklund Eva; Hendricks Oliver; Vedder Daisy; Sokka-Isler Tuulikki; Husmark Tomas; Ljosa Maud-Kristine Aga; Brodin Eli; Ellingsen Torkell; Soderbergh Annika; Rizk Milad; Olsson Asa Reckner; Larsson Per; Uhrenholt Line; Just Soren Andreas; Stevens David John; Laurberg Trine Bay; Bakland Gunnstein; Olsen Inge C; van Vollenhoven Ronald; NORD-STAR study group. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial. BMJ (Clinical research ed.). (2020) 371  ppm4328', '10.1136/bmj.m4328', '']\n",
      "['9256746', 'Hamdy H; McKendry RJ; Mierins E; Liver JA. Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial. Arthritis and rheumatism. (1987) 30 4 pp361-368', '10.1002/art.1780300401', '']\n",
      "['9258041', 'Hamilton J; McInnes IB; Thomson EA; Porter D; Hunter JA; Madhok R; Capell HA. Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area. Annals of the rheumatic diseases. (2001) 60 6 pp566-572', '10.1136/ard.60.6.566', '']\n",
      "['9260191', 'Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skj‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ædt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; P‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ædenphant J; Hansen G; Lindegaard H; de Carvalho A; ‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßstergaard M; H‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬Ærslev-Petersen K; CIMESTRA Study Group. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis and rheumatism. (2006) 54 5 pp1401-1409', '10.1002/art.21796', '']\n",
      "['9263109', 'Hanyu T; Arai K; Ishikawa H. Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis. Japanese Journal of Rheumatology. (1999) 9 1 pp31-44', '10.1007/bf03041257', 'http://link.springer.com/article/10.1007/BF03041257/fulltext.html']\n",
      "['9263178', 'Hara M; Abe T; Sugawara S; Mizushima Y; Hoshi K; Irimajiri S; Hashimoto H; Yoshino S; Matsui N; Nobunaga M; Nakano S. Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study. Modern rheumatology / the Japan Rheumatism Association. (2007) 17 1 pp1-9', '10.3109/s10165-006-0542-y', '']\n",
      "['11083986', \"Hartman L; Rasch LA; Turk SA; Ter Wee MM; Kerstens PJSM; van der Laken CJ; Nurmohamed MT; van Schaardenburg D; van Tuyl LHD; Voskuyl AE; Boers M; Lems WF. Favorable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial. Rheumatology (Oxford, England). (2022)   pp\", '10.1093/rheumatology/keac582', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac582/47033273/keac582.pdf']\n",
      "['9736761', 'Kameda H; Wada K; Takahashi Y; Hagino O; van Hoogstraten H; Graham N; Tanaka Y. Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: a Japan phase 3 trial (HARUKA). Modern rheumatology. (2019)   pp', '10.1080/14397595.2019.1639939', '']\n",
      "['9743090', 'Kameda Hideto; Wada Kazuteru; Takahashi Yoshinori; Hagino Owen; van Hoogstraten Hubert; Graham Neil; Tanaka Yoshiya. Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: a Japan phase 3 trial (HARUKA). Modern rheumatology. (2020) 30 2 pp239-248', '10.1080/14397595.2019.1639939', '']\n",
      "['11088273', 'Kameda Hideto; Wada Kazuteru; Takahashi Yoshinori; Hagino Owen; van Hoogstraten Hubert; Graham Neil; Tanaka Yoshiya. Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: a Japan phase 3 trial (HARUKA). Modern rheumatology. (2020) 30 2 pp239-248', '10.1080/14397595.2019.1639939', '']\n",
      "['9257190', 'Kumar S; Oakley S. Early treatment of rheumatoid arthritis and effects on work and quality of life. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp118-119', '10.1111/1756-185x.70164', '']\n",
      "['9257701', 'Oakley S; Major G; Mathers D; Van Der Kallen J; Collins M; Toh M; Ratnarajah S; De Malmanche T; Esmaili N. A randomised controlled trial evaluating the effect of adalimumab upon biomarkers of cardiovascular risk in ACPA-positive rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3306-3308', '10.1101/2025.01.26.25321158', '']\n",
      "['9261257', 'Oakley S; Esmaili N; Major G; Mathers D; Ratnarajah S; Van Der Kallen J; Collins M; Toh M; Glass J. A randomised controlled trial evaluating the effect of humira upon endothelial function in ACPA positive rheumatoid arthritis-an interim analysis. Arthritis and Rheumatology. (2014) 66  ppS211', '10.1101/2025.01.26.25321158', '']\n",
      "['9737769', 'Kumar S; Oakley S. Early treatment of rheumatoid arthritis and effects on work and quality of life-late follow-up of patients from the hunter humira and endothelial function in early rheumatoid arthritis trial (hunter heart). Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp13', '10.1093/rheumatology/key066', 'http://academic.oup.com/rheumatology/article-pdf/57/7/1194/25068667/key066.pdf']\n",
      "['9738800', 'Kumar S; Oakley S. Early treatment of rheumatoid arthritis and effects on work and quality of life. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp118-119', '10.1111/1756-185x.70164', '']\n",
      "['9740327', 'ACTRN12611000972921. The Hunter Humira and Endothelial Function in Early Rheumatoid Arthritis Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12611000972921. (2011)   pp', '10.1186/isrctn90051516', '']\n",
      "['11085420', 'Hua Li; Du Hongwei; Ying Mingliang; Wu Honghua; Fan Jia; Shi Xiaowei. Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: a single-center, randomized, double-blind clinical trial. Medicine. (2020) 99 27 ppe20824', '10.1097/md.0000000000020824', '']\n",
      "['9737350', 'Anonymous. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study. American journal of medicine. (1995) 98 2 pp156-168', '10.1016/s0002-9343(99)80399-4', '']\n",
      "['9261273', 'Bae SC; Lee SR; Ahn Y. Quality of life assessments in Korean patients with rheumatoid arthritis (Ra): An analysis from the phase iii trial to evaluate equivalence of the etanercept biosimilar hd203 and enbrel in combination with methotrexate (MTX) in patients with RA; the Hera study. Value in health. (2014) 17  7 ppA374', '10.1016/j.jval.2014.08.2578', '']\n",
      "['9262219', 'Bae SC; Kim J; Choe JY; Park W; Lee SH; Park YB; Shim SC; Lee SS; Sung YK; Choi CB; Lee SR; Park H; Ahn Y; HERA Study Investigators. A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study. Annals of the rheumatic diseases. (2017) 76 1 pp65-71', '10.1136/annrheumdis-2015-207613', '']\n",
      "['9736615', 'Bae S C; Kim J; Choe J Y; Park W; Lee S H; Park Y B; Shim S C; Lee S S; Sung Y K; Choi C B; Lee S R; Park H; Ahn Y. A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study. Annals of the rheumatic diseases. (2016)   pp', '10.1136/annrheumdis-2015-207613', '']\n",
      "['9737456', 'NCT01270997. Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients. https://clinicaltrials.gov/show/NCT01270997. (2011)   pp', '10.1136/annrheumdis-2014-eular.3558', '']\n",
      "['9261026', 'Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Iwai K; Sakamaki Y; van der Heijde D; Miyasaka N; Koike T. Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 4 pp552-560', '10.3109/14397595.2013.843764', '']\n",
      "['9261403', 'Yamanaka H; Yamamoto K; Takeuchi T; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Iwai K; Sakamaki Y; Miyasaka N; Koike T. Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients without methotrexate co-administration: Results from the hikari study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.469', '']\n",
      "['9263456', 'Tanaka Y; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Shoji T; Miyasaka N; Koike T. Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 5 pp725-733', '10.3109/14397595.2013.865822', '']\n",
      "['9737709', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Wada Y; Shoji T; Miyasaka N; Koike T. Immunogenicity of certolizumab pegol without concomitant methotrexate and clinical response in rheumatoid arthritis patients: post-hoc analysis of the HIKARI study. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.1328', '']\n",
      "['9740938', 'NCT00791921. Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT00791921. (2008)   pp', '10.26226/morressier.56e174d9d462b8028d88ace2', '']\n",
      "['9260815', 'Jaimes-Hern‚Äö√†√∂¬¨‚àûndez J; Mel‚Äö√†√∂¬¨¬©ndez-Mercado CI; Mendoza-Fuentes A; Aranda-Pereira P; Casta‚Äö√†√∂¬¨¬±eda-Hern‚Äö√†√∂¬¨‚àûndez G. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial. Reumatologi‚àö√â‚àö√ña clinica. (2012) 8 5 pp243-249', '10.1016/j.reumae.2012.07.005', '']\n",
      "['9261938', 'Detert J; Bastian H; Listing J; Weiss A; Wassenberg S; Liebhaber A; Rockwitz K; Alten R; Kruger K; Rau R; Simon C; Gremmelsbacher E; Braun T; Marsmann B; Hohne-Zimmer V; Egerer K; Buttgereit F; Burmester G-R. Induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis (ra)-an investigator initiated randomized controlled trial. Annals of the rheumatic disease. (2013) 71 no pagination pp', '10.1136/annrheumdis-2012-eular.1828', '']\n",
      "['9263475', 'Detert J; Bastian H; Listing J; Weiss A; Wassenberg S; Liebhaber A; Rockwitz K. Efficacy of an induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritisan investigator initiated randomized controlled trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.1828', '']\n",
      "['9740323', 'EUCTR2006-003146-41-DE. A CONTROLLED RANDOMIZED DOUBLE-BLIND MULTICENTER STUDY COMPARING TWO THERAPY STRATEGIES IN DMARD-NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS OVER 48 WEEKS: INDUCTION THERAPY WITH ADALIMUMAB AND METHOTREXATE OVER 24 WEEKS FOLLOWED BY METHOTREXATE MONOTHERAPY UP TO WEEK 48 VS. METHOTREXATE MONOTHERAPY - HIT HARD. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003146-41-DE. (2006)   pp', '10.1186/isrctn36745608', '']\n",
      "['9262721', 'Wong P; Wu D; Mak QW; Cheng IT; Li TK; Li EK; Tam LS. Role of ultrasound in assessing disease activity in patients with early rheumatoid arthritis treated by two treat-to-target strategies. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp563', '10.1136/annrheumdis-2018-eular.6897', '']\n",
      "['9260525', 'Jones G; Sebba A; Gu J; Lowenstein MB; Calvo A; Gomez-Reino JJ; Siri DA; Tomsic M; Alecock E; Woodworth T; Genovese MC. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the rheumatic diseases. (2010) 69 1 pp88-96', '10.1136/ard.2008.105197', '']\n",
      "['9261011', 'Yamanaka H; Ishiguro N; Takeuchi T; Miyasaka N; Mukai M; Matsubara T; Uchida S; Akama H; Kupper H; Arora V; Tanaka Y. Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial. Rheumatology (Oxford, England). (2014) 53 5 pp904-913', '10.1093/rheumatology/ket465', 'http://academic.oup.com/rheumatology/article-pdf/53/5/904/6897526/ket465.pdf']\n",
      "['9739304', 'Tanaka Yoshiya; Yamanaka Hisashi; Ishiguro Naoki; Miyasaka Nobuyuki; Kawana Katsuyoshi; Hiramatsu Katsutoshi; Takeuchi Tsutomu. Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study. RMD open. (2016) 2 1 ppe000189', '10.1136/rmdopen-2015-000189', '']\n",
      "['9740117', 'JapicCTI-090751. A study of Adalimumab in Japanese subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-090751. (2009)   pp', '10.1186/isrctn68762628', '']\n",
      "['9742992', 'NCT00870467. A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00870467. (2009)   pp', '10.1097/01.tpm.0000418562.99372.00', '']\n",
      "['9258371', 'Hu Y; Tu S; Liu P. A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. Journal of Tongji Medical University / Tong ji yi ke da xue xue bao. (2001) 21 1 pp72-74', '10.1007/bf02888043', 'https://link.springer.com/article/10.1007/BF02888043/fulltext.html']\n",
      "['9260420', 'Hu D; Bao C; Chen S; Gu J; Li Z; Sun L; Han X; Ni L. A comparison study of a recombinant tumor necrosis factor receptor: fc fusion protein (rhTNFR: fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatology international. (2009) 29 3 pp297-303', '10.1007/s00296-008-0681-x', 'http://link.springer.com/article/10.1007/s00296-008-0681-x/fulltext.html']\n",
      "['9262119', 'Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH. Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study. Zhonghua nei ke za zhi [chinese journal of internal medicine]. (2009) 48 11 pp916-921', '10.1002/art.24643', '']\n",
      "['9260801', 'Huang Z; Yang B; Shi Y; Cai B; Li Y; Feng W; Fu Y; Luo L; Wang L. Anti-TNF-≈í¬± therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis. Cellular immunology. (2012) 279 1 pp25-29', '10.1016/j.cellimm.2012.09.001', '']\n",
      "['9260988', 'Huang J; Xie B; Li Q; Xie X; Zhu S; Wang M; Peng W; Gu J. Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis. European journal of pharmacology. (2013) 698 1-3 pp429-434', '10.1016/j.ejphar.2012.10.030', '']\n",
      "['9742659', 'Huffstutter JE; Kafka S; Brent LH; Matucci-Cerinic M; Tang KL; Chevrier M; Sprabery T; DeHoratius RJ. Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study. Current medical research and opinion. (2017) 33 4 pp657-666', '10.1080/03007995.2016.1277195', '']\n",
      "['9737629', 'ACTRN12615000557538. HUNTER HEART-RA-2 (HHRA-2) STUDY  A Randomised Controlled Trial Evaluating the Effects of Humira Upon Cardiovascular Risk as Measured by Endothelial Function in patients with Rheumatoid Arthritis who Test Positive for Anti-CCP Antibodies as well as those who Test Negative for Anti-CCP Antibodies. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12615000557538. (2015)   pp', '10.1093/rheumatology/kev088.052', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i69/5179924/kev088.052.pdf']\n",
      "['9738326', 'Huyen TT. Co-morbidities in patients with rheumatoid arthritis treated with Tocilizumab. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp203', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9257969', 'Bissell L-A; Hensor E; Mackie SL; Burska A; Nam JL; Kozera L; Keen HI; Villeneuve E; Eberl H; Donica H; Conaghan PG; Andrews J; Emery P; Morgan AW. Improvement in insulin resistance greater with the use of infliximab following intensive treatment of early rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS1182', '10.1093/rheumatology/kew306', 'http://academic.oup.com/rheumatology/article-pdf/55/12/2181/8324890/kew306.pdf']\n",
      "['9260750', 'Kavanaugh A; Fleischmann RM; Emery P; Kupper H; Redden L; Guerette B; Santra S; Smolen JS. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Annals of the rheumatic diseases. (2013) 72 1 pp64-71', '10.1136/annrheumdis-2011-201247', '']\n",
      "['9261230', 'Nam JL; Villeneuve E; Conaghan PG; Hensor E; Keen HI; Amarasena R; Gough AK. A preliminary report of remission induction with two therapeutic strategies with infliximab or high dose intravenous steroids for the treatment of rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.1839', '']\n",
      "['9262001', 'Dumitru RB; Hensor EM; Nam J; Wakefield RJ; Emery P; Buch MH. Association between power doppler ultrasound (PDUS) and disease activity in early rheumatoid arthritis (RA) patients: results from the idea study. Annals of the rheumatic diseases. (2015) 74  pp888', '10.1136/annrheumdis-2015-eular.5869', '']\n",
      "['9262184', 'Bissell LA; Hensor EM; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Andrews J; Emery P; Morgan AW. Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study. Rheumatology (oxford, england). (2016) 55 12 pp2181-2190', '10.1093/rheumatology/kew306', 'http://academic.oup.com/rheumatology/article-pdf/55/12/2181/8324890/kew306.pdf']\n",
      "['9736674', 'Bissell L; Hensor EMA; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Andrews J; Emery P; Morgan AW. Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis--results from the IDEA study. Rheumatology. (2016) 55 12 pp2181-2190', '10.1093/rheumatology/kew306', 'http://academic.oup.com/rheumatology/article-pdf/55/12/2181/8324890/kew306.pdf']\n",
      "['9737620', 'ISRCTN48638981. A multicentre randomised double-blind placebo-controlled study comparing two regimens of combination induction therapy in early disease-modifying anti-rheumatic drug na‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßve rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN48638981. (2007)   pp', '10.1186/isrctn48638981', '']\n",
      "['9740322', 'EUCTR2005-005013-37-GB. A multi-centre randomised double dummy double blind study comparing two regimens of combination induction therapy in early DMARD naive Rheumatoid Arthritis: the IDEA study (Infliximab as Induction Therapy in Early Rheumatoid Arthritis) - IDEA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-005013-37-GB. (2006)   pp', '10.1186/isrctn48638981', '']\n",
      "['9741280', 'Mortimer I; Bissell LA; Hensor EMA; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Emery P; Morgan AW; Andrews J. Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology (Oxford, England). (2019) 58 9 pp1684-1686', '10.1093/rheumatology/kez114', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kez114/28531699/kez114.pdf']\n",
      "['9738450', 'Ikonomidis I; Pavlidis G; Katsimbri P; Andreadou I; Triantafyllidi H; Tsoumani M; Varoudi M; Thymis I; Triantafyllou C; Kostelli G; Frogoudaki A; Vrettou AR; Boumpas D; Alexopoulos D; Iliodromitis E. Effects of interleukin 6 inhibitor tocilizumab on endothelial glycocalyx, vascular and myocardial function compared to prednisolone. European heart journal. (2019) 40 Supplement 1 pp2665', '10.1093/eurheartj/ehz745.0837', 'http://academic.oup.com/eurheartj/article-pdf/40/Supplement_1/ehz745.0837/30197984/ehz745.0837.pdf']\n",
      "['9742307', 'Ikonomidis I; Pavlidis G; Katsimbri P; Andreadou I; Triantafyllidi H; Varoudi M; Vlastos D; Kostelli G; Benas D; Lekakis J; Boumpas D; Iliodromitis E. Improvement of myocardial and vascular function by inhibition of Interleukin 1 and 6 in patients with rheumatoid arthritis: a comparative study. European heart journal cardiovascular imaging. (2019) Conference: 22nd Annual Meeting of the European Association of Echocardiography, EUROECHO 2018. Italy. 20 Supplement 1 ppi917', '10.1093/eurheartj/ehy566.p5426', 'http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy566.P5426/25578935/ehy566.p5426.pdf']\n",
      "['9738118', 'Ikonomidis Ignatios; Pavlidis George; Katsimbri Pelagia; Andreadou Ioanna; Triantafyllidi Helen; Tsoumani Maria; Varoudi Maria; Vlastos Dimitrios; Makavos George; Kostelli Gavriella; Betaenas Dimitrios; Lekakis John; Parissis John; Boumpas Dimitrios; Alexopoulos Dimitrios; Iliodromitis Efstathios. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.. Clinical research in cardiology : official journal of the German Cardiac Society. (2019 Oct) 108 10 pp1093-1101', '10.1007/s00392-019-01443-9', 'https://link.springer.com/article/10.1007/s00392-019-01443-9/fulltext.html']\n",
      "['9740584', 'Ikonomidis I; Pavlidis G; Katsimbri P; Andreadou I; Triantafyllidi H; Varoudi M; Kostelli G; Benas D; Triantafyllis C; Efentakis P; Vrettou AR; Frogoudaki A; Lekakis J; Boumpas D; Iliodromitis E. Effects of inhibition of interleukin 1 and 6 activity on myocardial and vascular function compared with prednisolone in patients with rheumatoid arthritis. European heart journal. (2018) 39 Supplement 1 pp1120-1121', '10.1093/eurheartj/ehy566.p5426', 'http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy566.P5426/25578935/ehy566.p5426.pdf']\n",
      "['11088119', 'Ikonomidis Ignatios; Pavlidis George; Katsimbri Pelagia; Lambadiari Vaia; Parissis John; Andreadou Ioanna; Tsoumani Maria; Boumpas Dimitrios; Kouretas Dimitrios; Iliodromitis Efstathios. Tocilizumab improves oxidative stress and endothelial glycocalyx: a mechanism that may explain the effects of biological treatment on COVID-19. Food and chemical toxicology. (2020) 145  pp111694', '10.1016/j.fct.2020.111694', '']\n",
      "['9259287', 'Landew‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬© RB; Goei Th‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö√∫ HS; van Rijthoven AW; Breedveld FC; Dijkmans BA. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis and rheumatism. (1994) 37 5 pp637-643', '10.1002/art.1780370506', '']\n",
      "['9257379', 'Tak PP; Rigby WF; Rubbert-Roth A; Peterfy CG; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw TM; IMAGE Investigators. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Annals of the rheumatic diseases. (2011) 70 1 pp39-46', '10.1136/ard.2010.137703', '']\n",
      "['9737094', 'Tak P P; Rigby W; Rubbert-Roth A; Peterfy C; Van Vollenhoven; R F; Stohl W; Healy E; Hessey E; Reynard M; Shaw T. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Annals of the rheumatic diseases. (2011)   pp', '10.1136/annrheumdis-2011-200170', '']\n",
      "['9737186', 'EUCTR2005-002395-15-IT. A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab in combination with methotrexate (MTX) compared to MTX alone, in methotrexate-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002395-15-IT. (2006)   pp', '10.3410/f.14174.471676', '']\n",
      "['9738986', 'Tak P P; Jones G; Rigby W; Rubbert-Roth A; Peterfy C; Van Vollenhoven; R F; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw T. Rituximab (RTX) in combination with methotrexate (MTX) significantly inhibits joint damage and improves clinical outcomes in patients with early active rheumatoid arthritis (ra) who are naive to mtx: a randomised active comparator placebo-controlled trial (image). Internal medicine journal. (2010) 40 SUPPL. 3 pp16', '10.1136/ard.2010.137703', '']\n",
      "['9738987', 'Tak P P; Rigby W; Rubbert A; Peterfy C; Van Vollenhoven; R F; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw T. Rituximab plus methotrexate (MTX) inhibits joint damage and improves clinical outcomes in patients with early, active Rheumatoid Arthritis (RA) who are naive to MTX. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1136/ard.2010.137703', '']\n",
      "['9741090', 'NCT00299104. A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00299104. (2006)   pp', '10.2165/00128413-200615490-00037', '']\n",
      "['9738733', 'Moller-Bisgaard S; Horslev-Pedersen K; Ejbjerg B; Hetland M; Ornbjerg L; Glinatsi D; Moller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen J; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh N; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen H; Ostergaard M. The value of adding mri to a clinical treatto-target strategy in rheumatoid arthritis patients in clinical remission: clinical and radiographic outcomes from the imagine-RA randomised controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp58-59', '10.1136/annrheumdis-2018-eular.1204', '']\n",
      "['9742684', 'Moller-Bisgaard S; Horslev-Petersen K; Ejbjerg BJ; Hetland ML; Glinatsi D; Ornbjerg L; Moller JM; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski MR; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen A; Balding L; Jurik AG; Thomsen HS; Ostergaard M. The value of adding MRI to a clinical treat-to-target strategy in rheumatoid arthritis patients in clinical remission: clinical and radiographic outcomes from the imagine-RA randomized controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1596-1598', '10.1136/annrheumdis-2018-eular.1204', '']\n",
      "['11083756', 'Moller-Bisgaard S; Horslev-Petersen K; Glinatsi D; Ejbjerg B; Hetland ML; Mollenbach Moller J; Christensen R; Nielsen SM; Boesen M; Stengaard-Pedersen K; Madsen O; Jensen B; Villadsen JA; Hauge EM; Hendricks O; Lindegaard HM; Steen Krogh N; Jurik AG; Thomsen H; Ostergaard M. LONG TERM EFFICACY of A 2-YEAR MRI TREAT-TO-TARGET STRATEGY on DISEASE ACTIVITY, MRI INFLAMMATION and PHYSICAL FUNCTION in RHEUMATOID ARTHRITIS PATIENTS in CLINICAL REMISSION: FIVE YEAR FOLLOW-UP of the IMAGINE RA-COHORT. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp539-540', '10.1136/annrheumdis-2022-eular.3095', '']\n",
      "['11084416', 'Moller-Bisgaard S; Georgiadis S; Horslev-Petersen K; Ejbjerg B; Hetland ML; Ornbjerg L; Glinatsi D; Mollenbach Moller J; Boesen M; Stengaard-Pedersen K; Rintek Madsen O; Jensen B; Villadsen J; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard HM; Bliddal H; Steen Krogh N; Ellingsen T; Nielsen A; Balding L; Jurik AG; Thomsen H; Ostergaard M. Predictors of achieving stringent remission in patients with established rheumatoid arthritis in clinical remission following a treat-to-target strategy. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1405', '10.1136/annrheumdis-2020-eular.2512', '']\n",
      "['11084416', 'Moller-Bisgaard S; Georgiadis S; Horslev-Petersen K; Ejbjerg B; Hetland ML; Ornbjerg L; Glinatsi D; Mollenbach Moller J; Boesen M; Stengaard-Pedersen K; Rintek Madsen O; Jensen B; Villadsen J; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard HM; Bliddal H; Steen Krogh N; Ellingsen T; Nielsen A; Balding L; Jurik AG; Thomsen H; Ostergaard M. Predictors of achieving stringent remission in patients with established rheumatoid arthritis in clinical remission following a treat-to-target strategy. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1405', '10.1136/annrheumdis-2020-eular.2512', '']\n",
      "['9740971', 'NCT00425932. Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00425932. (2007)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9257147', 'Akdemir G; Heimans L; Bergstra SA; Goekoop RJ; van Oosterhout M; van Groenendael JHLM; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF. Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study. Annals of the rheumatic diseases. (2018) 77 1 pp111-118', '10.1136/annrheumdis-2017-211375', '']\n",
      "['9258379', 'Bergstra SA; Olivas Vergara OM; Akdemir G; Steup-Beekman GM; Ronday HK; Harbers JB; Landewe RBM; Allaart CF. The effect of treatment adjustments aimed at DAS remission on physical functioning in undifferentiated and rheumatoid arthritis patients in low disease activity. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1265-1266', '10.1002/art.39977', '']\n",
      "['9261039', 'Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Annals of the rheumatic diseases. (2014) 73 7 pp1356-1361', '10.1136/annrheumdis-2013-203243', '']\n",
      "['9261149', 'Wevers-De Boer KVC; Heimans L; Visser K; Schouffoer AA; Molenaar THE; Harbers JB; Bijkerk C; Speyer I; De Buck M; De Sonnaville PB; Grillet BA; Huizinga T; Allaart CF. Remission after one year in ACPA positive and ACPA negative patients with early arthritis. Arthritis and rheumatism. (2012) 64  ppS172', '10.1136/annrheumdis-2013-eular.1221', '']\n",
      "['9261421', 'Heimans L; Wevers-de Boer KVC; Visser K; Ronday HK; Oosterhout M; Harbers JB; Peeters AJ; Westedt ML; De Buck PD; De Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF. Remission after one year follow up of the improved-study, a randomized clinical trial aiming at remission in patients with early rheumatoid and undifferentiated arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2518', '']\n",
      "['9262005', 'Akdemir G; Heimans L; Wevers-De Boer K; Verheul M; Schouffoer A; Van Oosterhout M; Harbers J; Bijkerk C; Steup-Beekman G; Lard L; Huizinga T; Trouw L; Allaart C. Predictive factors of radiological progression after two years of remission steered treatment in early arthritis patients. Annals of the rheumatic diseases. (2015) 74  pp674', '10.1136/annrheumdis-2015-eular.2309', '']\n",
      "['9262448', 'Bergstra SA; Olivas O; Akdemir G; Riyazi N; Collee G; Van Groenendael JH; Landewe RB; Allaart CF. Further treatment intensifications in undifferentiated and rheumatoid arthritis patients already in low disease activity have limited benefit towards physical functioning. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp793', '10.1136/annrheumdis-2017-eular.1606', '']\n",
      "['9262527', 'Akdemir G; Heimans L; Goekoop RJ; Van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman GM; Lard LR; De Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF. Clinical and radiological outcomes of 5 years remission steered treatment in early rheumatoid and undifferentiated arthritis patients. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp4291-4292', '10.1136/annrheumdis-2016-eular.2724', '']\n",
      "['9262533', 'Akdemir G; Heimans L; Goekoop RJ; Van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman GM; Lard L; De Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF. Five year outcomes of remission steered treatment including drug tapering strategies in early arthritis patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp122-123', '10.1136/annrheumdis-2016-eular.2724', '']\n",
      "['9742814', 'EUCTR2006-006186-16-NL. IMPROVED: induction therapy with Methotrexate and Prednisone in Rheumatoid Or Very Early arthritic Disease  A randomized clinical trial in patients with recent-onset arthritis to compare the efficacy of DMARD combination therapy including prednisone with combination therapy including adalimumab, a TNF-blocking agent  - IMPROVED. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006186-16-NL. (2007)   pp', '10.1186/isrctn11916566', '']\n",
      "['9743074', 'Bergstra Sytske Anne; Van Der Pol Joy A; Riyazi Naghmeh; Goekoop-Ruiterman Yvonne P M; Kerstens Pit J S M; Lems Willem; Huizinga Tom W J; Allaart Cornelia F. Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?. RMD open. (2020) 6 1 pp', '10.1136/rmdopen-2020-001242', '']\n",
      "['11084951', 'Bergstra Sytske Anne; Van Der Pol Joy A; Riyazi Naghmeh; Goekoop-Ruiterman Yvonne P M; Kerstens Pit J S M; Lems Willem; Huizinga Tom W J; Allaart Cornelia F. Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?. RMD open. (2020) 6 1 pp', '10.1136/rmdopen-2020-001242', '']\n",
      "['11085209', 'Kelly C; Matteson E; Aringer M; Burmester GR; Mueller H; Moros L; Rohr K; Kolb M. Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (ra-ild) in the inbuild trial. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp69', '10.1136/annrheumdis-2021-eular.969', '']\n",
      "['11084372', 'Hider S; Machin A; Bucknall M; Jinks C; Healey E; Finney A; Cooke K; Wathall S; Mallen C; Chew-Graham C. Undertaking an integrated nurse led review (INCLUDE) for patients with inflammatory conditions: does it change management of morbidities?. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii71-ii72', '10.1093/rheumatology/keaa111.141', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.141/33102532/keaa111.141.pdf']\n",
      "['11084372', 'Hider S; Machin A; Bucknall M; Jinks C; Healey E; Finney A; Cooke K; Wathall S; Mallen C; Chew-Graham C. Undertaking an integrated nurse led review (INCLUDE) for patients with inflammatory conditions: does it change management of morbidities?. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii71-ii72', '10.1093/rheumatology/keaa111.141', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.141/33102532/keaa111.141.pdf']\n",
      "['9740774', 'Sugano E; Tanaka E; Inoue E; Abe M; Kawano M; Saka K; Sugitani N; Shimizu Y; Ochiai M; Yamaguchi R; Sugimoto N; Ikari K; Nakajima A; Taniguchi A; Yamanaka H. Discrepancy between the efficacy of biological dmards based on randomized controlled trials and the efficacy of biological dmards in real-world settings in patients with rheumatoid arthritis: a study using the IORRA cohort. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1045-', '10.1136/annrheumdis-2019-eular.6589', '']\n",
      "['9257643', 'Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A. The potent inhibitory effect of beta-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on anti-cyclic citrullinated peptide antibodies, rheumatoid factor and antidsDNA antibodies in patients with rheumatoid arthritis. Current drug discovery technologies. (2017) 14 3 pp206-214', '10.2174/1570163814666170321113059', '']\n",
      "['11085699', 'Asoudeh F; Djafarian K; Akhalghi M; Mahmoudi M; Jamshidi AR; Farhadi E; Esmaillzadeh A. The effect of probiotic cheese consumption on inflammatory and anti-inflammatory markers, disease severity, and symptoms in patients with rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled trial. Trials. (2022) 23 1 pp180', '10.1186/s13063-022-06113-2', 'https://link.springer.com/article/10.1186/s13063-022-06113-2/fulltext.html']\n",
      "['9256751', 'Ishaq M; Muhammad JS; Hameed K; Mirza AI. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Modern rheumatology / the Japan Rheumatism Association. (2011) 21 4 pp375-380', '10.3109/s10165-010-0405-4', '']\n",
      "['9259779', 'Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis. Bangladesh Medical Research Council bulletin. (2000) 26 1 pp1-7', '10.3329/bmrcb.v46i1.47463', 'https://www.banglajol.info/index.php/BMRCB/article/download/47463/34541']\n",
      "['11085889', 'Hider Samantha L; Bucknall Milica; Jinks Clare; Cooke Kelly; Cooke Kendra; Desilva Erandie Ediriweera; Finney Andrew G; Healey Emma L; Herron Daniel; Machin Annabelle R; Mallen Christian D; Wathall Simon; Chew-Graham Carolyn A. A pilot study of a nurse-led integrated care review (the INCLUDE review) for people with inflammatory rheumatological conditions in primary care: feasibility study findings. Pilot and feasibility studies. (2021) 7 1 pp9', '10.1186/s40814-020-00750-7', 'http://link.springer.com/article/10.1186/s40814-020-00750-7/fulltext.html']\n",
      "['9742748', 'ISRCTN75505683. Remission induction study in early Rheumatoid Arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN75505683. (2010)   pp', '10.1186/isrctn75505683', '']\n",
      "['9261426', 'Matsubara T; Inoue H; Iwahashi M; Yamazaki A; Takeuchi T. A multi-center, double-dummy, double-blind study of subcutaneous (SC) abatacept (ABA) compared with intraveneous (IV) ABA in japanese rheumatoid arthritis patients with inadequate response to methotrexate. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2090', '']\n",
      "['9261634', 'Amano K; Matsubara T; Tanaka T; Inoue H; Iwahashi M; Kanamono T; Nakano T; Uchimura S; Izumihara T; Yamazaki A; Karyekar CS; Takeuchi T. Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders. Modern Rheumatology. (2015) 25  5 pp665-671', '10.3109/14397595.2015.1012786', '']\n",
      "['9261660', 'Iwahashi M; Inoue H; Matsubara T; Tanaka T; Amano K; Kanamono T; Nakano T; Uchimura S; Izumihara T; Yamazaki A; Karyekar CS; Takeuchi T. Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 6 pp885-891', '10.3109/14397595.2014.881954', '']\n",
      "['9261665', 'Tanaka Y; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Shoji T; Miyasaka N; Koike T. Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study. Modern rheumatology. (2014) 24 5 pp734-743', '10.3109/14397595.2014.881709', '']\n",
      "['9261672', 'Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Sakamaki Y; van der Heijde D; Miyasaka N; Koike T. Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 5 pp715-724', '10.3109/14397595.2013.864224', '']\n",
      "['9740939', 'NCT00791999. Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT00791999. (2008)   pp', '10.26226/morressier.56e174d9d462b8028d88ace2', '']\n",
      "['9261549', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Kobayashi M; Shoji T; Togo O; Miyasaka N; Koike T. Better clinical responses seen early with the loading dose of certolizumab pegol are maintained until one year. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1447', '']\n",
      "['9261471', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Kobayashi M; Shoji T; Miyasaka N; Koike T. Post-HOC analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS989', '10.3109/14397595.2015.1109182', '']\n",
      "['9261655', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Miyasaka N; Koike T. Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies. Modern rheumatology / the Japan Rheumatism Association. (2015) 25 1 pp11-20', '10.3109/14397595.2014.904475', '']\n",
      "['9261942', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Kobayashi M; Shoji T; Togo O; Miyasaka N; Koike T. Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in japanese patients with active rheumatoid arthritis. Modern rheumatology. (2016) 26 4 pp473-480', '10.3109/14397595.2015.1109182', '']\n",
      "['9739142', 'Takeuchi T; Yamamoto K; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Shoji T; Miyasaka N; Koike T. Clinical response at 12 weeks predicts long-term remission and the extent of radiographic progression in japanese patients with rheumatoid arthritis treated with certolizumab pegol with and without methotrexate coadministration. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS563-S564', '10.3109/14397595.2014.904475', '']\n",
      "['9739145', 'Tanaka Y; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Eguchi K; Watanabe A; Origasa H; Okamoto T; Wada Y; Shoji T; Miyasaka N; Koike T. Comprehensive disease remission achieved by certolizumab pegol treatment, and factors associated with certolizumab pegol comprehensive disease remission, in rheumatoid arthritis patients with predominantly high disease activity. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS990', '10.1136/annrheumdis-2013-eular.2616', '']\n",
      "['9258057', 'Kremer J; Genovese MC; Keystone E; Taylor P; Zuckerman SH; Schlichting DE; Nantz E; Beattie SD; Macias WL. Increases in serum cholesterol with baricitinib treatment are associated with favourable changes in apolipoprotein content and with improvement in DAS28-CRP in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  ppA51', '10.1136/annrheumdis-2015-207259.116', '']\n",
      "['9258061', 'Kremer J; Genovese MC; Keystone E; Taylor P; Zuckerman SH; Schlichting DE; Beattie SD; Macias WL. Baricitinib effects on serum cholesterol and circulating lipid particles in a phase 2B study in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  ppA83', '10.1136/annrheumdis-2015-207259.190', '']\n",
      "['9258343', 'Keystone EC; Taylor PC; Drescher E; Schlichting DE; Beattie SD; Berclaz PY; Lee CH; Fidelus-Gort RK; Luchi ME; Rooney TP; Macias WL; Genovese MC. Safety and efficacy of baricitinib at 24‚Äö√Ñ√ñweeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate. Annals of the rheumatic diseases. (2015) 74 2 pp333-340', '10.1136/annrheumdis-2014-206478', '']\n",
      "['9261094', 'Taylor P; Genovese M; Keystone EC; Drescher E; Berclaz P-Y; Lee C; Fidelus-Gort R; Schlichting D; Beattie S; Luchi M; Macias W. 24-Week results of a blinded phase IIB dose-ranging study of baricitinib, an oral JAK1/JAK2 inhibitor, in combination with traditional dmards in patients with rheumatoid arthritis. Rheumatology (United Kingdom). (2013) 52  ppi44-i45', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9261109', 'Peterfy CG; Emery P; Genovese MC; Keystone E; Taylor P; Berclaz P-Y; DiCarlo JC; Lee CH; Schlichting DE; Beattie SD; Luchi ME; Macias W. Magnetic resonance imaging substudy in a phase 2b dose-ranging study of baricitinib, an oral janus kinase 1/janus kinase 2 inhibitor, in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS1050-S1051', '10.3899/jrheum.171469', '']\n",
      "['9261110', 'Genovese MC; Keystone E; Taylor P; Drescher E; Berclaz P-Y; Lee CH; Schlichting DE; Beattie SD; Fidelus-Gort RK; Luchi ME; Macias W. 24-Week results of a blinded phase 2b dose-ranging study of baricitinib, an oral janus kinase 1/januse kinase 2 inhibitor, in combination with traditional disease modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS1049-S1050', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9261145', 'Smolen JS; Schlichting DE; Sterling KL; Keystone E; Taylor P; Genovese MC; Johnson L; Rizo Rodriguez JC; Lee CH; Gaich CL. 12-and 24-week patient-reported outcomes from a phase 2B dose-ranging study of baricitinib, an oral janus kinase 1/janus kinase 2 inhibitor, in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS214', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9261284', 'Chalabi Y; Peterfy C; Genovese M; Emery P; Taylor P; Schlichting D; Beattie S; Macias W; Keystone E. Magnetic resonance imaging substudy in a phase 2B dose-ranging study of baricitinib, an oral janus kinase 1/janus kinase 2 inhibitor, in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Journal of rheumatology. (2014) 41  7 pp1505', '10.3899/jrheum.171469', '']\n",
      "['9261285', 'Baker M; Chalabi Y; Genovese M; Taylor P; Schlichting D; Beattie S; Macias W; Keystone E. Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: 52 week safety and efficacy in an open-label, long-term extension study. Journal of rheumatology. (2014) 41  7 pp1504', '10.1136/annrheumdis-2013-205124.71', '']\n",
      "['9261286', 'Chalabi Y; Smolen J; Taylor P; Genovese M; Lee C; Schlichting D; Macias W; Keystone E. 12-and 24-week patient-reported outcomes from a phase 2B dose-ranging study of baricitinib, an oral janus kinase 1/ janus kinase 2 inhibitor, in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Journal of rheumatology. (2014) 41  7 pp1497-1498', '10.1136/annrheumdis-2013-205124.71', '']\n",
      "['9261360', 'Kremer J; Genovese MC; Keystone E; Taylor P; Zuckerman SH; Schlichting DE; Beattie SD; Macias WL. Baricitinib effects on serum cholesterol and circulating lipid particles in a phase 2B study in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.754', '']\n",
      "['9261370', 'Taylor P; Genovese MC; Keystone E; Schlichting D; Beattie S; Macias W. Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: Safety and efficacy in open-label, long-term extension study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.252', '']\n",
      "['9261431', 'Keystone E; Taylor P; Genovese M; Schlichting D; Beattie S; Gaich C; Fidelus Gort R; Luchi M; Macias WL. 12-week results of a phase 2B dose-ranging study of LY3009104 (INCB028050), an oral JAK1/JAK2 inhibitor, in combination with traditional dmards in patients with rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9261445', 'Taylor P; Genovese M; Keystone E; Schlichting D; Beattie S; Macias W. Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: Safety and efficacy in an open-label, long-term extension study1. Annals of the Rheumatic Disease. (2014) 73  pp', '10.1136/annrheumdis-2013-205124.71', '']\n",
      "['9261495', 'Keystone E; Genovese MC; Taylor P; Zhu B; Beattie SD; De Bono S; Rooney T; Schlichting DE; Macias W. Lack of early clinical response to treatment with baricitinib predicts low probability of achieving long term DAS28-ESR low disease activity or remission in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS607', '10.1136/annrheumdis-2013-eular.252', '']\n",
      "['9261515', 'Genovese M; Keystone E; Taylor P; Drescher E; Berclaz PY; Lee CH; Schlichting DE; Beattie SD; Fidelus-Gort RK; Luchi ME; Macias W. Results of a blinded Phase2b dose-ranging study of baricitinib in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2013) 16  pp62', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9262011', 'Taylor P; Genovese MC; Keystone E; Weinblatt M; Rancourt J; Nantz E; Schlichting D; Zuckerman S; Macias W. Effects of baricitinib on multibiomarker disease activity scores and their components in a phase 2b study in moderate-to-severe rheumatoid arthritis patients. Annals of the rheumatic diseases. (2015) 74  pp257-258', '10.1136/annrheumdis-2015-eular.1628', '']\n",
      "['9262169', 'Kremer J; Genovese M; Keystone E; Taylor P; Zuckerman S; Schlichting D; Nantz E; Beattie S; MacIas W; Suters A. Increases in serum cholesterol with baricitinib treatment are associated with favorable changes in apolipoprotein content and with improvement in DAS28-CRP in patients with rheumatoid arthritis. Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp28-29', '10.1136/annrheumdis-2015-207259.116', '']\n",
      "['9262349', 'Keystone EC; Genovese MC; Schlichting DE; De La Torre I; Beattie SD; Rooney TP; Taylor PC. Safety and efficacy of baricitinib through 128 weeks in an open-label, longterm extension study in patients with rheumatoid arthritis. Journal of rheumatology. (2018) 45 1 pp14-21', '10.3899/jrheum.161161', '']\n",
      "['9263604', 'Keystone E; Taylor P; Genovese MC; Schlichting DE; De La Torre I; Beattie SD; Rooney T; Pum G. Safety and efficacy of baricitinib through 128 weeks in an open-label, long-term extension study in patients with rheumatoid arthritis. Journal fur mineralstoffwechsel. (2015) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie und Rehabilitation 2015. Austria. 22 4 pp115-116', '10.3899/jrheum.161161', '']\n",
      "['9263607', 'Kremer J; Genovese MC; Keystone E; Taylor P; Zuckerman SH; Schlichting DE; Nantz E; Beattie SD; Macias WL; Pum G. Increases in serum cholesterol with baricitinib treatment are associated with favorable changes in apolipoprotein content and with improvement in DAS28-CRP in patients with rheumatoid arthritis. Journal fur mineralstoffwechsel. (2015) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie und Rehabilitation 2015. Austria. 22 4 pp113-114', '10.1136/annrheumdis-2015-207259.116', '']\n",
      "['9738912', 'Keystone E; Taylor P; Genovese M; Schlichting D; De La Torre; Beattie S; Rooney T. Safety and efficacy of baricitinib through 128 weeks in an open-label, long-term extension study in patients with rheumatoid arthritis. Journal of rheumatology. (2015) 42 7 pp1292', '10.3899/jrheum.161161', '']\n",
      "['9738995', 'Taylor P; Genovese M; Keystone E; Schlichting D; Beattie S; Macias W; Lundmark J. Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study. Scandinavian journal of rheumatology. (2014) 43 SUPPL. 127 pp59', '10.1136/annrheumdis-2013-205124.71', '']\n",
      "['9738996', 'Taylor P C; Genovese M C; Keystone E; Weinblatt M; Rancourt J; Nantz E; Schlichting D E; Zuckerman S H; Macias W L. Effects of baricitinib on multibiomarker disease activity scores and their components in a phase 2B study in moderate-to-severe rheumatoid arthritis patients. Annals of the rheumatic diseases. (2016) 75 SUPPL. 1 ppA62-A63', '10.1136/annrheumdis-2016-209124.148', '']\n",
      "['9740016', 'EUCTR2010-022504-42-GB. A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2b Study of LY3009104 in Patients with Active Rheumatoid Arthritis on background Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-022504-42-GB. (2010)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9740606', 'Peterfy C; DiCarlo J; Emery P; Genovese MC; Keystone EC; Taylor PC; Schlichting DE; Beattie SD; Luchi M; Macias W. Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of rheumatology. (2019)   pp', '10.3899/jrheum.171469', '']\n",
      "['9741922', 'Keystone Edward C; Genovese Mark C; Schlichting Douglas E; de la Torre Inmaculada; Beattie Scott D; Rooney Terence P; Taylor Peter C. Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis. Journal of rheumatology. (2018) 45 1 pp14-21', '10.3899/jrheum.161161', '']\n",
      "['9743084', 'Peterfy Charles; DiCarlo Julie; Emery Paul; Genovese Mark C; Keystone Edward C; Taylor Peter C; Schlichting Doug E; Beattie Scott D; Luchi Monica; Macias William. MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of rheumatology. (2019) 46 8 pp887-895', '10.3899/jrheum.171469', '']\n",
      "['11083811', 'Peterfy Charles; DiCarlo Julie; Emery Paul; Genovese Mark C; Keystone Edward C; Taylor Peter C; Schlichting Doug E; Beattie Scott D; Luchi Monica; Macias William. MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of rheumatology. (2019) 46 8 pp887-895', '10.3899/jrheum.171469', '']\n",
      "['11085198', 'Boesen M; Beattie S D; Schlichting D E; Kubassova O. Novel quantitative digital image analysis methodology for assessment of inflammatory changes in MRI data in a post-hoc analysis of data acquired from a phase IIb study of baricitinib in patients with active rheumatoid arthritis. European journal of radiology. (2021) 143  pp109877', '10.1016/j.ejrad.2021.109877', '']\n",
      "['9741363', 'Harigai Masayoshi; Takeuchi Tsutomu; Smolen Josef S; Winthrop Kevin L; Nishikawa Atsushi; Rooney Terence P; Saifan Chadi G; Issa Maher; Isaka Yoshitaka; Akashi Naotsugu; Ishii Taeko; Tanaka Yoshiya. Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: an integrated analysis of Phases 2 and 3 trials. Modern rheumatology. (2020) 30 1 pp36-43', '10.1080/14397595.2019.1583711', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2019.1583711']\n",
      "['11084340', 'Taylor PC; Takeuchi T; Burmester GR; Durez P; Smolen JS; Deberdt W; Issa M; Terres JR; Bello N; Winthrop KL. Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Annals of the rheumatic diseases. (2022) 81 3 pp335-343', '10.1136/annrheumdis-2021-221276', '']\n",
      "['11084340', 'Taylor PC; Takeuchi T; Burmester GR; Durez P; Smolen JS; Deberdt W; Issa M; Terres JR; Bello N; Winthrop KL. Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Annals of the rheumatic diseases. (2022) 81 3 pp335-343', '10.1136/annrheumdis-2021-221276', '']\n",
      "['11088713', 'Harigai M; Takeuchi T; Smolen JS; Winthrop KL; Nishikawa A; Rooney TP; Saifan CG; Issa M; Isaka Y; Akashi N; Ishii T; Tanaka Y. Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: an integrated analysis of Phases 2 and 3 trials. . (2020) 30 1 pp36', '10.1080/14397595.2019.1583711', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2019.1583711']\n",
      "['9261034', 'Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF; ORAL Start Investigators. Tofacitinib versus methotrexate in rheumatoid arthritis. New England journal of medicine. (2014) 370 25 pp2377-2386', '10.1056/nejmoa1310476', '']\n",
      "['9742042', 'Jeffery LE; Calder P; Filer A; Raza K; Buckley C; McInnes I; Taylor P; Fisher B. Plasma levels of polyunsaturated omega 3 eicosapentaenoic acid are associated with anti-TNF response in rheumatoid arthritis, and inhibit the etanercept driven rise in Th17 cell differentiation in vitro. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi42', '10.1093/rheumatology/kev085.004', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i42/5179391/kev085.004.pdf']\n",
      "['9260923', 'Takeuchi T; Miyasaka N; Zang C; Alvarez D; Fletcher T; Wajdula J; Yuasa H; Vlahos B. A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis. Modern rheumatology / the Japan Rheumatism Association. (2013) 23 4 pp623-633', '10.3109/s10165-012-0742-6', '']\n",
      "['9736538', 'Takeuchi Tsutomu; Miyasaka Nobuyuki; Pedersen Ron; Sugiyama Noriko; Hirose Tomohiro. Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naive patients with active rheumatoid arthritis. Modern rheumatology. (2020) 30 2 pp259-268', '10.1080/14397595.2019.1589918', 'https://academic.oup.com/mr/article-pdf/30/2/259/45523391/mr0259.pdf']\n",
      "['9737636', 'Takeuchi T; Miyasaka N; Pedersen R; Sugiyama N; Hirose T. Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-na‚àö√òve patients with active rheumatoid arthritis. Modern rheumatology. (2019)   pp', '10.1080/14397595.2019.1589918', 'https://academic.oup.com/mr/article-pdf/30/2/259/45523391/mr0259.pdf']\n",
      "['11087994', 'Takeuchi Tsutomu; Miyasaka Nobuyuki; Pedersen Ron D; Sugiyama Noriko; Hirose Tomohiro. Radiographic and clinical effects of 10 mg and 25 mg twice-weekly etanercept over 52 weeks in Japanese patients with active rheumatoid arthritis. Modern rheumatology. (2021) 31 2 pp319-325', '10.1080/14397595.2020.1805142', '']\n",
      "['11088283', 'Takeuchi Tsutomu; Miyasaka Nobuyuki; Pedersen Ron; Sugiyama Noriko; Hirose Tomohiro. Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naive patients with active rheumatoid arthritis. Modern rheumatology. (2020) 30 2 pp259-268', '10.1080/14397595.2019.1589918', 'https://academic.oup.com/mr/article-pdf/30/2/259/45523391/mr0259.pdf']\n",
      "['9257448', 'Kameda H; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Takeuchi T; Japan Biological Agent Study Integrated Consortium. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Modern rheumatology / the Japan Rheumatism Association. (2010) 20 6 pp531-538', '10.3109/s10165-010-0324-4', '']\n",
      "['9260856', 'Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study. Journal of rheumatology. (2011) 38 8 pp1585-1592', '10.3899/jrheum.110014', '']\n",
      "['9741206', 'NCT00688103. Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan. https://clinicaltrials.gov/show/NCT00688103. (2008)   pp', '10.1136/annrheumdis-2014-eular.1253', '']\n",
      "['9257923', \"Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. British journal of rheumatology. (1998) 37 9 pp992-1002\", '10.1093/rheumatology/37.9.992', 'http://academic.oup.com/rheumatology/article-pdf/37/9/992/18106482/370992.pdf']\n",
      "['9260135', \"Plant MJ; O'Sullivan MM; Lewis PA; Camilleri JP; Coles EC; Jessop JD. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?. Rheumatology (Oxford, England). (2005) 44 9 pp1181-1185\", '10.1093/rheumatology/keh707', 'http://academic.oup.com/rheumatology/article-pdf/44/9/1181/14117917/keh707.pdf']\n",
      "['9257401', 'Kerstens PJ; Boerbooms AM; Jeurissen ME; de Graaf R; Mulder J; van de Putte LB. Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine. Journal of rheumatology. (2000) 27 5 pp1148-1155', '10.1016/s0049-0172(95)80009-3', '']\n",
      "['9257514', 'Boerbooms AM; Kerstens PJ; van Loenhout JW; Mulder J; van de Putte LB. Infections during low-dose methotrexate treatment in rheumatoid arthritis. Seminars in arthritis and rheumatism. (1995) 24 6 pp411-421', '10.1016/s0049-0172(95)80009-3', '']\n",
      "['9259181', 'Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Annals of internal medicine. (1991) 114 12 pp999-1004', '10.7326/0003-4819-114-12-999', '']\n",
      "['9259216', 'Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis and rheumatism. (1993) 36 8 pp1070-1079', '10.1002/art.1780360807', '']\n",
      "['9262911', 'Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Mulder J; Rasker JJ; Kruijsen MW; Haverman JF; van Beusekom HJ; Muller WH. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial. Arthritis and rheumatism. (1991) 34 8 pp961-972', '10.1002/art.1780340805', '']\n",
      "['9736639', 'CTRI/2016/11/007508. Comparison of 2 different combination therapy in patients with Rheumatoid Arthritis failing Methotrexate monotherapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/11/007508. (2016)   pp', '10.5455/medscience.2015.04.8350', '']\n",
      "['9739537', 'Belani P. Comparison of sulfasalazine versus lefunomide based combinaton disease modifying ant rheumatc drug therapy (DMARD) in patients with Rheumatoid arthritis failing Methotrexate monotherapy: a randomized control trial. Indian journal of rheumatology. (2018) 13 6 Supplement 1 ppS86-S87', '10.1007/s00296-021-04994-1', 'https://link.springer.com/article/10.1007/s00296-021-04994-1/fulltext.html']\n",
      "['11083953', 'Belani PJ; Kavadichanda CG; Negi VS. Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial. . (2022) 42 5 pp771', '10.1007/s00296-021-04994-1', 'https://link.springer.com/article/10.1007/s00296-021-04994-1/fulltext.html']\n",
      "['11084834', 'Belani PJ; Kavadichanda CG; Negi VS. Comparison between leflunomide and sulfasalazineÔøΩbased triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial. Rheumatology international. (2021) 42 5 pp771-782', '10.1007/s00296-021-04994-1', 'https://link.springer.com/article/10.1007/s00296-021-04994-1/fulltext.html']\n",
      "['9261184', 'Joo K; Heejung K; Lim M-J; Kwon S-R; Park W. Safety and efficacy of TNFa inhibitor versus leflunomide in patients with rheumatoid arthritis inadequately responding to methotrexate in Korea. International journal of rheumatic diseases. (2012) 15  pp53-54', '10.4078/jrd.2013.20.3.166', 'http://pdf.medrang.co.kr/JRD/2013/020/Jkra020-03-05.pdf']\n",
      "['9737368', 'Pablos Jose Luis; Navarro Federico; Blanco Francisco Jose; Roman-Ivorra Jose Antonio; Alonso Alberto; Martin Mola Emilio; Cantalejo Miguel; Ercole Liliana; Rivero Natividad; study investigators. Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study. Clinical and experimental rheumatology. (2019) 37 3 pp437-444', '10.1136/annrheumdis-2015-eular.4501', '']\n",
      "['9737974', 'UMIN000003880. Keeping cartilagious quality by adalimumab in patient with rheumatoid arthritis in Kansai area. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003880. (2010)   pp', '10.1186/isrctn90051516', '']\n",
      "['9261883', 'Okano T; Inui K; Tada M; Sugioka Y; Mamoto K; Koike T; Nakamura H. Medication interval of adalimumab for rheumatoid arthritis patients might BE extended after the achievement of low disease activity-kabuki study. Annals of the rheumatic diseases. (2015) 74  pp471', '10.1136/annrheumdis-2015-eular.2609', '']\n",
      "['9257183', 'Tanaka Y; Wada K; Takahashi Y; Hagino O; Van Hoogstraten H; Graham N; Kameda H. Efficacy and safety of sarilumab plus methotrexate in a phase 3 trial in Japanese patients with active rheumatoid arthritis (KAKEHASI). International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp200', '10.1186/s13075-019-1856-4', 'http://link.springer.com/article/10.1186/s13075-019-1856-4/fulltext.html']\n",
      "['9738803', 'Tanaka Y; Wada K; Takahashi Y; Hagino O; Van Hoogstraten H; Graham N; Kameda H. Efficacy and safety of sarilumab plus methotrexate in a phase 3 trial in Japanese patients with active rheumatoid arthritis (KAKEHASI). International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp200', '10.1186/s13075-019-1856-4', 'http://link.springer.com/article/10.1186/s13075-019-1856-4/fulltext.html']\n",
      "['11085750', 'Tanaka Yoshiya; Takahashi Toshiya; Van Hoogstraten Hubert; Praestgaard Amy; Kato Naoto; Kameda Hideto. Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab. Clinical and experimental rheumatology. (2022)   pp', '10.55563/clinexprheumatol/jq9u8f', '']\n",
      "['11088333', 'Tanaka Y; Takahashi T; Van Hoogstraten H; Praestgaard A; Kato N; Kameda H. Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab. . (2022)   pp', '10.55563/clinexprheumatol/jq9u8f', '']\n",
      "['11085706', 'Tanaka Y; Takahashi T; Sumi M; Hagino O; Van Hoogstraten H; Xu C; Kato N; Kameda H. Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials. Modern rheumatology. (2022) 32 4 pp686-695', '10.1093/mr/roab066', 'https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roab066/41926408/roab066.pdf']\n",
      "['9261401', 'Kang YM; Park W; Park YE; Choe JY; Bae S-C; Cho CS; Shim SC; Lee SK; Suh C-H; Cha H-S; Song YW; You B; Lee SS; Lee SH; Park MC. Efficacy and safety of certolizumab pegol (CZP) with concomitant methotrexate (MTX) in korean rheumatoid arthritis (RA) patients (PTS) with an inadequate response to MTX. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.501', '']\n",
      "['9736743', 'Kang Young Mo; Park Young-Eun; Park Won; Choe Jung-Yoon; Cho Chul-Soo; Shim Seung-Cheol; Bae Sang Cheol; Suh Chang-Hee; Cha Hoon-Suk; Koh Eun Mi; Song Yeong-Wook; Yoo Bin; Lee Shin-Seok; Park Min-Chan; Lee Sang-Heon; Arendt Catherine; Koetse Willem; Lee Soo-Kon. Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis. The Korean journal of internal medicine. (2018) 33 6 pp1224-1233', '10.3904/kjim.2016.213', 'http://kjim.org/upload/kjim-2016-213.pdf']\n",
      "['9738086', 'Kang Young Mo; Park Young-Eun; Park Won; Choe Jung-Yoon; Cho Chul-Soo; Shim Seung-Cheol; Bae Sang Cheol; Suh Chang-Hee; Cha Hoon-Suk; Koh Eun Mi; Song Yeong-Wook; Yoo Bin; Lee Shin-Seok; Park Min-Chan; Lee Sang-Heon; Arendt Catherine; Koetse Willem; Lee Soo-Kon. Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis. The Korean journal of internal medicine. (2018)   pp', '10.3904/kjim.2016.213', 'http://kjim.org/upload/kjim-2016-213.pdf']\n",
      "['9740940', 'NCT00993317. A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00993317. (2009)   pp', '10.26226/morressier.56e174d9d462b8028d88ace2', '']\n",
      "['9739569', 'UMIN000011520. Keep persistent efficacy by Abstaining from biological treatment after Numerical SDAI remission with AdalImumab (KANSAI study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011520. (2013)   pp', '10.1186/isrctn64177501', '']\n",
      "['9260182', 'Karanikolas G; Charalambopoulos D; Andrianakos A; Antoniades C; Katsilambros N. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis. Journal of rheumatology. (2006) 33 3 pp486-489', '10.1093/rheumatology/ken223', 'http://academic.oup.com/rheumatology/article-pdf/47/9/1384/5063075/ken223.pdf']\n",
      "['9258150', 'Kay J; Matteson EL; Dasgupta B; Nash P; Durez P; Hall S; Hsia EC; Han J; Wagner C; Xu Z; Visvanathan S; Rahman MU. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis and rheumatism. (2008) 58 4 pp964-975', '10.1002/art.23383', '']\n",
      "['9260487', 'Visvanathan S; Wagner C; Rojas J; Kay J; Dasgupta B; Matteson EL; Mack M; Baker DG; Rahman MU. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy. Journal of rheumatology. (2009) 36 7 pp1371-1379', '10.3899/jrheum.080755', '']\n",
      "['9738908', 'Kay J; Matteson E L; Dasgupta B; Nash P; Durez P; Hall S; Hsia E C; Han J; Wagner C; Xu Z; Visvanathan S; Rahman M U. Erratum: golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis and rheumatism. (2010) 62 11 pp3518', '10.1002/art.30103', '']\n",
      "['9740941', 'NCT00207714. An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00207714. (2005)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9259995', 'Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2004) 50 2 pp353-363', '10.1002/art.20019', '']\n",
      "['9259729', 'Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis. Journal of rheumatology. (2000) 27 2 pp324-331', '10.1002/art.10215', '']\n",
      "['9260349', 'Kim H-Y; Lee S-K; Song YW; Yoo D-H; Koh E-M; Yoo B; Luo A. A randomized, double-blind, placebo-controlled, phase III study of the human anti-tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate. APLAR Journal of Rheumatology. (2007) 10 1 pp9-16', '10.1111/j.1479-8077.2007.00248.x', '']\n",
      "['9258519', 'Kim J; Ryu H; Yoo DH; Park SH; Song GG; Park W; Cho CS; Song YW. A clinical trial and extension study of infliximab in Korean patients with active rheumatoid arthritis despite methotrexate treatment. Journal of Korean medical science. (2013) 28 12 pp1716-1722', '10.3346/jkms.2013.28.12.1716', 'https://synapse.koreamed.org/pdf/10.3346/jkms.2013.28.12.1716']\n",
      "['9743019', 'NCT00202852. A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED). https://clinicaltrials.gov/show/NCT00202852. (2005)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9261321', 'Koroleva MV; Raskina TA. The effect of rituximab therapy on bone mineral density with rheumatoid arthritis patients. Osteoporosis international. (2014) 25  ppS374', '10.14412/1995-4484-2016-530-534', 'http://rsp.ima-press.net/rsp/article/viewFile/2295/1499']\n",
      "['9261322', 'Koroleva MV; Raskina TA. Effect of rituximab therapy on life quality with rheumatoid arthritis patients. Osteoporosis international. (2014) 25  ppS365-S366', '10.14412/1996-7012-2013-2383', '']\n",
      "['9257818', 'Kraan MC; de Koster BM; Elferink JG; Post WJ; Breedveld FC; Tak PP. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients. Arthritis and rheumatism. (2000) 43 7 pp1488-1495', '10.1002/1529-0131(200007)43:7<1488::aid-anr11>3.0.co;2-g', '']\n",
      "['9257948', 'Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers. Arthritis and rheumatism. (2000) 43 8 pp1820-1830', '10.1002/1529-0131(200008)43:8<1820::aid-anr18>3.0.co;2-d', '']\n",
      "['9259897', 'Kremer JM; Genovese MC; Cannon GW; Caldwell JR; Cush JJ; Furst DE; Luggen ME; Keystone E; Weisman MH; Bensen WM; Kaine JL; Ruderman EM; Coleman P; Curtis DL; Kopp EJ; Kantor SM; Waltuck J; Lindsley HB; Markenson JA; Strand V; Crawford B; Fernando I; Simpson K; Bathon JM. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Annals of internal medicine. (2002) 137 9 pp726-733', '10.7326/0003-4819-137-9-200211050-00007', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-137-9-200211050-00007']\n",
      "['9260048', 'Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. Journal of rheumatology. (2004) 31 8 pp1521-1531', '10.7326/0003-4819-137-9-200211050-00007', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-137-9-200211050-00007']\n",
      "['9256854', 'Westhovens R; Kremer JM; Moreland LW; Emery P; Russell AS; Li T; Aranda R; Becker JC; Qi K; Dougados M. Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study. Journal of rheumatology. (2009) 36 4 pp736-742', '10.3899/jrheum.080813', '']\n",
      "['9258650', 'Emery P; Kosinski M; Li T; Martin M; Williams GR; Becker JC; Blaisdell B; Ware JE; Birbara C; Russell AS. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. Journal of rheumatology. (2006) 33 4 pp681-689', '10.1136/ard.2006.057018', '']\n",
      "['9260122', 'Kremer JM; Dougados M; Emery P; Durez P; Sibilia J; Shergy W; Steinfeld S; Tindall E; Becker JC; Li T; Nuamah IF; Aranda R; Moreland LW. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis and rheumatism. (2005) 52 8 pp2263-2271', '10.1002/art.21201', '']\n",
      "['9261051', 'Westhovens R; Kremer JM; Emery P; Russell AS; Alten R; Barr‚àö¬© E; Dougados M. Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study. Clinical and experimental rheumatology. (2014) 32 4 pp553-562', '10.3899/jrheum.080813', '']\n",
      "['9263141', 'Kremer JM; Westhovens R; Leon M; Di Giorgio E; Alten R; Steinfeld S; Russell A; Dougados M; Emery P; Nuamah IF; Williams GR; Becker JC; Hagerty DT; Moreland LW. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. New England journal of medicine. (2003) 349 20 pp1907-1915', '10.1056/nejmoa035075', '']\n",
      "['9741063', 'NCT00162266. Abatacept With Methotrexate- Phase IIB. https://clinicaltrials.gov/show/NCT00162266. (2005)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9261558', 'Kremer J; Kivitz A; Simon-Campos J; Nasanov E; Tony H; Vlahos B; Hammond C; Bukowski J; Li H; Schulman S; Raber S; Zuckerman A; Isaacs J. Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2492', '']\n",
      "['9258303', 'Kremer JM; Cohen S; Wilkinson BE; Connell CA; French JL; Gomez-Reino J; Gruben D; Kanik KS; Krishnaswami S; Pascual-Ramos V; Wallenstein G; Zwillich SH. A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone. Arthritis and rheumatism. (2012) 64 4 pp970-981', '10.1002/art.33419', '']\n",
      "['9736771', 'EUCTR2006-005036-24-SE. A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE TREATMENT OF SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO METHOTREXATE ALONE. - N/A. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005036-24-SE. (2007)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9738499', 'Kremer J; Cohen S; Wilkinson B; Gruben D; Wallenstein GV; Kanik KS; Zwillich SH. Safety and efficacy after 24 week (Wk) dosing of the oral JAK inhibitor CP-690,550 (CP) in combination with methotrexate (MTX) in patients (PTS) with active rheumatoid arthritis (RA). Arthritis and rheumatism. (2009) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 09 Atlanta, GA United States. Conference Start: 20101106 Conference End: 20101111. Conference Publication: var.pagings pp1925', '10.1002/art.33419', '']\n",
      "['9740950', 'NCT00413660. Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00413660. (2006)   pp', '10.3109/9780203214237-213', '']\n",
      "['9261956', 'Wallenstein GV; Kanik KS; Wilkinson B; Cohen S; Cutolo M; Fleishmann R; Genovese MC; Gomez Reino J; Gruben D; Kremer J; Krishnaswami S; Lee EB; Pascual-Ramos V; Strand V; Zwillich SH. Effects of the oral janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two phase 2 randomised controlled trials. Clinical and experimental rheumatology. (2016) 34 3 pp430-442', '10.1136/rmdopen-2016-000308', '']\n",
      "['9259313', 'Kr‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†¬¨¬•ger K; Schattenkirchner M. Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis--results of a double-blind multicentre study. Clinical rheumatology. (1994) 13 2 pp248-255', '10.1007/bf02249021', 'https://link.springer.com/article/10.1007/BF02249021/fulltext.html']\n",
      "['9263349', 'Kume K; Amano K; Yamada S; Hatta K; Ohta H; Kuwaba N. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. Journal of rheumatology. (2011) 38 10 pp2169-2171', '10.3899/jrheum.110340', '']\n",
      "['9257169', 'Kume K; Yamada S; Hatta K; Amano K; Kuwaba N; Ohta H. Tocilizumab improves bone mineral density compared with abatacept in patients with TNF blockers-resistant active rheumatoid arthritis. An open label randomized controlled trial. Arthritis and rheumatism. (2012) 64  ppS192-S193', '10.1093/rheumatology/ket468', 'http://academic.oup.com/rheumatology/article-pdf/53/5/900/6897613/ket468.pdf']\n",
      "['9261400', 'Kume K; Amano K; Hatta K; Ohta H. Tocilizumab improves BMD compared with abatacept in patients with TNF blockers-resiistant active RA. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.545', '']\n",
      "['9263468', 'Kume K; Amano K; Yamada S; Hatta K. Tocilizumab improves arterial stiffness compared with abatacept in patients with TNF blockers-resistant active rheumatoid arthritis.an open label randomized controlled trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3899/jrheum.110340', '']\n",
      "['9257870', 'Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study. Journal of the Formosan Medical Association / Taiwan yi zhi. (2004) 103 8 pp618-623', '10.1016/s0929-6646(09)60071-1', '']\n",
      "['9260816', 'Leirisalo-Repo M; Kautiainen H; Laasonen L; Korpela M; Kauppi MJ; Kaipiainen-Sepp‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫nen O; Luosuj‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫rvi R; Luukkainen R; Karjalainen A; Bl‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´¬¨¬®¬¨¬¢field H; Uutela T; Ilva K; Julkunen HA; Paimela L; Puolakka K; Moilanen E; Hannonen PJ; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; NEO-RACo Study Group. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Annals of the rheumatic diseases. (2013) 72 6 pp851-857', '10.4324/9780203187838.bmatt3', '']\n",
      "['9259432', 'van den Borne BE; Landew‚àö¬© RB; The HS; Breedveld FC; Dijkmans BA. Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquine. Scandinavian journal of rheumatology. (1996) 25 5 pp307-316', '10.3109/03009749609104063', '']\n",
      "['9260932', 'Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region. Journal of clinical rheumatology. (2014) 20 1 pp25-33', '10.1097/rhu.0000000000000055', '']\n",
      "['9262573', 'Bautista GG; Xavier RM; De La Vega M; Abraham Simon-Campos J; Solano G; Pedersen RD; Vlahos B; Borlenghi C. Relationship between clinical assessments and patient-reported outcomes: post hoc analysis of a randomized, open-label study of etanercept in LatinAmerican patientswith rheumatoidarthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS72', '10.2147/oarrr.s228866', 'https://www.dovepress.com/getfile.php?fileID=54690']\n",
      "['9737047', 'NCT00848354. Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy. https://clinicaltrials.gov/show/NCT00848354. (2009)   pp', '10.1007/s00393-023-01316-7', 'https://link.springer.com/article/10.1007/s00393-023-01316-7/fulltext.html']\n",
      "['9737511', 'Guerra Bautista Generoso; Xavier Ricardo Machado; de la Vega Maria; Simon-Campos J Abraham; Solano Gaston; Pedersen Ronald D; Vlahos Bonnie; Borlenghi Cecilia. Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis. Open access rheumatology : research and reviews. (2019) 11  pp275-281', '10.2147/oarrr.s228866', 'https://www.dovepress.com/getfile.php?fileID=54690']\n",
      "['9738577', 'Bautista GG; Xavier RM; De La Vega M; Abraham Simon-Campos J; Solano G; Pedersen RD; Vlahos B; Borlenghi C. Relationship between clinical assessments and patient-reported outcomes: post hoc analysis of a randomized, open-label study of etanercept in LatinAmerican patientswith rheumatoidarthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS72', '10.2147/oarrr.s228866', 'https://www.dovepress.com/getfile.php?fileID=54690']\n",
      "['9738939', 'Machado D A; Guzman R; Xavier R M; Simon J A; Mele L; Shen Q; Pedersen R; Kotak S; Vlahos B. Two-year safety and efficacy experience in patients with methotrexate-resistant active rheumatoid arthritis treated with etanercept and conventional disease-modifying anti-rheumatic drugs in the Latin American region. Open rheumatology journal. (2016) 10  pp13-25', '10.2174/1874312901610010013', 'https://openrheumatologyjournal.com/contents/volumes/V10/TORJ-10-13/TORJ-10-13.pdf']\n",
      "['9741426', '. Clinical improvements as predictors of improvements in patient-reported outcomes: post hoc analysis of a randomized, open-label study of etanercept in latin american patients with rheumatoid arthritis. Open access rheumatology: research and reviews. (2019) 11  pp275-281', '10.2147/oarrr.s228866', 'https://www.dovepress.com/getfile.php?fileID=54690']\n",
      "['9260888', 'Wassenberg S; Rau R; Zeidler H. A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - The Low-Dose Prednisolone Trial. Clinical and experimental rheumatology. (2011) 29  5 SUPPL. 68 ppS68-S72', '10.1002/art.21421', '']\n",
      "['9737481', 'EUCTR2007-000886-40-IT. Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naive - DMARD early RA-patients. - LEADER. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000886-40-IT. (2008)   pp', '10.1093/rheumatology/kes321', 'http://academic.oup.com/rheumatology/article-pdf/52/6/1132/5196633/kes321.pdf']\n",
      "['9258921', 'Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE. Gold levels produced by treatment with auranofin and sodium aurothiomalate. Annals of the rheumatic diseases. (1983) 42 5 pp566-570', '10.1136/ard.42.5.566', '']\n",
      "['9258569', 'Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. International journal of rheumatic diseases. (2016) 19 11 pp1143-1156', '10.1111/1756-185x.12723', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12723']\n",
      "['9261315', 'Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC. Safety and efficacy of subcutaneous golimumab in chinese patients with active rheumatoid arthritis despite MTX therapy: Results from a randomized, placebo-controlled, phase 3 trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1338', '']\n",
      "['9261499', 'Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC. Safety and efficacy of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite MTX therapy: Results from a randomized, placebo-controlled, phase 3 trial. Arthritis and rheumatism. (2013) 65 var.pagings ppS598-S599', '10.1136/annrheumdis-2013-eular.1338', '']\n",
      "['9262046', 'Li H; Shen L; Li C; Wu R. Efficacy and safety of rh-tnfr: fc versus glucocorticoid in patients with moderate and severe rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp171', '10.1007/s10165-004-0352-z', '']\n",
      "['9740969', 'NCT01248780. Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy. https://clinicaltrials.gov/show/NCT01248780. (2010)   pp', '10.3410/f.718325310.793492804', '']\n",
      "['9259516', 'M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Leirisalo-Repo M; Nissil‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫ M; Kautiainen H; Korpela M; Laasonen L; Julkunen H; Luukkainen R; Vuori K; Paimela L; Bl‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´¬¨¬®¬¨¬¢field H; Hakala M; Ilva K; Yli-Kerttula U; Puolakka K; J‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫rvinen P; Hakola M; Piirainen H; Ahonen J; P‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫lvim‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫ki I; Forsberg S; Koota K; Friman C. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (London, England). (1999) 353 9164 pp1568-1573', '10.4324/9780203187838.bmatt3', '']\n",
      "['9262714', 'Lila A; Denisov L; Plaksina T; Smakotina S; Kunder E; Soroka N; Kastanayan A; Nesmeyanova O; Antipova O; Ilivanova E; Eremeeva A; Dokukina E; Chernyaeva E; Ivanov R. Efficacy and safety of BCD-055 (infliximab biosimilar) in rheumatoid arthritis. results of BCD-055-3/lira phase 3 clinical study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Suppl  2 pp316-317', '10.1136/annrheumdis-2018-eular.2332', '']\n",
      "['9261406', 'Lisbona MP; Maymo J; Solano A; Almirall M; Sanchez S; Pamies A; Navallas M; Carbonell J. Comparative assessment of methotrexate and leflunomide by magnetic resonance imaging in patients with early rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.3334', '']\n",
      "['9257778', 'Bay-Jensen AC; Platt A; Byrjalsen I; Vergnoud P; Christiansen C; Karsdal MA. Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study. Seminars in arthritis and rheumatism. (2014) 43  4 pp470-478', '10.1016/j.semarthrit.2013.07.008', '']\n",
      "['9258154', 'Kremer JM; Blanco R; Halland AM; Brzosko M; Burgos-Vargas R; Mela CM; Rowell L; Fleischmann RM. Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial. Clinical and experimental rheumatology. (2016) 34 4 pp625-633', '10.1093/rheumatology/keu101.016', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i92/9578473/keu101.016.pdf']\n",
      "['9260790', 'Fleischmann RM; Halland AM; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Kremer JM. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results. Journal of rheumatology. (2013) 40 2 pp113-126', '10.3899/jrheum.120447', '']\n",
      "['9260861', 'Kremer JM; Blanco R; Brzosko M; Burgos-Vargas R; Halland AM; Vernon E; Ambs P; Fleischmann R. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. Arthritis and rheumatism. (2011) 63 3 pp609-621', '10.1002/art.30158', '']\n",
      "['9261115', 'Karsdal MA; Bay-Jensen AC; Byrjalsen I; Kenwright A; Platt A; Sornasse T; Christiansen C. Identification of serological biomarker profiles associated with response to IL-6 intervention in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS916', '10.1136/annrheumdis-2012-eular.1810', '']\n",
      "['9261124', 'Bay-Jensen AC; Byrjalsen I; Kenwright A; Sornasse T; Christiansen C; Karsdal MA. Differential effect of 4 and 8 mg/kg tocilizumab in combination with methotrexate on serum biomarkers of cartilage, connective tissue and bone turnover. Arthritis and rheumatism. (2012) 64  ppS572', '10.1016/j.semarthrit.2013.07.008', '']\n",
      "['9261304', 'Kremer JM; Halland A-M; Brzosko M; Burgos-Vargas R; Mela CM; Vernon E; Fleischmann R. Tocilizumab inhibits radiographic progression and improves physical function in patients with rheumatoid arthritis at 5 years with maintenance of clinical efficacy over time. Rheumatology (United Kingdom). (2014) 53  ppi92', '10.1093/rheumatology/keu101.016', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i92/9578473/keu101.016.pdf']\n",
      "['9261342', 'Kremer J; Halland A-M; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Fleischmann R. Lithe: Tocilizumab (TCZ) inhibits radiographic progression and improves physical function in patients (PTS) with rheumatoid arthritis (RA) at 5 years with maintenance of clinical efficacy over time. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9261441', 'Bay-Jensen AC; Byrjalsen I; Kenwright A; Platt A; Karsdal MA. Identification of serological biomarker profiles associated with early response to tocilizumab in rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1810', '']\n",
      "['9261991', 'Staehr Gudman N; Byrjalsen I; Musa K; Kehlet SN; Karsdal MA; Bay-Jensen AC. Epithelial changes in response to tocilizumab combined with methotrexate in rheumatoid arthritis: evaluated on circulating fragments of type IV collagen. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s13075-023-03242-0', 'https://link.springer.com/article/10.1186/s13075-023-03242-0/fulltext.html']\n",
      "['9262541', 'Siebuhr AS; Kjelgaard-Petersen CF; Sun S; Byrjalsen I; Christiansen C; Karsdal MA; Bay-Jensen A-C. Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis. Clinical and experimental rheumatology. (2018) 36 1 pp94-101', '10.1097/rhu.0000000000000150', '']\n",
      "['9263376', 'Smolen JS; Avila JC; Aletaha D. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction. Annals of the rheumatic diseases. (2012) 71 5 pp687-693', '10.1136/annrheumdis-2011-200395', '']\n",
      "['9263591', 'Kremer J; Halland A; Rischmueller M; Major G; Taylor A; Brzosko M; Burgos-Vargas R; Mela C; Rowell L; Fleischmann R. Lithe: 5-year follow-up data demonstrate maintenance of clinical efficacy over time with the use of tocilizuman (TCZ) in patients with rheumatoid arthritis (RA) (encore). Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp26-27', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9736511', 'Li Z G; Fleischmann R; Rischmueller M; Kissel K; Vernon E; Kremer J. Tocilizumab inhibits radiographic progression and reduces disease activity continuously over time in patients with rheumatoid arthritis (RA). International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp97-98', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9738648', '. Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis. Clinical and experimental rheumatology. (2018) 36 1 pp94-101', '10.2217/ijr.13.26', '']\n",
      "['9738868', 'Fleischmann R; Burgos-Vargas R; Ambs P; Alecock E; Kremer J. LITHE: tocilizumab inhibits radiographic progression and improves physical function in rheumatoid arthritis (RA) patients (Pts) at 2 yrs with increasing clinical efficacy over time. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp637', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9738869', 'Fleischmann R; Burgos-Vargas R; Ambs P; Alecock E; Kremer J. Inhibition of radiographic progression and improvements in physical function at 2 years, with increasing clinical efficacy over time, in Rheumatoid Arthritis (RA) patients treated with Tocilizumab (TCZ): the lithe study. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9738871', 'Fleischmann R M; Blanco R; Castelar-Pinheiro G; Vernon E; Mela C; Kremer J M. Tocilizumab (TCZ) plus methotrexate (MTX) in rheumatoid arthritis (RA) patients (pts) who increased TCZ dose from 4 mg/kg to 8 mg/kg: LITHE radiographic and safety data. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp2262', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9738891', 'Hall S; Fleischmann R. Tocilizumab inhibits radiological progression and improves physical function in rheumatoid arthritis (RA) patients at 2 years with increasing clinical efficacy over time. Internal medicine journal. (2010) 40 SUPPL. 3 pp13-14', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9738925', 'Kremer J M; Furst D E; Burgos-Vargas R; Dudler J; Mela C M; Vernon E; Fleischmann R M. LITHE: tocilizumab (TCZ) inhibits radiographic progression and improves physical function in rheumatoid arthritis (RA) patients (pts) at 3 years with maintenance of clinical efficacy over time. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1819', '10.1136/annrheumdis-2013-eular.1829', '']\n",
      "['9739088', 'Karsdal M A; Siebuhr A S; Leeming D J; Byrjalsen I; Christiansen C; Platt A; Bay-Jensen A C. Structural progressors in rheumatoid arthritis identified by serology-identification of the patients in most need of intensive treatment. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.1211', '']\n",
      "['9739131', 'Siebuhr A S; Bay-Jensen A C; Leeming D J; Platt A; Byrjalsen I; Christiansen C; Van De Heijde; Karsdal M A. Responders to tocilizumab identified by serological measurement of connective tissue type I collagen in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS376-S377', '10.1186/ar4266', 'https://link.springer.com/article/10.1186/ar4266/fulltext.html']\n",
      "['9741079', 'NCT00106535. A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT00106535. (2005)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['11088121', 'Blair J P M; Bay-Jensen A-C; Tang M H; Frederiksen P; Bager C; Karsdal M; Brunak S. Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis. Scientific reports. (2020) 10 1 pp13975', '10.1038/s41598-020-70942-x', 'https://www.nature.com/articles/s41598-020-70942-x']\n",
      "['9261071', 'Halland A-M. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate at one year - The LITHE study. European Musculoskeletal Review. (2012) 7  2 pp108-111', '10.3899/jrheum.120447', '']\n",
      "['9737355', 'Bay-Jensen AC; Thudium CS; Christiansen C; Karsdal MA. Identification of tocilizumab treated RA patients, whom are not likely to show long-term clinical benefit; reanalysis of the biomarker sub-study of lithe. Arthritis and rheumatology. (2018) 70 Supplement 9 pp645-646', '10.1186/s13075-023-03242-0', 'https://link.springer.com/article/10.1186/s13075-023-03242-0/fulltext.html']\n",
      "['9740062', 'EUCTR2004-003733-14-ES. A randomized, double-blind, parallel group study of the safety and prevention of structural joint damage during treatment with MRA versus placebo, in combination with methotrexate, in patients with moderate to severe active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003733-14-ES. (2005)   pp', '10.1016/s0084-3873(09)79342-3', '']\n",
      "['9257697', 'Gudman NS; Juhl P; Thudium CS; Siebuhr AS; Byrjalsen I; Karsdal MA; Bay-Jensen AC. Basement membrane remodeling is significantly increased with rheumatoid arthritis and suppressed by il6 inhibition: analysis of two phase III clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2063-2065', '10.1002/art.39977', '']\n",
      "['9742532', 'Gudmann Natasja Staehr; Junker Peter; Juhl Pernille; Thudium Christian Schneider; Siebuhr Anne Sofie; Byrjalsen Inger; Karsdal Morten Asser; Bay-Jensen Anne Christine. Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis. Clinical and experimental rheumatology. (2018) 36 5 pp829-835', '10.1136/annrheumdis-2016-eular.5828', '']\n",
      "['9256897', 'Gudmann NS; Junker P; Juhl P; Thudium CS; Siebuhr AS; Byrjalsen I; Karsdal MA; Bay-Jensen A-C. Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis. Clinical and experimental rheumatology. (2018) 36 5 pp829-835', '10.1136/annrheumdis-2016-eular.5828', '']\n",
      "['9740889', 'Liu D. PMS16 EFFECTS OF HYDROXYCHLOROQUINE ON THROMBOSIS FACTORS AND INFLAMMATORY CYTOKINES IN PATIENTS WITH ELDERLY RHEUMATOID ARTHRITIS. Value in health. (2019) 22 Supplement 3 ppS696', '10.1016/j.jval.2019.09.1560', '']\n",
      "['9742481', 'Machein U; Buss B; Spiller I; Braun J; Rudwaleit M; Faerber L; Sieper J. Effective treatment of early rheumatoid arthritis with a combination of methotrexate, prednisolone and cyclosporin. Rheumatology. (2002) 41 1 pp110-111', '10.1093/rheumatology/41.1.110', 'http://academic.oup.com/rheumatology/article-pdf/41/1/110/18095594/410110.pdf']\n",
      "['9258274', 'MacIsaac KD; Baumgartner R; Kang J; Loboda A; Peterfy C; DiCarlo J; Riek J; Beals C. Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients. PloS one. (2014) 9 12 ppe113937', '10.1371/journal.pone.0113937', '']\n",
      "['9261337', 'Beals C; Baumgartner R; Peterfy C; Balanescu A; Mirea G; Harabagiu A; Popa S; Cheng A; Feng D; Fox R; Vallee M-H; Ashton E; DiCarlo J; Dardzinski B. Treatment effects measured by dynamic contrast enhanced MRI and Ramris for rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2216', '']\n",
      "['9262327', 'Beals C; Baumgartner R; Peterfy C; Balanescu A; Mirea G; Harabagiu A; Popa S; Cheng A; Feng D; Ashton E; DiCarlo J; Vallee MH; Dardzinski BJ. Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: comparison of dynamic contrast enhanced assessments with semi-quantitative scoring. PloS one. (2017) 12 12 ppe0187397', '10.1371/journal.pone.0187397', '']\n",
      "['9737655', 'NCT01313520. A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136). https://clinicaltrials.gov/show/NCT01313520. (2011)   pp', '10.1016/j.mri.2013.12.008', '']\n",
      "['9257756', 'Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis and rheumatism. (1998) 41 9 pp1552-1563', '10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w', '']\n",
      "['9739046', 'Charles P J; Smeenk R J T; De Jong; Feldmann M; Maini R N. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis and rheumatism. (2000) 43 11 pp2383-2390', '10.1002/1529-0131(200011)43:11<2383::aid-anr2>3.3.co;2-4', '']\n",
      "['9257256', \"Mandl P; Balint PV; Brault Y; Backhaus M; D'Agostino MA; Grassi W; van der Heijde D; de Miguel E; Wakefield RJ; Logeart I; Dougados M. Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study. Arthritis and rheumatism. (2012) 64 4 pp1272-1282\", '10.1002/art.33491', '']\n",
      "['9739111', \"Mandl P; Balint P V; Brault Y; Backhaus M; D'Agostino M A; Grassi W; Van Der Heijde; D M. Psychometric properties of synovitis assessed in rheumatoid arthritis: improved intraobserver reliability of ultrasound vs. clinical evaluation in an ancillary study of the etanercept versus DMARDs randomized, prospective, multicentre study. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1629\", '10.1002/art.33491', '']\n",
      "['9740989', 'NCT00706797. Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects. https://clinicaltrials.gov/show/NCT00706797. (2008)   pp', '10.31525/ct1-nct04204603', '']\n",
      "['11085719', 'Hellstrom WJG; Dolhain RJEM; Ritter TE; Watkins TR; Arterburn SJ; Dekkers G; Gillen A; Tonussi C; Gilles L; Oortwijn A; Van Beneden K; de Vries DE; Sikka SC; Vanderschueren D; Reinisch W. MANTA and MANTA-RAy: rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases. Advances in therapy. (2022) 39 7 pp3403-3422', '10.1007/s12325-022-02168-4', 'https://link.springer.com/article/10.1007/s12325-022-02168-4/fulltext.html']\n",
      "['9263124', 'Marchesoni A; Battafarano N; Arreghini M; Panni B; Gallazzi M; Tosi S. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone. Rheumatology (Oxford, England). (2003) 42 12 pp1545-1549', '10.1093/rheumatology/keg394', 'http://academic.oup.com/rheumatology/article-pdf/42/12/1545/9533421/keg394.pdf']\n",
      "['9260252', 'Marcora SM; Chester KR; Mittal G; Lemmey AB; Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. American journal of clinical nutrition. (2006) 84 6 pp1463-1472', '10.1093/ajcn/84.6.1463', 'http://academic.oup.com/ajcn/article-pdf/84/6/1463/23891098/znu01206001463.pdf']\n",
      "['9261297', 'Ostergaard M; Jacobsson L; Schaufelberger C; Sejer- Hansen M; Bijlsma J; Dudek A; Rell-Bakalarska M; Staelens F; Haake R; Sundman-Engberg B; Bliddal H. Magnetic resonance imaging (MRI) assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled Phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8, and 16. Scandinavian journal of rheumatology. (2014) 43  pp14', '10.1136/annrheumdis-2014-eular.2096', '']\n",
      "['9261477', 'Ostergaard M; Jacobsson L; Schaufelberger C; Sejer-Hansen M; Bijlsma J; Dudek A; Rell-Bakalarska M; Staelens F; Haake R; Sundman-Engberg B; Bliddal H. Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging At Week 0, 1, 2, 4, 8 and 16. Arthritis and rheumatism. (2013) 65  ppS842', '10.1136/annrheumdis-2014-eular.2096', '']\n",
      "['9261545', 'Ostergaard M; Jacobsson L; Schaufelberger C; Sejer-Hansen M; Bijlsma J; Dudek A; Rell-Bakalarska M; Staelens F; Haake R; Sundman-Engberg B; Bliddal H. Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIB study applying magnetic resonance imaging at weeks 0, 1, 2, 4, 8 and 16. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2096', '']\n",
      "['9261574', '‚àö√≤stergaard M; Jacobsson LT; Schaufelberger C; Hansen MS; Bijlsma JW; Dudek A; Rell-Bakalarska M; Staelens F; Haake R; Sundman-Engberg B; Bliddal H. MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16. Annals of the rheumatic diseases. (2015) 74 6 pp1156-1163', '10.1136/annrheumdis-2014-206359', '']\n",
      "['9262415', 'Axelsen MB; Bliddal H; Jacobssen LTH; Hansen MS; Dudek A; Rell-Bakalarska M; Boesen M; Stefanek J; Sundman-Engberg B; Ostergaard M. Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial - impact of applying joint coverage quality criteria. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1419', '10.1136/annrheumdis-2017-eular.1946', '']\n",
      "['9738138', 'Axelsen MB; Boesen M; Bliddal H; Jacobsson L; Hansen MS; Ostergaard M. Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis. Scandinavian journal of rheumatology. (2019)   pp1-7', '10.1080/03009742.2019.1639820', '']\n",
      "['9738381', 'EUCTR2009-013758-33-SE. MULTICENTER STUDY WITH A 16-WEEK DOUBLE-BLIND, PLACEBO-CONTROLLED (DURING THE INITIAL 2 WEEKS) RANDOMIZED PERIOD, FOLLOWED BY A 24-WEEK OPEN LABEL EXTENSION TO ASSESS MAGNETIC RESONANCE IMAGE-VERIFIED EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-013758-33-SE. (2010)   pp', '10.1002/art.23964', '']\n",
      "['9741571', 'Axelsen M B; Boesen M; Bliddal H; Jacobsson Lth; Hansen M S; Ostergaard M. Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis. Scandinavian journal of rheumatology. (2020) 49 2 pp105-111', '10.1080/03009742.2019.1639820', '']\n",
      "['11088260', 'Axelsen M B; Boesen M; Bliddal H; Jacobsson Lth; Hansen M S; Ostergaard M. Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis. Scandinavian journal of rheumatology. (2020) 49 2 pp105-111', '10.1080/03009742.2019.1639820', '']\n",
      "['9263165', 'Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Annals of the rheumatic diseases. (2007) 66 2 pp235-241', '10.1136/ard.2006.057133', '']\n",
      "['9739819', 'ISRCTN65477168. A randomised controlled study of combination therapy in rheumatoid arthritis (RA) patients with a suboptimal response to sulphasalazine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN65477168. (2002)   pp', '10.1186/isrctn65477168', '']\n",
      "['9258755', 'Mason M; Currey HL; Barnes CG; Dunne JF; Hazleman BL; Strickland ID. Azathioprine in rheumatoid arthritis. British medical journal. (1969) 1 5641 pp420-422', '10.1136/bmj.1.5641.420', '']\n",
      "['9739982', 'UMIN000010286. Maintenance Trial by Orencia in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010286. (2013)   pp', '10.1186/isrctn01982076', '']\n",
      "['9741287', '. Correction: abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study (RMD Open (2018) 4 (e000813) DOI: 10.1136/rmdopen-2018-000813). RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2018-000813corr1', '']\n",
      "['9741338', '. Correction: abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study (RMD Open (2018) 4 (e000813) DOI: 10.1136/rmdopen-2018-000813). RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2018-000813corr1', '']\n",
      "['9741625', 'Matsubara Tsukasa; Inoue Hiroshi; Nakajima Toshihiro; Tanimura Kazuhide; Sagawa Akira; Sato Yukio; Osano Kei; Nagano Shuji; Ueki Yukitaka; Hanyu Tadamasa; Hashizume Koichi; Amano Norihito; Tanaka Yoshiya; Takeuchi Tsutomu. Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study. RMD open. (2018) 4 2 ppe000813', '10.1136/rmdopen-2018-000813', '']\n",
      "['11083683', 'Tanaka Y; Matsubara T; Hashizume K; Amano N; Takeuchi T. Efficacy and safety of abatacept in biologic-na√Øve patients with active rheumatoid arthritis by background methotrexate dose: post hoc analysis of a randomized, placebo-controlled, phase 4 study. Modern rheumatology. (2022) 32 3 pp500-507', '10.1093/mr/roab029', 'https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roab029/41746624/roab029.pdf']\n",
      "['9261689', 'Ohta S; Tsuru T; Terao K; Mogi S; Suzaki M; Shono E; Ishida Y; Tarumi E; Imai M. Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study). Journal of clinical pharmacology. (2014) 54 1 pp109-119', '10.1002/jcph.185', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.185']\n",
      "['9261271', \"Mcloughlin E; O'Neill F; Sutill E; Patel N; Aiuto FD; Kay C; Landmesser U; Charakida M; Taylor PC; Deanfield JE. Anti-TNF therapy improves endothelial protective functions of HDL in patients with rheumatoid arthritis. European heart journal. (2014) 35  pp218\", '10.1136/heartjnl-2015-308953', '']\n",
      "['9261186', 'Mcinnes I; Lee JS; Thompson L; Giles JT; Bathon JM; Salmon JE; Beaulieu AD; Codding CE; Delles C; Sattar N. The effects of tocilizumab treatment on lipids and inflammatory/prothrombotic markers in patients (pts) with rheumatoid arthritis (RA): Data from the randomized, controlled, Measure study. European heart journal. (2012) 33  pp281', '10.1136/annrheumdis-2013-204345', '']\n",
      "['9263498', 'McInnes IB; Thompson L; Giles JT; Bathon JM; Salmon JE; Beaulieu AD; Codding CE; Carlson TH; Delles C; Lee JS; Sattar N. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Annals of the rheumatic diseases. (2015) 74 4 pp694-702', '10.1136/annrheumdis-2013-204345', '']\n",
      "['9740044', 'EUCTR2007-001114-17-GB. A Mechanism of Action study to evaluate the effects of IL-6 receptor blockade with tocilizumab (TCZ) on lipids, arterial stiffness, and markers of atherogenic risk in patients with moderate to severe active rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001114-17-GB. (2008)   pp', '10.1007/s10165-011-0419-6', '']\n",
      "['9260500', 'Krum H; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.. Eur J Heart Fail. (2009) 11 6 pp542-50', '10.1093/eurjhf/hfp054', '']\n",
      "['11083956', 'Dhir V; Aggarwal A; Gupta R; Leishangthem B; Naidu G; Khullar A; Maurya S; Dhawan V; Sharma S; Sharma A; Jain S. How fast can methotrexate be escalated in rheumatoid arthritis A multicentre, parallelgroup randomized controlled trial (MEIRA)?. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp51-52', '10.1136/annrheumdis-2021-eular.3864', '']\n",
      "['11085220', 'Jain S; Dhir V; Aggarwal A; Gupta R; Leishangthem B; Naidu G; Khullar A; Dhawan V; Sharma SK; Sharma A; Jain S. PREDICTORS of RESPONSE to METHOTREXATE MONOTHERAPY in ACTIVE RHEUMATOID ARTHRITIS: RESULTS from A MULTICENTRE, RANDOMIZED CONTROLLED TRIAL (MEIRA). . (2022) 81  pp548', '10.1136/annrheumdis-2022-eular.4257', '']\n",
      "['9262675', 'Menshikova I; Dzhenzhera N; Pak Y; Kolosova I. Comparison of efficacy of tofacitinib vs. etanercept treatment in rheumatoid arthtritis patients with high activity disease by ultrasound evaluation with power doppler (1 year treatment period). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp976', '10.1136/annrheumdis-2018-eular.6605', '']\n",
      "['9260066', 'Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J; METGO Study Group. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis and rheumatism. (2005) 52 5 pp1360-1370', '10.1002/art.21018', '']\n",
      "['9257987', 'Goossens PH; Heemskerk B; van Tongeren J; Zwinderman AH; Vliet Vlieland TP; Huizinga TW. Reliability and sensitivity to change of various measures of hand function in relation to treatment of synovitis of the metacarpophalangeal joint in rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 8 pp909-913', '10.1093/rheumatology/39.8.909', 'http://academic.oup.com/rheumatology/article-pdf/39/8/909/11364728/390909.pdf']\n",
      "['9259496', 'Bluhm GB; Sharp JT; Tilley BC; Alarcon GS; Cooper SM; Pillemer SR; Clegg DO; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Leisen JC; Buckley L; Duncan H; Tuttleman M; Li S; Fowler SE. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. Journal of rheumatology. (1997) 24 7 pp1295-1302', '10.7326/0003-4819-122-2-199501150-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-122-2-199501150-00001']\n",
      "['9736681', 'Alarcon G S; Tilley B C; Li S; Fowler S E; Pillemer S R. Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. Journal of rheumatology. (1999) 26 5 pp1065-1067', '10.1002/art.1790110409', '']\n",
      "['9738935', 'Lindqvist H M; Gjertsson I; Eneljung T; Winkvist A. Influence of blue mussel (Mytilus edulis) intake on disease activity in female patients with rheumatoid arthritis: the MIRA randomized cross-over dietary intervention. Nutrients. (2018) 10 4 pp481', '10.3390/nu10040481', '']\n",
      "['9737176', 'jRCT1031180088. MIRACLE Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-jRCT1031180088. (2019)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9740520', 'UMIN000030584. MIRACLE (Methotrexate inadequate response patient with Rheumatoid Arthritis treated by Adalimumab in combination with Low-dose Methotrexate) Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000030584. (2017)   pp', '10.3410/f.14174.471676', '']\n",
      "['9257858', 'Rubbert-Roth A; Tak PP; Zerbini C; Tremblay JL; Carre√±o L; Armstrong G; Collinson N; Shaw TM; MIRROR Trial Investigators. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Rheumatology (Oxford, England). (2010) 49 9 pp1683-1693', '10.1093/rheumatology/keq116', 'http://academic.oup.com/rheumatology/article-pdf/49/9/1683/5050686/keq116.pdf']\n",
      "['9260873', 'Rubbert-Roth A; Tak PP; Zerbini C; Tremblay J-L; Carreno L; Armstrong G; Collinson N; Shaw T. Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: Results of a Phase III randomized study (MIRROR): Reply. Rheumatology. (2011) 50  3 pp632-633', '10.1093/rheumatology/keq401', 'http://academic.oup.com/rheumatology/article-pdf/50/3/632/5067955/keq401.pdf']\n",
      "['11085702', 'Skaria TG; Sreeprakash A; Umesh R; Joseph S; Mohan M; Ahmed S; Mehta P; Oommen SE; Benny J; Paulose A; Paul A; George J; Sukumaran A; Babu SS; Navas S; Vijayan A; Joseph S; Nalianda KK; Narayanan K; Shenoy P. Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials. The lancet rheumatology. (2022) 4 11 ppe755-e764', '10.1016/s2665-9913(22)00228-4', '']\n",
      "['9258064', 'Mladenovic V; Domljan Z; Rozman B; Jajic I; Mihajlovic D; Dordevic J; Popovic M; Dimitrijevic M; Zivkovic M; Campion G. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis and rheumatism. (1995) 38 11 pp1595-1603', '10.1002/art.1780381111', '']\n",
      "['9261849', 'Strand V; Rendas-Baum R; Chen C; Joseph G; Graham N; Van Hoogstraten H; Genovese MC; Huizenga T. Predicting the need for rescue medication using baseline variables: evidence from rheumatoid arthritis (RA) patients in the sarilumab mobility phase 3 trial. Annals of the rheumatic diseases. (2015) 74  pp1000-1001', '10.1136/annrheumdis-2015-eular.2853', '']\n",
      "['9261075', 'Genovese MC; Kivitz AJ; Campos JAS; Rell-Bakalarska M; Fleischmann RM; Radin AR; Huang X; Huizinga TWJ. Sarilumab for the treatment of moderate-to-severe rheumatoid arthritis: Results of a phase 2, randomized, double-blind, placebo-controlled, international study. Arthritis and rheumatism. (2011) 63  12 pp4041-4042', '10.1136/annrheumdis-2012-eular.1706', '']\n",
      "['9261127', 'Genovese MC; Fleischmann RM; Jasson M; Radin AR; Hamilton J; Huizinga TWJ. Sarilumab, a subcutaneously-administered, fully-human monoclonal antibody inhibitor of the il-6 receptor: Effects on hemoglobin levels in a clinical trial for the treatment of moderate-to-severe rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 var.pagings ppS568', '10.1136/annrheumdis-2013-eular.1843', '']\n",
      "['9261444', 'Huizinga TW; Kivitz AJ; Rell-Bakalarska M; Fleischmann RM; Jasson M; Radin AR; Genovese MC. Sarilumab for the treatment of moderate-to-severe rheumatoid arthritis: Results of a phase 2, randomized, double-blind, placebo-controlled, international study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1706', '']\n",
      "['9261463', 'Winthrop KL; Momtahen T; Fiore S; Weinstein SP; Van Adelsberg J; Wu R; Graham N. Sarilumab, a subcutaneously administered, fully human monoclonal antibody inhibitor of the IL-6 receptor alpha: 12 week infection rates by level of circulating neutrophils in rheumatoid arthritis and ankylosing spondylitis. Arthritis and rheumatism. (2013) 65  ppS1008', '10.1136/annrheumdis-2013-eular.1843', '']\n",
      "['9261548', 'Fiore S; Boyapati A; Hamon SC; Van Adelsberg J; Liu M; Hamilton JD. Il-6 receptor (IL-6R) blockade with sarilumab reduced circulating markers related to synovial inflammation and structural damage in patients with rheumatoid arthritis (RA) in a phase 2 study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3852', '']\n",
      "['9261675', 'Huizinga TW; Fleischmann RM; Jasson M; Radin AR; van Adelsberg J; Fiore S; Huang X; Yancopoulos GD; Stahl N; Genovese MC. Sarilumab, a fully human monoclonal antibody against IL-6R≈í¬± in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial. Annals of the rheumatic diseases. (2014) 73 9 pp1626-1634', '10.1136/annrheumdis-2013-204405', '']\n",
      "['9738261', 'Kavanaugh A; Decktor DL; Fan C; Van Adelsberg J; Martincova R; Genovese MC. A profile of the efficacy of sarilumab plus methotrexate in rheumatoid arthritis patients: results of a 52-week, phase 3, randomized, double-blind, placebo-controlled, international study. Arthritis and rheumatology. (2014)   ppS1233-S1234', '10.1136/annrheumdis-2015-eular.4772', '']\n",
      "['9257745', 'Van Der Heijde D; Van Adelsberg J; Van Hoogstraten H; Iglesias-Rodriguez M; Mangan E; Graham N; Dukovic D; Spindler A; Genovese MC. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2035-2038', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9258020', 'Fiore S; Genovese M; Fan C; Decktor D; Fleischmann R. Clinical and radiographic efficacy of sarilumab plus methotrexate in biologic-experienced and biologic-naive patients with rheumatoid arthritis in a phase 3, randomized, double-blind, placebo-controlled study. Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1217', '10.1136/annrheumdis-2015-eular.4772', '']\n",
      "['9258191', 'Boyapati A; Gabay C; Msihid J; Graham N; Fiore S; Hamilton JD. Evaluation of bone and joint proteins for prognostic association with radiographic progression and disease activity in methotrexate inadequate responder rheumatoid arthritis patients in a sarilumab phase 3 study. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp40', '10.1186/s13075-016-1132-9', 'http://link.springer.com/content/pdf/10.1186/s13075-016-1132-9.pdf']\n",
      "['9258193', 'Mark CG; Stanislav M; Van Hoogstraten H; Martincova R; Fan C; Van Adelsberg J. Efficacy of sarilumab plus methotrexate in achieving clinical remission, using 4 different definitions, in patients with active, moderate-to-severe rheumatoid arthritis in a phase 3 study. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp41', '10.1093/rheumatology/kex063.052', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex063.052/19706214/kex063.052.pdf']\n",
      "['9258195', 'Kavanaugh A; Kivitz AJ; Miranda PC; Fiore S; Fay J; Fan C; Van Adelsberg J; Huizinga TWJ. Efficacy and safety of sarilumab plus mtx in subgroups of patients with rheumatoid arthritis in a phase 3 study. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp42', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['9258284', 'Genovese MC; Parrino J; Mangan EK; Boddy A; Van Hoogstraten H. Efficacy and safety of sarilumab in Asian patients with rheumatoid arthritis and an inadequate response to methotrexate. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp195', '10.1136/annrheumdis-2016-eular.4280', '']\n",
      "['9261568', 'Genovese M; Fleischmann RM; Kivitz AJ; Rell-Bakalarska M; Martincova R; Fiore S; Rohane P; Van Hoogstraten H; Fan C; Van Adelsberg J; Weinstein S; Graham N; Stahl N; Yancopoulos G; Huizinga TW; Van Der Heijde D. Effects of sarilumab plus MTX on clinical, radiographic, and functional endpoints in patients with moderate-to-severe rheumatoid arthritis: Results of a phase 3, randomized, double-blind, placebo-controlled, international study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3001', '']\n",
      "['9261761', 'Strand V; Kosinski M; Joseph G; Chen C; Van Hoogstraten H; Graham N; Huizenga T; Genovese MC. Improvements in health related quality of life (HRQOL) reported by rheumatoid arthritis (RA) patients in a randomized controlled trial [RCT] of sarilumab [MOBILITY] that met or exceeded the patient acceptable symptom state [PASS] and normative values. Annals of the rheumatic diseases. (2015) 74  pp440', '10.1136/annrheumdis-2015-eular.3185', '']\n",
      "['9261860', 'Genovese MC; Decktor DL; Parrino J; Boddy A; Graham N. Effect of increased sarilumab dose on efficacy and safety outcomes in poorly responding rheumatoid arthritis (RA) patients: the mobility study. Annals of the rheumatic diseases. (2015) 74  pp727', '10.1136/annrheumdis-2015-eular.4607', '']\n",
      "['9261862', 'Van Der Heijde D; Genovese MC; Fan C; Fiore S; Decktor DL; Fleischmann R. Clinical and radiographic efficacy of sarilumab plus methotrexate in biologic-experienced and biologic-naive patients with rheumatoid arthritis in a phase 3, randomized, double-blind, placebo-controlled international study. Annals of the rheumatic diseases. (2015) 74  pp722', '10.1136/annrheumdis-2015-eular.4772', '']\n",
      "['9261877', 'Genovese MC; Nguyen D; Van Hoogstraten H; Van Adelsburg J; Wu R; Huizinga TWJ. Efficacy of sarilumab in moderate and severe rheumatoid arthritis AS defined by baseline das28-crp scores: the mobility study. Annals of the rheumatic diseases. (2015) 74  pp486', '10.1136/annrheumdis-2015-eular.4674', '']\n",
      "['9261985', 'Genovese MC; Stanislav M; Van Hoogstraten H; Martincova R; Fan C; Van Adelsberg J. Efficacy of sarilumab plus methotrexate in achieving clinical remission, using 4 different definitions, in patients with active, moderate-to-severe rheumatoid arthritis in a phase 3 study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1093/rheumatology/kex063.052', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex063.052/19706214/kex063.052.pdf']\n",
      "['9261989', 'Kavanaugh A; Kivitz AJ; Miranda P; Fiore S; Fay J; Fan C; Van Adelsberg J; Huizinga TWJ. Efficacy and safety of sarilumab plus MTX in subgroups of patients with rheumatoid arthritis in a phase 3 study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.39093', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39093']\n",
      "['9262253', 'Genovese M; Van Adelsberg J; Van Hoogstraten H; Iglesias-Rodriguez M; Mangan E; Graham N; Jayawardena S; Spindler A; Fiore S. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp895', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9262456', 'Damask A; Boyapati A; Hamilton JD; Hamon S; Paccard C; Parrino J; Van Adelsberg J; Graham NM; Penn J; Lopez A; Reid J; Overton J; Baras A; Shuldiner AR; Paulding C. UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp570-571', '10.1136/annrheumdis-2017-eular.5016', '']\n",
      "['9262574', 'Van Der Heijde D; Van Hoogstraten H; Iglesias-Rodriguez M; Mangan EK; Spindler A; Genovese MC. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS70', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9262614', 'Genovese MC; van Adelsberg J; Fan C; Graham NMH; van Hoogstraten H; Parrino J; Mangan EK; Spindler A; Huizinga TWJ; van der Heijde D; EXTEND study investigators. Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes. Rheumatology (Oxford, England). (2018) 57 8 pp1423-1431', '10.1093/rheumatology/key121', 'http://academic.oup.com/rheumatology/article-pdf/57/8/1423/25193914/key121.pdf']\n",
      "['9263584', 'Fleischmann R; Genovese M; Fan C; Fiore S; Decktor D. Efficacy and safety of sarilumab plus methotrexate in patients with rheumatoid arthritis using biologics and in those who are biologic-naive. Journal of clinical rheumatology. Conference: 19th pan american league of associations for rheumatology congress. Panama. (2016) 22 3 pp122', '10.1136/annrheumdis-2015-eular.4772', '']\n",
      "['9736522', 'Boyapati A; Msihid J; Cousin E; Cai L; Van Adelsberg J; Hamilton JD; Graham N; Momtahen T; Fiore S. Blockade of IL-6R signaling by sarilumab suppressed circulating markers of bone resorption and synovial damage in rheumatoid arthritis patients from a phase 3, randomized, double-blind, placebo-controlled, international study. Arthritis and rheumatology. (2014)   ppS1220-S1221', '10.1186/s13075-016-1132-9', 'http://link.springer.com/content/pdf/10.1186/s13075-016-1132-9.pdf']\n",
      "['9737116', 'Genovese M C; Van Adelsberg; Van Hoogstraten; Iglesias-Rodriguez M; Mangan E K; Graham N; Spindler A. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Rheumatology (united kingdom). (2017) 56 Supplement 2 pp', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9737545', 'Van Der Heijde D; Van Hoogstraten H; Iglesias-Rodriguez M; Mangan EK; Spindler A; Genovese MC. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS70', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9737714', 'Van Der Heijde D; Van Adelsberg J; Fay J; Van Hoogstraten H; Mangan EK; Graham N; Fan C; Spindler A; Genovese MC. Clinical and radiographic outcomes after 2 years of sarilumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp724', '10.1136/annrheumdis-2016-eular.4389', '']\n",
      "['9738353', '. Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 Years of sarilumab plus methotrexate treatment. RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2018-000887', '']\n",
      "['9738447', 'PER-072-11. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, TWO-PART, DOSE RANGING AND CONFIRMATORY STUDY WITH AN OPERATIONALLY SEAMLESS DESIGN, EVALUATING EFFICACY AND SAFETY OF SAR153191 IN ADDITION TO METHOTREXATE (MTX) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO ARE INADEQUATE RESPONDERS TO MTX THERAPY. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-072-11. (2011)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9738484', 'Fleischmann R; Decktor DL; Fan C; Van Hoogstraten H; Genovese MC. Comparable efficacy with sarilumab plus methotrexate in biologic-experienced and biologic-naive patients with moderate-to-severe rheumatoid arthritis from a phase 3, randomized, double-blind, placebo-controlled, international study. Arthritis and rheumatology. (2014)   ppS1232-S1233', '10.1136/annrheumdis-2015-eular.4772', '']\n",
      "['9738485', 'Strand V; Joseph G; Van Hoogstraten H; Chen C-I; Fan C; Carita P; Graham N; Momtahen T; Genovese MC. Impact of sarilumab on health related quality of life (HRQoL), fatigue, and sleep in rheumatoid arthritis patients at week 24-results of a phase 3, randomized, double-blind, placebo-controlled, multi-center study. Arthritis and rheumatology. (2014)   ppS669-S670', '10.1136/annrheumdis-2015-eular.3185', '']\n",
      "['9738627', 'Genovese Mark C; van Adelsberg Janet; Fan Chunpeng; Graham Neil M H; van Hoogstraten Hubert; Parrino Janie; Mangan Erin K; Spindler Alberto; Huizinga Tom W J; van der Heijde Desiree; EXTEND study investigators. Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes. Rheumatology (Oxford, England). (2018) 57 8 pp1423-1431', '10.1093/rheumatology/key121', 'http://academic.oup.com/rheumatology/article-pdf/57/8/1423/25193914/key121.pdf']\n",
      "['9739002', 'Van Der Heijde; Fan C; Van Hoogstraten; Mangan E K; Van Adelsberg; Miranda P C; Genovese M C. Consistency of radiographic responses with sarilumab plus methotrexate across subpopulations of patients with rheumatoid arthritis in a phase 3 study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp685', '10.1136/annrheumdis-2016-eular.4363', '']\n",
      "['9739755', 'CTRI/2012/05/002630. A randmized double blind trial to evaluate efficacy and safety of SAR153191 on top of methotrexate in patients with active Rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/05/002630. (2012)   pp', '10.1016/j.reumae.2012.07.005', '']\n",
      "['9740001', 'EUCTR2009-016266-90-PT. Evaluation of SAR153191 (REGN88) on top of methotrexate in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-016266-90-PT. (2010)   pp', '10.1186/isrctn14741429', '']\n",
      "['9740794', 'Nasonov EL; Stanislav ML; Raskina TA; Kuropatkin GV; Shirinsky IV; Rebrov AP; Shostak NA; Alikhanov BA; Ushakov EN; Kamalova RG; Smakotina SA; Simanenkov VI; Pavsun AS; Zaharjan II; Yakushin SS; Sandin MYu. Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III mobility study). Nauchno-prakticheskaya revmatologiya. (2019) 57 2 pp142-148', '10.14412/1995-4484-2019-142-148', 'https://rsp.ima-press.net/rsp/article/viewFile/2696/1819']\n",
      "['9741088', 'NCT01061736. Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients. https://clinicaltrials.gov/show/NCT01061736. (2010)   pp', '10.1186/s13075-019-1856-4', 'http://link.springer.com/article/10.1186/s13075-019-1856-4/fulltext.html']\n",
      "['9741347', 'Genovese Mark C; van der Heijde Desiree; Lin Yong; St John Gregory; Wang Sheldon; van Hoogstraten Hubert; Gomez-Reino Juan Jose; Kivitz Alan; Maldonado-Cocco Jose Antonio; Seriolo Bruno; Stanislav Marina; Burmester Gerd R. Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 Years of sarilumab plus methotrexate treatment. RMD open. (2019) 5 2 ppe000887', '10.1136/rmdopen-2018-000887', '']\n",
      "['9742493', 'Genovese MC; Mangan EK; Kimura T; Iglesias-Rodriguez M; Van Hoogstraten H; Huizinga TWJ. Duration of response in a phase 3 study of sarilumab plus methotrexate in patients with rheumatoid arthritis (RA). Internal medicine journal. (2018) Conference: 58th Annual Scientific Meeting of the Australian Rheumatology Association with the Rheumatology Health Professionals Association, ARA 2018. Australia. 48 Supplement 4 pp20-21', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['11083645', 'Burmester GR; Morello JP; Hagino O; Praestgaard A; Fiore S; Genovese MC. Association between low hemoglobin and radiographic progression over 52 weeks in patients with rheumatoid arthritis: results from a phase 3 trial of sarilumab. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp983', '10.1136/annrheumdis-2020-eular.2008', '']\n",
      "['11083728', 'Strand V; Msihid J; Kimura T; Boyapati A; St John G; Wei W. High baseline serum il-6 predicts increased sarilumab treatment response for patient reported symptoms and health-related quality of life among ra patients with inadequate response to MTX. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii98', '10.1093/rheumatology/keaa111.208', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.208/33102354/keaa111.208.pdf']\n",
      "['9257437', 'Genovese MC; Van Hoogstraten H; Mangan EK; Jayawardena S; Burmester GR. Sarilumab as monotherapy or combination therapy in patients with RA and intolerance or inadequate response to methotrexate. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp6-7', '10.1136/annrheumdis-2017-eular.1275', '']\n",
      "['9737437', '. Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient. ClinicoEconomics and outcomes research. (2019) 11  pp117-128', '10.2147/ceor.s183076', 'https://www.dovepress.com/getfile.php?fileID=47866']\n",
      "['9738182', 'Genovese MC; Van Hoogstraten H; Mangan EK; Jayawardena S; Burmester GR. Sarilumab as monotherapy or combination therapy in patients with RA and intolerance or inadequate response to methotrexate. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp6-7', '10.1136/annrheumdis-2017-eular.1275', '']\n",
      "['9740647', 'Boyapati A; Msihid J; Schwartzman S; Choy E; Burmester GR; Lam G; Kimura T; Sadeh J; Graham NMH. High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment response. Rheumatology (united kingdom). (2019) 58 Supplement 3 ppiii68-iii69', '10.1093/rheumatology/kez106.068', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.068/28712722/kez106.068.pdf']\n",
      "['11083859', 'Boyapati A; Schwartzman S; Msihid J; Choy E; Genovese MC; Burmester GR; Lam G; Kimura T; Sadeh J; Weinreich DM; Yancopoulos GD; Graham NMH. High Serum Interleukin-6 is Associated With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab from Adalimumab or Methotrexate in a Post Hoc Analysis. . (2020)   pp', '10.1002/art.41299', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41299']\n",
      "['11084468', 'Burmester GR; Bykerk VP; Buch MH; Tanaka Y; Kameda H; Praestgaard A; van Hoogstraten H; Fernandez-Nebro A; Huizinga T. Sarilumab monotherapy versus sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis. . (2021)   pp', '10.1093/rheumatology/keab676', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab676/40434877/keab676.pdf']\n",
      "['9257193', 'Burmester G; Genovese M; Hrycaj P; Van Hoogstraten H; St John G; Iglesias-Rodriguez M; Lin Y; Dong Q; Fleischmann R. Long-term efficacy of sarilumab in rheumatoid arthritis: results from three phase 3 clinical trials and their open-label extensions. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp200', '10.1136/annrheumdis-2020-eular.1977', '']\n",
      "['9262651', 'Curtis JR; St John G; Panucci M; Maldonado-Cocco JA. Reversible decreases in absolute neutrophil count (ANC) in rheumatoid arthritis (RA) patients (PTS) on sarilumab: comparison of dose delay and dose decrease vs continued treatment. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp946', '10.1136/annrheumdis-2018-eular.1371', '']\n",
      "['9736605', 'Gossec L; Boklage S; St John G; Van Hoogstraten H; Kimura T. Pain is improved in around 50% of patients and fatigue in 40% of patients with rheumatoid arthritis treated with sarilumab in the target, mobility and monarch trials. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1683-1684', '10.1136/annrheumdis-2019-eular.3239', '']\n",
      "['9736737', 'Bingham C; Boklage S; Kimura T; Cella D. Facit-fatigue to promis-fatigue cross-walked data from monarch, mobility and target randomized clinical trials of sarilumab for the treatment of moderately-to-severely active rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1419', '10.1136/annrheumdis-2019-eular.3239', '']\n",
      "['9738081', 'Curtis JR; St John G; Panucci M; Maldonado-Cocco JA. Reversible decreases in absolute neutrophil count (ANC) in rheumatoid arthritis (RA) patients (PTS) on sarilumab: comparison of dose delay and dose decrease vs continued treatment. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp946', '10.1136/annrheumdis-2018-eular.1371', '']\n",
      "['9738802', 'Burmester G; Genovese M; Hrycaj P; Van Hoogstraten H; St John G; Iglesias-Rodriguez M; Lin Y; Dong Q; Fleischmann R. Long-term efficacy of sarilumab in rheumatoid arthritis: results from three phase 3 clinical trials and their open-label extensions. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp200', '10.1136/annrheumdis-2020-eular.1977', '']\n",
      "['9738876', 'Genovese M; Fleischmann R; Mangan E; Van Hoogstraten; Lin Y; Iglesias-Rodriguez M; Kimura T; Vargas J I; Lee E B; Huizinga T; Burmester G. Efficacy and safety of sarilumab in subgroups of patients with active rheumatoid arthritis from three phase 3 studies. International journal of rheumatic diseases. (2018) 21 Supplement 1 pp199', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['11084010', 'Choy E; Bykerk V; Lee Y; St John G; Van Hoogstraten H; Ford K; Praestgaard A; Sebba A. Noninflammatory pain is a frequent phenomenon in rheumatoid arthritis and responds well to treatment with sarilumab. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp984-985', '10.1136/annrheumdis-2020-eular.2015', '']\n",
      "['11084341', 'Choy Ernest; Bykerk Vivian; Lee Yvonne C; van Hoogstraten Hubert; Ford Kerri; Praestgaard Amy; Perrot Serge; Pope Janet; Sebba Anthony. Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab. Rheumatology (Oxford, England). (2022)   pp', '10.1093/rheumatology/keac659', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac659/47881791/keac659.pdf']\n",
      "['11086532', 'Genovese MC; Burmester GR; Gossec L; Van Hoogstraten H; Praestgaard A; St John G; Huizinga T; Aletaha D; Fleischmann R. Associations between rheumatoid arthritis disease activity and patient-reported outcomes in sarilumab clinical trials. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp299-300', '10.1136/annrheumdis-2020-eular.1977', '']\n",
      "['11086665', 'Bykerk V; Wei W; Boklage S; Kimura T; Fiore S; St John G. Impact of sarilumab on unacceptable pain and inflammation control in moderately-to-severely active rheumatoid arthritis (RA) patients in 3 phase 3 studies. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii139', '10.1093/rheumatology/keaa109.024', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa109.024/33102648/keaa109.024.pdf']\n",
      "['9742099', 'Fleischmann R; Lin Y; St John G; Van der Heijde D; Qiu C; Jose Gomez-Reino J; Maldonado-Cocco JA; Stanislav M; Seriolo B; Burmester GR. Long-term safety with sarilumab plus conventional synthetic disease- modifying antirheumatic drugs (csDMARDs) and sarilumab monotherapy in rheumatoid arthritis (RA): an integrated analysis with 9,000 patient- years (Pt-Yrs) of follow-up. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2809-2811', '10.1093/rheumatology/kez106.080', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.080/28710381/kez106.080.pdf']\n",
      "['9742916', '. Long-term safety with sarilumab plus conventional synthetic disease- modifying antirheumatic drugs (csDMARDs) and sarilumab monotherapy in rheumatoid arthritis (RA): an integrated analysis with 9,000 patient- years (Pt-Yrs) of follow-up. Arthritis and rheumatology. (2018) 70  pp2809-2811', '10.1093/rheumatology/kez106.080', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.080/28710381/kez106.080.pdf']\n",
      "['9256823', 'Genovese MC; Mangan EK; Fay J; Kimura T; Van Hoogstraten H; Fleischmann R. Improvements in remission and low disease activity are achieved with ongoing sarilumab treatment, in patients with rheumatoid arthritis in 2 phase 3 studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/key075.441', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.441/24768357/key075.441.pdf']\n",
      "['9257741', 'Genovese MC; Fleischmann R; Mangan E; Van Adelsberg J; Iglesias-Rodriguez M; Dukovic D; Fan C; Huizinga TWJ. Efficacy and safety of sarilumab in subgroups of patients with rheumatoid arthritis from 2 phase 3 studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2032-2035', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['9258141', 'Fleischmann R; Mangan E; Van Hoogstraten H; Kivitz A; Burmester G. Onset of action of sarilumab in patients with rheumatoid arthritis in 2 phase 3 studies. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp28', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9262250', 'Fleischmann R; Mangan E; Van Adelsberg J; Fay J; Van Hoogstraten H; Bauer D; Kimura T; Kivitz A; Burmester G; Fiore S. Onset of action of sarilumab in patients with rheumatoid arthritis in 2 phase III studies. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp896-897', '10.1136/annrheumdis-2016-eular.4436', '']\n",
      "['9262420', 'Paccard C; Msihid J; Brisacier A; Damask A; Paulding C; Zilberstein M; Boyapati A. Sarilumab suppresses thrombosis-related gene expression in circulating blood cells in MTX-IR and TNF-IR patients with active rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp844', '10.1136/annrheumdis-2017-eular.5183', '']\n",
      "['9262609', 'Genovese MC; Mangan EK; Fay J; Kimura T; Van Hoogstraten H; Fleischmann R. Improvementsin remission and low disease activity are achieved with ongoing sarilumabtreatment, in patients with rheumatoid arthritis in two phase III studies. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii134-iii135', '10.1093/rheumatology/key075.441', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.441/24768357/key075.441.pdf']\n",
      "['9262656', 'Strand V; Hagino O; Guillonneau S; Boklage S; Reaney M; Sadeh J; Narcisse N; Mangan E; Kirmura T. Depressive symptoms in patients with rheumatoid arthritis in sarilumab target and mobility trials and impact of treatment. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp964', '10.1136/annrheumdis-2018-eular.3723', '']\n",
      "['9736695', 'Genovese MC; Fleischmann R; Hagino O; Hu C-C; Pena-Rossi C; Sadeh J; Graham NMH; Mangan EK; Van Hoogstraten H; Mandrup-Poulsen T. The effect of sarilumab in combination with csdmards on fasting glucose and glycosylated hemoglobin in patients with rheumatoid arthritis with and without diabetes. Internal medicine journal. (2018) Conference: 58th Annual Scientific Meeting of the Australian Rheumatology Association with the Rheumatology Health Professionals Association, ARA 2018. Australia. 48 Supplement 4 pp22', '10.1093/rheumatology/kez106.053', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.053/28711942/kez106.053.pdf']\n",
      "['9736968', 'Genovese MC; Fleischmann R; Mangan EK; Iglesias-Rodriguez M; Huizinga TWJ. Efficacyand safetyof sarilumab in subgroups of patients with rheumatoid arthritis from 2 phase-3 studies. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS68-S69', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['9737359', 'Emery P; Van Hoogstraten H; Mangan EK; Van Adelsberg J; Fan C; Kivitz A; Da Pinheiro GRC; Huizinga TW. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide antibody status in patients with rheumatoid arthritis. Rheumatology (united kingdom). (2017) Conference: Rheumatology 2017. United Kingdom. 56 Supplement 2 ppii140-ii141', '10.1093/rheumatology/kex062.230', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.230/19705884/kex062.230.pdf']\n",
      "['9738149', 'Genovese MC; Mangan EK; Fay J; Kimura T; Van Hoogstraten H; Fleischmann R. Improvementsin remission and low disease activity are achieved with ongoing sarilumabtreatment, in patients with rheumatoid arthritis in two phase III studies. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii134-iii135', '10.1093/rheumatology/key075.441', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.441/24768357/key075.441.pdf']\n",
      "['9738528', 'Genovese MC; Fleischmann R; Mangan EK; Van Adelsberg J; Iglesias-Rodriguez M; Fan C; Huizinga TW. Efficacy and safety of sarilumab in subgroups of patients with rheumatoid arthritis from 2 phase 3 studies. Rheumatology (united kingdom). (2017) Conference: Rheumatology 2017. United Kingdom. 56 Supplement 2 ppii137-ii138', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['9738555', 'Emery P; Van Hoogstraten H; Mangan E; Kivitz A; Pinheiro G; Huizinga T. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide autoantibody status in patients with rheumatoid arthritis. Internal medicine journal. (2017) Conference: New Zealand Rheumatology Association and Australian Rheumatology Association with the Rheumatology Health Professionals Association Joint Annual Scientific Meeting. New Zealand. 47 pp 29-30 pp', '10.1093/rheumatology/kex062.230', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.230/19705884/kex062.230.pdf']\n",
      "['9738714', 'Strand V; Hagino O; Guillonneau S; Boklage S; Reaney M; Sadeh J; Narcisse N; Mangan E; Kirmura T. Depressive symptoms in patients with rheumatoid arthritis in sarilumab target and mobility trials and impact of treatment. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp964', '10.1136/annrheumdis-2018-eular.3723', '']\n",
      "['9738878', 'Genovese M C; Fleischmann R; Mangan E K; Van Adelsberg; Iglesias-Rodriguez M; Fan C; Huizinga T W. Efficacy and safety of sarilumab in subgroups of patients with rheumatoid arthritis from 2 phase 3 studies. Rheumatology (united kingdom). (2017) 56 Supplement 2 pp', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['9739064', 'Emery P; Van Hoogstraten; Mangan E; Kivitz A; Pinheiro G; Huizinga T. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide autoantibody status in patients with rheumatoid arthritis. Internal medicine journal. (2017) 47 Supplement 2 pp29-30', '10.1093/rheumatology/kex062.230', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.230/19705884/kex062.230.pdf']\n",
      "['9739065', 'Emery P; Van Hoogstraten; Mangan E K; Van Adelsberg; Fan C; Kivitz A; Da R C Pinheiro G; Huizinga T. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide antibody status in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp732', '10.1136/annrheumdis-2016-eular.4415', '']\n",
      "['9739405', 'Emery P; Van Hoogstraten H; Mangan EK; Van Adelsberg J; Fan C; Kivitz A; Da RC Pinheiro G; Huizinga T. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide antibody status in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp732-', '10.1136/annrheumdis-2016-eular.4415', '']\n",
      "['9742603', 'Emery P; Van Hoogstraten; Mangan E K; Van Adelsberg; Fan C; Kivitz A; Da Pinheiro; G R C; Huizinga T W. Clinical responses of sarilumab based on rheumatoid factor and anti-cyclic citrullinated peptide antibody status in patients with rheumatoid arthritis. Rheumatology (united kingdom). (2017) 56 Supplement 2 pp', '10.1093/rheumatology/kex062.230', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.230/19705884/kex062.230.pdf']\n",
      "['9742605', 'Fleischmann R; Genovese M C; Van Adelsberg; Mangan E; Iglesias-Rodriguez M; Dukovic D; Huizinga T W J. Pooled safety and efficacy of sarilumab in rheumatoid arthritis patients 65 years of age and older. Arthritis and rheumatology. (2016) 68 Supplement 10 pp1993-1996', '10.1093/rheumatology/kex062.223', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.223/19705870/kex062.223.pdf']\n",
      "['11084582', 'Fleischmann R; Selmi C; Gonzalez-Gay MA; Van Hoogstraten H; Hagino O; Rajput T; John GS; Buttgereit F; Genovese MC. Glucocorticoid dose is progressively reduced in patients with rheumatoid arthritis (Ra) receiving sarilumab: results from the open label extend study. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii108', '10.1093/rheumatology/keaa111.229', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.229/33102732/keaa111.229.pdf']\n",
      "['9742217', 'Burmester GR; Lin Y; St John G; Wang S; Gomez-Reino JJ; Maldonado-Cocco JA; Salazar JC; Van Der Heijde D; Genovese MC. Long-term efficacy with 5-year-radiographic results and safety of sarilumab in combination with csdmards in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp946-947', '10.1136/annrheumdis-2018-eular.1373', '']\n",
      "['9256824', 'Burmester GR; Fiore S; Hu C-C; Fay J; Lee EB; Genovese MC. Efficacy and safety of switching from adalimumab to sarilumab in an open-label extension of a phase 3 monotherapy trial in patients with active rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9258125', 'Burmester G; Lin Y; Mangan E; Van Hoogstraten H; Vargas J; Lee E. Efficacy and safety of sarilumab versus adalimumab in a phase 3, randomized, double-blind, monotherapy study in patients with active rheumatoid arthritis with intolerance or inadequate response to methotrexate. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp26', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9258381', 'Burmester G; Lin Y; Patel R; Van Adelsberg J; Mangan E; Van Hoogstraten H; Bauer D; Vargas JI; Lee EB. Efficacy and safety of sarilumab versus adalimumab in a phase 3, randomized, double-blind, monotherapy study in patients with active rheumatoid arthritis with intolerance or inadequate response to methotrexate. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4308-4309', '10.1136/annrheumdis-2016-210310', '']\n",
      "['9262189', 'Burmester GR; Lin Y; Patel R; van Adelsberg J; Mangan EK; Graham NM; van Hoogstraten H; Bauer D; Ignacio Vargas J; Lee EB. Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial. Annals of the rheumatic diseases. (2017) 76 5 pp840-847', '10.1136/annrheumdis-2016-210310', '']\n",
      "['9262590', 'Burmester GR; Fiore S; Hu C-C; Van Hoogstraten H; Bong Lee E; Genovese MC. Efficacy and safety of switching from adalimumab to sarilumab in an open-label extension of a phase 3 monotherapy trial in patients with active rheumatoid arthritis (RA). Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp21', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9738271', 'Burmester GR; Lin Y; Mangan EK; Van Hoogstraten H; Kimura T; Vargas JI; Lee EB. Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with active rheumatoid arthritis in the phase 3 monarch study, including subpopulations. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp849', '10.1136/annrheumdis-2017-eular.4540', '']\n",
      "['9738594', 'Burmester GR; Fiore S; Hu C-C; Fay J; Lee EB; Genovese MC. Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii132-iii133', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9738619', 'Burmester G; Fiore S; Hu C-C; Fay J; Lee E-B; Genovese M. Efficacy and safety of switching from adalimumab to sarilumab in an open-label extension of a phase 3 monotherapy trial in patients with active rheumatoid arthritis. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1035', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9739507', 'Burmester GR; Hagino O; Dong Q; Stanislav M; Gomez-Centeno A; Selmi C; Huizinga TWJ; Mangan E; Gabay C; Genovese MC. Unique changes in hemoglobin with sarilumab versus adalimumab are independent of better disease control in patients with rheumatoid arthritis (RA). Arthritis and rheumatology. (2018) 70 Supplement 9 pp1688-1690', '10.1093/rheumatology/kez106.053', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.053/28711942/kez106.053.pdf']\n",
      "['9739684', 'EUCTR2014-002541-22-HU. Efficacy and safety of Sarilumab and Adalimumab monotherapy in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-002541-22-HU. (2014)   pp', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9739860', 'PER-081-14. A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY ASSESSING THE EFFICACY AND SAFETY OF SARILUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-081-14. (2015)   pp', '10.1016/j.jval.2018.04.1323', '']\n",
      "['9741220', 'NCT02332590. Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH). https://clinicaltrials.gov/show/NCT02332590. (2015)   pp', '10.1136/annrheumdis-2017-eular.4540', '']\n",
      "['9742492', 'Burmester GR; Fiore S; Hu C-C; Van Hoogstraten H; Bong Lee E; Genovese MC. Efficacy and safety of switching from adalimumab to sarilumab in an open-label extension of a phase 3 monotherapy trial in patients with active rheumatoid arthritis (RA). Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp21', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9743040', '. Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension. RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2019-001017', '']\n",
      "['9743101', 'Burmester Gerd R; Strand Vibeke; Rubbert-Roth Andrea; Amital Howard; Raskina Tatiana; Gomez-Centeno Antonio; Pena-Rossi Claudia; Gervitz Leon; Thangavelu Karthinathan; St John Gregory; Boklage Susan; Genovese Mark C. Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension. RMD open. (2019) 5 2 ppe001017', '10.1136/rmdopen-2019-001017', '']\n",
      "['9743224', 'Burmester GR; Strand V; Rubbert-Roth A; Amital H; Raskina T; Gomez-Centeno A; Pena-Rossi C; Gervitz L; Thangavelu K; St John G; Boklage S; Genovese MC. Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension. RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2019-001017', '']\n",
      "['11083741', 'Curtis J; Aletaha D; Burmester GR; Ford K; Van Hoogstraten H; Leher H; Thangavelu K; Bykerk V. Likelihood of clinical worsening among rheumatoid arthritis patients who achieved a partial response to adalimumab and were subsequently switched to sarilumab. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp296', '10.1136/annrheumdis-2020-eular.1729', '']\n",
      "['9262510', 'Gossec L; Strand V; Proudfoot C; Chen C; Guillonneau S; Kimura T; Van Hoogstraten H; Mangan E; Reaney M. Rheumatoid arthritis (RA) impact following treatment with sarilumab: patient reported outcomes using the raid scale from two randomized phase III trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp575-576', '10.1136/annrheumdis-2017-eular.3448', '']\n",
      "['9737279', '. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. Rheumatology (united kingdom). (2019) 58  ppiii61-iii62', '10.1093/rheumatology/kez106.053', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.053/28711942/kez106.053.pdf']\n",
      "['9737527', '. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. Annals of the rheumatic diseases. (2019) 78  pp1128-1129', '10.1136/annrheumdis-2019-eular.3259', '']\n",
      "['9738374', '. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. International journal of rheumatic diseases. (2019) 22  pp206-', '10.1136/annrheumdis-2019-eular.3259', '']\n",
      "['9741532', 'Gossec Laure; Strand Vibeke; Proudfoot Clare; Chen Chieh-I; Guillonneau Sophie; Kimura Toshio; van Hoogstraten Hubert; Mangan Erin; Reaney Matthew. Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale. Journal of rheumatology. (2019) 46 10 pp1259-1267', '10.3899/jrheum.180904', '']\n",
      "['9742346', 'Genovese MC; Burmester GR; Hagino O; Van Hoogstraten H; Mangan E; Thangavelu K; Fleischmann R; Mandrup-Poulsen T. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1128-1129', '10.1136/annrheumdis-2019-eular.3259', '']\n",
      "['9742382', 'Burmester GR; Hagino O; Van Hoogstraten H; Mangan E; Thangavelu K; Fleischmann R; Wilson E; Mandrup-Poulsen T. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. Rheumatology (united kingdom). (2019) Conference: 2019 Annual Conference of the British Society for Rheumatology, BSR 2019. United Kingdom. 58 Supplement 3 ppiii61-iii62', '10.1093/rheumatology/kez106.053', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.053/28711942/kez106.053.pdf']\n",
      "['11083614', 'Gossec Laure; Strand Vibeke; Proudfoot Clare; Chen Chieh-I; Guillonneau Sophie; Kimura Toshio; van Hoogstraten Hubert; Mangan Erin; Reaney Matthew. Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale. Journal of rheumatology. (2019) 46 10 pp1259-1267', '10.3899/jrheum.180904', '']\n",
      "['9259064', 'Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial. Journal of rheumatology. (1989) 16 3 pp302-306', '10.1093/rheumatology/37.11.1220', 'http://academic.oup.com/rheumatology/article-pdf/37/11/1220/18105859/371220.pdf']\n",
      "['9256797', 'Moreland LW; Bucy RP; Weinblatt ME; Mohler KM; Spencer-Green GT; Chatham WW. Immune function in patients with rheumatoid arthritis treated with etanercept. Clinical immunology (Orlando, Fla.). (2002) 103 1 pp13-21', '10.1006/clim.2001.5183', '']\n",
      "['9259501', 'Moreland LW; Schiff MH; Baumgartner SW; Tindall EA; Fleischmann RM; Bulpitt KJ; Weaver AL; Keystone EC; Furst DE; Mease PJ; Ruderman EM; Horwitz DA; Arkfeld DG; Garrison L; Burge DJ; Blosch CM; Lange ML; McDonnell ND; Weinblatt ME. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Annals of internal medicine. (1999) 130 6 pp478-486', '10.7326/0003-4819-130-6-199903160-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-130-6-199903160-00004']\n",
      "['9259731', 'Mathias SD; Colwell HH; Miller DP; Moreland LW; Buatti M; Wanke L. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clinical therapeutics. (2000) 22 1 pp128-139', '10.1016/s0149-2918(00)87984-9', '']\n",
      "['9258514', 'Moreland LW; Alten R; Van den Bosch F; Appelboom T; Leon M; Emery P; Cohen S; Luggen M; Shergy W; Nuamah I; Becker JC. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis and rheumatism. (2002) 46 6 pp1470-1479', '10.1002/art.10294', '']\n",
      "['9260224', 'Mottaghi P; Karimzade H. Does chloroquine decrease liver enzyme abnormalities induced by methoterexate in patients with rheumatoid arthritis?. Journal of research in medical sciences. (2005) 10 3 pp135-138', '10.1016/j.mehy.2005.08.039', '']\n",
      "['9737054', 'EUCTR2015-003140-39-BG. A Study to EValuate the Efficacy and Safety of JTE-051 in Subjects with Active Rheumatoid Arthritis (MOVE-RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003140-39-BG. (2016)   pp', '10.1186/isrctn50655730', '']\n",
      "['9742778', 'PER-046-15. A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF JTE-051 ADMINISTERED FOR 12 WEEKS TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS (MOVE-RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-046-15. (2015)   pp', '10.1186/isrctn61635363', '']\n",
      "['9260440', 'Agrawal NM; Aziz K. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs. Journal of rheumatology. Supplement. (1998) 51 51 pp17-20', '10.1097/00013614-199306000-00006', '']\n",
      "['11087226', 'Rubbert-Roth A; Combe B; Szekanecz Z; Hall S; Haraoui B; Attar S; Ekwall AKH; Song Y; Shaw T; Nagy O; Xavier R. CONSISTENCY in TIME to RESPONSE with UPADACITINIB AS MONOTHERAPY or COMBINATION THERAPY and ACROSS PATIENT POPULATIONS with RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp613-614', '10.1136/annrheumdis-2022-eular.1591', '']\n",
      "['9259494', 'Munro R; Morrison E; McDonald AG; Hunter JA; Madhok R; Capell HA. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1997) 56 6 pp374-377', '10.1136/ard.56.6.374', '']\n",
      "['9260904', 'Ogata A. Usefulness of the subcutaneous formulation of tocilizumab: Results of phase III trial in Japan. [Japanese]. Japanese Pharmacology and Therapeutics. (2013) 41  10 pp951-958', '10.1136/annrheumdis-2012-eular.2637', '']\n",
      "['9261346', 'Ogata A. Normalization of C-reactive protein within the first 8 weeks is a predictive factor for the effectiveness of subcutaneous tocilizumab monotherapy in Japanese rheumatoid arthritis patients: Results from the musashi study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1345', '']\n",
      "['9262091', 'Ogata A; Amano K; Dobashi H; Inoo M; Ishii T; Kasama T; Kawai S; Kawakami A; Koike T; Miyahara H; Miyamoto T; Munakata Y; Murasawa A; Nishimoto N; Ogawa N; Ojima T; Sano H; Shi K; Shono E; Suematsu E; Takahashi H; Tanaka Y; Tsukamoto H; Nomura A. Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: results from the 2-year Open-label Extension of the MUSASHI Study. Journal of rheumatology. (2015) 42 5 pp799-809', '10.3899/jrheum.140665', '']\n",
      "['9738949', 'Ogata A. Effectiveness and tolerability of subcutaneous tocilizumab in rheumatoid arthritis patients switched from intravenous tocilizumab: results from the extension period of the musashi study. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS555', '10.1136/annrheumdis-2012-eular.2637', '']\n",
      "['9739116', 'Ogata A. The musashi study: comparison of subcutaneous tocilizumab monotherapy versus intravenous tocilizumab monotherapy: results from a double-blind, parallel-group, comparative phase III non-inferiority study in japanese patients with rheumatoid arthritis. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.2637', '']\n",
      "['9257116', 'Kaeley GS; MacCarter DK; Goyal JR; Liu S; Chen K; Griffith J; Kupper H; Garg V; Kalabic J. Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: results From the MUSICA Trial. Rheumatology and therapy. (2018) 5 1 pp123-134', '10.1007/s40744-018-0105-7', 'http://link.springer.com/article/10.1007/s40744-018-0105-7/fulltext.html']\n",
      "['9261250', 'Kaeley GS; Nishio MJ; MacCarter D; Griffith J; Kupper H; Garg V; Kalabic J. Similar improvements in physical function, quality of life and work productivity among rheumatoid arthritis patients treated with 2 different doses of methotrexate in combination with adalimumab. Arthritis and Rheumatology. (2014) 66  ppS1042-S1043', '10.1136/annrheumdis-2015-eular.1473', '']\n",
      "['9261258', 'Kaeley GS; Nishio MJ; Goyal J; MacCarter D; Wells A; Cardoso A; Liu S; Kalabic J; Kupper H. The use of ultrasound to detect residual joint inflammation in patients with rheumatoid arthritis in clinical disease remission. Arthritis and Rheumatology. (2014) 66  ppS52', '10.1136/annrheumdis-2015-eular.1216', '']\n",
      "['9261490', 'Ahmed G; Goss SL; Klein CE; Mozaffarian N; Kaeley GS; Awni W. Adalimumab in combination with high and low dose-methotrexate in rheumatoid arthritis patients with inadequate response to methotrexate: Pharmacokinetic results from the musica study. Arthritis and rheumatism. (2013) 65  ppS623-S624', '10.1016/j.clinthera.2018.01.002', '']\n",
      "['9261760', 'Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Cardoso A; Liu S; Kalabic J; Kupper H. The use of ultrasound to detect residual joint inflammation in patients with rheumatoid arthritis in clinical disease remission. Annals of the rheumatic diseases. (2015) 74  pp447-448', '10.1136/annrheumdis-2015-eular.1216', '']\n",
      "['9261870', 'Kaeley G; Nishio MJ; MacCarter D; Griffith J; Garg V; Kupper H; Kalabic J. Similar improvements in quality of sleep, satisfaction with medication and sexual impairment among rheumatoid arthritis patients upon initiation of adalimumab in combination with two doses of methotrexate. Annals of the rheumatic diseases. (2015) 74  pp704-705', '10.1136/annrheumdis-2015-eular.1473', '']\n",
      "['9261929', 'Kaeley G; Evangelisto AM; Nishio MJ; Liu S; Kupper H. Impact of methotrexate dose reduction upon initiation of adalimumab on clinical and ultrasonographic parameters in patients with moderate to severe rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 no pagination pp', '10.1136/annrheumdis-2014-eular.1133', '']\n",
      "['9262336', 'Kaeley GS; Evangelisto AM; Nishio MJ; Goss SL; Liu S; Kalabic J; Kupper H. Methotrexate Dosage Reduction Upon Adalimumab Initiation: clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial. Journal of rheumatology. (2016) 43 8 pp1480-1489', '10.3899/jrheum.151009', '']\n",
      "['9737862', 'Kaeley GS; MacCarter DK; Goyal JR; Liu S; Chen K; Griffith J; Kupper H; Garg V; Kalabic J. Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: results From the MUSICA Trial. Rheumatology and therapy. (2018) 5 1 pp123-134', '10.1007/s40744-018-0105-7', 'http://link.springer.com/article/10.1007/s40744-018-0105-7/fulltext.html']\n",
      "['9738035', 'Kaeley Gurjit S; MacCarter Daryl K; Pangan Aileen L; Wang Xin; Kalabic Jasmina; Ranganath Veena K. Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate. Journal of rheumatology. (2018) 45 12 pp1628-1635', '10.3899/jrheum.171232', '']\n",
      "['9738283', 'NCT01185288. A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA). https://clinicaltrials.gov/show/NCT01185288. (2010)   pp', '10.1016/1043-6618(92)91298-u', '']\n",
      "['9739087', 'Kaeley G S; Nishio M J; Goyal J R; MacCarter D K; Wells A F; Cardoso A; Chen S; Kalabic J; Kupper H. Changes in ultrasonographic vascularity upon initiation of adalimumab combination therapy in rheumatoid arthritis patients with inadequate response to methotrexate. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.1389', '']\n",
      "['9742672', 'Kaeley GS; Evangelisto AM; Nishio MJ; Liu S; Kupper H. Impact of methotrexate dose reduction upon initiation of adalimumab on clinical and ultrasonographic parameters in patients with moderate to severe rheumatoid arthritis. Rheumatology (united kingdom). (2014) 53  ppi86-i87', '10.1093/rheumatology/keu101.004', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i86/9578446/keu101.004.pdf']\n",
      "['11085187', '. A study comparing extended release and immediate release formulations of EQ121 in adult healthy volunteers of Chinese descent- Part C. . (2022)   pp', '10.23880/beba-16000151', 'https://medwinpublishers.com/BEBA/comparative-bioequivalence-studies-of-two-metformin-extended-release-formulations-in-healthy-thai-volunteers.pdf']\n",
      "['11085193', 'Bagadia L. A randomised controlled trial using individualised homeopathic treatment for modifying anger and blood pressure in patients with essential hypertension - Comparison against standard care treatment. . (2020) 109 1 pp', '10.1055/s-0040-1702098', '']\n",
      "['11085194', 'Coles AJ; Jones JL; Vermersch P; Traboulsee A; Bass AD; Boster A; Chan A; Comi G; Fernandez O; Giovannoni G; Kubala Havrdova E; LaGanke C; Montalban X; Oreja-Guevara C; Piehl F; Wiendl H; Ziemssen T. Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: benefit/risk following review of trial and post-marketing data. Multiple sclerosis journal. (2022) 28 5 pp842-846', '10.1177/13524585211061335', 'https://journals.sagepub.com/doi/pdf/10.1177/13524585211061335']\n",
      "['11085196', 'Luo Z; Zhou K; Wang H; Pei F; Zhou Z. Comparison between Mid-Term Results of Total Knee Arthroplasty with Single-Radius versus Multiple-Radii Posterior-Stabilized Prostheses. Journal of knee surgery. (2022) 35 2 pp204-214', '10.1055/s-0040-1713897', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0040-1713897.pdf']\n",
      "['11085207', 'Somers TJ; Blumenthal JA; Dorfman CS; Huffman KM; Edmond SN; Miller SN; Wren AA; Caldwell D; Keefe FJ. Effects of a Weight and Pain Management Program in Patients With Rheumatoid Arthritis With Obesity: a Randomized Controlled Pilot Investigation. JCR: journal of clinical rheumatology. (2022) 28 1 pp7-13', '10.1097/rhu.0000000000001793', '']\n",
      "['11085211', '. Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis. . (2020)   pp', '10.1093/med/9780198831433.003.0011', '']\n",
      "['11085212', '. Effect of Laser Puncture on Rheumatoid Arthritis Patients. . (2020)   pp', '10.21203/rs.3.rs-43812/v1', 'https://www.researchsquare.com/article/rs-43812/v1']\n",
      "['11085213', '. Management Of Rheumatoid Arthritis with the help of Ayurvedic medicated herbs given as Enema (BASTI KARMA). . (2020)   pp', '10.47070/ijraps.v4i2.81', 'https://ijraps.in/index.php/ijraps/article/download/81/73']\n",
      "['11085214', '. A Randomized Double-blind Controlled Study on the Effect of Different Compatibility Ratios of Peony and Glycyrrhizae Herbs on the Clinical Efficacy of Jiedu Tongluo Shengjin Granules. . (2020)   pp', '10.1186/s13063-018-2633-4', 'http://link.springer.com/article/10.1186/s13063-018-2633-4/fulltext.html']\n",
      "['11085218', 'Zhao Lianyu; Li Meilin; Xu Yanping; Liu Lijuan; Zhang Mingying; Chen Guangxing. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial. Trials. (2019) 20 1 pp801', '10.1186/s13063-019-4005-0', 'http://link.springer.com/article/10.1186/s13063-019-4005-0/fulltext.html']\n",
      "['11085227', 'Genovese Mark C; Durez Patrick; Fleischmann Roy; Tanaka Yoshiya; Furst Daniel; Yamanaka Hisashi; Korneva Elena; Vasyutin Igor; Takeuchi Tsutomu. Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies. European journal of rheumatology. (2021) 8 3 pp120-129', '10.5152/eurjrheum.2021.19207', '']\n",
      "['11085230', 'Tong X; Heng TB; Gupta A; Shaw C; Gromala D; Li L. FitViz-Ad: a Non-Intrusive Reminder to Support and Encourage Rheumatoid Arthritis Patients with Physical Activity. Postgraduate medicine. (2019) 131 SUPPL 1 pp121-122', '10.2352/issn.2470-1173.2018.01.vda-332', '']\n",
      "['11085235', '. The Effect of topical Henna oil on pain in chronic sciatica patients. . (2021)   pp', '10.1016/j.jep.2023.116519', '']\n",
      "['11085250', 'Han Yong; Jin Jingri; Wu Fushun; Wang Zhiwei. Impacts of Low-Dose Total Glycosides of Tripterygium wilfordii plus Methotrexate on Immunological Function and Inflammation Level in Patients with Rheumatoid Arthritis. Computational and mathematical methods in medicine. (2022) 2022  pp7523673', '10.1155/2022/7523673', 'http://downloads.hindawi.com/journals/cmmm/2022/7523673.pdf']\n",
      "['11085252', 'Ruperto N; Lovell DJ; Synoverska O; Abud Mendoza C; Spindler A; Vyzhga Y; Tirosh I; Imundo L; Alexeeva E; Chiraseveenuprapund P; Shi H; Sawyerr G; Blum A; Klaus P; Shapiro A; Diehl A; Ebrahim A; Martini A; Brunner HI. Impact of concomitant methotrexate use and prior bdmard exposure on tofacitinib efficacy and safety in patients with polyarticular course juvenile idiopathic arthritis: post hoc analysis of a phase 3 withdrawal study. Pediatric rheumatology. (2021) 19 SUPPL 1 pp', '10.3899/jrheum.2024-0536', '']\n",
      "['11085253', 'Gossec L; Flipo RM; Schaeverbeke T; Albert C; Baillet A; Boissier MC; Confavreux C; Cormier G; Dernis E; Gervais Solau E; Godot S; Gottenberg JE; Goupille P; Lassoued S; Lequerre T; Liote F; Marcelli C; Maugars Y; Nguyen M; Perdriger A; Pers YM; Pertuiset E; Poiroux L; Rosenberg C; Roux C; Ruyssen-Witrand A; Soubrier M; Vergne-Salle P; Zarnitsky C; Fakra E; Marotte H; Levy-Weil FE. Sarilumab improved patient-perceived impact of rheumatoid arthritis whatever the baseline disease activity: first results from an interventional non controlled study: saripro, in moderate and severe rheumatoid arthritis patients. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp626', '10.1136/annrheumdis-2020-eular.5518', '']\n",
      "['11085255', \". Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia. . (2022)   pp\", '10.3747/co.v17i1.474', '']\n",
      "['11085263', 'Sharma RS; Pallua J; Schirmer M. Placebo-Related Adverse Events in Rheumatoid Arthritis. . (2022) 12 2 pp', '10.3390/biom12020303', '']\n",
      "['11085264', '. UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma. . (2021)   pp', '10.1097/gox.0000000000003373', '']\n",
      "['11085265', 'Studenic P; Aletaha D; De Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision. Annals of the rheumatic diseases. (2022) 82 1 pp74-80', '10.1136/ard-2022-223413', '']\n",
      "['11085267', 'Yousefi S; Zanjani Z; Omidi A; Zamani B; Sayyah M. Comparison of Mindfulness-Based Stress Reduction Therapy and Cognitive-Behavioral Therapy of Chronic Fatigue, Sleep Quality, Executive Function and Disease Activity in Patients with Rheumatoid Arthritis. Journal of contemporary psychotherapy. (2022)   pp', '10.1007/s10879-022-09558-3', 'https://link.springer.com/article/10.1007/s10879-022-09558-3/fulltext.html']\n",
      "['11085269', 'Bay-Jensen A-C; Kraus V; Frederiksen P; Ladel C; Karsdal MA. TYPE I COLLAGEN TURNOVER IN OSTEOARTHRITIS. A COMPARATIVE BIOMARKER INVESTIGATION IN THE OAI-FNIH STUDY. Osteoarthritis and cartilage. (2022) 30 Supplement 1 ppS112-S113', '10.1016/j.joca.2022.02.142', '']\n",
      "['11085272', 'Kerschbaumer Andreas; Stimakovits Nina Maria; Smolen Josef S; Stefanova Tijen; Chwala Eva; Aletaha Daniel. Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis. Annals of the rheumatic diseases. (2023)   pp', '10.1136/ard-2022-223349', '']\n",
      "['11085273', 'Saito Shuntaro; Suzuki Katsuya; Yoshimoto Keiko; Kondo Yasushi; Kikuchi Jun; Hanaoka Hironari; Kaneko Yuko; Takeuchi Tsutomu. Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients. Clinical and experimental rheumatology. (2022)   pp', '10.55563/clinexprheumatol/k0ctlf', '']\n",
      "['11085274', 'Stinson JN; Lalloo C; Hundert AS; Campillo S; Cellucci T; Dancey P; Duffy C; Ellsworth J; Feldman BM; Huber AM; Johnson N; Jong G; Oen K; Rosenberg AM; Shiff NJ; Spiegel L; Tse SML; Tucker L; Victor JC. Teens taking charge: a randomized controlled trial of a web-based self-management program with telephone support for adolescents with juvenile idiopathic arthritis. Journal of medical Internet research. (2020) 22 7 ppe16234', '10.2196/preprints.16234', '']\n",
      "['11085278', 'Suzuki Misaki; Shoji Satoshi; Miyoshi So; Krishnaswami Sriram. Model-Based Comparison of Dose-Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients. Journal of clinical pharmacology. (2020) 60 2 pp198-208', '10.1002/jcph.1514', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1514']\n",
      "['11085280', 'Winkler A; Sun W; De S; Jiao A; Nusrat Sharif M; Symanowicz PT; Athale S; Shin JH; Wang J; Jacobson BA; Ramsey SJ; Dower K; Andreyeva T; Liu H; Hegen M; Homer BL; Brodfuehrer J; Tilley M; Gilbert SA; Danto SI; Beebe JJ; Barnes BJ; Pascual V; Lin L-L; Kilty I; Fleming M; Rao VR. The IRAK4 kinase inhibitor PF-06650833 blocks inflammation in preclinical models of rheumatologic disease and in humans enrolled in a randomized clinical trial. . (2021)   pp', '10.1002/art.41953', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41953']\n",
      "['11085281', '. 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis. . (2022)   pp', '10.2165/00128413-200414230-00013', '']\n",
      "['11085283', 'Cupido AJ; Asselbergs FW; Natarajan P; Ridker PM; Hovingh GK; Schmidt AF. Dissecting the IL-6 pathway in cardiometabolic disease: a Mendelian randomization study on both IL6 and IL6R. British journal of clinical pharmacology. (2022) 88 6 pp2875-2884', '10.1111/bcp.15191', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15191']\n",
      "['11085284', 'Buch MH; Takeuchi T; Rajendran V; Gottenberg JE; Pechonkina A; Tan Y; Gong Q; Van Beneden K; Caporali R. CLINICAL OUTCOMES UP to WEEK 48 of ONGOING FILGOTINIB (FIL) RHEUMATOID ARTHRITIS (RA) LONG-TERM EXTENSION (LTE) TRIAL of BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG (BDMARD) INADEQUATE RESPONDERS (IR) INITIALLY on FIL or PLACEBO in A PHASE 3 PARENT STUDY (PS). Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1325-1326', '10.1136/annrheumdis-2022-eular.1624', '']\n",
      "['11085292', 'Li SiNi; Li JianHe; Peng LiuBao; Li YaMin; Wan XiaoMin. Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure. Rheumatology and therapy. (2021) 8 2 pp775-791', '10.1007/s40744-021-00300-4', 'https://link.springer.com/article/10.1007/s40744-021-00300-4/fulltext.html']\n",
      "['11085293', 'Bouman Chantal A M; van Herwaarden Noortje; Blanken Annelies B; Van der Laken Conny J; Gotthardt Martin; Oyen Wim J G; den Broeder Alfons A; van der Maas Aatke; van den Ende Cornelia H. 18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value. Rheumatology (Oxford, England). (2022) 61 SI ppSI6-SI13', '10.1093/rheumatology/keab842', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab842/41146146/keab842.pdf']\n",
      "['11085294', '. The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus. . (2021)   pp', '10.1016/j.cct.2022.106755', '']\n",
      "['11085295', '. Leflunomide and Hydroxychloroquine combination therapy  for primary Sj√∂gren‚Äôs Syndrome. . (2021)   pp', '10.33540/204', '']\n",
      "['11085296', 'Gautam S; Kumar R; Kumar U; Dada R. Improvement in mitochondrial integrity and fertility potential in men with Rheumatoid arthritis by yoga based lifestyle intervention. Human reproduction (Oxford, England). (2020) 35 SUPPL 1 ppi168-i169', '10.1093/humrep/deac107.016', 'https://academic.oup.com/humrep/article-pdf/37/Supplement_1/deac107.016/44305507/deac107.016.pdf']\n",
      "['11085299', 'Takai Chinatsu; Ito Satoshi; Kobayashi Daisuke; Nemoto Tetsuya; Lee Hyunho; Abe Asami; Otani Hiroshi; Nakazono Kiyoshi; Murasawa Akira; Ishikawa Hajime. Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: a Retrospective Analysis from a Single Center. Internal medicine (Tokyo, Japan). (2020) 59 16 pp1963-1970', '10.2169/internalmedicine.3934-19', '']\n",
      "['11085303', \"Hedstrom A; Kvarnstrom M; Lindberg G; Alsabeah S; Alsabeah H; Ndegwa N; Lohr JM; Haas SL; Vujasinovic M. High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency. Scandinavian journal of gastroenterology. (2022) 57 10 pp1250-1256\", '10.1080/00365521.2022.2065888', '']\n",
      "['11085307', 'Aldridge J; Andersson K; Gjertsson I; Hultgard Ekwall A-K; Hallstrom M; Van Vollenhoven R; Lundell A-C; Rudin A. Blood PD-1+TFh and CTLA-4+CD4+T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis. Rheumatology (united kingdom). (2022) 61 3 pp1233-1242', '10.1093/rheumatology/keab454', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab454/38843987/keab454.pdf']\n",
      "['11085315', 'Busby Amanda D; Wason James; Pratt Arthur G; Young Adam; Isaacs John D; Nikiphorou Elena. The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data. Rheumatology (Oxford, England). (2022) 61 11 pp4297-4304', '10.1093/rheumatology/keac139', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac139/43540309/keac139.pdf']\n",
      "['11085316', 'Chantzichristos D; Svensson P-A; Garner T; Glad CAM; Walker BR; Bergthorsdottir R; Ragnarsson O; Trimpou P; Stimson RH; Borresen SW; Feldt-Rasmussen U; Jansson P-A; Skrtic S; Stevens A; Johannsson G. Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial. eLife. (2021) 10  ppe62236', '10.7554/elife.62236', 'https://cdn.elifesciences.org/articles/62236/elife-62236-v1.pdf']\n",
      "['11085321', '. Impact of Photodynamic Therapy as an Adjunct to Non-surgical Periodontal Treatment on Clinical and Biochemical Parameters Among Patients Having Mild Rheumatoid Arthritis With Periodontitis. . (2021)   pp', '10.1016/j.pdpdt.2021.102698', '']\n",
      "['11085323', 'Elnaggar RK; Mahmoud WS; Abdelbasset WK; Alqahtani BA; Alrawaili SM; Elfakharany MS. Low-energy laser therapy application on knee joints as an auxiliary treatment in patients with polyarticular juvenile idiopathic arthritis: a dual-arm randomized clinical trial. Lasers in medical science. (2022) 37 3 pp1737-1746', '10.1007/s10103-021-03427-6', 'https://link.springer.com/article/10.1007/s10103-021-03427-6/fulltext.html']\n",
      "['11085332', 'Nielsen MA; Koster D; Stengaard-Pedersen K; Busson P; Junker P; Horslev-Petersen K; Hetland ML; Ostergaard M; Hvid M; Kragstrup TW; Deleuran B. PLASMA GALECTIN-9 IS ASSOCIATED with CLINICAL DISEASE ACTIVITY in TREATMENT NAIVE EARLY RHEUMATOID ARTHRITIS, UNAFFECTED by DMARD TREATMENT, and in VITRO MODULATES the SECRETION of MCP-1 and IL-6 in RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp462-463', '10.1136/annrheumdis-2022-eular.1213', '']\n",
      "['11085333', 'Shen B; Shi S; Cui H; Li Y; Chen H; Jin H; Xu J; Liu Z; Jin Y. A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs. Frontiers in pediatrics. (2022) 10  pp905182', '10.3389/fped.2022.905182', '']\n",
      "['11085336', 'Spekking K; De Boer P; Bergstra SA; Van Den Berg JM; Schonenberg-Meinema D; Van Suijlekom-Smit LW; Van Rossum MA; Koopman-Keemink Y; Ten Cate R; Allaart CF; Brinkman DM; Hissink Muller PCE. Treatment to target reduced pain significantly in children with juvenile idiopathic arthritis participating in the best for kids study. Pediatric rheumatology. (2021) 19 SUPPL 1 pp', '10.1136/annrheumdis-2021-eular.988', '']\n",
      "['9262604', 'Nakamura Y; Suzuki T; Yamazaki H; Kato H. Tofacitinib versus non-tumor necrosis factor biologics for patients with active rheumatoid arthritis. Archives of rheumatology. (2018) 33 2 pp154-159', '10.5606/archrheumatol.2018.6366', '']\n",
      "['9737187', 'Nakamura Yukio; Suzuki Takako; Yamazaki Hideshi; Kato Hiroyuki. Tofacitinib versus non-tumor necrosis factor biologics for patients with active rheumatoid arthritis. Archives of rheumatology. (2018) 33 2 pp154-159', '10.5606/archrheumatol.2018.6366', '']\n",
      "['9739949', 'EUCTR2005-004530-40-AT. Induction of remission in RA patients at low disease activity by additional Infliximab-therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-004530-40-AT. (2005)   pp', '10.1136/ard.2009.121491', '']\n",
      "['9739638', 'EUCTR2008-005525-11-FR. A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera¬¨√Ü) and tocilizumab (RoActemra¬¨√Ü) versus tocilizumab therapy in patients with active rheumatoid arthritis with an incomplete response to methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-005525-11-FR. (2009)   pp', '10.1016/s0084-3873(08)70006-3', '']\n",
      "['9742722', 'EUCTR2009-011206-42-CZ. A Randomized, Double Blind, Placebo Controlled, Dose Ranging, Parallel Group, Phase 2 Study of INCB028050 Compared to Background Therapy in Patients with Active Rheumatoid Arthritis with Inadequate Response to Any Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy including Biologics. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011206-42-CZ. (2009)   pp', '10.1186/isrctn48638981', '']\n",
      "['9737677', 'EUCTR2010-021020-94-HU. A randomized, double-blind, parallel-group, placebo- and active calibrator-controlled study assessing the clinical benefit of SAR153191 subcutaneous (SC) on top of methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who have failed previous tumor necrosis factor-alpha (TNF-a) antagonists. - Effect of  SAR153191with Methotrexate in patients with active rheumatoid arthritis who failed TNF-a. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021020-94-HU. (2010)   pp', '10.1186/isrctn89222125', '']\n",
      "['9737283', 'EUCTR2010-019935-37-FI. A pragmatic, randomized, parallel group study of the effect on disease remission, work productivity, and tolerability of tocilizumab in combination with DMARDs and individually designed best practice DMARD therapy in patients with early, moderate to severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019935-37-FI. (2010)   pp', '10.3410/f.718056357.793482541', '']\n",
      "['9739709', 'EUCTR2010-023587-40-ES. A randomized, double-blind, parallel-group study of the reduction of signs and symptoms during treatment with tocilizumab versus adalimumab, both in combination with MTX, in patients with moderate to severe active rheumatoid arthritis and an inadequate response to treatment with only one TNF inhibitor. Estudio randomizado, doble ciego, de grupos paralelos de la reducci‚àö‚â•n de los signos y s‚àö‚â†ntomas durante el tratamiento con tocilizumab versus con adalimumab, ambos asociados con MTX, en pacientes con artritis reumatoide activa moderada a severa y respuesta inadecuada al tratamiento con s‚àö‚â•lo un inhibidor de TNF. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-023587-40-ES. (2011)   pp', '10.1016/j.jval.2015.09.037', '']\n",
      "['9261854', 'Shin K; Park S-H; Park W; Baek H-J; Lee Y-J; Kang S-W; Choe J-Y; Yoo W-H; Park Y-B; Song J-S; Yoo B; Yoo D-H; Song YW. Monthly ibandronate reduces bone loss in osteopenic women with rheumatoid arthritis receiving long-term glucocorticoids: a 48-week double-blinded randomized placebo-controlled investigator-initiated trial. Annals of the rheumatic diseases. (2015) 74  pp762', '10.1136/annrheumdis-2015-eular.3204', '']\n",
      "['9737513', 'NCT01373151. Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate. https://clinicaltrials.gov/show/NCT01373151. (2011)   pp', '10.1002/art.33419', '']\n",
      "['11087976', 'Kavanaugh Arthur; Westhovens Rene R; Winthrop Kevin L; Lee Susan J; Tan YingMeei; An Di; Ye Lei; Sundy John S; Besuyen Robin; Meuleners Luc; Stanislavchuk Mykola; Spindler Alberto J; Greenwald Maria; Alten Rieke; Genovese Mark C. Safety and Efficacy of Filgotinib: up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs. Journal of rheumatology. (2021) 48 8 pp1230-1238', '10.3899/jrheum.201183', '']\n",
      "['9262453', 'Winthrop KL; Wouters A; Choy EH; Nduaka C; Biswas P; Wang L; Hodge J; Lazariciu I; Soma K; Mojcik CF; Rigby WFC. The effectiveness of zoster vaccine in RA patients subsequently treated with tofacitinib. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp148-149', '10.1136/annrheumdis-2017-eular.2437', '']\n",
      "['9262503', 'Secher AE; Glintborg B; Gudbergsen H; Krogh NS; Jensen DV; Sorensen IJ; Christensen R; Skougaard M; Hetland ML. Comparing electronic collection of patient reported outcomes at home versus touch-screens in the waiting area among patients with arthritis in clinical practice: a randomised agreement study with online recruitment using Danbio. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp456-457', '10.1136/annrheumdis-2017-eular.3726', '']\n",
      "['11085740', 'Constantin Arnaud; Caporali Roberto; Edwards Christopher J; Fonseca Joao Eurico; Iannone Florenzo; Keystone Edward; Schulze-Koops Hendrik; Kwon Taek; Kim Seungmin; Yoon SangWook; Kim Dong-Hyeon; Park Gahee; Yoo Dae Hyun. Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomised phase III trial. Rheumatology (Oxford, England). (2022)   pp', '10.1093/rheumatology/keac689', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac689/48844044/keac689.pdf']\n",
      "['9740476', 'EUCTR2017-000947-41-FR. ORENCIA VERSUS ROACTEMRA BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TNF ALPHA INHIBITOR INADEQUATE RESPONDER PATIENTS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-000947-41-FR. (2017)   pp', '10.1186/isrctn62900439', '']\n",
      "['9739561', 'NCT03784261. Usefulness of Non TNF Usage in RA Patients. Https://clinicaltrials.gov/show/nct03784261. (2018)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9740623', 'NCT03976245. A Randomized Trial of Advanced Therapeutics in Rheumatoid Arthritis (RA). Https://clinicaltrials.gov/show/nct03976245. (2019)   pp', '10.31525/ct1-nct03976245', '']\n",
      "['11088648', '. Treatment of Pregnancy RA. . (2020)   pp', '10.1093/rheumatology/kev091.033', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i184/5181708/kev091.033.pdf']\n",
      "['11088636', '. Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: a Feasibility Study. . (2021)   pp', '10.1016/j.autrev.2004.08.030', '']\n",
      "['9257435', 'Kuusalo L; Puolakka K; Kautiainen H; Karjalainen A; Malmi T; Paimela L; Leirisalo-Repo M; Rantalaiho V; NEO-RACo Study Group. High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis. Clinical rheumatology. (2018) 37 6 pp1689-1694', '10.1007/s10067-017-3958-1', 'http://link.springer.com/article/10.1007/s10067-017-3958-1/fulltext.html']\n",
      "['9258156', 'Kuusalo LA; Puolakka KT; Kautiainen H; Alasaarela EM; Hannonen PJ; Julkunen HA; Kaipiainen-Sepp√§nen OA; Korpela MM; M√∂tt√∂nen TT; Paimela LH; Peltomaa RL; Yli-Kerttula TK; Leirisalo-Repo M; Rantalaiho VM; NEO-RACo Study Group. Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial. Clinical and experimental rheumatology. (2016) 34 6 pp1038-1044', '10.3899/jrheum.190139', '']\n",
      "['9260736', \"Moreland LW; O'Dell JR; Paulus HE; Curtis JR; Bathon JM; St Clair EW; Bridges SL; Zhang J; McVie T; Howard G; van der Heijde D; Cofield SS; TEAR Investigators. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis and rheumatism. (2012) 64 9 pp2824-2835\", '10.1002/art.34498', '']\n",
      "['9261298', \"Kuusalo L; Rantalaiho V; Kautiainen H; Korpela M; Puolakka K; Leirisalo-Repo M. Impact of physicians' activity and adherence to treat-totarget strategy on outcomes in early rheumatoid arthritis: A subanalysis of the Neo-RACo trial. Scandinavian journal of rheumatology. (2014) 43  pp1-2\", '10.3109/03009742.2015.1043142', '']\n",
      "['9261299', 'Rantalaiho V; Martikainen J; Kautiainen H; Puolakka K; Leirisalo-Repo M. Initial infliximab is not cost-effective added on to a remission-targeted combination therapy in early rheumatoid arthritis: The 2-year results of the randomized clinical NEO-RACo trial. Scandinavian journal of rheumatology. (2014) 43  pp1', '10.1136/annrheumdis-2014-eular.3265', '']\n",
      "['9261700', 'Rantalaiho V; Kautiainen H; Korpela M; Hannonen P; Kaipiainen-Sepp‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫nen O; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Kauppi M; Karjalainen A; Laiho K; Laasonen L; Hakola M; Peltomaa R; Leirisalo-Repo M; NEO-RACo Study Group. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial. Annals of the rheumatic diseases. (2014) 73 11 pp1954-1961', '10.4324/9780203187838.bmatt3', '']\n",
      "['9261723', \"Kuusalo L; Puolakka K; Kautiainen H; Bl‚àö‚Ä¢field H; Eklund KK; Ilva K; Kaipiainen-Sepp‚àö¬ßnen O; Karjalainen A; Korpela M; Valleala H; Leirisalo-Repo M; Rantalaiho V; Neo-RACo Study Group. Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the neo-raco trial. Scandinavian journal of rheumatology. (2015) 44  6 pp449-455\", '10.3109/03009742.2015.1043142', '']\n",
      "['9261813', 'Rantalaiho V; Leirisalo-Repo M; Kautiainen H; Mankinen P; Martikainen J; Puolakka K. Vitality, presenteeism, and their determinants in patients with early rheumatoid arthritis treated with a 6-month induction infliximab therapy added on a triple combination therapy. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.6328', '']\n",
      "['9261847', 'Kuusalo L; Puolakka K; Kautiainen H; Leirisalo-Repo M; Rantalaiho V. Depressive symptoms and the risk of work disability in early rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp1014', '10.1136/annrheumdis-2015-eular.3163', '']\n",
      "['9261868', 'Puolakka K; Kautiainen H; Rantalaiho V; Martikainen J; Leirisalo-Repo M. A 6-month induction treatment with infliximab added on intensive combination therapy with conventional dmards and low-dose prednisolone saves work productivity loss during the first treatment year in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp707-708', '10.1136/annrheumdis-2015-eular.6328', '']\n",
      "['9261899', 'Kuusalo L; Puolakka K; Kautiainen H; Leirisalo-Repo M; Rantalaiho V. Impact of neglecting intra-articular glucocorticoid-injections in remission targeted treatment of early rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp237', '10.1136/annrheumdis-2015-eular.3150', '']\n",
      "['9262277', 'V‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫n‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫nen T; Vuolteenaho K; Kautiainen H; Nieminen R; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞tt‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞nen T; Hannonen P; Korpela M; Kauppi MJ; Laiho K; Kaipiainen-Sepp‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫nen O; Luosuj‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫rvi R; Uusitalo T; Uutela T; Leirisalo-Repo M; Moilanen E; NEO-RACo Study Group. Glycoprotein YKL-40: a potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. Plos one. (2017) 12 8 ppe0183294', '10.4324/9780203187838.bmatt3', '']\n",
      "['9263490', 'Rantalaiho V; Kautiainen H; J√§rvenp√§√§ S; Korpela M; Malmi T; Hannonen P; Kaipiainen-Sepp√§nen O; Yli-Kerttula T; M√∂tt√∂nen T; Mustila A; Karjalainen A; Paimela L; Uutela T; Leirisalo-Repo M; NEO-RACo Study Group. Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial. Journal of rheumatology. (2014) 41 12 pp2379-2385', '10.3899/jrheum.140267', '']\n",
      "['9737049', 'Rantalaiho V; Martikainen J; Kautiainen H; Puolakka K; Leirisalo-Repo M. Initial infliximab is not cost-effective in otherwise actively treated early rheumatoid arthritis. The 2-year follow-up results of the randomized clinical NEO-RACo trial. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.3265', '']\n",
      "['9737869', '. Excellent outcomes sustained even in long-term when targeted treatment with a combination of traditional DMARDS is used in early rheumatoid arthritis. The 10-year follow-up results of a randomized clinical trial, the Neo-Raco trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp240-241', '10.1136/annrheumdis-2016-eular.2426', '']\n",
      "['9738129', 'Kuusalo Laura; Puolakka Kari; Kautiainen Hannu; Karjalainen Anna; Malmi Timo; Paimela Leena; Leirisalo-Repo Marjatta; Rantalaiho Vappu; NEO-RACo Study Group. High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis. Clinical rheumatology. (2018) 37 6 pp1689-1694', '10.1007/s10067-017-3958-1', 'http://link.springer.com/article/10.1007/s10067-017-3958-1/fulltext.html']\n",
      "['9738932', 'Leirisalo-Repo M; Kautiainen H; Laasonen L; Mottonen T; Hannonen P; Korpela M; Kauppi M; Kaipiainen-Seppanen O; Luosujarvi R; Blafield H; Moilanen E. A randomized double-blind placebo-controlled study on addition of 6-month induction therapy with infliximab to triple DMARD plus prednisolone therapy in patients with early active rheumatoid arthritis: high remission rates and no joint destruction during first 2 years. The neo-raco study. Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1371/journal.pone.0183294', '']\n",
      "['9738956', 'Rantalaiho V; Kautiainen H; Korpela M; Hannonen P; Kaipiainen-Seppanen O; Mottonen T; Kauppi M; Karjalainen A; Laiho K; Laasonen L; Hakola M; Peltomaa R; Leirisalo-Repo M; Alasaarela E; Blafield H; Eklund K K; Ilva K; Julkunen H; Kononoff A; Krogerus M L; Luosujarvi R; Luukkainen R; Malmi T; Niinisalo H; Paimela L; Puolakka K; Pollanen J; Uusitalo T; Uutela T; Valleala H; Vuori K; Moilanen E; Nieminen R; Vuolteenaho K. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial. Annals of the rheumatic diseases. (2013)   pp', '10.1136/annrheumdis-2013-203497', '']\n",
      "['9738957', 'Rantalaiho V; Sandstrom T; Koski J; Kautiainen H; Leirisalo-Repo M. Excellent outcomes sustained even in long-term when targeted treatment with a combination of traditional DMARDS is used in early rheumatoid arthritis. The 10-year follow-up results of a randomized clinical trial, the Neo-Raco trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp240-241', '10.1136/annrheumdis-2016-eular.2426', '']\n",
      "['9741395', 'Sandstrom Tia; Rantalaiho Vappu; Yli-Kerttula Timo; Kautiainen Hannu; Malmi Timo; Karjalainen Anna; Uusitalo Tea; Julkunen Heikki; Kaipiainen-Seppanen Oili; Paimela Leena; Puolakka Kari; Uutela Toini; Mottonen Timo; Hannonen Pekka; Leirisalo-Repo Marjatta; Laasonen Leena; Kauppi Markku; NEO-RACo Study Group. Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study. Journal of rheumatology. (2019)   pp', '10.3899/jrheum.190139', '']\n",
      "['9743010', 'NCT00908089. TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00908089. (2009)   pp', '10.1016/b978-032305475-1.50045-8', '']\n",
      "['11083771', 'Vuolteenaho K; Tuure L; Nieminen R; Laasonen L; Leirisalo-Repo M; Moilanen E; Leirisalo-Repo M; Mottonen T; Korpela M; Kauppi M; Luosujarvi R; Alasaarela E; Blafield H; Eklund KK; Hakola M; Hannonen P; Ilva K; Julkunen H; Kaipiainen-Seppanen O; Karjalainen A; Kononoff A; Krogerus M-L; Laiho K; Luukkainen R; Malmi T; Niinisalo H; Paimela L; Peltomaa R; Puolakka K; Rantalaiho V; Uusitalo T; Uutela T; Valleala H; Vuori K. Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab. Scandinavian journal of rheumatology. (2021) 51 3 pp180-185', '10.1136/annrheumdis-2013-203497', '']\n",
      "['11088148', 'Sandstrom Tia; Rantalaiho Vappu; Yli-Kerttula Timo; Kautiainen Hannu; Malmi Timo; Karjalainen Anna; Uusitalo Tea; Julkunen Heikki; Kaipiainen-Seppanen Oili; Paimela Leena; Puolakka Kari; Uutela Toini; Mottonen Timo; Hannonen Pekka; Leirisalo-Repo Marjatta; Laasonen Leena; Kauppi Markku; NEO-RACo Study Group. Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study. Journal of rheumatology. (2020) 47 8 pp1160-1164', '10.3899/jrheum.190139', '']\n",
      "['9257227', 'Neumann VC; Shinebaum R; Cooke EM; Wright V. Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine. British journal of rheumatology. (1987) 26 5 pp334-337', '10.1093/rheumatology/26.5.334', 'http://academic.oup.com/rheumatology/article-pdf/26/5/334/5040326/26-5-334.pdf']\n",
      "['9258922', 'Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. British medical journal (Clinical research ed.). (1983) 287 6399 pp1099-1102', '10.1136/bmj.287.6399.1099', '']\n",
      "['9259015', 'Neumann V; Hopkins R; Dixon J; Watkins A; Bird H; Wright V. Combination therapy with pulsed methylprednisolone in rheumatoid arthritis. Annals of the rheumatic diseases. (1985) 44 11 pp747-751', '10.1136/ard.44.11.747', '']\n",
      "['9257559', 'Michelsen B; Fagerli KM; Lie E; Hammer HB; Haugeberg G; Kristianslund EK; Kvien TK. Do depression and anxiety reduce the chance of remission in rheumatoid arthritis and psoriatic arthritis?. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4122-4124', '10.1002/art.39977', '']\n",
      "['9262697', 'Gehin JE; Goll GL; Warren DJ; Syversen SW; Sexton J; Strand EK; Kvien TK; Bolstad N; Lie E. Anti-drug antibodies to certolizumab pegol are associated with low drug levels and reduced clinical response at 3 months in patients with inflammatory joint diseases. Data from the nor-DMARD study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp844', '10.1136/annrheumdis-2018-eular.5257', '']\n",
      "['9737750', 'Syversen SW; Goll GL; Jorgensen KK; Olsen IC; Sandanger O; Gehin JE; Warren DJ; Sexton J; Mork C; Jahnsen Jo; Kvien TK; Bolstad N; Haavardsholm EA. Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study). Trials. (2020) 21 1 pp', '10.1186/s13063-019-3734-4', 'http://link.springer.com/article/10.1186/s13063-019-3734-4/fulltext.html']\n",
      "['9741622', 'Syversen Silje W; Goll Guro L; Jorgensen Kristin K; Olsen Inge C; Sandanger Oystein; Gehin Johanna E; Warren David J; Sexton Joseph; Mork Cato; Jahnsen Jorgen; Kvien Tore K; Bolstad Nils; Haavardsholm Espen A. Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study). Trials. (2020) 21 1 pp13', '10.1186/s13063-019-3734-4', 'http://link.springer.com/article/10.1186/s13063-019-3734-4/fulltext.html']\n",
      "['11085755', 'Brun MK; Goll GL; Jorgensen KK; Sexton J; Gehin JE; Sandanger O; Olsen IC; Klaasen RA; Warren DJ; Mork C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA; Syversen SW. Risk factors for anti-drug antibody formation to infliximab: secondary analyses of a randomised controlled trial. Journal of internal medicine. (2022) 292 3 pp477-491', '10.1111/joim.13495', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13495']\n",
      "['11086091', 'Brun MK; Goll GL; Jorgensen KK; Sandanger O; Sexton J; Olsen IC; Gehin JE; Warren DJ; Klaasen RA; Zettel C; Aga Ljosa MK; Haugen AJ; Njalla RJ; Bruun TJ; Michelsen B; Strand EK; Skorpe S; Bragnes YH; Mielnik P; Mork C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA; Syversen SW. Risk factors for anti-infliximab antibody formation: results from the randomized controlled NOR-DRUM A trial. Scandinavian journal of rheumatology. (2021) 50 SUPPL 130 pp2-3', '10.1136/annrheumdis-2021-eular.1380', '']\n",
      "['11086170', 'Brun MK; Goll GL; Jorgensen KK; Sexton J; Gehin JE; Sandanger O; Olsen I; Klaasen RA; Warren DJ; Mork C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA; Syversen SW. Risk factors for anti-infliximab antibody formation: results from the randomised controlled nor-drum a trial. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp185', '10.1136/annrheumdis-2021-eular.1380', '']\n",
      "['11086455', 'Jorgensen KK; Syvertsen SW; Goll GL; Sandanger O; Sexton J; Gehin J; Brun MK; Warren DJ; Olsen IC; Mork C; Kvien TK; Bolstad N; Haavardsholm EA; Jahnsen J. Proactive therapeutic drug monitoring in the early phase of infliximab therapy: results from a 30 week multicentre randomised trial of 400 patients (the nor-drum study). United European gastroenterology journal. (2020) 8 8 SUPPL pp399', '10.1136/annrheumdis-2020-eular.1082', '']\n",
      "['11086606', 'Syversen SW; Goll GL; Jorgensen KK; Sandanger O; Sexton J; Olsen I; Gehin J; Brun MK; Warren D; Mork C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA. Therapeutic drug monitoring compared to standard treatment of patients starting infliximab therapy: results from a multicentre randomised trial of 400 patients. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp12', '10.1136/annrheumdis-2020-eular.1082', '']\n",
      "['11088233', 'Syversen Silje W; Goll Guro L; Jorgensen Kristin K; Olsen Inge C; Sandanger Oystein; Gehin Johanna E; Warren David J; Sexton Joseph; Mork Cato; Jahnsen Jorgen; Kvien Tore K; Bolstad Nils; Haavardsholm Espen A. Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study). Trials. (2020) 21 1 pp13', '10.1186/s13063-019-3734-4', 'http://link.springer.com/article/10.1186/s13063-019-3734-4/fulltext.html']\n",
      "['9258392', 'Goll GL; Olsen IC; Jorgensen KK; Lorentzen M; Bolstad N; Haavardsholm EA; Lundin KEA; Mork C; Jahnsen J; Kvien TK. Biosimilar infliximab (CT-P13) is not inferior to originator infliximab: results from a 52-week randomized switch trial in Norway. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4389-4392', '10.1016/s0016-5085(17)30572-3', '']\n",
      "['9262256', 'J‚Äö√†√∂‚Äö√†√®rgensen KK; Olsen IC; Goll GL; Lorentzen M; Bolstad N; Haavardsholm EA; Lundin KEA; M‚Äö√†√∂‚Äö√†√®rk C; Jahnsen J; Kvien TK; NOR-SWITCH study group. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Lancet (london, england). (2017) 389 10086 pp2304-2316', '10.1093/ecco-jcc/jjx002.099', 'http://academic.oup.com/ecco-jcc/article-pdf/11/suppl_1/S62/10449287/jjx002.099.pdf']\n",
      "['9262292', \"Joergensen KK; Olsen IC; Goll GL; Lorentzen M; Bolstad N; Berset IP; Haavardsholm EA; Lundin KE; Mork C; Kvien TK; Jahnsen J. Biosimilar infliximab (CT-P13) is not inferior to originator infliximab: explorative ibd subgroup-analyses in Crohn's disease and ulcerative colitis from the nor-switch trial. Gastroenterology. (2017) Conference: Digestive Disease Week 2017, DDW 2017. United States. 152 5 Supplement 1 ppS65-S66\", '10.1016/s0016-5085(17)30572-3', '']\n",
      "['9262451', 'Goll GL; Olsen IC; Lundin KEA; Jorgensen KK; Lorentzen M; Klaasen RA; Warren DJ; Mork C; Jahnsen J; Haavardsholm EA; Kvien TK; Bolstad N. Immunogenicity in patients switching from stable originator infliximab treatment to CT-P13: analyses across six diseases from the 52-week randomized nor-switch study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp472', '10.1136/annrheumdis-2017-eular.4112', '']\n",
      "['9262464', 'Goll GL; Olsen IC; Bolstad N; Jorgensen KK; Lorentzen M; Mork C; Jahnsen J; Haavardsholm EA; Kvien TK. Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the nor-switch study: explorative analysis of RA patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp549-550', '10.1136/annrheumdis-2017-eular.2319', '']\n",
      "['9736901', 'Goll GLo; Bolstad N; Iria I; Klaasen R; Jorgensen KK; Olsen IC; Valido A; Saavedra MJ; Fonseca JE; Lorentzen M; Mork C; Lundin KEA; Warren DJ; Haavardsholm EA; Jahnsen J; Kvien T; Goncalves J. Immunogenicity of originator and biosimilar infliximab: anti-drug antibody occurence, cross-reactivity and epitope specificities across six diseases. Analyses from a norwegian randomized switching trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp771-772', '10.1136/annrheumdis-2018-eular.5554', '']\n",
      "['9738600', \"Kaasen Jorgensen KK; Goll GL; Sexton J; Olsen IC; Bolstad N; Lundin KEA; Berset IP; Haavardsholm EA; Mork C; Kvien TK; Jahnsen J. Biosimilar infliximab (CT-P13) is not inferior to originator infliximab: explorative subgroupanalyses in Crohn's disease and ulcerative colitis in the nor-switch extension trial. United european gastroenterology journal. (2017) Conference: 25th United European Gastroenterology Week, UEG 2017. Spain. 5 8 pp1140-1141\", '10.1016/s0016-5085(17)30572-3', '']\n",
      "['9738716', 'Goll GL; Jorgensen KK; Sexton J; Olsen IC; Bolstad N; Lorentzen M; Haavardsholm EA; Mork C; Jahnsen J; Kvien TK. Long-term safety and efficacy of biosimilar infliximab (CT-P13) after switching from originator infliximab: results from the 26-week open label extension of a Norwegian randomised trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1383-1384', '10.1136/annrheumdis-2018-eular.4620', '']\n",
      "['9741099', 'NCT02148640. The NOR-SWITCH Study. https://clinicaltrials.gov/show/NCT02148640. (2014)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9743201', 'Goll GL; Bolstad N; Iria I; Klaasen RA; Jorgensen KK; Olsen IC; Valido A; Saavedra MJ; Fonseca JE; Lundin K; Warren DJ; Haavardsholm E; Jahnsen J; Kvien TK; Goncalves J. The fine specificity of anti-drug antibody responses to originator and biosimilar infliximab: analyses across five diseases from the 52-week randomized nor-switch study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp852-853', '10.1136/annrheumdis-2018-eular.5554', '']\n",
      "['9262658', 'Goll GL; Jorgensen KK; Sexton J; Olsen IC; Bolstad N; Lorentzen M; Haavardsholm EA; Mork C; Jahnsen J; Kvien TK. Long-term safety and efficacy of biosimilar infliximab (CT-P13) after switching from originator infliximab: results from the 26-week open label extension of a Norwegian randomised trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1383-1384', '10.1136/annrheumdis-2018-eular.4620', '']\n",
      "['9261296', 'Seddighzadeh M. NORD-STAR: A multicentre, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis. Scandinavian journal of rheumatology. (2014) 43  pp31-32', '10.1093/rheumatology/kew144.001', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i90/5078829/kew144.001.pdf']\n",
      "['9262357', 'Glinatsi D; Heiberg MS; Rudin A; Nordstr‚àö‚àÇm D; Haavardsholm EA; Gudbjornsson B; ‚àö√≤stergaard M; Uhlig T; Grondal G; H‚àö‚àèrslev-Petersen K; van Vollenhoven R; Hetland ML. Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study. Trials. (2017) 18 1 pp161', '10.1186/s13063-017-1891-x', 'http://link.springer.com/content/pdf/10.1186/s13063-017-1891-x.pdf']\n",
      "['9738930', 'Lampa J; Rudin A; Haavardsholm E; Uhlig T; Heiberg M S; Ostergaard M; Horslev-Petersen K; Hetland M L; Krabbe S; Glinatsi D; Grondal G; Gudbjornsson B; Nurmohamed M; Blanken A; Aulin M R; Sokka T; Nordstrom D; Van Vollenhoven. The NORD-STAR trial in early rheumatoid arthritis: a headto-head comparison of aggressive conventional therapy and three biological therapies and comparison of two deescalation strategies in patients who respond to treatment. Scandinavian journal of rheumatology. (2018) 47 Supplement 129 pp11-12', '10.1186/s13063-017-1891-x', 'http://link.springer.com/content/pdf/10.1186/s13063-017-1891-x.pdf']\n",
      "['9741139', 'NCT01491815. Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction. https://clinicaltrials.gov/show/NCT01491815. (2011)   pp', '10.1093/rheumatology/kev088.076', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i80/5180096/kev088.076.pdf']\n",
      "['11083764', 'Dijkshoorn B; Antovic A; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Grondal G; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Nurmohamed M. PROFOUND ANTICOAGULANT EFFECTS of INITIAL ANTIRHEUMATIC TREATMENTS in EARLY RHEUMATOID ARTHRITIS PATIENTS: a NORD-STAR SPIN-OFF STUDY. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp40-41', '10.1136/annrheumdis-2022-eular.2288', '']\n",
      "['11084387', 'Lend K; van Vollenhoven RF; Lampa J; Lund Hetland M; Haavardsholm EA; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Koopman FA; Twisk JWR; van der Horst-Bruinsma I. Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial. The lancet rheumatology. (2022) 4 10 ppe688-e698', '10.1016/s2665-9913(22)00186-2', '']\n",
      "['11084387', 'Lend K; van Vollenhoven RF; Lampa J; Lund Hetland M; Haavardsholm EA; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Koopman FA; Twisk JWR; van der Horst-Bruinsma I. Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial. The lancet rheumatology. (2022) 4 10 ppe688-e698', '10.1016/s2665-9913(22)00186-2', '']\n",
      "['11084812', 'Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg M; Twisk J; Krabbe S; Lend K; Olsen I; Lindqvist J; Ekwall AKH; Gron KL; Kapetanovic MC; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljosa MKA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Reckner A; Larsson P; Uhrenholt L; Just SA; Stevens D; Laurberg TB; Bakland G; Van Vollenhoven R. A multicenter randomized study in early rheumatoid arthritis to compare active conventional therapy versus three biological treatments: 24 week efficacy results of the nord-star trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp13-14', '10.1136/annrheumdis-2020-eular.689', '']\n",
      "['11085666', 'Aldridge J; Lundell AC; Andersson K; Mark L; Lund Hetland M; √òstergaard M; Uhlig T; Schrumpf Heiberg M; Haavardsholm EA; Nurmohamed M; Lampa J; Nordstr√∂m D; H√∏rslev-Petersen K; Gudbjornsson B; Gr√∂ndal G; van Vollenhoven R; Rudin A. Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis. Clinical and experimental rheumatology. (2022) 40 7 pp1393-1402', '10.55563/clinexprheumatol/idogmj', '']\n",
      "['11087249', 'Stevens D; Heiberg M; Kazemi A; Van Vollenhoven R; Lampa J; Rudin A; Lend K; Hetland ML; Ostergaard M; Nurmohamed M; Horslev-Petersen K; Nordstrom D; Gudbjornsson B; Uhlig T; Haavardsholm EA; Hammer HB. PLASMA CALPROTECTIN WAS ASSESSED in MULTIPLE BIOLOGICAL TREATMENT STRATEGIES for EARLY RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp515', '10.1136/annrheumdis-2022-eular.1034', '']\n",
      "['11087271', 'Ostergaard M; Van Vollenhoven R; Rudin A; Hetland ML; Heiberg M; Nordstrom D; Nurmohamed M; Gudbjornsson B; Midtboll Ornbjerg L; Boyesen P; Olsen I; Lend K; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic MC; Aga AB; Faustini F; Parmanne P; Lorenzen T; Cagnotto G; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Lindegaard HM; Ljosa MKA; Brodin E; Soderbergh A; Rizk M; Hermansson E; Uhrenholt L; Larsson P; Just SA; Bakland G; Stevens D; Laurberg TB; Haavardsholm EA; Lampa J. CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB or ACTIVE CONVENTIONAL THERAPY in EARLY RHEUMATOID ARTHRITIS: CLINICAL and RADIOGRAPHIC 48-WEEKS RESULTS of the INVESTIGATOR-INITIATED RANDOMIZED NORD-STAR TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp38-40', '10.1136/annrheumdis-2022-eular.868', '']\n",
      "['9260942', 'Nam JL; Villeneuve E; Hensor EM; Conaghan PG; Keen HI; Buch MH; Gough AK; Green MJ; Helliwell PS; Keenan AM; Morgan AW; Quinn M; Reece R; van der Heijde DM; Wakefield RJ; Emery P. Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the rheumatic diseases. (2014) 73 1 pp75-85', '10.1136/annrheumdis-2013-203440', '']\n",
      "['9261097', 'Normand R; Derambure C; Hiron M; Le Loet X; Vittecoq O; Lequerre T. Pathways induced by etanercept and adalimumab are specific in ra patients. Annals of the rheumatic diseases. (2013) 72  ppA54', '10.1136/annrheumdis-2013-203221.18', '']\n",
      "['9738654', 'NCT01602588. A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG). Https://clinicaltrials.gov/show/nct01602588. (2012)   pp', '10.1186/isrctn37123666', '']\n",
      "['9737190', 'EUCTR2012-002760-27-SK. Extension study to evaluate the long term efficacy, safety and tolerability of secukinumab in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002760-27-SK. (2012)   pp', '10.1093/rheumatology/kew166.009', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i187/5080308/kew166.009.pdf']\n",
      "['9741048', 'NCT01350804. Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor ‚âà√≠¬¨¬± (Anti-TNF‚âà√≠¬¨¬±) Agents (CAIN457F2309 and CAIN457F2309E1). https://clinicaltrials.gov/show/NCT01350804. (2011)   pp', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9258083', \"Wijnands MJ; Nuver-Zwart IH; van Riel PL; van 't Hof MA; Gribnau FW; van De Putte LB. Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients. Scandinavian journal of rheumatology. (1991) 20 1 pp52-57\", '10.3109/03009749109165922', '']\n",
      "['9259062', 'van der Heijde DM; van Riel PL; Nuver-Zwart IH; Gribnau FW; vad de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet (London, England). (1989) 1 8646 pp1036-1038', '10.1016/s0140-6736(89)92442-2', '']\n",
      "['9739362', 'Nam JL; Villeneuve E; Hensor EM; Wakefield RJ; Conaghan PG; Green MJ; Gough A; Quinn M; Reece R; Cox SR; Buch MH; van der Heijde DM; Emery P. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Annals of the rheumatic diseases. (2014) 73 6 pp1027-1036', '10.1136/annrheumdis-2013-204882', '']\n",
      "['9259113', 'van der Heijde DM; van Riel PL; Nuver-Zwart IH; van de Putte LB. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up. Lancet (London, England). (1990) 335 8688 pp539', '10.1016/0140-6736(90)90771-v', '']\n",
      "['9259160', 'van der Heijde DM; van Riel PL; van de Putte LB. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scandinavian journal of rheumatology. (1990) 19 6 pp407-412', '10.3109/03009749009097629', '']\n",
      "['9259361', \"O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. New England journal of medicine. (1996) 334 20 pp1287-1291\", '10.1056/nejm199605163342002', '']\n",
      "['9258508', \"O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2002) 46 5 pp1164-1170\", '10.1002/art.10228', '']\n",
      "['9262393', 'Lichtenstein GR; Loftus EV; Bloom S; Lawendy N; Friedman GS; Zhang H; Wang W; Thorpe AJ; Nduaka CI; Su C. Tofacitinib, an oral Janus Kinase inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study. American journal of gastroenterology. Conference: 82nd annual scientific meeting of the american college of gastroenterology. United states. (2017) 112 Supplement 1 ppS395', '10.14309/00000434-201710001-00714', '']\n",
      "['9257269', 'Bloom S; Lichtenstein GR; Loftus EV; Lawendy N; Friedman GS; Zhang H; Wang W; Thorpe AJ; Nduaka CI; Su C. Tofacitinib, an oral jak inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study. Gut. Conference: british society of gastroenterology annual general meeting 2017, BSG 2018. United kingdom. (2018) 67 Supplement 1 ppA62-A63', '10.1136/gutjnl-2018-bsgabstracts.123', '']\n",
      "['11088359', 'Tanaka Y; Kawanishi M; Nakanishi M; Yamasaki H; Takeuchi T. Efficacy and safety of the anti-TNF multivalent NANOBODY¬Æ compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 52-week result of a phase II/III study (OHZORA trial). . (2022)   pp', '10.1093/mr/roac119', 'https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roac119/46459994/roac119.pdf']\n",
      "['9737109', 'Kivitz AJ; FitzGerald O; Nash P; Pang S; Azevedo VF; Kudlacz E; Wang C; Graham D; Takiya L. Efficacy of tofacitinib by background methotrexate dose in patients with psoriatic arthritis: a post-hoc analysis of pooled data from 2 phase 3 trials. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1575', '10.1136/annrheumdis-2018-eular.1278', '']\n",
      "['9736623', 'Burmester GR; Rigby WFC; Choy E; Nash P; Winthrop K; Mease PJ; Young P; Hendrikx T; Wang C; Menon S; Graham D. Changes in lymphocytes and lymphocyte subsets in tofacitinib-treated patients with psoriatic arthritis. Arthritis and rheumatology. (2018) 70  pp2887-2889', '10.1136/annrheumdis-2018-eular.3490', '']\n",
      "['9256986', 'Brahe C; Ostergaard M; Johansen J; Defranoux N; Wang X; Bolce R; Sasso E; Ornbjerg L; Horslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam M; Hansen I; Lottenburger T; Ammitzboll C; Jorgensen A; Krintel S; Raun J; Hetland M. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Scandinavian journal of rheumatology. (2018)   pp1-8', '10.1080/03009742.2018.1464206', '']\n",
      "['9257267', 'Greisen SR; M‚àö‚àèller HJ; Stengaard-Pedersen K; Hetland ML; H‚àö‚àèrslev-Petersen K; Junker P; ‚àö√≤stergaard M; Hvid M; Deleuran B. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs. Clinical and experimental rheumatology. (2015) 33 4 pp498-502', '10.3109/03009742.2013.823517', '']\n",
      "['9257500', 'Heftdal LD; Stengaard-Pedersen K; Hetland ML; Horslev-Petersen K; Junker P; Ostergaard M; Hvid M; Deleuran B; Moller HJ; Greisen S. Soluble CD206 plasma levels decreases with treatment and reflects anti-TNFa discontinuation in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3549-3550', '10.1080/00365513.2017.1331462', '']\n",
      "['9257547', 'Krintel SB; Dehlendorff C; Hetland ML; HOrslev-Petersen K; Andersen KK; Junker P; POdenphant J; Ellingsen T; Ahlquist P; Lindegaard HM; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; JOrgensen A; Raun J; AmmitzbOll CG; Ostergaard M; Stengaard-Pedersen K; Johansen JS. Prediction of treatment response to adalimumab: A double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis. Pharmacogenomics journal. (2016) 16  2 pp141-146', '10.1038/tpj.2015.30', 'https://www.nature.com/articles/tpj201530']\n",
      "['9257962', 'Horslev-Petersen K; Hetland ML; Junker P; Podenphant J; Ellingsen T; Ahlqvist P; Lindegaard HM; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Jorgensen A; Krintel SB; Raun J; Ammitzboll CG; Johansen J; Ostergaard M; Stengaard-Pedersen K. Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab; year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis (opera). Arthritis and rheumatism. (2013) 65  ppS1148', '10.1136/annrheumdis-2013-eular.740', '']\n",
      "['9257978', 'Krintel SB; Dehlendorff C; Hetland ML; Horslev-Petersen K; Andersen KK; Junker P; Podenphant J; Ellingsen T; Ahlqvist P; Lindegaard HM; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Jorgensen A; Raun J; Ammitzboll CG; Ostergaard M; Stengaard-Pedersen K; Johansen JS. Microrna expression profiles associated with response to adalimumab and methotrexate versus methotrexate: A placebo-controlled clinical trial. Arthritis and rheumatism. (2013) 65  ppS374-S375', '10.1136/annrheumdis-2013-eular.1742', '']\n",
      "['9258618', 'Ammitzboll CG; Thiel S; Jensenius JC; Ellingsen T; Horslev-Petersen K; Hetland ML; Junker P; Krogh NS; Ostergaard M; Stengaard-Pedersen K. Brief report: M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  12 pp3045-3050', '10.1002/art.38179', '']\n",
      "['9260927', 'Ammitzb‚àö‚àèll CG; Thiel S; Jensenius JC; Ellingsen T; H‚àö‚àèrslev-Petersen K; Hetland ML; Junker P; Krogh NS; ‚àö√≤stergaard M; Stengaard-Pedersen K. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 12 pp3045-3050', '10.1002/art.38179', '']\n",
      "['9259067', 'Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Annals of the rheumatic diseases. (1989) 48 5 pp389-395', '10.1136/ard.48.5.389', '']\n",
      "['9261354', 'Laustsen JK; Kruse Rasmussen T; Steengaard-Pedersen K; Hetland ML; Horslev-Petersen K; Hvid M; Deleuran BW. OX40 and ox40l are highly associated with autoantibody formation in early rheumatoid arthritis, and predict flare after anti-TNF discontinuation. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1145', '']\n",
      "['9261452', 'Axelsen MB; Eshed I; Horslev-Petersen K; Steengaard-Petersen K; Hetland ML; Moller JM; Junker P; Podenphant J; Ellingsen T; Ahlquist P; Lindegaard HM; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzboll CG; Jorgensen A; Krintel SB; Raun J; Johansen JS; Krogh NS; Ostergaard M. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without added adalimumab reduces synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: The opera magnetic resonance imaging sub-study. Arthritis and rheumatism. (2013) 65  ppS1199', '10.1136/annrheumdis-2013-204537', '']\n",
      "['9261498', 'Horslev-Petersen K; Ornbjerg LM; Hetland ML; Junker P; Podenphant J; Ellingsen T; Ahlqvist P; Lindegaard HM; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Jorgensen A; Krintel SB; Raun J; Ammitzboll CG; Johansen J; Ostergaard M; Stengaard-Pedersen K. Induction therapy with adalimumab on top of an aggressive treat-to-target strategy with methotrexate and intraarticular corticosteroid reduces radiographic erosive progression in early rheumatoid arthritis, even after withdrawal of adalimumab. Results of a 2-year trial (OPERA). Arthritis and rheumatism. (2013) 65  ppS600-S601', '10.1136/annrheumdis-2013-eular.740', '']\n",
      "['9261524', 'Ammitzboll CG; Steffensen R; Junker P; Ostergaard M; Johansen J; Podenphant J; Hetland ML; Lindegaard HM; Ellingsen T; Stengaard-Pedersen K. Genotypic and haplotypic effects of 7 single-nucleotide polymorphisms in the CRP gene on levels of c-reactive protein and DAS28 in a cohort of 180 untreated newly diagnosed rheumatoid arthritis patients (opera study). Arthritis and rheumatism. (2013) 65  ppS64-S65', '10.1186/s13075-014-0475-3', 'https://link.springer.com/article/10.1186/s13075-014-0475-3/fulltext.html']\n",
      "['9261910', 'Ammitzboll CG; Steffensen R; Thiel S; Jensenius JC; Horslev-Petersen K; Ellingsen T; Hetland ML; Junker P; Ostergaard M; Stengaard-Pedersen K. Polymorphisms in the FCN1 gene coding for m-ficolin are associated with disease activity, radiographic damage and are the strongest predictors of DAS28 remission in 180 DMARD naive early rheumatoid arthritis patients. Annals of the rheumatic diseases. (2015) 74  pp96', '10.1136/annrheumdis-2015-eular.1521', '']\n",
      "['9262034', 'H‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürslev-Petersen K; Hetland ML; ‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢¬¨√ürnbjerg LM; Junker P; P‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üdenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzb‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üll CG; J‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürgensen A; Krintel SB; Raun J; Johansen JS; ‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢¬¨√üstergaard M; Stengaard-Pedersen K; OPERA Study-Group. Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA). Annals of the rheumatic diseases. (2016) 75 9 pp1645-1653', '10.4324/9780203187838.bmatt3', '']\n",
      "['9262097', 'Andersen T; Hvid M; Johansen C; Stengaard-Pedersen K; Hetland ML; H‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürslev-Petersen K; Junker P; ‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢¬¨√üstergaard M; Deleuran B. Interleukin-23 in early disease development in rheumatoid arthritis. Scandinavian journal of rheumatology. (2015) 44 6 pp438-442', '10.4324/9780203187838.bmatt3', '']\n",
      "['9262148', 'Ornbjerg LM; Ostergaard M; Jensen TD; Horslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzboll CG; Jorgensen A; Krintel SB; Raun JL; Hetland ML. Hand bone loss in early rheumatoid arthritis is independent of adalimumab treatment-results from a randomized controlled clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1603-1604', '10.1136/annrheumdis-2016-eular.3000', '']\n",
      "['9262260', '√òrnbjerg LM; √òstergaard M; Jensen T; H√∏rslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzb√∏ll CG; J√∏rgensen A; Krintel SB; Raun J; Hetland ML; OPERA Study Group; Slot O; Nielsen LK; Skj√∏dt H; Majgaard O; Lorenzen T; Horn HC; Kowalski M; Johansen IL; Pedersen PM; Manilo N; Bliddal H. Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial. Clinical rheumatology. (2017) 36 4 pp781-789', '10.1007/s10067-016-3489-1', 'http://link.springer.com/article/10.1007/s10067-016-3489-1/fulltext.html']\n",
      "['9262272', 'Heftdal LD; Stengaard-Pedersen K; Ornbjerg LM; Hetland ML; Horslev-Petersen K; Junker P; Ostergaard M; Hvid M; Deleuran B; Moller HJ; Greisen SR. Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity. Scandinavian journal of clinical and laboratory investigation. (2017) 77 5 pp385-389', '10.1080/00365513.2017.1331462', '']\n",
      "['9263503', 'Axelsen MB; Eshed I; H‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürslev-Petersen K; Stengaard-Pedersen K; Hetland ML; M‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üller J; Junker P; P‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üdenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzb‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Üll CG; J‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂¬¨√Ürgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; ‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢¬¨√üstergaard M; OPERA study group. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Annals of the rheumatic diseases. (2015) 74 5 pp867-875', '10.4324/9780203187838.bmatt3', '']\n",
      "['9737576', 'Horslev-Petersen K; Hetland M L; Junker P; Podenphant J; Ellingsen T; Ahlqvist P; Lindegaard H M. Adalimumab added to methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, dmard-nave patients with rheumatoid arthritisan investigator-initiated randomized, controlled, double-blinded study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.2605', '']\n",
      "['9738121', 'Skejo C; Nielsen MA; Hvid M; Hansen AS; Stengaard-Pedersen K; Hetland ML; Horslev-Petersen K; Junker P; Oostergaard M; Greisen SR; Deleuran M; Deleuran B. T-cell immunoglobulin and mucin domain 3 (Tim-3) is increased in active rheumatoid arthritis and associated with clinical disease activity and radiographic progression. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1067-1068', '10.1136/annrheumdis-2019-eular.4614', '']\n",
      "['9738357', 'Horslev-Petersen K; Hetland M L; Junker P; Podenphant J; Ellingsen T J; Ahlqvist P; Lindegaard H M; Linauskas A; Schlemmer A; Dam M Y; Hansen I; Lottenburger T; Jorgensen A; Krintel S B; Raun J; Ammitzboll C G; Johansen J S; Ostergaard M; Stengaard-Pedersen K. Improved remission rates acquired by adding adalimumab to methotrexate and intraarticular glucocorticoid cannot be maintained after withdrawal of adalimumab. A 2-year investigator initiated randomised, controlled study on early rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.740', '']\n",
      "['9738612', 'Brahe C; Ostergaard M; Johansen J; Defranoux N; Wang X; Bolce R; Sasso E; Ornbjerg L; Horslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam M; Hansen I; Lottenburger T; Ammitzboll C; Jorgensen A; Krintel S; Raun J; Hetland M. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Scandinavian journal of rheumatology. (2018)   pp1-8', '10.1080/03009742.2018.1464206', '']\n",
      "['9738814', 'Axelsen M B; Eshed I; Horslev-Petersen K; Stengaard-Pedersen K; Hetland M L; Moller J; Junker P; Podenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam M Y; Hansen I; Horn H C; Ammitzboll C G; Jorgensen A; Krintel S B; Raun J; Krogh N S; Johansen J S; Ostergaard M; Slot O; Nielsen L K; Henrik Skjodt; Majgaard O; Lorenzen T; Kowalski M; Johansen I L; Pedersen P M; Manilo N; Bliddal H; Thomsen H; Boesen M. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204537', '']\n",
      "['9738902', 'Horslev-Petersen K; Hetland M L; Junker P; Podenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam M Y; Hansen I; Horn H C; Jorgensen A; Krintel S; Raun J; Ammitzboll C G; Johansen J S; Ostergaard M; Stengaard-Pedersen K. Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis: 1-year results of the investigator-initiated, double-blinded randomized clinical trial (OPERA). Scandinavian journal of rheumatology. (2012) 41 SUPPL. 126 pp17-18', '10.1136/annrheumdis-2012-eular.2605', '']\n",
      "['9739377', 'Brahe C H; Ostergaard M; Johansen J S; Defranoux N; Wang X; Bolce R; Sasso E H; Ornbjerg L M; Horslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam M Y; Hansen I; Lottenburger T; Ammitzboll C; Jorgensen A; Krintel S B; Raun J; Hetland M L. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Scandinavian journal of rheumatology. (2019) 48 1 pp9-16', '10.1080/03009742.2018.1464206', '']\n",
      "['9739406', 'Kristensen A-M; Hetland ML; Horslev-Petersen K; Junker P; Ostergaard M; Stengaard-Pedersen K; Hollsberg P; Hvid M; Deleuran B. Soluble CD83 plasma levels are associated with disease activity and course of disease in early rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp909-', '10.1136/annrheumdis-2016-eular.3850', '']\n",
      "['9739490', 'Brahe CH; Ostergaard M; Johansen J; Defranoux N; Hwang C-C; Bolce R; Sasso E; Horslev-Petersen K; Steengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzboll C; Jorgensen A; Krintel S; Raun J; Hetland ML. Changes in multi-biomarker disease activity (MBDA) score correlate with changes in established disease activity measurements in patients with early RA from the opera study. Annals of the rheumatic diseases. (2016) 75  pp450-', '10.1136/annrheumdis-2016-eular.3459', '']\n",
      "['9739500', 'Axelsen MB; Eshed I; Horslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Moller J; Junker P; Podenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzboll CG; Jorgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Ostergaard M; Slot O; Nielsen LK; Henrik Skjodt; Majgaard O; Lorenzen T; Kowalski M; Johansen IL; Pedersen PM; Manilo N; Bliddal H; Thomsen H; Boesen M. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204537', '']\n",
      "['9740180', 'EUCTR2007-000082-38-DK. The OPERA Study.   Optimized treatment algorithm in early rheumatoid arthritis: methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis.  A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the additive effect of adalimumab concerning inflammatory control and inhibition of erosive development.  - The OPERA Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000082-38-DK. (2007)   pp', '10.1186/isrctn14554919', '']\n",
      "['9740841', 'Sode Jacob; Krintel Sophine B; Carlsen Anting Liu; Hetland Merete L; Johansen Julia S; Horslev-Petersen Kim; Stengaard-Pedersen Kristian; Ellingsen Torkell; Burton Mark; Junker Peter; Ostergaard Mikkel; Heegaard Niels H H. Plasma MicroRNA profiles in patients with early rheumatoid arthritis responding to adalimumab plus methotrexate vs methotrexate alone: a placebo-controlled clinical trial. Journal of rheumatology. (2018) 45 1 pp53-61', '10.3899/jrheum.170266', '']\n",
      "['9741125', 'NCT00660647. Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT00660647. (2008)   pp', '10.1038/nrrheum.2015.153', 'https://www.nature.com/articles/nrrheum.2015.153']\n",
      "['9742787', 'ISRCTN52833273. Outcomes of Periodontal Therapy in Rheumatoid Arthritis (OPERA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN52833273. (2014)   pp', '10.1186/isrctn52833273', '']\n",
      "['11083836', 'Masic D; Stengaard-Pedersen K; Logstrup BB; Horslev-Petersen K; Hetland ML; Junker P; Ostergaard M; Ammitzbol C; Moller S; Christensen R; Ellingsen T. Effects of adalimumab added to treat-totarget strategy with methotrexate and intra-articular triamcinolone on lipids in early-and treatment naive rheumatoid patients: secondary analyses from the multicenter double-blind, randomized, placebo-controlled opera trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp611', '10.1136/annrheumdis-2020-eular.739', '']\n",
      "['11085789', 'Raft M B; Hetland M L; Brahe C H; Horslev-Petersen K; Midtboll Ornbjerg L; Junker P; Biln N; Stengaard-Pedersen K; Ostergaard M. Serum 14-3-3eta as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial. Scandinavian journal of rheumatology. (2022)   pp1-11', '10.1080/03009742.2022.2087900', '']\n",
      "['11088019', 'Masic Dzenan; Stengaard-Pedersen Kristian; Logstrup Brian Bridal; Horslev-Petersen Kim; Hetland Merete Lund; Junker Peter; Ostergaard Mikkel; Ammitzboll Christian; Moller Soren; Christensen Robin; Ellingsen Torkell. Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial. Rheumatology international. (2021) 41 3 pp543-549', '10.1007/s00296-020-04756-5', 'http://link.springer.com/article/10.1007/s00296-020-04756-5/fulltext.html']\n",
      "['11088321', 'de Pablo P; Serban S; Lopez-Oliva I; Rooney J; Hill K; Raza K; Filer A; Chapple I; Dietrich T. Outcomes of Periodontal therapy in Rheumatoid Arthritis: the OPERA feasibility randomised trial. . (2022)   pp', '10.1111/jcpe.13756', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpe.13756']\n",
      "['9260271', 'Furst DE; Gaylis N; Bray V; Olech E; Yocum D; Ritter J; Weisman M; Wallace DJ; Crues J; Khanna D; Eckel G; Yeilding N; Callegari P; Visvanathan S; Rojas J; Hegedus R; George L; Mamun K; Gilmer K; Troum O. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Annals of the rheumatic diseases. (2007) 66 7 pp893-899', '10.1136/ard.2006.068304', '']\n",
      "['9737623', 'Bejerano C; Oreiro N; Fernandez-Lopez C; Pinto-Tasende JA; Atanes A; Aspe B; Grana G; Freire M; Acasuso M; De Toro J; Blanco FJ. Clinical evaluation usefulness of standardized protocol strategies of dose reduction in patients with rheumatoid arthritis in clinical remission treated with biologic therapies. The optibio study. Annals of the rheumatic diseases. (2016) 75  pp486-', '10.1136/annrheumdis-2016-eular.4839', '']\n",
      "['9257601', 'Bejerano C; Oreiro N; Fernandez-Lopez C; Pinto-Tasende JA; Atanes A; De Aspe B; Gil GG; Freire M; Acasuso M; Pertega S; De Toro FJ; Blanco FJ. Clinical evaluation usefulness of standardized protocol strategies of dose reduction in patients with rheumatoid arthritis in clinical remission treated with biologic therapies. The optibio study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp853-855', '10.1136/annrheumdis-2016-eular.4839', '']\n",
      "['9257146', 'Fleischmann R; Van Vollenhoven RF; Smolen JS; Emery P; Florentinus S; Rathmann SS; Kupper H; Kavanaugh A. Long-term outcomes of early rheumatoid arthritis patients initiated with adalimumab plus methotrexate compared with methotrexate alone following a targeted treatment Approach. Arthritis and rheumatism. (2012) 64  ppS335-S336', '10.1093/rheumatology/keu101.009', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i89/9578456/keu101.009.pdf']\n",
      "['9257164', 'Smolen JS; Fleischmann R; Emery P; Van Vollenhoven RF; Florentinus S; Faccin F; Rathmann SS; Kupper H; Kavanaugh A. Functional disability in early rheumatoid arthritis-contributions of disease activity and structural damage, and the impact of different treatment strategies. Arthritis and rheumatism. (2012) 64  ppS212-S213', '10.1136/annrheumdis-2013-eular.737', '']\n",
      "['9257913', 'Mozaffarian N; Smolen JS; Devanarayan V; Hong F; Kavanaugh A. Biomarkers identify radiographic progressors and clinical responders among patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1213', '']\n",
      "['9258114', 'Smolen JS; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Gu‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬©rette B; Kupper H; Redden L; Arora V; Kavanaugh A. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet (London, England). (2014) 383 9914 pp321-332', '10.1016/s0140-6736(13)61751-1', '']\n",
      "['9258360', 'Smolen JS; Van Vollenhoven RF; Wolfe BA; Chen S; Suboticki JL; Kavanaugh A. Adalimumab (HUMIRA) halts radiographic progression and reduces disease activity in patients with a poor initial response to methotrexate. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp771-772', '10.1002/art.39977', '']\n",
      "['9257950', 'Proudman SM; Conaghan PG; Richardson C; Griffiths B; Green MJ; McGonagle D; Wakefield RJ; Reece RJ; Miles S; Adebajo A; Gough A; Helliwell P; Martin M; Huston G; Pease C; Veale DJ; Isaacs J; van der Heijde DM; Emery P. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis and rheumatism. (2000) 43 8 pp1809-1819', '10.1002/1529-0131(200008)43:8<1809::aid-anr17>3.0.co;2-d', '']\n",
      "['9261057', 'Smolen JS; Emery P; Fleischmann R. Erratum: Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: The randomised controlled (Lancet (2014) 383 (321-32)). Lancet. (2014) 383  9914 pp308', '10.1016/s0140-6736(13)61751-1', '']\n",
      "['9261138', 'Skapenko A; Smolen JS; Kavanaugh A; Arora V; Kupper H; Schulze-Koops H. Genetic effects of HLA-DRB1, IL4R, and Fc+RIIb on long-term treatment responses in patients with early rheumatoid arthritis: 78-week results of a phase 4 study. Arthritis and rheumatism. (2012) 64  ppS431', '10.1136/annrheumdis-2012-eular.257', '']\n",
      "['9261150', 'Kavanaugh A; Van Vollenhoven RF; Emery P; Shaw JW; Cifaldi MA; Florentinus S; Smolen JS. Patient-reported outcomes in early rheumatoid arthritis patients failing to achieve stable low disease activity: Comparing addition of adalimumab to methotrexate monotherapy with maintenance on adalimumab plus methotrexate. Arthritis and rheumatism. (2012) 64  ppS162-S163', '10.1136/annrheumdis-2012-eular.3069', '']\n",
      "['9261224', 'Emery P; Kavanaugh AF; Smolen J; Cifaldi MA; Chaves L; Guerette B; Arora V. Combination therapy with adalimumabmethotrexate significantly improved work ability, physical function, fatigue, and other patient-reported outcomes in early rheumatoid arthritis: Results from a 26-week analysis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.450', '']\n",
      "['9261305', 'Smolen JS; Van Vollenhoven RF; Fleischmann R; Emery P; Florentinus S; Rathmann SS; Cardoso A; Kupper H; Kavanaugh A. Efficacy of adalimumab plus methotrexate therapy in rheumatoid arthritis non-responders receiving methotrexate monotherapy or adalimumab combination therapy: Results from the optima trial. Rheumatology (United Kingdom). (2014) 53  ppi89', '10.1093/rheumatology/keu101.009', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i89/9578456/keu101.009.pdf']\n",
      "['9261389', 'Kavanaugh A; Smolen JS; Ganguli A; Kupper H; Cifaldi M; Chen N; Revicki D. Work instability in early rheumatoid arthritis with elevated risk of employment loss: Effects of adalimumab/methotrexate combination therapy versus methotrexate in a randomized clinical trial. Arthritis and rheumatism. (2013) 65  ppS195-S196', '10.1093/rheumatology/keu098.015', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i78/9578387/keu098.015.pdf']\n",
      "['9261404', 'Kavanaugh A; Emery P; Van Vollenhoven R; Cifaldi M; Shaw J; Chen N; Smolen J. Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.450', '']\n",
      "['9261418', 'Kavanaugh AF; Emery P; Van Vollenhoven R; Cifaldi MA; Shaw JW; Chen N; Smolen JS. Comparisons of work productivity and patient-reported outcomes through 78 weeks among optima study arms 2, 4, and 5. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2610', '']\n",
      "['9262361', 'Anonymous. Erratum: adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial (The Lancet (2014) 383(9914) (321-332) (S0140673613617511) (10.1016/S0140-6736(13)61751-1)). Lancet. (2014) 383 9914 pp308', '10.1016/s0140-6736(13)61751-1', '']\n",
      "['9262423', 'Smolen JS; Emery P; Zhang H; Wang X; Suboticki J; Sainsbury I; Kavanaugh A. Predicting maintenance of response based on disease characteristics and early clinical response in rheumatoid arthritis patients upon withdrawal of adalimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp785', '10.1136/annrheumdis-2017-eular.2503', '']\n",
      "['9262572', 'Kavanaugh A; Van Vollenhoven RF; Sunkureddi P; Zhang Y; Suboticki JL; Smolen JS. Disease flares among early rheumatoid arthritis patients treatedwith continued methotrexate either alone or in combination with adalimumab (humira). Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS75-S76', '10.1136/annrheumdis-2018-eular.2638', '']\n",
      "['9262674', 'Kavanaugh A; Van Vollenhoven R; Sunkureddi P; Zhang Y; Suboticki J; Smolen J. Disease flares among early rheumatoid arthritis patients treated with continued methotrexate either alone or in combination with adalimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1371-1372', '10.1136/annrheumdis-2018-eular.2638', '']\n",
      "['9737095', 'Kavanaugh A; Emery P; Fleischmann R; Van Vollenhoven; Pavelka K; Durez P; Guerette B; Santra S; Redden L; Kupper H; Smolen J S. Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: results of a phase 4, double-blind, placebo-controlled trial. Rheumatology (united kingdom). (2012) 51 SUPPL. 3 pp', '10.1016/s0140-6736(13)61751-1', '']\n",
      "['9737512', 'NCT00420927. Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00420927. (2007)   pp', '10.3410/f.14174.471676', '']\n",
      "['9738576', 'Kavanaugh A; Van Vollenhoven RF; Sunkureddi P; Zhang Y; Suboticki JL; Smolen JS. Disease flares among early rheumatoid arthritis patients treatedwith continued methotrexate either alone or in combination with adalimumab (humira). Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS75-S76', '10.1136/annrheumdis-2018-eular.2638', '']\n",
      "['9738725', 'Kavanaugh A; Van Vollenhoven R; Sunkureddi P; Zhang Y; Suboticki J; Smolen J. Disease flares among early rheumatoid arthritis patients treated with continued methotrexate either alone or in combination with adalimumab. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1371-1372', '10.1136/annrheumdis-2018-eular.2638', '']\n",
      "['9738905', 'Kavanaugh A; Fleischmann R; Emery P; Guerette B; Redden L; Patra K; Smolen J S. Clinical and functional improvements in early RA following treatment with Adalimumab plus methotrexate compared with methotrexate monotherapy: 26-week Results of the optima trial. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1791', '10.1136/annrheumdis-2011-201247', '']\n",
      "['9738906', 'Kavanaugh A; Fleischmann R M; Emery P; Kupper H; Redden L; Guerette B; Santra S; Smolen J S. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Annals of the rheumatic diseases. (2012)   pp', '10.1136/annrheumdis-2011-201247', '']\n",
      "['9738979', 'Skapenko A; Schulze-Koops H; Devanarayan V; Idler K; Hong F; Smolen J S; Kavanaugh A; Kupper H; Waring J F. Identification of genetic variants associated with response to adalimumab plus methotrexate in patients with early rheumatoid arthritis. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS497', '10.1136/annrheumdis-2014-eular.1318', '']\n",
      "['9739062', 'Emery P; Smolen J S; Fleischmann R; Van Vollenhoven; Florentinus S; Santra S; Kupper H; Redden L; Kavanaugh A. Achieving long-term comprehensive disease control with adalimumab and methotrexate in patients with early rheumatoid arthritis in the optima study. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.2628', '']\n",
      "['9739135', 'Smolen J S; Kavanaugh A; Aletaha D; Florentinus S; Li Y; Lagunes I. The impact of early treatment with adalimumab on rheumatoid factor and anti-citrullinated peptide antibody levels in patients with rheumatoid arthritis in the optima trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp229-230', '10.1136/annrheumdis-2016-eular.1311', '']\n",
      "['9739152', 'Van Vollenhoven; R F; Betts K; Signorovitch J; Bao C; Shaw J W; Ganguli A. A prediction model that identifies patients most likely to benefit from first-line therapy with adalimumab plus methotrexate in early rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.1462', '']\n",
      "['9739162', 'Waring J F; Devanarayan V; Idler K; Hong F; Smolen J S; Kavanaugh A; Kupper H; Schulze-Koops H; Skapenko A. Application of a multiplex gene polymorphism assay for variants associated with rheumatoid arthritis susceptibility-results of 168 SNPs tested in the optima study. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.1178', '']\n",
      "['9739941', 'EUCTR2006-004139-31-AT. A Multicenter, Randomized, Double-Period, Double - Blind Study to Determine the Optimal Protocol for Treatment Initiation with Methotrexate and Adalimumab Combination Therapy in Patients with Early Rheumatoid Arthritis. - OPTIMA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-004139-31-AT. (2007)   pp', '10.3410/f.14174.471676', '']\n",
      "['9258180', 'Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate. Rheumatology (oxford, england). (2016) 55 8 pp1458-1465', '10.1093/rheumatology/kew056', 'http://academic.oup.com/rheumatology/article-pdf/55/8/1458/9448792/kew056.pdf']\n",
      "['9261308', 'Emery P; Smolen J; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Karunaratne PM; Kavanaugh A. Work related outcomes in early rheumatoid arthritis patients with elevated risk of employment loss: Results from two randomized clinical trials (OPTIMA and PROWD) on the effect of adalimumab and methotrexate combination therapy versus methotrexate monotherapy over 6 months of treatment. Rheumatology (United Kingdom). (2014) 53  ppi78', '10.1093/rheumatology/keu098.015', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i78/9578387/keu098.015.pdf']\n",
      "['9738344', 'Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate. Rheumatology. (2016) 55 8 pp1458-1465', '10.1093/rheumatology/kew056', 'http://academic.oup.com/rheumatology/article-pdf/55/8/1458/9448792/kew056.pdf']\n",
      "['9257557', 'Kavanaugh A; Van Vollenhoven RF; Wolfe BA; Florentinus S; Chen S; Suboticki JL; Smolen JS. Predictors of inadequate response and rapid radiographic progression in patients with early rheumatoid arthritis receiving methotrexate: a post hoc analysis of 2 randomized, controlled trials of adalimumab. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3579-3580', '10.1136/annrheumdis-2017-eular.1892', '']\n",
      "['9262428', 'Kavanaugh A; Van Vollenhoven RF; Wolfe BA; Florentinus S; Chen S; Suboticki JL; Smolen JS. Predictors of inadequate response and rapid radiographic progression in patients with early rheumatoid arthritis receiving methotrexate: a post hoc analysis of 2 randomized, controlled trials of adalimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp822-823', '10.1136/annrheumdis-2017-eular.1892', '']\n",
      "['9739089', 'Kavanaugh A; Van Vollenhoven; R F; Sunkureddi P; Zhang Y; Suboticki J L; Smolen J S. Disease flares among early rheumatoid arthritis patients treated with continued methotrexate either alone or in combination with adalimumab (Humira). Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2018-eular.2638', '']\n",
      "['9261828', 'Leeb B; Lunzer R; Fasching P; Herold M; Zamani O; Graninger W. The safety and effect on disease activity of tocilizumab in combination with MTX versus tocilizumab monotherapy in patients with mild to moderate RA: an attempt to optimise the treatment response. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1093/rheumatology/kev088.058', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i71/5179990/kev088.058.pdf']\n",
      "['9261834', 'Herold M; Fasching P; Graninger W; Lunzer R; Zamani O; Leeb B. Efficacy of tocilizumab monotherapy in patients with RA is not influenced by ACPA positivity. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1093/rheumatology/kev088.058', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i71/5179990/kev088.058.pdf']\n",
      "['9261835', 'Herold M; Fasching P; Graninger W; Lunzer R; Zamani O; Leeb B. Increased serum lipids under tocilizumab is not influenced by methotrexate. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1097/bor.0b013e3282ffdeca', '']\n",
      "['9739666', 'Leeb B; Lunzer R; Fasching P; Herold M; Zamani O; Graninger WB. The safety and effect on disease activity of tocilizumab in combination with MTX versus tocilizumab monotherapy in patients with mild to moderate rheumatoid arthritis. Journal fur mineralstoffwechsel. (2016) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie and Rehabilitation. Austria. 23 4 pp133-134', '10.1093/rheumatology/kew144.004', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i92/5078851/kew144.004.pdf']\n",
      "['9739688', 'EUCTR2011-001863-39-AT. A study of saftey and efficacy of Tocilizumab (TCZ) in combination with Methotrexate (MTX) versus Tocilizumab Monotherapy in patients with mild to moderate rheumatoid arthritis, who have not adequately responded to their current treatment with MTX. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001863-39-AT. (2011)   pp', '10.1136/annrheumdis-2013-eular.246', '']\n",
      "['9258112', 'Smolen JS; Beaulieu A; Rubbert-Roth A; Ramos-Remus C; Rovensky J; Alecock E; Woodworth T; Alten R; OPTION Investigators. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet (London, England). (2008) 371 9617 pp987-997', '10.1016/s0140-6736(08)60453-5', '']\n",
      "['9260527', 'Garnero P; Thompson E; Woodworth T; Smolen JS. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone. Arthritis and rheumatism. (2010) 62 1 pp33-43', '10.1002/art.25053', '']\n",
      "['9736785', 'Dejaco C; Duftner C. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Journal fur mineralstoffwechsel. (2008) 15 2 pp101-102', '10.1016/s0084-3873(09)79339-3', '']\n",
      "['9739123', 'Ramos-Remus C; Muriel-Vizcaino R. The OPTION trial: inhibition of the interleukin-6 receptor with tocilizumab in patients with rheumatoid arthritis. Future rheumatology. (2008) 3 5 pp429-434', '10.2217/17460816.3.5.429', '']\n",
      "['9740301', 'EUCTR2004-003741-40-SK. A randomized, double-blind, parallel group study of the safety and reduction of signs and symptoms during treatment with MRA versus placebo, in combination with methotrexate, in patients with moderate to severe active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003741-40-SK. (2004)   pp', '10.1016/s0084-3873(09)79342-3', '']\n",
      "['9740909', 'NCT00106548. A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00106548. (2005)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9742895', '. The OPTION trial: inhibition of the interleukin-6 receptor with tocilizumab in patients with rheumatoid arthritis. Future rheumatology. (2008) 3 5 pp429-434', '10.2217/17460816.3.5.429', '']\n",
      "['9262603', 'Strand V; Michalska M; Birchwood C; Pei J; Tuckwell K; Finch R; Kivitz AJ; Smolen JS; Burmester GR. Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2017-000602', '']\n",
      "['9742496', 'Strand V; Michalska M; Birchwood C; Pei J; Tuckwell K; Finch R; Kivitz AJ; Smolen JS; Burmester GR. Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2017-000602', '']\n",
      "['9741483', 'Shafran Inbal Haya; Alasti Farideh; Smolen Josef S; Aletaha Daniel. Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab. Annals of the rheumatic diseases. (2020) 79 7 pp874-882', '10.1136/annrheumdis-2019-215987', '']\n",
      "['11084363', 'Sebba A; Han J; Mohan S. Pain and other patient-reported outcomes in patients with rheumatoid arthritis who did or did not achieve treatment response based on improvement in swollen joints in tocilizumab clinical trials. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp994-995', '10.1136/annrheumdis-2020-eular.967', '']\n",
      "['11084363', 'Sebba A; Han J; Mohan S. Pain and other patient-reported outcomes in patients with rheumatoid arthritis who did or did not achieve treatment response based on improvement in swollen joints in tocilizumab clinical trials. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp994-995', '10.1136/annrheumdis-2020-eular.967', '']\n",
      "['9263311', 'Smolen JS; Aletaha D. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis and rheumatism. (2011) 63 1 pp43-52', '10.1002/art.27740', '']\n",
      "['9736514', 'Bonfiglioli R; Smolen J; Kissel K; Maldonado Cocco; Ramos-Remus C. Tocilizumab improves systemic symptoms of rheumatoid arthritis in patients with an inadequate response to DMARDs. Journal of clinical rheumatology. (2010) 16 SUPPL. 3 ppS32', '10.2217/17460816.3.5.429', '']\n",
      "['9261056', 'Keystone EC; Anisfeld A; Ogale S; Devenport JN; Curtis JR. Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatment. Journal of rheumatology. (2014) 41  2 pp216-226', '10.3899/jrheum.130489', '']\n",
      "['9260624', 'Frey N; Grange S; Woodworth T. Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2010) 50 7 pp754-766', '10.1177/0091270009350623', '']\n",
      "['9736999', 'EUCTR2010-020738-24-GB. To see whether for patients with established rheumatoid arthritis that have already achieved a good response to Tumour Necrosis Factor Inhibitor (TNF inhibitor) treatment, whether the treatment be tapered to a minimum dose without affecting the control of disease activity. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020738-24-GB. (2010)   pp', '10.1186/isrctn28955701', '']\n",
      "['9261757', 'Galloway JB; Kingsley G; Ma M; Lorente-Canovas B; Cope A; Ibrahim F; Scott DL. Optimising treatment with TNF inhibitors in rheumatoid arthritis with different dose tapering strategies: The OPTTIRA trial. Annals of the rheumatic diseases. (2015) 74  pp706', '10.1136/annrheumdis-2015-eular.4684', '']\n",
      "['9262689', 'Bechman K; Sin FE; Ibrahim F; Norton S; Scott D; Cope A; Galloway J. Psychological and functional states predict disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: a post-hoc analysis of data from the optimisingTNF tapering in RA (OPTTIRA) cohort. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp279-280', '10.1136/annrheumdis-2018-eular.3077', '']\n",
      "['9736599', 'Bechman K; Sin FE; Ibrahim F; Norton S; Scott D; Cope A; Galloway J. Psychological and functional states predict disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: a post-hoc analysis of data from the optimisingTNF tapering in RA (OPTTIRA) cohort. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp279-280', '10.1136/annrheumdis-2018-eular.3077', '']\n",
      "['9736877', 'Bechman K; Sin FE; Ibrahim F; Norton S; Matcham F; Scott DL; Cope A; Galloway J. Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial. RMD open. (2018) 4 1 pp', '10.1136/rmdopen-2018-000676', '']\n",
      "['9738044', 'Galloway J; Kingsley G; Ma M; Lorente-Canovas B; Walker D; Pande I; Cope A; Scott DG; Dore CJ; Ibrahim F; Scott DL. Optimizing treatment with TNF inhibitors in rheumatoid arthritis: is dose tapering practical in optimal responders? the OPTTIRA trial. Rheumatology (united kingdom). (2015) 54 Supplement 1 ppi74-i75', '10.1136/annrheumdis-2015-eular.4684', '']\n",
      "['9258704', 'Fleischmann R; Mease PJ; Schwartzman S; Hwang LJ; Soma K; Connell CA; Takiya L; Bananis E. Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group. Clinical rheumatology. (2017) 36 1 pp15-24', '10.1007/s10067-016-3436-1', 'http://link.springer.com/article/10.1007/s10067-016-3436-1/fulltext.html']\n",
      "['9261197', 'Van Der Heijde D; Tanaka Y; Fleischmann R; Keystone EC; Kremer JM; Zerbini CAF; Cardiel M. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, in combination with methotrexate reduced the progression of structural damage in patients with rheumatoid arthritis: A 24-month phase 3 study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.37816', '']\n",
      "['9261468', 'Strand V; Van Der Heijde D; Zerbini CAF; Connell CA; Gruben D; Riese R; Wallenstein G. Oral scan: Effects of the oral JAK inhibitor tofacitinib in combination with methotrexate on patient reported outcomes in a 24-month phase 3 trial of active rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS996-S997', '10.1136/annrheumdis-2013-eular.786', '']\n",
      "['9261992', 'Fleischmann R; Mease PJ; Schwartzman S; Hwang L-J; Patel A; Soma K; Connell CA; Takiya L; Bananis E. Effect of methotrexate dose on the efficacy of tofacitinib: treatment outcomes from a phase 3 clinical trial of patients with rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1274', '']\n",
      "['9263392', 'van der Heijde D; Tanaka Y; Fleischmann R; Keystone E; Kremer J; Zerbini C; Cardiel MH; Cohen S; Nash P; Song YW; Tegzov‚àö¬∞ D; Wyman BT; Gruben D; Benda B; Wallenstein G; Krishnaswami S; Zwillich SH; Bradley JD; Connell CA; ORAL Scan Investigators. Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis and rheumatism. (2013) 65 3 pp559-570', '10.1002/art.37816', '']\n",
      "['9737797', 'Strand Vibeke; van der Heijde Desiree; Tanaka Yoshiya; Keystone Edward; Kremer Joel; Zerbini Cristiano A F; Cardiel Mario H; Cohen Stanley; Nash Peter; Song Yeong-Wook; Tegzova Dana; Gruben David; Wallenstein Gene; Connell Carol A; Fleischmann Roy; ORAL Scan investigators. Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study. Clinical and experimental rheumatology. (2019)   pp', '10.1002/art.40803', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40803']\n",
      "['9738049', 'Strand V; van der Heijde D; Tanaka Y; Keystone E; Kremer J; Zerbini CAF; Cardiel MH; Cohen S; Nash P; Song Y-W; Tegzova D; Gruben D; Wallenstein G; Connell CA; Fleischmann R. Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study. Clinical and experimental rheumatology. (2019)   pp', '10.1002/art.40803', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40803']\n",
      "['9738870', 'Fleischmann R; Mease P; Schwartzman S; Hwang L J; Soma K; Connell C; Takiya L; Bananis E. Effect of methotrexate dose on the efficacy of tofacitinib: treatment outcomes from a phase 3 clinical trial of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp258-259', '10.1136/annrheumdis-2016-eular.1274', '']\n",
      "['9739945', 'EUCTR2008-007023-26-GR. PHASE 3 RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-007023-26-GR. (2009)   pp', '10.1186/isrctn49455679', '']\n",
      "['9740951', 'NCT00847613. A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate. https://clinicaltrials.gov/show/NCT00847613. (2009)   pp', '10.18535/jmscr/v4i10.20', '']\n",
      "['9741222', 'Strand V; van der Heijde D; Tanaka Y; Keystone E; Kremer J; Zerbini CAF; Cardiel MH; Cohen S; Nash P; Song Y-W; Tegzova D; Gruben D; Wallenstein G; Connell CA; Fleischmann R. Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study. Clinical and experimental rheumatology. (2019)   pp', '10.1002/art.40803', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40803']\n",
      "['11084742', 'Strand Vibeke; van der Heijde Desiree; Tanaka Yoshiya; Keystone Edward; Kremer Joel; Zerbini Cristiano A F; Cardiel Mario H; Cohen Stanley; Nash Peter; Song Yeong-Wook; Tegzova Dana; Gruben David; Wallenstein Gene; Connell Carol A; Fleischmann Roy; ORAL Scan investigators. Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study. Clinical and experimental rheumatology. (2020) 38 5 pp848-857', '10.1002/art.40803', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40803']\n",
      "['9262467', 'Yamanaka H; Tanaka Y; Takeuchi T; Sugiyama N; Hirose T; Yoshii N; Morishima Y; Toyoizumi S. Effects of tofacitinib, an oral janus kinase inhibitor, on patient-reported outcomes in Japanese patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp274-275', '10.1136/annrheumdis-2017-eular.1402', '']\n",
      "['9738348', '. Baseline characteristics and outcomes in patients with anaemia in clinical studies of tofacitinib in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp753-754', '10.1136/annrheumdis-2019-eular.399', '']\n",
      "['9738402', '. Changes in key laboratory values with tofacitinib 5 mg bid treatment in patients with psoriatic arthritis and rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1682-1683', '10.1136/annrheumdis-2019-eular.1290', '']\n",
      "['9738892', 'Hall S; Nash P; Rischmueller M; Bossingham D; Cook N; Kwok K; Thirunavukkarasu K. Tofacitinib, an oral Janus kinase inhibitor: pooled Phase 3 analysis of efficacy and safety in an Australian rheumatoid arthritis study population. International journal of rheumatic diseases. (2012) 15 SUPPL. 1 pp65', '10.1007/s40744-018-0118-2', 'https://link.springer.com/article/10.1007/s40744-018-0118-2/fulltext.html']\n",
      "['9741239', '. Changes in key laboratory values with tofacitinib 5 mg BID treatment in patients with psoriatic arthritis and rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1682-1683', '10.1136/annrheumdis-2019-eular.1290', '']\n",
      "['11085670', 'Bessette L; Mysler E; Kinch CD; Kwok K; Lukic T; On PV; van Vollenhoven RF. Impact of Tofacitinib on Components of the ACR Response Criteria: post Hoc Analysis of Phase III and Phase IIIb/IV Trials. Journal of rheumatology. (2022) 49 6 pp566-576', '10.3899/jrheum.210707', '']\n",
      "['9738668', 'Ogdie A; De Vlam K; McInnes I; Mease P; Baer P; Lukic T; Kwok K; Wang C; Hsu M-A; Maniccia A. Effect of tofacitinib on reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PSA), and ankylosing spondylitis (AS). Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1001', '10.1136/annrheumdis-2018-eular.3247', '']\n",
      "['9743188', 'Ogdie A; DeVlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Kwok K; Wang C; Hsu M-A; Maniccia A. Effect of tofacitinib on reducing pain in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp971-972', '10.1136/annrheumdis-2018-eular.3247', '']\n",
      "['9740569', '. Frequency and duration of early non-serious adverse events in rheumatoid arthritis patients treated with tofacitinib 5 Mg twice daily as monotherapy and combination therapy. Arthritis and rheumatology. (2018) 70  pp1699-1700', '10.1136/annrheumdis-2019-eular.418', '']\n",
      "['9263579', 'Cook N; Nash P; Hall S; Thirunavukkarasu K; Witcombe D; Krishnaswami S; Hoffman E; Connell C. Tofacitinib, an oral Janus kinase inhibitor: post-hoc analyses of efficacy and safety of monotherapy vs combination therapy in a phase 3 rheumatoid arthritis (RA) population. Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp30', '10.1007/s40744-018-0118-2', 'https://link.springer.com/article/10.1007/s40744-018-0118-2/fulltext.html']\n",
      "['9742151', 'Bykerk VP; Van Vollenhoven R; Connell C; Gruben D; Fallon L; Woolcott J; Keystone E. Identification of distinct disease activity trajectories in patients with rheumatoid arthritis receiving tofacitinib over 12 months. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp969', '10.1136/annrheumdis-2018-eular.1281', '']\n",
      "['11084843', 'Bartlett SJ; Bingham CO; van Vollenhoven R; Murray C; Gruben D; Gold DA; Cella D. The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials. . (2022) 24 1 pp', '10.1186/s13075-022-02724-x', 'https://link.springer.com/article/10.1186/s13075-022-02724-x/fulltext.html']\n",
      "['11086183', 'Jones HN; Strand V; Schulze-Koops H; Mysler E; Kinch C; Gruben DC; Germino R; Connell CA; Eder L. Sex differences in the efficacy and safety of tofacitinib in rheumatoid arthritis patients: a post hoc analysis of phase 3 and long-term extension trials. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp565-566', '10.1136/annrheumdis-2021-eular.359', '']\n",
      "['9261133', 'Burmester GR; Van Der Heijde D; Strand V; Zerbini CAF; Connell CA; Mebus CA; Zwillich SH; Bradley JD; Gruben D; Wallenstein G. Effects of tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis receiving stable-dose methotrexate: Results of two phase 3 studies. Arthritis and rheumatism. (2012) 64 var.pagings ppS549', '10.1002/acr.22453', '']\n",
      "['9740838', 'Takeuchi Tsutomu; Yamanaka Hisashi; Yamaoka Kunihiro; Arai Shoko; Toyoizumi Shigeyuki; DeMasi Ryan; Fukuma Yuri; Hirose Tomohiro; Sugiyama Naonobu; Zwillich Samuel H; Tanaka Yoshiya. Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: a post hoc analysis of clinical trial data. Modern rheumatology. (2019) 29 5 pp756-766', '10.1080/14397595.2018.1553489', '']\n",
      "['9256887', 'Kaine J; Tesser J; DeMasi R; Takiya L; Wang L; Snyder M; Fan H; Wollenhaupt J. Re-establishment of efficacy of tofacitinib, an oral janus kinase inhibitor, in rheumatoid arthritis patients after temporary discontinuation. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1007/s10067-020-04956-1', 'http://link.springer.com/article/10.1007/s10067-020-04956-1/fulltext.html']\n",
      "['9261895', 'Wollenhaupt J; Silverfield J; Lee EB; Wood SP; Terry KK; Nakamura H; Kwok K; Anisfeld A; Nduaka C; Wang L. Tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension up to 6 years. Annals of the rheumatic diseases. (2015) 74  pp259', '10.1136/annrheumdis-2015-eular.2859', '']\n",
      "['9262047', 'Lee HE; Chen C; Chapman D; Dasic G; Wang L; Llamado LJ. Safety, tolerability for tofacitinib, an oral JAK inhibitor in open-label, long-term extension up to 6.5 years, in korean rheumatoid arthritis patients. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp192-193', '10.1136/annrheumdis-2016-eular.1258', '']\n",
      "['9262371', 'Kaine J; Tesser J; DeMasi R; Takiya L; Wang L; Snyder M; Fan H; Wollenhaupt J. Reestablishment of efficacy of tofacitinib, an oral janus kinase inhibitor, in rheumatoid arthritis patients after temporary discontinuation. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp275-276', '10.1136/annrheumdis-2017-eular.2375', '']\n",
      "['9736572', 'Kaine J; Tesser J; DeMasi R; Takiya L; Wang L; Snyder M; Fan H; Bandi V; Wollenhaupt J. Efficacy of tofacitinib after temporary discontinuation in patients with rheumatoid arthritis: analysis of data from open-label long-term extension studies. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp69-70', '10.1136/annrheumdis-2018-eular.3755', '']\n",
      "['9737091', 'Wollenhaupt J; Silverfield J; Lee E B; Wood S P; Terry K; Nakamura H; Kwok K; Anisfeld A; Nduaka C; Riese R; Wang L. Tofacitinib, an oral Janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension up to 6 years. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS375', '10.1136/annrheumdis-2015-eular.2859', '']\n",
      "['9737925', 'Kaine Jeffrey; Tesser John; Takiya Liza; DeMasi Ryan; Wang Lisy; Snyder Mark; Soma Koshika; Fan Haiyun; Bandi Vara; Wollenhaupt Jurgen. Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis. Clinical rheumatology. (2020) 39 7 pp2127-2137', '10.1007/s10067-020-04956-1', 'http://link.springer.com/article/10.1007/s10067-020-04956-1/fulltext.html']\n",
      "['9739166', 'Wollenhaupt J J; Silverfield J C; Lee E B; Wood S; Soma K; Wang L; Nakamura H. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: open-label, long-term extension studies up to 36 months. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2015-eular.2859', '']\n",
      "['9741020', 'NCT00661661. Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan. https://clinicaltrials.gov/show/NCT00661661. (2008)   pp', '10.1007/s10165-008-0058-8', '']\n",
      "['9742199', 'Wollenhaupt J; Silverfield J; Lee EB; Terry K; Kwok K; Strengholt S; DeMasi R; Wang L. Tofacitinib, an oral Janus Kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 9 years. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp978', '10.1136/annrheumdis-2018-eular.1733', '']\n",
      "['9743152', 'Pope Janet E; Keystone Edward; Jamal Shahin; Wang Lisy; Fallon Lara; Woolcott John; Lazariciu Irina; Chapman Douglass; Haraoui Boulos. Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years. ACR open rheumatology. (2019) 1 2 pp73-82', '10.1002/acr2.1010', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr2.1010']\n",
      "['9743215', 'Mueller RB; Schulze-Koops H; Furst DE; Cohen S; Kwok K; Maniccia A; Wang L; Akylbekova E; Ackermann G; Von Kempis J. Effect of a step-up or step-down in tofacitinib dose on efficacy and safety in patients with rheumatoid arthritis in longterm extension studies. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp66-67', '10.1136/annrheumdis-2018-eular.3110', '']\n",
      "['11084760', 'Mueller Ruediger B; Schulze-Koops Hendrik; Furst Daniel E; Cohen Stanley B; Kwok Kenneth; Wang Lisy; Killeen Tim; von Kempis Johannes. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel). Clinical rheumatology. (2022) 41 4 pp1045-1055', '10.1007/s10067-021-05908-z', 'https://link.springer.com/article/10.1007/s10067-021-05908-z/fulltext.html']\n",
      "['11088219', 'Kaine Jeffrey; Tesser John; Takiya Liza; DeMasi Ryan; Wang Lisy; Snyder Mark; Soma Koshika; Fan Haiyun; Bandi Vara; Wollenhaupt Jurgen. Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis. Clinical rheumatology. (2020) 39 7 pp2127-2137', '10.1007/s10067-020-04956-1', 'http://link.springer.com/article/10.1007/s10067-020-04956-1/fulltext.html']\n",
      "['9741226', 'Cohen SB; Pope J; Haraoui B; Irazoque-Palazuelos F; Korkosz M; Diehl A; Rivas JL; Lukic T; Liu S; Stockert L; Iikuni N; Keystone EC. Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial. The lancet rheumatology. (2019) 1 1 ppe23-e34', '10.1016/s2665-9913(19)30005-0', '']\n",
      "['9742311', 'Anonymous. Correction to Lancet Rheumatol 2019; 1: e23-34 (The Lancet Rheumatology (2019) 1(1) (e23-e34), (S2665991319300050), (10.1016/S2665-9913(19)30005-0)). The lancet rheumatology. (2019) 1 4 ppe205', '10.1016/s2665-9913(19)30095-5', '']\n",
      "['9742953', 'Cohen SB; Pope J; Haraoui B; Irazoque-Palazuelos F; Korkosz M; Diehl A; Rivas JL; Lukic T; Liu S; Stockert L; Iikuni N; Keystone E. Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 MG once daily + methotrexate: a randomised non-inferiority phase 3B/4 study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp260-261', '10.1136/annrheumdis-2019-eular.8657', '']\n",
      "['11086140', 'Fleischmann R; Haraoui B; Buch MH; Gold D; Sawyerr G; Shi H; Diehl A; Lee K. Analysis of disease activity measures in the context of a methotrexate withdrawal study among patients with rheumatoid arthritis treated with tofacitinib 11 mg once daily + methotrexate: post hoc analysis of data from oral shift. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp251', '10.1136/annrheumdis-2021-eular.56', '']\n",
      "['11086185', 'Cohen SB; Chen YH; Sugiyama N; Rivas JL; Diehl A; Lukic T; Paulissen J; Fan H; Hirose T; Keystone E. Clinical and functional response to tofacitinib in patients with rheumatoid arthritis: probability plot analysis of results from a 48-week phase 3b/4 methotrexate withdrawal study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp564-565', '10.1136/annrheumdis-2021-eular.358', '']\n",
      "['11086187', 'Yamaoka K; Cohen SB; Sugiyama N; Shi H; Rivas JL; Diehl A; Smolen JS. Predictors of durable clinical response to tofacitinib 11 mg once daily with or without methotrexate in patients with rheumatoid arthritis: post hoc analysis of data from a phase 3b/4 methotrexate withdrawal study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp563-564', '10.1136/annrheumdis-2021-eular.357', '']\n",
      "['9258422', 'Fleischmann R; Kremer J; Cush J; Schulze-Koops H; Connell CA; Bradley JD; Gruben D; Wallenstein GV; Zwillich SH; Kanik KS; ORAL Solo Investigators. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. New England journal of medicine. (2012) 367 6 pp495-507', '10.1056/nejmoa1109071', '']\n",
      "['9739913', 'EUCTR2008-007788-17-DE. PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-007788-17-DE. (2009)   pp', '10.1007/s12688-018-0181-3', 'http://link.springer.com/article/10.1007/s12688-018-0181-3/fulltext.html']\n",
      "['9740949', 'NCT00814307. A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00814307. (2008)   pp', '10.1002/art.1780400110', '']\n",
      "['9256855', 'Smolen JS; Aletaha D; Gruben D; Zwillich SH; Krishnaswami S; Mebus C. Brief Report: remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: a Comparison of Various Remission Criteria. Arthritis and rheumatology. (2017) 69 4 pp728-734', '10.1002/art.39996', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39996']\n",
      "['9256885', 'Ogdie A; De Vlam K; McInnes IB; Mease PJ; Baer P; Lukic T; Kwok K; Wang C; Hsu M-A; Maniccia A. Effect of tofacitinib on reducing pain in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/rmdopen-2019-001042', '']\n",
      "['9256893', 'Schwartzman S; Van Vollenhoven RF; Matsumoto AK; Orange D; Shah S; DeMasi R; Fan H; Dahl P; Wouters A; Keystone EC. Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2018-eular.2676', '']\n",
      "['9257539', 'Hall S; Nash P; Rischmueller M; Wiid Z; Witcombe D; Gruben D; DeMasi R; Lukic T. Efficacy of tofacitinib in patients who are inadequate responders to disease-modifying antirheumatic drugs according to early versus late duration of rheumatoid arthritis: post-hoc analysis of data from phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1999-2001', '10.1002/art.39977', '']\n",
      "['9258190', 'Bird P; Hall S; Nash P; Connell C; Kwok K; Witcombe D; Thirunavukkarasu K. Tofacitinib: treatment outcomes in seropositive versus seronegative patients in a phase 3 rheumatoid arthritis population. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp32', '10.1136/rmdopen-2018-000742', '']\n",
      "['9261176', 'Al-Maini M; Li ZG; Liu Y; Al Emadi S; Zwillich SH; Bradley JD; Gruben D; Youseif EA; He SL; Rahman MU. Tofacitinib, an oral Janus kinase inhibitor, in the treatment of rheumatoid arthritis: Summary of five Phase 3 studies. International journal of rheumatic diseases. (2012) 15  pp67', '10.1136/annrheumdis-2012-eular.2108', '']\n",
      "['9262611', 'Ogdie A; De Vlam K; McInnes I; Mease P; Baer P; Lukic T; Kwok K; Wang C; Hsu M-A; Maniccia A. Effect of tofacitinib on reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PSA), and ankylosing spondylitis (AS). Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1001', '10.1136/annrheumdis-2018-eular.3247', '']\n",
      "['9262666', 'Schwartzman S; Van Vollenhoven R; Matsumoto A; Orange D; Shah S; DeMasi R; Fan H; Dahl P; Wouters A; Keystone E. Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp918', '10.1136/annrheumdis-2018-eular.2676', '']\n",
      "['9738267', 'Radominski S C; Cardiel M H; Citera G; Goecke A; Jaller J J; Lomonte A B V; Miranda P; Velez P; Xibille D; Kwok K; Rojo R; Garcia E G. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: pooled efficacy and safety analyses of Phase 3 and long-term extension studies. Reumatologia clinica. (2017) 13 4 pp201-209', '10.1016/j.reuma.2016.04.010', '']\n",
      "['9738540', 'Strand V; Kanik KS; Connell C; Wilkinson B; Gruben D; Wallenstein G. Effects of tofacitinib, an oral janus kinase inhibitor, on work limitations in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2013 San Diego, CA United States. Conference Start: 20131025 Conference End: 20131030. Conference Publication: var.pagings ppS1002', '10.1155/2013/357904', 'http://downloads.hindawi.com/archive/2013/357904.pdf']\n",
      "['9740464', 'Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib. RMD open. (2019) 5 1 pp', '10.1136/rmdopen-2018-000742', '']\n",
      "['9740592', 'Bird Paul; Bensen William; El-Zorkany Bassel; Kaine Jeffrey; Manapat-Reyes Bernadette Heizel; Pascual-Ramos Virginia; Witcombe David; Soma Koshika; Zhang Richard; Thirunavukkarasu Krishan. Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: a Comprehensive Review of Phase 3 Efficacy and Safety. Journal of clinical rheumatology. (2019) 25 3 pp115-126', '10.1097/rhu.0000000000000786', '']\n",
      "['9741321', 'Bird Paul; Hall Stephen; Nash Peter; Connell Carol A; Kwok Kenneth; Witcombe David; Thirunavukkarasu Krishan. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib. RMD open. (2019) 5 1 ppe000742', '10.1136/rmdopen-2018-000742', '']\n",
      "['9737737', 'Dikranian A; Wollenhaupt J; Azevedo VF; Bessette L; Gold D; Rivas JL; Shi H; Wang L; Woolcott J; Shapiro A; Nash P. Frequencyand duration of early non-serious adverse events in rheumatoid arthritis patients treated with tofacitinib 5 mg twice dailyas monotherapyand combination therapy. Journal of clinical rheumatology. (2019) Conference: 21st Pan American Rheumatology Congress, PANLAR 2019. Ecuador. 25 3 Supplement ppS50', '10.1136/annrheumdis-2019-eular.418', '']\n",
      "['9742094', 'Dikranian A; Wollenhaupt J; Azevedo VF; Bessette L; Gold D; Rivas JL; Shi H; Wang L; Woolcott J; Shapiro A; Nash P. Frequency and duration of early non-serious adverse events in rheumatoid arthritis patients treated with tofacitinib 5 Mg twice daily as monotherapy and combination therapy. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp1699-1700', '10.1136/annrheumdis-2019-eular.418', '']\n",
      "['9742978', '. Frequency and duration of early non-serious adverse events in rheumatoid arthritis patients treated with tofacitinib 5 mg twice daily as monotherapy and combination therapy. Annals of the rheumatic diseases. (2019) 78  pp1690-1691', '10.1136/annrheumdis-2019-eular.418', '']\n",
      "['9261986', 'Zerbini C; Radominski S; Cardiel MH; Castaneda O; Romero F; Citera G; Neira O; De Leon DP; Hoffman E; Rojo R. Efficacy and safety of tofacitinib monotherapy versus combination therapy in a latin american subpopulation of patients with rheumatoid arthritis: a pooled phase 3 analysis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1793', '']\n",
      "['9263585', 'Zerbini CAF; Radominski SC; Cardiel MH; Castaneda O; Romero F; Citera G; Neira O; De Leon DP; Hoffman E; Rojo R. Efficacy and safety of to facitinib monotherapy versus combination therapy in a Latin American subpopulation of patients with rheumatoid arthritis: a pooled phase 3 analysis. Journal of clinical rheumatology. Conference: 19th pan american league of associations for rheumatology congress. Panama. (2016) 22 3 pp121-122', '10.1136/annrheumdis-2016-eular.1793', '']\n",
      "['9741397', 'Chopra Arvind; Shobha Vineeta; Chandrashekara Srikantiah; Veeravalli Sarath C M; Sharma Reena; Rao Uppuluri R; Pandya Sapan; Wagh Shrikant; Kadel Jugal K; Thorat Amit V; Adhav Charles; Santos Estrella Paul; Yu Wei; Kwok Kenneth; Wouters Ann. Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: a post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years. International journal of rheumatic diseases. (2020)   pp', '10.1111/1756-185x.13853', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13853']\n",
      "['9261469', 'Strand V; Alten RE; Nduaka CI; Riese R; Gruben D; Zwillich SH; Andrews J; Wallenstein G. Improvements in physical function correlate with improvements in health related quality of life: Reported outcomes in rheumatoid arthritis patients treated with tofacitinib: Results from 3 randomized phase 3 trials. Arthritis and rheumatism. (2013) 65  ppS993-S994', '10.1002/acr.23004', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23004']\n",
      "['9737501', '. Frequencyand duration of early non-serious adverse events in rheumatoid arthritis patients treated with tofacitinib 5 mg twice dailyas monotherapyand combination therapy. Journal of clinical rheumatology. (2019) 25 3 ppS50-', '10.1136/annrheumdis-2019-eular.418', '']\n",
      "['9261129', 'Van Vollenhoven RF; Krishnaswami S; Benda B; Gruben D; Wilkinson B; Mebus CA; Zwillich SH; Bradley J. Tofacitinib and adalimumab achieve similar rates of low disease activity in rheumatoid arthritis-lack of improvement in disease activity score by 3 months predicts low likelihood of low disease activity at 1 year. Arthritis and rheumatism. (2012) 64  ppS556', '10.1002/acr.23585', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23585']\n",
      "['9261195', 'Van Vollenhoven RF; Fleischmann RM; Cohen SB; Lee EB; Meijide G; Wagner S; Forejtova S. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab versus placebo in patients with rheumatoid arthritis on background methotrexate: A phase 3 study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1056/nejmoa1112072', '']\n",
      "['9261423', 'Van Vollenhoven RF; Wallenstein G; Lee EB; Fleischmann R; Zwillich SH; Gruben D; Koncz T; Bradley J; Wilkinson B; Strand V. Effects of tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab on patient reported outcomes in a phase 3 study of active rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2116', '']\n",
      "['9261936', 'Genovese M; Van Vollenhoven R; Wilkinson B; Wang L; Zwillich S; Gruben D; Benda B; Jones T; Bradley J. Tofacitinib, an oral janus kinase inhibitor, in a rheumatoid arthritis open-label extension study following adalimumab therapy in a phase 3 randomised clinical trial. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.251', '']\n",
      "['9261949', 'Strand V; van Vollenhoven RF; Lee EB; Fleischmann R; Zwillich SH; Gruben D; Koncz T; Wilkinson B; Wallenstein G. Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 6 pp1031-1041', '10.1093/rheumatology/kev442', 'http://academic.oup.com/rheumatology/article-pdf/55/6/1031/18097871/kev442.pdf']\n",
      "['9737608', 'Strand V; van Vollenhoven RF; Eun Bong Lee; Fleischmann R; Zwillich SH; Gruben D; Koncz T; Wilkinson B; Wallenstein G. Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. Rheumatology. (2016) 55 6 pp1031-1041', '10.1093/rheumatology/kev442', 'http://academic.oup.com/rheumatology/article-pdf/55/6/1031/18097871/kev442.pdf']\n",
      "['9739003', 'Van Vollenhoven R; Cohen S; Mendelsohn A; Bananis E; Fan H; Takiya L; Fleischmann R. Efficacy of adalimumab and tofacitinib in rheumatoid arthritis: post-HOC analyses from a phase 3 study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1042', '10.1136/annrheumdis-2016-eular.3234', '']\n",
      "['9742892', '. Tofacitinib, an oral janus kinase inhibitor, in a rheumatoid arthritis open-label extension study following adalimumab therapy in a phase 3 randomised clinical trial. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS190-S191', '10.1136/annrheumdis-2013-eular.251', '']\n",
      "['9260734', 'van Vollenhoven RF; Fleischmann R; Cohen S; Lee EB; Garc‚àö‚â†a Meijide JA; Wagner S; Forejtova S; Zwillich SH; Gruben D; Koncz T; Wallenstein GV; Krishnaswami S; Bradley JD; Wilkinson B; ORAL Standard Investigators. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. New England journal of medicine. (2012) 367 6 pp508-519', '10.1056/nejmoa1112072', '']\n",
      "['9737681', 'NCT00853385. A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00853385. (2009)   pp', '10.1186/s13075-018-1676-y', 'http://link.springer.com/article/10.1186/s13075-018-1676-y/fulltext.html']\n",
      "['9738884', 'Genovese M C; Van Vollenhoven; R F; Wilkinson B; Wang L; Zwillich S H; Gruben D; Benda B; Jones T V. Tofacitinib, an oral janus kinase inhibitor, in a rheumatoid arthritis open-label extension study following adalimumab therapy in a phase 3 randomised clinical trial. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS190-S191', '10.1136/annrheumdis-2013-eular.251', '']\n",
      "['9740297', 'EUCTR2008-008338-35-SK. PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE COMPARATOR, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-008338-35-SK. (2009)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['11086517', 'Winthrop K; Gold D; Henrohn D; Wang L; Shapiro A; Shi H; Citera G; Schulze-Koops H. Age-based (<65 vs >=65 years) incidence of infections and serious infections in tofacitinib-, adalimumab- and placebo-treated patients with rheumatoid arthritis: a post hoc analysis of phase 2, phase 3 and phase 3b/4 tofacitinib studies. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1007-1008', '10.1136/annrheumdis-2020-eular.1432', '']\n",
      "['9257993', 'Rendas-Baum R; Kosinski M; Singh A; Mebus CA; Wilkinson BE; Wallenstein GV. Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials. Rheumatology (oxford, england). (2017) 56 8 pp1386-1394', '10.1093/rheumatology/kex087', 'http://academic.oup.com/rheumatology/article-pdf/56/8/1386/24245881/kex087.pdf']\n",
      "['9261546', 'Rendas-Baum R; Kosinski M; Singh A; Mebus C; Wilkinson B; Riese R; Wallenstein G. Estimated medical expenditures among patients with rheumatoid arthritis undergoing treatment with tofacitinib, an oral Janus kinase inhibitor. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2476', '']\n",
      "['9741339', 'Rendas-Baum R; Kosinski M; Singh A; Mebus CA; Wilkinson BE; Wallenstein GV. Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials. Rheumatology. (2017) 56 8 pp1386-1394', '10.1093/rheumatology/kex087', 'http://academic.oup.com/rheumatology/article-pdf/56/8/1386/24245881/kex087.pdf']\n",
      "['9737130', 'Ciurea A; Distler O; Killeen T; Akylbekova E; Kwok K; Wang L; Ospelt C; Frank-Bertoncelj M. Joint-specific responses to tofacitinib and adalimumab in rheumatoid arthritis: a post hoc analysis of data from oral standard and oral strategy. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp742-743', '10.1136/annrheumdis-2019-eular.1196', '']\n",
      "['9256858', 'Fleischmann R; Connell CA; Fan H; Strengholt S. C-reactive protein levels in patients with or without structural progression: a post-HOC analysis from a phase 3 tofacitinib trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40321', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40321']\n",
      "['9257506', 'Keystone E; Van Vollenhoven RF; Wilkinson B; Fallon L; Hwang L-J; Chapman D; DeMasi R; Lee EB. Lack of early change in disease activity score predicts the likelihood of achieving low disease activity at month 6: tofacitinib monotherapy versus methotrexate in methotrexate-naive patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1998-1999', '10.1136/annrheumdis-2016-eular.1853', '']\n",
      "['9258164', \"Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2005) 52 1 pp27-35\", '10.1002/art.20712', '']\n",
      "['9261111', 'Lee EB; Fleischmann RM; Hall S; Van Vollenhoven RF; Bradley J; Gruben D; Koncz T; Krishnaswami S; Wallenstein G; Zwillich SH; Wilkinson BE. Radiographic, clinical and functional comparison of tofacitinib monotherapy versus methotrexate in methotrexate-naive patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS1049', '10.1056/nejmoa1310476', '']\n",
      "['9261357', 'Strand V; Fleischmann R; Alten RE; Koncz T; Zwillich SH; Bradley JD; Gruben D; Wilkinson B; Krishaswami S; Wallenstein G. Oral start: Effects of the oral JAK inhibitor tofacitinib monotherapy versus methotrexate on patient-reported outcomes in the phase 3 oral start trial of active rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.786', '']\n",
      "['9261361', 'Huizinga TWJ; Fleischmann R; Van Vollenhoven R; Gruben D; Wilkinson B; Koncz T; Bradley J; Zwillich SH; Benda B. Tofacitinib monotherapy is effective in methotrexate-naive patients with disease duration less than 6 months: A post-HOC analysis of early rheumatoid arthritis subjects in a phase 3 trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.753', '']\n",
      "['9261448', 'Fleischmann RM; Lee EB; Hall S; Wilkinson BE; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein G; Zwillich SH; Van Vollenhoven RF. Tofacitinib monotherapy versus methotrexate in methotrexate-naive patients with rheumatoid arthritis: Radiographic, clinical and functional comparison. Arthritis and rheumatism. (2013) 65  12 pp3323', '10.1056/nejmoa1310476', '']\n",
      "['9261476', 'Strand V; Van Der Heijde D; Landewe R; Lee EB; Wilkinson B; Zwillich SH; Bradley J; Mebus C; Benda B; Gruben D. Remission at 3 or 6 months and radiographic non-progression at 12 months in methotrexate-naive rheumatoid arthritis patients treated with tofacitinib or methotrexate: A post-HOC analysis of the oral start trial. Arthritis and rheumatism. (2013) 65  ppS842-S843', '10.1136/annrheumdis-2013-eular.753', '']\n",
      "['9261516', 'Lee EB; Fleischmann RM; Hall S; Van Vollenhoven RF; Rahman MU; Koncz T; Wilkinson BE. Clinical, functional and radiographic comparison of tofacitinib monotherapy versus methotrexate in methotrexate-naive patients with rheumatoid arthritis. International journal of rheumatic diseases. (2013) 16  pp62', '10.1136/annrheumdis-2013-eular.753', '']\n",
      "['9261564', 'Alten R; Strand V; Fleischmann R; Koncz T; Zwillich S; Bradley J; Gruben D; Wilkinson B; Krishnaswami S; Wallenstein G. Effects of tofacitinib monotherapy versus methotrexate on patient-reported outcomes in the 2-year phase 3 oral start trial in methotrexate-naive patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3168', '']\n",
      "['9261894', 'Fleischmann R; Strand V; Wilkinson B; Kwok K; Bananis E. Relationship between different clinical measurements and patient-reported outcomes: results from a phase 3 study of tofacitinib or methotrexate in methotrexate-naive patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp259-260', '10.1136/annrheumdis-2015-eular.3928', '']\n",
      "['9736616', 'Strand Vibeke; Lee Eun Bong; Fleischmann Roy; Alten Rieke E; Koncz Tamas; Zwillich Samuel H; Gruben David; Wilkinson Bethanie; Krishnaswami Sriram; Wallenstein Gene. Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial. RMD open. (2016) 2 2 ppe000308', '10.1136/rmdopen-2016-000308', '']\n",
      "['9736783', 'Fleischmann Roy; Strand Vibeke; Wilkinson Bethanie; Kwok Kenneth; Bananis Eustratios. Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naive patients with rheumatoid arthritis. RMD open. (2016) 2 1 ppe000232', '10.1136/rmdopen-2015-000232', '']\n",
      "['9738837', 'Charles-Schoeman C; Dikranian A; Taylor J; Wilkinson B; Jones T; Kwok K; Nduaka C. Assessment of lipid changes in patients with early rheumatoid arthritis treated with tofacitinib or methotrexate over 24 months. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS209', '10.1093/rheumatology/kew329', 'http://academic.oup.com/rheumatology/article-pdf/56/1/46/8668657/kew329.pdf']\n",
      "['9739436', 'Keystone E; Van Vollenhoven RF; Wilkinson B; Fallon L; Hwang L-J; Chapman D; DeMasi R; Lee EB. Lack of early change in disease activity score predicts the likelihood of achieving low disease activity at month 6: tofacitinib monotherapy versus methotrexate in methotrexate-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp250-', '10.1136/annrheumdis-2016-eular.1853', '']\n",
      "['9741111', 'NCT01039688. Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX. https://clinicaltrials.gov/show/NCT01039688. (2009)   pp', '10.1002/cca.2940', '']\n",
      "['9742820', 'EUCTR2009-016987-34-BE. Phase 3 Randomized, Double-Blind Study of the Efficacy and Safety of 2 Doses of CP-690,550 Compared to Methotrexate in Methotrexate-Na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-016987-34-BE. (2010)   pp', '10.1186/isrctn49455679', '']\n",
      "['9256883', 'Moeller B; Finckh A; Scholz G; Shi H; Connell CA; Strengholt S. Baseline anemia as a predictor of radiographic progression in tofacitinib-treated rheumatoid arthritis patients: post hoc analyses from two phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40321', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40321']\n",
      "['9739443', 'Strand V; Kavanaugh A; Kivitz AJ; van der Heijde D; Kwok K; Akylbekova E; Soonasra A; Snyder M; Connell C; Bananis E; Smolen JS. Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses. Rheumatology and therapy. (2018) 5 2 pp341-353', '10.1007/s40744-018-0113-7', 'https://link.springer.com/article/10.1007/s40744-018-0113-7/fulltext.html']\n",
      "['9740567', '. Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials. Clinical rheumatology. (2018) 37 8 pp2043-2053', '10.1007/s10067-018-4077-3', 'http://link.springer.com/article/10.1007/s10067-018-4077-3/fulltext.html']\n",
      "['9256875', 'Smolen JS; Shergy W; Wright GC; DeMasi R; Kwok K; Mojcik CF; Iikuni N; Tatulych S; Citera G. American college of rheumatology response rates determined using 28 versus 68/66 joint count in patients with rheumatoid arthritis receiving tofacitinib in phase 3 studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40321', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40321']\n",
      "['9257523', 'Bergman MJ; Yazici Y; Dikranian A; Bourret J; Zang C; Mojcik CF; Bananis E. Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: an analysis of data from 6 phase 3 studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1985-1986', '10.1007/s10067-018-4077-3', 'http://link.springer.com/article/10.1007/s10067-018-4077-3/fulltext.html']\n",
      "['9262436', 'Schwartzman S; Sunkureddi P; Takiya L; Snyder M; Fan H; Lukic T; Roberts J; Rigby W F C. Comparison of tofacitinib efficacy in patients with moderate vs severe rheumatoid arthritis: pooled analysis of phase 3 studies. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1202-1203', '10.1136/annrheumdis-2017-eular.1846', '']\n",
      "['9263556', 'Charles-Schoeman C; Wicker P; Gonzalez-Gay MA; Boy M; Zuckerman A; Soma K; Geier J; Kwok K; Riese R. Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral janus kinase inhibitor. Seminars in arthritis and rheumatism. (2016) 46 3 pp261-271', '10.1016/j.semarthrit.2016.05.014', '']\n",
      "['9738844', 'Kivitz AJ; Cohen S; Keystone E; van Vollenhoven RF; Haraoui B; Kaine J; Fan H; Connell CA; Bananis E; Takiya L; Fleischmann R. A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population. Seminars in arthritis and rheumatism. (2018)   pp', '10.1016/j.semarthrit.2018.07.006', '']\n",
      "['9738976', 'Schwartzman S; Sunkureddi P; Takiya L; Snyder M; Fan H; Lukic T; Roberts J; Rigby W F C. Comparison of tofacitinib efficacy in patients with moderate vs severe rheumatoid arthritis: pooled analysis of phase 3 studies. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.1846', '']\n",
      "['9739354', 'Kivitz Alan J; Cohen Stanley; Keystone Edward; van Vollenhoven Ronald F; Haraoui Boulos; Kaine Jeffrey; Fan Haiyun; Connell Carol A; Bananis Eustratios; Takiya Liza; Fleischmann Roy. A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population. Seminars in arthritis and rheumatism. (2018) 48 3 pp406-415', '10.1016/j.semarthrit.2018.07.006', '']\n",
      "['9740535', '. Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: pooled efficacy and safety analyses of data from phase III studies. Revista colombiana de reumatologia. (2018) 25 4 pp233-244', '10.1016/j.rcreu.2018.08.002', '']\n",
      "['9260732', 'Burmester GR; Blanco R; Charles-Schoeman C; Wollenhaupt J; Zerbini C; Benda B; Gruben D; Wallenstein G; Krishnaswami S; Zwillich SH; Koncz T; Soma K; Bradley J; Mebus C; ORAL Step investigators. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet (London, England). (2013) 381 9865 pp451-460', '10.1016/s0140-6736(12)61424-x', '']\n",
      "['9261196', 'Burmester G-R; Blanco R; Charles-Schoeman C; Wollenhaupt J; Zerbini CAF; Benda B; Gruben D. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, in combination with methotrexate, in patients with active rheumatoid arthritis with an inadequate response to tumor necrosis factor-inhibitors: A 6-month phase 3 study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1016/s0140-6736(12)61424-x', '']\n",
      "['9736536', 'EUCTR2009-014296-40-DE. PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUATE RESPONSE TO TNF INHIBITORS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-014296-40-DE. (2009)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9741134', 'NCT00960440. Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors. https://clinicaltrials.gov/show/NCT00960440. (2009)   pp', '10.1177/1759720x211002682', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X211002682']\n",
      "['9261941', 'Christina C-S; Burmester G; Nash P; Zerbini CAF; Soma K; Kwok K; Hendrikx T; Bananis E; Fleischmann R. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. (2016) 75 7 pp1293-1301', '10.1136/annrheumdis-2014-207178', '']\n",
      "['9262222', 'Charles-Schoeman C; Burmester G; Nash P; Zerbini CA; Soma K; Kwok K; Hendrikx T; Bananis E; Fleischmann R. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. (2016) 75 7 pp1293-1301', '10.1136/annrheumdis-2014-207178', '']\n",
      "['9262222', 'Charles-Schoeman C; Burmester G; Nash P; Zerbini CA; Soma K; Kwok K; Hendrikx T; Bananis E; Fleischmann R. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. (2016) 75 7 pp1293-1301', '10.1136/annrheumdis-2014-207178', '']\n",
      "['9736978', 'Hall Stephen; Nash Peter; Rischmueller Maureen; Bossingham David; Bird Paul; Cook Nicola; Witcombe David; Soma Koshika; Kwok Kenneth; Thirunavukkarasu Krishan. Tofacitinib, an Oral Janus Kinase Inhibitor: pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population. Rheumatology and therapy. (2018)   pp', '10.1007/s40744-018-0118-2', 'https://link.springer.com/article/10.1007/s40744-018-0118-2/fulltext.html']\n",
      "['9738269', 'Hall S; Nash P; Rischmueller M; Bossingham D; Bird P; Cook N; Witcombe D; Soma K; Kwok K; Thirunavukkarasu K. Tofacitinib, an Oral Janus Kinase Inhibitor: pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population. Rheumatology and therapy. (2018) 5 2 pp383-401', '10.1007/s40744-018-0118-2', 'https://link.springer.com/article/10.1007/s40744-018-0118-2/fulltext.html']\n",
      "['9738719', 'Schwartzman S; Van Vollenhoven R; Matsumoto A; Orange D; Shah S; DeMasi R; Fan H; Dahl P; Wouters A; Keystone E. Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp918', '10.1136/annrheumdis-2018-eular.2676', '']\n",
      "['9742213', 'Dikranian A; Gonzalez-Gay MA; Wellborne F; Alvaro-Gracia JM; Takiya L; Stockert L; Chapman D; Tatulych S; Dahl P; Curtis JR. The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp925-926', '10.1136/annrheumdis-2018-eular.1284', '']\n",
      "['11086071', 'Thongpooswan S; Schneeberger EE; Chokboonpium S; Gunay LM; Shi H; Wee J; Abou-Raya A. Impact of tofacitinib on liver function tests in patients with rheumatoid arthritis: a post-hoc analysis. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp87-89', '10.1136/annrheumdis-2013-eular.1776', '']\n",
      "['9256865', 'Calabrese LH; Abud-Mendoza C; Lindsey S; Lee SH; Takiya L; Iikuni N; Soma K; Luo Z; Fleischmann R. Evaluation of live zoster vaccine in a subset of patients with rheumatoid arthritis treated with tofacitinib with or without methotrexate, and adalimumab with methotrexate: results from a phase 3B/4 randomized trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2018-eular.1469', '']\n",
      "['9262232', 'Fleischmann R; Mysler E; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS; Adams L; Ally MM; du Plooy MC; Louw IC; Nayiager S; Nel CB; Nel D; Reuter H; Soloman AS; Spargo CE; Hall S; Rischmueller M; Sharma SD; Will RK; Youssef PP; Arroyo C; Baes RP; Dulos RB; Hao LT; Lanzon AE; Lichauco JJT; Mangubat JH; Ramiterre EB; Reyes BHM; Tan PP; Choe J-Y; Kang YM; Kwon SR; Lee S-H; Lee S-S; Yoo D-H; Lin H-Y; Luo S-F; Tsai S-T; Tsai W-C; Tseng J-C; Wei C-CC; Asavatanabodee P; Nantiruj K; Nilganuwong S; Uea-Areewongsa P; Majstorovic LB; Bacic SM; Batalov AZ; Georgieva-Slavcheva G; Mihailova M; Nikolov NG; Penev DP; Spasov YA; Stanimirova K; Todorov S; Toncheva AR; Yordanova N; Mosterova Z; Novosad L; Prochazkova L; Stehlikova H; Stejfova Z; Kiseleva N; Pank L; Savi T; Alexandra B-G; Amital H; Mevorach D; Rosner IA; Mihailova A; Stumbra-Stumberga E; Basijokiene V; Lietuvininkiene V; Unikiene D; Brzezicki J; Dudek AM; Glowacka-Kulesz MB; Grabowicz-Wasko B; Hajduk-Kubacka S; Hilt J; Hrycaj P; Jeka S; Kolasa R; Krogulec M; Mastalerz H; Olak-Popko A; Owczarek E; Ruzga Z; Walczak A; Ancuta CI; Ancuta I; Balanescu AR; Berghea F; Bojin S; Arvunescu MAI; Ionescu RM; Mociran E; Pavel M; Rednic S; Voie A; Zainea CM; Bugrova OV; Demin A; Ershova OB; Gavrisheva IA; Krechikova DG; Kuropatkin GV; Marusenko IM; Menshikova IV; Noskov SM; Rebrov AP; Smakotina SA; Yakushin SS; Zhilyaev E; Ramos JJA; Garcia FJB; Nebro AF; Esteban SP; Burson JMS; Sala RS; Ataman S; Hizmetli S; Kuru O; Douglas KM; Emery P; Moots RJ; Ong VH; Sheeran TP; Faraawi RY; Lessard C; Mendoza CA; Avila-Armengol HE; Zapata FIA; Irazoque-Palazuelos FC; Cecena MAM; Pacheco-Tena CF; Rizo-Rodriguez JC; Rodriguez-Torres IM; Aelion JA; Caciolo BA; Calmes JM; Chatpar P; Dayal N; De Jesus A; Dikranian AH; Diri E; Fairfax MJ; Fenton IF; Fleischmann RM; Gaylis NB; George RL; Halter DG; Hernandez P; Hole SA; Hou AC; Huff JP; Kafaja S; Kennedy AC; Kenney H; Kimmel SC; Kirby BS; Kivitz AJ; Legerton CW; Lindsey SM; Mallepalli JR; Mathews SD; Metyas SK; Mizutani WT; Najam S; Nascimento JM; Pang SW; Patel RC; Poiley JE; Ramirez CE; Reddy R; Rehman Q; Schnitz WM; Scoville CD; Shergy WJ; Silverfield JC; Singhal AK; Smallwood-Sherrer YR; Songcharoen SN; Stack MT; Stohl W; Su T-IK; Udell J; Waraich S; Weidmann CE; Wei N; Wiesenhutter CW; Winkler AE; Zagar KE; Berman A; Mysler EF; Hidalgo RAP; Venarotti HO; Sariego IAG; Calabresse REJ; Ruiz-Tagle JIV; Vargas LFMB; Berrocal AE; Portocarrero MGL; Jesus F; Pena R. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. Lancet. (2017) 390 10093 pp457-468', '10.1016/s0140-6736(17)31618-5', '']\n",
      "['9262549', 'Fleischmann R; Mysler E; Hall S; Kivitz A; Moots R; Luo Z; Tatulych S; DeMasi R; Soma K; Zhang R; Takiya L; Mojcik C; Krishnaswami S; Menon S; Smolen J. Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3B/4 randomised trial. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp149-150', '10.1136/annrheumdis-2017-eular.7113', '']\n",
      "['9262655', 'Strand V; Mysler E; Moots RJ; Wallenstein G; DeMasi R; Gruben D; Soma K; Iikuni N; Fleischmann R. Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: patient-reported outcomes from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp990-991', '10.1136/annrheumdis-2018-eular.1312', '']\n",
      "['9262665', 'Fleischmann R; Wollenhaupt J; Cohen S; Smolen JS; Dahl P; Iikuni N; Shi H; Tatulych S; Takiya L. Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp985-986', '10.1136/annrheumdis-2018-eular.1533', '']\n",
      "['9736591', 'Fleischmann R; Mysler E; Hall S; Kivitz A; Moots R; Luo Z; Tatulych S; DeMasi R; Soma K; Zhang R; Takiya L; Mojcik C; Krishnaswami S; Menon S; Smolen J. Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3B/4 randomised trial. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp149-150', '10.1136/annrheumdis-2017-eular.7113', '']\n",
      "['9737329', 'PER-070-14. A PHASE 3B/4 RANDOMIZED DOUBLE BLIND STUDY OF 5 MG OF TOFACITINIB WITH AND WITHOUT METHOTREXATE IN COMPARISON TO ADALIMUMAB WITH METHOTREXATE IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-070-14. (2015)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9737391', '. Clinical and functional response to tofacitinib and adalimumab in patients with rheumatoid arthritis: probability plot analysis of results from the oral strategy trial. Arthritis and rheumatology. (2018) 70  pp661-662', '10.1136/annrheumdis-2018-eular.3735', '']\n",
      "['9737599', 'Fleischmann R; Wollenhaupt J; Cohen S; Smolen JS; Dahl P; Iikuni N; Shi H; Tatulych S; Takiya L. Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp985-986', '10.1136/annrheumdis-2018-eular.1533', '']\n",
      "['9738222', 'Takeuchi T; Smolen JS; Fleischmann R; Iikuni N; Fan H; Soma K; Akylbekova E; Hirose T. Clinical and functional response to tofacitinib and adalimumab in patients with rheumatoid arthritis: probability plot analysis of results from the oral strategy trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp987-988', '10.1136/annrheumdis-2018-eular.3735', '']\n",
      "['9738707', 'Calabrese LH; Abud-Mendoza C; Lindsey S; Lee S-H; Takiya L; Iikuni N; Soma K; Luo Z; Fleischmann R. Evaluation of live zoster vaccine in a subset of patients with rheumatoid arthritis treated with tofacitinib with or without methotrexate, and adalimumab with methotrexate: results from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp971', '10.1136/annrheumdis-2018-eular.1469', '']\n",
      "['9738713', 'Strand V; Mysler E; Moots RJ; Wallenstein G; DeMasi R; Gruben D; Soma K; Iikuni N; Fleischmann R. Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: patient-reported outcomes from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp990-991', '10.1136/annrheumdis-2018-eular.1312', '']\n",
      "['9739773', 'EUCTR2014-000358-13-HR. A clinical trial to assess a novel medicine in the treatment of patients with moderately to severely active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-000358-13-HR. (2015)   pp', '10.1016/j.jval.2015.03.937', '']\n",
      "['9740611', 'Takeuchi T; Tanaka Y; Yamanaka H; Yamaoka K; Sugiyama N; Toyoizumi S; Iikuni N; Hirose T; Morishima Y; Yoshii N; Fleischmann R. Efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate in rheumatoid arthritis by baseline methotrexate dose. International journal of rheumatic diseases. (2019) 22 Supplement 3 pp197-198', '10.1136/annrheumdis-2019-eular.587', '']\n",
      "['9740785', 'Takeuchi T; Tanaka Y; Sugiyama N; Iikuni N; Soma K; Shi H; Mysler E; Moots RJ; Smolen JS; Fleischmann R. Efficacy of tofacitinib monotherapy, tofacitinib with methotrexate and adalimumab with methotrexate in patients with early (‚àö¬¢‚Äö√Ñ‚àû¬¨¬ß2 years) vs established (>2 years) rheumatoid arthritis: a post hoc analysis of data from oral strategy. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp373-374', '10.1136/annrheumdis-2019-eular.587', '']\n",
      "['9742090', 'Takeuchi T; Smolen JS; Fleischmann R; Iikuni N; Fan H; Soma K; Akylbekova E; Hirose T. Clinical and functional response to tofacitinib and adalimumab in patients with rheumatoid arthritis: probability plot analysis of results from the oral strategy trial. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp661-662', '10.1136/annrheumdis-2018-eular.3735', '']\n",
      "['9742105', 'Rezaei S; Taheri S; Tahmasebi N; Peiravian F; Yousefi N. COST-EFFECTIVENESS OF TOFACITINIB COMPARED WITH ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN IRAN. Value in health. (2018) Conference: ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems. Spain. 21 Supplement 3 ppS295-S296', '10.1016/j.jval.2018.09.1761', '']\n",
      "['9742304', 'Strand V; Mysler E; Moots RJ; Wallenstein GV; Demasi R; Gruben D; Soma K; Iikuni N; Smolen JS; Fleischmann R. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2019-001040', '']\n",
      "['9742971', 'Strand V; Mysler E; Moots RJ; Wallenstein GV; Demasi R; Gruben D; Soma K; Iikuni N; Smolen JS; Fleischmann R. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. RMD open. (2019) 5 2 pp', '10.1136/rmdopen-2019-001040', '']\n",
      "['9743051', 'Strand Vibeke; Mysler Eduardo; Moots Robert J; Wallenstein Gene V; DeMasi Ryan; Gruben David; Soma Koshika; Iikuni Noriko; Smolen Josef S; Fleischmann Roy. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. RMD open. (2019) 5 2 ppe001040', '10.1136/rmdopen-2019-001040', '']\n",
      "['9262647', 'Calabrese LH; Abud-Mendoza C; Lindsey S; Lee S-H; Takiya L; Iikuni N; Soma K; Luo Z; Fleischmann R. Evaluation of live zoster vaccine in a subset of patients with rheumatoid arthritis treated with tofacitinib with or without methotrexate, and adalimumab with methotrexate: results from a phase 3b/4 randomised trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp971', '10.1136/annrheumdis-2018-eular.1469', '']\n",
      "['9736971', 'PER-037-14. PHASE 3B/4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR (TNF) INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-037-14. (2014)   pp', '10.17918/00004872', '']\n",
      "['9742795', 'EUCTR2013-003177-99-AT. A clinical study to evaluate the safety of two different doses of Tofacitinib for the treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003177-99-AT. (2015)   pp', '10.31525/ct1-nct04179513', '']\n",
      "['11083681', 'Weitz JI; Szekanecz Z; Charles-Schoeman C; Vranic I; Sahin B; Paciga SA; Wang Z; Hyde C; Martin DA. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. . (2022) 8 2 pp', '10.1136/rmdopen-2022-002571', '']\n",
      "['11084080', 'Giles JT; Charles-Schoeman C; Buch MH; Dougados M; Szekanecz Z; Ytterberg SR; Koch GG; Wu J; Wang C; Kwok K; Menon S; Chen Y; Cesur TY; Rivas JL; Yndestad A; Diehl A; Bhatt DL. ASSOCIATION between BASELINE STATIN TREATMENT and MAJOR ADVERSE CARDIOVASCULAR EVENTS in PATIENTS with RHEUMATOID ARTHRITIS: a POST HOC ANALYSIS of ORAL SURVEILLANCE. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp518-519', '10.1136/annrheumdis-2022-eular.1255', '']\n",
      "['11084081', 'Charles-Schoeman C; Fleischmann RM; Mysler E; Greenwald M; Wang C; Chen AS; Connell CA; Woolcott J; Menon S; Chen Y; Lee K; Szekanecz Z. RISK of VENOUS THROMBOEMBOLIC EVENTS in PATIENTS with RHEUMATOID ARTHRITIS AGED >=50 YEARS with >=1 CARDIOVASCULAR RISK FACTOR: RESULTS from A PHASE 3B/4 RANDOMISED STUDY of TOFACITINIB VS TUMOUR NECROSIS FACTOR INHIBITORS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp358-359', '10.1136/annrheumdis-2022-eular.1016', '']\n",
      "['11084711', 'Buch MH; Charles-Schoeman C; Curtis J; Dougados M; Bhatt DL; Giles JT; Ytterberg SR; Koch GG; Vranic I; Wu J; Wang C; Kwok K; Menon S; Rivas JL; Yndestad A; Connell CA; Szekanecz Z. MAJOR ADVERSE CARDIOVASCULAR EVENTS, MALIGNANCIES and VENOUS THROMBOEMBOLISM by BASELINE CARDIOVASCULAR RISK: a POST HOC ANALYSIS of ORAL SURVEILLANCE. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp356-357', '10.1136/annrheumdis-2022-eular.1182', '']\n",
      "['11085619', 'Ytterberg SR; Bhatt DL; Mikuls TR; Koch GG; Fleischmann R; Rivas JL; Germino R; Menon S; Sun Y; Wang C; Shapiro AB; Kanik KS; Connell CA; ORAL Surveillance Investigators. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. New England journal of medicine. (2022) 386 4 pp316-326', '10.1056/nejmoa2109927', '']\n",
      "['11085708', 'Balanescu AR; Citera G; Pascual-Ramos V; Bhatt DL; Connell CA; Gold D; Chen AS; Sawyerr G; Shapiro AB; Pope JE; Schulze-Koops H. Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial. Annals of the rheumatic diseases. (2022) 81 11 pp1491-1503', '10.1136/ard-2022-222405', '']\n",
      "['11085774', 'Weitz JI; Szekanecz Z; Charles-Schoeman C; Vranic I; Sahin B; Paciga SA; Wang Z; Hyde C; Martin DA. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD open. (2022) 8 2 pp11', '10.1136/rmdopen-2022-002571', '']\n",
      "['11087228', 'Charles-Schoeman C; Buch MH; Dougados M; Bhatt DL; Giles JT; Ytterberg SR; Koch GG; Vranic I; Wu J; Wang C; Menon S; Rivas JL; Yndestad A; Connell CA; Szekanecz Z. RISK FACTORS for MAJOR ADVERSE CARDIOVASCULAR EVENTS in PATIENTS AGED >=50 YEARS with RHEUMATOID ARTHRITIS and >=1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: a POST HOC ANALYSIS of ORAL SURVEILLANCE. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp611-612', '10.1136/annrheumdis-2022-eular.1234', '']\n",
      "['11087241', 'Szekanecz Z; Charles-Schoeman C; Vranic I; Sahin B; Paciga SA; Wang Z; Hyde C; Martin D; Weitz JI. BIOMARKERS to PREDICT RISK of VENOUS THROMBOEMBOLISM in PATIENTS with RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB or TUMOUR NECROSIS FACTOR INHIBITORS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp179-180', '10.1136/annrheumdis-2022-eular.787', '']\n",
      "['11087247', 'Karpouzas G; Szekanecz Z; Baecklund E; Mikuls T; Bhatt DL; Shi H; Wang C; Sawyerr G; Chen Y; Menon S; Connell CA; Ytterberg SR; Mortezavi M. RELATIONSHIP between DISEASE ACTIVITY and MAJOR ADVERSE EVENTS in PATIENTS with RHEUMATOID ARTHRITIS on TOFACITINIB or TNF INHIBITORS: a POST HOC ANALYSIS of ORAL SURVEILLANCE. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp517-518', '10.1136/annrheumdis-2022-eular.1238', '']\n",
      "['11087344', 'Szekanecz Z; Giles JT; Buch MH; Ytterberg SR; Dougados M; Bhatt DL; Koch GG; Vranic I; Wu J; Wang C; Kwok K; Menon S; Rivas JL; Yndestad A; Connell CA; Charles-Schoeman C. INCIDENCE of MAJOR ADVERSE CARDIOVASCULAR EVENTS STRATIFIED by GEOGRAPHIC REGION and BASELINE CARDIOVASCULAR RISK: a POST HOC ANALYSIS of ORAL SURVEILLANCE. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp278-279', '10.1136/annrheumdis-2022-eular.1180', '']\n",
      "['9260948', 'Kremer J; Li ZG; Hall S; Fleischmann R; Genovese M; Martin-Mola E; Isaacs JD; Gruben D; Wallenstein G; Krishnaswami S; Zwillich SH; Koncz T; Riese R; Bradley J. Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial. Annals of internal medicine. (2013) 159 4 pp253-261', '10.7326/0003-4819-159-4-201308200-00006', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-159-4-201308200-00006']\n",
      "['9261200', 'Strand V; Kremer JM; Li ZG; Hall S; Fleischmann RM; Genovese MC; Martin-Mola E. Tofacitinib (CP-690,550) in combination with traditional disease-modifying anti-rheumatic drugs: Phase 3 study patient-reported outcomes in patients with active rheumatoid arthritis and an inadequate response to disease-modifying anti-rheumatic drugs. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1016/j.semarthrit.2015.09.004', '']\n",
      "['9262500', 'Li Z; An Y; Li G; Wang L; Kwok K; Wu Q. Effects of tofacitinib on patient-reported outcomes in a phase 3 study of Chinese patients with active rheumatoid arthritis and an inadequate response to DMARDs. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp285-286', '10.1136/annrheumdis-2017-eular.2273', '']\n",
      "['9736659', 'Li Zhan-Guo; Liu Yi; Xu Hu-Ji; Chen Zhi-Wei; Bao Chun-De; Gu Jie-Ruo; Zhao Dong-Bao; An Yuan; Hwang Lie-Ju; Wang Lisy; Kremer Joel; Wu Qi-Zhe. Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis. Chinese medical journal. (2018) 131 22 pp2683-2692', '10.4103/0366-6999.245157', '']\n",
      "['9738738', 'Li Zhanguo; An Yuan; Su Houheng; Li Xiangpei; Xu Jianhua; Zheng Yi; Li Guiye; Kwok Kenneth; Wang Lisy; Wu Qizhe. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: patient-reported outcomes from a Phase 3 randomized controlled trial. International journal of rheumatic diseases. (2018) 21 2 pp402-414', '10.1111/1756-185x.13244', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13244']\n",
      "['9740065', 'EUCTR2008-008337-11-GR. PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE  SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND DMARDS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-008337-11-GR. (2009)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9258456', 'Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: patient-reported outcomes from a Phase 3 randomized controlled trial. International journal of rheumatic diseases. (2018) 21 2 pp402-414', '10.1111/1756-185x.13244', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13244']\n",
      "['9740948', 'NCT00856544. A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications. https://clinicaltrials.gov/show/NCT00856544. (2009)   pp', '10.1002/art.1780400110', '']\n",
      "['9258145', 'Porter D; van Melckebeke J; Dale J; Messow CM; McConnachie A; Walker A; Munro R; McLaren J; McRorie E; Packha m J; Buckley CD; Harvie J; Taylor P; Choy E; Pitzalis C; McInnes IB. Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis WHO require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. Lancet (london, england). (2016) 388 10041 pp239-247', '10.1016/s0140-6736(16)00380-9', '']\n",
      "['9737817', 'EUCTR2009-011268-13-GB. Optimal management of rheumatoid arthritis patients who require biologic therapy (ORBIT study) - ORBIT study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011268-13-GB. (2010)   pp', '10.7287/peerj.6771v0.1/reviews/2', '']\n",
      "['9740332', 'PACTR201208000399382. ORBIT study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201208000399382. (2012)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9741183', 'NCT01021735. Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy. https://clinicaltrials.gov/show/NCT01021735. (2009)   pp', '10.1093/med/9780199556755.003.0006', '']\n",
      "['9740224', 'EUCTR2010-020743-12-BE. A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an Inadequate Response to Methotrexate - OSKIRA - 1. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020743-12-BE. (2010)   pp', '10.3410/f.1097731.553845', '']\n",
      "['9738207', 'Gudmann NS; Platt A; Karsdal M; Bay-Jensen AC. C4M-a blood-based biomarker-is an objective marker of disease activity and radiographic status: replication and validation or previous findings in the oskira rheumatoid arthritis studies. Annals of the rheumatic diseases. (2016) 75  pp459-', '10.1136/annrheumdis-2016-eular.3573', '']\n",
      "['9739132', 'Siebuhr A S; Platt A; Karsdal M A; Bay-Jensen A C. C1m is a serological biomarker for identification of structural progressors in rheumatoid arthritis; validation in 3 phase iii clinical trials. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp682-683', '10.1136/annrheumdis-2016-eular.4022', '']\n",
      "['9257503', 'Platt A; Bay-Jensen AC; Braddock M; Jenkins M; Musa K; Thudium CS; Kjelgaard-Petersen CF; Graham E; Keeler S; Slynn G; Weinblatt M; Karsdal MA. The effect of fostamatinib with methotrexate on circulating biomarkers of synovium, cartilage and bone metabolism: potential utility for clinical development decision making in rheumatoid arthriti. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3550-3551', '10.1002/art.40527', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40527']\n",
      "['9261388', \"Dawes P; Dimic A; Genovese MC; Van Der Heijde D; Jenkins M; O'Brien C; Oemar B; Vencovsky J; Weinblatt M. Oskira-2: A phase III, multicenter, randomized, double-blind, placebo-controlled parallel-group study of 2 dosing regimens of fostamatinib in rheumatoid arthritis patients with an inadequate response to disease-modifying antirheumatic drugs. Arthritis and rheumatism. (2013) 65  ppS198-S199\", '10.1002/art.38851', '']\n",
      "['9738036', 'EUCTR2010-020744-35-IT. A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Response to DMARDs. D4300C00002 - OSKIRA-2. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020744-35-IT. (2010)   pp', '10.1186/isrctn07772084', '']\n",
      "['9258656', \"Genovese MC; van der Heijde DM; Keystone EC; Spindler AJ; Benhamou C; Kavanaugh A; Fudman E; Lampl K; O'Brien C; Duffield EL; Poiley J; Weinblatt ME. A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-Œ± antagonist. Journal of rheumatology. (2014) 41 11 pp2120-2128\", '10.3899/jrheum.140238', '']\n",
      "['9261387', \"Genovese M; Van Der Heijde D; Keystone E; Spindler A; Benhamou C-L; Kavanaugh A; Fudman E; Lampl K; O'Brien C; Duffield E; Poiley J; Weinblatt M. Oskira-3: A phase III, multicenter, randomized, double-blind, placebo-controlled parallel-group study of 2 dosing regimens of fostamatinib in rheumatoid arthritis patients with an inadequate response to a tumor necrosis factor-alpha antagonist. Arthritis and rheumatism. (2013) 65  ppS199-S200\", '10.3899/jrheum.140238', '']\n",
      "['9742768', 'PER-003-12. (OSKIRA-3): a PHASE III, MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY OF TWO DOSING REGIMENS OF FOSTAMATINIB DISODIUM IN RHEUMATOID ARTHRITIS PATIENTS WOTH INADEQUATE RESPONSE TO A TNF-ALPHA ANTAGONIST. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-003-12. (2012)   pp', '10.3899/jrheum.140238', '']\n",
      "['9262082', 'Taylor PC; Genovese MC; Greenwood M; Ho M; Nasonov E; Oemar B; Stoilov R; Vencovsky J; Weinblatt M. OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy. Annals of the rheumatic diseases. (2015) 74 12 pp2123-2129', '10.1136/annrheumdis-2014-205361', '']\n",
      "['9738310', 'NCT01264770. Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT01264770. (2010)   pp', '10.3410/f.732763351.793564277', '']\n",
      "['9261066', 'Kitas GD; Abreu G; Jedrychowicz-Rosiak K; Miller JL; Nakov R; Panfilov S; Vencovsky J; Wang M; Weinblatt ME; White WB. The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of the OSKIRA-ABPM (ambulatory blood pressure monitoring) randomized trial. Journal of the American Society of Hypertension : JASH. (2014) 8 11 pp780-790', '10.1016/j.jash.2014.08.013', '']\n",
      "['9261493', 'Kitas G; Abreu G; Jedrychowicz-Rosiak K; Miller J; Nakov R; Panfilov S; Vencovsky J; Wang M; Weinblatt M; White WB. The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis-results of the OSKIRA ambulatory blood pressure monitoring trial. Arthritis and rheumatism. (2013) 65  ppS617', '10.1016/j.jash.2014.08.013', '']\n",
      "['9257922', 'Lassere MN; Edmonds J; Johnson KR. Rheumatoid arthritis: What are the predictors of rheumatologists\\' \"usual care\" management?. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.404', '']\n",
      "['9263637', 'Hartman O; Kovanen PT; Lehtonen J; Eklund KK; Sinisalo J. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. European heart journal. Cardiovascular pharmacotherapy. (2017) 3 2 pp92-97', '10.1093/ehjcvp/pvw035', 'http://academic.oup.com/ehjcvp/article-pdf/3/2/92/11007810/pvw035.pdf']\n",
      "['11084577', 'Garcia-Moreno C; Morla R; Frade-Sosa B; Tobalina L; Gomara MJ; Sanmarti R; Haro I. ANTIBODIES AGAINST MODIFIED PROTEIN/PEPTIDE SPECIFICITIES in RECENT-ONSET PALINDROMIC RHEUMATISM MAY DETERMINE the EVOLUTION to RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1225-1226', '10.1136/annrheumdis-2022-eular.3228', '']\n",
      "['11084390', 'Frade-Sosa B; Morla R; Tobalina L; Perez-Garcia C; Haro I; Sanmarti R. ABATACEPT VERSUS HYDROXYCHLOROQUINE in PALINDROMIC RHEUMATISM: a MULTICENTER RANDOMIZED CLINICAL TRIAL (PALABA STUDY): TRIAL DESIGN and PATIENTS CHARACTERISTICS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1227', '10.1136/annrheumdis-2022-eular.3316', '']\n",
      "['9742815', 'EUCTR2009-017163-42-SE. Pain modulation in RA ‚Äö√Ñ√¨ Influence of adalimumab. A randomized, placebo-controlled study using functional magnetic resonance imaging - PARADE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-017163-42-SE. (2010)   pp', '10.1016/j.mri.2010.03.008', '']\n",
      "['9741190', 'EUCTR2019-000505-72-NL. Baricitinib in patients suffering from Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-000505-72-NL. (2019)   pp', '10.25021/jcll.2019.8.117.57', '']\n",
      "['9261179', 'Hsu B; Smolen J; Weinblatt M; Sheng S. Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. International journal of rheumatic diseases. (2012) 15  pp61', '10.1136/annrheumdis-2012-eular.2065', '']\n",
      "['9262886', 'Pinals RS; Kaplan SB; Lawson JG; Hepburn B. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis and rheumatism. (1986) 29 12 pp1427-1434', '10.1002/art.1780291202', '']\n",
      "['9259251', 'Pinheiro GR; Helfenstein J‚Äö√†√∂‚Äö√†¬¥nior M; Ferraz MB; Atra E. A short-term randomized controlled study with methotrexate in rheumatoid arthritis. Revista da Associac‚àö√â‚àö√ºa‚àö√â‚àö√¢o Me‚àö√â‚àö√ñdica Brasileira (1992). (1993) 39 2 pp91-94', '10.3109/03009749409103721', '']\n",
      "['11083899', 'Larkin L; McKenna S; Pyne T; Gallagher S; Glynn L; Fraser A; Esbensen BA; Kennedy N. FEASIBILITY of A PHYSIOTHERAPIST LED, BEHAVIOUR CHANGE INTERVENTION to IMPROVE PHYSICAL ACTIVITY in PEOPLE with RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1093-1094', '10.1136/annrheumdis-2022-eular.407', '']\n",
      "['9257903', 'Yoo DH; Racewicz A; Brzezicki J; Yatsyshyn R; Tobias Arteaga E; Baranauskaite A; Abud-Mendoza C; Navarra S; Eullaran R; Kadinov V; Goecke Sariego I; Byrne P; Park W; Lee SJ; Kim HU; Muller-Ladner U. A phase 3 randomised controlled trial to compare CT-P13 with infliximab in patients with active rheumatoid arthritis: 54 week results from the planetra study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.273', '']\n",
      "['9260772', 'Yoo DH; Hrycaj P; Miranda P; Ramiterre E; Piotrowski M; Shevchuk S; Kovalenko V; Prodanovic N; Abello-Banfi M; Gutierrez-Ure‚àö¬±a S; Morales-Olazabal L; Tee M; Jimenez R; Zamani O; Lee SJ; Kim H; Park W; M‚àö¬∫ller-Ladner U. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. Annals of the rheumatic diseases. (2013) 72 10 pp1613-1620', '10.1136/annrheumdis-2012-203090', '']\n",
      "['9261551', 'Yoo D-H; Park W; Brzosko M; Geher P; Andersone D; Jaworski J; Rekalov D; Oparanov B; Kausiene R; Pacheco-Tena C; Lee S. Disease activity assessment using the DAS28, CDAI and SDAI and effect of anti-drug antibody on clinical response in a randomized, double-blind, comparative trial of CT-P13 and innovator infliximab: Planetra study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3707', '']\n",
      "['9262157', 'Yoo DH; Prodanovic N; Jaworski J; Miranda P; Ramiterre E; Lanzon A; Baranauskaite A; Wiland P; Abud-Mendoza C; Oparanov B; Smiyan S; Kim H; Lee SJ; Kim S; Park W. Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study. Annals of the rheumatic diseases. (2017) 76 2 pp355-363', '10.1136/annrheumdis-2015-208786', '']\n",
      "['9262532', 'Yoo DH; Park W; Shim SC; Suh CH; Lee SJ; Lee SY; Lee SH; Suh JH. No correlation between body mass index and clinical response to infliximab: post-HOC analysis of planetra. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp1005', '10.1136/annrheumdis-2016-eular.2040', '']\n",
      "['9738895', 'Hanyang D H Y; Prodanovic N; Jaworski J; Miranda P; Ramiterre E B; Lanzon A; Baranauskaite A; Wiland P; Abud-Mendoza C; Oparanov B; Smiyan S; Son Y K; Park W; Muller-Ladner U. Efficacy and safety of CT-P13 (infliximab biosimilar) over two years in patients with rheumatoid arthritis: comparison between continued CT-P13 and switching from infliximab to CT-P13. Arthritis and rheumatism. (2013) 65 12 pp3319', '10.1136/annrheumdis-2015-208786', '']\n",
      "['9739613', 'EUCTR2010-018646-31-SK. A Randomized, Double Blind, Parallel-Group, Phase 3 Study to Demonstrate Equivalence in Efficacy and Safety of CT-P13 Compared With Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-018646-31-SK. (2010)   pp', '10.1136/annrheumdis-2012-203090', '']\n",
      "['9740955', 'NCT01217086. Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA). https://clinicaltrials.gov/show/NCT01217086. (2010)   pp', '10.1136/annrheumdis-2014-eular.3056', '']\n",
      "['9736717', 'Shin K; Baek H J; Kang Y M; Kang S W; Cha H S; Jun J B; Park S H; Lee Y J; Song Y W. Efficacy and safety of add-on treatment of tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate: a 24-week double-blinded randomized non-inferiority study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp253', '10.1136/annrheumdis-2016-eular.6061', '']\n",
      "['9739649', 'Shin K; Baek HJ; Kang YM; Kang SW; Cha HS; Jun JB; Park SH; Lee YJ; Song YW. Efficacy and safety of add-on treatment of tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate: a 24-week double-blinded randomized non-inferiority study. Annals of the rheumatic diseases. (2016) 75  pp253-', '10.1136/annrheumdis-2016-eular.6061', '']\n",
      "['9257511', 'Moghadam MG; Vonkeman HE; Ten Klooster PM; Lamers-Karnebeek F; Tekstra J; Van Schaeybroeck B; Klaasen R; Van Onna M; Moens HJB; Visser H; Schilder A; Kok MR; Landewe R; Van Riel PLCM; Van De Laar MAFJ; Jansen T. Clinical predictors of TNF-inhibitor free disease control in patients with rheumatoid arthritis after stopping TNFi treatment: results from a dutch multicentre pragmatic open-label randomized controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4019-4020', '10.1186/s41927-019-0071-x', 'http://link.springer.com/article/10.1186/s41927-019-0071-x/fulltext.html']\n",
      "['9261907', 'Lamers-Karnebeek FBG; Jansen T; Van Riel P; Luime J; Jacobs J. Ultrasonography AS predictor for flare in rheumatoid arthritis patients with low disease activity: nine month results from poet-us-study. Annals of the rheumatic diseases. (2015) 74  pp140', '10.1136/annrheumdis-2015-eular.5185', '']\n",
      "['9262421', 'Klooster PMT; Ghiti-Moghadam M; Lamers-Karnebeek F; Vonkeman H; Sasso E; Riel PV; Laar MVD; Jansen TL. Predictive value of a single measurement of the multi-biomarker disease activity (MBDA) score for disease flares within 6 and 12 months in rheumatoid arthritis patients using tumor necrosis factor inhibitors and conventional synthetic DMARDs. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1140-1141', '10.1136/annrheumdis-2017-eular.4998', '']\n",
      "['9738656', 'Moghadam MG; Lamers-Karnebeek FBG; Vonkeman HE; ten Klooster PM; Tekstra J; Schilder AM; Visser H; Sasso EH; Chernoff D; Lems WF; Van Schaardenburg D-J; Landewe R; Bernelot Moens HJ; Radstake TRDJ; Van Riel PLCM; van de Laar MAFJ; Jansen TL. Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment. PloS one. (2018) 13 5 pp', '10.1371/journal.pone.0192425', '']\n",
      "['9739393', 'Lamers-Karnebeek FBG; Luime J; Van Riel P; Jacobs J; Jansen T. Prediction of flare after stopping TNF-inhibitor by baseline ultrasonography and patient characteristics in rheumatoid arthritis patients with low disease activity: 12-month results. Annals of the rheumatic diseases. (2016) 75  pp125-', '10.1136/annrheumdis-2016-eular.5031', '']\n",
      "['9740222', 'NTR3112. Potential Optimalisation of (Expediency) and Effectiveness of TNF-blockers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR3112. (2011)   pp', '10.1007/s00296-011-1797-y', 'http://link.springer.com/article/10.1007/s00296-011-1797-y/fulltext.html']\n",
      "['9741223', 'Moghadam MG; Lamers-Karnebeek FBG; Vonkeman HE; ten Klooster PM; Tekstra J; van Schaeybroeck B; Klaasen R; van Onna M; Bernelot Moens HJ; Visser H; Schilder AM; Kok MR; Landewe RBM; van Riel PLCM; van de Laar MAFJ; Jansen TL. Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment. BMC rheumatology. (2019) 3 1 pp', '10.1186/s41927-019-0071-x', 'http://link.springer.com/article/10.1186/s41927-019-0071-x/fulltext.html']\n",
      "['9741684', 'Lamers-Karnebeek Femke B G; Jacobs Johannes W G; Radstake Timothy R D J; van Riel Piet L C M; Jansen Tim L. Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity. Rheumatology (Oxford, England). (2019) 58 3 pp427-431', '10.1093/rheumatology/key292', 'http://academic.oup.com/rheumatology/article-pdf/58/3/427/27900726/key292.pdf']\n",
      "['9741839', 'Ghiti Moghadam Marjan; Lamers-Karnebeek Femke B G; Vonkeman Harald E; Ten Klooster Peter M; Tekstra Janneke; Schilder Annemarie M; Visser Henk; Sasso Eric H; Chernoff David; Lems Willem F; van Schaardenburg Dirk-Jan; Landewe Robert; Bernelot Moens Hein J; Radstake Timothy R D J; van Riel Piet L C M; van de Laar Mart A F J; Jansen Tim L; Dutch National POET Collaboration. Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment. PloS one. (2018) 13 5 ppe0192425', '10.1371/journal.pone.0192425', '']\n",
      "['9258459', 'Rongen GA; van Ingen I; Kok M; Vonkeman H; Janssen M; Jansen TL. Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs. Clinical rheumatology. (2018) 37 4 pp909-916', '10.1007/s10067-017-3961-6', 'http://link.springer.com/article/10.1007/s10067-017-3961-6/fulltext.html']\n",
      "['9259199', 'Porter DR; Capell HA; Hunter J. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy. Journal of rheumatology. (1993) 20 4 pp645-649', '10.1186/isrctn65477168', '']\n",
      "['9740000', 'EUCTR2009-012218-30-PT. A randomized, double-blind, placebo-controlled study to assess the efficacy of tocilizumab (TCZ) + non-biological DMARD in reducing synovitis as measured by magnetic resonance imaging (MRI) at 12 weeks after initiation of treatment in patients with moderate to severe rheumatoid arthritis (RA) with inadequate response to non-biological DMARDs - PORTRAIT. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012218-30-PT. (2009)   pp', '10.1136/annrheumdis-2013-eular.1840', '']\n",
      "['9738886', 'Gerlag D; Safy M; Maijer K; De Hair; Tas S; Starmans-Kool M; Van Tubergen; Janssen M; Tak P P. Prevention of rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease: the prairi study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp125-126', '10.1136/annrheumdis-2016-eular.6042', '']\n",
      "['9739399', 'Gerlag Danielle M; Safy Mary; Maijer Karen I; Tang Man Wai; Tas Sander W; Starmans-Kool Mirian J F; van Tubergen Astrid; Janssen Matthijs; de Hair Maria; Hansson Monika; de Vries Niek; Zwinderman Aeilko H; Tak Paul P. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Annals of the rheumatic diseases. (2019) 78 2 pp179-185', '10.1136/annrheumdis-2017-212763', '']\n",
      "['9740169', 'NTR2442. PRAIRI. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR2442. (2010)   pp', '10.12677/qre.2014.11003', '']\n",
      "['9257272', 'Sparks JA; Iversen MD; Miller Kroouze R; Mahmoud TG; Triedman NA; Kalia SS; Atkinson ML; Lu B; Deane KD; Costenbader KH; Green RC; Karlson EW. Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives. Contemporary clinical trials. (2014) 39 1 pp145-157', '10.1016/j.cct.2014.08.007', '']\n",
      "['9738972', 'Schenker H; Hess A; Konerth L; Sergeeva M; Prade J; Kleyer A; Reiser M; Hueber A J; Englbrecht M; Feist E; Voll R; Bannert B; Baerwald C; Rosch J; Dorfler A; Da Silva; J A P; Damjanov N; Schett G; Rech J. Prediction of response to certolizumab-pegol in rheumatoid arthritis by functional MRI of the brain-an interim analysis of an ongoing investigator initiated phase iii trial. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.5067', '']\n",
      "['11083652', 'Schenker HM; Tascilar K; Konerth L; Sergeeva M; Prade J; Strobelt S; Kleyer A; Simon D; Mendez L; Hagen M; Schonau V; Hueber A; Roesch J; Dorfler A; Hess A; Schett G; Rech J. Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain ? Study protocol for a randomized double-blind controlled study. . (2021) 22  pp', '10.1016/j.conctc.2021.100770', '']\n",
      "['11085021', 'Rech J; Tascilar K; Schenker H; Hagen M; Sergeeva M; Selvakumar M; Konerth L; Prade J; Strobelt S; Schonau V; Valor L; Hueber A; Simon D; Kleyer A; Behrens F; Baerwald C; Finzel S; Voll R; Feist E; Da Silva JAP; Doerfler A; Damjanov N; Hess A; Schett G. Longitudinal change in the central nervous system pain response after treatment with certolizumab or placebo. a post-hoc analysis from the precepra trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp77-78', '10.1136/annrheumdis-2020-eular.5249', '']\n",
      "['11085587', 'Schenker HM; Tascilar K; Konerth L; Sergeeva M; Prade J; Strobelt S; Kleyer A; Simon D; Mendez L; Hagen M; Schonau V; Hueber A; Roesch J; Dorfler A; Hess A; Schett G; Rech J. Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled study. Contemporary clinical trials communications. (2021) 22  pp100770', '10.1016/j.conctc.2021.100770', '']\n",
      "['9261185', 'Tada M; Koike T; Okano T; Sugioka Y; Mamoto K; Nakamura H. Analysis of predictive factors for radiographic progression in low- and standard-dose etanercept therapy for rheumatoid arthritis (Sub-analysis of PRECEPT study). International journal of rheumatic diseases. (2012) 15  pp53', '10.1136/annrheumdis-2012-eular.3088', '']\n",
      "['9261212', 'Tada M; Okano T; Sugioka Y; Mamoto K; Wakitani S; Nakamura H; Koike T. Prevention of cartilage destruction by etanercept (precept) study: The comparison of joint destruction between low-dose and standard-dose etanercept in rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1093/rheumatology/kes188', 'http://academic.oup.com/rheumatology/article-pdf/51/12/2164/5101606/kes188.pdf']\n",
      "['9263428', 'Tada M; Koike T; Okano T; Sugioka Y; Wakitani S; Fukushima K; Sakawa A; Uehara K; Inui K; Nakamura H. Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study. Rheumatology (Oxford, England). (2012) 51 12 pp2164-2169', '10.1093/rheumatology/kes188', 'http://academic.oup.com/rheumatology/article-pdf/51/12/2164/5101606/kes188.pdf']\n",
      "['9739748', 'UMIN000001798. Prevention of cartilage destruction in rheumatoid arthritis by etanercept (PRECEPT study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000001798. (2009)   pp', '10.1093/rheumatology/kes188', 'http://academic.oup.com/rheumatology/article-pdf/51/12/2164/5101606/kes188.pdf']\n",
      "['9257980', 'Obeid S; Libby P; Husni ME; Pfeffer MA; Wisniewski LM; Wolski KE; Wang Q; Nissen SE; Luscher TF. Cardiorenal risks of celecoxib, naproxen or ibuprofen in arthritis patients: a sub-anaylsis from the precision trial. Circulation. (2017) Conference: Resuscitation Science Symposium, ReSS 2017. United States. 136 Suppl  1 pp', '10.1093/eurheartj/ehy566.p5421', 'http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy566.P5421/25578788/ehy566.p5421.pdf']\n",
      "['9738629', 'Solomon Daniel H; Libby Peter; Yeomans Neville D; Wang Qiuqing; Wolski Kathy E; Nissen Steven E; Husni M Elaine. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial. Rheumatology (Oxford, England). (2018) 57 8 pp1364-1369', '10.1093/rheumatology/key105', 'http://academic.oup.com/rheumatology/article-pdf/57/8/1364/25193911/key105.pdf']\n",
      "['9263601', 'Ruschitzka F; Borer JS; Krum H; Flammer AJ; Yeomans ND; Libby P; Luscher TF; Solomon DH; Husni ME; Graham DY; Davey DA; Wisniewski LM; Menon V; Fayyad R; Beckerman B; Iorga D; Lincoff AM; Nissen SE; PRECISION-ABPM Investigators. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. European heart journal. (2017) 38 44 pp3282-3292', '10.1093/eurheartj/ehx508', 'http://academic.oup.com/eurheartj/article-pdf/38/44/3282/36614558/ehx508.pdf']\n",
      "['9738307', 'Curtis JR; Churchill M; Kivitz A; Gauer L; Herrem C; Carter D; Melin J; Yazici Y. Identification of a patient phenotype which impacts response to therapy in rheumatoid arthritis clinical trials: certolizumab pegol phase 4 trial data. Arthritis and rheumatology. (2014) Conference: 2014 ACR/ARHP Annual Meeting Boston, MA United States. Conference Start: 20141114 Conference End: 20141119. Conference Publication: var.pagings ppS811', '10.1002/art.39322', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39322']\n",
      "['9741119', 'NCT01255761. A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects. https://clinicaltrials.gov/show/NCT01255761. (2010)   pp', '10.3310/hta14suppl2/01', 'https://njl-admin.nihr.ac.uk/document/download/2001308']\n",
      "['9262732', 'Emery P; Burmester G; Naredo E; Lagunes I; Zhang Y; Wang X; Hojnik M; Conaghan PG. Low inflammation on magnetic resonance imaging in patients with rheumatoid arthritis that achieved sustained clinical remission on adalimumab: data from the predictra study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp283-284', '10.1136/annrheumdis-2018-eular.4804', '']\n",
      "['9736910', 'Emery Paul; Burmester Gerd R; Naredo Esperanza; Zhou Yijie; Hojnik Maja; Conaghan Philip G. Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA). BMJ open. (2018) 8 2 ppe019007', '10.1136/bmjopen-2017-019007', '']\n",
      "['9738373', 'Emery Paul; Burmester Gerd R; Naredo Esperanza; Sinigaglia Luigi; Lagunes Ivan; Koenigsbauer Franziska; Conaghan Philip G. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2020-217246', '']\n",
      "['9738779', 'Emery P; Burmester G; Naredo E; Lagunes I; Zhang Y; Wang X; Hojnik M; Conaghan PG. Low inflammation on magnetic resonance imaging in patients with rheumatoid arthritis that achieved sustained clinical remission on adalimumab: data from the predictra study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp283-284', '10.1136/annrheumdis-2018-eular.4804', '']\n",
      "['9739530', 'Emery P; Burmester GR; Naredo E; Galindo IL; Zhang Y; Wang X; Hojnik M; Conaghan PG. Low inflammation on magnetic resonance imaging in patients with rheumatoid arthritis that achieved sustained clinical remission on adalimumab. Arthritis and rheumatology. (2018) 70 Supplement 9 pp609-610', '10.1136/annrheumdis-2018-eular.4804', '']\n",
      "['9741149', 'NCT02198651. A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects. https://clinicaltrials.gov/show/NCT02198651. (2014)   pp', '10.1136/annrheumdis-2019-eular.3118', '']\n",
      "['9741362', 'Emery P; Burmester GR; Naredo E; Sinigaglia L; Lagunes I; Koenigsbauer F; Conaghan PG. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2020-217246', '']\n",
      "['9742436', 'Emery P; Burmester GR; Naredo E; Sinigaglia L; Lagunes I; Koenigsbauer F; Conaghan PG. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases. (2020)  no pagination pp', '10.1136/annrheumdis-2020-217246', '']\n",
      "['11088179', 'Emery Paul; Burmester Gerd R; Naredo Esperanza; Sinigaglia Luigi; Lagunes Ivan; Koenigsbauer Franziska; Conaghan Philip G. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases. (2020) 79 8 pp1023-1030', '10.1136/annrheumdis-2020-217246', '']\n",
      "['9737768', 'NCT04147026. Prediction Medical Device for Rheumatoid Arthritis (PREDIRA). https://clinicaltrials.gov/show/NCT04147026. (2019)   pp', '10.31525/ct1-nct04147026', '']\n",
      "['11088116', 'Freites-Nunez Dalifer; Baillet Athan; Rodriguez-Rodriguez Luis; Nguyen Minh Vu Chuong; Gonzalez Isidoro; Pablos Jose Luis; Balsa Alejandro; Vazquez Monica; Gaudin Philippe; Fernandez-Gutierrez Benjamin. Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA). Trials. (2020) 21 1 pp755', '10.1186/s13063-020-04683-7', 'https://link.springer.com/article/10.1186/s13063-020-04683-7/fulltext.html']\n",
      "['9256795', 'Hoff M; Kvien TK; K‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö¬∫lvesten J; Elden A; Haugeberg G. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Annals of the rheumatic diseases. (2009) 68 7 pp1171-1176', '10.1136/ard.2008.091264', '']\n",
      "['9257225', 'Breedveld F; Keystone E; Van Der Heijde D; Landewe R; Smolen JS; Guerette B; McIlraith M; Kupper H; Liu S; Kavanaugh A. Initial combination therapy with adalimumab plus methotrexate leads to better long-term outcomes than with either monotherapy in patients with early rheumatoid arthritis: 8-year results of an open-label extension of a phase 3 trial. Rheumatology (United Kingdom). (2012) 51  ppiii118-iii119', '10.1136/annrheumdis-2013-eular.718', '']\n",
      "['9257605', 'Kimel M; Cifaldi M; Chen N; Revicki D. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. Journal of rheumatology. (2008) 35 2 pp206-215', '10.1016/s1098-3015(10)67228-2', '']\n",
      "['9257905', 'Smolen JS; van der Heijde DM; Keystone EC; van Vollenhoven RF; Goldring MB; Gu‚àö¬©rette B; Cifaldi MA; Chen N; Liu S; Landew‚àö¬© RB. Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Annals of the rheumatic diseases. (2013) 72 7 pp1156-1162', '10.1136/annrheumdis-2012-201620', '']\n",
      "['9259477', 'Rau R; Herborn G; Menninger H; Blechschmidt J. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. British journal of rheumatology. (1997) 36 3 pp345-352', '10.1093/rheumatology/36.3.345', 'http://academic.oup.com/rheumatology/article-pdf/36/3/345/18105159/360345.pdf']\n",
      "['9260481', 'Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. Journal of rheumatology. (2009) 36 7 pp1429-1441', '10.3899/jrheum.081018', '']\n",
      "['9260929', 'Keystone EC; Breedveld FC; van der Heijde D; Landew‚àö¬© R; Florentinus S; Arulmani U; Liu S; Kupper H; Kavanaugh A. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension. Journal of rheumatology. (2014) 41 1 pp5-14', '10.3899/jrheum.130543', '']\n",
      "['9261102', 'Keystone E; Weinblatt; Haraoui B; Guerette B; Mozaffarian N; Patra K; Kavanaugh A. Clinical and radiographic implications of time to treatment response in patients with early rheumatoid arthritis. Reumatologia Clinica Suplementos. (2011) 7  pp145', '10.3899/jrheum.121468', '']\n",
      "['9261151', 'Van Vollenhoven RF; Shaw JW; Cifaldi MA; Signorovitch J; Wu EQ; Samuelson T; Faust E; Emery P. Differences in short-term radiographic progression following early response to adalimumab plus methotrexate vs. methotrexate alone. Arthritis and rheumatism. (2012) 64  ppS160-S161', '10.3899/jrheum.081018', '']\n",
      "['9261343', 'Strand V; Liu S; Mozaffarian N. Systematic radiographic progression in individual joints before and after methotrexate-/+ adalimumab treatment in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1755', '']\n",
      "['9263255', 'Aletaha D; Funovits J; Breedveld FC; Sharp J; Segurado O; Smolen JS. Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis and rheumatism. (2009) 60 5 pp1242-1249', '10.1002/art.24433', '']\n",
      "['9263316', 'van der Heijde D; Breedveld FC; Kavanaugh A; Keystone EC; Landew‚àö¬© R; Patra K; Pangan AL. Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER. Journal of rheumatology. (2010) 37 11 pp2237-2246', '10.3899/jrheum.100208', '']\n",
      "['9263377', 'Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study. Journal of rheumatology. (2012) 39 1 pp63-72', '10.3899/jrheum.101161', '']\n",
      "['9263473', 'Breedveld FC; Keystone E; Van Der Heijde D; Landewe R; Smolen J; Guerette B; McIlraith M. Initial combination therapy with adalimumab plus methotrexate leads to better long-term outcomes than with either monotherapy in patients with early rheumatoid arthritis: 8-year results of an open-label extension of a phase 3 trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2013-eular.718', '']\n",
      "['9737473', 'Keystone E; Roy S; Chen N; Rasty S; Guerette B; Cifaldi M; Landewe R. Patients with early rheumatoid arthritis reported better physical functioning with adalimumab plus methotrexate than with methotrexate alone. Journal of rheumatology. (2010) 37 6 SUPPL. 2 pp1293', '10.3899/jrheum.081018c2', '']\n",
      "['9737555', '. Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis. RMD open. (2018) 4 1 pp', '10.1136/rmdopen-2017-000637', '']\n",
      "['9737642', 'Landewe R; Keystone E; Smolen J; Goldring M; Gu‚àö¬©rette B; Patra K; Cifaldi M; Van Der Heijde D. Disconnect between disease activity and joint space narrowing for patients with early ra treated with adalimumab plus methotrexate but not methotrexate alone: case for anti-TNF cartilage protection. Rheumatology. (2011) 50  ppiii113-', '10.1136/annrheumdis-2012-201620', '']\n",
      "['9738439', 'NCT00195663. Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00195663. (2005)   pp', '10.1016/s1098-3015(10)67228-2', '']\n",
      "['9738915', 'Keystone E C; Weinblatt M E; Haraoui B; Guerette B; Mozaffarian N; Patra K; Kavanaugh A. Clinical and radiographic implications of time to treatment response in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1102', '10.3899/jrheum.121468', '']\n",
      "['9739037', 'Bojke C; Cifaldi M; Ray S; Van Hout. Maintenance of physical function improves employment status over time for patients with early rheumatoid arthritis. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1093/rheumatology/keu101.016', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i92/9578473/keu101.016.pdf']\n",
      "['9739104', 'Landew‚àö¬© R; Keystone E; Smolen J; Goldring M; Gu‚àö¬©rette B; Patra K; Cifaldi M; Van Der Heijde D. Disconnect between disease activity and joint space narrowing for patients with early RA treated with adalimumab plus methotrexate but not methotrexate alone: case for anti-TNF cartilage protection. Journal of rheumatology. (2011) 38 6 pp1156', '10.1136/annrheumdis-2012-201620', '']\n",
      "['9739534', 'Landew R; Keyston E; Smole; Goldrin M; Gu‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬©rett B; Patra K; Cifaldi M; Van Der Heijde D. Disconnect between disease activity and joint space narrowing for patients with early RA treated with adalimumab plus methotrexate but not methotrexate alone: case for anti-TNF cartilage protection. Reumatologia clinica suplementos. (2011) 7  pp144-', '10.1136/annrheumdis-2012-201620', '']\n",
      "['9739644', 'Van Vollenhoven R; Cifaldi M; Boonen A; Roy S; Chen N; Strand V. H2607country of residence affects the ability of patients with rheumatoid arthritis (RA) to achieve a favorable employment status. Arthritis and rheumatism. (2010) 62  pp65-', '10.1002/art.27722', '']\n",
      "['9740475', '. Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis. RMD open. (2018) 4 1 pp', '10.1136/rmdopen-2017-000637', '']\n",
      "['9257517', 'Keystone EC; Betts KA; Schlacher CA; Song Y; Ganguli A; Griffith J. Incremental benefit of radiographic inhibition on long-term outcomes in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3544-3545', '10.1002/art.39977', '']\n",
      "['9257607', 'Kavanaugh A; Haraoui B; Sunkureddi P; Wolfe B; Wang L; Suboticki J; Keystone E. The relationship between elevations in crp with physical function and radiographic progression over the long-term in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp651-652', '10.1002/art.39977', '']\n",
      "['9261887', 'Moller B; Florentinus S; Ganz F; Li Y; Kupper H; Finckh A. Anemia is an independent predictor of radiographic damage progression in anti-tnf-treated rheumatoid arthritis patients from two large phase III trials. Annals of the rheumatic diseases. (2015) 74  pp426', '10.1136/annrheumdis-2015-eular.1271', '']\n",
      "['9262008', 'Smolen JS; Kavanaugh A; Sainsbury I; Liu S; Florentinus S; Keystone EC; Emery P. Does attainment of clinical remission lead to comprehensive disease control in rheumatoid arthritis patients?. Annals of the rheumatic diseases. (2015) 74  pp463', '10.1136/annrheumdis-2015-eular.1291', '']\n",
      "['9739149', 'Van Der Heijde; Landewe R; Keystone E C; Breedveld F C; Liu S; Mozaffarian N. Analysis of integrated radiographic data for two long-term, open-label extension studies of adalimumab. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS439-S440', '10.1136/annrheumdis-2012-eular.459', '']\n",
      "['9262506', 'Smolen J; Gabay C; Aletaha D; Emery P; Sainsbury I; Zhang Y; Kavanaugh A. The importance of sustained remission for longterm outcomes in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp242', '10.1136/annrheumdis-2017-eular.2779', '']\n",
      "['9738727', 'Smolen J; Bu X; Wang X; Suboticki J; Kavanaugh A. Characteristics of patients with early rheumatoid arthritis who have a delayed response to treatment with methotrexate in monotherapy or in combination with adalimumab. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp605', '10.1136/annrheumdis-2018-eular.2635', '']\n",
      "['9261087', 'Wu EQ; Cifaldi M; Diener M; Kaltenboeck A; Ganguli A; Bergman M. Indirect comparison of joint damage prevention with adalimumab v. Abatacept, each in combination with methotrexate, in early rheumatoid arthritis. Value in health. (2013) 16  7 ppA555', '10.1016/j.jval.2013.08.1449', '']\n",
      "['9261293', 'Keystone E; Van Der Heijde D; Landewe R; Breedveld F; Liu S; Mozaffarian N. Analysis of integrated radiographic data for two longterm, open-label extension studies of adalimumab. Journal of rheumatology. (2013) 40  6 pp968', '10.1136/annrheumdis-2012-eular.459', '']\n",
      "['9262679', 'Smolen J; Bu X; Wang X; Suboticki J; Kavanaugh A. Characteristics of patients with early rheumatoid arthritis who have a delayed response to treatment with methotrexate in monotherapy or in combination with adalimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp605', '10.1136/annrheumdis-2018-eular.2635', '']\n",
      "['9742622', 'Smolen J S; Kavanaugh A; Van Der Heijde; Florentinus S; Rathmann S S; Kupper H; Keystone E C. Disease activity and structural damage-related differences in functional disability in early and established rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.737', '']\n",
      "['9257404', 'Emery P; Kavanaugh A; Bao Y; Ganguli A; Mulani P. Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?. Annals of the rheumatic diseases. (2015) 74 12 pp2165-2174', '10.1136/annrheumdis-2014-205302', '']\n",
      "['9736929', 'Keystone E C; Breedveld F C; Van Der Heijde; Van Vollenhoven; R F; Florentinus S; Faccin F; Liu S; Kupper H; Kavanaugh A. Achieving comprehensive disease control in long-standing or early rheumatoid arthritis patients treated with adalimumab plus methotrexate versus methotrexate alone. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS559', '10.1136/annrheumdis-2013-eular.719', '']\n",
      "['9739093', 'Keystone E C; Breedveld F C; Heijde D V D; Van Vollenhoven; R F; Emery P; Smolen J S; Sainsbury I; Florentinus S; Kupper H; Chen K; Kavanaugh A. Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. RMD open. (2017) 3 2 ppe000445', '10.1136/rmdopen-2017-000445', '']\n",
      "['9257154', 'Strand V; Jones TV; Li W; Koenig AS; Kotak S. Factors that impact work productivity in the preserve trial: A randomized controlled trial of combination etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 S10 ppS777', '10.1136/annrheumdis-2012-eular.1385', '']\n",
      "['9257637', 'Smolen J; Jones H; Mahgoub E; Pedersen R; Marshall L. Association between flare and radiographic progression in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3495-3497', '10.1002/art.39977', '']\n",
      "['9257925', 'Strand V; Jones TV; Li W; Koenig AS; Kotak S. Predictors of work impairment in a randomized controlled trial of etanercept-methotrexate therapy in patients with moderate rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1385', '']\n",
      "['9260789', 'Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet (London, England). (2013) 381 9870 pp918-929', '10.1016/s0140-6736(12)61811-x', '']\n",
      "['9261076', 'Smolen JS; Ilivanova E; Hall S; Irazoque-Palazuelos F; Park M-C; Kotak S; Hammond C; Pedersen R; Szumski A; Koenig AS; Vlahos B. Low disease activity or remission induction with etanercept 50 mg and methotrexate in moderately active rheumatoid arthritis: Maintenance of response and safety of etanercept 50 mg, 25 mg, or placebo in combination with methotrexate in a randomized double-blind study. Arthritis and rheumatism. (2011) 63  12 pp4041', '10.1016/s0140-6736(12)61811-x', '']\n",
      "['9261170', 'Szekanecz Z; Yen JH; Miranda P; Szumski A; Bananis E; Kotak S; Rahman M; Tang B. Impact of etanercept-methotrexate therapy on patient-reported outcomes in moderately active rheumatoid arthritis (RA) patients of europe, latin America, and Asia. Value in health. (2012) 15  7 ppA674', '10.1016/j.jval.2012.08.419', '']\n",
      "['9261183', 'Pavelka K; Khalil A; Koenig AS; Szumsk A; Youseif EA; Bananis E; Yen J-H; Burgo RV. Maintenance of response with conventional- or reduced-dose etanercept therapy or biologic free after induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis participating in the PRESERVE study in Europe, Latin America, and Asia. International journal of rheumatic diseases. (2012) 15  pp54-55', '10.1016/j.jval.2012.08.419', '']\n",
      "['9261351', 'Keystone E; Haraoui B; Thorne C; Poulin-Costello M; Trottier E; Vieira A; Pope JE. Response to etanercept-methotrexate therapy and etanercept monotherapy in rheumatoid arthritis patients with moderate and severe disease in the cameo trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1288', '']\n",
      "['9261417', 'Smolen JS; Szumski A; Koenig AS; Jones TV. Predictors of loss of clinical remission with etanercept 50 mg, 25 mg or placebo combined with methotrexate in moderate rheumatoid arthritis patients: Results of the preserve trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2621', '']\n",
      "['9262543', 'Smolen JS; Jones H; Mahgoub E; Pedersen R; Marshall L. Association between flare and radiographic progression in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp832', '10.1136/annrheumdis-2017-eular.1854', '']\n",
      "['9263492', 'Pavelka K; Burgos-Vargas R; Miranda P; Guzman R; Yen J-H; Izzi MA; Szekanecz Z; Tang B; Szumski A; Kotak S; Bananis E; Koenig AS; Mahgoub EY; Rahman MU. Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia. International journal of clinical rheumatology. (2014) 9  5 pp415-430', '10.2217/ijr.14.27', '']\n",
      "['9736660', 'Smolen JS; Jones H; Mahgoub E; Pedersen R; Marshall L. Association between flare and radiographic progression in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp832', '10.1136/annrheumdis-2017-eular.1854', '']\n",
      "['9743013', 'NCT00565409. Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00565409. (2007)   pp', '10.1007/s11926-009-0055-8', 'http://link.springer.com/article/10.1007/s11926-009-0055-8/fulltext.html']\n",
      "['11085181', 'Hirose T; Kawaguchi I; Murata T; Atsumi T. Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment with Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan. Value in health regional issues. (2022) 28  pp105-111', '10.1016/j.vhri.2021.06.012', '']\n",
      "['9737973', 'Alten R; Mysler E; Wajdula A; Jones H; Pedersen R; Marshall L. Efficacy of etanercept by body mass index in women and men with rheumatoid arthritis: a post HOC analysis of three randomized trials. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1668-1669', '10.1136/annrheumdis-2018-eular.3253', '']\n",
      "['9738770', 'Alten R; Mysler E; Wajdula A; Jones HE; Pedersen R; Marshall L. Efficacy of etanercept by body mass index in women and men with rheumatoid arthritis: a post HOC analysis of three randomised trials. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp564-565', '10.1136/annrheumdis-2018-eular.3253', '']\n",
      "['9262717', 'Alten R; Mysler E; Wajdula A; Jones HE; Pedersen R; Marshall L. Efficacy of etanercept by body mass index in women and men with rheumatoid arthritis: a post HOC analysis of three randomised trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp564-565', '10.1136/annrheumdis-2018-eular.3253', '']\n",
      "['9262123', 'Li R; Zhao JX; Su Y; He J; Chen LN; Gu F; Zhao C; Deng XR; Zhou W; Hao YJ; Xue Y; Liu HX; Zhao Y; Zou QH; Liu XY; Zhu P; Sun LY; Zhang ZL; Zou HJ; Li XF; Liu Y; Fang YF; Keystone E; McInnes IB; Li ZG. High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): a multicenter randomized clinical trial. Medicine. (2016) 95 28 ppe3968', '10.1097/md.0000000000003968', '']\n",
      "['9257432', 'C√©spedes-Cruz A; Guti√©rrez-Su√°rez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalh√£es C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N; Pediatric Rheumatology International Trials Organization (PRINTO). Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Annals of the rheumatic diseases. (2008) 67 3 pp309-314', '10.1136/ard.2007.075895', '']\n",
      "['9261830', 'Huizinga TWJ; Batalov A; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E. Namilumab, an anti-granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody: results of the first study in patients with mild-to-moderate rheumatoid arthritis (RA). Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s13075-017-1267-3', 'http://link.springer.com/content/pdf/10.1186/s13075-017-1267-3.pdf']\n",
      "['9261859', 'Huizinga TWJ; Batalov A; Yablanski K; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E. First-in-patient study of namilumab, an anti-gm-csf monoclonal antibody, in active rheumatoid arthritis: results of the PRIORA phase ib study. Annals of the rheumatic diseases. (2015) 74  pp733', '10.1136/annrheumdis-2015-eular.1602', '']\n",
      "['9261336', 'Emery P; Wiland P; Dudler J; Ionescu RM; Vlahos B; Bukowski J; Pedersen R; Williams T; Gaylord S; Kotak S. Reduced/withdrawn dose of etanercept-methotrexate therapy of early rheumatoid arthritis has a favorable impact on patient-reported outcomes compared with MTX alone or placebo: The prize study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2267', '']\n",
      "['9261352', 'Emery P; Hammoudeh M; FitzGerald O; Combe B; Martin Mola E; Bukowski J; Pedersen R; Williams T; Gaylord S; Vlahos B. Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: The prize study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1216', '']\n",
      "['9261458', 'Emery P; Spieler W; Stopinska-Polaszewska M; Korshunov NI; Bukowski J; Pedersen R; Williams T; Gaylord S; Vlahos B. Assessing maintenance of remission after withdrawal of etanercept plus methotrexate, methotrexate alone, or placebo in early rheumatoid arthritis patients who achieved remission with etanercept and methotrexate: The prize study. Arthritis and rheumatism. (2013) 65  ppS1149', '10.1136/annrheumdis-2013-eular.1216', '']\n",
      "['9261567', 'Emery P; Pedersen R; Bukowski J; Marshall L. Early response to etanercept-methotrexate induction therapy predicts sustained remission with reduced-dose combination regimen in the prize study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1704', '']\n",
      "['9261875', 'Zhang W; Bansback N; Sun H; Pedersen R; Kotak S; Anis AH. Influence of tapering etanercept on work productivity outcomes in patients with early rheumatoid arthritis tapered: 117 week results from the prize study. Annals of the rheumatic diseases. (2015) 74  pp548-549', '10.1136/annrheumdis-2015-eular.1864', '']\n",
      "['9736922', 'Zhang W; Bansback N; Sun H; Pedersen R; Kotak S; Anis A H. The impact of etanercept and methotrexate treatment on work productivity in patients with rheumatoid arthritis: results from phase 2 of the prize study. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.1198', '']\n",
      "['9738205', 'NCT00913458. Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00913458. (2009)   pp', '10.1186/isrctn49682259', '']\n",
      "['9739343', 'Emery P; Pedersen R; Bukowski J; Marshall L. Predictors of remission maintenance after etanercept tapering or withdrawal in early rheumatoid arthritis: results from the PRIZE study. Open rheumatology journal. (2018) 12 1 pp179-188', '10.2174/1874312901812010179', 'https://openrheumatologyjournal.com/contents/volumes/V12/TORJ-12-179/TORJ-12-179.pdf']\n",
      "['9258081', 'van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis and rheumatism. (2007) 56 5 pp1424-1432', '10.1002/art.22525', '']\n",
      "['9260931', 'van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study). Annals of the rheumatic diseases. (2014) 73 2 pp396-400', '10.1136/annrheumdis-2012-202967', '']\n",
      "['9262201', 'Burgers LE; Allaart CF; Huizinga TWJ; van der Helm-van Mil AHM. Brief Report: clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: a Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example. Arthritis and rheumatology. (2017) 69 5 pp926-931', '10.1002/art.40062', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40062']\n",
      "['9739876', 'ISRCTN21334657. Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN21334657. (2005)   pp', '10.1186/isrctn21334657', '']\n",
      "['9260064', \"Sarzi-Puttini P; D'Ingianna E; Fumagalli M; Scarpellini M; Fiorini T; Ch‚Äö√†√∂¬¨¬©ri‚Äö√†√∂¬¨¬©-Ligni‚Äö√†√∂¬¨√Üre EL; Panni B; Fiorentini F; Corbelli V; Beyene NB; Mastaglio C; Severi C; Locati M; Cazzola M; Menozzi G; Monti G; Saccardo F; Alfieri G; Atzeni F. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. Rheumatology international. (2005) 25 1 pp15-22\", '10.1007/s00296-003-0384-2', 'http://link.springer.com/article/10.1007/s00296-003-0384-2/fulltext.html']\n",
      "['9263297', 'Bejarano V; Conaghan PG; Proudman SM; Buch MH; Brown AK; Emery P. Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis. Annals of the rheumatic diseases. (2009) 68 5 pp761-763', '10.1136/ard.2008.091553', '']\n",
      "['9737153', \"Kroot E J J A; De Jong; B A W; Van Leeuwen; M A; Swinkels H; Van Den Hoogen; F H J; Van 't Hof; Van De Putte; L B A; Van Rijswijk; M H; Van Venrooij; W J; Van Riel; P L C M. Treatment of poor-prognosis early rheumatoid arthritis: a randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis and rheumatism. (2000) 43 8 pp1809-1819\", '10.1002/1529-0131(200008)43:8<1831::aid-anr19>3.0.co;2-6', '']\n",
      "['9740179', 'ISRCTN14554919. Induction of true remission in early poor prognosis (erosive) rheumatoid arthritis (RA) - a randomised study of methotrexate and intra-articular corticosteroids or placebo. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN14554919. (2002)   pp', '10.1186/isrctn14554919', '']\n",
      "['9260326', 'Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis and rheumatism. (2008) 58 5 pp1310-1317', '10.1002/art.23449', '']\n",
      "['9261719', 'Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis. Value in health. (2015) 18  8 pp1008-1015', '10.1016/j.jval.2015.09.2941', '']\n",
      "['9737717', 'Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis. Value in health. (2015) 18 8 pp1008-1015', '10.1016/j.jval.2015.09.2941', '']\n",
      "['9256780', 'Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Plos ONE [electronic resource]. (2017) 12 2 ppe0169830', '10.1371/journal.pone.0169830', '']\n",
      "['9738671', 'Deyab G; Hokstad I; Aaseth J; Smastuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I. Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis. Journal of trace elements in medicine and biology. (2018) 49  pp91-97', '10.1016/j.jtemb.2018.05.001', '']\n",
      "['9258923', 'Pullar T; Hunter JA; Capell HA. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. British medical journal (Clinical research ed.). (1983) 287 6399 pp1102-1104', '10.1136/bmj.287.6399.1102', '']\n",
      "['9258996', 'Pullar T; Hunter JA; Capell HA. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. British journal of rheumatology. (1985) 24 3 pp269-276', '10.1093/rheumatology/24.3.269', 'http://academic.oup.com/rheumatology/article-pdf/24/3/269/5033660/24-3-269.pdf']\n",
      "['9741275', 'NCT04311567. Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease. https://clinicaltrials.gov/show/NCT04311567. (2020)   pp', '10.1177/17534666221135314/v1/review2', '']\n",
      "['11083770', '. Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease. . (2020)   pp', '10.1177/17534666221135314/v1/review2', '']\n",
      "['9258036', 'Bejarano V; Conaghan PG; Quinn MA; Saleem B; Emery P. Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis. Rheumatology (Oxford, England). (2010) 49 10 pp1971-1974', '10.1093/rheumatology/keq194', 'http://academic.oup.com/rheumatology/article-pdf/49/10/1971/5031205/keq194.pdf']\n",
      "['9256966', 'Scott IC; Ibrahim F; Simpson G; Kowalczyk A; White-Alao B; Hassell A; Plant M; Richards S; Walker D; Scott DL. A randomised trial evaluating anakinra in early active rheumatoid arthritis. Clinical and experimental rheumatology. (2016) 34  1 pp88-93', '10.3899/jrheum.110169', '']\n",
      "['9261062', 'Haugeberg G; Conaghan PG; Quinn M. Bone loss in patients with active early rheumatoid arthritis: Infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study (Annals of the Rheumatic Diseases (2009) 68, (1898-1901)). Annals of the rheumatic diseases. (2011) 70  8 pp1519', '10.1136/ard.2008.106484', '']\n",
      "['9739998', 'EUCTR2012-002535-28-NL. A Randomised, open labelled study in anti-TNFa inadequate responders to investigate the mechanisms for Response - Resistance to Rituximab versus Tocilizumab in RA (R4-RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002535-28-NL. (2016)   pp', '10.1093/ecco-jcc/jjw019.014', 'http://academic.oup.com/ecco-jcc/article-pdf/10/suppl_1/S12/7528778/jjw019.014.pdf']\n",
      "['9742782', 'ISRCTN97443826. Ultrasound Guided Synovial Biopsy to determine treatment response to Rituxumab versus Tocilizumab. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN97443826. (2013)   pp', '10.1186/isrctn97443826', '']\n",
      "['11084177', 'Rivellese F; Surace AEA; Goldmann K; Sciacca E; Cubuk C; Giorli G; John CR; Nerviani A; Fossati-Jimack L; Thorborn G; Ahmed M; Prediletto E; Church SE; Hudson BM; Warren SE; McKeigue PM; Humby F; Bombardieri M; Barnes MR; Lewis MJ; Pitzalis C; Rivellese F; Giorli G; Nerviani A; Fossati-Jimack L; Thorborn G; Humby F; Bombardieri M; Lewis MJ; Durez P; Buch MH; Rizvi H; Mahto A; Montecucco C; Lauwerys B; Ng N; Ho P; Romao VC; da Fonseca JEC; Verschueren P; Kelly S; Sainaghi PP; Gendi N; Dasgupta B; Cauli A; Reynolds P; Canete JD; Ramirez J; Celis R; Moots R; Taylor PC; Edwards CJ; Isaacs J; Sasieni P; Choy E; Thompson C; Bugatti S; Bellan M; Congia M; Holroyd C; Pratt A; White L; Warren L; Peel J; Hands R; Hadfield G; Pitzalis C. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. . (2022)   pp', '10.1038/s41591-022-01789-0', 'https://www.nature.com/articles/s41591-022-01789-0']\n",
      "['11084227', 'Humby Frances; Durez Patrick; Buch Maya H; Lewis Myles J; Rizvi Hasan; Rivellese Felice; Nerviani Alessandra; Giorli Giovanni; Mahto Arti; Montecucco Carlomaurizio; Lauwerys Bernard; Ng Nora; Ho Pauline; Bombardieri Michele; Romao Vasco C; Verschueren Patrick; Kelly Stephen; Sainaghi Pier Paolo; Gendi Nagui; Dasgupta Bhaskar; Cauli Alberto; Reynolds Piero; Canete Juan D; Moots Robert; Taylor Peter C; Edwards Christopher J; Isaacs John; Sasieni Peter; Choy Ernest; Pitzalis Costantino; R4RA collaborative group. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet (london, england). (2021) 397 10271 pp305-317', '10.1016/s0140-6736(20)32341-2', '']\n",
      "['11084710', 'Rivellese F; Cubuk C; Surace A; Goldmann K; Sciacca E; Giorli G; Nerviani A; Fossati-Jimack L; Thorborn G; Bombardieri M; Barnes M; Lewis M; Pitzalis C. CELL LINEAGE-SPECIFIC TRANSCRIPT DECONVOLUTION of SYNOVIAL BIOPSIES from the R4RA TRIAL IDENTIFIES CELL POPULATIONS ASSOCIATED with RESPONSE to RITUXIMAB and TOCILIZUMAB. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp56-57', '10.1136/annrheumdis-2022-eular.4794', '']\n",
      "['11085000', 'Humby Frances; Durez Patrick; Buch Maya H; Lewis Myles J; Bombardieri Michele; John Christopher; Rizvi Hasan; Warren Louise; Peel Joanna; Fossati-Jimack Liliane; Hands Rebecca E; Giorli Giovanni; Rivellese Felice; Canete Juan D; Taylor Peter C; Sasieni Peter; Fonseca Joao E; Choy Ernest; Pitzalis Costantino. Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT. . (2022)   pp', '10.3310/gopl1729', 'https://njl-admin.nihr.ac.uk/document/download/2040214']\n",
      "['11085705', 'Rivellese F; Surace AEA; Goldmann K; Sciacca E; √áubuk C; Giorli G; John CR; Nerviani A; Fossati-Jimack L; Thorborn G; Ahmed M; Prediletto E; Church SE; Hudson BM; Warren SE; McKeigue PM; Humby F; Bombardieri M; Barnes MR; Lewis MJ; Pitzalis C; R4RA collaborative group. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nature medicine. (2022) 28 6 pp1256-1268', '10.1038/s41591-022-01789-0', 'https://www.nature.com/articles/s41591-022-01789-0']\n",
      "['9257180', 'Yue Y; Hu J; Bao C; Li X; Spindler AJ; Zhang X; Xu J; He D; Li Z; Wang G; Sun J; Ji F; Zhan L; Rooney T; Gaich C; Zerbini C. Patient-reported outcomes from a phase 3 study (RA-BALANCE) of baricitinib versus placebo in rheumatoid arthritis. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp40', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9257185', 'Yang Y; Hu J; Bao C; Li X; Zhang X; Xu J; He D; Li Z; Wang G; Sun J; Ji F; Zhan L; Rooney T. Efficacy and safety of Baricitinib in Mtx-Ir Chinese patients with rheumatoid arthritis: 52 week results from a phase 3 study. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp3', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9262648', 'Hu J; Bao C; Li X; Spindler A; Zhang X; Xu J; Li Z; Wang G; Sun J; Ji F; Tao H; Zhan L; Rooney T; Zerbini C. Efficacy and safety of baricitinib in MTX-IR patients with rheumatoid arthritis: 52 week results from a phase 3 study (RA-balance). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp969-970', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9737449', 'Yue Y; Hu J; Bao C; Li X; Spindler AJ; Zhang X; Xu J; He D; Li Z; Wang G; Sun J; Ji F; Zhan L; Rooney T; Gaich C; Zerbini C. Patient-reported outcomes from a phase 3 study (RA-BALANCE) of baricitinib versus placebo in rheumatoid arthritis. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp40', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9738708', 'Hu J; Bao C; Li X; Spindler A; Zhang X; Xu J; Li Z; Wang G; Sun J; Ji F; Tao H; Zhan L; Rooney T; Zerbini C. Efficacy and safety of baricitinib in MTX-IR patients with rheumatoid arthritis: 52 week results from a phase 3 study (RA-balance). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp969-970', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9738804', 'Yang Y; Hu J; Bao C; Li X; Zhang X; Xu J; He D; Li Z; Wang G; Sun J; Ji F; Zhan L; Rooney T. Efficacy and safety of Baricitinib in Mtx-Ir Chinese patients with rheumatoid arthritis: 52 week results from a phase 3 study. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp3', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9740602', 'Li Z; Yang Y; Hu J; Bao C; Li X; Li X; Xu J; Zhang X; Xu J; He D; Li Z; Wang G; Wu H; Ji F; Zhan L; Rooney T; Gaich C. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo in rheumatoid arthritis patients: chinese subpopulation analysis in RA-BALANCE. International journal of rheumatic diseases. (2019) 22  pp217-', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9741398', 'Li Zhanguo; Hu Jiankang; Bao Chunde; Li Xingfu; Li Xiangpei; Xu Jianhua; Spindler Alberto J; Zhang Xiao; Xu Jian; He Dongyi; Li Zhijun; Wang Guochun; Yang Yue; Wu Hanjun; Ji Fei; Tao Haoxun; Zhan Lujing; Bai Fan; Rooney Terence P; Zerbini Cristiano A F. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clinical and experimental rheumatology. (2020)   pp', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9742398', 'Yang Y; Hu J; Bao C; Li X; Zhang X; Xu J; He D; Li Z; Wang G; Wu H; Ji F; Zhan L; Rooney T; Gaich C. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo in rheumatoid arthritis patients: chinese subpopulation analysis in RA-BALANCE. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp217', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['9742432', 'Hu J; Bao C; Li X; Spindler AJ; Zhang X; Xu J; He D; Li Z; Wang G; Yang Y; Wu H; Ji F; Tao H; Zhan L; Bai F; Rooney TP; Zerbini CAF. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clinical and experimental rheumatology. (2020)   pp', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['11083842', 'Yang Yue; Xu Jianhua; Xu Jian; Li Xingfu; Hu Jiankang; Li Xiangpei; Zhang Xiao; He Dongyi; Bao Chunde; Li Zhijun; Wang Guochun; Zerbini Cristiano A F; Spindler Alberto J; Kannowski Carol L; Wu Hanjun; Ji Fei; Zhan Lujing; Liu Mengru; Li Zhanguo. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. Therapeutic advances in musculoskeletal disease. (2021) 13  pp1759720X211006964', '10.1177/1759720x211006964', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X211006964']\n",
      "['11084846', 'Li Zhanguo; Hu Jiankang; Bao Chunde; Li Xingfu; Li Xiangpei; Xu Jianhua; Spindler Alberto J; Zhang Xiao; Xu Jian; He Dongyi; Li Zhijun; Wang Guochun; Yang Yue; Wu Hanjun; Ji Fei; Tao Haoxun; Zhan Lujing; Bai Fan; Rooney Terence P; Zerbini Cristiano A F. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clinical and experimental rheumatology. (2020) 38 4 pp732-741', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['11085577', 'Yang Y; Li X-F; Zhang X; Bao C-D; Hu J-K; Xu J-H; Li X-P; Xu J; He D-Y; Li Z-J; Wang G-C; Wu H-J; Ji F; Zhan L-J; Zerbini CAF; Li Z-G. Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: results from Study RA-BALANCE. Rheumatology and therapy. (2020) 7 4 pp851-866', '10.1007/s40744-020-00231-6', 'https://link.springer.com/article/10.1007/s40744-020-00231-6/fulltext.html']\n",
      "['11086001', 'Yang Y; Xu J; Hu J; Li X; Zhang X; He D; Bao C; Wang G; Zerbini CAF; Spindler AJ; Kannowski CL; Wu H; Ji F; Zhan L; Liu M; Li Z. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. Therapeutic advances in musculoskeletal disease. (2021) 13  pp', '10.1177/1759720x211006964', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X211006964']\n",
      "['11086283', 'Hu J; Bao C; Li X; Spindler AJ; Zhang X; Xu J; He D; Li Z; Wang G; Yang Y; Wu H; Ji F; Tao H; Zhan L; Bai F; Rooney TP; Zerbini CAF. Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study. Clinical and experimental rheumatology. (2020) 38 4 pp732-741', '10.1136/annrheumdis-2018-eular.1983', '']\n",
      "['11088030', 'Li Zhan-Guo; Hu Jian-Kang; Li Xiang-Pei; Yang Yue; Li Xing-Fu; Xu Jian-Hua; Zhang Xiao; Xu Jian; Bao Chun-De; He Dong-Yi; Li Zhi-Jun; Wang Guo-Chun; Zuo Xiao-Xia; Liu Yi; Xiao Zheng-Yu; Chen Jin-Wei; Xin Xia-Fei; Li Jing-Yang; Jiang Lin-Di; Liu Meng-Ru; Ji Fei; Li Chen-Ge. Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: results from Study RA-BALANCE. Advances in therapy. (2021) 38 1 pp772-781', '10.1007/s12325-020-01572-y', 'https://link.springer.com/article/10.1007/s12325-020-01572-y/fulltext.html']\n",
      "['11088582', 'Li Z-G; Hu J-K; Li X-P; Yang Y; Li X-F; Xu J-H; Zhang X; Xu J; Bao C-D; He D-Y; Li Z-J; Wang G-C; Zuo X-X; Liu Y; Xiao Z-Y; Chen J-W; Xin X-F; Li J-Y; Jiang L-D; Liu M-R; Ji F; Li C-G. Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: results from Study RA-BALANCE. . (2020)   pp', '10.1007/s12325-020-01572-y', 'https://link.springer.com/article/10.1007/s12325-020-01572-y/fulltext.html']\n",
      "['11088873', 'Yang Y; Xu J; Xu J; Li X; Hu J; Li X; Zhang X; He D; Bao C; Li Z; Wang G; Zerbini CAF; Spindler AJ; Kannowski CL; Wu H; Ji F; Zhan L; Liu M; Li Z. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. . (2021) 13  pp', '10.1177/1759720x211006964', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X211006964']\n",
      "['9257088', 'Bingham CO; Cella D; Bartlett SJ; Delozier A; Quebe A; Sun L; Otawa S; Gaich CL. Linking FACIT fatigue data to PROMIS fatigue scores to enhance interpretability: data from phase 3 baricitinib rheumatoid arthritis trials. Quality of life research. Conference: 25th annual conference of the international society for quality of life research, ISOQOL 2018. Ireland. (2018) 27 Supplement 1 ppS120-S121', '10.1136/annrheumdis-2018-eular.1890', '']\n",
      "['9257200', 'Genovese MC; Kremer J; Zamani O; Ludivico C; Krogulec M; Xie L; Beattie SD; Koch AE; Cardillo TE; Rooney TP; Macias WL; de Bono S; Schlichting DE; Smolen JS. Baricitinib in Patients with Refractory Rheumatoid Arthritis. New England journal of medicine. (2016) 374 13 pp1243-1252', '10.1056/nejmoa1507247', '']\n",
      "['9258025', 'Genovese M; Kremer J; Zamani O; Ludivico C; Krogulec M; Xie L; Beattie S; Koch A; Cardillo T; Rooney T; Macias W; Schlichting D; Smolen J; Bookman A. Baricitinib, an oral janus kinase (JAK)1/JAK2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to tnf inhibitors: results of the phase 3 RA-beacon study. Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1188', '10.1136/annrheumdis-2015-eular.1427', '']\n",
      "['9261826', 'Genovese MC; Kremer JM; Kartman C; Schlichting DE; Xie L; Carmack T; Macias WL; Smolen JS. Previous biologic disease-modifying antirheumatic drug (BDMARD) exposure and efficacy and safety analysis from a phase 3 study of baricitinib in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitors. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.1435', '']\n",
      "['9261853', 'Smolen JS; Kremer J; Gaich C; DeLozier AM; Schlichting D; Xie L; Genovese MC. Patient-reported outcomes from a phase 3 study of baricitinib in patients with rheumatoid arthritis (RA) and an inadequate response to tumor necrosis factor inhibitors. Annals of the rheumatic diseases. (2015) 74  pp785-786', '10.1136/annrheumdis-2015-eular.1435', '']\n",
      "['9261916', 'Genovese MC; Kremer J; Zamani O; Ludivico C; Krogulec M; Xie L; Beattie S; Koch AE; Cardillo T; Rooney T; Macias W; Schlichting D; Smolen JS. Baricitinib, an oral janus kinase (jak)1/jak2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors: results of the phase 3 ra-beacon study. Annals of the rheumatic diseases. (2015) 74  pp75-76', '10.1136/annrheumdis-2015-eular.1427', '']\n",
      "['9262210', 'Smolen JS; Kremer JM; Gaich CL; DeLozier AM; Schlichting DE; Xie L; Stoykov I; Rooney T; Bird P; S‚àö¬∞nchez Burs‚àö‚â•n JM; Genovese MC; Combe B. Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). Annals of the rheumatic diseases. (2017) 76 4 pp694-700', '10.1136/annrheumdis-2016-209821', '']\n",
      "['9262558', 'Genovese MC; Kremer JM; Kartman CE; Schlichting DE; Xie L; Carmack T; Pantojas C; Sanchez Burson J; Tony HP; Macias WL; Rooney TP; Smolen JS. Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis. Rheumatology (Oxford, England). (2018) 57 5 pp900-908', '10.1093/rheumatology/kex489', 'http://academic.oup.com/rheumatology/article-pdf/57/5/900/25092428/kex489.pdf']\n",
      "['9263605', 'Genovese MC; Kremer J; Zamani O; Ludivico C; Krogulec M; Xie L; Beattie SD; Koch AE; Cardillo T; Rooney T; Macias W; Schlichting DE; Smolen JS. Baricitinib, an oral janus kinase (JAK)1/JAK2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors: results of the phase-3 RA-beacon study. Journal fur mineralstoffwechsel. (2015) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie und Rehabilitation 2015. Austria. 22 4 pp115', '10.1136/annrheumdis-2015-eular.1427', '']\n",
      "['9736648', 'Zamani O; Combe B; Tony HP; Sanchez Burson J; Tahir H; Ostergaard M; Augendre-Ferrante B; Beselin A; Larsson E; Casillas M; Smolen J. Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: 24-week phase 3 RA-BEACON study results. Swiss medical weekly. (2016) Conference: Annual Meeting Swiss Society of Rheumatology, SGR/SSR 2016. Switzerland. 146 Supplement 217 pp3S', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9736852', 'Zamani O; Combe B; Tony HP; Sanchez Burson J; Tahir H; Ostergaard M; Augendre-Ferrante B; Beselin A; Larsson E; Casillas M; Smolen J. Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: 24-week phase 3 RA-BEACON study results. Swiss medical weekly. (2016) 146  pp3S-', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9736858', 'Zamani O; Combe B; Tony H-P; Sanchez Burson J; Tahir H; Ostergaard M; Augendre-Ferrante B; Beselin A; Larsson E; Casillas M; Smolen J. Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: summary results from the 24-week phase 3 RA-BEACON study. Journal fur mineralstoffwechsel. (2016) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie and Rehabilitation. Austria. 23 4 pp135', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9738569', 'Genovese MC; Kremer JM; Kartman CE; Schlichting DE; Xie L; Carmack T; Pantojas C; Sanchez Burson J; Tony HP; Macias WL; Rooney TP; Smolen JS. Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis. Rheumatology (Oxford, England). (2018) 57 5 pp900-908', '10.1093/rheumatology/kex489', 'http://academic.oup.com/rheumatology/article-pdf/57/5/900/25092428/kex489.pdf']\n",
      "['9739508', 'Pope JE; Quebe A; Zhu B; Sun L; Gaich CL; De Leonardis F; Cardoso A; Genovese MC. Assessment of pain relief with baricitinib by treatment history in patients with refractory rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2815-2816', '10.1093/rheumatology/kez106.075', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.075/28713118/kez106.075.pdf']\n",
      "['9740212', 'EUCTR2012-002323-15-AT. A Phase 3 Study in Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002323-15-AT. (2013)   pp', '10.1002/psb.0010021', '']\n",
      "['9740462', 'Zamani O; Combe B; Tony H-P; Sanchez Burson J; Tahir H; Ostergaard M; Augendre-Ferrante B; Beselin A; Larsson E; Casillas M; Smolen J. Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors: summary results from the 24-week phase 3 RA-BEACON study. Journal fur mineralstoffwechsel. (2016) 23 4 pp135-', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9741158', 'NCT01721044. A Moderate to Severe Rheumatoid Arthritis Study. https://clinicaltrials.gov/show/NCT01721044. (2012)   pp', '10.1358/dot.2012.48.8.1855926', '']\n",
      "['11083912', 'Caporali R; Aletaha D; Sanmarti R; Takeuchi T; Mo D; Haladyj E; Zaremba-Pechmann L; Taylor PC. LONG-TERM EFFICACY of BARICITINIB in PATIENTS with RHEUMATOID ARTHRITIS with INADEQUATE RESPONSE to BDMARDS: RESULTS from RA-BEYOND FOLLOWING 6.9 YEARS of TREATMENT. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp617-618', '10.1136/annrheumdis-2022-eular.1759', '']\n",
      "['9256866', 'Emery P; Taylor PC; Weinblatt M; Tanaka Y; Keystone EC; Dow ER; Higgs R; Macias WL; Rocha G; Rooney TP; Schlichting DE; Zuckerman SH; McInnes IB. Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis patients, from a phase 3 study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2018-ewrr2018.108', '']\n",
      "['9256953', 'Bacci ED; DeLozier AM; Lin CY; Gaich CL; Rooney T; Hoffman R; Wyrwich KW. Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis. Health and quality of life outcomes. (2017) 15 1 pp239', '10.1186/s12955-017-0813-7', 'http://link.springer.com/content/pdf/10.1186/s12955-017-0813-7.pdf']\n",
      "['9257125', 'Papadimitropoulos M; Gonzaga JR; Goncalves L; Martinez-Osuna P; Zhu B; Gaich CL; Garcia EG. Long-term work productivity improvement from phase 3 baricitinib ra-beam study: latin American subgroup analysis. Value in health. Conference: ISPOR 20th annual european congress. United kingdom. (2017) 20 9 ppA940', '10.1016/j.jval.2017.08.2992', '']\n",
      "['9257647', 'Kremer JM; Genovese MC; Muram D; Zhong J; Alam J; Schiff M. Effects of baseline patient characteristics on baricitinib efficacy in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3557-3558', '10.1002/art.39977', '']\n",
      "['9258273', 'Emery P; Taylor PC; Weinblatt ME; Tanaka Y; Keystone EC; Dow ER; Higgs R; Macias WL; Rocha G; Rooney TP; Schlichting DE; Zuckerman SH; McInnes IB; Holzkaemper T. Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. Annals of the rheumatic diseases. (2018) 77 (Supplement 1) Supplement 1 ppA52', '10.1136/annrheumdis-2018-ewrr2018.108', '']\n",
      "['9261804', 'Taylor PC; Keystone EC; Van Der Heijde D; Tanaka Y; Ishii T; Emoto K; Yang L; Arora V; Gaich CL; Rooney T; Schlichting DE; Macias W; De Bono S; Weinblatt ME. Baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis (RA) and an inadequate response to background methotrexate therapy: results of a phase 3 study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1056/nejmoa1608345', '']\n",
      "['9262150', 'Taylor PC; Keystone EC; van der Heijde D; Weinblatt ME; Del Carmen Morales L; Reyes Gonzaga J; Yakushin S; Ishii T; Emoto K; Beattie S; Arora V; Gaich C; Rooney T; Schlichting D; Macias WL; de Bono S; Tanaka Y. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis. New england journal of medicine. (2017) 376 7 pp652-662', '10.1056/nejmoa1608345', '']\n",
      "['9262244', 'Taylor P; Keystone E; Rooney T; De Bono S; Bradley J; Muram D; Xie L; Issa M; Ortmann R; Tanaka Y; Faraawi R. Efficacy and safety of switching from adalimumab to baricitinib: phase 3 data in patients with rheumatoid arthritis. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp890-891', '10.1136/annrheumdis-2018-214529', '']\n",
      "['9262441', 'Kvien TK; Van Riel P; Rubbert-Roth A; Blanco R; Liu-Leage SS; Larsson E; Lund H; Lopez-Romero P; Zaremba-Pechmann L; Emery P. Baricitinib versus adalimumab in patients with active rheumatoid arthritis: analysis of patients achieving a moderate eular response at week 4. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp794-795', '10.1136/annrheumdis-2017-eular.2217', '']\n",
      "['9262444', 'Pincus T; Zhu B; Larmore CJ; Bradley JD; Patel N; Gaich CL; Koch AE. A RAPID3-like index documents superior efficacy of baricitinib to adalimumab and placebo, similar to DAS28 and cdai in the ra-beam clinical trial in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp794', '10.1136/annrheumdis-2017-eular.1813', '']\n",
      "['9262483', 'Dougados M; Zhu B; Tang AC; Quebe A; Stoykov I; Cai Z; Ishida M; Gaich C. A high level of clinical response based on composite indices is associated with improved health-related quality of life: analyses from a phase 3 clinical trial in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp524', '10.1136/annrheumdis-2017-eular.1344', '']\n",
      "['9262484', 'Fautrel B; Van De Laar M; Kirkham B; Alten R; Cseuz R; Van Der Geest S; Zhu B; De Leonardis F; Taylor P. Differences in patient-reported outcomes between baricitinib and comparators among patients with rheumatoid arthritis who achieved low disease activity or remission. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp230', '10.1136/annrheumdis-2017-eular.2213', '']\n",
      "['9262554', 'Dougados M; Fautrel B; Van De Laar; M A F J; Kirkham B; Alten R; Cseuz R; Smolen J; Sanchez-Burson J; Bird P; Scheinberg M; Van Den Bosch; Barry J; Durand F; Zhu B; De Leonardis; Taylor P. Summary of baricitinib effect on patient-reported outcomes (pros) in methotrexate-inadequate responder patient population. Internal medicine journal. (2018) 48 (Supplement 4) Supplement 4 pp42-43', '10.1093/rheumatology/key075.450', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.450/24768376/key075.450.pdf']\n",
      "['9262577', 'Taylor P; Fleischmann R; Perkins E; Lisse J; Zhu B; Gaich C; Zhang X; Schlichting D; Dickson C; Takeuchi T; Moyano S. Rapid and sustained pain improvement in rheumatoid arthritis patients treated with baricitinib compared toadalimumab or placebo. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS84', '10.1093/rheumatology/kez106.075', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.075/28713118/kez106.075.pdf']\n",
      "['9263550', 'Tanaka Y; Fleischmann R; Schiff M; Takeuchi T; Keystone E; Weinblatt M; Zuckerman S; Issa M; Thanabalasundrum S; Augendre-Ferrante B; De Bono S; Schlichting D; Rooney TP; Macias WL; Taylor P. Characterization of changes in lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis in a phase 3 study (RA-beam). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp262-263', '10.1136/annrheumdis-2016-eular.1513', '']\n",
      "['9263609', 'Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Annals of the rheumatic diseases. (2017) 76 11 pp1853-1861', '10.1136/annrheumdis-2017-211259', '']\n",
      "['9736552', 'Taylor P; Keystone E; Tanaka Y; Van Der Heijde D; Zhong J; Thanabalasundrum S; Ruotolo G; Schlichting D; Rooney TP; Macias WL; Zuckerman S; De Bono S; Weinblatt M. Baricitinib effects on lipid and NMR-measured lipoprotein profiles in a phase 3 study in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp257-258', '10.1136/annrheumdis-2016-eular.1595', '']\n",
      "['9736673', 'Weinblatt ME; Taylor PC; Keystone EC; Ortmann RA; Issa M; Xie L; De Bono S; Tanaka Y. Efficacy and safety of switching from adalimumab to baricitinib: long-term data from phase 3 extension study in patients with rheumatoid arthritis. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp981-982', '10.1002/art.40700', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40700']\n",
      "['9736892', 'Michaud Kaleb; Pope Janet E; Emery Paul; Zhu Baojin; Gaich Carol L; DeLozier Amy M; Zhang Xiang; Dickson Christina L; Smolen Josef S. Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. Rheumatology and therapy. (2019) 6 3 pp409-419', '10.1007/s40744-019-0164-4', 'https://link.springer.com/article/10.1007/s40744-019-0164-4/fulltext.html']\n",
      "['9736967', '. Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM. Journal of clinical medicine. (2019) 8 9 pp', '10.3390/jcm8091394', '']\n",
      "['9737073', '. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp412-413', '10.1136/annrheumdis-2016-eular.1239', '']\n",
      "['9737098', 'Tanaka Yoshiya; Fautrel Bruno; Keystone Edward C; Ortmann Robert A; Xie Li; Zhu Baojin; Issa Maher; Patel Himanshu; Gaich Carol L; de Bono Stephanie; Rooney Terence P; Taylor Peter C. Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 7 pp890-898', '10.1136/annrheumdis-2018-214529', '']\n",
      "['9737221', 'Taylor PC; Lee YC; Fleischmann R; Takeuchi T; Perkins EL; Fautrel B; Zhu B; Quebe AK; Gaich CL; Zhang X; Dickson CL; Schlichting DE; Patel H; Durand F; Emery P. Achieving pain control in rheumatoid arthritis with baricitinib or adalimumab plus methotrexate: results from the RA-BEAM trial. Journal of clinical medicine. (2019) 8 6 pp', '10.3390/jcm8060831', '']\n",
      "['9737370', 'Fautrel B; Taylor P C; Michaud K; Patel H; Zhu B; Gaich C L; Guo J; Quebe A; Tanaka Y. Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.1346', '']\n",
      "['9737834', 'Keystone E; Taylor P; Tanaka Y; Gaich C; DeLozier A M; Dudek A; Velasco Zamora; Covarrubias Cobos; De Bono; Arora V; Yang L; Linetzky B; Weinblatt M E. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp412-413', '10.1136/annrheumdis-2016-eular.1239', '']\n",
      "['9738069', 'Pope J; Michaud K; Emery P; Zhu B; Gaich C; DeLozier A; Zhang X; Dickson C; Smolen JS. Reduction in fatigue and pain are associated with improved work productivity in patients with RA. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1302', '10.1136/annrheumdis-2018-eular.1932', '']\n",
      "['9738089', 'Van De Laar M; Pope J; Lee Y; Fautrel B; Ikeda K; Quebe A; Zhang X; Gaich C; De Leonardis F; Lisse J; Workman J; Taylor PC. Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1601', '10.1136/annrheumdis-2019-eular.542', '']\n",
      "['9738304', 'Taylor Peter C; Lee Yvonne C; Fleischmann Roy; Takeuchi Tsutomu; Perkins Elizabeth L; Fautrel Bruno; Zhu Baojin; Quebe Amanda K; Gaich Carol L; Zhang Xiang; Dickson Christina L; Schlichting Douglas E; Patel Himanshu; Durand Frederick; Emery Paul. Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: results from the RA-BEAM Trial. Journal of clinical medicine. (2019) 8 6 pp', '10.3390/jcm8060831', '']\n",
      "['9738305', 'Dougados M; Fautrel B; Van De Laar; M A F J; Kirkham B; Alten R; Cseuz R; Smolen J; Sanchez-Burson J; Bird P; Scheinberg M; Van Den Bosch; Barry J; Durand F; Zhu B; De Leonardis; Taylor P. Summary of baricitinib effect on patient-reported outcomes (pros) in methotrexate-inadequate responder patient population. Internal medicine journal. (2018) 48 (Supplement 4) Supplement 4 pp42-43', '10.1093/rheumatology/key075.450', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.450/24768376/key075.450.pdf']\n",
      "['9738437', 'Taylor PC; Keystone EC; Van Der Heijde D; Tanaka Y; Ishii T; Emoto K; Yang L; Arora V; Gaich C; Rooney T; Schlichting D; Macias WL; De Bono S; Weinblatt ME. Baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study. Swiss medical weekly. (2016) Conference: Annual Meeting Swiss Society of Rheumatology, SGR/SSR 2016. Switzerland. 146 Supplement 217 pp9S', '10.1016/s1169-8330(16)30348-9', '']\n",
      "['9738578', 'Taylor P; Fleischmann R; Perkins E; Lisse J; Zhu B; Gaich C; Zhang X; Schlichting D; Dickson C; Takeuchi T; Moyano S. Rapid and sustained pain improvement in rheumatoid arthritis patients treated with baricitinib compared toadalimumab or placebo. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS84', '10.1093/rheumatology/kez106.075', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.075/28713118/kez106.075.pdf']\n",
      "['9738595', 'Dougados M; Fautrel BJ; Van De Laar MAFJ; Kirkham B; Alten R; Cseuz R; Smolen JS; Sanchez-Burson J; Bird P; Scheinberg M; Van Den Bosch F; Barry J; Durand F; Zhu B; De Leonardis F; Taylor PC. Summary of baricitinib effect on patientreported outcomes (PROS) in methotrexateinadequate responder patient population. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii140-iii141', '10.1093/rheumatology/key075.450', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.450/24768376/key075.450.pdf']\n",
      "['9738645', \"Keating GM; Perry CM. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. BioDrugs. (2002) 16 2 pp111-148\", '10.2165/00063030-200216020-00005', '']\n",
      "['9738681', 'Fleischmann R; Spindler A; Kivitz A; Ching D; Mangan EK; Kimura T; Iglesias-Rodriguez M; Burmester GR. Similar efficacy and safety of sarilumab 150 mg or 200 mg Q2W regardless of primary (1degree) or secondary (2degree) failure with TNF inhibitors. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp328', '10.1136/annrheumdis-2018-eular.1374', '']\n",
      "['9738997', 'Taylor P C; Krogulec M; Dudek A; Dudler J; Drescher E; Cseuz R; Kausiene R; Andersone D; Unikiene D; Burson J S; Alonso R B; Dvorak Z; Ghizdavescu A; Irto I; Larsson E; Bello N; Barry J; Durand F; Holzkamper T; Otawa S; De Bono; Keystone E C; Rubbert-Roth A; Combe B; De La Torre. Efficacy and safety of baricitinib versus placebo and adalimumab in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate: summary results from the 52-week phase 3 RA-BEAM study. Rheumatology (united kingdom). (2017) 56 Supplement 2 pp', '10.1093/rheumatology/kex061', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/ii26/13720440/kex061.pdf']\n",
      "['9739427', 'Taylor PC; Tanaka Y; Cardoso A; Zhong J; Chen Y-F; Workman JL; Del Carmen Morales L; Schiff M. Baricitinib: early vs. delayed start in patients with rheumatoid arthritis. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp588-590', '10.1002/art.40700', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40700']\n",
      "['9739552', 'Giles JT; Nurmohamed MT; Rinder HM; Krishnan V; Crowe BJ; Saifan C; Dorner T. Mean platelet volume changes with baricitinib indicate reduced new platelet production in baricitinib-treated rheumatoid arthritis patients. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1698-1699', '10.1002/art.40680', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40680']\n",
      "['9739738', 'EUCTR2012-002322-73-HU. A Phase 3 Study in Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002322-73-HU. (2012)   pp', '10.1186/isrctn27093749', '']\n",
      "['9740474', '. Reduction in disease activity in patients with RA and an inadequate response to MTX: baricitinib compared to adalimumab and placebo. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1004', '10.3899/jrheum.180300', '']\n",
      "['9740485', '. Reduction in disease activity in patients with RA and an inadequate response to MTX: baricitinib compared to adalimumab and placebo. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1004', '10.3899/jrheum.180300', '']\n",
      "['9740605', 'Nash P; Pope J; Smolen J; Weinblatt M; Taylor PC; Keystone E; Cardoso A; Zhu B; Xie L; Stoykov I; Durez P; Tanaka Y. Efficacy of baricitinib compared with adalimumab and placebo in patients with rheumatoid arthritis: post-hoc analyses from RA-BEAM and RA-BEYOND trials. International journal of rheumatic diseases. (2019) 22 Supplement 3 pp144-145', '10.1136/annrheumdis-2017-211259', '']\n",
      "['9740863', '. Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA. Annals of the rheumatic diseases. (2019) 78  pp1601-', '10.1136/annrheumdis-2019-eular.542', '']\n",
      "['9741335', '. Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM. Journal of clinical medicine. (2019) 8 9 pp', '10.3390/jcm8091394', '']\n",
      "['9741966', 'Fautrel Bruno; Kirkham Bruce; Pope Janet E; Takeuchi Tsutomu; Gaich Carol; Quebe Amanda; Zhu Baojin; de la Torre Inmaculada; De Leonardis Francesco; Taylor Peter C. Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: exploratory Analyses from RA-BEAM. Journal of clinical medicine. (2019) 8 9 pp', '10.3390/jcm8091394', '']\n",
      "['9742400', 'Genovese M; Burmester G; Hagino O; Van Hoogstraten H; Mangan E; Thangavelu K; Fleischmann R; Mandrup-Poulsen T. Effect of sarilumab on glycosylated hemoglobin in patients with rheumatoid arthritis and diabetes. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp206', '10.1136/annrheumdis-2019-eular.3259', '']\n",
      "['9742543', 'Genovese M C; Da R C Pinheiro G; Mangan E K; Lin Y; Van Adelsberg; Van Hoogstraten; Thompson D; Fleischmann R. Efficacy of sarilumab plus CSDMARDS in rheumatoid arthritis patients who had an inadequate response to one or more than one prior TNF inhibitor. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp730-731', '10.1136/annrheumdis-2016-eular.4280', '']\n",
      "['9742555', 'Papadimitropoulos M; Zerbini C; Ramos-Remus C; Martinez-Osuna P; Zhu B; Gaich CL; Garcia EG; Golcalves LF. Patient-re ported outcomes from phase 3 baricitinib ra-begin study: latin American subgroup analysis. Value in health. (2017) Conference: ISPOR 20th Annual European Congress. United Kingdom. 20 9 ppA939-', '10.1016/j.jval.2017.08.2986', '']\n",
      "['9742885', 'Taylor PC; Keystone EC; Van Der Heijde D; Tanaka Y; Ishii T; Emoto K; Yang L; Arora V; Gaich C; Rooney T; Schlichting D; Macias WL; De Bono S; Weinblatt ME. Baricitinib versus placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study. Swiss medical weekly. (2016) 146  pp9S-', '10.1056/nejmoa1608345', '']\n",
      "['9743221', 'Nash P; Pope J; Cardoso A; Casillas M; Schlichting D; Zhu B; Beattie S; Smolen J. Reduction in disease activity in patients with RA and an inadequate response to MTX: baricitinib compared to adalimumab and placebo. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1004', '10.1093/rheumatology/keaa111.230', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.230/33102750/keaa111.230.pdf']\n",
      "['11085400', 'Ostor A; Fautrel B; Van De Laar M; Kirkham B; Alten R; Cseuz R; Van Der Geest S; Zhu B; de Leonardis F; Taylor P. Differences in patient-reported outcomes between baricitinib and comparators among patients with rheumatoid arthritis who achieved low disease activity or remission. Internal medicine journal. (2020) 50 SUPPL 2 pp25-26', '10.1136/annrheumdis-2017-eular.2213', '']\n",
      "['11085424', 'Strand V; Sebba A; Jia B; Birt J; Quebe A; Zhang H; Taylor PC. Rapid and concurrent improvements in patient-reported outcomes of rheumatoid arthritis with baricitinib in ra-beam. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp561', '10.1136/annrheumdis-2021-eular.65', '']\n",
      "['11086084', 'Taylor P; Blanco Alonso R; Ikeda K; Jia B; Che YF; Wall C; Halady E; Fautrel B; Hanssen-Bauer A. Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis. Scandinavian journal of rheumatology. (2021) 50 SUPPL 130 pp27-28', '10.1136/annrheumdis-2021-eular.182', '']\n",
      "['11086089', 'Taylor P; Pope J; Ikeda K; Zhang X; Jia B; Quebe A; Zhang H; Chen YF; Gaich C; Holzkaemper T; Cardoso A; Gerwien J. Baricitinib provides better pain relief across all disease activity levels compared with placebo and adalimumab in rheumatoid arthritis. Scandinavian journal of rheumatology. (2021) 50 SUPPL 130 pp19-20', '10.1093/rheumatology/keaa111.230', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.230/33102750/keaa111.230.pdf']\n",
      "['11086189', 'Taylor PC; Blanco R; Ikeda K; Jia B; Chen YF; Walls C; Haladyj E; Fautrel B. Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp563', '10.1136/annrheumdis-2021-eular.182', '']\n",
      "['9257599', 'Taylor PC; Keystone E; Ortmann R; Issa M; Xie L; Muram D; Bradley JD; De Bono S; Rooney T; Tanaka Y. Efficacy and safety of switching from adalimumab to baricitinib: phase 3 data in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1971-1973', '10.1002/art.39977', '']\n",
      "['9262307', 'Taylor PC; Krogulec M; Dudek A; Dudler J; Drescher E; Cseuz R; Kausiene R; Andersone D; Unikiene D; Burson JS; Alonso RB; Dvorak Z; Ghizdavescu A; Irto I; Larsson E; Bello N; Barry J; Durand F; Holzkamper T; Otawa S; De Bono S; Keystone EC; Rubbert-Roth A; Combe B; Torre IDL. Baricitinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: results of a 52-week study. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp37', '10.1093/rheumatology/kex061', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/ii26/13720440/kex061.pdf']\n",
      "['9737208', '. Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA. Annals of the rheumatic diseases. (2019) 78  pp1601-', '10.1136/annrheumdis-2019-eular.542', '']\n",
      "['9738284', 'NCT01710358. A Study in Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01710358. (2012)   pp', '10.1358/dot.2012.48.8.1855926', '']\n",
      "['9262690', 'Bingham CO; Gaich C; DeLozier AM; Quebe A; Sun L; Otawa S; Pope J. Converting patient-reported physical function outcomes scores to promis metric scores in phase 3 trials of baricitinib in rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp553-554', '10.1136/annrheumdis-2018-eular.2001', '']\n",
      "['9737031', 'Bingham CO; Bartlett SJ; Cella D; DeLozier AM; Sun L; Quebe A; Otawa S; Gaich CL. Development of a crosswalk for FACIT-10 (psychometric work). Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2739-2740', '10.1002/art.40700', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40700']\n",
      "['9738731', 'Bingham CO; Gaich C; DeLozier AM; Quebe A; Sun L; Otawa S; Pope J. Converting patient-reported physical function outcomes scores to promis metric scores in phase 3 trials of baricitinib in rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp553-554', '10.1136/annrheumdis-2018-eular.2001', '']\n",
      "['9740648', 'Taylor PC; Fleischmann R; Takeuchi T; Pope J; Genovese MC; Zhu B; Gaich C; Zhang X; Dickson C; Quebe A; De Leonardis F; Cardoso A; Kouris I; Durez P. Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors. Rheumatology (united kingdom). (2019) 58 Supplement 3 ppiii72', '10.1093/rheumatology/kez106.075', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.075/28713118/kez106.075.pdf']\n",
      "['9256839', 'Wu Z-P; Zhang P; Bai J-Z; Liang Y; He J-S; Wang J-C. Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: a meta-analysis of randomized controlled trials. Experimental and therapeutic medicine. (2018) 16 3 pp2449-2459', '10.3892/etm.2018.6495', '']\n",
      "['9257378', 'Keystone E; Genovese M; Smolen J; Takeuchi T; Hyslop D; Macias W; Rooney T; Chen L; Dickson C; Camp J; Cardillo T; Ishii T; Winthrop K; Otawa S. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) 45 7 pp1003', '10.3899/jrheum.171361', '']\n",
      "['9258137', 'Genovese M; Smolen J; Takeuchi T; Hyslop D; MacIas W; Rooney T; Chen L; Dickson C; Riddle J; Cardillo T; Winthrop K. Safety profile of baricitinib in patients with active rhaumatoid arthritis: an integrated analysis. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp31', '10.3899/jrheum.171361', '']\n",
      "['9258140', 'Genovese M; Smolen J; Takeuchi T; Hyslop D; MacIas W; Rooney T; Chen L; Dickson C; Riddle J; Cardillo T; Winthrop K. Safety profile of baricitinib in patients with active rhaumatoid arthritis: an integrated analysis. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47 Supplement 2 pp28', '10.3899/jrheum.171361', '']\n",
      "['9262579', 'Genovese MC; Smolen JS; Takeuchi T; Hyslop D; Macias WL; Rooney TP; Chen L; Dickson CL; Camp JR; Cardillo TE; Ishii T; Winthrop KL; Garcia EG. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS83', '10.3899/jrheum.171361', '']\n",
      "['9736508', 'Genovese M; Smolen J; Takeuchi T; Rooney T; Dickson C; Yang X-Y; Saifan C; Cardoso A; Issa M; Ishii T; Winthrop K; Gomez D. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 6 years: an updated integrated safety analysis. Journal of clinical rheumatology. (2019) 25 3 Supplement ppS49-S50', '10.1136/annrheumdis-2019-eular.691', '']\n",
      "['9737883', 'Genovese MC; Smolen JS; Takeuchi T; Hyslop D; Macias WL; Rooney TP; Chen L; Dickson CL; Camp JR; Cardillo TE; Ishii T; Winthrop KL; Garcia EG. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS83', '10.3899/jrheum.171361', '']\n",
      "['9737995', 'Genovese M; Smolen J; Takeuchi T; Hyslop D; Macias W; Rooney T; Chen L; Dickson C; Riddle J; Cardillo T; Ishii T; Winthrop K; Larsson E. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Scandinavian journal of rheumatology. (2018) Conference: 37th Scandinavian Congress of Rheumatology. Finland. 47 Supplement 129 pp35', '10.3899/jrheum.171361', '']\n",
      "['9738183', '. Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis. Arthritis and rheumatology. (2019) 71 7 pp1042-1055', '10.1002/art.40841', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40841']\n",
      "['9739402', 'Genovese M; Smolen J; Takeuchi T; Hyslop D; Macias W; Rooney T; Chen L; Dickson C; Riddle J; Cardillo T; Ishii T; Winthrop K; Larsson E. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Scandinavian journal of rheumatology. (2018) 47  pp35-', '10.3899/jrheum.171361', '']\n",
      "['9740576', 'Hall S; Genovese MC; Smolen JS; Weinblatt M; Winthrop K; Taylor P; Burmester G; Bosch FVD; Dudler J; Rooney T; Dickson C; Issa M; Ishii T; Saifan C; Walls C; Adhami P; Takeuchi T. Safety of baricitinib: update from up to 6 years of treatment in rheumatoid arthritis clinical trials. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp11-12', '10.1136/annrheumdis-2019-eular.691', '']\n",
      "['9742085', 'Huizinga T; Kay J; Harigai M; Keystone E; Smolen J; Rosas J; Emery P; Hall S; Van Den BF; Scheinberg M; Dudler J; Liao R; Meszaros G; Barry J; Kremer J. Effects of baricitinib on haematological laboratory parameters in patients with rheumatoid arthritis. Swiss medical weekly. (2018) Conference: Joint Congress of the Swiss Society of Rheumatology SSR and the Swiss Society for Allergology and Immunology SSAI. Switzerland. 148 Supplement 231 pp19S', '10.1093/rheumatology/key075.589', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.589/24768654/key075.589.pdf']\n",
      "['9742100', 'Weinblatt M; Taylor PC; Burmester GR; Saifan C; Walls CD; Issa M; Rooney TP; Takeuchi T. Cardiovascular safety-update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp3163-3165', '10.1002/art.40841', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40841']\n",
      "['9742691', 'Genovese MC; Smolen JS; Takeuchi T; Rooney TP; Dickson CL; Yang X-Y; Saifan C; Cardoso A; Issa M; Ishii T; Winthrop K. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 6 years: an updated integrated safety analysis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1075-1076', '10.1016/s2665-9913(20)30032-1', '']\n",
      "['9742904', '. Cardiovascular safety-update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials. Arthritis and rheumatology. (2018) 70  pp3163-3165', '10.1093/rheumatology/kew144.027', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i103/5079126/kew144.027.pdf']\n",
      "['9742959', 'Genovese MC; Smolen JS; Takeuchi T; Burmester GR; Brinker D; Rooney T; Zhong J; Mo D; Saifan C; Cardoso A; Issa M; Wu W-S; Winthrop K. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 7 years: an updated integrated safety analysis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp308-309', '10.1136/annrheumdis-2019-eular.691', '']\n",
      "['9742969', 'Hall S; Genovese M; Smolen J; Weinblatt M; Winthrop K; Taylor P; Burmester G; Van Den Bosch F; Dudler J; Rooney T; Dickson C; Issa M; Ishii T; Saifan C; Adhami P; Takeuchi T. Safety of baricitinib: update from up to 6 years of treatment in rheumatoid arthritis clinical trials. Swiss medical weekly. (2019) 149  pp9S-', '10.1136/annrheumdis-2019-eular.691', '']\n",
      "['9258562', 'Taylor P; Zhu B; Gaich C; Zhang X; DeLozier AM; Schlichting D; Patel H; Durand F; Fautrel B. Baricitinib showed rapid and greater reduction in pain compared to adalimumab or placebo in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp788', '10.1136/annrheumdis-2017-eular.1346', '']\n",
      "['9262698', 'Bingham CO; Gaich C; DeLozier AM; Quebe A; Sun L; Otawa S; Pope J. Converting patient-reported outcome measures of fatigue and pain to promis scores: data from phase 3 baricitinib rheumatoid arthritis trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp274-275', '10.1136/annrheumdis-2018-eular.1890', '']\n",
      "['9738798', 'Bingham CO; Cella D; Bartlett SJ; Delozier A; Quebe A; Sun L; Otawa S; Gaich CL. Linking FACIT fatigue data to PROMIS fatigue scores to enhance interpretability: data from phase 3 baricitinib rheumatoid arthritis trials. Quality of life research. (2018) Conference: 25th Annual Conference of the International Society for Quality of Life Research, ISOQOL 2018. Ireland. 27 Supplement 1 ppS120-S121', '10.1136/annrheumdis-2018-eular.1890', '']\n",
      "['9742526', 'Bingham CO; Gaich C; DeLozier AM; Quebe A; Sun L; Otawa S; Pope J. Converting patient-reported outcome measures of fatigue and pain to promis scores: data from phase 3 baricitinib rheumatoid arthritis trials. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp274-275', '10.1136/annrheumdis-2018-eular.1890', '']\n",
      "['11086552', 'Strand V; Sun L; Ross Terres J; Kannowski CL. Number needed to treat to achieve minimum clinically significant differences in patientreported outcomes in patients treated with baricitinib. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp599-600', '10.1136/annrheumdis-2020-eular.1440', '']\n",
      "['9256956', 'Bacci ED; DeLozier AM; Lin CY; Gaich CL; Zhang X; Rooney T; de Bono S; Hoffman R; Wyrwich KW. Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis. Health and quality of life outcomes. (2017) 15 1 pp237', '10.1186/s12955-017-0807-5', 'http://link.springer.com/content/pdf/10.1186/s12955-017-0807-5.pdf']\n",
      "['9257545', 'Wells AF; Greenwald M; Bradley JD; Alam J; Arora VK; Kartman CE. Efficacy and safety of baricitinib in patients with rheumatoid arthritis and an inadequate response to conventional disease-modifying antirheumatic drugs: a United States subpopulation analysis from two phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1965-1966', '10.1007/s40744-018-0110-x', 'https://link.springer.com/article/10.1007/s40744-018-0110-x/fulltext.html']\n",
      "['9257594', 'Fleischmann R; Alam J; Arora V; Bradley JD; Schlichting DE; Muram D. Safety and efficacy of baricitinib in elderly patients with moderate to severe rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1970-1971', '10.1002/art.39977', '']\n",
      "['9258326', 'Kavanaugh A; Helt C; Muram D; Alam J; Arora V; Pinto Correia AL; De La Torre I; Van Vollenhoven R. Concomitant use of conventional synthetic DMARDs and response to baricitinib. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp228-229', '10.1136/annrheumdis-2017-eular.1342', '']\n",
      "['9262382', 'Kremer JM; Schiff M; Muram D; Zhong J; Alam J; Genovese MC. Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2017-000581', '']\n",
      "['9736687', '. Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids. Rheumatology and therapy. (2018) 5 2 pp525-536', '10.1007/s40744-018-0128-0', 'https://link.springer.com/article/10.1007/s40744-018-0128-0/fulltext.html']\n",
      "['9738845', 'Wells AF; Greenwald M; Bradley JD; Alam J; Arora V; Kartman CE. Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: a Subset Analysis. Rheumatology and therapy. (2018) 5 1 pp43-55', '10.1007/s40744-018-0110-x', 'https://link.springer.com/article/10.1007/s40744-018-0110-x/fulltext.html']\n",
      "['9740591', 'Bingham CO; Gaich CL; Delozier AM; Engstrom KD; Naegeli AN; De Bono S; Banerjee P; Taylor PC. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials. (2019) 20 1 pp', '10.1186/s13063-019-3272-0', 'http://link.springer.com/article/10.1186/s13063-019-3272-0/fulltext.html']\n",
      "['9742012', 'van Vollenhoven Ronald; Helt Cameron; Arora Vipin; Zhong Jinglin; Correia Ana Pinto; de la Torre Inma; Muram David. Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids. Rheumatology and therapy. (2018) 5 2 pp525-536', '10.1007/s40744-018-0128-0', 'https://link.springer.com/article/10.1007/s40744-018-0128-0/fulltext.html']\n",
      "['9742551', 'Bacci ED; DeLozier AM; Lin C-Y; Gaich CL; Zhang X; Rooney T; de Bono S; Hoffman R; Wyrwich KW. Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis. Health and quality of life outcomes. (2017) 15 1 pp', '10.1186/s12955-017-0807-5', 'http://link.springer.com/content/pdf/10.1186/s12955-017-0807-5.pdf']\n",
      "['11087206', 'Caporali R; Aletaha D; Sanmarti R; Takeuchi T; Mo D; Haladyj E; Zaremba-Pechmann L; Taylor PC. LONG-TERM EFFICACY of BARICITINIB in PATIENTS with RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE to CSDMARDS: RESULTS from RA-BEYOND UP to 7 YEARS of TREATMENT. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp630-631', '10.1136/annrheumdis-2022-eular.4546', '']\n",
      "['9257393', 'Takeuchi T; Genovese M; Haraoui B; Li Z; Xie L; Klar R; Correia AP; Otawa S; Lopez-Romero P; De La Torre I; Rooney T; Smolen J. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) 45 7 pp1054', '10.1136/annrheumdis-2018-eular.2000', '']\n",
      "['9262661', 'Takeuchi T; Genovese MC; Haraoui B; Li Z; Xie L; Klar R; Correia AP; Otawa S; Lopez-Romero P; De La Torre I; Rooney T; Smolen JS. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp988-989', '10.1136/annrheumdis-2018-eular.2000', '']\n",
      "['9738721', 'Genovese MC; Dougados M; Schwartzman S; Schlichting D; Beattie S; Xie L; Cardoso A; Smolen JS. Efficacy of baricitinib in patients with rheumatoid arthritis who failed 2 or more DMARDs. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp980', '10.1136/annrheumdis-2018-eular.1889', '']\n",
      "['11085868', 'Pope Janet E; Lee Yvonne C; Curtis Jeffrey R; Mo Daojun; Xie Li; Dickson Christina L; Schlichting Douglas E; Cardoso Anabela; Simon Lee S; Taylor Peter C. Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: a Post Hoc Analysis of Phase 3 Trials of Baricitinib. ACR open rheumatology. (2022) 4 3 pp254-258', '10.1002/acr2.11380', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11380']\n",
      "['11088665', 'Pope JE; Lee YC; Curtis JR; Mo D; Xie L; Dickson CL; Schlichting DE; Cardoso A; Simon LS; Taylor PC. Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: a Post Hoc Analysis of Phase 3 Trials of Baricitinib. . (2021)   pp', '10.1002/acr2.11380', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11380']\n",
      "['9256992', 'van der Heijde D; Durez P; Schett G; Naredo E; Ostergaard M; Meszaros G; De Leonardis F; de la Torre I; Lopez-Romero P; Schlichting D; Nantz E; Fleischmann R. Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study. Clinical rheumatology. (2018) 37 9 pp2381-2390', '10.1007/s10067-018-4221-0', 'http://link.springer.com/article/10.1007/s10067-018-4221-0/fulltext.html']\n",
      "['9258257', 'Fleischmann R; Takeuchi T; Schiff M; Schlichting D; Xie L; Issa M; Stoykov I; Lisse JR; Martinez-Osuna P; Rooney T; Zerbini CA. Effects of baricitinib on patients who stop methotrexate monotherapy and switch to baricitinib monotherapy. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp789-790', '10.1136/annrheumdis-2017-eular.1334', '']\n",
      "['9258565', 'Takeuchi T; Fleischmann R; Schiff M; Issa M; Macias W; Rooney T; Zuckerman S; Schlichting D; McInnes I. Characterization of changes in lymphocyte subsets in baricitinib-treated patients with early, DMARD naive, rheumatoid arthritis in a phase 3 study. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp1147', '10.1136/annrheumdis-2017-eular.1336', '']\n",
      "['9261827', 'Fleischmann R; Takeuchi T; Schlichting DE; Macias WL; Rooney T; Gurbuz S; Stoykov I; Beattie SD; Kuo W-L; Schiff M. Baricitinib, methotrexate, or baricitinib plus methotrexate in patients with early rheumatoid arthritis WHO had received limited or no treatment with disease-modifying anti-rheumatic drugs (dmards): phase 3 trial results. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.39953', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39953']\n",
      "['9262468', 'Van Der Heijde D; Durez P; Schett G; Naredo E; Ostergaard M; Meszaros G; Bello N; De La Torre I; Lopez-Romero P; Schlichting D; Nantz E; Fleischmann R. Structural damage progression in patients treated with methotrexate, baricitinib monotherapy or baricitinib + methotrexate based on their level of clinical response in the phase 3 RA-begin study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp233', '10.1136/annrheumdis-2017-eular.2223', '']\n",
      "['9262693', 'Martinez Gamboa L; Bang H; Issa M; Zuckerman S; Cardoso A; Holzkaemper T; De Leonardis F; De La Torre I; Tanaka Y; Feist E. Autoantibody profiling for response to baricitinib in patients with rheumatoid arthritis and no or limited exposure to methotrexate. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp276-277', '10.1136/annrheumdis-2018-eular.1927', '']\n",
      "['9260556', 'Soubrier M; Pu‚Äö√†√∂¬¨¬©chal X; Sibilia J; Mariette X; Meyer O; Combe B; Flipo RM; Mulleman D; Berenbaum F; Zarnitsky C; Schaeverbeke T; Fardellone P; Dougados M. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Rheumatology (Oxford, England). (2009) 48 11 pp1429-1434', '10.1093/rheumatology/kep261', 'http://academic.oup.com/rheumatology/article-pdf/48/11/1429/5064201/kep261.pdf']\n",
      "['9736491', 'van der Heijde Desiree; Durez Patrick; Schett Georg; Naredo Esperanza; Ostergaard Mikkel; Meszaros Gabriella; De Leonardis Francesco; de la Torre Inmaculada; Lopez-Romero Pedro; Schlichting Douglas; Nantz Eric; Fleischmann Roy. Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study. Clinical rheumatology. (2018) 37 9 pp2381-2390', '10.1007/s10067-018-4221-0', 'http://link.springer.com/article/10.1007/s10067-018-4221-0/fulltext.html']\n",
      "['9738732', 'Martinez Gamboa L; Bang H; Issa M; Zuckerman S; Cardoso A; Holzkaemper T; De Leonardis F; De La Torre I; Tanaka Y; Feist E. Autoantibody profiling for response to baricitinib in patients with rheumatoid arthritis and no or limited exposure to methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp276-277', '10.1136/annrheumdis-2018-eular.1927', '']\n",
      "['9739463', 'Schiff M; Takeuchi T; Gaich C; DeLozier AM; Schlichting D; Kuo W-L; Durez P; Carmack T; Won J-E; Fleischmann R. Patient-reported outcomes from a phase 3 study of baricitinib in patients with early rheumatoid arthritis who had received limited or no treatment with disease-modifying anti-rheumatic drugs. Annals of the rheumatic diseases. (2016) 75  pp419-', '10.1136/annrheumdis-2016-eular.1248', '']\n",
      "['9739591', 'Fautrel B; Zhu B; Taylor PC; Van De Laar M; Emery P; De Leonardis F; Gaich CL; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R. Comparative effectiveness in pain and HAQ-DI improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csDMARD-na‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚Äö√¢¬ßve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC). Arthritis and rheumatology. (2018) 70 Supplement 9 pp650-651', '10.1136/annrheumdis-2018-eular.1997', '']\n",
      "['9740461', 'Fleischmann R; Takeuchi T; Schlichting DE; Macias WL; Rooney T; Gurbuz S; Stoykov I; Beattie SD; Kuo WL; Schiff M. Baricitinib, methotrexate, or baricitinib plus methotrexate in patients with early rheumatoid arthritis who had received limited/no treatment with disease-modifying anti-rheumatic drugs: phase 3 trial results. Swiss medical weekly. (2016) 146  pp3S-', '10.1136/annrheumdis-2016-eular.1248', '']\n",
      "['9740710', 'Fleischmann R; Schiff M; Kvien TK; Gabay C; Durez P; Cardoso A; Zhong J; Chen Y-F; Workman J; Takeuchi T. Early versus delayed start of baricitinib in patients with rheumatoid arthritis in a phase 3 trial of patients Na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¢¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö‚â§ve to methotrexate treatment. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp306-307', '10.1136/annrheumdis-2019-eular.975', '']\n",
      "['9741157', 'NCT01711359. A Study in Participants With Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01711359. (2012)   pp', '10.1358/dot.2012.48.8.1855926', '']\n",
      "['9742053', 'Fleischmann R; Takeuchi T; Schlichting DE; Macias WL; Rooney T; Gurbuz S; Stoykov I; Beattie SD; Kuo WL; Schiff M. Baricitinib, methotrexate, or baricitinib plus methotrexate in patients with early rheumatoid arthritis who had received limited/no treatment with disease-modifying anti-rheumatic drugs: phase 3 trial results. Swiss medical weekly. (2016) Conference: Annual Meeting Swiss Society of Rheumatology, SGR/SSR 2016. Switzerland. 146 Supplement 217 pp3S', '10.1002/art.39953', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39953']\n",
      "['9742714', 'EUCTR2012-002324-32-DE. A Phase 3 Study in Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002324-32-DE. (2012)   pp', '10.1358/dot.2012.48.8.1855926', '']\n",
      "['11084411', 'Taylor PC; Alten R; Alvaro Gracia JM; Kaneko Y; Walls C; Quebe A; Jia B; Bello N; Terres JR; Fleischmann R. Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy. RMD open. (2022) 8 1 pp', '10.1136/rmdopen-2021-001994', '']\n",
      "['11085663', 'Lopez-Romero P; de la Torre I; Haladyj E; Aletaha D; Smolen JS. Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2022) 81 5 pp622-631', '10.1136/annrheumdis-2021-221323', '']\n",
      "['11088787', 'Taylor PC; Alten R; √Ålvaro Gracia JM; Kaneko Y; Walls C; Quebe A; Jia B; Bello N; Terres JR; Fleischmann R. Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy. . (2022) 8 1 pp', '10.1136/rmdopen-2021-001994', '']\n",
      "['9258395', 'Winthrop KL; Lindsey S; Weinblatt M; Takeuchi T; Hyslop D; Issa M; Chen L; Bradley J; Dickson C; Fleischmann R. Herpes zoster in patients with moderate to severe rheumatoid arthritis treated with baricitinib. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4042-4044', '10.1002/art.39977', '']\n",
      "['9262387', 'Ishiguro N; Dougados M; Cai Z; Zhu B; Ishida M; Sato M; Gaich C; Quebe A; Stoykov I; Tanaka Y. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: post hoc analyses of overall and Japanese results from two phase 3 clinical trials. Modern rheumatology. (2018)   pp1-10', '10.1080/14397595.2017.1422232', '']\n",
      "['9262512', 'Van Der Heijde D; Schiff M; Tanaka Y; Klar R; Xie L; Meszaros G; Ishii T; Casillas M; Ortmann R; Emery P. Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp510-511', '10.1136/annrheumdis-2017-eular.1324', '']\n",
      "['9737562', 'Moeller B; Durez P; Finckh A; Lopez-Romero P; Perrier C; De Leonardis F; De La Torre I; Taylor PC. Association between baseline haemoglobin levels and radiographic joint damage progression in patients with rheumatoid arthritis treated with baricitinib or standard of care. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1117-1118', '10.1136/annrheumdis-2019-eular.976', '']\n",
      "['9737744', 'Ishiguro Naoki; Dougados Maxime; Cai Zhihong; Zhu Baojin; Ishida Masato; Sato Masayo; Gaich Carol; Quebe Amanda; Stoykov Ivaylo; Tanaka Yoshiya. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: post hoc analyses of overall and Japanese results from two phase 3 clinical trials. Modern rheumatology. (2018) 28 6 pp950-959', '10.1080/14397595.2017.1422232', '']\n",
      "['9738843', \"Kaneko Yuko; Takeuchi Tsutomu; Cai Zhihong; Sato Masayo; Awakura Kenta; Gaich Carol; Zhu Baojin; Guo Jiaying; Tanaka Yoshiya. Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: a post hoc analysis of overall and Japanese results from phase 3 clinical trials. Modern rheumatology. (2018) 28 6 pp960-967\", '10.1080/14397595.2017.1422304', '']\n",
      "['9739009', 'Weinblatt M; Taylor P; Tanaka Y; Keystone E; Schiff M; Fleischmann R; Yang L; Arora V; De Bono; Holzkaemper T; Schlichting D; Takeuchi T. Response to baricitinib at 4 weeks predicts response at 12 and 24 weeks in patients with rheumatoid arthritis: results from two phase 3 studies. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp255-256', '10.1136/annrheumdis-2016-eular.1597', '']\n",
      "['9741240', '. Association between baseline hemoglobin levels and radiographic joint damage progression in patients with rheumatoid arthritis treated with baricitinib or standard of care. Swiss medical weekly. (2019) 149  pp8S-', '10.1136/annrheumdis-2019-eular.976', '']\n",
      "['11083603', 'Smolen JS; Xie L; Jia B; Taylor PC; Burmester GR; Tanaka Y; Elias A; Cardoso A; Ortmann R; Walls C; Dougados M. Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1016', '10.1136/annrheumdis-2020-eular.2398', '']\n",
      "['11083901', 'Lopez-Romero P; de la Torre I; Haladyj E; Aletaha D; Smolen JS. Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis. . (2022)   pp', '10.1136/annrheumdis-2021-221323', '']\n",
      "['11086070', 'Smolen J; Xie L; Jia B; Taylor P; Burmester G; Tanaka Y; Elias A; Cardoso A; Ortmann R; Walls C; Dougados M. Efficacy of baricitinib in patients with moderateto-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp249', '10.1136/annrheumdis-2020-eular.2398', '']\n",
      "['11086102', 'Smolen JS; Xie L; Jia B; Taylor PC; Burmester G; Tanaka Y; Elias A; Cardoso A; Ortmann R; Walls C; Dougados M; Barragan JA. Efficacy of baricitinib in patients with moderateto-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study. Journal of clinical rheumatology. (2021) 27 SUPPL 1 ppS110', '10.1093/rheumatology/keaa576', 'http://academic.oup.com/rheumatology/article-pdf/60/5/2256/37935753/keaa576.pdf']\n",
      "['9741558', 'van der Heijde Desiree; Schiff Michael; Tanaka Yoshiya; Xie Li; Meszaros Gabriella; Ishii Taeko; Casillas Marta; Ortmann Robert A; Emery Paul. Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. RMD open. (2019) 5 1 ppe000898', '10.1136/rmdopen-2019-000898', '']\n",
      "['9741558', 'van der Heijde Desiree; Schiff Michael; Tanaka Yoshiya; Xie Li; Meszaros Gabriella; Ishii Taeko; Casillas Marta; Ortmann Robert A; Emery Paul. Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. RMD open. (2019) 5 1 ppe000898', '10.1136/rmdopen-2019-000898', '']\n",
      "['11084436', 'van der Heijde D; Kartman CE; Xie L; Beattie S; Schlichting D; Mo D; Durez P; Tanaka Y; Fleischmann R. Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: results from RA-BEYOND. Journal of rheumatology. (2021) 49 2 pp133-141', '10.3899/jrheum.210346', '']\n",
      "['9257387', 'Tanaka Y; Atsumi T; Amano K; Harigai M; Ishii T; Kawaguchi O; Rooney TP; Akashi N; Takeuchi T. Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: subgroup analyses of four multinational phase 3 randomized trials. Modern rheumatology. (2018) 28 4 pp583-591', '10.1080/14397595.2017.1392057', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1392057']\n",
      "['9258136', 'Genovese M; Takeuchi T; Xie L; Issa M; Pinto Correia A; Rooney T; Emoto K; Smolen J. Baricitinib dose step-down following disease control in patients with rheumatoid arthritis. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp30', '10.1136/annrheumdis-2016-eular.1610', '']\n",
      "['9737878', 'Taylor Peter C; Kremer Joel M; Emery Paul; Zuckerman Steven H; Ruotolo Giacomo; Zhong Jinglin; Chen Lei; Witt Sarah; Saifan Chadi; Kurzawa Monika; Otvos James D; Connelly Margery A; Macias William L; Schlichting Douglas E; Rooney Terence P; de Bono Stephanie; McInnes Iain B. Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies. Annals of the rheumatic diseases. (2018) 77 7 pp988-995', '10.1136/annrheumdis-2017-212461', '']\n",
      "['9738585', 'Van Der Heijde D; Schiff M; Tanaka Y; Klar R; Xie L; Meszaros G; Ishii T; Casillas M; Ortmann R; Emery P; Moyano S. Low joint damage progression rates in baricitinib-treated patients with rheumatoid arthritis. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS84', '10.1136/rmdopen-2019-000898', '']\n",
      "['9738621', 'Takeuchi T; Genovese M; Haraoui B; Li Z; Xie L; Klar R; Correia AP; Otawa S; Lopez-Romero P; De La Torre I; Rooney T; Smolen J. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1054', '10.1136/annrheumdis-2018-eular.2000', '']\n",
      "['9738658', 'Smolen JS; Dougados M; Takeuchi T; Genovese MC; Haraoui B; Klar R; Kavanaugh A; Alonso RB; Dudler J; Taylor PC; Nash P; Zerbini CA; Durez P; Pum G; Arthanari S; De Leonardis F; Van Vollenhoven R. Durability, maintenance and effects of dose reduction following prolonged treatment with baricitinib. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii144-iii145', '10.1093/rheumatology/key075.457', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.457/24768390/key075.457.pdf']\n",
      "['9738695', 'Tanaka Yoshiya; Atsumi Tatsuya; Amano Koichi; Harigai Masayoshi; Ishii Taeko; Kawaguchi Osamu; Rooney Terence P; Akashi Naotsugu; Takeuchi Tsutomu. Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: subgroup analyses of four multinational phase 3 randomized trials. Modern rheumatology. (2018) 28 4 pp583-591', '10.1080/14397595.2017.1392057', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1392057']\n",
      "['9740720', 'Chen Y-H; Chen Y-M; Smolen JS; Takeuchi T; Muller R; Walker D; Liao R; Perrier C; Wu W-S; Winthrop K. Incidence rate and characterization of herpes zoster in patients with moderate-tosevere rheumatoid arthritis: an update from baricitinib clinical studies. Annals of the rheumatic diseases. (2019) 78  pp755-', '10.1136/annrheumdis-2019-eular.1130', '']\n",
      "['9742348', 'Chen Y-H; Chen Y-M; Smolen JS; Takeuchi T; Muller R; Walker D; Liao R; Perrier C; Wu W-S; Winthrop K. Incidence rate and characterization of herpes zoster in patients with moderate-tosevere rheumatoid arthritis: an update from baricitinib clinical studies. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp755', '10.1136/annrheumdis-2019-eular.1130', '']\n",
      "['9737078', 'NCT03915964. A study of baricitinib (LY3009104) in participants with rheumatoid arthritis. https://clinicaltrials.gov/show/NCT03915964. (2019)   pp', '10.31525/ct1-nct03915964', '']\n",
      "['9258026', 'Dougados M; Van Der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie S; De La Torre I; Rooney T; Schlichting D; De Bono S; Emery P; Bookman A. Baricitinib, an oral janus kinase (JAK)1/JAK2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to cdmard therapy: results of the phase 3 RA-build study. Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1188', '10.1136/annrheumdis-2015-eular.6539', '']\n",
      "['9258133', 'Genovese M; Van Der Heijde D; Dougados M; Chen Y; Greenwald M; Drescher E; Klar R; Xie L; De La Torre I; Rooney T; Witt S; Schlichting D; De Bono S; Emery P. Baricitinib inhibits radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis (RA) and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS). Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp32', '10.1136/rmdopen-2018-000662', '']\n",
      "['9261810', 'Emery P; Gaich CL; DeLozier AM; De Bono S; Liu J; Chang C; Dougados M. Patient-reported outcomes from a phase 3 study of baricitinib in patients with rheumatoid arthritis with inadequate response to conventional synthetic disease-modifying antirheumatic drugs. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/rmdopen-2016-000410', '']\n",
      "['9261912', 'Dougados M; Van Der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie S; De La Torre I; Rooney T; Schlichting D; De Bono S; Emery P. Baricitinib, an oral janus kinase (jak)1/jak2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to cdmard therapy: results of the phase 3 ra-build study. Annals of the rheumatic diseases. (2015) 74  pp79-80', '10.1136/annrheumdis-2015-eular.6539', '']\n",
      "['9262199', 'Dougados M; van der Heijde D; Chen YC; Greenwald M; Drescher E; Liu J; Beattie S; Witt S; de la Torre I; Gaich C; Rooney T; Schlichting D; de Bono S; Emery P. Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study. Annals of the rheumatic diseases. (2017) 76 1 pp88-95', '10.1136/annrheumdis-2016-210094', '']\n",
      "['9263606', 'Dougados M; Van Der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie SD; De La Torre I; Rooney T; Schlichting DE; De Bono S; Emery P; Smolen JS. Baricitinib, an oral janus kinase (JAK)1/JAK2 inhibitor, in patients with active rheumatoid arthritis (RA) and an inadequate response to cDMARD therapy: results of the phase-3 RA-build study. Journal fur mineralstoffwechsel. (2015) Conference: Jahrestagung der Osterreichischen Gesellschaft fur Rheumatologie und Rehabilitation 2015. Austria. 22 4 pp114-115', '10.1136/annrheumdis-2015-eular.6539', '']\n",
      "['9738073', 'Van Der Heijde; Dougados M; Chen Y C; Greenwald M; Drescher E; Klar R; Xie L; De La Torre; Rooney T P; Witt S; Schlichting D; DeBono S; Emery P. Baricitinib inhibits radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis (RA) and an inadequate response to CSDMARDS. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp244-245', '10.1136/annrheumdis-2016-eular.1611', '']\n",
      "['9738123', 'Van Der Heijde D; Dougados M; Chen Y-C; Greenwald M; Drescher E; Klar R; Xie L; De La Torre I; Rooney TP; Witt SL; Schlichting DE; De Bono S; Emery P. Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic Disease-Modifying antirheumatic drugs. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2018-000662', '']\n",
      "['9738253', 'Takeuchi T; Genovese M; Xie L; Issa M; Pinto Correia AL; Rooney T; Emoto K; Smolen J. Baricitinib dose step-down following disease control in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp144-', '10.1136/annrheumdis-2016-eular.1610', '']\n",
      "['9739553', 'Fleischmann R; Genovese MC; Cardoso A; Sun L; Chen Y-F; Walls CD; Schlichting DE; Takeuchi T; Dougados M; Smolen JS; Curtis JR. Longitudinal efficacy analysis of patients with active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: response following rescue from baricitinib 2mg to 4mg once-daily. Arthritis and rheumatology. (2018) 70 Supplement 9 pp622-624', '10.1136/annrheumdis-2018-eular.1889', '']\n",
      "['9739795', 'EUCTR2012-002339-27-IT. A Phase 3 Study in Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002339-27-IT. (2012)   pp', '10.1186/isrctn27093749', '']\n",
      "['9740539', '. Effect of baricitinib on joint-related biomarkers in patients with moderate-to-severe rheumatoid arthritis. Arthritis and rheumatology. (2018) 70  pp2264-', '10.1186/s13075-020-02340-7', 'https://link.springer.com/article/10.1186/s13075-020-02340-7/fulltext.html']\n",
      "['9741159', 'NCT01721057. A Study in Moderate to Severe Rheumatoid Arthritis Participants. https://clinicaltrials.gov/show/NCT01721057. (2012)   pp', '10.1358/dot.2012.48.8.1855926', '']\n",
      "['9742054', 'Emery P; Krogulec M; Blanco Alonso R; Rossini M; Raeman F; Walker D; Petru Ghizdavescu A; Irto I; Luz Rentero M; Casillas M; De La Torre I; Dougados M. Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inappropriate response to conventional diseasemodifying anti-rheumatic drugs: 24-week phase 3 RA-BUILD study summary results. Swiss medical weekly. (2016) Conference: Annual Meeting Swiss Society of Rheumatology, SGR/SSR 2016. Switzerland. 146 Supplement 217 pp3S', '10.1016/s1169-8330(16)30402-1', '']\n",
      "['9742096', 'Thudium CS; Bay-Jensen AC; Cahya S; Dow ER; Karsdal MA; Koch AE; Zhang W; Benschop RJ. Effect of baricitinib on joint-related biomarkers in patients with moderate-to-severe rheumatoid arthritis. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2264', '10.1186/s13075-020-02340-7', 'https://link.springer.com/article/10.1186/s13075-020-02340-7/fulltext.html']\n",
      "['9742542', 'Emery P; Blanco R; Maldonado Cocco; Chen Y C; Gaich C L; Delozier A M; De Bono; Liu J; Rooney T; Chang C H C; Dougados M. Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD open. (2017) 3 1 ppe000410', '10.1136/rmdopen-2016-000410', '']\n",
      "['9261823', 'Kremer J; Dougados M; Genovese MC; Emery P; Yang L; De Bono S; Holzkaemper T; Iikuni N; Schlichting DE; Smolen JS. Response to baricitinib at 4 weeks predicts response at 12 and 24 weeks in patients with rheumatoid arthritis: results from two phase 3 studies. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1597', '']\n",
      "['9263549', 'Emery P; McInnes I; Genovese MC; Smolen JS; Kremer J; Dougados M; Schlichting DE; Rooney T; Issa M; De Bono S; Macias WL; Rogai V; Zuckerman SH; Taylor PC. Characterisation of changes in lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis in two phase 3 studies. Annals of the rheumatic diseases. Conference: 36th european workshop for rheumatology research. York united kingdom. Conference start: 20160225. Conference end: 20160227. Conference publication: (var.pagings). (2016) 75  ppA62', '10.1136/annrheumdis-2016-209124.147', '']\n",
      "['11085147', 'Wells AF; Jia B; Xie L; Valenzuela GJ; Keystone EC; Li Z; Quebe AK; Griffing K; Otawa S; Haraoui B. Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2¬†mg in Patients with Active Rheumatoid Arthritis: post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study. Rheumatology and therapy. (2021) 8 2 pp987-1001', '10.1007/s40744-021-00317-9', 'https://link.springer.com/article/10.1007/s40744-021-00317-9/fulltext.html']\n",
      "['11088870', 'Wells AF; Jia B; Xie L; Valenzuela GJ; Keystone EC; Li Z; Quebe AK; Griffing K; Otawa S; Haraoui B. Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2[REPLACEMENT CHARACTER]mg in Patients with Active Rheumatoid Arthritis: post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study. . (2021) 8 2 pp987', '10.1007/s40744-021-00317-9', 'https://link.springer.com/article/10.1007/s40744-021-00317-9/fulltext.html']\n",
      "['9740150', 'PER-042-13. A STUDY OF SARILUMAB AND METHOTREXATE (MTX) VERSUS ETANERCEPT AND MTX IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-042-13. (2014)   pp', '10.26226/morressier.56e174d9d462b8028d88ace2', '']\n",
      "['9740223', 'EUCTR2012-001984-66-LV. An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-001984-66-LV. (2013)   pp', '10.1186/isrctn49682259', '']\n",
      "['9737261', \"Genovese MC; Spindler A; Sagawa A; Park W; Dudek A; Kivitz A; Chao J; Chan LSM; Barchuk W; Nirula A. Safety and efficacy of LY3337641, a Bruton's tyrosine kinase inhibitor in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled, 2-part phase 2 study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1109-1110\", '10.1136/annrheumdis-2019-eular.2672', '']\n",
      "['9263530', 'Peterfy C; Emery P; Tak PP; ‚àö√≤stergaard M; DiCarlo J; Otsa K; Navarro Sarabia F; Pavelka K; Bagnard MA; Gylvin LH; Bernasconi C; Gabriele A. MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: Results from the randomised, placebo-controlled, double-blind RA-SCORE study. Annals of the rheumatic diseases. (2016) 75  1 pp170-177', '10.1136/annrheumdis-2014-206015', '']\n",
      "['9739769', 'EUCTR2007-001585-33-NL. A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (MabThera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in patients with rheumatoid arthritis and inadequate response to methotrexate - the SCORE study. - SCORE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001585-33-NL. (2007)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9741016', 'NCT00578305. A Study of Rituximab (MabThera¬¨√Ü/Rituxan¬¨√Ü) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. https://clinicaltrials.gov/show/NCT00578305. (2007)   pp', '10.31525/ct1-nct04038970', '']\n",
      "['9260997', 'Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial. Journal of rheumatology. (2014) 41 4 pp648-657', '10.3899/jrheum.130945', '']\n",
      "['9261228', 'Kivitz A; Schechtman J; Texter M; Fichtner A; Chartash E. Assessment of immune responses to pneumococcal and influenza vaccines in patients with rheumatoid arthritis receiving certolizumab pegol. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1097/01.mib.0000438824.11624.d5', '']\n",
      "['9741118', 'NCT00993668. Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines. https://clinicaltrials.gov/show/NCT00993668. (2009)   pp', '10.1097/01.mib.0000438824.11624.d5', '']\n",
      "['9257560', 'Genovese MC; Durez P; Fleischmann R; Tanaka Y; Furst DE; Yamanaka H; Vasyutin I; Kaviarasu T; Korneva E; Koloda D; Takeuchi T. Olokizumab treatment of both western and asian patients with rheumatoid arthritis who have failed anti-TNF treatment results in sustained improvements in patient-reported outcomes. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1981-1983', '10.1016/j.jval.2016.09.1141', '']\n",
      "['9257575', 'Reeve R; Weilert D; Korneva E; Koloda D; Fatenejad S. Dose-response modeling is a useful tool to determine doses for phase 3: experience from olokizumab. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1980-1981', '10.1136/annrheumdis-2016-eular.2066', '']\n",
      "['9261048', 'Genovese MC; Fleischmann R; Furst D; Janssen N; Carter J; Dasgupta B; Bryson J; Duncan B; Zhu W; Pitzalis C; Durez P; Kretsos K. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the rheumatic diseases. (2014) 73 9 pp1607-1615', '10.1136/annrheumdis-2013-204760', '']\n",
      "['9262078', 'Genovese MC; Durez P; Fleischmann R; Tanaka Y; Furst DE; Yamanaka H; Vasyutin I; Kaviarasu T; Korneva E; Koloda D; Takeuchi T. Olokizumab treatment of both western and asian patients with rheumatoid arthritis who have failed anti-TNF treatment results in sustained improvements in patient-reported outcomes. Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA543-A544', '10.1016/j.jval.2016.09.1141', '']\n",
      "['9738875', 'Genovese M; Fleischmann R; Furst D; Janssen N; Carter J; Dasgupta B; Pitzalis C; Vasyutin I; Kaviarasu T; Krotkova A; Durez P. Improvements in patient-reported outcomes with olokizumab treatment in patients with active, moderate to severe rheumatoid arthritis who had failed previous anti-TNF therapy: results from the RA0056 double-blind, randomized controlled study, and RA0057, its open-label extension. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp718-719', '10.1136/annrheumdis-2016-eular.3602', '']\n",
      "['9739097', 'Kirwan J; Coteur G; Dures E; Nicklin J; Bryson J; Hewlett S. Validity and responsiveness of the bristol rheumatoid arthritis fatigue multidimensional questionnaire (BRAF-MDQ) in a randomized controlled clinical trial. Value in health. (2014) 17 7 ppA568-A569', '10.1016/j.jval.2014.08.1896', '']\n",
      "['9739124', 'Reeve R; Krotkova A; Weilert D; Fatenejad S. Dose response modeling is a useful tool to determine doses for phase 3: experience from olokizumab. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1031-1032', '10.1136/annrheumdis-2016-eular.2066', '']\n",
      "['9740504', '. Validity and responsiveness of the bristol rheumatoid arthritis fatigue multidimensional questionnaire (BRAF-MDQ) in a randomized controlled clinical trial. Value in health. (2014) 17 7 ppA568-A569', '10.1016/j.jval.2014.08.1896', '']\n",
      "['9740997', 'NCT01242488. Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. https://clinicaltrials.gov/show/NCT01242488. (2010)   pp', '10.1016/s1098-3015(11)72191-x', '']\n",
      "['9260770', \"O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E; CSP 551 RACAT Investigators. Therapies for active rheumatoid arthritis after methotrexate failure. New England journal of medicine. (2013) 369 4 pp307-318\", '10.1056/nejmoa1303006', '']\n",
      "['9261131', \"O'Dell JR; Mikuls TR; Taylor T; Ahluwalia V; Brophy M; Warren S; Lew R; Phibbs C; Anis AH; Cannella AC; Kunkel GA; Erickson AR; Keystone E. Rheumatoid arthritis comparison of active therapies in methotrexate suboptimal responders: Validation of the strategy of conventional disease modifying anti-rheumatic drugs before biologicals. Arthritis and rheumatism. (2012) 64  ppS551-S552\", '10.1136/annrheumdis-2013-eular.752', '']\n",
      "['9261739', \"Mikuls TR; Coburn B; Sayles H; Yu F; Brophy M; O'Dell JR; Klassen LW; Thiele GM. Antibody to malondialdehyde-acetaldehyde (MAA) adducts serve as biomarkers of treatment response in rheumatoid arthritis. Arthritis and Rheumatology. (2015) 67 no pagination pp\", '10.1002/art.38969', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.38969']\n",
      "['9262529', \"Johnson T; Mikuls TR; Sayles H; Duryee MJ; Thiele GM; Brophy M; O'Dell JR. Favorable changes in lipid profile with additive DMARD therapy in rheumatoid arthritis patients failing methotrexate monotherapy. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp3527-3528\", '10.1002/art.39977', '']\n",
      "['9263596', \"Quach LT; Chang BH; Brophy MT; Soe Thwin S; Hannagan K; O'Dell JR. Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events. Rheumatology (oxford, england). (2017) 56 3 pp378-383\", '10.1093/rheumatology/kew412', 'http://academic.oup.com/rheumatology/article-pdf/56/3/378/10630953/kew412.pdf']\n",
      "['9736686', \"Leatherman S; Wu H; Keystone E; Brophy M; O'Dell J. Compliance in the rheumatoid arthritis comparison of active therapies trial: triple vs etanercept. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1033\", '10.4172/2161-1149.1000227', '']\n",
      "['9738817', \"Bansback N; Phibbs C; Sun H; O'Dell J R; Brophy M; Keystone E C; Leatherman S; Mikuls T R; Anis A H. Cost-effectiveness of adding etanercept vs. Sulfasalazine and hydroxychloroquine to methotrexate therapy: a randomized noninferiority trial. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1214-S1215\", '10.7326/m16-0713', 'https://www.acpjournals.org/doi/pdf/10.7326/M16-0713']\n",
      "['9740978', 'NCT00405275. Rheumatoid Arthritis: comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00405275. (2006)   pp', '10.1016/s1098-3015(11)72224-0', '']\n",
      "['9741424', \"Quach LT; Bei-Hung Chang; Brophy MT; Thwin SS; Hannagan K; O'Dell JR. Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events. Rheumatology. (2017) 56 3 pp378-383\", '10.1093/rheumatology/kew412', 'http://academic.oup.com/rheumatology/article-pdf/56/3/378/10630953/kew412.pdf']\n",
      "['9260307', 'Bruyn GA; Tate G; Caeiro F; Maldonado-Cocco J; Westhovens R; Tannenbaum H; Bell M; Forre O; Bjorneboe O; Tak PP; Abeywickrama KH; Bernhardt P; van Riel PL; RADD Study Group. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study. Annals of the rheumatic diseases. (2008) 67 8 pp1090-1095', '10.1136/ard.2007.078808', '']\n",
      "['9256920', 'Strand V; Burmester GR; Ogale S; Devenport J; John A; Emery P. Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study. Rheumatology (Oxford, England). (2012) 51 10 pp1860-1869', '10.1093/rheumatology/kes131', 'http://academic.oup.com/rheumatology/article-pdf/51/10/1860/5152234/kes131.pdf']\n",
      "['9260374', 'Emery P; Keystone E; Tony HP; Cantagrel A; van Vollenhoven R; Sanchez A; Alecock E; Lee J; Kremer J. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Annals of the rheumatic diseases. (2008) 67 11 pp1516-1523', '10.1136/ard.2008.092932', '']\n",
      "['9260832', 'Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522). Seminars in arthritis and rheumatism. (2012) 42 2 pp131-139', '10.1016/j.semarthrit.2012.01.004', '']\n",
      "['9737296', 'Hall S; Youssef P; Kissel K; Vernon E; John A; Emery P. Tocilizumab improves health-related quality of life (QoL) in patients with rheumatoid arthritis (RA) and inadequate response to prior TNF inhibitor therapy (TNFi-IR): RADIATE. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp98-99', '10.1136/annrheumdis-2012-eular.541', '']\n",
      "['9738737', 'Juhl Pernille; Thudium Christian S; Gudmann Natasja S; Karsdal Morten A; Bay-Jensen Anne-Christine; Siebuhr Anne Sofie. IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study. Clinical and experimental rheumatology. (2018) 36 4 pp568-574', '10.1016/j.semarthrit.2012.01.004', '']\n",
      "['9738969', 'Sanchez Ortiz; Kissel K; Alecock E; Emery P. Tocilizumab improves health-related quality of life in RA patients with inadequate response to prior anti-TNF therapy: the RADIATE study. Journal of clinical rheumatology. (2010) 16 SUPPL. 3 ppS43', '10.1093/rheumatology/kes115', 'http://academic.oup.com/rheumatology/article-pdf/51/suppl_5/v22/5055090/kes115.pdf']\n",
      "['9739061', 'Emery P; Keystone E; Tony H P; Law A; Woodworth T; Kremer J. Tocilizumab significantly improves patient outcomes regardless of prior inadequate response to tumour necrosis factor antagonists in rheumatoid arthritis. Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1136/ard.2008.092932', '']\n",
      "['9739434', 'Juhl P; Siebuhr AS; Thudium C; Gudmann NS; Karsdal M; Bay-Jensen A-C. Effect of tocilizumab combined with methotrexate on blood-based neoepitope biomarkers in the radiate study. Annals of the rheumatic diseases. (2016) 75  pp978-', '10.1136/annrheumdis-2016-eular.4008', '']\n",
      "['9739796', 'EUCTR2005-000884-25-IS. A randomized, double-blind, placebo-controlled, parallel group study of the safety and reduction of signs and symptoms during treatment with MRA versus placebo, in combination with methotrexate in patients with moderate to severe active rheumatoid arthritis and an inadequate response to previous anti-TNF therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-000884-25-IS. (2005)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9741065', 'NCT00106522. A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00106522. (2005)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9257390', 'Panayi GS; Kirkham B; Chaabo K; Hall C; Vincent A; Vasconcelos J; Prevost T; Garrood T; Corrigall V. Results of a single dose ascending firstin-man trial of a novel biologic, human stress protein rasolvir (BIP), in rheumatoid arthritis (RA): The ragulo trial. Inflammation research. (2015) 64  2 SUPPL. 1 ppS99', '10.1136/annrheumdis-2015-eular.3346', '']\n",
      "['9740806', 'Tanaka Yoshiya; Takeuchi Tsutomu; Tanaka Sakae; Kawakami Atsushi; Iwasaki Manabu; Song Yeong Wook; Chen Yi-Hsing; Wei James Cheng-Chung; Lee Sang-Heon; Rokuda Mitsuhiro; Izutsu Hiroyuki; Ushijima Satoshi; Kaneko Yuichiro; Akazawa Rio; Shiomi Teruaki; Yamada Emi. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3). Annals of the rheumatic diseases. (2019) 78 10 pp1320-1332', '10.1136/annrheumdis-2019-215163', '']\n",
      "['9737161', 'Tanaka Y; Takeuchi T; Rokuda M; Izutsu H; Kaneko Y; Shiomi T; Yamada E. Patient- and physician-reported outcomes from RAJ4: a randomised, double-blind, placebo-controlled study of the efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis (RA) who had an inadequate response to methotrexate (mtx). Annals of the rheumatic diseases. (2019) 78  pp756-', '10.1136/annrheumdis-2019-eular.2629', '']\n",
      "['9738262', 'NCT03700021. Response to Treatment With Intravenous Abatacept Adults With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03700021. (2018)   pp', '10.4274/raed.galenos.2020.07078', '']\n",
      "['9256771', 'Kavanaugh A; Smolen JS; Emery P; Keystone E; Strand V; Purcaru O; Van Vollenhoven R. Long-term benefits over more than 4 years of certolizumab pegol combination therapy on workplace and household productivity, and participation in social activities in rheumatoid arthritis: Results from the open-label extension study of rapid. Value in health. (2013) 16  7 ppA570', '10.1016/j.jval.2013.08.1529', '']\n",
      "['9256907', 'Keystone E; Heijde Dv; Mason D; Landew‚àö¬© R; Vollenhoven RV; Combe B; Emery P; Strand V; Mease P; Desai C; Pavelka K. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis and rheumatism. (2008) 58 11 pp3319-3329', '10.1002/art.23964', '']\n",
      "['9257288', 'Keystone E; Landewe R; Van Vollenhoven R; Combe B; Strand V; Mease P; Shaughnessy L; VanLunen B; Van Der Heijde D; Phenix B. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from a 52-week randomized controlled trial and open-label extension study. Journal of rheumatology. (2014) 41  7 pp1454-1455', '10.1093/rheumatology/keu101.024', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i96/9578489/keu101.024.pdf']\n",
      "['9257975', 'Keystone E; Landewe R; Van Vollenhoven R; Combe B; Strand V; Mease PJ; Shaughnessy L; VanLunen B; Van Der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from a 52-week randomized controlled trial and open-label extension study. Arthritis and rheumatism. (2013) 65 var.pagings ppS596-S597', '10.1093/rheumatology/keu101.024', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i96/9578489/keu101.024.pdf']\n",
      "['9260706', 'Keystone EC; Curtis JR; Fleischmann RM; Furst DE; Khanna D; Smolen JS; Mease PJ; Schiff MH; Coteur G; Davies O; Combe B. Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trial. Journal of rheumatology. (2011) 38 6 pp990-996', '10.3899/jrheum.100935', '']\n",
      "['9261086', 'Berenbaum F; Pham T; Fautrel B; Joubert JM; De Chalus T; Riou Franca L; Claudepierre P. Early response to certolizumab pegol in rheumatoid arthritis predicts outcome at one year. Value in health. (2013) 16  7 ppA556', '10.1016/j.jval.2013.08.1452', '']\n",
      "['9261699', 'Keystone E; Landew‚àö¬© R; van Vollenhoven R; Combe B; Strand V; Mease P; Shaughnessy L; VanLunen B; van der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension. Annals of the rheumatic diseases. (2014) 73 12 pp2094-2100', '10.1136/annrheumdis-2013-203695', '']\n",
      "['9263367', 'Keystone EC; Combe B; Smolen J; Strand V; Goel N; van Vollenhoven R; Mease P; Landew‚àö¬© R; Fleischmann R; Luijtens K; van der Heijde D. Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial. Rheumatology (Oxford, England). (2012) 51 9 pp1628-1638', '10.1093/rheumatology/kes082', 'http://academic.oup.com/rheumatology/article-pdf/51/9/1628/5068193/kes082.pdf']\n",
      "['9263368', 'van der Heijde D; Keystone EC; Curtis JR; Landew‚àö¬© RB; Schiff MH; Khanna D; Kvien TK; Ionescu L; Gervitz LM; Davies OR; Luijtens K; Furst DE. Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: a post-hoc analysis of the RAPID 1 trial. Journal of rheumatology. (2012) 39 7 pp1326-1333', '10.3899/jrheum.111171', '']\n",
      "['9737382', 'Pfeil Alexander; Nussbaum Anica; Renz Diane M; Jung Christian; Oelzner Peter; Malich Ansgar; Wolf Gunter; Bottcher Joachim. Inhibition of periarticular bone loss is associated with clinical remission and ACR70-Response in rheumatoid arthritis. Rheumatology international. (2019) 39 4 pp637-645', '10.1007/s00296-018-4226-7', 'http://link.springer.com/article/10.1007/s00296-018-4226-7/fulltext.html']\n",
      "['9737658', 'Keystone E C; Fleischmann R; Smolen J; Strand V; Landewe R; Combe B; Mease P; Ansari Z; Goel N; Van Der Heijde; Emery P. The efficacy of certolizumab pegol added to methotrexate is sustained over 2 years in the treatment of rheumatoid arthritis. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1093/rheumatology/kes082', 'http://academic.oup.com/rheumatology/article-pdf/51/9/1628/5068193/kes082.pdf']\n",
      "['9737767', 'Combe B; Schwartzman S; Massarotti E; Keystone E; Luijtens K; Van Der Heijde. Incremental benefit of open-label certolizumab pegol + MTX in Rheumatoid Arthritis (RA) patients following double-blind placebo + MTX treatment out to 2 years. Journal of rheumatology. (2010) 37 6 SUPPL. 2 pp1292', '10.1093/rheumatology/kes082', 'http://academic.oup.com/rheumatology/article-pdf/51/9/1628/5068193/kes082.pdf']\n",
      "['9738017', 'EUCTR2004-002993-49-HU. A Phase III multicentre, double blind, placebo-controlled, parallel group 52-week study to assess the efficacy and safety of 2 dose regimens of lyophilised CDP870 given subcutaneously as additional medication to methotrexate in the treatment of signs and symptoms and preventing structural damage in patients with active rheumatoid arthritis who have an incomplete response to methotrexate. - CDP870 signs and symptoms and structural damage study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-002993-49-HU. (2004)   pp', '10.1186/isrctn49455679', '']\n",
      "['9738494', 'Keystone E; Landewe R; van Vollenhoven R; Combe B; Strand V; Mease P; et al. 5-Year results from the RAPID 1 trial and open-label extension: long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 12 ppA228-9', '10.1136/annrheumdis-2013-eular.720', '']\n",
      "['9738896', 'Haraoui B; Combe B; Champsaur M; Luijtens K; Keystone E. Effects of different steroid doses on adverse events and radiographic progression of certolizumab pegol-treated rheumatoid arthritis patients. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.3031', '']\n",
      "['9738914', 'Keystone E C; Fleischmann R; Smolen J S; Strand V; Landewe R; Combe B; Mease P J. The efficacy of certolizumab pegol added to methotrexate is sustained over 2 years in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1666', '10.1093/rheumatology/kes082', 'http://academic.oup.com/rheumatology/article-pdf/51/9/1628/5068193/kes082.pdf']\n",
      "['9741236', '. Computer-based evaluation of joint space narrowing in patients with rheumatoid arthritis treated with with certolizumab pegol. Annals of the rheumatic diseases. (2019) 78  pp2046-', '10.1136/annrheumdis-2019-eular.4061', '']\n",
      "['9742541', 'Combe B; Schwartzman S; Massarotti E; Keystone E C; Luijtens K; Van Der Heijde; D M F M. Incremental benefit of open-label certolizumab pegol MTX in rheumatoid arthritis (RA) patients following double-blind placebo MTX treatment out to 2 years. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1668', '10.1002/art.23964', '']\n",
      "['9743004', 'NCT00152386. A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00152386. (2005)   pp', '10.1007/s00393-016-0133-z', 'http://link.springer.com/article/10.1007/s00393-016-0133-z/fulltext.html']\n",
      "['9743117', 'Berenbaum Francis; Pham Thao; Claudepierre Pascal; de Chalus Thibault; Joubert Jean-Michel; Saadoun Carine; Riou Franca Lionel; Fautrel Bruno. Early non-response to certolizumab pegol in rheumatoid arthritis predicts treatment failure at one year. Data from a randomised phase III clinical trial. Joint, bone, spine. (2018) 85 1 pp59-64', '10.1016/j.jbspin.2017.01.011', '']\n",
      "['9260552', 'Kavanaugh A; Smolen JS; Emery P; Purcaru O; Keystone E; Richard L; Strand V; van Vollenhoven RF. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis and rheumatism. (2009) 61 11 pp1592-1600', '10.1002/art.24828', '']\n",
      "['9261993', \"Curtis JR; De Longueville M; O'Brien C; Haraoui B. Improvement in disease activity and the long-term risk of serious infectious events in rheumatoid arthritis patients treated with certolizumab pegol. Arthritis and rheumatology. (2015) 67 no pagination pp\", '10.1136/annrheumdis-2015-eular.1268', '']\n",
      "['9737556', 'Keystone E C; Smolen J S; Strand V; Kumke T; Mountian I; Walker S; Landewe R B M. Multiple approaches for implementation of long-term efficacy: interpretation of certolizumab pegol data in rheumatoid arthritis case study. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS1080', '10.1136/annrheumdis-2014-eular.1813', '']\n",
      "['9739206', 'Hazes J M; Taylor P; Strand V; Purcaru O; Coteur G; Mease P. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology. (2010) 49 10 pp1900-1910', '10.1093/rheumatology/keq109', 'http://academic.oup.com/rheumatology/article-pdf/49/10/1900/5018828/keq109.pdf']\n",
      "['11086348', 'Tanaka Y; Li Z; Inanc N; Xavier R; Tilt N; Cara C; Saadoun C; Takeuchi T. Certolizumab pegol in patients with rheumatoid arthritis: pooled efficacy analysis of phase 3 clinical trials across baseline rheumatoid factor quartiles. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp78', '10.1136/annrheumdis-2020-eular.2069', '']\n",
      "['11086540', 'Tanaka Y; Li Z; Inanc N; Xavier R; Tilt N; Cara C; Saadoun C; Takeuchi T. Certolizumab pegol in patients with rheumatoid arthritis: pooled efficacy analysis of phase 3 clinical trials across baseline rheumatoid factor quartiles. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp271-272', '10.1136/annrheumdis-2020-eular.2069', '']\n",
      "['9257285', 'Smolen J; Van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewe R; Haraoui B; Walker S; Van Der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from a 24-week randomized controlled trial and open-label extension study. Journal of rheumatology. (2014) 41  7 pp1505-1506', '10.1186/s13075-015-0767-2', '']\n",
      "['9257963', 'Smolen JS; Van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff MH; Landewe R; Haraoui B; Walker S; Van Der Heijde D. Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from a 24-week randomized controlled trial and open-label extension study. Arthritis and rheumatism. (2013) 65  ppS988-S989', '10.1186/s13075-015-0767-2', '']\n",
      "['9260651', 'Strand V; Smolen JS; van Vollenhoven RF; Mease P; Burmester GR; Hiepe F; Khanna D; Nika‚àö√ò E; Coteur G; Schiff M. Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial. Annals of the rheumatic diseases. (2011) 70 6 pp996-1002', '10.1136/ard.2010.143586', '']\n",
      "['9261104', 'Smolen J; Van Vollenhoven R; Kavanaugh A; Fichtner A; Strand V; Vencovsky J; Van Der Heijde D. Efficacy and safety of certolizumab pegol plus methotrexate in patients with rheumatoid arthritis: 3-year data from the rapid 2 study. Reumatologia Clinica Suplementos. (2011) 7  pp136', '10.1186/s13075-015-0767-2', '']\n",
      "['9263295', 'Smolen J; Landew‚àö¬© RB; Mease P; Brzezicki J; Mason D; Luijtens K; van Vollenhoven RF; Kavanaugh A; Schiff M; Burmester GR; Strand V; Vencovsky J; van der Heijde D. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Annals of the rheumatic diseases. (2009) 68 6 pp797-804', '10.1136/ard.2008.101659', '']\n",
      "['9737981', 'EUCTR2005-002326-63-SK. A Phase III Multi‚Äö√Ñ√¨center, Double‚Äö√Ñ√¨blind, Placebo‚Äö√Ñ√¨controlled, Parallel Group 24‚Äö√Ñ√¨Week Study to Assess the Efficacy and Safety of Two Dose Regimens of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis who have an Incomplete Response to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002326-63-SK. (2005)   pp', '10.1002/art.23964', '']\n",
      "['9740974', 'NCT00160602. A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00160602. (2005)   pp', '10.1186/s13075-015-0767-2', '']\n",
      "['9256864', 'Bi L; Li Y; He L; Xu H; Gu J; Wang G; Zhang Z; Liu Y; Boehnlein M; Dunkel J; Shao J; Harris K; Li Z. Rapid onset of response observed with certolizumab pegol in rheumatoid arthritis patients with inadequate response to methotrexate: efficacy and safety results of a randomized, double-blind, placebo-controlled phase 3 study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1002/art.40321', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40321']\n",
      "['9737285', 'Bi Liqi; Li Yuhui; He Lan; Xu Huji; Jiang Zhenyu; Wang Yongfu; Li Xiangpei; Wei Wei; Gu Jieruo; Wang Guochun; Zhang Zhiyi; Zhou Bin; Liu Yi; Wu Zhenbiao; Liu Huaxiang; He Dongyi; Lv Zhaoping; Li Zhijun; Zuo Xiaoxia; Dong Lingli; Wu Huaxiang; Zhang Hao; Chen Haiying; Bao Chunde; Zhang Zhuoli; Zhang Miaojia; Song Hui; Zheng Yi; Jiang Lindi; Liu Xiangyuan; Boehnlein Marion; Dunkel Jochen; Shao Jing; Harris Kristina; Li Zhanguo. Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. Clinical and experimental rheumatology. (2019) 37 2 pp227-234', '10.1038/s41392-022-00887-2', 'https://www.nature.com/articles/s41392-022-00887-2']\n",
      "['9742118', 'Bi L; Li Y; He L; Xu H; Gu J; Wang G; Zhang Z; Liu Y; Boehnlein M; Dunkel J; Shao J; Li Z. Safety and efficacy of certolizumab pegol in Chinese patients with rheumatoid arthritis: an open label extension of the RAPID-C study. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp184', '10.1007/s10165-004-0352-z', '']\n",
      "['11083888', 'Li Z; Bi L; Gong L; Wang Y; Xu H; He L; Wu Z; Jiang Z; Liu Y; Nurminen T; Hou M; Tu L; Saadoun C. Effect of certolizumab pegol on workplace and household productivity in chinese patients with active rheumatoid arthritis (RAPID-C Study). International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp256-257', '10.1136/annrheumdis-2014-eular.2007', '']\n",
      "['9739326', 'NCT03578900. Quality of Life and Sj√∂gren Syndrome. Https://clinicaltrials.gov/show/nct03578900. (2018)   pp', '10.1007/springerreference_109687', '']\n",
      "['9260018', 'de Jong Z; Munneke M; Jansen LM; Ronday K; van Schaardenburg DJ; Brand R; van den Ende CH; Vliet Vlieland TP; Zuijderduin WM; Hazes JM. Differences between participants and nonparticipants in an exercise trial for adults with rheumatoid arthritis. Arthritis and rheumatism. (2004) 51 4 pp593-600', '10.1002/art.20531', '']\n",
      "['9260321', 'de Jong Z; Munneke M; Vilim V; Zwinderman AH; Kroon HM; Ronday HK; Lems WF; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM; Degroot J. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study. Rheumatology (Oxford, England). (2008) 47 6 pp868-871', '10.1093/rheumatology/ken052', 'http://academic.oup.com/rheumatology/article-pdf/47/6/868/5050808/ken052.pdf']\n",
      "['9258174', 'Menninger H; Herborn G; Sander O; Blechschmidt J; Rau R. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis. British journal of rheumatology. (1998) 37 10 pp1060-1068', '10.1093/rheumatology/37.10.1060', 'http://academic.oup.com/rheumatology/article-pdf/37/10/1060/18105758/371060.pdf']\n",
      "['9258207', 'Herborn G; Rau R; Menninger H; Elhardt D; Schmitt J. Data of two years of the comparative study methotrexate/aurothiomalate in 102 patients. Zeitschrift fu√É√†r Rheumatologie. (1992) 51 4 pp163-171', '10.1016/0049-0172(91)90047-4', '']\n",
      "['9258313', 'Rau R; Herborn G; Menninger H; Sangha O. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. British journal of rheumatology. (1998) 37 11 pp1220-1226', '10.1093/rheumatology/37.11.1220', 'http://academic.oup.com/rheumatology/article-pdf/37/11/1220/18105859/371220.pdf']\n",
      "['9258523', 'Herborn G; Rau R; Menninger H; Elhardt D; Schmitt J. Interim report on 102 patients after two years in a double blind comparison of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis.  ZWEIJAHRESDATEN DER VERGLEICHSSTUDIE METHOTREXAT/AUROTHIOMALAT VON 102 PATIENTEN. Zeitschrift fur Rheumatologie. (1992) 51 4 pp163-171', '10.1016/0049-0172(91)90047-4', '']\n",
      "['9260062', 'St Clair EW; van der Heijde DM; Smolen JS; Maini RN; Bathon JM; Emery P; Keystone E; Schiff M; Kalden JR; Wang B; Dewoody K; Weiss R; Baker D; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis and rheumatism. (2004) 50 11 pp3432-3443', '10.1002/art.20568', '']\n",
      "['9259530', 'Sander O; Herborn G; Bock E; Rau R. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate. Annals of the rheumatic diseases. (1999) 58 5 pp281-287', '10.1136/ard.58.5.281', '']\n",
      "['9259769', 'Rau R; Herborn G; Zueger S; Fenner H. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. Journal of rheumatology. (2000) 27 11 pp2566-2575', '10.1002/art.10718', '']\n",
      "['9262934', 'Rau R; Herborn G; Karger T; Menninger H; Elhardt D; Schmitt J. A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: an interim report on 102 patients after 12 months. Seminars in arthritis and rheumatism. (1991) 21 2 Suppl 1 pp13-20', '10.1016/0049-0172(91)90047-4', '']\n",
      "['9263103', 'Rau R; Herborn G; Menninger H; Sangha O. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology (Oxford, England). (2002) 41 2 pp196-204', '10.1093/rheumatology/41.2.196', 'http://academic.oup.com/rheumatology/article-pdf/41/2/196/18095590/410196.pdf']\n",
      "['9740283', 'UMIN000017440. In methotrexate resistant rheumatoid arthritis, switching methotrexate to tofacitinib versus adding tofacitinib to methotrexate, open labeled, multicenter randomized non-inferiority study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000017440. (2015)   pp', '10.1002/acr.20494', '']\n",
      "['9740701', 'ChiCTR1900024107. A randomized, controlled, open label, multicenter clinical trial to evaluate the efficacy and safety of recombinant tumor necrosis factor receptor: fc fusion protein (rhTNFR: fc) with Methotrexate in active rheumatoid arthritis (ReABLE-II). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900024107. (2019)   pp', '10.1177/106002809703101111', 'https://journals.sagepub.com/doi/pdf/10.1177/106002809703101111']\n",
      "['11088818', '. Experimental Medicine Studies of Brain and Peripheral Immune Mechanisms for Sickness Behaviours in Patients With Rheumatoid Arthritis. . (2021)   pp', '10.1007/s10238-001-8014-3', 'http://link.springer.com/article/10.1007/s10238-001-8014-3/fulltext.html']\n",
      "['9257221', 'Pope J; Fleischmann R; Dougados M; Bingham CO; Massarotti EM; Wollenhaupt J; Duncan B; Coteur G; Weinblatt M. Rapid reductions in fatigue and sleep problems and correlation with improvements in patient-reported outcomes in patients with active rheumatoid arthritis treated with certolizumab pegol in the realistic 12-week phase iiib randomized controlled study. Rheumatology (United Kingdom). (2012) 51  ppiii135-iii136', '10.1016/j.jval.2011.08.447', '']\n",
      "['9257223', 'Weinblatt ME; Fleischmann R; Van Vollenhoven R; Emery P; Huizinga TWJ; Goldermann R; Duncan B; Timoshanko J; Luijtens K; Davies O; Dougados M. Certolizumab pegol in patients with active rheumatoid arthritis aligned with nice guidance for anti-tnf therapy: Post-HOC analyses of the realistic phase IIIB randomized controlled study. Rheumatology (United Kingdom). (2012) 51  ppiii125-iii126', '10.1186/s13075-015-0841-9', '']\n",
      "['9261218', 'Weinblatt M; Fleischmann RM; Vollenhoven RF; Van Emery P; Huizinga TWJ; Cutolo M; Goldermann R. Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: Week 28 results from a phase IIIB randomized controlled study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1186/s13075-015-0841-9', '']\n",
      "['9263365', 'Weinblatt ME; Fleischmann R; Huizinga TW; Emery P; Pope J; Massarotti EM; van Vollenhoven RF; Wollenhaupt J; Bingham CO; Duncan B; Goel N; Davies OR; Dougados M. Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study. Rheumatology (Oxford, England). (2012) 51 12 pp2204-2214', '10.1093/rheumatology/kes150', 'http://academic.oup.com/rheumatology/article-pdf/51/12/2204/5101143/kes150.pdf']\n",
      "['9261189', 'Weinblatt M; Pope J; Fleischmann R; Bingham C; Coteur G; Dougados M. Patient reported disease activity including joint assessment: A comparison of RADAI (Rheumatoid Arthritis Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) in patients treated with certolizumab pegol over 12 weeks. Journal of rheumatology. (2012) 39  8 pp1707-1708', '10.1186/s13075-015-0849-1', 'http://link.springer.com/article/10.1186/s13075-015-0849-1/fulltext.html']\n",
      "['9740155', 'EUCTR2008-005427-28-DE. A Phase IIIb, multicenter study with a 12-week double-blind, placebo-controlled, randomized period followed by an open-label, extension phase to evaluate the safety and efficacy of certolizumab pegol administered to patients with active rheumatoid arthritis. - Realistic. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-005427-28-DE. (2008)   pp', '10.1111/dom.14642/v1/review5', '']\n",
      "['9741117', 'NCT00717236. Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00717236. (2008)   pp', '10.2399/raed.15.s1s1', '']\n",
      "['9739300', 'Tahir Hasan; Deodhar Atul; Genovese Mark; Takeuchi Tsutomu; Aelion Jacob; Van den Bosch; Filip; Haemmerle Sibylle; Richards Hanno B. Secukinumab in Active Rheumatoid Arthritis after Anti-TNFalpha Therapy: a Randomized, Double-Blind Placebo-Controlled Phase 3 Study. Rheumatology and therapy. (2017) 4 2 pp475-488', '10.1007/s40744-017-0086-y', 'https://link.springer.com/article/10.1007/s40744-017-0086-y/fulltext.html']\n",
      "['9736982', 'Clements P J; Yu D T Y; Levy J. Effects of cyclophosphamide on B and T lymphocytes in rheumatoid arthritis. Arthritis and rheumatism. (1974) 17 4 pp347-353', '10.1002/art.1780170403', '']\n",
      "['9262562', 'den Broeder AA; Verhoef LM; Fransen J; Thurlings R; van den Bemt BJF; Teerenstra S; Boers N; den Broeder N; van den Hoogen FHJ. Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial. Trials. (2017) 18 1 pp403', '10.1186/s13063-017-2134-x', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2134-x.pdf']\n",
      "['9738571', 'den Broeder AA; Verhoef LM; Fransen J; Thurlings R; van den Bemt BJF; Teerenstra S; Boers N; den Broeder N; van den Hoogen FHJ. Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial. Trials. (2017) 18 1 pp403', '10.1186/s13063-017-2134-x', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2134-x.pdf']\n",
      "['9739603', 'EUCTR2016-002908-15-NL. REDO study: research into the effects of lower doses rituximab in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002908-15-NL. (2016)   pp', '10.1186/isrctn05568900', '']\n",
      "['9740711', 'Verhoef LM; Den Broeder N; Thurlings RM; Van Der Laan WH; Van Der Weele W; Kok M; Bernelot Moens HJ; Woodworth T; Van Den Bemt B; Van Den Hoogen F; Den Broeder A. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp264-265', '10.1016/s2665-9913(19)30066-9', '']\n",
      "['9741271', 'Verhoef LM; den Broeder N; Thurlings RM; van der Laan WH; van der Weele W; Kok MR; Bernelot Moens HJ; Woodworth TG; van den Bemt BJF; van den Hoogen FHJ; den Broeder AA. Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial. The lancet rheumatology. (2019) 1 3 ppe145-e153', '10.1016/s2665-9913(19)30066-9', '']\n",
      "['11085145', 'Den Broeder N; Verhoef LM; De Man YA; Kok MR; Thurlings RM; Van Der Weele W; Van Den Bemt B; Van Den Hoogen F; Van Der Maas A; Den Broeder A. LONG-TERM EFFECTIVENESS of ULTRA-LOW DOSES of RITUXIMAB in RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp597-598', '10.1136/annrheumdis-2022-eular.2903', '']\n",
      "['9740176', 'EUCTR2015-002156-27-AT. Reduced-dose Rituximab in rheumatoid arthritis patients in remission ‚Äì the REDOREM study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-002156-27-AT. (2015)   pp', '10.1186/isrctn14909030', '']\n",
      "['9261161', 'Jobanputra P; Maggs F; Deeming A; Carruthers D; Rankin E; Jordan A; Faizal A; Goddard C; Pugh M; Bowman S; Brailsford S; Nightingale P. Randomized efficacy and discontinuation study of etanercept versus adalimumab (Red sea): A pragmatic, open-label, non-inferiority study of first TNF inhibitor use in rheumatoid arthritis: 1-year data. Rheumatology (United Kingdom). (2012) 51  ppiii116-iii117', '10.1136/bmjopen-2012-001395', '']\n",
      "['9261462', 'De Pablo P; Maggs FM; Carruthers D; Faizal AA; Pugh MT; Jobanputra P. Incidence of diabetes and effect of etanercept and adalimumab on HbA1c over 1 year: Data from a randomised trial in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS1009', '10.1136/annrheumdis-2013-eular.2601', '']\n",
      "['9739570', 'EUCTR2006-006275-21-GB. A Randomised, Pragmatic, Open-label study of Adalimumab versus Etanercept for Rheumatoid Arthritis. - Adalimumab versus Etanercept for RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006275-21-GB. (2011)   pp', '10.1186/isrctn95861172', '']\n",
      "['9739127', 'Schiff M H; Genovese M C; Bello A E; Grahn A Y; Johnson K E; Kivitz A J. Efficacy, safety, and tolerability of a single-tablet combination of ibuprofen-famotidine: results in patients who require nonsteroidal anti-inflammatory drugs for osteoarthritis, rheumatoid arthritis, or chronic pain. Pain medicine (united states). (2012) 13 2 pp340', '10.14309/00000434-200910003-01424', '']\n",
      "['9258503', 'Bello AE; Kent JD; Holt RJ. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons. Physician and sportsmedicine. (2015) 43 3 pp193-199', '10.1080/00913847.2015.1066229', '']\n",
      "['9263101', \"Reece RJ; Kraan MC; Radjenovic A; Veale DJ; O'Connor PJ; Ridgway JP; Gibbon WW; Breedveld FC; Tak PP; Emery P. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis and rheumatism. (2002) 46 2 pp366-372\", '10.1002/art.10084', '']\n",
      "['9261861', 'Jacobs I; Yin D; Melia LA; Gumbiner B; Suster M; Thomas D; Meng X. A phase I trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp724', '10.1136/annrheumdis-2015-eular.3934', '']\n",
      "['9262070', 'Williams JH; Hutmacher MM; Zierhut ML; Becker J-C; Gumbiner B; Spencer-Green G; Melia LA; Liao K-H; Suster M; Yin D; Li R; Meng X. Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab. British journal of clinical pharmacology. (2016) 82 6 pp1568-1579', '10.1111/bcp.13094', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13094']\n",
      "['9739582', 'Cohen S; Emery P; Greenwald M; Yin D; Becker J-C; Melia LA; Li R; Gumbiner B; Thomas D; Spencer-Green G; Meng X. A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. British journal of clinical pharmacology. (2016)   pp', '10.1111/bcp.12916', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12916']\n",
      "['9741163', 'NCT01526057. A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01). https://clinicaltrials.gov/show/NCT01526057. (2012)   pp', '10.1136/annrheumdis-2014-eular.5444', '']\n",
      "['9741141', 'NCT01643928. Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04). https://clinicaltrials.gov/show/NCT01643928. (2012)   pp', '10.1136/annrheumdis-2014-eular.5444', '']\n",
      "['9737313', 'Cohen Stanley B; Radominski Sebastiao C; Kameda Hideto; Kivitz Alan J; Tee Michael; Cronenberger Carol; Zhang Min; Hackley Sarah; Rehman Muhammad I; von Richter Oliver; Alten Rieke. Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: week 54-78 Data From a Randomized, Double-Blind, Phase III Trial. BioDrugs. (2020) 34 2 pp197-207', '10.1007/s40259-019-00403-z', 'http://link.springer.com/article/10.1007/s40259-019-00403-z/fulltext.html']\n",
      "['9741114', 'NCT02222493. A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). https://clinicaltrials.gov/show/NCT02222493. (2014)   pp', '10.1186/s13075-018-1646-4', 'http://link.springer.com/article/10.1186/s13075-018-1646-4/fulltext.html']\n",
      "['9741320', 'Alten Rieke; Batko Bogdan; Hala Tomas; Kameda Hideto; Radominski Sebastiao C; Tseluyko Vira; Babic Goran; Cronenberger Carol; Hackley Sarah; Rehman Muhammad; von Richter Oliver; Zhang Min; Cohen Stanley. Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54. RMD open. (2019) 5 1 ppe000876', '10.1136/rmdopen-2018-000876', '']\n",
      "['9742845', 'EUCTR2013-004148-49-PL. RANDOMIZED STUDY OF PF-06438179 AND INFLIXIMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-004148-49-PL. (2014)   pp', '10.1080/14712598.2019.1635583', 'https://tandfonline.com/doi/pdf/10.1080/14712598.2019.1635583']\n",
      "['9742909', 'Alten R; Batko B; Hala T; Kameda H; Radominski SC; Tseluyko V; Babic G; Cronenberger C; Hackley S; Rehman M; Von Richter O; Zhang M; Cohen S. Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54. Open heart. (2019) 6 1 pp', '10.1136/rmdopen-2018-000876', '']\n",
      "['11088232', 'Cohen Stanley B; Radominski Sebastiao C; Kameda Hideto; Kivitz Alan J; Tee Michael; Cronenberger Carol; Zhang Min; Hackley Sarah; Rehman Muhammad I; von Richter Oliver; Alten Rieke. Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: week 54-78 Data From a Randomized, Double-Blind, Phase III Trial. BioDrugs. (2020) 34 2 pp197-207', '10.1007/s40259-019-00403-z', 'http://link.springer.com/article/10.1007/s40259-019-00403-z/fulltext.html']\n",
      "['9740213', 'EUCTR2014-000352-29-CZ. A Study of PF-06410293 (Adalimumab-Pfizer) and Adalimumab (Humira) in Combination with Methotrexate in Subjects with Active Rheumatoid Arthritis (REFLECTIONS B538-02). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-000352-29-CZ. (2014)   pp', '10.31525/ct1-nct04230213', '']\n",
      "['9741142', 'NCT02480153. A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira¬¨√Ü) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). https://clinicaltrials.gov/show/NCT02480153. (2015)   pp', '10.31525/ct1-nct04230213', '']\n",
      "['9256779', 'Keystone E; Emery P; Peterfy CG; Tak PP; Cohen S; Genovese MC; Dougados M; Burmester GR; Greenwald M; Kvien TK; Williams S; Hagerty D; Cravets MW; Shaw T. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Annals of the rheumatic diseases. (2009) 68 2 pp216-221', '10.1136/ard.2007.085787', '']\n",
      "['9260218', 'Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC; REFLEX Trial Group. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis and rheumatism. (2006) 54 9 pp2793-2806', '10.1002/art.22025', '']\n",
      "['9260335', 'Keystone E; Burmester GR; Furie R; Loveless JE; Emery P; Kremer J; Tak PP; Broder MS; Yu E; Cravets M; Magrini F; Jost F. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis and rheumatism. (2008) 59 6 pp785-793', '10.1002/art.23715', '']\n",
      "['9260581', 'Cohen SB; Keystone E; Genovese MC; Emery P; Peterfy C; Tak PP; Cravets M; Shaw T; Hagerty D. Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate. Annals of the rheumatic diseases. (2010) 69 6 pp1158-1161', '10.1136/ard.2009.119222', '']\n",
      "['9261205', 'Keystone E; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C. Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.2640', '']\n",
      "['9261413', 'Keystone E; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H. Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2640', '']\n",
      "['9263393', 'Keystone EC; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H. Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study. Journal of rheumatology. (2012) 39 12 pp2238-2246', '10.3899/jrheum.120573', '']\n",
      "['9739036', 'Blocka K; Mease P J; Keystone E. SDAI and CDAI for predicting outcome of a second course of Rituximab for patients with rheumatoid arthritis (RA). Journal of rheumatology. (2009) 36 11 pp2565', '10.3899/jrheum.080663', '']\n",
      "['9741057', 'NCT00468546. A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy. https://clinicaltrials.gov/show/NCT00468546. (2007)   pp', '10.1186/isrctn27093749', '']\n",
      "['9742540', 'Cividino A; Cohen S; Keystone E. Continued inhibition of structural damage in rheumatoid arthritis patients treated with rituximab at 2 years: REFLEX study. Journal of rheumatology. (2009) 36 11 pp2592-2593', '10.1136/ard.2009.119222', '']\n",
      "['9257759', \"Register KA; Cannella AC; Mikuls TR; O'Dell JR. Leflunomide, sulfasalazine and hydroxychloroquine for rheumatoid arthritis: efficacious but poorly tolerated. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2014-2015\", '10.1002/art.39977', '']\n",
      "['9257902', 'Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?. Annals of the rheumatic diseases. (2005) 64 1 pp44-51', '10.1136/ard.2003.016709', '']\n",
      "['9739108', 'Luchikhina E; Karateev D; Demidova N; Loukina G; Kanonirova M; Mouraviev Y; Gridneva G; Aleksandrova E; Novikov A; Nasonov E. Effect of fast escalation of the dose of subcutaneous methotrexate on the need for biological DMARDS in patients with very early and established rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp246', '10.1136/annrheumdis-2016-eular.5986', '']\n",
      "['9739939', 'EUCTR2015-004858-17-NL. REMission INDuction in very early Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-004858-17-NL. (2016)   pp', '10.1186/isrctn49682259', '']\n",
      "['9742333', \"Van Roon J; Der Heijden E; Blokland S; Lopes A; Moret F; Welsing P; Janssen N; Rosenberg T; Pandit A; Tao W; Hillen M; Kruize AA; Radstake TR. Clinical efficacy of leflunomide/hydroxychloroquine combination therapy in primary Sjogren's syndrome is predicted by serum proteome biomarkers - Results from repurpss-I. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp396\", '10.1136/annrheumdis-2019-eular.5681', '']\n",
      "['11087181', 'Richardson M; Curtis J; Evangelista M; Levine Y; Chernoff D. / #676 VAGUS NERVE STIMULATION TO TREAT RHEUMATOID ARTHRITIS: RATIONALE, OBJECTIVES AND DESIGN OF THE RESET-RA STUDY: TRACK 3: VAGUS NERVE STIMULATION / TOOLS TO INFORM PATIENT CARE. Neuromodulation. (2022) 25 7 Supplement ppS149', '10.1016/j.neurom.2022.08.160', '']\n",
      "['11083914', '. A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis. . (2022)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9740207', 'EUCTR2008-002381-55-ES. Evaluaci‚Äö√†√∂‚Äö√¢‚Ä¢n de la Eficacia de Rituximab en pacientes con Artritis Reumatoide a trav‚Äö√†√∂¬¨¬©s de la medici‚Äö√†√∂‚Äö√¢‚Ä¢n, por Resonancia Magn‚Äö√†√∂¬¨¬©tica de Mano, de los par‚Äö√†√∂¬¨‚àûmetros cl‚Äö√†√∂‚Äö√¢‚Ä†nicos de la enfermedad. Estudio RESONAR.  Efficacy of rituximab in patients with Rheumatoid Arthritis, by measurement of disease parameters through magnetic resonance of the hand. RESONAR study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-002381-55-ES. (2008)   pp', '10.4995/thesis/10251/193057', 'https://riunet.upv.es/bitstream/10251/193057/1/Moya%20-%20Estudio%20sistemico%20de%20una%20estructura%20exoesqueletica%20para%20la%20rehabilitacion%20de%20la%20atrofia%20mu....pdf']\n",
      "['9740953', \"Mavragani CP; Moutsopoulos HM. Sj√É¬∂gren's syndrome: old and new therapeutic targets. Journal of autoimmunity. (2019)   pp\", '10.1016/j.jaut.2019.102364', '']\n",
      "['9261872', 'Haschka J; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Reiser M; Finzel S; Tony H-P; Kleinert S; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Wendler J; Schuch F; Ronneberger M; Lorenz H-M; Nuesslein H; Alten R; Demary W; Henes J; Schett G; Rech J. Retro-study of reduction of therapy in patients with rheumatoid arthritis in ongoing remission. Annals of the rheumatic diseases. (2015) 74  pp668', '10.1136/annrheumdis-2015-eular.5961', '']\n",
      "['9262649', 'Erhard J; Hagen M; Englbrecht M; Haschka J; Reiser M; Kleyer A; Hueber AJ; Manger B; Figueiredo C; Cobra JF; Tony H-P; Finzel S; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H; Nuesslein H; Alten R; Henes J; Krueger K; Schett G; Rech J. Loosing DAS28-ESR, but staying in boolean remission-is it possible? Data from the prospective, randomised retro trial on rheumatoid arthritis patients in stable remission. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1307-1308', '10.1136/annrheumdis-2018-eular.5521', '']\n",
      "['9263541', 'Rech J; Hueber AJ; Finzel S; Englbrecht M; Haschka J; Manger B; Kleyer A; Reiser M; Cobra JF; Figueiredo C; Tony HP; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz HM; Nuesslein H; Alten R; Henes J; Krueger K; Schett G. Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment. Annals of the rheumatic diseases. (2016) 75 9 pp1637-1644', '10.1136/annrheumdis-2015-207900', '']\n",
      "['9738162', 'Valor L; Hagen M; Reiser M; Kleyer A; Hartmann F; Manger B; Schett G; Rech J; Retro KT; Haschka J; Englbrecht M; Hueber A; Figueiredo C; Fogagnolo J; Tony HP; Finzel S; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz HM; Nusslein H; Alten R; Henes J; Kruger K. Factors associated with persistent drugfree remission in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp730', '10.1136/annrheumdis-2015-eular.5961', '']\n",
      "['9738184', 'Hagen Melanie; Englbrecht Matthias; Haschka Judith; Reiser Michaela; Kleyer Arnd; Hueber Axel; Manger Bernhard; Figueiredo Camille; Cobra Jayme Fogagnolo; Tony Hans-Peter; Finzel Stephanie; Kleinert Stefan; Wendler Jorg; Schuch Florian; Ronneberger Monika; Feuchtenberger Martin; Fleck Martin; Manger Karin; Ochs Wolfgang; Lorenz Hans-Martin; Nusslein Hubert; Alten Rieke; Henes Jorg; Kruger Klaus; Schett Georg; Rech Jurgen. Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: combination of Multibiomarker Disease Activity Score and Autoantibody Status. Journal of rheumatology. (2019) 46 5 pp460-466', '10.3899/jrheum.180028', '']\n",
      "['9739395', 'Hagen M; Figueiredo C; Cobra JF; Reiser M; Haschka J; Englbrecht M; Hueber A; Manger B; Kleyer A; Finzel S; Tony H-P; Wendler J; Kleinert S; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H-M; Nuesslein H; Alten R; Henes JC; Krueger K; Schett G; Rech J. Effects of dmard tapering on treatment costs in rheumatoid arthritis patients-an analysis from the prospective randomized controlled retrostudy. Annals of the rheumatic diseases. (2016) 75  pp688-', '10.1136/annrheumdis-2016-eular.4840', '']\n",
      "['11083680', 'Hagen Melanie; Englbrecht Matthias; Haschka Judith; Reiser Michaela; Kleyer Arnd; Hueber Axel; Manger Bernhard; Figueiredo Camille; Cobra Jayme Fogagnolo; Tony Hans-Peter; Finzel Stephanie; Kleinert Stefan; Wendler Jorg; Schuch Florian; Ronneberger Monika; Feuchtenberger Martin; Fleck Martin; Manger Karin; Ochs Wolfgang; Lorenz Hans-Martin; Nusslein Hubert; Alten Rieke; Henes Jorg; Kruger Klaus; Schett Georg; Rech Jurgen. Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: combination of Multibiomarker Disease Activity Score and Autoantibody Status. Journal of rheumatology. (2019) 46 5 pp460-466', '10.3899/jrheum.180028', '']\n",
      "['11086167', 'Sokolova MV; Rech J; Hagen M; Schett G; Steffen U. Association of anti-citrullinated protein antibodies of iga subclasses with sustained remission and flare in rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp461', '10.1136/annrheumdis-2021-eular.2004', '']\n",
      "['11086591', 'Vodencarevic A; Tascilar K; Hartmann F; Reiser M; Bayat S; Knitza J; Valor L; Hagen M; Hueber A; Kleyer A; Zimmermann-Rittereiser M; Schett G; Simon D. Prediction of flares for rheumatoid arthritis patients on biologic DMARDs using machine learning and subsets of variables available to physicians, patients and payers. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp959-960', '10.1136/annrheumdis-2020-eular.1553', '']\n",
      "['9262493', 'Hagen M; Englbrecht M; Haschka J; Reiser M; Kleyer A; Hueber A; Manger B; Figuereido C; Fogagnolo Cobra J; Tony H-P; Finzel S; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H-M; Nuesslein H; Alten R; Henes J; Krueger K; Schett G; Rech J. Multi-biomarker disease activity and autoantibody status lead to cost effective tapering algorithms in rheumatoid arthritis patients in sustained remission. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp159', '10.1136/annrheumdis-2017-eular.2988', '']\n",
      "['9738400', 'Stephan M; Tascilar K; Hagen M; Haschka J; Reiser M; Hartmann F; Kleyer A; Hueber A; Manger B; Figuereido C; Cobra J; Tony H-P; Finzel S; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H-M; Nuesslein H; Alten R; Henes J; Krueger K; Schett G; Rech J. Physical function in RA patients in remission undergoing tapering and/or stopping of DMARDs. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp321-322', '10.1136/annrheumdis-2019-eular.3987', '']\n",
      "['9738200', 'EUCTR2009-017325-19-FI. ‚Äö√Ñ√∫The effect of Six months Adalimumab Treatment on Sick Leaves and retirement in Patients with rheumatoid Arthritis who are at risk of losing their ability to work‚Äö√Ñ√π. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-017325-19-FI. (2009)   pp', '10.1186/isrctn36516369', '']\n",
      "['9741212', 'NCT02293590. RICE: remission by Intra-articular Injection Plus CErtolizumab. https://clinicaltrials.gov/show/NCT02293590. (2014)   pp', '10.1136/annrheumdis-2018-eular.5556', '']\n",
      "['9740800', 'Rigby W; Buckner J; Bridges L; Nys M; Gao S; Polinsky M; Johnsen A; Ray N; Bykerk V. The effect of HLA-DRB1 risk alleles on the clinical efficacy of abatacept and adalimumab in seropositive biologic-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¢¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö‚â§ve patients with early, moderate-to-severe RA: data from a head-to-head single blindedtrial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp263-264', '10.1136/annrheumdis-2019-eular.8668', '']\n",
      "['9258033', 'Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T. Prediction of clinical response after 1 year of infliximab therapy in rheumatoid arthritis based on disease activity at 3 months: posthoc analysis of the RISING study. Journal of rheumatology. (2015) 42 4 pp599-607', '10.3899/jrheum.140572', '']\n",
      "['9260563', 'Takeuchi T; Miyasaka N; Inoue K; Abe T; Koike T; RISING study. Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Modern rheumatology / the Japan Rheumatism Association. (2009) 19 5 pp478-487', '10.3109/s10165-009-0195-8', '']\n",
      "['9260700', 'Takeuchi T; Miyasaka N; Tatsuki Y; Yano T; Yoshinari T; Abe T; Koike T. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2011) 70 7 pp1208-1215', '10.1136/ard.2011.153023', '']\n",
      "['9260823', 'Takeuchi T; Miyasaka N; Tatsuki Y; Yano T; Yoshinari T; Abe T; Koike T. Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study. Annals of the rheumatic diseases. (2012) 71 9 pp1583-1585', '10.1136/annrheumdis-2011-201069', '']\n",
      "['9261032', \"Hofauer B; Bas M; Manour N; Knopf A. Liposomal local therapy as treatment for sicca symptoms in patients with primary Sj√∂gren's syndrome. HNO. (2013) 61 11 pp921-927\", '10.1007/s00106-013-2736-x', 'http://link.springer.com/article/10.1007/s00106-013-2736-x/fulltext.html']\n",
      "['9739141', 'Takeuchi T; Tatsuki Y; Yano T; Yoshinari T; Miyasaka N; Abe T; Koike T. Clinical efficacy of infliximab is maximized when both circulating TNF and IL-6 are suppressed in the treatment of rheumatoid arthritisresults from the rising study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2011-201069', '']\n",
      "['9740985', 'NCT00691028. Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00691028. (2008)   pp', '10.2165/00002018-200831100-00165', '']\n",
      "['11083846', 'Fujieda Yuichiro; Horita Tetsuya; Nishimoto Naoki; Tanimura Kazuhide; Amasaki Yoshiharu; Kasahara Hideki; Furukawa Shin; Takeda Tsuyoshi; Fukaya Shinji; Matsui Kazuo; Tsutsumi Akito; Furusaki Akira; Sagawa Akira; Katayama Kou; Takeuchi Kaoru; Katsumata Kazuaki; Kurita Takashi; Shane Peter; Kato Masaru; Oku Kenji; Yasuda Shinsuke; Takahata Masahiko; Iwasaki Norimasa; Atsumi Tatsuya. Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): a multicentre, double-blind, randomized, placebo-controlled trial. Modern rheumatology. (2021) 31 3 pp593-599', '10.1080/14397595.2020.1812835', '']\n",
      "['9737244', 'C000000452. Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanercept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-C000000452. (2006)   pp', '10.1186/isrctn49682259', '']\n",
      "['9257976', 'Gottenberg J-E; Brocq O; Perdriger A; Lassoued S; Berthelot J-M; Wendling D; Euller-Ziegler LE; Soubrier M; Richez C; Fautrel B; Constantin AL; Mariette X; Morel J; Gilson M; Cormier G; Salmon JH; Rist S; Liote F; Marotte H; Bonnet C; Marcelli C; Sellam J; Meyer O; Solau-Gervais E; Guis S; Ziza J-M; Zarnitsky C; Valckenaere I; Vittecoq O; Saraux A; Pers Y-M; Gayraud M; Bolla G; Claudepierre P; Ardizzone M; Dernis E; Breban MA; Fain O; Balblanc J-C; Aberkane O; Vazel M; Back C; Perrodeau E; Ravaud P; Sibilia J. Therapeutic strategy in patients with rheumatoid arthritis and insufficient response to a 1st anti-TNF: Results of the multicenter randomized controlled \"roc\" trial. Arthritis and rheumatism. (2013) 65  ppS624-S625', '10.1001/jama.2016.13512', '']\n",
      "['9263557', 'Gottenberg J-E; Brocq O; Perdriger A; Lassoued S; Berthelot J-M; Wendling D; Euller-Ziegler L; Soubrier M; Richez C; Fautrel B; Constantin AL; Mariette X; Morel J; Gilson M; Cormier G; Salmon JH; Rist S; Liot F; Marotte H; Bonnet C; Marcelli C; Sellam J; Meyer O; Solau-Gervais E; Guis S; Ziza J-M; Zarnitsky C; Chary-Valckenaere I; Vittecoq O; Saraux A; Pers Y-M; Gayraud M; Bolla G; Claudepierre P; Ardizzone M; Dernis E; Breban MA; Fain O; Balblanc J-C; Aberkane O; Vazel M; Back C; Candon S; Chatenoud L; Perrodeau E; Sibilia J; Ravaud P. NonTNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA - journal of the american medical association. (2016) 316 11 pp1172-1180', '10.1001/jama.2016.13512', '']\n",
      "['9737174', 'Gorlier C; Oufella HA; Laurans L; Rousseau A; Georgin-Lavialle S; Sokol H; Berenbaum F; Tabassome S; Gottenberg J-E; Sellam J. Serum level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1): a new biomarker of disease activity in rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2270', '10.1111/1756-185x.13656', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13656']\n",
      "['9737198', 'Gottenberg Jacques-Eric; Brocq Olivier; Perdriger Aleth; Lassoued Slim; Berthelot Jean-Marie; Wendling Daniel; Euller-Ziegler Liana; Soubrier Martin; Richez Christophe; Fautrel Bruno; Constantin Arnaud L; Mariette Xavier; Morel Jacques; Gilson Melanie; Cormier Gregoire; Salmon Jean Hugues; Rist Stephanie; Liote Frederic; Marotte Hubert; Bonnet Christine; Marcelli Christian; Sellam Jeremie; Meyer Olivier; Solau-Gervais Elisabeth; Guis Sandrine; Ziza Jean-Marc; Zarnitsky Charles; Chary-Valckenaere Isabelle; Vittecoq Olivier; Saraux Alain; Pers Yves-Marie; Gayraud Martine; Bolla Gilles; Claudepierre Pascal; Ardizzone Marc; Dernis Emmanuelle; Breban Maxime A; Fain Olivier; Balblanc Jean-Charles; Aberkane Ouafaa; Vazel Marion; Back Christelle; Candon Sophie; Chatenoud Lucienne; Perrodeau Elodie; Sibilia Jean; Ravaud Philippe. Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: a Randomized Clinical Trial. JAMA. (2016) 316 11 pp1172-1180', '10.1001/jama.2016.13512', '']\n",
      "['9739486', 'Sordet C; Chatelus E; Ravaud P; Sibilia J; Gottenberg J-E. Comparaison of self assessment of disease activity to DAS28 in rheumatoid arthritis: data from the randomized ‚Äö√Ñ√∂‚àö√ë‚àö‚à´roc‚Äö√Ñ√∂‚àö√ë‚àöœÄ trial. Annals of the rheumatic diseases. (2016) 75  pp408-', '10.1136/annrheumdis-2016-eular.6072', '']\n",
      "['9739509', 'Felten R; Alyanakian M-A; Chatenoud L; Sibilia J; Gandjbakhch F; Lukas C; Gottenberg J-E. Change in RF and anti-CCP isotype levels in RA patients treated with anti-TNF, abatacept, rituximab or tocilizumab and correlation with clinical and radiographic outcomes: data from a randomized trial. Arthritis and rheumatology. (2018) 70  pp616-', '10.55563/clinexprheumatol/hfceu3', '']\n",
      "['9740910', 'NCT01000441. Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01000441. (2009)   pp', '10.1016/s1098-3015(11)72191-x', '']\n",
      "['9741414', 'Nguyen Minh Vu Chuong; Courtier Anais; Adrait Annie; Defendi Federica; Coute Yohann; Baillet Athan; Guigue Lisa; Gottenberg Jacques-Eric; Dumestre-Perard Chantal; Brun Virginie; Gaudin Philippe. Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFalpha. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05030-6', 'http://link.springer.com/article/10.1007/s10067-020-05030-6/fulltext.html']\n",
      "['9743100', 'Virone Alexandre; Bastard Jean-Philippe; Fellahi Soraya; Capeau Jacqueline; Rouanet Stephanie; Sibilia Jean; Ravaud Philippe; Berenbaum Francis; Gottenberg Jacques-Eric; Sellam Jeremie. Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. RMD open. (2019) 5 2 ppe000897', '10.1136/rmdopen-2019-000897', '']\n",
      "['9743174', 'Felten R; Alyanakian M-A; Chatenoud L; Sibilia J; Gandjbakhch F; Lukas C; Gottenberg J-E. Change in RF and anti-CCP isotype levels in RA patients treated with anti-TNF, abatacept, rituximab or tocilizumab and correlation with clinical and radiographic outcomes: data from a randomized trial. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp616', '10.1002/art.40700', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40700']\n",
      "['11083786', 'Roongta R; Sircar G; Ghosh P; Sit H; Ghosh D. COMPARISON of RITUXIMAB VERSUS LEFLUNOMIDE in COMBINATION with METHOTREXATE in PATIENTS with ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE TREATMENT-AN OPEN LABEL, RANDOMISED CONTROLLED TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1328-1329', '10.1136/annrheumdis-2022-eular.1913', '']\n",
      "['9260975', 'Yazici Y; Curtis JR; Ince A; Baraf HS; Lepley DM; Devenport JN; Kavanaugh A. Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy  Study). Clinical and experimental rheumatology. (2013) 31 3 pp358-364', '10.1136/ard.2010.148700', '']\n",
      "['9263328', 'Yazici Y; Curtis JR; Ince A; Baraf H; Malamet RL; Teng LL; Kavanaugh A. Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. Annals of the rheumatic diseases. (2012) 71 2 pp198-205', '10.1136/ard.2010.148700', '']\n",
      "['9736879', 'NCT00531817. A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00531817. (2007)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9262305', 'Oba K; Horie N; Sato N; Saito K; Takeuchi T; Mimori T; Miyasaka N; Koike T; Tanaka Y. Remission induction by Raising the dose of Remicade in RA (RRRR) study: rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis. Contemporary clinical trials communications. (2017) 8  pp49-54', '10.1016/j.conctc.2017.08.007', '']\n",
      "['9739546', 'Tanaka Y; Oba K; Koike T; Miyasaka N; Mimori T; Takeuchi T; Hirata S; Tanaka E; Yasuoka H; Kaneko Y; Murakami K; Koga T; Nakano K; Amano K; Ushio K; Atsumi T; Inoo M; Hatta K; Mizuki S; Nagaoka S; Tsunoda S; Dobashi H; Horie N; Sato N. Sustained clinical remission after discontinuation of infliximab with a raising dose strategy in patients with rheumatoid arthritis (RRRR study): a randomized controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp3170-3172', '10.1136/annrheumdis-2019-216169', '']\n",
      "['9742783', 'UMIN000005113. Evaluation of the clinical remission and its sustainment after discontinuation of infliximab in patients with rheumatoid arthritis who receive \"programmed\"  treatment in randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005113. (2011)   pp', '10.1016/j.conctc.2017.08.007', '']\n",
      "['11087617', \"Tanaka Y; Oba K; Takeuchi T. Response to: comment on Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al ' by Berkhout et al. Annals of the rheumatic diseases. (2021) 80 11 ppE173\", '10.1136/annrheumdis-2019-216593', '']\n",
      "['9258234', 'Urata Y; Abe S; Devers B; Nakamura Y; Takemoto H; Furukawa K-I. A novel dose reduction therapy using biological disease-modifying anti-rheumatic drugs to target matrix metalloproteinase 3 normalization together with a simplified disease activity index <3.3 yields effects non-inferior to standard care in rheumatoid arthritis with regards maintaining remission. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp204-205', '10.1136/annrheumdis-2016-eular.2309', '']\n",
      "['9262433', 'Urata Y; Abe S; Devers B; Nakamura Y; Takemoto H; Furukawa K-I. Characteristics of patients who respond poorly to reduction of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis; Rt-4 study post hoc analysis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp800', '10.1136/annrheumdis-2017-eular.2498', '']\n",
      "['9258129', 'Salaffi F; Carotti M; Cervini C. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy. Clinical rheumatology. (1995) 14 4 pp458-463', '10.1007/bf02207682', 'http://link.springer.com/article/10.1007/BF02207682/fulltext.html']\n",
      "['9260274', 'Nishimoto N; Hashimoto J; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Murata N; van der Heijde D; Kishimoto T. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Annals of the rheumatic diseases. (2007) 66 9 pp1162-1167', '10.1136/ard.2006.068064', '']\n",
      "['9260474', 'Hashimoto J; Garnero P; van der Heijde D; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Yoshikawa H; Nishimoto N. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs. Modern rheumatology / the Japan Rheumatism Association. (2009) 19 3 pp273-282', '10.3109/s10165-009-0170-4', '']\n",
      "['9260657', 'Hashimoto J; Garnero P; van der Heijde D; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Yoshikawa H; Nishimoto N. Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study. Modern rheumatology / the Japan Rheumatism Association. (2011) 21 1 pp10-15', '10.3109/s10165-010-0325-3', '']\n",
      "['9737766', 'JapicCTI-050016. A controlled, randomized trial of MRA monotherapy in patients with rheumatoid arthritis(RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-050016. (2005)   pp', '10.1186/isrctn44344800', '']\n",
      "['9740286', 'JapicCTI-050018. Double-blind, parallel-group, controlled Phase 3 study of MRA in rheumatoid arthritis(RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-050018. (2005)   pp', '10.1186/isrctn07336279', '']\n",
      "['9257011', 'Williamson E; McConkey C; Heine P; Dosanjh S; Williams M; Lamb SE. Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial. BMJ open. (2017) 7 4 ppe013121', '10.1136/bmjopen-2016-013121', '']\n",
      "['9260896', 'Adams J; Bridle C; Dosanjh S; Heine P; Lamb SE; Lord J; McConkey C; Nichols V; Toye F; Underwood MR; Williams MA; Williamson EM. Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): Design of a randomised controlled trial of a hand and upper limb exercise intervention - ISRCTN89936343. BMC musculoskeletal disorders. (2012) 13  pp', '10.1186/1471-2474-13-230', 'http://link.springer.com/article/10.1186/1471-2474-13-230/fulltext.html']\n",
      "['9261770', 'Dritsaki M. From theory to practice: Case study from the SARAH trial. Annals of the rheumatic diseases. (2015) 74  pp52-53', '10.1136/annrheumdis-2015-eular.6729', '']\n",
      "['9256869', 'Emery P; Hoogstraten HV; Jayawardena S; Mangan EK; Cejas P; Verschueren P. Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/key075.446', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.446/24768368/key075.446.pdf']\n",
      "['9258142', 'Genovese M; Van Hoogstraten H; Mangan E; Graham N; Spindler A. Clinical and radiographic outcomes after 3 years of sarilumab in patients with rheumatoid arthritis. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp29', '10.1093/rheumatology/kex061.003', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex061.003/19705332/kex061.003.pdf']\n",
      "['9262589', 'Emery P; Van Hoogstraten H; Jayawardena S; Mangan EK; Cejas P; Verschueren P. Efficacy of sarilumab in patients with rheumatoid arthritis (RA) who previously received sarilumab or tocilizumab. Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp21', '10.1093/rheumatology/key075.446', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.446/24768368/key075.446.pdf']\n",
      "['9262685', 'Verschueren P; Emery P; Van Hoogstraten H; Dong Q; Mangan EK; Den Broeder A. Efficacy of sarilumab in patients with rheumatoid arthritis with and without previous response to tocilizumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp327-328', '10.1136/annrheumdis-2018-eular.1376', '']\n",
      "['9736542', 'EUCTR2012-003536-23-NL. To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003536-23-NL. (2013)   pp', '10.1093/ww/9780199540884.013.u214791', '']\n",
      "['9736907', 'Emery P; Van Hoogstraten H; Jayawardena S; Mangan E; Cejas P; Verschueren P. Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii137-iii138', '10.1093/rheumatology/key075.446', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.446/24768368/key075.446.pdf']\n",
      "['9737540', 'NCT01768572. To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN). https://clinicaltrials.gov/show/NCT01768572. (2013)   pp', '10.1007/s40278-013-4807-x', 'http://link.springer.com/article/10.1007/s40278-013-4807-x/fulltext.html']\n",
      "['9737756', 'Verschueren P; Emery P; Van Hoogstraten H; Dong Q; Mangan EK; Den Broeder A. Efficacy of sarilumab in patients with rheumatoid arthritis with and without previous response to tocilizumab. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp327-328', '10.1136/annrheumdis-2018-eular.1376', '']\n",
      "['9738581', 'Emery P; Van Hoogstraten H; Jayawardena S; Mangan EK; Cejas P; Verschueren P. Efficacy of sarilumab in patients with rheumatoid arthritis (RA) who previously received sarilumab or tocilizumab. Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp21', '10.1093/rheumatology/key075.446', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.446/24768368/key075.446.pdf']\n",
      "['9740583', 'Emery Paul; Rondon Juan; Parrino Janie; Lin Yong; Pena-Rossi Claudia; van Hoogstraten Hubert; Graham Neil M H; Liu Nancy; Paccaly Anne; Wu Richard; Spindler Alberto. Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2018) 58 5 pp849-858', '10.1093/rheumatology/key361', 'http://academic.oup.com/rheumatology/article-pdf/58/5/849/28720005/key361.pdf']\n",
      "['9741082', 'NCT02057250. To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT02057250. (2014)   pp', '10.31525/ct1-nct04171414', '']\n",
      "['9737463', 'EUCTR2013-002790-22-HU. To evaluate the immunogenicity and safety of sarilumab administered as monotherapy in patients with rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-002790-22-HU. (2014)   pp', '10.1093/rheumatology/key075.438', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.438/24768351/key075.438.pdf']\n",
      "['9737986', 'NCT02121210. To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT02121210. (2014)   pp', '10.1136/annrheumdis-2015-eular.4607', '']\n",
      "['9738434', 'Wells Alvin F; Parrino Janie; Mangan Erin K; Paccaly Anne; Lin Yong; Xu Christine; Fan Chunpeng; Graham Neil M H; van Hoogstraten Hubert; Torri Albert. Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs. Rheumatology and therapy. (2019) 6 3 pp339-352', '10.1007/s40744-019-0157-3', 'https://link.springer.com/article/10.1007/s40744-019-0157-3/fulltext.html']\n",
      "['9263254', 'Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J; Kishimoto T. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Modern rheumatology / the Japan Rheumatism Association. (2009) 19 1 pp12-19', '10.3109/s10165-008-0125-1', '']\n",
      "['9259706', 'Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Archives of internal medicine. (1999) 159 21 pp2542-2550', '10.1002/1529-0131(200109)44:9<1984::aid-art346>3.0.co;2-b', '']\n",
      "['11088173', 'Emery P; Suh C-H; Weinblatt M E; Smolen J S; Keystone E C; Genovese M; Vencovsky J; Kay J; Hong E; Baek Y; Ghil J. Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis. Scandinavian journal of rheumatology. (2020) 49 5 pp361-370', '10.1080/03009742.2020.1732458', '']\n",
      "['9737784', 'Emery P; Suh C-H; Weinblatt M E; Smolen J S; Keystone E C; Genovese M; Vencovsky J; Kay J; Hong E; Baek Y; Ghil J. Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis. Scandinavian journal of rheumatology. (2020)   pp1-10', '10.1080/03009742.2020.1732458', '']\n",
      "['9260875', 'Ernst E. A blueprint for placebo-controlled double-blind studies of complex, individualised interventions. Focus on Alternative and Complementary Therapies. (2011) 16  1 pp49', '10.1111/j.2042-7166.2010.01070_7.x', '']\n",
      "['9259056', 'Scott DL; Dawes PT; Tunn E; Fowler PD; Shadforth MF; Fisher J; Clarke S; Collins M; Jones P; Popert AJ. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study. British journal of rheumatology. (1989) 28 2 pp128-133', '10.1093/rheumatology/28.2.128', 'http://academic.oup.com/rheumatology/article-pdf/28/2/128/5040583/28-2-128.pdf']\n",
      "['9738497', 'Tak PP; Mease PJ; Genovese MC; Kremer JM; Haraoui B; Tanaka Y; Bingham CO. Efficacy and safety of Ocrelizumab in patients with active rheumatoid arthritis who have an inadequate response to at least one TNF inhibitor: results from the phase III SCRIPT trial. Arthritis and rheumatism. (2010) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 10 Philadelphia, PA United States. Conference Start: 20091016 Conference End: 20091021. Conference Publication: var.pagings pp2169', '10.1002/art.33353', '']\n",
      "['9741155', \"NCT00476996. A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-Œ± Therapy (SCRIPT). https://clinicaltrials.gov/show/NCT00476996. (2007)   pp\", '10.2169/internalmedicine.45.0156', '']\n",
      "['9261837', 'Okano T; Inui K; Tada M; Sugioka Y; Mamoto K; Koike T; Nakamura H. Additional intensive treatment for rheumatoid arthritis patients with positive power doppler signals reduce the radiological joint damage even after achieving clinical remission-scrum study-. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.2616', '']\n",
      "['9738113', 'UMIN000009535. Suppress the joint destruction in clinical remission patients who have active synovitis of ultrasonographic assessment by increasing the dose of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009535. (2012)   pp', '10.1186/isrctn24868111', '']\n",
      "['9258520', 'Curtis JR; Trivedi M; Haraoui B; Emery P; Park GS; Collier DH; Aras GA; Chung J. Defining and characterizing sustained remission in patients with rheumatoid arthritis. Clinical rheumatology. (2018) 37 4 pp885-893', '10.1007/s10067-017-3923-z', 'http://link.springer.com/article/10.1007/s10067-017-3923-z/fulltext.html']\n",
      "['9738740', 'Curtis Jeffrey R; Trivedi Mona; Haraoui Boulos; Emery Paul; Park Grace S; Collier David H; Aras Girish A; Chung James. Defining and characterizing sustained remission in patients with rheumatoid arthritis. Clinical rheumatology. (2018) 37 4 pp885-893', '10.1007/s10067-017-3923-z', 'http://link.springer.com/article/10.1007/s10067-017-3923-z/fulltext.html']\n",
      "['11083852', 'Curtis J; Karis E; Bykerk V; Kricorian G; Yen P; Emery P; Haraoui P; Collier D; Stolshek B. Effect of withdrawing etanercept or methotrexate on patient-reported outcomes in rheumatoid arthritis patients in remission on combination therapy: results from the seam-ra trial. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp66', '10.1136/annrheumdis-2021-eular.1863', '']\n",
      "['11084509', 'Curtis JR; Stolshek B; Emery P; Haraoui B; Karis E; Kricorian G; Collier DH; Yen PK; Bykerk VP. Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: results From the SEAM-RA Trial. Journal of clinical rheumatology. (2023) 29 1 pp16-22', '10.1097/rhu.0000000000001893', '']\n",
      "['11085635', 'Conaghan PG; Mysler E; Tanaka Y; Da Silva-Tillmann B; Shaw T; Liu J; Ferguson R; Enejosa JV; Cohen S; Nash P; Rigby W; Burmester G. Upadacitinib in Rheumatoid Arthritis: a Benefit-Risk Assessment Across a Phase III Program. Drug safety. (2021) 44(5)  pp515-530', '10.1007/s40264-020-01036-w', 'https://link.springer.com/article/10.1007/s40264-020-01036-w/fulltext.html']\n",
      "['11086080', 'Tanaka Y; Cohen S; Van Vollenhoven R; Curtis J; Calabrese L; Zerbini C; Bessette L; Richez C; Lagunes-Galindo I; Liu J; Camp H; Song Y; Anyanwu S; Burmester G. Integrated safety profile of upadacitinib with up to 4.5 years of exposure in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp110-111', '10.1136/annrheumdis-2021-eular.1856', '']\n",
      "['9262601', 'Genovese MC; Fleischmann R; Combe B; Hall S; Rubbert-Roth A; Zhang Y; Zhou Y; Mohamed M-EF; Meerwein S; Pangan AL. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial. Lancet. (2018) 391 10139 pp2513-2524', '10.1016/s0140-6736(18)31116-4', '']\n",
      "['9262633', 'Genovese MC; Fleischmann R; Combe B; Hall S; Zhang Y; Zhou Y; Mohamed MF; Meerwein S; Pangan AL. Upadacitinib in patients with active rheumatoid arthritis and inadequate response or intolerance to biological dMARDS: a phase 3 randomized, placebocontrolled, double-blind study of a selective JAK1 inhibitor. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp970', '10.1136/annrheumdis-2018-eular.4180', '']\n",
      "['9262657', 'Strand V; Schiff M; Tundia N; Friedman A; Meerwein S; Pangan A; Ganguli A; Fuldeore M; Song Y; Pope J. Patient reported outcomes of upadacitinib: results from biologic inadequate responders (select beyond phase iii trial). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp990', '10.1136/annrheumdis-2018-eular.1254', '']\n",
      "['9736676', 'Weinblatt M; Thomson G; Chen K; Meerwein S; Schlacher C; Cush J. Clinical responses in patients with inadequate response to bdmards upon treatment with upadacitinib. Annals of the rheumatic diseases. (2019) 78  pp759-', '10.1136/annrheumdis-2019-eular.3083', '']\n",
      "['9736941', 'Andrea R-R; Genovese MC; Combe B; Hall S; Sheng Z; Sebastian M; Roy F. Upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological DMARDs: results at 60 weeks from the SELECT-BEYOND Study. Swiss medical weekly. (2019) 149  pp7S-', '10.1136/annrheumdis-2019-eular.2285', '']\n",
      "['9737046', 'Genovese MC; Fleischmann R; Combe B; Hall S; Zhang Y; Zhou Y; Mohamed MF; Meerwein S; Pangan AL. Upadacitinib in patients with active rheumatoid arthritis and inadequate response or intolerance to biological dMARDS: a phase 3 randomized, placebocontrolled, double-blind study of a selective JAK1 inhibitor. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp970', '10.1136/annrheumdis-2018-eular.4180', '']\n",
      "['9738157', 'Genovese MC; Combe B; Hall S; Rubbert-Roth A; Zhong S; Meerwein S; Pangan A; Fleischmann R. Upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological dMARDs: results at 60 weeks from the select-beyond study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp360-361', '10.1136/annrheumdis-2019-eular.2285', '']\n",
      "['9738590', 'Genovese Mark C; Fleischmann Roy; Combe Bernard; Hall Stephen; Rubbert-Roth Andrea; Zhang Ying; Zhou Yijie; Mohamed Mohamed-Eslam F; Meerwein Sebastian; Pangan Aileen L. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial. Lancet (london, england). (2018) 391 10139 pp2513-2524', '10.1016/s0140-6736(18)31116-4', '']\n",
      "['9738715', 'Strand V; Schiff M; Tundia N; Friedman A; Meerwein S; Pangan A; Ganguli A; Fuldeore M; Song Y; Pope J. Patient reported outcomes of upadacitinib: results from biologic inadequate responders (select beyond phase iii trial). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp990', '10.1136/annrheumdis-2018-eular.1254', '']\n",
      "['9739512', 'Wells AF; Lee YC; Tundia N; Suboticki J; Chen K; Friedman A; Strand V. Effect of upadacitinib on pain and morning stiffness in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic disease-modifying anti-rheumatic drugs. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2806-2807', '10.1136/annrheumdis-2018-eular.1202', '']\n",
      "['9739612', 'EUCTR2015-003335-35-PT. A Study to Compare ABT-494 to Placebo in Subjects with Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who have an Inadequate Response or Intolerance to Biologic DMARDs (SELECT-BEYOND). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003335-35-PT. (2016)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9741162', 'NCT02706847. A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs. https://clinicaltrials.gov/show/NCT02706847. (2016)   pp', '10.3390/biomedicines11071987', '']\n",
      "['9742190', 'FitzGerald O; Rubbert-Roth A; Chen K; Meerwein S; Enejosa J; Shaw T; Wells AF. Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csDMARDS or bDMARDs. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp981', '10.1136/annrheumdis-2018-eular.4221', '']\n",
      "['9742352', 'Kremer J; Van Den Bosch F; Rubbert-Roth A; Radominski SC; Burmester GR; Camp H; Meerwein S; Howard M; Song Y; Zhong S; Combe B. A comparison of upadacitinib plus methotrexate and upadacitinib plus other CSDMARDS in patients with rheumatoid arthritis: an analysis of two phase 3 studies. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp749-750', '10.1136/annrheumdis-2019-eular.2572', '']\n",
      "['9742364', 'Weinblatt M; Thomson G; Chen K; Meerwein S; Schlacher C; Cush J. Clinical responses in patients with inadequate response to bdmards upon treatment with upadacitinib. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp759', '10.1136/annrheumdis-2019-eular.3083', '']\n",
      "['11086345', 'Genovese M; Combe B; Hall S; Rubbert-Roth A; Zhong S; Meerwein S; Pangan A; Fleischmann R. Upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological DMARDs: results at 60 weeks from SELECT-BEYOND. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp23', '10.1136/annrheumdis-2019-eular.2285', '']\n",
      "['11087322', 'Van Vollenhoven R; Hall S; Wells AF; Meerwein S; Song Y; Suboticki J; Fleischmann RM. SUSTAINABILITY of RESPONSE to UPADACITINIB among PATIENTS with ACTIVE RHEUMATOID ARTHRITIS REFRACTORY to BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1290-1291', '10.1136/annrheumdis-2022-eular.1191', '']\n",
      "['11085152', 'Bergman Martin; Buch Maya H; Tanaka Yoshiya; Citera Gustavo; Bahlas Sami; Wong Ernest; Song Yanna; Zueger Patrick; Ali Mira; Strand Vibeke. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials. Rheumatology and therapy. (2022) 9 6 pp1517-1529', '10.1007/s40744-022-00483-4', 'https://link.springer.com/article/10.1007/s40744-022-00483-4/fulltext.html']\n",
      "['11086488', 'Bergman MJ; Tanaka Y; Citera G; Bahlas S; Ali M; Meerwein S; Song Y; Strand V. Upadacitinib treatmentand the routine assessment of patient index data 3 (rapid3) among patients with rheumatoid arthritis. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS11', '10.1136/annrheumdis-2020-eular.1261', '']\n",
      "['11086624', 'Bergman M; Tanaka Y; Citera G; Bahlas S; Ali M; Meerwein S; Song Y; Strand V. Upadacitinib treatment and the routine assessment of patient index data 3 (RAPID3) among patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp315-316', '10.1136/annrheumdis-2020-eular.1261', '']\n",
      "['11087490', 'Rubbert-Roth A; Combe B; Szekanecz Z; Hall S; Haraoui B; Attar SMH; Ekwall A-KH; Song Y; Shaw T; Nagy O; Xavier RM. CONSISTENCY IN TIME TO RESPONSE WITH UPADACITINIB (UPA) AS MONOTHERAPY OR COMBINATION THERAPY AND ACROSS PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS (RA). Internal medicine journal. (2022) 52 SUPPL 3 pp29', '10.1136/annrheumdis-2022-eular.1591', '']\n",
      "['11088335', 'Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Zueger P; Ali M; Strand V. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials. . (2022)   pp', '10.1007/s40744-022-00483-4', 'https://link.springer.com/article/10.1007/s40744-022-00483-4/fulltext.html']\n",
      "['9737363', 'Van Vollenhoven R; Dore R; Chen K; Camp HS; Enejosa J; Shaw T; Suboticki JL; Hall S. Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic dmards. Rheumatology (united kingdom). (2019) Conference: 2019 Annual Conference of the British Society for Rheumatology, BSR 2019. United Kingdom. 58 Supplement 3 ppiii63', '10.1093/rheumatology/kez106.056', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.056/28712106/kez106.056.pdf']\n",
      "['9740804', 'Sornasse T; Sokolove J; McInnes I. Treatment with upadacitinib results in the normalization of key pathobiologic pathways in patients with rheumatoid arthritis: biomarker results from the phase 3 SELECTNEXT and select-beyond studies. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp365-366', '10.1136/annrheumdis-2019-eular.2994', '']\n",
      "['9740858', '. A comparison of upadacitinib plus methotrexate and upadacitinib plus other csDMARDs in patients with rheumatoid arthritis: an analysis of two phase 3 studies. Annals of the rheumatic diseases. (2019) 78  pp749-750', '10.1136/annrheumdis-2019-eular.2572', '']\n",
      "['9742966', '. The association between patient reported outcomes and clinical measures among rheumatoid arthritis patients: analyses using phase 3 clinical trials of upadacitinib. Journal of clinical rheumatology. (2019) 25 3 ppS54-', '10.1186/s13075-022-02891-x', 'https://link.springer.com/article/10.1186/s13075-022-02891-x/fulltext.html']\n",
      "['11086176', 'Charles-Schoeman C; Giles JT; Lane N; Choy E; Camp H; Song Y; Anyanwu S; McInnes I. Relationship between changes in lipid levels and improvement in disease activity outcomes in patients with rheumatoid arthritis receiving upadacitinib treatment: pooled analysis of data from two phase 3 studies. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp569', '10.1136/annrheumdis-2021-eular.606', '']\n",
      "['9742092', 'Strand V; Damjanov N; Scoville C; Tundia N; Camp HS; Chen K; Suboticki J; Van Vollenhoven R. The association between patient reported outcomes and clinical measures among rheumatoid arthritis patients: analyses using phase 3 clinical trials of upadacitinib. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2832-2833', '10.1002/art.40700', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40700']\n",
      "['9740158', 'EUCTR2016-000933-37-ES. Study to Compare ABT-494 to Abatacept in Subjects with Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who have an Inadequate Response or Intolerance to Biologic DMARDs (SELECT-CHOICE). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000933-37-ES. (2016)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['11083627', 'Rubbert-Roth Andrea; Enejosa Jeffrey; Pangan Aileen L; Haraoui Boulos; Rischmueller Maureen; Khan Nasser; Zhang Ying; Martin Naomi; Xavier Ricardo M. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. New England journal of medicine. (2020) 383 16 pp1511-1521', '10.1056/nejmoa2008250', '']\n",
      "['11083669', 'Rubbert-Roth A; Sparks JA; Constantin A; Xavier RM; Song Y; Suboticki JL; Fleischmann RM. Impact of Serologic Status on Clinical Responses to Upadacitinib or Abatacept in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Biologic DMARDs: sub-Group Analysis from the Phase 3 SELECTCHOICE Study. Swiss medical weekly. (2022) 152 Supplement 261 pp13S', '10.1136/annrheumdis-2022-eular.2448', '']\n",
      "['11083675', 'Rubbert-Roth A; Xavier R; Haraoui B; Baraf HSB; Rischmueller M; Martin N; Song Y; Suboticki J; Cush J. Clinical responses to upadacitinib or abatacept in patients with rheumatoid arthritis by type of prior biologic diseasemodifying antirheumatic drug: data from the phase 3 select-choice study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp580', '10.1136/annrheumdis-2021-eular.2114', '']\n",
      "['11084831', 'Van Vollenhoven R; Rubbert-Roth A; Hall S; Xavier RM; Shmagel A; Song Y; Anyanwu SI; Strand V. Impact of Upadacitinib Versus Abatacept on Individual Disease Outcomes in Patients With Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs. Swiss medical weekly. (2022) 152 Supplement 261 pp14S', '10.1136/annrheumdis-2022-eular.2536', '']\n",
      "['11085052', 'Bergman M; Tundia N; Martin N; Suboticki JL; Patel J; Goldschmidt D; Song Y; Wright GC. Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial. . (2022) 24 1 pp', '10.1186/s13075-022-02940-5', 'https://link.springer.com/article/10.1186/s13075-022-02940-5/fulltext.html']\n",
      "['11085399', 'Rubbert-Roth A; Enejosa J; Pangan A; Xavier R; Haraoui B; Rischmueller M; Khan N; Zhang Y; Martin N; Genovese MC. Efficacy and safety of upadacitinib versus abatacept in patients with active rheumatoid arthritis and prior inadequate response or intolerance to biologic disease-modifying anti-rheumatic drugs (SELECT-CHOICE): a double-blind, randomized controlled phase 3 trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp1015-1016', '10.1136/annrheumdis-2020-eular.2059', '']\n",
      "['11086093', 'Andrea R-R; Ricardo X; Boulos H; Herbert SBB; Maureen R; Naomi M; Yanna S; Jessica LS; John JC. Clinical responses to upadacitinib or abatacept in patients with rheumatoid arthritis by type of prior biologic disease-modifying antirheumatic drug: data from the phase 3 SELECT-CHOICE study. Swiss medical weekly. (2021) 151 SUPPL 252 pp21S', '10.1136/annrheumdis-2021-eular.2114', '']\n",
      "['11087211', 'Van Vollenhoven R; Rubbert-Roth A; Hall S; Xavier R; Shmagel A; Song Y; Anyanwu S; Strand V. IMPACT of UPADACITINIB VERSUS ABATACEPT on INDIVIDUAL DISEASE OUTCOMES in PATIENTS with RHEUMATOID ARTHRITIS and INADEQUATE RESPONSES to BIOLOGIC DMARDS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp626', '10.1136/annrheumdis-2022-eular.2536', '']\n",
      "['11087298', 'Rubbert-Roth A; Sparks J; Constantin A; Xavier R; Song Y; Suboticki J; Fleischmann RM. IMPACT of SEROLOGIC STATUS on CLINICAL RESPONSES to UPADACITINIB or ABATACEPT in PATIENTS with RHEUMATOID ARTHRITIS and PRIOR INADEQUATE RESPONSE to BIOLOGIC DMARDS: SUB-GROUP ANALYSIS from the PHASE 3 SELECT-CHOICE STUDY. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1302-1303', '10.1136/annrheumdis-2022-eular.2448', '']\n",
      "['9737346', 'Genovese MC; Fleischmann R; Blanco R; Hall S; Thomson G; Van Den Bosch F; Zerbini C; Enejosa JJ; Li Y; Demasi R; Song I-H. Switching between the JAK1-selective inhibitor-upadacitinib and adalimumab following initial non-response: clinical and functional outcomes among rheumatoid arthritis patients. Annals of the rheumatic diseases. (2019) 78  pp83-84', '10.1136/annrheumdis-2019-eular.2886', '']\n",
      "['9740060', 'EUCTR2015-003333-95-SK. A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects with Rheumatoid Arthritis who are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003333-95-SK. (2015)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9740712', 'Strand V; Bergman M; Tundia N; Ostor A; Durez P; Song I-H; Enejosa JJ; Schlacher C; Song Y; Fleischmann R. Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to methotrexate: results from select-compare. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp738-739', '10.1136/annrheumdis-2019-eular.287', '']\n",
      "['9740775', 'Fleischmann Roy M; Genovese Mark C; Enejosa Jeffrey V; Mysler Eduardo; Bessette Louis; Peterfy Charles; Durez Patrick; Ostor Andrew; Li Yihan; Song In-Ho. Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response. Annals of the rheumatic diseases. (2019) 78 11 pp1454-1462', '10.1136/annrheumdis-2019-215764', '']\n",
      "['9742728', 'Fleischmann R; Pangan AL; Mysler E; Bessette L; Peterfy C; Durez P; Ostor A; Li Y; Zhou Y; Othman AA; Song I-H; Genovese MC. A phase 3, randomized, double-blind study comparing upadacitinib to placebo and to adalimumab, in patients with active rheumatoid arthritis with inadequate response to methotrexate. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp988-990', '10.1002/art.41032', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41032']\n",
      "['9742950', 'Fleischmann R; Enejosa J; Song I-H; Mysler E; Bessette L; Peterfy C; Durez P; Ostor A; Yihan L; Zhou Y; Genovese MC. Safety and effectiveness of upadacitinib or adalimumab in patients with rheumatoid arthritis: results at 48 weeks from the select-compare study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp744-745', '10.1136/annrheumdis-2019-eular.4258', '']\n",
      "['11083726', 'Fleischmann R; Song IH; Enejosa J; Mysler E; Bessette L; Durez P; Ostor A; Swierkot J; Song Y; Genovese MC. Long-term safety and effectiveness of upadacitinib or adalimumab in patients with rheumatoid arthritis: results at 72 weeks from the select-compare study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp323', '10.1136/annrheumdis-2020-eular.1418', '']\n",
      "['11084716', 'Mysler E; Tanaka Y; Kavanaugh A; Aletaha D; Taylor PC; Song IH; Shaw T; Song Y; Demasi R; Ali M; Fleischmann R. Impact of upadacitinib or adalimumab as initial therapy on the achievement of 48-week treatment goals in patients with rheumatoid arthritis and inadequate response to methotrexate: post hoc analysis of a phase 3 study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp566-567', '10.1136/annrheumdis-2021-eular.474', '']\n",
      "['11084813', 'Nash P; Kavanaugh A; Buch MH; Combe B; Bessette L; Song IH; Song Y; Suboticki J; Fleischmann R. Sustainability of response between upadacitinib and adalimumab among patients with rheumatoid arthritis and prior inadequate response to methotrexate. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp647-648', '10.1136/annrheumdis-2020-eular.1230', '']\n",
      "['11084820', 'Sornasse T; Cai F; Hong F; Anyanwu S; Song IH; Bukhari M. PREDICTORS of REMISSION in RHEUMATOID ARTHRITIS PATIENTS TREATED with UPADACITINIB or ADALIMUMAB in the SELECT-COMPARE PHASE 3 STUDY: CLINICAL STATUS at WEEK 12, but NOT STANDARD LABORATORY MEASURES, PROVIDES the BEST CURRENT PREDICTOR of REMISSION at WEEK 26. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp533-534', '10.1136/annrheumdis-2022-eular.2544', '']\n",
      "['11085009', 'Mysler E; Tanaka Y; Kavanaugh A; Aletaha D; Taylor PC; Song I-H; Shaw T; Song Y; DeMasi R; Ali M; Fleischmann R. Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE. . (2022)   pp', '10.1093/rheumatology/keac477', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac477/45787369/keac477.pdf']\n",
      "['11085098', 'Pavelka K; Szekanecz Z; Damjanov N; Anic B; Tomsic M; Mazurov V; Maksimovic M; Nagy O; Swierkot J; Petranova T; Veldi T; Baranauskaite A; Codreanu C; Andersone D; Fleischmann R. Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients. Drugs in context. (2020) 9  pp', '10.7573/dic.2020-7-5', 'https://www.drugsincontext.com/wp-content/uploads/2020/10/dic.2020-7-5.pdf']\n",
      "['11085301', 'Fleischmann R; Mysler E; Bessette L; Peterfy CG; Durez P; Tanaka Y; Swierkot J; Khan N; Bu X; Li Y; Song IH. Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study. . (2022) 8 1 pp', '10.1136/rmdopen-2021-002012', '']\n",
      "['11085504', 'Pavelka K; Szekanecz Z; Damjanov N; Anic B; Tomsic M; Mazurov V; Maksimovic M; Nagy O; Swierkot J; Petranova T; Veldi T; Baranauskaite A; Codreanu C; Andersone D; Fleischmann R. Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients. . (2020) 9  pp', '10.7573/dic.2020-7-5', 'https://www.drugsincontext.com/wp-content/uploads/2020/10/dic.2020-7-5.pdf']\n",
      "['11085565', 'Tanaka Y; Fleischmann R; Mysler E; Bessette L; Peterfy C; Durez P; Swierkot J; Khan N; Bu X; Li Y; Song I. Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results at 3 years from SELECT-COMPARE. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp112', '10.1136/annrheumdis-2021-eular.535', '']\n",
      "['11085581', 'Fleischmann RM; Blanco R; Hall S; Thomson GTD; Van den Bosch FE; Zerbini C; Bessette L; Enejosa J; Li Y; Song Y; DeMasi R; Song IH. Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 4 pp432-439', '10.1136/annrheumdis-2020-218412', '']\n",
      "['11085606', 'Fleischmann R; Mysler E; Bessette L; Peterfy CG; Durez P; Tanaka Y; Swierkot J; Khan N; Bu X; Li Y; Song IH. Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study. RMD open. (2022) 8 1 pp', '10.1136/rmdopen-2021-002012', '']\n",
      "['11085787', 'Mysler Eduardo; Tanaka Yoshiya; Kavanaugh Arthur; Aletaha Daniel; Taylor Peter C; Song In-Ho; Shaw Tim; Song Yanna; DeMasi Ryan; Ali Mira; Fleischmann Roy. Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE. Rheumatology (Oxford, England). (2022)   pp', '10.1093/rheumatology/keac477', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac477/45787369/keac477.pdf']\n",
      "['11086139', 'Fleischmann R; Mysler E; Bessette L; Peterfy C; Durez P; Tanaka Y; Swierkot J; Khan N; Bu X; Li Y; Song IH. Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results at 3 years from the select-compare study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp251-252', '10.1136/annrheumdis-2021-eular.535', '']\n",
      "['11086204', 'Nash P; Kavanaugh A; Buch M; Combe B; Bessette L; Song I-H; Song Y; Suboticki J; Fleischmann R. Sustainability of response between Upadacitinib and adalimumab among patients with rheumatoid arthritis and prior inadequate response to methotrexate. Internal medicine journal. (2021) 51 SUPPL 2 pp46-47', '10.1136/annrheumdis-2020-eular.1230', '']\n",
      "['11086208', 'Ostor A; Fleischmann R; Song I-H; Enejosa J; Mysler E; Bessette L; Durez P; Swierkot J; Song Y; Genovese M. Long-term safety and effectiveness of Upadacitinib or adalimumab in patients with rheumatoid arthritis: results at 72 weeks. Internal medicine journal. (2021) 51 SUPPL 2 pp39', '10.1136/annrheumdis-2020-eular.1418', '']\n",
      "['11086255', 'Pavelka K; Szekanecz Z; Damjanov N; Anic B; Tomsic M; Mazurov V; Maksimovic M; Nagy O; Swierkot J; Petranova T; Veldi T; Baranauskaite A; Codreanu C; Andersone D; Fleischmann R. Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients. Drugs in context. (2020) 9  pp2020-7-5', '10.7573/dic.2020-7-5', 'https://www.drugsincontext.com/wp-content/uploads/2020/10/dic.2020-7-5.pdf']\n",
      "['11087152', 'Fleischmann R; Combe B; Ostor A; Tena CFP; Khan N; Suboticki JL; Shmagel A; Song Y; Lagunes-Galindo I; Burmester GR. Clinical Outcomes Associated with Glucocorticoid Discontinuation Among Patients With Rheumatoid Arthritis Receiving Upadacitinib or Adalimumab. Swiss medical weekly. (2022) 152 Supplement 261 pp16S', '10.1136/annrheumdis-2022-eular.2505', '']\n",
      "['11087221', 'Nash P; Kavanaugh A; Buch MH; Combe B; Bessette L; Song IH; Shaw T; Song Y; Suboticki J; Fleischmann RM. SUSTAINABILITY of RESPONSE between UPADACITINIB and ADALIMUMAB in PATIENTS with RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS from the SELECT-COMPARE TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp591-592', '10.1136/annrheumdis-2022-eular.1268', '']\n",
      "['11087263', 'Fleischmann RM; Combe B; Ostor A; Pacheco Tena CF; Khan N; Suboticki J; Shmagel A; Song Y; Lagunes-Galindo I; Burmester GR. CLINICAL OUTCOMES ASSOCIATED with GLUCOCORTICOID DISCONTINUATION among PATIENTS with RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB or ADALIMUMAB. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp533', '10.1136/annrheumdis-2022-eular.2505', '']\n",
      "['11087491', 'Nash P; Kavanaugh A; Buch MH; Combe B; Bessette L; Song I-H; Shaw T; Song Y; Suboticki J; Fleischmann R. SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL. Internal medicine journal. (2022) 52 SUPPL 3 pp27', '10.1093/rheumatology/keac132.027', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac132.027/43436367/keac132.027.pdf']\n",
      "['11087538', 'Buch MH; Nash P; Kavanaugh A; Combe B; Bessette L; Song I-H; Shaw T; Song Y; Suboticki JL; Fleischmann R. SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL. Rheumatology (united kingdom). (2022) 61 SUPPL 1 ppi14-i15', '10.1093/rheumatology/keac132.027', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac132.027/43436367/keac132.027.pdf']\n",
      "['11088343', 'Conaghan P; Cohen S; Burmester G; Mysler E; Nash P; Tanaka Y; Rigby W; Patel J; Shaw T; Betts KA; Patel P; Liu J; Sun R; Fleischmann R. Benefit‚ÄìRisk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis. . (2022) 9 1 pp191', '10.1007/s40744-021-00399-5', 'https://link.springer.com/article/10.1007/s40744-021-00399-5/fulltext.html']\n",
      "['11083898', 'Conaghan PG; Pavelka K; Hsieh S-C; Bonnington TL; Kent TC; Edwards CJ. Treating rheumatoid arthritis patients withmoderate disease activity: an analysis of theupadacitinib SELECT Phase III randomised studies. Rheumatology (united kingdom). (2021) 60 SUPPL 1 ppi69-i70', '10.1093/rheumatology/keab247.122', 'http://academic.oup.com/rheumatology/article-pdf/60/Supplement_1/keab247.122/37399780/keab247.122.pdf']\n",
      "['9736856', 'Van Vollenhoven R; Takeuchi T; Pangan A; Friedman A; Chen S; Rischmueller M; Blanco R; Xavier R; Strand V. Monotherapy with upadacitinib in MTX-na‚àö√â¬¨√òve patients with rheumatoid arthritis: results at 48 weeks from the select-early study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp376-377', '10.1136/annrheumdis-2019-eular.3350', '']\n",
      "['9736966', 'EUCTR2015-003334-27-SK. A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate Monotherapy in Subjects with Rheumatoid Arthritis (RA) Who have not Previously taken Methotrexate (SELECT-EARLY). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003334-27-SK. (2015)   pp', '10.1080/14397595.2020.1847776', '']\n",
      "['9737610', 'Van Vollenhoven R; Takeuchi T; Pangan AL; Friedman A; Mohamed MF; Chen S; Rischmueller M; Blanco R; Xavier RM; Strand V. A phase 3, randomized, double-blind study comparing upadacitinib monotherapy to MTX monotherapy in MTX-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂¬¨√Üve patients with active rheumatoid arthritis. Journal of clinical rheumatology. (2019) 25 3 ppS4-', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9740578', 'Van Vollenhoven R; Takeuchi T; Pangan AL; Friedman A; Mohamed MF; Chen S; Rischmueller M; Blanco R; Xavier RM; Strand V. A phase 3, randomized controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naive patients with active rheumatoid arthritis. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp173-174', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9740784', 'Strand V; Tundia N; Radominski S; Friedman A; Dunlap K; Goldschmidt D; Bergman M. Upadacitinib monotherapy improves patientreported outcomes in methotrexate-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¢¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö‚â§ve patients with moderately to severely active rheumatoid arthritis: results from selectearly. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp372-373', '10.1136/annrheumdis-2019-eular.978', '']\n",
      "['9742395', 'Van Vollenhoven R; Takeuchi T; Pangan AL; Friedman A; Mohamed MF; Chen S; Rischmueller M; Blanco R; Xavier RM; Strand V. A phase 3, randomized, double-blind study comparing upadacitinib monotherapy to MTX monotherapy in MTX-naIve patients with active rheumatoid arthritis. Journal of clinical rheumatology. (2019) Conference: 21st Pan American Rheumatology Congress, PANLAR 2019. Ecuador. 25 3 Supplement ppS4', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9742660', 'Van Vollenhoven R; Takeuchi T; Pangan AL; Friedman A; Mohamed M-E; Chen S; Rischmueller M; Blanco R; Xavier RM; Strand V. A phase 3, randomized, controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naive patients with active rheumatoid arthritis. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp990-992', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9742935', 'Van Vollenhoven R; Takeuchi T; Pangan AL; Friedman A; Mohamed MF; Chen S; Rischmueller M; Blanco R; Xavier RM; Strand V. A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¢¬¨¬®¬¨¬Æ‚Äö√†√∂‚àö‚â§ve patients with active rheumatoid arthritis. Rheumatology (united kingdom). (2019) 58 Supplement 3 ppiii64', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['11083874', 'Van Vollenhoven R; Takeuchi T; Rischmueller M; Blanco R; Xavier R; Howard M; Friedman A; Song Y; Strand V. Upadacitinib monotherapy in methotrexatena√ève patients with rheumatoid arthritis: results at 72 weeks from select-early. . (2020) 79 SUPPL 1 pp334', '10.1136/annrheumdis-2020-eular.1857', '']\n",
      "['11084117', 'Takeuchi Tsutomu; Rischmueller Maureen; Blanco Ricardo; Xavier Ricardo M; Ueki Yukitaka; Atsumi Tatsuya; Chen Su; Friedman Alan; Pangan Aileen L; Strand Vibeke; van Vollenhoven Ronald F. Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naive Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern rheumatology. (2021) 31 3 pp534-542', '10.1080/14397595.2020.1847776', '']\n",
      "['9259607', 'Suarez AME; Fitzgerald A; Grace M; Russell AS. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (myochrysineregistered trade mark) in the treatment of rheumatoid arthritis. Journal of rheumatology. (1988) 15 5 pp753-756', '10.1093/rheumatology/37.11.1220', 'http://academic.oup.com/rheumatology/article-pdf/37/11/1220/18105859/371220.pdf']\n",
      "['11085127', 'Takeuchi T; Van Vollenhoven R; Aelion J; Chavez N; Mannucci P; Singhal A; Swierkot J; Friedman A; Khan N; Li Y; Bu X; Klaff J; Strand V. Long-term efficacy and safety of upadacitinib in patients with rheumatoid arthritis: 3-year results from the SELECT-EARLY study. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp109-110', '10.1136/annrheumdis-2021-eular.530', '']\n",
      "['11085386', 'Van Vollenhoven R; Takeuchi T; Rischmueller M; Blanco R; Xavier R; Howard M; Friedman A; Song Y; Strand V. Upadacitinib monotherapy in methotrexatenaIve patients with rheumatoid arthritis: results at 72 weeks from select-early. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp334-335', '10.1136/annrheumdis-2020-eular.1857', '']\n",
      "['11086179', 'Van Vollenhoven R; Takeuchi T; Aelion J; Chavez N; Mannucci Walter P; Singhal A; Swierkot J; Friedman A; Khan N; Li Y; Bu X; Klaff J; Strand V. Long-term safety and efficacy of upadacitinib in patients with rheumatoid arthritis: 3-year results from the selectearly study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp568-569', '10.1136/annrheumdis-2021-eular.530', '']\n",
      "['11086203', 'Rischmueller M; Takeuchi T; Blanco R; Xavier R; Howard M; Friedman A; Song Y; Strand V. Upadacitinib monotherapy in methotrexate-naive patients with rheumatoid arthritis: results at 72 weeks. Internal medicine journal. (2021) 51 SUPPL 2 pp47', '10.1136/annrheumdis-2020-eular.1857', '']\n",
      "['9737678', 'Cohen SB; Van Vollenhoven R; Winthrop K; Zerbini C; Tanaka Y; Bessette L; Yihan L; Khan N; Hendrickson B; Burmester GR. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the select phase 3 clinical program. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp357', '10.1136/annrheumdis-2019-eular.3403', '']\n",
      "['11084832', 'Cohen SB; Van Vollenhoven RF; Winthrop KL; Zerbini CAF; Tanaka Y; Bessette L; Zhang Y; Khan N; Hendrickson B; Enejosa JV; Burmester GR. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. Annals of the rheumatic diseases. (2021) 80 3 pp304-311', '10.1136/annrheumdis-2020-218510', '']\n",
      "['11084857', 'Kavanaugh A; Szekanecz Z; Keystone EC; Rubbert-Roth A; Hall S; Xavier R; Polido-Pereira J; Song I-H; Martin N; Song Y; Anyanwu SI; Nash P. Predictors of response: baseline characteristics and early treatment responses associated with achievement of remission and low disease activityamong upadacitinib-treated patients with rheumatoid arthritis. Journal of clinical rheumatology. (2021) 27 SUPPL 1 ppS81', '10.1136/annrheumdis-2021-eular.2137', '']\n",
      "['11084879', 'Strand Vibeke; Tundia Namita; Wells Alvin; Buch Maya H; Radominski Sebastiao C; Camp Heidi S; Friedman Alan; Suboticki Jessica L; Dunlap Kendall; Goldschmidt Debbie; Bergman Martin. Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY. Rheumatology (Oxford, England). (2021) 60 7 pp3209-3221', '10.1093/rheumatology/keaa770', 'http://academic.oup.com/rheumatology/article-pdf/60/7/3209/38850164/keaa770.pdf']\n",
      "['11085447', 'Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Tundia N; Suboticki J; Strand V. Routine assessment of patient index data 3 (rapid3) in patients with rheumatoid arthritis treated with long-term upadacitinib therapy. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp579', '10.1136/annrheumdis-2021-eular.2090', '']\n",
      "['11086190', 'Kavanaugh A; Szekanecz Z; Keystone EC; Rubbert-Roth A; Hall S; Xavier R; Polido-Pereira J; Song IH; Martin N; Song Y; Anyanwu S; Nash P. Predictors of response: baseline characteristics and early treatment responses associated with achievement of remission and low disease activity among upadacitinib-treated patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp329-330', '10.1136/annrheumdis-2021-eular.2137', '']\n",
      "['9740766', 'Peterfy C; Genovese MC; Song I-H; Friedman A; Hall S; Mysler E; Durez P; Baraliakos X; Enejosa JJ; Shaw T; Yihan L; Chen S; Strand V. Inhibition of structural joint damage with upadacitinib as monotherapy or in combination with methotrexate in patients with rheumatoid arthritis: 1 year outcomes from the select phase 3 program. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp369-370', '10.1136/annrheumdis-2019-eular.2871', '']\n",
      "['11083705', 'Hall S. Radiographic outcomes in patients with rheumatoid arthritis receiving Upadacitinib as monotherapy or in combination with methotrexate: results at 2 years. Internal medicine journal. (2021) 51 SUPPL 2 pp47', '10.1136/annrheumdis-2020-eular.1869', '']\n",
      "['11083906', 'Peterfy CG; Strand V; Friedman A; Hall S; Mysler E; Durez P; Baraliakos X; Enejosa JV; Shaw T; Li Y; Chen S; Song IH. Inhibition of Structural Joint Damage Progression with Upadacitinib in Rheumatoid Arthritis: 1-Year Outcomes from the SELECT Phase 3 Program. Rheumatology (Oxford, England). (2022) 61 8 pp3246-3256', '10.1093/rheumatology/keab861', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab861/41927982/keab861.pdf']\n",
      "['11085163', 'Peterfy C; Strand V; Genovese MC; Friedman A; Enejosa JJ; Hall S; Mysler E; Durez P; Baraliakos X; Shaw T; Song Y; Li Y; Song IH. Radiographic outcomes in patients with rheumatoid arthritis receiving upadacitinib as monotherapy or in combination with methotrexate: results at 2 years from the select-compare and select-early studies. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp330-331', '10.1136/annrheumdis-2020-eular.1869', '']\n",
      "['11086491', 'Peterfy CG; Genovese MC; Song I-H; Friedman A; Hall S; Mysler E; Durez P; Baraliakos X; Enejosa JV; Shaw T; Li Y; Chen S; Strand V. Inhibition of structural joint damagewith upadacitinib as monotherapyor in combination with methotrexate in patients with rheumatoid arthritis. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS9-S10', '10.1093/rheumatology/keab861', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab861/41927982/keab861.pdf']\n",
      "['9741233', '. Characterization of remission in patients with rheumatoid arthritis treated with upadacitinib or comparators. Annals of the rheumatic diseases. (2019) 78  pp362-', '10.1136/annrheumdis-2019-eular.2003', '']\n",
      "['9742356', 'Hall S; Takeuchi T; Thomson G; Emery P; Combe B; Everding A; Pavelka K; Song Y; Shaw T; Friedman A; Song I-H; Mysler E. Characterization of remission in patients with rheumatoid arthritis treated with upadacitinib or comparators. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp362', '10.1136/annrheumdis-2019-eular.2003', '']\n",
      "['11086180', 'Combe B; Buttgereit F; Ostor A; Xavier R; Saraux A; Daridon C; Famulla K; Song Y; Lagunes-Galindo I; Burmester GR. Impact of concomitant glucocorticoids on the clinical efficacy and safety of upadacitinib in patients with rheumatoid arthritis: an ad hoc analysis of data from three phase 3 studies. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp567-568', '10.1136/annrheumdis-2021-eular.480', '']\n",
      "['11086201', 'Ostor A; Combe B; Buttgereit F; Xavier R; Saraux A; Daridon C; Famulla K; Song Y; Lagunes-Galindo I; Burmester G. Impact of concomitant glucocorticoids on the clinical efficacy and safety of upadacitinib in patients with rheumatoid arthritis: an ad hoc analysis of data from three phase 3 studies. Internal medicine journal. (2021) 51 SUPPL 2 pp36-37', '10.1136/annrheumdis-2021-eular.480', '']\n",
      "['9262637', 'Smolen J; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman A; Camp H; Pangan A. Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp67-68', '10.1136/annrheumdis-2018-eular.4237', '']\n",
      "['9737275', '. Erratum: department of Error (The Lancet (2019) 393(10188) (2303‚àö¬¢‚Äö√á¬®‚Äö√Ñ√∫2311), (S0140673619304192), (10.1016/S0140-6736(19)30419-2)). Lancet. (2019) 393 10191 pp2590-', '10.1016/s0140-6736(19)31472-2', '']\n",
      "['9737552', 'NCT02706951. A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY). https://clinicaltrials.gov/show/NCT02706951. (2016)   pp', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9737584', 'Smolen Josef S; Pangan Aileen L; Emery Paul; Rigby William; Tanaka Yoshiya; Vargas Juan Ignacio; Zhang Ying; Damjanov Nemanja; Friedman Alan; Othman Ahmed A; Camp Heidi S; Cohen Stanley. Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. Lancet (london, england). (2019) 393 10188 pp2303-2311', '10.1016/s0140-6736(19)30419-2', '']\n",
      "['9738682', 'Smolen J; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman A; Camp H; Pangan A. Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp67-68', '10.1136/annrheumdis-2018-eular.4237', '']\n",
      "['9739429', 'Smolen JS; Cohen S; Emery P; Rigby WFC; Tanaka Y; Zhang Y; Friedman A; Othman AA; Camp HS; Pangan AL. Upadacitinib as monotherapy: a phase 3 randomized controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp987-988', '10.1093/rheumatology/kez106.059', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.059/28712306/kez106.059.pdf']\n",
      "['9739522', 'Strand V; Buch M; Tundia N; Camp HS; Suboticki J; Goldschmidt D; Wells AF. Upadacitinib monotherapy improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to methotrexate. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2833-2834', '10.1093/rheumatology/keaa770', 'http://academic.oup.com/rheumatology/article-pdf/60/7/3209/38850164/keaa770.pdf']\n",
      "['9740189', 'EUCTR2015-003376-75-AT. A Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) Monotherapy in Subjects with Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003376-75-AT. (2016)   pp', '10.1093/rheumatology/kez106.058', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.058/28712254/kez106.058.pdf']\n",
      "['9740577', 'Smolen JS; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman AA; Camp HS; Pangan AL. Upadacitinib as monotherapy: phase 3 randomized controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp200', '10.1093/rheumatology/kez106.059', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.059/28712306/kez106.059.pdf']\n",
      "['9740640', 'Smolen JS; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman AA; Camp HS; Pangan AL. Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. Rheumatology (united kingdom). (2019) Conference: 2019 Annual Conference of the British Society for Rheumatology, BSR 2019. United Kingdom. 58 Supplement 3 ppiii64-iii65', '10.1093/rheumatology/kez106.059', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.059/28712306/kez106.059.pdf']\n",
      "['9740801', 'Smolen JS; Emery P; Rigby W; Tanaka Y; Vargas JI; Damjanov N; Jain M; Sui Y; Enejosa J; Pangan A; Camp H; Cohen SB. Upadacitinib as monotherapy in patients with rheumatoid arthritis: results at 48 weeks from the select-monotherapy study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp371-372', '10.1136/annrheumdis-2019-eular.491', '']\n",
      "['9742906', 'Smolen JS; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman AA; Camp HS; Pangan AL. Upadacitinib as monotherapy: a phase 3 randomized controlled double-blind study in patients with active rheumatoid arthritis and inadequate responsetomethotrexate. Journal of clinical rheumatology. (2019) Conference: 21st Pan American Rheumatology Congress, PANLAR 2019. Ecuador. 25 3 Supplement ppS52', '10.1093/rheumatology/kez106.059', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.059/28712306/kez106.059.pdf']\n",
      "['11086075', 'Tanaka Y; Smolen J; Emery P; Rigby W; Vargas J; Damjanov N; Jain M; Song Y; Khan N; Enejosa J; Cohen S. Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 84 weeks, SELECT-MONOTHERAPY study. International journal of rheumatic diseases. (2021) 24 SUPPL 2 pp238', '10.1136/annrheumdis-2020-eular.961', '']\n",
      "['11086346', 'Tanaka Y; Smolen JS; Emery P; Rigby W; Ignacio Vargas J; Damjanov N; Jain M; Sui Y; Enejosa J; Pangan AL; Camp HS; Cohen S. Upadacitinib as monotherapy in patients with rheumatoid arthritis: results at 48 weeks from the SELECT-MONOTHERAPY study. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp79', '10.1136/annrheumdis-2019-eular.491', '']\n",
      "['11086548', 'Smolen JS; Emery P; Rigby W; Tanaka Y; Ignacio Vargas J; Damjanov N; Jain M; Song Y; Khan N; Enejosa JJ; Cohen SB. Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 84 weeks from the selectmonotherapy study. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp331-332', '10.1136/annrheumdis-2020-eular.961', '']\n",
      "['11084320', 'Edwards Christopher J; Sawant Ruta; Garg Vishvas; Du Ella X; Friedman Alan; Betts Keith A. A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and therapy. (2021) 8 1 pp167-181', '10.1007/s40744-020-00257-w', 'http://link.springer.com/article/10.1007/s40744-020-00257-w/fulltext.html']\n",
      "['11084320', 'Edwards Christopher J; Sawant Ruta; Garg Vishvas; Du Ella X; Friedman Alan; Betts Keith A. A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and therapy. (2021) 8 1 pp167-181', '10.1007/s40744-020-00257-w', 'http://link.springer.com/article/10.1007/s40744-020-00257-w/fulltext.html']\n",
      "['9737171', 'Buch M; Wells AF; Rubbert-Roth A; Jain M; Schlacher C; Camp H; Li Y; Song Y; Nash P. A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two phase 3 trials. Annals of the rheumatic diseases. (2019) 78  pp356-', '10.1136/annrheumdis-2019-eular.2626', '']\n",
      "['9737445', 'Buch M; Wells AF; Rubbert-Roth A; Jain M; Schlacher C; Camp H; Li Y; Song Y; Nash P. A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two phase 3 trials. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp356', '10.1136/annrheumdis-2019-eular.2626', '']\n",
      "['9740832', 'Andrea R-R; Buch Maya H; Wells Alvin F; Manish J; Casey S; Heidi CS; Yihan L; Yanna S; Peter N. A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two Phase 3 trials. Swiss medical weekly. (2019) 149  pp8S-', '10.1136/annrheumdis-2019-eular.2626', '']\n",
      "['11083727', 'Kavanaugh A; Buch MH; Combe B; Bessette L; Song IH; Song Y; Suboticki J; Nash P. Sustainability of response to upadacitinib as monotherapy or in combination among patients with rheumatoid arthritis and prior inadequate response to conventional synthetic DMARDs. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp327-328', '10.1136/annrheumdis-2020-eular.1233', '']\n",
      "['11084890', 'Kavanaugh A; Buch M; Combe B; Bessette L; Song I; Song Y; Suboticki J; Nash P. Sustainability of response to upadacitinib alone or in combination among rheumatoid arthritis patients with inadequate response to conventional synthetic DMARDs. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp53', '10.1136/annrheumdis-2020-eular.1233', '']\n",
      "['11085119', 'Buch MH; Wells AF; Rubbert-Roth A; Jain M; Schlacher C; Camp HS; Li Y; Song Y; Nash P. A comparative analysis of upadacitinib monotherapyand upadacitinib combination therapy for the treatment of rheumatoid arthritis from two phase 3 trials. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS10', '10.1136/annrheumdis-2019-eular.2626', '']\n",
      "['9262553', 'Burmester GR; Kremer JM; Van Den Bosch F; Li Y; Zhou Y; Othman AA; Pangan AL; Camp HS. A phase-3 randomized, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Journal of clinical rheumatology. (2018) 24 (3 Supplement 1) 3 Supplement 1 ppS88', '10.1093/rheumatology/key075.466', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.466/24768408/key075.466.pdf']\n",
      "['9262602', 'Burmester GR; Kremer JM; Van den Bosch F; Kivitz A; Bessette L; Li Y; Zhou Y; Othman AA; Pangan AL; Camp HS. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. (2018) 391 10139 pp2503-2512', '10.1016/s0140-6736(18)31115-2', '']\n",
      "['9262659', 'Strand V; Pope J; Tundia N; Friedman A; Camp HS; Pangan A; Ganguli A; Fuldeore M; Goldschmidt D; Schiff M. Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from selectnext. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp989-990', '10.1136/annrheumdis-2018-eular.1202', '']\n",
      "['9262722', 'Burmester G; Kremer J; Van Den Bosch F; Li Y; Zhou Y; Othman A; Pangan A; Camp H. A phase 3 randomised, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp68-69', '10.1136/annrheumdis-2018-eular.3131', '']\n",
      "['9736515', 'Burmester G R; Kremer J; Van Den Bosch; Li Y; Zhou Y; Othman A A; Pangan A L; Camp H S. A phase III randomised placebo-controlled double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Rheumatology (united kingdom). (2018) 57 Supplement 3 pp', '10.1093/rheumatology/key075.466', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.466/24768408/key075.466.pdf']\n",
      "['9736595', 'Burmester G; Kremer J; Van Den Bosch F; Li Y; Zhou Y; Othman A; Pangan A; Camp H. A phase 3 randomised, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp68-69', '10.1136/annrheumdis-2018-eular.3131', '']\n",
      "['9738563', 'Burmester GR; Kremer JM; Van Den Bosch F; Li Y; Zhou Y; Othman AA; Pangan AL; Camp HS. A phase-3 randomized, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Journal of clinical rheumatology. (2018) 24 (3 Supplement 1) 3 Supplement 1 ppS88', '10.1093/rheumatology/key075.466', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.466/24768408/key075.466.pdf']\n",
      "['9738591', 'Burmester Gerd R; Kremer Joel M; Van den Bosch Filip; Kivitz Alan; Bessette Louis; Li Yihan; Zhou Yijie; Othman Ahmed A; Pangan Aileen L; Camp Heidi S. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet (london, england). (2018) 391 10139 pp2503-2512', '10.1016/s0140-6736(18)31115-2', '']\n",
      "['9738657', 'Burmester GR; Kremer J; Van Den Bosch F; Li Y; Zhou Y; Othman AA; Pangan AL; Camp HS. A phase III randomised placebo-controlled double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii148-iii149', '10.1093/rheumatology/key075.466', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.466/24768408/key075.466.pdf']\n",
      "['9738717', 'Strand V; Pope J; Tundia N; Friedman A; Camp HS; Pangan A; Ganguli A; Fuldeore M; Goldschmidt D; Schiff M. Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from selectnext. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp989-990', '10.1136/annrheumdis-2018-eular.1202', '']\n",
      "['9739810', 'EUCTR2015-003332-13-LV. A Study Comparing ABT-494 to Placebo in Subjects with Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who have an Inadequate Response to csDMARDs Alone (SELECT-NEXT). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003332-13-LV. (2016)   pp', '10.1080/14397595.2018.1553265', '']\n",
      "['9740760', 'Burmester GR; Van Den Bosch F; Bessette L; Kivitz A; Yihan L; Friedman A; Pangan A; Camp H; Kremer J. Long-term safety and efficacy of upadacitinib in patients with rheumatoid arthritis and an inadequate response to CSDMARDS: results at 60 weeks from the select-next study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp735-736', '10.1136/annrheumdis-2019-eular.3082', '']\n",
      "['9741161', 'NCT02675426. A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone. https://clinicaltrials.gov/show/NCT02675426. (2016)   pp', '10.1080/14397595.2018.1553265', '']\n",
      "['9742537', 'Burmester G R; Kremer J; Van Den Bosch; Li Y; Zhou Y; Othman A A; Pangan A L; Camp H S. A phase 3 randomized, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective JAK-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic DMARDs. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1093/rheumatology/key075.466', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.466/24768408/key075.466.pdf']\n",
      "['9737764', '. A comparison of upadacitinib plus methotrexate and upadacitinib plus other CSDMARDS in patients with rheumatoid arthritis: an analysis of two phase 3 studies. Annals of the rheumatic diseases. (2019) 78  pp749-750', '10.1136/annrheumdis-2019-eular.2572', '']\n",
      "['9740669', '. Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csDMARDs or bDMARDs. Swiss medical weekly. (2018) 148  pp22S-', '10.1093/rheumatology/kez106.060', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.060/28712366/kez106.060.pdf']\n",
      "['9740860', '. Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csdmards or bdmards. Rheumatology (united kingdom). (2019) 58  ppiii65-', '10.1093/rheumatology/kez106.060', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.060/28712366/kez106.060.pdf']\n",
      "['9741337', '. A comparison of upadacitinib plus methotrexate and upadacitinib plus other csDMARDs in patients with rheumatoid arthritis: an analysis of two phase 3 studies. Swiss medical weekly. (2019) 149  pp8S-9S', '10.1136/annrheumdis-2019-eular.2572', '']\n",
      "['9742084', 'FitzGerald O; Rubbert-Roth A; Chen K; Meerwein S; Enejosa J; Shaw T; Wells A. Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csDMARDs or bDMARDs. Swiss medical weekly. (2018) Conference: Joint Congress of the Swiss Society of Rheumatology SSR and the Swiss Society for Allergology and Immunology SSAI. Switzerland. 148 Supplement 231 pp22S', '10.1093/rheumatology/kez106.060', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.060/28712366/kez106.060.pdf']\n",
      "['9742380', 'FitzGerald O; Rubbert-Roth A; Chen K; Meerwein S; Enejosa J; Shaw T; Wells AF. Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csdmards or bdmards. Rheumatology (united kingdom). (2019) Conference: 2019 Annual Conference of the British Society for Rheumatology, BSR 2019. United Kingdom. 58 Supplement 3 ppiii65', '10.1093/rheumatology/kez106.060', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez106.060/28712366/kez106.060.pdf']\n",
      "['11086486', 'Kremer JM; Van Den Bosch F; Rubbert-Roth A; Radominski SC; Burmester GR; Camp HS; Meerwein S; Howard M; Song Y; Zhong S; Combe B. A comparison of upadacitinib plus methotrexate and upadacitinib plus other csdmards in patients with rheumatoid arthritis: an analysis of two phase 3 studies. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS11-S12', '10.1136/annrheumdis-2019-eular.2572', '']\n",
      "['9737200', 'Strand V; Damjanov N; Scoville C; Tundia N; Camp H; Chen K; Suboticki JL; Van Vollenhoven R. The association between patient reported outcomes and clinical measures among rheumatoid arthritis patients: analyses using phase 3 clinical trials of upadacitinib. Journal of clinical rheumatology. (2019) Conference: 21st Pan American Rheumatology Congress, PANLAR 2019. Ecuador. 25 3 Supplement ppS54', '10.1093/rheumatology/keaa770', 'http://academic.oup.com/rheumatology/article-pdf/60/7/3209/38850164/keaa770.pdf']\n",
      "['9740667', '. The association between patient reported outcomes and clinical measures among rheumatoid arthritis patients: analyses using phase 3 clinical trials of upadacitinib. Arthritis and rheumatology. (2018) 70  pp2832-2833', '10.1186/s13075-022-02891-x', 'https://link.springer.com/article/10.1186/s13075-022-02891-x/fulltext.html']\n",
      "['9262634', 'Tanaka Y; Takeuchi T; Yamaoka K; Oribe M; Kawano M; Zhou Y; Othman AA; Pangan AL; Kitamura S; Matsuda N; Meerwein S; Kameda H. A phase 2b/3 randomised, placebo-controlled, double-blind study of upadacitinib, a selective jak1 inhibitor, in Japanese patients with active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp991-992', '10.1136/annrheumdis-2018-eular.4302', '']\n",
      "['9738679', 'Tanaka Y; Takeuchi T; Yamaoka K; Oribe M; Kawano M; Zhou Y; Othman AA; Pangan AL; Kitamura S; Matsuda N; Meerwein S; Kameda H. A phase 2b/3 randomised, placebo-controlled, double-blind study of upadacitinib, a selective jak1 inhibitor, in Japanese patients with active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp991-992', '10.1136/annrheumdis-2018-eular.4302', '']\n",
      "['9741349', 'Kameda H; Takeuchi T; Yamaoka K; Oribe M; Kawano M; Zhou Y; Othman AA; Pangan AL; Kitamura S; Meerwein S; Tanaka Y. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/keaa084', 'http://academic.oup.com/rheumatology/article-pdf/59/11/3303/34038133/keaa084.pdf']\n",
      "['9741409', 'Kameda Hideto; Takeuchi Tsutomu; Yamaoka Kunihiro; Oribe Motohiro; Kawano Mitsuhiro; Zhou Yijie; Othman Ahmed A; Pangan Aileen L; Kitamura Susumu; Meerwein Sebastian; Tanaka Yoshiya. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/keaa084', 'http://academic.oup.com/rheumatology/article-pdf/59/11/3303/34038133/keaa084.pdf']\n",
      "['9742451', 'Kameda H; Takeuchi T; Yamaoka K; Oribe M; Kawano M; Zhou Y; Othman AA; Pangan AL; Kitamura S; Meerwein S; Tanaka Y. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/keaa084', 'http://academic.oup.com/rheumatology/article-pdf/59/11/3303/34038133/keaa084.pdf']\n",
      "['11083754', 'Kameda H; Takeuchi T; Yamaoka K; Oribe M; Kawano M; Asabe S; Yokoyama M; Meerwein S; Tanaka Y. Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to csDMARDs: results from SELECT-SUNRISE. International journal of rheumatic diseases. (2020) 23 SUPPL 1 pp31', '10.1186/s13075-020-02387-6', 'http://link.springer.com/article/10.1186/s13075-020-02387-6/fulltext.html']\n",
      "['11088192', 'Kameda Hideto; Takeuchi Tsutomu; Yamaoka Kunihiro; Oribe Motohiro; Kawano Mitsuhiro; Zhou Yijie; Othman Ahmed A; Pangan Aileen L; Kitamura Susumu; Meerwein Sebastian; Tanaka Yoshiya. Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Rheumatology (Oxford, England). (2020) 59 11 pp3303-3313', '10.1093/rheumatology/keaa084', 'http://academic.oup.com/rheumatology/article-pdf/59/11/3303/34038133/keaa084.pdf']\n",
      "['9740469', 'Saraux A; Hudry C; Zinovieva E; Herman-Demars H; Aouadi L; Arif A; Arty-Hue H; Banal F; Banse C; Baron J-J; Basch A; Berton V; Bitar S; Cantagrel A; Cayla P; Combe B; Cornaille-Lafage G; Duplantier D; Dellaroli ME; Ferrazzi V; Flipo R-M; Fulpin J; Gardiol J-C; Guilyardi C; Hacene A; Jarrige D; Jourdan M; Laillet H; Lamer F; Lassoued S; Lupo-Mattatia G; Marzynski E; Melac-Ducamp S; Monod P; Naim C; Negrier-Chassaing I; Ngasseu P; Plat D; Prothery D; Roch-Bras F; Saraux A; Schaeverbeke T; Sebaa K; Senbel E; Soubrier M; Sourisseau-Diverres G; Soutif D; Straus C; Tauveron P; Timsit M-A; Vedere V; Viu P; Werner-Leyval S. Use of Auto-Injector for Methotrexate Subcutaneous Self-Injections: high Satisfaction Level and Good Compliance in SELF-I Study, a Randomized, Open-Label, Parallel Group Study. Rheumatology and therapy. (2019) 6 1 pp47-60', '10.1007/s40744-018-0134-2', 'https://link.springer.com/article/10.1007/s40744-018-0134-2/fulltext.html']\n",
      "['9736958', 'Buttgereit F; Burmester GR; Nebesky JM; Devenport J; Donath MY; John MR. Impact of glucocorticoid tapering on markers of bone metabolism in patients with rheumatoid arthritis who achieved low disease activity or remission on tocilizumab: exploratory analyis from a randomized controlled trial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp115-116', '10.1136/annrheumdis-2019-eular.2703', '']\n",
      "['11088131', 'Burmester Gerd R; Buttgereit Frank; Bernasconi Corrado; Alvaro-Gracia Jose M; Castro Nidia; Dougados Maxime; Gabay Cem; van Laar Jacob M; Nebesky Jan Michael; Pethoe-Schramm Attila; Salvarani Carlo; Donath Marc Y; John Markus R; SEMIRA collaborators. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Lancet (london, england). (2020) 396 10246 pp267-276', '10.1136/annrheumdis-2019-eular.2883', '']\n",
      "['9260618', \"Emery P; Deodhar A; Rigby WF; Isaacs JD; Combe B; Racewicz AJ; Latinis K; Abud-Mendoza C; Szczepanski LJ; Roschmann RA; Chen A; Armstrong GK; Douglass W; Tyrrell H. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). Annals of the rheumatic diseases. (2010) 69 9 pp1629-1635\", '10.1136/ard.2009.119933', '']\n",
      "['9261061', \"Emery P; Deodhar A; Rigby WF. Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) (Annals of the Rheumatic Diseases (2010) 69, (1629-1635)). Annals of the rheumatic diseases. (2011) 70  8 pp1519\", '10.1136/ard.2009.119933', '']\n",
      "['9738231', 'NCT00299130. A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00299130. (2006)   pp', '10.2165/00128413-200615490-00037', '']\n",
      "['9739683', 'EUCTR2005-002392-32-SE. A randomised, placebo controlled, double-blind, parallel group, international study to evaluate the safety and efficacy of rituximab (MabThera/Rituxan) in combination with methotrexate, compared to methotrexate monotherapy, in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002392-32-SE. (2005)   pp', '10.1186/isrctn49455679', '']\n",
      "['9260722', 'Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis and rheumatism. (2011) 63 12 pp3681-3691', '10.1002/art.30596', '']\n",
      "['9260683', 'Shashikumar NS; Shivamurthy MC; Chandrashekara S. Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis. Indian journal of pharmacology. (2010) 42 6 pp358-361', '10.4103/0253-7613.71916', '']\n",
      "['9738372', 'Shashikumar NS; Shivamurthy MC; Chandrashekara S. Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis. Indian journal of pharmacology. (2010) 42 6 pp358-361', '10.4103/0253-7613.71916', '']\n",
      "['9742558', 'Shim SC; Park SH; Bae SC; Song YW; MacAraeg GM; Delvaux A; Dalvi A; Becker J-C. Efficacy and safety of abatacept in Korean patients with active rheumatoid arthritis and inadequate response to methotrexate: a phase III, multicenter, randomized, double-blind, placebo-controlled bridging study. International journal of rheumatic diseases. (2010) Conference: 14th Congress of Asia Pacific League of Associations for Rheumatology, APLAR 2010 Hong Kong Hong Kong. Conference Start: 20100711 Conference End: 20100715. Conference Publication: var.pagings pp101', '10.3410/f.1097731.553845', '']\n",
      "['9737022', 'JapicCTI-142505. Phase III study of MRA-SC 162 mg/week. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-142505. (2014)   pp', '10.1093/rheumatology/kew121.002', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i60/5076059/kew121.002.pdf']\n",
      "['9738106', 'Ogata Atsushi; Tanaka Yoshiya; Ishii Tomonori; Kaneko Motohide; Miwa Hiroko; Ohsawa Shino; Yamakawa Reiji; SHINOBI Study Group. Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: results from the open-label extension of the SHINOBI study. Modern rheumatology. (2019) 29 5 pp767-774', '10.1080/14397595.2018.1533514', '']\n",
      "['9260561', 'Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis and rheumatism. (2010) 62 1 pp64-74', '10.1002/art.25034', '']\n",
      "['9741093', 'NCT00282308. A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate. https://clinicaltrials.gov/show/NCT00282308. (2006)   pp', '10.2165/00128413-200615490-00037', '']\n",
      "['9259578', 'Sigidin YA; Usova SB. Comparative study of cyclosporin A in systemic rheumatoid arthritis. Int j immunother. (1994) 10 2 pp61-65', '10.1007/bf03258523', 'http://link.springer.com/article/10.1007/BF03258523/fulltext.html']\n",
      "['9257606', 'Zeidler HK; Kvien TK; Hannonen P; Wollheim FA; F‚àö‚àèrre O; Geidel H; Hafstr‚àö‚àÇm I; Kaltwasser JP; Leirisalo-Repo M; Manger B; Laasonen L; Markert ER; Prestele H; Kurki P. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. British journal of rheumatology. (1998) 37 8 pp874-882', '10.1093/rheumatology/37.8.874', 'http://academic.oup.com/rheumatology/article-pdf/37/8/874/18106270/370874.pdf']\n",
      "['9258304', 'Kvien TK; Zeidler HK; Hannonen P; Wollheim FA; F‚àö‚àèrre O; Hafstr‚àö‚àÇm I; Kaltwasser JP; Leirisalo-Repo M; Manger B; Laasonen L; Prestele H; Kurki P. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Annals of the rheumatic diseases. (2002) 61 6 pp511-516', '10.1136/ard.61.6.511', '']\n",
      "['9257337', 'Singh CP; Kaur Brar G; Singh G; Singh N; Singh J. The open randomised trial of cyclosporine vs methotrexate in refractory rheumatoid arthritis. Journal of Internal Medicine of India. (2000) 3 1 pp19-25', '10.21203/rs.3.rs-1236248/v1', 'https://www.researchsquare.com/article/rs-1236248/v1']\n",
      "['9261106', 'Singh H; Mathur R; Arya S; Gupta V; Ghangas N; Singhania A; Lather K; Garg K. Comparison of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide alone in patients of rheumatoid arthritis. Indian Journal of Rheumatology. (2012) 7  ppS31', '10.1016/j.injr.2016.03.002', 'https://journals.sagepub.com/doi/pdf/10.1016/j.injr.2016.03.002']\n",
      "['9257767', 'Bingham III C; Tanaka Y; Karpouzas G; Takeuchi T; Aletaha D; Thorne C; Sheng S; Xu W; Rao R; Fei K; Hsu B; Agarwal P; Popik S; Kurrasch R; Peterson S; Ganguly R; Han C; McQuarrie K. Treatment with sirukumab, an anti-IL6 cytokine monoclonal antibody, improves fatigue and health-related physical and emotional well being in patients with active rheumatoid arthritis refractory to conventional or biologic therapy: results of 2 global, placebo-controlled, phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2012-2014', '10.1136/annrheumdis-2016-eular.4229', '']\n",
      "['9262546', 'Takeuchi T; Tanaka Y; Schiff M; Harigai M; Brown K; Rao R; Fei K; Popik S; Yoshizawa K; Wang Q; Hsu B. Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp581', '10.1136/annrheumdis-2017-eular.6413', '']\n",
      "['9737115', 'Takeuchi T; Tanaka Y; Schiff M; Harigai M; Brown K; Rao R; Fei K; Popik S; Yoshizawa K; Wang Q; Hsu B. Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp581', '10.1136/annrheumdis-2017-eular.6413', '']\n",
      "['9737735', 'Xu Yan; Hu Chuanpu; Zhuang Yanli; Hsu Benjamin; Xu Zhenhua; Zhou Honghui. Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin-6, in Patients With Moderately to Severely Active Rheumatoid Arthritis. Journal of clinical pharmacology. (2018) 58 7 pp939-951', '10.1002/jcph.1101', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1101']\n",
      "['9257626', 'Karpouzas G; Takeuchi T; Thorne C; Sheng S; Li X; Rao R; Fei K; Hsu B. Prediction of inhibition of radiographic progression by sirukumab, an anti-IL-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite disease-modifying anti-rheumatic drug treatment: results of a global, phase 3 trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3578-3579', '10.1016/j.jval.2016.09.1074', '']\n",
      "['9257711', 'Thorne C; Karpouzas G; Takeuchi T; Sheng S; Xu W; Rao R; Fei K; Hsu B. Analysis of a phase 3 study evaluating the efficacy of sirukumab, an anti-IL-6 cytokine monoclonal antibody, across subgroups in patients with active rheumatoid arthritis despite treatment with disease-modifying anti-rheumatic drugs. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2023-2024', '10.1016/j.jval.2016.09.1074', '']\n",
      "['9262080', 'Takeuchi T; Karpouzas G; Thorne C; McQuarrie K; Sheng S; Xu W; Peterson S; Ganguly R; Han C; Fei K; Hsu B. Work productivity/interference and general health status improvements with sirukumab, an anti-IL-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite treatment with disease-modifying anti-rheumatic drugs: results from the phase 3 sirround-d study. Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA542', '10.1016/j.jval.2016.09.1135', '']\n",
      "['9262081', 'Takeuchi T; Thorne C; Karpouzas G; Sheng S; Xu W; Rao R; Fei K; Hsu B. Results of a phase 3, randomized, double-blind, placebo-controlled study of the efficacy and safety of sirukumab, an anti-il-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite disease-modifying anti-rheumatic drug treatment (sirround-D). Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA531', '10.1016/j.jval.2016.09.1074', '']\n",
      "['9262309', 'Takeuchi T; Thorne C; Karpouzas G; Sheng S; Xu W; Rao R; Fei K; Hsu B; Tak PP. Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study. Annals of the rheumatic diseases. (2017) 76 12 pp2001-2008', '10.1136/annrheumdis-2017-211328', '']\n",
      "['9262375', 'Takeuchi T; Tanaka Y; Yamanaka H; Harigai M; Nakano T; Akagi K; Ukyo Y; Hsu B. Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: subgroup analysis of a phase 3 study. Modern rheumatology. (2018)   pp1-9', '10.1080/14397595.2018.1428929', '']\n",
      "['9262501', 'Strand V; McQuarrie K; Li N; Ganguly R. Improvements in health-related quality of life with sirukumab are statistically significant, clinically meaningful, and meet or exceed normative values in rheumatoid arthritis patients with inadequate response to disease-modifying antirheumatic drugs: post hoc analyses of a phase 3 trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp578-579', '10.1136/annrheumdis-2017-eular.3917', '']\n",
      "['9739494', 'Thorne C; Takeuchi T; Karpouzas GA; Sheng S; Kurrasch R; Fei K; Hsu B. Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study. RMD open. (2018) 4 2 pp', '10.1136/rmdopen-2018-000731', '']\n",
      "['9741106', 'NCT01604343. A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D). https://clinicaltrials.gov/show/NCT01604343. (2012)   pp', '10.1136/annrheumdis-2019-eular.2127', '']\n",
      "['9742006', 'Thorne Carter; Takeuchi Tsutomu; Karpouzas George Athanasios; Sheng Shihong; Kurrasch Regina; Fei Kaiyin; Hsu Benjamin. Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study. RMD open. (2018) 4 2 ppe000731', '10.1136/rmdopen-2018-000731', '']\n",
      "['9742483', 'Takeuchi T; Tanaka Y; Yamanaka H; Harigai M; Nakano T; Akagi K; Ukyo Y; Hsu B. Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: subgroup analysis of a phase 3 study. Modern rheumatology. (2018)   pp1-9', '10.1080/14397595.2018.1428929', '']\n",
      "['9257716', 'Dasgupta B; Walsh A; Sweet K; Peffer N; Franks C; Ma K; Sims M; Campbell K; Loza M. Distinct baseline serum molecular profile and pharmacodynamic effects of sirukumab, an anti-IL-6 cytokine monoclonal antibody, in asian-pacific patients with active rheumatoid arthritis despite DMARD or anti-TNFalpha therapy across two global phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2027-2028', '10.33590/emjrheumatol/10314940', '']\n",
      "['9262489', 'Sun Y; Hsu B; Wang D; Curran M; Drevets WC; Chen G; Wittenberg GM. Improvement in measures of depressed mood and anhedonia in two randomized, placebo-controlled phase iii studies of sirukumab, a human anti-interleukin-6 antibody, in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp250', '10.1136/annrheumdis-2017-eular.3263', '']\n",
      "['9258382', 'Taylor PC; Schiff M; Wang Q; Jiang Y; Kurrasch R; Daga S; Rao R; Hsu B; Tak P-P. Efficacy and safety of monotherapy with sirukumab, an anti-IL-6 cytokine monoclonal antibody, compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis: results of a global, randomized, double-blind, parallel-group, phase 3 study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4309-4311', '10.1136/annrheumdis-2017-212496', '']\n",
      "['9262584', 'Taylor PC; Schiff MH; Wang Q; Jiang Y; Zhuang Y; Kurrasch R; Daga S; Rao R; Tak PP; Hsu B. Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. Annals of the rheumatic diseases. (2018) 77 5 pp658-666', '10.1136/annrheumdis-2017-212496', '']\n",
      "['9736628', 'Sweet Kristen; Dasgupta Bidisha; de Vries Dick; Gourley Ian; Hsu Benjamin; Loza Matthew J; Taylor Peter C. Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial. Annals of the rheumatic diseases. (2019) 78 10 pp1439-1441', '10.1136/annrheumdis-2019-215183', '']\n",
      "['9258368', 'Tanaka Y; Aletaha D; Peterson S; Ganguly R; Kurrasch R; Popik S; Agarwal P; Li N. Work productivity and general health status improvements with sirukumab, an anti-IL-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite anti-TNF therapy: results from the phase 3 sirround-T study. Value in health. Conference: ISPOR 22nd annual international meeting. United states. (2017) 20 5 ppA149', '10.1136/annrheumdis-2017-eular.3597', '']\n",
      "['9258385', 'Aletaha D; Bingham C; Tanaka Y; Agarwal P; Kurrasch R; Tak P-P; Popik S. Efficacy and safety of sirukumab, an anti-IL-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite anti-tnf therapy: results from a randomized, double-blind, placebo-controlled, global, phase 3 Study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4311-4312', '10.1016/s0140-6736(17)30401-4', '']\n",
      "['9258387', 'Tanaka Y; Aletaha D; Bingham C; Agarwal P; Kurrasch R; Popik S. Efficacy of sirukumab, an anti-IL-6 cytokine monoclonal antibody, based upon prior use of non-anti-TNF biologics in patients with active rheumatoid arthritis despite anti-tnf therapy: results from a global phase 3 study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4312-4313', '10.1136/annrheumdis-2017-eular.3597', '']\n",
      "['9258393', 'Tanaka Y; Bingham C; Aletaha D; Agarwal P; Popik S; Kurrasch R; Peterson S; Ganguly R; Han C; McQuarrie K. Sirukumab, an anti-IL-6 cytokine monoclonal antibody, significantly improves physical function and reduces morning stiffness in patients with active rheumatoid arthritis despite anti-TNF therapy: results from a global, randomized, placebo-controlled, phase 3 trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2008-2009', '10.1136/annrheumdis-2017-eular.3597', '']\n",
      "['9258485', 'Tanaka Y; Takeuchi T; Harigai M; Yamanaka H; Nakano T; Akagi K; Ukyo Y; Hsu B. Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T). Modern rheumatology. (2018)   pp1-8', '10.1080/14397595.2018.1452345', '']\n",
      "['9736829', 'NCT01606761. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T). https://clinicaltrials.gov/show/NCT01606761. (2012)   pp', '10.1136/annrheumdis-2012-eular.1708', '']\n",
      "['9742903', 'Tanaka Yoshiya; Takeuchi Tsutomu; Harigai Masayoshi; Yamanaka Hisashi; Nakano Toshikazu; Akagi Koshiro; Ukyo Yoshifumi; Hsu Benjamin. Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T). Modern rheumatology. (2019) 29 2 pp306-313', '10.1080/14397595.2018.1452345', '']\n",
      "['9257932', 'Dougados M; Combe B; Le Loet X; Tebib J; Sibilia J; Rouanet S; Jourdan R; Mariette X. One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 x 1g): Results of a 2-year multi-center randomized controlled trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2052', '']\n",
      "['9260834', 'Ruyssen-Witrand A; Rouanet S; Combe B; Dougados M; Le Lo‚Äö√†√∂¬¨¬•t X; Sibilia J; Tebib J; Mariette X; Constantin A. Fc‚âà√≠‚Äö√¢‚Ä¢ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Annals of the rheumatic diseases. (2012) 71 6 pp875-877', '10.1136/annrheumdis-2011-200337', '']\n",
      "['9261028', 'Mariette X; Rouanet S; Sibilia J; Combe B; Le Lo‚Äö√†√∂¬¨¬•t X; Tebib J; Jourdan R; Dougados M. Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial. Annals of the rheumatic diseases. (2014) 73 8 pp1508-1514', '10.1136/annrheumdis-2013-203480', '']\n",
      "['9737507', 'NCT01126541. SMART Study: a Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy. https://clinicaltrials.gov/show/NCT01126541. (2010)   pp', '10.1186/isrctn89222125', '']\n",
      "['9258383', 'Larsen A; Kvien TK; Schattenkirchner M; Rau R; Scott DL; Smolen JS; Rozman B; Westhovens R; Tikly M; Oed C; Rosenburg R; European Leflunomide Study Group. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scandinavian journal of rheumatology. (2001) 30 3 pp135-142', '10.1080/030097401300162897', '']\n",
      "['9259813', 'Scott DL; Smolen JS; Kalden JR; van de Putte LB; Larsen A; Kvien TK; Schattenkirchner M; Nash P; Oed C; Loew-Friedrich I; European Leflunomide Study Group. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Annals of the rheumatic diseases. (2001) 60 10 pp913-923', '10.1136/ard.60.10.913', '']\n",
      "['9259840', 'Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R; European Leflunomide Study Group. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. Journal of rheumatology. (2001) 28 9 pp1983-1991', '10.1136/ard.60.10.913', '']\n",
      "['9259915', 'Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. Lancet. (1999) 353 9149 pp259-266', '10.1016/s0140-6736(98)09403-3', '']\n",
      "['9259954', 'Kalden JR; Schattenkirchner M; S‚àö‚àÇrensen H; Emery P; Deighton C; Rozman B; Breedveld F. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study. Arthritis and rheumatism. (2003) 48 6 pp1513-1520', '10.1002/art.11015', '']\n",
      "['9742629', 'Bruyn G A W; Griep E N; Korff K J; Ferraccioli G F; De Vita; Smolen J S; Scott D L; Kalden J T; Low-Friedrich I; Oed C. Leflunomide for active rheumatoid arthritis (multiple letters). Lancet. (1999) 353 9167 pp1883-1884', '10.1016/s0140-6736(05)75090-x', '']\n",
      "['9260850', 'Rigby W; Tony HP; Oelke K; Combe B; Laster A; von Muhlen CA; Fisheleva E; Martin C; Travers H; Dummer W. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. Arthritis and rheumatism. (2012) 64 2 pp350-359', '10.1002/art.33317', '']\n",
      "['9737831', 'Rigby WFC; Tony HPT; Oelke KR; Combe BG; Laster AJ; Travers H; Von Muhlen CA. Efficacy and safety of ocrelizumab in patients with active rheumatoid arthritis who had an inadequate response to methotrexate: results from the phase III STAGE trial. Arthritis and rheumatism. (2010) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 10 Philadelphia, PA United States. Conference Start: 20091016 Conference End: 20091021. Conference Publication: var.pagings pp383', '10.1002/art.33317', '']\n",
      "['9740061', 'EUCTR2006-005147-28-AT. A randomized, double-blind, parallel group, international study to evaluate the safety and efficacy of ocrelizumab compared to placebo in patients with active rheumatoid arthritis continuing methotrexate treatment. - STAGE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005147-28-AT. (2007)   pp', '10.3899/jrheum.110994', '']\n",
      "['9740310', 'NTR5265. Statins to Prevent Rheumatoid Arthritis (STAPRA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR5265. (2015)   pp', '10.1136/rmdopen-2021-001591', '']\n",
      "['11088725', 'van Boheemen L; Turk S; Beers-Tas MV; Bos W; Marsman D; Griep EN; Starmans-Kool M; Popa CD; van Sijl A; Boers M; Nurmohamed MT; van Schaardenburg D. Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. . (2021) 7 1 pp', '10.1136/rmdopen-2021-001591', '']\n",
      "['9259990', 'Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Journal of rheumatology. (2003) 30 12 pp2563-2571', '10.1002/art.546', '']\n",
      "['9260355', 'Furst D E; Schiff M H; Fleischmann R M; Strand V; Birbara C A; Compagnone D; Fischkoff S A; Chartash E K. Adalimumab, a Fully Human Anti-Tumor Necrosis Factor-a Monoclonal Antibody, and Concomitant Standard Antirheumatic Therapy for the Treatment of Rheumatoid Arthritis: Results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Journal of rheumatology. (2003) 30 12 pp2563-2571', '10.1002/art.546', '']\n",
      "['9738501', 'Cella D; Yount S; Sorensen M; Chartash E; Sengupta N; Grober J; et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. Journal of rheumatology. (2005) 32 5 pp811-819', '10.4172/2161-1149.1000193', '']\n",
      "['9740188', 'UMIN000015175. Head-to-head comparison of Subcutaneous Tocilizumab versus Abatacept for Rheumatoid arthritis : prospective, randomized trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000015175. (2014)   pp', '10.3410/f.718006008.793492813', '']\n",
      "['9739617', 'UMIN000012690. Study of Actemura Remission induction of RA and Sequential Maintenance of Remission by Reasonable cost Treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012690. (2013)   pp', '10.1186/isrctn75505683', '']\n",
      "['9260185', 'Westhovens R; Yocum D; Han J; Berman A; Strusberg I; Geusens P; Rahman MU; START Study Group. The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial. Arthritis and rheumatism. (2006) 54 4 pp1075-1086', '10.1002/art.21734', '']\n",
      "['9260268', 'Rahman MU; Strusberg I; Geusens P; Berman A; Yocum D; Baker D; Wagner C; Han J; Westhovens R. Double-blinded infliximab dose escalation in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2007) 66 9 pp1233-1238', '10.1136/ard.2006.065995', '']\n",
      "['9258192', 'Stephen O; Gabor M; David M; Der Kallen John V; Mark C; Marc T; John G; Siva R; Theo DM; Niloofar E. Humira and endothelial function in rheumatoid arthritis a randomised controlled trial: preliminary findings. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp10', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9260658', 'Verstappen SM; McCoy MJ; Roberts C; Dale NE; Hassell AB; Symmons DP; Steroids In Very Early Arthritis Investigators. Disease activity, smoking, and reproductive-related predictors of poor prognosis in patients with very early inflammatory polyarthritis. Journal of rheumatology. (2011) 38 3 pp429-433', '10.3899/jrheum.100756', '']\n",
      "['9739999', 'ISRCTN10618686. Stratification of biologic therapies for rheumatoid arthritis by pathobiology. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN10618686. (2015)   pp', '10.1186/isrctn10618686', '']\n",
      "['9742871', 'EUCTR2017-004079-30-BE. Stratification of biologic Therapies for Rheumatoid Arthritis by Pathobiology. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-004079-30-BE. (2018)   pp', '10.1186/isrctn10618686', '']\n",
      "['9737825', 'ISRCTN43336433. Can we identify predictors of treatment responses to biologic therapies in patients with rheumatoid arthritis?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN43336433. (2019)   pp', '10.1186/isrctn43336433', '']\n",
      "['9740436', 'EUCTR2017-004079-30-PT. Stratification of biologic Therapies for Rheumatoid Arthritis by Pathobiology. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-004079-30-PT. (2018)   pp', '10.1186/isrctn10618686', '']\n",
      "['9257644', 'Marotte H; Rinaudo-Gaujous M; Paul S; Fautrel B. TNF blocker concentrations or detection of antibodies against anti-TNF before a tapering process are not predictive to relapse. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3379-3380', '10.1136/annrheumdis-2016-eular.5823', '']\n",
      "['9257765', 'Sigaux J; Bailly F; Gandjbakhch F; Foltz V; Tubach F; Gossec L; Fautrel B. Long-term sustainability of TNF-blocker injection spacing in rheumatoid arthritis: results of a 3-year long-term observational follow-up of a tapering randomised controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp802-803', '10.1136/rmdopen-2017-000474', '']\n",
      "['9257911', 'Fautrel B; Pham T; Morel J; Alfaiate T; Dernis E; Gaudin P; Mariette X; Tubach F. Impact of progressive spacing of TNF-blocker injections on signs and symptoms of rheumatoid arthritis patients in DAS28 remission: The strass randomized controled trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.708', '']\n",
      "['9257961', 'Pham T; Morel J; Alfaiate T; Dernis E; Gaudin P; Brocq O; Solau-Gervais E; Berthelot J-M; Balblanc J-C; Mariette X; Tubach F; Fautrel B. Predictive factors of relapse or persistent stable remission for rheumatoid arthritis (RA) patients in remission in a TNF blocker-spacing strategy trial (STRASS trial). Arthritis and rheumatism. (2013) 65  ppS1021', '10.1136/annrheumdis-2014-206696', '']\n",
      "['9257968', 'Fautrel B; Pham T; Morel J; Alfaiate T; Dernis E; Gaudin P; Brocq O; Solau-Gervais E; Berthelot J-M; Balblanc J-C; Mariette X; Tubach F. Results of the STRASS trial regarding impact of progressive spacing of TNF-blocker injections in rheumatoid arthritis patients in DAS28 remission: Is there a difference between drugs-adalimumab and etanercept-or their mode of use-monotherapy or combination?. Arthritis and rheumatism. (2013) 65  ppS1150', '10.1136/annrheumdis-2014-206696', '']\n",
      "['9261368', 'Fautrel B; Gandjbakhch F; Foltz V; Pham T; Morel J; Alfaiate T; Dernis E; Gaudin P; Mariette X; Tubach F. Targeting the lowest efficacious dose for rheumatoid arthritis patients in remission: Clinical and structural impact of a step-down strategy trial based on progressive spacing of TNF-blocker injections (strass trial). Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.271', '']\n",
      "['9261905', 'Vanier A; Tubach F; Alfaiate T; Mariette X; Fautrel B. Step-down strategy of spacing tnf-blockers injections for established rheumatoid arthritis in remission: a cost-utility analysis based on the strass trial. Annals of the rheumatic diseases. (2015) 74  pp178', '10.1136/annrheumdis-2015-eular.4473', '']\n",
      "['9262156', 'Johnson C. Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease. Current opinion in rheumatology. (2017) (no pagination) 3 pp254-259', '10.1097/bor.0000000000000380', '']\n",
      "['9262486', 'Barral C; Hajage D; Fautrel B; Lafforgue P; Tubach F; Pham T. Tool and threshold predicting a successful biological DMARDs tapering in patients with RA remission determination. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp58', '10.1136/annrheumdis-2017-eular.5786', '']\n",
      "['9736477', 'Portier A; Gossec L; Tubach F; Alfaiate T; Pham T; Saraux A; Soubrier M; Schaeverbeke T; Maillefert JF; Mariette X; Hajage D; Fautrel B. Patient-perceived flares in rheumatoid arthritis: a sub-analysis of the STRASS treatment tapering strategy trial. Joint, bone, spine. (2017) 84 5 pp577-581', '10.1016/j.jbspin.2016.10.001', '']\n",
      "['9739133', 'Sigaux J; Bailly F; Gossec L; Alfaiate T; Gandjbakhch F; Foltz V; Morel J; Dernis E; Gaudin P; Brocq O; Berthelot J M; Balblanc J C; Mariette X; Tubach F; Fautrel B. Fifty percent of patients who tapered TNF-blockers while in stable remission are able to maintain a tapered regimen at 3 year: long term follow-up extension of the strass trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp484-485', '10.1136/annrheumdis-2016-eular.1902', '']\n",
      "['9740836', 'Kossi S; Sasso EH; Marotte H; Liu X; Tubach F; Hajage D; Fautrel B. Ability of the multi-biomarker disease activity score to identify rheumatoid arthritis patients in remission at risk of relapse after tnf-blocker tapering. an ancillary study of the strass trial. Annals of the rheumatic diseases. (2019) 78  pp1430-', '10.1136/annrheumdis-2019-eular.5988', '']\n",
      "['9741002', 'NCT00780793. Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study. https://clinicaltrials.gov/show/NCT00780793. (2008)   pp', '10.1016/j.jval.2017.01.005', '']\n",
      "['9258270', 'Nishimoto N; Yoshizaki K; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Hashimoto J; Azuma J; Kishimoto T. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2004) 50 6 pp1761-1769', '10.1002/art.20303', '']\n",
      "['9260144', 'Straub RH; H√§rle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. Arthritis and rheumatism. (2006) 54 6 pp1778-1785', '10.1002/art.21826', '']\n",
      "['9260478', 'Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Annals of the rheumatic diseases. (2009) 68 10 pp1580-1584', '10.1136/ard.2008.092866', '']\n",
      "['9263375', 'van Eijk IC; Nielen MM; van der Horst-Bruinsma I; Tijhuis GJ; Boers M; Dijkmans BA; van Schaardenburg D. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Rheumatology (Oxford, England). (2012) 51 4 pp686-694', '10.1093/rheumatology/ker355', 'http://academic.oup.com/rheumatology/article-pdf/51/4/686/5101944/ker355.pdf']\n",
      "['9742762', 'ISRCTN56637846. STRategies in Early Arthritis Management. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN56637846. (2005)   pp', '10.1186/isrctn56637846', '']\n",
      "['9259941', 'Lee H; Kimko HC; Rogge M; Wang D; Nestorov I; Peck CC. Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clinical pharmacology and therapeutics. (2003) 73 4 pp348-365', '10.1016/s0009-9236(02)17635-1', '']\n",
      "['9257037', 'Tak PP; Rigby W; Rubbert-Roth A; Peterfy C; van Vollenhoven RF; Stohl W; Healy E; Hessey E; Reynard M; Shaw T. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Annals of the rheumatic diseases. (2012) 71 3 pp351-357', '10.1136/annrheumdis-2011-200170', '']\n",
      "['9259684', 'Suarez-Almazor ME; Russell AS. Parenteral methotrexate or gold for rheumatoid arthritis: A follow up. Clinical and experimental rheumatology. (1990) 8 2 pp163-166', '10.1002/14651858.cd000957', '']\n",
      "['9260941', 'Burmester GR; Rubbert-Roth A; Cantagrel A; Hall S; Leszczynski P; Feldman D; Rangaraj MJ; Roane G; Ludivico C; Lu P; Rowell L; Bao M; Mysler EF. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Annals of the rheumatic diseases. (2014) 73 1 pp69-74', '10.1136/annrheumdis-2013-203523', '']\n",
      "['9261540', 'Burmester G; Rubbert-Roth A; Cantagrel A; Hall S; Leszczynski P; Feldman D; Rangaraj MJ; Roane G; Ludivico C; Mysler E; Bennett MJ; Rowell L; Bao M. The efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional dmards in patients with ra at week 97 (summacta). Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1347', '']\n",
      "['9263524', 'Burmester GR; Rubbert-Roth A; Cantagrel A; Hall S; Leszczynski P; Feldman D; Rangaraj MJ; Roane G; Ludivico C; Bao M; Rowell L; Davies C; Mysler EF. Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Annals of the rheumatic diseases. (2016) 75  1 pp68-74', '10.1136/annrheumdis-2015-207281', '']\n",
      "['9738032', 'Burmester G R; Andrea R R; Cantagrel A G; Hall S; Leszczynski P; Feldman D; Rangaraj M J; Roane G; Ludivico C L; Ramirez F; Bao M. A randomized, double-blind, parallel group study of the safety and efficacy of tocilizumab SC versus tocilizumab IV, in combination with traditional dmards in patients with moderate to severe RA. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS1075', '10.1136/annrheumdis-2013-eular.1831', '']\n",
      "['9738835', 'Burmester G R; Rubbert-Roth A; Cantagrel A; Hall S; Leszczynski P; Feldman D; Rangaraj M J; Roane G; Ludivico C; Mysler E; Rowell L; Vranic I. Summacta: a randomized, double-blind, parallel group study of the safety and efficacy of tocilizumab SC versus tocilizumab IV, in combination with traditional dmards in patients with moderate to severe RA. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.1831', '']\n",
      "['9740151', 'EUCTR2010-018375-22-ES. A randomized, double-blind, parallel group study of the safety and effect on clinical outcome of tocilizumab SC versus tocilizumab IV, in combination with traditional disease modifying anti-rheumatoid arthritis drugs (DMARDs), in patients with oderate to severe active rheumatoid arthritis. Estudio randomizado, doble ciego, con grupos de tratamiento paralelos, para evaluar la seguridad y el efecto sobre el resultado cl‚àö‚â†nico de tocilizumab SC frente a tocilizumab IV en combinaci‚àö‚â•n con f‚àö¬∞rmacos antirreum‚àö¬∞ticos modificadores de la enfermedad (FAMEs) tradicionales, en pacientes con artritis reumatoide activa moderada a severa. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-018375-22-ES. (2010)   pp', '10.3410/f.718056357.793482541', '']\n",
      "['9742548', 'Hall S; Bird P; Rischmueller M; Rubbert-Roth A; Cantagrel A; Leszczynski P; Feldman D; Rangaraj M; Roane G; Ludivico C; Mysler E; Rowell L; Douglass W; Burmester G. Summacta: a randomized, double-blind, parallel group study of the safety and efficacy of tocilizumab subcutaneous (SC) versus tocilizumab intravenous (IV), in combination with traditional dmards in patients with moderate-to-severe rheumatoid arthritis (RA). Internal medicine journal. (2013) 43 SUPPL. 2 pp13', '10.1136/annrheumdis-2013-eular.1831', '']\n",
      "['9743015', 'NCT01194414. A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01194414. (2010)   pp', '10.3410/f.718056357.793482541', '']\n",
      "['9260570', 'Mease PJ; Cohen S; Gaylis NB; Chubick A; Kaell AT; Greenwald M; Agarwal S; Yin M; Kelman A. Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial. Journal of rheumatology. (2010) 37 5 pp917-927', '10.3899/jrheum.090442', '']\n",
      "['9257413', 'Takeuchi T; Kaneko Y; Atsumi T; Tanaka Y; Inoh M; Kobayashi H; Amano K; Miyata M; Murakawa Y; Fujii T; Kawakami A; Yamanaka H; Yamamoto K; Miyasaka N; Mimori T; Tanaka E; Nagasawa H; Yasuoka H; Hirata S. Clinical and radiographic effects after 52-week of adding tocilizumab or switching to tocilizumab in ra patients with inadequate response to methotrexate: Results from a prospective randomized controlled study (surprise study). Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2439', '']\n",
      "['9257904', 'Takeuchi T; Kaneko Y; Atsumi T; Tanaka Y; Inoh M; Kobayashi H; Amano K; Miyata M; Murakawa Y; Fujii T; Kawakami A; Yamanaka H; Yamamoto K; Miyasaka N; Mimori T. Adding tocilizumab or switching to tocilizumab monotherapy in RA patients with inadequate response to methotrexate: 24-week results from a randomized controlled study (surprise study). Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.245', '']\n",
      "['9262221', 'Kaneko Y; Atsumi T; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Nagasawa H; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T. Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study). Annals of the rheumatic diseases. (2016) 75 11 pp1917-1923', '10.1136/annrheumdis-2015-208426', '']\n",
      "['9262596', 'Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). Annals of the rheumatic diseases. (2018) (no pagination)  pp', '10.1136/annrheumdis-2018-213416', '']\n",
      "['9262696', 'Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (the second year of the surprise study). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp105-106', '10.1136/annrheumdis-2018-eular.1819', '']\n",
      "['9736991', 'UMIN000002744. Success of tocilizumab in RA patients with remission induction and sustained efficacy after discontinuation. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002744. (2009)   pp', '10.1186/isrctn75505683', '']\n",
      "['9738588', 'Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). Annals of the rheumatic diseases. (2018) (no pagination)  pp', '10.1136/annrheumdis-2018-213416', '']\n",
      "['9738734', 'Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (the second year of the surprise study). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp105-106', '10.1136/annrheumdis-2018-eular.1819', '']\n",
      "['9740642', 'Kaneko Yuko; Kato Masaru; Tanaka Yoshiya; Inoo Masayuki; Kobayashi-Haraoka Hitomi; Amano Koichi; Miyata Masayuki; Murakawa Yohko; Yasuoka Hidekara; Hirata Shintaro; Tanaka Eiichi; Miyasaka Nobuyuki; Yamanaka Hisashi; Yamamoto Kazuhiko; Takeuchi Tsutomu; SURPRISE study group. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). Annals of the rheumatic diseases. (2018) 77 9 pp1268-1275', '10.1136/annrheumdis-2018-213416', '']\n",
      "['9740741', 'Kato M; Kaneko Y; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Nagasawa H; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Yokota I; Atsumi T; Takeuchi T. Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: a post hoc analysis of the SURPRISE study. Modern rheumatology. (2019)   pp', '10.1080/14397595.2019.1621026', '']\n",
      "['9740791', 'Kato M; Kaneko Y; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Nagasawa H; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Yokota I; Atsumi T; Takeuchi T. Predictive factors for remission achievement by tocilizumab monotherapy in patients with rheumatoid arthritis after inadequate response to methotrexate: a post hoc analysis of the surprise study. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp714-715', '10.1136/annrheumdis-2019-eular.505', '']\n",
      "['9741526', 'Kato Masaru; Kaneko Yuko; Tanaka Yoshiya; Inoo Masayuki; Kobayashi-Haraoka Hitomi; Amano Koichi; Miyata Masayuki; Murakawa Yohko; Yasuoka Hidekata; Hirata Shintaro; Nagasawa Hayato; Tanaka Eiichi; Miyasaka Nobuyuki; Yamanaka Hisashi; Yamamoto Kazuhiko; Yokota Isao; Atsumi Tatsuya; Takeuchi Tsutomu. Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: a post hoc analysis of the SURPRISE study. Modern rheumatology. (2020) 30 3 pp442-449', '10.1080/14397595.2019.1621026', '']\n",
      "['9743009', 'NCT01120366. Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation. https://clinicaltrials.gov/show/NCT01120366. (2010)   pp', '10.1136/annrheumdis-2015-eular.1829', '']\n",
      "['11088281', 'Kato Masaru; Kaneko Yuko; Tanaka Yoshiya; Inoo Masayuki; Kobayashi-Haraoka Hitomi; Amano Koichi; Miyata Masayuki; Murakawa Yohko; Yasuoka Hidekata; Hirata Shintaro; Nagasawa Hayato; Tanaka Eiichi; Miyasaka Nobuyuki; Yamanaka Hisashi; Yamamoto Kazuhiko; Yokota Isao; Atsumi Tatsuya; Takeuchi Tsutomu. Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: a post hoc analysis of the SURPRISE study. Modern rheumatology. (2020) 30 3 pp442-449', '10.1080/14397595.2019.1621026', '']\n",
      "['9256788', 'Rezaei H; Saevarsdottir S; Geborek P; Petersson IF; van Vollenhoven RF; Forslind K. Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial. BMC musculoskeletal disorders. (2013) 14  pp79', '10.1186/1471-2474-14-79', 'http://link.springer.com/article/10.1186/1471-2474-14-79/fulltext.html']\n",
      "['9257053', 'van Vollenhoven RF; Geborek P; Forslind K; Albertsson K; Ernestam S; Petersson IF; Chatzidionysiou K; Bratt J; Swefot study group. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. Lancet (london, england). (2012) 379 9827 pp1712-1720', '10.1016/s0140-6736(12)60027-0', '']\n",
      "['9260501', 'van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; C‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö√°ster L; Waltbrand E; Zickert A; Theander J; Th‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö√°rner A; Hellstr‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö√°m H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; W‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö‚Ä†‚àö√°rnert M; Bratt J. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet (London, England). (2009) 374 9688 pp459-466', '10.1016/s0140-6736(09)60944-2', '']\n",
      "['9260952', 'Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S. Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial. JAMA internal medicine. (2013) 173 15 pp1407-1414', '10.1001/jamainternmed.2013.7801', '']\n",
      "['9260984', 'Karlsson JA; Neovius M; Nilsson J‚àö√ñ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial. Annals of the rheumatic diseases. (2013) 72 12 pp1927-1933', '10.1136/annrheumdis-2012-202062', '']\n",
      "['9261207', 'Eriksson J; Neovius M; Bratt J; Petersson IF; Van Vollenhoven RF; Geborek P; Ernestam S. Sick leave and disability pension in patients with early rheumatoid arthritis randomized to infliximab plus methotrexate or triple therapy: One-year results. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2013-205060', '']\n",
      "['9261353', 'Hambardzumyan K; Saevarsdottir S; Bolce R; Forslind K; Ernestam S; Petersson I; Geborek P; Chernoff D; Haney D; Sasso EH; Van Vollenhoven RF. Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: Results from the swefot trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1188', '']\n",
      "['9261367', 'Eriksson J; Karlsson JA; Bratt J; Petersson IF; Van Vollenhoven RF; Ernestam S; Geborek P; Neovius M. Cost-effectiveness of biologic versus conventional combination treatment in early rheumatoid arthritis: 2-year results of the randomised controlled swefot trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.299', '']\n",
      "['9261440', 'Karlsson JA; Neovius M; Nilsson J-A; Petersson IF; Bratt J; Van Vollenhoven RF; Ernestam S; Geborek P. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality of life results of the randomised, controlled swefot trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1838', '']\n",
      "['9261482', 'Hambardzumyan K; Saevarsdottir S; Bolce R; Forslind K; Ernestam S; Petersson IF; Geborek P; Chernoff D; Haney DJ; Sasso EH; Van Vollenhoven RF. In early rheumatoid arthritis, the 12 individual biomarkers that comprise the multiple biomarker disease activity score relate differentially to clinical response and radiographic progression: Results from a randomized trial. Arthritis and rheumatism. (2013) 65  ppS762', '10.1136/annrheumdis-2013-eular.1188', '']\n",
      "['9261508', 'Levitsky A; Forslind K; Van Vollenhoven RF. Predicted versus observed radiographic progression in a rheumatoid arthritis randomized trial. Arthritis and rheumatism. (2013) 65  ppS564', '10.1136/annrheumdis-2013-eular.698', '']\n",
      "['9261509', 'Hambardzumyan K; Bolce R; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Saevarsdottir S; Petersson IF; Geborek P; Ernestam S; Van Vollenhoven RF. A multi-biomarker disease activity score correlates with radiographic progression in early rheumatoid arthritis: Results from a randomized trial. Arthritis and rheumatism. (2013) 65  ppS555', '10.1136/annrheumdis-2013-eular.1188', '']\n",
      "['9261580', 'Eriksson JK; Karlsson JA; Bratt J; Petersson IF; van Vollenhoven RF; Ernestam S; Geborek P; Neovius M. Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial. Annals of the rheumatic diseases. (2015) 74 6 pp1094-1101', '10.1136/annrheumdis-2013-205060', '']\n",
      "['9261661', 'Saevarsdottir S; Rezaei H; Geborek P; Petersson I; Ernestam S; Albertsson K; Forslind K; van Vollenhoven RF; SWEFOT study group. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial. Annals of the rheumatic diseases. (2015) 74 8 pp1509-1514', '10.1136/annrheumdis-2013-204601', '']\n",
      "['9261902', 'Levitsky A; Erlandsson M; Van Vollenhoven RF; Bokarewa MI. Serum survivin predicts treatment response in active rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp224', '10.1136/annrheumdis-2015-eular.3151', '']\n",
      "['9261927', 'Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; Van Vollenhoven RF; Lundberg K. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Annals of the rheumatic diseases. (2016) 75 2 pp356-361', '10.1136/annrheumdis-2014-205698', '']\n",
      "['9262105', 'Levitsky A; Forslind K; van Vollenhoven RF. Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial. Scandinavian journal of rheumatology. (2015) 44 5 pp348-353', '10.3109/03009742.2015.1019560', '']\n",
      "['9262727', 'Olofsson T; Wallman JK; Joud A; Schelin ME; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Unacceptable, refractory pain despite inflammation control in early rheumatoid arthritis and its relation to treatment strategy: results from the randomised controlled swefot trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp117', '10.1136/annrheumdis-2018-eular.2924', '']\n",
      "['9262731', 'Olofsson T; Wallman JK; Joud A; Schelin ME; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Less pain over 2 years with biological compared to conventional combination therapy in early rheumatoid arthritis: results from the randomised controlled swefot trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp310', '10.1136/annrheumdis-2018-eular.1844', '']\n",
      "['9263330', 'Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial. Annals of the rheumatic diseases. (2012) 71 2 pp186-191', '10.1136/annrheumdis-2011-200038', '']\n",
      "['9736867', 'Levitsky A; Saevarsdottir S; Brismar K; Hambardzumyan K; Lourdudoss C; Van Vollenhoven RF. Obesity is associated with worse clinical outcomes yet limited radiographic progression in early rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp448-', '10.1136/annrheumdis-2016-eular.2907', '']\n",
      "['9738775', 'Olofsson T; Wallman JK; Joud A; Schelin ME; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Unacceptable, refractory pain despite inflammation control in early rheumatoid arthritis and its relation to treatment strategy: results from the randomised controlled swefot trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp117', '10.1136/annrheumdis-2018-eular.2924', '']\n",
      "['9738778', 'Olofsson T; Wallman JK; Joud A; Schelin ME; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Less pain over 2 years with biological compared to conventional combination therapy in early rheumatoid arthritis: results from the randomised controlled swefot trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp310', '10.1136/annrheumdis-2018-eular.1844', '']\n",
      "['9738840', 'Bolce R; Karnawat S; Tang S; Hennessey K. The multi-biomarker disease activity score in methotrexate incomplete responders predicts clinical responses to non-biological versus biological therapy in early RA. Journal of managed care and specialty pharmacy. (2016) Conference: AMCP Managed Care and Specialty Pharmacy Annual Meeting 2016. United States. 22 4-A SUPPL. ppS103-S104', '10.18553/jmcp.2019.25.3-a.s1', '']\n",
      "['9738951', 'Olofsson T; Wallman JK; Joud A; Schelin M; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Less pain over two years with biological compared to conventional combination therapy in early rheumatoid arthritis: results from the randomized controlled SWEFOT trial. Scandinavian journal of rheumatology. (2018) 47 Supplement 129 pp6-7', '10.1136/annrheumdis-2018-eular.1844', '']\n",
      "['9739078', 'Hambardzumyan K; Bolce R J; Saevarsdottir S; Forslind K; Wallman J K; Van Vollenhoven; R F. The multi-biomarker disease activity score in methotrexate incomplete responders predicts clinical responses to non-biological versus biological therapy in early ra. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp688-689', '10.1136/annrheumdis-2016-eular.4258', '']\n",
      "['9739277', 'Hambardzumyan Karen; Bolce Rebecca J; Saevarsdottir Saedis; Forslind Kristina; Wallman Johan K; Cruickshank Scott E; Sasso Eric H; Chernoff David; van Vollenhoven; Ronald F. Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial. RMD open. (2016) 2 1 ppe000197', '10.1136/rmdopen-2015-000197', '']\n",
      "['9739401', 'Olofsson T; Wallman JK; Joud A; Schelin M; Ernestam S; Van Vollenhoven R; Saevarsdottir S; Lampa J. Unacceptable, refractory pain despite inflammation control in early rheumatoid arthritis and its relation to treatment strategy: results from the randomized controlled SWEFOT trial. Scandinavian journal of rheumatology. (2018) 47  pp1-', '10.1136/annrheumdis-2018-eular.2924', '']\n",
      "['9739821', 'UMIN000008281. Dose-escalation study of infliximab or methotrexate based on the disease activity in patients with rheumatoid arthritis treated with infliximab. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008281. (2012)   pp', '10.1136/annrheumdis-2012-eular.2097', '']\n",
      "['9740903', 'NCT00764725. Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT). https://clinicaltrials.gov/show/NCT00764725. (2008)   pp', '10.1136/annrheumdis-2017-eular.4914', '']\n",
      "['9742270', 'Hambardzumyan K; Hermanrud C; Marits P; Vivar N; Ernestam S; Wallman JK; Van Vollenhoven RF; Fogdell-Hahn A; Saevarsdottir S. Female gender and positive rheumatoid factor predict low serum infliximab levels and positive anti-drug antibodies, which associate with treatment failure on infliximab in patients with early rheumatoid arthritis. Report from the swefot trial population. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp165', '10.1136/annrheumdis-2018-eular.2877', '']\n",
      "['9742607', 'Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson I F; Wallman J K; Ernestam S; Bolce R J; van Vollenhoven; R F. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure. Arthritis and rheumatology. (2017) 69 5 pp953-963', '10.1002/art.40019', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40019']\n",
      "['9742619', 'Rezaei H; Saevarsdottir S; Forslind K; Geborek P; Petersson I F; Ernestam S; Bratt J. Patients with early rheumatoid arthritis (RA) who respond well to methotrexate monotherapy have less metacarpal bone loss, measured by digital X-ray radiogrammetry (DXR), than those who need add-on therapy. Findings from a randomized trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1186/1471-2474-14-79', 'http://link.springer.com/article/10.1186/1471-2474-14-79/fulltext.html']\n",
      "['11088036', 'Miller Heather; Wallman Johan K; Petersson Ingemar F; Saevarsdottir Saedis; Soderling Jonas; Ernestam Sofia; Askling Johan; van Vollenhoven Ronald; Neovius Martin. Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine. Rheumatology (Oxford, England). (2021) 60 5 pp2217-2222', '10.1093/rheumatology/keaa553', 'http://academic.oup.com/rheumatology/article-pdf/60/5/2217/37935817/keaa553.pdf']\n",
      "['9258217', \"Navarro Coy NC; Brown S; Bosworth A; Davies CT; Emery P; Everett CC; Fernandez C; Gray JC; Hartley S; Hulme C; Keenan AM; McCabe C; Redmond A; Reynolds C; Scott D; Sharples LD; Pavitt S; Buch MH. The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. BMC musculoskeletal disorders. (2014) 15  pp452\", '10.1186/1471-2474-15-452', 'http://link.springer.com/article/10.1186/1471-2474-15-452/fulltext.html']\n",
      "['9737284', '. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health technology assessment. (2018) 22 34 pp1-280', '10.3310/hta22340', 'https://njl-admin.nihr.ac.uk/document/download/2003401']\n",
      "['9739991', 'EUCTR2005-001633-14-DK. Randomised, multi-center, open-label, parallel-group study comparing adalimumab (Humira?) 40 mg s.c. eow versus infliximab (Remicade?) 3 mg/kg i.v. every 6. week in RA patients with unsustainable clinical response to infliximab 3 mg/kg every 8. week  - The SWITCH Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001633-14-DK. (2005)   pp', '10.1111/j.1365-2133.2012.11041.x', '']\n",
      "['9740484', '. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health technology assessment. (2018) 22 34 pp1-280', '10.3310/hta22340', 'https://njl-admin.nihr.ac.uk/document/download/2003401']\n",
      "['9741067', 'NCT01295151. SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. https://clinicaltrials.gov/show/NCT01295151. (2011)   pp', '10.1186/isrctn89222125', '']\n",
      "['9742884', 'Brown Sarah; Everett Colin C; Naraghi Kamran; Davies Claire; Dawkins Bryony; Hulme Claire; McCabe Christopher; Pavitt Sue; Emery Paul; Sharples Linda; Buch Maya H. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health technology assessment (Winchester, England). (2018) 22 34 pp1-280', '10.3310/hta22340', 'https://njl-admin.nihr.ac.uk/document/download/2003401']\n",
      "['11086192', 'Syngle A; Garg N; Chauhan K. Amelioration of endothelial dysfunction with jak inhibition in rheumatoid arthritis: jak cv-risk reduction study. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp318-319', '10.1136/annrheumdis-2021-eular.3753', '']\n",
      "['9261153', 'Urata Y; Nakamura Y; Furukawa K-I. Initial introduction of treat-to-target strategy in patients with recent onset rheumatoid arthritis is more effective than delayed introduction of strategy with more clinical and functional remission achieved for 2-years: Results of the treating to twine targets (T-4) study. Arthritis and rheumatism. (2012) 64  ppS156', '10.1136/annrheumdis-2013-203748', '']\n",
      "['9261201', 'Kume K; Amano K; Yamada S; Hatta K. Tocilizumab monotherapy improves BONE mineral density as well as TNF Blockers plus methotrexate with methotrexate-resistant activerheumatoid arthritis. An open-label randomized clinical trial. T-BONE Trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1093/rheumatology/ket468', 'http://academic.oup.com/rheumatology/article-pdf/53/5/900/6897613/ket468.pdf']\n",
      "['9257049', 'Bassiouni H; Spargo CE; Vlahos B; Jones HE; Pedersen R; Shirazy K. Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis. Rheumatology and therapy. (2018) 5 1 pp149-158', '10.1007/s40744-018-0094-6', 'http://link.springer.com/article/10.1007/s40744-018-0094-6/fulltext.html']\n",
      "['9258005', 'Pavelka K; Akkoc N; Al-Maini M; Zerbini CAF; Karateev DE; Nasonov EL; Rahman MU; Pedersen R; Dinh A; Shen Q; Vasilescu R; Kotak S; Mahgoub E; Vlahos B. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access. Rheumatology international. (2017) 37 9 pp1469-1479', '10.1007/s00296-017-3749-7', 'https://link.springer.com/article/10.1007/s00296-017-3749-7/fulltext.html']\n",
      "['9258341', 'Zerbini CAF; Abud-Mendoza C; Mendez-Patarroyo P; De Angelo Andrade M; Pedersen R; Vlahos B; Borlenghi CE. Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: subset analysis of a randomized trial. Medicine. (2018) 97 36 ppe11989', '10.1097/md.0000000000011989', '']\n",
      "['9262055', 'Louthenroo W; Chang CC; Salido E; Marshall L; Pedersen R; Llamado LJ. Maintenance of LDA and remission with etanercept-dmard combination treatment compared with dmards alone in asian patients with active rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp167', '10.1007/s40744-018-0094-6', 'http://link.springer.com/article/10.1007/s40744-018-0094-6/fulltext.html']\n",
      "['9263587', 'Zerbini C; Real R; Pedersen R; Shen Q; Kotak S. Remission maintenance with etaqnercept-DMARD combination therapy compared with DMARDS alone in Latin America patients with active rheumatoid arthritis. Journal of clinical rheumatology. Conference: 19th pan american league of associations for rheumatology congress. Panama. (2016) 22 3 pp130-131', '10.1007/s40744-018-0094-6', 'http://link.springer.com/article/10.1007/s40744-018-0094-6/fulltext.html']\n",
      "['9737342', 'Zerbini Cristiano A F; Abud-Mendoza Carlos; Mendez-Patarroyo Paul; De Angelo Andrade Mauricio; Pedersen Ron; Vlahos Bonnie; Borlenghi Cecilia Elena. Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: subset analysis of a randomized trial. Medicine. (2018) 97 36 ppe11989', '10.1097/md.0000000000011989', '']\n",
      "['9738329', 'Bassiouni H; Spargo CE; Vlahos B; Jones HE; Pedersen R; Shirazy K. Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis. Rheumatology and therapy. (2018) 5 1 pp149-158', '10.1007/s40744-018-0094-6', 'http://link.springer.com/article/10.1007/s40744-018-0094-6/fulltext.html']\n",
      "['9739026', 'Akkoc N; Zerbini C A; Karateev D; Pedersen R; Vlahos B; Marshall L; Bao C; Al-Maini M; Shen Q. Potential predictors for achieving and/or maintaining low disease activity or remission in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp201-202', '10.1136/annrheumdis-2016-eular.1856', '']\n",
      "['9743016', 'NCT01578850. Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening. https://clinicaltrials.gov/show/NCT01578850. (2012)   pp', '10.1002/cca.3831', '']\n",
      "['9257026', 'Scott DL; Ibrahim F; Kelly C; Birrell F; Chakravarty K; Walker D; Maddison P; Kingsley G. Randomized controlled trial of tumournecrosis-factor inhibitors against combination intensive therapy with conventional DMARDS in established rheumatoid arthritis: The tacit trial. Rheumatology (United Kingdom). (2013) 52  ppi31', '10.1136/bmj.h1046', '']\n",
      "['9258471', \"Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews. Health technology assessment (Winchester, England). (2014) 18 66 ppi-xxiv, 1-164\", '10.3310/hta18660', 'https://njl-admin.nihr.ac.uk/document/download/2002095']\n",
      "['9263512', \"Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Walker D; Kelly C; Birrell F; Chakravarty K; Maddison P; Heslin M; Patel A; Kingsley GH. Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. BMJ (Clinical research ed.). (2015) 350  pph1046\", '10.1136/bmj.h1046', '']\n",
      "['9737989', 'EUCTR2007-001190-28-GB. Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis - TACIT. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001190-28-GB. (2007)   pp', '10.1186/isrctn37438295', '']\n",
      "['9741367', 'Scott DL; Ibrahim F; Farewell V; O‚Äö√Ñ√¥Keeffe AG; Walker D; Kelly C; Birrell F; Chakravarty K; Maddison P; Heslin M; Patel A; Kingsley GH. Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. BMJ: british medical journal. (2015) 350 8000 pph1046', '10.1136/bmj.h1046', '']\n",
      "['11088365', 'Ibrahim F; Tom BDM; Scott DL; Prevost AT. Characterization of missing data patterns and mechanisms in longitudinal composite outcome trial in rheumatoid arthritis. . (2022) 14  pp', '10.1177/1759720x221114103', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X221114103']\n",
      "['9740245', 'UMIN000016844. The clinical study for seeking strategy how to treat rheumatoid arthritis by TNF Inhibitors. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000016844. (2015)   pp', '10.2165/00128413-200012500-00003', '']\n",
      "['11088217', 'Pinto Ana Jessica; Pecanha Tiago; Meireles Kamila; Benatti Fabiana Braga; Bonfiglioli Karina; de Sa Pinto Ana Lucia; Lima Fernanda Rodrigues; Pereira Rosa Maria Rodrigues; Irigoyen Maria Claudia Costa; Turner James Edward; Kirwan John P; Owen Neville; Dunstan David W; Roschel Hamilton; Gualano Bruno. A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: protocol and rationale of the Take a STAND for Health study. Trials. (2020) 21 1 pp171', '10.1186/s13063-020-4104-y', 'http://link.springer.com/article/10.1186/s13063-020-4104-y/fulltext.html']\n",
      "['9260818', 'Takeuchi T; Matsubara T; Nitobe T; Suematsu E; Ohta S; Honjo S; Abe T; Yamamoto A; Miyasaka N; Japan Abatacept Study Group. Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. Modern rheumatology / the Japan Rheumatism Association. (2013) 23 2 pp226-235', '10.3109/s10165-012-0668-z', '']\n",
      "['9263481', 'Hasegawa M; Hiraoka M; Ito K; Roy A; Imai Y. Longitudinal abatacept exposure-response characterization in Japanese rheumatoid arthritis patients. Journal of clinical pharmacology. (2011) 51  9 pp1327', '10.1007/s10928-011-9221-5', 'http://link.springer.com/article/10.1007/s10928-011-9221-5/fulltext.html']\n",
      "['9738944', 'Nakaoka Y; Isobe M; Takei S; Tanaka Y; Ishii T; Yokota S; Nomura A; Yoshida S; Nishimoto N. Long-term efficacy and safety of tocilizumab in patients with refractory takayasu arteritis treated continuously over 52 weeks: results from phase 3, randomized, double-blind, placebo-controlled trial and open-label extension in Japan. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-211878', '']\n",
      "['9260805', 'Tam LS; Shang Q; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial. Journal of rheumatology. (2012) 39 12 pp2267-2275', '10.3899/jrheum.120541', '']\n",
      "['9736562', 'Tam L S; Shang Q; Li E K; Lee K L; Leung Y Y; Ying K Y; Yim C W. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritisa randomized trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3899/jrheum.120541', '']\n",
      "['9739977', 'EUCTR2008-000105-11-DE. Effectiveness after 4 and 24 weeks and safety of tocilizumab in patients with active RA - TAMARA - Tocilizumab And DMARDs: achievements in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000105-11-DE. (2008)   pp', '10.1136/ard.2010.139725', '']\n",
      "['9738889', 'Greenwald M; Shergy W; Kaine J L; Sweetser M T; Gilder K; Linnik M D. Safety of rituximab in combination with a TNF inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial (TAME). Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1957-', '10.1002/art.30194', '']\n",
      "['9257658', 'Tanaka Y; Takeuchi T; Yamanaka H; Nakamura H; Toyoizumi S; Zwillich S. Efficacy and safety of tofacitinib AS monotherapy in japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study. Modern rheumatology. (2015) 25 4 pp514-521', '10.3109/14397595.2014.995875', '']\n",
      "['9261198', 'Takeuchi T; Tanaka Y; Yamanaka H; Suzuki M; Nakamura H; Yazawa KK; Toyoizumi S. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, as monotherapy in patients with active rheumatoid arthritis: A comparison between japanese and global populations over 12 weeks of dosing in phase 2b studies. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1186/s13075-016-0932-2', '']\n",
      "['9261199', 'Tanaka Y; Takeuchi T; Yamanaka H; Suzuki M; Nakamura H; Toyoizumi S; Bradley JD. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, as monotherapy in japanese patients with active rheumatoid arthritis: A 12-week phase 2b study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3109/14397595.2014.995875', '']\n",
      "['9739139', 'Suzuki M; Neelakantan S; Peterson M; Hutmacher M; Krishnaswami S. Dose response modeling of tofacitinib (CP-690,550) for the treatment of signs and symptoms of rheumatoid arthritis. Clinical pharmacology and therapeutics. (2012) 91 SUPPL. 1 ppS76', '10.1002/jcph.1514', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1514']\n",
      "['9740956', 'NCT00687193. Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan. https://clinicaltrials.gov/show/NCT00687193. (2008)   pp', '10.1002/art.23361', '']\n",
      "['9742975', '. Model-Based Comparison of Dose-Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients. Journal of clinical pharmacology. (2019)   pp', '10.1002/jcph.1514', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1514']\n",
      "['9261479', 'Tanaka Y; Emoto K; Tsujimoto M; Schlichting DE; Macias W. 12-Week results of a phase 2b dose-ranging study of baricitinib, an oral JAK1/ JAK2 inhibitor in japanese patients with rheumatoid arthritis on background methotrexate therapy. Arthritis and rheumatism. (2013) 65  ppS765', '10.1136/annrheumdis-2012-eular.1965', '']\n",
      "['9261514', 'Matsubara T; Schlichting D; Emoto K; Tsujimoto M; Macias W. Efficacy and safety of baricitinib in Japanese RA patients at 12 weeks. International journal of rheumatic diseases. (2014) 17  pp43', '10.1136/annrheumdis-2014-eular.1366', '']\n",
      "['9261552', 'Tanaka Y; Emoto K; Tsujimoto M; Schlichting D; Macias W. Efficacy and safety of baricitinib in japanese rheumatoid arthritis patients at 12 weeks. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1366', '']\n",
      "['9262384', 'Tanaka Y; Ishii T; Cai Z; Schlichting D; Rooney T; Macias W. Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: a 52-week, randomized, single-blind, extension study. Modern rheumatology. (2018) 28 1 pp20-29', '10.1080/14397595.2017.1307899', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1307899']\n",
      "['9263534', 'Tanaka Y; Emoto K; Cai Z; Aoki T; Schlichting D; Rooney T; Macias W. Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis receiving background methotrexate therapy: A 12-week, double-blind, randomized placebo-controlled study. Journal of rheumatology. (2016) 43  3 pp504-511', '10.3899/jrheum.150613', '']\n",
      "['9738166', 'JapicCTI-111709. A Randomized, Double-Blind, Placebo-Controlled, Dose Ranging, Parallel-Group, Phase 2 Study of LY3009104 in Japanese Patients with Active Rheumatoid Arthritis on Background Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-111709. (2011)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9738992', 'Tanaka Y; Emoto K; Cai Z; Aoki T; Schlichting D; Rooney T. Erratum: efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: a 12-week, Double-blind, Randomized Placebo-controlled Study (Journal of Rheumatology May 2016 43(5): (998)); doi: 10.3899/jrheum.150613.C1. Journal of rheumatology. (2016) 43 5 pp998', '10.3899/jrheum.150613', '']\n",
      "['9738993', 'Tanaka Y; Emoto K; Cai Z; Schlichting D E; Rooney T; Macias W. Efficacy and safety of baricitinib in Japanese rheumatoid arthritis patients during a 52 week extension phase. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS652', '10.1080/14397595.2017.1307899', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1307899']\n",
      "['9743033', 'NCT01469013. Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy. https://clinicaltrials.gov/show/NCT01469013. (2011)   pp', '10.31525/ct1-nct03915964', '']\n",
      "['9743044', '. Erratum: safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment (Journal of Rheumatology (2019) 46 (7-18) DOI: 10.3899/jrheum.171361). Journal of rheumatology. (2019) 46 12 pp1648-1649', '10.3899/jrheum.171361.c1', '']\n",
      "['9740090', 'EUCTR2012-004631-22-BE. TapERA: tapering Etanercept in Reumatoid Artritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-004631-22-BE. (2012)   pp', '10.1007/s40278-012-0211-1', 'http://link.springer.com/article/10.1007/s40278-012-0211-1/fulltext.html']\n",
      "['9740761', 'Bertrand D; Mannaerts J; Badot V; Corluy L; De Cock D; De Knop K; De Wergifosse I; Geens E; Hoffman I; Joly J; Langenaken C; Lenaerts J; Lenaerts J; Pazmino S; Stouten V; Taelman V; Walschot M; Westhovens R; Verschueren P. Maintaining remission in patients with established rheumatoid arthritis while tapering etanercept: an insight in the TapERA trial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1137', '10.1136/annrheumdis-2019-eular.3055', '']\n",
      "['11086609', 'Bertrand D; Stouten V; Pazmino S; De Cock D; Moeyersoons A; Westhovens R; Joly J; Verschueren P. The flare-RA questionnaire can identify omeract flares in patients with rheumatoid arthritis included in the tapera trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp885-886', '10.1136/annrheumdis-2020-eular.2832', '']\n",
      "['9257418', 'Van Der Ven M; Kuijper M; Gerards A; Tchetverikov I; Weel A; Van Zeben J; Hazes M; Luime J. Can we use ultrasound to identify rheumatoid arthritis patients in remission who can taper their medication?. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2012', '']\n",
      "['9262692', 'Van Mulligen E; Weel AEAM; Kuijper TM; Luime JJ; Hazes JMW; De Jong PHP. Gradual tapering tnf blockers versus conventional synthetic dmards in patients with rheumatoid arthritis in sustained remission: first year results of the randomised controlled tara-study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp107', '10.1136/annrheumdis-2018-eular.1908', '']\n",
      "['9262720', 'Van Mulligen E; Weel AEAM; Kuijper TM; Luime JJ; Hazes JMW; De Jong PHP. Cost-effectiveness of tapering TNF blockers versus conventional synthetic dmards in rheumatoid arthritis: first year results of the randomised controlled tara-study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp196', '10.1136/annrheumdis-2018-eular.2051', '']\n",
      "['9739412', 'Van Der Ven M; Martijn Kuijper T; Gerards AH; Tchetverikov I; Weel AEAM; Van Zeben D; Hazes JMW; Luime JJ. Can we use ultrasound to identify rheumatoid arthritis patients in remission who cannot taper their medication?. Arthritis and rheumatology. (2014) 66  ppS51-', '10.1136/annrheumdis-2014-eular.2012', '']\n",
      "['9740613', 'van Mulligen Elise; de Jong Pascal Hendrik Pieter; Kuijper Tjallingius Martijn; van der Ven Myrthe; Appels Cathelijne; Bijkerk Casper; Harbers Joop B; de Man Yael; Molenaar T H Esmeralda; Tchetverikov Ilja; Goekoop-Ruiterman Yvonne P M; van Zeben Jende; Hazes Johanna M W; Weel Angelique E A M; Luime Jolanda J. Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study. Annals of the rheumatic diseases. (2019) 78 6 pp746-753', '10.1136/annrheumdis-2018-214970', '']\n",
      "['9740780', \"Van Mulligen E; Weel A; Kuijper M; Hazes J; Van Der Helm-Van Mil A; De Jong P. Flaring of rheumatoid arthritis due to tapering of DMARDs: how does it affect patients' well-being? A study on patient reported outcomes. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1125\", '10.1136/annrheumdis-2019-eular.4550', '']\n",
      "['9741318', 'van Mulligen E; Weel AEAM; Kuijper TM; Hazes JMW; van der Helm- van Mil AHM; de Jong PHP. The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients. Seminars in arthritis and rheumatism. (2020)   pp', '10.1016/j.semarthrit.2020.02.011', '']\n",
      "['9741394', 'van Mulligen Elise; Weel Angelique E; Hazes J M; van der Helm-van Mil Annette; de Jong Pascal Hendrik Pieter. Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2020-eular.1417', '']\n",
      "['9742426', 'van Mulligen E; Weel AE; Hazes JM; van der Helm-van Mil A; de Jong PHP. Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial. Annals of the rheumatic diseases. (2020)   pp', '10.1136/annrheumdis-2020-eular.1417', '']\n",
      "['9742528', 'Van Mulligen E; Weel AEAM; Kuijper TM; Luime JJ; Hazes JMW; De Jong PHP. Cost-effectiveness of tapering TNF blockers versus conventional synthetic dmards in rheumatoid arthritis: first year results of the randomised controlled tara-study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp196', '10.1136/annrheumdis-2018-eular.2051', '']\n",
      "['11086577', 'Van Mulligen E; Weel A; Kuijper M; Hazes J; De Jong P. Two-year cost-effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the tara trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp175', '10.1136/annrheumdis-2020-eular.740', '']\n",
      "['11087422', 'Looijen AEM; van Mulligen E; van der Helm-van Mil AHM; de Jong PHP. Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients. Rheumatology (Oxford, England). (2022) 61 8 ppe216-e218', '10.1093/rheumatology/keac154', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac154/43222926/keac154.pdf']\n",
      "['11088196', 'van Mulligen E; Weel A E A M; Kuijper T M; Hazes J M W; van der Helm-van Mil A H M; de Jong P H P. The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients. Seminars in arthritis and rheumatism. (2020) 50 3 pp423-431', '10.1016/j.semarthrit.2020.02.011', '']\n",
      "['11088579', 'Looijen AEM; van Mulligen E; van der Helm-van Mil AHM; de Jong PHP. Tapering subcutaneous methotrexate causes more disease flares compared to tapering oral administration in established rheumatoid arthritis patients. . (2022)   pp', '10.1093/rheumatology/keac154', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac154/43222926/keac154.pdf']\n",
      "['9256837', 'Gabay C; Msihid J; Zilberstein M; Paccard C; Lin Y; Graham NMH; Boyapati A. Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2017-000607', '']\n",
      "['9256871', 'Fleischmann R; Van Hoogstraten H; Jayawardena S; Mangan EK; Ching D; Burmester GR. Efficacy of sarilumab in combination with CSDMARDs in patients with rheumatoid arthritis and inadequate response to TNF inhibitors by baseline levels of disease activity. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/key075.439', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.439/24768353/key075.439.pdf']\n",
      "['9257106', 'Burmester GR; Van Hoogstraten H; Mangan EK; Lin Y; Graham NMH; Kimura T; Hrycaj P. Efficacy of sarilumab plus csDMARDs in subgroups of patients with rheumatoid arthritis and an inadequate response to TNF inhibitors. International journal of rheumatic diseases. Conference: 19th asia pacific league of associations for rheumatology congress, APLAR 2017.. (2017) 20 Supplement 1 pp39-40', '10.1136/annrheumdis-2017-eular.5155', '']\n",
      "['9257576', 'Gabay C; Msihid J; Daskalakis N; Barbot A; Zilberstein M; Boyapati A. Effect of sarilumab on circulating biomarkers of bone and joint destruction in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3537-3539', '10.1002/art.39977', '']\n",
      "['9258135', 'Genovese M; Pinheiro G; Mangan E; Lin Y; Van Hoogstraten H; Fleischmann R. Efficacy of sarilumab plus CSDMARDS in rheumatoid arthritis patients who had an inadequate response to one or more than one prior TNF inhibitor. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp29', '10.1136/annrheumdis-2016-eular.4280', '']\n",
      "['9258622', 'Burmester G; Hrycaj P; Pacheco-Tena C; Van Hoogstraten H; Mangan EK; Lin Y; Bauer D; Fay J; Parrino J; Kivitz A. Clinical remission outcomes with sarilumab plus csdmards in active, moderate-to-severe ra patients with inadequate response to tumor necrosis factor inhibitors. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp727-728', '10.1136/annrheumdis-2016-eular.4231', '']\n",
      "['9258731', 'Fleischmann R; Geraldo Da RCP; Brzezicki J; Hrycaj P; Lin Y; Van Adelsberg J; Graham N; Van Hoogstraten H; Bauer D; Gerd RB. Efficacy and safety of sarilumab in combination with csdmards in patients with active rheumatoid arthritis who were inadequate responders or intolerant of anti-TNF-alpha therapy: results from a phase 3 study. Internal medicine journal. Conference: 57th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2016) 46  pp41', '10.1002/art.39944', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39944']\n",
      "['9261829', 'Fleischmann R; Castelar-Pinheiro G; Brzezicki J; Hrycaj P; Lin Y; Van Adelsberg J; Graham N; Van Hoogstraten H; Bauer D; Burmester G. Efficacy and safety of sarilumab in combination with csdmards in patients with active rheumatoid arthritis WHO were inadequate responders or intolerant of anti-tnf-+/- therapy: results from a phase 3 study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.39944', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39944']\n",
      "['9261836', 'Strand V; Kosinski M; Graham N; Chen C-I; Joseph GJ; Bauer D; Lin Y; Pacheco-Tena C; Fleischmann R. Impact of sarilumab on fatigue, pain, morning stiffness, productivity, and health related quality of life (hrqol) in patients with active rheumatoid arthritis WHO were inadequate responders or intolerant of anti-tnf-+/- therapy: results from a phase 3 study (RCT). Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s13075-016-1096-9', 'http://link.springer.com/content/pdf/10.1186/s13075-016-1096-9.pdf']\n",
      "['9262251', 'Genovese M; Pinheiro G; Mangan E; Lin Y; Van Adelsberg J; Van Hoogstraten H; Kimura T; Fleischmann R; Fiore S. Efficacy of sarilumab plus csDMARDs in rheumatoid arthritis patients who had an inadequate response to one or more than one prior TNF inhibitor. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp896', '10.1136/annrheumdis-2016-eular.4280', '']\n",
      "['9262255', 'Strand V; Mahajan P; Chen C; Van Hoogstraten H; Mangan EK; Hagino O; Graham N; Pinheiro GdaRC; Kivitz A. Benefit of sarilumab with csdmards on patient productivity in work, household work and family, social, leisure activities in TNF-IR RA patients. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 pp 985 pp985-', '10.1136/annrheumdis-2016-eular.4295', '']\n",
      "['9262636', 'Fleischmann R; Spindler A; Kivitz A; Ching D; Mangan EK; Kimura T; Iglesias-Rodriguez M; Burmester GR. Similar efficacy and safety of sarilumab 150 mg or 200 mg Q2W regardless of primary (1degree) or secondary (2degree) failure with TNF inhibitors. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp328', '10.1136/annrheumdis-2018-eular.1374', '']\n",
      "['9262704', 'Strand V; Boklage S; Mangan E; Reaney M; Iglesias-Rodriguez M; Kimura T. Patient-reported outcomes with sarilumab in patients with rheumatoid arthritis are similar regardless of primary or secondary failure with tumour necrosis factor inhibitors. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp615-616', '10.1136/annrheumdis-2018-eular.3668', '']\n",
      "['9736710', 'Strand V; Mahajan P; Chen C; Van Hoogstraten H; Mangan EK; Hagino O; Graham N; Pinheiro GdaRC; Kivitz A. Benefit of sarilumab with csdmards on patient productivity in work, household work and family, social, leisure activities in TNF-IR RA patients. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 pp 985 pp985-', '10.1136/annrheumdis-2016-eular.4295', '']\n",
      "['9736851', 'Strand V; Boklage S; Mangan E; Reaney M; Iglesias-Rodriguez M; Kimura T. Patient-reported outcomes with sarilumab in patients with rheumatoid arthritis are similar regardless of primary or secondary failure with tumour necrosis factor inhibitors. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp615-616', '10.1136/annrheumdis-2018-eular.3668', '']\n",
      "['9737216', 'PER-033-13. A STUDY ASSESSING THE EFFICACY AND SAFETY OF SARILUMAB ADDED TO NON-BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-033-13. (2014)   pp', '10.31525/ct1-nct04115748', '']\n",
      "['9738153', 'EUCTR2011-003538-16-SK. To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-003538-16-SK. (2013)   pp', '10.1093/ww/9780199540884.013.u196300', '']\n",
      "['9738459', 'Fleischmann R; St John G; Kimura T; Iglesias-Rodriguez M; Rosner I; Burmester GR. Sustained response in a phase III study of sarilumab plus nonbiologic disease modifying anti-rheumatic drugs in patients with active, moderate-to-severe rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors. Rheumatology (united kingdom). (2018) Conference: 2018 Annual Conference of the British Society for Rheumatology. United Kingdom. 57 Supplement 3 ppiii138-iii139', '10.1093/rheumatology/key075.447', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.447/24768370/key075.447.pdf']\n",
      "['9738586', 'Fleischmann R; John GSt; Kimura T; Iglesias-Rodriguez M; Van Hoogstraten H; Rosner I; Burmester GR. Sustained response in a phase 3 study of sarilumab plus nonbiologic disease-modifying antirheumatic drugs in patients with active, moderate-to-severe rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors. Internal medicine journal. (2018) Conference: 58th Annual Scientific Meeting of the Australian Rheumatology Association with the Rheumatology Health Professionals Association, ARA 2018. Australia. 48 Supplement 4 pp21-22', '10.1093/rheumatology/key075.447', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.447/24768370/key075.447.pdf']\n",
      "['9741091', 'NCT01709578. To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET). https://clinicaltrials.gov/show/NCT01709578. (2012)   pp', '10.2165/00042310-199505030-00003', '']\n",
      "['9742513', 'Gabay C; Msihid J; Zilberstein M; Paccard C; Lin Y; Graham NMH; Boyapati A. Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2017-000607', '']\n",
      "['9742932', 'Gossec L; Strand V; Proudfoot C; Chen C-I; Guillonneau S; Kimura T; van Hoogstraten H; Mangan E; Reaney M. Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale. Journal of rheumatology. (2019)   pp', '10.3899/jrheum.180904', '']\n",
      "['11083685', 'Fleischmann R; Selmi C; Gonzalez-Gay MA; Van Hoogstraten H; Hagino O; Rajput T; John GS; Buttgereit F; Genovese MC. Glucocorticoid dose is progressively reduced in patients with rheumatoid arthritis receiving sarilumab: results from the open-label extend study. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS80', '10.1093/rheumatology/keaa111.229', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.229/33102732/keaa111.229.pdf']\n",
      "['11083696', 'Fleischmann R; Genovese MC; Maslova K; Leher H; Praestgaard A; Burmester GR. Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis with 1 or >1 prior tumor necrosis factor inhibitor failures. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp987', '10.1136/annrheumdis-2020-eular.332', '']\n",
      "['11084037', 'Fleischmann R; Genovese MC; Maslova K; Leher H; Praestgaard A; Burmester GR. Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors. Rheumatology (Oxford, England). (2021) 60 11 pp4991-5001', '10.1093/rheumatology/keab355', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab355/38821510/keab355.pdf']\n",
      "['9257692', 'Giles JT; Liao K; Paynter N; Wohlfahrt A; Zartoshti A; Broderick R; Solomon DH; Bathon J. Delineating the effects of rheumatoid arthritis pharmacotherapies on vascular inflammation: rationale and design of a clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2065-2066', '10.1002/art.39977', '']\n",
      "['11085232', 'Solomon DH; Giles JT; Liao KP; Ridker PM; Rist PM; Glynn RJ; Broderick R; Lu F; Murray MT; Vanni K; Santacroce LM; Abohashem S; Robson PM; Fayad Z; Mani V; Tawakol A; Bathon J. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. . (2022)   pp', '10.1136/ard-2022-223302', '']\n",
      "['11085585', 'Giles JT; Rist PM; Liao KP; Tawakol A; Fayad ZA; Mani V; Paynter NP; Ridker PM; Glynn RJ; Lu F; Broderick R; Murray M; Vanni KMM; Solomon DH; Bathon JM. Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: rationale and Design of the TARGET Trial. ACR open rheumatology. (2021) 3 6 pp371-380', '10.1002/acr2.11256', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11256']\n",
      "['11085745', 'Solomon Daniel H; Giles Jon T; Liao Katherine P; Ridker Paul M; Rist Pamela M; Glynn Robert J; Broderick Rachel; Lu Fengxin; Murray Meredith T; Vanni Kathleen; Santacroce Leah M; Abohashem Shady; Robson Philip M; Fayad Zahi; Mani Venkatesh; Tawakol Ahmed; Bathon Joan; TARGET Trial Consortium. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2022)   pp', '10.1136/ard-2022-223302', '']\n",
      "['9260518', 'Tascioglu F; Oner C; Armagan O. Comparison of low dose methotrexate and combination therapy with methotrexate and sulphasalazine in the treatment of early rheumatoid arthritis. Journal. (2003) 14 3 pp142-149', '10.1007/s00296-003-0298-z', 'http://link.springer.com/article/10.1007/s00296-003-0298-z/fulltext.html']\n",
      "['9263132', 'Tascioglu F; Oner C; Armagan O. The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatology international. (2003) 23 5 pp231-235', '10.1007/s00296-003-0298-z', 'http://link.springer.com/article/10.1007/s00296-003-0298-z/fulltext.html']\n",
      "['9258705', 'Takeuchi T; Yamanaka H; Ishiguro N; Miyasaka N; Mukai M; Matsubara T; Uchida S; Akama H; Kupper H; Arora V; Tanaka Y. Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study. Annals of the rheumatic diseases. (2014) 73 3 pp536-543', '10.1136/annrheumdis-2012-202433', '']\n",
      "['9260736', \"Moreland LW; O'Dell JR; Paulus HE; Curtis JR; Bathon JM; St Clair EW; Bridges SL; Zhang J; McVie T; Howard G; van der Heijde D; Cofield SS; TEAR Investigators. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis and rheumatism. (2012) 64 9 pp2824-2835\", '10.1002/art.34498', '']\n",
      "['9739556', 'Tascioglu F; Oner C; Armagan O. Comparison of low dose methotrexate and combination therapy with methotrexate and sulphasalazine in the treatment of early rheumatoid arthritis. Journal of rheumatology and medical rehabilitation. (2003) 14 3 pp142-149', '10.1007/s00296-003-0298-z', 'http://link.springer.com/article/10.1007/s00296-003-0298-z/fulltext.html']\n",
      "['9260773', \"O'Dell JR; Curtis JR; Mikuls TR; Cofield SS; Bridges SL; Ranganath VK; Moreland LW; TEAR Trial Investigators. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial. Arthritis and rheumatism. (2013) 65 8 pp1985-1994\", '10.1002/art.38012', '']\n",
      "['9260773', \"O'Dell JR; Curtis JR; Mikuls TR; Cofield SS; Bridges SL; Ranganath VK; Moreland LW; TEAR Trial Investigators. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial. Arthritis and rheumatism. (2013) 65 8 pp1985-1994\", '10.1002/art.38012', '']\n",
      "['9260780', \"Navarro-Mill‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬™n I; Charles-Schoeman C; Yang S; Bathon JM; Bridges SL; Chen L; Cofield SS; Dell'Italia LJ; Moreland LW; O'Dell JR; Paulus HE; Curtis JR. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis and rheumatism. (2013) 65 6 pp1430-1438\", '10.1002/art.37916', '']\n",
      "['9260780', \"Navarro-Mill‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ‚Äö√Ñ√∂‚àö‚Ä†‚àö¬™n I; Charles-Schoeman C; Yang S; Bathon JM; Bridges SL; Chen L; Cofield SS; Dell'Italia LJ; Moreland LW; O'Dell JR; Paulus HE; Curtis JR. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis and rheumatism. (2013) 65 6 pp1430-1438\", '10.1002/art.37916', '']\n",
      "['9260960', \"Curtis JR; McVie T; Mikuls TR; Reynolds RJ; Navarro-Mill‚àö¬∞n I; O'Dell J; Moreland LW; Bridges SL; Ranganath VK; Cofield SS. Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial. Journal of rheumatology. (2013) 40 5 pp572-578\", '10.3899/jrheum.120715', '']\n",
      "['9261449', \"Charles-Schoeman C; Lee YY; Shahbazian A; Elashoff D; Wong X; Curtis JR; Navarro-Millan I; Yang S; Chen L; Cofield S; Moreland LW; Paulus HE; O'Dell J; Bathon JM; Bridges Jr SL; Reddy ST. Improvement in high density lipoprotein function in early rheumatoid arthritis patients treated with methotrexate monotherapy or combination therapy in the treatment of early rheumatoid arthritis trial. Arthritis and rheumatism. (2013) 65  12 pp3321\", '10.1002/art.39833', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39833']\n",
      "['9261449', \"Charles-Schoeman C; Lee YY; Shahbazian A; Elashoff D; Wong X; Curtis JR; Navarro-Millan I; Yang S; Chen L; Cofield S; Moreland LW; Paulus HE; O'Dell J; Bathon JM; Bridges Jr SL; Reddy ST. Improvement in high density lipoprotein function in early rheumatoid arthritis patients treated with methotrexate monotherapy or combination therapy in the treatment of early rheumatoid arthritis trial. Arthritis and rheumatism. (2013) 65  12 pp3321\", '10.1002/art.39833', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39833']\n",
      "['9261481', 'Metes ID; Chew DW; Patel AM; Balasubramani GK; Curtis JR; Bridges Jr SL; Wisniewski SR; Moreland LW; Levesque MC. Serum amyloid a levels model rheumatoid arthritis disease activity better than c-reactive protein levels especially during treatment with anti-tumor necrosis factor alpha therapy (etanercept). Arthritis and rheumatism. (2013) 65  ppS762', '10.1186/s13075-016-1009-y', 'http://link.springer.com/article/10.1186/s13075-016-1009-y/fulltext.html']\n",
      "['9261489', 'Metes ID; Chew DW; Patel AM; Balasubramani GK; Louis Bridges Jr S; Curtis JR; Wisniewski SR; Moreland LW; Levesque MC. Anti-tumor necrosis factor alpha therapy (etanercept) plus methotrexate lowers serum amyloid a levels to a greater extent than triple oral disease modifying anti-rheumatic drug therapy in early rheumatoid arthritis subjects. Arthritis and rheumatism. (2013) 65  ppS626', '10.1002/art.37757', '']\n",
      "['9261489', 'Metes ID; Chew DW; Patel AM; Balasubramani GK; Louis Bridges Jr S; Curtis JR; Wisniewski SR; Moreland LW; Levesque MC. Anti-tumor necrosis factor alpha therapy (etanercept) plus methotrexate lowers serum amyloid a levels to a greater extent than triple oral disease modifying anti-rheumatic drug therapy in early rheumatoid arthritis subjects. Arthritis and rheumatism. (2013) 65  ppS626', '10.1002/art.37757', '']\n",
      "['9261679', \"Aslibekyan S; Sha J; Redden DT; Moreland LW; O'Dell JR; Curtis JR; Mikuls TR; Reynolds RJ; Danila MI; Bridges SL. Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 4 pp785-786\", '10.1136/annrheumdis-2013-204263', '']\n",
      "['9261679', \"Aslibekyan S; Sha J; Redden DT; Moreland LW; O'Dell JR; Curtis JR; Mikuls TR; Reynolds RJ; Danila MI; Bridges SL. Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 4 pp785-786\", '10.1136/annrheumdis-2013-204263', '']\n",
      "['9261987', \"Danve A; Sayles H; Mikuls TR; O'Dell JR. Male gender and higher hemoglobin predict response to methotrexate in rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp\", '10.4172/2161-1149.1000227', '']\n",
      "['9263477', \"Maska L; O'Dell JR; Curtis JR; Bridges SL; Moreland LW; Cofield S; Mikuls TR. Active smoking is not associated with treatment response in early rheumatoid arthritis in a large randomized blinded trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp\", '10.1002/art.38012', '']\n",
      "['9737013', 'Fuchs P A; Lal L; Fuchs H A; Swint J. Cost-effectiveness and cost-utility analyses comparing strategies for initial treatment of rheumatoid arthritis using published outcomes: economic lessons from the tear trial. Value in health. (2015) 18 7 ppA671', '10.1016/j.jval.2015.09.2454', '']\n",
      "['9737529', \"Charles-Schoeman C; Wang X; Lee Y Y; Shahbazian A; Navarro-Millan I; Yang S; Chen L; Cofield S S; Moreland L W; O'Dell J; Bathon J M; Paulus H; Bridges S L; Curtis J R. Association of Triple Therapy with Improvement in Cholesterol Profiles over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis and rheumatology. (2016) 68 3 pp577-586\", '10.1002/art.39502', '']\n",
      "['9740244', 'EUCTR2004-002006-30-GB. Triple therapy in early active rheumatoid arthritis - TEAR. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-002006-30-GB. (2005)   pp', '10.1055/b-0034-61126', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-61126.pdf']\n",
      "['9740244', 'EUCTR2004-002006-30-GB. Triple therapy in early active rheumatoid arthritis - TEAR. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-002006-30-GB. (2005)   pp', '10.1055/b-0034-61126', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-61126.pdf']\n",
      "['9740994', 'NCT00259610. Treatment of Early Aggressive Rheumatoid Arthritis (TEAR). https://clinicaltrials.gov/show/NCT00259610. (2005)   pp', '10.1002/art.34498', '']\n",
      "['9740994', 'NCT00259610. Treatment of Early Aggressive Rheumatoid Arthritis (TEAR). https://clinicaltrials.gov/show/NCT00259610. (2005)   pp', '10.1002/art.34498', '']\n",
      "['9739186', \"Cornec D; Jousse-Joulin S; Costa S; Marhadour T; Marcorelles P; Berthelot J M; Hachulla E; Hatron P Y; Goeb V; Vittecoq O; Nowak E; Pers J O; Devauchelle-Pensec V; Saraux A. High grade salivary gland involvement, assessed by histology or ultrasonography, is associated with a poor response to rituximab in primary Sjogren's syndrome patients. Annals of the rheumatic diseases. (2015) 74 SUPPL. 2 pp143\", '10.1136/annrheumdis-2015-eular.4156', '']\n",
      "['9262431', \"Fisher BA; Everett CC; Rout J; O'Dywer JL; Emery P; Pitzalis C; Ng W-F; Carr A; Pease CT; Price EJ; Sutcliffe N; Makdissi J; Gendi NS; Hall FC; Ruddock SP; Fernandez C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Sharples LD; Bombardieri M; Bowman SJ. Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the tractiss multicentre randomised trial sub-study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1205-1206\", '10.1136/annrheumdis-2017-eular.3138', '']\n",
      "['9736864', 'NCT03813771. Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve Early RA Patients Based on na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve T-cell Stratification. Https://clinicaltrials.gov/show/nct03813771. (2019)   pp', '10.1186/isrctn17694963', '']\n",
      "['9741181', 'EUCTR2016-002344-16-GB. Targeted treatment early with etanercept and methotrexate or methotrexate with treat to target (standard) care for treatment-naive early rheumatoid arthritis patients, based on baseline naive T-cell frequency. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002344-16-GB. (2017)   pp', '10.1186/isrctn17694963', '']\n",
      "['11088666', 'Mucke J; Knitza J; Muehlensiepen F; Grahammer M; Stenzel R; Simon D; Kleyer A; Kronke G; Sharp C; Bendzuck G; Korinth M; Elling-Audersch C; Vuillerme N; Schett G; Pecher A-C; Krusche M. TELERA‚ÄîAsynchronous TELEmedicine for Patients With Rheumatoid Arthritis: study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial. . (2021) 8  pp', '10.3389/fmed.2021.791715', '']\n",
      "['9256743', 'Landewe R; Van Der Heijde D; Klareskog L; Van Vollenhoven R; Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis and rheumatism. (2006) 54 10 pp3119-3125', '10.1002/art.22143', '']\n",
      "['9257843', 'Zhou H; Mayer PR; Wajdula J; Fatenejad S. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2004) 44 11 pp1235-1243', '10.1177/0091270004268049', '']\n",
      "['9257854', 'van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. Annals of the rheumatic diseases. (2006) 65 3 pp328-334', '10.1136/ard.2005.035709', '']\n",
      "['9258162', 'van der Heijde D; Landew‚àö¬© R; Klareskog L; Rodr‚àö‚â†guez-Valverde V; Settas L; Pedersen R; Fatenejad S. Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study. Arthritis and rheumatism. (2005) 52 1 pp49-60', '10.1002/art.20775', '']\n",
      "['9258445', 'Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Mart‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√Ñ√∂‚àö¬¢‚Äö√Ñ‚Ä†n Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M; TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet (London, England). (2004) 363 9410 pp675-681', '10.1016/s0140-6736(04)15640-7', '']\n",
      "['9260130', 'van der Heijde D; Klareskog L; Boers M; Landew‚àö¬© R; Codreanu C; Bolosiu HD; Pedersen R; Fatenejad S; TEMPO Investigators. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Annals of the rheumatic diseases. (2005) 64 11 pp1582-1587', '10.1136/ard.2004.034371', '']\n",
      "['9260184', 'van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S; TEMPO Study Investigators. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis and rheumatism. (2006) 54 4 pp1063-1074', '10.1002/art.21655', '']\n",
      "['9260361', 'van der Heijde D; Landew‚àö¬© R; van Vollenhoven R; Fatenejad S; Klareskog L. Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial. Annals of the rheumatic diseases. (2008) 67 9 pp1267-1270', '10.1136/ard.2007.081331', '']\n",
      "['9260370', 'Kavanaugh A; Klareskog L; van der Heijde D; Li J; Freundlich B; Hooper M. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate. Annals of the rheumatic diseases. (2008) 67 10 pp1444-1447', '10.1136/ard.2008.094524', '']\n",
      "['9260443', 'Keystone E; Freundlich B; Schiff M; Li J; Hooper M. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA. Journal of rheumatology. (2009) 36 3 pp522-531', '10.3899/jrheum.080663', '']\n",
      "['9260585', 'Lukas C; van der Heijde D; Fatenajad S; Landew‚àö¬© R. Repair of erosions occurs almost exclusively in damaged joints without swelling. Annals of the rheumatic diseases. (2010) 69 5 pp851-855', '10.1136/ard.2009.119156', '']\n",
      "['9261685', 'Cannon GW; Wang BC; Park GS; Koenig A; Collier DH; Keystone EC. Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience. Clinical and experimental rheumatology. (2013) 31 6 pp919-925', '10.1136/annrheumdis-2012-eular.2614', '']\n",
      "['9263217', 'van der Heijde D; Klareskog L; Landew‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬© R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis and rheumatism. (2007) 56 12 pp3928-3939', '10.1002/art.23141', '']\n",
      "['9263298', 'Dias EM; Lukas C; Landew‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á¬¨¬®¬¨¬Æ¬¨¬®¬¨¬© R; Fatenejad S; van der Heijde D. Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis. Annals of the rheumatic diseases. (2008) 67 3 pp375-379', '10.1136/ard.2007.072785', '']\n",
      "['9263309', 'Emery P; Breedveld F; van der Heijde D; Ferraccioli G; Dougados M; Robertson D; Pedersen R; Koenig AS; Freundlich B; Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study. Arthritis and rheumatism. (2010) 62 3 pp674-682', '10.1002/art.27268', '']\n",
      "['9739230', 'Schulze-Koops H; Deeg M; Runge C; Volmer T; Brecht J G. Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study. Zeitschrift fur Rheumatologie. (2009) 68 10 pp836-841', '10.1007/s00393-009-0506-7', 'http://link.springer.com/article/10.1007/s00393-009-0506-7/fulltext.html']\n",
      "['9740895', 'NCT00393471. Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00393471. (2006)   pp', '10.1097/01.rhu.0000226594.72861.bd', '']\n",
      "['9261891', 'De Benedetti F; Ruperto N; Brunner H; Keane C; Wells C; Wang J; Calvo I; Cuttica R; Ravelli A; Schneider R; Eleftheriou D; Wouters C; Xavier R; Zemel L; Baildam E; Burgos-Vargas R; Dolezalova P; Garay SM; Joos R; Grom A; Wulffraat N; Zuber Z; Zulian F; Martini A; Lovell D. Safety and efficacy of tocilizumab in patients with systemic juvenile idiopathic arthritis: 5-year data from tender, a phase 3 clinical trial. Annals of the rheumatic diseases. (2015) 74  pp384', '10.1136/annrheumdis-2015-eular.3186', '']\n",
      "['9737855', 'NCT01400516. Teriparatide for Joint Erosions in Rheumatoid Arthritis: the TERA Trial. https://clinicaltrials.gov/show/NCT01400516. (2011)   pp', '10.53347/rid-14925', '']\n",
      "['9740200', 'EUCTR2007-003623-20-ES. Estudio de los efectos de la terapia anti-c‚àö¬©lula B (rituximab) sobre la inmunopatolog‚àö‚â†a del tejido sinovial y las c‚àö¬©lulas B de sangre perif‚àö¬©rica en artritis reumatoide (Estudio TESICE-AR).  Study of the B-cell-targeted therapy (rituximab) effects on the synovial tissue inmunopathology and peripheral blood B cells in rheumatoid arthritis (TESICE-AR study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-003623-20-ES. (2008)   pp', '10.2307/j.ctvr7fb5r.6', '']\n",
      "['11086668', 'Nikiphorou E. Intensive management in moderate established rheumatoid arthritis: the titrate trial. Rheumatology (united kingdom). (2020) 59 Supplement 2 ppii51', '10.1093/rheumatology/keaa111.086', 'http://academic.oup.com/rheumatology/article-pdf/59/Supplement_2/keaa111.086/33102914/keaa111.086.pdf']\n",
      "['11088111', 'Scott David; Ibrahim Fowzia; Hill Harry; Tom Brian; Prothero Louise; Baggott Rhiannon R; Bosworth Ailsa; Galloway James B; Georgopoulou Sofia; Martin Naomi; Neatrour Isabel; Nikiphorou Elena; Sturt Jackie; Wailoo Allan; Williams Frances M K; Williams Ruth; Lempp Heidi. The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: the titrate trial. Seminars in arthritis and rheumatism. (2020) 50 5 pp1182-1190', '10.1016/j.semarthrit.2020.07.014', '']\n",
      "['9260822', 'Semb AG; Kvien TK; DeMicco DA; Fayyad R; Wun CC; LaRosa JC; Betteridge J; Pedersen TR; Holme I. Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. Arthritis and rheumatism. (2012) 64 9 pp2836-2846', '10.1002/art.34524', '']\n",
      "['9738192', 'Zayat AS; Wong C; Cuthbert R; Ash Z; Bingham SJ; Emery P; Buch MH. Imaging and histopathological changes to tocilizumab in patients with moderate to severe RA: a single centre randomized double-blind placebo-controlled study. Annals of the rheumatic diseases. (2016) 75  pp720-', '10.1136/annrheumdis-2016-eular.5304', '']\n",
      "['9739023', 'Zayat A S; Wong C; Cuthbert R; Ash Z; Bingham S J; Emery P; Buch M H. Imaging and histopathological changes to tocilizumab in patients with moderate to severe RA: a single centre randomized double-blind placebo-controlled study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp720', '10.1136/annrheumdis-2016-eular.5304', '']\n",
      "['9739599', 'ISRCTN21216199. Efficacy of tocilizumab in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN21216199. (2010)   pp', '10.1186/isrctn21216199', '']\n",
      "['9739761', 'EUCTR2008-003011-12-GB. Prospective Randomised Double-Blind Placebo Controlled Study Assessing the Efficacy of Tocilizumab with Synovial Analysis in Patients with Rheumatoid Arthritis - TOCRA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-003011-12-GB. (2009)   pp', '10.1016/s0084-3873(09)79339-3', '']\n",
      "['9740792', 'Kedra J; Dieude P; Marotte H; Lafourcade A; Ducourau E; Schaeverbeke T; Perdriger A; Soubrier M; Morel J; Constantin A; Dernis E; Royant V; Salmon J-H; Pham T; Gottenberg J-E; Pertuiset E; Dougados M; Devauchelle-Pensec V; Gaudin P; Cormier G; Goupille P; Mariette X; Berenbaum F; Alcaix D; Rouidi SA; Berthelot J-M; Monnier A; Piroth C; Liote F; Goeb V; Gaujoux-Viala C; Valckenaere IC; Hajage D; Tubach F; Fautrel B. Towards the lowest efficacious dose (TOLEDO): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission. Annals of the rheumatic diseases. (2019) 78  pp715-716', '10.1136/annrheumdis-2019-eular.5060', '']\n",
      "['9740796', 'Joanna K; Dieude P; Marotte H; Lafourcade A; Ducourau E; Schaeverbeke T; Perdriger A; Soubrier M; Morel J; Constantin A; Dernis E; Royant V; Salmon J-H; Pham T; Gottenberg J-E; Pertuiset E; Dougados M; Devauchelle-Pensec V; Gaudin P; Cormier G; Goupille P; Mariette X; Berenbaum F; Alcaix D; Rouidi SA; Berthelot J-M; Monnier A; Piroth C; Liote F; Goeb V; Gaujoux-Viala C; Valckenaere IC; Hajage D; Tubach F; Fautrel B. Towards the lowest efficacious dose (TOLEDO): results of a multicenter noninferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp715-716', '10.1136/annrheumdis-2019-eular.5060', '']\n",
      "['9261123', 'Durez P; Depresseux G; Avaux M; Toukap AN; Lauwerys B; De Bellefon LM; Stoenoiu MS; Houssiau FA. Remission induction in early active rheumatoid arthritis: Comparison of tocilizumab versus methotrexate monotherapy. Arthritis and rheumatism. (2012) 64  ppS575', '10.1136/annrheumdis-2013-eular.1852', '']\n",
      "['9736487', 'EUCTR2017-003037-28-NL. Efficacy of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease modifying anti-rheumatic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-003037-28-NL. (2019)   pp', '10.1093/rheumatology/kew144.004', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i92/5078851/kew144.004.pdf']\n",
      "['9738143', 'Van Der Leeuw MS; Welsing PMJ; De Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; Van Laar JM. Effectiveness of TOcilizumab in comparison to Prednisone in Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial. Trials. (2020) 21 1 pp', '10.1186/s13063-020-04260-y', 'http://link.springer.com/article/10.1186/s13063-020-04260-y/fulltext.html']\n",
      "['9741560', 'van der Leeuw Matthijs S; Welsing Paco M J; de Hair Maria J H; Jacobs Johannes W G; Marijnissen Anne C A; Linn-Rasker Suzanne P; Fodili Faouzia; Bos Reinhard; Tekstra Janneke; van Laar Jacob M. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial. Trials. (2020) 21 1 pp313', '10.1186/s13063-020-04260-y', 'http://link.springer.com/article/10.1186/s13063-020-04260-y/fulltext.html']\n",
      "['11083617', 'van der Leeuw Matthijs S; Welsing Paco M J; de Hair Maria J H; Jacobs Johannes W G; Marijnissen Anne C A; Linn-Rasker Suzanne P; Fodili Faouzia; Bos Reinhard; Tekstra Janneke; van Laar Jacob M. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial. Trials. (2020) 21 1 pp313', '10.1186/s13063-020-04260-y', 'http://link.springer.com/article/10.1186/s13063-020-04260-y/fulltext.html']\n",
      "['11088735', 'Van Der Leeuw MS; Welsing PMJ; De Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; Van Laar JM. Effectiveness of TOcilizumab in comparison to Prednisone in Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial. . (2020) 21 1 pp', '10.1186/s13063-020-04260-y', 'http://link.springer.com/article/10.1186/s13063-020-04260-y/fulltext.html']\n",
      "['9737257', 'EUCTR2008-008309-23-FR. Etude clinique comparative en double aveugle versus placebo sur la rapidit‚àö¬© d‚Äö√Ñ√¥action du tocilizumab sur le soulagement des patients atteints de polyarthrite rhumato‚àö√òde active avec r‚àö¬©ponse inad‚àö¬©quate aux DMARDs et/ou aux bioth‚àö¬©rapies. - TORPEDO. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-008309-23-FR. (2009)   pp', '10.21651/cfaf.2009.29..1', '']\n",
      "['9742582', 'Sanmarti R; Martin Mola; Fonseca J E; Veale D J; Escudero A; Gonzalez C. Clinical remission in subjects with rheumatoid arthritis treated with subcutaneous tocilizumab as monotherapy or in combination with methotrexate or other synthetic DMARDs: a realworld clinical trial (tospace). Annals of the rheumatic diseases. (2017) 76 Supplement 2 pp840', '10.1136/annrheumdis-2017-eular.4951', '']\n",
      "['9256793', 'Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis and rheumatism. (2008) 58 10 pp2968-2980', '10.1002/art.23940', '']\n",
      "['9257179', 'Mirjafari H; Wang J; Klearman M; Youssef P; Wong P; Bruce I. Insulin resistance is improved by tocilizumab therapy in rheumatoid arthritis: results from the toward study (encore). Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp25', '10.1136/annrheumdis-2013-eular.1259', '']\n",
      "['9263542', 'Welsh P; Tuckwell K; McInnes IB; Sattar N. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis. (2016) 254  pp167-171', '10.1016/j.atherosclerosis.2016.10.016', '']\n",
      "['9737516', 'NCT00106574. A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00106574. (2005)   pp', '10.1016/s1098-3015(11)72189-1', '']\n",
      "['9738887', 'Gomez-Reino J J; Nasonov E L; McKay J D; Mysler E F; Da Silva; Alecock E; Woodworth T; Genovese M C. Rapid and significant reduction in disease activity with tocilizumab in combination with six different DMARDs in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs: the toward study. Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1002/art.23940', '']\n",
      "['9741758', 'Bazzichi Laura; Nacci Francesca; Sinigaglia Luigi; Bianchino Laura; Caporali Roberto. Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial. Clinical rheumatology. (2019) 38 3 pp841-849', '10.1007/s10067-018-4327-4', 'http://link.springer.com/article/10.1007/s10067-018-4327-4/fulltext.html']\n",
      "['9736632', \"Ruscitti Piero; Masedu Francesco; Alvaro Saverio; Airo Paolo; Battafarano Norma; Cantarini Luca; Cantatore Francesco Paolo; Carlino Giorgio; D'Abrosca Virginia; Frassi Micol; Frediani Bruno; Iacono Daniela; Liakouli Vasiliki; Maggio Roberta; Mule Rita; Pantano Ilenia; Prevete Immacolata; Sinigaglia Luigi; Valenti Marco; Viapiana Ombretta; Cipriani Paola; Giacomelli Roberto. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial. PLoS medicine. (2019) 16 9 ppe1002901\", '10.1371/journal.pmed.1002901', '']\n",
      "['9737388', \"Ruscitti P; Masedu F; Alvaro S; Airo P; Battafarano N; Cantarini L; Cantatore FP; Carlino G; D'Abrosca V; Frassi M; Frediani B; Iacono D; Liakouli V; Maggio R; Mule R; Pantano I; Prevete I; Sinigaglia L; Valenti M; Viapiana O; Cipriani P; Giacomelli R. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial. PLoS medicine. (2019) 16 9 pp\", '10.1371/journal.pmed.1002901', '']\n",
      "['11086584', 'Ruscitti P; Alvaro S; Liakouli V; Sensini F; Cipriani P; Giacomelli R. Efficacy of IL-1 inhibition on rheumatoid arthritis and type 2 diabetes, long-term findings from track study, a multicentre, open-label, randomised controlled trial. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp289-290', '10.1136/annrheumdis-2020-eular.3448', '']\n",
      "['9257158', 'Solomon DH; Lee SB; Zak A; Corrigan C; Agosti J; Bitton A; Harrold L; Losina E; Lu B; Pincus T; Radner H; Smolen J; Katz JN; Fraenkel L. Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: rationale and design of the TRACTION trial. Seminars in arthritis and rheumatism. (2016) 46 1 pp81-87', '10.1016/j.semarthrit.2016.02.009', '']\n",
      "['11084808', 'Solomon JJ; Danoff SK; Woodhead FA; Hurwitz S; Maurer R; Glaspole I; Dellaripa PF; Gooptu B; Vassallo R; Cox PG; Flaherty KR; Adamali HI; Gibbons MA; Troy L; Forrest IA; Lasky JA; Spencer LG; Golden J; Scholand MB; Chaudhuri N; Perrella MA; Lynch DA; Chambers DC; Kolb M; Spino C; Raghu G; Goldberg HJ; Rosas IO; TRAIL1 Network Investigators. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet respiratory medicine. (2023) 11 1 pp87-96', '10.1101/2022.04.01.22273270', '']\n",
      "['11088302', 'Solomon Joshua J; Danoff Sonye K; Goldberg Hilary J; Woodhead Felix; Kolb Martin; Chambers Daniel C; DiFranco Donna; Spino Cathy; Haynes-Harp Shana; Hurwitz Shelley; Peters Elizabeth B; Dellaripa Paul F; Rosas Ivan O; Trail Network. The Design and Rationale of the Trail1 Trial: a Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Advances in therapy. (2019) 36 11 pp3279-3287', '10.1007/s12325-019-01086-2', 'http://link.springer.com/article/10.1007/s12325-019-01086-2/fulltext.html']\n",
      "['11088877', 'Solomon J; Danoff SK; Goldberg HJ; Chambers D; Mauer R; Hurwitz S; Spino C; Kolb MR; Woodhead F; Rosas IO. Baseline characteristics of participants in the treatment for rheumatoid arthritis and interstitial lung disease 1 (trail1) trial. . (2021) 203 9 pp', '10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1812', '']\n",
      "['9742822', 'EUCTR2005-005295-32-GB. Trial in rheumatoid arthritis of lisinopril (TRALIS) - TRALIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-005295-32-GB. (2005)   pp', '10.1186/isrctn30714266', '']\n",
      "['9260486', 'Claessen SJ; Hazes JM; Huisman MA; van Zeben D; Luime JJ; Weel AE. Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial. BMC musculoskeletal disorders. (2009) 10  pp71', '10.1186/1471-2474-10-71', 'http://link.springer.com/article/10.1186/1471-2474-10-71/fulltext.html']\n",
      "['9259826', \"Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. Journal of rheumatology. (2000) 27 3 pp623-629\", '10.1080/03009740902842190', '']\n",
      "['9260989', 'de Jong PH; Quax RA; Huisman M; Gerards AH; Feelders RA; de Sonnaville PB; Luime JJ; Weel AE; Hazes JM. Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study. Annals of the rheumatic diseases. (2013) 72 10 pp1659-1663', '10.1136/annrheumdis-2012-202152', '']\n",
      "['9261037', 'de Jong PH; Hazes JM; Han HK; Huisman M; van Zeben D; van der Lubbe PA; Gerards AH; van Schaeybroeck B; de Sonnaville PB; van Krugten MV; Luime JJ; Weel AE. Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Annals of the rheumatic diseases. (2014) 73 7 pp1331-1339', '10.1136/annrheumdis-2013-204788', '']\n",
      "['9261225', 'De Jong PHP; Hazes J; Barendregt PJ; Huisman AM; Van Zeben D; Van Der Lubbe PA; Gerards AH. Combination of disease-modifying antirheumatic drugsprohibits the need of early initiation of biologicals, independent of glucocorticosteroids. A clinical trial to investigate different induction therapies in early rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.3058', '']\n",
      "['9262213', 'de Jong PH; Hazes JM; Buisman LR; Barendregt PJ; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PB; Grillet BA; Luime JJ; Weel AE. Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial. Rheumatology (oxford, england). (2016) 55 12 pp2138-2147', '10.1093/rheumatology/kew321', 'http://academic.oup.com/rheumatology/article-pdf/55/12/2138/8324915/kew321.pdf']\n",
      "['9262215', 'Kuijper TM; Luime JJ; de Jong PH; Gerards AH; van Zeben D; Tchetverikov I; de Sonnaville PB; van Krugten MV; Grillet BA; Hazes JM; Weel AE. Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial. Annals of the rheumatic diseases. (2016) 75 12 pp2119-2123', '10.1136/annrheumdis-2016-209272', '']\n",
      "['9262404', 'Gosselt HR; De Rotte MC; Hazes JM; De Jonge R; Heil SG. Increase in global dna methylation at 3 months of methotrexate use is not associated to response in early ra patients. Annals of the rheumatic diseases. Conference: 38th european workshop for rheumatology research. Switzerland. (2018) 77 Supplement 1 ppA70', '10.1136/annrheumdis-2018-ewrr2018.144', '']\n",
      "['9262560', 'Kuijper TM; Luime JJ; Xiong H; de Jong P; van der Lubbe P; van Zeben D; Tchetverikov I; Hazes J; Weel A. Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study. Scandinavian journal of rheumatology. (2018) 47 3 pp178-184', '10.1080/03009742.2017.1349176', 'https://www.tandfonline.com/doi/pdf/10.1080/03009742.2017.1349176']\n",
      "['9262686', 'Luurssen-Masurel N; Weel AE; De Jong AM; Hazes JMW; Erasmus MC PHP. Which cDMARD strategy is most effective in newly diagnosed seronegative rheumatoid arthritispatients; post-hoc analysis of the treach study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp901-902', '10.1136/annrheumdis-2018-eular.3214', '']\n",
      "['9263439', 'de Jong PH; Hazes JM; van Zeben D; van der Lubbe PA; de Jager MH; de Sonnaville PB; Luime JJ; Weel AE. Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria. Rheumatology (Oxford, England). (2012) 51 7 pp1269-1277', '10.1093/rheumatology/kes008', 'http://academic.oup.com/rheumatology/article-pdf/51/7/1269/5091066/kes008.pdf']\n",
      "['9737496', 'NTR986. Treatment in the Rotterdam Early Arthritis Cohort. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR986. (2007)   pp', '10.1186/isrctn26791028', '']\n",
      "['9738003', 'Kuijper TM; Luime JJ; Xiong H; de Jong P; van der Lubbe P; van Zeben D; Tchetverikov I; Hazes J; Weel A. Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study. Scandinavian journal of rheumatology. (2018) 47 3 pp178-184', '10.1080/03009742.2017.1349176', 'https://www.tandfonline.com/doi/pdf/10.1080/03009742.2017.1349176']\n",
      "['9738511', 'de Jong PH; Hazes JM; van Zeben D; van der Lubbe PA; de Jager MH; de Sonnaville PB; Luime JJ; Weel AE. Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria. Rheumatology (Oxford, England). (2012) 51 7 pp1269-1277', '10.1093/rheumatology/kes008', 'http://academic.oup.com/rheumatology/article-pdf/51/7/1269/5091066/kes008.pdf']\n",
      "['9741332', 'de Jong PHP; Hazes JM; Buisman LR; Barendregt PJ; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PBJ; Grillet BA; Luime JJ; Weel AEAM. Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: costutility analysis of the tREACH trial. Rheumatology. (2016) 55 12 pp2138-2147', '10.1093/rheumatology/kew321', 'http://academic.oup.com/rheumatology/article-pdf/55/12/2138/8324915/kew321.pdf']\n",
      "['9741336', '. Comparative effectiveness of rituximab, tocilizumab and TNFi biologics in Rheumatoid Arthritis patients. Influence of clinical and inflammatory profiles. Annals of the rheumatic diseases. (2019) 78  pp1655-', '10.1136/annrheumdis-2019-eular.7072', '']\n",
      "['9742525', 'Luurssen-Masurel N; Weel AE; De Jong AM; Hazes JMW; Erasmus MC PHP. Which cDMARD strategy is most effective in newly diagnosed seronegative rheumatoid arthritispatients; post-hoc analysis of the treach study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp901-902', '10.1136/annrheumdis-2018-eular.3214', '']\n",
      "['11083805', 'Nathalie Luurssen-Masurel; Mulligen Van Elise; Maria Weel Angelique Elisabeth Adriana; Wilhelmina Hazes Johanna Maria; Pieter de Jong Pascal Hendrik; tREACH group investigators. Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients. Rheumatology (Oxford, England). (2021) 60 12 pp5765-5774', '10.1093/rheumatology/keab251', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab251/37781547/keab251.pdf']\n",
      "['11083858', 'Luurssen-Masurel N; van Mulligen E; Weel-Koenders AEAM; Hazes JMW; de Jong PHP. The susceptibility of attaining and maintaining DMARD-free remission in different (rheumatoid) arthritis phenotypes. . (2021)   pp', '10.1093/rheumatology/keac168', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac168/43222921/keac168.pdf']\n",
      "['11083891', 'Luurssen-Masurel N; Van Mulligen E; Weel-Koenders AEAM; Hazes JMW; De Jong PHP. The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes. Rheumatology (united kingdom). (2022) 61 6 pp2275-2284', '10.1093/rheumatology/keac168', 'https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac168/43222921/keac168.pdf']\n",
      "['11084529', 'Luurssen-Masurel N; Weel A; Hazes J; De Jong P. Comparing cost-utility of DMARDs in seronegative rheumatoid arthritis patients; a treach subanalysis. Annals of the rheumatic diseases. (2020) 79 SUPPL 1 pp176-177', '10.1136/annrheumdis-2020-eular.1394', '']\n",
      "['9262729', 'Van Der Pol JA; Brilman EG; De Jong PH; Weel AE; Hazes JM; Huizinga TW; Allaart CF. Corticosteroid bridging strategies with methotrexate monotherapy in early rheumatoid and undifferentiated arthritis; a comparison of efficacy and toxicity in the treach and improved studies. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Suppl  2 pp65', '10.1136/annrheumdis-2018-eular.1912', '']\n",
      "['9736581', 'Van Der Pol JA; Brilman EG; De Jong PH; Weel AE; Hazes JM; Huizinga TW; Allaart CF. Corticosteroid bridging strategies with methotrexate monotherapy in early rheumatoid and undifferentiated arthritis; a comparison of efficacy and toxicity in the treach and improved studies. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp65', '10.1136/annrheumdis-2018-eular.1912', '']\n",
      "['11084412', 'Krijbolder DI; Verstappen M; van Dijk BT; Dakkak YJ; Burgers LE; Boer AC; Park YJ; de Witt-Luth ME; Visser K; Kok MR; Molenaar ETH; de Jong PHP; Bohringer S; Huizinga TWJ; Allaart CF; Niemantsverdriet E; van der Helm-van Mil AHM. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet. (2022) 400 10348 pp283-294', '10.1016/s0140-6736(22)01193-x', '']\n",
      "['11087259', 'Kr Ijbolder D; Verstappen M; Van Dijk B; Dakkak Y; Burgers L; Boer A; Jung Pa R K Y; De Witt M; Visser K; Kok MR; Molenaar E; De Jong P; Bohringer S; Huizinga T; Allaart C; Niemantsverdriet E; Van Der Helm-Van Mil A. INTERVENTION with METHOTREXATE in ARTHRALGIA at RISK for RHEUMATOID ARTHRITIS to REDUCE the DEVELOPMENT of PERSISTENT ARTHRITIS and ITS DISEASE BURDEN (TREAT EARLIER): a DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp48-49', '10.1136/annrheumdis-2022-eular.264', '']\n",
      "['11088098', 'Niemantsverdriet Ellis; Dakkak Yousra J; Burgers Leonie E; Bonte-Mineur Femke; Steup-Beekman Gerda M; van der Kooij Sjoerd M; Boom Hido D; Allaart Cornelia F; de Jong Pascal H P; van der Helm-van Mil Annette H M. TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol. Trials. (2020) 21 1 pp862', '10.1186/s13063-020-04731-2', 'https://link.springer.com/article/10.1186/s13063-020-04731-2/fulltext.html']\n",
      "['9739762', 'EUCTR2014-004472-35-NL. TREAT EARLY ARTHRALGIA TO REVERSE OR LIMIT IMPENDING EXACERBATION TO RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004472-35-NL. (2014)   pp', '10.1186/s13063-020-04731-2', 'https://link.springer.com/article/10.1186/s13063-020-04731-2/fulltext.html']\n",
      "['9739718', 'UMIN000002169. Safety and efficacy of 3 DMARDs for 2 years of treatment in patients with early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002169. (2009)   pp', '10.1136/annrheumdis-2023-eular.1276', '']\n",
      "['9262669', 'Hunt L; Hensor E; Naraghi K; Wakefield RJ; Emery P; Buch MH. Tocilizumab in early rheumatoid arthritis delivers clinical and ultrasound-confirmed rapid and deep remission with abolition of PD-tremera study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp955', '10.1136/annrheumdis-2018-eular.5494', '']\n",
      "['9737185', 'Hunt L; Hensor E; Naraghi K; Wakefield RJ; Emery P; Buch MH. Tocilizumab in early rheumatoid arthritis delivers clinical and ultrasound-confirmed rapid and deep remission with abolition of PD-tremera study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp955', '10.1136/annrheumdis-2018-eular.5494', '']\n",
      "['9738272', 'NCT04157010. Tocilizumab REMission in Early RA. https://clinicaltrials.gov/show/NCT04157010. (2019)   pp', '10.31525/ct1-nct04157010', '']\n",
      "['9261581', 'Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Annals of the rheumatic diseases. (2015) 74 6 pp1078-1086', '10.1136/annrheumdis-2013-204807', '']\n",
      "['9259258', 'Trnavsk‚àöŒ© K; Gatterov‚àö¬∞ J; Linduskov‚àö¬∞ M; Peliskov‚àö¬∞ Z. Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Zeitschrift fu√É√†r Rheumatologie. (1993) 52 5 pp292-296', '10.1007/s003930050056', 'http://link.springer.com/article/10.1007/s003930050056/fulltext.html']\n",
      "['9259685', 'Trnavsky K; Gatterova J; Linduskova M. Combined treatment of rheumatoid arthritis with hydroxychloroquine and methotrexate. Report on a one-year study. [Czech]. Ceska Revmatologie. (1994) 2  pp74-78', '10.14412/1995-4484-2009-139', '']\n",
      "['9258070', \"Buchbinder R; Bombardier C; Yeung M; Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis and rheumatism. (1995) 38 11 pp1568-1580\", '10.1002/art.1780381108', '']\n",
      "['9259129', 'Tugwell P; Bombardier C; Gent M; Bennett KJ; Bensen WG; Carette S; Chalmers A; Esdaile JM; Klinkhoff AV; Kraag GR. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet (London, England). (1990) 335 8697 pp1051-1055', '10.1016/0140-6736(90)92630-z', '']\n",
      "['9256998', 'Tugwell P; Pincus T; Yocum D; Stein M; Gluck O; Kraag G; McKendry R; Tesser J; Baker P; Wells G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. New England journal of medicine. (1995) 333 3 pp137-141', '10.1056/nejm199507203330301', '']\n",
      "['9262978', 'Stein CM; Brooks RH; Pincus T. Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis. Arthritis and rheumatism. (1997) 40 9 pp1721-1723', '10.1002/art.1780400926', '']\n",
      "['9262981', 'Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis and rheumatism. (1997) 40 10 pp1843-1851', '10.1002/art.1780401018', '']\n",
      "['9742785', 'EUCTR2013-002777-22-DK. Targeted Ultrasound in Rheumatoid Arthritis (TURA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-002777-22-DK. (2013)   pp', '10.1007/s11298-013-0692-0', 'http://link.springer.com/article/10.1007/s11298-013-0692-0/fulltext.html']\n",
      "['9256833', 'Teitsma XM; Jacobs JWG; Welsing PMJ; Petho-Schramm A; Borm MEA; Van Laar JM; Lafeber FPJ; Bijlsma JWJ. Effect of treat-to-target tocilizumab-and methotrexate-based strategies on health-related quality of life in newly diagnosed rheumatoid arthritis patients: results of the U-ACT-early trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/kex386', 'http://academic.oup.com/rheumatology/article-pdf/57/2/309/23610062/kex386.pdf']\n",
      "['9256857', 'Teitsma XM; Jacobs JWG; Welsing PMJ; Petho-Schramm A; Borm MEA; Van Laar JM; Lafeber FPJ; Bijlsma JWJ. Tocilizumab inhibits progression of erosive joint damage in early rheumatoid arthritis more effectively than step-up methotrexate therapy. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/kex386', 'http://academic.oup.com/rheumatology/article-pdf/57/2/309/23610062/kex386.pdf']\n",
      "['9256881', 'Teitsma XM; Jacobs JWG; Mokry M; Petho-Schramm A; Borm MEA; Van Laar JM; Bijlsma JWJ; Lafeber FPJ. Differentially co-expressed gene networks in previously dmard-naive patients with early RA achieving sustained drug-free remission after step-up methotrexate therapy. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1186/s13075-017-1378-x', 'http://link.springer.com/content/pdf/10.1186/s13075-017-1378-x.pdf']\n",
      "['9257326', 'Teitsma XM; Jacobs JWG; Welsing PMJ; Petho-Schramm A; Borm MEA; Hendriks L; Denissen NHAM; van Laar JM; Lafeber FPJG; Bijlsma JWJ. Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy. Rheumatology (oxford, england). (2017) 56 12 pp2179-2189', '10.1093/rheumatology/kex319', 'http://academic.oup.com/rheumatology/article-pdf/56/12/2179/22019719/kex319.pdf']\n",
      "['9261914', 'Bijlsma JW; Welsing PM; Woodworth TG; Middelink LM; Bernasconi C; Borm ME; Lafeber FP; Jacobs JW. Rapid and sustained remission in early rheumatoid arthritis (RA) treated to target with tocilizumab, methotrexate, or their combination: the u-act-early strategy study. Annals of the rheumatic diseases. (2015) 74  pp77-78', '10.1136/annrheumdis-2015-eular.2287', '']\n",
      "['9262379', 'Teitsma XM; Jacobs JWG; Welsing PMJ; Petho-Schramm A; Borm MEA; van Laar JM; Lafeber FPG; Bijlsma JWJ. Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies. Rheumatology (united kingdom). (2018) 57 2 pp309-317', '10.1093/rheumatology/kex386', 'http://academic.oup.com/rheumatology/article-pdf/57/2/309/23610062/kex386.pdf']\n",
      "['9262443', 'Teitsma XM; Jacobs JW; Welsing PM; Petho-Schramm A; Borm ME; Van Laar JM; Lafeber FP; Bijlsma JW. Effect of tocilizumab in DMARD-naive early rheumatoid arthritis patients on health-related quality of life: results of the U-Act-Early trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp855', '10.1136/annrheumdis-2017-eular.2190', '']\n",
      "['9262460', 'Teitsma XM; Jacobs JW; Mokry M; Petho-Schramm A; Borm ME; Van Laar JM; Bijlsma JW; Lafeber FP. Weighted gene co-expression network analysis of DMARD-naive early RA patients achieving sustained drug-free remission after initiating tocilizumab therapy. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp177-178', '10.1136/annrheumdis-2017-eular.2197', '']\n",
      "['9262597', 'Teitsma XM; Jacobs JWG; Welsing PMJ; De Jong PHP; Hazes JMW; Weel AEAM; Petho-Schramm A; Borm MEA; Van Laar JM; Lafeber FPJG; Bijlsma JWJ. Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors. Annals of the rheumatic diseases. (2018) (no pagination) 9 pp1261-1267', '10.1136/annrheumdis-2018-eular.3463', '']\n",
      "['9736590', '. Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies. Rheumatology (united kingdom). (2018) 57 2 pp309-317', '10.1093/rheumatology/kex386', 'http://academic.oup.com/rheumatology/article-pdf/57/2/309/23610062/kex386.pdf']\n",
      "['9736677', 'NCT01034137. A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Na‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö‚â§ve Patients With Early Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01034137. (2009)   pp', '10.1093/rheumatology/kev080.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i28/5179183/kev080.006.pdf']\n",
      "['9737844', 'Teitsma XM; Jacobs JWG; Welsing PMJ; Peth‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚Äö√Ñ‚Ä†‚Äö√†√∂‚àö¬∞-Schramm A; Borm MEA; Laar JMV; Lafeber FPJG; Bijlsma JWJ. Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies. Rheumatology. (2018) 57 2 pp309-317', '10.1093/rheumatology/kex386', 'http://academic.oup.com/rheumatology/article-pdf/57/2/309/23610062/kex386.pdf']\n",
      "['9738059', 'Teitsma X; Jacobs J; Welsing P; Woodworth T; Petho-Schramm A; Borm M; Bernasconi C; Lafeber F; Bijlsma J W J. Predicting the need for additional treatment in early rheumatoid arthritis patients treated to target on methotrexate monotherapy. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1136/annrheumdis-2016-eular.1406', '']\n",
      "['9738258', 'Verhoeven MMA; Tekstra J; Welsing PMJ; Petho-Schramm A; Borm MEA; Bruyn GAW; Bos R; Griep EN; Klaasen R; van Laar JM; Lafeber FPJG; Bijlsma JWJ; de Hair MJH; Jacobs JWG. Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate. Rheumatology (Oxford, England). (2019)   pp', '10.1093/rheumatology/kez602', 'http://academic.oup.com/rheumatology/article-pdf/59/9/2325/33686157/kez602.pdf']\n",
      "['9738383', 'Teitsma Xavier M; Jacobs Johannes W G; Welsing Paco M J; de Jong Pascal H P; Hazes Johanna M W; Weel Angelique E A M; Petho-Schramm Attila; Borm Michelle E A; van Laar Jacob M; Lafeber Floris P J G; Bijlsma Johannes W J. Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors. Annals of the rheumatic diseases. (2018) 77 9 pp1261-1267', '10.1136/annrheumdis-2018-eular.3463', '']\n",
      "['9739378', 'Teitsma Xavier M; Jacobs Johannes W G; Concepcion Arno N; Petho-Schramm Attila; Borm Michelle E A; van Laar Jacob M; Bijlsma Johannes W J; Lafeber Floris P J G. Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics. Clinical and experimental rheumatology. (2018) 36 6 pp976-983', '10.1136/annrheumdis-2018-eular.3467', '']\n",
      "['9740233', 'EUCTR2009-013316-12-NL. A multi-center, randomized, double blind, placebo controlled study to evaluate remission in DMARD and biological na√Øve early reumatoid arthritis (RA) subjects treated with  tocilizumab (TCZ) plus tight control methotrexate (MTX) treatment, TCZ monotherapy or tight control MTX monotherapy. - U-Act-Early. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-013316-12-NL. (2009)   pp', '10.1136/annrheumdis-2014-eular.2178', '']\n",
      "['9740248', 'ChiCTR-TRC-09000469. Strategic management of anti-rheumatoid arthritis treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-09000469. (2009)   pp', '10.1007/978-3-7643-8238-4_3', 'http://link.springer.com/content/pdf/10.1007/978-3-7643-8238-4_3.pdf']\n",
      "['11084374', 'Verhoeven Maxime M A; Tekstra Janneke; Welsing Paco M J; Petho-Schramm Attila; Borm Michelle E A; Bruyn George A W; Bos Reinhard; Griep Ed N; Klaasen Ruth; van Laar Jacob M; Lafeber Floris P J G; Bijlsma Johannes W J; de Hair Marjolein J H; Jacobs Johannes W G. Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate. Rheumatology (Oxford, England). (2020) 59 9 pp2325-2333', '10.1093/rheumatology/kez602', 'http://academic.oup.com/rheumatology/article-pdf/59/9/2325/33686157/kez602.pdf']\n",
      "['11084374', 'Verhoeven Maxime M A; Tekstra Janneke; Welsing Paco M J; Petho-Schramm Attila; Borm Michelle E A; Bruyn George A W; Bos Reinhard; Griep Ed N; Klaasen Ruth; van Laar Jacob M; Lafeber Floris P J G; Bijlsma Johannes W J; de Hair Marjolein J H; Jacobs Johannes W G. Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate. Rheumatology (Oxford, England). (2020) 59 9 pp2325-2333', '10.1093/rheumatology/kez602', 'http://academic.oup.com/rheumatology/article-pdf/59/9/2325/33686157/kez602.pdf']\n",
      "['9736500', 'Verhoeven M; Tekstra J; Van Laar MJ; Bijlsma JWJ; Pethoe-Schramm A; Borm M; Lafeber F; Welsing P. Does initiating tocilizumab lead to better disease control compared to initiating mtx with low-moderate dose prednisone in early rheumatoid arthritis; an indirect comparison of u-act-early and camera-ii treat-to-target trials. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp758', '10.1136/annrheumdis-2019-eular.3276', '']\n",
      "['9740786', 'Verhoeven M; Tekstra J; Jacob Van Laar M; Bijlsma JWJ; Pethoe-Schramm A; Borm M; Lafeber F; Welsing P. Does initiating tocilizumab lead to better disease control compared to initiating MTX with low-moderate dose prednisone in early rheumatoid arthritis; an indirect comparison of U-Act-early and camera-II treat-to-target trials. Annals of the rheumatic diseases. (2019) 78  pp758-', '10.1136/annrheumdis-2019-eular.3276', '']\n",
      "['9258462', 'Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¥‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂¬¨¬±weeks of treatment: the CareRA trial. Annals of the rheumatic diseases. (2015) 74 1 pp27-34', '10.1136/annrheumdis-2014-205489', '']\n",
      "['9259738', 'Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and rheumatism. (2000) 43 3 pp506-514', '10.1002/1529-0131(200003)43:3<506::aid-anr5>3.0.co;2-u', '']\n",
      "['9259843', 'Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis and rheumatism. (2001) 44 9 pp1984-1992', '10.1002/1529-0131(200109)44:9<1984::aid-art346>3.0.co;2-b', '']\n",
      "['9259913', 'Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis and rheumatism. (2003) 48 3 pp625-630', '10.1002/art.10824', '']\n",
      "['9263098', 'Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C. Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial. PharmacoEconomics. (2002) 20 1 pp61-70', '10.2165/00019053-200220010-00006', '']\n",
      "['9263117', 'Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G. Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Arthritis and rheumatism. (1999) 42 9 pp1870-1878', '10.1002/1529-0131(199909)42:9<1870::aid-anr11>3.0.co;2-d', '']\n",
      "['9739120', 'Pincus T; Amara I; Koch G G. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of rheumatology 20% criteria. Arthritis and rheumatism. (2005) 52 4 pp1031-1036', '10.1002/art.20995', '']\n",
      "['9258599', 'Scott DL; Strand V. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database. Rheumatology (Oxford, England). (2002) 41 8 pp899-909', '10.1093/rheumatology/41.8.899', 'http://academic.oup.com/rheumatology/article-pdf/41/8/899/5034082/410899.pdf']\n",
      "['9259737', 'Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and rheumatism. (2000) 43 3 pp495-505', '10.1002/1529-0131(200003)43:3<495::aid-anr4>3.0.co;2-u', '']\n",
      "['9738531', 'Smolen JS; Emery P. Efficacy and safety of leflunomide in active rheumatoid arthritis. Rheumatology. (2000) 39 SUPPL. 1 pp48-56', '10.1093/oxfordjournals.rheumatology.a031495', 'http://academic.oup.com/rheumatology/article-pdf/39/suppl_1/48/18109152/39s1048.pdf']\n",
      "['9740182', 'UMIN000015616. Biologic MateR clinical performance test for ADA and TCZ Efficacy prediction. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000015616. (2014)   pp', '10.1089/clinomi.01.12.01', '']\n",
      "['9737020', 'Liang Jiang; Wang Qianyu; Huang Weichen; Yang Changfu; Pan Chun; Chen Xiangyun; Liu Yang. Heiguteng Zhuifenghuoluo capsule inhibits the expression of NF-kappaB in synovial tissues of rats with collagen-induced arthritis and alleviates joint inflammation. Xi bao yu fen zi mian yi xue za zhi [Chinese journal of cellular and molecular immunology]. (2019) 35 3 pp193-198', '10.1155/2020/4297354', 'http://downloads.hindawi.com/journals/jir/2020/4297354.pdf']\n",
      "['9739976', 'UMIN000023006. Usefullness of infliximab as a second tumor necrosis factor inhibitor in patients with rheumatoid arthritis with inadequate response to tumor necrosis factor inhibitor. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000023006. (2016)   pp', '10.4021/jocmr630w', '']\n",
      "['9256924', 'Usdadiya J; Mehra S; Jain V; Singh B; Emmanuel D; Jain A; Mithun CB; Misra DP; Negi VS. Comparison of combination disease modifying antirheumatic drugs (DMARDs) with methotrexate monotherapy in early rheumatoid arthritis: an open label randomized trial. Indian journal of rheumatology. Conference: 32nd annual national conference of the indian rheumatology association, IRACON 2016. India. (2016) 11 5 Supplement ppS86-S87', '10.4103/0973-3698.194551', '']\n",
      "['9257591', 'Ryan C; Sobell J M; Leonardi C L; Lynde C W; Karunaratne M; Valdecantos W C; Hendrickson B A. Safety of Adalimumab Dosed Every Week and Every Other Week: focus on Patients with Hidradenitis Suppurativa or Psoriasis. American journal of clinical dermatology. (2018) 19 3 pp437-447', '10.1007/s40257-017-0341-6', 'http://link.springer.com/article/10.1007/s40257-017-0341-6/fulltext.html']\n",
      "['9258481', 'van de Putte LB; Atkins C; Malaise M; Sany J; Russell AS; van Riel PL; Settas L; Bijlsma JW; Todesco S; Dougados M; Nash P; Emery P; Walter N; Kaul M; Fischkoff S; Kupper H. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Annals of the rheumatic diseases. (2004) 63 5 pp508-516', '10.1136/ard.2003.013052', '']\n",
      "['9259270', 'van der Veen MJ; Bijlsma JW. The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis. Clinical rheumatology. (1993) 12 4 pp500-505', '10.1007/bf02231779', 'http://link.springer.com/article/10.1007/BF02231779/fulltext.html']\n",
      "['9257469', 'van Jaarsveld CH; Jacobs JW; van der Veen MJ; Blaauw AA; Kruize AA; Hofman DM; Brus HL; van Albada-Kuipers GA; Heurkens AH; ter Borg EJ; Haanen HC; van Booma-Frankfort C; Schenk Y; Bijlsma JW. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands. Annals of the rheumatic diseases. (2000) 59 6 pp468-477', '10.1136/ard.59.6.468', '']\n",
      "['9259781', 'van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 12 pp1374-1382', '10.1093/rheumatology/39.12.1374', 'http://academic.oup.com/rheumatology/article-pdf/39/12/1374/18108457/391374.pdf']\n",
      "['9262876', 'van Rijthoven AW; Dijkmans BA; Goei The HS; Hermans J; Montnor-Beckers ZL; Jacobs PC; Cats A. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Annals of the rheumatic diseases. (1986) 45 9 pp726-731', '10.1136/ard.45.9.726', '']\n",
      "['9262897', 'Dijkmans BA; van Rijthoven AW; Goei The HS; Montnor-Beckers ZL; Jacobs PC; Cats A. Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis. European journal of clinical pharmacology. (1987) 31 5 pp541-545', '10.1007/bf00606627', 'http://link.springer.com/article/10.1007/BF00606627/fulltext.html']\n",
      "['9257459', 'Anderson RB; Needleman RD; Gatter RA; Andrews RP; Scarola JA. Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis. Journal of rheumatology. (1988) 15 4 pp556-560', '10.3109/03009748809105296', '']\n",
      "['9258053', 'Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group (SRU). A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Annals of the rheumatic diseases. (2005) 64 1 pp38-43', '10.1136/ard.2003.014928', '']\n",
      "['9737926', 'NCT02433184. Very Early Versus Delayed Etanercept in Patients With RA. https://clinicaltrials.gov/show/NCT02433184. (2015)   pp', '10.1136/annrheumdis-2019-216539corr1', '']\n",
      "['9739471', 'Erhayiem B; Pavitt S; Baxter P; Andrews J; Greenwood JP; Buch MH; Plein S. Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial. Trials. (2014)   pp436-', '10.1186/1745-6215-15-436', 'http://link.springer.com/article/10.1186/1745-6215-15-436/fulltext.html']\n",
      "['9739635', 'EUCTR2010-023910-30-GB. A Prospective, Single-centre, Randomised Study Evaluating the Clinical, Imaging and Immunological Depth of Remission Achieved by Very Early versus Delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA) - Very Early versus Delayed Etanercept in patients with RA (VEDERA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-023910-30-GB. (2011)   pp', '10.1186/s12891-016-0915-0', 'http://link.springer.com/article/10.1186/s12891-016-0915-0/fulltext.html']\n",
      "['9743043', 'Emery Paul; Horton Sarah; Dumitru Raluca Bianca; Naraghi Kamran; van der Heijde Desiree; Wakefield Richard J; Hensor Elizabeth M A; Buch Maya H. Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the rheumatic diseases. (2020) 79 4 pp464-471', '10.1136/annrheumdis-2019-216539', '']\n",
      "['11087544', 'Shukla R; Hum R; Ho P; Wakefield RJ; Emery P; Buch MH. IN A TREATMENT-NAiVE, EARLY RHEUMATOID ARTHRITIS COHORT, BASELINE ULTRASOUND POWER DOPPLER SYNOVITIS AND TENOSYNOVITIS ARE HIGHLY ASSOCIATED WITH REMISSION WHEN TREATED WITH FIRST LINE ETANERCEPT + METHOTREXATE (MTX) BUT NOT MTX ALONE. Rheumatology (united kingdom). (2022) 61 SUPPL 1 ppi120-i121', '10.1093/rheumatology/keac133.214', 'https://academic.oup.com/rheumatology/article-pdf/61/Supplement_1/keac133.214/43436672/keac133.214.pdf']\n",
      "['11088720', 'Emery P; Horton S; Dumitru RB; Naraghi K; van der Heijde D; Wakefield RJ; Hensor EMA; Buch MH. Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. . (2020) 79 4 pp464', '10.1136/annrheumdis-2019-216539', '']\n",
      "['9740317', 'EUCTR2005-000549-13-CZ. A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study of Two Doses of VX-702 in Subjects with Moderate to Severe Rheumatoid Arthritis - VeRA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-000549-13-CZ. (2005)   pp', '10.1186/isrctn61635363', '']\n",
      "['9257076', 'Damjanov N; Kauffman RS; Spencer-Green GT. Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis and rheumatism. (2009) 60 5 pp1232-1241', '10.1002/art.24485', '']\n",
      "['9260545', 'Westhovens R; Robles M; Ximenes AC; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Covucci A; Helfrick R; Bathon J. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors. Annals of the rheumatic diseases. (2009) 68 12 pp1870-1877', '10.1136/ard.2008.101121', '']\n",
      "['9257167', 'Bingham III CO; Rizzo WC; Klearman M; Hassanali A; Upmanyu R; Kivitz AJ. Preliminary results from a controlled study assessing the humoral immune response to vaccines in rheumatoid arthritis patients treated with tocilizumab. Arthritis and rheumatism. (2012) 64  ppS151', '10.1136/annrheumdis-2013-204427', '']\n",
      "['9263507', 'Bingham CO; Rizzo W; Kivitz A; Hassanali A; Upmanyu R; Klearman M. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Annals of the rheumatic diseases. (2015) 74 5 pp818-822', '10.1136/annrheumdis-2013-204427', '']\n",
      "['9740944', 'NCT01163747. A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA). https://clinicaltrials.gov/show/NCT01163747. (2010)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9742668', 'Bingham III CO; Rizzo W; Kivitz A; Hassanali A; Upmanyu R; Klearman M. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204427', '']\n",
      "['9256851', 'Cohen SB; Alonso-Ruiz A; Klimiuk PA; Lee E; Peter N; Czeloth N; Jayadeva G. Biosimilar candidate bi 695501 and adalimumab reference product have similar efficacy and safety in patients with moderately-to-severely active rheumatoid arthritis (RA): 1-year results from a phase III study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2017-eular.3405', '']\n",
      "['9262509', 'Cohen S; Alonso-Ruiz A; Klimiuk PA; Lee E; Peter N; Sonderegger I; Assudani D. Similar efficacy and safety of biosimilar candidate BI 695501 and adalimumab originator reference product in patients with moderate to severe active rheumatoid arthritis: 24 week results from a phase iii clinical study (voltaire-RA). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp553', '10.1136/annrheumdis-2017-eular.3405', '']\n",
      "['9262593', 'Cohen SB; Alonso-Ruiz A; Klimiuk PA; Lee EC; Peter N; Sonderegger I; Assudani D. Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study. Annals of the rheumatic diseases. (2018) 77 6 pp914-921', '10.1136/annrheumdis-2017-212245', '']\n",
      "['9737166', 'EUCTR2012-002945-40-HU. BI695501 compared to adalimumab in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-002945-40-HU. (2014)   pp', '10.1186/isrctn68762628', '']\n",
      "['9737997', 'Cohen Stanley B; Alonso-Ruiz Alberto; Klimiuk Piotr A; Lee Eric C; Peter Nuala; Sonderegger Ivo; Assudani Deepak. Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study. Annals of the rheumatic diseases. (2018) 77 6 pp914-921', '10.1136/annrheumdis-2017-212245', '']\n",
      "['9741107', 'NCT02137226. BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT02137226. (2014)   pp', '10.2217/vjbm-2023-0007-media', '']\n",
      "['9258640', 'Walters MT; Cawley MI. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate. Annals of the rheumatic diseases. (1988) 47 11 pp924-929', '10.1136/ard.47.11.924', '']\n",
      "['9257542', 'Ward JR; Williams HJ; Boyce E; et al. Comparion of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses. American journal of medicine. (1983) 75 6A pp133-137', '10.1016/0002-9343(83)90486-2', '']\n",
      "['9258203', 'Lundberg MS; Cannon GW; Ward JR. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients. Arthritis and rheumatism. (1988) 31 7 pp909-913', '10.1002/art.1780310713', '']\n",
      "['9258929', 'Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and rheumatism. (1983) 26 11 pp1303-1315', '10.1002/art.1780261102', '']\n",
      "['9258936', 'Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses. American journal of medicine. (1983) 75 6A pp133-137', '10.1016/0002-9343(83)90486-2', '']\n",
      "['9258959', 'Meenan RF; Anderson JJ; Kazis LE; Egger MJ; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP; Blocka KL. Outcome assessment in clinical trials. Evidence for the sensitivity of a health status measure. Arthritis and rheumatism. (1984) 27 12 pp1344-1352', '10.1002/art.1780271204', '']\n",
      "['9258960', 'Kazis LE; Anderson JJ; Meenan RF; Gertman PM. Three-dimensional vector graphics: a method for displaying results in a drug trial. Computers and biomedical research, an international journal. (1984) 17 6 pp542-553', '10.1016/0010-4809(84)90019-3', '']\n",
      "['9258974', 'Weinblatt ME; Coblyn JS; Fox DA; Fraser PA; Holdsworth DE; Glass DN; Trentham DE. Efficacy of low-dose methotrexate in rheumatoid arthritis. New England journal of medicine. (1985) 312 13 pp818-822', '10.1056/nejm198503283121303', '']\n",
      "['9258516', 'Weinblatt ME; Kremer JM; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Fox RI; Jackson CG; Lange M; Burge DJ. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. New England journal of medicine. (1999) 340 4 pp253-259', '10.1056/nejm199901283400401', '']\n",
      "['9259953', 'Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Arthritis and rheumatism. (2003) 48 6 pp1493-1499', '10.1002/art.11142', '']\n",
      "['9261254', 'Alemao EA; Joo S; Banerjee S; Emery P; Weinblatt M. Impact of rapid attainment of stringent measures of efficacy in rheumatoid arthritis on patient-reported outcomes. Arthritis and Rheumatology. (2014) 66  ppS599', '10.1136/annrheumdis-2014-eular.1515', '']\n",
      "['9261486', 'Weinblatt M; Mease P; Mysler E; Takeuchi T; Drescher E; Berman A; Zilberstein M; Xing J; Emery P. A phase IIB study of the efficacy and safety of subcutaneous clazakizumab (anti-IL-6 monoclonal antibody) with or without methotrexate in adults with moderate-to-severe active rheumatoid arthritis and an inadequate response to methotrexate. Arthritis and rheumatism. (2013) 65  ppS735-S736', '10.1136/annrheumdis-2014-eular.3754', '']\n",
      "['9261531', \"Alemao E; Joo S; Banerjee S; Emery P; Weinblatt M; L'Italien G. Impact of anti-IL-6 monoclonal antibody, clazakizumab, on patient-reported outcomes in patients with rheumatoid arthritis and an inadequate response to methotrexate in a phase IIB study. Annals of the rheumatic diseases. (2014) 73  pp\", '10.1136/annrheumdis-2014-eular.1515', '']\n",
      "['9261536', 'Weinblatt M; Mease P; Mysler E; Takeuchi T; Drescher E; Berman A; Zilberstein M; Xing J; Emery P. A phase iib study of the efficacy and safety of subcutaneous clazakizumab (anti-IL-6 monoclonal antibody) with or without methotrexate in adults with moderate-to-severe active rheumatoid arthritis and an inadequate response to methotrexate. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3754', '']\n",
      "['9737663', 'PER-043-11. A PHASE IIB , RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, DOSE-RANGING, PLACEBO/ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMS-945429 SUBCUTANEOUS INJECTION WITH OR WITHOUT METHOTREXATE IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-043-11. (2011)   pp', '10.1002/art.39249', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39249']\n",
      "['9260273', 'Weisman MH; Paulus HE; Burch FX; Kivitz AJ; Fierer J; Dunn M; Kerr DR; Tsuji W; Baumgartner SW. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases. Rheumatology (Oxford, England). (2007) 46 7 pp1122-1125', '10.1093/rheumatology/kem033', '']\n",
      "['9259581', 'Westedt ML; Dijkmans BAC; Hermans J. Azathioprine compared with methotrexate for rheumatoid arthritis: An open randomized clinical trial. Revue Du Rhumatisme (English Edition).. (1994) 61 9 pp523-529', '10.1016/j.reumae.2012.07.005', '']\n",
      "['9742590', 'Westedt M L; Dijkmans B A; Hermans J. Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study. Revue du rhumatisme. (1994) 61 9 pp591-597', '10.1016/j.rhum.2011.06.007', '']\n",
      "['9257281', 'Williams HJ; Ward JR. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. (1983) 12 SUPPL. 51 pp92-99', '10.3109/03009748309095360', '']\n",
      "['9258183', 'Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: A post hoc analysis of three controlled trials. Pharmacotherapy. (1990) 10 2 I pp79-84', '10.1002/j.1875-9114.1990.tb02553.x', '']\n",
      "['9258995', 'Williams HJ; Willkens RF; Samuelson CO; Alarc‚Äö√†√∂‚Äö√¢‚Ä¢n GS; Guttadauria M; Yarboro C; Polisson RP; Weiner SR; Luggen ME; Billingsley LM. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and rheumatism. (1985) 28 7 pp721-730', '10.1002/art.1780280702', '']\n",
      "['9259105', 'Tugwell P; Bombardier C; Buchanan WW; Goldsmith C; Grace E; Bennett KJ; Williams HJ; Egger M; Alarcon GS; Guttadauria M. Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Archives of internal medicine. (1990) 150 1 pp59-62', '10.1001/archinte.1990.00390130073009', '']\n",
      "['9259153', 'Cannon GW; Reading JC; Ward JR; Blonquist LJ; Collette LB. Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate. Scandinavian journal of rheumatology. (1990) 19 4 pp285-294', '10.3109/03009749009102535', '']\n",
      "['9259273', 'Polisson RP; Dooley MA; Dawson DV; Pisetsky DS. Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate. Arthritis and rheumatism. (1994) 37 1 pp50-56', '10.1002/art.1780370108', '']\n",
      "['9258115', 'Williams HJ; Ward JR; Dahl SL; Clegg DO; Willkens RF; Oglesby T; Weisman MH; Schlegel S; Michaels RM; Luggen ME. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis and rheumatism. (1988) 31 6 pp702-713', '10.1002/art.1780310602', '']\n",
      "['9259436', 'Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. Journal of rheumatology. (1996) 23 11 pp1856-1861', '10.1002/art.1780370108', '']\n",
      "['9260565', 'Choi HK; Slot MC; Pan G; Weissbach CA; Niles JL; Merkel PA. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis and rheumatism. (2000) 43 11 pp2488-2492', '10.1002/1529-0131(200011)43:11<2488::aid-anr16>3.0.co;2-x', '']\n",
      "['9257820', 'Willkens RF; Urowitz MB; Stablein DM; McKendry RJ; Berger RG; Box JH; Fiechtner JJ; Fudman EJ; Hudson NP; Marks CR. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and rheumatism. (1992) 35 8 pp849-856', '10.1002/art.1780350802', '']\n",
      "['9258345', 'Willkens RF; Sharp JT; Stablein D; Marks C; Wortmann R. Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. Arthritis and rheumatism. (1995) 38 12 pp1799-1806', '10.1002/art.1780381213', '']\n",
      "['9259164', 'McKendry RJ. Azathioprine and methotrexate as combination chemotherapy in rheumatoid arthritis. Journal of rheumatology. Supplement. (1990) 25  pp28-33', '10.1016/s0950-3579(05)80017-2', '']\n",
      "['9259409', 'Willkens RF; Stablein D. Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial. Journal of rheumatology. Supplement. (1996) 44 suppl pp64-68', '10.1002/art.1780390830', '']\n",
      "['9259125', 'Winkler V; V‚àö¬©rtes P. Sulphasalazine treatment in rheumatoid arthritis. Annals of the rheumatic diseases. (1990) 49 3 pp202', '10.1136/ard.49.3.202-a', '']\n",
      "['9260473', 'Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2009) 68 8 pp1277-1284', '10.1136/ard.2007.086157', '']\n",
      "['9739953', 'ISRCTN29665463. A placebo-controlled trial of anti-TNFa chimeric monoclonal antibody (infliximab, remicade) in the modification of vascular disease markers in active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN29665463. (2007)   pp', '10.1186/isrctn29665463', '']\n",
      "['9257344', 'Woodland J; Chaput DSDM; Evans SJW; et al. Azathioprine in rheumatoid arthritis: Double-blind study of full versus half doses versus placebo. Annals of the rheumatic diseases. (1981) 40 4 pp355-359', '10.1136/ard.40.4.355', '']\n",
      "['9736902', 'Woodland J; Chaput De Saintonge; D M; Evans S J W; Currey H L F. Azathioprine in rheumatoid arthritis: double-blind study of full vs half dosage vs placebo. Annals of the rheumatic diseases. (1980) 39 6 pp605-606', '10.1136/ard.40.4.355', '']\n",
      "['9257323', \"Hammond A; O'Brien R; Woodbridge S; Bradshaw L; Prior Y; Radford K; Culley J; Whitham D; Ruth Pulikottil-Jacob null. Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trial. BMC musculoskeletal disorders. (2017) 18 1 pp315\", '10.1186/s12891-017-1671-5', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1671-5.pdf']\n",
      "['9742823', 'UMIN000015462. Clinical study on drug holiday with regulated rheumatoid arthritis activity after treatment with tofacitinib (Xanadu study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000015462. (2014)   pp', '10.1007/s10067-014-2500-y', 'http://link.springer.com/article/10.1007/s10067-014-2500-y/fulltext.html']\n",
      "['9257597', 'Zeb S; Wazir N; Waqas M; Taqweem A. Comparison of short-term efficacy of leflunomide and methotrexate in active rheumatoid arthritis. Journal of postgraduate medical institute. (2016) 30 2 pp177-180', '10.5455/medscience.2015.04.8350', '']\n",
      "['11085020', 'Zeng X; Zhao D-B; Radominski S; Keiserman M; Lee CK; Meerwein S; Enejosa J; Sui Y; Mohamed M-E; Park W. Efficacyand safetyof upadacitinib in patients from china, brazil, and south koreawith rheumatoid arthritiswho have had inadequate response to conventional synthetic disease-modifying antirheumatic drugs. Journal of clinical rheumatology. (2020) 20 3 SUPPL 1 ppS98-S99', '10.1136/annrheumdis-2020-eular.1521', '']\n",
      "['11086105', 'Zeng X; Zhao D; Radominski S; Keiserman M; Lee CK; Martin N; Meerwein S; Sui Y; Park W. Long-term efficacy and safety of upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results at 64 weeks. Journal of clinical rheumatology. (2021) 27 SUPPL 1 ppS104', '10.1136/annrheumdis-2021-eular.1807', '']\n",
      "['11086122', 'Zeng X; Zhao D; Radominski S; Keiserman M; Lee CK; Martin N; Meerwein S; Sui Y; Park W. Long-term efficacy and safety of upadacitinib in patients from china, brazil, and south Korea with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results at 64 weeks. Annals of the rheumatic diseases. (2021) 80 SUPPL 1 pp1156-1157', '10.1136/annrheumdis-2021-eular.1807', '']\n",
      "['11087303', 'Zeng X; Liu Y; Hu J; Li J; Wang Y; Zhao D; Wu L; Xiao Z; Li Z; Xu J; Meerwein S; Xie Y; Liang P. EFFICACY and SAFETY of UPADACITINIB in A CHINESE SUBGROUP of PATIENTS with RHEUMATOID ARTHRITIS and INADEQUATE RESPONSE to CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS. Annals of the rheumatic diseases. (2022) 81 Supplement 1 pp1324', '10.1136/annrheumdis-2022-eular.1119', '']\n",
      "['9739752', 'UMIN000001281. Strategic reduction of joint destruction in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000001281. (2008)   pp', '10.7554/elife.85553.sa0', '']\n",
      "['9260295', 'Zhang F-C; Hou Y; Huang F; Wu D-H; Bao C-D; Ni L-Q; Yao C. Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A preliminary study from China. APLAR Journal of Rheumatology. (2006) 9 2 pp127-130', '10.1111/j.1479-8077.2006.00186.x', '']\n",
      "['9739926', 'ChiCTR-TRC-10001060. Efficacy and safety of infliximab in Chinese patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10001060. (2010)   pp', '10.1186/isrctn49455679', '']\n",
      "['9738498', 'Zhao Z; Huang F; Yamei Z. Treatment of rheumatoid arthritis with Rituximab and Methotrexate: a multicenter, randomized, double-blind, placebo-controlled trial. International journal of rheumatic diseases. (2010) Conference: 14th Congress of Asia Pacific League of Associations for Rheumatology, APLAR 2010 Hong Kong Hong Kong. Conference Start: 20100711 Conference End: 20100715. Conference Publication: var.pagings pp100', '10.1111/j.1479-8077.2006.00194.x', '']\n",
      "['9262056', 'Zhu R; Shen H; Da M; Lu J. Effects of etanercept biomimics on lipid profiles in patients with rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp166-167', '10.1136/annrheumdis-2016-eular.2271', '']\n",
      "['9742673', 'Zhu R; Shen H. Effects of etanercept biomimics on lipid profiles in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp238-', '10.1136/annrheumdis-2016-eular.2271', '']\n",
      "['9256735', 'Xi Bao Y; Kwok Wong C; Kwok Ming Li E; Shan Tam L; Chung Leung P; Bing Yin Y; Wai Kei Lam C. Immunomodulatory effects of Lingzhi and San-Miao-San supplementation on patients with rheumatoid arthritis. Immunopharmacology and immunotoxicology. (2006) 28 2 pp197-200', '10.1080/08923970600815097', '']\n",
      "['9256736', 'Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women. Annals of the rheumatic diseases. (1987) 46 3 pp237-243', '10.1136/ard.46.3.237', '']\n",
      "['9256737', 'Pasalic KS; Gosic K; Gavrilovic A; Vojinovic J. Additional impact on muscle function when treating active rheumatoid arthritis patients with high alfacalcidol doses. Vojnosanitetski pregled. (2017) 74 11 pp1036-1042', '10.2298/vsp160227300s', '']\n",
      "['9256738', 'Menci S; Rossi M; Del Curatolo G; Orsucci PL. [Parsalmide, a new synthetic substance, in inflammatory and arthrosic arthropathies. Double-blind controlled clinical trial]. Minerva medica. (1976) 67 52 pp3403-3408', '10.1037/e649442010-001', '']\n",
      "['9256739', 'Franchi R. [Controlled clinical trial of a new synthetic preparation (parsalmide) in the treatment of inflammatory and degenerative arthro-myopathies]. Minerva medica. (1976) 67 52 pp3397-3402', '10.23736/s0026-4806.24.09104-3', '']\n",
      "['9256740', 'Alavi A; Goodfellow L; Fraser O; Tarelli E; Bland M; Axford J. A double-blind, randomized, placebo-controlled study to explore the efficacy of a dietary plant-derived polysaccharide supplement in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2011) 50 6 pp1111-1119', '10.1093/rheumatology/keq427', 'http://academic.oup.com/rheumatology/article-pdf/50/6/1111/5050903/keq427.pdf']\n",
      "['9256741', 'Jacobs JWG; Van Everdingen AA; Verstappen SMM; Bijlsma JWJ. Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo. Arthritis and rheumatism. (2006) 54 5 pp1422-1428', '10.1002/art.21809', '']\n",
      "['9256742', 'Kremer JM; Davies JM; Rynes RI; Fink S; Lawrence DA; Petrillo GF; Mullaly PM. Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study. Arthritis and rheumatism. (1995) 38 5 pp601-607', '10.1002/art.1780380504', '']\n",
      "['9256744', 'Novak P; Burger H; Tomsic M; Marincek C; Vidmar G. Influence of foot orthoses on plantar pressures, foot pain and walking ability of rheumatoid arthritis patients--a randomised controlled study. Disability and rehabilitation. (2009) 31 8 pp638-645', '10.1080/09638280802239441', '']\n",
      "['9256745', 'Hicklin JA; Hingorani K; Lloyd KN; Templeton JS; Wilkinson M. Azapropazone compared with indomethacin in the treatment of rheumatoid arthritis. Practitioner. (1976) 217 1301 pp799-803', '10.1185/03007997609109284', '']\n",
      "['9256747', 'Knijff-Dutmer EA; Kalsbeek-Batenburg EM; Koerts J; van de Laar MA. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2002) 41 4 pp458-461', '10.1093/rheumatology/41.4.458', 'http://academic.oup.com/rheumatology/article-pdf/41/4/458/5057862/410458.pdf']\n",
      "['9256748', 'Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; F√∏rre O; Ebringer A. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Annals of the rheumatic diseases. (1995) 54 3 pp221-224', '10.1136/ard.54.3.221', '']\n",
      "['9256749', 'Jacobs JW; Rasker JJ; van Riel PL; Gribnau FW; van de Putte LB. Rheumajecta and vasolastine in the treatment of rheumatoid arthritis--the results of a placebo-controlled, double-blind trial of a complementary treatment. Scandinavian journal of rheumatology. (1991) 20 6 pp434-440', '10.3109/03009749109096823', '']\n",
      "['9256750', 'Inamdar A; Merlo-Pich E; Gee M; Makumi C; Mistry P; Robertson J; et al. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach. Journal of psychopharmacology (Oxford, England). (2014) 28 6 pp570-581', '10.1177/0269881114529377', 'https://journals.sagepub.com/doi/pdf/10.1177/0269881114529377']\n",
      "['9256753', \"Torley HI; Madhok R; Capell HA; Brouwer RM; Maddison PJ; Black CM; Englert H; Dormandy JA; Watson HR. A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Annals of the rheumatic diseases. (1991) 50 11 pp800-804\", '10.1136/ard.50.11.800', '']\n",
      "['9256754', 'Doube A; Davies J; Notarianni L; Holgate K; Fenn GC. Effect of misoprostol on concentrations of prostaglandins in synovial fluid. Annals of the rheumatic diseases. (1991) 50 11 pp797-799', '10.1136/ard.50.11.797', '']\n",
      "['9256755', 'Liang DF; Huang F; Zhang JL; Yang CH; Zhang H; Guo JH; Zhao Z. [A randomized, single-blind, parallel, controlled clinical study on single intra-articular injection of etanercept in treatment of inflammatory knee arthritis]. Zhonghua nei ke za zhi [Chinese journal of internal medicine]. (2010) 49 11 pp930-934', '10.1177/1179544118773068', 'https://journals.sagepub.com/doi/pdf/10.1177/1179544118773068']\n",
      "['9256756', 'El-Ghobarey AF; Rennie JA; Hadidi T; Hamid HA; Mavrikakis M. A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. Current medical research and opinion. (1976) 4 6 pp432-435', '10.1185/03007997609111999', '']\n",
      "['9256757', 'Hatakka K; Martio J; Korpela M; Herranen M; Poussa T; Laasanen T; Saxelin M; Vapaatalo H; Moilanen E; Korpela R. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scandinavian journal of rheumatology. (2003) 32 4 pp211-215', '10.1080/03009740310003695', '']\n",
      "['9256758', 'Baluom M; Samara E; Grossbard EB; Lau DT. Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2011) 51 9 pp1310-1318', '10.1177/0091270010381496', '']\n",
      "['9256759', 'Yxfeldt A; W√•llberg-Jonsson S; Hultdin J; Rantap√§√§-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scandinavian journal of rheumatology. (2003) 32 4 pp205-210', '10.1080/03009740310003686', '']\n",
      "['9256760', 'Lahdenne P; Vahasalo P; Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Annals of the rheumatic diseases. (2003) 62 3 pp245-247', '10.1136/ard.62.3.245', '']\n",
      "['9256761', 'Estellat C; Tubach F; Seror R; Alfaiate T; Ravaud P. Control treatments in randomized controlled trials are often deemed not acceptable in the context of care. The example of biologics in rheumatoid arthritis. Pharmacoepidemiology and drug safety. (2013) 22  pp356-357', '10.1016/j.jclinepi.2015.08.016', '']\n",
      "['9256762', 'Ahlmen M; Ahlmen J; Svalander C; Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clinical rheumatology. (1987) 6 1 pp27-38', '10.1007/bf02200997', 'http://link.springer.com/article/10.1007/BF02200997/fulltext.html']\n",
      "['9256763', 'Ryu J; Sakamoto A; Honda T; Saito S. The postoperative drain-clamping method for hemostasis in total knee arthroplasty. Reducing postoperative bleeding in total knee arthroplasty. Bulletin (Hospital for Joint Diseases (New York, N.Y.)). (1997) 56 4 pp251-254', '10.1007/978-4-431-68529-6_23', 'http://link.springer.com/content/pdf/10.1007/978-4-431-68529-6_23.pdf']\n",
      "['9256764', 'Solomon DH; Avorn J; Wang PS; Vaillant G; Cabral D; Mogun H; Sturmer T. Prescription opioid use among older adults with arthritis or low back pain. Arthritis and rheumatism. (2006) 55 1 pp35-41', '10.1002/art.21697', '']\n",
      "['9256765', 'Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database. International journal of rheumatic diseases. (2018) 21 9 pp1670-1677', '10.1111/1756-185x.13300', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13300']\n",
      "['9256766', 'Hirvonen H; Kautiainen H; Moilanen E; Mikkelsson M; Leirisalo-Repo M. The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis. Rheumatology international. (2017) 37 9 pp1481-1487', '10.1007/s00296-017-3771-9', 'http://link.springer.com/article/10.1007/s00296-017-3771-9/fulltext.html']\n",
      "['9256767', 'Wang CJ; Wang JW; Weng LH; Hsu CC; Huang CC; Chen HS. The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. Journal of bone and joint surgery. American volume. (2003) 85-A 11 pp2121-2126', '10.2106/00004623-200311000-00009', '']\n",
      "['9256768', 'Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc. Scandinavian journal of rheumatology. (1976) 5 4 pp241-247', '10.3109/03009747609099913', '']\n",
      "['9256769', 'Salzer J; Svenningsson R; Alping P; Novakova L; Bjorck A; Fink K; Islam-Jakobsson P; Malmestrom C; Axelsson M; Vagberg M; Sundstrom P; Lycke J; Piehl F; Svenningsson A. Rituximab in multiple sclerosis. Neurology. (2016) 87 20 pp2074-2081', '10.1212/wnl.0000000000003331', '']\n",
      "['9256770', 'Moffet H; Noreau L; Parent E; Drolet M. Feasibility of an eight-week dance-based exercise program and its effects on locomotor ability of persons with functional class III rheumatoid arthritis. Arthritis care and research. (2000) 13 2 pp100-111', '10.1002/1529-0131(200004)13:2<100::aid-anr4>3.0.co;2-v', '']\n",
      "['9256772', 'Yaqoob P; Knapper JA; Webb DH; Williams CM; Newsholme EA; Calder PC. Effect of olive oil on immune function in middle-aged men. American journal of clinical nutrition. (1998) 67 1 pp129-135', '10.1093/ajcn/67.1.129', 'http://academic.oup.com/ajcn/article-pdf/67/1/129/23189439/129.pdf']\n",
      "['9256773', 'Buckland-Wright JC; Clarke GS; Chikanza IC; Grahame R. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. Journal of rheumatology. (1993) 20 2 pp243-247', '10.1093/rheumatology/33.3.249', 'http://academic.oup.com/rheumatology/article-pdf/33/3/249/5030766/33-3-249.pdf']\n",
      "['9256774', 'Gheita TA; Kenawy SA. Effectiveness of Nigell sativ oil in the management of rheumatoid arthritis patients: Placebo controlled study. Phytotherapy research : PTR. (2012) 26  8 pp1246-1248', '10.1002/ptr.3679', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.3679']\n",
      "['9256775', 'Jia J; Peng H; Chen S. Evaluation of the role of human beta-defensin 3 in modulation of immunity and inflammatory response after knee replacement. Experimental and therapeutic medicine. (2017) 13 4 pp1343-1346', '10.3892/etm.2017.4100', '']\n",
      "['9256776', 'Moiseev SV; Novikov PI; Semenkova EN; Strizhakov LA; Gulyaev SV; Yanushkevich TN; Nikiforova NV; Meshkov AD; Panasyuk VV; Sokorin YD; Taranova MV; Parfenova SA; Dubrovskaya LV; Zhabina ES; Kuznetsova EI; Lopatina IA; Bulanov NM; Mukhin NA. Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases. TerapevticheskiiÃÜ arkhiv. (2013) 85 5 pp37-43', '10.14412/1995-4484-2013-640', '']\n",
      "['9256778', 'Jurczak W; Moreira I; Setty Govindbabu K; Munhoz E; Echeveste M-A; Giri P; Castro N; Pereira J; Luiza A; Alexeev S; Osmanov D; Zhu P; Alexandrova S; Zubel A; Harlin O; Amersdorffer J. Equivalent efficacy of a biosimilar rituximab and reference rituximab in previously untreated advanced follicular lymphoma: extended results of ASSIST-FL, a confirmatory phase III study. Annals of oncology. Conference: 42nd ESMO congress, ESMO 2017. Spain. (2017) 28 Supplement 5 ppv355', '10.1093/annonc/mdx373', 'http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx373/19940156/mdx373.pdf']\n",
      "['9256781', 'Middleton KR; Ward MM; Haaz S; Velummylum S; Fike A; Acevedo AT; Tataw-Ayuketah G; Dietz L; Mittleman BB; Wallen GR. A pilot study of yoga as self-care for arthritis in minority communities. Health and quality of life outcomes. (2013) 11  pp55', '10.1186/1477-7525-11-55', '']\n",
      "['9256782', 'Weinblatt ME; Weissman BN; Holdsworth DE; Fraser PA; Maier AL; Falchuk KR; Coblyn JS. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis and rheumatism. (1992) 35 2 pp129-137', '10.1002/art.1780350202', '']\n",
      "['9256783', 'Rhee SH; Parker JC; Smarr KL; Petroski GF; Johnson JC; Hewett JE; Wright GE; Multon KD; Walker SE. Stress management in rheumatoid arthritis: what is the underlying mechanism?. Arthritis care and research. (2000) 13 6 pp435-442', '10.1002/1529-0131(200012)13:6<435::aid-art15>3.0.co;2-j', '']\n",
      "['9256784', \"McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease. The Cochrane database of systematic reviews. (2014) 8  ppCD003459\", '10.1002/14651858.cd003459.pub3', '']\n",
      "['9256785', 'Davis JD; Turner RA; Collins RL; Ruchte IR; Kaufmann JS. Fenoprofen, aspirin, and gold induction in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1977) 21 1 pp52-61', '10.1002/cpt197721152', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt197721152']\n",
      "['9256786', 'Kadir N; Grayson MF; Campbell ED. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis. Annals of clinical research. (1983) 15 1 pp4-9', '10.1136/ard.34.2.186', '']\n",
      "['9256787', 'Suomi R; Collier D. Effects of arthritis exercise programs on functional fitness and perceived activities of daily living measures in older adults with arthritis. Archives of physical medicine and rehabilitation. (2003) 84 11 pp1589-1594', '10.1053/s0003-9993(03)00278-8', '']\n",
      "['9256789', \"Maccagno A; Di Giorgio E; Romanowicz A. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. Current medical research and opinion. (1991) 12 7 pp423-429\", '10.1185/03007999109111513', '']\n",
      "['9256790', 'Bombardier C; Raboud J. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group. Controlled clinical trials. (1991) 12 4 Suppl pp243S-256S', '10.1016/s0197-2456(05)80028-5', '']\n",
      "['9256792', 'Mena HR; Ward JR; Zuckner J; Wolski KP; Briney WG; Giansiracusa J. Treatment of rheumatoid arthritis with flurbiprofen or ibuprofen. Journal of clinical pharmacology. (1977) 17 1 pp56-62', '10.1002/j.1552-4604.1977.tb04586.x', '']\n",
      "['9256794', 'van de Putte LB; Rau R; Breedveld FC; Kalden JR; Malaise MG; van Riel PL; Schattenkirchner M; Emery P; Burmester GR; Zeidler H; Moutsopoulos HM; Beck K; Kupper H. Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Annals of the rheumatic diseases. (2003) 62 12 pp1168-1177', '10.1136/ard.2003.009563', '']\n",
      "['9256796', 'Loebl DH; Craig RM; Culic DD; Ridolfo AS; Falk J; Schmid FR. Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA. (1977) 237 10 pp976-981', '10.1001/jama.1977.03270370048021', '']\n",
      "['9256798', 'Boureau F; Boccard E. Placebo-controlled study of the analgesic efficacy of a combination of paracetamol and codeine in rheumatoid arthritis. Acta therapeutica. (1991) 17 2 pp123-136', '10.2165/00044011-199918030-00003', '']\n",
      "['9256799', \"Tsifetaki N; Kitsos G; Paschides CA; Alamanos Y; Eftaxias V; Voulgari PV; Psilas K; Drosos AA. Oral pilocarpine for the treatment of ocular symptoms in patients with Sj√∂gren's syndrome: a randomised 12 week controlled study. Annals of the rheumatic diseases. (2003) 62 12 pp1204-1207\", '10.1136/ard.2002.003889', '']\n",
      "['9256800', 'Sambrook PN; Hughes DR; Nelson AE; Robinson BG; Mason RS. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the rheumatic diseases. (2003) 62 12 pp1215-1217', '10.1136/ard.2003.008839', '']\n",
      "['9256801', 'Stockman A; Varigos GA; Muirden KD. Comparison of effectiveness of mefenamic acid and ibuprofen in treatment of rheumatoid arthritis. Medical journal of Australia. (1976) 2 22 pp819-821', '10.5694/j.1326-5377.1976.tb115394.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1976.tb115394.x']\n",
      "['9256802', 'Kirchheiner B; Fossgreen J; Tophoj E; Zachariae E. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin. Rheumatology and rehabilitation. (1976) Suppl  pp50-51', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9256803', 'Karademir S; Oƒüuz D; Senocak F; Ocal B; Karakurt C; Cabuk F. Tolmetin and salicylate therapy in acute rheumatic fever: Comparison of clinical efficacy and side-effects. Pediatrics international. (2003) 45 6 pp676-679', '10.1111/j.1442-200x.2003.01801.x', '']\n",
      "['9256804', 'Sydnes OA; Brath HK; Haerum LB; Straume S. Clinical evaluation of keto profen (Orudis) in rheumatoid arthritis: results of a multi-centre double-blind trial against phenylbutazone. Rheumatology and rehabilitation. (1976) Suppl  pp43-44', '10.1093/rheumatology/15.5.43', 'http://academic.oup.com/rheumatology/article-pdf/15/5/43/5038967/15-5-43.pdf']\n",
      "['9256805', 'Kennedy AC. Ketoprofen in the treatment of rheumatoid arthritis. Rheumatology and rehabilitation. (1976) Suppl Suppl pp34-36', '10.1093/rheumatology/15.5.34', 'http://academic.oup.com/rheumatology/article-pdf/15/5/34/5038865/15-5-34.pdf']\n",
      "['9256806', \"Walters MT; Rubin CE; Keightley SJ; Ward CD; Cawley MI. A double-blind, cross-over, study of oral N-acetylcysteine in Sj√∂gren's syndrome. Scandinavian journal of rheumatology. Supplement. (1986) 61  pp253-258\", '10.1080/15027732.1986.12461423', '']\n",
      "['9256807', 'Sigidin IaA; Pokryshkin VI. A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis. TerapevticheskiiÃÜ arkhiv. (1987) 59 4 pp73-76', '10.1016/s0168-8278(87)80350-1', '']\n",
      "['9256808', \"Karlson EW; Shadick NA; Cook NR; Buring JE; Lee IM. Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis and rheumatism. (2008) 59 11 pp1589-1595\", '10.1002/art.24194', '']\n",
      "['9256809', 'Stock T; Fleishaker D; Wang X; Mukherjee A; Mebus C. Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. International journal of rheumatic diseases. (2017) 20 8 pp960-970', '10.1111/1756-185x.13053', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13053']\n",
      "['9256810', 'Rutner M; Fitzek J; Jahnel-Kracht H; Otto J; Krause W. [Therapy of rheumatic disease with a hydroxyethylsalicylate gel. Results of 2 clinical studies of effectiveness and bioavailability]. Fortschritte der Medizin. (1995) 113 8 pp111-113', '10.1007/bf03368218', '']\n",
      "['9256812', 'Hasson SH; Henderson GH; Daniels JC; Schieb DA. Exercise training and dexamethasone iontophoressis in rheumatoid arthritis: A case study. PHYSIOTHERAPY CANADA. (1991) 43 2 pp11-14', '10.1002/art.1790010308', '']\n",
      "['9256813', 'Selvakumar G; Gaur GS; Negi VS; Sharma VK. Cardiac autonomic functions and disease activity in the patients of rheumatoid arthritis. Indian journal of physiology and pharmacology. Conference: 63rd annual conference of physiologists and pharmacologists of india. India. (2017) 61 5 Suppl 1 pp104', '10.25259/ijpp_302_2020', 'https://ijpp.com/continuing-professional-development-of-physiologists-role-of-association-of-physiologists-and-pharmacologists-of-india/']\n",
      "['9256814', 'Chalem F; Farias P; Lizarazo H; Pe√±a P. Diftalone: a new non-steroidal anti-inflammatory agent: comparative study with phenylbutazone in the treatment of rheumatoid arthritis. Journal of international medical research. (1977) 5 1 pp18-25', '10.1177/030006057700500103', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700500103']\n",
      "['9256815', 'Schmidt Z; Szil‚àö¬∞gyi M; Megyeri A; Mer‚àö¬©tey K. [Low-dose methotrexate therapy of rheumatoid arthritis in the elderly]. Orvosi hetilap. (1995) 136 22 pp1157-1161', '10.1556/650.1995.05.07', '']\n",
      "['9256816', 'Thygesen H; Dragalin V; Whitehead A; Whitehead J. A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis. Pharmaceutical statistics. (2012) 11  6 pp476-484', '10.1002/pst.1539', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpst.1539']\n",
      "['9256818', 'McLachlan AJ; Tett SE; Cutler DJ; Day RO. Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. British journal of clinical pharmacology. (1993) 36 1 pp78-81', '10.1111/j.1365-2125.1993.tb05897.x', '']\n",
      "['9256819', 'Portier A; Gossec L; Tubach F; Alfaiate T; Pham T; Saraux A; Soubrier M; Schaeverbeke T; Maillefert JF; Mariette X; Hajage D; Fautrel B. Patient-perceived flares in rheumatoid arthritis: a sub-analysis of the STRASS treatment tapering strategy trial. Joint, bone, spine. (2017) 84 5 pp577-581', '10.1016/j.jbspin.2016.10.001', '']\n",
      "['9256820', 'Hansen TM; Dickmeiss E; Jans H; Ingemann Hansen T; Ingeman-Nielsen M; Lorenzen I. Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Annals of the rheumatic diseases. (1987) 46 4 pp290-295', '10.1136/ard.46.4.290', '']\n",
      "['9256821', 'Chotanaphuti T; Ongnamthip P; Teeraleekul K; Kraturerk C. Comparative study between computer assisted-navigation and conventional technique in minimally invasive surgery total knee arthroplasty, prospective control study. Chotmaihet thangphaet [Journal of the Medical Association of Thailand]. (2008) 91 9 pp1382-1388', '10.1080/24699322.2016.1249959', 'https://tandfonline.com/doi/pdf/10.1080/24699322.2016.1249959']\n",
      "['9256822', 'Marques NJF; Samara AM. Double-blind crossover study. Cimetidine/placebo in patients with rheumatoid arthritis treated with indomethacin.  ESTUDO DUPLO-CEGO-CRUZADO - CIMETIDINA/PLACEBO EM PACIENTES COM ARTRITE REUMATOIDE TRATADOS COM INDOMETACINA. Folha medica. (1982) 85 SUPPL. 1 pp885-886', '10.11606/t.17.2021.tde-11042022-140938', 'https://www.teses.usp.br/teses/disponiveis/17/17144/tde-11042022-140938/publico/SARAHSELLALANGER.pdf']\n",
      "['9256825', 'Caldwell JR; Furst DE; Smith AL; Clark JA; Bonebrake RA; Gruhn WB; McIlwain HH; Logue CM. Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study. Journal of rheumatology. (1998) 25 1 pp30-35', '10.1002/art.39684', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39684']\n",
      "['9256826', 'Genovese MC; Glover J; Matsunaga N; Chisholm D; Alten R. Efficacy, safety and immunogenicity in randomized, double-blind (DB) and open-label extension (OLE) studies comparing FKB327, an adalimumab biosimilar, with the adalimumab reference product (humira; rp) in patients (PTS) with active rheumatoid arthritis (RA). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1136/annrheumdis-2019-eular.972', '']\n",
      "['9256827', 'Liehu C; Bin W; Ming L; Shaojun S; Weizong W; Haihang L; Jiacan S. Closed reduction and internal fixation versus total hip arthroplasty for displaced femoral neck fracture. Chinese Journal of Traumatology - English Edition. (2014) 17  2 pp63-68', '10.18502/jost.v6i4.5562', 'https://publish.kne-publishing.com/index.php/jost/article/download/5562/5410']\n",
      "['9256829', 'Mariano VJ; Frishman WH. Tocilizumab in Giant Cell Arteritis. Cardiology in review. (2018) 26 6 pp321-330', '10.1097/crd.0000000000000204', '']\n",
      "['9256831', \"Nakayamada S; Fujimoto T; Nonomura A; Saito K; Nakamura S; Tanaka Y. Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy. Rheumatology. (2009) 48 10 pp1279-1282\", '10.1093/rheumatology/kep228', 'http://academic.oup.com/rheumatology/article-pdf/48/10/1279/5054969/kep228.pdf']\n",
      "['9256834', 'Jelinek GA; Will R; Dusci LJ; Potter JM; Black KA. Intravenous regional administration of methylprednisolone in rheumatoid arthritis. Rheumatology international. (1991) 11 4-5 pp147-150', '10.1007/bf00332552', 'http://link.springer.com/article/10.1007/BF00332552/fulltext.html']\n",
      "['9256835', \"Messias AR; Brito AS; de Oliveira IL. Clinical evaluation of d-2-(6'-methoxy-2'-naphthyl)propionic acid (naproxen) in rheumatic conditions. Journal of clinical pharmacology. (1975) 15 4 Pt. 2 pp324-326\", '10.1002/j.1552-4604.1975.tb01459.x', '']\n",
      "['9256836', 'Yu JP; Zhang YZ; Li XY. Effect of strengthening PI and activating blood circulation therapy on serum levels of adrenocorticotrophic hormone and vascular endothelial growth factor in rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2007) 27 7 pp593-595', '10.47939/mh.v2i8.415', '']\n",
      "['9256838', 'Kaik B; Broll H. Multicenter double blind comparison of auranofin and Tauredon(Reg.trademark).  MULTIZENTRISCHER DOPPELBLINDVERGLEICH ZWISCHEN AURANOFIN(Reg.trademark) UND TAUREDON(Reg.trademark). Wiener klinische Wochenschrift. (1984) 96 SUPPL. 156 pp33-40', '10.1055/s-2008-1051092', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1051092.pdf']\n",
      "['9256840', 'Stock KP; Geisslinger G; Loew D; Beck WS; Bach GL; Brune K. S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis. Rheumatology international. (1991) 11 4-5 pp199-202', '10.1007/bf00332562', 'http://link.springer.com/article/10.1007/BF00332562/fulltext.html']\n",
      "['9256841', 'Muller-Fassbender H; Kaik B; Rau R; Schattenkirchner M; Zeidler H. Controlled double-blind comparative study between Auronofin and Aurothiomalate. Zeitschrift fur Rheumatologie. (1982) 41 4 pp125', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9256842', 'Hammond A; Young A; Kidao R. A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 1 pp23-30', '10.1136/ard.2002.001511', '']\n",
      "['9256844', 'Edmonds SE; Winyard PG; Guo R; Kidd B; Merry P; Langrish-Smith A; Hansen C; Ramm S; Blake DR. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Annals of the rheumatic diseases. (1997) 56 11 pp649-655', '10.1136/ard.56.11.649', '']\n",
      "['9256845', 'Reynolds PM; Rhymer AR; MacLeod MM; Buchanan WW. Comparison of sulindac and aspirin in rheumatoid arthritis. Current medical research and opinion. (1977) 4 7 pp485-491', '10.1185/03007997709109337', '']\n",
      "['9256846', \"Fisher B; Everett C; Rout J; O'Dwyer J; Emery P; Pitzalis C; Ng W-F; Carr A; Pease C; Price E; Sutcliffe N; Makdissi J; Tappuni A; Gendi N; Hall F; Ruddock S; Fernandez C; Hulme C; Davies K; Edwards CJ; Lanyon P; Moots RJ; Roussou E; Sharples L; Bombardieri M; Bowman S. Effect of rituximab on a salivary gland ultrasound score in primary sjogren's syndrome: results of multicentre double-blind randomised controlled trial sub-study. Arthritis and rheumatology. (2017) 69 Suppl 10 pp\", '10.1136/annrheumdis-2017-eular.3138', '']\n",
      "['9256847', 'Malandrino S; Angelini M; Baldini L; Barenghi L; Borsa M; Carrabba M; Ceriotti F; Tonon GC. Effects of suprofen on renal function in patients with rheumatoid arthritis. International journal of clinical pharmacology research. (1987) 7 4 pp259-263', '10.18535/jmscr/v4i2.51', '']\n",
      "['9256848', 'Essigman W; Lambert J; Sheldon P; Sweetman BJ; Wojtulewski J. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis. International journal of clinical pharmacology research. (1987) 7 4 pp251-257', '10.1185/03007998209109770', '']\n",
      "['9256849', 'Parker JC; Smarr KL; Slaughter JR; Johnston SK; Priesmeyer ML; Hanson KD; Johnson GE; Hewett JE; Hewett JE; Irvin WS; Komatireddy GR; Walker SE. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis and rheumatism. (2003) 49 6 pp766-777', '10.1002/art.11459', '']\n",
      "['9256850', 'Yocum DE; Furst DE; Kaine JL; Baldassare AR; Stevenson JT; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA; Tcrolimus Rheumatoid Arthritis Study Group. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis and rheumatism. (2003) 48 12 pp3328-3337', '10.1002/art.11363', '']\n",
      "['9256852', 'Hermann KG; Backhaus M; Schneider U; Labs K; Loreck D; Z√ºhlsdorf S; Schink T; Fischer T; Hamm B; Bollow M. Rheumatoid arthritis of the shoulder joint: comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging. Arthritis and rheumatism. (2003) 48 12 pp3338-3349', '10.1002/art.11349', '']\n",
      "['9256853', 'Hang Y; Qin X; Ren T; Cao J. Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids in health and disease. (2018) 17 1 pp146', '10.1186/s12944-018-0797-2', 'http://link.springer.com/article/10.1186/s12944-018-0797-2/fulltext.html']\n",
      "['9256856', 'Huskisson EC; Scott PJ. Floctafenine: a new analgesic for use in rheumatic diseases. Rheumatology and rehabilitation. (1977) 16 1 pp54-57', '10.1093/rheumatology/16.1.54', 'http://academic.oup.com/rheumatology/article-pdf/16/1/54/5026223/16-1-54.pdf']\n",
      "['9256859', 'Veys EM; Mielants H; Verbruggen G. Serum proteins in rheumatoid arthritis patients under immunomodulating treatment. Ricerca in clinica e in laboratorio. (1978) 8 SUPP.1 pp71-80', '10.1016/s0140-6736(78)90443-9', '']\n",
      "['9256860', 'Gallagher KS; Godwin J; Hendry GJ; Steultjens M; Woodburn J. A protocol for a randomised controlled trial of prefabricated versus customised foot orthoses for people with rheumatoid arthritis: the FOCOS RA trial. Journal of foot and ankle research. (2018) 11  pp24', '10.1186/s13047-018-0272-3', 'http://link.springer.com/article/10.1186/s13047-018-0272-3/fulltext.html']\n",
      "['9256862', 'Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY. Cevimeline for the treatment of xerostomia in patients with Sj√∂gren syndrome: a randomized trial. Archives of internal medicine. (2002) 162 11 pp1293-1300', '10.1001/archinte.162.11.1293', '']\n",
      "['9256863', 'Woodburn J; Helliwell PS; Barker S. Changes in 3D joint kinematics support the continuous use of orthoses in the management of painful rearfoot deformity in rheumatoid arthritis. Journal of rheumatology. (2003) 30 11 pp2356-2364', '10.1093/rheumatology/41.12.1406', 'http://academic.oup.com/rheumatology/article-pdf/41/12/1406/9533176/411406.pdf']\n",
      "['9256868', \"d'Elia HF; Carlsten H. The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scandinavian journal of immunology. (2008) 68 6 pp661-667\", '10.1111/j.1365-3083.2008.02186.x', '']\n",
      "['9256870', 'Gao GH; Li J; Xie HW; L‚àö¬∫ Z. [Therapeutic effect of infliximab on moderate and severe active rheumatoid arthritis]. Nan fang yi ke da xue xue bao [Journal of Southern Medical University]. (2010) 30 4 pp724-726', '10.1016/0049-0172(82)90010-5', '']\n",
      "['9256872', 'Young PJ; Weeden S; Kirwan JR. The analysis of a bivariate multi-state Markov transition model for rheumatoid arthritis with an incomplete disease history. Statistics in medicine. (1999) 18 13 pp1677-1690', '10.1002/(sici)1097-0258(19990715)18:13<1677::aid-sim154>3.0.co;2-n', '']\n",
      "['9256874', 'Burduli NN; Burduli NM. The influence of intravenous laser irradiation of the blood on the dynamics of leptin levels and the quality of life of the patients presenting with rheumatoid arthritis. Voprosy kurortologii, fizioterapii, i lechebnoiÃÜ fizicheskoiÃÜ kultury. (2015) 92 3 pp11-13', '10.17116/kurort2015311-13', '']\n",
      "['9256876', 'Hardware B; Johnson D; Hale C; Ndosi M; Adebajo A. Patients and nursing staff views of using the education needs assessment tool in rheumatology clinics: a qualitative study. Journal of clinical nursing. (2015) 24 7-8 pp1048-1058', '10.1111/jocn.12733', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjocn.12733']\n",
      "['9256877', 'Lau CS; McLaren M; Belch JJ. Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis. Clinical and experimental rheumatology. (1995) 13 1 pp87-90', '10.1016/0268-9499(90)90382-t', '']\n",
      "['9256878', 'Lussier A. Long-term clinical assessment of naproxen on rheumatoid arthritis patients and 51-Cr gastrointestinal bleeding on volunteers. Arzneimittel-Forschung. (1975) 25 2A pp294-298', '10.1002/j.1552-4604.1975.tb01460.x', '']\n",
      "['9256879', 'Al-Kaissi E; Al-Muhtaseb N. The influence of adding antibiotic in treatment of rheumatoid arthritis patients on Streptococcus pyogenes carrier rate and on the lipids profile. International Journal of Pharmacy and Pharmaceutical Sciences. (2015) 7  2 pp245-251', '10.22159/ijpps.2017v9i6.18335', 'https://innovareacademics.in/journals/index.php/ijpps/article/viewFile/18335/11118']\n",
      "['9256882', \"Lemaire V. Placebo controlled trial of gold salts and salazopyrine for the treatment of rheumatoid polyarthritis.  ESSAI CONTROLE DE TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE PAR LES SELS D'OR, LA SALAZOPYRINE OU LE PLACEBO. Concours medical. (1989) 111 23 pp2004\", '10.1016/s0151-9638(05)79812-4', '']\n",
      "['9256884', 'Williams HJ; Ward JR; Reading JC; Brooks RH; Clegg DO; Skosey JL; Weisman MH; Willkens RF; Singer JZ; Alarc‚àö‚â•n GS. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and rheumatism. (1992) 35 3 pp259-269', '10.1002/art.1780350304', '']\n",
      "['9256888', 'Lavie P; Lorber M; Tzischinsky O; Epstein R; Sharf Y. Wrist actigraphic measurements in patients with rheumatoid arthritis. A novel method to assess drug efficacy. DRUG INVEST. (1990) 2 SUPPL. 3 pp15-21', '10.1007/bf03258205', 'http://link.springer.com/article/10.1007/BF03258205/fulltext.html']\n",
      "['9256890', 'Achterberg J; McGraw P and Lawlis GF. Rheumatoid arthritis: a study of relaxation and temperature biofeedback training as an adjunctive therapy. Biofeedback Selfregulation. (1981) 6 2 pp207-223', '10.1007/bf00998870', 'http://link.springer.com/article/10.1007/BF00998870/fulltext.html']\n",
      "['9256891', 'Anonymous. Usability and patient perceptions of the sarilumab pen for treatment of RA. Journal of clinical outcomes management. (2018) 25 7 pp296-297', '10.1007/s40744-017-0090-2', 'http://link.springer.com/content/pdf/10.1007/s40744-017-0090-2.pdf']\n",
      "['9256892', 'Moreno M; Pontes C; Torres F; Sellas-Fernandez A; Almirall M; Torre-Alonso JC; Clavaguera T; Rodriguez-Lozano C; Linares LF; Urruticoechea-Arana A; Collantes-Estevez E; Morla R; Reina D; Cuende E; Zarco P; Fernandez-Espartero C; Garcia-Vicuna R; Sanz J; Juanola X; Vallano A; Blanco FJ; Sanmarti R; Calvo G; Avendano C; De Miguel E; Vives R; Gonzalez RV; Montilla-Morales CA; Gratacos-Masmitja J. Study of potential clinical and biologic predictors of maintaining good response at 1 year follow-up, in patients with ankylosing spondylitis under dose reduction of TNFI treatment. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017. United states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/ker083', 'http://academic.oup.com/rheumatology/article-pdf/50/10/1828/5061635/ker083.pdf']\n",
      "['9256894', 'Russell AS; Labelle JL. A double-blind crossover study of ketoprofen enteric-coated and ketoprofen non-enteric-coated tablets in patients with ankylosing spondylitis, osteoarthritis and rheumatoid arthritis. CURR THER RES, CLIN EXP. (1983) 33 2 pp185-191', '10.1007/bf03291603', 'http://link.springer.com/article/10.1007/BF03291603/fulltext.html']\n",
      "['9256895', 'Barlow JH and Wright CC. Knowledge in patients with rheumatoid arthritis: a longer term follow-up of an randomized controlled study of patient education leaflets. British Journal Rheumatology. (1998) 37 4 pp373-376', '10.1093/rheumatology/37.4.373', 'http://academic.oup.com/rheumatology/article-pdf/37/4/373/18106118/370373.pdf']\n",
      "['9256896', \"Fayet B; Bernard JA; Ammar J; Karpouzas I; Taylor Y; Abenhaim A; Renard G; Pouliquen Y. Temporary punctum plug in the treatment of chronic dry eye.  TRAITEMENT DES SECHERESSES LACRYMALES PAR OCCLUSION REVERSIBLE DES MEATS LACRYMAUX. RESULTATS COMPARES A UN GROUPE TEMOIN. Journal francais d'ophtalmologie. (1990) 13 3 pp123-133\", '10.1111/j.1365-2141.2006.06070.x', '']\n",
      "['9256898', 'Harth M; Davis P; Thompson JM; Menard H; Beaudet F. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study. Scandinavian journal of rheumatology. (1987) 16 3 pp177-184', '10.3109/03009748709165271', '']\n",
      "['9256899', 'Kvien TK; Pahle JA; H√∏yeraal HM; Sandstad B. Comparison of synovectomy and no synovectomy in patients with juvenile rheumatoid arthritis. A 24-month controlled study. Scandinavian journal of rheumatology. (1987) 16 2 pp81-91', '10.3109/03009748709102912', '']\n",
      "['9256900', 'Miller AC; Buckler JW; Sheldrake FE. Clinical studies of ibuprofen. CURRMEDRESOPIN. (1975) 3 8 pp589-593', '10.1185/03007997509110608', '']\n",
      "['9256901', 'Morgan GJ. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures. Scandinavian journal of rheumatology. Supplement. (1986) 63 63 pp29-35', '10.1080/15027732.1986.12461437', '']\n",
      "['9256902', \"Kuz'mina NN; Briu√©r EI; Isaeva LA; Alekseev LS; Shokh BP. [Double-blind evaluation of the therapeutic efficacy of D-penicillamine and hydroxychloroquine in juvenile rheumatoid arthritis]. Revmatologiia (Moscow, Russia). (1987)  1 pp7-12\", '10.1056/nejm198605153142001', '']\n",
      "['9256903', 'Weinblatt ME; Kavanaugh A; Burgos-Vargas R; Dikranian AH; Medrano-Ramirez G; Morales-Torres JL; Murphy FT; Musser TK; Straniero N; Vicente-Gonzales AV; Grossbard E. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis and rheumatism. (2008) 58 11 pp3309-3318', '10.1002/art.23992', '']\n",
      "['9256904', 'Canada AT; Little AH. The bioavailability of enteric coated acetylsalicylic acid: a comparative study in rheumatoid arthritis. I. CURRTHERRES. (1975) 18 5 pp727-732', '10.1007/bf03288095', 'http://link.springer.com/article/10.1007/BF03288095/fulltext.html']\n",
      "['9256905', 'Takeda S; Kaneoka H; Saito T. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol. Modern rheumatology / the Japan Rheumatism Association. (2008) 18 3 pp271-276', '10.3109/s10165-008-0055-y', '']\n",
      "['9256906', 'Martens M. Piroxicam treatment for postoperative pain of orthopedic surgery: A double-blind comparative study. Current therapeutic research, clinical and experimental. (1991) 49 5 pp750-763', '10.1016/s0011-393x(05)80524-7', '']\n",
      "['9256908', 'Franke M; Manz G. Comparison of fenoprofen and oxyphenbutazone in patients with rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1977) 21 1 pp43-49', '10.1185/03007997409115255', '']\n",
      "['9256909', 'Moorjani GR; Michael AA; Peisajovich A; Park KS; Sibbitt WL; Bankhurst AD. Patient pain and tissue trauma during syringe procedures: a randomized controlled trial. Journal of rheumatology. (2008) 35 6 pp1124-1129', '10.1097/rhu.0b013e31819c1fc4', '']\n",
      "['9256911', 'Gringras M. A clinical trial of Tofranil in rheumatic pain in general practice. Journal of international medical research. (1976) 4 2 Suppl pp41-49', '10.1177/030006057300100518', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057300100518']\n",
      "['9256912', 'Abdollahzad H; Alipour B; Aghdashi MA; Jafarabadi MA. Coenzyme Q10 supplementation in patients with rheumatoid arthritis: Are there any effects on cardiovascular risk factors?. European Journal of Integrative Medicine. (2015) 7  5 pp534-539', '10.1016/j.eujim.2015.09.003', '']\n",
      "['9256913', 'MacNeill AL; Dick WC. Imipramine and rheumatoid factor. Journal of international medical research. (1976) 4 2 Suppl pp23-27', '10.1185/03007997709110172', '']\n",
      "['9256914', 'Kwok KY; Leung MH. Tight control early rheumatoid arthritis clinic in Hong Kong: A pilot study. Hong Kong Medical Journal. (2012) 18  2 pp108-114', '10.12809/hkmj144309', 'https://www.hkmj.org/system/files/hkm1408p272.pdf']\n",
      "['9256915', 'Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sj√∂gren syndrome: a randomised controlled trial. Annals of the rheumatic diseases. (2008) 67 1 pp91-97', '10.1136/ard.2007.071563', '']\n",
      "['9256916', 'Stroescu V; Georgescu C; Voiosu R. Long-term controlled clinical trial of a new anti-inflammatory drug, diftalone, in rheumatoid arthritis. Journal of international medical research. (1976) 4 1 pp23-33', '10.1177/030006057600400103', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057600400103']\n",
      "['9256917', \"Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. Journal of clinical endocrinology and metabolism. (2009) 94 6 pp2044-2051\", '10.1210/jc.2009-0106', 'http://academic.oup.com/jcem/article-pdf/94/6/2044/9064742/jcem2044.pdf']\n",
      "['9256918', 'Garga N; Syngleb A; Krishanc P. Exploring the potential effect of HMG-CoA reductase inhibiton and Angiotensin receptor blockade on vascular function in rheumatoid arthritis. Indian journal of rheumatology. Conference: 32nd annual national conference of the indian rheumatology association, IRACON 2016. India. (2016) 11 5 Supplement ppS32-S33', '10.1016/s0973-3698(09)60002-9', '']\n",
      "['9256919', 'Syngle A; Garg N; Krishan P. Stem cell augmentation for cardiovascular risk in rheumatoid arthritis with olmesartan: star-o study. Indian journal of rheumatology. Conference: 32nd annual national conference of the indian rheumatology association, IRACON 2016. India. (2016) 11 5 Supplement ppS33', '10.1016/j.ihj.2014.10.337', '']\n",
      "['9256921', 'Chopra A; Kay J; Wyand MS; Chandrashekara S; Olakkengil AJ; Bhojani KS; Bhatia G; Rathi G; Thomas M; Maroli S; Thomson E; Shneyer L. A phase 3, randomized, bouble-blind, active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses. Indian journal of rheumatology. Conference: 30th annual conference of the indian rheumatology association, IRACON 2014. India. (2014) 9 5 Supplement ppS17', '10.1016/j.injr.2014.10.040', '']\n",
      "['9256922', 'Garg N; Syngle A; Krishan P; Verma I. Effect of Angiotensin II receptor blocker on inflammation and endothelial function in rheumatoid arthritis. Indian journal of rheumatology. Conference: 30th annual conference of the indian rheumatology association, IRACON 2014. India. (2014) 9 5 Supplement ppS20', '10.1016/j.injr.2014.10.049', '']\n",
      "['9256923', 'Dhir V; Sandhu A; Kaur J; Gupta N; Sood A; Kaur P; Sharma A; Sharma S. Does a higher dose of folic acid reduce adverse effects of methotrexate in rheumatoid arthritis? A randomized controlled trial. Indian journal of rheumatology. Conference: 30th annual conference of the indian rheumatology association, IRACON 2014. India. (2014) 9 5 Supplement ppS29', '10.1016/j.injr.2014.10.079', '']\n",
      "['9256925', 'McKenzie JM. An initial report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease. Rheumatology and rehabilitation. (1977) 16 2 pp78-82', '10.1093/rheumatology/16.2.78', 'http://academic.oup.com/rheumatology/article-pdf/16/2/78/5039418/16-2-78.pdf']\n",
      "['9256926', 'Hobkirk D; Rhodes M; Haslock I. Night medication in rheumatoid arthritis: II. Combined therapy with indomethacin and diazepam. Rheumatology and rehabilitation. (1977) 16 2 pp125-127', '10.1093/rheumatology/16.2.125', 'http://academic.oup.com/rheumatology/article-pdf/16/2/125/5039069/16-2-125.pdf']\n",
      "['9256927', \"Wu G-L; Wu N-Y; Li T-Y; Fan Y-S; Yu G-Y; Lu W-W. Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren's syndrome. Chinese journal of integrative medicine. (2015) 21  10 pp778-783\", '10.1007/s11655-015-2323-y', 'http://link.springer.com/article/10.1007/s11655-015-2323-y/fulltext.html']\n",
      "['9256928', 'De Faria A; Ritter A; Santa Catharina A; Brunelli V; Correa N; Sabbatini A; Almeida A; Barbaro N; Moreno H; Modolo R. Effects of TNF-alpha inhibiton on hemodynamic parameters and biomarkers in resistant hypertension: background, rationale, and design. Journal of hypertension. (2016) 34  ppe176', '10.1097/01.hjh.0000491827.30246.46', '']\n",
      "['9256929', 'Shiokawa Y; Horiuchi T; Honma M; Kageyama T; Okada T. [Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test]. RyuÃÑmachi. [Rheumatism]. (1977) 17 2 pp205-210', '10.1002/art.1780200804', '']\n",
      "['9256930', 'Gerber L; Furst G; Shulman B; Smith C; Thornton B; Liang M; Cullen K; Stevens MB; Gilbert N. Patient education program to teach energy conservation behaviors to patients with rheumatoid arthritis: a pilot study. Archives of physical medicine and rehabilitation. (1987) 68 7 pp442-445', '10.5014/ajot.41.2.102', 'https://research.aota.org/ajot/article-pdf/41/2/102/52518/102.pdf']\n",
      "['9256931', 'Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. British journal of rheumatology. (1987) 26 4 pp279-284', '10.1093/rheumatology/26.4.279', 'http://academic.oup.com/rheumatology/article-pdf/26/4/279/5027837/26-4-279.pdf']\n",
      "['9256932', 'Roelsgaard IK; Thomsen T; Ostergaard M; Christensen R; Hetland ML; Jacobsen S; Andersen L; Tonnesen H; Rollefstad S; Semb AG; Esbensen BA. The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial. Trials [electronic resource]. (2017) 18 1 pp570', '10.1186/s13063-017-2309-5', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2309-5.pdf']\n",
      "['9256933', 'Lovisi Neto BE; Jennings F; Barros Ohashi C; Silva PG; Natour J. Evaluation of the efficacy of an educational program for rheumatoid arthritis patients. Clinical and experimental rheumatology. (2009) 27 1 pp28-34', '10.1007/s10067-017-3917-x', 'http://link.springer.com/article/10.1007/s10067-017-3917-x/fulltext.html']\n",
      "['9256935', 'McCarthy DA; Bernhagen J; Taylor MJ; Hamblin AS; James I; Thompson PW; Perry JD. Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 1 pp13-18', '10.1136/ard.51.1.13', '']\n",
      "['9256937', 'Holst-Jensen SE; Pfeiffer-Jensen M; Monsrud M; Tarp U; Buus A; Hessov I; Thorling E and Stengaard-Pedersen K. Treatment of rheumatoid arthritis with a peptide diet. Scandinavial Journal Rheumatology. (1998) 27 3 pp329-336', '10.1080/03009749850154339', '']\n",
      "['9256938', 'Mavrikakis ME; MacLeod M; Buchanan WW; Hernandez LA; Rennie JA. Mefenamic acid: an under-rated antirheumatic?. Current medical research and opinion. (1977) 4 8 pp535-539', '10.1185/03007997709115267', '']\n",
      "['9256939', 'Bakker MF; Cavet G; Jacobs JW; Bijlsma JW; Haney DJ; Shen Y; Hesterberg LK; Smith DR; Centola M; van Roon JA; Lafeber FP; Welsing PM. Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Annals of the rheumatic diseases. (2012) 71 10 pp1692-1697', '10.1136/annrheumdis-2011-200963', '']\n",
      "['9256940', 'Harkcom TM; Lampman RM; Banwell BF and Castor CW. Therapeutic value of graded aerobic exercise training in rheumatoid arthritis. Arthritis Rheumatism. (1985) 28 1 pp32-39', '10.1002/art.1780280106', '']\n",
      "['9256941', 'Zhong QC. Clinical observation on treatment of scicca syndrome complicated with damage of blood system by TCM. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2003) 23 12 pp933-934', '10.53388/tmrim202307027', 'https://www.tmrjournals.com/public/articlePDF/20230926/ded3dc509323435a1cccfe160c6020f3.pdf']\n",
      "['9256942', 'den Broeder A; van de Putte L; Rau R; Schattenkirchner M; Van Riel P; Sander O; Binder C; Fenner H; Bankmann Y; Velagapudi R; Kempeni J; Kupper H. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. Journal of rheumatology. (2002) 29 11 pp2288-2298', '10.1136/annrheumdis-2001.1213', '']\n",
      "['9256943', 'Barnett ML; Kremer JM; St Clair EW; Clegg DO; Furst D; Weisman M; Fletcher MJ; Chasan-Taber S; Finger E; Morales A; Le CH; Trentham DE. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis and rheumatism. (1998) 41 2 pp290-297', '10.1002/1529-0131(199802)41:2<290::aid-art13>3.3.co;2-i', '']\n",
      "['9256944', 'Ostgard RD; Glerup H; Jurik AG; Kragstrup TW; Stengaard-Pedersen K; Hetland ML; Horslev-Petersen K; Junker P; Deleuran BW. Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients. Scandinavian journal of rheumatology. (2017) 46 6 pp441-445', '10.1080/03009742.2017.1286382', '']\n",
      "['9256945', 'Digby JW; Wehner S. A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis. Journal of international medical research. (1976) 4 6 pp427-431', '10.1177/030006057600400608', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057600400608']\n",
      "['9256946', 'Vergara-Castro JM; Arias LF; Greenberg BP. A comparative clinical trial of fenbufen and indomethacin in patients with rheumatoid arthritis. Journal of international medical research. (1976) 4 6 pp418-426', '10.1177/030006057600400607', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057600400607']\n",
      "['9256948', 'Rennie JA; MacLeod MM; Reynolds PN; El-Ghobarey AF. Comparison of sodium meclofenamate and indomethacin in rheumatoid arthritis. Current medical research and opinion. (1977) 4 8 pp580-583', '10.1185/03007997709115273', '']\n",
      "['9256950', 'De SM; Binder A; Hazleman BL. The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis. Annals of the rheumatic diseases. (1984) 43 6 pp790-793', '10.1136/ard.43.6.790', '']\n",
      "['9256951', 'Johannsen F; Hauschild B; Remvig L; Johnsen V; Petersen M and Bieler T. Low energy laser therapy in rheumatiod arthritis. Scandinavian Journal Rheumatology. (1994) 23 3 pp145-147', '10.3109/03009749409103048', '']\n",
      "['9256952', 'Chopra A; Saluja M; Kianifard T; Chitre D; Venugopalan A. Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis. Journal of Ayurveda and integrative medicine. (2018) 9 3 pp201-208', '10.1016/j.jaim.2017.07.009', '']\n",
      "['9256955', 'Alten R; Gromnica-Ihle E; Pohl C; Emmerich J; Steffgen J; Roscher R; Sigmund R; Schmolke B; Steinmann G. Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 2 pp170-176', '10.1136/ard.2002.004499', '']\n",
      "['9256957', 'Wauke K; Nagashima M; Kato N; Ogawa R; Yoshino S. Comparative study between thromboembolism and total knee arthroplasty with or without tourniquet in rheumatoid arthritis patients. Archives of orthopaedic and trauma surgery. (2002) 122 8 pp442-446', '10.1007/s00402-002-0404-9', 'http://link.springer.com/article/10.1007/s00402-002-0404-9/fulltext.html']\n",
      "['9256958', \"Tovar AR; G√≥mez E; Bourges H; Ort√≠z V; Kraus A; Torres N. Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sj√∂gren's syndrome. European journal of clinical nutrition. (2002) 56 11 pp1087-1093\", '10.1038/sj.ejcn.1601450', 'https://www.nature.com/articles/1601450']\n",
      "['9256959', 'Bobrove AM; Calin A. Efficacy and tolerance of a novel precision-dose formulation of indomethacin: Double-blind trials in rheumatoid arthritis and osteoarthritis. Current medical research and opinion. (1983) 8 SUPPL. 2 pp55-61', '10.1185/03007998309109824', '']\n",
      "['9256961', 'Ibrahim F; Lorente-C√°novas B; Dor√© CJ; Bosworth A; Ma MH; Galloway JB; Cope AP; Pande I; Walker D; Scott DL. Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?. Rheumatology (oxford, england). (2017) 56 11 pp2004-2014', '10.1093/rheumatology/kex315', 'http://academic.oup.com/rheumatology/article-pdf/56/11/2004/22316081/kex315.pdf']\n",
      "['9256962', 'Smyth CJ; Bartholomew BA; Mills DM; Steigerwald JC; Strong SJ; Recart S. Cyclophosphamide therapy for rheumatoid arthritis. Archives of internal medicine. (1975) 135 6 pp789-793', '10.1001/archinte.1975.00330060033004', '']\n",
      "['9256963', 'Prohaska E; Chlud K; Pfaller C. [On the treatment of chronic polyarthritis with cytostatic drugs. II. Oral application of Trenimon. Clinical and serological studies]. Zeitschrift fuÃàr Rheumaforschung. (1968) 27 1 pp39-47', '10.1017/s1120962300026354', '']\n",
      "['9256964', 'Zufferey PJ; Lanoisel√©e J; Chapelle C; Borisov DB; Bien JY; Lambert P; Philippot R; Molliex S; Delavenne X; investigators of the PeriOpeRative Tranexamic acid in hip arthrOplasty (PORTO) Study. Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty: a Randomized Controlled Trial. Anesthesiology. (2017) 127 3 pp413-422', '10.1097/aln.0000000000001787', 'http://pubs.asahq.org/anesthesiology/article-pdf/127/3/413/519776/20170900_0-00011.pdf']\n",
      "['9256967', 'Menkes CJ; G√¥ AL; Verrier P; Aignan M; Delbarre F. Double-blind study of erbium 169 injection (synoviorthesis) in rheumatoid digital joints. Annals of the rheumatic diseases. (1977) 36 3 pp254-256', '10.1136/ard.36.3.254', '']\n",
      "['9256969', 'Petrie J; Hazleman B. Credibility of placebo transcutaneous nerve stimulation and acupuncture. Clinical and experimental rheumatology. (1985) 3 2 pp151-153', '10.1093/med/9780199563678.003.0016', '']\n",
      "['9256970', 'Park W; Bozic-Majstorovic L; Milakovic D; Berrocal Kasay A; El-Khouri EC; Irazoque-Palazuelos F; Molina FFC; Shesternya P; Miranda P; Medina-Rodriguez FG; Wiland P; Jeka S; Chavez-Corrales J; Garmish O; Linde T; Rekalov D; Hrycaj P; Krause A; Fomina N; Piura O; Abello-Banfi M; Suh C; Shim SC; Lee SJ; Lee SY; Kim SH; Yoo DH. Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial. mAbs. (2018) 10 6 pp1-10', '10.1080/19420862.2018.1487912', '']\n",
      "['9256972', 'Elkayam O; Wigler I; Tishler M; Rosenblum I; Caspi D; Segal R; Fishel B; Yaron M. Effect of spa therapy in Tiberias on patients with rheumatoid arthritis and osteoarthritis. Journal of rheumatology. (1991) 18 12 pp1799-1803', '10.1002/art.1780310915', '']\n",
      "['9256973', 'Clarke DN; Mowat NA; Brunt PW; Bain LS. A comparison of a new slow release aspirin (\"slow aspirin\") with plain aspirin in the treatment of rheumatoid disease. Journal of international medical research. (1977) 5 4 pp270-275', '10.1177/030006057700500408', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700500408']\n",
      "['9256974', 'Andrade KM; Alfenas BF; Campos CH; Rodrigues Garcia RC. Mandibular movements in older people with rheumatoid arthritis. Oral surgery, oral medicine, oral pathology and oral radiology. (2017) 123 5 ppe153-e159', '10.1016/j.oooo.2017.01.014', '']\n",
      "['9256977', 'Rankin EC; Choy EH; Kassimos D; Kingsley GH; Sopwith AM; Isenberg DA; Panayi GS. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. British journal of rheumatology. (1995) 34 4 pp334-342', '10.1093/rheumatology/34.4.334', 'http://academic.oup.com/rheumatology/article-pdf/34/4/334/5020642/34-4-334.pdf']\n",
      "['9256978', 'van Gestel AM; Laan RF; Haagsma CJ; van de Putte LB; van Riel PL. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial. British journal of rheumatology. (1995) 34 4 pp347-351', '10.1093/rheumatology/34.4.347', 'http://academic.oup.com/rheumatology/article-pdf/34/4/347/5020850/34-4-347.pdf']\n",
      "['9256979', \"Calin A; Bennett RM; Sukhupunyaraksa S; Goldman AL; Montoya HE; O'Brien WM; Giuliano VJ; Schmid FR; Willkens RF; Sakofsky HY. Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. Journal of rheumatology. (1977) 4 2 pp153-157\", '10.1093/rheumatology/15.5.43', 'http://academic.oup.com/rheumatology/article-pdf/15/5/43/5038967/15-5-43.pdf']\n",
      "['9256980', 'Ortiz P; Bissada NF; Palomo L; Han YW; Al-Zahrani MS; Panneerselvam A; Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. Journal of periodontology. (2009) 80 4 pp535-540', '10.1902/jop.2009.080447', '']\n",
      "['9256981', 'Jick H; Pinals RS; Ullian R; Slone D; Muench H. Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (London, England). (1965) 2 7424 pp1203-1205', '10.1016/s0140-6736(65)90632-x', '']\n",
      "['9256982', 'Rejholec V. Long-term therapy of rheumatoid arthritis with Perclusone. Zeitschrift fur Rheumatologie. (1975) 34 5-6 pp141-148', '10.1007/s003930070025', 'http://link.springer.com/article/10.1007/s003930070025/fulltext.html']\n",
      "['9256983', 'Jiang Q; Tang XP; Chen XC; Xiao H; Liu P; Jiao J. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial. BMC complementary and alternative medicine. (2017) 17 1 pp444', '10.1186/s12906-017-1957-z', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1957-z.pdf']\n",
      "['9256984', 'Gordon GV; Polsky BG. Three-month trial of etodolac (Ultradol(Reg.trademark)) compared with aspirin and placebo in patients with rheumatoid arthritis. CURR THER RES, CLIN EXP. (1983) 33 1 pp89-99', '10.1016/0030-4220(83)90070-1', '']\n",
      "['9256985', \"Buondonno I; Rovera G; Sassi F; Rigoni MM; Lomater C; Parisi S; Pellerito R; Isaia GC; D'Amelio P. Vitamin D and immunomodulation in early rheumatoid arthritis: a randomized double-blind placebo-controlled study. Plos one. (2017) 12 6 ppe0178463\", '10.1371/journal.pone.0178463', '']\n",
      "['9256987', 'Freeman K; Hammond A; Lincoln NB. Use of cognitive-behavioural arthritis education programmes in newly diagnosed rheumatoid arthritis. Clinical rehabilitation. (2002) 16 8 pp828-836', '10.1191/0269215502cr565oa', 'https://journals.sagepub.com/doi/pdf/10.1191/0269215502cr565oa']\n",
      "['9256988', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; L√∏ppenthin K; Midtgaard J; Christensen R; √òstergaard M; Jennum PJ; Esbensen BA. The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. Annals of the rheumatic diseases. (2017) 76 9 pp1603-1606', '10.1136/annrheumdis-2016-210953', '']\n",
      "['9256989', 'Karras D; Stoykov I; Lems WF; Langdahl BL; Ljunggren O; Barrett A; Walsh JB; Fahrleitner-Pammer A; Rajzbaum G; Jakob F; Marin F. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-Year results from the EFOS study. Journal of rheumatology. (2012) 39  3 pp600-609', '10.3899/jrheum.110947', '']\n",
      "['9256990', 'Ichikawa Y; Nakajima M; Azuma T. [Late phase II clinical study of M-5011C on rheumatoid arthritis--a multi-institutional double-blind, three group comparative, dose finding study]. RyuÃÑmachi. [Rheumatism]. (1997) 37 6 pp851-866', '10.1002/art.1780200804', '']\n",
      "['9256991', 'Wantanakorn P; Harintajinda S; Chuthapisith J; Anurathapan U; Rattanatamrong P. A new mobile application to reduce anxiety in pediatric patients before bone marrow aspiration procedures. Hospital pediatrics. (2018) 8 10 pp643-650', '10.1542/hpeds.2018-0073', 'https://publications.aap.org/hospitalpediatrics/article-pdf/8/10/643/814898/hpeds_2018-0073.pdf']\n",
      "['9256993', \"O'Connor C; Haithem M; Browne P; Silke C; Whelan B. Hydrotherapy in the management of chronic pain. Irish journal of medical science. (2013) 182  ppS178\", '10.5040/9798400694868.ch-015', '']\n",
      "['9256994', 'Marwah RJ; Pickup ME; Al-Shakarchi H; Dixon JS; Lowe JR; Bird HA; Wright V. A pharmacological and clinical comparison of prednisolone and betamethasone in rheumatoid arthritis. European journal of clinical pharmacology. (1982) 23 4 pp321-325', '10.1007/bf00613613', 'http://link.springer.com/article/10.1007/BF00613613/fulltext.html']\n",
      "['9256995', 'G√ºler-Y√ºksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Hulsmans HM; de Beus WM; Han KH; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Annals of the rheumatic diseases. (2008) 67 6 pp823-828', '10.1136/ard.2007.073817', '']\n",
      "['9256997', 'Albrektsson BE; Carlsson LV; Freeman MA; Herberts P; Ryd L. Proximally cemented versus uncemented Freeman-Samuelson knee arthroplasty. A prospective randomised study. Journal of bone and joint surgery. British volume. (1992) 74 2 pp233-238', '10.1302/0301-620x.74b2.1544959', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.74B2.1544959']\n",
      "['9256999', 'Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. New England journal of medicine. (1995) 333 3 pp142-146', '10.1093/rheumatology/37.9.930', 'http://academic.oup.com/rheumatology/article-pdf/37/9/930/18106401/370930.pdf']\n",
      "['9257000', 'Cardoe N; Steele CE. A double-blind crossover comparison of tolmetin sodium and phenylbutazone in the treatment of rheumatoid arthritis. Current medical research and opinion. (1976) 4 10 pp688-694', '10.1185/03007997609112003', '']\n",
      "['9257001', 'Smolen JS; Cohen SB; Tony HP; Scheinberg M; Kivitz A; Balanescu A; Gomez-Reino J; Cen L; Zhu P; Shisha T. A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 9 pp1598-1602', '10.1136/annrheumdis-2017-211281', '']\n",
      "['9257003', 'Malchow-M√∏ller A. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs. Scandinavian journal of gastroenterology. Supplement. (1987) 127 127 pp87-91', '10.3109/00365528709090957', '']\n",
      "['9257004', 'Bombardier C; Peloso PM; Goldsmith CH. Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group. Journal of rheumatology. (1995) 22 4 pp617-624', '10.1016/0149-2918(95)80061-1', '']\n",
      "['9257005', 'Nesher G; Sonnenblick M; Dwolatzky T. Protective effect of misoprostol on indomethacin induced renal dysfunction in elderly patients. Journal of rheumatology. (1995) 22 4 pp713-716', '10.2165/00128415-199505610-00005', '']\n",
      "['9257006', 'Gall EP; Caperton EM; McComb JE; et al. Clinical comparison of ibuprofen, fenoprofen calcium, naproxen and tolmetin sodium in rheumatoid arthritis. Journal of rheumatology. (1982) 9 3 pp402-407', '10.1001/jama.1977.03270390076033', '']\n",
      "['9257007', 'Leslie RD. Mefenamic acid compared with ibuprofen in the treatment of rheumatoid arthritis. Journal of international medical research. (1977) 5 3 pp161-163', '10.1177/030006057700500303', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700500303']\n",
      "['9257012', 'Migliore A; Massafra U; Bizzi E; Argento G; Diamanti AP; Germano V; Tormenta S; Arduini F; Iannessi F; Granatas M; Lagan√† B. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study. European review for medical and pharmacological sciences. (2012) 16 3 pp363-369', '10.1016/j.ultrasmedbio.2012.04.006', '']\n",
      "['9257013', 'Pihlajamaki KK; Lindberg RLP. Bupivacaine with and without adrenaline in interscalene brachial plexus blockade. Studies in patients with rheumatoid arthritis. British journal of anaesthesia. (1987) 59 11 pp1420-1424', '10.1093/bja/59.11.1420', 'http://academic.oup.com/bja/article-pdf/59/11/1420/810500/59-11-1420.pdf']\n",
      "['9257014', 'Solomon L; Abrams G. Bumadizone calcium in the treatment of rheumatoid arthritis. South African medical journal. (1977) 52 10 pp391-393', '10.1080/20786204.2009.10873866', '']\n",
      "['9257015', \"Khurshudian AV. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sj√∂gren's syndrome. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. (2003) 95 1 pp38-44\", '10.1067/moe.2003.30', '']\n",
      "['9257016', 'Bremov√° A; Pƒïgr√≠mov√° E; Rejholec V; Susta A; Truhl√°r P; Vykydal M. Double blind, multicenter study of diftalone and indomethacin in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1977) 17  pp1-9', '10.3109/03009747709095461', '']\n",
      "['9257017', 'Bettinson KA; Pinder IM; Moran CG; Weir DJ; Lingard EA. All-polyethylene compared with metal-backed tibial components in total knee arthroplasty at ten years. A prospective, randomized controlled trial. Journal of bone and joint surgery. American volume. (2009) 91 7 pp1587-1594', '10.2106/jbjs.g.01427', '']\n",
      "['9257019', 'Paulshus Sundlisaeter N; Aga A-B; Olsen IC; Hammer HB; Uhlig T; Van Der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Annals of the rheumatic diseases. (2018) (no pagination)  pp', '10.1136/annrheumdis-2017-212830', '']\n",
      "['9257020', 'Klemp P; Meyers OL. Clinical trial of tolmetin and aspirin in the treatment of rheumatoid arthritis. South African medical journal. (1977) 52 5 pp167-169', '10.1185/03007997609112004', '']\n",
      "['9257021', 'Sifuentes-Cant√∫ C; Contreras-Y√°√±ez I; Saldarriaga L; Lozada AC; Guti√©rrez M; Pascual-Ramos V. The added value of musculoskeletal ultrasound to clinical evaluation in the treatment decision of rheumatoid arthritis outpatients: physician experience matters. BMC musculoskeletal disorders. (2017) 18 1 pp390', '10.1186/s12891-017-1747-2', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1747-2.pdf']\n",
      "['9257023', 'Jonderko G; Gabryel A; Galaszek Z; et al. Comparative crossover double blind study with profenid and indomethacin in patients with rheumatoid arthritis.  VERGLEICHENDE CROSSOVER-DOPPELBLINDSTUDIE MIT PROFENID UND INDOMETAZIN BEI PATIENTEN MIT RHEUMATOID-ARTHRITIS. Z GESAMTE INN MED IHRE GRENZGEB. (1982) 37 8 pp242-245', '10.1080/03009742.1979.12088616', '']\n",
      "['9257024', 'Cardoe N; Hart FD. Double-blind multicentre UK hospital studies of isoxicam vs naproxen. British journal of clinical pharmacology. (1986) 22 Suppl 2 22 Suppl 2 pp167S-172S', '10.1111/j.1365-2125.1986.tb03000.x', '']\n",
      "['9257025', 'Williams MA; Heine PJ; McConkey C; Lord J; Dosanjh S; Williamson E; Adams J; Underwood M; Lamb SE; Team ST. Sarah: Strengthening and stretching for people with rheumatoid arthritis of the hands: A randomized controlled trial. Rheumatology (United Kingdom). (2013) 52  ppi31-i32', '10.1136/annrheumdis-2013-eular.303', '']\n",
      "['9257027', 'Doi T; Akai M; Fujino K; Hoshino Y; Iwaya T; Sunami Y. Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2010) 20 1 pp24-33', '10.3109/s10165-009-0227-4', '']\n",
      "['9257028', 'Fasulo SM; Testa EJ; Lawler SM; Fitzgerald M; Lowe JT; Jawa A. A Preoperative Educational Video Improves Patient Satisfaction and Perceived Knowledge, but Not Patient Understanding for Total Shoulder Arthroplasty: a Randomized, Surgeon-Blinded Study. Journal of shoulder and elbow arthroplasty. (2018) 2 no pagination pp', '10.1177/2471549218792966', 'https://journals.sagepub.com/doi/pdf/10.1177/2471549218792966']\n",
      "['9257029', 'Pirouzpanah S; Mahboob S; Sanayei M; Hajaliloo M; Safaeiyan A. The effect ofchamomile tea consumption on inflammation among rheumatoid arthritis patients: randomized clinical trial. Progress in nutrition. (2017) 19 Supplement 1 pp27-33', '10.1016/j.nut.2019.110656', '']\n",
      "['9257030', 'Fricton J; Rindal DB; Rush W; Flottemesch T; Vazquez G; Thoele MJ; Durand E; Enstad C; Rhodus N. The effect of electronic health records on the use of clinical care guidelines for patients with medically complex conditions. Journal of the American Dental Association (1939). (2011) 142 10 pp1133-1142', '10.14219/jada.archive.2011.0082', '']\n",
      "['9257031', 'Levinson JE; Baum J; Brewer E; Fink C; Hanson V; Schaller J. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. Journal of pediatrics. (1977) 91 5 pp799-804', '10.1016/s0022-3476(77)81045-7', '']\n",
      "['9257032', \"Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. New England journal of medicine. (1992) 326 16 pp1043-1049\", '10.1056/nejm199204163261602', '']\n",
      "['9257033', 'Alleva JM; Diedrichs PC; Halliwell E; Peters ML; Dures E; Stuijfzand BG; Rumsey N. More than my RA: a randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program. Journal of consulting and clinical psychology. (2018) 86 8 pp666-676', '10.1037/ccp0000317', 'http://psycnet.apa.org/journals/ccp/86/8/666.pdf']\n",
      "['9257034', 'Waters TS; Bentley G. Patellar resurfacing in total knee arthroplasty. A prospective, randomized study. Journal of bone and joint surgery. American volume. (2003) 85-A 2 pp212-217', '10.2106/00004623-200302000-00005', '']\n",
      "['9257035', 'Kremer JM; Rigby W; Singer NG; Birchwood C; Gill D; Reiss W; Pei J; Michalska M. Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: results From a Randomized, Controlled Trial. Arthritis and rheumatology. (2018) 70 8 pp1200-1208', '10.1002/art.40493', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40493']\n",
      "['9257036', 'Harigai M; Tsuchiya T; Kawana K; Kurimoto S. Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients. Modern rheumatology. (2017)   pp1-9', '10.1080/14397595.2017.1304159', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1304159']\n",
      "['9257038', 'Lu SJ; Shao J; Li XR. Clinical observation on treatment of rheumatoid arthritis by combined therapy with methotrexate, sulfasalazine and chinese herbal medicine. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2002) 22 8 pp571-573', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9257039', 'Wu YJ; Lao ZY; Zhang ZL. Clinical observation on small doses tripterygium wilfordii polyglycoside combined with methotrexate in treating rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2001) 21 12 pp895-896', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9257040', 'Amor B; Dougados M. Cyclosporin A in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1991) 11 1 pp162-171', '10.1002/art.1780311022', '']\n",
      "['9257041', 'Giannini EH; Brewer EJ. Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis. Clinical rheumatology. (1987) 6 2 pp197-201', '10.1007/bf02201024', 'http://link.springer.com/article/10.1007/BF02201024/fulltext.html']\n",
      "['9257042', 'Garc√≠a-Morteo O; Maldonado-Cocco JA; Cuttica R; Garay SM. Piroxicam in juvenile rheumatoid arthritis. European journal of rheumatology and inflammation. (1987) 8 1 pp49-53', '10.1007/bf02030759', 'http://link.springer.com/article/10.1007/BF02030759/fulltext.html']\n",
      "['9257044', 'Tindall EA; Sharp JT; Burr A; Katz TK; Wallemark CB; Verburg K; Lefkowith JB. A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib. Clinical therapeutics. (2002) 24 12 pp2051-2063', '10.1016/s0149-2918(02)80096-0', '']\n",
      "['9257046', 'Sk√∂ldstam L; Hagfors L; Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2003) 62 3 pp208-214', '10.1136/ard.62.3.208', '']\n",
      "['9257047', 'Chingale AA; Wali DS. Effect of Dhatri Bhallataka Vati in amavata with special reference to rheumatoid arthritis. International Journal of Research in Ayurveda and Pharmacy. (2016) 7  1 pp49-52', '10.7897/2277-4343.07110', '']\n",
      "['9257048', 'Issa SF; Christensen AF; Lindegaard HM; Hetland ML; Horslev-Petersen K; Stengaard-Pedersen K; Ejbjerg BJ; Lottenburger T; Ellingsen T; Pedersen JK; Junker K; Svendsen A; Tarp U; Ostergaard M; Junker P. Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity. Scandinavian journal of immunology. (2017) 86 6 pp471-478', '10.1111/sji.12619', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fsji.12619']\n",
      "['9257051', 'Edwards W. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: A 12-week study. Clinical therapeutics. (1983) 5 5 pp495-503', '10.1016/j.clinthera.2007.06.016', '']\n",
      "['9257054', 'Hazleman BL; Bulgen DY. A comparative study of the long-term efficacy of flurbiprofen and indomethacin in the treatment of rheumatoid arthritis, with special reference to iron metabolism. Current medical research and opinion. (1977) 5 1 pp58-63', '10.1185/03007997709108978', '']\n",
      "['9257055', 'Siegmeth W. A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis. Current medical research and opinion. (1977) 5 1 pp64-73', '10.1185/03007997709108979', '']\n",
      "['9257056', 'Brewis ID. A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis. Current medical research and opinion. (1977) 5 1 pp48-52', '10.1185/03007997709108976', '']\n",
      "['9257057', 'Brooks PM; Khong TK. Flurbiprofen-aspirin interaction: a double-blind crossover study. Current medical research and opinion. (1977) 5 1 pp53-57', '10.1185/03007997709108977', '']\n",
      "['9257058', 'Joshi VR; Lele RD; Virani AR; Nagarwala HK; Pispati PK; Desai MM. Steroid-sparing action of flurbiprofen: use of an additional parameter of joint scans with 99m technetium. Current medical research and opinion. (1977) 5 1 pp43-47', '10.1185/03007997709108975', '']\n",
      "['9257059', 'Nordstr√∂m DC; Honkanen VE; Nasu Y; Antila E; Friman C; Konttinen YT. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatology international. (1995) 14 6 pp231-234', '10.1007/bf00262088', 'http://link.springer.com/article/10.1007/BF00262088/fulltext.html']\n",
      "['9257060', 'Parada L; Marstein JP; Danilov A. Tolerability of the COX-1/COX-2 inhibitor lornoxicam in the treatment of acute and rheumatic pain. Pain management. (2016) 6 5 pp445-454', '10.2217/pmt.16.7', '']\n",
      "['9257061', 'Barabino S; Rolando M; Camicione P; Ravera G; Zanardi S; Giuffrida S; Calabria G. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. (2003) 22 2 pp97-101', '10.1097/00003226-200303000-00002', '']\n",
      "['9257062', 'Cardoe N. A double-blind crossover study to compare the efficacy of three dosage levels of flurbiprofen in the treatment of rheumatoid disease and osteoarthrosis. Current medical research and opinion. (1977) 5 1 pp99-105', '10.1185/03007997709108985', '']\n",
      "['9257063', 'Huskisson EC; Scott PJ; Boyle S; Patrick M. Flurbiprofen at night. Current medical research and opinion. (1977) 5 1 pp85-87', '10.1185/03007997709108982', '']\n",
      "['9257064', 'Pipitone V; Numo R; Loizzi P. Flurbiprofen in rheumatoid arthritis therapy. Current medical research and opinion. (1977) 5 1 pp88-90', '10.1185/03007997709108983', '']\n",
      "['9257065', 'Franco PA; Ferri S; Di Mummo O. Controlled clinical trial comparing flurbiprofen and phenylbutazone in patients with rheumatoid arthritis. Current medical research and opinion. (1977) 5 1 pp74-76', '10.1185/03007997709108980', '']\n",
      "['9257066', 'Kruger HH. Flurbiprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind crossover study. Current medical research and opinion. (1977) 5 1 pp77-84', '10.1185/03007997709108981', '']\n",
      "['9257067', 'Schuster F; Beier A; Eberl R; Tausch G. [Preliminary report on experience with immunosuppressive therapy in progressive chronic (rheumatoid) polyarthritis and collagen diseases]. Zeitschrift fuÃàr Rheumaforschung. (1969) 28 1 pp12-20', '10.1136/ard.28.5.488', '']\n",
      "['9257068', 'Silva PG; Lombardi I; Breitschwerdt C; Poli Ara√∫jo PM; Natour J. Functional thumb orthosis for type I and II boutonniere deformity on the dominant hand in patients with rheumatoid arthritis: a randomized controlled study. Clinical rehabilitation. (2008) 22 8 pp684-689', '10.1177/0269215508088989', 'https://journals.sagepub.com/doi/pdf/10.1177/0269215508088989']\n",
      "['9257069', 'Chlud K; Kaik B. Clinical studies of the interaction between tolmetin and glibenclamide. International journal of clinical pharmacology and biopharmacy. (1977) 15 9 pp409-410', '10.1007/bf03284536', 'http://link.springer.com/article/10.1007/BF03284536/fulltext.html']\n",
      "['9257070', 'Million R. Butacote and naproxen: a comparison of effectiveness in rheumatoid arthritis. Journal of international medical research. (1977) 5 Suppl 2 5 Suppl 2 pp77-80', '10.1177/030006057700502s15', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700502S15']\n",
      "['9257071', 'Regalado RG. Butacote and ibuprofen: a comparative assessment in rheumatic diseases in general practice. Journal of international medical research. (1977) 5 Suppl 2 5 Suppl 2 pp70-76', '10.1177/030006057700502s14', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700502S14']\n",
      "['9257072', 'Orme ML. Phenylbutazone: plasma concentrations and effectiveness in patients with rheumatoid arthritis. Journal of international medical research. (1977) 5 Suppl 2 5 Suppl 2 pp40-47', '10.1177/030006057700502s09', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700502S09']\n",
      "['9257074', 'Ansell BM; Hall MA; Moran H; Fowler PD. Juvenile chronic polyarthritis: clinical sub-groups and response to medication. Journal of international medical research. (1977) 5 Suppl 2  pp52-58', '10.1177/030006057700502s11', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700502S11']\n",
      "['9257075', 'Kurowski M; Thabe H. The transsynovial distribution of oxaprozin. Agents and actions. (1989) 27 3-4 pp458-460', '10.1007/bf01972852', 'http://link.springer.com/article/10.1007/BF01972852/fulltext.html']\n",
      "['9257077', 'Zhang F; Gao Z; Yu J. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2007) 21 12 pp1302-1304', '10.2106/jbjs.m.01086', '']\n",
      "['9257078', 'Kraaimaat FW; Brons MR; Geenen R; Bijlsma JW. The effect of cognitive behavior therapy in patients with rheumatoid arthritis. Behaviour research and therapy. (1995) 33 5 pp487-495', '10.1016/0005-7967(94)00094-z', '']\n",
      "['9257079', 'Iversen L; Eidsmo L; Austad J; de Rie M; Osmancevic A; Skov L; Talme T; Bachmann I; van de Kerkhof P; Stahle M; Banerjee R; Oliver J; Fasth AER; Frueh J. Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study. Journal of the European Academy of Dermatology and Venereology : JEADV. (2018) (no pagination) 11 pp1930-1939', '10.1111/jdv.14979', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjdv.14979']\n",
      "['9257080', 'Kremer J; Ritchlin C; Mendelsohn A; Baker D; Kim L; Xu Z; Han J; Taylor P. Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. Arthritis and rheumatism. (2010) 62 4 pp917-928', '10.1002/art.27348', '']\n",
      "['9257081', 'Gao SM; Xu JH; Ding CH; Xu SY. A randomized controlled clinical trial of actarit in the treatment of rheumatoid arthritis. Chinese Pharmaceutical Journal. (2002) 37 12 pp951-953', '10.1186/1745-6215-12-137', 'http://link.springer.com/article/10.1186/1745-6215-12-137/fulltext.html']\n",
      "['9257083', 'Ferwerda M; van Beugen S; van Middendorp H; Visser H; Vonkeman H; Creemers M; van Riel P; Kievit W; Evers A. Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: economic Evaluation of a Randomized Controlled Trial. Journal of medical Internet research. (2018) 20 10 ppe260', '10.2196/jmir.9997', '']\n",
      "['9257085', 'Peretz A; Cantinieaux B; N√®ve J; Siderova V; Fondu P. Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases. Journal of trace elements and electrolytes in health and disease. (1994) 8 3-4 pp189-194', '10.1007/0-306-47466-2_310', '']\n",
      "['9257086', 'Runge LA; Pinals RS; Lourie SH; Tomar RH. Treatment of rheumatoid arthritis with levamisole. A controlled trial. Arthritis and rheumatism. (1977) 20 8 pp1445-1448', '10.1002/art.1780200801', '']\n",
      "['9257087', 'Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis and rheumatism. (1977) 20 8 pp1464-1472', '10.1002/art.1780200804', '']\n",
      "['9257090', \"Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H. Effectiveness of rituximab treatment in primary Sj√∂gren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2010) 62 4 pp960-968\", '10.1002/art.27314', '']\n",
      "['9257091', 'Nair R; Saag KG. The use of low-dose glucocorticoids for the treatment of early rheumatoid arthritis: What can we learn about bone effects of glucocorticoids from randomized controlled trials?. Current rheumatology reports. (2006) 8  1 pp47-48', '10.1007/s11926-006-0024-4', 'http://link.springer.com/article/10.1007/s11926-006-0024-4/fulltext.html']\n",
      "['9257092', 'Furst DE; Levine S; Srinivasan R; Metzger AL; Bangert R; Paulus HE. A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. Arthritis and rheumatism. (1977) 20 8 pp1473-1480', '10.1002/art.1780200805', '']\n",
      "['9257093', 'van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Martin Mola E; Pedersen R; Robertson D; Chang D; Koenig A; Freundlich B; Etanercept Study Investigators. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. Annals of the rheumatic diseases. (2009) 68 7 pp1113-1118', '10.1136/ard.2008.094375', '']\n",
      "['9257095', 'Lopes RV; Furtado RN; Parmigiani L; Rosenfeld A; Fernandes AR; Natour J. Accuracy of intra-articular injections in peripheral joints performed blindly in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2008) 47 12 pp1792-1794', '10.1093/rheumatology/ken355', 'http://academic.oup.com/rheumatology/article-pdf/47/12/1792/5048119/ken355.pdf']\n",
      "['9257096', 'Pinho Mde N; Oliveira RD; Novaes AB; Voltarelli JC. Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Brazilian dental journal. (2009) 20 5 pp355-364', '10.1590/s0103-64402009000500001', 'http://www.scielo.br/pdf/bdj/v20n5/v20n5a01.pdf']\n",
      "['9257097', 'Janoudi N; Omran N; Huseein W; Alosaimi H; Baamer M; Irfanullahsiddiqui M; Fathaddien O; Almoallim H. Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia. International journal of rheumatic diseases. Conference: 19th asia pacific league of associations for rheumatology congress, APLAR 2017.. (2017) 20 Supplement 1 pp32', '10.2147/oarrr.s142411', 'https://www.dovepress.com/getfile.php?fileID=38919']\n",
      "['9257099', 'Hunter JA; Capell HA; Pullar T; Madhok R. General practitioner assistance with gold and penicillamine therapy of rheumatoid arthritis--a four year prospective study. Scottish medical journal. (1987) 32 3 pp74-76', '10.1177/003693308703200305', 'https://journals.sagepub.com/doi/pdf/10.1177/003693308703200305']\n",
      "['9257100', 'Bliddal H; Hellesen C; Ditlevsen P; Asselberghs J; Lyager L. Soft-laser therapy of rheumatoid arthritis. Scandinavian journal of rheumatology. (1987) 16 4 pp225-228', '10.3109/03009748709102921', '']\n",
      "['9257101', 'Winthrop K; Lindsey S; Weinblatt M; Takeuchi T; Hyslop D; Issa M; Chen L; Dickson C; Bradley J; Fleischmann R. Herpes zoster in patients with moderate to severe rheumatoid arthritis treated with baricitinib. International journal of rheumatic diseases. Conference: 19th asia pacific league of associations for rheumatology congress, APLAR 2017.. (2017) 20 Supplement 1 pp57', '10.1136/annrheumdis-2017-eular.1312', '']\n",
      "['9257103', \"Planten O. 'Piroxicam mane versus piroxicam nocte. A double-blind comparison of the effect of one dose piroxicam in the morning with that of one dose piroxicam in the evening in patients with rheumatoid arthritis. TIJDSCHR GENEESMIDDELENONDERZ. (1984) 9 2 pp72-75\", '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9257104', 'Hutting N; Richardson J; Johnston V. The role of self-management in the treatment of musculoskeletal disorders. Manual therapy. Conference: IFOMPT 2016 conference. United kingdom. Conference start: 20160704. Conference end: 20160708. (2016) 25  ppe15-e17', '10.1016/j.math.2016.05.013', '']\n",
      "['9257105', 'Ohrndorf S. No benefit from an ultrasound tight control strategy in patients with early rheumatoid arthritis. Deutsche medizinische wochenschrift (1946). (2016) 141 23 pp1674', '10.1055/s-0042-119247', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-119247.pdf']\n",
      "['9257107', 'Sparks JA; Barbhaiya M; Karlson EW; Ritter SY; Raychaudhuri S; Corrigan CC; Lu F; Selhub J; Chasman DI; Paynter NP; Ridker PM; Solomon DH. Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study. Seminars in arthritis and rheumatism. (2017) 47 1 pp133-142', '10.1016/j.semarthrit.2017.02.003', '']\n",
      "['9257108', \"Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot J-M; Chiche L; Hachulla E; Hatron P-Y; Goeb V; Vittecoq O; Saraux A; Pers J-O. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjogren's syndrome. Journal of autoimmunity. (2016) 67  pp102-110\", '10.1016/j.jaut.2015.11.002', '']\n",
      "['9257109', 'Tam LP; Shang Q; Li EK; Wong PC; Kwok KY; Kun EW; Yim IC; Lee VK; Yip RM; Pang SH; Lao VW; Mak Q; Cheng I; Lau X; Li TK; Zhu TY; Lee AP; Tam L-S. Can achieving sustained DAS remission prevent arterial stiffness progression in early rheumatoid arthritis-a post-hoc analysis of a randomized controlled study. International journal of rheumatic diseases. Conference: 19th asia pacific league of associations for rheumatology congress, APLAR 2017.. (2017) 20 Supplement 1 pp130', '10.1136/annrheumdis-2017-eular.3367', '']\n",
      "['9257110', 'Kim BY; Hong S-J; Kim H-S; Seo YI; Sheen D; Son KM; Moon KW; Kim SS. Efficacy and safety of mizoribine in active rheumatoid arthritis patients unsuccessfuLly treated with DMARDs: open label, multicenter, randomized study. International journal of rheumatic diseases. Conference: 19th asia pacific league of associations for rheumatology congress, APLAR 2017.. (2017) 20 Supplement 1 pp120', '10.1136/annrheumdis-2018-eular.5094', '']\n",
      "['9257111', 'Nissil√§ M; Isom√§ki H; Koota K; Larsen A; Raunio K. Osmic acid in rheumatoid synovitis. A controlled study. Scandinavian journal of rheumatology. (1977) 6 3 pp158-160', '10.3109/03009747709095442', '']\n",
      "['9257112', \"Kaarela K; Mutru O. Xerostomia in Sjogren's syndrome treated with Sali-Synt(Reg.trademark). A double-blind cross-over trial. Scandinavian journal of rheumatology. (1982) 11 1 pp39-40\", '10.3109/03009748209098112', '']\n",
      "['9257113', 'Garza Elizondo MA; Mondragon VM. Flurbiprofen vs Diclofenac in rheumatic diseases of the musculo-skeletal system. [Spanish]. Investigacion medica internacional. (1990) 17 1 pp16-22', '10.1007/978-3-031-47379-1_1', '']\n",
      "['9257114', 'Trudeau K; Wall R; Pujol L; DasMahapatra P; Pavek M; Wing Venuti S; Zacharoff K. A randomized controlled trial of an online pain self-management program for people with arthritis pain. Journal of pain. (2013) 14  4 SUPPL. 1 ppS87', '10.1016/j.jpain.2013.01.687', '']\n",
      "['9257115', 'Kivitz A; Baret-Cormel L; van Hoogstraten H; Wang S; Parrino J; Xu C; Stanislav M. Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and therapy. (2018) 5 1 pp231-242', '10.1007/s40744-017-0090-2', 'http://link.springer.com/content/pdf/10.1007/s40744-017-0090-2.pdf']\n",
      "['9257119', 'Nicolis FB; Schiavetti L; Porzio F; Manzini A; Marchetti M; Acocella G. Therapeutic activity of diftalone in rheumatoid arthritis: a short-term controlled evaluation. International journal of clinical pharmacology, therapy and toxicology. (1974) 10 4 pp239-254', '10.1016/b978-0-08-021308-8.50624-4', '']\n",
      "['9257120', 'Proudman SM; James MJ; Spargo LD; Metcalf RG; Sullivan TR; Rischmueller M; Flabouris K; Wechalekar MD; Lee AT; Cleland LG. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the rheumatic diseases. (2015) 74 1 pp89-95', '10.1136/annrheumdis-2013-204145', '']\n",
      "['9257121', 'Stinson J; Ahola Kohut S; Forgeron P; Amaria K; Bell M; Kaufman M; Luca N; Luca S; Harris L; Victor C; Spiegel L. The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis. Pediatric rheumatology online journal. (2016) 14 1 pp48', '10.1186/s12969-016-0108-2', '']\n",
      "['9257122', 'Vibeke S; Genovese M; Mallya UG; Richards H; Mpofu S. Health-related quality of life (HRQOL) improvement with secukinumab in patients with rheumatoid arthritis: Results from a dosefinding study. Dermatology and Therapy. (2012) 2  ppS54', '10.1136/annrheumdis-2012-eular.582', '']\n",
      "['9257123', 'Gnanasakthy A; Kosinski M; Genovese M; Mallya UG; Mpofu S. Association between reduction in disease activity, pain severity and health-related quality of life (HRQoL) among rheumatoid arthritis (RA) patients treated with secukinumab. Dermatology and Therapy. (2012) 2  ppS43-S44', '10.1136/annrheumdis-2012-eular.507', '']\n",
      "['9257124', 'Stamuli E; Torgerson D; Northgraves M; Ronaldson S; Cherry L. Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment. Value in health. Conference: ISPOR 20th annual european congress. United kingdom. (2017) 20 9 ppA537', '10.1016/j.jval.2017.08.785', '']\n",
      "['9257126', \"Balint G; el-Ghobary A; Capell H; Madkour M; Dick WC; Ferguson MM; Anwar-ul-haq M. Sj√∂gren's syndrome: a contraindication to levamisole treatment?. British medical journal. (1977) 2 6099 pp1386-1387\", '10.1136/bmj.2.6099.1386', '']\n",
      "['9257128', \"Akdemir G; Markusse IM; Goekoop-Ruiterman YP; Steup-Beekman GM; Grillet BA; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF. Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission. Clinical rheumatology. (2017) 36 2 pp317-326\", '10.1007/s10067-016-3405-8', 'http://link.springer.com/article/10.1007/s10067-016-3405-8/fulltext.html']\n",
      "['9257129', 'Price GE; Ford DK. Therapeutic trial of a pyrazole derivative, KB-95, for patients with rheumatoid arthritis. Canadian Medical Association journal. (1963) 88  pp989-991', '10.1001/jama.1963.03700240111072', '']\n",
      "['9257130', 'Batticciotto A; Ravasio R; Riva M; Sarzi-Puttini P. Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate. Advances in therapy. (2016) 33 8 pp1360-1373', '10.1007/s12325-016-0372-z', '']\n",
      "['9257132', 'Nenonen MT; Helve TA; Rauma AL; H√§nninen OO. Uncooked, lactobacilli-rich, vegan food and rheumatoid arthritis. British journal of rheumatology. (1998) 37 3 pp274-281', '10.1093/rheumatology/37.3.274', 'http://academic.oup.com/rheumatology/article-pdf/37/3/274/18106061/370274.pdf']\n",
      "['9257133', \"Niedermann K; Buchi S; Ciurea A; Kubli R; Steurer-Stey C; Villiger PM; De Bie RA. Six and 12 months' effects of individual joint protection education in people with rheumatoid arthritis: a randomized controlled trial. Scandinavian journal of occupational therapy. (2012) 19 4 pp360-369\", '10.3109/11038128.2011.611820', '']\n",
      "['9257134', 'Hofschneider PH; Winter U; Lemmel E-M; Brolz B; Gaus W; Schmid S; et al. Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. Rheumatology international. (1992) 12 5 pp175-185', '10.1007/bf00302149', 'http://link.springer.com/article/10.1007/BF00302149/fulltext.html']\n",
      "['9257135', 'Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients. Journal of rheumatology. (1993) 20 2 pp263-267', '10.1093/rheumatology/34.5.421', 'http://academic.oup.com/rheumatology/article-pdf/34/5/421/5030490/34-5-421.pdf']\n",
      "['9257136', 'G√ºler-Y√ºksel M; Allaart CF; Watt I; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Schaardenburg D; van Krugten MV; Dijkmans BA; Huizinga TW; Lems WF; Kloppenburg M. Treatment with TNF-Œ± inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. Osteoarthritis and cartilage. (2010) 18 10 pp1256-1262', '10.1016/j.joca.2010.07.011', '']\n",
      "['9257137', 'Wang J; Zou X; Cong L; Liu H. Clinical effectiveness and cost-effectiveness of nurse-led care in Chinese patients with rheumatoid arthritis: a randomized trial comparing with rheumatologist-led care. International journal of nursing practice. (2018) 24 1) (no pagination pp', '10.1111/ijn.12605', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijn.12605']\n",
      "['9257139', 'Haavardsholm EA; Aga AB; Olsen IC; Lillegraven S; Hammer HB; Uhlig T; Fremstad H; Madland TM; Lexberg √ÖS; Haukeland H; R√∏devand E; H√∏ili C; Stray H; Noraas A; Hansen IJ; Bakland G; Nordberg LB; van der Heijde D; Kvien TK. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ (clinical research ed.). (2016) 354  ppi4205', '10.1136/bmj.i4205', '']\n",
      "['9257140', 'Dale J; Purves D; McConnachie A; Porter D; McInnes IB. Tightening up: Musculoskeletal ultrasound could further individualise treatment decisions in early rheumatoid arthritis patients treated by a step-up DMARD escalation regimen. Arthritis and rheumatism. (2012) 64  ppS1129', '10.1002/acr.22218', '']\n",
      "['9257141', 'Sajjan Shenoy N; Rahman M; Aggarwal A; Misra R. Therapy in enthesitis related arthritis Category of JIA: Methotrexate or NSAIDs. Indian Journal of Rheumatology. (2012) 7  ppS48', '10.1016/s0973-3698(10)60487-6', '']\n",
      "['9257142', \"Zhou Y; Jin L; Kong F; Zhang H; Fang X; Chen Z; Wang G; Li X; Li X. Clinical and immunological consequences of total glucosides of paeony treatment in Sj√∂gren's syndrome: a randomized controlled pilot trial. International immunopharmacology. (2016) 39  pp314-319\", '10.1016/j.intimp.2016.08.006', '']\n",
      "['9257143', 'Pope J; Carter Thorne J; Haraoui BP; Psaradellis E; Sampalis J. Do patients with active RA have differences in disease activity and perceptions if anti-TNF naive versus anti-TNF experienced? baseline results of the optimization of adalimumab trial. Medical science monitor. (2012) 18  8 ppPI17-PI20', '10.12659/msm.883250', '']\n",
      "['9257144', 'Silverstein FE; Graham DY; Senior JR; Davies HW; Struthers BJ; Bittman RM; Geis GS. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Annals of internal medicine. (1995) 123 4 pp241-249', '10.7326/0003-4819-123-4-199508150-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-123-4-199508150-00001']\n",
      "['9257148', 'Patru S; Matei D; Marcu IR; Bighea AC. Effects of an intensive exercise program on rheumatoid arthritis patients. Osteoporosis international. Conference: 18th world conference on osteoporosis, degenerative disease and musculoskeletal disorders, WCO-IOF-ESCEO 2018. Poland. (2018) 29 1 Supplement 1 ppS283-S284', '10.1007/s00198-018-4437-5', 'http://link.springer.com/article/10.1007/s00198-018-4437-5/fulltext.html']\n",
      "['9257149', 'DiPerri T; Auteri A; Fumagalli M; Gandini R; Giordano A; Giordano M; Scaricabarozzi I; Vaiani G; Vatti M. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis. International journal of clinical pharmacology, therapy, and toxicology. (1987) 25 8 pp443-447', '10.1111/j.1532-5415.1990.tb04420.x', '']\n",
      "['9257150', 'Brunner HI; Ruperto N; Tzaribachev N; Horneff G; Chasnyk VG; Panaviene V; Abud-Mendoza C; Reiff A; Alexeeva E; Rubio-Perez N; Keltsev V; Kingsbury DJ; Del Rocio Maldonado Velazquez M; Nikishina I; Silverman ED; Joos R; Smolewska E; Bandeira M; Minden K; van Royen-Kerkhof A; Emminger W; Foeldvari I; Lauwerys BR; Sztajnbok F; Gilmer KE; Xu Z; Leu JH; Kim L; Lamberth SL; Loza MJ; Lovell DJ; Martini A. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial. Annals of the rheumatic diseases. (2018) 77 1 pp21-29', '10.1136/annrheumdis-2016-210456', '']\n",
      "['9257151', 'Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Tanner SB; Stein CM. Peroxisome proliferator-activated receptor gamma agonist treatment for rheumatoid arthritis: A proof-of-concept randomized controlled trial. Arthritis and rheumatism. (2012) 64  ppS363', '10.1186/ar4290', 'https://link.springer.com/article/10.1186/ar4290/fulltext.html']\n",
      "['9257152', 'Zhao L; Jiang Z; Zhang Y; Ma H; Cai C. Analysis of efficacy and safety of treatment of active rheumatoid arthritis with iguratimod and methotrexate. Biomedical research (india). (2017) 28 5 pp2353-2359', '10.1007/s10067-020-04986-9', 'http://link.springer.com/article/10.1007/s10067-020-04986-9/fulltext.html']\n",
      "['9257153', 'Deodhar SD; McLeod MM; Dick WC; Buchanan WW. A short-term comparative trial of salsalate and indomethacin in rheumatoid arthritis. Current medical research and opinion. (1977) 5 2 pp185-188', '10.1185/03007997709110162', '']\n",
      "['9257155', 'Valerie D-P; Mariette X; Sandrine J-J; Berthelot J-M; Perdriger A; Hachulla E; Puechal X; Le Guern V; Sibilia J; Gottenberg J-E; Chiche Sr L; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Pers J-O; Nowak E; Saraux A. Tolerance and efficacy of rituximab in primary sjogren syndrome: Final results of a randomized controlled trial. Arthritis and rheumatism. (2012) 64  ppS1079', '10.1136/annrheumdis-2012-eular.1748', '']\n",
      "['9257156', 'Muller PCEH; Yildiz B; Allaart CF; Brinkman DMC; Van Rossum MAJ; Van Den Berg JM; Van Suijlekom-Smit LWA; Cate RT; De Vries MC. Randomized clinical trial in pediatric rheumatology: Are parents and patients in equipoise?. Arthritis and rheumatism. (2012) 64  ppS849', '10.1186/s12910-018-0336-8', 'http://link.springer.com/article/10.1186/s12910-018-0336-8/fulltext.html']\n",
      "['9257157', 'Berry H; Fernandes L; Clarke AK; Hamilton EB; Davies J; Dixon AJ. Indoprofen and naproxen in the treatment of rheumatoid arthritis: a clinical trial. British medical journal. (1978) 1 6108 pp274-276', '10.1136/bmj.1.6108.274', '']\n",
      "['9257159', 'Panush RS; Stroud RM; Webster EM. Food-induced (allergic) arthritis: Inflammatory arthritis exacerbated by milk. Arthritis and rheumatism. (1986) 29 2 pp220-226', '10.1002/art.1780290210', '']\n",
      "['9257160', 'Hall GM; Spector TD; Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis and rheumatism. (1995) 38 7 pp902-906', '10.1002/art.1780380705', '']\n",
      "['9257161', \"Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Abu-Shakra M; Sarvagil-Maman H; Padova H; Caspi D; Rosner I. Tocilizumab in adult Still's disease: The Israeli experience. Arthritis and rheumatism. (2012) 64  ppS83\", '10.3899/jrheum.130881', '']\n",
      "['9257162', 'Proudman S; Spargo L; Hall C; McWilliams L; Lee A; Rischmueller M; Gibson R; James M; Cleland LG. Fish oil in rheumatoid arthritis: A randomised, double blind trial comparing high dose with low dose. Arthritis and rheumatism. (2012) 64  ppS196', '10.1016/j.phanu.2013.11.034', '']\n",
      "['9257163', 'Greenwald MW; Szczepanski L; Kennedy AC; Lee CH; Polasek E; Veenhuizen M; Jones-Taha R; Berclaz P-Y. Long-term safety and efficacy of tabalumab, an anti-B-cell activating factor monoclonal antibody, in patients with rheumatoid arthritis: A 52-week, open-label extension study. Arthritis and rheumatism. (2012) 64 var.pagings ppS193-S194', '10.1186/s13075-014-0415-2', 'https://link.springer.com/article/10.1186/s13075-014-0415-2/fulltext.html']\n",
      "['9257166', 'Ornbjerg LM; Ostergaard M; Boyesen P; Thormann A; Tarp U; Bohme W; Dencker D; Lindegaard HM; Poulsen UE; Hansen A; Ringsdal VS; Schlemmer A; Graudal N; Andersen AR; Espesen J; Kollerup G; Christensen TG; Pelck R; Glintborg B; Madsen OR; Jensen DV; Majgaard O; Hetland ML. Risk factors for radiographic progression during TNF-inhibitor treatment in 932 rheumatoid arthritis patients treated in clinical practice: Results from the nationwide danish danbio registry. Arthritis and rheumatism. (2012) 64  ppS157-S158', '10.1136/annrheumdis-2012-201319', '']\n",
      "['9257168', 'Kume K; Yamada S; Hatta K; Amano K; Ohta H; Kuwaba N. Combination of intra-articular steroid injection and infliximab more effective than infliximab in rapid radiographic progression patients with rheumatoid arthritis: A randomized, open label, X ray reader blinded study. Arthritis and rheumatism. (2012) 64  ppS193', '10.1136/annrheumdis-2013-eular.739', '']\n",
      "['9257170', \"Balint G; El GA; Mavrikakis M; et al. Clinical and laboratory studies in patients with rheumatoid arthritis and Sjogren's syndrome treated with levamisole. Rheumatologia, balneologia, allergologia. (1979) 20 3 pp172-181\", '10.1093/oxfordjournals.qjmed.a067548', 'http://academic.oup.com/qjmed/article-pdf/47/3/385/4513956/47-3-385.pdf']\n",
      "['9257171', 'Moller-Bisgaard S; Horslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Moller J; Krogh NS; Stengaard-Pedersen K; Ostergaard M. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial. Trials. (2015) 16  pp178', '10.1186/s13063-015-0693-2', 'http://link.springer.com/article/10.1186/s13063-015-0693-2/fulltext.html']\n",
      "['9257172', 'Petera P; Tausch G; Br√∂ll H; Eberl R. Double blind trial involving: Teorema, a new antirheumatic, vs. indometacin in rheumatoid diseases. International journal of clinical pharmacology and biopharmacy. (1977) 15 12 pp581-584', '10.1007/978-1-4684-3285-5_27', 'http://link.springer.com/content/pdf/10.1007/978-1-4684-3285-5_27.pdf']\n",
      "['9257173', 'Ide M; Suzuki Y; Ichikawa Y; Mizushima Y. Influence of long-term low-dose methotrexate therapy on periarticular and generalized osteoporosis in rheumatoid arthritis. Japanese Journal of Rheumatology. (1999) 9 1 pp75-85', '10.1007/bf03041262', 'http://link.springer.com/article/10.1007/BF03041262/fulltext.html']\n",
      "['9257174', 'Taibanguay N; Chaiamnuay S; Asavatanabodee P; Narongroeknawin P. Effect of patient education on medication adherence in patient with rheumatoid arthritis: a randomized controlled trial. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp196', '10.2147/ppa.s192008', 'https://www.dovepress.com/getfile.php?fileID=47466']\n",
      "['9257175', 'Jin LH; Kim B-H; Lee JH; Lee K; Kwack K; Yim S-V. Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate. Translational and clinical pharmacology. (2017) 25 4 pp166-172', '10.12793/tcp.2017.25.4.166', 'https://synapse.koreamed.org/pdf/10.12793/tcp.2017.25.4.166']\n",
      "['9257176', 'Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus. Clinical therapeutics. (2016) 38 6 pp1417-1434.e2', '10.1016/j.clinthera.2016.03.028', '']\n",
      "['9257177', 'Nochioka K; Biering-Sorensen T; Hansen KW; Sorensen R; Pedersen S; Jorgensen PG; Iversen A; Shimokawa H; Jeger R; Kaiser C; Pfisterer M; Galatius S. Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitats Trial-PROspective Validation Examination (BASKET-PROVE) sub-study. European heart journal: acute cardiovascular care. (2017) 6 8 pp778-786', '10.1177/2048872616649860', 'http://journals.sagepub.com/doi/pdf/10.1177/2048872616649860']\n",
      "['9257178', 'Tanaka Y; Van Der Aa A; Jamoul C; Tasset C; Harrison P; Westhovens R. Rapid and sustained effect of filgotinib, an oral JAK1-selective inhibitor, on patient-reported outcomes: results from a Phase 2B RA study. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp207', '10.1136/annrheumdis-2016-eular.3894', '']\n",
      "['9257181', 'Wong P; Wu D; Mak QWK; Cheng ITH; Li TK; Li EK; Tam L-S. Role of ultrasound in assessing disease activity in patients with early rheumatoid arthritis treated by two treat-to-target strategies. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp213', '10.1136/annrheumdis-2018-eular.6897', '']\n",
      "['9257184', \"Ardita A; Adem A; Argjend T. Efficacy of Biotene Oral Balance in secondary Sjogren's syndrome patients. Oral diseases. (2010) 16  6 pp539\", '10.1111/j.1601-0825.2012.01932.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1601-0825.2012.01932.x']\n",
      "['9257186', 'Karki C; Panchal S; Baynton E; Shah-Manek B. Effect of patient involvement in treatment decision making on disease outcomes in rheumatoid arthritis in the EU5. Value in health. Conference: 23rd annual meeting of the international society for pharmacoeconomics and outcomes research, ISPOR 2018. United states. (2018) 21 Supplement 1 ppS260', '10.1016/j.jval.2018.04.1735', '']\n",
      "['9257187', 'Piga M; Tradori I; Pani D; Barabino G; Dess√¨ A; Raffo L; Mathieu A. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology. Journal of rheumatology. (2014) 41 7 pp1324-1333', '10.3899/jrheum.130912', '']\n",
      "['9257188', 'Hossain MA; Akbar FA; Thompson M. Floctafenine (Idarac) in the management of rheumatoid arthritis. Rheumatology and rehabilitation. (1977) 16 4 pp260-264', '10.1093/rheumatology/16.4.260', 'http://academic.oup.com/rheumatology/article-pdf/16/4/260/5026345/16-4-260.pdf']\n",
      "['9257191', 'Liu J; Huang CB; Wang Y; Xu GQ; Cheng YY; Feng YX; Liu L; Qi YJ. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: study protocol of a multicenter randomized controlled trial. Journal of integrative medicine. (2013) 11 6 pp428-434', '10.3736/jintegrmed2013059', '']\n",
      "['9257192', 'Salesi M; Ghasemian R; Karimifar M; Farajzadegan Z; Gholamnezhad M. Anti-inflammatory effects of different statins in rheumatoid arthritis: a randomized double-blind controlled clinical trial. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp181', '10.15171/ipp.2019.09', 'http://immunopathol.com/pdf/ipp-5-e09.pdf']\n",
      "['9257194', 'Zwikker H; van den Bemt B; van den Ende C; van Lankveld W; Broeder AD; van den Hoogen F; van de Mosselaar B; van Dulmen S. Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritis. Patient education and counseling. (2012) 89  1 pp143-151', '10.1016/j.pec.2012.07.007', '']\n",
      "['9257195', 'Engel P. [Neurotropic vitamins in rheumatic diseases]. Fortschritte der Medizin. (1975) 93 34 pp1745-1747', '10.1007/s15006-016-9024-0', 'http://link.springer.com/content/pdf/10.1007/s15006-016-9024-0.pdf']\n",
      "['9257196', 'Todoerti M; Scir√® CA; Boffini N; Bugatti S; Montecucco C; Caporali R. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis. Annals of the New York Academy of Sciences. (2010) 1193 1 pp139-145', '10.1111/j.1749-6632.2009.05367.x', '']\n",
      "['9257197', 'Nakahara I; Nakamura N; Nishii T; Miki H; Sakai T; Sugano N. Minimum five-year follow-up wear measurement of longevity highly cross-linked polyethylene cup against cobalt-chromium or zirconia heads. Journal of arthroplasty. (2010) 25 8 pp1182-1187', '10.1016/j.arth.2009.09.006', '']\n",
      "['9257198', \"Epstein JB; Decoteau WE; Wilkinson A. Effect of Sialor in treatment of xerostomia in Sjogren's syndrome. Oral Surgery, Oral Medicine, Oral Pathology. (1983) 56 5 pp495-499\", '10.1016/0030-4220(83)90096-8', '']\n",
      "['9257199', 'Jasani MK; Downie WW; Samuels BM; Buchanan WW. Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Annals of the rheumatic diseases. (1968) 27 5 pp457-462', '10.1136/ard.27.5.457', '']\n",
      "['9257201', 'Hsia SH; Duran P; Davidson MB. A pilot, head-to-head comparison of hydroxychloroquine (HCQ) with pioglitazone (PIO) as third-line agents in type 2 diabetic patients failing metformin and a sulfonylurea (SU). Diabetes. Conference: 78th scientific sessions of the american diabetes association, ADA 2018. United states. (2018) 67 Supplement 1 ppA314', '10.2337/db18-1172-p', 'https://diabetesjournals.org/diabetes/article/67/Supplement_1/1172-P/53913/A-Pilot-Head-to-Head-Comparison-of']\n",
      "['9257202', 'Janse Van Rensburg C; Fletcher L; Viljoen M; Coertzen C; Grant R; Ramagole M; Collins R; Ker J. Efficacy ofanexercise programon the functional capacity and disease activity in females with rheumatoid arthritis. Journal of science and medicine in sport. (2010) 13  ppe60', '10.1016/j.jsams.2010.10.589', '']\n",
      "['9257203', \"Yokoi N; Kato H; Kinoshita S. The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sj√∂gren's syndrome: a pilot study. Eye (london, england). (2016) 30 6 pp857-864\", '10.1038/eye.2016.54', 'http://www.nature.com/articles/eye201654']\n",
      "['9257204', 'Tingey P; Khanafer M; Singh K; Thompson A; Le Riche N; Barra L; Haig S; Rohekar G; Rohekar S; Nielson W; Pope JE. Social persuasion in rheumatology: a randomized trial of testimonials on television in the rheumatology clinic waiting room to increase attendance for multidisciplinary education. Rheumatology international. (2014) 34 7 pp903-907', '10.1007/s00296-014-2961-y', 'http://link.springer.com/article/10.1007/s00296-014-2961-y/fulltext.html']\n",
      "['9257206', 'Fagan DJ; Evans A; Ghandour A; Prabhkaran P; Clay NR. A controlled clinical trial of postoperative hand elevation at home following day-case surgery. Journal of hand surgery (Edinburgh, Scotland). (2004) 29 5 pp458-460', '10.1016/j.jhsb.2004.04.008', 'https://journals.sagepub.com/doi/pdf/10.1016/J.JHSB.2004.04.008']\n",
      "['9257208', 'Amor B; Dougados M; Mery C; Dardenne M; Bach JF. Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials. Annals of the rheumatic diseases. (1987) 46 7 pp549-554', '10.1136/ard.46.7.549', '']\n",
      "['9257209', \"Caruso I; Santandrea S; Sarzi Puttini P; Montrone F; Boccassini L; Azzolini V; Cazzola M; Dell'Acqua D. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin. Journal of international medical research. (1992) 20 1 pp61-77\", '10.1177/030006059202000108', 'https://journals.sagepub.com/doi/pdf/10.1177/030006059202000108']\n",
      "['9257210', \"Caruso I; Boccassini L; Cazzola M; Santandrea S; Montrone F; Dell'Acqua D; Salvaggio A. Multiple intra-articular treatment of rheumatoid arthritis: a randomized prospective study comparing rifamycin SV with pefloxacin. Journal of international medical research. (1992) 20 1 pp27-39\", '10.1177/030006059202000104', 'https://journals.sagepub.com/doi/pdf/10.1177/030006059202000104']\n",
      "['9257211', 'Foell D; Wulffraat N; Wedderburn LR; Wittkowski H; Frosch M; Gerss J; Stanevicha V; Mihaylova D; Ferriani V; Tsakalidou FK; Foeldvari I; Cuttica R; Gonzalez B; Ravelli A; Khubchandani R; Oliveira S; Armbrust W; Garay S; Vojinovic J; Norambuena X; Gamir ML; Garc√≠a-Consuegra J; Lepore L; Susic G; Corona F; Dolezalova P; Pistorio A; Martini A; Ruperto N; Roth J; Paediatric Rheumatology International Trials Organization (PRINTO). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA. (2010) 303 13 pp1266-1273', '10.1001/jama.2010.375', 'https://jama.jamanetwork.com/ama/content_public/journal/jama/4506/joc05029_1266_1273.pdf']\n",
      "['9257212', 'Konig H; Saal J. Quantitative MRT for treatment control using the non-steroidal anti-rheumatic substance ademetionin.  QUANTITIV AUSGEWERTETE KERNSPINTOMOGRAPHIE ALS THERAPIEKONTROLLE DES NICHT-STEROIDALEN ANTIRHEUMATIKUMS ADEMETIONIN: PILOTSTUDIE BEI GONARTHROSE-PATIENTEN. ROFO FORTSCHR GEB RONTGENSTR NEUEN BILDGEBENDEN VERFAHREN. (1990) 152 2 pp214-219', '10.1055/s-2008-1046853', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1046853.pdf']\n",
      "['9257213', 'Ancu≈£a C; Ancu≈£a E; Miu S; Iordache C; Belibou C; Chirieac R. Adalimumab therapy in patients with active rheumatoid arthritis. Revista medico-chirurgicalaÃÜÃÜ a SocietaÃÜÃÜtÃßÃúii de Medici sÃßÃßi NaturalisÃßÃßti din IasÃßÃßi. (2009) 113 3 pp710-715', '10.1016/j.bone.2009.03.368', '']\n",
      "['9257214', 'Trentham DE; Belli JA; Bloomer WD; Anderson RJ; Lane H; Reinherz EL; Austen KF. 2,000-centiGray total lymphoid irradiation for refractory rheumatoid arthritis. Arthritis and rheumatism. (1987) 30 9 pp980-987', '10.1002/art.1780300904', '']\n",
      "['9257215', 'Holford NH; Williams PE; Muirhead GJ; Mitchell A; York A. Population pharmacodynamics of romazarit. British journal of clinical pharmacology. (1995) 39 3 pp313-320', '10.1111/j.1365-2125.1995.tb04454.x', '']\n",
      "['9257216', 'Roth SH; Bennett RE; Mitchell CS; Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation. Archives of internal medicine. (1987) 147 10 pp1798-1801', '10.1001/archinte.1987.00370100112018', '']\n",
      "['9257217', 'Siddle HJ; Redmond AC; Waxman R; Dagg AR; Alcacer-Pitarch B; Wilkins RA; Helliwell PS. Debridement of painful forefoot plantar callosities in rheumatoid arthritis: The carrot randomized controlled trial. Rheumatology (United Kingdom). (2012) 51  ppiii32', '10.1007/s10067-012-2134-x', 'http://link.springer.com/article/10.1007/s10067-012-2134-x/fulltext.html']\n",
      "['9257218', 'Mercer L; Galloway J; Low A; Watson K; Lunt M; Dixon W; Symmons D; Hyrich K. The risk of solid cancer in patients receiving anti-tumour necrosis factor therapy for rheumatoid arthritis: Results from the british society for rheumatology biologics register. Rheumatology (United Kingdom). (2012) 51  ppiii40', '10.1016/s0140-6736(13)60506-1', '']\n",
      "['9257219', 'Mitchell RA; Woolf D; Murray-Leslie C; Huskisson EC; Wojtulewski J; Ansell B; Liyanage SP; Doyle D; Colston J; English JR. Problems in assessing the possible disease-modifying effect of naproxen. British journal of clinical practice. (1987) 41 1 pp560-565', '10.1111/j.1742-1241.1987.tb08057.x', '']\n",
      "['9257224', 'Dehghan A; Rahimpour S; Soleymani-Salehabadi H; Owlia MB. Role of vitamin D in flare ups of rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (2014) 73 5 pp461-464', '10.1007/s00393-013-1297-4', 'http://link.springer.com/article/10.1007/s00393-013-1297-4/fulltext.html']\n",
      "['9257226', 'Guo X; Higgs BW; Bay-Jensen A-C; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. Rheumatology (oxford, england). (2018) 57 1 pp175-184', '10.1093/rheumatology/kex383', 'http://academic.oup.com/rheumatology/article-pdf/57/1/175/22779903/kex383.pdf']\n",
      "['9257228', 'Soubrier M; Lukas C; Sibilia J; Fautrel B; Roux F; Gossec L; Patternotte S; Dougados M. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Annals of the rheumatic diseases. (2011) 70 4 pp611-615', '10.1136/ard.2010.137695', '']\n",
      "['9257229', 'Cannon GW; Emkey RD; Denes A; Cohen SA; Saway PA; Wolfe F; Jaffer AM; Weaver AL; Cogen L; Gulinello J; Kennedy SM; Schindler JD. Prospective two-year followup of recombinant inteferon-gamma in rheumatoid arthritis. Journal of rheumatology. (1990) 17 3 pp304-310', '10.1002/anr.1780320805', '']\n",
      "['9257230', 'Wawrzy≈Ñska-Pagowska J; Graff-Wr√≥blewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan]. Zeitschrift fuÃàr Rheumaforschung. (1973) 32 1 pp32-39', '10.3109/rhe1.1970.16.issue-1-4.12', '']\n",
      "['9257231', 'Pinals RS; Harris ED; Burnett JB; Gerber DA. Treatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trial. Journal of rheumatology. (1977) 4 4 pp414-419', '10.1007/s00296-006-0145-0', 'http://link.springer.com/article/10.1007/s00296-006-0145-0/fulltext.html']\n",
      "['9257232', 'Weintraub M; Jacox RF; Angevine CD; Atwater EC. Piroxicam (CP 16171) in rheumatoid arthritis: a controlled clinical trial with novel assessment techniques. Journal of rheumatology. (1977) 4 4 pp393-404', '10.1002/art.1780160118', '']\n",
      "['9257233', 'Trentham DE; Fife RS; Carpenter BA; Box JH; Trout R; Lanser ME. Amiprilose hydrochloride for the treatment of rheumatoid arthritis. Journal of clinical rheumatology. (2000) 6 1 pp10-18', '10.1097/00124743-200002000-00002', '']\n",
      "['9257234', 'Thorpe PC; Isaac PF; Rodgers J. A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients. Current therapeutic research, clinical and experimental. (1975) 17 2 pp149-155', '10.1185/03007997509113660', '']\n",
      "['9257235', 'Verdickt W; Moran C; Hantzschel H; Fraga AM; Stead H; Geis GS. A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. (1992) 21 2 pp85-91', '10.3109/03009749209095074', '']\n",
      "['9257236', 'Fletcher MR; Loebl W; Scott JT. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance. Annals of the rheumatic diseases. (1975) 34 2 pp190-194', '10.1136/ard.34.2.190', '']\n",
      "['9257237', 'van Erk MJ; Wopereis S; Rubingh C; van Vliet T; Verheij E; Cnubben NH; Pedersen TL; Newman JW; Smilde AK; van der Greef J; Hendriks HF; van Ommen B. Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC medical genomics. (2010) 3  pp5', '10.1186/1755-8794-3-5', 'http://link.springer.com/article/10.1186/1755-8794-3-5/fulltext.html']\n",
      "['9257238', 'Kingsley G. An update on synthetic DMARD therapy. Scandinavian journal of rheumatology. (2012) 41  pp3-4', '10.1080/030097499750042227', '']\n",
      "['9257239', 'Primdahl J; Horn HC; Horslev-Petersen K. Shared care and nursing consultations: A useful alternative to rheumatologist-initiated follow-up in outpatients with rheumatoid arthritis. Results from a 2-year randomized controlled trial. Scandinavian journal of rheumatology. (2012) 41  pp35-36', '10.3109/03009742.2014.928945', '']\n",
      "['9257241', 'Huskisson EC; Scott J. Sulindac. Trials of a new anti-inflammatory drug. Annals of the rheumatic diseases. (1978) 37 1 pp89-92', '10.1136/ard.37.1.89', '']\n",
      "['9257242', 'Berry H; Barrett JJ; Ford-Hutchinson A; Hamilton EB. Radioisotope scanning using a gamma camera. Annals of the rheumatic diseases. (1978) 37 1 pp76-77', '10.1136/ard.37.1.76', '']\n",
      "['9257243', 'Castles JJ; Moore TL; Vaughan JH; Bolzan JA; Lee M; Lidsky MD; Caldwell JR; Ehrlich GE; Sharp JT; Kaye R. Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis. Archives of internal medicine. (1978) 138 3 pp362-366', '10.1001/archinte.1978.03630270016011', '']\n",
      "['9257244', 'Lussier A; Arsenault A; Varady J. Gastrointestinal microbleeding after aspirin and naproxen. Clinical pharmacology and therapeutics. (1978) 23 4 pp402-407', '10.1002/cpt1978234402', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1978234402']\n",
      "['9257245', 'Lambert JR; Wright V. A double-blind comparison of benoxaprofen and placebo in rheumatoid arthritis. Current medical research and opinion. (1977) 5 3 pp269-272', '10.1185/03007997709110178', '']\n",
      "['9257246', 'Freeman AM; Golding DN; Steele CE. A double-blind crossover study comparing tolmetin and indomethacin in the treatment of rheumatoid arthritis. Current medical research and opinion. (1977) 5 3 pp262-265', '10.1185/03007997709110176', '']\n",
      "['9257247', 'Fowler PD; MacNeill A; Spencer D; Robinson ET; Dick WC. Imipramine, rheumatoid arthritis and rheumatoid factor. Current medical research and opinion. (1977) 5 3 pp241-246', '10.1185/03007997709110172', '']\n",
      "['9257248', \"D'Omezon Y; Vincent G. Study by French clinicians on the action of naproxen in rheumatoid arthritis.  ETUDE DES CLINICIENS FRANCAIS SUR L'ACTION DU NAPROXENE DANS LA P.C.E. JSCIMEDLILLE. (1974) 92 12 pp365-374\", '10.3109/03009747309097119', '']\n",
      "['9257249', 'Ahmad M; Murtaza G; Akhtar N; Siddique F; Khan SA. Bioequivalence study of two brands of meloxicam tablets in healthy human Pakistani male subjects. Acta poloniae pharmaceutica. (2011) 68 1 pp115-119', '10.1055/s-0031-1296616', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1296616.pdf']\n",
      "['9257250', 'Cohen L. A controlled study of Trancopal in sleep disturbances due to rheumatic disease. Journal of international medical research. (1978) 6 2 pp111-114', '10.1177/030006057800600207', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057800600207']\n",
      "['9257251', 'Gao IK; Leins C; Bohlen H; Heilig B; Lemmel EM. Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (1998) 57 2 pp95-100', '10.1007/s003930050066', 'http://link.springer.com/article/10.1007/s003930050066/fulltext.html']\n",
      "['9257252', 'Van Rensburg DCJ; Ker JA; Grant CC; Fletcher L. Effect of exercise on cardiac autonomic function in females with rheumatoid arthritis. Clinical rheumatology. (2012) 31  8 pp1155-1162', '10.1007/s10067-012-1985-5', '']\n",
      "['9257253', 'Huskisson EC; Scott J. Analgesic and anti-inflammatory properties of indoprofen. Rheumatology and rehabilitation. (1979) 18 1 pp49-52', '10.1093/rheumatology/18.1.49', 'http://academic.oup.com/rheumatology/article-pdf/18/1/49/5026581/18-1-49.pdf']\n",
      "['9257254', 'Hewlett S; Kirwan J; Pollock J; Mitchell K; Hehir M; Blair PS; Memel D; Perry MG. Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial. BMJ (Clinical research ed.). (2005) 330 7484 pp171', '10.1136/bmj.38265.493773.8f', '']\n",
      "['9257255', 'Harkness JAL; Griffin AJ; Heinrich I; et al. A double-blind comparative study of metronidazole and placebo in rheumatoid arthritis. Rheumatology and rehabilitation. (1982) 21 4 pp231-234', '10.1093/rheumatology/21.4.231', 'http://academic.oup.com/rheumatology/article-pdf/21/4/231/5027616/21-4-231.pdf']\n",
      "['9257257', \"Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. Journal of rheumatology. (1987) 14 4 pp745-750\", '10.1016/0002-8703(91)90846-a', '']\n",
      "['9257258', 'Fudman EJ; Till GO; Fox IH. Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis. Journal of rheumatology. (1987) 14 4 pp686-691', '10.1093/rheumatology/26.5.321', 'http://academic.oup.com/rheumatology/article-pdf/26/5/321/5040166/26-5-321.pdf']\n",
      "['9257259', 'van de Laar MA; van der Korst JK. Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Annals of the rheumatic diseases. (1992) 51 3 pp298-302', '10.1136/ard.51.3.298', '']\n",
      "['9257260', 'Weinblatt ME; McInnes IB; Kremer JM; Miranda P; Vencovsky J; Guo X; White WI; Ryan PC; Godwood A; Albulescu M; Close D; Burmester GR. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis and rheumatology. (2018) 70 1 pp49-59', '10.1002/art.40323', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40323']\n",
      "['9257261', 'Li J; Zhang X; Zheng Q; Zhu Y; Wang H; Ma H; Jhanji V; Chen W. Comparative Evaluation of Silicone Hydrogel Contact Lenses and Autologous Serum for Management of Sjogren Syndrome-Associated Dry Eye. Cornea. (2015) 34  9 pp1072-1078', '10.1097/ico.0000000000000515', '']\n",
      "['9257262', 'Caporali R; Bellometti S; Rossi S; Bogliolo L; Klersy C; Montecucco C. Safety of mud-bath applications in moderately active rheumatoid arthritis. Journal of musculoskeletal pain. (2010) 18 1 pp81-87', '10.3109/10582450903495866', '']\n",
      "['9257263', 'Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis. Clinical therapeutics. (2014) 36 7 pp1005-1015', '10.1016/j.clinthera.2014.05.063', '']\n",
      "['9257264', 'Papas AS; Fernandez MM; Castano RA; Gallagher SC; Trivedi M; Shrotriya RC. Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sj√∂grens syndrome. Advances in experimental medicine and biology. (1998) 438  pp973-978', '10.1007/978-1-4615-5359-5_139', '']\n",
      "['9257265', \"Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sj√∂gren's syndrome. The MGI PHARMA Sj√∂gren's Syndrome Study Group. Advances in experimental medicine and biology. (1998) 438  pp979-983\", '10.1007/978-1-4615-5359-5_140', '']\n",
      "['9257266', 'Curtis JR; Lee EB; Martin G; Mariette X; Terry KK; Chen Y; Geier J; Andrews J; Kaur M; Fan H; Nduaka CI. Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme. Clinical and experimental rheumatology. (2017) 35 4 pp614-622', '10.1136/annrheumdis-2015-eular.3068', '']\n",
      "['9257268', 'Ding C-Z; Yao Y; Feng X-B; Fang Y; Zhao C; Wang Y. Clinical Analysis of Chinese Patients With Rheumatoid Arthritis Treated With Leflunomide and Methotrexate Combined With Different Dosages of Glucocorticoid. Current Therapeutic Research - Clinical and Experimental. (2012) 73  4-5 pp123-133', '10.1016/j.curtheres.2012.06.001', '']\n",
      "['9257270', \"Prieur AM. D-penicillamine in the treatment of juvenile chronic arthritis; a multicentric double-blind prospective study; preliminary results.  TRAITEMENT DES ARTHRITES CHRONIQUES JUVENILES PAR LA D-PENICILLAMINE AU COURS D'UN ETUDE PROSPECTIVE MULTICENTRIQUE EN DOUBLE INSU. RESULTATS PRELIMINAIRES. RHUMATOLOGIE (PARIS). (1981) 11 7 pp497-499\", '10.1097/01241398-198509000-00086', '']\n",
      "['9257271', 'McTaggart-Cowan H; Regier DA; Peacock SJ. Exploring the role of disease labels on general population preferences. Quality of life research. Conference: 22nd annual conference of the international society for quality of life research, ISOQOL. Canada. (2015) 24 1 Supplement 1 pp178', '10.1007/s11136-015-1078-4', 'https://link.springer.com/article/10.1007/s11136-015-1078-4/fulltext.html']\n",
      "['9257273', 'Zhao YX; Liu Y. Clinical observation on effects of leflunomid and total glucosides of paeony on rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 4 pp355-357', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9257274', 'Richards IM; Fraser SM; Hunter JA; Capell HA. Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. Annals of the rheumatic diseases. (1987) 46 9 pp667-669', '10.1136/ard.46.9.667', '']\n",
      "['9257275', \"Wu GL; Han YM; Fan YS. Effects of chinese herbal medicine for yiqi yangyin quyu in treating sj√∂gren's syndrome and on patients' immunologic function. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 4 pp322-324\", '10.37766/inplasy2022.7.0033', '']\n",
      "['9257276', 'Bradley LA; Young LD; Anderson KO; Turner RA; Agudelo CA; McDaniel LK; Pisko EJ; Semble EL; Morgan TM. Effects of psychological therapy on pain behavior of rheumatoid arthritis patients. Treatment outcome and six-month followup. Arthritis and rheumatism. (1987) 30 10 pp1105-1114', '10.1002/art.1780301004', '']\n",
      "['9257277', 'Wylie G; Appelboom T; Bolten W; Breedveld FC; Feely J; Leeming MR; Le Lo√´t X; Manthorpe R; Marcolongo R; Smolen J. A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. British journal of rheumatology. (1995) 34 6 pp554-563', '10.1093/rheumatology/34.6.554', 'http://academic.oup.com/rheumatology/article-pdf/34/6/554/5023460/34-6-554.pdf']\n",
      "['9257282', \"Genovese MC; Kavanaugh A; Weinblatt ME; Peterfy C; DiCarlo J; White ML; O'Brien M; Grossbard EB; Magilavy DB. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents. Arthritis and rheumatism. (2011) 63 2 pp337-345\", '10.1002/art.30114', '']\n",
      "['9257283', 'Song L; Yu J; Zhang T. [Comparative study on early complication after total knee arthroplasty surgery by different incisions]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2009) 23 3 pp274-277', '10.1097/00029330-200808010-00004', '']\n",
      "['9257284', 'Wevers-De Boer K; Visser K; Heimans L; Ronday HK; Molenaar E; Groenendael JHLM; Peeters AJ; Westedt M-L; Collee G; De Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF. Extended report: Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Annals of the rheumatic diseases. (2012) 71  9 pp1472-1477', '10.1136/annrheumdis-2011-200736', '']\n",
      "['9257286', 'Siu S; Haraoui B; Keeling S; Dutz J; Bessette L; Pope J. The effects of tumor necrosis factor inhibitors and corticosteroids on bone mineral density in patients with rheumatoid arthritis and ankylosing spondylitis: A meta-analysis of randomized controlled trials. Journal of rheumatology. (2014) 41  7 pp1491', '10.1002/acr.22519', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22519']\n",
      "['9257287', 'Brosseau L; Wells G; Brooks S; Bell M; De Angelis G; Loew L. The knowledge-to-action cycle (KTAC): A Canadian model to guide the dissemination and the implementation of the bilingual people getting a grip on arthritis self-management program. Journal of rheumatology. (2014) 41  7 pp1520', '10.1177/0017896912471031', 'https://journals.sagepub.com/doi/pdf/10.1177/0017896912471031']\n",
      "['9257289', 'Wang C-C; Lee S-H; Lin H-Y; Liu F-W; Chiou H-J; Chan R-C; Chou C-L. Short-term effect of ultrasound-guided low-molecular-weight hyaluronic acid injection on clinical outcomes and imaging changes in patients with rheumatoid arthritis of the ankle and foot joints. A randomized controlled pilot trial. Ultrasound in medicine and biology. Conference: 16th world federation for ultrasound in medecine and biology congress, WFUMB 2017 in conjunction with the 9th asian conference on ultrasound contrast imaging and chinese taipei society of ultrasound in medicine annual convention. Taiwan (republic of china). (2017) 43 Supplement 1 ppS199', '10.1016/j.ultrasmedbio.2017.08.1679', '']\n",
      "['9257291', 'Forster J. The Arbeitsgemeinschaft fur Kinder und Jugendrheumatologie (German/Swiss/Austrian working group on juvenile rheumatic diseases) presents a design of a prospective controlled trial in children with oligoarthritis type I. [German]. Zeitschrift fur Rheumatologie. (2000) 59 2 pp122-123', '10.1007/s003930050216', 'http://link.springer.com/article/10.1007/s003930050216/fulltext.html']\n",
      "['9257292', 'Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S; Pediatric Rheumatology International Trials Organization. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. Arthritis and rheumatism. (2005) 52 2 pp563-572', '10.1002/art.20860', '']\n",
      "['9257294', 'Ghazi SA; Fowler PD. A clinical trial of a new anti-inflammatory/analgesic compound in rheumatoid arthritis - GP 45 840. Journal of international medical research. (1973) 1  pp591-599', '10.1177/030006057300100701', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057300100701']\n",
      "['9257295', 'Sigidin YaA; Muravyov YuV; Sidelnikova SM; Taletene IP. Controlled (double blind) trial of different schedules for levamisole application to the treatment of rheumatoid arthritis. Terapevticheskii arkhiv. (1983) 55 9 pp90-94', '10.26442/00403660.2023.12.202554', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/626343/142220']\n",
      "['9257296', 'Stumpe KO; Overlack A. Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: an efficacy, safety, and compatibility study of novel design, the Perindopril Therapeutic Safety Study. American journal of medicine. (1992) 92 4B pp98S-101S', '10.1016/0002-9343(92)90157-7', '']\n",
      "['9257297', 'Li YS; Tong PJ; Ma HZ. Toxicity attenuation and efficacy potentiation effect of liquorice on treatment of rheumatoid arthritis with tripterygium wilfordii. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 12 pp1117-1119', '10.1007/bf02969658', 'https://link.springer.com/article/10.1007/BF02969658/fulltext.html']\n",
      "['9257298', 'H√∏yeraal HM; Fr√∏land SS; Salvesen CF; Munthe E; Natvig JB; K√•ss E; Blichfeldt P; Hegna TM; Revlem E; Sandstad B; Hjort NL. No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. Annals of the rheumatic diseases. (1978) 37 2 pp175-179', '10.1136/ard.37.2.175', '']\n",
      "['9257299', 'Feinberg J. Effect of the arthritis health professional on compliance with use of resting hand splints by patients with rheumatoid arthritis. Arthritis care and research. (1992) 5 1 pp17-23', '10.1002/art.1790050106', '']\n",
      "['9257300', 'Waltham-Weeks CD. Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study. Current medical research and opinion. (1987) 10 8 pp540-547', '10.1185/03007998709108963', '']\n",
      "['9257301', 'Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh YI; Kang SW; Lee YJ; Jung HG. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. Clinical therapeutics. (2007) 29 5 pp862-873', '10.1016/j.clinthera.2007.05.006', '']\n",
      "['9257302', 'Mahmood NMA; Hussain SA; Khan HAEK. Azilsartan as \"Add-On\" Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis. Biomed research international. (2018) 2018  pp7164291', '10.1155/2018/7164291', 'http://downloads.hindawi.com/journals/bmri/2018/7164291.pdf']\n",
      "['9257303', 'Reid DM; Hughes RA; Laan RFJM; Sacco-Gibson NA; Wenderoth DH; Adami S; Eusebio RA; Devogelaer J-P. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial. Journal of bone and mineral research. (2000) 15 6 pp1006-1013', '10.1359/jbmr.2000.15.6.1006', 'https://academic.oup.com/jbmr/article-pdf/15/6/1006/56602916/5650150603.pdf']\n",
      "['9257304', 'Zha QL; He YT; Lu YX. Exploration on relationship between platelet count and efficacy of chinese medicine and western medicine in treating rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2007) 27 1 pp29-32', '10.3736/jcim20080107', '']\n",
      "['9257305', 'Royer GL; Moxley TE; Hearron MS; Miyara A; Shenker BM. A long-term double-blind clinical trial of ibuprofen and indomethacin in rheumatoid arthritis. Journal of international medical research. (1975) 3 3 pp158-171', '10.1177/030006057500300304', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057500300304']\n",
      "['9257306', 'Michot F; Ajdacic K; Glaus L. A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone). Journal of international medical research. (1975) 3 3 pp153-157', '10.1177/030006057500300303', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057500300303']\n",
      "['9257307', 'D√ºrrigl T; Vitaus M; Pucar I; Miko M. Diclofenac sodium (Voltaren): results of a multi-centre comparative trial in adult-onset rheumatoid arthritis. Journal of international medical research. (1975) 3 3 pp139-144', '10.1177/030006057500300301', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057500300301']\n",
      "['9257308', 'Sydnes OA. Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study. European journal of rheumatology and inflammation. (1981) 4 3 pp318-322', '10.3109/03009747309097118', '']\n",
      "['9257309', 'Hill HF; Hill AG. Ankylosing spondylitis: open long-term and double-blind crossover studies with naproxen. Journal of clinical pharmacology. (1975) 15 4 Pt. 2 pp355-362', '10.1002/j.1552-4604.1975.tb01464.x', '']\n",
      "['9257310', 'Giaccai L; Melani F; Pengue L. [Results of a double-blind controlled study of the comparative effects of ketoprofen and ibuprofen in orthopedic patients]. Clinica terapeutica. (1978) 84 4 pp375-385', '10.1136/bmj.4.5884.82', '']\n",
      "['9257311', 'Rooney T; Roux-Lombard P; Veale DJ; FitzGerald O; Dayer JM; Bresnihan B. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. Annals of the rheumatic diseases. (2010) 69 4 pp706-714', '10.1136/ard.2009.108324', '']\n",
      "['9257312', 'Dalbeth N; Saag KG; Palmer WE; Choi HK; Hunt B; MacDonald PA; Thienel U; Gunawardhana L. Effects of Febuxostat in Early Gout: a Randomized, Double-Blind, Placebo-Controlled Study. Arthritis and rheumatology. (2017) 69 12 pp2386-2395', '10.1002/art.40233', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40233']\n",
      "['9257313', 'Lea AP; Goa KL. Pirazolac. Clinical immunotherapeutics. (1996) 6 6 pp506-510', '10.1007/bf03259371', 'http://link.springer.com/article/10.1007/BF03259371/fulltext.html']\n",
      "['9257314', 'Ruperto N; Lovell DJ; Cuttica R; Woo P; Meiorin S; Wouters C; Silverman ED; Balogh Z; Henrickson M; Davidson J; Foeldvari I; Imundo L; Simonini G; Oppermann J; Xu S; Shen YK; Visvanathan S; Fasanmade A; Mendelsohn A; Martini A; Giannini EH; Paediatric Rheumatology INternational Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Annals of the rheumatic diseases. (2010) 69 4 pp718-722', '10.1186/1546-0096-6-s1-s3', 'http://link.springer.com/article/10.1186/1546-0096-6-S1-S3/fulltext.html']\n",
      "['9257315', 'Raffaeli W; Pari C; Corvetta A; Sarti D; Di Sabatino V; Biasi G; Galeazzi M. Oxycodone/acetaminophen at low dosage: an alternative pain treatment for patients with rheumatoid arthritis. Journal of opioid management. (2010) 6 1 pp40-46', '10.5055/jom.2010.0003', 'https://wmpllc.org/ojs/index.php/jom/article/download/869/879']\n",
      "['9257316', 'Reid DW; Misso NL; Aggarwal S; Thompson PJ; Johns DP; Walters EH. Tolerance and rebound with zafirlukast in patients with persistent asthma. Journal of negative results in biomedicine. (2008) 7 1 pp3', '10.1186/1477-5751-7-3', 'http://link.springer.com/article/10.1186/1477-5751-7-3/fulltext.html']\n",
      "['9257317', 'Ramelet AS; Fonjallaz B; Rio L; Zoni S; Ballabeni P; Rapin J; Gueniat C; Hofer M. Impact of a nurse led telephone intervention on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: a crossover randomized clinical trial. BMC pediatrics. (2017) 17 1 pp168', '10.1186/s12887-017-0926-5', 'http://link.springer.com/content/pdf/10.1186/s12887-017-0926-5.pdf']\n",
      "['9257319', 'Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. BMC musculoskeletal disorders. (2017) 18 1 pp310', '10.1186/s12891-017-1673-3', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1673-3.pdf']\n",
      "['9257321', 'Teule M. Double-blind comparative multicenter study of the efficacy and safety of a slow-release tablet of 200-mg ketoprofen once daily and a 50-mg ketoprofen capsule four times daily. CURR THER RES, CLIN EXP. (1986) 40 6 pp1129-1146', '10.1016/s0011-393x(05)80684-8', '']\n",
      "['9257322', 'Rooney PJ; Capell HA; Paterson S; Buchanan WW; Dick WC. Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. British journal of clinical pharmacology. (1978) 5 5 pp453-455', '10.1111/j.1365-2125.1978.tb01654.x', '']\n",
      "['9257324', 'van der Lubbe PA; Dijkmans BA; Markusse HM; N√§ssander U; Breedveld FC. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis and rheumatism. (1995) 38 8 pp1097-1106', '10.1002/art.1780380812', '']\n",
      "['9257325', 'Kremer JM; Lawrence DA; Petrillo GF; Litts LL; Mullaly PM; Rynes RI; Stocker RP; Parhami N; Greenstein NS; Fuchs BR. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis and rheumatism. (1995) 38 8 pp1107-1114', '10.1002/art.1780380813', '']\n",
      "['9257327', 'Salesi M; Mottaghi P; Karimifar M; Farajzadegan Z. Intravenous pamidronate for refractory rheumatoid arthritis. Journal of research in medical sciences. (2012) 17  5 pp422-427', '10.4103/2277-9175.98156', '']\n",
      "['9257328', \"Frost-Larsen K; Isager H; Manthorpe R. Sj√∂rgren's syndrome treated with bromhexine: a randomised clinical study. British medical journal. (1978) 1 6127 pp1579-1581\", '10.1136/bmj.1.6127.1579', '']\n",
      "['9257329', 'Dela Cruz Adriane M; Carmody Thomas; Greer Tracy L; Rethorst Chad D; Warden Diane; Walker Robrina; Trivedi Madhukar H. Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders. American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. (2016) 25 3 pp215-220', '10.1111/ajad.12363', '']\n",
      "['9257330', 'Goulding NJ; Knight SM; Godolphin JL; Guyre PM. Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 4 pp465-468', '10.1136/ard.51.4.465', '']\n",
      "['9257331', 'Porter D; Madhok R; Hunter JA; Capell HA. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 4 pp461-464', '10.1136/ard.51.4.461', '']\n",
      "['9257332', 'Sheikh A; Naqvi SHA; Naqvi SHS; Sheikh K. Itraconazole: Its possible role in inhibiting angiogenesis in Rheumatoid Arthritis. Medical hypotheses. (2012) 79  3 pp313-314', '10.1016/j.mehy.2012.05.019', '']\n",
      "['9257333', 'Kim JM; Moon MS. Squatting following total knee arthroplasty. Clinical orthopaedics and related research. (1995) 313 313 pp177-186', '10.1097/00003086-198406000-00018', '']\n",
      "['9257334', 'Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Clinical therapeutics. (2005) 27 1 pp64-77', '10.1016/j.clinthera.2005.01.002', '']\n",
      "['9257335', 'Sharma BK; Haslock I. Night medication in rheumatoid arthritis. III. the use of sulindac. Current medical research and opinion. (1978) 5 6 pp472-475', '10.1185/03007997809111917', '']\n",
      "['9257336', 'Saxena RP; Saxena U. A comparative trial of ketoprofen and ibuprofen in patients with rheumatic disease. Current medical research and opinion. (1978) 5 6 pp484-488', '10.1185/03007997809111919', '']\n",
      "['9257338', 'Martin RW; Enck RD; Tellinghuisen DJ; Eggebeen AT; Birmingham JD; Head AJ. Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis. Medical decision making. (2017) 37 5 pp577-588', '10.1177/0272989x17696995', 'https://journals.sagepub.com/doi/pdf/10.1177/0272989X17696995']\n",
      "['9257339', 'Meyers OL. A preliminary evaluation of metronidazole v. placebo in patients with active rheumatoid arthritis. South African medical journal. (1988) 74 6 pp300', '10.1177/008124639302300101', 'https://journals.sagepub.com/doi/pdf/10.1177/008124639302300101']\n",
      "['9257340', 'Jamar R; Dequeker J. Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial. Current medical research and opinion. (1978) 5 6 pp433-438', '10.1185/03007997809111911', '']\n",
      "['9257341', 'Forrest CM; Mackay GM; Stoy N; Stone TW; Darlington LG. Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. British journal of clinical pharmacology. (2007) 64 4 pp517-526', '10.1111/j.1365-2125.2007.02911.x', '']\n",
      "['9257343', 'Mohamed M-EF; Camp HS; Jiang P; Padley RJ; Asatryan A; Othman AA. Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis. Clinical pharmacokinetics. (2016) 55 12 pp1547-1558', '10.1007/s40262-016-0419-y', 'http://link.springer.com/article/10.1007/s40262-016-0419-y/fulltext.html']\n",
      "['9257345', 'Evans S; Cousins L; Tsao JC; Subramanian S; Sternlieb B; Zeltzer LK. A randomized controlled trial examining Iyengar yoga for young adults with rheumatoid arthritis: a study protocol. Trials. (2011) 12  pp19', '10.1186/1745-6215-12-19', 'http://link.springer.com/article/10.1186/1745-6215-12-19/fulltext.html']\n",
      "['9257346', 'Nguyen MTT; Lindegaard H; Hendricks O; Jorgensen CS; Kantso B; Friis-Moller N. Initial serological response after prime-boost pneumococcal vaccination in rheumatoid arthritis patients: results of a randomized controlled trial. Journal of rheumatology. (2017) 44 12 pp1794-1803', '10.3899/jrheum.161407', '']\n",
      "['9257347', 'Delbarre F; Mery C. Trial of indoprofen against placebo and against indomethacin in rheumatoid arthritis.  ESTUDIO A CORTO PLAZO DE INDOPHOFENO COMPARADO CON UN PLACEBO Y CON INDOMETACINA EN LA POLIARTRITIS REUMATOIDE. REV ESP REUM ENFERM OSTEOART. (1979) 22 4 pp307-328', '10.1016/j.reuma.2015.11.019', '']\n",
      "['9257349', 'Kopp S; Akerman S; Nilner M. Short-term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporomandibular joint. Journal of craniomandibular disorders. (1991) 5 4 pp231-238', '10.1016/0278-2391(87)90443-5', '']\n",
      "['9257350', 'Doreen MS; Boardman PL; Fowler PD; Poole PH. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial. Rheumatology and rehabilitation. (1978) 17 2 pp95-102', '10.1093/rheumatology/17.2.95', 'http://academic.oup.com/rheumatology/article-pdf/17/2/95/5027233/17-2-95.pdf']\n",
      "['9257351', 'Vinterberg H; Donde R; Andersen RB. [Transcutaneous nerve-stimulation for relief of pain in patients with rheumatoid arthritis]. Ugeskrift for laeger. (1978) 140 20 pp1149-1150', '10.1016/0304-3959(78)90034-9', '']\n",
      "['9257352', 'Laforest S; Nour K; Gignac M; Gauvin L; Parisien M; Poirier M-C. Short-term effects of a self-management intervention on health status of housebound older adults with arthritis. Journal of applied gerontology. (2008) 27 5 pp539-567', '10.1177/0733464808319712', 'https://journals.sagepub.com/doi/pdf/10.1177/0733464808319712']\n",
      "['9257353', 'Hazleman BL; Thomas PP. Single-blind comparative study of nabumetone (Relafen) versus naproxen in the treatment of rheumatoid arthritis. American journal of medicine. (1987) 83 4B pp60-64', '10.1016/0002-9343(87)90596-1', '']\n",
      "['9257354', 'Vasey FB; Germain BF; Espinoza LR; Box P; Bockow BI; Lipani JA; Mullen BJ; Brodsky AL; Fleischmann RM; Fogari RA. Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel study. American journal of medicine. (1987) 83 4B pp55-59', '10.1016/0002-9343(87)90595-x', '']\n",
      "['9257355', 'Brobyn RD. Nabumetone in the treatment of active adult rheumatoid arthritis. American journal of medicine. (1987) 83 4B pp50-54', '10.1016/0002-9343(87)90594-8', '']\n",
      "['9257356', 'Bernhard GC; Appelrouth DJ; Bankhurst AD; Biundo J; Bockow BI; Brobyn RD; Brodsky AL; Burch FX; Chang RW; Cohen MH. Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin. American journal of medicine. (1987) 83 4B pp44-49', '10.1016/0002-9343(87)90593-6', '']\n",
      "['9257357', 'Lanier BG; Turner RA; Collins RL; Senter RG. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. American journal of medicine. (1987) 83 4B pp40-43', '10.1016/0002-9343(87)90592-4', '']\n",
      "['9257358', 'Turner RA; Brindley DA; Mitchell FN. Nabumetone: a single-center three-week comparison with placebo in the treatment of rheumatoid arthritis. American journal of medicine. (1987) 83 4B pp36-39', '10.1016/0002-9343(87)90591-2', '']\n",
      "['9257360', 'Roth SH. Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy. American journal of medicine. (1987) 83 4B pp25-30', '10.1016/0002-9343(87)90589-4', '']\n",
      "['9257361', 'Greb WH; von Schrader HW; Cerlek S; Dominis M; Hauptmann E; Zeniƒá N. Endoscopic studies of nabumetone in patients with rheumatoid arthritis. A comparative endoscopic and histologic evaluation. American journal of medicine. (1987) 83 4B pp19-24', '10.1016/0002-9343(87)90588-2', '']\n",
      "['9257362', 'Breakwell LM; Getty CJM; Dobson P. The efficacy of autologous blood transfusion in bilateral total knee arthroplasty. The Knee. (2000) 7 3 pp145-147', '10.1016/s0968-0160(00)00032-6', '']\n",
      "['9257363', 'Jamilian H; Nokani M; Ghasemi M; Tavakoli N. The effectiveness of cognitive-behavioral group therapy on quality of life in Iranian patients with rheumatoid arthritis. European psychiatry. Conference: 26th european congress of psychiatry, EPA 2018. France. (2018) 48 Supplement 1 ppS257', '10.1016/s0924-9338(14)78438-x', '']\n",
      "['9257364', 'Nilsson KG; Bj√∂rnebrink J; Hietala SO; K√§rrholm J. Scintimetry after total knee arthroplasty. Prospective 2-year study of 18 cases of arthrosis and 15 cases of rheumatoid arthritis. Acta orthopaedica Scandinavica. (1992) 63 2 pp159-165', '10.3109/17453679209154814', '']\n",
      "['9257365', 'Emery P; Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Cheong SY; Ghil J. Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4. Annals of the rheumatic diseases. (2017) 76 12 pp1986-1991', '10.1136/annrheumdis-2017-211591', '']\n",
      "['9257366', 'Bijlsma JW; Huber-Bruning O; Thijssen JH. Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Annals of the rheumatic diseases. (1987) 46 10 pp777-779', '10.1136/ard.46.10.777', '']\n",
      "['9257367', 'Sandstedt E. PReS-FINAL-2049: Bone health, muscle strength, activity. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-p62', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P62.pdf']\n",
      "['9257368', 'Bos J; Armbrust W; Geertzen J; Sauer P; Dijkstra P; Van Brussel M; Cappon J; Lelieveld O. PReS-FINAL-2148: Rheumates@work a cognitive behavioural internet based intervention promoting physical activity in children with juvenile idiopathic arthritis: Preliminary results of a randomized clinical trail. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-p160', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P160.pdf']\n",
      "['9257369', 'Sawyer L; Diamantopoulos A; Brunner HI; De Benedetti F; Ruperto N; Dejonckheere F; Keane C. PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: An indirect comparison. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-p82', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P82.pdf']\n",
      "['9257370', 'Caruso I; Fumagalli M; Boccassini L; Puttini SP; Santandrea S; Giniselli G; et al. Treatment of depression in rheumatoid arthritic patients. A comparison of S-adenosylmethionine (Samyr) and placebo in a double-blind study. Clinical trials journal. (1987) 24 4 pp305-310', '10.1016/s0140-6736(84)91360-6', '']\n",
      "['9257372', 'Huskisson EC. The time course of the action of piroxicam. EUR J RHEUMATOL INFLAM. (1981) 4 3 pp376-377', '10.1136/ard.39.5.532-a', '']\n",
      "['9257374', 'Pownall R; Pickvance NJ. The optimum interval between flurbiprofen doses--scheduling for circadian rhythms in rheumatoid arthritis. British journal of clinical practice. (1987) 41 4 pp689-693', '10.1111/j.1742-1241.1987.tb08092.x', '']\n",
      "['9257375', 'Escott BG; Ronald K; Judd MG; Bogoch ER. NeuFlex and Swanson metacarpophalangeal implants for rheumatoid arthritis: prospective randomized, controlled clinical trial. Journal of hand surgery. (2010) 35 1 pp44-51', '10.1016/j.jhsa.2009.09.020', '']\n",
      "['9257376', 'Tomlinson B; Hu M; Lee VW; Lui SS; Chu TT; Poon EW; Ko GT; Baum L; Tam LS; Li EK. ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clinical pharmacology and therapeutics. (2010) 87 5 pp558-562', '10.1038/clpt.2009.232', '']\n",
      "['9257377', 'van Vliet-Daskalopoulou E; Jentjens T; Scheffer RT. Intra-articular rimexolone in the rheumatoid knee: a placebo-controlled, double-blind, multicentre trial of three doses. British journal of rheumatology. (1987) 26 6 pp450-453', '10.1093/rheumatology/26.6.450', 'http://academic.oup.com/rheumatology/article-pdf/26/6/450/5027958/26-6-450.pdf']\n",
      "['9257380', 'Chandrasekaran AN; Sambandam PR; Lal HM; Ramakrishnan S; Porkodi R; Krishnamurthy V; Achutan K. Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs. Journal of the Association of Physicians of India. (1991) 39 12 pp919-921', '10.3109/9780203214237-61', '']\n",
      "['9257381', 'Roberts SD; Vir C; Porter KG. Once-daily piroxicam in rheumatoid arthritis: A double-blind cross-over comparison with aloxiprin. EUR J RHEUMATOL INFLAM. (1981) 4 3 pp323-331', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9257382', 'Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. (1988) 61 2 pp209-220', '10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l', '']\n",
      "['9257383', 'Fishman P; Yehuda SB. CF101 for the treatment of autoimmune inflammatory diseases: Data from phase 2 clinical trials in patients with rheumatoid arthritis, psoriasis and dry eye syndrome. Purinergic signalling. (2010) 6  ppS3', '10.1016/j.ophtha.2009.11.029', '']\n",
      "['9257384', 'Genovese MC; Van den Bosch F; Roberson SA; Bojin S; Biagini IM; Ryan P; Sloan-Lancaster J. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis and rheumatism. (2010) 62 4 pp929-939', '10.1002/art.27334', '']\n",
      "['9257385', 'Huizinga T; Nigrovic P; Ruderman E; Schulze-Koops H. Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a Phase II, randomized, placebo-controlled, dose-finding trial - Commentary. International Journal of Advances in Rheumatology. (2011) 9  4 pp149-150', '10.1002/art.30373', '']\n",
      "['9257386', 'McCarthy GM; McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. Journal of rheumatology. (1992) 19 4 pp604-607', '10.2337/diacare.15.1.15', 'https://diabetesjournals.org/care/article-pdf/15/1/15/441029/15-1-15.pdf']\n",
      "['9257388', 'Atkinson M; Khanna V; M√©nard H; Russel AS; Tannenbaum H. A comparison of tenoxicam and piroxicam in the treatment of rheumatoid arthritis. Journal of rheumatology. (1992) 19 4 pp538-542', '10.3109/03009748909103718', '']\n",
      "['9257389', 'Boers M; Bensen WG; Ludwin D; Goldsmith CH; Tugwell P. Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment. Journal of rheumatology. (1992) 19 4 pp534-537', '10.1093/rheumatology/38.8.789-a', '']\n",
      "['9257391', 'Yousef Yengej FA; Limper M; Leavis HL. Statins for prevention of cardiovascular disease in systemic lupus erythematosus. Netherlands journal of medicine. (2017) 75 3 pp99-105', '10.1016/b978-0-12-801917-7.00042-5', '']\n",
      "['9257392', 'Wright K; Kherani R; Zhao S; Goldsmith C. Do inflammatory arthritis inpatients receiving group music therapy improve pain compared to music listening over the 6 weeks using a randomised controlled open-label trial?: \"One good thing about music, when it hits, you feel no pain\". Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) 45 7 pp979-980', '10.4103/1357-6283.120709', '']\n",
      "['9257394', 'Abou-Raya S; Abou-Raya A. Cognitive behavioural therapy for treatment of insomnia in older adults with symptomatic knee osteoarthritis: A randomized trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2614', '']\n",
      "['9257396', 'Vliet Vlieland TPM; Zwinderman AH; Breedveld FC. Favourable effect of a short period of inpatient multidisciplinary team care i rheumatoid arthritis: a randomized trial. Nederlands tijdschrift voor geneeskunde. (1997) 141 15 pp727-731', '10.1002/art.10665', '']\n",
      "['9257397', 'Thomsen T; Aadahl M; Hetland ML; Beyer N; Loeppenthin K; Esbensen BA. Reduction of sedentary behaviour in patients with rheumatoid arthritis. A randomized feasibility study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3097', '']\n",
      "['9257398', 'Taylor-Gjevre R; Nair B; Bath B; Okpalauwaekwe U; Sharma M; Penz E; Trask C; Stewart S. Addressing rural and remote access disparities for patients with inflammatory arthritis through videoconferencing and innovative inter-professional care models. Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) 45 7 pp1001-1002', '10.1002/msc.1215', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1215']\n",
      "['9257399', \"Hammond A; Prior Y; O'Brien R; Woodbridge S; Radford K. Work rehabilitation in inflammatory arthritis: A pilot randomised controlled trial. Annals of the rheumatic diseases. (2014) 73  pp\", '10.1136/annrheumdis-2014-eular.5378', '']\n",
      "['9257400', 'Huang D; Peng Y; Su P; Ye W; Liang A. The effect of continuous passive motion after total knee arthroplasty on joint function. Chinese journal of clinical rehabilitation. (2003) 7 11 pp1661-1662', '10.5005/jp/books/13027_84', '']\n",
      "['9257402', 'Boire G; Dobkin P; Gaboury I; Gervais F; Beaulieu M-C; Dagenais P; Roberge P; Roux S. Addressing persistent depressive symptoms in rheumatoid arthritis patients with controlled disease. Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) 45 7 pp1027-1028', '10.26443/ijwpc.v7i1.210', 'https://ijwpc.mcgill.ca/article/download/210/250']\n",
      "['9257403', 'Furuta E; Yoshioka K; Sato H; Yorozu H; Ichibangase Y; Tawara T; Yasuda M; Nobunaga M. Effect of the octylphthalide bathing on rheumatoid arthritis. Journal of Japanese Association of Physical Medicine Balneology and Climatology. (1995) 58 3 pp174-179', '10.2169/internalmedicine.35.478', '']\n",
      "['9257405', 'Suzuki M; Tse S; Hirai M; Kurebayashi Y. Application of Physiologically-Based Pharmacokinetic Modeling for the Prediction of Tofacitinib Exposure in Japanese. The Kobe journal of medical sciences. (2017) 62 6 ppE150-E161', '10.1002/jcph.1679', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1679']\n",
      "['9257407', 'Mizushina K; Ogura T; Hirata A; Hayashi N; Kameda H. Possible preventive effect of salazosulfapyridine on the development of pneumocystis pneumonia in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3092', '']\n",
      "['9257408', 'Smith JA; Thompson DJ; Whitcup SM; Suhler E; Clarke G; Smith S; Robinson M; Kim J; Barron KS. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis and rheumatism. (2005) 53 1 pp18-23', '10.1002/art.20904', '']\n",
      "['9257409', 'Bonafede M; Johnson BH; Tang D; Shah N; Harrison D; Collier D. Adherence and persistence with triple non-biologic disease modifying antirheumatic drug therapy and etanercept-methotrexate combination therapy in us patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1913', '']\n",
      "['9257410', 'Euesden J; Matcham F; Hotopf M; Steer S; Cope AP; Lewis CM; Scott IC. The Relationship Between Mental Health, Disease Severity, and Genetic Risk for Depression in Early Rheumatoid Arthritis. Psychosomatic medicine. (2017) 79 6 pp638-645', '10.1097/psy.0000000000000462', '']\n",
      "['9257411', 'Clauss M; Bolliger L; Brandenberger D; Ochsner PE; Ilchmann T. Similar effect of stem geometry on radiological changes with 2 types of cemented straight stem. Acta orthopaedica. (2016) 87  2 pp120-125', '10.3109/17453674.2015.1104153', '']\n",
      "['9257412', 'van den Hout WB; de Jong Z; Munneke M; Hazes JM; Breedveld FC; Vliet Vlieland TP. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis. Arthritis and rheumatism. (2005) 53 1 pp39-47', '10.1002/art.20903', '']\n",
      "['9257414', 'Sekiguchi M; Fujii T; Matsui K; Murakami K; Morita S; Ohmura K; Kawahito Y; Nishimoto N; Mimori T; Sano H. Differences in predictive factors for sustained clinical remission with abatacept between younger and elderly patients with biologic-naive rheumatoid arthritis: results from the abroad study. Journal of rheumatology. (2016) 43 11 pp1974-1983', '10.3899/jrheum.160051', '']\n",
      "['9257415', 'Batticciotto A; Covelli M; Dinoia L; Rinaldi A; Giacuzzo S; Govoni M; Biasi D; Dal Forno I; Benucci M; Li Gobbi F; Caporali R; Todoerti M; Cimmino MA; Zampogna G; Marchesoni A; Gibertini P; Pellerito R; Vitetta R; De Vita S; Quartuccio L; Paolazzi G; Sarzi-Puttini P. Rituximab retention rate in clinical practice: A large multicentre italian cohort of rheumatoid arthritis patients. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3994', '']\n",
      "['9257416', 'Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J. Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components. Zeitschrift fuÃàr Rheumatologie. (2006) 65 6 pp527-534', '10.1007/s00393-005-0024-1', 'http://link.springer.com/article/10.1007/s00393-005-0024-1/fulltext.html']\n",
      "['9257419', 'Negi A; Pandey P; Singh B. A clinical study to evaluate the efficacy of Saindhavadi Taila Matra Vasti in the management of Amavata W.S.R. rheumatoid arthritis. Asian journal of pharmaceutical and clinical research. (2017) 10 12 pp435-439', '10.22159/ajpcr.2017.v10i12.20647', 'https://innovareacademics.in/journals/index.php/ajpcr/article/viewFile/20647/13347']\n",
      "['9257420', 'de Buck PD; de Bock GH; van Dijk F; van den Hout WB; Vandenbroucke JP; Vliet Vlieland TP. Sick leave as a predictor of job loss in patients with chronic arthritis. International archives of occupational and environmental health. (2006) 80 2 pp160-170', '10.1007/s00420-006-0116-5', 'http://link.springer.com/article/10.1007/s00420-006-0116-5/fulltext.html']\n",
      "['9257421', 'Cheung P; Lahiri M; Teng GG; Lim A; Lau TC; Lateef A; Mak A; Gossec L; March L. A randomized controlled TRIAL of improving patient self-assessment of synovitis in rheumatoid arthritis with education by ultrasonography: The raeus study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2203', '']\n",
      "['9257422', 'Siu S; Haraoui B; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Pope JE. Effect of disease modifying drugs on bone mineral density in patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis: A meta-analysis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2540', '']\n",
      "['9257423', 'Kivitz A; Maciag P; Gulati P; Du S; Connolly SE; Davies P; Li X; Repsher T; Haggerty HG; Londei M. Lack of efficacy of CCR1 antagonist BMS-817399 in patients with moderate to severe rheumatoid arthritis: Results of 12-week proof-of-concept study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3871', '']\n",
      "['9257425', 'Huizinga T; Nigrovic P; Ruderman E; Schulze-Koops H. CCR5 blockade in rheumatoid arthritis: A randomised, double-blind, placebo-controlled clinical trial. Commentary. International Journal of Advances in Rheumatology. (2011) 9  1 pp26', '10.1007/s00296-002-0278-8', 'http://link.springer.com/article/10.1007/s00296-002-0278-8/fulltext.html']\n",
      "['9257427', 'Mishra P; Trivedi V. Acupuncture in the treatment of rheumatoid arthritis: Results of a randomized controlled trial. Annals of the rheumatic diseases. (2014) 73 Suppl2 pp226', '10.1136/annrheumdis-2014-eular.2199', '']\n",
      "['9257428', 'Huizinga T; Nigrovic P; Ruderman E; Schulze-Koops H. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, Phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents - Commentary. International Journal of Advances in Rheumatology. (2011) 9  2 pp74', '10.1002/art.30114', '']\n",
      "['9257429', 'Shiozawa S; Shiozawa K; Kita M; Kishida T; Fujita T; Imura S. A preliminary study on the effect of alpha-interferon treatment on the joint inflammation and serum calcium in rheumatoid arthritis. British journal of rheumatology. (1992) 31 6 pp405-408', '10.1093/rheumatology/31.6.405', 'http://academic.oup.com/rheumatology/article-pdf/31/6/405/5035196/31-6-405.pdf']\n",
      "['9257430', 'Minor MA; Hewett JE. Physical fitness and work capacity in women with rheumatoid arthritis. Arthritis care and research. (1995) 8 3 pp146-154', '10.1002/art.1790080306', '']\n",
      "['9257433', 'Lee P; Rose BS; Anderson JA; Caughey DE. Naproxen in the treatment of rheumatoid arthritis. New Zealand medical journal. (1978) 87 614 pp425-427', '10.1111/j.1445-5994.1978.tb04799.x', '']\n",
      "['9257434', 'Karag√ºlle M; Karde≈ü S; Karag√ºlle MZ. Long-term efficacy of spa therapy in patients with rheumatoid arthritis. Rheumatology international. (2018) 38 3 pp353-362', '10.1007/s00296-017-3926-8', 'http://link.springer.com/article/10.1007/s00296-017-3926-8/fulltext.html']\n",
      "['9257436', 'Tulina D. Double blind study of combined IL-1Ra (Reginapep) treatment with cartilage and synovial MitoOrganelles peptides of patients with acute rheumatoid arthritis. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp110', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9257438', 'Park JY; Kim KA; Lee YH; Park SW; Lee GH; Ryu JH. Pharmacokinetic comparison and bioequivalence of two leflunomide formulations in humans: a single dose, randomized, open-label, two-way crossover study. International journal of clinical pharmacology and therapeutics. (2010) 48 4 pp291-295', '10.5414/cpp48291', '']\n",
      "['9257439', 'Lucker GP; van de Kerkhof PC; Cruysberg JR; der Kinderen DJ; Steijlen PM. Topical treatment of Sj√∂gren-Larsson syndrome with calcipotriol. Dermatology (Basel, Switzerland). (1995) 190 4 pp292-294', '10.1159/000246719', 'https://www.karger.com/Article/Pdf/246719']\n",
      "['9257440', 'Bijlsma A. The long-term efficacy and tolerability of Voltaren (diclofenac sodium) and indomethacin in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1978)  22 pp74-80', '10.3109/03009747809097221', '']\n",
      "['9257441', 'Kajander A; Martio J. Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: a comparative double-blind study. Scandinavian journal of rheumatology. Supplement. (1978) 1978 22 pp57-62', '10.3109/03009747809097218', '']\n",
      "['9257442', 'Bijlsma A; ten Pas JG. A study of the anti-inflammatory effect of Voltaren in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1978) 1978 22 pp46-50', '10.3109/03009747809097216', '']\n",
      "['9257443', 'Mutru O; Penttil√§ M; Pesonen J; Salmela P; Suhonen O; Sonck T. Diclofenac sodium (Voltaren) and indomethacin in the ambulatory treatment of rheumatoid arthritis: a double-blind multicentre study. Scandinavian journal of rheumatology. Supplement. (1978) 1978 22 pp51-56', '10.3109/03009747809097217', '']\n",
      "['9257444', 'Ruotsi A; Skrifvars B. A long-term double-blind comparative study on proquazone (Biarison) and ibuprofen in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1978) 1978 21 pp28-32', '10.3109/03009747809095672', '']\n",
      "['9257445', 'Bragstad A. A comparative, double-blind trial with proquazone and naproxen in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1978) 1978 21 pp33-35', '10.3109/03009747809095673', '']\n",
      "['9257446', 'De Faria AP; Santa-Catharina A; Ritter A; Modolo R; Pioli M; Pires N; Bertolo M; Moreno H. Effects of tnf-alpha inhibiton on hemodynamic parameters and biomarkers in resistant hypertension. Journal of hypertension. Conference: 28th scientific meeting of the european society of hypertension, ESH 2018. Spain. (2018) 36 Suppl  1 ppe48-e49', '10.1097/01.hjh.0000539092.97172.4f', '']\n",
      "['9257447', 'Camus JP; Fournie A; Ayrolles C; et al. A double-blind comparative trial of Bi-Profenid tablets and Profenid capsules in inflammatory joint disease. Semaine des hopitaux. (1983) 59 46 pp3221-3224', '10.1212/wnl.58.11.1660', '']\n",
      "['9257450', 'Chan FKL; Ching JYL; Tse YK; Lam K; Wong GLH; Ng SC; Lee V; Au KWL; Cheong PK; Suen BY; Chan H; Kee KM; Lo A; Wong VWS; Wu JCY; Kyaw MH. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet (london, england). (2017) 389 10087 pp2375-2382', '10.1016/s0140-6736(17)30981-9', '']\n",
      "['9257451', 'Hermann F; Forster A; Chenevard R; Enseleit F; H√ºrlimann D; Corti R; Spieker LE; Frey D; Hermann M; Riesen W; Neidhart M; Michel BA; Hellermann JP; Gay RE; L√ºscher TF; Gay S; Noll G; Ruschitzka F. Simvastatin improves endothelial function in patients with rheumatoid arthritis. Journal of the American College of Cardiology. (2005) 45 3 pp461-464', '10.1016/j.jacc.2004.11.006', '']\n",
      "['9257452', 'Kamel M; Serafi T. Fucose concentrations in sera from patients with rheumatoid arthritis. Clinical and experimental rheumatology. (1995) 13 2 pp243-246', '10.1093/rheumatology/34.7.7', 'http://academic.oup.com/rheumatology/article-pdf/34/7/7/5044582/34-7-7.pdf']\n",
      "['9257453', 'Scott J; Dieppe PA; Huskisson EC. Continuous and intermittent levamisole. A controlled trial. Annals of the rheumatic diseases. (1978) 37 3 pp259-261', '10.1136/ard.37.3.259', '']\n",
      "['9257454', 'Hall GH; Jones BJ; Head AC; Jones VE. Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Annals of the rheumatic diseases. (1978) 37 4 pp351-356', '10.1136/ard.37.4.351', '']\n",
      "['9257455', 'Tak PP; Bacchi M; Bertolino M. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. European journal of drug metabolism and pharmacokinetics. (2006) 31 2 pp109-116', '10.1007/bf03191127', 'http://link.springer.com/article/10.1007/BF03191127/fulltext.html']\n",
      "['9257456', \"Sugai S; Koike T; Miyasaka N; Konno A; Fujibayashi T; Sumida T; Kawai S; Origasa H. Dose-finding study of oral pilocarpine for the treatment of xerostomia associated with Sjogren's syndrome. [Japanese]. Japanese Pharmacology and Therapeutics. (2007) 35 SUPPL. 2 ppS141-S153\", '10.3109/s10165-004-0338-x', '']\n",
      "['9257457', 'Berry H; Swinson D; Jones J; Hamilton EB. Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (1978) 37 4 pp370-372', '10.1136/ard.37.4.370', '']\n",
      "['9257460', 'Howard DL. A double-blind crossover evaluation of ketoprofen (Orudis) and placebo in rheumatoid arthritis with assessment of long-term tolerance. Journal of international medical research. (1978) 6 4 pp300-305', '10.1177/030006057800600407', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057800600407']\n",
      "['9257461', 'Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study. International journal of rheumatic diseases. (2018) 21 5 pp1010-1017', '10.1111/1756-185x.12910', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12910']\n",
      "['9257462', 'Helm KF; Marks JG; Leyden JJ; Guzzo C; Krueger GG; Griffiths TW; Griffiths CE. Topical auranofin ointment for the treatment of plaque psoriasis. Journal of the American Academy of Dermatology. (1995) 33 3 pp517-519', '10.1016/0190-9622(95)91402-1', '']\n",
      "['9257464', 'Torrente-Segarra V; Acosta Pereira A; Morla R; Ruiz JM; Clavaguera T; Figuls R; Corominas H; Geli C; Rosello R; de Agustin JJ; Alegre C; Perez C; Garcia A; Rodriguez de la Serna A. VARIAR Study: assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist. Reumatologia clinica. (2016) 12 6 pp319-322', '10.1016/j.reumae.2015.11.020', '']\n",
      "['9257465', 'Mease P; Genovese MC; Gladstein G; Kivitz AJ; Ritchlin C; Tak PP; Wollenhaupt J; Bahary O; Becker JC; Kelly S; Sigal L; Teng J; Gladman D. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis and rheumatism. (2011) 63 4 pp939-948', '10.1002/art.30176', '']\n",
      "['9257466', 'Kim KH; Kang KW; Kim DI; Kim HJ; Yoon HM; Lee JM; Jeong JC; Lee MS; Jung HJ; Choi SM. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial. Menopause (New York, N.Y.). (2010) 17 2 pp269-280', '10.1097/gme.0b013e3181bfac3b', '']\n",
      "['9257467', \"Prior Y; Bodell S; Amanna A; Hammond A. Rheumatoid arthritis patients' views of a vocational rehabilitation intervention provided by rheumatology occupational therapists. Rheumatology (United Kingdom). (2014) 53  ppi121-i122\", '10.1093/rheumatology/keu106.008', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i121/9578623/keu106.008.pdf']\n",
      "['9257470', 'Murayama T; Ubukata A; Nakazaki S. [The treatment of rheumatoid arthritis with low dose pulse methotrexate--comparative study with other disease modifying antirheumatic drugs]. RyuÃÑmachi. [Rheumatism]. (1992) 32 1 pp3-11', '10.1136/annrheumdis-2001.1119', '']\n",
      "['9257471', 'Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients. American journal of gastroenterology. (1995) 90 9 pp1485-1488', '10.1016/0016-5085(95)22899-3', '']\n",
      "['9257472', 'Dunagan FM; McGill PE; Kelman AW; Whiting B. Naproxen dose and concentration: response relationship in rheumatoid arthritis. British journal of rheumatology. (1988) 27 1 pp48-53', '10.1093/rheumatology/27.1.48', 'http://academic.oup.com/rheumatology/article-pdf/27/1/48/5040125/27-1-48.pdf']\n",
      "['9257473', 'Ahern MJ; Harrison W; Hollingsworth P; Bradley J; Laing B; Bayliss C. A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. Australian and New Zealand journal of medicine. (1991) 21 6 pp844-849', '10.1111/j.1445-5994.1991.tb01405.x', '']\n",
      "['9257474', 'Cutolo M. Selective estrogen receptor agonism lacks clinical benefit in rheumatoid arthritis: comment on the article by van Vollenhoven et al. Arthritis and rheumatism. (2010) 62 12 pp3832-3833', '10.1002/art.27722', '']\n",
      "['9257475', 'Dos Santos MF; Furtado RN; Konai MS; Castiglioni ML; Marchetti RR; Silva CP; Natour J. Effectiveness of radiation synovectomy with Yttrium-90 and Samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, randomized, double-blinded trial. Clinical rheumatology. (2011) 30 1 pp77-85', '10.1007/s10067-010-1626-9', 'http://link.springer.com/article/10.1007/s10067-010-1626-9/fulltext.html']\n",
      "['9257476', 'Loudon JK; Cagle PE; Figoni SF; Nau KL; Klein RM. A submaximal all-extremity exercise test to predict maximal oxygen consumption. Medicine and science in sports and exercise. (1998) 30 8 pp1299-1303', '10.1097/00005768-199808000-00019', '']\n",
      "['9257477', 'Brosseau L; Judd MG; Marchand S; Robinson VA; Tugwell P; Wells G; Yonge K. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand. Cochrane database of systematic reviews (Online). (2003)  3 ppCD004377', '10.1002/14651858.cd004377', '']\n",
      "['9257478', 'Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Liot√© F; Debiais F; Juvin R; Le Goff P; Masson C. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. Journal of rheumatology. (1998) 25 8 pp1457-1461', '10.1007/bf02283116', 'https://link.springer.com/article/10.1007/BF02283116/fulltext.html']\n",
      "['9257479', 'van den Borne BE; Landew‚àö¬© RB; Goei The HS; Rietveld JH; Zwinderman AH; Bruyn GA; Breedveld FC; Dijkmans BA. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. Journal of rheumatology. (1998) 25 8 pp1493-1498', '10.1007/s100670050121', 'http://link.springer.com/article/10.1007/s100670050121/fulltext.html']\n",
      "['9257480', 'Hilliquin P; Chermat-Izard V; Menkes CJ. A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis. Journal of rheumatology. (1998) 25 8 pp1502-1507', '10.1136/gut.48.1.62', '']\n",
      "['9257481', 'Hammond A; Lincoln N; Sutcliffe L. A crossover trial evaluating an educational-behavioural joint protection programme for people with rheumatoid arthritis. Patient Education Counseling. (1999) 37 1 pp19-32', '10.1016/s0738-3991(98)00093-7', '']\n",
      "['9257482', \"Liew MS; Zhang M; Kim E; Akpek EK. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. British journal of ophthalmology. (2012) 96 12 pp1498-1503\", '10.1136/bjophthalmol-2012-301767', '']\n",
      "['9257483', 'Blyth T; Stirling A; Coote J; Land D; Hunter JA. Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide?. British journal of rheumatology. (1998) 37 7 pp770-772', '10.1093/rheumatology/37.7.770', 'http://academic.oup.com/rheumatology/article-pdf/37/7/770/18106340/370770.pdf']\n",
      "['9257484', 'Otter S; Church A; Murray A; Lucas J; Creasey N; Woodhouse J; Grant R; Cooper H. The effects of reflexology in reducing the symptoms of fatigue in people with rheumatoid arthritis: a preliminary study. Journal of alternative and complementary medicine (New York, N.Y.). (2010) 16 12 pp1251-1252', '10.1089/acm.2010.0557', '']\n",
      "['9257485', 'Vasiljevic D; Veselinovic M; Jovanovic M; Jeremic N; Arsic A; Vucic V; Lucic-Tomic A; Zivanovic S; Djuric D; Jakovljevic V. Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis. Clinical rheumatology. (2016) 35 8 pp1909-1915', '10.1007/s10067-016-3168-2', 'http://link.springer.com/article/10.1007/s10067-016-3168-2/fulltext.html']\n",
      "['9257486', 'Shishavan NG; Gargari BP; Kolahi S; Hajialilo M; Jafarabadi MA; Javadzadeh Y. Effects of vitamin K on matrix metalloproteinase-3 and rheumatoid factor in women with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Journal of the american college of nutrition. (2016) 35 5 pp392-398', '10.1080/07315724.2015.1026004', '']\n",
      "['9257488', 'Ansell BM; Carter ME; Gumpel JM; Meanock I; Rosenburg J; Steele CE. Clinical studies with tolmetin: open study and a double-blind cross-over comparison with aspirin in rheumatoid arthritis. Rheumatology and rehabilitation. (1978) 17 3 pp150-154', '10.1093/rheumatology/17.3.150', 'http://academic.oup.com/rheumatology/article-pdf/17/3/150/5038740/17-3-150.pdf']\n",
      "['9257489', \"Klestov AC; Webb J; Latt D; Schiller G; McNamara K; Young DY; et al. Treatment of xerostomia: A double-blind trial in 108 patients with Sjogren's syndrome. Oral Surgery, Oral Medicine, Oral Pathology. (1981) 51 6 pp594-599\", '10.1016/s0030-4220(81)80008-4', '']\n",
      "['9257490', \"De SS; Dryll A; Dreiser R. Clinical trial with bucloxic acid (CB 804) in rheumatology.  RESULTATS D'ESSAIS CLINIQUES DU BUCLOXATE DE CALCIUM (804 CB) EN RHUMATOLOGIE. ARZNEIMITTEL-FORSCH. (1974) 24 9A pp1425-1428\", '10.1016/s0335-7457(76)80040-8', '']\n",
      "['9257491', 'de Bl‚àö¬©court JJ. [Gold treatment in primary chronic polyarthritis (p.c.P.). Results of a double-blind study]. Verhandlungen der Deutschen Gesellschaft fu√É√†r Rheumatologie. (1978) 5  pp257-261', '10.1007/978-3-642-85459-0_38', '']\n",
      "['9257492', 'Tsvetkova ES. [Comparative effectiveness of voltaren and indomethacin in rheumatoid arthritis (according to the data of a double-blind study)]. TerapevticheskiiÃÜ arkhiv. (1978) 50 9 pp26-30', '10.3109/03009747809097218', '']\n",
      "['9257493', 'Liu J; Wang Y; Huang C; Xu J; Li Z; Xu L; He L; Sun Y; Wang Y; Xu S; Zhao P; Mao T; Tan B; Zhu F; Zhang P; Fang L. Efficacy and safety of Xinfeng capsule in patients with rheumatoid arthritis: a multi-center parallel-group double-blind randomized controlled trial. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2015) 35 5 pp487-498', '10.1016/s0254-6272(15)30130-8', '']\n",
      "['9257494', \"van der Giesen FJ; Nelissen RG; van Lankveld WJ; Kremers-Selten C; Peeters AJ; Stern EB; le Cessie S; Vliet Vlieland TP. Swan neck deformities in rheumatoid arthritis: a qualitative study on the patients' perspectives on hand function problems and finger splints. Musculoskeletal care. (2010) 8 4 pp179-188\", '10.1002/msc.180', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.180']\n",
      "['9257495', 'Casimiro L; Barnsley L; Brosseau L; Milne S; Robinson VA; Tugwell P; Wells G. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis. Cochrane database of systematic reviews (Online). (2005)  4 ppCD003788', '10.1002/14651858.cd003788.pub2', '']\n",
      "['9257497', 'Lazzerini PE; Acampa M; Hammoud M; Maffei S; Capecchi PL; Selvi E; Bisogno S; Guideri F; Galeazzi M; Pasini FL. Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. Journal of rheumatology. (2008) 35 10 pp1958-1965', '10.1007/s00395-007-0686-8', 'http://link.springer.com/article/10.1007/s00395-007-0686-8/fulltext.html']\n",
      "['9257498', 'Reveille JD; Alarcon GS; Fowler SE; Pillemer SR; Neuner R; Clegg DO; Mikhail IS; Trentham DE; Leisen JCC; Bluhm G; Cooper SM; Duncan H; Tuttleman M; Heyse SP; Sharp JT; Tilley B. HLA-DRB1 genes and disease severity in rheumatoid arthritis. Arthritis and rheumatism. (1996) 39 11 pp1802-1807', '10.1002/art.1780391105', '']\n",
      "['9257499', 'Nilsen KH; Jayson MI; Dixon AS. Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study. British medical journal. (1978) 2 6145 pp1124', '10.1136/bmj.2.6145.1124', '']\n",
      "['9257501', 'Mirelli E; Fichera G; Volpe AD; Lasala M. Endoscopic study of the gastro-intestinal tolerance of glucamethacin. Current medical research and opinion. (1978) 5 8 pp648-654', '10.1185/03007997809110202', '']\n",
      "['9257502', \"L'Ami MJ; Marsman AF; Krieckaert CLM; Nurmohamed MT; Ruwaard J; Visman IM; Kneepkens EL; Wolbink G. Tapering of adalimumab based on therapeutic drug monitoring in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4022-4024\", '10.1136/annrheumdis-2016-eular.2328', '']\n",
      "['9257504', 'Arjmandi BH; Khalil DA; Lucas EA; Smith BJ; Sinichi N; Hodges SB; Juma S; Munson ME; Payton ME; Tivis RD; Svanborg A. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. (2004) 11 7-8 pp567-575', '10.1016/j.phymed.2003.11.001', '']\n",
      "['9257507', 'Somer M; Kallio J; Pesonen U; Pyykk√∂ K; Huupponen R; Scheinin M. Influence of hydroxychloroquine on the bioavailability of oral metoprolol. British journal of clinical pharmacology. (2000) 49 6 pp549-554', '10.1046/j.1365-2125.2000.00197.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.2000.00197.x']\n",
      "['9257508', 'Krajka-Lauer J; Zdybel E; Kokot W; Gaweckl M; Raczy≈Ñska K; Adamski J; Iwaszkiewicz-Bilikiewicz B. [Microbiological evaluation of conjunctival sac in Sj√∂gren syndrome patients]. Klinika oczna. (2004) 106 3 Suppl pp528-529', '10.1097/00006231-200001000-00006', '']\n",
      "['9257509', 'Koski JM; Hermunen H. Intra-articular glucocorticoid treatment of the rheumatoid wrist. An ultrasonographic study. Scandinavian journal of rheumatology. (2001) 30 5 pp268-270', '10.1080/030097401753180336', '']\n",
      "['9257510', 'De Jonge MJ; Manders SHM; Huis AMP; Van De Laar MAFJ; Van Riel PLCM; Hulscher MEJL. Systematic development of a patient-centered strategy to improve tight control in daily clinical practice. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1492-1493', '10.1002/art.39977', '']\n",
      "['9257512', \"Persiani S; Manzotti C; Vitalini C; Giacovelli G; Girolami F; D'Amato M; Caselli G; Rovati LC. A first-in-human study of CR6086, a new potent EP4 prostanoid receptor antagonist, demonstrates good safety and tolerability at therapeutically relevant exposures. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1992-1993\", '10.33590/emjrheumatol/10314940', '']\n",
      "['9257513', 'Boonstra M; Dorjee AL; Quint KD; Huizinga TWJ; Scherer HU; De Vries-Bouwstra JK. The effect of rituximab on b cells in skin and peripheral blood in systemic sclerosis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3898-3900', '10.1002/art.39977', '']\n",
      "['9257515', 'Fu P-L; Li X-H; Wu Y-L; Xie Q-Y; Sun J-Y; Wu H-S. Comparison of midvastus and standard medial parapatellar approaches in total knee arthroplasty. Journal of Clinical Rehabilitative Tissue Engineering Research. (2008) 12 9 pp1793-1796', '10.3760/cma.j.issn.0366-6999.20140229', '']\n",
      "['9257516', 'Paek SI; Kim SH; Kim H; Chung MK; Lee J; Kwok S-K; Ju JH; Park S-H; Sohng KY. Effects of an educational program using treat to target strategy in Korean patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1489', '10.1002/art.39977', '']\n",
      "['9257518', 'Messmer E; Leonardi A; Amrane M; Ismail D; Figueiredo FC; Baudouin C. Pooling of two randomized phase III clinical trials of ciclosporin 1 mg/mL cationic emulsion (CsA CE) as a treatment for severe keratitis in patients with dry eye disease (DED). Investigative ophthalmology and visual science. Conference: 2016 annual meeting of the association for research in vision and ophthalmology, ARVO 2016. United states. (2016) 57 12 pp2871', '10.1111/j.1755-3768.2015.0664', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2015.0664']\n",
      "['9257519', \"Katsumoto T; Winter H; Kotwal S; Murray E; Zhao R; Florero M; Lin A; Moein A; Wang R; Bremer M; Kokubu S; Serone A; Morimoto A; Chinn L; Herman A. Safety, pharmacokinetics, and biomarker profile from phase 1 clinical trials of healthy volunteers treated with gdc-0853, a highly selective reversible oral bruton's tyrosine kinase (BTK) inhibitor. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3545-3546\", '10.1002/cpt.1056', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.1056']\n",
      "['9257521', 'Saito S; Suzuki K; Yamaoka K; Amano K; Tokuhira M; Takeuchi T. Restoration of decreased lymphocyte counts and the shift to th1 and effector memory CD8+T cell subsets associate with spontaneous regression of lympho-proliferative disorders developed in RA patients treated with methotrexate. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3456-3458', '10.1136/annrheumdis-2017-eular.4662', '']\n",
      "['9257522', 'De Thurah A; Appel Esbensen B; Roelsgaard IK; Frandsen TF; Primdahl J. The effect of nurse-led follow-up in rheumatoid arthritis. A systematic review and meta-analysis of randomized controlled trails. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1484-1485', '10.1136/rmdopen-2017-000481', '']\n",
      "['9257524', 'Berry H; Bloom B; Fernandes L; Morris M. Comparison of timegadine and naproxen in rheumatoid arthritis. A placebo controlled trial. Clinical rheumatology. (1983) 2 4 pp357-361', '10.1007/bf02041555', 'http://link.springer.com/article/10.1007/BF02041555/fulltext.html']\n",
      "['9257526', 'Yasuda S; Ohmura K; Kanazawa H; Kurita T; Kon Y; Ishii T; Jodo S; Tanimura K; Minami M; Izumiyama T; Matsumoto T; Amasaki Y; Suzuki Y; Kasahara H; Yamauchi N; Tsutsumi A; Takemori H; Koike T; Atsumi T. Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR)-a prospective, multicentered, single arm clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1987-1988', '10.1080/14397595.2017.1286714', '']\n",
      "['9257527', 'de Farias CC; Allemann N; Gomes J√Å. Randomized trial comparing amniotic membrane transplantation with lamellar corneal graft for the treatment of corneal thinning. Cornea. (2016) 35  4 pp438-444', '10.1097/ico.0000000000000754', '']\n",
      "['9257528', \"Bach GL; Fotiades P. [Treatment of rheumatoid arthritis with biarison. Results of a double-blind study with placebo (author's transl)]. Medizinische Klinik. (1978) 73 43 pp1517-1522\", '10.3109/03009747809095672', '']\n",
      "['9257529', 'Silverman MH; Strand V; Markovits D; Nahir M; Reitblat T; Molad Y; Rosner I; Rozenbaum M; Mader R; Adawi M; Caspi D; Tishler M; Langevitz P; Rubinow A; Friedman J; Green L; Tanay A; Ochaion A; Cohen S; Kerns WD; Cohn I; Fishman-Furman S; Farbstein M; Yehuda SB; Fishman P. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. Journal of rheumatology. (2008) 35 1 pp41-48', '10.1186/ar2078', 'https://link.springer.com/article/10.1186/ar2078/fulltext.html']\n",
      "['9257530', 'El-Ghobarey AF; Mavrikakis ME; Macleod M; Reynolds PM; Capell HA; Spencer DG; Balint G; Mathieu JP; McAllister T; Cooney A; Dick WC. Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Quarterly journal of medicine. (1978) 47 187 pp385-400', '10.1093/oxfordjournals.qjmed.a067548', 'http://academic.oup.com/qjmed/article-pdf/47/3/385/4513956/47-3-385.pdf']\n",
      "['9257532', 'Chopra A; Lavin P; Patwardhan B; Chitre D. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. Journal of rheumatology. (2000) 27 6 pp1365-1372', '10.1097/01.rhu.0000138087.47382.6d', '']\n",
      "['9257533', 'Valleala H; Teronen O; Friman C; Sorsa T; Solovieva S; Konttinen YT. Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritis. Journal of rheumatology. (2000) 27 6 pp1570-1572', '10.1016/s0945-053x(99)00030-x', '']\n",
      "['9257534', 'J√≥nsson T; Thorsteinsson H; Arinbjarnarson S; Thorsteinsson J; Valdimarsson H. Clinical implications of IgA rheumatoid factor subclasses. Annals of the rheumatic diseases. (1995) 54 7 pp578-581', '10.1136/ard.54.7.578', '']\n",
      "['9257535', 'De SM; Hazleman BL. Long-term azathioprine in rheumatoid arthritis: A double-blind study. Annals of the rheumatic diseases. (1981) 40 6 pp560-563', '10.1136/ard.40.6.560', '']\n",
      "['9257536', 'Lamberts DW; Langston DP; Chu W. A clinical study of slow-releasing artificial tears. Ophthalmology. (1978) 85 8 pp794-800', '10.1016/s0161-6420(78)35610-4', '']\n",
      "['9257537', 'Baker PN; Khaw FM; Kirk LM; Esler CN; Gregg PJ. A randomised controlled trial of cemented versus cementless press-fit condylar total knee replacement: 15-year survival analysis. Journal of bone and joint surgery. British volume. (2007) 89 12 pp1608-1614', '10.1302/0301-620x.89b12.19363', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.89B12.19363']\n",
      "['9257538', 'Bhettay E; Thomson AJ. Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis. South African medical journal. (1978) 54 7 pp276-278', '10.1007/bf03297797', 'http://link.springer.com/article/10.1007/BF03297797/fulltext.html']\n",
      "['9257540', 'Rasch L; Van Tuyl L; Kremer M; Bultink IEM; Boers M; Lems WF. Change in bone mineral density with high-dose prednisone in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp444-445', '10.1530/boneabs.5.p463', '']\n",
      "['9257541', \"Gofton JP; O'Brien W. Roentgenographic findings during auranofin treatment. American journal of medicine. (1983) 75 6A pp142-144\", '10.1016/0002-9343(83)90488-6', '']\n",
      "['9257543', 'Liu T-J; Zhang J-C; Gao X-Z; Tan Z-B; Wang J-J; Zhang P-P; Cheng A-B; Zhang S-B. Clinical research of goal-directed fluid therapy in elderly patients with radical resection of bladder cancer. Journal of cancer research and therapeutics. (2018) 14 8 Supplement ue 1 ppS173-S179', '10.4103/0973-1482.183206', '']\n",
      "['9257544', 'Anderson DR; Gross M; Robinson KS; Petrie D; Leighton R; Stanish W; Alexander D; Mitchell M; Flemming B; Gent M. Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications: the Postarthroplasty Screening Study (PASS). Chest. (1998) 114 2 Suppl Evidence pp119S-122S', '10.1378/chest.114.2_supplement.119s', '']\n",
      "['9257546', 'Kivitz AJ; Gupta R; Valenzuela G; Smith E; Rehman Q; El Kadi H; Bretton E; Aelion JA; Chadha A; Tesser J; Hough D; Korish S; Schafer PH; Ringheim G; Sutherland D; Li L. A phase 2a, 4-week double-blind, proof-of-concept efficacy and safety study of CC-292 versus placebo as co-therapy with methotrexate in active rheumatoid arthritis (RA). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1967-1968', '10.3899/jrheum.150613.c1', '']\n",
      "['9257548', 'Winthrop KL; Silverfield J; Racewicz A; Neal J; Lee EB; Hrycaj P; Gomez-Reino J; Soma K; Mebus C; Wilkinson B; Hodge J; Fan H; Wang T; Bingham CO. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  4 pp687-695', '10.1136/annrheumdis-2014-207191', '']\n",
      "['9257549', \"Carpenter D; Geryk L; Roberts C; Jonas BL; Blalock SJ. Rheumatoid arthritis patients' ability to accurately recall DMARD information immediately following an office visit with their rheumatologist. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp736-739\", '10.1002/art.39977', '']\n",
      "['9257550', 'Chatzidionysiou K; Emamikia S; Nam JL; Ramiro S; Smolen J; Van Der Heijde D; Dougados M; Bijlsma JWJ; Burmester G; Scholte-Voshaar M; Van Vollenhoven R; Landewe R. Efficacy and safety of conventional and targeted synthetic disease-modifying antirheumatic drugs as well as glucocorticoids: a systematic literature review informing the 2016 update of the eular recommendations for the management of rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3434-3437', '10.1136/annrheumdis-2016-210711', '']\n",
      "['9257551', 'Visvanathan S; Ramanujam M; Schoelch C; Baum P; Vinisko R; Thiedmann R; Muller-Ladner U; Daniluk S; Ptaszynski R; Padula S; Fine JS; Steffgen J. Treatment with BI 655064 (antagonistic anti-CD40 antibody) modulates clinical and biomarker parameters associated with rheumatoid arthritis (RA). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1968-1969', '10.1136/annrheumdis-2016-eular.2051', '']\n",
      "['9257553', 'Roberts B; Langridge A; Wilkinson J; Jones E; Lea E; Hargreaves B; Walker D; Lee M. Single 1G infusion vs double 1G infusion of rituximab in rheumatoid arthritis in a large teaching hospital: potential clinical benefits and financial savings. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3420-3421', '10.1002/art.39977', '']\n",
      "['9257554', \"Ngo W; Caffery B; Srinivasan S; Jones LW. Effect of lid debridement-scaling on dry eye signs and symptoms in Sjogren's syndrome. Investigative ophthalmology and visual science. Conference: 2015 annual meeting of the association for research in vision and ophthalmology, ARVO 2015. United states. (2015) 56 7 pp2487\", '10.1097/opx.0000000000000668', '']\n",
      "['9257555', 'Slade A; Koo P; He Y; Espie P; Auger-Sarrazin A; Rush JS; Gergely P. Assessment of safety, pharmacokinetics and pharmacodynamics of a novel anti CD40 monoclonal antibody, CFZ533, in healthy volunteers and in rheumatoid arthritis patients. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1959-1960', '10.1136/annrheumdis-2016-eular.3467', '']\n",
      "['9257556', 'Suomi R; Koceja DM. Postural sway characteristics in women with lower extremity arthritis before and after an aquatic exercise intervention. Archives of physical medicine and rehabilitation. (2000) 81 6 pp780-785', '10.1053/apmr.2000.4433', '']\n",
      "['9257558', \"Doerner T; Posch M; Wagner F; Hueser A; Fischer T; Mooney L; Petricoul O; Maguire P; Pal P; Doucet J; Cabanski M; Kamphausen E; Kazma R; Oliver S. Safety and efficacy of single dose VAY736 (anti-BAFF-R mAb) in patients with primary Sjogren's syndrome (PSS). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4052-4054\", '10.1136/annrheumdis-2016-eular.5840', '']\n",
      "['9257561', 'Aimer P; Stamp LK; Stebbings S; Cameron V; Kirby S; Treharne G. Exploring perceptions of a rheumatoid arthritis specific smoking cessation programme. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1482-1483', '10.1002/msc.1209', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1209']\n",
      "['9257562', 'Witcher J; Fleischmann R; Chindalore VL; Hansen RJ; Hu L; Radtke D; Voelker J; Gomez E; McColm J. Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus. British journal of clinical pharmacology. (2016) 81 5 pp908-917', '10.1111/bcp.12860', '']\n",
      "['9257564', 'Eklund KK; Leirisalo-Repo M; Ranta P; M√§ki T; Kautiainen H; Hannonen P; Korpela M; Hakala M; J√§rvinen P; M√∂tt√∂nen T. Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis. Clinical and experimental rheumatology. (2007) 25 5 pp684-689', '10.1080/03009740701753689', '']\n",
      "['9257565', 'Kuusalo L; Kautiainen H; Sokka-Isler T; Uutela T; Pirila L; Yli-Kerttula T; Kauppi MJ; Rannio T; Paalanen K; Kokko A; Asikainen J; Borodina J; Paltta J; Laiho K; Mullanmaa A; Puolakka K. Automated cell phone monitoring of disease activity and medication adherence in early rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4215-4217', '10.1002/acr.23846', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23846']\n",
      "['9257566', 'Glinatsi D; Bird P; Gandjbakhch F; Haavardsholm EA; Conaghan PG; Ostergaard M. Reliability and responsiveness of an omeract tenosynovitis magnetic resonance imaging scoring system for the rheumatoid arthritis wrist and hand. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1232-1233', '10.1136/annrheumdis-2016-eular.1445', '']\n",
      "['9257567', 'Atchia I; Kane D; Reed MR; Isaacs JD; Birrell F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Annals of the rheumatic diseases. (2011) 70 1 pp110-116', '10.1136/ard.2009.127183', '']\n",
      "['9257568', 'Anonymous. Baricitinib in patients with refractory rheumatoid arthritis.. Journal fur mineralstoffwechsel. (2016) 23 2 pp60-61', '10.3410/f.726253940.793518617', '']\n",
      "['9257569', 'Sileghem A; Geusens P; Dequeker J. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 6 pp761-764', '10.1136/ard.51.6.761', '']\n",
      "['9257570', 'Marshall DA; Hunter JA; Capell HA. Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 6 pp758-760', '10.1136/ard.51.6.758', '']\n",
      "['9257571', 'Alarc‚àö‚â•n GS; Casta‚àö¬±eda O; Nair MG; Ferr‚àö¬∞ndiz M; Koopman WJ; Krumdieck CL. Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (1992) 51 5 pp600-603', '10.1136/ard.51.5.600', '']\n",
      "['9257572', 'Gottenberg J-E; Morel J; Constantin A; Bardin T; Cantagrel A; Combe B; Dougados M; Flipo R-M; Saraux A; Schaeverbeke T; Sibilia J; Soubrier M; Vittecoq O; Perrodeau E; Ravaud P; Mariette X. Similar rates of death, serious infections, cancers, major cardiovascular events in patients treated with abatacept, rituximab and tocilizumab: long-term registry data in 4498 patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3536-3537', '10.1093/rheumatology/kex238', 'http://academic.oup.com/rheumatology/article-pdf/56/10/1746/20118614/kex238.pdf']\n",
      "['9257573', 'Hazarbassanov R; Yamasato C; Miura D; Barros J; Gomes JAP. Topical immunomodulator use in the treatment of primary or secondary Sjogren dry eye disease patients. Investigative ophthalmology and visual science. Conference: 2014 annual meeting of the association for research in vision and ophthalmology, ARVO 2014. United states. (2014) 55 13 pp3684', '10.1167/iovs.14-15332', '']\n",
      "['9257574', 'Gottenberg J-E; Morel J; Constantin A; Bardin T; Cantagrel AG; Combe B; Dougados M; Flipo R-M; Saraux A; Schaeverbeke T; Sibilia J; Soubrier M; Vittecoq O; Perrodeau E; Ravaud P; Mariette X. Long-term registry data in 4498 patients with rheumatoid arthritis indicate a similar safety but a different drug retention between abatacept, rituximab and tocilizumab. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2550-2553', '10.1136/bmj.l67', '']\n",
      "['9257577', 'Husni ME; Solomon DH; Wolski KE; Wisniewski LM; Nissen SE. The cardiovascular safety of celecoxib versus ibuprofen or naproxen in 24,081 patients with osteoarthritis or rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4354-4355', '10.1002/art.39977', '']\n",
      "['9257578', 'de Jong PH; Weel AE; de Man YA; Huisman AM; Gerards AH; van Krugten MV; Luime JJ; Hazes JM. Brief Report: to squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 10 pp3095-3101', '10.1002/art.34568', '']\n",
      "['9257579', 'Cooper JC; Eberhard BA; Punaro M; Ardoin SP; Brunner HI; Hsu J; Wagner-Weiner L; Rouster-Stevens K; Schanberg LE; Klein-Gitelman M; Von Scheven E. A pilot study of consensus treatment plans for induction therapy in childhood proliferative lupus nephritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1743-1744', '10.1002/art.38438', '']\n",
      "['9257580', 'Barbo A; Suarez-Almazor M; Lopez-Olivo MA. Impact of decision-making role preferences in the efficacy of a multimedia patient education tool for patients with common rheumatologic conditions. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1473-1474', '10.1002/art.39977', '']\n",
      "['9257581', 'Sokolove J; Schiff M; Fleischmann R; Weinblatt ME; Connolly SE; Johnsen A; Zhu J; Maldonado MA; Patel S; Robinson WH. Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial. Annals of the rheumatic diseases. (2016) 75  4 pp709-714', '10.1136/annrheumdis-2015-207942', '']\n",
      "['9257582', 'Ogata A; Takagi N; Miwa H. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in RA patients with an inadequate response to subcutaneous tocilizumab every other week. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1973-1974', '10.1080/14397595.2017.1332507', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1332507']\n",
      "['9257583', 'Allyn L; Zoller L; Backman CL; Lacaille D. Content analysis of ergonomic recommendations using the ergonomic assessment tool for arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4348', '10.1002/art.39977', '']\n",
      "['9257584', 'Zamora NV; Tayar J; Lopez-Olivo MA; Christensen R; Suarez-Almazor M. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1974-1975', '10.1136/annrheumdis-2016-eular.4449', '']\n",
      "['9257585', 'Gottenberg J-E; Morel J; Constantin A; Bardin T; Cantagrel AG; Combe B; Dougados M; Flipo R-M; Saraux A; Schaeverbeke T; Sibilia J; Soubrier M; Vittecoq O; Perrodeau E; Ravaud P; Mariette X. Seropositivity for RF or ACPA predicts long term drug retention with rituximab, but not with abatacept and tocilizumab : long-term registry data in 4498 patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3535-3536', '10.1136/bmj.l67', '']\n",
      "['9257586', 'M‚àö¬ßkisara P; Nissil‚àö¬ß M; Kajander A; Martio J; von Essen R; Anttila P; M‚àö¬ßkisara GL. Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Scandinavian journal of rheumatology. (1978) 7 3 pp166-170', '10.3109/03009747809095648', '']\n",
      "['9257587', \"Gottenberg J-E; Dorner T; Bootsma H; Devauchelle-Pensec V; Bowman S; Kosutic G; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Mariette X; Gordon C. Epratuzumab treatment of patients with systemic lupus erythematosus and secondary Sjogren's syndrome: an exploratory analysis of phase 3 studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3594-3596\", '10.1002/art.40425', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40425']\n",
      "['9257588', 'Griffin AJ; Grahame R; Bloch M; Gibson T. Ketoprofen: double-blind cross-over study with indomethacin administered as a combined suppository/capsule regime in patients with rheumatoid arthritis. A preliminary report. Rheumatology and rehabilitation. (1978) Suppl Suppl pp84-89', '10.1093/rheumatology/xvii.suppl.84', 'http://academic.oup.com/rheumatology/article-pdf/XVII/suppl/84/5163114/XVII-suppl-84.pdf']\n",
      "['9257589', 'Ferraccioli G; Guerra P; Rizzi V; Bartoli E. Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases. Journal of rheumatology. (1995) 22 6 pp1060-1064', '10.1210/endo-118-2-888', 'http://academic.oup.com/endo/article-pdf/118/2/888/10677444/endo0888.pdf']\n",
      "['9257592', 'Wollheim FA; Lindroth Y; Sj√∂blom KG. A comparison of ketoprofen and naproxen in rheumatoid arthritis. Rheumatology and rehabilitation. (1978) Suppl Suppl pp78-83', '10.1093/rheumatology/xvii.suppl.78', 'http://academic.oup.com/rheumatology/article-pdf/XVII/suppl/78/5163110/XVII-suppl-78.pdf']\n",
      "['9257593', 'Zhao Q; Chen X; Hou Y; Jiang J; Zhong W; Yao X; Wang W; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, pharmacodynamics, safety, and clinical activity of multiple doses of RCT-18 in chinese patients with systemic lupus erythematosus. Journal of clinical pharmacology. (2016) 56 8 pp948-959', '10.1002/jcph.686', '']\n",
      "['9257595', 'Schned ES; Doyle MA; Glickstein SL; Schousboe JT; Reinertsen JL; Baglioni AJ; Tolson TF. Team managed outpatient care for early onset chronic inflammatory arthritis. Journal of rheumatology. (1995) 22 6 pp1141-1148', '10.1093/rheumatology/34.7.22', 'http://academic.oup.com/rheumatology/article-pdf/34/7/22/5043150/34-7-22.pdf']\n",
      "['9257596', \"Zhang L; Jiang W; Chu C-Q; Liu Y. Therapeutic efficacy of iguratimod in patients with primary Sjogren's syndrome. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3596-3597\", '10.1002/art.39977', '']\n",
      "['9257598', 'Zwetkowa ES. Comparative study of efficacy of Voltaren and indomethacin in chronic polyarthritis (double-blind trial). Die Therapiewoche. (1980) 30 15 pp2616-2618', '10.26226/morressier.5afadd88f314ac000849ae6b', '']\n",
      "['9257600', 'Jiao J; Yin H-B; Tang X-P; Gong X; Jiang Q. Tripterygium wilfordii hook f applied topically in patients with active rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3475-3476', '10.1002/art.39977', '']\n",
      "['9257603', 'Sukenik S; Buskila D; Neumann L; Kleiner-Baumgarten A. Mud pack therapy in rheumatoid arthritis. Clinical rheumatology. (1992) 11 2 pp243-247', '10.1007/bf02207966', 'http://link.springer.com/article/10.1007/BF02207966/fulltext.html']\n",
      "['9257604', 'Mayoux-Benhamou A; Giraudet-Le Quintrec JS; Ravaud P; Champion K; Dernis E; Zerkak D; Roy C; Kahan A; Revel M; Dougados M. Influence of patient education on exercise compliance in rheumatoid arthritis: a prospective 12-month randomized controlled trial. Journal of rheumatology. (2008) 35 2 pp216-223', '10.1016/s0168-6054(99)85186-1', '']\n",
      "['9257608', 'Genovese MC; Weinblatt M; Aelion JA; Mansikka HT; Peloso PM; Chen K; Li Y; Othman AA; Khatri A; Khan NS; Padley RJ. ABT-122, a TNF- and IL-17-targeted dual variable domain (DVD)-igTM in rheumatoid arthritis patients with inadequate response to methotrexate: results from a phase 2 trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp855-857', '10.1002/art.40580', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40580']\n",
      "['9257609', 'Salman S; Jawad HM; Shukur S. Atorvastatin in treatment of rheumatoid arthritis. International journal of rheumatic diseases. (2014) 17  pp58', '10.1136/ard.48.2.174-a', '']\n",
      "['9257610', 'Hagen M; Figueiredo CP; Cobra JF; Haschka J; Reiser M; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Finzel S; Tony H-P; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H-M; Nusslein HG; Alten R; Henes JC; Kruger K; Schett G; Rech J. Effects of DMARD tapering on treatment costs and work productivity in rheumatoid arthritis patients-an analysis from the prospective randomized controlled retro-study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp124-126', '10.1136/annrheumdis-2016-eular.4840', '']\n",
      "['9257611', 'Konthur Z; Wiemkes MM; Haupl T; Burmester GR; Skriner K. Rituximab treated non responder rheumatoid arthritis patients are generating a new autoantibody repertoire. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2736-2737', '10.1136/annrheumdis-2016-eular.2977', '']\n",
      "['9257612', 'Ruzek M; Konrad M; Conlon D; Grebe KM; Slavin A; Mansikka HT; Cuff C; Padley RJ. ABT-122, an anti-TNF/anti-IL-17 dual variable domain antibody, alters T cell responses in human subjects. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp852-853', '10.1002/art.39977', '']\n",
      "['9257613', 'Gibson RG; Gibson SL; MacNeill AD; Gray GH; Dick WC; Buchanan WW. Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. British journal of clinical pharmacology. (1978) 6 5 pp391-395', '10.1111/j.1365-2125.1978.tb04602.x', '']\n",
      "['9257614', 'Gossec L; Soubrier M; Foissac F; Molto A; Bardin T; Berenbaum F; Cantagrel A; Cerato MH; Chales GH; Chary-Valckenaere I; Combe B; Labous ED; Euller-Ziegler L; Flipo R-M; Gaudin P; Gilson M; Guis S; Mariette X; Mouterde G; Pouplin S; Richette P; Saraux A; Schaeverbeke T; Sibilia J; Fayet F; Dougados M. One third of patients with established rheumatoid arthritis (RA) are correctly vaccinated against influenza and pneumococcus and this is increasing: 3 year longitudinal assessment of 776 patients. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1874-1876', '10.1136/annrheumdis-2016-eular.2462', '']\n",
      "['9257615', 'Peterfy C; Bird P; Countryman P; Joshua F; Hall S; Griffiths H; Youssef P; Holmes A. Enriching rheumatoid arthritis trial cohorts with erosion progressors by screening for active erosions (erosions with osteitis) with mri. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1642-1643', '10.1002/art.39977', '']\n",
      "['9257616', 'Sweezie R; Bell M; Goldsmith CH; Chiu I; Gutlin A; Sandhu S. Long-term stability of the 5-item compliance questionnaire rheumatology as a measure of adherence in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3361-3362', '10.1002/art.39977', '']\n",
      "['9257617', 'Gibson RG; Gibson SL; MacNeill AD; Buchanan WW. Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. British journal of clinical pharmacology. (1980) 9 5 pp453-459', '10.1111/j.1365-2125.1980.tb05840.x', '']\n",
      "['9257618', 'Khatri A; Klunder B; Minocha M; Mansikka HT; Othman AA. Exposure-response analyses of efficacy of ABT-122, a dual-variable domain immunoglobulin (DVD-IgTM) targeting TNF-alpha and IL-17a, compared with adalimumab in subjects with rheumatoid arthritis and background MTX. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp847-848', '10.1002/art.39977', '']\n",
      "['9257619', 'Parisi S; Carrara G; Scire CA; Batticciotto A; Bellis E; Canzoni M; De Lucia O; Farina I; Venditti C; Iagnocco A; Filippou G. Relationship between the prevalence of subclinical tenosynovitis and therapy in patients with RA in clinical remission: results from Italian society of rheumatology study group. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp184-186', '10.1093/rheumatology/kew258', 'http://academic.oup.com/rheumatology/article-pdf/55/10/1826/17389032/kew258.pdf']\n",
      "['9257620', 'Valleala H; Laitinen K; Pylkkanen L; Konttinen YT; Friman C. Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - Double blind placebo controlled study. Inflammation research. (2001) 50 12 pp598-601', '10.1007/pl00000240', 'http://link.springer.com/article/10.1007/PL00000240/fulltext.html']\n",
      "['9257621', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; Loeppenthin K; Midtgaard J; Christensen R; Ostergaard M; Jennum P; Esbensen BA. The efficacy of motivational counselling and sms-reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp590-591', '10.1136/annrheumdis-2016-eular.4668', '']\n",
      "['9257622', 'Ward L; Stebbings S; Athens J; Cherkin D; Baxter GD. Yoga for pain and sleep quality in rheumatoid arthritis: A pilot randomized controlled trial. Journal of alternative and complementary medicine (New York, N.Y.). (2014) 20  5 ppA88', '10.1089/acm.2014.5231.abstract', '']\n",
      "['9257623', 'Smolen JS; Choe J-Y; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Choi J; Rho YH. Comparable safety and immunogenicity and sustained efficacy after transition to SB2 (an infliximab biosimilar) vs ongoing reference infliximab (remicade) in patients with rheumatoid arthritis: results of phase III transition study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3506-3508', '10.1136/annrheumdis-2016-eular.3122', '']\n",
      "['9257624', 'Seneca T; Hauge EM; Maribo T. Comparable effect of partly supervised and self-administered exercise programme in early rheumatoid arthritis--a randomised, controlled trial. Danish medical journal. (2015) 62 8 ppA5127', '10.1186/isrctn18282428', '']\n",
      "['9257625', 'Geusens P; Alten R; Rovensky J; Sloan VS; Krammer G; Kralidis G; Richardson P. Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis. International journal of clinical practice. (2004) 58 11 pp1033-1041', '10.1111/j.1368-5031.2004.00398.x', '']\n",
      "['9257627', 'Kumar P; Strang A; Ho M; Maple C; Radederstoff D; Morley K; Belch J. The effects of borage oil supplementation on non-steroidal anti-inflammatory drug requirements in patients with rheumatoid arthritis. Journal of Complementary and Integrative Medicine. (2008) 5 1 pp23', '10.2202/1553-3840.1133', '']\n",
      "['9257628', 'Grace EM; Rosenfeld JM; Sweeney GD; Buchanan WW. The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis. Current medical research and opinion. (1987) 10 9 pp580-591', '10.1185/03007998709112411', '']\n",
      "['9257629', 'Ammitzboll-Danielsen M; Ostergaard M; Fana V; Glinatsi D; Dohn UM; Ornbjerg LM; Naredo E; Terslev L. Intramuscular versus ultrasound guided peritendinous glucocorticoid injection for tenosynovitis in patients with rheumatoid arthritis-a randomised, double-blind, controlled study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2509-2511', '10.1136/annrheumdis-2016-eular.1707', '']\n",
      "['9257630', 'Hagfors L; Leanderson P; Sk√∂ldstam L; Andersson J; Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutrition journal. (2003) 2  pp5', '10.1186/1475-2891-2-5', 'http://link.springer.com/article/10.1186/1475-2891-2-5/fulltext.html']\n",
      "['9257631', 'Xu X; Dong B; Hsu C-H; Hu C; Lei C; Song J; Lu J; Beutler A. Physician/site staff assessments contribute to high placebo response in rheumatoid arthritis clinical trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3501-3503', '10.1002/art.39977', '']\n",
      "['9257633', 'Graninger M; Handl-Zeller L; Hohenberg G; Staudenherz A; Kainberger F; Graninger W. Teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy. Annals of the rheumatic diseases. (2005) 64 1 pp138-140', '10.1136/ard.2004.021766', '']\n",
      "['9257634', 'Grant E; Schwickart M; Godwood A; Moate R; Song E; Chavez C; Albulescu M; Close D; Liang M; Mustelin T; Yao Z; Ranade K. Lack of autoantibodies to peptidyl arginine deiminase 4 predict increased efficacy of mavrilimumab in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3559-3560', '10.1002/art.39977', '']\n",
      "['9257635', 'Kumar A; Dhir V; Sharma A; Sharma S; Singh S. Comparison of intra-articular methylprednisolone acetate with triamcinolone acetonide in acutely swollen knee joint of patients with chronic inflammatory arthritis-a randomized controlled trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3484-3487', '10.1016/j.clinthera.2016.11.023', '']\n",
      "['9257636', 'Burgers LE; Allaart CF; Huizinga TWJ; Van Der Helm-van Mil AHM. Clinical trials aiming to prevent the development of rheumatoid arthritis cannot detect prevention without adequate risk stratification; a trial performed in uapatients as example. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3562-3563', '10.1002/art.40062', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40062']\n",
      "['9257638', 'Vasanthakumar V; Haslock I. The effects of differing pharmaceutical preparations of indomethacin on night pain and morning stiffness in patients with rheumatoid arthritis. Current medical research and opinion. (1987) 10 9 pp592-595', '10.1185/03007998709112412', '']\n",
      "['9257639', 'Fernandez-Diaz C; Loricera J; Castaneda S; Ojeda-Garcia C; Olive A; Carreira PE; Sandoval TP; Retuerto M; Perez ECC; Rodriguez-Muguruza S; Flores BJR; Hernandez-Cruz B; Urruticoechea A; Alonso OM; Palma D; Arboleya L; Bonilla G; Hernandez-Rodriguez I; Delgado C; Molinero RE; Escribano AR; Madrigal JB; Bernal JA; Rodriguez-Gomez M; Casasempere PV; Alvarez-Rodriguez B; Manteca MCF; Sanjuan FO; Narvaez J; Moreno MJ; Lopez-corbeto M; Mena-Vazquez N; Dominguez-Casas LC; Aguilera-Cros C; Mora-Cuesta V; Palmou-Fontana N; Gonzalez-Gay MA; Hernandez JL; Blanco R. Abatacept in rheumatoid arthritis with interstitial lung disease: a multicenter study of 55 patients. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3477-3480', '10.1136/annrheumdis-2016-eular.5255', '']\n",
      "['9257641', 'Yan C; Chiu K; Ng F; Chan P; Fang C. A randomized controlled trial comparing patient specific instruments with conventional instruments and computer navigation in total knee arthroplasty. Osteoarthritis and cartilage. (2014) 22  ppS469-S470', '10.1016/j.joca.2014.02.894', '']\n",
      "['9257642', 'Zeidler H; Kaik B; Mueller-Fassbender H; et al. Auranofin (SKF 39162) and sodium thiomalate. A double blind comparative multicentre study. Arthritis and rheumatism. (1981) 24 4 SUPPL. pp144', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9257645', 'Lewi PJ; Symoens J. Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study. Journal of rheumatology. Supplement. (1978) 4  pp17-25', '10.1016/s0140-6736(78)92335-8', '']\n",
      "['9257646', 'Veys EM; Mielants H. Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. Journal of rheumatology. Supplement. (1978) 4  pp31-41', '10.1016/s0140-6736(78)90443-9', '']\n",
      "['9257648', 'Klunder B; Khatri A; Minocha M; Peloso P; Othman AA. ABT-122, an immunoglobulin targeting both TNF-alpha and IL-17a, does not provide significantly greater efficacy compared with adalimumab in subjects with psoriatic arthritis: results from exposure-response analyses. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2151-2152', '10.1093/rheumatology/key312', 'http://academic.oup.com/rheumatology/article-pdf/58/2/352/27583915/key312.pdf']\n",
      "['9257649', 'M√∂ller B; Listing J; Krause A; Kaltwasser JP. Clinical day care treatment of patients with rheumatoid arthritis: concept of a new outcome-oriented evaluation project. Zeitschrift fuÃàr Rheumatologie. (2000) 59 2 pp128-130', '10.1007/s003930050218', 'http://link.springer.com/article/10.1007/s003930050218/fulltext.html']\n",
      "['9257650', 'Mease P; Ritchlin C; Rubant S; Varothai N; Hojnik M; Okun M; Gottlieb A. Disconnect between radiographic progression and skin or arthritic outcomes in psoriatic arthritis patients treated with adalimumab. Journal of the American Academy of Dermatology. (2015) 72  5 SUPPL. 1 ppAB230', '10.1016/j.jaad.2015.02.931', '']\n",
      "['9257652', 'Sparks JA; Iversen MD; Yu Z; Triedman NA; Prado MG; Kroouze RM; Kalia SS; Mody EA; Helfgott SM; Todd DJ; Dellaripa PF; Bermas BL; Deane KD; Costenbader KH; Lu B; Green RC; Karlson EW. A randomized controlled trial of rheumatoid arthritis risk disclosure personalized to genetics, autoantibodies, and lifestyle among unaffected first-degree relatives: the personalized risk estimator for RA (pre-RA) family study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1311-1313', '10.1002/acr.23411', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23411']\n",
      "['9257653', 'Fleischmann R; Wollenhaupt J; Cohen S; Weinblatt M; Wang L; Fan H; Andrews J; Takiya L; Bananis E. Discontinuation of methotrexate or glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib: clinical efficacy data from long-term extension studies. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2054-2056', '10.1007/s40744-018-0093-7', 'http://link.springer.com/article/10.1007/s40744-018-0093-7/fulltext.html']\n",
      "['9257654', 'Ormseth MJ; Bradham W; Elumogo C; Palanisamy S; Liu C; Lawson M; Soslow J; Kawel N; Bluemke DA; Stein CM. Myocardial structure, function, and fibrosis in patients with rheumatoid arthritis and matched control subjects. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1860-1861', '10.3899/jrheum.170770', '']\n",
      "['9257655', 'Gorostiza I; Angulo EU; Arango CG; Perez CE; De Dios JR; Alvarez B; Escribano AR; Stoye C; Vasques M; Otano JB; Escobar A; Trancho Z; Del Agua AR; Del Rio L; Martinez A; Nagore D. Prospective, intervention, multicenter study of utility of biologic drug monitoring with respect to the efficacy and cost of adalimumab tapering in patients with rheumatic diseases (34-week descriptive data). Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp835-836', '10.1007/s40744-021-00345-5', 'https://link.springer.com/article/10.1007/s40744-021-00345-5/fulltext.html']\n",
      "['9257656', 'Eidsaunet W; Borkje B; Larsen S; et al. Response to two NSAIDs: Diclofenac and naproxen in rheumatoid arthritis. CURR THER RES, CLIN EXP. (1983) 33 6I pp966-975', '10.1002/cpt1979263399', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1979263399']\n",
      "['9257657', 'Amaricai E; Catan L; Popa D; Dragoi M; Nemes D. Metabolic syndrome in patients with autoimmune inflammatory rheumatisms. Biomedical research (india). (2018) 29 11 pp2416-2420', '10.4066/biomedicalresearch.62-18-412', '']\n",
      "['9257659', 'Jardini L; Findlay R; Burgi E; Hinderer K; Agarwal A. Auditory changes associated with moderate blood salicylate levels. Rheumatology and rehabilitation. (1978) 17 4 pp233-236', '10.1093/rheumatology/17.4.233', 'http://academic.oup.com/rheumatology/article-pdf/17/4/233/5035717/17-4-233.pdf']\n",
      "['9257660', 'Kluger J; Leech S; Reidenberg MM; Lloyd V; Drayer DE. Long-term antiarrhythmic therapy with acetylprocainamide. American journal of cardiology. (1981) 48 6 pp1124-1132', '10.1016/0002-9149(81)90330-1', '']\n",
      "['9257661', 'Murthy MH; Rhymer AR; Wright V. Indomethacin or prednisolone at night in rheumatoid arthritis?. Rheumatology and rehabilitation. (1978) 17 1 pp8-13', '10.1093/rheumatology/17.1.8', 'http://academic.oup.com/rheumatology/article-pdf/17/1/8/5039339/17-1-8.pdf']\n",
      "['9257662', 'Brunner HI; Ruperto N; Hazra A; Wang R; Mebus C; Alvey C; Lamba M; Krishnaswami S; Stock TC; Conte U; Wang M; Tzaribachev N; Foeldvari I; Horneff G; Kingsbury D; Koskova E; Smolewska E; Vehe RK; Zuber Z; Lovell DJ; Martini A. Pharmacokinetics, safety, and tolerability of tofacitinib in pediatric patients from two to less than eighteen years of age with juvenile idiopathic arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp494-495', '10.1136/annrheumdis-2016-eular.2640', '']\n",
      "['9257663', \"Cibere J; Sibley JT; Haga M. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. Journal of rheumatology. (2002) 29 2 pp339-346\", '10.1385/1-59259-299-6:75', '']\n",
      "['9257665', 'Florence N; Diderichsen P; Cox E; Sharma S; Tasset C. Dose selection of filgotinib, a selective JAK1 inhibitor, for rheumatoid arthritis phase 3 studies: exposure-DAS28 and acr modeling approach. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2052-2053', '10.1002/art.39977', '']\n",
      "['9257666', 'Kozloski GD; De Vito JM; Kisicki JC; Johnson JB. The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis and rheumatism. (1992) 35 7 pp761-764', '10.1002/art.1780350708', '']\n",
      "['9257667', 'Zerbini CAF; Muram D; Arora VK; Alam J; Curtis JR. Effect of BMI on baricitinib efficacy: pooled analysis from two phase 3 rheumatoid arthritis clinical trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2048-2049', '10.1002/art.39977', '']\n",
      "['9257668', 'Sellam J; Hendel-Chavez H; Rouanet S; Abbed K; Combe B; Le Lo√´t X; Tebib J; Sibilia J; Taoufik Y; Dougados M; Mariette X. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis and rheumatism. (2011) 63 4 pp933-938', '10.1002/art.30233', '']\n",
      "['9257669', \"Abdulahad WH; Meijer JM; Kroese FG; Meiners PM; Vissink A; Spijkervet FK; Kallenberg CG; Bootsma H. B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sj√∂gren's syndrome: a double-blind, placebo-controlled study. Arthritis and rheumatism. (2011) 63 4 pp1116-1123\", '10.1002/art.30236', '']\n",
      "['9257670', 'Dupuis LL; Koren G; Silverman ED; Laxer RM. Influence of food on the bioavailability of oral methotrexate in children. Journal of rheumatology. (1995) 22 8 pp1570-1573', '10.1097/00007691-199506000-00006', '']\n",
      "['9257672', 'Cisternas MG; Michaud K. Comparative improvement in health-related quality of life for RA patients between TNF-alpha inhibitors, other biologics, and tofacitinib: results from a US-wide observational study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp828-830', '10.33590/emjrheumatol/10314940', '']\n",
      "['9257673', 'Ngo W; Caffery B; Srinivasan S; Jones LW. Effect of Lid Debridement-Scaling in Sj√∂gren Syndrome Dry Eye. Optometry and vision science. (2015) 92 9 ppe316-20', '10.1097/opx.0000000000000668', '']\n",
      "['9257674', 'Rongen GA; Van Ingen I; Jansen TL. Impaired vasodilator function in rheumatoid arthritis patients who flared due to stopping adalimumab or etanercept. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3337-3338', '10.1002/art.39977', '']\n",
      "['9257675', 'Shiokawa Y. Clinical evaluation of lobenzarit (CCA), a non-antiinflammatory immunomodulation, in rheumatoid arthritis (RA). A multicenter, double-blind, placebo-controlled study. INT J IMMUNOPHARM. (1982) 4 4 pp318', '10.1016/0192-0561(82)90263-6', '']\n",
      "['9257676', 'Nissil√§ M; Anttila P; H√§m√§l√§inen M; Jalava S. Comparison of chemical, radiation and surgical synovectomy for knee joint synovitis. Scandinavian journal of rheumatology. (1978) 7 4 pp225-228', '10.3109/03009747809095660', '']\n",
      "['9257677', 'Huskisson EC; Scott J; Dieppe P. Benoxaprofen: a clinical trial with an unusual design. Rheumatology and rehabilitation. (1978) 17 4 pp254-258', '10.1093/rheumatology/17.4.254', 'http://academic.oup.com/rheumatology/article-pdf/17/4/254/5035926/17-4-254.pdf']\n",
      "['9257678', 'Highton J; Grahame R. A comparative trial of benoxaprofen and naproxen. Rheumatology and rehabilitation. (1978) 17 4 pp259-264', '10.1093/rheumatology/17.4.259', 'http://academic.oup.com/rheumatology/article-pdf/17/4/259/5035965/17-4-259.pdf']\n",
      "['9257679', 'Prado MG; Kroouze RM; Yu Z; Iversen MD; Triedman NA; Kalia SS; Deane KD; Costenbader KH; Lu B; Green RC; Karlson EW; Sparks JA. Effectiveness of a web-based personalized rheumatoid arthritis risk tool with or without a health educator for knowledge of RA risk factors. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1307-1308', '10.1002/acr.23510', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23510']\n",
      "['9257680', 'Morgan NL; Ransford GL; Morgan LP; Driban JB; Wang C. Mindfulness is associated with psychological symptoms, self-efficacy, and quality of life among patients with symptomatic knee osteoarthritis. Osteoarthritis and cartilage. (2013) 21  ppS257-S258', '10.1016/j.joca.2013.02.535', '']\n",
      "['9257683', 'Gibson K; Castrejon I; Pincus T; Bryant KJ. Recognition of secondary fibromyalgia using an index of 3 components of the multi-dimensional health assessment questionnaire: 90% agreement with acr criteria for fibromyalgia. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2872-2874', '10.1002/acr2.11053', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11053']\n",
      "['9257686', \"Kivitz AJ; O'Dell JR; Takeuchi T; Tanaka Y; Nakashima S; Kelleher C; Hodge J; Finck B. Quality of life outcomes following therapy with chs-0214 and etanercept (ENBREL): randomized, double-blind study in subjects with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp845-847\", '10.1002/art.39977', '']\n",
      "['9257687', \"Camerlain M; Leung CY; Santerre A; et al. Double blind evaluation of the effects of acupuncture in the treatment of rheumatoid arthritis of the knee.  EVALUATION DE L'ACUPUNCTURE DANS L'ARTHRITE RHUMATOIDE. Union medicale du Canada. (1981) 110 12 pp1041-1044\", '10.1186/1472-6882-7-35', 'http://link.springer.com/article/10.1186/1472-6882-7-35/fulltext.html']\n",
      "['9257688', 'Barroso N; Woodworth TG; Guillemin F; Furst DE; Brook J; Kafaja S; Elashoff D; Fautrel B; Ranganath V. Assessment of the American-english version of the French flare in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3264-3266', '10.1007/s10067-019-04755-3', 'http://link.springer.com/article/10.1007/s10067-019-04755-3/fulltext.html']\n",
      "['9257690', 'Breedveld F; Wang X; Cardoso A; Keystone E. The relative performance of 28-joint disease activity score based on creactive protein with three versus four components in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp638-639', '10.1002/art.39977', '']\n",
      "['9257691', 'Vergara F; Ruta S; Zacariaz J; Marin J; Rosa J; Garcia-Monaco R; Soriano ER. Utility of power doppler ultrasound-detected synovitis for the prediction of short term flare in rheumatoid arthritis patients in clinical remission. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp704-706', '10.3899/jrheum.161347', '']\n",
      "['9257693', 'Braun J; K√§stner P; Flaxenberg P; W√§hrisch J; Hanke P; Demary W; von Hin√ºber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A; MC-MTX.6/RH Study Group. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis and rheumatism. (2008) 58 1 pp73-81', '10.1002/art.23144', '']\n",
      "['9257694', 'Tak PP; Thurlings RM; Rossier C; Nestorov I; Dimic A; Mircetic V; Rischmueller M; Nasonov E; Shmidt E; Emery P; Munafo A. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis and rheumatism. (2008) 58 1 pp61-72', '10.1002/art.23178', '']\n",
      "['9257695', \"Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic D; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Hamilton S; Johnson A; Huang B; Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis and rheumatism. (2012) 64 6 pp2012-2021\", '10.1002/art.34343', '']\n",
      "['9257696', \"Seitsalo H; Niemel√§ RK; Marinescu-Gava M; Vuotila T; Tj√§derhane L; Salo T. Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sj√∂gren's syndrome: a randomized, double-blind, placebo controlled cross-over study. Journal of negative results in biomedicine. (2007) 6  pp11\", '10.1186/1477-5751-6-11', 'http://link.springer.com/article/10.1186/1477-5751-6-11/fulltext.html']\n",
      "['9257698', 'Park JK; Lee MAL; Lee KH; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB. Effect of temporary methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomized clinical trial. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2648-2650', '10.1002/art.42644', '']\n",
      "['9257699', 'Fogari R; Bonebrake RA. Aspirin- and placebo-controlled study of isoxicam in the treatment of rheumatoid arthritis. Seminars in arthritis and rheumatism. (1982) 12 2 SUPPL. 2 pp165-169', '10.1016/0049-0172(82)90069-5', '']\n",
      "['9257700', 'Tonga E; Duger T; Karatas M. Effectiveness of client-centered occupational therapy in patients with rheumatoid arthritis: Exploratory randomized controlled trial. Archives of Rheumatology. (2016) 31  1 pp6-13', '10.5606/archrheumatol.2016.5478', '']\n",
      "['9257702', 'Ball JA; Greenwald M. Dermal temperature is an excelent prognostic indicator to guide RA therapy. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2685-2686', '10.1002/art.39977', '']\n",
      "['9257704', 'Harrison MJ; Hassell A; Dawes PT; Scott DL; Knight SM; Davis MJ; Mulherin D; Symmons DP. The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice. Rheumatology (Oxford, England). (2007) 46 5 pp849-855', '10.1093/rheumatology/kel445', 'http://academic.oup.com/rheumatology/article-pdf/46/5/849/6700486/kel445.pdf']\n",
      "['9257705', 'Pineda-Juarez JA; Ogata-Medel M; Lozada-Mellado M; Castillo-Martinez L; Hinojosa-Azaola A; Gonzalez-Contreras M; Cervantes-Gaytan R; Garcia-Morales JM; Alcocer-Varela J; Orea-Tejeda A; Llorente L. Effect of a dynamic exercise program in combination with a mediterranean diet in strength, joint mobility and disease activity in women with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3303-3304', '10.1097/rhu.0000000000001064', '']\n",
      "['9257706', 'Mohamed M-E; Zeng J; Song I-H; Othman AA. Pharmacokinetics of ABT-494 with the once-daily extended-release tablet formulation being utilized in the ongoing rheumatoid arthritis phase 3 trials. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2028-2029', '10.1136/annrheumdis-2017-eular.3224', '']\n",
      "['9257707', 'Loza M; Sweet K; Peffer N; Franks C; Ma K; Campbell K; Sims M; Dasgupta B. Consistent pharmacodynamic effects of sirukumab, an anti-IL-6 cytokine monoclonal antibody, on serum analytes across four phase 3 clinical trials in rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2029-2030', '10.1002/art.39977', '']\n",
      "['9257708', 'Baluom M; Grossbard EB; Mant T; Lau DT. Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies. British journal of clinical pharmacology. (2013) 76 1 pp78-88', '10.1111/bcp.12048', '']\n",
      "['9257709', 'Mary LKA; Gill GK; Chandra Mouli KS; Shobha V. Pulmonary symptoms are under represented in Rheumatoid arthritis. Indian journal of rheumatology. (2014) Conference: 30th Annual Conference of the Indian Rheumatology Association, IRACON 2014. India. 9 5 Supplement ppS22-S23', '10.1016/j.injr.2014.10.058', '']\n",
      "['9257710', 'Gerlag DM; Haringman JJ; Smeets TJ; Zwinderman AH; Kraan MC; Laud PJ; Morgan S; Nash AF; Tak PP. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis and rheumatism. (2004) 50 12 pp3783-3791', '10.1002/art.20664', '']\n",
      "['9257712', 'Smith MD; Ahern MJ; Roberts-Thomson PJ. Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?. Annals of the rheumatic diseases. (1988) 47 1 pp28-33', '10.1136/ard.47.1.28', '']\n",
      "['9257713', 'Bird P; Rischmueller M; Feletar M; Grant G; Staples MP; Hall S. Real world treat to target strategy in rheumatoid arthritis: radiograph and MRI outcomes in three cohorts with 18 month follow up. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3299-3300', '10.1002/art.39977', '']\n",
      "['9257714', 'Saykaly RJ; Love DW; Simon JA; DeGuzmann R; Gabovitch E. Comparative efficacy of pirprofen and aspirin in rheumatoid arthritis. Journal of clinical pharmacology. (1979) 19 1 pp56-63', '10.1002/j.1552-4604.1979.tb01617.x', '']\n",
      "['9257715', 'Peterson S; Pacou M; Belhadi D; Van Sanden S; Webb T; Ganguly R; Kurrasch R; Rao R; Hsu B; Fei K; Kielar D; Alfonso R. Network meta-analysis to assess the relative efficacy of sirukumab, an anti-IL-6 cytokine monoclonal antibody, in combination therapy for patients with active rheumatoid arthritis despite conventional DMARDs. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2025-2027', '10.1002/art.39977', '']\n",
      "['9257717', 'Reid RT. Pirprofen and aspirin in rheumatoid arthritis: A double-blind comparison study. Journal of clinical pharmacology. (1980) 20 2-3 pp145-150', '10.1002/j.1552-4604.1980.tb02536.x', '']\n",
      "['9257718', 'Lickliter J; Wu Y; Hua Y; Yuan I; Dai G; Li X; Wang J; Sai Y; Sun Z; Pan A; Li J; Su W. A phase I, randomized, double blind, placebo-controlled, dose escalating study of the safety, tolerability and pharmacokinetics and pharmacodynamics of single and multiple doses of HMPL-523 in australian male healthy subjects. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2018-2020', '10.33590/emjrheumatol/10314940', '']\n",
      "['9257719', 'Beattie KA; Ioannidis G; Scheffler S; Totterman S; Schreyer E; Larche M. Assessing agreement among measures of inflammation detected on magnetic resonance imaging, ultrasound and clinical findings in the feet of patients with early rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp210-212', '10.1002/art.39977', '']\n",
      "['9257720', 'Cohen S; Emery P; Greenwald M; Yin D; Becker J-C; Melia LA; Li R; Gumbiner B; Thomas D; Spencer-Green G; Meng X. A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. British journal of clinical pharmacology. (2016) 82 1 pp129-138', '10.1111/bcp.12916', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12916']\n",
      "['9257721', 'Singh VK; Bhandari RB; Rana BB. Effect of yogic package on rheumatoid arthritis. Indian journal of physiology and pharmacology. (2011) 55 4 pp329-335', '10.5005/jp/books/14244_34', '']\n",
      "['9257722', 'Galluppi GR; Wisniacki N; Stebbins C. Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-tnf-like weak inducer of apoptosis (anti-tweak) monoclonal antibody. British journal of clinical pharmacology. (2016) 82 1 pp118-128', '10.1111/bcp.12914', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12914']\n",
      "['9257723', 'Chen X; Zhao Q; Hou Y; Jiang J; Zhong W; Wang W; Yao X; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel blys/april fusion protein, in patients with rheumatoid arthritis. British journal of clinical pharmacology. (2016) 82 1 pp41-52', '10.1111/bcp.12908', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12908']\n",
      "['9257724', 'Giannini EH; Brewer EJ; Kuzmina N; Alekseev L; Shokh BP. Characteristics of responders and nonresponders to slow-acting antirheumatic drugs in juvenile rheumatoid arthritis. Arthritis and rheumatism. (1988) 31 1 pp15-20', '10.1002/art.1780310103', '']\n",
      "['9257725', 'Fraser P; Chin W; Kao A. Atacicept: integrated safety profile from phase II randomized placebo-controlled studies in autoimmune diseases. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1020-1022', '10.1002/art.39977', '']\n",
      "['9257726', 'McArthur AW; Ferry DG; Palmer DG. A comparative study of indomethacin and ibuprofen. Medical journal of Australia. (1979) 1 1 pp25-27', '10.5694/j.1326-5377.1979.tb111959.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1979.tb111959.x']\n",
      "['9257727', 'Rahimnia A-R; Panahi Y; Alishiri G; Sharafi M; Sahebkar A. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: findings from a randomized double-blind placebo-controlled trial. Drug research. (2015) 65 10 pp521-525', '10.1055/s-0034-1384536', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0034-1384536.pdf']\n",
      "['9257728', 'Tweehuysen L; Van Den Bemt BJF; Van Ingen IL; De Jong AJL; Van Der Laan WH; Van Den Hoogen FHJ; Den Broeder AA. Clinical and immunogenicity outcomes after switching treatment from innovator infliximab to biosimilar infliximab in rheumatic diseases in daily clinical practice. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp821-823', '10.1002/art.40324', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40324']\n",
      "['9257729', 'Barrera P; Van Der Maas A; Van Ede AE; Kiemeney BALM; Laan RFJM; Van De Putte LBA; Van Riel PLCM. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis. Rheumatology. (2002) 41 4 pp430-439', '10.1093/rheumatology/41.4.430', 'http://academic.oup.com/rheumatology/article-pdf/41/4/430/5057763/410430.pdf']\n",
      "['9257731', 'Yoo D-H; Majstorovic LB; Kasay AB; El-Khouri EC; Irazoque-Palazuelos F; Molina FC; Miranda P; Shesternya P; Medina-Rodriguez FG; Wiland P; Jeka S; Garmish O; Hrycaj P; Rekalov D; Fomina N; Zisman D; Park Y-B; Kang YM; Suh C-H; Shim SC; Lee SJ; Lee SY; Park W. Efficacy and safety of CT-P10, rituximab biosimilar candidate, and innovator rituximab in patients with rheumatoid arthritis: results from phase 3 randomized controlled trial over 24 weeks. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2040-2042', '10.1093/rheumatology/kez152', 'http://academic.oup.com/rheumatology/article-pdf/58/12/2193/31145163/kez152.pdf']\n",
      "['9257733', 'Genovese MC; Weinblatt M; Keystone EC; Baranauskaite A; Cheong SY; Ghil J. Efficacy after transition to SB5 from reference adalimumab (Humira) Vs. continuation of SB5 or reference adalimumab by antibodies developed after transition from a SB5 phase III study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp816-817', '10.1136/annrheumdis-2016-eular.3331', '']\n",
      "['9257734', 'Callinan NJ; Mathiowetz V. Soft versus hard resting hand splints in rheumatoid arthritis: pain relief, preference, and compliance. The American journal of occupational therapy : official publication of the American Occupational Therapy Association. (1996) 50 5 pp347-353', '10.5014/ajot.50.5.347', 'https://research.aota.org/ajot/article-pdf/50/5/347/59091/347.pdf']\n",
      "['9257735', 'Suh C-H; Kasay AB; El-Khouri EC; Miranda P; Majstorovic LB; Jeka S; Hrycaj P; Rekalov D; Wiland P; Krause A; Szombati I; Mihailova A; Hospodarskyy I; Piotrowski M; Kwon S-R; Lee E-Y; Yoo D-H; Park W; Shim S-C; Lee S-J; Kwon TS. Pharmacokinetics and safety of three formulations of rituximab (CT-P10, US-sourced innovator rituximab and eu-sourced innovator rituximab) in patients with rheumatoid arthritis: results from phase 3 randomized controlled trial over 24 weeks. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2038-2040', '10.1007/s40259-018-00331-4', 'http://link.springer.com/article/10.1007/s40259-018-00331-4/fulltext.html']\n",
      "['9257736', 'Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis and rheumatism. (2002) 46 6 pp1460-1469', '10.1002/art.10307', '']\n",
      "['9257737', 'Duda J; Fenton S; Van Zanten JV; Metsios G; Rouse P; Ntoumanis N; Yu C; Koutedakis Y; Kitas GD. A self-determination theory based intervention to increase levels of cardiorespiratory fitness, self-determined motivation, physical activity and improve health outcomes among patients living with Rheumatoid Arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp677-678', '10.1136/annrheumdis-2015-eular.4764', '']\n",
      "['9257738', 'Bianchi G; Caporali R; Todoerti M; Mattana P. Methotrexate and rheumatoid arthritis: current evidence regarding subcutaneous versus oral routes of administration. Advances in therapy. (2016) 33 3 pp369-378', '10.1007/s12325-016-0295-8', '']\n",
      "['9257740', 'Lelieveld O; Armbrust W; Geertzen J; De Graaf I; Van Leeuwen M; Sauer P; Van Weert E; Bouma J. Promoting physical activity in children with juvenile idiopathic arthritis through an internet-based program: Results of a pilot randomised controlled trial. Physiotherapy (United Kingdom). (2011) 97 var.pagings ppeS680-eS681', '10.1002/acr.20085', '']\n",
      "['9257742', 'Cseuz R; Zimmerman J; Panayi GS. Daily and alternate-day azathioprine treatment in rheumatoid arthritis: a twelve-week controlled clinical trial. British journal of rheumatology. (1992) 31 7 pp501-502', '10.1093/rheumatology/31.7.501', 'http://academic.oup.com/rheumatology/article-pdf/31/7/501/5041656/31-7-501.pdf']\n",
      "['9257743', 'Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary clinical trials. (2012) 33 1 pp159-171', '10.1016/j.cct.2011.09.009', '']\n",
      "['9257744', 'Senabre-Gallego JM; Rosas J; Llinares-Tello F; Marco-Mingot M; Pons A; Barber X; Santos-Soler G; Salas-Heredia E; Cano C; Lorente M; Sanchis M; Molina J; Garcia-Carrasco M. Clinical activity, ultrasound assessment and drug monitoring in rheumatoid arthritis patients receiving anti-TNF-alpha therapy with extended interval of administration. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp813-814', '10.1136/annrheumdis-2014-eular.2990', '']\n",
      "['9257746', 'Gilbert A; Lee J; Semanik P; Song J; Pellegrini C; Pinto D; Dunlop DD; Chang RW; Ehrlich-Jones LS. The improving motivation for physical activity in arthritis clinical trial for adults with knee osteoarthritis and rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp3053-3055', '10.1002/art.39977', '']\n",
      "['9257747', 'Chan FK. Celecoxib reduced gi events more than diclofenac plus omeprazole in patients with osteoarthritis or rheumatoid arthritis. Annals of internal medicine. (2011) 154  2 ppJC1-9', '10.7326/0003-4819-154-2-201101180-02009', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-154-2-201101180-02009']\n",
      "['9257748', 'Heron S; Urmston M; Woby SR. A randomised controlled trial investigating the effectiveness of three different modes of exercise for chronic shoulder impingement syndrome. Physiotherapy (United Kingdom). (2011) 97  ppeS481', '10.1016/j.physio.2016.09.001', '']\n",
      "['9257749', 'Semb AG; Holme I; Kvien TK; Pedersen TR; Semb AG; Holme I; et al. Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial. Rheumatology. (2011) 50 2 pp324-329', '10.1093/rheumatology/keq295', 'http://academic.oup.com/rheumatology/article-pdf/50/2/324/17387210/keq295.pdf']\n",
      "['9257750', 'Bengtsson A; Bengtsson M; Nilsson I; S√∂rensen J. Effects of intravenous regional administration of methylprednisolone plus mepivacaine in rheumatoid arthritis. Scandinavian journal of rheumatology. (1998) 27 4 pp277-280', '10.1080/030097498442389', '']\n",
      "['9257751', 'Shiroky JB; Neville C; Skelton JD. High dose intravenous methotrexate for refractory rheumatoid arthritis. Journal of rheumatology. (1992) 19 2 pp247-251', '10.1002/anr.1780320916', '']\n",
      "['9257752', 'Ichikawa Y; Shinozawa T; Yoshida T; Kameda H; Suzuki Y; Kawai S; Yamada H; Matsuda T. [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1995) 35 4 pp663-670', '10.1002/art.1780350203', '']\n",
      "['9257753', 'Risheim H; Kjaerheim V; Arneberg P. Improvement of oral hygiene in patients with rheumatoid arthritis. Scandinavian journal of dental research. (1992) 100 3 pp172-175', '10.1111/j.1600-0722.1992.tb01735.x', '']\n",
      "['9257754', 'Alvan G; Ekstrand R. Clinical effects of indomethacin and additive clinical effect of indomethacin during salicylate maintenance therapy. Scandinavian journal of rheumatology. (1981) 10 SUPPL. 39 pp29-32', '10.3109/03009748109095331', '']\n",
      "['9257755', 'Breitschwerdt B; Goeser T; Tissot JD; Trendelenburg M; Sis-Kluzik JM; Andrassy K. Hepatitis virus-related and ethanol-induced chronic liver disease with or without cryoglobulins--is there a difference concerning clinical or laboratory manifestation?. Infection. (1999) 27 4-5 pp248-251', '10.1007/s150100050021', 'http://link.springer.com/article/10.1007/s150100050021/fulltext.html']\n",
      "['9257757', 'Liebling MR; McLaughlin K; Boonsue S; et al. A double-blind placebo controlled trial of pulse-methylprednisolone in SLE nephritis: A preliminary report. Arthritis and rheumatism. (1980) 23 6 pp711', '10.1016/j.semarthrit.2021.08.012', '']\n",
      "['9257758', 'Simon LS; Lanza FL; Lipsky PE; Hubbard RC; Talwalker S; Schwartz BD; Isakson PC; Geis GS. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis and rheumatism. (1998) 41 9 pp1591-1602', '10.1002/1529-0131(199809)41:9<1591::aid-art9>3.0.co;2-j', '']\n",
      "['9257760', 'Lemmel EM; Obert HJ; Hofschneider PH. Low-dose gamma interferon in treatment of rheumatoid arthritis. Lancet (London, England). (1988) 1 8585 pp598', '10.1016/s0140-6736(88)91403-1', '']\n",
      "['9257762', \"Messias AR; Brito AS; De OIL. Clinical evaluation of naproxen in rheumatoid conditions.  AVALIACAO CLINICA DO ACIDO D 2 (6' METOXI 2' NAFTIL) - PROPIONICO (NAPROXEN) (1) NA DOENCA REUMATOIDE. Folha medica. (1974) 68 6 pp621-622\", '10.1002/j.1552-4604.1975.tb01459.x', '']\n",
      "['9257763', 'Hubsher JA; Ballard IM; Walker BR; Gold JA. A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis. Journal of international medical research. (1979) 7 1 pp69-76', '10.1177/030006057900700111', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057900700111']\n",
      "['9257764', 'Li J; Gunsior M; Ly N; Godwood A; Howe D; Albulescu M; Butler LH; Arbaugh K; Faggioni R. Pharmacokinetics, pharmacodynamics, and immunogenicity of MEDI4920, a novel, engineered CD40 ligand antagonist, in healthy volunteers. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2017-2018', '10.1002/art.39977', '']\n",
      "['9257766', 'Ferguson J; Leeming MR. Lack of photosensitising potential of tenidap, a novel anti-rheumatic agent. British journal of clinical pharmacology. (1995) 39 Suppl 1  pp63S-66S', '10.1111/j.1365-2125.1995.tb04506.x', '']\n",
      "['9257768', 'Abbott A; Tyni-Lenne R; Hedlund R. The effectiveness of physiotherapeutic rehabilitation and issues of outcome prediction after lumbar fusion surgery. Physiotherapy (United Kingdom). (2011) 97  ppeS20-eS21', '10.1007/s00586-011-1709-6', 'http://link.springer.com/article/10.1007/s00586-011-1709-6/fulltext.html']\n",
      "['9257769', \"Str√∂mbeck BE; Theander E; Jacobsson LT. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome. Rheumatology (Oxford, England). (2007) 46 5 pp868-871\", '10.1093/rheumatology/kem004', 'http://academic.oup.com/rheumatology/article-pdf/46/5/868/6701089/kem004.pdf']\n",
      "['9257770', 'Mikhael EM; Gorial FI; Majeed IA. Effect of rosuvastatin as adjuvant therapy to methotrexate on hematological parameters in patients with moderately-highly active rheumatoid arthritis. Journal of Experimental and Integrative Medicine. (2013) 3  2 pp127-131', '10.5455/jeim.170413.or.065', 'https://ejmanager.com/mnstemps/4/4-1359999028.pdf']\n",
      "['9257771', 'Kaine JL; Kivitz AJ; Birbara C; Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. Journal of rheumatology. (2007) 34 2 pp272-279', '10.1097/01.mib.0000438824.11624.d5', '']\n",
      "['9257773', 'De Castro Alcantara AC; Leite CAC; Leite ACRM; Sidrim JJC; Silva Jr FS; Rocha FAC. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis. Journal of rheumatology. (2014) 41  2 pp338-344', '10.3899/jrheum.130294', '']\n",
      "['9257774', 'Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial. Journal of rheumatology. (2014) 41 2 pp286-292', '10.3899/jrheum.130658', '']\n",
      "['9257775', 'Gatt A; Formosa C; Otter S. Foot orthoses in the management of chronic subtalar and talo crural joint pain in rheumatoid arthritis. Foot (edinburgh, scotland). (2016) 27  pp27-31', '10.1016/j.foot.2016.03.004', '']\n",
      "['9257776', 'Paulus HE; Williams HJ; Ward JR; et al. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold. Arthritis and rheumatism. (1984) 27 7 pp721-727', '10.1002/art.1780270701', '']\n",
      "['9257777', 'Bellamy N; Beaulieu A; Bombardier C; Huang S; Kraag G; M√©nard HA; Russell AS; Tannenbaum H; Willans M; Campbell J. Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial. Current medical research and opinion. (1992) 12 10 pp640-651', '10.1185/03007999209111531', '']\n",
      "['9257779', 'Vetter G; Placchi M; Joubert L. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients. International journal of clinical pharmacology, therapy, and toxicology. (1982) 20 5 pp240-245', '10.1007/978-3-642-68690-0_34', 'http://link.springer.com/content/pdf/10.1007/978-3-642-68690-0_34.pdf']\n",
      "['9257780', 'Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF; SWEFOT Trial Investigators Group. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Annals of the rheumatic diseases. (2011) 70 3 pp469-475', '10.1136/ard.2010.139212', '']\n",
      "['9257781', 'Nakamura H; Ito H; Kimura Y; Takeda A; Ogawa H; Kanazawa S; Kuroda T; Inada M; Harada H; Kishimoto T; Zenda S; Terabayashi M; Saeki K; Wada M; Igarashi A; Uemiya M; Kobayashi Y; Hayashi E. The importance of initial daily administration of interferon alpha for the eradication of hepatitis C virus in patients with chronic hepatitis C: a multicenter randomized trial. Hepato-gastroenterology. (1998) 45 22 pp1045-1055', '10.1016/s1386-6346(01)00139-5', '']\n",
      "['9257782', 'Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. Journal of nutritional biochemistry. (2013) 24 7 pp1367-1372', '10.1016/j.jnutbio.2012.11.004', '']\n",
      "['9257783', 'Matteson EL; Yocum DE; St Clair EW; Achkar AA; Thakor MS; Jacobs MR; Hays AE; Heitman CK; Johnston JM. Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. Arthritis and rheumatism. (1995) 38 9 pp1187-1193', '10.1002/art.1780380903', '']\n",
      "['9257784', \"Sany J; Clot J; Combe B; et al. Treatment of rheumatoid arthritis. A comparative study of placenta eluted immunoglobulins G and venoglobulins.  TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE. ETUDE COMPARATIVE DE L'EFFET DES IMMUNOGLOBULINES G ELUEES DU PLACENTA ET DE CELUI DES VEINOGLOBULINES. Presse medicale (Paris, France : 1983). (1987) 16 15 pp723-724\", '10.1016/0002-9343(85)90213-x', '']\n",
      "['9257786', 'Moreland LW; Sewell KL; Trentham DE; Bucy RP; Sullivan WF; Schrohenloher RE; Shmerling RH; Parker KC; Swartz WG; Woodworth TG. Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension. Arthritis and rheumatism. (1995) 38 9 pp1177-1186', '10.1002/art.1780380902', '']\n",
      "['9257787', 'Blackburn WD; Prupas HM; Silverfield JC; Poiley JE; Caldwell JR; Collins RL; Miller MJ; Sikes DH; Kaplan H; Fleischmann R. Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. Arthritis and rheumatism. (1995) 38 10 pp1447-1456', '10.1002/art.1780381011', '']\n",
      "['9257788', 'Tak PP; van der Lubbe PA; Cauli A; Daha MR; Smeets TJ; Kluin PM; Meinders AE; Yanni G; Panayi GS; Breedveld FC. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis and rheumatism. (1995) 38 10 pp1457-1465', '10.1002/art.1780381012', '']\n",
      "['9257789', 'Veys EM; Huskisson EC; Rosenthal M; et al. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Annals of the rheumatic diseases. (1982) 41 5 pp441-443', '10.1136/ard.41.5.441', '']\n",
      "['9257790', 'van der Heide A; Remme CA; Hofman DM; Jacobs JW; Bijlsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis and rheumatism. (1995) 38 10 pp1466-1474', '10.1002/art.1780381013', '']\n",
      "['9257792', 'Martin M; Kosinski M; Bjorner JB; Ware JE; Maclean R; Li T. Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale. Quality of life research. (2007) 16 4 pp647-660', '10.1007/s11136-007-9193-5', 'http://link.springer.com/article/10.1007/s11136-007-9193-5/fulltext.html']\n",
      "['9257793', 'van Middendorp H; Sorbi MJ; van Doornen LJ; Bijlsma JW; Geenen R. Feasibility and induced cognitive-emotional change of an emotional disclosure intervention adapted for home application. Patient education and counseling. (2007) 66 2 pp177-187', '10.1016/j.pec.2006.11.009', '']\n",
      "['9257794', 'Guild GN; Labib SA. Clinical outcomes in high flexion total knee arthroplasty were not superior to standard posterior stabilized total knee arthroplasty. A multicenter, prospective, randomized study. Journal of arthroplasty. (2014) 29 3 pp530-534', '10.1016/j.arth.2013.07.035', '']\n",
      "['9257795', \"Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Pu√©chal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Hatron PY; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Seror R; Pers JO; Meiners PM; Vissink A; Bootsma H; Nowak E; Saraux A. Development of the Sj√∂gren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. Rheumatology (Oxford, England). (2015) 54 9 pp1699-1708\", '10.1093/rheumatology/kev114', 'http://academic.oup.com/rheumatology/article-pdf/54/9/1699/18097303/kev114.pdf']\n",
      "['9257796', 'Suponitskaia EV; Smirnov AV; Aleksandrova EN; Novikov AA; Nasonov EL. [Effect of small-dose glucocorticoids on the course of early rheumatic arthritis]. Klinicheskaia meditsina. (2004) 82 9 pp39-42', '10.1136/annrheumdis-2015-eular.2284', '']\n",
      "['9257797', 'Brooks PM; Dougan MA; Mugford S; Meffin E. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. Journal of rheumatology. (1982) 9 5 pp723-726', '10.17918/00005537', '']\n",
      "['9257798', 'Nissila M; Jalava S; Groppi W. Indoprofen versus indomethacin and placebo. A double-blind three-way cross-over trial in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1981) 4 1 pp74-78', '10.1002/art.23361', '']\n",
      "['9257799', 'Emery P; Vencovsk‚àöŒ© J; Sylwestrzak A; Leszczy‚âà√ëski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan VM; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J. A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2017) 76 1 pp51-57', '10.1136/annrheumdis-2015-207588', '']\n",
      "['9257800', 'Treadwell BL; Tweed JM. Diclofenac in rheumatoid disease. New Zealand medical journal. (1979) 89 628 pp43-45', '10.1111/j.1445-5994.1979.tb04124.x', '']\n",
      "['9257801', 'Jacono A; Caso P; Gualtieri S; et al. Clinical study of possible interactions between indoprofen and oral anti-coagulants. EUR J RHEUMATOL INFLAM. (1981) 4 1 pp32-35', '10.1016/j.clinthera.2013.07.346', '']\n",
      "['9257802', 'Nyfos L. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1979) 1979 24 pp5-7', '10.1080/03009742.1979.12088618', '']\n",
      "['9257803', 'Franchimont P; Heynen G; Berghs H; Remans J; Vroninks P. Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis. Scandinavian journal of rheumatology. (1979) 8 1 pp43-48', '10.1080/03009747909105333', '']\n",
      "['9257804', 'Ammitzb√∏ll F. Fenbufen and indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study. Scandinavian journal of rheumatology. Supplement. (1979) 23 23 pp5-10', '10.1080/03009742.1979.12088616', '']\n",
      "['9257805', 'Rejholec V; Vapaatalo H; Tokola O; Gothoni G. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1979) 1979 24 pp13-16', '10.1080/03009742.1979.12088620', '']\n",
      "['9257806', 'Choe JY; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Choi J; Rho YH; Smolen JS. A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2017) 76 1 pp58-64', '10.1136/annrheumdis-2015-207764', '']\n",
      "['9257807', 'Aguilera X; Martinez-Zapata MJ; Hinarejos P; Jordan M; Leal J; Gonzalez JC; et al. Topical and intravenous tranexamic acid reduce blood loss compared to\\nroutine hemostasis in total knee arthroplasty: a multicenter,\\nrandomized, controlled trial. Archives of orthopaedic and trauma surgery. (2015) 135 7 pp1017-1025', '10.1007/s00402-015-2232-8', 'http://link.springer.com/article/10.1007/s00402-015-2232-8/fulltext.html']\n",
      "['9257808', 'Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study. Lancet. (2017) 389 10075 pp1206-1217', '10.1016/s0140-6736(17)30401-4', '']\n",
      "['9257810', \"Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis and rheumatism. (2000) 43 7 pp1473-1477\", '10.1002/1529-0131(200007)43:7<1473::aid-anr9>3.0.co;2-n', '']\n",
      "['9257811', \"Quartuccio L; Salvin S; Corazza L; Gandolfo S; Fabris M; De Vita S. Efficacy of belimumab and targeting of rheumatoid factor-positive b-cell expansion in sjogren's syndrome: follow-up after the end of the phase II open-label BELISS study. Clinical and experimental rheumatology. (2016) 34 2 pp311-314\", '10.1093/rheumatology/kev257', 'http://academic.oup.com/rheumatology/article-pdf/54/12/2249/17388479/kev257.pdf']\n",
      "['9257812', 'Sun Y; Wang P; Li H; Li M; Xu Y; Sun W; Wang L; Yang Y; Zhang X; Ma L. Efficacy and safety of combined etanercept and iguratimod for active rheumatoid arthritis. Biomedical research (india). (2016) 27 2 pp470-474', '10.21203/rs.3.rs-1980301/v1', 'https://www.researchsquare.com/article/rs-1980301/v1']\n",
      "['9257813', 'Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED. The cost effectiveness of auranofin: results of a randomized clinical trial. Journal of rheumatology. (1988) 15 1 pp35-42', '10.1007/bf02203383', 'http://link.springer.com/article/10.1007/BF02203383/fulltext.html']\n",
      "['9257814', 'Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. Journal of rheumatology. (1988) 15 1 pp28-34', '10.1093/rheumatology/27.1.44', 'http://academic.oup.com/rheumatology/article-pdf/27/1/44/5040088/27-1-44.pdf']\n",
      "['9257815', 'Mehta S; Dasarathy S; Tandon RK; Mathur M; Malaviya AN. A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis. American journal of gastroenterology. (1992) 87 8 pp996-1000', '10.1136/gut.52.6.820', '']\n",
      "['9257816', 'Fishel B; Weiss S; Yaron M. Diflunisal in rheumatoid arthritis. Inflammation. (1981) 5 3 pp253-261', '10.1007/bf00914448', 'http://link.springer.com/article/10.1007/BF00914448/fulltext.html']\n",
      "['9257817', 'Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis and rheumatism. (2000) 43 7 pp1478-1487', '10.1002/1529-0131(200007)43:7<1478::aid-anr10>3.0.co;2-m', '']\n",
      "['9257819', 'John H; Hale ED; Treharne GJ; Kitas GD; Carroll D. A randomized controlled trial of a cognitive behavioural patient education intervention versus a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease . Rheumatology (united kingdom). (2012) 51  ppiii77', '10.1093/rheumatology/kes237', 'http://academic.oup.com/rheumatology/article-pdf/52/1/81/5176981/kes237.pdf']\n",
      "['9257821', 'Nikas SN; Voulgari PV; Alamanos Y; Papadopoulos CG; Venetsanopoulou AI; Georgiadis AN; Drosos AA. Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study. Annals of the rheumatic diseases. (2006) 65 2 pp257-260', '10.1136/ard.2005.039099', '']\n",
      "['9257822', 'Bird HA; Ring EF; Bacon PA. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Annals of the rheumatic diseases. (1979) 38 1 pp36-39', '10.1136/ard.38.1.36', '']\n",
      "['9257823', 'Chaput de Saintonge DM; Evans SJ; Crane GJ; Kirwan JR. Clinical trials and clinical practice: do doctors use the same criteria to judge outcome?. British journal of clinical pharmacology. (1997) 44 6 pp583-586', '10.1046/j.1365-2125.1997.t01-1-00614.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.1997.t01-1-00614.x']\n",
      "['9257824', 'Lee SJ; Park W; Park SH; Shim SC; Baek HJ; Yoo DH; Kim HA; Lee SK; Leee YJ; Park YE; Cha HS; Park JK; Lee EY; Lee EB; Song YW. Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients. Journal of immunology research. (2015) 2015  pp487230', '10.1155/2015/487230', 'http://downloads.hindawi.com/journals/jir/2015/487230.pdf']\n",
      "['9257825', 'Wiland P; Dudler J; Veale D; Tahir H; Pedersen R; Bukowski J; Vlahos B; Williams T; Gaylord S; Kotak S. The effect of reduced or withdrawn etanercept-methotrexate therapy on patient-reported outcomes in patients with early rheumatoid arthritis. Journal of rheumatology. (2016) 43 7 pp1268-1277', '10.3899/jrheum.151179', '']\n",
      "['9257826', 'Zeng H; Zeng P; Xie Y; Tang Y; Li F. A randomized controlled clinical trial to evaluate the efficacy of recombinant human tumor necrosis factor-a receptor type II fusion protein antibody in juvenile idiopathic arthritis. Allergy: European Journal of Allergy and Clinical Immunology. (2013) 68  pp11', '10.1136/annrheumdis-2014-eular.5459', '']\n",
      "['9257827', 'Diacinti D; Vullo F; Cannavale G; Lucchino B; Di Franco M; Cipriani C; Minisola S; Gori G; Catalano C. Early pulmonary alterations in patients with anti-citrullinated protein antibody-positive rheumatoid arthritis using HRCT. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2017. Italy. (2017) 28  ppS381', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9257828', 'Hill J. Patient satisfaction in a nurse-led rheumatology clinic. Journal of advanced nursing. (1997) 25 2 pp347-354', '10.1046/j.1365-2648.1997.1997025347.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2648.1997.1997025347.x']\n",
      "['9257829', 'Stephens WH; El-Ghobarey AF; Macleod MM; Buchanan WW. A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis. Current medical research and opinion. (1979) 5 10 pp754-758', '10.1185/03007997909109009', '']\n",
      "['9257830', 'Biegert C; Wagner I; L√ºdtke R; K√∂tter I; Lohm√ºller C; G√ºnaydin I; Taxis K; Heide L. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. Journal of rheumatology. (2004) 31 11 pp2121-2130', '10.1002/ptr.981', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.981']\n",
      "['9257831', 'Diamantopulos P; Miccoli G. [Double-blind comparative study of difenpyrammide and indomethacin in clinical research with patients]. Clinica terapeutica. (1979) 88 1 pp33-44', '10.1080/22953337.1979.11718671', '']\n",
      "['9257832', 'Davis JD; Struth AG; Turner RA; Pisko EJ; Ruchte IR. Pirprofen and aspirin in the treatment of rheumatoid arthritis. Clinical pharmacology and therapeutics. (1979) 25 5 Pt 1 pp618-623', '10.1002/cpt1979255part1618', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1979255part1618']\n",
      "['9257833', 'Markusse IM; Landewe R; Wolterbeek R; Ho M; Jenkins M; van der Heijde D. Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 7 pp1295-1300', '10.1093/rheumatology/kew030', 'http://academic.oup.com/rheumatology/article-pdf/55/7/1295/18097584/kew030.pdf']\n",
      "['9257834', 'Mahidashtizad S; Salajegheh A. Effects of aquatic therapy versus conventional land-based exercise on pain relief in rheumatoid arthritis. Regional anesthesia and pain medicine. (2013) 38 1 pp', '10.1016/s1754-3207(11)70780-5', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS1754-3207%2811%2970780-5']\n",
      "['9257835', 'Weintraub M; Francetic I; Hasday JD; et al. Tiopinac in rheumatoid arthritis: A three-phase dose-ranging, efficacy, and aspirin-withdrawal protocol. Clinical pharmacology and therapeutics. (1980) 27 5 pp579-585', '10.1038/clpt.1980.82', '']\n",
      "['9257836', 'Panicheeva S; Ngsriwongse S; Mokkhavesa C; Teerapong P; Kaojarern S. Original versus generic piroxicams, their cost-effective evaluation in rheumatoid arthritis (RA) patients. Chotmaihet thangphaet [Journal of the Medical Association of Thailand]. (1992) 75 2 pp104-109', '10.2165/00128413-200716150-00017', '']\n",
      "['9257837', 'Haugeberg G; Morton S; Emery P; Conaghan PG. Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritis. Annals of the rheumatic diseases. (2011) 70 1 pp184-187', '10.1136/ard.2009.128124', '']\n",
      "['9257839', 'Motivala SJ; Khanna D; FitzGerald J; Irwin MR. Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor alpha antagonists. Arthritis and rheumatism. (2008) 58 2 pp376-383', '10.1002/art.23165', '']\n",
      "['9257840', 'Bulthuis Y; Mohammad S; Braakman-Jansen LM; Drossaers-Bakker KW; van de Laar MA. Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: results of a randomized controlled clinical trial. Arthritis and rheumatism. (2008) 59 2 pp247-254', '10.1002/art.23332', '']\n",
      "['9257842', 'Sleath B; Chewning B; de Vellis BM; Weinberger M; de Vellis RF; Tudor G; Beard A. Communication about depression during rheumatoid arthritis patient visits. Arthritis and rheumatism. (2008) 59 2 pp186-191', '10.1002/art.23347', '']\n",
      "['9257845', 'Miyamoto S; Kageyama Y; Ozeki T; Suzuki M; Ichikawa T; Inoue T. Bone mineral density after total joint arthroplasty of lower extremities in rheumatoid arthritis patients. Archives of orthopaedic and trauma surgery. (2001) 121 3 pp127-130', '10.1007/s004020000196', 'http://link.springer.com/article/10.1007/s004020000196/fulltext.html']\n",
      "['9257846', 'Nemtsov BF; Benenson EV; Timina OV. [Pulse therapy with prospidin and methotrexate: comparative efficacy in rheumatoid arthritis (12-month controlled study)]. Klinicheskaia meditsina. (1998) 76 8 pp24-28', '10.14412/1995-4484-2003-1359', '']\n",
      "['9257847', 'Fioravanti A; Marabini S; Matucci-Cerinic M; Montemerani M; Moscato P; Cagnoni M; Marcolongo R. Effectiveness of somatostatin administered intra-articularly into the knee joint in patients with rheumatoid arthritis. A CONTROLled double BLIND study vs PLACEBO.  EFFICACIA DELLA SOMATOSTATIN SOMMINISTRATA PER VIA INTRA-ARTICOLARE NEL GINOCCHIO DI PAZIENTI CON ARTRITE REUMATOIDE. STUDIO IN DOPPIO-CIECO CONTROLLATO VERSO PLACEBO. G ITAL RIC CLIN TER. (1991) 12 5 pp130-134', '10.1007/s40619-016-0201-2', 'http://link.springer.com/article/10.1007/s40619-016-0201-2/fulltext.html']\n",
      "['9257848', 'Kvien TK; Greenwald M; Peloso PM; Wang H; Mehta A; Gammaitoni A. Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib. BMC musculoskeletal disorders. (2015) 16  pp26', '10.1186/s12891-015-0468-7', 'http://link.springer.com/article/10.1186/s12891-015-0468-7/fulltext.html']\n",
      "['9257849', 'Mullane JF; Salem S. Double-blind evaluation of the effect of etodolac and placebo on uric acid levels. CURR THER RES, CLIN EXP. (1988) 43 3 pp552-557', '10.1038/clpt.1988.199', '']\n",
      "['9257850', 'Menkes CJ. Radioisotope synoviorthesis in rheumatoid arthritis. Rheumatology and rehabilitation. (1979) Suppl  pp45-46', '10.1093/rheumatology/xviii.suppl.45', 'http://academic.oup.com/rheumatology/article-pdf/XVIII/suppl/45/5153173/XVIII-suppl-45.pdf']\n",
      "['9257851', 'Yates DB; Scott JT; Ramsey N. Double-blind trial of 90Y for chronic inflammatory synovitis of the knee. Rheumatology and rehabilitation. (1979) Suppl  pp46-47', '10.1093/rheumatology/xviii.suppl.46', 'http://academic.oup.com/rheumatology/article-pdf/XVIII/suppl/46/5153190/XVIII-suppl-46.pdf']\n",
      "['9257852', 'Siu AM; Chui DY. Evaluation of a community rehabilitation service for people with rheumatoid arthritis. Patient education and counseling. (2004) 55 1 pp62-69', '10.1016/j.pec.2003.08.001', '']\n",
      "['9257853', 'Haskett S; Backman C; Porter B; Goyert J; Palejko G. A crossover trial of custom-made and commercially available wrist splints in adults with inflammatory arthritis. Arthritis and rheumatism. (2004) 51 5 pp792-799', '10.1002/art.20699', '']\n",
      "['9257855', 'van den Ende CH; Breedveld FC; le Cessie S; Dijkmans BA; de Mug AW; Hazes JM. Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial. Annals of the rheumatic diseases. (2000) 59 8 pp615-621', '10.1136/ard.59.8.615', '']\n",
      "['9257856', 'Wankya BM; Awadh S; Mwai SJ. Tolfenamic acid and ibuprofen in rheumatoid arthritis: a double-blind cross over study. East African medical journal. (1981) 58 8 pp622-625', '10.1177/030006057200100106', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057200100106']\n",
      "['9257857', 'Runge LA; Pinals RS; Tomar RH. Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes. Annals of the rheumatic diseases. (1979) 38 2 pp122-127', '10.1136/ard.38.2.122', '']\n",
      "['9257859', 'Smyth CJ; Clark GM. Phenylbutazone in rheumatoid arthritis. J-Chronic-Dis. (1957) 5 Jun pp734-750', '10.1016/0021-9681(57)90081-4', '']\n",
      "['9257860', 'Shi Y; Zhang H; Du X; Zhang M; Yin Y; Zhou C; Song S; Fu X; Li S; Liu Y; Li H; Li X; Wu X; Zhu Y. A double blind observation for therapeutic effects of the tong luo kai bi tablets on rheumatoid arthritis. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (1999) 19 3 pp166-172', '10.1039/d4ra00097h/v3/response1', '']\n",
      "['9257861', 'Choy EH; Chikanza IC; Kingsley GH; Corrigall V; Panayi GS. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scandinavian journal of immunology. (1992) 36 2 pp291-298', '10.1111/j.1365-3083.1992.tb03102.x', '']\n",
      "['9257862', 'Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study. Rheumatology (Oxford, England). (2007) 46 6 pp994-998', '10.1093/rheumatology/kem030', '']\n",
      "['9257863', 'Gleeson RE; Evans R; Ackroyd CE; Webb J; Newman JH. Fixed or mobile bearing unicompartmental knee replacement? A comparative cohort study. The Knee. (2004) 11 5 pp379-384', '10.1016/j.knee.2004.06.006', '']\n",
      "['9257864', \"Usmani ZA; Catcheside P; Antic N; Rischmueller M; Smith M; Gordon T; McEvoy RD. Surfactant for OSA in patients with primary Sjogren's syndrome-a randomised, placebo controlled, cross over study. Journal of Sleep Research. Conference: 23rd Annual Scientific Meeting of the Australasian Sleep Association and Australasian Sleep Technologists Association: Sleep and the City, Sleep DownUnder 2011 Sydney, NSW Australia. Conference Start: 20111027 Conference End: 20111029. Conference Publication: (var.pagings). (2011) 20  pp43\", '10.1016/j.sleep.2012.06.010', '']\n",
      "['9257865', 'Atakhodzhaeva ZA; Sigidin IaA. Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis. TerapevticheskiiÃÜ arkhiv. (1987) 59 12 pp30-33', '10.1007/bf03305911', 'http://link.springer.com/article/10.1007/BF03305911/fulltext.html']\n",
      "['9257866', 'Ruchkin IN; Burdeƒ≠nyƒ≠ AP. [Auriculo-electropuncture in rheumatoid arthritis (a double-blind study)]. TerapevticheskiiÃÜ arkhiv. (1987) 59 12 pp26-30', '10.1185/03007998709108963', '']\n",
      "['9257867', 'Ahlmen M; Sullivan M; Bjelle A. Team versus non-team outpatient care in rheumatoid arthritis. A comprehensive outcome evaluation including an overall health measure. Arthritis and rheumatism. (1988) 31 4 pp471-479', '10.1002/art.1780310403', '']\n",
      "['9257868', 'Nader TA; Smith DE; Dillbeck MC; Schanbacher V; Dillbeck SL; Gallois P; Beall-Rougerie S; Schneider RH; Nidich SI; Kaplan GP; Belok S. A double blind randomized controlled trial of Maharishi Vedic vibration technology in subjects with arthritis. Frontiers in bioscience. (2001) 6  ppH7-H17', '10.2741/a720', '']\n",
      "['9257871', 'Issa SF; Christensen AF; Lottenburger T; Junker K; Lindegaard H; H√∏rslev-Petersen K; Junker P. Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals. Scandinavian journal of immunology. (2015) 82 1 pp70-75', '10.1111/sji.12301', '']\n",
      "['9257872', 'Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. British journal of rheumatology. (1995) 34 8 pp747-755', '10.1093/rheumatology/34.8.747', 'http://academic.oup.com/rheumatology/article-pdf/34/8/747/5031382/34-8-747.pdf']\n",
      "['9257873', 'Srinivasan A; Amos M; Webley M. The effects of joint washout and steroid injection compared with either joint washout or steroid injection alone in rheumatoid knee effusion. British journal of rheumatology. (1995) 34 8 pp771-773', '10.1093/rheumatology/34.8.771', 'http://academic.oup.com/rheumatology/article-pdf/34/8/771/5031667/34-8-771.pdf']\n",
      "['9257874', 'Stein CM; He H; Pincus T; Wood AJ. Cyclosporine impairs vasodilation without increased sympathetic activity in humans. Hypertension. (1995) 26 4 pp705-710', '10.1161/01.hyp.26.4.705', '']\n",
      "['9257875', 'Mcbain H; Shipley M; Olaleye A; Moore S; Newman S. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: a randomised controlled trial. Annals of the rheumatic diseases. (2016) 75 7 pp1343-1349', '10.1136/annrheumdis-2015-207768', '']\n",
      "['9257876', 'Kajander A; von Essen R; Isom√§ki H; Cantell K. Interferon treatment of rheumatoid arthritis. Lancet (London, England). (1979) 1 8123 pp984-985', '10.1016/s0140-6736(79)91771-9', '']\n",
      "['9257877', 'Burry HC; Witherington L. A comparison of sulindac with ibuprofen in the management of rheumatoid arthritis. New Zealand medical journal. (1979) 89 634 pp298-300', '10.1111/j.1445-5994.1979.tb04203.x', '']\n",
      "['9257878', 'Havranek H. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis. European journal of rheumatology and inflammation. (1987) 9 2 pp105-108', '10.1093/rheumatology/keh168', '']\n",
      "['9257879', 'Eastell R; Devogelaer JP; Peel NF; Chines AA; Bax DE; Sacco-Gibson N; Nagant de Deuxchaisnes C; Russell RG. Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients. Osteoporosis international. (2000) 11 4 pp331-337', '10.1007/s001980070122', 'http://link.springer.com/article/10.1007/s001980070122/fulltext.html']\n",
      "['9257880', 'Montrone F; Fumagalli M; Pellegrini P; Ratti G; Sala G; Liverta C; Pollini C; Pontiroli AE. A double-blind cross-over evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis. Rheumatology and rehabilitation. (1979) 18 2 pp114-118', '10.1093/rheumatology/18.2.114', 'http://academic.oup.com/rheumatology/article-pdf/18/2/114/5038961/18-2-114.pdf']\n",
      "['9257881', 'Blechman WJ; Lechner BL. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis. Rheumatology and rehabilitation. (1979) 18 2 pp119-124', '10.1093/rheumatology/18.2.119', 'http://academic.oup.com/rheumatology/article-pdf/18/2/119/5038983/18-2-119.pdf']\n",
      "['9257882', 'Lopez-Garcia JS; Garcia-Lozano I; Rivas L; Ramirez N; Raposo R; Mendez MT. Autologous serum eye drops diluted with sodium hyaluronate: Clinical and experimental comparative study. Acta ophthalmologica. (2014) 92  1 ppe22-e29', '10.1111/aos.12167', '']\n",
      "['9257884', 'Menon N; Kothari SY; Gogna A; Sharma R. Comparison of intra-articular glucocorticoid injections with DMARDs versus DMARDs alone in rheumatoid arthritis. Journal of the Association of Physicians of India. (2014) 62 8 pp673-676', '10.1038/ncprheum0126', 'http://www.nature.com/articles/ncprheum0126']\n",
      "['9257885', 'Slaughter JR; Parker JC; Martens MP; Smarr KL; Hewett JE. Clinical outcomes following a trial of sertraline in rheumatoid arthritis. Psychosomatics. (2002) 43 1 pp36-41', '10.1176/appi.psy.43.1.36', '']\n",
      "['9257886', \"Prieur AM; Piussan Ch; Manigne P; et al. Juvenile chronic arthritis. Double blind study of the efficiency and tolerance of D-penicillamine.  ARTHRITE CHRONIQUE JUVENILE. ETUDE EN DOUBLE INSU DE L'EFFICACITE ET DE LA TOLERANCE DE LA D-PENICILLAMINE. Archives francaises de pediatrie. (1985) 42 2 pp91-96\", '10.1002/art.1780280404', '']\n",
      "['9257887', 'Boussina I; Toussaint M; Ott H; Hermans P; Fallet GH. A double-blind study of erbium169 synoviorthesis in rheumatoid digital joints. Results after one year. Scandinavian journal of rheumatology. (1979) 8 2 pp71-74', '10.3109/03009747909105339', '']\n",
      "['9257888', 'Gupta MK; Shrivastava AK; Chauhan APS; Gaur DS; Mishra KK; Sharma S. Comparative study of the shiva guggulu and simhanada guggulu in the management of amavata (rheumatoid arthritis). International journal of applied pharmaceutics. (2016) 8 2 pp5-12', '10.46607/iamj0209022021', '']\n",
      "['9257889', 'Bruno A; Pagano G; Benzi L; Di Ciani G; Spallone V; Calabrese G; Passeri A. Change in glucose metabolism after long-term treatment with deflazacort and betamethasone. European journal of clinical pharmacology. (1992) 43 1 pp47-50', '10.1007/bf02280753', 'http://link.springer.com/article/10.1007/BF02280753/fulltext.html']\n",
      "['9257890', 'Ferraccioli G; Falleti E; De Vita S; Di Poi E; Damato R; Casatta L; Salaffi F. Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy. Journal of rheumatology. (1998) 25 10 pp1874-1879', '10.1136/ard.56.5.336a', '']\n",
      "['9257891', 'Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. Journal of rheumatology. (1998) 25 10 pp1880-1886', '10.1136/ard.58.9.525', '']\n",
      "['9257892', \"Singh M; Stark PC; Palmer CA; Gilbard JP; Papas AS. Effect of omega-3 and vitamin E supplementation on dry mouth in patients with Sj√∂gren's syndrome. Special care in dentistry. (2010) 30 6 pp225-229\", '10.1111/j.1754-4505.2010.00158.x', '']\n",
      "['9257893', 'M√§ki-Pet√§j√§ KM; Elkhawad M; Cheriyan J; Joshi FR; Ost√∂r AJ; Hall FC; Rudd JH; Wilkinson IB. Anti-tumor necrosis factor-Œ± therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation. (2012) 126 21 pp2473-2480', '10.1161/circulationaha.112.120410', '']\n",
      "['9257894', 'Kiff PS; Stead H; Morant SV; Shield MJ. Arthrotec, diclofenac and ibuprofen in general practice. European journal of rheumatology and inflammation. (1994) 14 3 Suppl pp31-38', '10.1093/rheumatology/33.suppl_1.186', 'http://academic.oup.com/rheumatology/article-pdf/33/suppl_1/186/5043119/33-suppl_1-186.pdf']\n",
      "['9257895', 'Wu JW; Wong YC. Elective unilateral total knee replacement using continuous femoral nerve blockade versus conventional patient-controlled analgesia: perioperative patient management based on a multidisciplinary pathway. Xianggang yi xue za zhi [Hong Kong medical journal]. (2014) 20 1 pp45-51', '10.12809/hkmj133899', 'https://www.hkmj.org/system/files/hkm1402p45.pdf']\n",
      "['9257896', 'Yurdakul S; Nezhdi Mustafa B; Fresko I; Seyahi E; Yazici H. The consort criteria for eligibilty, study settings, locations, and center effects are seldom met in randomised clinical trials. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2286', '']\n",
      "['9257897', 'van Holten J; Pavelka K; Vencovsky J; Stahl H; Rozman B; Genovese M; Kivitz AJ; Alvaro J; Nuki G; Furst DE; Herrero-Beaumont G; McInnes IB; Musikic P; Tak PP. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 1 pp64-69', '10.1136/ard.2003.020347', '']\n",
      "['9257898', 'Talybov FIu; Dubrovina NA; Kalinin NN; Petrova VI; Movshev BE. [Comparative assessment of various programs of plasmapheresis in the combined treatment of patients with rheumatoid arthritis]. Klinicheskaia meditsina. (1992) 70 2 pp51-54', '10.1016/0896-8411(92)90095-8', '']\n",
      "['9257899', 'Radia M; Furst DE. Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. Journal of rheumatology. (1988) 15 2 pp242-246', '10.1007/bf03308310', 'http://link.springer.com/article/10.1007/BF03308310/fulltext.html']\n",
      "['9257900', 'Moreira E; Jones A; Oliveira HV; Jennings F; Fernandes A; Natour J. Effectiveness of insole use on rheumatoid feet: A randomized controlled trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2671', '']\n",
      "['9257906', 'Heine P; Williams MA; McConkey C; Lord J; Dosanjh S; Williamson E; Adams J; Underwood M; Lamb SE. Sarah: Strengthening and stretching for people with rheumatoid arthritis of the hands: A randomised controlled trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.303', '']\n",
      "['9257907', 'Ekstrand R; Alvian G; Magnusson A; et al. Additive clinical effect of indomethacin suppositories during salicylate therapy in rheumatoid patients. Scandinavian journal of rheumatology. (1981) 10 2 pp69-75', '10.3109/03009748109095275', '']\n",
      "['9257908', 'Korczowska I; ≈Åacki JK; Leszczy≈Ñski P; Mackiewicz SH. Bone tissue metabolism in patients with rheumatoid arthritis treated with glucocorticosteroids. Polskie Archiwum Medycyny WewneÃ®trznej. (2000) 104 2 pp455-465', '10.1136/annrheumdis-2001.628', '']\n",
      "['9257909', 'Dougados M; Perrodeau E; Fayet F; Gaudin P; Cerato MH; Le Loet X; Flipo RM; Chabrefy L; Mouterde G; Euller-Ziegler L; Schaeverbeke T; Fautrel B; Saraux A; Valckaenaere I; Chales G; Dernis E; Richette P; Mariette X; Berenbaum F; Sibilia J; Ravaud P. Impact of a nurse led program of patient self-assessment of disease activity on the management of rheumatoid arthritis: Results of a prospective, multicentre, randomized, controlled trial (comedra). Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.489', '']\n",
      "['9257910', 'Manning V; Hurley M; Scott DL; Choy E; Bearne L. Upper limb exercise, education and self management in early rheumatoid arthritis (the extra programme)-results from a randomised controlled trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.442', '']\n",
      "['9257912', 'Ferwerda M; Spillekom S; Van Middendorp H; Van Beugen S; Kievit W; Fransen J; Visser H; Van Oijen P; Taal E; Van Riel P; De Jong E; Van De Kerkhof P; Van Der Laar M; Evers A. The patient-therapist relationship as an indicator for treatment success in E-health treatments for patients with rheumatoid arthritis and psorias. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1118', '']\n",
      "['9257914', 'Alkan Melikoglu M; Senel K. Aerobic exercise training improves cardiovascular risk in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1084', '']\n",
      "['9257915', 'Yoo DH; Suh C-H; Shim SC; Jeka S; Molina FFC; Hrycaj P; Wiland P; Lee EY; Medina-Rodriguez FG; Shesternya P; Radominski S; Stanislav M; Kovalenko V; Sheen DH; Myasoutova L; Lim MJ; Choe J-Y; Lee SJ; Lee SY; Kim SH; Park W. Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: results up to Week 72 of a Phase I Randomized Controlled Trial. Biodrugs. (2017) 31 4 pp357-367', '10.1007/s40259-017-0232-7', 'http://link.springer.com/article/10.1007/s40259-017-0232-7/fulltext.html']\n",
      "['9257917', \"Wang M; Donovan-Hall M; Adams J. People's perceptions and beliefs about their ability to exercise with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp\", '10.1136/annrheumdis-2013-eular.1716', '']\n",
      "['9257918', 'Giorgianni G; Ottaviani C; Soliano A; Campi N. Efficacy of tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Current Therapeutic Research - Clinical and Experimental. (1992) 51 2 pp175-184', '10.1016/s0011-393x(05)80470-9', '']\n",
      "['9257920', 'Hickling P; Jacoby RK; Kirwan JR. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. British journal of rheumatology. (1998) 37 9 pp930-936', '10.1093/rheumatology/37.9.930', 'http://academic.oup.com/rheumatology/article-pdf/37/9/930/18106401/370930.pdf']\n",
      "['9257921', 'Strand V; Genovese M; Mallya U; Richards H; Mpofu S. Improvements in health-related quality of life (HRQOL) in patients with rheumatoid arthritis (RA) receiving secukinumab: Results of a dose-finding study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.582', '']\n",
      "['9257926', 'Niedermann K; de Bie RA; Kubli R; Ciurea A; Steurer-Stey C; Villiger PM; B√ºchi S. Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial. Patient education and counseling. (2011) 82 1 pp42-48', '10.1016/j.pec.2010.02.014', '']\n",
      "['9257927', 'Capela RC; Saad-Magalhaes C. Equivalence of disease activity tools for juvenile idiopathic arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1125', '']\n",
      "['9257928', 'Couderc M; Mathieu S; Glace B; Soubrier M. Efficacy of anakinra in pseudogout: Report of 3 cases. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1067', '']\n",
      "['9257929', 'Aryaeian N; Shahram F; Djalali M. Effect of vitamin E on immunity and inflammation in adults with active rheumatoid arthritis (RA). Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1465', '']\n",
      "['9257930', 'Primdahl J; Horn HC; Petersen R; Horslev-Petersen K. Clinical and radiological outcome in outpatients with rheumatoid arthritis followed by medical, nursing or shared care-a two year randomised controlled trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1798', '']\n",
      "['9257931', 'Kume K; Amano K; Hatta K; Ohta H. Treating to target ultrasound with clinical remission better effects than clinical remission in RRP. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2074', '']\n",
      "['9257934', 'Jansen JP; Vieira MC; Bradley JD; Cappelleri JC; Zwillich SH; Wallenstein GV. Meta-analysis of joint structural deterioration over time in minimally treated rheumatoid arthritis patients. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2523', '']\n",
      "['9257935', 'Wittenborg A; Petersen G; Lorkowski G; Brabant T. [Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis]. Zeitschrift fuÃàr Rheumatologie. (1998) 57 4 pp215-221', '10.1007/s003930050094', 'http://link.springer.com/article/10.1007/s003930050094/fulltext.html']\n",
      "['9257936', 'Bird P; Wollenhaup J; Lee S-H; Szekanecz Z; Neira O; Hammond C; Vlahos B; Szumski A; Koenig AS; Kotak S. Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.3422', '']\n",
      "['9257937', 'Tijhuis GJ; Vliet Vlieland TP; Zwinderman AH; Hazes JM. A comparison of the Futuro wrist orthosis with a synthetic ThermoLyn orthosis: utility and clinical effectiveness. Arthritis care and research. (1998) 11 3 pp217-222', '10.1002/art.1790110309', '']\n",
      "['9257939', 'Park JK; Lee MA; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Annals of the rheumatic diseases. (2017) 76 9 pp1559-1565', '10.1136/annrheumdis-2017-211128', '']\n",
      "['9257940', 'Baan H; Haagsma CJ; van de Laar MA. Corticosteroid injections reduce size of rheumatoid nodules. Clinical rheumatology. (2006) 25 1 pp21-23', '10.1007/s10067-005-1098-5', 'http://link.springer.com/article/10.1007/s10067-005-1098-5/fulltext.html']\n",
      "['9257941', 'Reading AE; Hand DJ; Sledmere CM. A comparison of response profiles obtained on the McGill pain questionnaire and an adjective checklist. Pain. (1983) 16 4 pp375-383', '10.1016/0304-3959(83)90151-3', '']\n",
      "['9257942', 'Li L; Zhang Y; Ma L; Ji P; Yim S; Chowdhury B; Doddapaneni S; Liu J; Wang Y; Sahajwalla C. Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 1: binary Model). Journal of clinical pharmacology. (2017) 57 9 pp1097-1106', '10.1002/jcph.891', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.891']\n",
      "['9257943', 'Ryan PB; Rush DR; Nicholas TA; Graham DG. A double-blind comparison of fenoprofen calcium, acetaminophen, and placebo in the palliative treatment of common nonbacterial upper respiratory infections. Current therapeutic research, clinical and experimental. (1987) 41 1 pp17-23', '10.1016/j.curtheres.2017.04.004', '']\n",
      "['9257944', 'Li L; Zhang Y; Ma L; Ji P; Yim S; Chowdhury BA; Doddapaneni S; Liu J; Wang Y; Sahajwalla C. Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: continuous Model). Journal of clinical pharmacology. (2017) 57 9 pp1107-1125', '10.1002/jcph.967', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.967']\n",
      "['9257945', 'Gibson R G; Gibson S L M; Macneill A D; Buchanan W W. The place for non-pharmaceutical therapy in chronic rheumatoid arthritis: A critical study of homoeopathy. British homoeopathic journal. (1980) 69 3 pp121-133', '10.1016/s0007-0785(80)80040-8', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1016/S0007-0785(80)80040-8.pdf']\n",
      "['9257946', \"Liu A; Liu W. Clinical study on treatment of Sjogren's syndrome by combination of Chinese traditional medicine. Journal of Pure and Applied Microbiology. (2013) 7  1 pp317-322\", '10.1016/s0254-6272(13)60146-6', '']\n",
      "['9257947', 'McInnes J; Larson MG; Daltroy LH; Brown T; Fossel AH; Eaton HM; Shulman-Kirwan B; Steindorf S; Poss R; Liang MH. A controlled evaluation of continuous passive motion in patients undergoing total knee arthroplasty. JAMA. (1992) 268 11 pp1423-1428', '10.1097/00132586-199304000-00052', '']\n",
      "['9257949', 'Oude Voshaar MAH; Moghadam MG; Vonkeman HE; Ten Klooster PM; Van Schaardenburg D; Tekstra J; Visser H; Van De Laar MAFJ; Jansen TL. Measuring disease exacerbation and flares in rheumatoid arthritis: comparison of commonly used disease activity indices and individual measures. Journal of rheumatology. (2017) 44 8 pp1118-1124', '10.3899/jrheum.160915', '']\n",
      "['9257951', \"Mejjad O; Vittecoq O; Pouplin S; Grassin-Delyle L; Weber J; Le Lo√´t X; Groupe de Recherche sur le Handicap de l'Appareil Locomoteur. Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients. Joint, bone, spine. (2004) 71 6 pp542-545\", '10.1016/j.jbspin.2003.09.007', '']\n",
      "['9257952', 'Astbury C; Hill J; Bird HA. Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine. Annals of the rheumatic diseases. (1988) 47 4 pp323-327', '10.1136/ard.47.4.323', '']\n",
      "['9257953', 'Lems WF; Jahangier ZN; Jacobs JW; Bijlsma JW. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clinical and experimental rheumatology. (1995) 13 3 pp293-297', '10.1093/rheumatology/36.2.220', 'http://academic.oup.com/rheumatology/article-pdf/36/2/220/9930342/360220.pdf']\n",
      "['9257954', 'Swezey RL; Spiegel TM; Cretin S; Clements P. Arthritic hand response to pressure gradient gloves. Archives of physical medicine and rehabilitation. (1979) 60 8 pp375-377', '10.1016/j.apmr.2016.08.287', '']\n",
      "['9257955', 'Cuperus N; Vlieland TV; Mahler E; Kersten C; Hoogeboom T; Van Den Ende E. The clinical burden of generalized osteoarthritis represented by activity limitations and health related quality of life: A cross-sectional study. Arthritis and rheumatism. (2013) 65  ppS775-S776', '10.1007/s00296-014-3149-1', 'http://link.springer.com/article/10.1007/s00296-014-3149-1/fulltext.html']\n",
      "['9257956', 'Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache. Headache. (2005) 45 9 pp1151-1162', '10.1111/j.1526-4610.2005.00238.x', '']\n",
      "['9257957', 'Unk JA; Brasington R. Efficacy study of multimedia rheumatoid arthritis patient education program. Journal of the american association of nurse practitioners. (2014) 26 7 pp370-377', '10.1002/2327-6924.12064', '']\n",
      "['9257958', 'Bass AR; Lee Y-Y; Lyman S; Westrich GH; Gage BF. The effect of statin therapy on venous thromboembolism after hip or knee arthroplasty. Arthritis and rheumatism. (2013) 65 var.pagings ppS901', '10.1016/j.arth.2016.09.033', '']\n",
      "['9257960', 'Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. American journal of gastroenterology. (2001) 96 4 pp1019-1027', '10.1111/j.1572-0241.2001.03740.x', '']\n",
      "['9257964', 'Leng X; Xiao W; Zhu X; Xu Z; Yu W; Lu J; Wang J; Xia X; Li Y; Liu Y; Tang H; Zhao D; Shi Y; Xu H; Bao J; Chen L; Lin L; Zhou L; Chen G; Zhang W; Zhao Y. Ultrasonographic monitoring of response to infliximab in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS987-S988', '10.1007/s10067-016-3176-2', 'http://link.springer.com/article/10.1007/s10067-016-3176-2/fulltext.html']\n",
      "['9257965', 'Alheresh R; Allaire SH; Lavalley MP; Vaughan M; Keysor JJ. Baseline work participation of a novel intervention to prevent work disability among persons with arthritis: The \"work it\" study. Arthritis and rheumatism. (2013) 65  ppS1220-S1221', '10.3233/wor-162331', '']\n",
      "['9257966', 'Evans CE; Chughtai AY; Blumsohn A; Giles M; Eastell R. The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women. European journal of clinical nutrition. (1997) 51 6 pp394-399', '10.1038/sj.ejcn.1600420', 'https://www.nature.com/articles/1600420']\n",
      "['9257970', 'Farboud A; Choy E. Serological investigation of IgG levels and subclasses in rheumatoid arthritis patients following ingestion of bovine type II collagen: results of a double blind, randomised controlled trial. Clinical rheumatology. (2011) 30 2 pp193-199', '10.1007/s10067-010-1473-8', 'http://link.springer.com/article/10.1007/s10067-010-1473-8/fulltext.html']\n",
      "['9257971', 'Seideman P; Melander A. Equianalgesic effects of paracetamol and indomethacin in rheumatoid arthritis. British journal of rheumatology. (1988) 27 2 pp117-122', '10.1093/rheumatology/27.2.117', 'http://academic.oup.com/rheumatology/article-pdf/27/2/117/5027849/27-2-117.pdf']\n",
      "['9257972', 'De Cock D; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P; CareRA study group*. A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients. Scandinavian journal of rheumatology. (2014) 43 1 pp1-8', '10.3109/03009742.2013.805242', '']\n",
      "['9257973', 'K√•ss AS; F√∏rre OT; Fagerland MW; Gulseth HC; Torjesen PA; Hollan I. Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study. Scandinavian journal of rheumatology. (2014) 43 1 pp22-27', '10.3109/03009742.2013.825007', '']\n",
      "['9257974', \"Meiners PM; Vissink A; Spijkervet FKL; Haacke EA; Abdulahad WH; Brouwer E; Huitema MG; Sillevis Smitt-Kamminga N; Kroese FGM; Arends S; Bootsma H. Abatacept reduces disease activity in early primary sjogren's syndrome: One year results from a phase ii open-label study. Arthritis and rheumatism. (2013) 65  ppS229\", '10.1136/annrheumdis-2013-eular.317', '']\n",
      "['9257979', 'Mewa AA; Rosenbloom D; Grace EM; Brooks P; Bellamy N; Denko C; Norman G; Buchanan WW. Effects of aspirin, naloxone and placebo. Clinical rheumatology. (1987) 6 4 pp526-531', '10.1007/bf02330589', 'http://link.springer.com/article/10.1007/BF02330589/fulltext.html']\n",
      "['9257981', 'Balogh Z; Papazoglou SN; MacLeod M; Buchanan WW. A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis. Current medical research and opinion. (1979) 6 2 pp148-153', '10.1185/03007997909109412', '']\n",
      "['9257982', 'Hewlett S; Ambler N; Almeida C; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kirwan J; Plummer Z; Rooke C; Thorn J; Tomkinson K; Pollock J; RAFT Study Team. Protocol for a randomised controlled trial for reducing arthritis fatigue by clinical teams (RAFT) using cognitive-behavioural approaches. BMJ open. (2015) 5 8 ppe009061', '10.1136/bmjopen-2015-009061', '']\n",
      "['9257983', 'Palmer M; Highton J; Palmer DG. A double blind comparison of tiaprofenic acid with placebo. New Zealand medical journal. (1988) 101 845 pp240-241', '10.2165/00003495-198800351-00013', '']\n",
      "['9257985', 'Manniche C; Malchow-M√∏ller A. [The influence of non-steroidal anti-inflammatory drugs (NSAID) in the treatment of peptic ulcer. A prospective randomized study]. Ugeskrift for laeger. (1987) 149 32 pp2143-2144', '10.1136/gut.28.2.226', '']\n",
      "['9257986', 'Franke A; Reiner L; Pratzel HG; Franke T; Resch KL. Long-term efficacy of radon spa therapy in rheumatoid arthritis--a randomized, sham-controlled study and follow-up. Rheumatology (Oxford, England). (2000) 39 8 pp894-902', '10.1093/rheumatology/39.8.894', 'http://academic.oup.com/rheumatology/article-pdf/39/8/894/18109002/390894.pdf']\n",
      "['9257988', 'Ridolfo AS; Ashbrook EM; Schmid GE; et al. A double-blind study comparing benoxaprofen, aspirin, and benoxaprofen plus aspirin in patients with rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1982) 5 2 pp239-245', '10.1185/03007997709110178', '']\n",
      "['9257989', 'Williams MA; Williamson EM; Heine PJ; Nichols V; Glover MJ; Dritsaki M; Adams J; Dosanjh S; Underwood M; Rahman A; McConkey C; Lord J; Lamb SE. Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation. Health technology assessment (Winchester, England). (2015) 19 19 pp1-222', '10.3310/hta19190', 'https://njl-admin.nihr.ac.uk/document/download/2002122']\n",
      "['9257990', 'Stephens S; Botteman MF; Cifaldi MA; van Hout BA. Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease. BMJ open. (2015) 5 6 ppe006560', '10.1136/bmjopen-2014-006560', '']\n",
      "['9257991', 'Rahman WA; Garbuz DS; Masri BA. Randomized controlled trial of radiographic and patient-assessed outcomes following fixed versus rotating platform total knee arthroplasty. Journal of arthroplasty. (2010) 25 8 pp1201-1208', '10.1016/j.arth.2009.10.002', '']\n",
      "['9257992', 'Kubo S; Yamaoka K; Amano K; Nagano S; Tohma S; Suematsu E; Nagasawa H; Iwata K; Tanaka Y. Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study. Rheumatology (united kingdom). (2017) 56 8 pp1293-1301', '10.1093/rheumatology/kex068', 'http://academic.oup.com/rheumatology/article-pdf/56/8/1293/18801161/kex068.pdf']\n",
      "['9257994', 'Pillemer SR; Fowler SE; Tilley BC; Alarcon GS; Heyse SP; Trentham DE; Neuner R; Clegg DO; Leisen JCC; Cooper SM; Duncan H; Tuttleman M. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. Arthritis and rheumatism. (1997) 40 3 pp419-425', '10.1002/art.1780400305', '']\n",
      "['9257995', 'Nestorov I; Munafo A; Papasouliotis O; Visich J. Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2008) 48 4 pp406-417', '10.1177/0091270008315312', '']\n",
      "['9257996', 'Rice DM. Comparison of diflunisal and piroxicam in the management of patients with rheumatoid arthritis. Clinical therapeutics. (1987) 10 1 pp92-97', '10.1007/bf03291052', 'http://link.springer.com/article/10.1007/BF03291052/fulltext.html']\n",
      "['9257997', \"Bizzarro A; Valentini G; Di MG; et al. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. Journal of clinical endocrinology and metabolism. (1987) 64 1 pp32-36\", '10.1210/jcem-64-1-32', 'http://academic.oup.com/jcem/article-pdf/64/1/32/10498823/jcem0032.pdf']\n",
      "['9257998', 'Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. Journal of rheumatology. (2007) 34 5 pp952-957', '10.1002/art.22054', '']\n",
      "['9257999', 'Huber AM; Tomlinson GA; Koren G; Feldman BM. Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials. Journal of rheumatology. (2007) 34 5 pp1125-1132', '10.1186/isrctn95255919', '']\n",
      "['9258000', 'Kometani T; Fukuda T; Kakuma T; Kawaguchi K; Tamura W; Kumazawa Y; Nagata K. Effects of alpha-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans. Immunopharmacology and immunotoxicology. (2008) 30 1 pp117-134', '10.1080/08923970701812688', '']\n",
      "['9258001', 'Hamilton J; Brydson G; Fraser S; Grant M. Walking ability as a measure of treatment effect in early rheumatoid arthritis. Clinical rehabilitation. (2001) 15 2 pp142-147', '10.1191/026921501667663055', 'https://journals.sagepub.com/doi/pdf/10.1191/026921501667663055']\n",
      "['9258002', 'Fautrel B; Pham T; Tubach F; Alfaiate T; Morel J; Dernis E; Puechal XJ; Gaudin P; Mariette X. Tapering TNF-blockers in established rheumatoid arthritis patients in DAS28 remission: Results of a DAS28-driven step-down strategy randomized controlled trial. Arthritis and rheumatism. (2012) 64  12 pp4169-4170', '10.1136/annrheumdis-2013-eular.708', '']\n",
      "['9258003', 'Ajeganova S; Svensson B; Hafstr√∂m I; BARFOT Study Group. Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. BMJ open. (2014) 4 4 ppe004259', '10.1136/bmjopen-2013-004259', '']\n",
      "['9258004', 'Taylor K; De Joya A. The effect of circuit training in a modified constraint induced movement therapy program. Archives of physical medicine and rehabilitation. (2013) 94  10 ppe29', '10.1016/j.apmr.2013.08.096', '']\n",
      "['9258006', 'Ostergaard M; Hansen MS; Stoltenberg MB; Gideon P; Jensen KE; Klarlund M; Lorenzen I. [Magnetic resonance imaging as a marker of inflammation, destruction and prognosis in rheumatoid arthritis wrists]. Ugeskrift for laeger. (2000) 162 31 pp4145-4149', '10.1002/1529-0131(199905)42:5<918::aid-anr10>3.0.co;2-2', '']\n",
      "['9258007', 'Syngle A; Garg N; Krishan P; Verma I. Stem cell augmentation for cardiovascular risk in Rheumatoid Arthritis: STAR study. Indian heart journal. (2014) 66  ppS120', '10.1016/j.ihj.2014.10.337', '']\n",
      "['9258008', 'Aida Babaeva AR; Usachyova MN; Solodenkova KS; Osadchuk MA. Low-dose anti-cytokine treatment impacts on heart failure with preserved ejection fraction in active rheumatoid arthritis. European journal of heart failure. Conference: heart failure 2016 and the 3rd world congress on acute heart failure. Florence italy. Conference start: 20160521. Conference end: 20160524. Conference publication: (var.pagings). (2016) 18  pp459', '10.1201/b13888-25', '']\n",
      "['9258009', 'Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study. Pediatric rheumatology online journal. (2017) 15 1 pp11', '10.1186/s12969-017-0138-4', 'http://link.springer.com/content/pdf/10.1186/s12969-017-0138-4.pdf']\n",
      "['9258010', 'Tanaka N; Sakahashi H; Hirose K; Ishima T; Ishii S. Volume of a wash and the other conditions for maximum therapeutic effect of arthroscopic lavage in rheumatoid knees. Clinical rheumatology. (2006) 25 1 pp65-69', '10.1007/s10067-005-1143-4', 'http://link.springer.com/article/10.1007/s10067-005-1143-4/fulltext.html']\n",
      "['9258011', \"Izumi M; Eguchi K; Nakamura H; Takagi Y; Kawabe Y; Nakamura T. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sj√∂gren's syndrome. Annals of the rheumatic diseases. (1998) 57 8 pp464-469\", '10.1136/ard.57.8.464', '']\n",
      "['9258012', 'Rolla G; Brussino L; Scappaticci E; Morello M; Innarella R; Rosina F; Bucca C. Source of exhaled nitric oxide in primary biliary cirrhosis. Chest. (2004) 126 5 pp1546-1551', '10.1378/chest.126.5.1546', '']\n",
      "['9258013', 'Keefe FJ; Lefebvre JC; Kerns RD; Rosenberg R; Beaupre P; Prochaska J; Prochaska JO; Caldwell DS. Understanding the adoption of arthritis self-management: stages of change profiles among arthritis patients. Pain. (2000) 87 3 pp303-313', '10.1016/s0304-3959(00)00294-3', '']\n",
      "['9258014', 'Combe B; V√©licitat P; Garz√≥n N; Bluhmki E. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients. Inflammation research. (2001) 50 Suppl 1  ppS10-6', '10.1007/pl00022374', 'https://link.springer.com/article/10.1007/PL00022374/fulltext.html']\n",
      "['9258015', 'Vidal L; Kneer W; Baturone M; Sigmund R. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder. Inflammation research. (2001) 50 Suppl 1  ppS24-9', '10.1007/pl00022376', 'https://link.springer.com/article/10.1007/PL00022376/fulltext.html']\n",
      "['9258017', \"Walitt B; Pettinger M; Weinstein A; Katz J; Torner J; Wasko MC; Howard BV; Women's Health Initiative Investigators. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis and rheumatism. (2008) 59 3 pp302-310\", '10.1002/art.23325', '']\n",
      "['9258018', 'Sharpe L; Allard S; Sensky T. Five-year followup of a cognitive-behavioral intervention for patients with recently-diagnosed rheumatoid arthritis: effects on health care utilization. Arthritis and rheumatism. (2008) 59 3 pp311-316', '10.1002/art.23312', '']\n",
      "['9258019', 'Brodin N; Eurenius E; Jensen I; Nisell R; Opava CH; PARA Study Group. Coaching patients with early rheumatoid arthritis to healthy physical activity: a multicenter, randomized, controlled study. Arthritis and rheumatism. (2008) 59 3 pp325-331', '10.1002/art.23327', '']\n",
      "['9258022', 'Kumar VN; Redford JB. Transcutaneous nerve stimulation in rheumatoid arthritis. Archives of physical medicine and rehabilitation. (1982) 63 12 pp595-596', '10.1016/s0003-9993(95)81187-7', '']\n",
      "['9258023', 'Davis MC; Zautra AJ; Wolf LD; Tennen H; Yeung EW. Mindfulness and cognitive-behavioral interventions for chronic pain: Differential effects on daily pain reactivity and stress reactivity. Journal of consulting and clinical psychology. (2015) 83  1 pp24-35', '10.1037/a0038200', 'http://psycnet.apa.org/journals/ccp/83/1/24.pdf']\n",
      "['9258024', 'Schattenkirchner M; Br‚àö‚àÇll H; Kaik B; M‚àö¬∫ller-Fassbender H; Rau R; Zeidler H. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study. Klinische Wochenschrift. (1988) 66 4 pp167-174', '10.1007/bf01727786', 'http://link.springer.com/article/10.1007/BF01727786/fulltext.html']\n",
      "['9258028', 'Sweezie R; Bell M; Goldsmith C; Chiu I; Gutlin A; Sandhu S. Reliability analysis of two short medication adherence questionnaires in patients with rheumatoid arthritis. Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1154', '10.1007/s00296-016-3566-4', 'http://link.springer.com/article/10.1007/s00296-016-3566-4/fulltext.html']\n",
      "['9258029', 'Lacaille D; Carruthers E; Van As B; Goldsmith C; Horlock H; Li L; Townsend A; Mitchell B; Adam P. Proof of concept study of the arthritis health journal: an online tool to promote self-monitoring in people with rheumatoid arthritis (RA). Journal of rheumatology. Conference: 71st annual meeting of the canadian rheumatology association, CRA 2016. Canada. Conference start: 20160217. Conference end: 20160220. (2016) 43 6 pp1228', '10.1002/art.39977', '']\n",
      "['9258030', 'Honkanen PB; Tiihonen R; Skytt√§ ET; Ik√§valko M; Lehto MU; Konttinen YT. Bioreconstructive poly-L/D-lactide implant compared with Swanson prosthesis in metacarpophalangeal joint arthroplasty in rheumatoid patients: a randomized clinical trial. Journal of hand surgery, European volume. (2010) 35 9 pp746-753', '10.1177/1753193410375777', 'https://journals.sagepub.com/doi/pdf/10.1177/1753193410375777']\n",
      "['9258031', 'Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet (London, England). (2000) 356 9227 pp385-390', '10.1016/s0140-6736(00)02530-7', '']\n",
      "['9258032', 'Edwards JC; Leandro MJ; Cambridge G. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20. Current directions in autoimmunity. (2005) 8  pp175-192', '10.1159/000082103', '']\n",
      "['9258034', 'Barsky AJ; Ahern DK; Orav EJ; Nestoriuc Y; Liang MH; Berman IT; Kingsbury JR; Sy JT; Wilk KG. A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis. Seminars in arthritis and rheumatism. (2010) 40 3 pp222-232', '10.1016/j.semarthrit.2010.04.001', '']\n",
      "['9258035', 'Barner A. Review of clinical trials and benefit/risk ratio of meloxicam. Scandinavian journal of rheumatology. Supplement. (1996) 102 102 pp29-37', '10.3109/03009749609097228', '']\n",
      "['9258037', 'Nishimoto N; Takagi N. Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study. Modern rheumatology / the Japan Rheumatism Association. (2010) 20 6 pp539-547', '10.3109/s10165-010-0328-0', '']\n",
      "['9258038', 'Stenberg VI; Fiechtner JJ; Rice JR; Miller DR; Johnson LK. Endocrine control of inflammation: rheumatoid arthritis double-blind, crossover clinical trial. International journal of clinical pharmacology research. (1992) 12 1 pp11-18', '10.1016/j.clinthera.2007.06.016', '']\n",
      "['9258039', 'Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. Journal of rheumatology. (1995) 22 7 pp1235-1240', '10.1007/bf02114396', 'http://link.springer.com/article/10.1007/BF02114396/fulltext.html']\n",
      "['9258040', 'McIlwain HH; Platt RD. Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes. American journal of medicine. (1988) 84 5A pp56-60', '10.1016/0002-9343(88)90479-2', '']\n",
      "['9258043', 'Collantes E; Curtis SP; Lee KW; Casas N; McCarthy T; Melian A; Zhao PL; Rodgers DB; McCormick CL; Lee M; Lines CR; Gertz BJ; Etoricoxib Rheumatoid Arthritis Study Group. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. BMC family practice. (2002) 3  pp10', '10.1186/1471-2296-3-10', 'http://link.springer.com/article/10.1186/1471-2296-3-10/fulltext.html']\n",
      "['9258044', 'Han CD; Lee DH; Yang IH. Intra-synovial ropivacaine and morphine for pain relief after total knee arthroplasty: a prospective, randomized, double blind study. Yonsei medical journal. (2007) 48 2 pp295-300', '10.3349/ymj.2007.48.2.295', '']\n",
      "['9258045', 'Sk√∂ldstam L; B√∂rjesson O; Kj√§llman A; Seiving B; Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scandinavian journal of rheumatology. (1992) 21 4 pp178-185', '10.3109/03009749209099218', '']\n",
      "['9258047', 'Reynolds WJ; Shaar SF; Buik A; Lancee WJ. Oxaprozin: a once-daily treatment regimen in rheumatoid arthritis. Journal of rheumatology. (1979) 6 3 pp345-350', '10.1007/bf03302037', 'http://link.springer.com/article/10.1007/BF03302037/fulltext.html']\n",
      "['9258048', 'Parker JC; Frank RG; Beck NC; Smarr KL; Buescher KL; Phillips LR; Smith EI; Anderson SK; Walker SE. Pain management in rheumatoid arthritis patients. A cognitive-behavioral approach. Arthritis and rheumatism. (1988) 31 5 pp593-601', '10.1002/art.1780310503', '']\n",
      "['9258049', 'Pullar T; Myall O; Haigh JR; Lowe JR; Dixon JS; Bird HA. The effect of indomethacin on the psychomotor function of patients with rheumatic diseases. British journal of rheumatology. (1988) 27 3 pp227-229', '10.1093/rheumatology/27.3.227', 'http://academic.oup.com/rheumatology/article-pdf/27/3/227/5036029/27-3-227.pdf']\n",
      "['9258050', 'Shipley ME; Bacon PA; Berry H; Hazleman BL; Sturrock RD; Swinson DR; Williams IA. Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study. British journal of rheumatology. (1988) 27 3 pp211-214', '10.1093/rheumatology/27.3.211', 'http://academic.oup.com/rheumatology/article-pdf/27/3/211/5035922/27-3-211.pdf']\n",
      "['9258051', 'Solari N; Palmisani E; Consolaro A; Rosina S; Bracciolini G; Novelli A; Martini A; Ravelli A. Frequency of remission in children with juvenile idiopathic arthritis treated with etanercept: Methodological considerations and preliminary results from a single center. Clinical drug investigation. (2013) 33  SUPPL.2 ppS134-S137', '10.1136/annrheumdis-2012-eular.1687', '']\n",
      "['9258052', 'M√§kel√§ A-L; Lempi√§inen M; Yrj√§n√§ T; Haapasaari J. Benorylate in the treatment of children with juvenile rheumatoid arthritis. SCANDINAVIAN-JOURNAL-OF-RHEUMATOLOGY.-SUPPLEMENT. (1979)  suppl 25 pp1-7', '10.1080/03009742.1979.12088621', '']\n",
      "['9258055', 'van Hulst LT; Creemers MC; Fransen J; Li LC; Grol R; Hulscher ME; van Riel PL. How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention. Rheumatology (Oxford, England). (2010) 49 4 pp741-748', '10.1093/rheumatology/kep407', 'http://academic.oup.com/rheumatology/article-pdf/49/4/741/5061441/kep407.pdf']\n",
      "['9258056', 'St Clair EW; Wilkinson WE; Pisetsky DS; Sexton DJ; Drew R; Kraus VB; Greenwald RA. The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2001) 44 5 pp1043-1047', '10.1002/1529-0131(200105)44:5<1043::aid-anr183>3.3.co;2-3', '']\n",
      "['9258060', 'Gautam VK; Sambandam B; Singh S; Gupta P; Gupta R; Maini L. The role of tranexamic acid in reducing blood loss in total knee replacement. Journal of Clinical Orthopaedics and Trauma. (2013) 4  1 pp36-39', '10.1016/j.jcot.2013.01.007', '']\n",
      "['9258062', 'Moreland LW; Pratt PW; Mayes MD; Postlethwaite A; Weisman MH; Schnitzer T; Lightfoot R; Calabrese L; Zelinger DJ; Woody JN. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis and rheumatism. (1995) 38 11 pp1581-1588', '10.1002/art.1780381109', '']\n",
      "['9258063', 'Weinblatt ME; Maddison PJ; Bulpitt KJ; Hazleman BL; Urowitz MB; Sturrock RD; Coblyn JS; Maier AL; Spreen WR; Manna VK. CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis and rheumatism. (1995) 38 11 pp1589-1594', '10.1002/art.1780381110', '']\n",
      "['9258066', 'Awni WM; Granneman GR; Locke CS; Brandwein SR; Dube LM. Population pharmacokinetics of zileution, a selective 5-lipoxygenase inhibitor, in patients with rheumatoid arthritis. European journal of clinical pharmacology. (1995) 48 2 pp155-160', '10.1007/bf00192742', 'http://link.springer.com/article/10.1007/BF00192742/fulltext.html']\n",
      "['9258067', 'Farooqui AN; Ahmad SL; Mansuri FA. Efficacy of cyclosporin-A in refractory rheumatoid arthritis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. (2004) 14 3 pp139-141', '10.29271/jcpsp.2019.01.1', '']\n",
      "['9258068', 'Murphy D; Failla JM; Koniuch MP. Steroid versus placebo injection for trigger finger. Journal of hand surgery. (1995) 20 4 pp628-631', '10.1016/s0363-5023(05)80280-1', '']\n",
      "['9258069', 'De BJJ. Treatment of rheumatoid arthritis with gold.  DE BEHANDELING VAN REUMATOIDE ARTHRITIS MET GOUD. NEDTGENEESK. (1974) 118 12 pp401-404', '10.1007/978-1-349-08808-9_2', '']\n",
      "['9258071', 'Kvien T K; Hoyeraal H M; Sandstad B. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficiency in a single-centre 24-week double-blind parallel study. Scandinavian journal of rheumatology. (1984) 13 4 pp342-350', '10.3109/03009748409111307', '']\n",
      "['9258072', 'Dirksen A; Rasmussen SN; Manthorpe R. Fecal blood loss caused by two differently microencapsulated acetylsalicylic acid preparations in patients with rheumatoid arthritis. A prospective crossover study. Scandinavian journal of rheumatology. (1982) 11 3 pp129-132', '10.3109/03009748209098177', '']\n",
      "['9258073', 'Rasker JJ; Kardaun SH. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis. Scandinavian journal of rheumatology. (1982) 11 3 pp168-170', '10.3109/03009748209098185', '']\n",
      "['9258074', 'Lindholm L; Ekdahl C; H√•kansson E; Melander A; Olsson S; Svensson B; W√§hlin-Boll E. Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1981) 10 4 pp289-295', '10.3109/03009748109095317', '']\n",
      "['9258075', 'Lorber A; Jackson WH; Simon TM. Assessment of immune response during chrysotherapy. Comparison of gold sodium thiomalate vs. auranofin. Scandinavian journal of rheumatology. (1981) 10 2 pp129-137', '10.3109/03009748109095285', '']\n",
      "['9258076', 'Baber N; Halliday L; Littler T; Orme M; Sibeon RG; Chan K. The effect of indomethacin on renal function in man. Scandinavian journal of rheumatology. (1980) 9 1 pp52-54', '10.1080/03009748009098129', '']\n",
      "['9258077', 'Gumpel JM; Matthews SA; Fisher M. Synoviorthesis with erbium-169: a double-blind controlled comparison of erbium-169 with corticosteroid. Annals of the rheumatic diseases. (1979) 38 4 pp341-343', '10.1136/ard.38.4.341', '']\n",
      "['9258078', 'Sheppeard H; Aldin A; Ward DJ. Osmic acid versus yttrium-90 in rheumatoid synovitis of the knee. Scandinavian journal of rheumatology. (1981) 10 3 pp234-236', '10.3109/03009748109095304', '']\n",
      "['9258079', 'Skrifvars B; Nissil√§ M. Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report. Scandinavian journal of rheumatology. (1980) 9 1 pp33-38', '10.1080/03009748009098125', '']\n",
      "['9258080', \"Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sj√∂gren's syndrome. Arthritis and rheumatism. (2007) 56 5 pp1464-1477\", '10.1002/art.22603', '']\n",
      "['9258082', 'Lehtinen K; Ollikainen A; Savolainen L; Waris T; Laine V; Clarke TK. Niflumic acid in the treatment of rheumatoid arthritis. SCANDINAVIAN-JOURNAL-OF-RHEUMATOLOGY.-SUPPLEMENT. (1973)  1 pp5-7', '10.3109/03009747309095201', '']\n",
      "['9258084', 'Peltomaa R; Paimela L; Helve T; Leirisalo-Repo M. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study. Scandinavian journal of rheumatology. (1995) 24 6 pp330-335', '10.3109/03009749509095176', '']\n",
      "['9258085', 'Si L; Wang X; Kong Y; Lian B; Chi ZH; Cui CL; Sheng XN; Mao LL; Tang BX; Li SM; Yan QX; Guo J. A phase II randomized study of adjuvant imatinib versus high-dose interferon alpha-2b for resected high-risk c-kit mutated melanoma. Journal of clinical oncology. (2013)   pp', '10.1200/jco.2013.31.15_suppl.e20027', '']\n",
      "['9258086', 'Trang LE; L√∂vgren O; Norlund AE; Horn R; Walaas O. Cyclic nucleotides and catecholamines in rheumatoid arthritis. Scandinavian journal of rheumatology. (1983) 12 2 pp171-176', '10.3109/03009748309102906', '']\n",
      "['9258087', 'Grindulis KA; Calverley M; Constable TJ; Forster PJ; Ahmed ME; McConkey B. A comparison between clinical and laboratory tests in rheumatoid arthritis. Scandinavian journal of rheumatology. (1983) 12 3 pp285-288', '10.3109/03009748309098551', '']\n",
      "['9258088', 'Martio J; Kahela P. Comparison of three slow-release acetylsalicylic acid preparations in rheumatoid arthritis. Scandinavian journal of rheumatology. (1983) 12 3 pp305-309', '10.3109/03009748309098554', '']\n",
      "['9258089', 'Haataja M; Nissil‚àö¬ß M; Ruutsalo HM. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Scandinavian journal of rheumatology. (1978) 7 4 pp212-214', '10.3109/03009747809095657', '']\n",
      "['9258091', 'Genant HK. Interleukin-1 receptor antagonist treatment of rheumatoid arthritis patients: radiologic progression and correlation of Genant/Sharp and Larsen scoring methods. Seminars in arthritis and rheumatism. (2001) 30 5 Suppl 2 pp26-32', '10.1053/sarh.2001.23697', '']\n",
      "['9258092', 'Blake DR; Robson P; Ho M; Jubb RW; McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford, England). (2006) 45 1 pp50-52', '10.1093/rheumatology/kei183', 'http://academic.oup.com/rheumatology/article-pdf/45/1/50/9448000/kei183.pdf']\n",
      "['9258093', 'Mannheimer C; Lund S; Carlsson CA. The effect of transcutaneous electrical nerve stimulation (TNS) on joint pain in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1978) 7 1 pp13-16', '10.1016/0304-3959(79)90051-4', '']\n",
      "['9258094', 'Laaksonen AL; Koskiahde V; Juva K. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine. Scandinavian journal of rheumatology. (1974) 3 2 pp103-108', '10.3109/03009747409115809', '']\n",
      "['9258095', 'Dellhag B; Wollersj√∂ I; Bjelle A. Effect of active hand exercise and wax bath treatment in rheumatoid arthritis patients. Arthritis care and research. (1992) 5 2 pp87-92', '10.1002/art.1790050207', '']\n",
      "['9258096', 'Lavigne JV; Ross CK; Berry SL; Hayford JR; Pachman LM. Evaluation of a psychological treatment package for treating pain in juvenile rheumatoid arthritis. Arthritis care and research. (1992) 5 2 pp101-110', '10.1002/art.1790050209', '']\n",
      "['9258097', 'Ekblom B; L√∂vgren O; Alderin M; Fridstr√∂m M; S√§tterstr√∂m G. Effect of short-term physical training on patients with rheumatoid arthritis I. SCANDINAVIAN-JOURNAL-OF-RHEUMATOLOGY. (1975) 4 4 pp80-86', '10.3109/03009747509095619', '']\n",
      "['9258098', 'Kahan A; M√∂dder G; Menkes CJ; Verrier P; Devaux JY; Bonmartin A; De Rycke Y; Manil L; Chossat F; Tebib J. 169Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints. Clinical and experimental rheumatology. (2004) 22 6 pp722-726', '10.1097/00006231-200104000-00009', '']\n",
      "['9258099', 'Vuopala U; Isom√§ki H; Kaipainen WJ. Dimethyl sulfoxide (DMSO) ointment in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. (1969) 15  pp139-144', '10.3109/rhe1.1969.15.issue-1-4.21', '']\n",
      "['9258100', 'M√ºller W; Pavelka K; Fridrich R. Treatment of chronic articular effusions with 90-yttrium (90Y). SCANDINAVIAN-JOURNAL-OF-RHEUMATOLOGY. (1975) 4  pp216-220', '10.3109/03009747509165259', '']\n",
      "['9258101', 'Lindsay DJ; Ring EF; Coorey PF; Jayson MI. Synovial irrigation in rheumatoid arthritis. Acta rheumatologica Scandinavica. (1971) 17 3 pp169-174', '10.3109/rhe1.1971.17.issue-1-4.23', '']\n",
      "['9258102', 'Camp AV. Tiaprofenic acid in the treatment of rheumatoid arthritis. Rheumatology and rehabilitation. (1981) 20 3 pp181-183', '10.1093/rheumatology/20.3.181', 'http://academic.oup.com/rheumatology/article-pdf/20/3/181/5026952/20-3-181.pdf']\n",
      "['9258104', 'Coates L; Moverley A; McParland L; Brown S; Collier H; Brown SR; Navarro-Coy N; Emery P; Conaghan P; Helliwell P. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial. Lancet. (2014) 383  ppS36', '10.1016/s0140-6736(14)60299-3', '']\n",
      "['9258105', 'Helmy M; Shohayeb M; Helmy MH; el-Bassiouni EA. Antioxidants as adjuvant therapy in rheumatoid disease. A preliminary study. Arzneimittel-Forschung. (2001) 51 4 pp293-298', '10.1055/s-0031-1300040', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1300040.pdf']\n",
      "['9258106', 'Moreland LW; Morgan EE; Adamson TC; Fronek Z; Calabrese LH; Cash JM; Markenson JA; Matsumoto AK; Bathon J; Matteson EL; Uramoto KM; Weyand CM; Koopman WJ; Heck LW; Strand V; Diveley JP; Carlo DJ; Nardo CJ; Richieri SP; Brostoff SW. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis and rheumatism. (1998) 41 11 pp1919-1929', '10.1002/1529-0131(199811)41:11<1919::aid-art5>3.3.co;2-t', '']\n",
      "['9258107', 'Lussier A; Mykal D; Menard H; et al. Long term clinical assessment of naproxen on rheumatoid arthritis patients and sup 5sup 1Cr gastrointestinal bleeding on volunteers. ARZNEIMITTEL-FORSCH. (1975) 25 2A pp294-298', '10.1002/j.1552-4604.1975.tb01460.x', '']\n",
      "['9258108', 'Boers M; van Rijthoven AW; Goei Th‚àö¬Æ HS; Dijkmans BA; Cats A. Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients. Transplantation proceedings. (1988) 20 3 Suppl 4 pp371-375', '10.1016/0049-0172(92)90046-g', '']\n",
      "['9258109', 'Du X; Zhang H; Fu X. Clinical study on tripterygium wilfordii complex ester tablet in treating rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (1998) 18 2 pp88-91', '10.1007/bf02934156', 'https://link.springer.com/article/10.1007/BF02934156/fulltext.html']\n",
      "['9258111', 'Yokota S; Imagawa T; Mori M; Miyamae T; Aihara Y; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet (London, England). (2008) 371 9617 pp998-1006', '10.1016/s0140-6736(08)60454-7', '']\n",
      "['9258113', 'Camus JP. Action of myrtecaine combined with diethylamine salicylate in local treatment of various rheumatismal disorders.  ACTION DE LA MYRTECAINE ASSOCIEE AU SALICYLATE DE DIETHYLAMINE, EN TRAITEMENT LOCAL, DANS DIVERSES AFFECTIONS RHUMATISMALES. RHUMATOLOGIE (AIX LES BAINS). (1975) 27 1 pp35-38', '10.1016/s0929-693x(99)80091-8', '']\n",
      "['9258116', 'Shabani Y; Rastmanesh R; Kaviani S; Jamshidi AR. Effect of N-3 fatty acids supplementation on production of inflammatory cytokines by peripheral mononuclear cells. Journal of isfahan medical school. (2009) 27 97) (no pagination pp', '10.1002/vms3.713/v1/review1', '']\n",
      "['9258117', 'Hemmings FJ; Farhan M; Rowland J; Banken L; Jain R. Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 5 pp537-543', '10.1093/rheumatology/40.5.537', 'http://academic.oup.com/rheumatology/article-pdf/40/5/537/18095049/400537.pdf']\n",
      "['9258118', \"Tausch G; Broell H; Dunky A; Eberl R. Double blind (cross over) study with naproxen and indometacin in patients with chronic polyarthritis.  DOPPELBLIND ('CROSS OVER') PRUFUNG MIT PROXEN UND INDOMETACIN BEI PATIENTEN MIT CHRONISCHER POLYARTHRITIS. FORTSCHRMED. (1975) 93 8 pp403-406\", '10.1007/978-3-642-85316-6_139', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_139.pdf']\n",
      "['9258119', 'Tausch G; Eberl R; Tuschl P. Efficacy of Voltaren in rheumatic diseases; clinical experience and results of clinical experimental investigations.  KLINISCHE ERFAHRUNGEN UND ERGEBNISSE KLINISCH EXPERIMENTELLER UNTERSUCHUNGEN MIT VOLTAREN BEI RHEUMATISCHEN ERKRANKUNGEN. WIENMEDWSCHR. (1976) 126 10 pp132-137', '10.3109/03009747309097116', '']\n",
      "['9258121', \"Zhu F; Liu J; Wang G; Fang L; Zhang P; Tan B. Xinfeng Capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/NF-Œ∫B signaling pathway. Xi bao yu fen zi mian yi xue za zhi [Chinese journal of cellular and molecular immunology]. (2016) 32 10 pp1366-1371\", '10.1016/j.molimm.2024.06.002', '']\n",
      "['9258122', 'Coluccia D; Wolf OT; Kollias S; Roozendaal B; Forster A; de Quervain DJ. Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. Journal of neuroscience. (2008) 28 13 pp3474-3478', '10.1523/jneurosci.4893-07.2008', '']\n",
      "['9258123', 'Egeth M; Soosaar J; Nash P; Choquette D; Infante R; Ramey DR; Sahakian S; Lai A; Kim JJ; Wu D. Patient and Healthcare Professionals Preference for Brenzys vs. Enbrel Autoinjector for Rheumatoid Arthritis: a Randomized Crossover Simulated-Use Study. Advances in therapy. (2017) 34 5 pp1157-1172', '10.1007/s12325-017-0523-x', 'http://link.springer.com/article/10.1007/s12325-017-0523-x/fulltext.html']\n",
      "['9258126', 'Reed GW; Abdallah MS; Shao M; Wolski K; Wisniewski L; Yeomans N; Luscher TF; Borer JS; Graham DY; Husni ME; Solomon DH; Libby P; Menon V; Lincoff AM; Nissen SE. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. Journal of the American College of Cardiology. (2018) 71 16 pp1741-1751', '10.1016/j.jacc.2018.02.036', '']\n",
      "['9258127', 'Grennan DM; Ferry DG; Ashworth ME; Kenny RE; Mackinnon M. The aspirin-ibuprofen interaction in rheumatoid arthritis. British journal of clinical pharmacology. (1979) 8 5 pp497-503', '10.1111/j.1365-2125.1979.tb01033.x', '']\n",
      "['9258128', 'Maini RN; Elliott MJ; Brennan FM; Williams RO; Chu CQ; Paleolog E; Charles PJ; Taylor PC; Feldmann M. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunological reviews. (1995) 144  pp195-223', '10.1111/j.1600-065x.1995.tb00070.x', '']\n",
      "['9258130', 'Chow KVC; Lester S; McWilliams L; Metcalf R; Lee A; Wechalekar M; Hill C; Proudman S. Supplementation with omega-3 fish oil has no effect on bone mineral density in rheumatoid arthritis: a 3-year randomized controlled trial. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp5', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9258131', 'Kivitz A; Olech E; Borofsky MA; Zazueta B; Navarro-Sarabia F; Radominski SC; Merrill JT; Pacheco-Tena C; Pei J; Nasmyth-Miller C; Pope JE. Two-year efficacy and safety of subcutaneous tocilizumab in combination with disease-modifying antirheumatic drugs including escalation to weekly dosing in rheumatoid arthritis. Journal of rheumatology. (2018) 45 4 pp456-464', '10.3899/jrheum.161539', '']\n",
      "['9258134', 'Simon D; Prieur AM; Quartier P; Charles Ruiz J; Czernichow P. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study. Journal of clinical endocrinology and metabolism. (2007) 92 7 pp2567-2573', '10.1210/jc.2006-2877', 'http://academic.oup.com/jcem/article-pdf/92/7/2567/11059286/jcem2567.pdf']\n",
      "['9258138', 'Grainger R; Townsley H; Harrison A; Stebbings S; Stamp L; Taylor W. Consensus discussion increases the concordance of joint counts performed by people with rheumatoid arthritis with joint counts performed by rheumatologists. Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp31', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9258139', 'Pile K; Aletaha D; Tanaka Y; Agarwal P; Kurrasch R; Tak P; Popik S. Efficacy and safety of sirukumab, an anti-IL-6 cytokine monoclonal antibody, in patients with active rheumatoid arthritis despite anti-TNF therapy: results from a randomized, double-blind, placebo-controlled global phase 3 study (sirround-t). Internal medicine journal. Conference: new zealand rheumatology association and australian rheumatology association with the rheumatology health professionals association joint annual scientific meeting. New zealand. (2017) 47  pp27', '10.1016/s0140-6736(17)30401-4', '']\n",
      "['9258144', 'Torgy√°n S; Wagner L; Neumann T; Pakuts B; Cs√°nyi M. A comparative study with indomethacin and combined indomethacin sodium-salicylate in rheumatoid arthritis. International journal of clinical pharmacology and biopharmacy. (1979) 17 11 pp439-441', '10.1016/b978-0-08-023768-8.51735-7', '']\n",
      "['9258146', 'Schulze-Koops H; Davis LS; Haverty TP; Wacholtz MC; Lipsky PE. Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. Journal of rheumatology. (1998) 25 11 pp2065-2076', '10.1046/j.1365-2249.1996.d01-828.x', 'https://academic.oup.com/cei/article-pdf/106/2/190/42204577/j.1365-2249.1996.d01-828.x.pdf']\n",
      "['9258149', 'Brus H; van de Laar M; Taal E; Rasker J; Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient education and counseling. (1999) 36 1 pp57-64', '10.1016/s0738-3991(98)00087-1', '']\n",
      "['9258153', \"Delbarre F; Mery C; De GA. Short term study of effect of indoprofen in rheumatoid arthritis (comparison with placebo and indometacin).  ETUDE A COURT TERME DE L'EFFET D'UN TRAITEMENT PAR L'INDOPROFENE DANS LA POLYARTHRITE RHUMATOIDE (COMPARAISON A UN PLACEBO ET A L'INDOMETACINE). RHUMATOLOGIE (PARIS). (1977) 7 5 pp471-480\", '10.1007/bf03014530', 'http://link.springer.com/article/10.1007/BF03014530/fulltext.html']\n",
      "['9258155', 'Fu Y; Li G; Zhang X; Xing G; Hu X; Yang L; Li D. Lipid extract from hard-shelled mussel (Mytilus coruscus) improves clinical conditions of patients with rheumatoid arthritis: a randomized controlled trial. Nutrients. (2015) 7 1 pp625-645', '10.3390/nu7010625', '']\n",
      "['9258157', 'Egsmose C; Lund B; Andersen RB. Timegadine: more than a non-steroidal for the treatment of rheumatoid arthritis. A controlled, double-blind study. Scandinavian journal of rheumatology. (1988) 17 2 pp103-111', '10.3109/03009748809098769', '']\n",
      "['9258158', 'Balogh Z; Ruzsonyi E. Triamcinolone hexacetonide versus betamethasone. A double-blind comparative study of the long-term effects of intra-articular steroids in patients with juvenile chronic arthritis. Scandinavian journal of rheumatology. Supplement. (1987) 67  pp80-82', '10.3109/03009748809105305', '']\n",
      "['9258159', 'Daymond TJ; Thompson M; Akbar FA; Chestney V. A controlled trial of tiaprofenic acid versus ibuprofen in rheumatoid arthritis. Rheumatology and rehabilitation. (1979) 18 4 pp257-260', '10.1093/rheumatology/18.4.257', 'http://academic.oup.com/rheumatology/article-pdf/18/4/257/5039498/18-4-257.pdf']\n",
      "['9258160', 'Kawenoki-Minc E; Gburek Z; Sadkiewicz S; Keller B; Piotrowska E; Rajpert D; Reszkowska H. [Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test]. Reumatologia. (1979) 17 3 pp365-374', '10.1016/0049-0172(82)90071-3', '']\n",
      "['9258161', 'Young LD; Bradley LA; Turner RA. Decreases in health care resource utilization in patients with rheumatoid arthritis following a cognitive behavioral intervention. Biofeedback and self-regulation. (1995) 20 3 pp259-268', '10.1007/bf01474517', 'http://link.springer.com/article/10.1007/BF01474517/fulltext.html']\n",
      "['9258166', 'Kerstens PJ; Boerbooms AM; Jeurissen ME; Fast JH; Assmann KJ; van de Putte LB. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. Journal of rheumatology. (1992) 19 6 pp867-871', '10.1007/bf02030360', 'http://link.springer.com/article/10.1007/BF02030360/fulltext.html']\n",
      "['9258167', 'Stojanovic I; Budimir M; Vuletic N. Comparative double blind trial of intraarticular injections of aprotinin hydrocortisone and physiological saline in rheumatoid arthritis (Serbocroatian). ACTA RHEUMATOLBELGRAD. (1974) 4 2 pp135-142', '10.1136/ard.33.6.574-a', '']\n",
      "['9258168', \"Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska MA; Baranovsky A; Sike R; Stoyanova K; Meuleners L; Tasset CT; Van Der Aa A; Harrison P. Maintenance of clinical effect in patients with moderateto-severe Crohn's disease treated with filgotinib, a selective JAK1 inhibitor: exploratory 20-week data analysis of the phase 2 fitzroy study. Gastroenterology. (2017) Conference: Digestive Disease Week 2017, DDW 2017. United States. 152 5 Supplement 1 ppS601\", '10.1016/s0016-5085(17)32146-7', '']\n",
      "['9258169', 'Rau R; Simianer S; van Riel PL; van de Putte LB; Kr‚àö¬∫ger K; Schattenkirchner M; Allaart CF; Breedveld FC; Kempeni J; Beck K; Kupper H. Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. Scandinavian journal of rheumatology. (2004) 33 3 pp145-153', '10.1080/03009740410005467', '']\n",
      "['9258170', 'Oyemade GA; Onadeko BO. A controlled clinical study comparing sulindac with ibuprofen and aspirin in the treatment of musculo-skeletal diseases. Journal of international medical research. (1979) 7 6 pp556-559', '10.1177/030006057900700615', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057900700615']\n",
      "['9258171', 'McArthur PA; Milner RH. A prospective randomized comparison of Sutter and Swanson silastic spacers. Journal of hand surgery (Edinburgh, Scotland). (1998) 23 5 pp574-577', '10.1016/s0266-7681(98)80004-1', 'https://journals.sagepub.com/doi/pdf/10.1016/S0266-7681%2898%2980004-1']\n",
      "['9258172', 'Davys HJ; Turner DE; Helliwell PS; Conaghan PG; Emery P; Woodburn J. Debridement of plantar callosities in rheumatoid arthritis: a randomized controlled trial. Rheumatology (Oxford, England). (2005) 44 2 pp207-210', '10.1093/rheumatology/keh435', 'http://academic.oup.com/rheumatology/article-pdf/44/2/207/9446661/keh435.pdf']\n",
      "['9258173', 'Allam A; Kostova Z; Nakamoto K; Schulz PJ. The effect of social support features and gamification on a Web-based intervention for rheumatoid arthritis patients: randomized controlled trial. Journal of medical Internet research. (2015) 17 1 ppe14', '10.2196/jmir.3510', '']\n",
      "['9258176', 'H‚àö¬ßuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. British journal of rheumatology. (1998) 37 10 pp1110-1117', '10.1093/rheumatology/37.10.1110', 'http://academic.oup.com/rheumatology/article-pdf/37/10/1110/18105809/371110.pdf']\n",
      "['9258177', 'Hardin JG; Kirk KA. Comparative effectiveness of five analgesics for the pain of rheumatoid synovitis. Journal of rheumatology. (1979) 6 4 pp405-412', '10.1016/b978-0-323-09138-1.00097-8', '']\n",
      "['9258178', 'Luftschein S; Bienenstock H; Varady JC; Stitt FW. Increasing dose of naproxen in rheumatoid arthritis: use with and without corticosteroids. Journal of rheumatology. (1979) 6 4 pp397-404', '10.1007/bf03302314', 'http://link.springer.com/article/10.1007/BF03302314/fulltext.html']\n",
      "['9258179', 'McWilliams DF; Marshall M; Jayakumar K; Doherty S; Doherty M; Zhang W; Kiely PD; Young A; Walsh DA. Erosive and osteoarthritic structural progression in early rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 8 pp1477-1488', '10.1093/rheumatology/kew197', 'http://academic.oup.com/rheumatology/article-pdf/55/8/1477/17389457/kew197.pdf']\n",
      "['9258182', 'Najafi TF; Hejazi M; Meshkat M; Hajibabakashani S. Quality of life and performing acupuncture on 150 patients suffering from chronic pains: A randomized and intervention study before and after performing. Iranian Red Crescent Medical Journal. (2013) 15 3 pp', '10.5812/ircmj.1411', '']\n",
      "['9258184', 'Doyle DV; Perrett D; Foster OJF; Ensor M; Scott DL. The long term use of D-penicillamine for treating rheumatoid arthritis: Is continuous therapy necessary?. British journal of rheumatology. (1993) 32 7 pp614-617', '10.1093/rheumatology/32.7.614', 'http://academic.oup.com/rheumatology/article-pdf/32/7/614/5043820/32-7-614.pdf']\n",
      "['9258185', 'Furst DE; Fleischmann R; Kopp E; Schiff M; Edwards C; Solinger A; Macri M; 990136 Study Group. A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis. Journal of rheumatology. (2005) 32 12 pp2303-2310', '10.1136/annrheumdis-2001.1188', '']\n",
      "['9258186', 'Ruijgrok EJ; Lee WC; Wee A; Kloppenburg M; Kok MR; Boxma-De Klerk BM; Basoski NM. Efficacy of hydroxychloroquine in primary hand osteoarthritis: a randomised, double blind, placebo controlled trial. European journal of hospital pharmacy. Conference: 22nd annual congress of the european association of hospital pharmacists, EAHP 2017. France. (2017) 24  ppA176', '10.1136/ejhpharm-2017-000640.389', '']\n",
      "['9258188', 'Sk√∂ldstam L; Larsson L; Lindstr√∂m FD. Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scandinavian journal of rheumatology. (1979) 8 4 pp249-255', '10.3109/03009747909114631', '']\n",
      "['9258189', \"Talal N; Quinn JH; Daniels TE. The clinical effects of electrostimulation on salivary function of Sj√∂gren's syndrome patients. A placebo controlled study. Rheumatology international. (1992) 12 2 pp43-45\", '10.1007/bf00300975', 'http://link.springer.com/article/10.1007/BF00300975/fulltext.html']\n",
      "['9258196', \"Drosos AA; Moutsopoulos NM. [Effectiveness and safety of using cyclosporin A in the treatment of primary Sj√∂gren's syndrome]. TerapevticheskiiÃÜ arkhiv. (1988) 60 4 pp77-80\", '10.1136/ard.45.9.732', '']\n",
      "['9258197', 'Flammer AJ; Sudano I; Hermann F; Gay S; Forster A; Neidhart M; K√ºnzler P; Enseleit F; P√©riat D; Hermann M; Nussberger J; Luscher TF; Corti R; Noll G; Ruschitzka F. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation. (2008) 117 17 pp2262-2269', '10.1161/circulationaha.107.734384', '']\n",
      "['9258198', 'Huskisson EC; Jaffe IA; Scott J; Dieppe PA. 5-Thiopyridoxine in rheumatoid arthritis: clinical and experimental studies. Arthritis and rheumatism. (1980) 23 1 pp106-110', '10.1002/art.1780230118', '']\n",
      "['9258199', 'Deodhar SD; Sethi R. A comparative study of fenbufen and indomethacin in patients with rheumatoid arthritis. Current medical research and opinion. (1979) 6 4 pp263-266', '10.1185/03007997909109434', '']\n",
      "['9258200', 'Lacki JK; Mackiewicz SH; Wiktorowicz KE. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate. Archivum immunologiae et therapiae experimentalis. (1994) 42 4 pp287-290', '10.1007/5.1661-4917', '']\n",
      "['9258201', 'Camus JP; Prier A. Treatment of rheumatoid arthritis with pirprofen. Comparison of 2 dosage regimens. La Nouvelle presse meÃÅdicale. (1982) 11 33 pp2481-2483', '10.1016/s0300-9084(82)80304-0', '']\n",
      "['9258202', 'Parkkila T; Belt EA; Hakala M; Kautiainen H; Leppilahti J. Comparison of Swanson and Sutter metacarpophalangeal arthroplasties in patients with rheumatoid arthritis: a prospective and randomized trial. Journal of hand surgery. (2005) 30 6 pp1276-1281', '10.1016/j.jhsa.2005.06.011', '']\n",
      "['9258204', 'Pipitone V; Loizzi P; Casula PL; Bignamini AA. Double-blind clinical evaluation of a new anti-inflammatory drug, protacine, versus indomethacin. Current medical research and opinion. (1979) 6 4 pp287-298', '10.1185/03007997909109440', '']\n",
      "['9258205', 'Leggett S; van der Zee-Neuen A; Boonen A; Beaton D; Bojinca M; Bosworth A; Dadoun S; Fautrel B; Hagel S; Hofstetter C; Lacaille D; Linton D; Mihai C; Petersson IF; Rogers P; Scir√© C; Verstappen SM; at-work productivity global measure working group. Content validity of global measures for at-work productivity in patients with rheumatic diseases: an international qualitative study. Rheumatology (oxford, england). (2016) 55 8 pp1364-1373', '10.1093/rheumatology/kev435', 'http://academic.oup.com/rheumatology/article-pdf/55/8/1364/17389349/kev435.pdf']\n",
      "['9258206', 'Mason U; Aldrich J; Breedveld F; Davis CB; Elliott M; Jackson M; Jorgensen C; Keystone E; Levy R; Tesser J; Totoritis M; Truneh A; Weisman M; Wiesenhutter C; Yocum D; Zhu J. CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis. Journal of rheumatology. (2002) 29 2 pp220-229', '10.1201/9780429260360-19', '']\n",
      "['9258208', 'Bhasin RC; Bhuttani P; Krishnan CV; Sachdev S. Flurbiprofen and phenylbutazone in rheumatoid arthritis and osteoarthrosis: a double-blind study. Journal of the Association of Physicians of India. (1979) 27 5 pp379-383', '10.1093/rheumatology/15.5.56', 'http://academic.oup.com/rheumatology/article-pdf/15/5/56/5039121/15-5-56.pdf']\n",
      "['9258209', 'Solomon DH; Warsi A; Brown-Stevenson T; Farrell M; Gauthier S; Mikels D; Lee TH. Does self-management education benefit all populations with arthritis? A randomized controlled trial in a primary care physician network. Journal of rheumatology. (2002) 29 2 pp362-368', '10.1359/jbmr.070717', 'https://academic.oup.com/jbmr/article-pdf/22/11/1808/56551199/5650221121.pdf']\n",
      "['9258210', 'Liu J; Wan L; Huang CB; Wang Y; Pan YZ; Xie XL. Effect of xinfeng capsule on lipoprotein metabolism of rheumatoid arthritis patients. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2015) 35 9 pp1060-1064', '10.1016/s0254-6272(14)60058-3', '']\n",
      "['9258211', 'Lu W; Liu Y; Han Y; Qin Z; Song X; Li T. Function of CD4 recovery and decreasing immune activation of a chinese herb: TWHF. Topics in antiviral medicine. Conference: 25th conference on retroviruses and opportunistic infections, CROI 2018. United states. (2018) 26 Supplement 1 pp218s-219s', '10.1358/dot.2015.51.3.2313927', '']\n",
      "['9258212', 'Furst DE; Caldwell JR; Klugman MP; Enthoven D; Rittweger K; Scheer R; Sarkissian E; Dromgoole S. Serum concentration and dose-response relationships for carprofen in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1988) 44 2 pp186-194', '10.1038/clpt.1988.135', '']\n",
      "['9258213', \"Drosos AA; van Vliet-Dascalopoulou E; Andonopoulos AP; Galanopoulou V; Skopouli FN; Moutsopoulos HM. Nandrolone decanoate (deca-durabolin) in primary Sj√∂gren's syndrome: a double blind pilot study. Clinical and experimental rheumatology. (1988) 6 1 pp53-57\", '10.1007/bf00290201', 'http://link.springer.com/article/10.1007/BF00290201/fulltext.html']\n",
      "['9258215', 'Bianchi PA; Vigo PL; Polli EE. The effect of three nonsteroid, anti inflammatory drugs on the gastric mucosa.  VALUTAZIONE DEGLI EFFETTI DI ALCUNI FARMACI ANTI INFIAMMATORI NON STEROIDEI SULLA MUCOSA GASTRICA. Minerva medica. (1976) 67 33 pp2133-2137', '10.1042/cs070039pa', 'https://portlandpress.com/clinsci/article-pdf/70/s13/39P/819006/cs070039pb.pdf']\n",
      "['9258216', 'Booth SL; Golly I; Sacheck JM; Roubenoff R; Dallal GE; Hamada K; Blumberg JB. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. American journal of clinical nutrition. (2004) 80 1 pp143-148', '10.1093/ajcn/80.1.143', 'http://academic.oup.com/ajcn/article-pdf/80/1/143/23715009/znu00704000143.pdf']\n",
      "['9258218', 'Tawakol A; Ribaudo H; Ishai AE; McKhann A; Solomon DH; Fayad ZA; Deeks SG; Lederman MM; Grinspoon SK; Stein JH; Ridker PM; Currier JS; Hsue P. Impact of methotrexate on arterial inflammation in persons with treated HIV. Topics in antiviral medicine. Conference: 25th conference on retroviruses and opportunistic infections, CROI 2018. United states. (2018) 26 Supplement 1 pp297s', '10.1093/cid/ciy781', 'http://academic.oup.com/cid/article-pdf/68/11/1877/28653483/ciy781.pdf']\n",
      "['9258219', 'Larsson I; Fridlund B; Arvidsson B; Teleman A; Svedberg P; Bergman S. A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial. BMC musculoskeletal disorders. (2015) 16  pp354', '10.1186/s12891-015-0817-6', '']\n",
      "['9258221', 'Cardoe N; Fowler PD. Diclofenac sodium (Voltarol): a double-blind comparative study with ibuprofen in patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1979) Suppl 2 Suppl 2 pp89-99', '10.1093/rheumatology/xii.suppl.39', 'http://academic.oup.com/rheumatology/article-pdf/XII/suppl/39/5079700/XII-suppl-39.pdf']\n",
      "['9258222', 'Doreen MS; Boardman PL; Fowler PD; Poole PH. Diclofenac (Voltarol) in rheumatoid arthritis: a report of a double-blind trial. Rheumatology and rehabilitation. (1979) Suppl 2 Suppl 2 pp78-80', '10.1093/rheumatology/17.2.95', 'http://academic.oup.com/rheumatology/article-pdf/17/2/95/5027233/17-2-95.pdf']\n",
      "['9258223', 'Jaswal S; Mehta HC; Sood AK; Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clinica chimica acta; international journal of clinical chemistry. (2003) 338 1-2 pp123-129', '10.1016/j.cccn.2003.08.011', '']\n",
      "['9258224', 'Ciccolunghi SN; Chaudri HA; Schubiger BI. The value and results of long-term studies with diclofenac sodium (Voltarol). Rheumatology and rehabilitation. (1979) Suppl 2  pp100-115', '10.3109/03009747809097223', '']\n",
      "['9258225', 'Barnes CG; Berry H; Carter ME; Downie WW; Fowler PD; Moll JM; Perry JD; Sawaf MS; Wright V. Diclofenac sodium (Voltarol) and indomethacin: a multicentre comparative study in rheumatoid arthritis and osteoarthritis. Rheumatology and rehabilitation. (1979) Suppl 2 2 pp135-143', '10.1093/rheumatology/17.2.95', 'http://academic.oup.com/rheumatology/article-pdf/17/2/95/5027233/17-2-95.pdf']\n",
      "['9258226', 'Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2001) 60 7 pp660-669', '10.1136/ard.60.7.660', '']\n",
      "['9258227', 'Po‚àö‚â•r G; Strand V; Leflunomide Multinational Study Group. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial. Rheumatology (Oxford, England). (2004) 43 6 pp744-749', '10.1093/rheumatology/keh168', '']\n",
      "['9258228', 'Stroescu V. Dose range study of diftalone in rheumatoid arthritis. Pharmatherapeutica. (1976) 1 3 pp187-192', '10.1016/b978-0-08-021308-8.50624-4', '']\n",
      "['9258229', 'McCarey DW; McInnes IB; Madhok R; Hampson R; Scherbakov O; Ford I; Capell HA; Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet (London, England). (2004) 363 9426 pp2015-2021', '10.1016/s0140-6736(04)16449-0', '']\n",
      "['9258230', 'Dima A; Groseanu L; Balanescu A; Predeteanu D; Opris-Belinski D; Borangiu A; Mazilu D; Bojinca V; Ionescu R. Cognitive dysfunction in connective tissue diseases. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp435', '10.1136/annrheumdis-2017-eular.5206', '']\n",
      "['9258231', \"L'ami MJ; Krieckaert CLM; Nurmohamed MT; Van Vollenhoven RF; Rispens T; Boers M; Wolbink GJ. Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial. Annals of the rheumatic diseases. (2018) 77 4 pp484-487\", '10.1136/annrheumdis-2017-211781', '']\n",
      "['9258232', 'Rajaei E; Mowla K; Ghorbani A; Bahadoram S; Bahadoram M; Dargahi-Malamir M. The effect of omega-3 fatty acids in patients with active rheumatoid arthritis receiving dmards therapy: double-blind randomized controlled trial. Global journal of health science. (2015) 8 7 pp18-25', '10.5539/gjhs.v8n7p18', 'http://www.ccsenet.org/journal/index.php/gjhs/article/viewFile/52769/29170']\n",
      "['9258233', 'Veys EM; Mielants H; Verbruggen G; Grosclaude JP; Meyer W; Galazka A; Schindler J. Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo. Journal of rheumatology. (1988) 15 4 pp570-574', '10.1016/0192-0561(88)90421-3', '']\n",
      "['9258235', 'Machold KP; Neumann K; Smolen JS. Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study. Annals of the rheumatic diseases. (1992) 51 9 pp1039-1043', '10.1136/ard.51.9.1039', '']\n",
      "['9258238', 'van den Hout WB; de Buck PD; Vliet Vlieland TP. Cost-utility analysis of a multidisciplinary job retention vocational rehabilitation program in patients with chronic arthritis at risk of job loss. Arthritis and rheumatism. (2007) 57 5 pp778-786', '10.1002/art.22786', '']\n",
      "['9258239', 'McCloskey E; Chiu S; Lenaghan E; Shepstone L; Birrell F; Harvey N. Impact of falls on fractures and mortality-an opportunity for intervention and enhancement of fracture prediction?. Osteoporosis international. Conference: osteoporosis conference 2016. United kingdom. (2016) 27 2 Supplement ppS617', '10.1007/s00198-019-05270-6', 'http://link.springer.com/article/10.1007/s00198-019-05270-6/fulltext.html']\n",
      "['9258240', 'Weiss JE; Haines KA; Chalom EC; Li SC; Walco GA; Nyirenda TL; Edelheit B; Kimura Y. A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis. Pediatric rheumatology online journal. (2015) 13  pp36', '10.1186/s12969-015-0034-8', '']\n",
      "['9258241', 'Marcolongo R; Coppi R; Zannella F. [Double-blind cross-over clinical study of the effectiveness and tolerability of fenbufen versus ibuprofen in the therapy of rheumatoid arthritis]. Clinica terapeutica. (1979) 90 1 pp47-62', '10.1080/03009742.1979.12088616', '']\n",
      "['9258242', 'Dougados M; Combe B; Beveridge T; Bourdeix I; Lallemand A; Amor B; Sany J. IX 207-887 in rheumatoid arthritis. A double-blind placebo-controlled study. Arthritis and rheumatism. (1992) 35 9 pp999-1006', '10.1002/art.1780350904', '']\n",
      "['9258244', 'Lemmel EM; Brackertz D; Franke M; Gaus W; Hartl PW; Machalke K; Mielke H; Obert HJ; Peter HH; Sieper J. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatology international. (1988) 8 2 pp87-93', '10.1007/bf00271840', 'http://link.springer.com/article/10.1007/BF00271840/fulltext.html']\n",
      "['9258245', 'Mangan EK; Parrino J; Wu R; Paccaly A; Van Hoogstraten H. Pharmacodynamic effect and safety of single-dose administration of subcutaneous sarilumab or intravenous tocilizumab in patients with rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp196', '10.1093/rheumatology/key361', 'http://academic.oup.com/rheumatology/article-pdf/58/5/849/28720005/key361.pdf']\n",
      "['9258247', 'Rouse PC; Veldhuijzen Van Zanten JJ; Metsios GS; Ntoumanis N; Yu CA; Koutedakis Y; Fenton SA; Coast J; Mistry H; Kitas GD; Duda JL. Fostering autonomous motivation, physical activity and cardiorespiratory fitness in rheumatoid arthritis: protocol and rationale for a randomised control trial. BMC musculoskeletal disorders. (2014) 15  pp445', '10.1186/1471-2474-15-445', 'http://link.springer.com/article/10.1186/1471-2474-15-445/fulltext.html']\n",
      "['9258248', 'Vischer TL. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Annals of the rheumatic diseases. (1988) 47 7 pp582-587', '10.1136/ard.47.7.582', '']\n",
      "['9258249', \"Gottenberg J-E; Dorner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjogren's Syndrome: post Hoc Analyses From the EMBODY Trials. Arthritis and rheumatology. (2018) 70 5 pp763-773\", '10.1002/art.40425', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40425']\n",
      "['9258250', 'Gong K; Zhang Z; Sun X; Zhang X; Li A; Yan J; Luo Q; Gao Y; Feng Y. The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure. American heart journal. (2006) 151 1 pp62-68', '10.1016/j.ahj.2005.02.040', '']\n",
      "['9258251', 'Brooks PM; Hill W; Geddes R. Diclofenac and ibuprofen in rheumatoid arthritis and osteoarthritis. Medical journal of Australia. (1980) 1 1 pp29-30', '10.5694/j.1326-5377.1980.tb134572.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1980.tb134572.x']\n",
      "['9258252', 'Maksymowych WP; Blackburn WD; Tami JA; Shanahan WR. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis. Journal of rheumatology. (2002) 29 3 pp447-453', '10.1097/01.tp.0000128857.77893.d2', '']\n",
      "['9258253', 'Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ; Meloxicam Rheumatoid Arthritis Investigators. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. Journal of rheumatology. (2002) 29 3 pp436-446', '10.1093/rheumatology/35.suppl_1.17', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_1/17/5043123/35-suppl_1-17.pdf']\n",
      "['9258254', 'VanderBorght A; De Keyser F; Geusens P; De Backer M; Malaise M; Baeten D; Van den Bosch F; Veys EM; Raus J; Stinissen P. Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral). Journal of rheumatology. (2002) 29 3 pp416-426', '10.1093/rheumatology/39.11.1189', 'http://academic.oup.com/rheumatology/article-pdf/39/11/1189/18108472/391189.pdf']\n",
      "['9258255', 'Friedman S; Gruber MA. Ultrasonography of the hip in the evaluation of children with seronegative juvenile rheumatoid arthritis. Journal of rheumatology. (2002) 29 3 pp629-632', '10.1097/00002281-200209000-00010', '']\n",
      "['9258256', 'Tada M; Koike T; Okano T; Sugioka Y; Wakitani S; Mamoto K; Inui K; Nakamura H. Preference of surgical procedure for the forefoot deformity in the rheumatoid arthritis patients--a prospective, randomized, internal controlled study. Modern Rheumatology. (2015) 25  3 pp362-366', '10.3109/14397595.2014.956984', '']\n",
      "['9258258', 'Nelissen RG; Valstar ER; Rozing PM. The effect of hydroxyapatite on the micromotion of total knee prostheses. A prospective, randomized, double-blind study. Journal of bone and joint surgery. American volume. (1998) 80 11 pp1665-1672', '10.2106/00004623-199811000-00014', '']\n",
      "['9258259', 'Durez P; Vandepapeliere P; Miranda P; Toncheva A; Berman A; Kehler T; Mociran E; Fautrel B; Mariette X; Dhellin O; Fanget B; Ouary S; Grouard-Vogel G; Boissier MC. Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial. PloS one. (2014) 9 12 ppe113465', '10.1371/journal.pone.0113465', '']\n",
      "['9258260', 'Bird HA; Rhind VM; Wright V. Rheumajecta in the treatment of rheumatoid arthritis. Rheumatology and rehabilitation. (1980) 19 1 pp60-61', '10.1093/rheumatology/19.1.60', 'http://academic.oup.com/rheumatology/article-pdf/19/1/60/5026335/19-1-60.pdf']\n",
      "['9258261', 'Ehrlich GE; Miller SB; Zeiders RS. Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis. Rheumatology and rehabilitation. (1980) 19 1 pp30-41', '10.1093/rheumatology/19.1.30', 'http://academic.oup.com/rheumatology/article-pdf/19/1/30/5026196/19-1-30.pdf']\n",
      "['9258263', 'Teh LG; Madhok R; Capell HA. Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis?. British journal of clinical pharmacology. (1984) 17 2 pp157-159', '10.1111/j.1365-2125.1984.tb02330.x', '']\n",
      "['9258264', 'Matucci-Cerinic M; Casini A. Ketoprofen vs etofenamate in a controlled double-blind study: evidence of topical effectiveness in soft tissue rheumatic pain. International journal of clinical pharmacology research. (1988) 8 3 pp157-160', '10.1186/isrctn94738550', '']\n",
      "['9258265', 'Hay KD; Thomson WM. A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. (2002) 93 3 pp271-275', '10.1067/moe.2002.120521', '']\n",
      "['9258266', 'Kirwan JR; H√§llgren R; Mielants H; Wollheim F; Bjorck E; Persson T; Book C; Bowman S; Byron M; Cox N; Field M; Kanerud L; Leirisalo-Repo M; Malaise M; Mohammad A; Palmer R; Petersson IF; Ringertz B; Sheldon P; Simonsson M; Snowden N; Van den Bosch F. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 6 pp688-695', '10.1136/ard.2003.008573', '']\n",
      "['9258267', 'Van dBHR; Bijlsma JWJ. Can oestrogens be used as adjuvant therapy in female patients with rheumatoid arthritis?. British journal of rheumatology. (1989) 28 SUPPL. ISS. I pp24-27', '10.1093/rheumatology/xxviii.suppl_1.24', 'http://academic.oup.com/rheumatology/article-pdf/XXVIII/suppl_1/24/5103121/XXVIII-suppl_1-24.pdf']\n",
      "['9258268', 'Stroescu V; Georgescu C; Voiosu R. A controlled clinical trial of a new anti inflammatory drug, diftalone, in rheumatoid arthritis. JINTMEDRES. (1974) 2 5 pp338-346', '10.1016/b978-0-08-021308-8.50624-4', '']\n",
      "['9258269', 'Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P; Treatment of Psoriatic Arthritis Study Group. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis and rheumatism. (2004) 50 6 pp1939-1950', '10.1002/art.20253', '']\n",
      "['9258272', 'Goebel KM. Comparative double blind trial of pirprofen, indomethacin, and placebo in the treatment of rheumatoid arthritis. La Nouvelle presse meÃÅdicale. (1982) 11 33 pp2484-2486', '10.1093/rheumatology/21.2.101', 'http://academic.oup.com/rheumatology/article-pdf/21/2/101/5027114/21-2-101.pdf']\n",
      "['9258276', \"Moerman RV; Arends S; Meiners PM; Brouwer E; Spijkervet FKL; Kroese FGM; Vissink A; Bootsma H. EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial. Annals of the rheumatic diseases. (2014) 73  2 pp472-474\", '10.1136/annrheumdis-2013-203736', '']\n",
      "['9258277', 'Lee M-Y; Park S-K; Park S-Y; Byun J-H; Lee S-M; Ko S-K; Lee E-K. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea. Clinical therapeutics. (2015) 37 8 pp1662-1676', '10.1016/j.clinthera.2015.07.001', '']\n",
      "['9258279', 'Wasko MC; Hsia EC; Kirkham B; Touboul PJ; Fleischmann R; Genovese MC; Matteson EL; Lu J; Xu W; Rahman MU. Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides. Journal of clinical rheumatology. (2014) 20 1 pp1-10', '10.1097/rhu.0000000000000053', '']\n",
      "['9258280', 'Giordano N; Borghi C; Sancasciani S; Morozzi G; Fioravanti A; Magaro L; Marcucci P; Fattorini L; Marcolongo R. Efficacy and safety of an iron chelating agent, deferoxamine, in patients with rheumatoid arthritis and hyposideremic anemia. Current therapeutic research, clinical and experimental. (1990) 48 6 pp959-968', '10.1136/bmj.289.6450.961', '']\n",
      "['9258281', 'Schmidt KL; Ott VR. Coeruloplasmin and immunoglobulins during a controlled therapeutic trial with D(-)penicillamine in rheumatoid arthritis.  COERULOPLASMIN UND IMMUNGLOBULINE UNTER KONTROLLIERTER D PENICILLAMIN THERAPIE BEI RHEUMATOIDER ARTHRITIS. ZRHEUMATOL. (1976) 35 3-4 pp154-163', '10.1007/978-3-642-85287-9_17', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85287-9_17.pdf']\n",
      "['9258282', 'Heinle K; Adam A; Gradl M; Wiseman M; Adam O. Concentration of selenium in erythrocytes of patients with rheumatoid arthritis in relation to clinical and laboratory signs of inflammation.  SLEENKONZENTRATION IN DEN ERYTHROZYGEN BEI PATIENTEN MIT RHEUMATOIDER ARTHRITIS. KLINISCHE UND LABORCHEMISCHE ENTZUNDUNGSZEICHEN UNTER SUPPLEMENTIERUNG MIT SELEN. Medizinische Klinik. (1997) 92 SUPPL. 3 pp29-31', '10.1007/bf03041958', 'http://link.springer.com/article/10.1007/BF03041958/fulltext.html']\n",
      "['9258283', 'Bello AE; Kent JD; Grahn AY; Ball J; Holt RJ. One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia. Current medical research and opinion. (2015) 31 3 pp397-405', '10.1185/03007995.2014.999152', '']\n",
      "['9258285', 'Goebel KM; Hahn E; Hausmann L; Storck U; Kaffarnik H; Neurath F. [Current aspects of rheumatoid arthritis]. Fortschritte der Medizin. (1979) 97 40 pp1793-1798', '10.1007/978-3-642-85316-6_81', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_81.pdf']\n",
      "['9258286', 'Akner G; Cederholm T. Treatment of protein-energy malnutrition in chronic nonmalignant disorders. American journal of clinical nutrition. (2001) 74 1 pp6-24', '10.1093/ajcn/74.1.6', 'http://academic.oup.com/ajcn/article-pdf/74/1/6/23964337/6.pdf']\n",
      "['9258288', 'Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS. T cell signal transducer and activator of transcription (STAT) 4 and 6 are affected by adalimumab therapy in rheumatoid arthritis. Clinical and experimental rheumatology. (2010) 28 2 pp208-214', '10.47671/tvg.67.14-15.2001007', '']\n",
      "['9258289', 'Ingegnoli F; Fantini F; Griffini S; Soldi A; Meroni PL; Cugno M. Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis. Clinical and experimental rheumatology. (2010) 28 2 pp254-257', '10.1016/j.jaut.2008.07.002', '']\n",
      "['9258290', 'Taylor PC; Steuer A; Gruber J; McClinton C; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; Maini RN. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 1 pp47-53', '10.1002/art.21544', '']\n",
      "['9258292', \"Heine PJ; Williams MA; Williamson E; Bridle C; Adams J; O'Brien A; Evans D; Lamb SE; SARAH Team. Development and delivery of an exercise intervention for rheumatoid arthritis: strengthening and stretching for rheumatoid arthritis of the hand (SARAH) trial. Physiotherapy. (2012) 98 2 pp121-130\", '10.1016/j.physio.2011.03.001', '']\n",
      "['9258293', 'Frost PM; Shirlaw PJ; Challacombe SJ; Fernandes-Naglik L; Walter JD; Ide M. Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients. Oral diseases. (2006) 12 1 pp57-62', '10.1111/j.1601-0825.2005.01161.x', '']\n",
      "['9258295', 'Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound. Bone. (2003) 33 4 pp575-581', '10.1016/s8756-3282(03)00208-4', '']\n",
      "['9258296', 'Kullich W; Schwann H. Changes of circulating immune complexes and inactivated C3b in rheumatoid arthritis during 12 months therapy with oral enzymes compared to oral gold.  ZIRKULIERENDE IMMUNKOMPLEXE UND DAS KOMPLEMENTFRAGMENT IC3B BEI CHRONISCHER POLYARTHRITIS WAHREND EINER 12MONATIGEN THERAPIE MIT ORALEN ENZYMEN IM VERGLEICH ZU ORALEM GOLD. Wiener medizinische Wochenschrift (1946). (1992) 142 22 pp493-497', '10.1007/bf01478460', 'http://link.springer.com/article/10.1007/BF01478460/fulltext.html']\n",
      "['9258298', 'Delazar A; Sarker SD; Nahar L; Jalali SB; Modaresi M; Hamedeyazdan S; Babaei H; Javadzadeh Y; Asnaashari S; Moghadam SB. Rhizomes of Eremostachys laciniata: Isolation and structure elucidation of chemical constituents and a clinical trial on inflammatory diseases. Advanced Pharmaceutical Bulletin. (2013) 3  2 pp385-393', '10.34172/ps.2019.65', 'https://ps.tbzmed.ac.ir/PDF/ps-26-203.pdf']\n",
      "['9258299', \"Solomon DH; Katz JN; La Tourette AM; Coblyn JS. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis and rheumatism. (2004) 51 3 pp383-387\", '10.1002/art.20403', '']\n",
      "['9258300', \"Pillemer SR; Leakan RA; Sankar V; Manny J; Baum BJ; Smith J; Chaudhry U; Fox PC; Radfar L; Ligier S; Brennan MT. Prominent adverse effects of thalidomide in primary Sj√∂gren's syndrome. Arthritis and rheumatism. (2004) 51 3 pp505-506\", '10.1002/art.20416', '']\n",
      "['9258301', 'Baumgartner H; Hohmeister R; Blumenberg-Novoselac N. An observer-blind crossover study to compare the efficacies of flurbiprofen, indomethacin and naproxen given orally and rectally in the relief of night pain and morning stiffness due to rheumatoid arthritis. Journal of international medical research. (1988) 16 3 pp189-196', '10.1177/030006058801600304', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058801600304']\n",
      "['9258305', 'Zhuang Y; Lyn S; Lv Y; Xu Z; Bouman-Thio E; Masterson T; Ford JA; Keen M; Petty KJ; Davis HM; Zhou H. Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trial. Clinical drug investigation. (2013) 33 11 pp795-800', '10.1007/s40261-013-0124-7', 'http://link.springer.com/article/10.1007/s40261-013-0124-7/fulltext.html']\n",
      "['9258307', 'Ballesteros R; Ansoleaga JJ; Tapounet R. The efficacy and tolerance of aceclofenac in rheumatoid arthritis. A double-blind study v. placebo. Clinical trials journal. (1990) 27 1 pp12-19', '10.1007/bf02229644', 'http://link.springer.com/article/10.1007/BF02229644/fulltext.html']\n",
      "['9258308', 'Allen M; Oberle K; Grace M; Russell A. Elk velvet antler in rheumatoid arthritis: phase II trial. Biological research for nursing. (2002) 3 3 pp111-118', '10.1177/1099800402003003001', 'https://journals.sagepub.com/doi/pdf/10.1177/1099800402003003001']\n",
      "['9258309', 'Parker JC; Singsen BH; Hewett JE; et al. Educating patients with rheumatoid arthritis: A prospective analysis. Archives of physical medicine and rehabilitation. (1984) 65 12 pp771-774', '10.1016/0003-9993(94)90780-3', '']\n",
      "['9258310', 'Fumagalli M; Montrone F; Vernazza M; Tirrito M; Santandrea S; Caruso I. [Diphenpiramide in the treatment of rheumatoid arthritis: short-time double-blind study of its comparison with indomethacin]. Clinica terapeutica. (1979) 89 6 pp581-588', '10.1002/art.1780230418', '']\n",
      "['9258311', 'Jajiƒá Z; Malaise M; Nekam K; Ko√≥ E; Dank√≥ K; Kovacs M; Scarpignato C. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (2005) 23 6 pp809-818', '10.1093/rheumatology/44.suppl_1.i96', 'http://academic.oup.com/rheumatology/article-pdf/44/suppl_1/i96/5059863/i96.pdf']\n",
      "['9258312', 'Petrov VI; Babaeva AR; Cherevkova EV; Kachanova MV; Zabolotneva YA; Tarasov SA; Dugina YL; Sergeeva SA. Efficiency and safety of long-term artrofoon treatment in rheumatoid arthritis. Bulletin of experimental biology and medicine. (2009) 148 3 pp486-488', '10.1007/s10517-010-0743-4', 'http://link.springer.com/article/10.1007/s10517-010-0743-4/fulltext.html']\n",
      "['9258314', 'Moreland L; Gugliotti R; King K; Chase W; Weisman M; Greco T; Fife R; Korn J; Simms R; Tesser J; Hillson J; Caldwell J; Schnitzer T; Lyons D; Schwertschlag U. Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis research. (2001) 3 4 pp247-252', '10.1186/ar309', 'https://link.springer.com/article/10.1186/ar309/fulltext.html']\n",
      "['9258316', 'Pincus T; Cutolo M. Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. (2015) 22  pp46-50', '10.1159/000362734', 'https://karger.com/nim/article-pdf/22/1-2/46/3905374/000362734.pdf']\n",
      "['9258317', 'Chaitow J; De Benedetti F; Brunner H; Ruperto N; Allen R; Murray K; et al. Tocilizumab in patients with systemic juvenile idiopathic arthritis: efficacy data from the placebo-controlled 12-week part of the phase III tender trial [Abstract]. Internal medicine journal. (2011) 41 S1 pp32', '10.1186/1546-0096-9-s1-p164', 'http://link.springer.com/article/10.1186/1546-0096-9-S1-P164/fulltext.html']\n",
      "['9258320', 'Mowat AG; Nichols PJ; Hollings EM; Haworth RJ; Aitken LC. A comparison of follow-up regimes in rheumatoid arthritis. Annals of the rheumatic diseases. (1980) 39 1 pp12-17', '10.1136/ard.39.1.12', '']\n",
      "['9258321', 'Fleischmann RM; Wagner F; Kivitz AJ; Mansikka HT; Khan N; Liu J; Hong F; Ruzek M; Padley RJ. Safety, tolerability, and pharmacodynamics of ABT-122, a dual TNF-and IL-17-targeted dual variable domain (DVD)-IgTM in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp498', '10.1136/annrheumdis-2016-eular.3676', '']\n",
      "['9258322', 'Lisbona MP; Maym‚àö‚â• J; Perich J; Almirall M; Carbonell J. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept. Annals of the rheumatic diseases. (2010) 69 6 pp1117-1122', '10.1136/ard.2009.116277', '']\n",
      "['9258323', 'Arvidsson S; Bergman S; Arvidsson B; Fridlund B; Tingstr√∂m P. Effects of a self-care promoting problem-based learning programme in people with rheumatic diseases: a randomized controlled study. Journal of advanced nursing. (2013) 69 7 pp1500-1514', '10.1111/jan.12008', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjan.12008']\n",
      "['9258324', 'Shadmanfar S; Labibzadeh N; Emadedin M; Jaroughi N; Azimian V; Mardpour S; Kakroodi FA; Bolurieh T; Hosseini SE; Chehrazi M; Niknejadi M; Baharvand H; Gharibdoost F; Aghdami N. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. (2018) 20 4 pp499-506', '10.1016/j.jcyt.2017.12.009', '']\n",
      "['9258325', 'Wittenberg G; Stylianou A; Zhang Y; Sun Y; Jagannatha PS; Wang D; Hsu B; Curran M; Khan S; Chen G; Bullmore ET; Drevets W. Comparative effects of immune-targeted therapies on depressed mood and anhedonia across 18 placebo-controlled immunology and oncology clinical trials. Neuropsychopharmacology. Conference: 55th annual meeting of the american college of neuropsychopharmacology, ACNP 2016. United states. Conference start: 20161204. Conference end: 20161208. (2016) 41  ppS181-S182', '10.1038/s41380-019-0471-8', 'http://www.nature.com/articles/s41380-019-0471-8']\n",
      "['9258327', 'Ferraz MB; Visioni RA; Oliveira LM; Ciconelli RM; Atra E. Intravenous methylprednisolone therapy in rheumatoid arthritis: a comparative dose study. Scandinavian journal of rheumatology. (1992) 21 5 pp260-261', '10.3109/03009749209099236', '']\n",
      "['9258328', 'Hannequin JR. Efficacy of Arthrotec in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1992) 96 96 pp7-14', '10.3109/03009749209095094', '']\n",
      "['9258329', 'Geis GS. Overall safety of Arthrotec. Scandinavian journal of rheumatology. Supplement. (1992) 96 Supplement pp33-36', '10.3109/03009749209095097', '']\n",
      "['9258330', 'Jubb RW; Platt P; Price TR. Double-blind comparison of etodolac sustained-release tablets and piroxicam capsules in patients with rheumatoid arthritis: An interim report. Current therapeutic research, clinical and experimental. (1992) 52 6 pp769-779', '10.1016/s0011-393x(05)80048-7', '']\n",
      "['9258331', 'de Melo Gomes JA. The safety of Arthrotec in patients with rheumatoid arthritis or osteoarthritis: an assessment of the upper gastrointestinal tract by endoscopy. Scandinavian journal of rheumatology. Supplement. (1992) 96  pp23-31', '10.3109/03009749209095096', '']\n",
      "['9258333', 'Xu J-H; Ding C-H; Xu S-Y; Zhang Y-C; Li X-P; Sun G-H; Shuai Z-W; Wang F; Xu S-Q; Liu S. A double-blind, randomized controlled clinical study of meloxicam and nabumetone in the treatment of rheumatoid arthritis. [Chinese]. Chinese Pharmaceutical Journal. (2002) 37 4 pp310-312', '10.1186/ar2870', 'https://link.springer.com/article/10.1186/ar2870/fulltext.html']\n",
      "['9258334', 'Prioreschi A; Tikly M; McVeigh JA. A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis. BMC musculoskeletal disorders. (2014) 15  pp403', '10.1186/1471-2474-15-403', 'http://link.springer.com/article/10.1186/1471-2474-15-403/fulltext.html']\n",
      "['9258335', 'Winkvist A; Barebring L; Gjertsson I; Ellegard L; Lindqvist HM. A randomized controlled cross-over trial investigating the effect of anti-inflammatory diet on disease activity and quality of life in rheumatoid arthritis: the Anti-inflammatory Diet in Rheumatoid Arthritis (ADIRA) study protocol. Nutrition journal. (2018) 17 1) (no pagination pp', '10.1186/s12937-018-0354-x', 'http://link.springer.com/article/10.1186/s12937-018-0354-x/fulltext.html']\n",
      "['9258336', 'Van Soesbergen RM; Hoefnagel CA; Marcuse HR; Dijkstra PF; Bernelot Moens HJ. Radiosynoviorthesis of the knee: a doubleblind trial of 1 versus 5 mCi Gold-198. Clinical rheumatology. (1988) 7 2 pp224-230', '10.1007/bf02204459', 'http://link.springer.com/article/10.1007/BF02204459/fulltext.html']\n",
      "['9258337', 'Yu WY; Shen SW; Yang ZH. A clinical study of Suogudan granule in the treatment of rheumatoid arthritis. Chinese journal of integrative medicine. (2005) 11 4 pp255-259', '10.1007/bf02835785', 'http://link.springer.com/article/10.1007/BF02835785/fulltext.html']\n",
      "['9258338', 'Maddali Bongi S; Del Rosso A; Mikhaylova S; Landi G; Ferretti B; Cavigli E; Baccini M; Matucci-Cerinic M. A comparison of two podiatric protocols for metatarsalgia in patients with rheumatoid arthritis and osteoarthritis. Clinical and experimental rheumatology. (2014) 32 6 pp855-863', '10.1136/annrheumdis-2013-eular.782', '']\n",
      "['9258339', 'Gardiner BM. Psychological aspects of rheumatoid arthritis. Psychological medicine. (1980) 10 1 pp159-163', '10.1017/s0033291700039702', '']\n",
      "['9258340', 'Chaudhry I; Husain N; Kiran T; Husain MO; Khosu A; Rahman R; Hamirani MM; Kazmi A; Baig S; Haddad PM; Buch MH; Qurashi I; Fu B; Deakin B. Selective benefit of low dose methotrexate on positive symptoms of schizophrenia in a randomized double-blind placebo-controlled 12-week feasibility trial. Neuropsychopharmacology. Conference: 55th annual meeting of the american college of neuropsychopharmacology, ACNP 2016. United states. Conference start: 20161204. Conference end: 20161208. (2016) 41  ppS228', '10.1186/1745-6215-16-9', 'http://link.springer.com/article/10.1186/1745-6215-16-9/fulltext.html']\n",
      "['9258342', 'Usha PR; Naidu MUR; Datla R. Clinical efficacy and tolerability evaluation of pentoxifylline in rheumatoid arthritis: A double-blind, randomised, placebo-controlled study. Clinical drug investigation. (2002) 22 5 pp329-339', '10.2165/00044011-200222050-00007', '']\n",
      "['9258344', 'Vignos PJ; Thompson HM; Katz S; Moskowitz RW; Fink S; Svec KH. Comprehensive care and psycho-social factors in rehabilitation in chronic rheumatoid arthritis: a controlled study. Journal of chronic diseases. (1972) 25 8 pp457-467', '10.1016/0021-9681(72)90209-3', '']\n",
      "['9258346', 'Parker JC; Smarr KL; Buckelew SP; Stucky-Ropp RC; Hewett JE; Johnson JC; Wright GE; Irvin WS; Walker SE. Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis and rheumatism. (1995) 38 12 pp1807-1818', '10.1002/art.1780381214', '']\n",
      "['9258348', 'Atkinson M; Germain G; Lee P. The efficacy and safety of sulindac (400 mg vs 600 mg daily) in rheumatoid arthritis. A Canadian Multicentre Study. Journal of rheumatology. (1988) 15 6 pp1001-1004', '10.1093/rheumatology/keh168', '']\n",
      "['9258349', 'Bao C; Chang CC; Shen Q; Pedersen R; Marshall L; Llamado LJ; Singh E. Etanercept-DMARD induction therapy in active rheumatoid arthritis: interim treat-to-target study results from Asia. International journal of rheumatic diseases. (2015) 18  pp21', '10.1136/annrheumdis-2015-eular.1689', '']\n",
      "['9258350', 'Schorn D. Diflunisal in rheumatoid arthritis. A controlled trial. South African medical journal. (1981) 60 24 pp936-937', '10.1007/bf00914448', 'http://link.springer.com/article/10.1007/BF00914448/fulltext.html']\n",
      "['9258351', \"Hanauer SB; Feagan BG; Lichtenstein GR; Mayer LF; Schreiber S; Colombel JF; Rachmilewitz D; Wolf DC; Olson A; Bao W; Rutgeerts P; ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (London, England). (2002) 359 9317 pp1541-1549\", '10.1016/s0140-6736(02)08512-4', '']\n",
      "['9258352', 'Minami M; Kaneda K. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA]. RyuÃÑmachi. [Rheumatism]. (1995) 35 5 pp780-791', '10.1002/art.1780311201', '']\n",
      "['9258353', 'Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M; Long-Term Etodolac Study Investigators. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs. Journal of rheumatology. (2004) 31 3 pp470-481', '10.21203/rs.2.23604/v1', 'https://www.researchsquare.com/article/rs-14170/v1']\n",
      "['9258354', \"Tapper-Jones LM; Aldred MJ; Cadogan SJ; Walker DM; Dolby AE; Hopkins R; Nuki G; Beck L. Sj√∂gren's syndrome treated with bromhexine: a reassessment. British medical journal. (1980) 280 6228 pp1356\", '10.1136/bmj.280.6228.1356', '']\n",
      "['9258356', 'van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2002) 41 6 pp658-665', '10.1093/rheumatology/41.6.658', 'http://academic.oup.com/rheumatology/article-pdf/41/6/658/18095695/410658.pdf']\n",
      "['9258357', 'Dore RK; Cohen SB; Lane NE; Palmer W; Shergy W; Zhou L; Wang H; Tsuji W; Newmark R; Denosumab RA Study Group. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Annals of the rheumatic diseases. (2010) 69 5 pp872-875', '10.1136/ard.2009.112920', '']\n",
      "['9258358', 'Du X; Si H; Li X. Clinical study of moxibustion on the meridian Dumai in the treatment of rheumatoid arthritis. Akupunktur. (1993) 21 4 pp260-264', '10.1007/978-3-662-05631-8_9', '']\n",
      "['9258359', 'Deodhar SD; Sethi R; Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian journal of medical research. (1980) 71  pp632-634', '10.1111/j.2042-7158.1973.tb09131.x', 'https://academic.oup.com/jpp/article-pdf/25/6/447/60375390/j.2042-7158.1973.tb09131.x.pdf']\n",
      "['9258361', 'Santos MF; Furtado RN; Konai MS; Castiglioni ML; Marchetti RR; Natour J. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial. Clinics (SaÃÉo Paulo, Brazil). (2009) 64 12 pp1187-1193', '10.1590/s1807-59322009001200008', 'http://www.scielo.br/pdf/clin/v64n12/08.pdf']\n",
      "['9258362', 'van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis and rheumatism. (2001) 44 7 pp1515-1524', '10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7', '']\n",
      "['9258363', 'Ridolfo AS; Crabtree RE; Johnson DW; Rockhold FW. Gastrointestinal microbleeding: comparisons between benoxaprofen and other nonsteroidal antiinflammatory agents. Journal of rheumatology. Supplement. (1980) 6  pp36-47', '10.1002/cpt1973142226', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1973142226']\n",
      "['9258364', 'Harrold LR; Reed GW; Harrington JT; Barr CJ; Saunders KC; Gibofsky A; Greenberg JD; John A; Devenport J; Kremer JM. The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network. BMC musculoskeletal disorders. (2014) 15  pp389', '10.1186/1471-2474-15-389', 'http://link.springer.com/article/10.1186/1471-2474-15-389/fulltext.html']\n",
      "['9258365', 'Vaishya R; Vijay V; Agarwal AK; Chowdhry P. Letter to the Editor on \"Comparison of Customized Cutting Block and Conventional Cutting Instruments in Total Knee Arthroplasty: a Randomized Controlled Trial\". Journal of arthroplasty. (2018) 33 10 pp3362', '10.1016/j.arth.2018.05.039', '']\n",
      "['9258366', 'Uhrin Z; Wang BW; Matsuda Y; Strober S; Genovese MC. Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival. Arthritis and rheumatism. (2001) 44 7 pp1525-1528', '10.1002/1529-0131(200107)44:7<1525::aid-art274>3.0.co;2-3', '']\n",
      "['9258367', 'Alarc√≥n GS; Casta√±eda O; Ferr√°ndiz M; Krumdieck CL; Koopman WJ. Efficacy and safety of 10-deazaaminopterin in the treatment of rheumatoid arthritis. A one-year continuation, double-blind study. Arthritis and rheumatism. (1992) 35 11 pp1318-1321', '10.1002/art.1780351112', '']\n",
      "['9258369', \"Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK. Towards personalised treatment in primary Sjogren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Annals of the rheumatic diseases. (2016) 75 11 pp1933-1938\", '10.1136/annrheumdis-2015-208304', '']\n",
      "['9258370', 'Semeraro F; Forbice E; Nascimbeni G; Taglietti M; Romano V; Guerra G; Costagliola C. Effect of autologous serum eye drops in patients with Sjogren syndrome-related dry eye: clinical and In Vivo confocal microscopy evaluation of the ocular surface. In vivo (Athens, Greece). (2016) 30 6 pp931-938', '10.21873/invivo.11016', 'http://iv.iiarjournals.org/content/30/6/931.full.pdf']\n",
      "['9258372', 'Jager DJ; Karagozoglu KH; Maarse F; Brand HS; Forouzanfar T. Sialendoscopy of Salivary Glands Affected by Sj√∂gren Syndrome: a Randomized Controlled Pilot Study. Journal of oral and maxillofacial surgery. (2016) 74 6 pp1167-1174', '10.1016/j.joms.2015.12.019', '']\n",
      "['9258373', 'Sander O; Rau R. [Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion protein (TNFR55-IgG1)--long term follow-up of 80 personal cases]. Zeitschrift fuÃàr Rheumatologie. (1998) 57 5 pp307-311', '10.1007/s003930050117', 'http://link.springer.com/article/10.1007/s003930050117/fulltext.html']\n",
      "['9258374', 'Liu DF; Guo MY; Zhang-jun null. Treatment of active rheumatoid arthritis by sanhuang yilong decoction. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2008) 28 8 pp743-746', '10.1016/s0254-6272(18)30895-1', '']\n",
      "['9258375', 'Bienkowska J; Allaire N; Thai A; Goyal J; Plavina T; Nirula A; Weaver M; Newman C; Petri M; Beckman E; Browning JL. Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis. PloS one. (2014) 9 11 ppe112545', '10.1371/journal.pone.0112545', '']\n",
      "['9258376', 'Weinblatt M; Baranauskaite A; Niebrzydowski J; Dokoupilova E; Zielinska A; Sitek-Ziolkowska K; Jaworski J; Racewicz A; Pileckyte M; Jedrychowicz-Rosiak K; Zhdan V; Cheong SY; Ghil J. Sustained efficacy and comparable safety and immunogenicity after transition to SB5 (an adalimumab biosimilar) vs. Continuation of SB5 or reference adalimumab (Humira) in patients with rheumatoid arthritis: results of phase III study. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp790-792', '10.1136/annrheumdis-2016-eular.1762', '']\n",
      "['9258377', 'Genovese MC; Weinblatt M; Mansikka HT; Peloso PM; Chen K; Li Y; Liu J; Padley RJ. Dual cytokine inhibition with ABT-122, a TNF-and IL-17-targeted dual variable domain immunoglobulin (DVD-IGTM): results from a 24-week open-label extension study in patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4313-4315', '10.1002/art.40580', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40580']\n",
      "['9258380', 'Gerlag DM; Safy M; Maijer KI; Tas SW; Starmans-Kool M; Van Tubergen A; Janssen M; Tak P-P. A single infusion of rituximab delays the onset of arthritis in subjects at high risk of developing RA. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4044-4045', '10.1002/art.39977', '']\n",
      "['9258386', 'Emery P; Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Cheong SY; Ghil J. Additional efficacy results of SB4 (etanercept biosimilar) up to week 100: comparison between continuing SB4 and switching from reference etanercept (enbrel) to SB4. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp789-790', '10.1136/annrheumdis-2016-eular.3137', '']\n",
      "['9258388', 'van de Putte LB; Sander O; Rau R. Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion proteins (TNFR55-IgG1)--results of double-blind placebo-controlled studies over 3 months. Zeitschrift fuÃàr Rheumatologie. (1998) 57 5 pp302-306', '10.1007/s003930050116', 'http://link.springer.com/article/10.1007/s003930050116/fulltext.html']\n",
      "['9258389', 'Gottenberg J-E; Morel J; Constantin A; Bardin T; Cantagrel AG; Combe B; Dougados M; Flipo R-M; Saraux A; Schaeverbeke T; Sibilia J; Soubrier M; Vittecoq O; Perrodeau E; Ravaud P; Mariette X. Monotherapy with abatacept, rituximab or tocilizumab is not associated with a significantly lower long term retention than combination with synthetic DMARD: long-term registry data in 4498 real-life patients with rheumatoid arthritis. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2006-2008', '10.1136/bmj.l67', '']\n",
      "['9258394', 'Gossec L; Servy H; Soubrier M; Joubert J-M; Czarlewski W; Combe B; Berthelot J-M; Wendling D; Cantagrel A; Dernis E; Grange L; Beauvais C; Perdriger A; Nataf H; Dougados M. Access to an active, interactive self-assessment e-health platform improves patient-physician communication in rheumatoid arthritis: results of a randomized controlled trial including 320 patients over 1 year. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1770-1771', '10.1016/j.jbspin.2017.11.015', '']\n",
      "['9258396', 'Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis. Transplantation proceedings. (1998) 30 8 pp4135-4136', '10.1016/s0041-1345(98)01370-0', '']\n",
      "['9258397', 'Choi IA; Baek HJ; Cho CS; Lee YA; Chung WT; Park YE; Lee YJ; Park YB; Lee J; Lee SS; Yoo WH; Song JS; Kang SW; Kim HA; Song YW. Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial. BMC musculoskeletal disorders. (2014) 15  pp375', '10.1186/1471-2474-15-375', 'http://link.springer.com/article/10.1186/1471-2474-15-375/fulltext.html']\n",
      "['9258399', 'Mart√≠n-Mola E; Gij√≥n-Ba√±os J; Ansoleaga JJ. Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatology international. (1995) 15 3 pp111-116', '10.1007/bf00302127', 'http://link.springer.com/article/10.1007/BF00302127/fulltext.html']\n",
      "['9258400', 'Solomon DH; Lu B; Losina E; Agosti J; Zak A; Corrigan C; Yu Z; Lee S; Bitton A; Harrold LR; Pincus T; Radner H; Smolen J; Fraenkel L; Katz JN. Implementation of treat to target in rheumatoid arthritis through a learning collaborative. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp4299-4301', '10.1002/art.40111', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40111']\n",
      "['9258401', 'Gossec L; Foissac F; Soubrier M; Molto A; Fayet F; Bardin T; Berenbaum F; Cantagrel A; Cerato MH; Chales GH; Chary-Valckenaere I; Combe B; Labous ED; Euller-Ziegler L; Flipo R-M; Gaudin P; Gilson M; Guis S; Mariette X; Mouterde G; Pouplin S; Richette P; Saraux A; Schaeverbeke T; Sibilia J; Dougados M. Is the self-assessment of disease activity (auto-DAS28) by patients a feasible and acceptable measure over the long term in rheumatoid arthritis (RA)? Three-year follow-up of a nurse-led program in 771 patients with established RA. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp1764-1765', '10.1093/rheumatology/kez094', 'http://academic.oup.com/rheumatology/article-pdf/58/8/1498/28984668/kez094.pdf']\n",
      "['9258403', 'Smolen JS; Aletaha D; Grisar JC; Stamm TA; Sharp JT. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials. Annals of the rheumatic diseases. (2010) 69 6 pp1058-1064', '10.1136/ard.2009.114652', '']\n",
      "['9258405', \"Steller M; Chou L; Daniels TE. Electrical stimulation of salivary flow in patients with Sj√∂gren's syndrome. Journal of dental research. (1988) 67 10 pp1334-1337\", '10.1177/00220345880670101701', 'https://journals.sagepub.com/doi/pdf/10.1177/00220345880670101701']\n",
      "['9258406', 'Claassen AAOM; van den Ende CHM; Meesters JJL; Pellegrom S; Kaarls-Ohms BM; Vooijs J; Willemsen-de Mey GEMP; Vliet Vlieland TPM. How to best distribute written patient education materials among patients with rheumatoid arthritis: a randomized comparison of two strategies. BMC health services research. (2018) 18 1 pp211', '10.1186/s12913-018-3039-4', 'http://link.springer.com/article/10.1186/s12913-018-3039-4/fulltext.html']\n",
      "['9258407', 'Meijer L; Hery-Arnaud G; Le Berre R; Nowak E; Le Roux L; Gueganton L; et al. Rosco-cf, a safety and efficacy clinical trial of (r)-roscovitine in CF patients. Journal of cystic fibrosis. (2016) 15 Suppl 1  ppS42', '10.1016/s1569-1993(18)30196-6', '']\n",
      "['9258408', 'Mohamed MEF; Zeng J; Song IH; Othman AA. ABT-494 pharmacokinetics following administration of the once-daily extended-release tablet formulation being utilized in the ongoing rheumatoid arthritis phase 3 trials. Annals of the rheumatic diseases. (2017) 76 (Supplement 2) Supplement 2 pp268-269', '10.1136/annrheumdis-2017-eular.3224', '']\n",
      "['9258409', \"Ekstrand R; Alv√°n G; L'e Orme M; Lewander R; Palm√©r L; Sarby B. Double-blind dose-response study of indomethacin in rheumatoid arthritis. European journal of clinical pharmacology. (1980) 17 6 pp437-442\", '10.1007/bf00570161', 'http://link.springer.com/article/10.1007/BF00570161/fulltext.html']\n",
      "['9258410', 'Meeus M; Hermans L; Ickmans K; Struyf F; Van Cauwenbergh D; Bronckaerts L; De Clerck LS; Moorken G; Hans G; Grosemans S; Nijs J. Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: A double-blind randomized controlled trial. Pain practice. (2015) 15  2 pp98-106', '10.1111/papr.12181', '']\n",
      "['9258412', 'Ching DW; Petrie JP; Klemp P; Jones JG. Injection therapy of superficial rheumatoid nodules. British journal of rheumatology. (1992) 31 11 pp775-777', '10.1093/rheumatology/31.11.775', 'http://academic.oup.com/rheumatology/article-pdf/31/11/775/5029226/31-11-775.pdf']\n",
      "['9258413', 'Liu De-Fang; Luo Y; Yan J; Zou W; Guo Min; Hu Y-H; Yang M; Zhang J; Yun M-D; Li K; Yang Mei; Li H. Effect of Sanhuang Yilong Decoction combined MTX on the expression of serum IL-1, IL-6, and IL-17 in rheumatoid arthritis patients of accumulated dampness-heat syndrome. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2015) 35 1 pp33-36', '10.1016/s0254-6272(18)30895-1', '']\n",
      "['9258414', 'Hanrahan PS; Russell AS. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. Journal of rheumatology. (1988) 15 7 pp1078-1080', '10.1093/rheumatology/28.2.147', 'http://academic.oup.com/rheumatology/article-pdf/28/2/147/5040783/28-2-147.pdf']\n",
      "['9258415', 'Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis and rheumatism. (1998) 41 12 pp2196-2204', '10.1002/1529-0131(199812)41:12<2196::aid-art15>3.3.co;2-u', '']\n",
      "['9258416', 'Perkins DJ; St Clair EW; Misukonis MA; Weinberg JB. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2). Arthritis and rheumatism. (1998) 41 12 pp2205-2210', '10.1002/1529-0131(199812)41:12<2205::aid-art16>3.0.co;2-q', '']\n",
      "['9258417', 'Coulthard LR; Geiler J; Mathews RJ; Church LD; Dickie LJ; Cooper DL; Wong C; Savic S; Bryer D; Buch MH; Emery P; Morgan AW; McDermott MF. Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. Clinical and experimental immunology. (2012) 170 1 pp36-46', '10.1111/j.1365-2249.2012.04626.x', 'https://academic.oup.com/cei/article-pdf/170/1/36/41907571/j.1365-2249.2012.04626.x.pdf']\n",
      "['9258418', 'Schorn D. Osteoporosis in the rheumatoid hand--the effects of treatment with D-penicillamine and oral gold salts. South African medical journal. (1983) 63 4 pp121-123', '10.1093/rheumatology/16.4.223', 'http://academic.oup.com/rheumatology/article-pdf/16/4/223/5026017/16-4-223.pdf']\n",
      "['9258419', 'Reinberg A; Manfredi R; Kahn MF; Chaoua D; Chaoua Y; Delcambre B; Le GP; Maugars Y; Valat JP. Tenoxicam chronotherapy of rheumatic diseases. ANNU REV CHRONOPHARMACOLOGY. (1990) 7 - pp293-296', '10.1146/annurev.pa.11.040171.002323', '']\n",
      "['9258421', 'Emery P; Burmester GR; Naredo E; Zhou Y; Hojnik M; Conaghan PG. Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the Im. BMJ open. (2018) 8 2 ppe019007', '10.1136/bmjopen-2017-019007', '']\n",
      "['9258423', 'Scheiman JM; Elta GH. Gastroduodenal mucosal damage with salsalate versus aspirin: Results of experimental models and endoscopic studies in humans. Seminars in arthritis and rheumatism. (1990) 20 2 pp121-127', '10.1016/0049-0172(90)90025-b', '']\n",
      "['9258424', 'Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P; 20000223 Study Group. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis and rheumatism. (2004) 50 5 pp1412-1419', '10.1002/art.20221', '']\n",
      "['9258428', 'Gupta P; Friberg LE; Karlsson MO; Krishnaswami S; French J. A semi-mechanistic model of CP-690,550-induced reduction in neutrophil counts in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2010) 50 6 pp679-687', '10.1177/0091270009346060', '']\n",
      "['9258429', 'Nissen SE; Yeomans ND; Solomon DH; Luscher TF; Libby P; Husni ME; Graham DY; Borer JS; Wisniewski LM; Wolski KE; Wang Q; Menon V; Ruschitzka F; Gaffney M; Beckerman B; Berger MF; Bao W; Lincoff AM. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. New england journal of medicine. (2016) 375 26 pp2519-2529', '10.1056/nejmoa1611593', '']\n",
      "['9258430', 'Loizzi P; Muratore M; Bruni G; Sacchetti G. A double-blind, crossover comparison between indoprofen and aspirin in rheumatoid arthritis. Current medical research and opinion. (1980) 6 9 pp598-605', '10.1185/03007998009109495', '']\n",
      "['9258431', 'Dequeker J; Stevens E; Wuyts L. A controlled trial of magnesium dithiosalicylate compared with aspirin in rheumatoid arthritis. Current medical research and opinion. (1980) 6 9 pp589-592', '10.1185/03007998009109493', '']\n",
      "['9258432', \"Sidorov VD; Grigor'eva VD; Pershin SB; Bobkova AS; Korovkina EG. [The combined action of an ultrahigh-frequency electrical field bitemporally and decimeter waves on the thymus area in the combined therapy of rheumatoid arthritis patients]. Voprosy kurortologii, fizioterapii, i lechebnoiÃÜ fizicheskoiÃÜ kultury. (1992)  4 pp9-13\", '10.17116/kurort20219806259', '']\n",
      "['9258434', 'Bakir E; Baglama SS; Gursoy S. The effects of reflexology on pain and sleep deprivation in patients with rheumatoid arthritis: a randomized controlled trial. Complementary therapies in clinical practice. (2018) 31  pp315-319', '10.1016/j.ctcp.2018.02.017', '']\n",
      "['9258435', 'Raskina T; Koroleva M; Dydykina I; Letaeva M. Effect of rituximab on quality of life with rheumatoid arthritis women to baseline bone mineral density. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2016. Malaga spain. Conference start: 20160414. Conference end: 20160417. Conference publication: (var.pagings). (2016) 27 1 SUPPL. 1 ppS434', '10.1007/s00198-016-3522-x', 'http://link.springer.com/article/10.1007/s00198-016-3522-x/fulltext.html']\n",
      "['9258436', \"O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis and rheumatism. (2006) 54 2 pp621-627\", '10.1002/art.21620', '']\n",
      "['9258437', 'Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone marrow transplantation. (1998) 22 11 pp1035-1041', '10.1038/sj.bmt.1701486', 'https://www.nature.com/articles/1701486']\n",
      "['9258438', 'Hetland ML; √òstergaard M; Ejbjerg B; Jacobsen S; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skj√∏dt H; Ellingsen T; Lindegaard H; P√∏denphant J; H√∏rslev-Petersen K; CIMESTRA study group. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP. Annals of the rheumatic diseases. (2012) 71 6 pp851-856', '10.1136/annrheumdis-2011-200632', '']\n",
      "['9258439', 'Daymond TJ; Rowell FJ. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs. (1988) 35 Suppl 1  pp4-8', '10.2165/00003495-198800351-00004', '']\n",
      "['9258440', 'Metsios GS; Stavropoulos-Kalinoglou A; Veldhuijzen van Zanten JJ; Nightingale P; Sandoo A; Dimitroulas T; Kitas GD; Koutedakis Y. Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 4 pp748-751', '10.1136/annrheumdis-2013-203291', '']\n",
      "['9258441', 'Franchimont P; Mailleux E. [Double-blind clinical trial of aspirin and Fenbufen in rheumatoid arthritis]. Acta rhumatologica. (1979) 3 4 pp249-259', '10.1080/03009742.1979.12088616', '']\n",
      "['9258442', 'Wallentin L; Sk√∂ldstam L. Lipoproteins and cholesterol esterification rate in plasma during a 10-day modified fast in man. American journal of clinical nutrition. (1980) 33 9 pp1925-1931', '10.1093/ajcn/33.9.1925', 'http://academic.oup.com/ajcn/article-pdf/33/9/1925/24154973/1925.pdf']\n",
      "['9258443', 'Espersen GT; Grunnet N; Lervang HH; Nielsen GL; Thomsen BS; Faarvang KL; Dyerberg J; Ernst E. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clinical rheumatology. (1992) 11 3 pp393-395', '10.1007/bf02207200', 'http://link.springer.com/article/10.1007/BF02207200/fulltext.html']\n",
      "['9258444', 'van der Veen MJ; Bijlsma JW. Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis. Clinical rheumatology. (1992) 11 3 pp388-392', '10.1007/bf02207199', 'http://link.springer.com/article/10.1007/BF02207199/fulltext.html']\n",
      "['9258446', 'Nielsen GL; Faarvang KL; Thomsen BS; Teglbjaerg KL; Jensen LT; Hansen TM; Lervang HH; Schmidt EB; Dyerberg J; Ernst E. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. European journal of clinical investigation. (1992) 22 10 pp687-691', '10.1111/j.1365-2362.1992.tb01431.x', '']\n",
      "['9258448', 'Shimada Y; Munakata Y; Inoo M; Hanada R; Yamada A; Takubo R; Shiramoto M. Pharmacokinetics, pharmacodynamics, safety, and tolerability of a novel anti-IL-6 receptor recycling antibody SA237: first in-human phase 1 single-and multipledose studies. European journal of neurology. Conference: 2nd congress of the european academy of neurology. Copenhagen denmark. Conference start: 20160528. Conference end: 20160531. Conference publication: (var.pagings). (2016) 23  pp203', '10.1136/annrheumdis-2018-eular.2410', '']\n",
      "['9258449', 'Hill J; Bird H; Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Annals of the rheumatic diseases. (2001) 60 9 pp869-875', '10.1016/s0003-4967(24)43387-6', '']\n",
      "['9258450', 'Buljina AI; Taljanovic MS; Avdic DM; Hunter TB. Physical and exercise therapy for treatment of the rheumatoid hand. Arthritis and rheumatism. (2001) 45 4 pp392-397', '10.1002/1529-0131(200108)45:4<392::aid-art353>3.0.co;2-2', '']\n",
      "['9258451', 'Lyngberg K; Danneskiold-Sams√∏e B; Halskov O. The effect of physical training on patients with rheumatoid arthritis: changes in disease activity, muscle strength and aerobic capacity. A clinically controlled minimized cross-over study. Clinical and experimental rheumatology. (1988) 6 3 pp253-260', '10.1016/0003-9993(94)90003-5', '']\n",
      "['9258452', 'Leak AM; Richter MR; Clemens LE; Hall MA; Ansell BM. A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. Clinical and experimental rheumatology. (1988) 6 2 pp157-160', '10.1093/rheumatology/31.9.631', 'http://academic.oup.com/rheumatology/article-pdf/31/9/631/5037139/31-9-631.pdf']\n",
      "['9258454', 'Wang Z; Tao XJ. Treatment of rheumatoid arthritis by yangxue tongluo recipe combined with immunosuppressive agents: a clinical observation. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2014) 34 3 pp276-278', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9258455', 'He WZ; Yin ZH; Gao JH; Ye ZZ; Xie Y; Kong WH; Chen YS. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study]. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2014) 34 3 pp267-271', '10.1136/annrheumdis-2013-eular.2617', '']\n",
      "['9258457', 'Ding CH; Xu SY; Li CY; Wei W; Sun GH; Xu JH; Wang JK; Liu SN; Wu CM; Ren KJ. A randomized, controlled clinical trial of mimesulide in the treatment of 171 cases of rheumatoid arthritis. Chinese Pharmaceutic Journal. (1998) 33 12 pp752-755', '10.1186/ar2870', 'https://link.springer.com/article/10.1186/ar2870/fulltext.html']\n",
      "['9258460', 'Huang CB; Liu J; Chen X; Wang Y; Zhang WD; Chen RL; Wang GZ; Fan HX. Treatment of rheumatoid arthritis by xinfeng capsule: an efficacy observation. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2013) 33 12 pp1599-1602', '10.1016/s0254-6272(15)30058-3', '']\n",
      "['9258461', 'Schoels M; Aletaha D; Funovits J; Kavanaugh A; Baker D; Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Annals of the rheumatic diseases. (2010) 69 8 pp1441-1447', '10.1136/ard.2009.122259', '']\n",
      "['9258463', 'van der Zwaard BC; van der Horst HE; Knol DL; Vanwanseele B; Elders PJ. Treatment of forefoot problems in older people: a randomized clinical trial comparing podiatric treatment with standardized shoe advice. Annals of family medicine. (2014) 12 5 pp432-440', '10.1370/afm.1684', '']\n",
      "['9258464', \"Jensen RB; Thankamony A; O'Connell SM; Kirk J; Donaldson M; Ivarsson SA; S√∂der O; Roche E; Hoey H; Dunger DB; Juul A. A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age Study. European journal of endocrinology / European Federation of Endocrine Societies. (2014) 171 4 pp509-518\", '10.1530/eje-14-0419', 'https://eje.bioscientifica.com/view/journals/eje/171/4/509.xml']\n",
      "['9258465', 'Harvey NC; Oden A; Johansson H; Burge R; Mitlak B; Kanis JA; McCloskey EV. Efficacy of teriparatide for prevention of vertebral and nonvertebral fracture is not altered by baseline fracture probability. Osteoporosis international. (2015) 26  1 SUPPL. 1 ppS203-S204', '10.1007/s00198-015-3173-3', 'http://link.springer.com/article/10.1007/s00198-015-3173-3/fulltext.html']\n",
      "['9258466', 'Hirano F; Takazoe A; Kashiwaya T; Saito H; Nishimura H. Eldecalcitol, a new active vitamin D analog, decreased bone turnover and increased lumbar and total hip bone mineral density in rheumatic disease patients. Osteoporosis international. (2015) 26  1 SUPPL. 1 ppS241-S242', '10.1016/j.bone.2013.06.005', '']\n",
      "['9258467', 'Middleton KR; Haaz Moonaz S; Hasni SA; Magana Lopez M; Tataw-Ayuketah G; Farmer N; Wallen GR. Yoga for systemic lupus erythematosus (SLE): clinician experiences and qualitative perspectives from students and yoga instructors living with SLE. Complementary therapies in medicine. (2018) 41  pp111-117', '10.1016/j.ctim.2018.09.001', '']\n",
      "['9258468', 'Malmstrom K; Kotey P; Coughlin H; Desjardins PJ. A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. Clinical journal of pain. (2004) 20 3 pp147-155', '10.1097/00002508-200405000-00004', '']\n",
      "['9258469', 'Genovese MC; Durez P; Richards HB; Supronik J; Dokoupilova E; Aelion JA; Lee SH; Codding CE; Kellner H; Ikawa T; Hugot S; Ligozio G; Mpofu S. One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study. Journal of rheumatology. (2014) 41 3 pp414-421', '10.3899/jrheum.130637', '']\n",
      "['9258470', 'Koroleva MV; Raskina TA; Malyshenko OS. Effect of rituximab on quality of life with rheumatoid arthritis patients to baseline bone mineral density. Osteoporosis international. (2015) 26  1 SUPPL. 1 ppS277-S278', '10.14412/1995-4484-2016-530-534', 'http://rsp.ima-press.net/rsp/article/viewFile/2295/1499']\n",
      "['9258473', 'Raskina TA; Koroleva MV; Malyshenko OS. Effect of rituximab on bonemineral density in patients with different initial activity of rheumatoid arthritis. Osteoporosis international. (2015) 26  1 SUPPL. 1 ppS280', '10.14412/1996-7012-2015-3-16-20', 'http://mrj.ima-press.net/index.php/mrj/article/viewFile/633/621']\n",
      "['9258479', 'Weinblatt ME; Kremer JM; Coblyn JS; Helfgott S; Maier AL; Petrillo G; Henson B; Rubin P; Sperling R. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis. Journal of rheumatology. (1992) 19 10 pp1537-1541', '10.1002/art.1780340413', '']\n",
      "['9258482', 'Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebasti√°n ON; Flores D; Riopedre AM; Redondo G; L√°zaro A. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. Journal of rheumatology. (1992) 19 10 pp1520-1526', '10.1093/rheumatology/31.8.573', 'http://academic.oup.com/rheumatology/article-pdf/31/8/573/5036366/31-8-573a.pdf']\n",
      "['9258488', 'Kolodny AL. Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis. Journal of rheumatology. (1988) 15 8 pp1205-1211', '10.3109/03009747809097218', '']\n",
      "['9258489', 'Schorn D; Seymour MA. Indomethacin or sulindac at night in rheumatoid arthritis. South African medical journal. (1981) 59 25 pp913-914', '10.3109/03009748109095327', '']\n",
      "['9258491', 'Sieper J; Kary S; S√∂rensen H; Alten R; Eggens U; H√ºge W; Hiepe F; K√ºhne A; Listing J; Ulbrich N; Braun J; Zink A; Mitchison NA. Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis and rheumatism. (1996) 39 1 pp41-51', '10.1002/art.1780390106', '']\n",
      "['9258492', 'Choy EH; Pitzalis C; Cauli A; Bijl JA; Schantz A; Woody J; Kingsley GH; Panayi GS. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis and rheumatism. (1996) 39 1 pp52-56', '10.1002/art.1780390107', '']\n",
      "['9258493', \"van der Reijden WA; van der Kwaak H; Vissink A; Veerman EC; Amerongen AV. Treatment of xerostomia with polymer-based saliva substitutes in patients with Sj√∂gren's syndrome. Arthritis and rheumatism. (1996) 39 1 pp57-63\", '10.1002/art.1780390108', '']\n",
      "['9258494', 'Daltroy LH; Robb-Nicholson C; Iversen MD; Wright EA; Liang MH. Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. British journal of rheumatology. (1995) 34 11 pp1064-1069', '10.1093/rheumatology/34.11.1064', 'http://academic.oup.com/rheumatology/article-pdf/34/11/1064/5042856/34-11-1064.pdf']\n",
      "['9258496', 'Yang M; Luo Y; Liu T; Zhong X; Yan J; Huang Q; Tao J; He Q; Guo M. The Effect of Puerarin on Carotid Intima-Media Thickness in Patients With Active Rheumatoid Arthritis: a Randomized Controlled Trial. Clinical therapeutics. (2018) (no pagination)  pp', '10.1016/j.clinthera.2018.08.014', '']\n",
      "['9258499', 'Romiti A; Martelletti P; Spagna G; Giacovazzo M. A double-blind cross-over comparative trial of the non-steroid glucamethacin (Teoremac 140) and indomethacin. Treatment of 40 rheumatoid patients. Clinical trials journal. (1979) 16 4 pp108-113', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9258500', \"Theander E; Horrobin DF; Jacobsson LT; Manthorpe R. Gammalinolenic acid treatment of fatigue associated with primary Sj√∂gren's syndrome. Scandinavian journal of rheumatology. (2002) 31 2 pp72-79\", '10.1080/03009740252937577', '']\n",
      "['9258501', 'Maksimov A A; Shaikov A V; Speransky A I; Solovyev S K. Pulse therapy with methylprednisolone and cyclophosphamide in systemic juvenile rheumatoid arthritis. Results of an open, parallel, controlled, randomized of 12 months duration, trial. Terapevticheskii arkhiv. (1992) 64 5 pp47-51', '10.1002/art.1780401019', '']\n",
      "['9258502', 'Gogas H; Ioannovich J; Dafni U; Stavropoulou-Giokas C; Frangia K; Tsoutsos D; Panagiotou P; Polyzos A; Papadopoulos O; Stratigos A; Markopoulos C; Bafaloukos D; Pectasides D; Fountzilas G; Kirkwood JM. Prognostic significance of autoimmunity during treatment of melanoma with interferon. New England journal of medicine. (2006) 354 7 pp709-718', '10.1056/nejmoa053007', '']\n",
      "['9258504', 'Buske C; Kim W; Kwak L; Coiffier B; Jurczak W; Sancho JM; Zhavrid E; Kim J; Hernandez Rivas JA; Prokharau A; Vasilica M; Nagarkar R; Osmanov D; Lee S; Bae Y; Ogura M. A double-blind, randomized phase 3 study to compare efficacy and safety of CT-P10 to rituximab in combination with CVP in patients with advanced-stage follicular lymphoma. Hematological oncology. Conference: 14th international conference on malignant lymphoma palazzo dei congressi. Switzerland. (2017) 35  pp218-220', '10.1002/hon.2438_83', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2438_83']\n",
      "['9258505', 'Seifert MH; Engler C. Naproxen suppositories in combination with oral naproxen, indomethacin and ibuprofen in the treatment of rheumatoid arthritis. Current medical research and opinion. (1980) 7 1 pp38-42', '10.1185/03007998009116513', '']\n",
      "['9258506', 'Schmidt M; Sorensen HT; Pedersen L. Cardiovascular risks associated with diclofenac initiation: a nationwide emulated randomized trial. European heart journal. (2017) 38 (Supplement 1) Supplement 1 pp217', '10.1093/eurheartj/ehx502.1015', 'http://academic.oup.com/eurheartj/article-pdf/38/suppl_1/ehx502.1015/19620219/ehx502.1015.pdf']\n",
      "['9258507', 'Denko CW; Malemud CJ. The serum growth hormone to somatostatin ratio is skewed upward in rheumatoid arthritis patients. Frontiers in bioscience. (2004) 9  pp1660-1664', '10.2741/1354', '']\n",
      "['9258509', 'Karag√ºlle M; Karde≈ü S; Di≈ü√ßi R; Karag√ºlle MZ. Spa therapy adjunct to pharmacotherapy is beneficial in rheumatoid arthritis: a crossover randomized controlled trial. International journal of biometeorology. (2018) 62 2 pp195-205', '10.1007/s00484-017-1441-y', 'http://link.springer.com/article/10.1007/s00484-017-1441-y/fulltext.html']\n",
      "['9258510', 'Johnsen AK; Schiff MH; Mease PJ; Moreland LW; Maier AL; Coblyn JS; Helfgott SM; Leff JA; Weinblatt ME. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study. Journal of rheumatology. (2006) 33 4 pp659-664', '10.1002/art.23493', '']\n",
      "['9258513', \"Wolfs JF; Peul WC; Boers M; van Tulder MW; Brand R; van Houwelingen HJ; Thomeer RT. Rationale and design of The Delphi Trial--I(RCT)2: international randomized clinical trial of rheumatoid craniocervical treatment, an intervention-prognostic trial comparing 'early' surgery with conservative treatment. BMC musculoskeletal disorders. (2006) 7  pp14\", '10.1186/1471-2474-7-14', 'http://link.springer.com/article/10.1186/1471-2474-7-14/fulltext.html']\n",
      "['9258515', 'Wang SK; Green LA; Gutwein AR; Drucker NA; Motaganahalli RL; Fajardo A; Babbey CM; Murphy MP. Rationale and design of the ARREST trial investigating mesenchymal stem cells in the treatment of small abdominal aortic aneurysm. Annals of vascular surgery. (2018) 47  pp230-237', '10.1016/j.avsg.2017.08.044', '']\n",
      "['9258517', 'Malin M; Verronen P; Korhonen H; Syvaoja E-L; Salminen S; Mykkanen H; Arvilommi H; Eerola E; Isolauri E. Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: Evaluation of effect on gut defence mechanisms. Inflammopharmacology. (1997) 5 3 pp219-236', '10.1007/s10787-997-0001-1', 'https://link.springer.com/article/10.1007/s10787-997-0001-1/fulltext.html']\n",
      "['9258518', 'Yocum DE; Klippel JH; Wilder RL; Gerber NL; Austin HA; Wahl SM; Lesko L; Minor JR; Preuss HG; Yarboro C. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study. Annals of internal medicine. (1988) 109 11 pp863-869', '10.7326/0003-4819-109-11-863', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-109-11-863']\n",
      "['9258521', 'Tao X; Younger J; Fan FZ; Wang B; Lipsky PE. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis and rheumatism. (2002) 46 7 pp1735-1743', '10.1002/art.10411', '']\n",
      "['9258522', 'Roth SH. Benoxaprofen: Once a day vs twice a day in patients with rheumatoid arthritis or osteoarthritis. Journal of rheumatology. (1980) 7 SUPPL.6 pp68-75', '10.1001/archopht.1980.01020041030004', 'https://archopht.jamanetwork.com/ama/content_public/journal/ophth/17907/archopht_98_12_004.pdf']\n",
      "['9258524', 'Van Vollenhoven RF; Emery P; Bingham III CO; Keystone EC; Fleischmann RM; Furst DE; Tyson N; Collinson N; Lehane PB. Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients. Annals of the rheumatic diseases. (2013) 72  9 pp1496-1502', '10.1136/annrheumdis-2012-201956', '']\n",
      "['9258525', 'Johnson DP; Eastwood DM. Beneficial effects of continuous passive motion after total condylar knee arthroplasty. Annals of the Royal College of Surgeons of England. (1992) 74 6 pp412-416', '10.31979/etd.c95j-wtz9', '']\n",
      "['9258526', 'Ehsanullah RS; Page MC; Tildesley G; Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ (Clinical research ed.). (1988) 297 6655 pp1017-1021', '10.1136/bmj.297.6655.1017', '']\n",
      "['9258527', 'Sester M; van Leth F; Bruchfeld J; Bumbacea D; Cirillo DM; Dilektasli AG; Dom√≠nguez J; Duarte R; Ernst M; Eyuboglu FO; Gerogianni I; Girardi E; Goletti D; Janssens JP; Julander I; Lange B; Latorre I; Losi M; Markova R; Matteelli A; Milburn H; Ravn P; Scholman T; Soccal PM; Straub M; Wagner D; Wolf T; Yalcin A; Lange C; TBNET. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. American journal of respiratory and critical care medicine. (2014) 190 10 pp1168-1176', '10.1164/rccm.201405-0967oc', '']\n",
      "['9258528', 'Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy. (1999) 19 1 pp88-93', '10.1592/phco.19.1.88.30515', '']\n",
      "['9258529', 'Manorot M; Rojanasathien N; Louthrenoo W; Tonsuwannont W; Teekachunhatean S. Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis. Chotmaihet thangphaet [Journal of the Medical Association of Thailand]. (1998) 81 12 pp978-985', '10.35755/jmedassocthai.2024.11.873-880-01337', '']\n",
      "['9258530', 'Blitz J; Stern SM; Marzan K. Do pedometers with or without education on exercise increase functional walking capacity and physical activity level in adolescents with juvenile idiopathic arthritis?. Physiotherapy theory and practice. (2018) 34 5 pp359-366', '10.1080/09593985.2017.1401189', '']\n",
      "['9258531', 'Wells G; Boers M; Shea B; Tugwell P; Westhovens R; Saurez-Almazor M; Buchbinder R. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. Journal of rheumatology. (1999) 26 1 pp217-221', '10.1093/rheumatology/40.8.896', 'http://academic.oup.com/rheumatology/article-pdf/40/8/896/5045152/400896.pdf']\n",
      "['9258533', 'Baumgartner H; Boyle CM. Diflusinal compared with naproxen in rheumatoid arthritis. Schweizerische medizinische Wochenschrift. (1982) 112 8 pp281-285', '10.1002/art.1780250818', '']\n",
      "['9258534', 'Anderson LG; Bina PR. Double blind cross-over trial comparing fenbufen and acetylsalicylic acid in rheumatoid arthritis. Arzneimittel-Forschung. (1980) 30 4A pp735-739', '10.1093/rheumatology/x.suppl_1.76', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/76/24422041/10-suppl_1-76.pdf']\n",
      "['9258535', \"Fidelix T; Czapkowski A; Azjen S; Andriolo A; Neto PH; Trevisani V. Low-level laser therapy for xerostomia in primary Sj√∂gren's syndrome: a randomized trial. Clinical rheumatology. (2018) 37 3 pp729-736\", '10.1007/s10067-017-3898-9', 'http://link.springer.com/article/10.1007/s10067-017-3898-9/fulltext.html']\n",
      "['9258536', 'Valdes EF; Barclay CA; Traballi CA. Clinical evaluation of the thienothiazine derivative, Ro 12-0068, in rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1982) 31 3 I pp402-407', '10.1007/bf03297160', 'http://link.springer.com/article/10.1007/BF03297160/fulltext.html']\n",
      "['9258537', 'Wallace D; Goldfinger D; Lowe C; et al. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. New England journal of medicine. (1982) 306 23 pp1406-1410', '10.1056/nejm198206103062307', '']\n",
      "['9258538', 'Skosey JL. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis. Journal of rheumatology. Supplement. (1988) 16  pp5-8', '10.1093/rheumatology/kem1012', 'http://academic.oup.com/rheumatology/article-pdf/46/suppl_1/i25/5047042/kem1012.pdf']\n",
      "['9258539', 'Mikulaschek WM. An update on long-term efficacy and safety with benoxaprofen. European journal of rheumatology and inflammation. (1982) 5 2 pp206-215', '10.1093/rheumatology/kew166.009', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i187/5080308/kew166.009.pdf']\n",
      "['9258540', 'Pascart T; Philippe P; Drumez E; Deprez X; Cortet B; Duhamel A; Houvenagel E; Flipo R-M. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study. International journal of rheumatic diseases. (2016) 19 11 pp1093-1102', '10.1111/1756-185x.12845', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12845']\n",
      "['9258541', 'Manteuffel VG; Storck U; Goebel FD; et al. Clinical effectiveness of carprofen versus diclofenac sodium in cases of rheumatoid arthritis. A double blind study. Die Therapiewoche. (1982) 32 34 pp3924-3929', '10.3109/03009748009101380', '']\n",
      "['9258542', 'Roth SH; Cryan WS; Harris BK; et al. Long-term double-blind comparison of fenbufen with aspirin in the treatment of rheumatoid arthritis. Pharmacology. (1982) 25 Suppl. 1 pp63-72', '10.1159/000137780', '']\n",
      "['9258544', 'Emery P; Clarke A; Williams P; Kill D; Cree F; Redhead R; Poland M. Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients. Journal of rheumatology. Supplement. (1992) 36 19 Suppl 36 pp41-47', '10.3109/03009747809095673', '']\n",
      "['9258545', 'Brownfield A. Aromatherapy in arthritis: a study. Nursing standard (Royal College of Nursing (Great Britain) : 1987). (1998) 13 5 pp34-35', '10.7748/ns.13.5.34.s46', '']\n",
      "['9258546', 'Fleischmann RM. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis. Journal of rheumatology. Supplement. (1992) 36 19 Suppl 36 pp32-40', '10.1007/s10067-021-05933-y', 'https://link.springer.com/article/10.1007/s10067-021-05933-y/fulltext.html']\n",
      "['9258547', 'Balme HW; Wojtulewski JA; Huskisson EC. Clinical experience with tolmetin sodium. Current medical research and opinion. (1980) 7 2 pp127-130', '10.1185/03007998009112039', '']\n",
      "['9258548', 'Manders SHM; Kievit W; Adang E; Jansen TJ; Stolk JN; Visser H; Schilder AM; Vonkeman HE; Van De Laar MAFJ; Van Riel PLCM. Effectiveness of TNF inhibitor treatment with various methotrexate doses in patients with rheumatoid arthritis: Results from clinical practice. Annals of the rheumatic diseases. (2015) 74  3 ppe24', '10.1136/annrheumdis-2014-207005', '']\n",
      "['9258549', 'Willich SN; Rossnagel K; Roll S; Wagner A; Mune O; Erlendson J; Kharazmi A; S√∂rensen H; Winther K. Rose hip herbal remedy in patients with rheumatoid arthritis - a randomised controlled trial. Phytomedicine. (2010) 17 2 pp87-93', '10.1016/j.phymed.2009.09.003', '']\n",
      "['9258550', 'Sj√∂quist ES; Almqvist L; Asenl√∂f P; Lampa J; Opava CH. Physical-activity coaching and health status in rheumatoid arthritis: a person-oriented approach. Disability and rehabilitation. (2010) 32 10 pp816-825', '10.3109/09638280903314069', '']\n",
      "['9258551', 'Verstappen SM; McCoy MJ; Roberts C; Dale NE; Hassell AB; Symmons DP; STIVEA investigators. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Annals of the rheumatic diseases. (2010) 69 3 pp503-509', '10.1136/ard.2009.119149', '']\n",
      "['9258553', 'Wang H; Liu H; Liu M; Wang W; Zhu L; Huang H; Hu P; Jiang J. Pharmacokinetics of LBPT and its primary metabolites, as well as tolerability in the first-in-human study. European journal of pharmaceutical sciences. (2017) 100  pp87-93', '10.1016/j.ejps.2016.12.038', '']\n",
      "['9258554', 'Tam LH; Shang Q; Li EK; Wong PC; Kwok KY; Kun EW; Yim IC; Lee VK; Yip RM; Pang SH; Lao VW; Mak QW; Cheng IT; Lau XS; Li TK; Zhu TY; Lee AP; Tam LS. Effect of treat-to-target strategies aiming at remission of arterial stiffness in early rheumatoid arthritis: a randomized controlled study. Journal of rheumatology. (2018) 45 9 pp1229-1239', '10.3899/jrheum.171128', '']\n",
      "['9258555', 'Yang M; Guo MY; Luo Y; Yun MD; Yan J; Liu T; Xiao CH. Effect of Artemisia annua extract on treating active rheumatoid arthritis: a randomized controlled trial. Chinese journal of integrative medicine. (2017) 23 7 pp496-503', '10.1007/s11655-016-2650-7', 'http://link.springer.com/article/10.1007/s11655-016-2650-7/fulltext.html']\n",
      "['9258556', 'Waggoner CD; LeLieuvre RB. A method to increase compliance to exercise regimens in rheumatoid arthritis patients. Journal of behavioral medicine. (1981) 4 2 pp191-201', '10.1007/bf00844270', 'http://link.springer.com/article/10.1007/BF00844270/fulltext.html']\n",
      "['9258558', \"Gambino A; Broccoletti R; Cafaro A; Cabras M; Carcieri P; Arduino PG. Impact of a sodium carbonate spray combined with professional oral hygiene procedures in patients with Sjogren's syndrome: an explorative study. Gerodontology. (2017) 34 2 pp208-214\", '10.1111/ger.12250', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fger.12250']\n",
      "['9258559', 'Figueirinhas J. Double blind trial of proglumethacin versus ibuprophene in the treatment of rheumatoid arthritis. Preliminary trial. Arquivos de Reumatologia e Doencas Osteo-Articulares. (1982) 4 6 pp215-221', '10.1002/art.23361', '']\n",
      "['9258560', \"Aragona P; Di Stefano G; Ferreri F; Spinella R; Stilo A. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sj√∂gren's syndrome patients. British journal of ophthalmology. (2002) 86 8 pp879-884\", '10.1136/bjo.86.8.879', '']\n",
      "['9258561', 'Magaro M; Altomonte L; Zoli A; Mirone L; De Sole P; Di Mario G; Lippa S; Oradei A. Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1988) 47 10 pp793-796', '10.1136/ard.47.10.793', '']\n",
      "['9258563', \"Alves MB; Motta AC; Messina WC; Migliari DA. Saliva substitute in xerostomic patients with primary Sj√∂gren's syndrome: a single-blind trial. Quintessence international (Berlin, Germany : 1985). (2004) 35 5 pp392-396\", '10.4172/2153-0769.1000128', '']\n",
      "['9258564', 'Taha AS; Dahill S; Morran C; Hudson N; Hawkey CJ; Lee FD; Sturrock RD; Russell RI. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology. (1999) 116 2 pp254-258', '10.1016/s0016-5085(99)70120-4', '']\n",
      "['9258566', 'Gibson RG; Gibson SL; Conway V; Chappell D. Perna canaliculus in the treatment of arthritis. Practitioner. (1980) 224 1347 pp955-960', '10.1016/s0965-2299(98)80003-4', '']\n",
      "['9258567', 'Jani RH; Gupta R; Bhatia G; Rathi G; Ashok Kumar P; Sharma R; Kumar U; Gauri LA; Jadhav P; Bartakke G; Haridas V; Jain D; Mendiratta SK. A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2016) 19 11 pp1157-1168', '10.1111/1756-185x.12711', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12711']\n",
      "['9258568', 'Von Manteuffel G; Storck U; Scholz HJ; Goebel KM. Double-blind study of the clinical efficacy of carprofen vs diclofenac-Na in rheumatoid arthritis. Zeitschrift fur Rheumatologie. (1982) 41 4 ppNo.80', '10.3109/03009748309095333', '']\n",
      "['9258571', 'Brown JH; Kazis LE; Spitz PW; et al. The dimensions of health outcomes: A cross-validated examination of health status measurement. American journal of public health. (1984) 74 2 pp159-161', '10.2105/ajph.74.2.159', '']\n",
      "['9258572', 'Feinberg JR; Brandt KD. Allied health team management of rheumatoid arthritis patients. The American journal of occupational therapy : official publication of the American Occupational Therapy Association. (1984) 38 9 pp613-620', '10.5014/ajot.38.9.613', 'https://research.aota.org/ajot/article-pdf/38/9/613/50467/613.pdf']\n",
      "['9258573', 'Grekhov RA; Aleksandrov AV; Alekhina IIu; Zborovskiƒ≠ AB. Use of life quality indices in the rehabilitation therapy of inflammatory and degenerative rheumatic diseases. TerapevticheskiiÃÜ arkhiv. (2009) 81 12 pp51-54', '10.1136/annrheumdis-2022-eular.3240', '']\n",
      "['9258574', 'Kay J; Fleischmann R; Keystone E; Hsia EC; Hsu B; Mack M; Goldstein N; Braun J; Kavanaugh A. Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Annals of the rheumatic diseases. (2015) 74 3 pp538-546', '10.1136/annrheumdis-2013-204195', '']\n",
      "['9258575', 'Westhovens R; Robles M; Ximenes AC; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Murthy B. Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis. Annals of the rheumatic diseases. (2015) 74 3 pp564-568', '10.1136/annrheumdis-2014-206149', '']\n",
      "['9258576', 'Sarzi Puttini P; Cazzola M; Boccassini L; Ciniselli G; Santandrea S; Caruso I; Benvenuti C. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. Journal of international medical research. (1988) 16 5 pp331-337', '10.1177/030006058801600502', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058801600502']\n",
      "['9258579', 'Djordjevic V; Djokic G; Domic D; Zivkovic N; Jankovic L; Milicic B; Djukic Dejanovic S. Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications. European neuropsychopharmacology. Conference: 29th european college of neuropsychopharmacology congress, ECNP 2016. Austria. Conference start: 20160917. Conference end: 20160920. (2016) 26  ppS537', '10.1016/s0924-977x(16)31576-0', '']\n",
      "['9258580', 'Yamamuro T; Okumura H; Ueo T; Tanaka H. The effects of alfacalcidol on bone loss in rheumatoid arthritic patients. INT J IMMUNOTHER. (1990) 6 1 pp37-46', '10.1097/00003086-199002000-00012', '']\n",
      "['9258581', 'Chen X; Huang R; Yan J; Liu Z; Chu Y; Huang Q. Treatment of Refractory Rheumatoid Arthritis by Huayu Tongbi Recipe Combined Methotrexate. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2015) 35 11 pp1326-1330', '10.3389/fmed.2020.00484', '']\n",
      "['9258582', 'Bahadoria S; Ahmadzadeh A; Ardekani MRS; Kamalinejad M; Keshavarze M; Salamzadehf J. Does regular use of a complementary medicine of Olea Europe and Ficus carica have adverse effects on lipid profile and fasting blood glucose of rheumatoid arthritis (RA) patients under treatment with DMARD regimens containing methotrexate?. Iranian journal of pharmaceutical research. (2016) 15 4 pp933-940', '10.1136/annrheumdis-2012-eular.261', '']\n",
      "['9258583', 'Barker AL; Talevski J; Morello RT; Nolan GA; De Silva RD; Briggs AM. Jumping into the deep-end: results from a pilot impact evaluation of a community-based aquatic exercise program. Clinical rheumatology. (2016) 35 6 pp1593-1601', '10.1007/s10067-015-3096-6', 'http://link.springer.com/article/10.1007/s10067-015-3096-6/fulltext.html']\n",
      "['9258584', 'Kon Y; Katayama K; Okubo T; Sato T; Fukai R; Abe S; Ito H; Ichikawa S; Kamishima T. Long-term inhibition of radiographic joint damage by tofacitinib monotherapy in rheumatoid arthritis patients with rapid radiographic progression about eight cases. Modern rheumatology case reports. (2017) 1 2 pp35-42', '10.1080/24725625.2017.1292867', '']\n",
      "['9258585', 'Winthrop KL; Park S-H; Gul A; Cardiel MH; Gomez-Reino JJ; Tanaka Y; Kwok K; Lukic T; Mortensen E; Ponce De Leon D; Riese R; Valdez H. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 6 pp1133-1138', '10.1136/annrheumdis-2015-207319', '']\n",
      "['9258586', 'Ndosi M; Johnson D; Young T; Hardware B; Hill J; Hale C; Maxwell J; Roussou E; Adebajo A. Effects of needs-based patient education on self-efficacy and health outcomes in people with rheumatoid arthritis: a multicentre, single blind, randomised controlled trial. Annals of the rheumatic diseases. (2016) 75 6 pp1126-1132', '10.1136/annrheumdis-2014-207171', '']\n",
      "['9258587', 'Collier DH; Bitman B; Coles A; Liu L; Kumar S; Judd C. A novel electromechanical autoinjector, AutoTouchTM, for self-injection of etanercept: real-world use and benefits. Postgraduate medicine. (2017) 129 1 pp118-125', '10.1080/00325481.2017.1251291', '']\n",
      "['9258588', 'Al-Nahdi M. Efficacy and tolerability of long-term tenoxicam versus piroxicam in patients with rheumatoid arthritis or osteoarthritis. Current therapeutic research, clinical and experimental. (1992) 52 4 pp639-645', '10.1016/s0011-393x(05)80470-9', '']\n",
      "['9258589', 'Liebling MR; Leib E; McLaughlin K; Blocka K; Furst DE; Nyman K; Paulus HE. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Annals of internal medicine. (1981) 94 1 pp21-26', '10.7326/0003-4819-94-1-21', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-94-1-21']\n",
      "['9258590', 'Baber N; Sibeon R; Laws E; Halliday L; Orme M; Littler T. Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing. British journal of clinical pharmacology. (1980) 10 4 pp387-392', '10.1111/j.1365-2125.1980.tb01775.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1980.tb01775.x']\n",
      "['9258591', \"Karsh J; Pavlidis N; Schiffman G; Moutsopoulos HM. Immunization of patients with Sj√∂gren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Arthritis and rheumatism. (1980) 23 11 pp1294-1298\", '10.1002/art.1780231111', '']\n",
      "['9258592', 'Grasedyck K; Filchner R; Gross W. Interindividual double-blind comparison of pirprofen and indomethacin in patients with chronic polyarthritis. Fortschritte der Medizin. (1985) 103 7 A pp170-172', '10.1007/bf03366591', '']\n",
      "['9258593', 'Wei N; Delauter SK; Erlichman MS. The holmium YAG laser in office based arthroscopy of the knee: comparison with standard interventional instruments in patients with arthritis. Journal of rheumatology. (1997) 24 9 pp1806-1808', '10.1097/00124743-199508000-00004', '']\n",
      "['9258594', 'Fahmy Z. Double-blind study with isoxicam i.v. in inflammatory and degenerative joint affections. Die Medizinische Welt. (1985) 36 13 pp395-398', '10.1016/0002-9343(85)90177-9', '']\n",
      "['9258595', \"Bachmann F. [Fenclofenac in the treatment of rheumatoid arthritis (author's transl)]. Deutsche medizinische Wochenschrift (1946). (1980) 105 52 pp1806-1809\", '10.1055/s-2008-1070963', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1070963.pdf']\n",
      "['9258596', \"Loizzi P; Semmola MV; D'Ingianna E; Trotta F; Ferri S; Tuzi T; Nacchiero M; Calabro A; Fesce E; Trevisani L; Brambati M; Giannelli C; Psilogenis M. Effectiveness of sulglycotide (Gliptide) in prevention of gastric lesions from non-steroidal anti-inflammatory drugs in patients with rheumatic disease. A controlled double-blind endoscopic study v. placebo. Clinical trials journal. (1990) 27 3 pp164-174\", '10.3109/00365529309103128', '']\n",
      "['9258597', 'Kolarz G; Scherak O; El-Shohoumi M; Blankenhorn G. High-dose vitamin E in rheumatoid arthritis / Hochdosiertes Vitamin E bei chronischer Polyarthritis. Aktuelle Rheumatologie. (1990) 15 6 pp233-237', '10.1055/s-2008-1047457', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047457.pdf']\n",
      "['9258600', 'Myers LW; Ellison GW; Fahey JL; Tesler A; Gottlieb MS. Clinical drawbacks of total lymphoid irradiation: the cons [Comment in: Lancet, 1986; 1: 1405-1409]. Neurology. (1988) 38 Suppl 2 7 pp38-41', '10.1016/s0140-6736(86)91554-0', '']\n",
      "['9258601', 'David C. Comparison of the tolerance and efficacy of ketoprofen (Oruvail) and ibuprofen (Brufen) in patients with rheumatoid arthritis and osteo-arthritis. A randomized, double-blind, cross-over trial. Clinical trials journal. (1990) 27 3 pp196-202', '10.1136/bmj.4.5884.82', '']\n",
      "['9258602', 'Whitaker JN; Mitchell GW; Cutter GR. Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis. [Comment in: Ann Neurol, 1995; 37: 30-40; Comment in: J Neurol Neurosurg Psychiatry, 1993; 56: 1217-1218; Comment in: N Engl J Med, 1983; 308: 173-180; Comment in: Ann Neurol, 1990; 27: 591-605; Comment in: Neurology, 1991; 41: 533-539; Comment in: Neurology, 1993; 34: 755-756]. Annals of neurology. (1995) 37 1 pp5-6', '10.1002/ana.410370104', '']\n",
      "['9258603', \"Herrlinger JD; Kriegel W; Drews J; H‚àö‚àÇlscher F; Schmidt R. Clinical trial in couples of effectiveness and side-effects of gold and D-penicillamine in long term treatment of rheumatoid arthritis (author's transl). Klinische Wochenschrift. (1980) 58 16 pp839-845\", '10.1007/bf01491105', 'http://link.springer.com/article/10.1007/BF01491105/fulltext.html']\n",
      "['9258604', 'Jacobs JWG; Rasker JJ; Van RPLCM; Gribnau FWJ; Van dPBA. The treatment of fibromyalgia with rheumajecta and vasolastine; Results of a randomized, placebocontrolled, double-blind study (I: Reply).  BEHANDELING MET RHEUMAJECTA EN VASOLASTINE VAN PRIMAIRE FIBROMYALGIE; RESULTATEN VAN EEN GERANDOMISEERD, PLACEBO-GECONTROLEERD, DUBBELBLIND ONDERZOEK (I: REPLY). Nederlands tijdschrift voor geneeskunde. (1990) 134 27 pp1322', '10.3109/03009749109096823', '']\n",
      "['9258605', 'Hissink MW. The treatment of fibromyalgia with rheumajecta and vasolastine; Results of a randomized, placebocontrolled, double-blind study (I).  BEHANDELING MET RHEUMAJECTA EN VASOLASTINE VAN PRIMAIRE FIBROMYALGIE; RESULTATEN VAN EEN GERANDOMISEERD, PLACEBO-GECONTROLEERD, DUBBELBLIND ONDERZOEK (I). Nederlands tijdschrift voor geneeskunde. (1990) 134 27 pp1321-1322', '10.5177/ntvt.2015.04.14265', '']\n",
      "['9258606', 'Ambanelli U; Nervetti A; Colombo B; Cherie-Ligniere G; Gualdi I; Marcolongo R; Fioravanti A; Sabadini L; Materazzi M; Perpignano G; Bogliolo A; Serni U; Frosecchi M; Marin G; Semmola MV; Bufalino L; Gardini F. Piroxicam-beta-cyclodextrin in the treatment of rheumatic diseases: A prospective study. Current therapeutic research, clinical and experimental. (1990) 48 1 pp58-68', '10.1016/s0011-393x(05)80469-2', '']\n",
      "['9258607', 'Vargov√° V; Vesel√Ω R; Sasinka M; T√∂r√∂k C. [Will administration of omega-3 unsaturated fatty acids reduce the use of nonsteroidal antirheumatic agents in children with chronic juvenile arthritis?]. CasopiÃÅs leÃÅkarÃÜuÃä cÃÜeskyÃÅch. (1998) 137 21 pp651-653', '10.1108/nfs.2008.01738dab.011', '']\n",
      "['9258608', 'Sharpe L; Sensky T; Timberlake N; Ryan B; Allard S. Long-term efficacy of a cognitive behavioural treatment from a randomized controlled trial for patients recently diagnosed with rheumatoid arthritis. Rheumatology (Oxford, England). (2003) 42 3 pp435-441', '10.1093/rheumatology/keg144', 'http://academic.oup.com/rheumatology/article-pdf/42/3/435/9444640/420435.pdf']\n",
      "['9258609', 'Shadick NA; Sowell NF; Frits ML; Hoffman SM; Hartz SA; Booth FD; Sweezy M; Rogers PR; Dubin RL; Atkinson JC; Friedman AL; Augusto F; Iannaccone CK; Fossel AH; Quinn G; Cui J; Losina E; Schwartz RC. A randomized controlled trial of an internal family systems-based psychotherapeutic intervention on outcomes in rheumatoid arthritis: a proof-of-concept study. Journal of rheumatology. (2013) 40 11 pp1831-1841', '10.3899/jrheum.121465', '']\n",
      "['9258611', 'David J; Loftus J; Hesp R; Ansell BM; Reeve J; Woo PM. Spinal and somatic growth in patients with juvenile chronic arthritis treated for up to 2 years with deflazacort. Clinical and experimental rheumatology. (1992) 10 6 pp621-624', '10.1093/rheumatology/32.suppl_2.31', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_2/31/5041428/32-suppl_2-31.pdf']\n",
      "['9258612', 'Treves R; Jacob P; Arnaud M; et al. Dapsone in the treatment of rheumatoid arthritis. Double blind study (11 cases) and open study (7 cases). Revue du rhumatisme et des maladies osteo-articulaires. (1985) 52 10 pp587-589', '10.1016/s1169-8330(16)30570-1', '']\n",
      "['9258613', 'Benenson EV; Nemtsov BF; Maximov TA; et al. Prospidin, a new basic agent for the treatment of rheumatoid arthritis: A clinical study of the drug efficacy in the controlled and double blind tests. Revmatologiia (Moscow, Russia). (1985) 3  pp36-40', '10.14412/1995-4484-2003-1359', '']\n",
      "['9258614', 'Gibson SLM; Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Complementary therapies in medicine. (1998) 6  pp122-126', '10.1016/s0965-2299(98)80003-4', '']\n",
      "['9258615', 'Man M-S; Chaplin K; Mann C; Bower P; Brookes S; Fitzpatrick B; Guthrie B; Shaw A; Hollinghurst S; Mercer S; Rafi I; Thorn J; Salisbury C. BMJ open improving the management of multimorbidity in general practice: protocol of a cluster randomised controlled trial (the 3D study). BMJ open. (2016) 6 4 ppe011261', '10.1136/bmjopen-2016-011261', '']\n",
      "['9258616', 'Meinicke J; Danneskiold-Sams√∏e B. Diclofenac sodium (Voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study. Scandinavian journal of rheumatology. Supplement. (1980) 35 35 pp1-8', '10.3109/03009748009101380', '']\n",
      "['9258623', 'Pasalic KS; Gosic K; Gavrilovic A; Damjanov N; Vojinovic J. The effects on disease activity and bone turn-over markers of three months treatment with alfacalcidol or pred-nisone in active rheumatoid arthritis female patients. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2017. Italy. (2017) 28  ppS303', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9258624', 'Raskina T; Koroleva M; Malyshenko O. Effect of rituximab on quality of life with rheumatoid arthritis men to baseline bone mineral density. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2017. Italy. (2017) 28  ppS449', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9258625', 'Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Pu√©chal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Hatron PY; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Pers JO; Nowak E; Saraux A. Treatment of primary Sj√∂gren syndrome with rituximab: a randomized trial. Annals of internal medicine. (2014) 160 4 pp233-242', '10.7326/m13-1085', 'https://www.acpjournals.org/doi/pdf/10.7326/M13-1085']\n",
      "['9258626', 'Caldwell JR; Germain BF; Lourie SH; McLaughlin GE; Poiley JE; Vreede PD; Wilson CH. Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study. Journal of rheumatology. (1988) 15 10 pp1476-1479', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9258627', 'Cleland LG; French JK; Betts WH; Murphy GA; Elliott MJ. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. Journal of rheumatology. (1988) 15 10 pp1471-1475', '10.1016/s0950-3579(88)80012-8', '']\n",
      "['9258628', 'Angulo DL; Colwell CWJr. Use of postoperative TENS and continuous passive motion following total knee replacement. J ORTHOP SPORT PHYS THER. (1990) 11 12 pp599-604', '10.2519/jospt.1990.11.12.599', '']\n",
      "['9258629', 'Noble BA; Loh RS; MacLennan S; Pesudovs K; Reynolds A; Bridges LR; Burr J; Stewart O; Quereshi S. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. British journal of ophthalmology. (2004) 88 5 pp647-652', '10.1136/bjo.2003.026211', '']\n",
      "['9258630', 'Lee HM; Ciancio SG; T√ºter G; Ryan ME; Komaroff E; Golub LM. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. Journal of periodontology. (2004) 75 3 pp453-463', '10.1902/jop.2004.75.3.453', '']\n",
      "['9258632', 'Liu J; Li H; Chen X. [Effects of traditional Chinese medicine for invigorating spleen to resolve dampness and dredging collaterals on patients with rheumatoid arthritis and anemia]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2006) 4 4 pp348-354', '10.3736/jcim20060406', '']\n",
      "['9258633', 'Willans MJ; Wehner SE; Bourgouin J; Carter M. Double-blind study of ketoprofen capsules and enteric-coated tablets in the maintenance treatment of patients with rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1985) 38 6 pp870-879', '10.1016/s0011-393x(05)80048-7', '']\n",
      "['9258634', 'Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; Van Der Heijde D; McConnachie A; McInnes IB; Porter D. Targeting ultrasound remission in early rheumatoid arthritis: the results of the taser study, a randomised clinical trial. Annals of the rheumatic diseases. (2016) 75 6 pp1043-1050', '10.1136/annrheumdis-2015-208941', '']\n",
      "['9258636', 'Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; M√ºller P; Sch√ºtz E. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases]. Zeitschrift fuÃàr Gastroenterologie. (1988) 26 6 pp310-313', '10.3109/00365528809095946', '']\n",
      "['9258637', 'Schnitzer TJ; Yocum DE; Michalska M; Balius R; Snider ME; Hays A; Thurmond LM; Johnston JM. Subcutaneous administration of CAMPATH-1H: clinical and biological outcomes. Journal of rheumatology. (1997) 24 6 pp1031-1036', '10.1002/art.1780380903', '']\n",
      "['9258638', 'Olsen N; Halberg P; Halskov O; Bentzon MW. Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs. Annals of the rheumatic diseases. (1988) 47 12 pp995-1000', '10.1136/ard.47.12.995', '']\n",
      "['9258639', 'Williams IA; Mitchell AD; Rothman W; Tallett P; Williams K; Pitt P. Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone. Annals of the rheumatic diseases. (1988) 47 11 pp930-933', '10.1136/ard.47.11.930', '']\n",
      "['9258641', 'Lee S; Cho Y; Kim J; Kang JW; Yoon GY; Lee J-H; Jung S-Y; Kwon O; Shin K-M; Lee J-D. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial. Trials. (2018) 19 1) (no pagination pp', '10.1186/s13063-018-2849-3', 'http://link.springer.com/article/10.1186/s13063-018-2849-3/fulltext.html']\n",
      "['9258642', 'Khaw FM; Kirk LM; Morris RW; Gregg PJ. A randomised, controlled trial of cemented versus cementless press-fit condylar total knee replacement. Ten-year survival analysis. Journal of bone and joint surgery. British volume. (2002) 84 5 pp658-666', '10.1302/0301-620x.84b5.0840658', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.84B5.0840658']\n",
      "['9258643', 'Mobedi Z; Soleimani F; Rafieian M; Parvin N; Taheri E. The effect of oral royal jelly on clinical disease activity index (CDAI) and morning stiffness in patients with rheumatoid arthritis (RA); A randomized double-blind, placebo-controlled trial. Journal of Isfahan Medical School. (2013) 31  252 pp1428-1434', '10.1007/s10067-021-05670-2', 'https://link.springer.com/article/10.1007/s10067-021-05670-2/fulltext.html']\n",
      "['9258644', 'Solomon DH; Husni ME; Wolski KE; Wisniewski LM; Borer JS; Graham DY; Libby P; Lincoff AM; Luscher TF; Menon V; Yeomans ND; Wang Q; Bao W; Berger MF; Nissen SE. Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: a Randomized Clinical Trial. Arthritis and rheumatology. (2018) 70 4 pp537-546', '10.1002/art.40400', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40400']\n",
      "['9258645', 'Grant EN; Bellamy N; Fryday-Field K; Disney T; Driedger A; Hobby K. Double-blind randomized controlled trial and six-year open follow-up of yttrium-90 radiosynovectomy versus triamcinolone hexacetonide in persistent rheumatoid knee synovitis. Inflammopharmacology. (1992) 1 3 pp231-238', '10.1007/bf02735372', 'http://link.springer.com/article/10.1007/BF02735372/fulltext.html']\n",
      "['9258646', 'Jones MC; Hunter JA. A pilot study of terfenadine as adjunctive therapy in rheumatoid arthritis. British journal of clinical practice. (1988) 42 6 pp235-237', '10.1111/j.1742-1241.1988.tb08567.x', '']\n",
      "['9258647', 'Yamamoto S; Mitomo T; Saito T; Inoue K; Uchida S; Namiki O; Murasawa A; Suzuki A; Mitsui T; Takasugi K; Matsuda T; Shibuya T. Randomized comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin. JPN J RHEUMATOL. (1992) 4 1 pp33-53', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9258648', 'Rasch LA; van Tuyl LH; Lems WF; Boers M. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis. Neuroimmunomodulation. (2015) 22 1-2 pp51-56', '10.1159/000362728', 'https://www.karger.com/Article/Pdf/362728']\n",
      "['9258649', 'Jacobs JW; Bijlsma JW; van Laar JM. Glucocorticoids in early rheumatoid arthritis: are the benefits of joint-sparing effects offset by the adverse effect of osteoporosis? the effects on bone in the utrecht study and the CAMERA-II study. Neuroimmunomodulation. (2015) 22 1-2 pp66-71', '10.1159/000362729', 'https://www.karger.com/Article/Pdf/362729']\n",
      "['9258651', 'Cavelti-Weder C; Timper K; Seelig E; Keller C; Osranek M; Lssing U; Spohn G; Maurer P; Muller P; Jennings GT; Willers J; Saudan P; Donath MY; Bachmann MF. Development of an interleukin-1beta vaccine in patients with type 2 diabetes. Molecular therapy. (2016) 24 5 pp1003-1012', '10.1038/mt.2015.227', '']\n",
      "['9258652', 'Antognetti R. Activity of flunoxaprofen in rheumatoid arthritis: A double blind study versus naproxen. Archivio di medicina interna. (1988) 39 3 pp187-196', '10.1185/03007998709108963', '']\n",
      "['9258653', 'Guti√©rrez MA; Garc√≠a ME; Rodriguez JA; Mardonez G; Jacobelli S; Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. Journal of rheumatology. (1999) 26 2 pp277-281', '10.1111/j.1479-8077.2007.00271.x', '']\n",
      "['9258654', 'Emery P; Hammoudeh M; FitzGerald O; Combe B; Martin-Mola E; Buch MH; Krogulec M; Williams T; Gaylord S; Pedersen R; Bukowski J; Vlahos B. Sustained remission with etanercept tapering in early rheumatoid arthritis. New England journal of medicine. (2014) 371 19 pp1781-1792', '10.1056/nejmoa1316133', '']\n",
      "['9258655', 'Kjelgaard-Petersen CF; Platt A; Braddock M; Jenkins MA; Musa K; Graham E; Gantzel T; Slynn G; Weinblatt ME; Karsdal MA; Thudium CS; Bay-Jensen A-C. Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis. Arthritis and rheumatology. (2018) 70 9 pp1419-1428', '10.1002/art.40527', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40527']\n",
      "['9258657', 'Lorenz HM; Antoni C; Valerius T; Repp R; Gr√ºnke M; Schwerdtner N; N√ºsslein H; Woody J; Kalden JR; Manger B. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. Journal of immunology (Baltimore, Md. : 1950). (1996) 156 4 pp1646-1653', '10.4049/jimmunol.156.4.1646', 'https://journals.aai.org/jimmunol/article-pdf/156/4/1646/1071963/1646.pdf']\n",
      "['9258658', \"Winblad B; Kilander L; Eriksson S; Minthon L; B√•tsman S; Wetterholm AL; Jansson-Blixt C; Haglund A; Severe Alzheimer's Disease Study Group. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet (London, England). (2006) 367 9516 pp1057-1065\", '10.1016/s0140-6736(06)68350-5', '']\n",
      "['9258659', 'Ikonomidis I; Tzortzis S; Andreadou I; Paraskevaidis I; Katseli C; Katsimbri P; Pavlidis G; Parissis J; Kremastinos D; Anastasiou-Nana M; Lekakis J. Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circulation. Cardiovascular imaging. (2014) 7 4 pp619-628', '10.1161/circimaging.113.001193', '']\n",
      "['9258660', 'Fiszman P; Perpetuo JBR; Sidi A. Long-term study with tenoxicam in rheumatoid arthritis. European journal of rheumatology and inflammation. (1987) 9 1-2 pp86-90', '10.3109/03009748909103716', '']\n",
      "['9258661', 'Boston PF; Constad D. A general practice study of flurbiprofen sustained-release. British journal of clinical practice. (1988) 42 1 SUPPL. pp3-8', '10.1111/j.1742-1241.1988.tb08506.x', '']\n",
      "['9258662', 'Liu J; Cao Y; Huang C; Wang Y; Chen X; Zhang W; Wang G; Fan H; Ge Y; Chen R; Zong R; Qi Y; Sun Y; Liu Y; Wang F. Use of xinfeng capsule to treat abarticular pathologic changes in patients with rheumatoid arthritis. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2014) 34 5 pp532-538', '10.1016/s0254-6272(15)30058-3', '']\n",
      "['9258663', \"Nigam DK; Agarwal R; Pandey GS; Verma AN. Efficacy and tolerability of 'Norvedan-Fentiazac' in rheumatoid arthritis: Double blind study versus ibuprofen. Clinician. (1987) 51 13 pp443-448\", '10.1185/03007997909109513', '']\n",
      "['9258664', 'Kondo H; Abe T; Hashimoto H; Uchida S; Irimajiri S; Hara M; Sugawara S. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. Journal of rheumatology. (2004) 31 2 pp243-251', '10.3109/s10165-006-0542-y', '']\n",
      "['9258665', 'Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis and rheumatism. (2002) 46 8 pp2020-2028', '10.1002/art.10427', '']\n",
      "['9258666', 'Baber N; Halliday L; Laws E; Littler T; Orme M; Sibeon R. Indomethacin in rheumatoid arthritis. Comparison of oral and rectal administration [proceedings]. British journal of clinical pharmacology. (1979) 8 4 pp383P', '10.1111/j.1365-2125.1979.tb04730.x', '']\n",
      "['9258667', 'Bjorner JB; Rose M; Gandek B; Stone AA; Junghaenel DU; Ware JE. Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. Journal of clinical epidemiology. (2014) 67 1 pp108-113', '10.1016/j.jclinepi.2013.07.016', '']\n",
      "['9258668', 'Yu X; Zhang L; Wang L; Lu W; Sun F; Xu P; Lan G. MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial. Clinical rheumatology. (2018) 37 4 pp917-925', '10.1007/s10067-017-3956-3', 'http://link.springer.com/article/10.1007/s10067-017-3956-3/fulltext.html']\n",
      "['9258669', 'Pavelka Sr K; Pavelka Jr K; Vacha J. A combination of oral and rectal therapy with nonsteroidal antirheumatics (A double blind comparison of fluorbiprofen and indometacin in the treatment of RA). Fysiatricky a Revmatologicky Vestnik. (1988) 66 3 pp159-165', '10.1016/0016-5085(95)27940-7', '']\n",
      "['9258670', 'McKnight PT; Kwoh CK. Randomized, controlled trial of compression gloves in rheumatoid arthritis. Arthritis care and research. (1992) 5 4 pp223-227', '10.1002/art.1790050407', '']\n",
      "['9258671', 'Pooja BA; Bhatted S; Bhojani MK. Role of valukasveda and vaitarana basti in the management of Amavata (Rheumatoid Arthritis). International Journal of Research in Ayurveda and Pharmacy. (2013) 4  5 pp712-714', '10.7897/2277-4343.04518', '']\n",
      "['9258672', 'Van JCHM; Van DHA. Favourable results of early second-phase antirheumatic drugs in rheumatoid arthritis.  GUNSTIGE RESULTATEN VAN VROEGE TWEEDEFASEMEDICATIE BIJ REUMATOIDE ARTRITIS. Nederlands tijdschrift voor geneeskunde. (1997) 141 15 pp732-736', '10.2143/tvg.62.3.2021429', '']\n",
      "['9258673', 'G√≥mez-Reino JJ. Long-term therapy for rheumatoid arthritis. Lancet (London, England). (1996) 347 8998 pp343-344', '10.1016/s0140-6736(96)90531-0', '']\n",
      "['9258674', 'ten Wolde S; Breedveld FC; Hermans J; Vandenbroucke JP; van de Laar MA; Markusse HM; Janssen M; van den Brink HR; Dijkmans BA. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (London, England). (1996) 347 8998 pp347-352', '10.1016/s0140-6736(96)90535-8', '']\n",
      "['9258675', 'Lussier A; Rouleau L; Caron M; T√©treault L. Comparative evaluation of carprofen and indomethacin in rheumatoid patients. International journal of clinical pharmacology, therapy, and toxicology. (1980) 18 11 pp482-487', '10.1002/j.1552-4604.1981.tb05656.x', '']\n",
      "['9258676', 'Hasegawa M; Horiki N; Tanaka K; Wakabayashi H; Tano S; Katsurahara M; Uchida A; Takei Y; Sudo A. The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group. Modern rheumatology / the Japan Rheumatism Association. (2013) 23 6 pp1172-1178', '10.1007/s10165-012-0819-2', '']\n",
      "['9258677', 'Yu LC; Rohner TJ; Kaltreider DL; Hu TW; Igou JF; Dennis PJ. Profile of urinary incontinent elderly in long-term care institutions [see comments]. Journal of the American Geriatrics Society. (1990) 38 4 pp433-439', '10.1111/j.1532-5415.1990.tb03542.x', '']\n",
      "['9258678', 'Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook RD; Kaplan MJ. The peroxisome proliferator activated receptor-Œ≥ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. Journal of the American Heart Association. (2013) 2 6 ppe000441', '10.1161/jaha.113.000441', '']\n",
      "['9258680', 'Conaghan PG; Ostergaard M; Bowes MA; Wu C; Fuerst T; Van Der Heijde D; Irazoque-Palazuelos F; Soto-Raices O; Hrycaj P; Xie Z; Zhang R; Wyman BT; Bradley JD; Soma K; Wilkinson B. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. Annals of the rheumatic diseases. (2016) 75 6 pp1024-1033', '10.1136/annrheumdis-2015-208267', '']\n",
      "['9258681', 'Foo J; Mennini F; Rodriguez Heredia JM; Choquette D; Attina G; Jimenez Merino S; Mtibaa M; Alemao E; Gaultney J. Cost per response for abatacept compared with adalimumab in the treatment of patients with rheumatoid arthritis based on anti-citrullinated protein antibody titres in Italy, Spain and Canada. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp415', '10.1136/annrheumdis-2016-eular.1995', '']\n",
      "['9258682', 'Pavelka Jr K; Pavelka Sr K; Trnavsky K. Dynamics of the analgesic effect of non-steroidal anti-inflammatory drugs - Ibuprofen-lysinsalt versus diclofenac. Fortschritte der Medizin. (1989) 107 12 pp66-72', '10.1007/978-94-009-2492-5_1', 'http://link.springer.com/content/pdf/10.1007/978-94-009-2492-5_1.pdf']\n",
      "['9258683', 'Aryaeian N; Shahram F; Djalali M; Eshragian MR; Djazayeri A; Sarrafnejad A; Salimzadeh A; Naderi N; Maryam C. Effect of conjugated linoleic acids, vitamin E and their combination on the clinical outcome of Iranian adults with active rheumatoid arthritis. International journal of rheumatic diseases. (2009) 12 1 pp20-28', '10.1111/j.1756-185x.2009.01374.x', '']\n",
      "['9258684', \"Chossat E; Paolozzi L; Delecoeuillerie G; Asch L. A double blind, randomised comparison of tiopronine versus gold salts in the treatment of rhumatoid arthritis.  ESSAI CONTROLE COMPARANT TIOPRONINE ET SELS D'OR INJECTABLES DANS LE TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE. Rhumatologie. (1992) 44 4 pp83-88\", '10.1016/s0248-8663(05)80833-1', '']\n",
      "['9258685', 'Sacerdote P; Carrabba M; Galante A; Pisati R; Manfredi B; Panerai AE. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. Inflammation research. (1995) 44 11 pp486-490', '10.1007/bf01837915', 'http://link.springer.com/article/10.1007/BF01837915/fulltext.html']\n",
      "['9258686', 'Kulkarni SG; Parikh SS; Shankhpal PD; Desai SA; Borges NE; Desai SB; Vora IM; Kalro RH. Gastric emptying of solids in long-term NSAID users: correlation with endoscopic findings and Helicobacter pylori status. American journal of gastroenterology. (1999) 94 2 pp382-386', '10.1111/j.1572-0241.1999.00863.x', '']\n",
      "['9258687', 'Conrad KJ; Budiman-Mak E; Roach KE; Hedeker D; Caraballada R; Burks D; Moore H. Impacts of foot orthoses on pain and disability in rheumatoid arthritics. Journal of clinical epidemiology. (1996) 49 1 pp1-7', '10.1016/0895-4356(96)00534-3', '']\n",
      "['9258688', 'Furst GP; Gerber LH; Smith CC; Fisher S; Shulman B. A program for improving energy conservation behaviors in adults with rheumatoid arthritis. The American journal of occupational therapy : official publication of the American Occupational Therapy Association. (1987) 41 2 pp102-111', '10.5014/ajot.41.2.102', 'https://research.aota.org/ajot/article-pdf/41/2/102/52518/102.pdf']\n",
      "['9258689', \"Fellet AJ; Scotton AS. Tenoxicam vs. diclofenac sodium 'retard' in the treatment of rheumatoid arthritis. A double blind comparative trial. Folha medica. (1989) 98 5 pp337-344\", '10.3109/03009748909103717', '']\n",
      "['9258690', 'van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis and rheumatism. (2004) 51 2 pp233-238', '10.1002/art.20251', '']\n",
      "['9258691', 'Gupta AK; Grober JS; Hamilton TA; Ellis CN; Siegel MT; Voorhees JJ; McCune WJ. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. Journal of rheumatology. (1995) 22 5 pp894-898', '10.1007/s00296-002-0278-8', 'http://link.springer.com/article/10.1007/s00296-002-0278-8/fulltext.html']\n",
      "['9258692', \"Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Pu√©chal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J. Inefficacy of infliximab in primary Sj√∂gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj√∂gren's Syndrome (TRIPSS). Arthritis and rheumatism. (2004) 50 4 pp1270-1276\", '10.1002/art.20146', '']\n",
      "['9258693', 'Taylor PC; Steuer A; Gruber J; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; McClinton C; Maini RN. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis and rheumatism. (2004) 50 4 pp1107-1116', '10.1002/art.20123', '']\n",
      "['9258694', 'de Jong Z; Munneke M; Lems WF; Zwinderman AH; Kroon HM; Pauwels EK; Jansen A; Ronday KH; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM. Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. Arthritis and rheumatism. (2004) 50 4 pp1066-1076', '10.1002/art.20117', '']\n",
      "['9258697', 'Abdullaeva GK; Shakimova Sh B. Assessment of the efficacy of rheumatoid arthritis therapy with drugs of local use. Revmatologiia (Moscow, Russia). (1989) 4  pp35-39', '10.35465/27.3.2019.pp77-94', '']\n",
      "['9258698', 'Sartini S; Zuffa F; Menarini C. Evaluation of tolerance and effectiveness of movens suppositories (meclofenamic acid) in the treatment of patients with rheumatoid arthritis in the acute phase. Controlled double blind clinical study. Gazzetta medica italiana. (1989) 148 5 pp141-151', '10.4172/1745-7580.1000087', '']\n",
      "['9258699', 'Fulton AS; Hill AM; Williams MT; Howe PR; Frith PA; Wood LG; Garg ML; Coates AM. Feasibility of œâ-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. Trials. (2013) 14  pp107', '10.1186/1745-6215-14-107', 'https://link.springer.com/content/pdf/10.1186/1745-6215-14-107.pdf']\n",
      "['9258701', 'Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis and rheumatism. (1999) 42 2 pp357-365', '10.1002/1529-0131(199902)42:2<357::aid-anr19>3.0.co;2-j', '']\n",
      "['9258702', 'Seca S; Kirch S; Cabrita AS; Greten HJ. Evaluation of the effect of acupuncture on hand pain, functional deficits and health-related quality of life in patients with rheumatoid arthritis--a study protocol for a multicenter, double-blind, randomized clinical trial. Journal of integrative medicine. (2016) 14 3 pp219-227', '10.1016/s2095-4964(16)60254-6', '']\n",
      "['9258703', 'Gianfranceschi P; Fasani G; Speciani AF. Rheumatoid arthritis and the drop in tolerance to foods: elimination diets and the reestablishment of tolerance by low-dose diluted food. Annals of the New York Academy of Sciences. (1996) 778  pp379-381', '10.1111/j.1749-6632.1996.tb21149.x', '']\n",
      "['9258706', 'Mavrikakis ME; McLeod M; Hernandez LA; et al. Comparison of benorylate tablets with ibuprofen in rheumatoid arthritis. Pharmatherapeutica. (1977) 1 9 pp621-624', '10.1093/rheumatology/14.2.76', 'http://academic.oup.com/rheumatology/article-pdf/14/2/76/5026006/14-2-76.pdf']\n",
      "['9258707', 'Kean WF; Kraag GR; Rooney PJ; Capell HA. Clinical therapeutic trial of aspirin and azapropazone in rheumatoid arthritis when prescribed singly and in combination. Current medical research and opinion. (1981) 7 3 pp164-167', '10.1185/03007998109114257', '']\n",
      "['9258708', 'Paul S; Lohani KH; Sattar A; Barua A; Alam S; Khabir K; Chy AY; Siddique AN; Dutta AK. Efficacy of antioxidant vitamins (A, C, E) in combination with methotrexate versus methotrexate alone in the treatment of rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp186', '10.23954/osj.v3i1.1359', 'https://osjournal.org/ojs/index.php/OSJ/article/viewFile/1359/116']\n",
      "['9258709', 'Zwikker HE; van den Ende CH; van Lankveld WG; den Broeder AA; van den Hoogen FH; van de Mosselaar B; van Dulmen S; van den Bemt BJ. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient education and counseling. (2014) 94 3 pp356-361', '10.1016/j.pec.2013.12.002', '']\n",
      "['9258710', 'Quartier P; Allantaz F; Cimaz R; Pillet P; Messiaen C; Bardin C; Bossuyt X; Boutten A; Bienvenu J; Duquesne A; Richer O; Chaussabel D; Mogenet A; Banchereau J; Treluyer JM; Landais P; Pascual V. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Annals of the rheumatic diseases. (2011) 70 5 pp747-754', '10.1136/ard.2010.134254', '']\n",
      "['9258713', 'Kaplan S; Kozin F. A controlled study of group counseling in rheumatoid arthritis. Journal of rheumatology. (1981) 8 1 pp91-99', '10.1080/03009748109095266', '']\n",
      "['9258715', 'Hida T; Sakai Y; Ito K; Imagama S. Collar fixation is not mandatory after cervical laminoplasty-a randomized controlled study. Spine. (2015) Conference: 43rd Annual Meeting of the Cervical Spine Research Society, CSRS 2015. United States. 2015 Supplement 2 pp288-289', '10.1097/brs.0000000000001994', '']\n",
      "['9258716', 'Mowla K; Rajai E; Ghorbani A; Dargahi-Malamir M; Bahadoram M; Mohammadi S. Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: double-Blind Randomized Controlled Trial. Journal of clinical and diagnostic research JCDR. (2016) 10 5 ppOC32-6', '10.7860/jcdr/2016/16538.7814', '']\n",
      "['9258717', 'Nordemar R; Ekblom B; Zachrisson L; Lundqvist K. Physical training in rheumatoid arthritis: a controlled long-term study. I. Scandinavian journal of rheumatology. (1981) 10 1 pp17-23', '10.1080/03009748109095265', '']\n",
      "['9258718', 'Nordemar R. Physical training in rheumatoid arthritis: A controlled long-term study. II. Functional capacity and general attitudes. Scandinavian journal of rheumatology. (1981) 10 1 pp25-30', '10.1080/03009748109095266', '']\n",
      "['9258719', 'Lund HI; Donde R; Petersen PH. A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1980) 37  pp1-6', '10.3109/03009748109095327', '']\n",
      "['9258720', 'Singer F; Bouda H; Broll H; Dunky A; Eberl R; Fasching U; Klein G; Mayrhofer F; Rainer F; Wiegmeth W; Smolen J. Efficacy and tolerability of tenoxicam versus diclofenac in rheumatoid arthritis. Results of a double-blind study. Drug Investigation. (1990) 2 SUPPL. 3 pp54-55', '10.1007/bf03258219', 'http://link.springer.com/article/10.1007/BF03258219/fulltext.html']\n",
      "['9258721', 'Gao JS; Wu H; Tian J. Treatment of patients with juvenile rheumatoid arthritis with combination of\\nleflunomide and methotrexate. Zhonghua er ke za zhi. Chinese journal of pediatrics. (2003) 41 6 pp435-438', '10.53555/etdthz08', '']\n",
      "['9258722', 'Bolten W; Ges√§nger S; Rechtziegler H; Dullenkopf B. Acemetacin and tenoxicam in symptomatic treatment of arthrosis patients. Die Medizinische Welt. (1990) 41  pp1063-1068', '10.1007/978-3-322-90669-4_1', 'http://link.springer.com/content/pdf/10.1007/978-3-322-90669-4_1.pdf']\n",
      "['9258725', \"Fasching U. [Comparison of the efficacy of diflunisal and acetylsalicylic acid in rheumatoid arthritis (author's transl)]. Wiener medizinische Wochenschrift (1946). (1981) 131 3 pp82-86\", '10.3109/03009748109095317', '']\n",
      "['9258726', 'Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. Journal of periodontology. (2013) 84 12 ppe74-84', '10.1902/jop.2013.130079', '']\n",
      "['9258728', 'Schairer H; Stoeben E; Koelle G. Preliminary results of a controlled trial of gold salts and penicillamine in treatment of juvenile rheumatoid arthritis. ZRHEUMATOL. (1976) 35 SUP. 4 pp54-56', '10.1136/ard.35.5.463', '']\n",
      "['9258729', 'Martin MFR; Dixon JS; Sitton NG; Wright V. Studies of D-penicillamine and hydroxychloroquine used in combination in the treatment of rheumatoid arthritis. J DRUG DEV. (1993) 5 4 pp207-214', '10.1002/art.1780270304', '']\n",
      "['9258730', 'Conn DL; Pan Y; Easley KA; Comeau DL; Carlone JP; Culler SD; Tiliakos A. The effect of the Arthritis Self-Management Program on outcome in African Americans with rheumatoid arthritis served by a public hospital. Clinical rheumatology. (2013) 32 1 pp49-59', '10.1007/s10067-012-2090-5', 'http://link.springer.com/article/10.1007/s10067-012-2090-5/fulltext.html']\n",
      "['9258732', 'Machold KP; Landew√© R; Smolen JS; Stamm TA; van der Heijde DM; Verpoort KN; Brickmann K; V√°zquez-Mellado J; Karateev DE; Breedveld FC; Emery P; Huizinga TW. The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Annals of the rheumatic diseases. (2010) 69 3 pp495-502', '10.1136/ard.2009.122473', '']\n",
      "['9258733', 'Eberhard BA; Sylvester KL; Ansell BM. A comparative study of orthoplast cock-up splints versus ready-made Droitwich work splints in juvenile chronic arthritis. Disability and rehabilitation. (1993) 15 1 pp41-43', '10.3109/09638289309165869', '']\n",
      "['9258734', 'Hoshi K; Mizushima Y; Shiokawa Y; Kageyama T; Honma M; Kashiwazaki S; Shichikawa K; Tsunematsu T; Kaneko K. Double-blind study with liposteroid in rheumatoid arthritis. Drugs under experimental and clinical research. (1985) 11 9 pp621-626', '10.1002/art.1780200804', '']\n",
      "['9258735', 'Dick-Smith JB. Clinical trial of ibufenac. Medical journal of Australia. (1966) 1 7 pp263-264', '10.5694/j.1326-5377.1966.tb19699.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1966.tb19699.x']\n",
      "['9258736', 'Gum OB. A controlled study of two preparations, paramethasone, propoxyphene, and aspirin and propoxyphene and aspirin in the treatment of arthritis. American journal of the medical sciences. (1966) 251 3 pp328-332', '10.1097/00000441-196603000-00012', '']\n",
      "['9258737', 'Barnardo DE; Currey HL; Mason RM; Fox WR; Weatherall M. Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. British medical journal. (1966) 2 5509 pp342-343', '10.1136/bmj.2.5509.342', '']\n",
      "['9258739', 'Donnelly P; Lloyd K; Campbell H. Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. British medical journal. (1967) 1 5532 pp69-75', '10.1136/bmj.1.5532.69', '']\n",
      "['9258740', 'Rauterberg W. [Double-blind test with indomethacin and phenylbutazone in primary chronic polyarthritis]. Die Medizinische Welt. (1966) 47  pp2581-2583', '10.1093/rheumatology/15.5.27', 'http://academic.oup.com/rheumatology/article-pdf/15/5/27/5038837/15-5-27.pdf']\n",
      "['9258741', 'Jick H; Slone D; Dinan B; Muench H. Evaluation of drug efficacy by a preference technic. New England journal of medicine. (1966) 275 25 pp1399-1403', '10.1056/nejm196612222752502', '']\n",
      "['9258742', 'Pinals RS; Frank S. Relative efficacy of indomethacin and acetylsalicylic acid in rheumatoid arthritis. New England journal of medicine. (1967) 276 9 pp512-514', '10.1056/nejm196703022760906', '']\n",
      "['9258743', 'Sydnes OA. Controlled clinical trial of flufenamic acid in rheumatoid arthritis. Acta rheumatologica Scandinavica. (1967) 13 1 pp55-62', '10.3109/rhe1.1967.13.issue-1-4.06', '']\n",
      "['9258744', 'Thune S. Comparison of phenyl- and monophenylbutazone (Mobutazon), especially in respect to the incidence of side effects. A double-blind study. Acta rheumatologica Scandinavica. (1967) 13 1 pp63-80', '10.3109/rhe1.1967.13.issue-1-4.07', '']\n",
      "['9258745', 'Besser GM; Butler PW; Plumpton FS. Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. British medical journal. (1967) 4 5576 pp391-394', '10.1136/bmj.4.5576.391', '']\n",
      "['9258746', 'Myles AB; Bacon PA; Williams KA. Mefenamic acid in rheumatoid arthritis. Annals of the rheumatic diseases. (1967) 26 6 pp494-498', '10.1136/ard.26.6.494', '']\n",
      "['9258747', 'Nelson JK; Neill DW; Montgomery DA; MacKay JS; Sheridan B; Weaver JA. Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients. British medical journal. (1968) 1 5591 pp557-558', '10.1136/bmj.1.5591.557', '']\n",
      "['9258748', 'Kater RM. Double-blind evaluation of the analgesic and toxic effects of flufenamic acid and mefenamic acid in patients with chronic pain. Medical journal of Australia. (1968) 1 20 pp848-851', '10.5694/j.1326-5377.1968.tb28958.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1968.tb28958.x']\n",
      "['9258749', 'Gotoff SP; McCue SA; Wendell PW. Sustained-release aspirin in children. Journal of pediatrics. (1968) 73 1 pp127-131', '10.1016/s0022-3476(68)80051-4', '']\n",
      "['9258750', 'Kersley GD. Phenformin (Dibotin) in polyarthritis. Annals of the rheumatic diseases. (1968) 27 4 pp374-376', '10.1136/ard.27.4.374', '']\n",
      "['9258751', 'Graudal H. [Parameters of arthritis activity in double-blind studies on pollen therapy in rheumatoid arthritis]. Zeitschrift fuÃàr Rheumaforschung. (1968) 27 5 pp186-192', '10.1002/acr.22618', '']\n",
      "['9258752', 'Kirk JA; Kersley GD. Heat and cold in the physical treatment of rheumatoid arthritis of the knee. A controlled clinical trial. Annals of physical medicine. (1968) 9 7 pp270-274', '10.1093/rheumatology/9.7.270', 'http://academic.oup.com/rheumatology/article-pdf/9/7/270/5210964/9-7-270.pdf']\n",
      "['9258753', 'Katz S; Vignos PJ; Moskowitz RW; Thompson HM; Svec KH. Comprehensive outpatient care in rheumatoid arthritis. A controlled study. JAMA. (1968) 206 6 pp1249-1254', '10.1001/jama.1968.03150060023004', '']\n",
      "['9258754', 'Downie WW; Whaley K; Wright MA; Bell MA; Taylor AK. Comparison of the adrenocorticotrophic activities of two synthetic polypeptides: synacthen and DW 75. British medical journal. (1968) 4 5629 pp487-489', '10.1136/bmj.4.5629.487', '']\n",
      "['9258756', 'Maxson TR; Compton EL. Controlled study of a new antiarthritic substance. Annals of allergy. (1969) 27 2 pp54-64', '10.1016/s1081-1206(10)62418-0', '']\n",
      "['9258757', 'Ingpen ML. A controlled clinical trial of sustained-action dextropropoxyphene hydrochloride. British journal of clinical practice. (1969) 23 3 pp113-115', '10.1111/j.1742-1241.1969.tb03223.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-1241.1969.tb03223.x']\n",
      "['9258758', 'Wright V; Walker WC; McGuire RJ. Indomethacin in the treatment of rheumatoid arthritis. A controlled trial comparing indomethacin, phenylbutazone, and placebo. Annals of the rheumatic diseases. (1969) 28 2 pp157-162', '10.1136/ard.28.2.157', '']\n",
      "['9258759', 'Dick WC; Cunningham GM; Nuki G; Jasani MK; Whaley K. Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Annals of the rheumatic diseases. (1969) 28 2 pp187-190', '10.1136/ard.28.2.187', '']\n",
      "['9258760', 'Joyce CR; Caple G; Mason M; Reynolds E; Mathews JA. Quantitative study of doctor-patient communication. Quarterly journal of medicine. (1969) 38 150 pp183-194', '10.1093/oxfordjournals.qjmed.a067175', 'http://academic.oup.com/qjmed/article-pdf/38/2/183/4510748/38-2-183.pdf']\n",
      "['9258761', \"D'Ingianna E. [Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations)]. Reumatismo. (1967) 19 3 pp180-182\", '10.4081/reumatismo.2002.238', '']\n",
      "['9258763', 'Nyfos L; Lunding NC. Clinical test of Kebuzon versus phenylbutazone in rheumatoid arthritis. Acta rheumatologica Scandinavica. (1968) 14 2 pp148-160', '10.3109/rhe1.1968.14.issue-1-4.17', '']\n",
      "['9258764', 'Mathies H; Eichhorn M. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study]. Medizinische Monatsschrift. (1967) 21 11 pp510-516', '10.5694/j.1326-5377.1968.tb28958.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1968.tb28958.x']\n",
      "['9258765', 'Scott WA. The relief of pain with an antidepressant in arthritis. Practitioner. (1969) 202 212 pp802-807', '10.4172/2167-0846.c1.006', '']\n",
      "['9258766', 'Bain LS; Masheter HC. Flufenamic acid and indomethacin in rheumatoid arthritis. Annals of physical medicine. (1966) Suppl  pp104-108', '10.1093/rheumatology/viii.suppl_1.104', 'http://academic.oup.com/rheumatology/article-pdf/VIII/suppl_1/104/5384876/VIII-suppl_1-104.pdf']\n",
      "['9258767', 'Sydnes OA. A controlled clinical trial of flufenamic acid in rheumatoid arthritis. Annals of physical medicine. (1966) Suppl  pp93-98', '10.1093/rheumatology/viii.suppl_1.93', 'http://academic.oup.com/rheumatology/article-pdf/VIII/suppl_1/93/5385137/VIII-suppl_1-93.pdf']\n",
      "['9258768', 'Cardoe N. A clinical trial of flufenamic acid in the treatment of rheumatoid arthritis. Annals of physical medicine. (1966) Suppl  pp99-103', '10.1093/rheumatology/viii.suppl_1.99', 'http://academic.oup.com/rheumatology/article-pdf/VIII/suppl_1/99/5385148/VIII-suppl_1-99.pdf']\n",
      "['9258769', 'Dick C; Dick PH; Nuki G; Whaley K; Boyle JA; Shenkin A; Downie WW; Buchanan WW. Effect of anti-inflammatory drug therapy on clearance of 133-Xe from knee joints of patients with rheumatoid arthritis. British medical journal. (1969) 3 5665 pp278-280', '10.1136/bmj.3.5665.278', '']\n",
      "['9258770', 'Herman JH; Jasin HE; Smiley JD; Ziff M. Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis and rheumatism. (1969) 12 5 pp515-519', '10.1002/art.1780120508', '']\n",
      "['9258771', 'Dick-Smith JB. Ibuprofen, aspirin and placebo in the treatment of rheumatoid arthritis--a double-blind clinical trial. Medical journal of Australia. (1969) 2 17 pp853-859', '10.5694/j.1326-5377.1969.tb107460.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1969.tb107460.x']\n",
      "['9258772', 'Chalmers TM; Kellgren JH; Platt DS. Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1969) 28 6 pp595-601', '10.1136/ard.28.6.595', '']\n",
      "['9258773', 'Lindsay DJ; Ring EF; Coorey PF; Jayson MI. Joint irrigation in rheumatoid arthritis: a controlled trial. Annals of the rheumatic diseases. (1969) 28 6 pp679-680', '10.1136/ard.28.6.679', '']\n",
      "['9258774', 'Woodbury JF; Turner WA; Tiongson R. Rheumatoid arthritis: comparison of treatment with monophenylbutazone and phenylbutazone. Canadian Medical Association journal. (1969) 101 13 pp69-71', '10.1001/jama.1952.02930250011004', '']\n",
      "['9258775', 'Corbett M; Seifert MH; Hacking C; Webb S. Comparison between local injections of silicone oil and hydrocortisone acetate in chronic arthritis. British medical journal. (1970) 1 5687 pp24-25', '10.1136/bmj.1.5687.24', '']\n",
      "['9258776', 'Santamar√≠a A; Serra Peralba A; Barcel√≥ P; Asensi E; Salvador F. [Comparison of the effectiveness of the double blind test and the tolerance of phenylbutazone and indomethacin in a series of patients with chronic progressive polyarthritis]. Revista espanÃÉola de reumatismo y enfermedades osteoarticulares. (1968) 12 5 pp283-287', '10.17235/reed.2020.7449/2020', '']\n",
      "['9258777', 'Pavelka K; Wagenhauser F. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin. Current therapeutic research, clinical and experimental. (1970) 12 2 pp69-72', '10.1016/s0011-393x(05)80239-5', '']\n",
      "['9258778', 'Vignon G; Boissel JP; Cibert M. [Comparative double-blind trial of 16091 RP and indomethacin in chronic polyarthritis]. Revue du rhumatisme et des maladies osteÃÅo-articulaires. (1969) 36 12 pp715-723', '10.1016/j.rhum.2016.06.005', '']\n",
      "['9258779', 'Lambotte F. Therapeutic activity of 4-allyloxy-3-chlorophenylacetic acid. Arzneimittel-Forschung. (1970) 20 4 pp569-571', '10.1016/s0021-9673(01)96820-7', '']\n",
      "['9258780', 'Balbi L. [Double-blind studies of the antipyretic activity of mephenamic acid as compared with that of amidopyrine and a placebo]. Minerva medica. (1970) 61 50 pp2787-2791', '10.51415/10321/1413', '']\n",
      "['9258781', 'Calabro JJ; Paulus HE. Anti-inflammatory effect of acetylsalicylic acid in rheumatoid arthritis. Clinical orthopaedics and related research. (1970) 71  pp124-131', '10.1097/00003086-197007000-00016', '']\n",
      "['9258782', 'Decker JL; Mainland D. Assessment of drug efficacy in rheumatoid arthritis. New England journal of medicine. (1970) 283 17 pp928-929', '10.1056/nejm197010222831709', '']\n",
      "['9258783', 'Rushford WA; Fowler PD. Assessment of enteric-coated phenylbutazone in general practice. Practitioner. (1970) 205 229 pp671-676', '10.1177/030006057700502s13', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700502S13']\n",
      "['9258784', 'White JR; Sage JN. Effects of a counterirritant on muscular distress in patients with arthritis. Physical therapy. (1971) 51 1 pp36-42', '10.1093/ptj/51.1.36', 'http://academic.oup.com/ptj/article-pdf/51/1/36/22718627/ptj0036.pdf']\n",
      "['9258785', 'Lewis-Faning E; Fowler PD. Drug treatment of rheumatic disorders in general practice. A comparative study of aspirin and an alkali-phenylbutazone preparation. British journal of clinical practice. (1971) 25 3 pp123-129', '10.1111/j.1742-1241.1971.tb09282.x', '']\n",
      "['9258786', \"Nyfos L. Controlled clinical trial of 1-(2'-methyl-2'-dimethyl amino-ethyl)-3-phenyl indole HCl (A28A) in rheumatoid arthritis compared with indomethacin (Confortid). Acta rheumatologica Scandinavica. (1971) 17 2 pp115-124\", '10.3109/rhe1.1971.17.issue-1-4.17', '']\n",
      "['9258787', 'McGuire RJ; Wright V. A statistical approach to indices of disease activity in rheumatoid arthritis with reference to a trial of indomethacin. Proceedings of the Royal Society of Medicine. (1971) 64 6 pp658', '10.1177/003591577106400632', 'http://journals.sagepub.com/doi/pdf/10.1177/003591577106400632']\n",
      "['9258788', 'Bridgman JF; Bruckner F; Bleehen NM. Radioactive yttrium in the treatment of rheumatoid knee effusions. Preliminary evaluation. Annals of the rheumatic diseases. (1971) 30 2 pp180-182', '10.1136/ard.30.2.180', '']\n",
      "['9258789', 'Nicolle FV; Holt PJ; Calnan JS. Prophylactic synovectomy of the joints of the rheumatoid hand. Clinical trial with 4 to 8-year follow-up. Annals of the rheumatic diseases. (1971) 30 5 pp476-480', '10.1136/ard.30.5.476', '']\n",
      "['9258790', 'Skinner M; Cathcart ES; Mills JA; Pinals RS. Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study. Arthritis and rheumatism. (1971) 14 6 pp727-732', '10.1002/art.1780140607', '']\n",
      "['9258791', 'Brooks CD; Schmid FR; Biundo J; Blau S; Gonzalez-Alcover R; Gowans JD; Hurd E; Partridge RE; Tarpley EL. Ibuprofen and aspirin in the treatment of rheumatoid arthritis. A cooperative double-blind trial. Rheumatology and physical medicine. (1970) 10  ppSuppl 10:48-63', '10.1093/rheumatology/x.suppl_1.48', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/48/24422033/10-suppl_1-48.pdf']\n",
      "['9258792', 'Hingorani K. Double-blind crossover trial comparing ibuprofen with flufenamic acid in rheumatoid arthritis. Rheumatology and physical medicine. (1970) 10  ppSuppl 10:76-82', '10.1093/rheumatology/x.suppl_1.76', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/76/24422041/10-suppl_1-76.pdf']\n",
      "['9258793', 'Franke M; Manz G. Benorylate and indomethacin in the treatment of rheumatoid disease: a double-blind clinical trial. Current therapeutic research, clinical and experimental. (1972) 14 3 pp113-122', '10.1177/030006057400200111', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057400200111']\n",
      "['9258794', 'Pavelka K; Vojt√≠sek O; Br√©mov√° A; H√°ndlov√° D; Kankov√° D; Kr√°lov√° M. [Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too]. CasopiÃÅs leÃÅkarÃÜuÃä cÃÜeskyÃÅch. (1972) 111 22 pp514-517', '10.1093/rheumatology/12.2.68', 'http://academic.oup.com/rheumatology/article-pdf/12/2/68/5039206/12-2-68.pdf']\n",
      "['9258795', 'Phillips J; Rogerson R. A double-blind comparative trial of aspirin preparation and ibuprofen in general practice. British journal of clinical practice. (1972) 26 3 pp113-115', '10.1111/j.1742-1241.1972.tb04392.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-1241.1972.tb04392.x']\n",
      "['9258796', 'Mikkelsen OA. Tanderil in surgery of rheumatic diseases. A double blind trial at dorsal synovectomy of the wrist joint. Acta chirurgica Scandinavica. (1972) 138 6 pp576-580', '10.3109/17453676608989414', '']\n",
      "['9258797', 'Anylward M; Davies DB. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders. British journal of clinical practice. (1972) 26 11 pp517-523', '10.1111/j.1742-1241.1972.tb05065.x', '']\n",
      "['9258798', 'Gyory AN; Bloch M; Burry HC; Grahame R. Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin. British medical journal. (1972) 4 5837 pp398-400', '10.1136/bmj.4.5837.398', '']\n",
      "['9258799', 'Bain LS; Balch HW; Wetherly JM; Yeadon A. Intraarticular triamcinolone hexacetonide: double-blind comparison with methylprednisolone. British journal of clinical practice. (1972) 26 12 pp559-561', '10.1111/j.1742-1241.1972.tb05075.x', '']\n",
      "['9258800', 'Cathcart BJ; Vince JD; Gordon AJ; Bell MA; Chalmers IM. Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes. Annals of the rheumatic diseases. (1973) 32 1 pp62-65', '10.1136/ard.32.1.62', '']\n",
      "['9258801', 'Vince JD; Kremer D. Double-blind trial of diazepam in rheumatoid arthritis. Practitioner. (1973) 210 256 pp264-267', '10.1136/ard.32.1.62', '']\n",
      "['9258802', 'Curtis JE; Sharp JT; Lidsky MD; Hersh EM. Immune response of patients with rheumatoid arthritis during cyclophosphamide treatment. Arthritis and rheumatism. (1973) 16 1 pp34-42', '10.1002/art.1780160106', '']\n",
      "['9258803', 'Sperryn PN; Hamilton EB; Parsons V. Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis. Annals of the rheumatic diseases. (1973) 32 2 pp157-161', '10.1136/ard.32.2.157', '']\n",
      "['9258804', 'Huskisson EC; Berry H; Browett JP; Balme HW. Measurement of inflammation. II. Comparison of technetium clearance and thermography with standard methods in a clinical trial. Annals of the rheumatic diseases. (1973) 32 2 pp99-102', '10.1136/ard.32.2.99', '']\n",
      "['9258805', 'De Salcedo I; Carrington MD; Santos JA; Silva JL. A clinical and laboratory study of some metabolic and hormonal effects of CI-583 Na compared with CI-440 and indomethacin in patients with rheumatoid arthritis. Hormones. (1970) 1 4 pp193-208', '10.1159/000178181', 'https://www.karger.com/Article/Pdf/178181']\n",
      "['9258806', 'Lussier A; Segre EJ; Multz CV; MacCannell K; Alexander SJ; Howard DL; Boost G; Varady J; Strauss W. Naproxen: a novel approach to dose-finding efficacy trails in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1973) 14 3 pp434-441', '10.1002/cpt1973143434', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1973143434']\n",
      "['9258807', 'Evans DP; Lees LJ. Trial design for assessing initiation of anti-inflammatory therapy. Scandinavian journal of rheumatology. (1972) 1 1 pp9-14', '10.3109/03009747209102986', '']\n",
      "['9258808', 'Kajander A; Laine V; Gothoni G. Effect of tolfenamic acid in rheumatoid arthritis. Scandinavian journal of rheumatology. (1972) 1 2 pp91-93', '10.3109/03009747209103003', '']\n",
      "['9258809', 'Lussier A; Regoli D; Gysling E; Boost G; Varady JC. Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritis. International journal of clinical pharmacology, therapy and toxicology. (1973) 7 1 pp6-12', '10.1002/cpt1973143434', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1973143434']\n",
      "['9258810', 'Urowitz MB; Gordon DA; Smythe HA; Pruzanski W; Ogryzio MA. Azathioprine in rheumatoid arthritis. A double-blind, cross over study. Arthritis and rheumatism. (1973) 16 3 pp411-418', '10.1002/art.1780160319', '']\n",
      "['9258811', 'Ward JR; Klauber M; Gleichert JE; Willkens RF; Rotstein J; Katz WA; Pierce WE. A controlled multicenter trial of 2,3-dihydro-1-H-pyridino (2,3-b)(1,4)-thiazine-2-one in rheumatoid arthritis. Journal of clinical pharmacology. (1973) 13 5 pp218-225', '10.1002/j.1552-4604.1973.tb00211.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/j.1552-4604.1973.tb00211.x']\n",
      "['9258812', 'Shiokawa Y; Matsumoto J. [Clinical test of B64114 for rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1972) 12 3 pp283-290', '10.1002/art.1780200804', '']\n",
      "['9258813', 'Ridolfo AS; Mikulaschek WM; Gruber CM; Scholz NE. Screening rapidly acting anti-inflammatory agents in patients with rheumatoid arthritis. American journal of the medical sciences. (1973) 265 5 pp375-379', '10.1097/00000441-197305000-00004', '']\n",
      "['9258814', 'Shiokawa Y; Honma M; Irimajiri S. [Results of the controlled experiment of new anti-inflammatory agent, Clonixin, in chronic rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1973) 12 4 pp366-372', '10.1002/art.1780200804', '']\n",
      "['9258815', 'Shiokawa Y; Yamamoto M; Onoda T. [Effectiveness of 16091 R.P.(metiazinic acid) in rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1973) 12 4 pp373-393', '10.1002/art.1780160322', '']\n",
      "['9258816', 'Lidsky MD; Sharp JT; Billings S. Double-blind study of cyclophosphamide in rheumatoid arthritis. Arthritis and rheumatism. (1973) 16 2 pp148-153', '10.1002/art.1780160203', '']\n",
      "['9258817', 'Aylward M; Maddock J. Plasma-tryptophan levels in depression. Lancet (London, England). (1973) 1 7809 pp936', '10.1016/s0140-6736(73)91389-5', '']\n",
      "['9258818', 'Pavelka K; Vojt√≠sek O; Br√©mov√° A; Kankov√° D; H√°ndlov√° D. [Comparison of alclofenac and phenylbutazone effects in short-term therapy of chronic arthritis (double-blind test)]. FysiatrickyÃÅ a reumatologickyÃÅ vestniÃÅk. (1973) 51 4 pp212-219', '10.1185/03007997309111691', '']\n",
      "['9258819', 'Porro A. [Antipyretic activity of mefenamic acid. Double-blind clinical studies in comparison with amidopyrine and a placebo]. Minerva medica. (1971) 62 79 pp3786-3790', '10.1080/09513590.2019.1590544', '']\n",
      "['9258820', 'White JR. Effects of a counterirritant on perceived pain and hand movement in patients with arthritis. Physical therapy. (1973) 53 9 pp956-960', '10.1093/ptj/53.9.956', 'http://academic.oup.com/ptj/article-pdf/53/9/956/22704277/ptj0956.pdf']\n",
      "['9258821', 'Pavelka K; Susta A; Vojt√≠sek O; Br√©mov√° A; Kankov√° D; H√°ndlov√° D; Malecek J. Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis. Arzneimittel-Forschung. (1973) 23 6 pp842-846', '10.1093/rheumatology/12.2.68', 'http://academic.oup.com/rheumatology/article-pdf/12/2/68/5039206/12-2-68.pdf']\n",
      "['9258822', 'Golding JR; Andrews FM; Camp V; Day AT; Freeman AM; Golding DN; Hill AG; Lyle WH; Mowat AG. Controlled trial of penicillamine in severe rheumatoid arthritis. Annals of the rheumatic diseases. (1973) 32 4 pp385-386', '10.1136/ard.32.4.385', '']\n",
      "['9258823', 'Colombo B; Ch√©ri√© Ligni√©re G; Carrabba M. [Results of a controlled clinical double blind study between isobutylphenylpropionic acid and indomethacin]. Minerva medica. (1973) 64 48 pp2522-2526', '10.1186/isrctn88583133', '']\n",
      "['9258824', 'Giacovazzo M; Paoluzi P; Pallone F; Spagna G. [Double-blind clinical experiences with a new anti-rheumatic drug: ibuprofen. Gastroscopic and gastrobioptic study of cases of drug intolerance]. Minerva medica. (1973) 64 48 pp2558-2560', '10.2165/00044011-199600111-00008', '']\n",
      "['9258825', 'Aylward M. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects. British journal of clinical practice. (1973) 27 7 pp255-260', '10.1111/j.1742-1241.1973.tb09038.x', '']\n",
      "['9258826', 'Shiokawa Y; Kageyama T; Sakuma A. [Clinical evaluation of mepirizole (DA-398) in the treatment of chronic rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1973) 13 2 pp206-220', '10.1002/art.1780200804', '']\n",
      "['9258827', 'Lee P; Webb J; Anderson J; Buchanan WW. Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. British medical journal. (1973) 2 5868 pp685-688', '10.1136/bmj.2.5868.685', '']\n",
      "['9258828', 'Zutshi DW; Marr S; Bloch M; Mason RM. Double-blind cross-over study of Orudis and placebo in fifty patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1973) 12 2 pp62-67', '10.1093/rheumatology/12.2.62', 'http://academic.oup.com/rheumatology/article-pdf/12/2/62/5039159/12-2-62.pdf']\n",
      "['9258829', 'Pavelka K; Susta A; Vojt√≠sek O; Bremov√° A; Kankov√° D; H√°ndlov√° D; Malecek J. Double-blind comparison of ibuprofen and phenylbutazone in the short-term treatment of rheumatoid arthritis. Rheumatology and rehabilitation. (1973) 12 2 pp68-73', '10.1093/rheumatology/12.2.68', 'http://academic.oup.com/rheumatology/article-pdf/12/2/68/5039206/12-2-68.pdf']\n",
      "['9258830', 'Fries JF; Britton MC. Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation. Arthritis and rheumatism. (1973) 16 5 pp629-634', '10.1002/art.1780160507', '']\n",
      "['9258831', 'Mills SB; Bloch M; Bruckner FE. Double-blind cross-over study of ketoprofen and ibuprofen in management of rheumatoid arthritis. British medical journal. (1973) 4 5884 pp82-84', '10.1136/bmj.4.5884.82', '']\n",
      "['9258832', 'Goebel KM; Storck U; Neurath F. Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet (London, England). (1981) 1 8228 pp1015-1017', '10.1016/s0140-6736(81)92185-1', '']\n",
      "['9258833', 'Huskisson EC; Scott J; Bryans R. Seatone is ineffective in rheumatoid arthritis. British medical journal (Clinical research ed.). (1981) 282 6273 pp1358-1359', '10.1136/bmj.282.6273.1358', '']\n",
      "['9258834', 'Gowans JD. Six-month, double-blind comparison of sodium meclofenamate (\"Meclomen\\') with buffered aspirin in the treatment of rheumatoid arthritis. Current medical research and opinion. (1981) 7 6 pp384-391', '10.1185/03007997509114781', '']\n",
      "['9258835', 'Meyers OL; Klemp P. An oral formulation of gold for the treatment of rheumatoid arthritis. South African medical journal. (1981) 59 27 pp969-971', '10.1080/20786204.2009.10873866', '']\n",
      "['9258836', 'Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R. Sustained release indomethacin: a double blind comparison with indomethacin suppositories. New Zealand medical journal. (1981) 93 682 pp261-262', '10.1177/030006058100900612', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058100900612']\n",
      "['9258837', 'Karsh J; Klippel JH; Plotz PH; Decker JL; Wright DG; Flye MW. Lymphapheresis in rheumatoid arthritis. A randomized trial. Arthritis and rheumatism. (1981) 24 7 pp867-873', '10.1002/art.1780240701', '']\n",
      "['9258838', 'Finstad R. A double-blind, crossover, multicentre study of piroxicam and indomethacin in the treatment of rheumatoid arthritis. British journal of clinical practice. (1981) 35 1 pp35-39', '10.1111/j.1742-1241.1981.tb08214.x', '']\n",
      "['9258839', 'Dequeker J; Mardjuardi A. Treatment of rheumatoid arthritis with flurbiprofen: a comparison with enteric-coated aspirin. Current medical research and opinion. (1981) 7 7 pp418-422', '10.1185/03007998109114278', '']\n",
      "['9258840', 'Huskisson EC; Engler C. A single-dose analgesic study of naproxen sodium and soluble aspirin in patients with rheumatoid arthritis. Current medical research and opinion. (1981) 7 7 pp471-474', '10.1185/03007998109114286', '']\n",
      "['9258841', 'Kagan G; Huddlestone L; Wolstencroft P. Flufenamic acid and placebo compared in rheumatoid arthritis and osteoarthritis. Journal of international medical research. (1981) 9 4 pp253-256', '10.1177/030006058100900403', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058100900403']\n",
      "['9258842', 'Kowanko IC; Pownall R; Knapp MS; Swannell AJ; Mahoney PG. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. British journal of clinical pharmacology. (1981) 11 5 pp477-484', '10.1111/j.1365-2125.1981.tb01153.x', '']\n",
      "['9258843', 'Palmer DG; Ferry DG; Gibbins BL; Hall SM; Grennan DM; Lum J; Myers DB. Ibuprofen and diflunisal in rheumatoid arthritis: a double-blind comparative trial. New Zealand medical journal. (1981) 94 688 pp45-47', '10.1185/03007998309112388', '']\n",
      "['9258844', 'Read PW; Fernandes L; Harris P; Henderson M; Goodwill CJ; Smith P. Dental study in patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1981) 20 2 pp108-112', '10.1093/rheumatology/20.2.108', 'http://academic.oup.com/rheumatology/article-pdf/20/2/108/5039622/20-2-108.pdf']\n",
      "['9258845', 'Bossingham DH; McQueen AK; Mowat AG. Knee function after intra-articular hydrocortisone. Rheumatology and rehabilitation. (1981) 20 2 pp98-101', '10.1093/rheumatology/20.2.98', 'http://academic.oup.com/rheumatology/article-pdf/20/2/98/5040187/20-2-98.pdf']\n",
      "['9258846', 'Wasner C; Britton MC; Kraines RG; Kaye RL; Bobrove AM; Fries JF. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. JAMA. (1981) 246 19 pp2168-2172', '10.1001/jama.1981.03320190026021', '']\n",
      "['9258847', \"Manthorpe R; Frost-Larsen K; H√∏j L; Isager H; Prause JU. Bromhexine treatment of Sj√∂gren's syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva. Scandinavian journal of rheumatology. (1981) 10 3 pp177-180\", '10.3109/03009748109095294', '']\n",
      "['9258848', 'Pavelka K; Susta A; Kankov√° D; Vojt√≠sek O. Comparison of three therapeutic regimens using nonsteroidal antirheumatic drugs in patients with rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (1981) 40 4 pp165-170', '10.1007/s00393-003-0458-2', 'http://link.springer.com/article/10.1007/s00393-003-0458-2/fulltext.html']\n",
      "['9258849', \"Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D. Clinical trial of bromhexine in Sj√∂gren's syndrome. Annals of ophthalmology. (1981) 13 8 pp971-973\", '10.1016/0002-9394(81)90650-4', '']\n",
      "['9258850', 'Clarke AK; Macleod M; Steinberg VL; Wenley WG. A double-blind, cross-over study of naproxen sodium and soluble aspirin in rheumatoid arthritis. British journal of clinical practice. (1981) 35 4 pp143-146', '10.1111/j.1742-1241.1981.tb08244.x', '']\n",
      "['9258851', 'Mowat AG; Mowat AM. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine. Journal of rheumatology. (1981) 8 4 pp575-580', '10.1093/rheumatology/16.4.223', 'http://academic.oup.com/rheumatology/article-pdf/16/4/223/5026017/16-4-223.pdf']\n",
      "['9258852', 'G√ºnther R; Herold M; Halberg E; Halberg F. Circadian placebo and ACTH effects on urinary cortisol in arthritics. Peptides. (1980) 1 4 pp387-390', '10.1016/0196-9781(80)90019-4', '']\n",
      "['9258853', 'Simmons TC; Weinstein WM; Shapira M; Grossman MI. A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions. Prostaglandins. (1981) 21 Suppl  pp165-173', '10.1016/0090-6980(81)90134-9', '']\n",
      "['9258854', 'McKenzie JM. Report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease. Rheumatology and rehabilitation. (1981) 20 4 pp198-202', '10.1093/rheumatology/20.4.198', 'http://academic.oup.com/rheumatology/article-pdf/20/4/198/5033311/20-4-198.pdf']\n",
      "['9258855', 'Ring EF; Dieppe PA; Bacon PA. The thermographic assessment of inflammation and anti-inflammatory drugs in osteoarthritis. British journal of clinical practice. (1981) 35 7-8 pp263-264', '10.1111/j.1742-1241.1981.tb08278.x', '']\n",
      "['9258856', 'Martio J; Uuspaa V. Ketoprofen and pethidine in the treatment of post-operative pain following synovectomy. A double-blind trial on rheumatoid arthritis patients. British journal of clinical practice. (1981) 35 7-8 pp265', '10.1111/j.1742-1241.1981.tb08279.x', '']\n",
      "['9258857', 'Steven MM; Hunter JA; Murdoch RM; Capell HA. Does the order of second-line treatment in rheumatoid arthritis matter?. British medical journal (Clinical research ed.). (1982) 284 6309 pp79-81', '10.1136/bmj.284.6309.79', '']\n",
      "['9258858', 'De Moor M; Ooghe R. A double-blind comparison of flurbiprofen and indomethacin suppositories in the treatment of osteoarthrosis and rheumatoid disease. Journal of international medical research. (1981) 9 6 pp495-500', '10.1177/030006058100900612', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058100900612']\n",
      "['9258859', \"Manthorpe R; Frost-Larsen K; Isager H; Prause JU. Lack of lacrimal gland improvement by NA-872 in Sj√∂gren's syndrome. Acta ophthalmologica. (1981) 59 3 pp428-429\", '10.1111/j.1755-3768.1981.tb03008.x', '']\n",
      "['9258860', 'Ormiston MC; Vaughton KC; Thornton EJ; La Coste JJ; Milroy E. The comparative effectiveness of tiaprofenic acid and aspirin in the treatment of post-prostatectomy pain. British journal of clinical practice. (1981) 35 10 pp360-362', '10.1111/j.1742-1241.1981.tb08314.x', '']\n",
      "['9258861', 'Reynolds PM; McLeod MM; Dick WC. Clozic (ICI 55,897) in rheumatoid arthritis--a controlled comparison with gold. British journal of clinical practice. (1981) 35 9 pp306-308', '10.1111/j.1742-1241.1981.tb08296.x', '']\n",
      "['9258862', 'Pinals RS; Robertson F; Blechman WJ. A double-blind comparison of high and low doses of levamisole in rheumatoid arthritis. Journal of rheumatology. (1981) 8 6 pp949-951', '10.1093/rheumatology/20.1.50', 'http://academic.oup.com/rheumatology/article-pdf/20/1/50/5021766/20-1-50.pdf']\n",
      "['9258863', 'Jalava S; Virsiheimo B. Triamcinolone hexacetonide in the treatment of therapy-refractory gonitis. Journal of international medical research. (1982) 10 1 pp53-58', '10.1177/030006058201000111', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058201000111']\n",
      "['9258864', \"Crone M; Geimer R. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)]. Wiener medizinische Wochenschrift (1946). (1981) 131 23-24 pp597-601\", '10.1007/bf03314301', 'http://link.springer.com/article/10.1007/BF03314301/fulltext.html']\n",
      "['9258865', 'Symoens J. Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group. Annals of the rheumatic diseases. (1982) 41 2 pp159-163', '10.1136/ard.41.2.159', '']\n",
      "['9258866', 'Day RO; Furst DE; Dromgoole SH; Kamm B; Roe R; Paulus HE. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1982) 31 6 pp733-740', '10.1038/clpt.1982.103', '']\n",
      "['9258867', 'Br√∂ll H. Long-term, double-blind, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis. European journal of rheumatology and inflammation. (1981) 4 1 pp126-134', '10.3109/03009747409097135', '']\n",
      "['9258868', 'del Campo JB. Double-blind multicentre, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis patients under basic steroid treatment. European journal of rheumatology and inflammation. (1981) 4 1 pp135-143', '10.1093/rheumatology/21.2.101', 'http://academic.oup.com/rheumatology/article-pdf/21/2/101/5027114/21-2-101.pdf']\n",
      "['9258869', 'Passeri M; Ferretti G; Monica C; Fanfani A; Bergamini N. Study of the possible interactions of indoprofen on the diuretic effect of furosemide. European journal of rheumatology and inflammation. (1981) 4 1 pp36-40', '10.1093/rheumatology/20.3.174', 'http://academic.oup.com/rheumatology/article-pdf/20/3/174/5026899/20-3-174.pdf']\n",
      "['9258870', 'Kolarz G. Double-blind, cross-over, international multicentre investigation of two doses of indoprofen compared with ASA and placebo in rheumatoid arthritis. European journal of rheumatology and inflammation. (1981) 4 1 pp53-59', '10.1093/rheumatology/12.2.62', 'http://academic.oup.com/rheumatology/article-pdf/12/2/62/5039159/12-2-62.pdf']\n",
      "['9258871', 'Delbarre F. Short-term study of indoprofen in comparison with placebo and indomethacin in rheumatoid arthritis. European journal of rheumatology and inflammation. (1981) 4 1 pp66-73', '10.1080/03009748109095263', '']\n",
      "['9258872', 'Seigmund H; Schneider B. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent. European journal of rheumatology and inflammation. (1981) 4 1 pp79-86', '10.1093/rheumatology/20.1.54', 'http://academic.oup.com/rheumatology/article-pdf/20/1/54/5021815/20-1-54.pdf']\n",
      "['9258873', 'Rhymer AR; Hart CB; Daurio C. A double-blind trial comparing indomethacin sustained release capsules (Indocid-R) with indomethacin capsules in patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1982) 21 2 pp101-106', '10.1093/rheumatology/21.2.101', 'http://academic.oup.com/rheumatology/article-pdf/21/2/101/5027114/21-2-101.pdf']\n",
      "['9258874', 'Thrower PA; Doyle DV; Scott J; Huskisson EC. Thymopoietin in rheumatoid arthritis. Rheumatology and rehabilitation. (1982) 21 2 pp72-77', '10.1093/rheumatology/21.2.72', 'http://academic.oup.com/rheumatology/article-pdf/21/2/72/5027654/21-2-72.pdf']\n",
      "['9258875', 'Brewer EJ; Giannini EH; Baum J; Bernstein B; Fink CW; Emery HM; Schaller JG. Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study. Journal of rheumatology. (1982) 9 1 pp123-128', '10.1097/01241398-199009000-00034', '']\n",
      "['9258876', 'Chipman JJ; Boyar RM; Fink CW. Anterior-pituitary adrenal function of gold-treated patients with juvenile rheumatoid arthritis. Journal of rheumatology. (1982) 9 1 pp63-68', '10.1093/rheumatology/35.4.350', 'http://academic.oup.com/rheumatology/article-pdf/35/4/350/5043574/35-4-350.pdf']\n",
      "['9258877', 'Caruso I; Montrone F; Fumagalli M; Patrono C; Santandrea S; Gandini MC. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. Annals of the rheumatic diseases. (1982) 41 3 pp232-236', '10.1136/ard.41.3.232', '']\n",
      "['9258878', 'Wright V; Hopkins R; Burton K. How long should we talk to patients? A study in doctor-patient communication. Annals of the rheumatic diseases. (1982) 41 3 pp250-252', '10.1136/ard.41.3.250', '']\n",
      "['9258879', 'Amor B; Mery C; de Gery A. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis. Arthritis and rheumatism. (1982) 25 6 pp698-703', '10.1002/art.1780250614', '']\n",
      "['9258880', 'Williams IA; Baylis EM; Shipley ME. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet (London, England). (1982) 2 8292 pp237-240', '10.1016/s0140-6736(82)90323-3', '']\n",
      "['9258881', \"Scott DL; Roden S; Low-Beer TS; Takavarasha L. Prescribing non-steroidal anti-inflammatory drugs: a prospective study of patients' preference. Postgraduate medical journal. (1982) 58 677 pp146-148\", '10.1136/pgmj.58.677.146', 'https://academic.oup.com/pmj/article-pdf/58/677/146/50216649/postgradmedj-58-146.pdf']\n",
      "['9258882', 'Adams KR; Halliday LD; Sibeon RG; Baber N; Littler T; Orme ML. A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations. British journal of clinical pharmacology. (1982) 14 2 pp286-289', '10.1111/j.1365-2125.1982.tb01977.x', '']\n",
      "['9258883', 'Bozsoky S; Zahumenszky Z. A 3-month, double-blind study of proglumetacin and naproxen in the treatment of rheumatoid arthritis. Current medical research and opinion. (1982) 8 2 pp89-96', '10.1185/03007998209109763', '']\n",
      "['9258884', 'Fostiropoulos G; Croydon EA. A comparative study of the effectiveness and safety of two non-steroidal anti-inflammatory agents, nabumetone and naproxen in rheumatoid arthritis. Journal of international medical research. (1982) 10 4 pp204-208', '10.1177/030006058201000402', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058201000402']\n",
      "['9258885', 'Rosenthal M. The application of an extract of human placenta in the treatment of rheumatic affections. International journal of tissue reactions. (1982) 4 2 pp147-151', '10.1016/s0143-4004(82)80012-x', '']\n",
      "['9258886', 'di Munno O; Sarchi C. Effectiveness of tolmetin in rheumatoid arthritis: evaluation by means of a new method. Methods and findings in experimental and clinical pharmacology. (1982) 4 3 pp203-206', '10.1358/mf.2004.26.5.831324', '']\n",
      "['9258887', 'Nissil√§ M; Nuotio P; von Essen R; M√§kisara P. Low-dose penicillamine treatment of RA. Comparison of 600 mg and 300 mg regimens. Scandinavian journal of rheumatology. (1982) 11 3 pp161-164', '10.3109/03009748209098183', '']\n",
      "['9258888', 'Carr G; Dougan M; Brooks PM; Maycock S. Night-time indomethacin in rheumatoid arthritis. Current medical research and opinion. (1982) 8 3 pp197-199', '10.1185/03007998209112383', '']\n",
      "['9258889', 'Bernhard GC. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose. Journal of rheumatology. Supplement. (1982) 8  pp149-153', '10.1093/rheumatology/32.5.375', 'http://academic.oup.com/rheumatology/article-pdf/32/5/375/5041782/32-5-375.pdf']\n",
      "['9258890', 'Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. Journal of rheumatology. Supplement. (1982) 8 8 pp173-178', '10.1016/0002-9343(83)90484-9', '']\n",
      "['9258891', 'Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. Journal of rheumatology. Supplement. (1982) 8 8 pp179-183', '10.3109/03009748709165271', '']\n",
      "['9258892', 'Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Journal of rheumatology. Supplement. (1982) 8 8 pp184-189', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9258893', 'Smith PR; Brown GM; Meyers OL. An open comparative study of auranofin vs. gold sodium thiomalate. Journal of rheumatology. Supplement. (1982) 8  pp190-196', '10.1007/bf03342618', 'http://link.springer.com/article/10.1007/BF03342618/fulltext.html']\n",
      "['9258894', 'Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Journal of rheumatology. Supplement. (1982) 8  pp197-200', '10.3109/03009748809105278', '']\n",
      "['9258895', 'Ayrolles C; Fournie A. Pirprofen in the treatment of rheumatoid arthritis. La Nouvelle presse meÃÅdicale. (1982) 11 33 pp2487-2490', '10.1002/art.1780330615', '']\n",
      "['9258896', 'Roth H; Levasseur YJ; Ryan R. Comparative therapeutic activity of pirprofen and acetylsalicylic acid in rheumatoid arthritis. A 12-month controlled multicenter study. La Nouvelle presse meÃÅdicale. (1982) 11 33 pp2517-2521', '10.1016/j.lpm.2016.05.004', '']\n",
      "['9258897', 'McKnight PT; Schomburg FL. Air pressure splint effects on hand symptoms of patients with rheumatoid arthritis. Archives of physical medicine and rehabilitation. (1982) 63 11 pp560-564', '10.1016/j.apmr.2008.09.031', '']\n",
      "['9258898', 'Scott DL; Roden S; Marshall T; Kendall MJ. Variations in responses to non-steroidal anti-inflammatory drugs. British journal of clinical pharmacology. (1982) 14 5 pp691-694', '10.1111/j.1365-2125.1982.tb04958.x', '']\n",
      "['9258899', 'Kvien TK; H√∏yeraal HM; Sandstad B. Assessment methods of disease activity in juvenile rheumatoid arthritis--evaluated in a prednisolone/placebo double-blind study. Journal of rheumatology. (1982) 9 5 pp696-702', '10.3109/03009748409111307', '']\n",
      "['9258900', 'Goebel KM; Storck U. Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knees. American journal of medicine. (1983) 74 1 pp124-128', '10.1016/0002-9343(83)91128-2', '']\n",
      "['9258901', \"Thompson M; Daymond TJ; Essigman WK; Huskisson EC; Wojtulewski JA. Short-term efficacy and tolerance of tiaprofenic acid ('Surgam') in rheumatoid arthritis and osteoarthritis: multi-centre, placebo-controlled trials. Current medical research and opinion. (1982) 8 4 pp215-223\", '10.1185/03007998209109770', '']\n",
      "['9258902', 'Steinsson K; Weinstein A; Korn J; Abeles M. Low dose methotrexate in rheumatoid arthritis. Journal of rheumatology. (1982) 9 6 pp860-866', '10.1016/0002-9343(85)90312-2', '']\n",
      "['9258903', 'Abelson K; Langley GB; Sheppeard H; Vlieg M; Wigley RD. Transcutaneous electrical nerve stimulation in rheumatoid arthritis. New Zealand medical journal. (1983) 96 727 pp156-158', '10.1007/bf00541180', 'http://link.springer.com/article/10.1007/BF00541180/fulltext.html']\n",
      "['9258904', 'Ud√©n AM; Trang L; Venizelos N; Palmblad J. Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1983) 42 1 pp45-51', '10.1136/ard.42.1.45', '']\n",
      "['9258905', 'Dwosh IL; Giles AR; Ford PM; Pater JL; Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. New England journal of medicine. (1983) 308 19 pp1124-1129', '10.1056/nejm198305123081903', '']\n",
      "['9258906', 'Jalava S. A double blind crossover study of carprofen and indomethacin in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1983) 48  pp5-9', '10.3109/03009748309095333', '']\n",
      "['9258907', 'Jalava S; Saario R. Treatment of finger joints with local steroids. A double-blind study. Scandinavian journal of rheumatology. (1983) 12 1 pp12-14', '10.3109/03009748309101996', '']\n",
      "['9258908', 'Panush RS; Carter RL; Katz P; Kowsari B; Longley S; Finnie S. Diet therapy for rheumatoid arthritis. Arthritis and rheumatism. (1983) 26 4 pp462-471', '10.1002/art.1780260403', '']\n",
      "['9258909', 'Zuccollo R; Mackinnon MJ; Fraser KM; Hall SM; Palmer DG. Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial. Current medical research and opinion. (1983) 8 5 pp302-309', '10.1185/03007998309112388', '']\n",
      "['9258910', 'Bunde B; Deckers Y; Dequeker J. Fentiazac in rheumatoid arthritis: comparison with sulindac and long-term tolerance. Current medical research and opinion. (1983) 8 5 pp310-314', '10.1185/03007998309112389', '']\n",
      "['9258911', 'Ibba G; Uras R; Perpignano G. Double-blind comparison of glucametacin and ketoprofen in chronic arthropathies. Current medical research and opinion. (1983) 8 5 pp321-326', '10.1185/03007998309112391', '']\n",
      "['9258912', 'Burton WD; Hazleman BL. Fenbufen and indomethacin: a comparative study in rheumatoid arthritis. Clinical therapeutics. (1983) 5 3 pp260-267', '10.1007/bf03303609', 'http://link.springer.com/article/10.1007/BF03303609/fulltext.html']\n",
      "['9258913', 'Grace EM; Mewa A; Rooney PJ; Buchanan WW. Clinical therapeutic trial of sodium meclofenamate and naproxen in rheumatoid arthritis, with comments on the use of placebos in clinical trials. Current medical research and opinion. (1983) 8 6 pp417-424', '10.1185/03007998309111748', '']\n",
      "['9258914', 'Cherie-Ligniere G; Colamussi V; Cozzolongo AC; Loizzi P; Frizziero L; Mattara L; Zorzin L. A multicentre comparison of flurbiprofen and naproxen in rheumatoid arthritis: a four-week study in 118 patients. Journal of international medical research. (1983) 11 2 pp85-89', '10.1177/030006058301100204', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058301100204']\n",
      "['9258915', 'Nilsson F; Norberg B; Frederiksen B; Eriksson S. The role of the MA-sensitive leukocyte chemotaxis in rheumatoid arthritis. A randomized double-blind clinical trial of griseofulvin treatment. Scandinavian journal of rheumatology. (1983) 12 2 pp113-118', '10.3109/03009748309102895', '']\n",
      "['9258916', 'del Toro RA; Concepci√≥n R. Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis. Clinical therapeutics. (1983) 5 4 pp436-444', '10.1007/bf03303378', 'http://link.springer.com/article/10.1007/BF03303378/fulltext.html']\n",
      "['9258917', 'Petrick TJ; Black ME. Double-blind multicenter studies with meclofenamate sodium in the treatment of rheumatoid arthritis in the United States and Canada. Arzneimittel-Forschung. (1983) 33 4A pp631-635', '10.1136/bmj.287.6399.1102', '']\n",
      "['9258918', 'Dunky A; Mattern H. European double-blind multicenter study comparing meclofenamate sodium and indomethacin in the treatment of rheumatoid arthritis. Arzneimittel-Forschung. (1983) 33 4A pp636-640', '10.1016/0049-0172(82)90071-3', '']\n",
      "['9258919', 'Bird HA; Leatham PA; Lowe JR; Downie WW; Fowler PD; Wright V. A phenylbutazone dose-finding study in rheumatoid arthritis. European journal of clinical pharmacology. (1983) 24 6 pp773-776', '10.1007/bf00607086', 'http://link.springer.com/article/10.1007/BF00607086/fulltext.html']\n",
      "['9258920', \"Kahan A; Weber S; Amor B; Menkes CJ; Saporta L; Hodara M; Guerin F; Degeorges M. Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon). European heart journal. (1983) 4 Suppl C Suppl C pp123-129\", '10.1093/eurheartj/4.suppl_c.123', 'http://academic.oup.com/eurheartj/article-pdf/4/suppl_C/123/1305714/4-suppl_C-123.pdf']\n",
      "['9258924', 'Wojtulewski JA; Walter J. Treatment of sleep disturbance in arthritis with chlormezanone. Current medical research and opinion. (1983) 8 7 pp456-460', '10.1185/03007998309109782', '']\n",
      "['9258925', 'Esp≈ïito Santo J; da Silva JP; da Costa JT; Gomes JM; Queiroz MV. Double-blind evaluation of low-dose proglumetacin versus naproxen in rheumatoid arthritis out-patients. Current medical research and opinion. (1983) 8 7 pp524-530', '10.1185/03007998309109792', '']\n",
      "['9258926', 'Kvien TK; Reimers S. Drug handling and patient compliance in an outpatient paediatric trial. Journal of clinical and hospital pharmacy. (1983) 8 3 pp251-257', '10.1111/j.1365-2710.1983.tb01104.x', '']\n",
      "['9258927', 'Bernstein J. Overview of efficacy of fenbufen in rheumatoid arthritis and osteoarthritis. American journal of medicine. (1983) 75 4B pp70-74', '10.1016/0002-9343(83)90331-5', '']\n",
      "['9258928', 'Lussier A; T√©treault L; Lebel E. Comparative study of gastrointestinal microbleeding caused by aspirin, fenbufen, and placebo. American journal of medicine. (1983) 75 4B pp80-83', '10.1016/0002-9343(83)90333-9', '']\n",
      "['9258930', \"Matts SG; Boston PF. Paracetamol plus metoclopramide ('Paramax') as an adjunct analgesic in the treatment of arthritis. Current medical research and opinion. (1983) 8 8 pp547-552\", '10.1185/03007998309109796', '']\n",
      "['9258931', 'Rothwell KG. Efficacy and safety of a non-acetylated salicylate, choline magnesium trisalicylate, in the treatment of rheumatoid arthritis. Journal of international medical research. (1983) 11 6 pp343-348', '10.1177/030006058301100604', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058301100604']\n",
      "['9258932', 'Richards AM; Burry HC; Treadwell BL; Tweed JM; Mowles E. Nabumetone, a new non-steroidal anti-inflammatory drug: a comparison with naproxen. New Zealand medical journal. (1983) 96 745 pp1015-1016', '10.1016/0049-3848(93)90555-3', '']\n",
      "['9258933', 'Haapasaari J; Wuolijoki E; Ylijoki H. Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scandinavian journal of rheumatology. (1983) 12 4 pp325-330', '10.3109/03009748309099735', '']\n",
      "['9258934', 'Wenger ME; Alexander S; Bland JH; Blechman WJ. Auranofin versus placebo in the treatment of rheumatoid arthritis. American journal of medicine. (1983) 75 6A pp123-127', '10.1016/0002-9343(83)90484-9', '']\n",
      "['9258935', 'Weiss TE. Auranofin: dose-related risk to benefit. American journal of medicine. (1983) 75 6A pp128-132', '10.1016/0002-9343(83)90485-0', '']\n",
      "['9258937', 'Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis. American journal of medicine. (1983) 75 6A pp138-141', '10.1016/0002-9343(83)90487-4', '']\n",
      "['9258938', 'Isom√§ki H; Martio J; Kaarela K; Kajander A; Koota K; Lehtinen K; Luukkainen R; Martio T; Nissil√§ M; Nuotio P. Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs. British journal of rheumatology. (1984) 23 1 pp61-65', '10.1093/rheumatology/23.1.61', 'http://academic.oup.com/rheumatology/article-pdf/23/1/61/5039837/23-1-61.pdf']\n",
      "['9258939', 'Mbuyi-Muamba JM; Dequeker J. Piroxicam versus naproxen in rheumatoid arthritis. Current medical research and opinion. (1983) 8 9 pp612-617', '10.1185/03007998309109806', '']\n",
      "['9258940', 'Meijers KA; Valkenburg HA; Cats A. A synovectomy trial and the history of early knee synovitis in rheumatoid arthritis. A multicentre study. Rheumatology international. (1983) 3 4 pp161-166', '10.1007/bf00541595', 'http://link.springer.com/article/10.1007/BF00541595/fulltext.html']\n",
      "['9258941', \"Bunch TW; O'Duffy JD; Tompkins RB; O'Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (1984) 27 3 pp267-276\", '10.1002/art.1780270304', '']\n",
      "['9258942', 'Million R; Kellgren JH; Poole P; Jayson MI. Long-term study of management of rheumatoid arthritis. Lancet (London, England). (1984) 1 8381 pp812-816', '10.1016/s0140-6736(84)92270-0', '']\n",
      "['9258943', 'Caruso I; Fumagalli M; Boccassini L; Sarzi Puttini P; Ciniselli G; Cavallari G. Antidepressant activity of S-adenosylmethionine. Lancet (London, England). (1984) 1 8382 pp904', '10.1016/s0140-6736(84)91360-6', '']\n",
      "['9258944', 'Mowat AM; Mowat AG; Jones CW; Engler C. A comparison of once and twice daily naproxen in rheumatoid arthritis. British journal of clinical practice. (1984) 38 3 pp95-98', '10.1111/j.1742-1241.1984.tb07260.x', '']\n",
      "['9258945', 'Clemens LE; Ansell BM; Bernstein RM; Hall MA; McCauley D. A comparison of low dose levamisole and penicillamine in rheumatoid arthritis. Australian and New Zealand journal of medicine. (1983) 13 6 pp578-582', '10.1111/j.1445-5994.1983.tb02607.x', '']\n",
      "['9258946', 'Alam MN; Kabir MZ. Comparative study of piroxicam and ibuprofen in rheumatoid arthritis. Bangladesh Medical Research Council bulletin. (1983) 9 2 pp54-59', '10.1016/0049-0172(85)90054-x', '']\n",
      "['9258947', 'Turner RA; Whipple JP; Shackleford RW. Diflunisal 500-750 mg versus aspirin 2600-3900 mg in the treatment of rheumatoid arthritis. Pharmacotherapy. (1984) 4 3 pp151-157', '10.1002/j.1875-9114.1984.tb03341.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1875-9114.1984.tb03341.x']\n",
      "['9258948', 'Salom IL; Jacob G; Jallad N; Perdomo CA; Mullane JF; Weidler D. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males. Journal of clinical pharmacology. (1984) 24 5-6 pp240-246', '10.1002/j.1552-4604.1984.tb02780.x', '']\n",
      "['9258949', 'Langley GB; Sheppeard H; Johnson M; Wigley RD. The analgesic effects of transcutaneous electrical nerve stimulation and placebo in chronic pain patients. A double-blind non-crossover comparison. Rheumatology international. (1984) 4 3 pp119-123', '10.1007/bf00541180', 'http://link.springer.com/article/10.1007/BF00541180/fulltext.html']\n",
      "['9258950', \"Prause JU; Frost-Larsen K; H√∏j L; Isager H; Manthorpe R. Lacrimal and salivary secretion in Sj√∂gren's syndrome: the effect of systemic treatment with bromhexine. Acta ophthalmologica. (1984) 62 3 pp489-497\", '10.1111/j.1755-3768.1984.tb08430.x', '']\n",
      "['9258951', 'Kitt R; Scott DL; Coulton BL; Popert AJ. Nitrogen mustard in severe rheumatoid arthritis. Clinical rheumatology. (1983) 2 1 pp27-35', '10.1007/bf02032065', 'http://link.springer.com/article/10.1007/BF02032065/fulltext.html']\n",
      "['9258952', 'Wafin F; Valindas E; Wuolijoki E. Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis. Clinical rheumatology. (1984) 3 1 pp67-70', '10.1007/bf02715698', 'http://link.springer.com/article/10.1007/BF02715698/fulltext.html']\n",
      "['9258953', 'Bird HA; Le Gallez P; Dixon JS; Surrall KE; Cole DS; Goldman MH; Wright V. A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis. Clinical rheumatology. (1984) 3 Suppl 1  pp57-66', '10.1007/bf03342623', 'http://link.springer.com/article/10.1007/BF03342623/fulltext.html']\n",
      "['9258954', 'Franchimont P; Hauwaert C; Vanschoubroek K. Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin. Clinical rheumatology. (1984) 3 Suppl 1  pp75-82', '10.1007/bf03342625', 'http://link.springer.com/article/10.1007/BF03342625/fulltext.html']\n",
      "['9258955', 'Veys EM; Verbruggen G; Suykens S; Mielants H; Ackerman K; Van Lerbeirghe J; Heynen G. Lymphocyte sub-population counts after a single 40 mg administration of piroxicam in 20 patients with rheumatoid arthritis. A placebo-controlled study. Inflammation. (1984) 8 Suppl  ppS115-22', '10.1007/bf00915719', 'http://link.springer.com/article/10.1007/BF00915719/fulltext.html']\n",
      "['9258956', \"Manthorpe R; Hagen Petersen S; Prause JU. Primary Sj√∂gren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation. Rheumatology international. (1984) 4 4 pp165-167\", '10.1007/bf00541208', 'http://link.springer.com/article/10.1007/BF00541208/fulltext.html']\n",
      "['9258957', \"Manthorpe R; Petersen SH; Prause JU. Mucosolvan in the treatment of patients with primary Sj√∂gren's syndrome. Results from a double-blind cross-over investigation. Acta ophthalmologica. (1984) 62 4 pp537-541\", '10.1111/j.1755-3768.1984.tb03965.x', '']\n",
      "['9258958', 'Fancourt GJ; Flavell Matts SG. A double-blind comparison of meptazinol versus placebo in chronic rheumatoid arthritis and osteoarthritis. Current medical research and opinion. (1984) 9 3 pp184-191', '10.1185/03007998409109578', '']\n",
      "['9258961', 'Halberg P; Bentzon MW; Crohn O; Gad I; Halskov O; Heyn J; Ingemann M; Junker P; Lorenzen I; M√∏ller I. Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies. Danish medical bulletin. (1984) 31 5 pp403-409', '10.1007/bf02201028', 'http://link.springer.com/article/10.1007/BF02201028/fulltext.html']\n",
      "['9258962', 'Katona G; Vargas RB. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis. European journal of rheumatology and inflammation. (1983) 6 3 pp233-241', '10.3109/03009748309095333', '']\n",
      "['9258963', 'Devereaux MD; Douglas WA. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1983) 6 3 pp274-278', '10.3109/03009747809097218', '']\n",
      "['9258964', 'Lund B; Graae A; Sonne I; Andersen RB. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters. European journal of rheumatology and inflammation. (1983) 6 3 pp279-287', '10.3109/03009748809098769', '']\n",
      "['9258965', 'Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Journal of rheumatology. (1984) 11 6 pp760-763', '10.1007/s00296-021-04994-1', 'https://link.springer.com/article/10.1007/s00296-021-04994-1/fulltext.html']\n",
      "['9258966', 'Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW. Gold vs D-penicillamine double blind study and followup. Journal of rheumatology. (1984) 11 6 pp764-767', '10.1002/art.1780220418', '']\n",
      "['9258967', \"Gofton JP; O'Brien WM; Hurley JN; Scheffler BJ. Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo. Journal of rheumatology. (1984) 11 6 pp768-771\", '10.3109/03009748609092673', '']\n",
      "['9258968', 'Svendsen UG; Gerstoft J; Hansen TM; Christensen P; Lorenzen I. The renal excretion of prostaglandins and changes in plasma renin during treatment with either sulindac or naproxen in patients with rheumatoid arthritis and thiazide treated heart failure. Journal of rheumatology. (1984) 11 6 pp779-782', '10.3109/03009748609101451', '']\n",
      "['9258969', 'Kremer JM; Bigauoette J; Michalek AV; Timchalk MA; Lininger L; Rynes RI; Huyck C; Zieminski J; Bartholomew LE. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet (London, England). (1985) 1 8422 pp184-187', '10.1016/s0140-6736(85)92024-0', '']\n",
      "['9258970', 'Vadilenkaitis VV; Matulis AA. [Artificial synovial fluid for the intra-articular treatment of rheumatoid arthritis and osteoarthritis (chemical synthesis and clinico-experimental and biomechanical data)]. TerapevticheskiiÃÜ arkhiv. (1984) 56 11 pp73-77', '10.1080/03009747309097145', '']\n",
      "['9258971', \"Kahan A; Amor B; Menkes CJ. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon. Annals of the rheumatic diseases. (1985) 44 1 pp30-33\", '10.1136/ard.44.1.30', '']\n",
      "['9258972', 'Davies J; Bacon PA; Hall ND; Ring EF. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis. Clinical rheumatology. (1984) 3 4 pp553-554', '10.1007/bf02031283', 'http://link.springer.com/article/10.1007/BF02031283/fulltext.html']\n",
      "['9258973', 'Bara S; Wagenh√§user FJ. [Onset of effect of isoxicam and piroxicam. A double-blind parallel study]. Fortschritte der Medizin. (1985) 103 4 pp73-76', '10.1007/s15006-012-0762-3', 'http://link.springer.com/article/10.1007/s15006-012-0762-3/fulltext.html']\n",
      "['9258975', 'Sharma RP; Smillie J; Palmer DG. Gold concentrations and toxicity during oral gold treatment with auranofin. Pharmacology. (1985) 30 2 pp115-120', '10.1159/000138059', '']\n",
      "['9258976', 'Strober S; Tanay A; Field E; Hoppe RT; Calin A; Engleman EG; Kotzin B; Brown BW; Kaplan HS. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Annals of internal medicine. (1985) 102 4 pp441-449', '10.7326/0003-4819-102-4-441', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-102-4-441']\n",
      "['9258977', 'Larkin JG; Capell HA; Sturrock RD. Seatone in rheumatoid arthritis: a six-month placebo-controlled study. Annals of the rheumatic diseases. (1985) 44 3 pp199-201', '10.1136/ard.44.3.199', '']\n",
      "['9258978', 'Davis P; Menard H; Thompson J; Harth M; Beaudet F. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. Journal of rheumatology. (1985) 12 1 pp60-67', '10.3109/03009748709165271', '']\n",
      "['9258979', 'Malaise MG; Hauwaert C; Franchimont P; Danneskiold-Samsoe B; Bach-Andersen R; Gross D; Gerber H; Gerschpacher H; Stocker H; Bolla K. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study. Lancet (London, England). (1985) 1 8433 pp832-836', '10.1016/s0140-6736(85)92205-6', '']\n",
      "['9258980', 'Schorn D. A comparative study of isoxicam and naproxen in rheumatoid arthritis. South African medical journal. (1985) 67 12 pp452-454', '10.1007/bf03313428', 'http://link.springer.com/article/10.1007/BF03313428/fulltext.html']\n",
      "['9258981', 'Elmstedt E; Lindholm TS; Nilsson OS; T√∂rnkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta orthopaedica Scandinavica. (1985) 56 1 pp25-27', '10.3109/17453678508992973', '']\n",
      "['9258982', 'Prieur AM; Piussan C; Manigne P; Bordigoni P; Griscelli C. Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study. Arthritis and rheumatism. (1985) 28 4 pp376-382', '10.1002/art.1780280404', '']\n",
      "['9258983', 'Bird HA; Dixon JS; Finney PL; Leatham PA; Lowe JR; Pickup ME; Rhind VM; Rushton A; Sitton NG; Wright V. A clinical and biochemical evaluation of Clozic, a novel disease modifying drug in rheumatoid arthritis. Clinical and experimental rheumatology. (1983) 1 2 pp93-99', '10.1007/bf00271835', 'http://link.springer.com/article/10.1007/BF00271835/fulltext.html']\n",
      "['9258984', 'Taborn J; Anderson S; Goldberg M; Kantrowitz F; Menander-Huber K; Gross J. Relief of morning stiffness: a comparative study of naproxen and ibuprofen. Current medical research and opinion. (1985) 9 6 pp359-365', '10.1185/03007998509109604', '']\n",
      "['9258985', 'Grace EM; Bellamy N; Kassam Y; Buchanan WW. Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Current medical research and opinion. (1985) 9 6 pp426-429', '10.1185/03007998509109614', '']\n",
      "['9258986', 'J√§ntti J; Isom√§ki H; Laitinen O; Nikkari T; Sepp√§l√§ E; Vapaatalo H. Linoleic acid treatment in inflammatory arthritis. International journal of clinical pharmacology, therapy, and toxicology. (1985) 23 2 pp89-91', '10.1007/bf02031615', 'http://link.springer.com/article/10.1007/BF02031615/fulltext.html']\n",
      "['9258987', 'Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. International journal of clinical pharmacology research. (1984) 4 6 pp395-401', '10.3109/9780203214237-212', '']\n",
      "['9258988', 'Molin L; Schmid F; Bolla K. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis. International journal of clinical pharmacology research. (1984) 4 6 pp445-449', '10.1007/bf02919060', 'https://link.springer.com/article/10.1007/BF02919060/fulltext.html']\n",
      "['9258989', 'Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis. International journal of clinical pharmacology research. (1984) 4 6 pp451-457', '10.1007/bf02919062', 'https://link.springer.com/article/10.1007/BF02919062/fulltext.html']\n",
      "['9258990', 'Shearn MA; Fireman BH. Stress management and mutual support groups in rheumatoid arthritis. American journal of medicine. (1985) 78 5 pp771-775', '10.1016/0002-9343(85)90282-7', '']\n",
      "['9258991', 'Larsen A. Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study. International journal of clinical pharmacology research. (1985) 5 1 pp17-23', '10.1111/j.1742-1241.1981.tb08244.x', '']\n",
      "['9258992', \"Manthorpe R; Staub Nielsen L; Hagen Petersen S; Prause JU. Lewis blood type frequency in patients with primary Sj√∂gren's syndrome. A prospective study including analyses for A1A2BO, Secretor, MNSs, P, Duffy, Kell, Lutheran and rhesus blood groups. Scandinavian journal of rheumatology. (1985) 14 2 pp159-162\", '10.3109/03009748509165497', '']\n",
      "['9258993', 'Igarashi M; Ogawa N; Nobunaga T. [Double-blind evaluation comparing CS-600 (loxoprofen sodium) and indomethacin in the treatment of rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1985) 25 1 pp61-72', '10.1016/0049-0172(82)90071-3', '']\n",
      "['9258994', 'Langley GB; Fowles M; Sirett P; Vlieg M; Wigley RD. Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis. New Zealand medical journal. (1985) 98 781 pp490-492', '10.1016/0049-0172(85)90052-6', '']\n",
      "['9258997', 'Scheinberg MA; Weltman E. Plasmapheresis vs total lymphoid irradiation in the treatment of severe rheumatoid arthritis. Clinical and experimental rheumatology. (1985) 3 2 pp127-130', '10.1016/s0009-9260(85)80094-5', '']\n",
      "['9258998', 'Nichol FE; Daymond TJ; Pandit NA; Sheldon P; Swannell AJ. A controlled trial of tiaprofenic acid against indomethacin in patients with rheumatoid arthritis. International journal of clinical pharmacology research. (1985) 5 3 pp157-159', '10.1093/rheumatology/18.4.257', 'http://academic.oup.com/rheumatology/article-pdf/18/4/257/5039498/18-4-257.pdf']\n",
      "['9258999', 'Symmons D; Clark B; Panayi G; Geddawi M. Differential dosing study of pirazolac, a new non-steroidal anti-inflammatory agent, in patients with rheumatoid arthritis. Current medical research and opinion. (1985) 9 8 pp542-547', '10.1185/03007998509109632', '']\n",
      "['9259000', \"Bocanegra TS; Dicenta C; Carpignano M; Neu DC; Bolognese JA. Diflunisal ('Dolobid') once-a-day in the treatment of rheumatoid arthritis. Current medical research and opinion. (1985) 9 8 pp568-577\", '10.1185/03007998509109636', '']\n",
      "['9259001', 'Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis. Survey of immunologic research. (1985) 4 Suppl 1 4 Suppl 1 pp87-93', '10.1007/bf02919062', 'https://link.springer.com/article/10.1007/BF02919062/fulltext.html']\n",
      "['9259002', 'Brighton SW; De la Harpe AL. Comparison of isoxicam and naproxen in patients with rheumatoid arthritis. A 4-week parallel group, double-blind study. South African medical journal. (1985) 68 4 pp232-234', '10.1007/bf03313428', 'http://link.springer.com/article/10.1007/BF03313428/fulltext.html']\n",
      "['9259004', 'Kvien TK; H√∏yeraal HM; Sandstad B. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial. Journal of rheumatology. (1985) 12 3 pp533-539', '10.1007/bf02031282', 'http://link.springer.com/article/10.1007/BF02031282/fulltext.html']\n",
      "['9259005', \"Webb J; McCredie M. Primary Sj√∂gren's syndrome treated with Efamol/efavit. A double-blind cross-over investigation. Rheumatology international. (1985) 5 4 pp191\", '10.1007/bf00541523', 'http://link.springer.com/article/10.1007/BF00541523/fulltext.html']\n",
      "['9259006', 'Slobodina GA. Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report). Terapevticheskii√É√ú arkhiv. (1985) 57 7 pp131-136', '10.17116/terarkh201688124-10', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/32043/pdf']\n",
      "['9259007', 'Kvien TK; Olsson B; H√∏yeraal HM. Acetylsalicylic acid and juvenile rheumatoid Arthritis. Effect of dosage interval on the serum salicylic acid level. Acta paediatrica Scandinavica. (1985) 74 5 pp755-759', '10.1111/j.1651-2227.1985.tb10026.x', '']\n",
      "['9259008', 'Hawkes J; Care G; Dixon JS; Bird HA; Wright V. Comparison of three physiotherapy regimens for hands with rheumatoid arthritis. British medical journal (Clinical research ed.). (1985) 291 6501 pp1016', '10.1136/bmj.291.6501.1016', '']\n",
      "['9259009', 'Chlud K; Pangerl S. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study. Pharmatherapeutica. (1985) 4 2 pp113-121', '10.1016/0049-0172(85)90052-6', '']\n",
      "['9259010', 'Benenson EV; Nemtsov BF; Maksimov TA; Kurmanalieva AK; Beƒ≠shenov AD. [A new basic agent, prospidin, in the therapy of rheumatoid arthritis. Research on its clinical effectiveness in a controlled and double-blind trial]. Revmatologiia (Moscow, Russia). (1985)  3 pp36-40', '10.14412/1995-4484-2003-1359', '']\n",
      "['9259011', 'Reese RW. Long-term studies of isoxicam in the treatment of rheumatoid arthritis. American journal of medicine. (1985) 79 4B pp12-16', '10.1016/0002-9343(85)90175-5', '']\n",
      "['9259012', 'Burch FX. Evaluation of the safety of isoxicam. American journal of medicine. (1985) 79 4B pp28-32', '10.1016/0002-9343(85)90178-0', '']\n",
      "['9259013', 'Williams PI. Adverse effects of isoxicam in relation to age. American journal of medicine. (1985) 79 4B pp38-40', '10.1016/0002-9343(85)90181-0', '']\n",
      "['9259014', 'Simson J. Six-month, double-blind comparison of isoxicam with buffered aspirin in rheumatoid arthritis. American journal of medicine. (1985) 79 4B pp7-11', '10.1016/0002-9343(85)90174-3', '']\n",
      "['9259016', 'Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate. Arthritis and rheumatism. (1985) 28 11 pp1211-1218', '10.1002/art.1780281104', '']\n",
      "['9259017', 'Kvien TK; H√∏yeraal HM; Sandstad B. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis. Scandinavian journal of rheumatology. (1985) 14 4 pp346-354', '10.3109/03009748509102037', '']\n",
      "['9259018', 'Tarp U; Overvad K; Thorling EB; Graudal H; Hansen JC. Selenium treatment in rheumatoid arthritis. Scandinavian journal of rheumatology. (1985) 14 4 pp364-368', '10.3109/03009748509102039', '']\n",
      "['9259019', 'Kvien TK; Larheim TA; H√∏yeraal HM; Sandstad B. Radiographic temporomandibular joint abnormalities in patients with juvenile chronic arthritis during a controlled study of sodium aurothiomalate and D-penicillamine. British journal of rheumatology. (1986) 25 1 pp59-66', '10.1093/rheumatology/25.1.59', 'http://academic.oup.com/rheumatology/article-pdf/25/1/59/5040183/25-1-59.pdf']\n",
      "['9259020', 'Williams PL; Ansell BM; Bell A; Cain AR; Chamberlain MA; Clarke AK; Craft AW; Hollingworth P; Keegan D; Roberts SD. Multicentre study of piroxicam versus naproxen in juvenile chronic arthritis, with special reference to problem areas in clinical trials of nonsteroidal anti-inflammatory drugs in childhood. British journal of rheumatology. (1986) 25 1 pp67-71', '10.1093/rheumatology/25.1.67', 'http://academic.oup.com/rheumatology/article-pdf/25/1/67/5040213/25-1-67.pdf']\n",
      "['9259021', 'Emery P; Gibson T. A double-blind study of the simple analgesic nefopam in rheumatoid arthritis. British journal of rheumatology. (1986) 25 1 pp72-76', '10.1093/rheumatology/25.1.72', 'http://academic.oup.com/rheumatology/article-pdf/25/1/72/5040269/25-1-72.pdf']\n",
      "['9259022', 'Darlington LG; Ramsey NW; Mansfield JR. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet (London, England). (1986) 1 8475 pp236-238', '10.1016/s0140-6736(86)90774-9', '']\n",
      "['9259023', 'Fries JF; Bloch DA; Sharp JT; McShane DJ; Spitz P; Bluhm GB; Forrester D; Genant H; Gofton P; Richman S. Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. Arthritis and rheumatism. (1986) 29 1 pp1-9', '10.1002/art.1780290101', '']\n",
      "['9259024', 'Hanly JG; Hassan J; Moriarty M; Barry C; Molony J; Casey E; Whelan A; Feighery C; Bresnihan B. Lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized study comparing 750-rad treatment with 2,000-rad treatment. Arthritis and rheumatism. (1986) 29 1 pp16-25', '10.1002/art.1780290103', '']\n",
      "['9259025', 'Van der Leeden H; Dijkmans BA; Hermans J; Cats A. A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis. Clinical rheumatology. (1986) 5 1 pp56-61', '10.1007/bf02030968', 'http://link.springer.com/article/10.1007/BF02030968/fulltext.html']\n",
      "['9259026', 'Jacob G; Messina M; Kennedy J; Epstein C; Sanda M; Mullane J. Minimum effective dose of etodolac for the treatment of rheumatoid arthritis. Journal of clinical pharmacology. (1986) 26 3 pp195-202', '10.1002/j.1552-4604.1986.tb02933.x', '']\n",
      "['9259027', \"Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases. International angiology. (1985) 4 2 pp221-223\", '10.1093/oxfordjournals.eurheartj.a061923', 'http://academic.oup.com/eurheartj/article-pdf/6/8/702/1874944/6-8-702.pdf']\n",
      "['9259028', 'Manthorpe R; H√∏rbov S; Sylvest J; Vinterberg H. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Scandinavian journal of rheumatology. (1986) 15 1 pp13-22', '10.3109/03009748609092663', '']\n",
      "['9259029', 'Johnsen V; Bjerkhoel F; Bj√∏rneboe O; B√∏rresen B; Finstad R; Hansen K; Moen F. Duration of morning stiffness in rheumatic patients after medication with enteric-coated and plain naproxen tablets. Scandinavian journal of rheumatology. (1986) 15 1 pp37-40', '10.3109/03009748609092666', '']\n",
      "['9259030', 'Christensen K. A double-blind placebo-controlled evaluation of fenflumizole in rheumatoid arthritis. Scandinavian journal of rheumatology. (1986) 15 1 pp80-84', '10.3109/03009748609092673', '']\n",
      "['9259031', 'Brown BL; Johnson JH; Stiger TR. Flurbiprofen versus naproxen in the treatment of rheumatoid arthritis. American journal of medicine. (1986) 80 3A pp105-109', '10.1016/0002-9343(86)90124-5', '']\n",
      "['9259032', 'Brown BL; Daenzer CL; Hearron MS; Johnson JH. Comparison of two dosing schedules of flurbiprofen for patients with rheumatoid arthritis. Twice-daily versus four-times-a-day schedules. American journal of medicine. (1986) 80 3A pp19-22', '10.1016/0002-9343(86)90106-3', '']\n",
      "['9259033', 'Lomen PL; Turner LF; Lamborn KR; Brinn EL. Flurbiprofen in the treatment of rheumatoid arthritis. A comparison with aspirin. American journal of medicine. (1986) 80 3A pp89-95', '10.1016/0002-9343(86)90120-8', '']\n",
      "['9259034', 'Shand DG; Epstein C; Kinberg-Calhoun J; Mullane JF; Sanda M. The effect of etodolac administration on renal function in patients with arthritis. Journal of clinical pharmacology. (1986) 26 4 pp269-274', '10.1002/j.1552-4604.1986.tb03522.x', '']\n",
      "['9259035', 'Kvien TK; H√∏yeraal HM; Sandstad B. Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. Journal of rheumatology. (1986) 13 1 pp118-123', '10.3109/03009748409111307', '']\n",
      "['9259036', 'Brewer EJ; Giannini EH; Kuzmina N; Alekseev L. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. New England journal of medicine. (1986) 314 20 pp1269-1276', '10.1056/nejm198605153142001', '']\n",
      "['9259037', 'Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol. Quarterly journal of medicine. (1986) 58 225 pp19-27', '10.1093/oxfordjournals.qjmed.a067936', 'http://academic.oup.com/qjmed/article-pdf/58/1/19/4368557/58-1-19.pdf']\n",
      "['9259038', 'Prieur AM; Piussan C; Manigne P; Bordigoni P; Griscelli C; Reinert P; de Goujon F; Lefur JM; Garnier JM. [ Chronic juvenile arthritis. Double-blind study of efficacy and tolerance of D-penicillamine]. Revue du rhumatisme et des maladies osteÃÅo-articulaires. (1986) 53 1 pp13-14', '10.1002/art.1780280404', '']\n",
      "['9259039', 'McLaughlin GE. A double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis. Seminars in arthritis and rheumatism. (1985) 14 3 Suppl 1 pp11-13', '10.1016/0049-0172(85)90054-x', '']\n",
      "['9259040', 'Meisel AD; Germain BF. The efficacy of piroxicam in comparison with sulindac in the treatment of rheumatoid arthritis. Seminars in arthritis and rheumatism. (1985) 14 3 Suppl 1 pp7-10', '10.1016/0049-0172(85)90053-8', '']\n",
      "['9259041', 'Dunagan FM; McGill PE; Kelman AW; Whiting B. Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis. British journal of clinical pharmacology. (1986) 21 4 pp409-416', '10.1111/j.1365-2125.1986.tb05215.x', '']\n",
      "['9259042', 'McCrea JD; Telford AM; Kaye CM; Boyd MW. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis. Current medical research and opinion. (1986) 10 2 pp73-81', '10.1185/03007998609110422', '']\n",
      "['9259043', 'Macfarlane JG; Jalali S; Grace EM. Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. Current medical research and opinion. (1986) 10 2 pp89-93', '10.1185/03007998609110424', '']\n",
      "['9259044', 'Feltelius N; H√§llgren R. Sulphasalazine in ankylosing spondylitis. Annals of the rheumatic diseases. (1986) 45 5 pp396-399', '10.1136/ard.45.5.396', '']\n",
      "['9259045', 'Fumagalli M; Cunietti E; Vaiani G; Monti M; Ferrari F; Gandini R. Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis. Clinical therapeutics. (1986) 8 3 pp292-300', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9259046', 'Carette S; Calin A; McCafferty JP; Wallin BA. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis and rheumatism. (1989) 32 2 pp158-165', '10.1002/anr.1780320208', '']\n",
      "['9259047', 'Bellamy N; Kreeft JH. A comparative analysis of two dosing strategies of flurbiprofen in rheumatoid arthritis: an application of sequential trial design. Clinical and investigative medicine. MeÃÅdecine clinique et experimentale. (1988) 11 6 pp441-445', '10.1007/bf02735394', 'http://link.springer.com/article/10.1007/BF02735394/fulltext.html']\n",
      "['9259048', 'Swinson DR; Booth J; Baker RD. Nefopam in rheumatoid arthritis. Results of a double-blind placebo controlled study. Clinical rheumatology. (1988) 7 3 pp411-412', '10.1007/bf02239203', 'http://link.springer.com/article/10.1007/BF02239203/fulltext.html']\n",
      "['9259049', 'Davis FM; Laurenson VG; Gillespie WJ; Wells JE; Foate J; Newman E. Deep vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia. Journal of bone and joint surgery. British volume. (1989) 71 2 pp181-185', '10.1302/0301-620x.71b2.2925731', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.71B2.2925731']\n",
      "['9259050', 'Frank RG; Kashani JH; Parker JC; Beck NC; Brownlee-Duffeck M; Elliott TR; Haut AE; Atwood C; Smith E; Kay DR. Antidepressant analgesia in rheumatoid arthritis. Journal of rheumatology. (1988) 15 11 pp1632-1638', '10.1037//0735-7028.19.2.206', '']\n",
      "['9259051', 'J√§ntti J; Nikkari T; Solakivi T; Vapaatalo H; Isom√§ki H. Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids. Annals of the rheumatic diseases. (1989) 48 2 pp124-127', '10.1136/ard.48.2.124', '']\n",
      "['9259052', 'Hill JC. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. British journal of ophthalmology. (1989) 73 2 pp151-154', '10.1136/bjo.73.2.151', '']\n",
      "['9259053', 'Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Archives of internal medicine. (1989) 149 4 pp775-779', '10.1001/archinte.1989.00390040017004', '']\n",
      "['9259054', 'Kantharia BK; Goulding NJ; Hall ND; Davies J; Maddison PJ; Bacon PA; Farr M; Wojtulewski JA; Englehart KM; Liyanage SP. Thymopentin (TP-5) in the treatment of rheumatoid arthritis. British journal of rheumatology. (1989) 28 2 pp118-123', '10.1093/rheumatology/28.2.118', 'http://academic.oup.com/rheumatology/article-pdf/28/2/118/5040509/28-2-118.pdf']\n",
      "['9259055', 'Larsen A; Petersson I; Svensson B. Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis. British journal of rheumatology. (1989) 28 2 pp124-127', '10.1093/rheumatology/28.2.124', 'http://academic.oup.com/rheumatology/article-pdf/28/2/124/5040539/28-2-124.pdf']\n",
      "['9259057', 'Job-Deslandre C; Menk√®s CJ. [Treatment of rheumatoid polyarthritis with dapsone. A controlled study versus placebo]. Revue du rhumatisme et des maladies osteÃÅo-articulaires. (1989) 56 4 pp313-316', '10.1016/s1169-8330(03)00330-2', '']\n",
      "['9259058', 'Turner R. Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis. Seminars in arthritis and rheumatism. (1988) 17 3 Suppl 2 pp29-35', '10.1016/0049-0172(88)90042-x', '']\n",
      "['9259059', 'Wallis PJ; Lodwick R; Sinha SK; Constable TJ. Effect of naproxen on renal haemodynamics in elderly patients with arthritis. Age and ageing. (1989) 18 1 pp26-30', '10.1093/ageing/18.1.26', 'http://academic.oup.com/ageing/article-pdf/18/1/26/76476/18-1-26.pdf']\n",
      "['9259060', 'Janssen M; Van Leeuwen MH; Albrecht H; Dijkmans BA. A double-blind parallel group comparative study of lonazolac-calcium and diclofenac in patients with rheumatoid arthritis. Clinical rheumatology. (1988) 7 4 pp545-547', '10.1007/bf02030968', 'http://link.springer.com/article/10.1007/BF02030968/fulltext.html']\n",
      "['9259061', 'Brackertz D; Vischer TL. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study. Journal of rheumatology. (1989) 16 1 pp19-23', '10.1007/bf00270248', 'http://link.springer.com/article/10.1007/BF00270248/fulltext.html']\n",
      "['9259063', 'Soden M; Hassan J; Scott DL; Hanly JG; Moriarty M; Whelan A; Feighery C; Bresnihan B. Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads. Arthritis and rheumatism. (1989) 32 5 pp523-530', '10.1002/anr.1780320503', '']\n",
      "['9259065', 'Furst DE; Koehnke R; Burmeister LF; Kohler J; Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. Journal of rheumatology. (1989) 16 3 pp313-320', '10.1002/jps.2600780219', '']\n",
      "['9259066', 'M√ºller P; Dammann HG; Langer M; Leucht U; Simon B. [Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs]. Zeitschrift fuÃàr Gastroenterologie. (1989) 27 2 pp83-86', '10.1097/00004836-198904000-00012', '']\n",
      "['9259068', 'Ralston SH; Hacking L; Willocks L; Bruce F; Pitkeathly DA. Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis. Annals of the rheumatic diseases. (1989) 48 5 pp396-399', '10.1136/ard.48.5.396', '']\n",
      "['9259069', 'Mart√≠nez RO; Casas H; Mazure PA; Leczycki H; Cosen JN; Canievsky L; Abib A. [Gastroduodenal lesions in rheumatoid arthritis. Evaluation and treatment]. Acta gastroenterologica Latinoamericana. (1988) 18 2 pp87-96', '10.18692/1810-4800-2016-5-59-64', '']\n",
      "['9259070', 'Shepherd HA; Fine D; Hillier K; Jewell R; Cox N. Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs. A pilot study. American journal of medicine. (1989) 86 6A pp49-54', '10.1016/0002-9343(89)90157-5', '']\n",
      "['9259071', 'Berg KJ; Forre O; Djoseland O; Mikkelsen M; Narverud J; Rugstad HE. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clinical nephrology. (1989) 31 5 pp232-238', '10.1038/ki.1986.125', '']\n",
      "['9259072', 'Janke A; Badurski J; Stasiewicz J; Sajewicz I; Namiot Z. Calcitonin versus cimetidine or De-Nol in gastric ulcer treatment. An endoscopically controlled trial. Deutsche Zeitschrift fuÃàr Verdauungs- und Stoffwechselkrankheiten. (1988) 48 5 pp239-243', '10.1007/bf03298078', 'http://link.springer.com/article/10.1007/BF03298078/fulltext.html']\n",
      "['9259073', 'Yamauchi Y; Tsunematsu T; Konda S; Hoshino T; Itokawa Y; Hoshizaki H. [A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA)]. RyuÃÑmachi. [Rheumatism]. (1989) 29 1 pp11-24', '10.1002/art.23361', '']\n",
      "['9259074', 'Taha AS; McLaughlin S; Sturrock RD; Russell RI. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy. British journal of rheumatology. (1989) 28 4 pp329-332', '10.1093/rheumatology/28.4.329', 'http://academic.oup.com/rheumatology/article-pdf/28/4/329/5024441/28-4-329.pdf']\n",
      "['9259075', 'Briancon D. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy. Clinical rheumatology. (1989) 8 Suppl 1  pp63-72', '10.1007/bf02214111', 'http://link.springer.com/article/10.1007/BF02214111/fulltext.html']\n",
      "['9259076', 'Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis. International journal of clinical pharmacology research. (1989) 9 3 pp217-222', '10.1016/s0011-393x(05)80239-5', '']\n",
      "['9259077', 'Preston SJ; Arnold MH; Beller EM; Brooks PM; Buchanan WW. Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. British journal of clinical pharmacology. (1989) 27 5 pp607-611', '10.1111/j.1365-2125.1989.tb03423.x', '']\n",
      "['9259078', 'Punzi L; Schiavon F; Cavasin F; Ramonda R; Gambari PF; Todesco S. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clinical and experimental rheumatology. (1989) 7 3 pp247-250', '10.1007/bf02207661', 'http://link.springer.com/article/10.1007/BF02207661/fulltext.html']\n",
      "['9259079', 'Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (1989) 32 8 pp964-973', '10.1002/anr.1780320805', '']\n",
      "['9259080', 'Huskisson EC; Greenwood A. Four popular anti-inflammatories. Which?. British journal of clinical practice. (1988) 42 10 pp415-418', '10.1111/j.1742-1241.1988.tb08617.x', '']\n",
      "['9259081', 'Riskin WG; Gillings DB; Scarlett JA. Amiprilose hydrochloride for rheumatoid arthritis. Annals of internal medicine. (1989) 111 6 pp455-465', '10.7326/0003-4819-111-6-455', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-111-6-455']\n",
      "['9259082', 'Pavelka K; Sen KP; Pel√≠skov√° Z; V√°cha J; Trnavsk√Ω K. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens. Annals of the rheumatic diseases. (1989) 48 7 pp542-546', '10.1136/ard.48.7.542', '']\n",
      "['9259083', 'Pattrick M; Heptinstall S; Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Annals of the rheumatic diseases. (1989) 48 7 pp547-549', '10.1136/ard.48.7.547', '']\n",
      "['9259084', 'Kaarela K; Lehtinen K; Skinh√∏j A; Andersen F. The effect of different indomethacin formulations in young and elderly patients: a comparative controlled clinical trial. Current medical research and opinion. (1989) 11 7 pp427-431', '10.1185/03007998909115929', '']\n",
      "['9259085', 'Matulis AA; Dadonene IG; Matskevichius ZK. [Efficacy of polyvinylpyrrolidone solutions of various concentrations in patients with rheumatic diseases of the joints]. TerapevticheskiiÃÜ arkhiv. (1989) 61 5 pp108-112', '10.1136/ard.48.8.654', '']\n",
      "['9259086', 'Oliunin IuA; Balabanova RM; Drozdovskiƒ≠ BIa; Ikonnikov AI. [Radioisotope synovectomy in multi-modality treatment of rheumatoid arthritis]. TerapevticheskiiÃÜ arkhiv. (1989) 61 5 pp58-62', '10.14412/1996-7012-2019-1-101-107', 'https://mrj.ima-press.net/mrj/article/viewFile/894/858']\n",
      "['9259087', 'Ciuffetti G; Ciacca A; Mercuri M; Lombardini R; Maragoni G; Scarponi AM. Correlation between clinical and laboratory findings when the whole blood filterability rate is modified by ticlopidine in the treatment of rheumatoid arthritis. British journal of rheumatology. (1989) 28 5 pp424-427', '10.1093/rheumatology/28.5.424', 'http://academic.oup.com/rheumatology/article-pdf/28/5/424/5041736/28-5-424.pdf']\n",
      "['9259088', 'Montrone F; Caruso I; Cazzola M. Salsalate in the treatment of rheumatoid arthritis: a double-blind clinical and gastroscopic trial versus piroxicam. I. Clinical trial. Journal of international medical research. (1989) 17 4 pp316-319', '10.1177/030006058901700402', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058901700402']\n",
      "['9259089', 'Bianchi Porro G; Petrillo M; Ardizzone S. Salsalate in the treatment of rheumatoid arthritis: a double-blind clinical and gastroscopic trial versus piroxicam. II. Endoscopic evaluation. Journal of international medical research. (1989) 17 4 pp320-323', '10.1177/030006058901700403', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058901700403']\n",
      "['9259090', 'Jaji∆í√° I; Markan-Sosi∆í√° V; Sosi∆í√° Z; Jaji∆í√° Z. [Double-blind study of the effects of sulfasalazine in patients with rheumatoid arthritis]. Reumatizam. (1988) 35 1-6 pp66-71', '10.33112/gripla.35.8', '']\n",
      "['9259091', 'Matveƒ≠kov GP; Tsarev VP; Titov LP. [Controlled blind study of the effectiveness of hemosorption in rheumatoid arthritis]. Revmatologiia (Moscow, Russia). (1989)  2 pp15-19', '10.35465/27.1.2019.pp3-15', '']\n",
      "['9259092', 'Tao XL; Sun Y; Dong Y; Xiao YL; Hu DW; Shi YP; Zhu QL; Dai H; Zhang NZ. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chinese medical journal. (1989) 102 5 pp327-332', '10.1002/art.10411', '']\n",
      "['9259093', 'Hauzeur JP; Appelboom T. Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis. Rheumatology international. (1989) 9 2 pp71-76', '10.1007/bf00270248', 'http://link.springer.com/article/10.1007/BF00270248/fulltext.html']\n",
      "['9259094', 'Caldwell JR; Weaver AL; Brown SK; McCormack GH. Endoscopic evaluation of rioprostil in the management of non-steroidal anti-inflammatory drug-induced gastritis: an interim analysis. Scandinavian journal of gastroenterology. Supplement. (1989) 164 164 pp239-241', '10.3109/00365528909091220', '']\n",
      "['9259095', 'Minor MA; Hewett JE; Webel RR; Anderson SK; Kay DR. Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis and rheumatism. (1989) 32 11 pp1396-1405', '10.1002/anr.1780321108', '']\n",
      "['9259096', 'Ogle C. Diclofenac. Connecticut medicine. (1989) 53 10 pp603-604', '10.2307/44369089', 'https://scholarlypublishingcollective.org/uip/chr/article-pdf/doi/10.2307/44369089/1419919/44369089.pdf']\n",
      "['9259097', 'Emery P; Bowman S; Wedderburn L; Grahame R. Suprascapular nerve block for chronic shoulder pain in rheumatoid arthritis. BMJ (Clinical research ed.). (1989) 299 6707 pp1079-1080', '10.1136/bmj.299.6707.1079', '']\n",
      "['9259098', 'Pritchard MH; Munro J. Successful treatment of juvenile chronic arthritis with a specific antiviral agent. British journal of rheumatology. (1989) 28 6 pp521-524', '10.1093/rheumatology/28.6.521', 'http://academic.oup.com/rheumatology/article-pdf/28/6/521/5028478/28-6-521.pdf']\n",
      "['9259099', 'Verstraeten A; Dequeker J; Nijs J; Geusens P. Prevention of postmenopausal bone loss in rheumatoid arthritis patients. A two-year prospective study. Clinical and experimental rheumatology. (1989) 7 4 pp351-358', '10.1016/8756-3282(87)90166-9', '']\n",
      "['9259100', 'Vreugdenhil G; Swaak AJ; Kontoghiorghes GJ; van Eijk HG. Efficacy and safety of oral iron chelator L1 in anaemic rheumatoid arthritis patients. Lancet (London, England). (1989) 2 8676 pp1398-1399', '10.1016/s0140-6736(89)92011-4', '']\n",
      "['9259101', 'Lalos J; Tsachalos P; Gallis L. Long-term (four year) clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1989) 80 80 pp67-70', '10.3109/03009748909103716', '']\n",
      "['9259102', \"O'Brien K; Essigman WK; Little S. A comparison of the effects of tenoxicam and piroxicam on grip strength in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1989) 80  pp81-85\", '10.3109/03009748909103718', '']\n",
      "['9259104', 'Helewa A; Bombardier C; Goldsmith CH; Menchions B; Smythe HA. Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis and rheumatism. (1989) 32 12 pp1505-1514', '10.1002/anr.1780321203', '']\n",
      "['9259106', 'Osborn TG; Parks RL; Moore TL; Grisanti MW; Nesher G; Caciolo BA. Diflunisal versus naproxen in the management of rheumatoid arthritis. Clinical therapeutics. (1989) 11 6 pp736-743', '10.1136/ard.51.3.350', '']\n",
      "['9259107', 'Fioravanti A; Giordano N; Megale F; Jovane D; Franci A; Marcolongo R. [Efficacy and tolerability of flunoxaprofen in the treatment of rheumatoid arthritis. A cross-over clinical study using naproxen]. Clinica terapeutica. (1989) 131 2 pp83-91', '10.1002/art.1780310806', '']\n",
      "['9259108', \"Swift GL; Heneghan M; Williams GT; Williams BD; O'Sullivan MM; Rhodes J. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs. Digestion. (1989) 44 2 pp86-94\", '10.1159/000199896', 'https://www.karger.com/Article/Pdf/199896']\n",
      "['9259109', 'Morgan SL; Baggott JE; Vaughn WH; Young PK; Austin JV; Krumdieck CL; Alarc√≥n GS. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis and rheumatism. (1990) 33 1 pp9-18', '10.1002/art.1780330102', '']\n",
      "['9259110', 'Simpson J; Golding DN; Freeman AM; Cooke D; Hooper PA; Jamieson V; Osborne C. A large multicentre, parallel group, double-blind study comparing tenoxicam and piroxicam in the treatment of osteoarthritis and rheumatoid arthritis. British journal of clinical practice. (1989) 43 9 pp328-333', '10.1111/j.1742-1241.1989.tb08762.x', '']\n",
      "['9259111', 'Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA. Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study. British journal of rheumatology. (1990) 29 1 pp46-49', '10.1093/rheumatology/29.1.46', 'http://academic.oup.com/rheumatology/article-pdf/29/1/46/5040793/29-1-46.pdf']\n",
      "['9259112', 'Lanza F; Rack MF; Doucette M; Ekholm B; Goldlust B; Wilson R. An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen. Journal of rheumatology. (1989) 16 12 pp1570-1574', '10.1007/bf01540567', 'http://link.springer.com/article/10.1007/BF01540567/fulltext.html']\n",
      "['9259114', 'Ekdahl C; Andersson SI; Moritz U; Svensson B. Dynamic versus static training in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1990) 19 1 pp17-26', '10.3109/03009749009092618', '']\n",
      "['9259115', 'Sepp√§l√§ E; Nissil√§ M; Isom√§ki H; Wuorela H; Vapaatalo H. Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1990) 19 1 pp71-75', '10.3109/03009749009092624', '']\n",
      "['9259116', 'Johnson DP. The effect of continuous passive motion on wound-healing and joint mobility after knee arthroplasty. Journal of bone and joint surgery. American volume. (1990) 72 3 pp421-426', '10.2106/00004623-199072030-00016', '']\n",
      "['9259117', 'Boers M; Dijkmans BA; van Rijthoven AW; Goei Th‚àö¬Æ HS; Cats A. Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. Journal of rheumatology. (1990) 17 1 pp38-42', '10.1016/0049-0172(92)90046-g', '']\n",
      "['9259118', \"Murav'ev IuV; Loskutova TT; Anikina NV; Shcherbakov AB; Sokolov VB. The effect of dimethyl sulfoxide on the thromboelastographic indices and the microcirculation in patients with rheumatic diseases. TerapevticheskiiÃÜ arkhiv. (1989) 61 12 pp106-109\", '10.1136/ard.48.12.1023', '']\n",
      "['9259119', 'van der Tempel H; Tulleken JE; Limburg PC; Muskiet FA; van Rijswijk MH. Effects of fish oil supplementation in rheumatoid arthritis. Annals of the rheumatic diseases. (1990) 49 2 pp76-80', '10.1136/ard.49.2.76', '']\n",
      "['9259120', 'Sukenik S; Buskila D; Neumann L; Kleiner-Baumgarten A; Zimlichman S; Horowitz J. Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Annals of the rheumatic diseases. (1990) 49 2 pp99-102', '10.1136/ard.49.2.99', '']\n",
      "['9259121', 'Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial. Arthritis and rheumatism. (1990) 33 3 pp330-338', '10.1002/art.1780330305', '']\n",
      "['9259122', 'Iglehart IW; Sutton JD; Bender JC; Shaw RA; Ziminski CM; Holt PA; Hochberg MC; Zizic TM; Engle EW; Stevens MB. Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study. Journal of rheumatology. (1990) 17 2 pp159-162', '10.1016/s0973-3698(10)60276-2', '']\n",
      "['9259123', 'Roth S; Bennett R; Caldron P; Hartman R; Mitchell C; Doucette M; Ekholm B; Goldlust B; Lee E; Wilson R. Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study. Seminars in arthritis and rheumatism. (1990) 19 4 Suppl 2 pp11-19', '10.1016/0049-0172(90)90025-b', '']\n",
      "['9259124', 'April P; Abeles M; Baraf H; Cohen S; Curran N; Doucette M; Ekholm B; Goldlust B; Knee CM; Lee E. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?. Seminars in arthritis and rheumatism. (1990) 19 4 Suppl 2 pp20-28', '10.1016/0049-0172(82)90069-5', '']\n",
      "['9259127', 'Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?. British journal of rheumatology. (1990) 29 2 pp126-127', '10.1093/rheumatology/29.2.126', 'http://academic.oup.com/rheumatology/article-pdf/29/2/126/5029052/29-2-126.pdf']\n",
      "['9259128', \"Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. Arthritis and rheumatism. (1990) 33 4 pp466-476\", '10.1097/01241398-199009000-00034', '']\n",
      "['9259130', 'Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups. Gastroenterology. (1990) 98 6 pp1549-1557', '10.1016/0016-5085(90)91089-o', '']\n",
      "['9259131', 'Brzeski M; Madhok R; Hunter JA; Capell HA. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis. Annals of the rheumatic diseases. (1990) 49 5 pp293-295', '10.1136/ard.49.5.293', '']\n",
      "['9259132', 'Cush JJ; Jasin HE; Johnson R; Lipsky PE. Relationship between clinical efficacy and laboratory correlates of inflammatory and immunologic activity in rheumatoid arthritis patients treated with nonsteroidal antiinflammatory drugs. Arthritis and rheumatism. (1990) 33 5 pp623-633', '10.1002/art.1780330504', '']\n",
      "['9259133', 'Baerwald C; Goebel KM; Krause A; Heymanns J. A randomized controlled trial of ciamexon versus placebo in the immunomodulatory treatment of rheumatoid arthritis. Arthritis and rheumatism. (1990) 33 5 pp733-738', '10.1002/art.1780330517', '']\n",
      "['9259134', 'Kremer JM; Lawrence DA; Jubiz W; DiGiacomo R; Rynes R; Bartholomew LE; Sherman M. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis and rheumatism. (1990) 33 6 pp810-820', '10.1002/art.1780330607', '']\n",
      "['9259135', 'Hill J; Bird HA; Fenn GC; Lee CE; Woodward M; Wright V. A double-blind crossover study to compare lysine acetyl salicylate (Aspergesic) with ibuprofen in the treatment of rheumatoid arthritis. Journal of clinical pharmacy and therapeutics. (1990) 15 3 pp205-211', '10.1111/j.1365-2710.1990.tb00376.x', '']\n",
      "['9259136', 'Ganz PA. Methods of assessing the effect of drug therapy on quality of life. Drug safety. (1990) 5 4 pp233-242', '10.2165/00002018-199005040-00001', '']\n",
      "['9259137', 'Numo R. Multicentre double-blind study of the efficacy, safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis. Drugs under experimental and clinical research. (1990) 16 1 pp17-27', '10.1177/155989770600600311', '']\n",
      "['9259138', 'Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin]. Ryu√É√ëmachi. [Rheumatism]. (1990) 30 1 pp26-44', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9259139', 'Corkill MM; Kirkham BW; Chikanza IC; Gibson T; Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial. British journal of rheumatology. (1990) 29 4 pp274-279', '10.1093/rheumatology/29.4.274', 'http://academic.oup.com/rheumatology/article-pdf/29/4/274/5028753/29-4-274.pdf']\n",
      "['9259140', 'Pincus T; Olsen NJ; Russell IJ; Wolfe F; Harris ER; Schnitzer TJ; Boccagno JA; Krantz SB. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. American journal of medicine. (1990) 89 2 pp161-168', '10.1016/0002-9343(90)90294-n', '']\n",
      "['9259141', 'Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Annals of the rheumatic diseases. (1990) 49 6 pp354-358', '10.1136/ard.49.6.354', '']\n",
      "['9259142', 'Wong CS; Champion G; Smith MD; Soden M; Wetherall M; Geddes RA; Hill WR; Ahern MJ; Roberts-Thomson PJ. Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study. Annals of the rheumatic diseases. (1990) 49 6 pp370-372', '10.1136/ard.49.6.370', '']\n",
      "['9259143', 'Caperton EM; Heim-Duthoy KL; Matzke GR; Peterson PK; Johnson RC. Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial. Archives of internal medicine. (1990) 150 8 pp1677-1682', '10.1001/archinte.1990.00040031677015', '']\n",
      "['9259144', 'Capell HA; Marabani M; Madhok R; Torley H; Hunter JA. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Quarterly journal of medicine. (1990) 75 276 pp335-344', '10.1093/oxfordjournals.qjmed.a068442', 'http://academic.oup.com/qjmed/article-pdf/75/1/335/4497887/75-1-335.pdf']\n",
      "['9259145', 'Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. BMJ (Clinical research ed.). (1990) 301 6746 pp268-270', '10.1136/bmj.301.6746.268', '']\n",
      "['9259146', 'Lawrence AG; Houang ET; Hiscock E; Wells MB; Colli E; Scatigna M. Single dose therapy of vaginal candidiasis: a comparative trial of fenticonazole vaginal ovules versus clotrimazole vaginal tablets. Current medical research and opinion. (1990) 12 2 pp114-120', '10.1185/03007999009110479', '']\n",
      "['9259147', \"Bacon P; Luqmani RA; Barry C; Foley-Nolan D; Grahame R; West J; Hazleman BL; Adebajo AO; Hughes GR; Abdullah M. A comparison of two formulations of indomethacin ('Flexin Continus' tablets and 'Indocid' capsules) in the treatment of rheumatoid arthritis. Current medical research and opinion. (1990) 12 2 pp121-127\", '10.1185/03007999009110480', '']\n",
      "['9259148', 'Le Gallez P; Bird HA; Wright V. A comparison of choline magnesium trisalicylate and acetylsalicylic acid in patients with rheumatoid arthritis. Current medical research and opinion. (1990) 12 2 pp71-75', '10.1185/03007999009110473', '']\n",
      "['9259149', 'Atkinson MH; Buchanan WW; Fitzgerald AA; Lussier A; Tannenbaum HH. A comparison of flurbiprofen and naproxen in the treatment of rheumatoid arthritis: a Canadian multi-centre study. Current medical research and opinion. (1990) 12 2 pp76-85', '10.1185/03007999009110474', '']\n",
      "['9259150', 'Eriksson LO; Sturfelt G; Thysell H; Wollheim FA. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. American journal of medicine. (1990) 89 3 pp313-321', '10.1016/0002-9343(90)90344-d', '']\n",
      "['9259151', 'Bassam B; Balabanova RM. [The efficacy of immunomodulating therapy in rheumatoid arthritis]. TerapevticheskiiÃÜ arkhiv. (1990) 62 5 pp32-35', '10.14412/1995-4484-2003-1366', '']\n",
      "['9259152', 'Sukenik S; Neumann L; Buskila D; Kleiner-Baumgarten A; Zimlichman S; Horowitz J. Dead Sea bath salts for the treatment of rheumatoid arthritis. Clinical and experimental rheumatology. (1990) 8 4 pp353-357', '10.1136/ard.49.2.99', '']\n",
      "['9259154', 'Tulleken JE; Limburg PC; Muskiet FA; van Rijswijk MH. Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis. Arthritis and rheumatism. (1990) 33 9 pp1416-1419', '10.1002/art.1780330914', '']\n",
      "['9259155', 'Giannini EH; Brewer EJ; Miller ML; Gibbas D; Passo MH; Hoyeraal HM; Bernstein B; Person DA; Fink CW; Sawyer LA. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. Journal of pediatrics. (1990) 117 4 pp645-652', '10.1016/s0022-3476(05)80708-5', '']\n",
      "['9259156', 'Dennison WB; Loeser RF; Turner RA; Johnson JA; Wells HB. A double blind placebo controlled trial of low dose clotrimazole in rheumatoid arthritis. Journal of rheumatology. (1990) 17 8 pp1003-1007', '10.3109/9780203214237-61', '']\n",
      "['9259157', 'Enis JE; Gardner R; Robledo MA; Latta L; Smith R. Comparison of patellar resurfacing versus nonresurfacing in bilateral total knee arthroplasty. Clinical orthopaedics and related research. (1990) 260 260 pp38-42', '10.1097/00003086-199011000-00008', '']\n",
      "['9259158', 'Bacon PA. An overview of the efficacy of etodolac in arthritic disorders. European journal of rheumatology and inflammation. (1990) 10 1 pp22-34', '10.1007/bf02274749', 'http://link.springer.com/article/10.1007/BF02274749/fulltext.html']\n",
      "['9259159', 'Kazis LE; Callahan LF; Meenan RF; Pincus T. Health status reports in the care of patients with rheumatoid arthritis. Journal of clinical epidemiology. (1990) 43 11 pp1243-1253', '10.1016/0895-4356(90)90025-k', '']\n",
      "['9259161', 'Verstraeten A; Sileghem A; Dequeker J. OM-8980 and D-penicillamine in the treatment of rheumatoid arthritis. A 12-month double-blind randomized study. Scandinavian journal of rheumatology. (1990) 19 6 pp422-431', '10.3109/03009749009097631', '']\n",
      "['9259162', 'Vischer TL. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis. Clinical rheumatology. (1990) 9 3 pp356-361', '10.1007/bf02114396', 'http://link.springer.com/article/10.1007/BF02114396/fulltext.html']\n",
      "['9259163', 'Crowley B; Hamill JJ; Lyndon S; McKellican JF; Williams P; Miller AJ. Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial. Current medical research and opinion. (1990) 12 3 pp143-150', '10.1185/03007999009111495', '']\n",
      "['9259165', 'Boers M; Dijkmans BA; Breedveld FC; Camps JA; Chang PC; Van Brummelen P; Pauwels EK; Cats A. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. British journal of rheumatology. (1991) 30 1 pp56-59', '10.1093/rheumatology/30.1.56', 'http://academic.oup.com/rheumatology/article-pdf/30/1/56/5041302/30-1-56.pdf']\n",
      "['9259166', 'Smith DM; Johnson JA; Loeser R; Turner RA. Evaluation of Tenidap (CP-66,248) on human neutrophil arachidonic acid metabolism, chemotactic potential and clinical efficacy in the treatment of rheumatoid arthritis. Agents and actions. (1990) 31 1-2 pp102-109', '10.1007/bf02003228', 'http://link.springer.com/article/10.1007/BF02003228/fulltext.html']\n",
      "['9259167', 'Evard F; Neumann V; Hopkins R; Wright V. Pulsed methylprednisolone therapy in rheumatoid arthritis. Annals of the rheumatic diseases. (1991) 50 1 pp66', '10.1136/ard.50.1.66-a', '']\n",
      "['9259168', 'Chatham W; Williams G; Moreland L; Parker JW; Ross C; Alarc√≥n SG; Alarc√≥n GS. Intraarticular corticosteroid injections: should we rest the joints?. Arthritis care and research. (1989) 2 2 pp70-74', '10.1002/anr.1790020209', '']\n",
      "['9259169', 'Bianchi Porro G; Caruso I; Petrillo M; Montrone F; Ardizzone S. A double-blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients. Journal of internal medicine. (1991) 229 1 pp5-8', '10.1111/j.1365-2796.1991.tb00298.x', '']\n",
      "['9259170', 'Buckley LM; Vacek PM; Cooper SM. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Journal of rheumatology. (1990) 17 9 pp1158-1161', '10.1002/cca.371', '']\n",
      "['9259171', 'Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis and rheumatism. (1991) 34 3 pp287-295', '10.1002/art.1780340306', '']\n",
      "['9259172', 'Saul PA; Korlipara K. Acemetacin and indomethacin in the treatment of rheumatoid arthritis: a double-blind comparative study in general practice. Current medical research and opinion. (1991) 12 5 pp332-341', '10.1185/03007999109112669', '']\n",
      "['9259173', 'Stothard J; Thompson AE; Sherris D. Correction of ulnar drift during silastic metacarpo-phalangeal joint arthroplasty. Journal of hand surgery (Edinburgh, Scotland). (1991) 16 1 pp61-65', '10.1016/0266-7681(91)90129-c', 'https://journals.sagepub.com/doi/pdf/10.1016/0266-7681%2891%2990129-C']\n",
      "['9259174', 'Lancaster-Smith MJ; Jaderberg ME; Jackson DA. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut. (1991) 32 3 pp252-255', '10.1136/gut.32.3.252', '']\n",
      "['9259175', 'Furst DE; Erikson N; Clute L; Koehnke R; Burmeister LF; Kohler JA. Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. Journal of rheumatology. (1990) 17 12 pp1628-1635', '10.1093/rheumatology/kev088.077', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i80/5180100/kev088.077.pdf']\n",
      "['9259176', 'Pullar T; Wrigley H; Newton K; Toothill C; Wright V. A study of adjunctive copper sulphate treatment in patients with rheumatoid arthritis who have relapsed while taking D-penicillamine. British journal of clinical pharmacology. (1991) 31 1 pp105-107', '10.1111/j.1365-2125.1991.tb03866.x', '']\n",
      "['9259177', 'Wykman A; Olsson E; Axdorph G; Goldie I. Total hip arthroplasty. A comparison between cemented and press-fit noncemented fixation. Journal of arthroplasty. (1991) 6 1 pp19-29', '10.1016/s0883-5403(06)80153-1', '']\n",
      "['9259178', 'Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis. Clinical rheumatology. (1990) 9 4 pp461-474', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9259179', \"Wijnands M; van Riel P; van 't Hof M; Gribnau F; van de Putte L. Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study. Journal of rheumatology. (1991) 18 2 pp184-187\", '10.3109/03009749109165922', '']\n",
      "['9259180', 'Chard MD; Crisp AJ. Astemizole, an H1 antagonist, has no additional therapeutic effect in rheumatoid arthritis. Journal of rheumatology. (1991) 18 2 pp203-204', '10.1093/rheumatology/23.3.232-a', 'http://academic.oup.com/rheumatology/article-pdf/23/3/232/5040205/23-3-232b.pdf']\n",
      "['9259182', 'de Queiros MF. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis. Clinical therapeutics. (1991) 13 1 pp38-46', '10.1185/03007999109111660', '']\n",
      "['9259183', 'Helewa A; Goldsmith CH; Lee P; Bombardier C; Hanes B; Smythe HA; Tugwell P. Effects of occupational therapy home service on patients with rheumatoid arthritis. Lancet (London, England). (1991) 337 8755 pp1453-1456', '10.1016/0140-6736(91)93138-y', '']\n",
      "['9259184', 'Borg AA; Davis MJ; Fowler PD; Shadforth MF; Dawes PT. Rifampicin in early rheumatoid arthritis. Scandinavian journal of rheumatology. (1993) 22 1 pp39-42', '10.3109/03009749309095110', '']\n",
      "['9259185', 'Ahern MJ; Wetherall M; Leslie A; James RH; Roberts-Thomson PJ; Rennie GC. A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis. British journal of clinical practice. (1992) 46 4 pp229-233', '10.1111/j.1742-1241.1992.tb10353.x', '']\n",
      "['9259186', 'Minor MA; Brown JD. Exercise maintenance of persons with arthritis after participation in a class experience. Health education quarterly. (1993) 20 1 pp83-95', '10.1177/109019819302000108', 'https://journals.sagepub.com/doi/pdf/10.1177/109019819302000108']\n",
      "['9259187', 'Sheeran TP; Roobottom CA; Wanklyn PD; Winkles J; Richardson K; Emery P. The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis. Clinical and experimental rheumatology. (1993) 11 1 pp49-52', '10.1093/rheumatology/32.4.319', 'http://academic.oup.com/rheumatology/article-pdf/32/4/319/5030351/32-4-319.pdf']\n",
      "['9259188', 'Dick WC; Franchimont P; Veys E. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis. Clinical therapeutics. (1993) 15 1 pp148-159', '10.1185/03007999109111660', '']\n",
      "['9259189', \"O'Connor TP; Anderson AM; Lennox B; Muldoon C. A novel sustained-release formulation of ibuprofen provides effective once-daily therapy in the treatment of rheumatoid arthritis and osteoarthritis. British journal of clinical practice. (1993) 47 1 pp10-13\", '10.1111/j.1742-1241.1993.tb10373.x', '']\n",
      "['9259190', \"Gravenmade EJ; Vissink A. Mucin-containing lozenges in the treatment of intraoral problems associated with Sj√∂gren's syndrome. A double-blind crossover study in 42 patients. Oral surgery, oral medicine, and oral pathology. (1993) 75 4 pp466-471\", '10.1016/0030-4220(93)90172-z', '']\n",
      "['9259191', 'Haugen MA; Kjeldsen-Kragh J; Skakkebaek N; Landaas S; Sjaastad O; Movinkel P; F√∏rre O. The influence of fast and vegetarian diet on parameters of nutritional status in patients with rheumatoid arthritis. Clinical rheumatology. (1993) 12 1 pp62-69', '10.1007/bf02231561', 'http://link.springer.com/article/10.1007/BF02231561/fulltext.html']\n",
      "['9259193', 'Gado K; Emery P. Modified suprascapular nerve block with bupivacaine alone effectively controls chronic shoulder pain in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1993) 52 3 pp215-218', '10.1136/ard.52.3.215', '']\n",
      "['9259194', 'van den Brink HR; Lems WF; van Everdingen AA; Bijlsma JW. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Annals of the rheumatic diseases. (1993) 52 4 pp302-305', '10.1136/ard.52.4.302', '']\n",
      "['9259195', 'Seideman P; Beck O; Eksborg S; Wennberg M. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1993) 35 4 pp409-412', '10.1111/j.1365-2125.1993.tb04158.x', '']\n",
      "['9259196', 'Weinblatt ME; Polisson R; Blotner SD; Sosman JL; Aliabadi P; Baker N; Weissman BN. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis and rheumatism. (1993) 36 5 pp613-619', '10.1002/art.1780360507', '']\n",
      "['9259197', 'Lemmel EM. Comparison of pyritinol and auranofin in the treatment of rheumatoid arthritis. The European Multicentre Study Group. British journal of rheumatology. (1993) 32 5 pp375-382', '10.1093/rheumatology/32.5.375', 'http://academic.oup.com/rheumatology/article-pdf/32/5/375/5041782/32-5-375.pdf']\n",
      "['9259198', 'Brighton SW; Lubbe JE; van der Merwe CA. The effect of a long-term exercise programme on the rheumatoid hand. British journal of rheumatology. (1993) 32 5 pp392-395', '10.1093/rheumatology/32.5.392', 'http://academic.oup.com/rheumatology/article-pdf/32/5/392/5041968/32-5-392.pdf']\n",
      "['9259200', 'Loftus JK; Reeve J; Hesp R; David J; Ansell BM; Woo PM. Deflazacort in juvenile chronic arthritis. Journal of rheumatology. Supplement. (1993) 37  pp40-42', '10.1093/rheumatology/32.suppl_2.31', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_2/31/5041428/32-suppl_2-31.pdf']\n",
      "['9259201', 'Shiroky JB; Neville C; Esdaile JM; Choquette D; Zummer M; Hazeltine M; Bykerk V; Kanji M; St-Pierre A; Robidoux L. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (1993) 36 6 pp795-803', '10.1002/art.1780360609', '']\n",
      "['9259202', 'Furst DE; Anderson W. Differential effects of diclofenac and aspirin on serum glutamic oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritis. Arthritis and rheumatism. (1993) 36 6 pp804-810', '10.1002/art.1780360610', '']\n",
      "['9259203', 'Loose LD; Sipe JD; Kirby DS; Kraska AR; Weiner ES; Shanahan WR; Leeming MR; Farrow P; Stack CB; Ting N. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. British journal of rheumatology. (1993) 32 Suppl 3  pp19-25', '10.1093/rheumatology/32.suppl_3.19', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_3/19/5029125/32-suppl_3-19.pdf']\n",
      "['9259204', \"Porter DR; Capell HA. The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. British journal of rheumatology. (1993) 32 6 pp463-466\", '10.1093/rheumatology/32.6.463', 'http://academic.oup.com/rheumatology/article-pdf/32/6/463/5029848/32-6-463.pdf']\n",
      "['9259205', \"Fox PC; Datiles M; Atkinson JC; Macynski AA; Scott J; Fletcher D; Valdez IH; Kurrasch RH; Delapenha R; Jackson W. Prednisone and piroxicam for treatment of primary Sj√∂gren's syndrome. Clinical and experimental rheumatology. (1993) 11 2 pp149-156\", '10.1097/00002281-199609000-00008', '']\n",
      "['9259206', 'Zuinen C. Diclofenac/misoprostol vs diclofenac/placebo in treating acute episodes of tendinitis/bursitis of the shoulder. Drugs. (1993) 45 Suppl 1  pp17-23', '10.2165/00003495-199300451-00006', '']\n",
      "['9259207', 'Hansen TM; Hansen G; Langgaard AM; Rasmussen JO. Longterm physical training in rheumatoid arthritis. A randomized trial with different training programs and blinded observers. Scandinavian journal of rheumatology. (1993) 22 3 pp107-112', '10.3109/03009749309099253', '']\n",
      "['9259208', 'Haar D; S‚àö‚àèlvkjaer M; Unger B; Rasmussen KJ; Christensen L; Hansen TM. A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. Scandinavian journal of rheumatology. (1993) 22 3 pp113-118', '10.3109/03009749309099254', '']\n",
      "['9259209', 'Sharp JT; Wolfe F; Corbett M; Isomaki H; Mitchell DM; Furst DE; Sibley J; Shipley M. Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification?. Annals of the rheumatic diseases. (1993) 52 5 pp332-337', '10.1136/ard.52.5.332', '']\n",
      "['9259210', \"Kruize AA; Hen√© RJ; Kallenberg CG; van Bijsterveld OP; van der Heide A; Kater L; Bijlsma JW. Hydroxychloroquine treatment for primary Sj√∂gren's syndrome: a two year double blind crossover trial. Annals of the rheumatic diseases. (1993) 52 5 pp360-364\", '10.1136/ard.52.5.360', '']\n",
      "['9259211', 'Choy EH; Kingsley GH. Anti-CD4 therapy in rheumatoid arthritis. Clinical and experimental rheumatology. (1993) 11 Suppl 8  ppS147-9', '10.1093/rheumatology/32.suppl_4.39', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_4/39/5041847/32-suppl_4-39.pdf']\n",
      "['9259212', 'Woodworth TG. Early clinical studies of IL-2 fusion toxin in patients with severe rheumatoid arthritis and recent onset insulin-dependent diabetes mellitus. Clinical and experimental rheumatology. (1993) 11 Suppl 8  ppS177-80', '10.1201/9781482273533-12', '']\n",
      "['9259213', 'Lonauer G; Tisscher JR; Lim HG; Bijlsma JW. Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis. Current medical research and opinion. (1993) 13 2 pp70-77', '10.1185/03007999309111535', '']\n",
      "['9259214', 'Geisslinger G; Stock KP; Loew D; Bach GL; Brune K. Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1993) 35 6 pp603-607', '10.1111/j.1365-2125.1993.tb04189.x', '']\n",
      "['9259215', 'Hoenig H; Groff G; Pratt K; Goldberg E; Franck W. A randomized controlled trial of home exercise on the rheumatoid hand. Journal of rheumatology. (1993) 20 5 pp785-789', '10.21203/rs.3.rs-4230565/v1', 'https://www.researchsquare.com/article/rs-4230565/v1']\n",
      "['9259217', 'Choy EH; Kingsley GH; Corkill MM; Panayi GS. Intramuscular methylprednisolone is superior to pulse oral methylprednisolone during the induction phase of chrysotherapy. British journal of rheumatology. (1993) 32 8 pp734-739', '10.1093/rheumatology/32.8.734', 'http://academic.oup.com/rheumatology/article-pdf/32/8/734/5031562/32-8-734.pdf']\n",
      "['9259218', 'M√ºller-Fassbender HR. A 6-month randomized dose range study of OM-8980 in rheumatoid arthritis. British journal of rheumatology. (1993) 32 8 pp746-750', '10.1093/rheumatology/32.8.746', 'http://academic.oup.com/rheumatology/article-pdf/32/8/746/5031773/32-8-746.pdf']\n",
      "['9259219', 'Seideman P. Methotrexate--the relationship between dose and clinical effect. British journal of rheumatology. (1993) 32 8 pp751-753', '10.1093/rheumatology/32.8.751', 'http://academic.oup.com/rheumatology/article-pdf/32/8/751/5031872/32-8-751.pdf']\n",
      "['9259220', 'Kirkham BW; Davison SC; Corkill MM; Barbatis C; Panayi GS. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy. Journal of rheumatology. (1993) 20 6 pp935-939', '10.1093/rheumatology/29.4.274', 'http://academic.oup.com/rheumatology/article-pdf/29/4/274/5028753/29-4-274.pdf']\n",
      "['9259221', 'Weinblatt ME; Maier AL; Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. Journal of rheumatology. (1993) 20 6 pp950-952', '10.3109/9780203214237-213', '']\n",
      "['9259222', 'Hoza J; Kadlecov√° T; Nƒïmcov√° D; Havelka S. Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis. Acta Universitatis Carolinae. Medica. (1991) 37 1-2 pp80-83', '10.1007/bf00332561', 'http://link.springer.com/article/10.1007/BF00332561/fulltext.html']\n",
      "['9259223', 'Marchesoni A; Sinigaglia L; Ranza R; Varenna M; Battafarano N; Tosi S. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. Scandinavian journal of rheumatology. (1993) 22 4 pp194-198', '10.3109/03009749309099270', '']\n",
      "['9259224', 'Eversmeyer W; Poland M; DeLapp RE; Jensen CP. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. American journal of medicine. (1993) 95 2A pp10S-18S', '10.1016/0002-9343(93)90391-2', '']\n",
      "['9259225', 'Morgan GJ; Poland M; DeLapp RE. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. American journal of medicine. (1993) 95 2A pp19S-27S', '10.1016/0002-9343(93)90392-3', '']\n",
      "['9259226', 'Lister BJ; Poland M; DeLapp RE. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. American journal of medicine. (1993) 95 2A pp2S-9S', '10.1016/0002-9343(93)90390-b', '']\n",
      "['9259227', 'Seideman P. Better effect of methotrexate on C-reactive protein during daily compared to weekly treatment in rheumatoid arthritis. Clinical rheumatology. (1993) 12 2 pp210-213', '10.1007/bf02231528', 'http://link.springer.com/article/10.1007/BF02231528/fulltext.html']\n",
      "['9259228', 'Henriksson K; Uribe A; Sandstedt B; Nord CE. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis. Digestive diseases and sciences. (1993) 38 9 pp1688-1696', '10.1007/bf01303179', 'http://link.springer.com/article/10.1007/BF01303179/fulltext.html']\n",
      "['9259229', 'Kovarik JM; Mueller EA; Gaber M; Johnston A; J√§hnchen E. Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration. Journal of clinical pharmacology. (1993) 33 6 pp513-521', '10.1002/j.1552-4604.1993.tb04697.x', '']\n",
      "['9259230', 'Goldby LJ; Scott DL. The way forward for hydrotherapy. British journal of rheumatology. (1993) 32 9 pp771-773', '10.1093/rheumatology/32.9.771', 'http://academic.oup.com/rheumatology/article-pdf/32/9/771/5041768/32-9-771.pdf']\n",
      "['9259231', 'Sany J; Anaya JM; Canovas F; Combe B; Jorgensen C; Saker S; Thaury MN; Gavroy JP. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. Journal of rheumatology. (1993) 20 7 pp1129-1132', '10.1002/art.1780371210', '']\n",
      "['9259232', 'Nobunaga M; Yasuda M. Comparison of clinical effects of bucillamine between additive combination and single administration study in rheumatoid arthritis. Agents and actions. Supplements. (1993) 44  pp105-109', '10.1007/bf02242941', 'http://link.springer.com/article/10.1007/BF02242941/fulltext.html']\n",
      "['9259233', 'Trentham DE; Dynesius-Trentham RA; Orav EJ; Combitchi D; Lorenzo C; Sewell KL; Hafler DA; Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science (New York, N.Y.). (1993) 261 5129 pp1727-1730', '10.1126/science.8378772', '']\n",
      "['9259234', 'Goemaere S; Ackerman C; Veys EM; Mielants H; Popelier N; Thompson PW. A double-blind study to determine the duration of action of flurbiprofen in a sustained release preparation. Clinical and experimental rheumatology. (1993) 11 4 pp405-408', '10.1093/rheumatology/32.6.521', 'http://academic.oup.com/rheumatology/article-pdf/32/6/521/5030947/32-6-521.pdf']\n",
      "['9259235', 'Yamashita I; Miyatsu M; Kamo Y; Atsuta Y; Onozawa T. [Effect of 1 alpha-OH-D3 on the bone metabolism after high tibial osteotomy]. Nihon Seikeigeka Gakkai zasshi. (1993) 67 9 pp804-815', '10.2169/naika.82.1923', '']\n",
      "['9259236', 'Dreiser RL. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis. Rheumatology international. (1993) 13 2 Suppl ppS13-8', '10.1007/bf00290279', 'http://link.springer.com/article/10.1007/BF00290279/fulltext.html']\n",
      "['9259237', 'Schattenkirchner M. The safety profile of sustained-release etodolac. Rheumatology international. (1993) 13 2 Suppl ppS31-5', '10.1007/bf00290282', 'http://link.springer.com/article/10.1007/BF00290282/fulltext.html']\n",
      "['9259238', \"Laan RF; van Riel PL; van de Putte LB; van Erning LJ; van't Hof MA; Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Annals of internal medicine. (1993) 119 10 pp963-968\", '10.7326/0003-4819-119-10-199311150-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-119-10-199311150-00001']\n",
      "['9259239', 'Leventhal LJ; Boyce EG; Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Annals of internal medicine. (1993) 119 9 pp867-873', '10.7326/0003-4819-119-9-199311010-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-119-9-199311010-00001']\n",
      "['9259240', 'L‚àö‚â•pez-M‚àö¬©ndez A; Daniel WW; Reading JC; Ward JR; Alarc‚àö‚â•n GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis and rheumatism. (1993) 36 10 pp1364-1369', '10.1002/art.1780361006', '']\n",
      "['9259241', 'van der Lubbe PA; Reiter C; Breedveld FC; Kr√ºger K; Schattenkirchner M; Sanders ME; Riethm√ºller G. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis and rheumatism. (1993) 36 10 pp1375-1379', '10.1002/art.1780361008', '']\n",
      "['9259243', 'Lau CS; Morley KD; Belch JJ. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study. British journal of rheumatology. (1993) 32 11 pp982-989', '10.1093/rheumatology/32.11.982', 'http://academic.oup.com/rheumatology/article-pdf/32/11/982/5031010/32-11-982.pdf']\n",
      "['9259244', 'Peltonen R; Toivanen P; Eerola E. Effect of a non-steroidal anti-inflammatory drug, naproxen, on faecal microbial flora. British journal of rheumatology. (1993) 32 11 pp996-999', '10.1093/rheumatology/32.11.996', 'http://academic.oup.com/rheumatology/article-pdf/32/11/996/5031171/32-11-996.pdf']\n",
      "['9259245', \"Uddenfeldt P; Leden I; Rubin B. A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening. Current medical research and opinion. (1993) 13 3 pp127-132\", '10.1185/03007999309111541', '']\n",
      "['9259246', 'Jallad NS; Cattan A; Weidler DJ. Efficacy of misoprostol in controlling indomethacin induced fecal blood loss in arthritic patients. International journal of clinical pharmacology, therapy, and toxicology. (1993) 31 8 pp376-381', '10.1097/00000441-198611000-00004', '']\n",
      "['9259247', 'Rooney TW; Furst DE; Koehnke R; Burmeister L. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. Journal of rheumatology. (1993) 20 8 pp1297-1302', '10.1097/bor.0b013e3282fb7caa', '']\n",
      "['9259248', 'Giannini EH; Cassidy JT; Brewer EJ; Shaikov A; Maximov A; Kuzmina N. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Seminars in arthritis and rheumatism. (1993) 23 1 pp34-46', '10.1016/s0049-0172(05)80025-3', '']\n",
      "['9259252', 'al-Quorain AA; Satti MB; Marwah S; al-Nahdi M; al-Habdan I. Non-steroidal anti-inflammatory drug-induced gastropathy: a comparative endoscopic and histopathological evaluation of the effects of tenoxicam and diclofenac. Journal of international medical research. (1993) 21 2 pp89-97', '10.1177/030006059302100204', 'https://journals.sagepub.com/doi/pdf/10.1177/030006059302100204']\n",
      "['9259253', 'Faur√© BT; Benjamin JB; Lindsey B; Volz RG; Schutte D. Comparison of the subvastus and paramedian surgical approaches in bilateral knee arthroplasty. Journal of arthroplasty. (1993) 8 5 pp511-516', '10.1016/s0883-5403(06)80022-7', '']\n",
      "['9259254', 'Seideman P. Additive effect of combined naproxen and paracetamol in rheumatoid arthritis. British journal of rheumatology. (1993) 32 12 pp1077-1082', '10.1093/rheumatology/32.12.1077', 'http://academic.oup.com/rheumatology/article-pdf/32/12/1077/5041831/32-12-1077.pdf']\n",
      "['9259255', 'Heussler JK; Hinchey G; Margiotta E; Quinn R; Butler P; Martin J; Sturgess AD. A double blind randomised trial of low power laser treatment in rheumatoid arthritis. Annals of the rheumatic diseases. (1993) 52 10 pp703-706', '10.1136/ard.52.10.703', '']\n",
      "['9259257', 'Curkoviƒá B; Vituliƒá V; Babiƒá-Nagliƒá D; D√ºrrigl T. The influence of heat and cold on the pain threshold in rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (1993) 52 5 pp289-291', '10.1002/art.1790060308', '']\n",
      "['9259259', 'Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. Scandinavian journal of gastroenterology. (1993) 28 10 pp875-878', '10.3109/00365529309103128', '']\n",
      "['9259260', 'Rauma AL; Nenonen M; Helve T; H√§nninen O. Effect of a strict vegan diet on energy and nutrient intakes by Finnish rheumatoid patients. European journal of clinical nutrition. (1993) 47 10 pp747-749', '10.1079/bjn2000234', '']\n",
      "['9259261', 'Baslund B; Lyngberg K; Andersen V; Halkjaer Kristensen J; Hansen M; Klokker M; Pedersen BK. Effect of 8 wk of bicycle training on the immune system of patients with rheumatoid arthritis. Journal of applied physiology (Bethesda, Md. : 1985). (1993) 75 4 pp1691-1695', '10.1152/jappl.1993.75.4.1691', '']\n",
      "['9259262', 'Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. Journal of rheumatology. (1993) 20 11 pp1845-1849', '10.1093/rheumatology/36.1.86', 'http://academic.oup.com/rheumatology/article-pdf/36/1/86/18104735/360086.pdf']\n",
      "['9259263', 'Cannon GW; Emkey RD; Denes A; Cohen SA; Saway PA; Wolfe F; Jaffer AM; Weaver AL; Manaster BJ; McCarthy KA. Prospective 5-year followup of recombinant interferon-gamma in rheumatoid arthritis. Journal of rheumatology. (1993) 20 11 pp1867-1873', '10.1002/anr.1780320805', '']\n",
      "['9259264', 'van den Brink HR; van Everdingen AA; van Wijk MJ; Jacobs JW; Bijlsma JW. Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1993) 52 12 pp862-865', '10.1136/ard.52.12.862', '']\n",
      "['9259265', 'MacDonald AG; Murphy EA; Capell HA; Bankowska UZ; Ralston SH. Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. Annals of the rheumatic diseases. (1994) 53 1 pp54-57', '10.1136/ard.53.1.54', '']\n",
      "['9259266', 'Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases. European journal of clinical pharmacology. (1993) 45 Suppl 1  ppS29-34', '10.1007/bf01844201', 'http://link.springer.com/article/10.1007/BF01844201/fulltext.html']\n",
      "['9259267', 'Lenderking WR; Gelber RD; Cotton DJ; Cole BF; Goldhirsch A; Volberding PA; Testa MA. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. New England journal of medicine. (1994) 330 11 pp738-743', '10.1056/nejm199403173301102', '']\n",
      "['9259268', 'Gough A; Sheeran T; Arthur V; Panayi G; Emery P. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study. Scandinavian journal of rheumatology. (1994) 23 1 pp46-48', '10.3109/03009749409102135', '']\n",
      "['9259269', 'Galeazzi M; Marcolongo R. A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs under experimental and clinical research. (1993) 19 3 pp107-115', '10.2165/00044011-199917020-00002', '']\n",
      "['9259271', 'van der Lubbe PA; Reiter C; Miltenburg AM; Kr√ºger K; de Ruyter AN; Rieber EP; Bijl JA; Riethm√ºller G; Breedveld FC. Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action. Scandinavian journal of immunology. (1994) 39 3 pp286-294', '10.1111/j.1365-3083.1994.tb03373.x', '']\n",
      "['9259272', 'Hall GM; Daniels M; Huskisson EC; Spector TD. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Annals of the rheumatic diseases. (1994) 53 2 pp112-116', '10.1136/ard.53.2.112', '']\n",
      "['9259274', 'Neuberger GB; Smith KV; Black SO; Hassanein R. Promoting self-care in clients with arthritis. Arthritis care and research. (1993) 6 3 pp141-148', '10.1002/art.1790060306', '']\n",
      "['9259275', 'Zvereva KV; Gladkova ND; Grunina EA; Logunov PL. [The choice of the method for intravascular laser therapy in rheumatoid arthritis]. TerapevticheskiiÃÜ arkhiv. (1994) 66 1 pp29-32', '10.1007/3-540-29662-x_180', '']\n",
      "['9259276', 'Yasuda M; Sakai K; Oribe M; Yoshioka K; Takahashi H; Ohtsuka E; Wada T; Shiokawa S; Yamamoto M; Ichibangase Y. Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate. Journal of rheumatology. (1994) 21 1 pp44-50', '10.1007/bf02242941', 'http://link.springer.com/article/10.1007/BF02242941/fulltext.html']\n",
      "['9259277', 'Helewa A; Smythe HA; Goldsmith CH. Can specially trained physiotherapists improve the care of patients with rheumatoid arthritis? A randomized health care trial. Journal of rheumatology. (1994) 21 1 pp70-79', '10.1002/anr.1780321203', '']\n",
      "['9259278', 'McLachlan AJ; Tett SE; Cutler DJ; Day RO. Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis. British journal of rheumatology. (1994) 33 3 pp235-239', '10.1093/rheumatology/33.3.235', 'http://academic.oup.com/rheumatology/article-pdf/33/3/235/5030528/33-3-235.pdf']\n",
      "['9259279', 'Hill J; Bird HA; Harmer R; Wright V; Lawton C. An evaluation of the effectiveness, safety and acceptability of a nurse practitioner in a rheumatology outpatient clinic. British journal of rheumatology. (1994) 33 3 pp283-288', '10.1093/rheumatology/33.3.283', 'http://academic.oup.com/rheumatology/article-pdf/33/3/283/5031366/33-3-283.pdf']\n",
      "['9259280', 'Lambert CM; Hurst NP; Lochhead A; McGregor K; Hunter M; Forbes J. A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. British journal of rheumatology. (1994) 33 4 pp383-388', '10.1093/rheumatology/33.4.383', 'http://academic.oup.com/rheumatology/article-pdf/33/4/383/5024511/33-4-383.pdf']\n",
      "['9259281', 'Milligan PA; McGill PE; Howden CW; Kelman AW; Whiting B. The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disorders. European journal of clinical pharmacology. (1993) 45 6 pp507-512', '10.1007/bf00315306', 'http://link.springer.com/article/10.1007/BF00315306/fulltext.html']\n",
      "['9259282', 'Morgan T; Anderson A. Interaction of indomethacin with felodipine and enalapril. Journal of hypertension. Supplement. (1993) 11 Suppl 5 5 ppS338-S339', '10.1097/00004872-199312050-00148', '']\n",
      "['9259283', 'Hall J; Clarke AK; Elvins DM; Ring EF. Low level laser therapy is ineffective in the management of rheumatoid arthritic finger joints. British journal of rheumatology. (1994) 33 2 pp142-147', '10.1093/rheumatology/33.2.142', 'http://academic.oup.com/rheumatology/article-pdf/33/2/142/5020122/33-2-142.pdf']\n",
      "['9259284', 'Blyth T; Hunter JA; Stirling A. Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. British journal of rheumatology. (1994) 33 5 pp461-463', '10.1093/rheumatology/33.5.461', 'http://academic.oup.com/rheumatology/article-pdf/33/5/461/5042514/33-5-461.pdf']\n",
      "['9259285', 'Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis. Journal of rheumatology. (1994) 21 2 pp203-208', '10.1093/rheumatology/34.5.421', 'http://academic.oup.com/rheumatology/article-pdf/34/5/421/5030490/34-5-421.pdf']\n",
      "['9259286', 'Kloppenburg M; Breedveld FC; Terwiel JP; Mallee C; Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis and rheumatism. (1994) 37 5 pp629-636', '10.1002/art.1780370505', '']\n",
      "['9259288', 'Gevers G; Dequeker J; van Holsbeeck M; van Vliet-Daskalopoulou E. A high dose (up to 200 mg) tolerance and efficacy study of intra-articular rimexolone (Org 6216) in rheumatoid synovitis of the knee. Clinical rheumatology. (1994) 13 1 pp103-109', '10.1007/bf02229875', 'http://link.springer.com/article/10.1007/BF02229875/fulltext.html']\n",
      "['9259289', 'Benenson EV; Timina OB. Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: a controlled 6-month clinical trial. Clinical rheumatology. (1994) 13 1 pp54-59', '10.1007/bf02229866', 'http://link.springer.com/article/10.1007/BF02229866/fulltext.html']\n",
      "['9259290', 'Prete PE; Zane J; Krailo M; Bulanowski M. Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin. Clinical rheumatology. (1994) 13 1 pp60-69', '10.1007/bf02229867', 'http://link.springer.com/article/10.1007/BF02229867/fulltext.html']\n",
      "['9259291', 'Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein. Journal of laboratory and clinical medicine. (1994) 123 5 pp721-727', '10.32592/rr.2025.10.2.55', '']\n",
      "['9259292', 'Kjeldsen-Kragh J; Haugen M; F√∏rre O; Laache H; Malt UF. Vegetarian diet for patients with rheumatoid arthritis: can the clinical effects be explained by the psychological characteristics of the patients?. British journal of rheumatology. (1994) 33 6 pp569-575', '10.1093/rheumatology/33.6.569', 'http://academic.oup.com/rheumatology/article-pdf/33/6/569/5031236/33-6-569.pdf']\n",
      "['9259293', 'Geusens P; Wouters C; Nijs J; Jiang Y; Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis and rheumatism. (1994) 37 6 pp824-829', '10.1002/art.1780370608', '']\n",
      "['9259294', 'Heytman M; Ahern MJ; Smith MD; Roberts-Thomson PJ. The longterm effect of pulsed corticosteroids on the efficacy and toxicity of chrysotherapy in rheumatoid arthritis. Journal of rheumatology. (1994) 21 3 pp435-441', '10.1136/ard.48.2.108', '']\n",
      "['9259295', 'Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil). American journal of gastroenterology. (1994) 89 7 pp1014-1020', '10.3109/00365529409105361', '']\n",
      "['9259296', 'Peltonen R; Kjeldsen-Kragh J; Haugen M; Tuominen J; Toivanen P; F√∏rre O; Eerola E. Changes of faecal flora in rheumatoid arthritis during fasting and one-year vegetarian diet. British journal of rheumatology. (1994) 33 7 pp638-643', '10.1093/rheumatology/33.7.638', 'http://academic.oup.com/rheumatology/article-pdf/33/7/638/5042435/33-7-638.pdf']\n",
      "['9259297', 'Sharma A; Provenzale D; McKusick A; Kaplan MM. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology. (1994) 107 1 pp266-270', '10.1016/0016-5085(94)90085-x', '']\n",
      "['9259298', 'Eberhardt R; Kr√ºger K; Reiter W; Gross W; Zwingers T. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. Arzneimittel-Forschung. (1994) 44 5 pp642-647', '10.2165/00128415-199404980-00052', '']\n",
      "['9259299', \"Prause JU; Bjerrum K; Johansen S. Effect of sodium sucrose-sulfate on the ocular surface of patients with keratoconjunctivitis sicca in Sj√∂gren's syndrome. Advances in experimental medicine and biology. (1994) 350  pp691-696\", '10.1007/978-1-4615-2417-5_116', '']\n",
      "['9259300', 'Stenstr√∂m CH. Home exercise in rheumatoid arthritis functional class II: goal setting versus pain attention. Journal of rheumatology. (1994) 21 4 pp627-634', '10.1097/bor.0b013e3283235ac4', '']\n",
      "['9259301', 'T√∏rholm C; Broeng L; J√∏rgensen PS; Bjerregaard P; Josephsen L; J√∏rgensen PK; Hagen K; Knudsen JB. Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study. Journal of bone and joint surgery. British volume. (1991) 73 3 pp434-438', '10.1302/0301-620x.73b3.1670445', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.73B3.1670445']\n",
      "['9259302', 'Callahan CM; Hendrie HC; Dittus RS; Brater DC; Hui SL; Tierney WM. Improving treatment of late life depression in primary care: a randomized clinical trial. Journal of the American Geriatrics Society. (1994) 42 8 pp839-846', '10.1111/j.1532-5415.1994.tb06555.x', '']\n",
      "['9259303', 'Montrone F; Petrillo M; Caruso I; Bianchi Porro G. A comparison of severe gastric damage as a result of pirprofen and naproxen treatment in rheumatoid arthritis: a controlled endoscopic study. Journal of internal medicine. (1994) 236 2 pp153-159', '10.1111/j.1365-2796.1994.tb01277.x', '']\n",
      "['9259304', 'Shoji H; Wolf A; Packard S; Yoshino S. Cruciate retained and excised total knee arthroplasty. A comparative study in patients with bilateral total knee arthroplasty. Clinical orthopaedics and related research. (1994) 305 305 pp218-222', '10.1097/00003086-199408000-00026', '']\n",
      "['9259305', 'Tracy TS; Worster T; Bradley JD; Greene PK; Brater DC. Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1994) 37 5 pp453-456', '10.1111/j.1365-2125.1994.tb05713.x', '']\n",
      "['9259306', 'Caldwell JR. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis. Clinical therapeutics. (1994) 16 2 pp222-235', '10.1111/j.1365-2125.1994.tb05713.x', '']\n",
      "['9259307', 'Faarvang KL; Nielsen GL; Thomsen BS; Teglbjaerg KL; Hansen TM; Lervang HH; Schmidt EB; Dyerberg J; Ernst E. [Fish oils and rheumatoid arthritis. A randomized and double-blind study]. Ugeskrift for laeger. (1994) 156 23 pp3495-3498', '10.1111/j.1365-2362.1992.tb01431.x', '']\n",
      "['9259308', 'Haugen MA; Kjeldsen-Kragh J; F√∏rre O. A pilot study of the effect of an elemental diet in the management of rheumatoid arthritis. Clinical and experimental rheumatology. (1994) 12 3 pp275-279', '10.1007/bf02242946', 'http://link.springer.com/article/10.1007/BF02242946/fulltext.html']\n",
      "['9259309', 'Ivey M; Johnston RV; Uchida T. Cryotherapy for postoperative pain relief following knee arthroplasty. Journal of arthroplasty. (1994) 9 3 pp285-290', '10.1016/0883-5403(94)90083-3', '']\n",
      "['9259310', 'Kollerup G; Hansen M; H√∏rslev-Petersen K. Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. British journal of rheumatology. (1994) 33 9 pp816-820', '10.1093/rheumatology/33.9.816', 'http://academic.oup.com/rheumatology/article-pdf/33/9/816/5042392/33-9-816.pdf']\n",
      "['9259311', 'Leventhal LJ; Boyce EG; Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. British journal of rheumatology. (1994) 33 9 pp847-852', '10.1093/rheumatology/33.9.847', 'http://academic.oup.com/rheumatology/article-pdf/33/9/847/5043094/33-9-847.pdf']\n",
      "['9259312', \"Aubriot JH; Guincestre JY; Grandbastien B. [Value of continuous passive motion in the early rehabilitation of total knee arthroplasty. Prospective study apropos of 120 medical records]. Revue de chirurgie orthopeÃÅdique et reÃÅparatrice de l'appareil moteur. (1993) 79 7 pp586-590\", '10.1016/s0035-1040(05)84342-9', '']\n",
      "['9259314', 'Lipsitz SR; Kim K; Zhao L. Analysis of repeated categorical data using generalized estimating equations. Statistics in medicine. (1994) 13 11 pp1149-1163', '10.1002/sim.4780131106', '']\n",
      "['9259315', \"Elliott SL; Yeomans ND; Buchanan RR; Smallwood RA. Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial. Scandinavian journal of rheumatology. (1994) 23 4 pp171-176\", '10.3109/03009749409103056', '']\n",
      "['9259316', 'Maccagno A; Di Giorgio E; Roldan EJ; Caballero LE; Perez Lloret A. Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1994) 23 4 pp211-214', '10.3109/03009749409103063', '']\n",
      "['9259317', 'Edmonds J; Smart R; Laurent R; Butler P; Brooks P; Hoschl R; Wiseman J; George S; Lovegrove F; Warwick A. A comparative study of the safety and efficacy of dysprosium-165 hydroxide macro-aggregate and yttrium-90 silicate colloid in radiation synovectomy--a multicentre double blind clinical trial. Australian Dysprosium Trial Group. British journal of rheumatology. (1994) 33 10 pp947-953', '10.1093/rheumatology/33.10.947', 'http://academic.oup.com/rheumatology/article-pdf/33/10/947/5042804/33-10-947.pdf']\n",
      "['9259318', 'Kraag GR; Gordon DA; M√©nard HA; Russell AS; Kalish GH. Patient compliance with tenoxicam in family practice. Clinical therapeutics. (1994) 16 3 pp581-593', '10.2165/00003088-199426010-00003', '']\n",
      "['9259319', 'Roth SH; Bennett R; Caldron P; Mitchell C; Swenson C; Koepp R. A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen. Journal of rheumatology. (1994) 21 6 pp1118-1123', '10.2165/00044011-199509030-00007', '']\n",
      "['9259320', 'Elliott MJ; Maini RN; Feldmann M; Kalden JR; Antoni C; Smolen JS; Leeb B; Breedveld FC; Macfarlane JD; Bijl H. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet (London, England). (1994) 344 8930 pp1105-1110', '10.1016/s0140-6736(94)90628-9', '']\n",
      "['9259321', 'Schnabel A; Reinhold-Keller E; Willmann V; Gross WL. Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis. Rheumatology international. (1994) 14 1 pp33-38', '10.1007/bf00302669', 'http://link.springer.com/article/10.1007/BF00302669/fulltext.html']\n",
      "['9259322', 'Lacki JK; Porawska W; Sobieska M; Mackiewicz SH; M√ºller W. Acute phase response in rheumatoid arthritis patients treated with low doses of cyclosporin A. Rheumatology international. (1994) 14 1 pp39-40', '10.1007/bf00302670', 'http://link.springer.com/article/10.1007/BF00302670/fulltext.html']\n",
      "['9259323', 'Matveƒ≠kov AG; Artishevskaia NI; Bezkrovnaia VG. [The chronobiological aspects of lysosomal enzyme activity in the synovial fluid and of remission in rheumatoid inflammation]. TerapevticheskiiÃÜ arkhiv. (1994) 66 5 pp13-17', '10.1515/cclm.1994.32.4.319', '']\n",
      "['9259324', 'Weinblatt ME; Kaplan H; Germain BF; Block S; Solomon SD; Merriman RC; Wolfe F; Wall B; Anderson L; Gall E. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis and rheumatism. (1994) 37 10 pp1492-1498', '10.1002/art.1780371013', '']\n",
      "['9259325', 'Hall GM; Daniels M; Doyle DV; Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis and rheumatism. (1994) 37 10 pp1499-1505', '10.1002/art.1780371014', '']\n",
      "['9259327', 'Weinblatt ME; Germain BF; Kremer JM; Wall BA; Weisman MH; Maier AL; Coblyn JS. Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial. Arthritis and rheumatism. (1994) 37 9 pp1321-1325', '10.1002/art.1780370908', '']\n",
      "['9259328', 'Ruf J; Feldt-Rasmussen U; Heged√ºs L; Ferrand M; Carayon P. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases. Journal of clinical endocrinology and metabolism. (1994) 79 5 pp1404-1409', '10.1210/jcem.79.5.7962336', 'http://academic.oup.com/jcem/article-pdf/79/5/1404/10504705/jcem1404.pdf']\n",
      "['9259329', 'Chalmers A; Scheifele D; Patterson C; Williams D; Weber J; Shuckett R; Teufel A. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. Journal of rheumatology. (1994) 21 7 pp1203-1206', '10.1016/s2665-9913(19)30094-3', '']\n",
      "['9259330', 'Franck H; Ittel TH; Tasch O; Herborn G; Rau R. Osteocalcin in patients with rheumatoid arthritis. A one-year followup study. Journal of rheumatology. (1994) 21 7 pp1256-1259', '10.1007/bf00302154', 'http://link.springer.com/article/10.1007/BF00302154/fulltext.html']\n",
      "['9259332', 'H√§kkinen A; H√§kkinen K; Hannonen P. Effects of strength training on neuromuscular function and disease activity in patients with recent-onset inflammatory arthritis. Scandinavian journal of rheumatology. (1994) 23 5 pp237-242', '10.3109/03009749409103722', '']\n",
      "['9259333', 'Menninger H; Reinhardt S; S√∂ndgen W. Intra-articular treatment of rheumatoid knee-joint effusion with triamcinolone hexacetonide versus sodium morrhuate. A prospective study. Scandinavian journal of rheumatology. (1994) 23 5 pp249-254', '10.3109/03009749409103724', '']\n",
      "['9259334', 'Morgan SL; Baggott JE; Vaughn WH; Austin JS; Veitch TA; Lee JY; Koopman WJ; Krumdieck CL; Alarc√≥n GS. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Annals of internal medicine. (1994) 121 11 pp833-841', '10.7326/0003-4819-121-11-199412010-00002', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-121-11-199412010-00002']\n",
      "['9259335', 'Greenwald RA; Moak SA; Golub LM. Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis. Annals of the New York Academy of Sciences. (1994) 732  pp419-421', '10.1111/j.1749-6632.1994.tb24772.x', '']\n",
      "['9259336', 'Kloppenburg M; Terwiel JP; Mall√©e C; Breedveld FC; Dijkmans BA. Minocycline in active rheumatoid arthritis. A placebo-controlled trial. Annals of the New York Academy of Sciences. (1994) 732  pp422-423', '10.1111/j.1749-6632.1994.tb24773.x', '']\n",
      "['9259337', 'Lyngberg KK; Harreby M; Bentzen H; Frost B; Danneskiold-Sams√∏e B. Elderly rheumatoid arthritis patients on steroid treatment tolerate physical training without an increase in disease activity. Archives of physical medicine and rehabilitation. (1994) 75 11 pp1189-1195', '10.1016/0003-9993(94)90003-5', '']\n",
      "['9259338', 'Oosterveld FG; Rasker JJ. Effects of local heat and cold treatment on surface and articular temperature of arthritic knees. Arthritis and rheumatism. (1994) 37 11 pp1578-1582', '10.1002/art.1780371104', '']\n",
      "['9259339', 'Kurowski M; Menninger H; Pauli E. The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients. International journal of clinical pharmacology and therapeutics. (1994) 32 8 pp433-440', '10.1016/j.clpt.2004.12.212', '']\n",
      "['9259341', 'Martens HF; Sheets PK; Tenover JS; Dugowson CE; Bremner WJ; Starkebaum G. Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy. Journal of rheumatology. (1994) 21 8 pp1427-1431', '10.1093/rheumatology/31.8.573', 'http://academic.oup.com/rheumatology/article-pdf/31/8/573/5036366/31-8-573a.pdf']\n",
      "['9259342', \"Nived O; Sturfelt G; Eckern√§s SA; Singer P. A comparison of 6 months' compliance of patients with rheumatoid arthritis treated with tenoxicam and naproxen. Use of patient computer data to assess response to treatment. Journal of rheumatology. (1994) 21 8 pp1537-1541\", '10.55563/clinexprheumatol/ua2zfc', '']\n",
      "['9259343', 'Haugen MA; Kjeldsen-Kragh J; Bjerve KS; H√∏stmark AT; F√∏rre O. Changes in plasma phospholipid fatty acids and their relationship to disease activity in rheumatoid arthritis patients treated with a vegetarian diet. British journal of nutrition. (1994) 72 4 pp555-566', '10.1079/bjn19940059', '']\n",
      "['9259344', 'Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations. European journal of rheumatology and inflammation. (1992) 12 2 pp27-30', '10.1016/s0016-5085(08)60098-0', '']\n",
      "['9259345', 'Faun√∏ P; Suomalainen O; Rehnberg V; Hansen TB; Kr√∏ner K; Soimakallio S; Nielsen E. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin. Journal of bone and joint surgery. American volume. (1994) 76 12 pp1814-1818', '10.2106/00004623-199412000-00007', '']\n",
      "['9259346', 'Tilley BC; Alarc√≥n GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Annals of internal medicine. (1995) 122 2 pp81-89', '10.7326/0003-4819-122-2-199501150-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-122-2-199501150-00001']\n",
      "['9259347', 'Kirkham BW; Navarro FJ; Corkill MM; Panayi GS. In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 beta. Journal of rheumatology. (1994) 21 9 pp1615-1619', '10.1093/rheumatology/36.9.935', 'http://academic.oup.com/rheumatology/article-pdf/36/9/935/18105666/360935.pdf']\n",
      "['9259348', 'Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis. Journal of rheumatology. (1994) 21 9 pp1637-1641', '10.1007/bf03041309', 'http://link.springer.com/article/10.1007/BF03041309/fulltext.html']\n",
      "['9259349', 'Arendt-Nielsen L; Drewes AM; Svendsen L; Brennum J. Quantitative assessment of joint pain following treatment of rheumatoid arthritis with ibuprofen cream. Scandinavian journal of rheumatology. (1994) 23 6 pp334-337', '10.3109/03009749409099283', '']\n",
      "['9259350', 'Huskisson EC; Scott DL. A clinical comparison of two leading non-steroidal anti-inflammatory drugs. European journal of rheumatology and inflammation. (1991) 11 2 pp4-7', '10.2165/00003495-197815050-00005', '']\n",
      "['9259351', 'Huskisson EC. Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis. European journal of rheumatology and inflammation. (1991) 11 2 pp8-12', '10.1093/rheumatology/30.5.370', 'http://academic.oup.com/rheumatology/article-pdf/30/5/370/5042502/30-5-370.pdf']\n",
      "['9259352', 'S√°nchez Andrada S; Rodr√≠guez Valverde V. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis. European journal of rheumatology and inflammation. (1991) 11 4 pp15-20', '10.1002/1529-0131(199805)41:5<945::aid-art28>3.0.co;2-2', '']\n",
      "['9259353', 'Rodr√≠guez-de-la-Serna A; Geli-Ferrer C; Diaz-L√≥pez C; S√°nchez-Garc√≠a J. Comparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis. European journal of rheumatology and inflammation. (1991) 11 4 pp35-44', '10.1007/bf00193826', 'http://link.springer.com/article/10.1007/BF00193826/fulltext.html']\n",
      "['9259354', 'Serni U. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin. European journal of rheumatology and inflammation. (1993) 12 4 pp47-54', '10.2165/00044011-200019002-00009', '']\n",
      "['9259356', 'Littman BH; Drury CE; Zimmerer RO; Stack CB; Law CG. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap. Arthritis and rheumatism. (1995) 38 1 pp29-37', '10.1002/art.1780380105', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780380105']\n",
      "['9259357', \"G√ºnd√ºz K; Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sj√∂gren's syndrome. Acta ophthalmologica. (1994) 72 4 pp438-442\", '10.1111/j.1755-3768.1994.tb02792.x', '']\n",
      "['9259358', 'Eggelmeijer F; Papapoulos SE; van Paassen HC; Dijkmans BA; Valkema R; Westedt ML; Landman JO; Pauwels EK; Breedveld FC. Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthritis and rheumatism. (1996) 39 3 pp396-402', '10.1002/art.1780390307', '']\n",
      "['9259359', 'Ciconelli RM; Ferraz MB; Visioni RA; Oliveira LM; Atra E. A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis. British journal of rheumatology. (1996) 35 2 pp150-154', '10.1093/rheumatology/35.2.150', 'http://academic.oup.com/rheumatology/article-pdf/35/2/150/5043665/35-2-150.pdf']\n",
      "['9259360', 'Drevlow BE; Lovis R; Haag MA; Sinacore JM; Jacobs C; Blosche C; Landay A; Moreland LW; Pope RM. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis and rheumatism. (1996) 39 2 pp257-265', '10.1002/art.1780390212', '']\n",
      "['9259362', 'D‚ÄôLima DD; Colwell CW; Morris BA; Hardwick ME; Kozin F. The effect of preoperative exercise on total knee replacement outcomes. Clinical orthopaedics and related research. (1996) 326 326 pp174-182', '10.1097/00003086-199605000-00020', '']\n",
      "['9259363', 'van der Heide A; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; van der Veen MJ; Haanen HC; Hofman DM; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Dinant HJ; Kruize AA; Schenk Y. The effectiveness of early treatment with \"second-line\" antirheumatic drugs. A randomized, controlled trial. Annals of internal medicine. (1996) 124 8 pp699-707', '10.7326/0003-4819-124-8-199604150-00001', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-124-8-199604150-00001']\n",
      "['9259364', 'Reginster JY; Distel M; Bluhmki E. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis. British journal of rheumatology. (1996) 35 Suppl 1 Suppl 1 pp17-21', '10.1093/rheumatology/35.suppl_1.17', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_1/17/5043123/35-suppl_1-17.pdf']\n",
      "['9259365', 'Wojtulewski JA; Schattenkirchner M; Barcel√≥ P; Le Lo√´t X; Bevis PJ; Bluhmki E; Distel M. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis. British journal of rheumatology. (1996) 35 Suppl 1 35 Suppl 1 pp22-28', '10.1093/rheumatology/35.suppl_1.22', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_1/22/5043195/35-suppl_1-22.pdf']\n",
      "['9259366', 'Ghozlan PR; Bernhardt M; V√©licitat P; Bluhmki E. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis. British journal of rheumatology. (1996) 35 Suppl 1 SUPPL 1. pp51-55', '10.1093/rheumatology/35.suppl_1.51', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_1/51/5043555/35-suppl_1-51.pdf']\n",
      "['9259367', 'Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. New England journal of medicine. (1996) 334 22 pp1435-1439', '10.1056/nejm199605303342204', '']\n",
      "['9259369', 'Kanik KS; Yarboro CH; Naparstek Y; Plotz PH; Wilder RL. Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis. Arthritis and rheumatism. (1996) 39 6 pp1027-1029', '10.1002/art.1780390621', '']\n",
      "['9259370', 'Kassimos D; Choy EH; Grossman AB; Chikanza IC; Panayi GS. Endogenous opioid tone in patients with rheumatoid arthritis. British journal of rheumatology. (1996) 35 5 pp436-440', '10.1093/rheumatology/35.5.436', 'http://academic.oup.com/rheumatology/article-pdf/35/5/436/5036840/35-5-436.pdf']\n",
      "['9259371', 'Vliet Vlieland TP; Zwinderman AH; Vandenbroucke JP; Breedveld FC; Hazes JM. A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. British journal of rheumatology. (1996) 35 5 pp475-482', '10.1093/rheumatology/35.5.475', 'http://academic.oup.com/rheumatology/article-pdf/35/5/475/5037516/35-5-475.pdf']\n",
      "['9259372', 'Stannard JP; Harris RM; Bucknell AL; Cossi A; Ward J; Arrington ED. Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American journal of orthopedics (Belle Mead, N.J.). (1996) 25 2 pp127-134', '10.1016/s0883-5403(06)80108-7', '']\n",
      "['9259373', 'Tegelberg A; Kopp S. A 3-year follow-up of temporomandibular disorders in rheumatoid arthritis and ankylosing spondylitis. Acta odontologica Scandinavica. (1996) 54 1 pp14-18', '10.3109/00016359609003503', '']\n",
      "['9259374', 'Gado K; Emery P. Intra-articular guanethidine injection for resistant shoulder pain: a preliminary double blind study of a novel approach. Annals of the rheumatic diseases. (1996) 55 3 pp199-201', '10.1136/ard.55.3.199', '']\n",
      "['9259375', 'Hall GM; Larbre JP; Spector TD; Perry LA; Da Silva JA. A randomized trial of testosterone therapy in males with rheumatoid arthritis. British journal of rheumatology. (1996) 35 6 pp568-573', '10.1093/rheumatology/35.6.568', 'http://academic.oup.com/rheumatology/article-pdf/35/6/568/5043830/35-6-568.pdf']\n",
      "['9259376', 'Bagge E; Geijer M; Tarkowski A. Intra-articular administration of polyclonal immunoglobulin G in rheumatoid arthritis. A double-blind, placebo-controlled pilot study. Scandinavian journal of rheumatology. (1996) 25 3 pp174-176', '10.3109/03009749609080010', '']\n",
      "['9259377', 'McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis. Annals of the rheumatic diseases. (1996) 55 5 pp328-330', '10.1136/ard.55.5.328', '']\n",
      "['9259378', 'Kornasoff D; Maisenbacher J; Bowdler J; Raber A. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. Rheumatology international. (1996) 15 6 pp225-230', '10.1007/bf00290375', 'http://link.springer.com/article/10.1007/BF00290375/fulltext.html']\n",
      "['9259379', 'Tak PP; Taylor PC; Breedveld FC; Smeets TJ; Daha MR; Kluin PM; Meinders AE; Maini RN. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis and rheumatism. (1996) 39 7 pp1077-1081', '10.1002/art.1780390702', '']\n",
      "['9259380', 'Paleolog EM; Hunt M; Elliott MJ; Feldmann M; Maini RN; Woody JN. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis and rheumatism. (1996) 39 7 pp1082-1091', '10.1002/art.1780390703', '']\n",
      "['9259382', 'Olsen NJ; Brooks RH; Cush JJ; Lipsky PE; St Clair EW; Matteson EL; Gold KN; Cannon GW; Jackson CG; McCune WJ; Fox DA; Nelson B; Lorenz T; Strand V. A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group. Arthritis and rheumatism. (1996) 39 7 pp1102-1108', '10.1002/art.1780390705', '']\n",
      "['9259383', 'Badurski J; Jeziernicka E; Naruszewicz K; Racewicz A. Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale (VAS). Polski tygodnik lekarski (Warsaw, Poland : 1960). (1995) 50 44-47 pp37-40', '10.15557/pimr.2018.0030', '']\n",
      "['9259384', 'Pasero G; Marcolongo R; Serni U; Parnham MJ; Ferrer F. A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis. Current medical research and opinion. (1995) 13 6 pp305-315', '10.1185/03007999509110491', '']\n",
      "['9259385', 'Sebaldt RJ; Adachi JD; Bensen WG; Bianchi F; Cividano A; Craig GL; Cranney A; Kaminska E; Gordon M; Steele M; Goldsmith C. Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up. Scandinavian journal of rheumatology. Supplement. (1996) 103  pp91-93', '10.3109/03009749609103760', '']\n",
      "['9259386', 'Brett S; Baxter G; Cooper H; Johnston JM; Tite J; Rapson N. Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology. (1996) 88 1 pp13-19', '10.1046/j.1365-2567.1996.d01-650.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2567.1996.d01-650.x']\n",
      "['9259387', 'Flisiak R; Kalinowska A; Bobrowska E; Prokopowicz D. Enzyme immunoassay in the diagnosis of Lyme borreliosis. Roczniki Akademii Medycznej w Bia≈Çymstoku (1995). (1996) 41 1 pp83-89', '10.1007/978-3-642-77614-4_21', 'http://link.springer.com/content/pdf/10.1007/978-3-642-77614-4_21.pdf']\n",
      "['9259388', 'Westrich GH; Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. Journal of bone and joint surgery. American volume. (1996) 78 6 pp826-834', '10.2106/00004623-199606000-00004', '']\n",
      "['9259389', 'Pawlotsky Y; Le Dantec P; Jacquelinet C; Lapicque F; Goasguen J; Perdriger A; Veillard E; Guggenbuhl P; Netter P. Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac. Revue du rhumatisme (English ed.). (1996) 63 3 pp179-187', '10.1016/s1169-8330(00)80004-6', '']\n",
      "['9259390', 'Braun MG; Csernok E; Schmitt WH; Gross WL. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Journal of rheumatology. (1996) 23 5 pp826-830', '10.1097/bor.0b013e3283323538', '']\n",
      "['9259391', 'Giannini EH; Lovell DJ; Silverman ED; Sundel RP; Tague BL; Ruperto N. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. Journal of rheumatology. (1996) 23 5 pp919-924', '10.1186/1546-0096-6-s1-s3', 'http://link.springer.com/article/10.1186/1546-0096-6-S1-S3/fulltext.html']\n",
      "['9259392', 'Maisiak R; Austin J; Heck L. Health outcomes of two telephone interventions for patients with rheumatoid arthritis or osteoarthritis. Arthritis and rheumatism. (1996) 39 8 pp1391-1399', '10.1002/art.1780390818', '']\n",
      "['9259393', 'McCarty DJ. Results of controlled study of combination therapy with azathioprine and methotrexate in the treatment of rheumatoid arthritis revisited: comment on the article by Willkens et al. Arthritis and rheumatism. (1996) 39 8 pp1436-1437', '10.1002/art.1780390830', '']\n",
      "['9259394', 'Li RL; Liu PL; Wu XC. Clinical and experimental study on sustained release tablet of tripterygium wilfordii in treating rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (1996) 16 1 pp10-13', '10.1007/bf02969658', 'https://link.springer.com/article/10.1007/BF02969658/fulltext.html']\n",
      "['9259395', \"O'Toole PA; Sykes H; Phelan M; Thompson RN; Lombard MG. Duodenal mucosal ferritin in rheumatoid arthritis: implications for anaemia of chronic disease. QJM : monthly journal of the Association of Physicians. (1996) 89 7 pp509-514\", '10.1093/qjmed/89.7.509', 'http://academic.oup.com/qjmed/article-pdf/89/7/509/4330842/89-7-509.pdf']\n",
      "['9259396', 'Ryu J; Saito S; Honda T; Shimakura Y; Sano S. [Comparison between the arthroscopic and open synovectomies for rheumatoid knee--a retrospective and random study on the results of the two methods]. RyuÃÑmachi. [Rheumatism]. (1995) 35 6 pp880-888', '10.1007/978-4-431-68529-6_23', 'http://link.springer.com/content/pdf/10.1007/978-4-431-68529-6_23.pdf']\n",
      "['9259397', 'Schnabel A; Herlyn K; Burchardi C; Reinhold-Keller E; Gross WL. Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatology international. (1996) 15 5 pp195-200', '10.1007/bf00290521', 'http://link.springer.com/article/10.1007/BF00290521/fulltext.html']\n",
      "['9259398', \"Picco P; Gattorno M; Buoncompagni A; Pistoia V; Borrone C. 6-methylprednisolone 'mini-pulses': a new modality of glucocorticoid treatment in systemic onset juvenile chronic arthritis. Scandinavian journal of rheumatology.. (1996) 25 1 pp24-27\", '10.3109/03009749609082663', '']\n",
      "['9259399', 'Stenstr√∂m CH; Arge B; Sundbom A. Dynamic training versus relaxation training as home exercise for patients with inflammatory rheumatic diseases. A randomized controlled study. Scandinavian journal of rheumatology. (1996) 25 1 pp28-33', '10.3109/03009749609082664', '']\n",
      "['9259400', 'Cantatore FP; Introsso AM; Carrozzo M. Effects of bisphosphonates on interleukin 1, tumor necrosis factor alpha, and beta 2 microglobulin in rheumatoid arthritis. Journal of rheumatology. (1996) 23 6 pp1117-1118', '10.32592/rr.2023.8.3.107', '']\n",
      "['9259402', 'G‚àö‚àètzsche PC; Hansen M; Stoltenberg M; Svendsen A; Beier J; Faarvang KL; Wangel M; Rydgren L; Halberg P; Juncker P; Andersen V; Hansen TM; Endahl L. Randomized, placebo controlled trial of withdrawal of slow-acting antirheumatic drugs and of observer bias in rheumatoid arthritis. Scandinavian journal of rheumatology. (1996) 25 4 pp194-199', '10.3109/03009749609069987', '']\n",
      "['9259403', 'Nordstr√∂m DC; Konttinen YT; Solovieva S; Friman C; Santavirta S. In- and out-patient rehabilitation in rheumatoid arthritis. A controlled, open, longitudinal, cost-effectiveness study. Scandinavian journal of rheumatology. (1996) 25 4 pp200-206', '10.3109/03009749609069988', '']\n",
      "['9259404', 'Lacki JK; Samborski W; Mackiewicz S; Mackiewicz U. Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?. Upsala journal of medical sciences. (1995) 100 3 pp233-242', '10.3109/03009739509178909', '']\n",
      "['9259405', 'Rosemffet MG; Maldonado Cocco JA; Hunter B; Toblli J. Detection of distal renal tubular acidosis by urinary blood PCO2 gradient in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (1996) 14 3 pp351-352', '10.1097/rhu.0b013e31817738ce', '']\n",
      "['9259406', 'Mills SY; Jacoby RK; Chacksfield M; Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study. British journal of rheumatology. (1996) 35 9 pp874-878', '10.1093/rheumatology/35.9.874', 'http://academic.oup.com/rheumatology/article-pdf/35/9/874/5043717/35-9-874.pdf']\n",
      "['9259407', 'van Riel PL; van Gestel AM; van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. British journal of rheumatology. (1996) 35 Suppl 2  pp4-7', '10.1093/rheumatology/35.suppl_2.4', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_2/4/5043247/35-suppl_2-4.pdf']\n",
      "['9259410', \"O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. Journal of rheumatology. Supplement. (1996) 44 suppl44 pp72-74\", '10.1056/nejm199605163342002', '']\n",
      "['9259411', 'Egsmose C; Lund B; Borg G; Pettersson H; Berg E; Brodin U; Trang L. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. Journal of rheumatology. (1995) 22 12 pp2208-2213', '10.3109/03009748909095027', '']\n",
      "['9259412', 'Hunter JA; Parnham MJ; Balaguer XG. Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory. Clinical rheumatology. (1996) 15 4 pp329-334', '10.1007/bf02230353', 'http://link.springer.com/article/10.1007/BF02230353/fulltext.html']\n",
      "['9259413', \"Moreland LW; Heck LW; Koopman WJ; Saway PA; Adamson TC; Fronek Z; O'Connor RD; Morgan EE; Diveley JP; Richieri SP; Carlo DJ; Brostoff SW. V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study. Journal of rheumatology. (1996) 23 8 pp1353-1362\", '10.1111/j.1749-6632.1995.tb44514.x', '']\n",
      "['9259414', 'Ekstr√∂m P; Carling L; Wetterhus S; Wingren PE; Anker-Hansen O; Lundeg√•rdh G; Thorhallsson E; Unge P. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scandinavian journal of gastroenterology. (1996) 31 8 pp753-758', '10.3109/00365529609010347', '']\n",
      "['9259415', 'Kloppenburg M; Dijkmans BA; Verweij CL; Breedveld FC. Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline. Immunopharmacology. (1996) 31 2-3 pp163-169', '10.1016/0162-3109(95)00041-0', '']\n",
      "['9259416', 'Melton-Rogers S; Hunter G; Walter J; Harrison P. Cardiorespiratory responses of patients with rheumatoid arthritis during bicycle riding and running in water. Physical therapy. (1996) 76 10 pp1058-1065', '10.1093/ptj/76.10.1058', 'http://academic.oup.com/ptj/article-pdf/76/10/1058/10761150/ptj1058.pdf']\n",
      "['9259417', 'Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response. British journal of clinical pharmacology. (1996) 42 2 pp195-200', '10.1046/j.1365-2125.1996.04038.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.1996.04038.x']\n",
      "['9259418', 'Herrick AL; Grennan DM; Griffen K; Aarons L; Gifford LA. Lack of interaction between flucloxacillin and methotrexate in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1996) 41 3 pp223-227', '10.1111/j.1365-2125.1996.tb00186.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1996.tb00186.x']\n",
      "['9259419', 'Carpenter MT; West SG; Vogelgesang SA; Casey Jones DE. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics. (1996) 19 3 pp207-210', '10.3928/0147-7447-19960301-09', '']\n",
      "['9259420', \"Ferraccioli GF; Salaffi F; De Vita S; Casatta L; Avellini C; Carotti M; Beltrami CA; Cervini C; Bartoli E. Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sj√∂gren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clinical and experimental rheumatology. (1996) 14 4 pp367-371\", '10.1136/ard.55.5.311', '']\n",
      "['9259421', 'Andersson SI; Ekdahl C. Dynamic and static physical training in patients with rheumatoid arthritis: application of a self-appraisal and coping model. Disability and rehabilitation. (1996) 18 9 pp469-475', '10.3109/09638289609165911', '']\n",
      "['9259422', 'Walsh JK; Muehlbach MJ; Lauter SA; Hilliker NA; Schweitzer PK. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. Journal of rheumatology. (1996) 23 2 pp245-252', '10.1093/sleep/7.3.223', '']\n",
      "['9259423', 'Lisse JR. Clinical efficacy and safety of Naprelan versus Naprosyn in the treatment of rheumatoid arthritis. American journal of orthopedics (Belle Mead, N.J.). (1996) 25 9 Suppl pp21-29', '10.5312/wjo.v5.i4.504', '']\n",
      "['9259424', 'Van Groenendael JH; Markusse HM; Dijkmans BA; Breedveld FC. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Clinical rheumatology. (1996) 15 5 pp450-456', '10.1007/bf02229641', 'http://link.springer.com/article/10.1007/BF02229641/fulltext.html']\n",
      "['9259425', 'Perez-Ruiz F; Alonso-Ruiz A; Ansoleaga JJ. Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis. Clinical rheumatology. (1996) 15 5 pp473-477', '10.1007/bf02229644', 'http://link.springer.com/article/10.1007/BF02229644/fulltext.html']\n",
      "['9259426', 'Ince A; Yazici Y; Hamuryudan V; Yazici H. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study. Clinical rheumatology. (1996) 15 5 pp491-494', '10.1007/bf02229648', 'http://link.springer.com/article/10.1007/BF02229648/fulltext.html']\n",
      "['9259427', 'Masri BA; Laskin RS; Windsor RE; Haas SB. Knee closure in total knee replacement: a randomized prospective trial. Clinical orthopaedics and related research. (1996)  331 pp81-86', '10.1097/00003086-199610000-00011', '']\n",
      "['9259428', 'Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial. Family medicine. (1996) 28 3 pp204-210', '10.7326/0003-4819-115-10-787', '']\n",
      "['9259429', 'Zurier RB; Rossetti RG; Jacobson EW; DeMarco DM; Liu NY; Temming JE; White BM; Laposata M. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis and rheumatism. (1996) 39 11 pp1808-1817', '10.1002/art.1780391106', '']\n",
      "['9259430', 'Schnitzler CM; Biddulph SL; Mesquita JM; Gear KA. Bone structure and turnover in the distal radius and iliac crest: a histomorphometric study. Journal of bone and mineral research. (1996) 11 11 pp1761-1768', '10.1002/jbmr.5650111120', 'https://academic.oup.com/jbmr/article-pdf/11/11/1761/56503859/5650111120.pdf']\n",
      "['9259431', 'Benestad B; Vinje O; Veier√∏d MB; Vandvik IH. Quantitative and qualitative assessments of pain in children with juvenile chronic arthritis based on the Norwegian version of the Pediatric Pain Questionnaire. Scandinavian journal of rheumatology. (1996) 25 5 pp293-299', '10.3109/03009749609104061', '']\n",
      "['9259433', 'Hansen GV; Nielsen L; Kluger E; Thysen M; Emmertsen H; Stengaard-Pedersen K; Hansen EL; Unger B; Andersen PW. Nutritional status of Danish rheumatoid arthritis patients and effects of a diet adjusted in energy intake, fish-meal, and antioxidants. Scandinavian journal of rheumatology. (1996) 25 5 pp325-330', '10.3109/03009749609104066', '']\n",
      "['9259434', 'Schrohenloher RE; Koopman WJ; Woodworth TG; Moreland LW. Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis. Journal of rheumatology. (1996) 23 11 pp1845-1848', '10.1002/art.1780380902', '']\n",
      "['9259435', 'Moreland LW; Margolies G; Heck LW; Saway A; Blosch C; Hanna R; Koopman WJ. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. Journal of rheumatology. (1996) 23 11 pp1849-1855', '10.2165/00063030-199911030-00006', '']\n",
      "['9259437', 'Kotaniemi A; Piirainen H; Paimela L; Leirisalo-Repo M; Uoti-Reilama K; Lahdentausta P; Ruotsalainen P; Kataja M; V√§is√§nen E; Kurki P. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?. Journal of rheumatology. (1996) 23 11 pp1875-1879', '10.3109/03009749609069214', '']\n",
      "['9259438', 'McEntegart A; Porter D; Capell HA; Thomson EA. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial. Journal of rheumatology. (1996) 23 11 pp1887-1890', '10.1136/ard.51.4.461', '']\n",
      "['9259439', 'Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. American journal of gastroenterology. (1996) 91 11 pp2367-2371', '10.1007/978-0-585-32154-7_27', 'http://link.springer.com/content/pdf/10.1007/978-0-585-32154-7_27.pdf']\n",
      "['9259440', 'Busch U; Heinzel G; Narjes H; Nehmiz G. Interaction of meloxicam with cimetidine, Maalox, or aspirin. Journal of clinical pharmacology. (1996) 36 1 pp79-84', '10.1002/j.1552-4604.1996.tb04155.x', '']\n",
      "['9259441', 'Rall LC; Roubenoff R; Cannon JG; Abad LW; Dinarello CA; Meydani SN. Effects of progressive resistance training on immune response in aging and chronic inflammation. Medicine and science in sports and exercise. (1996) 28 11 pp1356-1365', '10.1097/00005768-199611000-00003', '']\n",
      "['9259442', 'Lacki JK; Klama K; Samborski W; Mackiewicz S; Mackiewicz U; Muller W. Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs. Materia medica Polona. Polish journal of medicine and pharmacy. (1995) 27 2 pp47-51', '10.3109/03009739509178909', '']\n",
      "['9259443', 'Ireys HT; Sills EM; Kolodner KB; Walsh BB. A social support intervention for parents of children with juvenile rheumatoid arthritis: results of a randomized trial. Journal of pediatric psychology. (1996) 21 5 pp633-641', '10.1093/jpepsy/21.5.633', 'http://academic.oup.com/jpepsy/article-pdf/21/5/633/2773720/21-5-633.pdf']\n",
      "['9259444', 'Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Annals of internal medicine. (1996) 125 12 pp961-968', '10.7326/0003-4819-125-12-199612150-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-125-12-199612150-00004']\n",
      "['9259445', 'Stern EB; Ytterberg SR; Krug HE; Mullin GT; Mahowald ML. Immediate and short-term effects of three commercial wrist extensor orthoses on grip strength and function in patients with rheumatoid arthritis. Arthritis care and research. (1996) 9 1 pp42-50', '10.1002/art.1790090109', '']\n",
      "['9259446', 'Maisiak R; Austin JS; West SG; Heck L. The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis: a randomized, controlled trial. Arthritis care and research. (1996) 9 1 pp60-66', '10.1002/art.1790090111', '']\n",
      "['9259448', 'Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Annals of the rheumatic diseases. (1996) 55 10 pp739-744', '10.1136/ard.55.10.739', '']\n",
      "['9259449', \"Anderson JJ; O'Neill A; Woodworth T; Haddad J; Sewell KL; Moreland LW. Health status response of rheumatoid arthritis to treatment with DAB486IL-2. Arthritis care and research. (1996) 9 2 pp112-119\", '10.1002/1529-0131(199604)9:2<112::aid-anr1790090207>3.0.co;2-x', '']\n",
      "['9259450', 'Li LC; Scudds RA; Heck CS; Harth M. The efficacy of dexamethasone iontophoresis for the treatment of rheumatoid arthritic knees: a pilot study. Arthritis care and research. (1996) 9 2 pp126-132', '10.1002/1529-0131(199604)9:2<126::aid-anr1790090209>3.0.co;2-k', '']\n",
      "['9259451', 'Stern EB; Ytterberg SR; Krug HE; Mahowald ML. Finger dexterity and hand function: effect of three commercial wrist extensor orthoses on patients with rheumatoid arthritis. Arthritis care and research. (1996) 9 3 pp197-205', '10.1002/1529-0131(199606)9:3<197::aid-anr1790090308>3.0.co;2-w', '']\n",
      "['9259452', 'Hall J; Skevington SM; Maddison PJ; Chapman K. A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis care and research. (1996) 9 3 pp206-215', '10.1002/1529-0131(199606)9:3<206::aid-anr1790090309>3.0.co;2-j', '']\n",
      "['9259453', 'Andonopoulos AP; Siambi V; Makri M; Christofidou M; Markou C; Vagenakis AG. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clinical rheumatology. (1996) 15 6 pp599-603', '10.1007/bf02238551', 'http://link.springer.com/article/10.1007/BF02238551/fulltext.html']\n",
      "['9259454', 'van den Ende CH; Hazes JM; le Cessie S; Mulder WJ; Belfor DG; Breedveld FC; Dijkmans BA. Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial. Annals of the rheumatic diseases. (1996) 55 11 pp798-805', '10.1136/ard.55.11.798', '']\n",
      "['9259455', 'Booji A; Biewenga-Booji CM; Huber-Bruning O; Cornelis C; Jacobs JW; Bijlsma JW. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1996) 55 11 pp811-815', '10.1136/ard.55.11.811', '']\n",
      "['9259456', 'Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study. Clinical and experimental rheumatology. (1996) 14 6 pp625-631', '10.3109/9780203214237-211', '']\n",
      "['9259457', 'Rennie HJ. Evaluation of the effectiveness of a metacarpophalangeal ulnar deviation orthosis. Journal of hand therapy. (1996) 9 4 pp371-377', '10.1016/s0894-1130(96)80044-5', '']\n",
      "['9259458', 'Prupas HM; Loose LD; Spindler JS; Dietz AJ; Gum OB; Weisman MH; Gordon G; Wolf RE; Turner RA; Collins RL; Germain BF; Katz P; Ballou SP; Wolfe F; Daniels JC; April PA; Willkens RF; Pariser K; Hepburn B; Zizic TM; Ting N; Mehrban M. Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study. Scandinavian journal of rheumatology. (1996) 25 6 pp345-351', '10.3109/03009749609065645', '']\n",
      "['9259459', 'Saggini R; Zoppi M; Vecchiet F; Gatteschi L; Obletter G; Giamberardino MA. Comparison of electromotive drug administration with ketorolac or with placebo in patients with pain from rheumatic disease: a double-masked study. Clinical therapeutics. (1996) 18 6 pp1169-1174', '10.1016/s0149-2918(96)80071-3', '']\n",
      "['9259460', 'Veys EM; Menkes CJ; Emery P. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (1997) 40 1 pp62-68', '10.1002/art.1780400110', '']\n",
      "['9259462', 'Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissil√§ M; Sahlberg D; Bj√∂rneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M. Efficacy and safety of meloxicam in patients with rheumatoid arthritis. Journal of rheumatology. (1997) 24 2 pp282-290', '10.1093/rheumatology/35.suppl_1.17', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_1/17/5043123/35-suppl_1-17.pdf']\n",
      "['9259463', 'Lightfoot R. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group. Journal of rheumatology. Supplement. (1997) 47 47 pp10-16', '10.1007/bf00290279', 'http://link.springer.com/article/10.1007/BF00290279/fulltext.html']\n",
      "['9259464', 'Neustadt DH. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis. Journal of rheumatology. Supplement. (1997) 47 SUPPL. pp17-22', '10.1093/rheumatology/xii.suppl.39', 'http://academic.oup.com/rheumatology/article-pdf/XII/suppl/39/5079700/XII-suppl-39.pdf']\n",
      "['9259465', 'Schnitzer TJ; Constantine G. Etodolac (Lodine) in the treatment of osteoarthritis: recent studies. Journal of rheumatology. Supplement. (1997) 47 47 pp23-31', '10.1007/bf00290279', 'http://link.springer.com/article/10.1007/BF00290279/fulltext.html']\n",
      "['9259466', 'Zvereva KV; Grunina EA. [The negative effects of low-intensity laser therapy in rheumatoid arthritis]. TerapevticheskiiÃÜ arkhiv. (1996) 68 5 pp22-24', '10.1016/s0031-9406(05)66866-6', '']\n",
      "['9259467', 'Lewonowski K; Dorr LD; McPherson EJ; Huber G; Wan Z. Medialization of the patella in total knee arthroplasty. Journal of arthroplasty. (1997) 12 2 pp161-167', '10.1016/s0883-5403(97)90062-0', '']\n",
      "['9259468', 'Arvidson NG; Gudbj√∂rnsson B; Larsson A; H√§llgren R. The timing of glucocorticoid administration in rheumatoid arthritis. Annals of the rheumatic diseases. (1997) 56 1 pp27-31', '10.1136/ard.56.1.27', '']\n",
      "['9259469', 'Vliet Vlieland TP; Breedveld FC; Hazes JM. The two-year follow-up of a randomized comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis. British journal of rheumatology. (1997) 36 1 pp82-85', '10.1093/rheumatology/36.1.82', 'http://academic.oup.com/rheumatology/article-pdf/36/1/82/18104733/360082.pdf']\n",
      "['9259470', 'Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Sinigaglia L; Gualtieri G. Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Vox sanguinis. (1997) 72 2 pp93-100', '10.1159/000461969', '']\n",
      "['9259471', 'T√ºrck D; Busch U; Heinzel G; Narjes H. Clinical pharmacokinetics of meloxicam. Arzneimittel-Forschung. (1997) 47 3 pp253-258', '10.2165/00044011-199509050-00004', '']\n",
      "['9259472', 'Kalden-Nemeth D; Grebmeier J; Antoni C; Manger B; Wolf F; Kalden JR. NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy. Rheumatology international. (1997) 16 6 pp249-255', '10.1007/bf01375657', 'http://link.springer.com/article/10.1007/BF01375657/fulltext.html']\n",
      "['9259473', 'Ovadia D; Luger E; Bickels J; Menachem A; Dekel S. Efficacy of closed wound drainage after total joint arthroplasty. A prospective randomized study. Journal of arthroplasty. (1997) 12 3 pp317-321', '10.1016/s0883-5403(97)90029-2', '']\n",
      "['9259474', 'Engh GA; Holt BT; Parks NL. A midvastus muscle-splitting approach for total knee arthroplasty. Journal of arthroplasty. (1997) 12 3 pp322-331', '10.1016/s0883-5403(97)90030-9', '']\n",
      "['9259475', 'Kovarik JM; Mueller EA; Gerbeau C; Tarral A; Francheteau P; Guerret M. Cyclosporine and nonsteroidal antiinflammatory drugs: exploring potential drug interactions and their implications for the treatment of rheumatoid arthritis. Journal of clinical pharmacology. (1997) 37 4 pp336-343', '10.1002/j.1552-4604.1997.tb04311.x', '']\n",
      "['9259476', 'Bianchi Porro G; Lazzaroni M; Petrillo M. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. American journal of gastroenterology. (1997) 92 4 pp663-667', '10.1016/0016-5085(95)22902-7', '']\n",
      "['9259478', 'Box SA; Pullar T. Sulphasalazine in the treatment of rheumatoid arthritis. British journal of rheumatology. (1997) 36 3 pp382-386', '10.1093/rheumatology/36.3.382', 'http://academic.oup.com/rheumatology/article-pdf/36/3/382/18105186/360382.pdf']\n",
      "['9259479', 'Andersen LS; Hansen EL; Knudsen JB; Wester JU; Hansen GV; Hansen TM. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects. Journal of rheumatology. (1997) 24 5 pp830-837', '10.1136/ard.49.6.349', '']\n",
      "['9259480', 'Rep MH; van Oosten BW; Roos MT; Ad√®r HJ; Polman CH; van Lier RA. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. Journal of clinical investigation. (1997) 99 9 pp2225-2231', '10.1172/jci119396', '']\n",
      "['9259481', \"O'Dell JR; Haire CE; Palmer W; Drymalski W; Wees S; Blakely K; Churchill M; Eckhoff PJ; Weaver A; Doud D; Erikson N; Dietz F; Olson R; Maloley P; Klassen LW; Moore GF. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (1997) 40 5 pp842-848\", '10.1002/art.1780400510', '']\n",
      "['9259482', 'Drosos AA; Tsifetaki N; Tsiakou EK; Timpanidou M; Tsampoulas C; Tatsis CK; Kotoulas K; Moutsopoulos HM. Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study. Clinical and experimental rheumatology. (1997) 15 3 pp263-267', '10.1007/bf02114394', 'http://link.springer.com/article/10.1007/BF02114394/fulltext.html']\n",
      "['9259483', 'Hudson N; Taha AS; Russell RI; Trye P; Cottrell J; Mann SG; Swanell AJ; Sturrock RD; Hawkey CJ. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology. (1997) 112 6 pp1817-1822', '10.1053/gast.1997.v112.pm9178671', '']\n",
      "['9259485', \"Murav'ev IuV; Lebedeva VV; Nasonova VA. [The intra-articular therapy with triamcinolone acetonide and betamethasone of rheumatoid arthritis patients: a double-blind study]. TerapevticheskiiÃÜ arkhiv. (1997) 69 5 pp32-33\", '10.1097/md.0000000000016714', '']\n",
      "['9259486', 'Kopeikina LT; Kamper EF; Koutsoukos V; Bassiakos Y; Stavridis I. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity. Clinical rheumatology. (1997) 16 3 pp254-260', '10.1007/bf02238960', 'http://link.springer.com/article/10.1007/BF02238960/fulltext.html']\n",
      "['9259487', 'Skeith KJ; Hussain MS; Coutts RT; Ramos-Remus C; Avina-Zubieta JA; Russell AS. Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia. Clinical rheumatology. (1997) 16 3 pp291-295', '10.1007/bf02238966', 'http://link.springer.com/article/10.1007/BF02238966/fulltext.html']\n",
      "['9259488', 'Kim HA; Song YW. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis. Rheumatology international. (1997) 17 1 pp5-9', '10.1007/pl00006849', 'http://link.springer.com/article/10.1007/PL00006849/fulltext.html']\n",
      "['9259489', 'Tugwell P; Ludwin D; Gent M; Roberts R; Bensen W; Grace E; Baker P. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs. Journal of rheumatology. (1997) 24 6 pp1122-1125', '10.1016/0140-6736(90)92630-z', '']\n",
      "['9259490', 'Jevtic V; Watt I; Rozman B; Kos-Golja M; Praprotnik S; Logar D; Presetnik M; Demsar F; Jarh O; Campion G; Musikic P. Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients. Clinical and experimental rheumatology. (1997) 15 2 pp151-156', '10.1016/s0009-9260(05)80277-6', '']\n",
      "['9259491', 'Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New England journal of medicine. (1997) 337 3 pp141-147', '10.1056/nejm199707173370301', '']\n",
      "['9259492', 'Puscas I; Puscas C; Coltau M; Pasca R; Torres J; M√°rquez M; Herrero E; Fillat O; Ortiz JA. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions. Arzneimittel-Forschung. (1997) 47 4A pp568-572', '10.1046/j.1440-1681.2000.03212.x', '']\n",
      "['9259493', 'Miller K. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study. Hepato-gastroenterology. (1997) 44 15 pp872-879', '10.1016/s0016-5085(97)80018-2', '']\n",
      "['9259495', 'Creamer P; Keen M; Zananiri F; Waterton JC; Maciewicz RA; Oliver C; Dieppe P; Watt I. Quantitative magnetic resonance imaging of the knee: a method of measuring response to intra-articular treatments. Annals of the rheumatic diseases. (1997) 56 6 pp378-381', '10.1136/ard.56.6.378', '']\n",
      "['9259497', 'Kelley JE; Lumley MA; Leisen JC. Health effects of emotional disclosure in rheumatoid arthritis patients. Health psychology. (1997) 16 4 pp331-340', '10.1037//0278-6133.16.4.331', '']\n",
      "['9259498', 'Rand T; Imhof H; Czerny C; Breitenseher M; Machold K; Turetschek K; Trattnig S. Discrimination between fluid, synovium, and cartilage in patients with rheumatoid arthritis: contrast enhanced Spin Echo versus non-contrast-enhanced fat-suppressed Gradient Echo MR imaging. Clinical radiology. (1999) 54 2 pp107-110', '10.1016/s0009-9260(99)91070-x', '']\n",
      "['9259499', \"Amosova KM; Iaremenko OB; Potapkov OV; Ivashchenko NA. A comparative evaluation of the efficacy of peroral and intravenous pulse therapy with methylprednisolone in rheumatic diseases. Likars'ka sprava / Ministerstvo okhorony zdorov'ia UkraiÃàny. (1998)  7 pp48-52\", '10.1136/ard.49.7.567', '']\n",
      "['9259500', 'Meding JB; Ritter MA; Keating EM; Faris PM; Edmondson K. A comparison of collared and collarless femoral components in primary cemented total hip arthroplasty: a randomized clinical trial. Journal of arthroplasty. (1999) 14 2 pp123-130', '10.1016/s0883-5403(99)90114-6', '']\n",
      "['9259502', 'Geusens P; Dequeker J; Vanhoof J; Stalmans R; Boonen S; Joly J; Nijs J; Raus J. Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study. Annals of the rheumatic diseases. (1998) 57 12 pp724-727', '10.1136/ard.57.12.724', '']\n",
      "['9259503', 'Miyamoto S; Kageyama Y; Ozeki T; Hiyoshi M; Suzuki M; Inoue T. Effects of glucocorticoids on bone mineral density in rheumatoid arthritis patients. A longitudinal study. Archives of orthopaedic and trauma surgery. (1999) 119 1-2 pp18-21', '10.1007/s004020050348', 'http://link.springer.com/article/10.1007/s004020050348/fulltext.html']\n",
      "['9259504', 'Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (1999) 42 3 pp431-437', '10.1002/1529-0131(199904)42:3<431::aid-anr6>3.0.co;2-2', '']\n",
      "['9259505', 'Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissil‚àö¬ß M; Keystone EC; Kraag GR; Bj‚àö‚àèrneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics. Journal of rheumatology. (1999) 26 3 pp556-562', '10.1097/00007890-199806270-00068', '']\n",
      "['9259507', 'Lundgren S; Stenstr√∂m CH. Muscle relaxation training and quality of life in rheumatoid arthritis. A randomized controlled clinical trial. Scandinavian journal of rheumatology. (1999) 28 1 pp47-53', '10.1080/03009749950155788', '']\n",
      "['9259508', 'Leibing E; Pfingsten M; Bartmann U; Rueger U; Schuessler G. Cognitive-behavioral treatment in unselected rheumatoid arthritis outpatients. Clinical journal of pain. (1999) 15 1 pp58-66', '10.1097/00002508-199903000-00009', '']\n",
      "['9259509', 'Smyth JM; Stone AA; Hurewitz A; Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA. (1999) 281 14 pp1304-1309', '10.1001/jama.281.14.1304', '']\n",
      "['9259510', 'Matsuno H; Yudoh K; Kondo M; Goto M; Kimura T. Biochemical effect of intra-articular injections of high molecular weight hyaluronate in rheumatoid arthritis patients. Inflammation research. (1999) 48 3 pp154-159', '10.1007/s000110050439', 'http://link.springer.com/article/10.1007/s000110050439/fulltext.html']\n",
      "['9259511', \"Tishler M; Yaron I; Shirazi I; Yossipov Y; Yaron M. Increased salivary interleukin-6 levels in patients with primary Sj√∂gren's syndrome. Rheumatology international. (1999) 18 4 pp125-127\", '10.1007/s002960050070', 'http://link.springer.com/article/10.1007/s002960050070/fulltext.html']\n",
      "['9259512', 'Arborelius M; Konttinen YT; Nordstr√∂m DC; Solovieva SA. Gly-X-Y repeat sequences in the treatment of active rheumatoid arthritis. Rheumatology international. (1999) 18 4 pp129-135', '10.1007/s002960050071', 'http://link.springer.com/article/10.1007/s002960050071/fulltext.html']\n",
      "['9259513', 'Dhondt W; Willaeys T; Verbruggen LA; Oostendorp RA; Duquet W. Pain threshold in patients with rheumatoid arthritis and effect of manual oscillations. Scandinavian journal of rheumatology. (1999) 28 2 pp88-93', '10.1080/030097499442540', '']\n",
      "['9259514', 'Ostergaard M; Hansen M; Stoltenberg M; Gideon P; Klarlund M; Jensen KE; Lorenzen I. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis and rheumatism. (1999) 42 5 pp918-929', '10.1002/1529-0131(199905)42:5<918::aid-anr10>3.0.co;2-2', '']\n",
      "['9259515', 'Devlin J; Wagstaff K; Arthur V; Emery P. Granisetron (Kytril) suppresses methotrexate-induced nausea and vomiting among patients with inflammatory arthritis and is superior to prochlorperazine (Stemetil). Rheumatology (Oxford, England). (1999) 38 3 pp280-282', '10.1093/rheumatology/38.3.280', 'http://academic.oup.com/rheumatology/article-pdf/38/3/280/18106557/280.pdf']\n",
      "['9259517', 'van der Horst-Bruinsma IE; Huizinga TW; Lagaay EM; Hazes JM; Breedveld FC; Schreuder GM; Tomson TA; Zwinderman AH; van Rood JJ; de Vries RR. The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis. Rheumatology (Oxford, England). (1999) 38 1 pp53-58', '10.1093/rheumatology/38.1.53', 'http://academic.oup.com/rheumatology/article-pdf/38/1/53/18106507/53.pdf']\n",
      "['9259518', 'Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study. Revue du rhumatisme (English ed.). (1999) 66 4 pp214-219', '10.1016/j.monrhu.2015.09.003', '']\n",
      "['9259519', 'Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Okada M; Ishizuka T; Kawakami M; Ohsuzu F. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Therapeutic apheresis. (1999) 3 2 pp178-185', '10.1046/j.1526-0968.1999.00136.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1526-0968.1999.00136.x']\n",
      "['9259521', 'Wiland P; Szechi≈Ñski J. N-acetyl-beta-D-glucosaminidase urinary excretion as an early indicator of kidney damage in rheumatoid arthritis patients starting on parenteral gold and Depo-Medrone/placebo injections. Clinical rheumatology. (1999) 18 2 pp106-113', '10.1007/s100670050066', 'http://link.springer.com/article/10.1007/s100670050066/fulltext.html']\n",
      "['9259522', 'Di Munno O; Mazzantini M; Milani S; Pasero G. Clinical equivalence between deflazacort oral drops and tablets in active rheumatoid arthritis. Clinical rheumatology. (1999) 18 2 pp140-144', '10.1007/s100670050072', 'http://link.springer.com/article/10.1007/s100670050072/fulltext.html']\n",
      "['9259523', 'McKown KM; Carbone LD; Kaplan SB; Aelion JA; Lohr KM; Cremer MA; Bustillo J; Gonzalez M; Kaeley G; Steere EL; Somes GW; Myers LK; Seyer JM; Kang AH; Postlethwaite AE. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis and rheumatism. (1999) 42 6 pp1204-1208', '10.1002/1529-0131(199906)42:6<1204::aid-anr17>3.0.co;2-u', '']\n",
      "['9259525', 'Knijff-Dutmer EA; Martens A; vd Laar MA. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1999) 58 4 pp257-259', '10.1136/ard.58.4.257', '']\n",
      "['9259526', 'McMeeken J; Stillman B; Story I; Kent P; Smith J. The effects of knee extensor and flexor muscle training on the timed-up-and-go test in individuals with rheumatoid arthritis. Physiotherapy research international. (1999) 4 1 pp55-67', '10.1002/pri.1999.4.1.55', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpri.1999.4.1.55']\n",
      "['9259527', \"Helliwell PS; O'Hara M; Holdsworth J; Hesselden A; King T; Evans P. A 12-month randomized controlled trial of patient education on radiographic changes and quality of life in early rheumatoid arthritis. Rheumatology (Oxford, England). (1999) 38 4 pp303-308\", '10.1093/rheumatology/38.4.303', 'http://academic.oup.com/rheumatology/article-pdf/38/4/303/18106624/380303.pdf']\n",
      "['9259528', 'Jenkins EA; Walker-Bone KE; Wood A; McCrae FC; Cooper C; Cawley MI. The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate. Scandinavian journal of rheumatology. (1999) 28 3 pp152-156', '10.1080/03009749950154211', '']\n",
      "['9259529', 'H√§kkinen A; Sokka T; Kotaniemi A; Kautiainen H; Jappinen I; Laitinen L; Hannonen P. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. Journal of rheumatology. (1999) 26 6 pp1257-1263', '10.1002/1529-0131(200103)44:3<515::aid-anr98>3.0.co;2-5', '']\n",
      "['9259531', 'Gordon MM; Porter DR; Capell HA. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Annals of the rheumatic diseases. (1999) 58 5 pp288-290', '10.1136/ard.58.5.288', '']\n",
      "['9259532', \"Veale DJ; Reece RJ; Parsons W; Radjenovic A; O'Connor PJ; Orgles CS; Berry E; Ridgway JP; Mason U; Boylston AW; Gibbon W; Emery P. Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology. Annals of the rheumatic diseases. (1999) 58 6 pp342-349\", '10.1136/ard.58.6.342', '']\n",
      "['9259533', 'Wis≈Çowska M; Sypu≈Ça S; Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatology international. (1999) 18 5-6 pp163-169', '10.1007/s002960050079', 'http://link.springer.com/article/10.1007/s002960050079/fulltext.html']\n",
      "['9259534', 'Drosos AA; Voulgari PV; Psychos DN; Tsifetaki N; Bai M. Sicca syndrome in patients with sarcoidosis. Rheumatology international. (1999) 18 5-6 pp177-180', '10.1007/s002960050081', 'http://link.springer.com/article/10.1007/s002960050081/fulltext.html']\n",
      "['9259535', 'Peeters HR; Jongen-Lavrencic M; Bakker CH; Vreugdenhil G; Breedveld FC; Swaak AJ. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures. Rheumatology international. (1999) 18 5-6 pp201-206', '10.1007/s002960050085', 'http://link.springer.com/article/10.1007/s002960050085/fulltext.html']\n",
      "['9259536', 'Foppiani L; Sulli A; Prete C; Sessarego P; Piredda S; Seriolo B; Cutolo M; Giusti M. Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients. Annals of the New York Academy of Sciences. (1999) 876  pp83-87', '10.1111/j.1749-6632.1999.tb07625.x', '']\n",
      "['9259537', \"Sidorov VD; Mamiliaeva DR; Gontar' EV; Reformatskaia SIu. [The interauricular laser therapy of rheumatoid arthritis]. Voprosy kurortologii, fizioterapii, i lechebnoiÃÜ fizicheskoiÃÜ kultury. (1999)  3 pp35-43\", '10.17116/kurort2015119-22', '']\n",
      "['9259538', 'Widman J; Isacson J. Surgical hemostasis after tourniquet release does not reduce blood loss in knee replacement. A prospective randomized study of 81 patients. Acta orthopaedica Scandinavica. (1999) 70 3 pp268-270', '10.3109/17453679908997805', '']\n",
      "['9259539', \"O'Dell JR; Paulsen G; Haire CE; Blakely K; Palmer W; Wees S; Eckhoff PJ; Klassen LW; Churchill M; Doud D; Weaver A; Moore GF. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis and rheumatism. (1999) 42 8 pp1691-1695\", '10.1002/1529-0131(199908)42:8<1691::aid-anr18>3.0.co;2-s', '']\n",
      "['9259540', \"O'Duffy EK; Clunie GP; Lui D; Edwards JC; Ell PJ. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Annals of the rheumatic diseases. (1999) 58 9 pp554-558\", '10.1136/ard.58.9.554', '']\n",
      "['9259541', 'Bianchi Porro G; Montrone F; Lazzaroni M; Manzionna G; Caruso I. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis. Italian journal of gastroenterology and hepatology. (1999) 31 5 pp378-385', '10.1046/j.1365-2036.1998.00313.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.1998.00313.x']\n",
      "['9259543', 'Kjeldsen-Kragh J. Rheumatoid arthritis treated with vegetarian diets. American journal of clinical nutrition. (1999) 70 3 Suppl pp594S-600S', '10.1093/ajcn/70.3.594s', 'http://academic.oup.com/ajcn/article-pdf/70/3/594s/23937703/594s.pdf']\n",
      "['9259544', 'Boers M. Combination therapy in rheumatoid arthritis. Lancet (London, England). (1999) 354 9182 pp952', '10.1016/s0140-6736(05)75700-7', '']\n",
      "['9259545', \"Abuzakouk M; Feighery C; Kelleher D; O'Briain DS; Jones E; Weir D; Casey E; O'Farrelly C. Increased HLA-DR and CD44 antigen expression in the gut: evidence of extraarticular immunological activity in rheumatoid arthritis. Journal of rheumatology. (1999) 26 9 pp1869-1876\", '10.1136/gut.39.3.396', '']\n",
      "['9259546', 'Ertenli I; Kiraz S; Ert√ºrk H; Haznedaroglu IC; Celik I; Calg√ºneri M; Kirazli S. Circulating thrombopoietin in systemic sclerosis. Journal of rheumatology. (1999) 26 9 pp1939-1941', '10.1007/s10067-003-0733-2', 'http://link.springer.com/article/10.1007/s10067-003-0733-2/fulltext.html']\n",
      "['9259547', 'Knops N; Wulffraat N; Lodder S; Houwen R; de Meer K. Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis. Journal of rheumatology. (1999) 26 9 pp2039-2043', '10.1007/s002960050099', 'http://link.springer.com/article/10.1007/s002960050099/fulltext.html']\n",
      "['9259548', \"Iakimtchouk K; Myrmel H; Jonsson R. Serological screening for hepatitis B and C and human herpesvirus 6 in Norwegian patients with primary Sj√∂gren's syndrome. Journal of rheumatology. (1999) 26 9 pp2065-2066\", '10.1080/03009749950155599', '']\n",
      "['9259549', 'Klepper SE. Effects of an eight-week physical conditioning program on disease signs and symptoms in children with chronic arthritis. Arthritis care and research. (1999) 12 1 pp52-60', '10.1002/1529-0131(199902)12:1<52::aid-art9>3.0.co;2-x', '']\n",
      "['9259550', 'David J; Townsend S; Sathanathan R; Kriss S; Dor√© CJ. The effect of acupuncture on patients with rheumatoid arthritis: a randomized, placebo-controlled cross-over study. Rheumatology (Oxford, England). (1999) 38 9 pp864-869', '10.1093/rheumatology/38.9.864', '']\n",
      "['9259551', 'Denisov LN; Andrianova IV; Timofeeva SS. Garlic effectiveness in rheumatoid arthritis. TerapevticheskiiÃÜ arkhiv. (1999) 71 8 pp55-58', '10.17116/terarkh201688124-10', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/32043/pdf']\n",
      "['9259552', 'Felson DT; LaValley MP; Baldassare AR; Block JA; Caldwell JR; Cannon GW; Deal C; Evans S; Fleischmann R; Gendreau RM; Harris ER; Matteson EL; Roth SH; Schumacher HR; Weisman MH; Furst DE. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial. Arthritis and rheumatism. (1999) 42 10 pp2153-2159', '10.1002/1529-0131(199910)42:10<2153::aid-anr16>3.0.co;2-w', '']\n",
      "['9259553', 'Luis M; Pacheco-Tena C; Cazar‚àö‚â†n-Barrientos J; Lino-P‚àö¬©rez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis and rheumatism. (1999) 42 10 pp2160-2165', '10.1002/1529-0131(199910)42:10<2160::aid-anr17>3.0.co;2-t', '']\n",
      "['9259554', 'Scholten C; Brodowicz T; Graninger W; Gardavsky I; Pils K; Pesau B; Eggl-Tyl E; Wanivenhaus A; Zielinski CC. Persistent functional and social benefit 5 years after a multidisciplinary arthritis training program. Archives of physical medicine and rehabilitation. (1999) 80 10 pp1282-1287', '10.1016/s0003-9993(99)90030-8', '']\n",
      "['9259555', 'Smeets TJ; Kraan MC; Versendaal J; Breedveld FC; Tak PP. Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. Journal of rheumatology. (1999) 26 10 pp2089-2093', '10.1002/1529-0131(200002)43:2<270::aid-anr5>3.0.co;2-h', '']\n",
      "['9259556', 'Altman RD; Schiff M; Kopp EJ. Cyclosporine A in rheumatoid arthritis: randomized, placebo controlled dose finding study. Journal of rheumatology. (1999) 26 10 pp2102-2109', '10.1093/rheumatology/41.10.1142', 'http://academic.oup.com/rheumatology/article-pdf/41/10/1142/9532839/411142.pdf']\n",
      "['9259557', 'Ahern M; Nicholls E; Simionata E; Clark M; Bond M. Clinical and psychological effects of hydrotherapy in rheumatic diseases. Clinical Rehabilitation.. (1995) 9 3 pp204-212', '10.1177/026921559500900305', 'https://journals.sagepub.com/doi/pdf/10.1177/026921559500900305']\n",
      "['9259558', 'Alpigiani MG; Ravera G; Buzzanca C; Devescovi R; Fiore P; Iester A. Use of n-3 fatty acids in Juvenile Chronic Arthritis (JCA). [Italian]. Pediatria Medica e Chirurgica. (1996) 18 4 pp387-390', '10.4081/pmc.2012.2', 'http://pediatrmedchir.org/index.php/pmc/article/viewFile/2/2']\n",
      "['9259559', 'Appelboom T; Franchimont P. Proglumetacin versus indometacin in rheumatoid arthritis: a double- blind multicenter study. Advances in therapy. (1994) 11 5 pp228-234', '10.1007/bf00270248', 'http://link.springer.com/article/10.1007/BF00270248/fulltext.html']\n",
      "['9259560', 'Boureau F; Boccard E. The analgesic efficacy and safety of a paracetamol-codeine association were studied in 40 patients with residual pain in spite of a balanced specific treatment for their rheumatoid arthritis. Rhumatologie. (1994) 46 6 pp157-163', '10.2165/00044011-199918030-00003', '']\n",
      "['9259561', \"Caruso I; Montrone F; Boari L; Davoli C; Beyene NB; Caporali R; Gandini R; Fumagalli M; Baratelli E; Broggini M; Canesi MB; Muscara M; Manzoni A; Locati M; D'Ingianna E; Fiorentini F. Lornoxicam versus diclofenac in rheumatoid arthritis: A double-blind, multicenter study. Advances in therapy. (1994) 11 3 pp132-138\", '10.1007/978-1-4612-5012-8_30', 'http://link.springer.com/content/pdf/10.1007/978-1-4612-5012-8_30.pdf']\n",
      "['9259562', 'Chlud K; Dominkus M. Diclofenac versus diclofenac + hyaluronic acid in topical administration Preliminary results of a double-blind controlled trial. ROUND TABLE SER R SOC MED. (1994) - 33 pp72-75', '10.58837/chula.the.2017.516', '']\n",
      "['9259563', 'Delmas PD; Lambert R; Capron MH. Misoprostol for preventing gastric erosions induced by nonsteroidal antiinflammatory drugs in patients with rheumatic diseases. Revue du rhumatisme (English ed.). (1994) 61 2 pp115-120', '10.1136/ard.45.7.616', '']\n",
      "['9259565', 'Gebuhr P; Sletgard J; Dalsgard J; Soelberg M; Keisu K; Hanninen A; Crawford M. Heterotopic ossification after hip arthroplasty - A randomized double-blind multicenter study of tenoxicam in 147 hips. Acta Orthopaedica Scandinavica.. (1996) 67 1 pp29-32', '10.3109/17453679608995604', '']\n",
      "['9259566', 'Gotzsche PC; Hansen M; Stoltenberg M; Svendsen A; Beier J; Faarvang KL; Wangel M; Rydgren L; Halberg P; Juncker P; Andersen V; Hansen TM; Endahl L. Randomized, placebo controlled tial of withdrawal of slow-acting antirheumatic drugs and of observer bias in rheumatoid arthritis. Scandinavian Journal of Rheumatology.. (1996) 25 4 pp194-199', '10.3109/03009749609069987', '']\n",
      "['9259567', 'Konrad K. Randomized, double blind, placebo-controlled study of ultrasonic treatment of the hands of rheumatoid arthritis patients. European journal of physical and rehabilitation medicine. (1994) 4 5 pp155-157', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9259568', 'Mannerkorpi K; Bjelle A. Evaluation of a home training programme to improve shoulder function in rheumatoid arthritis patients. Physiotherapy theory and practice. (1994) 10 2 pp69-76', '10.3109/09593989409047443', '']\n",
      "['9259569', 'Marcolongo R; Barreca C; Cocco R; Minari C; Biasi G; Chindamo D; Tofi C; Palazzini E. Efficacy of a prolonged-release dosage form of diclofenac sodium in some rheumatic diseases. Current Therapeutic Research - Clinical and Experimental. (1996) 57 9 pp711-719', '10.1016/s0011-393x(96)80076-2', '']\n",
      "['9259570', 'Menge M. Therapy of chronic polyarthritis: Comparative study with oxaceprol versus diclofenac. [German]. Die Therapiewoche. (1996) 46 30 pp1666-1669', '10.1007/bf03314460', 'http://link.springer.com/article/10.1007/BF03314460/fulltext.html']\n",
      "['9259571', 'Partio E; Wirta J. Comparison of patellar resurfacing and nonresurfacing in total knee arthroplasty: A prospective randomized study. Journal of Orthopaedic Rheumatology.. (1995) 8 2 pp69-74', '10.51168/sjhrafrica.v5i3.1068', '']\n",
      "['9259572', 'Paulus HE. Clinical trial design for evaluating combination therapies. British Journal of Rheumatology.. (1995) 34 SUPPL. 2 pp92-95', '10.1093/rheumatology/xxxiv.suppl_2.92', 'http://academic.oup.com/rheumatology/article-pdf/XXXIV/suppl_2/92/5288071/XXXIV-suppl_2-92.pdf']\n",
      "['9259573', 'Ribeiro SD. Efficacy and tolerability of two antiinflammatory drugs: Diclofenac sodium and piroxicam, in rheumatoid arthritis treatment. Double-blind comparative study. Folha Medica.. (1996) 113 1 pp77-85', '10.1016/0049-0172(85)90054-x', '']\n",
      "['9259574', 'Rodriguez LC; Bilbao A; Naranjo A; Ojeda S; Francisco F. Patient education in rheumatoid arthritis: Its influence in the disease outcome. Revista Espanola De Reumatologia.. (1996) 23 2 pp40-48', '10.1016/j.rbre.2014.03.011', '']\n",
      "['9259575', 'Roth SH; Bennett RE; Caldron PH; Mitchell CS; Swenson CM. Endoscopic Evaluation of the long term effects of diclofenac sodium and naproxen in elderly patients with arthritis. Clinical Drug Investigation.. (1995) 9 3 pp171-179', '10.2165/00044011-199509030-00007', '']\n",
      "['9259576', 'Ryu J; Saito S; Honda T; Sano S. Comparison between arthroscopic and open synovectomy for the rheumatoid knee: A retrospective study on the results of the two methods. Journal of Orthopaedic Rheumatology.. (1996) 9 1 pp28-32', '10.1007/bf00449922', 'http://link.springer.com/article/10.1007/BF00449922/fulltext.html']\n",
      "['9259577', 'Schnabel A; Reinhold KE; Willmann V; Dihlmann W; Gross WL. Side effects and efficacy of 15 mg and 25 mg methotrexate per week in rheumatoid arthritis. Zeitschrift fur Rheumatologie. (1994) 53 3 pp142-149', '10.1007/bf00302669', 'http://link.springer.com/article/10.1007/BF00302669/fulltext.html']\n",
      "['9259579', \"Van BHJ; Haverman JF. ECSTRA study. A double-blind, placebo-controlled study on the effects of adding misoprostol to a 'standard treatment' of rheumatoid arthritis. TGO Tijdschrift Voor Therapie Geneesmiddel En Onderzoek.. (1995) 20 3 pp7-11\", '10.1093/rheumatology/35.11.1142', 'http://academic.oup.com/rheumatology/article-pdf/35/11/1142/18094933/35-11-1142.pdf']\n",
      "['9259580', 'Weisman MH; Hagaman C; Yaksh TL; Lotz M. Preliminary findings on the role of neuropeptide suppression by topical agents in the management of rheumatoid arthritis. Seminars in arthritis and rheumatism. (1994) 23 SUPPL. 3 pp18-24', '10.1016/s0049-0172(10)80022-8', '']\n",
      "['9259582', 'Ahern MJ; Hall ND; Case K; Maddison PJ. D-penicillamine withdrawal in rheumatoid arthritis. ANN-RHEUM-DIS. (1984) 43 2 pp213-217', '10.1136/ard.43.2.213', '']\n",
      "['9259583', 'Bedi SS; Eberl R; Million R; Silas AM. Fenclofenac and diclofenac in the treatment of rheumatoid arthritis. BR-J-RHEUMATOL. (1984) 23 3 pp214-219', '10.1093/rheumatology/23.3.214', 'http://academic.oup.com/rheumatology/article-pdf/23/3/214/5040051/23-3-214.pdf']\n",
      "['9259584', 'Benvenuti C; Longoni L. Multicentre study on effectiveness and safety of flurbiprofen versus alternative therapy in 738 rheumatic patients. CURR-THER-RES,-CLIN-EXP. (1983) 34 1I pp30-44', '10.29011/crcdo-103.100003', '']\n",
      "['9259585', 'Berry H; Bloom B; Mace BEW; Hamilton EBD. Comparison of indoprofen (Flosint) and diclofenac in rheumatoid arthritis. A placebo controlled trial. CLIN-TRIALS-J. (1982) 19 4 pp248-259', '10.1007/bf02041555', 'http://link.springer.com/article/10.1007/BF02041555/fulltext.html']\n",
      "['9259586', 'Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. Journal of rheumatology. (1988) 15 12 pp1747-1754', '10.3109/03009748909095027', '']\n",
      "['9259587', 'Carrabba M; Conte W; Favalli E; et al. Double-blind short-term study on flurbiprofen and indomethacin in rheumatoid arthritis. CURR-THER-RES,-CLIN-EXP. (1982) 32 2 pp282-287', '10.1185/03007997709108981', '']\n",
      "['9259588', 'Caruso I; Fumagalli M; Tirrito M; et al. Double blind study with a new anti-rheumatic drug sulindac in the treatment of rheumatoid arthritis. Comparison with acetylsalicylic acid. EUR-J-RHEUMATOL-INFLAM. (1978) 1 1 pp58-65', '10.1186/isrctn48638981', '']\n",
      "['9259589', 'De SM; Hazleman BL; Dippy JE. Diflunisal and aspirin: A comparative study in rheumatoid arthritis. RHEUMATOL-REHABIL. (1980) 19 2 pp126-130', '10.1093/rheumatology/19.2.126', 'http://academic.oup.com/rheumatology/article-pdf/19/2/126/5020740/19-2-126.pdf']\n",
      "['9259590', \"Eastmond CJ; Hopkins R; Wright V. A comparative controlled study of tiaprofenic acid ('surgam') and naproxen in the treatment of rheumatoid arthritis. CURR-MED-RES-OPIN. (1982) 7 9 pp605-609\", '10.1185/03007998209110105', '']\n",
      "['9259591', 'Fasching U. Diflunisal vs ibuprofen in rheumatoid arthritis. WIEN-KLIN-WOCHENSCHR. (1983) 95 24 pp869-872', '10.1007/s10354-010-0795-0', 'http://link.springer.com/article/10.1007/s10354-010-0795-0/fulltext.html']\n",
      "['9259592', \"Frost LK; Isager H; Manthorpe R. Sjogren's syndrome treated with bromhexine: A randomized clinical study. BR-MED-J. (1978) 1 6127 pp1579-1581\", '10.1136/bmj.1.6127.1579', '']\n",
      "['9259593', 'Gallo M; La MG. A controlled trial of epirizole in the management of rheumatoid arthritis. CLIN-TER. (1983) 106 6 pp429-433', '10.1007/bf02041555', 'http://link.springer.com/article/10.1007/BF02041555/fulltext.html']\n",
      "['9259594', 'Hawkes J; Care G; Dixon JS; et al. A comparison of three different physiotherapy treatments for rheumatoid arthritis of the hands. PHYSIOTHER-PRACT. (1986) 2 4 pp155-160', '10.3109/09593988609037744', '']\n",
      "['9259595', 'Horslev PK; Helin P; Beyer JM; Boesen PD. Rheumatoid arthritis: Supplemental L-cysteine in penicillamine non- responders. CLIN-TRIALS-J. (1985) 22 1 pp63-70', '10.1136/bmj.287.6394.711', '']\n",
      "['9259596', 'Jensen EM; Fossgreen J; Kirchheiner B; et al. Treatment of rheumatoid arthritis with carprofen (Imadyl (Reg.trademark)) or indomethacin: A randomized multicentre trial. CURR-THER-RES,-CLIN-EXP. (1980) 28 6I pp882-887', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9259597', 'Keiding G; Sorensen K. A randomized, double-blind, within-patient trial of diclofenac sodium (Voltaren(Reg.trademark)) and naproxen in the treatment of rheumatoid arthritis. CURR-THER-RES,-CLIN-EXP. (1981) 29 1II pp183-192', '10.3109/03009747809097218', '']\n",
      "['9259598', 'Kirchheiner B; Fossgreen J; Jensen EM; et al. A new anti-inflammatory agent, carprofen (Imadyl(Reg.trademark)) in rheumatoid arthritis: A randomized multicentre comparison with indomethacin. CURR-THER-RES,-CLIN-EXP. (1980) 28 6I pp875-881', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9259599', 'Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A. Immunoregulating treatment of rheumatoid arthritis with thymopentin: a multi-centre placebo-controlled trial of 119 patients. Deutsche medizinische Wochenschrift (1946). (1988) 113 5 pp172-176', '10.1055/s-2008-1067614', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1067614.pdf']\n",
      "['9259600', 'Mattingly PC; Mowat AG. Zinc sulphate in rheumatoid arthritis. ANN-RHEUM-DIS. (1982) 41 5 pp456-457', '10.1136/ard.41.5.456', '']\n",
      "['9259601', 'Muller FH; Kaik D; Rau R; et al. Auranofin and sodium aurothiomalate in treatment of rheumatoid arthritis. Die Therapiewoche. (1983) 33 33 pp4245-4252', '10.1007/bf02030507', 'http://link.springer.com/article/10.1007/BF02030507/fulltext.html']\n",
      "['9259602', 'Nikolic J. A comparative double blind trial of diftalone and phenylbutazone in rheumatoid arthritis. Pharmatherapeutica. (1977) 1 8 pp528-534', '10.1177/030006057700500103', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057700500103']\n",
      "['9259603', 'Norn MS. Treatment of keratoconjunctivitis sicca with liquid paraffin or polyvinyl alcohol in double blind trials. ACTA-OPHTHALMOL. (1977) 55 6 pp945-950', '10.1111/j.1755-3768.1977.tb05675.x', '']\n",
      "['9259604', 'Nuti R; Righi GA; Turchetti V; Vattimo A. Effects of nandrolone decanoate on bone mineral content and intestinal calcium absorption. Minerva medica. (1984) 75 3-4 pp109-113', '10.1007/bf03348448', 'http://link.springer.com/article/10.1007/BF03348448/fulltext.html']\n",
      "['9259605', 'Ratnarajah S; Mearrick PT; Major GAC; et al. Efficacy of twice- versus thrice-daily carprofen in active rheumatoid arthritis. CURR-THER-RES,-CLIN-EXP. (1982) 32 1I pp59-64', '10.5001/omj.2011.03', '']\n",
      "['9259606', 'Scott JT. Trials of radioactive yttrium in treatment of rheumatoid arthritis. Die Therapiewoche. (1979) 29 4 pp502-504', '10.1093/rheumatology/xviii.suppl.36', 'http://academic.oup.com/rheumatology/article-pdf/XVIII/suppl/36/5153061/XVIII-suppl-36.pdf']\n",
      "['9259608', 'Tannenbaum H; Esdaile J; Topp JR; Rostogi RB. A double-blind, multicenter, controlled study on diclofenac (voltaren (Reg.trademark)) and naproxen in patients with rheumatoid arthritis (R.A. CURR-THER-RES,-CLIN-EXP. (1984) 35 3 pp357-362', '10.3109/03009747809097218', '']\n",
      "['9259609', 'Taube H. Immunostimulation in the treatment of chronic joint rheumatism. Results of a double blind study. MUNCH-MED-WOCHENSCHR. (1977) 119 46 pp1505-1508', '10.1002/art.1780200804', '']\n",
      "['9259610', 'Tursi A; Loria MP; Todesco S; Viara M. A double-blind clinical trial of carprofen (Imadyl) v. indomethacin in rheumatoid arthritis. CLIN-TRIALS-J. (1983) 20 6 pp319-326', '10.1007/bf00567116', 'http://link.springer.com/article/10.1007/BF00567116/fulltext.html']\n",
      "['9259611', 'Van KC; Giannini EH; Lovell DJ. Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients. Arthritis and rheumatism. (1988) 31 10 pp1252-1258', '10.1002/art.1780311006', '']\n",
      "['9259612', 'Verdickt W; Dequeker J; Ceuppens JL; et al. Effect of lymphoplasmapheresis on clinical indices and T cell subsets in rheumatoid arthritis. A double-blind controlled study. ARTHRITIS-RHEUM. (1983) 26 12 pp1419-1426', '10.1002/art.1780261202', '']\n",
      "['9259613', 'Ward JR; Williams HJ. Interim observations on benefit/risk of azathioprine versus D- penicillamine in the treatment of rheumatoid arthritis. ANN-RHEUM-DIS. (1982) 41 Suppl.1 pp23-25', '10.1136/ard.41.suppl_1.23', '']\n",
      "['9259614', 'Wasner C; Guy KR; Britton MC; Fries JF. A randomized blind crossover trial of six nonsteroidal antiinflammatory agents in rheumatoid arthritis and ankylosing spondylitis. ARTHRITIS-RHEUM. (1979) 22 6 pp671', '10.1001/jama.1981.03320190026021', '']\n",
      "['9259615', 'Zorzin L; Maira MG; Giobbio A; Capone M. Remarks on the use of slow release sodium diclofenac to the management of patients with rheumatoid arthritis. CLIN-TER. (1985) 114 2 pp105-110', '10.1016/s0049-0172(85)80015-9', '']\n",
      "['9259616', 'Bruce JR; Riggin CS; Parker JC; Walker SE; Meyer AA; Wellman FE; Kunce J. Pain management in rheumatoid arthritis: Cognitive behavior modification and transcutaneous neural stimulation. ARTHRITIS CARE RES.. (1988) 1 2 pp78-84', '10.1002/art.1790010204', '']\n",
      "['9259617', 'Kim H-A; Lim Y-S; Song Y-W; Kim H-Y; Park S-W; Yoo B; Moon H-B; Choi S-W; Lee S-K; Lee J-S; Lee Y-W; Chun Y-K; Park S-Y. Effect of deflazacort and prednisolone on bone and glucose metabolism in patients with rheumatoid arthritis. Journal of Korean Society for Clinical Pharmacology and Therapeutics. (1995) 3 2 pp177-186', '10.12793/jkscpt.1995.3.2.177', 'https://www.tcpharm.org/pdf/10.12793/jkscpt.1995.3.2.177']\n",
      "['9259618', 'Orozco-Alcala JJ; Barrera-Tenorio EF. Long-term treatment with tenoxicam in rheumatoid arthritis. EUR. J. RHEUMATOL. INFLAM.. (1987) 9 1-2 pp118-121', '10.1007/bf02032281', 'http://link.springer.com/article/10.1007/BF02032281/fulltext.html']\n",
      "['9259619', 'Cutolo M; Barisone G; Seriolo B; Accardo S. Juxta-articular osteoporosis in rheumatoid arthritis: Reversal by local subcutaneous calcitonin. CURR. THER. RES. CLIN. EXP.. (1990) 48 6 pp1126-1135', '10.1136/ard.53.8.550-a', '']\n",
      "['9259620', 'Fenton SF; Ryan JP; Bensen WG. A double-blind, crossover, multicenter study of piroxicam and naproxen in rheumatoid arthritis. CURR. THER. RES., CLIN. EXP.. (1988) 44 6 pp1058-1070', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9259621', 'Ferraz MB; Quaresma MR; Aquino LRL; Atra E; Tugwell P; Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. Journal of rheumatology. (1990) 17 8 pp1022-1024', '10.1093/rheumatology/29.3.193', 'http://academic.oup.com/rheumatology/article-pdf/29/3/193/5041311/29-3-193.pdf']\n",
      "['9259622', 'Appelbaum KA; Blanchard EB; Hickling EJ; Alfonso M. Cognitive behavioral treatment of a veteran population with moderate to severe rheumatoid arthritis. BEHAV. THER.. (1988) 19 4 pp489-502', '10.1016/s0005-7894(88)80019-4', '']\n",
      "['9259623', 'Jonderko G; Szopinski J; Galaszek M; Galaszek Z. Influence of heat and cold air therapy in sequence on the pain threshold as well as on the subjective pain feeling in rheumatoid arthritis.  EINFLUSS VON GLEICHZEITIGEN WARME- UND KALTETHERAPIEMASSNAHMEN AUF DIE SCHMERZSCHWELLE WIE AUF DIE SUBJEKTIVE SCHMERZBEURTEILUNG BEI KRANKEN MIT CHRONISCHER POLYARTHRITIS. Z. PHYS. MED. BALNEOL. MED. KLIMATOL.. (1990) 19 1 pp49-53', '10.1055/s-2008-1061825', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1061825.pdf']\n",
      "['9259624', 'Vignon E; Courcier S; Laborde C; Goehrs JM. Flurbiprofen sustained-release 200 mg and ketoprofen sustained-release 200 mg in the treatment of rheumatoid arthritis. REV. RHUM. ENGL. ED.. (1993) 60 7-8 pp440-444', '10.1007/bf03299793', 'http://link.springer.com/article/10.1007/BF03299793/fulltext.html']\n",
      "['9259625', 'Ambanelli U; Nervetti A; Colombo B; Cherie-Ligniere G; Gualdi I; Marcolongo R; Fioravanti A; Sabadini L; Materazzi M; Perpignano G; Bogliolo A; Serni U; Frosecchi M; Marin G; Semmola MV; Bufalino L; Gardini F. beta-cyclodextrin-piroxicam in the treatment of rheumatic diseases: A prospective study. J. DRUG DEV. SUPPL.. (1991) 4 1 pp55-66', '10.2165/00044011-200019002-00009', '']\n",
      "['9259626', 'Bywaters EGL; Camp AV; Day AT; et al. A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis. By the multicentre trial group. British journal of rheumatology. (1986) 25 2 pp184-192', '10.1093/rheumatology/25.2.184', 'http://academic.oup.com/rheumatology/article-pdf/25/2/184/5027688/25-2-184.pdf']\n",
      "['9259627', 'Gaus W; Wiesenauer M. Efficiency of a homoeopathic drug in rheumatoid arthritis - Discussion of critical remarks and outlook.  WIRKSAMKEITSNACHWEIS EINES HOMOOPATHIKUMS BEI CHRONISCHER POLYARTHRITIS - STELLUNGNAHME ZUR KRITIK UND AUSBLICK. AKTUEL. RHEUMATOL.. (1993) 18 5 pp159-162', '10.1055/s-2008-1047330', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047330.pdf']\n",
      "['9259628', 'McIlwain HH; Worley WE; Berman RS; et al. A double-blind multicenter study of sulindac once daily versus sulindac twice daily in rheumatoid arthritis. CURR. THER. RES., CLIN. EXP.. (1987) 41 5 pp679-691', '10.1007/bf03306513', 'http://link.springer.com/article/10.1007/BF03306513/fulltext.html']\n",
      "['9259629', \"Niculescu D; Naghiu M; Andronescu V; et al. Immunomodulation through incomplete Freund's adjuvans in the early stage of rheumatoid arthritis.  IMMUNOMODULATION DURCH INKOMPLETTES FREUND-ADJUVANS IM FRUHSTADIUM DER RHEUMATOIDEN ARTHRITIS. AKTUEL. RHEUMATOL.. (1986) 11 1 pp12-18\", '10.1055/s-2008-1047976', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047976.pdf']\n",
      "['9259630', 'Williams J; Harvey J; Tannenbaum H. Use of superficial heat versus ice for the rheumatoid arthritic shoulder: A pilot study. PHYSIOTHERAPY CANADA. (1986) 38 1 pp8-13', '10.3138/ptc.2009-09-s6', '']\n",
      "['9259631', 'Corvetta A; Della BR; Luchetti MM; Pomponio G; Ciuffoletti V. Tenoxicam and ketoprofen level monitoring with high performance liquid chromatography in patients affected by rheumatoid arthritis. Clinical and experimental rheumatology. (1991) 9 2 pp143-148', '10.1016/b978-0-12-370725-3.50031-2', '']\n",
      "['9259632', 'Geis GS; Stead H; Wallemark C-B; Nicholson PA. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. Journal of rheumatology. (1991) 18 SUPPL. 28 pp11-14', '10.3109/03009749209095074', '']\n",
      "['9259633', 'Wiesenauer M; Gaus W. A randomized double-blind trial on the efficiency of a homeopathic drug for rheumatoid arthritis. AKTUEL. RHEUMATOL.. (1991) 16 1 pp1-9', '10.1055/s-2008-1047372', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047372.pdf']\n",
      "['9259634', 'Goats GC; Flett E; Hunter JA; Stirling A. Low intensity laser and phototherapy for rheumatoid arthritis. Physiotherapy. (1996) 82 5 pp311-320', '10.1016/s0031-9406(05)66866-6', '']\n",
      "['9259635', 'Dreiser RL. A comparison of the efficacy of etodolac SR (Lodine (R)SR) and etodolac (Lodine (R)) in patients with rheumatoid arthritis or osteoarthritis. Rheumatology international. (1993) 13 2 SUPPL. ppS13-S18', '10.1007/bf00290279', 'http://link.springer.com/article/10.1007/BF00290279/fulltext.html']\n",
      "['9259636', 'Duthie JJR; Hill A; Lewis FE; et al. Controlled trial of synovectomy of knee and metacarpophalangeal joints in rheumatoid arthritis. ANNRHEUMDIS. (1976) 35 5 pp437-442', '10.1136/ard.35.5.437', '']\n",
      "['9259637', 'Littman BH; Schumacher HRJr; Boyle DL; Weisman MH; Firestein GS. Effect of tenidap on metalloproteinase gene expression in rheumatoid arthritis: A synovial biopsy study. Journal of clinical rheumatology. (1997) 3 4 pp194-202', '10.1097/00124743-199708000-00004', '']\n",
      "['9259639', 'Stenstr√∂m CH; Arge B; Sundbom A. Home exercise and compliance in inflammatory rheumatic diseases--a prospective clinical trial. Journal of rheumatology. (1997) 24 3 pp470-476', '10.3109/03009749609082664', '']\n",
      "['9259640', 'Komatireddy GR; Leitch RW; Cella K; Browning G; Minor M. Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III. Journal of rheumatology. (1997) 24 8 pp1531-1539', '10.1093/rheumatology/kew130.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i111/5076851/kew130.005.pdf']\n",
      "['9259641', 'Palmgren N; Jensen GF; Kaae K; Windelin M; Colov HC. Low-power laser therapy in rheumatoid arthritis. Lasers in medical science. (1989) 4 3 pp193-196', '10.1007/bf02032435', 'http://link.springer.com/article/10.1007/BF02032435/fulltext.html']\n",
      "['9259642', 'Fostiropoulos GA; Zissis NP; Marketos G. Once weekly administration of levamisole in rheumatoid arthritis. Clinical and investigative medicine. Medecine clinique et experimentale. (1982) 5 4 pp255-258', '10.1007/bf03318716', 'http://link.springer.com/article/10.1007/BF03318716/fulltext.html']\n",
      "['9259643', 'Kajino A; Yoshino SI; Kameyama S; Kohda M; Nagashima S. Comparison of the results of bilateral total knee arthroplasty with and without patellar replacement for rheumatoid arthritis. Journal of bone and joint surgery. American volume. (1997) 79 4 pp570-574', '10.2106/00004623-199704000-00014', '']\n",
      "['9259644', 'Jacob GB; Hart KK; Mullane JF; et al. Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. CURR THER RES, CLIN EXP. (1983) 33 4 pp703-713', '10.1038/clpt.1984.100', '']\n",
      "['9259645', 'Amante CM. Randomized comparative study on programmed released ketoprofen vs. piroxicam in the treatment of rheumatoid arthritis. PHILIPP-J-INTERN-MED. (1988) 26 2 pp69-73', '10.1007/bf03258209', 'http://link.springer.com/article/10.1007/BF03258209/fulltext.html']\n",
      "['9259646', 'Carrol GJ; Will RK; Breidahl PD; Tinsley LM. Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis. Rheumatology international. (1988) 8 6 pp251-255', '10.1007/bf00270980', 'http://link.springer.com/article/10.1007/BF00270980/fulltext.html']\n",
      "['9259647', 'Jaeger W. Treatment of severe courses of keratoconjunctivitis sicca with Eledoisin. KLIN MONATSBL AUGENHEILKD. (1988) 192 2 pp163-166', '10.1055/s-2008-1050096', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1050096.pdf']\n",
      "['9259648', 'Gualdi A; Bonollo L; Martini A; Forgione A. Non-steroidal anti-inflammatory drugs for topical therapy in traumatology: A double-blind study with flunoxaprofen and ketoprofen. Riforma medica. (1987) 102 10 pp401-404', '10.1007/978-94-010-9772-7_6', 'http://link.springer.com/content/pdf/10.1007/978-94-010-9772-7_6.pdf']\n",
      "['9259649', 'Haupt E; Hoppe FK; Rechziegler H; Zundorf P. On the question of interaction between nonsteroidal anti-inflammatory drugs and oral antidiabetics: Acemetacin - glibenclamide. Z-RHEUMATOL. (1987) 46 4 pp170-173', '10.1111/pim.13057/v1/review1', '']\n",
      "['9259650', 'Gerber L; Furst G; Shulman B; et al. Patient educaton program to teach energy conservation behaviors to patients with rheumatoid arthritis: A pilot study. ARCH-PHYS-MED-REHABIL. (1987) 68 7 pp442-445', '10.5014/ajot.41.2.102', 'https://research.aota.org/ajot/article-pdf/41/2/102/52518/102.pdf']\n",
      "['9259651', 'Rell-Bakalarska M; Filipowicz-Sosnowska A; Garwolinska H; Zabek J. Assessment of the results of combined treatment with cyclophosphamide and prednisone or methotrexate and prednisone in patients with rheumatoid arthritis with concomitant vasculitis:  OCENA WYNIKOW SKOJARZONEGO LECZENIA CYKLOFOSFAMIDEM I PREDNIZONEM ORAZ METOTREKSATEM I PREDNIZONEM CHORYCH NA REUMATOIDALNE ZAPALENIE STAWOW ZE WSPOLISTNIEJACYM ZAPALENIEM NACZYN. Reumatologia. (1998) 36 1 pp15-22', '10.5114/reum.2018.74741', 'https://reu.termedia.pl/pdf-85640-85692']\n",
      "['9259652', 'Carpentier N; Bertin P; Marquet P; Sabot C; Bonnet C; Debord J; Lach‚àö¬¢tre G; Tr‚àö¬Æves R. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?. Journal of rheumatology. (1998) 25 7 pp1270-1275', '10.2165/00003088-200038040-00003', '']\n",
      "['9259653', \"Sander O; Herborn G; Rau R. Is H15 (Extract of Boswellia serrata, 'incense') an efficient supplementation to established drug therapy in RA? - Results of a double blinded pilot trial:  IST H15 (HARZEXTRAKT VON BOSWELLIA SERRATA, 'WEIHRAUCH') EINE SINNVOLLE ERGANZUNG ZUR ETABLIERTEN MEDIKAMENTOSEN THERAPIE DER CHRONISCHEN POLYARTHRITIS? - ERGEBNISSE EINER DOPPELBLINDEN PILOTSTUDIE. Zeitschrift fur Rheumatologie. (1998) 57 1 pp11-16\", '10.1007/s003930050051', 'http://link.springer.com/article/10.1007/s003930050051/fulltext.html']\n",
      "['9259654', 'Zohmann A; Hawel R; Klein G; Kullich W; Lotsch G. S(+)-ibuprofen (dexibuprofen) - Excellent tolerance has not to be combined with poor clinical efficacy. Inflammopharmacology. (1998) 6 1 pp75-79', '10.1007/s10787-998-0008-2', 'https://link.springer.com/article/10.1007/s10787-998-0008-2/fulltext.html']\n",
      "['9259655', 'Biswas NR; Biswas K; Pandey M; Pandy RM. Treatment of osteoarthritis, rheumatoid arthritis and non-specific arthritis with a herbal drug: A double-blind, active drug controlled parallel study. JK Practitioner. (1998) 5 2 pp129-132', '10.1111/j.2042-7166.1997.tb00706.x', '']\n",
      "['9259656', 'Kerschbaumer F; Kandziora F; Herresthal J; Hertel A; Hor G. Combined arthroscopic and radiation synovectomy in rheumatoid arthritis:  SYNOVEKTOMIE UND SYNOVIORTHESE ALS KOMBINATIONSTHERAPIE BEI RHEUMATOIDER ARTHRITIS. Der Orthopade. (1998) 27 3 pp188-196', '10.1007/s001320050220', '']\n",
      "['9259657', 'Miyagi K; Azuma T; Naitoh A; Sakaida H; Sakata M; Nakagawa T; Miyahara H; Shirataka M. A 15-year follow-up study on the outcome in patients with early rheumatoid arthritis. Japanese Journal of Rheumatology. (1998) 8 2 pp117-129', '10.3109/bf03041335', '']\n",
      "['9259658', \"Vignes S; Wechsler B; Amoura Z; Papo T; Frances C; Huong DLT; Veyssier P; Godeau P; Piette J-C. Intravenous immunoglobulin in adult Still's disease refractory to non- steroidal anti-inflammatory drugs. Clinical and experimental rheumatology. (1998) 16 3 pp295-298\", '10.1016/s0248-8663(97)80896-x', '']\n",
      "['9259659', 'Karbowski A; Schwitalle M; Eckardt A. Oxaprozin versus diclofenac in the treatment of rheumatoid arthritis:  THERAPIE DER RHEUMATOIDEN ARTHRITIS MIT NICHTSTEROIDALEN ANTIPHLOGISTIKA: OXAPROZIN VERSUS DICLOFENAC. Aktuelle Rheumatologie. (1998) 23 1 pp11-15', '10.1055/s-2008-1043572', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1043572.pdf']\n",
      "['9259660', 'Maetzel A; Ferraz MB; Bombardier C. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs. Arthritis and rheumatism. (1998) 41 1 pp16-25', '10.1002/1529-0131(199801)41:1<16::aid-art3>3.0.co;2-4', '']\n",
      "['9259661', 'Peltonen R; Nenonen M; Helve T; H√§nninen O; Toivanen P; Eerola E. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. British journal of rheumatology. (1997) 36 1 pp64-68', '10.1093/rheumatology/36.1.64', 'http://academic.oup.com/rheumatology/article-pdf/36/1/64/18104711/360064.pdf']\n",
      "['9259662', 'McLaughlin G. Choline magnesium trisalicylate vs. naproxen in rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1982) 32 4 pp579-585', '10.1007/bf03306125', 'http://link.springer.com/article/10.1007/BF03306125/fulltext.html']\n",
      "['9259663', 'van Bijsterveld OP; Westers JC. Treatment of keratoconjunctivitis sicca. Klinische Monatsblatter fur Augenheilkunde. (1980) 177 1 pp52-57', '10.1055/s-2008-1057608', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1057608.pdf']\n",
      "['9259664', 'Altman RD; Schultz DR; Collins Yudiskas B; et al. The effects of a partially purified fraction of an ant venom in rheumatoid arthritis. Arthritis and rheumatism. (1984) 27 3 pp277-284', '10.1002/art.1780270305', '']\n",
      "['9259665', 'Bahous I; Rosenthal M. Basic treatment of rheumatoid arthritis with an immunomodulating agent at two distinct dosage regimens: A double blind clinical study. International Journal of Immunotherapy. (1987) 3 4 pp265-270', '10.1186/isrctn48638981', '']\n",
      "['9259666', 'Bostr√∂m C; Harms-Ringdahl K; Karreskog H; Nordemar R. Effects of static and dynamic shoulder rotator exercises in women with rheumatoid arthritis: a randomised comparison of impairment, disability, handicap, and health. Scandinavian journal of rheumatology. (1998) 27 4 pp281-290', '10.1080/030097498442398', '']\n",
      "['9259667', 'Caldwell JR; Roth SH; Bohan A; Brandon ML; Carstens SA; Chubick A; Ferraro L; Finch WR; Fleischmann RN; Gordon RD; Greco T; Harris ER; Hirschberg JM; Kohn NN; Maurer KH; Miller JL; Owens D; Rutstein JE; Samuels BS. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Journal of rheumatology. (1994) 21 4 pp689-695', '10.1185/03007999109111664', '']\n",
      "['9259668', 'Calin A; Saunders D; Bennett R; et al. Auranofin: 1 mg or 9 mg? The search for the appropriate dose. Journal of rheumatology. (1982) 9 Suppl. 8 pp146-148', '10.3109/03009748209098183', '']\n",
      "['9259669', 'Cush JJ; Lipsky PE; Postlethwaite AE; Schrohenloher RE; Saway A; Koopman WJ. Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis and rheumatism. (1990) 33 1 pp19-28', '10.1002/art.1780330103', '']\n",
      "['9259670', 'Feldmann JL; Mery C; Amor B; Kahan A; de Gery A; Delbarre F. Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results. Scandinavian journal of rheumatology. (1981) 10 1 pp1-8', '10.1080/03009748109095263', '']\n",
      "['9259671', 'Grindulis KA; McConkey B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?. Scandinavian journal of rheumatology. (1985) 14 3 pp265-270', '10.3109/03009748509100404', '']\n",
      "['9259672', 'Harris Jr ED; Emkey RD; Nichols JE; Newberg A. Low dose prednisone therapy in rheumatoid arthritis: A double blind study. Journal of rheumatology. (1983) 10 5 pp713-721', '10.1002/art.1780270913', '']\n",
      "['9259673', 'Janssen M; Dijkmans BA; Vandenbroucke JP; van Duijn W; Pena AS; Lamers CB. Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold. Annals of the rheumatic diseases. (1992) 51 9 pp1036-1038', '10.1136/ard.51.9.1036', '']\n",
      "['9259674', 'Kowanko IC; Pownall R; Knapp MS; et al. Time of day of prednisolone administration in rheumatoid arthritis. Annals of the rheumatic diseases. (1982) 41 5 pp447-452', '10.1136/ard.41.5.447', '']\n",
      "['9259675', 'Lacki JK; Mackiewicz SH. The effect of immunosuppressive drugs on expression of surface antigens of lymphocytes in patients with rheumatoid arthritis. Polskie Archiwum Medycyny WewneÃ®trznej. (1997) 97 2 pp134-143', '10.3109/03009739509178909', '']\n",
      "['9259676', 'Menard HA; Mathieu JP; de M R; Lussier A. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?. Journal of rheumatology. (1979) 6  pp156-162', '10.1093/rheumatology/35.7.620', 'http://academic.oup.com/rheumatology/article-pdf/35/7/620/5036610/35-7-620.pdf']\n",
      "['9259677', 'Michaels RM; Reading JC; Beezhold DH; Ward JR. Serum phospholipase A2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two. Journal of rheumatology. (1996) 23 2 pp226-229', '10.1002/art.1780361006', '']\n",
      "['9259678', 'Pasero G; Pellegrini P; Ambanelli U; et al. Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis and rheumatism. (1982) 25 8 pp923-929', '10.1002/art.1780250803', '']\n",
      "['9259679', 'Piotrowski M; Szczepanski L; Dmoszynska M. Treatment of rheumatic conditions with local instillation of betamethasone and methylprednisolone - Comparison of efficacy and frequency of irritative, pain reaction. Reumatologia. (1998) 36 1 pp78-84', '10.1136/annrheumdis-2013-eular.2922', '']\n",
      "['9259680', 'Rasmussen GG; Brandslund I; Urfe P; Teisner B; Siersted HC; Hindersson P; Lund HI; Nielsen EF; Arfelt E; Jensen A. Lack of effect of tranexamic acid on rheumatoid arthritis. Scandinavian journal of rheumatology. (1984) 13 4 pp369-373', '10.3109/03009748409111311', '']\n",
      "['9259681', 'Shiokawa Y; Horiuchi Y; Mizushima Y; et al. A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. Journal of rheumatology. (1984) 11 5 pp615-623', '10.1016/0192-0561(82)90263-6', '']\n",
      "['9259682', 'Singleton CM; Wild JH. A double-blind comparison of aspirin and pirprofen in the treatment of rheumatoid arthritis. Journal of rheumatology. (1980) 7 6 pp865-870', '10.1002/j.1552-4604.1980.tb02536.x', '']\n",
      "['9259683', 'Sprekeler R; Lemmel EM; Obert H-J. Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma. Zeitschrift fur Rheumatologie. (1990) 49 1 pp1-7', '10.1016/s0140-6736(88)91403-1', '']\n",
      "['9259686', \"Williams HJ; Reading JC; Ward JR; O'Brien WM. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis. Arthritis and rheumatism. (1980) 23 5 pp521-527\", '10.1002/art.1780230502', '']\n",
      "['9259687', 'Tegelberg A; Kopp S. Short-term effect of physical training on temperomandibular joint disorder in individuals with rheumatoid arthritis and ankylosing spondylitis. Acta odontologica scandinavica. (1988) 46 1 pp49-56', '10.3109/00016358809004746', '']\n",
      "['9259688', 'Harvey EJ; Leclerc J; Brooks CE; Burke DL. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. Journal of arthroplasty. (1997) 12 3 pp291-296', '10.1016/s0883-5403(97)90025-5', '']\n",
      "['9259689', 'Pieroni PF; Gramajo RJ; et al. Therapeutic activity and safety of diftalone in rheumatoid arthritis: a double-blind evaluation in comparison with indomethacin. Pharmatherapeutica. (1976) 1 5 pp262-269', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9259690', 'Hamilton RA; Kremer JM. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. British journal of rheumatology. (1997) 36 1 pp86-90', '10.1093/rheumatology/36.1.86', 'http://academic.oup.com/rheumatology/article-pdf/36/1/86/18104735/360086.pdf']\n",
      "['9259691', 'Schubiger BI; Ciccolunghi SN; Tanner K. Comparative tolerability of diclofenac and indomethacin suppositories in rheumatic disease. Pharmatherapeutica. (1978) 2 2 pp114-119', '10.1177/030006058000800213', 'https://journals.sagepub.com/doi/pdf/10.1177/030006058000800213']\n",
      "['9259692', 'Loizzi P; Pipitone V; Bignamini AA. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders. Pharmatherapeutica. (1980) 2 5 pp285-292', '10.1185/03007997909109440', '']\n",
      "['9259693', \"Willkens RF; Vreede P. Sodium meclofenamate ('Meclomen') in the treatment of rheumatoid arthritis: a double-blind comparison with aspirin and placebo. Pharmatherapeutica. (1981) 2 9 pp587-596\", '10.3109/9780203214237-212', '']\n",
      "['9259695', 'Muheim G; Crutchlow WP. 18F and 85Sr scintimetry in the study of primary arthropathies. British journal of radiology. (1971) 44 520 pp290-294', '10.1259/0007-1285-44-520-290', '']\n",
      "['9259697', 'Helewa A; Goldsmith CH; Smythe HA. The modified sphygmomanometer-an instrument to measure muscle strength: a validation study. Journal of chronic diseases. (1981) 34 7 pp353-361', '10.1016/0021-9681(81)90073-4', '']\n",
      "['9259698', 'Valentini G; Tirri G; Longatti S. Relative efficacy and tolerance of tiaprofenic acid and ketoprofen in rheumatoid arthritis. Drugs. (1988) 35 Suppl 1  pp87-89', '10.2165/00003495-198800351-00020', '']\n",
      "['9259699', 'Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. Journal of rheumatology. (1998) 25 9 pp1694-1704', '10.1093/rheumatology/kem001', '']\n",
      "['9259700', 'Kardamakis D; Berry RJ. Low-dose total-body irradiation in the management of refractory rheumatoid arthritis. British journal of radiology. (1987) 60 711 pp297-299', '10.1259/0007-1285-60-711-297', '']\n",
      "['9259701', 'Hansen M; Podenphant J; Florescu A; Stoltenberg M; Borch A; Kluger E; S√∏rensen SF; Hansen TM. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects. Annals of the rheumatic diseases. (1999) 58 11 pp713-718', '10.1136/ard.58.11.713', '']\n",
      "['9259702', 'Ash G; Dickens CM; Creed FH; Jayson MI; Tomenson B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology (Oxford, England). (1999) 38 10 pp959-967', '10.1093/rheumatology/38.10.959', 'http://academic.oup.com/rheumatology/article-pdf/38/10/959/18108243/380959.pdf']\n",
      "['9259703', 'Choy EH; Rankin EC; Kassimos D; Vetterlein O; Garyfallos A; Ravirajan CT; Sopwith M; Eastell R; Kingsley GH; Isenberg DA; Panayi GS. The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis. Journal of rheumatology. (1999) 26 11 pp2310-2317', '10.1093/rheumatology/34.4.334', 'http://academic.oup.com/rheumatology/article-pdf/34/4/334/5020642/34-4-334.pdf']\n",
      "['9259704', 'Cantatore FP; Acquista CA; Pipitone V. Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. Journal of rheumatology. (1999) 26 11 pp2318-2323', '10.1093/rheumatology/keg375', 'http://academic.oup.com/rheumatology/article-pdf/42/11/1429/5058836/keg375.pdf']\n",
      "['9259705', 'Schnitzer TJ; Truitt K; Fleischmann R; Dalgin P; Block J; Zeng Q; Bolognese J; Seidenberg B; Ehrich EW. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. Clinical therapeutics. (1999) 21 10 pp1688-1702', '10.1016/s0149-2918(99)80048-4', '']\n",
      "['9259707', 'Stein A; Yassouridis A; Szopko C; Helmke K; Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain. (1999) 83 3 pp525-532', '10.1016/s0304-3959(99)00156-6', '']\n",
      "['9259708', 'Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. (1999) 282 20 pp1921-1928', '10.1001/jama.282.20.1921', '']\n",
      "['9259709', \"O'Dell JR. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate. Clinical and experimental rheumatology. (1999) 17 6 Suppl 18 ppS53-8\", '10.1016/b978-1-4160-3285-4.10056-7', '']\n",
      "['9259710', 'Bankhurst AD. Etanercept and methotrexate combination therapy. Clinical and experimental rheumatology. (1999) 17 6 Suppl 18 ppS69-72', '10.1186/1546-0096-10-s1-a59', 'http://link.springer.com/article/10.1186/1546-0096-10-S1-A59/fulltext.html']\n",
      "['9259711', 'Antoni C; Kalden JR. Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (1999) 17 6 Suppl 18 ppS73-7', '10.1016/s0140-6736(99)05246-0', '']\n",
      "['9259712', 'Varbanova BB; Dyankov ED. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis. Advances in experimental medicine and biology. (1999) 455  pp331-336', '10.1007/978-1-4615-4857-7_50', 'http://link.springer.com/content/pdf/10.1007/978-1-4615-4857-7_50.pdf']\n",
      "['9259713', 'Taukumova LA; Mouravjoy YuV null; Gribakin SG. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis. Advances in experimental medicine and biology. (1999) 455  pp367-373', '10.1007/978-1-4615-4857-7_56', 'http://link.springer.com/content/pdf/10.1007/978-1-4615-4857-7_56.pdf']\n",
      "['9259714', 'Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis. Journal of rheumatology. (1999) 26 12 pp2539-2543', '10.1177/00912700022009305', '']\n",
      "['9259715', 'Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup. Journal of rheumatology. (1999) 26 12 pp2544-2550', '10.1007/s00296-006-0145-0', 'http://link.springer.com/article/10.1007/s00296-006-0145-0/fulltext.html']\n",
      "['9259716', 'Emery P; Zeidler H; Kvien TK; Guslandi M; Naudin R; Stead H; Verburg KM; Isakson PC; Hubbard RC; Geis GS. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet (London, England). (1999) 354 9196 pp2106-2111', '10.1016/s0140-6736(99)02332-6', '']\n",
      "['9259717', 'van Jaarsveld CH; ter Borg EJ; Jacobs JW; Schellekens GA; Gmelig-Meyling FH; van Booma-Frankfort C; de Jong BA; van Venrooij WJ; Bijlsma JW. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clinical and experimental rheumatology. (1999) 17 6 pp689-697', '10.1007/978-3-642-76189-8_20', '']\n",
      "['9259718', 'Calg‚àö¬∫neri M; Pay S; Cali‚âà√ºkaner Z; Apra‚âà√º S; Kiraz S; Ertenli I; Cobankara V. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clinical and experimental rheumatology. (1999) 17 6 pp699-704', '10.1097/rhu.0000000000000410', '']\n",
      "['9259719', 'Hendry GD; Schrieber L; Bryce D. Patients teach students: partners in arthritis education. Medical education. (1999) 33 9 pp674-677', '10.1046/j.1365-2923.1999.00524.x', '']\n",
      "['9259720', 'Knudson KG; Spiegel TM; Furst D. Outpatient educational program for rheumatoid arthritis patients. Patient counselling and health education. (1981) 3 2 pp77-82', '10.1016/s0738-3991(81)80063-8', '']\n",
      "['9259721', 'Oermann MH; Doyle TH; Clark LR; Rivers CL; Rose VY. Effectiveness of self-instruction for arthritis patient education. Patient education and counseling. (1986) 8 3 pp245-254', '10.1016/0738-3991(86)90003-0', '']\n",
      "['9259722', 'Basler HD. Group treatment for pain and discomfort. Patient education and counseling. (1993) 20 2-3 pp167-175', '10.1016/0738-3991(93)90130-o', '']\n",
      "['9259723', 'Taal E; Riemsma RP; Brus HL; Seydel ER; Rasker JJ; Wiegman O. Group education for patients with rheumatoid arthritis. Patient education and counseling. (1993) 20 2-3 pp177-187', '10.1016/0738-3991(93)90131-f', '']\n",
      "['9259724', 'Emery P. Disease modification in rheumatoid arthritis with leflunomide. Scandinavian journal of rheumatology. Supplement. (1999) 112  pp9-14', '10.1080/030097499750042236', '']\n",
      "['9259725', 'Smolen JS. Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1999) 112  pp15-21', '10.1080/030097499750042245-1', '']\n",
      "['9259726', 'Scott DL. Leflunomide improves quality of life in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1999) 112  pp23-29', '10.1080/030097499750042254-1', '']\n",
      "['9259727', 'Schiff MH. Leflunomide versus methotrexate: a comparison of the European and American experience. Scandinavian journal of rheumatology. Supplement. (1999) 112 112 pp31-35', '10.1080/030097499750042263', '']\n",
      "['9259728', 'Lorenz HM; Gr‚Äö√†√∂¬¨‚à´nke M; Hieronymus T; Antoni C; N‚Äö√†√∂¬¨‚à´sslein H; Schaible TF; Manger B; Kalden JR. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2. Journal of rheumatology. (2000) 27 2 pp304-310', '10.1016/s0165-2478(97)85159-0', '']\n",
      "['9259730', 'Krug H; Broadwell LK; Berry M; DeLapp R; Palmer RH; Mahowald M. Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis. Clinical therapeutics. (2000) 22 1 pp40-52', '10.1016/s0149-2918(00)87976-x', '']\n",
      "['9259732', 'Lovell DJ; Giannini EH; Reiff A; Cawkwell GD; Silverman ED; Nocton JJ; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Whitmore J; Finck BK. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. New England journal of medicine. (2000) 342 11 pp763-769', '10.1056/nejm200003163421103', '']\n",
      "['9259733', 'Weitoft T; Uddenfeldt P. Importance of synovial fluid aspiration when injecting intra-articular corticosteroids. Annals of the rheumatic diseases. (2000) 59 3 pp233-235', '10.1136/ard.59.3.233', '']\n",
      "['9259734', 'Bapuji AT; Rambhau D; Srinivasu P; Rao BR; Apte SS. Time dependent influence of diazepam on the pharmacokinetics of ibuprofen in man. Drug metabolism and drug interactions. (1999) 15 1 pp71-81', '10.1515/dmdi.1999.15.1.71', '']\n",
      "['9259735', 'Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Kr‚àö¬∫ger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group. Rheumatology (Oxford, England). (2000) 39 2 pp156-164', '10.1093/rheumatology/39.2.156', 'http://academic.oup.com/rheumatology/article-pdf/39/2/156/18108853/390156.pdf']\n",
      "['9259736', 'Ueki Y; Yamasaki S; Kanamoto Y; Kawazu T; Yano M; Matsumoto K; Miyake S; Tominaga Y; Iwamoto U; Suemitsu J; Matsuno Y; Sizume Y; Takenaka Y; Eguchi K. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 2 pp165-171', '10.1093/rheumatology/39.2.165', 'http://academic.oup.com/rheumatology/article-pdf/39/2/165/18108878/390165.pdf']\n",
      "['9259739', 'Sukenik S; Flusser D; Codish S; Abu-Shakra M. Balneotherapy at the Dead Sea area for knee osteoarthritis. Israel Medical Association journal. (1999) 1 2 pp83-85', '10.1007/s002960000085', 'http://link.springer.com/article/10.1007/s002960000085/fulltext.html']\n",
      "['9259740', 'Moreland LW; McCabe DP; Caldwell JR; Sack M; Weisman M; Henry G; Seely JE; Martin SW; Yee CL; Bendele AM; Frazier JL; Kohno T; Cosenza ME; Lyons SA; Dayer JM; Cohen AM; Edwards CK. Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis. Journal of rheumatology. (2000) 27 3 pp601-609', '10.1136/ard.59.suppl_1.i41', '']\n",
      "['9259741', 'Avisar R; Robinson A; Appel I; Yassur Y; Weinberger D. Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. Cornea. (2000) 19 2 pp145-147', '10.1097/00003226-200003000-00005', '']\n",
      "['9259742', 'Blondon H. Specific cyclo-oxygenase inhibitors. 2. Gastric toxicity?. Presse meÃÅdicale (Paris, France : 1983). (2000) 29 9 pp482-483', '10.1111/j.1476-5381.1983.tb10727.x', '']\n",
      "['9259743', 'Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A. Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Zeitschrift fuÃàr Rheumatologie. (2000) 59 Suppl 1 Suppl 1 pp48-52', '10.1007/s003930070040', 'http://link.springer.com/article/10.1007/s003930070040/fulltext.html']\n",
      "['9259744', 'Dequeker J; Borghs H; Van Cleemput J; Nevens F; Verleden G; Nijs J. Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol. Zeitschrift fuÃàr Rheumatologie. (2000) 59 Suppl 1  pp53-57', '10.1007/s003930070041', 'http://link.springer.com/article/10.1007/s003930070041/fulltext.html']\n",
      "['9259746', 'Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. Journal of rheumatology. (2000) 27 4 pp841-850', '10.1016/s0140-6736(99)05246-0', '']\n",
      "['9259747', 'Rooney M; Davies UM; Reeve J; Preece M; Ansell BM; Woo PM. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. Journal of rheumatology. (2000) 27 4 pp1073-1081', '10.1042/cs078013pb', 'https://portlandpress.com/clinsci/article-pdf/78/s22/13P/822085/cs078013pc.pdf']\n",
      "['9259748', 'Lerndal T; Svensson B. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 3 pp316-320', '10.1093/rheumatology/39.3.316', 'http://academic.oup.com/rheumatology/article-pdf/39/3/316/5044766/390316.pdf']\n",
      "['9259749', 'Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis and rheumatism. (2000) 43 5 pp1001-1009', '10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p', '']\n",
      "['9259750', 'Esselinckx W; Bacon PA; Ring EF; Crooke D; Collins AJ; Demottaz D. A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis. British journal of clinical pharmacology. (1978) 5 5 pp447-451', '10.1111/j.1365-2125.1978.tb01653.x', '']\n",
      "['9259751', 'Fowler PD; Dawes PT; John VA; Shotton PA. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation. European journal of clinical pharmacology. (1986) 31 4 pp469-472', '10.1007/bf00613526', 'http://link.springer.com/article/10.1007/BF00613526/fulltext.html']\n",
      "['9259752', 'Geis GS. Update on clinical developments with celecoxiv, a new specific COX-2 inhibitor: What can we expect?. Scand-J-Rheumatol. (1999) 28 Suppl 109  pp31-37', '10.1080/030097499750042407', '']\n",
      "['9259753', 'Godfrey C; Sweeney K; Miller K; Hamilton R; Kremer J. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. British journal of clinical pharmacology. (1998) 46 4 pp369-376', '10.1046/j.1365-2125.1998.00790.x', '']\n",
      "['9259754', 'Huskisson EC; Grayson MF. Indomethacin or amylobarbitone sodium for sleep in rheumatoid arthritis, with some observations on the use of sequential analysis. Br-J-Clin-Pharmacol. (1974) 1  pp151-154', '10.1111/j.1365-2125.1974.tb00224.x', '']\n",
      "['9259755', 'Kaarela K; Lehtinen K; M√§kisara P; Holttinen K; Lamminsivu U; Gordin A. Pharmacokinetics and tolerance of slow-release indomethacin tablets in rheumatoid arthritis. European journal of clinical pharmacology. (1982) 23 4 pp349-351', '10.1007/bf00613619', 'http://link.springer.com/article/10.1007/BF00613619/fulltext.html']\n",
      "['9259756', 'Scholz H-J; Adamczyk A; Haringer E; Kasper P. Treatment of rheumatoid arthritis and osteoarthritis. Multicenter trial tenoxicam versus piroxicam. [German]. Munchener medizinische Wochenschrift (1950). (1988) 130 6 pp94-96', '10.1007/bf03296792', 'http://link.springer.com/article/10.1007/BF03296792/fulltext.html']\n",
      "['9259757', 'Vedanthan PK; Menon MM; Bell TD; Bergin D. Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma. Journal of allergy and clinical immunology. (1977) 60 1 pp8-13', '10.1016/0091-6749(77)90077-x', '']\n",
      "['9259758', 'Budiman-Mak E; Conrad KJ; Roach KE. The Foot Function Index: a measure of foot pain and disability. Journal of clinical epidemiology. (1991) 44 6 pp561-570', '10.1016/0895-4356(91)90220-4', '']\n",
      "['9259759', 'Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L. Clinical pharmacology and efficiency of benorylate in patients with rheumatoid arthritis. Australian and New Zealand journal of medicine. (1978) 8  pp22-28', '10.1111/j.1445-5994.1978.tb02398.x', '']\n",
      "['9259760', 'Mayo PR; Skeith K; Russell AS; Jamali F. Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. British journal of clinical pharmacology. (2000) 50 6 pp605-613', '10.1046/j.1365-2125.2000.00314.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.2000.00314.x']\n",
      "['9259761', \"Kohriyama K; Katayama Y. Disproportion of helper T cell subsets in peripheral blood of patients with primary Sj√∂gren's syndrome. Autoimmunity. (2000) 32 1 pp67-72\", '10.3109/08916930008995989', '']\n",
      "['9259762', \"Tjon SS; Geurts AC; van't Pad Bosch P; Laan RF; Mulder T. Postural control in rheumatoid arthritis patients scheduled for total knee arthroplasty. Archives of physical medicine and rehabilitation. (2000) 81 11 pp1489-1493\", '10.1053/apmr.2000.9627', '']\n",
      "['9259763', 'Multon KD; Parker JC; Smarr KL; Stucky RC; Petroski G; Hewett JE; Wright GE; Rhee SH; Walker SE. Effects of stress management on pain behavior in rheumatoid arthritis. Arthritis and rheumatism. (2001) 45 2 pp122-128', '10.1002/1529-0131(200104)45:2<122::aid-anr163>3.0.co;2-7', '']\n",
      "['9259764', 'Kirwan J; Byron M; Watt I. The relationship between soft tissue swelling, joint space narrowing and erosive damage in hand X-rays of patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 3 pp297-301', '10.1093/rheumatology/40.3.297', 'http://academic.oup.com/rheumatology/article-pdf/40/3/297/18095079/400297.pdf']\n",
      "['9259765', 'Sharpe L; Sensky T; Timberlake N; Ryan B; Brewin CR; Allard S. A blind, randomized, controlled trial of cognitive-behavioural intervention for patients with recent onset rheumatoid arthritis: preventing psychological and physical morbidity. Pain. (2001) 89 2-3 pp275-283', '10.1016/s0304-3959(00)00379-1', '']\n",
      "['9259766', 'H√§kkinen A; Sokka T; Kotaniemi A; Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis and rheumatism. (2001) 44 3 pp515-522', '10.1002/1529-0131(200103)44:3<515::aid-anr98>3.0.co;2-5', '']\n",
      "['9259767', 'Agren JJ; Tvrzicka E; Nenonen MT; Helve T; H√§nninen O. Divergent changes in serum sterols during a strict uncooked vegan diet in patients with rheumatoid arthritis. British journal of nutrition. (2001) 85 2 pp137-139', '10.1079/bjn2000234', '']\n",
      "['9259768', 'St√•l O; Borg A; Fern√∂ M; K√§llstr√∂m AC; Malmstr√∂m P; Nordenskj√∂ld B; South Sweden Breast Cancer Group. Southeast Sweden Breast Cancer Group. ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer. Annals of oncology. (2000) 11 12 pp1545-1550', '10.1023/a:1008313310474', 'http://academic.oup.com/annonc/article-pdf/11/12/1545/19477993/11-12-1545.pdf']\n",
      "['9259770', 'Grennan DM; Gray J; Loudon J; Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Annals of the rheumatic diseases. (2001) 60 3 pp214-217', '10.1136/ard.60.3.214', '']\n",
      "['9259771', 'Matsuda S; Kondo M; Mashima T; Hoshino S; Shinohara N; Sumida S. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty. Orthopedics. (2001) 24 1 pp41-44', '10.3928/0147-7447-20010101-17', '']\n",
      "['9259772', 'Cunnane G; Madigan A; Murphy E; FitzGerald O; Bresnihan B. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 1 pp62-69', '10.1093/rheumatology/40.1.62', 'http://academic.oup.com/rheumatology/article-pdf/40/1/62/18094557/400062.pdf']\n",
      "['9259773', 'Nakamura H; Nagashima M; Ishigami S; Wauke K; Yoshino S. The anti-rheumatic effect of multiple synovectomy in patients with refractory rheumatoid arthritis. International orthopaedics. (2000) 24 5 pp242-245', '10.1007/s002640000168', 'http://link.springer.com/article/10.1007/s002640000168/fulltext.html']\n",
      "['9259774', 'Lineker SC; Bell MJ; Wilkins AL; Badley EM. Improvements following short term home based physical therapy are maintained at one year in people with moderate to severe rheumatoid arthritis. Journal of rheumatology. (2001) 28 1 pp165-168', '10.2310/6640.2006.00001', '']\n",
      "['9259775', 'Stone AA; Smyth JM; Kaell A; Hurewitz A. Structured writing about stressful events: exploring potential psychological mediators of positive health effects. Health psychology. (2000) 19 6 pp619-624', '10.1037//0278-6133.19.6.619', '']\n",
      "['9259777', \"Cazzola M; Antivalle M; Sarzi-Puttini P; Dell'Acqua D; Panni B; Caruso I. Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study. Clinical and experimental rheumatology. (2000) 18 5 pp571-577\", '10.1080/030097400447688', '']\n",
      "['9259778', 'Voog O; Alstergren P; Leibur E; Kallikorm R; Kopp S. Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life sciences. (2000) 68 5 pp591-602', '10.1016/s0024-3205(00)00965-6', '']\n",
      "['9259780', 'Bird H; Broggini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. Journal of rheumatology. (2000) 27 12 pp2791-2797', '10.1097/00004850-200201000-00004', '']\n",
      "['9259782', 'Volker D; Fitzgerald P; Major G; Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. Journal of rheumatology. (2000) 27 10 pp2343-2346', '10.1201/9781420036695.ch22', '']\n",
      "['9259783', 'H√§nninen null; Kaartinen K; Rauma AL; Nenonen M; T√∂rr√∂nen R; H√§kkinen AS; Adlercreutz H; Laakso J. Antioxidants in vegan diet and rheumatic disorders. Toxicology. (2000) 155 1-3 pp45-53', '10.1016/s0300-483x(00)00276-6', '']\n",
      "['9259784', 'Matthews DA; Marlowe SM; MacNutt FS. Effects of intercessory prayer on patients with rheumatoid arthritis. Southern medical journal. (2000) 93 12 pp1177-1186', '10.1097/00007611-200012000-00008', '']\n",
      "['9259785', 'Barlow JH; Turner AP; Wright CC. A randomized controlled study of the Arthritis Self-Management Programme in the UK. Health education research. (2000) 15 6 pp665-680', '10.1093/her/15.6.665', 'http://academic.oup.com/her/article-pdf/15/6/665/9809360/150665.pdf']\n",
      "['9259786', 'Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. Journal of rheumatology. (2000) 27 8 pp1876-1883', '10.1016/s1098-3015(11)70890-7', '']\n",
      "['9259787', 'St Clair EW; Cohen SB; Lee ML; Fleischmann RM; Lee SH; Moreland LW; Olsen NJ; Pratt PW; Yocum DE; Heck L; Winkelhake J; Holcenberg JS; Shulman MJ. Treatment of rheumatoid arthritis with a DR4/1 peptide. Journal of rheumatology. (2000) 27 8 pp1855-1863', '10.1097/rhu.0000000000000834', '']\n",
      "['9259788', 'Nakamura H; Ueki Y; Sakito S; Matsumoto K; Yano M; Miyake S; Tominaga Y; Eguchi K. Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide. Clinical and experimental rheumatology. (2000) 18 4 pp445-450', '10.1046/j.1526-0968.2001.00375.x', '']\n",
      "['9259789', 'Sarzi-Puttini P; Comi D; Boccassini L; Muzzupappa S; Turiel M; Panni B; Salvaggio A. Diet therapy for rheumatoid arthritis. A controlled double-blind study of two different dietary regimens. Scandinavian journal of rheumatology. (2000) 29 5 pp302-307', '10.1080/030097400447688', '']\n",
      "['9259791', 'De Rosa SC; Zaretsky MD; Dubs JG; Roederer M; Anderson M; Green A; Mitra D; Watanabe N; Nakamura H; Tjioe I; Deresinski SC; Moore WA; Ela SW; Parks D; Herzenberg LA; Herzenberg LA. N-acetylcysteine replenishes glutathione in HIV infection. European journal of clinical investigation. (2000) 30 10 pp915-929', '10.1046/j.1365-2362.2000.00736.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2362.2000.00736.x']\n",
      "['9259792', 'Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Digestive and liver disease. (2000) 32 3 pp201-208', '10.1016/s1590-8658(00)80821-x', '']\n",
      "['9259793', 'Griffith SM; Fisher J; Clarke S; Montgomery B; Jones PW; Saklatvala J; Dawes PT; Shadforth MF; Hothersall TE; Hassell AB; Hay EM. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?. Rheumatology (Oxford, England). (2000) 39 10 pp1102-1109', '10.1093/rheumatology/39.10.1102', 'http://academic.oup.com/rheumatology/article-pdf/39/10/1102/5044975/391102.pdf']\n",
      "['9259794', 'Svensson B; Schaufelberger C; Teleman A; Theander J. Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy. Rheumatology (Oxford, England). (2000) 39 9 pp1031-1036', '10.1093/rheumatology/39.9.1031', 'http://academic.oup.com/rheumatology/article-pdf/39/9/1031/18109257/391031.pdf']\n",
      "['9259795', 'Westby MD; Wade JP; Rangno KK; Berkowitz J. A randomized controlled trial to evaluate the effectiveness of an exercise program in women with rheumatoid arthritis taking low dose prednisone. Journal of rheumatology. (2000) 27 7 pp1674-1680', '10.1093/rheumatology/31.8.573', 'http://academic.oup.com/rheumatology/article-pdf/31/8/573/5036366/31-8-573a.pdf']\n",
      "['9259796', 'Tett SE; Cutler DJ; Beck C; Day RO. Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study. Journal of rheumatology. (2000) 27 7 pp1656-1660', '10.1093/rheumatology/33.3.235', 'http://academic.oup.com/rheumatology/article-pdf/33/3/235/5030528/33-3-235.pdf']\n",
      "['9259797', 'Chalmers AC; Busby C; Goyert J; Porter B; Schulzer M. Metatarsalgia and rheumatoid arthritis--a randomized, single blind, sequential trial comparing 2 types of foot orthoses and supportive shoes. Journal of rheumatology. (2000) 27 7 pp1643-1647', '10.4172/2167-7921.1000157', '']\n",
      "['9259798', 'Paulus HE; Di Primeo D; Sanda M; Lynch JM; Schwartz BA; Sharp JT; Genant HK; Weissman BN. Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis. Journal of rheumatology. (2000) 27 7 pp1632-1637', '10.1053/sarh.2001.23697', '']\n",
      "['9259799', 'Patel BR. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders. Journal of the Indian Medical Association. (2000) 98 5 pp250-252', '10.48165/ijabms.2021.233703', '']\n",
      "['9259800', 'Briancon D; Peterschmitt J; Laviec G. Double-blind parallel-group evaluation of the safety and efficacy of etodolac capsules compared with piroxicam capsules in patients with rheumatoid arthritis. Acta therapeutica. (1991) 17 1 pp35-47', '10.1016/s0011-393x(05)80048-7', '']\n",
      "['9259801', 'Sewell H; Bulstrode S; Clarke AK; Hall J; Ring EFJ. A double-blind study of the effects of pulsed electromagnetic energy (Megapulse) on pain and inflammation in knee joints of patients with rheumatoid arthritis. Physiotherapy theory and practice. (1991) 7 4 pp258', '10.3109/09593988609022428', '']\n",
      "['9259802', 'Andrade Padilla JM; Aguilar JA; Reynoso P; Romero G; Ortiz CD. Double-blind trial with ketoprophene + chlorzoxazone and ketoprophene in most frequent osteomuscular problems in the outpatient practice. Investigacion medica internacional. (1995) 22 2 pp52-57', '10.18502/acta.v61i5.13481', 'https://publish.kne-publishing.com/index.php/ACTA/article/download/13481/12663']\n",
      "['9259803', 'G√∂bel D; Gratz S; von Rothkirch T; Becker W. Chronic polyarthritis and radiosynoviorthesis: a prospective, controlled study of injection therapy with erbium 169 and rhenium 186. Zeitschrift fuÃàr Rheumatologie. (1997) 56 4 pp207-213', '10.1007/s003930050036', 'http://link.springer.com/article/10.1007/s003930050036/fulltext.html']\n",
      "['9259804', 'Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; M√ºller W. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Zeitschrift fuÃàr Rheumatologie. (1994) 53 2 pp76-82', '10.1136/ard.53.7.480-a', '']\n",
      "['9259805', 'Nitz JC and Luparia L. The use of EMG biofeedback in quadriceps strengthening exercise for rheumatoid arthritis patients: a clinical trial. Australian Journal Physiotherapy. (1983) 29 4 pp127-132', '10.1016/s0004-9514(14)60669-3', '']\n",
      "['9259806', 'Pilger A; Bach GL; M√ºller-Fassbender H; Reiter W; Eberhardt R. [Flurbiprofen and indomethacin in chronic polyarthritis and gonarthrosis - a comparative multicentric double-blind cross-over study]. Zeitschrift fuÃàr Rheumatologie. (1981) 40 2 pp87-92', '10.1136/ard.33.2.129', '']\n",
      "['9259807', 'Raspe HH; Deck R; Mattussek S. The outcome of traditional or comprehensive outpatient care for rheumatoid arthritis (RA). Results of an open, non-randomized, 2-year prospective study. Zeitschrift fuÃàr Rheumatologie. (1992) 51 Suppl 1 Suppl 1 pp61-66', '10.1093/rheumatology/kes284', 'http://academic.oup.com/rheumatology/article-pdf/51/suppl_6/vi3/5057018/kes284.pdf']\n",
      "['9259808', 'Simon B; Dammann HG; M√ºller P. [Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study]. Zeitschrift fuÃàr Rheumatologie. (1987) 46 Suppl 1 Suppl.1 pp40-46', '10.3757/jser.46.suppl-2_44', '']\n",
      "['9259809', 'Pereira JA; Belcher HJ. A comparison of metacarpophalangeal joint silastic arthroplasty with or without crossed intrinsic transfer. Journal of hand surgery (Edinburgh, Scotland). (2001) 26 3 pp229-234', '10.1054/jhsb.2001.0574', 'https://journals.sagepub.com/doi/pdf/10.1054/jhsb.2001.0574']\n",
      "['9259810', 'Gendreau RM; Prosorba Clinical Trial Group. A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis. Therapeutic apheresis. (2001) 5 2 pp79-83', '10.1046/j.1526-0968.2001.005002079.x', '']\n",
      "['9259811', 'Sasso EH; Merrill C; Furst TE. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis. Therapeutic apheresis. (2001) 5 2 pp84-91', '10.1046/j.1526-0968.2001.005002084.x', '']\n",
      "['9259814', 'Hammond A; Freeman K. One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 9 pp1044-1051', '10.1093/rheumatology/40.9.1044', 'http://academic.oup.com/rheumatology/article-pdf/40/9/1044/11365388/401044.pdf']\n",
      "['9259815', 'Fisher P; Scott DL. A randomized controlled trial of homeopathy in rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 9 pp1052-1055', '10.1093/rheumatology/40.9.1052', 'http://academic.oup.com/rheumatology/article-pdf/40/9/1052/18109406/401052.pdf']\n",
      "['9259816', 'Sigidin YA; Loukina GV; Skurkovich B; Skurkovich S. Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scandinavian journal of rheumatology. (2001) 30 4 pp203-207', '10.1080/030097401316909530', '']\n",
      "['9259817', 'Peretz A; Siderova V; N√®ve J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scandinavian journal of rheumatology. (2001) 30 4 pp208-212', '10.1080/030097401316909549', '']\n",
      "['9259818', 'Dell H-D; Doersing M; Fischer W. Metabolism and pharmacokinetics of acemetacin in man. [German]. Arzneimittel-Forschung/Drug Research. (1980) 30 8 A pp1391-1398', '10.1007/978-3-642-74386-3_3', 'http://link.springer.com/content/pdf/10.1007/978-3-642-74386-3_3.pdf']\n",
      "['9259819', \"Ekstrand R; Alvan G; L'e Orme M. Double blind dose-effect study with indomethacin in rheumatoid arthritis. [German]. Aktuelle Gerontologie. (1981) 11 2 pp69\", '10.1007/bf00570161', 'http://link.springer.com/article/10.1007/BF00570161/fulltext.html']\n",
      "['9259820', 'Geisslinger G; Schuster O; Stock K-P; Loew D; Bach GL; Brune K. Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. European journal of clinical pharmacology. (1990) 38 5 pp493-497', '10.1007/bf02336690', 'http://link.springer.com/article/10.1007/BF02336690/fulltext.html']\n",
      "['9259821', 'Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA. Enterric coated naproxen; A double blind trial comparing the tolerance of enteric coated and standard formulations. European journal of rheumatology and inflammation. (1992) 12 2 pp27-30', '10.1185/03007999209111531', '']\n",
      "['9259822', 'Kean W; Buchanan W; Pelletier J-P; Haraoui B; Choquette D; Senecal J-L; Gascon J; Germain G; Menard H; Huang S; Elie R; Gerecz-Simon E. Open study on the efficacy and safety of long-term use of surgam-SR (sustained-release form of tiaprofenic acid) in rheumatoid arthritis patients. Inflammopharmacology. (1993) 2 1 pp63-70', '10.1007/bf02663742', 'https://link.springer.com/article/10.1007/BF02663742/fulltext.html']\n",
      "['9259823', 'Mucha C. Muscle blood flow in rheumatoid arthritis followed by local heat therapy. [German]. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. (1998) 8 3 pp71-74', '10.1055/a-2289-4202', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-2289-4202.pdf']\n",
      "['9259824', 'Muller P; Jackisch P; Simon B. Circadian aspects of diclofenac gastroduodenopathy and roxatidine prophylaxis. Zeitschrift fur Rheumatologie. (1993) 52 5 pp297-300', '10.1007/s003930170089', 'http://link.springer.com/article/10.1007/s003930170089/fulltext.html']\n",
      "['9259825', \"Sandborn WJ; Hanauer SB; Katz S; Safdi M; Wolf DG; Baerg RD; Tremaine WJ; Johnson T; Diehl NN; Zinsmeister AR. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology. (2001) 121 5 pp1088-1094\", '10.1053/gast.2001.28674', '']\n",
      "['9259827', 'Fraser DA; Thoen J; Dj√∏seland O; F√∏rre O; Kjeldsen-Kragh J. Serum levels of interleukin-6 and dehydroepiandrosterone sulphate in response to either fasting or a ketogenic diet in rheumatoid arthritis patients. Clinical and experimental rheumatology. (2000) 18 3 pp357-362', '10.1007/s100670050125', 'http://link.springer.com/article/10.1007/s100670050125/fulltext.html']\n",
      "['9259828', 'Healy DA; Wallace FA; Miles EA; Calder PC; Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids. (2000) 35 7 pp763-768', '10.1007/s11745-000-0583-1', '']\n",
      "['9259829', 'Bressolle F; Kinowski JM; Morel J; Pouly B; Sany J; Combe B. Folic acid alters methotrexate availability in patients with rheumatoid arthritis. Journal of rheumatology. (2000) 27 9 pp2110-2114', '10.1136/ard.57.2.110', '']\n",
      "['9259830', 'Hewlett S; Mitchell K; Haynes J; Paine T; Korendowych E; Kirwan JR. Patient-initiated hospital follow-up for rheumatoid arthritis. Rheumatology (Oxford, England). (2000) 39 9 pp990-997', '10.1093/rheumatology/39.9.990', 'http://academic.oup.com/rheumatology/article-pdf/39/9/990/18109192/390990.pdf']\n",
      "['9259831', 'Choy EH; Connolly DJ; Rapson N; Jeal S; Brown JC; Kingsley GH; Panayi GS; Johnston JM. Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients. Rheumatology (Oxford, England). (2000) 39 10 pp1139-1146', '10.1093/rheumatology/39.10.1139', 'http://academic.oup.com/rheumatology/article-pdf/39/10/1139/18108331/391139.pdf']\n",
      "['9259832', 'Wang D; Miller R; Zheng J; Hu C. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam. Journal of clinical pharmacology. (2000) 40 11 pp1257-1266', '10.1177/009127000004001110', 'https://onlinelibrary.wiley.com/doi/pdf/10.1177/009127000004001110']\n",
      "['9259834', 'Fox PC; Cummins MJ; Cummins JM. Use of orally administered anhydrous crystalline maltose for relief of dry mouth. Journal of alternative and complementary medicine (New York, N.Y.). (2001) 7 1 pp33-43', '10.1089/107555301300004510', '']\n",
      "['9259835', 'Moreland LW; Cohen SB; Baumgartner SW; Tindall EA; Bulpitt K; Martin R; Weinblatt M; Taborn J; Weaver A; Burge DJ; Schiff MH. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. Journal of rheumatology. (2001) 28 6 pp1238-1244', '10.1136/annrheumdis-2001.1209', '']\n",
      "['9259836', 'Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis. Journal of rheumatology. (2001) 28 8 pp1793-1799', '10.47671/tvg.59.22.5001733', '']\n",
      "['9259837', \"McGonagle D; Pease C; Marzo-Ortega H; O'Connor P; Gibbon W; Emery P. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. Journal of rheumatology. (2001) 28 8 pp1837-1841\", '10.1136/ard.60.11.1058', '']\n",
      "['9259838', 'Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)]. TerapevticheskiiÃÜ arkhiv. (2001) 73 5 pp12-15', '10.4236/jibtva.2015.41001', 'http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jibtva.2015.41001']\n",
      "['9259839', 'van der Laan W; Molenaar E; Ronday K; Verheijen J; Breedveld F; Greenwald R; Dijkmans B; TeKoppele J. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. Journal of rheumatology. (2001) 28 9 pp1967-1974', '10.1186/ar341', '']\n",
      "['9259841', 'Schwartz JI; Agrawal NG; Wong PH; Bachmann KA; Porras AG; Miller JL; Ebel DL; Sack MR; Holmes GB; Redfern JS; Gertz BJ. Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients. Journal of clinical pharmacology. (2001) 41 10 pp1120-1130', '10.1177/00912700122012616', '']\n",
      "['9259842', 'Segal NA; Toda Y; Huston J; Saeki Y; Shimizu M; Fuchs H; Shimaoka Y; Holcomb R; McLean MJ. Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial. Archives of physical medicine and rehabilitation. (2001) 82 10 pp1453-1460', '10.1053/apmr.2001.24309', '']\n",
      "['9259844', 'Choy EH; Scott DL; Kingsley GH; Thomas S; Murphy AG; Staines N; Panayi GS. Control of rheumatoid arthritis by oral tolerance. Arthritis and rheumatism. (2001) 44 9 pp1993-1997', '10.1002/1529-0131(200109)44:9<1993::aid-art347>3.0.co;2-a', '']\n",
      "['9259845', 'Tijhuis GJ; de Jong Z; Zwinderman AH; Zuijderduin WM; Jansen LM; Hazes JM; Vliet Vlieland TP. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford, England). (2001) 40 10 pp1112-1119', '10.1093/rheumatology/40.10.1112', 'http://academic.oup.com/rheumatology/article-pdf/40/10/1112/18094686/401112.pdf']\n",
      "['9259846', 'Hafstr√∂m I; Ringertz B; Sp√•ngberg A; von Zweigbergk L; Brannemark S; Nylander I; R√∂nnelid J; Laasonen L; Klareskog L. A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford, England). (2001) 40 10 pp1175-1179', '10.1093/rheumatology/40.10.1175', 'http://academic.oup.com/rheumatology/article-pdf/40/10/1175/5056949/401175.pdf']\n",
      "['9259847', \"Diri E; Mat C; Hamuryudan V; Yurdakul S; Hizli N; Yazici H. Papulopustular skin lesions are seen more frequently in patients with Beh√ßet's syndrome who have arthritis: a controlled and masked study. Annals of the rheumatic diseases. (2001) 60 11 pp1074-1076\", '10.1136/ard.60.11.1074', '']\n",
      "['9259848', 'Maeda M; Ichiki Y; Aoyama Y; Kitajima Y. Surfactant protein D (SP-D) and systemic scleroderma (SSc). Journal of dermatology. (2001) 28 9 pp467-474', '10.1111/j.1346-8138.2001.tb00013.x', '']\n",
      "['9259849', 'Chijiwa T; Nishiya K; Hashimoto K. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indicators for anaemia. Clinical rheumatology. (2001) 20 5 pp307-313', '10.1007/s100670170018', 'http://link.springer.com/article/10.1007/s100670170018/fulltext.html']\n",
      "['9259850', \"O'Dell JR; Blakely KW; Mallek JA; Eckhoff PJ; Leff RD; Wees SJ; Sems KM; Fernandez AM; Palmer WR; Klassen LW; Paulsen GA; Haire CE; Moore GF. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis and rheumatism. (2001) 44 10 pp2235-2241\", '10.1002/1529-0131(200110)44:10<2235::aid-art385>3.0.co;2-a', '']\n",
      "['9259852', 'Tananuvat N; Daniell M; Sullivan LJ; Yi Q; McKelvie P; McCarty DJ; Taylor HR. Controlled study of the use of autologous serum in dry eye patients. Cornea. (2001) 20 8 pp802-806', '10.1097/00003226-200111000-00005', '']\n",
      "['9259853', 'Halle F; Marfil F; Sioufi A; Dubois JP; Gioud-Paquet M; Lenoir G; Prieur AM. Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. European journal of drug metabolism and pharmacokinetics. (1991) 16 1 pp29-34', '10.1007/bf03189871', 'http://link.springer.com/article/10.1007/BF03189871/fulltext.html']\n",
      "['9259854', 'Fahrer H; Hoeflin F; Lauterburg BH; Peheim E; Levy A; Vischer TL. Diet and fatty acids: Can fish substitute for fish oil?. Clinical and experimental rheumatology. (1991) 9 4 pp403-406', '10.1016/0952-3278(91)90191-7', '']\n",
      "['9259855', 'Caughey GE; Mantzioris E; Gibson RA; Cleland LG; James MJ. The effect on human tumor necrosis factor alpha and interleukin 1beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. American journal of clinical nutrition. (1996) 63 1 pp116-122', '10.1093/ajcn/63.1.116', 'http://academic.oup.com/ajcn/article-pdf/63/1/116/23184261/116.pdf']\n",
      "['9259856', \"O'Dell G; Gilg JR; Palmer J; Haire W; Klassen C; Moore L. Pneumococcal vaccine in rheumatoid arthritis: decreased response while taking methotrexate. Journal of clinical rheumatology. (1996) 2 2 pp59-63\", '10.1097/00124743-199604000-00001', '']\n",
      "['9259857', 'Alarcon IJ; Moreland GS; Jaffe LW; Phillips K; Bocanegra RM; Russell T. The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: will we ever have consensus about its use?. Journal of clinical rheumatology. (1996) 2 1 pp6-8', '10.1097/00124743-199602000-00003', '']\n",
      "['9259858', 'Bianchi M; Broggini M. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. International journal of clinical practice. Supplement. (2002)  128 pp11-19', '10.1111/j.1742-1241.2007.01453.x', '']\n",
      "['9259859', 'Bensen W; Weaver A; Espinoza L; Zhao WW; Riley W; Paperiello B; Recker DP. Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen. Rheumatology (Oxford, England). (2002) 41 9 pp1008-1016', '10.1093/rheumatology/41.9.1008', 'http://academic.oup.com/rheumatology/article-pdf/41/9/1008/9533205/411008.pdf']\n",
      "['9259860', 'Laine L; Bombardier C; Hawkey CJ; Davis B; Shapiro D; Brett C; Reicin A. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology. (2002) 123 4 pp1006-1012', '10.1053/gast.2002.36013', '']\n",
      "['9259861', 'Geusens PP; Truitt K; Sfikakis P; Zhao PL; DeTora L; Shingo S; Lau CS; Kalla A; Tate G. A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. (2002) 31 4 pp230-238', '10.1080/030097402320318431', '']\n",
      "['9259862', 'Caruso I; Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. British medical journal. (1980) 280 6207 pp75-78', '10.1136/bmj.280.6207.75', '']\n",
      "['9259863', 'Fiszman P; Perpetuo JBR; Sidi A. A long-term study comparing tenoxicam and piroxicam in rheumatoid arthritis. [Portuguese]. Folha medica. (1989) 98 3 pp163-166', '10.1007/bf03296792', 'http://link.springer.com/article/10.1007/BF03296792/fulltext.html']\n",
      "['9259864', 'Obach J; Asensi E; Benito P; Diaz C; Geli C; Galdo F; Grana G; Gijon Banos J; Martin Mola E; Torrijos A; Navarro Sarabia M; Campos S. Effectiveness and tolerance of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. [Spanish]. Revista Espanola de Reumatologia. (1992) 19 6 pp263-268', '10.1007/bf00302127', 'http://link.springer.com/article/10.1007/BF00302127/fulltext.html']\n",
      "['9259865', 'Zhao SZ; Fiechtner JI; Tindall EA; Dedhiya SD; Zhao WW; Osterhaus JT; Yu SS. Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib. Arthritis care and research. (2000) 13 2 pp112-121', '10.1002/1529-0131(200004)13:2<112::aid-anr5>3.0.co;2-l', '']\n",
      "['9259866', 'Bombardier C; Laine L; Reicin A; Shapiro D; Burgos-Vargas R; Davis B; Day R; Ferraz MB; Hawkey CJ; Hochberg MC; Kvien TK; Schnitzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. New England journal of medicine. (2000) 343 21 pp1520-1528', '10.1056/nejm200011233432103', '']\n",
      "['9259867', 'Furst DE; Felson D; Thoren G; Gendreau RM. Immunoadsorption for the treatment of rheumatoid arthritis: Final results of a randomized trial. Therapeutic apheresis. (2000) 4 5 pp363-373', '10.1046/j.1526-0968.2000.004005363.x', '']\n",
      "['9259868', 'Yilmaz L; Ozoran K; Gunduz OH; Ucan H; Yucel M. Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids. Rheumatology international. (2000) 20 2 pp65-69', '10.1007/s002960000080', 'http://link.springer.com/article/10.1007/s002960000080/fulltext.html']\n",
      "['9259869', 'Tom√°s-Escu√© A; Ribas ME. Analgesic effect of oxyphenylbutazone in rheumatology. Blind crossed test in 50 cases. Medicina Cl√≠nica. (1974) 62 4 pp286-289', '10.1093/rheumatology/13.4.198', 'http://academic.oup.com/rheumatology/article-pdf/13/4/198/5025874/13-4-198.pdf']\n",
      "['9259870', 'Bedi SS. Double-blind comparison of alclofenac and aspirin in the treatment of rheumatoid arthritis. Journal of international medical research. (1974) 2  pp228-235', '10.1177/030006057400200309', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057400200309']\n",
      "['9259871', 'Domljan Z; Durrigl T. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis. Clinical rheumatology. (1984) 3  pp217-222', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9259872', 'Ortiz Z Shea B Suarez Almazor ME Moher D Wells GA Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. Journal of rheumatology. (1998) 25 1 pp36-43', '10.1002/14651858.cd000951', '']\n",
      "['9259873', 'Mur E; Hartig F; Eibl G; Schirmer M. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. Journal of rheumatology. (2002) 29 4 pp678-681', '10.1002/art.42739', '']\n",
      "['9259874', 'Chang DJ; Desjardins PJ; Chen E; Polis AB; McAvoy M; Mockoviak SH; Geba GP. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Clinical therapeutics. (2002) 24 4 pp490-503', '10.1016/s0149-2918(02)85126-8', '']\n",
      "['9259875', 'Brunner HI; Lovell DJ; Finck BK; Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. Journal of rheumatology. (2002) 29 5 pp1058-1064', '10.1002/art.3', '']\n",
      "['9259876', 'Li-Tsang CW; Hung LK; Mak AF. The effect of corrective splinting on flexion contracture of rheumatoid fingers. Journal of hand therapy. (2002) 15 2 pp185-191', '10.1053/hanthe.2002.v15.015018', '']\n",
      "['9259877', 'Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium. Clinical and experimental rheumatology. (2002) 20 3 pp351-358', '10.1097/bor.0b013e3282fb7caa', '']\n",
      "['9259879', 'Pandya S; Aggarwal A; Misra R. Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study. Rheumatology international. (2002) 22 1 pp1-4', '10.1007/s00296-002-0186-y', 'http://link.springer.com/article/10.1007/s00296-002-0186-y/fulltext.html']\n",
      "['9259880', 'Horton TC; Jackson R; Mohan N; Hambidge JE. Is routine splintage following primary total knee replacement necessary? A prospective randomised trial. The Knee. (2002) 9 3 pp229-231', '10.1016/s0968-0160(02)00022-4', '']\n",
      "['9259881', 'Woodburn J; Barker S; Helliwell PS. A randomized controlled trial of foot orthoses in rheumatoid arthritis. Journal of rheumatology. (2002) 29 7 pp1377-1383', '10.1186/isrctn53598448', '']\n",
      "['9259882', 'Tanaka N; Sakahashi H; Sato E; Hirose K; Ishima T; Ishii S. Intra-articular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion. Rheumatology international. (2002) 22 4 pp151-154', '10.1007/s00296-002-0214-y', 'http://link.springer.com/article/10.1007/s00296-002-0214-y/fulltext.html']\n",
      "['9259883', 'Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S; Etoricoxib Rheumatoid Arthritis Study Group. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. Journal of rheumatology. (2002) 29 8 pp1623-1630', '10.1186/1471-2296-3-10', 'http://link.springer.com/article/10.1186/1471-2296-3-10/fulltext.html']\n",
      "['9259884', 'Liang Q; Tang T; Zhang H. [Clinical investigation of effects of bizhongxiao decoction (BZX) on rheumatoid arthritis on active phase]. Hunan yi ke da xue xue bao [Bulletin of Hunan Medical University]. (2000) 25 5 pp449-452', '10.5962/bhl.title.136523', '']\n",
      "['9259885', 'Michalsen A; Weidenhammer W; Melchart D; Langhorst J; Saha J; Dobos G. [Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes--well-being and side effects with and without mineral supplements]. Forschende Komplementarmedizin und klassische Naturheilkunde [Research in complementary and natural classical medicine]. (2002) 9 4 pp221-227', '10.1159/000066032', 'https://www.karger.com/Article/Pdf/66032']\n",
      "['9259886', 'Bannwarth B; Dorval E; Caekaert A; Barthelemy P. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole. Journal of rheumatology. (2002) 29 9 pp1975-1980', '10.1016/s0016-5085(00)83070-x', '']\n",
      "['9259887', 'Choy EH; Hazleman B; Smith M; Moss K; Lisi L; Scott DG; Patel J; Sopwith M; Isenberg DA. Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial. Rheumatology (Oxford, England). (2002) 41 10 pp1133-1137', '10.1093/rheumatology/41.10.1133', 'http://academic.oup.com/rheumatology/article-pdf/41/10/1133/9532827/411133.pdf']\n",
      "['9259888', 'Choy EH; Panayi GS; Emery P; Madden S; Breedveld FC; Kraan MC; Kalden JR; Rascu A; Brown JC; Rapson N; Johnston JM. Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial. Rheumatology (Oxford, England). (2002) 41 10 pp1142-1148', '10.1093/rheumatology/41.10.1142', 'http://academic.oup.com/rheumatology/article-pdf/41/10/1142/9532839/411142.pdf']\n",
      "['9259889', 'Pavelk√° K; Gatterov√° J; Olejarov√° M; Machacek S; Giacovelli G; Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Archives of internal medicine. (2002) 162 18 pp2113-2123', '10.1001/archinte.162.18.2113', '']\n",
      "['9259890', 'Tanzer M; Smith K; Burnett S. Posterior-stabilized versus cruciate-retaining total knee arthroplasty: balancing the gap. Journal of arthroplasty. (2002) 17 7 pp813-819', '10.1054/arth.2002.34814', '']\n",
      "['9259891', 'Carmichael SJ; Beal J; Day RO; Tett SE. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. Journal of rheumatology. (2002) 29 10 pp2077-2083', '10.2147/oarrr.s11386', '']\n",
      "['9259892', 'Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis. Journal of rheumatology. (2002) 29 10 pp2092-2098', '10.1093/rheumatology/36.3.338', 'http://academic.oup.com/rheumatology/article-pdf/36/3/338/18105157/360338.pdf']\n",
      "['9259893', 'Tijhuis GJ; Zwinderman AH; Hazes JM; Van Den Hout WB; Breedveld FC; Vliet Vlieland TP. A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritis. Arthritis and rheumatism. (2002) 47 5 pp525-531', '10.1002/art.10665', '']\n",
      "['9259895', 'Carter ND; Khan KM; McKay HA; Petit MA; Waterman C; Heinonen A; Janssen PA; Donaldson MG; Mallinson A; Riddell L; Kruse K; Prior JC; Flicker L. Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ : Canadian Medical Association journal. (2002) 167 9 pp997-1004', '10.1136/bjsm.35.5.348', '']\n",
      "['9259896', 'Pasero GP; Di Munno O. [Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis]. Reumatismo. (2002) 54 3 pp238-242', '10.4081/reumatismo.2002.238', '']\n",
      "['9259898', 'Nuki G; Bresnihan B; Bear MB; McCabe D; European Group Of Clinical Investigators. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2002) 46 11 pp2838-2846', '10.1002/art.10578', '']\n",
      "['9259899', 'Garnero P; Landew√© R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis and rheumatism. (2002) 46 11 pp2847-2856', '10.1002/art.10616', '']\n",
      "['9259900', 'Rapoff MA; Belmont J; Lindsley C; Olson N; Morris J; Padur J. Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health psychology. (2002) 21 6 pp620-623', '10.1037//0278-6133.21.6.620', '']\n",
      "['9259901', 'Evers AW; Kraaimaat FW; van Riel PL; de Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain. (2002) 100 1-2 pp141-153', '10.1016/s0304-3959(02)00274-9', '']\n",
      "['9259902', 'Wadbo M; L√∂fdahl CG; Larsson K; Skoogh BE; Tornling G; Arwestr√∂m E; Bengtsson T; Str√∂m K; Swedish Society of Respiratory Medicine. Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. The European respiratory journal. (2002) 20 5 pp1138-1146', '10.1183/09031936.02.00301702', '']\n",
      "['9259903', 'Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis and rheumatism. (2002) 46 12 pp3143-3150', '10.1002/art.10623', '']\n",
      "['9259904', 'Hepburn TW; Totoritis MC; Davis CB. Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2003) 42 1 pp54-61', '10.1093/rheumatology/keg030', 'http://academic.oup.com/rheumatology/article-pdf/42/1/54/5036389/420054.pdf']\n",
      "['9259905', 'Hill J; Bird H. The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2003) 42 1 pp66-70', '10.1093/rheumatology/keg032', 'http://academic.oup.com/rheumatology/article-pdf/42/1/66/5036511/420066.pdf']\n",
      "['9259906', 'Tijhuis GJ; Zwinderman AH; Hazes JM; Breedveld FC; Vlieland PM. Two-year follow-up of a randomized controlled trial of a clinical nurse specialist intervention, inpatient, and day patient team care in rheumatoid arthritis. Journal of advanced nursing. (2003) 41 1 pp34-43', '10.1046/j.1365-2648.2003.02503.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2648.2003.02503.x']\n",
      "['9259908', \"Conaghan PG; O'Connor P; McGonagle D; Astin P; Wakefield RJ; Gibbon WW; Quinn M; Karim Z; Green MJ; Proudman S; Isaacs J; Emery P. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis and rheumatism. (2003) 48 1 pp64-71\", '10.1002/art.10747', '']\n",
      "['9259910', 'Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. (2003) 124 2 pp288-292', '10.1053/gast.2003.50054', '']\n",
      "['9259911', 'Walker AF; Bundy R; Hicks SM; Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine. (2002) 9 8 pp681-686', '10.1078/094471102321621269', '']\n",
      "['9259912', 'Immer FF; Immer-Bansi AS; Trachsel N; Berdat PA; Eigenmann V; Curatolo M; Carrel TP. Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial. Annals of thoracic surgery. (2003) 75 2 pp490-495', '10.1016/s0003-4975(02)04311-4', '']\n",
      "['9259914', 'Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury III PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: A randomized, placebo-controlled, fixed- dose, multicenter trial. Archives of internal medicine. (1999) 159 2 pp174-181', '10.1001/archinte.159.2.174', '']\n",
      "['9259916', 'Risheim H; Arneberg P; Birkhed D. Oral sugar clearance and root caries prevalence in rheumatic patients with dry mouth symptoms. Caries research. (1992) 26 6 pp439-444', '10.1159/000261484', '']\n",
      "['9259917', 'Pillemer S; Gulko P; Ligier S; Yarboro C; Gourley M; Goldbach-Mansky R; Siegel R; Hirsch R; Pucino F; Tilley B; Wilder RL. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. Journal of rheumatology. (2003) 30 1 pp41-43', '10.1002/1529-0131(199908)42:8<1696::aid-anr19>3.0.co;2-k', '']\n",
      "['9259918', 'Liang QH; Zhang HX; Tang T. [The effects of bizhongxiao decotion (BZX) on T-lymphocyte subsets in the peripheral blood of patients with rheumatoid arthritis]. Hunan yi ke da xue xue bao [Bulletin of Hunan Medical University]. (2001) 26 6 pp534-536', '10.3724/sp.j.1008.2009.00098', '']\n",
      "['9259919', 'Adam O; Beringer C; Kless T; Lemmen C; Adam A; Wiseman M; Adam P; Klimmek R; Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatology international. (2003) 23 1 pp27-36', '10.1007/s00296-002-0234-7', 'http://link.springer.com/article/10.1007/s00296-002-0234-7/fulltext.html']\n",
      "['9259920', 'Cohen SB; Woolley JM; Chan W; Anakinra 960180 Study Group. Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis. Journal of rheumatology. (2003) 30 2 pp225-231', '10.1136/annrheumdis-2001.1171', '']\n",
      "['9259921', 'den Broeder AA; Wanten GJ; Oyen WJ; Naber T; van Riel PL; Barrera P. Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. Journal of rheumatology. (2003) 30 2 pp232-237', '10.1097/00042737-199812000-00246', '']\n",
      "['9259922', 'Zhou DQ; Liu DX. Juanbi mixture in treating 100 cases of rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2002) 22 5 pp386-387', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9259923', 'Rosenstein ED; Kushner LJ; Kramer N; Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins, leukotrienes, and essential fatty acids. (2003) 68 3 pp213-218', '10.1016/s0952-3278(02)00272-7', '']\n",
      "['9259924', 'Kavanaugh A; Genovese M; Baughman J; Kivitz A; Bulpitt K; Olsen N; Weisman M; Matteson E; Furst D; van Vollenhoven R; Anderson J; Cohen S; Wei N; Meijerink J; Jacobs C; Mocci S. Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial. Journal of rheumatology. (2003) 30 3 pp449-454', '10.1002/art.42637', '']\n",
      "['9259925', 'Cibere J; Deng Z; Lin Y; Ou R; He Y; Wang Z; Thorne A; Lehman AJ; Tsang IK; Esdaile JM. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis. Journal of rheumatology. (2003) 30 3 pp465-467', '10.1002/art.20697', '']\n",
      "['9259926', 'Valleala H; Laasonen L; Koivula MK; Mandelin J; Friman C; Risteli J; Konttinen YT. Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. Journal of rheumatology. (2003) 30 3 pp468-473', '10.1530/eje.0.1480527', 'https://eje.bioscientifica.com/view/journals/eje/148/5/527.xml']\n",
      "['9259927', 'Hasegawa J; Nagashima M; Yamamoto M; Nishijima T; Katsumata S; Yoshino S. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. Journal of rheumatology. (2003) 30 3 pp474-479', '10.1007/s00296-005-0042-y', 'http://link.springer.com/article/10.1007/s00296-005-0042-y/fulltext.html']\n",
      "['9259928', 'Uziel Y; Berkovitch M; Gazarian M; Koren G; Silverman ED; Schneider R; Laxer RM. Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial. Journal of rheumatology. (2003) 30 3 pp594-596', '10.1046/j.1525-1470.1998.1998015129.x', '']\n",
      "['9259929', 'Benitez-del-Castillo JM; Aranguez C; Garcia-Sanchez J. Corneal epithelial permeability and dry eye treatment. Advances in experimental medicine and biology. (2002) 506 Pt A pp703-706', '10.1007/978-1-4615-0717-8_98', '']\n",
      "['9259930', 'Schwartz JI; Mukhopadhyay S; Porras AG; Viswanathan-Aiyer KJ; Adcock S; Ebel DL; Gertz BJ. Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects. Journal of clinical pharmacology. (2003) 43 2 pp187-192', '10.1177/0091270002239828', '']\n",
      "['9259931', 'Kirwan JR; Mitchell K; Hewlett S; Hehir M; Pollock J; Memel D; Bennett B. Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheumatoid arthritis extended to 4 years. Rheumatology (Oxford, England). (2003) 42 3 pp422-426', '10.1093/rheumatology/keg130', 'http://academic.oup.com/rheumatology/article-pdf/42/3/422/9444632/420422.pdf']\n",
      "['9259933', 'van den Hout WB; Tijhuis GJ; Hazes JM; Breedveld FC; Vliet Vlieland TP. Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Annals of the rheumatic diseases. (2003) 62 4 pp308-315', '10.1136/ard.62.4.308', '']\n",
      "['9259934', 'Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients. Rheumatology (Oxford, England). (2003) 42 4 pp541-548', '10.1093/rheumatology/keg171', 'http://academic.oup.com/rheumatology/article-pdf/42/4/541/9444518/420541.pdf']\n",
      "['9259935', 'van Roon J; Wijngaarden S; Lafeber FP; Damen C; van de Winkel J; Bijlsma JW. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. Journal of rheumatology. (2003) 30 4 pp648-651', '10.1093/rheumatology/keh583', 'http://academic.oup.com/rheumatology/article-pdf/44/6/729/9446990/keh583.pdf']\n",
      "['9259936', 'Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM; Rheumatology Group 791. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis. Journal of rheumatology. (2003) 30 4 pp680-690', '10.1093/rheumatology/34.4.347', 'http://academic.oup.com/rheumatology/article-pdf/34/4/347/5020850/34-4-347.pdf']\n",
      "['9259937', 'Tijhuis GJ; Kooiman KG; Zwinderman AH; Hazes JM; Breedveld FC; Vliet Vlieland TP. Validation of a novel satisfaction questionnaire for patients with rheumatoid arthritis receiving outpatient clinical nurse specialist care, inpatient care, or day patient team care. Arthritis and rheumatism. (2003) 49 2 pp193-199', '10.1002/art.10994', '']\n",
      "['9259938', 'Shanahan EM; Ahern M; Smith M; Wetherall M; Bresnihan B; FitzGerald O. Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain. Annals of the rheumatic diseases. (2003) 62 5 pp400-406', '10.1136/ard.62.5.400', '']\n",
      "['9259939', 'Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2003) 62 5 pp423-426', '10.1136/ard.62.5.423', '']\n",
      "['9259940', \"Crowe J; Henderson J. Pre-arthroplasty rehabilitation is effective in reducing hospital stay. Canadian journal of occupational therapy. Revue canadienne d'ergotheÃÅrapie. (2003) 70 2 pp88-96\", '10.1177/000841740307000204', 'https://journals.sagepub.com/doi/pdf/10.1177/000841740307000204']\n",
      "['9259942', 'Valleala H; Mandelin J; Laasonen L; Koivula MK; Risteli J; Konttinen YT. Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis. European journal of endocrinology / European Federation of Endocrine Societies. (2003) 148 5 pp527-530', '10.1530/eje.0.1480527', 'https://eje.bioscientifica.com/view/journals/eje/148/5/527.xml']\n",
      "['9259943', 'Mease PJ. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis. Skin therapy letter. (2003) 8 1 pp1-4', '10.1007/s00105-005-1006-6', 'http://link.springer.com/article/10.1007/s00105-005-1006-6/fulltext.html']\n",
      "['9259944', 'Misra AN; Hussain MR; Fiddian NJ; Newton G. The role of the posterior cruciate ligament in total knee replacement. Journal of bone and joint surgery. British volume. (2003) 85 3 pp389-392', '10.1302/0301-620x.85b3.13182', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.85B3.13182']\n",
      "['9259945', 'Svensson B; Pettersson H. Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis. Scandinavian journal of rheumatology. (2003) 32 2 pp83-88', '10.1080/03009740310000085', '']\n",
      "['9259946', 'Hawkey CJ; Laine L; Simon T; Quan H; Shingo S; Evans J; Rofecoxib Rheumatoid Arthritis Endoscopy Study Group. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. Gut. (2003) 52 6 pp820-826', '10.1136/gut.52.6.820', '']\n",
      "['9259947', 'van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?. Clinical and experimental rheumatology. (2003) 21 2 pp155-160', '10.7326/0003-4819-136-1-200201010-00006', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-136-1-200201010-00006']\n",
      "['9259948', 'Huisman AM; Siewertsz van Everdingen AA; Wenting MJ; Lafeber F; van Reesema DR; Jacobs JW; Bijlsma JW. Glucocorticoid receptor up-regulation in early rheumatoid arthritis treated with low dose prednisone or placebo. Clinical and experimental rheumatology. (2003) 21 2 pp217-220', '10.7326/0003-4819-136-1-200201010-00006', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-136-1-200201010-00006']\n",
      "['9259949', 'Huemer M; F√∂dinger M; Huemer C; Sailer-H√∂ck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; St√∂ckler-Ipsiroglu S. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study. Clinical and experimental rheumatology. (2003) 21 2 pp249-255', '10.1186/s12969-021-00644-9', 'https://link.springer.com/article/10.1186/s12969-021-00644-9/fulltext.html']\n",
      "['9259950', 'Leese PT; Recker DP; Kent JD. The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. Journal of clinical pharmacology. (2003) 43 5 pp504-513', '10.1177/0091270003043005005', '']\n",
      "['9259951', 'Loutfi I; Nair MK; Ebrahim AK. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance. Journal of nuclear medicine technology. (2003) 31 2 pp81-85', '10.1007/3-540-27847-8_13', 'http://link.springer.com/content/pdf/10.1007/3-540-27847-8_13.pdf']\n",
      "['9259952', 'Ersek M; Turner JA; McCurry SM; Gibbons L; Kraybill BM. Efficacy of a self-management group intervention for elderly persons with chronic pain. Clinical journal of pain. (2003) 19 3 pp156-167', '10.1097/00002508-200305000-00003', '']\n",
      "['9259955', 'Fransen J; Stucki G; Twisk J; Chamot AM; Gerster JC; Langenegger T; Seitz M; Michel BA; mebers of the Swiss Clinical Quality Management in Rheumatoid Arthritis (SCQM). Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial. Annals of the rheumatic diseases. (2003) 62 7 pp624-629', '10.1136/ard.62.7.624', '']\n",
      "['9259956', 'Svensson B; Ahlm√©n M; Forslind K. Treatment of early RA in clinical practice: a comparative study of two different DMARD/corticosteroid options. Clinical and experimental rheumatology. (2003) 21 3 pp327-332', '10.3109/03009742.2015.1070902', '']\n",
      "['9259957', 'van der Laan WH; Ronday HK; TeKoppele JM; Breedveld FC; Huizinga TW; Verheijen JH. No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study. Clinical and experimental rheumatology. (2003) 21 3 pp359-362', '10.1186/ar341', '']\n",
      "['9259958', 'Verstappen SM; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; Borg EJ; Hofman DM; van der Veen MJ; Utrecht Arthritis Cohort Study Group. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis and rheumatism. (2003) 48 7 pp1797-1807', '10.1002/art.11170', '']\n",
      "['9259961', 'Oh H; Seo W. Decreasing pain and depression in a health promotion program for people with rheumatoid arthritis. Journal of nursing scholarship. (2003) 35 2 pp127-132', '10.1111/j.1547-5069.2003.00127.x', '']\n",
      "['9259962', \"D'Elia HF; Larsen A; Mattsson LA; Waltbrand E; Kvist G; Mellstr√∂m D; Saxne T; Ohlsson C; Nordborg E; Carlsten H. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. Journal of rheumatology. (2003) 30 7 pp1456-1463\", '10.1136/ard.62.7.617', '']\n",
      "['9259963', 'Haringman JJ; Kraan MC; Smeets TJ; Zwinderman KH; Tak PP. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2003) 62 8 pp715-721', '10.1136/ard.62.8.715', '']\n",
      "['9259965', 'Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Clinical therapeutics. (2003) 25 6 pp1700-1721', '10.1016/s0149-2918(03)80164-9', '']\n",
      "['9259967', \"Shevchuk SV; Stanislavchuk MA; Pentiuk OO. Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis. Likars'ka sprava / Ministerstvo okhorony zdorov'ia Ukrai√É√†ny. (2003)  3-4 pp34-41\", '10.53555/etdthz08', '']\n",
      "['9259968', 'Rogmark C; Carlsson A; Johnell O; Sembo I. Costs of internal fixation and arthroplasty for displaced femoral neck fractures: a randomized study of 68 patients. Acta orthopaedica Scandinavica. (2003) 74 3 pp293-298', '10.1080/00016470308540843', '']\n",
      "['9259969', 'Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. American journal of gastroenterology. (2003) 98 8 pp1725-1733', '10.1111/j.1572-0241.2003.07598.x', '']\n",
      "['9259970', 'Sparmann M; Wolke B; Czupalla H; Banzer D; Zink A. Positioning of total knee arthroplasty with and without navigation support. A prospective, randomised study. Journal of bone and joint surgery. British volume. (2003) 85 6 pp830-835', '10.1302/0301-620x.85b6.13722', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.85B6.13722']\n",
      "['9259971', 'de Jong Z; Munneke M; Zwinderman AH; Kroon HM; Jansen A; Ronday KH; van Schaardenburg D; Dijkmans BA; Van den Ende CH; Breedveld FC; Vliet Vlieland TP; Hazes JM. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis and rheumatism. (2003) 48 9 pp2415-2424', '10.1002/art.11216', '']\n",
      "['9259972', 'Avunduk AM; Avunduk MC; Varnell ED; Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. American journal of ophthalmology. (2003) 136 4 pp593-602', '10.1016/s0002-9394(03)00326-x', '']\n",
      "['9259973', 'Spiegel JS; Spiegel TM; Ward NB. Rehabilitation for rheumatoid arthritis patients. A controlled trial. Arthritis and rheumatism. (1986) 29 5 pp628-637', '10.1002/art.1780290507', '']\n",
      "['9259974', 'Uthgenannt H; Havemann R; Mohing W. The influence of acematacin and indometacin on gastrointestinal blood loss in normal volunteers and rheumatic patients. [Portuguese]. Arquivos brasileiros de medicina. (1986) 60 6 pp527-530', '10.1111/j.1742-1241.1981.tb08267.x', '']\n",
      "['9259975', 'Van Offel JF; Schuerwegh AJ; Bridts CH; Bracke PG; Stevens WJ; De Clerck LS. Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clinical and experimental rheumatology. (2001) 19 1 pp13-20', '10.47671/tvg.59.22.5001733', '']\n",
      "['9259976', 'Song J; Suh CH; Park YB; Lee SH; Yoo NC; Lee JD; Kim KH; Lee SK. A phase I/IIa study on intra-articular injection of holmium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis. European journal of nuclear medicine. (2001) 28 4 pp489-497', '10.1007/s002590000470', 'http://link.springer.com/article/10.1007/s002590000470/fulltext.html']\n",
      "['9259977', 'Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM. Protective effect of folinic acid on low-dose methotrexate genotoxicity. Zeitschrift fur Rheumatologie. (2001) 60 2 pp63-68', '10.1007/s003930170075', 'http://link.springer.com/article/10.1007/s003930170075/fulltext.html']\n",
      "['9259978', 'Ramos-Remus C; Dorazco-Barragan G; Aceves-Avila FJ; Alcaraz-Lopez F; Fuentes-Ramirez F; Michel-Diaz J; Torres-Bugarin O; Ventura-Aguilar A; Zu√±iga-Gonz√°lez G. Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients. Clinical and experimental rheumatology. (2002) 20 2 pp208-212', '10.1002/art.39297', '']\n",
      "['9259979', 'Karatay S; Senel K; Ugur M; Yildirim K. The timing of low dose glucocorticoid therapy in treatment of rheumatoid arthritis. Pain Clinic. (2002) 13 4 pp305-312', '10.1163/15685690260138910', '']\n",
      "['9259980', 'Van Ede AE; Laan RFJM; Rood MJ; Huizinga TWJ; Van De Laar MAFJ; Van Denderen JC; Westgeest AAA; Romme TC; De Rooij DJRAM; Jacobs MJM; De Boo ThM; Van Der Wilt GJ; Severens JL; Hartman M; Krabbe PFM; Dijkmans BAC; Breedveld FC; Van De Putte LBA. The effect of folic- or folinic-acid comedication on the toxicity and efficacy of methotrexate in the treatment of patients with rheumatoid arthritis; a 48-week, randomised, double-blind, placebo-controlled study. [Dutch]. Nederlands tijdschrift voor geneeskunde. (2002) 146 28 pp1322-1327', '10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7', '']\n",
      "['9259981', 'Mazzantini M; Di Munno O; Metelli MR; Bulleri M; Giordani R. Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers. Aging clinical and experimental research. (2002) 14 3 pp197-201', '10.1007/bf03324436', 'http://link.springer.com/article/10.1007/BF03324436/fulltext.html']\n",
      "['9259982', 'Jakez-Ocampo J; Richaud-Patin Y; Sim√≥n JA; Llorente L. Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study. Joint, bone, spine. (2002) 69 3 pp307-311', '10.1016/s1297-319x(02)00397-4', '']\n",
      "['9259983', 'Yeomans N; Wilson I; L√•ngstr√∂m G; Hawkey C; Naesdal J; Walan A; Wiklund I. Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scandinavian journal of rheumatology. (2001) 30 6 pp328-334', '10.1080/030097401317148516', '']\n",
      "['9259985', 'Pavelka K; Recker DP; Verburg KM. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Rheumatology (Oxford, England). (2003) 42 10 pp1207-1215', '10.1093/rheumatology/keg359', 'http://academic.oup.com/rheumatology/article-pdf/42/10/1207/5047822/keg359.pdf']\n",
      "['9259986', 'Zulian F; Martini G; Gobber D; Agosto C; Gigante C; Zacchello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford, England). (2003) 42 10 pp1254-1259', '10.1093/rheumatology/keg358', 'http://academic.oup.com/rheumatology/article-pdf/42/10/1254/5047796/keg358.pdf']\n",
      "['9259987', 'H√§kkinen A; Sokka T; Hannonen P. A home-based two-year strength training period in early rheumatoid arthritis led to good long-term compliance: a five-year followup. Arthritis and rheumatism. (2004) 51 1 pp56-62', '10.1002/art.20088', '']\n",
      "['9259988', 'Van Riel P. Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate. Clinical and experimental rheumatology. (2003) 21 6 pp695-696', '10.1097/01.rhu.0000226617.72573.f3', '']\n",
      "['9259989', 'Palermo TM; Valenzuela D; Stork PP. A randomized trial of electronic versus paper pain diaries in children: impact on compliance, accuracy, and acceptability. Pain. (2004) 107 3 pp213-219', '10.1016/j.pain.2003.10.005', '']\n",
      "['9259993', 'Verstappen SM; Jacobs JW; Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. The Utrecht experience with different treatment strategies in early rheumatoid arthritis. Clinical and experimental rheumatology. (2003) 21 5 Suppl 31 ppS165-8', '10.1093/rheumatology/keh400', 'http://academic.oup.com/rheumatology/article-pdf/44/2/202/9446611/keh400.pdf']\n",
      "['9259994', 'Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Arthritis and rheumatism. (2004) 50 2 pp364-371', '10.1002/art.20167', '']\n",
      "['9259996', 'Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. Journal of immunology (Baltimore, Md. : 1950). (2003) 171 11 pp6267-6274', '10.4049/jimmunol.171.11.6267', 'https://journals.aai.org/jimmunol/article-pdf/171/11/6267/1172823/6267.pdf']\n",
      "['9259997', 'Kobelt G; Jonsson L; Young A; Eberhardt K. The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study. Rheumatology. (2003) 42 2 pp326-335', '10.1093/rheumatology/keg107', 'http://academic.oup.com/rheumatology/article-pdf/42/2/326/18095782/420326.pdf']\n",
      "['9259998', 'Esler CNA; Blakeway C; Fiddian NJ. The use of a closed-suction drain in total knee arthroplasty. Journal of bone and joint surgery. British volume. (2003) 85 2 pp215-217', '10.1302/0301-620x.85b2.13357', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.85B2.13357']\n",
      "['9259999', \"Fan W-S; Hung H-L; Liao H-P; Lai N-S. Topical cyclosporine therapy for keratoconjunctivitis sicca in Sjogrens' syndrome. Tzu Chi Medical Journal. (2003) 15 2 pp85-89\", '10.2460/javma.1991.199.08.1043', 'https://avmajournals.avma.org/view/journals/javma/199/8/javma.1991.199.08.1043.xml']\n",
      "['9260000', 'Aggarwal A; Misra R. Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis. Rheumatology international. (2003) 23 3 pp134-137', '10.1007/s00296-002-0267-y', 'http://link.springer.com/article/10.1007/s00296-002-0267-y/fulltext.html']\n",
      "['9260001', 'Mucha C. Posttherapeutic forearm blood flow after application of rising temperature arm baths and parafango packs in healthy volunteers and in patients with chronic rheumatoid arthritis. [Slovak]. Rehabilitacia. (2003) 36 2 pp119-123', '10.4102/sajp.v58i2.118', '']\n",
      "['9260002', 'Straw R; Kulkarni S; Attfield S; Wilton TJ. Posterior cruciate ligament at total knee replacement. Journal of bone and joint surgery. British volume. (2003) 85 5 pp671-674', '10.1302/0301-620x.85b5.13812', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.85B5.13812']\n",
      "['9260003', 'Lodder MC; Van Pelt PA; Lems WF; Kostense PJ; Koks CHW; Dijkmans BAC. Effects of high dose intravenous pamidronate on disease activity and bone metabolism in patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial [3]. Journal of rheumatology. (2003) 30 9 pp2080-2082', '10.1007/s00198-005-0037-2', 'http://link.springer.com/article/10.1007/s00198-005-0037-2/fulltext.html']\n",
      "['9260004', 'Sokka T. Early rheumatoid arthritis in Finland. Clinical and experimental rheumatology. (2003) 21 5 SUPPL. 31 ppS133-S137', '10.1016/s1521-6942(03)00077-9', '']\n",
      "['9260005', 'Durmus M; Koroglu A; Demirbilek S; Ozgul U; Ozcan Ersoy M. The Postoperative Analgesic Effects of Celecoxib and Rofecoxib in Total Abdominal Hysterectomy. [Turkish]. Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi. (2003) 31 7 pp363-367', '10.5152/tjar.2013.30', '']\n",
      "['9260006', 'Freund KG; Houshian S; Riegels-Nielsen P. Occlusion and stability of two different femoral canal plugs in cemented hip arthroplasty. A prospective and randomized study, with a two year follow-up. Hip international. (2003) 13 3 pp142-147', '10.1177/112070000301300304', 'https://journals.sagepub.com/doi/pdf/10.1177/112070000301300304']\n",
      "['9260008', 'Freeman HJ. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs. Canadian Journal of Gastroenterology. (1998) 12 8 pp537-539', '10.1016/s0016-5085(98)80782-8', '']\n",
      "['9260009', 'Jansen T; Spoorenberg A; Houtman PM; Van Roon EN; Laan R. The effect of folic- or folinic-acid comedication on the toxicity and efficacy of methotrexate in the treatment of patients with rheumatoid arthritis; a 48-week, randomised, double-blind, placebo-controlled study [2] (multiple letters). Nederlands tijdschrift voor geneeskunde. (2002) 146 45 pp2168', '10.1186/isrctn49455679', '']\n",
      "['9260010', 'Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Ter√°n L; Galv√°n-Villegas F; Garc√≠a-Figueroa J; Jara LJ; Barile L; GRECIA Group. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis. Archives of medical research. (2004) 35 1 pp36-42', '10.1016/j.arcmed.2003.07.008', '']\n",
      "['9260011', 'Schrieber L; Hendry GD; Hunter D. Musculoskeletal examination teaching in rheumatoid arthritis education: Trained patient educators compared to nonspecialist doctors. Journal of rheumatology. (2000) 27 6 pp1531-1532', '10.1093/rheumatology/kel126', 'http://academic.oup.com/rheumatology/article-pdf/45/11/1404/18096802/kel126.pdf']\n",
      "['9260012', 'Smeets TJ; Kraan MC; van Loon ME; Tak PP. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis and rheumatism. (2003) 48 8 pp2155-2162', '10.1002/art.11098', '']\n",
      "['9260013', 'Wilson I; Langstrom G; Wahlqvist P; Walan A; Wiklund I; Naesdal J. Management of gastroduodenal ulcers and gastrointestinal symptoms associated with nonsteroidal anti-inflammatory drug therapy: A summary of four comparative trials with omeprazole, ranitidine, misoprostol, and placebo. Current therapeutic research, clinical and experimental. (2001) 62 12 pp835-850', '10.1016/s0011-393x(01)80089-8', '']\n",
      "['9260014', 'Yeomans ND. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. American journal of medicine. (1998) 104 3 A pp56S-61S', '10.1016/s0002-9343(97)00213-1', '']\n",
      "['9260015', 'Van Ryn J; Kink-Eiband M; Kuritsch I; Feifel U; Hanft G; Wallenstein G; Trummlitz G; Pairet M. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers. Journal of clinical pharmacology. (2004) 44 7 pp777-784', '10.1177/0091270004266623', '']\n",
      "['9260016', \"Savelkoul M; de Witte LP. Mutual support groups in rheumatic diseases: Effects and participants' perceptions. Arthritis and rheumatism. (2004) 51 4 pp605-608\", '10.1002/art.20538', '']\n",
      "['9260017', \"Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sj√∂gren's syndrome. Arthritis and rheumatism. (2004) 51 4 pp601-604\", '10.1002/art.20540', '']\n",
      "['9260019', 'Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Annals of the rheumatic diseases. (2004) 63 9 pp1069-1074', '10.1136/ard.2003.012914', '']\n",
      "['9260020', 'Shanahan EM; Smith MD; Wetherall M; Lott CW; Slavotinek J; FitzGerald O; Ahern MJ. Suprascapular nerve block in chronic shoulder pain: are the radiologists better?. Annals of the rheumatic diseases. (2004) 63 9 pp1035-1040', '10.1136/ard.2003.015909', '']\n",
      "['9260021', 'Kraan MC; Smeets TJ; van Loon MJ; Breedveld FC; Dijkmans BA; Tak PP. Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 9 pp1056-1061', '10.1136/ard.2003.014738', '']\n",
      "['9260024', 'Frediani B; Falsetti P; Bisogno S; Baldi F; Acciai C; Filippou G; Bacarelli MR; Filipponi P; Galeazzi M; Marcolongo R. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. Journal of rheumatology. (2004) 31 6 pp1083-1087', '10.1136/ard.2003.011064', '']\n",
      "['9260025', \"Adams BK; Al Attia HM; Parkar S. Salivary gland scintigraphy in Sj√∂gren's syndrome: are quantitative indices the answer?. Nuclear medicine communications. (2003) 24 9 pp1011-1016\", '10.1097/00006231-200309000-00010', '']\n",
      "['9260026', 'Zhou H; Buckwalter M; Boni J; Mayer P; Raible D; Wajdula J; Fatenejad S; Sanda M. Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis. International journal of clinical pharmacology and therapeutics. (2004) 42 5 pp267-276', '10.5414/cpp42267', '']\n",
      "['9260027', 'Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. European journal of clinical nutrition. (2004) 58 6 pp839-845', '10.1038/sj.ejcn.1601883', 'https://www.nature.com/articles/1601883']\n",
      "['9260028', \"Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K. Therapeutic effect of cevimeline on dry eye in patients with Sj√∂gren's syndrome: a randomized, double-blind clinical study. American journal of ophthalmology. (2004) 138 1 pp6-17\", '10.1016/j.ajo.2004.02.010', '']\n",
      "['9260030', 'Capell HA; Madhok R; Hunter JA; Porter D; Morrison E; Larkin J; Thomson EA; Hampson R; Poon FW. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Annals of the rheumatic diseases. (2004) 63 7 pp797-803', '10.1136/ard.2003.014050', '']\n",
      "['9260031', 'Broderick JE; Stone AA; Smyth JM; Kaell AT. The feasibility and effectiveness of an expressive writing intervention for rheumatoid arthritis via home-based videotaped instructions. Annals of behavioral medicine. (2004) 27 1 pp50-59', '10.1207/s15324796abm2701_7', '']\n",
      "['9260032', 'Zhou X; Zhou Z; Jin M; Wang H; Wu M; Song Y; Cheng H. Clinical study of qingluo tongbi granules in treating 63 patients with rheumatoid arthritis of the type of yin-deficiency and heat in collaterals. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2004) 24 2 pp83-87', '10.1109/vlsi-tsa.2017.7942474', '']\n",
      "['9260033', \"Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR. Etanercept in Sj√∂gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis and rheumatism. (2004) 50 7 pp2240-2245\", '10.1002/art.20299', '']\n",
      "['9260034', 'Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A; Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis and rheumatism. (2004) 50 7 pp2191-2201', '10.1002/art.20288', '']\n",
      "['9260036', 'H√§kkinen A; Sokka T; Kautiainen H; Kotaniemi A; Hannonen P. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up. Annals of the rheumatic diseases. (2004) 63 8 pp910-916', '10.1136/ard.2003.013003', '']\n",
      "['9260037', 'Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatology international. (2004) 24 2 pp63-70', '10.1007/s00296-003-0361-9', 'http://link.springer.com/article/10.1007/s00296-003-0361-9/fulltext.html']\n",
      "['9260038', 'Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. Journal of rheumatology. (2004) 31 5 pp902-908', '10.1093/rheumatology/41.6.658', 'http://academic.oup.com/rheumatology/article-pdf/41/6/658/18095695/410658.pdf']\n",
      "['9260040', 'Grigor C; Capell H; Stirling A; McMahon AD; Lock P; Vallance R; Kincaid W; Porter D. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet (London, England). (2004) 364 9430 pp263-269', '10.1016/s0140-6736(04)16676-2', '']\n",
      "['9260041', 'Vlak T; Eldar R. Disability in rheumatoid arthritis after monotherapy with DMARDs. International Journal Rehabilitation Research. (2003) 26 3 pp207-212', '10.1097/01.mrr.0000088445.78481.43', '']\n",
      "['9260042', \"Chrubasik S; Wink M. Traditional herbal therapy for the treatment of rheumatic pain: Preparations from devil's claw and stinging nettle. Pain Digest. (1998) 8 2 pp94-101\", '10.1093/rheumatology/40.12.1388', 'http://academic.oup.com/rheumatology/article-pdf/40/12/1388/9533048/401388.pdf']\n",
      "['9260043', 'Imbesi V; Manzionna G; Bianchi Porro G. Double blind, double dummy endoscopic comparison of the mucosal protective effects of misoprostol vs ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Argomenti di Gastroenterologia Clinica. (1997) 10 5 pp209-214', '10.1016/0016-5085(95)22902-7', '']\n",
      "['9260044', 'Yanagawa A; Endo T; Kusakari K; Kudo T; Shimada J; Mizushima Y. Endoscopic evaluation of aceclofenac-induced gastroduodenal mucosal damage: A double-blind comparison with sodium diclofenac and placebo. Japanese Journal of Rheumatology. (1998) 8 3 pp249-259', '10.1007/bf03041246', 'http://link.springer.com/article/10.1007/BF03041246/fulltext.html']\n",
      "['9260045', \"Maev IV; V'iuchnova ES; Staseva IV. [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs]. TerapevticheskiiÃÜ arkhiv. (2004) 76 2 pp27-30\", '10.21518/2079-701x-2018-1-80-85', 'http://www.med-sovet.pro/jour/article/viewFile/2273/2256']\n",
      "['9260046', 'Saha MT; Haapasaari J; Hannula S; Sarna S; Lenko HL. Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study. Journal of rheumatology. (2004) 31 7 pp1413-1417', '10.1097/00019616-199201000-00016', '']\n",
      "['9260047', 'Zulian F; Martini G; Gobber D; Plebani M; Zacchello F; Manners P. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford, England). (2004) 43 10 pp1288-1291', '10.1093/rheumatology/keh313', '']\n",
      "['9260050', 'Hammond A; Freeman K. The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Clinical rehabilitation. (2004) 18 5 pp520-528', '10.1191/0269215504cr766oa', 'https://journals.sagepub.com/doi/pdf/10.1191/0269215504cr766oa']\n",
      "['9260053', 'Cremers SC; Lodder MC; Den Hartigh J; Vermeij P; Van Pelt P; Lems WF; Papapoulos SE; Dijkmans BA. Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis. Journal of rheumatology. (2004) 31 9 pp1732-1737', '10.1200/jco.2004.22.90140.881', '']\n",
      "['9260054', 'Hartmann SN; Rordorf CM; Milosavljev S; Branson JM; Chales GH; Juvin RR; Lafforgue P; Le Parc JM; Tavernier CG; Meyer OC. Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients. Annals of pharmacotherapy. (2004) 38 10 pp1582-1587', '10.1345/aph.1e044', 'https://journals.sagepub.com/doi/pdf/10.1345/aph.1E044']\n",
      "['9260055', 'Fransen J; Laan RF; Van Der Laar MA; Huizinga TW; Van Riel PL. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 10 pp1222-1226', '10.1136/ard.2003.018861', '']\n",
      "['9260056', 'Sundrarjun T; Komindr S; Archararit N; Dahlan W; Puchaiwatananon O; Angthararak S; Udomsuppayakul U; Chuncharunee S. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. Journal of international medical research. (2004) 32 5 pp443-454', '10.1177/147323000403200501', 'https://journals.sagepub.com/doi/pdf/10.1177/147323000403200501']\n",
      "['9260057', 'Morgan SL; Oster RA; Lee JY; Alarc√≥n GS; Baggott JE. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis and rheumatism. (2004) 50 10 pp3104-3111', '10.1002/art.20516', '']\n",
      "['9260058', 'Coats TL; Borenstein DG; Nangia NK; Brown MT. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clinical therapeutics. (2004) 26 8 pp1249-1260', '10.1016/s0149-2918(04)80081-x', '']\n",
      "['9260059', 'de Jong Z; Munneke M; Zwinderman AH; Kroon HM; Ronday KH; Lems WF; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM; Huizinga TW. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Annals of the rheumatic diseases. (2004) 63 11 pp1399-1405', '10.1136/ard.2003.015826', '']\n",
      "['9260060', 'Tebib JG; Manil LM; M√∂dder G; Verrier P; De Rycke Y; Bonmartin A; Devaux JY; Chossat F; Menkes CJ; Kahan A. Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis (RA): a two-year follow-up randomized controlled multicentre study. Clinical and experimental rheumatology. (2004) 22 5 pp609-616', '10.1097/00006231-200104000-00009', '']\n",
      "['9260061', 'Samborski W; Stratz T; Mackiewicz S; M√ºller W. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scandinavian journal of rheumatology. Supplement. (2004) 119  pp51-54', '10.1080/03009740410007050', '']\n",
      "['9260063', 'Bolten W. Treatment of NSAID-induced gastrointestinal complaints by comedication with the prostagladin analogue misoprostol in rheumatoid arthritis patients. A multicentred double-blind placebo controlled study. AKTUEL RHEUMATOL. (1989) 14 5 pp214-220', '10.1007/bf00270248', 'http://link.springer.com/article/10.1007/BF00270248/fulltext.html']\n",
      "['9260065', 'Kr√ºger K. Selective inhibition of t-cell activation with fusion protein ctla4lg AS a new treatment option for rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (2005) 64 1 pp40-41', '10.1007/s00393-005-0620-0', 'http://link.springer.com/article/10.1007/s00393-005-0620-0/fulltext.html']\n",
      "['9260067', 'Silverman E; Mouy R; Spiegel L; Jung LK; Saurenmann RK; Lahdenne P; Horneff G; Calvo I; Szer IS; Simpson K; Stewart JA; Strand V; Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Leflunomide or methotrexate for juvenile rheumatoid arthritis. New England journal of medicine. (2005) 352 16 pp1655-1666', '10.1056/nejmoa041810', '']\n",
      "['9260068', \"Merkel PA; Lo GH; Holbrook JT; Tibbs AK; Allen NB; Davis JC; Hoffman GS; McCune WJ; St Clair EW; Specks U; Spiera R; Petri M; Stone JH; Wegener's Granulomatosis Etanercept Trial Research Group. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Annals of internal medicine. (2005) 142 8 pp620-626\", '10.7326/0003-4819-142-8-200505030-00011', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-142-8-200505030-00011']\n",
      "['9260070', 'Ribeiro J; Le√£o A; Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. Journal of clinical periodontology. (2005) 32 4 pp412-416', '10.1111/j.1600-051x.2005.00689.x', '']\n",
      "['9260071', 'Karateev AE; Nasonov EL; Radenska-Lopovok SG. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. TerapevticheskiiÃÜ arkhiv. (2005) 77 2 pp46-49', '10.14412/1995-4484-2004-1380', '']\n",
      "['9260072', 'Bradley JD; Dmitrienko AA; Kivitz AJ; Gluck OS; Weaver AL; Wiesenhutter C; Myers SL; Sides GD. A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. Journal of rheumatology. (2005) 32 3 pp417-423', '10.1002/art.38949', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38949']\n",
      "['9260073', 'Wang C; Roubenoff R; Lau J; Kalish R; Schmid CH; Tighiouart H; Rones R; Hibberd PL. Effect of Tai Chi in adults with rheumatoid arthritis. Rheumatology (Oxford, England). (2005) 44 5 pp685-687', '10.1093/rheumatology/keh572', 'http://academic.oup.com/rheumatology/article-pdf/44/5/685/9447531/keh572.pdf']\n",
      "['9260074', 'Codish S; Abu-Shakra M; Flusser D; Friger M; Sukenik S. Mud compress therapy for the hands of patients with rheumatoid arthritis. Rheumatology international. (2005) 25 1 pp49-54', '10.1007/s00296-003-0402-4', 'http://link.springer.com/article/10.1007/s00296-003-0402-4/fulltext.html']\n",
      "['9260075', 'Bilberg A; Ahlm√©n M; Mannerkorpi K. Moderately intensive exercise in a temperate pool for patients with rheumatoid arthritis: a randomized controlled study. Rheumatology (Oxford, England). (2005) 44 4 pp502-508', '10.1093/rheumatology/keh528', 'http://academic.oup.com/rheumatology/article-pdf/44/4/502/9447114/keh528.pdf']\n",
      "['9260076', 'Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition (Burbank, Los Angeles County, Calif.). (2005) 21 2 pp131-136', '10.1016/j.nut.2004.03.023', '']\n",
      "['9260077', 'Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis. American journal of gastroenterology. (2005) 100 5 pp1043-1050', '10.1111/j.1572-0241.2005.40701.x', '']\n",
      "['9260079', 'Eichler HG; Mavros P; Geling O; Hunsche E; Kong S. Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents. International journal of clinical pharmacology and therapeutics. (2005) 43 5 pp209-216', '10.5414/cpp43209', '']\n",
      "['9260080', 'Delaney R; Trail IA; Nuttall D. A comparative study of outcome between the Neuflex and Swanson metacarpophalangeal joint replacements. Journal of hand surgery (Edinburgh, Scotland). (2005) 30 1 pp3-7', '10.1016/j.jhsb.2004.10.013', 'https://journals.sagepub.com/doi/pdf/10.1016/J.JHSB.2004.10.013']\n",
      "['9260081', 'M√∂ller K; Sollerman C; Geijer M; Kopylov P; T√§gil M. Avanta versus Swanson silicone implants in the MCP joint--a prospective, randomized comparison of 30 patients followed for 2 years. Journal of hand surgery (Edinburgh, Scotland). (2005) 30 1 pp8-13', '10.1016/j.jhsb.2004.09.011', 'https://journals.sagepub.com/doi/pdf/10.1016/J.JHSB.2004.09.011']\n",
      "['9260082', 'Wetherell MA; Byrne-Davis L; Dieppe P; Donovan J; Brookes S; Byron M; Vedhara K; Horne R; Weinman J; Miles J. Effects of emotional disclosure on psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study. Journal of health psychology. (2005) 10 2 pp277-285', '10.1177/1359105305049778', 'https://journals.sagepub.com/doi/pdf/10.1177/1359105305049778']\n",
      "['9260084', 'Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis and rheumatism. (2005) 52 4 pp1227-1236', '10.1002/art.20967', '']\n",
      "['9260085', 'Mukics A; Agnes B; Gyula S; Vilmos T. [The effectiveness of a benzydamine rinse in the management of stomato-glossopyrosis]. Fogorvosi szemle. (2005) 98 1 pp15-19', '10.33891/fsz.114.2.94-98', 'https://ojs.mtak.hu/index.php/fogorv-szemle/article/download/8753/7143']\n",
      "['9260086', 'Haugeberg G; Strand A; Kvien TK; Kirwan JR. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial. Archives of internal medicine. (2005) 165 11 pp1293-1297', '10.1001/archinte.165.11.1293', '']\n",
      "['9260088', 'Shi W; Wang YM; Li LS; Yan M; Li D; Chen NN; Chen BY. Safety and Efficacy of Oral Nonsteroidal Anti-Inflammatory Drugs in Patients with Rheumatoid Arthritis: A Six-Month Randomised Study. Clinical drug investigation. (2004) 24 2 pp89-101', '10.2165/00044011-200424020-00004', '']\n",
      "['9260089', 'Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; Van De Laar M. Bioavailability of Higher Dose Methotrexate Comparing Oral and Subcutaneous Administration in Patients with Rheumatoid Arthritis. Journal of rheumatology. (2004) 31 4 pp645-648', '10.1136/ard.2003.019828', '']\n",
      "['9260090', 'Brunnmuller U; Zeidler H; Alten R; Gromnica-Ihle E. Effective Analgesic Therapy with Tilidine/Naloxone for Patients with Rheumatoid Arthritis. [German]. Aktuelle Rheumatologie. (2004) 29 1 pp35-39', '10.1055/s-2004-812921', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2004-812921.pdf']\n",
      "['9260091', 'Hirai K; Ono M; Kawai K. Efficacy of cevimeline for the treatment of dry eye. [Japanese]. Folia Ophthalmologica Japonica. (2004) 55 2 pp114-117', '10.1111/aos.13972_436', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.13972_436']\n",
      "['9260092', 'Franks PJ; Moody M; Moffatt CJ; Patton J; Bradley L; Chaloner D; Stevens J; Lewis C. Quality of life in a trial of short stretch versus four-layer bandaging in the management of chronic venous ulceration. Phlebology / Venous Forum of the Royal Society of Medicine. (2004) 19 2 pp87-91', '10.1258/026835504323080371', 'https://journals.sagepub.com/doi/pdf/10.1258/026835504323080371']\n",
      "['9260093', 'Arnetz JE; Almin I; Bergstrom K; Franzen Y; Nilsson H. Active patient involvement in the establishment of physical therapy goals: Effects on treatment outcome and quality of care. Advances in physiotherapy. (2004) 6 2 pp50-69', '10.1080/14038190310017147', '']\n",
      "['9260094', \"Papas AS; Sherrer YS; Charney M; Golden HE; Medsger Jr TA; Walsh BT; Trivedi M; Goldlust B; Gallagher SC. Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine: A randomized, placebo-controlled, dose-adjustment study. Journal of clinical rheumatology. (2004) 10 4 pp169-177\", '10.1097/01.rhu.0000135553.08057.21', '']\n",
      "['9260096', 'Bianchi M; Broggini M. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. [Slovak]. Rheumatologia. (2004) 18 3 pp121-128', '10.2165/00003495-200363001-00006', '']\n",
      "['9260097', 'Wu H-X; Zhu C-L; Luo H-Z; Liu H-G; Li J-Q; Chen H-Z; Wu Z-E. Curative effect of radon spring bathing on rheumatoid arthritis and its mechanism. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2004) 8 24 pp4978-4979', '10.1007/s10330-004-0219-y', 'http://link.springer.com/article/10.1007/s10330-004-0219-y/fulltext.html']\n",
      "['9260098', 'Verges J; Montell E; Tomas E; Cumelles G; Castaneda G; Marti N; Moller I. Weather conditions can influence rheumatic diseases. Proceedings of the Western Pharmacology Society. (2004) 47  pp134-136', '10.1136/annrheumdis-2013-eular.2353', '']\n",
      "['9260099', 'Piche T. Comparison of the risk of ulcer complications with lumiracoxib with naproxen and ibuprofen in the therapeutic arthritis research and gastrointestinal event trial (TARGET) study: A randomized controlled trial. [French]. Hepato-Gastro. (2004) 11 6 pp488-489', '10.1016/s0140-6736(04)16893-1', '']\n",
      "['9260100', \"Aragona P; Stilo A; Ferreri F; Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sj√∂gren's syndrome patients. Eye (London, England). (2005) 19 5 pp535-539\", '10.1038/sj.eye.6701537', 'http://www.nature.com/articles/6701537']\n",
      "['9260102', 'Rudge S; Hailwood S; Horne A; Lucas J; Wu F; Cundy T. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology (Oxford, England). (2005) 44 6 pp813-818', '10.1093/rheumatology/keh538', 'http://academic.oup.com/rheumatology/article-pdf/44/6/813/9446781/keh538.pdf']\n",
      "['9260103', 'Kobelt G; Lindgren P; Singh A; Klareskog L. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial. Annals of the rheumatic diseases. (2005) 64 8 pp1174-1179', '10.1136/ard.2004.032789', '']\n",
      "['9260104', \"Gescuk B; Wu AJ; Whitcher JP; Daniels TE; Lund S; Fye K; Davis JC. Lamivudine is not effective in primary Sj√∂gren's syndrome. Annals of the rheumatic diseases. (2005) 64 9 pp1326-1330\", '10.1136/ard.2004.031393', '']\n",
      "['9260105', 'Choy EH; Kingsley GH; Khoshaba B; Pipitone N; Scott DL; Intramuscular Methylprednisolone Study Group. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Annals of the rheumatic diseases. (2005) 64 9 pp1288-1293', '10.1136/ard.2004.030908', '']\n",
      "['9260106', 'Ishii Y; Matsuda Y. Effect of tourniquet pressure on perioperative blood loss associated with cementless total knee arthroplasty: a prospective, randomized study. Journal of arthroplasty. (2005) 20 3 pp325-330', '10.1016/j.arth.2004.10.001', '']\n",
      "['9260107', 'Fransen J; Moens HB; Speyer I; van Riel PL. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Annals of the rheumatic diseases. (2005) 64 9 pp1294-1298', '10.1136/ard.2004.030924', '']\n",
      "['9260108', 'Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis. International journal of tissue reactions. (2005) 27 1 pp15-21', '10.3410/f.726141758.793558002', '']\n",
      "['9260109', 'Flink H; Tegelberg A; Lagerl√∂f F. Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Archives of oral biology. (2005) 50 6 pp553-559', '10.1016/j.archoralbio.2004.10.015', '']\n",
      "['9260110', 'Ko SH; Choi SW; Ye SK; Cho BL; Kim HS; Chung MH. Comparison of the antioxidant activities of nine different fruits in human plasma. Journal of medicinal food. (2005) 8 1 pp41-46', '10.1089/jmf.2005.8.41', '']\n",
      "['9260111', 'Illnait J; Terry H; M√°s R; Fern√°ndez L; Carbajal D. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study. Journal of medicinal food. (2005) 8 1 pp63-68', '10.1089/jmf.2005.8.63', '']\n",
      "['9260112', 'Powell M; Seid M; Szer IS. Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomized trial. Journal of rheumatology. (2005) 32 5 pp943-950', '10.1093/rheumatology/keab765', 'http://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keab765/41048853/keab765.pdf']\n",
      "['9260113', 'Marcora S; Lemmey A; Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clinical nutrition (Edinburgh, Scotland). (2005) 24 3 pp442-454', '10.1016/j.clnu.2005.01.006', '']\n",
      "['9260114', 'Camp NJ; Cox A; di Giovine FS; McCabe D; Rich W; Duff GW. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis. Genes and immunity. (2005) 6 6 pp467-471', '10.1038/sj.gene.6364228', 'https://www.nature.com/articles/6364228']\n",
      "['9260115', 'Munneke M; de Jong Z; Zwinderman AH; Ronday HK; van Schaardenburg D; Dijkmans BA; Kroon HM; Vliet Vlieland TP; Hazes JM. Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthritis and rheumatism. (2005) 53 3 pp410-417', '10.1002/art.21165', '']\n",
      "['9260117', 'van Marle S; van Vliet A; Sollie F; Kambayashi Y; Yamada-Sawada T. Safety, tolerability and pharmacokinetics of oral S-3304, a novel matrix metalloproteinase inhibitor, in single and multiple dose escalation studies in healthy volunteers. International journal of clinical pharmacology and therapeutics. (2005) 43 6 pp282-293', '10.5414/cpp43282', '']\n",
      "['9260118', 'Kim YH; Sohn KS; Kim JS. Range of motion of standard and high-flexion posterior stabilized total knee prostheses. A prospective, randomized study. Journal of bone and joint surgery. American volume. (2005) 87 7 pp1470-1475', '10.2106/00004623-200507000-00008', '']\n",
      "['9260119', 'Kiss H; Raffl M; Neumann D; Hutter J; Dorn U. Epinephrine-augmented hypotensive epidural anesthesia replaces tourniquet use in total knee replacement. Clinical orthopaedics and related research. (2005)  436 pp184-189', '10.1097/01.blo.0000161825.90633.12', '']\n",
      "['9260121', 'Sohail MT; Chaudhry MI; Usman MK; Mian T; Ishaq MN. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders. Phytotherapy research : PTR. (2005) 19 4 pp365-368', '10.1002/ptr.1680', '']\n",
      "['9260123', 'Heiberg MS; Nordv√•g BY; Mikkelsen K; R√∏devand E; Kaufmann C; Mowinckel P; Kvien TK. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis and rheumatism. (2005) 52 8 pp2506-2512', '10.1002/art.21209', '']\n",
      "['9260124', 'Haila S; Koskinen A; Tenovuo J. Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial. Homeopathy. (2005) 94 3 pp175-181', '10.1016/j.homp.2005.03.002', '']\n",
      "['9260126', 'van Lankveld W; van Helmond T; N√§ring G; de Rooij DJ; van den Hoogen F. Partner participation in cognitive-behavioral self-management group treatment for patients with rheumatoid arthritis. Journal of rheumatology. (2004) 31 9 pp1738-1745', '10.3109/03009742.2010.517214', '']\n",
      "['9260127', 'Martin BI; Levenson LM; Hollingworth W; Kliot M; Heagerty PJ; Turner JA; Jarvik JG. Randomized clinical trial of surgery versus conservative therapy for carpal tunnel syndrome. BMC musculoskeletal disorders. (2005) 6  pp2', '10.1186/1471-2474-6-2', 'https://link.springer.com/article/10.1186/1471-2474-6-2/fulltext.html']\n",
      "['9260129', 'Weitoft T; Larsson A; Saxne T; R√∂nnblom L. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 12 pp1750-1753', '10.1136/ard.2004.035022', '']\n",
      "['9260131', 'Prasad N; Padmanabhan V; Mullaji A. Comparison between two methods of drain clamping after total knee arthroplasty. Archives of orthopaedic and trauma surgery. (2005) 125 6 pp381-384', '10.1007/s00402-005-0813-7', 'http://link.springer.com/article/10.1007/s00402-005-0813-7/fulltext.html']\n",
      "['9260132', 'Parkkila TJ; Belt EA; Hakala M; Kautiainen HJ; Leppilahti J. Grading of radiographic osteolytic changes after silastic metacarpophalangeal arthroplasty and a prospective trial of osteolysis following use of Swanson and Sutter prostheses. Journal of hand surgery (Edinburgh, Scotland). (2005) 30 4 pp382-387', '10.1016/j.jhsb.2004.03.019', 'https://journals.sagepub.com/doi/pdf/10.1016/J.JHSB.2004.03.019']\n",
      "['9260133', 'Stark LJ; Janicke DM; McGrath AM; Mackner LM; Hommel KA; Lovell D. Prevention of osteoporosis: a randomized clinical trial to increase calcium intake in children with juvenile rheumatoid arthritis. Journal of pediatric psychology. (2005) 30 5 pp377-386', '10.1093/jpepsy/jsi061', 'http://academic.oup.com/jpepsy/article-pdf/30/5/377/2750241/jsi061.pdf']\n",
      "['9260134', 'Ng CM; Bruno R; Combs D; Davies B. Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial. Journal of clinical pharmacology. (2005) 45 7 pp792-801', '10.1177/0091270005277075', '']\n",
      "['9260136', 'Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2006) 65 1 pp35-39', '10.1136/ard.2005.038851', '']\n",
      "['9260137', 'Du JH; Dong BD. Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of paeony in treating rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2005) 25 6 pp540-542', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9260138', 'Sharrock NE; Go G; Mayman D; Sculco TP. Decreases in pulmonary artery oxygen saturation during total hip arthroplasty variations using 2 leg positioning techniques. Journal of arthroplasty. (2005) 20 4 pp499-502', '10.1016/j.arth.2004.09.056', '']\n",
      "['9260140', 'van Rossum MA; Boers M; Zwinderman AH; van Soesbergen RM; Wieringa H; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA; Dutch Juvenile Idiopathic Arthritis Study Group. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. Arthritis and rheumatism. (2005) 52 9 pp2865-2872', '10.1002/art.21247', '']\n",
      "['9260141', 'Baslund B; Tvede N; Danneskiold-Samsoe B; Larsson P; Panayi G; Petersen J; Petersen LJ; Beurskens FJ; Schuurman J; van de Winkel JG; Parren PW; Gracie JA; Jongbloed S; Liew FY; McInnes IB. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis and rheumatism. (2005) 52 9 pp2686-2692', '10.1002/art.21249', '']\n",
      "['9260142', 'Furtado RN; Oliveira LM; Natour J. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study. Journal of rheumatology. (2005) 32 9 pp1691-1698', '10.1186/s42358-025-00452-9', 'https://link.springer.com/article/10.1186/s42358-025-00452-9/fulltext.html']\n",
      "['9260143', 'Adams EH; Breiner S; Cicero TJ; Geller A; Inciardi JA; Schnoll SH; Senay EC; Woody GE. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. Journal of pain and symptom management. (2006) 31 5 pp465-476', '10.1016/j.jpainsymman.2005.10.006', '']\n",
      "['9260145', 'Geusens PP; Landew√© RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis and rheumatism. (2006) 54 6 pp1772-1777', '10.1002/art.21896', '']\n",
      "['9260146', 'Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clinical therapeutics. (2006) 28 3 pp340-351', '10.1016/j.clinthera.2006.03.007', '']\n",
      "['9260147', 'Weitoft T; R√∂nnblom L. Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients. Annals of the rheumatic diseases. (2006) 65 7 pp955-957', '10.1136/ard.2005.041525', '']\n",
      "['9260149', 'Olivecrona C; Tidermark J; Hamberg P; Ponzer S; Cederfj√§ll C. Skin protection underneath the pneumatic tourniquet during total knee arthroplasty: a randomized controlled trial of 92 patients. Acta orthopaedica. (2006) 77 3 pp519-523', '10.1080/17453670610012539', '']\n",
      "['9260150', 'Zhao Y-P; Zhang Z-Y. Level of homocysteine in patients with rheumatoid arthritis and the effects of methopterin and folic acid. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2005) 9 27 pp22-23', '10.1002/cca.371', '']\n",
      "['9260151', 'Wu Q-Y; Cao J-Q; Guo L; Lin Y-P; Yu Q-H. Amelioration of knee joint function by intra-articular injection of methotrexate and dexamethasone in patients with rheumatoid. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2005) 9 27 pp27-29', '10.1186/isrctn17127122', '']\n",
      "['9260152', 'Huang W-Q. Effect of 99Tc methylenediphosphonate injection on morning stiffness duration and tender swollen index of patients with rheumatoid arthritis. Chinese Journal of Clinical Rehabilitation. (2005) 9 19 pp196-197', '10.1186/s40064-016-2066-z', 'http://link.springer.com/article/10.1186/s40064-016-2066-z/fulltext.html']\n",
      "['9260153', 'Tang T-F; Liang Q-H; Luo X; Chen J; Li X-L. Effects of bizhongxiao decoction on serum matrix metalloproteinase 3 and its tissue inhibitors of metalloproteinase 1 in patients with rheumatoid arthritis at active phase. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2005) 9 15 pp114-116', '10.3736/jcim20101008', '']\n",
      "['9260154', 'Ichikawa Y; Saito T; Yamanaka H; Akizuki M; Kondo H; Kobayashi S; Oshima H; Kawai S; Hama N; Yamada H; Mimori T; Amano K; Tanaka Y; Matsuoka Y; Yamamoto S; Matsubara T; Murata N; Asai T; Suzuki Y; Okano Y; Akaboshi T; Fujii T; Hirakata M; Suzuki T; Takubo N; Miyata Y; Sato Y; Nishimoto N; Saito E; Sawada S; Rikimaru A; Yamagata H; Toma S; Ito K; Yoshida K. Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: A multicenter, double-blind, randomized controlled study. Modern Rheumatology. (2005) 15 5 pp323-328', '10.3109/s10165-005-0420-z', '']\n",
      "['9260155', 'Kunert KS; Tisdale AS; Stern ME; Smith JA; Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Archives of ophthalmology (Chicago, Ill. : 1960). (2000) 118 11 pp1489-1496', '10.1001/archopht.118.11.1489', 'https://archopht.jamanetwork.com/ama/content_public/journal/ophth/9881/ecs90290.pdf']\n",
      "['9260156', 'Li YN; Zhao YS; Li X. Study on abnormality and regulation of t-lymphocyte subsets in peripheral blood of rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2002) 22 5 pp359-361', '10.1007/bf02934304', 'https://link.springer.com/article/10.1007/BF02934304/fulltext.html']\n",
      "['9260158', 'Sultan N; Pope JE; Clements PJ; Scleroderma Trials Study Group. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma. Rheumatology (Oxford, England). (2004) 43 4 pp472-478', '10.1093/rheumatology/keh070', 'http://academic.oup.com/rheumatology/article-pdf/43/4/472/9533547/keh070.pdf']\n",
      "['9260159', 'Strand V; Cohen S; Crawford B; Smolen JS; Scott DL; Leflunomide Investigators Groups. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology (Oxford, England). (2004) 43 5 pp640-647', '10.1093/rheumatology/keh140', 'http://academic.oup.com/rheumatology/article-pdf/43/5/640/14117482/keh140.pdf']\n",
      "['9260160', 'Kneitz C; Wilhelm M; Tony HP. Improvement of refractory rheumatoid arthritis after depletion of B cells. Scandinavian journal of rheumatology. (2004) 33 2 pp82-86', '10.1080/03009740310004379', '']\n",
      "['9260161', 'Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 2 pp303-305', '10.1136/ard.2004.023119', '']\n",
      "['9260162', 'Vgontzas AN; Zoumakis E; Lin HM; Bixler EO; Trakada G; Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. Journal of clinical endocrinology and metabolism. (2004) 89 9 pp4409-4413', '10.1210/jc.2003-031929', '']\n",
      "['9260163', 'Tascioglu F; Colak O; Armagan O; Alatas O; Oner C. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatology international. (2005) 26 1 pp21-29', '10.1007/s00296-004-0496-3', 'http://link.springer.com/article/10.1007/s00296-004-0496-3/fulltext.html']\n",
      "['9260164', 'Broderick JE; Junghaenel DU; Schwartz JE. Written emotional expression produces health benefits in fibromyalgia patients. Psychosomatic medicine. (2005) 67 2 pp326-334', '10.1097/01.psy.0000156933.04566.bd', '']\n",
      "['9260165', 'Sk√∂ldstam L; Brudin L; Hagfors L; Johansson G. Weight reduction is not a major reason for improvement in rheumatoid arthritis from lacto-vegetarian, vegan or Mediterranean diets. Nutrition journal. (2005) 4  pp15', '10.1186/1475-2891-4-15', 'https://link.springer.com/article/10.1186/1475-2891-4-15/fulltext.html']\n",
      "['9260166', 'Melikoglu MA; Karatay S; Senel K; Akcay F. Association between dynamic exercise therapy and IGF-1 and IGFBP-3 concentrations in the patients with rheumatoid arthritis. Rheumatology international. (2006) 26 4 pp309-313', '10.1007/s00296-005-0605-y', 'http://link.springer.com/article/10.1007/s00296-005-0605-y/fulltext.html']\n",
      "['9260167', 'Allanore Y; Kahan A; Sellam J; Ekindjian OG; Borderie D. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis. Clinica chimica acta; international journal of clinical chemistry. (2006) 365 1-2 pp143-148', '10.1016/j.cca.2005.08.010', '']\n",
      "['9260168', 'Aydoƒü E; Bal A; Aydoƒü ST; Cakci A. Evaluation of dynamic postural balance using the Biodex Stability System in rheumatoid arthritis patients. Clinical rheumatology. (2006) 25 4 pp462-467', '10.1007/s10067-005-0074-4', 'http://link.springer.com/article/10.1007/s10067-005-0074-4/fulltext.html']\n",
      "['9260169', 'Symmons D; Tricker K; Harrison M; Roberts C; Davis M; Dawes P; Hassell A; Knight S; Mulherin D; Scott DL; British Rheumatoid Outcome Study Group. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford, England). (2006) 45 5 pp558-565', '10.1093/rheumatology/kei169', 'http://academic.oup.com/rheumatology/article-pdf/45/5/558/9448075/kei169.pdf']\n",
      "['9260170', 'L‚àö¬∫ AP; He YT; Zha QL; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH. [Correlations of clinical symptoms and treatment efficacy in patients with rheumatoid arthritis treated with Chinese herbal drugs or Western medicine]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2005) 3 6 pp432-437', '10.3736/jcim20050604', '']\n",
      "['9260172', \"O'Brien AV; Jones P; Mullis R; Mulherin D; Dziedzic K. Conservative hand therapy treatments in rheumatoid arthritis--a randomized controlled trial. Rheumatology (Oxford, England). (2006) 45 5 pp577-583\", '10.1093/rheumatology/kei215', 'http://academic.oup.com/rheumatology/article-pdf/45/5/577/9448204/kei215.pdf']\n",
      "['9260174', 'Tanaka N; Sakahashi H; Hirose K; Ishima T; Ishii S. Augmented subscapularis muscle transposition for rotator cuff repair during shoulder arthroplasty in patients with rheumatoid arthritis. Journal of shoulder and elbow surgery. (2006) 15 1 pp2-6', '10.1016/j.jse.2005.04.004', '']\n",
      "['9260175', 'Parkkila TJ; Belt EA; Hakala M; Kautiainen HJ; Leppilahti J. Survival and complications are similar after Swanson and Sutter implant replacement of metacarpophalangeal joints in patients with rheumatoid arthritis. Scandinavian journal of plastic and reconstructive surgery and hand surgery. (2006) 40 1 pp49-53', '10.1080/02844310500327753', '']\n",
      "['9260176', 'Ogrendik M; Hakguder A; Keser N. Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study. Rheumatology (Oxford, England). (2006) 45 5 pp636-637', '10.1093/rheumatology/kel020', 'http://academic.oup.com/rheumatology/article-pdf/45/5/636/9448449/kel020.pdf']\n",
      "['9260177', 'Ryan S; Hassell AB; Lewis M; Farrell A. Impact of a rheumatology expert nurse on the wellbeing of patients attending a drug monitoring clinic. Journal of advanced nursing. (2006) 53 3 pp277-286', '10.1111/j.1365-2648.2006.03725.x', '']\n",
      "['9260178', 'Li LC; Davis AM; Lineker SC; Coyte PC; Bombardier C. Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: a randomized controlled trial. Arthritis and rheumatism. (2006) 55 1 pp42-52', '10.1002/art.21692', '']\n",
      "['9260179', 'Gonzalez-Juanatey C; Llorca J; Garcia-Porrua C; Martin J; Gonzalez-Gay MA. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis and rheumatism. (2006) 55 1 pp150-153', '10.1002/art.21707', '']\n",
      "['9260181', 'Scheiman JM; Yeomans ND; Talley NJ; Vakil N; Chan FK; Tulassay Z; Rainoldi JL; Szczepanski L; Ung KA; Kleczkowski D; Ahlbom H; Naesdal J; Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. American journal of gastroenterology. (2006) 101 4 pp701-710', '10.1111/j.1572-0241.2006.00499.x', '']\n",
      "['9260183', 'Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. Journal of rheumatology. (2006) 33 5 pp854-861', '10.2165/00002512-200623020-00006', '']\n",
      "['9260187', 'Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. Journal of rheumatology. (2006) 33 5 pp985-995', '10.1097/01.rhu.0000226591.31900.02', '']\n",
      "['9260188', 'Westhovens R; Houssiau F; Joly J; Everitt DE; Zhu Y; Sisco D; Van Hartingsveldt B; Mascelli MA; Graham MA; Durez P; Bouman-Thio E. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis. Journal of rheumatology. (2006) 33 5 pp847-853', '10.1016/j.clpt.2004.12.056', '']\n",
      "['9260189', 'Kuuliala K; Orpana A; Leirisalo-Repo M; Kautiainen H; Hurme M; Hannonen P; Korpela M; M√∂tt√∂nen T; Paimela L; Puolakka K; Karjalainen A; Repo H. Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Annals of the rheumatic diseases. (2006) 65 9 pp1241-1243', '10.1136/ard.2006.055137', '']\n",
      "['9260190', 'Cuomo G; Molinaro G; La Montagna G; Migliaresi S; Valentini G. [A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens]. Reumatismo. (2006) 58 1 pp22-25', '10.4081/reumatismo.2006.22', '']\n",
      "['9260192', \"Jarrett SJ; Conaghan PG; Sloan VS; Papanastasiou P; Ortmann CE; O'Connor PJ; Grainger AJ; Emery P. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 5 pp1410-1414\", '10.1002/art.21824', '']\n",
      "['9260193', 'Kirwan JR; Hickey SH; H√§llgren R; Mielants H; Bj√∂rck E; Persson T; Wollheim FA. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 5 pp1415-1421', '10.1002/art.21747', '']\n",
      "['9260194', 'Stark LJ; Davis AM; Janicke DM; Mackner LM; Hommel KA; Bean JA; Lovell D; Heubi JE; Kalkwarf HJ. A randomized clinical trial of dietary calcium to improve bone accretion in children with juvenile rheumatoid arthritis. Journal of pediatrics. (2006) 148 4 pp501-507', '10.1016/j.jpeds.2005.11.043', '']\n",
      "['9260196', 'Castaneda O; Nair MG. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis. Journal of rheumatology. (2006) 33 5 pp862-864', '10.1097/01.rhu.0000226590.60046.56', '']\n",
      "['9260197', 'Williams GW; Kivitz AJ; Brown MT; Verburg KM. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms. Clinical therapeutics. (2006) 28 2 pp204-221', '10.1016/j.clinthera.2006.01.016', '']\n",
      "['9260198', 'Mitlyng BL; Singh JA; Furne JK; Ruddy J; Levitt MD. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. American journal of hematology. (2006) 81 6 pp432-438', '10.1002/ajh.20644', '']\n",
      "['9260200', 'Korczowska I; Lacki JK. Changes in certain biochemical markers of bone turnover in rheumatoid arthritis patients treated with short-term low dose glucocorticosteroids. PrzeglaÃßd lekarski. (2005) 62 12 pp1384-1386', '10.1136/annrheumdis-2001.628', '']\n",
      "['9260201', 'Grondal L; Brostr√∂m E; Wretenberg P; Stark A. Arthrodesis versus Mayo resection: the management of the first metatarsophalangeal joint in reconstruction of the rheumatoid forefoot. Journal of bone and joint surgery. British volume. (2006) 88 7 pp914-919', '10.1302/0301-620x.88b7.17472', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.88B7.17472']\n",
      "['9260202', 'Lovell DJ; Glass D; Ranz J; Kramer S; Huang B; Sierra RI; Henderson CJ; Passo M; Graham B; Bowyer S; Higgins G; Rennebohm R; Schikler KN; Giannini E. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 7 pp2235-2242', '10.1002/art.21956', '']\n",
      "['9260203', 'Dyjas R; Bu≈Çanowski M; Ficek R; Witkowicz J; Chudek J; Wiecek A. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hormones in females with rheumatoid arthritis. Polskie Archiwum Medycyny WewneÃ®trznej. (2005) 114 2 pp731-737', '10.1093/ndt/13.5.1200', 'http://academic.oup.com/ndt/article-pdf/13/5/1200/9896665/131200.pdf']\n",
      "['9260204', 'Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; L√ºhmann R; Fischer R. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. American journal of gastroenterology. (2006) 101 8 pp1747-1755', '10.1111/j.1572-0241.2006.00686.x', '']\n",
      "['9260205', 'Rahme H; Mattsson P; Wikblad L; Larsson S. Cement and press-fit humeral stem fixation provides similar results in rheumatoid patients. Clinical orthopaedics and related research. (2006) 448  pp28-32', '10.1097/01.blo.0000224007.25636.85', '']\n",
      "['9260206', 'van der Linde MJ; Garling EH; Valstar ER; Tonino AJ; Nelissen RG. Periapatite may not improve micromotion of knee prostheses in rheumatoid arthritis. Clinical orthopaedics and related research. (2006) 448  pp122-128', '10.1097/01.blo.0000224005.18013.ee', '']\n",
      "['9260207', 'Bagheri-Nesami M; Mohseni-Bandpei MA; Shayesteh-Azar M. The effect of Benson Relaxation Technique on rheumatoid arthritis patients: extended report. International journal of nursing practice. (2006) 12 4 pp214-219', '10.1111/j.1440-172x.2006.00568.x', '']\n",
      "['9260208', 'Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Annals of the New York Academy of Sciences. (2006) 1069  pp420-427', '10.1196/annals.1351.040', '']\n",
      "['9260209', 'Haringman JJ; Gerlag DM; Smeets TJ; Baeten D; van den Bosch F; Bresnihan B; Breedveld FC; Dinant HJ; Legay F; Gram H; Loetscher P; Schmouder R; Woodworth T; Tak PP. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis and rheumatism. (2006) 54 8 pp2387-2392', '10.1002/art.21975', '']\n",
      "['9260210', 'Hirvonen HE; Mikkelsson MK; Kautiainen H; Pohjolainen TH; Leirisalo-Repo M. Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomised single blinded controlled trial. Clinical and experimental rheumatology. (2006) 24 3 pp295-301', '10.1007/s00296-017-3771-9', 'http://link.springer.com/article/10.1007/s00296-017-3771-9/fulltext.html']\n",
      "['9260211', 'Vendittoli PA; Lavigne M; Girard J; Roy AG. A randomised study comparing resection of acetabular bone at resurfacing and total hip replacement. Journal of bone and joint surgery. British volume. (2006) 88 8 pp997-1002', '10.1302/0301-620x.88b8.17615', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.88B8.17615']\n",
      "['9260212', 'Slappendel R; Weber EW; H√©mon YJ; M√§hler S; Dal√©n T; Rouwet EF; van Os JJ; Vosmaer A; van der Ark PD. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment. Acta orthopaedica. (2006) 77 4 pp677-683', '10.1080/17453670610012782', '']\n",
      "['9260213', 'Kirwan J. Early rheumatoid arthritis: combination therapy with disease-modifying antirheumatic drugs and low-dose glucocorticoids?. Nature clinical practice. Rheumatology. (2006) 2 4 pp182-183', '10.1038/ncprheum0162', 'http://www.nature.com/articles/ncprheum0162']\n",
      "['9260214', 'Harris ED. Glucocorticoid therapy in rheumatoid arthritis: intra-articular injections versus systemic administration. Nature clinical practice. Rheumatology. (2006) 2 4 pp184-185', '10.1038/ncprheum0160', 'http://www.nature.com/articles/ncprheum0160']\n",
      "['9260215', 'Alarc√≥n GS. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy. Nature clinical practice. Rheumatology. (2006) 2 6 pp296-297', '10.1038/ncprheum0195', 'http://www.nature.com/articles/ncprheum0195']\n",
      "['9260216', 'Whelton A; Lefkowith JL; West CR; Verburg KM. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney international. (2006) 70 8 pp1495-1502', '10.1038/sj.ki.5001766', '']\n",
      "['9260220', 'Vanags D; Williams B; Johnson B; Hall S; Nash P; Taylor A; Weiss J; Feeney D. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet (London, England). (2006) 368 9538 pp855-863', '10.1016/s0140-6736(06)69210-6', '']\n",
      "['9260221', 'M√§ki-Pet√§j√§ KM; Hall FC; Booth AD; Wallace SM; Yasmin null; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. (2006) 114 11 pp1185-1192', '10.1161/circulationaha.105.601641', '']\n",
      "['9260222', \"Wu CH; Hsieh SC; Lee KL; Li KJ; Lu MC; Yu CL. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sj√∂gren's syndrome in Taiwan--a double-blind, placebo-controlled trial. Journal of the Formosan Medical Association / Taiwan yi zhi. (2006) 105 10 pp796-803\", '10.1016/s0929-6646(09)60266-7', '']\n",
      "['9260223', 'Zhao H-J; Zuo X-X; You Y-H; Luo H; Wang Y-P. Yunke for improving the swelling and pain of joint in patients with rheumatoid arthritis. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2005) 9 11 pp28-30', '10.55111/j.issn2709-1961.202109043', '']\n",
      "['9260225', 'Ringe JD; Faber H; Fahramand P; Schacht E. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. Journal of rheumatology. (2005) 32 SUPPL. 76 pp33-40', '10.1007/s00296-003-0361-9', 'http://link.springer.com/article/10.1007/s00296-003-0361-9/fulltext.html']\n",
      "['9260226', 'Chang FY; Chang MC; Wang ST; Yu WK; Liu CL; Chen TH. Can povidone-iodine solution be used safely in a spinal surgery?. European spine journal. (2006) 15 6 pp1005-1014', '10.1007/s00586-005-0975-6', 'http://link.springer.com/article/10.1007/s00586-005-0975-6/fulltext.html']\n",
      "['9260227', 'N√∫√±ez M; N√∫√±ez E; Yoldi C; Quint√≥ L; Hern√°ndez MV; Mu√±oz-G√≥mez J. Health-related quality of life in rheumatoid arthritis: therapeutic education plus pharmacological treatment versus pharmacological treatment only. Rheumatology international. (2006) 26 8 pp752-757', '10.1007/s00296-005-0071-6', 'http://link.springer.com/article/10.1007/s00296-005-0071-6/fulltext.html']\n",
      "['9260229', 'Klareskog L; Gaubitz M; Rodriguez-Valverde V; Malaise M; Dougados M; Wajdula J; Etanercept Study 301 Investigators. A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. (2006) 65 12 pp1578-1584', '10.1136/ard.2005.038349', '']\n",
      "['9260232', \"Raj N; Badcock LJ; Brown GA; Deighton CM; O'Reilly SC. Undergraduate musculoskeletal examination teaching by trained patient educators--a comparison with doctor-led teaching. Rheumatology (Oxford, England). (2006) 45 11 pp1404-1408\", '10.1093/rheumatology/kel126', 'http://academic.oup.com/rheumatology/article-pdf/45/11/1404/18096802/kel126.pdf']\n",
      "['9260233', 'Jahangier ZN; Jacobs JW; Kraan MC; Wenting MJ; Smeets TJ; Bijlsma JW; Lafeber FP; Tak PP. Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids. Annals of the rheumatic diseases. (2006) 65 10 pp1286-1292', '10.1136/ard.2005.042333', '']\n",
      "['9260234', 'Ogrendik M. Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study. Rheumatology international. (2006) 26 12 pp1132-1137', '10.1007/s00296-006-0145-0', 'http://link.springer.com/article/10.1007/s00296-006-0145-0/fulltext.html']\n",
      "['9260235', \"Bilsborough W; Keen H; Taylor A; O'Driscoll GJ; Arnolda L; Green DJ. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatology international. (2006) 26 12 pp1125-1131\", '10.1007/s00296-006-0147-y', 'http://link.springer.com/article/10.1007/s00296-006-0147-y/fulltext.html']\n",
      "['9260236', 'Carson JW; Keefe FJ; Affleck G; Rumble ME; Caldwell DS; Beaupre PM; Kashikar-Zuck S; Sandstrom M; Weisberg JN. A comparison of conventional pain coping skills training and pain coping skills training with a maintenance training component: a daily diary analysis of short- and long-term treatment effects. Journal of pain. (2006) 7 9 pp615-625', '10.1016/j.jpain.2006.02.008', '']\n",
      "['9260238', 'Kawai S; Hashimoto H; Kondo H; Murayama T; Kiuchi T; Abe T. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. Journal of rheumatology. (2006) 33 11 pp2153-2161', '10.1007/s10165-012-0817-4', '']\n",
      "['9260239', \"Zandbelt MM; Houbiers JG; van den Hoogen FH; Meijerink J; van Riel PL; in't Hout J; van de Putte LB. Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis. Journal of rheumatology. (2006) 33 9 pp1726-1733\", '10.1136/ard.2009.117234', '']\n",
      "['9260240', 'Gillis ME; Lumley MA; Mosley-Williams A; Leisen JC; Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Annals of behavioral medicine. (2006) 32 2 pp135-146', '10.1207/s15324796abm3202_11', '']\n",
      "['9260241', 'Strand EB; Kerns RD; Christie A; Haavik-Nilsen K; Klokkerud M; Finset A. Higher levels of pain readiness to change and more positive affect reduce pain reports--a weekly assessment study on arthritis patients. Pain. (2007) 127 3 pp204-213', '10.1016/j.pain.2006.08.015', '']\n",
      "['9260243', 'Pasqui F; Mastrodonato L; Ceccarelli F; Scrivo R; Magrini L; Riccieri V; Di Franco M; Gentili M; Valesini G; Spadaro A. [Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs]. Reumatismo. (2006) 58 3 pp191-198', '10.4081/reumatismo.2006.191', '']\n",
      "['9260244', 'Weisman MH; Durez P; Hallegua D; Aranda R; Becker JC; Nuamah I; Vratsanos G; Zhou Y; Moreland LW. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis. Journal of rheumatology. (2006) 33 11 pp2162-2166', '10.1002/art.21501', '']\n",
      "['9260245', 'Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Sams√∏e B; Torp-Pedersen S. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (2006) 35 5 pp341-345', '10.1080/03009740600844530', '']\n",
      "['9260248', 'Pettersson K; Wagnsj√∂ P; Hulin E. NeuFlex compared with Sutter prostheses: a blind, prospective, randomised comparison of Silastic metacarpophalangeal joint prostheses. Scandinavian journal of plastic and reconstructive surgery and hand surgery. (2006) 40 5 pp284-290', '10.1080/02844310600940612', '']\n",
      "['9260250', 'Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. Arthritis and rheumatism. (2006) 54 12 pp3782-3789', '10.1002/art.22214', '']\n",
      "['9260251', 'van den Berg MH; Ronday HK; Peeters AJ; le Cessie S; van der Giesen FJ; Breedveld FC; Vliet Vlieland TP. Using internet technology to deliver a home-based physical activity intervention for patients with rheumatoid arthritis: A randomized controlled trial. Arthritis and rheumatism. (2006) 55 6 pp935-945', '10.1002/art.22339', '']\n",
      "['9260253', 'Muller SD; Deehan DJ; Holland JP; Outterside SE; Kirk LM; Gregg PJ; McCaskie AW. Should we reconsider all-polyethylene tibial implants in total knee replacement?. Journal of bone and joint surgery. British volume. (2006) 88 12 pp1596-1602', '10.1302/0301-620x.88b12.17695', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.88B12.17695']\n",
      "['9260254', 'Neri S; Pulvirenti D; Bertino G. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b. Clinical drug investigation. (2006) 26 11 pp655-662', '10.2165/00044011-200626110-00005', '']\n",
      "['9260255', 'Furuzawa-Carballeda J; Fenutria-Ausmequet R; Gil-Espinosa V; Lozano-Soto F; Teliz-Meneses MA; Romero-Trejo C; Alcocer-Varela J. Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial. Clinical and experimental rheumatology. (2006) 24 5 pp514-520', '10.1016/j.clim.2006.04.533', '']\n",
      "['9260257', 'Nelson EA; Prescott RJ; Harper DR; Gibson B; Brown D; Ruckley CV. A factorial, randomized trial of pentoxifylline or placebo, four-layer or single-layer compression, and knitted viscose or hydrocolloid dressings for venous ulcers. Journal of vascular surgery. (2007) 45 1 pp134-141', '10.1016/j.jvs.2006.09.043', '']\n",
      "['9260259', 'Rall LC; Meydani SN; Kehayias JJ; wson-Hughes B; Roubenoff R. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis and rheumatism. (1996) 39 3 pp415-426', '10.1002/art.1780390309', '']\n",
      "['9260260', 'Khanna M; Shirodkar M A; Gottlieb A B. Etanercept therapy in patients with autoimmunity and hepatitis C. Journal of dermatological treatment. (2003) 14 4 pp229-232', '10.1080/09546630310020470', '']\n",
      "['9260261', 'Fyrand L; Moum T; Finset A; Glennas A. The effect of social network intervention for women with rheumatoid arthritis. Family process. (2003) 42 1 pp71-89', '10.1111/j.1545-5300.2003.00071.x', '']\n",
      "['9260262', 'Hart FD; Boardman PL. Indomethacin and phenylbutazone: a comparison. British medical journal. (1965) 2 5473 pp1281-1284', '10.1136/bmj.2.5473.1281', '']\n",
      "['9260263', 'Pe√±arrubia MJ; Odriozola J; Gonz√°lez C; Massagu√© I; Miguel A; Gonz√°lez San Miguel JD; P√©rez Encinas M; Lavilla E; Giraldo MP; Casado LF; Ferrer S; Steegmann JL; Spanish Group on IFN and CML. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses. Annals of hematology. (2003) 82 12 pp750-758', '10.1007/s00277-003-0724-z', 'http://link.springer.com/article/10.1007/s00277-003-0724-z/fulltext.html']\n",
      "['9260264', 'Nakamura H; Masuko K; Yudoh K; Kato T; Kamada T; Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatology international. (2007) 27 3 pp213-218', '10.1007/s00296-006-0197-1', 'http://link.springer.com/article/10.1007/s00296-006-0197-1/fulltext.html']\n",
      "['9260265', 'Franke A; Reiner L; Resch KL. Long-term benefit of radon spa therapy in the rehabilitation of rheumatoid arthritis: a randomised, double-blinded trial. Rheumatology international. (2007) 27 8 pp703-713', '10.1007/s00296-006-0293-2', 'https://link.springer.com/article/10.1007/s00296-006-0293-2/fulltext.html']\n",
      "['9260267', 'Zhou H; Jang H; Fleischmann RM; Bouman-Thio E; Xu Z; Marini JC; Pendley C; Jiao Q; Shankar G; Marciniak SJ; Cohen SB; Rahman MU; Baker D; Mascelli MA; Davis HM; Everitt DE. Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis. Journal of clinical pharmacology. (2007) 47 3 pp383-396', '10.1177/0091270006298188', '']\n",
      "['9260270', 'Zautra AJ; Parrish BP; Van Puymbroeck CM; Tennen H; Davis MC; Reich JW; Irwin M. Depression history, stress, and pain in rheumatoid arthritis patients. Journal of behavioral medicine. (2007) 30 3 pp187-197', '10.1007/s10865-007-9097-4', 'http://link.springer.com/article/10.1007/s10865-007-9097-4/fulltext.html']\n",
      "['9260272', 'Kim YH; Kim JS; Kim DY. Clinical outcome and rate of complications after primary total knee replacement performed with quadriceps-sparing or standard arthrotomy. Journal of bone and joint surgery. British volume. (2007) 89 4 pp467-470', '10.1302/0301-620x.89b4.18663', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.89B4.18663']\n",
      "['9260275', 'van Rossum MA; van Soesbergen RM; Boers M; Zwinderman AH; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA; Dutch Juvenile Idiopathic Arthritis Study group. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Annals of the rheumatic diseases. (2007) 66 11 pp1518-1524', '10.1136/ard.2006.064717', '']\n",
      "['9260277', 'Bechtold S; Ripperger P; Dalla Pozza R; Bonfig W; H√§fner R; Michels H; Schwarz HP. Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study. Journal of clinical endocrinology and metabolism. (2007) 92 8 pp3013-3018', '10.1210/jc.2007-0544', 'http://academic.oup.com/jcem/article-pdf/92/8/3013/10405170/jcem3013.pdf']\n",
      "['9260278', 'Ho DM; Huo MH. Are critical pathways and implant standardization programs effective in reducing costs in total knee replacement operations?. Journal of the American College of Surgeons. (2007) 205 1 pp97-100', '10.1016/j.jamcollsurg.2007.03.009', '']\n",
      "['9260279', 'Schlademann S; H√ºppe A; Raspe H. Results of a randomised controlled trial on the acceptance and the outcomes of a counselling on medical inpatient rehabilitation in gainfully employed members of statutory health insurances with rheumatoid arthritis (clinicaltrials.gov identifier NCT00229541). Gesundheitswesen (Bundesverband der AÃàrzte des OÃàffentlichen Gesundheitsdienstes (Germany)). (2007) 69 6 pp325-335', '10.1055/s-2007-982519', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-982519.pdf']\n",
      "['9260280', 'Neuberger GB; Aaronson LS; Gajewski B; Embretson SE; Cagle PE; Loudon JK; Miller PA. Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis. Arthritis and rheumatism. (2007) 57 6 pp943-952', '10.1002/art.22903', '']\n",
      "['9260281', 'Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study. Clinical therapeutics. (2007) 29 6 pp1071-1085', '10.1016/j.clinthera.2007.06.016', '']\n",
      "['9260282', 'Clucas AT; Shah A; Zhang YD; Chow VF; Gladue RP. Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715. Clinical pharmacokinetics. (2007) 46 9 pp757-766', '10.2165/00003088-200746090-00003', '']\n",
      "['9260283', 'M√§ki-Pet√§j√§ KM; Booth AD; Hall FC; Wallace SM; Brown J; McEniery CM; Wilkinson IB. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. Journal of the American College of Cardiology. (2007) 50 9 pp852-858', '10.1016/j.jacc.2007.04.076', '']\n",
      "['9260284', 'Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis. Journal of clinical rheumatology. (2007) 13 4 pp193-198', '10.1097/rhu.0b013e318124a483', '']\n",
      "['9260285', 'Wong M; Jiang BY; McNeill K; Farish S; Kirkham B; Chowienczyk P. Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (2007) 36 4 pp265-269', '10.1080/03009740701286771', '']\n",
      "['9260287', 'Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Clinical therapeutics. (2007) 29 7 pp1390-1402', '10.1016/j.clinthera.2007.07.021', '']\n",
      "['9260288', 'Yamada S; Takagi H; Tsuchiya H; Nakajima T; Ochiai H; Ichimura A; Iwata H; Toriyama T. Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. Yakugaku zasshi. (2007) 127 9 pp1491-1496', '10.1248/yakushi.127.1491', '']\n",
      "['9260289', 'Filip RS; Pierzynowski SG; Lindegard B; Wernerman J; Haratym-Maj A; Podgurniak M. Alpha-ketoglutarate decreases serum levels of C-terminal cross-linking telopeptide of type I collagen (CTX) in postmenopausal women with osteopenia: six-month study. International journal for vitamin and nutrition research. Internationale Zeitschrift fuÃàr Vitamin- und ErnaÃàhrungsforschung. Journal international de vitaminologie et de nutrition. (2007) 77 2 pp89-97', '10.1024/0300-9831.77.2.89', '']\n",
      "['9260290', 'Olsen NJ; Teal GP; Brooks RH. IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritis. Agents and actions. (1991) 34 1-2 pp169-171', '10.1007/bf01993268', 'http://link.springer.com/article/10.1007/BF01993268/fulltext.html']\n",
      "['9260291', 'Paulus HE; Egger MJ; Ward JR; Williams HJ. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis and rheumatism. (1990) 33 4 pp477-484', '10.1002/art.1780330403', '']\n",
      "['9260292', 'Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet. (2006) 368 9549 pp1771-1781', '10.1016/s0140-6736(06)69666-9', '']\n",
      "['9260293', 'Nour K; Laforest S; Gauvin L; Gignac M. Behavior change following a self-management intervention for housebound older adults with arthritis: An experimental study. International journal of behavioral nutrition and physical activity. (2006) 3  pp12', '10.1186/1479-5868-3-12', 'https://link.springer.com/content/pdf/10.1186/1479-5868-3-12.pdf']\n",
      "['9260294', 'Cannon CP; Curtis SP; Bolognese JA; Laine L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. American heart journal. (2006) 152 2 pp237-245', '10.1016/j.ahj.2006.05.024', '']\n",
      "['9260296', 'Vendittoli P-A; Lavigne M; Roy A-G; Lusignan D. A prospective randomized clinical trial comparing metal-on-metal total hip arthroplasty and metal-on-metal total hip resurfacing in patients less than 65 years old. Hip international. (2006) 16 SUPPL. 4 ppS73-S81', '10.5301/hip.2008.1446', '']\n",
      "['9260297', 'Hallan G; Aamodt A; Furnes O; Skredderstuen A; Haugan K; Havelin LI. Palamed G compared with Palacos R with gentamicin in Charnley total hip replacement. Journal of bone and joint surgery. British volume. (2006) 88 9 pp1143-1148', '10.1302/0301-620x.88b9.18008', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.88B9.18008']\n",
      "['9260299', 'Mukherjee D. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor. Thrombosis and haemostasis. (2006) 96 4 pp407-412', '10.1160/th06-07-0384', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH06-07-0384.pdf']\n",
      "['9260301', 'Farahani P; Levine M; Goeree R. A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics. Journal of evaluation in clinical practice. (2006) 12 4 pp463-470', '10.1111/j.1365-2753.2006.00731.x', '']\n",
      "['9260302', 'Tsvetkova ES. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)]. Terapevticheskii arkhiv. (1985) 57 8 pp40-43', '10.26442/00403660.2023.05.202196', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/551819/132626']\n",
      "['9260303', 'Schnitzer TJ; Fricke Jr JR; Gitton X; Jayawardene S; Sloan VS. Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: Results of three dose-response studies. Journal. (2005) 21 1 pp151-161', '10.1185/030079904x20231', '']\n",
      "['9260306', \"Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sj√∂gren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. Clinical rheumatology. (2008) 27 4 pp429-436\", '10.1007/s10067-007-0723-x', 'http://link.springer.com/article/10.1007/s10067-007-0723-x/fulltext.html']\n",
      "['9260309', 'Kanbe K; Inoue K; Inoue Y; Suzuki Y. Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis. Clinical rheumatology. (2008) 27 4 pp497-501', '10.1007/s10067-007-0790-z', 'http://link.springer.com/article/10.1007/s10067-007-0790-z/fulltext.html']\n",
      "['9260310', 'Allen M; Oberle K; Grace M; Russell A; Adewale AJ. A randomized clinical trial of elk velvet antler in rheumatoid arthritis. Biological research for nursing. (2008) 9 3 pp254-261', '10.1177/1099800407309505', 'https://journals.sagepub.com/doi/pdf/10.1177/1099800407309505']\n",
      "['9260312', 'Lisbona MP; Maymo J; Perich J; Almirall M; P‚àö¬©rez-Garc‚àö‚â†a C; Carbonell J. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks. Journal of rheumatology. (2008) 35 3 pp394-397', '10.3109/03009742.2013.776104', '']\n",
      "['9260313', 'Saleem B; Mackie S; Quinn M; Nizam S; Hensor E; Jarrett S; Conaghan PG; Emery P. Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?. Annals of the rheumatic diseases. (2008) 67 8 pp1178-1180', '10.1136/ard.2007.084269', '']\n",
      "['9260314', 'Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. Journal of rheumatology. (2008) 35 3 pp407-413', '10.1272/jnms.76.240', '']\n",
      "['9260315', 'Katayama K; Matsuno T. Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study. Clinical drug investigation. (2008) 28 3 pp149-158', '10.2165/00044011-200828030-00002', '']\n",
      "['9260316', 'Olofsson C; Nyg√•rds EB; Ponzer S; Fagrell B; Przybelski R; Keipert PE; Winslow N; Winslow RM. A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfusion medicine (Oxford, England). (2008) 18 1 pp28-39', '10.1111/j.1365-3148.2007.00811.x', '']\n",
      "['9260317', 'Braun IM; Liang MH; Orav EJ; Ahern DK; Barsky AJ. A personality characteristic, somatic absorption, and the perception of somatic symptoms in rheumatoid arthritis patients. Journal of rheumatology. (2008) 35 5 pp782-789', '10.1016/s0033-3182(99)71204-1', '']\n",
      "['9260318', 'Boesen M; Boesen L; Jensen KE; Cimmino MA; Torp-Pedersen S; Terslev L; Koenig M; Danneskiold-Sams√∏e B; R√∏gind H; Bliddal H. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. Journal of rheumatology. (2008) 35 4 pp584-591', '10.1016/j.ejrad.2007.08.037', '']\n",
      "['9260319', 'Galarraga B; Ho M; Youssef HM; Hill A; McMahon H; Hall C; Ogston S; Nuki G; Belch JJ. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford, England). (2008) 47 5 pp665-669', '10.1093/rheumatology/ken024', 'http://academic.oup.com/rheumatology/article-pdf/47/5/665/5050405/ken024.pdf']\n",
      "['9260320', 'Amin A; Watson A; Mangwani J; Nawabi DH; Nawabi D; Ahluwalia R; Loeffler M. A prospective randomised controlled trial of autologous retransfusion in total knee replacement. Journal of bone and joint surgery. British volume. (2008) 90 4 pp451-454', '10.1302/0301-620x.90b4.20044', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.90B4.20044']\n",
      "['9260325', 'Cohen SB; Dore RK; Lane NE; Ory PA; Peterfy CG; Sharp JT; van der Heijde D; Zhou L; Tsuji W; Newmark R; Denosumab Rheumatoid Arthritis Study Group. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis and rheumatism. (2008) 58 5 pp1299-1309', '10.1002/art.23417', '']\n",
      "['9260327', 'van der Heijde D; Landew√© R; Einstein S; Ory P; Vosse D; Ni L; Lin SL; Tsuji W; Davis JC. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis and rheumatism. (2008) 58 5 pp1324-1331', '10.1002/art.23471', '']\n",
      "['9260328', 'Lovell DJ; Reiff A; Ilowite NT; Wallace CA; Chon Y; Lin SL; Baumgartner SW; Giannini EH; Pediatric Rheumatology Collaborative Study Group. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis and rheumatism. (2008) 58 5 pp1496-1504', '10.1002/art.23427', '']\n",
      "['9260329', 'Stiefel F; Zdrojewski C; Bel Hadj F; Boffa D; Dorogi Y; So A; Ruiz J; de Jonge P. Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial. Psychotherapy and psychosomatics. (2008) 77 4 pp247-256', '10.1159/000129658', 'https://www.karger.com/Article/Pdf/129658']\n",
      "['9260330', 'Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. Journal of rheumatology. (2008) 35 5 pp936-938', '10.3109/s10165-010-0305-7', '']\n",
      "['9260331', 'L√º LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial. Chinese medical journal. (2008) 121 7 pp615-619', '10.1097/00029330-200804010-00008', '']\n",
      "['9260332', 'Ikonomidis I; Lekakis JP; Nikolaou M; Paraskevaidis I; Andreadou I; Kaplanoglou T; Katsimbri P; Skarantavos G; Soucacos PN; Kremastinos DT. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. (2008) 117 20 pp2662-2669', '10.1161/circulationaha.107.731877', '']\n",
      "['9260334', \"Forsblad d'Elia H; Pullerits R; Carlsten H; Bokarewa M. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford, England). (2008) 47 7 pp1082-1087\", '10.1093/rheumatology/ken187', 'http://academic.oup.com/rheumatology/article-pdf/47/7/1082/5067341/ken187.pdf']\n",
      "['9260336', 'Warnke A; Schug B; Vanderbist F; Blume H. Importance of the formulation for a chronopharmacologically optimised way of pain therapy. Results of a comparative bioavailability study of tramadol extended-release capsules after single-dose evening versus morning administration. MMW Fortschritte der Medizin. (2008) 150 Suppl 1  pp36-42', '10.1007/bf03365585', '']\n",
      "['9260337', 'Zautra AJ; Davis MC; Reich JW; Nicassario P; Tennen H; Finan P; Kratz A; Parrish B; Irwin MR. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. Journal of consulting and clinical psychology. (2008) 76 3 pp408-421', '10.1037/0022-006x.76.3.408', 'http://psycnet.apa.org/journals/ccp/76/3/408.pdf']\n",
      "['9260338', 'Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis. Arthritis and rheumatism. (2008) 59 7 pp905-910', '10.1002/art.23824', '']\n",
      "['9260339', 'Lorig KR; Ritter PL; Laurent DD; Plant K. The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia. Arthritis and rheumatism. (2008) 59 7 pp1009-1017', '10.1002/art.23817', '']\n",
      "['9260340', 'Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study. Arthritis and rheumatism. (2008) 58 7 pp1921-1930', '10.1002/art.23493', '']\n",
      "['9260341', 'Vergunst CE; Gerlag DM; Lopatinskaya L; Klareskog L; Smith MD; van den Bosch F; Dinant HJ; Lee Y; Wyant T; Jacobson EW; Baeten D; Tak PP. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. Arthritis and rheumatism. (2008) 58 7 pp1931-1939', '10.1002/art.23591', '']\n",
      "['9260342', 'Luz KR; Furtado RN; Nunes CC; Rosenfeld A; Fernandes AR; Natour J. Ultrasound-guided intra-articular injections in the wrist in patients with rheumatoid arthritis: a double-blind, randomised controlled study. Annals of the rheumatic diseases. (2008) 67 8 pp1198-1200', '10.1136/ard.2007.084616', '']\n",
      "['9260343', 'Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-P√©rez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalh√£es C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; Paediatric Rheumatology INternational Trials Organization; Pediatric Rheumatology Collaborative Study Group. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet (London, England). (2008) 372 9636 pp383-391', '10.1016/s0140-6736(08)60998-8', '']\n",
      "['9260345', 'Pesce E; Struma E; Giri SN; Margolin SB. Antirheumatic effect of pirfenidone in a double blind clinical pilot trial in humans. Research communications in molecular pathology and pharmacology. (2004) 115-116  pp39-48', '10.1016/s0006-2952(02)01213-3', '']\n",
      "['9260346', 'Rani PU; Naidu MUR. Clinical efficacy and safety evaluation of eazmov plus in rheumatoid arthritis. Phytomedica. (2006) 7  pp1-7', '10.2165/00044011-200222050-00007', '']\n",
      "['9260348', 'Banuelos-Ramirez D; Ramirez-Palma MM; Balcazar-Sanchez ME; Sanchez-Alonso S. Rapid application of infliximab. Efficacy and complications. [Spanish]. Reumatologia clinica. (2007) 3 4 pp171-175', '10.1016/s2173-5743(07)70240-x', '']\n",
      "['9260350', 'Ozoran K; Yildirim M; Onder M; Sivas F; Inanir A. The bone mineral density effects of calcitonin and alendronate combined therapy in patients with rheumatoid arthritis. APLAR Journal of Rheumatology. (2007) 10 1 pp17-22', '10.1111/j.1479-8077.2007.00249.x', '']\n",
      "['9260351', 'Hennessy K; Burns J; Penkala S. Reducing plantar pressure in rheumatoid arthritis: A comparison of running versus off-the-shelf orthopaedic footwear. Clinical biomechanics (Bristol, Avon). (2007) 22 8 pp917-923', '10.1016/j.clinbiomech.2007.04.011', '']\n",
      "['9260352', 'Bitler CM; Matt K; Irving M; Hook G; Yusen J; Eagar F; Kirschner K; Walker B; Crea R. Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis. Nutrition research (New York, N.Y.). (2007) 27 8 pp470-477', '10.1016/j.nutres.2007.06.003', '']\n",
      "['9260353', 'Saida K; Zhigang Z; Ozawa K; Konishi T; Saida T. Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome. Internal medicine (Tokyo, Japan). (1999) 38 8 pp636-642', '10.2169/internalmedicine.38.636', '']\n",
      "['9260354', 'Bruyn GA. Thalidomide (celgene corp). IDrugs : the investigational drugs journal. (1998) 1 4 pp490-500', '10.1517/13543784.7.12.2043', '']\n",
      "['9260356', 'Lovell D J; Giannini E H; Reiff A; Jones O Y; Schneider R; Olson J C; Stein L D; Gedalia A; Ilowite N T; Wallace C A; Lange M; Finck B K; Burge D J. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis and rheumatism. (2003) 48 1 pp218-226', '10.1002/art.10710', '']\n",
      "['9260357', 'Chopra A; Bichile L; Rajadhyaksha A G; Gadgil D; Maroli S; Goregaonkar A B; Dhaon B K. Randomized double-blind clinical drug trials of meloxicam in rheumatoid arthritis and osteoarthritis knees: An Indian experience. APLAR Journal of Rheumatology. (2004) 7 2 pp108-116', '10.1111/j.1479-8077.2004.00070.x', '']\n",
      "['9260360', 'Zanette Sde A; Born IG; Brenol JC; Xavier RM. A pilot study of acupuncture as adjunctive treatment of rheumatoid arthritis. Clinical rheumatology. (2008) 27 5 pp627-635', '10.1007/s10067-007-0759-y', 'http://link.springer.com/article/10.1007/s10067-007-0759-y/fulltext.html']\n",
      "['9260362', 'Kanbe K; Inoue K; Inoue Y; Suzuki Y. Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis. Clinical rheumatology. (2008) 27 6 pp777-781', '10.1007/s10067-008-0850-z', 'http://link.springer.com/article/10.1007/s10067-008-0850-z/fulltext.html']\n",
      "['9260364', 'Schwartz JI; Dallob AL; Larson PJ; Laterza OF; Miller J; Royalty J; Snyder KM; Chappell DL; Hilliard DA; Flynn ME; Cavanaugh PF; Wagner JA. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. Journal of clinical pharmacology. (2008) 48 6 pp745-754', '10.1177/0091270008317590', '']\n",
      "['9260365', 'Rastmanesh R; Abargouei AS; Shadman Z; Ebrahimi AA; Weber CE. A pilot study of potassium supplementation in the treatment of hypokalemic patients with rheumatoid arthritis: a randomized, double-blinded, placebo-controlled trial. Journal of pain. (2008) 9 8 pp722-731', '10.1016/j.jpain.2008.03.006', '']\n",
      "['9260366', 'Radhofer-Welte S; Dittrich P; Simin M; Branebjerg PE. Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteers. Clinical drug investigation. (2008) 28 6 pp345-351', '10.2165/00044011-200828060-00002', '']\n",
      "['9260367', 'Wang C. Tai Chi improves pain and functional status in adults with rheumatoid arthritis: results of a pilot single-blinded randomized controlled trial. Medicine and sport science. (2008) 52  pp218-229', '10.1159/000134302', '']\n",
      "['9260369', 'Greaves CJ; Harlow TN. Exploration of the validity of weak magnets as a suitable placebo in trials of magnetic therapy. Complementary therapies in medicine. (2008) 16 3 pp177-180', '10.1016/j.ctim.2008.01.002', '']\n",
      "['9260372', 'Nasonova VA; Lukina GV; Sigidin IaA. [Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis]. TerapevticheskiiÃÜ arkhiv. (2008) 80 5 pp30-37', '10.14412/1996-7012-2012-727', '']\n",
      "['9260375', 'He Y; Lu A; Zha Y; Tsang I. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients. Complementary therapies in medicine. (2008) 16 4 pp206-211', '10.1016/j.ctim.2007.08.005', '']\n",
      "['9260376', 'He Y; Lu A; Lu C; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Tsang I. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis. American journal of Chinese medicine. (2008) 36 4 pp675-683', '10.1142/s0192415x08006144', '']\n",
      "['9260377', 'Lovell DJ; Ruperto N; Goodman S; Reiff A; Jung L; Jarosova K; Nemcova D; Mouy R; Sandborg C; Bohnsack J; Elewaut D; Foeldvari I; Gerloni V; Rovensky J; Minden K; Vehe RK; Weiner LW; Horneff G; Huppertz HI; Olson NY; Medich JR; Carcereri-De-Prati R; McIlraith MJ; Giannini EH; Martini A; Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. New England journal of medicine. (2008) 359 8 pp810-820', '10.1056/nejmoa0706290', '']\n",
      "['9260378', 'Grekhov RA; Aleksandrov AV; Kedrov VL; Zborovskiƒ≠ AB. [The evaluation of the quality of life as a criterion of the efficiency of rehabilitating treatment in rheumatoid arthritis]. Klinicheskaia meditsina. (2008) 86 7 pp39-42', '10.18411/1512-0112-2018-1(274)-74-79', '']\n",
      "['9260379', 'Liu XD; Zhang JL; Zheng HG; Liu FY; Chen Y. Clinical randomized study of bee-sting therapy for rheumatoid arthritis. Zhen ci yan jiu  [Acupuncture research]. (2008) 33 3 pp197-200', '10.5353/th_b4100505', '']\n",
      "['9260381', 'Silva AC; Jones A; Silva PG; Natour J. Effectiveness of a night-time hand positioning splint in rheumatoid arthritis: a randomized controlled trial. Journal of rehabilitation medicine. (2008) 40 9 pp749-754', '10.2340/16501977-0240', '']\n",
      "['9260382', 'Owczarczyk K; Hellmann M; Fliedner G; R√∂hrs T; Maizus K; Passon D; Hallek M; Rubbert A. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate. Annals of the rheumatic diseases. (2008) 67 11 pp1648-1649', '10.1136/ard.2007.087023', '']\n",
      "['9260383', 'Haslock I; Monro R; Nagarathna R; Nagendra H R; Raghuram N V. Measuring the effects of yoga in rheumatoid arthritis. British journal of rheumatology. (1994) 33 8 pp787-788', '10.1093/rheumatology/33.8.787-a', 'http://academic.oup.com/rheumatology/article-pdf/33/8/787/5032023/33-8-787b.pdf']\n",
      "['9260384', \"Alpoz E; Guneri P; Onder G; Cankaya H; Kabasakal Y; and Kose T. The efficacy of xialine in patients with Sjogren's syndrome: a single-blind, cross-over study. Clinical oral investigations. (2008) 12 2 pp165-172\", '10.1007/s00784-007-0159-3', 'http://link.springer.com/article/10.1007/s00784-007-0159-3/fulltext.html']\n",
      "['9260385', 'Russo E B. Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management. (2008) 4 1 pp245-259', '10.2147/tcrm.s1928', 'https://www.dovepress.com/getfile.php?fileID=2719']\n",
      "['9260386', 'Barabas K; Balint G; Gaspardy G; Meretey K; Piroska E and Molnar E. Controlled clinical and experimental investigations with Nd-Phosphate-Glass-Laser in patients with rheumatoid arthritis. Zeitschrift Physiotherapie. (1989) 41 5 pp293-296', '10.1055/s-2008-1065412', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1065412.pdf']\n",
      "['9260387', 'Tan L; Yuen KM; Hager S; Musial F; Dobos GJ. Therapeutic effects of an external Chinese medical bath on 64 fasting and non-fasting patients with rheumatoid arthritis. Deutsche Zeitschrift fur Akupunktur. (2008) 51 2 pp21-25', '10.1016/j.dza.2008.05.001', '']\n",
      "['9260388', 'Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 2 pp335-344', '10.1002/art.24266', '']\n",
      "['9260389', \"Roesel M; Heinz C; Heimes B; Koch JM; Heiligenhaus A. Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis--a prospective randomized study. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefe's archive for clinical and experimental ophthalmology]. (2008) 246 11 pp1609-1615\", '10.1007/s00417-008-0886-4', 'http://link.springer.com/article/10.1007/s00417-008-0886-4/fulltext.html']\n",
      "['9260391', 'Coaccioli S; Allegra A; Di Cato L; Puxeddu A. Clinical efficacy and tolerance of nabumetone in articular and non-articular rheumatic disorders: personal experience during 12 weeks of treatment. Panminerva medica. (1998) 40 2 pp110-115', '10.3109/rhe1.1956.2.issue-1-4.13', '']\n",
      "['9260393', 'Syngle A; Vohra K; Kaur L; Sharma S. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scandinavian journal of rheumatology. (2009) 38 1 pp15-22', '10.1080/03009740802279709', '']\n",
      "['9260394', 'Ilowite N; Porras O; Reiff A; Rudge S; Punaro M; Martin A; Allen R; Harville T; Sun YN; Bevirt T; Aras G; Appleton B. Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clinical rheumatology. (2009) 28 2 pp129-137', '10.1007/s10067-008-0995-9', 'http://link.springer.com/content/pdf/10.1007/s10067-008-0995-9.pdf']\n",
      "['9260395', 'Kim YH; Cho SH; Kim RS. Drainage versus nondrainage in simultaneous bilateral total hip arthroplasties. Journal of arthroplasty. (1998) 13 2 pp156-161', '10.1016/s0883-5403(98)90093-6', '']\n",
      "['9260396', 'Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M. Desmopressin and low-dose ACTH test in rheumatoid arthritis. European journal of endocrinology / European Federation of Endocrine Societies. (1998) 138 3 pp294-301', '10.1530/eje.0.1380294', 'https://eje.bioscientifica.com/view/journals/eje/138/3/294.xml']\n",
      "['9260397', 'Ji H; Yao S; Luo Q; Cao X. TCM treatment of rheumatoid arthritis by supplementing the kidney and invigorating the blood circulation. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2002) 22 4 pp252-255', '10.12677/tcm.2025.142111', '']\n",
      "['9260398', 'Laine L; Goldkind L; Curtis SP; Connors LG; Yanqiong Z; Cannon CP. How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. American journal of gastroenterology. (2009) 104 2 pp356-362', '10.1038/ajg.2008.149', '']\n",
      "['9260399', 'Walker JS; Carmody JJ. Experimental pain in healthy human subjects: gender differences in nociception and in response to ibuprofen. Anesthesia and analgesia. (1998) 86 6 pp1257-1262', '10.1097/00000539-199806000-00023', '']\n",
      "['9260400', 'Morgan SL; Baggott JE; Lee JY; Alarc√≥n GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. Journal of rheumatology. (1998) 25 3 pp441-446', '10.1002/art.10280', '']\n",
      "['9260401', 'Aryaeian N; Shahram F; Djalali M; Eshragian MR; Djazayeri A; Sarrafnejad A; Naderi N; Chamari M; Fatehi F; Zarei M. Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis. Vascular health and risk management. (2008) 4 6 pp1423-1432', '10.2147/vhrm.s3822', 'https://www.dovepress.com/getfile.php?fileID=4319']\n",
      "['9260404', 'Sharif M; Salisbury C; Taylor DJ; Kirwan JR. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis and rheumatism. (1998) 41 7 pp1203-1209', '10.1002/1529-0131(199807)41:7<1203::aid-art9>3.0.co;2-2', '']\n",
      "['9260405', \"Zherebkin VV. The use of acupuncture reflexotherapy in treating patients with rheumatoid arthritis. Likars'ka sprava / Ministerstvo okhorony zdorov'ia UkraiÃàny. (1997)  6 pp175-177\", '10.31640/jvd.7-8.2020(2)', '']\n",
      "['9260406', 'Staalesen Strumse YA; Nordvag BY; Stanghelle JK; R√∏sland M; Winther A; Pajunen PA; Garen T; Flat√∏ B. The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and cold climate. Scandinavian journal of rheumatology. (2009) 38 1 pp28-37', '10.1080/03009740802304549', '']\n",
      "['9260408', 'Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; L√ºscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE; PRECISION Investigators. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. American heart journal. (2009) 157 4 pp606-612', '10.1016/j.ahj.2008.12.014', '']\n",
      "['9260409', 'Ring D; Simmons BP; Hayes M. Continuous passive motion following metacarpophalangeal joint arthroplasty. Journal of hand surgery. (1998) 23 3 pp505-511', '10.1016/s0363-5023(05)80469-1', '']\n",
      "['9260410', 'Ost√∂r AJ. Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis. Clinical rheumatology. (2008) 27 11 pp1343-1353', '10.1007/s10067-008-0964-3', 'http://link.springer.com/content/pdf/10.1007/s10067-008-0964-3.pdf']\n",
      "['9260411', 'Ehlebracht-K√∂nig I; B√∂nisch A; P√∂nicke J. [Fractionated inpatient rehabilitation: results from a randomized controlled trial]. Die Rehabilitation. (2009) 48 1 pp30-38', '10.1055/s-0028-1105913', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0028-1105913.pdf']\n",
      "['9260412', 'Straub RH; Pongratz G; Hirvonen H; Pohjolainen T; Mikkelsson M; Leirisalo-Repo M. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6. Annals of the rheumatic diseases. (2009) 68 4 pp572-578', '10.1136/ard.2008.089458', '']\n",
      "['9260413', 'Daoud A; Gloria CJ; Taningco G; Hammerschlag MR; Weiss S; Gelling M; Roblin PM; Joks R. Minocycline treatment results in reduced oral steroid requirements in adult asthma. Allergy and asthma proceedings. (2008) 29 3 pp286-294', '10.2500/aap.2008.29.3121', '']\n",
      "['9260414', 'Forrest CM; Stoy N; Stone TW; Harman G; Mackay GM; Oxford L; Darlington LG. Adenosine and cytokine levels following treatment of rheumatoid arthritis with dipyridamole. Rheumatology international. (2006) 27 1 pp11-17', '10.1007/s00296-006-0212-6', 'http://link.springer.com/article/10.1007/s00296-006-0212-6/fulltext.html']\n",
      "['9260415', 'Wendling D; Racadot E; Aug√© B; Toussirot E. Soluble intercellular adhesion molecule 1 in spondylarthropathies. Clinical rheumatology. (1998) 17 3 pp202-204', '10.1007/bf01451047', 'http://link.springer.com/article/10.1007/BF01451047/fulltext.html']\n",
      "['9260416', 'Brus HL; van de Laar MA; Taal E; Rasker JJ; Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Annals of the rheumatic diseases. (1998) 57 3 pp146-151', '10.1136/ard.57.3.146', '']\n",
      "['9260417', 'Kim YH; Cho SH; Kim RS. Drainage versus nondrainage in simultaneous bilateral total knee arthroplasties. Clinical orthopaedics and related research. (1998) (347) 347 pp188-193', '10.1097/00003086-199802000-00021', '']\n",
      "['9260418', 'Zukowski TH; Jorgensen RA; Dickson ER; Lindor KD. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. American journal of gastroenterology. (1998) 93 6 pp958-961', '10.1111/j.1572-0241.1998.00287.x', '']\n",
      "['9260419', 'Bernateck M; Becker M; Schwake C; Hoy L; Passie T; Parlesak A; Fischer MJ; Fink M; Karst M. Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Auricular acupuncture and autogenic training in rheumatoid arthritis. Forschende KomplementaÃàrmedizin (2006). (2008) 15 4 pp187-193', '10.1159/000141929', '']\n",
      "['9260421', 'Iqbal MS; Saeed M; Taqi SG. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate. Biological trace element research. (2008) 126 1-3 pp56-64', '10.1007/s12011-008-8184-x', 'http://link.springer.com/article/10.1007/s12011-008-8184-x/fulltext.html']\n",
      "['9260422', 'van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis and rheumatism. (1998) 41 5 pp808-816', '10.1002/1529-0131(199805)41:5<808::aid-art6>3.0.co;2-t', '']\n",
      "['9260423', \"Price EJ; Rigby SP; Clancy U; Venables PJ. A double blind placebo controlled trial of azathioprine in the treatment of primary Sj√∂gren's syndrome. Journal of rheumatology. (1998) 25 5 pp896-899\", '10.1016/s1521-6942(04)00036-1', '']\n",
      "['9260424', 'Pagnotta A; Baron M; Korner-Bitensky N. The effect of a static wrist orthosis on hand function in individuals with rheumatoid arthritis. Journal of rheumatology. (1998) 25 5 pp879-885', '10.1002/art.1790010305', '']\n",
      "['9260425', 'Pope JE; Stevens A; Rooks M. A randomized double blind trial of verbal NSAID education compared to verbal and written education. Journal of rheumatology. (1998) 25 4 pp771-775', '10.1186/isrctn34382782', '']\n",
      "['9260426', 'Walker DJ; Heslop P; Chandler C. Ambulatory activity as an objective and quantifiable measure of nonsteroidal therapy. Journal of rheumatology. (1998) 25 4 pp768-770', '10.1093/rheumatology/37.9.969', 'http://academic.oup.com/rheumatology/article-pdf/37/9/969/18106434/370969.pdf']\n",
      "['9260427', \"Baillet A; Payraud E; Niderprim VA; Nissen MJ; Allenet B; Fran√ßois P; Grange L; Casez P; Juvin R; Gaudin P. A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomized controlled trial. Rheumatology (Oxford, England). (2009) 48 4 pp410-415\", '10.1093/rheumatology/ken511', 'http://academic.oup.com/rheumatology/article-pdf/48/4/410/5064274/ken511.pdf']\n",
      "['9260428', 'Foeldvari I; Szer IS; Zemel LS; Lovell DJ; Giannini EH; Robbins JL; West CR; Steidle G; Krishnaswami S; Bloom BJ. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. Journal of rheumatology. (2009) 36 1 pp174-182', '10.3899/jrheum.080073', '']\n",
      "['9260429', 'Lambert CM; Hurst NP; Forbes JF; Lochhead A; Macleod M; Nuki G. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (Clinical research ed.). (1998) 316 7136 pp965-969', '10.1136/bmj.316.7136.965', '']\n",
      "['9260430', 'Mathieux R; Marotte H; Battistini L; Sarrazin A; Berthier M; Miossec P. Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis. Annals of the rheumatic diseases. (2009) 68 3 pp400-403', '10.1136/ard.2008.094532', '']\n",
      "['9260431', \"List T; Lundeberg T; Lundstr√∂m I; Lindstr√∂m F; Ravald N. The effect of acupuncture in the treatment of patients with primary Sj√∂gren's syndrome. A controlled study. Acta odontologica Scandinavica. (1998) 56 2 pp95-99\", '10.1080/00016359850136058', '']\n",
      "['9260432', 'Bode C; Taal E; Emons PA; Galetzka M; Rasker JJ; Van de Laar MA. Limited results of group self-management education for rheumatoid arthritis patients and their partners: explanations from the patient perspective. Clinical rheumatology. (2008) 27 12 pp1523-1528', '10.1007/s10067-008-0961-6', '']\n",
      "['9260433', 'Koryem HK; Taha KM; Ibrahim IK; Younes LK. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients. International journal of clinical pharmacology research. (1998) 18 1 pp31-37', '10.1016/j.ejr.2017.09.002', '']\n",
      "['9260434', 'Marchesoni A; Fantini F; Battafarano N; Zeni S; Ruiu G; Padula A; Taglione E; Pasero G; Leoni L. Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients. Rheumatology international. (1998) 17 5 pp197-202', '10.1007/s002960050034', 'http://link.springer.com/article/10.1007/s002960050034/fulltext.html']\n",
      "['9260435', 'Hsieh LF; Chen SC; Chuang CC; Chai HM; Chen WS; He YC. Supervised aerobic exercise is more effective than home aerobic exercise in female chinese patients with rheumatoid arthritis. Journal of rehabilitation medicine. (2009) 41 5 pp332-337', '10.2340/16501977-0330', '']\n",
      "['9260436', 'Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN; HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet (London, England). (2009) 373 9671 pp1253-1263', '10.1016/s0140-6736(09)60250-6', '']\n",
      "['9260437', \"Kasama T; Shiozawa F; Isozaki T; Matsunawa M; Wakabayashi K; Odai T; Yajima N; Miwa Y; Negishi M; Ide H. Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sj√∂gren's syndrome. Modern rheumatology / the Japan Rheumatism Association. (2008) 18 5 pp455-459\", '10.3109/s10165-008-0078-4', '']\n",
      "['9260439', 'McKenna F. Diclofenac/misoprostol: the European clinical experience. Journal of rheumatology. Supplement. (1998) 51  pp21-30', '10.2165/00003495-199300451-00007', '']\n",
      "['9260441', 'Drewes AM; Bjerreg√•rd K; Taagholt SJ; Svendsen L; Nielsen KD. Zopiclone as night medication in rheumatoid arthritis. Scandinavian journal of rheumatology. (1998) 27 3 pp180-187', '10.1080/030097498440787', '']\n",
      "['9260442', 'Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines]. TerapevticheskiiÃÜ arkhiv. (1998) 70 5 pp32-37', '10.4236/jibtva.2015.41001', 'http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jibtva.2015.41001']\n",
      "['9260444', 'Shigaki CL; Smarr KL; Gong Y; Donovan-Hanson K; Siva C; Johnson RA; Ge B; Musser DR. Social interactions in an online self-management program for rheumatoid arthritis. Chronic illness. (2008) 4 4 pp239-246', '10.1177/1742395308097862', 'https://journals.sagepub.com/doi/pdf/10.1177/1742395308097862']\n",
      "['9260445', 'Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients. Scandinavian journal of rheumatology. (2009) 38 1 pp6-10', '10.1080/03009740802363768', '']\n",
      "['9260446', 'Katz S J; Russell A S. Are modified-release corticosteroids good therapeutic options for patients with RA?. Journal. (2008) 4 6 pp290-291', '10.1038/ncprheum0805', 'http://www.nature.com/articles/ncprheum0805']\n",
      "['9260447', 'Dass S; Bowman S J; Vital E M; Ikeda K; Pease C T; Hamburger J; Richards A; Rauz S; Emery P. Reduction of fatigue in Sjogren syndrome with rituximab: Results of a randomised, double-blind, placebo-controlled pilot study. Journal. (2008) 67 11 pp1541-1544', '10.1136/ard.2007.083865', '']\n",
      "['9260448', 'Otomo S; Sugita M; Yano T. Visual hallucinations on eye closure after orthopedic surgery under general anesthesia. Journal of anesthesia. (2008) 22 4 pp439-442', '10.1007/s00540-008-0665-8', 'http://link.springer.com/article/10.1007/s00540-008-0665-8/fulltext.html']\n",
      "['9260450', 'Choong PF; Dowsey MM; Stoney JD. Does accurate anatomical alignment result in better function and quality of life? Comparing conventional and computer-assisted total knee arthroplasty. Journal of arthroplasty. (2009) 24 4 pp560-569', '10.1016/j.arth.2008.02.018', '']\n",
      "['9260451', 'Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Pu√©chal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M; Eprodisate for AA Amyloidosis Trial Group. Eprodisate for the treatment of renal disease in AA amyloidosis. New England journal of medicine. (2007) 356 23 pp2349-2360', '10.1056/nejmoa065644', '']\n",
      "['9260452', 'Al-Katma MK; Bissada NF; Bordeaux JM; Sue J; Askari AD. Control of periodontal infection reduces the severity of active rheumatoid arthritis. Journal of clinical rheumatology. (2007) 13 3 pp134-137', '10.1097/rhu.0b013e3180690616', '']\n",
      "['9260453', 'Wright MG. Micro-encapsulated aspirin (Levius) compared with aloxiprin (Palaprin Forte) in the treatment of rheumatoid arthritis. Journal of international medical research. (1976) 4 4 pp272-275', '10.1177/030006057600400410', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057600400410']\n",
      "['9260454', 'Vergunst CE; Gerlag DM; Dinant H; Schulz L; Vinkenoog M; Smeets TJ; Sanders ME; Reedquist KA; Tak PP. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Rheumatology (Oxford, England). (2007) 46 12 pp1773-1778', '10.1093/rheumatology/kem222', 'http://academic.oup.com/rheumatology/article-pdf/46/12/1773/5060920/kem222.pdf']\n",
      "['9260455', 'Blechman WJ; Zane S. Fenoprofen calcium in steroid treated rheumatoid arthritis: efficacy, safety, and steroid-sparing effect. Journal of rheumatology. (1976) 2  pp38-42', '10.1093/rheumatology/kev091.044', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i189/5181763/kev091.044.pdf']\n",
      "['9260456', 'Duff IF; Neukom JE; Himes JE. Fenoprofen in patients with rheumatoid arthritis receiving maintenance gold therapy. Journal of rheumatology. (1976) 2  pp32-37', '10.1177/030006057300100205', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057300100205']\n",
      "['9260457', 'Zuckner J; Auclair RJ. Fenoprofen calcium therapy in rheumatoid arthritis. Journal of rheumatology. (1976) 2 2 pp18-25', '10.1093/rheumatology/15.3.136', 'http://academic.oup.com/rheumatology/article-pdf/15/3/136/5036509/15-3-136-t.pdf']\n",
      "['9260458', 'Nissil√§ M. Osmic acid treatment for rheumatoid synovitis. Annals of clinical research. (1975) 7 3 pp202-204', '10.3109/03009747509165441', '']\n",
      "['9260459', 'Lee P; Anderson JA; Miller J; Webb J; Buchanan WW. [Comparative evaluation of the therapeutic efficiency of flurbiprofene in rheumatoid polyarthritis]. Revue du rhumatisme et des maladies osteÃÅo-articulaires. (1975) 42 6 pp423-429', '10.1016/j.rhum.2016.06.005', '']\n",
      "['9260460', 'Madden J; Shearman CP; Dunn RL; Dastur ND; Tan RM; Nash GB; Rainger GE; Brunner A; Calder PC; Grimble RF. Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation. Nutrition, metabolism, and cardiovascular diseases : NMCD. (2009) 19 4 pp247-252', '10.1016/j.numecd.2008.06.011', '']\n",
      "['9260461', 'Steen KS; Lems WF; Visman IM; de Koning MH; van de Stadt RJ; Twisk JW; de Leest HT; Dijkmans BA; Nurmohamed MT. The effect of Helicobacter pylori eradication on C-reactive protein and the lipid profile in patients with rheumatoid arthritis using chronic NSAIDs. Clinical and experimental rheumatology. (2009) 27 1 pp170', '10.1097/mcg.0b013e3181595b40', '']\n",
      "['9260462', 'Gschwend MH; Erenmemi≈üoƒülu A; Martin W; Tamur U; Kanzik I; Hincal AA. Pharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjects. Arzneimittel-Forschung. (2007) 57 5 pp264-268', '10.1055/s-0031-1296616', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1296616.pdf']\n",
      "['9260463', 'Moore LA; Kaufman MD; Algozzine R; Irish N; Martin M; Posey CR. Adherence to therapy: using an evidence-based protocol. Rehabilitation nursing. (2007) 32 6 pp227-232', '10.1002/j.2048-7940.2007.tb00179.x', '']\n",
      "['9260464', 'Billings R; Burry HC; Grahame R; Berry DJ; Donovan B. A double-blind cross-over trail of Prenazone and aspirin in the management of rheumatoid arthritis. Rheumatology and rehabilitation. (1975) 14 2 pp61-70', '10.1093/rheumatology/14.2.61', 'http://academic.oup.com/rheumatology/article-pdf/14/2/61/5025868/14-2-61.pdf']\n",
      "['9260465', 'T√∫nez I; Feij√≥o M; Huerta G; Montilla P; Mu√±oz E; Ru√≠z A; Collantes E. The effect of infliximab on oxidative stress in chronic inflammatory joint disease. Current medical research and opinion. (2007) 23 6 pp1259-1267', '10.1185/030079907x187955', '']\n",
      "['9260466', 'Fotiades P; Bach GL. [Azur compound as an \"interval drug\" for rheumatic diseases]. Therapie der Gegenwart. (1975) 114 12 pp2132-2141', '10.1136/ard.35.1.83', '']\n",
      "['9260467', 'Mullin GT. Sodium meclofenamate for rheumatoid arthritis: an early double-blind evaluation. Current therapeutic research, clinical and experimental. (1975) 18 6 pp785-792', '10.1185/03007998309111748', '']\n",
      "['9260468', 'Gulati PD; Lamba S; Rizvi SN; Vaishnava H. A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis. Journal of the Association of Physicians of India. (1975) 23 12 pp897-901', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9260469', 'Chen Q; Zhou Z; Shao Y. [Intraoperative imaging to monitor prosthetic fixation for total hip arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2006) 20 12 pp1172-1175', '10.1007/978-981-19-3606-7_26', '']\n",
      "['9260470', 'Highton TC; McArthur AW. Pilot study on the effect of New Zealand green mussel on rheumatoid arthritis. New Zealand medical journal. (1975) 81 535 pp261-262', '10.1111/j.1445-5994.1975.tb03876.x', '']\n",
      "['9260471', 'Hyrich KL; Deighton C; Watson KD; BSRBR Control Centre Consortium; Symmons DP; Lunt M; British Society for Rheumatology Biologics Register. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity. Rheumatology (Oxford, England). (2009) 48 10 pp1323-1327', '10.1093/rheumatology/kep242', 'http://academic.oup.com/rheumatology/article-pdf/48/10/1323/5056033/kep242.pdf']\n",
      "['9260472', \"McDonald DD. Older adults' pain descriptions. Pain management nursing. (2009) 10 3 pp142-148\", '10.1016/j.pmn.2008.09.004', '']\n",
      "['9260475', 'Luzi G; Lagan√† B; Salemi S; Di Rosa R. Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?. Clinica terapeutica. (2009) 160 2 pp121-123', '10.1186/1479-5876-12-77', 'https://link.springer.com/content/pdf/10.1186/1479-5876-12-77.pdf']\n",
      "['9260476', 'Pavelka K; Jarosov‚Äö√†√∂¬¨‚àû K; Such‚Äö√†√∂≈í¬© D; Senolt L; Chroust K; Dusek L; Vencovsk‚Äö√†√∂≈í¬© J. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Annals of the rheumatic diseases. (2009) 68 8 pp1285-1289', '10.1136/ard.2008.090860', '']\n",
      "['9260477', 'van Middendorp H; Geenen R; Sorbi MJ; van Doornen LJ; Bijlsma JW. Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychotherapy and psychosomatics. (2009) 78 3 pp145-151', '10.1159/000206868', 'https://www.karger.com/Article/Pdf/206868']\n",
      "['9260479', 'Tian X; Zhao Y; Li ZG. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis]. Zhonghua yi xue za zhi. (2009) 89 10 pp673-676', '10.7717/peerj.17477/supp-1', '']\n",
      "['9260480', 'Fiehn C; Kessler S. Is the treatment response in elderly patients with rheumatoid arthritis diminished? Results of a prospective study over 3 months. Zeitschrift fuÃàr Rheumatologie. (2009) 68 1 pp69-74', '10.1007/s00393-008-0413-3', 'http://link.springer.com/article/10.1007/s00393-008-0413-3/fulltext.html']\n",
      "['9260482', 'Homer D; Nightingale P; Jobanputra P. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal care. (2009) 7 2 pp78-92', '10.1002/msc.141', '']\n",
      "['9260484', 'Sibbitt WL; Peisajovich A; Michael AA; Park KS; Sibbitt RR; Band PA; Bankhurst AD. Does sonographic needle guidance affect the clinical outcome of intraarticular injections?. Journal of rheumatology. (2009) 36 9 pp1892-1902', '10.3899/jrheum.090013', '']\n",
      "['9260485', 'Louly PG; Medeiros-Souza P; Santos-Neto L. N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough. Clinical therapeutics. (2009) 31 5 pp1007-1013', '10.1016/j.clinthera.2009.05.015', '']\n",
      "['9260488', 'Weinblatt ME; Maier AL; Fraser PA; Coblyn JS. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. Journal of rheumatology. (1998) 25 2 pp238-242', '10.1002/art.1780310203', '']\n",
      "['9260489', 'Bell MJ; Lineker SC; Wilkins AL; Goldsmith CH; Badley EM. A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis. Journal of rheumatology. (1998) 25 2 pp231-237', '10.1016/0197-2456(95)91338-6', '']\n",
      "['9260490', 'Yu Z; Wang L; Gui J. [Accuracy improvement of acetabular component placement using non-image based surgical navigation system]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2007) 21 10 pp1057-1061', '10.21203/rs.3.rs-955508/v1', 'https://www.researchsquare.com/article/rs-955508/v1']\n",
      "['9260491', 'Bj√∏rneboe O; Moen F; Nygaard H; Haavik TK; Svensson B. CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA. Scandinavian journal of rheumatology. (1998) 27 1 pp26-31', '10.1080/030097498441137', '']\n",
      "['9260492', 'Karateev AE; Uspenskiƒ≠ IuP; Pakhomova IG; Nasonov EL. [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate]. TerapevticheskiiÃÜ arkhiv. (2009) 81 6 pp62-67', '10.1016/j.gie.2017.03.999', '']\n",
      "['9260493', 'Sergiets NA; Erov NK. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil]. Terapevticheskii√É√ú arkhiv. (2009) 81 6 pp34-37', '10.14412/1995-4484-2009-139', '']\n",
      "['9260495', 'Schipper LG; Fransen J; Barrera P; den Broeder AA; Van Riel PL. Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?. Rheumatology (Oxford, England). (2009) 48 10 pp1247-1253', '10.1093/rheumatology/kep158', 'http://academic.oup.com/rheumatology/article-pdf/48/10/1247/5048388/kep158.pdf']\n",
      "['9260496', 'Pham T; Roy C; Mariette X; Liot√© F; Durieux P; Ravaud P. Effect of response format for clinical vignettes on reporting quality of physician practice. BMC health services research. (2009) 9  pp128', '10.1186/1472-6963-9-128', 'http://link.springer.com/article/10.1186/1472-6963-9-128/fulltext.html']\n",
      "['9260497', 'de Jonge P; Hadj FB; Boffa D; Zdrojewski C; Dorogi Y; So A; Ruiz J; Stiefel F. Prevention of major depression in complex medically ill patients: preliminary results from a randomized, controlled trial. Psychosomatics. (2009) 50 3 pp227-233', '10.1176/appi.psy.50.3.227', '']\n",
      "['9260498', 'Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate. Arthritis and rheumatism. (2009) 61 7 pp979-987', '10.1002/art.24643', '']\n",
      "['9260499', 'Kremer JM; Bloom BJ; Breedveld FC; Coombs JH; Fletcher MP; Gruben D; Krishnaswami S; Burgos-Vargas R; Wilkinson B; Zerbini CA; Zwillich SH. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis and rheumatism. (2009) 60 7 pp1895-1905', '10.1002/art.24567', '']\n",
      "['9260502', 'Bae SC; Jung WJ; Lee EJ; Yu R; Sung MK. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition. (2009) 28 1 pp56-62', '10.1080/07315724.2009.10719762', '']\n",
      "['9260503', 'Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients. Journal of clinical rheumatology. (2009) 15 4 pp165-171', '10.1097/rhu.0b013e318190f95f', '']\n",
      "['9260504', 'Mohammad A; Kilcoyne A; Bond U; Regan M; Phelan M. Methotrexate information booklet study 2008. Clinical and experimental rheumatology. (2009) 27 4 pp649-650', '10.1097/rhu.0b013e3181b126c1', '']\n",
      "['9260505', 'Burgos RA; Hancke JL; Bertoglio JC; Aguirre V; Arriagada S; Calvo M; C√°ceres DD. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clinical rheumatology. (2009) 28 8 pp931-946', '10.1007/s10067-009-1180-5', 'http://link.springer.com/article/10.1007/s10067-009-1180-5/fulltext.html']\n",
      "['9260506', \"Pullerits R; d'Elia HF; Tarkowski A; Carlsten H. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford, England). (2009) 48 7 pp785-790\", '10.1093/rheumatology/kep079', 'http://academic.oup.com/rheumatology/article-pdf/48/7/785/5061847/kep079.pdf']\n",
      "['9260508', 'Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Annals of the rheumatic diseases. (2009) 68 8 pp1247-1254', '10.1136/ard.2008.089375', '']\n",
      "['9260509', 'Krum H; Swergold G; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. Journal of hypertension. (2009) 27 4 pp886-893', '10.1097/hjh.0b013e328325d831', '']\n",
      "['9260510', 'van der Giesen FJ; van Lankveld WJ; Kremers-Selten C; Peeters AJ; Stern EB; Le Cessie S; Nelissen RG; Vliet Vlieland TP. Effectiveness of two finger splints for swan neck deformity in patients with rheumatoid arthritis: a randomized, crossover trial. Arthritis and rheumatism. (2009) 61 8 pp1025-1031', '10.1002/art.24866', '']\n",
      "['9260512', 'Pincus T; Swearingen CJ; Luta G; Sokka T. Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial. Annals of the rheumatic diseases. (2009) 68 11 pp1715-1720', '10.1136/ard.2008.095539', '']\n",
      "['9260513', 'Schiff M; Pritchard C; Huffstutter JE; Rodriguez-Valverde V; Durez P; Zhou X; Li T; Bahrt K; Kelly S; Le Bars M; Genovese MC. The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial. Annals of the rheumatic diseases. (2009) 68 11 pp1708-1714', '10.1136/ard.2008.099218', '']\n",
      "['9260514', 'Vincken PW; ter Braak BP; van Erkel AR; Bloem RM; van Luijt PA; Coene LN; De Lange S; Bloem JL. Only MR can safely exclude patients from arthroscopy. Skeletal radiology. (2009) 38 10 pp977-982', '10.1007/s00256-009-0679-9', 'http://link.springer.com/article/10.1007/s00256-009-0679-9/fulltext.html']\n",
      "['9260515', 'Konai MS; Vilar Furtado RN; Dos Santos MF; Natour J. Monoarticular corticosteroid injection versus systemic administration in the treatment of rheumatoid arthritis patients: a randomized double-blind controlled study. Clinical and experimental rheumatology. (2009) 27 2 pp214-221', '10.1590/s1807-59322009001200008', 'http://www.scielo.br/pdf/clin/v64n12/08.pdf']\n",
      "['9260516', 'Noskov SM; Snigireva AV; Dolgova LN; Somova MA; Polyakov DP. The use of homeopathic preparation Vozraston in the therapy of patients with rheumatoid arthritis. Bulletin of experimental biology and medicine. (2003) 135 Suppl 7  pp94-95', '10.1023/a:1024703418601', 'https://link.springer.com/article/10.1023/A:1024703418601/fulltext.html']\n",
      "['9260519', 'Gimsa U; Sieper J; Braun J; Mitchison NA. Type II collagen serology: a guide to clinical responsiveness to oral tolerance?. Rheumatology international. (1997) 16 6 pp237-240', '10.1007/bf01375655', 'http://link.springer.com/article/10.1007/BF01375655/fulltext.html']\n",
      "['9260521', 'Alten RE; Zerbini C; Jeka S; Irazoque F; Khatib F; Emery P; Bertasso A; Rabbia M; Caulfield JP. Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy. Annals of the rheumatic diseases. (2010) 69 2 pp364-367', '10.1136/ard.2008.104802', '']\n",
      "['9260522', 'Macedo AM; Oakley SP; Panayi GS; Kirkham BW. Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy. Arthritis and rheumatism. (2009) 61 11 pp1522-1530', '10.1002/art.24563', '']\n",
      "['9260523', 'Vergunst CE; Gerlag DM; von Moltke L; Karol M; Wyant T; Chi X; Matzkin E; Leach T; Tak PP. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study. Arthritis and rheumatism. (2009) 60 12 pp3572-3581', '10.1002/art.24978', '']\n",
      "['9260524', 'Lu C; Zha Q; Chang A; He Y; Lu A. Pattern differentiation in Traditional Chinese Medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis. Journal of alternative and complementary medicine (New York, N.Y.). (2009) 15 9 pp1021-1025', '10.1089/acm.2009.0065', '']\n",
      "['9260529', 'Jackson L; Binning J; Potter J. Plantar pressures in rheumatoid arthritis using prefabricated metatarsal padding. Journal of the American Podiatric Medical Association. (2004) 94 3 pp239-245', '10.7547/0940239', 'http://meridian.allenpress.com/japma/article-pdf/94/3/239/1416565/0940239.pdf']\n",
      "['9260530', \"van Vollenhoven RF; Houbiers JG; Buttgereit F; In 't Hout J; Boers M; Leij S; Kvien TK; Dijkmans BA; Szczepa≈Ñski L; Szombati I; Sierakowski S; Miltenburg AM. The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. Arthritis and rheumatism. (2010) 62 2 pp351-358\", '10.1002/art.27196', '']\n",
      "['9260531', 'Li B; Wen Y; Wu H; Qian Q; Lin X; Zhao H. The effect of tourniquet use on hidden blood loss in total knee arthroplasty. International orthopaedics. (2009) 33 5 pp1263-1268', '10.1007/s00264-008-0647-3', '']\n",
      "['9260532', 'Kogure T; Tatsumi T; Sato H; Oku Y; Kishi D; Ito T. Traditional herbal medicines (Kampo) for patients with rheumatoid arthritis receiving concomitant methotrexate: a preliminary study. Alternative therapies in health and medicine. (2010) 16 1 pp46-51', '10.4137/cmamd.s3136', 'http://journals.sagepub.com/doi/pdf/10.4137/CMAMD.S3136']\n",
      "['9260533', 'Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Kerstens PJ; Nielen MM; Vos K; van Schaardenburg D; Speyer I; Seys PE; Breedveld FC; Allaart CF; Dijkmans BA. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Annals of the rheumatic diseases. (2010) 69 1 pp65-69', '10.1136/ard.2008.097683', '']\n",
      "['9260534', 'Crowley DC; Lau FC; Sharma P; Evans M; Guthrie N; Bagchi M; Bagchi D; Dey DK; Raychaudhuri SP. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. International journal of medical sciences. (2009) 6 6 pp312-321', '10.7150/ijms.6.312', '']\n",
      "['9260535', 'Liu YM; Liu GY; Liu Y; Li SJ; Jia JY; Zhang MQ; Lu C; Zhang YM; Li XN; Yu C. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers. Clinical therapeutics. (2009) 31 8 pp1787-1795', '10.1016/j.clinthera.2009.08.008', '']\n",
      "['9260536', 'Ogrendik M. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Clinical therapeutics. (2009) 31 8 pp1754-1764', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9260537', 'Dietz V; van der Vaart CH; van der Graaf Y; Heintz P; Schraffordt Koops SE. One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine descent: a randomized study. International urogynecology journal. (2010) 21 2 pp209-216', '10.1007/s00192-009-1014-7', '']\n",
      "['9260538', 'Brennan FM; Browne KA; Green PA; Jaspar JM; Maini RN; Feldmann M. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. British journal of rheumatology. (1997) 36 6 pp643-650', '10.1093/rheumatology/36.6.643', 'http://academic.oup.com/rheumatology/article-pdf/36/6/643/18110113/360643.pdf']\n",
      "['9260540', 'Berkhof J; Knol DL; Rijmen F; Twisk JW; Uitdehaag BJ; Boers M. Relapse-remission and remission-relapse switches in rheumatoid arthritis patients were modeled by random effects. Journal of clinical epidemiology. (2009) 62 10 pp1085-1094', '10.1016/j.jclinepi.2008.11.013', '']\n",
      "['9260541', 'Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2009) 49 10 pp1202-1209', '10.1177/0091270009338939', '']\n",
      "['9260542', 'Koffeman EC; Genovese M; Amox D; Keogh E; Santana E; Matteson EL; Kavanaugh A; Molitor JA; Schiff MH; Posever JO; Bathon JM; Kivitz AJ; Samodal R; Belardi F; Dennehey C; van den Broek T; van Wijk F; Zhang X; Zieseniss P; Le T; Prakken BA; Cutter GC; Albani S. Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis and rheumatism. (2009) 60 11 pp3207-3216', '10.1002/art.24916', '']\n",
      "['9260543', 'He YT; Zha QL; Yu JP; Tan Y; Lu C; Lu AP. [Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2008) 6 1 pp32-36', '10.3736/jcim20080107', '']\n",
      "['9260544', 'T√§gil M; Geijer M; Malcus P; Kopylov P. Correlation between range of motion and implant fracture: a 5 year follow-up of 72 joints in 18 patients in a randomized study comparing Swanson and Avanta/Sutter MCP silicone prosthesis. Journal of hand surgery, European volume. (2009) 34 6 pp743-747', '10.1177/1753193409346793', 'https://journals.sagepub.com/doi/pdf/10.1177/1753193409346793']\n",
      "['9260548', 'Lemmey AB; Marcora SM; Chester K; Wilson S; Casanova F; Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis and rheumatism. (2009) 61 12 pp1726-1734', '10.1002/art.24891', '']\n",
      "['9260549', 'Joy MS; Gipson DS; Powell L; MacHardy J; Jennette JC; Vento S; Pan C; Savin V; Eddy A; Fogo AB; Kopp JB; Cattran D; Trachtman H. Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. American journal of kidney diseases. (2010) 55 1 pp50-60', '10.1053/j.ajkd.2009.08.019', '']\n",
      "['9260550', 'Forslind K; Boonen A; Albertsson K; Hafstr√∂m I; Svensson B; Barfot Study Group. Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis. Scandinavian journal of rheumatology. (2009) 38 6 pp431-438', '10.3109/03009740902939376', '']\n",
      "['9260551', 'Lin Q; Gu JR; Li TW; Zhang FC; Lin ZM; Liao ZT; Wei QJ; Cao SY; Li L. Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chinese medical journal. (2009) 122 15 pp1784-1789', '10.1007/s00296-009-1313-9', '']\n",
      "['9260553', 'Herschbach P; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G; Book K; Dinkel A. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychotherapy and psychosomatics. (2010) 79 1 pp31-38', '10.1159/000254903', 'https://www.karger.com/Article/Pdf/254903']\n",
      "['9260554', 'Scardina GA; Ruggieri A; Messina P. Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. Journal of oral science. (2009) 51 3 pp407-410', '10.2334/josnusd.51.407', '']\n",
      "['9260555', 'Nikitina NM; Rebrov AP. The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia. Kardiologiia. (2009) 49 9 pp21-26', '10.20996/1819-6446-2009-5-3-67-70', 'http://www.rpcardio.com/jour/article/viewFile/666/690']\n",
      "['9260557', 'Lin Q; Lin Z; Gu J; Huang F; Li T; Wei Q; Liao Z; Cao S; Jiang Y; Huang J. Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatology international. (2010) 30 3 pp317-323', '10.1007/s00296-009-0958-8', 'http://link.springer.com/article/10.1007/s00296-009-0958-8/fulltext.html']\n",
      "['9260558', 'Sizova LV; Bagirova GG; Chernysheva TV. [Comparative analysis of effectiveness and safety of diclofenac and nimesulide in patients with early rheumatoid arthritis]. Klinicheskaia meditsina. (2009) 87 10 pp62-66', '10.14412/1995-4484-2008-412', '']\n",
      "['9260560', 'Coombs JH; Bloom BJ; Breedveld FC; Fletcher MP; Gruben D; Kremer JM; Burgos-Vargas R; Wilkinson B; Zerbini CA; Zwillich SH. Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases. (2010) 69 2 pp413-416', '10.1136/ard.2009.108159', '']\n",
      "['9260564', \"Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis and rheumatism. (2002) 46 9 pp2301-2309\", '10.1002/art.10495', '']\n",
      "['9260567', 'Leonardsson O; Sernbo I; Carlsson A; Akesson K; Rogmark C. Long-term follow-up of replacement compared with internal fixation for displaced femoral neck fractures: results at ten years in a randomised study of 450 patients. Journal of bone and joint surgery. British volume. (2010) 92 3 pp406-412', '10.1302/0301-620x.92b3.23036', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.92B3.23036']\n",
      "['9260568', 'Vendittoli PA; Ganapathi M; Roy AG; Lusignan D; Lavigne M. A comparison of clinical results of hip resurfacing arthroplasty and 28 mm metal on metal total hip arthroplasty: a randomised trial with 3-6 years follow-up. Hip international. (2010) 20 1 pp1-13', '10.1177/112070001002000101', 'https://journals.sagepub.com/doi/pdf/10.1177/112070001002000101']\n",
      "['9260569', 'Bahadori B; Uitz E; Thonhofer R; Trummer M; Pestemer-Lach I; McCarty M; Krejs GJ. omega-3 Fatty acids infusions as adjuvant therapy in rheumatoid arthritis. JPEN. Journal of parenteral and enteral nutrition. (2010) 34 2 pp151-155', '10.1177/0148607109342130', 'http://journals.sagepub.com/doi/pdf/10.1177/0148607109342130']\n",
      "['9260573', 'Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. Journal of rheumatology. (2010) 37 4 pp692-703', '10.3899/jrheum.090817', '']\n",
      "['9260574', 'Kolahi S; Ghorbanihaghjo A; Alizadeh S; Rashtchizadeh N; Argani H; Khabazzi AR; Hajialilo M; Bahreini E. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clinical biochemistry. (2010) 43 6 pp576-580', '10.1016/j.clinbiochem.2009.12.011', '']\n",
      "['9260575', 'den Uyl D; Geusens PP; van Berkum FN; Houben HH; Jebbink MC; Lems WF. Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial. Clinical rheumatology. (2010) 29 5 pp465-472', '10.1007/s10067-009-1328-3', '']\n",
      "['9260576', 'Taniguchi H; Ebina M; Kondoh Y; Ogura T; Azuma A; Suga M; Taguchi Y; Takahashi H; Nakata K; Sato A; Takeuchi M; Raghu G; Kudoh S; Nukiwa T; Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis. The European respiratory journal. (2010) 35 4 pp821-829', '10.1183/09031936.00005209', '']\n",
      "['9260577', 'Mandel DR; Eichas K; Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC complementary and alternative medicine. (2010) 10  pp1', '10.1186/1472-6882-10-1', 'http://link.springer.com/article/10.1186/1472-6882-10-1/fulltext.html']\n",
      "['9260578', 'Bj√∏rgul K; Novicoff WM; Andersen ST; Brevig K; Thu F; Wiig M; Ahlund O. No differences in outcomes between cemented and uncemented acetabular components after 12-14 years: results from a randomized controlled trial comparing Duraloc with Charnley cups. Journal of orthopaedics and traumatology. (2010) 11 1 pp37-45', '10.1007/s10195-010-0082-2', 'https://link.springer.com/article/10.1007/s10195-010-0082-2/fulltext.html']\n",
      "['9260579', 'Bismuth E; Chevenne D; Czernichow P; Simon D. Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis. Hormone research in p√¶diatrics. (2010) 73 6 pp465-472', '10.1159/000313589', 'https://www.karger.com/Article/Pdf/313589']\n",
      "['9260580', 'Petrov VI; Babaeva AR; Solodenkova KS; Cherevkova EV; Zabolotneva YA; Kachanova MV; Sergeeva SA. Effect of combination of anticytokine preparations anaferon and artrofoon on immune inflammation in rheumatoid arthritis. Bulletin of experimental biology and medicine. (2009) 148 3 pp489-492', '10.1007/s10517-010-0744-3', 'http://link.springer.com/article/10.1007/s10517-010-0744-3/fulltext.html']\n",
      "['9260583', 'Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-P√©rez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalh√£es C; Chavez-Corrales J; Huemer C; Kivitz A; Blanco FJ; Foeldvari I; Hofer M; Horneff G; Huppertz HI; Job-Deslandre C; Loy A; Minden K; Punaro M; Nunez AF; Sigal LH; Block AJ; Nys M; Martini A; Giannini EH; Paediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study Group. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis and rheumatism. (2010) 62 6 pp1792-1802', '10.1002/art.27431', '']\n",
      "['9260586', 'Sokoloviƒá S; Kasumagiƒá S; Mackiƒá-Duroviƒá M; Aganoviƒá-Musinoviƒá I. The impact of Rituximab therapy on the chromosomes of patients with Rheumatoid arthritis. Udruzenje basicnih mediciniskih znanosti [Bosnian journal of basic medical sciences]. (2010) 10 2 pp121-124', '10.17305/bjbms.2010.2706', 'http://www.bjbms.org/ojs/index.php/bjbms/article/download/2706/587']\n",
      "['9260587', 'Bos WH; Dijkmans BA; Boers M; van de Stadt RJ; van Schaardenburg D. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial. Annals of the rheumatic diseases. (2010) 69 3 pp571-574', '10.1136/ard.2008.105767', '']\n",
      "['9260588', 'Shen B; Tang X; Yang J; Li Y; Zhou ZK; Kang PD; Pei FX. [Effects of perioperative administration of celecoxib on pain management and recovery of function after total knee replacement]. Zhonghua wai ke za zhi [Chinese journal of surgery]. (2009) 47 2 pp116-119', '10.1080/17453670710014365', '']\n",
      "['9260589', 'Sheng ZH; Liu YB; Huang YX. Clinical observation on treatment of active rheumatoid arthritis with chinese herbal medicine. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2008) 28 11 pp990-993', '10.1007/bf02934417', 'https://link.springer.com/article/10.1007/BF02934417/fulltext.html']\n",
      "['9260590', 'Ichikawa Y; Saito T; Yamanaka H; Akizuki M; Kondo H; Kobayashi S; Oshima H; Kawai S; Hama N; Yamada H; Mimori T; Amano K; Tanaka Y; Matsuoka Y; Yamamoto S; Matsubara T; Murata N; Asai T; Suzuki Y; Study Group for the Japanese Ministry of Health, Labor and Welfare, Research for Establishment of Therapeutic Guidelines in Early Rheumatoid Arthritis Program. Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later. Journal of rheumatology. (2010) 37 4 pp723-729', '10.3899/jrheum.090776', '']\n",
      "['9260591', '√òstergaard M; Baslund B; Rigby W; Rojkovich B; Jorgensen C; Dawes PT; Wiell C; Wallace DJ; Tamer SC; Kastberg H; Petersen J; Sierakowski S. Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study. Arthritis and rheumatism. (2010) 62 8 pp2227-2238', '10.1002/art.27524', '']\n",
      "['9260592', 'Meireles SM; Jones A; Jennings F; Suda AL; Parizotto NA; Natour J. Assessment of the effectiveness of low-level laser therapy on the hands of patients with rheumatoid arthritis: a randomized double-blind controlled trial. Clinical rheumatology. (2010) 29 5 pp501-509', '10.1007/s10067-009-1347-0', 'http://link.springer.com/article/10.1007/s10067-009-1347-0/fulltext.html']\n",
      "['9260594', 'Cannon CP; Chen C; Curtis SP; Viscusi J; Ahmed T; Dibattiste PM. A comparison of cardiovascular biomarkers in patients treated for three months with etoricoxib, celecoxib, ibuprofen, and placebo. Archives of drug information. (2008) 1 1 pp4-13', '10.1111/j.1753-5174.2007.00002.x', '']\n",
      "['9260595', 'Acosta Pereira A; Torrente Segarra V; Morla Novell R; Rodriguez De La Serna A. Joint lavage of the shoulder. [Spanish]. DOLOR. (2008) 23 3 pp149-156', '10.1016/s1063-4584(09)60530-6', '']\n",
      "['9260596', 'de Jong Z; Munneke M; Kroon HM; van Schaardenburg D; Dijkmans BAC; Hazes JMW; Vliet Vlieland TPM. Long-term follow-up of a high-intensity exercise program in patients with rheumatoid arthritis. Clinical rheumatology. (2009) 28 6 pp663-671', '10.1007/s10067-009-1125-z', '']\n",
      "['9260597', 'Hafstrem I; Albertsson K; Boonen A; Van Der Heijde D; Landewe R; Svensson B. Remission achieved after 2 years treatment with low-dose prednisolone in addition to diseasemodifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: An open 2-year continuation study. Annals of the rheumatic diseases. (2009) 68 4 pp508-513', '10.1136/ard.2008.087833', '']\n",
      "['9260598', 'Wohlrab D; Zeh A; Mendel T; Hein W. Quadsparing approach in total knee arthroplasty. [German]. Operative Orthopadie und Traumatologie. (2009) 21 1 pp25-34', '10.1007/s00064-009-1603-0', 'http://link.springer.com/article/10.1007/s00064-009-1603-0/fulltext.html']\n",
      "['9260599', \"Slifer KJ; DeMore M; Vona-Messersmith N; Pulbrook-Vetter V; Beck M; Dalhquist L; Bellipanni K; Johnson E. Comparison of two brief parent-training interventions for child distress during parent-administered needle procedures. Children's health care. (2009) 38 1 pp23-48\", '10.1080/02739610802615831', '']\n",
      "['9260600', 'Kume K; Amano K; Amano K; Yamada S; Nagata H; Hatta K. The effect of alendronate, a bisphosphonate, for bone destruction prevention in patients with early rheumatoid arthritis [Abstract]. Internal medicine journal. (2009) 39 S2 ppA69', '10.1093/rheumatology/ket468', 'http://academic.oup.com/rheumatology/article-pdf/53/5/900/6897613/ket468.pdf']\n",
      "['9260604', 'Bianchetti AA; Lava SA; Bettinelli A; Rizzi M; Simonetti GD; Bianchetti MG. Preference for formulations containing calcium and vitamin D(3) in childhood: a randomized-sequence, open-label trial. Clinical therapeutics. (2010) 32 6 pp1083-1087', '10.1016/j.clinthera.2010.06.006', '']\n",
      "['9260605', 'Hagell P; Hedin P-J; Meads DM; Nyberg L; McKenna SP. Effects of method of translation of patient-reported health outcome questionnaires: a randomized study of the translation of the rheumatoid arthritis quality of life (RAQoL) instrument for Sweden. Value in health. (2010) 13 4 pp425-430', '10.1111/j.1524-4733.2009.00677.x', '']\n",
      "['9260606', 'Maksymowych WP; Salonen D; Inman RD; Rahman P; Lambert RG; CANDLE Study Group. Low-dose infliximab (3 mg/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a randomized placebo-controlled study. Journal of rheumatology. (2010) 37 8 pp1728-1734', '10.3899/jrheum.091043', '']\n",
      "['9260607', 'Rijckborst V; ter Borg MJ; Cakaloglu Y; Ferenci P; Tabak F; Akdogan M; Simon K; Raptopoulou-Gigi M; Ormeci N; Zondervan PE; Verhey E; van Vuuren AJ; Hansen BE; Janssen HL; PARC Study Group. A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. American journal of gastroenterology. (2010) 105 8 pp1762-1769', '10.1038/ajg.2010.186', 'http://www.nature.com/articles/ajg2010186']\n",
      "['9260608', 'Ichinose M; Fujimoto T; Fukuchi Y. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Respiratory medicine. (2010) 104 2 pp228-236', '10.1016/j.rmed.2009.11.011', '']\n",
      "['9260609', 'van Kuijk AW; Vergunst CE; Gerlag DM; Bresnihan B; Gomez-Reino JJ; Rouzier R; Verschueren PC; van der Leij C; van de Leij C; Maas M; Kraan MC; Tak PP. CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial. Annals of the rheumatic diseases. (2010) 69 11 pp2013-2016', '10.1136/ard.2010.131235', '']\n",
      "['9260610', 'Weinblatt ME; Kavanaugh A; Genovese MC; Musser TK; Grossbard EB; Magilavy DB. An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. New England journal of medicine. (2010) 363 14 pp1303-1312', '10.1056/nejmoa1000500', '']\n",
      "['9260611', 'Yang C; Zhu Q; Han Y; Zhu J; Wang H; Cong R; Zhang D. Minimally-invasive total hip arthroplasty will improve early postoperative outcomes: a prospective, randomized, controlled trial. Irish journal of medical science. (2010) 179 2 pp285-290', '10.1007/s11845-009-0437-y', 'http://link.springer.com/article/10.1007/s11845-009-0437-y/fulltext.html']\n",
      "['9260612', 'Rudd RE; Blanch DC; Gall V; Chibnik LB; Wright EA; Reichmann W; Liang MH; Katz JN. A randomized controlled trial of an intervention to reduce low literacy barriers in inflammatory arthritis management. Patient education and counseling. (2009) 75 3 pp334-339', '10.1016/j.pec.2009.03.001', '']\n",
      "['9260614', 'Leino KA; P√§lve HK; Tiusanen HT; Tuppurainen TT. The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta anaesthesiologica Scandinavica. (2010) 54 7 pp863-870', '10.1111/j.1399-6576.2010.02255.x', '']\n",
      "['9260616', 'Phillpotts C; Creamer P; Andrews T. Teaching medical students about chronic disease: patient-led teaching in rheumatoid arthritis. Musculoskeletal care. (2010) 8 1 pp55-60', '10.1002/msc.169', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.169']\n",
      "['9260620', 'Hurkmans EJ; van den Berg MH; Ronday KH; Peeters AJ; le Cessie S; Vlieland TP. Maintenance of physical activity after Internet-based physical activity interventions in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2010) 49 1 pp167-172', '10.1093/rheumatology/kep285', 'http://academic.oup.com/rheumatology/article-pdf/49/1/167/10652413/kep285.pdf']\n",
      "['9260621', 'Peters MJ; Watt P; Cherry L; Welsh P; Henninger E; Dijkmans BA; McInnes IB; Nurmohamed MT; Sattar N. Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies. Annals of the rheumatic diseases. (2010) 69 9 pp1687-1690', '10.1136/ard.2009.114207', '']\n",
      "['9260622', \"Landew√© RB; Houbiers JG; Van den Bosch F; in't Hout J; Verschueren PC; Meijerink JH; van den Hoogen FH; Masek BA; Bruyn GA; Wouters JM; Voskuyl AE; van Laar JM; Bijlsma JJ; van der Heijde DM; Breedveld FC; van de Putte LB; Miltenburg AM; de Keyser F. Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. Annals of the rheumatic diseases. (2010) 69 9 pp1655-1659\", '10.1136/ard.2009.117234', '']\n",
      "['9260623', 'Goto M. A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis. Modern rheumatology / the Japan Rheumatism Association. (2010) 20 3 pp238-243', '10.3109/s10165-009-0261-2', '']\n",
      "['9260628', 'Cheung R; Cheng TT; Dong Y; Lin HY; Lai K; Lau CS; Feng H; Parsons B. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis. International journal of rheumatic diseases. (2010) 13 2 pp151-157', '10.1111/j.1756-185x.2010.01463.x', '']\n",
      "['9260629', 'Abrahamyan L; Beyene J; Feng J; Chon Y; Willan AR; Schmeling H; Horneff G; Keystone EC; Feldman BM. Response times follow lognormal or gamma distribution in arthritis patients. Journal of clinical epidemiology. (2010) 63 12 pp1363-1369', '10.1016/j.jclinepi.2009.11.019', '']\n",
      "['9260631', 'Huang SC; Wei JC; Wu DJ; Huang YC. Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis. European journal of clinical nutrition. (2010) 64 9 pp1007-1013', '10.1038/ejcn.2010.107', 'https://www.nature.com/articles/ejcn2010107']\n",
      "['9260633', 'Stinson JN; McGrath PJ; Hodnett ED; Feldman BM; Duffy CM; Huber AM; Tucker LB; Hetherington CR; Tse SM; Spiegel LR; Campillo S; Gill NK; White ME. An internet-based self-management program with telephone support for adolescents with arthritis: a pilot randomized controlled trial. Journal of rheumatology. (2010) 37 9 pp1944-1952', '10.3899/jrheum.091327', '']\n",
      "['9260634', 'Rooney T; Edwards CK; Gogarty M; Greenan L; Veale DJ; FitzGerald O; Dayer JM; Bresnihan B. Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. Rheumatology international. (2010) 30 12 pp1571-1580', '10.1007/s00296-009-1191-1', 'http://link.springer.com/article/10.1007/s00296-009-1191-1/fulltext.html']\n",
      "['9260635', 'Gerlag DM; Hollis S; Layton M; Vencovsk‚àöŒ© J; Szekanecz Z; Braddock M; Tak PP; ESCAPE Study Group. Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. Arthritis and rheumatism. (2010) 62 11 pp3154-3160', '10.1002/art.27652', '']\n",
      "['9260636', 'Bu Y; Yu J; Zhao X; Zheng D; Zhang T. [Clinical research of posterior cruciate ligament-retained mobile-bearing total knee arthroplasty in treatment of rheumatoid arthritis]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2010) 24 6 pp696-700', '10.1016/j.arth.2007.11.018', '']\n",
      "['9260637', 'Allen ZA; Shanahan EM; Crotty M. Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment. BMC neurology. (2010) 10 83 pp83', '10.1186/1471-2377-10-83', 'http://link.springer.com/article/10.1186/1471-2377-10-83/fulltext.html']\n",
      "['9260639', 'Siems W; Bresgen N; Brenke R; Siems R; Kitzing M; Harting H; Eckl PM. Pain and mobility improvement and MDA plasma levels in degenerative osteoarthritis, low back pain, and rheumatoid arthritis after infrared A-irradiation. Acta biochimica Polonica. (2010) 57 3 pp313-319', '10.18388/abp.2010_2410', 'https://ojs.ptbioch.edu.pl/index.php/abp/article/download/2410/1027']\n",
      "['9260641', 'Zhang X; Huang Y; Navarro MT; Hisoire G; Caulfield JP. A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis. Journal of clinical pharmacology. (2010) 50 9 pp1031-1038', '10.1177/0091270009357433', 'https://onlinelibrary.wiley.com/doi/pdf/10.1177/0091270009357433']\n",
      "['9260642', \"Pavelka K; Wagenh√§user R; Geirega'i R. [Benorylat in the treatment of chronic progressive polyarthritis]. Zeitschrift fuÃàr Rheumaforschung. (1971) 30 1 pp45-49\", '10.1016/s0140-6736(01)29211-3', '']\n",
      "['9260643', 'Furst DE; Venkatraman MM; Krishna Swamy BG; McGann M; Booth-Laforce C; Ram Manohar P; Sarin R; Mahapatra A; Krishna Kumar PR. Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis. Annals of the rheumatic diseases. (2011) 70 2 pp392-393', '10.1136/ard.2010.136226', '']\n",
      "['9260644', 'Alten R; D√∂ring G; Cutolo M; Gromnica-Ihle E; Witte S; Straub R; Buttgereit F. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone. Journal of rheumatology. (2010) 37 10 pp2025-2031', '10.3899/jrheum.100051', '']\n",
      "['9260645', 'Page TH; Turner JJ; Brown AC; Timms EM; Inglis JJ; Brennan FM; Foxwell BM; Ray KP; Feldmann M. Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood. Journal of immunology (Baltimore, Md. : 1950). (2010) 185 6 pp3694-3701', '10.4049/jimmunol.1000906', 'https://academic.oup.com/jimmunol/article-pdf/185/6/3694/61612614/1000906.pdf']\n",
      "['9260646', 'Hirabayashi Y; Ishii T; Harigae H. Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice. Rheumatology international. (2010) 30 8 pp1041-1048', '10.1007/s00296-009-1095-0', 'http://link.springer.com/content/pdf/10.1007/s00296-009-1095-0.pdf']\n",
      "['9260648', 'Schmitt C; Kuhn B; Zhang X; Kivitz AJ; Grange S. Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis. Clinical pharmacology and therapeutics. (2011) 89 5 pp735-740', '10.1038/clpt.2011.35', '']\n",
      "['9260649', 'Tang TT; Song Y; Ding YJ; Liao YH; Yu X; Du R; Xiao H; Yuan J; Zhou ZH; Liao MY; Yao R; Jevallee H; Shi GP; Cheng X. Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. Journal of lipid research. (2011) 52 5 pp1023-1032', '10.1194/jlr.m010876', '']\n",
      "['9260652', 'Bakker MF; Jacobs JW; Welsing PM; Vreugdenhil SA; van Booma-Frankfort C; Linn-Rasker SP; Ton E; Lafeber FP; Bijlsma JW; Utrecht Arthritis Cohort Study Group. Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study. Annals of the rheumatic diseases. (2011) 70 6 pp1099-1103', '10.1136/ard.2010.137943', '']\n",
      "['9260653', 'Hoff M; Kvien TK; K√§lvesten J; Elden A; Kavanaugh A; Haugeberg G. Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study. BMC musculoskeletal disorders. (2011) 12  pp54', '10.1186/1471-2474-12-54', 'http://link.springer.com/article/10.1186/1471-2474-12-54/fulltext.html']\n",
      "['9260654', 'Reese JB; Somers TJ; Keefe FJ; Mosley-Williams A; Lumley MA. Pain and functioning of rheumatoid arthritis patients based on marital status: is a distressed marriage preferable to no marriage?. Journal of pain. (2010) 11 10 pp958-964', '10.1016/j.jpain.2010.01.003', '']\n",
      "['9260655', 'El-Barbary AM; Hussein MS; Rageh EM; Hamouda HE; Wagih AA; Ismail RG. Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis. Journal of rheumatology. (2011) 38 2 pp229-235', '10.3899/jrheum.100582', '']\n",
      "['9260656', \"Forsblad-d'Elia H; Carlsten H. Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial. Annals of the rheumatic diseases. (2011) 70 6 pp1167-1168\", '10.1136/ard.2010.137133', '']\n",
      "['9260660', 'Sibbitt WL; Band PA; Chavez-Chiang NR; Delea SL; Norton HE; Bankhurst AD. A randomized controlled trial of the cost-effectiveness of ultrasound-guided intraarticular injection of inflammatory arthritis. Journal of rheumatology. (2011) 38 2 pp252-263', '10.3899/jrheum.100866', '']\n",
      "['9260661', 'Engvall IL; Brismar K; Hafstr√∂m I; Tengstrand B. Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study. Scandinavian journal of rheumatology. (2011) 40 3 pp161-168', '10.3109/03009742.2010.523012', '']\n",
      "['9260662', 'Fasanmade AA; Adedokun OJ; Ford J; Hernandez D; Johanns J; Hu C; Davis HM; Zhou H. Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis. European journal of clinical pharmacology. (2009) 65 12 pp1211-1228', '10.1007/s00228-009-0718-4', 'http://link.springer.com/content/pdf/10.1007/s00228-009-0718-4.pdf']\n",
      "['9260664', 'Sostek MB; Fort JG; Estborn L; Vikman K. Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers. Current medical research and opinion. (2011) 27 4 pp847-854', '10.1185/03007995.2011.555756', '']\n",
      "['9260665', 'Lumley MA; Leisen JC; Partridge RT; Meyer TM; Radcliffe AM; Macklem DJ; Naoum LA; Cohen JL; Lasichak LM; Lubetsky MR; Mosley-Williams AD; Granda JL. Does emotional disclosure about stress improve health in rheumatoid arthritis? Randomized, controlled trials of written and spoken disclosure. Pain. (2011) 152 4 pp866-877', '10.1016/j.pain.2011.01.003', '']\n",
      "['9260667', 'Ferrante A; Giardina AR; Ciccia F; Parrinello G; Licata G; Avellone G; Giardina E; Impastato R; Triolo G. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatology international. (2009) 30 2 pp193-198', '10.1007/s00296-009-0935-2', 'http://link.springer.com/article/10.1007/s00296-009-0935-2/fulltext.html']\n",
      "['9260669', 'Langley JM; Risi G; Caldwell M; Gilderman L; Berwald B; Fogarty C; Poling T; Riff D; Baron M; Frenette L; Sheldon E; Collins H; Shepard M; Dionne M; Brune D; Ferguson L; Vaughn D; Li P; Fries L. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. Journal of infectious diseases. (2011) 203 12 pp1729-1738', '10.1093/infdis/jir172', 'http://academic.oup.com/jid/article-pdf/203/12/1729/18063814/jir172.pdf']\n",
      "['9260670', 'Zhang C; Zha QL; He YT; Jiang M; L√º C; L√º AP. The extraarticular symptoms influence ACR response in the treatment of rheumatoid arthritis with biomedicine: a single-blind, randomized, controlled, multicenter trial in 194 patients. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2011) 31 1 pp50-55', '10.1016/s0254-6272(11)60012-5', '']\n",
      "['9260671', 'Shen HB; Bai YJ; Huo ZJ; Li WN; Tang XP. Assessment of clinical effect of therapy combining disease with syndrome on rheumatoid arthritis. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2011) 31 1 pp39-43', '10.1016/s0254-6272(11)60009-5', '']\n",
      "['9260672', 'Dairaghi DJ; Zhang P; Wang Y; Seitz LC; Johnson DA; Miao S; Ertl LS; Zeng Y; Powers JP; Pennell AM; Bekker P; Schall TJ; Jaen JC. Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose. Clinical pharmacology and therapeutics. (2011) 89 5 pp726-734', '10.1038/clpt.2011.33', '']\n",
      "['9260674', 'Hewlett S; Ambler N; Almeida C; Cliss A; Hammond A; Kitchen K; Knops B; Pope D; Spears M; Swinkels A; Pollock J. Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy. Annals of the rheumatic diseases. (2011) 70 6 pp1060-1067', '10.1136/ard.2010.144691', '']\n",
      "['9260675', 'Walker SL; Nicholls PG; Dhakal S; Hawksworth RA; Macdonald M; Mahat K; Ruchal S; Hamal S; Hagge DA; Neupane KD; Lockwood DN. A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment. PLoS neglected tropical diseases. (2011) 5 4 ppe1041', '10.1371/journal.pntd.0001041', '']\n",
      "['9260677', 'Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadala G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Journal of clinical gastroenterology. (2010) 44 9 ppe210-e217', '10.1097/mcg.0b013e3181d88af5', '']\n",
      "['9260678', 'Chan FK; Scheiman JM; Lanas A; Berger M; Li MC; Goldstein JL. Celecoxib versus diclofenac and omeprazole: A randomized controlled trial comparing a composite outcome across the entire GI tract (The condor trial). Gastroenterology. (2010) 138 5 SUPPL. 1 ppS20', '10.1016/s0016-5085(10)60093-5', '']\n",
      "['9260679', 'Li C; Nijat A; Askar M. No clear advantage to use of wound drains after unilateral total knee arthroplasty: a prospective randomized, controlled trial. Journal of arthroplasty. (2011) 26 4 pp519-522', '10.1016/j.arth.2010.05.031', '']\n",
      "['9260680', 'Reid A; Brady A; Blake C; Mongey AB; Veale DJ; FitzGerald O; Cusack T. Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFŒ± therapy medication. BMC musculoskeletal disorders. (2011) 12  pp11', '10.1186/1471-2474-12-11', 'http://link.springer.com/article/10.1186/1471-2474-12-11/fulltext.html']\n",
      "['9260681', 'Abufarag A; Aigner S; Czeloth N; D√É¬§lken B; Koch H; Niemann G; Uherek C; Osterroth F; Wartenberg-Demand A; Haefeli WE; Schopf RC; Enk A. Selective activation of naturally occurring regulatory T cells (Tregs) by the monoclonal antibody BT-061 as a novel therapeutic opportunity in psoriasis: early clinical results after single doses. Journal of investigative dermatology. (2010) 130 Suppl 2 ppS64', '10.1182/blood.v116.21.3060.3060', 'https://ashpublications.org/blood/article/116/21/3060/112043/BT062-An-AntibodyDrug-Conjugate-Directed-Against']\n",
      "['9260682', \"Spiteri A; Mitra M; Menon G; Casini A; Adams D; Ricketts C; Hickling P; Fuller ET; Fuller JR. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sj√É¬∂gren's syndrome. Journal fran√É¬ßais d'ophtalmologie. (2007) 30 4 pp357-364\", '10.1016/s0181-5512(07)89605-7', '']\n",
      "['9260684', 'Ogrendik M; Karagoz N. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial. Postgraduate medicine. (2011) 123 5 pp220-227', '10.3810/pgm.2011.09.2478', '']\n",
      "['9260686', 'Tokem Y; Argon G; Keser G. Case management in care of Turkish rheumatoid arthritis patients. Rehabilitation nursing. (2011) 36 5 pp205-213', '10.1002/j.2048-7940.2011.tb00197.x', '']\n",
      "['9260688', 'Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; H√∏rslev-Petersen K; J√∏rgensen A; Hvid M; Deleuran B. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Clinical and experimental rheumatology. (2011) 29 4 pp689-692', '10.3109/03009742.2013.823517', '']\n",
      "['9260689', 'Zayat AS; Conaghan PG; Sharif M; Freeston JE; Wenham C; Hensor EM; Emery P; Wakefield RJ. Do non-steroidal anti-inflammatory drugs have a significant effect on detection and grading of ultrasound-detected synovitis in patients with rheumatoid arthritis? Results from a randomised study. Annals of the rheumatic diseases. (2011) 70 10 pp1746-1751', '10.1136/annrheumdis-2011-200017', '']\n",
      "['9260690', 'Yazici Y; Moniz Reed D; Klem C; Rosenblatt L; Wu G; Kremer JM. Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomized clinical trial data. Clinical and experimental rheumatology. (2011) 29 3 pp494-499', '10.1093/rheumatology/kew144.014', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i97/5079008/kew144.014.pdf']\n",
      "['9260692', 'Zhang C; Jiang M; Lu A. A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial. Trials. (2011) 12  pp137', '10.1186/1745-6215-12-137', 'http://link.springer.com/article/10.1186/1745-6215-12-137/fulltext.html']\n",
      "['9260693', 'Pineda Mde L; Thompson SF; Summers K; de Leon F; Pope J; Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical science monitor. (2011) 17 6 ppCR347-54', '10.12659/msm.881808', '']\n",
      "['9260694', 'Tynj√§l√§ P; V√§h√§salo P; Tarkiainen M; Kr√∂ger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Annals of the rheumatic diseases. (2011) 70 9 pp1605-1612', '10.1136/ard.2010.143347', '']\n",
      "['9260695', 'Sj√∂quist ES; Brodin N; Lampa J; Jensen I; Opava CH; PARA study group. Physical activity coaching of patients with rheumatoid arthritis in everyday practice: a long-term follow-up. Musculoskeletal care. (2011) 9 2 pp75-85', '10.1002/msc.199', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.199']\n",
      "['9260697', 'Burmester GR; Feist E; Sleeman MA; Wang B; White B; Magrini F. Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-Œ±, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Annals of the rheumatic diseases. (2011) 70 9 pp1542-1549', '10.1136/ard.2010.146225', '']\n",
      "['9260699', 'Antoniades C; Demosthenous M; Tousoulis D; Antonopoulos AS; Vlachopoulos C; Toutouza M; Marinou K; Bakogiannis C; Mavragani K; Lazaros G; Koumallos N; Triantafyllou C; Lymperiadis D; Koutsilieris M; Stefanadis C. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension. (2011) 58 1 pp93-98', '10.1161/hypertensionaha.110.168245', '']\n",
      "['9260701', 'Breedland I; van Scheppingen C; Leijsma M; Verheij-Jansen NP; van Weert E. Effects of a group-based exercise and educational program on physical performance and disease self-management in rheumatoid arthritis: a randomized controlled study. Physical therapy. (2011) 91 6 pp879-893', '10.2522/ptj.20090010', 'http://academic.oup.com/ptj/article-pdf/91/6/879/17503855/ptj0879.pdf']\n",
      "['9260704', 'Roux CH; Breuil V; Valerio L; Amoretti N; Brocq O; Albert C; Grisot C; Allam Y; Chevalier P; Pradier C; Euller-Ziegler L. Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study. Journal of rheumatology. (2011) 38 6 pp1009-1011', '10.3899/jrheum.100828', '']\n",
      "['9260705', 'Gabay C; Bel M; Combescure C; Ribi C; Meier S; Posfay-Barbe K; Grillet S; Seebach JD; Kaiser L; Wunderli W; Guerne PA; Siegrist CA; H1N1 Study Group. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis and rheumatism. (2011) 63 6 pp1486-1496', '10.1002/art.30325', '']\n",
      "['9260708', 'Genovese MC; Cohen SB; Wofsy D; Weinblatt ME; Firestein GS; Brahn E; Strand V; Baker DG; Tong SE. A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis. Journal of rheumatology. (2011) 38 5 pp846-854', '10.3899/jrheum.100602', '']\n",
      "['9260709', 'Bao J; Yue T; Liu W; Zhang Q; Zhou L; Xu HJ; Dai SM. Secondary failure to treatment with recombinant human IL-1 receptor antagonist in Chinese patients with rheumatoid arthritis. Clinical rheumatology. (2011) 30 5 pp697-701', '10.1007/s10067-010-1654-5', 'http://link.springer.com/article/10.1007/s10067-010-1654-5/fulltext.html']\n",
      "['9260710', 'Jahangier ZN; Jacobs JW; Swen WA; Moolenburgh JD; Bruyn GA; Griep EN; Bijlsma JW. Can simple ultrasonography predict the clinical effect of intra-articular injection therapy of the knee joint?. Clinical rheumatology. (2011) 30 6 pp749-755', '10.1007/s10067-010-1614-0', 'http://link.springer.com/article/10.1007/s10067-010-1614-0/fulltext.html']\n",
      "['9260711', 'Brien S; Lachance L; Prescott P; McDermott C; Lewith G. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford, England). (2011) 50 6 pp1070-1082', '10.1093/rheumatology/keq234', 'http://academic.oup.com/rheumatology/article-pdf/50/6/1070/5048466/keq234.pdf']\n",
      "['9260712', 'Strasser B; Leeb G; Strehblow C; Schobersberger W; Haber P; Cauza E. The effects of strength and endurance training in patients with rheumatoid arthritis. Clinical rheumatology. (2011) 30 5 pp623-632', '10.1007/s10067-010-1584-2', 'http://link.springer.com/article/10.1007/s10067-010-1584-2/fulltext.html']\n",
      "['9260713', 'Roth T; Price JM; Amato DA; Rubens RP; Roach JM; Schnitzer TJ. The effect of eszopiclone in patients with Insomnia and coexisting rheumatoid arthritis: A pilot study. Primary care companion to the Journal of clinical psychiatry. (2009) 11 6 pp292-301', '10.4088/pcc.08m00749bro', '']\n",
      "['9260714', 'Binsfeld H; Szczepanski L; Waechter S; Richarz U; Sabatowski R. A Randomized Study to Demonstrate Noninferiority of Once-Daily OROS Hydromorphone with Twice-Daily Sustained-Release Oxycodone for Moderate to Severe Chronic Noncancer Pain. Pain practice. (2010) 10 5 pp404-415', '10.1111/j.1533-2500.2009.00342.x', '']\n",
      "['9260715', 'Cojocaru L; Rusali A; Craiu E; Suta M. The efficacy and safety of simvastatin in patients with rheumatoid arthritis. Archives of the Balkan Medical Union. (2010) 45 1 pp49-53', '10.1155/2013/326258', 'http://downloads.hindawi.com/journals/ad/2013/326258.pdf']\n",
      "['9260716', 'Ding F; Zhang Y; Chang Y. Effects of Sanwushaoxie decoction on IL-18, TNF-alpha, IL-4 and IL-10 in patients with rheumatoid arthritis. [Chinese]. Zhongguo Zhongyao Zazhi. (2010) 35 6 pp790-793', '10.4268/cjcmm20100629', '']\n",
      "['9260718', 'Turiel M; Tomasoni L; Sitia S; Cicala S; Gianturco L; Ricci C; Atzeni F; De Gennaro Colonna V; Longhi M; Sarzi-Puttini P. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovascular therapeutics. (2010) 28 5 ppe53-e64', '10.1111/j.1755-5922.2009.00119.x', '']\n",
      "['9260719', 'Zhou XY; Wang L; Yu W; Jiang Q; Wang P; Tang XP. [One-year evaluation of radiographic progress in patients with rheumatoid arthritis treated by Qingre Huoxue decoction]. Zhongguo gu shang [China journal of orthopaedics and traumatology]. (2011) 24 12 pp992-996', '10.1007/s11655-011-0793-0', 'http://link.springer.com/article/10.1007/s11655-011-0793-0/fulltext.html']\n",
      "['9260721', 'Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Lo√´t X; Combe B; Dougados M; Mariette X; Taoufik Y. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 12 pp3692-3701', '10.1002/art.30599', '']\n",
      "['9260723', 'Pincus T. The clinical efficacy of 3 mg/day prednisone in patients with rheumatoid arthritis: evidence from a randomized, double-blind, placebo-controlled withdrawal clinical trial. Clinical and experimental rheumatology. (2011) 29 5 Suppl 68 ppS73-6', '10.1136/ard.2008.095539', '']\n",
      "['9260724', 'Ndosi M; Lewis M; Hale C; Quinn H; Ryan S; Emery P; Bird H; Hill J. A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multi-centre study. International journal of nursing studies. (2011) 48 8 pp995-1001', '10.1016/j.ijnurstu.2011.01.010', '']\n",
      "['9260725', 'Rocca A; Compagna R; De Vito D; Della Corte GA; Bianco T; Amato B. Compression therapy in chronic venous disease. European Surgical Research. Conference: 24th National Congress of the Italian Society of Young Surgeon, SPIGC 2011 Naples Italy. Conference Start: 20111013 Conference End: 20111016. Conference Publication: (var.pagings). (2012) 49 3-4 pp140', '10.1159/000341743', 'https://www.karger.com/Article/Pdf/341743']\n",
      "['9260726', 'Ruperto N; Brunner HI; Quartier P; Constantin T; Wulffraat N; Horneff G; Brik R; McCann L; Kasapcopur O; Rutkowska-Sak L; Schneider R; Berkun Y; Calvo I; Erguven M; Goffin L; Hofer M; Kallinich T; Oliveira SK; Uziel Y; Viola S; Nistala K; Wouters C; Cimaz R; Ferrandiz MA; Flato B; Gamir ML; Kone-Paut I; Grom A; Magnusson B; Ozen S; Sztajnbok F; Lheritier K; Abrams K; Kim D; Martini A; Lovell DJ; PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. New England journal of medicine. (2012) 367 25 pp2396-2406', '10.1056/nejmoa1205099', '']\n",
      "['9260727', 'De Benedetti F; Brunner HI; Ruperto N; Kenwright A; Wright S; Calvo I; Cuttica R; Ravelli A; Schneider R; Woo P; Wouters C; Xavier R; Zemel L; Baildam E; Burgos-Vargas R; Dolezalova P; Garay SM; Merino R; Joos R; Grom A; Wulffraat N; Zuber Z; Zulian F; Lovell D; Martini A; PRINTO; PRCSG. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. New England journal of medicine. (2012) 367 25 pp2385-2395', '10.1056/nejmoa1112802', '']\n",
      "['9260729', 'Tanaka Y; Maeshima K; Maeshima Y; Yamaoka K. In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis. Annals of the rheumatic diseases. (2012) 71 Suppl 2  ppi70-4', '10.1136/annrheumdis-2011-200595', '']\n",
      "['9260730', 'den Uyl D; van Raalte DH; Nurmohamed MT; Lems WF; Bijlsma JW; Hoes JN; Dijkmans BA; Diamant M. Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. Arthritis and rheumatism. (2012) 64 3 pp639-646', '10.1002/art.33378', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.33378']\n",
      "['9260731', \"Liu Y Wu E Q Bensimon A G Fan C P S Bao Y Ganguli A Yang M Cifaldi M and Mulani P. Cost per responder associated with biologic therapies for crohn's disease, psoriasis, and rheumatoid arthritis. . (2012) 29 7 pp620-634\", '10.1007/s12325-012-0035-7', '']\n",
      "['9260733', 'Liu YM; Chen Q; Zhang MQ; Liu GY; Jia JY; Pu HH; Liu Y; Hu CY; Lu C; Wang W; Cao WE; Song B; Song YX; Zhu JM; Yu C. A parallel design study to assess the bioequivalence of generic and branded hydroxychloroquine sulfate tablets in healthy volunteers. Arzneimittel-Forschung. (2012) 62 12 pp644-649', '10.1055/s-0032-1329962', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1329962.pdf']\n",
      "['9260735', \"Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD; UK Dermatology Clinical Trials Network‚Äôs STOP GAP Trial Team. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials. (2012) 13  pp51\", '10.1186/1745-6215-13-51', 'http://link.springer.com/article/10.1186/1745-6215-13-51/fulltext.html']\n",
      "['9260738', 'Dobie I; Bennett D; Spence DJ; Murray JM; Beverland DE. Periarticular local anesthesia does not improve pain or mobility after THA. Clinical orthopaedics and related research. (2012) 470 7 pp1958-1965', '10.1007/s11999-012-2241-7', '']\n",
      "['9260739', 'Strand V; Sharp V; Koenig AS; Park G; Shi Y; Wang B; Zack DJ; Fiorentino D. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Annals of the rheumatic diseases. (2012) 71 7 pp1143-1150', '10.1136/annrheumdis-2011-200387', '']\n",
      "['9260740', \"Krausz S; Boumans MJ; Gerlag DM; Lufkin J; van Kuijk AW; Bakker A; de Boer M; Lodde BM; Reedquist KA; Jacobson EW; O'Meara M; Tak PP. Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 6 pp1750-1755\", '10.1002/art.34339', '']\n",
      "['9260741', 'Verbruggen G; Wittoek R; Vander Cruyssen B; Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Annals of the rheumatic diseases. (2012) 71 6 pp891-898', '10.1136/ard.2011.149849', '']\n",
      "['9260744', 'Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD. Effect of long-term, low-dose erythromycin on pulmonary\\nexacerbations among patients with non-cystic fibrosis\\nbronchiectasis: the BLESS randomized controlled trial. JAMA: journal of the american medical association. (2013) 309 12 pp1260-1267', '10.1001/jama.2013.2290', '']\n",
      "['9260745', 'Dirven L; van den Broek M; van Groenendael JH; de Beus WM; Kerstens PJ; Huizinga TW; Allaart CF; Lems WF. Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC musculoskeletal disorders. (2012) 13  pp125', '10.1186/1471-2474-13-125', 'http://link.springer.com/article/10.1186/1471-2474-13-125/fulltext.html']\n",
      "['9260746', 'Paudyal P; Perry M; Child S; Gericke CA. Evaluation of a patient-initiated review system in rheumatoid arthritis: an implementation trial protocol. BMC musculoskeletal disorders. (2012) 13  pp120', '10.1186/1471-2474-13-120', 'http://link.springer.com/article/10.1186/1471-2474-13-120/fulltext.html']\n",
      "['9260747', 'van Vilsteren M; Boot CR; Steenbeek R; van Schaardenburg D; Voskuyl AE; Anema JR. An intervention program with the aim to improve and maintain work productivity for workers with rheumatoid arthritis: design of a randomized controlled trial and cost-effectiveness study. BMC public health. (2012) 12  pp496', '10.1186/1471-2458-12-496', 'http://link.springer.com/article/10.1186/1471-2458-12-496/fulltext.html']\n",
      "['9260751', 'Zwolak R; Majdan M; Sk√≥rski M; Chrapko B. Efficacy of radiosynoviorthesis and its impact on chosen inflammatory markers. Rheumatology international. (2012) 32 8 pp2339-2344', '10.1007/s00296-011-1956-1', '']\n",
      "['9260752', 'Parulekar AD; Boomer JS; Patterson BM; Yin-Declue H; Deppong CM; Wilson BS; Jarjour NN; Castro M; Green JM. A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation. American journal of respiratory and critical care medicine. (2013) 187 5 pp494-501', '10.1164/rccm.201207-1205oc', '']\n",
      "['9260753', 'de Brouwer SJ; Kraaimaat FW; Sweep FC; Donders RT; Eijsbouts A; van Koulil S; van Riel PL; Evers AW. Psychophysiological responses to stress after stress management training in patients with rheumatoid arthritis. PloS one. (2011) 6 12 ppe27432', '10.1371/journal.pone.0027432', '']\n",
      "['9260754', 'Dinkel A; Herschbach P; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G; Book K. Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases. Behavioral medicine (Washington, D.C.). (2012) 38 1 pp1-5', '10.1080/08964289.2011.640364', '']\n",
      "['9260755', 'Zangi HA; Mowinckel P; Finset A; Eriksson LR; H√∏ystad T√ò; Lunde AK; Hagen KB. A mindfulness-based group intervention to reduce psychological distress and fatigue in patients with inflammatory rheumatic joint diseases: a randomised controlled trial. Annals of the rheumatic diseases. (2012) 71 6 pp911-917', '10.1136/annrheumdis-2011-200351', '']\n",
      "['9260756', 'Mohd LG; Wafai ZA; Saleem SM. Variability of plasma concentrations of Amitriptyline and its metabolite Nortriptyline by blood pressure alterations in patients of depression: a PK/PD model. Pharmacologyonline. (2012) 1  pp1-9', '10.1097/00007691-198703000-00002', '']\n",
      "['9260758', 'Pope J; Thorne JC; Haraoui BP; Psaradellis E; Sampalis J. Do patients with active RA have differences in disease activity and perceptions if anti-TNF na√Øve versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial. Medical science monitor. (2012) 18 8 ppPI17-20', '10.12659/msm.883250', '']\n",
      "['9260761', 'Angel K; Provan SA; Fagerhol MK; Mowinckel P; Kvien TK; Atar D. Effect of 1-year anti-TNF-Œ± therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. American journal of hypertension. (2012) 25 6 pp644-650', '10.1038/ajh.2012.12', 'http://academic.oup.com/ajh/article-pdf/25/6/644/17460057/25_6_644.pdf']\n",
      "['9260762', 'Gupta P; Alvey C; Wang R; Dowty ME; Fahmi OA; Walsky RL; Riese RJ; Krishnaswami S. Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data. British journal of clinical pharmacology. (2012) 74 1 pp109-115', '10.1111/j.1365-2125.2012.04168.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.2012.04168.x']\n",
      "['9260763', 'Sharpe L; Schrieber L. A blind randomized controlled trial of cognitive versus behavioral versus cognitive-behavioral therapy for patients with rheumatoid arthritis. Psychotherapy and psychosomatics. (2012) 81 3 pp145-152', '10.1159/000332334', 'https://www.karger.com/Article/Pdf/332334']\n",
      "['9260764', 'Khagram R; Dave A R; Mehta C S; Shukla V S. Clinical effect of matra basti and vatari guggulu in the management of amavata (rheumatoid arthritis). AYU. (2010) 31 3 pp343-350', '10.4103/0974-8520.77167', '']\n",
      "['9260765', \"Donatsky O; Johnsen T; Holmstrup P; Bertram U. Effect of Saliment¬Æ on parotid salivary gland secretion and on xerostomia caused by Sj√∂gren's syndrome. Scandinavian journal of dental research. (1982) 90 2 pp157-162\", '10.1111/j.1600-0722.1982.tb01539.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0722.1982.tb01539.x']\n",
      "['9260766', 'Pourahmad M; Rahiminejad M; Fadaei S; Kashafi H. Effects of camel thorn distillate on recurrent oral aphthous lesions. Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology]. (2010) 8 5 pp348-353', '10.1111/j.1610-0387.2010.07316.x', '']\n",
      "['9260767', \"Belch JJ; Ansell D; Madhok R; O'Dowd A; Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Annals of the rheumatic diseases. (1988) 47 2 pp96-104\", '10.1136/ard.47.2.96', '']\n",
      "['9260768', 'Aiyappan V; Catcheside P; Mcevoy D; Harmer L; Stadler D; Deacon N; et al. A randomised placebo controlled cross-over trial of airway\\nhumidification in patients with primary sjogrens syndrome (PSS) and\\nits effect on sleep apnea and sleep quality [Abstract]. Sleep and biological rhythms. (2013) 11 Suppl S2 pp48', '10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a6160', '']\n",
      "['9260769', 'Everett BM; Pradhan AD; Solomon DH; Paynter N; Macfadyen J; Zaharris E; Gupta M; Clearfield M; Libby P; Hasan AA; Glynn RJ; Ridker PM. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. American heart journal. (2013) 166 2 pp199-207.e15', '10.1016/j.ahj.2013.03.018', '']\n",
      "['9260774', 'Genovese MC; Lee E; Satterwhite J; Veenhuizen M; Disch D; Berclaz PY; Myers S; Sides G; Benichou O. A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate. Annals of the rheumatic diseases. (2013) 72 9 pp1453-1460', '10.1136/annrheumdis-2012-202864', '']\n",
      "['9260775', 'Boers M; Buttgereit F. A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis. Rheumatology (Oxford, England). (2013) 52 8 pp1435-1437', '10.1093/rheumatology/ket145', 'http://academic.oup.com/rheumatology/article-pdf/52/8/1435/5069518/ket145.pdf']\n",
      "['9260776', 'McElhaney JE; Beran J; Devaster JM; Esen M; Launay O; Leroux-Roels G; Ruiz-Palacios GM; van Essen GA; Caplanusi A; Claeys C; Durand C; Duval X; El Idrissi M; Falsey AR; Feldman G; Frey SE; Galtier F; Hwang SJ; Innis BL; Kovac M; Kremsner P; McNeil S; Nowakowski A; Richardus JH; Trofa A; Oostvogels L; Influence65 study group. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. The Lancet. Infectious diseases. (2013) 13 6 pp485-496', '10.1016/s1473-3099(13)70046-x', '']\n",
      "['9260777', 'Meeus M; Ickmans K; Struyf F; Hermans L; Van Noesel K; Oderkerk J; Declerck LS; Moorkens G; Hans G; Grosemans S; Nijs J. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial. Pain physician. (2013) 16 2 ppE61-70', '10.36076/ppj.2013/16/e61', '']\n",
      "['9260778', 'Srikesavan CS; Shay B; Robinson DB; Szturm T. Task-oriented training with computer gaming in people with rheumatoid arthritisor osteoarthritis of the hand: study protocol of a randomized controlled pilot trial. Trials. (2013) 14  pp69', '10.1186/1745-6215-14-69', 'https://link.springer.com/content/pdf/10.1186/1745-6215-14-69.pdf']\n",
      "['9260779', 'Zhao SS; Wang J. [Short-term clinical observation on compound Xiatianwu combined with methotrexate in treating rheumatoid arthritis]. Zhongguo Zhong yao za zhi [China journal of Chinese materia medica]. (2012) 37 23 pp3664-3666', '10.4268/cjcmm20122332', '']\n",
      "['9260781', \"Kingsbury SR; Tharmanathan P; Adamson J; Arden NK; Birrell F; Cockayne S; Dickson J; Doherty M; Dziedzic KS; Grainger A; Hewitt CE; O'Neill TW; Scott DL; Vincent TL; Wakefield RJ; Watt FE; Torgerson DJ; Conaghan PG. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial. Trials. (2013) 14  pp64\", '10.1186/1745-6215-14-64', 'https://link.springer.com/content/pdf/10.1186/1745-6215-14-64.pdf']\n",
      "['9260782', 'Derendorf H; Ruebsamen K; Clarke L; Schaeffler A; Kirwan JR. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis. Journal of clinical pharmacology. (2013) 53 3 pp326-333', '10.1177/0091270012444315', '']\n",
      "['9260784', 'Doyle MK; Rahman MU; Frederick B; Birbara CA; de Vries D; Toedter G; Wu X; Chen D; Ranganath VK; Westerman ME; Furst DE. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial. Rheumatology (Oxford, England). (2013) 52 7 pp1214-1219', '10.1093/rheumatology/kes381', 'http://academic.oup.com/rheumatology/article-pdf/52/7/1214/17387967/kes381.pdf']\n",
      "['9260785', 'Chen Z; Li XP; Li ZJ; Xu L; Li XM. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. International immunopharmacology. (2013) 15 3 pp474-477', '10.1016/j.intimp.2013.01.021', '']\n",
      "['9260786', 'Devogelaer JP; Sambrook P; Reid DM; Goemaere S; Ish-Shalom S; Collette J; Su G; Bucci-Rechtweg C; Papanastasiou P; Reginster JY. Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. Rheumatology (Oxford, England). (2013) 52 6 pp1058-1069', '10.1093/rheumatology/kes410', 'http://academic.oup.com/rheumatology/article-pdf/52/6/1058/5198208/kes410.pdf']\n",
      "['9260787', 'Genovese MC; Bojin S; Biagini IM; Mociran E; Cristei D; Mirea G; Georgescu L; Sloan-Lancaster J. Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. Arthritis and rheumatism. (2013) 65 4 pp880-889', '10.1002/art.37820', '']\n",
      "['9260791', 'Engvall IL; Svensson B; Boonen A; van der Heijde D; Lerner UH; Hafstr√∂m I; BARFOT study group. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. Rheumatology (Oxford, England). (2013) 52 4 pp733-742', '10.1093/rheumatology/kes369', 'http://academic.oup.com/rheumatology/article-pdf/52/4/733/5085295/kes369.pdf']\n",
      "['9260792', 'Genovese MC; Fleischmann RM; Greenwald M; Satterwhite J; Veenhuizen M; Xie L; Berclaz PY; Myers S; Benichou O. Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Annals of the rheumatic diseases. (2013) 72 9 pp1461-1468', '10.1136/annrheumdis-2012-202775', '']\n",
      "['9260796', 'Angadi DS; Brown S; Crawfurd EJ. Cemented polyethylene and cementless porous-coated acetabular components have similar outcomes at a mean of seven years after total hip replacement: a prospective randomised study. Journal of bone and joint surgery. British volume. (2012) 94 12 pp1604-1610', '10.1302/0301-620x.94b12.28060', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.94B12.28060']\n",
      "['9260797', 'Westhovens R; Keyser FD; Rekalov D; Nasonov EL; Beetens J; Van der Aa A; Wigerinck P; Namour F; Vanhoutte F; Durez P. Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial. Annals of the rheumatic diseases. (2013) 72 5 pp741-744', '10.1136/annrheumdis-2012-202221', '']\n",
      "['9260802', 'Chen XX; Dai Q; Huang AB; Wu HX; Zhao DB; Li XF; Hu SX; Yang NP; Tao Y; Xu JH; Jiang LD; Bao CD. A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII: fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis. Clinical rheumatology. (2013) 32 1 pp99-108', '10.1007/s10067-012-2096-z', 'http://link.springer.com/article/10.1007/s10067-012-2096-z/fulltext.html']\n",
      "['9260803', 'Tarakci E; Yeldan I; Baydogan SN; Olgar S; Kasapcopur O. Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. Journal of rehabilitation medicine. (2012) 44 11 pp962-967', '10.2340/16501977-1051', '']\n",
      "['9260806', 'Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T; Japan Biological Agent Integrated Consortium (JBASIC). A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study. Annals of the rheumatic diseases. (2013) 72 2 pp310-312', '10.1136/annrheumdis-2012-201804', '']\n",
      "['9260807', 'Sunil SA; Srikanth MV; Rao NS; Murthy KV. Chronotherapeutic drug delivery from indomethacin compression coated tablets for early morning pain associated rheumatoid arthritis. Current drug delivery. (2013) 10 1 pp109-121', '10.2174/1567201811310010017', '']\n",
      "['9260809', \"Nordstr√∂m D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. Journal of rheumatology. (2012) 39 10 pp2008-2011\", '10.3899/jrheum.111549', '']\n",
      "['9260810', 'Kellner HL; Li C; Essex MN. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial. Current medical research and opinion. (2012) 28 9 pp1537-1545', '10.1185/03007995.2012.717528', '']\n",
      "['9260821', 'Hjeltnes G; Hollan I; F√∏rre √ò; Wiik A; Lyberg T; Mikkelsen K; Agewall S. Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-Œ± inhibitors. Journal of rheumatology. (2012) 39 7 pp1341-1347', '10.3899/jrheum.111401', '']\n",
      "['9260824', 'Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Br√∂ll H; H√∂gger P; Erlacher L. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-na√Øve adult patients with rheumatoid arthritis. Clinical therapeutics. (2012) 34 5 pp1195-1203', '10.1016/j.clinthera.2012.03.059', '']\n",
      "['9260826', 'Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis. Journal of rheumatology. (2012) 39 6 pp1171-1178', '10.3899/jrheum.110978', '']\n",
      "['9260827', 'Tiihonen RP; Skytt√§ ET; Kaarela K; Ik√§valko M; Belt EA. Reconstruction of the trapeziometacarpal joint in inflammatory joint disease using interposition of autologous tendon or poly-L-D-lactic acid implants: a prospective clinical trial. Journal of plastic surgery and hand surgery. (2012) 46 2 pp113-119', '10.3109/2000656x.2012.669202', '']\n",
      "['9260829', 'Nikolaou VS; Edwards MR; Bogoch E; Schemitsch EH; Waddell JP. A prospective randomised controlled trial comparing three alternative bearing surfaces in primary total hip replacement. Journal of bone and joint surgery. British volume. (2012) 94 4 pp459-465', '10.1302/0301-620x.94b4.27735', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.94B4.27735']\n",
      "['9260830', 'Seymour M; P√©tavy F; Chiesa F; Perry H; Lukey PT; Binks M; Donatien PD; Freidin AJ; Eckersley RJ; McClinton C; Heath K; Prodanovic S; Radunovic G; Pilipovic N; Damjanov N; Taylor PC. Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis. Clinical and experimental rheumatology. (2012) 30 2 pp254-261', '10.3410/f.1164186.15267056', '']\n",
      "['9260831', 'Chandran B; Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy research : PTR. (2012) 26 11 pp1719-1725', '10.1002/ptr.4639', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.4639']\n",
      "['9260833', 'Stock TC; Bloom BJ; Wei N; Ishaq S; Park W; Wang X; Gupta P; Mebus CA. Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. Journal of rheumatology. (2012) 39 4 pp720-727', '10.3899/jrheum.110874', '']\n",
      "['9260835', 'Mease P; Strand V; Shalamberidze L; Dimic A; Raskina T; Xu LA; Liu Y; Smith J. A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate. Annals of the rheumatic diseases. (2012) 71 7 pp1183-1189', '10.1136/annrheumdis-2011-200704', '']\n",
      "['9260837', 'Valleala H; Laasonen L; Koivula MK; Risteli J; Konttinen YT. Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis. Clinical and experimental rheumatology. (2012) 30 1 pp114-117', '10.1530/eje.0.1480527', 'https://eje.bioscientifica.com/view/journals/eje/148/5/527.xml']\n",
      "['9260838', 'Ma MH; Ibrahim F; Walker D; Hassell A; Choy EH; Kiely PD; Williams R; Walsh DA; Young A; Scott DL. Remission in early rheumatoid arthritis: predicting treatment response. Journal of rheumatology. (2012) 39 3 pp470-475', '10.3899/jrheum.110169', '']\n",
      "['9260839', 'Harigai M; Tanaka Y; Maisawa S; JA21963 Study Group. Safety and efficacy of various dosages of ocrelizumab in Japanese patients with rheumatoid arthritis with an inadequate response to methotrexate therapy: a placebo-controlled double-blind parallel-group study. Journal of rheumatology. (2012) 39 3 pp486-495', '10.3899/jrheum.110994', '']\n",
      "['9260840', \"Racovan M; Walitt B; Collins CE; Pettinger M; Parks CG; Shikany JM; Wactawski-Wende J; Manson JE; Moreland L; Wright N; Jackson R; Howard BV. Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial. Rheumatology international. (2012) 32 12 pp3823-3830\", '10.1007/s00296-011-2268-1', 'http://link.springer.com/article/10.1007/s00296-011-2268-1/fulltext.html']\n",
      "['9260841', 'Zhuang Y; Xu Z; Frederick B; de Vries DE; Ford JA; Keen M; Doyle MK; Petty KJ; Davis HM; Zhou H. Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study. Clinical therapeutics. (2012) 34 1 pp77-90', '10.1016/j.clinthera.2011.11.015', '']\n",
      "['9260842', 'Gheita TA; Kenawy SA. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytotherapy research : PTR. (2012) 26 8 pp1246-1248', '10.1002/ptr.3679', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.3679']\n",
      "['9260843', 'Yellin M; Paliienko I; Balanescu A; Ter-Vartanian S; Tseluyko V; Xu LA; Tao X; Cardarelli PM; Leblanc H; Nichol G; Ancuta C; Chirieac R; Luo A. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 6 pp1730-1739', '10.1002/art.34330', '']\n",
      "['9260844', 'Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Br√∂ll H; H√∂gger P; Kalipciyan M; Jilma B. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Clinical and experimental rheumatology. (2011) 29 6 pp963-969', '10.1016/j.clinthera.2012.03.059', '']\n",
      "['9260845', 'Taylor PC; Ritchlin C; Mendelsohn A; Baker D; Kim L; Xu Z; Mack M; Kremer J. Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab. Journal of rheumatology. (2011) 38 12 pp2572-2580', '10.3899/jrheum.110570', '']\n",
      "['9260846', 'Urata Y; Uesato R; Tanaka D; Nakamura Y; Motomura S. Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study. Annals of the rheumatic diseases. (2012) 71 4 pp534-540', '10.1136/annrheumdis-2011-200108', '']\n",
      "['9260847', 'Meeus M; Ickmans K; De Clerck LS; Moorkens G; Hans G; Grosemans S; Nijs J. Serotonergic descending inhibition in chronic pain: design, preliminary results and early cessation of a randomized controlled trial. In vivo (Athens, Greece). (2011) 25 6 pp1019-1025', '10.1111/papr.12613', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fpapr.12613']\n",
      "['9260848', 'Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra. Thrombosis and haemostasis. (2011) 106 5 pp959-967', '10.1160/th11-02-0117', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH11-02-0117.pdf']\n",
      "['9260849', 'Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Alm√•s B; Jorde R. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial. Osteoporosis international. (2012) 23 1 pp201-211', '10.1007/s00198-011-1752-5', 'http://link.springer.com/article/10.1007/s00198-011-1752-5/fulltext.html']\n",
      "['9260851', 'Krishnaswami S; Hutmacher MM; Robbins JL; Bello A; West C; Bloom BJ. Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis. Journal of clinical pharmacology. (2012) 52 8 pp1134-1149', '10.1177/0091270011412184', '']\n",
      "['9260852', 'Jiang Q; Zhou XY; Wang L; Yu W; Wang P; Cao W; Tang XP. A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction (). Chinese journal of integrative medicine. (2012) 18 4 pp256-261', '10.1007/s11655-011-0793-0', 'http://link.springer.com/article/10.1007/s11655-011-0793-0/fulltext.html']\n",
      "['9260853', 'Lin CS; Yang XY; Dai L. Multi-center clinical study on therapeutic effect of kunxian capsule on rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2011) 31 6 pp769-774', '10.47939/mh.v2i8.415', '']\n",
      "['9260854', 'Chopra A; Saluja M; Tillu G; Venugopalan A; Narsimulu G; Handa R; Bichile L; Raut A; Sarmukaddam S; Patwardhan B. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clinical rheumatology. (2012) 31 2 pp259-269', '10.1007/s10067-011-1809-z', 'http://link.springer.com/article/10.1007/s10067-011-1809-z/fulltext.html']\n",
      "['9260855', 'Keystone EC; Shirinsky VS; Simon LS; Pedder S; Hewitt LA; CH-1504 Study Group. Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: results of a phase II multicenter randomized study. Journal of rheumatology. (2011) 38 9 pp1875-1883', '10.3899/jrheum.101038', '']\n",
      "['9260857', 'Salesi M; Farajzadegan Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatology international. (2012) 32 7 pp2129-2133', '10.1007/s00296-011-1944-5', 'http://link.springer.com/article/10.1007/s00296-011-1944-5/fulltext.html']\n",
      "['9260858', 'David M; Akerman L; Ziv M; Kadurina M; Gospodinov D; Pavlotsky F; Yankova R; Kouzeva V; Ramon M; Silverman MH; Fishman P. Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. Journal of the European Academy of Dermatology and Venereology : JEADV. (2012) 26 3 pp361-367', '10.1111/j.1468-3083.2011.04078.x', '']\n",
      "['9260860', 'Lee HJ; Lee JS; Jung HJ; Song KS; Yang JJ; Park CW. Comparison of joint line position changes after primary bilateral total knee arthroplasty performed using the navigation-assisted measured gap resection or gap balancing techniques. Knee surgery, sports traumatology, arthroscopy. (2011) 19 12 pp2027-2032', '10.1007/s00167-011-1468-2', 'http://link.springer.com/article/10.1007/s00167-011-1468-2/fulltext.html']\n",
      "['9260862', 'Kang XZ; Wu QF; Wang KH. Efficacy of integrative medicine for the treatment of rheumatoid arthritis and its effect on glucocorticoid receptor expression. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2010) 30 12 pp1261-1264', '10.3736/jcim20080107', '']\n",
      "['9260863', 'Jiang YQ; Liang QH; Xiong XG. Effect of bizhongxiao decoction on proteomics of peripheral blood mononuclear cells in patients with rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2010) 30 11 pp1160-1164', '10.1007/bf02934304', 'https://link.springer.com/article/10.1007/BF02934304/fulltext.html']\n",
      "['9260864', 'Chavez-Chiang NR; Sibbitt WL; Band PA; DeLea SL; Park KS; Bankhurst AD. The outcomes and cost-effectiveness of intraarticular injection of the rheumatoid knee. Rheumatology international. (2012) 32 2 pp513-518', '10.1007/s00296-010-1718-5', 'http://link.springer.com/article/10.1007/s00296-010-1718-5/fulltext.html']\n",
      "['9260865', 'Liu Y; Wang S; Shen L; Xu Y. Effects of simvastatin on the function of dendritic cells in patients with rheumatic arthritis. Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban [Journal of Huazhong University of Science and Technology. Medical sciences ]. (2010) 30 6 pp741-745', '10.1007/s11596-010-0650-y', 'http://link.springer.com/article/10.1007/s11596-010-0650-y/fulltext.html']\n",
      "['9260866', 'Zhou CY; Tang JY; Fang DY. Clinical study on active rheumatoid arthritis treated with simiao xiaobi decoction. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2010) 30 3 pp275-279', '10.1530/endoabs.56.p482', '']\n",
      "['9260867', 'Zuo C; Chen YT; Wang ZM. Clinical efficacy of corydalis composite combined with methotrexate in treating rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2009) 29 11 pp1023-1025', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9260868', 'Liu XD; Zhang JL; Ye LH. Effects of wenhua juanbi recipe on tnf-alpha and il-1beta in peripheral blood of rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2009) 29 9 pp787-790', '10.1007/bf02934304', 'https://link.springer.com/article/10.1007/BF02934304/fulltext.html']\n",
      "['9260869', 'Vidor LP; Torres IL; Cust√≥dio de Souza IC; Fregni F; Caumo W. Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study. Journal of pain and symptom management. (2013) 46 3 pp422-432', '10.1016/j.jpainsymman.2012.08.019', '']\n",
      "['9260870', 'De Dios Sancho EP; Martin-Nogueras AM. Influence of the physical therapy on the health and quality of life of the rheumatic patient. [Spanish]. Reumatologia clinica. (2011) 7  4 pp224-229', '10.1016/s2173-5743(11)70050-8', '']\n",
      "['9260871', 'Pan N; Lehman TJA. Does continued treatment with methotrexate in juvenile idiopathic arthritis in remission prevent flare?. Current rheumatology reports. (2011) 13  2 pp97-99', '10.1007/s11926-011-0164-z', 'http://link.springer.com/article/10.1007/s11926-011-0164-z/fulltext.html']\n",
      "['9260872', 'Aulakh TS; Kuiper JH; Dixey J; Richardson JB. Hip resurfacing for rheumatoid arthritis: Independent assessment of 11-year results from an international register. International orthopaedics. (2011) 35  6 pp803-808', '10.1007/s00264-010-1046-0', 'http://link.springer.com/article/10.1007/s00264-010-1046-0/fulltext.html']\n",
      "['9260874', 'Khan MOA; Mohiuddin E; Usmanghani K; Hannan A; Akram M; Ali Shah SM; Asif M. Clinical evaluation of herbal medicines for the treatment of rheumatoid arthritis. Pakistan Journal of Nutrition. (2011) 10  1 pp51-53', '10.3923/pjn.2011.51.53', '']\n",
      "['9260876', 'Cho Y; Lolis E. When anti-CCR2 treatment for arthritis strikes out. Arthritis and rheumatism. (2011) 63  1 pp23-25', '10.1002/art.30104', '']\n",
      "['9260877', 'Anonymous. Sulforaphane glucosinolate monograph. Alternative medicine review. (2010) 15  4 pp352-360', '10.1007/978-1-137-05902-4_30', '']\n",
      "['9260878', 'Mitchell E. RCT of treatments for pyoderma gangrenosum: Time to get involved. Wounds UK. (2010) 6  4 pp27-32', '10.1186/isrctn35898459', '']\n",
      "['9260879', 'Haraoui B; Bokarewa M; Kallmeyer I; Bykerk VP. Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: The RESET trial. Journal of rheumatology. (2011) 38  12 pp2548-2556', '10.3899/jrheum.110444', '']\n",
      "['9260880', 'Martin P; De Medeiros AC; Goldenstein-Schainberg C. The role of tumor necrosis factor inhibitors in the treatment of juvenile idiopathic arthritis. [Portuguese]. Revista brasileira de reumatologia. (2006) 46  2 pp126-133', '10.1590/s0482-50042006000200007', 'http://www.scielo.br/pdf/rbr/v46n2/a07v46n2.pdf']\n",
      "['9260881', 'Maksymowych WP. Reporting process of randomized controlled trials [4]. CMAJ : Canadian Medical Association journal. (2004) 170  9 pp1375', '10.1503/cmaj.1032026', '']\n",
      "['9260882', 'Martinez-Lavin M; Vidal M; Barbosa R-E; Pineda C; Casanova J-M; Nava A. Norepinephrine-evoked pain in fibromyalgia. A randomized pilot studyISCRTN70707830. BMC musculoskeletal disorders. (2002) 3  pp1-6', '10.1186/1471-2474-3-2', 'http://link.springer.com/article/10.1186/1471-2474-3-2/fulltext.html']\n",
      "['9260883', 'Durnez A; Vanderschueren G; Lateur L; Westhovens R; Verschueren P. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort. Annals of the rheumatic diseases. (2011) 70  4 pp634-637', '10.1136/ard.2010.135319', '']\n",
      "['9260885', 'Kivitz A; Cohen S; Dowd JE; Edwards W; Thakker S; Wellborne FR; Renz CL; Segurado OG. Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial. Clinical therapeutics. (2006) 28  10 pp1619-1629', '10.1016/j.clinthera.2006.10.006', '']\n",
      "['9260886', 'Curtis SP; Ng J; Yu Q; Shingo S; Bergman G; McCormick CL; Reicin AS. Renal Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs in Controlled Clinical Trials. Clinical therapeutics. (2004) 26  1 pp70-83', '10.1016/s0149-2918(04)90007-0', '']\n",
      "['9260887', 'Pincus T. The clinical efficacy of 3 mg/day prednisone in patients with rheumatoid arthritis: Evidence from a randomised, double-blind, placebo-controlled withdrawal clinical trial. Clinical and experimental rheumatology. (2011) 29  5 SUPPL. 68 ppS73-S76', '10.1136/ard.2008.095539', '']\n",
      "['9260889', 'Mobini M; Kashi Z; Mohammad Pour AR; Adibi E. The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis. Iranian Red Crescent Medical Journal. (2011) 13  10 pp749-751', '10.5812/ircmj.19005', '']\n",
      "['9260890', 'El Miedany Y; El Gaafary M; El Arousy N; Ahmed I; Youssef S; Palmer D. Arthritis education: the integration of patient-reported outcome measures and patient self-management. Clinical and experimental rheumatology. (2012) 30 6 pp899-904', '10.1155/2016/5371682', 'http://downloads.hindawi.com/archive/2016/5371682.pdf']\n",
      "['9260891', 'Hu C; Xu Z; Mendelsohn AM; Zhou H. Latent variable indirect response modeling of categorical endpoints representing change from baseline. Journal of pharmacokinetics and pharmacodynamics. (2013) 40  1 pp81-91', '10.1007/s10928-012-9288-7', 'http://link.springer.com/article/10.1007/s10928-012-9288-7/fulltext.html']\n",
      "['9260892', 'Stancik R; Zvarka J; Hlavac M; Kubinec V; Rovensky J. Collagen type I in the treatment of painful osteoarthritis of the knee. [Polish, English]. Reumatologia. (2012) 50  5 pp390-396', '10.5114/reum.2012.31397', 'https://reu.termedia.pl/pdf-160237-86748']\n",
      "['9260894', 'Cho YK; Huang W; Kim GY; Lim BS. Comparison of autologous serum eye drops with different diluents. Current eye research. (2013) 38 1 pp9-17', '10.3109/02713683.2012.720340', '']\n",
      "['9260895', 'Leah E. Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis. Nature Reviews Rheumatology. (2012) 8  10 pp561', '10.1038/nrrheum.2012.145', 'https://www.nature.com/articles/nrrheum.2012.145']\n",
      "['9260897', 'Field T; Diego M; Delgado J; Garcia D; Funk CG. Rheumatoid arthritis in upper limbs benefits from moderate pressure massage therapy. Complementary therapies in clinical practice. (2013) 19 2 pp101-103', '10.1016/j.ctcp.2012.12.001', '']\n",
      "['9260898', 'Dogu B; Sirzai H; Yilmaz F; Polat B; Kuran B. Effects of isotonic and isometric hand exercises on pain, hand functions, dexterity and quality of life in women with rheumatoid arthritis. Rheumatology international. (2013) 33 10 pp2625-2630', '10.1007/s00296-013-2787-z', 'http://link.springer.com/article/10.1007/s00296-013-2787-z/fulltext.html']\n",
      "['9260899', \"Qiu W; Liu Z; Ao M; Li X; Wang W. Punctal plugs versus artificial tears for treating primary Sj√∂gren's syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function. Rheumatology international. (2013) 33 10 pp2543-2548\", '10.1007/s00296-013-2769-1', 'http://link.springer.com/article/10.1007/s00296-013-2769-1/fulltext.html']\n",
      "['9260900', 'Muller-Ladner U; Flipo RM; Vincendon P; Brault Y; Kielar D. Comparison of patient satisfaction with two different etanercept delivery systems: A randomised controlled study in patients with rheumatoid arthritis. Zeitschrift fur Rheumatologie. (2012) 71  10 pp890-899', '10.1007/s00393-012-1034-4', 'http://link.springer.com/article/10.1007/s00393-012-1034-4/fulltext.html']\n",
      "['9260901', 'Han T-X; Li C-F; Wang J; Kuang W-Y; Zhou Y-F; Deng J-H. Clinical efficacy of mycophenolate mofetil in the treatment of systemic-onset juvenile idiopathic arthritis. [Chinese]. Chinese Journal of Contemporary Pediatrics. (2013) 15  8 pp666-670', '10.1186/1546-0096-6-s1-p33', 'http://link.springer.com/article/10.1186/1546-0096-6-S1-P33/fulltext.html']\n",
      "['9260902', 'Chen GQ; Zhang HW; Li ZF; Yu YT; Guo DM. [A 2-year follow-up results of knee arthroscopic synovectomy plus disease modifying antirheumatic drugs for the treatment of rheumatoid arthritis]. Zhonghua yi xue za zhi. (2011) 91 29 pp2034-2037', '10.2147/ppa.s98034', '']\n",
      "['9260903', 'Hjeltnes G; Hollan I; Forre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-alpha-inhibitor. Clinical and experimental rheumatology. (2013) 31  3 pp415-421', '10.3109/03009742.2012.656698', '']\n",
      "['9260905', 'Saviola G; Abdi-Ali L; Campostrini L; Sacco S; Baiardi P; Manfredi M; Benucci M; Bucci M; Cirino G. Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study. Rheumatology international. (2013) 33 11 pp2833-2838', '10.1007/s00296-013-2822-0', 'http://link.springer.com/article/10.1007/s00296-013-2822-0/fulltext.html']\n",
      "['9260906', 'Annegret F; Thomas F. Long-term benefits of radon spa therapy in rheumatic diseases: results of the randomised, multi-centre IMuRa trial. Rheumatology international. (2013) 33 11 pp2839-2850', '10.1007/s00296-013-2819-8', 'http://link.springer.com/article/10.1007/s00296-013-2819-8/fulltext.html']\n",
      "['9260908', 'Baruth M; Wilcox S; Schoffman DE; Becofsky K. Factors associated with disability in a sample of adults with arthritis. Disability and health journal. (2013) 6 4 pp377-384', '10.1016/j.dhjo.2013.04.008', '']\n",
      "['9260909', 'Kumar MP; Rai NP. A clinical study on ajmodadi churna and eranda taila in the management of amavata (rheumatoid arthritis). International Research Journal of Pharmacy. (2013) 4  6 pp211-213', '10.7897/2230-8407.04647', '']\n",
      "['9260911', 'Karatoprak C; Uyar S; Abanonu GB; Pehlevan SM; Okuroglu N; Demirtunc R. The levels of beta-thromboglobulin in female rheumatoid arthritis patients as activation criteria. Rheumatology international. (2013) 33  5 pp1229-1232', '10.1007/s00296-012-2511-4', 'http://link.springer.com/article/10.1007/s00296-012-2511-4/fulltext.html']\n",
      "['9260912', 'Daien CI; Fesler P; Du Cailar G; Daien V; Mura T; Dupuy A-M; Cristol J-P; Ribstein J; Combe B; Morel J. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  6 pp881-887', '10.1136/annrheumdis-2012-201489', '']\n",
      "['9260913', 'Lee HY; Hale CA; Hemingway B; Woolridge MW. Tai Chi exercise and auricular acupressure for people with rheumatoid arthritis: an evaluation study. Journal of clinical nursing. (2012) 21 19-20 pp2812-2822', '10.1111/j.1365-2702.2011.04058.x', '']\n",
      "['9260914', 'Li L; Zhang X; Cui Y; Lu Y-Y; Wang S-X; Dong G-F; Shi Y-Z; Luo R-Q; Lei Y-X. Effect of recombinant human tumor necrosis factor receptor type II-Fc fusion protein antibody on cytokines and bone metabolism in patients with juvenile idiopathic arthritis. [Chinese]. National Medical Journal of China. (2010) 90  31 pp2205-2208', '10.1177/106002809703101111', 'https://journals.sagepub.com/doi/pdf/10.1177/106002809703101111']\n",
      "['9260915', 'Muratore M; Quarta E; Quarta L. Intramuscular neridronate in patients with rheumatoid arthritis using corticosteroids: Evaluation of treatment adherence in a randomized, open-label comparison with other bisphosphonates. Acta bio-medica. (2013) 84  1 pp23-29', '10.2147/dddt.s12139', '']\n",
      "['9260917', 'DiGiovanni CW; Lin SS; Baumhauer JF; Daniels T; Younger A; Glazebrook M; Anderson J; Anderson R; Evangelista P; Lynch SE; North American Orthopedic Foot and Ankle Study Group. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/Œ≤-TCP): an alternative to autogenous bone graft. Journal of bone and joint surgery. American volume. (2013) 95 13 pp1184-1192', '10.2106/jbjs.k.01422', '']\n",
      "['9260918', \"Wu GL; Li TY; Fan YS; Yu GY; Chen J. Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren's syndrome. Chinese journal of integrative medicine. (2013) 19 9 pp696-700\", '10.1007/s11655-013-1565-9', 'http://link.springer.com/article/10.1007/s11655-013-1565-9/fulltext.html']\n",
      "['9260919', 'Hoff M; Kavanaugh A; Haugeberg G. Hand bone loss in patients with psoriatic arthritis: posthoc analysis of IMPACT II data comparing infliximab and placebo. Journal of rheumatology. (2013) 40 8 pp1344-1348', '10.3899/jrheum.121376', '']\n",
      "['9260920', 'da Silva KN; Teixeira LE; Imoto AM; Atallah AN; Peccin MS; Trevisani VF. Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial. Rheumatology international. (2013) 33 9 pp2269-2275', '10.1007/s00296-013-2706-3', 'http://link.springer.com/article/10.1007/s00296-013-2706-3/fulltext.html']\n",
      "['9260921', 'Boon H. Meaning response of homeopathic consultation more beneficial than specific effect of homeopathic remedies in rheumatoid arthritis patients. Focus on Alternative and Complementary Therapies. (2013) 18  3 pp149-150', '10.1111/fct.12032', '']\n",
      "['9260922', 'Naito Y; Yamaguchi S; Mori Y; Nakajima K; Hashimoto S; Tomaru M; Satoh Y; Hitomi Y; Karita M; Hiwatashi T; Kawahito Y; Yoshikawa T. A randomized, double-blind, sham-controlled study of static electric field therapy by high voltage alternating current for active rheumatoid arthritis. Journal of clinical biochemistry and nutrition. (2013) 53  1 pp63-67', '10.3164/jcbn.13-13', '']\n",
      "['9260925', 'Kurrasch R; Brown JC; Chu M; Craigen J; Overend P; Patel B; Wolfe S; Chang DJ. Subcutaneously administered ofatumumab in rheumatoid arthritis: a phase I/II study of safety, tolerability, pharmacokinetics, and pharmacodynamics. Journal of rheumatology. (2013) 40 7 pp1089-1096', '10.3899/jrheum.121118', '']\n",
      "['9260926', 'Cao YX; Liu J; Zhu Y. Effect of xinfeng capsule on the cardiac function in patients with rheumatoid arthritis. Chinese journal of integrative medicine. (2011) 17 10 pp738-743', '10.1007/s11655-011-0873-1', 'http://link.springer.com/article/10.1007/s11655-011-0873-1/fulltext.html']\n",
      "['9260928', 'Chuengsamarn S; Rattanamongkolgul S; Phonrat B; Tungtrongchitr R; Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. Journal of nutritional biochemistry. (2014) 25 2 pp144-150', '10.1016/j.jnutbio.2013.09.013', '']\n",
      "['9260930', 'Primdahl J; S√∏rensen J; Horn HC; Petersen R; H√∏rslev-Petersen K. Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity--patient outcomes from a 2-year, randomised controlled trial. Annals of the rheumatic diseases. (2014) 73 2 pp357-364', '10.1136/annrheumdis-2012-202695', '']\n",
      "['9260933', 'Migita K; Izumi Y; Jiuchi Y; Kozuru H; Kawahara C; Izumi M; Sakai T; Nakamura M; Motokawa S; Nakamura T; Kawakami A. Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis. Clinical and experimental immunology. (2014) 175 2 pp208-214', '10.1111/cei.12234', 'https://academic.oup.com/cei/article-pdf/175/2/208/41083484/cei12234.pdf']\n",
      "['9260935', 'Alshryda S; Mason J; Vaghela M; Sarda P; Nargol A; Maheswaran S; Tulloch C; Anand S; Logishetty R; Stothart B; Hungin AP. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). Journal of bone and joint surgery. American volume. (2013) 95 21 pp1961-1968', '10.2106/jbjs.l.00907', '']\n",
      "['9260936', \"Chen FY; Xue B; Wang H. Analysis of the clinical efficacy of yiqi fumai injection combined hydroxychloroquine sulfate tablet for treating sjogren's syndrome. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2012) 32 12 pp1621-1623\", '10.70976/j.2096-0964.2020.11.15-24', 'https://www.tcmjc.com/doi/10.70976/j.2096-0964.2020.11.15-24']\n",
      "['9260939', 'Salesi M; Sadeghihaddadzavareh S; Nasri P; Namdarigharaghani N; Farajzadegan Z; Hajalikhani M. The role of bromocriptine in the treatment of patients with active rheumatoid arthritis. International journal of rheumatic diseases. (2013) 16 6 pp662-666', '10.1111/1756-185x.12015', '']\n",
      "['9260940', 'Jie HY; Wu QF; Ding ZX. Clinical study of biqi capsule combined with methotrexate for treatment of rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2012) 32 2 pp195-198', '10.1007/bf02836428', 'http://link.springer.com/article/10.1007/BF02836428/fulltext.html']\n",
      "['9260943', 'McInnes IB; Kim HY; Lee SH; Mandel D; Song YW; Connell CA; Luo Z; Brosnan MJ; Zuckerman A; Zwillich SH; Bradley JD. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study. Annals of the rheumatic diseases. (2014) 73 1 pp124-131', '10.1136/annrheumdis-2012-202442', '']\n",
      "['9260946', 'de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate. Arthritis and rheumatism. (2013) 65 11 pp2803-2813', '10.1002/art.38113', '']\n",
      "['9260949', 'Monsarrat P; Vergnes JN; Cantagrel A; Algans N; Cousty S; K√©moun P; Bertrand C; Arriv√© E; Bou C; S√©darat C; Schaeverbeke T; Nabet C; Sixou M. Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trial. Trials. (2013) 14  pp253', '10.1186/1745-6215-14-253', '']\n",
      "['9260950', \"Pollard RP; Abdulahad WH; Bootsma H; Meiners PM; Spijkervet FK; Huitema MG; Burgerhof JG; Vissink A; Kroese FG. Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome. Annals of the rheumatic diseases. (2013) 72 12 pp2048-2050\", '10.1136/annrheumdis-2013-203447', '']\n",
      "['9260951', 'MacPherson H; Tilbrook H E; Richmond S J; Atkin K; Ballard K; Bland M; Eldred J; Essex H N; Hopton A; Lansdown H; Muhammad U; Parrott S; Torgerson D; Wenham A; Woodman J; Watt I. Alexander Technique Lessons, Acupuncture Sessions or usual care for patients with chronic neck pain (ATLAS): study protocol for a randomised controlled trial. Trials. (2013) 14 1 pp209', '10.1186/1745-6215-14-209', '']\n",
      "['9260953', 'Mendon√ßa TM; Terreri MT; Silva CH; Neto MB; Pinto RM; Natour J; Len CA. Effects of Pilates exercises on health-related quality of life in individuals with juvenile idiopathic arthritis. Archives of physical medicine and rehabilitation. (2013) 94 11 pp2093-2102', '10.1016/j.apmr.2013.05.026', '']\n",
      "['9260954', 'Zhang X; Chen YC; Fettner S; Rowell L; Gott T; Grimsey P; Unsworth A. Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis. International journal of clinical pharmacology and therapeutics. (2013) 51 8 pp620-630', '10.5414/cp201904', '']\n",
      "['9260955', 'Lovell DJ; Giannini EH; Reiff AO; Kimura Y; Li S; Hashkes PJ; Wallace CA; Onel KB; Foell D; Wu R; Biedermann S; Hamilton JD; Radin AR. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis. Arthritis and rheumatism. (2013) 65 9 pp2486-2496', '10.1002/art.38042', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.38042']\n",
      "['9260956', \"Tanner K; Roy N; Merrill RM; Kendall K; Miller KL; Clegg DO; Heller A; Houtz DR; Elstad M. Comparing nebulized water versus saline after laryngeal desiccation challenge in Sj√∂gren's Syndrome. Laryngoscope. (2013) 123 11 pp2787-2792\", '10.1002/lary.24148', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.24148']\n",
      "['9260957', 'Peabody JW; Strand V; Shimkhada R; Lee R; Chernoff D. Impact of rheumatoid arthritis disease activity test on clinical practice. PloS one. (2013) 8 5 ppe63215', '10.1371/journal.pone.0063215', '']\n",
      "['9260959', 'Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study. Journal of clinical endocrinology and metabolism. (2013) 98 7 pp2746-2754', '10.1210/jc.2012-4201', 'http://academic.oup.com/jcem/article-pdf/98/7/2746/9046897/jcem2746.pdf']\n",
      "['9260961', 'Hendry GJ; Watt GF; Brandon M; Friel L; Turner DE; Lorgelly PK; Gardner-Medwin J; Sturrock RD; Woodburn J. The effectiveness of a multidisciplinary foot care program for children and adolescents with juvenile idiopathic arthritis: an exploratory trial. Journal of rehabilitation medicine. (2013) 45 5 pp467-476', '10.2340/16501977-1130', '']\n",
      "['9260962', 'Chen L; Qi H; Jiang D; Wang R; Chen A; Yan Z; Xiao J. The new use of an ancient remedy: a double-blinded randomized study on the treatment of rheumatoid arthritis. American journal of Chinese medicine. (2013) 41 2 pp263-280', '10.1142/s0192415x13500195', '']\n",
      "['9260963', 'Zhang X; Georgy A; Rowell L. Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects. International journal of clinical pharmacology and therapeutics. (2013) 51 6 pp443-455', '10.5414/cp201819', '']\n",
      "['9260965', 'Stohl W; Merrill JT; McKay JD; Lisse JR; Zhong ZJ; Freimuth WW; Genovese MC. Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study. Journal of rheumatology. (2013) 40 5 pp579-589', '10.3899/jrheum.120886', '']\n",
      "['9260966', 'Lee SE; Joe HB; Park JH; Yi IK; Choi YH; Han KR; Kim C. Distribution range of cervical interlaminar epidural injections: a comparative study with 2.5 mL, 5 mL, and 10 mL of contrast. Pain physician. (2013) 16 2 pp155-164', '10.36076/ppj.2013/16/155', '']\n",
      "['9260969', 'Sakai N; Inoue T; Kunugiza Y; Tomita T; Mashimo T. Continuous femoral versus epidural block for attainment of 120¬∞ knee flexion after total knee arthroplasty: a randomized controlled trial. Journal of arthroplasty. (2013) 28 5 pp807-814', '10.1016/j.arth.2012.09.013', '']\n",
      "['9260970', \"Teljeur C; Smith SM; Paul G; Kelly A; O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. European journal of general practice. (2013) 19 1 pp17-22\", '10.3109/13814788.2012.714768', '']\n",
      "['9260971', 'Cutolo M; Bolosiu H; Perdriset G; LEADER Study Group. Efficacy and safety of leflunomide in DMARD-naive patients with early rheumatoid arthritis: comparison of a loading and a fixed-dose regimen. Rheumatology (Oxford, England). (2013) 52 6 pp1132-1140', '10.1093/rheumatology/kes321', 'http://academic.oup.com/rheumatology/article-pdf/52/6/1132/5196633/kes321.pdf']\n",
      "['9260972', 'Koksvik HS; Hagen KB; R√∏devand E; Mowinckel P; Kvien TK; Zangi HA. Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides. Annals of the rheumatic diseases. (2013) 72 6 pp836-843', '10.1136/annrheumdis-2012-202296', '']\n",
      "['9260973', 'Radicioni M; Connolly S; Stroppolo F; Granata G; Loprete L; Leuratti C. Bioequivalence study of a novel orodispersible tablet of meloxicam in a porous matrix after single-dose administration in healthy volunteers. International journal of clinical pharmacology and therapeutics. (2013) 51 3 pp234-243', '10.5414/cp201781', '']\n",
      "['9260974', 'Weinblatt ME; Kavanaugh A; Genovese MC; Jones DA; Musser TK; Grossbard EB; Magilavy DB. Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial. Journal of rheumatology. (2013) 40 4 pp369-378', '10.3899/jrheum.120923', '']\n",
      "['9260977', 'Ruyssen-Witrand A; Rouanet S; Combe B; Dougados M; Le Lo√´t X; Sibilia J; Tebib J; Mariette X; Constantin A. Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients. Rheumatology (Oxford, England). (2013) 52 4 pp636-641', '10.1093/rheumatology/kes344', 'http://academic.oup.com/rheumatology/article-pdf/52/4/636/5084669/kes344.pdf']\n",
      "['9260978', 'Ouyang GL; Feng XH; Xiao LB; Huang Z; Xia Q; Zhu F. [Effects of Chinese herbal medicine Qianggu Capsule on patients with rheumatoid arthritis-induced osteoporosis: a report of 82 cases]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2012) 10 12 pp1394-1399', '10.3736/jcim20121210', '']\n",
      "['9260979', 'Yang S; Lukey P; Beerahee M; Hoke F. Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases. Clinical pharmacokinetics. (2013) 52 3 pp187-198', '10.1007/s40262-012-0025-6', 'http://link.springer.com/article/10.1007/s40262-012-0025-6/fulltext.html']\n",
      "['9260980', 'Siddle HJ; Redmond AC; Waxman R; Dagg AR; Alcacer-Pitarch B; Wilkins RA; Helliwell PS. Debridement of painful forefoot plantar callosities in rheumatoid arthritis: the CARROT randomised controlled trial. Clinical rheumatology. (2013) 32 5 pp567-574', '10.1007/s10067-012-2134-x', 'http://link.springer.com/article/10.1007/s10067-012-2134-x/fulltext.html']\n",
      "['9260981', 'Aragona P; Spinella R; Rania L; Postorino E; Sommario MS; Roszkowska AM; Puzzolo D. Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sj√∂gren syndrome. European journal of ophthalmology. (2013) 23 3 pp368-376', '10.5301/ejo.5000229', 'https://journals.sagepub.com/doi/pdf/10.5301/ejo.5000229']\n",
      "['9260985', 'Dischereit G; Tarner IH; M√ºller-Ladner U; Lange U. Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study. Clinical rheumatology. (2013) 32 3 pp377-381', '10.1007/s10067-012-2128-8', 'http://link.springer.com/article/10.1007/s10067-012-2128-8/fulltext.html']\n",
      "['9260986', 'Sarah Trial Team; Adams J; Bridle C; Dosanjh S; Heine P; Lamb SE; Lord J; McConkey C; Nichols V; Toye F; Underwood MR; Williams MA; Williamson EM. Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): design of a randomised controlled trial of a hand and upper limb exercise intervention--ISRCTN89936343. BMC musculoskeletal disorders. (2012) 13  pp230', '10.1186/1471-2474-13-230', 'http://link.springer.com/article/10.1186/1471-2474-13-230/fulltext.html']\n",
      "['9260987', 'Wang NH; Yan JT; Sun WQ; Hu YS; Xia J; Wei LC; Jia J; Ouyang GL; He Y; Guo YM; Xu J. [Effects of early application of Tuina treatment on quadriceps surface myoelectricity in patients after total knee arthroplasty: a randomized controlled trial]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2012) 10 11 pp1247-1253', '10.3736/jcim20121108', '']\n",
      "['9260990', 'Pope J; Thorne C; Cividino A; Lucas K. Effect of rheumatologist education on systematic measurements and treatment decisions in rheumatoid arthritis: the metrix study. Journal of rheumatology. (2012) 39 12 pp2247-2252', '10.3899/jrheum.120597', '']\n",
      "['9260992', 'Franca Ivan Leonardo Avelino; Ribeiro Ana Cristina Medeiros; Aikawa Nadia Emi; Saad Carla Goncalves Schain; Moraes Julio Cesar Bertacine; Goldstein-Schainberg Claudia; Laurindo Ieda Maria Magalhaes; Precioso Alexander Roberto; Ishida Maria Akiko; Sartori Ana Marli Christovam; Silva Clovis Artur; Bonfa Eloisa. TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. Rheumatology (Oxford, England). (2012) 51 11 pp2091-2098', '10.1093/rheumatology/kes202', 'http://academic.oup.com/rheumatology/article-pdf/51/11/2091/5032326/kes202.pdf']\n",
      "['9260993', 'L√≥pez-Garc√≠a JS; Garc√≠a-Lozano I. Use of containers with sterilizing filter in autologous serum eyedrops. Ophthalmology. (2012) 119 11 pp2225-2230', '10.1016/j.ophtha.2012.06.028', '']\n",
      "['9260994', \"Pollard RP; Abdulahad WH; Vissink A; Hamza N; Burgerhof JG; Meijer JM; Visser A; Huitema MG; Spijkervet FK; Kallenberg CG; Bootsma H; Kroese FG. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Annals of the rheumatic diseases. (2013) 72 1 pp146-148\", '10.1136/annrheumdis-2012-202071', '']\n",
      "['9260995', 'Henness S; Yang LPH. Modified-release prednisone: In patients with rheumatoid arthritis. Drugs. (2013) 73  18 pp2067-2076', '10.1007/s40265-013-0148-6', 'http://link.springer.com/article/10.1007/s40265-013-0148-6/fulltext.html']\n",
      "['9260996', 'Bos PK. CORR insights: The effect of infrapatellar fat pad excision on complications after minimally invasive TKA: A randomized controlled trial. Clinical orthopaedics and related research. (2014) 472  2 pp702-703', '10.1007/s11999-013-3362-3', '']\n",
      "['9260998', 'Javadi F; Eghtesadi S; Ahmadzadeh A; Aryaeian N; Zabihiyeganeh M; Foroushani AR; Jazayeri S. The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis. International journal of preventive medicine. (2014) 5  3 pp293-301', '10.1080/07315724.2016.1140093', '']\n",
      "['9260999', 'Katz JN; Brophy RH; Chaisson CE; De Chaves L; Cole BJ; Dahm DL; Donnell-Fink LA; Guermazi A; Haas AK; Jones MH; Levy BA; Mandl LA; Martin SD; Marx RG; Miniaci A; Matava MJ; Palmisano J; Reinke EK; Richardson BE; Rome BN; Safran-Norton CE; Skoniecki DJ; Solomon DH; Smith MV; Spindler KP; Stuart MJ; Wright J; Wright RW. Arthroscopic partial meniscectomy was not more effective than physical therapy for meniscal tear and knee osteoarthritis. Journal of bone and joint surgery. American volume. (2013) 95  22 pp2058', '10.1056/nejmoa1301408', '']\n",
      "['9261000', 'Urata Y; Nakamura Y; Furukawa K. Comparison of initial versus delayed introduction of a treat-to-target strategy in patients with recent-onset rheumatoid arthritis: results of the T-4 3-year study. Annals of the rheumatic diseases. (2014) 73 2 pp470-472', '10.1136/annrheumdis-2013-203748', '']\n",
      "['9261002', 'Tanaka Y; Kawai S; Takeuchi T; Yamamoto K; Miyasaka N. Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study. Modern rheumatology / the Japan Rheumatism Association. (2013) 23 6 pp1045-1052', '10.3109/s10165-012-0817-4', '']\n",
      "['9261003', 'Chrubasik S; Chrubasik C; Kunzel O; Black A. Patient-perceived benefit during one year of treatment with Doloteffin. Phytomedicine. (2007) 14 6 pp371-376', '10.1016/j.phymed.2007.04.011', '']\n",
      "['9261004', 'Miehle W. Leflunomid (Arava). Internistische Praxis. (2001) 41 1 pp155-162', '10.1007/3-7985-1630-8_11', '']\n",
      "['9261006', 'Sato K; Adachi T; Shirai N; Naoi N. Continuous versus single-injection sciatic nerve block added to continuous femoral nerve block for analgesia after total knee arthroplasty: a prospective, randomized, double-blind study. Regional anesthesia and pain medicine. (2014) 39 3 pp225-229', '10.1097/aap.0000000000000076', '']\n",
      "['9261009', 'Loppenthin K; Esbensen BA; Jennum P; Ostergaard M; Christensen JF; Thomsen T; Bech JS; Midtgaard J. Effect of intermittent aerobic exercise on sleep quality and sleep disturbances in patients with rheumatoid arthritis - Design of a randomized controlled trial. BMC musculoskeletal disorders. (2014) 15 1 pp49', '10.1186/1471-2474-15-49', 'http://link.springer.com/article/10.1186/1471-2474-15-49/fulltext.html']\n",
      "['9261010', 'Babazadeh S; Dowsey MM; Stoney JD; Choong PF. Gap balancing sacrifices joint-line maintenance to improve gap symmetry: a randomized controlled trial comparing gap balancing and measured resection. Journal of arthroplasty. (2014) 29 5 pp950-954', '10.1016/j.arth.2013.09.036', '']\n",
      "['9261014', 'Bjorner Jakob B; Rose Matthias; Gandek Barbara; Stone Arthur A; Junghaenel Doerte U; Ware Jr John E. Difference in method of administration did not significantly\\nimpact item response: An IRT-based analysis from the\\nPatient-Reported Outcomes Measurement Information System (PROMIS)\\ninitiative. Quality of life research. (2014) 23 1 pp217-227', '10.1007/s11136-013-0451-4', 'http://link.springer.com/article/10.1007/s11136-013-0451-4/fulltext.html']\n",
      "['9261016', \"Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic DS; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance (CARRA). Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. Journal of rheumatology. (2014) 41 6 pp1163-1170\", '10.3899/jrheum.131503', '']\n",
      "['9261020', 'Sadra V; Khabbazi A; Kolahi S; Hajialiloo M; Ghojazadeh M. Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: a preliminary study. International journal of rheumatic diseases. (2014) 17 4 pp389-393', '10.1111/1756-185x.12278', '']\n",
      "['9261021', 'Horneff G; Burgos-Vargas R; Constantin T; Foeldvari I; Vojinovic J; Chasnyk VG; Dehoorne J; Panaviene V; Susic G; Stanevica V; Kobusinska K; Zuber Z; Mouy R; Rumba-Rozenfelde I; Breda L; Dolezalova P; Job-Deslandre C; Wulffraat N; Alvarez D; Zang C; Wajdula J; Woodworth D; Vlahos B; Martini A; Ruperto N. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study. Annals of the rheumatic diseases. (2014) 73  6 pp1114-1122', '10.1136/annrheumdis-2012-203046', '']\n",
      "['9261022', 'Hara M; Ishiguro N; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Yamamoto K; Iguratimod-Clinical Study Group. Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 3 pp410-418', '10.3109/14397595.2013.843756', '']\n",
      "['9261024', 'Li L; Chen F; Xu L; Zheng Q. Population pharmacokinetics of rhTNFR-Fc in Chinese patients with rheumatic arthritis. International journal of clinical pharmacology and therapeutics. (2014) 52 7 pp612-619', '10.5414/cp202063', '']\n",
      "['9261025', 'Kurasawa T; Nagasawa H; Kishimoto M; Amano K; Takeuchi T; Kameda H. Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: an open, randomized, controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2014) 24 4 pp561-566', '10.3109/14397595.2013.844886', '']\n",
      "['9261027', 'Schiff MH; Jaffe JS; Freundlich B. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: Drug-exposure limitations of oral methotrexate at doses >15 mg may be overcome with subcutaneous administration. Annals of the rheumatic diseases. (2014) 73  8 pp1549-1551', '10.1136/annrheumdis-2014-205228', '']\n",
      "['9261031', 'Pei X; Huang L; Han G; Li R; Wang Z; Han X. [Effectiveness comparison of different tibial intramedullary nail guide rod in total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2013) 27 10 pp1162-1166', '10.1007/s00167-010-1152-y', 'http://link.springer.com/article/10.1007/s00167-010-1152-y/fulltext.html']\n",
      "['9261033', 'Ishibashi T; Sato B; Shibata S; Sakai T; Hara Y; Naritomi Y; Koyanagi S; Hara H; Nagao T. Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study. International immunopharmacology. (2014) 21 2 pp468-473', '10.1016/j.intimp.2014.06.001', '']\n",
      "['9261035', 'Coda A; Fowlie PW; Davidson JE; Walsh J; Carline T; Santos D. Foot orthoses in children with juvenile idiopathic arthritis: a randomised controlled trial. Archives of disease in childhood. (2014) 99 7 pp649-651', '10.1136/archdischild-2013-305166', '']\n",
      "['9261036', 'Cakir T; Evcik FD; Subasi V; Gokce IY; Kavuncu V. The effectiveness of aquatic exercises in the treatment of rheumatoid arthritis. [Turkish]. Turk Osteoporoz Dergisi. (2014) 20  1 pp10-15', '10.4274/tod.08760', 'http://cms.galenos.com.tr/FileIssue/9/327/article/10-15.pdf']\n",
      "['9261038', 'Angiolillo DJ; Datto C; Raines S; Yeomans ND. Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies. Journal of thrombosis and thrombolysis. (2014) 38 1 pp11-23', '10.1007/s11239-013-1035-4', 'http://link.springer.com/article/10.1007/s11239-013-1035-4/fulltext.html']\n",
      "['9261040', 'Olsen-Bergem H; Bj√∏rnland T. A cohort study of patients with juvenile idiopathic arthritis and arthritis of the temporomandibular joint: outcome of arthrocentesis with and without the use of steroids. International journal of oral and maxillofacial surgery. (2014) 43 8 pp990-995', '10.1016/j.ijom.2014.03.018', '']\n",
      "['9261041', 'Pariser RJ. A response to <>. Journal of the American Academy of Dermatology. (2014) 70  5 pp951', '10.1016/j.jaad.2013.10.052', '']\n",
      "['9261042', \"Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sj√∂gren's syndrome: a randomized, double-blind, placebo-controlled clinical trial. Chinese medical journal. (2014) 127 15 pp2721-2726\", '10.1155/2017/1315432', 'http://downloads.hindawi.com/journals/ecam/2017/1315432.pdf']\n",
      "['9261043', 'L√≥pez Mantec√≥n AM; Garrido G; Delgado-Hern√°ndez R; Garrido-Su√°rez BB. Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study. Phytotherapy research : PTR. (2014) 28 8 pp1163-1172', '10.1002/ptr.5108', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.5108']\n",
      "['9261045', 'Lumley MA; Keefe FJ; Mosley-Williams A; Rice JR; McKee D; Waters SJ; Partridge RT; Carty JN; Coltri AM; Kalaj A; Cohen JL; Neely LC; Pahssen JK; Connelly MA; Bouaziz YB; Riordan PA. The effects of written emotional disclosure and coping skills training in rheumatoid arthritis: a randomized clinical trial. Journal of consulting and clinical psychology. (2014) 82 4 pp644-658', '10.1037/a0036958', 'http://psycnet.apa.org/journals/ccp/82/4/644.pdf']\n",
      "['9261047', 'Smolen JS; Weinblatt ME; Sheng S; Zhuang Y; Hsu B. Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2014) 73 9 pp1616-1625', '10.1136/annrheumdis-2013-205137', '']\n",
      "['9261050', 'Pichlmeier U; Heuer KU. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate. Clinical and experimental rheumatology. (2014) 32 4 pp563-571', '10.1177/2050312114564241', 'https://journals.sagepub.com/doi/pdf/10.1177/2050312114564241']\n",
      "['9261052', 'Alipour B; Homayouni-Rad A; Vaghef-Mehrabany E; Sharif SK; Vaghef-Mehrabany L; Asghari-Jafarabadi M; Nakhjavani MR; Mohtadi-Nia J. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. International journal of rheumatic diseases. (2014) 17 5 pp519-527', '10.1111/1756-185x.12333', '']\n",
      "['9261053', 'Puente R; Illnait J; Mas R; Mendoza S; Carbajal D; Fernandez J; Mesa M; Prieto Y. Effects of D-002, a mixture of beeswax alcohols, co-administered with green-lipped mussel extract, on osteoarthritis symptoms. International Journal of Pharmaceutical Sciences Review and Research. (2014) 27  1 pp209-216', '10.3904/kjim.2014.29.2.191', 'http://www.kjim.org/upload/kjim-29-2-8_191-202.pdf']\n",
      "['9261054', 'Gottenberg JE; Ravaud P; Pu√©chal X; Le Guern V; Sibilia J; Goeb V; Larroche C; Dubost JJ; Rist S; Saraux A; Devauchelle-Pensec V; Morel J; Hayem G; Hatron P; Perdriger A; Sene D; Zarnitsky C; Batouche D; Furlan V; Benessiano J; Perrodeau E; Seror R; Mariette X. Effects of hydroxychloroquine on symptomatic improvement in primary Sj√∂gren syndrome: the JOQUER randomized clinical trial. JAMA. (2014) 312 3 pp249-258', '10.1001/jama.2014.7682', '']\n",
      "['9261055', 'Goel R; Hassell KL; Machado RF; Barst RJ; Yovetich N; Kato GJ; et al. Non-cardiopulmonary factors affecting the six-minute walk distance in patients with sickle cell disease: results from the Walk-PHaSST study [abstract]. Blood. (2011) 118 21 ppAbstract no: 1074', '10.1182/blood.v118.21.1074.1074', 'https://ashpublications.org/blood/article/118/21/1074/78807/NonCardiopulmonary-Factors-Affecting-the-SixMinute']\n",
      "['9261058', 'Ridker PM. Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?. Transactions of the American Clinical and Climatological Association. (2013) 124  pp174-190', '10.1111/j.1538-7836.2009.03404.x', '']\n",
      "['9261059', 'Harigai M; Takamura A; Atsumi T; Dohi M; Hirata S; Kameda H; Nagasawa H; Seto Y; Koike T; Miyasaka N. Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: A report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs. Modern Rheumatology. (2013) 23  2 pp284-296', '10.3109/s10165-012-0657-2', '']\n",
      "['9261063', \"Primdahl J; Wagner L; Horslev-Petersen K. Being an outpatient with rheumatoid arthritis - a focus group study on patients' self-efficacy and experiences from participation in a short course and one of three different outpatient settings. Scandinavian journal of caring sciences. (2011) 25  2 pp394-403\", '10.1111/j.1471-6712.2010.00854.x', '']\n",
      "['9261064', 'Sandooghi M; Zakeri Z; Almasy S; Dashipour AR. A Comparative Study on Atorvastatin Versus Methotrexate in Rheumatoid Arthritis in a Double Blind Placebo control Trial. Shiraz E Medical Journal. (2011) 12  4 pp189-195', '10.3109/9780203214237-61', '']\n",
      "['9261065', 'Furst DE; Venkatraman MM; McGann M; Manohar PR; Booth-LaForce C; Sarin R; Sekar PG; Raveendran KG; Mahapatra A; Gopinath J; Kumar PRK. Erratum: Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis (Journal of Clinical Rheumatology (2011) 17 (185-192)). Journal of clinical rheumatology. (2011) 17  7 pp407', '10.1097/rhu.0b013e31821c0310', '']\n",
      "['9261067', 'Hochberg MC; Wohlreich M; Gaynor P; Hanna S; Risser R. Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. Journal of rheumatology. (2012) 39  2 pp352-358', '10.3899/jrheum.110307', '']\n",
      "['9261069', 'Rahnama N; Mazloum V. Effects of strengthening and aerobic exercises on pain severity and function in patients with knee rheumatoid arthritis. International journal of preventive medicine. (2012) 3  7 pp493-498', '10.31983/jahmt.v2i4.5739', 'https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JAHMT/article/viewFile/5739/pdf']\n",
      "['9261072', 'Burmester GR; Weinblatt ME; Barbarash O; Vatutin M; Szombati I; Stoilov R; Matsievskaya G; Venalis A; Esfandiari E; Grove G; Saurigny D; Sleeman MA; Godwood A; Magrini F. Mavrilimumab (an anti-GM-csfralpha monoclonal antibody) in subjects with rheumatoid arthritis: Results of a phase 2 randomized, double-blind, placebo-controlled study. Arthritis and rheumatism. (2011) 63  12 pp4044', '10.1136/annrheumdis-2012-eular.2061', '']\n",
      "['9261073', 'Nash PT; Hall S; Strand V; Kartvelishvili E; Kilasonia L; Williams B; Dobbin C; Vanags D. Efficacy and safety of subcutaneous recombinant chaperonin10 in patients with active rheumatoid arthritis despite methotrexate treatment. Arthritis and rheumatism. (2011) 63  12 pp4043', '10.1002/art.23383', '']\n",
      "['9261074', 'Fleischmann R; Spencer-Green GT; Fan F; Frankovic B; Luo X; Hoock T; Damjanov N. Dose ranging study of VX-509, an oral selective JAK3 inhibitor, as monotherapy in patients with active rheumatoid arthritis (RA). Arthritis and rheumatism. (2011) 63  12 pp4042', '10.1002/art.38949', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38949']\n",
      "['9261077', 'Kellner H; Essex M; Li C. Safety and efficacy of nsaids in elderly arthritis patients: A subgroup analysis. Osteoarthritis and cartilage. (2011) 19  ppS144', '10.1016/s1063-4584(11)60338-5', '']\n",
      "['9261078', 'Salesi M; Sadeghihaddadzavareh S; Nasri P; Namdarigharaghani N. Efficacy of bromocriptine in patients with active rheumatoid arthritis receiving methotrexate therapy. European journal of internal medicine. (2011) 22  ppS85', '10.1016/s0953-6205(11)60346-4', '']\n",
      "['9261080', 'Ikonomidis I; Tzortzis S; Lekakis J; Kremastinos DT; Dasou P; Andreadou I; Nikolaou M; Katsimbri P; Paraskevaidis I; Anastasiou-Nana M. Inhibition of interleukin-1 activity reduces apoptosis leading to improved speckle tracking myocardial deformation in patients with rheumatoid arthritis with and without CAD. European heart journal. (2011) 32  pp600', '10.1016/s0735-1097(11)60254-4', '']\n",
      "['9261081', 'Togni S; Maramaldi G; Di Pierro F; Biondi M. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clinical, cosmetic and investigational dermatology. (2014) 7  pp321-327', '10.2147/ccid.s69240', '']\n",
      "['9261083', 'Ikonomidis I; Tzortzis S; Tellis C; Andreadou I; Katsimbri P; Paraskevaidis I; Parissis J; Anastasiou-Nana M; Tselepis A; Lekakis J. Association of LpPLA2 activity with coronary and LV function in patients with coronary artery disease and coexistent rheumatoid arthritis: Effects of Interleukin-1 inhibition. European heart journal. (2013) 34  pp118-119', '10.1093/eurheartj/eht307.p614', '']\n",
      "['9261084', 'Le HV; Poole C; Brookhart AM; Schoenbach VJ; Beach KJ; Sturmer T. Effects of aggregation of medical codes on the performance of the high-dimensional propensity score (HD-PS) algorithm. Pharmacoepidemiology and drug safety. (2013) 22  pp181', '10.1186/1471-2288-13-142', 'http://link.springer.com/article/10.1186/1471-2288-13-142/fulltext.html']\n",
      "['9261088', 'Zhuang Y; Hsu B; Xu Z; Ford J; Keen M; Davis HM; Zhou H. Sirukumab pharmacokinetics following multiple subcutaneous administrations in patients with rheumatoid arthritis despite methotrexate therapy. Clinical Pharmacology in Drug Development. (2013) 2  pp36-37', '10.1016/j.clinthera.2011.11.015', '']\n",
      "['9261089', \"Naftali T; Mechoulam R; Gabay G; Stein A; Bronshtein M; Mari A; Konikoff FM. Cannabidiol treatment does not effect active crohn's disease. Gastroenterology. (2013) 144  5 SUPPL. 1 ppS180\", '10.1016/s0016-5085(13)60641-1', '']\n",
      "['9261090', 'Yalcin U; Cakir T; Uckun A; Toraman NF. Is the muscle strength improvement affected by knee osteoarthritis severity?, Diz Osteoratrit Siddeti Egzersizle Kuvvet Kazanimini Etkiler mi?. [Turkish, English]. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi. (2013) 59  pp345', '10.5152/tftrd.2014.04372', '']\n",
      "['9261091', 'Dotu B; Sirzai H; Yilmaz F; Polat B; Kuran B. Comparison of the effects of isotonic and isometric hand exercises on pain, hand functions, dexterity and quality of life in patients with rheumatoid arthritis, Romatoid Artritli Hastalarda Izotonik ve Izometrik El Egzersizlerinin Atri, El Fonksiyonlari ve Yasam Kalitesi Uzerine Etkilerinin Karsilastirilmasi. [Turkish, English]. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi. (2013) 59  pp238', '10.1007/s00296-013-2787-z', 'http://link.springer.com/article/10.1007/s00296-013-2787-z/fulltext.html']\n",
      "['9261092', 'Ferguson AM; Thomas VN; Lempp H; Cope A; Scott DL; Simpson C; Weinman J; Agarwal S; Kirkham B; Patel A; Ibrahim F. Improving adherence in rheumatoid arthritis: A pilot study. Rheumatology (United Kingdom). (2013) 52  ppi107', '10.1080/13548506.2015.1009917', '']\n",
      "['9261093', 'Ravindran V. Impact of rheumatoid arthritis disease education on adherence to therapy and followups: A prospective controlled study from India. Rheumatology (United Kingdom). (2013) 52  ppi82', '10.3899/jrheum.130350', '']\n",
      "['9261095', 'Baildam E; Ruperto N; Brunner H; Zuber Z; Keane C; Harari O; Kenwright A; Cuttica RJ; Keltsev V; Xavier R; Penades IC; Nikishina I; Rubio-Perez N; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Opoka-Winiarska V; Quartier P; Silva CA; Silverman ED; Spindler A; Lovell DJ; Martini A; De Benedetti F. Efficacy and safety of tocilizumab in polyarticular juvenile idiopathic arthritis: Cherish results at week 40. Rheumatology (United Kingdom). (2013) 52  ppi35', '10.1136/annrheumdis-2013-eular.265', '']\n",
      "['9261098', 'Kirkham B; Boggs R; Li W; Nab HW; Tarallo M. The importance of managing arthritis in patients with both moderate-to-severe psoriasis and psoriatic arthritis. Value in health. (2013) 16  3 ppA227', '10.1016/j.jval.2013.03.1152', '']\n",
      "['9261099', 'Smith M; Taylor A; Youssef P; Hall S; Nash P; Sebba A; Rubbert-Roth A; Scali J; Alten R; Kremer J; Pitts L; Van Vollenhoven R; Genovese M. Long-term safety of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) and a mean treatment duration of 3.7 years. Internal medicine journal. (2013) 43  pp33', '10.1136/annrheumdis-2013-eular.1383', '']\n",
      "['9261101', 'Gnanasakthy A; Kosinski M; Genovese M; Mallya UG; Mpofu S. Association between ACR improvement and healthrelated quality of life (HRQoL) among rheumatoid arthritis (RA) patients treated with secukinumab. Dermatology and Therapy. (2012) 2  ppS59-S60', '10.1136/annrheumdis-2012-eular.504', '']\n",
      "['9261103', 'Van Vollenhoven R; Blocka K; Emery P; Bingham C; Keystone E ; Fleischmann R; Furst D; Macey K; Sweetser M; Lehane P; Farmer P; Long S. Long-term safety of rituximab (RTX): Rheumatoid arthritis (RA) clinical trials and retreatment population. Reumatologia Clinica Suplementos. (2011) 7 var.pagings pp137', '10.3899/jrheum.090856', '']\n",
      "['9261105', 'Ravindran V. Impact of rheumatoid arthritis disease education on adherence to therapy and follow ups in a prospective controlled study. Indian Journal of Rheumatology. (2012) 7  ppS35', '10.1016/s0973-3698(11)60109-x', '']\n",
      "['9261108', \"Vanhoutte F; Mazur M; Van Der Aa A; Wigerinck P; Van 'T Klooster G. Selective JAK1 inhibition in the treatment of rheumatoid arthritis: Proof of concept with GLPG0634. Arthritis and rheumatism. (2012) 64  ppS1051\", '10.1136/annrheumdis-2012-eular.1946', '']\n",
      "['9261113', 'Bearne LM; Manning VL; Scott DL; Choy E; Hurley MV. A brief exercise and self management programme improves upper limb disability in people with early rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS1027', '10.1093/rheumatology/keu319', 'http://academic.oup.com/rheumatology/article-pdf/54/2/302/6896828/keu319.pdf']\n",
      "['9261116', 'Yamaoka K; Kubo S; Sonomoto K; Hirata S; Cavet G; Bolce R; Rowe MW; Chernoff D; Defranoux N; Saito K; Tanaka Y. Correlation of a multi-biomarker disease activity (vectra DA) score with clinical disease activity and its components with radiographic progression in rheumatoid arthritis patients treated with tofacitinib. Arthritis and rheumatism. (2012) 64  ppS914-S915', '10.1136/annrheumdis-2012-eular.2110', '']\n",
      "['9261117', 'Van Der Goes MC; Jacobs JWG; Jurgens MS; Bakker MF; Van Der Veen MJ; Van Der Werf JH; Welsing PMJ; Bijlsma JWJ. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone, if osteoporosis prophylaxis is applied?. Arthritis and rheumatism. (2012) 64  ppS846', '10.1007/s00198-012-2073-z', '']\n",
      "['9261119', 'Brunner H; Ruperto N; Zuber Z; Keane C; Harari O; Kenwright A; Cuttica RJ; Keltsev V; Xavier R; Penades IC; Nikishina I; Nadina R-P; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Violetta O-W; Quartier P; Silva CA; Silverman ED; Spindler A; Lovell DJ; Martini A; De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: Data from a phase 3 trial. Arthritis and rheumatism. (2012) 64  ppS682', '10.1136/annrheumdis-2013-eular.265', '']\n",
      "['9261122', 'Fleischmann R; Kivitz AJ; Wagner F; Feinstein JA; Fuhr U; Rech J; Sidhu J; Hill PL; Oliver R; Kretsos K. A pilot study investigating the tolerability and pharmacodynamic effect of single intravenous/subcutaneous doses of olokizumab, an anti-interleukin-6 monoclonal antibody, in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 var.pagings ppS576-S577', '10.1002/art.1780391102', '']\n",
      "['9261130', 'Churchill MA; Flores-Suarez LF; Wallace DJ; Phillips K; Martin RW; Cardiel MH; Kaine J; Bautista E; Salinger DH; Stevens E; Russell CB; Martin DA. A phase IB multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab (AMG 827), a human anti-interleukin 17 receptor (IL-17R) antibody, in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS555', '10.1186/ar4347', 'https://link.springer.com/article/10.1186/ar4347/fulltext.html']\n",
      "['9261132', 'Winthrop KL; Racewicz A; Lee EB; Wilkinson B; Zwillich SH; Soma K; Rottinghaus S; Kawabata T; Riese R; Wood S; Bradley J; Bingham III CO. Evaluation of influenza and pneumococcal vaccine responses in patients with rheumatoid arthritis receiving tofacitinib. Arthritis and rheumatism. (2012) 64  ppS550', '10.1136/annrheumdis-2013-eular.368', '']\n",
      "['9261134', 'Keystone E; Cohen SB; Emery P; Kremer JM; Dougados MR; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H. Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors. Arthritis and rheumatism. (2012) 64  ppS548', '10.1136/annrheumdis-2012-eular.526', '']\n",
      "['9261135', 'Ignatenko S; Skrumsager BK; Steensberg A; Mouritzen U. First in human study with recombinant anti-IL-21 monoclonal antibody in healthy subjects and patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS547', '10.5414/cp202474', '']\n",
      "['9261136', 'Moreira E; Jones A; Oliveira HA; Jennings F; Fernandes ARC; Natour J. Effect of insoles on the rheumatoid foot. Arthritis and rheumatism. (2012) 64  ppS527', '10.1136/annrheumdis-2012-eular.376', '']\n",
      "['9261139', 'Stern SM; Blitz JR; Richards A; Marzan KAB. A family based pedometer walking program in an adolescent population with juvenile idiopathic arthritis. Arthritis and rheumatism. (2012) 64  ppS375-S376', '10.1002/art.38531', '']\n",
      "['9261140', 'Kass A; Forre OT; Fagerland M; Gulseth HC; Torjesen P; Hollan I. Cetrorelix, a gonadotropin-releasing hormone antagonist, significantly reduces tumour-necrosis-factor-alpha and demonstrates efficacy in patients with active rheumatoid arthritis: A proof-of-concept, double-blind, randomised trial. Arthritis and rheumatism. (2012) 64  ppS363-S364', '10.1136/annrheumdis-2012-eular.1885', '']\n",
      "['9261143', 'De Benedetti F; Ruperto N; Espada G; Gerloni V; Flato B; Horneff G; Myones BL; Onel K; Frane J; Kenwright A; Lipman TH; Bharucha KN; Martini A; Lovell DJ. Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: 2-year data from a phase 3 clinical trial. Arthritis and rheumatism. (2012) 64  ppS327', '10.1136/annrheumdis-2013-eular.2162', '']\n",
      "['9261144', 'Brunner HI; Ruperto N; Quartier P; Constantin T; Wulffraat N; Horneff G; Brik R; McCann L; Ozdogan H; Rutkowska-Sak L; Schneider R; Berkun Y; Calvo I; Erguven M; Goffin L; Hofer M; Kallinich T; Lheritier K; Abrams K; Stancati A; Lovell DJ; Martini A. Efficacy and safety of canakinumab in patients with active systemic juvenile idiopathic arthritis and fever: Results from two pivotal phase 3 trials. Arthritis and rheumatism. (2012) 64  ppS326-S327', '10.1186/1546-0096-9-s1-o21', 'http://link.springer.com/article/10.1186/1546-0096-9-S1-O21/fulltext.html']\n",
      "['9261146', 'Durez P; Miranda P; Toncheva A; Berman Sr A; Rillo OL; Boutsen Y; Kehler T; Mociran E; Soto Saez L; Fautrel B; Mariette X; Solakov P; Lucero E; Vlak T; Grazio S; Mastrovic K; Chiriac R; Grouard-Vogel G; Dhellin O; Ouary S; Vandepapeliere P; Boissier M-C. Active immunization with tnf-kinoid in rheumatoid arthritis patients with secondary resistance to tumor necrosis factor-alpha antagonists is safe and immunogenic. Arthritis and rheumatism. (2012) 64  ppS209', '10.1136/annrheumdis-2012-eular.2609', '']\n",
      "['9261147', 'Haque UJ; Bingham III CO; Bartlett SJ. Effects of vitamin D repletion and maintenance therapy on clinical indicators of disease activity in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS207-S208', '10.1016/j.semarthrit.2024.152576', '']\n",
      "['9261148', 'Van Vollenhoven RF; Emery P; Bingham III CO; Keystone E; Fleischmann RM; Furst DE; Tyson N; Mehbob A; Lehane PB. Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial program. Arthritis and rheumatism. (2012) 64 var.pagings ppS199', '10.1136/annrheumdis-2012-eular.2085', '']\n",
      "['9261152', 'Alten R; Grahn A; Rice P; Buttgereit F. Improved fatigue-related quality of life in CAPRA-2, a 12 week study of 5-mg modified (delayed) release prednisone in rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  ppS159-S160', '10.1136/rmdopen-2015-000134', '']\n",
      "['9261156', 'Hochberg MC; Lao L; Langenberg P; Fong HHS; Lee DY-W; Berman B. Efficacy and safety of the chinese herbal compound hou-lou-xiao-ling dan in patients with osteoarthritis of the knee: Results of a phase II international study. Arthritis and rheumatism. (2012) 64 10 ppS112', '10.1016/j.joca.2015.06.007', '']\n",
      "['9261157', 'Zhang X; Hsu J; Brunner H; De Benedetti F; Le Gallo C; Zuber Z; Cuttica R; Keltsev V; Xavier R; Calvo Penedes I; Rubio-Perez N; Chasnyk V; Horneff G; Opoka-Winiarska V; Quartier P; Silva C; Spindler A; Baildam E; Gamir ML; Martin A; Siri DA; Smolewska E; Lovell D; Ruperto N; Martini A. Pharmacokinetics (PK) and pharmacodynamics (PD) of tocilizumab (TCZ) in polyarticular-course juvenile idiopathic arthritis (PCJIA). Clinical pharmacology and therapeutics. (2013) 93  ppS8-S89', '10.1186/1546-0096-11-s2-o15', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-O15.pdf']\n",
      "['9261163', 'Durez P; Genovese MC; Richards HB; Supronik J; Dokoupilova E; Aelion JA; Lee S-H; Codding CE; Kellner H; Ikawa T; Hugot S; Ligozio G; Mpofu S. Secukinumab treatment provides sustained response over one year in patients with rheumatoid arthritis. Rheumatology (United Kingdom). (2012) 51  ppiii29', '10.3899/jrheum.130637', '']\n",
      "['9261165', 'Schydlowsky P; Szkudlarek M; Madsen OR. Treatment of frozen shoulder with subcutaneous TNF-alpha blockade compared with local glucocorticoid injection: A randomized pilot study. Scandinavian journal of rheumatology. (2012) 41  pp47', '10.1007/s10067-012-1993-5', 'http://link.springer.com/article/10.1007/s10067-012-1993-5/fulltext.html']\n",
      "['9261166', 'Lawitz E; Swain MG; Sheikh AM; Reddy KR; Chojkier M; Towner WJ; Brainard DM; Pang PS; McNally J; McHutchison JG; Pockros P; Schiff ER. Characteristics of the Interferon-Ineligible and Interferon- Intolerant Hepatitis C Patients Enrolled in a Large Phase 2 Clinical Study. Hepatology (Baltimore, Md.). (2012) 56 var.pagings pp573A-574A', '10.1016/s0168-8278(13)60063-x', '']\n",
      "['9261167', 'Wei L; MacDonald TM. Drop-out rates in patients with and without screening period in the scot trial. Pharmacoepidemiology and drug safety. (2012) 21  pp87', '10.1002/pds.v21.12', '']\n",
      "['9261168', 'Senolt L; Hansen BB; Strandberg-Larsen M; Dokoupilova E. Improvements in physical function and disability in patients with rheumatoid arthritis after treatment with NNC0109-0012 (anti-IL- 20 mAb) in a phase 2A trial. Value in health. (2012) 15  7 ppA439', '10.1016/j.jval.2012.08.1357', '']\n",
      "['9261169', 'Kavanaugh A; McInnes IB; Krueger GG; Gladman D; Beutler A; Gathany T; Mease P. Early and sustained remission associated with normalized physical function and health-related quality of life and significantly improved productivity in patients with active psoriatic arthritis treated with golimumab: GO-REVEAL 2-year data. Journal of managed care pharmacy. (2011) 17  3 pp246', '10.1016/j.jval.2011.02.749', '']\n",
      "['9261171', 'Kellner H; Durez P; Genovese M; Codding C; Ligozio G; Richards H; Escrig C; Mpofu S. Unaltered lipid profile in patients with rheumatoid arthritis receiving secukinumab: Results from a randomized, double-blind, placebo-controlled, phase II study. Zeitschrift fur Rheumatologie. (2012) 71  pp99', '10.1136/annrheumdis-2012-eular.2084', '']\n",
      "['9261172', 'Kellner H; Genovese M; Durez P; Codding C; Ligozio G; Richards H; Escrig C; Mpofu S. Patients with rheumatoid arthritis profit from secukinumab treatment as evicenced by improved ACR50, HAQ-DI and EULAR remission rates. Zeitschrift fur Rheumatologie. (2012) 71  pp92', '10.1136/annrheumdis-2012-eular.2076', '']\n",
      "['9261173', 'Ruperto N; Brunner H; Quartier P; Constantin T; Wulffraat N; Horneff G; Brik R; McCann L; Kasapcopur O; Rutkowska-Sak L; Schneider R; Berkun Y; Calvo I; Erguven M; Goffin L; Hofer M; Kallinich T; Oliveira S; Uziel Y; Nistala K; Wouters C; Cimaz R; Ferrandiz M; Flato B; Gamir M; Kone-Paut I; Grom A; Magnusson B; Ozen S; Sztajnbok F; Lheritier K; Abrams K; Kim D; Martini A; Lovell D. Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis: Results of two randomized phase 3 trials. Zeitschrift fur Rheumatologie. (2012) 71  pp37', '10.1136/annrheumdis-2012-eular.1180', '']\n",
      "['9261174', 'Dogu B; Sirzai H; Yilmaz F; Polat B; Kuran B. Comparison of effects of isotonic and isometric hand exercises on pain, hand functions, dexterity and quality of life in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2012) 15  pp142', '10.1007/s00296-013-2787-z', 'http://link.springer.com/article/10.1007/s00296-013-2787-z/fulltext.html']\n",
      "['9261177', 'Khabbazi A; Hajialilo M; Jovani MN; Kolahi S; Sadra V. Comparing control of rheumatoid arthritis flare up in pulse therapy with dexamethasone and methylprednisolone. International journal of rheumatic diseases. (2012) 15  pp65', '10.1111/1756-185x.12278', '']\n",
      "['9261178', 'Oskouei AK; Hajialilo M; Nakhjovani M; Kolahi S; Safari Z. Effect of vitamin D supplementation on rheumatoid arthritis activity. International journal of rheumatic diseases. (2012) 15  pp64', '10.1136/annrheumdis-2020-eular.239', '']\n",
      "['9261182', 'Kay J; Beutler A; Kavanaugh A; Hsu B; Keystone E; Hsia E; Braun J; MacK M; Doyle M; Fleischmann R. Golimumab 3-Year safety update: An analysis of pooled data from the long term extensions of randomized, double-blind, placebo-controlled studies in rheumatoid arthritis, psoriatic Arthritis, and ankylosing spondylitis. International journal of rheumatic diseases. (2012) 15  pp58', '10.1136/annrheumdis-2012-eular.3080', '']\n",
      "['9261188', 'Hubert MM; Parison D; Martel M-J; Lafontaine D. Indirect comparison of biologics in rheumatology; Cost per responder and number needed to treat. Journal of rheumatology. (2012) 39  8 pp1712', '10.1016/j.jval.2021.04.086', '']\n",
      "['9261192', 'Jeppesen J; Christensen A; Herlin T; Leegaard A; Thastum M. Results of a waitlist controlled psychological group treatment program for children with juvenile idiopathic arthritis and their parents. Journal of psychosomatic research. (2012) 72  6 pp487', '10.1136/annrheumdis-2012-eular.2440', '']\n",
      "['9261193', 'Kavanaugh A; Emery P; Fleischmann R; Van Vollenhoven RF; Pavelka K; Durez P; Guerette B. Withdrawal of adalimumab in early rheumatoid arthritis patients who attained stable low disease activity with adalimumab plus methotrexate: Results of a phase 4, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1016/s0140-6736(13)61751-1', '']\n",
      "['9261203', 'Fleischmann RM; Poiley JE; Stoilov R; Strand V; Freiman J; Oravecz T; Sands A. The oral S1P lyase inhibitor LX3305 (LX2931) demonstrates favorable safety and potential clinical benefit at 12-weeks in a phase 2 proof-of-concept trial in patients with active rheumatoid arthritis on stable methotrexate therapy. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.30194', '']\n",
      "['9261204', 'Oldroyd AGS; Halsey JP; Goodson N; Evans B; Greenbank C; Gore D; Bukhari M. The lancaster osteoporosis predictora novel tool to identify individuals with osteoporosis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.30144', '']\n",
      "['9261209', 'Hsu B. Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-il-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.1708', '']\n",
      "['9261210', 'Hsu B; Sheng S; Smolen J; Weinblatt M. Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-interleukin-6 monoclonal antibody, in active rheumatoid arthritis patients despite methotrexate therapy. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.2065', '']\n",
      "['9261211', 'Guedes LKN; Ribeiro ACM; Moraes JCB; Saad CGS; Aikawa NE; Neto EFB; Pasotto S. Reproducibility of composite scores: Disease activity 28-joints score, simplified disease activity score and clinical disease activity score in the evaluation of rheumatoid arthritis(ra) disease activity: Pursuit for a gold standard. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/acr.20621', '']\n",
      "['9261213', 'Genovese MC; Durez P; Richards HB; Supronik J; Dokoupilova E; Aelion JA; Lee S-H. One year efficacy and safety results of a phase II trial of secukinumab in patients with rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3899/jrheum.130637', '']\n",
      "['9261214', 'Durez P; De Bellefon LM; Depresseux G; Toukap AN; Lauwerys B; Houssiau FA. Infliximab versus placebo in adult patients with ACPA positive undifferentiated arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1093/rheumatology/keu160', 'http://academic.oup.com/rheumatology/article-pdf/53/7/1347/10653707/keu160.pdf']\n",
      "['9261219', 'Furie R; Nicholls K; Cheng T-T; Houssiau F; Burgos-Vargas R; Chen S-L; Aranda R. Efficacy and safety of abatacept over 12 months in patients with lupus nephritis: Results from a multicenter, randomized, double-blind, placebo-controlled phase II/III study. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 ppS962-3', '10.1002/art.38260', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38260']\n",
      "['9261220', 'Weinblatt ME; Kavanaugh A; Genovese MC; Jones DA; Musser TK; Grossbard EB; Magilavy DB. Effects of the oral syk inhibitor, fostamatinib (r788), on health-related quality of life in a phase II study of active rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.3899/jrheum.120923', '']\n",
      "['9261223', 'Bukh G; Hansen MS; Larsen S. Continued tocilizumab infusion for rheumatoid arthritis is well tolerated and safe at an accelerated infusion rate. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2014-eular.2089', '']\n",
      "['9261227', 'Khan NA; Singh M; Spencer H; Torralba KD. Association of funding source with characteristics of clinical trials of rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.34393', '']\n",
      "['9261229', 'Westhovens R; De Keyser F; Rekalov D; Nasonov EL; Beetens J; Van Der Aa A; Wigerinck P. A twelve-week exploratory phase ii trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-202221', '']\n",
      "['9261231', 'Tanaka Y; Kawai S; Takeuchi T; Yamamoto K; Tani S; Okada T; Miyasaka N. A calcineurin inhibitor FK506 suppresses joint destruction in patients with early rheumatoid arthritis and low disease activity. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1007/s10165-012-0817-4', '']\n",
      "['9261232', 'Bushnell DM; Mccarrier KP; Martin ML; Paczkowski R; Shen W; Buesching D. Paper and web equivalence of the ensemble MDS - A tool used to collect phenotypic information prior to treatment. Value in health. (2012) 15  4 ppA51', '10.1016/j.jval.2012.03.282', '']\n",
      "['9261235', 'Nelson F; Zvirbulis R; Pilla AA. Non-invasive electromagnetic field therapy produces rapid and substantial pain reduction in early knee osteoarthritis: A randomized double-blind pilot study. Osteoarthritis and cartilage. (2012) 20  ppS174', '10.1016/j.joca.2012.02.265', '']\n",
      "['9261236', 'Campos GC; Rezende MU; Pailo AF; Frucchi R; Pasqualin T. Evaluation of the effect of adding corticosteroid to viscosupplementation: A prospective and randomized study. Osteoarthritis and cartilage. (2012) 20  ppS169-S170', '10.1016/j.joca.2012.02.257', '']\n",
      "['9261237', 'Rezende MU; Campos GC; Pailo AF; Frucchi R; Pasqualim T. Evaluation of the effect of adding corticosteroid to viscosupplementation: A prospective and randomized study. Osteoporosis international. (2012) 23  ppS132-S133', '10.1016/j.joca.2012.02.257', '']\n",
      "['9261239', 'Fogarty FA; Booth RJ; Gamble GD; Dalbeth N; Consedine NS. The effect of mindfulness-based stress reduction on disease activity in people with rheumatoid arthritis: a randomised controlled trial. Annals of the rheumatic diseases. (2015) 74 2 pp472-474', '10.1136/annrheumdis-2014-205946', '']\n",
      "['9261240', 'Nanus DE; Filer AD; Hughes B; Fisher BA; Taylor PC; Stewart PM; Buckley CD; McInnes I; Cooper MS; Raza K. TNFalpha regulates cortisol metabolism in vivo in patients with inflammatory arthritis. Annals of the rheumatic diseases. (2015) 74  2 // () *Sir Jules Thorn Charitable Trust* pp464-469', '10.1136/annrheumdis-2013-203926', '']\n",
      "['9261241', 'De Rotte MCFJ; Den Boer E; De Jong PHP; Pluijm SMF; Bulatovic Calasan M; Weel AE; Huisman AM; Gerards AH; Van Schaeybroeck B; Wulffraat NM; Lindemans J; Hazes JMW; De Jonge R. Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  2 // () *Pfizer* pp408-414', '10.1136/annrheumdis-2013-203725', '']\n",
      "['9261242', 'Chen X; Hou Y; Jiang J; Zhao Q; Zhong W; Wang W; Yao X; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis. Clinical pharmacokinetics. (2014) 53 11 pp1033-1044', '10.1007/s40262-014-0175-9', 'http://link.springer.com/article/10.1007/s40262-014-0175-9/fulltext.html']\n",
      "['9261243', 'Aryaeian N; Djalali M; Shahram F; Djazayery A; Eshragian MR. Effect of conjugated linoleic acid, vitamin E, alone or combined on immunity and inflammatory parameters in adults with active rheumatoid arthritis: A randomized controlled trial. International journal of preventive medicine. (2014) 5  12 pp1567-1577', '10.1111/j.1756-185x.2009.01374.x', '']\n",
      "['9261244', 'S√∏rensen J; Primdahl J; Horn HC; H√∏rslev-Petersen K. Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial. Scandinavian journal of rheumatology. (2015) 44 1 pp13-21', '10.3109/03009742.2014.928945', '']\n",
      "['9261245', 'Adebajo AO; Johnson D; Bernadette H; Hale C; Ndosi M. Evaluation of the effuc educational needs assessment tool (ENAT) focused patient education on health outcomes in patients with rheumatolid arthritis-a randomised controlled trial. Arthritis and Rheumatology. (2014) 66  ppS1318', '10.1186/isrctn51523281', '']\n",
      "['9261246', 'McBain H; Shipley M; Olaleye A; Moore S; Hirani S; Newman S. The development and evaluation of a self-monitoring and patient-initiated follow-up service for people with rheumatoid or psoriatic arthritis on methotrexate. Arthritis and Rheumatology. (2014) 66  ppS1316', '10.1093/rheumatology/keu098.013', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i77/9578383/keu098.013.pdf']\n",
      "['9261247', \"Azeez M; Clancy C; O'Dwyer T; Wilson F; Cunnane G. Effects of exercise on body composition, cardiovascular fitness, muscle strength, and cognition in patients with rheumatoid arthritis: A randomised controlled trial of a patient-specific exercise programme. Arthritis and Rheumatology. (2014) 66  ppS1274\", '10.1007/s10067-020-04937-4', 'http://link.springer.com/article/10.1007/s10067-020-04937-4/fulltext.html']\n",
      "['9261248', 'Chang S; Sawyer L; Dejonckheere F. Indirect comparison of tocilizumab and tofacitinib in patients with rheumatoid arthritis. Arthritis and Rheumatology. (2014) 66  ppS1093', '10.1016/j.jval.2014.08.2580', '']\n",
      "['9261249', 'Carolina Araujo A; Moraes-Fontes MF; Santos L; Riso N. Omega-3 fatty acids and Mediterranean diet as complimentary therapies for rheumatoid arthritis. Arthritis and Rheumatology. (2014) 66  ppS1050', '10.1201/9781420006186-15', '']\n",
      "['9261251', 'Aimer P; Treharne G; Stebbings S; Frampton C; Cameron V; Kirby S; Stamp LK. A pilot randomized controlled trial of a tailored smoking cessation intervention for rheumatoid arthritis patients. Arthritis and Rheumatology. (2014) 66  ppS1035', '10.1002/acr.22960', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22960']\n",
      "['9261252', 'Van Vilsteren M; Boot C; Van Schaardenburg D; Steenbeek R; Voskuyl AE; Anema J. Effectiveness of a workplace integrated care intervention on work productivity in workers with rheumatoid arthritis. Arthritis and Rheumatology. (2014) 66  ppS920-S921', '10.1007/s10926-015-9624-z', 'http://link.springer.com/article/10.1007/s10926-015-9624-z/fulltext.html']\n",
      "['9261253', 'Baker J; Conaghan PG; Emery P; Baker D; Ostergaard M. Early MRI endpoints provide a valid measure of structural damage while reducing study duration and participant numbers in rheumatoid arthritis clinical trials. Arthritis and Rheumatology. (2014) 66  ppS832', '10.1002/art.38810', '']\n",
      "['9261256', 'Charles-Schoeman C; Burmester G; Nash P; Zerbini CAF; Anway S; Kwok K; Hendrikx T; Bananis E; Fleischmann R. Efficacy and safety of tofacitinib following inadequate response to nonbiologic DMARD or biologic DMARD. Arthritis and Rheumatology. (2014) 66  ppS212-S213', '10.1136/annrheumdis-2014-207178', '']\n",
      "['9261259', 'Durcan L; Wilson F; Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: A randomised controlled study. Irish journal of medical science. (2014) 183  3 SUPPL. 1 ppS110-S111', '10.3899/jrheum.131282', '']\n",
      "['9261260', \"O'Connor C; Dunne Shannon U; Mc Gowan B; Whelan B; Silke C. Hydrotherapy results in reduced pain and fatigue in patients with arthritis. Irish journal of medical science. (2014) 183  3 SUPPL. 1 ppS106\", '10.21203/rs.3.rs-5994342/v1', 'https://www.researchsquare.com/article/rs-5994342/v1']\n",
      "['9261261', 'Chang RW; Semanik PA; Lee J; Feinglass J; Ehrlich-Jones L; Dunlop DD. Improving physical activity in arthritis clinical trial (IMPAACT): study design, rationale, recruitment, and baseline data. Contemporary clinical trials. (2014) 39 2 pp224-235', '10.1016/j.cct.2014.08.010', '']\n",
      "['9261262', 'Le≈õniewicz J; Pieszy≈Ñski I; Zboralski K; Florkowski A. The effect of selected physical procedures on mobility in women with rheumatoid arthritis. Polski merkuriusz lekarski. (2014) 37 222 pp335-337', '10.36740/merkur202405119', '']\n",
      "['9261264', 'Lamb SE; Williamson EM; Heine PJ; Adams J; Dosanjh S; Dritsaki M; Glover MJ; Lord J; McConkey C; Nichols V; Rahman A; Underwood M; Williams MA; Strengthening and Stretching for Rheumatoid Arthritis of the Hand Trial (SARAH) Trial Team. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet (London, England). (2015) 385 9966 pp421-429', '10.1016/s0140-6736(14)60998-3', '']\n",
      "['9261265', 'Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study. Journal of rheumatology. (2014) 41 11 pp2114-2119', '10.3899/jrheum.131412', '']\n",
      "['9261268', 'Mei Y; Xiaochun L; Rongjuan F; Gengrong W; Hangyuan G. Cardiovascular inflammatory factors changes in patients with rheumatoid arthritis and intervention of atorvastatin. Journal of the American College of Cardiology. (2014) 64  16 SUPPL. 1 ppC108', '10.1016/j.jacc.2014.06.503', '']\n",
      "['9261269', 'De Benedetti F; Ruperto N; Zuber Z; Cuttica R; Keltsev V; Xavier R; Calvo I; Nikishina I; Rubio N; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Opoka-Winiarska V; Quartier P; Silva C; Silverman E; Spindler A; Keane C; Bharucha K; Wang J; Lovell D; Martini A; Brunner HI. Efficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: 2-Year data from the cherish study. Rheumatology (United Kingdom). (2014) 53  ppiii1-iii2', '10.1093/rheumatology/keu268.002', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_3/iii1/5134139/keu268.002.pdf']\n",
      "['9261270', 'De Benedetti F; Ruperto N; Espada G; Gerloni V; Flato B; Horneff G; Myones BL; Onel K; Frane J; Wang J; Lipman TH; Bharucha KN; Martini A. Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: 2-Year data from a phase 3 clinical trial. Rheumatology (United Kingdom). (2014) 53  ppiii1', '10.1093/rheumatology/keu268.001', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_3/iii1/18096116/keu268.001.pdf']\n",
      "['9261272', 'Sturner KH; Stellmann J-P; Paul F; Dorr J; Martin R; Heesen C. Safety, tolerability and efficacy of Boswellic acids in relapsing-remitting multiple sclerosis - The SABA proofof-concept trial. Multiple sclerosis (Houndmills, Basingstoke, England). (2014) 20  1 SUPPL. 1 pp88-89', '10.1016/j.jneuroim.2014.08.069', '']\n",
      "['9261274', 'Rokhlina F; Novik G. PW01-040-Definition of polymorphism C3435T MDR1 gene in JIA. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s1-a93', 'http://link.springer.com/article/10.1186/1546-0096-11-S1-A93/fulltext.html']\n",
      "['9261275', 'Ben-Zvi I; Kukuy OL; Lidar M; Feld O; Perski O; Kivity S; Langevitz P; Pistrom B; Livneh A. P01-031-Anakinra for colchicine resistant FMF. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s1-a35', 'http://link.springer.com/article/10.1186/1546-0096-11-S1-A35/fulltext.html']\n",
      "['9261276', 'Hidaka T. Leukocytapheresis for rheumatoid arthritis. Therapeutic apheresis and dialysis. (2013) 17  5 ppA19-A20', '10.1111/j.1744-9987.1997.tb00139.x', '']\n",
      "['9261277', 'Fingerhutova S; Saifridova M; Vranova M; Dolezalova P; Sebkova S; Bohm M; Nemcova D; Obrsalova J. Is there an evidence for the role of multidisciplinary team in the management of active juvenile idiopathic arthritis?. Pediatric Rheumatology. (2014) 12  pp', '10.1186/1546-0096-12-s1-p177', 'http://link.springer.com/content/pdf/10.1186/1546-0096-12-S1-P177.pdf']\n",
      "['9261278', 'Wulffraat NM; Ruperto N; Brunner HI; Oliveira S; Uziel Y; Nistala K; Cimaz R; Ferrandiz MA; Flato B; Gamir M; Kone-Paut I; Gaillez C; Lheritier K; Abrams K; Martini A; Lovell D. Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients. Pediatric Rheumatology. (2014) 12  pp', '10.1186/1546-0096-12-s1-p68', 'http://link.springer.com/content/pdf/10.1186/1546-0096-12-S1-P68.pdf']\n",
      "['9261279', 'Bracciolini GP; Davi S; Pistorio A; Consolaro A; Verazza S; Lattanzi B; Filocamo G; Dalpra S; Gattinara M; Gerloni V; Insalaco A; De Benedetti F; Civino A; Presta G; Breda L; Lepore L; Maggio C; Garofalo F; Magni-Manzoni S; Rigante D; Buoncompagni A; Gattorno M; Malattia C; Picco P; Viola S; Ruperto N; Martini A; Ravelli A. A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis. Pediatric Rheumatology. (2014) 12  pp', '10.1186/1546-0096-12-s1-p1', 'http://link.springer.com/content/pdf/10.1186/1546-0096-12-S1-P1.pdf']\n",
      "['9261280', 'Khan A; Dubois S; Rahman Z; Khan OA; Derzko C. A randomized, double-blind, placebo controlled study to evaluate the effects of alendronate (ALN) on bone mineral density (BMD) and bone turnover in perimenopausal women with low BMD. Osteoporosis international. (2014) 25  1 SUPPL. 1 ppS55-S56', '10.1016/j.jocd.2014.04.095', '']\n",
      "['9261281', 'Burgos-Vargas R; Tse S; Horneff G; Pangan A; Unnebrink K; Anderson J. Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis. Journal of rheumatology. (2014) 41  7 pp1531-1532', '10.1002/art.38414', '']\n",
      "['9261292', 'Hsia E; Fortin I; Rioux E; Chaker N. Follow-up project : Study on the impact of physical therapy in etanercept-treated patients. Journal of rheumatology. (2013) 40  6 pp969', '10.3109/03009742.2013.776104', '']\n",
      "['9261294', 'Haraoui B; Fallon L; Riese R; Kwok K; Valdez H. Tofacitinib, an oral Janus Kinase inhibitor: Effects of baseline glucocorticoid use on selected infections in pooled phase 3 and longterm extension rheumatoid arthritis study populations. Journal of rheumatology. (2013) 40  6 pp961', '10.1155/2013/357904', 'http://downloads.hindawi.com/archive/2013/357904.pdf']\n",
      "['9261295', 'Seneca T; Hauge EM; Maribo T. Comparison of a 12-week partly supervised exercise programme with a self-administered exercise programme for patients with newly diagnosed rheumatoid arthritis. Scandinavian journal of rheumatology. (2014) 43  pp75-76', '10.1093/rheumatology/kev046.005', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i6/5178571/kev046.005.pdf']\n",
      "['9261300', 'Scotti V; Meattini I; Cecchini S; De Feo ML; Saieva C; De Luca Cardillo C; Livi L. A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral bisphosphonate treatment on bone mineral density in osteopenic women receiving adjuvant aromatase inhibitors: Interim analysis of \"BONADIUV\" trial. Journal of clinical oncology. (2014) 32 15 SUPPL. 1 pp', '10.1200/jco.2014.32.15_suppl.tps658', '']\n",
      "['9261301', 'Ravelli A; Malattia C; Ruperto N; Palmisani E; Pederzoli S; Pistorio A; Brunner HI; Cuttica R; Penades IC; Garay SM; Eleftheriou D; Wouters C; Wang J; Devlin C; Lovell DJ; Martini A; De Benedetti F. Assessment of radiographic progression in patients with systemic juvenile idiopathic arthritis treated with tocilizumab: 2-year results from the tender trial. Rheumatology (United Kingdom). (2014) 53  ppi167-i168', '10.1093/rheumatology/keu125.011', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i167/9578910/keu125.011.pdf']\n",
      "['9261310', 'Havrdova E; Belova A; Goloborodko A; Tisserant A; Jones I; Garren H; Johns D. Positive proof of concept of AIN457, an antibody against interleukin-17A, in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). (2012) 18  4 SUPPL. 1 pp513', '10.1016/j.msard.2018.12.013', '']\n",
      "['9261312', 'Van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann RM; Furst D; Hessey EW; Vashishtha A; Mehbob A; Lehane PB. Long-term safety of rituximab: Pooled analysis of the rheumatoid arthritis global clinical trial programme over 11 years. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1857', '']\n",
      "['9261316', 'Kerr G; Yazici Y; Swearingen C; Luo C; Espinoza L; Sherrer Y; Treadwell E; Mosley-Williams A; Alamino Perez R; Dowell S; Godoy A; Paul M. Less than 5% of ethnic minority rheumatoid arthritis (RA) patients meet inclusion criteria for randomized controlled clinical trials (RCT). Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1255', '']\n",
      "['9261323', 'Kozaki T; Tagashira M; Yamanishi K; Osawa Y; Ellis B; Kayanoki T; Ooishi R; Sugiyama K; Tsuruta K; Kohira T; Tsurui K. Evaluation of drug-drug interaction between the novel cpla2 inhibitor ak106-001616 and methotrexate in rheumatoid arthritis patients. Clinical pharmacology and therapeutics. (2014) 95  ppS21', '10.3109/00498254.2014.1000430', '']\n",
      "['9261324', 'Malattia C; Ruperto N; Palmisani E; Pederzoli S; Pistorio A; Brunner HI; Cuttica R; Calvo I; Garay SM; Eleftheriou D; Wouters C; Wang J; Devlin C; Lovell D; Martini A; De Benedetti F; Ravelli A. PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-p147', 'https://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P147.pdf']\n",
      "['9261325', 'De Benedetti F; Ruperto N; Zuber Z; Cuttica R; Xavier R; Calvo I; Rubio N; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Opoka-Winiarska V; Quartier P; Spindler A; Keane C; Bharucha K; Wang J; Lovell D; Martini A; Brunner HI. PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-o15', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-O15.pdf']\n",
      "['9261326', 'Burgos-Vargas R; Tse S; Horneff G; Pangan AL; Unnebrink K; Anderson JK. PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-o14', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-O14.pdf']\n",
      "['9261327', 'Ruperto N; Lovell DJ; Jarosova K; Nemcova D; Vargova V; Michels H; Chalom EC; Ilowite N; Wouters C; Brunner HI; Kracht KK; Kupper H; Giannini E; Martini A; Mozaffarian N. PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis. Pediatric Rheumatology. (2013) 11  pp', '10.1186/1546-0096-11-s2-o4', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-O4.pdf']\n",
      "['9261328', 'Scott D; Woltz J; Loiseau C. Zoledronic acid reduces femoral bone loss following total HIP arthroplasty. Journal of bone and mineral research. (2010) 25  ppS475', '10.1016/j.arth.2012.08.007', '']\n",
      "['9261329', 'Mathur J; Mills P; Naing S; Limsui D. Supplementation of vitamin D3 (cholecalciferol) in patients with ulcerative colitis and hypovitaminosis D: A prospective randomized trial. Gastroenterology. (2014) 146  5 SUPPL. 1 ppS-454', '10.1016/s0016-5085(14)61628-0', '']\n",
      "['9261330', 'Chan FKL; Kee KM; Lee VW; Ching J. Rabeprazole for the prevention of gastroduodenal injury associated with nonsteroidal anti-inflammatory drugs (NSAIDS): A double-blind randomized trial. Gastroenterology. (2014) 146  5 SUPPL. 1 ppS-208', '10.1016/s0016-5085(14)60737-x', '']\n",
      "['9261331', 'Ma L; Ji P; Wang Y; Zhao L; Xu Y; Doddapaneni S; Sahajwalla CG. Exposure-response modeling and simulation of the efficacy endpoints in rheumatoid arthritis. Journal of pharmacokinetics and pharmacodynamics. (2013) 40  1 SUPPL. 1 ppS73', '10.1007/s10928-014-9385-x', 'http://link.springer.com/article/10.1007/s10928-014-9385-x/fulltext.html']\n",
      "['9261332', 'Rouse PC; Duda JL; Veldhuijzen Van Zanten JJ; Metsios GS; Ntoumanis N; Yu C-A; Kitas GD. Feelings of competence and relatedness during physical activity are related to well-being in rheumatoid arthritis patients: Preliminary findings from a randomized control trial. Annals of the rheumatic diseases. (2013) 72 Suppl3 pp1093', '10.1136/annrheumdis-2013-eular.3152', '']\n",
      "['9261333', 'Zhu T; Sawamoto T; Valluri U; Lewand M; Cao Y; Swan S; Lasseter K; Matson M; Holman J; Keirns J. Pharmacokinetics, safety, and tolerability of ASP015K, a novel janus kinase inhibitor, in healthy volunteers. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2686', '']\n",
      "['9261334', 'Ye Z; He W; Yin Z; Gao J; Xie Y. Clinical study on etanercept combined with tripterygium wilfordii polyglycoside for treatment of eldly rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.2617', '']\n",
      "['9261338', 'Gladman D; Fleischmann R; Coteur G; Woltering F; Mease PJ. Effect of certolizumab pegol on the multiple facets of psoriatic arthritis as reported by patients with and without prior anti-TNF exposure: 24-week patient-reported outcome results of rapid-PSA study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1985', '']\n",
      "['9261340', 'Senolt L; Hansen BB; Strandberg-Larsen M; Dokoupilova E. Improvements in patient-reported physical function, pain and global disease activity in patients with rheumatoid arthritis after treatment with nnc0109-0012 (anti-IL-20 mAb) in a phase 2A trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1838', '']\n",
      "['9261344', 'Brodsky A; Diri E; Garcia-DeLaTorre I; Alvarez DF; Bencan C; Bukowski J; Zang C. Clinical efficacy of 2 dosing regimens of TRU-015, a B cell-depleting agent, in subjects with active seropositive rheumatoid arthritis compared with placebo on a stable background of methotrexate. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1371', '']\n",
      "['9261349', 'Vollenhoven RV; Franck-Larsson K; Leirisalo-Repo M; Uhlig T; Jansson M; Larsson E; Hutchinson K; Ostergaard M. In rheumatoid arthritis patients with stable low disease activity on methotrexate plus etanercept, continuation of etanercept at 50 mg or 25 mg weekly are both clinically superior to discontinuation: Results from a randomized, 3-arm, double-blind study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1312', '']\n",
      "['9261355', 'Orlova E; Karateev D; Nasonov E; Kochetkov A. Comparative efficacy of gym high-intensity dynamic exercises and therapeutic exercises in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.1079', '']\n",
      "['9261356', 'Sieper J; Kivitz A; Van Tubergen A; Deodhar A; Coteur G; Woltering F; Landewe R. Rapid improvements in patient-reported outcomes with certolizumab pegol in patients with axial spondyloarthritis, including ankylosing spondylitis: 24-week results of rapid-axSpA study. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.888', '']\n",
      "['9261358', 'Schiff MH; Simon LS; Dave KJ; Jaffe J; Freundlich B. Self-administered methotrexate using a medi-jet auto-injector improves bioavailability compared with oral methotrexate in adults with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.777', '']\n",
      "['9261359', \"Vanhoutte FP; Van Der Aa A; Meuleners L; Van 't Klooster G. Safety and efficacy of GLPG0634, a selective JAK1 inhibitor in patients with rheumatoid arthritis: Results of a 4-week phase ii a dose ranging, multi-center trial. Annals of the rheumatic diseases. (2013) 72  pp\", '10.1136/annrheumdis-2013-eular.757', '']\n",
      "['9261362', 'Yamanishi K; Ellis B; Kudo K; Kayanoki T; Dews I; Ostor A; Wilson A. The novel cPLA2 inhibitor AK106-001616 is a new category of anti-inflammatory/analgesic drug demonstrating efficacy and favorable tolerability in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.751', '']\n",
      "['9261363', 'Moctezuma F; Martinez A; Enkerlin H; Garcia C; Chavez B; Salazar-Teran N; Molina A; Revilla J. Comparative, randomized, simple blind to evaluate efficacy and safety of infinitam (etanercept), associated with methotrexate compared with enbrel (etanercept) associated with methotrexate in patients with modeate and severe rheumatoid arthritisj. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.736', '']\n",
      "['9261365', 'Catlett IM; Legedza AK; Sewell L; Hoock T. The effect of VX-509, a selective oral JAK3 inhibitor, on plasma biomarkers of disease activity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.688', '']\n",
      "['9261366', 'Winthrop KL; Neal J; Hrycaj P; Soma K; Wilkinson B; Hodge J; Zwillich SH; Wang T; Rottinghaus S; Kawabata T; Riese R; Mebus C; Bradley JD; Bingham III CO. Evaluation of influenza and pneumococcal vaccine responses in rheumatoid arthritis patients using tofacitinib. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.368', '']\n",
      "['9261369', 'De Benedetti F; Ruperto N; Zuber Z; Keane C; Harari O; Kenwright A; Cuttica R; Keltsev V; Xavier R; Calvo I; Nikishina I; Rubio-Perez N; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Opoka-Winiarska V; Quartier P; Silva C; Silverman E; Spindler A; Martini A; Lovell D; Brunner H. Efficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: Data from a phase 3 trial. Annals of the rheumatic diseases. (2013) 72  pp', '10.1136/annrheumdis-2013-eular.265', '']\n",
      "['9261372', 'Tarakci E; Yeldan I; Baydogan S; Olgar S; Kasapcopur O. The efficacy of land-based home exercise program in patients with juvenile idiopathic arthritis: A randomized-controlled, single-blind study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2933', '']\n",
      "['9261373', 'Jeppesen JH; Herlin T; Christensen AE; Leegaard A; Thastum M. A waitlist controlled trial of the efficacy of a psychological treatment program for children with juvenile idiopathic arthritis and their parents. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2440', '']\n",
      "['9261374', 'Quartier P; Erguven M; Horneff G; Berkun Y; Lheritier K; Kim D; Abrams K; Constantin T. IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1184', '']\n",
      "['9261375', 'Unk JA. Efficacy study of multimedia to educate rheumatoid arthritis patients. Arthritis and rheumatism. (2013) 65  ppS420', '10.1002/2327-6924.12064', '']\n",
      "['9261376', 'Juyal M; Ware A; Houk J; Mina R. Electronic learning module enhances rheumatology education. Arthritis and rheumatism. (2013) 65  ppS411', '10.1002/art.38167', '']\n",
      "['9261378', 'Dale J; Stirling A; McInnes IB; Porter D. Targeting ultrasound remission in early rheumatoid arthritis-results of the TaSER study. Arthritis and rheumatism. (2013) 65  ppS338-S339', '10.1136/annrheumdis-2015-208941', '']\n",
      "['9261379', 'Schiff MH; Simon LS; Freundlich B; Jaffe J; Dave KJ. Drug exposure limitations of oral methotrexate (MTX) at doses>15mgs may be overcome by using a subcutaneousmtxauto-injector in patients with rheumatoid arthritis (RA). Arthritis and rheumatism. (2013) 65  ppS337-S338', '10.1136/annrheumdis-2014-205228', '']\n",
      "['9261380', 'Burgos-Vargas R; Tse SML; Horneff G; Pangan AL; Unnebrink K; Anderson JK. Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis. Arthritis and rheumatism. (2013) 65  ppS336', '10.1186/1546-0096-11-s2-o14', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-O14.pdf']\n",
      "['9261381', 'Brunner IH; Ruperto N; Zuber Z; Cuttica RJ; Xavier R; Calvo I; Rubio N; Alekseeva E; Chasnyk V; Chavez J; Horneff G; Opoka-Winiarska V; Quartier P; Spindler A; Keane C; Bharucha KN; Wang J; Lovell DJ; Martini A; De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: 2-year data from cherish. Arthritis and rheumatism. (2013) 65  ppS335', '10.1002/art.38415', '']\n",
      "['9261382', \"Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic D; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ. Predictors and sustainability of clinical inactive disease in polyarticular juvenile idiopathic arthritis given aggressive therapy very early in the disease course. Arthritis and rheumatism. (2013) 65  ppS334-S335\", '10.1002/art.34343', '']\n",
      "['9261383', 'Adami S; Beaulieu A; Rahman P; Seriolo B; Lee JS; Krammer G; Porter B; Thulasiraman A; Richards HB. A randomized placebo-controlled phase 2 study to evaluate efficacy, safety and tolerability of two secukinumab loading dose regimens in subjects with active rheumatoid arthritis despite treatment with methotrexate. Arthritis and rheumatism. (2013) 65  ppS220', '10.3899/jrheum.150117', '']\n",
      "['9261395', 'Leu JH; Mendelsohn AM; Ford J; Davis HM; Xu Z. Body surface area-based dosing approach produced comparable golimumab exposure across different age ranges after subcutaneous administration of golimumab in pediatric patients with juvenile idiopathic arthritis. Arthritis and rheumatism. (2013) 65  ppS123', '10.1002/art.38452', '']\n",
      "['9261396', 'Kingsbury DJ; Quartier P; Arora V; Kalabic J; Kupper H; Mozaffarian N. Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to >4 years or >4 years weighing <15 kg. Arthritis and rheumatism. (2013) 65  ppS117', '10.1186/1546-0096-11-s2-p173', 'https://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P173.pdf']\n",
      "['9261397', 'Malattia C; Ruperto N; Palmisani E; Pederzoli S; Pistorio A; Brunner HI; Cuttica RJ; Calvo I; Garay SM; Eleftheriou D; Wouters C; Wang J; Devlin C; Lovell DJ; Martini A; De Benedetti F; Ravelli A. Assessment of radiographic progression in patients with systemic juvenile idiopathic arthritis treated with tocilizumab: 2-year results from the tender trial. Arthritis and rheumatism. (2013) 65  ppS115-S116', '10.1002/art.38482', '']\n",
      "['9261398', 'De Benedetti F; Brunner HI; Baildam EM; Burgos-Vargas R; Horneff G; Huppertz H-I; Minden K; Myones BL; Onel K; Wang J; Bharucha KN; Lovell DJ; Martini A; Ruperto N. Neutropenia with tocilizumab treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis. Arthritis and rheumatism. (2013) 65  ppS114', '10.1002/art.38430', '']\n",
      "['9261399', 'Schneider R; Brunner HI; Ruperto N; Wulffraat N; Quartier P; Brik R; McCann L; Foster HE; Frosch M; Gerloni V; Harel L; Len C; Houghton K; Joos R; Abrams K; Lheritier K; Kessabi S; Martini A; Lovell DJ. Marked improvement in patient reported outcomes of children with active systemic juvenile idiopathic arthritis with canakinumab treatment-results of the phase iii program. Arthritis and rheumatism. (2013) 65  ppS111-S112', '10.1186/1546-0096-11-s2-p170', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P170.pdf']\n",
      "['9261407', 'Traistaru RM; Rogoveanu O; Matei D; Popescu R. Chronic low back pain in osteoporotic females with rheumatoid arthritis a randomized clinical trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.3321', '']\n",
      "['9261410', 'Abou-Raya S; Abou-Raya A; Sallam N. Methotrexate: A therapeutic option in symptomatic knee osteoarthritis: Randomized placebo-controlled trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2756', '']\n",
      "['9261411', 'Leszczynski P; Eshof MK; Stegmann HVB; Hundahl Mooller NP; Graff LB. NNC0109-0012 (anti-IL-20 MAB), well tolerated in patients with rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2654', '']\n",
      "['9261412', 'Al Kotbi N; Jensen L; Graff LB. NNC0109-0012 (anti-IL-20 MAB), well tolerated in healthy subjects and patients with rheumatoid arthritis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2653', '']\n",
      "['9261419', 'Durez P; Miranda P; Toncheva A; Berman A; Rillo OL; Boutsen Y; Kehler T; Mociran E; Soto Saez L; Fautrel B; Mariette X; Sokalov P; Lucero E; Vlak T; Grazio S; Mastrovic K; Chirieac R; Grouard-Vogel G; Dhellin O; Ouary S; Fanget B; Vandepapeliere P; Boissier M-C. Active therapeutic immunization with TNF-kinoid in rheumatoid arthritis patients with secondary resistance to tnfalpha antagonists is safe and immunogenic. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2609', '']\n",
      "['9261422', 'Wulffraat N; Kallinich T; McCann L; Brik R; Rutkowska-Sak L; Ferrandiz M; Lheritier K; Kim D; Gnanasakthy A; Ozdogan H. Changes in health-related quality of life in systemic juvenile idiopathic arthritis patients after single dose of canakinumab. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2293', '']\n",
      "['9261424', 'Catlett IM; Luo X; Penney MS; Pray ME; Spencer-Green G; Botfield M; Hoock T. Biomarker assessment of VX-509, an investigational selective JAK3 inhibitor, in healthy volunteers. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2106', '']\n",
      "['9261425', 'Pereira DF; Furtado RNV; Natour J; Machado NP. Effectiveness and tolerance infiltration intraarticular corticosteroid according to dose. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2102', '']\n",
      "['9261427', 'Durez P; Genovese M; Kellner H; Codding C; Ligozio G; Richards H; Escrig C; Mpofu S. Lack of effect of secukinumab treatment on the lipid profile in patients with rheumatoid arthritis: Results from a randomized, double-blind, placebo-controlled, phase II study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2084', '']\n",
      "['9261428', 'Hsu B; Sheng S; Smolen JS; Weinblatt ME. Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2065', '']\n",
      "['9261429', 'Burmester G; Weinblatt M; McInnes I; Barbarash O; Esfandieri E; Sleeman M; Godwood A; Magrini F. Mavrilimumab in rheumatoid arthritis: Results of a phase 2 double-blind, placebo controlled study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2061', '']\n",
      "['9261430', 'Van Vollenhoven RF; Wax S; Copt S; Tak PP. Safety and efficacy of atacicept in combination with rituximab in patients with rheumatoid arthritis: Results from the atacicept for reduction of signs and symptoms in rheumatoid arthritis trial (III). Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.2055', '']\n",
      "['9261432', 'Senolt L; Gothberg M; Valencia X; Dokoupilova E. Efficacy and safety of nnc0109-0012 (anti-IL-20 MAB) in patients with rheumatoid arthritis: Results from a phase 2a trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1964', '']\n",
      "['9261434', 'Mease PJ; Fleischmann R; Deodhar A; Wollenhaupt J; Kielar D; Woltering F; Stach C; Hoepken B; Arledge T; Van Der Heijde D. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24 week results of a phase 3 double blind randomized placebo-controlled study (rapid-PSA). Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1961', '']\n",
      "['9261435', \"Vanhoutte FP; Mazur M; Namour F; Van Der Aa A; Wigerinck P; Van'T Klooster GAE. Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial. Annals of the Rheumatic Disease. (2013) 71  pp\", '10.1136/annrheumdis-2012-eular.1946', '']\n",
      "['9261436', 'Hara M; Ishiguro N; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Yamamoto K. Efficacy and safety evaluation of iguratimod, a novel anti-rheumatic agent-a double-blind, comparative study of iguratimod-MTX combination in rheumatoid arthritis patients with an inadequate response to MTX. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1888', '']\n",
      "['9261437', 'Tak PP; Balanescu A; Tseluyko V; Bojin S; Drescher E; Dairaghi D; Miao S; Marchesin V; Jaen J; Schall TJ; Bekker P. Orally-administered CCR1 antagonist CCX354-C in a phase 2 rheumatoid arthritis study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1886', '']\n",
      "['9261438', 'Kass A; Gulseth HC; Hollan I; Fagerland M; Torjesen P; Forre O. Cetrorelix, a gonadotropin-releasing hormone antagonist, significantly reduces TNF-alpha and demonstrates efficacy in patients with active rheumatoid arthritis: A proof-of-concept, double-blind randomised trial. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1885', '']\n",
      "['9261439', 'Park W; Hrycaj P; Kovalenko V; Miranda P; Gutierrez-Urena S; Lee Y; Lim M; Ahn C; Kim H; Yoo D; Braun J. A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1850', '']\n",
      "['9261442', 'Hsu B; Sheng S; Weinblatt ME; Smolen JS. Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1708', '']\n",
      "['9261443', 'Damjanov N; Tlustochowicz M; Aelion J; Dimic A; Greenwald M; Diehl A; Bhattacharya I; Menon S; Gourley I. Safety and efficacy of SBI-087 in subjects with active rheumatoid arthritis in a phase 2 randomized, double-blind, placebo-controlled study. Annals of the Rheumatic Disease. (2013) 71  pp', '10.1136/annrheumdis-2012-eular.1707', '']\n",
      "['9261450', 'Genovese MC; Van Vollenhoven R; Bloom BJ; Jiang JG; Kinnman N. A phase 2B, 12-week study of VX-509, an oral selective janus kinase 3 inhibitor, in combination with background methotrexate in rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  12 pp3320', '10.1136/annrheumdis-2014-eular.2487', '']\n",
      "['9261451', 'Jousse-Joulin S; Devauchelle-Pensec V; Cornec D; Gestin S; Bressollette L; Marhadour T; Pers J-O; Nowak E; Saraux A. Ultrasonographic salivary glands response to rituximab in primary sjogren syndrome patients in the tolerance and efficacy of rituximab in primary sjogren syndrome study is not associated with the anatomopathology changes. Arthritis and rheumatism. (2013) 65  ppS1236', '10.1002/art.39088', '']\n",
      "['9261453', 'Takeuchi T; Tanaka Y; Ishiguro N; Yamanaka H; Yoneda T; Genant HK; Van Der Heijde D. Dose-response effects of denosumab, a novel subcutaneous rankl inhibitor, on the progression of bone erosion in japanese patients with rheumatoid arthritis treated with methotrexate: Results of phase ii drive study-a twelve month placebo controlled, randomized, double blind study. Arthritis and rheumatism. (2013) 65  ppS1198', '10.1136/annrheumdis-2015-208052', '']\n",
      "['9261456', \"Aranow C; Cush JJ; Bolster MB; Striebich CC; Dall'Era M; Mackay M; Olech E; Frech TM; Box J; Keating RM; Wasko MCM; St Clair EW; Kivitz A; Diamond B; Davidson A; Spychala M; Goldmuntz EA. A double-blind randomized placebo-controlled trial of lovastatin in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS1181-S1182\", '10.1093/rheumatology/kez471', 'http://academic.oup.com/rheumatology/article-pdf/59/7/1505/33420445/kez471.pdf']\n",
      "['9261457', 'Michaud K; Askling J; Yamanaka H; Symmons D; Holmqvist M; Frisell T; Reed G; Pappas DA; Tanaka E; Inoue E; Verstappen SMM; Garwood C; Horne L; Lampl K; Berglind N; Franzen S; Nyberg F; Tran T; Ho M; Greenberg JD. Can RA registries provide contextual safety data for modern RCTS?. Arthritis and rheumatism. (2013) 65  ppS1178', '10.1136/annrheumdis-2015-208698', '']\n",
      "['9261461', 'Tammara B; Miyoshi S; Hey-Hadavi J. Pharmacokinetic and pharmacodynamic characterization of a dissociated agonist of glucocorticoid receptor, following multiple dose administration in healthy japanese adult subjects. Arthritis and rheumatism. (2013) 65  ppS1009-S1010', '10.5414/cp202659', '']\n",
      "['9261464', 'Van Vollenhoven RF; Rubbert-Roth A; Sebba A; Porter-Brown B; Rowell L; Napalkov P; Smart D. Tocilizumab in patients with rheumatoid arthritis and rates of malignancy: Results from long-term extension clinical trials. Arthritis and rheumatism. (2013) 65  ppS1005', '10.1093/rheumatology/keu101.015', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i91/9578471/keu101.015.pdf']\n",
      "['9261465', 'Strand V; Suthoff E; Fleischmann RM; Vera-Llonch M; Jiang J; Zhang Y; Kinnman N. Effects of VX-509, an investigational oral selective janus kinase 3 (JAK3) inhibitor, on patient-reported outcomes in a phase 2A study of patients with active rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS1004-S1005', '10.1136/annrheumdis-2014-eular.2487', '']\n",
      "['9261466', 'Van Vollenhoven R; Emery P; Bingham III CO; Keystone E; Fleischmann RM; Furst DE; Hessey EW; Mehbob A; Lehane PB. Long-term safety of rituximab: Pooled analysis of the rheumatoid arthritis global clinical trial program over 11 years. Arthritis and rheumatism. (2013) 65  ppS1000', '10.1136/annrheumdis-2013-eular.1857', '']\n",
      "['9261467', 'Stock T; Fleishaker D; Wang X; Mukherjee A; Mebus C. Phase 2 evaluation of PF-04171327, a dissociated agonist of the glucocorticoid receptor, for the treatment of rheumatoid arthritis in patients with an inadequate response to methotrexate. Arthritis and rheumatism. (2013) 65  ppS997', '10.1111/1756-185x.13053', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13053']\n",
      "['9261473', 'Kerr GS; Yazici Y; Swearingen C; Luo C; Sherrer YRS; Treadwell EL; Mosley-Williams AD; Espinoza LR; Alamino RP; Dowell S; Garcia-Vallardes I; Lawrence-Ford T; Godoy A; Ince A; Flower C. Less than 5% of ethnic minority rheumatoid arthritis patients meet inclusion criteria for randomized controlled clinical trials. Arthritis and rheumatism. (2013) 65  ppS960-S961', '10.1136/annrheumdis-2013-eular.1255', '']\n",
      "['9261474', 'Fraenkel L; Wilhelms E; Reyna V. Do numbers make a difference?. Arthritis and rheumatism. (2013) 65  ppS919', '10.1016/s0049-0172(96)80015-1', '']\n",
      "['9261475', 'Xiong Y; Wang W; Ebling W; Sun H; Luttringer O; Abrams K; Ruperto N; Brunner H. Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis. Arthritis and rheumatism. (2013) 65  ppS865-S866', '10.1186/1546-0096-11-s2-p181', 'http://link.springer.com/content/pdf/10.1186/1546-0096-11-S2-P181.pdf']\n",
      "['9261478', 'Luchi M; Fidelus-Gort R; Douglas D; Zhang H; Flores R; Newton R; Scherle P; Yeleswaram S; Chen X; Sandor V. A randomized, dose-ranging, placebo-controlled, 84-day study of INCB039110, a selective janus kinase-1 inhibitor, in patients with active rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS765-S766', '10.3109/09546634.2015.1115819', '']\n",
      "['9261480', 'Weinblatt M; Genovese MC; Ho M; Hollis S; Rosiak-Jedrychowicz K; Kavanaugh A; Millson D; Leon G; Wang M; Van Der Heijde D. Oskira-1: A phase III, multicenter, randomized, double-blind, placebo-controlled parallel-group study of 2 dosing regimens of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate. Arthritis and rheumatism. (2013) 65 var.pagings ppS763-S764', '10.1002/art.38851', '']\n",
      "['9261483', \"Ilowite NT; Prather K; Lokhnygina Y; Schanberg LE; Elder M; Milojevic D; Verbsky JW; Spalding SJ; Kimura Y; Imundo LF; Punaro MG; Sherry DD; Tarvin SE; Zemel LS; Birmingham JD; Gottlieb BS; Miller ML; O'Neil KM; Ruth NM; Wallace CA; Singer NG; Sandborg CI. The randomized placebo phase study of rilonacept in the treatment of systemic juvenile idiopathic arthritis. Arthritis and rheumatism. (2013) 65  ppS757-S758\", '10.1002/art.38699', '']\n",
      "['9261484', 'Burmester GR; Durez P; Shestakova G; Li Y; Wang A; Lewitzky S; Koroleva I; Lee D; Hueber W. Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in a cohort of patients with active rheumatoid arthritis: An exploratory phase 2 biomarker study. Arthritis and rheumatism. (2013) 65  ppS736-S737', '10.1093/rheumatology/kev258', 'http://academic.oup.com/rheumatology/article-pdf/55/1/49/18096374/kev258.pdf']\n",
      "['9261485', 'Yoo D-H; Park W; Jeka S; Molina FC; Hrycaj P; Wiland P; Spieler W; Brzezicki J; Lee EY; Medina-Rodriguez FG; Shesternya P; Radominski S; Stanislav M; Kovalenko V; Sheen DH; Lim MJ; Choe J-Y; Lee SY; Shim S-C; Suh C-H. A randomized, controlled, multicenter, 2-arm, parallel-group, double-blind study to demonstrate the equivalence of CT-P10 to innovator rituximab with respect to pharmacokinetic profile in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS736', '10.1007/s40259-017-0232-7', 'http://link.springer.com/article/10.1007/s40259-017-0232-7/fulltext.html']\n",
      "['9261487', 'Burmester G-R; Takeuchi T; Barbarash O; Porter D; Saurigny D; Close D; Godwood A; Yang Y; Fernandes AW. Early and sustained improvement in pain and physical function as measured by visual analog scale and short form-36 physical component summary score in rheumatoid arthritis patients treated with mavrilimumab, an investigational anti-GM-CSFR-alpha monoclonal antibody, in a phase 2a study. Arthritis and rheumatism. (2013) 65  ppS734', '10.1136/annrheumdis-2013-eular.1359', '']\n",
      "['9261488', 'De Jong PHP; Hazes JMW; Han KH; Huisman AM; Van Zeben D; Van Der Lubbe PA; Gerards AH; Van Schaeybroeck B; De Sonnaville PB; Krugten MV; Luime JJ; Weel AEAM. Initial triple DMARD therapy is more efficient than methotrexate monotherapy in recent onset rheumatoid arthritis; 1-year data of a randomized clinical trial (tREACH). Arthritis and rheumatism. (2013) 65  ppS717', '10.1136/annrheumdis-2013-204788', '']\n",
      "['9261494', 'Inderjeeth C; Redfern A; Huang M; Hardiman Y; Grant T; Fritz LC; Fuller D; Haughey D; Totoritis MC. Safety, pharmacokinetics, and pharmacodynamics of San-300, a novel monoclonal antibody against very late antigen-1: Results of a phase 1 study in healthy volunteers and patients with active rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS610', '10.1186/ar4312', 'https://link.springer.com/article/10.1186/ar4312/fulltext.html']\n",
      "['9261497', 'Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K. Efficacy and safety of a novel disease-modifying antirheumatic drug, iguratimod, as add-on therapy for patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 var.pagings ppS601-S602', '10.1136/annrheumdis-2020-eular.2691', '']\n",
      "['9261501', 'Dokoupilova E; Jeka S; Vencovsky J; Badurski J; Prins K; Strand V; Keystone EC; Van Vollenhoven RF; Wollenhaupt J; Wartenberg-Demand A; Niemann G; Abufarag A; Aigner S; Kaiser S; Rharbaoui F; Czeloth N; Wolter R; Dalken B; Holzkamper T. Use of a biologic marker for an integrated pharmacodynamic and clinical analysis to inform further clinical development, including dose selection for the phase 2B trial-treat 2B-of tregalizumab in rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS596', '10.1136/annrheumdis-2017-212478', '']\n",
      "['9261502', 'Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook R; Kaplan MJ. The peroxisome proliferator activated receptor-gamma pioglitazone decreases cardiovascular risk and disease activity in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65  ppS596', '10.1161/jaha.113.000441', '']\n",
      "['9261503', 'Ormseth MJ; Bian A; Oeser AM; Cunningham A; Shintani A; Tanner SB; Stein CM. Reversing vascular dysfunction in rheumatoid arthritis: Peroxisome proliferator-activated receptor gamma agonist therapy improves augmentation index but not endothelial function. Arthritis and rheumatism. (2013) 65  ppS586', '10.1002/art.38686', '']\n",
      "['9261504', 'Tanaka Y; Takeuchi T; Ishiguro N; Yamanaka H; Yoneda T; Genant HK; Van Der Heijde D. Estimation of the effect of denosumab on bone loss from the results of the 12-month phase II study in patients with rheumatoid arthritis (RA) on background methotrexate (MTX). Arthritis and rheumatism. (2013) 65  ppS585', '10.1136/annrheumdis-2015-208052', '']\n",
      "['9261506', 'Pachon J; Kivitz A; Heuer K-U; Pichlmeier U. Successful self-administration of methotrexate in rheumatoid arthritis patients using a prefilled autoinjector pen. Arthritis and rheumatism. (2013) 65  ppS572-S573', '10.1177/2050312114564241', 'https://journals.sagepub.com/doi/pdf/10.1177/2050312114564241']\n",
      "['9261510', 'Bourgeois AL; Thole A; Salamon T; Calvet P; Cantagrel A; Civade E; Morin MC. Prescription of rituximab in Rheumatology: Audit of practices. International journal of clinical pharmacy. (2013) 35  6 pp1294-1295', '10.1136/ejhpharm-2016-000875.161', '']\n",
      "['9261511', 'Kavanaugh A; Mease PJ; Strand V; Purcaru O; Curtis JR. Effect of certolizumab pegol on workplace and household productivity in united states patients with rheumatoid arthritis with or without prior anti-TNF exposure: Results from the predict study. Value in health. (2014) 17  3 ppA53', '10.1016/j.jval.2014.03.311', '']\n",
      "['9261512', 'Kameda H; Kurasawa T; Nagasawa H; Kishimoto M; Amano K; Takeuchi T. DMARD combination therapy in RA after infliximab discontinuation. International journal of rheumatic diseases. (2014) 17  pp58', '10.3109/14397595.2013.844886', '']\n",
      "['9261513', 'Syngle A; Garg N; Krishan P. Rosuvastatin improves endothelial dysfunction in RA. International journal of rheumatic diseases. (2014) 17  pp55', '10.1136/annrheumdis-2014-eular.5272', '']\n",
      "['9261517', 'Ye Z; He W; Yin Z; Gao J; Xie YAN. Clinical study on etanercept combined with Tripterygium wilfordii polyglycoside for treatment of eldly rheumatoid arthritis. International journal of rheumatic diseases. (2013) 16  pp58', '10.1136/annrheumdis-2013-eular.2617', '']\n",
      "['9261518', 'Bao J; Liu W; Zhao J; Xu HJ. Serum chemokines in patients with rheumatoid arthritis treated with recombinant human IL-1 receptor antagonist. International journal of rheumatic diseases. (2013) 16  pp35', '10.5114/ceji.2014.43717', '']\n",
      "['9261519', 'Singh H; Talapatra P; Mathur R; Singhania A; Lather K; Garg K; Deep G; Chaudhary V; Vikram; Parmindar. Role of atorvastatin on disease activity of rheumatoid arthritis patients. Indian Journal of Rheumatology. (2013) 8  ppS30', '10.1097/rhu.0000000000000073', '']\n",
      "['9261521', 'Dhaon P; Das SK; Agarwal G. Methotrexate once weekly versus methotrexate twice to thrice weekly in Divided Doses in Rheumatoid Arthritis-Preliminary Results. Indian Journal of Rheumatology. (2013) 8  ppS17', '10.1111/1756-185x.12910', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12910']\n",
      "['9261522', 'Dalemans W. Stem cell therapy for RA. Human gene therapy. (2013) 24  12 ppA18-A19', '10.1089/hum.2013.2513', '']\n",
      "['9261523', 'Falkner B; Nickeson RW; Zemel L; Iorga D; Brown PB; Berger MF. Effects of celebrex vs. Naproxen on blood pressure in pediatric subjects with juvenile idiopathic arthritis (JIA). Journal of the american society of hypertension. (2014) 8  4 SUPPL. 1 ppe53', '10.1016/j.jash.2014.03.116', '']\n",
      "['9261525', 'Behrens F; Ostergaard M; Stoilov R; Wiland P; Huizinga TW; Berenfus VY; Tak P-P; Vladeva S; Rech J; Rubbert-Roth A; Korkosz M; Rekalov D; Zupanets IA; Ejbjerg BJ; Geiseler J; Fresenius J; Korolkiewicz RP; Schottelius AJ; Burkhardt H. First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1B/2A randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2012) 64  12 pp4171-4172', '10.1136/annrheumdis-2013-204816', '']\n",
      "['9261526', \"Gottenberg J-E; Ravaud P; Puechal X; Le Guern V; Sibilia J; Goeb V; Larroche C; Dubost JJ; Rist S; Saraux A; Morel J; Hayem G; Hachulla E; Perdriger A; Sene D; Zarnitsky C; Perrodeau E; Batouche D; Furlan V; Benessiano J; Seror R; Mariette X. Inefficacy of hydroxychoroquine in primary sjogren's syndrome: Results of the joquer randomized placebo-controlled trial in primary sjogren's syndrome. Arthritis and rheumatism. (2012) 64  12 pp4170-4171\", '10.1136/annrheumdis-2013-eular.319', '']\n",
      "['9261529', 'Iaremenko O; Mykytenko G; Iaremenko K; Matiyaschuk I; Ivashkivsky O. Efficacy and tolerability of a homeopathic medication incena in patients with rheumatoid arthritis (randomized, double-blind, placebo-controlled study). Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2889', '']\n",
      "['9261530', 'Schiff M; Combe B; Dorner T; Kremer JM; Huizinga TW; Veenhuizen M; Gill A; Zou H; Komocsar W; Berclaz P-Y; Ortmann R; Lee C. Efficacy and safety of tabalumab, an anti-b cell activating factor monoclonal antibody, in patients with rheumatoid arthritis WHO HAD an inadequate response to TNF-alpha inhibitors: Results from a phase 3 Multicenter, Randomized, Double-Blind study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3305', '']\n",
      "['9261535', 'Daniluk S; Skrumsager BK; Leszczynski P. Safety and tolerability of the anti-C5AR humanised monoclonal antibody NNC0151-0000 in patients with rheumatoid arthritis: A phase 2, randomised, double-blind, placebo-controlled, multiple-dose trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3239', '']\n",
      "['9261538', 'Van Breukelen D; Castro Cabezas M; Klop B; De Vries MA; Van Der Meulen N; Van Der Arend J; Van De Geijn G-JM; Janssen HW; Van Casteren-Messidoro C; Birnie E; Hazes MJ; Van Zeben J. Delayed progression of carotid intima media thickness in patients with rheumatoid arthritis: 1-year results of the Francis study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1631', '']\n",
      "['9261539', \"Van Beneden K; Verschueren K; Willems W; Wouters H; D'Artois J; De Swert K; Arold G; De Bruyn S. Impact of clinical remission on physical function in patients with rheumatoid arthritis treated with ALX-0061: Post-HOC analysis of phase I/II data. Annals of the rheumatic diseases. (2014) 73  pp\", '10.1136/annrheumdis-2014-eular.2875', '']\n",
      "['9261541', 'Wagner F; Lange CF; Nowak M; Ignatenko S. First human dose of the anti-c5a receptor-targeting, human monoclonal antibody nnc0215-0384 in patients with rheumatoid arthritis: A phase 1, randomised, double-blind, single-dose, dose-escalation trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2156', '']\n",
      "['9261542', 'Lindegaard HM; Johansen PB; Grondal G; Jensen ECN; Juul L; Schlemmer AM; Agular BM; Hansen IMJ. Fast infusion of tocilizumab in rheumatoid arthritis is well tolerated. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2089', '']\n",
      "['9261547', 'Warren M; Hughes S; Flaim J; Singleton W; Yamashita M; Genovese M. ISIS-CRP RX: Pharmacokinetics, pharmacodynamics, safety and tolerability of an antisense oligonucleotide specific for inhibition of CRP in inflammation. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2538', '']\n",
      "['9261553', 'Liu W; Wu Y-H; Hu S-Y; Gao M-L; Wang H-Y; Song Y-J; Yang B-Z-X; Yao H; Qi X-B; Li G. A multicenter, randomized, double-blinded, placebo-controlled trial evaluating the efficacy and of tong Luo Hua Shi capsule, a modernized tibetan medicine, in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3132', '']\n",
      "['9261554', 'Lamba M; Wang R; Fletcher T; Alvey C; Hazra A; Kushner J; Larmann J; Stock T. Pharmacokinetics, bioavailability and safety of a modified release once daily formulation of tofacitinib in healthy volunteers. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1521', '']\n",
      "['9261555', 'Ajeganova S; Svensson B; Hafstrom I. Low-dose prednisolone treatment of early rheumatoid arthritis was associated with increased risk of cerebrovascular but not coronary artery events: Ten year follow-up of a two-year randomized trial. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2536', '']\n",
      "['9261556', 'Genovese MC; Hsia E; Belkowski S; Chien C; Masterson T; Thurmond R; Manthey C; Yan D; Ge T; Greenspan A. Results from a phase 2a, randomized, multicenter, double-blind, placebo-controlled, parallel-group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2404', '']\n",
      "['9261557', 'Baum P; Schoelch C; Zimdahl-Gelling H; Brown M; Webb D; Padula S; Hilbert J; Giessmann T; Steffgen J. Evaluation of safety, pharmacokinetics and pharmacodynamics of BI 638683, a novel CCR1 antagonist. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2352', '']\n",
      "['9261560', 'Syngle A; Verma I; Krishan P. Efficacy and safety of spironolactone in the treatment of rheumatoid arthritis and ankylosing spondylitis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.5165', '']\n",
      "['9261561', 'Syngle A; Garg N; Krishan P. Rosuvastatin improves inflammation and vascular function in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.5290', '']\n",
      "['9261562', 'Syngle A; Garg N; Krishan P. Rosuvastatin and olmesartan improve inflammation and endothelial dysfunction in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.5272', '']\n",
      "['9261563', 'Wulffraat NM; Ruperto N; Brunner HI; Oliveira S; Uziel Y; Nistala K; Cimaz R; Ferrandiz MA; Flato B; Gamir ML; Kone-Paut I; Gaillez C; Lheritier K; Abrams K; Martini A; Lovell DJ. Maintenance of efficacy by canakinumab treatment in systemic juvenile idiopathic arthritis patients. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1215', '']\n",
      "['9261565', 'Van Vollenhoven R; Genovese MC; Zhang Y; Kinnman N. A phase 2B, 24-week study of VX-509 (DECERNOTINIB), an oral selective janus kinase 3 inhibitor, in combination with background methotrexate in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2487', '']\n",
      "['9261566', 'Takeuchi T; Tanaka Y; Iwasaki M; Ishikura H; Saeki S; Kaneko Y; Garg J. A phase 2b study of an oral JAK inhibitor ASP015K monotherapy in Japanese patients with moderate to severe rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1536', '']\n",
      "['9261569', 'Chopra A; Srikantiah C; Cg P; Montero E; Melarkode R. Itolizumab, a human anti-CD6 monoclonal antibody, for treatment of rheumatoid arthritis: Results of a randomized, placebo controlled, phase 2 study. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.2818', '']\n",
      "['9261570', 'Kay J; Chopra A; Chandrashekara S; Olakkengil DJ; Bhojani KS; Bhatia G; Rathi G; Thomas M; Maroli S; Thomson ES; Shneyer L; Wyand MS. A phase 3, randomized, double-blind, active comparator study of the efficacy and safety of BOW015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses. Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.1595', '']\n",
      "['9261571', 'Bae S-C; Kim J-S; Choe J-Y; Park W; Lee S-R; Ahn Y; Seo Y. A randomized, double-blind, phase 3 equivalence TRIAL comparing the etanercept biosimilar, HD203, with ENBREL, in combination with methotrexate (MTX) in patients with Rheumatoid Arthritis (RA). Annals of the rheumatic diseases. (2014) 73  pp', '10.1136/annrheumdis-2014-eular.3558', '']\n",
      "['9261572', 'Aragona P; Aguennouz M; Rania L; Postorino E; Sommario MS; Roszkowska AM; De Pasquale MG; Pisani A; Puzzolo D. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology. (2015) 122 1 pp62-71', '10.1016/j.ophtha.2014.07.048', '']\n",
      "['9261577', 'Fleischmann R; Van Der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E; Kvien TK. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?. Annals of the rheumatic diseases. (2015) 74  6 pp1132-1137', '10.1136/annrheumdis-2013-204920', '']\n",
      "['9261578', 'Brunner HI; Ruperto N; Zuber Z; Keane C; Harari O; Kenwright A; Lu P; Cuttica R; Keltsev V; Xavier RM; Calvo I; Nikishina I; Rubio-P√©rez N; Alexeeva E; Chasnyk V; Horneff G; Opoka-Winiarska V; Quartier P; Silva CA; Silverman E; Spindler A; Baildam E; G√°mir ML; Martin A; Rietschel C; Siri D; Smolewska E; Lovell D; Martini A; De Benedetti F; Paediatric Rheumatology International Trials Organisation PRINTO; Pediatric Rheumatology Collaborative Study Group (PRCSG). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. Annals of the rheumatic diseases. (2015) 74 6 pp1110-1117', '10.1136/annrheumdis-2013-eular.265', '']\n",
      "['9261579', 'Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Annals of the rheumatic diseases. (2015) 74 6 pp1102-1109', '10.1136/annrheumdis-2013-204986', '']\n",
      "['9261582', 'Behrens F; Tak PP; √òstergaard M; Stoilov R; Wiland P; Huizinga TW; Berenfus VY; Vladeva S; Rech J; Rubbert-Roth A; Korkosz M; Rekalov D; Zupanets IA; Ejbjerg BJ; Geiseler J; Fresenius J; Korolkiewicz RP; Schottelius AJ; Burkhardt H. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the rheumatic diseases. (2015) 74 6 pp1058-1064', '10.1136/annrheumdis-2013-204816', '']\n",
      "['9261585', 'Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74 6 pp1311-1316', '10.1136/annrheumdis-2014-206028', '']\n",
      "['9261586', 'Emery P; Gottenberg JE; Rubbert-Roth A; Sarzi-Puttini P; Choquette D; Martinez Taboada VM; Barile-Fabris L; Moots RJ; Ostor A; Andrianakos A; Gemmen E; Mpofu C; Chung C; Gylvin LH; Finckh A. Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Annals of the rheumatic diseases. (2015) 74  6 pp979-984', '10.1136/annrheumdis-2013-203993', '']\n",
      "['9261587', 'Romero-Cerecero O; Zamilpa A; Tortoriello J. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis in patients with diabetic foot ulcer: a randomized, controlled pilot study. Planta medica. (2015) 81 4 pp272-278', '10.1055/s-0034-1396315', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0034-1396315.pdf']\n",
      "['9261588', 'Rubin KH; Holmberg T; Rothmann MJ; H√∏iberg M; Barkmann R; Gram J; Hermann AP; Bech M; Rasmussen O; Gl√ºer CC; Brixen K. The risk-stratified osteoporosis strategy evaluation study (ROSE): a randomized prospective population-based study. Design and baseline characteristics. Calcified tissue international. (2015) 96 2 pp167-179', '10.1007/s00223-014-9950-8', 'http://link.springer.com/article/10.1007/s00223-014-9950-8/fulltext.html']\n",
      "['9261590', 'Kierkegaard S; Jorgensen PB; Soballe K; Mechlenburg I. Pelvic movements are restored to reference values during stair climbing but not during stepping one year after uni-compartmental knee arthroplasty-a secondary analysis of a randomized controlled trial. Osteoarthritis and cartilage. (2015) 23  ppA111-A112', '10.1016/j.joca.2015.02.830', '']\n",
      "['9261592', 'Kozaki T; Tagashira M; Yamanishi K; Ellis B; Kayanoki T; Ooishi R; Sugiyama K; Matsuda S; Tsuruta K; Kohira T; Tsurui K. Evaluation of drug-drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients. Xenobiotica; the fate of foreign compounds in biological systems. (2015) 45  7 pp615-624', '10.3109/00498254.2014.1000430', '']\n",
      "['9261593', \"Namour F; Diderichsen PM; Cox E; Vayssiere B; Van der Aa A; Tasset C; Van't Klooster G. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection. Clinical pharmacokinetics. (2015) 54  8 pp859-874\", '10.1007/s40262-015-0240-z', 'http://link.springer.com/article/10.1007/s40262-015-0240-z/fulltext.html']\n",
      "['9261594', 'Cheung PP; Lahiri M; Teng GG; Lim AY; Lau TC; Lateef A; Mak A; Gossec L; March L. A randomized controlled trial for improving patient self-assessment of synovitis in rheumatoid arthritis with education by ultrasonography: the RAEUS Study. Rheumatology (Oxford, England). (2015) 54 7 pp1161-1169', '10.1093/rheumatology/keu447', 'http://academic.oup.com/rheumatology/article-pdf/54/7/1161/5234397/keu447.pdf']\n",
      "['9261595', 'Joseph A. Utilisation of a single, postoperative drain in unilateral total hip replacement surgery: A randomised, prospective study. Hip international. (2012) 22  4 pp430', '10.1186/isrctn00324631', '']\n",
      "['9261596', 'Mouthon L. Management of relapses in vasculitis. Presse medicale. (2013) 42  4 PART 2 pp619-622', '10.1016/j.lpm.2013.02.307', '']\n",
      "['9261597', 'Charles P; Guillevin L. Rituximab for ANCA-associated vasculitides: The French experience. Presse medicale. (2013) 42  4 PART 2 pp534-536', '10.1016/j.lpm.2013.01.050', '']\n",
      "['9261599', 'Schmoll H-J; Riera-Knorrenschild J; Kroening H; Mayer F; Nitsche D; Ziebermayr R; Andel J; Arnold D; Wittig B; Scheithauer W. Updated results of the randomized phase 2 impact trial: Maintenance with TLR-9 agonist MGN1703 vs placebo in patients with metastatic colorectal carcinoma (MCRC). Annals of oncology. (2013) 24  ppiv16-iv17', '10.1093/annonc/mdt201.12', 'http://academic.oup.com/annonc/article-pdf/24/suppl_4/iv16/6675753/mdt201.12.pdf']\n",
      "['9261600', 'Bello AE; Grahn AY; Ball J; Kent JD; Holt RJ. One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension. Current medical research and opinion. (2015) 31 3 pp407-420', '10.1185/03007995.2014.1000086', '']\n",
      "['9261601', 'Sokolovic S; Dervisevic V; Fisekovic S. Depression and anxiety may reflect a disease activity in rheumatoid arthritis. Clinical and experimental rheumatology. (2014) 32  4 SUPPL. 83 ppS40', '10.5152/eurjrheumatol.2014.020', '']\n",
      "['9261602', 'Pasalic KAS; Radnic TZ; Damjanov N; Bukilica MS; Vojinovic J. Comparative effectiveness of alfacalcidol and prednisone after 3 months of treatment, in 35 rheumatoid arthritis patients. Clinical and experimental rheumatology. (2014) 32  4 SUPPL. 83 ppS38', '10.1136/annrheumdis-2019-eular.6048', '']\n",
      "['9261603', 'Van Breukelen-Van Der Stoep D; Van Zeben J; Klop B; De Vries M; Van Der Meulen N; Van Der Arend J; Van De Geijn G; Janssen H; Van Casteren-Messidoro C; Birnie E; Hazes J; Castro Cabezas M. Reduced progression of carotid intima media thickness in patients with rheumatoid arthritis: 1-year results of the francis study. Atherosclerosis. (2014) 235  2 ppe78', '10.1016/j.atherosclerosis.2014.05.202', '']\n",
      "['9261604', 'Tanaka K; Yamaguchi T; Hara M. Iguratimod for the treatment of rheumatoid arthritis in Japan. Expert review of clinical immunology. (2015) 11  5 pp565-573', '10.1586/1744666x.2015.1027151', '']\n",
      "['9261605', 'Harrison M; Bansback N. Preferences for new treatments diminish in the face of ambiguity. Value in health. (2015) 18  3 ppA164', '10.1016/j.jval.2015.03.952', '']\n",
      "['9261606', 'Reid A; Brady A; Mongey A; Veale DJ; FitzGerald O; Blake C; Cusack T. Effect of dynamic exercise on function in people with rheumatoid arthritis taking anti-TNFalpha medication: Results of a RCT. Physiotherapy (United Kingdom). (2011) 97  ppeS251-eS252', '10.1186/1471-2474-12-11', 'http://link.springer.com/article/10.1186/1471-2474-12-11/fulltext.html']\n",
      "['9261607', 'Hill J; Thorpe R; Bird H. Outcomes for patients with RA: a rheumatology nurse practitioner clinic compared to standard outpatient care. Musculoskeletal care. (2003) 1 1 pp5-20', '10.1002/msc.35', '']\n",
      "['9261609', 'Raffeiner B; Botsios C; Ometto F; Bernardi L; Stramare R; Todesco S; Sfriso P; Punzi L. Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose. Clinical and experimental rheumatology. (2015) 33 1 pp63-68', '10.1136/annrheumdis-2012-eular.2611', '']\n",
      "['9261610', 'Mart√≠n J; Torre F; Padierna A; Aguirre U; Gonz√°lez N; Matellanes B; Quintana JM. Interdisciplinary treatment of patients with fibromyalgia: improvement of their health-related quality of life. Pain practice. (2014) 14 8 pp721-731', '10.1111/papr.12134', '']\n",
      "['9261611', \"Cafaro A; Arduino PG; Gambino A; Romagnoli E; Broccoletti R. Effect of laser acupuncture on salivary flow rate in patients with Sjogren's syndrome. Lasers in medical science. (2015) 30  6 pp1805-1809\", '10.1007/s10103-014-1590-8', 'http://link.springer.com/article/10.1007/s10103-014-1590-8/fulltext.html']\n",
      "['9261613', 'Hodkinson B; Musenge E; Tikly M. Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index. Rheumatology (Oxford, England). (2015) 54 6 pp1033-1038', '10.1093/rheumatology/keu443', 'http://academic.oup.com/rheumatology/article-pdf/54/6/1033/17389690/keu443.pdf']\n",
      "['9261614', 'Chen Z; Wei S; Liu J; Sun W; He D; Guo J. Meridian-sinew release therapy for the treatment of refractory rheumatoid arthritis. International journal of clinical and experimental medicine. (2015) 8  6 pp8485-8496', '10.1155/2013/182528', 'http://downloads.hindawi.com/journals/ecam/2013/182528.pdf']\n",
      "['9261615', 'Keska R Paradowski TPWitonski D. Outcome in primary cemented total knee arthroplasty with or without drain: A prospective comparative study. Indian journal of orthopaedics. (2014) 48 4 pp404-409', '10.4103/0019-5413.136285', 'https://link.springer.com/article/10.4103/0019-5413.136285/fulltext.html']\n",
      "['9261616', 'Pandey S Joshi NPandya D. Clinical efficacy of Shiva Guggulu and Simhanada Guggulu in Amavata (Rheumatoid Arthritis). AYU (An International Quarterly Journal of Research in Ayurveda). (2012) 33 2 pp247-254', '10.4103/0974-8520.105246', '']\n",
      "['9261617', 'Mahto RR Dave ARShukla VD. A comparative study of Rasona Rasnadi Ghanavati and Simhanada Guggulu on Amavata with special reference to Rheumatoid arthritis. Ayu. (2011) 32 1 pp46-54', '10.4103/0974-8520.85724', '']\n",
      "['9261618', 'Sreekanth V Handa R Wali J Aggarwal PDwivedi S. Doxycycline in the treatment of rheumatoid arthritis--a pilot study. Journal of the Association of Physicians of India. (2000) 48 8 pp804-807', '10.1002/1529-0131(199904)42:4<824::aid-anr31>3.0.co;2-3', '']\n",
      "['9261619', 'Narendranathan M Chitra P Kurien MPhilip J. Ketotifen in prevention of indomethacin-induced gastropathy. Indian journal of gastroenterology. (1999) 18 2 pp76-77', '10.1016/s0895-4356(98)90023-3', '']\n",
      "['9261620', 'Ahmed W Kirmani S Qureshi H Alam SZuberi S. Misoprostol in the treatment of NSAID-induced gastroduodenal lesions. Indian journal of gastroenterology. (1991) 10 4 pp135-136', '10.1016/0016-5085(91)90044-l', '']\n",
      "['9261621', 'Barapatre R Prabhakaran L Rupwate RKamat S. Changes in bronchoalveolar lavage and lung function in rheumatoid arthritis. A controlled study. Journal of the Association of Physicians of India. (1990) 38 8 pp562-563', '10.1007/bf02719696', 'http://link.springer.com/article/10.1007/BF02719696/fulltext.html']\n",
      "['9261622', 'Desai MShetty R. Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis. Journal of the Association of Physicians of India. (1977) 25 10 pp703-707', '10.3109/03009747409097135', '']\n",
      "['9261624', 'Dougados M; Soubrier M; Perrodeau E; Gossec L; Fayet F; Gilson M; Cerato MH; Pouplin S; Flipo RM; Chabrefy L; Mouterde G; Euller-Ziegler L; Schaeverbeke T; Fautrel B; Saraux A; Chary-Valckenaere I; Chales G; Dernis E; Richette P; Mariette X; Berenbaum F; Sibilia J; Ravaud P. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the rheumatic diseases. (2015) 74 9 pp1725-1733', '10.1136/annrheumdis-2013-204733', '']\n",
      "['9261625', 'Yang J; Liu L; Zhang Q; Li M; Wang J. Effect of vitamin D on the recurrence rate of rheumatoid arthritis. Experimental and therapeutic medicine. (2015) 10  5 pp1812-1816', '10.3892/etm.2015.2747', '']\n",
      "['9261626', 'Knittle K; De Gucht V; Hurkmans E; Peeters A; Ronday K; Maes S; Vlieland TV. Targeting motivation and self-regulation to increase physical activity among patients with rheumatoid arthritis: a randomised controlled trial. Clinical rheumatology. (2015) 34 2 pp231-238', '10.1007/s10067-013-2425-x', 'http://link.springer.com/article/10.1007/s10067-013-2425-x/fulltext.html']\n",
      "['9261627', 'Proudman SM; Cleland LG; Metcalf RG; Sullivan TR; Spargo LD; James MJ. Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis. British journal of nutrition. (2015) 114 6 pp885-890', '10.1017/s0007114515002718', '']\n",
      "['9261628', 'Liu D; Guo M; Hu Y; Liu T; Yan J; Luo Y; Yun M; Yang M; Zhang J; Guo L. Effect of sanhuangwuji powder, anti-rheumatic drugs, and ginger-partitioned acupoint stimulation on the treatment of rheumatoid arthritis with peptic ulcer: a randomized controlled study. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2015) 35 3 pp273-280', '10.1016/s0254-6272(15)30097-2', '']\n",
      "['9261629', 'Aalbers CJ; Gerlag DM; Vervoordeldonk MJ; Tak PP; Landewe RB. Single-joint assessment for the evaluation of intraarticular treatment: Responsiveness and discrimination of the composite change index. Journal of rheumatology. (2015) 42  9 pp1672-1676', '10.3899/jrheum.140956', '']\n",
      "['9261630', 'Pavelka K; Chon Y; Newmark R; Lin S-L; Baumgartner S; Erondu N. A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate. Journal of rheumatology. (2015) 42  6 pp912-919', '10.3899/jrheum.141271', '']\n",
      "['9261631', 'Moonaz SH; Bingham CO; Wissow L; Bartlett SJ. Yoga in sedentary adults with arthritis: Effects of a randomized controlled pragmatic trial. Journal of rheumatology. (2015) 42  7 pp1194-1202', '10.3899/jrheum.141129', '']\n",
      "['9261632', 'Smolen JS; Weinblatt ME; van der Heijde D; Rigby WF; van Vollenhoven R; Bingham CO; Veenhuizen M; Gill A; Zhao F; Komocsar WJ; Berclaz PY; Ortmann R; Lee C. Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study. Annals of the rheumatic diseases. (2015) 74 8 pp1567-1570', '10.1136/annrheumdis-2014-207090', '']\n",
      "['9261633', 'Xiang N; Li XM; Zhang MJ; Zhao DB; Zhu P; Zuo XX; Yang M; Su Y; Li ZG; Chen Z; Li XP. Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis. International immunopharmacology. (2015) 28  1 pp802-807', '10.1016/j.intimp.2015.08.008', '']\n",
      "['9261636', 'Dhir V; Sandhu A; Kaur J; Pinto B; Kumar P; Kaur P; Sood A; Gupta N; Sharma A; Sharma S. Comparison of two different folic acid doses with methotrexate-a randomized controlled trial (Folvari Study). International journal of rheumatic diseases. (2015) 18  pp102', '10.1186/s13075-015-0668-4', 'https://link.springer.com/article/10.1186/s13075-015-0668-4/fulltext.html']\n",
      "['9261637', 'Capela RC; Corrente JE; Magalhaes CS. Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis. [Portuguese]. Revista brasileira de reumatologia. (2015) 55  1 pp31-36', '10.1016/j.rbre.2014.08.009', '']\n",
      "['9261638', 'Katz SJ; Leung S. Teaching methotrexate self-injection with a web-based video maintains patient care while reducing healthcare resources: a pilot study. Rheumatology international. (2015) 35 1 pp93-96', '10.1007/s00296-014-3076-1', 'http://link.springer.com/article/10.1007/s00296-014-3076-1/fulltext.html']\n",
      "['9261639', 'Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese. Chinese medical journal. (2014) 127 16 pp2894-2899', '10.3760/cma.j.issn.0366-6999.20140670', '']\n",
      "['9261641', 'Durcan L; Wilson F; Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: a randomized controlled study. Journal of rheumatology. (2014) 41 10 pp1966-1973', '10.3899/jrheum.131282', '']\n",
      "['9261645', 'Fleischmann R; Goldman JA; Leirisalo-Repo M; Zanetakis E; El-Kadi H; Kellner H; Bolce R; DeHoratius R; Wang J; Decktor D. Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study. Current medical research and opinion. (2014) 30 11 pp2139-2149', '10.1185/03007995.2014.942416', '']\n",
      "['9261647', 'Brodin N; Lohela-Karlsson M; Sw√§rdh E; Opava CH. Cost-effectiveness of a one-year coaching program for healthy physical activity in early rheumatoid arthritis. Disability and rehabilitation. (2015) 37 9 pp757-762', '10.3109/09638288.2014.940429', '']\n",
      "['9261648', 'Tavares R; Beattie KA; Bensen WG; Bobba RS; Cividino AA; Finlay K; Goeree R; Hart LE; Jurriaans E; Larche MJ; Parasu N; Tarride JE; Webber CE; Adachi JD. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials. (2014) 15  pp268', '10.1186/1745-6215-15-268', 'http://link.springer.com/article/10.1186/1745-6215-15-268/fulltext.html']\n",
      "['9261650', 'Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms. BioMed research international. (2014) 2014  pp368681', '10.1155/2014/368681', 'http://downloads.hindawi.com/journals/bmri/2014/368681.pdf']\n",
      "['9261651', 'Suhler EB; Lim LL; Beardsley RM; Giles TR; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Smith JR; Rosenbaum JT. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology. (2014) 121 10 pp1885-1891', '10.1016/j.ophtha.2014.04.044', '']\n",
      "['9261653', 'Golini J; Jones WL. Kre-Celazine(¬Æ) as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis - a pilot study. Journal of medicinal food. (2014) 17 9 pp1022-1026', '10.1089/jmf.2013.0169', '']\n",
      "['9261654', 'Oranskiy SP; Yeliseyeva LN. Urinary excretion of nephrin in rheumatoid arthritis patients with proteinuria. Clinical and experimental rheumatology. (2014) 32 4 pp572-574', '10.1007/bf02041562', 'http://link.springer.com/article/10.1007/BF02041562/fulltext.html']\n",
      "['9261657', 'He YT; Ou AH; Yang XB; Chen W; Fu LY; Lu AP; Yan XP; Feng XH; Su L; Song YJ; Zeng SP; Liu W; Qian X; Zhu WH; Lao YR; Xu WH; Wen ZH; He XH; Wang BJ; Chen GX; Xue SQ. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study. Rheumatology international. (2014) 34 12 pp1647-1655', '10.1007/s00296-014-3010-6', 'http://link.springer.com/article/10.1007/s00296-014-3010-6/fulltext.html']\n",
      "['9261658', 'Takeuchi T; Tanaka Y; Close D; Godwood A; Wu CY; Saurigny D. Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study. Modern rheumatology / the Japan Rheumatism Association. (2015) 25 1 pp21-30', '10.3109/14397595.2014.896448', '']\n",
      "['9261659', 'Wadley AJ; Veldhuijzen van Zanten JJ; Stavropoulos-Kalinoglou A; Metsios GS; Smith JP; Kitas GD; Aldred S. Three months of moderate-intensity exercise reduced plasma 3-nitrotyrosine in rheumatoid arthritis patients. European journal of applied physiology. (2014) 114 7 pp1483-1492', '10.1007/s00421-014-2877-y', 'http://link.springer.com/article/10.1007/s00421-014-2877-y/fulltext.html']\n",
      "['9261662', 'Cao L; Wang B; Li M; Song S; Weng W; Li H; Su J. Closed reduction and internal fixation versus total hip arthroplasty for displaced femoral neck fracture. Chinese journal of traumatology = zhonghua chuang shang za zhi. (2014) 17 2 pp63-68', '10.26717/bjstr.2021.33.005464', '']\n",
      "['9261663', 'Fan W; Zhao DB; Hu SX; Xu HJ; Zhang X; Zhang MJ; Chen ZW; Zhang FX; Zhu P; Li XF; Bi LQ; Zhou B; Bao CD. A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate. Rheumatology international. (2014) 34 11 pp1519-1527', '10.1007/s00296-014-2989-z', 'http://link.springer.com/article/10.1007/s00296-014-2989-z/fulltext.html']\n",
      "['9261664', 'Strand V; Kosinski M; Gnanasakthy A; Mallya U; Mpofu S. Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds. Health and quality of life outcomes. (2014) 12  pp31', '10.1186/1477-7525-12-31', 'https://link.springer.com/content/pdf/10.1186/1477-7525-12-31.pdf']\n",
      "['9261666', 'Meyfroidt S; van Hulst L; De Cock D; Van der Elst K; Joly J; Westhovens R; Hulscher M; Verschueren P. Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis. Scandinavian journal of rheumatology. (2014) 43 4 pp265-272', '10.3109/03009742.2013.863382', '']\n",
      "['9261668', 'Furtado RN; Pereira DF; da Luz KR; dos Santos MF; Konai MS; Mitraud Sde A; Rosenfeld A; Fernandes Ada R; Natour J. Effectiveness of imaging-guided intra-articular injection: a comparison study between fluoroscopy and ultrasound. Revista brasileira de reumatologia. (2013) 53 6 pp476-482', '10.1016/j.rbre.2013.07.001', '']\n",
      "['9261669', \"Brown S; Navarro Coy N; Pitzalis C; Emery P; Pavitt S; Gray J; Hulme C; Hall F; Busch R; Smith P; Dawson L; Bombardieri M; Wan-Fai N; Pease C; Price E; Sutcliffe N; Woods C; Ruddock S; Everett C; Reynolds C; Skinner E; Poveda-Gallego A; Rout J; Macleod I; Rauz S; Bowman S; TRACTISS trial team. The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sj√∂gren's Syndrome. BMC musculoskeletal disorders. (2014) 15  pp21\", '10.1186/1471-2474-15-21', 'http://link.springer.com/article/10.1186/1471-2474-15-21/fulltext.html']\n",
      "['9261671', 'Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW; SYCAMORE Trial Management Group. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials. (2014) 15  pp14', '10.1186/1745-6215-15-14', 'http://link.springer.com/article/10.1186/1745-6215-15-14/fulltext.html']\n",
      "['9261673', 'Gualtierotti R; Casella F; GrAM (Gruppo di Autoformazione Metodologica). Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?. Internal and emergency medicine. (2014) 9 2 pp223-224', '10.1007/s11739-013-1024-9', 'http://link.springer.com/article/10.1007/s11739-013-1024-9/fulltext.html']\n",
      "['9261678', 'Keystone EC; Haraoui B; Gu√©rette B; Mozaffarian N; Liu S; Kavanaugh A. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study. Journal of rheumatology. (2014) 41 2 pp235-243', '10.3899/jrheum.121468', '']\n",
      "['9261683', 'Wevers-de Boer KV; Heimans L; Visser K; K√§lvesten J; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman M; de Buck MP; de Sonnaville PB; Huizinga TW; Allaart CF. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1‚ÄÖyear in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study. Annals of the rheumatic diseases. (2015) 74 2 pp341-346', '10.1136/annrheumdis-2013-203749', '']\n",
      "['9261684', 'Woodman I. Rheumatoid arthritis: Optimizing treatment strategies in early RA. Nature reviews. Rheumatology. (2013) 9 12 pp695', '10.1038/nrrheum.2013.175', 'https://www.nature.com/articles/nrrheum.2013.175']\n",
      "['9261686', 'Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; H√∏rslev-Petersen K; Hvid M; Deleuran B. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scandinavian journal of rheumatology. (2014) 43 2 pp101-108', '10.3109/03009742.2013.823517', '']\n",
      "['9261688', 'Reiss L; Stolle J; Carl HD; Swoboda B. Recovery of knee function after total knee arthroplasty: different outcomes in patients with osteoarthritis and rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (2014) 73 6 pp559-564', '10.1007/s00393-013-1291-x', 'http://link.springer.com/article/10.1007/s00393-013-1291-x/fulltext.html']\n",
      "['9261690', 'Richmond SJ; Gunadasa S; Bland M; Macpherson H. Copper bracelets and magnetic wrist straps for rheumatoid arthritis--analgesic and anti-inflammatory effects: a randomised double-blind placebo controlled crossover trial. PloS one. (2013) 8 9 ppe71529', '10.1371/journal.pone.0071529', '']\n",
      "['9261694', 'Ndosi M; Lewis M; Hale C; Quinn H; Ryan S; Emery P; Bird H; Hill J. The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Annals of the rheumatic diseases. (2014) 73 11 pp1975-1982', '10.1136/annrheumdis-2013-203403', '']\n",
      "['9261695', 'Ellingsen T; Hansen I; Thorsen J; M√∏ller BK; Tarp U; Lottenburger T; Andersen LS; Skj√∏dt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; √òstergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; H√∏rslev-Petersen K; Stengaard-Pedersen K. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression. Scandinavian journal of rheumatology. (2014) 43 2 pp91-100', '10.3109/03009742.2013.803149', '']\n",
      "['9261696', 'Tiusanen H; M√§kel√§ K; Kiilunen M; Sarantsin P; Sipola E; Pesola M. The effect of different bearing surfaces on metal ion levels in urine following 28 mm metal-on-metal and 28 mm metal-on-polyethylene total hip arthroplasty. Scandinavian journal of surgery. (2013) 102 3 pp197-203', '10.1177/1457496913491874', 'https://journals.sagepub.com/doi/pdf/10.1177/1457496913491874']\n",
      "['9261698', 'Wisniacki N; Amaravadi L; Galluppi GR; Zheng TS; Zhang R; Kong J; Burkly LC. Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis. Clinical therapeutics. (2013) 35 8 pp1137-1149', '10.1016/j.clinthera.2013.06.008', '']\n",
      "['9261701', 'Wang JM; Tao QW; Zhang YZ; Xu Y; Yan XP. Treating rheumatoid arthritis patients of shen deficiency and cold invading syndrome by bushen quhan zhiwang decoction combined methotrexate: an evaluation of clinical efficacy and safety. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2013) 33 5 pp614-618', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9261704', 'L√≥pez-Garc√≠a JS; Garc√≠a-Lozano I; Rivas L; Ram√≠rez N; Raposo R; M√©ndez MT. Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study. Acta ophthalmologica. (2014) 92 1 ppe22-9', '10.1111/aos.12167', '']\n",
      "['9261705', 'Gr√∏nning K; Rannestad T; Skomsvoll JF; Rygg L√ò; Steinsbekk A. Long-term effects of a nurse-led group and individual patient education programme for patients with chronic inflammatory polyarthritis - a randomised controlled trial. Journal of clinical nursing. (2014) 23 7-8 pp1005-1017', '10.1111/jocn.12353', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocn.12353']\n",
      "['9261706', 'Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis. Journal of rheumatology. (2013) 40 9 pp1505-1512', '10.3899/jrheum.121346', '']\n",
      "['9261707', 'Larsson I; Fridlund B; Arvidsson B; Teleman A; Bergman S. Randomized controlled trial of a nurse-led rheumatology clinic for monitoring biological therapy. Journal of advanced nursing. (2014) 70 1 pp164-175', '10.1111/jan.12183', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jan.12183']\n",
      "['9261708', 'Aguilar-Lozano L; Castillo-Ortiz JD; Vargas-Serafin C; Morales-Torres J; Sanchez-Ortiz A; Sandoval-Castro C; Padilla-Ibarra J; Hernandez-Cuevas C; Ramos-Remus C. Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis. Journal of rheumatology. (2013) 40 7 pp1069-1073', '10.3899/jrheum.121427', '']\n",
      "['9261709', 'Hillegass MG; Field LC; Stewart SR; Borckardt JJ; Dong L; Kotlowski PE; Demos HA; Del Schutte H; Reeves ST. The efficacy of automated intermittent boluses for continuous femoral nerve block: a prospective, randomized comparison to continuous infusions. Journal of clinical anesthesia. (2013) 25 4 pp281-288', '10.1016/j.jclinane.2012.11.015', '']\n",
      "['9261710', 'Jensen TW; Hansen MS; H√∏rslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; P√∏denphant J; Stengaard-Petersen K; Junker P; √òstergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skj√∏dt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML; Cimestra study group. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Annals of the rheumatic diseases. (2014) 73 6 pp1123-1129', '10.1136/annrheumdis-2012-203171', '']\n",
      "['9261711', 'Aragona P; Rania L; Roszkowska AM; Spinella R; Postorino E; Puzzolo D; Micali A. Effects of amino acids enriched tears substitutes on the cornea of patients with dysfunctional tear syndrome. Acta ophthalmologica. (2013) 91 6 ppe437-44', '10.1111/aos.12134', '']\n",
      "['9261712', 'Weinblatt ME; Moreland LW; Westhovens R; Cohen RB; Kelly SM; Khan N; Pappu R; Delaet I; Luo A; Gujrathi S; Hochberg MC. Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program. Journal of rheumatology. (2013) 40 6 pp787-797', '10.3899/jrheum.120906', '']\n",
      "['9261718', 'Feinglass J; Song J; Semanik P; Lee J; Manheim L; Dunlop D; Chang RW. Association of functional status with changes in physical activity: insights from a behavioral intervention for participants with arthritis. Archives of physical medicine and rehabilitation. (2012) 93 1 pp172-175', '10.1016/j.apmr.2011.06.037', '']\n",
      "['9261720', 'Das S; Mohanty M; Padhan P. Outcome of rheumatoid arthritis following adjunct statin therapy. Indian journal of pharmacology. (2015) 47  6 pp605-609', '10.4103/0253-7613.169585', '']\n",
      "['9261722', 'Van Breukelen-Van Der Stoep DF; Zijlmans J; Van Zeben D; Klop B; Van De Geijn GJM; Van Der Meulen N; Hazes M; Birnie E; Cabezas MC. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (2015) 44  6 pp443-448', '10.3109/03009742.2015.1028997', '']\n",
      "['9261724', 'Takeuchi T; Yamanaka H; Tanaka Y; Sakurai T; Saito K; Ohtsubo H; Lee SJ; Nambu Y. Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis. Modern Rheumatology. (2015) 25  6 pp817-824', '10.3109/14397595.2015.1022297', '']\n",
      "['9261725', 'McNeill S; Fullen BM. Acupuncture for osteoarthritis of the knee: Common points and treatment parameters used. Physiotherapy (United Kingdom). (2015) 101  ppeS968-eS969', '10.1016/j.physio.2015.03.1825', '']\n",
      "['9261726', 'Williamson E; Williams M; Heine P; Adams J; Dosanjh S; Melina D; Glover M; Lord J; McConkey C; Nichols V; Rahman A; Underwood M; Lamb S. Sarah: Strengthening and stretching for people with rheumatoid arthritis of the hands: A randomised controlled trial. Physiotherapy (United Kingdom). (2015) 101  ppeS814-eS815', '10.1016/j.physio.2015.03.3701', '']\n",
      "['9261727', 'Goodwin PC; Al Qubaeissy K; Gregory W; Fatoye F; Yohannes AM. The effectiveness of aquatic physiotherapy in patients with rheumatoid arthritis: A randomised controlled trial. Physiotherapy (United Kingdom). (2015) 101  ppeS464-eS465', '10.1016/j.physio.2015.03.3251', '']\n",
      "['9261728', 'Fary RE; Slater H; Chua J; Ranelli S; Chan M; Briggs AM. Workforce capacity building in management of rheumatoid arthritis: A randomised controlled trial and cohort study of web-based E-learning for physiotherapists. Physiotherapy (United Kingdom). (2015) 101  ppeS375', '10.1016/j.physio.2015.03.593', '']\n",
      "['9261729', 'Ramanan AV; Dick AD; McKay A; Jones A; Williamson P; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1186/1745-6215-15-14', 'http://link.springer.com/article/10.1186/1745-6215-15-14/fulltext.html']\n",
      "['9261730', 'Lesuis N; Van Vollenhoven R; Hulscher M; Den Broeder A. Effects of two interventions on rheumatologists adherence to optimal care recommendations in rheumatoid arthritis: A combined before/after and randomized controlled trial. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1136/rmdopen-2015-000195', '']\n",
      "['9261731', 'Kostik M; Gaidar E; Dubko M; Snegireva L; Masalova V; Chikova I; Isupova E; Nikitina T; Serogodskaya E; Kalashnikova O; Ravelli A; Chasnyk V. The preventive effect of methotrexate on uveitis onset in JIA depends on uveitis risk factors. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.4210', '']\n",
      "['9261732', 'Lopez-Olivo MA; Barbo A; Rizvi T; Volk R; Lin H; Suarez-Almazor ME. Six-month effects of a multimedia patient education tool in patients with rheumatoid arthritis. A randomized controlled trial. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1002/acr.24362', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.24362']\n",
      "['9261733', 'Leff R; Kumar S; Nikulenkova N; Kaidashev I; Allen K; Dunbar J; Stern H; Adams J; Weinblatt M. Safety and efficacy results of a phase 2, double-blind, placebo-controlled clinical study of duvelisib with background methotrexate (MTX) in adults with moderate-to-severe rheumatoid arthritis (RA). Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1002/art.39249', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39249']\n",
      "['9261734', 'Yoo D-H; Park W; Suh C-H; Shim S-C; Jeka S; Molina FC; Hrycaj P; Spieler W; Wiland P; Brzezicki J; Lee EY; Medina-Rodriguez FG; Shesternya P; Radominski S; Stanislav M; Kovalenko V; Sheen D; Myasoutova L; Lim MJ; Choe J-Y; Kwon TS; Lee SJ. Efficacy and safety of rituximab biosimilar candidate (CT-P10) and innovator rituximab in patients with rheumatoid arthritis: Results from phase I randomized controlled trial over 72 weeks. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1007/s40259-017-0232-7', 'http://link.springer.com/article/10.1007/s40259-017-0232-7/fulltext.html']\n",
      "['9261735', 'Yoo D-H; Park W; Suh C-H; Shim S-C; Molina FC; Jeka S; Brzezicki J; Medina- Rodriguez FG; Hrycaj P; Wiland P; Lee EY; Shesternya P; Kovalenko V; Myasoutova L; Stanislav M; Radominski S; Lim MJ; Choe J-Y; Lee SY; Lee SJ. Efficacy and safety of switched CT-P10 from innovator rituximab compared to those of maintained CT-P10 in patients with rheumatoid arthritis up to 56 weeks. Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1007/s40259-017-0233-6', 'http://link.springer.com/article/10.1007/s40259-017-0233-6/fulltext.html']\n",
      "['9261736', 'Curtis JR; Turner A; Thomas C; Cofield S; Parks R; Ku JH; Messaoudi-Powers I; Wanzeck K; Winthrop KL. Safety, clinical and immunologic effectiveness of the live zoster vaccine administered to patients receiving anti-TNF biologics. Arthritis and Rheumatology. (2015) 67 no pagination ppConference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2015 San Francisco, CA United States. Conference Start: 20151106 Conference End: 20151111. Conference Publication: (var.pagings). 67 (no pagination', '10.1002/art.39448', '']\n",
      "['9261738', 'Van Vollenhoven RF; Keystone EC; Strand V; Pacheco-Tena C; Vencovsky J; Behrens F; Zipp D; Rharbaoui F; Wolter R; Tiemann R-D; Knierim L; Schmeidl R; Zhou X; Aigner S; Daelken B; Wartenberg-Demand A. A phase 2b study evaluating the efficacy and safety of subcutaneously administered tregalizumab in subjects with active rheumatoid arthritis (RA) despite treatment with methotrexate (MTX). Arthritis and Rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2017-212478', '']\n",
      "['9261740', \"Toz B; Inanc M; Erer B; Senturk N; Kamali S; Ocal L; Gul A. Biologic agents in refractory adult still's disease: Better response rates and acceptable safety with anakinra and tocilizumab. Arthritis and Rheumatology. (2015) 67 no pagination pp\", '10.1136/annrheumdis-2016-eular.4994', '']\n",
      "['9261741', 'Garcia R Jr; Yue JJ; Blumenthal S; Coric D; Patel VV; Leary SP; Dinh DH; Buttermann GR; Deutsch H; Girardi F; Billys J; Miller LE. Lumbar total disc replacement for discogenic low back pain: Two-year outcomes of the activL multicenter randomized controlled IDE clinical trial. Spine. (2015) 40  24 pp1873-1881', '10.1097/brs.0000000000001245', '']\n",
      "['9261742', 'Ngo W; Caffery B; Srinivasan S; Jones LW. Effect of Lid Debridement-Scaling in Sjogren Syndrome Dry Eye. Optometry and vision science. (2015) 92  9 ppe316-e320', '10.1097/opx.0000000000000668', '']\n",
      "['9261743', 'Genovese MC; Van Vollenhoven RF; Pacheco-Tena C; Zhang Y; Kinnman N. VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination with Methotrexate in Patients with Rheumatoid Arthritis. Arthritis and Rheumatology. (2016) 68  1 pp46-55', '10.1002/art.39473', '']\n",
      "['9261744', 'Takeuchi T; Tanaka Y; Yamanaka H; Amano K; Nagamine R; Park W; Shiozawa K; Tsukano M; Wei JC; Shao J; Togo O; Mashimo H. Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial. Modern Rheumatology. (2016) 26  1 pp15-23', '10.3109/14397595.2015.1074648', '']\n",
      "['9261745', 'Yonemoto Y; Okamura K; Takeuchi K; Ayabe K; Kaneko T; Matsushita M; Tamura Y; Iso T; Okura C; Otsuka K; Inoue H; Takagishi K. Comparison of golimumab 100-mg monotherapy to golimumab 50 mg plus methotrexate in patients with rheumatoid arthritis: Results from a multicenter, cohort study. Modern Rheumatology. (2016) 26  1 pp24-28', '10.3109/14397595.2015.1069472', '']\n",
      "['9261746', \"Prior Y; Amanna A; Hammond A. Rheumatology occupational therapists' line managers' views of a vocational rehabilitation programme delivered to patients with work problems. Annals of the rheumatic diseases. (2015) 74  pp1352\", '10.1136/annrheumdis-2015-eular.1998', '']\n",
      "['9261747', 'Salmon V; Hewlett S; Walsh N; Kirwan JR; Morris M; Urban M; Cramp F. Acceptability of a novel physical activity and self-management intervention for managing fatigue in rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp1322', '10.1136/annrheumdis-2015-eular.2229', '']\n",
      "['9261748', 'Hinkka H; Vaattanen S; Ala-Peijari S. Effects of cold mist shower on inflammatory arthritis patients; a cross-over controlled clinical trial. Annals of the rheumatic diseases. (2015) 74  pp1302-1303', '10.1136/annrheumdis-2015-eular.2692', '']\n",
      "['9261749', 'Wong P; Zhu TY; Qin L; Li EK; Tam L-S. Comparison of the effect of denosumab and alendronate on bone density and microarchitecture at the 2nd metacarpal head in rheumatoid arthritis females with low bone mass by high-resolution peripheral quantitative computer tomography: A randomized controlled pilot trial. Annals of the rheumatic diseases. (2015) 74  pp1021', '10.1136/annrheumdis-2015-eular.5816', '']\n",
      "['9261751', 'Van Der Goes MC; Jacobs JW; Boers M; Kirwan JR; Hafstrom I; Svensson B; Bijlsma JW. Long term effects of glucocorticoid therapy on radiological progression of joint damage in rheumatoid arthritis: An individual patient meta-analysis. Annals of the rheumatic diseases. (2015) 74  pp736', '10.1136/annrheumdis-2015-eular.6215', '']\n",
      "['9261752', 'Dhir V; Sandhu A; Kaur J; Pinto B; Kumar P; Gupta N; Sood A; Sharma S; Sharma A; Kaur P. Effect of two doses of folic acid on methotrexate toxicity and efficacy-a randomized controlled trial. Annals of the rheumatic diseases. (2015) 74  pp735', '10.1136/annrheumdis-2015-eular.1376', '']\n",
      "['9261754', 'Galeazzi M; Sebastiani GD; Bazzichi L; Garcia Gonzalez E; Ravenni N; Giovannoni L; Wilton J; Selvi E; Bardelli M; Baldi C; Iuliano A; Minisola G; Caporali R; Bombardieri S; Neri D. Dekavil (F8-IL10), a novel therapeutic approach for rheumatoid arthritis: Ongoing phase IB clinical trial results. Annals of the rheumatic diseases. (2015) 74  pp726-727', '10.1136/annrheumdis-2015-eular.3889', '']\n",
      "['9261755', 'Sarmiento-Monroy JC; Rodriguez-Lopez M; Molano-Gonzalez N; Rojas-Villarraga A; Mantilla RD. Subcutaneous abatacept in patients with rheumatoid arthritis: A real-life experience. Annals of the rheumatic diseases. (2015) 74  pp725', '10.1136/annrheumdis-2015-eular.5245', '']\n",
      "['9261756', 'Ghiti Moghadam M; Vonkeman HE; Ten Klooster PM; Van Riel PL; Van De Laar MA; Jansen TL. Randomized trial of stopping TNF-inhibitors in rheumatoid arthritis patients with stable remission or low disease activity in the Netherlands. Annals of the rheumatic diseases. (2015) 74  pp709', '10.1136/annrheumdis-2015-eular.2388', '']\n",
      "['9261758', 'Biryukova A; Shirinsky I; Shirinsky V. Efficacyand safety of simvastatinin uveitis associated with hlab27 and/or rheumatic diseases: A randomized, open-label study. Annals of the rheumatic diseases. (2015) 74  pp497', '10.1136/annrheumdis-2015-eular.5421', '']\n",
      "['9261759', 'Cannon GW; Teng CC; Tang DH; Leng J; Harrison DJ; Sauer B. Persistence and adherence with triple therapy and tumor necrosis factor inhibitor-methotrexate combination therapy in us veterans with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp460-461', '10.1136/annrheumdis-2015-eular.1199', '']\n",
      "['9261762', 'Cheung P; Lahiri M; Teng GG; Lim A; Gossec L; March L. Large joint involvement in asian rheumatoid arthritis patients: A longitudinal study of treatment outcomes using power doppler as a bedside monitoring tool in 101 patients. Annals of the rheumatic diseases. (2015) 74  pp437-438', '10.1136/annrheumdis-2015-eular.2755', '']\n",
      "['9261763', 'Orlova E; Karateev D; Denisov L; Kochetkov A; Nasonov E. Comparative efficacy of two exercises programs in patients with early rheumatoid arthritis: 6-month randomized controlled trial. Annals of the rheumatic diseases. (2015) 74  pp415', '10.1136/annrheumdis-2015-eular.5736', '']\n",
      "['9261764', 'Kostik MM; Gaidar EV; Dubko MF; Snegireva LS; Masalova VV; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG. The methotrexate treatment can prevent uveitis onset in juvenile idiopathic arthritis: The experience in cohort with increased proportion of methotrexate. Annals of the rheumatic diseases. (2015) 74  pp389', '10.1136/annrheumdis-2015-eular.4210', '']\n",
      "['9261765', \"De Vita S; Quartuccio L; Seror R; Salvin S; Ravaud P; Fabris M; Nocturne G; Gandolfo S; Isola M; Mariette X. Efficacy and safety of belimumab given for 12 months in primary sjogren's syndrome: The BELISS open-label phase II study. Annals of the rheumatic diseases. (2015) 74  pp338-339\", '10.1136/annrheumdis-2015-eular.3101', '']\n",
      "['9261766', 'Abdullah N. Placebo effect in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials. Annals of the rheumatic diseases. (2015) 74  pp263', '10.1136/annrheumdis-2015-eular.1398', '']\n",
      "['9261767', 'Wong P; Zhu TY; Qin L; Li EK; Tam L-S. Comparison of the effect of denosumab and alendronate on bone density and microarchitecture at the distal radius in rheumatoid arthritis females with low bone mass: A randomized controlled trial. Annals of the rheumatic diseases. (2015) 74  pp253', '10.1136/annrheumdis-2015-eular.2547', '']\n",
      "['9261768', 'Mehta P; Davy K; Williamson R; Rao R; Tak P-P. Meta-analysis of randomised controlled trials of biologics in DMARD-naive and DMARD-inadequate responder subjects with rheumatoid arthritis: Efficacy and safety. Annals of the rheumatic diseases. (2015) 74  pp239', '10.1136/annrheumdis-2015-eular.2358', '']\n",
      "['9261769', 'El Miedany Y; El Gaafary M; Youssef S; Palmer D. Electronic patient reported outcome measures (e-PROMs) for early arthritis in standard clinical practice: A pilot study. Annals of the rheumatic diseases. (2015) 74  pp65-66', '10.1136/annrheumdis-2015-eular.1409', '']\n",
      "['9261771', 'Esbensen BA. Reduction of sedentary behaviour in patients with rheumatoid arthritis-experiences from an intervention study. Annals of the rheumatic diseases. (2015) 74 var.pagings pp6-7', '10.1136/annrheumdis-2015-eular.6681', '']\n",
      "['9261772', 'Theroux MC; Olivant Fisher A; Rodriguez M; Brislin RP; Reichard KW; Shah SA; McCoy M; Brown M. Response to comments by Yibo et al. regarding our manuscript: Prophylactic methylprednisolone to reduce inflammation and improve outcomes from one lung ventilation in children: A randomized clinical trial. Paediatric anaesthesia. (2015) 25  10 pp1066-1067', '10.1111/pan.12725', '']\n",
      "['9261773', 'Dhaon P; Das S; Agarwal G; Asthana A. Oral or parenteral methotrexate once weekly versus oral methotrexate twice or thrice weekly in divided doses in rheumatoid arthritis. International journal of rheumatic diseases. (2015) 18  pp101-102', '10.1111/1756-185x.12910', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12910']\n",
      "['9261774', 'Khabbazi A; Hadi V; Kheirouri S. Effect of Nigella sativa oil extract on selected immuno cell markers and oxidative stress in rheumatoid arthritis. International journal of rheumatic diseases. (2015) 18  pp101', '10.3109/08820139.2016.1153649', '']\n",
      "['9261775', 'Khabbazi A; Hajialiloo M. A randomized double blind study of intraarticular dexamethasone and triamcinolone on the control of arthritis in rheumatoid arthritis. International journal of rheumatic diseases. (2015) 18  pp101', '10.1111/1756-185x.12278', '']\n",
      "['9261776', 'Wang Y; Liu J; Wang Y; Sun Y. Effect of Xinfeng capsule in the treatment of active rheumatoid arthritis: a randomized controlled trial. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2015) 35 6 pp626-631', '10.1016/s0254-6272(15)30150-3', '']\n",
      "['9261777', 'Alten R; Holt R; Grahn A; Rice P; Kent J; Buttgereit F; Gibofsky A. Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone. Scandinavian journal of rheumatology. (2015) 44 5 pp354-358', '10.3109/03009742.2015.1038582', '']\n",
      "['9261778', 'Leblong-Lecharpentier E; Barre A-C; Bonan I; Perdriger A. Compliance of hand orthosis in rheumatoid arthritis : A randomised, comparative, controlled study. Prosthetics and orthotics international. (2015) 39  pp324-325', '10.1016/j.rehab.2013.07.303', '']\n",
      "['9261779', 'Maki-Petaja K; Day L; Hall F; Ostor A; Wilkinson I. Tetrahydrobiopterin (BH4) improves endothelial function, but not aortic stiffness in patients with rheumatoid arthritis. Artery research. (2014) 8  4 pp132', '10.1016/j.artres.2014.09.093', '']\n",
      "['9261780', \"Coates LC; Moverley AR; McParland L; Brown S; Navarro-Coy N; O'Dwyer JL; Meads DM; Emery P; Conaghan PG; Helliwell PS. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. (2015) 386 10012 pp2489-2498\", '10.1016/s0140-6736(15)00347-5', '']\n",
      "['9261782', \"Kingsbury SR; Tharmanathan P; Arden NK; Batley M; Birrell F; Cocks K; Doherty M; Edwards CJ; Garrood T; Grainger AJ; Green M; Hewitt C; Hughes R; Moots R; O'Neill TW; Roddy E; Scott DL; Watt FE; Torgerson DJ; Conaghan PG. Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial. Trials. (2015) 16  pp77\", '10.1186/s13063-015-0602-8', 'http://link.springer.com/article/10.1186/s13063-015-0602-8/fulltext.html']\n",
      "['9261783', 'Gariballa S; Forster S. Malnutrition is an independent predictor of 1-year mortality following acute illness. British journal of nutrition. (2007) 98  pp332-336', '10.1017/s0007114507701708', '']\n",
      "['9261784', 'Svensson AL; Christensen R; Persson F; Logstrup BB; Giraldi A; Graugaard C; Fredberg U; Blegvad J; Thygesen T; Hansen IM; Colic A; Bagdat D; Ahlquist P; Jensen HS; Horslev-Petersen K; Sheetal E; Christensen TG; Svendsen L; Emmertsen H; Ellingsen T. Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. BMJ open. (2016) 6 4 ppe009134', '10.1136/bmjopen-2015-009134', '']\n",
      "['9261785', 'Kekecs Z; Szekely A; Varga K. Alterations in electrodermal activity and cardiac parasympathetic tone during hypnosis. Psychophysiology. (2016) 53 2 pp268-277', '10.1111/psyp.12570', '']\n",
      "['9261787', 'Carubbi F; Zugaro L; Cipriani P; Conchiglia A; Gregori L; Danniballe C; Letizia Pistoia M; Liakouli V; Ruscitti P; Ciccia F; Triolo G; Masciocchi C; Giacomelli R. Safety and efficacy of intra-articular anti-tumor necrosis factor alpha agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare. International journal of immunopathology and pharmacology. (2015) 29 2 pp252-266', '10.1177/0394632015593220', 'https://journals.sagepub.com/doi/pdf/10.1177/0394632015593220']\n",
      "['9261788', 'Kheirouri S; Hadi V; Alizadeh M. Immunomodulatory effect of nigella sativa oil on T lymphocytes in patients with rheumatoid arthritis. Immunological investigations. (2016) 45 4 pp271-283', '10.3109/08820139.2016.1153649', '']\n",
      "['9261789', 'Ignatenko S; Skrumsager BK; Mouritzen U. Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial. International journal of clinical pharmacology and therapeutics. (2016) 54 4 pp243-252', '10.5414/cp202474', '']\n",
      "['9261790', 'Lee C-J; Huang Y-H; Lin H-Y; Chou C-T; Tsai C-Y; Chen W-S; Chen M-H; Lin H-C. Randomized controlled trial of entecavir prophylaxis in patients with inflammatory arthritis and inactive HBV infection undergoing biologics treatment: the first interim report. Journal of hepatology. (2016) 64 2 SUPPL. 1 ppS587', '10.1016/s0168-8278(16)01078-3', '']\n",
      "['9261791', 'Kang S; Lee M; Yang J; Kim M; Lee W. Vitamin D status in healthy and rheumatoid arthritis groups. Clinical chemistry. (2014) 60 10 SUPPL. 1 ppS42', '10.1016/j.clim.2010.03.223', '']\n",
      "['9261792', 'Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Jiuchi Y; Kozuru H; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Mori N; Matsumori A; Kitagawa K; Takahi K; Ozawa T; Hamada N; Nakajima K; Nagai H; Tamura N; Suenaga Y; Kawabata M; Matsui T; Furukawa H; Kawakami K; Oishi K; Oish K. Opsonic and antibody responses to pneumococcal polysaccharide in rheumatoid arthritis patients receiving golimumab plus methotrexate. Medicine. (2015) 94 52 ppe2184', '10.1097/md.0000000000002184', '']\n",
      "['9261793', 'Van Vollenhoven RF; Wax S; Li Y; Tak PP. Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial. Arthritis and rheumatology. (2015) 67 11 pp2828-2836', '10.1002/art.39262', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39262']\n",
      "['9261794', \"Boudewyns V; O'Donoghue AC; Kelly B; West SL; Oguntimein O; Bann CM; McCormack LA. Influence of patient medication information format on comprehension and application of medication information: a randomized, controlled experiment. Patient education and counseling. (2015) 98 12 pp1592-1599\", '10.1016/j.pec.2015.07.003', '']\n",
      "['9261795', 'Strand V; Jones TV; Li W; Koenig AS; Kotak S. The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic scenarios. International journal of clinical rheumatology. (2015) 10 5 pp317-328', '10.2217/ijr.15.40', '']\n",
      "['9261797', 'Sorensen PS; Blinkenberg M. The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects. Therapeutic advances in neurological disorders. (2016) 9 1 pp44-52', '10.1177/1756285615601933', 'https://journals.sagepub.com/doi/pdf/10.1177/1756285615601933']\n",
      "['9261798', 'Bijlsma JW; Jacobs JW; Buttgereit F. Glucocorticoids in the treatment of rheumatoid arthritis. Clinical and experimental rheumatology. (2015) 33 4 Supplement 92 ppS34-S36', '10.1093/oso/9780198566304.003.0023', 'https://academic.oup.com/book/chapter-pdf/52405289/isbn-9780198566304-book-part-23.pdf']\n",
      "['9261801', 'Bowman S; Everett C; Bombardieri M; Busch R; Emery P; Hall F; Pease CT; Pitzalis C; Price E; Dawson L; Smith P; Sutcliffe N; Ng W-F; Fernandez C; Ruddock S; Sharples L; Reynolds C; Pavitt S. Preliminary results of a double-blind randomised trial of rituximab anti-b-cell therapy in patients with primary sjogrens syndrome. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/1471-2474-15-21', 'http://link.springer.com/article/10.1186/1471-2474-15-21/fulltext.html']\n",
      "['9261802', 'Haavardsholm EA; Aga A-B; Olsen IC; Hammer HB; Uhlig T; Fremstad H; Madland TM; Lexberg AS; Haukeland H; Rodevand E; Hoili C; Stray H; Bendvold AN; Hansen IJW; Bakland G; Nordberg LB; Lillegraven S; Van Der Heijde D; Kvien TK. Aiming for remission in rheumatoid arthritis: clinical and radiographic outcomes from a randomized controlled strategy trial investigating the added value of ultrasonography in a treatto-target regimen. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.3042', '']\n",
      "['9261803', 'Weinblatt ME; Baranauskaite A; Niebrzydowski J; Dokoupilova E; Zielinska A; Sitek-Ziolkowska K; Jaworski J; Racewicz A; Pileckyte M; Jedrychowicz-Rosiak K; Zhdan V; Cheong SY; Ghil J. A phase III, randomized, double-blind clinical study comparing SB5, an adalimumab biosimilar, with adalimumab reference product (humira) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy (24-week results). Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.40444', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40444']\n",
      "['9261805', \"St Clair EW; Baer AN; Noaiseh G; Parke A; Coca A; Utset T; Genovese MC; Wallace DJ; McNamara J; Boyle K; Keyes-Elstein L; Franchimont N; James JA. The clinical efficacy and safety of baminercept, a lymphotoxin-beta receptor fusion protein, in primary sjogren's syndrome: results from a randomized, double-blind, placebo-controlled phase II trial. Arthritis and rheumatology. (2015) 67 no pagination pp\", '10.1002/art.40513', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40513']\n",
      "['9261806', 'Harrold L; Reed GW; Harrington JT; Barr CJ; Saunders KC; Gibofsky A; Ruderman EM; Haselkorn T; Greenberg JD; John A; Kremer JM. A cluster-randomized trial of a behavioral intervention to incorporate a treat-to-target approach in the clinical care of rheumatoid arthritis patients in the united states. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/acr.23294', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23294']\n",
      "['9261807', 'Kavanaugh A; Gladman D; Edwards CJ; Poder A; Liote F; Bird PA; Schett G; McIlraith M; Teng L; Mease PJ. Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: pooled results from 3 phase 3, randomized, controlled trials. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.1487', '']\n",
      "['9261808', 'Matsumoto AK; Pavelka K; Rizzo W; Gupta R; Shergy W; Heycaj P; Zhang N; Kaur PP. Secondary efficacy endpoints: results from a phase 3 study comparing ABP 501 with adalimumab in subjects with moderate to severe rheumatoid arthritises. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-210459', '']\n",
      "['9261811', 'Alten R; Holt RJ; Kent JD; Buttgereit F. Analysis of morning stiffness response in rheumatoid arthritis patients with low disease activity receiving delayed-release prednisone plus dmards AS compared to placebo plus dmards. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2014-eular.1467', '']\n",
      "['9261812', 'Cho S-K; Kim D; Choi J; Lee S; Song ST; Bae GE; Kim HK; Sung Y-K. Impact of patient education on the satisfaction of rheumatoid arthritis patient : a randomized trial of nurse-led vs. Physician-led education. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.4078/jrd.2016.23.2.109', 'http://pdf.medrang.co.kr/JRD/2016/023/JRD023-02-06.pdf']\n",
      "['9261814', 'Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kuemmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz H-I. Induction and maintenance of remission by etanercept in enthesitis related arthritis jia-patients. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.39145', '']\n",
      "['9261815', 'Zack D; Baumann MJ; Korkosz M; Suljok G; Sramek P; Rojkovich B; Daniluk S; Bartalos J; Foster P. Results of a phase 1b/2a study of the safety, tolerability, pharmacokinetics and pharmacodynamics of xmab5871 in patients with rheumatoid arthritis (RA). Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.2851', '']\n",
      "['9261816', 'Kitas GD; Nightingale P; Armitage J; Sattar N; Belch J; Symmons DPM. Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.40892', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40892']\n",
      "['9261817', 'Choe J-Y; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Choi J; Rho YH; Smolen JS. A randomized, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product (remicade) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy: 54-week results. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.1583', '']\n",
      "['9261818', 'Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan V; Stasiuk B; Milasiene R; Rodriguez AAB; Cheong SY; Ghil J; Emery P. A phase III, randomized, double-blind clinical study comparing SB4, an etanercept biosimilar, with etanercept reference product (enbrel) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy (52-week results). Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.1220', '']\n",
      "['9261819', 'Takeuchi T; Yamanaka H; Harigai M; Tamamura R; Kato Y; Ukyo Y; Nakano T; Ota T; Hsu B; Tanaka Y. One-year safety of sirukumab monotherapy: results from a randomized, double-blind, parallel-group, multicenter study in japanese subjects with moderate to severe rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s13075-018-1536-9', 'http://link.springer.com/content/pdf/10.1186/s13075-018-1536-9.pdf']\n",
      "['9261820', 'Pablos JL; Sarabia F N; Blanco FJ; Ivorra JAR; Alonso A; Martin-Mola E; Cantalejo- Moreira M. Switch from tocilizumab + methotrexate to tocilizumab monotherapy. Maintenance of response in patients with rheumatoid arthritis at low disease activity. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.4501', '']\n",
      "['9261821', 'Bickham K; Van Der Heijde D; Rawal N; Sieper J; Scott B; Frontera N; Shah S; Stryszak P; Papanicolaou D; Popmihajlov Z; Peloso P. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib in patients with rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s12891-016-1275-5', 'http://link.springer.com/content/pdf/10.1186/s12891-016-1275-5.pdf']\n",
      "['9261824', 'Kavanaugh A; Ponce L; Cseuz R; Reshetko O; Stanislavchuk MA; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634), an oral JAK1 selective inhibitor is effective AS monotherapy in patients with active rheumatoid arthritis: results from a phase 2b dose ranging study. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.3862', '']\n",
      "['9261832', 'Fleischmann R; Wagner F; Kivitz AJ; Mansikka HT; Khan N; Liu J; Gagnon J; Hong F; Ruzek M; Padley RJ. Safety, tolerability, and pharmacodynamics of abt-122, a dual tnf-and il-17-targeted dual variable domain (dvd)-igtm in subjects with rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2016-eular.3676', '']\n",
      "['9261838', 'Yazdani R; Fayazi S; Khosravi V; Sheivandi S. Effects of progressive muscle relaxation on the quality of life of patients with rheumatoid arthritis. Avicenna journal of phytomedicine. (2015) 5  pp147-148', '10.1111/ijn.13015', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijn.13015']\n",
      "['9261839', 'Duda JL; Rouse PC; Veldhuijzen Van Zanten JJ; Metsios GS; Ntoumanis N; Yu C-A; Fenton SAM; Koutedakis Y; Kitas GD. A self-determination theory based intervention to promote autonomous motivation and physical activity engagement among patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74 var.pagings pp1332', '10.1136/annrheumdis-2015-eular.4764', '']\n",
      "['9261840', 'Silva DR; Jennings F; Moreira E; Natour J. Resistance training in patients with psoriatic arthritis improves function, disease activity and quality of life. Annals of the rheumatic diseases. (2015) 74  pp1315', '10.1136/annrheumdis-2015-eular.3107', '']\n",
      "['9261841', 'Kiraly M; Szanyo F; Bender T. Effect of underwater ultrasound therapy on hand function and quality of life in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74 2 pp1304', '10.1136/annrheumdis-2015-eular.6412', '']\n",
      "['9261843', 'Giollo A; Viapiana O; Orsolini G; Liuzza S; Troplini S; Risoli M; Dal Forno I; Idolazzi L; Gatti D; Rossini M; Adami S. Persistence of clinical remission by a decreased treatment regimen of 4 mg/kg intravenous tocilizumab: a randomized clinical trial. Annals of the rheumatic diseases. (2015) 74  pp1040', '10.1136/annrheumdis-2015-eular.3692', '']\n",
      "['9261844', 'Pavelka K; Akkoc N; Al-Maini M; Zerbini CA; Bao C; Karateev DE; Nasonov EL; Pedersen R; Dinh A; Shen Q; Vasilescu R; Mahgoub E; Vlahos B. Impact of combination etanercept-dmard induction therapy in active rheumatoid arthritis: interim results of an international treat-to-target study conducted in regions with limited biologic access. Annals of the rheumatic diseases. (2015) 74  pp1035', '10.1136/annrheumdis-2015-eular.1689', '']\n",
      "['9261845', 'Kay J; Chopra A; Chandrashekara S; Olakkengil D; Bhojani K; Bhatia G; Rathi G; Thomas M; Maroli S; Thomson E; Lassen C; Shneyer L; Wyand M. Secondary efficacy outcomes from a phase 3 study support clinical equivalence between BOW015 and infliximab in patients with active rheumatoid arthritis on stable methotrexate doses. Annals of the rheumatic diseases. (2015) 74  pp1034', '10.1136/annrheumdis-2015-eular.4286', '']\n",
      "['9261848', 'Cacciapaglia F; Iervolino S; Anelli MG; Mazzotta D; Zincarelli C; Pappone N; Iannone F; Lapadula G. Effects of physical activity and anti-tnf-alpha disease control on lipid profile of rheumatoid arthritis patients. Annals of the rheumatic diseases. (2015) 74  pp1009', '10.1136/annrheumdis-2015-eular.4074', '']\n",
      "['9261851', 'Harrold LR; Reed GW; Harrington JT; Barr CJ; Saunders KC; Gibofsky A; Greenberg JD; John A; Devenport J; Kremer JM. A cluster-randomized trial of a behavioral intervention to incorporate a treat-to-target approach in the clinical care of rheumatoid arthritis patients. Annals of the rheumatic diseases. (2015) 74  pp988-989', '10.1136/annrheumdis-2015-eular.2424', '']\n",
      "['9261855', 'Simic Pasalic K; Zivanovic Radnic T; Sefik Bukilica M; Andjelkovic A; Damjanov N; Vojinovic J. High doses of alfacalcidol or prednisone combined with basic therapy-are there some more advantages for patients with active rheumatoid arthritis?. Annals of the rheumatic diseases. (2015) 74  pp741', '10.1136/annrheumdis-2015-eular.5011', '']\n",
      "['9261856', 'Huang J; Yang F; Yogaratnam J; Shen J. The effect of deuteration of VX-509 (decernotinib) on drug-drug interactions (DDI) with midazolam. Annals of the rheumatic diseases. (2015) 74  pp740', '10.1136/annrheumdis-2015-eular.1810', '']\n",
      "['9261857', 'Conaghan PG; Ostergaard M; Bowes MA; Wu C; Fuerst T; Van Der Heijde D; Hrycaj P; Xie Z; Zhang R; Wyman BT; Bradley J; Soma K; Wilkinson B. Effects of tofacitinib on MRI endpoints in methotrexate-naive early rheumatoid arthritis: a phase 2 MRI study with semi-quantitative and quantitative endpoints. Annals of the rheumatic diseases. (2015) 74  pp738', '10.1136/annrheumdis-2015-eular.3505', '']\n",
      "['9261858', 'Buttgereit F; Strand V; Lee EB; McCabe D; Kolluri S; Tammara B; Rojo R; Hey-Hadavi J. Efficacy and safety of PF-04171327, a novel dissociated agonist of the glucocorticoid receptor (DAGR): results of a phase 2, randomized, double-blind study. Annals of the rheumatic diseases. (2015) 74  pp737-738', '10.1136/annrheumdis-2015-eular.4897', '']\n",
      "['9261863', 'Hsu B; Wang D; Sun Y; Salvadore G; Singh J; Curran M; Caers I; Drevets W; Wittenberg G; Chen G. Improvement in measures of depressed mood and anhedonia, and fatigue, in a randomized, placebo-controlled, phase 2 study of sirukumab, a human anti-interleukin-6 antibody, in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74 var.pagings pp720-721', '10.1136/annrheumdis-2015-eular.4081', '']\n",
      "['9261869', 'Choe J-Y; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Bang JY; Rho YH; Smolen JS. A randomised, double-blind, phase III study comparing sb2, an infliximab biosimilar, to the infliximab reference product (remicade) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2015) 74  pp706-707', '10.1136/annrheumdis-2015-eular.1583', '']\n",
      "['9261871', 'Kitas GD; Nightingale P; Armitage J; Sattar N; Belch J; Symmons D. Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA). Annals of the rheumatic diseases. (2015) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2015 Rome Italy. Conference Start: 20150610 Conference End: 20150613. Conference Publication:  pp688', '10.1136/annrheumdis-2015-eular.3071', '']\n",
      "['9261873', 'Syngle A; Verma I. Spironolactone abrogates production of proinflammatory cytokines in rheumatoid arthritis via inactivation of nuclear factor-kappa B. Annals of the rheumatic diseases. (2015) 74  pp652', '10.1136/annrheumdis-2015-eular.5344', '']\n",
      "['9261876', 'Dalbeth N; Saag K; Palmer W; Choi H; Li C; MacDonald P; Thienel U; Gunawardhana L. A multicenter, randomized, double-blind, phase 2 study to evaluate the effect of febuxostat versus placebo on joint damage in hyperuricemic subjects with early gout. Annals of the rheumatic diseases. (2015) 74  pp543', '10.1136/annrheumdis-2015-eular.1460', '']\n",
      "['9261878', 'Schwabe C; Wagner F; Filler I; Albulescu M; Rose P; Emerson B; Doan T; Rosenstock B; Joseph D; Hilbert J; Scholch C; Habeck J; Thiedmann R; Padula S; Steffgen J. Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 655064, an antagonistic anti-cd40 antibody in healthy volunteers. Annals of the rheumatic diseases. (2015) 74  pp484', '10.1136/annrheumdis-2015-eular.1525', '']\n",
      "['9261879', 'Jaraczewska-Baumann M; Korkosz M; Sulyok G; Sramek P; Rojkovich B; Daniluk S; Bartalos J; Zack DJ; Foster P. A phase 1B/2A study of the safety, tolerability, pharmacokinetics and pharmacodynamics of xmab5871 in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp481', '10.1136/annrheumdis-2015-eular.2851', '']\n",
      "['9261880', 'Kirkham B; Chaabo K; Hall C; Vincent A; Vasconcelos J; Prevost T; Panayi G; Corrigall V. Results of a single dose ascending first-in-man trial of a novel biologic, human stress protein rasolvir (BIP) in rheumatoid arthritis (RA): the ragulo trial. Annals of the rheumatic diseases. (2015) 74  pp480-481', '10.1136/annrheumdis-2015-eular.3346', '']\n",
      "['9261882', 'Pablos J; Navarro F; Blanco F; Roman-Ivorra J; Alonso A; Martin-Mola E; Cantalejo M. Maintenance of response in patients with rheumatoid arthritis (RA) after switching to TCZ administered alone compared to the combination of TCZ and MTX. Annals of the rheumatic diseases. (2015) 74  pp476-477', '10.1136/annrheumdis-2015-eular.4501', '']\n",
      "['9261884', 'Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan V; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J; Emery P. A phase III randomised, double-blind clinical study comparing SB4, an etanercept biosimilar, with etanercept reference product (enbrel) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy (24-week results). Annals of the rheumatic diseases. (2015) 74  pp467-468', '10.1136/annrheumdis-2015-eular.1220', '']\n",
      "['9261885', 'Kay J; Chopra A; Lassen C; Shneyer L; Wyand M. BOW015, a biosimilar infliximab: disease activity and disability outcomes from a phase 3 active comparator study in patients with active rheumatoid arthritis on stable methotrexate doses. Annals of the rheumatic diseases. (2015) 74  pp462-463', '10.1136/annrheumdis-2015-eular.4973', '']\n",
      "['9261888', 'Orlova E; Karateev D; Denisov L; Kochetkov A; Nasonov E. Evaluation of influence of complex rehabilitation program on functional ability of rheumatoid arthritis patients using cobs platform and en-treem movement analysis. Annals of the Rheumatic Diseases: the Eular Journal. (2015) 74  pp416', '10.1136/annrheumdis-2015-eular.5660', '']\n",
      "['9261889', 'Orlova E; Karateev D; Denisov L; Kochetkov A; Nasonov E. Efficacy of 6-month complex rehabilitation program in patients with early rheumatoid arthritis receiving adalimumab. Annals of the Rheumatic Diseases: the Eular Journal. (2015) 74  pp415-416', '10.1136/annrheumdis-2015-eular.5717', '']\n",
      "['9261890', 'Tarkiainen M; Tynjala P; Vahasalo P; Kroger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P. Health-related quality of life in patients with newly diagnosed JIA with different treatment strategies (ACUTE-JIA study). Annals of the rheumatic diseases. (2015) 74  pp387', '10.1136/annrheumdis-2015-eular.3291', '']\n",
      "['9261892', 'Lamba M; Wang R; Fletcher T; Alvey C; Kushner J; Stock T. Evaluation of single-dose and steady-state pharmacokinetics, bioavailability and tolerability of the modified release formulation of tofacitinib vs the immediate release formulation of tofacitinib in healthy volunteers. Annals of the rheumatic diseases. (2015) 74  pp262-263', '10.1136/annrheumdis-2015-eular.5068', '']\n",
      "['9261893', 'Ihata A; Kobayashi K; Osada A; Sakuma H; Tsuji F; Yoshimura T; Setoguchi C; Okamoto M; Nagaoka S. Single dose? Multiple doses? Comparison of MTX-PG concentration, safety and efficacy in patients with rheumadoid arthritis between single-and divided dosage regimens. Annals of the rheumatic diseases. (2015) 74  pp260', '10.1136/annrheumdis-2015-eular.2910', '']\n",
      "['9261896', 'Mohamed M-E; Camp H; Jiang P; Padley R; Asatryan A; Othman AA. Pharmacokinetics, safety and tolerability of the selective JAK1 inhibitor, ABT-494, in healthy volunteers and subjects with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp258', '10.1136/annrheumdis-2015-eular.1758', '']\n",
      "['9261900', 'De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravilingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van Der Elst K; Westhovens R; Verschueren P. Low-risk patients also benefit from remission induction treatment in early rheumatoid arthritis: week 52 results from the carera trial. Annals of the rheumatic diseases. (2015) 74  pp236-237', '10.1136/annrheumdis-2015-eular.3984', '']\n",
      "['9261903', 'Basoski N; Lee W; Ruijgrok L; Kloppenburg M; Boxma B; Kok MR; Weel AE. Efficacy of hydroxychloroquine in primary hand osteoarthritis: a randomized, double-blind, placebo controlled trial. Annals of the rheumatic diseases. (2015) 74  pp188', '10.1136/annrheumdis-2015-eular.5211', '']\n",
      "['9261904', 'Park JK; Shin K; Kang E-H; Ha Y-J; Lee KH; Lee EY; Lee YJ; Song YW; Lee EB. Efficacy and safety of GCSB-5 for hand osteoarthritis treatment: a placebo-controlled, double-blind, randomized trial. Annals of the rheumatic diseases. (2015) 74  pp187-188', '10.1136/annrheumdis-2015-eular.3240', '']\n",
      "['9261906', 'Okano T; Inui K; Tada M; Sugioka Y; Mamoto K; Koike T; Nakamura H. Additional intensive treatment for rheumatoid arthritis patients with positive power doppler signals even after achieving clinical remission might reduce the radiological joint damage -scrum study. Annals of the rheumatic diseases. (2015) 74  pp154', '10.1136/annrheumdis-2015-eular.2616', '']\n",
      "['9261909', 'Larsson I; Bergman S; Bremander A. Person-centred care (PCC) may improve health care consumer skills more than regular care-an RCT in patients with cia undergoing biological therapy. Annals of the rheumatic diseases. (2015) 74  pp104', '10.1136/annrheumdis-2015-eular.1907', '']\n",
      "['9261911', 'Hissink Muller P; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Van Den Berg JM; Bekkering P; Van Rossum M; Van Suijlekom-Smit LW; Allaart CF; Ten Cate R. Three treatment strategies in recent onset DMARD naive juvenile idiopathic arthritis: initial results of the best for kids-study. Annals of the rheumatic diseases. (2015) 74  pp94', '10.1136/annrheumdis-2015-eular.2048', '']\n",
      "['9261915', 'Smolen J; Agarwal SK; Ilivanova E; Xu XL; Miao Y; Mudivarthy S; Xu W; Radziszewski W; Greenspan A; Beutler A; Baker D. A phase 2 study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the rheumatic diseases. (2015) 74  pp76-77', '10.1136/annrheumdis-2015-eular.3989', '']\n",
      "['9261917', 'Wang D; Sun Y; Salvadore G; Singh J; Hsu B; Curran M; Caers I; Drevets WC; Wittenberg GM; Chen G. Interleukin-6 antibody sirukumab improves depressive symptoms in a randomized, placebo-controlled, phase 2 study in patients with rheumatoid arthritis. European neuropsychopharmacology. (2015) 25 var.pagings ppS462', '10.1016/s0924-977x(15)30625-8', '']\n",
      "['9261918', \"Sun Y; Wang D; Salvadore G; Singh J; Casper C; Van Rhee F; Vermeulen J; Caers I; Kent J; Drevets W; Chen G; Wittenberg G. Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric castlemen's disease. European neuropsychopharmacology. (2015) 25 var.pagings ppS403-S404\", '10.1016/s0924-977x(15)30532-0', '']\n",
      "['9261919', 'Sun TY; Wang D; Salvadore G; Singh J; Hsu B; Curran M; Casper C; Van Rhee F; Vermeulen J; Caers I; Kent J; Drevets W; Manji H; Chen G; Wittenberg G. The effect of IL-6 neutralizing agents on depressed mood and anhedonia in immunology and oncology clinical. Neuropsychopharmacology. (2015) 40 var.pagings ppS181-S182', '10.1016/j.bbi.2017.06.014', '']\n",
      "['9261920', 'Linberg BH; Mengshoel AM. Effect of a thin dynamic insole on pain and walking ability in rheumatoid arthritis. Physiotherapy (united kingdom). (2015) 101  ppeS885', '10.1016/j.physio.2015.03.1718', '']\n",
      "['9261921', 'Goodwin PC; Al Qubaeissy K; Yohannes AM; Fatoye F. The cost-effectiveness of aquatic physiotherapy for patients with rheumatoid arthritis. Physiotherapy (united kingdom). (2015) 101  ppeS465', '10.1016/j.physio.2015.03.3252', '']\n",
      "['9261924', 'Laires PA; Dezerto R; Mesquita R; Fonseca JE; Cernadas R; Miranda LC; Silva JC; Costa L; Nogueira AM. Effectiveness of a referral program for early arthritis diagnosis at primary care centers in portugal-preliminary results from the siara study. Value in health. (2015) 18 7 ppA658', '10.1016/j.jval.2015.09.2380', '']\n",
      "['9261926', 'Gargari BP; Kolahi S; Dehghan P; Khabbazi A; Mirtaheri E. Effects of alpha-lipoic acid supplementation on clinical status and anthropometric indices in women with rheumatoid arthritis. Current topics in nutraceutical research. (2015) 13 1 pp33-40', '10.1080/07315724.2014.910740', '']\n",
      "['9261928', 'Van Daele DJ; Bodeker KL; Trask DK. Celecoxib versus placebo in tonsillectomy: a prospective, randomized, double-blind placebo-controlled trial. Annals of otology, rhinology, and laryngology. (2016) 125 10 pp785-800', '10.1177/0003489416654707', 'https://journals.sagepub.com/doi/pdf/10.1177/0003489416654707']\n",
      "['9261930', 'McBain H; Shipley M; Olaleye A; Moore S; Newman SP. A self-monitoring and patient-initiated follow-up service for patients with rheumatoid or psoriatic arthritis: a randomized controlled trial. Annals of the rheumatic diseases. (2014) 73 no pagination pp', '10.1136/annrheumdis-2014-eular.4378', '']\n",
      "['9261931', 'Sawyer L; Diamantopoulos A; Brunner H; De Benedetti F; Ruperto N; Dejonckheere F; Keane C. Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.2194', '']\n",
      "['9261932', 'Vieira MC; Wallenstein G; Bradley J; Gruben D; Koncz T; Zwillich SH; Jansen JP. Tofacitinib versus biologic treatments in patients with active rheumatoid arthritis WHO have had an inadequate response to tumour necrosis factor inhibitors-a network meta-analysis. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.1841', '']\n",
      "['9261933', 'Zwikker H; Van Den Ende C; Van Dulmen S; Van Lankveld W; Den Broeder A; Van Den Hoogen F; Van De Mosselaar B; Van Den Bemt B. Effectiveness of a group-based intervention to improve medication beliefs and adherence in non-adherent patients with rheumatoid arthritis: a randomized controlled trial. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.1125', '']\n",
      "['9261934', 'Dhir V; Singla M; Gupta N; Goel P; Sagar V; Sharma A; Sharma S; Singh S. Randomized controlled trial comparing starting dose of 7.5 mg and 15mg per week of methotrexate in rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.785', '']\n",
      "['9261935', 'Kume K; Amano K; Yamada S; Kanazawa T; Ohta H; Hatta K. Combination of intra-articular steroid injection and etanercept more effective than etanercept in rapid radiographic progression patients with rheumatoid arthritis: a randomized, open label, x ray reader blinded study. Annals of the rheumatic diseases. (2013) 72 no pagination pp', '10.1136/annrheumdis-2013-eular.739', '']\n",
      "['9261939', 'Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N. Efficacy of the MAGE-A3 cancer immunotherapeutic AS adjuvant therapy in patients with resected mage-a3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. The lancet. Oncology. (2016) 17 6 pp822-835', '10.1016/s1470-2045(16)00099-1', '']\n",
      "['9261940', 'Sedjo RL; Flatt SW; Byers T; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Wyatt H; Rock CL. Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors. Supportive care in cancer. (2016) 24 8 pp3285-3293', '10.1007/s00520-016-3141-2', 'http://link.springer.com/article/10.1007/s00520-016-3141-2/fulltext.html']\n",
      "['9261943', 'Mochizuki T; Yano K; Ikari K; Hiroshima R; Takaoka H; Kawakami K; Koenuma N; Shirahata T; Momohara S. The efficacy of abatacept in japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice. Modern rheumatology. (2016) 26 4 pp499-506', '10.3109/14397595.2015.1109578', '']\n",
      "['9261945', 'Helli B; Mowla K; Mohammadshahi M; Jalali MT. Effect of sesamin supplementation on cardiovascular risk factors in women with rheumatoid arthritis. Journal of the american college of nutrition. (2016) 35 4 pp300-307', '10.1080/07315724.2015.1005198', '']\n",
      "['9261946', 'Vaghef-Mehrabany E; Homayouni-Rad A; Alipour B; Sharif SK; Vaghef-Mehrabany L; Alipour-Ajiry S. Effects of probiotic supplementation on oxidative stress indices in women with rheumatoid arthritis: a randomized double-blind clinical trial. Journal of the american college of nutrition. (2016) 35 4 pp291-299', '10.1080/07315724.2014.959208', '']\n",
      "['9261947', 'Zhang W; Kernstock RM; Karrer EE; Cohen SB; Chindalore VL; Kivitz AJ; Blahunka PC; Delgado-Herrera L; Zeiher BG; Samberg NL; Garg JP. A phase 1 dose-escalation study of ASP2409, a selective t-cell costimulation inhibitor, in stable rheumatoid arthritis patients on methotrexate therapy. Clinical pharmacology in drug development. (2016) 5 4 pp259-268', '10.1002/cpdd.237', '']\n",
      "['9261948', 'Dulgeroglu D; Bal A; Karaahmet O; Umay E; Noyan S; Cakci A. The effectiveness of galvanic electrotherapy and a conservative hand exercise program in a rheumatoid hand: a randomized controlled trial. Turkiye fiziksel tip ve rehabilitasyon dergisi. (2016) 62 2 pp132-142', '10.5606/tftrd.2016.81073', '']\n",
      "['9261950', 'Sandstad J; Stensvold D; Hoff M; Nes B M; Arbo I; Bye A. The effects of high intensity interval training in women with rheumatic disease: a pilot study. European journal of applied physiology. (2015) 115 10 pp2081-2089', '10.1007/s00421-015-3186-9', 'http://link.springer.com/article/10.1007/s00421-015-3186-9/fulltext.html']\n",
      "['9261951', 'Chopra A; Chandrashekara S; Iyer R; Rajasekhar L; Shetty N; Veeravalli SM; Ghosh A; Merchant M; Oak J; Londhey V; Barve A; Ramakrishnan MS; Montero E. Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study. Clinical rheumatology. (2016) 35 4 pp1059-1064', '10.1007/s10067-015-2988-9', 'http://link.springer.com/article/10.1007/s10067-015-2988-9/fulltext.html']\n",
      "['9261952', 'Takeuchi T; Tanaka Y; Iwasaki M; Ishikura H; Saeki S; Kaneko Y. Efficacy and safety of the oral janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in japan: a 12-week, randomised, double-blind, placebo-controlled phase iib study. Annals of the rheumatic diseases. (2016) 75 6 pp1057-1064', '10.1136/annrheumdis-2015-208279', '']\n",
      "['9261954', 'Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC. Sustained remission improves physical function in patients with established rheumatoid arthritis, and should BE a treatment goal: a prospective observational cohort study from southern sweden. Journal of rheumatology. (2016) 43 6 pp1017-1023', '10.3899/jrheum.150995', '']\n",
      "['9261960', 'Yousefi H; Chopra A; Farrokhseresht R; Sarmukaddam S; Noghabi FA; Bedekar N; Madani A. Epidemiological evaluation quality of life in patients suffering from early rheumatoid arthritis: a pragmatic, prospective, randomized, blind allocation controlled of a modular program group intervention. Epidemiology and health. (2015) 37  ppe2015048', '10.4178/epih/e2015048', 'http://www.e-epih.org/upload/pdf/epih-37-e2015048.pdf']\n",
      "['9261963', 'Zhong Y; Wang Y; Guo J; Chu H; Gao Y; Pang L. Blueberry improves the therapeutic effect of etanercept on patients with juvenile idiopathic arthritis: phase III study. Tohoku journal of experimental medicine. (2015) 237 3 pp183-191', '10.1620/tjem.237.183', '']\n",
      "['9261964', 'K√•ss A; Hollan I; Fagerland MW; Gulseth HC; Torjesen PA; F√∏rre √òT. Rapid anti-inflammatory effects of gonadotropin-releasing hormone antagonism in rheumatoid arthritis patients with high gonadotropin levels in the AGRA trial. Plos one. (2015) 10 10 ppe0139439', '10.1371/journal.pone.0139439', '']\n",
      "['9261965', 'Meade T; Dowswell E; Manolios N; Sharpe L. The motherhood choices decision aid for women with rheumatoid arthritis increases knowledge and reduces decisional conflict: a randomized controlled trial. BMC musculoskeletal disorders. (2015) 16  pp260', '10.1186/s12891-015-0713-0', 'http://link.springer.com/article/10.1186/s12891-015-0713-0/fulltext.html']\n",
      "['9261968', 'Matcham F; Norton S; Scott DL; Steer S; Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (oxford, england). (2016) 55 2 pp268-278', '10.1093/rheumatology/kev306', 'http://academic.oup.com/rheumatology/article-pdf/55/2/268/5158105/kev306.pdf']\n",
      "['9261970', 'Abdollahzad H; Aghdashi MA; Asghari Jafarabadi M; Alipour B. Effects of coenzyme Q10 supplementation on inflammatory cytokines (tnf-Œ±, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Archives of medical research. (2015) 46 7 pp527-533', '10.1016/j.arcmed.2015.08.006', '']\n",
      "['9261971', 'Sandiford NA; Skinner JA; East DJ; Butler-Manuel A; Hinves BL; Shepperd JA. Primary total hip arthroplasty with hydroxyapatite coated titanium femoral stems. Does design philosophy influence long term outcome? : results of a prospective randomised controlled trial with follow-up of 10-15 years. Acta orthopaedica belgica. (2014) 80 3 pp372-379', '10.1007/s00590-013-1405-9', 'http://link.springer.com/article/10.1007/s00590-013-1405-9/fulltext.html']\n",
      "['9261975', 'Genovese MC; Hsia E; Belkowski SM; Chien C; Masterson T; Thurmond RL; Manthey CL; Yan XD; Ge T; Franks C; Greenspan A. Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy. Journal of rheumatology. (2015) 42 10 pp1752-1760', '10.3899/jrheum.141580', '']\n",
      "['9261976', 'Popma JW; Snel FW; Haagsma CJ; Brummelhuis-Visser P; Oldenhof HG; van der Palen J; van de Laar MA. Comparison of 2 dosages of intraarticular triamcinolone for the treatment of knee arthritis: results of a 12-week randomized controlled clinical trial. Journal of rheumatology. (2015) 42 10 pp1865-1868', '10.3899/jrheum.141630', '']\n",
      "['9261977', \"Brightling CE; Chanez P; Leigh R; O'Byrne PM; Korn S; She D; May RD; Streicher K; Ranade K; Piper E. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. The lancet. Respiratory medicine. (2015) 3 9 pp692-701\", '10.1016/s2213-2600(15)00197-6', '']\n",
      "['9261979', 'Aalbers C; Gerlag D; Vos K; Vervoordeldonk M; Landew‚àö¬© R; Tak PP. Intra-articular etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF AS a potential therapeutic target for local treatment. Joint, bone, spine. (2015) 82 5 pp338-344', '10.1016/j.jbspin.2015.03.002', '']\n",
      "['9261981', 'Harvey NC; Kanis JA; Od√©n A; Burge RT; Mitlak BH; Johansson H; McCloskey EV. FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporosis international. (2015) 26 11 pp2677-2684', '10.1007/s00198-015-3173-3', 'http://link.springer.com/article/10.1007/s00198-015-3173-3/fulltext.html']\n",
      "['9261983', 'Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; et al. Randomized controlled trial comparing starting dose of 7.5 mg and 15 mg per week of methotrexate in rheumatoid arthritis. Internal medicine journal. (2013) 43  pp9', '10.1136/annrheumdis-2013-eular.785', '']\n",
      "['9261984', '. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy. Rheumatology (united kingdom). 54 (12) (pp 2188-2197), 2015. Date of publication: 2015.. (2015)   pp', '10.1093/rheumatology/kev249', 'http://academic.oup.com/rheumatology/article-pdf/54/12/2188/17388435/kev249.pdf']\n",
      "['9261988', 'Grom AA; Brunner HI; Ruperto N; Martini A; Lovell D; Pascual V; Lheritier K; Leon K; Abrams K; Ilowite N. Macrophage activation syndrome in systemic juvenile idiopathic arthritis patients treated with canakinumab: results from phase 3 trial program. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.39407', '']\n",
      "['9261990', 'Dalbeth N; Saag KG; Palmer W; Choi H; Hunt B; MacDonald P; Thienel U; Gunawardhana L. Imaging and safety assessments following treatment with febuxostat and placebo for 2 years in subjects with early gout. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1002/art.40233', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40233']\n",
      "['9261994', 'Chopra A; Saluja M; Knight A; Shneyer L; Lassen C; Wyand M; Kay J. Comparison of the stanford and indian health assessment questionnaires for disability outcomes in a phase 3, randomized, double-blind, active comparator study of infliximab and biosimilar infliximab BOW15 in rheumatoid arthritis. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1136/annrheumdis-2015-eular.4973', '']\n",
      "['9261995', 'Roemer F; Aydemir A; Lohmander S; Crema M; Marra MD; Muurahainen N; Eckstein F; Guermazi A. Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations. Arthritis and rheumatology. (2015) 67 no pagination pp', '10.1186/s12891-016-1128-2', 'http://link.springer.com/article/10.1186/s12891-016-1128-2/fulltext.html']\n",
      "['9261997', 'Namour F; Vayssiere B; Galien R; Fagard L; Van Der Aa A; Harrison P; Tasset C. Filgotinib (GLPG0634), a selective JAK1 inhibitor, shows similar PK and PD profiles in japanese and caucasian healthy volunteers. Annals of the rheumatic diseases. (2015) 74  pp1063-1064', '10.1136/annrheumdis-2015-eular.4457', '']\n",
      "['9261998', 'Jin DC; Wu C-Y; Roskos LK; Godwood A; Close D; Wang B. Exposure-efficacy analysis of mavrilimumab in rheumatoid arthritis: modeling and simulation of phase II clinical data. Annals of the rheumatic diseases. (2015) 74  pp1043', '10.1136/annrheumdis-2015-eular.4241', '']\n",
      "['9261999', 'Mohammed RHA. An exploratory study of the predictors of good eular response, DAS-28 remission, sustained responses to tnf-inhibitors therapy in refractory rheumatoid arthritis in clinical practice. Annals of the rheumatic diseases. (2015) 74  pp1037', '10.1136/annrheumdis-2015-eular.1026', '']\n",
      "['9262000', \"Ye Y; Schafer P; Thomas M; Weiss D; Gaudy A; Yang Z; Liu L; O'Mara E; Palmisano M. Effects of CC-220, a CRL4 cereblon E3 ubiquitin ligase modulator, on immune responses. Annals of the rheumatic diseases. (2015) 74  pp903\", '10.1136/annrheumdis-2015-eular.3487', '']\n",
      "['9262002', 'Smith PF; Krishnarajah J; Nunn PA; Hill RJ; Karr D; Tam D; Masjedizadeh M; Gourlay SG. A phase 1 clinical trial of prn1008, an oral, reversible, covalent BTK inhibitor demonstrates clinical safety and therapeutic levels of BTK occupancy without sustained systemic exposure. Annals of the rheumatic diseases. (2015) 74  pp742', '10.1136/annrheumdis-2015-eular.4289', '']\n",
      "['9262003', 'Emery P; Decktor DL; Nguyen D; Fan C; Kavanaugh A. Clinical and radiographic efficacy of sarilumab in rheumatoid arthritis patients with varied disease duration. Annals of the rheumatic diseases. (2015) 74  pp730', '10.1136/annrheumdis-2015-eular.4811', '']\n",
      "['9262004', 'Kay J; Lassen C; Trokan L; Wyand M. Safety profile of BOW015, a biosimilar infliximab, in healthy subjects and patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74  pp706', '10.1136/annrheumdis-2015-eular.4107', '']\n",
      "['9262006', 'Khan MF. A dual-center, double blind randomized study for a new scientific approach in assessment of tender joints in inflammatory arthritis using the smart joint assessor glove device (smart JAG device). Annals of the rheumatic diseases. (2015) 74  pp646', '10.1136/annrheumdis-2015-eular.1231', '']\n",
      "['9262007', 'Simon TA; Poncet C; Hochberg M; Boers M. Incidence rates of skin cancers during exposure to intravenous and subcutaneous abatacept in patients with rheumatoid arthritis: results from pooled clinical trial data. Annals of the rheumatic diseases. (2015) 74  pp477', '10.1136/annrheumdis-2015-eular.1724', '']\n",
      "['9262009', 'Bergstra S; Van Den Berg R; Bijkerk C; Gerards A; Goekoop R; Kerstens P; Lems W; Huizinga T; Landewe R; Allaart C. Erosions in the foot at baseline are predictive of orthopedic shoes use after 10 years of treat to target therapy-results from the best study. Annals of the rheumatic diseases. (2015) 74  pp438-439', '10.1136/annrheumdis-2015-eular.1959', '']\n",
      "['9262010', 'Van Vollenhoven RF; Tanaka Y; Lamba M; Collinge M; Hendrikx T; Hirose T; Toyoizumi S; Hazra A; Krishnaswami S. Relationship between NK cell count and important safety events in rheumatoid arthritis patients treated with tofacitinib. Annals of the rheumatic diseases. (2015) 74  pp258-259', '10.1136/annrheumdis-2015-eular.3674', '']\n",
      "['9262012', \"Lee J; Son J; Sin HJ; Woo J; Hadi S; Suh KH; Lee Y-M; Jang S; Jung J-A. Safety, pharmacokinetics and proof-of-mechanism of an oral bruton's tyrosine kinase inhibitor HM71224 in healthy adult volunteers. Annals of the rheumatic diseases. (2015) 74  pp261\", '10.1136/annrheumdis-2015-eular.2453', '']\n",
      "['9262016', \"Ragan C; Batchelor WH; Baum J; Black RL; Brown R; Clark GM; Cohen AS; Decker J; DeForest GK; Duff IS; Engleman EP; Healey LA; Jessar RA; Mainland D; Mills JA; Plotz C; Short CL; Steck I; Wallace SL; Weinberger HJ; Wheaton EA; ZvaiHer NJ; Hollingworth JW; Mikkelsen WM; O'Brien WM; Lasagna LA; Sutcliffe MI; Brown HE; Healey L; Kaplan D; Mikkelsen W. A three-month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference. Clinical pharmacology and therapeutics. (1967) 8 1 pp11-37\", '10.1002/cpt196781part111', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt196781part111']\n",
      "['9262017', 'Kim WS; Ogura M; Buske C; Coiffier B; Sancho J-M; Jurczak W; Kim JS; Nagarkar RV; Zhavrid E; Rivas JAH; Vinnyk Y; Tsirigotis P; Viero P; Volodicheva E; Fourie S; Soler J. Global phase I/III pharmacokinetic and efficacy study comparing CT-P10, a biosimilar candidate to the rituximab reference product in patients with advanced stage follicular lymphoma (AFL). Blood. (2015) 126 23 pp5111', '10.1182/blood.v126.23.5111.5111', 'https://ashpublications.org/blood/article/126/23/5111/94384/Global-Phase-IIII-Pharmacokinetic-and-Efficacy']\n",
      "['9262019', 'Jiao J; Tang XP; Yuan J; Liu X; Liu H; Zhang CY; Wang LY; Jiang Q. Effect of external applying compound tripterygium wilfordii hook F. on joint pain of rheumatoid arthritis patients. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 1 pp29-34', '10.1186/s12906-017-1957-z', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1957-z.pdf']\n",
      "['9262020', 'Jiang P; Zhang LY; Dai LL; Jiang XM. Treatment of rheumatoid arthritis by hebi recipe: an efficacy observation. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 1 pp24-28', '10.1016/s0254-6272(16)30039-5', '']\n",
      "['9262022', 'Jiang M; Zha Q; Zhang C; Lu C; Yan X; Zhu W; Liu W; Tu S; Hou L; Wang C; Zhang W; Liang Q; Fan B; Yu J; Zhang W; Liu X; Yang J; He X; Li L; Niu X; Liu Y; Guo H; He B; Zhang G; Bian Z; Lu A. Predicting and verifying outcome of tripterygium wilfordii hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial. Scientific reports. (2015) 5  pp9700', '10.1038/srep09700', 'https://www.nature.com/articles/srep09700']\n",
      "['9262025', 'Xu Y; Zhu Q; Song J; Liu H; Miao Y; Yang F; Wang F; Cheng W; Xi Y; Niu X; He D; Chen G. Regulatory effect of iguratimod on the balance of th subsets and inhibition of inflammatory cytokines in patients with rheumatoid arthritis. Mediators of inflammation. (2015) 2015  pp356040', '10.1155/2015/356040', 'http://downloads.hindawi.com/journals/mi/2015/356040.pdf']\n",
      "['9262026', 'Homayouni K; Foruzi S; Kalhori F. Effects of kinesiotaping versus non-steroidal anti-inflammatory drugs and physical therapy for treatment of pes anserinus tendino-bursitis: a randomized comparative clinical trial. Physician and sportsmedicine. (2016) 44 3 pp252-256', '10.1080/00913847.2016.1199251', '']\n",
      "['9262027', 'Leon Fernandez OS; Viebahn-Haensler R; Cabreja GL; Espinosa IS; Matos YH; Roche LD; Santos BT; Oru GT; Polo Vega JC. Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. European journal of pharmacology. (2016) 789  pp313-318', '10.1016/j.ejphar.2016.07.031', '']\n",
      "['9262028', 'Zhu T; Keirns J; Howieson C; Kaibara A; Goldwater R; Kivitz AJ; Chindalore V; Cohen S; Santos V; Akinlade B; Kernstock R; Delgado-Herrera L; Blahunka PC; Karrer EE; Garg JP; Samberg N; Zeiher BG. Pharmacokinetics, pharmacodynamics, safety, and tolerability of ASP2408, a potent selective t-cell costimulation modulator after single and multiple ascending doses in healthy volunteers and RA patients. Clinical pharmacology in drug development. (2016) 5 5 pp408-425', '10.1002/cpdd.251', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpdd.251']\n",
      "['9262029', 'Lunzer R. Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic multicenter, open-label randomized controlled trial.. Journal fur mineralstoffwechsel. (2016) 23 3 pp107', '10.3410/f.726141758.793558002', '']\n",
      "['9262030', 'Sahraian MA; Owji M; Naser Moghadasi A. Concomitant multiple sclerosis and another autoimmune disease: does the clinical course change?. Clinical neurology and neurosurgery. (2016) 150  pp92-95', '10.1016/j.clineuro.2016.09.003', '']\n",
      "['9262031', 'Bintcliffe OJ; Lee GYC; Rahman NM; Maskell NA. The management of benign non-infective pleural effusions. European respiratory review. (2016) 25 141 pp303-316', '10.1183/16000617.0026-2016', '']\n",
      "['9262032', 'Ebrahimzadeh Attari V; Ostadrahimi A; Asghari Jafarabadi M; Mehralizadeh S; Mahluji S. Changes of serum adipocytokines and body weight following zingiber officinale supplementation in obese women: a RCT. European journal of nutrition. (2016) 55 6 pp2129-2136', '10.1007/s00394-015-1027-6', 'http://link.springer.com/article/10.1007/s00394-015-1027-6/fulltext.html']\n",
      "['9262033', 'Thurmond RL; Greenspan A; Radziszewski W; Xu XL; Miao Y; Chen B; Ge TT; Zhou B; Baker DG; Pavlova D; Ritchlin CT; Tanaka Y; Takeuchi T; Smolen JS. Toreforant, a histamine H4 receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate therapy: results of 2 phase II studies. Journal of rheumatology. (2016) 43 9 pp1637-1642', '10.3899/jrheum.160164', '']\n",
      "['9262035', 'Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). Journal of the american academy of dermatology. (2016) 74 5 pp835-840', '10.1016/j.jaad.2016.01.020', '']\n",
      "['9262036', 'Santos I; Cantista P; Vasconcelos C; Amado J. Balneotherapy and rheumatoid arthritis: a randomized control trial. Israel medical association journal. (2016) 18 8 pp474-478', '10.1007/s00484-015-1108-5', 'http://link.springer.com/article/10.1007/s00484-015-1108-5/fulltext.html']\n",
      "['9262037', 'Pokuri VK; Kumar CU; Pingali U. A randomized, double-blind, placebo-controlled, cross-over study to evaluate analgesic activity of terminalia chebula in healthy human volunteers using a mechanical pain model. Journal of anaesthesiology, clinical pharmacology. (2016) 32 3 pp329-332', '10.4103/0970-9185.173365', '']\n",
      "['9262038', 'Cheung P; Lahiri M. WHO are the asian fibromyalgic rheumatoid arthritis (RA) patients? -evaluation using power doppler ultrasonography (PDUS). International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp176', '10.1136/annrheumdis-2017-eular.1598', '']\n",
      "['9262039', 'Yamei S; Lijun W. Clinical research. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp120', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262040', 'Yue J; Griffith JF; Shi L; Wang D; Shen J; Wong P; Li EK; Li TK; Zhu TY; Hung V; Qin L; Tam LS. Repair of bone erosion in rheumatoid arthritis by denosumab: an HRPQCT study. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp16', '10.1136/annrheumdis-2016-eular.1391', '']\n",
      "['9262041', 'Zhu H; Su Y; Zhang C; Li R; Li Z. Safety profiles of dmards in the treatment of rheumatoid arthritis: a non-interventional study in 1109 patients in china. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp197', '10.1007/s10165-004-0352-z', '']\n",
      "['9262042', 'Li X; Zhao J; Wang W; Ding J; Zheng Z; Leng N; Wu Z; Zhu P. Assessment of effect of knee joint synovial excision combined with cdmards on ACPA in patients with early rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp14', '10.1111/1756-185x.70164', '']\n",
      "['9262043', 'Zeng H; Tang Y. A randomized double-blind controlled trial of adalimumab in juvenile idiopathic arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp161', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262044', 'Zeng H; Ping Z. A randomized double-blind controlled clinical trial to evaluate the efficacy of recombinant human tnf-alpha receptor II fusion protein in juvenile idiopathic arthriti. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp149', '10.1136/annrheumdis-2014-eular.5459', '']\n",
      "['9262045', 'Ying Z; Li Z; Lijun W. The effect of psychological nursing in patients with rheumatoid arthritis (RA) application. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp183', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262048', 'Zeng H; Ping Z. Efficacy and safety of infliximab in juvenile idiopathic arthritis and juvenile ankylosing spondylitis: a randomized, double-blind, controlled study. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp9', '10.1136/annrheumdis-2014-eular.5363', '']\n",
      "['9262050', 'Dubey V. Efficacy of yoga therapy in rheumatoid arthritis patients with normal values on measures of inflammation. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp21', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262051', 'Tang X. The effect and safety of tocilizumab in refractory systemic JIA. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp158', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262052', 'Qingli M; Lijun W; Xinya M; Xin L. The value of serum glucose 6-phosphate isomerasein the diagnosis of rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp125', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9262054', 'Urata Y; Abe S; Devers B; Nakamura Y; Takemoto H; Furukawa KI. Impact of anticitrullinated protein antibodies on the disease relapses of rheumatoid arthritis on tapering biological disease-modifying antirheumatic drugs treatment. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp202', '10.1136/annrheumdis-2017-eular.2498', '']\n",
      "['9262057', 'Liu X; Zhuang J. Chronic disease management mode is benefit for the rheumatoid arthritis patients treated by the biological agents. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp165', '10.1111/1756-185x.70164', '']\n",
      "['9262058', 'Tee M; Lim P. Comparison of center-based and home-based exercises on rheumatoid arthritis patients experiencing fatigue. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp165', '10.1111/1756-185x.70164', '']\n",
      "['9262059', 'Meijer L; Hery-Arnaud G; Le Berre R; Nowak E; Le Roux L; Gueganton L; Mottier D; Rault G. ROSCO-CF, a safety and efficacy clinical trial of (r)-roscovitine in CF patients. Pediatric pulmonology. (2016) 51 Suppl 45  pp269', '10.1016/s1569-1993(18)30196-6', '']\n",
      "['9262060', 'Coskun R; Toz B; Demir S; Unal D; Gelincik A; Colakotlu B; Buyukozturk S. Successful desensitization of a delayed type local hypersensitivity reaction due to anakinra. Allergy: european journal of allergy and clinical immunology. Conference: 35th annual congress of the european academy of allergy and clinical immunology, EAACI 2016. Austria. Conference start: 20160611. Conference end: 20160615. (2016) 71  pp414', '10.1016/j.jaip.2016.12.008', '']\n",
      "['9262061', 'Salaffi F; Carotti M; Ciapetti A; Di Carlo M; Gasparini S; Farah S; Gutierrez M. Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach. BMC musculoskeletal disorders. (2016) 17  pp146', '10.1186/s12891-016-1002-2', 'http://link.springer.com/article/10.1186/s12891-016-1002-2/fulltext.html']\n",
      "['9262064', 'Genovese MC; Braun DK; Erickson JS; Berclaz PY; Banerjee S; Heffernan MP; Carlier H. Safety and efficacy of open-label subcutaneous ixekizumab treatment for 48 weeks in a phase II study in biologic-naive and TNF-IR patients with rheumatoid arthritis. Journal of rheumatology. (2016) 43 2 pp289-297', '10.3899/jrheum.140831', '']\n",
      "['9262065', 'Lee YC; Massarotti E; Edwards RR; Lu B; Liu C; Lo Y; Wohlfahrt A; Kim ND; Clauw DJ; Solomon DH. Effect of milnacipran on pain in patients with rheumatoid arthritis with widespread pain: a randomized blinded crossover trial. Journal of rheumatology. (2016) 43 1 pp38-45', '10.3899/jrheum.150550', '']\n",
      "['9262066', 'Okamura K; Yonemoto Y; Suto T; Okura C; Takagishi K. Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis. Modern rheumatology. (2015) 25 4 pp534-539', '10.3109/14397595.2014.998361', '']\n",
      "['9262067', 'Santos D; Cameron-Fiddes V. Effects of off-the-shelf foot orthoses on plantar foot pressures in patients with early rheumatoid arthritis. Journal of the american podiatric medical association. (2014) 104 6 pp610-616', '10.7547/8750-7315-104.6.610', 'http://meridian.allenpress.com/japma/article-pdf/104/6/610/1604880/8750-7315-104_6_610.pdf']\n",
      "['9262068', 'Damjanov N; Tlustochowicz M; Aelion J; Greenwald M; Diehl A; Bhattacharya I; Peeva E; Menon S; Gourley I. Safety and efficacy of SBI-087, a subcutaneous agent for b cell depletion, in patients with active rheumatoid arthritis: results from a phase II randomized, double-blind, placebo-controlled study. Journal of rheumatology. (2016) 43 12 pp2094-2100', '10.3899/jrheum.160146', '']\n",
      "['9262069', 'Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X. Acupuncture for Primary Sjogren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial. BMC complementary and alternative medicine. (2017) 17 1 pp61', '10.1186/s12906-017-1559-9', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1559-9.pdf']\n",
      "['9262071', 'Lebel S; Dion G; Marceau S; Biron S; Robert M; Biertho L. Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surgery for obesity and related diseases. (2016) 12 5 pp1014-1022', '10.1016/j.soard.2016.01.014', '']\n",
      "['9262072', 'Manoharan V; Grant AL; Harris AC; Hazratwala K; Wilkinson MP; McEwen PJ. Closed incision negative pressure wound therapy vs conventional dry dressings after primary knee arthroplasty: a randomized controlled study. Journal of arthroplasty. (2016) 31 11 pp2487-2494', '10.1016/j.arth.2016.04.016', '']\n",
      "['9262073', 'Diaz C; Martinez LJ; Eckels KH; Lin L; Campos M; Jarman RG; De La Barrera R; Lepine E; Collard A; Innis BL; Febo I; Thomas SJ; Schmidt AC. Phase 1 study of different formulations of a tetravalent dengue purified inactivated vaccine (DPIV): safety and immunogenicity data in healthy adults from puerto rico through month 13. American journal of tropical medicine and hygiene. Conference: 64th annual meeting of the american society of tropical medicine and hygiene, ASTMH 2015. United states. Conference start: 20151025. Conference end: 20151029. (2015) 93 4 Supplement pp372', '10.4269/ajtmh.17-0627', 'https://www.ajtmh.org/view/journals/tpmd/98/5/article-p1435.xml']\n",
      "['9262074', 'Milic DJ; Zivic S; Peric D; Petrovic J; Bogdanovic D. A randomized trial of elastic compression systems with high and very high sub-bandage pressure values in the prevention of recurrence of venous ulceration. Journal of vascular surgery. Venous and lymphatic disorders. (2015) 3 1 pp123', '10.1016/j.jvsv.2014.10.021', '']\n",
      "['9262075', 'Leiper K; Martin K; Ellis A; Subramanian S; Watson A; Christmas S; Howarth D; Campbell F; Rhodes JM. Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut. Conference: british society of gastroenterology annual general meeting 2010. United kingdom. Conference start: 20100322. Conference end: 20100325. (2010) 59  ppA3', '10.1016/s0016-5085(10)60393-9', '']\n",
      "['9262076', 'Laires PA; Dezerto R; Mesquita R; Fonseca JE; Cernadas R; Miranda LC; Silva JC; Costa L; Nogueira AM. Effectiveness of a referral program for early arthritis diagnosis at primary care centers in portugal-final results from the SIARA study. Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA546', '10.1016/j.jval.2016.09.1157', '']\n",
      "['9262079', \"Cortesi PA; Scalone L; Sinigaglia L; Sarzi-Puttini P; Montecucco C; Giacomelli R; Lapadula G; Olivieri I; Giardino AM; Mecchia M; Mantovani LG. Patients' preferences toward characteristics of treatment with biological agents differ according to experience with their rheumatic disease and treatment received or prescribed: results from the cara study. Value in health. Conference: ISPOR 19th annual european congress. Austria. Conference start: 20161029. Conference end: 20161102. (2016) 19 7 ppA542-A543\", '10.1016/j.jval.2016.09.1136', '']\n",
      "['9262083', \"Achuthan S; Ahluwalia J; Shafiq N; Bhalla A; Pareek A; Chandurkar N; Malhotra S. Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: a Proof of Concept Study. Journal of cardiovascular pharmacology and therapeutics. (2015) 20 2 pp174-180\", '10.1177/1074248414546324', 'https://journals.sagepub.com/doi/pdf/10.1177/1074248414546324']\n",
      "['9262084', 'Maderbacher G; Schaumburger J; Keshmiri A; Barthel M; Springorum HR; Craiovan B; Grifka J; Baier C. Pinless navigation in total knee arthroplasty: navigation reduced by the maximum?. International orthopaedics. (2015) 39 3 pp455-460', '10.1007/s00264-014-2529-1', 'http://link.springer.com/article/10.1007/s00264-014-2529-1/fulltext.html']\n",
      "['9262085', 'Kayacelebi AA; Willers J; Pham VV; Hahn A; Schneider JY; Rothmann S; Fr√∂lich JC; Tsikas D. Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. Amino acids. (2015) 47 9 pp1885-1891', '10.1007/s00726-015-1915-3', 'http://link.springer.com/article/10.1007/s00726-015-1915-3/fulltext.html']\n",
      "['9262086', 'Esbensen BA; Thomsen T; Hetland ML; Beyer N; Midtgaard J; L√∏ppenthin K; Jennum P; √òstergaard M; S√∏rensen J; Christensen R; Aadahl M. The efficacy of motivational counseling and SMS-reminders on daily sitting time in patients with rheumatoid arthritis: protocol for a randomized controlled trial. Trials. (2015) 16  pp23', '10.1186/s13063-014-0540-x', 'http://link.springer.com/article/10.1186/s13063-014-0540-x/fulltext.html']\n",
      "['9262088', 'Haschka J; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Reiser M; Finzel S; Tony HP; Kleinert S; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Wendler J; Schuch F; Ronneberger M; Lorenz HM; Nuesslein H; Alten R; Demary W; Henes J; Schett G; Rech J. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Annals of the rheumatic diseases. (2016) 75 1 pp45-51', '10.1136/annrheumdis-2014-206439', '']\n",
      "['9262093', 'Mirtaheri E; Gargari BP; Kolahi S; Dehghan P; Asghari-Jafarabadi M; Hajalilou M; Shakiba Novin Z; Mesgari Abbasi M. Effects of alpha-lipoic acid supplementation on inflammatory biomarkers and matrix metalloproteinase-3 in rheumatoid arthritis patients. Journal of the American College of Nutrition. (2015) 34 4 pp310-317', '10.1080/07315724.2014.910740', '']\n",
      "['9262094', 'Lundblad MS; Overgaard RV; G√∂thberg M; Fjording MS; Watson E. Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. Advances in therapy. (2015) 32 3 pp228-238', '10.1007/s12325-015-0191-7', 'http://link.springer.com/article/10.1007/s12325-015-0191-7/fulltext.html']\n",
      "['9262096', 'Fautrel B; Pham T; Alfaiate T; Gandjbakhch F; Foltz V; Morel J; Dernis E; Gaudin P; Brocq O; Solau-Gervais E; Berthelot JM; Balblanc JC; Mariette X; Tubach F. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: spacing of TNF-blocker injections in Rheumatoid ArthritiS Study). Annals of the rheumatic diseases. (2016) 75 1 pp59-67', '10.1136/annrheumdis-2014-206696', '']\n",
      "['9262098', 'Abdel-Rahman MS; Alkady EA; Ahmed S. Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: a clinical study. European journal of pharmacology. (2015) 761  pp273-278', '10.1016/j.ejphar.2015.06.014', '']\n",
      "['9262104', 'Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis. Rheumatology international. (2016) 36 2 pp295-300', '10.1007/s00296-015-3285-2', 'https://link.springer.com/article/10.1007/s00296-015-3285-2/fulltext.html']\n",
      "['9262109', 'Armbrust W; Bos JJ; Cappon J; van Rossum MA; Sauer PJ; Wulffraat N; van Wijnen VK; Lelieveld OT. Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis. Pediatric rheumatology online journal. (2015) 13  pp31', '10.1186/s12969-015-0029-5', 'http://link.springer.com/article/10.1186/s12969-015-0029-5/fulltext.html']\n",
      "['9262110', 'Baxter SV; Hale LA; Stebbings S; Gray AR; Smith CM; Treharne GJ. Walking is a Feasible Physical Activity for People with Rheumatoid Arthritis: a Feasibility Randomized Controlled Trial. Musculoskeletal care. (2016) 14 1 pp47-56', '10.1002/msc.1112', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1112']\n",
      "['9262111', 'Duan XW; Zhang XL; Mao SY; Shang JJ; Shi XD. Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial. Clinical rheumatology. (2015) 34 9 pp1513-1519', '10.1007/s10067-015-2999-6', 'https://link.springer.com/article/10.1007/s10067-015-2999-6/fulltext.html']\n",
      "['9262113', 'Gossec L; Danr√© A; Combe B; Le Lo√´t X; Tebib J; Sibilia J; Mariette X; Dougados M. Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: an open-label assessment of 175¬†patients. Joint, bone, spine. (2015) 82 6 pp451-454', '10.1016/j.jbspin.2015.02.007', '']\n",
      "['9262114', 'Tanaka Y; Harigai M; Takeuchi T; Yamanaka H; Ishiguro N; Yamamoto K; Ishii Y; Nakajima H; Baker D; Miyasaka N; Koike T. Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: post hoc analysis of the GO-FORTH study. Modern rheumatology. (2016) 26 3 pp323-330', '10.3109/14397595.2015.1086041', '']\n",
      "['9262115', 'Wan L; Liu J; Huang CB; Wang Y; Chen X; Zhang WD; Wang GZ; Fan HX; Ge Y; Chen RL; Cao YX; Zong RK; Liu TY. Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial. Chinese journal of integrative medicine. (2016) 22 3 pp168-176', '10.1007/s11655-015-2093-6', 'http://link.springer.com/article/10.1007/s11655-015-2093-6/fulltext.html']\n",
      "['9262116', 'Randsborg PH; Brinchmann J; L√∏ken S; Hanvold HA; Aae TF; √Ör√∏en A. Focal cartilage defects in the knee - a randomized controlled trial comparing autologous chondrocyte implantation with arthroscopic debridement. BMC musculoskeletal disorders. (2016) 17  pp117', '10.1186/s12891-016-0969-z', 'http://link.springer.com/article/10.1186/s12891-016-0969-z/fulltext.html']\n",
      "['9262117', 'Pot-Vaucel M; Aubert MP; Guillot P; Gl√©marec J; Berthelot JM; Le Goff B; Maugars Y. Randomised study versus control group of customised therapeutic education for patients in follow-up for rheumatoid arthritis. Joint, bone, spine. (2016) 83 2 pp199-206', '10.1016/j.jbspin.2015.05.017', '']\n",
      "['9262118', 'Bertoglio JC; Baumgartner M; Palma R; Ciampi E; Carcamo C; C√°ceres DD; Acosta-Jamett G; Hancke JL; Burgos RA. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC neurology. (2016) 16  pp77', '10.1186/s12883-016-0595-2', 'http://link.springer.com/article/10.1186/s12883-016-0595-2/fulltext.html']\n",
      "['9262120', 'Schafer W. The endoscopic release of the transverse carpal ligament for carpal tunnel syndrome.]. [German. Operative orthopadie und traumatologie. (1997) 9 2 pp141-148', '10.1097/00013414-200103000-00003', '']\n",
      "['9262121', 'Qi L; Tang Y; You Y; Qin F; Zhai L; Peng H; Nie R. Comparing the Effectiveness of Electroacupuncture with Different Grades of Knee Osteoarthritis: a Prospective Study. Cellular physiology and biochemistry. (2016) 39 6 pp2331-2340', '10.1159/000447925', 'https://www.karger.com/Article/Pdf/447925']\n",
      "['9262124', 'Hibi T; Hirohata S; Kikuchi H; Tateishi U; Sato N; Ozaki K; Kondo K; Ishigatsubo Y. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Medicine. (2016) 95 24 ppe3863', '10.1097/md.0000000000003863', '']\n",
      "['9262125', 'Gok Metin Z; Ozdemir L. The Effects of Aromatherapy Massage and Reflexology on Pain and Fatigue in Patients with Rheumatoid Arthritis: a Randomized Controlled Trial. Pain management nursing. (2016) 17 2 pp140-149', '10.1016/j.pmn.2016.01.004', '']\n",
      "['9262126', 'Moreira E; Jones A; Oliveira HA; Jennings F; Fernandes A; Natour J. Effectiveness of insole use in rheumatoid feet: a randomized controlled trial. Scandinavian journal of rheumatology. (2016) 45 5 pp363-370', '10.3109/03009742.2015.1110198', '']\n",
      "['9262127', 'Goodwin VA; Paudyal P; Perry MG; Day N; Hawton A; Gericke C; Ukoumunne OC; Byng R. Implementing a patient-initiated review system for people with rheumatoid arthritis: a prospective, comparative service evaluation. Journal of evaluation in clinical practice. (2016) 22 3 pp439-445', '10.1111/jep.12505', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjep.12505']\n",
      "['9262128', 'Lindegaard HM; Johansen P; Gr‚àö‚àÇndal G; Jensen EC; Juul L; Schlemmer AM; Agular B; Hansen I. Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious. Scandinavian journal of rheumatology. (2016) 45 4 pp262-266', '10.3109/03009742.2015.1112030', '']\n",
      "['9262129', 'Taneja A; Oosterholt SP; Danhof M; Della Pasqua O. Biomarker exposure-response relationships as the basis for rational dose selection: lessons from a simulation exercise using a selective COX-2 inhibitor. Journal of clinical pharmacology. (2016) 56 5 pp609-621', '10.1002/jcph.629', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.629']\n",
      "['9262130', 'Bansback N; Harrison M; Marra C. Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?. Medical decision making. (2016) 36 4 pp490-502', '10.1177/0272989x15600708', 'https://journals.sagepub.com/doi/pdf/10.1177/0272989X15600708']\n",
      "['9262131', 'Maringwa J; K√•gedal M; Hamr√©n UW; Martin P; Cox E; Hamr√©n B. Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA). Journal of clinical pharmacology. (2015) 55 3 pp328-335', '10.1002/jcph.406', '']\n",
      "['9262135', 'Hajialilo M; Ghorbanihaghjo A; Valaee L; Kolahi S; Rashtchizadeh N; Amirkhiz MB; Malekmahdavi I; Khabbazi A. A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis. Clinical rheumatology. (2016) 35 12 pp2887-2891', '10.1007/s10067-016-3397-4', 'http://link.springer.com/article/10.1007/s10067-016-3397-4/fulltext.html']\n",
      "['9262136', 'El Miedany Y; El Gaafary M; Youssef S; Ahmed I; Bahlas S; Hegazi M; Nasr A. Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission. Clinical rheumatology. (2016) 35 12 pp2915-2923', '10.1007/s10067-016-3413-8', 'http://link.springer.com/article/10.1007/s10067-016-3413-8/fulltext.html']\n",
      "['9262137', 'Aryaeian N; Shahram F; Djalali M. CLA Has a Useful Effect on Bone Markers in Patients with Rheumatoid Arthritis. Lipids. (2016) 51 12 pp1397-1405', '10.1007/s11745-016-4201-6', 'http://link.springer.com/article/10.1007/s11745-016-4201-6/fulltext.html']\n",
      "['9262140', 'Miedany YE; Gaafary ME; Youssef S; Bahlas S; Almedany S; Ahmed I; Palmer D. Toward electronic health recording: evaluation of electronic patient-reported outcome measures system for remote monitoring of early rheumatoid arthritis. Journal of rheumatology. (2016) 43 12 pp2106-2112', '10.3899/jrheum.151421', '']\n",
      "['9262141', 'Kim DY; Lee SS; Nomkhondorj O; Cho MG; Lee JJ; Hwang JT; Hong MS. Comparison between anterior and posterior approaches for ultrasound-guided glenohumeral steroid injection in primary adhesive capsulitis: a randomized controlled trial. Journal of clinical rheumatology. (2017) 23 1 pp51-57', '10.1097/rhu.0000000000000475', '']\n",
      "['9262142', 'Savage L; Coates L; Moverley A; Helliwell P. Detecting psoriatic arthritis in patients with psoriasis: does an educational leaflet improve attendance for screening?. British journal of dermatology. Conference: 96th annual meeting of british association of dermatologists. United kingdom. Conference start: 20160705. Conference end: 20160707. (2016) 175  pp36-37', '10.1111/bjd.14604', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjd.14604']\n",
      "['9262143', 'Klunder B; Mohamed M-EF; Othman AA. Population pharmacokinetics of ABT-494 in healthy subjects and in subjects with rheumatoid arthritis: com-bined analysis of phase i and II trials. Clinical pharmacology and therapeutics. Conference: 118th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2017. United states. Conference start: 20170315. Conference end: 20170317. (2017) 101  ppS79-S80', '10.1007/s40262-017-0605-6', 'http://link.springer.com/article/10.1007/s40262-017-0605-6/fulltext.html']\n",
      "['9262144', 'Mohamed M-EF; Zeng J; Jiang P; Hosmane B; Othman AA. Exposure-response analysis to assess the effect of ABT-494 on QT interval and utilization of a non-pharmacological approach to demonstrate ecg assay sensitivity. Clinical pharmacology and therapeutics. Conference: 118th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2017. United states. Conference start: 20170315. Conference end: 20170317. (2017) 101  ppS40', '10.1002/cpt.804', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.804']\n",
      "['9262145', 'Tanaka S; Harada S; Hiramatsu N; Nakaya R; Kawa-Mura M. Randomized, double-blind, placebo-controlled, PH1 study to evaluate safety and pharmacokinetics of AMG203 (namilumab) in healthy adult Japanese/caucasian male subjects. Clinical pharmacology and therapeutics. Conference: 118th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2017. United states. Conference start: 20170315. Conference end: 20170317. (2017) 101  ppS90', '10.5414/cp203235', '']\n",
      "['9262146', 'Kolahi S; Pourghassem Gargari B; Mesgari Abbasi M; Asghari Jafarabadi M; Ghamarzad Shishavan N. Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study. Nutrition research and practice. (2015) 9 2 pp186-191', '10.4162/nrp.2015.9.2.186', '']\n",
      "['9262147', 'Lee SY; GN KK; Chung BJ; Lee SW; Kim TK. Anterolateral Portal Is Less Painful than Superolateral Portal in Knee Intra-Articular Injection. Knee surg relat res. (2015) 27 4 pp228-232', '10.5792/ksrr.2015.27.4.228', '']\n",
      "['9262149', 'Inderjeeth C; Raymond W; Inderjeeth A. Comparing the electronic patient reported outcome (EPRO) tool versus the paper reported outcome (PPRO) tool in rheumatoid arthritis patients treated with certolizumab pegol. Arthritis and rheumatology. Conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2016. United states. Conference start: 20161111. Conference end: 20161116. (2016) 68  pp2688-2690', '10.1002/art.39977', '']\n",
      "['9262151', 'Chen XX; Li ZG; Wu HX; Zhao DB; Li XF; Xu JH; Tao Y; Yang NP; Hu SX; Huang AB; Jiang LD; Wang GC; Zhang X; Bao CD. A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate. Clinical rheumatology. (2016) 35 9 pp2175-2183', '10.1007/s10067-016-3302-1', 'http://link.springer.com/article/10.1007/s10067-016-3302-1/fulltext.html']\n",
      "['9262153', 'Lui K-J. Testing Equality in Ordinal Data with Repeated Measurements: a Model-Free Approach. International journal of biostatistics. (2016) 12 2) (no pagination pp', '10.1515/ijb-2015-0075', 'http://www.degruyter.com/view/j/ijb.2016.12.issue-2/ijb-2015-0075/ijb-2015-0075.xml']\n",
      "['9262154', 'Horvath R; Hurnakova J; Jankova R; Philipp T; Szczukova L; Hejduk K; Pavelka K. Efficacy of the first and subsequent treatment lines with adalimumab in patients with rheumatoid arthritis: data analysis from the Czech National Registry ATTRA.. Ceska revmatologie. (2016) 24 3 pp78-91', '10.1136/annrheumdis-2018-eular.2407', '']\n",
      "['9262155', \"Yoon CH; Lee HJ; Lee EY; Lee EB; Lee W-W; Kim MK; Wee WR. Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjogren's Syndrome: a Double-Blind Randomized Control Study. Journal of korean medical science. (2016) 31 7 pp1127-1135\", '10.3346/jkms.2016.31.7.1127', 'http://synapse.koreamed.org/pdf/10.3346/jkms.2016.31.7.1127']\n",
      "['9262158', 'Chen S; Ye Z; Zheng Q; Zeng J; Xu X; Liu H. Comparision of ultrasound and serology index in evaluation of rabbits with rheumatoid arthritis.. Chinese journal of medical imaging technology. (2016) 32 8 pp1160-1164', '10.7863/ultra.15.10044', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.7863%2Fultra.15.10044']\n",
      "['9262159', 'Javadi F; Ahmadzadeh A; Eghtesadi S; Aryaeian N; Zabihiyeganeh M; Rahimi Foroushani A; Jazayeri S. The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: a Double-Blind, Randomized Controlled Trial. Journal of the american college of nutrition. (2017) 36 1 pp9-15', '10.1080/07315724.2016.1140093', '']\n",
      "['9262162', 'Fautrel B; Morel J; Berthelot J-M; Constantin A; De Bandt M; Gaudin P; Maillefert J-F; Meyer O; Pham T; Saraux A; Solau-Gervais E; Vittecoq O; Wendling D; Erpelding M-L; Guillemin F. Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare. Arthritis and rheumatology. (2017) 69 2 pp309-319', '10.1002/art.39850', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39850']\n",
      "['9262163', 'Ghavipour M; Sotoudeh G; Tavakoli E; Mowla K; Hasanzadeh J; Mazloom Z. Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients. European journal of clinical nutrition. (2017) 71 1 pp92-96', '10.1038/ejcn.2016.151', 'https://www.nature.com/articles/ejcn2016151']\n",
      "['9262164', 'Schiff MH; Sadowski P. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis. Rheumatology international. (2017) 37 2 pp213-218', '10.1007/s00296-016-3621-1', 'http://link.springer.com/article/10.1007/s00296-016-3621-1/fulltext.html']\n",
      "['9262165', 'Kumar K; Sharma D. Comparison of efficacy of methyl prednisolone and triamcinolone in wrist ganglion using double dart technique and its application in an Indian population. Current orthopaedic practice. (2016) 27 6 pp614-617', '10.1097/bco.0000000000000426', '']\n",
      "['9262166', 'Van Den Bemt BJF. Randomised controlled non-inferiority study of disease activity guided dose reduction and withdrawal of adalimumab and etanercept compared to usual care in rheumatoid arthritis. European journal of hospital pharmacy. Conference: 21st congress of the european association of hospital pharmacists. Austria. Conference start: 20160316. Conference end: 20160318. (2016) 23  ppA171', '10.1136/ejhpharm-2016-000875.387', '']\n",
      "['9262167', 'Garcia Romero J; Vazquez Del Castillo M; Manes Sevilla M; Rubio Cebrian B; Segura Bedmar M. Rituximab efficacy in the treatment of autoimmune diseases. European journal of hospital pharmacy. (2015) 22  ppA79-A80', '10.1136/ejhpharm-2015-000639.190', '']\n",
      "['9262168', \"Al-Hamad A; Besi A; Porter S R; Fedele S. Salivary electrostimulation in primary Sjogren's syndrome: results from LEONIDAS-1 study. Oral diseases. (2014) 20  pp11\", '10.1111/odi.12952', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.12952']\n",
      "['9262170', 'Keystone E; Taylor P; Genovese M; Schlichting D; De La Torre I; Beattie S; Rooney T; Suters A. Safety and efficacy of baricitinib through 128 weeks in an open-label, long-term extension study in patients with rheumatoid arthritis. Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp26', '10.3899/jrheum.161161', '']\n",
      "['9262171', 'Keysor JJ; AlHeresh R; Vaughan M; LaValley MP; Allaire S. The Work-It Study for people with arthritis: study protocol and baseline sample characteristics. Work. 54(2):473-80, 2016 jun 14. (2016) 54 2 pp473-480', '10.3233/wor-162331', '']\n",
      "['9262172', 'Vanier A; Mariette X; Tubach F; Fautrel B; STRASS Study Group. Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: an Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial. Value in health. (2017) 20 4 pp577-585', '10.1016/j.jval.2017.01.005', '']\n",
      "['9262173', 'Nielsen MA; Andersen T; Etzerodt A; Kragstrup TW; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; H√∏rslev-Petersen K; Junker P; √òstergaard M; Hvid M; Moestrup SK; Deleuran B. A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis. Rheumatology (oxford, england). (2016) 55 10 pp1871-1879', '10.1093/rheumatology/kew237', 'http://academic.oup.com/rheumatology/article-pdf/55/10/1871/17388968/kew237.pdf']\n",
      "['9262174', 'Karag√ºlle M; Karde≈ü S; Karag√ºlle O; Di≈ü√ßi R; Avcƒ± A; Durak ƒ∞; Karag√ºlle MZ. Effect of spa therapy with saline balneotherapy on oxidant/antioxidant status in patients with rheumatoid arthritis: a single-blind randomized controlled trial. International journal of biometeorology. (2017) 61 1 pp169-180', '10.1007/s00484-016-1201-4', 'http://link.springer.com/article/10.1007/s00484-016-1201-4/fulltext.html']\n",
      "['9262177', 'Xia Z; Lyu J; Hou N; Song L; Li X; Liu H. Iguratimod in combination with methotrexate in active rheumatoid arthritis : therapeutic effects. Zeitschrift fur rheumatologie. (2016) 75 8 pp828-833', '10.1007/s00393-015-1641-y', 'http://link.springer.com/article/10.1007/s00393-015-1641-y/fulltext.html']\n",
      "['9262178', 'Lee JS; Chapman MJ; Piraino P; Lamerz J; Schindler T; Cutler P; Dernick G. Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: interleukin-6 receptor-alpha inhibition with tocilizumab. Proteomics. Clinical applications. (2016) 10 2 pp183-194', '10.1002/prca.201500036', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fprca.201500036']\n",
      "['9262179', 'Burgos-Vargas R; Horneff G; Tse SML; Quartier P; Unnebrink K; Anderson JK. Performance of disease activity measures in pediatric patients with enthesitis-related arthritis. Arthritis and rheumatology. Conference: 2017 ACR/ARHP pediatric rheumatology symposium. United states. (2017) 69  pp97-100', '10.1002/art.38414', '']\n",
      "['9262180', 'Turina MC; Ramiro S; Baeten DL; Mease P; Paramarta JE; Song IH; Pangan AL; Landewe R. A psychometric analysis of outcome measures in peripheral spondyloarthritis. Annals of the rheumatic diseases. (2016) 75 7 pp1302-1307', '10.1136/annrheumdis-2014-eular.1384', '']\n",
      "['9262181', 'Bell GM; Anderson AE; Diboll J; Reece R; Eltherington O; Harry RA; Fouweather T; MacDonald C; Chadwick T; McColl E; Dunn J; Dickinson AM; Hilkens CM; Isaacs JD. Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Annals of the rheumatic diseases. (2017) 76 1 pp227-234', '10.1136/annrheumdis-2015-208456', '']\n",
      "['9262182', 'Chiu H; Hollingworth S; Van Driel M; Magin P; Benham H. Under-reporting of socio-economic status in randomized control trials of biologic diseasemodifying anti-rheumatic drugs in rheumatoid arthritis. Rheumatology (united kingdom). (2017) 56 4 pp660-661', '10.1093/rheumatology/kew460', '']\n",
      "['9262183', 'Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW; SYCAMORE Study Group. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England journal of medicine. (2017) 376 17 pp1637-1646', '10.1056/nejmoa1614160', '']\n",
      "['9262185', 'Kavanaugh A; Kremer J; Ponce L; Cseuz R; Reshetko OV; Stanislavchuk M; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2). Annals of the rheumatic diseases. (2017) 76 6 pp1009-1019', '10.1136/annrheumdis-2016-210105', '']\n",
      "['9262187', 'Peterfy C; Strand V; Tian L; Ostergaard M; Lu Y; DiCarlo J; Countryman P; Deodhar A; Landewe R; Ranganath VK; Troum O; Conaghan PG. Short-Term changes on MRI predict long-Term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Annals of the rheumatic diseases. (2017) 76 6 pp992-997', '10.1136/annrheumdis-2016-210311', '']\n",
      "['9262188', 'Suzuki M; Tse S; Hirai M; Kurebayashi Y. Application of physiologieally-based pharmaeokinetie modeling for the prediction of tofaeitinib exposure in Japanese. The kobe journal of medical sciences. (2016) 62 6 ppE150-E161', '10.14789/jmj.62.s79', '']\n",
      "['9262190', 'Van Der Voort P; Valstar ER; Kaptein BL; Fiocco M; Van Der Heide HJL; Nelissen RGHH. Comparison of femoral component migration between Refobacin bone cement R and Palacos R + G in cemented total hip arthroplasty: a randomised controlled roentgen stereophotogrammetric analysis and clinical study. Bone and joint journal. (2016) 98-B 10 pp1333-1341', '10.1302/0301-620x.98b10.37116', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.98B10.37116']\n",
      "['9262191', 'Abood SJ; Gorial FI; Hussain SA. Safety of boron supplements in rheumatoid arthritis patients maintained on etanercept treatment. Pharmacie globale. (2016) 7 3 pp1-5', '10.5455/jice.20161204021549', 'https://ejmanager.com/mnstemps/55/55-1473762323.pdf']\n",
      "['9262193', 'Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis. Modern rheumatology. (2017) 27 3 pp411-416', '10.1080/14397595.2016.1208137', '']\n",
      "['9262194', 'Hinkka H; Vaattanen S; Ala-Peijari S; Nummi T. Effects of cold mist shower on patients with inflammatory arthritis: a crossover controlled clinical trial. Scandinavian journal of rheumatology. (2017) 46 3 pp206-209', '10.1080/03009742.2016.1199733', '']\n",
      "['9262195', 'Rome K; Clark H; Gray J; McMeekin P; Plant M; Dixon J. Clinical effectiveness and cost-effectiveness of foot orthoses for people with established rheumatoid arthritis: an exploratory clinical trial. Scandinavian journal of rheumatology. (2017) 46 3 pp187-193', '10.1080/03009742.2016.1196500', '']\n",
      "['9262202', 'Hahni M; Hirschmuller A; Baur H. The effect of foot orthoses with forefoot cushioning or metatarsal pad on forefoot peak plantar pressure in running. Journal of foot and ankle research. (2016) 9  pp44', '10.1186/s13047-016-0176-z', 'http://link.springer.com/article/10.1186/s13047-016-0176-z/fulltext.html']\n",
      "['9262203', 'Mori M; Morishima Y; Sugiyama N; Kokubo T; Takei S; Yokota S. Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: results from a postmarketing surveillance. Modern rheumatology. (2017)   pp1-7', '10.1080/14397595.2017.1310704', '']\n",
      "['9262204', 'Cooper JC; Eberhard BA; Punaro M; Ardoin SP; Brunner H; Hsu J; Wagner-Weiner L; Klein-Gitelman M; Rouster-Stevens KA; Schanberg LE; Von Scheven E. Corticosteroid regimen use in the pilot study of consensus treatment plans for induction therapy in childhood proliferative lupus nephritis. Arthritis and rheumatology. Conference: 2017 ACR/ARHP pediatric rheumatology symposium. United states. (2017) 69  pp142-143', '10.1002/art.38438', '']\n",
      "['9262205', 'Stinson JN; Campillo S; Cellucci T; Dancey P; Duffy CM; Ellsworth J; Feldman B; Huber A; Johnson N; McGrath P; Rosenberg A; Shiff NJ; Spiegel LR; Tse SML; Tucker L; Victor JC; Luca S. An internet-based self-management program for adolescents with juvenile idiopathic arthritis - A randomized controlled trial. Arthritis and rheumatology. Conference: 2017 ACR/ARHP pediatric rheumatology symposium. United states. (2017) 69  pp24-26', '10.2196/preprints.16234', '']\n",
      "['9262206', 'Stinson JN; Connelly M; Huber A; Luca N; Spiegel LR; Tsimicalis A; Luca S; Tajuddin N; Berard R; Barsalou J; Campillo S; Feldman B; Tse SML; Dancey P; Duffy CM; Johnson N; McGrath P; Shiff NJ; Tucker L; Victor JC. Feasibility testing of an internet-based psycho-educational game for children with juvenile idiopathic arthritis and their parents. Arthritis and rheumatology. Conference: 2017 ACR/ARHP pediatric rheumatology symposium. United states. (2017) 69  pp102-103', '10.1016/j.jpain.2016.01.335', '']\n",
      "['9262208', 'Smolen JS; Agarwal SK; Ilivanova E; Xu XL; Miao Y; Zhuang Y; Nnane I; Radziszewski W; Greenspan A; Beutler A; Baker D. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the rheumatic diseases. (2017) 76 5 pp831-839', '10.1136/annrheumdis-2016-209831', '']\n",
      "['9262209', 'Doma≈Ñska B; VanLunen B; Peterson L; Mountian I; Schiff M. Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert opinion on drug delivery. (2017) 14 1 pp15-22', '10.1080/17425247.2016.1256283', '']\n",
      "['9262211', 'Suzuki Y; Fukushima M; Sakuraba K; Sawaki K; Sekigawa K. Krill Oil Improves Mild Knee Joint Pain: a Randomized Control Trial. Plos one. (2016) 11 10 ppe0162769', '10.1371/journal.pone.0162769', '']\n",
      "['9262212', 'Ammitzb√∏ll-Danielsen M; √òstergaard M; Fana V; Glinatsi D; D√∏hn UM; √òrnbjerg LM; Naredo E; Terslev L. Intramuscular versus ultrasound-guided intratenosynovial glucocorticoid injection for tenosynovitis in patients with rheumatoid arthritis: a randomised, double-blind, controlled study. Annals of the rheumatic diseases. (2017) 76 4 pp666-672', '10.1136/annrheumdis-2016-209840', '']\n",
      "['9262214', 'Baker JF; Conaghan PG; Emery P; Baker DG; Ostergaard M. Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 3 pp486-490', '10.1136/annrheumdis-2016-209463', '']\n",
      "['9262216', 'Zamani B; Golkar HR; Farshbaf S; Emadi-Baygi M; Tajabadi-Ebrahimi M; Jafari P; Akhavan R; Taghizadeh M; Memarzadeh MR; Asemi Z. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. International journal of rheumatic diseases. (2016) 19 9 pp869-879', '10.1111/1756-185x.12888', '']\n",
      "['9262217', 'Genovese MC; Yang F; √òstergaard M; Kinnman N. Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings. Annals of the rheumatic diseases. (2016) 75 11 pp1979-1983', '10.1136/annrheumdis-2015-208901', '']\n",
      "['9262218', 'Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H. Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis. Modern rheumatology. (2016) 26 6 pp836-843', '10.3109/14397595.2016.1160969', '']\n",
      "['9262224', 'Rolando M; Vagge A. Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome. Journal of ocular pharmacology and therapeutics. (2017) 33 5 pp383-390', '10.1089/jop.2016.0147', '']\n",
      "['9262225', \"Peric T; Markovic D; Petrovic B; Radojevic V; Todorovic T; Radicevic BA; Heinemann RJ; Susic G; Popadic AP; Spiric VT. Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. Clinical oral investigations. (2015) 19 9 pp2153-2165\", '10.1007/s00784-015-1444-1', 'http://link.springer.com/article/10.1007/s00784-015-1444-1/fulltext.html']\n",
      "['9262226', \"Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjogren's syndrome: results of a pilot monocentric trial. Clinical otolaryngology. , 2017 jun 05. (2018) 43 1 pp96-102\", '10.1111/coa.12911', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcoa.12911']\n",
      "['9262227', 'Lee YK; Ha YC; Yoo J-I; Jo WL; Kim K-C; Koo KH. Mid-term results of the biolox delta ceramic-on-ceramic total hip arthroplasty. Bone and joint journal. (2017) 99B 6 pp741-748', '10.1302/0301-620x.99b6.bjj-2016-0486.r3', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.99B6.BJJ-2016-0486.R3']\n",
      "['9262228', 'Mccloskey EV; Johansson H; Oden A; Harvey NC; Jiang H; Modin S; Fitzpatrick L; Kanis JA. The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: a Post Hoc Analysis of the ACTIVE Study. Journal of bone and mineral research. (2017) 32 8 pp1625-1631', '10.1002/jbmr.3163', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.3163']\n",
      "['9262229', 'Ghandour TM; Ahmed Abdelrahman A; Mohamed Ibrahim A; Zaki MB. Does the degree of beach chair position during shoulder arthroscopy affect cerebral oxygenation? A prospective comparative study. Current orthopaedic practice. (2017) 28 4 pp353-357', '10.1097/bco.0000000000000518', '']\n",
      "['9262231', 'Macdonald TM; Hawkey CJ; Ford I; McMurray JJV; Scheiman JM; Hallas J; Findlay E; Grobbee DE; Hobbs FDR; Ralston SH; Reid DM; Walters MR; Webster J; Ruschitzka F; Ritchie LD; Perez-Gutthann S; Connolly E; Greenlaw N; Wilson A; Wei L; Mackenzie IS. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). European heart journal. (2017) 38 23 pp1843-1850', '10.1093/eurheartj/ehw387', 'http://academic.oup.com/eurheartj/article-pdf/38/23/1843/17710869/ehw387.pdf']\n",
      "['9262233', 'Kim WS; Buske C; Ogura M; Jurczak W; Sancho J-M; Zhavrid E; Kim JS; Hernandez-Rivas J-A; Prokharau A; Vasilica M; Nagarkar R; Osmanov D; Kwak LW; Lee SJ; Lee SY; Bae YJ; Coiffier B. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. The lancet haematology. (2017) 4 8 ppe362-e373', '10.1016/s2352-3026(17)30120-5', '']\n",
      "['9262234', 'Jurczak W; Moreira I; Kanakasetty GB; Munhoz E; Echeveste MA; Giri P; Castro N; Pereira J; Akria L; Alexeev S; Osmanov E; Zhu P; Alexandrova S; Zubel A; Harlin O; Amersdorffer J. Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. The lancet haematology. (2017) 4 8 ppe350-e361', '10.1016/s2352-3026(17)30106-0', '']\n",
      "['9262235', 'Chandrashekara S; Patted A. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: an exploratory study. International journal of rheumatic diseases. (2017) 20 7 pp825-831', '10.1111/1756-185x.12770', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12770']\n",
      "['9262236', 'Wang J; Zou X; Zhou L; Liu H. Patient satisfaction after nurse-led care in Chinese patients with rheumatoid arthritis: a China study. Biomedical research (india). (2017) 28 11 pp4972-4978', '10.1111/ijn.12605', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijn.12605']\n",
      "['9262243', 'Garner S; Creaser C; Martin L; Fenton T; Johns C; Barnabe C. Effect of personalized diet and exercise recommendations in early inflammatory arthritis: a randomized trial. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp891', '10.1002/msc.1214', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1214']\n",
      "['9262245', 'Choe J-Y; Smolen J; Keystone E; Genovese M; Lee Y; Rho Y-H; Therrien F. Efficacy and safety analysis by overall anti-drug antibody result up to week 30 in patients with rheumatoid arthritis treated with SB2 (an infliximab biosimilar) or reference infliximab in a phase III study. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp872', '10.1136/annrheumdis-2016-eular.3359', '']\n",
      "['9262246', 'Weinblatt M; Dorner T; Zeldin R; Schoen P; De Beuf K; Dombrecht E; Van Beneden K. Results of a subgroup analysis by access to biologics in a phase IIb study of vobarilizumab, an anti-interleukin 6 receptor Nanobody, in patients with moderate-to-severe rheumatoid arthritis despite treatment with methotrexate. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp880', '10.1136/annrheumdis-2017-eular.3732', '']\n",
      "['9262247', 'Weinblatt M; Dorner T; Zeldin R; Schoen P; De Beuf K; Dombrecht E; Van Beneden K. Results of a phase IIb study of vobarilizumab, an anti-interleukin 6 receptor Nanobody, in patients with moderate-to-severe rheumatoid arthritis despite treatment with methotrexate. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp880', '10.1136/annrheumdis-2017-eular.3732', '']\n",
      "['9262249', 'Genovese M; Weinblatt M; Keystone E; Baranauskaite A; Ghil J; Cheong S-Y. Impact of anti-drug antibodies on efficacy and safety up to week 24 from a phase iii study comparing SB5 (an adalimumab biosimilar) with reference adalimumab in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp878', '10.1136/annrheumdis-2016-eular.3331', '']\n",
      "['9262252', 'Emery P; Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Ghil J; Cheong S-Y. Comparison between continuing SB4 (etanercept biosimilar) and switching from reference etanercept to SB4: long-term safety and efficacy of SB4 from a phase III study. Journal of rheumatology. Conference: 72nd annual meeting of the canadian rheumatology association, CRA 2017. Canada. (2017) 44 6 pp877-878', '10.1136/annrheumdis-2016-eular.3137', '']\n",
      "['9262254', 'Ogura M; Buske C; Kim WS; Coiffier B; Kwak L; Jurczak W; Sancho JM; Zhavrid E; Kim JS; Hernandez Rivas JA; Prokharau A; Vasilica M; Nagarkar R; Osmanov D; Lee SJ; Lee SY; Bae YJ. A double-blind, randomized phase 3 study to compare efficacy and safety of CT-P10 to innovator rituximab in combination with CVP in patients with previously untreated advanced follicular lymphoma. Haematologica. Conference: 22th congress of the european hematology association. Spain. (2017) 102  pp250', '10.1002/hon.2438_83', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2438_83']\n",
      "['9262257', 'Zamani B; Farshbaf S; Golkar HR; Bahmani F; Asemi Z. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. British journal of nutrition. (2017) 117 8 pp1095-1102', '10.1017/s000711451700085x', '']\n",
      "['9262264', 'Sun H; Van LM; Floch D; Jiang X; Klein UR; Abrams K; Sunkara G. Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis. Journal of clinical pharmacology. (2016) 56 12 pp1516-1527', '10.1002/jcph.754', '']\n",
      "['9262265', 'Lamba M; Wang R; Fletcher T; Alvey C; Kushner J; Stock TC. Extended-Release Once-Daily Formulation of Tofacitinib: evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food. Journal of clinical pharmacology. (2016) 56 11 pp1362-1371', '10.1002/jcph.734', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.734']\n",
      "['9262266', 'Hegazy SK; El-Ghany El-Sayed Sel-M; El-Hefnawy Mel-S. A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients. Journal of clinical pharmacology. (2016) 56 10 pp1272-1276', '10.1002/jcph.725', '']\n",
      "['9262267', 'Vista E; Hamijoyo L; Navarra S. Survey on the use of complementary therapies among filipinos with arthritis. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2017. Italy. (2017) 28  ppS459', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9262269', 'Mangoni AA; Baghdadi LR; Shanahan EM; Wiese MD; Tommasi S; Elliot D; Woodman RJ. Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study. Therapeutic advances in musculoskeletal disease. (2017) 9 9 pp213-229', '10.1177/1759720x17719850', 'https://journals.sagepub.com/doi/pdf/10.1177/1759720X17719850']\n",
      "['9262270', \"Corrado A; Di Bello V; D'Onofrio F; Maruotti N; Cantatore FP. Anti-TNF-alpha effects on anemia in rheumatoid and psoriatic arthritis. International journal of immunopathology and pharmacology. (2017) 30 3 pp302-307\", '10.1177/0394632017714695', 'https://journals.sagepub.com/doi/pdf/10.1177/0394632017714695']\n",
      "['9262271', 'Danese S; Peyrin-Biroulet L. To switch or not to switch: that is the biosimilar question. Nature reviews gastroenterology and hepatology. (2017) 14 9 pp508-509', '10.1038/nrgastro.2017.86', 'http://www.nature.com/articles/nrgastro.2017.86']\n",
      "['9262273', 'Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis. Journal of periodontal research. (2016) 51 1 pp103-111', '10.1111/jre.12288', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjre.12288']\n",
      "['9262274', 'Smolen JS; Choe JY; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Choi J; Rho YH. Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results. Rheumatology (oxford, england). (2017) 56 10 pp1771-1779', '10.1093/rheumatology/kex254', 'http://academic.oup.com/rheumatology/article-pdf/56/10/1771/24245795/kex254.pdf']\n",
      "['9262282', 'Cohen S; Genovese MC; Choy E; Perez-Ruiz F; Matsumoto A; Pavelka K; Pablos JL; Rizzo W; Hrycaj P; Zhang N; Shergy W; Kaur P. Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study. Annals of the rheumatic diseases. (2017) 76 10 pp1679-1687', '10.1136/annrheumdis-2016-210459', '']\n",
      "['9262285', 'Kumar A; Dhir V; Sharma S; Sharma A; Singh S. Efficacy of Methylprednisolone Acetate Versus Triamcinolone Acetonide Intra-articular Knee Injection in Patients With Chronic Inflammatory Arthritis: a 24-Week Randomized Controlled Trial. Clinical therapeutics. (2017) 39 1 pp150-158', '10.1016/j.clinthera.2016.11.023', '']\n",
      "['9262286', 'Lehtinen M; Eriksson T; Apter D; Hokkanen M; Natunen K; Paavonen J; Pukkala E; Angelo M G; Zima J; David M P; Datta S; Bi D; Struyf F; Dubin G. Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15¬†years: interim analysis of a large community-randomized controlled trial. Human vaccines and immunotherapeutics. (2016) 12 12 pp3177-3185', '10.1080/21645515.2016.1183847', 'https://www.tandfonline.com/doi/pdf/10.1080/21645515.2016.1183847']\n",
      "['9262287', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; L√∏ppenthin K; Midtgaard J; Christensen R; Esbensen BA. Motivational counselling and SMS-reminders for reduction of daily sitting time in patients with rheumatoid arthritis: a descriptive randomised controlled feasibility study. BMC musculoskeletal disorders. (2016) 17 1 pp434', '10.1186/s12891-016-1266-6', 'http://link.springer.com/article/10.1186/s12891-016-1266-6/fulltext.html']\n",
      "['9262288', 'Xie J; Ma J; Yao H; Yue C; Pei F. Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: a Randomized Clinical Trial. Journal of arthroplasty. (2016) 31 11 pp2458-2464', '10.1016/j.arth.2016.04.034', '']\n",
      "['9262289', 'Vanoglio F; Bernocchi P; Mule C; Garofali F; Mora C; Taveggia G; Scalvini S; Luisa A. Feasibility and efficacy of a robotic device for hand rehabilitation in hemiplegic stroke patients: a randomized pilot controlled study. Clinical rehabilitation. (2017) 31 3 pp351-360', '10.1177/0269215516642606', 'https://journals.sagepub.com/doi/pdf/10.1177/0269215516642606']\n",
      "['9262290', 'Weiler H; Germain I; Hazell T; Vanstone C. Forearm grip strength is maintained by 1000 IU of supplemental vitamin D over 6 months and moderately correlated to muscle area in men >80 y of age in long-term care. Osteoporosis international. (2017) Conference: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, WCO-IOF-ESCEO 2017. Italy. 28 pp S490-S491 pp', '10.1007/s00198-017-3935-1', 'http://link.springer.com/article/10.1007/s00198-017-3935-1/fulltext.html']\n",
      "['9262291', 'Eberhardson M; Hall S; Papp KA; Sterling TM; Stek JE; Pang L; Zhao Y; Parrino J; Popmihajlov Z. Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults with Autoimmune Disease: a Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Clinical infectious diseases. (2017) 65 7 pp1174-1182', '10.1093/cid/cix484', 'http://academic.oup.com/cid/article-pdf/65/7/1174/19918680/cix484.pdf']\n",
      "['9262293', 'Loftus EV; Sloan S; Ramachandran P; Yang Z; Guo C-Y; Gasink C. Comparison of rates of active tuberculosis infection in the phase 2 and 3 clinical trial programs for anti-IL12/23 and anti-TNFs. Gastroenterology. (2017) Conference: Digestive Disease Week 2017, DDW 2017. United States. 152 5 Supplement 1 ppS596', '10.1016/s0016-5085(17)32134-0', '']\n",
      "['9262295', 'Lei Y; Xie J; Xu B; Xie X; Huang Q; Pei F. The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. International orthopaedics. (2017) 41 10 pp2053-2059', '10.1007/s00264-017-3519-x', 'http://link.springer.com/article/10.1007/s00264-017-3519-x/fulltext.html']\n",
      "['9262297', 'Tynjala P; Tarkiainen M; Vahasalo P; Kroger L; Aalto K; Rebane K; Malin M; Markula-Patjas K; Piippo-Savolainen E; Lahdenne P. 3 year follow-up of acute-JIA cohort-aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp133-134', '10.1136/ard.2010.143347', '']\n",
      "['9262298', 'Spiegel LR; Stinson J; Campillo S; Cellucci T; Dancey P; Duffy C; Ellsworth J; Feldman B; Huber A; Johnson N; McGrath P; Rosenberg A; Shiff N; Tse S; Tucker L; Victor C; Luca S. An internet-based self-management program for adolescents with juvenile idiopathic arthritis (JIA): a randomized controlled trial (RCT). Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp133', '10.2196/preprints.16234', '']\n",
      "['9262299', 'Muller PH; Brinkman D; Schonenberg D; Van Den Bosch W; Koopman-Keemink Y; Brederije I; Bekkering P; Kuijpers T; Van Rossum M; Van Suijlekom-Smit LW; Van Den Berg JM; Boehringer S; Allaart CF; Ten Cate R. Three treatment strategies in recent onset dmard naive juvenile idiopathic arthritis: first results of clinical outcome after 24 months. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp9', '10.1136/annrheumdis-2018-eular.2623', '']\n",
      "['9262300', \"Sherratt FC; Roper L; Baildam E; Beresford MW; Stones SR; Ramanan A; Foster H; McErlane F; Rooney M; Peak M; Young B. Families' views on the feasibility of a corticosteroid trial in JIA: a qualitative study. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp132\", '10.1186/s12969-018-0293-2', 'http://link.springer.com/article/10.1186/s12969-018-0293-2/fulltext.html']\n",
      "['9262301', 'Tsinti M; Dermentzoglou V; Tsitsami E. Efficacy and tolerability of switching from subcutaneous to oral route of methotrexate administration in juvenile idiopathic arthritis. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp142-143', '10.5114/reum.2016.58757', 'https://reu.termedia.pl/pdf-62040-86358']\n",
      "['9262302', 'Mikola K; Aalto K; Lahdenne P; Kautiainen H. The usability of cell phone based automated monitoring of patients with juvenile idiopathic arthritis. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp136', '10.1186/s12969-023-00938-0', 'https://link.springer.com/article/10.1186/s12969-023-00938-0/fulltext.html']\n",
      "['9262303', 'Arman N; Tarakci E; Tarakci D; Kasapcopur O. The effect of task-oriented training with video-based games on activity performance and participation in children with juvenile idiopathic arthritis. Pediatric rheumatology. Conference: 24th paediatric rheumatology european society congress. Greece. (2017) 15  pp44-45', '10.1097/phm.0000000000001001', '']\n",
      "['9262304', 'Cagini C; Torroni G; Fiore T; Cerquaglia A; Lupidi M; Aragona P; Iaccheri B. Tear Film Stability in Sjogren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops. Journal of ocular pharmacology and therapeutics. (2017) 33 7 pp539-542', '10.1089/jop.2016.0149', '']\n",
      "['9262308', 'Tanaka Y; Van Der Aa A; Jamoul C; Tasset C; Harrison P; Westhovens R. Effect of baseline BMI on efficacy and safety of filgotinib in rheumatoid arthritis patients: post-hoc analysis from phase 2B study. International journal of rheumatic diseases. (2017) Conference: 19th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2017. . 20 Supplement 1 pp91-92', '10.1136/annrheumdis-2017-eular.5428', '']\n",
      "['9262313', 'El Miedany Y; El Gaafary M; Youssef S; Bahlas S; Almedany S; Ahmed I; Palmer D. Toward Electronic Health Recording: evaluation of Electronic Patient-reported Outcome Measures System for Remote Monitoring of Early Rheumatoid Arthritis. Journal of rheumatology. (2016) 43 12 pp2106-2112', '10.3899/jrheum.151421', '']\n",
      "['9262314', 'Zernicke J; Kedor C; M√ºller A; Burmester GR; Rei√ühauer A; Feist E. A prospective pilot study to evaluate an animated home-based physical exercise program as a treatment option for patients with rheumatoid arthritis. BMC musculoskeletal disorders. (2016) 17 1 pp351', '10.1186/s12891-016-1208-3', 'http://link.springer.com/article/10.1186/s12891-016-1208-3/fulltext.html']\n",
      "['9262315', 'Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC musculoskeletal disorders. (2016) 17  pp331', '10.1186/s12891-016-1170-0', 'http://link.springer.com/article/10.1186/s12891-016-1170-0/fulltext.html']\n",
      "['9262317', 'Kiraly M; Varga Z; Szanyo F; Kiss R; Hodosi K; Bender T. Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis - a randomized controlled trial. Brazilian journal of physical therapy. (2017) 21 3 pp199-205', '10.1016/j.bjpt.2017.04.002', '']\n",
      "['9262318', 'Sun Y; Wittenberg G; Chen G; Drevets W; Hsu B; Curran M. Improvement in measures of depressed mood and anhedonia in two randomized, placebo-controlled phase III studies of sirukumab, a human anti-interleukin-6 antibody, in patients with rheumatoid arthritis. Biological psychiatry. (2017) Conference: 72nd Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP 2017. United States. 81 10 Supplement 1 ppS123', '10.1016/j.biopsych.2017.02.314', '']\n",
      "['9262319', 'Okano T; Inui K; Tada M; Sugioka Y; Mamoto K; Wakitani S; Koike T; Nakamura H. Loss of lean body mass affects low bone mineral density in patients with rheumatoid arthritis-results from the TOMORROW study. Modern rheumatology. (2017) 27 6 pp946-952', '10.1080/14397595.2017.1289645', '']\n",
      "['9262320', 'Imanaka T; Sato I; Tanaka S; Kawakami K. Predictive factors for the placebo effect in clinical trials for dry eye: a pooled analysis of three clinical trials. British journal of ophthalmology. (2017) 101 11 pp1471-1474', '10.1136/bjophthalmol-2016-309887', '']\n",
      "['9262321', 'Gogna A; Gulati S. Low versus high dose adalimumab in ankylosing spondylitis patients. Indian journal of rheumatology. (2017) Conference: 33rd Annual Conference of the Indian Rheumatology Association, IRACON 2017. India. 12 5 Supplement 1 ppS62-S63', '10.1016/s0973-3698(09)60002-9', '']\n",
      "['9262322', \"Horneff G; Seyger M M B; Arikan D; Kalabic J; Anderson J K; Lazar A; Williams D A; Wang C; Tarzynski-Potempa R; Hyams J S. Safety of adalimumab in pediatric patients with polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriasis, and Crohn's disease. Arthritis and rheumatology. (2016) 68  pp489-491\", '10.1136/annrheumdis-2016-eular.4386', '']\n",
      "['9262323', 'Lichtenstein G R; Loftus E V; Bloom S; Lawendy N; Friedman G; Zhang H; Wang W; Thorpe A J; Nduaka C; Su C. Tofacitinib, an oral Janus Kinase inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study. United european gastroenterology journal. (2017) 5 (5 Supplement 1) 5 Supplement 1 ppA39-A40', '10.14309/00000434-201710001-00714', '']\n",
      "['9262324', \"Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Tasset C; Van Der Aa A; Harrison P. Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn's disease: final analysis of the phase 2 fitzroy study. United european gastroenterology journal. (2016) 4 (5 Supplement 1) 5 Supplement 1 ppA44-A45\", '10.1016/s0016-5085(16)34280-9', '']\n",
      "['9262325', \"Vermeire S; Van Der Aa A; Jamoul C; Tasset C; Harrison P; D'Haens G R. Effect of disease duration and location on clinical remission in crohn's disease patients treated with filgotinib, a selective JAK1 inhibitor: post-hoc analysis from the phase 2 fitzroy study. United european gastroenterology journal. (2017) 5 (5 Supplement 1) 5 Supplement 1 ppA2-A3\", '10.1016/s0016-5085(16)34280-9', '']\n",
      "['9262326', 'Volkers A G; Jansen J M. Similar trial-efficacy of infliximab-biosimilar compared to infliximab-biological in patients with inflammatory bowel disease in remission-a randomized, controlled, double blind, phase 4 noninferiority trial. United european gastroenterology journal. (2017) 5 (5 Supplement 1) 5 Supplement 1 ppA307', '10.26226/morressier.59a6b344d462b80290b5431b', '']\n",
      "['9262328', 'Edwards CJ; J K √ñst√∂r A; Naisbett-Groet B; Kiely P. Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial. Rheumatology (Oxford, England). (2018) 57 1 pp84-91', '10.1093/rheumatology/kex358', 'http://academic.oup.com/rheumatology/article-pdf/57/1/84/24148849/kex358.pdf']\n",
      "['9262329', 'Zhou Y; Zhu J; Li LB; He TF; Chen XY; Zheng YY; Chen YF. Effects of Electroacupuncture on Joint Function in Rheumatoid Arthritis Patients of Liver- and Kidney-Yin Deficiency Type. Zhen CI yan jiu = acupuncture research. (2016) 41 5 pp440-446', '10.1111/dom.15354/v3/response1', '']\n",
      "['9262330', 'Emery P; Vencovsk‚àöŒ© J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan VM; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J. 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. Rheumatology (Oxford, England). (2017) 56 12 pp2093-2101', '10.1093/rheumatology/kex269', 'http://academic.oup.com/rheumatology/article-pdf/56/12/2093/24245610/kex269.pdf']\n",
      "['9262332', 'Solomon DH; Husni ME; Libby PA; Yeomans ND; Lincoff AM; Lœãscher TF; Menon V; Brennan DM; Wisniewski LM; Nissen SE; Borer JS. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: a Secondary Analysis of the PRECISION Trial. American journal of medicine. (2017) 130 12 pp1415-1422.e4', '10.1016/j.amjmed.2017.06.028', '']\n",
      "['9262334', 'Zhang W; Chen MR; Hu JY. Medicinal-powder-separated Long-snake Moxibustion over the Governor Vessel with Different Skin Vesiculation Conditions for Treatment of Patients with Rheumatoid Arthritis. Zhen CI yan jiu = acupuncture research. (2016) 41 4 pp327-333', '10.1016/j.wjam.2018.03.009', '']\n",
      "['9262335', 'Du XZ; Wang JH; Zhang XH; Tian JX; Qin XG; Fang XL; Tian L; Yuan B. Influence of Heat-reinforcing Needling on Expression of Plasma Atp 5 O mRNA and Atp 6 V 1 B 2 mRNA in Patients with Rheumatoid Arthritis of Wind-cold-damp Retention Type. Zhen CI yan jiu = acupuncture research. (2016) 41 4 pp303-307', '10.1038/s41598-020-78530-9', 'https://www.nature.com/articles/s41598-020-78530-9']\n",
      "['9262337', 'Alten R; Bingham CO; Cohen SB; Curtis JR; Kelly S; Wong D; Genovese MC. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept. BMC musculoskeletal disorders. (2016) 17  pp231', '10.1186/s12891-016-1082-z', 'http://link.springer.com/article/10.1186/s12891-016-1082-z/fulltext.html']\n",
      "['9262338', 'Boers M; Aletaha D; Mela CM; Baker DG; Smolen JS. Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials. Journal of rheumatology. (2016) 43 6 pp1024-1026', '10.3899/jrheum.150932', '']\n",
      "['9262339', 'Liu W; Wu YH; Hu SY; Zhong CL; Gao ML; Liu DW; Wang HY; Chen MZ; Song YJ; Yang BZ; Zheng QS; Yao H; Qi XB; Li G. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis. Trials. (2016) 17  pp359', '10.1186/s13063-016-1481-3', '']\n",
      "['9262340', 'Bernton E; Gannon W; Kramer W; Kranz E. PRTX-100 and methotrexate in patients with active rheumatoid arthritis: a Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study. Clinical pharmacology in drug development. (2014) 3 6 pp477-486', '10.1002/cpdd.116', '']\n",
      "['9262342', 'Xie Y; Zeng H. Efficacy and safety of infliximab in juvenile idiopathic arthritis and juvenile ankylosing spondylitis: a randomised, double-blind, controlled study. Hong kong journal of paediatrics. (2018) Conference: 13th Congress of Asian Society for Pediatric Research. Hong Kong. 23 1 pp44-45', '10.1136/annrheumdis-2014-eular.5363', '']\n",
      "['9262347', \"He B; DeJulio T; Chen Y; Petrich A. A case of delayed diagnosis of Hodgkin's lymphoma. Diagnosis. Conference: 7th international conference of the diagnostic error in medicine. United states. (2015) 2 1 ppeA35\", '10.1515/dx-2015-0001', 'http://www.degruyter.com/view/j/dx.2015.2.issue-1/dx-2015-0001/dx-2015-0001.xml']\n",
      "['9262348', 'Mease PJ; Jeka S; Jaller JJ; Kitumnuaypong T; Louthrenoo W; Mann H; Matsievskaia G; Soriano ER; Jia B; Wang C; Nie J; Hsia E. CNTO6785, a fully human antIInterleukin 17 monoclonal antibody, in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomized, placebo-controlled, phase II, dose-ranging study. Journal of rheumatology. (2018) 45 1 pp22-31', '10.3899/jrheum.161238', '']\n",
      "['9262350', 'Li Z-R; Cheng L-M; Wang K-Z; Yang N-P; Yang S-H; He W; Wang Y-S; Wang Z-M; Yang P; Liu X-Z; Luo Y-Z; Sun W; Wang H-T; Zheng L-Z; Wang X-L; Qin L. Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial. Journal of orthopaedic translation. (2018) 12  pp36-44', '10.1016/j.jot.2017.11.001', '']\n",
      "['9262351', 'Zhang X; Chua L; Ernest C; Macias W; Rooney T; Tham LS. Dose/exposure-response modeling to support dosing recommendation for phase III development of baricitinib in patients with rheumatoid arthritis. CPT: pharmacometrics and systems pharmacology. (2017) 6 12 pp804-813', '10.1002/psp4.12251', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsp4.12251']\n",
      "['9262352', 'Grine L; Segaert S; De La Brassinne M; Ghislain P-D; Willaert F; Hillary T; Lambert J. Treat to target in psoriasis: a Belgian attempt to define a tight control strategy for psoriasis management. British journal of dermatology. Conference: 8th international congress psoriasis from gene to clinic. United kingdom. (2017) 177 5 ppe282', '10.1111/jdv.16104', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16104']\n",
      "['9262353', 'Kim WS; Coiffier B; Buske C; Ogura M; Kwak L; Jurczak W; Sancho JM; Zhavrid E; Kim JS; Hernandez-Rivas J-A; Prokharau A; Vasilica M; Nagarkar R; Lee SJ; Lee SY; Bae YJ. CT-P10 versus reference rituximab in combination with CVP in advanced-stage follicular lymphoma: phase 3, double-blind, randomized trial. Annals of oncology. Conference: 3rd european society for medical oncology asia congress, ESMO 2017. Singapore. (2017) 28 Supplement 10 ppx94', '10.1093/annonc/mdx664.001', 'http://academic.oup.com/annonc/article-pdf/28/suppl_10/mdx664.001/21936685/mdx664.001.pdf']\n",
      "['9262354', 'Fenton SAM; Veldhuijzen van Zanten JJCS; Metsios GS; Rouse PC; Yu C-A; Kitas GD; Duda JL. Autonomy support, light physical activity and psychological well-being in Rheumatoid Arthritis: a cross-sectional study. Mental health and physical activity. (2018) 14  pp11-18', '10.1016/j.mhpa.2017.12.002', '']\n",
      "['9262355', 'Kim WS; Coiffier B; Buske C; Ogura M; Kwak LW; Bae Y; Kim S; Kim M; Lee S; Kwak D; Lee H. Clinical factors impact on pharmacokinetics of CT-P10 and reference rituximab in patients with advanced-stage follicular lymphoma. Blood. Conference: 59th annual meeting of the american society of hematology, ASH 2017. United states. (2017) 130 Supplement 1) (no pagination pp', '10.1182/blood-2018-99-112716', 'https://ashpublications.org/blood/article/132/Supplement%201/1616/273201/Similar-Efficacy-and-Safety-of-CTP10-and-Reference']\n",
      "['9262356', 'Watkins B; Qayed M; Bratrude B; Betz K; Brown M; Rhodes J; Sinclair S; Suessmuth Y; Yu A; Hebert K; Pasquini MC; Choi SW; Davis J; Duncan C; Giller R; Grimley M; Harris AC; Jacobsohn DA; Lalefar N; Norkin M; Pulsipher MA; Shenoy S; Blazar B; Langston A; Horan JT; Kean L. T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival. Blood. Conference: 59th annual meeting of the american society of hematology, ASH 2017. United states. (2017) 130 Supplement 1) (no pagination pp', '10.1016/j.bbmt.2018.12.129', '']\n",
      "['9262358', 'Fenton SAM; Veldhuijzen van Zanten JJCS; Kitas GD; Duda JL; Rouse PC; Yu CA; Metsios GS. Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity. BMC musculoskeletal disorders. (2017) 18 1 pp131', '10.1186/s12891-017-1473-9', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1473-9.pdf']\n",
      "['9262359', 'van Vilsteren M; Boot CR; Twisk JW; van Schaardenburg D; Steenbeek R; Voskuyl AE; Anema JR. Effectiveness of an integrated care intervention on supervisor support and work functioning of workers with rheumatoid arthritis. Disability and rehabilitation. (2017) 39 4 pp354-362', '10.3109/09638288.2016.1145257', 'https://tandfonline.com/doi/pdf/10.3109/09638288.2016.1145257']\n",
      "['9262360', 'van Vilsteren M; Boot CR; Voskuyl AE; Steenbeek R; van Schaardenburg D; Anema JR. Process Evaluation of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis. Journal of occupational rehabilitation. (2016) 26 3 pp382-391', '10.1007/s10926-015-9624-z', 'http://link.springer.com/article/10.1007/s10926-015-9624-z/fulltext.html']\n",
      "['9262372', 'Emery P; Tanaka Y; Cardillo TE; Schlichting DE; Beattie S; Chen L; Rooney TP; Smolen JS. Temporary interruptions of study drug during the baricitinib phase 3 rheumatoid arthritis program. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp527-528', '10.1136/annrheumdis-2017-eular.1326', '']\n",
      "['9262373', 'Combe B; Balsa A; Sarzi-Puttini P; Tony H-P; De Torre I; Rogai V; Durand F; Jahangir A; Witt S; Zhong J; Dougados M. Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp510', '10.1136/annrheumdis-2017-eular.2227', '']\n",
      "['9262374', 'Alten R; Glover J; Matsunaga N; Chisholm D; Genovese M. Efficacy and safety results of a phase iii study comparing FKB327, an adalimumab biosimilar, with the adalimumab reference product in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp59', '10.1136/annrheumdis-2017-eular.2220', '']\n",
      "['9262377', 'Anonymous. Erratum to: a randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: results of the 12-week double-blind period (Modern Rheumatology, (2018), 28, 1, (76-84), 10.1080/14397595.2017.1332507). Modern rheumatology. (2018) 28 1 pp(v)', '10.1080/14397595.2017.1332507', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1332507']\n",
      "['9262378', 'Dong F; Li M; Liu J. Effect of department of orthopedics rehabilitation integrated mode on knee joint pain, function and quality of life in total knee arthroplasty. Biomedical research (india). (2017) 28 21 pp9534-9537', '10.1007/978-1-4612-5050-0_14', 'http://link.springer.com/content/pdf/10.1007/978-1-4612-5050-0_14.pdf']\n",
      "['9262381', 'Smolen JS; Choe J-Y; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Lee Y; Rho YH. Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study. Annals of the rheumatic diseases. (2018) 77 2 pp234-240', '10.1136/annrheumdis-2017-211741', '']\n",
      "['9262383', 'Kalati M; Kashanian M; Jahdi F; Naseri M; Haghani H; Sheikhansari N. Evening primrose oil and labour, is it effective? A randomised clinical trial. Journal of obstetrics and gynaecology. (2018) 38 4 pp488-492', '10.1080/01443615.2017.1386165', '']\n",
      "['9262385', 'Ogata A; Tanaka Y; Ishii T; Kaneko M; Miwa H; Ohsawa S. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: results of the 12-week double-blind period. Modern rheumatology. (2018) 28 1 pp76-84', '10.1080/14397595.2017.1332507', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1332507']\n",
      "['9262386', 'Gossec L; Cantagrel A; Soubrier M; Berthelot J-M; Joubert J-M; Combe B; Czarlewski W; Wendling D; Dernis E; Grange L; Beauvais C; Perdriger A; Nataf H; Dougados M; Servy H. An e-health interactive self-assessment website (Sanoia) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients. Joint, bone, spine. (2018) (no pagination)  pp', '10.1016/j.jbspin.2017.11.015', '']\n",
      "['9262388', 'Mohamed M-EF; Camp HS; Jungerwirth S; Othman AA. Pharmacokinetics of upadacitinib in healthy Japanese and Chinese subjects and comparability to western subjects. Clinical pharmacology and therapeutics. Conference: 119th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2018. United states. (2018) 103 Supplement 1 ppS80', '10.1016/j.clpt.2003.11.040', '']\n",
      "['9262390', 'Lamba M; Lee J; Chapel S; Chen C; Krishnaswami S; Mukherjee A; Furst D; Vrijens B. Simulating the clinical impact of incomplete adherence during treatment with tofacitinib: implications of an indirect pharmacokinetic/pharmacodynamic relationship. Clinical pharmacology and therapeutics. Conference: 119th annual meeting of the american society for clinical pharmacology and therapeutics, ASCPT 2018. United states. (2018) 103 Supplement 1 ppS75', '10.1358/dof.2018.043.06.2813111', '']\n",
      "['9262392', 'Mahadevan U; Baumgart DC; Dubinsky MC; Lawendy N; Friedman GS; Konijeti GG; Grochenig HP; Jones TV; Marren A; Thorpe AJ; Nduaka CI; Su C. Pregnancy outcomes in the tofacitinib ulcerative colitis octave studies. American journal of gastroenterology. Conference: 82nd annual scientific meeting of the american college of gastroenterology. United states. (2017) 112 Supplement 1 ppS410-S411', '10.14309/00000434-201710001-00740', '']\n",
      "['9262395', \"Xin W; Leung KC; Lo EC; Mok MY; Leung MH. A randomized, double-blind, placebo-controlled clinical trial of fluoride varnish in preventing dental caries of Sjogren's syndrome patients. BMC oral health. (2016) 16 1 pp102\", '10.1186/s12903-016-0296-7', 'http://link.springer.com/article/10.1186/s12903-016-0296-7/fulltext.html']\n",
      "['9262396', 'Yarema N; Fedortsiv O; Palasiuk B. Influence of omega-3 polyunsaturated fatty acids on the structure of immunocompetent cell membranes and the parameters of cellular and humoral immunity in children with rheumatoid arthritis. Family medicine and primary care review. (2018) 20 1 pp78-82', '10.5114/fmpcr.2018.73707', '']\n",
      "['9262397', 'David H; Aupiais C; Louveau B; Quartier P; Jacqz-Aigrain E; Carel J-C; Simon D. Growth outcomes after GH therapy of patients given long-term corticosteroids for juvenile idiopathic arthritis. Journal of clinical endocrinology and metabolism. (2017) 102 12 pp4578-4587', '10.1210/jc.2017-01455', 'http://academic.oup.com/jcem/article-pdf/102/12/4578/22224599/jc.2017-01455.pdf']\n",
      "['9262398', \"Lesuis N; van Vollenhoven RF; Akkermans RP; Verhoef LM; Hulscher ME; den Broeder AA. Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback. Clinical and experimental rheumatology. (2018) 36 1 pp21-28\", '10.1136/rmdopen-2015-000195', '']\n",
      "['9262399', \"Chow V; Kaliyaperumal A; Zhang N; Miller J; Mytych D; Starcevic Manning M; Wala I; Wang H; Krishnan E. Development of anti-drug antibodies among those treated with adalimumab and ABP 501 and its impact on serum drug concentration in randomised controlled studies. Journal of crohn's and colitis. Conference: 13th congress of european crohn's and colitis organisation, ECCO 2018. Austria. (2018) 12 Supplement 1 ppS309\", '10.1093/ecco-jcc/jjx180.531', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S309/23744382/jjx180.531.pdf']\n",
      "['9262400', \"Winthrop KL; Melmed GY; Vermeire S; Long MD; Chan G; Pedersen RD; Lawendy N; Thorpe AJ; Nduaka CI; Su C. Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib. Journal of crohn's and colitis. Conference: 13th congress of european crohn's and colitis organisation, ECCO 2018. Austria. (2018) 12 Supplement 1 ppS364\", '10.1093/ecco-jcc/jjx180.639', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S363/23744672/jjx180.639.pdf']\n",
      "['9262401', \"Palaparthy R; Schmitt S; Rehman MI; Cai C-H; Wang K; Von Richter O. Incidence and impact of immunogenicity in a randomised, double-blind phase III study comparing a proposed infliximab biosimilar (PF-06438179/GP1111) with reference infliximab. Journal of crohn's and colitis. Conference: 13th congress of european crohn's and colitis organisation, ECCO 2018. Austria. (2018) 12 Supplement 1 ppS386\", '10.1093/ecco-jcc/jjx180.681', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S386/23744781/jjx180.681.pdf']\n",
      "['9262402', \"Sands BE; Taub PR; Feagan BG; Armuzzi A; Friedman GS; Moscariello M; Lawendy N; Pedersen RD; Chan G; Nduaka CI; Quirk D; Salese L; Su C. The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme. Journal of crohn's and colitis. Conference: 13th congress of european crohn's and colitis organisation, ECCO 2018. Austria. (2018) 12 Supplement 1 ppS023\", '10.1093/ecco-jcc/jjx180.032', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S023/23742169/jjx180.032.pdf']\n",
      "['9262403', \"Winthrop KL; Loftus EV; Baumgart DC; Reinisch W; Thorpe AJ; Nduaka CI; Lawendy N; Chan G; Pedersen RD; Friedman GS; Su C. Tofacitinib for the treatment of ulcerative colitis: analysis of infection rates from the OCTAVE clinical programme. Journal of crohn's and colitis. Conference: 13th congress of european crohn's and colitis organisation, ECCO 2018. Austria. (2018) 12 Supplement 1 ppS351-S352\", '10.1093/ecco-jcc/jjx180.614', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S351/23744608/jjx180.614.pdf']\n",
      "['9262405', 'Leung YME; Wong KY; Tam LS. HPR evaluation of rheumatology nurse-led clinic in managing patients with rheumatoid arthritis: a retrospective study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1541-1542', '10.1136/annrheumdis-2017-eular.6236', '']\n",
      "['9262406', 'Mak WY; Shang Q; Lau XSL; Lee AP-W; Yu CM; Li EK-M; Wong PCH; Tam LHP; Kwok KY; Yip ML; Pang HT; Lao VW-N; Yim IC-W; Tam LS. HPR can achieving sustained DAS remission prevent progression of sub-clinical atherosclerosis? A prospective cohort study in early rheumatoid arthritis (ERA). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Suppl  2 pp1520-1521', '10.1136/annrheumdis-2017-eular.3367', '']\n",
      "['9262407', 'Claes K; Van Hecke A; Jacques P. HPR shared care of rheumatologist and nurse consultations in follow up of rheumatoid arthritis and spondyloarthritis outpatients with low disease activity: a monocentric, randomized controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1481', '10.1136/annrheumdis-2017-eular.2341', '']\n",
      "['9262408', 'Risum K; Selvaag AM; Molberg O; Dagfinrud H; Sanner H. HPR facilitators and barriers for participation in physical activities in juvenile idiopathic arthritis patients and healthy controls. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1517', '10.1136/annrheumdis-2017-eular.6063', '']\n",
      "['9262409', 'Glinatsi D; Ostergaard M; Terslev L; Ohrndorf S; Ammitsboll-Danielsen M. Development and validation of a flourescence optical imaging rheumatoid arthritis scoring system for synovitis in the wrist and hand. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1409-1410', '10.1136/annrheumdis-2017-eular.4633', '']\n",
      "['9262410', 'Bartholdy C; Henriksen M; Waehrens E; Ellegaard K. HPR assessment of local disease activity after an intensive hand exercise program in patients with rheumatoid arthritis measured by ultrasound imaging: an exploratory randomized controlled trail. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1481', '10.1136/annrheumdis-2017-eular.5193', '']\n",
      "['9262411', 'Nilssen IR; Koksvik H; Gronning K; Steinsbekk A. HPR rehabilitation in warm climate for young adults with inflammatory rheumatic disease. A 12 months randomized controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1480-1481', '10.1136/annrheumdis-2017-eular.2256', '']\n",
      "['9262412', 'Bergsten U; Almehed K; Jacobsson L. HPr gothenburg nurse led tight control study-gotnet. A study comparing \"care as usual\" with nurse led clinic, tight control and person centred care in patients with rheumatoid arthritis (RA) and with moderate/high disease activity. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1513', '10.1136/annrheumdis-2017-eular.2659', '']\n",
      "['9262413', \"Bergsten U; Sjo A-S. HPR gothenburg nurse led tight control study-gotnet. patients' experiences of nurse-led care and tight control. a qualitative study of patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1512-1513\", '10.1136/annrheumdis-2017-eular.4675', '']\n",
      "['9262414', 'Lee PF; Cheung YS; Lam CK; Leung MC; Chan CM; Ng WL. HPR phone follow-up program enhances treatment safety and drug concordance on disease modifying anti-rheumatic drugs (DMARDs) therapy for rheumatology patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1493-1494', '10.1136/annrheumdis-2017-eular.4421', '']\n",
      "['9262416', 'Lam HM; Wan MC; Tam LS. Impact of small to medium dose of prednisolone on bone mineral density among early rheumatoid arthritis patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1125-1126', '10.1136/annrheumdis-2017-eular.2842', '']\n",
      "['9262417', \"Budde P; Doucet J; Zucht H-D; Kazma R; Maguire P; Avrameas A; Valentin M-A; Oliver S; Schulz-Knappe P; Vitaliti A. Serum autoantibody profiling of primary Sjogren's syndrome patients reveals novel biomarkers associated with the disease, disease activity, and clinical response to VAY736. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp886\", '10.1136/annrheumdis-2017-eular.1905', '']\n",
      "['9262418', 'Ucar E; Gorostiza I; Gomez C; Perez CE; De Dios JR; Alvarez B; Ruibal A; Stoye C; Vasques M; Belzunegui J; Escobar A; Trancho Z; Ruiz Del Agua A; Martinez A; Jorquera C; Nagore D. Prospective, intervention, multicenter study of utility of biologic drug monitoring with respect to the efficacy and cost of adalimumab tapering in patients with rheumatic diseases: preliminary results of ingebio study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp826', '10.1136/annrheumdis-2017-eular.4785', '']\n",
      "['9262419', 'Nordberg LB; Lillegraven S; Aga A-B; Olsen IC; Lie E; Hammer HB; Uhlig T; Van Der Heijde D; Kvien TK; Haavardsholm EA. Ultrasonography and intra-articular injection therapy in early rheumatoid arthritis: results from the randomised arctic trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1017', '10.1136/annrheumdis-2017-eular.2505', '']\n",
      "['9262422', \"Doucet J; Kazma R; Cabanski M; Kamphausen E; Maguire P; Avrameas A; Valentin M-A; Li Y; Auger-Sarrazin A; Kaiser S; Follet P; Oliver S; Vitaliti A. Identification of novel biomarkers associated with disease activity of primary Sjogren's syndrome and clinical response to vay736. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1229\", '10.1136/annrheumdis-2017-eular.4736', '']\n",
      "['9262424', 'Suh C-H; Chalouhi El Khouri E; Miranda P; Cons Molina FF; Shesternya P; Medina-Rodriguez F; Wiland P; Jeka S; Chavez-Corrales J; Linde T; Hrycaj P; Hospodarskyy I; Abello-Banfi M; Jaworski J; Piotrowski M; Park W; Shim SC; Lee SJ; Lee SY; Yoo DH. Randomised double-blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp824-825', '10.1136/annrheumdis-2017-eular.6553', '']\n",
      "['9262425', 'Li H; Zeng H. The efficent regulation of tocilizumab for the expression of CD4+/CD8+ T/CD19 + B cells and the immunoglobulin in systemic juvenile idiopathic arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1189', '10.1136/annrheumdis-2017-eular.2114', '']\n",
      "['9262427', 'Keeling SO; Savu A; Kaul P. Impact of maternal systemic autoimmune rheumatic diseases on neonatal outcomes: a populationlevel analysis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp766', '10.1136/annrheumdis-2017-eular.4561', '']\n",
      "['9262432', 'Damask A; Boyapati A; Hamilton JD; Hamon S; Paccard C; Parrino J; Van Adelsberg J; Graham NM; Penn J; Lopez A; Reid J; Overton J; Baras A; Shuldiner AR; Paulding C. The ASP358ALA variant in the IL6R gene is significantly associated with differences in soluble IL-6R protein levels but not with differences in sarilumab response in rheumatoid arthritis (RA) patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp838', '10.1136/annrheumdis-2017-eular.4983', '']\n",
      "['9262434', 'Wu R. Efficacy and safety of yisaipu, a recombinant human tumor necrosis factor-alpha receptor ii IGG FC fusion protein in Chinese patients with moderate to severe rheumatoid Arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1185', '10.1136/annrheumdis-2017-eular.1867', '']\n",
      "['9262437', 'Bely M; Apathy A. Systemic autoimmune vasculitis in rheumatoid arthritis-a postmortem clinicopathologic study of 161 patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1252-1253', '10.1136/annrheumdis-2017-eular.1223', '']\n",
      "['9262438', 'Emery P; Vencovsky J; Keystone E; Ghil J; Cheong SY; Hong EE. Maintenance and improvement in clinical efficacy between week 12 and 24 in patients with rheumatoid arthritis treated with sb4 or reference etanercept. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp834', '10.1136/annrheumdis-2017-eular.3344', '']\n",
      "['9262439', 'Takeuchi T; Genovese M; Haraoui B; Xie L; Klar R; Luisa Pinto Correia A; Rooney T; Otawa S; Smolen JS. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp795-796', '10.1136/annrheumdis-2017-eular.1073', '']\n",
      "['9262442', 'Suda M; Ohde S; Tsuda T; Kishimoto M; Okada M. Safety and efficacy of alternate-day corticosteroids as adjunctive therapy in rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp813', '10.1136/annrheumdis-2017-eular.4160', '']\n",
      "['9262445', 'Farina I; Galuppi E; Ciancio G; De Giorgio C; Scire CA; Govoni M. Impact of early arthritis clinic on the rate of treatment with biologics in rheumatoid arthritis: interrupted time series analysis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp1127-1128', '10.1136/annrheumdis-2017-eular.6481', '']\n",
      "['9262447', 'Soubrier M; Pereira B; Frayssac T; Fan A; Couderc M; Malochet-Guinamand S; Mathieu S; Tatar Z; Tournadre A; Dubost J-J. Retention rates of adalimumab, etanercept, and infliximab as 1st-or 2nd-line biotherapy for rheumatoid arthritis patients in daily practice in auvergne. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp813', '10.1136/annrheumdis-2017-eular.3676', '']\n",
      "['9262449', \"O'Dell J; Kivitz A; Takeuchi T; Tanaka Y; Louw I; Tiabut T; Nakashima S; Hodge J; Tang H; Finck B. Switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp831\", '10.1136/annrheumdis-2017-eular.2480', '']\n",
      "['9262450', 'Nieto-Gonzalez JC; Lopez-Longo FJ; Estrada E; Naredo E. Salivary gland ultrasound is related to autoimmunity in primary sjogren syndrome. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp737', '10.1136/annrheumdis-2017-eular.3571', '']\n",
      "['9262452', 'Gossec L; Soubrier M; Foissac F; Fayet F; Balandraud N; Bardin T; Beauvais C; Chales G; Chary-Valckenaere I; Dernis E; Euller-Ziegler L; Flipo R-M; Gilson M; Marhadour T; Mariette X; Mouterde G; Pouplin S; Richette P; Ruyssen-Witrand A; Schaeverbeke T; Sordet C; Dougados M. Prevalence and incidence over 3 years of different comorbidities in rheumatoid arthritis (RA): a 3 year longitudinal study in 769 established ra patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Suppl  2 pp811', '10.1136/annrheumdis-2017-eular.2978', '']\n",
      "['9262454', 'Choquette D; Bessette L; Alemao E; Haraoui B; Massicotte F; Mtibaa M; Muratti E; Pelletier J-P; Postema R; Raynauld J-P; Remillard M-A; Sauvageau D; Turcotte A; Villeneuve E; Coupal L. Retention rates of TNF inhibitors and abatacept used as a first biologic DMARD in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata registry. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp571-572', '10.1136/annrheumdis-2017-eular.2326', '']\n",
      "['9262455', 'Van Den Bosch F; Ostor A; Wassenberg S; Anderson JK; Chen N; Wang C; Garg V; Kalabic J. Impact of participation in the adalimumab patient support program on functional and clinical outcomes among patients with rheumatoid arthritis: passion study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp829-830', '10.1136/annrheumdis-2017-eular.1876', '']\n",
      "['9262458', 'Ducourau E; Rispens T; Dernis E; Le Guilchard F; Andras L; Perdriger A; Lespessailles E; Martin A; Cormier G; Armingeat T; Devauchelle-Pensec V; Solau-Gervais E; Le Goff B; De Vries A; Piver E; Ternant D; Goupille P; Mulleman D. Methotrexate reduces adalimumab immunogenicity in patients with spondyloarthritis: a randomized clinical trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp335-336', '10.1136/annrheumdis-2017-eular.1527', '']\n",
      "['9262459', 'Tokunaga K; Shiraishi A; Oshikawa H; Hagino N; Nishino J; Tohma S. Comparison of efficacy between combination therapy with iguratimod and sulfasalazine with methotrexate in japanese patients with rheumatoid arthritis: propensity score analysis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp278', '10.1136/annrheumdis-2017-eular.6157', '']\n",
      "['9262461', 'Bergstra SA; Allaart CF; Van Den Berg R; Chopra A; Govind N; Huizinga TW; Landewe RB. Similar short term clinical response to initial treatment with high versus low dose methotrexate in mono-and combination therapy in early rheumatoid arthritis patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp146', '10.1136/annrheumdis-2017-eular.1601', '']\n",
      "['9262465', 'Neumann T; Dawczynski C; Dittrich M; Goetze K; Welzel A; Oelzner P; Voelker S; Schaible AM; Troisi F; Thomas L; Pace S; Koeberle A; Werz O; Schlattmann P; Lorkowski S; Jahreis G. Docosahexaenoic acid treatment of rheumatoid arthritis: a randomized, double-blind, placebo-controlled, cross-over study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp115', '10.1136/annrheumdis-2017-eular.6759', '']\n",
      "['9262466', \"O'Dell J; Kivitz A; Papp K; Leonardi C; Jensen K; Tang H; Finck B. Randomized, double-blind, global clinical trial to evaluate equivalence of CHS-1420 to adalimumab in patients with psoriasis and psoriatic arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp144\", '10.1136/annrheumdis-2017-eular.2490', '']\n",
      "['9262470', 'Kafaja S; Segal KR; Skerrett D; Itescu S; Furst DE. Allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp566-567', '10.1136/annrheumdis-2017-eular.1106', '']\n",
      "['9262472', 'Gerasimova E; Popkova T; Cherkasova M; Alexandrova E; Novokov A. Matrix metalloproteinase-3 and antibodies (IgG) against oxidized low-density lipoprotein levels in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp254', '10.1136/annrheumdis-2017-eular.5217', '']\n",
      "['9262473', 'Wiesenhutter C. The use of a blinded truncated ultrasound power doppler joint count validates efficacy data from an early phase open label drug study treating rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp232', '10.1136/annrheumdis-2017-eular.2537', '']\n",
      "['9262478', 'Burmester G; Michaels MA; Close D; Godwood A; Middleton K; Miranda P; Vencovsky J; Kremer J; McInnes IB; Albulescu M; Weinblatt M. Results of a longitudinal review of pulmonary function and safety data in a phase iib clinical programme testing granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor antagonist mavrilimumab for treatment of rheumatoid arthritis (RA). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp564-565', '10.1136/annrheumdis-2017-eular.3131', '']\n",
      "['9262480', 'Charles-Schoeman C; Kremer J; Krishnaswami S; Soma K; Geier J; Zhang R; Strengholt S; Burmester G. Comparison of tofacitinib safety and efficacy in rheumatoid arthritis patients with inadequate response to conventional synthetic DMARDs, or to one or more biological DMARDs. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp271-272', '10.1136/annrheumdis-2017-eular.2346', '']\n",
      "['9262481', 'Gossec L; Desthieux C; Cantagrel A; Soubrier M; Berthelot JM; Joubert JM; Combe B; Czarlewski W; Wendling D; Dernis E; Grange L; Beauvais C; Perdriger A; Nataf H; Dougados M; Servy H. Patient-perceived coping was associated with patient-perceived quality of patient-physician interactions in 320 patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp428-429', '10.1136/annrheumdis-2017-eular.1973', '']\n",
      "['9262482', 'Pope J; Rampakakis E; Grant E; Bessette L; Lazovskis J; Haraoui B; Sampalis JS. DMARD withdrawal in ra patients achieving therapeutic response with certolizumab pegol combined with DMARDs: interim results from a canadian observational randomized study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp58', '10.1136/annrheumdis-2017-eular.6654', '']\n",
      "['9262485', 'Gossec L; Cantagrel A; Soubrier M; Joubert JM; Czarlewski W; Combe B; Berthelot JM; Wendling D; Dernis E; Grange L; Beauvais C; Perdriger A; Nataf H; Dougados M; Servy H. Are rheumatoid arthritis patients willing to use an e-health interactive self-assessment website? analyses of 159 patients from a randomised controlled trial over 12 months. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp428', '10.1136/annrheumdis-2017-eular.1972', '']\n",
      "['9262487', 'Vencovsky J; Emery P; Keystone E; Ghil J; Cheong SY; Hong EE. Impact of anti-drug antibody and injection site reaction on efficacy: 24-week results from a phase iii study comparing SB4 (etanercept biosimilar) with reference etanercept in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp137', '10.1136/annrheumdis-2017-eular.3043', '']\n",
      "['9262488', 'Giusti A; Manara M; Bruschi E; Azzolini V; Belai Beyene N; Corbanese S; De Gennaro F; Martin-Martin LS; Molica Colella AB; Pozzi MR; Romeo N; Rossini T; Severino A; Sinigaglia L; Bianchi G. Clinical characteristics of rheumatoid arthritis patients ongoing methotrexate therapy not achieving das28 \"low diseases activity\": a matched case-control analysis from the MARI study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp270', '10.1136/annrheumdis-2017-eular.4619', '']\n",
      "['9262491', 'Blavnsfeldt A-BG; Thomsen MD; Tarp S; Langdahl B; Hauge E; De Thurah A. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp248-249', '10.1136/annrheumdis-2017-eular.5750', '']\n",
      "['9262494', 'Tsutsumino M; Sakai R; Kihara M; Amano K; Yoshimi R; Inoo M; Dobashi H; Sugihara T; Hidaka T; Kohsaka H; Miyasaka N; Harigai M. Outcomes of the rapid dose escalation of methotrexate in Japanese patients with early rheumatoid arthritis; results from a randomized controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp265-266', '10.1136/annrheumdis-2017-eular.3335', '']\n",
      "['9262495', 'Landewe R; Ritchlin CT; Coates LC; Aletaha D; Guerette B; Zhang Y; Ganz F; Hojnik M. Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp97', '10.1136/annrheumdis-2017-eular.1337', '']\n",
      "['9262496', 'Michaud K; Zhu B; Gaich C; DeLozier AM; Arora V; Dickson C; Smolen JS. Pain reduction is associated with improved work productivity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp517', '10.1136/annrheumdis-2017-eular.1345', '']\n",
      "['9262497', 'Chhibar PS; Ehresmann G. Anakinra as a successful treatment of idiopathic recurrent pericarditis: taper or not to taper? case series at the university of Southern California. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp421-422', '10.1136/annrheumdis-2017-eular.1141', '']\n",
      "['9262498', \"Hope HF; Hyrich K; Varney F; Wilkes S; Verstappen SM; Cordingley L. Patients' positive beliefs and certainty predict methotrexate adherence in a rheumatoid arthritis cohort: the rams study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp265\", '10.1136/annrheumdis-2017-eular.2463', '']\n",
      "['9262499', 'Nordberg LB; Lillegraven S; Aga A-B; Olsen IC; Lie E; Hammer HB; Uhlig T; Van Der Heijde D; Kvien TK; Haavardsholm EA. Disease course in seronegative RA patients classified according to the 2010 ACR/EULAR criteria. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp538', '10.1136/annrheumdis-2017-eular.4967', '']\n",
      "['9262502', 'Simon T; Gelarden T; Nkhoma E; Zhou M; Banerjee S; Winthrop K. Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: analysis of all available clinical trial data. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp93-94', '10.1136/annrheumdis-2017-eular.2306', '']\n",
      "['9262504', 'Baudouin C; Darvish-Zargar M; Holland EJ; Chan CC; Nichols KK; Tauber J; Raychaudhuri A; Roy M; Shojaei A. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: combined evidence from 5 randomized controlled trials. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp152-153', '10.1136/annrheumdis-2017-eular.5890', '']\n",
      "['9262505', 'Galeazzi M; Sebastiani G; Voll R; Wollenhaupt J; Viapiana O; Dudler J; Selvi E; Baldi C; Bardelli M; Bannert B; Finzel S; Specker C; Sarzi Puttini P; Bootz F; Neri D. Safety, tolerability and initial signs of efficacy of the fully human immunocytokine dekavil (F8IL10): a novel therapeutic approach for rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp92-93', '10.1136/annrheumdis-2017-eular.4840', '']\n",
      "['9262507', 'Dorner T; Weinblatt M; Durez P; Alten R; Van Beneden K; Dombrecht EJ; De Beuf K; Schoen P; Zeldin RK. Remission and maintenance of efficacy in a phase 2b study of vobarilizumab, an anti-interleukin 6 receptor nanobody, in patients with moderate-to-severe rheumatoid arthritis despite treatment with methotrexate. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp92', '10.1136/annrheumdis-2017-eular.3732', '']\n",
      "['9262508', 'Carron P; Varkas G; Cypers H; Van Praet L; Elewaut D; Van Den Bosch F. High drug-free remission in early peripheral spondyloarthritis after induction therapy with golimumab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp62', '10.1136/annrheumdis-2017-eular.1656', '']\n",
      "['9262511', 'Dorner T; Weinblatt M; Van Beneden K; Dombrecht EJ; De Beuf K; Schoen P; Zeldin RK. Results of a phase 2b study of vobarilizumab, an anti-interleukin-6 receptor nanobody, as monotherapy in patients with moderate to severe rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp575', '10.1136/annrheumdis-2017-eular.3746', '']\n",
      "['9262513', 'Smolen JS; Choe J-Y; Keystone E; Rho YH; Lee Y; Lee S. Radiographic progression by disease activity states in patients with rheumatoid arthritis treated with SB2 or reference infliximab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp552', '10.1136/annrheumdis-2017-eular.5524', '']\n",
      "['9262514', 'Thurah A; Steengaard-Pedersen K; Axelsen M; Fredberg U; Schougaard LMV; Hjollund NHI; Pfeiffer-Jensen M; Laurberg TB; Lomborg K; Maribo T. A TELE-health follow-up strategy for tight control of disease activity in rheumatoid arthritis: results of the non-inferiority randomised controlled trail (the Tera study). Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp454-455', '10.1136/annrheumdis-2017-eular.2995', '']\n",
      "['9262515', 'Goll GL; Olsen IC; Bolstad N; Jorgensen KK; Lorentzen M; Mork C; Jahnsen J; Haavardsholm EA; Kvien TK. Disease worsening and safety in patients switching from originator infliximab to biosimilar infliximab (CT-P13) in the randomized nor-switch-study: explorative analysis in spa patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp338-339', '10.1136/annrheumdis-2017-eular.4438', '']\n",
      "['9262516', 'Heslinga M; Lambert G; Thedrez A; Kastelein J; Nurmohamed M. Association between plasma lipids, disease activity and PCSK9 levels in RA patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2017. Spain. (2017) 76 Supplement 2 pp259', '10.1136/annrheumdis-2017-eular.2121', '']\n",
      "['9262519', 'Orkmez MG; Altindag O; Orkmez M; Akyol A; Tarakcioglu M; Gursoy S; Gur A. The effect of anti-TNF therapies on serum prohepcidin level in the patientswith rheumatoid arthritis. Turkish journal of biochemistry. Conference: 28th national biochemistry congress. Turkey. (2017) 42 Supplement 1 pp39', '10.1515/tjb-2022-0169', '']\n",
      "['9262520', \"Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Meuleners L; Tasset C; Van Der Aa A; Harrison P. Maintenance of clinical effect in patients with moderate-to-severe Crohn's disease treated with filgotinib, a selective JAK1 inhibitor: exploratory 20-week data analysis of the phase 2 FITZROY study. Journal of crohn's and colitis. Conference: 12th congress of the european crohn's and colitis organisation, ECCO 2017. Spain. (2017) 11 Supplement 1 ppS13-S14\", '10.1093/ecco-jcc/jjx002.022', 'http://academic.oup.com/ecco-jcc/article-pdf/11/suppl_1/S13/10448987/jjx002.022.pdf']\n",
      "['9262521', \"Sandborn WJ; Sands BE; Danese S; D'Haens GR; Vermeire S; Schreiber S; Feagan B; Reinisch W; Friedman G; Woodworth D; Zhang H; Lawendy N; Niezychowski W; Su C; Panes J. Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial. Journal of crohn's and colitis. Conference: 12th congress of the european crohn's and colitis organisation, ECCO 2017. Spain. (2017) 11 Supplement 1 ppS19-S20\", '10.1093/ecco-jcc/jjx002.031', 'http://academic.oup.com/ecco-jcc/article-pdf/11/suppl_1/S19/10449019/jjx002.031.pdf']\n",
      "['9262522', \"Kingsbury SR; Tharmanathan P; Keding A; Ronaldson S; Grainger A; Wakefield R; Arundel C; Birrell F; Doherty M; Vincent T; Watt FE; Dziedzic K; aO'Neill T; Arden N; Scott DL; Dickson J; Garrood T; Green M; Menon A; Sheeran T; Torgerson D; Conaghan PG. Hydroxychloroquine in hand OA; results of the UK hero trial. Osteoarthritis and cartilage. Conference: 2017 osteoarthritis research society international, OARSI world congress. United states. (2017) 25 Supplement 1 ppS3-S4\", '10.1016/j.joca.2017.02.012', '']\n",
      "['9262523', \"Dervieux T; Kremer JM; O'Malley T; Kivitz AJ; Conklin J; Weinblatt M. Differing contribution of methotrexate polyglutamation to infliximab and adalimumab exposure as compared to etanercept. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp785-786\", '10.1002/art.39977', '']\n",
      "['9262524', 'Zhang S-X; Miao M; Liu X-Q; Ma X-W; Wu X-Y; Li X-F. The efficacy and safety of low dose IL-2 therapy in over-treated patients with rheumatoid arthritis: a preliminary study. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp4041-4042', '10.1002/art.39977', '']\n",
      "['9262526', 'Glicklich A; Grayson P; Blanchetot C; Zhou Q; Kretz-Rommel A. The development of a new anti-interleukin 6 blocker for rheumatoid arthritis patients. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp1997-1998', '10.1002/art.39977', '']\n",
      "['9262530', 'Wang T; Lademacher C; Blahunka P; Howieson C; Yang T; Wojtkowski T; Kikuchi M; Townsend R. Pharmacokinetics (PK), pharmacodynamics (PD), and safety of ASP5094, an anti-alpha-9-integrin monoclonal antibody, following single intravenous doses in healthy subjects. Arthritis and rheumatology. (2016) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2016. United States. 68 Supplement 10 pp2053-2054', '10.1002/art.39977', '']\n",
      "['9262531', 'Osue HO; Enwezor FNC; Idowu BT; Cassel-Brown A; Jones B; Abiose A; Engelbrecht F; Edeghere H. Comparing antibody responses to Onchocerca volvulus and non-parasite antigens in placebo-controlled and ivermectin-treated onchocerciasis patients. African journal of clinical and experimental microbiology. (2017) 18 1 pp42-48', '10.4314/ajcem.v18i1.6', '']\n",
      "['9262534', 'Eremenco S; Stringer S; Gleeson S; Landrian A; Falcon I. Qualitative equivalence between paper and electronic tablet versions and usability of 12 patient-reported outcome instruments for rheumatoid arthritis. Value in health. Conference: ISPOR 21st annual international meeting research. Washington, DC united states. Conference start: 20160521. Conference end: 20160525. Conference publication: (var.pagings). (2016) 19 3 ppA92', '10.1016/j.jval.2016.03.1732', '']\n",
      "['9262535', 'Zhang B; Chen G; Li H-L; Ren H-P; Yang T; Chen M; Guo L-G. Efficacy of compound Xiatianwu tablets in elderly patients witli osteoporotic distal radius fractures. Zhongguo zhongyao zazhi. (2015) 40 12 pp2445-2448', '10.4268/cjcmm20151234', '']\n",
      "['9262536', 'Matsuno H; Tomomitsu M; Hagino A; Shin S; Lee J; Song YW. Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate. Annals of the rheumatic diseases. (2018) 77 4 pp488-494', '10.1136/annrheumdis-2017-212172', '']\n",
      "['9262537', 'Hermans L; Nijs J; Calders P; De Clerck L; Moorkens G; Hans G; Grosemans S; Roman De Mettelinge T; Tuynman J; Meeus M. Influence of Morphine and Naloxone on Pain Modulation in Rheumatoid Arthritis, Chronic Fatigue Syndrome/Fibromyalgia, and Controls: a Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study. Pain practice. (2018) 18 4 pp418-430', '10.1111/papr.12613', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fpapr.12613']\n",
      "['9262538', 'Shim SC; Majstorovic LB; Kasay AB; El-Khouri EC; Irazoque-Palazuelos F; Molina FC; Medina-Rodriguez FG; Miranda P; Shesternya P; Corrales JC; Wiland P; Jeka S; Garmish O; Hrycaj P; Fomina N; Park W; Suh CH; Lee SJ; Lee SY; Yoo DH. Efficacy and safety of rituximab biosimilar, CT-P10, after a single switch from innovator rituximabs in patients with rheumatoid arthritis: results from phase 3 randomized controlled trial over 72 weeks. Arthritis and rheumatology conference: american college of rheumatology/association of rheumatology health professionals annual scientific meeting, ACR/ARHP 2017 united states. (2017) 69 Supplement 10) (no pagination pp', '10.1093/rheumatology/kez152', 'http://academic.oup.com/rheumatology/article-pdf/58/12/2193/31145163/kez152.pdf']\n",
      "['9262539', \"Herman AE; Chinn LW; Kotwal SG; Murray ER; Zhao R; Florero M; Lin A; Moein A; Wang R; Bremer M; Kokubu S; Serone AP; Hanze EL; Viberg A; Morimoto AM; Winter HR; Katsumoto TR. Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor. Clinical pharmacology and therapeutics. (2018) 103 6 pp1020-1028\", '10.1002/cpt.1056', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.1056']\n",
      "['9262542', 'Sheng-Xiao Z; Xiao-Wen M; Xiao-Qing L; Miao M; Xiao-Yan W; Hong-Qing N; Cai-Hong W; Xiao-Feng L. Low dose interleukin-2 combined with tocilizumab selectively increases regulatory t cells helping refractory rheumatoid arthritis patients achieve remission more rapidly. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp839', '10.1136/annrheumdis-2017-eular.3611', '']\n",
      "['9262544', 'Yoo D H; Park W; Suh C H; Shim S C; Lee S J; Bae Y J; Park C; Koo J H. Rituximab is effective in the treatment of rheumatoid arthritis regardless of body mass index. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp548', '10.1136/annrheumdis-2017-eular.5591', '']\n",
      "['9262548', 'Cozmuta R; Fraenkel L; Wilhelms E; Reyna V; Nolte J. The influence of risk presentation format on willingness to start a medication. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp453', '10.1136/annrheumdis-2017-eular.5169', '']\n",
      "['9262551', 'Burmester GR; FitzGerald O; Winthrop K; Azevedo VF; Rigby WFC; Kanik KS; Wang C; Biswas P; Jones T; Menon S; Palmetto N; Rojo R. Integrated safety summaryof tofacitinib in psoriatic arthritis clinical studies. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS8', '10.1136/annrheumdis-2017-eular.1573', '']\n",
      "['9262552', 'Burmester GR; Panaccione R; Gordon KB; Rosenbaum J; Arikan D; Lau WL; Tarzynski-Potempa R. Long-term safetyofadalimumab (HUMIRA) in adult patients from global clinical trials across multiple indications: an updated analysis in 29,987 patients representing 56,951 patient-years. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS151', '10.1136/annrheumdis-2018-eular.3158', '']\n",
      "['9262556', \"Keshav S; Goh J; Hart A; Levison S; McLaughlin S; Van Der Aa A; Galien R; Pan Y; Meuleners L; Jamoul C; Tasset C; Harrison P; Vermeire S. Filgotinib, a selective JAK1 inhibitor, induces clinical remission and a reduction in PSTAT3 levels in patients with active Crohn's disease: results from the phase II fitzroy study. Gut. (2017) 66 (Supplement 2) Supplement 2 ppA25\", '10.1055/s-0037-1604799', '']\n",
      "['9262559', 'Ammerlaan J; van Os-Medendorp H; de Boer-Nijhof N; Scholtus L; Kruize AA; van Pelt P; Prakken B; Bijlsma H. Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis. Pediatric rheumatology online journal. (2017) 15 1 pp75', '10.1186/s12969-017-0201-1', 'http://link.springer.com/content/pdf/10.1186/s12969-017-0201-1.pdf']\n",
      "['9262563', 'Cao G; Huang Q; Xu B; Huang Z; Xie J; Pei F. Multimodal Nutritional Management in Primary Total Knee Arthroplasty: a Randomized Controlled Trial. Journal of arthroplasty. (2017) 32 11 pp3390-3395', '10.1016/j.arth.2017.06.020', '']\n",
      "['9262564', 'Atalay S; van den Reek JMPA; van Vugt LJ; Otero ME; van de Kerkhof PCM; den Broeder AA; Kievit W; de Jong EMGJ. Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial. BMC dermatology. (2017) 17 1 pp6', '10.1186/s12895-017-0057-6', 'http://link.springer.com/content/pdf/10.1186/s12895-017-0057-6.pdf']\n",
      "['9262565', 'Wang CC; Lee SH; Lin HY; Liu FW; Chiou HJ; Chan RC; Chou CL. Short-term effect of ultrasound-guided low-molecular-weight hyaluronic acid injection on clinical outcomes and imaging changes in patients with rheumatoid arthritis of the ankle and foot joints. A randomized controlled pilot trial. Modern rheumatology. (2017) 27 6 pp973-980', '10.1080/14397595.2016.1270496', '']\n",
      "['9262567', 'Ahmadi H; Jamshidi AR; Gharibdoost F; Mahmoudi M; Rastkari N; Mostafaei S; Fattahi MJ; Vojdanian M; Cuzzocrea S; Rehm BHA; Matsuo H; Hosseini M; Aghazadeh Z; Mortazavi-Jahromi SS; Mirshafiey A. A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of beta-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology. (2018) 26 3 pp737-745', '10.1007/s10787-018-0475-z', 'http://link.springer.com/article/10.1007/s10787-018-0475-z/fulltext.html']\n",
      "['9262568', 'Ogata Medel M; Lozada Mellado M; Garcia Morales JM; Hinojosa Azaola A; Morales Herrero N; Llorente L; Alcocer Varela J; Pineda Juarez JA; Cervantes Gaytan R; Castillo Martinez L. Effect of a dynamic exercise program in combination with a mediterranean diet in weight and handgrip strength in women with rheumatoid arthritis. Clinical and experimental rheumatology. Conference: 17th mediterranean congress of rheumatology. Italy. (2018) 36 Supplement 109 ppS78', '10.1097/rhu.0000000000001064', '']\n",
      "['9262569', 'Ailioaie LM; Ailioaie C. Effects of mediterranean diet and physical therapy in early stages of oligoarticular juvenile idiopathic arthritis. Clinical and experimental rheumatology. Conference: 17th mediterranean congress of rheumatology. Italy. (2018) 36 Supplement 109 ppS76', '10.1136/annrheumdis-2018-eular.6431', '']\n",
      "['9262570', 'Park JK; Lee YJ; Shin K; Ha Y-J; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Annals of the rheumatic diseases. (2018) 77 6 pp898-904', '10.1136/annrheumdis-2018-213222', '']\n",
      "['9262571', 'Fernandez-Avila DG; Ruiz AJ; Gil F; Mora SA; Tobar C; Gutierrez JM; Rosselli-Cock D. The effect ofan educational intervention, based on clinical simulation on the diagnosis of rheumatoid arthritis and osteoarthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS96', '10.1002/msc.1228', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1228']\n",
      "['9262575', 'Santana K; Romero M; Le V; Fletcher T; Lamba M. Pharmacokinetics of tofacitinib modified-release formulation in healthy Mexican subjects. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS68', '10.1097/rhu.0000000000000802', '']\n",
      "['9262576', 'Rojas Tessel R; Buschiazzo E; Lizarraga A; Sosa J; Fernandez L; Juarez V; Mariana Q; Aciar M; Marengo F; Citera G. The role ofwritten standardized information in patients with recently diagnosed rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS68', '10.1093/rheumatology/kei500', 'http://academic.oup.com/rheumatology/article-pdf/45/suppl_2/ii7/5044902/kei500.pdf']\n",
      "['9262578', 'Liberman F; Elgart J; Strusberg I. Economic benefit of controlled clinical trials: the avoidable cost in drugs for the treatment of rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS64', '10.1016/j.vhri.2018.10.007', '']\n",
      "['9262581', 'Weinblatt ME; Baranauskaite A; Dokoupilova E; Zielinska A; Jaworski J; Racewicz A; Pileckyte M; Jedrychowicz-Rosiak K; Baek I; Ghil J. Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: fifty-Two-Week Phase III Randomized Study Results. Arthritis and rheumatology. (2018) 70 6 pp832-840', '10.1002/art.40444', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40444']\n",
      "['9262582', 'Sirenko O; Kuryata O. Endothelial function, insulin resistance, adiponectin level in hypertensive females with rheumatoid arthritis and its correction with l-arginine aspartate. Cardiovascular research. Conference: 5th congress of the ESC council on basic cardiovascular science: frontiers in cardiovascular biology 2018. Austria. (2018) 114 Suppl  1 ppS75-S76', '10.1093/cvr/cvy060.211', 'http://academic.oup.com/cardiovascres/article-pdf/114/suppl_1/S75/24691942/cvy060.211.pdf']\n",
      "['9262583', 'McKenna SG; Donnelly AE; Esbensen BA; Fraser AD; Kennedy NM. The impact of exercise on sleep (time, quality, and disturbance) in patients with rheumatoid arthritis: a study protocol for a pilot randomised controlled trial. Rheumatology international. (2018) 38 7 pp1-8', '10.1007/s00296-018-4052-y', 'http://link.springer.com/article/10.1007/s00296-018-4052-y/fulltext.html']\n",
      "['9262585', 'Lee YH; Bae S-C. Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Zeitschrift fur Rheumatologie. (2018) 77 4 pp335-342', '10.1007/s00393-016-0254-4', 'http://link.springer.com/article/10.1007/s00393-016-0254-4/fulltext.html']\n",
      "['9262586', 'Vaghef-Mehrabany E; Rad AH; Alipour B; Vaghef-Mehrabany L; Asl MS. Formulation and design of probiotic supplements for rheumatoid arthritis patients. Pharmaceutical sciences. (2018) 24 1 pp44-51', '10.15171/ps.2018.08', 'http://journals.tbzmed.ac.ir/PHARM/Manuscript/PHARM-24-44.pdf']\n",
      "['9262587', 'Shishehbor F; Rezaeyan Safar M; Rajaei E; Haghighizadeh MH. Cinnamon Consumption Improves Clinical Symptoms and Inflammatory Markers in Women With Rheumatoid Arthritis. Journal of the American College of Nutrition. (2018) 37 8 pp1-6', '10.1080/07315724.2018.1460733', '']\n",
      "['9262588', 'Kumar S; Oakley S. Early treatment of rheumatoid arthritis and effects on work and quality of life-late follow-up of patients from the hunter humira and endothelial function in early rheumatoid arthritis trial (hunter heart). Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp13', '10.1093/rheumatology/key066', 'http://academic.oup.com/rheumatology/article-pdf/57/7/1194/25068667/key066.pdf']\n",
      "['9262591', 'Trivedi V; Bansal Y. The role of methotrexate monotherapy along with vitamin D in newly diagnosed rheumatoid arthritis. Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp20', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9262592', 'Mu R; Liang J; Sun L; Zhang Z; Liu X; Huang C; Zhu P; Zuo X; Gu J; Li X; Li X; Liu Y; Feng P; Li Z. A randomized multicenter clinical trial of 99 Tc-methylene diphosphonate in treatment of rheumatoid arthritis. International journal of rheumatic diseases. (2018) 21 1 pp161-169', '10.1111/1756-185x.12934', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12934']\n",
      "['9262594', 'Tasplnar O; Gultepe I; Keskin Y; Aydln T; Kepekci M; Mutluer AS; Hocaoglu IT. Evaluation in terms of dietary habits of rheumatic process: a clinical study. Journal of back and musculoskeletal rehabilitation. (2018) 31 1 pp23-27', '10.3233/bmr-150476', '']\n",
      "['9262595', 'Khatri A; Othman AA. Population Pharmacokinetics of the TNF-alpha and IL-17A Dual-Variable Domain Antibody ABT-122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: analysis of Phase 1 and 2 Clinical Trials. Journal of clinical pharmacology. (2018) 58 6 pp803-813', '10.1002/jcph.1068', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1068']\n",
      "['9262599', 'Batooei M; Tahamoli-Roudsari A; Basiri Z; Yasrebifar F; Shahdoust M; Eshraghi A; Mehrpooya M; Ataei S. Evaluating the effect of oral n-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Reviews on recent clinical trials. (2018) 13 2 pp132-138', '10.2174/1574887113666180307151937', '']\n",
      "['9262600', 'John-Baptiste A; Becker T; Fung K; Lipscombe LL; Austin PC; Anderson GM. Bayesian synthesis using prior information on fracture risk from randomized trials to analyze post-market data. Journal of clinical epidemiology. (2018) 101  pp79-86', '10.1016/j.jclinepi.2018.05.025', '']\n",
      "['9262606', 'Allam NM; Koura GMR; Alrawaili SM; Hamada HA; Khater HA; Balbaa AA. The effect of siwan therapy in management of patients with rheumatoid arthritis: a single blind randomized controlled trial. Biomedical research (india). (2018) 29 7 pp1400-1406', '10.4066/biomedicalresearch.29-17-2906', '']\n",
      "['9262607', 'Apsangikar P; Chaudhry S; Naik M; Deoghare S; Joseph J. A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate. Indian journal of rheumatology. (2018) 13 2 pp84-89', '10.4103/injr.injr_107_17', 'https://journals.sagepub.com/doi/pdf/10.4103/injr.injr_107_17']\n",
      "['9262608', 'Tveter A; Nossum R; Mehl Eide R; Klokkeide A; Matre K; Olsen M; Andreassen O; Osteras N; Kjeken I. Map-hand-a reliable and valid tool measuring activity performance in patients with hand osteoarthritis. Osteoarthritis and cartilage. Conference: 2018 osteoarthritis research society international, OARSI world congress. United kingdom. (2018) 26 Supplement 1 ppS242', '10.1016/j.joca.2018.02.500', '']\n",
      "['9262610', 'Burmester GR; Panaccione R; Gordon KB; Rosenbaum J; Arikan D; Lau WL; Tarzynski-Potempa R. Long-term safety of adalimumab (humira) in adult patients from global clinical trials across multiple indications: an updated analysis in 29,987 patients representing 56,95 patient-years. Journal of clinical and aesthetic dermatology. (2018) 11 (5 Supplement 1) 5 Supplement 1 ppS24', '10.1136/annrheumdis-2018-eular.3158', '']\n",
      "['9262612', 'Lomonte ABV; Radominski SC; Marcolino FMD; Brenol CV; Zerbini CAF; Garc√≠a EG; Akylbekova EL; Rojo R; de Leon DP. Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: pooled efficacy and safety analyses. Medicine. (2018) 97 31 ppe11609', '10.1097/md.0000000000011609', '']\n",
      "['9262616', 'Solomon DH; Libby P; Yeomans ND; Wang Q; Wolski KE; Nissen SE; Husni ME. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial. Rheumatology (Oxford, England). (2018) 57 8 pp1364-1369', '10.1093/rheumatology/key105', 'http://academic.oup.com/rheumatology/article-pdf/57/8/1364/25193911/key105.pdf']\n",
      "['9262617', 'Heinze-Milne S; Bakowsky V; Giacomantonio N; Grandy SA. Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial. BMJ open. (2017) 7 12 ppe018540', '10.1136/bmjopen-2017-018540', '']\n",
      "['9262619', 'Martin NH; Ibrahim F; Tom B; Galloway J; Wailoo A; Tosh J; Lempp H; Prothero L; Georgopoulou S; Sturt J; Scott DL; TITRATE Programme Investigators. Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial. Trials. (2017) 18 1 pp591', '10.1186/s13063-017-2330-8', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2330-8.pdf']\n",
      "['9262620', 'Albach FN; Wagner F; H√ºser A; Igel J; Joseph D; Hilbert J; Schoelch C; Padula SJ; Steffgen J. Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. European journal of clinical pharmacology. (2018) 74 2 pp161-169', '10.1007/s00228-017-2362-8', 'http://link.springer.com/article/10.1007/s00228-017-2362-8/fulltext.html']\n",
      "['9262621', 'Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid\\nin rheumatoid arthritis patients with symptom pattern of damp heat obstruction. Journal of traditional chinese medicine = chung i tsa chih ying wen pan. (2016) 36 5 pp625-633', '10.1016/s0254-6272(16)30082-6', '']\n",
      "['9262623', 'Bonafede MM; McMorrow D; Marshall A; Gupta K; Pazirandeh M. Healthcare resource utilization and costs among commercially insured patients with juvenile idiopathic arthritis (JIA) in the United States. Value in health. (2018) Conference: 23rd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2018. United States. 21 Supplement 1 ppS125', '10.1016/j.jval.2018.04.850', '']\n",
      "['9262624', 'Astorga G; Cubillos A; Masson L; Silva J J. Active rheumatoid arthritis: effect of dietary supplementation with omega 3 oils. Double-blind controlled study. Rev. Med. Chile. (1991) 119 3 pp267-272', '10.7326/0003-4819-111-9-757', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-111-9-757']\n",
      "['9262626', 'Cheng TT; Chen YC; Yu SF; Lai HM; Su FM; Su BYJ; Chiu WC; Hsu CY; Chen JF; Ko CH. The impact of low dose glucocorticoid on disease activity, BMD, fragility fracture, and 10-year probability of fracture in rheumatoid arthritis (RA) patients. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS236', '10.1186/s13075-018-1515-1', 'http://link.springer.com/content/pdf/10.1186/s13075-018-1515-1.pdf']\n",
      "['9262627', 'Traistaru R; Matei D; Kamal D; Bumbea AM; Rogoveanu O. Home training and dorsal pain in osteoporotic females with rheumatoid arthritis: a randomized clinicaltrial. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS409', '10.1007/s00198-018-4437-5', 'http://link.springer.com/article/10.1007/s00198-018-4437-5/fulltext.html']\n",
      "['9262628', 'Kusumo SA; Isbagio H; Marhamah S; Intan C; Antono D; Harimurti K. Effect of periodontal treatment on eselectin level in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) 77 Suppl 2 pp941', '10.1136/annrheumdis-2018-eular.6244', '']\n",
      "['9262629', 'Choquette D; Rahman P; Chow A; Faraawi R; Olszynski W; Rampakakis E; Asin-Milan O; Osborne B; Lehman AJ; Nantel F. Consolidated long-term safety of infliximab in inflammatory arthritis from a prospective, observational registry. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1380-1381', '10.1136/annrheumdis-2018-eular.4644', '']\n",
      "['9262630', 'Syngle A; Garg N; Krishan P. Amelioration of inflammatory disease activity and vascular inflammation with HMGCOA reductase inhibition and angiotensin receptor blockade in rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Suppl  2 pp973', '10.1136/annrheumdis-2018-eular.5605', '']\n",
      "['9262631', 'Krueger K; Eder R; Mueller C; Rietzler K. Assessing the risk of RA patients for comorbid conditions through a structured nurse-led interview-the eriko study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp119', '10.1136/annrheumdis-2018-eular.1268', '']\n",
      "['9262632', 'Heinze-Milne S; Zahavich A; Bakowsky V; Giacomantonio N; Grandy S. The impact of cardiac rehabilitation on cardiovascular risk in individuals with rheumatoid arthritis. Journal of cardiopulmonary rehabilitation and prevention. (2017) Conference: 2017 Annual Scientific Meeting of the Canadian Association of Cardiovascular Prevention and Rehabilitation. Canada. 37 6 pp458', '10.1097/hcr.0000000000000309', '']\n",
      "['9262635', 'Mease PJ; Kremer J; Cohen S; Curtis JR; Charles-Schoeman C; Loftus EV; Greenberg J; Palmetto N; Kanik KS; Graham D; Wang C; Biswas P; Chan G; DeMasi R; Valdez H; Hendrikx T; Jones TV. Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp983', '10.1136/annrheumdis-2018-eular.3048', '']\n",
      "['9262638', 'Mckenna SG; Donnelly A; Appel Esbensen B; Comber L; Ng WL; Maqsood A; Fraser A; Kennedy N. The impact of exercise on sleep in people with rheumatoid arthritis: a pilot randomised controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1786', '10.1136/annrheumdis-2018-eular.2307', '']\n",
      "['9262639', 'Kirchgesner T; Vande Berg B; Sokolova T; Meric De Bellefon L; Nzeusseu A; Stoenoiu M; Durez P. Evaluation of MRI RAMRIS score and clinical response in patients with ACPA positive undifferentiated arthritistreated with infliximab versus placebo. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1764', '10.1136/annrheumdis-2018-eular.3504', '']\n",
      "['9262640', 'Kwok GSK; Cheung TT; Tang MLM; Yuen CKY; Chung HY; Lau WCS. Nursing consultation versus rheumatologist follow up for patients with stable rheumatoid arthritis: a randomized controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1819-1820', '10.1136/annrheumdis-2018-eular.3217', '']\n",
      "['9262641', 'De Agustin JJ; Erra A; Ponce A; Moragues C; Diaz C; Moya P; Reina D; Estrada P; Casado E; Moreno M; Ramirez J; Mateo L; Pujol M; Ros S; Santo P; Sirvent EL; Narvaez J; Sanmarti R; Garcia Yebenes M; Carmona L. Development and validation of an ultrasonographic activity score (USAS) for rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1697-1698', '10.1136/annrheumdis-2018-eular.3824', '']\n",
      "['9262642', 'Bertoldo E; Mansoldo C; Martinis F; Dallagiacoma G; Biasi D; Rossini M; Pieropan S. Can dmards therapy modify clinical history of oligoarticular juvenile idiopathic arthritis (JIA)?. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1656', '10.1136/annrheumdis-2018-eular.2612', '']\n",
      "['9262643', 'Reina-Bueno M; Munuera-Martinez PV; Vazquez-Bautista C; Perez-Garcia S; Rosende-Bautista C. Effect of custom-made foot orthoses versus placebo in patients with rheumatoid arthritis: randomised clinical trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1793', '10.1136/annrheumdis-2018-eular.3421', '']\n",
      "['9262644', \"Prior Y; Arafin N; Bartley C; Hammond A. HPR inflammatory or rheumatoid arthritis patients' perspectives on the effect of arthritis gloves on their hand pain and function (a-gloves trial): a qualitative study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1866\", '10.1136/annrheumdis-2018-eular.5980', '']\n",
      "['9262645', 'Senara SH; Abdel wahed WY; Mabrouk SE. Importance of patient education for management of rheumatoid arthritispatients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1331', '10.1136/annrheumdis-2018-eular.2246', '']\n",
      "['9262646', 'Song YW; Matsuno H; Park M-C; Tomomitsu M; Shin S; Lee J. Efficacy and safety of switching from etanercept product to LBEC0101 (etanercept biosimilar) compared with continuing LBEC0101 in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1389-1390', '10.1136/annrheumdis-2018-eular.1316', '']\n",
      "['9262653', 'Yoshioka Y; Katayama K; Kasama T; Sato M; Ohno S; Amasaki Y; Kataoka H; Kanai D; Suda A; Okamoto M; Sasano M; Nagaoka S; Sagawa A. Weekly split dose compared with single dose oral methotrexate reduced polyglutamylation in red blood cells and increased the risk of adverse events in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp992', '10.1136/annrheumdis-2018-eular.5046', '']\n",
      "['9262654', 'Torrente-Segarra V; Fernandez Prada M; Exposito R; Garrido Punal N; Sanchez-Andrade A; Lamua-Riazuelo JR; Olive A; Tovar JV. How good elderly rheumatoid arthritis patients respond at first year of treatment with certolizumab pegol?. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp964-965', '10.1136/annrheumdis-2018-eular.1727', '']\n",
      "['9262662', 'Katayama K. Possible linkage between intestinal bacteria composition changes and disease activity in patients with rheumatoid arthritis treated with natural milk antibodies against enteric bacteria and their toxins. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1406', '10.1136/annrheumdis-2018-eular.2320', '']\n",
      "['9262663', 'Weitoft T; Oberg K. The dosing of intra-articular triamcinolone hexacetonide for knee synovitis in chronic polyarthritis-a randomized controlled study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp987', '10.1136/annrheumdis-2018-eular.2483', '']\n",
      "['9262664', 'Fleischmann R; Furst DE; Brasington R; Connolly-Strong E; Liu J; Barton ME. A multicenter study assessing the efficacy and safety of repository corticotropin injection in patients with rheumatoid arthritis: preliminary interim data from the open-label treatment period. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp986', '10.1136/annrheumdis-2018-eular.5768', '']\n",
      "['9262668', 'Van Der Ven M; Kuijper M; Gerards A; Tchetverikov I; Weel A; Van Zeben D; Bijkerk C; DeMan Y; Hazes M; Luime J. Three-monthly ultrasound monitoring of rheumatoid arthritis patients tapering their medication has limited value in predicting disease relapse. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp914', '10.1136/annrheumdis-2018-eular.6424', '']\n",
      "['9262670', 'Genovese MC; Dougados M; Schwartzman S; Schlichting D; Beattie S; Xie L; Cardoso A; Smolen JS. Efficacy of baricitinib in patients with rheumatoid arthritis who failed 2 or more DMARDs. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp980', '10.1136/annrheumdis-2018-eular.1889', '']\n",
      "['9262673', 'Van Der Pol JA; Bergstra SA; Riyazi N; Goekoop-Ruiterman YP; Chopra A; Kerstens P; Lems WF; Tsonaka R; Huizinga TW; Allaart CF. Window or no window: earlier is better when treating rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp910-911', '10.1136/annrheumdis-2018-eular.1743', '']\n",
      "['9262676', 'Bianchi G; Camellino D; Locaputo A; Diana P; Giusti A; Girasole G; Kremer J; Weinblatt M. Step-down methotrexate therapy in rheumatoid arthritis (stemetra): a pilot study to assess the safety and the tolerability of high-dose methotrexate. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp975', '10.1136/annrheumdis-2018-eular.2768', '']\n",
      "['9262677', 'Krishnan E; Zhang N; Wang H. Two-year consolidated safety data for ABP 501 in patients with moderate to severe rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp951', '10.1136/annrheumdis-2018-eular.6746', '']\n",
      "['9262680', 'Goll GL; Bolstad N; Iria I; Klaasen RA; Jorgensen KK; Olsen IC; Valido A; Saavedra MJ; Fonseca JE; Lundin K; Warren DJ; Haavardsholm E; Jahnsen J; Kvien TK; Goncalves J. The fine specificity of anti-drug antibody responses to originator and biosimilar infliximab: analyses across five diseases from the 52-week randomized nor-switch study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp852-853', '10.1136/annrheumdis-2018-eular.5554', '']\n",
      "['9262681', 'Janse Van Rensburg DC; Ker JA; Grant CC; Fletcher L. Exercise may decrease syncope secondary to postural change in females with rheumatoid arthritis: pilot study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp860-861', '10.1136/annrheumdis-2018-eular.6261', '']\n",
      "['9262682', 'Galeazzi M; Sebastiani G; Voll R; Viapiana O; Dudler J; Zufferey P; Selvi E; Finzel S; Bootz FS; Neri D. Dekavil (F8IL10)-update on the results of clinical trials investigating the immunocytokine in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp603-604', '10.1136/annrheumdis-2018-eular.5550', '']\n",
      "['9262687', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; Loppenthin KB; Midtgaard J; Christensen R; Nielsen SM; Ostergaard M; Jennum P; Esbensen BA. Hpr the efficacy of motivational counselling and sms-reminders on daily sitting time in patients with rheumatoid arthritis: 22 months followup of a randomised, parallel-group trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Suppl  2 pp159', '10.1136/annrheumdis-2018-eular.4595', '']\n",
      "['9262688', 'Adami G; Viapiana O; Bogliolo L; Cantatore FP; Varenna M; Malavolta N; Del Puente A; Muratore M; Orsolini G; Gatti D; Rossini M. An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp555', '10.1136/annrheumdis-2018-eular.5235', '']\n",
      "['9262691', 'Alexeeva E; Dvoryakovskaya T; Denisova R; Nikishina I; Zholobova E; Malievskiy V; Santalova G; Stadler E; Balykova L; Spivakovskiy Y; Becker I; Horneff G. A randomised, double-blind, parallel study to compare rates of remission (inactive disease) in patients with JIA on MTX treatment alone versus a combination of MTX and etanercept. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp486', '10.1136/annrheumdis-2018-eular.2843', '']\n",
      "['9262694', 'Zuidema R; Van Gaal B; Meek I; Van Den Ende E; Van Dulmen S; Fransen J; Nijhuis R. HPR effectiveness of an e-health tailored selfmanagement program for patients with rheumatoid arthritis: an explorative RCT. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp130', '10.1136/annrheumdis-2018-eular.6542', '']\n",
      "['9262695', 'Moller-Bisgaard S; Horslev-Pedersen K; Ejbjerg B; Hetland M; Ornbjerg L; Glinatsi D; Moller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen J; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh N; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen H; Ostergaard M. The value of adding mri to a clinical treatto-target strategy in rheumatoid arthritis patients in clinical remission: clinical and radiographic outcomes from the imagine-RA randomised controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp58-59', '10.1136/annrheumdis-2018-eular.1204', '']\n",
      "['9262699', 'Linauskas A. What evidence is there that diets help people with RMDs?. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp39-40', '10.1136/annrheumdis-2018-eular.7773', '']\n",
      "['9262700', 'Schett G; Finzel S; Kraus S; Regensburger A; Kocijan R; Rech J. Tocilizumab achieves better repair of focal bone erosions than tumour necrosis factor inhibition in RA patients-data from the prospective rebone study on erosion repair. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp572', '10.1136/annrheumdis-2018-eular.3188', '']\n",
      "['9262701', 'Sweeney A-MT; Madsen OR; Dreyer L; Hansen A. Hpr outpatient follow up on demand for patients with rheumatoid arthritis-a two-year randomised controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp152', '10.1136/annrheumdis-2018-eular.1666', '']\n",
      "['9262702', 'Soriano ER; Madariaga H; Castaneda O; Citera G; Schneeberger EE; Cardiel MH; Hendrikx T; Graham D; Shi H; Ponce De Leon D. Liver enzyme abnormalities after tofacitinib treatment in patients with hepatic steatosis from the rheumatoid arthritis, psoriatic arthritis and psoriasis clinical programmes. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp593-594', '10.1136/annrheumdis-2018-eular.2517', '']\n",
      "['9262703', 'Nordberg LB; Lillegraven S; Aga A-B; Sexton J; Lie E; Hammer HB; Olsen IC; Uhlig T; Van Der Heijde D; Kvien TK; Haavardsholm EA. Ultrasound power doppler activity predicts clinical joint swelling in early rheumatoid arthritis patients: secondary analyses from the arctic trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp126-127', '10.1136/annrheumdis-2018-eular.5318', '']\n",
      "['9262705', 'Moller-Bisgaard S; Horslev-Pedersen K; Ejbjerg B; Glinatsi D; Hetland M; Ornbjerg L; Moller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen J; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh N; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen H; Ostergaard M. An MRI guided treat-to-target strategy in rheumatoid arthritis patients in clinical remission improved MRI inflammation but not damage progression-results from the imagine-RA randomised controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp126', '10.1136/annrheumdis-2018-eular.3074', '']\n",
      "['9262706', 'Starritt G; Brennan D. A pilot study to assess the relationship between smoking and drug inefficacy in rheumatoid arthritis-part of a quality improvement project aimed at smoking cessation. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp318-319', '10.1136/annrheumdis-2018-eular.7345', '']\n",
      "['9262707', \"Dorner T; Zeher M; Laessing U; Chaperon F; De Buck S; Hasselberg A; Valentin M-A; Ma S; Cabanski M; Kalis C; Burkhart C; Gergely P. A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjogren's syndrome. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp174\", '10.1136/annrheumdis-2018-eular.3111', '']\n",
      "['9262708', 'Krishnan E; Mytych D; Zhang N; Wang H; Kaliyaperumal A. Immunogenicity associated with a transition from adalimumab reference product to ABP 501 in patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp318', '10.1136/annrheumdis-2018-eular.7225', '']\n",
      "['9262709', 'Barendregt AM; Van Gulik C; Groot P; Dolman K; Van Den Berg M; Nassar Sheikh Rashid A; Schonenberg-Meinema D; Lavini C; Rosendahl K; Hemke R; Kuijpers TW; Maas M; Nusman CM. Prolonged image acquisition time after contrast agent administration results in increased synovial thickness on postcontrast MRI of Jia patients: standardisation is key. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp101', '10.1136/annrheumdis-2018-eular.4780', '']\n",
      "['9262710', 'Dominguez Casas LC; Calvo-Rio V; Maiz-Alonso O; Blanco A; Beltran E; Martinez Acosta L; Alvarez De Buergo MC; Rubio-Romero E; Diaz-Valle D; Lopez-Gonzalez R; Garcia-Aparicio A; JuanMas A; Pons E; Demetrio-Pablo R; Vegas-Revenga N; Blanco R; Gonzalez-Gay M. Anti-TNFalpha versus rituximab in refractory peripheral ulcerative keratitis associated to rheumatic diseases. Multicenter study of 24 patients. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp591-592', '10.1136/annrheumdis-2018-eular.2622', '']\n",
      "['9262712', 'Hissink Muller P; Brinkman D; Schonenberg-Meinema D; Van Den Bosch W; Koopman-Keemink Y; Brederije I; Bekkering P; Kuijpers T; Van Rossum M; Van Suijlekom-Smit L; Van Den Berg JM; Boehringer S; Allaart CF; Ten Cate R. Treatment strategy study in new onset DMARD naive juvenile idiopathic arthritis first results on 24 months clinical outcome. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp478', '10.1136/annrheumdis-2018-eular.2623', '']\n",
      "['9262713', 'Alsaed O; Alamilah L; Al-Radideh O; Elkhalifa M; Al-Allaf A-W. Clinical utility of ANA-elia vs anaimmunofluorescence in connective tissue disease. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp815', '10.1136/annrheumdis-2018-eular.5705', '']\n",
      "['9262715', 'Alten R; Tseluyko V; Hala T; Mehmedagic S; Pileckyte M; Dokoupilova E; Jovic D; Rehman M; Zhang M; Sewell L; Hackley S; Salts S; Cronenberger C; Schumacher K; VonRichter O; Batko B. Efficacy, safety and immunogenicity from week 30 to week 54 in a randomised, doubleblind phase iii study comparing a proposed infliximab biosimilar (PF-06438179/gp1111) with reference infliximab. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp612-613', '10.1136/annrheumdis-2018-eular.5121', '']\n",
      "['9262716', 'Westhovens R; Yoo DH; Jaworski J; Matyska-Piekarska E; Smiyan S; Ivanova D; Zielinska A; Raussi E-K; Batalov A; Lee SJ; Lee SY; Suh JH. Novel formulation of CT-P13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp315', '10.1136/annrheumdis-2018-eular.1810', '']\n",
      "['9262723', 'Andersson S; Lange E; Kucherski D; Svedlund S; Onnheim K; Lord J; Martensson I-L; Mannerkorpi K; Gjertsson I. Intense aerobic and resistance exercise reduces the frequency of peripheral blood regulatory cell populations in elderly patients with rheumatoid arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp587-588', '10.1136/annrheumdis-2018-eular.4668', '']\n",
      "['9262724', 'El Miedany Y; Lotfy H; El Aroussy N; Mekkawy D; Nasef SI; Hassan W; Farag Y; Almedany S; El Deriny G; Eissa M; El Gaafary M. Share decision making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp219', '10.1136/annrheumdis-2018-eular.2792', '']\n",
      "['9262726', 'Marques ML; Brites L; Marques A; Daniel A; Santiago M; Pereira Da Silva JA. Factors associated with annual percentage changes in bone mineral density: a-14 years prospective population-based study. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp452-453', '10.1136/annrheumdis-2018-eular.5293', '']\n",
      "['9262730', 'Ferwerda M; Van Beugen S; Van Middendorp H; Visser H; Vonkeman H; Creemers M; Van Riel P; Kievit W; Evers A. HPR an economic evaluation of a tailored guided internet-based cognitive behavioural intervention for patients with rheumatoid arthritisas an addition to usual care. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp217', '10.1136/annrheumdis-2018-eular.5349', '']\n",
      "['9262733', \"Handa R. Chikungunya-A rheumatologist's perspective. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp8\", '10.1111/j.1479-8077.2007.00263.x', '']\n",
      "['9262734', 'Chen H; Lin C-H. Epidemiology of immune-mediated inflammatory diseases in a Taiwanese nationwide ankylosing spondylitis cohort. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp51-52', '10.1111/1756-185x.70164', '']\n",
      "['9262735', 'Nuki G; Downie WW; Dick WC; Whaley K; Spooner JB; Darby-Dowman MA; Buchanan WW. Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Annals of the rheumatic diseases. (1973) 32 5 pp436-443', '10.1136/ard.32.5.436', '']\n",
      "['9262736', 'Nicholls A; Snaith ML; Maini RN; Scott JT. Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis. Annals of the rheumatic diseases. (1973) 32 6 pp589-591', '10.1136/ard.32.6.589', '']\n",
      "['9262737', 'Murray HS; Strottman MP; Cooke AR. Effect of several drugs on gastric potential difference in man. British medical journal. (1974) 1 5896 pp19-21', '10.1136/bmj.1.5896.19', '']\n",
      "['9262738', 'Sydnes OA. A clinical investigation of niflumic acid in the treatment of rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 1  pp8-11', '10.3109/03009747309095202', '']\n",
      "['9262739', 'Finkbeiner G. [Treatment of the diseases of the extended rheumatic sphere form with paracetamol (Dolo-arthrosetten)]. MuÃànchener medizinische Wochenschrift (1950). (1973) 115 42 pp1855-1857', '10.1136/ard.9.1.38', '']\n",
      "['9262740', 'Brohult J; Jonson B. Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial. Scandinavian journal of rheumatology. (1973) 2 4 pp173-176', '10.3109/03009747309097085', '']\n",
      "['9262741', 'Trnavsk‚àöŒ© K; Schultz P; Sitaj S. [Treatment of progressive polyarthritis using gold. Report on a double-blind test]. Fysiatricky√É√Ö a reumatologicky√É√Ö vestni√É√Ök. (1973) 51 6 pp355-366', '10.3406/roma.1924.4593', '']\n",
      "['9262742', 'Pavelka K; Vojt√≠sek O; Br√©mova A; Kankov√° D; Handlov√° D. Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis. Current medical research and opinion. (1973) 1 6 pp342-350', '10.1185/03007997309111691', '']\n",
      "['9262743', 'Sigler JW; Bluhm GB; Duncan H; Sharp JT; Ensign DC; McCrum WR. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Annals of internal medicine. (1974) 80 1 pp21-26', '10.7326/0003-4819-80-1-21', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-80-1-21']\n",
      "['9262744', 'Kennedy AC; Lee P; Webb J; Deodhar S. Evaluation of the effect and duration of triamcinolone acetonide in the treatment of rheumatoid arthritis. Current medical research and opinion. (1973) 1 4 pp212-218', '10.1185/03007997309111670', '']\n",
      "['9262745', 'Yy DT; Clements PJ; Peter JB; Levy J; Paulus HE; Barnett EV. Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy. Arthritis and rheumatism. (1974) 17 1 pp37-45', '10.1002/art.1780170107', '']\n",
      "['9262746', 'Lussier A; Myhal D; Boost G; Varady J; Segre E; Strauss W. Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patients. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp113-120', '10.3109/03009747309097109', '']\n",
      "['9262747', 'Willkens RF. Double-blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp132-136', '10.3109/03009747309097112', '']\n",
      "['9262748', 'Helby-Petersen P; Ibfelt H; Rossel I. A double-blind crossover comparison of naproxen and placebo in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp145-149', '10.3109/03009747309097115', '']\n",
      "['9262749', 'Kogstad O. A double-blind cross-over study of naproxen and indomethacin in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp159-163', '10.3109/03009747309097118', '']\n",
      "['9262750', 'Diamond H; Alexander S; Kuzell W; Lussier A; Odone D; Tompkins R. A multi-center double-blind crossover comparison study of naproxen and aspirin in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp171-175', '10.3109/03009747309097120', '']\n",
      "['9262751', 'Hill HF; Hill AG; Mowat AG; Ansell BM; Mathews JA; Seifert MH; Gumpel JM; Christie GA. Multi-centre double-blind cross-over trial comparing naproxen and aspirin in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp176-181', '10.3109/03009747309097121', '']\n",
      "['9262752', 'Curtarelli G; Romussi M. Gastro-intestinal bleeding under treatment with naproxen. Scandinavian journal of rheumatology. Supplement. (1973) 2  pp48-49', '10.3109/03009747309097096', '']\n",
      "['9262753', 'Das KV; Sundaram P. Comparative study of the clinical effects of ibuprofen and indomethacin in rheumatoid arthritis. Journal of the Indian Medical Association. (1973) 61 4 pp170-173', '10.1093/rheumatology/xii.suppl.39', 'http://academic.oup.com/rheumatology/article-pdf/XII/suppl/39/5079700/XII-suppl-39.pdf']\n",
      "['9262754', 'Huskisson EC; Wojtulewski JA; Berry H; Scott J; Hart FD; Balme HW. Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. British medical journal. (1974) 1 5900 pp176-180', '10.1136/bmj.1.5900.176', '']\n",
      "['9262755', \"Maneksha S. 'Safapryn' and benorylate--a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis. Current medical research and opinion. (1973) 1 9 pp563-568\", '10.1185/03007997309111722', '']\n",
      "['9262756', 'Sacks S. Diclophenac sodium in rheumatoid arthritis and osteo-arthritis. South African medical journal. (1974) 48 6 pp213-215', '10.1001/jama.1910.02550400049023', '']\n",
      "['9262757', 'Multz CV; Bernhard GC; Blechman WC; Zane S; Restifo RA; Varady JC. A comparison of intermediate-dose aspirin and placebo in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1974) 15 3 pp310-315', '10.1002/cpt1974153310', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1974153310']\n",
      "['9262758', 'Bridgman JF; Bruckner F; Eisen V; Tucker A; Bleehen NM. Irradiation of the synovium in the treatment of rheumatoid arthritis. Quarterly journal of medicine. (1973) 42 166 pp357-367', '10.1093/oxfordjournals.qjmed.a067341', 'http://academic.oup.com/qjmed/article-pdf/42/2/357/4450168/42-2-357.pdf']\n",
      "['9262759', 'Deodhar SD; Dick WC; Hodgkinson R; Buchanan WW. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Quarterly journal of medicine. (1973) 42 166 pp387-401', '10.1093/oxfordjournals.qjmed.a067343', 'http://academic.oup.com/qjmed/article-pdf/42/2/387/4450206/42-2-387.pdf']\n",
      "['9262760', 'Pinder I. Synovectomy with drilling of the rheumatoid knee. Proceedings of the Royal Society of Medicine. (1974) 67 2 pp107-109', '10.1177/003591577406700210', 'http://journals.sagepub.com/doi/pdf/10.1177/003591577406700210']\n",
      "['9262761', 'Hill HF; Hill AG; Mowat AG; Ansell BM; Mathews JA; Seifert MH; Gumpel JM; Christie GA. Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Annals of the rheumatic diseases. (1974) 33 1 pp12-19', '10.1136/ard.33.1.12', '']\n",
      "['9262762', 'Thorpe P; Marchant-Williams R. The role of an antidepressant, dibenzepin (Noveril), in the relief of pain in chronic arthritic states. Medical journal of Australia. (1974) 1 8 pp264-266', '10.5694/j.1326-5377.1974.tb93144.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1974.tb93144.x']\n",
      "['9262763', 'Grennan DM; Watkins C; Kennedy AC. Preliminary clinical evaluation of azapropazone in rheumatoid arthritis. Current medical research and opinion. (1974) 2 2 pp67-71', '10.1185/03007997409114247', '']\n",
      "['9262764', 'Berkowitz SS; Bernhard G; Bilka PJ; Blechman WJ; Marchesano JM; Rosenthal M; Wortham GF. Tolmetin versus placebo for the treatment of rheumatoid arthritis: a sequential double-blind clinical trial. Current therapeutic research, clinical and experimental. (1974) 16 5 pp442-451', '10.1002/art.23361', '']\n",
      "['9262765', 'Dornan J; Reynolds WJ. Comparison of ibuprofen and acetylsalicylic acid in the treatment of rheumatoid arthritis. Canadian Medical Association journal. (1974) 110 12 pp1370-1372', '10.1185/03007997409115243', '']\n",
      "['9262766', 'Solomon L; Abrams G. Voltaren in the treatment of rheumatoid arthritis. South African medical journal. (1974) 48 22 pp949-952', '10.1080/20786204.2009.10873866', '']\n",
      "['9262767', 'Anderson IF. Trial of a new antirheumatic agent. South African medical journal. (1974) 48 21 pp899-903', '10.1185/03007997409115257', '']\n",
      "['9262768', \"Trnavsk√Ω K; Schultz P; Sit'aj S. [Treatment of rheumatoid arthritis with gold. A double-blind study]. Zeitschrift fuÃàr Rheumatologie. (1974) 33 3 pp138-148\", '10.1007/s003930050055', 'http://link.springer.com/article/10.1007/s003930050055/fulltext.html']\n",
      "['9262769', 'Kennedy AC; Watkins C; Brooks P; Grennan D. Clinical evaluation of niflumic acid (Squibb) in rheumatoid arthritis. Current medical research and opinion. (1974) 2 1 pp32-36', '10.1185/03007997409111738', '']\n",
      "['9262770', 'Rooney PJ; Watkins C; Ahola SJ; Gray GI; Dick WC. A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis. Current medical research and opinion. (1974) 2 1 pp43-50', '10.1185/03007997409111740', '']\n",
      "['9262771', 'Aylward M; Parker RJ; Maddock J. Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor. Annals of the rheumatic diseases. (1974) 33 3 pp268-272', '10.1136/ard.33.3.268', '']\n",
      "['9262772', 'Proctor JD; Evans EF; Campos V; Velandia J; Pollack D; Wingfield WL; Wasserman AJ. Tolerance to pirprofen and preliminary efficacy trial in rheumatoid arthritis. Clinical pharmacology and therapeutics. (1974) 16 1 pp69-76', '10.1002/cpt1974161part169', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1974161part169']\n",
      "['9262773', 'Kalos A; Dixon AS; Weber JC. Xipamid in the treatment of oedema in rheumatoid arthritis. Rheumatology and rehabilitation. (1974) 13 2 pp81-87', '10.1093/rheumatology/13.2.81', 'http://academic.oup.com/rheumatology/article-pdf/13/2/81/5018493/13-2-81.pdf']\n",
      "['9262774', 'Kersley GD; Gibson DJ; Ring F. Use of triamcinolone acetonide in the treatment of rheumatoid arthritis with digestive disorders. A clinical trial showing the value and dangers of long-acting parenteral steroid therapy. Rheumatology and rehabilitation. (1974) 13 2 pp88-91', '10.1093/rheumatology/13.2.88', 'http://academic.oup.com/rheumatology/article-pdf/13/2/88/5018627/13-2-88.pdf']\n",
      "['9262775', 'Lee P; Kennedy AC; Anderson J; Buchanan WW. Benefits of hospitalization in rheumatoid arthritis. Quarterly journal of medicine. (1974) 43 170 pp205-214', '10.1093/oxfordjournals.qjmed.a067383', 'http://academic.oup.com/qjmed/article-pdf/43/2/205/4568539/43-2-205.pdf']\n",
      "['9262776', 'Zutshi DW; Stern D; Bloch M; Mason RM. Ketoprofen: double-blind cross-over study with indomethacin in patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1974) 13 1 pp10-16', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9262778', 'Sturrock RD; Watkins C; Lee P; Brooks PM; Dick WC. Double-blind controlled assessment of the effect of intra-articular hydrocortisone and urokinase in rheumatoid arthritis. Current medical research and opinion. (1974) 2 5 pp288-290', '10.1185/03007997409115236', '']\n",
      "['9262779', \"Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA. Proceedings: Penicillamine or gold for rheumatoid arthritis? Multicentre trial using 'blind' observers. The first six months. Annals of the rheumatic diseases. (1974) 33 4 pp399\", '10.1136/ard.33.4.399-a', '']\n",
      "['9262781', 'Huskisson EC; Berry H; Scott J; Balme HW. Tolectin for rheumatoid arthritis. Rheumatology and rehabilitation. (1974) 13 3 pp132-134', '10.1093/rheumatology/13.3.132', 'http://academic.oup.com/rheumatology/article-pdf/13/3/132/5038292/13-3-132.pdf']\n",
      "['9262782', 'Huskisson EC. Simple analgesics for arthritis. British medical journal. (1974) 4 5938 pp196-200', '10.1136/bmj.4.5938.196', '']\n",
      "['9262783', 'Lee P; Baxter A; Dick WC; Webb J. An assessment of grip strength measurement in rheumatoid arthritis. Scandinavian journal of rheumatology. (1974) 3 1 pp17-23', '10.3109/03009747409165124', '']\n",
      "['9262784', 'Szanto E. A double-blind comparison of naproxen and indomethacin in rheumatoid arthritis. Scandinavian journal of rheumatology. (1974) 3 3 pp118-120', '10.3109/03009747409097135', '']\n",
      "['9262785', 'Brogden RN; Speight TM; Avery GS. Ketoprofen: a preliminary report of its pharmacological activity and therapeutic efficacy in rheumatic disorders. Drugs. (1974) 8 3 pp168-175', '10.2165/00003495-197408030-00003', '']\n",
      "['9262786', 'Taylor TV; Rimmer S; Day B; Butcher J; Dymock IW. Ascorbic acid supplementation in the treatment of pressure-sores. Lancet (London, England). (1974) 2 7880 pp544-546', '10.1016/s0140-6736(74)91874-1', '']\n",
      "['9262787', 'Meyers OL; Quantock OP; Joubert PG; Louw DFDP null; Marais DF; McDonald Scott WA; M√ºller FO. A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. South African medical journal. (1974) 48 48 pp2013-2017', '10.1136/ard.48.1.69', '']\n",
      "['9262788', 'Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report. Annals of the rheumatic diseases. (1974) 33 6 pp532-535', '10.1136/ard.33.6.532', '']\n",
      "['9262789', 'Gumpel JM; Hall A; Ansell B. Proceedings: A double-blind comparative trial of cyclophosphamide and gold in rheumatoid arthritis. Annals of the rheumatic diseases. (1974) 33 6 pp574', '10.1136/ard.33.6.574-a', '']\n",
      "['9262790', 'Grayson MF; Huskisson EC. A sequential trial of indomethacin and sodium amylobarbitone at night in rheumatoid arthritis, with comments on the statistical method. Rheumatology and rehabilitation. (1974) 13 4 pp176-178', '10.1093/rheumatology/13.4.176', 'http://academic.oup.com/rheumatology/article-pdf/13/4/176/5025728/13-4-176.pdf']\n",
      "['9262791', 'Louyot P; Tamisier JN; Pourel J. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology]. Arzneimittel-Forschung. (1974) 24 9A SUPPL pp1428-1431', '10.1016/s0335-7457(76)80040-8', '']\n",
      "['9262792', 'Reynolds PM; Whorwell PJ. A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis. Current medical research and opinion. (1974) 2 8 pp461-464', '10.1185/03007997409115243', '']\n",
      "['9262793', 'Hunter T; Urowitz MB; Gordon DA; Smythe HA; Ogryzlo MA. Azathioprine in rheumatoid arthritis: a long-term follow-up study. Arthritis and rheumatism. (1975) 18 1 pp15-20', '10.1002/art.1780180103', '']\n",
      "['9262794', 'Huskisson EC. Long-term use of fenoprofen in rheumatoid arthritis: the therapeutic ratio. Current medical research and opinion. (1974) 2 9 pp545-550', '10.1185/03007997409115255', '']\n",
      "['9262795', 'Barraclough DR; Lenaghan E; Muirden KD. A comparison of flurbiprofen and aspirin in the treatment of rheumatoid arthritis. Medical journal of Australia. (1974) 2 26 pp925-927', '10.5694/j.1326-5377.1974.tb93775.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1974.tb93775.x']\n",
      "['9262796', 'Fran√ßon F. [Recent Anglo-Saxon works on chrysotherapy of rehumatoid arthritis]. Revue meÃÅdicale de LieÃÄge. (1974) 29 22 pp695-697', '10.1017/s0263675100000569', '']\n",
      "['9262797', 'Shiokawa Y; Okada T; Saegusa K; Kawakami Y; Takahashi S. [Double blind cross-over studies on the dose level of protizinic acid (17, 190 RP)]. RyuÃÑmachi. [Rheumatism]. (1974) 14 2 pp121-132', '10.1002/art.1780200804', '']\n",
      "['9262798', \"G A null; Le G√¥ A; Delbarre F. Analysis of various parameters in the technique of the rheumatoid rosette test (attemped standardization). Biomedicine / [publieÃÅe pour l'A.A.I.C.I.G.]. (1974) 20 6 pp431-441\", '10.1016/s0002-9343(70)80077-8', '']\n",
      "['9262799', 'Convery FR; Gunn DR; Hughes JD; Martin WE. The relative safety of polymethylmethacrylate. A controlled clinical study of randomly selected patients treated with Charnley and ring total hip replacements. Journal of bone and joint surgery. American volume. (1975) 57 1 pp57-64', '10.2106/00004623-197557010-00010', '']\n",
      "['9262800', 'Goldie IF; Gunterberg B; Tiselius P. An objective evaluation of naproxen for the inflammatory reaction in the rheumatoid hand. Scandinavian journal of rheumatology. (1974) 3 4 pp161-168', '10.3109/03009747409095599', '']\n",
      "['9262801', 'Man SC; Baragar FD. Preliminary clinical study of acupuncture in rheumatoid arthritis. Journal of rheumatology. (1974) 1 1 pp126-129', '10.1097/00132586-197406000-00035', '']\n",
      "['9262802', 'Fostiropoulos G. [Comparison of the activity of alclofenac and of acetylsalicylic acid in rheumatoid arthritis; a double blind study and cross permutation]. TheÃÅrapie. (1974) 29 6 pp933-939', '10.1177/030006057400200309', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057400200309']\n",
      "['9262803', 'Pasquariello G; Mainardi L; Luvar√† A. The therapeutic activity of diftalone in rheumatoid arthritis: crossover comparison with indomethacin. Current medical research and opinion. (1975) 3 2 pp109-120', '10.1185/03007997509113657', '']\n",
      "['9262804', 'Haataja M; Kalliomaki JL. Effects of a single massive intravenous dose of hydrocortisone in rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1975) 17 1 pp80-87', '10.1185/03007997509113657', '']\n",
      "['9262805', 'Aeidler H. [Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis]. Arzneimittel-Forschung. (1975) 25 2A pp315-318', '10.1002/j.1552-4604.1975.tb01464.x', '']\n",
      "['9262806', 'Wasson J; Downie WW; Shenkin A; Nuki G; Bell MA; Buchanan W. The effects of morphine and nalorphine on the plasma 11-hydroxycorticosteroid response to insulin-induced hypoglycaemia in patients with rheumatoid arthritis. Current medical research and opinion. (1975) 3 3 pp163-168', '10.1185/03007997509113665', '']\n",
      "['9262807', 'Lee P; Watson M; Webb J; Anderson J; Buchanan W. Therapeutic effectiveness of paracetamol in rheumatoid arthritis. International journal of clinical pharmacology and biopharmacy. (1975) 11 1 pp68-75', '10.1185/03007997409112306', '']\n",
      "['9262808', 'Husby G; K√•ss E; Spongsveen KL. Comparative double-blind trial of intra-articular injections of two long-acting forms of betamethasone. Scandinavian journal of rheumatology. (1975) 4 3 pp118-120', '10.3109/03009747509165439', '']\n",
      "['9262809', 'Bowers DE; Dyer HR; Fosdick WM; Keller KE; Rosenberg AL; Sussman P; Vancil ME. Naproxen in rheumatoid arthritis. A controlled trial. Annals of internal medicine. (1975) 83 4 pp470-475', '10.7326/0003-4819-83-4-470', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-83-4-470']\n",
      "['9262810', 'Maddock J; Rees P; Holly F; Aylward M. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. Current medical research and opinion. (1975) 3 5 pp286-297', '10.1185/03007997509114779', '']\n",
      "['9262811', 'Haslock I. The effect of alclofenac on clinical and laboratory measures of disease activity in rheumatoid arthritis: preliminary results. Current medical research and opinion. (1975) 3 5 pp298-308', '10.1185/03007997509114780', '']\n",
      "['9262812', 'Bedi SS. Double-blind comparison of alclofenac and aspirin in the treatment of rheumatoid arthritis. Part II: high dosage regime for assessment of analgesic and anti-inflammatory activity. Current medical research and opinion. (1975) 3 5 pp309-320', '10.1185/03007997509114781', '']\n",
      "['9262813', 'White AG; Martin VM. A comparison of alclofenac and indomethacin in the relief of rheumatoid morning stiffness. Current medical research and opinion. (1975) 3 5 pp329-332', '10.1185/03007997509114783', '']\n",
      "['9262814', 'Hernandez LA; MacLeod M; Grennan DM; Palmer DG; Buchanan WW. Clinical evaluation of two daily doses of naproxen and indomethacin: result of a double-blind crossover trail. Current medical research and opinion. (1975) 3 6 pp359-366', '10.1185/03007997509114787', '']\n",
      "['9262815', 'Mitchell AB. Oral iron tolerance. Postgraduate medical journal. (1974) 50 589 pp702-706', '10.1136/pgmj.50.589.702', 'https://academic.oup.com/pmj/article-pdf/50/589/702/50254707/postgradmedj-50-702.pdf']\n",
      "['9262816', 'Laine V; Koota U; Larsen A; Raunio K; Nissil√§ M. Clinical experience with osmic acid in the treatment of joint effusion in rheumatoid arthritis. Preliminary report of a controlled clinical trial. Advances in clinical pharmacology. (1974) 6  pp130-133', '10.3109/03009747709095442', '']\n",
      "['9262817', 'Alexander SJ. Clinical experience with naproxen in rheumatoid arthritis. Archives of internal medicine. (1975) 135 11 pp1429-1435', '10.1001/archinte.1975.00330110019003', '']\n",
      "['9262818', 'Bachmann F; Stroescu O; Hartl W. [Double blind and dosage studies on tolectine in rheumatoid arthritis]. Zeitschrift fuÃàr Allgemeinmedizin. (1975) 51 30 pp1382-1386', '10.3109/9780203214237-211', '']\n",
      "['9262819', 'Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method]. Zeitschrift fuÃàr Rheumatologie. (1975) 34 9-10 pp350-365', '10.4103/ajim.ajim_80_21', '']\n",
      "['9262820', 'Haslock I; Omar AS; Wright V. A comparison of micro-encapsulated aspirin and indomethacin in the treatment of rheumatoid arthritis. British journal of clinical practice. (1975) 29 11 pp311-314', '10.1111/j.1742-1241.1975.tb05114.x', '']\n",
      "['9262821', 'Huskisson EC; Scott J; Balme HW; Dieppe PA; Trapnell J; Willoughby DA. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (London, England). (1976) 1 7956 pp393-395', '10.1016/s0140-6736(76)90218-x', '']\n",
      "['9262822', 'Chamberlain MA; Keenan J. The effect of low doses of prednisolone compared with placebo on function and on the hypothalamic pituitary adrenal axis in patients with rheumatoid arthritis. Rheumatology and rehabilitation. (1976) 15 1 pp17-23', '10.1093/rheumatology/15.1.17', 'http://academic.oup.com/rheumatology/article-pdf/15/1/17/5026268/15-1-17.pdf']\n",
      "['9262823', 'Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Annals of the rheumatic diseases. (1975) 34 5 pp416-421', '10.1136/ard.34.5.416', '']\n",
      "['9262824', 'Cade R; Stein G; Pickering M; Schlein E; Spooner G. Low dose, long-term treatment of rheumatoid arthritis with azathioprine. Southern medical journal. (1976) 69 4 pp388-392', '10.1097/00007611-197604000-00003', '']\n",
      "['9262825', 'Huskisson EC; Woolf DL; Balme HW; Scott J; Franklin S. Four new anti-inflammatory drugs: responses and variations. British medical journal. (1976) 1 6017 pp1048-1049', '10.1136/bmj.1.6017.1048', '']\n",
      "['9262826', 'Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. British medical journal. (1976) 1 6017 pp1052-1054', '10.1136/bmj.1.6017.1052', '']\n",
      "['9262827', 'Tanaka S; Ito T; Mori E; Muroga T; Nakajima A. Double-blind study of Naproxen in osteoarthritis of the knee joint. Journal of rheumatology. (1976) 3 1 pp27-36', '10.3109/03009747609095640', '']\n",
      "['9262828', 'Fostiropoulos G. A double-blind cross-over study of clopirac and ketoprofen in rheumatoid arthritis. Journal belge de rhumatologie et de meÃÅdecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde. (1975) 30 Spec no  pp100-106', '10.2307/3686963', '']\n",
      "['9262829', 'Vetter G. Double-blind cross-over study of clopirac and naproxen in rheumatoid arthritis. Journal belge de rhumatologie et de meÃÅdecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde. (1975) 30 Spec no  pp107-111', '10.2307/3686963', '']\n",
      "['9262830', 'Vetter G. A double-blind comparison of clopirac and indomethacin in the treatment of rheumatoid arthritis. Journal belge de rhumatologie et de meÃÅdecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde. (1975) 30 Spec no  pp118-122', '10.2307/3686963', '']\n",
      "['9262831', 'Goddeeris T; Dequeker J. Treatment of rheumatoid arthritis with clopirac: comparison with aspirin. Journal belge de rhumatologie et de meÃÅdecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde. (1975) 30 Spec no  pp131-137', '10.2307/3686920', '']\n",
      "['9262832', 'de Salcedo I; Silva JL; Carrington MD; Lemos MM. Double-blind study comparing clopirac with a placebo in rheumatoid arthritis. Journal belge de rhumatologie et de meÃÅdecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde. (1975) 30 Spec no  pp64-73', '10.2307/3686334', '']\n",
      "['9262833', 'Dippy JE; Pritchard MH; Lloyd KN. A trial of micro-encapsulated and enteric-coated aspirin in rheumatoid arthritis. Rheumatology and rehabilitation. (1976) 15 2 pp77-80', '10.1093/rheumatology/15.2.77', 'http://academic.oup.com/rheumatology/article-pdf/15/2/77/5039410/15-2-77.pdf']\n",
      "['9262834', 'Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V. Some studies of feprazone. Rheumatology and rehabilitation. (1976) 15 2 pp81-86', '10.1093/rheumatology/15.2.81', 'http://academic.oup.com/rheumatology/article-pdf/15/2/81/5039440/15-2-81.pdf']\n",
      "['9262835', 'Townes AS; Sowa JM; Shulman LE. Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis and rheumatism. (1976) 19 3 pp563-573', '10.1002/art.1780190308', '']\n",
      "['9262836', 'Cats A. A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents and actions. (1976) 6 1-3 pp355-363', '10.1007/bf01972255', 'http://link.springer.com/article/10.1007/BF01972255/fulltext.html']\n",
      "['9262837', 'Willkens RF; Segre EJ. Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis and rheumatism. (1976) 19 4 pp677-682', '10.1002/1529-0131(197607/08)19:4<677::aid-art1780190404>3.0.co;2-a', '']\n",
      "['9262838', 'Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet (London, England). (1976) 2 7985 pp539-542', '10.1016/s0140-6736(76)91793-1', '']\n",
      "['9262839', \"Rejholec V. [The long term treatment of rheumatoid arthritis with niflumic acid or indometazin in double blind controlled trial (author's transl)]. Medizinische Klinik. (1976) 71 71 pp1188-1191\", '10.1186/isrctn61074476', '']\n",
      "['9262840', \"Walker WR; Keats DM. An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions. Agents and actions. (1976) 6 4 pp454-459\", '10.1007/bf01965151', 'http://link.springer.com/article/10.1007/BF01965151/fulltext.html']\n",
      "['9262842', 'Kirchheiner B; Trang L; Wollheim FA. Diclophenax sodium (Voltaren) in rheumatoid arthritis: a double-blind comparison with indomethacin and placebo. International journal of clinical pharmacology and biopharmacy. (1976) 13 4 pp292-297', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9262843', 'Schmid FR; Culic DD. Antiinflammatory drugs and gastrointestinal bleeding: a comparison of aspirin and ibuprofen. Journal of clinical pharmacology. (1976) 16 8-9 pp418-425', '10.1002/j.1552-4604.1976.tb02416.x', '']\n",
      "['9262844', 'Cordrey LJ. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies. Journal of the American Geriatrics Society. (1976) 24 10 pp440-446', '10.1111/j.1532-5415.1976.tb03256.x', '']\n",
      "['9262845', 'Bayley TR; Haslock I. Night medication in rheumatoid arthritis. Journal of the Royal College of General Practitioners. (1976) 26 169 pp591-594', '10.1093/rheumatology/16.2.125', 'http://academic.oup.com/rheumatology/article-pdf/16/2/125/5039069/16-2-125.pdf']\n",
      "['9262846', 'Marks JS; Stewart IM; Hunter JA. Intra-articular methotrexate in rheumatoid arthritis. Lancet (London, England). (1976) 2 7990 pp857-858', '10.1016/s0140-6736(76)91250-2', '']\n",
      "['9262847', 'Orme M; Holt PJ; Hughes GR; Bulpitt CJ; Draffan GH; Thorgeirsson SS; Williams F; Davies DS. Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1976) 3 1 pp185-191', '10.1111/j.1365-2125.1976.tb00587.x', '']\n",
      "['9262848', 'Pavelka K; Vojtisek O; Bremov√° A; Kaukov√° D; H√°ndlov√° D. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone). International journal of clinical pharmacology and biopharmacy. (1976) 14 1 pp20-28', '10.1093/rheumatology/12.2.68', 'http://academic.oup.com/rheumatology/article-pdf/12/2/68/5039206/12-2-68.pdf']\n",
      "['9262849', 'Lee P; Anderson JA; Miller J; Webb J; Buchanan WW. Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. Journal of rheumatology. (1976) 3 3 pp283-294', '10.1136/bmj.2.5868.685', '']\n",
      "['9262850', 'Peltola P. A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp111-113', '10.1093/rheumatology/15.5.56', 'http://academic.oup.com/rheumatology/article-pdf/15/5/56/5039121/15-5-56.pdf']\n",
      "['9262851', 'Sydnes O; Brath HK; Haerum LB; Straume S. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp119-122', '10.1093/rheumatology/15.5.43', 'http://academic.oup.com/rheumatology/article-pdf/15/5/43/5038967/15-5-43.pdf']\n",
      "['9262852', 'Grahame R; Burry HC. Ketoprofen -- a new anti-rheumatic agent. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp133-136', '10.1093/rheumatology/15.5.22', 'http://academic.oup.com/rheumatology/article-pdf/15/5/22/5038802/15-5-22.pdf']\n",
      "['9262853', 'Zutshi D; Mason M. Ketoprofen in rheumatoid arthritis: its tolerance and therapeutic effect. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp77-84', '10.3109/03009747609099896', '']\n",
      "['9262854', 'Fossgreen J; Kirchheiner B; Petersen FO; Tophoj E; Zachariae E. Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp93-98', '10.1093/rheumatology/15.5.50', 'http://academic.oup.com/rheumatology/article-pdf/15/5/50/5039034/15-5-50.pdf']\n",
      "['9262855', 'Lussier A; Camerlain M; Menard H; Myhal D; Wehner S. A double-blind cross-over evaluation of ketoprofen and aspirin in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement. (1976) 1976 0 pp99-104', '10.1093/rheumatology/15.5.56', 'http://academic.oup.com/rheumatology/article-pdf/15/5/56/5039121/15-5-56.pdf']\n",
      "['9262856', 'Tausch G; Br√∂ll H; Dunky A; Eberl R. Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis. Scandinavian journal of rheumatology. (1976) 5 3 pp145-150', '10.3109/03009747609165453', '']\n",
      "['9262857', 'Metzger WH; McAdam L; Bluestone R; Guth PH. Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans. American journal of digestive diseases. (1976) 21 11 pp963-968', '10.1007/bf01071908', 'http://link.springer.com/article/10.1007/BF01071908/fulltext.html']\n",
      "['9262858', 'Pipitone V. Double-blind comparison of the antirheumatic activity and gastric side-effects of indomethacin used alone or in combination with a gastro-protective agent, proglumide. Current medical research and opinion. (1976) 4 4 pp267-277', '10.1185/03007997609109317', '']\n",
      "['9262859', 'Capell HA; McLeod MM; Hern√°ndez LA; Grennan DM; Templeton JS. Comparison of azapropazone and naproxen in rheumatoid arthritis. Current medical research and opinion. (1976) 4 4 pp285-289', '10.1185/03007997609109319', '']\n",
      "['9262860', 'Weinstein A; Rothfield NF. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study. Journal of rheumatology. (1986) 13 2 pp308-312', '10.1093/rheumatology/25.2.184', 'http://academic.oup.com/rheumatology/article-pdf/25/2/184/5027688/25-2-184.pdf']\n",
      "['9262861', 'Kovalesky A; Sherry DD; Lehman TJ. The use of lidocaine to reduce the pain of myochrysine injections for children with juvenile rheumatoid arthritis. Journal of rheumatology. (1986) 13 2 pp356-357', '10.1093/oso/9780192632920.003.0029', 'https://academic.oup.com/book/chapter-pdf/52154560/isbn-9780192632920-book-part-29.pdf']\n",
      "['9262862', 'Ash G; Baker R; Rajapakse C; Swinson DR. Study of sulphamethoxazole in rheumatoid arthritis. British journal of rheumatology. (1986) 25 3 pp285-287', '10.1093/rheumatology/25.3.285', 'http://academic.oup.com/rheumatology/article-pdf/25/3/285/5040480/25-3-285.pdf']\n",
      "['9262863', 'Weisman MH. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis. Clinical therapeutics. (1986) 8 4 pp427-438', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9262864', 'Dixon AS; Harrison RA; Pocock P. Trial of Isotoner gloves for morning stiffness and pain in rheumatoid arthritis. British journal of clinical practice. (1986) 40 7 pp271-272', '10.1111/j.1742-1241.1986.tb07975.x', '']\n",
      "['9262865', 'Visch LL; Gravenmade EJ; Schaub RM; Van Putten WL; Vissink A. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes. International journal of oral and maxillofacial surgery. (1986) 15 4 pp395-400', '10.1016/s0300-9785(86)80027-8', '']\n",
      "['9262866', 'Berg KJ; F√∏rre O; Bjerkhoel F; Amundsen E; Dj√∏seland O; Rugstad HE; Westre B. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney international. (1986) 29 6 pp1180-1187', '10.1038/ki.1986.125', '']\n",
      "['9262867', \"Oxholm P; Manthorpe R; Prause JU; Horrobin D. Patients with primary Sj√∂gren's syndrome treated for two months with evening primrose oil. Scandinavian journal of rheumatology. (1986) 15 2 pp103-108\", '10.3109/03009748609102073', '']\n",
      "['9262868', 'Szanto E. Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study. Scandinavian journal of rheumatology. (1986) 15 2 pp97-102', '10.3109/03009748609102072', '']\n",
      "['9262869', 'Bird HA; Hill J; Leatham P; Wright V. A study to determine the clinical relevance of the pharmacokinetic interaction between aspirin and diclofenac. Agents and actions. (1986) 18 3-4 pp447-449', '10.1007/bf01965010', 'http://link.springer.com/article/10.1007/BF01965010/fulltext.html']\n",
      "['9262870', 'Hochberg MC. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis. Annals of internal medicine. (1986) 105 4 pp528-535', '10.7326/0003-4819-105-4-528', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-105-4-528']\n",
      "['9262871', 'Standel W; Josenhants G. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis. European journal of rheumatology and inflammation. (1985) 8 1 pp28-38', '10.14412/1996-7012-2009-532', '']\n",
      "['9262872', 'Mathias Filho AP; Sidi A. Long-term study with Ro 12-0068 (tenoxicam) in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1985) 8 1 pp3-8', '10.1007/bf03313565', 'http://link.springer.com/article/10.1007/BF03313565/fulltext.html']\n",
      "['9262873', 'Trofimova TM; Alekberova ZS; Pokryshkin VI; Kobaladze SG; Taletene IP. Study of pirprofen (rengasil) combined with maintenance doses of corticosteroids in rheumatoid arthritis in a double-blind multicenter trial. TerapevticheskiiÃÜ arkhiv. (1986) 58 7 pp95-97', '10.3109/03009748609102072', '']\n",
      "['9262874', 'Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. American journal of medicine. (1986) 81 4 pp565-578', '10.1016/0002-9343(86)90539-5', '']\n",
      "['9262875', 'Capell HA; Lewis D; Carey J. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis. Annals of the rheumatic diseases. (1986) 45 9 pp705-711', '10.1136/ard.45.9.705', '']\n",
      "['9262877', \"Drosos AA; Skopouli FN; Costopoulos JS; Papadimitriou CS; Moutsopoulos HM. Cyclosporin A (CyA) in primary Sj√∂gren's syndrome: a double blind study. Annals of the rheumatic diseases. (1986) 45 9 pp732-735\", '10.1136/ard.45.9.732', '']\n",
      "['9262878', 'Strauss GD; Spiegel JS; Daniels M; Spiegel T; Landsverk J; Roy-Byrne P; Edelstein C; Ehlhardt J; Falke R; Hindin L. Group therapies for rheumatoid arthritis. A controlled study of two approaches. Arthritis and rheumatism. (1986) 29 10 pp1203-1209', '10.1002/art.1780291004', '']\n",
      "['9262879', 'Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam. American journal of the medical sciences. (1986) 292 5 pp272-276', '10.1097/00000441-198611000-00004', '']\n",
      "['9262880', 'Vischer TL; Sinniger M; Ott H; Gerster JC. A randomized, double-blind trial comparing a pulse of 1000 with 250 mg methylprednisolone in rheumatoid arthritis. Clinical rheumatology. (1986) 5 3 pp325-326', '10.1007/bf02054249', 'http://link.springer.com/article/10.1007/BF02054249/fulltext.html']\n",
      "['9262881', 'Van Riel PL; Larsen A; Van de Putte LB; Gribnau FW. Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clinical rheumatology. (1986) 5 3 pp359-364', '10.1007/bf02054254', 'http://link.springer.com/article/10.1007/BF02054254/fulltext.html']\n",
      "['9262882', 'Nishioka K; Tanaka T; Mobunaga M. [Result of a double-blind clinical study of EB-382 (Alminoprofen) in rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1986) 26 3 pp210-220', '10.1002/art.1780120508', '']\n",
      "['9262883', 'Bhettay E. Double-blind study of sulindac and aspirin in juvenile chronic arthritis. South African medical journal. (1986) 70 12 pp724-726', '10.1136/bmj.293.6541.270', '']\n",
      "['9262884', 'Rae KJ; Mackay CN; McNeil CJ; Brown DH; Smith WE; Lewis D; Capell HA. Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin. Annals of the rheumatic diseases. (1986) 45 10 pp839-846', '10.1136/ard.45.10.839', '']\n",
      "['9262885', 'Dawes PT; Fowler PD; Jackson R; Collins M; Shadforth MF; Stone R; Scott DL. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Annals of the rheumatic diseases. (1986) 45 11 pp945-949', '10.1136/ard.45.11.945', '']\n",
      "['9262888', 'Peddinani MV; Savery F; Hang LM. Human leukocyte interferon in the treatment of rheumatoid arthritis. Clinical therapeutics. (1986) 9 1 pp39-43', '10.1007/978-1-4612-4864-4_15', 'http://link.springer.com/content/pdf/10.1007/978-1-4612-4864-4_15.pdf']\n",
      "['9262889', 'Kremer JM; Jubiz W; Michalek A; Rynes RI; Bartholomew LE; Bigaouette J; Timchalk M; Beeler D; Lininger L. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Annals of internal medicine. (1987) 106 4 pp497-503', '10.7326/0003-4819-106-4-497', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-106-4-497']\n",
      "['9262890', \"Sanderson IR; Udeen S; Davies PS; Savage MO; Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Archives of disease in childhood. (1987) 62 2 pp123-127\", '10.1136/adc.62.2.123', '']\n",
      "['9262891', \"Dalavanga YA; Detrick B; Hooks JJ; Drosos AA; Moutsopoulos HM. Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sj√∂gren's syndrome. Annals of the rheumatic diseases. (1987) 46 2 pp89-92\", '10.1136/ard.46.2.89', '']\n",
      "['9262892', 'Bruno A; Cavallo-Perin P; Cassader M; Pagano G. Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics. Archives of internal medicine. (1987) 147 4 pp679-680', '10.1001/archinte.1987.00370040061011', '']\n",
      "['9262893', 'Furst DE; Blocka K; Cassell S; Harris ER; Hirschberg JM; Josephson N; Lachenbruch PA; Trimble RB; Paulus HE. A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritis. Arthritis and rheumatism. (1987) 30 2 pp146-154', '10.1002/art.1780300204', '']\n",
      "['9262894', 'Alarc√≥n GS; Billingsley LM; Clegg DO; Hardin JG; Klippel J; Luggen ME; Polisson RP; Singer JZ; Szydlo L; Willkens RF. Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid arthritis. Arthritis and rheumatism. (1987) 30 2 pp218-220', '10.1002/art.1780300213', '']\n",
      "['9262895', 'Bennett RM. A 12-week, double-blind, multicenter study comparing diflunisal twice daily and ibuprofen four times daily in the treatment of rheumatoid arthritis. Clinical therapeutics. (1986) 9 Suppl C SUPPL. C pp27-36', '10.1093/rheumatology/xii.suppl.39', 'http://academic.oup.com/rheumatology/article-pdf/XII/suppl/39/5079700/XII-suppl-39.pdf']\n",
      "['9262896', 'Turner RA; Shackleford RW; Whipple JP. Comparison of diflunisal and aspirin in long-term treatment of patients with rheumatoid arthritis. Clinical therapeutics. (1986) 9 Suppl C SUPPL. C pp37-46', '10.1002/j.1875-9114.1984.tb03341.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1875-9114.1984.tb03341.x']\n",
      "['9262898', 'Manniche C; Malchow-M√∏ller A; Andersen JR; Pedersen C; Hansen TM; Jess P; Helleberg L; Rasmussen SN; Tage-Jensen U; Nielsen SE. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut. (1987) 28 2 pp226-229', '10.1136/gut.28.2.226', '']\n",
      "['9262899', \"Levine JD; Fye K; Heller P; Basbaum AI; Whiting-O'Keefe Q. Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. Journal of rheumatology. (1986) 13 6 pp1040-1043\", '10.1093/rheumatology/34.7.7', 'http://academic.oup.com/rheumatology/article-pdf/34/7/7/5044582/34-7-7.pdf']\n",
      "['9262900', 'Kremer JM; Rynes RI; Bartholomew LE. Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study. American journal of medicine. (1987) 82 4 pp781-786', '10.1016/0002-9343(87)90015-5', '']\n",
      "['9262901', 'Van Deusen J; Harlowe D. The efficacy of the ROM Dance Program for adults with rheumatoid arthritis. The American journal of occupational therapy : official publication of the American Occupational Therapy Association. (1987) 41 2 pp90-95', '10.5014/ajot.41.2.90', 'https://research.aota.org/ajot/article-pdf/41/2/90/52476/90.pdf']\n",
      "['9262902', 'Leonard PA; Bienz SR; Clegg DO; Ward JR. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine. Journal of rheumatology. (1987) 14 1 pp55-59', '10.3109/03009748709102172', '']\n",
      "['9262903', 'Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study. Clinical and experimental rheumatology. (1991) 9 Suppl 6  pp41-45', '10.1093/rheumatology/32.suppl_2.39', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_2/39/5041508/32-suppl_2-39.pdf']\n",
      "['9262904', 'Andrade LE; Ferraz MB; Atra E; Castro A; Silva MS. A randomized controlled trial to evaluate the effectiveness of homeopathy in rheumatoid arthritis. Scandinavian journal of rheumatology. (1991) 20 3 pp204-208', '10.3109/03009749109103022', '']\n",
      "['9262905', 'Huber B. [Therapy of degenerative rheumatic diseases. Need for additional analgesic medication with Phytodolor N]. Fortschritte der Medizin. (1991) 109 11 pp248-250', '10.1007/s15006-017-9777-0', 'http://link.springer.com/content/pdf/10.1007/s15006-017-9777-0.pdf']\n",
      "['9262906', 'Wendling D; Wijdenes J; Racadot E; Morel-Fourrier B. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. Journal of rheumatology. (1991) 18 3 pp325-327', '10.1007/bf02283116', 'https://link.springer.com/article/10.1007/BF02283116/fulltext.html']\n",
      "['9262907', 'Rau R; Herborn G; Karger T; Menninger H; Elhardt D; Schmitt J. A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. Journal of rheumatology. (1991) 18 3 pp328-333', '10.1016/0049-0172(91)90047-4', '']\n",
      "['9262908', 'Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Small R; Wolfe F. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. Journal of rheumatology. (1991) 18 3 pp334-338', '10.1002/art.1780371013', '']\n",
      "['9262909', \"Miyawaki S; Torikai K; Natsume I; Nobunaga T; Ohtsuka E; Suzuki T; Ohno S; Tojoh T; Ogasawara T; Hashimoto H. [Evaluation of two quantitative tests for salivary secretion--the chewing gum test and the Saxon test in normal subjects and in patients with Sj√∂gren's syndrome]. RyuÃÑmachi. [Rheumatism]. (1991) 31 1 pp22-27\", '10.58837/chula.the.2020.233', '']\n",
      "['9262910', 'Wester JU; Haerslev T; Mathiesen FK; Jespersen SM; Hansen TM. [Naproxen versus indomethacin as night-time medication for patients with rheumatoid arthritis]. Ugeskrift for laeger. (1991) 153 27 pp1937-1939', '10.1093/rheumatology/16.2.125', 'http://academic.oup.com/rheumatology/article-pdf/16/2/125/5039069/16-2-125.pdf']\n",
      "['9262912', 'Lotke PA; Faralli VJ; Orenstein EM; Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. Journal of bone and joint surgery. American volume. (1991) 73 7 pp1037-1040', '10.2106/00004623-199173070-00011', '']\n",
      "['9262913', 'Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort. Pediatrics. (1991) 88 3 pp428-436', '10.1093/rheumatology/32.suppl_2.31', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_2/31/5041428/32-suppl_2-31.pdf']\n",
      "['9262914', 'Radermacher J; Jentsch D; Scholl MA; Lustinetz T; Fr√∂lich JC. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. British journal of clinical pharmacology. (1991) 31 5 pp537-541', '10.1111/j.1365-2125.1991.tb05576.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1991.tb05576.x']\n",
      "['9262915', 'Smith DM; Johnson JA; Turner RA. Biochemical perturbations of BW 91Y (3-deazaadenosine) on human neutrophil chemotactic potential and lipid metabolism. International journal of tissue reactions. (1991) 13 1 pp1-18', '10.1007/bf02003228', 'http://link.springer.com/article/10.1007/BF02003228/fulltext.html']\n",
      "['9262916', 'Poulsen A. Psychodynamic, time-limited group therapy in rheumatic disease--a controlled study with special reference to alexithymia. Psychotherapy and psychosomatics. (1991) 56 1-2 pp12-23', '10.1159/000288525', '']\n",
      "['9262917', 'van Rijthoven AW; Dijkmans BA; Th‚àö¬Æ HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. Journal of rheumatology. (1991) 18 6 pp815-820', '10.1136/ard.45.9.726', '']\n",
      "['9262918', 'Brzeski M; Madhok R; Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. British journal of rheumatology. (1991) 30 5 pp370-372', '10.1093/rheumatology/30.5.370', 'http://academic.oup.com/rheumatology/article-pdf/30/5/370/5042502/30-5-370.pdf']\n",
      "['9262919', 'Borg G; Allander E; Berg E; Brodin U; From A; Trang L. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. Journal of rheumatology. (1991) 18 7 pp1015-1020', '10.3109/03009748909095027', '']\n",
      "['9262920', 'Buchanan WW; Kean WF; St-Jean J; Gerecz-Simon E; Elie R. Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter study. Journal of rheumatology. (1991) 18 7 pp1046-1054', '10.1007/bf02663742', 'https://link.springer.com/article/10.1007/BF02663742/fulltext.html']\n",
      "['9262921', 'Kjeldsen-Kragh J; Haugen M; Borchgrevink CF; Laerum E; Eek M; Mowinkel P; Hovi K; F√∏rre O. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet (London, England). (1991) 338 8772 pp899-902', '10.1016/0140-6736(91)91770-u', '']\n",
      "['9262922', 'Morgan SL; Baggott JE; Refsum H; Ueland PM. Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Clinical pharmacology and therapeutics. (1991) 50 5 Pt 1 pp547-556', '10.1038/clpt.1991.180', '']\n",
      "['9262923', 'Bender T; Gid√≥falvi E. [The effect of ultrasonic therapy in rheumatoid arthritis of the temporomandibular joint]. Fogorvosi szemle. (1991) 84 8 pp229-232', '10.33891/fsz.110.1.3-6', 'https://ojs.mtak.hu/index.php/fogorv-szemle/article/download/4912/3862']\n",
      "['9262924', 'Nilsson KG; K√§rrholm J; Ekelund L; Magnusson P. Evaluation of micromotion in cemented vs uncemented knee arthroplasty in osteoarthrosis and rheumatoid arthritis. Randomized study using roentgen stereophotogrammetric analysis. Journal of arthroplasty. (1991) 6 3 pp265-278', '10.1016/s0883-5403(06)80174-9', '']\n",
      "['9262925', 'Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. Journal of rheumatology. (1991) 18 8 pp1240-1242', '10.1097/01241398-199009000-00034', '']\n",
      "['9262926', 'Nishioka N; Nobunaga M; Sakuma A. [A double blind comparative study of 1g/day, 2g/day salazosulfapyridine and placebo in rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1991) 31 3 pp327-345', '10.1002/art.1780361104', '']\n",
      "['9262927', 'Nishioka K; Azuma T; Iwasaki Y. [A double blind comparative study between salazosulfapyridine enteric coated tablets (PJ-306) and lobenzarit disodium (CCA) in rheumatoid arthritis]. RyuÃÑmachi. [Rheumatism]. (1991) 31 3 pp346-367', '10.1002/art.1780200804', '']\n",
      "['9262928', 'Heurkens AH; Westedt ML; Breedveld FC. Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Archives of internal medicine. (1991) 151 11 pp2249-2254', '10.1001/archinte.1991.00400110099020', '']\n",
      "['9262929', 'Deal CL; Schnitzer TJ; Lipstein E; Seibold JR; Stevens RM; Levy MD; Albert D; Renold F. Treatment of arthritis with topical capsaicin: a double-blind trial. Clinical therapeutics. (1991) 13 3 pp383-395', '10.1001/archinte.1991.00400110079017', '']\n",
      "['9262930', 'Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R; Marcolengo R. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis. Italian journal of gastroenterology. (1991) 23 3 pp119-123', '10.1016/0016-5085(91)90044-l', '']\n",
      "['9262931', \"Rhodus NL; Schuh MJ. Effects of pilocarpine on salivary flow in patients with Sj√∂gren's syndrome. Oral surgery, oral medicine, and oral pathology. (1991) 72 5 pp545-549\", '10.1016/0030-4220(91)90491-t', '']\n",
      "['9262932', 'Lemmel EM; Gaus W; Hofschneider PH. Multicenter double-blind trial of interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (1991) 34 12 pp1621-1622', '10.1002/art.23361', '']\n",
      "['9262935', 'Schattenkirchner M. Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis. Current medical research and opinion. (1991) 12 8 pp497-506', '10.1185/03007999109111660', '']\n",
      "['9262936', 'Corkill MM; Kirkham BW; Haskard DO; Barbatis C; Gibson T; Panayi GS. Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. Journal of rheumatology. (1991) 18 10 pp1453-1460', '10.1093/rheumatology/30.6.459', 'http://academic.oup.com/rheumatology/article-pdf/30/6/459/5030408/30-6-459.pdf']\n",
      "['9262937', 'Kjeldsen-Kragh J; Haugen M; Ff√∏rre O. Diet therapy in rheumatoid arthritis. Lancet (London, England). (1992) 339 8787 pp250', '10.1016/0140-6736(92)90059-c', '']\n",
      "['9262938', \"Shiokawa Y; Nobunaga M; Saito T; Sakita T; Miwa T; Nakamura K; Gunji A; Aoki K. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--I. Evaluation of mucosal prophylactic effects by a placebo-controlled double blind comparative study]. RyuÃÑmachi. [Rheumatism]. (1991) 31 5 pp554-571\", '10.1136/gut.32.8.963-b', '']\n",
      "['9262939', 'Joyce DA; Will RK; Hoffman DM; Laing B; Blackbourn SJ. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Annals of the rheumatic diseases. (1991) 50 12 pp913-914', '10.1136/ard.50.12.913', '']\n",
      "['9262940', 'Lebel L; Gabrielsson J; Laurent TC; Gerdin B. Kinetics of circulating hyaluronan in humans. 4. European journal of clinical investigation. (1994) 24 9 pp621-626', '10.1111/j.1365-2362.1994.tb01114.x', '']\n",
      "['9262941', 'Owen SG; Francis HW; Roberts MS. Disappearance kinetics of solutes from synovial fluid after intra-articular injection. British journal of clinical pharmacology. (1994) 38 4 pp349-355', '10.1111/j.1365-2125.1994.tb04365.x', '']\n",
      "['9262942', 'Kjeldsen-Kragh J; Haugen M; Borchgrevink CF; F√∏rre O. Vegetarian diet for patients with rheumatoid arthritis--status: two years after introduction of the diet. Clinical rheumatology. (1994) 13 3 pp475-482', '10.1007/bf02242946', 'http://link.springer.com/article/10.1007/BF02242946/fulltext.html']\n",
      "['9262943', 'Ekdahl C; Ekman R; Petersson I; Svensson B. Dynamic training and circulating neuropeptides in patients with rheumatoid arthritis: a comparative study with healthy subjects. International journal of clinical pharmacology research. (1994) 14 2 pp65-74', '10.1016/0304-3959(92)90188-h', '']\n",
      "['9262944', 'Pettersson T; S√∂derblom T; Nyberg P; Riska H; Linko L; Klockars M. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus. Journal of rheumatology. (1994) 21 10 pp1820-1824', '10.1378/chest.86.2.273-a', '']\n",
      "['9262945', 'Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. Journal of rheumatology. (1994) 21 10 pp1922-1926', '10.3109/03009749609103760', '']\n",
      "['9262946', 'Pirisi M; Scott C; Fabris C; Ferraccioli G; Soardo G; Ricci R; Toniutto P; Avellini C; Vitulli D; Miotti AM. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scandinavian journal of gastroenterology. (1994) 29 10 pp940-942', '10.3109/00365529409094867', '']\n",
      "['9262947', 'Anderson KO; Bradley LA; Turner RA; Agudelo CA; Pisko EJ. Pain behavior of rheumatoid arthritis patients enrolled in experimental drug trials. Arthritis care and research. (1994) 7 2 pp64-68', '10.1002/art.1790070204', '']\n",
      "['9262948', 'Meyer CL; Hawley DJ. Characteristics of participants in water exercise programs compared to patients seen in a rheumatic disease clinic. Arthritis care and research. (1994) 7 2 pp85-89', '10.1002/art.1790070207', '']\n",
      "['9262950', 'Murphy EA; Bell AL; Wojtulewski J; Brzeski M; Madhok R; Capell HA. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ (Clinical research ed.). (1994) 309 6965 pp1337-1338', '10.1136/bmj.309.6965.1337', '']\n",
      "['9262951', 'Eggelmeijer F; Papapoulos SE; van Paassen HC; Dijkmans BA; Breedveld FC. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. Journal of rheumatology. (1994) 21 11 pp2016-2020', '10.1002/art.1780390307', '']\n",
      "['9262953', 'Ferry JJ; Della-Coletta AA; Weber DJ; VanderLugt JT. Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers. Journal of clinical pharmacology. (1994) 34 11 pp1109-1115', '10.1002/j.1552-4604.1994.tb01988.x', '']\n",
      "['9262954', 'Geissner E; Jungnitsch G; Schmitz J. Psychological treatment approaches in pain. A comparative study of therapies in patients with chronic polyarthritis. Zeitschrift fuÃàr klinische Psychologie, Psychopathologie und Psychotherapie / im Auftrag der GoÃàrres-Gesellschaft. (1994) 42 4 pp319-338', '10.1026/1616-3443/a000220', '']\n",
      "['9262955', 'van Schaardenburg D; Valkema R; Dijkmans BA; Papapoulos S; Zwinderman AH; Han KH; Pauwels EK; Breedveld FC. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis and rheumatism. (1995) 38 3 pp334-342', '10.1002/art.1780380307', '']\n",
      "['9262956', 'Fernandes L; Jenkins R. Investigation into the duration of action of sustained-release ibuprofen in osteoarthritis and rheumatoid arthritis. Current medical research and opinion. (1994) 13 4 pp242-250', '10.1185/03007999409110489', '']\n",
      "['9262957', 'Kerstens PJ; Boerbooms AM; Jeurissen ME; Westgeest TA; Van Erp A; Mulder J; van de Putte LB. Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Journal of rheumatology. (1994) 21 12 pp2190-2194', '10.1007/bf02204463', 'http://link.springer.com/article/10.1007/BF02204463/fulltext.html']\n",
      "['9262958', 'van der Heide A; Jacobs JW; Schenk Y; Bijlsma JW. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis. Journal of rheumatology. (1994) 21 12 pp2195-2199', '10.1016/0049-0172(92)90022-6', '']\n",
      "['9262959', 'De Graaf TW; Van Ommen EC; Van der Stelt ME; Kerstens PJ; Boerbooms AM; Van Dijk W. Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study. Journal of rheumatology. (1994) 21 12 pp2209-2216', '10.1016/s0049-0172(95)80009-3', '']\n",
      "['9262960', 'Silverman ED; Cawkwell GD; Lovell DJ; Laxer RM; Lehman TJ; Passo MH; Zemel LS; Giannini EH. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. Journal of rheumatology. (1994) 21 12 pp2353-2358', '10.1016/s0950-3579(98)80018-6', '']\n",
      "['9262961', 'Kalla AA; Smith PR; Brown GM; Meyers OL; Chalton D. Responsiveness of Keitel functional index compared with laboratory measures of disease activity in rheumatoid arthritis. British journal of rheumatology. (1995) 34 2 pp141-149', '10.1093/rheumatology/34.2.141', 'http://academic.oup.com/rheumatology/article-pdf/34/2/141/5034710/34-2-141.pdf']\n",
      "['9262962', 'Sukenik S; Neumann L; Flusser D; Kleiner-Baumgarten A; Buskila D. Balneotherapy for rheumatoid arthritis at the Dead Sea. Israel journal of medical sciences. (1995) 31 4 pp210-214', '10.1136/ard.49.2.99', '']\n",
      "['9262963', 'Kavanaghi R; Workman E; Nash P; Smith M; Hazleman BL; Hunter JO. The effects of elemental diet and subsequent food reintroduction on rheumatoid arthritis. British journal of rheumatology. (1995) 34 3 pp270-273', '10.1093/rheumatology/34.3.270', 'http://academic.oup.com/rheumatology/article-pdf/34/3/270/5043131/34-3-270.pdf']\n",
      "['9262964', 'Agrawal NM; Van Kerckhove HE; Erhardt LJ; Geis GS. Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study. Digestive diseases and sciences. (1995) 40 5 pp1125-1131', '10.1007/bf02064210', 'http://link.springer.com/article/10.1007/BF02064210/fulltext.html']\n",
      "['9262965', 'van den Borne BE; Landew√© RB; Goei The HS; Mattie H; Breedveld FC; Dijkmans BA. Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis. British journal of clinical pharmacology. (1995) 39 2 pp172-175', '10.1111/j.1365-2125.1995.tb04425.x', '']\n",
      "['9262966', 'de Queiroz MV; Beaulieu A; Kruger K; Woods E; Stead H; Geis S. Double-blind comparison of the efficacy of diclofenac/misoprostol and diclofenac in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1994) 14 2 pp5-13', '10.3109/03009749209095074', '']\n",
      "['9262967', 'Kjeldsen-Kragh J; Mellbye OJ; Haugen M; Mollnes TE; Hammer HB; Sioud M; F√∏rre O. Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet. Scandinavian journal of rheumatology. (1995) 24 2 pp85-93', '10.3109/03009749509099290', '']\n",
      "['9262969', 'Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. Journal of rheumatology. (1997) 24 8 pp1489-1494', '10.7326/0003-4819-125-12-199612150-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-125-12-199612150-00004']\n",
      "['9262970', 'Nordstr√∂m D; Lindroth Y; Marsal L; Hafstr√∂m I; Henrich C; Rantap√§√§-Dahlqvist S; Engstr√∂m-Laurent A; Fyhrquist F; Friman C. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatology international. (1997) 17 2 pp67-73', '10.1007/s002960050011', 'http://link.springer.com/article/10.1007/s002960050011/fulltext.html']\n",
      "['9262971', 'Johannsen F; Brodin U; Emmertsen H; Hansen TM; Faarvang KL; Bugge P; Nielsen GL; Jensen OH; Beyer J; Danneskiold-Sams‚àö‚àèe B; Jarner D; Arfeldt E; Krohn L; Nielsen H; Nielsen SE. A stepwise increased dose of auranofin does not influence gastrointestinal side-effects. Clinical and experimental rheumatology. (1997) 15 4 pp454-455', '10.3109/03009749709065709', '']\n",
      "['9262972', 'Dezube BJ; Lederman MM; Chapman B; Georges DL; Dogon AL; Mudido P; Reis-Lishing J; Cheng SL; Silberman SL; Crumpacker CS. The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels. Journal of infectious diseases. (1997) 176 3 pp807-810', '10.1086/517308', 'http://academic.oup.com/jid/article-pdf/176/3/807/2588670/176-3-807.pdf']\n",
      "['9262974', 'Riemsma RP; Taal E; Brus HL; Rasker JJ; Wiegman O. Coordinated individual education with an arthritis passport for patients with rheumatoid arthritis. Arthritis care and research. (1997) 10 4 pp238-249', '10.1002/art.1790100405', '']\n",
      "['9262975', 'Fransen M; Edmonds J. Off-the-shelf orthopedic footwear for people with rheumatoid arthritis. Arthritis care and research. (1997) 10 4 pp250-256', '10.1002/art.1790100406', '']\n",
      "['9262976', 'Morgan SL; Anderson AM; Hood SM; Matthews PA; Lee JY; Alarc√≥n GS. Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis. Arthritis care and research. (1997) 10 1 pp9-17', '10.1002/art.1790100103', '']\n",
      "['9262977', \"Smarr KL; Parker JC; Wright GE; Stucky-Ropp RC; Buckelew SP; Hoffman RW; O'Sullivan FX; Hewett JE. The importance of enhancing self-efficacy in rheumatoid arthritis. Arthritis care and research. (1997) 10 1 pp18-26\", '10.1002/art.1790100104', '']\n",
      "['9262979', 'Clegg DO; Dietz F; Duffy J; Willkens RF; Hurd E; Germain BF; Wall B; Wallace DJ; Bell CL; Sleckman J. Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine. Journal of rheumatology. (1997) 24 10 pp1896-1902', '10.3109/03009749609082662', '']\n",
      "['9262980', 'Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarc√≥n GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. Journal of rheumatology. (1997) 24 10 pp1910-1915', '10.1002/art.1780400305', '']\n",
      "['9262982', 'van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couv√©e JE. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group. Clinical rheumatology. (1997) 16 5 pp471-476', '10.1007/bf02238940', 'http://link.springer.com/article/10.1007/BF02238940/fulltext.html']\n",
      "['9262983', 'G√∂bel D; Gratz S; von Rothkirch T; Becker W; Willert HG. Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a prospective study of three treatment regimens. Rheumatology international. (1997) 17 3 pp105-108', '10.1007/s002960050017', 'http://link.springer.com/article/10.1007/s002960050017/fulltext.html']\n",
      "['9262984', 'Davis D; Charles PJ; Potter A; Feldmann M; Maini RN; Elliott MJ. Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade. British journal of rheumatology. (1997) 36 9 pp950-956', '10.1093/rheumatology/36.9.950', 'http://academic.oup.com/rheumatology/article-pdf/36/9/950/18105682/360950.pdf']\n",
      "['9262985', 'Goodnough LT; Marcus RE. The erythropoietic response to erythropoietin in patients with rheumatoid arthritis. Journal of laboratory and clinical medicine. (1997) 130 4 pp381-386', '10.1016/s0022-2143(97)90037-8', '']\n",
      "['9262986', 'Brus HL; Taal E; van de Laar MA; Rasker JJ; Wiegman O. Patient education and disease activity: a study among rheumatoid arthritis patients. Arthritis care and research. (1997) 10 5 pp320-324', '10.1002/art.1790100506', '']\n",
      "['9262987', 'Lindroth Y; Brattstr√∂m M; Bellman I; Ekestaf G; Olofsson Y; Str√∂mbeck B; Stenshed B; Wikstr√∂m I; Nilsson JA; Wollheim FA. A problem-based education program for patients with rheumatoid arthritis: evaluation after three and twelve months. Arthritis care and research. (1997) 10 5 pp325-332', '10.1002/art.1790100507', '']\n",
      "['9262988', 'Mathies H. [Randomization in clinical studies--empirically founded or only a dogma?]. Der Internist. (1997) 38 10 pp1008', '10.1007/s001080050113', 'http://link.springer.com/article/10.1007/s001080050113/fulltext.html']\n",
      "['9262989', 'Walker JS; Sheather-Reid RB; Carmody JJ; Vial JH; Day RO. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of \"responders\" and \"nonresponders\". Arthritis and rheumatism. (1997) 40 11 pp1944-1954', '10.1002/art.1780401105', '']\n",
      "['9262990', 'Priolo F; Bacarini L; Cammisa M; Cerase A; Ferrara R; Della Casa-Alberighi O. Radiographic changes in the feet of patients with early rheumatoid arthritis. GRISAR (Gruppo Reumatologi Italiani Studio Artrite Reumatoide). Journal of rheumatology. (1997) 24 11 pp2113-2118', '10.1093/rheumatology/35.suppl_2.8', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_2/8/5043314/35-suppl_2-8.pdf']\n",
      "['9262991', 'Hunt PG; Rose CD; McIlvain-Simpson G; Tejani S. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. Journal of rheumatology. (1997) 24 11 pp2230-2232', '10.2165/00128413-200515180-00028', '']\n",
      "['9262992', 'H√§kkinen A; M√§lki√§ E; H√§kkinen K; J√§ppinen I; Laitinen L; Hannonen P. Effects of detraining subsequent to strength training on neuromuscular function in patients with inflammatory arthritis. British journal of rheumatology. (1997) 36 10 pp1075-1081', '10.1093/rheumatology/36.10.1075', 'http://academic.oup.com/rheumatology/article-pdf/36/10/1075/18104836/361075.pdf']\n",
      "['9262994', 'Field T; Hernandez-Reif M; Seligman S; Krasnegor J; Sunshine W; Rivas-Chacon R; Schanberg S; Kuhn C. Juvenile rheumatoid arthritis: benefits from massage therapy. Journal of pediatric psychology. (1997) 22 5 pp607-617', '10.1093/jpepsy/22.5.607', 'http://academic.oup.com/jpepsy/article-pdf/22/5/607/2692527/22-5-607.pdf']\n",
      "['9262995', 'Schirmer M; Mur E; Pfeiffer KP; Thaler J; Konwalinka G. The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial. Scandinavian journal of rheumatology. (1997) 26 5 pp376-379', '10.3109/03009749709065702', '']\n",
      "['9262996', 'Adachi JD; Bell MJ; Bensen WG; Bianchi F; Cividino A; Sebaldt RJ; Gordon M; Ioannidis G; Goldsmith C. Fluoride therapy in prevention of rheumatoid arthritis induced bone loss. Journal of rheumatology. (1997) 24 12 pp2308-2313', '10.1093/rheumatology/36.2.255', 'http://academic.oup.com/rheumatology/article-pdf/36/2/255/9930349/360255.pdf']\n",
      "['9262997', 'Zuo X; Duan L; Cao Z; Wen B; Yuan X. A clinical study on rheumatoid arthritis treated by Cu.Zn-SOD. Bulletin of Hunan Medical University. (1995) 20 3 pp275-277', '10.2210/pdb2z7w/pdb', '']\n",
      "['9262998', \"Li M; Zhang G; Zhang J. Study on the treatment of rheumatoid arthritis with rheumanin compound. J. XI'AN MED. UNIV. CHIN. ED.. (1994) 15 1 pp79-83\", '10.1186/s13020-023-00750-8', 'https://link.springer.com/article/10.1186/s13020-023-00750-8/fulltext.html']\n",
      "['9262999', 'Iwegbu CG; Patel RJ; McLeod P; Helal B. A double-blind comparison of piroxicam mane with piroxicam nocte in patients awaiting hip and/or knee joint replacement. EUR. J. RHEUMATOL. INFLAM.. (1981) 4 3 pp342-347', '10.1111/j.1742-1241.1981.tb08216.x', '']\n",
      "['9263000', 'Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: A relatively bone-sparing effect of deflazacort. British journal of rheumatology. (1993) 32 SUPPL. 2 pp31-38', '10.1093/rheumatology/32.suppl_2.31', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_2/31/5041428/32-suppl_2-31.pdf']\n",
      "['9263001', 'Emery P; Clarke A; Williams P; Kill D; Cree F; Redhead R; Poland M. Erratum: Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: A multicenter, double blind, randomized, parallel group trial in hospital outpatients (J Rheumatol 1992; 19:41-47). Journal of rheumatology. (1993) 20 5 pp924', '10.3109/03009747809095673', '']\n",
      "['9263002', 'Watkins B; Darrah J; Pain K. Reliability of passive ankle dorsiflexion measurements in children: Comparison of universal and biplane goniometers. Pediatric physical therapy. (1995) 7 1 pp3-8', '10.1097/00001577-199507010-00002', '']\n",
      "['9263003', 'Jalava S; Skinhoj A; Andersen F. Indomethacin treatment and rheumatoid arthritis: A comparative study of two dose regimens. CURR. THER. RES., CLIN. EXP.. (1989) 45 6 pp962-966', '10.1136/ard.48.7.542', '']\n",
      "['9263004', 'Porzio F; Schattenkirchner M. Double-blind comparison of etodolac sustained-release tablets and diclofenac sustained-release tablets in patients with rheumatoid arthritis. CURR. THER. RES. CLIN. EXP.. (1993) 53 2 pp144-153', '10.1016/s0011-393x(05)80239-5', '']\n",
      "['9263005', 'Auteri A; Pasqui AL; Bruni F; Di RM; Bova G; Saletti M; Campoccia G; Fanetti G. Effect of a long-term treatment with two different corticosteroids on patients suffering from rheumatoid arthritis: Clinical and immunological study. INT. J. IMMUNOTHER.. (1994) 10 2 pp67-75', '10.1016/1043-6618(92)90662-u', '']\n",
      "['9263006', 'Jacob G; Sanda M; Mullane J; et al. Long-term evaluation of the efficacy and safety of etodolac in the treatment of rheumatoid arthritis. ADV. THER.. (1985) 2 3 pp82-95', '10.1186/ar3719', 'http://link.springer.com/article/10.1186/ar3719/fulltext.html']\n",
      "['9263007', 'Simon LS; Robinson DR; Basch C. Naproxen levels in plasma and synovial fluid of patients with rheumatoid arthritis. CLIN. THER.. (1991) 13 SUPPL. A pp35-43', '10.1021/acs.jproteome.6b00386.s003', '']\n",
      "['9263008', 'Graziano FM. Once-daily or twice-daily administration of naproxen in patients with rheumatoid arthritis. CLIN. THER.. (1991) 13 SUPPL. A pp20-25', '10.2165/00128413-199107980-00041', '']\n",
      "['9263009', 'Miyagi K. Double blind comparative study on the effect of low energy laser irradiation to rheumatoid arthritis. J. JPN. ASSOC. PHYS. MED. BALNEOL. CLIMATOL.. (1989) 52 3 pp117-126', '10.1007/978-3-642-60306-8_106', 'http://link.springer.com/content/pdf/10.1007/978-3-642-60306-8_106.pdf']\n",
      "['9263010', 'Accardo S; Seriolo B; Samanta E; Cutolo M. Controlled-release naproxen in rheumatoid arthritis. CURR. THER. RES. CLIN. EXP.. (1991) 49 6 pp936-942', '10.1136/ard.53.8.550-a', '']\n",
      "['9263011', 'Jacob G; Messina M; Caperton E; et al. Safety and efficacy of etodolac, once or twice a day, in the treatment of active rheumatoid arthritis. CURR. THER. RES., CLIN. EXP.. (1985) 37 6 pp1124-1129', '10.1007/bf03311745', 'http://link.springer.com/article/10.1007/BF03311745/fulltext.html']\n",
      "['9263012', 'Eberhardt R; Schurmann W. Treatment of patients with chronic rheumaoid arthritis with diclofenac. A cross-over-study of a new preparation versus a standard preparation.  BEHANDLUNG DER CHRONISCHEN POLYARTHRITIS MIT DICLOFENAC. CROSS-OVER-STUDIE MIT EINER NEUEN ZUBEREITUNGSFORM IM VERGLEICH MIT DER STANDARDPRAPARATION. Fortschritte der Medizin. (1985) 103 11 pp305-308', '10.1007/978-3-642-85316-6_79', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_79.pdf']\n",
      "['9263013', 'Lindroth Y; Bauman A; Barnes C; McCredie M; Brooks PM. A controlled evaluation of arthritis education. British journal of rheumatology. (1989) 28 1 pp7-12', '10.1093/rheumatology/28.1.7', 'http://academic.oup.com/rheumatology/article-pdf/28/1/7/5028899/28-1-7.pdf']\n",
      "['9263014', 'Camarri E; Chirone E; Benvenuti C. Double-blind placebo controlled cross-over study on cimetidine-prophylactic effect in patients under steroid treatment. Preliminary data. INT. J. CLIN. PHARMACOL. THER. TOXICOL.. (1980) 18 6 pp258-260', '10.1046/j.1365-2036.2003.01641.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01641.x']\n",
      "['9263015', 'Sollerman CJ; Geijer M. Polyurethane versus silicone for endoprosthetic of the metacarpophalangeal joints in rheumatoid arthritis. Scandinavian journal of plastic and reconstructive surgery and hand surgery. (1996) 30 2 pp145-150', '10.3109/02844319609056397', '']\n",
      "['9263016', 'Rejholec V; Vitulova V; Vachtenheim J. Preliminary observations from a double blind crossover study to evaluate the efficacy of flurbiprofen given at different times of day in the treatment of rheumatoid arthritis. ANNU REV CHRONOPHARMACOLOGY. (1984) 1  pp357-360', '10.1185/03007997709108981', '']\n",
      "['9263017', 'Karaoglan B; Erten A; Ayhan F; Dumlu S; Oguz A; Erdem R. The effects of etodolac on the clinical course and gastric mucosal PGE of knee osteoarthritis. Gazi Medical Journal. (1995) 6 4 pp169-172', '10.1016/0016-5085(95)23267-2', '']\n",
      "['9263018', \"Trang LE; Lovgren O; Bendz R; Mjos O. The effect of fasting on plasma cyclic adenosine-3',5'-monophosphate in rheumatoid arthritis. Scandinavian journal of rheumatology. (1980) 9 4 pp229-233\", '10.3109/03009748009112353', '']\n",
      "['9263019', 'Bird HA; Hill J; Lowe JR; Wright V. A double-blind comparison of tenoxicam (tolcotil, mobiflex) at two doses against ibuprofen in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1984) 7 2 pp28-32', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9263020', 'Raman D; Laycock T; Haslock I. Comparison of two indomethacin treatments as night medication in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1980) 3 3 pp194-198', '10.1093/rheumatology/16.2.125', 'http://academic.oup.com/rheumatology/article-pdf/16/2/125/5039069/16-2-125.pdf']\n",
      "['9263021', 'Marcolongo R; Giordano N; Fioravanti A; et al. Clinical pharmacology of a slow-release ketoprofen preparation: a double-blind, crossover comparison with plain ketoprofen in rheumatoid arthritis. CURR THER RES, CLIN EXP. (1984) 35 5 pp721-726', '10.1111/j.1440-1681.1986.tb00938.x', '']\n",
      "['9263022', 'Flavell-Matts SG; Ward PJ. A double blind comparison of meptazinal versus pentazocine in chronic rheumatoid and osteoarthritis. British journal of clinical practice. (1980) 34 10 pp286-289', '10.1111/j.1742-1241.1980.tb08186.x', '']\n",
      "['9263023', 'Wood ND; Aitken M; Durston S; Harris S; McClelland GR; Sharp S. Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis. Agents and Actions Supplements. (1997) 49 - pp49-55', '10.1007/978-3-0348-8857-8_8', 'http://link.springer.com/content/pdf/10.1007/978-3-0348-8857-8_8.pdf']\n",
      "['9263024', 'Weinberger A; Fischer D-G; Rubinstein M; et al. A crossover study comparing diflunisal to diclofenac sodium in rheumatoid arthritis. A correlation with serum interferon-like activity. RHUMATOLOGIE (PARIS). (1985) 15 4 NO. 79 pp215-219', '10.1016/s0049-0172(85)80015-9', '']\n",
      "['9263025', \"Carrabba M; Chevallard M; Angelini M; Montagnani G. Suprofen in rheumatoid arthritis: Double-blind crossover trial against naproxen.  IL SUPROFENE NELL'ARTRITE REUMATOIDE: INDAGINE IN DOPPIO CIECO CROSS-OVER CONTRO NAPROXENE SODICO. Reumatismo. (1986) 38 SUPPL. 1 pp41-47\", '10.4081/reumatismo.2002.238', '']\n",
      "['9263026', 'Domljan Z; Durrigl T. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1983) 6 3 pp291-296', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9263027', 'Huskisson EC; Greenwood A. Naproxen and piroxicam. A comparative trial in rheumatoid arthritis. EUR J RHEUMATOL INFLAM. (1983) 6 3 pp242-246', '10.1007/bf02041555', 'http://link.springer.com/article/10.1007/BF02041555/fulltext.html']\n",
      "['9263028', 'Williams HJ; Ward JR; Reading JC; et al. Low-dose D-penicillamine therapy in rheumatoid arthritis: A controlled, double-blind clinical trial. Arthritis and rheumatism. (1983) 26 5 pp581-592', '10.1002/art.1780260502', '']\n",
      "['9263029', 'Brown GL; Curtsinger L; Jurkiewicz MJ; Nahai F; Schultz G. Stimulation of healing of chronic wounds by epidermal growth factor. Plastic and reconstructive surgery. (1991) 88 2 pp189-196', '10.1097/00006534-199108000-00002', '']\n",
      "['9263030', 'Pavelka KSr; Peliskova Z; Pavelka KJr; Trnavsky K. Double-blind, treble crossover comparison of Czechoslovak piroxicam (Leciva) with three reference commercial brands of piroxicam of different provenance in therapy of rheumatoid arthritis. FARMAKOTER ZPR. (1989) 35 1 pp13-24', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9263031', 'Ejstrup L; Freisleben SS; Hellesen C; et al. Controlled release indomethacin (indotard(Reg.trademark)). Clinical trial in patients with rheumatoid athritis. Scandinavian journal of rheumatology. (1984) 13 2 pp147-150', '10.3109/03009748409100378', '']\n",
      "['9263032', 'Hill JC. Slow-release artificial tea inserts in the treatment of dry eyes in patients with rheumatoid arthritis. British journal of ophthalmology. (1989) 73 2 pp151-154', '10.1136/bjo.73.2.151', '']\n",
      "['9263033', 'Culic DD; Battaglia MC; Wichman C; Schmid FR. Efficacy of compression gloves in rheumatoid arthritis. American journal of physical medicine. (1979) 58 6 pp278-284', '10.1093/rheumatology/kev089.045', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i111/5180571/kev089.045.pdf']\n",
      "['9263034', 'McLachlan AJ; Tett SE; Cutler DJ; Day RO. Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate. Chirality. (1994) 6 4 pp360-364', '10.1002/chir.530060421', '']\n",
      "['9263035', 'Bullingham R; Shah J; Goldblum R; Schiff M. Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients. British journal of clinical pharmacology. (1996) 41 6 pp513-516', '10.1046/j.1365-2125.1996.03636.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.1996.03636.x']\n",
      "['9263036', 'Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. Journal of rheumatology. (1995) 22 6 pp1055-1059', '10.7326/0003-4819-125-12-199612150-00004', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-125-12-199612150-00004']\n",
      "['9263037', 'Reginster JY; Crommen J; Renson M; Franchimont P. Percutaneous administration of indomethacin in rheumatoid arthritis. Evaluation of two topical preparations. Current therapeutic research, clinical and experimental. (1990) 47 3 pp548-553', '10.1185/03007998709112412', '']\n",
      "['9263038', 'Fowler PD. A double-blind comparison of diclofenac sodium (Voltarol(Reg.trademark)) and placebo in inpatients with rheumatoid arthritis. Rheumatology and rehabilitation. (1979) 18 2 SUPPL. pp75-77', '10.1093/rheumatology/17.2.95', 'http://academic.oup.com/rheumatology/article-pdf/17/2/95/5027233/17-2-95.pdf']\n",
      "['9263039', \"Harrewyn JM; Amor B. A double-blind comparative study of slow-release ketoprofen and placebo in chronic inflammatory joint disease.  ETUDE COMPARATIVE A DOUBLE INSU DU KETOPROFENE A LIBERATION PROLONGEE ET D'UN PLACEBO DANS LES RHUMATISMES INFLAMMATOIRES CHRONIQUES. Semaine des hopitaux. (1983) 59 46 pp3225-3228\", '10.1016/j.monrhu.2022.07.004', '']\n",
      "['9263040', \"Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2 year double blind-placebo controlled study.  L'AURANOFINE AMELIORE LE DEVENIR DES MALADES ATTEINTS DE POLYARTHRITE RHUMATOIDE DEBUTANTE. RESULTATS A 2 ANS D'UNE ETUDE CONTROLEE EN DOUBLE AVEUGLE CONTRE PLACEBO. Rhumatologie. (1989) 41 8 pp33-45\", '10.3109/03009748909095027', '']\n",
      "['9263041', 'Bach GL; Stock K-P; Hudepohl M. Treatment of NSAID-induced gastrointestinal lesions with misoprostol.  DIE THERAPIE NSAR-INDUZIERTER GASTROINTESTINALER LASIONEN MIT MISOPROSTOL. Zeitschrift fur Rheumatologie. (1991) 50 3 pp175-180', '10.1055/s-2008-1047499', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047499.pdf']\n",
      "['9263042', \"Dougados M; Listrat V; Duchesne L; Amor B. Comparative study of the efficacy of ketoprofen according to the route of administration (intramuscular or oral). A double-blind, placebo-controlled study in patients with rheumatoid arthritis.  EFFICACITE COMPAREE DU KETOPROFENE EN FONCTION DE SA VOIE D'ADMINISTRATION (INTRA-MUSCULAIRE OU PER OS). UNE ETUDE EN DOUBLE AVEUGLE CONTRE PLACEBO AU COURS DE LA POLYARTHRITE RHUMATOIDE. REV RHUM MAL OSTEO-ARTICULAIRES. (1992) 59 11 pp769-773\", '10.1016/s0750-7658(05)81899-4', '']\n",
      "['9263043', 'Needs CJ; Smith M; Boutagy J; Donovan S; Cosh D; McCredie M; Brooks PM. Comparison of methylprednisolone (1 g IV) with prednisolone (1 g orally) in rheumatoid arthritis: A pharmacokinetic and clinical study. Journal of rheumatology. (1988) 15 2 pp224-228', '10.1136/ard.47.1.28', '']\n",
      "['9263044', 'Skoldstam L; Larsson L; Lindstrom FD. Effects of fasting and lactovegetarian diet on rheumatoid arthritis. Scandinavian journal of rheumatology. (1979) 8 4 pp249-255', '10.3109/03009747909114631', '']\n",
      "['9263045', 'Mavrikakis ME; Madkour MM; Spencer DM; Balint GP. Double-blind study comparing the therapeutic effect of a new non-steroidal anti-inflammatory drug, sulindac, with benorylate in tablet form in rheumatoid arthritis. Pharmatherapeutica. (1977) 1 10 pp681-685', '10.1093/rheumatology/32.11.982', 'http://academic.oup.com/rheumatology/article-pdf/32/11/982/5031010/32-11-982.pdf']\n",
      "['9263046', 'Dromgoole SH; Cassell S; Furst DE; Paulus HE. Availability of salicylate from salsalate and aspirin. Clinical pharmacology and therapeutics. (1983) 34 4 pp539-545', '10.1038/clpt.1983.211', '']\n",
      "['9263047', 'Ferraccioli GF; Salaffi F; Nervetti A; Manganelli P. Long-term outcome with gold thiosulphate and tiopronin in 200 rheumatoid patients. Clinical and experimental rheumatology. (1989) 7 6 pp577-581', '10.1016/s0140-6736(87)92399-3', '']\n",
      "['9263048', 'Puffer E. [Trafuril liniment as adjuvant of balneotherapy]. Wiener medizinische Wochenschrift (1946). (1968) 118 40 pp837-840', '10.1055/s-0028-1138239', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0028-1138239.pdf']\n",
      "['9263049', 'Rahlfs VW. Conventional statistics and useful statistics. Arzneimittel-Forschung. (1995) 45 2 pp205-210', '10.1016/0167-9473(95)90171-x', '']\n",
      "['9263050', 'Santavuori P; Moren R. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjogren type. Neuropadiatrie. (1977) 8 4 pp333-344', '10.1055/s-0028-1091529', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0028-1091529.pdf']\n",
      "['9263051', 'Siegmeth W; Herkner W. [Experiences with a new combination drug (Realin) in the treatment of acute rheumatic conditions]. Wiener medizinische Wochenschrift (1946). (1974) 124 39 pp569-573', '10.1046/j.1563-258x.2003.03037.x', '']\n",
      "['9263052', 'Lipsky PE; Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. Journal of rheumatology. Supplement. (1997) 49  pp9-14', '10.1093/rheumatology/36.suppl_1.143', 'http://academic.oup.com/rheumatology/article-pdf/36/Suppl_1/143/29225938/36-suppl_1-143.pdf']\n",
      "['9263053', 'Hansen G; Nielsen L; Kluger E; Thysen MH; Emmertsen H; Steng√•rd-Pedersen K; Lund EC; Unger B; Andersen PW. [Nutritional status of Danish patients with rheumatoid arthritis and effects of a diet adjusted in energy intake, fish content and antioxidants]. Ugeskrift for laeger. (1998) 160 21 pp3074-3078', '10.3109/03009749609104066', '']\n",
      "['9263054', 'Westhovens R; Verwilghen J; Dequeker J. Total lymphoid irradiation in rheumatoid arthritis. A ten-year followup. Arthritis and rheumatism. (1997) 40 3 pp426-429', '10.1002/art.1780400306', '']\n",
      "['9263055', 'Yocum DE. Combination therapy with cyclosporin in rheumatoid arthritis. British journal of rheumatology. (1996) 35 Suppl 2  pp19-23', '10.1093/rheumatology/35.suppl_2.19', 'http://academic.oup.com/rheumatology/article-pdf/35/suppl_2/19/5043144/35-suppl_2-19.pdf']\n",
      "['9263056', 'Bozsoky S; Zahumenszky Z. Protacine, a new nonsteroidal anti-inflammatory agent: Double-blind evaluation of its therapeutic potential. Clinical therapeutics. (1980) 2 6 pp409-420', '10.1007/bf03292247', 'http://link.springer.com/article/10.1007/BF03292247/fulltext.html']\n",
      "['9263057', 'Giuliano V; Scharff Jr EU. Clinical comparison of two salicylates in rheumatoid arthritis patients on maintenance gold therapy. Current therapeutic research, clinical and experimental. (1980) 28 1 pp61-71', '10.15688/jvolsu11.2015.2.13', '']\n",
      "['9263058', 'Heiter A; Tausch G; Eberl R. Comparison of acemetacin with indometacin in a controlled double-blind study on patients suffering from rheumatoid arthritis. Arzneimittel-Forschung. (1980) 30 8 A pp1427-1433', '10.1002/j.1552-4604.1980.tb02536.x', '']\n",
      "['9263059', 'Badia-Flores J; Munoz Barradas F. The treatment of rheumatoid arthritis with acemetacin and indometacin. Arzneimittel-Forschung. (1980) 30 8 A pp1433-1437', '10.1007/978-3-642-74386-3_3', 'http://link.springer.com/content/pdf/10.1007/978-3-642-74386-3_3.pdf']\n",
      "['9263060', 'Kronhagel R. Clinical results of a double-blind study with the new antirheumatic agent acemetacin. Arzneimittel-Forschung. (1980) 30 8 A pp1445-1448', '10.1007/978-3-642-74386-3_3', 'http://link.springer.com/content/pdf/10.1007/978-3-642-74386-3_3.pdf']\n",
      "['9263061', 'Bunchuk NV; Nasonova VA; Sigidin Ya A. Controlled (double blind) trial of levamisol in rheumatoid arthritis. Terapevticheskii arkhiv. (1980) 52 6 pp93-98', '10.1080/030097401316909530', '']\n",
      "['9263062', \"O'Laughlin JC; Silvoso GR; Ivey KJ. Effects of an H2-blocker on gastric ulcers in patients taking aspirin: A double-blind study. Gastroenterology. (1980) 78 5 II pp1230\", '10.1007/bf01391742', 'http://link.springer.com/article/10.1007/BF01391742/fulltext.html']\n",
      "['9263063', 'Pipino F; Franchin F. Double blind clinical study with a non-steroid anti-inflammatory drug: glucametacine. Minerva medica. (1980) 71 39 pp2845-2850', '10.1186/isrctn70915202', '']\n",
      "['9263064', \"Cadogan SJ; Tapper-Jones L; Aldred M; Huws D; et al. Double-blind clinical trial of Bromhexine in Sjogren's syndrome. Journal of dental research. (1980) 59 SPEC.1SS. DI pp1827\", '10.1136/bmj.280.6228.1356', '']\n",
      "['9263065', 'Katona G; Vargas RB. A new derivative of propionic acid, tiaprofenic acid, and its efficacy in the treatment of rheumatoid arthritis: Comparative study with ibuprofen. Current therapeutic research, clinical and experimental. (1981) 29 1 I pp1-11', '10.1093/rheumatology/20.3.181', 'http://academic.oup.com/rheumatology/article-pdf/20/3/181/5026952/20-3-181.pdf']\n",
      "['9263066', 'Trnavsky K; Zbojanova M; Bosmansky K. Diflunisal in rheumatoid arthritis. A double-blind therapeutical study report. Casopis lekaru ceskych. (1981) 120 19 pp582-585', '10.1001/jama.1964.03070100135060', '']\n",
      "['9263067', 'Siro B. Comparative study of the clinical effect of indomethacin and indomethacin-sodium salicylate combination. Multicentric, double-blind study. Magyar Reumatologia. (1981) 22 Suppl. pp35-39', '10.1016/b978-0-08-023768-8.51735-7', '']\n",
      "['9263068', 'Levernieux J. Comparative double-blind trial of diflunisal and acetylsalicylic acid in rheumatological practice. Rhumatologie - Revue International de Rhumatologie. (1981) 11 Conf. pp41-44', '10.1016/j.rhum.2006.10.233', '']\n",
      "['9263069', 'Templeton JS. Azapropazone - twice or four times daily?. European journal of rheumatology and inflammation. (1981) 4 3 pp401-407', '10.1093/rheumatology/17.4.219', 'http://academic.oup.com/rheumatology/article-pdf/17/4/219/5035571/17-4-219.pdf']\n",
      "['9263070', 'Nienhuis RLF. A double-blind clinical trial with D-penicillamine in patients with rheumatoid arthritis. Acta therapeutica. (1981) 7 4 pp323-334', '10.1002/art.1780241204', '']\n",
      "['9263071', 'Katona G; Burgos Vargas R. A comparative study of two different doses of thiaprofenic acid in the treatment of rheumatoid arthritis. Investigacion medica internacional. (1981) 8 4 pp303-308', '10.1385/1-59259-239-2:389', '']\n",
      "['9263072', 'Siegmund H; Schneider B. Results of a double blind comparison of indometacin and indoprofen, a new nonsteroid antirheumatic agent. Die Therapiewoche. (1981) 31 41 pp6642-6651', '10.1097/00003226-198605010-00009', '']\n",
      "['9263073', 'Mizushima Y; Shiokawa Y; Honma M; Kageyama T. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. International journal of tissue reactions. (1983) 5 1 pp35-39', '10.1007/bf03303467', 'http://link.springer.com/article/10.1007/BF03303467/fulltext.html']\n",
      "['9263074', 'Khan FM. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis. Clinical therapeutics. (1983) 5 5 pp483-487', '10.1016/j.clinthera.2006.01.016', '']\n",
      "['9263075', 'Lavalle C; Moreno J; Miranda JM; Bravo G. Naproxen in rheumatoid arthritis. Cross double blind study with three therapeutic schemes. Compendium de Investigaciones Clinicas Latinoamericanas. (1983) 3 1 pp36-40', '10.3109/03009747309097118', '']\n",
      "['9263076', 'Garcia Rafanell J. Delmetacin. Drugs of the future. (1983) 8 9 pp764-766', '10.1358/dof.1983.008.09.71726', '']\n",
      "['9263077', 'Humberto Lizarazo P; Pena Cortes M. Single-blind parallel study comparing naproxen with sulindac and with diclofenac in rheumatoid arthritis. Current therapeutic research, clinical and experimental. (1983) 34 4 II pp701-707', '10.1016/s0011-393x(05)80239-5', '']\n",
      "['9263078', 'Grosse Kielisch Chr; Bach GL. Therapy of rheumatoid arthritis. Double-blind study with proglumetacine vs. diclofenac. Munchener medizinische Wochenschrift (1950). (1983) 125 47 pp1105-1106', '10.4081/reumatismo.2002.238', '']\n",
      "['9263079', 'Simon F. Double-blind comparison of acetylsalicylic acid alone and plus ascorbic acid and glucuronamide for analgesic effect in patients with chronic rheumatic disease. Gazette Medicale. (1984) 91 2 pp77-79', '10.1016/0304-3959(89)90021-3', '']\n",
      "['9263080', 'Hoshi K. Clinical effect of halopredone acetate for intra-articular steroid in rheumatoid arthritis. A controlled double blind test. Therapeutic Research. (1984) 1 3 pp493-499', '10.2492/jsir1981.3.28', '']\n",
      "['9263081', 'Kolarz G; Mayrhofer F; Singer F; et al. Short-term treatment of rheumatoid arthritis with parenteral dexindoprofen. A multicentre double blind controlled study with indomethacin. Current therapeutic research, clinical and experimental. (1984) 36 6 pp1210-1220', '10.1111/j.1742-1241.1981.tb08214.x', '']\n",
      "['9263082', 'Urbanova Z; Gatterova J; Olejarova M; Pavelka K. Radiosynoviorthesis with 90Y - Results of a clinical study. Ceska Revmatologie. (1997) 5 3 pp140-142', '10.1136/annrheumdis-2001.419', '']\n",
      "['9263084', 'Deicher H; Fricke R. [Studies on therapy of rheumatoid arthritis (progressive chronic polyarthritis) with cytostatic drugs]. Zeitschrift fuÃàr Rheumaforschung. (1969) 28 1 pp20-29', '10.1136/ard.28.5.488', '']\n",
      "['9263085', 'Dixon A. A double-blind, crossover comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis. Aktuelle Rheumatologie. (1980) 5 Suppl SPEC. ISS.1 pp19-28', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9263086', 'Havelka S; Pƒïgr√≠mov√° E; Trnavsk√Ω K; Slav√≠k M; Elis J. [6-azauridine-triacetate in the therapy of chronic polyarthritis]. Zeitschrift fuÃàr Rheumaforschung. (1969) 28 1 pp29-35', '10.1016/0006-2952(69)90171-3', '']\n",
      "['9263087', 'van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and rheumatism. (2001) 44 11 pp2525-2530', '10.1002/1529-0131(200111)44:11<2525::aid-art432>3.0.co;2-b', '']\n",
      "['9263089', 'Bechtold S; Ripperger P; M√ºhlbayer D; Truckenbrodt H; H√§fner R; Butenandt O; Schwarz HP. GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone. Journal of clinical endocrinology and metabolism. (2001) 86 12 pp5737-5744', '10.1210/jcem.86.12.8083', 'http://academic.oup.com/jcem/article-pdf/86/12/5737/9169330/jcem5737.pdf']\n",
      "['9263090', 'Hidaka T; Suzuki K; Kawakami M; Okada M; Kataharada K; Shinohara T; Takamizawa-Matsumoto M; Ohsuzu F. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Journal of clinical apheresis. (2001) 16 2 pp74-81', '10.1002/jca.1016', '']\n",
      "['9263091', 'Sharpe L; Sensky T; Allard S. The course of depression in recent onset rheumatoid arthritis: the predictive role of disability, illness perceptions, pain and coping. Journal of psychosomatic research. (2001) 51 6 pp713-719', '10.1016/s0022-3999(01)00266-5', '']\n",
      "['9263092', 'de Nijs RN; Jacobs JW; Bijlsma JW; Lems WF; Laan RF; Houben HH; ter Borg EJ; Huisman AM; Bruyn GA; van Oijen PL; Westgeest AA; Algra A; Hofman DM; Osteoporosis Working Group, Dutch Society for Rheumaology. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2001) 40 12 pp1375-1383', '10.1093/rheumatology/40.12.1375', 'http://academic.oup.com/rheumatology/article-pdf/40/12/1375/9532976/401375.pdf']\n",
      "['9263093', 'van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Annals of internal medicine. (2002) 136 1 pp1-12', '10.7326/0003-4819-136-1-200201010-00006', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-136-1-200201010-00006']\n",
      "['9263094', 'Anonymous. Summaries for patients. Prednisone for rheumatoid arthritis. Annals of internal medicine. (2002) 136 1 ppI-26', '10.7326/0003-4819-136-1-200201010-00002', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-136-1-200201010-00002']\n",
      "['9263095', \"Johansson G; Andersson G; Edwardsson S; Bj√∂rn AL; Manthorpe R; Attstr√∂m R. Effects of mouthrinses with linseed extract Salinum without/with chlorhexidine on oral conditions in patients with Sj√∂gren's syndrome. A double-blind crossover investigation. Gerodontology. (2001) 18 2 pp87-94\", '10.1111/j.1741-2358.2001.00087.x', '']\n",
      "['9263096', 'Rabeneck L; Wristers K; Goldstein JL; Eisen G; Dedhiya SD; Burke TA. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. American journal of gastroenterology. (2002) 97 1 pp32-39', '10.1111/j.1572-0241.2002.05419.x', '']\n",
      "['9263099', 'White WB; Faich G; Whelton A; Maurath C; Ridge NJ; Verburg KM; Geis GS; Lefkowith JB. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. American journal of cardiology. (2002) 89 4 pp425-430', '10.1016/s0002-9149(01)02265-2', '']\n",
      "['9263102', 'Bearne LM; Scott DL; Hurley MV. Exercise can reverse quadriceps sensorimotor dysfunction that is associated with rheumatoid arthritis without exacerbating disease activity. Rheumatology (Oxford, England). (2002) 41 2 pp157-166', '10.1093/rheumatology/41.2.157', 'http://academic.oup.com/rheumatology/article-pdf/41/2/157/18095558/410157.pdf']\n",
      "['9263104', 'Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2002) 46 3 pp614-624', '10.1002/art.10141', '']\n",
      "['9263105', \"Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sj√∂gren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis and rheumatism. (2002) 46 3 pp748-754\", '10.1002/art.510', '']\n",
      "['9263106', 'Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis. Arthritis and rheumatism. (2002) 47 1 pp59-66', '10.1002/art1.10245', '']\n",
      "['9263110', 'Yurtkuran M; Yurtkuran MA; Dilek K; Gullulu M; Karakoc Y; Ozbek L; Bingol U. A randomized, controlled study of balneotherapy in patients with rheumatoid arthritis. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. (1999) 9 3 pp92-96', '10.1055/s-2008-1061791', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1061791.pdf']\n",
      "['9263111', 'Weaver A; Chatwell R; Churchill M; Kastanek L; Beyene J; Garceau R; Docsa S; Diani A. Improved gastrointestinal tolerance and patient preference of enteric- coated sulfasalazine versus uncoated sulfasalazine tablets in patients with rheumatoid arthritis. Journal of clinical rheumatology. (1999) 5 4 pp193-200', '10.1097/00124743-199908000-00003', '']\n",
      "['9263112', 'Carneiro JRM; Sato EI. Randomized double-blind clinical study with methotrexate in systemic lupus erythematosus. [Portuguese]. Revista brasileira de reumatologia. (1999) 39 4 pp203-210', '10.1016/j.rbre.2016.01.002', '']\n",
      "['9263113', \"Pedersen A; Gerner N; Palmvang I; Hoier-Madsen M. LongoVital in the treatment of Sjogren's syndrome. Clinical and experimental rheumatology. (1999) 17 5 pp533-538\", '10.1007/pl00006844', 'http://link.springer.com/article/10.1007/PL00006844/fulltext.html']\n",
      "['9263114', 'Glowinski J; Boccard E. Placebo-controlled study of the analgesic efficacy of a paracetamol 500 mg/Codeine 30 mg combination together with low-dose vs high-dose diclofenac in rheumatoid arthritis. Clinical drug investigation. (1999) 18 3 pp189-197', '10.2165/00044011-199918030-00003', '']\n",
      "['9263116', 'Wong AL; Wong WK; Harker J; Sterz M; Bulpitt K; Park G; Ramos B; Clements P; Paulus H. Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Journal of rheumatology. (1999) 26 12 pp2551-2561', '10.1002/art.1790090607', '']\n",
      "['9263118', 'Berliner M and Piegsa M. Effects of therapeutic ultrasound in a water bath on skin microcirculation and skin temperature in rheumatoid arthritis. Eur journal phys med rehabilation. (1997) 7 2 pp46-49', '10.1006/mvre.1997.2025', '']\n",
      "['9263119', 'Lorig KR; Mazonson PD; Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis and rheumatism. (1993) 36 4 pp439-446', '10.1002/art.1780360403', '']\n",
      "['9263120', 'Mainardi CL; Walter JM; Spiegel PK; Goldkamp OG and Harris ED. Rheumatoid arthritis: failure of daily heat therapy to affect its progression. Archives Physical Medicine Rehabilitation. (1979) 60 9 pp390-393', '10.1016/s0003-9993(95)80029-8', '']\n",
      "['9263121', 'Verhoeven AC; Boers M; van der Liden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis. Journal of rheumatology. (2000) 27 12 pp2801-2809', '10.1007/978-3-211-79280-3_701', 'http://link.springer.com/content/pdf/10.1007/978-3-211-79280-3_701.pdf']\n",
      "['9263122', 'Sainz De La Maza Serra M null; Sim√≥n Castellvi C null; Kabbani O. [Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca]. Archivos de la Sociedad EspanÃÉola de OftalmologiÃÅa. (2000) 75 11 pp751-756', '10.1016/j.oftal.2024.04.014', '']\n",
      "['9263123', 'Tuleja E; Mejza F; Cmiel A; Szczeklik A. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men. Arteriosclerosis, thrombosis, and vascular biology. (2003) 23 6 pp1111-1115', '10.1161/01.atv.0000074879.19006.51', '']\n",
      "['9263125', 'Foell D; Kane D; Bresnihan B; Vogl T; Nacken W; Sorg C; Fitzgerald O; Roth J. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford, England). (2003) 42 11 pp1383-1389', '10.1093/rheumatology/keg385', 'http://academic.oup.com/rheumatology/article-pdf/42/11/1383/5059062/keg385.pdf']\n",
      "['9263126', 'Takken T; Van Der Net J; Kuis W; Helders PJ. Aquatic fitness training for children with juvenile idiopathic arthritis. Rheumatology (Oxford, England). (2003) 42 11 pp1408-1414', '10.1093/rheumatology/keg386', 'http://academic.oup.com/rheumatology/article-pdf/42/11/1408/5059123/keg386.pdf']\n",
      "['9263127', 'Sheldon P. Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide. Rheumatology international. (2003) 23 4 pp154-158', '10.1007/s00296-002-0278-8', 'http://link.springer.com/article/10.1007/s00296-002-0278-8/fulltext.html']\n",
      "['9263129', 'Hamilton SF; Campbell NR; Kara M; Watson J; Connors M. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis. Journal of rheumatology. (2003) 30 9 pp1948-1950', '10.1093/rheumatology/keg277', 'http://academic.oup.com/rheumatology/article-pdf/42/8/989/5022999/420989.pdf']\n",
      "['9263130', 'Lodder MC; Van Pelt PA; Lems WF; Kostense PJ; Koks CH; Dijkmans BA. Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial. Journal of rheumatology. (2003) 30 9 pp2080-2081', '10.1007/s00198-005-0037-2', 'http://link.springer.com/article/10.1007/s00198-005-0037-2/fulltext.html']\n",
      "['9263131', 'Weitoft T; R√∂nnblom L. Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis. Annals of the rheumatic diseases. (2003) 62 10 pp1013-1015', '10.1136/ard.62.10.1013', '']\n",
      "['9263133', 'Bianchi M; Broggini M. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs. (2003) 63 Suppl 1  pp37-46', '10.2165/00003495-200363001-00006', '']\n",
      "['9263134', 'Hashkes PJ; Tauber T; Somekh E; Brik R; Barash J; Mukamel M; Harel L; Lorber A; Berkovitch M; Uziel Y; Pediatric Rheumatlogy Study Group of Israel. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial. Journal of pediatrics. (2003) 143 3 pp399-401', '10.1067/s0022-3476(03)00388-3', '']\n",
      "['9263135', 'Furst DE; Weisman M; Paulus HE; Bulpitt K; Weinblatt M; Polisson R; Zaug M; Kneer J; Van der Auwera P; Stevens RM. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis. Journal of rheumatology. (2003) 30 10 pp2123-2126', '10.1177/106002809703101111', 'https://journals.sagepub.com/doi/pdf/10.1177/106002809703101111']\n",
      "['9263136', 'Yang W; Ouyang J; Zhu K; Zhou S; Peng Z. TCM treatment for 40 cases of rheumatoid arthritis with channel blockage due to yin deficiency. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2003) 23 3 pp172-174', '10.1055/b-0034-67018', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-67018.pdf']\n",
      "['9263137', 'Munneke M; de Jong Z; Zwinderman AH; Jansen A; Ronday HK; Peter WF; Boonman DC; van den Ende CH; Vliet Vlieland TP; Hazes JM. Adherence and satisfaction of rheumatoid arthritis patients with a long-term intensive dynamic exercise program (RAPIT program). Arthritis and rheumatism. (2003) 49 5 pp665-672', '10.1002/art.11382', '']\n",
      "['9263138', 'von Scheele B; Pe√±a B; Wong J; Niculescu L. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial. Rheumatology (Oxford, England). (2003) 42 Suppl 3  ppiii53-9', '10.1093/rheumatology/keg498', 'http://academic.oup.com/rheumatology/article-pdf/42/suppl_3/iii53/5057825/keg498.pdf']\n",
      "['9263139', 'Allaire SH; Li W; LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial. Arthritis and rheumatism. (2003) 48 11 pp3212-3218', '10.1002/art.11256', '']\n",
      "['9263140', 'Davis JC; Van Der Heijde D; Braun J; Dougados M; Cush J; Clegg DO; Kivitz A; Fleischmann R; Inman R; Tsuji W; Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis and rheumatism. (2003) 48 11 pp3230-3236', '10.1002/art.11325', '']\n",
      "['9263142', 'van Gelder T; Smits P. Pilot studies: One swallow does not make a summer.. Netherlands journal of medicine. (2003) 61 9 pp270-272', '10.1016/0090-3019(84)90212-x', '']\n",
      "['9263143', 'Jermany J; Branson J; Schmouder R; Guillaume M; Rordorf C. Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects. Journal of clinical pharmacology. (2005) 45 10 pp1172-1178', '10.1177/0091270005280377', '']\n",
      "['9263144', 'Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis and rheumatism. (2005) 52 10 pp3030-3038', '10.1002/art.21295', '']\n",
      "['9263145', 'Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. Journal of rheumatology. (2005) 32 10 pp1911-1917', '10.1002/art.20870', '']\n",
      "['9263146', 'de Buck PD; le Cessie S; van den Hout WB; Peeters AJ; Ronday HK; Westedt ML; Breedveld FC; Vliet Vlieland TP. Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. Arthritis and rheumatism. (2005) 53 5 pp682-690', '10.1002/art.21452', '']\n",
      "['9263147', 'Sany J; Kaiser MJ; Jorgensen C; Trape G. Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 11 pp1647-1649', '10.1136/ard.2005.037499', '']\n",
      "['9263148', 'Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafstr√∂m I. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis and rheumatism. (2005) 52 11 pp3360-3370', '10.1002/art.21298', '']\n",
      "['9263149', 'Wassenberg S; Rau R; Steinfeld P; Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis and rheumatism. (2005) 52 11 pp3371-3380', '10.1002/art.21421', '']\n",
      "['9263150', 'Jahangier ZN; Jacobs JW; Lafeber FP; Moolenburgh JD; Swen WA; Bruyn GA; Griep EN; ter Borg EJ; Bijlsma JW. Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen-month, randomized, double-blind, placebo-controlled, crossover trial. Arthritis and rheumatism. (2005) 52 11 pp3391-3402', '10.1002/art.21376', '']\n",
      "['9263152', 'Lukaczer D; Darland G; Tripp M; Liska D; Lerman RH; Schiltz B; Bland JS. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Phytotherapy research : PTR. (2005) 19 10 pp864-869', '10.1002/ptr.1709', '']\n",
      "['9263153', 'Bing√∂l U; Altan L; Yurtkuran M. Low-power laser treatment for shoulder pain. Photomedicine and laser surgery. (2005) 23 5 pp459-464', '10.1089/pho.2005.23.459', '']\n",
      "['9263154', 'Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. Journal of rheumatology. (2005) 32 11 pp2095-2101', '10.5152/akd.2010.031', '']\n",
      "['9263158', 'Lorig K; Ritter PL; Plant K. A disease-specific self-help program compared with a generalized chronic disease self-help program for arthritis patients. Arthritis and rheumatism. (2005) 53 6 pp950-957', '10.1002/art.21604', '']\n",
      "['9263159', 'Anonymous. Mitoxantrone reduces relapse rate and slows disease progression in worsening multiple sclerosis. Drugs and Therapy Perspectives. (2005) 21 3 pp1-4', '10.2165/00042310-200521030-00001', '']\n",
      "['9263160', 'Popa C; Netea MG; Radstake TRDS; Van Riel PL; Barrera P; Van Der Meer JWM. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Annals of the rheumatic diseases. (2005) 64 8 pp1195-1198', '10.1136/ard.2004.032243', '']\n",
      "['9263161', 'Sanchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Annals of Allergy, Asthma and Immunology. (2005) 94 1 pp34-38', '10.1016/s1081-1206(10)61282-3', '']\n",
      "['9263162', 'Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporosis international. (2006) 17 5 pp716-723', '10.1007/s00198-005-0037-2', 'http://link.springer.com/article/10.1007/s00198-005-0037-2/fulltext.html']\n",
      "['9263163', 'Alten R. Long-term therapy with the selective costimulation modulator ctla4lg in rheumatoid arthritis. Zeitschrift fuÃàr Rheumatologie. (2006) 65 3 pp252-253', '10.1007/s00393-005-0025-0', 'http://link.springer.com/article/10.1007/s00393-005-0025-0/fulltext.html']\n",
      "['9263164', 'Williams AE; Rome K; Nester CJ. A clinical trial of specialist footwear for patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2007) 46 2 pp302-307', '10.1093/rheumatology/kel234', 'http://academic.oup.com/rheumatology/article-pdf/46/2/302/6699669/kel234.pdf']\n",
      "['9263166', 'Weinblatt M; Schiff M; Goldman A; Kremer J; Luggen M; Li T; Chen D; Becker JC. Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial. Annals of the rheumatic diseases. (2007) 66 2 pp228-234', '10.1136/ard.2006.055111', '']\n",
      "['9263167', 'Gerlag DM; Boyle DL; Rosengren S; Nash T; Tak PP; Firestein GS. Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment. Annals of the rheumatic diseases. (2007) 66 4 pp545-547', '10.1136/ard.2006.059790', '']\n",
      "['9263169', 'Nestorov I; Zitnik R; DeVries T; Nakanishi AM; Wang A; Banfield C. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. British journal of clinical pharmacology. (2006) 62 4 pp435-445', '10.1111/j.1365-2125.2006.02581.x', '']\n",
      "['9263170', 'van den Berg MH; Ronday HK; Peeters AJ; Voogt-van der Harst EM; Munneke M; Breedveld FC; Vliet Vlieland TP. Engagement and satisfaction with an Internet-based physical activity intervention in patients with rheumatoid arthritis. Rheumatology (Oxford, England). (2007) 46 3 pp545-552', '10.1093/rheumatology/kel341', 'http://academic.oup.com/rheumatology/article-pdf/46/3/545/6700738/kel341.pdf']\n",
      "['9263171', 'Pollard LC; Murray J; Moody M; Stewart EJ; Choy EH. A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2007) 66 5 pp687-689', '10.1136/ard.2006.059436', '']\n",
      "['9263172', 'Davies LM; Fargher EA; Tricker K; Dawes P; Scott DL; Symmons D. Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?. Annals of the rheumatic diseases. (2007) 66 5 pp658-663', '10.1136/ard.2006.061234', '']\n",
      "['9263173', 'D√≠az-Gonz√°lez F; Alten RH; Bensen WG; Brown JP; Sibley JT; Dougados M; Bombardieri S; Durez P; Ortiz P; de-Miquel G; Staab A; Sigmund R; Salin L; Leledy C; Polmar SH. Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2007) 66 5 pp628-632', '10.1136/ard.2006.062554', '']\n",
      "['9263174', 'Mazi√®res B; Hucher M; Za√Øm M; Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases. (2007) 66 5 pp639-645', '10.1136/ard.2006.059899', '']\n",
      "['9263175', 'Richards BL; Spies J; McGill N; Richards GW; Vaile J; Bleasel JF; Youssef PP. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Internal medicine journal. (2007) 37 2 pp101-107', '10.1111/j.1445-5994.2007.01266.x', '']\n",
      "['9263176', 'Mansour K; Leonhardt CJ; Kalk WW; Bootsma H; Bruin KJ; Blanksma LJ; Sj√∂gren Workgroup. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sj√∂gren syndrome: a uniocular evaluation. Cornea. (2007) 26 2 pp147-150', '10.1097/01.ico.0000244877.30997.6a', '']\n",
      "['9263177', 'Marzo-Ortega H; Green MJ; Keenan AM; Wakefield RJ; Proudman S; Emery P. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis and rheumatism. (2007) 57 1 pp154-160', '10.1002/art.22467', '']\n",
      "['9263179', 'Yamao J; Kikuchi E; Matsumoto M; Nakayama M; Ann T; Kojima H; Mitoro A; Yoshida M; Yoshikawa M; Yajima H; Miyauchi Y; Ono H; Akiyama K; Sakurai G; Kinoshita Y; Haruma K; Takakura Y; Fukui H. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). Journal of gastroenterology. (2006) 41 12 pp1178-1185', '10.1007/s00535-006-1952-5', 'http://link.springer.com/article/10.1007/s00535-006-1952-5/fulltext.html']\n",
      "['9263180', 'Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Clinical therapeutics. (2006) 28 12 pp2052-2060', '10.1016/j.clinthera.2006.12.019', '']\n",
      "['9263181', 'Podas T; Nightingale JM; Oldham R; Roy S; Sheehan NJ; Mayberry JF. Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone. Postgraduate medical journal. (2007) 83 976 pp128-131', '10.1136/pgmj.2006.050245', 'https://academic.oup.com/pmj/article-pdf/83/976/128/50023222/postgradmedj-83-128.pdf']\n",
      "['9263182', 'Hoenig H; Pieper C; Branch LG; Cohen HJ. Effect of motorized scooters on physical performance and mobility: a randomized clinical trial. Archives of physical medicine and rehabilitation. (2007) 88 3 pp279-286', '10.1016/j.apmr.2006.11.022', '']\n",
      "['9263183', 'Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. Southern medical journal. (2007) 100 2 pp135-139', '10.1097/01.smj.0000254190.54327.3b', '']\n",
      "['9263184', 'Eversden L; Maggs F; Nightingale P; Jobanputra P. A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis. BMC musculoskeletal disorders. (2007) 8  pp23', '10.1186/1471-2474-8-23', 'http://link.springer.com/article/10.1186/1471-2474-8-23/fulltext.html']\n",
      "['9263185', 'Bresnihan B; Gerlag DM; Rooney T; Smeets TJ; Wijbrandts CA; Boyle D; Fitzgerald O; Kirkham BW; McInnes IB; Smith M; Ulfgren AK; Veale DJ; Tak PP. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. Journal of rheumatology. (2007) 34 3 pp620-622', '10.3899/jrheum.090348', '']\n",
      "['9263186', 'Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. Journal of the American College of Nutrition. (2007) 26 1 pp39-48', '10.1080/07315724.2007.10719584', '']\n",
      "['9263187', 'Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Current medical research and opinion. (2007) 23 3 pp515-522', '10.1185/030079906x167642', '']\n",
      "['9263190', 'He YT; Zha QL; Yan XP. Analysis on symptomatic factors of rheumatoid arthritis and its correlation with therapeutic efficacy. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2005) 25 12 pp1077-1081', '10.37766/inplasy2025.3.0072', '']\n",
      "['9263191', 'Liu W; Zhang L; Xu Z. Clinical observation on treatment of rheumatoid arthritis with biqi capsule. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 2 pp157-159', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9263192', \"Zhou H; Zhong Y. Clinical observation on liang's anti-rheumatism and rheumatoid granule in rheumatoid arthritis in the active stage. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 3 pp248-250\", '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9263193', 'Zha QL; He YT; Yu JP. Correlations between diagnostic information and therapeutic efficacy in rheumatoid arthritis analyzed with decision tree model. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2006) 26 10 pp871-876', '10.3736/jcim20080107', '']\n",
      "['9263194', 'Zha QL; He YT; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH; Lin SQ; L√º C; L√º AP. [Predictive role of diagnostic information in treatment efficacy of rheumatoid arthritis based on neural network model analysis]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2007) 5 1 pp32-38', '10.3736/jcim20070107', '']\n",
      "['9263195', 'Masiero S; Boniolo A; Wassermann L; Machiedo H; Volante D; Punzi L. Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial. Clinical rheumatology. (2007) 26 12 pp2043-2050', '10.1007/s10067-007-0615-0', 'http://link.springer.com/article/10.1007/s10067-007-0615-0/fulltext.html']\n",
      "['9263196', 'Fiehn C; Jacki S; Heilig B; Lampe M; Wiesm‚Äö√†√∂¬¨‚à´ller G; Richter C; R‚Äö√†√∂‚Äö√†√áther E; Rochel E; Gao I. Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone. Rheumatology international. (2007) 27 10 pp975-979', '10.1007/s00296-007-0347-0', 'https://link.springer.com/article/10.1007/s00296-007-0347-0/fulltext.html']\n",
      "['9263197', 'Hafstr√∂m I; Rohani M; Deneberg S; W√∂rnert M; Jogestrand T; Frosteg√•rd J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study. Journal of rheumatology. (2007) 34 9 pp1810-1816', '10.5606/archrheumatol.2016.5739', '']\n",
      "['9263198', 'van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ; Etanercept Study 400 Investigators. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Annals of the rheumatic diseases. (2008) 67 2 pp182-188', '10.1136/ard.2007.076166', '']\n",
      "['9263199', 'Ruperto N; Lovell DJ; Cuttica R; Wilkinson N; Woo P; Espada G; Wouters C; Silverman ED; Balogh Z; Henrickson M; Apaz MT; Baildam E; Fasth A; Gerloni V; Lahdenne P; Prieur AM; Ravelli A; Saurenmann RK; Gamir ML; Wulffraat N; Marodi L; Petty RE; Joos R; Zulian F; McCurdy D; Myones BL; Nagy K; Reuman P; Szer I; Travers S; Beutler A; Keenan G; Clark J; Visvanathan S; Fasanmade A; Raychaudhuri A; Mendelsohn A; Martini A; Giannini EH; Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis and rheumatism. (2007) 56 9 pp3096-3106', '10.1002/art.22838', '']\n",
      "['9263203', 'Thumboo J; Wee HL; Cheung YB; Machin D; Luo N; Feeny D; Fong KY. Computerized administration of health-related quality of life instruments compared to interviewer administration may reduce sample size requirements in clinical research: a pilot randomized controlled trial among rheumatology patients. Clinical and experimental rheumatology. (2007) 25 4 pp577-583', '10.1111/j.1524-4733.2007.00174.x', '']\n",
      "['9263204', 'Li EK; Tam LS; Wong CK; Li WC; Lam CW; Wachtel-Galor S; Benzie IF; Bao YX; Leung PC; Tomlinson B. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis and rheumatism. (2007) 57 7 pp1143-1150', '10.1002/art.22994', '']\n",
      "['9263205', 'Pradhan EK; Baumgarten M; Langenberg P; Handwerger B; Gilpin AK; Magyari T; Hochberg MC; Berman BM. Effect of Mindfulness-Based Stress Reduction in rheumatoid arthritis patients. Arthritis and rheumatism. (2007) 57 7 pp1134-1142', '10.1002/art.23010', '']\n",
      "['9263206', 'Singh-Grewal D; Schneiderman-Walker J; Wright V; Bar-Or O; Beyene J; Selvadurai H; Cameron B; Laxer RM; Schneider R; Silverman ED; Spiegel L; Tse S; Leblanc C; Wong J; Stephens S; Feldman BM. The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trial. Arthritis and rheumatism. (2007) 57 7 pp1202-1210', '10.1002/art.23008', '']\n",
      "['9263207', 'Jain AK; Sukhija J; Dwedi S; Sood A. Effect of topical cyclosporine on tear functions in tear-deficient dry eyes. Annals of ophthalmology (Skokie, Ill.). (2007) 39 1 pp19-25', '10.1007/bf02697322', 'http://link.springer.com/article/10.1007/BF02697322/fulltext.html']\n",
      "['9263208', \"Bulthuis Y; Drossaers-Bakker KW; Taal E; Rasker J; Oostveen J; van't Pad Bosch P; Oosterveld F; van de Laar M. Arthritis patients show long-term benefits from 3 weeks intensive exercise training directly following hospital discharge. Rheumatology (Oxford, England). (2007) 46 11 pp1712-1717\", '10.1093/rheumatology/kem236', 'http://academic.oup.com/rheumatology/article-pdf/46/11/1712/5052873/kem236.pdf']\n",
      "['9263209', 'Tam LS; Leung PC; Li TK; Zhang L; Li EK. Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study. BMC complementary and alternative medicine. (2007) 7  pp35', '10.1186/1472-6882-7-35', 'http://link.springer.com/article/10.1186/1472-6882-7-35/fulltext.html']\n",
      "['9263211', 'Verschueren P; Esselens G; Westhovens R. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis. Rheumatology (Oxford, England). (2008) 47 1 pp59-64', '10.1093/rheumatology/kem288', 'http://academic.oup.com/rheumatology/article-pdf/47/1/59/5062184/kem288.pdf']\n",
      "['9263212', 'Allison C; Fraser J. Grazax: an oral vaccine for the treatment of grass pollen allergy (hay fever). Issues in emerging health technologies. (2007)  107 pp1-4', '10.2165/00128413-200715740-00038', '']\n",
      "['9263213', 'Guis S; Balandraud N; Bouvenot J; Auger I; Toussirot E; Wendling D; Mattei JP; Nogueira L; Mugnier B; Legeron P; Landt O; Serre G; Roudier J; Roudier C. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis. Arthritis and rheumatism. (2007) 57 8 pp1426-1430', '10.1002/art.23092', '']\n",
      "['9263214', 'Stephens S; Singh-Grewal D; Bar-Or O; Beyene J; Cameron B; Leblanc CM; Schneider R; Schneiderman-Walker J; Selvadurai H; Silverman E; Spiegel L; Tse SM; Wright V; Feldman BM. Reliability of exercise testing and functional activity questionnaires in children with juvenile arthritis. Arthritis and rheumatism. (2007) 57 8 pp1446-1452', '10.1002/art.23089', '']\n",
      "['9263216', \"Mavragani CP; Niewold TB; Moutsopoulos NM; Pillemer SR; Wahl SM; Crow MK. Augmented interferon-alpha pathway activation in patients with Sj√∂gren's syndrome treated with etanercept. Arthritis and rheumatism. (2007) 56 12 pp3995-4004\", '10.1002/art.23062', '']\n",
      "['9263218', 'He Y; Lu A; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Lu C. Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine. Journal of clinical rheumatology. (2007) 13 6 pp317-321', '10.1097/rhu.0b013e31815d019b', '']\n",
      "['9263219', 'Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet (London, England). (2008) 371 9608 pp205-214', '10.1016/s0140-6736(08)60132-4', '']\n",
      "['9263221', 'Zhang G-X; Zhang Y-M; Cao S-Y. Ameliorating effect of external therapy of Chinese herb on joint function of patients with rheumatoid arthritis. [Chinese]. Chinese Journal of Clinical Rehabilitation. (2006) 10 3 pp24-26', '10.1142/9789811260377_0002', '']\n",
      "['9263222', 'Du T-X; Han X-F; Gao S-T. Effect of hanshibi granule on rheumatism due to blockage of cold and damp. Chinese Journal of Clinical Rehabilitation. (2006) 10 7 pp148-150', '10.26689/aogr.v2i2.7121', 'https://ojs.bbwpublisher.com/index.php/AOGR/article/download/7121/6138']\n",
      "['9263223', 'Benucci M; Dolenti S; Saviola G; Manfredi M. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]. Recenti progressi in medicina. (2006) 97 1 pp24-27', '10.1007/bf02500641', 'http://link.springer.com/article/10.1007/BF02500641/fulltext.html']\n",
      "['9263224', 'Fisher M. Hydrocortisone versus prednisolone in rheumatoid arthritis. Lancet. (1956) 261 6932 pp18-19', '10.1016/s0140-6736(56)91389-7', '']\n",
      "['9263225', 'Anon. MRC chronic myeloid leukaemia chemotherapy trial. Lancet. (1980)   pp1980', '10.1186/isrctn98986889', '']\n",
      "['9263226', 'Chandler GN; Wright V. Deleterious effect of intra-articular hydrocortisone. Lancet. (1958) 2 7048 pp661-663', '10.1016/s0140-6736(58)92262-1', '']\n",
      "['9263227', 'Kawai S; Tanaka K; Ohno I; Utsunomiya K; Seino Y. Safety of long-term tacrolimus therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients. Modern rheumatology / the Japan Rheumatism Association. (2008) 18 4 pp345-353', '10.3109/s10165-008-0058-8', '']\n",
      "['9263228', 'Liu W; Liu XY; Wang Y. Effect of chinese herbs in enhancing prednisone for treatment of refractory rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2007) 27 8 pp742-744', '10.47939/mh.v2i8.415', '']\n",
      "['9263229', 'Guo SY; Lin LJ; Chu H; Yang C; Gong DD; Tian J; Fu HX. [Efficacy of Lugua polypeptide injection on active rheumatoid arthritis]. Zhongguo gu shang [China journal of orthopaedics and traumatology]. (2008) 21 8 pp610-612', '10.21203/rs.3.rs-22347/v1', 'https://www.researchsquare.com/article/rs-22347/v1']\n",
      "['9263230', 'Richter JG; Becker A; Koch T; Nixdorf M; Willers R; Monser R; Schacher B; Alten R; Specker C; Schneider M. Self-assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires. Annals of the rheumatic diseases. (2008) 67 12 pp1739-1741', '10.1136/ard.2008.090209', '']\n",
      "['9263231', 'Hammond A; Bryan J; Hardy A. Effects of a modular behavioural arthritis education programme: a pragmatic parallel-group randomized controlled trial. Rheumatology (Oxford, England). (2008) 47 11 pp1712-1718', '10.1093/rheumatology/ken380', 'http://academic.oup.com/rheumatology/article-pdf/47/11/1712/14118159/ken380.pdf']\n",
      "['9263232', 'Mawatari T; Miura H; Hamai S; Shuto T; Nakashima Y; Okazaki K; Kinukawa N; Sakai S; Hoffmann PF; Iwamoto Y; Keaveny TM. Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: a prospective randomized clinical trial. Arthritis and rheumatism. (2008) 58 11 pp3340-3349', '10.1002/art.23988', '']\n",
      "['9263234', 'Cameron D. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva medica. (2008) 99 5 pp489-496', '10.1186/isrctn19325889', '']\n",
      "['9263235', 'Veehof MM; Taal E; Heijnsdijk-Rouwenhorst LM; van de Laar MA. Efficacy of wrist working splints in patients with rheumatoid arthritis: a randomized controlled study. Arthritis and rheumatism. (2008) 59 12 pp1698-1704', '10.1002/art.24078', '']\n",
      "['9263236', 'Adams J; Burridge J; Mullee M; Hammond A; Cooper C. The clinical effectiveness of static resting splints in early rheumatoid arthritis: a randomized controlled trial. Rheumatology (Oxford, England). (2008) 47 10 pp1548-1553', '10.1093/rheumatology/ken292', 'http://academic.oup.com/rheumatology/article-pdf/47/10/1548/5052203/ken292.pdf']\n",
      "['9263237', 'Tutunov VS; Popkova TV; Novikova DS; Nasonov EL; Kukhrchuk VV. Comparative assessment of antiinflammatory action of atorvastatin in ischemic heart disease and rheumatoid arthritis. Kardiologiia. (2008) 48 9 pp4-8', '10.14412/1995-4484-2010-826', '']\n",
      "['9263239', 'Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. Arthritis and rheumatism. (2008) 58 10 pp3255-3263', '10.1002/art.23809', '']\n",
      "['9263240', 'Zhang HF; Xiao WG. Clinical observation of shuxuetong injection in treating patients with active rheumatoid arthritis. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2008) 28 3 pp255-257', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9263241', \"d'Elia HF; Bjurman C; Rehnberg E; Kvist G; Konttinen YT. Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjogren syndrome: an explanatory interventional study. Annals of the rheumatic diseases. (2009) 68 2 pp285-286\", '10.1136/ard.2008.091256', '']\n",
      "['9263242', 'Laine L; Curtis SP; Langman M; Jensen DM; Cryer B; Kaur A; Cannon CP. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology. (2008) 135 5 pp1517-1525', '10.1053/j.gastro.2008.07.067', '']\n",
      "['9263243', 'Keefe FJ; Anderson T; Lumley M; Caldwell D; Stainbrook D; McKee D; Waters SJ; Connelly M; Affleck G; Pope MS; Weiss M; Riordan PA; Uhlin BD. A randomized, controlled trial of emotional disclosure in rheumatoid arthritis: can clinician assistance enhance the effects?. Pain. (2008) 137 1 pp164-172', '10.1016/j.pain.2007.08.031', '']\n",
      "['9263244', 'Zhang JH; Wang JP; Wang HJ. Clinical study on effect of total panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2007) 27 7 pp589-592', '10.1007/bf02969649', 'https://link.springer.com/article/10.1007/BF02969649/fulltext.html']\n",
      "['9263246', 'Ingegnoli F; Fantini F; Favalli EG; Soldi A; Griffini S; Galbiati V; Meroni PL; Cugno M. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. Journal of autoimmunity. (2008) 31 2 pp175-179', '10.1016/j.jaut.2008.07.002', '']\n",
      "['9263247', 'Liu XW; Zha QL; He YT. Comparative study on characteristics of chinese and western medicine for treatment of rheumatoid arthritis regarding cartilage erosion related blood biochemical and immunological factors. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2007) 27 12 pp1090-1093', '10.1007/bf02969660', 'https://link.springer.com/article/10.1007/BF02969660/fulltext.html']\n",
      "['9263248', 'Walker D; Adebajo A; Heslop P; Hill J; Firth J; Bishop P; Helliwell PS. Patient education in rheumatoid arthritis: the effectiveness of the ARC booklet and the mind map. Rheumatology (Oxford, England). (2007) 46 10 pp1593-1596', '10.1093/rheumatology/kem171', 'http://academic.oup.com/rheumatology/article-pdf/46/10/1593/5060840/kem171.pdf']\n",
      "['9263249', 'Carrasco R; Lovell DJ; Giannini EH; Henderson CJ; Huang B; Kramer S; Ranz J; Heubi J; Glass D. Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial. Arthritis and rheumatism. (2008) 58 12 pp3932-3940', '10.1002/art.24041', '']\n",
      "['9263251', 'Godfrey RG; de la Cruz S. Effect of ibuprofen dosage on patient response in rheumatoid arthritis. Arthritis and rheumatism. (1975) 18 2 pp135-137', '10.1002/art.1780180209', '']\n",
      "['9263252', 'Chamberlain MA; Wright V. A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis. Annals of the rheumatic diseases. (1975) 34 2 pp186-189', '10.1136/ard.34.2.186', '']\n",
      "['9263256', 'Cho NS; Hwang JH; Chang HJ; Koh EM; Park HS. Randomized controlled trial for clinical effects of varying types of insoles combined with specialized shoes in patients with rheumatoid arthritis of the foot. Clinical rehabilitation. (2009) 23 6 pp512-521', '10.1177/0269215508101737', 'https://journals.sagepub.com/doi/pdf/10.1177/0269215508101737']\n",
      "['9263257', 'Tian M; Liu J; Zhang Y; Tian Z; Wang L; Cao J; Sun Y; Sun Z. [An analysis of operation-correlated complications of total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2009) 23 1 pp55-59', '10.1055/s-0036-1582137', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0036-1582137.pdf']\n",
      "['9263259', 'Peltola P. Double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. Rheumatology and rehabilitation. (1976) Suppl  pp56', '10.1093/rheumatology/15.5.56', 'http://academic.oup.com/rheumatology/article-pdf/15/5/56/5039121/15-5-56.pdf']\n",
      "['9263260', 'Huffstutter J; Craig WD; Schimizzi G; Harshbarger J; Lisse J; Kasle S; Hymson L; Yocum D; Castro L; Hegedus R; Callegari P; Yeilding N; Gilmer K. A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis. Current medical research and opinion. (2007) 23 8 pp1967-1979', '10.1185/030079907x210624', '']\n",
      "['9263261', 'Decking R; Markmann Y; Mattes T; Puhl W; Scharf HP. On the outcome of computer-assisted total knee replacement. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca. (2007) 74 3 pp171-174', '10.55095/achot2007/027', 'http://achot.cz/doi/10.55095/achot2007/027.pdf']\n",
      "['9263262', 'Ekim A; Armagan O; Tascioglu F; Oner C; Colak M. Effect of low level laser therapy in rheumatoid arthritis patients with carpal tunnel syndrome. Swiss medical weekly. (2007) 137 23-24 pp347-352', '10.4414/smw.2007.11581', '']\n",
      "['9263263', 'Tengstrand B; Larsson E; Klareskog L; Hafstr√∂m I. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density. Scandinavian journal of rheumatology. (2007) 36 5 pp351-358', '10.1080/03009740701394021', '']\n",
      "['9263265', 'Brooks PM; Walker JJ; Bell MA; Buchanan WW; Rhymer AR. Indomethacin--aspirin interaction: a clinical appraisal. British medical journal. (1975) 3 5975 pp69-71', '10.1136/bmj.3.5975.69', '']\n",
      "['9263267', 'Matsumoto A; Melian A; Shah A; Curtis SP. Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. Current medical research and opinion. (2007) 23 9 pp2259-2268', '10.1185/030079907x219625', '']\n",
      "['9263268', 'Chung KC; Burns PB; Wilgis EF; Burke FD; Regan M; Kim HM; Fox DA. A multicenter clinical trial in rheumatoid arthritis comparing silicone metacarpophalangeal joint arthroplasty with medical treatment. Journal of hand surgery. (2009) 34 5 pp815-823', '10.1016/j.jhsa.2009.01.018', '']\n",
      "['9263269', 'Daza L; Martin-Jimenez R; De la Torre PX; Hern√°ndez E; Murillo B. Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition. European journal of endocrinology / European Federation of Endocrine Societies. (2007) 157 1 pp47-51', '10.1530/eje-06-0644', 'https://eje.bioscientifica.com/view/journals/eje/157/1/1570047.xml']\n",
      "['9263270', \"Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sj√∂gren's syndrome: a double-blind placebo-controlled multicenter trial. Modern rheumatology / the Japan Rheumatism Association. (2009) 19 2 pp114-124\", '10.3109/s10165-008-0141-1', '']\n",
      "['9263271', \"Shimizu N. [Clinical evaluation of drug efficacy by the double blind method in medicine (author's transl)]. Nihon Naika Gakkai zasshi [The Journal of the Japanese Society of Internal Medicine]. (1976) 65 1 pp15-29\", '10.2169/naika.65.15', '']\n",
      "['9263272', 'Polli E; Cortellaro M; Parrini L; Tessari L; Ch√©ri√® Ligni√®re G. [Pharmacological and clinical aspects of S-adenosylmethionine (SAMe) in primary degenerative arthropathy (osteoarthrosis)]. Minerva medica. (1975) 66 83 pp4443-4459', '10.7326/0003-4819-83-3-444_7', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-83-3-444_7']\n",
      "['9263273', 'Giraudet-Le Quintrec JS; Mayoux-Benhamou A; Ravaud P; Champion K; Dernis E; Zerkak D; Ouslimani A; Courpied JP; Revel M; Kahan A; Dougados M. Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. Journal of rheumatology. (2007) 34 8 pp1684-1691', '10.1016/s0168-6054(99)85186-1', '']\n",
      "['9263274', \"Fasching U; Eberl R. [Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)]. Wiener klinische Wochenschrift. Supplementum. (1976) 59 59 pp1-10\", '10.1002/art.1780190608', '']\n",
      "['9263275', 'Aylward M; Holly F; Maddock J; Wheeldon R. Treatment of rheumatoid arthritis with tolmetin: a comparison with alclofenac. Current medical research and opinion. (1976) 4 10 pp695-702', '10.1185/03007997609112004', '']\n",
      "['9263276', 'Aylward M; Maddock J; Parker RJ; Thomas SR; Holly F. Evaluation of tolmetin in the treatment of arthritis: open and controlled double-blind studies. Current medical research and opinion. (1976) 4 2 pp158-169', '10.1185/03007997609109297', '']\n",
      "['9263277', 'Thune S. A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis. Current medical research and opinion. (1976) 4 1 pp70-75', '10.1185/03007997609109284', '']\n",
      "['9263278', 'Brooks PM; Mason DI; McNeil R; Anderson JA; Buchanan WW. An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. Current medical research and opinion. (1976) 4 1 pp50-56', '10.1185/03007997609109281', '']\n",
      "['9263279', 'Grennan DM; McLeod M; Watkins C; Dick WC. Clinical assessment of azapropazone in rheumatoid arthritis. Current medical research and opinion. (1976) 4 1 pp44-49', '10.1185/03007997609109280', '']\n",
      "['9263280', 'Wright V; Goldberg AA. A trial of a phase-release aspirin preparation in rheumatoid arthritis. Scandinavian journal of rheumatology. (1976) 5 1 pp7-10', '10.1093/rheumatology/9.1.8', 'http://academic.oup.com/rheumatology/article-pdf/9/1/8/5021473/9-1-8.pdf']\n",
      "['9263281', 'Maggio-Cavaliere MB; Bonus L; Gum OB. A dual approach to the evaluation of the efficacy of a new rheumatoid arthritic agent--pirprofen. Journal of clinical pharmacology. (1976) 16 1 pp8-18', '10.1002/j.1552-4604.1976.tb01486.x', '']\n",
      "['9263282', 'Aylward M; Parker RJ; Holly F; Maddock J; Davies DB. Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis. British medical journal. (1975) 2 5961 pp7-9', '10.1136/bmj.2.5961.7', '']\n",
      "['9263283', 'Franchi R; Viara M; Liverta C; Pollini C; Pontiroli AE. Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind cross-over trial. European journal of clinical pharmacology. (1975) 8 3-4 pp205-208', '10.1007/bf00567116', 'http://link.springer.com/article/10.1007/BF00567116/fulltext.html']\n",
      "['9263284', 'Badia Flores JJ; Valdez Rojas S. Naproxen: corticosteroid-sparing effect in rheumatoid arthritis. Journal of clinical pharmacology. (1975) 15 4 Pt. 2 pp373-377', '10.1002/j.1552-4604.1975.tb01467.x', '']\n",
      "['9263285', 'Diamond H; Alexander S; Kuzell W; Lussier A; Odone D; Tompkins R. Naproxen and aspirin in rheumatoid arthritis: a multicenter double-blind crossover comparison study. Journal of clinical pharmacology. (1975) 15 4 Pt. 2 pp335-339', '10.1002/j.1552-4604.1975.tb01461.x', '']\n",
      "['9263286', 'Myhal D; Camerlain M; M√©nard H; Lussier A. Naproxen: long-term study in rheumatoid arthritis and \"placebo pulse\". Journal of clinical pharmacology. (1975) 15 4 Pt. 2 pp327-334', '10.1002/j.1552-4604.1975.tb01460.x', '']\n",
      "['9263287', 'Feij√≥o M; T√∫nez I; Tasset I; Montilla P; P√©rez-Guijo V; Mu√±oz-Gomariz E; Ruiz A; Schiotis R; Collantes E. Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases. Pharmacology. (2009) 83 4 pp211-216', '10.1159/000200022', 'https://www.karger.com/Article/Pdf/200022']\n",
      "['9263288', 'Dawczynski C; Schubert R; Hein G; M√ºller A; Eidner T; Vogelsang H; Basu S; Jahreis G. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. British journal of nutrition. (2009) 101 10 pp1517-1526', '10.1017/s0007114508076216', '']\n",
      "['9263289', 'Charles-Schoeman C; Khanna D; Furst DE; McMahon M; Reddy ST; Fogelman AM; Paulus HE; Park GS; Gong T; Ansell BJ. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. Journal of rheumatology. (2007) 34 7 pp1459-1464', '10.1002/art.24802', '']\n",
      "['9263290', 'Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skj√∏dt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; P√∏denphant J; Lindegaard H; Vestergaard A; √òstergaard M; H√∏rslev-Petersen K. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. Journal of rheumatology. (2009) 36 4 pp731-735', '10.3899/jrheum.080846', '']\n",
      "['9263291', 'Albrecht K; Albert C; Lange U; M√ºller-Ladner U; Strunk J. Different effects of local cryogel and cold air physical therapy in wrist rheumatoid arthritis visualised by power Doppler ultrasound. Annals of the rheumatic diseases. (2009) 68 7 pp1234-1235', '10.1136/ard.2008.096081', '']\n",
      "['9263292', 'Krueger K; Lino L; Dore R; Radominski S; Zhang Y; Kaur A; Simpson R; Curtis S. Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II). Annals of the rheumatic diseases. (2008) 67 3 pp315-322', '10.1136/ard.2007.082388', '']\n",
      "['9263293', 'Sigler JW; Ridolfo AS; Bluhm GB. Comparison of benefit-to-risk ratios of aspirin and fenoprofen: controlled multicentre study in rheumatoid arthritis. Journal of rheumatology. (1976) 2  pp49-60', '10.1093/rheumatology/15.2.77', 'http://academic.oup.com/rheumatology/article-pdf/15/2/77/5039410/15-2-77.pdf']\n",
      "['9263294', 'Gum OB. Fenoprofen in rheumatoid arthritis: a controlled crossover multi-centre study. Journal of rheumatology. (1976) 2  pp26-31', '10.1002/art.1780160507', '']\n",
      "['9263296', 'Sturrock R; Isaacs A; Hart FD. Feprazone compared with indomethacin in the management of rheumatoid arthritis. Practitioner. (1975) 215 1285 pp94-97', '10.1093/rheumatology/14.2.67', 'http://academic.oup.com/rheumatology/article-pdf/14/2/67/5025933/14-2-67.pdf']\n",
      "['9263299', 'Bain LS; el-Ghobarey AF; Collins RM; Sargent NW. Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis. British journal of clinical practice. (1975) 29 8 pp208-210', '10.1111/j.1742-1241.1975.tb03455.x', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-1241.1975.tb03455.x']\n",
      "['9263300', 'Blechman WJ; Schmid FR; April PA; Wilson CH; Brooks CD. Ibuprofen or aspirin in rheumatoid arthritis therapy. JAMA. (1975) 233 4 pp336-340', '10.1001/jama.1975.03260040030018', '']\n",
      "['9263301', 'Reynolds PM; Sturrock RD; Isaacs A; Hart FD. A double-blind cross-over trial of Prenazone (DA 2370) and phenylbutazone in rheumatoid arthritis. Rheumatology and rehabilitation. (1975) 14 2 pp67-70', '10.1093/rheumatology/14.2.67', 'http://academic.oup.com/rheumatology/article-pdf/14/2/67/5025933/14-2-67.pdf']\n",
      "['9263302', 'Giordano M; Capelli L; Chianese U. The therapeutic activity of 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid monohydrate glucosamide in rheumatoid arthritis (double blind trial). Arzneimittel-Forschung. (1975) 25 3 pp435-437', '10.1021/ja00759a047', '']\n",
      "['9263305', \"Cummins MJ; Papas A; Kammer GM; Fox PC. Treatment of primary Sj√∂gren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis and rheumatism. (2003) 49 4 pp585-593\", '10.1002/art.11199', '']\n",
      "['9263306', 'Wilson DJ; Mitchell JM; Kemp BJ; Adkins RH; Mann W. Effects of assistive technology on functional decline in people aging with a disability. Assistive technology. (2009) 21 4 pp208-217', '10.1080/10400430903246068', '']\n",
      "['9263308', 'Zhou CY; Pan Z; Ma F; Tang JY. [Controlled clinical trials of external using of Cheezheng Qingpeng ointment on reliving analgesia and swelling for the treatment of rheumatoid arthritis]. Zhongguo gu shang [China journal of orthopaedics and traumatology]. (2009) 22 12 pp917-919', '10.1186/s13063-022-06338-1', 'https://link.springer.com/article/10.1186/s13063-022-06338-1/fulltext.html']\n",
      "['9263310', 'Badsha H; Chhabra V; Leibman C; Mofti A; Kong KO. The benefits of yoga for rheumatoid arthritis: results of a preliminary, structured 8-week program. Rheumatology international. (2009) 29 12 pp1417-1421', '10.1007/s00296-009-0871-1', 'http://link.springer.com/article/10.1007/s00296-009-0871-1/fulltext.html']\n",
      "['9263313', 'Li J; Zheng K; Hu P. [Comparison of short-term result between high-flex and conventional posterior-stabilized prosthesis in total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi [Chinese journal of reparative and reconstructive surgery]. (2010) 24 3 pp278-281', '10.29011/2575-8241.001363', '']\n",
      "['9263314', 'Kawai S; Uchida E; Kondo M; Ohno S; Obata J; Nawata Y; Sugimoto K; Oribe M; Nagaya I. Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. Journal of clinical pharmacology. (2010) 50 10 pp1171-1179', '10.1177/0091270009355813', '']\n",
      "['9263315', 'Hueber W; Patel DD; Dryja T; Wright AM; Koroleva I; Bruin G; Antoni C; Draelos Z; Gold MH; Psoriasis Study Group; Durez P; Tak PP; Gomez-Reino JJ; Rheumatoid Arthritis Study Group; Foster CS; Kim RY; Samson CM; Falk NS; Chu DS; Callanan D; Nguyen QD; Uveitis Study Group; Rose K; Haider A; Di Padova F. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Science translational medicine. (2010) 2 52 pp52ra72', '10.1126/scitranslmed.3001107', '']\n",
      "['9263317', 'van den Bekerom MP; Hilverdink EF; Sierevelt IN; Reuling EM; Schnater JM; Bonke H; Goslings JC; van Dijk CN; Raaymakers EL. A comparison of hemiarthroplasty with total hip replacement for displaced intracapsular fracture of the femoral neck: a randomised controlled multicentre trial in patients aged 70 years and over. Journal of bone and joint surgery. British volume. (2010) 92 10 pp1422-1428', '10.1302/0301-620x.92b10.24899', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.92B10.24899']\n",
      "['9263318', 'Strietzel FP; Lafaurie GI; Mendoza GR; Alajbeg I; Pejda S; Vuletiƒá L; Mantilla R; Falc√£o DP; Leal SC; Bezerra AC; Tran SD; M√©nard HA; Kimoto S; Pan S; Mart√≠n-Granizo RA; Lozano ML; Zunt SL; Krushinski CA; Melilli D; Campisi G; Paderni C; Dolce S; Yepes JF; Lindh L; Koray M; Mumcu G; Elad S; Zeevi I; Barrios BC; L√≥pez S√°nchez RM; Beiski BZ; Wolff A; Konttinen YT. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis and rheumatism. (2011) 63 1 pp180-190', '10.1002/art.27766', '']\n",
      "['9263321', 'Boers M; Berkhof J; Twisk JW; Ader HJ; Bezemer D; Knol D; Kostense PJ; Kuik DJ; Uitdehaag BM. A new graph and scoring system simplified analysis of changing states: disease remissions in a rheumatoid arthritis clinical trial. Journal of clinical epidemiology. (2010) 63 6 pp633-637', '10.1016/j.jclinepi.2009.08.021', '']\n",
      "['9263324', 'Dobrydnjov I; Anderberg C; Olsson C; Shapurova O; Angel K; Bergman S. Intraarticular vs. extraarticular ropivacaine infusion following high-dose local infiltration analgesia after total knee arthroplasty: a randomized double-blind study. Acta orthopaedica. (2011) 82 6 pp692-698', '10.3109/17453674.2011.625535', '']\n",
      "['9263325', 'Gopinath K; Danda D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. International journal of rheumatic diseases. (2011) 14 4 pp332-339', '10.1111/j.1756-185x.2011.01684.x', '']\n",
      "['9263326', 'Curtis JR; Yang S; Chen L; Park GS; Bitman B; Wang B; Navarro-Millan I; Kavanaugh A. Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial. Annals of the rheumatic diseases. (2012) 71 2 pp206-212', '10.1136/ard.2011.153551', '']\n",
      "['9263329', 'Niu X; He D; Deng S; Li W; Xi Y; Xie C; Jiang T; Zhang JZ; Dong C; Chen G. Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis. Molecular immunology. (2011) 49 1-2 pp290-296', '10.1016/j.molimm.2011.08.020', '']\n",
      "['9263332', 'Emery P; Mease PJ; Rubbert-Roth A; Curtis JR; M√ºller-Ladner U; Gaylis NB; Williams S; Reynard M; Tyrrell H. Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis. Rheumatology (Oxford, England). (2011) 50 12 pp2223-2232', '10.1093/rheumatology/ker253', 'http://academic.oup.com/rheumatology/article-pdf/50/12/2223/17387138/ker253.pdf']\n",
      "['9263334', 'Boumans MJ; Houbiers JG; Verschueren P; Ishikura H; Westhovens R; Brouwer E; Rojkovich B; Kelly S; den Adel M; Isaacs J; Jacobs H; Gomez-Reino J; Holtkamp GM; Hastings A; Gerlag DM; Tak PP. Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Annals of the rheumatic diseases. (2012) 71 2 pp180-185', '10.1136/annrheumdis-2011-200298', '']\n",
      "['9263336', \"Wu GL; Li TY; Fan YS; Yu GY. Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome. Chinese journal of integrative medicine. (2011) 17 9 pp710-714\", '10.1007/s11655-011-0850-8', 'http://link.springer.com/article/10.1007/s11655-011-0850-8/fulltext.html']\n",
      "['9263337', 'Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. Current medical research and opinion. (2011) 27 10 pp2033-2042', '10.1185/03007995.2011.614935', '']\n",
      "['9263341', 'Obeid J; Larch√© MJ; Timmons BW. Optimizing the Wingate Anaerobic Cycling Test for youth with juvenile idiopathic arthritis. Pediatric exercise science. (2011) 23 3 pp303-310', '10.1123/pes.23.3.303', 'https://journals.humankinetics.com/view/journals/pes/23/3/article-p303.xml']\n",
      "['9263342', \"Porola P; Straub RH; Virkki LM; Konttinen YT; Nordstr√∂m DC. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sj√∂gren's syndrome. Scandinavian journal of rheumatology. (2011) 40 5 pp387-390\", '10.3109/03009742.2011.580000', '']\n",
      "['9263343', 'Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. Scandinavian journal of rheumatology. (2011) 40 6 pp411-421', '10.3109/03009742.2011.586649', '']\n",
      "['9263344', 'Taylor PC; Quattrocchi E; Mallett S; Kurrasch R; Petersen J; Chang DJ. Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial. Annals of the rheumatic diseases. (2011) 70 12 pp2119-2125', '10.1136/ard.2011.151522', '']\n",
      "['9263345', 'Kapetanovic MC; Roseman C; J√∂nsson G; Truedsson L; Saxne T; Geborek P. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis and rheumatism. (2011) 63 12 pp3723-3732', '10.1002/art.30580', '']\n",
      "['9263347', 'Dawczynski C; Hackermeier U; Viehweger M; Stange R; Springer M; Jahreis G. Incorporation of n-3 PUFA and Œ≥-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial. Lipids in health and disease. (2011) 10  pp130', '10.1186/1476-511x-10-130', 'https://link.springer.com/content/pdf/10.1186/1476-511X-10-130.pdf']\n",
      "['9263351', \"Easter A; Watt C. It's good to know: how treatment knowledge and belief affect the outcome of distant healing intentionality for arthritis sufferers. Journal of psychosomatic research. (2011) 71 2 pp86-89\", '10.1016/j.jpsychores.2011.02.003', '']\n",
      "['9263352', 'Heravian J; Saghafi M; Shoeibi N; Hassanzadeh S; Shakeri MT; Sharepoor M. A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine. International ophthalmology. (2011) 31 4 pp283-289', '10.1007/s10792-011-9456-6', 'http://link.springer.com/article/10.1007/s10792-011-9456-6/fulltext.html']\n",
      "['9263353', 'Alten R; Gomez-Reino J; Durez P; Beaulieu A; Sebba A; Krammer G; Preiss R; Arulmani U; Widmer A; Gitton X; Kellner H. Efficacy and safety of the human anti-IL-1Œ≤ monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study. BMC musculoskeletal disorders. (2011) 12  pp153', '10.1186/1471-2474-12-153', 'http://link.springer.com/article/10.1186/1471-2474-12-153/fulltext.html']\n",
      "['9263354', 'Amanatullah DF; Landa J; Strauss EJ; Garino JP; Kim SH; Di Cesare PE. Comparison of surgical outcomes and implant wear between ceramic-ceramic and ceramic-polyethylene articulations in total hip arthroplasty. Journal of arthroplasty. (2011) 26 6 Suppl pp72-77', '10.1016/j.arth.2011.04.032', '']\n",
      "['9263355', 'Jiang M; Zha Q; Lu C; He Y; Lu A. Association between tongue appearance in Traditional Chinese Medicine and effective response in treatment of rheumatoid arthritis. Complementary therapies in medicine. (2011) 19 3 pp115-121', '10.1016/j.ctim.2011.05.002', '']\n",
      "['9263356', 'Furst DE; Venkatraman MM; McGann M; Manohar PR; Booth-LaForce C; Sarin R; Sekar PG; Raveendran KG; Mahapatra A; Gopinath J; Kumar PR. Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. Journal of clinical rheumatology. (2011) 17 4 pp185-192', '10.1097/rhu.0b013e31821c0310', '']\n",
      "['9263357', 'Koevoets R; Klarenbeek NB; G√ºler-Y√ºksel M; van Oosterhout M; van Krugten MV; Kerstens PJ; Huizinga TW; Dijkmans BA; van der Heijde DM; Allaart CF. Simplified versions of the original disease activity score: validation in the BeSt trial. Annals of the rheumatic diseases. (2011) 70 8 pp1471-1474', '10.1136/ard.2010.149146', '']\n",
      "['9263359', 'Hayward WA; Haseler LJ; Kettwich LG; Michael AA; Sibbitt Wl; Bankhurst AD. Pressure generated by syringes: implications for hydrodissection and injection of dense connective tissue lesions. Scandinavian journal of rheumatology. (2011) 40 5 pp379-382', '10.3109/03009742.2011.560892', '']\n",
      "['9263360', 'Xu Z; Bouman-Thio E; Comisar C; Frederick B; Van Hartingsveldt B; Marini JC; Davis HM; Zhou H. Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study. British journal of clinical pharmacology. (2011) 72 2 pp270-281', '10.1111/j.1365-2125.2011.03964.x', '']\n",
      "['9263361', 'Kawai S; Takeuchi T; Yamamoto K; Tanaka Y; Miyasaka N. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial. Modern rheumatology / the Japan Rheumatism Association. (2011) 21 5 pp458-468', '10.3109/s10165-011-0425-8', '']\n",
      "['9263363', 'Tanaka C; Shiozawa K; Hashiramoto A; Shiozawa S. A study on the selection of DMARDs for the combination therapy with adalimumab. The Kobe journal of medical sciences. (2012) 58 2 ppE41-50', '10.1186/ar916', '']\n",
      "['9263364', 'Ghorbanihaghjo A; Kolahi S; Seifirad S; Rashtchizadeh N; Argani H; Hajialilo M; Khabazi A; Alizadeh S; Bahreini E. Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial. Archives of Iranian medicine. (2012) 15 9 pp549-552', '10.1016/j.clinbiochem.2009.12.011', '']\n",
      "['9263369', 'Nieuwenhuijse MJ; Valstar ER; Kaptein BL; Nelissen RG. The Exeter femoral stem continues to migrate during its first decade after implantation: 10-12 years of follow-up with radiostereometric analysis (RSA). Acta orthopaedica. (2012) 83 2 pp129-134', '10.3109/17453674.2012.672093', '']\n",
      "['9263370', 'Sugano K; Kontani T; Katsuo S; Takei Y; Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Soen S; Takeuchi T; Hiraishi H; Hiramatsu N. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. Journal of gastroenterology. (2012) 47 5 pp540-552', '10.1007/s00535-012-0541-z', '']\n",
      "['9263372', 'Pijls BG; Valstar ER; Kaptein BL; Fiocco M; Nelissen RG. The beneficial effect of hydroxyapatite lasts: a randomized radiostereometric trial comparing hydroxyapatite-coated, uncoated, and cemented tibial components for up to 16 years. Acta orthopaedica. (2012) 83 2 pp135-141', '10.3109/17453674.2012.665330', '']\n",
      "['9263373', \"Norheim KB; Harboe E; G√∏ransson LG; Omdal R. Interleukin-1 inhibition and fatigue in primary Sj√∂gren's syndrome--a double blind, randomised clinical trial. PloS one. (2012) 7 1 ppe30123\", '10.1371/journal.pone.0030123', '']\n",
      "['9263378', 'Holtmann G; van Rensburg C; Schwan T; Sander P; Siffert W. Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein Œ≤3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?. Digestion. (2011) 84 4 pp289-298', '10.1159/000331468', 'https://karger.com/dig/article-pdf/84/4/289/4034534/000331468.pdf']\n",
      "['9263380', 'Hasegawa M; Imai Y; Hiraoka M; Ito K; Roy A. Model-based determination of abatacept exposure in support of the recommended dose for Japanese rheumatoid arthritis patients. Journal of pharmacokinetics and pharmacodynamics. (2011) 38 6 pp803-832', '10.1007/s10928-011-9221-5', 'http://link.springer.com/article/10.1007/s10928-011-9221-5/fulltext.html']\n",
      "['9263385', 'Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial. Arthritis and rheumatism. (2011) 63 3 pp622-632', '10.1002/art.30194', '']\n",
      "['9263386', 'Oremus K; Sostaric S; Trkulja V; Haspl M. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. (2014) 54 1 pp31-41', '10.1111/trf.12224', '']\n",
      "['9263387', 'Draper T; Ormseth SR; Custodio M; Weisman MH; Irwin MR; and Nicassio PM. Identifying subgroups of rheumatoid arthritis patients based on levels of pain, disability, and depression [abstract]. Arthritis and rheumatism [abstracts of the annual scientific meeting of the american college of rheumatology and association of rheumatology health professionals; 2012 nov 9-14; washington, DC united states]. (2012) 64  ppS673', '10.1037/e546872013-222', '']\n",
      "['9263388', 'Ormseth SR; Draper T; Custodio M; Weisman MH; Irwin MR; and Nicassio PM. Examination of a multidimensional model of disability and role functioning in patients with rheumatoid arthritis [abstract]. Arthritis and rheumatism [abstracts of the annual scientific meeting of the american college of rheumatology and association of rheumatology health professionals; 2012 nov 9-14; washington, DC united states]. (2012) 64  ppS1142', '10.3899/jrheum.111068', '']\n",
      "['9263389', \"Sineglazova AV and Volchegorskii IA. [Effect of mexidol (2-ethyl-6-methyl-3-oxypyridine succinate) on the quality of life and depressive symptoms in women with rheumatoid arthritis]. [Russian]. Eksperimental'naia i klinicheskaia farmakologiia. (2013) 76 1 pp7-10\", '10.17816/kmj105189', 'https://kazanmedjournal.ru/kazanmedj/article/viewFile/105189/pdf']\n",
      "['9263390', 'Heijstek MW; Kamphuis S; Armbrust W; Swart J; Gorter S; de Vries LD; Smits GP; van Gageldonk PG; Berbers GA; Wulffraat NM. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. (2013) 309 23 pp2449-2456', '10.1001/jama.2013.6768', '']\n",
      "['9263394', 'John H; Hale ED; Treharne GJ; Kitas GD; Carroll D. A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford, England). (2013) 52 1 pp81-90', '10.1093/rheumatology/kes237', 'http://academic.oup.com/rheumatology/article-pdf/52/1/81/5176981/kes237.pdf']\n",
      "['9263395', 'Al-Awadi A; Olusi SO; Al-Zaid N; Prabha K. Serum beta2-microglobulin concentration correlates with urinary concentrations of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline in rheumatoid arthritis. Annals of Saudi medicine. (1998) 18  2 pp113-116', '10.5144/0256-4947.1998.113', '']\n",
      "['9263396', 'Itokazu M; Matsunaga T; Oshita Y. Efficacy and safety of auranofin in patients with active early rheumatoid arthritis. Clinical therapeutics. (1995) 17  1 pp60-73', '10.1016/0149-2918(95)80007-7', '']\n",
      "['9263397', 'Klareskog L; Gaubitz M; Rodriguez-Valverde V; Malaise M; Dougados M; Wajdula J. Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (2011) 29  2 pp238-247', '10.1136/ard.2005.038349', '']\n",
      "['9263398', 'Ouyang B-S; Gao J; Che J-L; Zhang Y; Li J; Yang H-Z; Hu T-Y; Yang M; Wu Y-J; Ji L-L. Effect of electro-acupuncture on tumor necrosis factor-alpha and vascular endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis. Chinese journal of integrative medicine. (2011) 17  7 pp505-509', '10.1007/s11655-011-0783-2', 'http://link.springer.com/article/10.1007/s11655-011-0783-2/fulltext.html']\n",
      "['9263399', 'Figen A; Gecene M; Gunduz R; Borman P; Yorgancioglu R. Long-term effects of comprehensive inpatient rehabilitation on function and disease activity in patients with chronic rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Rheumatology. (2011) 26  2 pp135-144', '10.5152/tjr.2011.020', '']\n",
      "['9263400', 'Salesi M; Haddadzavareh SS; Nasri P; Gharaghani NN; Farajzadegan Z. The effect of bromocriptine on the disease activity index in patients with rheumatoid arthritis. [Persian]. Journal of Isfahan Medical School. (2011) 29 133 pp', '10.1111/1756-185x.12015', '']\n",
      "['9263401', 'de los Angeles Pineda M; Thompson SF; Summers K; de Leon F; Pope J; Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical science monitor. (2011) 17  6 ppCR347-CR354', '10.12659/msm.881808', '']\n",
      "['9263402', 'Salesi M; Farajzadegan Z; Karimifar M. Is vitamin D effective on the disease activity index (DAS28) in rheumatoid arthritis?. [Persian]. Journal of Isfahan Medical School. (2011) 29 129 pp', '10.1016/s0953-6205(09)60481-7', '']\n",
      "['9263403', 'Gronning K; Skomsvoll JF; Rannestad T; Steinsbekk A. The effect of an educational programme consisting of group and individual arthritis education for patients with polyarthritis-A randomised controlled trial. Patient education and counseling. (2012) 88  1 pp113-120', '10.1016/j.pec.2011.12.011', '']\n",
      "['9263404', \"Krausz S; Boumans MJH; Gerlag DM; Lufkin J; Van Kuijk AWR; Bakker A; De Boer M; Lodde BM; Reedquist KA; Jacobson EW; O'Meara M; Tak PP. A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64  6 pp1750-1755\", '10.1002/art.34339', '']\n",
      "['9263405', 'Maram SR; Vidyadhara S; Raju NSV. Assessment of bioavailability of glucosamine hydrochloride MR 1500 mg tablets in healthy human subjects. International Journal of Pharmaceutical Sciences Review and Research. (2012) 14  1 pp69-72', '10.23880/beba-16000141', 'https://medwinpublishers.com/BEBA/BEBA16000141.pdf']\n",
      "['9263406', 'Du F; L√º LJ; Teng JL; Shen N; Ye P; Bao CD. T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro. International immunopharmacology. (2012) 13 1 pp54-60', '10.1016/j.intimp.2012.03.003', '']\n",
      "['9263407', 'Le Blay P; Mouterde G; Barnetche T; Morel J; Combe B. Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: Metaanalysis of randomized controlled trials. Journal of rheumatology. (2012) 39  4 pp712-715', '10.3899/jrheum.110982', '']\n",
      "['9263408', 'Baron F; Suciu S; Amadori S; Muus P; Zwierzina H; Denzlinger C; Delforge M; Thyss A; Selleslag D; Indrak K; Ossenkoppele G; de Witte T. Value of infliximab (Remicade) in patients with low-risk myelodys plastic syndrome: Final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia group. Haematologica. (2012) 97  4 pp529-533', '10.3324/haematol.2011.044347', '']\n",
      "['9263409', 'Khan RJ; Maor D; Hofmann M; Haebich S. A comparison of a less invasive piriformis-sparing approach versus the standard posterior approach to the hip: A randomised controlled trial. Journal of bone and joint surgery. British volume. (2012) 94 1 pp43-50', '10.1302/0301-620x.94b1.27001', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.94B1.27001']\n",
      "['9263411', 'Kumar U; Khan MA; Latha MS; Patnaik A; Mathew G; Binny K. Choline magnesium trisalicylate vs naproxen in the symptomatic treatment of rheumatoid arthritis: A randomized clinical trial. Asian Journal of Pharmaceutical and Clinical Research. (2012) 5  1 pp26-31', '10.1007/bf03306125', 'http://link.springer.com/article/10.1007/BF03306125/fulltext.html']\n",
      "['9263412', 'Sibbitt WL; Kettwich LG; Band PA; Chavez-Chiang NR; DeLea SL; Haseler LJ; Bankhurst AD. Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?. Scandinavian journal of rheumatology. (2012) 41 1 pp66-72', '10.3109/03009742.2011.599071', '']\n",
      "['9263414', 'Zhang W; Sun H; Emery P; Sato R; Singh A; Freundlich B; Anis AH. Does achieving clinical response prevent work stoppage or work absence among employed patients with early rheumatoid arthritis?. Rheumatology. (2012) 51  2 pp270-274', '10.1093/rheumatology/ker189', 'http://academic.oup.com/rheumatology/article-pdf/51/2/270/5024036/ker189.pdf']\n",
      "['9263415', 'Maniar RN; Baviskar JV; Singhi T; Rathi SS. To use or not to use continuous passive motion post-total knee arthroplasty presenting functional assessment results in early recovery. Journal of arthroplasty. (2012) 27 2 pp193-200.e1', '10.1016/j.arth.2011.04.009', '']\n",
      "['9263416', 'Figved W; Dahl J; Snorrason F; Frihagen F; R√∂hrl S; Madsen JE; Nordsletten L. Radiostereometric analysis of hemiarthroplasties of the hip--a highly precise method for measurements of cartilage wear. Osteoarthritis and cartilage. (2012) 20 1 pp36-42', '10.1016/j.joca.2011.11.006', '']\n",
      "['9263419', \"Elyan M; Khan MA. Another look at low-dose infliximab in treating ankylosing spondylitis: Editors' comments. Current rheumatology reports. (2007) 9  5 pp350-352\", '10.1007/s11926-008-0056-z', 'http://link.springer.com/article/10.1007/s11926-008-0056-z/fulltext.html']\n",
      "['9263420', 'Curtis JR; Saag KG. Prevention and treatment of glucocorticoid-induced osteoporosis. Current osteoporosis reports. (2007) 5  1 pp14-21', '10.1007/bf02938618', 'http://link.springer.com/article/10.1007/BF02938618/fulltext.html']\n",
      "['9263426', 'Cantini F; Niccoli L; Cassara E; Kaloudi O; Nannini C. Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: A long-term follow-up study. Biologics: Targets and Therapy. (2012) 6  pp201-206', '10.2147/btt.s31145', '']\n",
      "['9263427', 'Ishiguro N; Yamamoto K; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Hara M; Iguratimod-Clinical Study Group. Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial. Modern rheumatology / the Japan Rheumatism Association. (2013) 23 3 pp430-439', '10.3109/s10165-012-0724-8', '']\n",
      "['9263430', 'Genovese MC; Durez P; Richards HB; Supronik J; Dokoupilova E; Mazurov V; Aelion JA; Lee SH; Codding CE; Kellner H; Ikawa T; Hugot S; Mpofu S. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Annals of the rheumatic diseases. (2013) 72 6 pp863-869', '10.1136/annrheumdis-2012-201601', '']\n",
      "['9263432', 'Cima SR; Barone A; Porto JM; de Abreu DC. Strengthening exercises to improve hand strength and functionality in rheumatoid arthritis with hand deformities: a randomized, controlled trial. Rheumatology international. (2013) 33 3 pp725-732', '10.1007/s00296-012-2447-8', 'http://link.springer.com/article/10.1007/s00296-012-2447-8/fulltext.html']\n",
      "['9263433', 'Kumar P; Kennedy G; Khan F; Pullar T; Belch JJ. Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study. Scottish medical journal. (2012) 57 2 pp80-83', '10.1258/smj.2012.012004', 'https://journals.sagepub.com/doi/pdf/10.1258/smj.2012.012004']\n",
      "['9263434', 'Janse van Rensburg DC; Ker JA; Grant CC; Fletcher L. Effect of exercise on cardiac autonomic function in females with rheumatoid arthritis. Clinical rheumatology. (2012) 31 8 pp1155-1162', '10.1007/s10067-012-1985-5', '']\n",
      "['9263436', 'Chapurlat RD; Laroche M; Thomas T; Rouanet S; Delmas PD; de Vernejoul MC. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial. Osteoporosis international. (2013) 24 1 pp311-320', '10.1007/s00198-012-1947-4', 'http://link.springer.com/article/10.1007/s00198-012-1947-4/fulltext.html']\n",
      "['9263437', 'Tak PP; Mease PJ; Genovese MC; Kremer J; Haraoui B; Tanaka Y; Bingham CO; Ashrafzadeh A; Travers H; Safa-Leathers S; Kumar S; Dummer W. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight‚Äö√Ñ√∂‚àö√ë‚àö¬®week randomized, double-blind, placebo-controlled, parallel-group phase III trial. Arthritis and rheumatism. (2012) 64 2 pp360-370', '10.1002/art.33353', '']\n",
      "['9263438', 'Primdahl J; Wagner L; Holst R; H√∏rslev-Petersen K; AMBRA Study Group. The impact on self-efficacy of different types of follow-up care and disease status in patients with rheumatoid arthritis--a randomized trial. Patient education and counseling. (2012) 88 1 pp121-128', '10.1016/j.pec.2012.01.012', '']\n",
      "['9263440', 'Wada T; Son Y; Ozaki Y; Nomura S; Iida H. Clinical and radiographic results from a 2-year comparison of once-weekly versus twice-weekly administration of etanercept in biologics-naive patients with rheumatoid arthritis. Modern rheumatology / the Japan Rheumatism Association. (2012) 22 6 pp824-830', '10.3109/s10165-011-0591-8', '']\n",
      "['9263441', 'Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study. Rheumatology (Oxford, England). (2012) 51 4 pp695-700', '10.1093/rheumatology/ker389', 'http://academic.oup.com/rheumatology/article-pdf/51/4/695/5103789/ker389.pdf']\n",
      "['9263442', 'Gibiansky L; Frey N. Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach. Journal of pharmacokinetics and pharmacodynamics. (2012) 39 1 pp5-16', '10.1007/s10928-011-9227-z', 'http://link.springer.com/article/10.1007/s10928-011-9227-z/fulltext.html']\n",
      "['9263443', 'Gu N; Yi S; Kim TE; Kim J; Shin SG; Jang IJ; Yu KS. Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers. Clinical therapeutics. (2011) 33 12 pp2029-2037', '10.1016/j.clinthera.2011.10.022', '']\n",
      "['9263444', 'Damjanov N; Radunovic G; Prodanovic S; Vukovic V; Milic V; Simic Pasalic K; Jablanovic D; Seric S; Milutinovic S; Gavrilov N. Construct validity and reliability of ultrasound disease activity score in assessing joint inflammation in RA: comparison with DAS-28. Rheumatology (Oxford, England). (2012) 51 1 pp120-128', '10.1093/rheumatology/ker255', 'http://academic.oup.com/rheumatology/article-pdf/51/1/120/5022030/ker255.pdf']\n",
      "['9263445', 'Hu JL; Ouyang GL; Han DP; Xia Q; He Y; Huang Z; Zhu F; Sun ST. [Effects of Tuina and Chinese patent drug Shuxuetong injection on deep venous thrombosis and functional rehabilitation after total knee arthroplasty]. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine]. (2011) 9 10 pp1088-1093', '10.3736/jcim20111009', '']\n",
      "['9263446', 'El Miedany Y; El Gaafary M; Palmer D. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study. Rheumatology international. (2012) 32 10 pp3061-3068', '10.1007/s00296-011-2098-1', 'http://link.springer.com/article/10.1007/s00296-011-2098-1/fulltext.html']\n",
      "['9263447', 'Jiang M; Zha Q; He Y; Lu A. Risk factors of gastrointestinal and hepatic adverse drug reactions in the treatment of rheumatoid arthritis with biomedical combination therapy and Chinese medicine. Journal of ethnopharmacology. (2012) 141 2 pp615-621', '10.1016/j.jep.2011.07.026', '']\n",
      "['9263448', 'Martin RW; Brower ME; Geralds A; Gallagher PJ; Tellinghuisen DJ. An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis. Patient education and counseling. (2012) 86 3 pp329-334', '10.1016/j.pec.2011.06.001', '']\n",
      "['9263450', 'Khanal S; Tomlinson A. Tear physiology in dry eye associated with chronic GVHD. Bone marrow transplantation. (2012) 47 1 pp115-119', '10.1038/bmt.2011.36', 'https://www.nature.com/articles/bmt201136']\n",
      "['9263451', 'Laurberg TB; Ellingsen T; Thorsen J; M√∏ller BK; Hansen I; Tarp U; Hetland ML; H√∏rslev-Petersen K; Flyvbjerg A; Frystyk J; Stengaard-Pedersen K. Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-na√Øve rheumatoid arthritis patients is up-regulated and not influenced by 1¬†year of clinically effective treatment. Rheumatology international. (2012) 32 2 pp501-504', '10.1007/s00296-010-1683-z', 'http://link.springer.com/article/10.1007/s00296-010-1683-z/fulltext.html']\n",
      "['9263452', 'Biswas A; Park E; Bhattacharya R. Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited. Statistical methods in medical research. (2012) 21 4 pp379-392', '10.1177/0962280210385866', 'https://journals.sagepub.com/doi/pdf/10.1177/0962280210385866']\n",
      "['9263453', 'Candelas G; Abasolo L; Leon L; Lajas C; Loza E; Revenga M; Bachiller J; Collado P; Richi P; Blanco M; Jover JA. Diagnostic concordance between primary care physicians and rheumatologists in patients with work disability related to musculoskeletal disorders. Rheumatology international. (2011) 31 12 pp1549-1554', '10.1007/s00296-010-1522-2', 'http://link.springer.com/article/10.1007/s00296-010-1522-2/fulltext.html']\n",
      "['9263454', 'Kulova LA; Burduli NM. [The influence of intravenous laser therapy on the endothelial function and the state of microcirculation in the patients presenting with rheumatoid arthritis]. Voprosy kurortologii, fizioterapii, i lechebnoiÃÜ fizicheskoiÃÜ kultury. (2014)  3 pp9-12', '10.17116/kurort2015311-13', '']\n",
      "['9263455', 'Chandanwale AS; Sundar S; Latchoumibady K; Biswas S; Gabhane M; Naik M; Patel K. Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: A Phase III, 5-day open-label study. Journal of pain research. (2014) 7  pp455-463', '10.2147/jpr.s67817', '']\n",
      "['9263457', 'Kobelt G. Treating to target with etanercept in rheumatoid arthritis: Cost-effectiveness of dose reductions when remission is achieved. Value in health. (2014) 17  5 pp537-544', '10.1016/j.jval.2014.04.005', '']\n",
      "['9263458', 'Demary W; Schwenke H; Rockwitz K; Kastner P; Liebhaber A; Schoo U; Hubner G; Pichlmeier U; Guimbal-Schmolck C; Muller-Ladner U. Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: Patient preference and comparison of the self-injection experience. Patient preference and adherence. (2014) 8  pp1061-1071', '10.2147/ppa.s64111', '']\n",
      "['9263459', 'Ikonomidis I; Tzortzis S; Andreadou I; Paraskevaidis I; Katseli C; Katsimbri P; Pavlidis G; Parissis J; Kremastinos D; Anastasiou-Nana M; Lekakis J. Increased beneft of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis. Circulation: Cardiovascular Imaging. (2014) 7  4 pp619-628', '10.1161/circimaging.113.001193', '']\n",
      "['9263460', 'Richards B; Whittle S; Buchbinder R. The efficacy and safety of muscle relaxants in inflammatory arthritis: A cochrane systematic literature review. Internal medicine journal. (2011) 41  pp27-28', '10.1002/14651858.cd008922', '']\n",
      "['9263461', 'Katikireddi V; Hadwen T; Kubler P; Kevat S; Klestov A; Gunsberg M. Patterns of biologic agent use, efficacy, safety and retention rates in a public hospital and private practice setting. Internal medicine journal. (2011) 41  pp26', '10.1046/j.1445-5994.2001.00038.x', '']\n",
      "['9263462', \"Van Ommen G-J; Aartsma-Rus A; Evers M; Van Roon W; 'tHoen P-B; Kemaladewi D; Verbeek S; Yllmaz-Elis S; Dauwerse H; Lesnik-Oberstein S; Den Dunne JT; Goemans N; Tulinus M; Verschuuren J; De Kimpe S; Campion G; Van Deutekom J. Antisense-based exon skipping as a therapy for duchenne muscular dystrophy, status and prospects. European journal of neurology. (2011) 18  pp7\", '10.1016/s0960-8966(10)00126-4', '']\n",
      "['9263463', 'Marcheggiani Muccioli GM; Grassi A; Rimondi E; Zambelli L; Scarale A; Russo A; Filardo G; Zaffagnini S; Marcacci M. Conservative treatment of early stages of the non-traumatic avascular necrosis of the knee with pulsed electromagnetic fields: A 2-year minimum follow-up study. Journal of orthopaedics and traumatology. (2012) 13 var.pagings ppS11', '10.1016/j.ejrad.2012.11.011', '']\n",
      "['9263464', 'Anonymous. 67th Annual Meeting of the American Society For Surgery of the Hand, ASSH 2012. Journal of hand surgery. (2012) 37 8 SUPPL. 1 ppConference: 67th Annual Meeting of the American Society For Surgery of the Hand, ASSH 2012. Chicago, IL United States. Conference Start: 20120905. Conference End: 20120908. Conference Publication: (var.pagings). 37 (8 SUPPL. 1) (no pagination', '10.1016/j.jhsa.2012.10.020', '']\n",
      "['9263465', 'Aggarwal A; Rahman M; Shenoy S; Misra R. Therapy in enthesitis related arthritis category of JIA: Methotrexate or NSAIDs. International journal of rheumatic diseases. (2012) 15  pp126', '10.1186/ar3651', 'http://link.springer.com/article/10.1186/ar3651/fulltext.html']\n",
      "['9263466', 'Hendry G; Watt G; Brandon M; Friel L; Sturrock R; Gardner-Medwin J; Turner D; Woodburn J. A feasibility trial of multidisciplinary foot care for children and adolescents with juvenile idiopathic arthritis. Internal medicine journal. (2012) 42  pp7', '10.2340/16501977-1130', '']\n",
      "['9263467', 'Siqueira US; Orsini LG; Mello MT; Szejnfeld VL; Pinheiro MM. Water exercises do not improve body composition in women with rheumatoid arthritis: The hydratrial (hydrotherapy in rheumatoid arthritis). Archives of osteoporosis. (2012) 7  ppS143-S144', '10.1097/phm.0000000000000564', '']\n",
      "['9263470', 'Dougados M; Rouanet S; Sibilia J; Combe BG; Le Loet XX; Tebib JG; Jourdan R. One single infusion of rituximab 1G might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 1G): Results of a 2-year multi-center randomized controlled trial. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.2052', '']\n",
      "['9263472', \"Dures E; Kitchen K; Almeida C; Ambler N; Cliss A; Hammond A; Knops B. It's totally turned around the way I think: The patient perspective of cognitive behavioural therapy for fatigue in rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp\", '10.1002/acr.21562', '']\n",
      "['9263478', 'Wiklund I; Raluy M; Jangelind Y; Whiteman D; Conway AM; Pang F; Chen W-H; Muenzer J. The impact on health related quality of life (HRQOL) in patients with hunter syndrome. Molecular genetics and metabolism. (2012) 105  2 ppS66', '10.1016/j.ymgme.2011.11.179', '']\n",
      "['9263479', 'Menon S; Boy MG; Wang C; Wilkinson BE; Zwillich SH; Chan G; Krishnaswami S. Single and multiple-dose pharmacokinetics of tofacitinib (CP-690,550) from a double-blind, placebo-controlled, dose-escalation study in medically stable subjects with psoriasis. Clinical pharmacology and therapeutics. (2012) 91  ppS33', '10.1038/jid.2009.25', '']\n",
      "['9263482', 'Ravindran V; Alias G. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in persistent chikungunya arthritis: A 24-week randomised controlled study. Indian Journal of Rheumatology. (2011) 6  3 SUPPL. 1 ppS5', '10.1016/s0973-3698(11)60109-x', '']\n",
      "['9263483', 'Morimoto N; Yoshimura K; Niimi M; Ito T; Aya R; Fujitaka J; Tada H; Teramukai S; Murayama T; Toyooka C; Miura K; Takemoto S; Kanda N; Kawai K; Yokode M; Shimizu A; Suzuki S. Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers. Tissue engineering. Part A. (2013) 19 17-18 pp1931-1940', '10.1089/ten.tea.2012.0634', '']\n",
      "['9263484', 'Nalamachu S; Rauck RL; Hale ME; Florete OG; Robinson CY; Farr SJ. A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain. Journal of pain research. (2014) 7  pp669-678', '10.2147/jpr.s71536', '']\n",
      "['9263486', 'Shi JG; Chen X; Lee F; Emm T; Scherle PA; Lo Y; Punwani N; Williams WV; Yeleswaram S. The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers. Journal of clinical pharmacology. (2014) 54 12 pp1354-1361', '10.1002/jcph.354', '']\n",
      "['9263487', 'Bostr√∂m E; √ñhrn F; Hanze E; Sandstr√∂m M; Martin P; W√§hlby-Hamr√©n U. Exposure vs. response of blood pressure in patients with rheumatoid arthritis following treatment with fostamatinib. Journal of clinical pharmacology. (2014) 54 12 pp1337-1346', '10.1002/jcph.341', '']\n",
      "['9263489', \"Wallace CA; Ringold S; Bohnsack J; Spalding SJ; Brunner HI; Milojevic D; Schanberg LE; Higgins GC; O'Neil KM; Gottlieb BS; Hsu J; Punaro MG; Kimura Y; Hendrickson A. Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis. Journal of rheumatology. (2014) 41 12 pp2459-2465\", '10.3899/jrheum.140347', '']\n",
      "['9263491', 'Sim HS; Petznick A; Barbier S; Tan JH; Acharya UR; Yeo S; Tong L. A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction. Ophthalmology and Therapy. (2014) 3  1-2 // () *National Medical Research Council* pp37-48', '10.1007/s40123-014-0025-8', '']\n",
      "['9263493', 'Salman S; Shuker S. Atorvastatin for the treatment of rheumatoid arthritis in Iraq. American journal of tropical medicine and hygiene. (2014) 91  5 SUPPL. 1 pp512', '10.4269/ajtmh.914err', 'https://www.ajtmh.org/view/journals/tpmd/91/4/article-p862.xml']\n",
      "['9263495', 'Fan Y; Jin J; Sun Z; Li W; Lin J; Weng X; Qiu G. The limited use of a tourniquet during total knee arthroplasty: a randomized controlled trial. The Knee. (2014) 21 6 pp1263-1268', '10.1016/j.knee.2014.08.002', '']\n",
      "['9263496', 'Capita L; Chalita MR; dos Santos-Neto LL. Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye. Cornea. (2015) 34 2 pp188-192', '10.1097/ico.0000000000000325', '']\n",
      "['9263499', 'Komolafe AO; Ally MMTM; Van Tonder JJ; Greeff OBW. The anti-inflammatory properties of simvastatin can benefit statin-naive rheumatoid arthritis patients with associated risks for cardiovascular disease. South African family practice. (2015) 57  1 pp28-30', '10.1080/20786190.2014.995919', '']\n",
      "['9263500', 'Blakeney WG; Khan H; Khan RJ. Cluster hole versus solid cup in total hip arthroplasty: a randomized control trial. Journal of arthroplasty. (2015) 30 2 pp223-229', '10.1016/j.arth.2014.08.027', '']\n",
      "['9263501', 'Briot K; Rouanet S; Schaeverbeke T; Etchepare F; Gaudin P; Perdriger A; Vray M; Steinberg G; Roux C. The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint, bone, spine. (2015) 82 2 pp109-115', '10.1016/j.jbspin.2014.10.015', '']\n",
      "['9263502', 'Sadashiv KV. Comparative clinical study of Bhallatakadi churna and Eranda sneha in the management of Amavata with special reference to Rheumatoid arthritis. International Journal of Research in Ayurveda and Pharmacy. (2015) 6  1 pp35-38', '10.7897/2277-4343.0619', '']\n",
      "['9263504', 'Jiang X; Qu Q; Li M; Miao S; Li X; Cai W. Horsetail mixture on rheumatoid arthritis and its regulation on TNF-alpha and IL-10. Pakistan journal of pharmaceutical sciences. (2014) 27  6 pp2019-2023', '10.1159/000060522', '']\n",
      "['9263505', 'Pope JE; Haraoui B; Thorne JC; Vieira A; Poulin-Costello M; Keystone EC. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 12 pp2144-2151', '10.1136/annrheumdis-2013-203684', '']\n",
      "['9263508', 'Mazurov VI; Avlokhova SR. [The quality of life in patients with rheumatoid arthritis treated with rituximab]. Klinicheskaia meditsina. (2014) 92 12 pp42-48', '10.1093/rheumatology/kew166.012', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i187/5080330/kew166.012.pdf']\n",
      "['9263509', 'Hirsh JM; Davis LA; Quinzanos I; Keniston A; Caplan L. Health literacy predicts discrepancies between traditional written patient assessments and verbally administered assessments in rheumatoid arthritis. Journal of rheumatology. (2014) 41  2 pp256-264', '10.3899/jrheum.130664', '']\n",
      "['9263511', 'Lee WC; Ruijgrok EJ; Weel AE; Kloppenburg M; Kok MR; Boxma-De Klerk BM; Basoski NM. Efficacy of hydroxychloroquine in primary hand osteoarthritis: A randomized, double-blind, placebo controlled trial. Osteoarthritis and cartilage. (2015) 23  ppA46-A47', '10.1016/j.joca.2015.02.101', '']\n",
      "['9263513', 'Lin T; Gong L. Topical fluorometholone treatment for ocular dryness in patients with Sj√∂gren syndrome: a randomized clinical trial in China. Medicine. (2015) 94 7 ppe551', '10.1097/md.0000000000000551', '']\n",
      "['9263514', 'De Rossi SS; Thoppay J; Dickinson DP; Looney S; Stuart M; Ogbureke KU; Hsu S. A phase II clinical trial of a natural formulation containing tea catechins for xerostomia. Oral surgery, oral medicine, oral pathology and oral radiology. (2014) 118 4 pp447-454.e3', '10.1016/j.oooo.2014.06.015', '']\n",
      "['9263515', 'Zhang J; Gu J; Zheng J; Zheng M; Wang G; Gu Y; Okun M. Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebocontrolled, double-blind Study. Journal of the American Academy of Dermatology. (2015) 72  5 SUPPL. 1 ppAB232', '10.1016/j.jaad.2015.02.937', '']\n",
      "['9263517', 'Haghighi TH; Dousty Y; Fakhri MK. Effectiveness of group cognitive behavioral therapy on illness and pain perception in patients with rheumatoid arthritis. [Persian]. Scientific Journal of Kurdistan University of Medical Sciences. (2015) 20  3 pp45-57', '10.29252/ijhehp.7.3.360', 'http://journal.ihepsa.ir/article-1-886-en.pdf']\n",
      "['9263519', 'Hadi V; Kheirouri S; Alizadeh M; Khabbazi A; Hosseini H. Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. Avicenna Journal of Phytomedicine. (2016) 6  1 pp34-43', '10.3109/08820139.2016.1153649', '']\n",
      "['9263520', 'Lal R; Bell S; Challenger R; Hammock V; Nyberg M; Decker D; Becker PM; Young D. Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone. Journal of clinical pharmacology. (2016) 56  2 pp195-202', '10.1002/jcph.582', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.582']\n",
      "['9263522', \"Feldthusen C; Dean E; Forsblad-D'Elia H; Mannerkorpi K. Effects of person-centered physical therapy on fatigue-related variables in persons with rheumatoid arthritis: A randomized controlled trial. Archives of physical medicine and rehabilitation. (2016) 97  1 pp26-36\", '10.1016/j.apmr.2015.09.022', '']\n",
      "['9263525', 'Fuijkschot J; Seyger MMB; Bastiaans DET; Wevers RA; Roeleveld N; Willemsen MAAP. Zileuton for pruritus in sjogren-larsson syndrome: A randomized double-blind placebo-controlled crossover trial. Acta dermato-venereologica. (2016) 96  2 pp255-256', '10.2340/00015555-2195', '']\n",
      "['9263526', 'Van Vollenhoven RF; Ostergaard M; Leirisalo-Repo M; Uhlig T; Jansson M; Larsson E; Brock F; Franck-Larsson K. Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  1 pp52-58', '10.1136/annrheumdis-2014-205726', '']\n",
      "['9263528', 'Li Y; Sun X; Zhang X; Liu Y; Yang Y; Li R; Liu X; Jia R; Li Z. Establishment of a decision tree model for diagnosis of early rheumatoid arthritis by proteomic fingerprinting. International journal of rheumatic diseases. (2015) 18  8 pp835-841', '10.1111/1756-185x.12595', '']\n",
      "['9263529', 'Hassar M; Weintraub M. \"Uninformed\" consent and the wealthy volunteer: An analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clinical pharmacology and therapeutics. (1976) 20  4 pp379-386', '10.1002/cpt1976204379', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1976204379']\n",
      "['9263531', 'Gao Y. Clinical observation on yishen juanbi capsule combined with western medicine for treatment of elder-onset rheumatoid arthritis.. Chinese Traditional and Herbal Drugs. (2015) 46  11 pp1653-1655', '10.1007/bf02934417', 'https://link.springer.com/article/10.1007/BF02934417/fulltext.html']\n",
      "['9263532', 'Khoury SJ; Rochon J; Ding L; Byron M; Arnold DL; Cook S; Gao W; Tosta P; Sayre PH; Smilek D. Costimulatory blockade with abatacept (CTLA4-Ig) in relapsing-remitting multiple sclerosis: Results from the ACCLAIM trial. Multiple sclerosis (Houndmills, Basingstoke, England). (2015) 23  11 SUPPL. 1 pp269', '10.1177/1352458516662727', 'https://journals.sagepub.com/doi/pdf/10.1177/1352458516662727']\n",
      "['9263533', 'Burmester GR; Durez P; Shestakova G; Genovese MC; Schulze-Koops H; Li Y; Wang YA; Lewitzky S; Koroleva I; Berneis AA; Lee DM; Hueber W. Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis. Rheumatology (United Kingdom). (2016) 55  1 pp49-55', '10.1093/rheumatology/kev258', 'http://academic.oup.com/rheumatology/article-pdf/55/1/49/18096374/kev258.pdf']\n",
      "['9263535', 'Tlustochowicz W; Rahman P; Seriolo B; Krammer G; Porter B; Widmer A; Richards HB. Efficacy and safety of subcutaneous and intravenous loading dose regimens of secukinumab in patients with active rheumatoid arthritis: Results from a randomized phase II study. Journal of rheumatology. (2016) 43  3 pp495-503', '10.3899/jrheum.150117', '']\n",
      "['9263536', 'Lee JC; Menacherry S; Diehl MC; Giffear MD; White CJ; Juba R; Bagarazzi ML; Muthumani K; Boyer J; Agarwal V; Nicoletti F; Bart S; Kim JJ; Weiner DB; Sardesai NY. Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects. Clinical Pharmacology in Drug Development. (2016) 5  2 pp91-101', '10.1002/cpdd.193', '']\n",
      "['9263537', 'Thorner RM; Djordjevic D; Vuckmanovic C; Pesic B; Culafic B; Mark F. A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive medicine. (1973) 2 2 pp295-301', '10.1016/0091-7435(73)90072-8', '']\n",
      "['9263539', 'Xu H; Du J; Miao H; Zhou J; Chen X; Qian H. Effects of combination of iguratimod and NSAID on clinical indices and inflammatory markers in patients with rheumatoid arthritis. International journal of clinical and experimental medicine. (2016) 9 8 pp16511-16516', '10.1007/s10067-017-3668-8', 'http://link.springer.com/article/10.1007/s10067-017-3668-8/fulltext.html']\n",
      "['9263543', 'Cherkasova AV; Garmish IP. Influence on bone mineral density and pain syndrome in patients with rheumatoid arthritis combination calcium carbonate/vitamin D andossein hydroxyapatite complex. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2016. Malaga spain. Conference start: 20160414. Conference end: 20160417. Conference publication: (var.pagings). (2016) 27 1 SUPPL. 1 ppS127', '10.1007/s00198-016-3522-x', 'http://link.springer.com/article/10.1007/s00198-016-3522-x/fulltext.html']\n",
      "['9263544', 'McCloskey E; Harvey NC; Oden A; Jiang H; Modin S; Fitzpatrick LA; Kanis JA; Johansson H. Effect of investigational treatment abaloparatide for prevention of major osteoporotic fracture or any fracture is not altered by baseline fracture probability. Osteoporosis international. Conference: world congress on osteoporosis, osteoarthritis and musculoskeletal diseases, WCO-IOF-ESCEO 2016. Malaga spain. Conference start: 20160414. Conference end: 20160417. Conference publication: (var.pagings). (2016) 27 1 SUPPL. 1 ppS44-S45', '10.1007/s00198-016-3522-x', 'http://link.springer.com/article/10.1007/s00198-016-3522-x/fulltext.html']\n",
      "['9263545', 'Eghtesadi S; Javadi F; Jazayeri S; Ahmadzadeh A; Zabihiyeganeh M; Aryaeian N; Foroushani AR; Eghtesadi M. Effects of quercetin on oxidative and inflammatory markers and disease activity of rheumatoid arthritis patients. Annals of nutrition and metabolism. Conference: 12th european nutrition conference, FENS 2015. Berlin germany. Conference start: 20151020. Conference end: 20151023. Conference publication: (var.pagings). (2015) 67  pp306-307', '10.1080/07315724.2016.1140093', '']\n",
      "['9263551', 'Yu X; Zhang L; Wang L. Effect of double filtration plasmapheresis on MRI-bone erosion in RA. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp262', '10.1136/annrheumdis-2016-eular.1884', '']\n",
      "['9263552', 'Thorne C; Takeuchi T; Karpouzas G; McQuarrie K; Sheng S; Xu W; Peterson S; Ganguly R; Han C; Fei K; Hsu B. Favorable effects of sirukumab treatment on physical function and reductions in morning stiffness in patients with active rheumatoid arthritis and an inadequate response to disease-modifying anti-rheumatic drugs. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp1018-1019', '10.1136/annrheumdis-2016-eular.4308', '']\n",
      "['9263553', 'Castaneda-Hernandez G; Wyand M; Lassen C; Shneyer L; Kay J. Statistical assessment across multiple early time points validates biosimilarity of BOW015 to reference infliximab in patients with active rheumatoid arthritis on stable methotrexate doses. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology of the european league against rheumatism, EULAR 2016. United kingdom. Conference start: 20160608. Conference end: 20160611. (2016) 75  pp228-229', '10.1136/annrheumdis-2016-eular.2740', '']\n",
      "['9263554', 'Meiling X; Bi L; Li P; Ma C; Xu T; Zhang X. Iguratimod for the treatment of rheumatoid arthritis. International journal of rheumatic diseases. Conference: 18th asia pacific league of associations for rheumatology congress, APLAR. China. Conference start: 20160926. Conference end: 20160929. (2016) 19  pp191', '10.1046/j.0219-0494.2003.t01-3-00001.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.0219-0494.2003.t01-3-00001.x']\n",
      "['9263555', 'Kirkham B; Chaabo K; Hall C; Garrood T; Mant T; Allen E; Vincent A; Vasconcelos JC; Prevost AT; Panayi GS; Corrigall VM. Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis. Rheumatology (united kingdom). (2016) 55 11 pp1993-2000', '10.1093/rheumatology/kew287', 'http://academic.oup.com/rheumatology/article-pdf/55/11/1993/18096769/kew287.pdf']\n",
      "['9263558', 'Matsuno H. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids. Drugs in r and d. (2016) 16 4 pp347-353', '10.1007/s40268-016-0146-8', 'http://link.springer.com/article/10.1007/s40268-016-0146-8/fulltext.html']\n",
      "['9263560', 'Miyoshi S; Hey-Hadavi J; Nagaoka M; Tammara B. Pharmacokinetics and food-effect of fosdagrocorat (PF-04171327), a dissociated agonist of the glucocorticoid receptor, in healthy adult Caucasian and Japanese subjects. International journal of clinical pharmacology and therapeutics. (2016) 54 12 pp966-976', '10.5414/cp202659', '']\n",
      "['9263563', 'Shin K; Park SH; Park W; Baek HJ; Lee YJ; Kang SW; Choe JY; Yoo WH; Park YB; Song JS; Lee SG; Yoo B; Yoo DH; Song YW. Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: a 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial. Clinical therapeutics. (2017) 39 2 pp268-278.e2', '10.1016/j.clinthera.2017.01.008', '']\n",
      "['9263564', 'Alvaro-Gracia JM; Jover JA; Garcia-Vicuna R; Carreno L; Alonso A; Marsal S; Blanco F; Martinez-Taboada VM; Taylor P; Martin-Martin C; DelaRosa O; Tagarro I; Diaz-Gonzalez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Annals of the rheumatic diseases. (2017) 76 1 pp196-202', '10.1136/annrheumdis-2015-208918', '']\n",
      "['9263565', 'Ryu JH; Kim JI; Kim HS; Noh GJ; Lee KT; Chung EK. Pharmacokinetic Interactions Between Pelubiprofen and Eperisone Hydrochloride: a Randomized, Open-label, Crossover Study of Healthy Korean Men. Clinical therapeutics. (2017) 39 1 pp138-149', '10.1016/j.clinthera.2016.11.020', '']\n",
      "['9263567', 'Coates LC; Savage L; Waxman R; McGonagle DG; Moverley AR; Helliwell PS. An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas. Clinical rheumatology. (2017) 36 3 pp719-723', '10.1007/s10067-016-3503-7', 'http://link.springer.com/article/10.1007/s10067-016-3503-7/fulltext.html']\n",
      "['9263568', 'Tanaka Y; Yamanaka H; Takeuchi T; Inoue M; Saito K; Saeki Y; Lee SJ; Nambu Y. Safety and efficacy of CT-P13 in Japanese patients with rheumatoid arthritis in an extension phase or after switching from infliximab. Modern rheumatology. (2017) 27 2 pp237-245', '10.1080/14397595.2016.1206244', 'https://tandfonline.com/doi/pdf/10.1080/14397595.2016.1206244']\n",
      "['9263569', 'Ishiguro N; Atsumi T; Harigai M; Mimori T; Nishimoto N; Sumida T; Takeuchi T; Tanaka Y; Nakasone A; Takagi N; Yamanaka H. Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: the FIRST Bio study. Modern rheumatology. (2017) 27 2 pp217-226', '10.1080/14397595.2016.1206507', 'https://tandfonline.com/doi/pdf/10.1080/14397595.2016.1206507']\n",
      "['9263572', 'Yoo DH; Suh CH; Shim SC; Jeka S; Cons-Molina FF; Hrycaj P; Wiland P; Lee EY; Medina-Rodriguez FG; Shesternya P; Radominski S; Stanislav M; Kovalenko V; Sheen DH; Myasoutova L; Lim MJ; Choe JY; Lee SJ; Lee SY; Kwon TS; Park W. A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 3 pp566-570', '10.1136/annrheumdis-2016-209540', '']\n",
      "['9263573', 'Anonymous. Crisaborole (Eucrisa) for atopic dermatitis. Medical letter on drugs and therapeutics. (2017) 59 1515 pp34-35', '10.58347/tml.2023.1673b', '']\n",
      "['9263574', 'Xu P-G; Lei X-F; Ren B-D; Lv S-Y; Zhang J-L. Diclofenac transdermal patch versus the sustained release tablet: a randomized clinical trial in rheumatoid arthritic patients. Tropical journal of pharmaceutical research. (2017) 16 2 pp477-482', '10.4314/tjpr.v16i2.29', '']\n",
      "['9263575', 'Modi JV; Patel KR; Patel ZM; Patel HR; Dhanani SS; Shah BH. Dose response relationship of hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a randomised control study. International journal of pharmaceutical sciences and research. (2017) 8 2 pp856-858', '10.47760/ijpsm.2023.v08i07.007', '']\n",
      "['9263576', 'Aleixo P; Patto JV; Abrantes J. Effects of proprioceptive exercises on ankle dynamic joint stiffness. Gait and posture. Conference: 25th annual meeting of the european society for movement analysis in adults and children, ESMAC 2016. Spain. (2016) 49  pp69', '10.1016/j.gaitpost.2016.07.130', '']\n",
      "['9263577', 'Furie R; Werth VP; Lee E; Box E; Fondal M; Kivitz A; Chatham WW; Kalunian KC; Legerton C; Anolik JH; Korish S; Hough DR; Weiswasser M; Choi S; Schafer P. A phase 2, randomized, placebo-controlled, doubleblind, ascending dose study to evaluate efficacy, safety, and tolerability of CC 220 in subjects with systemic lupus erythematosus. Clinical and experimental rheumatology. Conference: 10th european lupus meeting. Italy. (2016) 34 4 Supplement 99 ppS77', '10.1136/lupus-2016-000179.79', '']\n",
      "['9263578', 'Lassere M; Johnson K. What C-reactive protein (CRP) reduction predicts a physical function benefit in rheumatoid arthritis (RA) clinical trials? The evaluation of CRP as a surrogate endpoint using the surrogate threshold effect (STE) and the biomarker-surrogate evaluation scheme (BSES). Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp31', '10.1186/1471-2288-12-27', 'http://link.springer.com/article/10.1186/1471-2288-12-27/fulltext.html']\n",
      "['9263580', 'Bird P; Bensen W; El-Zorkany B; Kaine J; Heizel Manapat-Reyes B; Pascual-Ramos V; Witcombe D; Anisfield A; Soma K; Zhang R; Thirunavukkarasu K. Comprehensive summary of the efficacy and safety of tofacitinib 5 mg twice daily in patients with rheumatoid arthritis and an inadequate response to disease-modifying antirheumatic drugs. Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp29', '10.1097/rhu.0000000000000786', '']\n",
      "['9263581', 'Sukhdeo A; Joshua F; Damodaran A; Shulruf B. A study on medical students learning ultrasound in rheumatoid arthritis (asmslura). Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp23', '10.1136/annrheumdis-2016-eular.6194', '']\n",
      "['9263582', 'Sandhu A; Kaur J; Pinto B; Kumar P; Gupta N; Kaur P; Sood A; Sharma A; Sharma S; Dhir V. Comparison of two different folic acid doses with methotrexate-a randomized controlled trial (Folvari Study). Internal medicine journal. Conference: 56th annual scientific meeting of the australian rheumatology association in conjunction with the rheumatology health professionals association. Australia. (2015) 45  pp33', '10.1186/s13075-015-0668-4', 'https://link.springer.com/article/10.1186/s13075-015-0668-4/fulltext.html']\n",
      "['9263583', 'Pavelka K; Akkoc N; Al-Maini M; Zerbini C; Bao C; Karateev D; Nasonov E; Rahman M; Pedersen R; Dinh A; Shen Q; Vasilescu R; Kotak S; Mahgoub E; Vlahos B. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDS alone in active rheumatoid arthritis: results of an international treat-to-target study with a double-blind, placebo-controlled maintenance phase. Journal of clinical rheumatology. Conference: 19th pan american league of associations for rheumatology congress. Panama. (2016) 22 3 pp127-128', '10.1007/s00296-017-3749-7', 'https://link.springer.com/article/10.1007/s00296-017-3749-7/fulltext.html']\n",
      "['9263586', 'Perez-Gilbe A; Lazaro MA; Barragan SD; Vargas F. Adherence to the treat-to-target strategyand impact on treatment outcomes in a cohort of patients with early rheumatoid arthritis in Latin America. Journal of clinical rheumatology. Conference: 19th pan american league of associations for rheumatology congress. Panama. (2016) 22 3 pp134', '10.1093/rheumatology/kew144.010', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i95/5078968/kew144.010.pdf']\n",
      "['9263588', 'Fary R; Slater H; Chua J; Ranelli S; Chan M; Briggs A. Building workforce capacity in management of rheumatoid arthritis: a single-blind, parallel, randomised controlled trial of web-based e-learning for physiotherapists to improv eknowledge and skills for the management of rheumatoid arthritis in community settings (trial registration: actrn12613000659707). Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp8', '10.1016/j.physio.2015.03.593', '']\n",
      "['9263589', 'Bird P; Shnier R. Examination of the effectiveness of diffusion weighted magnetic resonance imaging for identifying poor prognosis in patients with rheumatoid arthritis. Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp30', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9263590', 'Nash P; Genovese M; Hochberg M; Cohen R; Weinblatt M; Kaine J; Keystone E; Delaet I; Alten R. Prolonged exposure to subcutaneous and intravenous abatacept in patients with rheumatoid arthritis does not affect rates of infection, malignancy and autoimmune events: results from pooled clinical trial data. Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp29-30', '10.1136/annrheumdis-2013-eular.1854', '']\n",
      "['9263592', 'Proudman S; Cleland L; Lee A; Wechalekar M; Metcalf R; Sullivan T; Spargo L; James M. Relationship between plasma omega-3 fatty acids and clinical outcomes in recent onset rheumatoid arthritis. Internal medicine journal. Conference: 55th annual scientific meeting of the australian rheumatology association in conjunction with rheumatology health professionals. Australia. (2014) 44  pp24-25', '10.1017/s0007114515002718', '']\n",
      "['9263593', 'Nader A; Kluender B; Kwatra NV; Wegzyn C; Mostafa NM. Pharmacokinetic and exposure-response analyses for extrapolation of efficacy of adalimumab in adolescent patients with hidradenitis suppurativa. Experimental dermatology. Conference: 6th conference of the european hidradenitis suppurativa foundation e.v., EHSF 2017. Denmark. (2017) 26  pp29', '10.1111/exd.13282', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fexd.13282']\n",
      "['9263594', 'Ternant D; Passot C; Mulleman D; Desvignes C; Lecomte T; Paintaud G. Estimating pharmacokinetic parameters of infliximab using only one concentration measurement. Fundamental and clinical pharmacology. Conference: annual meeting of french society of pharmacology and therapeutics, and INSERM clinical research centers, CIC meeting 2017. France. (2017) 31  pp19', '10.1007/s40262-017-0621-6', 'http://link.springer.com/article/10.1007/s40262-017-0621-6/fulltext.html']\n",
      "['9263595', 'Herbelin L; Becker B; Dimachkie M; Statland J; Pasnoor M. Methotrexate polyglutamation in myasthenia gravis. Journal of clinical neuromuscular disease. Conference: 38th annual carrell-krusen neuromuscular symposium, CK 2016. United states. (2016) 17 3 pp178-179', '10.1212/wnl.86.16_supplement.p3.173', '']\n",
      "['9263597', 'Schulze-Koops H; Strand V; Nduaka C; DeMasi R; Wallenstein G; Kwok K; Wang L. Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. Rheumatology (oxford, england). (2017) 56 1 pp46-57', '10.1093/rheumatology/kew329', 'http://academic.oup.com/rheumatology/article-pdf/56/1/46/8668657/kew329.pdf']\n",
      "['9263598', 'Paskins Z; Whittle R; Hider S; Sultan AA; Edward R; Mallen C. Risk of fragility fracture over 10 years across eight inflammatory conditions: a UK population study. Osteoporosis international. Conference: osteoporosis conference 2016. United kingdom. (2016) 27 2 Supplement ppS616-S617', '10.1093/rheumatology/kex062.092', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.092/19705612/kex062.092.pdf']\n",
      "['9263599', 'Park W; Suh C-H; Shim SC; Molina FFC; Jeka S; Medina-Rodriguez FG; Hrycaj P; Wiland P; Lee EY; Shesternya P; Kovalenko V; Myasoutova L; Stanislav M; Radominski S; Lim MJ; Choe J-Y; Lee SJ; Lee SY; Kim SH; Yoo DH. Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis. Biodrugs. (2017) 31 4 pp369-377', '10.1007/s40259-017-0233-6', 'http://link.springer.com/article/10.1007/s40259-017-0233-6/fulltext.html']\n",
      "['9263600', 'Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain. BMC musculoskeletal disorders. (2017) 18 1 pp337', '10.1186/s12891-017-1664-4', 'http://link.springer.com/content/pdf/10.1186/s12891-017-1664-4.pdf']\n",
      "['9263602', 'Conrado DJ; Krishnaswami S; Shoji S; Kolluri S; Hey-Hadavi J; McCabe D; Rojo R; Tammara BK. Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose-response analysis. Journal of pharmacokinetics and pharmacodynamics. (2016) 43 3 pp325-341', '10.1007/s10928-016-9475-z', 'http://link.springer.com/article/10.1007/s10928-016-9475-z/fulltext.html']\n",
      "['9263603', \"Leung WK; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Namour F; Xin Y; Sharma S; Tasset C; Van Der Aa A; Harrison P; Vermeire S. Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn's disease: 10-week efficacy, safety and exposure-response analysis of the phase 2 FITZROY study. Journal of gastroenterology and hepatology. (2017) Conference: Asian Pacific Digestive Week, APDW 2017. Hong Kong. 32 Supplement 3 pp33\", '10.1016/s0016-5085(17)32146-7', '']\n",
      "['9263608', 'Schougaard L; Hjollund N. AmbuFlex-experiences of PRO-based clinical decision-making. Quality of life research. (2017) Conference: 24th Annual Conference of the International Society for Quality of Life Research, ISOQOL 2017. United States. 26 1 Supplement 1 pp8', '10.1007/s11136-017-1658-6', 'http://link.springer.com/article/10.1007/s11136-017-1658-6/fulltext.html']\n",
      "['9263610', 'Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: a Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study. Journal of medicinal food. (2017) 20 10 pp1022-1030', '10.1089/jmf.2017.3930', '']\n",
      "['9263611', 'El Aziz HGA; Hamada HA; El Khatib A. Impact of backward treadmill training on balance in children with juvenile rheumatoid arthritis: a randomized controlled study. Biomedical research (india). (2017) 28 17 pp7703-7708', '10.1093/jpepsy/28.1.17', 'http://academic.oup.com/jpepsy/article-pdf/28/1/17/9837232/17.pdf']\n",
      "['9263612', 'Gibiansky L; Gibiansky E; Frey N; Mallalieu NL; Petry C; Charoin J-E; Douglass W; Hsu JC. Bridging from intravenous to subcutaneous formulation of tocilizumab for optimal dose regimens in polyarticular juvenile idiopathic arthritis (pJIA). Journal of pharmacokinetics and pharmacodynamics. Conference: 8th american conference on pharmacometrics, acop 2017. United states. (2017) 44 1 Supplement 1 ppS132', '10.1136/annrheumdis-2017-eular.2483', '']\n",
      "['9263613', 'Yeomans ND; Graham DY; Husni ME; Solomon DH; Stevens T; Vargo JJ; Wang Q; Wisniewski LM; Wolski KE; Nissen SE. Gastrointestinal events in arthritis patients at increased cardiovascular risk treated chronically with celecoxib, naproxen or ibuprofen: the precision randomized controlled trial. Gastroenterology. Conference: digestive disease week 2017, DDW 2017. United states. (2017) 152 5 Supplement 1 ppS166', '10.1016/s0016-5085(17)30873-9', '']\n",
      "['9263614', \"Sandborn WJ; Sands BE; Danese S; D'Haens GR; Vermeire S; Schreiber S; Feagan BG; Reinisch W; Friedman G; Woodworth DA; Zhang H; Lawendy N; Niezychowski W; Su C; Panes J. Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomized controlled trial. Gastroenterology. Conference: digestive disease week 2017, DDW 2017. United states. (2017) 152 5 Supplement 1 ppS199\", '10.1016/s0016-5085(17)30971-x', '']\n",
      "['9263615', 'Syngle A; Garg N; Krishan P. Rosuvastatin improves inflammation and vascular function in rheumatoid arthritis. Indian journal of rheumatology. (2014) Conference: 30th Annual Conference of the Indian Rheumatology Association, IRACON 2014. India. 9 5 Supplement ppS17-S18', '10.1016/j.injr.2014.10.041', '']\n",
      "['9263616', \"Montalban X; Bojanowski J; Martin E; Willmer J. Design of a phase II dose range finding, efficacy and safety study of the Bruton's tyrosine kinase inhibitor evobrutinib (M2951) in relapsing multiple sclerosis patients. Multiple sclerosis journal. Conference: 7th joint ECTRIMS-ACTRIMS, MSPARIS2017. France. (2017) 23 3 Supplement 1 pp324\", '10.26226/morressier.59a3eda8d462b8028d8952b3', '']\n",
      "['9263617', 'Lumley MA; Anderson T; Ankawi B; Goldman G; Perri LM; Bianco JA; Keefe FJ. The working alliance and Clinician-assisted Emotional Disclosure for rheumatoid arthritis. Journal of psychosomatic research. (2018) 104  pp9-15', '10.1016/j.jpsychores.2017.11.004', '']\n",
      "['9263618', 'Lindqvist H; Gjertsson I; Eneljung T; Winkvist A. Blue mussel (Mytilus edulis) intake decreases disease activity (DAS-28 CRP) in female patients with rheumatoid arthritis: results from a randomized crossover dietary intervention. Annals of nutrition and metabolism. Conference: 21st international congress of nutrition, ICN 2017. Argentina. (2017) 71 Supplement 2 pp349', '10.3390/nu10040481', '']\n",
      "['9263619', 'Lo C-N; Xia G; Leung BP. The effect of nerve mobilization exercise in patients with rheumatoid arthritis: a pilot study. Reumatismo. (2017) 69 3 pp111-118', '10.4081/reumatismo.2017.918', 'http://www.reumatismo.org/index.php/reuma/article/viewFile/918/759']\n",
      "['9263620', 'Singh H; Kiran B; Kumar N; Yadav M; Mittal A; Mathur R. Comparison of clinical efficacy of split versus conventional weekly oral dose methotrexate in patients of rheumatoid arthritis: a case control study. Indian journal of rheumatology. Conference: 33rd annual conference of the indian rheumatology association, IRACON 2017. India. (2017) 12 5 Supplement 1 ppS45', '10.1016/j.injr.2016.03.002', 'https://journals.sagepub.com/doi/pdf/10.1016/j.injr.2016.03.002']\n",
      "['9263621', 'Stavropoulos A; Manthou E; Nakopoulou T; Georgakouli K; Jamurtas A. HPR effects of beetroot juice supplementation on endothelial function and markers of inflammation among patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 Suppl 2 pp1536-1537', '10.1136/annrheumdis-2017-eular.4519', '']\n",
      "['9263622', 'Fernandez-Diaz C; Martin-Lopez M; Carrasco-Cubero M; Reina-Sanz D; Rubio-Munoz P; Urruticoechea-Arana A; Miranda-Filloy J; Vegas-Revenga N; Dominguez-Casas L; Gonzalez-Gay M; Blanco R. Rituximab in rheumatoid arthritis with interstitial lung disease: a multicenter study. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp569-570', '10.1136/annrheumdis-2017-eular.3275', '']\n",
      "['9263624', 'Meijer L; Hery-Arnaud G; Le Berre R; Nowak E; Rault G; Mottier D. ROSCO-CF, a safety and efficacy clinical trial of (R)-roscovitine in cystic fibrosis patients. Journal of cystic fibrosis. (2018) 17 Suppl 3 ppS25', '10.1016/s1569-1993(18)30196-6', '']\n",
      "['9263627', 'Dokoupilov√° E; Aelion J; Takeuchi T; Malavolta N; Sfikakis PP; Wang Y; Rohrer S; Richards HB. Secukinumab after anti-tumour necrosis factor-Œ± therapy: a phase III study in active rheumatoid arthritis. Scandinavian journal of rheumatology. (2018) 47 4 pp276-281', '10.1080/03009742.2017.1390605', '']\n",
      "['9263629', 'Gao HL; Xiao LB; Zhai WT; He Y; Zhu F; Zheng L; Han XW. Comparison of analgesic effects between multimodal and patient-controlled intravenous analgesia in patients with rheumatoid arthritis in the perioperative period of total knee arthroplasty. Zhongguo gu shang [China journal of orthopaedics and traumatology]. (2017) 30 4 pp356-359', '10.21203/rs.3.rs-42566/v2', 'https://www.researchsquare.com/article/rs-42566/v2']\n",
      "['9263630', 'Gossage DL; Cieslarov√° B; Ap S; Zheng H; Xin Y; Lal P; Chen G; Smith V; Sundy JS. Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis. Clinical therapeutics. (2018) 40 1 pp156-165.e5', '10.1016/j.clinthera.2017.11.011', '']\n",
      "['9263632', 'Larkin L; Gallagher S; Fraser A; Kennedy N. Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial. Rheumatology international. (2017) 37 12 pp2095-2103', '10.1007/s00296-017-3850-y', 'http://link.springer.com/article/10.1007/s00296-017-3850-y/fulltext.html']\n",
      "['9263634', 'Genovese MC; Weinblatt ME; Mease PJ; Aelion JA; Peloso PM; Chen K; Li Y; Liu J; Othman AA; Khatri A; Mansikka HT; Leszczynski P. Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis. Rheumatology. 2018 jul 18. (2018) 57 11 pp1972-1981', '10.1093/rheumatology/key173', 'http://academic.oup.com/rheumatology/article-pdf/57/11/1972/26146562/key173.pdf']\n",
      "['9263635', 'Khandaker GM; Oltean BP; Kaser M; Dibben CRM; Ramana R; Jadon DR; Dantzer R; Coles AJ; Lewis G; Jones PB. Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ open. (2018) 8 9 ppe025333', '10.1136/bmjopen-2018-025333', '']\n",
      "['9263636', 'Paulshus Sundlisaeter N; Olsen IC; Aga A-B; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol. Rheumatology (Oxford, England). (2018) 57 11 pp2022-2031', '10.1093/rheumatology/key202', 'http://academic.oup.com/rheumatology/article-pdf/57/11/2022/26146618/key202.pdf']\n",
      "['9736478', 'Akbal N; Aydin K; Tezcan M E. Metabolic syndrome is not uncommon in treatment-naive rheumatoid arthritis patients. Netherlands journal of medicine. (2019) 77 6 pp204-209', '10.1111/1756-185x.13992', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13992']\n",
      "['9736479', 'IRCT201502244641N10. Effect of extract of Stoechas Lamiaceae on mild and moderate carpal tunnel syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201502244641N10. (2015)   pp', '10.1016/j.rehab.2018.05.270', '']\n",
      "['9736480', 'Killinger Zdenko; Gajdarova Lenka; Kuzma Martin; Krajcovicova Anna; Brazdilova Kristina; Jackuliak Peter; Payer Juraj. Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-up. Acta clinica Belgica. (2019) 74 2 pp121-125', '10.1080/17843286.2018.1512189', '']\n",
      "['9736481', \"NCT02147509. Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome. https://clinicaltrials.gov/show/NCT02147509. (2014)   pp\", '10.1097/icl.0000000000000000', '']\n",
      "['9736482', 'Oguro Nao; Yajima Nobuyuki; Miwa Yusuke. Age and quality of life in patients with rheumatoid arthritis treated with biologic agents. Modern rheumatology. (2020) 30 1 pp44-49', '10.1080/14397595.2018.1551274', '']\n",
      "['9736483', 'ISRCTN42466047. The effect of using copper heelers in alleviating joint and musculoskeletal aches and pains. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN42466047. (2010)   pp', '10.1186/isrctn42466047', '']\n",
      "['9736484', 'EUCTR2008-005212-40-SE. Pain mechanisms and fatigue in rheumatoid arthritis (RA) and healthy volunteers. Can antirheumatic and biological therapy affect pain processing and fatigue in RA? - RA PAIN PROCESSING. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-005212-40-SE. (2008)   pp', '10.1016/s1754-3207(11)70433-3', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS1754-3207%2811%2970433-3']\n",
      "['9736485', 'NCT00439062. Treatment of Rheumatoid Arthritis With Roxithromycin. https://clinicaltrials.gov/show/NCT00439062. (2007)   pp', '10.1016/b978-0-443-10110-6.50011-2', '']\n",
      "['9736486', 'Ebaid A; Mortada MA; Atwa E; Hammad NM. Serum IL17 correlated with inflammatory changes but not with bony changes in both hand osteoarthritis and rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1502', '10.1136/annrheumdis-2019-eular.2253', '']\n",
      "['9736489', 'ChiCTR-ONRC-12002082. Comparison of Corneal Sensitivity between FS-LASIK and Femtosecond Lenticule Extraction (ReLEx flex) or Small Incision Lenticule Extraction (ReLEx smile) For Myopic Eye. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-ONRC-12002082. (2012)   pp', '10.1007/s00417-013-2272-0', 'http://link.springer.com/article/10.1007/s00417-013-2272-0/fulltext.html']\n",
      "['9736490', 'EUCTR2011-004017-17-GB. Tocilizumab and Remission in early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-004017-17-GB. (2013)   pp', '10.1186/isrctn75505683', '']\n",
      "['9736492', 'Folmo HD; TerWee MM; Den Uyl D; Konijn NP; Kerstens PJ; Voskuyl AE; Van Schaardenburg D; Nurmohamed MT; Boers M; Lems WF. Decline in anti-CCP and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1297', '10.1136/annrheumdis-2018-eular.5167', '']\n",
      "['9736493', 'Perez-Vazquez F; Back M; Chavarria-Avila E; Gomez-Banuelos E; Ramos-Becerra CG; Pizano-Martinez O; Salazar-Paramo M; Grover-Paez F; Nava-Zavala AH; Cardona-Munoz EG; Cardona-Muller D; Duran-Barragan S; Mera-Riofrio VN; Prado-Bachega N; Vazquez-Del Mercado M. Enalapril influence on arterial stiffness in rheumatoid arthritis women: a randomized clinical trial. Frontiers in medicine. (2020) 6  pp', '10.3389/fmed.2019.00341', '']\n",
      "['9736494', 'DRKS00017272. The importance of motion diagnostics to promote early physical activity in children with rheumatic diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00017272. (2019)   pp', '10.1136/annrheumdis-2018-eular.7777', '']\n",
      "['9736495', 'IRCT2017052134062N1. The effect of dehydroepiandrosterone on quality of life. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017052134062N1. (2017)   pp', '10.1186/isrctn21578845', '']\n",
      "['9736496', 'NCT04161339. Anti-inflammatory drug and endothelial function. https://clinicaltrials.gov/show/NCT04161339. (2019)   pp', '10.31525/ct1-nct04161339', '']\n",
      "['9736497', 'CTRI/2013/05/003678. to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis.‚àö¬¢??. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2013/05/003678. (2013)   pp', '10.1186/isrctn05568900', '']\n",
      "['9736498', 'EUCTR2017-004226-15-DK. Can-Art Effect and safety of using Canabis derivatives for the treatment of pain in patients with inflammatory Arthritis, such as reumatoid arthritis and  ankylosing spondylitis,  the latter being a type of arthritis that causes a long term inflammation of the joints of the spine.  A randomized, double blinded, placebo controlled trial, i.e. in this drug trial, a control group is given a placebo while another group is given the Cannabis derivative being studied. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-004226-15-DK. (2018)   pp', '10.4172/2167-7921.s1-001', '']\n",
      "['9736499', 'UMIN000003294. Clinical assessment of secondary AA amyloidosis associated with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003294. (2010)   pp', '10.1097/01.rhu.0000226777.23501.87', '']\n",
      "['9736501', 'Powel LL. Commentary on The postmastectomy pain syndrome and topical capsaicin: a randomized trial. ONS nursing scan in oncology. (1993) 2 3 pp1-1', '10.1097/00132586-199308000-00049', '']\n",
      "['9736502', 'CTRI/2010/091/000070. Azathioprine Bioequivalence study in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2010/091/000070. (2010)   pp', '10.1055/s-0030-1248131', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0030-1248131.pdf']\n",
      "['9736503', 'EUCTR2013-003413-18-NL. Arthritis prevention with abatacept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003413-18-NL. (2015)   pp', '10.1093/ww/9780199540884.013.u209432', '']\n",
      "['9736504', 'Monnet Emmanuel; Choy Ernest H; McInnes Iain; Kobakhidze Tamta; de Graaf Kathy; Jacqmin Philippe; Lapeyre Genevieve; de Min Cristina. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Annals of the rheumatic diseases. (2020) 79 3 pp316-323', '10.1136/annrheumdis-2019-216487', '']\n",
      "['9736506', 'IRCT2015030321315N1. The effect of Adalimumab on treatment of Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015030321315N1. (2015)   pp', '10.1186/isrctn68762628', '']\n",
      "['9736507', 'CTRI/2018/03/012709. A clinical study to study the effect of  drug AKKINI CHOORANAM on Vali azhal keel vaayu Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/03/012709. (2018)   pp', '10.1016/j.jval.2018.07.687', '']\n",
      "['9736509', 'EUCTR2006-003983-73-DE. A Phase IIa Multicenter, Randomized, Double-Blind, Placebo -Controlled, Parallel Group Study of RWJ-445380 Cathepsin-S Inhibitor in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003983-73-DE. (2007)   pp', '10.1136/annrheumdis-2014-eular.2404', '']\n",
      "['9736510', 'IRCT201504119894N2. The  affect of aloe Vera  cream and infrared radiation therapy on diabetic foot ulcer. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201504119894N2. (2016)   pp', '10.1186/isrctn55474813', '']\n",
      "['9736512', 'Kappos L; Leppert D; Tinbergen J; Gerber M; Hauser S L. Risk of infections and malignancies after treatment with anti-CD20 monoclonal antibodies: ocrelizumab and rituximab in rheumatoid arthritis and multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). (2012) 18 4 SUPPL. 1 pp424', '10.1016/s0140-6736(12)60509-1', '']\n",
      "['9736513', 'Takeuchi T; Matsubara T; Atsumi T; Amano K; Ishiguro N; Sugiyama E; Yamaoka K; Genovese MC; Kalunian K; Walker D; Gottenberg J-E; De Vlam K; Mozaffarian N; Bartok B; Matzkies F; Gao J; Guo Y; Tasset C; Sundy J; Tanaka Y. Safety and efficacy of filgotinib in Japanese patients enrolled in a global phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic DMARDS. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1686-1687', '10.1136/annrheumdis-2019-eular.2123', '']\n",
      "['9736516', 'Matsuno H; Tomomitsu M; Hagino A; Shin S; Lee J; Song Y W. A phase III, multicenter, double-blind, randomized, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-212172', '']\n",
      "['9736517', 'IRCT2013052313441N1. effect of humor therapy on fatigue. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013052313441N1. (2014)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9736518', \"Marcolongo R; Coppi R; Zannella F. Double-blind cross-over clinical study of the effectiveness and tolerability of fenbufen versus ibuprofen in the therapy of rheumatoid arthritis. Sperimentazione clinica in double-blind cross-over sull'efficacia e tollerabilita del fenbufen versus ibuprofen nella terapia dell'artriet reumatoide.. (1979) 90 1 pp47-62\", '10.1136/bmj.4.5884.82', '']\n",
      "['9736519', 'DeClercq Vanessa; Cui Yunsong; Forbes Cynthia; Grandy Scott A; Keats Melanie; Parker Louise; Sweeney Ellen; Yu Zhijie Michael; Dummer Trevor J B. Adiposity Measures and Plasma Adipokines in Females with Rheumatoid and Osteoarthritis. Mediators of inflammation. (2017) 2017  pp4302412', '10.1155/2017/4302412', 'http://downloads.hindawi.com/journals/mi/2017/4302412.pdf']\n",
      "['9736520', 'Nagai Kota; Matsubayashi Keisuke; Ide Kazuki; Seto Kahori; Kawasaki Yohei; Kawakami Koji. Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: a Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies. Clinical drug investigation. (2020) 40 3 pp197-209', '10.1007/s40261-020-00887-6', 'http://link.springer.com/article/10.1007/s40261-020-00887-6/fulltext.html']\n",
      "['9736521', 'IRCT201405308698N14. Effect of colchicine on pericardial effusion after open heart surgery. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201405308698N14. (2014)   pp', '10.1136/heart.89.7.780', '']\n",
      "['9736523', 'NCT00869349. Living Well With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00869349. (2009)   pp', '10.1002/msc.1004', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1004']\n",
      "['9736524', 'Buttgereit Frank; Strand Vibeke; Lee Eun Bong; Simon-Campos Abraham; McCabe Dorothy; Genet Astrid; Tammara Brinda; Rojo Ricardo; Hey-Hadavi Judith. Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study. RMD open. (2019) 5 1 ppe000889', '10.1136/rmdopen-2018-000889', '']\n",
      "['9736525', 'Mohamed Mohamed-Eslam F; Trueman Sheryl; Othman Ahmed A; Han Jian-Hwa; Ju Tzuchi R; Marroum Patrick. Development of In Vitro-In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation. AAPS journal. (2019) 21 6 pp108', '10.1208/s12248-019-0378-y', 'http://link.springer.com/article/10.1208/s12248-019-0378-y/fulltext.html']\n",
      "['9736526', 'Yoshida K; Oda F; Shoujinaga T; Kawasaki M; Yoshida Y; Okada A; Suzuki T; Kawakami A; Origuchi T. Combination effect of exercise instruction and biologics on rheumatoid arthritis patients-a randomized controlled trial. International journal of rheumatic diseases. (2019) Conference: 21st Asia Pacific League of Associations for Rheumatology Congress, APLAR 2019. Australia. 22 Supplement 3 pp221', '10.1111/1756-185x.70164', '']\n",
      "['9736527', 'Burggraaf Benjamin; van Breukelen-van der Stoep Deborah F; de Vries Marijke A; Klop Boudewijn; Liem Anho H; van de Geijn Gert-Jan M; van der Meulen Noelle; Birnie Erwin; van der Zwan Ellen M; van Zeben Jende; Castro Cabezas Manuel. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial. Annals of the rheumatic diseases. (2019) 78 3 pp335-341', '10.1136/annrheumdis-2018-214075', '']\n",
      "['9736529', 'Orlova E; Karateev D; Denisov L; Kochetkov A; Nasonov E. Efficacy of two long-term exercise programs in patients with early rheumatoid arthritis: results of 12-month randomized controlled trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp893-894', '10.1136/annrheumdis-2016-eular.5447', '']\n",
      "['9736530', 'NCT00357903. Open-Label Extension Treatment With Etanercept (TNFR: fc) for Participating Patients in Etanercept (TNFR: fc) Clinical Trials. https://clinicaltrials.gov/show/NCT00357903. (2006)   pp', '10.2165/00126839-199901010-00025', '']\n",
      "['9736531', 'NCT01282255. Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01282255. (2011)   pp', '10.37473/fic/10.2174/2772432817666220202115623', '']\n",
      "['9736532', 'ChiCTR-OOQ-17013531. Study on the effect of continuous nursing on the quality of life of patients with rheumatoid arthritis combined with pulmonary interstitial lesions. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-OOQ-17013531. (2017)   pp', '10.26689/jcnr.v8i7.7885', 'https://ojs.bbwpublisher.com/index.php/JCNR/article/download/7885/6793']\n",
      "['9736533', 'Wang R H; Chen Y C; Wang W L; Qiu S W; Ye Q; Lin D. Effect of Juanbi decoction combied with methotrexate and leflunomide tablets on active stage rheumatoid arthritis with cold dampness syndrome. Chinese journal of experimental traditional medical formulae [zhongguo shi yan fang ji xue za zhi]. (2016) 22 6 pp167-171', '10.1186/s13063-018-2555-1', 'http://link.springer.com/article/10.1186/s13063-018-2555-1/fulltext.html']\n",
      "['9736534', 'Malhotra K; Sader S. A case of steroid and mycophenolate mofetil-resistant neuromyelitis optica exacerbation treated with plasma exchange. Journal of hospital medicine. (2011) 6 4 SUPPL. 2 ppS210-S211', '10.1007/s40278-020-85451-6', 'http://link.springer.com/article/10.1007/s40278-020-85451-6/fulltext.html']\n",
      "['9736535', 'Zeidler H; Kaltwasser JP; Leonard JP; Kohlmann T; Sigmund R; Degner F; et al. Prescription and tolerability of meloxicam in day-to-day practice: Postmarketing observational cohort study of 13,307 patients in germany. Journal of clinical rheumatology. (2002) 8 6 pp305-315', '10.1097/00124743-200212000-00005', '']\n",
      "['9736537', \"KCT0000080. Clinical trial Phase II for adult patients in order to evaluate efficacy and safety of Wemate¬Æ(Zinc Acexamate) regarding prevention of small bowel's erosion induced by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). http://www.who.int/trialsearch/Trial2.aspx?TrialID=KCT0000080. (2011)   pp\", '10.1186/isrctn91790322', '']\n",
      "['9736539', 'EUCTR2016-003630-25-BE. A Multicenter, Double-blind, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-003630-25-BE. (2017)   pp', '10.1136/rmdopen-2024-004476corr1', '']\n",
      "['9736540', 'ISRCTN16761141. Prevalence and severity of periodontitis in patients with rheumatoid arthritis (RA) and the effects of treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN16761141. (2017)   pp', '10.1186/isrctn16761141', '']\n",
      "['9736541', '√Ålvaro-Gracia JM; Jover JA; Garc√≠a-Vicu√±a R; Carre√±o L; Alonso A; Marsal S; Blanco F; Mart√≠nez-Taboada VM; Taylor P; Mart√≠n-Mart√≠n C; DelaRosa O; Tagarro I; D√≠az-Gonz√°lez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Annals of the rheumatic diseases. (2017) 76 1 pp196-202', '10.1136/annrheumdis-2015-208918', '']\n",
      "['9736543', 'IRCT20171106037265N1. comparison of the effect of Saffron and Duloxetine on pain and depression in Rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20171106037265N1. (2018)   pp', '10.1002/art.1790050406', '']\n",
      "['9736544', 'Winkvist Anna; Barebring Linnea; Gjertsson Inger; Ellegard Lars; Lindqvist Helen M. A randomized controlled cross-over trial investigating the effect of anti-inflammatory diet on disease activity and quality of life in rheumatoid arthritis: the Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA) study protocol. Nutrition journal. (2018) 17 1 pp44', '10.1186/s12937-018-0354-x', 'http://link.springer.com/article/10.1186/s12937-018-0354-x/fulltext.html']\n",
      "['9736545', 'Nash Peter; Vanhoof Johan; Hall Stephen; Arulmani Udayasankar; Tarzynski-Potempa Rita; Unnebrink Kristina; Payne Andrew N; Cividino Alfred. Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis. Rheumatology and therapy. (2016) 3 2 pp257-270', '10.1007/s40744-016-0041-3', 'https://link.springer.com/article/10.1007/s40744-016-0041-3/fulltext.html']\n",
      "['9736546', 'Chen X; Zhao Q; Hou Y; Jiang J; Zhong W; Wang W; Yao X; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis. British journal of clinical pharmacology. (2016)   pp', '10.1111/bcp.12908', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12908']\n",
      "['9736547', 'Maddali Bongi; Del Rosso; Cavigli E; Ferretti B; Matucci Cerinic. Treatment for metatharsalgia by plantar insoles and silicone orthosis for toes in patients with rheumatoid arthritis and osteoarthritis: a cross-over study. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.782', '']\n",
      "['9736548', 'Ma X P; Gao G Z; Lian J F. Observations on the Efficacy of Target Fire Red-hot Needling in Treating Articular Deformity Due to Rheumatoid Arthritis. Shanghai journal of acupuncture and moxibustion [shang hai zhen jiu za zhi]. (2016) 35 9 pp1099-1101', '10.1016/s1003-5257(17)30015-6', '']\n",
      "['9736549', 'NCT04120831. TOLERA: tolerance Enhancement in RA. Https://clinicaltrials.gov/show/nct04120831. (2019)   pp', '10.31525/ct1-nct04120831', '']\n",
      "['9736550', 'Westhovens R; Alten R; Pavlova D; Enriquez Sosa FE; Mazur M; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634), an oral JAK1 selective inhibitor is effective in combination with methotrexate in patients with active rheumatoid arthritis: results from a 24-week phase 2b dose ranging study. Annals of the rheumatic diseases. (2016) 75  pp142-', '10.1136/annrheumdis-2016-eular.1954', '']\n",
      "['9736551', 'IRCT201110191485N6. The impact of Dietary Approach to Stop Hypertension eating plan on features of  metabolic syndrome in children. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201110191485N6. (2012)   pp', '10.2337/diacare.29.04.06.dc06-0052', 'https://diabetesjournals.org/care/article-pdf/29/4/954/650350/zdc004060954-a.pdf']\n",
      "['9736553', 'Izumi K; Suzuki K; Hashimoto M; Endoh T; Doi K; Iwai Y; Inamo J; Ota Y; Kajio N; Kikuchi J; Sakata K; Takanashi S; Takahashi C; Takei H; Tamai H; Hiramoto K; Kaneko Y; Jinzaki M; Ko S; Takeuchi T. Automatic detection of hand joint region, ankylosis and subluxation in radiographic images using deep learning: development of artificial intelligence-based radiographic evaluation system for bone destruction. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1364', '10.1136/annrheumdis-2019-eular.4801', '']\n",
      "['9736554', \"ChiCTR-IOR-16009905. The role and mechanism of a preliminary study of Yangyin Huoxue Shengjin Fang in treating yin asthenia generating intrinsic heat toxin and blood stasis due to loss of body fluid of Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-16009905. (2016)   pp\", '10.3736/jcim20050112', '']\n",
      "['9736555', \"Plosker GL; Lyseng-Williamson KA. Adalimumab: in Crohn's disease. BioDrugs. (2007) 21 2 pp125-132\", '10.2165/00063030-200721020-00007', '']\n",
      "['9736556', 'UMIN000023989. Efficacy and safety of hydroxychloroquine for Japanese patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000023989. (2017)   pp', '10.1186/isrctn13331870', '']\n",
      "['9736557', 'IRCT2017082029132N4. Treatment of plantar fasciitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017082029132N4. (2017)   pp', '10.5040/9781350969124', '']\n",
      "['9736558', 'Zhao L; Li M; Xu Y; Liu L; Zhang M; Chen G. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial. Trials. (2019) 20 1 pp', '10.1186/s13063-019-4005-0', 'http://link.springer.com/article/10.1186/s13063-019-4005-0/fulltext.html']\n",
      "['9736559', 'Caldera F; Lasch K; Cao C; Bhayat F. LOWER INCIDENCE OF HERPES ZOSTER IN VEDOLIZUMAB-TREATED VS TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS. Gastroenterology. (2018) 154 6 Supplement 1 ppS-994', '10.1016/s0016-5085(18)33330-4', '']\n",
      "['9736560', 'da Mata ADSP; de Almeida Rato Amaral JP; Thomson WM; Barcelos F; Vaz Patto J; Pereira RMN; da Silva Marques DN. Patient related outcomes in Sjogren syndrome treated with stimulants of salivary secretion: randomized clinical trial. Oral diseases. (2019)   pp', '10.1111/odi.13251', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.13251']\n",
      "['9736563', 'NCT04192617. A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate. https://clinicaltrials.gov/show/NCT04192617. (2019)   pp', '10.31525/ct1-nct04192617', '']\n",
      "['9736564', 'Alliu Samson; Ugwu Justin; Babalola Omotooke; Obiagwu Chukwudi; Moskovits Norbert; Ayzenberg Sergey; Hollander Gerald; Frankel Robert; Shani Jacob. Outcomes of percutaneous coronary intervention (PCI) among patients with connective tissue disease: propensity match analysis. International journal of cardiology. (2020) 304  pp29-34', '10.1016/j.ijcard.2019.12.055', '']\n",
      "['9736565', 'Iqbal K; Saravanan V; Hamilton J; Heycock C; Rynne M; Kelly C. How effective is rituximab in the treatment of rheumatoid arthritis in the presence of chronic lung disease?. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi86', '10.1093/rheumatology/kev088.093', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i86/5180179/kev088.093.pdf']\n",
      "['9736566', \"Mikuls T R; O'Dell J R; Stoner J A; Parrish L A; Arend W P; Norris J M; Holers V M. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis and rheumatism. (2004) 50 12 pp3776-3782\", '10.1002/art.20659', '']\n",
      "['9736568', 'Ljung Lotta; Ueda Peter; Liao Katherine P; Greenberg Jeffrey D; Etzel Carol J; Solomon Daniel H; Askling Johan. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation. RMD open. (2018) 4 2 ppe000771', '10.1136/rmdopen-2018-000771', '']\n",
      "['9736569', 'Srikesavan Cynthia; Williamson Esther; Cranston Tim; Hunter John; Adams Jo; Lamb Sarah E. An Online Hand Exercise Intervention for Adults With Rheumatoid Arthritis (mySARAH): design, Development, and Usability Testing. Journal of medical Internet research. (2018) 20 6 ppe10457', '10.2196/preprints.10457', '']\n",
      "['9736570', 'Aeidler H. Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis. Klinische ergebnisse einer multizentralen doppelblindprufung von naproxen IM vergleich zu indometacin bei chronischer polyarthritis, spondylitis ankylopoetica und arthrosen. (1975) 25 2A pp315-318', '10.1007/978-3-642-85453-8_400', '']\n",
      "['9736571', 'EUCTR2017-003205-18-PL. Trial Extension to 39 Week Follow Up in the Randomized, Blinded Trial to compare a Single Injection of Cingal¬Æ (Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide) with Cross-Linked Sodium Hyaluronate alone and with Triamcinolone Hexacetonide alone for Providing Symptomatic Relief of Osteoarthritis of the Knee. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-003205-18-PL. (2017)   pp', '10.1177/1947603517703732', 'https://journals.sagepub.com/doi/pdf/10.1177/1947603517703732']\n",
      "['9736573', 'Kubota A; Suguro T; Nakajima A; Masayuki S; Masato S; Kentaro T; Kazuaki T. Histopathological change caused by biological treatment in rheumatoid arthritis synovial tissue. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1241', '10.1136/annrheumdis-2018-eular.3899', '']\n",
      "['9736574', 'Jacobsen S. Use of glucocorticoids in rheumatoid arthritis. Ugeskrift for laeger. (2000) 162 6 pp770-772', '10.1001/jama.1964.03070250126092', '']\n",
      "['9736575', 'Khan NA; Lombeida JI; Spencer HJ; Torralba KD. Influence of industry funding on the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Arthritis and rheumatism. (2009) 60  pp1393-', '10.1002/art.34393', '']\n",
      "['9736576', \"Gu W. Modified Mingmu Dihuang Decoction in the treatment of sjogren's syndrome for 42 cases. Chinese medicine modern distance education of china [zhong guo zhong yi yao xian dai yuan chen jiao yu]. (2016) 14 3 pp90-91\", '10.5353/th_b4807965', '']\n",
      "['9736577', '. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism. Prescrire international. (2003) 12 66 pp127-132', '10.1002/art.11277', '']\n",
      "['9736578', 'Dhir V; Sharma A; Singla M; Pallavi P; Khanna S S; Sagar V. What is the right dose to start methotrexate (7.5 or 15 mg) in Asian Indian rheumatoid arthritis? (A randomized controlled trial). International journal of rheumatic diseases. (2012) 15 var.pagings pp72', '10.1136/annrheumdis-2013-eular.785', '']\n",
      "['9736579', 'Hida T; Sakai Y; Ito K; Imagama S. Collar fixation is not mandatory after cervical laminoplasty-a randomized controlled study. Spine. (2015) Conference: 43rd Annual Meeting of the Cervical Spine Research Society, CSRS 2015. United States. 2015 Supplement 2 pp288-289', '10.1097/brs.0000000000001994', '']\n",
      "['9736580', 'Mortazavi-Jahromi Seyed Shahabeddin; Aslani Mona; Omidian Saiedeh; Ahmadzadeh Arman; Rezaieyazdi Zahra; Mirshafiey Abbas. Immunopharmacological effect of beta-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug development research. (2020) 81 3 pp295-304', '10.1002/ddr.21619', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21619']\n",
      "['9736582', 'Gron K; Glintborg B; Norgaard M; Mehnert F; Stergaard M; Dreyer L; Krogh NS; Bjorner JB; Hetland ML. Direct comparison of certolizumab pegol, abatacept and biosimilar infliximab in patients with rheumatoid arthritis treated in routine care. Observational data from the Danish Danbio registry analyzed like a randomized clinical trial. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1391', '10.1136/annrheumdis-2019-eular.2039', '']\n",
      "['9736583', 'Pappas D; Etzel C; Crabtree M; Best J; Zlotnick S; Kremer J. Impact of comorbidity burden and obesity on the effectiveness of tocilizumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp295', '10.1136/annrheumdis-2018-eular.1740', '']\n",
      "['9736584', 'Ringold S; Tomlinson G; Weiss PF; Schanberg LE; Feldman B; Riordan ME; Del Gaizo V; Dennos A; Murphy K; Kimura Y. An interim report of the childhood arthritis and rheumatology research alliance (CARRA) start time optimization of biologic therapy in polyarticular JIA (stop-JIA) study. Pediatric rheumatology. (2018) Conference: 25th European Paediatric Rheumatology Congress, PReS 2018. Portugal. 16 Supplement 2 pp', '10.1002/art.41888', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41888']\n",
      "['9736585', 'Wang Zhang; Wu Jiaqi; Li Dongyun; Tang Xuan; Zhao Yue; Cai Xiao; Chen Xianghong; Chen Xiumin; Huang Qingchun; Huang Runyue. Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial. Chinese medicine. (2020) 15  pp36', '10.1186/s13020-020-00319-9', 'https://link.springer.com/article/10.1186/s13020-020-00319-9/fulltext.html']\n",
      "['9736586', 'Nash P; Coates LC; Kivitz AJ; Mease PJ; Gladman DD; Covarrubias-Cobos JA; Kudlacz E; Menon S; Kanik KS. Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, in patients with active psoriatic arthritis: interim data from OPAL Balance, an open label, long-term extension study. Journal of the American Academy of Dermatology. (2017) Conference: 75th Annual Meeting of the American Academy of Dermatology. United States. 76 6 Supplement 1 ppAB224', '10.1136/annrheumdis-2017-eular.1414', '']\n",
      "['9736587', 'Uslu S; Can G; Senel S; Dalkilic E; Inanc N; Akar S; Kocaer SB; Birlik M; Capar S; Akkoc N; Onen F. The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the turkbio registry. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp329', '10.1136/annrheumdis-2018-eular.6440', '']\n",
      "['9736589', 'EUCTR2005-003173-24-FI. An open, randomized study treating refractory adult-onset Still¬¥s disease (AOSD) with interleukin-1 receptor antagonist anakinra (KineretR), compared to an established, single anti-rheumatic drug treatment. - AOSD Study 05. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003173-24-FI. (2005)   pp', '10.1136/annrheumdis-2014-eular.4914', '']\n",
      "['9736592', 'Noguera Hernando; Larrea Gayarre; Cruz Martinez. Sequential scintigrams of salivary glands in rheumatoid arthritis. Revista espanola de reumatologia. (1978) 5 3 pp159-166', '10.1136/ard.35.3.287-c', '']\n",
      "['9736593', \"Bagadia L. A randomised controlled trial using individualised homeopathic treatment for modifying anger and blood pressure in patients with essential hypertension - Comparison against standard care treatment. Homeopathy. (2020) Conference: 4th International Research Conference of Homeopathy Research Institute's, HRI 2019. United Kingdom. 109 1 pp\", '10.1055/s-0040-1702098', '']\n",
      "['9736594', 'Pettersson S; Demmelmaier I; Nordgren B; Dufour AB; Opava CH. HPR physical capacity contributes marginally in explaining variations of fatigue in persons moderately affected by rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp160', '10.1136/annrheumdis-2018-eular.4707', '']\n",
      "['9736596', 'Zuidema Rixt; van Dulmen Sandra; Nijhuis-van der Sanden Maria; Meek Inger; van den Ende Cornelia; Fransen Jaap; van Gaal Betsie. Efficacy of a Web-Based Self-Management Enhancing Program for Patients with Rheumatoid Arthritis: explorative Randomized Controlled Trial. Journal of medical Internet research. (2019) 21 4 ppe12463', '10.2196/preprints.12463', '']\n",
      "['9736597', 'Galluppi GR; Wisniacki N; Stebbins C. Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody. British journal of clinical pharmacology. (2016)   pp', '10.1111/bcp.12914', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12914']\n",
      "['9736598', 'ISRCTN77525474. Minimally invasive surgery in total hip arthroplasty: the two-incision technique versus conventional total hip arthroplasty - a prospective, randomised, controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN77525474. (2006)   pp', '10.1186/isrctn77525474', '']\n",
      "['9736600', 'EUCTR2010-023469-22-NL. A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis - ARA 290 in ARA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-023469-22-NL. (2010)   pp', '10.1186/isrctn16962255', '']\n",
      "['9736601', 'Strand V; Carpinella CM; Lee LK; Boklage S; Reaney M. The impact of rheumatoid arthritis on patient-reported outcomes: comparison between sarilumab clinical trials and real-world patient data. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2834-2836', '10.1136/annrheumdis-2018-eular.3668', '']\n",
      "['9736602', 'NCT03770923. Effect of Some Drugs on Rheumatoid Arithritis Activity. Https://clinicaltrials.gov/show/nct03770923. (2018)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9736603', 'EUCTR2006-006591-37-GR. A 3 Month, Randomised, Open Label, Parallel Group, Descriptive Study to Explore and Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (Etanercept Auto-Injector and the Etanercept Prefilled Syringe) in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006591-37-GR. (2007)   pp', '10.1186/isrctn95861172', '']\n",
      "['9736604', 'Kuitunen Ilari; Artama Miia; Eskelinen Antti; Skytta Eerik T; Huhtala Heini; Uotila Jukka. Pregnancy outcome in women after total hip replacement: a population-based study. European journal of obstetrics, gynecology, and reproductive biology. (2019) 238  pp143-147', '10.1016/j.ejogrb.2019.05.020', '']\n",
      "['9736606', 'Genant H. AIM extension study: abatacept (Orencia) and rheumatoid arthritis after five years. P and t. (2009) 34 8 pp448-', '10.31525/cmr-ed3b54', '']\n",
      "['9736607', 'ISRCTN53215499. Is hydrotherapy cost effective? The costs and outcome measures of hydrotherapy programmes compared with physiotherapy land techniques in children with rheumatoid conditions. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN53215499. (2003)   pp', '10.1186/isrctn53215499', '']\n",
      "['9736608', 'NTR6726. Exercise in patients with Rheumatoid Arthritis and Cardiovascular risks. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR6726. (2017)   pp', '10.1186/isrctn04121489', '']\n",
      "['9736609', 'NCT01999192. Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01999192. (2013)   pp', '10.1186/isrctn67054656', '']\n",
      "['9736610', 'Amarilyo Gil; Rothman Deborah; Manthiram Kalpana; Edwards Kathryn M; Li Suzanne C; Marshall Gary S; Yildirim-Toruner Cagri; Haines Kathleen; Ferguson Polly J; Lionetti Geraldina; Cherian Julie; Zhao Yongdong; DeLaMora Patricia; Syverson Grant; Nativ Simona; Twilt Marinka; Michelow Ian C; Stepanovskiy Yuriy; Thatayatikom Akaluck; Harel Liora; Akoghlanian Shoghik; Tucker Lori; Marques Mariana Correia; Srinivasalu Hemalatha; Propst Evan J; Licameli Greg R; Dedeoglu Fatma; Lapidus Sivia; CARRA PFAPA Consensus Treatment Plan Workgroup. Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group. Pediatric rheumatology online journal. (2020) 18 1 pp31', '10.1186/s12969-020-00424-x', 'https://link.springer.com/article/10.1186/s12969-020-00424-x/fulltext.html']\n",
      "['9736611', 'NCT00785928. A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy. https://clinicaltrials.gov/show/NCT00785928. (2008)   pp', '10.1186/ar3537', 'https://link.springer.com/article/10.1186/ar3537/fulltext.html']\n",
      "['9736612', 'Bak Ewelina; Marcisz Czeslaw; Borodzicz Adriana; Sternal Danuta; Krzeminska Sylwia. Comparison of health-related quality of life in patients with rheumatoid arthritis during conventional or conventional plus biological therapy in Poland. Patient preference and adherence. (2019) 13  pp223-231', '10.2147/ppa.s189152', 'https://www.dovepress.com/getfile.php?fileID=47710']\n",
      "['9736613', 'Kang JW; Kim NR; Eun JS; Kim JH; Kang JY; Seo JS; Bae GB; Lee SJ; Nam EJ; Kang YM. Juxta-articular bone health affects new carotid plaque formation independent with glucocorticoid therapy in postmenopausal patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp299-300', '10.1136/annrheumdis-2018-eular.6694', '']\n",
      "['9736614', 'Gul H; Ponchel F; Emery P. On tapering therapy for RA patients in clinical remission; flare on cs-DMARDs is predicted by clinical parameters and ultrasound, whereas T-cell abnormalities are predictive for b-DMARD tapering. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1143-1144', '10.1136/annrheumdis-2019-eular.6844', '']\n",
      "['9736617', 'NCT04428957. Telemonitoring of Treatment Effects in Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD). https://clinicaltrials.gov/show/NCT04428957. (2020)   pp', '10.1371/journal.pone.0278601', '']\n",
      "['9736618', 'Sestan M; Grguric D; Sedmak M; Kifer N; Frkovic M; Peric S; Potocki K; Vukojevic N; Jelusic M. Quality of life in juvenile idiopathic arthritis-associated uveitis: do we need a new assessment questionnaire?. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1330-1331', '10.1136/annrheumdis-2019-eular.5013', '']\n",
      "['9736619', 'Zuidema R; Van Gaal B; Meek I; Van Den Ende E; Van Dulmen S; Fransen J; Nijhuis R. HPR effectiveness of an e-health tailored selfmanagement program for patients with rheumatoid arthritis: an explorative RCT. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp130', '10.1136/annrheumdis-2018-eular.6542', '']\n",
      "['9736620', 'Scheper H; Van Hooven D; Van De Sande M; De Boer S; Mahdad R; Van Der Beek M; Visser L; De Boer M; Nelissen R. Treatment of prosthetic joint infection: debridement, antibiotics and implant retention with short duration of rifampicin. Open forum infectious diseases. (2016) 3  pp', '10.1093/ofid/ofw172.844', 'http://academic.oup.com/ofid/article-pdf/3/suppl_1/1141/28685616/ofw172.844.pdf']\n",
      "['9736621', 'CTRI/2010/091/000303. Azathioprine Bioequivalence study in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2010/091/000303. (2010)   pp', '10.1055/s-0030-1248131', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0030-1248131.pdf']\n",
      "['9736622', 'Wang Menglei; Huang Jing; Fan Huizhen; He Dan; Zhao Siyu; Shu Yisong; Li Hui; Liu Linlin; Lu Shuang; Xiao Cheng; Liu Yuanyan. Treatment of Rheumatoid Arthritis Using Combination of Methotrexate and Tripterygium Glycosides Tablets-A Quantitative Plasma Pharmacochemical and Pseudotargeted Metabolomic Approach. Frontiers in pharmacology. (2018) 9  pp1051', '10.3389/fphar.2018.01051', '']\n",
      "['9736624', 'Girolomoni G; Feldman SR; Emery P; Ghil J; Keum JW; Cheong SY; Hong E. Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study. British journal of dermatology. (2018) 178 3 ppe215-e216', '10.1111/bjd.16032', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjd.16032']\n",
      "['9736625', 'Wong P; Wu D; Mak QWK; Cheng ITH; Li TK; Li EK; Tam L-S. Role of ultrasound in assessing disease activity in patients with early rheumatoid arthritis treated by two treat-to-target strategies. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Supplement 1 pp213', '10.1136/annrheumdis-2018-eular.6897', '']\n",
      "['9736626', 'Chen H; Lin C-H. Epidemiology of immune-mediated inflammatory diseases in a Taiwanese nationwide ankylosing spondylitis cohort. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp51-52', '10.1111/1756-185x.70164', '']\n",
      "['9736627', 'da Mata Antonio Duarte Sola Pereira; Amaral Joao Pedro de Almeida Rato; Thomson William Murray; Barcelos Filipe; Vaz Patto Jose; Pereira Ruben Miguel Nunes; Marques Duarte Nuno da Silva. Patient-related outcomes in Sjogren syndrome treated with stimulants of salivary secretion: randomized clinical trial. Oral diseases. (2020) 26 2 pp313-324', '10.1111/odi.13251', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.13251']\n",
      "['9736629', 'IRCT2015111124999N1. The effect of vitamin D supplementation on reproductive outcomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015111124999N1. (2016)   pp', '10.1186/isrctn13994081', '']\n",
      "['9736631', 'Bastida Carla; Soy Dolors; Ruiz-Esquide Virginia; Sanmarti Raimon; Huitema Alwin D R. Exposure-response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components. British journal of clinical pharmacology. (2019) 85 8 pp1710-1718', '10.1111/bcp.13954', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.13954']\n",
      "['9736636', 'Sakellariou G; Scire CA; Rumi F; Carrara G; Cerra C; Migliazza S; Caporali R; Montecucco C. Early treatment and low dose corticosteroids might decrease mortality in early arthritis: results from the record linkage of clinical and administrative databases. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp277', '10.1136/annrheumdis-2018-eular.6260', '']\n",
      "['9736637', 'Peiteado D; Monjo I; Nuno L; Villalba A; Miranda ME; Fortea P; De Miguel E; Balsa A. Ultrasound predictive value in prearthritis. a prospective longitudinal study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1168', '10.1136/annrheumdis-2018-eular.4853', '']\n",
      "['9736638', 'Gossec Laure; Soubrier Martin; Foissac Frantz; Molto Anna; Richette Pascal; Beauvais Catherine; Ruyssen-Witrand Adeline; Perdriger Aleth; Chary-Valckenaere Isabelle; Mouterde Gael; Dernis Emanuelle; Euller-Ziegler Liana; Flipo Rene-Marc; Gilson Melanie; Guis Sandrine; Mariette Xavier; Pouplin Sophie; Marhadour Thierry; Schaeverbeke Thierry; Sordet Christelle; Fayet Francoise; Dougados Maxime. Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients. RMD open. (2019) 5 2 ppe000914', '10.1136/rmdopen-2019-000914', '']\n",
      "['9736640', 'Spanel AJ; Smith MP. Its all on your head. Journal of general internal medicine. (2019) 34 2 Supplement ppS568', '10.1037/a0022670', '']\n",
      "['9736641', 'Cheng LE; Amoura Z; Cheah B; Hiepe F; Sullivan BA; Zhou L; Arnold GE; Tsuji WH; Merrill JT; Chung JB. Brief Report: a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis. Arthritis and rheumatology. (2018) 70 7 pp1071-1076', '10.1002/art.40479', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40479']\n",
      "['9736642', 'Harrison R A; Harrison B J; Volker D; Garg M. Fish oils are beneficial to patients with established rheumatoid arthritis. Journal of rheumatology. (2001) 28 11 pp2563-2565', '10.1053/berh.2000.0124', '']\n",
      "['9736644', 'NCT00078793. Registry of Etanercept (Enbrel¬Æ) In Children With Juvenile Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00078793. (2004)   pp', '10.31525/cmr-5970b9', '']\n",
      "['9736645', 'NTR158. Quality management: improvement of patient care in recently diagnosed rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR158. (2005)   pp', '10.1186/isrctn72821021', '']\n",
      "['9736646', \"Garcia Denny Marcos; Reis de Oliveira Fabiola; Modulo Carolina Maria; Faustino Jacqueline; Barbosa Amanda Pires; Alves Monica; Rocha Eduardo Melani. Is Sjogren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests. PloS one. (2018) 13 12 ppe0208420\", '10.1371/journal.pone.0208420', '']\n",
      "['9736647', 'Bearne LM; Kaambwa B; Ratcliffe J; Choy E; Scott DL; Hurley MV; Manning VL. Economic evaluation of a brief education, self-management and upper limb exercise training programme in people with rheumatoid arthritis. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi6', '10.1093/rheumatology/keu319', 'http://academic.oup.com/rheumatology/article-pdf/54/2/302/6896828/keu319.pdf']\n",
      "['9736649', 'Velmakin S; Troitskaya E; Villevalde S; Kobalava Z. Adjustment of the threshold may improve cardiovascular risk stratification in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp587', '10.1136/annrheumdis-2018-eular.4381', '']\n",
      "['9736651', 'UMIN000017577. Tapering and withdrawal of Methotrexate(MTX) or Tocilizumab(TCZ), after achievement of RA remission in concomitant use of MTX and TCZ,a randomized control study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000017577. (2015)   pp', '10.1136/annrheumdis-2013-eular.1375', '']\n",
      "['9736652', 'Schett G; Finzel S; Kraus S; Regensburger A; Kocijan R; Rech J. Tocilizumab achieves better repair of focal bone erosions than tumour necrosis factor inhibition in RA patients-data from the prospective rebone study on erosion repair. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp572', '10.1136/annrheumdis-2018-eular.3188', '']\n",
      "['9736654', 'NCT01956188. Omega 3 in LES and APS. https://clinicaltrials.gov/show/NCT01956188. (2013)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9736656', 'Lauper Kim; Nordstrom Dan C; Pavelka Karel; Hernandez Maria Victoria; Kvien Tore K; Kristianslund Eirik Klami; Santos Maria Jose; Rotar Ziga; Iannone Florenzo; Codreanu Catalin; Lukina Galina; Gale Sara L; Sarsour Khaled; Luder Yves; Courvoisier Delphine Sophie; Gabay Cem. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. Annals of the rheumatic diseases. (2018) 77 9 pp1276-1282', '10.1136/annrheumdis-2017-212845', '']\n",
      "['9736657', 'IRCT201611165623N94. Effect of supplementation in treatment of patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201611165623N94. (2016)   pp', '10.1186/isrctn22788282', '']\n",
      "['9736658', 'NCT04034849. Effects of photobiomodulation in burning mouth syndrome. Https://clinicaltrials.gov/show/nct04034849. (2019)   pp', '10.31525/ct1-nct04034849', '']\n",
      "['9736661', 'EUCTR2011-005376-42-ES. A randomised, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy of NNC0114-0006 in subjects with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005376-42-ES. (2012)   pp', '10.1186/isrctn04296019', '']\n",
      "['9736662', 'NTR2500. The use of Fibrin Sealant in total knee replacement surgery. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR2500. (2010)   pp', '10.1016/j.otsr.2011.10.012', '']\n",
      "['9736663', 'EUCTR2012-004482-40-ES. Evaluation of a protocol for the reduction of doses in patients with rheumatoid arthritis (RA) in clinical remission in treatment with biological therapies. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-004482-40-ES. (2013)   pp', '10.1186/isrctn75505683', '']\n",
      "['9736664', 'Mohr Drewes A; Brock C; Rasmussen SE; Pfeiffer Jensen M. Transcutaneous vagus nerve stimulation in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1401', '10.1136/annrheumdis-2018-eular.3301', '']\n",
      "['9736665', 'CTRI/2011/09/001990. A clinical trial to study the effects of Revamilast in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2011/09/001990. (2011)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9736666', 'Du X; Si H; Li X. Clinical study of moxibustion on the meridian Dumai in the treatment of rheumatoid arthritis. Akupunktur. (1993) 21 4 pp260-264', '10.1007/978-3-662-05631-8_9', '']\n",
      "['9736668', 'Loft AG; Tarp U; Thomsen BS; Loft AGR; Tarp U; Thomsen BS. [Anakinra in the treatment of rheumatoid arthritis]. Ugeskrift for laeger. (2003) 165 39 pp3720-3724', '10.2172/5242630', '']\n",
      "['9736669', 'Aringer M. Cyclooxygenase-2-selective painkillers in rheumatology. Wiener medizinische Wochenschrift (1946). (2003) 153 5-6 pp100-103', '10.1046/j.1563-258x.2003.03005.x', '']\n",
      "['9736670', 'Lamba M; Wang R; Fletcher T; Alvey C; Kushner J; Stock TC. Extended-Release Once-Daily Formulation of Tofacitinib: evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food. Journal of clinical pharmacology. (2016)   pp', '10.1002/jcph.734', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.734']\n",
      "['9736671', 'EUCTR2013-001999-38-HU. A clinical study to test the efficacy of a new product (TNF-Kinoid) in patients with Rheumatoid Arthritis in whom treatment with methotrexate is not working anymore. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-001999-38-HU. (2013)   pp', '10.1186/isrctn24868111', '']\n",
      "['9736672', 'Ladhari Chayma; Le Blay Pierre; Vincent Thierry; Larbi Ahmed; Rubenstein Emma; Lopez Rosanna Ferreira; Jorgensen Christian; Pers Yves-Marie. Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study. BMC rheumatology. (2020) 4  pp5', '10.1186/s41927-019-0109-0', 'http://link.springer.com/article/10.1186/s41927-019-0109-0/fulltext.html']\n",
      "['9736678', 'Karimifar Mansoor; Sepehrifar Mohammad S; Moussavi Hamidreza; Sepehrifar Mohammad B; Mottaghi Peyman; Siavash Mansour; Karimifar Mozhgan. The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids. Journal of research in medical sciences. (2018) 23  pp105', '10.4103/jrms.jrms_869_17', '']\n",
      "['9736679', 'ACTRN12615000078550. Comparative assessment of the absorption of a generic formulation of ibuprofen sustained release tablet against the innovator ibuprofen tablet conducted under fasting conditions and at steady state in healthy male and female volunteers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12615000078550. (2015)   pp', '10.1016/j.clinthera.2019.04.040', '']\n",
      "['9736680', 'Triantafyllias K; Heller C; de Blasi M; Galle PR; Schwarting A. Diagnostic value of optical spectral transmission in rheumatoid arthritis: associations with clinical characteristics and comparison with joint ultrasonography. Journal of rheumatology. (2020)   pp', '10.3899/jrheum.190650', '']\n",
      "['9736682', \"ChiCTR-IPR-15005757. Prospective, Randomized, placebo-cOntrolled, double-blind, MultIcenter, parallel group Study to assess the Efficacy and safety of hydroxychloroquine in chinese patients with primary Sjogren's Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15005757. (2013)   pp\", '10.2139/ssrn.5090732', '']\n",
      "['9736683', 'Gautam S; Kumar M; Chaurasia P; Rana D; Dada R. Impact of yoga based lifestyle intervention on quality of life, depression and sperm oxidative DNA damage: a randomized controlled trial on infertile men with rheumatoid arthritis. Fertility and sterility. (2019) 112 3 Supplement ppe409', '10.1016/j.fertnstert.2019.07.1161', '']\n",
      "['9736684', 'Harnanik T; Soeroso J; Suryokusumo MG; Juliandhy T. Effects of hyperbaric oxygen on t helper 17/regulatory t polarization in antigen and collagen-induced arthritis: hypoxia-inducible factor-1√é¬± as a target. Oman medical journal. (2020) 35 1 pp', '10.5001/omj.2020.08', '']\n",
      "['9736688', 'Wang Liyun; Yin Jiafeng; Yang Bo; Qu Chengjuan; Lei Jian; Han Jing; Guo Xiong. Serious Selenium Deficiency in the Serum of Patients with Kashin-Beck Disease and the Effect of Nano-Selenium on Their Chondrocytes. Biological trace element research. (2020) 194 1 pp96-104', '10.1007/s12011-019-01759-7', 'http://link.springer.com/article/10.1007/s12011-019-01759-7/fulltext.html']\n",
      "['9736689', 'Tsuchiya A; Aomori T; Sakamoto M; Takeuchi A; Suzuki S; Jibiki A; Otsuka N; Ishioka E; Kaneko Y; Takeuchi T; Nakamura T. Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment. Die Pharmazie. (2017) 72 1 pp22-28', '10.1136/ejhpharm-2016-000875.408', '']\n",
      "['9736691', 'IRCT138811063182N1. The efficacy of Rosa damascena extract in the treatment of recurrent aphthous stomatitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138811063182N1. (2010)   pp', '10.1186/isrctn15873887', '']\n",
      "['9736692', 'Liu Y R; Qiao S Q. Acupuncture combined with vesiculating cupping for 110 patients with rheumatoid arthritis. World journal of acupuncture - moxibustion. (2015) 25 4 pp38-42', '10.1016/s1003-5257(17)30079-x', '']\n",
      "['9736693', 'NTR7209. Bright light therapy in rheumatoid arthritis to improve symptoms of fatigue and other disease outcomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR7209. (2018)   pp', '10.1186/isrctn36516369', '']\n",
      "['9736694', 'ACTRN12618000817246. Does Soft Tissue Balancing Using Intra-Operative Pressure Sensors Improve Clinical Outcomes in Total Knee Arthroplasty? A Multi-Centre Randomised Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12618000817246. (2018)   pp', '10.1186/isrctn32365985', '']\n",
      "['9736696', 'Kavanaugh A. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials. Bulletin of the NYU hospital for joint diseases. (2007) 65 Suppl 1  ppS16-20', '10.1136/annrheumdis-2012-eular.1479', '']\n",
      "['9736697', 'Ehrlich-Jones LS. Self-care behavior of African-American elderly with arthritis. Self-care behavior of african-american elderly with arthritis. (2001)   pp118 p', '10.1002/1529-0131(200108)45:4<340::aid-art346>3.0.co;2-5', '']\n",
      "['9736698', 'Kaltenborn Alexander; Frey-Wille Stefanie; Hoffmann Sebastian; Wille Jorn; Schulze Christoph; Settje Andreas; Vogt Peter M; Gutcke Andre; Ruettermann Mike. \"The risk of complications after carpal tunnel release in patients taking acetylsalicylic acid as platelet inhibition - A multi-center propensity score-matched study\". Plastic and reconstructive surgery. (2019)   pp', '10.1097/prs.0000000000006465', '']\n",
      "['9736699', 'EUCTR2014-000110-61-CZ. Study to assess the long-term efficacy and safety of FKB327 compared with Humira¬¨√Ü, when each is administered in combination with Methotrexate in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-000110-61-CZ. (2015)   pp', '10.1016/j.jval.2015.03.899', '']\n",
      "['9736700', '. Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study. RMD open. (2019) 5 1 pp', '10.1136/rmdopen-2018-000889', '']\n",
      "['9736701', 'Choy Ernest; Freemantle Nick; Proudfoot Clare; Chen Chieh-I; Pollissard Laurence; Kuznik Andreas; Van Hoogstraten Hubert; Mangan Erin; Carita Paulo; Huynh Thi-Minh-Thao. Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor alpha inhibitors: systematic literature review and network meta-analyses. RMD open. (2019) 5 1 ppe000798', '10.1136/rmdopen-2018-000798', '']\n",
      "['9736702', 'IRCT201205203140N4. Effect of vitamin K1 supplementation in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201205203140N4. (2012)   pp', '10.1186/isrctn22788282', '']\n",
      "['9736703', 'Buttgereit F; Nebesky JM; Burmester GR; Hochberg M; Bernasconi C; John MR; Donath MY. Glucocorticoid tapering in monthly 1-mg decrements does not result in clinically manifest adrenal insufficiency in patients with rheumatoid arthritis: learnings from the phase 3/4 semira study. Annals of the rheumatic diseases. (2019) 78  pp336-', '10.1136/annrheumdis-2019-eular.2113', '']\n",
      "['9736704', \"Maslihska M; Dmowska-Chalaba J; Mahczak M; Shen L; Suresh L; Kwiatkowska B. Rheumatoid factor in IGA, IGG and IGM immunoglobulin clases in primary Sjogren's syndrome. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp802\", '10.1136/annrheumdis-2019-eular.6365', '']\n",
      "['9736705', 'Blevins Jason L; Chiu Yu-Fen; Lyman Stephen; Goodman Susan M; Mandl Lisa A; Sculco Peter K; Figgie Mark P; McLawhorn Alexander S. Comparison of Expectations and Outcomes in Rheumatoid Arthritis Versus Osteoarthritis Patients Undergoing Total Knee Arthroplasty. Journal of arthroplasty. (2019) 34 9 pp1946-1952.e2', '10.1016/j.arth.2019.04.034', '']\n",
      "['9736706', 'Krishnan E; Zhang N; Wang H. Injection site reactions and injection site pain for the adalimumab biosimilar ABP 501: results from two double-blind randomized controlled studies. United european gastroenterology journal. (2018) 6 8 Supplement ppA451', '10.1093/ecco-jcc/jjx180.624', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S357/23744639/jjx180.624.pdf']\n",
      "['9736707', 'DRKS00013063. Prospective, Open, Non-randomized, Non-interventional Explorative, Comparative, Uncontrolled Cohort Study for Post Market Clinical Follow-Up of the \"BPK-S Integration\" UC in the Variants CoCr or Ceramic as Primary Implant. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00013063. (2018)   pp', '10.21203/rs.3.rs-1005080/v1', 'https://www.researchsquare.com/article/rs-1005080/v1']\n",
      "['9736708', 'Wang Taorong; Wang Gaoyuan; Zhang Ye; Zhang Junqiang; Cao Wei; Chen Xiaoyu. Effect of lentivirus-mediated overexpression or silencing of MnSOD on apoptosis of resveratrol-treated fibroblast-like synoviocytes in rheumatoid arthritis. European journal of pharmacology. (2019) 844  pp65-72', '10.1016/j.ejphar.2018.12.001', '']\n",
      "['9736709', 'IRCT201502224549N8. The effect of laser therapy on knee Osteoarthritis  treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201502224549N8. (2015)   pp', '10.1186/isrctn29365316', '']\n",
      "['9736711', '. Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials. Clinical gastroenterology and hepatology. (2019)   pp', '10.1016/j.cgh.2018.11.035', '']\n",
      "['9736712', \"Dorner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin M-A; Simonett C; Mooney L; Huser A; Gram H; Wagner FD; Oliver SJ. Treatment of primary Sj√∂gren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity. Annals of the rheumatic diseases. (2019)   pp\", '10.1136/annrheumdis-2018-214720', '']\n",
      "['9736713', 'Stavrakidou M; Trachana M; Koutsonikoli A; Spanidou K; Hristara-Papadopoulou A; Xinias I. The impact of a physiotherapy tele-rehabilitation program on children with juvenile idiopathic arthritis. Pediatric rheumatology. (2018) Conference: 25th European Paediatric Rheumatology Congress, PReS 2018. Portugal. 16 Supplement 2 pp', '10.31138/mjr.310823.tio', '']\n",
      "['9736714', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; Loppenthin KB; Midtgaard J; Christensen R; Nielsen SM; Ostergaard M; Jennum P; Esbensen BA. Hpr the efficacy of motivational counselling and sms-reminders on daily sitting time in patients with rheumatoid arthritis: 22 months followup of a randomised, parallel-group trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp159', '10.1136/annrheumdis-2018-eular.4595', '']\n",
      "['9736715', 'Arimoto Atsushi; Kitagawa Kazuko; Mita Norihiro; Takahashi Yoriko; Shibuya Eri; Sasaki Hiroshi. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjogren syndrome patients with or without punctal occlusions. Cornea. (2014) 33 8 pp806-811', '10.1097/ico.0000000000000155', '']\n",
      "['9736716', 'Vacchi Caterina; Visentini Marcella; Gragnani Laura; Fraticelli Paolo; Tavoni Antonio; Filippini Davide; Saccardo Francesco; Lauletta Gianfranco; Colantuono Stefania; Atzeni Fabiola; Pioltelli Pietro; Manfredi Andreina; Casato Milvia; Zignego Anna Linda; Monti Giuseppe; Pietrogrande Maurizio; Galli Massimo; Sebastiani Marco. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar). Internal and emergency medicine. (2020)   pp', '10.1007/s11739-020-02386-0', 'https://link.springer.com/article/10.1007/s11739-020-02386-0/fulltext.html']\n",
      "['9736718', 'Lee S-K; Oh S; Kim H-A; Park Y-B; Lee S-S; Shin K. Clinical outcomes of abatacept versus TNF inhibitors in ACPA-positive patients with rheumatoid arthritis: data from the biologic register kobio. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp331', '10.1136/annrheumdis-2018-eular.4357', '']\n",
      "['9736719', 'Klaudius I; Krueger K; Remstedt S; Thiele A. Golimumab improves work productivity and activity impairment in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PSA): 1-year results from a non-interventional trial in Germany. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp954-955', '10.1136/annrheumdis-2018-eular.2925', '']\n",
      "['9736720', 'ChiCTR-ONC-11001638. The relationship of wearing and metal ions level with the abduction angle of the acetabulum in total hip arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-ONC-11001638. (2011)   pp', '10.1016/j.arth.2004.09.008', '']\n",
      "['9736721', 'Bisson EJ; Finlayson M; Ekuma O; Marrie RA; Leslie WD. Accuracy of FRAX in people with multiple sclerosis: a Manitoba BMD registry-based cohort study. Journal of bone and mineral research. (2018) Conference: 2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des CongrEs de Montreal. Canada. 33 Supplement 1 pp284', '10.1002/jbmr.3682', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.3682']\n",
      "['9736722', 'NCT01148043. Pharmacological Treatment In Osteoarthritis. https://clinicaltrials.gov/show/NCT01148043. (2010)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9736723', 'Lee Hyunho; Ishikawa Hajime; Shibuya Tatsuaki; Takai Chinatsu; Nomura Yumi; Kobayashi Daisuke; Abe Asami; Otani Hiroshi; Ito Satoshi; Nakazono Kiyoshi; Ryu Keinosuke; Ishii Takao; Saito Shu; Abe Kaoru; Murasawa Akira. Changes in radiographic findings and plantar pressure distribution following forefoot reconstructive surgery for patients with rheumatoid arthritis. Modern rheumatology. (2019)   pp1-8', '10.1080/14397595.2019.1680094', '']\n",
      "['9736724', 'EUCTR2010-022243-38-LT. A Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-022243-38-LT. (2012)   pp', '10.1136/annrheumdis-2012-eular.1708', '']\n",
      "['9736726', 'Kremer J; Ritchlin C; Mendelsohn A; Baker D; Kim L; Xu Z; Han J; Taylor P. Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study. Arthritis and rheumatism. (2010) 62 4 pp917-928', '10.1002/art.27348', '']\n",
      "['9736727', 'NTR73. Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX). http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR73. (2005)   pp', '10.1186/isrctn21334657', '']\n",
      "['9736729', 'Porras Maximiliano; Rada Gabriel; Duran Josefina. Effects of Mediterranean diet on the treatment of rheumatoid arthritis. Medwave. (2019) 19 5 ppe7640', '10.5867/medwave.2019.05.7639', '']\n",
      "['9736730', 'UMIN000029917. Preservation of fertility by cryopreservation of ovarian tissue and autologous transplantation of ovarian tissue in premenopausal women diagnosed with malignant tumors. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000029917. (2017)   pp', '10.26226/morressier.596dfd56d462b80292387864', '']\n",
      "['9736732', 'Pablos Jose Luis; Jover Juan Angel; Roman-Ivorra Jose Andres; Inciarte-Mundo Jose; Dilla Tatiana; Sacristan Jose Antonio; Comellas Marta; Lizan Luis. Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making. Patient. (2020) 13 1 pp57-69', '10.1007/s40271-019-00381-y', 'http://link.springer.com/article/10.1007/s40271-019-00381-y/fulltext.html']\n",
      "['9736733', 'Dhaon Pooja; Das Siddharth K; Srivastava Ragini; Dhakad Urmila. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients. International journal of rheumatic diseases. (2018) 21 11 pp1933-1939', '10.1111/1756-185x.13110', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13110']\n",
      "['9736734', 'Erdogmus Siyar; Kendi Celebi Zeynep; Akturk Serkan; Kumru Gizem; Duman Neval; Ates Kenan; Erturk Sehsuvar; Nergizoglu Gokhan; Kutlay Sim; Sengul Sule; Keven Kenan. Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience. Amyloid. (2018) 25 2 pp115-119', '10.1080/13506129.2018.1474733', '']\n",
      "['9736735', 'Fautrel B; Zhu B; Taylor PC; van de Laar M; Emery P; De Leonardis F; Kannowski CL; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R. Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naive to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison. RMD open. (2020) 6 1 pp', '10.1136/rmdopen-2019-001131', '']\n",
      "['9736736', \"Myint Z; Qasrawi A; O'Neal R; Thomas CZ; Arnold SM; Wang P. Immune-related adverse events for different age groups using the FDA Adverse Event Reporting System. Journal of clinical oncology. (2019) Conference: 2019 Annual Meeting of the American Society of Clinical Oncology, ASCO 2019. United States. 37 Supplement 15 pp\", '10.1200/jco.2019.37.15_suppl.e14256', '']\n",
      "['9736738', 'Wang J; Zou X; Cong L; Liu H. Clinical effectiveness and cost-effectiveness of nurse-led care in Chinese patients with rheumatoid arthritis: a randomized trial comparing with rheumatologist-led care. International journal of nursing practice. (2018) 24 1 pp', '10.1111/ijn.12605', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijn.12605']\n",
      "['9736739', 'EUCTR2007-005905-23-GB. A Multi-center, Randomized, Double-blind, Placebo - controlled Study Comparing 80 mg of Adalimumab with Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing - M10-261, FINAL 30Nov07. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005905-23-GB. (2008)   pp', '10.1016/j.jaad.2011.11.778', '']\n",
      "['9736741', 'UMIN000002112. Healing Effect of Gastric mucosal Lesion of patient with Osteoarthritis or Rheumatism by Cox2-Inhibitor and Anti ulcer agent(Rebamipide) combination therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002112. (2009)   pp', '10.1016/0928-4680(94)90033-7', '']\n",
      "['9736742', 'IRCT2017050629508N6. Evaluation of the effect of omega 3 fatty acid  in patients with hashimoto thyroiditis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017050629508N6. (2017)   pp', '10.1186/isrctn57643242', '']\n",
      "['9736744', 'Iversen L; Eidsmo L; Austad J; de Rie M; Osmancevic A; Skov L; Talme T; Bachmann I; van de Kerkhof P; Stahle M; Banerjee R; Oliver J; Fasth A E R; Frueh J. Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study. Journal of the European Academy of Dermatology and Venereology : JEADV. (2018) 32 11 pp1930-1939', '10.1111/jdv.14979', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjdv.14979']\n",
      "['9736745', \"Dorner T; Zeher M; Laessing U; Chaperon F; De Buck S; Hasselberg A; Valentin M-A; Ma S; Cabanski M; Kalis C; Burkhart C; Gergely P. A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjogren's syndrome. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp174\", '10.1136/annrheumdis-2018-eular.3111', '']\n",
      "['9736747', 'IRCT2017071610340N17. The effect of dental interventions on the disease activity in Systemic Lupus Erythematosus. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017071610340N17. (2017)   pp', '10.1016/b978-0-323-04434-9.50060-9', '']\n",
      "['9736748', 'NCT03945149. A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold‚Ñ¢ in Healthy Subjects. Https://clinicaltrials.gov/show/nct03945149. (2019)   pp', '10.31525/ct1-nct03945149', '']\n",
      "['9736749', 'Reusch A; Braun J; Lakomek H-J; Lakomek M; Lind-Albrecht G; Janiche H; Cattelaens K; Hammel L; Demtroder F; Ehlebracht-Konig I; Polnau U; Specker C; Gerlich C; Kuffner R. Flexible programs and advanced training for rheumatological patient education. Zeitschrift fur Rheumatologie. (2019)   pp', '10.1007/s00393-019-00726-w', 'http://link.springer.com/article/10.1007/s00393-019-00726-w/fulltext.html']\n",
      "['9736750', 'PER-088-12. A PHASE IIA, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, WORLDWIDE, PROOF-OF-CONCEPT CLINICAL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF MK-8457 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE OR INTOLERANCE TO ANTI-TNF-Œ± THERAPY. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-088-12. (2012)   pp', '10.1186/isrctn46090514', '']\n",
      "['9736751', 'CTRI/2018/01/011532. Role of Vitamin D in pain relief in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/01/011532. (2018)   pp', '10.7754/clin.lab.2017.170610', '']\n",
      "['9736752', 'UMIN000021632. Clinical study for theraputic effect of LED light on arthritis in patientw with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021632. (2016)   pp', '10.1186/isrctn55552928', '']\n",
      "['9736753', 'Dawczynski C; Dittrich M; Neumann T; Goetze K; Welzel A; Oelzner P; Volker S; Schaible A M; Troisi F; Thomas L; Pace S; Koeberle A; Werz O; Schlattmann P; Lorkowski S; Jahreis G. Docosahexaenoic acid in the treatment of rheumatoid arthritis: a double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clinical nutrition (Edinburgh, Scotland). (2018) 37 2 pp494-504', '10.1016/j.clnu.2017.02.021', '']\n",
      "['9736755', 'Hammenfors DS; Nes PG; Milic V; Delli K; Hofauer B; Baldini C; Devauchelle-Pensec V; Theander E; Brun JG; Jonsson MV. Automating evaluation of salivary gland ultrasound images in PSS patients using the scattered transform algorithm-a pilot study. Annals of the rheumatic diseases. (2016) 75  pp1224-', '10.1136/annrheumdis-2016-eular.6033', '']\n",
      "['9736756', 'NCT00642629. A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes. https://clinicaltrials.gov/show/NCT00642629. (2008)   pp', '10.1186/isrctn13784998', '']\n",
      "['9736757', 'De Cienfuegos AA; Cantero-Nieto L; Garcia-Gomez JA; Robledo G; Trigo M; Ibanez JM; Gonzalez-Gay MA; Ortego N. Circulating fibroblast growth factor-23 is associated with dyslipidemia in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp332-333', '10.1136/annrheumdis-2019-eular.5076', '']\n",
      "['9736758', 'EUCTR2015-004173-32-DK. Personalized medicine: administration of TNF-alpha inhibitor treatment due to serum concentration measuring. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-004173-32-DK. (2015)   pp', '10.5553/eelc/187791072022007004003', '']\n",
      "['9736759', 'Iwamoto N; Sato S; Sumiyoshi R; Chiba K; Miyamoto N; Arinaga K; Kobayashi M; Yamamoto H; Osaki M; Kawakami A. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT. Trials. (2019) 20 1 pp', '10.1186/s13063-019-3589-8', 'http://link.springer.com/article/10.1186/s13063-019-3589-8/fulltext.html']\n",
      "['9736760', 'ISRCTN86638547. Efficacy of intra-articular injection for end stage hip osteoarthritis: can pain and disability be relieved?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN86638547. (2006)   pp', '10.1186/isrctn86638547', '']\n",
      "['9736762', 'EUCTR2014-004673-16-DE. Randomized, blinded, controlled study to compare the efficacy of  treatment with tocilizumab with or without glucocorticoids in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004673-16-DE. (2015)   pp', '10.1186/isrctn21216199', '']\n",
      "['9736763', '. Ethanercept: a review of its use in rheumatoid arthritis. Drugs. (1999) 57 6 pp945-966', '10.2165/00003495-199957060-00014', '']\n",
      "['9736764', \"Prior Y; Arafin N; Bartley C; Hammond A. HPR inflammatory or rheumatoid arthritis patients' perspectives on the effect of arthritis gloves on their hand pain and function (a-gloves trial): a qualitative study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1866\", '10.1136/annrheumdis-2018-eular.5980', '']\n",
      "['9736765', 'Harrold Leslie R; Reed George W; Best Jennie; Zlotnick Steve; Kremer Joel M. Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis. Rheumatology and therapy. (2018) 5 2 pp507-523', '10.1007/s40744-018-0127-1', 'https://link.springer.com/article/10.1007/s40744-018-0127-1/fulltext.html']\n",
      "['9736766', 'Hendricks Oliver; Andersen Tonny Elmose; Christiansen Afshin Ashouri; Primdahl Jette; Hauge Ellen Margrethe; Ellingsen Torkell; Horsted Tina Ingrid; Bachmann Anja Godske; Loft Anne Gitte; Bojesen Anders Bo; Ostergaard Mikkel; Lund Hetland Merete; Krogh Niels Steen; Roessler Kirsten Kaya; Petersen Kim Horslev. Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study. BMJ open. (2019) 9 6 ppe028197', '10.1136/bmjopen-2018-028197', '']\n",
      "['9736767', 'Buckley C; Campos JAS; Yakushin S; Zhdan V; Davy K; Inman D; Fisheleva E; Gupta A; Layton M; Mitchell N; Patel J; Williamson R; Tak P-P. A phase IIb dose-ranging study of anti-GM-CSF with methotrexate treatment in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2166-2167', '10.1136/annrheumdis-2019-eular.6035', '']\n",
      "['9736768', 'EUCTR2005-002969-37-ES. A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship. Estudio aleatorizado, de grupos paralelos y controlado con placebo de la administraci√≥n de una dosis √∫nica de GW856553 en pacientes con Artritis Reumatoide activa para investigar la relaci√≥n entre la dosis y respuesta sobre la prote√≠na C reactiva - GM2005/00244/00. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002969-37-ES. (2005)   pp', '10.4995/thesis/10251/193057', 'https://riunet.upv.es/bitstream/10251/193057/1/Moya%20-%20Estudio%20sistemico%20de%20una%20estructura%20exoesqueletica%20para%20la%20rehabilitacion%20de%20la%20atrofia%20mu....pdf']\n",
      "['9736769', 'RBR-3kzp25. Evaluation of two preventive schemes of dental extraction with amoxicillin in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors (anti-TNF-?) and methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RBR-3kzp25. (2015)   pp', '10.1186/isrctn62900439', '']\n",
      "['9736770', 'Walsh J A; Gottlieb A B; Hoepken B; Nurminen T; Mease P J. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4¬†years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial. Clinical rheumatology. (2018) 37 12 pp3285-3296', '10.1007/s10067-018-4227-7', 'http://link.springer.com/article/10.1007/s10067-018-4227-7/fulltext.html']\n",
      "['9736773', '. TNF-≈í¬± inhibitors decrease classical CD14hicd16‚Äö√†√≠ monocyte subsets in highly active, conventional treatment refractory rheumatoid arthritis and ankylosing spondylitis. International journal of molecular sciences. (2019) 20 2 pp', '10.3390/ijms20020291', '']\n",
      "['9736774', 'JapicCTI-121786. A phaseI,multiple-dose study of SA237. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-121786. (2012)   pp', '10.1109/access.2021.3108423', '']\n",
      "['9736775', 'IRCT20181128041784N1. Effectiveness of Aspirin 80, Aspirin 325, Enoxaparin and Rivoroxaban in Prevention of Coagulopathy  after Total Knee Arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20181128041784N1. (2019)   pp', '10.1302/0301-620x.106b6.bjj-2023-0783.r2', 'https://boneandjoint.org.uk/doi/10.1302/0301-620X.106B6.BJJ-2023-0783.R2/pdf']\n",
      "['9736776', 'Lee Seunghoon; Cho Yeeun; Kim Jihye; Kang Jung Won; Yoon Ga Young; Lee Jun-Hwan; Jung So-Young; Kwon Ojin; Shin Kyung-Min; Lee Jae-Dong. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial. Trials. (2018) 19 1 pp471', '10.1186/s13063-018-2849-3', 'http://link.springer.com/article/10.1186/s13063-018-2849-3/fulltext.html']\n",
      "['9736777', 'Menor Almagro R; Martinez RM; Rubio EM; Fernandez MM. Relationship between patient global assessment and pain assessment in the disease activity indexes in rheumatoid arthritis, and its correspondence with sonographic alterations. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1364', '10.1136/annrheumdis-2018-eular.7080', '']\n",
      "['9736778', 'Lubimova N; Goleva O; Fridman I; Sorokina L; Idrisova R; Kharit S; Kostik M. Anti-vaccine antibody levels in juvenile idiopathic arthritis patients: preliminary data in 90 patients. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp560-561', '10.1136/annrheumdis-2019-eular.2721', '']\n",
      "['9736779', 'NCT01423188. The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation. https://clinicaltrials.gov/show/NCT01423188. (2011)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9736780', 'Van Vollenhoven R; Cohen SB; Mease P; Peterfy CG; Spieler W; Boice J; Curtis S; Li Q; Yao R; Baumgartner R; Weng H. Efficacy and safety of MK-8457, a novel SYK inhibitor for the treatment of rheumatoid arthritis in two randomized, controlled, phase 2 studies. Arthritis and rheumatology. (2014)   ppS673-S674', '10.1002/art.39262', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39262']\n",
      "['9736781', 'ISRCTN55197693. Randomised comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN55197693. (2007)   pp', '10.1186/isrctn55197693', '']\n",
      "['9736782', 'De Faria AP; Santa-Catharina A; Ritter A; Modolo R; Pioli M; Pires N; Bertolo M; Moreno H. Effects of tnf-alpha inhibiton on hemodynamic parameters and biomarkers in resistant hypertension. Journal of hypertension. (2018) Conference: 28th Scientific Meeting of the European Society of Hypertension, ESH 2018. Spain. 36 Supplement 1 ppe48-e49', '10.1097/01.hjh.0000539092.97172.4f', '']\n",
      "['9736784', 'Coutinho M; Duarte C; Ferreira J; Da Silva. Ultrasound guided musculoskeletal procedures under peripheral nerve block: a pilot controlled study in rheumatic patients. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.5575', '']\n",
      "['9736787', 'Viara M; Franchi R; Liverta C; Pollini C; Pontiroli A E. Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double blind cross over trial. European journal of clinical pharmacology. (1975) 8 3-4 pp205-208', '10.1007/bf00567116', 'http://link.springer.com/article/10.1007/BF00567116/fulltext.html']\n",
      "['9736788', 'ISRCTN53598448. A randomised controlled trial investigating the efficacy of foot orthoses in rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN53598448. (2002)   pp', '10.1186/isrctn53598448', '']\n",
      "['9736789', 'Mueller Ruediger B; Hasler Caroline; Popp Florian; Mattow Frederik; Durmisi Mirsada; Souza Alexander; Hasler Paul; Rubbert-Roth Andrea; Schulze-Koops Hendrik; Kempis Johannes von. Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: a Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. Journal of clinical medicine. (2019) 8 10 pp', '10.3390/jcm8101548', '']\n",
      "['9736790', \"Fisher Benjamin A; Everett Colin C; Rout John; O'Dwyer John L; Emery Paul; Pitzalis Costantino; Ng Wan-Fai; Carr Andrew; Pease Colin T; Price Elizabeth J; Sutcliffe Nurhan; Makdissi Jimmy; Tappuni Anwar R; Gendi Nagui S T; Hall Frances C; Ruddock Sharon P; Fernandez Catherine; Hulme Claire T; Davies Kevin A; Edwards Christopher John; Lanyon Peter C; Moots Robert J; Roussou Euthalia; Richards Andrea; Sharples Linda D; Bombardieri Michele; Bowman Simon J. Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the rheumatic diseases. (2018) 77 3 pp412-416\", '10.1136/annrheumdis-2017-212268', '']\n",
      "['9736792', 'EUCTR2005-003436-21-CZ. A phase 2, multi-centre, randomised, double blind, placebo controlled study evaluating the efficacy, safety and pharmacokinetics of two doses of a candidate Disease Modifying Anti-Rheumatic Drug (DMARD), (SMP-114 120 mg and 240 mg once daily), administered in combination with ongoing methotrexate treatment in patients with active rheumatoid arthritis. - ASPECTS- Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment with SMP-114. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003436-21-CZ. (2005)   pp', '10.1186/isrctn32398235', '']\n",
      "['9736793', 'EUCTR2016-003682-26-PL. Phase 3 trial to Evaluate the Efficacy and Safety of CF101 Compared to Methotrexate in the Treatment of patients suffering of Early Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-003682-26-PL. (2018)   pp', '10.1186/isrctn49455679', '']\n",
      "['9736794', 'EUCTR2009-017438-32-BE. A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-017438-32-BE. (2010)   pp', '10.1186/isrctn62713985', '']\n",
      "['9736796', 'Marques ML; Brites L; Marques A; Daniel A; Santiago M; Pereira Da Silva JA. Factors associated with annual percentage changes in bone mineral density: a-14 years prospective population-based study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp452-453', '10.1136/annrheumdis-2018-eular.5293', '']\n",
      "['9736797', 'NTR4523. Evaluation of the prevalence, incidence and progression of bone erosions in rheumatoid arthritis (RA) by high-resolution peripheral quantitative computer tomography (HRpQCT) compared to standard imaging techniques. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4523. (2014)   pp', '10.1093/rheumatology/ket259', 'http://academic.oup.com/rheumatology/article-pdf/53/1/65/5039727/ket259.pdf']\n",
      "['9736798', 'Perez-Roman Diana I; Ortiz-Haro Ana B; Ruiz-Medrano Emmanuel; Contreras-Yanez Irazu; Pascual-Ramos Virginia. Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation. Rheumatology international. (2018) 38 4 pp599-606', '10.1007/s00296-017-3910-3', 'http://link.springer.com/article/10.1007/s00296-017-3910-3/fulltext.html']\n",
      "['9736799', 'Anderson J J; Bolognese J A; Felson D T. Comparison of Rheumatoid Arthritis Clinical Trial Outcome Measures: a Simulation Study. Arthritis and rheumatism. (2003) 48 11 pp3031-3038', '10.1002/art.11293', '']\n",
      "['9736800', 'Shiroky J B. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis. Journal of rheumatology. (1996) 23 SUPPL. 44 pp69-71', '10.1093/rheumatology/xxxiv.suppl_4.109', 'http://academic.oup.com/rheumatology/article-pdf/XXXIV/suppl_4/109/5067425/XXXIV-suppl_4-109.pdf']\n",
      "['9736801', 'CTRI/2016/01/006508. A Clinical Trial to study the clinical bioequivalence of of Methotrexate Tablets USP 2.5 mg (Test) of Eugia Pharma Specialities Limited, India  with Methotrexate Tablets USP 2.5 mg (Reference) of Dava Pharmaceuticals Inc USA in patients with mild to severe Psoriasis or Rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/01/006508. (2016)   pp', '10.4172/jbb.1000314', '']\n",
      "['9736802', 'NCT00667758. Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00667758. (2008)   pp', '10.1186/isrctn53514546', '']\n",
      "['9736803', 'Jin Li Hua; Kim Bo-Hyung; Lee Ji Hyun; Lee Kidong; Kwack KyuBum; Yim Sung-Vin. Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate. Translational and clinical pharmacology. (2017) 25 4 pp166-172', '10.12793/tcp.2017.25.4.166', 'https://synapse.koreamed.org/pdf/10.12793/tcp.2017.25.4.166']\n",
      "['9736804', 'Tanaka S. Emerging anti-osteoclast therapy for rheumatoid arthritis. Journal of orthopaedic science. (2018) (no pagination)  pp', '10.1016/j.jos.2018.06.001', '']\n",
      "['9736805', 'Van Den Bosch F; Wassenberg S; Zueger P; Kalabic J; Wu M; Monastiriakos K; Ostor A. Impact of prior biologic use on treatment response in patients with rheumatoid arthritis receiving adalimumab in routine clinical care: results from the passion study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp602', '10.1136/annrheumdis-2018-eular.6934', '']\n",
      "['9736806', 'Dakkak YJ; Matthijssen XME; van der Heijde DM; Reijnierse M; van der Helm-van Mil AHM. Reliability of Magnetic Resonance Imaging (MRI)-scoring of the Metatarsophalangeal-joints of the Foot According to the Rheumatoid Arthritis-MRI Score (RAMRIS). Journal of rheumatology. (2019)   pp', '10.1136/annrheumdis-2019-eular.3247', '']\n",
      "['9736807', 'EUCTR2012-003655-11-DE. Evaluation of long-term safety, tolerability and efficacy of GLPG0634 treatment in subjects with rheumatoid arthritis regarding subject‚Äôs disability, fatigue, and quality of life. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003655-11-DE. (2013)   pp', '10.1093/rheumatology/kew166.009', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i187/5080308/kew166.009.pdf']\n",
      "['9736808', 'Schrier Joost C; Keijsers Noel L; Matricali Giovanni A; Verheyen Cees C P M; Louwerens Jan Willem K. Resection or preservation of the metatarsal heads in rheumatoid forefoot surgery? A randomised clinical trial. Foot and ankle surgery. (2019) 25 1 pp37-46', '10.1016/j.fas.2017.07.1126', '']\n",
      "['9736809', 'Rosenzwajg Michelle; Lorenzon Roberta; Cacoub Patrice; Pham Hang Phuong; Pitoiset Fabien; El Soufi Karim; RIbet Claire; Bernard Claude; Aractingi Selim; Banneville Beatrice; Beaugerie Laurent; Berenbaum Francis; Champey Julien; Chazouilleres Olivier; Corpechot Christophe; Fautrel Bruno; Mekinian Arsene; Regnier Elodie; Saadoun David; Salem Joe-Elie; Sellam Jeremie; Seksik Philippe; Daguenel-Nguyen Anne; Doppler Valerie; Mariau Jeremie; Vicaut Eric; Klatzmann David. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Annals of the rheumatic diseases. (2019) 78 2 pp209-217', '10.1136/annrheumdis-2018-214229', '']\n",
      "['9736810', 'Ancuta C; Pomirleanu C; Paiu R; Iordache C; Ancuta E; Chirieac R. Biological DMARDs-induced lupus in patients with rheumatoid arthritis: a single centre experience. Lupus science and medicine. (2018) Conference: 11th European Lupus Meeting. Germany. 5 Supplement 1 ppA41', '10.1136/lupus-2018-abstract.67', '']\n",
      "['9736811', 'Milic D; Zivic S; Bogdanovic D; Jovanovic M. A randomized trial of class 2 and class 3 elastic compression in the prevention of recurrence of venous ulceration. Phlebology / Venous Forum of the Royal Society of Medicine. (2018) Conference: 19th Meeting of the European Venous Forum. Greece. 33 10 pp719', '10.1016/j.jvs.2009.11.033', '']\n",
      "['9736812', 'Hamidi Z; Aryaeian N; Abolghasemi J; Shirani F; Hadidi M; Fallah S; Moradi N. The effect of saffron supplement on clinical outcomes and metabolic profiles in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Phytotherapy research : PTR. (2020)   pp', '10.1002/ptr.6633', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.6633']\n",
      "['9736814', 'Ndosi M; Lewis M; Hale C; Quinn H; Ryan S; Emery P; Bird H; Hill J. The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Annals of the rheumatic diseases. (2013)   pp', '10.1136/annrheumdis-2013-203403', '']\n",
      "['9736815', 'Anonymous. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis? The Multicenter Salsalate/Aspirin Comparison Study Group. Journal of rheumatology. (1989) 16 3 pp321-327', '10.1093/rheumatology/8.6.208', 'http://academic.oup.com/rheumatology/article-pdf/8/6/208/5199203/8-6-208.pdf']\n",
      "['9736816', '. Oral apremilast is effective in the treatment of subjects with active psoriatic arthritis with and without concomitant methotrexate therapy. Journal of rheumatology.. (2012) 39 8 pp1709-1710', '10.1038/nrrheum.2012.56', 'http://www.nature.com/articles/nrrheum.2012.56']\n",
      "['9736818', \"McDonald D D; Fedo J. Older Adults' Pain Communication: the Effect of Interruption. Pain management nursing. (2009) 10 3 pp149-153\", '10.1016/j.pmn.2009.03.003', '']\n",
      "['9736820', \"Kamal Y; Kandil M; Eissa M; Yousef R; Elsaadany B. Probiotics as a prophylaxis to prevent oral candidiasis in patients with Sjogren's syndrome: a double-blinded, placebo-controlled, randomized trial. Rheumatology international. (2020) 26 6 pp873-879\", '10.1007/s00296-020-04558-9', 'https://link.springer.com/article/10.1007/s00296-020-04558-9/fulltext.html']\n",
      "['9736821', 'NCT00782444. Computer Navigation vs Conventional Technique in Knee Arthroplasty. https://clinicaltrials.gov/show/NCT00782444. (2008)   pp', '10.1016/j.arth.2011.08.009', '']\n",
      "['9736822', \"Bachok Norsa'adah; Biswal Biswa Mohan; Razak Noor Hayati Abdul; Zainoon Wan Mohd Nazri Wan; Mokhtar Kasmawati; Rahman Roselinda Abdul; Abdullah Mohd Faizal; Mustafa Siti Mimi Nadiya; Noza Nawi. Preliminary Comparative Study of Oral7 R Versus Salt-Soda Mouthwash on Oral Health Related Problems and Quality of Life among Head and Neck Cancer Patients Undergoing Radiotherapy. The malaysian journal of medical sciences : MJMS. (2018) 25 5 pp79-87\", '10.21315/mjms2018.25.5.8', '']\n",
      "['9736823', 'Eusden J; Matcham F; Steer S; Cope AP; Lewis CM; Scott IC. Reduced mental health in early rheumatoid arthritis is associated with genetic susceptibility for depression, disease severity and pain levels. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi49', '10.1093/rheumatology/kev087.006', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i49/5179483/kev087.006.pdf']\n",
      "['9736824', 'NCT04275206. The Anti-inflammatory Effects of Hark√°ny Medicinal Water. https://clinicaltrials.gov/show/NCT04275206. (2020)   pp', '10.31525/ct1-nct04275206', '']\n",
      "['9736826', 'Joshi R; Movahedi M; Rampakakis E; Cesta A; Sampalis J; Bombardier C. Impact of residential area on the profile of rheumatoid arthritis patients initiating their first biologic DMARD: results from the Ontario best practices research initiative (OBRI). Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1052', '10.1136/annrheumdis-2018-eular.2194', '']\n",
      "['9736827', 'IRCT20191021045171N1. Extra corporeal shock wave therapy for chronic Low back pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20191021045171N1. (2019)   pp', '10.1186/isrctn13785224', '']\n",
      "['9736828', 'EUCTR2010-022049-88-DE. \"Efficacy and safety study of a sequential therapy of tocilizumab (TCZ) and, if initially inade-quately responded to tocilizumab (TCZ), followed by rituximab (RTX) in DMARD-IR patients with rheumatoid arthritis (MIRAI)\" - MIRAI. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-022049-88-DE. (2010)   pp', '10.1136/annrheumdis-2015-eular.4500', '']\n",
      "['9736830', 'Sapundzhieva Tanya; Karalilova Rositsa; Batalov Anastas. Body Mass Index Impact on Disease Activity, Clinical and Sonographic Remission Rates in Patients with Rheumatoid Arthritis. Current rheumatology reviews. (2019) 15 3 pp215-223', '10.2174/1573397115666181130143239', '']\n",
      "['9736831', 'Harmatz P; Cattaneo F; Ardigo D; Geraci S; Lund AM; Borgwardt L. Toward establishment of a minimal clinically important difference in the treatment of alpha-mannosidosis: first results from velmanase alfa (human recombinant alpha-mannosidase) development program. Journal of inborn errors of metabolism and screening. (2017) Conference: 13th International Congress of Inborn Errors of Metabolism, ICIEM 2017. Brazil. 5 pp 362 pp', '10.1177/2326409818796854', 'http://journals.sagepub.com/doi/pdf/10.1177/2326409818796854']\n",
      "['9736832', 'Ghaderi Afshin; Nodehi Sayyed Reza Safaee; Bakhtiari Tahereh; Aslani Mona; Aghazadeh Zahra; Matsuo Hidenori; Rehm Bernd H A; Cuzzocrea Salvatore; Mirshafiey Abbas. Mannuronic Acid in Low-Risk and Intermediate-1-Risk Myelodysplastic Syndromes. Journal of clinical pharmacology. (2020) 60 7 pp879-888', '10.1002/jcph.1587', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1587']\n",
      "['9736833', 'EUCTR2007-006288-56-AT. Methotrexat-Polyglutamate als Marker fuer das klinische Outcome in der Therapie der rheumatoiden Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006288-56-AT. (2008)   pp', '10.1007/978-3-642-85287-9_6', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85287-9_6.pdf']\n",
      "['9736834', 'Cush J; Fox RI; Kavanaugh A; Kremer JM. Rheumatoid Arthritis: current Perspectives on DMARD Therapy. Medical crossfire. (2003) 5 8 pp27-45+48', '10.2165/00042310-200016010-00001', '']\n",
      "['9736835', 'EUCTR2005-002396-33-IT. A randomised, double-blind, international study to evaluate the  efficacy and safety of various re-treatment regimens of  rituximab in combination with methotrexate in RA patients with  an inadequate response to methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002396-33-IT. (2006)   pp', '10.1186/isrctn49455679', '']\n",
      "['9736836', 'NCT02514772. GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan¬¨¬®‚àö√ú or MabThera¬¨¬®‚àö√ú. https://clinicaltrials.gov/show/NCT02514772. (2015)   pp', '10.2165/00128413-200615440-00065', '']\n",
      "['9736837', 'ISRCTN22288225. Human stress protein (immunoglobulin Binding Protein [BiP]) for the treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN22288225. (2007)   pp', '10.1186/isrctn22288225', '']\n",
      "['9736838', 'Fleischmann R; Furst DE; Brasington R; Connolly-Strong E; Liu J; Barton ME. A multicenter study assessing the efficacy and safety of repository corticotropin injection in patients with rheumatoid arthritis: preliminary interim data from the open-label treatment period. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp986', '10.1136/annrheumdis-2018-eular.5768', '']\n",
      "['9736839', 'EUCTR2010-021344-17-IT. A non-randomized, multiple dose, three treatment period,  open-label, single sequence, single group study to evaluate  the pharmacokinetic effect of two doses of QTI571  (imatinib) on the co-administered drugs sildenafil and  bosentan in pulmonary arterial hypertension (PAH) patients. - ND. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021344-17-IT. (2011)   pp', '10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3357', '']\n",
      "['9736840', 'Vischer T L; Veys E; Symoens J. Levamisole in rheumatoid arthritis. A randomised double-blind study comparing two dosage regimens of levamisole with placebo. Lancet. (1978) 2 8098 pp1007-1012', '10.1016/s0140-6736(78)92335-8', '']\n",
      "['9736842', 'Bae Sang-Cheol; Lee Young Ho. Comparative efficacy and safety of TNF-inhibitor plus methotrexate versus oral triple therapy in patients with active rheumatoid arthritis inadequately responding to methotrexate: a meta-analysis of randomized controlled trials. International journal of clinical pharmacology and therapeutics. (2018) 56 6 pp263-269', '10.5414/cp203202', '']\n",
      "['9736843', 'Edwards C; Chyrok V; Monnet J; Ullmann M; Vlachos P. Safety, immunogenicity and efficacy of the proposed biosimilar MSB11022 (modified formulation) compared with adalimumab reference product in patients with moderately to severely active rheumatoid arthritis: AURIEL-RA, a randomised, doubleblind, phase III study. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp707', '10.1136/annrheumdis-2019-eular.4220', '']\n",
      "['9736844', 'Guseva I; Smirnov A; Demidova N; Krylov M; Avdeeva A; Samarkina E; Luchikhina E; Karateev E; Abramov D; Nasonov E. Polymorphisms of HLA-DRB1 and TNF-308 G/A are associated with radiographic joint destruction in patients with very early rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1300', '10.1136/annrheumdis-2018-eular.2515', '']\n",
      "['9736845', 'Vinci C. Antibodies to post-translationally modified collagen II in spondyloarthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp622-623', '10.1136/annrheumdis-2018-eular.4404', '']\n",
      "['9736846', 'Lamb Yvette N; Deeks Emma D. Sarilumab: a Review in Moderate to Severe Rheumatoid Arthritis. Drugs. (2018) 78 9 pp929-940', '10.1007/s40265-018-0929-z', 'http://link.springer.com/article/10.1007/s40265-018-0929-z/fulltext.html']\n",
      "['9736847', 'JapicCTI-142621. CHS-0214 Phase III trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-142621. (2014)   pp', '10.1186/isrctn27544579', '']\n",
      "['9736848', 'Wan Lei; Liu Jian; Huang Chuanbing; Zhang Xiaojun; Sun Yue; Liu Lei. Xinfeng capsule improves pulmonary function of rats with rheumatoid arthritis by inhibiting PKC/NF-kappaB pathway. Xi bao yu fen zi mian yi xue za zhi [Chinese journal of cellular and molecular immunology]. (2018) 34 7 pp589-594', '10.4172/2167-7921.1000172', '']\n",
      "['9736850', 'Risum K; Godang K; Marit Selvaag A; Hansen BH; Molberg O; Bollerslev J; Holm I; Dagfinrud H; Sanner H. Suboptimal muscle strength and bone health in patients with oligo-and polyarticular juvenile idiopathic arthritis diagnosed in the era of biologics. Pediatric rheumatology. (2018) Conference: 25th European Paediatric Rheumatology Congress, PReS 2018. Portugal. 16 Supplement 2 pp', '10.1186/s12969-018-0281-6', 'http://link.springer.com/article/10.1186/s12969-018-0281-6/fulltext.html']\n",
      "['9736853', 'ChiCTR-IOR-15006887. Drainage versus non-drainage in primary total knee arthroplasty without tourniquet: a prospective randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-15006887. (2015)   pp', '10.58837/chula.the.2008.768', '']\n",
      "['9736854', 'Wu Dan; Hou Si-Yuan; Zhao Shuai; Hou Lin-Xin; Jiao Ting; Xu Nan-Nan; Zhang Ning. Meta-analysis of IL-17 inhibitors in two populations of rheumatoid arthritis patients: biologic-naive or tumor necrosis factor inhibitor inadequate responders. Clinical rheumatology. (2019) 38 10 pp2747-2756', '10.1007/s10067-019-04608-z', 'http://link.springer.com/article/10.1007/s10067-019-04608-z/fulltext.html']\n",
      "['9736857', \"NCT00626665. Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma. https://clinicaltrials.gov/show/NCT00626665. (2008)   pp\", '10.1310/hpj4103-245', 'https://journals.sagepub.com/doi/pdf/10.1310/hpj4103-245']\n",
      "['9736860', 'NCT04178070. Phase ‚Ö† Clinical Trial of Gerilimzumab Injection in Healthy Subjects. https://clinicaltrials.gov/show/NCT04178070. (2019)   pp', '10.31525/ct1-nct04178070', '']\n",
      "['9736861', 'Roy-Hewitson C; Smith A; Oh J. Stable Multiple Sclerosis while on Pembrolizumab treatment for Metastatic Melanoma. European journal of neurology. (2019) Conference: 5th Congress of the European Academy of Neurology, EAN 2019. Norway. 26 Supplement 1 pp668', '10.1055/a-0873-8894', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0873-8894.pdf']\n",
      "['9736862', 'Wang J; Zou X; Cong L; Liu H. Clinical effectiveness and cost-effectiveness of nurse-led care in Chinese patients with rheumatoid arthritis: a randomized trial comparing with rheumatologist-led care. International journal of nursing practice. (2018) 24 1) (no pagination pp', '10.1111/ijn.12605', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijn.12605']\n",
      "['9736863', 'Pincus T. The American College of Rheumatology (ACR) core data set and derivative \"patient only\" indices to assess rheumatoid arthritis. Clinical and experimental rheumatology. (2005) 23 5 SUPPL. 39 ppS109-S113', '10.1002/art.20995', '']\n",
      "['9736865', 'Lovell DJ; Dare JA; Ball J; Francis-Sedlak M; LaMoreaux BD; Holt RJ. A 6-month, multicenter, open-label, exploratory study of fixed dose naproxen/ esomeprazole in adolescent patients with juvenile idiopathic arthritis (JIA). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1652-1653', '10.1136/annrheumdis-2018-eular.1089', '']\n",
      "['9736866', 'Martinelli Lourenzi F; Jones A; Freitas Pereira D; dos Santos JHCA; Vilar Furtado RN; Natour J. Effectiveness of an overall progressive resistance strength program for improving the functional capacity of patients with rheumatoid arthritis: a randomized controlled trial. Clinical rehabilitation. (2017) 31 11 pp1482-1491', '10.1177/0269215517698732', 'http://journals.sagepub.com/doi/pdf/10.1177/0269215517698732']\n",
      "['9736868', 'Bubb MR; Judd R; Chauffe AD. Incorporation of patient reported outcomes data in the care of us veterans with rheumatoid arthritis: a randomized, controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp3228-3229', '10.1002/art.41686', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41686']\n",
      "['9736869', 'Perry Elizabeth; Eggleton Paul; De Soyza Anthony; Hutchinson David; Kelly Clive. Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis. International journal of rheumatic diseases. (2017) 20 12 pp2003-2011', '10.1111/1756-185x.12702', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12702']\n",
      "['9736870', 'Ren L M; Li R; Chen L N; Zhu P; Gu F; Sun L Y; Zhao J X; Liu X Y; Guo J L; Bi L Q; Hao Y J; Zhang Z L; Mei Y F; Zhang Z Y; Liu H X; Li X F; Luo Y; Fang Y F; Li Z G; Su Y. Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study. International journal of rheumatic diseases. (2016) 19 7 pp651-657', '10.1111/1756-185x.12677', '']\n",
      "['9736871', 'Bolanos-Chamorro F; Hernandez-Palma LA; Vazquez-Murillo G; Cerpa-Cruz S; Munoz-Valle JF; Meda-Lara RM. Efficacy of hypnotic analgesia for the reduction of pain and negative emotional states in patients with rheumatoid arthritis of the hospital civil De guadalajara \"fray antonio alcalde\". Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp1199', '10.1136/annrheumdis-2017-eular.6983', '']\n",
      "['9736872', 'EUCTR2011-002392-41-BG. A trial to compare Z102 against Prednisone in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002392-41-BG. (2012)   pp', '10.1186/isrctn30714266', '']\n",
      "['9736873', \"NCT01501019. Exercise in Sjogren, Myositis and Takayasu's Arteritis. https://clinicaltrials.gov/show/NCT01501019. (2011)   pp\", '10.1055/b-0034-66857', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-66857.pdf']\n",
      "['9736874', 'CTRI/2017/05/008589. To study the effect of Yoga and Meditation on Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/05/008589. (2017)   pp', '10.18535/jmscr/v5i3.23', '']\n",
      "['9736875', 'ISRCTN75459849. A randomised, double-blinded, controlled trial of ultrasound guided and conventional clinical examination guided intra-articular corticosteroid injection of large and medium synovial joints in inflammation arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN75459849. (2007)   pp', '10.1186/isrctn75459849', '']\n",
      "['9736876', 'Paul S; Marotte H; Kavanaugh A; Goupille P; Kvien TK; de Longueville M; Mulleman D; Sandborn WJ; Vande Casteele N. Exposure‚àö¬¢‚Äö√á¬®‚Äö√Ñ√∫Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis. Clinical and translational science. (2020)   pp', '10.1111/cts.12760', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcts.12760']\n",
      "['9736878', 'EUCTR2006-000363-28-GB. DIFFERENTIATING THE MECHANISM OF ACTION OF ANTI  TNF-alpha AGENTS - DATA Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-000363-28-GB. (2006)   pp', '10.1186/isrctn44880063', '']\n",
      "['9736880', 'Payne C; Clark M; Patel S; Allawh T; Ty-Arias M-A; Davis A; Jayatilleke A. Awareness of fertility and contraception issues among women with rheumatologic diseases. Arthritis and rheumatology. (2018) 70 Suppl. 9 pp2674-2675', '10.1016/j.contraception.2018.04.014', '']\n",
      "['9736881', 'EUCTR2008-001241-26-HU. A randomized, placebo-controlled, double-blind, dose escalation study to evaluate the efficacy, safety and tolerability of the study drug BT971 in patients with rheumatoid arthritis receiving concomitant Methotrexate - n.a. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-001241-26-HU. (2008)   pp', '10.1186/isrctn49455679', '']\n",
      "['9736882', 'Raknes Guttorm; Smabrekke Lars. Low dose naltrexone: effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study. PloS one. (2019) 14 2 ppe0212460', '10.1371/journal.pone.0223545', '']\n",
      "['9736883', 'Miossec P; Youinou P; Le Goff; Moineau M P. Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Clinical rheumatology. (1982) 1 3 pp185-189', '10.1007/bf02042772', 'http://link.springer.com/article/10.1007/BF02042772/fulltext.html']\n",
      "['9736884', 'Gamal S M; Alkemary A K; Abdo M A; El Dakrony A H M. Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices. Reumatismo. (2018) 70 2 pp72-77', '10.4081/reumatismo.2018.999', 'https://www.reumatismo.org/index.php/reuma/article/download/999/787']\n",
      "['9736885', 'Collins J; Johansson F; Gale S; Kim S; Shrestha S; Sontag D; Stratton J; Huong T; Xu C; Losina E; Solomon D. Predicting remission among patients with rheumatoid arthritis starting tocilizumab monotherapy: model derivation and validation using conventional regression and machine learning. Annals of the rheumatic diseases. (2019) 78  pp727-', '10.1136/annrheumdis-2019-eular.4305', '']\n",
      "['9736886', 'Addorisio Meghan E; Imperato Gavin H; de Vos Alex F; Forti Steve; Goldstein Richard S; Pavlov Valentin A; van der Poll Tom; Yang Huan; Diamond Betty; Tracey Kevin J; Chavan Sangeeta S. Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external ear. Bioelectronic medicine. (2019) 5  pp4', '10.1186/s42234-019-0020-4', 'http://link.springer.com/article/10.1186/s42234-019-0020-4/fulltext.html']\n",
      "['9736887', \"Fleischmann Roy; Genovese Mark C; Lin Yong; St John Gregory; van der Heijde Desiree; Wang Sheldon; Gomez-Reino Juan Jose; Maldonado-Cocco Jose Antonio; Stanislav Marina; Kivitz Alan J; Burmester Gerd R. Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up. Rheumatology (Oxford, England). (2020) 59 2 pp292-302\", '10.1093/rheumatology/kez265', 'http://academic.oup.com/rheumatology/article-pdf/59/2/292/33920340/kez265.pdf']\n",
      "['9736888', \"Nived Per; Saxne Tore; Geborek Pierre; Mandl Thomas; Skattum Lillemor; Kapetanovic Meliha C. Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjogren's syndrome without disease modifying treatment. BMC rheumatology. (2018) 2  pp12\", '10.1186/s41927-018-0019-6', 'http://link.springer.com/article/10.1186/s41927-018-0019-6/fulltext.html']\n",
      "['9736889', 'Zhao Juan; Wang Yu; Geng Yan; Zhang Xiaohui; Deng Xuerong; Ji Lanlan; Song Zhibo; Zhang Zhuoli. Intensive therapy alleviates subclinical synovitis on ultrasound and disease activity and reduces flare in rheumatoid arthritis patients who have achieved clinical target - a randomized controlled trial. Seminars in arthritis and rheumatism. (2020) 50 4 pp673-679', '10.1016/j.semarthrit.2020.05.014', '']\n",
      "['9736890', 'Sullivan Emma; Kershaw Jim; Blackburn Stuart; Mahajan Puneet; Boklage Susan H. Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan. Rheumatology and therapy. (2020)   pp', '10.1007/s40744-020-00211-w', 'https://link.springer.com/article/10.1007/s40744-020-00211-w/fulltext.html']\n",
      "['9736891', 'ISRCTN86668322. Very early steroid therapy in arthritis - the Stop Arthritis Very Early (SAVE) trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN86668322. (2006)   pp', '10.1186/isrctn86668322', '']\n",
      "['9736893', 'Cheng P; Wang J. The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients. Journal of clinical laboratory analysis. (2020)   pp', '10.1002/jcla.23329', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcla.23329']\n",
      "['9736894', 'IRCT2014052517840N1. Applying model on level of activity daily living and pain in arthritis rheumatoid patient. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014052517840N1. (2015)   pp', '10.1002/anr.1780321225', '']\n",
      "['9736895', 'NCT03983408. Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease. Https://clinicaltrials.gov/show/nct03983408. (2019)   pp', '10.31525/ct1-nct03983408', '']\n",
      "['9736896', 'Khedr EM; El Fetoh NA; Herdan OO; El-Hammady DH; Khalifa H; Gamal RM; Ali AAM. Clinical and subclinical neuropsychiatric abnormalities in rheumatoid arthritis patients. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi84', '10.4103/1110-161x.155625', 'http://link.springer.com/article/10.4103/1110-161X.155625/fulltext.html']\n",
      "['9736897', 'Justet A; Borie R; Nunes H; Cottin V; Adam SM; Cadranel J; Bergot E; Wemeau-Stervineau LI; Naccache JM; Magois E; Frachon I; Gondouin A; Medhaoui A; Cordier JF; Valeyre D; Grandchamp B; Kanengiesser C; Crestani B. Safety and efficacy of pirfenidone in patients with lung fibrosis and TERT mutation. European respiratory journal. (2016) Conference: European Respiratory Society Annual Congress 2016. United Kingdom. 48 Supplement 60 pp', '10.1183/13993003.congress-2016.oa484', '']\n",
      "['9736898', 'Zhou Li; Xiao Dong-Mei; Qin Wen; Xie Bin-Hua; Wang Ting-Hui; Huang Hua; Zhao Bao-Jing; Han Xi; Sun Qing-Qing; Wu Xiu-Di; Cen Han. The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab. Journal of clinical laboratory analysis. (2019) 33 5 ppe22862', '10.1002/jcla.22862', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcla.22862']\n",
      "['9736899', 'Ali Eman Tariq; Jabbar Azza Sajed; Mohammed Ali Nazar. A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia. Anemia. (2019) 2019  pp3457347', '10.1155/2019/3457347', 'http://downloads.hindawi.com/journals/anemia/2019/3457347.pdf']\n",
      "['9736900', 'Gao S-M; Xu J-H; Ding C-H; Xu S-Y. A randomized controlled clinical trial of actarit in the treatment of rheumatoid arthritis. Chinese pharmaceutical journal. (2002) 37 12 pp951-953', '10.1186/1745-6215-12-137', 'http://link.springer.com/article/10.1186/1745-6215-12-137/fulltext.html']\n",
      "['9736903', 'Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: a Randomized Controlled Study. Arthritis and rheumatology. (2019) 71 6 pp952-963', '10.1002/art.40802', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40802']\n",
      "['9736904', 'IRCT2014032816490N2. Effects of GnRH and Raloxifen on the size of uterine lyomioma. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014032816490N2. (2014)   pp', '10.1186/isrctn31608625', '']\n",
      "['9736905', 'de Carvalho Jozelio Freire; Dos Santos Maria Natividade Pereira; de Oliveira Joyce Meyre Vieira; Lanty Silva Andrea Nogueira S; de Araujo Roberto Paulo Correia; Cardozo Juliana Bahia. Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion. Advances in rheumatology (london, england). (2018) 58 1 pp22', '10.1186/s42358-018-0016-x', 'http://link.springer.com/article/10.1186/s42358-018-0016-x/fulltext.html']\n",
      "['9736906', 'IRCT2013111515408N1. Survey on oral administration of black cumin on relieving clinical symptoms of knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013111515408N1. (2013)   pp', '10.1111/1756-185x.13066', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13066']\n",
      "['9736909', 'Kawalec Pawel; Sladowska Katarzyna; Malinowska-Lipien Iwona; Brzostek Tomasz; Kozka Maria. New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib. Therapeutics and clinical risk management. (2019) 15  pp275-284', '10.2147/tcrm.s192440', 'https://www.dovepress.com/getfile.php?fileID=48032']\n",
      "['9736911', 'Shen Hsuan-Shu; Chiang Jen-Huai; Hsiung Nai-Huan. Adjunctive Chinese Herbal Products Therapy Reduces the Risk of Ischemic Stroke Among Patients With Rheumatoid Arthritis. Frontiers in pharmacology. (2020) 11  pp169', '10.3389/fphar.2020.00169', '']\n",
      "['9736912', 'Maragalawaththa M G Sandeepanie K; Goyal Mandip. Efficacy of Seetarama Vati (A Sri Lankan traditional drug) and Vatari Guggulu in the management of Amavata (rheumatoid arthritis)-an open labeled randomized comparative clinical trial. Ayu. (2019) 40 2 pp97-103', '10.4103/ayu.ayu_65_18', '']\n",
      "['9736913', 'Jonsson MK; Falkowski K; Aliko A; Aga A-B; Lillegraven S; Sexton J; Fevang B-TS; Mydel P; Haavardsholm EA. Serum mediated peptidylarginine deiminase (PAD) activation in early rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp559-560', '10.1136/annrheumdis-2018-eular.2572', '']\n",
      "['9736915', 'ChiCTR-TRC-14004520. To study the signal pathways of Rheumatoid Arthritis Syndrome of Accumulated Dampness and intervention mechanism of Sanhuang Yilong Decoction based the theory that lung, spleen and kidney regulate water. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-14004520. (2014)   pp', '10.1016/s0254-6272(18)30895-1', '']\n",
      "['9736916', 'Vetter C. Rheumatoid arthritis: abatacept prevents activation of T-cells. Deutsche apotheker zeitung. (2008) 148 26 pp44-45', '10.1002/14651858.cd007277', '']\n",
      "['9736917', 'Ecker-Schlipf B. Rheumatoid arthritis: methotrexate plus etanercept is more effective than monotherapy. Medizinische Monatsschrift fur Pharmazeuten. (2009) 32 8 pp317-318', '10.7326/acpjc-2001-135-1-003', '']\n",
      "['9736918', 'Lizan L; Pablos J; Jover J; Ivorra J; Inciarte-Mundo J; Dilla T; Comellas M; Sacristan J. DEVELOPMENT OF A PATIENT DECISION AID (PDA) FOR PATIENTS WITH RHEUMATOID ARTHRITIS THAT REDUCES DECISIONAL CONFLICT AND IMPROVES READINESS FOR TREATMENT DECISION MAKING. Value in health. (2018) Conference: ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems. Spain. 21 Supplement 3 ppS299', '10.1016/j.jval.2018.09.1781', '']\n",
      "['9736919', 'Krylov M; Muraviev Y; Alekseeva A; Samarkina E; Guseva I; Konovalova N; Varlamov D. Rs12218 polymorphism in saa1 gene in the Russian population of RA patients is associated with secondary amyloidosis. A pilot study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1315-1316', '10.1136/annrheumdis-2018-eular.2465', '']\n",
      "['9736920', 'IRCT201109177274N2. A comparison between  casting and Corton injection vs. Corton injection in treatment of patients with wrist tendinitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201109177274N2. (2012)   pp', '10.1186/isrctn22916517', '']\n",
      "['9736921', 'Quartier P; Alexeeva E; Wouters C; Calvo I; Kallinich T; Magnusson B; Wulffraat N; Wei X; Slade A; Abrams K; Martini A. Canakinumab, on a reduced dose or a prolonged dose interval without concomitant corticosteroids and methotrexate, maintains efficacy in systemic juvenile idiopathic arthritis patients in clinical remission. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp3223-3224', '10.1136/annrheumdis-2019-eular.1558', '']\n",
      "['9736923', 'EUCTR2009-010955-29-NL. Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-010955-29-NL. (2009)   pp', '10.1136/annrheumdis-2016-eular.6042', '']\n",
      "['9736924', 'IRCT2017092720258N62. Comparison of the minimally invasive surgical treatment outcomes of itra-extra articular calcaneal fracture‚Äôs and non operative treatment in valiasr hospital. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017092720258N62. (2017)   pp', '10.53347/rid-52859', '']\n",
      "['9736925', 'Maki-Petaja KM; Day L; Cheriyan J; Hall FC; Ostor AJK; Shenker N; Wilkinson IB. Tetrahydrobiopterin supplementation improves endothelial function but does not alter aortic stiffness in patients with rheumatoid arthritis. Journal of the american heart association. (2016) 5 2 pp1-9', '10.1161/jaha.115.002762', '']\n",
      "['9736926', 'IRCT2015072123282N1. Evaluation of the effect of Elaeagnus angustifolia alone and in combination with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015072123282N1. (2015)   pp', '10.1007/s10067-017-3603-z', 'http://link.springer.com/article/10.1007/s10067-017-3603-z/fulltext.html']\n",
      "['9736927', 'EUCTR2011-002840-29-CZ. A study of multiple different dosages of JNJ-38518168 and placebo in patients with active Rheumatoid Arthritis who are also receiving methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002840-29-CZ. (2012)   pp', '10.1007/s00296-011-1944-5', 'http://link.springer.com/article/10.1007/s00296-011-1944-5/fulltext.html']\n",
      "['9736928', 'Zhao Q; Chen X; Hou Y; Jiang J; Zhong W; Yao X; Wang W; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus. Journal of clinical pharmacology. (2016)   pp', '10.1002/jcph.686', '']\n",
      "['9736931', 'Takahashi Nobunori; Kojima Toshihisa; Kida Daihei; Kaneko Atsushi; Hirano Yuji; Fujibayashi Takayoshi; Yabe Yuichiro; Takagi Hideki; Oguchi Takeshi; Hanabayashi Masahiro; Kato Takefumi; Funahashi Koji; Hayashi Masatoshi; Tsuboi Seiji; Kanayama Yasuhide; Sobue Yasumori; Asai Nobuyuki; Matsumoto Takuya; Watanabe Tatsuo; Asai Shuji; Ishiguro Naoki. Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis. Clinical rheumatology. (2019) 38 9 pp2451-2459', '10.1007/s10067-019-04581-7', 'http://link.springer.com/article/10.1007/s10067-019-04581-7/fulltext.html']\n",
      "['9736932', 'Espie P; He Y; Koo P; Sickert D; Dupuy C; Chokote E; Schuler R; Mergentaler H; Ristov J; Milojevic J; Verles A; Groenewegen A; Auger A; Avrameas A; Rotte M; Colin L; Tomek CS; Hernandez-Illas M; Rush JS; Gergely P. First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American journal of transplantation. (2019)   pp', '10.1111/ajt.15661', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajt.15661']\n",
      "['9736933', 'Kong X; Xing Y; Liu C; Zhao M. The efficacy of immunoadsorption with infliximab theraepy on the modulation of disease activity in patients with severe rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1399', '10.1136/annrheumdis-2018-eular.3602', '']\n",
      "['9736934', 'Mehsen-Cetre N; Gensburger D; Benhamou J; Chapurlat R. Improvement of severe bone pain from fibrous dysplasia of bone with tocilizumab treatment-A case report. Journal of bone and mineral research. (2017) 32  ppS389-', '10.1016/j.jbspin.2014.04.013', '']\n",
      "['9736935', 'ChiCTR-IOR-17012282. A Randomized Controlled Trial to Evaluate the Effectiveness of Grain-sized Moxibustion for Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-17012282. (2017)   pp', '10.1016/j.eujim.2020.101094', '']\n",
      "['9736936', 'Singh Ankita; Misra Ramnath; Aggarwal Amita. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis. Rheumatology international. (2019) 39 8 pp1431-1438', '10.1007/s00296-019-04344-2', 'http://link.springer.com/article/10.1007/s00296-019-04344-2/fulltext.html']\n",
      "['9736937', 'IRCT2014090319025N1. Efficacy of MabAsia (Adalimumab) in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014090319025N1. (2015)   pp', '10.1186/isrctn95861172', '']\n",
      "['9736938', 'Latocha K M; Loppenthin K B; Ostergaard M; Jennum P J; Christensen R; Hetland M; Rogind H; Lundbak T; Midtgaard J; Esbensen B A. Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial. Trials. (2020) 21 1 pp440', '10.1186/s13063-020-04282-6', 'https://link.springer.com/article/10.1186/s13063-020-04282-6/fulltext.html']\n",
      "['9736939', 'Jalali-Farahani Sara; Shojaei Fahimeh Alsadat; Parvin Parnian; Amiri Parisa. Comparison of health-related quality of life (HRQoL) among healthy, obese and chronically ill Iranian children. BMC public health. (2018) 18 1 pp1337', '10.1186/s12889-018-6239-2', 'http://link.springer.com/article/10.1186/s12889-018-6239-2/fulltext.html']\n",
      "['9736940', 'Zhou H; Liu L; Liu J-X; Huang Q-C; Liu Z-Q; Dong Y; Pan H-D; Wu F-C; Qiu P. Efficacy and underlying mechanisms of sinomenine in treating rheumatoid arthritis. European journal of immunology. (2019) Conference: 17th International Congress of Immunology. China. 49 Supplement 3 pp1915-1916', '10.1016/j.phymed.2018.12.030', '']\n",
      "['9736942', \"Fidelix T; Trevisani VFM; Santos L; Freitas D; Vieira LA; Rigueiro M. Schirmer test, van bijsterveld, OSS, and break-up time test in primary sjogren's syndrome. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1717\", '10.1136/annrheumdis-2019-eular.7280', '']\n",
      "['9736944', 'Kelly Ayano; Tong Allison; Tymms Kathleen; March Lyn; Craig Jonathan C; De Vera Mary; Evans Vicki; Hassett Geraldine; Toupin-April Karine; van den Bemt Bart; Teixeira-Pinto Armando; Alten Rieke; Bartlett Susan J; Campbell Willemina; Dawson Therese; Gill Michael; Hebing Renske; Meara Alexa; Nieuwlaat Robby; Shaw Yomei; Singh Jasvinder A; Suarez-Almazor Maria; Sumpton Daniel; Wong Peter; Christensen Robin; Beaton Dorcas; de Wit Maarten; Tugwell Peter; OMERACT-Adherence Group. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. (2018) 19 1 pp204', '10.1186/s13063-018-2565-z', 'http://link.springer.com/article/10.1186/s13063-018-2565-z/fulltext.html']\n",
      "['9736945', 'ChiCTR-TRC-09000383. Efficacy and safety of recombinant human IL-1 receptor antagonist in Chinese patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-09000383. (2009)   pp', '10.1002/art.10578', '']\n",
      "['9736946', 'Alten R; Genovese MC; Arai; Muniz R; Kellner H. Long-term safety, immunogenicity and efficacy in randomized, double-blind, and open-label extension studies comparing FKB327, an adalimumab biosimilar, with the adalimumab reference product in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1135-', '10.1136/annrheumdis-2019-eular.972', '']\n",
      "['9736947', 'Smyth C J. A method of drug evaluation in rheumatoid arthritis; results with phenylbutazone, oxyphenylbutazone, cortisone and prednisone. Annals of the New York Academy of Sciences. (1960) 86 1 pp292-306', '10.1111/j.1749-6632.1960.tb42812.x', '']\n",
      "['9736949', 'Rondier J; Cayla J; Tron F. Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases. Nouvelle presse medicale. (1978) 7 34 pp3023-3030', '10.1093/rheumatology/15.5.71', 'http://academic.oup.com/rheumatology/article-pdf/15/5/71/5039267/15-5-71.pdf']\n",
      "['9736950', 'Kirwan J; Coteur G; Dures E; Nicklin J; Bryson J; Hewlett S. Validity and responsiveness of the bristol rheumatoid arthritis fatigue multidimensional questionnaire (BRAF-MDQ) in a randomised controlled clinical trial. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.1561', '']\n",
      "['9736951', 'Kim Tae-Hwan; Lee Shin-Seok; Park Won; Song Yeong Wook; Suh Chang-Hee; Kim SooKyoung; Lee Young Nam; Yoo Dae Hyun. A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Clinical drug investigation. (2020) 40 6 pp541-553', '10.1007/s40261-020-00907-5', 'https://link.springer.com/article/10.1007/s40261-020-00907-5/fulltext.html']\n",
      "['9736952', 'IRCT2014101810599N2. Effects of regenerative agents injection in knee osteoarthrosis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014101810599N2. (2015)   pp', '10.22271/ortho.2021.v7.i2g.2670', '']\n",
      "['9736953', '. Anakinra (Kineret) for rheumatoid arthritis. Medical letter on drugs and therapeutics. (2002) 44 1124 pp18-19', '10.31525/cmr-117a8d7', '']\n",
      "['9736954', 'NCT00095173. BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00095173. (2004)   pp', '10.1093/oso/9780192632920.003.0016', 'https://academic.oup.com/book/chapter-pdf/52154547/isbn-9780192632920-book-part-16.pdf']\n",
      "['9736956', 'IRCT2016112530817N1. Study the effects of anti-inflammatory capsules (containing three of ginger, turmeric and black pepper) in patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016112530817N1. (2017)   pp', '10.20471/acc.2022.61.04.04', '']\n",
      "['9736959', \"Maarse F; Jager D-H-J; Forouzanfar T; Wolff J; Brand H-S. Tooth loss in Sjogren's syndrome patients compared to age and gender matched controls. Medicina oral, patologia oral y cirugia bucal. (2018) 23 5 ppe545-e551\", '10.4317/medoral.22545', '']\n",
      "['9736960', 'Shishehbor F; Rezaeyan Safar M; Rajaei E; Haghighizadeh MH. Cinnamon consumption improves clinical symptoms and inflammatory markers in women with rheumatoid arthritis. Journal of the American College of Nutrition. (2018) 37 8 pp685-690', '10.1080/07315724.2018.1460733', '']\n",
      "['9736961', 'UMIN000013440. To evaluate the efficacy and safety of subcutaneous and intravenous abatacept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013440. (2014)   pp', '10.3899/jrheum.141042', '']\n",
      "['9736962', 'ChiCTR-INR-16010290. The research for the treatment of Rheumatoid Arthritis with Warming yang and Smoothening Meridians. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16010290. (2016)   pp', '10.17925/usn.2008.04.01.34', 'http://www.touchneurology.com/system/files/private/articles/8325/pdf/tobinick.pdf']\n",
      "['9736963', 'Lee Jeong Seok; Ahmad Harris; Shim Seung-Cheol; Bae Sang-Cheol; Song Yeong Wook; Lee Eun Young. High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis. Patient. (2019) 12 3 pp319-326', '10.1007/s40271-018-0347-z', 'https://link.springer.com/article/10.1007/s40271-018-0347-z/fulltext.html']\n",
      "['9736964', 'Guevara M; Rivera I; Lopez G; Alvarez A; Riano A; Viada C; Uranga R. Effect and safety of ribofen in rheumatoid arthritis treatment. Acta farmaceutica bonaerense. (2004) 23 4 pp437-441', '10.3109/9780203624388-3', '']\n",
      "['9736965', 'Cole J C; Khanna D; Clements P J; Seibold J R; Tashkin D P; Paulus H E; Irwin M R; Motivala S J; Furst D E. Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Quality of life research. (2006) 15 8 pp1383-1394', '10.1007/s11136-006-0018-8', 'http://link.springer.com/article/10.1007/s11136-006-0018-8/fulltext.html']\n",
      "['9736972', 'NCT04268771. A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products. https://clinicaltrials.gov/show/NCT04268771. (2020)   pp', '10.31525/ct1-nct04268771', '']\n",
      "['9736973', 'Lee Young Ho; Song Gwan Gyu. Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: a Bayesian Network Meta-Analysis of Randomized Controlled Trials. Clinical drug investigation. (2020) 40 1 pp65-72', '10.1007/s40261-019-00863-9', 'http://link.springer.com/article/10.1007/s40261-019-00863-9/fulltext.html']\n",
      "['9736974', 'Saeed A; Mumtaz A; Lee S; Mullan R; Kane D. Optimal management of foot and ankle disease in rheumatoid arthritis: is a treat-totarget das driven protocol adequate?. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi80', '10.1093/rheumatology/kev088.075', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i80/5180086/kev088.075.pdf']\n",
      "['9736975', 'Katayama K; Matsuno H; Matsubara T. Which biologic agent is most suitable for an extended-interval treatment for rheumatoid arthritis ? results from a multicenter study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp943-944', '10.1136/annrheumdis-2018-eular.1464', '']\n",
      "['9736976', 'Monnet E; Choy EH; McInnes I; Kobakhidze T; De Graaf K; Jacqmin P; Lapeyre G; De Min C. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Annals of the rheumatic diseases. (2019)   pp', '10.1136/annrheumdis-2019-216487', '']\n",
      "['9736977', 'EUCTR2009-014824-40-CZ. An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621 following fortnightly administration for 48 weeks in patients with rheumatoid arthritis concomitantly taking methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-014824-40-CZ. (2009)   pp', '10.1002/art.1780400533', '']\n",
      "['9736979', 'UMIN000019941. The clinical study on the effectiveness of bone graft to the tibial interface in cementless total knee replacement. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000019941. (2015)   pp', '10.1302/3114-230355', '']\n",
      "['9736980', \". Factors associated with patients' loss to follow-up after finishing randomized clinical trial participation. Contemporary clinical trials. (2005) 26 1 pp38-44\", '10.1016/j.cct.2004.11.016', '']\n",
      "['9736983', 'EUCTR2008-006076-30-IT. Multicenter, randomised, open-label, parallel group, controlled study to evaluate the efficacy, tollerability and safety of BioFOAM dressing containing larve of Lucilia sericata in patients with chronic, vascular ulcers with/without evident infection versus standard treatment (idrogel. - ND. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006076-30-IT. (2009)   pp', '10.1186/isrctn13413322', '']\n",
      "['9736985', 'ISRCTN95861172. Randomised Efficacy and Discontinuation Study of Etanercept and Adalimumab (RED SEA): a pragmatic open label study in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN95861172. (2007)   pp', '10.1186/isrctn95861172', '']\n",
      "['9736986', 'Wallace CA. On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. Clinical and experimental rheumatology. (1999) 17 4 pp499-504', '10.1097/00124743-199912000-00004', '']\n",
      "['9736987', 'Lin J L. The clinical observation of rheumatoid arthritis treated with traditional Chinese and Western medicine treatment: 25 cases. Chinese journal of ethnomedicine and ethnophammcy[zhong guo min zu min jian yi yao]. (2016) 25 7 pp83-84', '10.1007/bf02838033', 'https://link.springer.com/article/10.1007/BF02838033/fulltext.html']\n",
      "['9736988', 'Khatri Amit; Goss Sandra; Jiang Ping; Mansikka Heikki; Othman Ahmed A. Pharmacokinetics of ABT-122, a TNF-alpha- and IL-17A-Targeted Dual-Variable Domain Immunoglobulin, in Healthy Subjects and Patients with Rheumatoid Arthritis: results from Three Phase I Trials. Clinical pharmacokinetics. (2018) 57 5 pp613-623', '10.1007/s40262-017-0580-y', 'http://link.springer.com/article/10.1007/s40262-017-0580-y/fulltext.html']\n",
      "['9736989', 'NCT03248518. Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases. https://clinicaltrials.gov/show/NCT03248518. (2017)   pp', '10.1136/annrheumdis-2017-eular.6096', '']\n",
      "['9736990', 'Lee Young Ho; Song Gwan Gyu. Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis. Zeitschrift fur Rheumatologie. (2020)   pp', '10.1007/s00393-020-00750-1', 'http://link.springer.com/article/10.1007/s00393-020-00750-1/fulltext.html']\n",
      "['9736992', 'UMIN000002991. Clinical study of a novel artificial wrist joint(NM002). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002991. (2010)   pp', '10.5005/jp/books/12248_4', '']\n",
      "['9736993', 'UMIN000022364. Treatment strategy of minodronate in osteoporotic patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000022364. (2016)   pp', '10.1186/isrctn13142685', '']\n",
      "['9736995', 'Lo CN; Xia G; Leung BP. The effect of nerve mobilization exercise in patients with rheumatoid arthritis: a pilot study. Reumatismo. (2017) 69 3 pp111-118', '10.4081/reumatismo.2017.918', 'http://www.reumatismo.org/index.php/reuma/article/viewFile/918/759']\n",
      "['9736996', 'NCT03743181. Impact of Clinical Pharmacy Services Provided for Patients With Active Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03743181. (2018)   pp', '10.33140/ijced.07.02.02', '']\n",
      "['9736997', 'IRCT2016020626394N1. Study of Effect of Myrtus extract on diabetic foot wounds. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016020626394N1. (2016)   pp', '10.1186/isrctn16824836', '']\n",
      "['9736998', 'DRKS00007920. Stepped movement-oriented rehabilitation and aftercare in patients with inflammatory and non-inflammatory diseases of the musculoskeletal system. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00007920. (2015)   pp', '10.1097/00004356-198806000-00020', '']\n",
      "['9737001', 'Ebina Kosuke; Hirao Makoto; Hashimoto Jun; Hagihara Keisuke; Kashii Masafumi; Kitaguchi Kazuma; Matsuoka Hozo; Iwahashi Toru; Chijimatsu Ryota; Yoshikawa Hideki. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis. Journal of bone and mineral metabolism. (2018) 36 4 pp478-487', '10.1007/s00774-017-0861-4', 'http://link.springer.com/article/10.1007/s00774-017-0861-4/fulltext.html']\n",
      "['9737002', 'Akdeniz B; Akyel N; Yildiz M; Sahin S; Adrovic A; Koker O; Bektas S; Dede E; Barut K; Kurugoglu S; Kasapcopur O. Comparison of the efficacy of physical examination and radiological imaging in detecting sacroiliitis in patients with juvenile spondyloarthropathies. Clinical and experimental rheumatology. (2020)   pp', '10.1097/rhu.0000000000001674', '']\n",
      "['9737004', 'Bonafede MM; McMorrow D; Marshall A; Gupta K; Pazirandeh M. Healthcare resource utilization and costs among commercially insured patients with juvenile idiopathic arthritis (JIA) in the United States. Value in health. (2018) Conference: 23rd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2018. United States. 21 Supplement 1 ppS125', '10.1016/j.jval.2018.04.850', '']\n",
      "['9737005', 'NCT02862574. Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT02862574. (2016)   pp', '10.3109/14397595.2016.1174394', '']\n",
      "['9737006', 'CTRI/2018/10/015943. A CLINICAL TRIAL TO COMPARE THE EFFECT OF LOW DOSE WITH CONVENTIONAL DOSE OF RITUXIMAB USED IN PATIENTS OF SEVERE PEMPHIGUS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/10/015943. (2018)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9737007', '. Comparison of the effect of rituximab (Roche) and rituximab biosimilar - BCD-020 (BIOCAD) on inflammatory and immunological biomarkers in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1642-', '10.1136/annrheumdis-2019-eular.2748', '']\n",
      "['9737008', 'Sham S; Tamilselvam T N; Mary T; Rajeswari S. Rituximab in biologically Naive RA patients and methotrexate nonresponders e a pilot study. Indian journal of rheumatology. (2013) 8 SUPPL. 1 ppS15', '10.1016/j.injr.2014.02.003', 'https://journals.sagepub.com/doi/pdf/10.1016/j.injr.2014.02.003']\n",
      "['9737009', 'Hang Yuanxing; Qin Xian; Ren Tianli; Cao Jianing. Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids in health and disease. (2018) 17 1 pp146', '10.1186/s12944-018-0797-2', 'http://link.springer.com/article/10.1186/s12944-018-0797-2/fulltext.html']\n",
      "['9737010', 'Karpouzas G; Takeuchi T; Thorne C; Sheng S; Kurrasch R; Fei K; Hsu B. Long-term effect of sirukumab, an anti-IL-6 cytokine monoclonal antibody, on radiographic progression in patients with active rheumatoid arthritis despite disease-modifying anti-rheumatic drug treatment: results of a global phase 3 trial. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1016/j.jval.2016.09.1074', '']\n",
      "['9737011', 'CTRI/2019/02/017740. Ayurvedic management of joints pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2019/02/017740. (2019)   pp', '10.1055/s-009-45411', '']\n",
      "['9737016', 'Edelaar L; Van Der Esch M; Nurmohamed M. How to deal with cardiovascular risk factors for physical activity and implement the pa recommendations in the rheumatologic practice?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp23-24', '10.1136/annrheumdis-2018-eular.7711', '']\n",
      "['9737017', 'Terslev L; Ostergaard M; Sexton J; Hammer HB. Is synovial hypertrophy without doppler activity in rheumatoid arthritis joints sensitive to change-results of a longitudinal ultrasound study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1179', '10.1136/annrheumdis-2018-eular.2265', '']\n",
      "['9737018', 'IRCT20180319039131N1. Effect of Family-Centered Empowerment Model on Quality of Life and               Self-Efficacy in Children with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20180319039131N1. (2019)   pp', '10.21203/rs.3.rs-2421142/v1', 'https://www.researchsquare.com/article/rs-2421142/v1']\n",
      "['9737021', 'UMIN000016928. Targeted Ultrasound in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000016928. (2015)   pp', '10.1186/isrctn36516369', '']\n",
      "['9737023', 'Rojas Tessel R; Buschiazzo E; Lizarraga A; Sosa J; Fernandez L; Juarez V; Mariana Q; Aciar M; Marengo F; Citera G. The role ofwritten standardized information in patients with recently diagnosed rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS68', '10.1093/rheumatology/kei500', 'http://academic.oup.com/rheumatology/article-pdf/45/suppl_2/ii7/5044902/kei500.pdf']\n",
      "['9737024', 'Smolen Josef S; Gladman Dafna; McNeil H Patrick; Mease Philip J; Sieper Joachim; Hojnik Maja; Nurwakagari Pascal; Weinman John. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD open. (2019) 5 1 ppe000585', '10.1136/rmdopen-2017-000585', '']\n",
      "['9737025', 'NCT01185353. A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy. https://clinicaltrials.gov/show/NCT01185353. (2010)   pp', '10.1016/b978-032305475-1.50043-4', '']\n",
      "['9737026', 'Ganesan Selvakumar; Gaur Girwar Singh; Negi Vir Singh; Sharma Vivek Kumar; Pal Gopal Krushna. Effect of Yoga Therapy on Disease Activity, Inflammatory Markers, and Heart Rate Variability in Patients with Rheumatoid Arthritis. Journal of alternative and complementary medicine (New York, N.Y.). (2020) 26 6 pp501-507', '10.1089/acm.2019.0228', '']\n",
      "['9737027', 'UMIN000006893. Postoperative Quadriceps Motor Power of Continuous Femoral Levobupivacaine 0.05% or 0.1%: a Prospective, Randomized Double-Blind Trial in Patients After Total Knee Arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000006893. (2012)   pp', '10.1213/ane.0b013e318168b493', '']\n",
      "['9737028', 'Nie YG; Wang FB; Wang J. Clinical control study of Lushi Runzao decoction in treatment of xerostomia of primary Sjogren syndrome. World chinese medicine [shi jie zhong yi yao za zhi]. (2016) 11 7 pp1230-1232', '10.4103/cmac.cmac_21_21', '']\n",
      "['9737029', 'NCT02260778. Treat-to-target in RA: collaboration To Improve adOption and adhereNce. https://clinicaltrials.gov/show/NCT02260778. (2014)   pp', '10.1007/s40274-015-2164-0', 'http://link.springer.com/article/10.1007/s40274-015-2164-0/fulltext.html']\n",
      "['9737030', 'EUCTR2010-021558-21-SK. A Clinical Study of AK106-001616 in Patients With Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021558-21-SK. (2010)   pp', '10.31219/osf.io/wp7sa', '']\n",
      "['9737032', 'CTRI/2019/02/017555. Evaluation of an Ayurvedic management on patients of Rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2019/02/017555. (2019)   pp', '10.31525/cmr-5970b9', '']\n",
      "['9737033', \"ChiCTR1900020954. A multicenter randomized controlled trial for Chere Cunjin granules in the treatment of Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900020954. (2019)   pp\", '10.21203/rs.1.5/v2', 'https://www.researchsquare.com/article/rs-5/v2']\n",
      "['9737034', 'Zamora N V; Tayar J; Lopez-Olivo M A; Christensen R; Suarez-Almazor M E. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp731-732', '10.1136/annrheumdis-2016-eular.4449', '']\n",
      "['9737035', 'CTRI/2019/01/017061. A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY  OF AGNILEPA (APPLICATION OF HERBAL PASTE) FOLLOWED BY VIRECHANA KARMA (PURGATION THERAPY) AND AGNILEPA FOLLOWED BY VAITARNA BASTI (MEDICATED ENEMA) IN AMAVATA WSR TO RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2019/01/017061. (2019)   pp', '10.21760/jaims.4.6.9', 'https://www.jaims.in/jaims/article/view/761']\n",
      "['9737036', 'Manai Meriem; van Middendorp Henriet; Veldhuijzen Dieuwke S; van der Pol Joy A; Huizinga Tom W J; Evers Andrea W M. Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol. Trials. (2020) 21 1 pp15', '10.1186/s13063-019-3777-6', 'http://link.springer.com/article/10.1186/s13063-019-3777-6/fulltext.html']\n",
      "['9737037', \"Miyamoto Samira T; Valim Valeria; Fisher Benjamin A. Health-related quality of life and costs in Sjogren's syndrome. Rheumatology (Oxford, England). (2019)   pp\", '10.1093/rheumatology/key370', 'http://academic.oup.com/rheumatology/article-pdf/60/6/2588/38694947/key370.pdf']\n",
      "['9737038', 'Yilmaz-Oner S; Gazel U; Can M; Atagunduz P; Direskeneli H; Inanc N. Sustained remission related factors in patients with rheumatoid arthritis: is it possible to predict sustained remission?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp565', '10.1136/annrheumdis-2018-eular.6881', '']\n",
      "['9737039', 'Mckinnon C; Antolovich G; Morgan P; Harvey A. Characteristics of pain in children dyskinetic cerebral palsy: a cross-sectional study. Developmental medicine and child neurology. (2019) Conference: American Academy for Cerebral Palsy and Developmental Medicine. United States. 61 Supplement 3 pp123', '10.1111/dmcn.14615', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdmcn.14615']\n",
      "['9737040', 'Kim MJ; Lee EB; Song YW; Park JK. Profile of common inflammatory markers in treatment-naive patients with systemic rheumatic diseases. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05049-9', 'https://link.springer.com/article/10.1007/s10067-020-05049-9/fulltext.html']\n",
      "['9737041', 'Haridas VM; Katta R; Nalawade A; Kharkar S; Zhdan V; Garmish O; Lopez-Lazaro L; Batra SS; Kankanwadi S. Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Na‚àö√â¬¨√òve Patients with Moderate-to-Severe Rheumatoid Arthritis: a Double-Blind, Randomized, Three-Arm Study. BioDrugs. (2020)   pp', '10.1007/s40259-020-00406-1', 'https://link.springer.com/article/10.1007/s40259-020-00406-1/fulltext.html']\n",
      "['9737042', 'Avila Marcel Y; Igua Angela M; Mora Amparo M. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. British journal of ophthalmology. (2018)   pp', '10.1136/bjophthalmol-2018-312072', '']\n",
      "['9737044', 'Bartok B; Winthrop KL; Genovese M; Combe BG; Tanaka Y; Kivitz A; Matzkies F; Ye L; Guo Y; Tasset CT; Sundy JS; Keystone E; Westhovens R; Rigby W; Burmester GR; Walker DR. POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS. Gastroenterology. (2020) Conference: Digestive Disease Week DDW) 2020. United States. 158 (6 Supplement 1 ppS-679', '10.1016/s0016-5085(20)32389-1', '']\n",
      "['9737045', 'Wang Y; Liu Y-C; Ma J. Clinical pathway and effectiveness of total knee arthroplasty. Chinese journal of tissue engineering research. (2015) 19 9 pp1340-1344', '10.1007/978-3-319-17554-6_9', '']\n",
      "['9737048', 'Cohen S; Zhang N; Kaur P. Biosimilar candidate ABP 501: additional efficacy analyses from the phase 3 study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp499', '10.1136/annrheumdis-2016-eular.3734', '']\n",
      "['9737051', 'SLCTR/2018/031. Effectiveness of mycophenolate mofetil vs azathioprin on progression of rheumatoid arthritis related interstitial lung disease in patients followed up at the rheumatology clinic, Teaching Hospital Karapitiya ‚Äì a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=SLCTR/2018/031. (2018)   pp', '10.1007/978-981-10-6750-1_7', '']\n",
      "['9737052', 'EUCTR2004-005210-37-CZ. A randomized, double-blind, placebo-controlled, parallel group study of the safety and reduction of signs and symptoms during treatment with MRA versus placebo, in combination with traditional DMARD therapy in patients with moderate to severe active rheumatoid arthritis and an inadequate response to current DMARD therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-005210-37-CZ. (2005)   pp', '10.1186/s40064-015-0895-9', 'http://link.springer.com/article/10.1186/s40064-015-0895-9/fulltext.html']\n",
      "['9737053', 'UMIN000004551. A comparative trial of Kampo formulas on insulin resistance and endothelial function. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004551. (2010)   pp', '10.1007/978-1-59259-716-1_13', '']\n",
      "['9737056', 'NCT01874977. Trial of a Physical Activity Intervention for RA Fatigue. https://clinicaltrials.gov/show/NCT01874977. (2013)   pp', '10.1093/rheumatology/kev089.040', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i109/5180546/kev089.040.pdf']\n",
      "['9737057', 'White-Lewis Sharon; Johnson Rebecca; Ye Sangbeak; Russell Cynthia. An equine-assisted therapy intervention to improve pain, range of motion, and quality of life in adults and older adults with arthritis: a randomized controlled trial. Applied nursing research. (2019) 49  pp5-12', '10.1016/j.apnr.2019.07.002', '']\n",
      "['9737058', \"Safonova T N; Gladkova O V; Boev V I. Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen's syndrome. Vestnik oftalmologii. (2019) 135 1 pp59-66\", '10.17116/oftalma201913501159', '']\n",
      "['9737059', 'CTRI/2011/05/001734. Efficacy and Safety of Hydroxychloroquine and Methotrexate Combination in Treatment of Juvenile Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2011/05/001734. (2011)   pp', '10.1007/s00296-011-2041-5', 'http://link.springer.com/article/10.1007/s00296-011-2041-5/fulltext.html']\n",
      "['9737060', 'NCT00855322. Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication. https://clinicaltrials.gov/show/NCT00855322. (2009)   pp', '10.1186/1471-2474-12-11', 'http://link.springer.com/article/10.1186/1471-2474-12-11/fulltext.html']\n",
      "['9737061', 'EUCTR2008-000170-20-FR. A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the Clinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid Arthritis Having an Inadequate Response to Methotrexate. Pharmacogenetics Blood Sample Amendment 01 (version 1.0, dated 19-Dec-2007); Revised Protocol 01, incorporating administrative letter 01 and amendment 03 (version 1.0, dated 12-Mar-2008). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000170-20-FR. (2008)   pp', '10.3899/jrheum.110994', '']\n",
      "['9737062', 'Ren J; Masi AT; Aldag JC; Asche CV. Hereditary, socio-behavioural, and immuno-hormonal predictors of incident rheumatoid arthritis and therapy response influences on survival versus matched control subjects using a generalised structural equation model. Clinical and experimental rheumatology. (2019)   pp', '10.1016/j.jval.2018.04.1450', '']\n",
      "['9737063', 'Yang Min; Luo Yong; Liu Tao; Zhong Xiaolong; Yan Jiao; Huang Qi; Tao Jie; He Qingjuan; Guo Mingyang; Hu Yonghe. The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: a Randomized Controlled Trial. Clinical therapeutics. (2018) 40 10 pp1752-1764.e1', '10.1016/j.clinthera.2018.08.014', '']\n",
      "['9737064', 'NCT01663116. Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients. https://clinicaltrials.gov/show/NCT01663116. (2012)   pp', '10.1136/annrheumdis-2001.1120', '']\n",
      "['9737065', 'ChiCTR1900022779. Gait difference between PS prosthesis and CR prosthesis after total knee arthroplasty: a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900022779. (2019)   pp', '10.31525/ct1-nct03877042', '']\n",
      "['9737066', 'Strand V; Landewe R; Van der Heijde D. Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis. Annals of the rheumatic diseases. (2002) 61 SUPPL. 2 ppii64-ii66', '10.1136/ard.61.suppl_2.ii64', '']\n",
      "['9737069', 'JapicCTI-101359. Phase IIa study of T-5224 in RA patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-101359. (2010)   pp', '10.1186/isrctn92755158', '']\n",
      "['9737070', 'ACTRN12614001097639. Comparative assessment of the absorption of a generic formulation of ibuprofen sustained release tablet against the innovator ibuprofen sustained release tablet conducted under fasting conditions in healthy male and female volunteers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12614001097639. (2014)   pp', '10.31838/ijpr/2020.sp2.538', '']\n",
      "['9737071', 'IRCT20190428043409N1. effect of saffron on dementia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20190428043409N1. (2019)   pp', '10.1016/j.jalz.2019.06.1230', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2019.06.1230']\n",
      "['9737072', 'Alemao E; Connolly S; Elbez Y; Rao A; Saini Y; Iannaccone C; Weinblatt ME; Shadick N. A comparative effectiveness study of abatacept and TNFi agents in patients with rheumatoid arthritis using real-world data. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1646-1647', '10.1136/annrheumdis-2019-eular.1447', '']\n",
      "['9737074', 'Liang L J. Rehabilitation nursing of integrated traditionaI Chinese and Western medicine on advanced rheumatoid arthritis for 86 Cases. Chinese medicine modern distance education of china[zhong guo zhong yi yao xian dai yuan cheng jiao yu]. (2016) 14 24 pp117-118', '10.1007/bf02935449', 'https://link.springer.com/article/10.1007/BF02935449/fulltext.html']\n",
      "['9737075', 'Kelley GA; Kelley KS; Callahan LF. Brief Report: state-Level Number of Physically Inactive US Adults With Arthritis Who can Improve Their Anxiety and Depression by Exercising. ACR open rheumatology. (2020)   pp', '10.1002/acr2.11110', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr2.11110']\n",
      "['9737076', 'De Cock D; Van Der Elst K; Stouten V; Peerboom D; Meyfroidt S; Joly J; Westhovens R; Verschueren P. Symptom onset and help-seeking trajectory of patients with rheumatoid arthritis. Rheumatology (united kingdom). (2015) 54 Supplement 1 ppi115', '10.1136/annrheumdis-2015-eular.4507', '']\n",
      "['9737077', \"Dervieux T; Conklin J; O'Malley T; Brady K; Alexander R; Shi J; Ibarra C; Mahler M; Kremer J; Weinblatt ME; Weinstein A. The combination of rheumatoid factors with antibody systems targeting citrullinated, Carbamylated and Peptidyl Arginine Deiminase autoantigens distinguishes Rheumatoid Arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp304\", '10.1136/annrheumdis-2019-eular.6351', '']\n",
      "['9737082', 'Park Jin Kyun; Lee Ye Ji; Bitoun Samuel; Winthrop Kevin L; Choi Yunhee; Lee Eun Bong; Mariette Xavier. Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 2 pp282-284', '10.1136/annrheumdis-2018-214025', '']\n",
      "['9737084', 'ChiCTR-TRC-10000850. Phase III clinical trial of Iguratimodin rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10000850. (2010)   pp', '10.18810/chictr', '']\n",
      "['9737085', 'Balbir-Gurman Alexandra; Arabi-Zuhabi Amal; Braun-Moscovici Yolanda. THE EMERGENCE OF RHEUMATOID ARTHRITIS AT THE AGE OF OVER 60 - A COMPARISON OF CLINICAL MANIFESTATIONS AND ACCESS TO TREATMENT PATTERN COMPARED TO YOUNGER PATIENTS. Harefuah. (2019) 158 9 pp563-567', '10.1016/j.semarthrit.2006.03.002', '']\n",
      "['9737086', 'Babaeva A; Kalinina EV; Zvonorenko MS; Solodenkova KS; Osadchuk MA. Cardiovascular risk evaluation in long standing rheumatoid arthritis: real clinical data. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1339', '10.1136/annrheumdis-2018-eular.6177', '']\n",
      "['9737087', 'UMIN000005590. Maintenance of remission by tocilizumab mono-therapy after remission obtained by combination  with methotrexate in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005590. (2011)   pp', '10.1186/isrctn49682259', '']\n",
      "['9737088', 'Cacciapaglia F; Fornaro M; Renna D; Cafarelli F; Lopalco G; Anelli MG; Scioscia C; Lapadula G; Iannone F. The effect of 5-years B-DMARDs treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp296-297', '10.1136/annrheumdis-2018-eular.3870', '']\n",
      "['9737089', 'RPCEC00000238. Phase I with CIGB-814 in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RPCEC00000238. (2017)   pp', '10.1186/isrctn27093749', '']\n",
      "['9737092', 'NTR3514. Management of fatigue in sicca syndromes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR3514. (2012)   pp', '10.1007/978-3-030-56824-5_7', '']\n",
      "['9737093', 'Vejlstrup Anne; Moller Ann Merete; Nielsen Claus Henrik; Damgaard Dres. Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery. Journal of inflammation research. (2019) 12  pp137-144', '10.2147/jir.s198611', 'https://www.dovepress.com/getfile.php?fileID=50183']\n",
      "['9737096', 'Hirvonen H; Kautiainen H; Moilanen E; Mikkelsson M; Leirisalo-Repo M. The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis. Rheumatology international. (2017) 37 9 pp1481-1487', '10.1007/s00296-017-3771-9', 'http://link.springer.com/article/10.1007/s00296-017-3771-9/fulltext.html']\n",
      "['9737097', 'Suh C-H; Yoo D-H; Park W; Shim S-C; Lee S-J; Ju Bae Y; Han SE; Lee SM. Joint damage progression according to disease activity states in patients with rheumatoid arthritis treated with CT-P10 and reference rituximab: up to 48 weeks results from phase III study. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2793-2794', '10.1136/annrheumdis-2016-eular.3416', '']\n",
      "['9737099', 'EUCTR2014-003012-36-BG. A Phase IIb Study for ALX-0061 Monotherapy in Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-003012-36-BG. (2015)   pp', '10.1007/978-1-907673-91-7_2', '']\n",
      "['9737100', 'Menshikova I; Dzhenzhera N; Pak Y; Kolosova I. Comparison of efficacy of tofacitinib vs. etanercept treatment in rheumatoid arthtritis patients with high activity disease by ultrasound evaluation with power doppler (1 year treatment period). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp976', '10.1136/annrheumdis-2018-eular.6605', '']\n",
      "['9737101', 'IRCT201207024105N10. The effects of probiotic supplementation on oxidative indices in women with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201207024105N10. (2012)   pp', '10.1080/07315724.2014.959208', '']\n",
      "['9737102', 'Dulgeroglu D; Bal A; Karaahmet O; Umay E; Noyan S; Cakci A. The effectiveness of galvanic current therapy and a conservative hand exercise program in a rheumatoid hand: a randomized controlled trial. Clinical and experimental rheumatology. (2014) 32 4 ppS22-', '10.5606/tftrd.2016.81073', '']\n",
      "['9737103', 'NCT01527383. A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009). https://clinicaltrials.gov/show/NCT01527383. (2012)   pp', '10.32388/shbjzs', '']\n",
      "['9737104', 'NCT01359943. Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate. https://clinicaltrials.gov/show/NCT01359943. (2011)   pp', '10.1186/isrctn49455679', '']\n",
      "['9737105', 'Verstappen SMM; Anderson J; Barton A; Hyrich KL. Higher cumulative dose of methotrexate during the first 12 weeks seems to be associated with better response in patients with rheumatoid arthritis. Rheumatology (united kingdom). (2015) Conference: Rheumatology 2015. United Kingdom. 54 Supplement 1 ppi80-i81', '10.1093/rheumatology/kev088.077', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i80/5180100/kev088.077.pdf']\n",
      "['9737106', 'Anonymous. Abstracts 20th PANLAR Meeting. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1) (no pagination pp', '10.1097/rhu.0000000000000802', '']\n",
      "['9737107', 'EUCTR2013-005543-90-BG. This trial is designed to determine the effects the investigational medicine, ABP 798 has on the human body , and what effects the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, rituximab, in patients with moderate or severe rheumatoid arthritis (RA). This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-005543-90-BG. (2014)   pp', '10.1186/isrctn71522737', '']\n",
      "['9737108', 'Tuteja S. A randomised, placebo-controlled, parallel group study to evaluate efficacy of homoeopathic medicine in patients with rheumatoid arthritis. Homeopathy. (2018) 107  pp', '10.1055/s-0038-1633342', '']\n",
      "['9737110', 'Fleischmann R; Furst D; Liu J; Zhu J; Connolly-Strong E; Brasington R. A multicenter study assessing the efficacy and safety of repository corticotropin injection in patients with rheumatoid arthritis: interim data from the open-label treatment period. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp359', '10.1136/annrheumdis-2019-eular.6083', '']\n",
      "['9737111', 'Tugwell P; Hart L; Kraag G; Park A; Dok C; Bianchi F; Goldsmith C; Buchanan W W. Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis. Journal of rheumatology. (1984) 11 4 pp457-461', '10.1016/s0197-2456(05)80017-0', '']\n",
      "['9737112', 'Emery P; Weinblatt M; Smolen J S; Keystone E; Genovese M; Vencovsky J; Kay J; Hong E; Baek Y; Ghil J. Impact of immunogenicity on clinical efficacy and administration related reaction in TNF inhibitors: a pooled-analysis from three biosimilar studies in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp310-311', '10.1136/annrheumdis-2018-eular.4362', '']\n",
      "['9737113', 'Van Mulligen E; Weel AEAM; Kuijper TM; Luime JJ; Hazes JMW; De Jong PHP. Gradual tapering tnf blockers versus conventional synthetic dmards in patients with rheumatoid arthritis in sustained remission: first year results of the randomised controlled tara-study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp107', '10.1136/annrheumdis-2018-eular.1908', '']\n",
      "['9737114', 'ISRCTN88886304. Physical Activity in Rheumatoid Arthritis: a randomised controlled multi-centre study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN88886304. (2006)   pp', '10.1186/isrctn88886304', '']\n",
      "['9737117', 'Grange S; Kuhn B; Riek M; Ghai J; Zhang X. A randomized, double blind, placebo controlled, parallel group study to investigate the safety, tolerability, and pharmacokinetics of tocilizumab following ascending single dose administration in healthy subjects. Clinical pharmacology and therapeutics. (2009) 85 SUPPL. 1 ppS59', '10.1016/j.clinthera.2009.01.003', '']\n",
      "['9737118', 'NCT01742468. Intervention With Long-chain n-3 Polyunsaturated Fatty Acids From Microalgae Oil in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01742468. (2012)   pp', '10.1016/j.biochi.2020.04.022', '']\n",
      "['9737119', 'NCT03891121. Occlusal splints or botulinum toxin?. Https://clinicaltrials.gov/show/nct03891121. (2019)   pp', '10.31525/ct1-nct03891121', '']\n",
      "['9737120', 'Scheper H; Van Hooven D; Van De Sande M; De Boer S; Mahdad R; Van Der Beek M; Visser L; De Boer M; Nelissen R. Treatment of prosthetic joint infection: debridement, antibiotics and implant retention with short duration of rifampicin. Open forum infectious diseases. (2016) Conference: ID Week 2016. United States. 3 Supplement 1 pp', '10.1093/ofid/ofw172.844', 'http://academic.oup.com/ofid/article-pdf/3/suppl_1/1141/28685616/ofw172.844.pdf']\n",
      "['9737121', 'Leung M-HA; Lau C-S; Choy E. Patient-based disease activity score predicts flare better than improvement-blood test provides insignificant contribution. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp560-561', '10.1136/annrheumdis-2018-eular.2746', '']\n",
      "['9737122', 'Chen Y-C. Tofacitinib versus adalimumab versus abatacept in severe rheumatoid arthritis using high resolution ultrasound evaluation. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp5', '10.1111/1756-185x.13188', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13188']\n",
      "['9737123', 'Costello R; Marsden A; Movahedi M; Lunt M; Emsley R; Dixon WG. The importance of assessing multiplicative and additive interaction: examining the effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritisand concomitant type II diabetes. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp65', '10.1136/annrheumdis-2018-eular.1755', '']\n",
      "['9737124', 'EUCTR2018-003933-14-EE. A study evaluating the effect of filgotinib on sperm parameters in adult males with active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or non-radiographic axial spondyloarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-003933-14-EE. (2019)   pp', '10.31525/ct1-nct03926195', '']\n",
      "['9737125', 'IRCT2014012415860N1. Comparative evaluation of efficacy of the Malva sylvestris and Alcea digitata formulation with an artificial saliva in the radiation induced xerostomia and quality of life in patients with head‚Äì and‚Äì neck cancers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014012415860N1. (2014)   pp', '10.1111/fct.12215', '']\n",
      "['9737126', 'Park JK; Choi Y; Winthrop KL; Song YW; Lee EB. Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial. Annals of the rheumatic diseases. (2019)   pp', '10.1136/annrheumdis-2019-215187', '']\n",
      "['9737127', 'Bengtsson C; Wahlin B; Braune A; Jonsson E; Wallberg-Jonsson S. Hydroxychloroquine improves the blood lipid profile in rheumatoid arthritis and systemic lupus erythematosus after four and eight weeks of treatment: a randomized interventional study. Scandinavian journal of rheumatology. (2018) 47  pp29-', '10.1371/journal.pone.0312546', '']\n",
      "['9737128', 'Iwamoto Naoki; Sato Shuntaro; Sumiyoshi Remi; Chiba Ko; Miyamoto Nanami; Arinaga Kumiko; Kobayashi Makiko; Yamamoto Hiroshi; Osaki Makoto; Kawakami Atsushi. Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT. Trials. (2019) 20 1 pp494', '10.1186/s13063-019-3589-8', 'http://link.springer.com/article/10.1186/s13063-019-3589-8/fulltext.html']\n",
      "['9737129', 'Lee YH; Seo YH. Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a network meta-analysis. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp124-125', '10.1136/annrheumdis-2018-eular.1644', '']\n",
      "['9737131', 'Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo M; Ghogomu ET. Biologics for rheumatoid arthritis: an overview of cochrane reviews. Arthritis and rheumatism. (2009) 60  pp1022-', '10.1002/14651858.cd007848.pub2', '']\n",
      "['9737133', 'ACTRN12617001627347. Does restoring the knee to its original alignment during knee replacement surgery provide better balance than traditional methods?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617001627347. (2017)   pp', '10.1007/s00167-017-4742-0', 'http://link.springer.com/article/10.1007/s00167-017-4742-0/fulltext.html']\n",
      "['9737134', 'Gautam S; Chaurasia P; Rana D; Kumar U; Dada R. Yoga enhances fertility potential and improves quality of life in infertile men with rheumatoid arthritis on disease-modifying antirheumatic drugs. Andrology. (2019) 7  pp78-', '10.1016/j.fertnstert.2019.07.1161', '']\n",
      "['9737135', 'Tada M; Inui K; Okano T; Mamoto K; Koike T; Nakamura H. Safety of Intra-articular Methotrexate Injection With and Without Electroporation for Inflammatory Small Joints in Patients With Rheumatoid Arthritis. Clinical medicine insights: arthritis and musculoskeletal disorders. (2019) 12  pp', '10.1177/1179544119886303', 'https://journals.sagepub.com/doi/pdf/10.1177/1179544119886303']\n",
      "['9737136', 'NCT00244166. Prednisolone in Active Ankylosing Spondylitis (AS). https://clinicaltrials.gov/show/NCT00244166. (2005)   pp', '10.53347/rid-194840', '']\n",
      "['9737137', 'NCT01852851. Employment and Arthritis: making it Work. https://clinicaltrials.gov/show/NCT01852851. (2013)   pp', '10.1177/0950017012460327', 'https://journals.sagepub.com/doi/pdf/10.1177/0950017012460327']\n",
      "['9737138', 'Colmegna I; Useche ML; Rodriguez K; McCormack D; Alfonso G; Patel A; Ramanakumar AV; Rahme E; Bernatsky S; Hudson M; Ward BJ. Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial. The lancet rheumatology. (2020) 2 1 ppe14-e23', '10.1016/s2665-9913(19)30094-3', '']\n",
      "['9737139', 'Takeuchi T; Tanaka Y; Tanaka S; Kawakami A; Iwasaki M; Rokuda M; Izutsu H; Ushijima S; Kaneko Y; Shiomi T; Yamada E. A phase 3 study of the efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis who had an inadequate response to methotrexate. Annals of the rheumatic diseases. (2019) 78  pp81-82', '10.1136/annrheumdis-2019-eular.1580', '']\n",
      "['9737140', 'NCT00106184. Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM). https://clinicaltrials.gov/show/NCT00106184. (2005)   pp', '10.3410/f.717964016.793465783', '']\n",
      "['9737141', 'Karatas Gulsah; Umay Ebru; Gurcay Eda. The Relationship Between Demographic Characteristics and Noninflammatory Complaints in Rheumatoid Arthritis Patients on Remission. Journal of clinical rheumatology. (2019)   pp', '10.1097/rhu.0000000000001068', '']\n",
      "['9737142', 'Filatova E; Erdes S. Pregabalin efficacy in the treatment of chronic pain in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp533-534', '10.1136/annrheumdis-2019-eular.3931', '']\n",
      "['9737143', 'Tanaka Y; Takeuchi T; Rokuda M; Izutsu H; Kaneko Y; Shiomi T; Yamada E. Patient-and physician-reported outcomes from RAJ4: a randomised, double-blind, placebo-controlled study of the efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX). Annals of the rheumatic diseases. (2019) 78  pp756-', '10.1136/annrheumdis-2019-eular.2629', '']\n",
      "['9737144', 'NCT01618019. N-3 PUFA and Rheumatoid Arthritis in Korea. https://clinicaltrials.gov/show/NCT01618019. (2012)   pp', '10.1097/01.tpm.0000418562.99372.00', '']\n",
      "['9737145', \"NCT02661243. Implantology and Sj√∂gren's syndrome: a multicenter prospective cohort study. Https://clinicaltrials.gov/show/nct02661243. (2015)   pp\", '10.1007/springerreference_109687', '']\n",
      "['9737146', 'CTRI/2019/02/017432. A study to evaluate the pain relieving effect of medicated enema and medicated purgation in the management of joint pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2019/02/017432. (2019)   pp', '10.4103/2667-0593.351380', '']\n",
      "['9737147', \"Kedor C; Listing J; Zernicke J; Weiss A; Behrens F; Blank N; Henes JC; Kekow J; Rubbert-Roth A; Schulze-Koops H; Seipelt E; Specker C; Feist E. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Annals of the rheumatic diseases. (2020)  no pagination pp\", '10.1136/annrheumdis-2020-217155', '']\n",
      "['9737148', 'EUCTR2012-001618-40-CZ. Evaluation of the blood concentration of Tabalumab after the administration of Tabalumab using prefilled syringe or auto-injector in patients with Rheumathoid Arthritis that have not responded correctly to treatment with Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-001618-40-CZ. (2012)   pp', '10.1016/j.jval.2011.08.465', '']\n",
      "['9737151', 'Nourmohammadi I; Athari-Nikazm S; Vafa MR; Bidari A; Jazayeri S; Hoshyarrad A; Hoseini F; Fasihi-Radmandi M. Effects of antioxidant supplementations on oxidative stress in rheumatoid arthritis patients. Journal of biological sciences. (2010) 10 1 pp63-66', '10.3923/jbs.2010.63.66', '']\n",
      "['9737152', \"NCT03700138. Intravenous Immunoglobulins for the Treatment of Primary Sj√∂gren's Syndrome Associated Painful Sensory Neuropathies. Https://clinicaltrials.gov/show/nct03700138. (2018)   pp\", '10.3109/9780203325940-40', '']\n",
      "['9737154', 'NCT04312815. A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX. https://clinicaltrials.gov/show/NCT04312815. (2020)   pp', '10.31525/ct1-nct04192617', '']\n",
      "['9737155', 'Schulze-Koops H; Holzkamper T; Ragavan S; Trollmo C; Malmstroem V; Becker C; Jonuleit H; Strand V; Aigner S; Czeloth N; Daelken B; Engling A; Koch H; Niemann G; Osterroth F; Uherek C; Wartenberg-Demand A; Ershova O; Sotnikova T; Orlov-Morozov A; Ferraccioli G. Selective activation of regulatory T cells (Tregs) by BT-061: clinical data from a completed phase IIa trial in rheumatoid arthritis (RA) and design of a multi-centre, double-blind, randomised, placebo-controlled, phase IIb dose-finding trial. Zeitschrift fur rheumatologie.. (2011) 70 SUPPL. 1 pp86', '10.1186/isrctn07772084', '']\n",
      "['9737156', \"UMIN000012912. Serum ferritin, HO-1, and CD163 for the diagnosis of adult-onset Still's disease: a multicenter study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012912. (2014)   pp\", '10.1097/md.0000000000030152', '']\n",
      "['9737157', 'Yue Jiang; Griffith James F; Xu Jiankun; Xiao Fan; Shi Lin; Wang Defeng; Wong Priscilla C H; Li Edmund K; Li Martin; Li Tena K; Mak Wah Yan; Zhu Tracy Y; Hung Vivian W; Qin Ling; Tam Lai-Shan. Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: an HR-pQCT study. Seminars in arthritis and rheumatism. (2018) 48 3 pp374-383', '10.1016/j.semarthrit.2018.05.001', '']\n",
      "['9737158', 'IRCT2012120811689N1. The effects of nigella sativa oil on rheumatoid arthritis treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012120811689N1. (2013)   pp', '10.1016/j.phymed.2018.04.018', '']\n",
      "['9737159', 'Tang Zhongren; Sun Quanwei; Ji Haixia. Observation of the clinical effect of the combined therapy of zushima tablet and western medicine in the treatment of rheumatoid arthritis and MRI test results. Pakistan journal of pharmaceutical sciences. (2019) 32 3 Special pp1415-1418', '10.5246/jcps.2025.03.022', '']\n",
      "['9737160', 'ISRCTN37977053. Development and evaluation of an education programme in rheumatoid arthritis: impact on compliance, function, disease progression and quality of life. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN37977053. (2004)   pp', '10.1186/isrctn37977053', '']\n",
      "['9737162', 'Burgos-Vargas Ruben; Cardiel Mario; Xibille Daniel; Pacheco-Tena Cesar; Pascual-Ramos Virginia; Abud-Mendoza Carlos; Mahgoub Ehab; Rahman Mahboob; Fan Haiyun; Rojo Ricardo; Garcia Erika; Santana Karina. Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: pooled efficacy and safety analyses from Phase 3 and LTE studies. Reumatologia clinica. (2019) 15 1 pp43-53', '10.1016/j.reuma.2017.04.006', '']\n",
      "['9737163', 'EUCTR2014-004616-12-DE. Study in patients with primary Sj√∂gren‚Äôs syndrome with the aim to assess safety, tolerability, pharmacokinetics (way the body absorbs, distributes, and gets rid of the drug) and preliminary efficacy of CDZ173. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004616-12-DE. (2016)   pp', '10.31525/ct1-nct04069026', '']\n",
      "['9737164', 'IRCT2016020724149N8. effects of \"back school\" training on neck pain in employees. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016020724149N8. (2016)   pp', '10.1186/isrctn13364486', '']\n",
      "['9737165', 'Lu Liudan; Liu Jihong; Mo Shan; Chen Haiyu. The Effect of Auricular Plaster Therapy on Insomnia in Patients with Rheumatoid Arthritis. Medical acupuncture. (2019) 31 2 pp130-133', '10.1089/acu.2019.1346', '']\n",
      "['9737167', 'Tchetina EV; Demidova NV; Markova GA. Clinical remission prediction using baseline gene expression in the peripheral blood of DMARD-naive rheumatoid arthritis patients treated with methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp907', '10.1136/annrheumdis-2018-eular.1873', '']\n",
      "['9737168', 'EUCTR2007-003508-36-DE. A randomised multi-centre, double-blind, placebo-controlled study of a new modified-release tablet formulation of prednisolone (Lodotra¬Æ) in patients with rheumatoid arthritis - CAPRA-2. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-003508-36-DE. (2008)   pp', '10.1186/isrctn76859006', '']\n",
      "['9737169', \"NCT04056221. Effects of acupuncture on Sj√∂gren's syndrome. Https://clinicaltrials.gov/show/nct04056221. (2019)   pp\", '10.1007/springerreference_109687', '']\n",
      "['9737170', '. Comparison study of recombinant human Interleukin-1 receptor antagonist for treating psoriatic and rheumatoid arthritis. Cytokine.. (2010) 52 1-2 pp22', '10.1016/j.cyto.2010.07.095', '']\n",
      "['9737172', 'Taibanguay Nichapa; Chaiamnuay Sumapa; Asavatanabodee Paijit; Narongroeknawin Pongthorn. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial. Patient preference and adherence. (2019) 13  pp119-129', '10.2147/ppa.s192008', 'https://www.dovepress.com/getfile.php?fileID=47466']\n",
      "['9737173', \"Ferreira Ricardo J O; de Wit Maarten; Henriques Marta; Pinto Ana F; Duarte Catia; Mateus Elsa; Mendes Gabriel; da Silva Jose A P; Ndosi Mwidimi. 'It can't be zero!' Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study. Rheumatology (Oxford, England). (2020) 59 5 pp1137-1147\", '10.1093/rheumatology/kez467', 'http://academic.oup.com/rheumatology/article-pdf/59/5/1137/36534286/kez467.pdf']\n",
      "['9737175', 'Amanatullah DF; Landa J; Strauss EJ; Garino JP; Kim SH; Di Cesare PE. Comparison of surgical outcomes and implant wear between ceramic-ceramic and ceramic-polyethylene articulations in total hip arthroplasty. Journal of arthroplasty. (2011) 26 6 Suppl pp72-77', '10.1016/j.arth.2011.04.032', '']\n",
      "['9737177', 'Dorner T; Tanaka Y; Petri M; Smolen JS; Dow ER; Higgs RE; Benschop RJ; Abel A; Silk ME; De Bono S; Hoffman RW. Baricitinib-associated changes in type I interferon gene signature during a 24-week phase 2 clinical SLE trial. Lupus science and medicine. (2019) 6 Supplement 1 ppA141', '10.1136/lupus-2019-lsm.185', '']\n",
      "['9737178', 'CTRI/2018/10/015921. A multicenter trial to characterize the rate and extent of Methotrexate absorption after oral administration and to assess the bioequivalence of the Methotrexate Tablets, USP 2.5mg. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/10/015921. (2018)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9737179', \"O'Dell J; Takeuchi T; Tanaka Y; Louw I; Tiabut T; Kai M; Oribe M; Nakashima S; Finck B. Randomized, double-blind study comparing CHS-0214 with etanercept in patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy. Annals of the rheumatic diseases. (2016) 75  pp143-\", '10.1136/annrheumdis-2016-eular.1800', '']\n",
      "['9737180', '. Improvements in measures of work productivity/interference and general health status with sirukumab treatment in patients with active rheumatoid arthritis despite disease-modifying anti-rheumatic drug treatment. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1033-1034', '10.1136/annrheumdis-2016-eular.4335', '']\n",
      "['9737181', 'Gaino JZ; Bertolo MB; Nunes CS; Barbosa CM; Sachetto Z; Davitt M; Magalhaes EDP. The structural index score-sis for rheumatoid foot and its relation to foot function, disability and physical performance tests. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1354', '10.1136/annrheumdis-2018-eular.3792', '']\n",
      "['9737182', 'Young Bradley L; Watson Shawna L; Perez Jorge L; McGwin Gerald; Singh Jasvinder A; Ponce Brent A. Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis. Journal of rheumatology. (2018) 45 2 pp158-164', '10.3899/jrheum.170001', '']\n",
      "['9737183', 'Bianchi P A; Vigo P L; Polli E E. Evaluation of the effects of some non-steroid anti-inflammatory agents on the gastric mucosa. Valutazione degli effetti di alcuni farmaci anti-inflammatori non steroidei sulla mucosa gastrica. (1976) 67 33 pp2133-2137', '10.1016/s0016-5107(75)73812-9', '']\n",
      "['9737184', 'IRCT2016021624149N26. THE THERAPEUTIC EFFECT OF INTERFERENTIAL CURRENT AND EXERCISE-THERAPY IN PATIENTS WITH KNEE OSTEOARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016021624149N26. (2016)   pp', '10.1177/02692155241278949', 'https://journals.sagepub.com/doi/pdf/10.1177/02692155241278949']\n",
      "['9737189', 'Domanska B; Peterson L; Mountian I; Schiff M H. Comparative usability study for a certolizumab pegol auto-injection device in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1002-1003', '10.1136/annrheumdis-2016-eular.2041', '']\n",
      "['9737191', 'ChiCTR-TRC-11001789. Effect of TGP combined with MTX and LEF on liver function in RA patients: clinical study protocol. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-11001789. (2011)   pp', '10.1200/jco.2017.35.15_suppl.6006', '']\n",
      "['9737192', \"Abdel El-Gaphar Omnia Ahmed Mohamed; Abo-Youssef Amira Mourad; Abo-Saif Ali Ahmed. Effect of Losartan in Complete Freund's Adjuvant -Induced Arthritis in Rats. Iranian journal of pharmaceutical research : IJPR. (2018) 17 4 pp1420-1430\", '10.13005/bpj/1329', '']\n",
      "['9737193', 'Quan Jiang; Xiao-Po Tang; Xian-Chun Chen; Hong Xiao; Ping Liu; Juan Jiao. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial. BMC complementary and alternative medicine. (2017) 17  pp1-6', '10.1186/s12906-017-1957-z', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1957-z.pdf']\n",
      "['9737194', 'UMIN000005614. Expression of CTLA4 on peripheral mononuclear cells of patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005614. (2011)   pp', '10.14293/p2199-8442.1.sop-.pzsgc9.v1', '']\n",
      "['9737195', 'IRCT2013092210336N4. Investigation of the Efficacy of Intra-articular Prolotherapy  on the Primary Osteoarthritis of Knee: patients‚Äô Level of Pain and Knee Joint‚Äôs Range of Motion. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013092210336N4. (2013)   pp', '10.1186/isrctn17127122', '']\n",
      "['9737196', 'Rahman P; Zummer M; Bessette L; Baer P; Haraoui B; Chow A; Kelsall J; Kapur S; Rampakakis E; Psaradellis E; Lehman AJ; Nantel F; Osborne B; Tkaczyk C. Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry. BMJ open. (2017) 7 8 ppe016619', '10.1136/bmjopen-2017-016619', '']\n",
      "['9737197', 'Favalli Ennio G; Becciolini Andrea; Carletto Antonio; Conti Fabrizio; Amato Giorgio; Fusaro Enrico; Quartuccio Luca; Egan Colin Gerard; Lo Monaco Andrea; Benucci Maurizio; Salaffi Fausto; Semeraro Angelo; Parisi Simone; Ceccarelli Fulvia; Piazza Ilaria; Foti Rosario. Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort. Rheumatology international. (2020) 40 2 pp263-272', '10.1007/s00296-019-04416-3', 'http://link.springer.com/article/10.1007/s00296-019-04416-3/fulltext.html']\n",
      "['9737199', 'EUCTR2007-001708-19-GB. A 3-month study of the efficacy and safety of SVS20 in patients with bilateral moderate dry eye syndrome : a prospective, double-masked, randomised, controlled, parallel-group, 3-arm, multicentre, phase III trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-001708-19-GB. (2007)   pp', '10.1186/isrctn91412460', '']\n",
      "['9737201', 'Boyadzhieva Vladimira; Stoilov Nikolay; Ivanova Mariana; Petrova Guenka; Stoilov Rumen. Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs. Frontiers in pharmacology. (2018) 9  pp1303', '10.3389/fphar.2018.01303', '']\n",
      "['9737202', \"Dardin; Trevisani VFM; Garcia ABA. Study on the effects of strenght training in pain and disease activity in women with primary Sjogren's syndrome. Advances in rheumatology. (2018) Conference: 35th Brazilian Congress of Rheumatology, SBR 2018. Brazil. 58 Supplement 1 pp\", '10.1186/s42358-018-0019-7', 'http://link.springer.com/article/10.1186/s42358-018-0019-7/fulltext.html']\n",
      "['9737203', 'Sung Yoon-Kyoung; Cho Soo-Kyung; Kim Dam; Won Soyoung; Choi Chan-Bum; Kim Tae-Hwan; Jun Jae-Bum; Yoo Dae-Hyun; Bae Sang-Cheol. Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy. The Korean journal of internal medicine. (2018) 33 5 pp1016-1024', '10.3904/kjim.2016.214', 'http://kjim.org/upload/kjim-2016-214.pdf']\n",
      "['9737204', 'UMIN000015794. Efficacy of monthly sodium risedronate for the treatment of corticosteroid induced osteoporosis in patients with rheumatoid arthritis (multicenter, double-blind, randomized, placebo-controlled, parallel-group study ). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000015794. (2014)   pp', '10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k', '']\n",
      "['9737205', 'Renner N; Kleyer A; Kronke G; Simon D; Rech J; Schett G; Welsch G; Pachowsky ML. Cartilage damage quantitatively assessed by MRI using T2 mapping in CCP-positive RA patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1181', '10.1136/annrheumdis-2018-eular.2849', '']\n",
      "['9737207', 'UMIN000008185. Pilot study on the efficacy and safty of low-dose tocilizumab therapy in elderly RA patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008185. (2012)   pp', '10.1186/isrctn44366049', '']\n",
      "['9737209', 'Brod SA. Ingested type I interferon: state of the art as treatment for autoimmunity. Experimental biology and medicine. (2002) 227 11 pp981-988', '10.1177/153537020222701105', 'http://journals.sagepub.com/doi/pdf/10.1177/153537020222701105']\n",
      "['9737210', 'Shetty S; Fisher M C; Ahmed A R. Review on the influence of protocol design on clinical outcomes in rheumatoid arthritis treated with Rituximab. Annals of pharmacotherapy. (2013) 47 3 pp311-323', '10.1345/aph.1r574', 'https://journals.sagepub.com/doi/pdf/10.1345/aph.1R574']\n",
      "['9737211', 'UMIN000012613. Reduction or withdrawal of etanercept after remission with etanerceptin patients with rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012613. (2013)   pp', '10.1186/s13075-019-1937-4', 'http://link.springer.com/article/10.1186/s13075-019-1937-4/fulltext.html']\n",
      "['9737212', 'Dawood Amal F; Younes Sheren; Alzamil Norah M; Alradini Faten A; Saja Maha Fahad. Inhibition of glycogen synthase kinase-3beta protects against collagen type II-induced arthritis associated with the inhibition of miR155/24 and inflammation and upregulation of apoptosis in rats. Archives of physiology and biochemistry. (2020)   pp1-9', '10.1111/1440-1681.13305/v3/response1', '']\n",
      "['9737213', 'EUCTR2016-002852-26-BG. MSB11022 in moderately to severely active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002852-26-BG. (2017)   pp', '10.5194/bg-2017-26-rc1', '']\n",
      "['9737214', 'Trenkic Bozinovic Marija S; Stankovic Babic Gordana; Petrovic Maja; Karadzic Jelena; Sarenac Vulovic Tatjana; Trenkic Milan. Role of optical coherence tomography in the early detection of macular thinning in rheumatoid arthritis patients with chloroquine retinopathy. Journal of research in medical sciences. (2019) 24  pp55', '10.4103/jrms.jrms_704_18', '']\n",
      "['9737217', 'Westhovens R; Yoo DH; Jaworski J; Matyska-Piekarska E; Smiyan S; Ivanova D; Zielinska A; Raussi E-K; Batalov A; Lee SJ; Lee SY; Suh JH. Novel formulation of CT-P13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp315', '10.1136/annrheumdis-2018-eular.1810', '']\n",
      "['9737218', 'Moyano Sebastian; Scolnik Marina; Vergara Facundo; Garcia Maria Victoria; Sabelli Mirtha Rosa; Rosa Javier Eduardo; Catoggio Luis Jose; Soriano Enrique Roberto. Evaluation of Learned Helplessness, Perceived Self-efficacy, and Functional Capacity in Patients With Fibromyalgia and Rheumatoid Arthritis. Journal of clinical rheumatology. (2019) 25 2 pp65-68', '10.1097/rhu.0000000000000769', '']\n",
      "['9737219', 'NCT00283712. Use of Infliximab for the Treatment of Pemphigus Vulgaris. https://clinicaltrials.gov/show/NCT00283712. (2006)   pp', '10.1007/s40278-024-65801-4', 'https://link.springer.com/article/10.1007/s40278-024-65801-4/fulltext.html']\n",
      "['9737222', 'Primdahl J; Horn HC; Petersen R; Horslev-Petersen K. OP0115 Clinical and radiological outcome in outpatients with rheumatoid arthritis followed by medical, nursing or shared care-a two year randomised controlled trial. Annals of the Rheumatic Disease. (2013) 71  pp92', '10.1136/annrheumdis-2012-eular.1798', '']\n",
      "['9737223', 'NCT03975595. Meditation Effects on Brain Function in Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03975595. (2019)   pp', '10.31525/ct1-nct03975595', '']\n",
      "['9737224', 'Patrignani P; Capone M L; Sciulli M G; Tacconelli S. New COXIBs: focus on etoricoxib. Trends in medicine. (2005) 5 1 pp69-84', '10.1016/j.brainresrev.2004.12.024', '']\n",
      "['9737225', 'Stein M; Vaillancourt J; Rampakakis E; Sampalis JS. Prospective observational study to evaluate the use of musculoskeletal ultrasonography in rheumatoid arthritis management: the ECHO study. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/keaa004', 'http://academic.oup.com/rheumatology/article-pdf/59/10/2746/33794877/keaa004.pdf']\n",
      "['9737226', 'Xie Xue-Jian; Shen Yu-Yan; Song Jie; Zhong Ling-Yu; Ning Yan-Hua; Zeng Xiang; Shan Jing-Yan; Liu Yang; Zhu Yan-Feng; Li Yun. The Effects of All-trans Retinoic Acid on the Expression of Inflammatory Cytokines and Cartilage Damage Related Protease in Rats with Collagen Induced Arthritis. Sichuan da xue xue bao. Yi xue ban [Journal of Sichuan University. Medical science edition]. (2016) 47 4 pp479-484', '10.1002/hon.2778/v2/response1', '']\n",
      "['9737227', 'CTRI/2018/07/014995. Pharmacokinetic study of two formulations of Azathioprine Tablets 50 mg in Adult Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/07/014995. (2018)   pp', '10.4172/jbb.1000141', '']\n",
      "['9737228', 'UMIN000029797. Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total hip arthroplasty: randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000029797. (2017)   pp', '10.1016/j.knee.2014.12.002', '']\n",
      "['9737229', 'Franco P A. Multicentre cross-over study and open trial of two forms of ibuprofen suppositories in patients with rheumatoid arthritis and osteoarthrosis. Panminerva medica. (1974) 16 9 pp278-288', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9737231', 'EUCTR2013-002805-76-ES. A 24-week placebo-controlled clinical study to evaluate the adequate dose, efficacy and safety of 3 doses of namilumab combined with methotrexate in subjects with moderate to severe rheumatoid arthritis followed by a 48-week active extension study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-002805-76-ES. (2014)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9737232', 'EUCTR2006-004713-18-BE. A phase II study assessing the curative effect of the combination of lobectomy followed by mediastinal concomitant radiochemotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer responding to induction chemotherapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-004713-18-BE. (2006)   pp', '10.1016/s0169-5002(09)70267-3', '']\n",
      "['9737233', 'Brunner H; Chen C; Martini A; Espada G; Joos R; Akikusa J; Chaitow J; Gamir MLG; Kimura Y; Rietschel C; Siri D; Smolewska E; Schmeling H; Brown D; De Benedetti F; Lovell D; Huang B; Ruperto N. Disability and health-related quality of life outcomes in patients with systemic or polyarticular juvenile idiopathic arthritis treated with tocilizumab in randomized controlled phase 3 trials. Hormone research in paediatrics. (2018) Conference: 27th Annual Meeting of the Latin American Pediatric Endocrinology Society, SLEP 2018. France. 90 Supplement 2 pp', '10.1136/annrheumdis-2019-eular.3392', '']\n",
      "['9737234', 'Kim MJ; Song YW; Lee EB; Park JK. Effect of short-term methotrexate discontinuation on the disease activity in patients with rheumatoid arthritis: posthoc-analysis of two randomized clinical trials. Annals of the rheumatic diseases. (2019) 78  pp82-', '10.1136/annrheumdis-2019-eular.2524', '']\n",
      "['9737235', 'Hasegawa Hitoshi. Design an Intervention Study. Methods in molecular biology (Clifton, N.J.). (2018) 1868  pp235-241', '10.1007/978-1-4939-8802-0_24', '']\n",
      "['9737236', 'EUCTR2008-000743-34-FR. A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients with Rheumatoid Arthritis Who Have Failed at Least One Biologic. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000743-34-FR. (2008)   pp', '10.3410/f.718241074.793528879', '']\n",
      "['9737237', 'Wang J-W; Mo Y-Q; Wang X-Y; Chen L-F; Ma J-D; Lin J-Z; Zheng D-H; Dai L. Add-on short-course tocilizumab accelerates dose tapering of glucocorticoids in rheumatoid arthritis: results from a Chinese prospective cohort study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp322-323', '10.1136/annrheumdis-2018-eular.5130', '']\n",
      "['9737238', \"ISRCTN10758297. The effect of a unique omega-3 supplement on dry mouth and dry eye in Sjogren's patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN10758297. (2007)   pp\", '10.1186/isrctn10758297', '']\n",
      "['9737239', 'Honkanen V; Lahdenne P. Juvenile rheumatoid arthritis. Duodecim; laaketieteellinen aikakauskirja. (2000) 116 8 pp839-843', '10.1007/s10067-010-1571-7', 'http://link.springer.com/article/10.1007/s10067-010-1571-7/fulltext.html']\n",
      "['9737240', \"Seppen Bart F; L'ami Merel J; Duarte Dos Santos Rico Sharon; Ter Wee Marieke M; Turkstra Franktien; Roorda Leo D; Catarinella Fabio S; van Schaardenburg Dirkjan; Nurmohamed Michael T; Boers Maarten; Bos Wouter H. A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: protocol for a Randomized Controlled Trial. JMIR research protocols. (2020) 9 2 ppe15105\", '10.2196/15105', '']\n",
      "['9737241', 'DRKS00004710. The origin and role of human CD21low B cells in autoimmune disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00004710. (2014)   pp', '10.58837/chula.the.2023.57', '']\n",
      "['9737242', 'NCT00711503. Anti-Interleukin-1 in Diabetes Action. https://clinicaltrials.gov/show/NCT00711503. (2008)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9737243', 'Pineda-Juarez Juan Antonio; Lozada-Mellado Mariel; Ogata-Medel Midori; Hinojosa-Azaola Andrea; Santillan-Diaz Cira; Llorente Luis; Orea-Tejeda Arturo; Alcocer-Varela Jorge; Espinosa-Morales Rolando; Gonzalez-Contreras Marco; Castillo-Martinez Lilia. Body composition evaluated by body mass index and bioelectrical impedance vector analysis in women with rheumatoid arthritis. Nutrition (Burbank, Los Angeles County, Calif.). (2018) 53  pp49-53', '10.1016/j.nut.2018.01.004', '']\n",
      "['9737245', 'Iraji F; Haftbaradaran E; Davashi S; Zolfaghari-Baghbaderani A; Bokaii-Jazi S. Comparing the improvement of unstable vitiligo in patients treated by topical PUVA-therapy alone, topical PUVA-therapy and oral vitamin D, and topical PUVA-therapy and oral vitamin D and vitamin B12. Journal of isfahan medical school. (2017) 34 416 pp1699-1705', '10.1201/b14220-8', '']\n",
      "['9737246', 'CTRI/2016/07/007097. Multi-centre, randomized, double-blind, two-arm, parallel group,  comparative clinical study to evaluate pharmacokinetic, efficacy and safety of Etanercept in Patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/07/007097. (2016)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9737247', 'ChiCTR1800015135. The evaluation of the effect of syndrome differentiation on the pain of patients with early knee paralysis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800015135. (2018)   pp', '10.26226/m.5ab3c881a874c60026559f94', '']\n",
      "['9737249', 'Solomon D; Lu F; Xu C; Colls J; Suh DH; Murray M; Corrigan C; Lee Y. Patient adherence with a smartphone app for disease monitoring in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp350-351', '10.1136/annrheumdis-2019-eular.4868', '']\n",
      "['9737251', 'Jiao Juan; Tang Xiaopo; Gong Xun; Yin Haibo; Jiang Quan; Wei Chengchung. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial. Journal of traditional chinese medicine = chung i tsa chih ying wen pan. (2019) 39 1 pp89-96', '10.1186/s12906-017-1957-z', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1957-z.pdf']\n",
      "['9737252', 'Pu H M; Zhao L Y; Cheng J M; Guo L H. Clinical study of warm acupuncture and moxibustion combined with acupoint injection of Cervus and Cucumis Polypeptide in treatment of rheumatoid arthritis. World chinese medicine [shi jie zhong yi yao]. (2016) 11 4 pp711-714', '10.4268/cjcmm20162127', '']\n",
      "['9737253', 'Adina Turcu-Stiolica; Mihaela-Simona Subtirelu; Lucia Ciurea Paulina; Stefan Cristian Dinescu; Maria Bogdan; Lili Barbulescu Andreea; Daniela-Gabriela Glavan; Razvan-Aurelian Turcu-Stiolica; Cristina Firulescu Sineta; Andreea Chisalau Beatrice; Dorina Parvanescu Cristina; Bogdan-Petre Stanoiu; Daniela Meca Andreea; Johny Neamtu; Florentin-Ananu Vreju. The Influence of Socio-Demographic Factors, Lifestyle and Psychiatric Indicators on Adherence to Treatment of Patients with Rheumatoid Arthritis: a Cross-Sectional Study. Medicina (Kaunas, Lithuania). (2020) 56 4 pp', '10.3390/medicina56040178', '']\n",
      "['9737255', 'NCT01721200. \"Learning About Biologics\"-Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01721200. (2012)   pp', '10.1093/rheumatology/kew075', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i3/5074376/kew075.pdf']\n",
      "['9737256', '. Ethanercept: a review of its use in rheumatoid arthritis. Drugs. (1999) 57 6 pp945-966', '10.2165/00003495-199957060-00014', '']\n",
      "['9737259', 'Boccardo J; Guerrero L; Ganga R; Rodriguez C; Manilov R. Importance of screening for detection of methicillin-resistant staphylococcus for decrease infection in orthopedic surgery. Orthopaedic journal of sports medicine. (2018) Conference: 117th American Anthropological Association Annual Meeting, AAA 2018. United States. 6 12 Supplement 5 pp', '10.1177/2325967118s00196', 'https://journals.sagepub.com/doi/pdf/10.1177/2325967118S00196']\n",
      "['9737260', 'EUCTR2008-000587-17-CZ. Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000587-17-CZ. (2008)   pp', '10.31525/ct1-nct04115839', '']\n",
      "['9737263', 'Otomo K; Koike T. TNF inhibitors for treatment of rheumatoid arthritis. Nihon Naika Gakkai zasshi [The Journal of the Japanese Society of Internal Medicine]. (2008) 97 10 pp2405-2412', '10.2169/naika.97.2405', '']\n",
      "['9737264', 'Sanmarti R; Martin-Mola E; Fonseca J E; Veale D J; Escudero-Contreras A; Gonzalez C M. Clinical remission in subjects with rheumatoid arthritis treated with subcutaneous tocilizumab as monotherapy or in combination with methotrexate or other synthetic DMARDs: a real-world clinical trial. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.4951', '']\n",
      "['9737265', 'Lin DF; Jiang YT; Zhang YL; Cao J; Guo XH; Pan YF; Gu JR. Seronegative RA group had milder synovitis and delayed progress of bone erosion than seropositive RA on wrists and hands in DMARDs-naive Chinese cohort. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1294', '10.1136/annrheumdis-2018-eular.4053', '']\n",
      "['9737266', 'Chastek B; Koep E; Mallya UG; Cockerham A; Choi J; Boklage S; Furst DE. Real-world interruptions in janus kinase inhibitor therapy observed among biologicnaive and biologic-experienced rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp949-950', '10.1136/annrheumdis-2018-eular.3456', '']\n",
      "['9737267', 'Sundin U; Aga A-B; Skare O; Norberg LB; Uhlig T; Hammer HB; Van Der Heijde D; Kvien TK; Lillegraven S; Haavardsholm E. Ultrasound in the management of early rheumatoid arthritis: MRI outcome data from the arctic randomized controlled strategy trial. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp142', '10.1136/annrheumdis-2019-eular.990', '']\n",
      "['9737268', 'IRCT201405265062N8. The effect of probiotic soy milk in the treatment of type 2 diabetes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201405265062N8. (2014)   pp', '10.31525/ct1-nct04296825', '']\n",
      "['9737269', 'NCT00746512. A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088). https://clinicaltrials.gov/show/NCT00746512. (2008)   pp', '10.2165/00128415-199404980-00052', '']\n",
      "['9737270', 'Baglan Yentur Songul; Tuna Zeynep; Mete Oguzhan; Gokkurt Ahmet; Tore Nurten Gizem; Kucuk Hamit; Goker Berna; Oskay Deran. Hand functions in systemic lupus erythematosus: a comparative study with rheumatoid arthritis patients and healthy subjects. Turkish journal of medical sciences. (2018) 48 4 pp840-844', '10.3906/sag-1803-183', '']\n",
      "['9737271', 'Ruperto N; Brunner HI; Hazra A; Stock T; Wang R; Mebus C; Alvey C; Lamba M; Krishnaswami S; Conte U; Wang M; Tzaribachev N; Foeldvari I; Horneff G; Kingsbury D; Koskova E; Smolewska E; Vehe RK; Zuber Z; Martini A; Lovell D. Pharmacokinetics, safety and tolerability of tofacitinib in paediatric patients from two to less than eighteen years of age with juvenile idiopathic arthritis. Pediatric rheumatology. (2017) 15  pp', '10.1136/annrheumdis-2016-eular.2640', '']\n",
      "['9737272', 'EUCTR2010-020992-21-SK. Comparison of efficacy of masitinib versus methotrexate in the treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020992-21-SK. (2011)   pp', '10.1186/isrctn24868111', '']\n",
      "['9737273', 'UMIN000026137. Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total knee arthroplasty: randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000026137. (2017)   pp', '10.1016/j.knee.2014.12.002', '']\n",
      "['9737274', 'IRCT2016083129508N2. Investigation  the effect of ginger powder on NF-KB, Ox-LDL,  lipid profile and clinical symptoms in Rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016083129508N2. (2016)   pp', '10.1016/j.autrev.2020.102741', '']\n",
      "['9737276', 'Ranza Roberto; de la Vega Maria Celina; Laurindo Ieda Maria Magalhaes; Gomez Maria Gimena; Titton David Cezar; Kakehasi Adriana Maria; Brigante Alejandro; Benitez Alejandro; Ranzolin Aline; Granel Amelia; Cappuccio Ana Maria; Quinteros Ana; Hayata Andre Luiz Shinji; Smichowski Andrea; Duarte Angela Luzia Branco P; Kahlow Barbara Stadler; Andia Carolina Sanchez; Brenol Claiton Viegas; Velozo Edson; Mussano Eduardo; Soriano Enrique R; Christopoulos Georges Basile; da Rocha Castelar Pinheiro Geraldo; de Castro Glaucio Ricardo Werner; Casado Gustavo; da Silveira Carvalho Hellen Mary; Exeni Ida Elena; da Silveira Ines Guimaraes; Petkovic Ingrid; Pereira Ivanio Alves; da Costa Izaias Pereira; Rosa Javier Eduardo; Miranda Jose Roberto Silva; de Moraes Julio Cesar Bertacini; Bertolo Manoel Barros; Buhl Manuel; Lazaro Maria Alicia; da Sauma Maria de Fatima Lobato C; de Medeiros Pinheiro Marcelo; Diaz Monica; de Vechi Monica Valeria Siqueira Santana; Cerda Osvaldo Luis; Astesana Pablo; Curi Pablo Finucci; Louzada-Jr Paulo; Teodoro Reginaldo Botelho; Toledo Roberto Acayaba; Papasidero Silvia; Valim Valeria; Fernandes Vander; Saurit Veronica; Bianchi Washington Alves; BIOBADABRASIL study group Sociedade Brasileira de Reumatologia and of the BIOBADASAR study group Sociedad Argentina de Reumatologia; de Melo Costa Pinto Rogerio; Descalzo Miguel Angel; Gomez-Reino Juan Jesus. Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR. Clinical rheumatology. (2019) 38 8 pp2129-2139', '10.1007/s10067-019-04516-2', 'http://link.springer.com/article/10.1007/s10067-019-04516-2/fulltext.html']\n",
      "['9737277', 'EUCTR2016-002035-15-FI. Outcome after total knee endoprosthesis under general or regional anesthesia, a randomized study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002035-15-FI. (2016)   pp', '10.21093/mj.v15i1.618', '']\n",
      "['9737278', 'Kotyla Przemyslaw; Batko Bogdan; Zuber Zbigniew; Almgren-Rachtan Agnieszka; Chudek Jerzy; Kucharz Eugeniusz Jozef. Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis. Advances in clinical and experimental medicine : official organ wroclaw medical university. (2019) 28 9 pp1229-1235', '10.17219/acem/105379', 'http://www.advances.umed.wroc.pl/pdf/2019/28/9/1229.pdf']\n",
      "['9737280', 'IRCT201109187577N1. Effect of  bromocriptine in the treatment of rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201109187577N1. (2011)   pp', '10.1007/s00296-011-2041-5', 'http://link.springer.com/article/10.1007/s00296-011-2041-5/fulltext.html']\n",
      "['9737281', 'Nowotny J; El-Zayat B; Goronzy J; Biewener A; Bausenhart F; Greiner S; Kasten P. Prospective randomized controlled trial in the treatment of lateral epicondylitis with a new dynamic wrist orthosis. European journal of medical research. (2018) 23 1 pp43', '10.1186/s40001-018-0342-9', 'http://link.springer.com/article/10.1186/s40001-018-0342-9/fulltext.html']\n",
      "['9737282', 'EUCTR2016-002337-30-ES. A study to evaluate the safety and efficacy of PF-06650833 in subjects with moderate to severely active rheumatoid arthritis who have an incomplete response to methotrexate treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002337-30-ES. (2017)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9737287', 'Vuka Ivana; Dosenovic Svjetlana; Marcius Tihana; Ferhatovic Hamzic Lejla; Vucic Katarina; Sapunar Damir; Puljak Livia. Efficacy and safety of pulsed radiofrequency as a method of dorsal root ganglia stimulation for treatment of non-neuropathic pain: a systematic review. BMC anesthesiology. (2020) 20 1 pp105', '10.1186/s12871-020-01023-9', 'https://link.springer.com/article/10.1186/s12871-020-01023-9/fulltext.html']\n",
      "['9737288', \"Ye BD; Jang BI; Borzan V; Lahat A; Pukitis A; Osipenko M; Mostovoy Y; Schreiber S; Reinisch W; Lee SJ; Suh JH; Lee SG; Lee J; Ben-Horin S. A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) FOR SUBCUTANEOUS ADMINISTRATION: 1-YEAR RESULT FROM A PHASE I OPEN-LABEL RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE CROHN'S DISEASE. Gastroenterology. (2019) 156 6 Supplement 1 ppS-1096\", '10.1016/s0016-5085(19)39701-x', '']\n",
      "['9737289', \"Iacono Daniela; Fasano Serena; Pantano Ilenia; D'Abrosca Virginia; Ruscitti Piero; Margiotta Domenico Paolo Emanuele; Navarini Luca; Maruotti Nicola; Grembiale Rosa Daniela; Cantatore Francesco Paolo; Afeltra Antonella; Giacomelli Roberto; Valentini Gabriele. Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: an Italian Multicentre Retrospective Study. Cardiology research and practice. (2019) 2019  pp2748035\", '10.1155/2019/2748035', 'http://downloads.hindawi.com/journals/crp/2019/2748035.pdf']\n",
      "['9737290', 'CTRI/2018/02/011865. A comparison of vaitarana Basti and matra basti in the disease Amavata called Rheumatoid arthritis in modern science. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/02/011865. (2018)   pp', '10.47070/ayushdhara.v10i6.1456', 'https://ayushdhara.in/index.php/ayushdhara/article/download/1456/1391']\n",
      "['9737291', 'IRCT2016040825732N5. The Effectiveness Of  Kinesio taping On The Electrodiagnostic Parameters Of  Median Nerve And Hand Functional Performance In Carpal Tunnel Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016040825732N5. (2016)   pp', '10.1186/isrctn82192319', '']\n",
      "['9737292', 'George MD; Baker JF; Ogdie A. Comparative persistence of methotrexate and tumor necrosis factor inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Journal of rheumatology. (2020) 47 6 pp826-834', '10.3899/jrheum.190299', '']\n",
      "['9737293', 'UMIN000021635. Study for theraputic effects of soy been peptides on rheumatoid arthritis-dose response study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021635. (2016)   pp', '10.1186/isrctn28793839', '']\n",
      "['9737294', 'Garcia Irene Garcia; Rodriguez-Rubio Miguel; Mariblanca Amelia Rodriguez; de Soto Lucia Martinez; Garcia Lucia Diaz; Villatoro Jaime Monserrat; Parada Javier Queiruga; Meseguer Enrique Seco; Rosales Maria J; Gonzalez Juan; Arribas Jose R; Carcas Antonio J; de la Oliva Pedro; Borobia Alberto M. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): a structured summary of a study protocol for a randomised controlled trial. Trials. (2020) 21 1 pp466', '10.1186/s13063-020-04436-6', 'https://link.springer.com/article/10.1186/s13063-020-04436-6/fulltext.html']\n",
      "['9737295', 'NCT01776398. Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies. https://clinicaltrials.gov/show/NCT01776398. (2013)   pp', '10.21203/rs.3.rs-3945120/v1', 'https://www.researchsquare.com/article/rs-3945120/v1']\n",
      "['9737297', 'Devine E B; Alfonso-Cristancho R; Sullivan S D. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy. (2011) 31 1 pp39-51', '10.1592/phco.31.1.39', '']\n",
      "['9737298', 'UMIN000004054. Effects of probiotics on rheumatoid knee joint required total knee joint arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004054. (2010)   pp', '10.1007/978-1-4471-1825-1_17', 'http://link.springer.com/content/pdf/10.1007/978-1-4471-1825-1_17.pdf']\n",
      "['9737299', 'NCT02995460. Interval Training Study in Psoriatic Arthritis. https://clinicaltrials.gov/show/NCT02995460. (2016)   pp', '10.53347/rid-18381', '']\n",
      "['9737300', 'CTRI/2017/08/009423. A Clinical Study on Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/08/009423. (2017)   pp', '10.1016/j.hpb.2018.06.056', '']\n",
      "['9737302', 'Westhovens Rene; Ravelingien Isabelle; Vandevyvere Klaas; Pansar Ingrid; Purcaru Oana; Kumke Thomas; Gyselbrecht Lieve. Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study. Acta clinica Belgica. (2019) 74 5 pp342-350', '10.1080/17843286.2018.1509923', '']\n",
      "['9737303', 'NCT01307787. Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01307787. (2011)   pp', '10.2522/ptj.20090010', 'http://academic.oup.com/ptj/article-pdf/91/6/879/17503855/ptj0879.pdf']\n",
      "['9737304', 'EUCTR2009-012141-34-GB. Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Total Hip Replacement. - (TRANX-H). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012141-34-GB. (2009)   pp', '10.1186/isrctn58762744', '']\n",
      "['9737305', 'IRCT2017080335480N1. spinal orthotic management of the elderly people with hyperkyphosis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017080335480N1. (2017)   pp', '10.5220/0009588802050209', '']\n",
      "['9737306', 'NCT01617421. Yoga as Self-Care for Arthritis in Minority Communities. https://clinicaltrials.gov/show/NCT01617421. (2012)   pp', '10.1186/1477-7525-11-55', '']\n",
      "['9737307', 'IRCT138807012227N2. Assessment of systemic effects of ginger on salivation in patients with post-radiotherapy xerostomia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138807012227N2. (2009)   pp', '10.1016/j.oos.2009.06.377', '']\n",
      "['9737308', 'NCT04230213. A Comparative Study Between PF-06410293 and Humira¬¨√Ü in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT04230213. (2020)   pp', '10.31525/ct1-nct04230213', '']\n",
      "['9737311', 'Paulus H E; Bulpitt K J. DC-ART Classification: review of relevant clinical studies. Journal of rheumatology. (1994) 21 SUPPL. 41 pp8-20', '10.1093/rheumatology/32.7.529', 'http://academic.oup.com/rheumatology/article-pdf/32/7/529/5041842/32-7-529.pdf']\n",
      "['9737312', 'Anusha Divvi; Chaly Preetha Elizabeth; Junaid Mohammed; Nijesh J E; Shivashankar K; Sivasamy Shyam. Efficacy of a mouthwash containing essential oils and curcumin as an adjunct to nonsurgical periodontal therapy among rheumatoid arthritis patients with chronic periodontitis: a randomized controlled trial. Indian journal of dental research. (2019) 30 4 pp506-511', '10.4103/ijdr.ijdr_662_17', '']\n",
      "['9737314', 'Mukherjee Dibyendu; Lahiry Sandeep; Thakur Sayanta; Chakraborty Dwaipayan Sarathi. Effect of 1,25 dihydroxy vitamin D3 supplementation on pain relief in early rheumatoid arthritis. Journal of family medicine and primary care. (2019) 8 2 pp517-522', '10.4103/jfmpc.jfmpc_446_18', '']\n",
      "['9737317', 'Hewlett Sarah; Almeida Celia; Ambler Nicholas; Blair Peter S; Choy Ernest H; Dures Emma; Hammond Alison; Hollingworth William; Kadir Bryar; Kirwan John Richard; Plummer Zoe; Rooke Clive; Thorn Joanna; Turner Nicholas; Pollock Jon; RAFT Study Group. Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT). Annals of the rheumatic diseases. (2019) 78 4 pp465-472', '10.1136/annrheumdis-2018-214469', '']\n",
      "['9737318', 'Jiang C-R; Li H-L. The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis. European review for medical and pharmacological sciences. (2018) 22 15 pp4800-4805', '10.26226/morressier.59a6b349d462b80290b552d4', '']\n",
      "['9737319', 'Khan A A; Dubois S; Khan O A; Rahman M Z; Derzko C. A randomized, double-blind, placebo-controlled study to evaluate the effects of alendronate (ALN) on bone mineral density (BMD) and bone turnover in perimenopausal women with low BMD. Endocrine reviews. (2014) 35 SUPPL. 3 pp', '10.1016/j.jocd.2014.04.095', '']\n",
      "['9737320', 'Hekmatpou Davood; Mortaji Sepideh; Rezaei Masoud; Shaikhi Millad. The Effectiveness of Olive Oil in Controlling Morning Inflammatory Pain of Phalanges and Knees Among Women With Rheumatoid Arthritis: a Randomized Clinical Trial. Rehabilitation nursing. (2018)   pp', '10.1097/rnj.0000000000000162', '']\n",
      "['9737323', 'IRCT201207109472N4. The effect of Ginger powder consumption on inflammation  and Immunity  in Rheumatoid arthritis disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201207109472N4. (2014)   pp', '10.1016/j.gene.2019.01.048', '']\n",
      "['9737324', 'NCT00124982. Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy. https://clinicaltrials.gov/show/NCT00124982. (2005)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9737325', 'Wang Nannan; Zhao Xiaoning; Huai Jiaxin; Li Yiran; Cheng Congcong; Bi Kaishun; Dai Ronghua. Arachidonic acid metabonomics study for understanding therapeutic mechanism of Huo Luo Xiao Ling Dan on rat model of rheumatoid arthritis. Journal of ethnopharmacology. (2018) 217  pp205-211', '10.1016/j.jep.2018.02.027', '']\n",
      "['9737328', 'NL8210. Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NL8210. (2019)   pp', '10.31525/ct1-nct04251741', '']\n",
      "['9737330', 'IRCT201012014104N3. The effect of hippotherapy simulator in mechanical low back pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201012014104N3. (2011)   pp', '10.3233/bmr-170832', '']\n",
      "['9737333', 'EUCTR2006-003142-42-DE. A Randomized, Double Blind, Placebo-controlled, Proof of Concept Study to evaluate Efficacy, Safety and Pharmacokinetics of two Different Doses of SC12267 (20mg, 35 mg) in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003142-42-DE. (2007)   pp', '10.1186/isrctn49455679', '']\n",
      "['9737334', 'Al Ani NA; Gorial FI; Khedir E; Hussein A; El Dershaby Y; AlJabban A. Adherence of etanercept in iraqi patients with rheumatoid arthritis: oneand five-year data from a local registry. Arthritis and rheumatology. (2018) 70 Supplement 9 pp302-303', '10.2147/oarrr.s368190', 'https://www.dovepress.com/getfile.php?fileID=81476']\n",
      "['9737335', 'Jansen TLThA; Spoorenberg A; Houtman PM; Van Roon EN; Laan RFJM. The effect of folic- or folinic-acid comedication on the toxicity and efficacy of methotrexate in the treatment of patients with rheumatoid arthritis; a 48-week, randomised, double-blind, placebo-controlled study [2] (multiple letters). Nederlands tijdschrift voor geneeskunde. (2002) 146 45 pp2168-', '10.1186/isrctn49455679', '']\n",
      "['9737336', 'Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blafield H; Leirisalo-Repo M. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis. Scandinavian journal of rheumatology. (2009) 38 2 pp96-103', '10.1080/03009740902756515', '']\n",
      "['9737337', 'CTRI/2018/12/016581. Study of Filgotinib to assess the Safety and Efficacy in Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/12/016581. (2018)   pp', '10.1186/isrctn50655730', '']\n",
      "['9737338', 'Chen Yang-Fan; Xu Sheng-Qian; Xu Yue-Chen; Li Wan-Jun; Chen Ke-Ming; Cai Jing; Li Mu. Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis. Clinical rheumatology. (2020) 39 6 pp1737-1745', '10.1007/s10067-019-04873-y', 'http://link.springer.com/article/10.1007/s10067-019-04873-y/fulltext.html']\n",
      "['9737339', 'ChiCTR-IOR-16009308. Explore Tai Chi exercise in improving knee osteoarthritis symptoms based on fMRI: a clinical study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-16009308. (2016)   pp', '10.1016/j.explore.2018.06.002', '']\n",
      "['9737340', 'EUCTR2006-006127-40-GB. Cerebral Blood Flow following TNF-alpha Antagonism in Rheumatoid Arthritis - a Pilot Study - TNF/CBF in RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006127-40-GB. (2006)   pp', '10.1186/isrctn62900439', '']\n",
      "['9737341', 'Wang Chrong-Reen; Liu Ming-Fei. Recombinant Soluble TNF-alpha Receptor Fusion Protein Therapy Reduces Insulin Resistance in Non-Diabetic Active Rheumatoid Arthritis Patients. ACR open rheumatology. (2020)   pp', '10.1002/acr2.11157', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr2.11157']\n",
      "['9737344', 'EUCTR2007-006527-13-BG. A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006527-13-BG. (2008)   pp', '10.1186/isrctn49455679', '']\n",
      "['9737345', 'Tada M; Inui K; Sugioka Y; Okano T; Yamada Y; Mandai K; Mamoto K; Koike T; Nakamura H. Comparison of bone mineral density between rheumatoid arthritis patients and healthy individuals over seven years from the tomorrow study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1623-1624', '10.1136/annrheumdis-2018-eular.2298', '']\n",
      "['9737349', 'Cagnin A; Choiniere M; Bureau NJ; Durand M; Mezghani N; Gaudreault N; Hagemeister N. Effective conservative care targeting mechanical markers as risk factors for knee osteoarthritis progression: a cluster randomized controlled trial. Osteoarthritis and cartilage. (2019) 27 Supplement 1 ppS485', '10.1016/j.joca.2019.02.537', '']\n",
      "['9737351', 'Bi Y N; Xiao C H; Pan C; Zhao X F; Cao Y Y; Yuan Yi; Zuo F F. The correlation study on syndrome differentiation of rheumatoid arthritis and joint high frequency ultrasound performance. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2015) 35 1 pp19-24', '10.1088/1009-1963/15/3/023', '']\n",
      "['9737353', \"Shichikawa K; Aritomi H; Ogawa N. A double-blind multi-center clinical trial of benoxaprofen against indomethacin in rheumatoid arthritis (author's transl). Ryumachi. [Rheumatism]. (1982) 22 1 pp88-102\", '10.1093/rheumatology/21.2.101', 'http://academic.oup.com/rheumatology/article-pdf/21/2/101/5027114/21-2-101.pdf']\n",
      "['9737354', 'Yang J L. Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial. Zhonghua nei ke za zhi [Chinese journal of internal medicine]. (1993) 32 7 pp486-488', '10.1016/s0084-3873(09)79332-0', '']\n",
      "['9737356', \"IRCT20120215009014N310. The effect of topical ointment containing Berberis vulgaris' extract versus placebo on the severity morning stiffness and range of motion in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20120215009014N310. (2019)   pp\", '10.58532/v3bgpn20p3ch1', '']\n",
      "['9737360', 'Aringer M; Leuchten N; Dorner T. Biologicals and small molecules for systemic lupus erythematosus. Zeitschrift fur Rheumatologie. (2020) 79 3 pp232-240', '10.1007/s00393-020-00767-6', 'http://link.springer.com/article/10.1007/s00393-020-00767-6/fulltext.html']\n",
      "['9737361', 'NCT03770273. Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis. Https://clinicaltrials.gov/show/nct03770273. (2018)   pp', '10.1016/j.jaci.2024.12.180', '']\n",
      "['9737362', 'IRCT201311014105N16. Effect of CoQ10 on rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201311014105N16. (2013)   pp', '10.1186/isrctn01982076', '']\n",
      "['9737364', 'Lovell DJ; Ruperto N; Reiff A; Jung L; Jarosova K; Mouy R; Kone-Paut I; Jones OY; Vargova V; Wouters C; Galindo IL; Mak C; Brunner HI; Martini A. Long-term disease control among patients with juvenile idiopathic arthritis receiving adalimumab (humira) treatment for up to six years. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2633-2634', '10.1136/rmdopen-2020-001208', '']\n",
      "['9737366', 'IRCT2017011824080N10. Effect of Aromathrapy on Anxiety and Severity of Fatigue. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017011824080N10. (2017)   pp', '10.1186/isrctn02536681', '']\n",
      "['9737367', 'NCT03589833. Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA. Https://clinicaltrials.gov/show/nct03589833. (2018)   pp', '10.4268/cjcmm20161826', '']\n",
      "['9737369', 'Zhang Chi; Guan Daogang; Jiang Miao; Liang Chao; Li Li; Zhao Ning; Zha Qinglin; Zhang Wandong; Lu Cheng; Zhang Ge; Liu Jian; Lu Aiping. Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial. Chinese medicine. (2019) 14  pp26', '10.1186/s13020-019-0247-8', 'http://link.springer.com/article/10.1186/s13020-019-0247-8/fulltext.html']\n",
      "['9737371', 'NCT01770106. RA Denosumab on Bone Microstructure Study. https://clinicaltrials.gov/show/NCT01770106. (2013)   pp', '10.1038/nrrheum.2016.189', 'https://www.nature.com/articles/nrrheum.2016.189']\n",
      "['9737372', 'UMIN000000658. Effects of rebamipide on nonsteroidal anti-inflammatory drugs-induced small bowel injury. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000000658. (2007)   pp', '10.1186/isrctn50390099', '']\n",
      "['9737373', 'Buckley C; Campos JS; Zhdan V; Becker B; Chauhan D; Davy K; Hawkes C; Inman D; Layton M; Patel J; Saurigny D; Mitchell N; Williamson R; Tak PP. GSK3196165 an investigational anti-GM-CSF monoclonal antibody, improves patient reported outcomes in a phase IIb study of patients with rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp191', '10.1136/annrheumdis-2019-eular.6035', '']\n",
      "['9737375', 'Smolen JS; Weinblatt M; Emery P; Keystone E; Genovese M; Myung G; Hong E; Baek I; Lee S; Ghil J. A pooled analysis of three TNF-a inhibitor biosimilar studies in patients with rheumatoid arthritis comparing radiographic progression by disease activity states. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp319-320', '10.1136/annrheumdis-2018-eular.4382', '']\n",
      "['9737377', \"NCT04035668. A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sj√∂gren's Syndrome. Https://clinicaltrials.gov/show/nct04035668. (2019)   pp\", '10.31525/ct1-nct04035668', '']\n",
      "['9737378', \"NCT01552681. Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sj√∂gren's Syndrome. https://clinicaltrials.gov/show/NCT01552681. (2012)   pp\", '10.1007/springerreference_176989', '']\n",
      "['9737381', 'ISRCTN70707830. Norepinephrine-evoked pain in fibromyalgia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN70707830. (2002)   pp', '10.1186/isrctn70707830', '']\n",
      "['9737383', 'Dellhag B; Bjelle A. A grip ability test for use in rheumatology practice. Journal of rheumatology. (1995) 22 8 pp1559-1565', '10.1093/rheumatology/30.2.123', 'http://academic.oup.com/rheumatology/article-pdf/30/2/123/5029255/30-2-123.pdf']\n",
      "['9737384', '. A pooled analysis of 1-year clinical outcomes among 6-month responders and non-responders from three randomised controlled studies of TNF inhibitor biosimilars in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1153-1154', '10.1136/annrheumdis-2019-eular.6611', '']\n",
      "['9737385', 'van Mulligen E; Weel A E A M; Kuijper T M; Hazes J M W; van der Helm-van Mil A H M; de Jong P H P. The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients. Seminars in arthritis and rheumatism. (2020) 50 3 pp423-431', '10.1016/j.semarthrit.2020.02.011', '']\n",
      "['9737387', 'Boone N; Sepriano A; Janknegt R; Van Der Kuy H; Peeters R; Landewe R. RAPID3 is not longitudinally associated with DAS28-ESR in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1319', '10.1136/annrheumdis-2018-eular.6910', '']\n",
      "['9737389', 'Esbensen BA. Re-evaluate life when broken sleep has a negative effect on inflammatory arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp45', '10.1136/annrheumdis-2018-eular.7675', '']\n",
      "['9737390', '. Bone quality, and the combination and penetration of cement-bone interface a comparative micro-ct study of osteoarthritis and rheumatoid arthritis. Medicine (united states). (2018) 97 35 pp', '10.1097/md.0000000000011987', '']\n",
      "['9737392', 'Paul S; Marotte H; Kavanaugh A; Goupille P; Kvien TK; de Longueville M; Mulleman D; Sandborn WJ; Vande Casteele N. Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis. Clinical and translational science. (2020)   pp', '10.1111/cts.12760', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcts.12760']\n",
      "['9737393', 'UMIN000009442. A randomized, double-blind, sham-controlled study of static electric field therapy by high voltage alternating current for active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009442. (2012)   pp', '10.3164/jcbn.13-13', '']\n",
      "['9737394', 'Magorivska I; Donczo B; Dumych T; Karmash A; Boichuk M; Hychka K; Mihalj M; Szabo M; Csanky E; Rech J; Guttman A; Vari S G; Bilyy R. Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis. Autoimmunity. (2018) 51 3 pp111-117', '10.1080/08916934.2018.1468886', '']\n",
      "['9737395', 'ISRCTN61534918. Effect of Assistive Technology in patients with Hand OsteoArthritis: a randomised, controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN61534918. (2007)   pp', '10.1186/isrctn61534918', '']\n",
      "['9737396', \"ChiCTR-INR-17011220. The Efficacy and Safety of Low Dose IL-2Therapy in Chinese patients with primary Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-17011220. (2017)   pp\", '10.1097/01.ebp.0000541782.57094.fc', '']\n",
      "['9737397', 'NCT03644160. A Physiotherapist Led Intervention to Promote Physical Activity in Rheumatoid Arthritis - a Pilot Study. Https://clinicaltrials.gov/show/nct03644160. (2018)   pp', '10.22605/rrh8103', '']\n",
      "['9737398', 'IRCT2015072923394N1. Effects of Aerobic Exercise on Hematologic Indices of Women with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015072923394N1. (2015)   pp', '10.4103/1735-1995.177356', '']\n",
      "['9737399', 'NCT00658047. A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00658047. (2008)   pp', '10.1093/rheumatology/kex062.196', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.196/19705816/kex062.196.pdf']\n",
      "['9737400', 'Johansson Bjorn; Daniel Ana C S; Herbers Claudia; Gerl Matthias; Kretz Florian T A. Clinical safety and efficacy of a hydrophilic acrylic intraocular lens in a real-world population: a 1-year follow-up retro-prospective study. BMC ophthalmology. (2020) 20 1 pp224', '10.1186/s12886-020-01493-y', 'https://link.springer.com/article/10.1186/s12886-020-01493-y/fulltext.html']\n",
      "['9737401', 'Rzeszutek Marcin; Pieta Malgorzata; Huzar Marek. Profiles of resources and body image in health and illness: a comparative study among females with rheumatoid arthritis, females with breast cancer and healthy controls. Brain and behavior. (2020) 10 1 ppe01488', '10.1002/brb3.1488', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbrb3.1488']\n",
      "['9737403', 'Daniluk S; Ptaszynski R; Mueller-Ladner U; Petrikova A; Kellner H; Dokoupilova E; Kwiatkowska B; Alten R; Schwabe C; Rosenstock B; Doan T; Thiedmann R; Fleischer F; Hilbert J; Visvanathan S; Padula S; Steffgen J. Safety and efficacy of BI 655064, an antagonistic anti-CD40 antibody in rheumatoid arthritis (RA) patients. Annals of the rheumatic diseases. (2016) 75  pp718-', '10.1136/annrheumdis-2016-eular.1271', '']\n",
      "['9737404', 'IRCT201105146472N1. The effect of using peak flow meter based on asthma action plan on asthma control. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201105146472N1. (2011)   pp', '10.21019/ale.2000.73', '']\n",
      "['9737405', 'CTRI/2018/07/015081. Study to see the role of Kala Vasti of Rasnadashmoolakam and Saidhvadya Taila Brhat in Amavata (Rheumatoid Arthritis). http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/07/015081. (2018)   pp', '10.47070/ayushdhara.v7i5.626', 'https://ayushdhara.in/index.php/ayushdhara/article/download/626/518']\n",
      "['9737406', 'Tanaka Y; Soen S; Yamanaka H; Yoneda T; Tanaka S; Nitta T; Okubo N; Genant H; Van Der Heijde D; Takeuchi T. Beneficial effects of denosumab on bone loss and bone erosion from results of long-term treatment in the phase 3, desirable study in patients with rheumatoid arthritis (RA) on background csdmards. Journal of bone and mineral research. (2018) 33  pp90-', '10.1136/annrheumdis-2018-eular.2290', '']\n",
      "['9737408', 'EUCTR2016-002852-26-DE. MSB11022 in moderately to severely active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002852-26-DE. (2016)   pp', '10.1007/s10067-019-04679-y', 'http://link.springer.com/article/10.1007/s10067-019-04679-y/fulltext.html']\n",
      "['9737409', 'Ozcaka Ozgun; Alpoz Esin; Nalbantsoy Ayse; Karabulut Gonca; Kabasakal Yasemin. Clinical periodontal status and inflammatory cytokines in primary Sjogren syndrome and rheumatoid arthritis. Journal of periodontology. (2018) 89 8 pp959-965', '10.1002/jper.17-0730', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2FJPER.17-0730']\n",
      "['9737410', 'Musch A. B-cell targeted therapy in rheumatoid arthritis: a promising treatment concept?. Medizinische Monatsschrift fur Pharmazeuten. (2005) 28 12 pp422-425', '10.1007/978-0-387-36003-4_18', 'http://link.springer.com/content/pdf/10.1007/978-0-387-36003-4_18.pdf']\n",
      "['9737411', 'George B; Radhakrishnan EK; Upadhya IV; Aswathy KK; Vyshak; Kamaleshwaran KK; Shinto A. 117 Lu labeled hydroxyapetatite (117 Lu Ha) in radiosynovectomy. Indian journal of nuclear medicine. (2015) Conference: 47th Annual conference of the Society of Nuclear Medicine, SNMICON 2015. India. 30 5 Supplement 1 ppS65-S66', '10.4103/0972-3919.170229', '']\n",
      "['9737412', 'Adey-Wakeling Z; Crotty M; Shanahan E M. Suprascapular nerve block for shoulder pain in the first year after stroke: a randomised controlled trial. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS464', '10.1161/strokeaha.113.002471', '']\n",
      "['9737413', 'UMIN000036182. Combination effect of exercise instruction and biologics on rheumatoid arthritis patients. -a randomized controlled trial-. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000036182. (2019)   pp', '10.1186/isrctn18282428', '']\n",
      "['9737414', 'Hadinedoushan Hossein; Noorbakhsh Parisa; Soleymani-Salehabadi Hossein. Tumor Necrosis Factor Alpha Gene Polymorphism and Association With Its Serum Level in Iranian Population with Rheumatoid Arthritis. Archives of rheumatology. (2016) 31 4 pp306-313', '10.5606/archrheumatol.2016.5907', '']\n",
      "['9737416', 'Naqvi AA; Hassali MA; Naqvi SBS; Aftab MT. Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial. Trials. (2019) 20 1 pp', '10.1186/s13063-019-3540-z', 'http://link.springer.com/article/10.1186/s13063-019-3540-z/fulltext.html']\n",
      "['9737417', 'Berger Joseph R; Malik Vineeta; Lacey Stuart; Brunetta Paul; Lehane Patricia B. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event. Journal of neurovirology. (2018) 24 3 pp323-331', '10.1007/s13365-018-0615-7', 'http://link.springer.com/article/10.1007/s13365-018-0615-7/fulltext.html']\n",
      "['9737418', 'Tveter A; Nossum R; Mehl Eide R; Klokkeide A; Matre K; Olsen M; Andreassen O; Osteras N; Kjeken I. Map-hand-a reliable and valid tool measuring activity performance in patients with hand osteoarthritis. Osteoarthritis and cartilage. Conference: 2018 osteoarthritis research society international, OARSI world congress. United kingdom. (2018) 26 Supplement 1 ppS242', '10.1016/j.joca.2018.02.500', '']\n",
      "['9737419', 'ChiCTR-IPR-16008793. A multi center, randomized, double blind, positive parallel controlled clinical study of Zhengqing Fengtongning sustained release tablets in the treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-16008793. (2016)   pp', '10.1097/md.0000000000029199', '']\n",
      "['9737420', 'IRCT2013111715424N1. Effect of sesamin supplementation in rheumatoid arthritis women. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013111715424N1. (2014)   pp', '10.1080/07315724.2015.1005198', '']\n",
      "['9737421', 'Shao L. Observation of early diagnosis index value and the clinical therapeutic effect of rheumatoid arthritis. China modern medicine [zhong guo dang dai yi yao]. (2016) 23 27 pp72-75', '10.7861/clinmed.2020-0727', '']\n",
      "['9737422', \"Weini Xin; Chiu Man Leung K; Chin Man Lo E; Mo Yin Mok; Moon Ho Leung. A randomized, double-blind, placebo-controlled clinical trial of fluoride varnish in preventing dental caries of Sj√∂gren's syndrome patients. BMC oral health. (2016) 16  pp1-11\", '10.1186/s12903-016-0296-7', 'http://link.springer.com/article/10.1186/s12903-016-0296-7/fulltext.html']\n",
      "['9737423', 'UMIN000001240. The efficacy of tocilizumab to patients with rheumatoid arthritis refractory to anti-TNF agents: the open trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000001240. (2008)   pp', '10.1186/isrctn95363507', '']\n",
      "['9737424', 'Wang H D; Nian F H; Jin F M. ZuShiMa Plaster in Treating Wrist Joint Diseases of 40 Cases of Rheumatoid Arthritis of Cold-dampness Stagnation Pattern. Western journal of traditional chinese medicine [xi bu zhong yi yao]. (2016) 29 10 pp107-109', '10.1142/9789813145870_0042', '']\n",
      "['9737425', 'Alcocer-Castillejos Natasha; Jimenez-Gonzalez Ariadna; Hinojosa-Azaola Andrea. No Difference in Cognitive Dysfunction Among Patients with ANCA-Associated Vasculitis, Rheumatoid Arthritis or Chronic Kidney Disease. Journal of the International Neuropsychological Society : JINS. (2019) 25 6 pp595-602', '10.1017/s1355617719000262', '']\n",
      "['9737426', 'Roberts WN; Hayes CW; Breitbach SA; Owen Jr DS. Dry taps and what to do about them: a pictorial essay on failed arthrocentesis of the knee. American journal of medicine. (1996) 100 4 pp461-464', '10.1016/s0002-9343(97)89524-1', '']\n",
      "['9737427', 'ISRCTN11478835. Education programmes for people with arthritis: a comparative study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN11478835. (2003)   pp', '10.1186/isrctn65171899', '']\n",
      "['9737428', \"IRCT2017080335382N2. Comparison of two therapeutic approach in Kienbock's disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017080335382N2. (2017)   pp\", '10.53347/rid-54105', '']\n",
      "['9737429', 'Paget SA. Efficacy of anakinra in bone: comparison to other biologics. Advances in therapy. (2002) 19 1 pp27-39', '10.1007/bf02850016', 'http://link.springer.com/article/10.1007/BF02850016/fulltext.html']\n",
      "['9737430', 'Choi In Ah; Sagawa Akira; Lee Eun Young; Lee Eun Bong; Song Yeong Wook. Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study. Journal of Korean medical science. (2020) 35 22 ppe155', '10.3346/jkms.2020.35.e155', 'https://jkms.org/pdf/10.3346/jkms.2020.35.e155']\n",
      "['9737431', 'IRCT2017011026394N2. Study of Thyme essential oil effect on infection control of diabetic foot ulcers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017011026394N2. (2017)   pp', '10.1186/isrctn14126613', '']\n",
      "['9737432', \"IRCT2017081635382N4. Effect of autologous blood transfusion on the treatment of De Quervain's disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017081635382N4. (2017)   pp\", '10.1111/j.1537-2995.2011.03293.x', '']\n",
      "['9737433', 'CTRI/2017/12/011051. A clinical trial to study the effect of two drugs,seetarama vati(A Sri Lankan Traditional Drug)vatari guggulu in the management of Amavata(Rheumatoid Arthritis). http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/12/011051. (2017)   pp', '10.4103/ayu.ayu_65_18', '']\n",
      "['9737434', 'Faissner Simon; Gold Ralf. Oral Therapies for Multiple Sclerosis. Cold spring harbor perspectives in medicine. (2019) 9 1 pp', '10.1101/cshperspect.a032011', '']\n",
      "['9737435', 'Adami G; Viapiana O; Bogliolo L; Cantatore FP; Varenna M; Malavolta N; Del Puente A; Muratore M; Orsolini G; Gatti D; Rossini M. An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp555', '10.1136/annrheumdis-2018-eular.5235', '']\n",
      "['9737436', 'Asai S; Nagai K; Kojima T; Takahashi N; Ishiguro N. The effect of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp306-307', '10.1136/annrheumdis-2018-eular.1715', '']\n",
      "['9737439', 'ACTRN12612000347864. A pilot study to investigate the effects of nocturnal humidification on sleep apnea and sleep quality, in patients with Primary Sjogren‚Äôs Syndrome(pSS). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12612000347864. (2012)   pp', '10.1016/j.sleep.2023.11.938', '']\n",
      "['9737440', 'Sokal A; Elefant E; Leturcq T; Beghin D; Mariette X; Seror R. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study. Osteoporosis international. (2019) 30 1 pp221-229', '10.1007/s00198-018-4672-9', 'http://link.springer.com/article/10.1007/s00198-018-4672-9/fulltext.html']\n",
      "['9737441', 'Correa Monica G; Pires Paula Rodrigues; Ribeiro Fernanda Vieira; Pimentel Suzana Peres; Cirano Fabiano Ribeiro; Napimoga Marcelo Henrique; Casati Marcio Z; Casarin Renato Correa Viana. Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats. PloS one. (2018) 13 10 ppe0204414', '10.1371/journal.pone.0204414', '']\n",
      "['9737442', 'Shin K; Lee S-K; Oh S; Kim H-A; Song YW. Treatment response of intravenous tocilizumab in patients with rheumatoid arthritis based on the level of prior exposure to biologic therapy: results from the Kobio. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp954', '10.1136/annrheumdis-2018-eular.6111', '']\n",
      "['9737444', 'UMIN000015646. The safety and usability assessment of sunscreen agents (cosmetics) for light-sensitive patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000015646. (2014)   pp', '10.1186/isrctn41695172', '']\n",
      "['9737446', 'IRCT20181128041778N1. Effect of Mindfulness-based stress reduction and Cognitive behavior Therapy in Rheumatoid Arthritis Patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20181128041778N1. (2019)   pp', '10.3410/f.1093939.548879', '']\n",
      "['9737447', 'Corrado A; Mele A; Sanpaolo E; Trotta A; Colia R; Cantatore FP. Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp293', '10.1136/annrheumdis-2018-eular.2496', '']\n",
      "['9737448', 'UMIN000036091. Open-label randomized controlled trials on the superiority of ultrasonic instruments in peripheral vascular access procedures in apheresis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000036091. (2019)   pp', '10.4172/2327-5146-c1-002', '']\n",
      "['9737450', 'Yurtkuran M; Ay A; Bingol U; Altan L. Evaluation of the spa therapy in Ataturk Balneotherapy and Rehabilitation Center. Physikalische medizin rehabilitationsmedizin kurortmedizin. (2005) 15 6 pp345-354', '10.1055/s-2005-867055', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2005-867055.pdf']\n",
      "['9737451', 'EUCTR2011-000102-21-SK. Safety and efficacy of secukinumab compared to placebo and abatacept in patients with active rheumatoid arthritis who did not respond to anti-TNFa agents. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-000102-21-SK. (2011)   pp', '10.1186/isrctn29665463', '']\n",
      "['9737452', 'NCT04321291. Information and Acceptability of Biosimilars. https://clinicaltrials.gov/show/NCT04321291. (2020)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9737453', 'NCT04201886. Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis. https://clinicaltrials.gov/show/NCT04201886. (2019)   pp', '10.31525/ct1-nct04201886', '']\n",
      "['9737454', 'Kessler R. CBT added to medical management improved clinical outcomes in rheumatoid arthritis. Evidence based mental health. (2001)   pp89-89', '10.1136/ebmh.4.3.89', '']\n",
      "['9737457', 'NTR856. A randomized, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR856. (2006)   pp', '10.1186/isrctn49455679', '']\n",
      "['9737458', 'NCT00293826. A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00293826. (2006)   pp', '10.31525/ct1-nct04199351', '']\n",
      "['9737459', 'NCT04136262. Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT04136262. (2019)   pp', '10.31525/ct1-nct04136262', '']\n",
      "['9737460', 'Sirenko O; Kuryata O. Endothelial function, insulin resistance, adiponectin level in hypertensive females with rheumatoid arthritis and its correction with l-arginine aspartate. Cardiovascular research. Conference: 5th congress of the ESC council on basic cardiovascular science: frontiers in cardiovascular biology 2018. Austria. (2018) 114 Suppl  1 ppS75-S76', '10.1093/cvr/cvy060.211', 'http://academic.oup.com/cardiovascres/article-pdf/114/suppl_1/S75/24691942/cvy060.211.pdf']\n",
      "['9737461', 'Mueller RB; Spaeth M; von Restorff C; Ackermann C; Schulze-Koops H; von Kempis J. Superiority of a treat-to-target strategy over conventional treatment with fixed csDMARD and corticosteroids: a multi-center randomized controlled trial in ra patients with an inadequate response to conventional synthetic DMARDs, and new therapy with certolizumab pegol. Journal of clinical medicine. (2019) 8 3 pp', '10.3390/jcm8030302', '']\n",
      "['9737462', 'Roodenrijs NMT; De Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Hwang CC; Liu X; Sasso EH; Van Laar JM. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1317', '10.1136/annrheumdis-2018-eular.1981', '']\n",
      "['9737464', 'Matsuno Hiroaki; Matsubara Tsukasa. A randomized double-blind parallel-group phase III study to compare the efficacy and safety of NI-071 and infliximab reference product in Japanese patients with active rheumatoid arthritis refractory to methotrexate. Modern rheumatology. (2019) 29 6 pp919-927', '10.1080/14397595.2018.1533063', '']\n",
      "['9737465', 'Krishnan E; Zhang N; Wang H. Two-year consolidated safety data for ABP 501 in patients with moderate to severe rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp951', '10.1136/annrheumdis-2018-eular.6746', '']\n",
      "['9737466', 'Queen R M; Franck C T; Schmitt D; Adams S B. Are There Differences in Gait Mechanics in Patients With A Fixed Versus Mobile Bearing Total Ankle Arthroplasty? A Randomized Trial. Clinical orthopaedics and related research. (2017) 475 10 pp2599-2606', '10.1007/s11999-017-5405-7', 'http://link.springer.com/article/10.1007/s11999-017-5405-7/fulltext.html']\n",
      "['9737467', 'Tony H P; Schulze-Koops H; Kruger K; Cohen S B; Kivitz A J; Jeka S; Vereckei E; Cen L; Kollins D. Comparison of switching from the originator rituximab to the biosimilar rituximab GP2013 or re-treatment with the originator rituximab in patients with active rheumatoid arthritis: safety and immunogenicity results from a multicenter, randomized, double-blind study. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1002/acr.23771', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23771']\n",
      "['9737468', 'Swinson D R; Zlosnick J; Jackson L. Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis. Annals of the rheumatic diseases. (1981) 40 3 pp235-239', '10.1136/ard.40.3.235', '']\n",
      "['9737470', 'Zhang Qing-Zhong; Hu Xian-Yun; Yao Wen-Qin; Wan Xiao-Li; Liang Zi-Cong; Dang Rong-Min; Yang Zheng-Min; Xia Ya-Lan. Pharmacologic Effect of Miao Medicine Illicium simonsii Maxim. on Collagen-Induced Arthritis in Rats. Evidence-based complementary and alternative medicine : eCAM. (2018) 2018  pp2398379', '10.1155/2018/2398379', 'http://downloads.hindawi.com/journals/ecam/2018/2398379.pdf']\n",
      "['9737471', 'NCT02171143. A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate. https://clinicaltrials.gov/show/NCT02171143. (2014)   pp', '10.1186/isrctn67656669', '']\n",
      "['9737472', 'Haslock D I; Wright V. A corticosteroid sparing agent in rheumatoid arthritis. A trial of nandrolone decanoate (Deca Durabolin). Clinical trials journal. (1971) 8 4 pp31-34', '10.1530/acta.0.109s00019', 'https://eje.bioscientifica.com/view/journals/eje/110/3_Suppla/acta_109_Suppl_271_003.xml']\n",
      "['9737474', 'Hepburn AL; Pearson N; Darlington G; Chard MD; Pilley C; Wajed J; Melath S; Naing A; Lloyd M. Screening for diabetes and steroid-induced hyperglycaemia in patients with rheumatoid arthritis is done poorly. Rheumatology (united kingdom). Conference: 2018 annual conference of the british society for rheumatology. United kingdom. (2018) 57 Supplement 3 ppiii70-iii71', '10.1093/rheumatology/key075.304', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.304/24768081/key075.304.pdf']\n",
      "['9737475', 'Smucny J; Chai G. Are Selective COX-2 Inhibitors as Effective as NSAIDs in Patients with Rheumatoid Arthritis?. American family physician. (2004) 69 3 pp595-596', '10.1038/ncpgasthep0963', 'http://www.nature.com/articles/ncpgasthep0963']\n",
      "['9737476', 'EUCTR2012-000439-17-HU. A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Worldwide, Dose-Ranging Clinical Trial with a Proof-of-Concept Lead Cohort to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 + MTX in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-000439-17-HU. (2012)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9737477', 'NCT00475111. Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study). https://clinicaltrials.gov/show/NCT00475111. (2007)   pp', '10.4021/jmc1275w', '']\n",
      "['9737478', '. Sarilumab (Kevzara) for rheumatoid arthritis. Medical letter on drugs and therapeutics. (2017) 59 1527 pp134-138', '10.58347/tml.2024.1702c', '']\n",
      "['9737479', 'ChiCTR-IPR-15006107. The clinical trial of tolerance of Ginsenoside compound K. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15006107. (2015)   pp', '10.18810/chictr', '']\n",
      "['9737480', 'Stankovic D; Pavic Nikolic M; Antonic Zakojc A. Implementation of nurse led clinic in rheumatology department ljubljana, slovenia. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1847', '10.1136/annrheumdis-2018-eular.5206', '']\n",
      "['9737482', 'ISRCTN42881741. Conform and non conform glenoid components in total shoulder replacements. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN42881741. (2006)   pp', '10.1186/isrctn42881741', '']\n",
      "['9737483', 'Kumagai K; Harigane K; Kusayama Y; Tezuka T; Choe H; Inaba Y; Saito T. Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison. Osteoporosis international. (2018) 29 7 pp1637-1642', '10.1007/s00198-018-4494-9', 'http://link.springer.com/article/10.1007/s00198-018-4494-9/fulltext.html']\n",
      "['9737485', 'NCT03660059. A Study to Assess Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX). Https://clinicaltrials.gov/show/nct03660059. (2018)   pp', '10.1136/annrheumdis-2019-eular.2629', '']\n",
      "['9737486', 'Kondo Naoki; Fujisawa Junichi; Endo Naoto. Subcutaneous Tocilizumab Is Effective for Treatment of Elderly-Onset Rheumatoid Arthritis. Tohoku journal of experimental medicine. (2020) 251 1 pp9-18', '10.1620/tjem.251.9', '']\n",
      "['9737487', 'Wang Yinghao; Chen Zhihuang; Liu Chen; Lu Xuehua; Yang Ce; Qiu Songping. Distributive differences of P2Xs between the forelimb and hind limb of adjuvant arthritis rats and intervention by Notopterygh rhizoma et radix. Pharmaceutical biology. (2019) 57 1 pp82-89', '10.1080/13880209.2018.1561730', 'https://tandfonline.com/doi/pdf/10.1080/13880209.2018.1561730']\n",
      "['9737490', 'NCT03877315. Patient Reported Outcome After Stemmed Versus Stemless Total Shoulder Arthroplasty for Glenohumeral Osteoarthritis. Https://clinicaltrials.gov/show/nct03877315. (2019)   pp', '10.31525/ct1-nct03877315', '']\n",
      "['9737491', 'NCT00147498. Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks. https://clinicaltrials.gov/show/NCT00147498. (2005)   pp', '10.1016/s0016-5085(09)62818-3', '']\n",
      "['9737492', 'UMIN000013076. Analysis of pathogenic role of soluble immune semaphorin in autoimmune diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013076. (2014)   pp', '10.3109/08916938909019954', '']\n",
      "['9737493', 'Orlova E; Karateev D; Denisov L; Kochetkov A; Nasonov E. 12-month complex rehabilitation program for rheumatoid arthritis patients receiving biologic dmards. Annals of the rheumatic diseases. (2016) 75  pp893-', '10.1136/annrheumdis-2016-eular.5365', '']\n",
      "['9737494', 'NCT01712399. A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01712399. (2012)   pp', '10.1097/01.tpm.0000418562.99372.00', '']\n",
      "['9737495', 'Garces K. Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis. Issues in emerging health technologies. (2001) 16  pp1-4', '10.1186/isrctn15819795', '']\n",
      "['9737497', 'Hadidi T; Phillis M Z; El-Ghobarey A F. Double blind cross-over study of large doses of ketoprofen and indomethacin in rheumatoid arthritis. Rhumatologie - revue international de rhumatologie. (1976) 6 3 pp219-222', '10.1185/03007997609111999', '']\n",
      "['9737498', 'Boers M; Nurmohamed M T; Doelman C J A; Lard L R; Verhoeven A C; Voskuyl A E; Huizinga T W J; Van De Stadt; R J; Dijkmans B A C; Van Der Linden; Sj. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2003) 62 9 pp842-845', '10.1136/ard.62.9.842', '']\n",
      "['9737499', 'ACTRN12609000435280. Is a Patented Strain of Bacillus coagulans Probiotic a Viable Adjunct Therapy for Relieving Symptoms of Rheumatoid Arthritis?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12609000435280. (2009)   pp', '10.1186/1472-6882-10-1', 'http://link.springer.com/article/10.1186/1472-6882-10-1/fulltext.html']\n",
      "['9737500', 'Kelesoglu Dincer AB; Aydemir Guloksuz EG; Torgutalp M; Yayla ME; Uslu Yurteri E; Sezer S; Okatan IE; Kinikli G; Turgay TM; Ates A. IL-33, a novel cytokine for FMF? How is it related with disease pathogenesis?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1671', '10.1136/annrheumdis-2018-eular.5080', '']\n",
      "['9737503', 'Strand V; Ghandehari H; Swearingen C; Tambiah J. Assessment of health-related quality of life in a 52-week, phase 2, randomized, controlled trial of a novel, intra-articular, WNT pathway inhibitor (SM04690) for treatment of knee osteoarthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1495-1496', '10.1136/annrheumdis-2018-eular.5547', '']\n",
      "['9737504', 'KCT0000564. A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Diseasemodifying Antirheumatic Drug Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=KCT0000564. (2012)   pp', '10.1136/annrheumdis-2014-eular.2404', '']\n",
      "['9737505', 'Shilkina N P; Spirin N N; Yunonin I E; Vinogradov A A. Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (2019) 119 3. Vyp. 2 pp68-75', '10.17116/jnevro201911903268', '']\n",
      "['9737506', 'Hasan SS; Schwindel LE; Fleckenstein C. Outcomes of prosthetic shoulder arthroplasty in patients forty years old or less. Arthroscopy - journal of arthroscopic and related surgery. (2017) Conference: 11th Biennial Congress of the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine. China. 33 10 Supplement 1 ppe159-e160', '10.1016/j.arthro.2017.08.204', '']\n",
      "['9737508', 'NCT04143230. Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool. https://clinicaltrials.gov/show/NCT04143230. (2019)   pp', '10.31525/ct1-nct04143230', '']\n",
      "['9737509', 'ISRCTN39262348. Effects of gustatory stimulants of salivary secretion on the pH and stimulation of saliva of Sj√∂gren?s syndrome patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN39262348. (2010)   pp', '10.1186/isrctn39262348', '']\n",
      "['9737510', 'Kirkham B; Chaabo K; Hall C; Garrood T; Mant T; Allen E; Vincent A; Vasconcelos JC; Prevost AT; Panayi GS; Corrigall VM. Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis. Rheumatology. (2016) 55 11 pp1993-2000', '10.1093/rheumatology/kew287', 'http://academic.oup.com/rheumatology/article-pdf/55/11/1993/18096769/kew287.pdf']\n",
      "['9737515', 'Taylor-Gjevre Regina; Nair Bindu; Bath Brenna; Okpalauwaekwe Udoka; Sharma Meenu; Penz Erika; Trask Catherine; Stewart Samuel Alan. Addressing rural and remote access disparities for patients with inflammatory arthritis through video-conferencing and innovative inter-professional care models. Musculoskeletal care. (2018) 16 1 pp90-95', '10.1002/msc.1215', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1215']\n",
      "['9737517', 'Iijima K. Rituximab for childhood refractory nephrotic syndrome. Pediatrics international. (2011) 53 5 pp617-621', '10.1111/j.1442-200x.2011.03432.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1442-200X.2011.03432.x']\n",
      "['9737518', 'Vakharia Ajit M; Cohen-Levy Wayne B; Vakharia Rushabh M; Sodhi Nipun; Mont Michael A; Roche Martin W. Perioperative Complications in Patients with Rheumatoid Arthritis Following Primary Total Knee Arthroplasty: an Analysis of 102,898 Patients. Journal of knee surgery. (2019) 32 11 pp1075-1080', '10.1055/s-0039-1692397', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0039-1692397.pdf']\n",
      "['9737519', 'Zhang W; Li H L. The effect comparison between long-snake-like moxibustion and warming acupuncture treating rheumatoid arthritis. Journal of jiangxi university of traditional chinese medicine [jiang xi zhong yi yao da xue xue bao]. (2016) 28 6 pp51-54', '10.37766/inplasy2021.8.0106', '']\n",
      "['9737520', 'Gjertsson I; Nilsson J; Andersson M; Leu Agelii M. The influence of age and sex on the progression of rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp278', '10.1136/annrheumdis-2018-eular.5390', '']\n",
      "['9737521', 'Gkizas C; Astrakas L; Zikou A; Kaltsonoudis E; Voulgari P; Argyropoulou M. Microstructural changes of the brain under anti-TNFa treatment for rheumatoid arthritis: histogram analysis of grey and white matter DTI metrics. Neuroradiology. (2019) Conference: 42nd Annual Meeting of the European Society of Neuroradiology - Diagnostic and Interventional, ESNR 2019. Norway. 61 1 ppS96-S97', '10.3174/ajnr.a3756', '']\n",
      "['9737522', 'NTR1210. Exploratory trial on intra-articular etanercept treatment in inflammatory arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1210. (2008)   pp', '10.1186/isrctn97686858', '']\n",
      "['9737523', 'Bouman Chantal A M; Tweehuysen Lieke; Haverkort Dieneke; van den Ende Cornelia H; van der Maas Aatke; den Broeder Alfons A. Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort study. Rheumatology advances in practice. (2018) 2 1 pprky008', '10.1093/rap/rky008', 'http://academic.oup.com/rheumap/article-pdf/2/1/rky008/28865981/rky008.pdf']\n",
      "['9737524', 'NCT02397798. Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study. https://clinicaltrials.gov/show/NCT02397798. (2015)   pp', '10.1186/isrctn28793839', '']\n",
      "['9737525', 'NCT03953261. Effect of Curcumin on Systemic Lupus Erythematosus. Https://clinicaltrials.gov/show/nct03953261. (2019)   pp', '10.31525/ct1-nct03953261', '']\n",
      "['9737526', '. A pooled analysis of 1-year clinical outcomes among 6-month responders and non-responders from three randomised controlled studies of TNF inhibitor biosimilars in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1153-1154', '10.1136/annrheumdis-2019-eular.6611', '']\n",
      "['9737530', 'Tam J; Lacaille D; Liu-Ambrose T; Shaw C; Xie H; Backman CL; Esdaile JM; Miller K; Petrella R; Li LC. Effectiveness of an online self-management tool, OPERAS (an On-demand Program to EmpoweR Active Self-management), for people with rheumatoid arthritis: a research protocol. Trials. (2019) 20 1 pp', '10.1186/s13063-019-3851-0', 'http://link.springer.com/article/10.1186/s13063-019-3851-0/fulltext.html']\n",
      "['9737531', 'NCT02986139. Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis. https://clinicaltrials.gov/show/NCT02986139. (2016)   pp', '10.1007/s40744-019-0152-8', 'https://link.springer.com/article/10.1007/s40744-019-0152-8/fulltext.html']\n",
      "['9737532', 'EUCTR2004-001909-10-GB. Effect of Rosuvastatin on surrogate markers for cardiovascular events and joint disease progression in patients with rheumatoid arthritis - RORA trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-001909-10-GB. (2005)   pp', '10.1186/isrctn41829447', '']\n",
      "['9737534', 'McBain H; Newman S; Shipley M; Olaleye A; Moore S. Experiences of a patient‚Äêinitiated self‚Äêmonitoring service in inflammatory arthritis: a qualitative exploration. Musculoskeletal care. (2018) 16 2 pp278-286', '10.1002/msc.1232', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1232']\n",
      "['9737535', 'Kon Y; Katayama K; Okubo T; Sato T; Fukai R; Abe S; Ito H; Ichikawa S; Kamishima T. Long-term inhibition of radiographic joint damage by tofacitinib monotherapy in rheumatoid arthritis patients with rapid radiographic progression about eight cases. Modern rheumatology case reports. (2017) 1 2 pp35-42', '10.1080/24725625.2017.1292867', '']\n",
      "['9737536', 'Song Jason Jungsik; Song Yeong Wook; Bae Sang Cheol; Cha Hoon-Suk; Choe Jung-Yoon; Choi Sung Jae; Kim Hyun Ah; Kim Jinseok; Kim Sung-Soo; Lee Choong-Ki; Lee Jisoo; Lee Sang-Heon; Lee Shin-Seok; Lee Soo-Kon; Lee Sung Won; Park Sung-Hwan; Park Won; Shim Seung Cheol; Suh Chang-Hee; Yoo Bin; Yoo Dae-Hyun; Yoo Wan-Hee. Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: result of a Multicenter Trial in Korea. Journal of Korean medical science. (2018) 33 52 ppe346', '10.1109/imw.2012.6213659', '']\n",
      "['9737537', 'Braun J; Krause D. Structured Delegation of Physician Services as Part of a Concept Based Cooperation for the Management of Inflammatory Rheumatic Diseases. Aktuelle rheumatologie. (2018) 43 5 pp410-411', '10.1055/a-0732-4823', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0732-4823.pdf']\n",
      "['9737538', 'Zhang AD; Kavanaugh A. Treat-to-Target in Psoriatic Arthritis. Rheumatic disease clinics of north america. (2019)   pp', '10.1016/j.rdc.2019.07.002', '']\n",
      "['9737541', 'Mertens Marty; Singh Jasvinder A. Anakinra for rheumatoid arthritis: a systematic review. Journal of rheumatology. (2009) 36 6 pp1118-1125', '10.3899/jrheum.090074', '']\n",
      "['9737542', 'ACTRN12617001223325. A Phase II Trial of Safety, Tolerability and Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617001223325. (2017)   pp', '10.1186/isrctn15169433', '']\n",
      "['9737543', 'Leroi Hermine; Badot Valerie; De Keyser Filip; Devinck Mieke; Geusens Piet; Kleimberg Sandra; Swinnen Carine; Roggeman Chantal. Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases. Rheumatology and therapy. (2020) 7 2 pp401-413', '10.1007/s40744-020-00210-x', 'https://link.springer.com/article/10.1007/s40744-020-00210-x/fulltext.html']\n",
      "['9737544', 'Garrood T; Scott DL. Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis. BioDrugs. (2001) 15 8 pp543-561', '10.2165/00063030-200115080-00006', '']\n",
      "['9737546', 'Shennak Mustafa; Al-Jaouni Rana; Kshirasagar Santhosh; Kasibhatta Ravi Sekhar; Godse Neelima; Al-Ghazawi Ahmad; Vittala Praveen; Bakhle Dhananjay. An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects. European journal of drug metabolism and pharmacokinetics. (2020)   pp', '10.1007/s13318-020-00613-9', 'http://link.springer.com/article/10.1007/s13318-020-00613-9/fulltext.html']\n",
      "['9737547', 'EUCTR2008-004754-33-SK. A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BG00012 when given with Methotrexate to Subjects with Active Rheumatoid Arthritis who have had an Inadequate Response to Coventional Disease-Modifying Anti-rheumatic Drug Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-004754-33-SK. (2008)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9737548', 'EUCTR2008-006075-75-HU. A Phase IIa, Multi-Centre, Randomized, Double-Blind, Two-Part, Controlled, Repeated-Dose Study of AK106-001616 in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006075-75-HU. (2009)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9737549', 'Ernst E. On: bernateck M, Becker M, Schwake C, Hoy L, Passie T, Parlesak A, Fischer MJ, Fink M, Karst M: adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Forsch Komplementmed 2008;15: 187-193. Forschende Komplementarmedizin (2006). (2008) 15 5 pp286-286', '10.1159/000141929', '']\n",
      "['9737550', 'UMIN000026819. A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000026819. (2017)   pp', '10.31525/ct1-nct03988231', '']\n",
      "['9737551', 'Watanabe K; Ishibe A; Watanabe J; Ota M; Fujii S; Ichikawa Y; Oba MS; Endo I. The effect of TJ-28 (Eppikajutsuto) on the prevention of hand-foot syndrome using Capecitabine for colorectal cancer: the Yokohama Clinical Oncology Group Study (YCOG1102). Indian journal of gastroenterology. (2020)   pp', '10.1007/s12664-020-01039-6', 'https://link.springer.com/article/10.1007/s12664-020-01039-6/fulltext.html']\n",
      "['9737554', 'CTRI/2018/09/015820. A effect of classical Ayurvedic treatments in patients with Psoriatic Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/09/015820. (2018)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9737557', 'Wronski Jakub; Fiedor Piotr; Gluszko Piotr. Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study. International journal of clinical pharmacy. (2019) 41 4 pp864-871', '10.1007/s11096-019-00859-7', 'http://link.springer.com/article/10.1007/s11096-019-00859-7/fulltext.html']\n",
      "['9737558', 'Rice Danielle B; Mehta Swati; Serrato Jonathan; Pope Janet E; Harth Manfred; Sequeira Keith; Morley-Forster Pat; Shapiro Allan P; Teasell Robert W. Stress in patients diagnosed with rheumatoid arthritis compared to chronic pain. Rehabilitation psychology. (2017) 62 4 pp571-579', '10.1037/rep0000103', 'http://psycnet.apa.org/journals/rep/62/4/571.pdf']\n",
      "['9737559', 'McCabe C J; Akehurst R L; Kirsch J; Whitfield M; Backhouse M; Woolf A D; Scott D L; Emery P; Haslock I. Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis: the impact on costs and outcomes in the UK. PharmacoEconomics. (1998) 14 2 pp191-199', '10.2165/00019053-199814020-00007', '']\n",
      "['9737560', 'Kim So Young; Min Chanyang; Oh Dong Jun; Choi Hyo Geun. Increased risk of asthma in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort. Scientific reports. (2019) 9 1 pp6957', '10.1038/s41598-019-43481-3', 'https://www.nature.com/articles/s41598-019-43481-3']\n",
      "['9737561', \"Jagpal Aprajita; O'Beirne Ronan; Morris Melanie S; Johnson Bernadette; Willig James; Yun Huifeng; Cherrington Andrea L; Fraenkel Liana; Curtis Jeffrey R; Safford Monika M; Navarro-Millan Iris. Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?. BMC rheumatology. (2019) 3  pp36\", '10.1186/s41927-019-0087-2', 'http://link.springer.com/article/10.1186/s41927-019-0087-2/fulltext.html']\n",
      "['9737563', 'NCT00319423. Exercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. a RCT. https://clinicaltrials.gov/show/NCT00319423. (2006)   pp', '10.1016/j.joca.2020.11.001', '']\n",
      "['9737565', 'IRCT201206094105N8. The effect of coenzyme Q10 on serum concentrations of adipokines and Malondialdehyde in non-alcoholic fatty liver disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201206094105N8. (2013)   pp', '10.21275/sr23616141539', '']\n",
      "['9737566', 'NCT01172327. Self-Directed Exercise Program for Adults With Arthritis. https://clinicaltrials.gov/show/NCT01172327. (2010)   pp', '10.1016/j.evalprogplan.2016.11.002', '']\n",
      "['9737567', 'Huo Y; Veldhuizen RD; van der Heijde D; Besselink NJ; Jacobs JW; van Laar JM; Viergever MA; Vincken KL; Lafeber FP; de Hair MJH. Automated joint space width quantification of hand and wrist joints: a proof of concept study. Clinical and experimental rheumatology. (2016) 34 pp 34-39 pp34-39', '10.1109/tbme.2017.2659223', '']\n",
      "['9737568', 'Fernandez-Diaz C; Loricera J; Castaneda S; Juan-Mas A; Carrasco-Cubero C; Casafont-Sole I; Almodovar R; Alvarez-Rivas N; Cros CA; Villa-Blanco I; Ordonez S; Romero-Yuste S; Ojeda-Garcia C; Hernandez-Rodriguez I; Lopez-Corbeto M; Lasanta ML; Ortiz-Sanjuan F; Alvarez-Rodriguez B; Ruibal-Escribano A; Exposito R; Retuerto-Guerrero M; Sandoval TP; Robles AL; Carreira P; Mena-Vazquez N; Urruticoechea-Arana A; Delgado-Beltran C; Sanchez JLA; Olive A; Rodriguez-Muguruza S; Bernal-Vidal JA; Perez ECC; Maiz-Alonso O; Castellanos-Moreira R; Rodiguez-Garcia S; Cabezas-Rodriguez I; Moreno M; Castellvi I; Rodriguez LMA; Gomez CG-M; Garcia-Magallon B; Salgado-Perez E; Rodiguez-Gomez M; Fito-Manteca C; Blanco JM; Sanchez DP; Vela-Casasempere P; Bonilla G; Lopez-Sanchez R; Fernandez-Melon J; Hidalgo C; Gonzalez-Gay MA; Blanco R. Abatacept in rheumatoid arthritis with interstitial lung disease. a multicentre study of 181 patients. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1617-1618', '10.1136/annrheumdis-2019-eular.6091', '']\n",
      "['9737569', \"NCT00363350. Rituximab Treatment in Sjogren's Syndrome. https://clinicaltrials.gov/show/NCT00363350. (2006)   pp\", '10.1097/01.rhu.0000226623.35553.b2', '']\n",
      "['9737570', 'Torrente-Segarra V; Bergstra S A; Solomon-Escoto K; Da Silva Jap; Veale D J; Al-Emadi S; Huizinga Twj. Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?. Scandinavian journal of rheumatology. (2018) 47 5 pp360-363', '10.1080/03009742.2017.1418423', '']\n",
      "['9737572', \"Danila MI; Chen L; Owensby JK; O'Beirne R; Melnick JA; Ruderman EM; Harrold LR; Curtis JR. Mitigating medication risk aversion in the confident treatment decisions for living with rheumatoid arthritis trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2149-2150\", '10.1136/annrheumdis-2019-eular.4292', '']\n",
      "['9737573', 'IRCT201511015623N58. Effect of supplementation in treatment of patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201511015623N58. (2015)   pp', '10.1186/isrctn22788282', '']\n",
      "['9737574', \"Keshav S; Goh J; Hart A; Levison S; McLaughlin S; Van Der Aa A; Galien R; Pan Y; Meuleners L; Jamoul C; Tasset C; Harrison P; Vermeire S. Filgotinib, a selective JAK1 inhibitor, induces clinical remission and a reduction in PSTAT3 levels in patients with active Crohn's disease: results from the phase II fitzroy study. Gut. (2017) 66 (Supplement 2) Supplement 2 ppA25\", '10.1055/s-0037-1604799', '']\n",
      "['9737575', 'Viana de Queiroz; Beaulieu A; Kruger K; Woods E; Stead H; Geis S. Double blind comparison of the efficacy of diclofenac/misoprostol and diclofenac in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1994) 14 2 pp5-13', '10.3109/03009749209095074', '']\n",
      "['9737577', 'EUCTR2017-000355-46-PL. Randomized, Blinded Trial to compare a Single Injection of Cingal¬Æ (Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide) with Cross-Linked Sodium Hyaluronate alone and with Triamcinolone Hexacetonide alone for Providing Symptomatic Relief of Osteoarthritis of the Knee. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-000355-46-PL. (2017)   pp', '10.1177/1947603517703732', 'https://journals.sagepub.com/doi/pdf/10.1177/1947603517703732']\n",
      "['9737578', 'NCT02167139. A Study Comparing SB5 to Humira¬¨√Ü in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy. https://clinicaltrials.gov/show/NCT02167139. (2014)   pp', '10.1136/annrheumdis-2016-eular.2021', '']\n",
      "['9737579', 'Ogata Medel M; Lozada Mellado M; Garcia Morales JM; Hinojosa Azaola A; Morales Herrero N; Llorente L; Alcocer Varela J; Pineda Juarez JA; Cervantes Gaytan R; Castillo Martinez L. Effect of a dynamic exercise program in combination with a mediterranean diet in weight and handgrip strength in women with rheumatoid arthritis. Clinical and experimental rheumatology. Conference: 17th mediterranean congress of rheumatology. Italy. (2018) 36 Supplement 109 ppS78', '10.1097/rhu.0000000000001064', '']\n",
      "['9737580', 'NCT03781310. Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03781310. (2018)   pp', '10.55563/clinexprheumatol/xn5i2y', '']\n",
      "['9737582', 'ISRCTN87502236. The effects of SCH 351125 on mononuclear cell trafficking to joints, synovial inflammation and expression of chemokines in subjects with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN87502236. (2007)   pp', '10.1186/isrctn87502236', '']\n",
      "['9737583', 'KCT0001516. Efficacy and safety of Korean Red Ginseng for Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=KCT0001516. (2015)   pp', '10.1186/isrctn13331870', '']\n",
      "['9737585', \"Fernandez Diaz; Blanco R; Calvo-Rio V; Loricera J; Sanchez-Burson J; Ortego N; Garcia-Serrano J L; Cordero-Coma M; Vazquez J; Beltran E; Valls Pascual; Maiz O; Blanco A; Torre I; Garcia-Aparicio A; Toyos J; Hernandez-Grafella M; Martinez-Costa L. Adalimumab optimization in behcet's syndrome refractory uveitis once obtained remission. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp396-397\", '10.1136/annrheumdis-2016-eular.3668', '']\n",
      "['9737586', \"Inamo J. Response to: 'Causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Lee. Annals of the rheumatic diseases. (2020)   pp\", '10.1136/annrheumdis-2019-216767', '']\n",
      "['9737587', 'Bergstra SA; Van Der Pol JA; Riyazi N; Goekoop-Ruiterman YP; Chopra A; Da Silva JAP; Kerstens PJSM; Lems WF; Tsonaka S; Huizinga TWJ; Allaart CF. Window or no window? earlier is better when treating rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2732-2733', '10.1136/annrheumdis-2018-eular.1743', '']\n",
      "['9737588', 'Brohawn P Z; Streicher K; Higgs B W; Morehouse C; Liu H; Illei G; Ranade K. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures. Lupus. (2019) 28 13 pp1524-1533', '10.1177/0961203319885447', 'https://journals.sagepub.com/doi/pdf/10.1177/0961203319885447']\n",
      "['9737589', 'Martinez-Morillo M; Prior-Espanol A; Brandy-Garcia A; Holgado S; Aparicio-Espinar M; Gifre L; Riveros-Frutos A; Sanguesa-Gomez C; Camins-Fabregas J; Casafont-Sole I; Nack A; Olive A; Soria LM. Comparison between different disease activity scores in elderly onset rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1592', '10.1136/annrheumdis-2019-eular.3453', '']\n",
      "['9737590', 'ChiCTR1900024902. A randomized, double-blind, prospective, controlled trial for Yishen-Tongbi-Tang in the treatment of active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900024902. (2019)   pp', '10.3389/fphar.2024.1320578', '']\n",
      "['9737591', 'Nordberg LB; Lillegraven S; Aga A-B; Sexton J; Lie E; Hammer HB; Olsen IC; Uhlig T; Van Der Heijde D; Kvien TK; Haavardsholm EA. Ultrasound power doppler activity predicts clinical joint swelling in early rheumatoid arthritis patients: secondary analyses from the arctic trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp126-127', '10.1136/annrheumdis-2018-eular.5318', '']\n",
      "['9737592', 'Berkhout Lea C; Vogelzang Erik H; Hart Margreet M; Loeff Floris C; Dijk Lisanne; Derksen Ninotska I L; Wieringa Roeland; van Leeuwen W Astrid; Krieckaert Charlotte L M; de Vries Annick; Nurmohamed Michael T; Wolbink Gerrit J; Rispens Theo. The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation. Clinical and experimental rheumatology. (2020) 38 2 pp306-313', '10.55563/clinexprheumatol/nlr4r8', '']\n",
      "['9737593', 'ChiCTR-IOR-17011552. The effect of pre-conception periodontal treatment on decreasing adverse pregnancy and birth outcomes and pathogenic mechanism. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-17011552. (2017)   pp', '10.1186/1471-2393-13-228', 'http://link.springer.com/article/10.1186/1471-2393-13-228/fulltext.html']\n",
      "['9737595', \"UMIN000014886. Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki University. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014886. (2014)   pp\", '10.1186/isrctn52833273', '']\n",
      "['9737596', 'Jiang M; Lu C; Chen G; Xiao C; Zha Q; Niu X; Chen S; Lu A. Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evidence-based complementary and alternative medicine. (2012) 2012  pp129452', '10.1155/2012/129452', 'http://downloads.hindawi.com/journals/ecam/2012/129452.pdf']\n",
      "['9737597', \"ChiCTR-IPR-16009933. Optimization and popularization of ILD rehabilitation exercises for patients with primary Sjogren's syndrome complicated with interstitial lung disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-16009933. (2016)   pp\", '10.1016/j.physio.2018.11.270', '']\n",
      "['9737598', 'NCT00035334. Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis. https://clinicaltrials.gov/show/NCT00035334. (2002)   pp', '10.1007/978-1-60761-631-3_13', '']\n",
      "['9737600', 'Weinblatt M; Baranauskaite A; Niebrzydowski J; Dokoupilova E; Zielinska A; Sitek-Ziolkowska K; Jaworski J; Racewicz A; Pileckyte M; Jedrychowicz-Rosiak K; Zhdan V; Cheong SY; Ghil J. Sustained efficacy and comparable safety and immunogenicity after transition to SB5 (an adalimumab biosimilar) vs continuation of the adalimumab reference product in patients with rheumatoid arthritis: result of phase III study. Annals of the rheumatic diseases. (2016) 75  pp487-', '10.1136/annrheumdis-2016-eular.1762', '']\n",
      "['9737601', 'Cannon G W; Pincus S H; Emkey R D; Denes A; Cohen S A; Wolfe F; Saway P A; Jaffer A M; Weaver A L; Cogen L; Schindler J D. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (2008) 58 2 Suppl ppS79-88', '10.1002/anr.1780320805', '']\n",
      "['9737602', 'Nakayama H. Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis. Nippon rinsho. Japanese journal of clinical medicine. (2007) 65 Suppl 9  pp499-503', '10.1097/rhu.0b013e31819b65bd', '']\n",
      "['9737604', 'Kavanaugh Arthur; Singh Rakesh; Karki Chitra; Etzel Carol J; Kremer Joel M; Greenberg Jeffrey D; Griffith Jenny. Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis. Clinical rheumatology. (2018) 37 8 pp2275-2280', '10.1007/s10067-018-4140-0', 'http://link.springer.com/article/10.1007/s10067-018-4140-0/fulltext.html']\n",
      "['9737605', 'Singh Jasvinder A; Tornberg Haley; Goodman Susan M. Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA). Joint, bone, spine. (2020) 87 4 pp307-313', '10.1016/j.jbspin.2020.02.009', '']\n",
      "['9737606', 'EUCTR2016-002862-30-PL. A medical research study to evaluate the safety and effectiveness of an investigational medication for rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002862-30-PL. (2017)   pp', '10.31525/ct1-nct04163991', '']\n",
      "['9737607', 'IRCT2014030316819N1. Effect of Restricted Calorie diet  in sciatic pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014030316819N1. (2014)   pp', '10.2337/db23-111-or', 'https://diabetesjournals.org/diabetes/article/72/Supplement_1/111-OR/150944/111-OR-Effect-of-Dulaglutide-plus-Calorie']\n",
      "['9737609', 'EUCTR2009-017306-36-NL. ANTI-IGE THERAPY (OMALIZUMAB) IN IGE-ACPA POSITIVE RA. - TIGER. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-017306-36-NL. (2010)   pp', '10.1201/9780203909003.ch13', '']\n",
      "['9737611', 'NCT01560455. European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions. https://clinicaltrials.gov/show/NCT01560455. (2011)   pp', '10.1002/ccd.25849', '']\n",
      "['9737612', 'Glintborg B; Lindstrom U; Di Giuseppe D; Askling J; Nordstrom D; Provan SA; Gudbjornsson B; Hetland ML; Aaltonen K; Geirsson AJ; Krogh NS; Jacobsson LTH. Similar one-year treatment retention of originator and biosimilar etanercept. Results of a nordic collaboration including 1015 patients with spondyloarthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp196-197', '10.1136/annrheumdis-2019-eular.995', '']\n",
      "['9737613', 'Nowotny J; El-Zayat B; Goronzy J; Biewener A; Bausenhart F; Greiner S; Kasten P. Prospective randomized controlled trial in the treatment of lateral epicondylitis with a new dynamic wrist orthosis 11 Medical and Health Sciences 1103 Clinical Sciences. European journal of medical research. (2018) 23 1) (no pagination pp', '10.1186/s40001-018-0342-9', 'http://link.springer.com/article/10.1186/s40001-018-0342-9/fulltext.html']\n",
      "['9737614', 'Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease P; Eder L; Strand V; Elmamoun M; Hojgaard P; Campbell I; Chau J; DeWit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai A-M. Content and face validity and feasibility of five candidate instruments for psoriatic arthritis randomised controlled trials: results from the psa omeract core set workshop at the grappa 2017 annual meeting. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1040-1041', '10.1136/annrheumdis-2018-eular.1906', '']\n",
      "['9737615', 'Santos Isabel; Cantista Pedro; Vasconcelos Carlos; Amado Joao. Balneotherapy and Rheumatoid Arthritis: a Randomized Control Trial. Israel Medical Association journal. (2016) 18 8 pp474-478', '10.1007/s00484-015-1108-5', 'http://link.springer.com/article/10.1007/s00484-015-1108-5/fulltext.html']\n",
      "['9737616', 'Song Meiyan; Li Fen; Xie Xi; Chen Jian; Tang Mengshi; Tian Jing; Du Jinfeng; Ge Yan; Li Shu; Xu Suqing. Association of short-term efficacy for infliximab in rheumatoid arthritis with plasma concentration and anti-drug antibody. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University. Medical sciences]. (2018) 43 9 pp982-986', '10.5353/th_b4836871', '']\n",
      "['9737618', 'Trieu Thomas; Sajjadi Seyed Ahmad; Kawas Claudia H; Nelson Peter T; Corrada Maria M. Risk factors of hippocampal sclerosis in the oldest old: the 90+ Study. Neurology. (2018) 91 19 ppe1788-e1798', '10.1212/wnl.0000000000006455', '']\n",
      "['9737619', 'IRCT138901263719N1. Effects of ?3-fatty acid supplement on blood vascular and systemic inflammation markers, oxidative stress , hematologic indices and Lp(a)  in hemodialysis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138901263719N1. (1900)   pp', '10.1159/000329727', 'https://www.karger.com/Article/Pdf/329727']\n",
      "['9737621', 'UMIN000020663. A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000020663. (2016)   pp', '10.1016/j.obmed.2024.100578', '']\n",
      "['9737622', \"Delbarre F; Le Go; Menkes C; Aignan M. Double blind statistical study of therapeutic effect of a radioactivy yttrium (90Y) charged colloid on rheumatoid arthritis of the knee. Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D. (1974) 279 12 pp1051-1054\", '10.1259/jrs.1912.0009', '']\n",
      "['9737624', 'NCT00398255. Healthier Living With Arthritis Online Program. https://clinicaltrials.gov/show/NCT00398255. (2006)   pp', '10.1037/e515802006-002', '']\n",
      "['9737625', 'Burgos-Vargas R; Tse SML; Minden K; Quartier P; Anderson JK; Unnebrink K; Galindo IL; Horneff G. The impact of adalimumab on growth in patients with pediatric enthesitis-related arthritis. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp2652', '10.1002/art.38414', '']\n",
      "['9737626', 'Akehurst R L; Backhouse M; Emery P; Haslock I; Kirsch J; McCabe C J; Scott D L; Whitfield M; Woolf A D. Nabumetone compared with Ibuprofen and a weighted NSAID combination: an economic evaluation. Journal of medical economics. (1998) 1 19-37 pp19-37', '10.3111/199801019037', '']\n",
      "['9737627', 'Furst DE. Dose-loading with hydroxychloroquine in rheumatoid arthritis: comment on the article by Furst et al [1] (multiple letters). Arthritis and rheumatism. (1999) 42 7 pp1556-', '10.1002/1529-0131(199907)42:7<1556::aid-anr35>3.0.co;2-a', '']\n",
      "['9737630', 'EUCTR2011-003953-25-DE. A Study of Two Different Adalimumab Formulations in Adults with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-003953-25-DE. (2012)   pp', '10.1186/isrctn68762628', '']\n",
      "['9737631', 'Dakkak YJ; Matthijssen XME; van der Heijde DM; Reijnierse M; van der Helm-van Mil AHM. Reliability of Magnetic Resonance Imaging (MRI)-scoring of the Metatarsophalangeal-joints of the Foot According to the Rheumatoid Arthritis-MRI Score (RAMRIS). Journal of rheumatology. (2019)   pp', '10.1136/annrheumdis-2019-eular.3247', '']\n",
      "['9737632', 'Yang Wei-Ming; Zhang Wei-Heng; Ying Hou-Qun; Xu Yan-Mei; Zhang Jing; Min Qing-Hua; Huang Bo; Lin Jin; Chen Juan-Juan; Wang Xiao-Zhong. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: albumin to fibrinogen ratio and C-reactive protein to albumin ratio. International immunopharmacology. (2018) 62  pp293-298', '10.1016/j.intimp.2018.07.007', '']\n",
      "['9737633', 'NTR2100. Tailored cognitive-behavioral E-health care in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR2100. (2009)   pp', '10.1002/art.23312', '']\n",
      "['9737634', 'Boyce Eric G; Rogan Edward L; Vyas Deepti; Prasad Neel; Mai Yvonne. Sarilumab: review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis. Annals of pharmacotherapy. (2018) 52 8 pp780-791', '10.1177/1060028018761599', 'https://journals.sagepub.com/doi/pdf/10.1177/1060028018761599']\n",
      "['9737635', 'Fernandez-Avila DG; Ruiz AJ; Gil F; Mora SA; Tobar C; Gutierrez JM; Rosselli-Cock D. The effect ofan educational intervention, based on clinical simulation on the diagnosis of rheumatoid arthritis and osteoarthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS96', '10.1002/msc.1228', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1228']\n",
      "['9737637', 'DRKS00012509. Biomonitoring of inflammation, therapy response and regeneration in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis during therapy with Certolizumab Pegol. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00012509. (2018)   pp', '10.1007/s40265-014-0239-z', 'http://link.springer.com/article/10.1007/s40265-014-0239-z/fulltext.html']\n",
      "['9737638', 'CTRI/2017/12/010976. \"Pharmaceutical  Analytical,Studies Of AMAVATARI RASA and its Clinical efficacy  in  AMAVATA (Rheumatoid Arthritis)\". http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/12/010976. (2017)   pp', '10.5530/jams.2016.1.16', '']\n",
      "['9737639', 'Alarcon G S; Koopman W J; Acton R T; Barger B O. Seronegative rheumatoid arthritis. A distinct immunogenetic disease?. Arthritis and rheumatism. (1982) 25 5 pp502-507', '10.1002/art.1780250503', '']\n",
      "['9737640', 'Zhang Ping-Heng; Liu Jian; Tan Bin; Wan Lei. Xinfeng Capsule Improved Blood Stasis State of Rheumatoid Arthritis Patients Based on Actl/NF-KB Signaling Pathway: mechanism and Effects. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 8 pp922-928', '10.1016/s0254-6272(18)30893-8', '']\n",
      "['9737643', 'UMIN000032603. the effect of music therapy on serum IL-6 levels in patient with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000032603. (2018)   pp', '10.22207/jpam.12.2.27', '']\n",
      "['9737644', 'NCT00124254. Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand. https://clinicaltrials.gov/show/NCT00124254. (2005)   pp', '10.1201/b14481-15', '']\n",
      "['9737645', 'Kawabata K; Matsumoto T; Kasai T; Chang SH; Hirose J; Tanaka S. Association between fall history and performance-based physical function and postural sway in patients with rheumatoid arthritis. Modern rheumatology. (2020)   pp', '10.1080/14397595.2020.1731134', '']\n",
      "['9737647', 'NTR1191. The efficacy of a multidisciplinary treatment program in patients with osteoarthritis of the hands. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1191. (2007)   pp', '10.1016/j.joca.2013.03.016', '']\n",
      "['9737648', 'IRCT2013030312689N1. effect of soymilk intake on inflammatory markers and oxidative stress. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013030312689N1. (2013)   pp', '10.7717/peerj.11264/fig-2', '']\n",
      "['9737649', 'Solomon Daniel H; Glynn Robert J; Karlson Elizabeth W; Lu Fengxin; Corrigan Cassandra; Colls Josh; Xu Chang; MacFadyen Jean; Barbhaiya Medha; Berliner Nancy; Dellaripa Paul F; Everett Brendan M; Pradhan Aruna D; Hammond Sarah P; Murray Meredith; Rao Deepak A; Ritter Susan Y; Rutherford Anna; Sparks Jeffrey A; Stratton Jackie; Suh Dong H; Tedeschi Sara K; Vanni Kathleen M M; Paynter Nina P; Ridker Paul M. Adverse Effects of Low-Dose Methotrexate: a Randomized Trial. Annals of internal medicine. (2020) 172 6 pp369-380', '10.7326/m19-3369', 'https://www.acpjournals.org/doi/pdf/10.7326/M19-3369']\n",
      "['9737650', 'Zhao J; Zhang Y; Zhang B; Yan Y; Ma J; Zhu Y; Li M. Thalidomide plus leflunomide for rheumatoid arthritis and its impacts on d-dimer expression. International journal of clinical and experimental medicine. (2018) 11 9 pp9827', '10.1111/cei.13080', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcei.13080']\n",
      "['9737651', 'Lederer Ann-Kathrin; Maul-Pavicic Andrea; Hannibal Luciana; Hettich Manuel; Steinborn Carmen; Grundemann Carsten; Zimmermann-Klemd Amy Marisa; Muller Alexander; Sehnert Bettina; Salzer Ulrich; Klein Reinhild; Voll Reinhard E; Samstag Yvonne; Huber Roman. Vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial. Clinical nutrition (Edinburgh, Scotland). (2020)   pp', '10.1016/j.clnu.2020.02.011', '']\n",
      "['9737652', 'Buitrago-Garcia D; Villarreal L; Cabrera M; Santos-Moreno P. Long term effectiveness of a treat to target approach and impact in overall health in patients with rheumatoid arthritis -a 3 year follow-up. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1842', '10.1136/annrheumdis-2018-eular.6101', '']\n",
      "['9737653', 'Anonymous. A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial. Journal of rheumatology. (1985) 12 1 pp68-77', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9737656', '. Correlation of disease activity, but not radiographic progression, with functional outcomes in adalimumab-treated patients with active psoriatic arthritis. Arthritis and rheumatism.. (2010) 62 SUPPL. 10 pp1930', '10.1016/j.jaad.2015.02.931', '']\n",
      "['9737657', 'Singh M L; Papas A S; Fox P C; Stevens A L; Boucher R C; Thelin B T; Johnson M R. Development of P552-02 to treat xerostomia in sjgrens syndrome. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp494', '10.1111/j.1601-0825.2008.01486.x', '']\n",
      "['9737659', 'EUCTR2006-004834-33-PL. A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 when Added to Stable Methotrexate in Patients with Moderate or Severe Active Rheumatoid Arthritis - Robust. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-004834-33-PL. (2008)   pp', '10.1186/isrctn44218911', '']\n",
      "['9737660', 'Pupim L; Unizony S; Cid M; Pilipski L; Gandhi R; Pirrello J; Ren A; Fang F; Martin D; Paolini J. A phase 2, randomized, double-blind placebo-controlled study to test the efficacy and safety of mavrilimumab in giant cell arteritis: study design and methodology. Rheumatology (united kingdom). (2019) 58  pp', '10.1093/rheumatology/kez063.060', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_2/kez063.060/28280903/kez063.060.pdf']\n",
      "['9737661', 'Xie Jun; Li Shaohua; Xiao Lianbo; Ouyang Guilin; Zheng Lin; Gu Yubiao; Gao Chengxin; Han Xiuwei. Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients. Journal of orthopaedic surgery and research. (2019) 14 1 pp421', '10.1186/s13018-019-1492-3', 'http://link.springer.com/article/10.1186/s13018-019-1492-3/fulltext.html']\n",
      "['9737662', 'EUCTR2009-015019-42-LT. Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children with Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015019-42-LT. (2010)   pp', '10.15690/vsp.v16i6.1823', 'http://vsp.spr-journal.ru:80/jour/article/viewFile/1837/752']\n",
      "['9737664', 'Vadell A; Hulander E; Barebring L; Gjertsson I; Lindqvist H; Winkvist A. Positive effects of an anti-inflammatory diet in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp757-758', '10.1136/annrheumdis-2019-eular.4522', '']\n",
      "['9737665', 'NCT04413617. TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE. https://clinicaltrials.gov/show/NCT04413617. (2020)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9737666', 'Lanas A. Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis? Commentary. Nature clinical practice gastroenterology and hepatology. (2007) 4 12 pp648-649', '10.1038/ncpgasthep0963', 'http://www.nature.com/articles/ncpgasthep0963']\n",
      "['9737667', 'Fu Q; Lu L; Xu J; Dai L; Zhijun L; He L; Zhu X; Sun L; Bao C. Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicenter, randomized, open-label clinical trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1091-1092', '10.1136/ard-2022-222486', '']\n",
      "['9737669', 'IRCT20190618043927N1. Effect of Vitamin D in pregnant women. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20190618043927N1. (2019)   pp', '10.3945/an.111.001701', 'http://academic.oup.com/advances/article-pdf/3/2/215/23735386/215.pdf']\n",
      "['9737670', 'Li Chaohong; Yin Songlou; Yin Hanqiu; Cao Lina; Zhang Ting; Wang Yong. Efficacy and safety of 22-oxa-calcitriol in patients with rheumatoid arthritis: a phase ii trial. Medical science monitor. (2018) 24  pp9127-9135', '10.12659/msm.911628', '']\n",
      "['9737671', 'Wilsdon Tom D; Whittle Samuel L; Thynne Tilenka Rj; Mangoni Arduino A. Methotrexate for psoriatic arthritis. The cochrane database of systematic reviews. (2019) 1  ppCD012722', '10.1002/14651858.cd012722.pub2', '']\n",
      "['9737672', 'Zhang Yan-Yan; Wang Jian; Jiang Ping; Wu Ji-Biao. Efficacy of Hebi Formula Combined Methotrexate on Early Rheumatoid Arthritis Patients with Dis- harmony of Gan and Pi Syndrome and Its Effects on Serum MMP-3 and RANK/RANKL/OPG Expressions. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 10 pp1197-1201', '10.1007/bf02934319', 'https://link.springer.com/article/10.1007/BF02934319/fulltext.html']\n",
      "['9737674', 'NCT01662973. Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis. https://clinicaltrials.gov/show/NCT01662973. (2012)   pp', '10.1136/annrheumdis-2017-eular.3346', '']\n",
      "['9737675', 'Ito Hiromu; Tsuji Shigeyoshi; Nakayama Masanori; Mochida Yuichi; Nishida Keiichiro; Ishikawa Hajime; Kojima Toshihisa; Matsumoto Takumi; Kubota Ayako; Mochizuki Takeshi; Sakuraba Koji; Matsushita Isao; Nakajima Arata; Hara Ryota; Haraguchi Akihisa; Matsubara Tsukasa; Kanbe Katsuaki; Nakagawa Natsuko; Hamaguchi Masahide; Momohara Shigeki; JOSRA Consortium. Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?. Journal of rheumatology. (2020) 47 4 pp502-509', '10.3899/jrheum.181100', '']\n",
      "['9737676', 'DRKS00000150. Effects of treatment with etanercept on fatigue, sleepiness, well being, sleep quality and selected immune parameters in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00000150. (2009)   pp', '10.5114/reum.2017.67600', 'https://reu.termedia.pl/pdf-69090-86304']\n",
      "['9737680', 'Palsson O; Wallman JK; Love TJ; Kapetanovic MC; Gunnarsson PS; Gudbjornsson B. The prescription of nsaids for patients with inflammatory arthritis is associated with patient but not physician assessed disease activity measures and decreases with initation of TNF inhibitor therapy. Annals of the rheumatic diseases. (2019) 78  pp66-', '10.1136/annrheumdis-2019-eular.4376', '']\n",
      "['9737682', 'Lister B J; Poland M; DeLapp R E. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. American journal of medicine. (1993) 95 2 A pp2A2S-2A3S', '10.1016/0002-9343(93)90390-b', '']\n",
      "['9737683', 'Rybar I; Masaryk P; Magyar R; Haniskova T; Revayova I. Osteoporosis reduces the health related quality of life in patients with rheumatoid arthritis. Osteoporosis international. (2012) 23 SUPPL. 3 ppS459-S460', '10.1007/s00198-012-2050-6', 'http://link.springer.com/article/10.1007/s00198-012-2050-6/fulltext.html']\n",
      "['9737684', 'El Miedany; Maha El Gaafary; Youssef S; Palmer D; Nasr A. Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping DMARDS/ biologic agents by ultrasonographic assessment in rheumatoid arthritis patients who achieved clinical remission. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp156', '10.1136/annrheumdis-2016-eular.4909', '']\n",
      "['9737685', 'Delmas P D; Lambert R; Capron M H. Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents. Revue du rhumatisme. (1994) 61 2 pp126-131', '10.1016/j.rhum.2008.08.001', '']\n",
      "['9737686', \"Achuthan S; Ahluwalia J; Shafiq N; Bhalla A; Pareek A; Chandurkar N; Malhotra S. Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: a Proof of Concept Study. Journal of cardiovascular pharmacology and therapeutics. (2015) 20 2 pp174-180\", '10.1177/1074248414546324', 'https://journals.sagepub.com/doi/pdf/10.1177/1074248414546324']\n",
      "['9737687', 'Li Y. Discussion on the value of oral Chinese herbal medicine combined with fumigation and massage therapy in the treatment of rheumatoid arthritis. Chinese medicine modern distance education of china[zhong guo zhong yi yai xian dai yuan cheng jiao yu]. (2016) 14 18 pp72-74', '10.56026/imu.18.1.40', '']\n",
      "['9737688', 'Patru S; Matei D; Marcu IR; Bighea AC. Effects of an intensive exercise program on rheumatoid arthritis patients. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS283-S284', '10.1007/s00198-018-4437-5', 'http://link.springer.com/article/10.1007/s00198-018-4437-5/fulltext.html']\n",
      "['9737689', 'EUCTR2009-012055-19-IE. A randomized, single-blind, placebo-controlled, parallel-group study evaluating the anti-inflammatory activity of GSK315234 in synovial biopsy tissue obtained from subjects with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012055-19-IE. (2010)   pp', '10.1186/isrctn70535562', '']\n",
      "['9737690', 'Burmester GR; Durez P; Shestakova G; Genovese MC; Schulze-Koops H; Yue Li; Wang YA; Lewitzky S; Koroleva I; Agarwal Berneis A; Lee DM; Hueber W. Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis. Rheumatology. (2016) 55 1 pp49-55', '10.1093/rheumatology/kev258', 'http://academic.oup.com/rheumatology/article-pdf/55/1/49/18096374/kev258.pdf']\n",
      "['9737691', 'Kaito Takashi; Ohshima Shiro; Fujiwara Hiroyasu; Makino Takahiro; Takenaka Shota; Sakai Yusuke; Yoshikawa Hideki. Predictors for progression of two different types of cervical lesions in rheumatoid arthritis treated with biologic agents. Journal of orthopaedic science. (2019) 24 2 pp214-218', '10.1016/j.jos.2018.09.001', '']\n",
      "['9737693', 'NCT00032227. Carpal Tunnel Syndrome: diagnosis and Treatment Trial. https://clinicaltrials.gov/show/NCT00032227. (2002)   pp', '10.1186/isrctn84286481', '']\n",
      "['9737694', 'Pehlivanoglu Tuna; Balci Halil Ibrahim; Demirel Mehmet; Cakmak Mehmet Fevzi; Yazicioglu Onder; Kilicoglu Onder Ismet. Prevalence of anterior knee pain after patellar retention total knee arthroplasty: comparison of patients with rheumatoid arthritis versus primary osteoarthritis. Acta orthopaedica et traumatologica turcica. (2019) 53 6 pp420-425', '10.1016/j.aott.2019.07.001', '']\n",
      "['9737695', 'Wen Hong-Yan; Luo Jing; Li Xiao-Feng; Wei Dan-Dan; Liu Yang. 1,25-Dihydroxyvitamin D3 modulates T cell differentiation and impacts on the production of cytokines from Chinese Han patients with early rheumatoid arthritis. Immunologic research. (2019) 67 1 pp48-57', '10.1007/s12026-018-9033-4', 'http://link.springer.com/article/10.1007/s12026-018-9033-4/fulltext.html']\n",
      "['9737696', 'Wang Bo; Shen Jiquan; Zhou Quan; Meng Deru; He Youwu; Chen Feifei; Wang Shuanghu; Ji Weiping. Effects of naringenin on the pharmacokinetics of tofacitinib in rats. Pharmaceutical biology. (2020) 58 1 pp225-230', '10.1080/13880209.2020.1738504', '']\n",
      "['9737698', 'EUCTR2017-000838-64-DK. An early phase study in patients with active Rheumatoid Arthritis to compare the safety and efficacy of AZD9567 and prednisolone. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-000838-64-DK. (2017)   pp', '10.1136/annrheumdis-2021-eular.632', '']\n",
      "['9737699', 'EUCTR2008-004931-39-PL. A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80 mg, 160 mg, and 320 mg ALD518 versus Placebo Administered as Multiple Intravenous Infusions to Patients with Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-004931-39-PL. (2008)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9737700', 'UMIN000011087. Efficacy of monthly minodronate for the treatment of osteoporosis associated with rheumatoid arthritis after previous treatment with bisphosphonates. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011087. (2013)   pp', '10.1530/endoabs.32.p96', '']\n",
      "['9737701', 'Low C; Conway R; Young F; Murray K; Convery H; Biniecka M; Fearon U; Veale D. Association of biometrics with disease characteristics and synovial phenotype in inflammatory arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp908', '10.1136/annrheumdis-2018-eular.5796', '']\n",
      "['9737702', 'EUCTR2014-004704-29-HU. This trial is designed to determine what effects the human body has on the investigational medicine, ABP 710, and what effects the body has on the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, infliximab, in patients with moderate or severe rheumatoid arthritis (RA).  This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004704-29-HU. (2016)   pp', '10.3810/pgm.1999.10.1.724', '']\n",
      "['9737703', 'ChiCTR-TRC-12001859. Treatment of coronary heart disease in rheumatoid arthritis with leflunomide combined  with ligustrazine in clinical research. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-12001859. (2012)   pp', '10.1186/isrctn16538701', '']\n",
      "['9737704', 'ChiCTR1900026257. A Randomized, Double-Blind Clinical Trial for Effect of Wisconsin Ginseng (Panax quinquefolius) in Improvement of Rheumatoid Arthritis Associated Fatigue. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900026257. (2019)   pp', '10.11648/j.ijcm.20200404.11', '']\n",
      "['9737705', 'Wang Xingqiang; Lei Dongyun; Ding Jie; Liu Shuang; Tao Li; Zhang Fan; Peng Jiangyun; Xu Jian. A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE. Journal of immunology research. (2018) 2018  pp4390789', '10.1155/2018/4390789', 'http://downloads.hindawi.com/journals/jir/2018/4390789.pdf']\n",
      "['9737706', \"Cioroianu A; Florescu LM; Bumbea AM; Ciurea PL; Musetescu AE. The correlation between Sjogren's syndrome and the development of osteoporosis: a study group. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS374\", '10.1007/s00198-018-4456-2', 'http://link.springer.com/article/10.1007/s00198-018-4456-2/fulltext.html']\n",
      "['9737707', 'Michielsens CAJ; Boers N; Den Broeder N; Wenink MH; Van Der Maas A; Mahler EAM; Mulder MLM; Van Der Heijde D; Van Den Hoogen FHJ; Verhoef LM; Den Broeder AA. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. Trials. (2020) 21 1 pp', '10.1186/s13063-019-4000-5', 'http://link.springer.com/article/10.1186/s13063-019-4000-5/fulltext.html']\n",
      "['9737708', 'Schattenkirchner M. Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study. Sulphasalazin (azulfidine RA) versus aurothioglukose in der therapie der chronischen polyarthritis--statusreport uber eine offene vergleichende, multizentrische langzeitstudie.. (1987) 46 2 pp67-70', '10.1055/s-2008-1047324', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2008-1047324.pdf']\n",
      "['9737710', '. Yoga for the management of pain and sleep in rheumatoid arthritis: a pilot randomized controlled trial. Musculoskeletal care. (2018) 16 1 pp39-47', '10.1002/msc.1201', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1201']\n",
      "['9737711', 'El-Ghobarey A F; Dick W C; Hadidi T; Hassan T A. Double blind comparison of two dose levels of alclofenac and placebo in rheumatoid arthritis. Rhumatologie - revue international de rhumatologie. (1980) 10 1 pp69-71', '10.1016/j.rhum.2003.12.002', '']\n",
      "['9737712', \"L'Ami MJ; Marsman AF; Krieckaert CL; Ruwaard J; Kneepkens EL; Nurmohamed MT; Wolbink GJ. Tapering of adalimumab based on therapeutic drug monitoring in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp1012-\", '10.1136/annrheumdis-2016-eular.2328', '']\n",
      "['9737713', 'Mohamed Mohamed-Eslam F; Trueman Sheryl; Feng Tian; Anderson Jaclyn; Marbury Thomas C; Othman Ahmed A. Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics. Journal of clinical pharmacology. (2019) 59 6 pp856-862', '10.1002/jcph.1375', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1375']\n",
      "['9737715', \"Avci Ali Berkant; Feist Eugen; Burmester Gerd Rudiger. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: what's the Difference?. BioDrugs. (2018) 32 6 pp531-546\", '10.1007/s40259-018-0320-3', 'http://link.springer.com/article/10.1007/s40259-018-0320-3/fulltext.html']\n",
      "['9737716', 'Andrade K M; Alfenas B F M; Rodrigues Garcia R C M. Influence of removable prostheses on mastication in elderly subjects with rheumatoid arthritis. Journal of oral rehabilitation. (2018) 45 4 pp295-300', '10.1111/joor.12592', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjoor.12592']\n",
      "['9737718', '. Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart. MMW Fortschritte der Medizin. (2003) 145 11 pp60-', '10.1007/s15006-018-0001-7', 'http://link.springer.com/article/10.1007/s15006-018-0001-7/fulltext.html']\n",
      "['9737719', 'Liu Lijun; Liu Shengyun; Wang Cong; Guan Wenjuan; Zhang Yinli; Hu Wenlu; Zhang Lei; He Yujie; Lu Jiameng; Li Tianfang; Liu Xiaojun; Xuan Yiyi; Wang Peisong. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: a Systematic Review. Journal of clinical rheumatology. (2019) 25 5 pp197-202', '10.1097/rhu.0000000000000810', '']\n",
      "['9737720', 'Strand V; Shalamberidze L; Dimic A; Smith J; Mukherjee R; Mease P. ALD518 (BMS945429), a high-affinity anti-interleukin-6 monoclonal antibody, provides improvements in health-related quality of life (HRQoL) in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate. Arthritis and rheumatism. (2010) 62  pp1096-', '10.1136/annrheumdis-2011-200704', '']\n",
      "['9737721', 'Stock T; Fleishaker D; Wang X; Mukherjee A; Mebus C. Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. International journal of rheumatic diseases. (2017) 20 8 pp960-970', '10.1111/1756-185x.13053', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13053']\n",
      "['9737722', 'ACTRN12616001082493. Effectiveness of foot orthoses in children with juvenile idiopathic arthritis: a randomised control trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12616001082493. (2016)   pp', '10.1186/isrctn49672274', '']\n",
      "['9737724', 'NCT01484561. A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01484561. (2011)   pp', '10.31525/ct1-nct04171414', '']\n",
      "['9737725', 'IRCT138902073812N1. Effect of Fish Oil supplements on Serum paraoxonase activity in female patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138902073812N1. (2010)   pp', '10.1016/s1567-5688(02)80295-1', '']\n",
      "['9737726', 'Liu X-G; Zhang Y; Ju W-F; Li C-Y; Mu Y-C. MiR-21 relieves rheumatoid arthritis in rats via targeting Wnt signaling pathway. European review for medical and pharmacological sciences. (2019) 23 3 Suppl pp96-103', '10.1042/bsr20180890', 'https://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20180890/844271/bsr-2018-0890.pdf']\n",
      "['9737729', 'Looney RJ; Stohl W. New and promising treatments for rheumatoid arthritis. American journal of orthopedics (Belle Mead, N.J.). (2007) 36 7 Suppl pp18-23', '10.1097/01.npr.0000422617.32208.00', '']\n",
      "['9737730', 'Lindqvist H; Gjertsson I; Calder P; Barebring L. Influence of blue mussel (mytilus edulis) intake on fatty acid composition in erythrocytes and plasma phospholipids and serum metabolites in women with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp365', '10.1136/annrheumdis-2019-eular.3009', '']\n",
      "['9737731', 'Koren M; Diaz C; Lin L; Martinez LJ; Eckels KH; Campos M; Jarman RG; De La Barrera R; Lepine E; Febo I; Innis BL; Vaughn DW; Wilson TM; Schmidt AC; Paris R; Thomas SJ. Safety and immunogenicity of different formulations of a tetravalent dengue purified inactivated vaccine (DPIV) in healthy adults from Puerto Rico through three years of follow-up. American journal of tropical medicine and hygiene. (2018) Conference: 67th Annual Meeting of the American Society of Tropical Medicine and Hygiene, ASTMH 2018. United States. 99 4 Supplement pp241', '10.4269/ajtmh.19-0461', 'https://www.ajtmh.org/view/journals/tpmd/102/5/article-p951.xml']\n",
      "['9737732', 'Hamdi W; Boudokhane M; Cherif I; Kaffel D; Maatallah K; Kchir M. Are patients experiencing different sort of fatigue depending on the type of chronic rheumatism?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1335', '10.1136/annrheumdis-2018-eular.5753', '']\n",
      "['9737733', 'UMIN000008812. Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008812. (2012)   pp', '10.1002/acr.21750', '']\n",
      "['9737734', 'Levitsky Adrian; Kisten Yogan; Lind Sara; Nordstrom Patric; Hultholm Helene; Lyander Jessica; Hammelin Viveka; Gentline Cidem; Giannakou Ioanna; Faustini Francesca; Skillgate Eva; van Vollenhoven Ronald; Sundberg Tobias. Joint Mobilization of the Hands of Patients With Rheumatoid Arthritis: results From an Assessor-Blinded, Randomized Crossover Trial. Journal of manipulative and physiological therapeutics. (2019) 42 1 pp34-46', '10.1016/j.jmpt.2018.04.007', '']\n",
      "['9737736', 'Brower M E; Tellinghuisen D J; Gallagher P J; Martin R W. Decision aid formats to communicate the effect of dmards on structural joint damage in rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1871', '10.1016/j.pec.2011.06.001', '']\n",
      "['9737738', 'NCT01554696. A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate. https://clinicaltrials.gov/show/NCT01554696. (2012)   pp', '10.31525/ct1-nct04204603', '']\n",
      "['9737739', 'Anonymous. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet (london, england). (1973) 1 7798 pp275-280', '10.1016/s0140-6736(73)91536-5', '']\n",
      "['9737740', \"Seppen B; L'ami MJ; Rico S; TerWee M; Turkstra F; Roorda LD; Catarinella F; Van Schaardenburg D; Nurmohamed M; Boers M; Bos WH. Development and testing of a smartphone application to self-monitor disease activity in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1384\", '10.1136/annrheumdis-2019-eular.4203', '']\n",
      "['9737741', 'Turgay Yildirim O; Gonullu E; Aydin F; Aksit E; Huseyinoglu Aydin A; Dagtekin E. Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population. Zeitschrift fur Rheumatologie. (2019) 78 2 pp190-194', '10.1007/s00393-018-0451-4', 'http://link.springer.com/article/10.1007/s00393-018-0451-4/fulltext.html']\n",
      "['9737742', 'Ginsberg; David L. Paroxetine effective for severe nondermatological pruritus. Primary psychiatry. (2004) 11 7 pp22-23', '10.2165/00128413-200414680-00025', '']\n",
      "['9737743', 'Scali J J; Rivelis L. Double-blind cross-over study of indoprofen versus ibuprofen and placebo in rheumatoid arthritis patients. European journal of rheumatology and inflammation. (1981) 4 1 pp93-96', '10.1093/rheumatology/12.2.62', 'http://academic.oup.com/rheumatology/article-pdf/12/2/62/5039159/12-2-62.pdf']\n",
      "['9737745', 'PER-028-11. A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY OF THE SAFETY AND THE EFFECT ON CLINICAL OUTCOME OF TOCILIZUMAB SC VERSUS PLACEBO SC IN COMBINATION WITH TRADITIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-028-11. (2011)   pp', '10.3410/f.718056357.793482541', '']\n",
      "['9737746', 'NCT00678782. Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis. https://clinicaltrials.gov/show/NCT00678782. (2008)   pp', '10.4172/2161-1149.1000133', '']\n",
      "['9737747', 'Stollerman G H; Bisno A L; Sullivan J M. Oral type II collagen vaccine for rheumatoid arthritis. Hospital practice. (1993) 28 12 pp27-28', '10.1080/21548331.1993.11442886', '']\n",
      "['9737748', 'EUCTR2019-000868-18-HU. Efficacy and safety of GSK3196165 versus placebo and sarilumab in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to biological DMARDs and/or Janus Kinase inhibitors. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2019-000868-18-HU. (2019)   pp', '10.31525/ct1-nct04134728', '']\n",
      "['9737749', 'NCT01211249. GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01211249. (2010)   pp', '10.2147/oarrr.s11386', '']\n",
      "['9737751', 'Imperato GH; Addorisio ME; De Vos AF; Forti S; Goldstein RS; Pavlov VA; Van Der Poll T; Yang H; Diamond B; Tracey KJ; Chavan SS. Experimental bioelectronic treatment with a vibrotactile device attenuates systemic inflammation. Shock (Augusta, Ga.). (2019) 51 6 Supplement 1 pp138-139', '10.1186/s42234-019-0020-4', 'http://link.springer.com/article/10.1186/s42234-019-0020-4/fulltext.html']\n",
      "['9737752', 'NCT01067820. ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation. https://clinicaltrials.gov/show/NCT01067820. (2010)   pp', '10.1201/9781498719346-20', '']\n",
      "['9737753', 'Blanken A; Agca R; Voskuijl A; Boellaard R; Van Der Laken C; Nurmohamed M. Vascular wall inflamation in rheumatoid arthritis patients decreases after 6 months of anti-inflammatory therapy with methotrexate or adalimumab as measured by 18F-FDG-PET/CT. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp292', '10.1136/annrheumdis-2018-eular.5660', '']\n",
      "['9737755', 'Kume K; Amano K; Yamada S; Kanazawa T; Komori H; Ohta H; Kuwaba N; Hatta K. Combination of intra-articular steroid injection and tocilizumab more effective than tocilizumab in rapid radiographic progression patients with rheumatoid arthritis. A randomized, open label, x ray reader blinded study. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS1181', '10.1136/annrheumdis-2013-eular.739', '']\n",
      "['9737757', 'Suzuki Keiko; Takeyama Sadaaki; Murakami Shinobu; Nagaoka Masahiro; Chiba Mirei; Igarashi Kaoru; Shinoda Hisashi. Structure-Dependent Effects of Bisphosphonates on Inflammatory Responses in Cultured Neonatal Mouse Calvaria. Antioxidants (basel, switzerland). (2020) 9 6 pp', '10.3390/antiox9060503', '']\n",
      "['9737758', 'ISRCTN85164658. Clinical trial of fluoride varnish in preventing dental caries of Sj√∂gren‚Äôs syndrome patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN85164658. (2016)   pp', '10.1186/isrctn85164658', '']\n",
      "['9737759', 'EUCTR2015-005268-41-GR. Preoperative administration of olaparib with or without cisplatin in patients who are candidates for surgery of carcinoma of the head and neck. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-005268-41-GR. (2016)   pp', '10.1200/jco.2017.35.15_suppl.tps6096', '']\n",
      "['9737760', \"Edman Maria C; Janga Srikanth R; Meng Zhen; Bechtold Mercy; Chen Alexander F; Kim Chongiin; Naman Luke; Sarma Arunava; Teekappanavar Neha; Kim Alice Y; Madrigal Sara; Singh Simranjit; Ortiz Elizabeth; Christianakis Stratos; Arkfeld Daniel G; Mack Wendy J; Heur Martin; Stohl William; Hamm-Alvarez Sarah F. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjogren's Syndrome patients. Scientific reports. (2018) 8 1 pp11044\", '10.1038/s41598-018-29411-9', 'https://www.nature.com/articles/s41598-018-29411-9']\n",
      "['9737762', 'Ho Lee Young; Gyu Song Gwan. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis. Journal of clinical pharmacy and therapeutics. (2020)   pp', '10.1111/jcpt.13142', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjcpt.13142']\n",
      "['9737763', 'Zhao X; Payne C; Wang F; Cui Y. Pharmacokinetics, safety and tolerability of single-and multiple-dose once-daily baricitinib in chinese healthy volunteers-a randomized placebo-controlled study. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp378', '10.1136/annrheumdis-2019-eular.4699', '']\n",
      "['9737765', 'IRCT2017050233783N1. Early low level laser therapy improved passive range of motion and decreased pain in patients with flexor tendon injury. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017050233783N1. (2017)   pp', '10.1089/pho.2018.4458', '']\n",
      "['9737770', 'Ozen Gulsen; Pedro Sofia; England Bryant R; Mehta Bella; Wolfe Frederick; Michaud Kaleb. Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs. ACR open rheumatology. (2019) 1 7 pp424-432', '10.1002/acr2.11064', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr2.11064']\n",
      "['9737771', 'EUCTR2006-005386-19-BE. Cytokines and inflammatory proteins gene expression study in synovial biopsies from rheumatoid arthritis patients refractory to anti-TNF therapy treated with Rituximab - Anti TNF resistant  RA / RTX / mini. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005386-19-BE. (2006)   pp', '10.2165/00128413-200715940-00028', '']\n",
      "['9737772', 'ChiCTR-INR-16007948. Individual Angle Versus Fixed Angle Distal Femoral Valgus Resection in Subjects with Valgus Deformity Undergoing Primary TKA: a Prospective Randomized Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16007948. (2016)   pp', '10.21037/aoj-2023-01', '']\n",
      "['9737773', 'Pombo M; Burgos D; Membriani ES; Limongi L; Putruele AM. Use of immunosuppressants in patients with autoimmune diseases and latent tuberculosis. American journal of respiratory and critical care medicine. Conference: american thoracic society international conference, ATS 2018. United states. (2018) 197 MeetingAbstracts) (no pagination pp', '10.1164/ajrccm.164.7.16471', '']\n",
      "['9737774', 'ChiCTR1800018020. Clinical plan optimization and curative effect re-evaluation of Chinese herbal compound Qing Bi granule for external application of heat syndrome in TCM. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800018020. (2018)   pp', '10.21037/lcm.2018.03.01', '']\n",
      "['9737775', 'EUCTR2009-010813-57-DE. A multicenter, randomized, double-blind, placebo-controlled, single dose study to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of intravenous and subcutaneous CDP6038 in male and female subjects with rheumatoid arthritis on a stable dose of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-010813-57-DE. (2009)   pp', '10.1111/dom.14590/v1/review3', '']\n",
      "['9737776', 'ChiCTR-IOR-15006748. Clinical application of C1 pedicle screw and lateral mass screw for atlantoaxial instability patients with C1 posterior arches measuring>4 mm: a prospective, double-blind, randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-15006748. (2015)   pp', '10.1016/j.spinee.2015.07.231', '']\n",
      "['9737777', 'Fayet Francoise; Fan Angelique; Rodere Malory; Savel Carine; Pereira Bruno; Soubrier Martin. Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education. Patient preference and adherence. (2020) 14  pp363-369', '10.2147/ppa.s240179', 'https://www.dovepress.com/getfile.php?fileID=56333']\n",
      "['9737778', 'ChiCTR1800016717. The Construction and Application of Tansitional Care Model on Patients with Rheumatoid Arthritis Based on Omaha System. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800016717. (2018)   pp', '10.1186/isrctn36516369', '']\n",
      "['9737780', \"Gaillet A; Champion K; Lefaucheur J-P; Trout H; Bergmann J-F; Sene D. Intravenous immunoglobulin efficacy for primary sj√∂gren's syndrome associated small fiber neuropathy. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1726\", '10.1016/j.autrev.2019.102387', '']\n",
      "['9737781', 'Michielsens Celia A J; Boers Nadine; den Broeder Nathan; Wenink Mark H; van der Maas Aatke; Mahler Elien A M; Mulder Michelle L M; van der Heijde Desiree; van den Hoogen Frank H J; Verhoef Lise M; den Broeder Alfons A. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. Trials. (2020) 21 1 pp90', '10.1186/s13063-019-4000-5', 'http://link.springer.com/article/10.1186/s13063-019-4000-5/fulltext.html']\n",
      "['9737782', 'Emery P; Burmester GR; Naredo E; Lagunes-Galindo I; Koenigsbauer F; Conaghan PG. A phase 4 trial assessing the impact of residual inflammation and clinical characteristics on the outcome of dose tapering of adalimumab in patients with rheumatoid arthritis who are in stable clinical remission. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1132-1133', '10.1136/annrheumdis-2019-eular.3118', '']\n",
      "['9737785', 'Keebler D; Teng E; Chia J; Galanter J; Peake J; Tuckwell K. Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials. Rheumatology (Oxford, England). (2020)   pp', '10.1093/rheumatology/keaa043', 'http://academic.oup.com/rheumatology/article-pdf/59/10/3023/33790358/keaa043.pdf']\n",
      "['9737786', 'Martinez-Feito A; Plasencia C; Navarro-Compan V; Hernandez-Breijo B; Pascual-Salcedo D; Nozal P; Diego C; Monjo I; Nuno L; Balsa A. Reduction of antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with previous failure to infliximab or adalimumab. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp595', '10.1136/annrheumdis-2018-eular.5545', '']\n",
      "['9737787', '. Effects of baricitinib on haematological laboratory parameters in patients with rheumatoid arthritis. Swiss medical weekly. (2018) 148  pp19S-', '10.1093/rheumatology/key075.589', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.589/24768654/key075.589.pdf']\n",
      "['9737788', 'Nikitinskaya O; Toroptsova N. Using frax and peripheral bone mineral density for identifying potential candidates for osteoporosis therapy among rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp288', '10.1136/annrheumdis-2018-eular.2598', '']\n",
      "['9737789', 'Shadick N A; Cook N R; Karlson E W; Ridker P M; Maher N E; Manson J E; Buring J E; Lee I M. C-reactive protein in the prediction of rheumatoid arthritis in women. Archives of internal medicine. (2006) 166 22 pp2490-2494', '10.1001/archinte.166.22.2490', '']\n",
      "['9737790', 'Rochon P A; Binns M A; Litner J A; Litner G M; Fischbach M S; Eisenberg D; Kaptchuk T J; Stason W B; Chalmers T C. Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment. Journal of clinical epidemiology. (1999) 52 2 pp113-122', '10.1016/s0895-4356(98)00149-8', '']\n",
      "['9737791', 'Yamaoka K; Kubo S; Li W; Sonomoto K; Hirata S; Sasso E H; Saito K; Defranoux N A; Tanaka Y. Effects of tofacitinib treatment on leptin and other components of the multi-biomarker disease activity score in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.2292', '']\n",
      "['9737792', 'Fries J F; Williams C A; Singh G; Ramey D R. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. Journal of rheumatology. (1997) 24 5 pp838-844', '10.1002/j.2326-5205.1989.tb00014.x', '']\n",
      "['9737793', 'De Salcedo; Arias L F; Greenberg B P. Fenbufen, a new nonsteroidal antiinflammatory agent: comparison with phenylbutazone in rheumatoid arthritis. Current therapeutic research - clinical and experimental. (1975) 18 2 pp295-302', '10.1177/030006057600400607', 'https://journals.sagepub.com/doi/pdf/10.1177/030006057600400607']\n",
      "['9737794', 'Lucena J; Chaer F G G; Reis R C; Souza B. Analysis of vitamin D receptor gene polymorphisms and bone mineral density in a population of women with rheumatoid arthritis in use of steroid. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS99', '10.1093/rheumatology/kev091.044', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i189/5181763/kev091.044.pdf']\n",
      "['9737795', 'Napp M; Horneff G. Tnf-inhibitor and leflunomide combination therapy in polyarticular juvenile idiopathic arthritis in clinical practice-lessons from the German biologics JIA registry (BIKER). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp479', '10.1136/annrheumdis-2018-eular.1716', '']\n",
      "['9737796', \"Callhoff J; Thiele K; Dorner T; Zink A; Henes J; Richter J; Albrecht K. Trends in employment and hospitalization in patients with Sjogren's syndrome 1993-2016: results from the German National Database. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1168\", '10.1136/annrheumdis-2019-eular.1183', '']\n",
      "['9737798', 'ChiCTR-IOR-17013007. External rotators hip muscle degeneration after posterolateral THA: a three-dimensional MRI-evident quantitative prospective study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-17013007. (2017)   pp', '10.1186/s12891-018-2367-1', 'http://link.springer.com/article/10.1186/s12891-018-2367-1/fulltext.html']\n",
      "['9737799', 'Desai Sonali; Stevens Emma; Emani Srinivas; Meyers Peter; Iversen Maura; Solomon Daniel H. Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: focus Group Study. JMIR formative research. (2020) 4 3 ppe15158', '10.2196/preprints.15158', '']\n",
      "['9737800', 'Pincus T. Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases. Seminars in arthritis and rheumatism. (1993) 23 2 SUPPL. 2 pp2-10', '10.1016/s0049-0172(10)80002-2', '']\n",
      "['9737802', 'Ruiz-Medrano Emmanuel; Espinosa-Ortega Hector Fabricio; Arce-Salinas Cesar Alejandro. The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis. Clinical rheumatology. (2019) 38 10 pp2709-2716', '10.1007/s10067-019-04574-6', 'http://link.springer.com/article/10.1007/s10067-019-04574-6/fulltext.html']\n",
      "['9737804', 'Swierkot J; Madej M; Rozumek G. Tnf alpha inhibitors influence the cardiovascular risk in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1666', '10.1136/annrheumdis-2019-eular.5026', '']\n",
      "['9737805', 'PER-076-12. A 24-WEEK, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE 2 STUDY OF DIFFERENT DOSES OF VX509 IN ADULT SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS ON STABLE METHOTREXATE THERAPY WITH 104-WEEK OPEN LABEL EXTENSION. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-076-12. (2012)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9737806', 'Fujimura T; Sato Y; Tanita K; Lyu C; Kambayashi Y; Amagai R; Otsuka A; Fujisawa Y; Yoshino K; Matsushita S; Uchi H; Yamamoto Y; Hata H; Funakoshi T; Nonomura Y; Tanaka R; Okuhira H; Wada N; Hashimoto A; Aiba S. Association of baseline serum levels of CXCL5 with the efficacy of nivolumab in advanced melanoma. Frontiers in medicine. (2019) 6 APR pp', '10.3389/fmed.2019.00086', '']\n",
      "['9737808', 'Lugo James P; Saiyed Zainulabedin M; Lau Francis C; Molina Jhanna Pamela L; Pakdaman Michael N; Shamie Arya Nick; Udani Jay K. Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. Journal of the International Society of Sports Nutrition. (2013) 10 1 pp48', '10.1186/1550-2783-10-48', 'https://link.springer.com/content/pdf/10.1186/1550-2783-10-48.pdf']\n",
      "['9737810', 'UMIN000021082. The effect of hyaluronic acid injection in patient with wrist synovitis Uncontrolled exploratory clinical study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021082. (2016)   pp', '10.31435/rsglobal_ws/30032024/8127', 'https://rsglobal.pl/index.php/ws/article/download/2727/2345']\n",
      "['9737811', 'TCTR20170809001. Effects of Leg Lifting Training Using a Lower Body Position Visual Feedback Device on Balance and Lower Extremity Strength in Elderly. http://www.who.int/trialsearch/Trial2.aspx?TrialID=TCTR20170809001. (2017)   pp', '10.5040/9781350970533', '']\n",
      "['9737812', 'Cheng TT; Chen YC; Yu SF; Lai HM; Su FM; Su BYJ; Chiu WC; Hsu CY; Chen JF; Ko CH. The impact of low dose glucocorticoid on disease activity, BMD, fragility fracture, and 10-year probability of fracture in rheumatoid arthritis (RA) patients. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS236', '10.1186/s13075-018-1515-1', 'http://link.springer.com/content/pdf/10.1186/s13075-018-1515-1.pdf']\n",
      "['9737813', 'IRCT201112251100N4. Radiopharmaceutical therapy of chronic inflammatory knee joint disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112251100N4. (2012)   pp', '10.1186/isrctn07564351', '']\n",
      "['9737814', 'UMIN000007786. \"Effect examination of infliximab to the effect insufficient example and the example of effect decrease of the 1st TNF inhibitor in rheumatoid arthritis  \". http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007786. (2012)   pp', '10.1186/isrctn68585617', '']\n",
      "['9737815', '. Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-tosevere rheumatoid arthritis in Spain. ClinicoEconomics and outcomes research. (2019) 11  pp395-403', '10.2147/ceor.s201621', 'https://www.dovepress.com/getfile.php?fileID=50401']\n",
      "['9737816', 'UMIN000010126. Efficacy and safety of treatment with moderate doses of corticosteroid and immunosuppressants in rheumatoid arthritis patients with interstitial lung disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010126. (2013)   pp', '10.1093/rheumatology/kev088.092', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i86/5180170/kev088.092.pdf']\n",
      "['9737818', 'van Ede AE; Laan RFJM; de Abreu RA; Stegeman ABJ; van de Putte LBA. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Annals of the rheumatic diseases. (2002) 61 12 pp1060-1064', '10.1136/ard.61.12.1060', '']\n",
      "['9737819', 'NCT04309227. Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations. https://clinicaltrials.gov/show/NCT04309227. (2020)   pp', '10.7717/peerj.17195/table-1', '']\n",
      "['9737820', 'Khedekar S; Shimpi P; Shyam A; Sancheti P. Use of art as therapeutic intervention for enhancement of hand function in patients with rheumatoid arthritis: a pilot study. Indian Journal of Rheumatology. (2017) 12 2 pp94-96', '10.4103/0973-3698.199130', '']\n",
      "['9737822', 'UMIN000005770. The examination about the performance and safe operation of the Motivative exercise evaluation device. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005770. (2011)   pp', '10.14813/ibra.2.41', '']\n",
      "['9737823', 'Gao HL; Xiao LB; Zhai WT; He Y; Zhu F; Zheng L; Han XW. Comparison of analgesic effects between multimodal and patient-controlled intravenous analgesia in patients with rheumatoid arthritis in the perioperative period of total knee arthroplasty. Zhongguo gu shang [China journal of orthopaedics and traumatology]. (2017) 30 4 pp356-359', '10.21203/rs.3.rs-42566/v2', 'https://www.researchsquare.com/article/rs-42566/v2']\n",
      "['9737824', 'Bakhtiari Tahereh; Azarian ShahinKhadem; Ghaderi Afshin; Ahmadzadeh Arman; Mirshafiey Abbas. Effect of Guluronic Acid (G2013), As a New Anti-inflammatory Drug on Gene Expression of Pro-inflammatory and Anti-inflammatory Cytokines and Their Transcription Factors in Rheumatoid Arthritis Patients. Iranian journal of allergy, asthma, and immunology. (2019) 18 6 pp639-648', '10.18502/ijaai.v18i6.2176', 'https://ec2-18-184-16-47.eu-central-1.compute.amazonaws.com/index.php/IJAAI/article/download/2176/1515']\n",
      "['9737826', 'Yue T; Fan X; Zhang Z; Liu Z; Guo M; Wang R; Bai F; Qin Y; Wang H. Wutou decoction, in combination with methotrexate, is more effective and equally tolerated, compared to methotrexate alone, in early active rheumatoid arthritis treatment. International journal of clinical and experimental medicine. (2019) 12 9 pp11930-11937', '10.1093/rheumatology/keg394', 'http://academic.oup.com/rheumatology/article-pdf/42/12/1545/9533421/keg394.pdf']\n",
      "['9737827', 'EUCTR2012-000610-11-BE. A  trial of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoid arthritis who are inadequate responders to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-000610-11-BE. (2012)   pp', '10.1136/annrheumdis-2012-eular.1964', '']\n",
      "['9737829', 'EUCTR2016-001224-63-CZ. A Phase 3 Study of Guselkumab in Subjects with Active Psoriatic Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-001224-63-CZ. (2017)   pp', '10.1186/isrctn49107623', '']\n",
      "['9737830', \"NCT04078386. A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sj√∂gren's Syndrome. Https://clinicaltrials.gov/show/nct04078386. (2019)   pp\", '10.31525/ct1-nct04078386', '']\n",
      "['9737832', 'Anvar Naiyer; Matlabi Hossein; Safaiyan Abdolrasoul; Allahverdipour Hamid; Kolahi Sousan. Effectiveness of self-management program on arthritis symptoms among older women: a randomized controlled trial study. Health care for women international. (2018) 39 12 pp1326-1339', '10.1080/07399332.2018.1438438', '']\n",
      "['9737835', 'NCT01426789. A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients. https://clinicaltrials.gov/show/NCT01426789. (2011)   pp', '10.3030/666798', '']\n",
      "['9737836', 'Williams H J; Ward J R; Egger M J; Reading J C; Samuelson C O; Altz-Smith M; Willkens R W; Solsky M A; Hayes S P; Furst D. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases. Clinical rheumatology. (1984) 3 Suppl 1  pp39-50', '10.1007/bf03342621', 'http://link.springer.com/article/10.1007/BF03342621/fulltext.html']\n",
      "['9737837', 'Keystone E C; Hewitt L A; Simon L S; Shirinsky V; Pedder S. CH-1504: a metabolically inert antifolate, is an effective and well-tolerated treatment for patients with moderate to severe rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1927', '10.3899/jrheum.101038', '']\n",
      "['9737838', 'Moghadam M G; Vonkeman H E; Ten Klooster; P M; Tekstra J; Van Schaardenburg; Starmans-kool M; Brouwer E; Bos R; Lems W F; Colin E; Allaart C F; Meek I L; Landewe R B M; Bernelot Moens; H J; Van Riel; Van De Laar; M A F J; Jansen T. Pragmatic multicenter open-label randomized controlled trial of stopping tnfinhibitors in rheumatoid arthritis patients in remission or stable low disease activity in the Netherlands. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1002/art.39626', '']\n",
      "['9737839', 'Muller PH; Brinkman DM; Schonenberg-Meinema D; Van Den Bosch WB; Koopman-Keemink Y; Bekkering P; Kuijpers T; Van Rossum M; Van Suijlekom-Smit L; Van Den Berg JM; Boehringer S; Allaart CF; Ten Cate R. Results after 24 months of drug-free inactive disease and flare frequency in juvenile idiopathic arthritis patients in a treatment-to-target strategy study. Pediatric rheumatology. (2018) Conference: 25th European Paediatric Rheumatology Congress, PReS 2018. Portugal. 16 Supplement 2 pp', '10.1136/annrheumdis-2018-eular.2623', '']\n",
      "['9737840', 'King JD; Rowland G; Villasante Tezanos AG; Warwick J; Kraus VB; Lattermann C; Jacobs CA. Joint Fluid Proteome after Anterior Cruciate Ligament Rupture Reflects an Acute Posttraumatic Inflammatory and Chondrodegenerative State. Cartilage. (2018) (no pagination)  pp', '10.1177/1947603518790009', 'https://journals.sagepub.com/doi/pdf/10.1177/1947603518790009']\n",
      "['9737841', 'EUCTR2004-001930-18-EE. A MULTI-CENTER, RANDOMIZED, BLINDED STUDY COMPARING THE EFFECT OF CRx-102 PLUS DMARD THERAPY TO THAT OF PLACEBO PLUS DMARD THERAPY ON SERUM C-REACTIVE PROTEIN (CRP) AND CYTOKINES IN SUBJECTS WITH RHEUMATOID ARTHRITIS                                                                                                                                                                                                          - CRx-102-RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-001930-18-EE. (2006)   pp', '10.1186/isrctn74570187', '']\n",
      "['9737842', 'Ghiti Moghadam Marjan; Lamers-Karnebeek Femke B G; Vonkeman Harald E; Ten Klooster Peter M; Tekstra Janneke; van Schaeybroeck Barbara; Klaasen Ruth; van Onna Marieke; Bernelot Moens Hein J; Visser Henk; Schilder Annemarie M; Kok Marc R; Landewe Robert B M; van Riel Piet L C M; van de Laar Mart A F J; Jansen Tim L; Dutch National POET Collaboration. Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment. BMC rheumatology. (2019) 3  pp3', '10.1186/s41927-019-0071-x', 'http://link.springer.com/article/10.1186/s41927-019-0071-x/fulltext.html']\n",
      "['9737843', 'NCT01873625. Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01873625. (2013)   pp', '10.1021/acs.jproteome.3c00697.s001', '']\n",
      "['9737845', 'Dollinger J; Neville C; Pineau C A; Vinet E; Hazel E; Lee J L F; Bernatsky S. Challenges to optimal rheumatology care: a patient-centered focus group study. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05091-7', 'https://link.springer.com/article/10.1007/s10067-020-05091-7/fulltext.html']\n",
      "['9737846', 'Kars Fertelli Tulay. Effects of Education About Rheumatoid Arthritis and Sexuality on the Sexual Problems of Women With Rheumatoid Arthritis. Clinical nursing research. (2020) 29 3 pp189-199', '10.1177/1054773819858493', 'http://journals.sagepub.com/doi/pdf/10.1177/1054773819858493']\n",
      "['9737847', 'SLCTR/2008/019. Mind on arthritis study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=SLCTR/2008/019. (2008)   pp', '10.1037/e412332008-019', '']\n",
      "['9737848', 'EUCTR2012-000609-58-DE. A trial of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoid arthritis who are inadequate responders to anti-TNFa biologics. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-000609-58-DE. (2012)   pp', '10.1007/s40265-024-02059-8', 'https://link.springer.com/article/10.1007/s40265-024-02059-8/fulltext.html']\n",
      "['9737849', 'Ponikowska Monika; Swierkot Jerzy; Nowak Beata; Korman Lucyna; Wiland Piotr. Autoantibody and metalloproteinase activity in early arthritis. Clinical rheumatology. (2019) 38 3 pp827-834', '10.1007/s10067-018-4326-5', 'http://link.springer.com/article/10.1007/s10067-018-4326-5/fulltext.html']\n",
      "['9737850', 'EUCTR2008-005708-18-GB. Prevention of metabolic complications of glucocorticoid excess - Prevention of metabolic complications of glucocorticoid excess. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-005708-18-GB. (2010)   pp', '10.1201/b16175-29', '']\n",
      "['9737851', 'Pope J E; Thorne J C; Cividino A A; Lucas K. A randomized controlled trial of rheumatologist education impacting on systematic measurements and treatment decisions in rheumatoid arthritis (RA): results of the Metrix study. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1735', '10.3899/jrheum.120597', '']\n",
      "['9737852', 'Al Ghafri A; Molloy ES. Audit on hydroxychloroquine related retinopathy screening in rheumatology patients in SVUH. Annals of the rheumatic diseases. (2019) 78 Supplement 2 pp1692', '10.1136/annrheumdis-2019-eular.196', '']\n",
      "['9737853', 'NCT04068246. The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients. Https://clinicaltrials.gov/show/nct04068246. (2019)   pp', '10.31525/ct1-nct04068246', '']\n",
      "['9737854', 'NCT00603512. Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan. https://clinicaltrials.gov/show/NCT00603512. (2008)   pp', '10.3109/9780203214237-213', '']\n",
      "['9737856', 'IRCT2016070428781N1. The effect of education on quality of life and stress in patients with intestinal stoma. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016070428781N1. (2016)   pp', '10.35630/2024/14/5.503', '']\n",
      "['9737857', 'Vass Caroline M; Davison Niall J; Vander Stichele Geert; Payne Katherine. A Picture is Worth a Thousand Words: the Role of Survey Training Materials in Stated-Preference Studies. Patient. (2020) 13 2 pp163-173', '10.1007/s40271-019-00391-w', 'http://link.springer.com/article/10.1007/s40271-019-00391-w/fulltext.html']\n",
      "['9737858', 'NCT03828344. Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03828344. (2019)   pp', '10.1177/0963689720965896', 'http://journals.sagepub.com/doi/pdf/10.1177/0963689720965896']\n",
      "['9737859', 'NCT02715908. A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX). https://clinicaltrials.gov/show/NCT02715908. (2016)   pp', '10.31525/ct1-nct03915769', '']\n",
      "['9737860', 'NCT04130178. Nerve Block of the Proximal Interphalangeal Joints PIPs in Rheumatoid Arthritis (RA) Patients: a Prospective Pilot Study. https://clinicaltrials.gov/show/NCT04130178. (2019)   pp', '10.31525/ct1-nct04130178', '']\n",
      "['9737863', 'NCT04335071. Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19). https://clinicaltrials.gov/show/NCT04335071. (2020)   pp', '10.3389/fmed.2020.571597', '']\n",
      "['9737865', 'Bae Sang-Cheol; Lee Young Ho. Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Clinical rheumatology. (2018) 37 2 pp323-330', '10.1007/s10067-017-3857-5', 'http://link.springer.com/article/10.1007/s10067-017-3857-5/fulltext.html']\n",
      "['9737866', 'Menander-Huber K B. Orgotein in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1981) 4 2 pp201-211', '10.1016/s0140-6736(81)92185-1', '']\n",
      "['9737867', 'Cuomo Giovanna; Molinaro Gabriella; La Montagna; Giovanni; Migliaresi Sergio; Valentini Gabriele. A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens. Analisi dei rapporti tra SDAI (simplified disease activity index) e DAS28 (disease activity score) in pazienti sottoposti a differenti terapie di fondo.. (2006) 58 1 pp22-25', '10.4081/reumatismo.2006.22', '']\n",
      "['9737868', 'Gehling M; Niebergall H. Non-opioid analgesics and co-analgesics in therapy of chronic pain. Nicht-opioidanalgetika und co-analgetika in der therapie chronischer schmerzen.. (1998) 92 1 pp41-46', '10.1007/bf02529690', 'http://link.springer.com/article/10.1007/BF02529690/fulltext.html']\n",
      "['9737870', 'Anonymous. Usability and patient perceptions of the sarilumab pen for treatment of RA. Journal of clinical outcomes management. (2018) 25 7 pp296-297', '10.1007/s40744-017-0090-2', 'http://link.springer.com/content/pdf/10.1007/s40744-017-0090-2.pdf']\n",
      "['9737871', 'NCT03830203. Comparative Study of BAT1806 to RoActemra¬¨√Ü in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate. Https://clinicaltrials.gov/show/nct03830203. (2019)   pp', '10.31525/ct1-nct04038970', '']\n",
      "['9737872', 'Rubbert-Roth Andrea; Jacobs Johannes W G; Bijlsma Johannes W J; Welsing Paco M J. A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement. Annals of the rheumatic diseases. (2018) 77 7 pp1085-1086', '10.1136/annrheumdis-2017-211485', '']\n",
      "['9737873', 'IRCT2014031717035N1. Effect of Exercise on gestational diabetes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014031717035N1. (2015)   pp', '10.1186/isrctn90645333', '']\n",
      "['9737874', 'IRCT201202187274N3. Therapeutic responses to Subcutaneous versus Intra-sheath sonographically guided corticosteroid injection in the management of Trigger Finger. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201202187274N3. (2012)   pp', '10.3944/aott.2012.2787', '']\n",
      "['9737875', 'IRCT20180207038664N1. The effect of curcumin supplementation in the treatment of patients with ulcerative colitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20180207038664N1. (2018)   pp', '10.47583/ijpsrr.2024.v84i09.016', '']\n",
      "['9737876', 'Bruni Cosimo; Bitti Roberta; Nacci Francesca; Cometi Laura; Tofani Lorenzo; Bartoli Francesca; Fiori Ginevra; Matucci-Cerinic Marco. Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05199-w', 'https://link.springer.com/article/10.1007/s10067-020-05199-w/fulltext.html']\n",
      "['9737877', 'IRCT201608044641N12. Effectiveness of Extra corporal Shock Wave therapy in the treatment of Knee Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201608044641N12. (2017)   pp', '10.1186/isrctn49594569', '']\n",
      "['9737879', 'Mogul Amanda; Corsi Katherine; McAuliffe Laura. Baricitinib: the Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis. Annals of pharmacotherapy. (2019) 53 9 pp947-953', '10.1177/1060028019839650', 'http://journals.sagepub.com/doi/pdf/10.1177/1060028019839650']\n",
      "['9737880', 'NCT00254293. Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT00254293. (2005)   pp', '10.1136/annrheumdis-2013-eular.2591', '']\n",
      "['9737881', 'Chen R; Zhao L; Song L; Chen H; Zhang X. Clinical characteristics and outcomes of lung-dominant rheumatoid arthritis. European journal of immunology. (2019) Conference: 17th International Congress of Immunology. China. 49 Supplement 3 pp983', '10.1002/eji.201970400', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.201970400']\n",
      "['9737882', 'Biltris R; Delmeiren H; Desproges-Gotteron R; Diverse P; Gerard R; Golstein M; Le Guen; Vetter G; Viara M. Double blind comparison of clopirac with indometacin in rheumatoid arthritis. Journal belge de rhumatologie ET de medicine physique. (1975) 30 Spec.nr. pp74-82', '10.1016/j.rhum.2008.10.007', '']\n",
      "['9737884', \"UMIN000004477. Efficacy and safety of hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome patients with annular erythema on the face and/or trunk. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004477. (2010)   pp\", '10.1177/10668969241234316/v1/review1', '']\n",
      "['9737885', 'Genovese M; Greenwald M; Cho C S; Berman A; Jin L; Cameron G; Wang L; Xie L; Braun D; Berclaz P Y; Banerjee S. A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: naive to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.1704', '']\n",
      "['9737886', 'Hattori Kyosuke; Hirano Yuji; Kanayama Yasuhide; Hattori Yosuke; Kato Takefumi; Takahashi Nobunori; Ishiguro Naoki; Kojima Toshihisa. Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors. Modern rheumatology. (2020)   pp1-8', '10.1080/14397595.2020.1740390', '']\n",
      "['9737887', 'NCT03667131. Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03667131. (2018)   pp', '10.4172/2167-7921.1000163', '']\n",
      "['9737888', 'Yoshii I. Clinical characteristics of non-responder to denosumab treatment for postmenopausal osteoporosis in japanese woman. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1619', '10.1136/annrheumdis-2018-eular.1263', '']\n",
      "['9737889', 'Leon L; Redondo M; Fernandez-Nebro A; Gomez S; Loza E; Montoro M; Garcia-Vicuna R; Galindo M. Expert recommendations on psychological needs of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1816', '10.1136/annrheumdis-2018-eular.6314', '']\n",
      "['9737890', 'NCT00467337. Medial-Wedge Insole is Highly Effective in the Treatment of Valgus Knee Osteoarthritis. https://clinicaltrials.gov/show/NCT00467337. (2007)   pp', '10.3410/f.1109233.565240', '']\n",
      "['9737891', 'EUCTR2016-000570-37-ES. Filgotinib Alone or in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have Not Yet Started Methotrexate Treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000570-37-ES. (2017)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9737892', 'EUCTR2016-000393-37-BG. A study to test the effectiveness of bimekizumab as a treatment for rheumatoid arthritis, to look for unwanted side effects and to measure how the drug is distributed, modified and cleared from the body. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000393-37-BG. (2016)   pp', '10.22159/ijap.2023v15i2.46158', 'https://innovareacademics.in/journals/index.php/ijap/article/download/46158/27793']\n",
      "['9737893', 'Ogdie A; Nowell WB; Reynolds R; Gavigan K; Venkatachalam S; De La Cruz M; Flood E; Schwartz EJ; Romero B; Park Y. Correlation between RAPID3 and promis10 in patients with ankylosing spondylitis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1553', '10.1136/annrheumdis-2018-eular.2996', '']\n",
      "['9737894', 'Albayrak Gezer Ilknur; Balkarli Ayse; Can Beray; Bagcaci Sinan; Kucuksen Sami; Kucuk Adem. Pain, depression levels, fatigue, sleep quality, and quality of life in elderly patients with rheumatoid arthritis. Turkish journal of medical sciences. (2017) 47 3 pp847-853', '10.3906/sag-1603-147', '']\n",
      "['9737895', 'CTRI/2016/06/007034. To compare bioavailibility of Methotrexate Tablets 2.5 mg( Amneal pharmaceuticals) with Methotrexate Tablets USP 2.5 mg (DAVA Pharmaceuticals, Inc.USA) in patients with mild to severe psoriasis or rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/06/007034. (2016)   pp', '10.1037/e309002004-001', '']\n",
      "['9737898', \"N'Dow SMS; Donnelly LA; Pearson ER; Rena G. Investigation of an association of the anti-inflammatory drug sulfasalazine on HbA1c in a large cohort of individuals with type 2 diabetes. Diabetologia. (2018) Conference: 54th Annual Meeting of the European Association for the Study Diabetes, EASD 2018. Germany. 61 Supplement 1 ppS147-S148\", '10.1007/s00125-018-4693-0', 'http://link.springer.com/article/10.1007/s00125-018-4693-0/fulltext.html']\n",
      "['9737899', 'Liu Cai-Li; Wang Ying-Ying. Effects of TNF-alpha/NF-kappa B signaling pathway on etanercept alleviating rheumatoid arthritis. Zhongguo ying yong sheng li xue za zhi [Chinese journal of applied physiology]. (2017) 33 4 pp373-376', '10.5962/bhl.title.82727', '']\n",
      "['9737900', 'Ishiguro Naoki; Shibata Kai; Yoshimura Akiko; Ikeuchi Satoshi; Ishii Mika. Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: post-hoc analysis of an all-case post-marketing surveillance study of iguratimod. Modern rheumatology. (2019)   pp1-7', '10.1080/14397595.2019.1649229', '']\n",
      "['9737901', \"Herman Ann E; Chinn Leslie W; Kotwal Shweta G; Murray Elaine R; Zhao Rui; Florero Marilyn; Lin Alyse; Moein Anita; Wang Rena; Bremer Meire; Kokubu Serika; Serone Adrian P; Hanze Eva L; Viberg Anders; Morimoto Alyssa M; Winter Helen R; Katsumoto Tamiko R. Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor. Clinical pharmacology and therapeutics. (2018) 103 6 pp1020-1028\", '10.1002/cpt.1056', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.1056']\n",
      "['9737902', 'Droste U. Diclofenac sodium compared with sulindac and placebo in a multicenter double blind study on rheumatoid arthritis. Verhandlungen der Deutschen Gesellschaft fur Rheumatologie. (1981) BD.7  pp327-328', '10.1007/978-3-642-85316-6_79', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_79.pdf']\n",
      "['9737903', 'Hart C B; Rhymer A R; Miola S R. INDOCIN SR (indomethacin, MSD) in the treatment of moderate to severe rheumatoid arthritis. Seminars in arthritis and rheumatism. (1982) 12 2 Suppl. 1 pp147-151', '10.1016/0049-0172(82)90018-x', '']\n",
      "['9737904', 'ISRCTN87397856. Investigation to see if cervical spine mobilisation can influence Cervicobrachial Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN87397856. (2007)   pp', '10.1186/isrctn87397856', '']\n",
      "['9737905', 'EUCTR2004-000362-12-CZ. A Double-Blind, Randomised, Dose-Ranging Study to Compare K-832 with Placebo in the treatment of Patients with Active Rheumatoid Arthritis - N/A. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000362-12-CZ. (2004)   pp', '10.1016/s0084-3873(09)79349-6', '']\n",
      "['9737907', 'Wang M; Huang J; Fan H; He D; Zhao S; Shu Y; Li H; Liu L; Lu S; Xiao C; Liu Y. Treatment of rheumatoid arthritis using combination of methotrexate and tripterygium glycosides tablets - A quantitative plasma pharmacochemical and pseudotargeted metabolomic approach. Frontiers in pharmacology. (2018) 9 OCT) (no pagination pp', '10.3389/fphar.2018.01051', '']\n",
      "['9737908', \"ChiCTR-TRC-13003948. The evaluation of clinical curative effect of 'supplying of shen and nourishing sui' law of electroacupuncture combined with ZeLing joint swelling mixture in the treatment of rheumatoid arthritis with yin-deficiency of liver and kidney pattern. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-13003948. (2013)   pp\", '10.25236/fmsr.2024.060207', 'https://francis-press.com/uploads/papers/oAW4x9OdZZVuIoHmdSNdVbKeJu7LZqarEW07rBXo.pdf']\n",
      "['9737909', \"La Paglia Giuliana Maria Concetta; Sanchez-Pernaute Olga; Alunno Alessia; Martinez-Becerra Maria Jose; Romero-Bueno Fredeswinda; Recuero Sheila; Borges Pablo Eder; Mahillo-Fernandez Ignacio; Garrido Jesus; Gerli Roberto; Herrero-Beaumont Gabriel; Naredo Esperanza. Ultrasound salivary gland involvement in Sjogren's syndrome vs. other connective tissue diseases: is it autoantibody and gland dependent?. Clinical rheumatology. (2020) 39 4 pp1207-1215\", '10.1007/s10067-019-04780-2', 'http://link.springer.com/article/10.1007/s10067-019-04780-2/fulltext.html']\n",
      "['9737910', 'George Michael D; Sauer Brian C; Teng Chia-Chen; Cannon Grant W; England Bryant R; Kerr Gail S; Mikuls Ted R; Baker Joshua F. Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis. Journal of rheumatology. (2019) 46 4 pp343-350', '10.3899/jrheum.180178', '']\n",
      "['9737911', 'Yang Shu; Xing Zhihua; Liu Tao; Zhou Jing; Liang Qinghua; Tang Tao; Cui Hanjin; Peng Weijun; Xiong Xingui; Wang Yang. Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis. Drug design, development and therapy. (2018) 12  pp463-473', '10.2147/dddt.s153927', 'https://www.dovepress.com/getfile.php?fileID=40809']\n",
      "['9737912', 'Bae S-C; Lee Y H. Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : a Bayesian network meta-analysis of randomized controlled trials. Zeitschrift fur Rheumatologie. (2018) 77 5 pp421-428', '10.1007/s00393-017-0292-6', 'http://link.springer.com/article/10.1007/s00393-017-0292-6/fulltext.html']\n",
      "['9737913', \"McCoy SS; Sampene E; Baer AN. Sjogren's syndrome is associated with reduced sex hormone exposure: a cross-sectional study. Clinical and experimental rheumatology. (2018) Conference: 14th International Symposium on Sjogren's Syndrome. United States. 36 3 Supplement 112 ppS283-S284\", '10.1002/acr.24014', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.24014']\n",
      "['9737914', \"Hakki Karagozoglu K; Vissink A; Forouzanfar T; Brand HS; Maarse F; Jan Jager DH. Sialendoscopy enhances salivary gland function in Sjogren's syndrome: a 6-month follow-up, randomised and controlled, single blind study. Annals of the rheumatic diseases. (2018) 77 7 pp1025-1031\", '10.1136/annrheumdis-2017-212672', '']\n",
      "['9737915', 'Mueller R; Popp F; Mattow F; Durmisi M; Souza A; Schulze-Koops H; Hasler P; Von Kempis J. Effectiveness, tolerability, and safety of tofacitinib in rheumatoid arthritis: a retrospective analysis of real-world data from the st. Gallen and Aarau cohort. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1409', '10.1136/annrheumdis-2018-eular.5524', '']\n",
      "['9737916', 'EUCTR2010-021184-32-AT. GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021184-32-AT. (2010)   pp', '10.7748/ns2012.06.26.42.32.p8688', '']\n",
      "['9737917', 'Aryaeian N; Sedehi SK; Khorshidi M; Zarezadeh M; Hosseini A; Shahram F. Effects of hydroalcoholic extract of Berberis Integerrima on the anthropometric indices and metabolic profile in active rheumatoid arthritis patients. Complementary therapies in medicine. (2020) 50  pp', '10.1016/j.ctim.2020.102331', '']\n",
      "['9737918', 'Cannon G; Teng C-C; Accortt NA; Collier DH; Lin T-C; Sauer BC. The ability of disease activity measures to predict major therapeutic change in us veterans with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp555-556', '10.1136/annrheumdis-2018-eular.1804', '']\n",
      "['9737921', 'Bearne LM; Kaambwa B; Ratcliffe J; Choy E; Scott DL; Hurley MV; Manning VL. Economic evaluation of a brief education, self-management and upper limb exercise training programme in people with rheumatoid arthritis. Rheumatology (united kingdom). (2015) 54  ppi6-', '10.1093/rheumatology/keu319', 'http://academic.oup.com/rheumatology/article-pdf/54/2/302/6896828/keu319.pdf']\n",
      "['9737923', 'Useche M; Starr J; Rodriguez K; Ramanakumar A; Hudson M; Ward B; Colmegna I. Reasons for non-participation in a randomized controlled trial comparing two seasonal influenza vaccines in rheumatoid arthritispatients. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp352', '10.1136/annrheumdis-2019-eular.6381', '']\n",
      "['9737924', 'Radziszewska A; Fisher C; Bray T; Choida V; Sen D; Hall-Craggs M; Ciurtin C. Cytokine signature does not correlate with pain or disease activity in well controlled ERA. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1571-1572', '10.1136/annrheumdis-2019-eular.2827', '']\n",
      "['9737927', 'Genovese MC; Berkowitz M; Conaghan PG; Davy K; Inman D; Fisheleva E; Gupta A; Janiczek R; Layton M; Mitchell N; Patel J; Smith JE; Williamson R; Tak P-P. A phase IIa mechanistic study of anti-GM-CSF (GSK3196165) with methotrexate treatment in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2787-2788', '10.1016/s2665-9913(20)30224-1', '']\n",
      "['9737928', 'EUCTR2014-000993-20-SE. Dosing of glucocorticoid (triamcinolone hexacetonid) when injecting knee joints of rheumatic diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-000993-20-SE. (2014)   pp', '10.1136/annrheumdis-2018-eular.2483', '']\n",
      "['9737931', 'ISRCTN06098697. A one month study of the efficacy and safety of SVS20 versus carbomer and saline in patients with bilateral moderate dry eye syndrome: a randomised, double blind, controlled, parallel group, pilot, phase II study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN06098697. (2008)   pp', '10.1186/isrctn06098697', '']\n",
      "['9737932', 'Kim Seokuee; Lee Hyeryeon; Ko Jae-Wook; Kim Jung-Ryul. Effects of Celecoxib on the QTc Interval: a Thorough QT/QTc Study. Clinical therapeutics. (2019) 41 11 pp2204-2218', '10.1016/j.clinthera.2019.09.004', '']\n",
      "['9737933', 'NCT01543594. Italian Registry of Arthritis on Biologic Therapy. https://clinicaltrials.gov/show/NCT01543594. (2012)   pp', '10.3390/proceedings2090532', '']\n",
      "['9737935', 'Baillet A; Trocme C; Courtier A; Nguyen C; Toussaint B; Epaulard O. Neutrophil-related biomarkers discriminate septic arthritis from other inflammatory arthritides: data from the bossa trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1054', '10.1136/annrheumdis-2018-eular.6705', '']\n",
      "['9737936', 'Cohen SB; Van Vollenhoven R; Winthrop K; Zerbini C; Tanaka Y; Bessette L; Yihan L; Khan N; Hendrickson B; Burmester GR. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the select phase 3 clinical program. Annals of the rheumatic diseases. (2019) 78  pp357-', '10.1136/annrheumdis-2019-eular.3403', '']\n",
      "['9737937', 'Anno Shohei; Okano Tadashi; Mamoto Kenji; Sugioka Yuko; Takeda Setsuko; Hashimoto Ayumi; Yamashita Emi; Morinaka Rika; Ueda Hatsue; Inui Kentaro; Koike Tatsuya; Nakamura Hiroaki. Comparison of median nerve stiffness with and without rheumatoid arthritis by ultrasound real-time tissue elastography: a propensity score matching study. Modern rheumatology. (2020) 30 3 pp481-488', '10.1080/14397595.2019.1602914', '']\n",
      "['9737938', 'Bukhanova D; Belov B; Trasova G; Erdes S; Dubinina T; Lukina G; Demidova N; Volkov A; Yudkina N. Assessment of efficacy and safety of a trivalent split-virus influenza vaccine in patients with rheumatic diseases. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp1060-1061', '10.1136/annrheumdis-2018-eular.1500', '']\n",
      "['9737939', 'Suzuki T. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist. Nippon rinsho. Japanese journal of clinical medicine. (2002) 60 12 pp2397-2400', '10.1016/j.clinthera.2004.12.019', '']\n",
      "['9737940', 'IRCT20170812035630N1. Study of the effect of curcumin on rheumatism. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20170812035630N1. (2018)   pp', '10.1186/isrctn90184217', '']\n",
      "['9737942', 'NCT00386048. Pain Management Protocol for Pediatric Sickle Cell Disease. https://clinicaltrials.gov/show/NCT00386048. (2006)   pp', '10.1093/oso/9780195169850.003.0036', '']\n",
      "['9737943', 'Rezaeepoor Mahsa; Pourjafar Mona; Tahamoli-Roudsari Ahmad; Basiri Zahra; Hajilooi Mehrdad; Solgi Ghasem. Altered expression of microRNAs may predict therapeutic response in rheumatoid arthritis patients. International immunopharmacology. (2020) 83  pp106404', '10.1016/j.intimp.2020.106404', '']\n",
      "['9737944', 'Stathakopoulos V; Evaggelatos A; Painesis G; Kottikas K. Rheumatoid arthritis in Greece: patient journey, access to treatment barriers and their impact to adherence. Annals of the rheumatic diseases. (2016) 75  pp1249-', '10.1136/annrheumdis-2016-eular.4613', '']\n",
      "['9737945', 'Moeller B; Finckh A; Alvaro-Gracia J-M; Scholz G; Aletaha D; Biondo F; Strengholt S; Rivas JL; Connell CA; Shi H. Baseline characteristics and outcomes in patients with anaemia in clinical studies of tofacitinib in rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp753-754', '10.1136/annrheumdis-2019-eular.399', '']\n",
      "['9737946', 'Boone N; Sepriano A; Janknegt R; Van DerKuy H; Peeters R; Landewe R. Treatment with methotrexate in rheumatoid arthritis patients on stable biological treatment gives better outcomes over time. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp914', '10.1136/annrheumdis-2018-eular.6775', '']\n",
      "['9737947', 'Sambrook P; Devogelaer J; Reginster J; Saag K; Roux C; Lau C; Papanastasioug P; Schoenborn-Kellenberger O; Maylandt K; Fashola T; Mesenbrink P; Reid D. Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoidinduced osteoporosis. Bone. (2009) 44 SUPPL. 1 ppS96', '10.1016/j.bone.2009.01.421', '']\n",
      "['9737948', 'Klink AJ; Tuell K; Szymialis R; Curtice T; Gupta K; Nero D; Feinberg BA. Choice of initial biologic disease-modifying antirheumatic drug impacts healthcare resource use among patients with rapidly progressing rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp528', '10.1136/annrheumdis-2018-eular.2114', '']\n",
      "['9737949', 'Cheesman S; Shah R; Lambert J; Cwynarski K; Townsend W; McNamara C; Virchis A; Ardeshna K. Responses to R-CHOP chemotherapy incorporating biosimilar rituximab (Truxima) for the first line treatment of diffuse large B-cell lymphoma-initial experience at University College London Hospital. Hemasphere. (2019) Conference: 24th Congress of the European Hematology Association. Netherlands. 3 Supplement 1 pp108-109', '10.1097/01.hs9.0000559460.76601.7a', '']\n",
      "['9737951', 'Boumans M J H; Houbiers J G A; Verschueren P; Ishikura H; Westhovens R; Brouwer E; Rojkovich B; Kelly S; den Adel; Isaacs J; Jacobs H; Gomez-Reino J; Holtkamp G M; Hastings A; Gerlag D M; Tak P P. Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Annals of the rheumatic diseases. (2011)   pp', '10.1136/annrheumdis-2011-200298', '']\n",
      "['9737952', 'Vetter G. Double blind cross over study of clopirac and naproxen in rheumatoid arthritis. Journal belge de rhumatologie ET de medicine physique. (1975) 30 Spec.nr. pp107-111', '10.3109/03009747309097118', '']\n",
      "['9737953', 'Kogstad O. A double blind cross over study of naproxen and indomethacin in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1973) 2 Sup.2 pp159-163', '10.3109/03009747309097118', '']\n",
      "['9737954', 'Obeid S; Libby P; Husni E; Pfeffer MA; Wisniewski LM; Davey DA; Wolski KE; Wang QW; Feng R; Nissen SE; Luscher TF. Cardiorenal risk of celecoxib compared to naproxen, or ibuprofen in arthritis patients: a sub-analysis of the PRECISION trial. European heart journal. (2018) Conference: European Society of Cardiology Congress, ESC 2018. Germany. 39 Supplement 1 pp1116-1117', '10.1093/eurheartj/ehy566.p5421', 'http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy566.P5421/25578788/ehy566.p5421.pdf']\n",
      "['9737955', 'Chlud K; Kaik B; Pangerl S. Indometacin glucosamide in the therapy of rheumatoid arthritis. Arzneimittel-forschung/drug research. (1978) 28 7 pp1200-1201', '10.1093/rheumatology/xvii.suppl.53', 'http://academic.oup.com/rheumatology/article-pdf/XVII/suppl/53/5163082/XVII-suppl-53.pdf']\n",
      "['9737956', 'UMIN000012399. Performance of Rheumascan in healthy subjects and patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012399. (2013)   pp', '10.7554/elife.01202.003', '']\n",
      "['9737957', 'Mytych D; Miller MJ; Starcevic Manning M; Wala I; Wang H; Zhang N; Krishnan E; Kaliyaperumal A. Time course of the incidence and magnitude of anti-drug antibodies to adalimumab and ABP 501 and among patients on concomitant immunomodulatory therapy. United european gastroenterology journal. (2018) 6 8 Supplement ppA450-A451', '10.1093/ecco-jcc/jjx180.878', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S490/23745275/jjx180.878.pdf']\n",
      "['9737959', 'Minator Sajjadi Mohammadreza; Keyhani Sohrab; Kazemi Seyyed Morteza; Hanafizadeh Behzad; Ebrahimpour Adel; Banasiri Mohammad. Patient Satisfaction Following Total Knee Arthroplasty: comparison of Short-Term Results in Rheumatoid Arthritis and Osteoarthritis. The archives of bone and joint surgery. (2019) 7 1 pp61-66', '10.2106/jbjs.18.01468', '']\n",
      "['9737960', \"Sandborn WJ; Panes J; D'Haens GR; Sands BE; Su C; Moscariello M; Jones TV; Pedersen RD; Friedman GS; Lawendy N; Chan G. TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 4.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS. Gastroenterology. (2018) 154 6 Supplement 1 ppS-178\", '10.1016/s0016-5085(18)31006-0', '']\n",
      "['9737961', 'NCT02141997. A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate. https://clinicaltrials.gov/show/NCT02141997. (2014)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9737962', 'Suto Takahito; Yonemoto Yukio; Okamura Koichi; Sakane Hideo; Takeuchi Kimihiko; Tamura Yasuyuki; Kaneko Tetsuya; Ayabe Keio; Chikuda Hirotaka. The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis. Modern rheumatology. (2019) 29 5 pp775-781', '10.1080/14397595.2018.1510879', '']\n",
      "['9737963', 'Zhang Fangze; Ma Cuili. Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients. Clinical rheumatology. (2018) 37 1 pp199-204', '10.1007/s10067-017-3806-3', 'http://link.springer.com/article/10.1007/s10067-017-3806-3/fulltext.html']\n",
      "['9737964', 'Wilkinson A; Reed M; Else S. Audit: impact of musculoskeletal ultrasound use in rheumatology clinics. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp2055', '10.1136/annrheumdis-2019-eular.5310', '']\n",
      "['9737965', 'Mohamed Mohamed-Eslam F; Klunder Ben; Camp Heidi S; Othman Ahmed A. Exposure-Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection. Clinical pharmacology and therapeutics. (2019) 106 6 pp1319-1327', '10.1002/cpt.1543', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1543']\n",
      "['9737966', 'ChiCTR-TRC-12001913. Pre-pregnancy periodontal disease therapy and inflammatory response related to pregnant outcomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-12001913. (2012)   pp', '10.1055/b-0034-75752', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-75752.pdf']\n",
      "['9737967', \"Giuffrida G; Bagnato G; Campenni A; Giovinazzo S; Keller K P; Alibrandi A; Roberts W N; Trimarchi F; Ruggeri R M. Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study. Journal of endocrinological investigation. (2020) 43 1 pp87-94\", '10.1007/s40618-019-01083-w', 'http://link.springer.com/article/10.1007/s40618-019-01083-w/fulltext.html']\n",
      "['9737968', 'EUCTR2011-001220-38-BE. A study identifying blood serum markers that predict response to a 12 week treatment with secukinumab in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001220-38-BE. (2011)   pp', '10.1007/s00296-018-4149-3', 'http://link.springer.com/article/10.1007/s00296-018-4149-3/fulltext.html']\n",
      "['9737969', 'Feldthusen Caroline; Mannerkorpi Kaisa. Factors of importance for reducing fatigue in persons with rheumatoid arthritis: a qualitative interview study. BMJ open. (2019) 9 5 ppe028719', '10.1136/bmjopen-2018-028719', '']\n",
      "['9737970', 'Svensson B; Forslind K; Andersson M. Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study. Scandinavian journal of rheumatology. (2020)   pp1-8', '10.1080/03009742.2020.1729404', '']\n",
      "['9737972', 'Lin W; Hsia P; Yang W; Horng C. The physio-psycho- social function of women with systemic lupus erythematosus and rheumatoid arthritis. Nursing research (10226265). (1999) 7 3 pp261-275', '10.1016/j.artres.2010.10.055', '']\n",
      "['9737975', 'Zhou Y; Luo Y; Yu Z; Liao C; Bai Y; Xiong Y; Yang C; Chen B; Tang Y; Li Y; Tjahjono AW; Liang F; Wu P. Effectiveness of grain-sized moxibustion for rheumatoid arthritis: study protocol for a randomized controlled trial. European journal of integrative medicine. (2020) 35  pp', '10.1016/j.eujim.2020.101094', '']\n",
      "['9737976', 'EUCTR2005-000902-30-GB. A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-000902-30-GB. (2005)   pp', '10.1055/b-0034-61126', 'http://www.thieme-connect.de/products/ebooks/pdf/10.1055/b-0034-61126.pdf']\n",
      "['9737977', 'Bingham Clifton O 3rd; Gaich Carol L; DeLozier Amy M; Engstrom Kathryn D; Naegeli April N; de Bono Stephanie; Banerjee Pixy; Taylor Peter C. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials. (2019) 20 1 pp182', '10.1186/s13063-019-3272-0', 'http://link.springer.com/article/10.1186/s13063-019-3272-0/fulltext.html']\n",
      "['9737978', 'Fernandez-Avila DG; Rojas MX; Ramirez C; Rodelo L; Soriano E. Effectiveness of the use of an algorithm in the diagnostic approach of joint pain patients by primary care physicians. Rheumatology international. (2020)   pp', '10.1007/s00296-020-04552-1', 'http://link.springer.com/article/10.1007/s00296-020-04552-1/fulltext.html']\n",
      "['9737979', 'Jndoyan Z T; Bablumyan A Yu; Ginosyan K V; Shekoyan S V. Correlations between indicators of interleukin-10 and interleukin-6 in patients with periodic disease. Terapevticheskii arkhiv. (2018) 90 3 pp38-41', '10.26442/terarkh201890338-41', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/32728/pdf']\n",
      "['9737982', 'UMIN000013885. Evaluation of cardiac risk in rheumatoid arthritis patients befoer and after treatment of Biologics in retrospective study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013885. (2014)   pp', '10.1186/ar4472', 'https://link.springer.com/article/10.1186/ar4472/fulltext.html']\n",
      "['9737983', 'Michael Gendreau. A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis. Therapeutic apheresis. (2001) 5 2 pp79-83', '10.1046/j.1526-0968.2001.005002079.x', '']\n",
      "['9737984', 'Zhu J Y; Lv S G. Observations on the Therapeutic Effect of Abdominal Acupuncture on Rheumatoid Arthritis. Shanghai journal of acupuncture and moxibustion [shang hai zhen jiu za zhi]. (2016) 35 9 pp1106-1108', '10.1016/s1003-5257(17)30079-x', '']\n",
      "['9737985', 'ChiCTR-TRC-08000293. Lateral patellar retinaculum release in total knee arthroplasty: a prospective randomized study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-08000293. (2008)   pp', '10.1007/s00167-013-2789-0', 'http://link.springer.com/article/10.1007/s00167-013-2789-0/fulltext.html']\n",
      "['9737987', 'Pappas Dimitrios A; Etzel Carol J; Crabtree Margaux; Blachley Taylor; Best Jennie; Zlotnick Steve; Kremer Joel M. Effectiveness of Tocilizumab in Patients With Rheumatoid Arthritis is Unaffected by Comorbidity Burden or Obesity: data From a US Registry. Journal of rheumatology. (2020)   pp', '10.3899/jrheum.190282', '']\n",
      "['9737988', 'Shi W; Wang Y M; Cheng N N; Chen B Y; Li D. Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs. Zhonghua liu xing bing xue za zhi. (2003) 24 11 pp1044-1048', '10.2139/ssrn.3903939', '']\n",
      "['9737990', 'Roelsgaard Ida K; Esbensen Bente A; Ostergaard Mikkel; Rollefstad Silvia; Semb Anne G; Christensen Robin; Thomsen Thordis. Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases. Cochrane database of systematic reviews (Online). (2019) 9  ppCD012958', '10.1002/14651858.cd012958.pub2', '']\n",
      "['9737991', 'Hemmati A A; Rajaee E; Houshmand G; Fakhroddin M A; Dargahi-MalAmir M; Hesam S; Maram N S. Study the effects of anti-inflammatory curcumex capsules containing three plants (ginger, curcumin and black pepper) in patients with active Rheumatoid Arthritis. IIOAB journal. (2016) 7 Supplement 5 pp389-392', '10.5539/gjhs.v8n7p18', 'http://www.ccsenet.org/journal/index.php/gjhs/article/viewFile/52769/29170']\n",
      "['9737992', 'Miler Marijana; Nikolac Gabaj Nora; Grazio Simeon; Vahtaric Antonio; Vrtaric Alen; Grubisic Frane; Skala Kavanagh Hana; Doko Vajdic Ines; Vrkic Nada. Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study. Rheumatology international. (2020)   pp', '10.1007/s00296-020-04607-3', 'https://link.springer.com/article/10.1007/s00296-020-04607-3/fulltext.html']\n",
      "['9737993', \"Nessen Thomas; Opava Christina H; Demmelmaier Ingrid. Physiotherapists' Adoption of a Theory-Based Skills Training Program in Guiding People with Rheumatoid Arthritis to Health-Enhancing Physical Activity. International journal of behavioral medicine. (2018) 25 4 pp438-447\", '10.1007/s12529-018-9716-1', 'http://link.springer.com/article/10.1007/s12529-018-9716-1/fulltext.html']\n",
      "['9737994', 'NCT02579096. Gout: allopurinol vs. Febuxostat. https://clinicaltrials.gov/show/NCT02579096. (2015)   pp', '10.1007/s40278-021-96727-4', 'https://link.springer.com/article/10.1007/s40278-021-96727-4/fulltext.html']\n",
      "['9737996', 'Lena N-K; Konstaninidis T; Aslanidou M; Triantafyllidis C; Panopoulou M; Tsigalou C. Late Breaking Abstract-Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement. European respiratory journal. (2017) Conference: European Respiratory Society International Congress, ERS 2017. Italy. 50 Supplement 61 pp', '10.1183/1393003.congress-2017.oa2894', '']\n",
      "['9737998', 'EUCTR2007-005775-34-GB. Clinical Trial of Maggots for Cleaning Leg Ulcers. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005775-34-GB. (2007)   pp', '10.1186/isrctn37496076', '']\n",
      "['9737999', 'Nagai Yoshiki; Yokogawa Naoto; Shimada Kota; Sugii Shoji. Comparison of the clinical characteristics and severity of community-acquired pneumonia between patients with rheumatoid arthritis treated with tocilizumab and those treated with TNF inhibitor. Modern rheumatology. (2019) 29 5 pp782-787', '10.1080/14397595.2018.1515059', '']\n",
      "['9738000', 'Megeff CE; Strayer SM. Celecoxib for rheumatoid arthritis. Journal of family practice. (2000) 49 2 pp108-109', '10.1016/s0300-7073(06)74300-6', '']\n",
      "['9738001', '. An integrated proteomics and antibody analysis of the U-Act-Early trial to identify markers of treatment response and disease progression in early rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1574-', '10.1136/annrheumdis-2019-eular.5049', '']\n",
      "['9738002', 'Kavanaugh A; Ponce L; Cseuz R; Reshetko O; Stanislavchuk M; Greenwald M; Van Der Aa; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634), an oral JAK1 selective inhibitor is effective as monotherapy in patients with active rheumatoid arthritis: results from a 24-week phase 2b dose ranging study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp247', '10.1136/annrheumdis-2016-eular.3862', '']\n",
      "['9738004', 'EUCTR2009-015653-20-NL. Prospective study on the effects of etanercept treatment in patients with rheumatoid arthritis who are na√Øve for TNF-alpha blocking therapy and patients who do not respond (anymore) to prior treatment with other anti-TNF-alpha medication - Not applicable. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015653-20-NL. (2010)   pp', '10.1186/isrctn89222125', '']\n",
      "['9738005', 'IRCT201206234105N9. The effects of probiotic supplementation on symptoms and inflammatory biomarkers in women with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201206234105N9. (2012)   pp', '10.1002/ptr.6723', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.6723']\n",
      "['9738006', 'Cutolo M; Straub RH; Buttgereit F. Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Annals of the rheumatic diseases. (2008) 67 7 pp905-908', '10.1136/ard.2008.088955', '']\n",
      "['9738007', 'NCT04349371. Saved From COVID-19. https://clinicaltrials.gov/show/NCT04349371. (2020)   pp', '10.1211/pj.2021.1.71749', '']\n",
      "['9738009', 'Arin G; Sonmez HE; Karaca NB; Sag E; Ozcadirci A; Demir S; Oflaz FB; Bilginer Y; Aydin Hakli D; Alpar R; Unal E; Ozen S. Which one has a greater effect on function and the psychosocial status in jia?: disease type or the presence of pain. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1858', '10.1136/annrheumdis-2018-eular.5860', '']\n",
      "['9738010', 'DRKS00005807. Refractory Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00005807. (2014)   pp', '10.55776/kli317', '']\n",
      "['9738011', 'SLCTR/2008/008. Trial of rituximab in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=SLCTR/2008/008. (2008)   pp', '10.1037/e535762009-008', '']\n",
      "['9738012', 'UMIN000006653. Trabecular Metal Primary Hip Prosthesis Registry Study -Multicenter clinical research in Japan and US-. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000006653. (2011)   pp', '10.52198/21.sti.38.os1436', '']\n",
      "['9738014', 'UMIN000004797. Clinical Study on the Efficacy and Safety of Z101101 in Total Hip Arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004797. (2011)   pp', '10.23977/medsc.2024.050220', 'https://www.clausiuspress.com/assets/default/article/2024/05/04/article_1714839567.pdf']\n",
      "['9738015', 'De Agustin JJ; Erra A; Ponce A; Moragues C; Diaz C; Moya P; Reina D; Estrada P; Casado E; Moreno M; Ramirez J; Mateo L; Pujol M; Ros S; Santo P; Sirvent EL; Narvaez J; Sanmarti R; Garcia Yebenes M; Carmona L. Development and validation of an ultrasonographic activity score (USAS) for rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1697-1698', '10.1136/annrheumdis-2018-eular.3824', '']\n",
      "['9738016', 'Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schulze-Koops H; Schett G; Spiera R; Unizony SH; Collinson N. Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab. Arthritis and rheumatology. (2019) 71 8 pp1329-1338', '10.1002/art.40876', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40876']\n",
      "['9738018', \"Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjogren's syndrome: results of a pilot monocentric trial. Clinical otolaryngology. (2018) 43 1 pp96-102\", '10.1111/coa.12911', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcoa.12911']\n",
      "['9738019', 'ISRCTN58751336. A prospective randomised trial to examine the therapeutic effects of hydrotherapy in chronic rheumatoid arthritic patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN58751336. (2002)   pp', '10.1186/isrctn58751336', '']\n",
      "['9738021', 'Lau Arthur N; Wong-Pack Matthew; Rodjanapiches Rod; Ioannidis George; Wade Sally; Spangler Leslie; Balasubramanian Akhila; Pannacciulli Nicola; Lin Celia J F; Roy-Gayos Patrick; Bensen William G; Bensen Robert; Adachi Jonathan D. Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. Journal of rheumatology. (2018) 45 2 pp170-176', '10.3899/jrheum.161270', '']\n",
      "['9738022', 'McIlroy S; Lam J; Grahovac G; Bell D. P155. Clinical outcomes of conservatively managed type II odontoid fractures in older people. Spine journal. (2019) Conference: Proceedings of the 34th Annual Meeting of the North American Spine Society. United States. 19 9 Supplement ppS230', '10.1016/j.spinee.2019.05.580', '']\n",
      "['9738023', 'ISRCTN16316564. Telemonitoring of patient administered score RAPID3 to deliver NICE compliant treatment in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN16316564. (2019)   pp', '10.1186/isrctn16316564', '']\n",
      "['9738024', '. Impact of inflammatory cytokine IL-1B on the expression of multiple drug resistance protein BCRP/ABCG2 in synoviocytes of patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) 78  pp1522-', '10.1136/annrheumdis-2019-eular.3261', '']\n",
      "['9738025', 'CTRI/2013/09/003963. Study to compare the safety and efficacy of etanercept of Intas Biopharmaceuticals Ltd against Enbrel‚àö√á¬¨√Ü in patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2013/09/003963. (2013)   pp', '10.1136/annrheumdis-2013-eular.736', '']\n",
      "['9738026', 'Wright V; Walker W C; McGuire R J. Lndomethacin in the treatment of rheumatoid arthritis. a controlled trial comparing indomethacin, phenylbutazone, and placebo. Ann.rheum.dis.. (1969) 28 2 pp1102-1116', '10.1136/ard.28.2.157', '']\n",
      "['9738027', 'Shi Lianjie; Ning Ying; Xu Liling; Li Jianhong; Zhang Xuewu. Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis. Biomed research international. (2018) 2018  pp7902760', '10.1155/2018/7902760', 'http://downloads.hindawi.com/journals/bmri/2018/7902760.pdf']\n",
      "['9738028', 'UMIN000020046. A study of the relationship between the HLA-DR beta 1 genotype and therapeutic response of abatacept (ABT) in patients with rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000020046. (2015)   pp', '10.1186/isrctn18262002', '']\n",
      "['9738029', 'IRCT20181130041802N1. Ghams inferior extremity on knee pain relief. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20181130041802N1. (2019)   pp', '10.1186/isrctn42045594', '']\n",
      "['9738030', 'Chua L; Macias W L; Tham L. An exposure-response model characterizing the time-course of DAS28-HSCRP in rheumatoid arthritis (RA) patients on baricitinib. Clinical pharmacology and therapeutics. (2013) 93 SUPPL. 1 ppS38', '10.1002/psp4.12251', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsp4.12251']\n",
      "['9738031', 'Brugueras N E; LeZotte L A; Moxley T E. Ibuprofen: a double-blind comparison of twice-a-day therapy with four-times-a-day therapy. Clinical therapeutics. (1978) 2 1 pp13-21', '10.1016/s0149-2918(01)80033-3', '']\n",
      "['9738033', 'Tak P P; Durez P; Gomez-Reino J J; Wittmer B; Chindalore V; Di Padova; Wright A M. AIN457 shows a good safety profile and clinical benefit in patients with active rheumatoid arthritis (RA) despite methotrexate therapy: 16-weeks results from a randomized proof-of-concept trial. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1922', '10.1002/art.24978', '']\n",
      "['9738034', 'UMIN000008840. Postoperative quadriceps strength of continuous femoral ropivacaine or levobupivacaine: a prospective, randomized double-blind trial after total knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008840. (2012)   pp', '10.1213/ane.0b013e318168b493', '']\n",
      "['9738037', 'NTR4853. Treat early arthralgia to reverse or limit impending exacerbation to rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4853. (2014)   pp', '10.1186/s13063-020-04731-2', 'https://link.springer.com/article/10.1186/s13063-020-04731-2/fulltext.html']\n",
      "['9738039', 'ChiCTR1900021808. A Phase 1, Randomized, Double-Blind and Paralle, Controlled Single-dose Clinical Trial of Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of QX003S  and Tocilizumab in Chinese Health Male Subjects. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900021808. (2019)   pp', '10.1111/dom.15441/v1/review1', '']\n",
      "['9738040', 'McCullough Patrick J; Lehrer Douglas S; Amend Jeffrey. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience. Journal of steroid biochemistry and molecular biology. (2019) 189  pp228-239', '10.1016/j.jsbmb.2018.12.010', '']\n",
      "['9738041', 'NCT03726788. Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis. Https://clinicaltrials.gov/show/nct03726788. (2018)   pp', '10.5005/jp/books/10399_19', '']\n",
      "['9738042', 'EUCTR2015-003638-28-DK. Treatment of osteoporosis in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003638-28-DK. (2015)   pp', '10.4000/methodos.4314', '']\n",
      "['9738043', 'CTRI/2018/12/016560. Clinical Study to evaluate the Efficacy and Safety of Curcumin in Patients with Chronic joint pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/12/016560. (2018)   pp', '10.1186/isrctn11180496', '']\n",
      "['9738046', 'Gorlier Clemence; Gottenberg Jacques-Eric; Laurans Ludivine; Simon Tabassome; Ait-Oufella Hafid; Sellam Jeremie. Serum level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a biomarker of synovitis in rheumatoid arthritis. International journal of rheumatic diseases. (2019) 22 9 pp1616-1618', '10.1111/1756-185x.13656', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13656']\n",
      "['9738047', 'ChiCTR1900024166. Chinese Medicine Prevention and Treatment Program for Pre-clinical Rheumatoid Arthritis: an Evidence-based Evaluation Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900024166. (2019)   pp', '10.1142/9789811260377_0002', '']\n",
      "['9738048', 'Bartels EM; Lund H; Danneskiold-Samsoe B. Pool exercise therapy of rheumatoid arthritis. Ugeskrift for laeger. (2001) 163 40 pp5507-5513', '10.1093/rheumatology/kep294', 'http://academic.oup.com/rheumatology/article-pdf/48/12/1520/5054242/kep294.pdf']\n",
      "['9738050', \"EUCTR2007-003537-16-NL. Estetrol Therapy in Sjogren's Syndrome: an Open Proof of Concept Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-003537-16-NL. (2007)   pp\", '10.1186/isrctn14760638', '']\n",
      "['9738051', 'NCT01058018. Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease. https://clinicaltrials.gov/show/NCT01058018. (2010)   pp', '10.1161/circulationaha.118.036240', '']\n",
      "['9738052', 'IRCT20141012019511N3. Efficacy of Cognitive-Behavioral Therapy Approach for Adherence and  Depression (CBT-AD) on Depression and Non-Adherence to treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20141012019511N3. (2018)   pp', '10.1016/j.cbpra.2006.11.006', '']\n",
      "['9738053', 'Flaherty KR; Wells AU; Clerisme-Beaty E; Cottin V; Devaraj A; Inoue Y; Richeldi L; Walsh S; Goeldner R; Schlenker-Herceg R; Brown KK. Characteristics of patients with progressive fibrosing interstitial lung diseases (ILDS) in the inbuild trial of nintedanib. American journal of respiratory and critical care medicine. (2019) Conference: 2019 International Conference of the American Thoracic Society , ATS 2019. United States. 199 9 pp', '10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5627', '']\n",
      "['9738054', \"Nagasaki Toshiki; Nagata Yuki; Wakita Yosuke; Yamada Shinsuke; Goto Hitoshi; Imanishi Yasuo; Onoda Naoyoshi; Emoto Masanori; Inaba Masaaki. Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditis. Minerva endocrinologica. (2018) 43 4 pp398-405\", '10.23736/s0391-1977.18.02725-6', '']\n",
      "['9738055', 'Ringold S; Tomlinson G; Weiss PF; Schanberg LE; Feldman BM; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Kimura Y. The childhood arthritis and rheumatology research alliance start time optimization of biologic therapy in polyarticular JIA study: interim report of baseline patient characteristics and treatment choices. Pediatric rheumatology. (2018) Conference: 2018 Childhood Arthritis and Rheumatology Research Alliance Scientific Meeting, CARRA 2018. United States. 16 Supplement 1 pp', '10.1002/art.41888', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41888']\n",
      "['9738056', 'Tan York Kiat; Moorakonda Rajesh Babu; Allen John Carson Jr; Chew Li-Ching; Thumboo Julian. Back to the basics: understanding joint swelling and tenderness at the wrist in rheumatoid arthritis through the use of ultrasonography. International journal of rheumatic diseases. (2019) 22 1 pp68-72', '10.1111/1756-185x.13389', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13389']\n",
      "['9738057', '. Abatacept improves synovitis as assessed by magnetic resonance imaging (MRI) in psoriatic arthritis-preliminary analysis from a single centre, placebo-controlled, crossover study. Arthritis and rheumatology.. (2014) 66 SUPPL. 10 ppS697', '10.1136/annrheumdis-2014-eular.5531', '']\n",
      "['9738058', 'Chang D J; Lamothe M; Stevens R M; Sigal L H. Dapsone in rheumatoid arthritis. Seminars in arthritis and rheumatism. (1996) 25 6 pp390-403', '10.1016/s0049-0172(96)80004-7', '']\n",
      "['9738062', 'Churakov O I; Shilkina N P. An ultrasonographic study of the major arteries of the neck in patients with rheumatoid arthritis. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. (2008) 14 1 pp39-42', '10.1177/000331977002100909', 'http://journals.sagepub.com/doi/pdf/10.1177/000331977002100909']\n",
      "['9738063', 'Schmalz G; Patschan D; Schmickler J; Bethke N; Scherzinger E; Muller GA; Ziebolz D; Patschan S. Oral health-related quality of life in different rheumatic diseases. Oral diseases. (2020)   pp', '10.1111/odi.13464', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.13464']\n",
      "['9738064', 'Horneff G; Ganser G; Foeldvari I; Weller-Heinemann F; Hospach A; Minden K; Klein A. Long term pharmacovigilance of biologics for juvenile idiopathic arthritis: the Bikerregistry. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp488-489', '10.1136/annrheumdis-2018-eular.2128', '']\n",
      "['9738065', 'Soriano ER; Madariaga HJ; Castaneda O; Citera G; Schneeberger EE; Cardiel MH; Hendrikx T; Graham D; Shi H; De Leon DP. Liver enzyme abnormalities after to facitinib treatment in patients with hepatic steatosis from the rheumatoid arthritis, psoriatic arthritis, and psoriasis clinical programs. Journal of clinical rheumatology. (2019) 25 3 ppS40-', '10.1136/annrheumdis-2018-eular.2517', '']\n",
      "['9738066', 'Hawkey C J; Wilson I; Naesdal J; Langstrom G; Swannell A J; Yeomans N D. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Gut. (2002) 51 3 pp344-350', '10.1136/gut.51.3.344', '']\n",
      "['9738067', 'Li LC; Feehan LM; Shaw C; Xie H; Sayre EC; Avina-Zubeita A; Grewal N; Townsend AF; Gromala D; Noonan G; Backman CL. A technology-enabled Counselling program versus a delayed treatment control to support physical activity participation in people with inflammatory arthritis: study protocol for the OPAM-IA randomized controlled trial. BMC rheumatology. (2017) 1 1) (no pagination pp', '10.1186/s41927-017-0005-4', 'http://link.springer.com/content/pdf/10.1186/s41927-017-0005-4.pdf']\n",
      "['9738070', 'ISRCTN62313758. High Intensity Training in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN62313758. (2008)   pp', '10.1186/isrctn62313758', '']\n",
      "['9738071', 'IRCT2016051320112N6. Erythropoietin versus dextrose prolotherapy in pain relief of knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016051320112N6. (2016)   pp', '10.4103/jrms.jrms_802_16', '']\n",
      "['9738072', 'NCT01040715. Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists. https://clinicaltrials.gov/show/NCT01040715. (2009)   pp', '10.26717/bjstr.2021.36.005811', '']\n",
      "['9738074', 'NCT01384422. Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients. https://clinicaltrials.gov/show/NCT01384422. (2011)   pp', '10.31525/ct1-nct03944096', '']\n",
      "['9738075', 'IRCT201108174242N2. Acupuncture in Treatment of Carpal Tunnel Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201108174242N2. (2011)   pp', '10.23880/ipcm-16000210', 'https://medwinpublishers.com/IPCM/tens-and-acupuncture-in-treatment-of-carpal-tunnel-syndrome.pdf']\n",
      "['9738076', 'IRCT2015062422901N1. Study of Buprenorphine augmentation in regular treatment of resistant obsessive compulsive disorder. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015062422901N1. (2015)   pp', '10.1186/isrctn83050762', '']\n",
      "['9738077', 'EUCTR2012-003654-86-HU. Evaluation of different oral doses and regimens of GLPG0634 given for 24 weeks in patients with active rheumatoid arthritis and an insufficient response to methotrexate alone. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003654-86-HU. (2013)   pp', '10.1007/s10067-013-2318-z', 'http://link.springer.com/article/10.1007/s10067-013-2318-z/fulltext.html']\n",
      "['9738078', 'NCT00000435. dnaJ Peptide for Relieving Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00000435. (2000)   pp', '10.1007/bf03300390', 'http://link.springer.com/article/10.1007/BF03300390/fulltext.html']\n",
      "['9738079', 'Wang Zengfu; Chen Dali; Wang Zhongwei. Effects of diclofenac on the pharmacokinetics of celastrol in rats and its transport. Pharmaceutical biology. (2018) 56 1 pp269-274', '10.1080/13880209.2018.1459740', '']\n",
      "['9738080', 'Gossage DL; Cieslarov√° B; Ap S; Zheng H; Xin Y; Lal P; Chen G; Smith V; Sundy JS. Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis. Clinical therapeutics. (2018) 40 1 pp156-165.e5', '10.1016/j.clinthera.2017.11.011', '']\n",
      "['9738082', \"L'Ami MJ; Ruwaard J; Krieckaert CL; Nurmohamed MT; Rispens T; Wolbink G. Therapeutic drug monitoring to optimise switching between biologic agents in rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp106-107\", '10.1136/annrheumdis-2018-eular.5238', '']\n",
      "['9738084', '. Erratum to: efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: results from a randomized phase II trial (Modern Rheumatology, (2016), 26, 1, (15-23), 10.3109/14397595.2015.1074648). Modern rheumatology. (2018) 28 5 pp911-912', '10.3109/14397595.2015.1074648', '']\n",
      "['9738085', 'Gronning K; Bratas O; Steinsbekk A. Which Factors Influence Self-Efficacy in Patients with Chronic Inflammatory Polyarthritis?. Musculoskeletal care. (2016) 14 2 pp77-86', '10.1002/msc.1114', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1114']\n",
      "['9738088', 'Siebuhr A S; Kehlet S N; Musa K; Byrjalsen I; Karsdal M A; Bay-Jensen A C. A serological biomarker of active mmp3, but total mmp3, can early assess treatment efficacy and differentiate doses of tocilizumab and an early change in active mmp3, but not total mmp3, is associated with radiographic change at 1 year. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1136/annrheumdis-2012-eular.1810', '']\n",
      "['9738090', 'UMIN000012473. Study for variations of safety and efficacy profile caused by division of weekly dose of methotrexate (preliminary study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012473. (2013)   pp', '10.1186/isrctn62739763', '']\n",
      "['9738092', 'Zhang Zhihui; Cao Ying; Yuan Qiang; Zhang Aiguo; Zhang Kaiqi; Wang Zhiwen. Shexiang-Wulong Pills Attenuate Rheumatoid Arthritis by Alleviating Inflammation in a Mouse Model of Collagen-Induced Arthritis. Evidence-based complementary and alternative medicine : eCAM. (2019) 2019  pp5308405', '10.1155/2019/5308405', 'http://downloads.hindawi.com/journals/ecam/2019/5308405.pdf']\n",
      "['9738093', 'Korani Mohsen; Jamshidi Mohammadnabi. The Effect of Aqueous Extract of Trachyspermum ammi Seeds and Ibuprofen on Inflammatory Gene Expression in the Cartilage Tissue of Rats with Collagen-Induced Arthritis. Journal of inflammation research. (2020) 13  pp133-139', '10.2147/jir.s236242', 'https://www.dovepress.com/getfile.php?fileID=56465']\n",
      "['9738094', 'Khalilieh Sauzanne; Hussain Azher; Montgomery Diana; Levine Vanessa; Shaw Peter M; Bodrug Inga; Mekokishvili Lally; Bailey-Smith Candice; Glasgow Xiaoli S; Cheng Amy; Martinho Monika; Iwamoto Marian. Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis. British journal of clinical pharmacology. (2018) 84 10 pp2292-2302', '10.1111/bcp.13670', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.13670']\n",
      "['9738095', 'Forrest C M; Harman G; McMillan R B; Rana C; Shaw S; Stone T W; Stoy N; Darlington L G. Purine Levels and Cytokine Release with Diuretic Administration in Rheumatoid Arthritis. Journal of applied research. (2003) 3 4 pp371-379', '10.1002/chin.200509207', '']\n",
      "['9738096', 'CTRI/2018/09/015765. A study to compare the improvement of hand function in patients suffering from Rheumatoid Arthritis by injecting Depot Methyl Prednisolone either in joints or in muscles. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2018/09/015765. (2018)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9738097', \"NCT04186871. Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sj√∂gren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT04186871. (2019)   pp\", '10.31525/ct1-nct04186871', '']\n",
      "['9738098', 'EUCTR2011-002894-48-BE. Efficacy, pharmacokinetics, and safety of BI 695500 in patients with rheumatoid arthritis: a randomized, double-blind, parallel arm, multiple dose, active comparator trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002894-48-BE. (2012)   pp', '10.1186/isrctn49455679', '']\n",
      "['9738100', 'UMIN000031019. An uncontrolled intervention trial on the effect of denosumab on QOL in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000031019. (2018)   pp', '10.3410/f.725949928.793558766', '']\n",
      "['9738101', 'Kameda Hideto; Uechi Eishi; Atsumi Tatsuya; Abud-Mendoza Carlos; Kamei Kazumasa; Matsumoto Tsugumi; Ponce de Leon Dario; Rehman Muhammad I; Zhang Min; Radominski Sebastiao C. A comparative study of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: a subgroup analysis. International journal of rheumatic diseases. (2020)   pp', '10.1111/1756-185x.13846', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.13846']\n",
      "['9738102', 'UMIN000006224. Evaluation of efficiency and safety of a new hip arthroplasty implant(AMU001)for patients with hip joint diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000006224. (2011)   pp', '10.1177/11207000251317655', 'https://journals.sagepub.com/doi/pdf/10.1177/11207000251317655']\n",
      "['9738103', 'Teramoto Atsushi; Nozaka Koji; Kamiya Tomoaki; Kashiwagura Takeshi; Shoji Hiroaki; Watanabe Kota; Shimada Yoichi; Yamashita Toshihiko. Screw Internal Fixation and Ilizarov External Fixation: a Comparison of Outcomes in Ankle Arthrodesis. Journal of foot and ankle surgery. (2020) 59 2 pp343-346', '10.1053/j.jfas.2019.09.012', '']\n",
      "['9738104', 'Suzuki Takako; Nakamura Yukio; Kato Hiroyuki. Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: an 18-month prospective study. Osteoporosis and sarcopenia. (2019) 5 4 pp122-127', '10.1016/j.afos.2019.11.004', '']\n",
      "['9738105', 'Goud C BK; B S. Role of tissue Doppler echocardiography in the diagnosis of early left ventricular dysfunction in rheumatoid arthritis. Indian heart journal. (2018) Conference: 70th Annual Conference of Cardiological Society of India. India. 70 Supplement 2 ppS22', '10.1016/j.ihj.2018.10.065', '']\n",
      "['9738108', 'Malayeri Alireza; Badparva Reza; Mombeini Mohammad Amin; Khorsandi Layasadat; Goudarzi Mehdi. Naringenin: a potential natural remedy against methotrexate-induced hepatotoxicity in rats. Drug and chemical toxicology. (2020)   pp1-8', '10.1080/01480545.2020.1719132', '']\n",
      "['9738109', 'Marino A; Cimaz R; Giani T; Simonini G; Stagi S. Auxological features in patients with juvenile idiopathic arthritis treated with biologic therapy preliminary study data. Hormone research in paediatrics. (2016) Conference: 55th Annual Meeting of the European Society for Paediatric Endocrinology, ESPE 2016. France. 86 Supplement 1 pp448', '10.1159/000449142', '']\n",
      "['9738110', 'Othman Ahmed A; Khatri Amit; Loebbert Ralf; Peloso Paul M. Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-alpha and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis. Clinical pharmacology in drug development. (2019) 8 4 pp492-502', '10.1002/cpdd.611', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpdd.611']\n",
      "['9738111', 'Horimoto Alex Magno Coelho; da Costa Izaias Pereira. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?. Revista brasileira de reumatologia. (2016) 56 4 pp287-298', '10.1016/j.rbre.2014.12.011', '']\n",
      "['9738112', 'Broms G; Kieler H; Ekbom A; Hellgren K; Gissler M; Lahesmaa-Korpinen A-M; Pedersen L; Schmitt-Egenolf M; Sorensen HT; Granath F. Tnf inhibitor treatment during pregnancy and risk of preterm birth. Pharmacoepidemiology and drug safety. (2018) Conference: 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Czechia. 27 Supplement 2 pp30-31', '10.1002/pds.4930', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpds.4930']\n",
      "['9738114', 'UMIN000016950. Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abatacept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000016950. (2015)   pp', '10.1186/isrctn27093749', '']\n",
      "['9738115', 'Riaz Amir; Daniyal Muhammad; Ghauri Muhammad Ishaq; Alam Hamza; Zaidi Syed Faisal; Usmanghani Khan; Wang Wei. To evaluate the efficacy and safety of CartiNovex plus tablet in osteoarthritis and rheumatoid arthritis. Pakistan journal of pharmaceutical sciences. (2018) 31 5(Supplementary) pp2033-2040', '10.1111/1440-1681.13282/v2/response1', '']\n",
      "['9738116', 'JapicCTI-060258. A randomized, double-blind, multicenter, placebo-controlled study to determine the efficacy and safety of BTDS compared to placebo in subjects with moderate to severe low back pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-060258. (2006)   pp', '10.1097/j.pain.0000000000000315', '']\n",
      "['9738117', 'Genovese M C; Weinblatt M; Keystone E; Baranauskaite A; Cheong S Y; Ghil J. Impact of anti-drug antibodies on efficacy and safety up to week 24 from a phase III study comparing SB5 (an adalimumab biosimilar) with adalimumab reference product in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp234', '10.1136/annrheumdis-2016-eular.3331', '']\n",
      "['9738119', 'Blackmore Derrick; Siddiqi Zaeem; Li Liang; Wang Nan; Maksymowych Walter. Beyond the antibodies: serum metabolomic profiling of myasthenia gravis. Metabolomics. (2019) 15 8 pp109', '10.1007/s11306-019-1571-9', 'http://link.springer.com/article/10.1007/s11306-019-1571-9/fulltext.html']\n",
      "['9738120', 'EUCTR2018-003877-91-DE. B cell therapy followed by T cell therapy to achieve immune tolerance in rheumatoid arthritis with ACPA antiboidies (TOLERA): an unblinded clinical trial  in one centre with random assignment to treatment  groups in adult patients who failed methotrexate therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-003877-91-DE. (2019)   pp', '10.1186/isrctn27093749', '']\n",
      "['9738122', 'Rho Young Hee; Rychlewska-Hanczewska Anna; Sliwowska Beata; Kim Tae Hyung. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis. Advances in therapy. (2019) 36 9 pp2287-2295', '10.1007/s12325-019-01027-z', 'https://link.springer.com/article/10.1007/s12325-019-01027-z/fulltext.html']\n",
      "['9738124', 'Lee Y H; Song G G. Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Zeitschrift fur Rheumatologie. (2019)   pp', '10.1007/s00393-019-00733-x', 'http://link.springer.com/article/10.1007/s00393-019-00733-x/fulltext.html']\n",
      "['9738125', 'NTR1969. Prevention of RA by B cell directed therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1969. (2009)   pp', '10.1186/isrctn36516369', '']\n",
      "['9738126', 'Khojah Hani M; Ahmed Sameh; Abdel-Rahman Mahran S; Elhakeim Eman H. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clinical rheumatology. (2018) 37 8 pp2035-2042', '10.1007/s10067-018-4080-8', 'http://link.springer.com/article/10.1007/s10067-018-4080-8/fulltext.html']\n",
      "['9738127', 'Thorne C; Karpouzas G; Takeuchi T; Sheng S; Xu W; Xu S; Kurrasch R; Fei K; Hsu B. Response and radiographic progression in biologic-na√Øve and biologic-experienced patients with rheumatoid arthritis treated with sirukumab. Annals of the rheumatic diseases. (2016) 75  pp723-', '10.1136/annrheumdis-2016-eular.4106', '']\n",
      "['9738128', \"Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S. Clinical trial of ambroxol (Mucosolvan) in Sjogren's syndrome. Tokai journal of experimental and clinical medicine. (1988) 13 3 pp165-169\", '10.2177/jsci.13.612', '']\n",
      "['9738130', 'Edgerton C; Radtchenko J; Holers VM. PMS4 OUTPATIENT COSTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH VS WITHOUT COMORBIDITIES. Value in health. (2020) Conference: ISPOR 2020. United States. 23 Supplement 1 ppS214', '10.1016/j.jval.2020.04.691', '']\n",
      "['9738131', 'ISRCTN37558313. Creatine supplementation to treat \"muscle wasting\" in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN37558313. (2013)   pp', '10.1186/isrctn37558313', '']\n",
      "['9738132', 'Moreno Rodriguez; Garcia De Vicuna; Goicoechea Garcia; Tornero Molina. Effects of an occupational therapy intervention in chronic pain perception and quality of life of patients with rheumatoid arthritis. Revista de la sociedad espanola del dolor. (2015) 22 3 pp95-101', '10.4321/s1134-80462015000300002', '']\n",
      "['9738133', 'Glatt Sophie; Taylor Peter C; McInnes Iain B; Schett Georg; Landewe Robert; Baeten Dominique; Ionescu Lucian; Strimenopoulou Foteini; Watling Mark I L; Shaw Stevan. Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study. Annals of the rheumatic diseases. (2019) 78 8 pp1033-1040', '10.1136/annrheumdis-2018-214943', '']\n",
      "['9738134', 'Yoo DH; Jaworski J; Matyska-Piekarska E; Smiyan S; Ivanova D; Zielinska A; Raussi E-K; Batalov A; Lee S; Suh J; Han N; Westhovens R. A novel formulation of CT-P13 (infliximab biosimilar) for subcutaneous administration: 1-year results from a part 1 of phase I/III randomized controlled trial in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp733', '10.1136/annrheumdis-2019-eular.1094', '']\n",
      "['9738135', 'Haraoui Boulos; Jamal Shahin; Ahluwalia Vandana; Fung Diana; Manchanda Tarang; Khraishi Majed. Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study. Rheumatology and therapy. (2018) 5 2 pp551-565', '10.1007/s40744-018-0130-6', 'https://link.springer.com/article/10.1007/s40744-018-0130-6/fulltext.html']\n",
      "['9738136', 'Kanayama Y; Tsuji T; Inagaki H; Futamura N; Ota K; Osada N; Adachi Y; Tachi H; Sugimoto R; Todoroki K. Cliniclal efficacy of denosumab comparison with either active vitamin D or native vitamin D on osteoporosis in patients with Japanese rheumatoid arthritis. Journal of bone and mineral research. (2019) Conference: 2019 Annual Meeting of the American Society for Bone and Mineral Research. United States. 34 Supplement 1 pp253', '10.1136/annrheumdis-2019-eular.6952', '']\n",
      "['9738137', 'Perzynska-Mazan J; Maslinska M; Gasik AR. P54-T Peripheral neuropathy and immunological profile of patients with primary Sjogren syndrome. Clinical neurophysiology. (2019) Conference: European Congress of Clinical Neurophysiology. Poland. 130 7 ppe55', '10.1016/j.clinph.2019.04.417', '']\n",
      "['9738139', 'Sorensen K. Intraarticular treatment of rheumatoid arthritis patients with steroids: a double-blind trial of schering 263/1 VS. depo-medrol. Current therapeutic research - clinical and experimental. (1978) 23 2 I pp173-186', '10.1185/03007997809111911', '']\n",
      "['9738140', \"NCT02398435. Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease. https://clinicaltrials.gov/show/NCT02398435. (2015)   pp\", '10.1136/annrheumdis-2018-214496', '']\n",
      "['9738142', 'Gok Kevser; Erol Kemal; Cengiz Gizem; Ozgocmen Salih. Comparison of Level of Fatigue and Disease Correlates in Patients With Rheumatoid Arthritis and Systemic Sclerosis. Archives of rheumatology. (2018) 33 3 pp316-321', '10.1136/annrheumdis-2016-eular.6192', '']\n",
      "['9738144', 'Gaafar Nada A G; Aslani Mona; Aghazadeh Zahra; Razavi A; Mirshafiey Abbas. The oral administration effect of drug mannuronic acid (M2000) on gene expression of matrix and tissue inhibitor of metalloproteinases in rheumatoid arthritis patients. Current drug discovery technologies. (2019)   pp', '10.2174/1570163816666190620113320', 'https://www.eurekaselect.com/172862/article']\n",
      "['9738146', 'Wang Yi-Ru; Liu Li; Wang Xiao-Yun; Wang Qiong; Yao Min; Cui Xue-Jun; Mao Jian-Chun; Liu Jian; Gu Xiao-Hua; Chen Yong-Li; Yu Xiang; Shi Qi; Liang Qian-Qian; Wang Yong-Jun. The efficacy of the traditional Chinese medicine Jia Wei Niu Bang Zi granule combined with methotrexate in treating active rheumatoid arthritis: a multicenter, randomized, double-blinded controlled clinical trial. Medicine. (2019) 98 6 ppe14424', '10.1097/md.0000000000014424', '']\n",
      "['9738147', 'Keating GM; Jarvis B. Management of rheumatoid arthritis: defining the role of etanercept. Disease management and health outcomes. (2002) 10 1 pp17-39', '10.2165/00115677-200210010-00003', '']\n",
      "['9738150', 'Callhoff J; Albrecht K; Hoffmann F; Luque Ramos A; Zink A. Low income is associated with lower functional capacity and higher disease burden in RA patients younger than 65. Annals of the rheumatic diseases. (2016) 75  pp120-', '10.1136/annrheumdis-2016-eular.1273', '']\n",
      "['9738152', 'EUCTR2016-000568-41-DE. Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000568-41-DE. (2016)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9738154', 'ChiCTR-TRC-09000473. Efficacy and safety of Alendronate on Structural Benefit and Inflammation in Rheumatoid Arthritis(RA): a randomized, open, placebo-controlled, multicentre clinical trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-09000473. (2009)   pp', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9738155', 'ISRCTN61762297. WORKWELL: testing work advice for people with arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN61762297. (2019)   pp', '10.1186/isrctn61762297', '']\n",
      "['9738156', 'Siebert S; Porter D; Paterson C; Hampson R; Gaya D; Latosinska A; Mischak H; Schanstra J; Mullen W; McInnes I. Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups. Scientific reports. (2017) 7 pp 40473 pp40473', '10.1038/srep40473', 'https://www.nature.com/articles/srep40473']\n",
      "['9738158', 'Lee Y H; Song G G. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs. Zeitschrift fur Rheumatologie. (2020)   pp', '10.1007/s00393-020-00796-1', 'https://link.springer.com/article/10.1007/s00393-020-00796-1/fulltext.html']\n",
      "['9738159', 'NCT01154647. Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes. https://clinicaltrials.gov/show/NCT01154647. (2010)   pp', '10.5606/archrheumatol.2020.7348', '']\n",
      "['9738160', 'Jung Gyu-Un; Han Ji-Young; Hwang Kyung-Gyun; Park Chang-Joo; Stathopoulou Panagiota G; Fiorellini Joseph P. Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis. Biomed research international. (2018) 2018  pp1465402', '10.1155/2018/1465402', 'http://downloads.hindawi.com/journals/bmri/2018/1465402.pdf']\n",
      "['9738161', 'Bai Bingqing; Chen Meng; Fu Lingyu; Liu Haina; Jin Lei; Wei Tingting; Xin Fangran. Quality of life and influencing factors of patients with rheumatoid arthritis in Northeast China. Health and quality of life outcomes. (2020) 18 1 pp119', '10.1186/s12955-020-01355-7', 'https://link.springer.com/article/10.1186/s12955-020-01355-7/fulltext.html']\n",
      "['9738163', \"Garcia ABA; Trevisani VFM; Dardin L; Minali PA. Exercise increases aerobic capacity in primary sj√∂gren's syndrome: a randomized controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1743-1744\", '10.3389/fmed.2021.719592', '']\n",
      "['9738164', 'NCT01164111. Preoperative Resistance Training in Patients Scheduled for Total Hip Arthroplasty. https://clinicaltrials.gov/show/NCT01164111. (2010)   pp', '10.1016/j.joca.2013.02.319', '']\n",
      "['9738165', 'Albert-Espi G; Martinez-Alberola N; Martin-Domenech R; Fernandez-Carballido C; Pedraz-Penalva T; Sivera F. A program for screening and treatment of cardiovascular risk factors in patients with chronic arthritis: 2-year results. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp297', '10.1136/annrheumdis-2018-eular.5301', '']\n",
      "['9738167', \"O'Dell JR; Moore GF; Klassen LW. Combination therapy in rheumatoid arthritis: a comment. Rheumatology. (1999) 38 6 pp577-\", '10.1093/rheumatology/38.6.577a', '']\n",
      "['9738168', 'Leiper K; Martin K; Ellis A; Subramanian S; Watson AJ; Christmas S; Howarth D; Campbell F; Rhodes JM. Randomised placebo-controlled trial of rituximab (Anti-CD20) in active ulcerative colitis. Gastroenterology. (2010) Conference: Digestive Disease Week, DDW 2010 New Orleans, LA United States. Conference Start: 20100501 Conference End: 20100506. Conference Publication: var.pagings ppS86', '10.1016/s0016-5085(10)60393-9', '']\n",
      "['9738169', 'Aylward M; Davies D B S. Double blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders. Brit. J. Clin. Pract.. (1972) 26 11 pp517-523', '10.1111/j.1742-1241.1972.tb05065.x', '']\n",
      "['9738170', '. Normal mortality of the cobra early rheumatoid arthritis trial cohort after 23 years follow up. Arthritis and rheumatology. (2018) 70  pp3362-3363', '10.1136/annrheumdis-2018-eular.3675', '']\n",
      "['9738171', 'Choi S; Macias W L; Tham L. An exposure-response model characterizing the time-course of ACR20, ACR50, and ACR70 in rheumatoid arthritis (RA) patients on baricitinib. Clinical pharmacology and therapeutics. (2013) 93 SUPPL. 1 ppS37-S38', '10.1038/psp.2014.41', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fpsp.2014.41']\n",
      "['9738172', 'Kunwar Sumit; Collins Christopher E; Constantinescu Florina. Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Clinical rheumatology. (2018) 37 10 pp2611-2620', '10.1007/s10067-018-4199-7', 'http://link.springer.com/article/10.1007/s10067-018-4199-7/fulltext.html']\n",
      "['9738173', 'Kay J; Weinblatt M; Keystone E; Genovese MC; Baranauskaite A; Cheong SY; Ghil J. Secondary efficacy results up to week 24 from a phase iii study comparing Sb5 (an adalimumab biosimiar) with adalimumab reference product in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2016) 75  pp231-', '10.1136/annrheumdis-2016-eular.2021', '']\n",
      "['9738174', 'NCT03827148. Impact of Pharmacist Intervention on Disease Knowledge, Rehabilitation and Medication Adherence, Treatment Induced Direct Cost, Health-related Quality of Life and Satisfaction in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT03827148. (2019)   pp', '10.1186/s13063-019-3540-z', 'http://link.springer.com/article/10.1186/s13063-019-3540-z/fulltext.html']\n",
      "['9738175', 'Chopra A; Saluja M; Kianifard T; Chitre D; Venugopalan A. Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis. Journal of Ayurveda and integrative medicine. (2018) 9 3 pp201-208', '10.1016/j.jaim.2017.07.009', '']\n",
      "['9738176', 'Liu Defang; Yan Jiao; Guo Mingyang; Luo Yong; Yang Mei; Yang Min; Zou Longfu. Effect of methotrexate combined with Sanhuang Yilong decoction on serum and synovial fluid aquaporin levels in rheumatoid arthritis dampness-heat blockage syndrome. Journal of traditional chinese medicine = chung i tsa chih ying wen pan. (2018) 38 4 pp618-624', '10.1016/s0254-6272(18)30895-1', '']\n",
      "['9738177', 'Vasilenko E; Samigullina RR; Mazurov VI; Trofimov EA; Gaydukova IZ. TNF-inhibitors and anti-B-cell treatment in patients with rheumatoid arthritis. Realworld data from the Russian North-western biological treatment cohort. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1379-1380', '10.1136/annrheumdis-2018-eular.6211', '']\n",
      "['9738178', 'ChiCTR-TRC-14004315. The Clinical application of damage control operation in elderly patients with multiple joint replacement and the orthopedic patients with organ failure. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-14004315. (2014)   pp', '10.1200/jco.2017.35.15_suppl.6006', '']\n",
      "['9738179', 'Karlsson Marie-Louise; Elkan Ann-Charlotte; Hafstrom Ingiald. Widespread pain and pain intensity in patients with early rheumatoid arthritis. A cross-sectional comparison between smokers and non-smokers. Nursing open. (2019) 6 3 pp942-947', '10.1002/nop2.284', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fnop2.284']\n",
      "['9738181', 'Darloy Jean; Segaud Nicolas; Salmon Jean-Hugues; Eschard Jean-Paul; Goeb Vincent; Deprez Xavier; Guyot Marie-Helene; Houvenagel Eric; Lecuyer Nicolas; Marguerie Laurent; Gally Samuel; Pau David; Idier Isabelle; Baudens Guy; Flipo Rene-Marc. Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: the RoSwitch Study. Rheumatology and therapy. (2019) 6 1 pp61-75', '10.1007/s40744-018-0138-y', 'https://link.springer.com/article/10.1007/s40744-018-0138-y/fulltext.html']\n",
      "['9738185', 'Mack A; Neely J. Adalimumab: the First Entirely Human Monoclonal Antibody for Rheumatoid Arthritis. P and t. (2003) 28 8 pp507-512', '10.1002/art.546', '']\n",
      "['9738186', 'DRKS00007341. A Randomized, Open-label Study of the Effect of MabThera Retreatment on Treatment Response in Patients With Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00007341. (2015)   pp', '10.1186/isrctn95861172', '']\n",
      "['9738187', \"Li B; Hou J; Yang Y; Piao X; Chen Y; Xue L; Wang D; Hu J; Li G; Wu X; Sun Y; Jin R. Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjogren's Syndrome: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Evidence-based complementary and alternative medicine. (2017) 2017  pp1315432\", '10.1155/2017/1315432', 'http://downloads.hindawi.com/journals/ecam/2017/1315432.pdf']\n",
      "['9738188', 'Bliddal H; Christensen R; Hojgaard L; Bartels E M; Ellegaard K; Zachariae R; Danneskiold-Samsoe B. Spiritual healing in the treatment of rheumatoid arthritis: an exploratory single centre, parallel-group, double-blind, three-arm, randomised, sham-controlled trial. Evidence-based complementary and alternative medicine. (2014) 2014  pp269431', '10.1155/2014/269431', 'http://downloads.hindawi.com/journals/ecam/2014/269431.pdf']\n",
      "['9738189', 'Gibson R G; Gibson S L M; MacNeill A D; Watson Buchanan. Homeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. British homeopathic journal. (1986) 75 3 pp148-157', '10.1016/s0007-0785(86)80010-2', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1016/S0007-0785(86)80010-2.pdf']\n",
      "['9738190', 'NCT02950142. Evidence-based Laboratory Test Order Sets in Primary Care. https://clinicaltrials.gov/show/NCT02950142. (2016)   pp', '10.1136/bmjopen-2021-059261', '']\n",
      "['9738191', 'Dalili Zahra; Bayazi Mohammad Hossein. The effectiveness of Mindfulness-Based Cognitive Therapy on the illness perception and Psychological Symptoms in patients with Rheumatoid Arthritis. Complementary therapies in clinical practice. (2019) 34  pp139-144', '10.1016/j.ctcp.2018.11.012', '']\n",
      "['9738193', \"Aranow Cynthia; Cush John; Bolster Marcy B; Striebich Christopher C; Dall'era Maria; Mackay Meggan; Olech Ewa; Frech Tracy; Box Jane; Keating Richard; Wasko Mary Chester; St Clair William; Kivitz Alan; Huang Weiquang; Ricketts PetaGay; Welch Beverly; Callahan Sherrie; Spychala Meagan; Boyle Karen; York Kate; Keyes-Elstein Lynette; Goldmuntz Ellen; Diamond Betty; Davidson Anne. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford, England). (2020) 59 7 pp1505-1513\", '10.1093/rheumatology/kez471', 'http://academic.oup.com/rheumatology/article-pdf/59/7/1505/33420445/kez471.pdf']\n",
      "['9738194', \"Suzuki Yasunori; Fujii Hiroshi; Nomura Hideki; Mizushima Ichiro; Yamada Kazunori; Yamagishi Masakazu; Kawano Mitsuhiro. Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjogren's syndrome: a retrospective cohort study. Modern rheumatology. (2018) 28 5 pp872-878\", '10.1080/14397595.2017.1418164', '']\n",
      "['9738195', 'Dev Shruti; Perti Sonali; Garhnayak Mirna; Sahoo Kalinga K; Dhal Angurbala; Garhnayak Lokanath. Intricate Estimation and Evaluation of Mandibular Movements in Geriatric Patients Suffering from Rheumatoid Arthritis. Journal of contemporary dental practice. (2017) 18 9 pp781-784', '10.5005/jp-journals-10024-2126', '']\n",
      "['9738196', 'NCT01600521. A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications. https://clinicaltrials.gov/show/NCT01600521. (2012)   pp', '10.3390/jcm10040876', '']\n",
      "['9738197', 'Liu Yuan; Jaquith Jane M; Mccarthy-Fruin Kathleen; Zhu Xingxing; Zhou Xian; Li Yanfeng; Crowson Cynthia; Davis John M 3rd; Thanarajasingam Uma; Zeng Hu. Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05162-9', 'https://link.springer.com/article/10.1007/s10067-020-05162-9/fulltext.html']\n",
      "['9738199', 'Allam NM; Koura GMR; Alrawaili SM; Hamada HA; Khater HA; Balbaa AA. The effect of siwan therapy in management of patients with rheumatoid arthritis: a single blind randomized controlled trial. Biomedical research (india). (2018) 29 7 pp1400-1406', '10.4066/biomedicalresearch.29-17-2906', '']\n",
      "['9738201', 'Mahmood Naza Mohammed Ali; Hussain Saad Abdulrahman; Mirza Raouf Rahim. Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study. Therapeutics and clinical risk management. (2018) 14  pp1379-1385', '10.2147/tcrm.s174693', 'https://www.dovepress.com/getfile.php?fileID=43532']\n",
      "['9738202', 'CTRI/2017/03/008063. To compare the efficacy and safety of BCD-055 (CJSC BIOCAD, Russia) and Remicade‚àö√á¬¨√Ü with methotrexate in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/03/008063. (2017)   pp', '10.31525/ct1-nct04227366', '']\n",
      "['9738203', 'NCT04246827. Rheumatoid Arthritis Coping Enhancement. https://clinicaltrials.gov/show/NCT04246827. (2020)   pp', '10.31525/ct1-nct04246827', '']\n",
      "['9738206', 'Stolyar Liya; Lahita Robert G; Panush Richard S. Rituximab use as induction therapy for lupus nephritis: a systematic review. Lupus. (2020)   pp961203320928412', '10.1177/0961203320928412', 'https://journals.sagepub.com/doi/pdf/10.1177/0961203320928412']\n",
      "['9738208', 'Cagnin A; Choiniere M; Bureau NJ; Durand M; Mezghani N; Gaudreault N; Hagemeister N. Impact of a personalized home exercise program for knee osteoarthritis patients on 3d kinematics: a cluster randomized controlled trial. Osteoarthritis and cartilage. (2019) 27 Supplement 1 ppS34-S35', '10.1016/j.joca.2019.02.051', '']\n",
      "['9738209', 'NCT03737344. BLOC-ICH: interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage. Https://clinicaltrials.gov/show/nct03737344. (2018)   pp', '10.1177/23969873231185208', 'https://journals.sagepub.com/doi/pdf/10.1177/23969873231185208']\n",
      "['9738210', 'Guin Aharna; Sinhamahapatra Pradyot; Misra Sanchaita; Choudhury Mazumder Sampurna Roy; Chatterjee Sudipta; Ghosh Alakendu. Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration. Biomedical journal. (2019) 42 6 pp394-402', '10.1016/j.bj.2019.01.007', '']\n",
      "['9738211', 'Mobedi Z; Soleimani F; Rafieian M; Parvin N; Taheri E. The effect of oral royal jelly on clinical disease activity index (CDAI) and morning stiffness in patients with rheumatoid arthritis (RA); A randomized double-blind, placebo-controlled trial. Journal of isfahan medical school. (2013) 31 252 pp1428-1434', '10.1007/s10067-021-05670-2', 'https://link.springer.com/article/10.1007/s10067-021-05670-2/fulltext.html']\n",
      "['9738212', 'Lv Q-W; Zhang W; Shi Q; Zheng W-J; Li X; Chen H; Wu Q-J; Jiang W-L; Li H-B; Gong L; Wei W; Liu H; Liu A-J; Jin H-T; Wang J-X; Liu X-M; Li Z-B; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin Y-F; Fei Y-Y; Su J-M; Zhao L-D; Jiang Y; Li J; Tang F-L; Zhang F-C; Lipsky PE; Zhang X. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204807', '']\n",
      "['9738213', 'Luczaj Wojciech; Moniuszko-Malinowska Anna; Domingues Pedro; Domingues Maria Rosario; Gindzienska-Sieskiewicz Ewa; Skrzydlewska Elzbieta. Plasma lipidomic profile signature of rheumatoid arthritis versus Lyme arthritis patients. Archives of biochemistry and biophysics. (2018) 654  pp105-114', '10.1016/j.abb.2018.07.021', '']\n",
      "['9738214', 'Park Jin Kyun; Kim Min Jung; Choi Yunhee; Winthrop Kevin; Song Yeong Wook; Lee Eun Bong. Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials. Clinical rheumatology. (2020) 39 2 pp375-379', '10.1007/s10067-019-04857-y', 'http://link.springer.com/article/10.1007/s10067-019-04857-y/fulltext.html']\n",
      "['9738215', \"EUCTR2007-002752-42-FR. FAKIR : variabilit√© pharmacocin√©tique et de la relation pharmacocin√©tique-phamacodynamique de l'infliximab (Remicade¬Æ) dans la polyarthrite rhumatoide - FAKIR. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-002752-42-FR. (2007)   pp\", '10.4414/phc-f.2021.10384', '']\n",
      "['9738216', \"Dardin; Trevisani VFM; Garcia ABA. Study on the effects of strenght training in pain and disease activity in women with primary Sjogren's syndrome. Advances in rheumatology. Conference: 35th brazilian congress of rheumatology, SBR 2018. Brazil. (2018) 58 Supplement 1) (no pagination pp\", '10.1186/s42358-018-0019-7', 'http://link.springer.com/article/10.1186/s42358-018-0019-7/fulltext.html']\n",
      "['9738217', 'NCT03580681. A Nutrition Intervention for Arthritis -4 (WCCR-ARTH4). Https://clinicaltrials.gov/show/nct03580681. (2018)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9738218', 'IRCT2017092023861N7. The effect of synbiotic supplementation on inflammation in Breast Cancer survivors with Lymphedema. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017092023861N7. (2017)   pp', '10.1080/01635581.2019.1616781', '']\n",
      "['9738219', 'NCT01235598. Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT01235598. (2010)   pp', '10.1093/rheumatology/kew121.004', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i61/5076096/kew121.004.pdf']\n",
      "['9738220', 'Ben Nessib D; Maatallah K; Ferjani H; Kaffel D; Hamdi W. Impact of Ramadan diurnal intermittent fasting on rheumatic diseases. Clinical rheumatology. (2020)   pp', '10.1007/s10067-020-05007-5', 'http://link.springer.com/article/10.1007/s10067-020-05007-5/fulltext.html']\n",
      "['9738221', 'ChiCTR1800020343. Moxibustion intervention for pain in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800020343. (2018)   pp', '10.1186/isrctn46762597', '']\n",
      "['9738223', 'Anvar Naiyer; Matlabi Hossein; Safaiyan Abdolrasoul; Allahverdipour Hamid; Kolahi Sousan. Effectiveness of self-management program on arthritis symptoms among older women: a randomized controlled trial study. Health care for women international. (2018)   pp1-14', '10.1080/07399332.2018.1438438', '']\n",
      "['9738225', 'Shichikawa K; Nagaya I; Ogawa N. Double-blind clinical trial of pirprofen in patients with rheumatoid arthritis. Ryumachi. [Rheumatism]. (1984) 24 5 pp407-414', '10.1002/art.23361', '']\n",
      "['9738226', 'Fettner Scott; Mela Christopher; Wildenhahn Florian; Tavanti Monica; Wells Christine; Douglass Wendy; Mallalieu Navita L. Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. Expert opinion on drug delivery. (2019) 16 5 pp551-561', '10.1080/17425247.2019.1604678', 'https://tandfonline.com/doi/pdf/10.1080/17425247.2019.1604678']\n",
      "['9738227', 'Barroso N; Woodworth T G; Furst D E; Guillemin F; Fautrel B J; Borazan N; Kafaja S; Brook J; Elashoff D A; Ranganath V K. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). Clinical rheumatology. (2020) 39 1 pp189-199', '10.1007/s10067-019-04755-3', 'http://link.springer.com/article/10.1007/s10067-019-04755-3/fulltext.html']\n",
      "['9738228', 'ChiCTR1800019268. Clinical study for probiotics on osteoporosis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800019268. (2018)   pp', '10.1186/isrctn11295995', '']\n",
      "['9738229', 'Atwa Essam Tawfik; Hussin Atef Goda; Mohamed Mona Rabie; Pasha Heba Fouad; Hammad Marwa. Carotid plaques in adult rheumatoid arthritis patients; association with paroxonase 1 enzymatic activity and Q192R paroxonase 1 gene polymorphism. Molecular biology reports. (2020) 47 6 pp4255-4262', '10.1007/s11033-020-05558-5', 'https://link.springer.com/article/10.1007/s11033-020-05558-5/fulltext.html']\n",
      "['9738230', 'NCT00095498. Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00095498. (2004)   pp', '10.1093/rheumatology/kew166.009', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i187/5080308/kew166.009.pdf']\n",
      "['9738232', 'Khadem Azarian Shahin; Jafarnezhad-Ansariha Fahimeh; Nazeri Sepideh; Azizi Gholamreza; Aghazadeh Zahra; Hosseinzadeh Elham; Mirshafiey Abbas. Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORgammat, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients. Immunopharmacology and immunotoxicology. (2020) 42 1 pp22-27', '10.1080/08923973.2019.1702053', '']\n",
      "['9738233', 'Sugimura Y; Kashiwagura T; Kobayashi M; Miyakoshi N; Shimada Y. Clinical outcome of 2 years treatment of the early phase rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1338', '10.1136/annrheumdis-2018-eular.7426', '']\n",
      "['9738234', 'NCT04038970. Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate. Https://clinicaltrials.gov/show/nct04038970. (2019)   pp', '10.31525/ct1-nct04038970', '']\n",
      "['9738235', 'El-Sheikh Sawsan M A; Abd El-Alim Abd El-Alim F; Galal Azza A A; El-Sayed Rehab G; El-Naseery Nesma I. Anti-arthritic effect of beta-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats. Life sciences. (2019) 233  pp116750', '10.1016/j.lfs.2019.116750', '']\n",
      "['9738236', 'Kurth T; Hennekens C H; Buring J E; Gaziano J M. Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis. Current rheumatology reports. (2004) 6 5 pp351-356', '10.1007/s11926-004-0009-0', 'http://link.springer.com/article/10.1007/s11926-004-0009-0/fulltext.html']\n",
      "['9738237', 'Yu Ju; Lin Zheng; Zhang Yu. Influence of authorized education on treatment compliance and quality of life of patients with rheumatoid arthritis. Chinese nursing research. (2015) 29 4B pp1323-1325', '10.11569/wcjd.v23.i10.1637', '']\n",
      "['9738238', 'Pavelka K; Zavada J; Kristkova Z; Szczukova L. Drug survival of adalimumab in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis over 10 years in realworld setting of Czech registry attra. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp605-606', '10.1136/annrheumdis-2018-eular.2407', '']\n",
      "['9738239', 'Feldmann J L; Mery C; Amor B. Treatment of rheumatoid arthritis with levamisole. A double blind controlled trial in 40 patients. European journal of rheumatology and inflammation. (1978) 1 3 pp267-271', '10.1080/03009748109095263', '']\n",
      "['9738240', 'NCT04356183. Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk. https://clinicaltrials.gov/show/NCT04356183. (2020)   pp', '10.1161/circ.149.suppl_1.p212', '']\n",
      "['9738241', 'Khadem Azarian Shahin; Akhlaghi Maassoumeh; Mahmoudi Mahdi; Mostafaei Shayan; Jamshidi Ahmad Reza; Nazeri Sepideh; Mirshafiey Abbas. A randomized clinical trial for the assessment of the efficacy and safety of guluronic acid (G2013) in patients with rheumatoid arthritis. Immunopharmacology and immunotoxicology. (2019) 41 1 pp95-101', '10.1080/08923973.2018.1555844', '']\n",
      "['9738242', 'Oshotse Christiana; Zullig Leah L; Bosworth Hayden B; Tu Pikuei; Lin Cheryl. Self-Efficacy and Adherence Behaviors in Rheumatoid Arthritis Patients. Preventing chronic disease. (2018) 15  ppE127', '10.5888/pcd15.180218', '']\n",
      "['9738244', 'EUCTR2010-019871-31-SK. A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK- 0663/Etoricoxib in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019871-31-SK. (2011)   pp', '10.1186/isrctn04296019', '']\n",
      "['9738245', 'IRCT201601027479N2. Effect of probiotic supplementation on diabetic nephropathy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201601027479N2. (2016)   pp', '10.7759/cureus.55149', '']\n",
      "['9738246', 'Shadick Nancy A; Gerlanc Nicole M; Frits Michelle L; Stolshek Bradley S; Brady Brenna L; Iannaccone Christine; Collier David; Cui Jing; Mutebi Alex; Weinblatt Michael E. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry. Clinical rheumatology. (2019) 38 11 pp3081-3092', '10.1007/s10067-019-04649-4', 'http://link.springer.com/article/10.1007/s10067-019-04649-4/fulltext.html']\n",
      "['9738247', 'Biswas Atanu; Bhattacharya Rahul; Das Soumyadeep. A response adaptive design for ordinal categorical responses. Journal of biopharmaceutical statistics. (2018) 28 6 pp1169-1181', '10.1080/10543406.2018.1439053', '']\n",
      "['9738248', 'Barendregt AM; Van Gulik C; Groot P; Dolman K; Van Den Berg M; Nassar Sheikh Rashid A; Schonenberg-Meinema D; Lavini C; Rosendahl K; Hemke R; Kuijpers TW; Maas M; Nusman CM. Prolonged image acquisition time after contrast agent administration results in increased synovial thickness on postcontrast MRI of Jia patients: standardisation is key. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp101', '10.1136/annrheumdis-2018-eular.4780', '']\n",
      "['9738250', 'PER-040-13. A PHASE 1B MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP STUDY TO CHARACTERIZE THE PHARMACOKINETICS OF A SINGLE DOSE OF ABATACEPT 125 MG ADMINISTERED SUBCUTANEOUSLY USING THE BD PHYSIOJECTTM  AUTOINJECTOR OR THE ULTRASAFE PASSIVE NEEDLE GUARD PREFILLED SYRINGE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-040-13. (2013)   pp', '10.1080/14712598.2022.2131391', '']\n",
      "['9738251', 'Sandborn WJ; Panes J; Sands BE; Reinisch W; Su C; Lawendy N; Koram N; Fan H; Jones TV; Modesto I; Quirk D; Danese S. Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development program. American journal of gastroenterology. (2019) 114 Supplement ppS377', '10.14309/01.ajg.0000592112.60675.de', '']\n",
      "['9738252', 'DRKS00008054. Development and evaluation of a communication skills training to improve social participation of persons with rheumatic diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00008054. (2015)   pp', '10.1080/10410236.2018.1431760', '']\n",
      "['9738254', 'CTRI/2017/08/009478. Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/08/009478. (2017)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9738255', 'Xiao D; Sun A; Sun Y; Yu Z. Cost-effectiveness analysis of etanercept combined with methotrexate in the treatment of rheumatoid arthritis. Chinese journal of evidence-based medicine. (2017) 17 7 pp843-847', '10.1097/md.0000000000016635', '']\n",
      "['9738256', 'EUCTR2011-000436-28-BG. A trial to compare Z102 against placebo in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-000436-28-BG. (2011)   pp', '10.1186/isrctn79105828', '']\n",
      "['9738257', 'NCT04333771. A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT04333771. (2020)   pp', '10.31525/ct1-nct04192617', '']\n",
      "['9738259', 'Wong P; Wu D; Mak QW; Cheng IT; Li TK; Li EK; Tam LS. Role of ultrasound in assessing disease activity in patients with early rheumatoid arthritis treated by two treat-to-target strategies. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp563', '10.1136/annrheumdis-2018-eular.6897', '']\n",
      "['9738260', 'IRCT2013022012540N1. Comparison of suppository Morphine with suppository Diclofenac on postoperative pain laparoscopic cholecystectomy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013022012540N1. (2013)   pp', '10.54393/pbmj.v5i6.591', 'https://pakistanbmj.com/journal/index.php/pbmj/article/download/591/459']\n",
      "['9738264', 'Reynolds JA; Briggs TA; Rice G; Bruce E; Haque S; McCarthy E; Herrick AL; Chinoy H; Duffy D; Crow YJ; Parker B; Bruce IN. Measurement of interferon alpha expression using multiple methodologies identifies a signature in a subgroup of connective tissue disease patients with haematological abnormalities. Arthritis and rheumatology. (2018) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018. United States. 70 Supplement 9 pp3191-3193', '10.1093/rheumatology/kez110.084', 'http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez110.084/28712338/kez110.084.pdf']\n",
      "['9738265', 'Garcia EG; Cortes JI; Boquet EM; Escandell CA; Verdejo IC; De La Rubia Navarro M; Fragio-Gil JJ; Mazario RG; Puig LG; Cordellat IM; Albuixech RN; Rodriguez JEO; Sanjuan FMO; Perales CP; Bernabeu EV; Herranz CN; Olmos IC; Cebrian ALG; Andres JLP; Ivorra JAR. Preliminar study of therapy adherence controlled by prescription of medication and self-perception adherence of inflammatory chronic disease patients. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp2069', '10.1136/annrheumdis-2019-eular.5937', '']\n",
      "['9738266', 'Sundin U; Aga A-B; Skare O; Norberg LB; Uhlig T; Hammer HB; Van Der Heijde D; Kvien TK; Lillegraven S; Haavardsholm E. Ultrasound in the management of early rheumatoid arthritis: MRI outcome data from the arctic randomized controlled strategy trial. Annals of the rheumatic diseases. (2019) 78  pp142-', '10.1136/annrheumdis-2019-eular.990', '']\n",
      "['9738270', 'UMIN000014037. Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014037. (2014)   pp', '10.4172/2329-9096.1000368', '']\n",
      "['9738273', 'NCT01006681. Vaccination Against Influenza H1N1 in Rheumatic Diseases. https://clinicaltrials.gov/show/NCT01006681. (2009)   pp', '10.5353/th_b5056168', '']\n",
      "['9738274', 'Guibert Fanny; Garnier Anne-Sophie; Wacrenier Samuel; Piccoli Giorgina; Djema Assia; Gansey Renaud; Demiselle Julien; Brilland Benoit; Cousin Maud; Besson Virginie; Duveau Agnes; El Nasser Khuzama; Coindre Jean-Philippe; Croue Anne; Saint-Andre Jean-Paul; Chevailler Alain; Subra Jean-Francois; Augusto Jean-Francois. Patients with ANCA-Associated Glomerulonephritis and Connective Tissue Diseases: a Comparative Study from the Maine-Anjou AAV Registry. Journal of clinical medicine. (2019) 8 8 pp', '10.3390/jcm8081218', '']\n",
      "['9738275', 'Batooei Minoo; Tahamoli-Roudsari Ahmad; Basiri Zahra; Yasrebifar Fatemeh; Shahdoust Maryam; Eshraghi Azadeh; Mehrpooya Maryam; Ataei Sara. Evaluating the effect of oral n-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Reviews on recent clinical trials. (2018) 13 2 pp132-138', '10.2174/1574887113666180307151937', '']\n",
      "['9738277', 'Khraishi Majed; Ivanovic Jelena; Zhang Yvonne; Millson Brad; Brabant Marie-Josee; Charland Katia; Woolcott John; Jones Heather. Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data. Clinical rheumatology. (2018) 37 9 pp2351-2360', '10.1007/s10067-018-4141-z', 'http://link.springer.com/article/10.1007/s10067-018-4141-z/fulltext.html']\n",
      "['9738278', 'Song Gwan Gyu; Lee Young Ho. Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. International journal of clinical pharmacology and therapeutics. (2020) 58 6 pp293-298', '10.5414/cp203635', '']\n",
      "['9738279', 'IRCT201308187531N3. The effect of group education on  self-management in patient with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201308187531N3. (2013)   pp', '10.1186/isrctn32195100', '']\n",
      "['9738280', 'Kwon OC; Oh JS; Kim Y-G; Lee C-K; Yoo B; Hong S. Optimal dose of vitamin D supplementation in osteoporosis patients with rheumatoid arthritis. Osteoporosis international. (2018) Conference: 18th World Conference on Osteoporosis, Degenerative Disease and Musculoskeletal Disorders, WCO-IOF-ESCEO 2018. Poland. 29 1 Supplement 1 ppS346', '10.1007/s00198-018-4456-2', 'http://link.springer.com/article/10.1007/s00198-018-4456-2/fulltext.html']\n",
      "['9738281', 'McTaggart-Cowan H; Regier DA; Peacock SJ. Exploring the role of disease labels on general population preferences. Quality of life research. (2015) Conference: 22nd Annual Conference of the International Society for Quality of Life Research, ISOQOL. Canada. 24 1 Supplement 1 pp178', '10.1007/s11136-015-1078-4', 'https://link.springer.com/article/10.1007/s11136-015-1078-4/fulltext.html']\n",
      "['9738282', \"ChiCTR1900021345. Effect of Iguratimod on Primary Sjogren's Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900021345. (2019)   pp\", '10.1186/isrctn15824224', '']\n",
      "['9738285', 'Al-Hakkak SMM; Al-Faham FSM; Al-Wadees AA; Akpinar MB. Assessment of arteriovenous fistulas made with the oval-shaped anastomosis technique in the end-stage renal disease patients. International journal of research in pharmaceutical sciences. (2019) 10 4 pp3669-3673', '10.26452/ijrps.v10i4.1751', 'https://pharmascope.org/index.php/ijrps/article/download/1751/2482']\n",
      "['9738287', 'Zhang H; Xu H; Chen S; Mao X. The application value of MRI in the diagnosis of subclinical inflammation in patients with rheumatoid arthritis in remission. Journal of orthopaedic surgery and research. (2018) 13 1 pp164', '10.1186/s13018-018-0866-2', 'http://link.springer.com/article/10.1186/s13018-018-0866-2/fulltext.html']\n",
      "['9738288', 'Langley RG; Kasichayanula S; Trivedi M; Aras G; Kaliyaperumal A; Yuraszeck T; Gibbs M; Kricorian G; Paller AS. Characterization of etanercept pharmacokinetics, immunogenicity, and efficacy in pediatric patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. (2017) Conference: 75th Annual Meeting of the American Academy of Dermatology. United States. 76 6 Supplement 1 ppAB67', '10.1002/jcph.1029', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1029']\n",
      "['9738289', 'NCT01947010. Pneumococcal Vaccination of Crohn Patients. https://clinicaltrials.gov/show/NCT01947010. (2013)   pp', '10.26226/morressier.5731f0d7d462b8029237fd71', '']\n",
      "['9738291', 'UMIN000020833. The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis: an open label multicenter randomized parallel study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000020833. (2016)   pp', '10.1186/isrctn95861172', '']\n",
      "['9738292', 'Choquette D; Rahman P; Chow A; Faraawi R; Olszynski W; Rampakakis E; Asin-Milan O; Osborne B; Lehman AJ; Nantel F. Consolidated long-term safety of infliximab in inflammatory arthritis from a prospective, observational registry. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1380-1381', '10.1136/annrheumdis-2018-eular.4644', '']\n",
      "['9738293', 'Kruger K; Selmi C; Cantagrel A; Abad MA; Freudensprung U; Rezk MF; Addison J. Benefit study: results of interim analysis of a pan-european observational study to evaluate real-world effectiveness of SB4 following transition from originator etanercept (ETN) in patients with rheumatoid arthritis (RA) or axial spondyloarthritis (AxSpA). Arthritis and rheumatology. (2018) 70 Supplement 9 pp2822-2823', '10.1136/annrheumdis-2019-eular.5665', '']\n",
      "['9738294', 'EUCTR2007-000896-41-BE. A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Once-Weekly Administration of Etanercept 50 mg, Etanercept 25 mg, and Placebo in Combination With Methotrexate in Subjects With Moderately Active Rheumatoid Arthritis Who Have Achieved an Adequate Response With Etanercept 50 mg Once Weekly and methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000896-41-BE. (2008)   pp', '10.1002/art.23493', '']\n",
      "['9738297', 'Tanaka Y; Van Der Aa A; Jamoul C; Tasset C; Harrison P; Westhovens R. Rapid and sustained effect of filgotinib, an oral JAK1-selective inhibitor, on patient-reported outcomes: results from a Phase 2B RA study. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp207', '10.1136/annrheumdis-2016-eular.3894', '']\n",
      "['9738298', 'Palylyk-Colwell E; McGahan L. Rituximab for rheumatoid arthritis. Issues in emerging health technologies. (2006)  89 pp1-4', '10.51731/cjht.2022.457', 'https://canjhealthtechnol.ca/index.php/cjht/article/download/RC1454/942']\n",
      "['9738299', 'NCT04227366. Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT04227366. (2020)   pp', '10.31525/ct1-nct04227366', '']\n",
      "['9738300', 'Furie R; Werth VP; Lee E; Box E; Fondal M; Kivitz A; Chatham WW; Kalunian KC; Legerton C; Anolik JH; Korish S; Hough DR; Weiswasser M; Choi S; Schafer P. A phase 2, randomized, placebo-controlled, doubleblind, ascending dose study to evaluate efficacy, safety, and tolerability of CC 220 in subjects with systemic lupus erythematosus. Clinical and experimental rheumatology. (2016) Conference: 10th European Lupus Meeting. Italy. 34 4 Supplement 99 ppS77', '10.1136/lupus-2016-000179.79', '']\n",
      "['9738301', 'Durez P; Mysler E; Smolen JS; Choe J-Y; Choi J; Rho YH. The 54-week results of interferon-gamma release assay in a phase III study comparing SB2, an infliximab biosimilar, to infliximab reference product in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp235-236', '10.1136/annrheumdis-2016-eular.2026', '']\n",
      "['9738302', 'Keystone E; Genovese M; Smolen J; Takeuchi T; Hyslop D; Macias W; Rooney T; Chen L; Dickson C; Camp J; Cardillo T; Ishii T; Winthrop K; Otawa S. Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 5.5 years: an updated integrated safety analysis. Journal of rheumatology. Conference: 73rd annual meeting of the canadian rheumatology association, CRA 2018. Canada. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1003', '10.3899/jrheum.171361', '']\n",
      "['9738303', 'Wu Wenwen; Yang Jinru; Gu Yaohua; Chen Xuyu; Tan Xiaodong. Dose-response Relationship between Sleep and Rheumatoid Arthritis. American journal of health behavior. (2020) 44 1 pp40-53', '10.5993/ajhb.44.1.5', '']\n",
      "['9738306', 'NCT03991520. Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms. Https://clinicaltrials.gov/show/nct03991520. (2019)   pp', '10.31525/ct1-nct03991520', '']\n",
      "['9738308', 'Xie J; Li S; Xiao L; Ouyang G; Zheng L; Gu Y; Gao C; Han X. Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients. Journal of orthopaedic surgery and research. (2019) 14 1 pp421-', '10.1186/s13018-019-1492-3', 'http://link.springer.com/article/10.1186/s13018-019-1492-3/fulltext.html']\n",
      "['9738309', 'EUCTR2006-005467-26-GB. A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BG9924 When Given in Combination With Methotrexate to Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005467-26-GB. (2007)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9738311', 'IRCT201409249472N7. Effects of aqueous extract of black barberry fruit on active rheumatoid arthritis Patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201409249472N7. (2015)   pp', '10.1002/ptr.6874', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.6874']\n",
      "['9738312', 'NCT01164579. Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA). https://clinicaltrials.gov/show/NCT01164579. (2010)   pp', '10.1016/s0973-3698(10)60474-8', '']\n",
      "['9738313', 'Chen X; Zhao Q; Hou Y; Jiang J; Zhong W; Wang W; Yao X; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis. British journal of clinical pharmacology. (2016)   pp', '10.1111/bcp.12908', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.12908']\n",
      "['9738314', 'El-Saka M H; Madi N M; Shahba A. The possible role of heat shock protein-70 induction in collagen-induced arthritis in rats. Physiology international. (2019) 106 2 pp128-139', '10.1556/2060.106.2019.17', 'https://akjournals.com/view/journals/2060/106/2/article-p128.xml']\n",
      "['9738316', 'Tokai Nao; Yoshida Shuzo; Kotani Takuya; Yoshikawa Ayaka; Kimura Yuko; Fujiki Youhei; Matsumura Yoko; Takeuchi Tohru; Makino Shigeki; Arawaka Shigeki. Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis. PloS one. (2018) 13 8 ppe0202601', '10.1371/journal.pone.0202601', '']\n",
      "['9738317', 'NTR4059. Proeftuin Integrative Medicine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4059. (2013)   pp', '10.1016/j.imr.2013.04.007', '']\n",
      "['9738318', 'Liu Xiaoyan; Xu Yan; Zhou Qing; Chen Minjiang; Liang Hongge; Zhao Jing; Zhong Wei; Wang Mengzhao. Clinicopathological features of lung cancer in patients with rheumatoid arthritis. Journal of thoracic disease. (2018) 10 7 pp3965-3972', '10.21037/jtd.2018.06.62', '']\n",
      "['9738319', 'CTRI/2011/07/001924. Study of two different starting doses of methotrexate when starting treatment in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2011/07/001924. (2011)   pp', '10.1007/s00296-011-2041-5', 'http://link.springer.com/article/10.1007/s00296-011-2041-5/fulltext.html']\n",
      "['9738320', 'ChiCTR-CNC-12002214. Study on the characteristics of intestinal microflora structure and the common spleen deficiency syndrome of rheumatoid arthritis, ankylosing spondylitis and gout. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-CNC-12002214. (2012)   pp', '10.1186/isrctn16838474', '']\n",
      "['9738321', 'Van Boheemen L; Van Beers-Tas M; Van Schaardenburg D; Nurmohamed MT. Lipid profile and cardiovascular risk in subjects at risk for developing rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp280', '10.1136/annrheumdis-2018-eular.3936', '']\n",
      "['9738322', 'Hammond A; Prior Y; Sutton C; Cotterill S; Heal C; Camacho E. HPR the effects of arthritis gloves on hand pain in people with rheumatoid or inflammatory arthritis: a randomised controlled trial (agloves trial). Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp222-223', '10.1136/annrheumdis-2018-eular.3524', '']\n",
      "['9738324', 'Torikai E; Suzuki D; Suzuki M; Matsuyama Y. Differences of disease impression and treatment expectation in rheumatoid arthritis patients with different disease activity. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1295', '10.1136/annrheumdis-2018-eular.4405', '']\n",
      "['9738330', 'Pincus T; Stein C M. Why randomized controlled clinical trials do not depict accurately long- term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies. Clinical and experimental rheumatology. (1997) 15 SUPPL. 17 ppS27-S38', '10.1007/s003930050059', 'http://link.springer.com/article/10.1007/s003930050059/fulltext.html']\n",
      "['9738331', 'Rai Sharan K; Howren Alyssa; Wilcox Elizabeth S; Townsend Anne F; Marra Carlo A; Avina-Zubieta J Antonio; De Vera Mary A. Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity. Patient preference and adherence. (2018) 12  pp2015-2025', '10.2147/ppa.s174672', 'https://www.dovepress.com/getfile.php?fileID=45028']\n",
      "['9738332', 'Burmester GR; Panaccione R; Gordon KB; Rosenbaum J; Arikan D; Lau WL; Tarzynski-Potempa R. Long-term safetyofadalimumab (HUMIRA) in adult patients from global clinical trials across multiple indications: an updated analysis in 29,987 patients representing 56,951 patient-years. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS151', '10.1136/annrheumdis-2018-eular.3158', '']\n",
      "['9738333', 'Arenas-Chavez Carlos Alberto; Wiche-Salinas Tomas; Valencia-Mercado Ignacio; Calle-Valdez Ronald; Vera-Gonzales Corina; Malaga-Contreras Stephanie; Flores-Rivera Fernando; Huanqui-Guerra Carlos. Anti-Inflammatory Effect of The Flavonoid Fraction of Lepechinia meyenii (Walp.) Epling (SAGE) on Leukocytes of Patients With Rheumatoid Arthritis. Revista peruana de medicina experimental y salud publica. (2018) 35 1 pp55-61', '10.17843/rpmesp.2018.351.3600', 'http://www.rpmesp.ins.gob.pe/index.php/rpmesp/article/viewFile/3600/2955']\n",
      "['9738334', 'Klunder Ben; Mohamed Mohamed-Eslam F; Othman Ahmed A. Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: analyses of Phase I and II Clinical Trials. Clinical pharmacokinetics. (2018) 57 8 pp977-988', '10.1007/s40262-017-0605-6', 'http://link.springer.com/article/10.1007/s40262-017-0605-6/fulltext.html']\n",
      "['9738335', 'UMIN000013750. Study on effects of cytokine targeted therapy on periodontal condition in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013750. (2014)   pp', '10.1186/isrctn60187959', '']\n",
      "['9738336', 'Huang J; Wojtkowski T; Blahunka P; Smulders R; Lademacher C. Multiple dose safety, tolerability, pharmacokinetics, and pharmacodynamics of ASP5094, an anti-alpha9 integrin monoclonal antibody, in patients with rheumatoid arthritis on methotrexate. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2161-2162', '10.1186/s13075-020-02336-3', 'https://link.springer.com/article/10.1186/s13075-020-02336-3/fulltext.html']\n",
      "['9738337', 'Simsek I; Yazici Y. Reporting of the recruitment process in randomized clinical trials of biological agents for the treatment of rheumatoid arthritis. Arthritis and rheumatism. (2010) 62  pp1559-', '10.1002/acr.21721', '']\n",
      "['9738338', 'EUCTR2007-000593-24-GB. An Open-Label, Observational Study of the Effects of Anti-TNF Therapy on Peripheral Blood and Synovial Biomarkers in Patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000593-24-GB. (2007)   pp', '10.1093/ww/9780199540884.013.u185924', '']\n",
      "['9738339', 'Tanaka Y; Takeuchi T; Yamanaka H; Nanki T; Umehara H; Yasuda N; Tago F; Kitahara Y; Kawakubo M; Torii K; Hojo S; Kawano T; Imai T. Efficacy and safety of E6011, an antifractalkine monoclonal antibody, in MTX-IR patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp188', '10.1136/annrheumdis-2019-eular.1671', '']\n",
      "['9738340', 'Lichtenstein GR; Loftus EV; Bloom S; Lawendy N; Chan G; Friedman GS; Zhang H; Wang W; Thorpe AJ; Nduaka CI; Su C. Tofacitinib, an oral janus kinase inhibitor, in the treatment of ulcerative colitis: an interim analysis of an open-label, long-term extension study with up to 4.9 years of treatment. United european gastroenterology journal. (2018) 6 8 Supplement ppA255-A256', '10.14309/00000434-201810001-00571', '']\n",
      "['9738341', 'IRCT201205263140N5. Effect of alpha-lipoic acid supplement in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201205263140N5. (2012)   pp', '10.1186/isrctn34018148', '']\n",
      "['9738342', 'Dankers W; Davelaar N; Asmawidjaja PS; Mus AM; Hazes JM; Colin EM; Lubberts E. 1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6+ TH memory cells and enhance the effect of TNF-alpha blockade. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp249', '10.1136/annrheumdis-2018-eular.6973', '']\n",
      "['9738343', 'NCT00291928. HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II. https://clinicaltrials.gov/show/NCT00291928. (2006)   pp', '10.2165/00128413-200615290-00009', '']\n",
      "['9738345', 'Matsumoto Takumi; Matsui Toshihiro; Hirano Fumio; Tohma Shigeto; Mori Masaaki. Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients. Modern rheumatology. (2020) 30 1 pp78-84', '10.1080/14397595.2018.1554228', '']\n",
      "['9738346', 'Khalaf Warqaa; Al-Rubaie Haithem Ahmed; Shihab Sami. Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin. Hematology reports. (2019) 11 1 pp7708', '10.4081/hr.2019.7708', 'https://www.pagepress.org/journals/index.php/hr/article/download/7708/7776']\n",
      "['9738347', 'Bliuc D; Tran T; Van Geel T; Adachi J; Berger C; Van Den Bergh J; Eisman J; Geusens P; Goltzman D; Hanley D; Josse R; Kaiser S; Kovacs C; Langsetmo L; Prior J; Nguyen T; Center J. Long-term risk of bone loss and fracture in rheumatoid arthritis and inflammatory bowel disease in the population-based Canadian Multicentre Osteoporosis Study (CaMos). Journal of bone and mineral research. (2018) Conference: 2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des CongrEs de Montreal. Canada. 33 Supplement 1 pp194', '10.1002/jbmr.4402', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4402']\n",
      "['9738349', 'IRCT2014041417268N1. Effects of Nitric Oxide releasing cream on bedsores. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014041417268N1. (2014)   pp', '10.1016/j.niox.2014.09.053', '']\n",
      "['9738351', 'Genovese M; Durez P; Richards H; Supronik J; Dokoupilova E; Aelion JA; Lee S-H; Codding CE; Kellner H; Ikawa T; Hugot S; Ligozio G; Mpofu S. Secukinumab improves signs and symptoms in patients with active rheumatoid arthritis: results of dose-finding, double blind, randomized, placebo controlled, phase II study. Dermatology and therapy.. (2012) 2 SUPPL. 1 ppS45', '10.3899/jrheum.130637', '']\n",
      "['9738352', 'Wilkens R F. Double blind crossover trial of naproxen and placebo in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1973) 2 sup.2 pp132-136', '10.3109/03009747309097112', '']\n",
      "['9738354', 'Kim J; Tsuda Y; Yamamoto K; Thiedmann R; Schoelch C; Norris S; Padula S; Steffgen J; Jang I J. Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of Bi 655064, an antagonistic anti-cd40 antibody following single-dose administration in Chinese and Japanese healthy volunteers. Arthritis and rheumatology. (2015) 67 SUPPL. 10 pp', '10.1136/annrheumdis-2015-eular.1525', '']\n",
      "['9738355', 'Dang AK; Schirmer D; Arellanes R; Wright B. Impact of rheumatoid arthritis on short-term in-hospital outcomes in patients with Guillain Barre syndrome undergoing plasma exchange vs. intravenous immunoglobulin treatment. PM and r. (2019) Conference: American Academy of Physical Medicine and Rehabilitation Annual Meeting , AAPM and R 2019. United States. 11 Supplement 2 ppS99', '10.1016/j.apmr.2019.08.159', '']\n",
      "['9738356', 'NCT00442611. A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma). https://clinicaltrials.gov/show/NCT00442611. (2007)   pp', '10.31525/ct1-nct04300426', '']\n",
      "['9738358', 'Lussier A; Lang J Y; Myhal D; Camerlain M. A double blind parallel study of ibuprofen compared with acetylsalicylic acid in the treatment of rheumatoid arthritis. UN.MED.CANADA. (1974) 103 8 pp1381-1835', '10.1002/j.1552-4604.1975.tb01460.x', '']\n",
      "['9738359', 'Qiu Chengfeng; Zhao Xiang; She Lang; Shi Zhihua; Deng Ziwei; Tan Liming; Tu Xiaojun; Jiang Shilong; Tang Bin. Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Lipids in health and disease. (2019) 18 1 pp54', '10.1186/s12944-019-0994-7', 'http://link.springer.com/article/10.1186/s12944-019-0994-7/fulltext.html']\n",
      "['9738360', 'Gossec L; Chauvin P; Saraux A; Hudry C; Cukierman G; De Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert J-M; Berenbaum F. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Annals of the rheumatic diseases. (2018) 77 2 pp258-263', '10.1136/annrheumdis-2017-212000', '']\n",
      "['9738361', 'Boyle DL; DePrimo SE; Calderon C; Chen D; Dunford PJ; Barchuk W; Firestein GS; Thurmond RL. Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study. Inflammation research. (2019)   pp', '10.1007/s00011-019-01218-y', 'http://link.springer.com/article/10.1007/s00011-019-01218-y/fulltext.html']\n",
      "['9738362', 'ISRCTN46762597. Effectiveness of occupational therapy (OT) intervention with patients with early stage rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN46762597. (2002)   pp', '10.1186/isrctn46762597', '']\n",
      "['9738363', 'ChiCTR-TRC-13003206. Implementation of Observational Pain Management Protocol to improve pain management for long-term institutionalised older residents with dementia: a Randomized Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-13003206. (2013)   pp', '10.1186/1745-6215-15-78', 'http://link.springer.com/article/10.1186/1745-6215-15-78/fulltext.html']\n",
      "['9738364', 'ChiCTR1800019277. The Zoledronic Acidameliorate theSecondary Osteoporosis in Rheumatoid Arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1800019277. (2018)   pp', '10.5772/25536', '']\n",
      "['9738365', 'Elshahaly M; Saleh M; Fahmy H; Othman M. Assessment of serum levels of 14-3-3h protein in rheumatoid arthritis: is it a specific marker for the disease?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1316', '10.1136/annrheumdis-2018-eular.4188', '']\n",
      "['9738366', 'Genovese MC; Gaylis N; Sikes D; Kivitz A; Horowitz DM; Peterfy C; Levine Y; Chernoff D. First-in-human study of novel implanted vagus nerve stimulation device to treat rheumatoid arthritis. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp264', '10.1136/annrheumdis-2019-eular.8716', '']\n",
      "['9738367', 'Liu K; Tomlinson G; Reed AM; Huber AM; Saarela O; Bout-Tabaku SM; Curran M; Dvergsten JA; Eberhard BA; Jung LK; Kim S; Ringold S; Rouster-Steven KA; Tesher M; Wahezi DM; Feldman BM. Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study. Journal of rheumatology. (2020)   pp', '10.3899/jrheum.190494', '']\n",
      "['9738368', 'Targonska-Stepniak B; Biskup M; Majdan M. Unfavourable cardiovascular risk profile in male patients with rheumatoid arthritis of low disease activity. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1288-1289', '10.1136/annrheumdis-2018-eular.3142', '']\n",
      "['9738369', 'Kerns JW; White A; Nashelsky J. Does psychiatric treatment help patients with intractable chronic pain?. Journal of family practice. (2006) 55 3 pp235-236', '10.1176/appi.pn.2020.4a1', '']\n",
      "['9738370', 'Dhir V; Singla M; Goyal P; Sagar V; Sharma A; Sharma S K. What is the right dose to start methotrexate (7.5 or 15mg) in rheumatoid arthritis? (A randomized controlled trial. Arthritis and rheumatism. (2012) 64 var.pagings ppS218-S219', '10.1016/j.clinthera.2014.05.063', '']\n",
      "['9738375', 'Genovese MC; Schiff M; Luggen ME; LeBars M; Becker JC; Aranda R; Li T; Elegbe A; Dougados M. Safety, efficacy and health-related quality of life (Hrqol) through 5 years of abatacept (Aba) treatment in patients with rheumatoid arthritis (Ra) and an inadequate response to anti-tumour necrosis factor (Tnf) therapy. Zeitschrift fur rheumatologie. (2010) Conference: 38. Kongress der Deutschen Gesellschaft fur Rheumatologie Hamburg Germany. Conference Start: 20100915 Conference End: 20100918. Conference Publication: var.pagings pp39', '10.3899/jrheum.111531', '']\n",
      "['9738377', 'Ayar Yavuz; Ersoy Alparslan; Oksuz Mustafa Ferhat; Ocakoglu Gokhan; Vuruskan Berna Aytac; Yildiz Abdulmecit; Isiktas Emel; Oruc Aysegul; Celikci Sedat; Arslan Ismail; Sahin Ahmet Bilgehan; Gullulu Mustafa. Clinical outcomes and survival in AA amyloidosis patients. Revista brasileira de reumatologia. (2017) 57 6 pp535-544', '10.1016/j.rbre.2017.02.002', '']\n",
      "['9738378', 'EUCTR2011-005008-14-HU. Not applicable. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005008-14-HU. (2012)   pp', '10.1080/00036811.2022.2102490', '']\n",
      "['9738379', 'Fleischmann R M; Baumgartner S W; Tindall E A; Weaver A L; Moreland L W; Schiff M H; Martin R W; Spencer-Green G T. Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results. Journal of rheumatology. (2003) 30 4 pp691-696', '10.1136/annrheumdis-2001.1210', '']\n",
      "['9738380', 'ChiCTR-IPR-15006572. The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss During Simultaneous Bilateral Total Knee Replacement: a Randomized, Double-blind, Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15006572. (2015)   pp', '10.31525/ct1-nct03867214', '']\n",
      "['9738382', 'Motta ACF; Marques VT; Cabral FF; Dos Santos Polvora TL; De Macedo LD; Inocenttini LMAR; Duarte MPF; Oliveira FR; Rocha EM; De Freitas O; Tirapelli C. Pilocarpine spray for the treatment of xerostomia: a randomized, double-blind, placebo-controlled trial. Clinical and experimental rheumatology. (2018) 36 3 Supplement 112 ppS319', '10.1016/j.oooo.2018.02.057', '']\n",
      "['9738384', 'Olsen Inge C; Lie Elisabeth; Vasilescu Radu; Wallenstein Gene; Strengholt Sander; Kvien Tore K. Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry. Rheumatology (Oxford, England). (2019) 58 3 pp481-491', '10.1093/rheumatology/key338', 'http://academic.oup.com/rheumatology/article-pdf/58/3/481/27900781/key338.pdf']\n",
      "['9738385', 'ISRCTN28468355. A pilot study assessing the clinical effectiveness of dipyridamole in patients with active disease on methotrexate for rheumatoid arthritis with imaging analysis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN28468355. (2005)   pp', '10.1186/isrctn28468355', '']\n",
      "['9738386', 'ChiCTR-TRC-10000963. Research on Compound Nanxing Pain Paste for cold dampness arthralgia of rheumatic arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10000963. (2010)   pp', '10.1002/acr.20347', '']\n",
      "['9738387', 'NCT00924625. The Use of Neuromuscular Electrical Stimulation to Reverse Muscle Atrophy in Patients With Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00924625. (2009)   pp', '10.1093/ptj/pzz079', 'http://academic.oup.com/ptj/advance-article-pdf/doi/10.1093/ptj/pzz079/28815196/pzz079.pdf']\n",
      "['9738388', \"EUCTR2012-000222-21-DE. Comparison of the patient's experience with the methotrexate pre-filled syringe and with the methrotexate pre-filled pen and preference of the patient for subcutaneous methotrexate injection. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-000222-21-DE. (2012)   pp\", '10.32388/fhcyxc', '']\n",
      "['9738389', 'McBain H; Newman S; Shipley M; Olaleye A; Moore S. Experiences of a patient-initiated self-monitoring service in inflammatory arthritis: a qualitative exploration. Musculoskeletal care. (2018) 16 2 pp278-286', '10.1002/msc.1232', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1232']\n",
      "['9738390', 'NCT01590966. Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFŒ± in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis. https://clinicaltrials.gov/show/NCT01590966. (2012)   pp', '10.1136/annrheumdis-2014-eular.2367', '']\n",
      "['9738391', 'Okojie PW; Attin OM. Cardiovascular disease, risk factor profile and self-reported health in Arizona. Annals of epidemiology. (2019) 36  pp70-', '10.1016/j.annepidem.2019.06.021', '']\n",
      "['9738393', \"Stevens B; Rodriguez M; Rakestraw A; O'neil K. Quality of life in subjects with pre-pubertal onset systemic lupus erythematosus. Annals of the rheumatic diseases. (2019) Conference: Annual European Congress of Rheumatology, EULAR 2019. Spain. 78 Supplement 2 pp1326-1327\", '10.1136/annrheumdis-2019-eular.4409', '']\n",
      "['9738394', 'Swanson G; Biglin M; Chouhan V; Raff H; Sanzo G; Bishehsari F; Keshavarzian A. CHRONOTHERAPY OF 6-MERCAPTOPURINE (6-MP) METABOLITES IN INFLAMMATORY BOWEL DISEASE: a CROSSOVER TRIAL. Gastroenterology. (2020) Conference: Digestive Disease Week DDW) 2020. United States. 158 (6 Supplement 1 ppS-466-S-467', '10.1016/s0016-5085(20)31847-3', '']\n",
      "['9738395', 'Quan J; Huadong Z; Ran P; Jinzhou C; Zhishun L; Xinyao Z. Acupuncture for Primary Sjogren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial. BMC complementary and alternative medicine. (2017) 17  pp1-8', '10.1186/s12906-017-1559-9', 'http://link.springer.com/content/pdf/10.1186/s12906-017-1559-9.pdf']\n",
      "['9738397', 'Khalilieh S; Hussain A; Levine V; Bodrug I; Mekokishvili L; Bailey-Smith C; Cheng A; Martinho M; Iwamoto M. The effect of tildrakizumab, a high-affinity, selective anti-IL23p19 monoclonal antibody (mAb), on cytochrome P450 (CYP) metabolism. Journal of the American Academy of Dermatology. (2017) Conference: 75th Annual Meeting of the American Academy of Dermatology. United States. 76 6 Supplement 1 ppAB252', '10.1016/j.jaad.2017.04.978', '']\n",
      "['9738398', 'Arad U; Elkayam O. Serum tocilizumab trough concentrations are associated with clinical disease activity index scores in adult rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp105', '10.1136/annrheumdis-2018-eular.5116', '']\n",
      "['9738399', 'PER-009-12. A PHASE, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTI-CENTER, RANDOMIZED WITHDRAWAL DESIGN TRIAL USING ADAPTIVE RANDOMIZATION COMPARING Z102 WITH PLACEBO IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-009-12. (2012)   pp', '10.1186/isrctn75684296', '']\n",
      "['9738401', 'George M; Baker J; Winthrop K; Alemao E; Chen L; Connolly S; Simon T; Wu Q; Xie F; Yang S; Curtis J. Comparative risk of biologic therapies and risk of glucocorticoids in patients with rheumatoid arthritis undergoing elective arthroplasty. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp163', '10.1136/annrheumdis-2018-eular.1463', '']\n",
      "['9738403', 'Trnavsky K; Zbojanova M; Svec V. Double blind experiment with eumol in rheumatoid arthritis. Fysiatricky a revmatologicky vestnik. (1978) 56 3 pp149-152', '10.1007/bf02032169', 'http://link.springer.com/article/10.1007/BF02032169/fulltext.html']\n",
      "['9738404', 'Lopez-Olivo MA; Foreman J; Lin H; Leung CH; Westrich-Robertson T; Hofstetter C; Peterson SK; Lyddiatt A; Leong AL; Willcockson IU; Suarez-Almazor M. Effects of social networking on chronic disease management in rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2151-2152', '10.1016/j.semarthrit.2022.152072', '']\n",
      "['9738405', 'Xie Zhongjian; Chen Yun; Gurbuz Sirel; Zhang Bin; Li Yujie; Bai Fan; Chen Yu. Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy. Clinical interventions in aging. (2019) 14  pp959-968', '10.2147/cia.s181929', 'https://www.dovepress.com/getfile.php?fileID=50107']\n",
      "['9738407', 'EUCTR2006-006032-22. TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis - TRACE RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006032-22-GB. (2007)   pp', '10.1186/isrctn41829447', '']\n",
      "['9738408', \"Kaneko Y; Kameda H; Ikeda K; Ishii T; Murakami K; Takamatsu H; Tanaka Y; Abe T; Takeuchi T. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Annals of the rheumatic diseases. (2018)   pp\", '10.1136/annrheumdis-2018-213920', '']\n",
      "['9738409', 'Viana de Queiros; M F. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis. Clinical therapeutics. (1991) 13 1 pp38-46', '10.1185/03007999109111660', '']\n",
      "['9738410', 'Roland S. Review: target-oriented drug treatment improves clinical outcomes more than routine care in rheumatoid arthritis - Commentary. Annals of internal medicine. (2010) 153 6 ppJC3-9', '10.7326/0003-4819-153-6-201009210-02009', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-153-6-201009210-02009']\n",
      "['9738411', 'NCT00302952. Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT00302952. (2006)   pp', '10.1093/oso/9780198566304.003.0027', 'https://academic.oup.com/book/chapter-pdf/52405293/isbn-9780198566304-book-part-27.pdf']\n",
      "['9738412', 'EUCTR2012-003439-41-LT. A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003439-41-LT. (2012)   pp', '10.1136/annrheumdis-2013-eular.688', '']\n",
      "['9738413', 'EUCTR2005-003694-25-IT. A randomized, double-blind, double-dummy, parallel group study to determine the efficacy and safety of RO4402257 monotherapy in comparison to methotrexate monotherapy in patients with active rheumatoid arthritis  RA . - ND. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003694-25-IT. (2006)   pp', '10.3410/f.732763351.793564277', '']\n",
      "['9738414', 'Lora M; Shimabukuro N; Cheng A; Hudson M; Colmegna I. Methotrexate enhances the immunopotency of human mesenchymal stromal cells. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1055', '10.1016/s1465-3249(23)00191-3', '']\n",
      "['9738415', \"Kim H; Kang J; Nam B; Kim JS; Yoo D-H. Increased serum level of IL-36 receptor antagonist is associated with active disease in patients with adult-onset still's disease. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1159\", '10.1136/annrheumdis-2018-eular.6753', '']\n",
      "['9738418', 'Khadem Azarian S; Akhlaghi M; Mahmoudi M; Mostafaei S; Jamshidi AR; Nazeri S; Mirshafiey A. A randomized clinical trial for the assessment of the efficacy and safety of guluronic acid (G2013) in patients with rheumatoid arthritis. Immunopharmacology and immunotoxicology. (2018)   pp', '10.1080/08923973.2018.1555844', '']\n",
      "['9738419', 'Hewlett S; Ambler N; Knops B; Cliss A; Almeida C; Pope D; Hammond A; Swinkels A; Kitchen K; Pollock J. Reducing the impact of rheumatoid arthritis fatigue: a randomized controlled trial of cognitive behavioural therapy. Rheumatology. (2010) 49  ppi16-', '10.1136/ard.2010.144691', '']\n",
      "['9738420', 'IRCT2014021916643N1. The effect of ergonomic latex pillow on neck arthrosis treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014021916643N1. (2016)   pp', '10.1016/j.jcm.2019.02.003', '']\n",
      "['9738421', '√áakƒ±r T; Evcik FD; Suba≈üƒ± V; G√∂k√ße ƒ∞Y; Kavuncu V. The effectiveness of aquatic exercises in the treatment of rheumatoid arthritis. [Turkish]. Turkish journal of osteoporosis / turk osteoporoz dergisi. (2014) 20  1 pp10-15', '10.4274/tod.08760', 'http://cms.galenos.com.tr/FileIssue/9/327/article/10-15.pdf']\n",
      "['9738422', 'Doria A; Stohl W; Schwarting A; Okada M; Scheinberg M; van Vollenhoven R; Hammer AE; Groark J; Bass D; Fox NL; Roth D; Gordon D. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. Arthritis and rheumatology. (2018) 70 8 pp1256-1264', '10.1002/art.40511', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40511']\n",
      "['9738423', 'Linauskas A. What evidence is there that diets help people with RMDs?. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp39-40', '10.1136/annrheumdis-2018-eular.7773', '']\n",
      "['9738424', 'NCT04057118. A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies. Https://clinicaltrials.gov/show/nct04057118. (2019)   pp', '10.31525/ct1-nct04057118', '']\n",
      "['9738425', 'Xiaoping Zhang; Yue Huang; Navarro MT; Hisoire G; Caulfield JP. A Proof-of-Concept and Drug-Drug Interaction Study of Pamapimod, a Novel p38 MAP Kinase Inhibitor, With Methotrexate in Patients With Rheumatoid Arthritis. Journal of clinical pharmacology. (2010) 50 9 pp1031-1038', '10.1177/0091270009357433', 'https://onlinelibrary.wiley.com/doi/pdf/10.1177/0091270009357433']\n",
      "['9738426', 'Hider Samantha L; Bucknall Milica; Cooke Kelly; Cooke Kendra; Finney Andrew G; Goddin Dave; Healey Emma L; Hennings Susie; Herron Daniel; Jinks Clare; Lewis Martyn; Machin Annabelle; Mallen Christian; Wathall Simon; Chew-Graham Carolyn A. The INCLUDE study: iNtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: protocol for a pilot randomized controlled trial. Journal of comorbidity. (2018) 8 1 pp2235042X18792373', '10.1177/2235042x18792373', 'https://journals.sagepub.com/doi/pdf/10.1177/2235042X18792373']\n",
      "['9738428', 'Al-Gareeb Ali Ismail A; Gorial Faiq Isho; Mahmood Ahmed S. Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study. Clinical rheumatology. (2018) 37 10 pp2633-2641', '10.1007/s10067-018-4164-5', 'http://link.springer.com/article/10.1007/s10067-018-4164-5/fulltext.html']\n",
      "['9738429', 'Wijaya NS; Basah K; Bahtiar A. Effects of pearl grass extract capsules on osteoarthritis subject. Pharmacognosy journal. (2020) 12 2 pp303-310', '10.5530/pj.2020.12.48', '']\n",
      "['9738430', \"Minali P A; Pimentel Cfmg; de Mello M T; Lima Gho; Dardin L P; Garcia Aba; Goni Tcs; Trevisani Vfm. Effectiveness of resistance exercise in functional fitness in women with primary Sjogren's syndrome: randomized clinical trial. Scandinavian journal of rheumatology. (2020) 49 1 pp47-56\", '10.1080/03009742.2019.1602880', '']\n",
      "['9738432', '. Etanercept demonstrates significant remission data as combination rheumatoid arthritis therapy. Formulary (Cleveland, Ohio). (2004) 39 2 pp64-', '10.1186/s13075-017-1484-9', 'http://link.springer.com/content/pdf/10.1186/s13075-017-1484-9.pdf']\n",
      "['9738433', 'Santana K; Romero M; Le V; Fletcher T; Lamba M. Pharmacokinetics of tofacitinib modified-release formulation in healthy Mexican subjects. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS68', '10.1097/rhu.0000000000000802', '']\n",
      "['9738435', 'IRCT20170513033941N66. Comparison of pioglitazone and linagliptin. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20170513033941N66. (2019)   pp', '10.1177/1479164116639229', 'https://journals.sagepub.com/doi/pdf/10.1177/1479164116639229']\n",
      "['9738436', 'ISRCTN20710193. Hypothesis generating study to identify the changes in synovial tissue early after initiation of infliximab therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN20710193. (2007)   pp', '10.1186/isrctn20710193', '']\n",
      "['9738438', 'UMIN000020711. Efficacy and safety of denosmab in patients with glucocorticoid-induced osteoporosis refractory to combination therapy with bisphosphonate and vitamin D. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000020711. (2016)   pp', '10.1007/bf02500762', 'http://link.springer.com/article/10.1007/BF02500762/fulltext.html']\n",
      "['9738440', 'Dakkak Yousra J; Matthijssen Xanthe M E; van der Heijde Desiree; Reijnierse Monique; van der Helm-van Mil Annette H. Reliability of Magnetic Resonance Imaging (MRI) Scoring of the Metatarsophalangeal Joints of the Foot according to the Rheumatoid Arthritis MRI Score. Journal of rheumatology. (2019)   pp', '10.3899/jrheum.190258', '']\n",
      "['9738441', 'NCT01463059. Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy. https://clinicaltrials.gov/show/NCT01463059. (2011)   pp', '10.1186/isrctn39045408', '']\n",
      "['9738442', 'Moroldo MB; Giannini EH. Estimates of the discriminant ability of definitions of improvement for juvenile rheumatoid arthritis. Journal of rheumatology. (1998) 25 5 pp986-989', '10.1002/1529-0131(199809)41:9<1620::aid-art12>3.0.co;2-l', '']\n",
      "['9738444', \"O'Brien W M; Sakofsky H Y; Schmid F R. A controlled double blind study of ketoprofen versus aspirin in the treatment of rheumatoid arthritis. Current therapeutic research - clinical and experimental. (1977) 21 5 pp689-696\", '10.1185/03007997809111911', '']\n",
      "['9738445', 'NCT01565655. A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT01565655. (2012)   pp', '10.31525/ct1-nct04049448', '']\n",
      "['9738446', 'Ornbjerg LM; Ostergaard M; Boyesen P; Thormann A; Tarp U; Bohme W; Dencker D. Discontinuation of TNF-inhibitor treatment in clinical practice has a negative impact on radiographic progression 2 years after initiation of therapy. Results from the nationwide Danish DANBIO registry. Arthritis and rheumatism. (2010) 62  pp1444-', '10.1136/annrheumdis-2012-201319', '']\n",
      "['9738448', 'NCT00984815. Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment. https://clinicaltrials.gov/show/NCT00984815. (2009)   pp', '10.1186/1471-230x-13-54', 'http://link.springer.com/article/10.1186/1471-230X-13-54/fulltext.html']\n",
      "['9738449', 'NCT03607903. Adalimumab Microneedles in Healthy Volunteers. Https://clinicaltrials.gov/show/nct03607903. (2018)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9738451', 'ISRCTN49594804. Evaluation of Arthritis Self-Management Programmes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN49594804. (2004)   pp', '10.1186/isrctn49594804', '']\n",
      "['9738452', 'Harrison M; Spooner L; Bansback N; Milbers K; Koehn C; Shojania K; Finckh A; Hudson M. Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals. PloS one. (2019) 14 4 pp', '10.1371/journal.pone.0216075', '']\n",
      "['9738453', 'UMIN000006061. The clinical assessment of rheumatoid arthritis using FDG-PET. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000006061. (2011)   pp', '10.23880/ijnmrs-16000101', '']\n",
      "['9738454', 'ChiCTR-INR-17011772. The efficacy and safety of metformin hydrochloride combined with atorvastatin in the treatment of rheumatoid arthritis with poor response to immunosuppressive agents. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-17011772. (2017)   pp', '10.1517/eods.2.4.347.21415', '']\n",
      "['9738455', 'Dischereit G; Goronzy J-E; Muller-Ladner U; Fetaj S; Lange U. Effects of serial mud baths on inflammatory rheumatic and degenerative diseases. Zeitschrift fur Rheumatologie. (2019) 78 2 pp143-154', '10.1007/s00393-018-0582-7', 'http://link.springer.com/article/10.1007/s00393-018-0582-7/fulltext.html']\n",
      "['9738456', 'Ganesan S; Gaur GS; Negi VS; Sharma VK; Pal GK. Effect of Yoga Therapy on Disease Activity, Inflammatory Markers, and Heart Rate Variability in Patients with Rheumatoid Arthritis. Journal of alternative and complementary medicine (New York, N.Y.). (2020)   pp', '10.1089/acm.2019.0228', '']\n",
      "['9738457', 'IRCT2016082129461N1. Effect of Topical Oil Melilotus officinalis on primary knee Osteoarthritis versus Diclofenac gel. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016082129461N1. (2017)   pp', '10.32592/rr.2024.9.4.175', '']\n",
      "['9738458', 'RBR-867k9g. Effects of a single session of Exercise in the blood pressure of patients with Rheumatoid Arthritis and High Blood Pressure. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RBR-867k9g. (2019)   pp', '10.1186/isrctn11181410', '']\n",
      "['9738460', 'Hekmatpou Davood; Mortaji Sepideh; Rezaei Masoud; Shaikhi Millad. The Effectiveness of Olive Oil in Controlling Morning Inflammatory Pain of Phalanges and Knees Among Women With Rheumatoid Arthritis: a Randomized Clinical Trial. Rehabilitation nursing. (2020) 45 2 pp106-113', '10.1097/rnj.0000000000000162', '']\n",
      "['9738461', 'Meeus M; Ickmans K; Struyf F; Hermans L; Van Noesel K; Oderkerk J; De Clerck LS; Moorkens G; Hans G; Grosemans S; Nijs J. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/ fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial. Pain physician. (2013) 16 2 ppE61-E70', '10.36076/ppj.2013/16/e61', '']\n",
      "['9738462', 'PER-018-11. A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY2127399 IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE THERAPY. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-018-11. (2011)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9738464', 'Cohen J; Sauter S; DeVellis R; DeVellis B. Evaluation of arthritis self-management courses led by laypersons and by professionals. Arthritis and rheumatism. (1986) 29 3 pp388-393', '10.1002/art.1780290312', '']\n",
      "['9738465', 'NCT04056039. Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct04056039. (2019)   pp', '10.31525/ct1-nct04056039', '']\n",
      "['9738466', 'Kim S; Lee H; Ko J-W; Kim J-R. Effects of Celecoxib on the QTc Interval: a Thorough QT/QTc Study. Clinical therapeutics. (2019)   pp', '10.1016/j.clinthera.2019.09.004', '']\n",
      "['9738467', 'Nelson EA. 3-layer paste bandages were more effective than 4 layer bandages for healing venous leg ulcers. Evidence-based nursing. (2004) 7 1 pp21', '10.1136/ebn.7.1.21', '']\n",
      "['9738468', 'Krause D; Schleusser B; Herborn G; Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis and rheumatism. (2000) 43 1 pp14-21', '10.1002/1529-0131(200001)43:1<14::aid-anr3>3.0.co;2-7', '']\n",
      "['9738470', 'EUCTR2011-000275-13-GB. Safety and efficacy of secukinumab compared to placebo in patients with active rheumatoid arthritis who did not respond to anti-TNFa drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-000275-13-GB. (2011)   pp', '10.31525/ct1-nct03970837', '']\n",
      "['9738471', 'Zhao Shangping; Chen Hong. Effectiveness of health education by telephone follow-up on self-efficacy among discharged patients with rheumatoid arthritis: a randomised control trial. Journal of clinical nursing. (2019) 28 21-22 pp3840-3847', '10.1111/jocn.15002', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocn.15002']\n",
      "['9738472', 'Whelton A; Maurath CJ; Verburg KM; Geis GS. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. American journal of therapeutics. (2000) 7 3 pp159-175', '10.1097/00045391-200007030-00004', '']\n",
      "['9738473', 'Bresnihan B. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Seminars in arthritis and rheumatism. (2001) 30 5 Suppl 2 pp17-20', '10.1053/sarh.2001.23701', '']\n",
      "['9738474', 'Calabrese LH. Anakinra treatment of patient with rheumatoid arthritis. Annals of pharmacotherapy. (2002) 36 7-8 pp1204-1209', '10.1345/1542-6270(2002)036<1204:atopwr>2.0.co;2', '']\n",
      "['9738475', 'Cohen SB; Strand V; Aguilar D; Ofman JJ. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology. (2004) 43 6 pp704-711', '10.1093/rheumatology/keh152', 'http://academic.oup.com/rheumatology/article-pdf/43/6/704/9445291/keh152.pdf']\n",
      "['9738476', 'Rau R; Sander O; Wassenberg S. Erosion healing in rheumatoid arthritis after anakinra treatment. Annals of the rheumatic diseases. (2003) 62 7 pp671-673', '10.1136/ard.62.7.671', '']\n",
      "['9738477', 'Riente; L. The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis. [Italian]. Reumatismo. (2004) 56 1, suppl 1 pp74-79', '10.4081/reumatismo.2004.1s.74', '']\n",
      "['9738478', 'Monsarrat Paul; Fernandez de Grado Gabriel; Constantin Arnaud; Willmann Claire; Nabet Cathy; Sixou Michel; Cantagrel Alain; Barnetche Thomas; Mehsen-Cetre Nadia; Schaeverbeke Thierry; Arrive Elise; Vergnes Jean-Noel; ESPERA Group. The effect of periodontal treatment on patients with rheumatoid arthritis: the ESPERA randomised controlled trial. Joint, bone, spine: revue du rhumatisme. (2019) 86 5 pp600-609', '10.1016/j.jbspin.2019.02.006', '']\n",
      "['9738479', 'UMIN000011033. Evaluation of physical therapy on physical function and QOL in patients with RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011033. (2013)   pp', '10.1007/978-981-19-6710-8_4', '']\n",
      "['9738480', 'Thomsen T; Aadahl M; Beyer N; Hetland ML; Loeppenthin KB; Midtgaard J; Christensen R; Esbensen BA. The efficacy of motivational counselling and sms-reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. Annals of the rheumatic diseases. (2016) Conference  pp166', '10.1136/annrheumdis-2016-eular.4668', '']\n",
      "['9738481', 'Gossage DL; Cieslarova B; Ap S; Zheng H; Zhao S; Xin Y; Lal P; Chen G; Smith V; Sundy JS. Results of a phase 1b study of the safety, tolerability, and pharmacokinetics of the MMP9 inhibitor GS-5745 in patients with rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2016) Conference  pp723-724', '10.1136/annrheumdis-2016-eular.3785', '']\n",
      "['9738482', 'Rebrov BA; Komarova EB; Blaginina II; Blagodarenko AB. Efficiency of complex therapy of rheumatoid arthritis using ramipril. Annals of the rheumatic diseases. (2016) Conference  pp248', '10.1136/annrheumdis-2016-eular.1899', '']\n",
      "['9738483', 'Takeuchi T; Genovese MC; Haraoui B; Li Z; Xie L; Klar R; Pinto-Correia A; Otawa S; Lopez-Romero P; De La Torre I; Macias W; Rooney TP; Smolen JS. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Annals of the rheumatic diseases. (2018) (no pagination)  pp', '10.1136/annrheumdis-2018-eular.2000', '']\n",
      "['9738486', 'NTR2298. Double Dose Treatment: corticosteroid injection therapy in arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR2298. (2010)   pp', '10.7547/1000105', 'https://www.apma.irl.pubfactory.com/view/journals/apms/100/2/1000105.xml']\n",
      "['9738487', 'Fleishaker D; Wang X; Menon S; Zeiher B G; Stock T C. A phase 2 study to assess the efficacy and safety of maraviroc, a CCR-5 antagonist in the treatment of rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 var.pagings pp397', '10.1186/ar3685', 'https://link.springer.com/article/10.1186/ar3685/fulltext.html']\n",
      "['9738488', 'Combe B; Velicitat P; Garzon N; Bluhmki E. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients. Inflammation research. (2001) 50 SUPPL. 1 ppS10-S16', '10.1007/pl00022374', 'https://link.springer.com/article/10.1007/PL00022374/fulltext.html']\n",
      "['9738489', 'ISRCTN49682259. Remission Induction in Very Early Rheumatoid Arthritis: a comparison of etanercept plus methotrexate plus steroid with standard therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN49682259. (2007)   pp', '10.1186/isrctn49682259', '']\n",
      "['9738490', 'Albach Fredrik N; Wagner Frank; Huser Andreas; Igel Julia; Joseph David; Hilbert James; Schoelch Corinna; Padula Steven J; Steffgen Jurgen. Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. European journal of clinical pharmacology. (2018) 74 2 pp161-169', '10.1007/s00228-017-2362-8', 'http://link.springer.com/article/10.1007/s00228-017-2362-8/fulltext.html']\n",
      "['9738492', 'IRCT20141108019853N6. The effects of garlic tablet in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20141108019853N6. (2019)   pp', '10.1186/isrctn14741429', '']\n",
      "['9738495', 'Ichikawa N; Yamanaka H. Maintenance therapy for rheumatoid arthritis after remission following successful treatment using biologics. Nihon rinsho [Japanese journal of clinical medicine]. (2007) 65 7 pp1293-1298', '10.2147/btt.s31145', '']\n",
      "['9738496', 'Goldstein JL; Fred E; Silverstein MD; et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2-inhibitor. American journal of gastroenterology. (2000) 95 7 pp1681-1690', '10.1016/s0002-9270(00)00986-2', '']\n",
      "['9738500', 'Watson DJ; Yu Q; Bolognese JA; Reicin AS; Simon TJ. The upper gastrointestinal safety of rofecoxib versus NSAIDs: an updated combined analysis. Current medical research and opinion. (2004) 20 10 pp1539-1548', '10.1185/030079904x3078', '']\n",
      "['9738502', 'Fortin PR; Lew RA; Liang MH; Wright EA; Beckett LA; Chalmers TC; et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. Journal of clinical epidemiology. (1995) 48 11 pp1379-1390', '10.1016/0895-4356(95)00028-3', '']\n",
      "['9738503', \"O'Brien W M; Grunwaldt E. Ketoprofen in the treatment of rheumatoid arthritis: double blind, cross over placebo comparison. Scandinavian journal of rheumatology. Supplement. (1976) 1976 sup.14 pp105-110\", '10.1093/rheumatology/15.5.56', 'http://academic.oup.com/rheumatology/article-pdf/15/5/56/5039121/15-5-56.pdf']\n",
      "['9738504', 'Loizzi P; Muratore M; Bruni G; Sacchetti G. A double-blind, crossover comparison between indoprofen and aspirin in rheumatoid arthritis. Current medical research and opinion. (1980) 6 9 pp598-604', '10.1185/03007998009109495', '']\n",
      "['9738505', 'Atkinson M H; Buchanan W W; Fitzgerald A A; Lussier A; Tannenbaum H H. A comparison of flurbiprofen and naproxen in the treatment of rheumatoid arthritis: a Canadian multi-centre study. Current medical research and opinion. (1990) 12 2 pp76-84', '10.1185/03007999009110474', '']\n",
      "['9738506', 'McKnight P T; Kwoh C K. Randomized, controlled trial of compression gloves in rheumatoid arthritis. Arthritis care and research. (1992) 5 4 pp223-228', '10.1002/art.1790050407', '']\n",
      "['9738507', 'Symmons D; Tricker K; Roberts C; Davies L; Dawes P; Scott D L. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health technology assessment (Winchester, England). (2005) 9 34 ppiii-iv, ix-x, 1-78', '10.3310/hta9340', 'https://njl-admin.nihr.ac.uk/document/download/2012248']\n",
      "['9738509', 'Goldbach-Mansky Raphaela; Wilson Mildred; Fleischmann Roy; Olsen Nancy; Silverfield Joel; Kempf Phillip; Kivitz Alan; Sherrer Yvonne; Pucino Frank; Csako Gyorgy; Costello Rene; Pham Tuyet Hang; Snyder Christopher; van der Heijde; Desiree; Tao Xuelian; Wesley Robert; Lipsky Peter E. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Annals of internal medicine. (2009) 151 4 pp229-251', '10.7326/0003-4819-151-4-200908180-00005', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-151-4-200908180-00005']\n",
      "['9738510', 'Brien S; Lachance L; Prescott P; McDermott C; Lewith G. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford, England). (2011) 50 6 pp1070-1082', '10.1093/rheumatology/keq234', 'http://academic.oup.com/rheumatology/article-pdf/50/6/1070/5048466/keq234.pdf']\n",
      "['9738512', \"Yasuda H; Niki H. Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjogren's Syndrome. Clinical drug investigation. (2002) 22 2 pp67-73\", '10.2165/00044011-200222020-00001', '']\n",
      "['9738513', 'Singh JA; Noorbaloochi S; Singh G. Golimumab for rheumatoid arthritis: a systematic review.  [49 refs]. Journal of rheumatology. (2010) 37 6 pp1096-1104', '10.3899/jrheum.091466', '']\n",
      "['9738514', 'Le Loet X; Nordstrom D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial. Journal of rheumatology. (2008) 35 8 pp1538-1544', '10.1155/2011/845496', 'http://downloads.hindawi.com/journals/ijr/2011/845496.pdf']\n",
      "['9738515', 'Tyndall A; Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clinical and experimental immunology. (2005) 141 1 pp1-9', '10.1111/j.1365-2249.2005.02806.x', 'https://academic.oup.com/cei/article-pdf/141/1/1/42080536/j.1365-2249.2005.02806.x.pdf']\n",
      "['9738516', 'Tyndall A; Gratwohl A. Immune ablation and stem-cell therapy in autoimmune disease clinical experience. Arthritis research. (2000) 2 4 pp276-280', '10.1186/ar102', '']\n",
      "['9738517', 'Sibilia J; Westhovens R. Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (2007) 25 5 Suppl 46 pps46-s56', '10.2165/00044011-200929030-00005', '']\n",
      "['9738518', 'Bensen WG. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience. Journal of rheumatology. (2000) 60 Supp pp17-24', '10.1007/s100670070024', 'http://link.springer.com/article/10.1007/s100670070024/fulltext.html']\n",
      "['9738519', 'Oksana Sirenko O. The impact of l-arginine aspartate on endothelial function, insulin resistance, adiponectin level in hypertensive females with rheumatoid arthritis. European journal of preventive cardiology. (2016) Conference  ppS17', '10.1093/cvr/cvy060.211', 'http://academic.oup.com/cardiovascres/article-pdf/114/suppl_1/S75/24691942/cvy060.211.pdf']\n",
      "['9738520', 'Del Prete F; Petrini A; Manfredi M; Meacci F. Quantification of surgical trauma: comparison of posterolateral surgical approach and anterior minimally invasive (AMIS) for total hip arthroplasty based on markers of inflammation (interleukins). Preliminary report. Hip international. (2014)   pp506-507', '10.1007/s10195-012-0199-6', '']\n",
      "['9738522', 'Gossec L; Steinberg G; Rouanet S; Combe B. Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS study. Clinical and experimental rheumatology. (2015) 33 5 pp664-670', '10.1136/annrheumdis-2012-eular.2028', '']\n",
      "['9738523', 'Kaye O; Beckers C; Malaise MG. New clinical applications of methotrexate in rheumatology.. Medecine ET hygiene. (1994) 52 2036 pp1665-1670', '10.1093/rheumatology/34.7.642', 'http://academic.oup.com/rheumatology/article-pdf/34/7/642/5044157/34-7-642.pdf']\n",
      "['9738524', 'DUBUSKE LM. MEDIATOR ASSAYS AND MODULATION OF INFLAMMATION IN ASTHMA - INTRODUCTION. Allergy proceedings. (1995) 16 2 pp55-58', '10.2500/108854195778771408', '']\n",
      "['9738526', 'Cahoon Jr WD; Kockler DR. Mycophenolate mofetil treatment of myasthenia gravis. Annals of pharmacotherapy. (2006) 40 2 pp295-298', '10.1345/aph.1g501', 'https://journals.sagepub.com/doi/pdf/10.1345/aph.1G501']\n",
      "['9738527', 'Goldin BR; Gorbach SL. Clinical indications for probiotics: an overview. Clinical infectious diseases. (2008) 46 SUPPL. 2 ppS96-S100', '10.1086/523333', 'http://academic.oup.com/cid/article-pdf/46/Supplement_2/S96/779790/46-Supplement_2-S96.pdf']\n",
      "['9738529', 'Schiff M; Beaulieu A; Scott DL; Rashford M. Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trials. Clinical drug investigation. (2010) 30 9 pp613-624', '10.2165/11537460-000000000-00000', '']\n",
      "['9738530', 'Keystone EC. B cells in rheumatoid arthritis: from hypothesis to the clinic. Rheumatology (Oxford, England). (2005) 44 Suppl 2 Suppl 2 ppii8-ii12', '10.1093/rheumatology/keh617', 'http://academic.oup.com/rheumatology/article-pdf/44/suppl_2/ii8/5044816/keh617.pdf']\n",
      "['9738532', 'Weinblatt ME. Efficacy of methotrexate in rheumatoid arthritis. British journal of rheumatology. (1995) 34 SUPPL. 2 pp43-48', '10.1093/rheumatology/xxxiv.suppl_2.43', 'http://academic.oup.com/rheumatology/article-pdf/XXXIV/suppl_2/43/5287874/XXXIV-suppl_2-43.pdf']\n",
      "['9738533', 'Anis AH; Tugwell PX; Wells GA; Stewart DG. A cost effectiveness analysis of cyclosporine in rheumatoid arthritis. Journal of rheumatology. (1996) 23 4 pp609-616', '10.1007/s00296-007-0342-5', 'http://link.springer.com/article/10.1007/s00296-007-0342-5/fulltext.html']\n",
      "['9738534', 'Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials. Journal of rheumatology. (1999) 26 3 pp712-716', '10.1093/rheumatology/38.8.789-a', '']\n",
      "['9738535', 'De Benedetti F; Ravelli A. Juvenile idiopathic arthritis: will etanercept be an improvement over current therapies?. BioDrugs. (2000) 14 2 pp93-98', '10.2165/00063030-200014020-00003', '']\n",
      "['9738536', '. Are rofecoxib and celecoxib safer nsaids?. Drug and therapeutics bulletin. (2000) 38 11 pp81-86', '10.2165/00128415-200410040-00006', '']\n",
      "['9738538', 'Strand V. Counterpoint from the trenches: a pragmatic approach to therapeutic trials in rheumatoid arthritis. Arthritis and rheumatism. (2004) 50 4 pp1344-1348', '10.1002/art.20153', '']\n",
      "['9738539', \"Van Woerkom JM; Kruize AA; Geenen R; Van Roon EN; Goldschmeding R; Verstappen SMM; Van Roon JAG; Bijlsma JWJ. Safety and efficacy of leflunomide in primary Sjogren's syndrome: a phase II pilot study. Annals of the rheumatic diseases. (2007) 66 8 pp1026-1032\", '10.1136/ard.2006.060905', '']\n",
      "['9738541', 'Genovese MC; Carlier H; Erickson J; Braun D; Banerjee S. Results of 64 weeks of treatment with an anti-IL-17 antibody, ixekizumab, in patients with rheumatoid arthritis in a phase 2 study. Arthritis and rheumatism. (2013) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2013 San Diego, CA United States. Conference Start: 20131025 Conference End: 20131030. Conference Publication: var.pagings ppS188', '10.1136/annrheumdis-2013-eular.1833', '']\n",
      "['9738542', 'Schnabel A; Gross WL. Low-dose methotrexate in rheumatic diseases - Efficacy, side effects, and risk factors for side effects. Seminars in arthritis and rheumatism. (1994) 23 5 pp310-327', '10.1016/0049-0172(94)90027-2', '']\n",
      "['9738543', 'Abu-Raddad E; DeGaetano A; Bihorel S; Fiedler-Kelly J; Sloan-Lancaster J. Pharmacokinetic (PK) and pharmacodynamic (PD) modelling of subcutaneous (SC) LY2189102, a neutralising IL-1beta antibody, in patients with type 2 diabetes mellitus. Diabetologia. (2011) Conference: 47th Annual Meeting of the European Association for the Study of Diabetes, EASD 2011 Lisbon Portugal. Conference Start: 20110912 Conference End: 20110916. Conference Publication: var.pagings ppS366-S367', '10.14341/2072-0351-6239', 'https://dia-endojournals.ru/dia/article/viewFile/6239/3998']\n",
      "['9738544', 'Khan A; Dubois S; Rahman Z; Khan OA; Derzko C. A randomized, double-blind, placebocontrolled study to evaluate the effects of alendronate (ALN) on bone mineral density (BMD) and bone turnover in perimenopausal women with low BMD. Journal of clinical densitometry. (2014) Conference: 2014 IOF-ISCD Skeletal Health Meeting Abstracts. Orlando, FL United States. Conference Start: 20140220. Conference End: 20140222. Conference Publication: var.pagings pp425-426', '10.1016/j.jocd.2014.04.095', '']\n",
      "['9738545', 'Adam O. Dietary Fatty Acids and Immune Reactions in Synovial Tissue. European journal of medical research. (2003) 8 8 pp381-387', '10.1007/978-1-4757-2043-3_4', '']\n",
      "['9738546', 'Kelly RB. Acupuncture for pain. American family physician. (2009) 80 5 pp481-484+506', '10.1016/j.osfp.2009.08.005', '']\n",
      "['9738547', 'Fernandez Diaz C; Cervantes EC; Castaneda S; Flores-Robles B; Carreira PE; Maiz O; Rodriguez Gomez M; Narvaez FJ; Blanco-Madrigal J; Mena N; Rodriguez S; Ortiz F; Exposito-Molinero R; Bernal JA; Delgado C; Palma D; Urruticoechea-Arana A; Ruibal A; Fito-Manteca C; Mora-Cuesta V; Palmou N; Hernandez JL; Blanco R. Abatacept in rheumatoid arthritis with interstitial lung disease: a multicentre study in 34 patients. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp722', '10.1136/annrheumdis-2016-eular.5255', '']\n",
      "['9738549', 'Kass A; Hollan I; Gulseth HC; Forre O. The association of gonadotropin-releasing hormone and cytokines in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 pp 60 pp60-', '10.1136/annrheumdis-2016-eular.5976', '']\n",
      "['9738550', 'Gladman DD; Charles-Schoeman C; McInnes IB; Veale DJ; Thiers B; Graham D; Wang C; Jones T; Wolk R; DeMasi R. Changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis: an integrated analysis across phase 3 and long-term extension studies. Arthritis and rheumatology. (2017) Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2017. United States. 69 Supplement 10 pp', '10.1136/annrheumdis-2018-eular.1459', '']\n",
      "['9738551', 'Strom M; Alfafara C; Desalvo J; McCallum M; Hopkins L; Pace T; Chow S; Levinsky D; Ruderman E; Billheimer D; Funk J. Eligibility of rheumatoid arthritis patients for a phase 1b clinical trial evaluating Turmeric supplementation. FASEB journal. (2017) Conference: Experimental Biology 2017, EB. United States. 31 1 Supplement 1 pp', '10.1096/fasebj.31.1_supplement.lb353', '']\n",
      "['9738552', 'Zhang X; Rowell L; Fettner S; Lau C; Teuber D. Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. International journal of clinical pharmacology and therapeutics. (2014) 52 1 pp27-38', '10.5414/cp201951', '']\n",
      "['9738553', 'NL1162. Effects of low-dose aspirin taken at bedtime on hypertension. https://www.trialregister.nl/trial/1162. (2008)   pp', '10.1097/00004872-201106001-00735', '']\n",
      "['9738554', 'Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis. Journal of periodontal research. (2016) 51 1 pp103-111', '10.1111/jre.12288', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjre.12288']\n",
      "['9738556', 'Yoo D H; Park W; Suh C H; Shim S C; Lee S J; Bae Y J; Park C; Koo J H. Rituximab is effective in the treatment of rheumatoid arthritis regardless of body mass index. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp548', '10.1136/annrheumdis-2017-eular.5591', '']\n",
      "['9738558', 'Cozmuta R; Fraenkel L; Wilhelms E; Reyna V; Nolte J. The influence of risk presentation format on willingness to start a medication. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp453', '10.1136/annrheumdis-2017-eular.5169', '']\n",
      "['9738559', 'Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A. The potent inhibitory effect of beta-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on anti-cyclic citrullinated peptide antibodies, rheumatoid factor and antidsDNA antibodies in patients with rheumatoid arthritis. Current drug discovery technologies. (2017) 14 3 pp206-214', '10.2174/1570163814666170321113059', '']\n",
      "['9738560', 'Ibrahim F; Lorente-C√°novas B; Dor√© CJ; Bosworth A; Ma MH; Galloway JB; Cope AP; Pande I; Walker D; Scott DL. Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis--a proof of principle and exploratory trial: is dose tapering practical in good responders?. Rheumatology (oxford, england). (2017) 56 11 pp2004-2014', '10.1093/rheumatology/kex315', 'http://academic.oup.com/rheumatology/article-pdf/56/11/2004/22316081/kex315.pdf']\n",
      "['9738561', 'Dale J; Alcorn N; Capell H; Madhok R. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Nature clinical practice. Rheumatology. (2007) 3 8 pp450-458', '10.1038/ncprheum0562', 'http://www.nature.com/articles/ncprheum0562']\n",
      "['9738562', 'Burmester GR; FitzGerald O; Winthrop K; Azevedo VF; Rigby WFC; Kanik KS; Wang C; Biswas P; Jones T; Menon S; Palmetto N; Rojo R. Integrated safety summaryof tofacitinib in psoriatic arthritis clinical studies. Journal of clinical rheumatology. (2018) Conference: 20th Pan-American League of Associations of Rheumatology Congress, PANLAR 2018. Argentina. 24 3 Supplement 1 ppS8', '10.1136/annrheumdis-2017-eular.1573', '']\n",
      "['9738565', 'Anderson JJ; Wells G; Verhoeven AC; Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis and rheumatism. (2000) 43 1 pp22-29', '10.1002/1529-0131(200001)43:1<22::aid-anr4>3.0.co;2-9', '']\n",
      "['9738566', 'Semanik P; Song J; Chang R W; Manheim L; Ainsworth B; Dunlop D. Assessing physical activity in persons with rheumatoid arthritis using accelerometry. Medicine and science in sports and exercise. (2010) 42 8 pp1493-1501', '10.1249/mss.0b013e3181cfc9da', '']\n",
      "['9738568', 'Criscione LG; Sugarman J; Sanders L; Pisetsky DS; Clair EW. Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis and rheumatism. (2003) 49 3 pp361-367', '10.1002/art.11057', '']\n",
      "['9738572', 'Cao G; Huang Q; Xu B; Huang Z; Xie J; Pei F. Multimodal Nutritional Management in Primary Total Knee Arthroplasty: a Randomized Controlled Trial. Journal of arthroplasty. (2017) 32 11 pp3390-3395', '10.1016/j.arth.2017.06.020', '']\n",
      "['9738573', 'Atalay S; van den Reek JMPA; van Vugt LJ; Otero ME; van de Kerkhof PCM; den Broeder AA; Kievit W; de Jong EMGJ. Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial. BMC dermatology. (2017) 17 1 pp6', '10.1186/s12895-017-0057-6', 'http://link.springer.com/content/pdf/10.1186/s12895-017-0057-6.pdf']\n",
      "['9738574', 'Wang CC; Lee SH; Lin HY; Liu FW; Chiou HJ; Chan RC; Chou CL. Short-term effect of ultrasound-guided low-molecular-weight hyaluronic acid injection on clinical outcomes and imaging changes in patients with rheumatoid arthritis of the ankle and foot joints. A randomized controlled pilot trial. Modern rheumatology. (2017) 27 6 pp973-980', '10.1080/14397595.2016.1270496', '']\n",
      "['9738579', 'Liberman F; Elgart J; Strusberg I. Economic benefit of controlled clinical trials: the avoidable cost in drugs for the treatment of rheumatoid arthritis. Journal of clinical rheumatology. Conference: 20th pan-american league of associations of rheumatology congress, PANLAR 2018. Argentina. (2018) 24 3 Supplement 1 ppS64', '10.1016/j.vhri.2018.10.007', '']\n",
      "['9738582', 'Trivedi V; Bansal Y. The role of methotrexate monotherapy along with vitamin D in newly diagnosed rheumatoid arthritis. Internal medicine journal. Conference: 58th annual scientific meeting of the australian rheumatology association with the rheumatology health professionals association, ARA 2018. Australia. (2018) 48 Supplement 4 pp20', '10.1046/j.1445-5994.2003.00001.x', 'http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1445-5994.2003.00001.x']\n",
      "['9738587', 'Nochioka K; Biering-Sorensen T; Hansen KW; Sorensen R; Pedersen S; Jorgensen PG; Iversen A; Shimokawa H; Jeger R; Kaiser C; Pfisterer M; Galatius S. Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitats Trial-PROspective Validation Examination (BASKET-PROVE) sub-study. European heart journal: acute cardiovascular care. (2017) 6 8 pp778-786', '10.1177/2048872616649860', 'http://journals.sagepub.com/doi/pdf/10.1177/2048872616649860']\n",
      "['9738589', 'Yang Y; He X; Zhao R; Guo W; Zhu M; Xing W; Jiang D; Liu C; Xu X. Serum IFN-gamma levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. Journal of translational medicine. (2018) 16 1) (no pagination pp', '10.1186/s12967-018-1541-4', 'https://link.springer.com/article/10.1186/s12967-018-1541-4/fulltext.html']\n",
      "['9738593', 'Apsangikar P; Chaudhry S; Naik M; Deoghare S; Joseph J. A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate. Indian journal of rheumatology. (2018) 13 2 pp84-89', '10.4103/injr.injr_107_17', 'https://journals.sagepub.com/doi/pdf/10.4103/injr.injr_107_17']\n",
      "['9738596', 'White WB; Kloner RA; Angiolillo DJ; Davidson MH. Cardiorenal Safety of OTC Analgesics. Journal of cardiovascular pharmacology and therapeutics. (2018) 23 2 pp103-118', '10.1177/1074248417751070', 'https://journals.sagepub.com/doi/pdf/10.1177/1074248417751070']\n",
      "['9738597', 'Obeid S; Libby P; Husni ME; Pfeffer MA; Wisniewski LM; Wolski KE; Wang Q; Nissen SE; Luscher TF. Cardiorenal risks of celecoxib, naproxen or ibuprofen in arthritis patients: a sub-anaylsis from the precision trial. Circulation. (2017) Conference: Resuscitation Science Symposium, ReSS 2017. United States. 136 Suppl  1 pp', '10.1093/eurheartj/ehy566.p5421', 'http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy566.P5421/25578788/ehy566.p5421.pdf']\n",
      "['9738598', 'Kane B. Response to Jani et al. A prospective, randomized, doubleblind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis. International journal of rheumatic diseases. (2017) 20 11 pp1791', '10.1111/1756-185x.12748', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12748']\n",
      "['9738601', 'Dokoupilov√° E; Aelion J; Takeuchi T; Malavolta N; Sfikakis PP; Wang Y; Rohrer S; Richards HB. Secukinumab after anti-tumour necrosis factor-Œ± therapy: a phase III study in active rheumatoid arthritis. Scandinavian journal of rheumatology. (2018) 47 4 pp276-281', '10.1080/03009742.2017.1390605', '']\n",
      "['9738604', '. The potent inhibitory effect of beta-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on anti-cyclic citrullinated peptide antibodies, rheumatoid factor and antidsDNA antibodies in patients with rheumatoid arthritis. Current drug discovery technologies. (2017) 14 3 pp206-214', '10.2174/1570163814666170321113059', '']\n",
      "['9738605', 'Aimer Pip; Stamp Lisa K; Stebbings Simon; Cameron Vicky; Kirby Sandra; Treharne Gareth J. Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal care. (2018) 16 1 pp74-81', '10.1002/msc.1209', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1209']\n",
      "['9738606', 'Stavropoulos A; Manthou E; Nakopoulou T; Georgakouli K; Jamurtas A. HPR effects of beetroot juice supplementation on endothelial function and markers of inflammation among patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2017) 76 Suppl 2 pp1536-1537', '10.1136/annrheumdis-2017-eular.4519', '']\n",
      "['9738607', 'Prakash A; Jarvis B. Leflunomide. A review of its use in active rheumatoid arthritis. Drugs. (1999) 58 6 pp1137-1164', '10.2165/00003495-199958060-00010', '']\n",
      "['9738608', 'Anonymous. Erratum to: a randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: results of the 12-week double-blind period (Modern Rheumatology, (2018), 28, 1, (76-84), 10.1080/14397595.2017.1332507). Modern rheumatology. (2018) 28 1 pp(v)', '10.1080/14397595.2017.1332507', 'https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1332507']\n",
      "['9738609', 'Traistaru R; Bumbea AM; Kamal D; Kamal C; Rogoveanu O. The role of rehabilitation in avascular necrosis of the humeral head-randomized study. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp895', '10.1136/annrheumdis-2016-eular.2965', '']\n",
      "['9738610', 'Park W; Bozic-Majstorovic L; Milakovic D; Berrocal Kasay A; El-Khouri EC; Irazoque-Palazuelos F; Molina FFC; Shesternya P; Miranda P; Medina-Rodriguez FG; Wiland P; Jeka S; Chavez-Corrales J; Garmish O; Linde T; Rekalov D; Hrycaj P; Krause A; Fomina N; Piura O; Abello-Banfi M; Suh C; Shim SC; Lee SJ; Lee SY; Kim SH; Yoo DH. Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial. mAbs. (2018) 10 6 pp1-10', '10.1080/19420862.2018.1487912', '']\n",
      "['9738613', 'Alleva Jessica M; Diedrichs Phillippa C; Halliwell Emma; Peters Madelon L; Dures Emma; Stuijfzand Bobby G; Rumsey Nichola. More than my RA: a randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program. Journal of consulting and clinical psychology. (2018) 86 8 pp666-676', '10.1037/ccp0000317', 'http://psycnet.apa.org/journals/ccp/86/8/666.pdf']\n",
      "['9738614', \"StClair EW; Baer AN; Wei C; Noaiseh G; Parke A; Coca A; Utset TO; Genovese MC; Wallace DJ; Mcnamara J; Boyle K; Keyes-Elstein L; Browning JL; Franchimont N; Smith K; Guthridge JM; Sanz I; James JA. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin beta Receptor Fusion Protein, in Primary Sjogren's Syndrome: results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial Clinical Efficacy and Safety of Baminercept, a Lymphotoxin beta Receptor Fusion Protein, in Primary Sjogren's Syndrome: results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial St.Clair et al. Arthritis and rheumatology. (2018) (no pagination) 9 pp1470-1480\", '10.1002/art.40513', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40513']\n",
      "['9738616', 'JIANG G; WAN B; HUANG W; CHEN L; DUAN B; WANG Y. Influence of acupotomy loosing on IL-6, IL-10 and TNF-alpha in synovial fluid of rheumatoid arthritis patients with elbow joint stiffness. World journal of acupuncture - moxibustion. (2018) (no pagination) 2 pp91-96', '10.1016/j.wjam.2018.06.010', '']\n",
      "['9738617', 'Hang Y; Qin X; Ren T; Cao J. Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids in health and disease. (2018) 17 1) (no pagination pp', '10.1186/s12944-018-0797-2', 'http://link.springer.com/article/10.1186/s12944-018-0797-2/fulltext.html']\n",
      "['9738618', 'Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Journal of arthroplasty. (2017) 32 9 pp2628-2638', '10.1016/j.arth.2017.05.001', '']\n",
      "['9738620', 'Taylor-Gjevre R; Nair B; Bath B; Okpalauwaekwe U; Sharma M; Penz E; Trask C; Stewart S. Addressing rural and remote access disparities for patients with inflammatory arthritis through videoconferencing and innovative inter-professional care models. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1001-1002', '10.1002/msc.1215', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1215']\n",
      "['9738622', 'Wright K; Kherani R; Zhao S; Goldsmith C. Do inflammatory arthritis inpatients receiving group music therapy improve pain compared to music listening over the 6 weeks using a randomised controlled open-label trial?: \"One good thing about music, when it hits, you feel no pain\". Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp979-980', '10.4103/1357-6283.120709', '']\n",
      "['9738624', 'Boire G; Dobkin P; Gaboury I; Gervais F; Beaulieu M-C; Dagenais P; Roberge P; Roux S. Addressing persistent depressive symptoms in rheumatoid arthritis patients with controlled disease. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1027-1028', '10.26443/ijwpc.v7i1.210', 'https://ijwpc.mcgill.ca/article/download/210/250']\n",
      "['9738625', \"Trujillo I; Molina C; Aguilera S; Mart√≠nez B; Pinto R. Effect of pilocarpine on salivary flow in patients with Sj√∂gren's syndrome. Revista de la Universidad Mayor. (2002) 1 1 pp43-55\", '10.21703/0718-5162.v21.n45.2022.005', '']\n",
      "['9738626', 'Lomonte Andrea B V; Radominski Sebastiao C; Marcolino Flora M D; Brenol Claiton V; Zerbini Cristiano A F; Garcia Erika G; Akylbekova Ermeg L; Rojo Ricardo; de Leon Dario Ponce. Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: pooled efficacy and safety analyses. Medicine. (2018) 97 31 ppe11609', '10.1097/md.0000000000011609', '']\n",
      "['9738630', 'Heinze-Milne Stefan; Bakowsky Volodko; Giacomantonio Nicholas; Grandy Scott A. Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial. BMJ open. (2017) 7 12 ppe018540', '10.1136/bmjopen-2017-018540', '']\n",
      "['9738631', 'Martin Naomi H; Ibrahim Fowzia; Tom Brian; Galloway James; Wailoo Allan; Tosh Jonathan; Lempp Heidi; Prothero Louise; Georgopoulou Sofia; Sturt Jackie; Scott David L; TITRATE Programme Investigators. Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial. Trials. (2017) 18 1 pp591', '10.1186/s13063-017-2330-8', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2330-8.pdf']\n",
      "['9738632', 'Sigurdardottir V; Husmark T; Svard A. Switching from reference product etanercept to the biosimilar SB4 in a real-life setting: follow-up of 147 patients. Annals of the rheumatic diseases. (2017) Conference: Annual European Congress of Rheumatology, EULAR 2017. Spain. 76 Supplement 2 pp835', '10.1136/annrheumdis-2017-eular.4391', '']\n",
      "['9738635', 'Luo G; Xin Y; Qin D; Yan A; Zhou Z; Liu Z. Correlation of interleukin-33 with Th cytokines and clinical severity of dry eye disease. Indian journal of ophthalmology. (2018) 66 1 pp39-43', '10.4103/ijo.ijo_405_17', '']\n",
      "['9738636', 'Genovese Mark C; Weinblatt Michael E; Mease Philip J; Aelion Jacob A; Peloso Paul M; Chen Kun; Li Yihan; Liu John; Othman Ahmed A; Khatri Amit; Mansikka Heikki T; Leszczynski Piotr. Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis. Rheumatology (Oxford, England). (2018) 57 11 pp1972-1981', '10.1093/rheumatology/key173', 'http://academic.oup.com/rheumatology/article-pdf/57/11/1972/26146562/key173.pdf']\n",
      "['9738637', 'Elmamoun M; Chandran V. Role of Methotrexate in the Management of Psoriatic Arthritis. Drugs. (2018) 78 6 pp611-619', '10.1007/s40265-018-0898-2', 'http://link.springer.com/article/10.1007/s40265-018-0898-2/fulltext.html']\n",
      "['9738639', 'Mease P; Ritchlin C; Rubant S; Varothai N; Hojnik M; Okun M; Gottlieb A. Disconnect between radiographic progression and skin or arthritic outcomes in patients with psoriatic arthritis treated with adalimumab. British journal of dermatology.. (2014) 171 6 ppe171-e172', '10.1016/j.jaad.2015.02.931', '']\n",
      "['9738640', 'McBain H; Shipley M; Moore S; Olaleye A; Hirani S; Newman SP. A self-monitoring and patient-initiated follow-up service for patients with rheumatoid or psoriatic arthritis: a randomized controlled trial. Rheumatology (united kingdom).. (2014) 53 SUPPL. 1 ppi77', '10.1093/rheumatology/keu098.013', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i77/9578383/keu098.013.pdf']\n",
      "['9738641', 'Aalbers CJ; Gerlag DM; Vos K; Wolbink G; Landewe R; Tak PP. Intra-articular etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled trial. Arthritis and rheumatism.. (2012) 64 SUPPL. 10 ppS574-S575', '10.1016/j.jbspin.2015.03.002', '']\n",
      "['9738643', 'Kremer JM; Keystone EC; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Jungerwirth S. Safety and efficacy of ABT-494, a novel selective jak1 inhibitor, in patients with active rheumatoid arthritis and inadequate response or intolerance to anti-TNF biologic therapy. Annals of the rheumatic diseases. (2016) Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2016. United Kingdom. 75 Supplement 2 pp1038-1039', '10.1136/annrheumdis-2016-eular.1448', '']\n",
      "['9738644', 'Gendelman O; Weitzman D; Rosenberg V; Shalev V; Chodick G; Amital H. Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab. British journal of clinical pharmacology. (2018) 84 4 pp786-795', '10.1111/bcp.13494', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.13494']\n",
      "['9738646', 'Choquette D; Bessette L; Alemao E; Haraoui B; Massicotte F; Mtibaa M; Muratti E; Pelletier J-P; Postema R; Raynauld J-P; Remillard M-A; Sauvageau D; Turcotte A; Villeneuve E; Coupal L. Retention rates of TNF inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the Rhumadata registry. Journal of rheumatology. (2018) Conference: 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018. Canada. 45 7 pp1053', '10.1136/annrheumdis-2017-eular.2326', '']\n",
      "['9738649', 'Attipoe L; Ciurtin C. Does health satisfaction and perception of treatment efficacy in patients with inflammatory arthritis correlate with disability and global health state?. Annals of the rheumatic diseases.. (2015) 74 SUPPL. 2 pp987', '10.1136/annrheumdis-2015-eular.4264', '']\n",
      "['9738650', 'Bakir Ercan; Baglama Sevgin Samancioglu; Gursoy Savas. The effects of reflexology on pain and sleep deprivation in patients with rheumatoid arthritis: a randomized controlled trial. Complementary therapies in clinical practice. (2018) 31 pp 315-319 pp315-319', '10.1016/j.ctcp.2018.02.017', '']\n",
      "['9738651', 'Lindqvist HM; Gjertsson I; Eneljung T; Winkvist A. Influence of Blue Mussel (. Nutrients. (2018) 10 4 pp', '10.3390/nu10040481', '']\n",
      "['9738652', 'Claassen Aniek A O M; van den Ende Cornelia H M; Meesters Jorit J L; Pellegrom Sanne; Kaarls-Ohms Brigitte M; Vooijs Jacoba; Willemsen-de Mey Gerardine E M P; Vliet Vlieland Thea P M. How to best distribute written patient education materials among patients with rheumatoid arthritis: a randomized comparison of two strategies. BMC health services research. (2018) 18 1 pp211', '10.1186/s12913-018-3039-4', 'http://link.springer.com/article/10.1186/s12913-018-3039-4/fulltext.html']\n",
      "['9738653', 'Elliott A; Wright G; Quinn A; Torrens D; Pendleton A; McHenry M. An experience of tight control in psoriatic arthritis management within the belfast trust. Rheumatology (united kingdom). (2018) Conference: 2018 Annual Conference of the British Society for Rheumatology. United Kingdom. 57 Supplement 3 ppiii189-iii190', '10.1093/rheumatology/key075.574', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.574/24768624/key075.574.pdf']\n",
      "['9738655', 'Khatri A; Othman AA. Population Pharmacokinetics of the TNF-alpha and IL-17A Dual-Variable Domain Antibody ABT-122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: analysis of Phase 1 and 2 Clinical Trials. Journal of clinical pharmacology. (2018) 58 6 pp803-813', '10.1002/jcph.1068', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1068']\n",
      "['9738659', 'Loef M; Kroon FP; Bergstra SA; Van Der Pol JA; Lems WF; Kerstens PJ; Allaart CF; Kloppenburg M. Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. Osteoarthritis and cartilage. (2018) Conference: 2018 Osteoarthritis Research Society International, OARSI World Congress. United Kingdom. 26 Supplement 1 ppS300-S301', '10.1016/j.joca.2018.02.604', '']\n",
      "['9738660', 'Garner Stephanie; Fenton Tanis; Martin Liam; Creaser Caitlin; Johns Carolyn; Barnabe Cheryl. Personalized diet and exercise recommendations in early rheumatoid arthritis: a feasibility trial. Musculoskeletal care. (2018) 16 1 pp167-172', '10.1002/msc.1214', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1214']\n",
      "['9738661', 'Rahlfs VW; Stat C. Reevaluation of some double-blind, randomized studies of dexibuprofen (Seractil): a state-of-the-art overview: studies in patients with lumbar vertebral column syndrome, rheumatoid arthritis, distortion of the ankle joint, gonarthrosis, ankylosing spondylitis, and activated coxarthrosis. Journal of clinical pharmacology. (1996) 36 12 SUPPL. pp33S-40S', '10.1002/j.1552-4604.1996.tb00007.x', '']\n",
      "['9738662', 'Giannini EH; Ruperto N; Ravelli A; Lovell DJ; Felson DT; Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis and rheumatism. (1997) 40 7 pp1202-1209', '10.1002/1529-0131(199707)40:7<1202::aid-art3>3.0.co;2-r', '']\n",
      "['9738663', 'Martini A. Etanercept improves active polyarticular juvenile rheumatoid arthritis. Clinical and experimental rheumatology. (2001) 19 2 pp122-124', '10.1186/ar-2000-66814', 'http://link.springer.com/article/10.1186/ar-2000-66814/fulltext.html']\n",
      "['9738664', 'Queneau P; Francon A; Graber-Duvernay B. Methodological reflections on 20 randomized clinical hydrotherapy trials in rheumatology. Therapie. (2001) 56 6 pp675-684', '10.1093/rheumatology/kep182', 'http://academic.oup.com/rheumatology/article-pdf/48/9/1155/5054820/kep182.pdf']\n",
      "['9738665', 'Tyndall A; Koike T. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Internal medicine (Tokyo, Japan). (2002) 41 8 pp608-612', '10.2169/internalmedicine.41.608', '']\n",
      "['9738666', 'Pereira DA; Baldi BG; Chulam CS; Arimura FE; Carvalho CR; Kairalla RA. Survival distinction in interstitial pneumonia with autoimmune features (IPAF) patients: results from a 5-year historical cohort in an interstitial lung diseases (ILD) population. American journal of respiratory and critical care medicine. (2018) Conference: American Thoracic Society International Conference, ATS 2018. United States. 197 MeetingAbstracts pp', '10.1164/ajrccm.2025.211.abstracts.a1843', '']\n",
      "['9738667', 'Amaricai E; Catan L; Popa D; Dragoi M; Nemes D. Metabolic syndrome in patients with autoimmune inflammatory rheumatisms. Biomedical research (india). (2018) 29 11 pp2416-2420', '10.4066/biomedicalresearch.62-18-412', '']\n",
      "['9738669', 'Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: fiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). Clinical trials (London, England). (2018) 15 3 pp268-277', '10.1177/1740774518761367', 'https://journals.sagepub.com/doi/pdf/10.1177/1740774518761367']\n",
      "['9738670', 'Mehra Pushkar; Henry Charles H; Giglou Kamyar R. Temporomandibular Joint Reconstruction in Patients With Autoimmune/Connective Tissue Disease. Journal of oral and maxillofacial surgery. (2018) 76 8 pp1660-1664', '10.1016/j.joms.2018.03.014', '']\n",
      "['9738672', 'Wang Weirong; Leu Jocelyn; Watson Rebecca; Xu Zhenhua; Zhou Honghui. Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFalpha Monoclonal Antibody. AAPS journal. (2018) 20 3 pp63', '10.1208/s12248-018-0219-4', 'http://link.springer.com/article/10.1208/s12248-018-0219-4/fulltext.html']\n",
      "['9738673', 'Fonseca Joao Eurico; Pereira da Silva Jose Antonio; Bernardes Miguel; Cernadas Rui; Canas da Silva Jose; Costa Lucia; Videira Taciana; C Miranda Luis; Barcelos Anabela; Laires Pedro A; Dezerto Raquel; D Pereira Marilia; Vidal Filomena; Cunha Esmeralda; Morais Ana; Martins Carla; Mesquita Rui. Effectiveness of a Referral Program for rheumatoid arthritis and axial spondyloarthritis Diagnosis at Primary Care Centers in Portugal - SIARA STUDY. Acta reumatologica portuguesa. (2018) 43 1 pp40-51', '10.1016/j.jval.2015.09.2380', '']\n",
      "['9738674', 'Piazzolla Andrea; Solarino Giuseppe; Bizzoca Davide; Montemurro Viola; Berjano Pedro; Lamartina Claudio; Martini Carlotta; Moretti Biagio. Spinopelvic parameter changes and low back pain improvement due to femoral neck anteversion in patients with severe unilateral primary hip osteoarthritis undergoing total hip replacement. European spine journal. (2018) 27 1 pp125-134', '10.1007/s00586-017-5033-7', 'http://link.springer.com/article/10.1007/s00586-017-5033-7/fulltext.html']\n",
      "['9738675', 'Fassio Angelo; Idolazzi Luca; Viapiana Ombretta; Benini Camilla; Vantaggiato Elisabetta; Bertoldo Francesco; Rossini Maurizio; Gatti Davide. In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls. Clinical rheumatology. (2017) 36 10 pp2377-2381', '10.1007/s10067-017-3734-2', 'http://link.springer.com/article/10.1007/s10067-017-3734-2/fulltext.html']\n",
      "['9738676', 'Kusumo SA; Isbagio H; Marhamah S; Intan C; Antono D; Harimurti K. Effect of periodontal treatment on eselectin level in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp941', '10.1136/annrheumdis-2018-eular.6244', '']\n",
      "['9738677', 'Syngle A; Garg N; Krishan P. Amelioration of inflammatory disease activity and vascular inflammation with HMGCOA reductase inhibition and angiotensin receptor blockade in rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp973', '10.1136/annrheumdis-2018-eular.5605', '']\n",
      "['9738678', 'Kurokawa H; Tanaka Y; Morita S; Taniguchi A; Kumai T. Total ankle arthroplasty combined with subtalar arthrodesis for the patient with rheumatoid arthrit. Foot and ankle surgery. (2017) Conference: 6th Scientific Meeting of the Triennial International Federation of Foot and Ankle Societies, IFFAS 2017. Portugal. 23 Supplement 1 pp76', '10.1016/j.fas.2017.07.317', '']\n",
      "['9738680', 'Mease PJ; Kremer J; Cohen S; Curtis JR; Charles-Schoeman C; Loftus EV; Greenberg J; Palmetto N; Kanik KS; Graham D; Wang C; Biswas P; Chan G; DeMasi R; Valdez H; Hendrikx T; Jones TV. Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp983', '10.1136/annrheumdis-2018-eular.3048', '']\n",
      "['9738683', 'Lau YN; Ng J; Lee SY; Li LC; Kwan CM; Fan SM; Leung BPL; Lo CN. A brief report on the clinical trial on neural mobilization exercise for joint pain in patients with rheumatoid arthritis. Zeitschrift fur Rheumatologie. (2018) (no pagination)  pp', '10.1007/s00393-018-0521-7', 'http://link.springer.com/article/10.1007/s00393-018-0521-7/fulltext.html']\n",
      "['9738684', 'Akdemir G; Markusse IM; Bergstra SA; Goekoop RJ; Molenaar ET; Van Groenendael JHLM; Kerstens PJSM; Lems WF; Huizinga TWJ; Allaart CF. Comparison between low disease activity or das remission as treatment target in patients with early active rheumatoid arthritis. RMD open. (2018) 4 1) (no pagination pp', '10.1136/rmdopen-2018-000649', '']\n",
      "['9738685', 'Wu Zhi-Peng; Zhang Pei; Bai Jian-Zhong; Liang Yuan; He Jin-Shan; Wang Jing-Cheng. Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: a meta-analysis of randomized controlled trials. Experimental and therapeutic medicine. (2018) 16 3 pp2449-2459', '10.3892/etm.2018.6495', '']\n",
      "['9738686', 'Jamilian H; Nokani M; Ghasemi M; Tavakoli N. The effectiveness of cognitive-behavioral group therapy on quality of life in Iranian patients with rheumatoid arthritis. European psychiatry. Conference: 26th european congress of psychiatry, EPA 2018. France. (2018) 48 Supplement 1 ppS257', '10.1016/s0924-9338(14)78438-x', '']\n",
      "['9738690', 'Liu Defang; Yan Jiao; Yun Mingdong; Yang Ming; Luo Yong; Zhang Jun; Guo Mingyang; Yang Mei; Yuan Weili; Zou Wei; Li Hua; Hu Yonghe. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid\\nin rheumatoid arthritis patients with symptom pattern of damp heat obstruction. Journal of traditional chinese medicine = chung i tsa chih ying wen pan. (2016) 36 5 pp625-633', '10.1016/s0254-6272(16)30082-6', '']\n",
      "['9738691', 'Chen MH; Lee MH; Liao HT; Chen WS; Lai CC; Tsai CY. Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment. Clinical rheumatology. (2018) 37 2 pp429-438', '10.1007/s10067-017-3965-2', 'http://link.springer.com/article/10.1007/s10067-017-3965-2/fulltext.html']\n",
      "['9738692', 'Gandhi AJ; Sharma S; Baranwal VK; Bedarkar P. Industrial approach of process validation of Bharjana (frying) process WSR to Eranda Bhrishta Haritaki: an experimental observation. International journal of green pharmacy. (2016) 10 4 Supplement ppS172-S177', '10.7897/2230-8407.04509', '']\n",
      "['9738693', 'Astorga G; Cubillos A; Masson L; Silva J J. Active rheumatoid arthritis: effect of dietary supplementation with omega 3 oils. Double-blind controlled study. Rev. Med. Chile. (1991) 119 3 pp267-272', '10.7326/0003-4819-111-9-757', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-111-9-757']\n",
      "['9738694', 'Karagulle Mine; Kardes Sinan; Karagulle Mufit Zeki. Long-term efficacy of spa therapy in patients with rheumatoid arthritis. Rheumatology international. (2018) 38 3 pp353-362', '10.23853/bsehm.2018.0577', '']\n",
      "['9738696', 'Dhaon Pooja; Das Siddharth K; Srivastava Ragini; Agarwal Girdhar; Asthana Akash. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study. International journal of rheumatic diseases. (2018) 21 5 pp1010-1017', '10.1111/1756-185x.12910', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1756-185X.12910']\n",
      "['9738697', 'Rubbert-Roth A; Perniok A. Treatment of patients with rheumatoid arthritis with the interleukin-1 receptor antagonist Anakinra (Kineret). Zeitschrift fur Rheumatologie. (2003) 62 4 pp367-377', '10.1007/s00393-003-0545-4', 'http://link.springer.com/article/10.1007/s00393-003-0545-4/fulltext.html']\n",
      "['9738698', 'Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Annals of the rheumatic diseases. (2000) 59 SUPPL. 1 ppi46-i49', '10.1136/ard.59.suppl_1.i46', '']\n",
      "['9738700', 'Tam Lydia Ho-Pui; Shang Qing; Li Edmund Kwok-Ming; Wong Priscilla Ching-Han; Kwok Kitty Yan; Kun Emily Wai-Lin; Yim Isaac Cheuk-Wan; Lee Violet Ka-Lai; Yip Ronald Man-Lung; Pang Steve Hin-Ting; Lao Virginia Weng-Nga; Mak Queenie Wah-Yan; Cheng Isaac Tsz-Ho; Lau Xerox Sze-Lok; Li Tena Ka-Yan; Zhu Tracy Yaner; Lee Alex Pui-Wai; Tam Lai-Shan. Effect of treat-to-target strategies aiming at remission of arterial stiffness in early rheumatoid arthritis: a randomized controlled study. Journal of rheumatology. (2018) 45 9 pp1229-1239', '10.3899/jrheum.171128', '']\n",
      "['9738701', 'Kruger K. Treatment of rheumatoid arthritis and other inflammatory rheumatic diseases with cyclosporin a - Update 1997. Aktuelle rheumatologie. (1998) 23 2 pp40-47', '10.1055/s-2007-1005864', 'http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-1005864.pdf']\n",
      "['9738702', 'NCT03606876. Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra¬Æ in Healthy Subjects. Https://clinicaltrials.gov/show/nct03606876. (2018)   pp', '10.31525/ct1-nct04152759', '']\n",
      "['9738703', 'Mckenna SG; Donnelly A; Appel Esbensen B; Comber L; Ng WL; Maqsood A; Fraser A; Kennedy N. The impact of exercise on sleep in people with rheumatoid arthritis: a pilot randomised controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1786', '10.1136/annrheumdis-2018-eular.2307', '']\n",
      "['9738704', 'Kwok GSK; Cheung TT; Tang MLM; Yuen CKY; Chung HY; Lau WCS. Nursing consultation versus rheumatologist follow up for patients with stable rheumatoid arthritis: a randomized controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1819-1820', '10.1136/annrheumdis-2018-eular.3217', '']\n",
      "['9738705', 'Reina-Bueno M; Munuera-Martinez PV; Vazquez-Bautista C; Perez-Garcia S; Rosende-Bautista C. Effect of custom-made foot orthoses versus placebo in patients with rheumatoid arthritis: randomised clinical trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1793', '10.1136/annrheumdis-2018-eular.3421', '']\n",
      "['9738706', 'Song YW; Matsuno H; Park M-C; Tomomitsu M; Shin S; Lee J. Efficacy and safety of switching from etanercept product to LBEC0101 (etanercept biosimilar) compared with continuing LBEC0101 in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1389-1390', '10.1136/annrheumdis-2018-eular.1316', '']\n",
      "['9738709', 'Erhard J; Hagen M; Englbrecht M; Haschka J; Reiser M; Kleyer A; Hueber AJ; Manger B; Figueiredo C; Cobra JF; Tony H-P; Finzel S; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz H; Nuesslein H; Alten R; Henes J; Krueger K; Schett G; Rech J. Loosing DAS28-ESR, but staying in boolean remission-is it possible? Data from the prospective, randomised retro trial on rheumatoid arthritis patients in stable remission. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1307-1308', '10.1136/annrheumdis-2018-eular.5521', '']\n",
      "['9738712', 'Yoshioka Y; Katayama K; Kasama T; Sato M; Ohno S; Amasaki Y; Kataoka H; Kanai D; Suda A; Okamoto M; Sasano M; Nagaoka S; Sagawa A. Weekly split dose compared with single dose oral methotrexate reduced polyglutamylation in red blood cells and increased the risk of adverse events in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp992', '10.1136/annrheumdis-2018-eular.5046', '']\n",
      "['9738718', 'Katayama K. Possible linkage between intestinal bacteria composition changes and disease activity in patients with rheumatoid arthritis treated with natural milk antibodies against enteric bacteria and their toxins. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp1406', '10.1136/annrheumdis-2018-eular.2320', '']\n",
      "['9738720', 'Van Der Ven M; Kuijper M; Gerards A; Tchetverikov I; Weel A; Van Zeben D; Bijkerk C; DeMan Y; Hazes M; Luime J. Three-monthly ultrasound monitoring of rheumatoid arthritis patients tapering their medication has limited value in predicting disease relapse. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp914', '10.1136/annrheumdis-2018-eular.6424', '']\n",
      "['9738724', 'Burmester G; Rigby WFC; Choy E; Nash P; Winthrop K; Mease PJ; Young P; Hendrikx T; Wang C; Menon S; Graham D. Changes in lymphocytes and lymphocyte subsets in tofacitinib-treated patients with psoriatic arthritis. Annals of the rheumatic diseases. Conference: annual european congress of rheumatology, EULAR 2018. Netherlands. (2018) 77 Supplement 2 pp1030', '10.1136/annrheumdis-2018-eular.3490', '']\n",
      "['9738726', 'Bianchi G; Camellino D; Locaputo A; Diana P; Giusti A; Girasole G; Kremer J; Weinblatt M. Step-down methotrexate therapy in rheumatoid arthritis (stemetra): a pilot study to assess the safety and the tolerability of high-dose methotrexate. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp975', '10.1136/annrheumdis-2018-eular.2768', '']\n",
      "['9738728', 'Galeazzi M; Sebastiani G; Voll R; Viapiana O; Dudler J; Zufferey P; Selvi E; Finzel S; Bootz FS; Neri D. Dekavil (F8IL10)-update on the results of clinical trials investigating the immunocytokine in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp603-604', '10.1136/annrheumdis-2018-eular.5550', '']\n",
      "['9738735', 'NCT03611283. Topical management of xerostomia with dry mouth products. Https://clinicaltrials.gov/show/nct03611283. (2018)   pp', '10.1201/9781003526995-8', '']\n",
      "['9738736', 'NCT03618784. Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03618784. (2018)   pp', '10.31525/ct1-nct04049448', '']\n",
      "['9738739', 'Rongen Gerard A; van Ingen Iris; Kok Marc; Vonkeman Harald; Janssen Matthijs; Jansen Tim L. Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs. Clinical rheumatology. (2018) 37 4 pp909-916', '10.1007/s10067-017-3961-6', 'http://link.springer.com/article/10.1007/s10067-017-3961-6/fulltext.html']\n",
      "['9738741', \"Fidelix Tania; Czapkowski Adriano; Azjen Sergio; Andriolo Adagmar; Neto Pedro Horvath; Trevisani Virginia. Low-level laser therapy for xerostomia in primary Sj√∂gren's syndrome: a randomized trial. Clinical rheumatology. (2018) 37 3 pp729-736\", '10.1007/s10067-017-3898-9', 'http://link.springer.com/article/10.1007/s10067-017-3898-9/fulltext.html']\n",
      "['9738742', 'Wang S Keisin; Green Linden A; Gutwein Ashley R; Drucker Natalie A; Motaganahalli Raghu L; Fajardo Andres; Babbey Clifford M; Murphy Michael P. Rationale and design of the ARREST trial investigating mesenchymal stem cells in the treatment of small abdominal aortic aneurysm. Annals of vascular surgery. (2018) 47  pp230-237', '10.1016/j.avsg.2017.08.044', '']\n",
      "['9738743', 'Karagulle Mine; Kardes Sinan; Disci Rian; Karagulle Mufit Zeki. Spa therapy adjunct to pharmacotherapy is beneficial in rheumatoid arthritis: a crossover randomized controlled trial. International journal of biometeorology. (2018) 62 2 pp195-205', '10.1007/s00484-017-1441-y', 'http://link.springer.com/article/10.1007/s00484-017-1441-y/fulltext.html']\n",
      "['9738744', 'Yang Min; Guo Ming-Yang; Luo Yong; Yun Ming-Dong; Yan Jiao; Liu Tao; Xiao Chang-Hong. Effect of Artemisia annua extract on treating active rheumatoid arthritis: a randomized controlled trial. Chinese journal of integrative medicine. (2017) 23 7 pp496-503', '10.1007/s11655-016-2650-7', 'http://link.springer.com/article/10.1007/s11655-016-2650-7/fulltext.html']\n",
      "['9738745', 'Ruperto N; Brunner HI; Hazra A; Wang R; Mebus C; Alvey C; Lamba M; Krishnaswami S; Conte U; Wang M; Tzaribachev N; Foeldvari I; Horneff G; Kingsbury D; Koskova E; Smolewska E; Vehe RK; Zuber Z; Martini A; Lovell D. Pharmacokinetics, safety, and tolerability of tofacitinib in paediatric patients from two to less than eighteen years of age with juvenile idiopathic arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1202-1203', '10.1136/annrheumdis-2016-eular.2640', '']\n",
      "['9738746', 'Miceli-Richard C; Combe B; Berenbaum F; Schaeverbeke T; Koppiker N; Logeart I; Dubanchet A; Dougados M. Free DKK-1 serum levels are unchanged in spondyloarthritis patients treated by anti-TNF-data from the sparse study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp807-808', '10.1136/annrheumdis-2016-eular.4654', '']\n",
      "['9738747', 'Merola JF; Herrera V; Palmer JB. Comorbidity burden and medication use between psoriatic arthritis patients with moderate-tosevere psoriasis vs. Those with minimal skin psoriasis in the US. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp651-652', '10.1136/annrheumdis-2016-eular.3816', '']\n",
      "['9738748', 'ChiCTR-IOR-17012447. Effects of Baduanjin Exercise Intervention on Limb Contracture among Cerebral Infarction Patients with Hemiplegia. Http://www.chictr.org.cn/showproj.aspx? Proj=20838. (2017)   pp', '10.25236/ijfm.2025.070101', 'https://francis-press.com/uploads/papers/LsDIZui936QtTje3ThxxVew3xzKbS67YJ32cpfuQ.pdf']\n",
      "['9738749', 'EUCTR2016-004138-12-DE; Drug Company. Study of the effect of ASP6294 for the treatment of bladder pain syndrome/interstitial cystitis in female subjects. Https://www.clinicaltrialsregister.eu/ctr-search/search? Query=eudract_number:2016-004138-12. (2017)   pp', '10.1007/978-3-319-61449-6_21', '']\n",
      "['9738751', 'Karki C; Panchal S; Baynton E; Shah-Manek B. Effect of patient involvement in treatment decision making on disease outcomes in rheumatoid arthritis in the EU5. Value in health. (2018) Conference: 23rd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2018. United States. 21 Supplement 1 ppS260', '10.1016/j.jval.2018.04.1735', '']\n",
      "['9738754', 'Bloom S; Lichtenstein GR; Loftus EV; Lawendy N; Friedman GS; Zhang H; Wang W; Thorpe AJ; Nduaka CI; Su C. Tofacitinib, an oral jak inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study. Gut. (2018) Conference: British Society of Gastroenterology Annual General Meeting 2017, BSG 2018. United Kingdom. 67 Supplement 1 ppA62-A63', '10.1136/gutjnl-2018-bsgabstracts.123', '']\n",
      "['9738755', 'Middleton Kimberly R; Haaz Moonaz Steffany; Hasni Sarfaraz A; Magana Lopez Miriam; Tataw-Ayuketah Gladys; Farmer Nicole; Wallen Gwenyth R. Yoga for systemic lupus erythematosus (SLE): clinician experiences and qualitative perspectives from students and yoga instructors living with SLE. Complementary therapies in medicine. (2018) 41  pp111-117', '10.1016/j.ctim.2018.09.001', '']\n",
      "['9738756', 'Yang M; Luo Y; Liu T; Zhong X; Yan J; Huang Q; Tao J; He Q; Guo M. The Effect of Puerarin on Carotid Intima-Media Thickness in Patients With Active Rheumatoid Arthritis: a Randomized Controlled Trial. Clinical therapeutics. (2018) (no pagination)  pp', '10.1016/j.clinthera.2018.08.014', '']\n",
      "['9738757', 'Othman AA; Khatri A; Loebbert R; Peloso PM. Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-alpha and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis. Clinical pharmacology in drug development. (2018) (no pagination)  pp', '10.1002/cpdd.611', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpdd.611']\n",
      "['9738758', 'Kjelgaard-Petersen CF; Platt A; Braddock M; Jenkins MA; Musa K; Graham E; Gantzel T; Slynn G; Weinblatt ME; Karsdal MA; Thudium CS; Bay-Jensen A-C. Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis. Arthritis and rheumatology. (2018) 70 9 pp1419-1428', '10.1002/art.40527', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40527']\n",
      "['9738759', 'Gehin JE; Goll GL; Warren DJ; Syversen SW; Sexton J; Strand EK; Kvien TK; Bolstad N; Lie E. Anti-drug antibodies to certolizumab pegol are associated with low drug levels and reduced clinical response at 3 months in patients with inflammatory joint diseases. Data from the nor-DMARD study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp844', '10.1136/annrheumdis-2018-eular.5257', '']\n",
      "['9738760', 'Sweeney A-MT; Madsen OR; Dreyer L; Hansen A. Hpr outpatient follow up on demand for patients with rheumatoid arthritis-a two-year randomised controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp152', '10.1136/annrheumdis-2018-eular.1666', '']\n",
      "['9738761', 'Soriano ER; Madariaga H; Castaneda O; Citera G; Schneeberger EE; Cardiel MH; Hendrikx T; Graham D; Shi H; Ponce De Leon D. Liver enzyme abnormalities after tofacitinib treatment in patients with hepatic steatosis from the rheumatoid arthritis, psoriatic arthritis and psoriasis clinical programmes. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp593-594', '10.1136/annrheumdis-2018-eular.2517', '']\n",
      "['9738762', 'Moller-Bisgaard S; Horslev-Pedersen K; Ejbjerg B; Glinatsi D; Hetland M; Ornbjerg L; Moller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen J; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh N; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen H; Ostergaard M. An MRI guided treat-to-target strategy in rheumatoid arthritis patients in clinical remission improved MRI inflammation but not damage progression-results from the imagine-RA randomised controlled trial. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp126', '10.1136/annrheumdis-2018-eular.3074', '']\n",
      "['9738763', 'Starritt G; Brennan D. A pilot study to assess the relationship between smoking and drug inefficacy in rheumatoid arthritis-part of a quality improvement project aimed at smoking cessation. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp318-319', '10.1136/annrheumdis-2018-eular.7345', '']\n",
      "['9738764', 'Krishnan E; Mytych D; Zhang N; Wang H; Kaliyaperumal A. Immunogenicity associated with a transition from adalimumab reference product to ABP 501 in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp318', '10.1136/annrheumdis-2018-eular.7225', '']\n",
      "['9738765', 'Dominguez Casas LC; Calvo-Rio V; Maiz-Alonso O; Blanco A; Beltran E; Martinez Acosta L; Alvarez De Buergo MC; Rubio-Romero E; Diaz-Valle D; Lopez-Gonzalez R; Garcia-Aparicio A; JuanMas A; Pons E; Demetrio-Pablo R; Vegas-Revenga N; Blanco R; Gonzalez-Gay M. Anti-TNFalpha versus rituximab in refractory peripheral ulcerative keratitis associated to rheumatic diseases. Multicenter study of 24 patients. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp591-592', '10.1136/annrheumdis-2018-eular.2622', '']\n",
      "['9738767', 'Alsaed O; Alamilah L; Al-Radideh O; Elkhalifa M; Al-Allaf A-W. Clinical utility of ANA-elia vs anaimmunofluorescence in connective tissue disease. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp815', '10.1136/annrheumdis-2018-eular.5705', '']\n",
      "['9738768', 'Lila A; Denisov L; Plaksina T; Smakotina S; Kunder E; Soroka N; Kastanayan A; Nesmeyanova O; Antipova O; Ilivanova E; Eremeeva A; Dokukina E; Chernyaeva E; Ivanov R. Efficacy and safety of BCD-055 (infliximab biosimilar) in rheumatoid arthritis. results of BCD-055-3/lira phase 3 clinical study. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp316-317', '10.1136/annrheumdis-2018-eular.2332', '']\n",
      "['9738769', 'Alten R; Tseluyko V; Hala T; Mehmedagic S; Pileckyte M; Dokoupilova E; Jovic D; Rehman M; Zhang M; Sewell L; Hackley S; Salts S; Cronenberger C; Schumacher K; VonRichter O; Batko B. Efficacy, safety and immunogenicity from week 30 to week 54 in a randomised, doubleblind phase iii study comparing a proposed infliximab biosimilar (PF-06438179/gp1111) with reference infliximab. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp612-613', '10.1136/annrheumdis-2018-eular.5121', '']\n",
      "['9738773', 'Andersson S; Lange E; Kucherski D; Svedlund S; Onnheim K; Lord J; Martensson I-L; Mannerkorpi K; Gjertsson I. Intense aerobic and resistance exercise reduces the frequency of peripheral blood regulatory cell populations in elderly patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp587-588', '10.1136/annrheumdis-2018-eular.4668', '']\n",
      "['9738777', 'Ferwerda M; Van Beugen S; Van Middendorp H; Visser H; Vonkeman H; Creemers M; Van Riel P; Kievit W; Evers A. HPR an economic evaluation of a tailored guided internet-based cognitive behavioural intervention for patients with rheumatoid arthritisas an addition to usual care. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp217', '10.1136/annrheumdis-2018-eular.5349', '']\n",
      "['9738781', 'NCT03718611. To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects. Https://clinicaltrials.gov/show/nct03718611. (2018)   pp', '10.31525/ct1-nct04158102', '']\n",
      "['9738782', 'NCT03707535. To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03707535. (2018)   pp', '10.1136/annrheumdis-2022-eular.1677', '']\n",
      "['9738783', 'NCT03715595. The T2T Study of RA Based on SSDM. Https://clinicaltrials.gov/show/nct03715595. (2018)   pp', '10.1136/annrheumdis-2019-eular.1577', '']\n",
      "['9738784', 'NCT03669367. EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study). Https://clinicaltrials.gov/show/nct03669367. (2018)   pp', '10.1001/jama.2024.1120', 'https://jamanetwork.com/journals/jama/articlepdf/2815859/jama_harris_2024_ib_240033_1710362813.63205.pdf']\n",
      "['9738785', 'NCT03678363. Tai Chi in Rheumatoid Arthritis (TaiChiRA). Https://clinicaltrials.gov/show/nct03678363. (2018)   pp', '10.33088/jmk.v9i1.293', 'http://jurnal.poltekkes-kemenkes-bengkulu.ac.id/index.php/jmk/article/download/293/158']\n",
      "['9738786', 'Gladman DD; Charles-Schoeman C; McInnes IB; Veale DJ; Thiers B; Graham D; Wang C; Jones TV; Wolk R; DeMasi R. An integrated analysis of changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis across phase 3 and long-term extension studies. Annals of the rheumatic diseases. (2018) Conference: Annual European Congress of Rheumatology, EULAR 2018. Netherlands. 77 Supplement 2 pp368', '10.1136/annrheumdis-2018-eular.1459', '']\n",
      "['9738787', \"Handa R. Chikungunya-A rheumatologist's perspective. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp8\", '10.1111/j.1479-8077.2007.00263.x', '']\n",
      "['9738788', \"Liu X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G. The efficacy and safety of total glucosides of peony in the treatment of primary Sjogren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial. Clinical rheumatology. (2018) (no pagination)  pp\", '10.1007/s10067-018-4315-8', 'http://link.springer.com/article/10.1007/s10067-018-4315-8/fulltext.html']\n",
      "['9738789', 'Xing Y D; Wang H J; Kong X D; Liu C Y; Cui D Y; Zhang Q. The efficacy of immunoadsorption with Infliximab theraepy on the modulation of disease activity in patients with severe rheumatoid arthritis. National medical journal of china. (2018) 98 23 pp1849-1853', '10.1136/annrheumdis-2018-eular.3602', '']\n",
      "['9738790', 'Khandaker Golam M; Oltean Bianca P; Kaser Muzaffer; Dibben Claire R M; Ramana Rajini; Jadon Deepak R; Dantzer Robert; Coles Alasdair J; Lewis Glyn; Jones Peter B. Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ open. (2018) 8 9 ppe025333', '10.1136/bmjopen-2018-025333', '']\n",
      "['9738791', 'Hartman Otto; Kovanen Petri T; Lehtonen Jukka; Eklund Kari K; Sinisalo Juha. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. European heart journal. Cardiovascular pharmacotherapy. (2017) 3 2 pp92-97', '10.1093/ehjcvp/pvw035', 'http://academic.oup.com/ehjcvp/article-pdf/3/2/92/11007810/pvw035.pdf']\n",
      "['9738792', 'Mease PJ; Genovese MC; Weinblatt ME; Peloso PM; Chen K; Othman AA; Li Y; Mansikka HT; Khatri A; Wishart N; Liu J. Phase II Study of ABT-122, a Tumor Necrosis Factor- and Interleukin-17A-Targeted Dual Variable Domain Immunoglobulin, in Patients With Psoriatic Arthritis With an Inadequate Response to Methotrexate. Arthritis and rheumatology. (2018) 70 11 pp1778-1789', '10.1002/art.40579', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40579']\n",
      "['9738793', 'Cohen Stanley B; Burgos-Vargas Ruben; Emery Paul; Jin Bo; Cronenberger Carol; Vazquez-Abad Maria-Dolores. Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis. Arthritis care and research. (2018) 70 11 pp1598-1606', '10.1002/acr.23586', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.23586']\n",
      "['9738794', 'Mariano Vincent J; Frishman William H. Tocilizumab in Giant Cell Arteritis. Cardiology in review. (2018) 26 6 pp321-330', '10.1097/crd.0000000000000204', '']\n",
      "['9738795', \"Kaneko Yuko; Kameda Hideto; Ikeda Kei; Ishii Tomonoti; Murakami Kosaku; Takamatsu Hyota; Tanaka Yoshiya; Abe Takayuki; Takeuchi Tsutomu. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Annals of the rheumatic diseases. (2018) 77 12 pp1720-1729\", '10.1136/annrheumdis-2018-213920', '']\n",
      "['9738796', 'Ferwerda Maaike; van Beugen Sylvia; van Middendorp Henriet; Visser Henk; Vonkeman Harald; Creemers Marjonne; van Riel Piet; Kievit Wietske; Evers Andrea. Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: economic Evaluation of a Randomized Controlled Trial. Journal of medical Internet research. (2018) 20 10 ppe260', '10.2196/jmir.9997', '']\n",
      "['9738799', 'Taibanguay N; Chaiamnuay S; Asavatanabodee P; Narongroeknawin P. Effect of patient education on medication adherence in patient with rheumatoid arthritis: a randomized controlled trial. International journal of rheumatic diseases. (2018) Conference: 20th Asia Pacific League of Associations for Rheumatology Congress, APLAR 2018. Taiwan Republic of China). 21 (Supplement 1 pp196', '10.2147/ppa.s192008', 'https://www.dovepress.com/getfile.php?fileID=47466']\n",
      "['9738801', 'Salesi M; Ghasemian R; Karimifar M; Farajzadegan Z; Gholamnezhad M. Anti-inflammatory effects of different statins in rheumatoid arthritis: a randomized double-blind controlled clinical trial. International journal of rheumatic diseases. Conference: 20th asia pacific league of associations for rheumatology congress, APLAR 2018. Taiwan (republic of china). (2018) 21 Supplement 1 pp181', '10.15171/ipp.2019.09', 'http://immunopathol.com/pdf/ipp-5-e09.pdf']\n",
      "['9738805', 'Gallagher Kellie S; Godwin Jon; Hendry Gordon J; Steultjens Martijn; Woodburn Jim. A protocol for a randomised controlled trial of prefabricated versus customised foot orthoses for people with rheumatoid arthritis: the FOCOS RA trial. Journal of foot and ankle research. (2018) 11  pp24', '10.1186/s13047-018-0272-3', 'http://link.springer.com/article/10.1186/s13047-018-0272-3/fulltext.html']\n",
      "['9738806', 'Kinase J. baricitinib (olumiantdegree) and rheumatoid arthritis Oral administration is not a sufficient advantage. Prescrire international. (2018) 27 196 pp201-205', '10.1358/dof.2013.38.9.2035778', '']\n",
      "['9738808', 'Ammitzboll-Danielsen M; Ostergaard M; Fane V; Glinatsi D; Dohn U M; Ornbjerg L M; Naredo E; Terslev L. A randomised, double-blind, controlled study of intramuscular versus ultrasound guided peritendinous betamethasone injection for tenosynovitis in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp103', '10.1136/annrheumdis-2016-eular.1707', '']\n",
      "['9738809', 'Anderson L G; Bina P R C. Double-blind cross-over trial comparing fenbufen and acetylsalicylic acid in rheumatoid arthritis. Arzneimittel-forschung/drug research. (1980) 30 4 a pp735-739', '10.1093/rheumatology/x.suppl_1.76', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/76/24422041/10-suppl_1-76.pdf']\n",
      "['9738810', 'Anonymous. Erratum: immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial (Therapeutic Apheresis (4: 5) (363-367)). Therapeutic apheresis. (2002) 6 1 pp99', '10.1046/j.1526-0968.2000.004005363.x', '']\n",
      "['9738811', 'Anonymous. 2011 ACR/ARHP Annual Scientific Meeting Late-Breaking Abstracts. Arthritis and rheumatism. (2011) 63 12 pp', '10.1002/art.33477', '']\n",
      "['9738812', 'April P A; Abeles M; Baraf H S B; Cohen S A; Curran N J; Doucette M L; Ekholm B P; Goldlust M B; Knee C M; Lee E A; Marcus R E; Parrino G R; Reese R W; Riskin W G; Samuels B S; Utsinger P D; Virshup A M; Wenger M E; Whelton J C. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?. Journal of rheumatology. (1989) 16 3 pp321-327', '10.1093/rheumatology/ker031', 'http://academic.oup.com/rheumatology/article-pdf/50/suppl_3/iii111/5061793/ker031.pdf']\n",
      "['9738813', 'Aryaeian N; Djalali M; Shahram F; Eshragian M R; Djazayeri A; Naderi N; Fatehi F; Zarei M; Chamari M. The effect of conjugated linoleic acids, vitamin E and their combination on lipid peroxidation in active rheumatoid arthritis. Journal of diabetes. (2011) 3 SUPPL. 1 pp235', '10.1111/j.1756-185x.2009.01374.x', '']\n",
      "['9738815', 'Bachmann F; Stroescu O; Hartl W. Double blind trial and dose range study of tolmetin in rheumatoid arthritis. Die Therapiewoche. (1977) 27 12 pp2262-2268', '10.1185/03007997709110176', '']\n",
      "['9738816', 'Bahadori S; Salamzadeh J; Kamalinejad M; Ardekanie M R S; Keshavarz M; Ahmadzadeh A. Study of the effect of an oral formulation of fig and olive on rheumatoid arthritis (RA) remission indicators: a randomized clinical trial. Iranian journal of pharmaceutical research. (2016) 15 3 pp537-545', '10.18502/ijaai.v20i5.7407', 'http://publish.kne-publishing.com/index.php/IJAAI/article/download/7407/7177']\n",
      "['9738819', 'Beatty D C; Masheter H C. The combination of anabolic steroids and corticosteroids in the treatment of rheumatoid arthritis. Proceedings of the Royal Society of Medicine. (1964) 7 8 pp671-672', '10.1177/003591576405700805', 'http://journals.sagepub.com/doi/pdf/10.1177/003591576405700805']\n",
      "['9738821', 'Behrens F; Tak P P; Ostergaard M; Stoilov R; Wiland P; Huizinga T W; Berenfus V Y; Vladeva S; Rech J; Rubbert-Roth A; Korkosz M; Rekalov D; Zupanets I A; Ejbjerg B J; Geiseler J; Fresenius J; Korolkiewicz R P; Schottelius A J; Burkhardt H. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204816', '']\n",
      "['9738822', 'Belomestnov P; Hamilton J; DiCioccio A T; Jasson M; Radin A R. Sarilumab, a subcutaneously-administered, fully-human monoclonal antibody inhibitor of the IL-6 receptor: pharmacokinetic profile and its relationship to changes in pharmacodynamic markers in patients with rheumatoid arthritis. Arthritis and rheumatism. (2012) 64 SUPPL. 10 ppS576', '10.1136/annrheumdis-2013-eular.1843', '']\n",
      "['9738823', 'Bernhard G C; Poiley J; Tarpley E L. A double blind, cooperative trial of tolmetin plus gold versus gold alone in treatment of rheumatoid arthritis, TOLMETIN: a NEW NON STEROIDAL ANTI INFLAMMATORY AGENT. ICS NO. 372. Excerpta medica. (1975)   pp122-132', '10.1016/0006-2952(76)90452-4', '']\n",
      "['9738824', 'Bhanumathi V. A study of Chitrarathai chooranam (Alpinia Officinarum Hance) in Valiazhal Keelvayu (Rheumatoid Arthritis): a randomized clinical trial. International journal of pharmacy and pharmaceutical sciences. (2012) 4 SUPPL. 2 pp3-5', '10.5246/jcps.2019.10.069', '']\n",
      "['9738825', 'Bijlsma A; Ten Pas; J G. A study of the anti inflammatory effect of voltaren in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1978) 7 SUPPL.22 pp46-50', '10.3109/03009747809097216', '']\n",
      "['9738826', 'Bingham Iii C O; Rizzo W; Kivitz A; Hassanali A; Upmanyu R; Klearman M. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Annals of the rheumatic diseases. (2014)   pp', '10.1136/annrheumdis-2013-204427', '']\n",
      "['9738828', 'Booij A; Biewenga-Booij C M; Huber-Bruning O; Cornelis C; Jacobs J W G; Bijlsma J W J. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Annals of the rheumatic diseases. (1996) 55 11 pp811-815', '10.1136/ard.55.11.811', '']\n",
      "['9738829', 'Borrachero Del Campo. Double-blind, multicentre, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis patients under basic steroid treatment. European journal of rheumatology and inflammation. (1981) 4 1 pp135-143', '10.1093/rheumatology/21.2.101', 'http://academic.oup.com/rheumatology/article-pdf/21/2/101/5027114/21-2-101.pdf']\n",
      "['9738830', 'Brezinschek H P. Expert comments on: \"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial\". Journal fur mineralstoffwechsel. (2008) 15 2 pp106-107', '10.3410/f.1097736.553852', '']\n",
      "['9738831', 'Brown J; Sim A K; De Ceular. Naudicelle in patients with rheumatoid arthritis. Rhumatologie - revue international de rhumatologie. (1980) 10 5 pp355-357', '10.1016/j.rhum.2006.10.233', '']\n",
      "['9738832', \"Brown L; Costazos J; Roisimblit A. Treatment of rheumatoid arthritis. A double blind comparison of diftalone (Aladione) and phenylbutazone in a three months' treatment course. Clinical trials journal. (1977) 14 2 pp50-57\", '10.1185/03007997609112003', '']\n",
      "['9738836', 'Buttgereit F; Mehta D P; Kirwan J R; Szechinski J; Boers M; Alten R H E; Supronik J; Szombati I; Romer U; Witte S; Saag K. Safety data for low-dose glucocorticoid chronotherapy of rheumatoid arthritis with 5mg Modified-Release (MR) prednisone in a randomized, double-blind, placebo-controlled trial. Zeitschrift fur Rheumatologie. (2010) 69 SUPPL. 1 pp38-39', '10.1136/annrheumdis-2011-201067', '']\n",
      "['9738838', 'Chatfield K; Mathie R T; Fisher P. Comment 2 on: homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford, England). (2011) 50 8 pp', '10.1093/rheumatology/ker120', 'http://academic.oup.com/rheumatology/article-pdf/50/8/1529/5065051/ker120.pdf']\n",
      "['9738839', 'Zak Agnes; Corrigan Cassandra; Yu Zhi; Bitton Asaf; Fraenkel Liana; Harrold Leslie; Smolen Josef S; Solomon Daniel H. Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial. Rheumatology (Oxford, England). (2018) 57 11 pp1933-1937', '10.1093/rheumatology/key179', 'http://academic.oup.com/rheumatology/article-pdf/57/11/1933/26146542/key179.pdf']\n",
      "['9738841', 'Kalati Mahnaz; Kashanian Maryam; Jahdi Fereshteh; Naseri Mohsen; Haghani Hamid; Sheikhansari Narges. Evening primrose oil and labour, is it effective? A randomised clinical trial. Journal of obstetrics and gynaecology. (2018) 38 4 pp488-492', '10.1080/01443615.2017.1386165', '']\n",
      "['9738842', 'Takeuchi Tsutomu; Tanaka Yoshiya; Yamanaka Hisashi; Harigai Masayoshi; Nakano Toshikazu; Akagi Koshiro; Ukyo Yoshifumi; Hsu Benjamin. Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: subgroup analysis of a phase 3 study. Modern rheumatology. (2018) 28 6 pp941-949', '10.1080/14397595.2018.1428929', '']\n",
      "['9738846', 'Alten R. Janus kinase inhibitors in rheumatology: baricitinib. Arzneimitteltherapie. (2018) 36 7-8 pp248-253', '10.1093/rheumatology/kex217', 'http://academic.oup.com/rheumatology/article-pdf/57/7/1131/25068646/kex217.pdf']\n",
      "['9738847', 'Winthrop Kevin L; Melmed Gil Y; Vermeire Severine; Long Millie D; Chan Gary; Pedersen Ronald D; Lawendy Nervin; Thorpe Andrew J; Nduaka Chudy I; Su Chinyu. Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib. Inflammatory bowel diseases. (2018) 24 10 pp2258-2265', '10.1093/ibd/izy131', 'http://academic.oup.com/ibdjournal/article-pdf/24/10/2258/25739076/izy131.pdf']\n",
      "['9738848', 'Cho S K; Kim D; Yoo D; Jang E J; Jun J B; Sung Y K. Korean Red Ginseng exhibits no significant adverse effect on disease activity in patients with rheumatoid arthritis: a randomized, double-blind, crossover study. Journal of ginseng research. (no pagination), 2017. (2018) Date of Publication: October 01 2 pp144-148', '10.1016/j.jgr.2017.01.006', '']\n",
      "['9738849', 'Cifuentes M; Del Barrio-Diaz; Vera-Kellet C. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjogren syndrome: a double-blind randomized controlled trial. British journal of dermatology. (2018)   pp', '10.1111/bjd.16442', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjd.16442']\n",
      "['9738850', 'Ciuffetti G; Ciacca A; Lombardini R; Scarponi A M; Mercuri M; Santambrogio L. Effects of ticlopidine on haemorheological factors in rheumatoid arthritis: a double-blind study. Biorheology. (1989) 26 3 pp569', '10.1093/rheumatology/28.5.424', 'http://academic.oup.com/rheumatology/article-pdf/28/5/424/5041736/28-5-424.pdf']\n",
      "['9738851', 'Clark H; Rome K; Atkinson I; Plant M; Dixon J. The clincal effectiveness of foot orthoses in rheumatoid arthritis. Rheumatology. (2010) 49 SUPPL. 1 pp', '10.1080/03009742.2016.1196500', '']\n",
      "['9738852', 'Coimbra de; F A; Seda H. Double-blind comparative trial with diclofenac sodium and indomethacin, combining 25 mg tablets and 100 mg suppositories in the treatment of rheumatoid arthritis. Revista brasileira de medicina. (1979) 36 4 pp166-168', '10.1080/03009742.1979.12088616', '']\n",
      "['9738853', 'Cvetkovic R S; Keating G. Anakinra. BioDrugs. (2002) 16 4 pp303-311', '10.2165/00063030-200216040-00005', '']\n",
      "['9738854', 'Davies J; Dixon St; A J; Ring E F J. A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis. European journal of rheumatology and inflammation. (1981) 4 3 pp314-317', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9738857', 'Di Munno; Pontrandolfo A; Tartarelli G. Isoxicam (Maxicam) A new non-steroidal anti-inflammatory drug with prolonged activity. A double-blind, cross-over, short-term comparison with piroxicam in rheumatoid arthritis. Clinical trials journal. (1984) 21 4 pp231-236', '10.1007/bf03316174', 'http://link.springer.com/article/10.1007/BF03316174/fulltext.html']\n",
      "['9738858', 'Dinai Y; Pras M. Levamisole in rheumatoid arthritis. Lancet. (1975) 2 7934 pp556', '10.1016/s0140-6736(75)90934-4', '']\n",
      "['9738859', 'dos Santos; M F; Furtado R N V; Konai M S; Castiglioni M L V; Marchetti R R; Natour J. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial. Clinics. (2009) 64 12 pp1187-1193', '10.1590/s1807-59322009001200008', 'http://www.scielo.br/pdf/clin/v64n12/08.pdf']\n",
      "['9738860', 'El Ghobarey; A F; Rennie J A N; Hadidi T. A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. Current medical research and opinion. (1976) 4 6 pp432-435', '10.1185/03007997609111999', '']\n",
      "['9738861', 'Elmuntaser K. Efficacy of leflunomide 100mg weekly compared to 10mg methotrexate weekly in patients with active rheumatoid arthritis. Clinical and experimental rheumatology. (2014) 32 4 SUPPL. 83 ppS43', '10.2165/00128413-200414480-00036', '']\n",
      "['9738866', 'Ernst E. On: bernateck M, Becker M, Schwake C, Hoy L, Passie T, Parlesak A, Fischer MJ, Fink M, Karst M: adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Forsch Komplementmed 2008;15: 187193. Forschende Komplementarmedizin. (2008) 15 5 pp286', '10.1159/000141929', '']\n",
      "['9738867', 'Fan W; Zhao D B; Hu S X; Xu H J; Zhang X; Zhang M J; Chen Z W; Zhang F X; Zhu P; Li X F; Bi L Q; Zhou B; Bao C D. A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate. Rheumatology international. (2014)   pp', '10.1007/s00296-014-2989-z', 'http://link.springer.com/article/10.1007/s00296-014-2989-z/fulltext.html']\n",
      "['9738874', 'Fletcher M J R. Erratum: treatment of rheumatoid arthritis with oral type II collagen: results of a multicenter, double-blind, placebo-controlled trial (Arthritis and Rheumatism (February 1998) (290-297)). Arthritis and rheumatism. (1998) 41 5 pp938', '10.1002/1529-0131(199802)41:2<290::aid-art13>3.0.co;2-r', '']\n",
      "['9738879', 'Genovese M C; Greenwald M W; Cho C S; Berman A; Jin L; Cameron G; Xie L. A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: nave to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1136/annrheumdis-2012-eular.1704', '']\n",
      "['9738880', 'Genovese M C; Kavanaugh A; Peterfy C; Magilavy D. An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis (RA): a 3 month randomized placebo controlled phase 2 study in patients with active RA who had failed biologic agents. Arthritis and rheumatism. (2009) 60 12 pp3860', '10.1002/art.30114', '']\n",
      "['9738881', 'Genovese M C; Kawabata T; Soma K; Menon S; Clark J D; Hodge J; Takiya L; Riese R; Krishnaswami S. Reversibility of pharmacodynamic effects after short-and long-term treatment with tofacitinib in patients with rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS193', '10.1002/art.38745', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38745']\n",
      "['9738885', 'Genovese M C; Weinblatt M E; Aelion J A; Mansikka H T; Peloso P M; Chen K; Li Y; Othman A A; Khatri A; Khan N S; Padley R J. ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: a Randomized, Double-Blind Study. Arthritis and rheumatology. (2018)   pp', '10.1002/art.40580', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40580']\n",
      "['9738890', 'Haavardsholm E A; Aga A B; Olsen I C; Lillegraven S; Hammer H B; Uhlig T; Fremstad H; Madland T M; Lexberg A S; Haukeland H; Rodevand E; Hoili C; Stray H; Bendvold A N; Hansen I J W; Bakland G; Nordberg L B; Heijde D V D; Kvien T K. Ultrasound in the management of rheumatoid arthritis: results from the randomized controlled arctic trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp123', '10.1136/annrheumdis-2016-eular.3042', '']\n",
      "['9738893', 'Hambleton J; Zhou L; Rogers S; Van Marle; Van Iersel; Zanghi J; Masteller E; Baker K; Wong B. A phase 1 study of FPA008, an anti-colony stimulating factor 1 receptor (anti-CSF1R) antibody in healthy volunteers and subjects with rheumatoid arthritis (RA): preliminary results. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS657', '10.1186/s13075-016-0973-6', '']\n",
      "['9738894', 'Hang W P; Li J; Xu J; Angqing C D; Ji Q; Liu X L; Nima D Z; Zeng S P; Zhang X; Cui T; Xie Q; Zhang Y. Double-blind randomized placebo controlled trial (phase II) on the efficacy and safety of Ranjiangduoji capsule in the treatment of patients with active rheumatoid arthritis (Rtention of Cold-damp in the collaterals). Chinese journal of evidence-based medicine. (2005) 5 4 pp286', '10.1097/00029330-200804010-00008', '']\n",
      "['9738898', 'Hartman Linda; Rasch Linda A; Klausch Thomas; Bijlsma Hans W J; Christensen Robin; Smulders Yvo M; Ralston Stuart H; Buttgereit Frank; Cutolo Maurizio; Da Silva Jose A P; Opris Daniela; Rovensky Jozef; Szamosi Szilvia; Middelink Leonie M; Lems Willem F; Boers Maarten. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial. Trials. (2018) 19 1 pp67', '10.1186/s13063-017-2396-3', 'http://link.springer.com/content/pdf/10.1186/s13063-017-2396-3.pdf']\n",
      "['9738899', 'Hewlett S E; Ambler N; Knops B; Cliss A; Almeida C; Pope D; Hammond A. Sustained reduction in fatigue impact in rheumatoid arthritis: RCT of cognitive behavioural therapy. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1325', '10.1136/ard.2010.144691', '']\n",
      "['9738900', 'Hickling M; Golor G; Jullion A; Shaw S; Kretsos K. Safety and pharmacokinetics of CDP6038, an ANTI-IL-6 monoclonal antibody, administered by subcutaneous injection and intravenous infusion to healthy male volunteers: a phase 1 study. Rheumatology (united kingdom). (2012) 51 SUPPL. 3 pp', '10.1002/cpdd.121', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.121']\n",
      "['9738901', 'Hkkinen A; Sokka T; Kotaniemi A; Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis and rheumatism. (2001) 44 3 pp515-522', '10.1002/1529-0131(200103)44:3<515::aid-anr98>3.3.co;2-x', '']\n",
      "['9738903', 'Karpouzas G; Thorne C; Takeuchi T; Tanaka Y; Yamanaka H; Harigai M; Ota T; Sheng S; Xu W; Xu S; Kurrasch R; Fei K; Hsu B. An analysis of laboratory results from 2 randomized, double-blind studies of sirukumab in patients with active rheumatoid arthritis refractory to disease-modifying anti-rheumatic drug treatment. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp726-727', '10.1136/annrheumdis-2016-eular.4126', '']\n",
      "['9738904', 'Katona G; Bondani A. Efficacy and tolerability of fentiazac in rheumatoid arthritis: double-blind study versus indomethacin. Current medical research and opinion. (1979) 6 2 SUPPL. pp71-78', '10.1185/03007997909109513', '']\n",
      "['9738909', 'Kay J; Weinblatt M; Keystone E; Genovese M C; Baranauskaite A; Cheong S Y; Ghil J. Secondary efficacy results up to week 24 from a phase iii study comparing Sb5 (an adalimumab biosimiar) with adalimumab reference product in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp231', '10.1136/annrheumdis-2016-eular.2021', '']\n",
      "['9738910', 'Kellner H; Gnanasakthy A; Kosinski M; Mallya U; Mpofu S. Measuring improvement of physical functioning with secukinumab treatment among RA patients using a combined score: an application of IRT methodology. Zeitschrift fur Rheumatologie. (2012) 71 SUPPL. 2 pp97-98', '10.1136/annrheumdis-2012-eular.505', '']\n",
      "['9738911', 'Kellner H L; Li C; Essex M N. Celecoxib and diclofenac plus omeprazole are similarly effective in the treatment of arthritis in patients at high gi risk in the CONDOR trial. Open rheumatology journal. (2013) 7 1 pp96-100', '10.2174/1874312901307010096', 'https://openrheumatologyjournal.com/contents/volumes/V7/TORJ-7-96/TORJ-7-96.pdf']\n",
      "['9738916', 'Khabbazi A; Kolahi S; Ghamarzad Shishavan; Pourghassem Gargari. Phylloquinone supplementation in rheumatoid arthritis. International journal of rheumatic diseases. (2014) 17 SUPPL. 1 pp59', '10.4162/nrp.2015.9.2.186', '']\n",
      "['9738917', 'Knittle K; De Gucht; Hurkmans E; Peeters A; Ronday K; Maes S; Vlieland T V. Targeting motivation and self-regulation to increase physical activity among patients with rheumatoid arthritis: a randomised controlled trial. Clinical rheumatology. (2013)   pp1-8', '10.1007/s10067-013-2425-x', 'http://link.springer.com/article/10.1007/s10067-013-2425-x/fulltext.html']\n",
      "['9738918', 'Kogstad O. A double-blind cross-over study of naproxen and indomethacin in patients with rheumatoid arthritis. Scandinavian journal of rheumatology. (1973)   pp', '10.3109/03009747309097118', '']\n",
      "['9738919', 'Kolb H; Herder C; Schloot N C; Koenig W; Heise T; Heinemann L; Martin S. Impact of atorvastatin treatment on residual beta cell function in recent-onset type 1 diabetes. Diabetes. (2010)   pp', '10.1371/journal.pone.0017554', '']\n",
      "['9738920', 'Kou Q A; Li L; Yao J Y; Wang Y J; Ma W H; Zhou C Y; Fang D Y. Treatment of rheumatoid arthritis arthralgia by xiaoyan zhitong paste: a clinical observation. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2013) 33 10 pp1320-1327', '10.1007/bf02836428', 'http://link.springer.com/article/10.1007/BF02836428/fulltext.html']\n",
      "['9738921', 'Krausz S; Boumans M J H; Gerlag D M; Lufkin J; Van Kuijk; A W R; Bakker A A B; De Boer. A phase IIa, randomized, double-blind, placebo-controlled clinical study of apilimod mesylate, an oral IL-12/IL-23 inhibitor, in patients with active rheumatoid arthritis. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1095', '10.1002/art.34339', '']\n",
      "['9738923', 'Kremer J; Rigby W; Singer N; Birchwood C; Gill D; Reiss W; Pei J; Michalska M. Sustained response following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial (comp-ACT). Annals of the rheumatic diseases. (2017) 76 Supplement 2 pp567-568', '10.1136/annrheumdis-2017-eular.2797', '']\n",
      "['9738927', 'Krueger H H. Comparison of flurbiprofen and indometacin in treatment of rheumatoid arthritis. Die Therapiewoche. (1980) 30 37 pp5909-5913', '10.52783/jchr.v14.i2.3511', '']\n",
      "['9738928', 'Kuusalo L; Sokka T; Pirila L; Kautiainen H; Puolakka K. Automated cell-phone monitoring of disease activity and medication problems in early rheumatoid arthritis. Scandinavian journal of rheumatology. (2018) 47 Supplement 129 pp21-22', '10.1136/annrheumdis-2013-eular.1672', '']\n",
      "['9738929', 'Lamba M; Wang R; Fletcher T; Alvey C; Hazra A; Kushner J; Larmann J; Stock T. Pharmacokinetics, bioavailability and safety of a modified-release once-daily formulation of tofacitinib in healthy volunteers. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS649-S650', '10.1136/annrheumdis-2014-eular.1521', '']\n",
      "['9738931', \"Landewe R B M; van der Heijde. Comment on: 'Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial' by Qian-wen et al. Annals of the rheumatic diseases. (2014)   pp\", '10.1136/annrheumdis-2014-206124', '']\n",
      "['9738934', 'Lin C S; Yang X Y; Dai L; Sun W F; Yang S F; Shen Y; Xu Q; Wang X D. Treatment of Kunxian capsule in rheumatoid arthritis patients: a multi-center trial. International journal of rheumatic diseases. (2010) 13 SUPPL. 1 pp106', '10.1136/annrheumdis-2020-eular.2109', '']\n",
      "['9738936', 'Liu J; Wang Y; Sun Y. Effect of Xinfeng capsule in the treatment of active rheumatoid arthritis: a randomized controlled trial. Journal of traditional Chinese medicine / Chung i tsa chih ying wen pan. (2015) 35 6 pp626-631', '10.1016/s0254-6272(15)30150-3', '']\n",
      "['9738937', 'Lo V; Meadows S. When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?. Journal of family practice. (2006) 55 3 pp260-262', '10.1038/ncpgasthep0963', 'http://www.nature.com/articles/ncpgasthep0963']\n",
      "['9738938', 'Lourenzi F M; Jones A; Pereira D F; Dos Santos; J H C A; Natour J. Global progressive resistance training improved functional capacity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2015) 74 SUPPL. 2 pp1323', '10.1136/annrheumdis-2015-eular.2451', '']\n",
      "['9738940', 'McMillen J I. Tolmetin sodium vs. ibuprofen in rheumatoid arthritic patients previously untreated with either drug: a double-blind crossover study. Current therapeutic research - clinical and experimental. (1977) 22 2 pp266-275', '10.1185/03007997609112003', '']\n",
      "['9738941', 'Meinicke J; Danneskiold-Samsoe B. Diclofenac sodium (voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study. Scandinavian journal of rheumatology. (1980) 9 Suppl. 35 pp', '10.3109/03009748009101380', '']\n",
      "['9738942', 'Mora Alfonso; S A; Fernandez D G; Sastre L F. The effect of an educational intervention based on clinical simulation in rheumatoid arthritis and osteoarthritis diagnosis by general practitioners: a randomized clinical trial. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp661', '10.1136/annrheumdis-2016-eular.5524', '']\n",
      "['9738943', 'Mowla K; Rajai E; Ghorbani A; Dargahi-Malamir M; Bahadoram M; Mohammadi S. Effect of atorvastatin on the disease activity and severity of rheumatoid arthritis: double-blind randomized controlled trial. Journal of clinical and diagnostic research. (2016) 10 5 ppOC32-OC36', '10.7860/jcdr/2016/16538.7814', '']\n",
      "['9738946', 'Nash P; Vanhoof J; Hall S; Tarzynski-Potempa R; Unnebrink K; Cividino A. A randomized crossover comparison of injection site pain with 40 mg/0.8 ml and 40 mg/0.4 ml formulations of adalimumab in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp497-498', '10.1136/annrheumdis-2016-eular.4338', '']\n",
      "['9738947', 'Norton H; Sibbitt W L; Bankhurst A; Delea S; Chavez-Chiang N; Band P. A randomized controlled trial of cost-effectiveness of ultrasound-guided intraarticular injection of inflammatory arthritis. Journal of investigative medicine. (2011) 59 1 pp188', '10.3899/jrheum.100866', '']\n",
      "['9738948', 'Nunes C V. Rheumatoid arthritis: a double blind comparative trial between fenbufen and phenylbutazone. Folha medica. (1975) 71 3 pp335-338', '10.1093/rheumatology/14.2.67', 'http://academic.oup.com/rheumatology/article-pdf/14/2/67/5025933/14-2-67.pdf']\n",
      "['9738950', 'Oliver R; VanLunen B; Mountian I; Brown E; Tatla D. Comparison of the bioavailability of a single dose of certolizumab pegol injected by prefilled syringe or by electro-mechanical auto-injection e-device: a phase 1, open-label, randomised, parallel group, single-centre bioequivalence study. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp961', '10.1136/annrheumdis-2018-eular.2422', '']\n",
      "['9738952', 'Othman A A; Khatri A; Loebbert R; Peloso P M. Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-alpha and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis. Clinical pharmacology in drug development. (2018)   pp', '10.1002/cpdd.611', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpdd.611']\n",
      "['9738958', 'Rasch L; Van Tuyl; Kremer M; Bultink I; Boers M; Lems W. Change in bone mineral density with high-dose prednisone in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp95', '10.1136/annrheumdis-2016-eular.2735', '']\n",
      "['9738959', 'Rau R; Wassenberg S; Zeidler H. Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis - Preliminary results of a multicenter, randomized, parallel, double blind study. Zeitschrift fur Rheumatologie. (2000) 59 SUPPL. 2 ppII90-II96', '10.1007/s003930070026', 'http://link.springer.com/article/10.1007/s003930070026/fulltext.html']\n",
      "['9738960', 'Reed G W; Shao M; Wolski K; Abdallah M; Wisniewski L; Yeomans N; Luscher T F; Borer J; Graham D Y; Husni E; Solomon D; Libby P; Menon V; Lincoff A; Nissen S. Dose escalation and the safety of celecoxib, ibuprofen, and naproxen: analysis of the precision trial. Journal of the American College of Cardiology. (2018) 71 11 Supplement 1 pp', '10.1016/s0735-1097(18)30626-0', '']\n",
      "['9738961', \"Reginster. Erratum: evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone: a double-blind, multiple-dosage, placebo-controlled study (Arthritis and Rheumatism (August 1992) (967-974)). Arthritis and rheumatism. (1993) 36 1 pp134\", '10.1002/art.1780350819', '']\n",
      "['9738962', 'Reid A; Brady A; Cusack T; Blake C; Mongey A B; Veale D J; Gerald O F. RCT Examining the effects of exercise for people with rheumatoid arthritis on anti-TNFalpha medication. Rheumatology. (2009) 48 SUPPL. 1 pp', '10.1186/1471-2474-12-11', 'http://link.springer.com/article/10.1186/1471-2474-12-11/fulltext.html']\n",
      "['9738963', 'Richmond S J. Magnet therapy for the relief of pain and inflammation in rheumatoid arthritis (CAMBRA): a randomised placebo-controlled crossover trial. Trials. (2008) 9  pp53', '10.1186/1745-6215-9-53', 'http://link.springer.com/article/10.1186/1745-6215-9-53/fulltext.html']\n",
      "['9738964', 'Robinson H; Abruzzo J L; Miyara A; Ward J R. Concomitant tolmetin and aspirin therapy for rheumatoid arthritis, TOLMETIN: a NEW NON STEROIDAL ANTI INFLAMMATORY AGENT. ICS NO. 372. Excerpta medica. (1975)   pp102-111', '10.1007/bf03286318', 'http://link.springer.com/article/10.1007/BF03286318/fulltext.html']\n",
      "['9738965', 'Rotstein J. A comparative study of tolmetin versus placebo in the treatment of rheumatoid arthritis, TOLMETIN: a NEW NON STEROIDAL ANTI INFLAMMATORY AGENT. ICS NO. 372. Excerpta medica. (1975)   pp34-47', '10.1016/0006-2952(76)90452-4', '']\n",
      "['9738967', 'Ryley N J; Corey P; Willans M; Percy J S; Russell A S; Bellamy N; Fitzgerald A; Menard H; Carette S; Kraag G R; Buchanan W W; Haraoui B; Pelletier J P; Choquette D; Khanna V N; Ryan P. Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Current medical research and opinion. (1988) 11 1 pp16-27', '10.1185/03007998809111126', '']\n",
      "['9738968', 'Sambrook P; Devogelaer J; Reginster J; Saag K; Roux C; Lau C; Papanastasiou P; Schoenborn-Kellenberger O; Maylandt K; Fashola T; Mesenbrink P; Reid D. Effect of a single I.V. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis. Bone. (2009) 44 SUPPL. 1 ppS94-S95', '10.1016/j.bone.2009.01.213', '']\n",
      "['9738970', 'Santo J E; Da Silva; J P; Da Costa; J T. Double-blind evaluation of low-dose proglumetacin versus naproxen in rheumatoid arthritis out-patients. Current medical research and opinion. (1983) 8 7 pp524-530', '10.1185/03007998309109792', '']\n",
      "['9738971', 'Schattenkirchner M; Brandt R; Fryda-Kaurimsky Z. A long-term study of D-penicillamine in the treatment of rheumatoid arthritis. Current therapeutic research - clinical and experimental. (1982) 32 2 pp274-281', '10.1016/s0011-393x(99)90002-4', '']\n",
      "['9738974', 'Schimmer B M; Myers A R. A double-blind controlled study of levamisole in rheumatoid arthritis. Arthritis and rheumatism. (1978) 21 5 pp589-590', '10.1002/art.1780230207', '']\n",
      "['9738975', 'Schrier J C; Keijsers N L; Matricali G A; Verheyen C C P M; Louwerens J W K. Resection or preservation of the metatarsal heads in rheumatoid forefoot surgery? A randomised clinical trial. Foot and ankle surgery. (2017)   pp', '10.1016/j.fas.2017.07.1126', '']\n",
      "['9738977', 'Siegmund H; Schneider B. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent. European journal of rheumatology and inflammation. (1981) 4 1 pp79-86', '10.1093/rheumatology/20.1.54', 'http://academic.oup.com/rheumatology/article-pdf/20/1/54/5021815/20-1-54.pdf']\n",
      "['9738978', 'Silva K N G; Teixeira L E P P; Imoto A M; Abrahao M I; Atallah A N; Peccin S; Trevisani V F M. Effectiveness of sensorimotor training in patients with rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1133', '10.1007/s00296-013-2706-3', 'http://link.springer.com/article/10.1007/s00296-013-2706-3/fulltext.html']\n",
      "['9738980', 'Smolen J S; Cohen S B; Scheinberg M; Shisha T; Kollins D; Zhu P; Cen L; Kivitz A J; Rodica Balanescu; Gomez-Reino J J; Tony H P. A randomized, double blind trial over 52 weeks to demonstrate bioequivalence of GP2013 and reference rituximab in patients with rheumatoid arthritis. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-211281', '']\n",
      "['9738982', 'Snaith M L; Scott J T; Davy B. The treatment of rheumatoid arthritis. A controlled comparison of clamidoxic add with placebo and phenylbutazone (Butazolidin). Clinical trials journal. (1971) 8 4 pp19-22', '10.1136/ard.12.1.20', '']\n",
      "['9738983', 'Solomon D H; Husni M E; Libby P A; Yeomans N D; Lincoff A M; Lupsilonscher T F; Menon V; Brennan D M; Wisniewski L M; Nissen S E; Borer J S. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: a Secondary Analysis of the PRECISION Trial. American journal of medicine. (2017) 130 12 pp1415', '10.1016/j.amjmed.2017.06.028', '']\n",
      "['9738985', 'Tak P P; Balanescu A; Tseluyko V; Bojin S; Drescher E; Dairaghi D; Miao S; Marchesin V; Jaen J; Schall T J; Bekker P. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: cARAT-2, a randomised, placebo controlled clinical trial. Annals of the rheumatic diseases. (2012)   pp', '10.1136/annrheumdis-2011-201605', '']\n",
      "['9738989', 'Takeuchi T; Karpouzas G; Thorne C; McQuarrie K; Sheng S; Xu W; Peterson S; Ganguly R; Han C; Fei K; Hsu B. Improvements in measures of work productivity/interference and general health status with sirukumab treatment in patients with active rheumatoid arthritis despite disease-modifying anti-rheumatic drug treatment. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp1033-1034', '10.1136/annrheumdis-2016-eular.4335', '']\n",
      "['9738990', 'Tam L S; Li E K; Shang Q; Tomlinson B; Lee V W; Lee K K; Li M. Effects of HMG-CoA reductase inhibitor on progression of carotid intima-media thickness and arterial stiffness in rheumatoid arthritis a randomized controlled trial. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1028', '10.3109/03009742.2011.586649', '']\n",
      "['9738991', 'Tanaka Y; Aletaha D; Agarwal P; Kurrasch R; Tak P P; Popik S. Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study. Annals of the rheumatic diseases. (2017) 76 Supplement 2 pp563-564', '10.1136/annrheumdis-2017-eular.6486', '']\n",
      "['9738998', 'Thorne C; Karpouzas G; Takeuchi T; Sheng S; Xu W; Xu S; Kurrasch R; Fei K; Hsu B. Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp723', '10.1136/annrheumdis-2016-eular.4106', '']\n",
      "['9739000', 'Traistaru R; Rogoveanu O; Popescu R. Role of \"memory harness\" for posture in osteoporotic females with rheumatoid arthritis: a randomized clinical trial. Osteoporosis international. (2013) 24 1 SUPPL. 1 ppS184', '10.1136/annrheumdis-2012-eular.3321', '']\n",
      "['9739001', 'Tuteja S. A randomised, placebo-controlled, parallel group study to evaluate efficacy of homoeopathic medicine in patients with rheumatoid arthritis. Homeopathy. (2018) 107 Supplement 1 pp', '10.1055/s-0038-1633342', '']\n",
      "['9739004', 'Veys E; Mielants H; Symoens J. A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis. Journal of rheumatology. (1978) 5 SUPPL.4 pp5-10', '10.1016/s0140-6736(78)90443-9', '']\n",
      "['9739005', 'Viara M. A double blind trial of clopirac and indometacin in rheumatoid arthritis. Journal belge de rhumatologie ET de medicine physique. (1975) 30 Spec.nr. pp123-130', '10.1007/bf00567116', 'http://link.springer.com/article/10.1007/BF00567116/fulltext.html']\n",
      "['9739006', 'Vignon E; Courcier S; Laborde C; Goehrs J M. LP 200mg flurbiprofen versus LP 200mg ketoprofen in rheumatoid arthritis in rheumatologic practice. Revue du rhumatisme. (1993) 60 7-8 pp530-535', '10.1016/s1169-8330(00)80087-3', '']\n",
      "['9739007', 'Vince J D; Kremer D; Cathcart B. The treatment of rheumatoid arthritis. a clinical evaluation of benorylate (benoral). Clintrials J.. (1972) 9 2 pp36-40', '10.1136/bmj.2.5812.483', '']\n",
      "['9739008', 'Wang Qiong; Wang Yi-Ru; Jia Qing-Yun; Liu Li; Xu Chong-Qing; Wang Xiao-Yun; Yao Min; Cui Xue-Jun; Shi Qi; Wang Yong-Jun; Liang Qian-Qian. The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial. Trials. (2018) 19 1 pp188', '10.1186/s13063-018-2555-1', 'http://link.springer.com/article/10.1186/s13063-018-2555-1/fulltext.html']\n",
      "['9739011', 'West H F; Lewis-Faning E. Controlled trial of methenlone acetate in prednisolonetreated rheumatoid arthritis patients. Annals of the rheumatic diseases. (1965) 24 6 pp576-580', '10.1136/ard.24.6.576', '']\n",
      "['9739016', 'Westhovens R; Van Der Aa; Jamoul C; Tasset C; Harrison P. Effect of baseline MTX dose on clinical efficacy and safety in rheumatoid arthritis patients treated with filgotinib: post-hoc analysis from a phase 2B study. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.5428', '']\n",
      "['9739019', 'Wiesenhutter C; Patel R; Lavery J; Tahir N; Hazan L; Kivitz A; Bretton E; Kaine J. A phase 1 dose-ranging repeated-dose trial of parenteral staphylococcal protein a (PRTX-100) in patients with active rheumatoid arthritis on methotrexate or leflunamide therapy. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS654-S655', '10.1136/annrheumdis-2014-eular.2170', '']\n",
      "['9739020', 'Yang D J; Xu F Y; Gan J H. Assessment of curative effect of aerobic exercise with quality of life questionnaire for patients with rheumatoid arthritis. Chinese journal of clinical rehabilitation. (2005) 9 35 pp150-151', '10.1002/acr.20620', '']\n",
      "['9739021', 'Yokogawa N; Dunham J S; Fisher L; Mellberg S; Vivino F B; Chase W; Kivitz A. A double-blind, placebo-controlled, crossover study using a latin square design to evaluate the safety, tolerability, and efficacy of NGX267 oral capsules in patients with xerostomia associated with sjgrens syndrome. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp477', '10.1136/gut.52.5.671', '']\n",
      "['9739022', 'Yue J; Griffith J F; Shi L; Wang D F; Shen J; Wong P; Li E K; Zhu T Y; Qin L; Tam L S. Repair of bone erosion in rheumatoid arthritis by denosumab: an HR-PQCT study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp251-252', '10.1136/annrheumdis-2016-eular.1391', '']\n",
      "['9739024', 'Zwikker H; Van Den Bemt B; Van Den Ende C; Den Broeder A; Van Den Hoogen F; Van Dulmen A. Effectiveness of a group-based intervention to improve medication beliefs and adherence in non-adherent patients with rheumatoid arthritis: a randomized controlled trial. International journal of clinical pharmacy. (2013) 35 6 pp1256', '10.1136/annrheumdis-2013-eular.1125', '']\n",
      "['9739025', 'Afonso M; Kollins D; Macke L; Woehling H; Wuerth G. Pharmacokinetics and safety of GP2015, a proposed etanercept biosimilar, administered subcutaneously by an autoinjector or prefilled syringe in healthy male subjects. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp233-234', '10.1136/annrheumdis-2016-eular.1304', '']\n",
      "['9739027', 'Aletaha D; Strand V; Smolen J S; Ward M M. Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results. Annals of the rheumatic diseases. (2008) 67 2 pp238-243', '10.1136/ard.2007.071415', '']\n",
      "['9739028', 'Allaart Cornelia F; Markusse Iris M; Lems Willem F. What have we learned from BeSt?. Clinical immunology (Orlando, Fla.). (2018) 186  pp74-78', '10.1016/j.clim.2017.09.017', '']\n",
      "['9739029', 'Anonymous. Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis. Zhonghua yi xue za zhi. (2001) 81 9 pp557-560', '10.1097/00004836-200104000-00006', '']\n",
      "['9739030', 'Baker M B; Bendit M; Campanile A M; Feeney M; Hodsman P; Toso J F. A randomised, single-blind, placebo-controlled dose escalation study to investigate the safety, tolerability and pharmacokinetics of a single intravenous infusion of GSK315234 in healthy volunteers. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp427', '10.1186/isrctn67656669', '']\n",
      "['9739031', 'Bepler C R; Rogers F B. A double-blind study using manganese against placebo in rheumatoid arthritis. American journal of medicine. (1957) 234 4 pp459', '10.1097/00000441-195710000-00011', '']\n",
      "['9739032', 'Berry H; Fernandes L; Ford-Hutchinson A W; Evans S J; Hamilton E B. Alclofenac and D penicillamine; comparative trial in rheumatoid arthritis. Annals of the rheumatic diseases. (1978) 37 1 pp93-97', '10.1136/ard.37.1.93', '']\n",
      "['9739033', 'Berry H; Huskisson E C. Treatment of rheumatoid arthritis: a trial of meprothixol. Clinical trials journal. (1972) 9 4 pp13-14', '10.1136/ard.31.5.402', '']\n",
      "['9739034', 'Bezerra E L M; Neto F A; Bezerra Vilar; M J. Blog versus traditional seminar: a comparative trial in rheumatology. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.21358', '']\n",
      "['9739035', 'Billings R; Burry H C; Grahame R; Berry D J; Donovan B. A double blind cross over trial of Prenazone and aspirin in the management of rheumatoid arthritis. Rheumatology and rehabilitation. (1975) 14 2 pp61-66', '10.1093/rheumatology/14.2.61', 'http://academic.oup.com/rheumatology/article-pdf/14/2/61/5025868/14-2-61.pdf']\n",
      "['9739038', 'Boyle D L; Wei N; Singhal A K; Mandel D R; Mease P; Kavanaugh A; Shurmur R; Hodge J; Luo Z; Krishnaswami S; Gruben D; Zwillich S H; Soma K; Bradley J D; Firestein G S. The JAK inihibitor tofacitinib suppresses synovial JAK-STAT signalling in rheumatoid arthritis. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS764', '10.1136/annrheumdis-2014-206028', '']\n",
      "['9739040', 'Brooks C D; Schmid F R; Biundo J. Ibuprofen and aspirin in the treatment of rheumatoid arthritis. A cooperative double blind trial. Rheum.phys.med.. (1970)   pp48-63', '10.1093/rheumatology/x.suppl_1.48', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/48/24422033/10-suppl_1-48.pdf']\n",
      "['9739041', 'Brorsson S; Thorstensson C; Nilsdotter A; Bremander A. Two different sets of handexercises improved grip strength after eight weeks in patients with arthritis. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.4883', '']\n",
      "['9739042', 'Brosseau L; Welch V; Wells G; Tugwell P; De Bie; Gam A; Harman K; Shea B; Morin M. Low level laser therapy for osteoarthritis and rheumatoid arthritis: a metaanalysis. Journal of rheumatology. (2000) 27 8 pp1961-1969', '10.1002/14651858.cd002046.pub3', '']\n",
      "['9739043', 'Burgos-Vargas R; Cardiel M; Xibille D; Pacheco-Tena C; Pascual-Ramos V; Abud-Mendoza C; Mahgoub E; Rahman M; Fan H; Rojo R; Garcia E; Santana K. Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: pooled efficacy and safety analyses from Phase 3 and LTE studies. Reumatologia clinica. (2017)   pp', '10.1016/j.reuma.2017.04.006', '']\n",
      "['9739044', 'Burmester G; Charles-Schoemann C; Isaacs J; Hendrikx T; Kwok K; Zwillich S H; Riese R. Tofacitinib, an oral janus kinase inhibitor: safety comparison in patients with rheumatoid arthritis and an inadequate response to nonbiologic or biologic disease-modifying anti-rheumatic drugs. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.766', '']\n",
      "['9739045', 'Cardoe N. Controlled trial of G27 202 (p-hydroxyphenylbutazone) in rheumatoid arthritis. Annals of the rheumatic diseases. (1959) 18 3 pp244-248', '10.1136/ard.18.3.244', '']\n",
      "['9739047', 'Chatelus E; Sordet C; Ravaud P; Sibilia J; Gottenberg J E. Criteria for choice by clincians of the therapeutic strategy in patients with insufficient response to a first anti-TNF: data from the randomized \"roc\" criteria. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp685-686', '10.1136/annrheumdis-2016-eular.6141', '']\n",
      "['9739048', 'Chodock A L. Crossover comparison of benoxaprofen and indomethacin in rheumatoid arthritis and osteoarthritis. European journal of rheumatology and inflammation. (1982) 5 2 pp246-257', '10.1007/bf02030758', 'http://link.springer.com/article/10.1007/BF02030758/fulltext.html']\n",
      "['9739049', 'Choe J Y; Smolen J S; Keystone E; Genovese M C; Choi J; Rho Y H. Efficacy and safety analysis by overall anti-drug antibody results up to week 30 in patients with rheumatoid arthritis treated with SB2 (an infliximab biosimilar) or infliximab reference product in phase iii study. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp232', '10.1136/annrheumdis-2016-eular.3359', '']\n",
      "['9739050', 'Clemett D; Goa K L. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs. (2000) 59 4 pp957-980', '10.2165/00003495-200059040-00017', '']\n",
      "['9739051', 'Cramer P; Demirkan F; Fraser G; Pristupa A; Bartlett N L; Dilhuydy M S; Loscertales J; Avigdor A; Rule S A; Samoilova O; Goy A; Ganguly S; Poggesi I; Lavezzi S M; De Nicolao; De Jong; Neyens M; Salman M; Howes A; Mahler M. Systemic exposure of rituximab increased by ibrutinib: pharmacokinetic results from the helios trial. Blood. (2016) 128 22 pp', '10.1182/blood.v128.22.4403.4403', 'https://ashpublications.org/blood/article/128/22/4403/101339/Systemic-Exposure-of-Rituximab-Increased-By']\n",
      "['9739052', 'Da Gama; G G; Vignoli M A V; Costa G B. Double blind comparative study between cortivazol and dexamethasone in patients with rheumatoid arthritis. Folha medica. (1973) 67 2 pp301-310', '10.1093/rheumatology/12.2.62', 'http://academic.oup.com/rheumatology/article-pdf/12/2/62/5039159/12-2-62.pdf']\n",
      "['9739055', 'Den Uyl; Raterman H G; Lems W F; Dijkmans B A C; Voskuyl A E; Van Schaardenburg; Kerstens P J S M. Short term treatment of high dose glucocorticoids improves the lipid profile in early rheumatoid arthritis. Arthritis and rheumatism. (2009) 60 SUPPL. 10 pp1631', '10.1136/annrheumdis-2012-eular.1834', '']\n",
      "['9739056', 'Den Uyl; Van Raalte; D H; Nurmohamed M T; Lems W F; Bijlsma J W J; Hoes J N; Dijkmans B A C. No deterioration of glucose levels during oral glucose tolerance tests following high-dose prednisolone treatment in early active rheumatoid arthritis. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.33378', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.33378']\n",
      "['9739057', 'Donneuy P; Lloyd K; Campbell H. Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. British medical journal (1857). (1967) 1 5 pp77-86', '10.1136/bmj.1.5532.69', '']\n",
      "['9739058', 'Ebina K; Hirao M; Hashimoto J; Yukioka M; Noguchi T; Yoshikawa H. Assessment of the effects of switching bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis. Arthritis and rheumatology. (2016) 68 Supplement 10 pp1349-1350', '10.1007/s00774-017-0861-4', 'http://link.springer.com/article/10.1007/s00774-017-0861-4/fulltext.html']\n",
      "['9739059', 'El Miedany; El Gaafary; Palmer D. A controlled pilot assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis. Rheumatology. (2011) 50 SUPPL. 3 pp', '10.1007/s00296-011-2098-1', 'http://link.springer.com/article/10.1007/s00296-011-2098-1/fulltext.html']\n",
      "['9739066', 'Emery P; Vencovsky J; Ghil J; Cheong S Y; Hong E. Evaluation of radiographic progression by disease activity states in patients with rheumatoid arthritis treated with sb4 or reference etanercept: results from a phase III study. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.3043', '']\n",
      "['9739067', 'Fleischmann R M; Szumski A; Jones H. Impact of the discordance between c-reactive protein and erythrocyte sedimentation rate on clinical response to combination etanerceptmethotrexate therapy in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp205-206', '10.1136/annrheumdis-2016-eular.1857', '']\n",
      "['9739068', 'Forgacs P; Bakos L; Csaszar G; Riesz E. Effect of intramuscular injection of pituitary tissue in rheumatoid arthritis. Annals of the rheumatic diseases. (1959) 18 1 pp34-36', '10.1136/ard.18.1.34', '']\n",
      "['9739069', \"Forsblad D'Elia; Larsen A; Mattsson L A; Waltbrand E; Kvist G; Mellstrom D; Saxne T; Ohlsson C; Nordborg E; Carlsten H. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. Journal of rheumatology. (2003) 30 7 pp1456-1463\", '10.1136/ard.62.7.617', '']\n",
      "['9739070', 'Freundlich B; Kivitz A; Jaffe J S. Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have functional limitations. Journal of clinical rheumatology. (2014) 20 5 pp256-260', '10.1097/rhu.0000000000000117', '']\n",
      "['9739071', 'Fries J; Rose M; Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and internet administration. Journal of rheumatology. (2011) 38 8 pp1759-1764', '10.3899/jrheum.110402', '']\n",
      "['9739073', 'Giordano M; Tirri G; Gallo M; Ara M. Double blind trial of ketoprofen in rheumatoid arthritis. Farmaco, edizione pratica. (1974) 29 11 pp621-628', '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9739074', 'Gnanasakthy A; Kosinski M; Genovese M; Mallya U; Mpofu S. Association between health-related quality of life (HRQOL) and ACR improvement among rheumatoid arthritis (RA) patients treated with secukinumab. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.504', '']\n",
      "['9739075', 'Gnanasakthy A; Kosinski M; Genovese M; Mallya U; Mpofu S. Health-related quality of life (HRQOL) benefits associated with reductions in disease activity and pain severity among rheumatoid arthritis (RA) patients treated with secukinumab. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.507', '']\n",
      "['9739076', \"Gofton J P; O'Brien W M. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis. Journal of rheumatology. (1982) 9 Suppl. 8 pp169-172\", '10.1093/rheumatology/19.1.14', 'http://academic.oup.com/rheumatology/article-pdf/19/1/14/5026109/19-1-14.pdf']\n",
      "['9739079', 'Hammond A; Jeffreson P; Jones N; Gallagher J; Jones T. Clinical applicability of an educational-behavioural joint protection programme for people with rheumatoid arthritis. British journal of occupational therapy. (2002) 65 9 pp405-412', '10.1177/030802260206500903', 'https://journals.sagepub.com/doi/pdf/10.1177/030802260206500903']\n",
      "['9739083', \"Heaton J M. THE TREATMENT of SJOGREN'S SYNDROME with HYDROXYCHLORO-QUINE. Amer. J. Ophtha L.. (1963) 55 5 pp983-986\", '10.1016/0002-9394(63)90378-7', '']\n",
      "['9739084', 'Helliwell P; Mease P J; Nurminen T; FitzGerald O. Further analysis of psoriatic arthritis disease activity score (PASDAS) and composite psoriatic disease activity index (CPDAI) using data from a placebo-controlled trial of certolizumab pegol in psoriatic arthritis. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.1654', '']\n",
      "['9739085', 'Hirohata S. Efficacy of leflunomide. Nippon rinsho. Japanese journal of clinical medicine. (2002) 60 12 pp2357-2363', '10.3999/jscpt.33.3_521s', '']\n",
      "['9739086', 'Honorato J; Cuena R; Azanza J R. Double-blind parallel clinical trial with tenoxicam in comparison with indomethacin in the treatment of rheumatoid arthritis. Revista de medicina de la Universidad de Navarra. (1984) 28 3 pp49-53', '10.15581/021.8553', 'https://revistas.unav.edu/index.php/revista-de-medicina/article/download/8553/7671']\n",
      "['9739090', 'Kay J; Fleischmann R; Keystone E; Hsia E C; Doyle M K; Hsu B; Mack M; Beutler A; Braun J; Kavanaugh A. Golimumab 3-year safety update: an analysis of pooled data from the long term extensions of randomized, double-blind, placebo-controlled studies in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.3080', '']\n",
      "['9739091', \"Kennedy N; Stokes E; O'Shea E; Murphy T B; Bresnihan B; FitzGerald O. Inpatient and outpatient rehabilitation for patients with rheumatoid arthritis: a clinical and economic assessment. Journal of medical economics. (2007) 10 4 pp515-528\", '10.3111/13696990701725850', '']\n",
      "['9739096', 'Kingsley G H; Ibrahim F; Scott D L. Quality of life in psoriatic arthritis: comparative results with rheumatoid arthritis using SF36 in trials using methotrexate. Rheumatology (united kingdom). (2012) 51 SUPPL. 3 pp', '10.1186/isrctn54376151', '']\n",
      "['9739098', 'Kivitz A; Hazan L; Hoffman K; Wallin B A. MORAb-022, an anti-granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody (MAB): results of the first study in patients with mild-to-moderate rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp507', '10.1136/annrheumdis-2016-eular.3186', '']\n",
      "['9739100', 'Kremer J; Taylor P; Mendelsohn A; Baker D; Kim L; Ritchlin C. Subcutaneous golimumab sustains effects of intravenous golimumab in patients with active rheumatoid arthritis: results of the go-live long term extension. Rheumatology. (2011) 50 SUPPL. 3 pp', '10.3899/jrheum.110570', '']\n",
      "['9739101', 'Krishnan E; Zhang N; Wang H; Kaushik R. Indirect standardised assessment of injection site pain following subcutaneous administration of citrate-free formulation of adalimumab and its biosimilar ABP 501. Annals of the rheumatic diseases. (2018) 77 Supplement 2 pp601-602', '10.1136/annrheumdis-2018-eular.6595', '']\n",
      "['9739102', 'Kruger H H. Treatment of rheumatoid arthritis with flufenamic acid. results of a controlled ntulti center trial. Therapiewoche (karlsruhe). (1969) 19 38 pp382-389', '10.1093/rheumatology/viii.suppl_1.93', 'http://academic.oup.com/rheumatology/article-pdf/VIII/suppl_1/93/5385137/VIII-suppl_1-93.pdf']\n",
      "['9739103', 'Krystal A D; McCall W V; Fava M; Joffe H; Soares C N; Huang H; Grinell T; Zummo J; Spalding W; Marshall R. Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. Primary care companion to the Journal of clinical psychiatry. (2012) 14 4 pp', '10.4088/pcc.11m01296', '']\n",
      "['9739105', 'Langley G B; Sheppeard H; Wigley R D. Placebo therapy in rheumatoid arthritis. Clinical and experimental rheumatology. (1983) 1 1 pp17-21', '10.1007/bf00541189', 'http://link.springer.com/article/10.1007/BF00541189/fulltext.html']\n",
      "['9739106', 'Lassen C F; Jensen C M; Torholm C; Krohn L M; Pelck R. Synovectomy in rheumatoid arthritis. Ugeskrift for laeger. (1995) 157 23 pp3311-3314', '10.1016/s1067-2516(09)80073-2', '']\n",
      "['9739107', 'Lee S J; Yoo D H; Park W; Muller-Ladner U; Pyo T N. Statistical evalution of joint damage prgression in patients with rheumatoid arthritis treated with infliximab or biosimilar infliximab (CT-P13) anti-TNF therapy: a role of sensitivity analysis for missing data evaluating similarity. Annals of the rheumatic diseases. (2014) 73 SUPPL. 2 pp', '10.1136/annrheumdis-2014-eular.3461', '']\n",
      "['9739110', 'Maki-Petaja K; Ostor A; Hall F; Shenker N; Day L; Elkhawad M; Wilkinson I. Improvement of endothelial function by tetrahydrobiopterin (BH4) supplementation does not alter aortic stiffness in patients with rheumatoid arthritis. British journal of clinical pharmacology. (2011) 71 6 pp973-974', '10.1016/j.artres.2014.09.093', '']\n",
      "['9739112', 'Manning V L; Kaambwa B; Ratcliffe J; Scott D L; Choy E; Hurley M V; Bearne L M. Economic evaluation of a brief Education, Self-management and Upper Limb Exercise Training in People with Rheumatoid Arthritis (EXTRA) programme: a trial-based analysis. Rheumatology (Oxford, England). (2015) 54 2 pp302-309', '10.1093/rheumatology/keu319', 'http://academic.oup.com/rheumatology/article-pdf/54/2/302/6896828/keu319.pdf']\n",
      "['9739113', 'McKenna F; Arguelles L; Burke T; Lefkowith J; Geis G S. Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis. Clinical and experimental rheumatology. (2002) 20 1 pp35-43', '10.1136/bmj.325.7365.619', '']\n",
      "['9739114', 'Mery C; Kreplack M; Amor B. Our experience with penicillamine in chemotherapy of rheumatoid arthritis. Rhumatologie - revue international de rhumatologie. (1976) 6 1 pp75-91', '10.1016/s1169-8330(03)00046-2', '']\n",
      "['9739115', 'Narayanan S; Lu Y; Hutchings R; Baynton E; Hautamaki E. Comparison of disease status and outcomes of patients with rheumatoid arthritis (RA) receiving adalimumab or etanercept monotherapy in Europe. Value in health. (2014) 17 7 ppA374', '10.1016/j.jval.2014.08.2579', '']\n",
      "['9739117', 'Ongenaert M; Dupont S; Vayssiere B; Brys R; Van Rompaey; Menet C; Galien R. Treatment of rheumatoid arthritis patients with the JAK1-selective inhibitor GLPG0634 reverses an arthritis-specific blood gene signature to healthy state. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS657-S658', '10.1136/annrheumdis-2015-eular.6491', '']\n",
      "['9739118', 'Petrov V I; Babaeva A R; Cherevkova E V; Epstein O I; Sergeeva S A. Efficiency of Potentiated Antibodies to Tumor Necrosis Factor-alpha (Artrofoon) in the Therapy of Patients with Rheumatoid Arthritis. Bulletin of experimental biology and medicine. (2003) 135-136 SUPPL. 1 pp155-158', '10.1023/a:1024700812666', 'https://link.springer.com/article/10.1023/A:1024700812666/fulltext.html']\n",
      "['9739119', 'Peynirci Cersit; Yagci I; Cersit S; Inanc N. The effect of cardiac rehabilitation program on disease activity, functional outcome and cardiovascular risk in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp705-706', '10.1136/annrheumdis-2016-eular.3877', '']\n",
      "['9739121', 'Pope J E; Thorne J C; Haraoui B; Sampalis J. Treating to target with TNFi in active established rheumatoid arthritis results in longer drug survival than routine care with TNFi: results from the Optimization of Humira RCT. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp344', '10.1002/acr.22010', '']\n",
      "['9739122', 'Porro G B; Montrone F; Petrillo M; Caruso I; Imbesi V. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients. American journal of gastroenterology. (1995) 90 9 pp1485-1488', '10.3109/00365529309103128', '']\n",
      "['9739125', 'Roll P; Tony H P. Anti-CD20 therapy in rheumatoid arthritis. Zeitschrift fur Rheumatologie. (2009) 68 5 pp370-379', '10.1007/s00393-009-0437-3', 'http://link.springer.com/article/10.1007/s00393-009-0437-3/fulltext.html']\n",
      "['9739126', 'Roth S H; Englund D W; Harris B K; Ross H A. Tolmetin with acetaminophen in the treatment of rheumatoid arthritis, TOLMETIN: a NEW NON STEROIDAL ANTI INFLAMMATORY AGENT. ICS NO. 372. Excerpta medica. (1975)   pp112-121', '10.1016/0006-2952(76)90452-4', '']\n",
      "['9739129', 'Shichikawa K; Onoda T. The value of niflumic acid in the management of rheumatoid arthritis. A multiclinic double blind comparative study of niflumic acid and flufenamic acid. RIUMACHI. (1976) 16 2 pp211', '10.3109/03009747309095203', '']\n",
      "['9739130', 'Shichikawa K; SugawaraS; Ogawa N. Effect of indoprofen in patients with rheumatoid arthritis. Ryumachi. [Rheumatism]. (1984) 24 1 pp63-73', '10.1002/art.1780221217', '']\n",
      "['9739134', 'Smolen J S; Choe J Y; Keystone E C; Rho Y H; Lee Y; Lee S. Radiographic progression by disease activity states in patients with rheumatoid arthritis treated with SB2 or reference infliximab. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.5524', '']\n",
      "['9739136', 'Smolen J S; Van Vollenhoven; R F; Kavanaugh A; Goel N; Fichtner A; Strand V; Vencovsky J. Efficacy and safety of certolizumab pegol plus methotrexate in patients with rheumatoid arthritis (RA): 3-Year data from the rapid 2 study. Arthritis and rheumatism. (2010) 62 SUPPL. 10 pp1806', '10.1186/s13075-015-0767-2', '']\n",
      "['9739137', 'Sokolowski A; Kramarzynska-Zawrzykraj E. Attempts to investigate the function of the autonomie nervous and endocrine system in chronic rheumatic diseases by formation of a conditioned reflex. Polskie Archiwum Medycyny Wewnetrznej. (1954) 24 3 pp373-382', '10.1201/9781315139395-6', '']\n",
      "['9739138', 'Soubrier M; Perrodeau E; Gaudin P; Cantagrel A; Le Loet; Flipo R; Guis S; Combe B; Euller-Ziegler L; Schaeverbeke T; Fautrel B; Saraux A; Chary-Valckenaere I; Chales G; Dernis E; Richette P; Mariette X; Berenbaum F; Sibilia J; Ravaud P; Dougados M. Impact of a nurse led program on the management of comorbidities in rheumatoid arthritis (RA). Results of a prospective, multicentre, randomized, controlled trial (comedra). Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.439', '']\n",
      "['9739144', 'Tanaka Y; Smolen J; Jones H; Szumski A; Marshall L; Emery P. Baseline characteristics and treatment outcomes of patients who achieve deep remission in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp188-189', '10.1136/annrheumdis-2016-eular.1784', '']\n",
      "['9739146', 'Trijau S; Servy H; Selamnia A M; Pradel V; Lafforgue P; Pham T. Personal health records in rheumatoid arthritis: quality and adhesion factors. Arthritis and rheumatism. (2011) 63 10 SUPPL. 1 pp', '10.1002/art.30228', '']\n",
      "['9739147', 'Tse S K; Chow S C; Qingshu Lu; Cosmatos D. Testing homogeneity of two zero-inflated poisson populations. Biometrical journal. (2009) 51 1 pp159-170', '10.1002/bimj.200710490', '']\n",
      "['9739148', 'Udata C; Yin D; Cai C H; Salts S; Hua S Y; Rehman M I; Meng X. Immunogenicity assessment of PF-06438179, a potential biosimilar to infliximab, in healthy volunteers. Arthritis and rheumatology. (2014) 66 SUPPL. 10 ppS660', '10.1136/annrheumdis-2015-eular.4209', '']\n",
      "['9739150', 'Van Tuyl; L H D; Lems W F; Voskuyl A E; Kerstens P J S M; Garnero P; Dijkmans B A C; Boers M. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial. Annals of the rheumatic diseases. (2008) 67 11 pp1574-1577', '10.1136/ard.2008.090712', '']\n",
      "['9739151', 'Van Vollenhoven; Ducournau P; Wintfeld N; Berger W; Alten R. Health assessment questionnaire-disability index (HAQ-DI) scores in patients with rheumatoid arthritis (RA) treated with tocilizumab plus conventional anti-rheumatic drugs. Value in health. (2009) 12 7 ppA434', '10.1016/s1098-3015(10)75146-9', '']\n",
      "['9739153', 'Van Vollenhoven; R F; Riese R; Krishnaswami S; Kawabata T; Fosser C; Rottinghaus S; Lamba M; Zwillich S H. Relationship between lymphocyte count and risk of infection in rheumatoid arthritis patients treated with tofacitinib. Arthritis and rheumatism. (2013) 65 SUPPL. 10 ppS994', '10.1136/annrheumdis-2013-eular.780', '']\n",
      "['9739155', 'Vencovsky J; Emery P; Keystone E C; Ghil J; Cheong S Y; Hong E. Impact of anti-drug antibody and injection site reaction on efficacy: 24-week results from a phase iii study comparing SB4 (etanercept biosimilar) with reference etanercept in patients with rheumatoid arthritis. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1136/annrheumdis-2017-eular.3043', '']\n",
      "['9739156', 'Vetter G. A double blind comparison of clopirac and indomethacin in the treatment of rheumatoid arthritis. Journal belge de rhumatologie ET de medicine physique. (1975) 30 Spec.nr. pp118-122', '10.1016/j.annrmp.2008.04.001', '']\n",
      "['9739157', 'Veys E M; Mielants H. Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. Journal of rheumatology. (1978) 5 SUPPL.4 pp31-42', '10.1016/s0140-6736(78)90443-9', '']\n",
      "['9739158', 'Veys E M; Mielants H. Levamisole treatment in rheumatoid arthritis. Acta rhumatologica. (1979) 3 3 pp219-230', '10.1002/art.1780231216', '']\n",
      "['9739159', \"Virkki L M; Porola P; Forsblad D'Elia; Valtysdottir S; Kvist G; Waltbrand E; Solovieva S A; Konttinen Y T. Dehydroepiandrosterone (DHEA) substitution treatment in severe fatigue in DHEA-deficient patients with primary Sjogren's syndrome. Scandinavian journal of rheumatology. (2010) 39 5 pp443-444\", '10.1002/acr.20022', '']\n",
      "['9739160', 'Vreede P D; Parrino G R. Double-blind comparison of meclofenamate sodium (Meclomen) with placebo in the treatment of rheumatoid arthritis. Current therapeutic research - clinical and experimental. (1982) 32 2 pp288-294', '10.3109/9780203214237-212', '']\n",
      "['9739161', 'Wanka J; Jones L I; Wood P H N; Dixon A S J. Indomethacin in rheumatic diseases. A controlled clinical trial. Annals of the rheumatic diseases. (1964) 23 3 pp218-225', '10.1136/ard.23.3.218', '']\n",
      "['9739163', 'Weinblatt M; Baranauskaite A; Ghil J; Cheong S Y; Hong E. Minimal and comparable radiographic progression by disease activity states in patients with rheumatoid arthritis who continued SB5 or reference adalimumab and who switched to SB5. Arthritis and rheumatology. (2017) 69 Supplement 10 pp', '10.1002/art.40444', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40444']\n",
      "['9739164', 'White W B; Strand V; Roberts R; Whelton A. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis. American journal of therapeutics. (2004) 11 4 pp244-250', '10.1097/01.mjt.0000127360.23508.04', '']\n",
      "['9739165', 'Wolf J; Kapral T; Grisar J; Stamm T; Koeller M; Smolen J S; Aletaha D. Glucocorticoid treatment in rheumatoid arthritis: low-dose therapy does not reduce responsiveness to higher doses. Clinical and experimental rheumatology. (2008) 26 1 pp113-116', '10.1186/ar3777', 'https://link.springer.com/article/10.1186/ar3777/fulltext.html']\n",
      "['9739167', 'Wu C Y; Chen X; Lu H; Esfandiari E; Magrini F; Godwood A; Ryan P; Kane C; Roskos L; Wang B. Pharmacokinetics and immunogenicity of mavrilimumab administered subcutaneously in subjects with rheumatoid arthritis. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.2639', '']\n",
      "['9739168', 'Yoo D; Miranda P; Piotrowski M; Ramiterre E; Kovalenko V; Prodanovic N; Tee M; Gutierrez-Urena S; Jimenez R; Zamani O; Lee S; Kim H; Park W; Muller-Ladner U. A randomized, double-blind, phase 3 study demonstrates clinical equivalence of CT-P13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis. Annals of the rheumatic disease. (2013) 71 SUPPL. 3 pp', '10.1136/annrheumdis-2012-eular.2600', '']\n",
      "['9739170', 'Agnew-Blais J C; Coblyn J S; Katz J N; Anderson R J; Mehta J; Solomon D H. Measuring quality of care for rheumatic diseases using an electronic medical record. Annals of the rheumatic diseases. (2009) 68 5 pp680-684', '10.1136/ard.2008.089318', '']\n",
      "['9739171', 'Ahlstrand I; Bjork M; Thyberg I; Falkmer T. Low levels of pain impact on valued life activities in women and men with rheumatoid arthritis. Annals of the rheumatic diseases. (2013) 72 SUPPL. 3 pp', '10.1136/annrheumdis-2013-eular.2319', '']\n",
      "['9739172', 'Ahmed H; Saeed M A. Modifiable cardiovascular risk factors in patients with rheumatoid arthritis and their association with disease activity. International journal of rheumatic diseases. (2016) 19 Supplement 2 pp185', '10.1136/annrheumdis-2016-eular.3027', '']\n",
      "['9739173', 'Akgol G; Gulkesen A; Telo S; Ulusoy H; Poyraz A K; Alkan G; Kaya A. Can serum asymmetric dimethyl-arginine and homocysteine levels be a new activity parameter of disease in patients with rheumatoid arthritis?. International journal of clinical and experimental medicine. (2016) 9 7 pp14586-14595', '10.5455/medscience.2020.06.097', 'https://ejmanager.com/mnstemps/53/53-1590575600.pdf']\n",
      "['9739174', 'Alam A; Lambert N; Lule J; Coppin H; Mazieres B; De Preval; Cantaerel A. Persistence of dominant T cell clones in synovial tissues during rheumatoid arthritis. Journal of immunology (Baltimore, Md. : 1950). (1996) 156 9 pp3480-3485', '10.4049/jimmunol.156.9.3480', 'https://journals.aai.org/jimmunol/article-pdf/156/9/3480/1060728/3480.pdf']\n",
      "['9739175', 'Aletaha D; Smolen J. Is computer-assisted management necessary for patients with early rheumatoid arthritis?: commentary. Nature clinical practice rheumatology. (2008) 4 7 pp338-339', '10.1038/ncprheum0817', 'http://www.nature.com/articles/ncprheum0817']\n",
      "['9739176', 'Alten R; Musch A. Abatacept in patients with rheumatoid arthritis. Arzneimitteltherapie. (2008) 26 1 pp9-16', '10.1002/14651858.cd007277', '']\n",
      "['9739177', 'Andresen P N; Hansen G; Horslev-Petersen K. Treatment of rheumatoid arthritis with leflunomide. Ugeskrift for laeger. (2000) 162 39 pp5228-5232', '10.1002/1529-0131(200003)43:3<495::aid-anr4>3.0.co;2-u', '']\n",
      "['9739178', 'Bergman G J D; Hochberg M C; Boers M; Wintfeld N; Kielhorn A; Jansen J P. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Seminars in arthritis and rheumatism. (2010) 39 6 pp425-441', '10.1016/j.semarthrit.2009.12.002', '']\n",
      "['9739179', 'Bertoli A M; Strusberg I; Fierro G A; Ramos M; Strusberg A M. Lack of correlation between satisfaction and knowledge in clinical trials participants: a pilot study. Contemporary clinical trials. (2007) 28 6 pp730-736', '10.1016/j.cct.2007.04.005', '']\n",
      "['9739180', \"Bowman S J; Pillemer S; Jonsson R; Asmussen K; Vitali C; Manthorpe R; Sutcliffe N. Revisiting Sjogren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatology. (2001) 40 10 pp1180-1188\", '10.1093/rheumatology/40.10.1180', 'http://academic.oup.com/rheumatology/article-pdf/40/10/1180/5056971/401180.pdf']\n",
      "['9739181', 'Bruhn C. Rituximab - Soon a therapeutic option for rheumatoid arthritis?. Deutsche apotheker zeitung. (2004) 144 40 pp40-42', '10.1016/s1098-3015(10)63265-2', '']\n",
      "['9739182', 'Canada A T; Little A H; Creighton E L. The bioavailability of enteric coated acetylsalicylic acid. A comparison with buffered ASA in rheumatoid arthritis II. Current therapeutic research - clinical and experimental. (1976) 19 5 pp554-557', '10.1007/bf03288095', 'http://link.springer.com/article/10.1007/BF03288095/fulltext.html']\n",
      "['9739183', 'Chaturvedi V. The economics rheumatoid arthritis treatment in Asia. International journal of rheumatic diseases. (2014) 17 SUPPL. 1 pp19', '10.1016/b978-1-4160-9993-2.00002-3', '']\n",
      "['9739185', 'Cook D A; Dimick J B; Gallagher D C; Escalante A; Del Rincon; Ferraccioli G F; Di Poi; Weinblatt M E; Burge D J. Etanercept in rheumatoid arthritis [1] (multiple letters). New England journal of medicine. (1999) 340 25 pp2000-2001', '10.1056/nejm199906243402512', '']\n",
      "['9739187', 'Cronstein B N. Leflunomide improves active rheumatoid arthritis equivalently to methotrexate. Clinical and experimental rheumatology. (2001) 19 4 pp369-370', '10.1097/01.rhu.0000226617.72573.f3', '']\n",
      "['9739189', 'Deeks J J; Smith L A; Bradley M D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. British medical journal. (2002) 325 7365 pp619-623', '10.1136/bmj.325.7365.619', '']\n",
      "['9739190', 'Diederichs C; Roehrs T; Stout R; Burger A; Lumley M; Roth T. Sleepiness and fatigue in fibromyalgia and rheumatoid arthritis patients. Sleep. (2009) 32 Suppl. S ppA336', '10.1016/j.sleep.2012.09.020', '']\n",
      "['9739191', 'Ding C; Guo Q; Xing X; Guo Y; Cui H. MRI features of the parotid gland in Sjogren syndrome. Chinese journal of radiology (china). (2014) 48 5 pp386-390', '10.5832/m139-1-118-0', '']\n",
      "['9739192', 'Domljan Z; Pucar I; Gosev M. Efficacy of tenoxicam in the treatment of patients with rheumatoid arthritis. Drug investigation. (1990) 2 SUPPL. 3 pp45-47', '10.1007/bf03258213', 'http://link.springer.com/article/10.1007/BF03258213/fulltext.html']\n",
      "['9739193', 'Dong H; Xu L; Bi L. An investigation on vitamin D levels in peripheral blood in rheumatoid arthritis. Wei sheng yan jiu [Journal of hygiene research]. (2012) 41 2 pp313-315', '10.5353/th_b3122222', '']\n",
      "['9739194', 'Dormidontov Korshunov; E N N I; Baranova Ya. Antirheumatic nonsteroid drugs in the therapy of patients with rheumatoid arthritis. Terapevticheskii arkhiv. (1978) 50 9 pp10-13', '10.26442/00403660.2024.05.202701', 'https://ter-arkhiv.ru/0040-3660/article/viewFile/631998/pdf']\n",
      "['9739195', 'Doyle A J; Gunn M L D; Gamble G D; Zhang M. Personal computer-based PACS display system: comparison with a dedicated PACS workstation for review of computed radiographic images in rheumatoid arthritis. Academic radiology. (2002) 9 6 pp646-653', '10.1016/s1076-6332(03)80309-4', '']\n",
      "['9739196', 'Dritsaki M; Petrou S; Williams M; Lamb S E. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand. Health and quality of life outcomes. (2017) 15 1 pp20', '10.1186/s12955-016-0584-6', 'http://link.springer.com/content/pdf/10.1186/s12955-016-0584-6.pdf']\n",
      "['9739197', 'Eguchi K. Adalimumab for therapy of rheumatoid arthritis. Nippon rinsho. Japanese journal of clinical medicine. (2005) 63 Suppl 1  pp526-533', '10.1358/dot.2005.41.3.892520', '']\n",
      "['9739198', 'Emery P. Rheumatoid arthritis: not yet curable with early intensive therapy. Lancet. (1997) 350 9074 pp304-305', '10.1016/s0140-6736(97)22031-3', '']\n",
      "['9739199', 'Enger K J; Bjornstad K; Rodevand E; Skomsvoll J F. Training effects on pain in rheumatoid arthritis. Tidsskrift for den Norske laegeforening. (2003) 123 11 pp1508-1510', '10.1001/jama.1964.03070110133085', '']\n",
      "['9739200', 'Filipowicz-Sosnowska A. Efficacy and safety of TNF inhibitors - Results of randomized controlled clinical trials. Reumatologia. (2006) 44 6 pp309-314', '10.1016/j.ophtha.2006.02.064', '']\n",
      "['9739201', 'Fiocco U; Vezzu M; Cozzi L; Todesco S. IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy. Reumatismo. (2004) 56 1 SUPPL. 1 pp62-73', '10.4081/reumatismo.2004.1s.62', '']\n",
      "['9739202', 'Fleischmann R. The long-term U.S. Study - A report on outcome and tolerance. European journal of rheumatology and inflammation. (1991) 11 3 pp50-53', '10.1016/0924-977x(91)90672-h', '']\n",
      "['9739203', 'Glinatsi D; Bird P; Gandjbakhch F; Haavardsholm E A; Conaghan P G; Ostergaard M. Reliability of an omeract rheumatoid arthritis tenosynovitis scoring system for wrist and hand. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp627-628', '10.1136/annrheumdis-2016-eular.1445', '']\n",
      "['9739204', 'Guler-Yuksel M; Bijsterbosch J; Goekoop-Ruiterman Y P M; De Vries-Bouwstra; J K; Ronday H K; Peeters A J; De Jonge-Bok; J M; Breedveld F C; Dijkmans B A C; Allaart C F; Lems W F. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Annals of the rheumatic diseases. (2007) 66 11 pp1508-1512', '10.1136/ard.2007.070839', '']\n",
      "['9739205', 'Hatori M; Kokubun S. The long-term efficacy and tolerability of the new anti-inflammatory agent Zaltoprofen in rheumatoid arthritis. Current medical research and opinion. (1998) 14 2 pp79-87', '10.1185/03007999809113346', '']\n",
      "['9739207', 'Horng M S. Early rheumatoid arthritis: is there a best treatment?. Journal of clinical outcomes management. (2007) 14 5 pp233-234', '10.1016/j.berh.2006.08.011', '']\n",
      "['9739208', 'Iking-Konert C. Therapy-refractive rheumatoid arthritis: effectiveness and reliability of abatecept and infliximab. Aktuelle rheumatologie. (2008) 33 5 pp239-240', '10.1007/s00393-007-0226-9', 'http://link.springer.com/article/10.1007/s00393-007-0226-9/fulltext.html']\n",
      "['9739209', 'Jonker C; Comijs H C; Smit J H. Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study. Neurobiology of aging. (2003) 24 4 pp583-588', '10.1016/s0197-4580(02)00188-4', '']\n",
      "['9739211', 'Joutsi-Korhonen L; Javela K; Hormila P; Kekomaki R. Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients. Clinical and laboratory haematology, supplement. (2001) 23 5 pp307-312', '10.1046/j.1365-2257.2001.00405.x', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2257.2001.00405.x']\n",
      "['9739212', 'Kamioka H; Tsutani K; Okuizumi H; Mutoh Y; Ohta M; Handa S; Okada S; Kitayuguchi J; Kamada M; Shiozawa N; Honda T. Effectiveness of aquatic exercise and balneotherapy: a summary of systematic reviews based on randomized controlled trials of water immersion therapies. Journal of epidemiology / Japan Epidemiological Association. (2010) 20 1 pp2-12', '10.2188/jea.je20090030', '']\n",
      "['9739213', 'Kampen W U. 60 years of radiosynoviorthesis-state of the art. Annals of the rheumatic diseases. (2016) 75 Supplement 2 pp31-32', '10.1136/annrheumdis-2016-eular.6290', '']\n",
      "['9739214', 'Kavanaugh A; Cohen S; Cush J. Inhibitors of tumor necrosis factor in rheumatoid arthritis: will that dog hunt?: editorial. Journal of rheumatology. (1998) 25 11 pp2049-2053', '10.1016/b978-0-323-06551-1.00061-0', '']\n",
      "['9739215', 'Kazuyoshi S; Tanaka Y. Efficacy of new biologics on bone destruction in rheumatoid arthritis. Clinical calcium. (2009) 19 3 pp372-380', '10.12688/f1000research.17296.1', 'https://f1000research.com/articles/8-533/v1/pdf']\n",
      "['9739216', 'Kozak T; Rychlik I. Development of hematopoietic stem cell transplantation in the treatment of autoimmune diseases. Transfuze dnes. (2001) 7 4 pp133-138', '10.1016/s0301-472x(01)00645-2', '']\n",
      "['9739217', 'Kozak T; Rychlik I. Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases. Israel Medical Association journal. (2002) 4 4 pp268-271', '10.3109/9780849358807-26', '']\n",
      "['9739218', 'Kristensen L E; Christensen R; Bliddal H; Geborek P; Danneskiold-Samsoe B; Saxne T. The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scandinavian journal of rheumatology. (2007) 36 6 pp411-417', '10.1080/03009740701607067', '']\n",
      "['9739219', 'Lamprecht P; Nitschmann S. Therapy of rheumatoid arthritis with etanercept. Internist. (2009) 50 5 pp633-634', '10.1007/s00108-009-2378-y', 'http://link.springer.com/article/10.1007/s00108-009-2378-y/fulltext.html']\n",
      "['9739220', 'Landewe R; Van der Heijde. Follow up studies in rheumatoid arthritis. Annals of the rheumatic diseases. (2002) 61 6 pp479-481', '10.1136/ard.61.6.479', '']\n",
      "['9739221', 'Lefebvre J C; Keefe F J; Affleck G; Raezer L B; Starr K; Caldwell D S; Tennen H. The relationship of arthritis self-efficacy to daily pain, daily mood, and daily pain coping in rheumatoid arthritis patients. Pain. (1999) 80 1-2 pp425-435', '10.1016/s0304-3959(98)00242-5', '']\n",
      "['9739222', 'MacLean C H; Mojica W A; Morton S C; Pencharz J; Hasenfeld Garland; Tu W; Newberry S J; Jungvig L K; Grossman J; Khanna P; Rhodes S; Shekelle P. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evidence report/technology assessment (Summary). (2004)  89 pp1-4', '10.1093/ajcn/82.3.611', 'http://academic.oup.com/ajcn/article-pdf/82/3/611/23959969/znu00905000611.pdf']\n",
      "['9739223', 'Maini R N; Taylor P C. Anti-cytokine therapy for rheumatoid arthritis. Annual review of medicine. (2000) 51  pp207-229', '10.1146/annurev.med.51.1.207', '']\n",
      "['9739224', \"Moreland L W. Etanercept (Enbrel(TM)), an inhibitor of tumor necrosis factor - A new option for treating rheumatoid arthritis. Today's therapeutic trends. (1999) 17 1 pp23-34\", '10.1016/s0889-857x(05)70027-2', '']\n",
      "['9739225', 'Paulus H E. Minocycline treatment of rheumatoid arthritis. Annals of internal medicine. (1995) 122 2 pp147-148', '10.7326/0003-4819-122-2-199501150-00012', 'https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-122-2-199501150-00012']\n",
      "['9739226', 'Pease C; Pope J E; Thorne C; Haraoui B P; Truong D; Bombardier C; Widdifield J; Psaradellis E; Sampalis J S; Bonner A. Canadian variation by province in rheumatoid arthritis initiating anti-tumor necrosis factor therapy: results from the optimization of adalimumab trial. Journal of rheumatology. (2010) 37 12 pp2469-2474', '10.3899/jrheum.091447', '']\n",
      "['9739227', 'Peloso P M; Wright J G; Bombardier C. A critical appraisal of toxicity indexes in rheumatology. Journal of rheumatology. (1995) 22 5 pp989-994', '10.1097/00124743-199804000-00004', '']\n",
      "['9739228', 'Ribbens C; Andre B; Jaspar J M; Kaye O; Kaiser M J; De Groote; Malaise M G. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. Journal of rheumatology. (2000) 27 4 pp888-893', '10.1093/rheumatology/39.12.1357', 'http://academic.oup.com/rheumatology/article-pdf/39/12/1357/18108397/391357.pdf']\n",
      "['9739229', 'Sano H. Selective COX-2 inhibitors for therapy of rheumatoid arthritis. Nippon rinsho. Japanese journal of clinical medicine. (2005) 63 Suppl 1  pp477-487', '10.3949/ccjm.69.suppl_1.si5', '']\n",
      "['9739231', 'Sharpe L; Ryan B; Allard S; Sensky T. Testing for the integrity of blinding in clinical trials: how valid are forced choice paradigms?. Psychotherapy and psychosomatics. (2003) 72 3 pp128-131', '10.1159/000069736', 'https://www.karger.com/Article/Pdf/69736']\n",
      "['9739232', 'Silman A; Kay A; Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis and rheumatism. (1992) 35 2 pp152-155', '10.1002/art.1780350205', '']\n",
      "['9739233', 'Silva H. Worldwide clinical experience with piroxicam FDDF. European journal of rheumatology and inflammation. (1995) 15 2 pp3-10', '10.1016/0926-9959(95)96112-l', '']\n",
      "['9739234', 'Smedslund G; Byfuglien M G; Olsen S U; Hagen K B. Effectiveness and Safety of Dietary Interventions for Rheumatoid Arthritis: a Systematic Review of Randomized Controlled Trials. Journal of the American Dietetic Association. (2010) 110 5 pp727-735', '10.1016/j.jada.2010.02.010', '']\n",
      "['9739235', 'Sokolovic S. Corticosteroid therapy and atherosclerosis risk in rheumatoid arthritis patients. Clinical and experimental rheumatology. (2009) 27 5 pp717', '10.1016/s0950-3579(05)80010-x', '']\n",
      "['9739236', 'Steen V D; Medsger Jr; T A. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis and rheumatism. (1999) 42 4 pp763-768', '10.1002/1529-0131(199904)42:4<763::aid-anr21>3.0.co;2-v', '']\n",
      "['9739238', 'Sun Z L; Wang L; Wang F Q; Xu Z Y; Qian X. Differential serum proteomic analysis of rheumatoid arthritis patients of cold-dampness arthralgia spasm syndrome. Zhongguo Zhong xi yi jie he za zhi [Chinese journal of integrated traditional and Western medicine]. (2013) 33 7 pp901-905', '10.55111/j.issn2709-1961.202107036', '']\n",
      "['9739239', 'Szechinski J; Wiland P; Szczepanski L; Chudzik D; Sierakowski S; Klimiuk P A. One year combined treatment with methotrexate and monoclonal antibodies anti-TNFalpha (Remicade) in patients with active rheumatoid arthritis - Multicenter clinical trial. Reumatologia. (2001) 39 3 pp200-207', '10.5414/cpp42434', '']\n",
      "['9739240', 'Van der Heide; Jacobs J W G; Haanen H C M; Bijlsma J W J. Is it possible to predict the first year extent of pain and disability for patients with rheumatoid arthritis?. Journal of rheumatology. (1995) 22 8 pp1466-1470', '10.1093/rheumatology/37.8.837', 'http://academic.oup.com/rheumatology/article-pdf/37/8/837/18106242/370837.pdf']\n",
      "['9739241', 'Van Roon; E N; Jansen T L Th A; Van den Bemt; P M L A; Bruyn G A W. New perspectives for rheumatic patients. Anti-TNFalpha therapy with etanercept and infliximab. Pharmaceutisch weekblad. (2001) 136 23 pp832-838', '10.1007/bf02293353', 'http://link.springer.com/article/10.1007/BF02293353/fulltext.html']\n",
      "['9739243', 'von Scheele; Pena B; Wong J; Niculescu L. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial. Rheumatology. (2003) 42 SUPPL. 3 pp', '10.1093/rheumatology/keg498', 'http://academic.oup.com/rheumatology/article-pdf/42/suppl_3/iii53/5057825/keg498.pdf']\n",
      "['9739246', 'Willich S N; Rossnagel K; Roll S; Wagner A; Mune O; Erlendson J; Kharazmi A; Sorenson H; Winther K. Patients with rheumatoid arthritis may benefit from a standardised powder of Rosa canina (rose hip). Focus on alternative and complementary therapies. (2010) 15 2 pp114-115', '10.1211/fact.15.2.0010', '']\n",
      "['9739247', 'Yamanaka H. Antirheumatic agents for treatment of rheumatoid arthritis. Nihon Naika Gakkai zasshi [The Journal of the Japanese Society of Internal Medicine]. (2008) 97 10 pp2399-2404', '10.2169/naika.97.2399', '']\n",
      "['9739248', 'Yazdani A; Singer L; Williams L; Mittoo S. Lung transplantation in rheumatoid arthritis compared with idiopathic pulmonary fibrosis and scleroderma. Journal of rheumatology. (2013) 40 6 pp960', '10.1016/j.healun.2014.01.858', '']\n",
      "['9739249', 'Yazici Y; Yazici H. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis. Clinical and experimental rheumatology. (2008) 26 3 pp449-452', '10.1002/art.37930', '']\n",
      "['9739250', 'Yelin E; Trupin L; Wong B; Rush S. The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. Journal of rheumatology. (2002) 29 9 pp1851-1857', '10.1002/art.10340', '']\n",
      "['9739251', 'Yukawa N; Mimori T. B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis. Clinical calcium. (2007) 17 4 pp569-576', '10.1002/art.22019', '']\n",
      "['9739252', 'Anonymous. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatoid diseases. Annals of the rheumatic diseases. (1959) 18 3 pp173-188', '10.1136/bmj.1.4873.1223', '']\n",
      "['9739254', 'Anonymous. A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis. Journal of rheumatology. Supplement. (1978) 4  pp5-10', '10.1136/ard.41.2.159', '']\n",
      "['9739255', 'Anonymous. Levamisole in rheumatoid arthritis. A randomised double-blind study comparing two dosage regimens of levamisole with placebo. Multicentre study group. Lancet (london, england). (1978) 2 8098 pp1007-1012', '10.1016/s0140-6736(78)92335-8', '']\n",
      "['9739256', 'Anonymous. The simultaneous assessment of four nonsteroidal antiinflammatory drugs in rheumatoid arthritis using a simple and rapid trial design. Australasia Multicentre Trial Group. Journal of rheumatology. (1980) 7 6 pp857-864', '10.1002/art.23929', '']\n",
      "['9739257', 'Anonymous. Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group. Annals of the rheumatic diseases. (1982) 41 2 pp159-163', '10.1136/ard.41.2.159', '']\n",
      "['9739258', 'Anonymous. Intra-articular radioactive yttrium and triamcinolone hexacetonide: an inconclusive trial. Arthritis and Rheumatism Council Multicentre Radiosynoviorthesis Trial Group. Annals of the rheumatic diseases. (1984) 43 4 pp620-623', '10.1136/ard.43.4.620', '']\n",
      "['9739259', 'Anonymous. A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis. The Multicentre Trial Group. British journal of rheumatology. (1986) 25 2 pp184-192', '10.1093/rheumatology/25.2.184', 'http://academic.oup.com/rheumatology/article-pdf/25/2/184/5027688/25-2-184.pdf']\n",
      "['9739260', 'Anonymous. Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Canadian Multicentre Study Group. Current medical research and opinion. (1988) 11 1 pp16-27', '10.1185/03007998809111126', '']\n",
      "['9739261', 'Anonymous. Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group. Rheumatology international. (1992) 12 5 pp175-185', '10.1007/bf00302149', 'http://link.springer.com/article/10.1007/BF00302149/fulltext.html']\n",
      "['9739262', 'Anonymous. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group. Journal of rheumatology. (1992) 19 11 pp1672-1677', '10.1093/rheumatology/keh412', 'http://academic.oup.com/rheumatology/article-pdf/44/1/105/9446156/keh412.pdf']\n",
      "['9739263', 'Atkinson M H; Brown T A; Robinson H S; Willkens R F. Crossover comparison of benoxaprofen and naproxen in rheumatoid arthritis. Journal of rheumatology. Supplement. (1980) 6  pp109-115', '10.3109/03009747309097115', '']\n",
      "['9739264', 'Brosseau Lucie; Wells George; Brooks-Lineker Sydney; Bennell Kim; Sherrington Cathie; Briggs Andrew; Sturnieks Daina; King Judy; Thomas Roanne; Egan Mary; Loew Laurianne; De Angelis; Gino; Casimiro Lynn; Toupin April; Karine; Cavallo Sabrina; Bell Mary; Ahmed Rukhsana; Coyle Doug; Poitras Stephane; Smith Christine; Pugh Arlanna; Rahman Prinon. Internet-based implementation of non-pharmacological interventions of the \"people getting a grip on arthritis\" educational program: an international online knowledge translation randomized controlled trial design protocol. JMIR research protocols. (2015) 4 1 ppe19', '10.2196/resprot.3572', '']\n",
      "['9739265', 'Chatzidionysiou Katerina; Turesson Carl; Teleman Annika; Knight Ann; Lindqvist Elisabet; Larsson Per; Coster Lars; Forslind Kristina; van Vollenhoven; Ronald; Heimburger Mikael. A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission. RMD open. (2016) 2 1 ppe000133', '10.1136/rmdopen-2015-000133', '']\n",
      "['9739266', 'Cifuentes M; Del Barrio-Diaz; Vera-Kellet C. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjogren syndrome: a double-blind randomized controlled trial. British journal of dermatology. (2018)   pp', '10.1111/bjd.16442', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjd.16442']\n",
      "['9739268', \"Dottori L; D'Ottavio D; Brundisini B. Calcifediol and calcitonin in the therapy of rheumatoid arthritis. A short-term controlled study. Calcifediolo e calcitonina nella terapia dell'artrite reumatoide. Studio controllato a breve termine.. (1982) 73 43 pp3033-3040\", '10.47222/2526-3544.rbto21466', 'https://revistas.ufrj.br/index.php/ribto/article/download/21466/pdf']\n",
      "['9739270', 'Fernandez-Avila Daniel G; Ruiz Alvaro J; Gil Fabian; Mora Sergio A; Tobar Carlos; Gutierrez Juan M; Rosselli Diego. The effect of an educational intervention, based on clinical simulation, on the diagnosis of rheumatoid arthritis and osteoarthritis. Musculoskeletal care. (2018) 16 1 pp147-151', '10.1002/msc.1228', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1228']\n",
      "['9739271', 'Garcia Rubio. Sodium diclofenac and ibuprofen in rheumatoid arthritis. Comparative double blind study. Diclofenac sodico e ibuprofen en artritis reumatoide. Estudio comparativo doble ciego. (1976) 41 7-8 pp270-272', '10.3109/03009748009101380', '']\n",
      "['9739272', 'Garcia Ruiz; Antonio J; Montesinos Galvez; Ana C; Perez Costillas; Lucia; Rebollo Pablo. A comparison of leflunomide and subcutaneous methotrexate in the treatment of rheumatoid arthritis: an approximation based on the number needed to treat. Comparacion de leflunomida y metotrexato subcutaneo en el tratamiento de la artritis reumatoide: una aproximacion basada en el numero de pacientes que es necesario tratar.. (2009) 5 2 pp66-70', '10.1016/j.reuma.2008.11.001', '']\n",
      "['9739274', \"Giordano M; Tirri G; Gallo M; Ara M. Double-blind tests on the therapeutic activity of ketoprophene against rheumatoid arthritis. Ricerca a doppio cieco sull'attivita terapeutica del ketoprofen nell'artrite reumatoide. (1974) 29 11 pp621-628\", '10.1093/rheumatology/13.1.10', 'http://academic.oup.com/rheumatology/article-pdf/13/1/10/5025054/13-1-10.pdf']\n",
      "['9739275', 'Graudal H. Parameters of arthritis activity in double-blind studies on pollen therapy in rheumatoid arthritis. Paramter der arthritisaktivitat IM doppelblindversuch uber pollentherapie bei rheumatoider arthritis.. (1968) 27 5 pp186-192', '10.1186/isrctn48092875', '']\n",
      "['9739276', 'Haddad J J. VX-745. Vertex Pharmaceuticals. Current opinion in investigational drugs (London, England : 2000). (2001) 2 8 pp1070-1076', '10.1517/13543784.9.9.2017', '']\n",
      "['9739279', 'Hingorani K. Double-blind crossover trial comparing ibuprofen with flufenamic acid in rheumatoid arthritis. Rheumatology and physical medicine. (1970) 10  ppSuppl-82', '10.1093/rheumatology/x.suppl_1.76', 'http://academic.oup.com/rheumatology/article-pdf/10/suppl_1/76/24422041/10-suppl_1-76.pdf']\n",
      "['9739280', 'Jonderko G; Gabryel A; Galaszek Z; Dyczek-Parys E; Nowicki L; Szczesny-Siwinski H. Comparative crossover double-blind study of profenid and indomethacin patients with rheumatoid arthritis. Vergleichende crossover-doppelblindstudie mit profenid und indometazin bei patienten mit rheumatoid-arthritis.. (1982) 37 8 pp242-245', '10.1080/03009742.1979.12088616', '']\n",
      "['9739281', '. A randomized controlled study to evaluate an experimental moisturizing mouthwash formulation in participants experiencing dry mouth symptoms. Oral surgery, oral medicine, oral pathology and oral radiology. (2018) 126 3 pp231-239.e5', '10.1016/j.oooo.2018.05.007', '']\n",
      "['9739282', \"Kaneko Yuko; Kameda Hideto; Ikeda Kei; Ishii Tomonoti; Murakami Kosaku; Takamatsu Hyota; Tanaka Yoshiya; Abe Takayuki; Takeuchi Tsutomu. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Annals of the rheumatic diseases. (2018)   pp\", '10.1136/annrheumdis-2018-213920', '']\n",
      "['9739284', 'Kullich W; Schwann H. Circulating immune complexes and complement fragment iC3b in chronic polyarthritis during 12 months therapy with oral enzymes in comparison with oral gold. Zirkulierende immunkomplexe und das komplementfragment ic3b bei chronischer polyarthritis wahrend einer 12monatigen therapie mit oralen enzymen IM vergleich zu oralem gold.. (1992) 142 22 pp493-497', '10.1007/978-3-642-85316-6_79', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_79.pdf']\n",
      "['9739285', \"Murav'ev Iu V; Lebedeva V V; Nasonova V A. The intra-articular therapy with triamcinolone acetonide and betamethasone of rheumatoid arthritis patients: a double-blind study. Vnutrisustavnaia terapiia triamtsinolonom atsetonidom i betametazonom bol'nykh revmatoidnym artritom: dvoinoe slepoe issledovanie.. (1997) 69 5 pp32-33\", '10.1097/md.0000000000016714', '']\n",
      "['9739286', \"Nemtsov B F; Benenson E V; Timina O V. Pulse therapy with prospidin and methotrexate: comparative efficacy in rheumatoid arthritis (12-month controlled study). Sravnitel'naia effektivnost' pul's-terapii prospidinom i metotreksatom pri revmatoidnom artrite (12-mesiachnoe kontroliruemoe issledovanie).. (1998) 76 8 pp24-28\", '10.14412/1995-4484-2003-1359', '']\n",
      "['9739287', 'Nia Nasrin Ghanbari; Afrasiabifar Ardashir; Behnammoghadam Mohammad. Comparing the effect of eye movement desensitization and reprocessing (EMDR) with guided imagery on pain severity in patients with rheumatoid arthritis. Journal of pain research. (2018) 11  pp2107-2113', '10.2147/jpr.s158981', 'https://www.dovepress.com/getfile.php?fileID=44819']\n",
      "['9739288', \"Oliunin Iu A; Solov'ev S K; Balabanova R M; Chiklikchi A S; Filipowicz-Sosnowska A; Garwolinska H; Stanislawska E. A comparative evaluation of combined immunocorrective therapy in rheumatoid arthritis with systemic manifestations (joint Soviet-Polish research). Sravnitel'naia otsenka kompleksnoi immunokorrigiruiushchei terapii revmatoidnogo artrita s sistemnymi proiavleniiami (sovmestnoe sovetsko-pol'skoe issledovanie).. (1992) 64 5 pp30-34\", '10.26782/jmcms.spl.10/2020.06.00048', '']\n",
      "['9739289', 'Ormrod Douglas; Wellington Keri; Wagstaff Antona J. Valdecoxib. Drugs. (2002) 62 14 pp2059-2053', '10.2165/00003495-200262140-00005', '']\n",
      "['9739290', 'Othman Ahmed A; Khatri Amit; Loebbert Ralf; Peloso Paul M. Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-alpha and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid Arthritis. Clinical pharmacology in drug development. (2018)   pp', '10.1002/cpdd.611', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpdd.611']\n",
      "['9739291', \"Rejholec V. The long term treatment of rheumatoid arthritis with niflumic acid or indometazin in double blind controlled trial (author's transl). Langzeitbehandlung der rheumatoiden arthritis mit nifluminsaure oder indometazin IM doppelblindversuch. (1976) 71  pp1188-1191\", '10.1007/978-3-642-85287-9_9', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85287-9_9.pdf']\n",
      "['9739292', 'Rexhepi Sylejman; Rexhepi Mjellma; Rexhepi Blerta; Sahatciu-Meka Vjollca; Mahmutaj Vigan. Evaluation of the Efficacy of Combined Therapy of Methotrexate and Etanercept versus Methotrexate as a Mono-Therapy. Open access macedonian journal of medical sciences. (2018) 6 5 pp786-789', '10.3889/oamjms.2018.173', 'https://spiroski.migration.publicknowledgeproject.org/index.php/mjms/article/download/oamjms.2018.173/2107']\n",
      "['9739293', 'Sainz De La Maza Serra; Simon Castellvi; Kabbani O. Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca. Esteroides topicos sin conservantes y oclusion de los puntos lagrimales para la queratoconjuntivitis sicca grave.. (2000) 75 11 pp751-756', '10.35537/10915/55214', '']\n",
      "['9739294', 'Schiff Michael; Combe Bernard; Dorner Thomas; Kremer Joel M; Huizinga Thomas W; Veenhuizen Melissa; Gill Anne; Komocsar Wendy; Berclaz Pierre-Yves; Ortmann Robert; Lee Chin. Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study. RMD open. (2015) 1 1 ppe000037', '10.1136/rmdopen-2014-000037', '']\n",
      "['9739295', 'Schlumpf U; Hofmann P. Comparison of mid- and high dosage methylprednisolone pulse therapy in chronic polyarthritis. Vergleich einer mittel- und hochdosierten methylprednisolonstosstherapie bei chronischer polyarthritis.. (1990) 49 3 pp160-164', '10.1007/978-3-642-85316-6_79', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_79.pdf']\n",
      "['9739296', 'Schmidt K L; Ott V R. Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis. Coeruloplasmin und immunglobuline unter kontrollierter d-penicillamin-therapie bei rheumatoider arthritis. (1976) 35 3-4 pp154-163', '10.1007/978-3-642-85287-9_17', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85287-9_17.pdf']\n",
      "['9739297', 'Schnabel A; Reinhold-Keller E; Willmann V; Dihlmann W; Gross W L. Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis. Nebenwirkungen und wirksamkeit von 15 mg und 25 mg methotrexat pro woche bei der chronischen polyarthritis.. (1994) 53 3 pp142-149', '10.1007/bf00302669', 'http://link.springer.com/article/10.1007/BF00302669/fulltext.html']\n",
      "['9739298', 'Schrier Joost C; Keijsers Noel L; Matricali Giovanni A; Verheyen Cees C P M; Louwerens Jan Willem K. Resection or preservation of the metatarsal heads in rheumatoid forefoot surgery? A randomised clinical trial. Foot and ankle surgery. (2017)   pp', '10.1016/j.fas.2017.07.1126', '']\n",
      "['9739299', 'Soubrier Martin; Lambert Celine; Combe Bernard; Gaudin Philippe; Thierry Thomas; Sibilia Jean; Dougados Maxime; Dubost Jean-Jacques. A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (2018)   pp', '10.1002/art.1780350904', '']\n",
      "['9739301', 'Takeuchi Tsutomu; Genovese Mark C; Haraoui Boulos; Li Zhanguo; Xie Li; Klar Rena; Pinto-Correia Ana; Otawa Susan; Lopez-Romero Pedro; de la Torre; Inmaculada; Macias William; Rooney Terence P; Smolen Josef S. Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study. Annals of the rheumatic diseases. (2018)   pp', '10.1136/annrheumdis-2018-eular.2000', '']\n",
      "['9739302', 'Tanaka Shingo; Harada Sayaka; Hiramatsu Naoto; Nakaya Ryou; Kawamura Masaki. Randomized, double-blind, placebo-controlled, phase I study of the safety and pharmacokinetics of namilumab in healthy Japanese and Caucasian men. International journal of clinical pharmacology and therapeutics. (2018) 56 11 pp507-517', '10.5414/cp203235', '']\n",
      "['9739303', 'Tanaka Yoshiya; Sugiyama Naonobu; Toyoizumi Shigeyuki; Lukic Tatjana; Lamba Manisha; Zhang Richard; Chen Connie; Stock Thomas; Valdez Hernan; Mojcik Christopher; Fan Haiyun; Deng Chenhui; Yuasa Hirotoshi. Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study. Rheumatology (Oxford, England). (2018)   pp', '10.1093/rheumatology/key250', 'http://academic.oup.com/rheumatology/article-pdf/58/1/70/27144804/key250.pdf']\n",
      "['9739305', 'Tausch G; Teherani D K; Broll H; Eberl R; Altmann H. Effect of D-penicillamine on zinc levels in blood and urine of patients with chronic polyarthritis. Einfluss von d-penicillamin auf zinkspiegel IM blut und harn bei patienten mit chronischer polyarthritis.. (1978) 37 5-6 pp148-152', '10.1007/978-3-642-85316-6_139', 'http://link.springer.com/content/pdf/10.1007/978-3-642-85316-6_139.pdf']\n",
      "['9739306', 'Vaghef-Mehrabany Elnaz; Vaghef-Mehrabany Leila; Asghari-Jafarabadi Mohammad; Homayouni-Rad Aziz; Issazadeh Karim; Alipour Beitullah. Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: a randomized placebo-controlled clinical trial. Health promotion perspectives. (2017) 7 2 pp95-101', '10.15171/hpp.2017.17', 'http://journals.tbzmed.ac.ir/HPP/Manuscript/HPP-7-95.pdf']\n",
      "['9739307', 'Ward Lesley; Stebbings Simon; Athens Josie; Cherkin Daniel; David Baxter G. Yoga for the management of pain and sleep in rheumatoid arthritis: a pilot randomized controlled trial. Musculoskeletal care. (2018) 16 1 pp39-47', '10.1002/msc.1201', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1201']\n",
      "['9739308', 'Cannon G W. Rofecoxib: a specific cyclooxygenase inhibitor. Drugs of today (Barcelona, Spain : 1998). (2000) 36 4 pp255-262', '10.1358/dot.2000.36.4.570204', '']\n",
      "['9739309', 'Eulderink F; Meijers K A. Pathology of the cervical spine in rheumatoid arthritis: a controlled study of 44 spines. Journal of pathology. (1976) 120 2 pp91-108', '10.1002/path.1711200205', '']\n",
      "['9739311', 'Hsieh L F; Didenko B; Schumacher H R; Jr; Torg J S. Isokinetic and isometric testing of knee musculature in patients with rheumatoid arthritis with mild knee involvement. Archives of physical medicine and rehabilitation. (1987) 68 5 Pt 1 pp294-297', '10.1016/s0003-9993(96)90298-1', '']\n",
      "['9739312', 'Panayi Gabriel S. B cell-directed therapy in rheumatoid arthritis--clinical experience. Journal of rheumatology. Supplement. (2005) 73  pp19-30', '10.1080/030097401750065382', '']\n",
      "['9739313', 'Paulus H E; Bulpitt K J. Rheumatoid arthritis. Outcome measures. Rheumatic diseases clinics of North America. (1995) 21 3 pp605-618', '10.1016/s0889-857x(21)00459-2', '']\n",
      "['9739314', 'Peliskova Z; Trnavsky K; Vacha J. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis. Zeitschrift fur Rheumatologie. (1987) 46 3 pp124-128', '10.1007/s003930050055', 'http://link.springer.com/article/10.1007/s003930050055/fulltext.html']\n",
      "['9739317', 'Mitchell P D; Reed K D; Aspeslet T L; Vandermause M F; Melski J W. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. Journal of clinical microbiology. (1994) 32 8 pp1958-1962', '10.1128/jcm.32.8.1958-1962.1994', 'https://journals.asm.org/doi/pdf/10.1128/jcm.32.8.1958-1962.1994']\n",
      "['9739318', 'Nakajima Mikio; Ueda Naoki; Ohara Hidetsugu; Abe Muneaki; Kinoshita Mitsuo. A comparative study of the effects of bucillamine and salazosulfapyridine in the treatment of rheumatoid arthritis. Modern rheumatology. (2009) 19 4 pp384-389', '10.3109/s10165-009-0169-x', '']\n",
      "['9739319', 'Strand V; Lee M L. Differential patterns of response in patients with rheumatoid arthritis following administration of an anti-CD 5 immunoconjugate. Clinical and experimental rheumatology. (1993) 11 Suppl 8  ppS161-3', '10.1093/rheumatology/32.suppl_4.39', 'http://academic.oup.com/rheumatology/article-pdf/32/suppl_4/39/5041847/32-suppl_4-39.pdf']\n",
      "['9739320', 'Kaur P; Cohen S; Papp K; Zhang N. ABP 501 (Amjevita) biosimilar to adalimumab: demonstration of value with lower perception of injection site pain. Journal of managed care and specialty pharmacy. (2017) Conference: AMCP Managed Care and Specialty Pharmacy Annual Meeting 2017. United States. 23 3-A SUPPL. ppS85-S86', '10.18553/jmcp.2017.23.3-a.s1', '']\n",
      "['9739321', 'Secher AE; Glintborg B; Gudbergsen H; Krogh NS; Sorensen IJ; Jensen DV; Christensen R; Skougaard M; Pedersen PL; Hetland ML. Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients. Scandinavian journal of rheumatology. (2018)   pp', '10.1080/03009742.2018.1522666', '']\n",
      "['9739322', 'Matucci-Cerinic M; Allanore Y; Kavanaugh A; Buch MH; Schulze-Koops H; Kucharz EJ; Woehling H; Babic G; Poetzl J; Davis A; Schwebig A. Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-To-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study. RMD open. (2018) 4 2 pp', '10.1136/rmdopen-2018-000757', '']\n",
      "['9739323', 'Ogura Michinori; Sancho Juan Manuel; Cho Seok-Goo; Nakazawa Hideyuki; Suzumiya Junji; Tumyan Gayane; Kim Jin Seok; Lennard Anne; Mariz Jose; Ilyin Nikolai; Jurczak Wojciech; Lopez Martinez Aurelio; Samoilova Olga; Zhavrid Edvard; Yanez Ruiz Eduardo; Trneny Marek; Popplewell Leslie; Coiffier Bertrand; Buske Christian; Kim Won-Seog; Lee Sang Joon; Lee Sung Young; Bae Yun Ju; Kwak Larry W. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial. The lancet. Haematology. (2018) 5 11 ppe543-e553', '10.1016/s2352-3026(18)30157-1', '']\n",
      "['9739324', 'Linberg Berit Hagemoen; Mengshoel Anne Marit. Effect of a thin customized insole on pain and walking ability in rheumatoid arthritis: a randomized study. Musculoskeletal care. (2018) 16 1 pp32-38', '10.1002/msc.1199', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmsc.1199']\n",
      "['9739325', 'NCT03574545. Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03574545. (2018)   pp', '10.1186/isrctn48638981', '']\n",
      "['9739327', 'NCT03579823. Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers. Https://clinicaltrials.gov/show/nct03579823. (2018)   pp', '10.17504/protocols.io.b72arqae', '']\n",
      "['9739328', 'NCT03592823. Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence. Https://clinicaltrials.gov/show/nct03592823. (2018)   pp', '10.4022/jafib.1773', '']\n",
      "['9739329', 'NCT03604406. The Immunogenicity and Safety of Zostavax¬Æ in Rheumatoid Arthritis Patients Using Abatacept. Https://clinicaltrials.gov/show/nct03604406. (2018)   pp', '10.3109/14397595.2016.1173986', '']\n",
      "['9739330', 'NCT03605251. Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03605251. (2018)   pp', '10.31525/ct1-nct03881059', '']\n",
      "['9739331', 'NCT03606707. Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients. Https://clinicaltrials.gov/show/nct03606707. (2018)   pp', '10.1007/978-1-4614-8951-1_11', '']\n",
      "['9739333', 'NCT03623867. PsA Secukinumab XCT Structural Progression Study. Https://clinicaltrials.gov/show/nct03623867. (2018)   pp', '10.1177/155989771451012', '']\n",
      "['9739334', 'NCT03632187. Abatacept in earLy Onset Polymyalgia Rheumatica: study ALORS. Https://clinicaltrials.gov/show/nct03632187. (2018)   pp', '10.1093/rheumatology/25.1.82', 'http://academic.oup.com/rheumatology/article-pdf/25/1/82/5040340/25-1-82.pdf']\n",
      "['9739335', \"NCT03639064. Cannabis Oil for Pain in Parkinson's Disease. Https://clinicaltrials.gov/show/nct03639064. (2018)   pp\", '10.1016/b978-0-12-800756-3.00110-1', '']\n",
      "['9739336', 'NCT03649178. Dietary Salt in Rheumatoid Arthritis. https://clinicaltrials.gov/show/NCT03649178. (2018)   pp', '10.26226/m.5beaf069e668b9000b9ad7c8', '']\n",
      "['9739337', 'NCT03679507. The Effect of Low Intensity Ultrasound Therapy on Chronic Pain Due to Osteoarthritis of the Knee. Https://clinicaltrials.gov/show/nct03679507. (2018)   pp', '10.21203/rs.3.rs-3490435/v1', 'https://www.researchsquare.com/article/rs-3490435/v1']\n",
      "['9739338', 'NCT03682705. A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03682705. (2018)   pp', '10.31525/ct1-nct03978520', '']\n",
      "['9739339', 'NCT03684148. Effects of Motor Imagery Intervention on Functional Recovery Following Total Knee Arthroplasty. Https://clinicaltrials.gov/show/nct03684148. (2018)   pp', '10.1302/3114-220914', '']\n",
      "['9739340', 'NCT03685188. Oxycodone and Sufentanil for Analgesia in Hip Surgery. Https://clinicaltrials.gov/show/nct03685188. (2018)   pp', '10.21203/rs.2.11027/v1', 'https://www.researchsquare.com/article/rs-1953/v1']\n",
      "['9739341', 'NCT03690466. Ultrasound Treatment of Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03690466. (2018)   pp', '10.7860/jcdr/2018/34127.11495', '']\n",
      "['9739342', 'NCT03699293. NSAIDs vs. Coxibs in the Presence of Aspirin. Https://clinicaltrials.gov/show/nct03699293. (2018)   pp', '10.1007/978-3-319-33889-7_13', '']\n",
      "['9739344', 'Schwabe Christian; Rosenstock Bernd; Doan Thi; Hamilton Paul; Dunbar P Rod; Eleftheraki Anastasia G; Joseph David; Hilbert James; Schoelch Corinna; Padula Steven J; Steffgen Jurgen. Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: a Potential Novel Treatment for Autoimmune Diseases. Journal of clinical pharmacology. (2018) 58 12 pp1566-1577', '10.1002/jcph.1278', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1278']\n",
      "['9739345', 'Askari R; Hashmi PM; Naeem-ul-Haq S; Zaidi SIH. The effect of drain vs. no drain on straight leg raising in post total knee replacement patients. Journal of the liaquat university of medical and health sciences. (2018) 17 3 pp152-156', '10.22442/jlumhs.181730568', '']\n",
      "['9739346', 'Ringold S; Tomlinson G; Weiss PF; Schanberg LE; Feldman B; Riordan ME; Del Gaizo V; Dennos A; Murphy K; Kimura Y. An interim report of the childhood arthritis and rheumatology research alliance (CARRA) start time optimization of biologic therapy in polyarticular JIA (stop-JIA) study. Pediatric rheumatology. Conference: 25th european paediatric rheumatology congress, pres 2018. Portugal. (2018) 16 Supplement 2) (no pagination pp', '10.1002/art.41888', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41888']\n",
      "['9739347', 'Ringold S; Tomlinson G; Weiss PF; Schanberg LE; Feldman BM; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Kimura Y. The childhood arthritis and rheumatology research alliance start time optimization of biologic therapy in polyarticular JIA study: interim report of baseline patient characteristics and treatment choices. Pediatric rheumatology. Conference: 2018 childhood arthritis and rheumatology research alliance scientific meeting, CARRA 2018. United states. (2018) 16 Supplement 1) (no pagination pp', '10.1002/art.41888', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41888']\n",
      "['9739348', 'Hanson K; Bourret J; Bassel M. Patient feedback and satisfaction with the RAPID3 pilot program. Journal of managed care and specialty pharmacy. (2015) Conference: Academy of Managed Care Pharmacy Nexus 2015. United States. 21 10-a SUPPL. ppS68-S69', '10.18553/jmcp.2014.20.10-a.s1', '']\n",
      "['9739350', 'Tanaka Yoshiya; Sugiyama Naonobu; Toyoizumi Shigeyuki; Lukic Tatjana; Lamba Manisha; Zhang Richard; Chen Connie; Stock Thomas; Valdez Hernan; Mojcik Christopher; Fan Haiyun; Deng Chenhui; Yuasa Hirotoshi. Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study. Rheumatology (Oxford, England). (2019) 58 1 pp70-79', '10.1093/rheumatology/key250', 'http://academic.oup.com/rheumatology/article-pdf/58/1/70/27144804/key250.pdf']\n",
      "['9739351', 'Amini Leila; Kalhor Mehri; Haghighi Anoushe; Seyedfatemi Naiemeh; Hosseini Fatemah. Effect of oral contraceptive pills on rheumatoid arthritis disease activity in women: a randomized clinical trial. Medical journal of the Islamic Republic of Iran. (2018) 32  pp61', '10.14196/mjiri.32.61', 'http://mjiri.iums.ac.ir/article-1-4290-en.pdf']\n",
      "['9739352', 'Van Hamersveld Koen T; Marang-Van De Mheen Perla J; Van Der Heide Huub J L; Van Der Linden-Van Der Zwaag Henrica M J; Valstar Edward R; Nelissen Rob G H H. Migration and clinical outcome of mobile-bearing versus fixed-bearing single-radius total knee arthroplasty. Acta orthopaedica. (2018) 89 2 pp190-196', '10.1080/17453674.2018.1429108', '']\n",
      "['9739353', \"Lopez-Pintor RM; Ramirez L; Serrano J; de Pedro M; Fernandez-Castro M; Casanas E; Hernandez G. Effects of Xerostom products on xerostomia in primary Sjogren's syndrome: a randomized clinical trial. Oral diseases. (2019) 25 3 pp772-780\", '10.1111/odi.13019', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fodi.13019']\n",
      "['9739355', 'Taylor Peter C; Schiff Michael H; Wang Qingmin; Jiang Yusang; Zhuang Yanli; Kurrasch Regina; Daga Shruti; Rao Ravi; Tak Paul P; Hsu Benjamin. Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. Annals of the rheumatic diseases. (2018) 77 5 pp658-666', '10.1136/annrheumdis-2017-212496', '']\n",
      "['9739357', 'Smolen Josef S; Choe Jung-Yoon; Prodanovic Nenad; Niebrzydowski Jaroslaw; Staykov Ivan; Dokoupilova Eva; Baranauskaite Asta; Yatsyshyn Roman; Mekic Mevludin; Porawska Wieslawa; Ciferska Hana; Jedrychowicz-Rosiak Krystyna; Zielinska Agnieszka; Lee Younju; Rho Young Hee. Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study. Annals of the rheumatic diseases. (2018) 77 2 pp234-240', '10.1136/annrheumdis-2017-211741', '']\n",
      "['9739358', \"l'Ami Merel J; Krieckaert Charlotte Lm; Nurmohamed Michael T; van Vollenhoven Ronald F; Rispens Theo; Boers Maarten; Wolbink Gerrit Jan. Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial. Annals of the rheumatic diseases. (2018) 77 4 pp484-487\", '10.1136/annrheumdis-2017-211781', '']\n",
      "['9739360', 'Le√≥n Fern√°ndez OS; Viebahn-Haensler R; Cabreja GL; Espinosa IS; Matos YH; Roche LD; Santos BT; Oru GT; Polo Vega JC. Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. European journal of pharmacology. (2016) 789  pp313-318', '10.1016/j.ejphar.2016.07.031', '']\n",
      "['9739364', 'Jaimes-Hern√°ndez J; Mel√©ndez-Mercado CI; Mendoza-Fuentes A; Aranda-Pereira P; Casta√±eda-Hern√°ndez G. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial. Reumatologia clinica. (2012) 8 5 pp243-249', '10.1016/j.reumae.2012.07.005', '']\n",
      "['9739366', 'Garc√≠a-Morteo O; Maldonado-Cocco JA; Cuttica R; Garay SM. Piroxicam in juvenile rheumatoid arthritis. European journal of rheumatology and inflammation. (1987) 8 1 pp49-53', '10.1007/bf02030759', 'http://link.springer.com/article/10.1007/BF02030759/fulltext.html']\n",
      "['9739367', 'Sonne M. Treatment of rheumatoid arthritis with dapsone. Ugeskrift for laeger. (1983) 145 37 pp2847-2848', '10.1001/jama.1964.03070250126092', '']\n",
      "['9739368', 'NCT03770702. Statins and ARBs on Rheumatoid Activity. Https://clinicaltrials.gov/show/nct03770702. (2018)   pp', '10.1179/175709310x12845438122791', '']\n",
      "['9739369', 'NCT03781375. Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03781375. (2018)   pp', '10.1186/ar-2000-66814', 'http://link.springer.com/article/10.1186/ar-2000-66814/fulltext.html']\n",
      "['9739370', 'NCT03789292. A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03789292. (2018)   pp', '10.31525/ct1-nct03970824', '']\n",
      "['9739371', 'NCT03810144. Impact of Guided Care With the Vectra DA Multi-biomarker Disease Activity (MBDA) Blood Test. Https://clinicaltrials.gov/show/nct03810144. (2019)   pp', '10.1007/s10067-018-4276-y', 'http://link.springer.com/article/10.1007/s10067-018-4276-y/fulltext.html']\n",
      "['9739372', 'NCT03813199. Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03813199. (2019)   pp', '10.31525/ct1-nct04049448', '']\n",
      "['9739373', 'NCT03815448. Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis. Https://clinicaltrials.gov/show/nct03815448. (2019)   pp', '10.1016/j.joca.2018.09.004', '']\n",
      "['9739374', 'NCT03823391. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03823391. (2019)   pp', '10.31525/ct1-nct03922607', '']\n",
      "['9739375', 'Moller-Bisgaard Signe; Horslev-Petersen Kim; Ejbjerg Bo; Hetland Merete Lund; Ornbjerg Lykke Midtboll; Glinatsi Daniel; Moller Jakob; Boesen Mikael; Christensen Robin; Stengaard-Pedersen Kristian; Madsen Ole Rintek; Jensen Bente; Villadsen Jan Alexander; Hauge Ellen-Margrethe; Bennett Philip; Hendricks Oliver; Asmussen Karsten; Kowalski Marcin; Lindegaard Hanne; Nielsen Sabrina Mai; Bliddal Henning; Krogh Niels Steen; Ellingsen Torkell; Nielsen Agnete H; Balding Lone; Jurik Anne Grethe; Thomsen Henrik S; Ostergaard Mikkel. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: the IMAGINE-RA Randomized Clinical Trial. JAMA. (2019) 321 5 pp461-472', '10.1001/jama.2018.21362', '']\n",
      "['9739376', 'Soubrier Martin; Lambert Celine; Combe Bernard; Gaudin Philippe; Thomas Thierry; Sibilia Jean; Dougados Maxime; Dubost Jean-Jacques. A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis. Clinical and experimental rheumatology. (2018) 36 6 pp1056-1060', '10.1002/art.1780350904', '']\n",
      "['9739379', \"Hu Wei; Xu Lei; Xu Chang-Song; Xu Mei-Mei; Guo Liang; Chen Yue-Yue; Xu Da-Ke; Xiang Cheng-Rong. Efficacy and Safety Evaluation of Liujin Runzao Concentrated Decoction in Treating Primary Sj√∂gren's Syndrome. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2017) 37 2 pp179-183\", '10.1111/ddi.70017/v2/response1', '']\n",
      "['9739380', \"Zhu Fu-Bing; Liu Jian; Fang Li; Zhang Ping-Heng; Tan Bing. Efficay Observation of Xinfeng Capsule for Treating 58 Cases of Sjogren's Syndrome. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 11 pp1323-1328\", '10.5353/th_991044122096503414', '']\n",
      "['9739381', 'Sun Yue; Liu Jian; Wan Lei. Effect of Xinfeng Capsule on Improving Pulmonary Function in Rheumatoid Arthritis Patients. Zhongguo zhong xi yi jie he za zhi zhongguo zhongxiyi jiehe zazhi = chinese journal of integrated traditional and western medicine. (2016) 36 7 pp814-820', '10.1016/s0254-6272(15)30150-3', '']\n",
      "['9739382', 'Simon LS; Weaver AL; Graham DY. Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers: commentary. Evidence-based medicine. (2000) 5 3 pp75-', '10.1136/ebm.5.3.75', '']\n",
      "['9739383', 'DiDomenico C; Goodearl A; Yarilina A; Sun V; Mitra S; Schwartz Sterman A; Bonassar L. Antibody charge affects depth-dependent diffusion in healthy articular cartilage. Journal of orthopaedic research. (2017) 35  pp', '10.1115/1.4037202', 'http://asmedigitalcollection.asme.org/biomechanical/article-pdf/doi/10.1115/1.4037202/6095702/bio_139_09_091005.pdf']\n",
      "['9739384', 'Ammitzboll-Danielsen M; Ostergaard M; Fane V; Glinatsi D; Dohn UM; Ornbjerg LM; Naredo E; Terslev L. A randomised, double-blind, controlled study of intramuscular versus ultrasound guided peritendinous betamethasone injection for tenosynovitis in rheumatoid arthritis patients. Annals of the rheumatic diseases. (2016) 75  pp103-', '10.1136/annrheumdis-2016-eular.1707', '']\n",
      "['9739385', 'Bergrath E; Wallenstein G; Gerbert R; Gruben D; Makin C. Tofacitinib versus biologic treatments in moderate to severe rheumatoid arthritis patients who have had an inadequate response to nonbiologic DMARDS: systematic literature review and network meta-analysis. Annals of the rheumatic diseases. (2016) 75  pp726-', '10.1136/annrheumdis-2016-eular.4456', '']\n",
      "['9739387', 'Kavanaugh A; Gladman DD; Edwards CJ; Poder A; Liote F; Bird P; Schett G; Nguyen D; Teng L; Mease PJ. Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: pooled results from 3 phase III, randomized, controlled trials. Annals of the rheumatic diseases. (2016) 75  pp346-', '10.1136/annrheumdis-2016-eular.1487', '']\n",
      "['9739388', 'Burmester GR; Panaccione R; Gordon KB; Rosenbaum J; Arikan D; Lau W; Tarzynski-Potempa R. Long-term safety of adalimumab (HUMIRA) in adult patients from global clinical trials across multiple indications: an updated analysis in 29,987 patients representing 56,951 patientyears. Journal of clinical and aesthetic dermatology. (2018) 11 5 ppS24-', '10.1136/annrheumdis-2018-eular.3158', '']\n",
      "['9739390', 'Rasch L; Van Tuyl L; Kremer M; Bultink I; Boers M; Lems W. Change in bone mineral density with high-dose prednisone in patients with rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp95-', '10.1136/annrheumdis-2016-eular.2735', '']\n",
      "['9739392', 'Galeazzi M; Voll R; Sebastiani G; Bazzichi L; Viapiana O; Dudler J; Sarzi-Puttini P; Selvi E; Iuliano A; Pedretti M; Giovannoni L; Bindi I; Bettini C; Ravenni N; Wilton J; Zufferey P; Ferraccioli G; Caporali R; Specker C; Wollenhaupt J; Neri D. A novel approach for rheumatoid arthritis: results of the ongoing clinical trials with the fully human immunocytokine dekavil (F8-IL10). Annals of the rheumatic diseases. (2016) 75  pp1028-', '10.1136/annrheumdis-2016-eular.4077', '']\n",
      "['9739394', 'Gossec L; Molto A; Foissac F; Fayet F; Mouterde G; Gaudin P; Soubrier M; Dougados M. One third of patients with established rheumatoid arthritis (RA) are correctly vaccinated against influenza and pneumococcus and this is increasing: 3 year longitudinal assessment of 776 patients. Annals of the rheumatic diseases. (2016) 75  pp418-', '10.1136/annrheumdis-2016-eular.2462', '']\n",
      "['9739396', 'Chopra A; Bichile L; Rajadhyaksha A G; Gadgil D; Maroli S; Goregaonkar A B; Dhaon B K. Randomized double-blind clinical drug trials of meloxicam in rheumatoid arthritis and osteoarthritis knees: an Indian experience. APLAR journal of rheumatology. (2004) 7 2 pp108-116', '10.1111/j.1479-8077.2004.00070.x', '']\n",
      "['9739397', 'Leonardi A; Messmer EM; Labetoulle M; Amrane M; Garrigue J-S; Ismail D; Sainz-De-La-Maza M; Figueiredo FC; Baudouin C. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies. British journal of ophthalmology. (2019) 103 1 pp125-131', '10.1136/bjophthalmol-2017-311801', '']\n",
      "['9739398', 'Darlington LG; Ramsey NW. Review of dietary therapy for rheumatoid arthritis. Comprehensive therapy. (1994) 20 9 pp490-494', '10.1093/rheumatology/32.6.507', 'http://academic.oup.com/rheumatology/article-pdf/32/6/507/5030671/32-6-507.pdf']\n",
      "['9739400', 'Roberts LJ. New drugs for rheumatoid arthritis. New England journal of medicine. (2004) 351 25 pp2659-2661; author reply 2659-2661', '10.1056/nejm200412163512522', '']\n",
      "['9739403', 'Andersson KM; Wasen C; Silfversward ST; Leifsdottir L; Erlandsson MC; Heckemann RA; Kalm M; Bokarewa MI. Physical functioning in rheumatoid arthritis is controlled by hippocampus and insulin-like growth factor-1 receptor signalling. Scandinavian journal of rheumatology. (2018) 47  pp28-', '10.1136/annrheumdis-2020-eular.5994', '']\n",
      "['9739404', 'Palsson O; Love TJ; Gunnarsson PS; Gudbjornsson B. First line tumour necrosis factor-Œ±-inhibitor therapy reduces non-steroidal anti-inflammatory drug need in patients with rheumatic diseases. Scandinavian journal of rheumatology. (2018) 47  pp33-', '10.1080/03009742.2024.2352967', '']\n",
      "['9739407', 'Langley RGB; Cohen AD; Foley P; Griffiths CEM; Lebwohl M; Leonardi C; Winthrop K; Proulx J; Rottinghaus ST; Wolk R; Thompson JR; Tatulych S; Mallbris L; Swanson R. Safety of tofacitinib, an oral janus kinase inhibitor: integrated data analysis from the global chronic plaque psoriasis clinical trials. Annals of the rheumatic diseases. (2016) 75  pp253-', '10.1136/annrheumdis-2016-eular.2394', '']\n",
      "['9739409', 'Lee Ching CP; Donath E; Sergeyenko Y; Mai D; Desai T; Shah A; Patel C; Kothadia SM; Morrison RL; Lee C-CJ; Tappy E; Kumar S. Drug retention and reasons for drug discontinuation of anti-TNF therapy in patients with rheumatoid arthritis. A network meta-analysis. Annals of the rheumatic diseases. (2016) 75  pp225-', '10.1136/annrheumdis-2016-eular.2029', '']\n",
      "['9739410', 'Cohen S; Zhang N; Kaur P. Biosimilar candidate ABP 501: additional efficacy analyses from the phase 3 study. Annals of the rheumatic diseases. (2016) 75  pp499-', '10.1136/annrheumdis-2016-eular.3734', '']\n",
      "['9739411', 'Marshall AA; Zaccardelli A; Yu Z; Prado MG; Liu X; Miller Kroouze R; Kalia SS; Green RC; Triedman NA; Lu B; Deane KD; Iversen MD; Karlson EW; Sparks JA. Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: a randomized controlled trial. Patient education and counseling. (2018)   pp', '10.1016/j.pec.2018.12.011', '']\n",
      "['9739413', 'Allison C. Abatacept as add-on therapy for rheumatoid arthritis. Issues in emerging health technologies. (2005)  73 pp1-4', '10.3315/jdcr.2008.1018', '']\n",
      "['9739414', 'Chung SJ; Park HJ; Ko SK; Park MC. Cost-effectiveness of celecoxib, nonselective NSAID and NSAID with proton-pump inhibitor in patients with rheumatoid arthritis in Korea. International journal of rheumatic diseases. (2010) 13  pp108-', '10.1016/s1098-3015(10)66810-6', '']\n",
      "['9739415', \"Lambert B; Carron P; D'Asseler Y; Bacher K; Van den Bosch F; Elewaut D; Verbruggen G; Beyaert R; Dumolyn C; De Vos F. 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study. EJNMMI research. (2016) 6 1 pp\", '10.1186/s13550-016-0245-0', 'http://link.springer.com/article/10.1186/s13550-016-0245-0/fulltext.html']\n",
      "['9739416', 'Rau R. Adalimumab (a fully human anti-tumour necrosis factor Œ± monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Annals of the rheumatic diseases. (2002) 61 SUPPL. 2 ppii70-ii73', '10.1136/ard.61.suppl_2.ii70', '']\n",
      "['9739417', 'Bresnihan B. Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis. Annals of the rheumatic diseases. (2002) 61 Suppl 2 ppii74-ii77', '10.1136/ard.61.suppl_2.ii74', '']\n",
      "['9739418', '. Rituximab mono/combo therapies show promise for severe rheumatoid arthritis. Formulary (Cleveland, Ohio). (2004) 39 2 pp74-75', '10.3726/978-1-4539-0572-2/10', '']\n",
      "['9739419', 'Chan FK; Scheiman JM; Lanas A; Berger M; Li MC; Goldstein JL. Celecoxib versus diclofenac and omeprazole: a randomized controlled trial comparing a composite outcome across the entire GI tract (The condor trial). Gastroenterology. (2010) 138 5 ppS20-', '10.1016/s0016-5085(10)60093-5', '']\n",
      "['9739420', 'Ciciriello S; Osborne RH; Buchbinder R; Wicks IP. Development of a multimedia patient education program about methotrexate treatment for rheumatoid arthritis. Internal medicine journal. (2010) 40  pp9-', '10.1016/j.semarthrit.2013.07.009', '']\n",
      "['9739421', 'Jeurissen MEC. Methotrexate versus azathioprine in rheumatoid arthritis. Pharmacy world and science. (1994) 16 1 pp27-29', '10.1007/bf01870936', 'http://link.springer.com/article/10.1007/BF01870936/fulltext.html']\n",
      "['9739422', 'Breedveld F. Rheumatoid arthritis: clinical picture and therapeutic considerations - Multiple faces of rheumatoid arthritis: diagnostic and therapeutic algorithms. Autoimmunity reviews. (2004) 3 SUPPL. 1 ppS22', '10.1016/j.autrev.2004.08.030', '']\n",
      "['9739423', 'Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis and rheumatism. (2003) 48 7 pp1771-1774', '10.1002/art.11156', '']\n",
      "['9739424', 'Ueland Thor; Kleveland Ola; Michelsen Annika E; Wiseth Rune; Damas Jan Kristian; Holven Kirsten B; Aukrust Pal; Gullestad Lars; Yndestad Arne; Halvorsen Bente. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. International journal of cardiology. (2019) 274  pp348-350', '10.1016/j.ijcard.2018.06.093', '']\n",
      "['9739425', 'Nasonov E L; Popkova T V. Atherosclerosis: perspectives of anti-inflammatory therapy. Terapevticheskii arkhiv. (2018) 90 5 pp4-12', '10.26442/terarkh20189054-12', '']\n",
      "['9739426', \"NCT03869008. Potential benefit for non invasive vagus nerve stimulation using gammacore in the treatment of raynaud's phenomena. . (2019)   pp\", '10.31525/ct1-nct03869008', '']\n",
      "['9739428', \"Heine PJ; Williams MA; Williamson E; Bridle C; Adams J; O'Brien A; Evans D; Lamb SE. Development and delivery of an exercise intervention for rheumatoid arthritis: strengthening and stretching for rheumatoid arthritis of the hand (SARAH) trial. Physiotherapy. (2012) 98 2 pp122-130\", '10.1016/j.physio.2011.03.001', '']\n",
      "['9739430', 'Kivitz A; Hazan L; Hoffman K; Wallin BA. MORAb-022, an anti-granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody (MAB): results of the first study in patients with mild-to-moderate rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2016) 75  pp507-', '10.1136/annrheumdis-2016-eular.3186', '']\n",
      "['9739431', 'Haavardsholm EA; Aga A-B; Olsen IC; Lillegraven S; Hammer HB; Uhlig T; Fremstad H; Madland TM; Lexberg AS; Haukeland H; Rodevand E; Hoili C; Stray H; Bendvold AN; Hansen IJW; Bakland G; Nordberg LB; Heijde DVD; Kvien TK. Ultrasound in the management of rheumatoid arthritis: results from the randomized controlled arctic trial. Annals of the rheumatic diseases. (2016) 75  pp123-', '10.1136/annrheumdis-2016-eular.3042', '']\n",
      "['9739432', 'Visvanathan S; Ramanujam M; Schoelch C; Vinisko R; Mueller-Ladner U; Padula S; Fine JS; Steffgen J. Treatment with BI 655064 (antagonistic anti-CD40 antibody) modulates biomarkers associated with rheumatoid arthritis (RA). Annals of the rheumatic diseases. (2016) 75  pp517-', '10.1136/annrheumdis-2016-eular.2051', '']\n",
      "['9739433', 'Smolen JS; DeLozier AM; De Bono S; Yang L; Gaich C. Work productivity and daily activity in patients with rheumatoid arthritis in four phase III randomized clinical trials of baricitinib. Annals of the rheumatic diseases. (2016) 75  pp416-', '10.1136/annrheumdis-2016-eular.1429', '']\n",
      "['9739435', 'Van Vollenhoven R; Cifaldi M; Ray S; Chen N; Weisman MH. Improvement in workplace and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study. Value in health. (2009) 12 7 ppA485-', '10.1016/s1098-3015(10)75291-8', '']\n",
      "['9739437', 'Sukhdeo A; Joshua F; Damodaran A; Shulruf B. A study on medical students learning ultrasound in rheumatoid arthritis (ASMSLURA). Annals of the rheumatic diseases. (2016) 75  pp113-', '10.1136/annrheumdis-2016-eular.6194', '']\n",
      "['9739438', \"Den Broeder AA; Van Den Bemt BJF. Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'. Annals of the rheumatic diseases. (2017)   pp\", '10.1136/annrheumdis-2017-212579', '']\n",
      "['9739439', 'Khatri Amit; Klunder Ben; Peloso Paul M; Othman Ahmed A. Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis. Rheumatology (Oxford, England). (2019) 58 2 pp352-360', '10.1093/rheumatology/key312', 'http://academic.oup.com/rheumatology/article-pdf/58/2/352/27583915/key312.pdf']\n",
      "['9739440', 'Ziegenfuss TN; Kerksick CM; Kedia AW; Sandrock J; Raub B; Lopez HL. Proprietary Milk Protein Concentrate Reduces Joint Discomfort While Improving Exercise Performance in Non-Osteoarthritic Individuals. Nutrients. (2019) 11 2 pp', '10.3390/nu11020283', '']\n",
      "['9739442', 'Sokka T; Pincus T. Rheumatoid arthritis: strategy more important than agent. Lancet. (2009) 374 9688 pp430-432', '10.1016/s0140-6736(09)61432-x', '']\n",
      "['9739445', 'Reynolds AW; Kocis PT; Liu G; Fox EJ. Comparison of osteoporosis pharmacotherapy fracture rates: analysis of a marketscan¬Æ claims database cohort. Journal of orthopaedic research. (2016) 34  pp', '10.5812/ijem.12104', '']\n",
      "['9739446', 'Khalvat A; Rostamian A; Najafizadeh SR; Movasseghi S. Evaluation of rheumatoid factor using ELISA versus latex method: a cross sectional study. Tehran university medical journal. (2008) 65 11 pp13-17', '10.54615/2231-7805.10.02.11', '']\n",
      "['9739447', 'Draper T; Ormseth SR; Custodio M; Weisman MH; Irwin MR; and Nicassio PM. Identifying subgroups of rheumatoid arthritis patients based on levels of pain, disability, and depression [abstract]. Arthritis and rheumatism [abstracts of the annual scientific meeting of the american college of rheumatology and association of rheumatology health professionals; 2012 nov 9-14; washington, DC united states]. (2012) 64  ppS673-', '10.1037/e546872013-222', '']\n",
      "['9739448', 'Zhao Q; Chen X; Hou Y; Jiang J; Zhong W; Yao X; Wang W; Li L; Fang J; Zhang F; Hu P. Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus. Journal of clinical pharmacology. (2016)   pp', '10.1002/jcph.686', '']\n",
      "['9739449', 'Kolarov Zl. Use of Rituximab (Mabthera) in rheumatology practice. Revmatologiia (Moscow, Russia). (2009) 17 1 pp36-41', '10.14412/1995-4484-2013-1263', '']\n",
      "['9739450', 'Matsuno H; Matsubara T. A randomized double-blind parallel-group phase III study to compare the efficacy and safety of NI-071 and infliximab reference product in Japanese patients with active rheumatoid arthritis refractory to methotrexate. Modern rheumatology. (2018)   pp', '10.1080/14397595.2018.1533063', '']\n",
      "['9739451', \"Jorkjend L; Johansson A; Johansson A-K; Bergenholtz A. Resting and stimulated whole salivary flow rates in Sj√∂gren's syndrome patients over time: a diagnostic aid for subsidized dental care?. Acta odontologica Scandinavica. (2004) 62 5 pp264-268\", '10.1080/00016350410001702', '']\n",
      "['9739452', 'Rabow M; Miller B. Concurrent palliative and oncologic care: symptom management for men with prostate cancer (411-A). Journal of pain and symptom management. (2011) 41 1 pp225-226', '10.1016/j.jpainsymman.2010.10.105', '']\n",
      "['9739453', 'Langevitz P; Livneh A; Bank I; Pras M. Minocycline in rheumatoid arthritis. Israel journal of medical sciences. (1996) 32 5 pp327-330', '10.2165/00002018-200022050-00007', '']\n",
      "['9739454', \"Lee SK; Xing J; Catlett I; Adamczyk R; Griffies A; Liu A; Murthy B; Nowak M. A novel reversibile bruton's tyrosine kinase (BTK) inhibitor (BMS-986142) provides favorable safety, pharmacokinetic, and pharmacodynamic profiles in healthy subjects. Annals of the rheumatic diseases. (2016) 75  pp256-\", '10.1136/annrheumdis-2016-eular.3360', '']\n",
      "['9739455', 'Karpouzas G; Thorne C; Takeuchi T; McQuarrie K; Sheng S; Xu W; Peterson S; Ganguly R; Han C; Fei K; Hsu B. Health-related physical and emotional well-being and fatigue improve significantly with sirukumab treatment: results of a phase 3 study in patients with active rheumatoid arthritis refractory to conventional disease-modifying anti-rheumatic drugs. Annals of the rheumatic diseases. (2016) 75  pp727-', '10.1136/annrheumdis-2016-eular.4229', '']\n",
      "['9739456', 'De Cock D; Stouten V; Van Der Elst K; Joly J; Smulders S; Engelen A; Devarwaere F; Westhovens R; Verschueren P. Translation and validation of the flemish version of the british delay questionnaire to measure help-seeking behaviour in patients with newly onset rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp1242-', '10.1136/annrheumdis-2016-eular.5484', '']\n",
      "['9739457', 'Kavanaugh A; Ponce L; Cseuz R; Reshetko O; Stanislavchuk M; Greenwald M; Van Der Aa A; Vanhoutte F; Tasset C; Harrison P. Filgotinib (GLPG0634), an oral JAK1 selective inhibitor is effective as monotherapy in patients with active rheumatoid arthritis: results from a 24-week phase 2b dose ranging study. Annals of the rheumatic diseases. (2016) 75  pp247-', '10.1136/annrheumdis-2016-eular.3862', '']\n",
      "['9739458', 'Wollenhaupt J; Silverfield J; Lee EB; Terry KK; Kwok K; Lazariciu I; Nduaka C; Connell CA; DeMasi R; Wang L. Tofacitinib, an oral JAK inhibitor, in the treatment of rheumatoid arthritis: safety and clinical and radiographic efficacy in open-label, long-term extension studies over 7 years. Annals of the rheumatic diseases. (2016) 75  pp252-', '10.1136/annrheumdis-2016-eular.1258', '']\n",
      "['9739460', 'Mora Alfonso SA; Fernandez DG; Sastre LF. The effect of an educational intervention based on clinical simulation in rheumatoid arthritis and osteoarthritis diagnosis by general practitioners: a randomized clinical trial. Annals of the rheumatic diseases. (2016) 75  pp661-', '10.1136/annrheumdis-2016-eular.5524', '']\n",
      "['9739461', 'Mary J; Debandt M; Lukas C; Morel J; Combe B. Comparison of the efficacy and tolerance of the ‚Äútriple oral therapy‚Äù versus ‚Äúanti-tnf plus methotrexate‚Äù in rheumatoid arthritis with inadequate response to methotrexate: a systematic literature review. Annals of the rheumatic diseases. (2016) 75  pp231-', '10.1136/annrheumdis-2016-eular.2061', '']\n",
      "['9739462', 'Choe J-Y; Smolen JS; Keystone E; Genovese MC; Choi J; Rho YH. Efficacy and safety analysis by overall anti-drug antibody results up to week 30 in patients with rheumatoid arthritis treated with SB2 (an infliximab biosimilar) or infliximab reference product in phase iii study. Annals of the rheumatic diseases. (2016) 75  pp232-', '10.1136/annrheumdis-2016-eular.3359', '']\n",
      "['9739464', 'Kirwan JR. Early therapy is nothing new in rheumatoid arthritis. Rheumatology. (2000) 39 12 pp1439-', '10.1093/rheumatology/39.12.1439', 'http://academic.oup.com/rheumatology/article-pdf/39/12/1439/18108652/391439.pdf']\n",
      "['9739465', 'Emmrich P; Kruse K. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Monatsschrift fur Kinderheilkunde. (2000) 148 8 pp785-', '10.1186/ar-2000-66814', 'http://link.springer.com/article/10.1186/ar-2000-66814/fulltext.html']\n",
      "['9739466', 'Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG. Performance of the RA disease activity measures and JADAS in polyarticular-course juvenile idiopathic arthritis. Arthritis and rheumatism. (2009) 60  pp236-', '10.1002/acr.20205', '']\n",
      "['9739467', 'Hegazy SK; El-Ghany El-Sayed SE-MA; El-Hefnawy ME-S. A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients. Journal of clinical pharmacology. (2016)   pp', '10.1002/jcph.725', '']\n",
      "['9739468', 'Ma MHY; Dahanayake C; Scott IC; Kingsley GH; Cope AP; Scott DL. Serological status: a predictor of response to intensive therapy in rheumatoid arthritis. Lancet. (2013) 381  ppS67-', '10.1016/s0140-6736(13)60508-5', '']\n",
      "['9739469', '. Oral cytokine inhibitor effective as anti-inflammatory agent in rheumatoid arthritis. Pharmaceutical journal. (2002) 268 7196 pp603-', '10.1021/acs.jmedchem.9b01130.s002', '']\n",
      "['9739470', '. Potential benefits of first human anti-TNF for rheumatoid arthritis. Pharmaceutical journal. (2001) 266 7153 pp844-', '10.1211/pj.2016.20201779', '']\n",
      "['9739472', '. 2nd Mexican-Canadian Congress of Rheumatology. Journal of rheumatology. (2011) 38 6 pp', '10.3899/jrheum.110506', '']\n",
      "['9739473', 'Gossec L; Molto A; Foissac F; Soubrier M; Fayet F; Gaudin P; Dougados M. Is the self-assessment of disease activity (auto-DAS28) by patients a feasible and acceptable measure over the long term in rheumatoid arthritis (RA)? three-year follow-up of a nurse-led program in 771 patients with established ra. Annals of the rheumatic diseases. (2016) 75  pp1250-', '10.1136/annrheumdis-2016-eular.2451', '']\n",
      "['9739474', 'Hetland ML. Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis. Ugeskrift for laeger. (2010) 172 26 pp2003; author reply 2003-2004', '10.1016/b978-032305475-1.50046-x', '']\n",
      "['9739475', 'Schnitzer T J; Fricke Jr J R; Gitton X; Jayawardene S; Sloan V S. Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies. Current medical research and opinion. (2005) 21 1 pp151-161', '10.1185/030079904x20231', '']\n",
      "['9739476', 'Vasanth LC; Paget SA. Early intervention in rheumatoid arthritis. American journal of orthopedics (Belle Mead, N.J.). (2007) 36 7 Suppl pp9-10, 15-17', '10.1007/978-1-908517-22-7_3', 'http://link.springer.com/content/pdf/10.1007/978-1-908517-22-7_3.pdf']\n",
      "['9739478', 'Johnson J; Wang MY. Interlukin-6 Receptor Inhibitor Tocilizumab: a New Treatment Option in Rheumatoid Arthritis?. Neurosurgery. (2008) 63 2 ppN8', '10.1227/01.neu.0000335796.72760.ec', '']\n",
      "['9739479', 'Plummer Z; Almeida C; Ambler N; Blair P; Choy E; Dures E; Hammond A; Hollingworth W; Kirwan J; Pollock J; Rooke C; Thorn J; Tomkinson K; Hewlett S. Cognitive therapy for reducing the impact of rheumatoid arthritis fatigue: sucessful strategies for meeting targets in a complex health care intervention. Annals of the rheumatic diseases. (2016) 75  pp1318-', '10.1136/annrheumdis-2016-eular.1968', '']\n",
      "['9739480', 'Caporali R; Bellometti S; Rossi S; Bogliolo L; Klersy C; Montecucco C. Safety of mud-bath applications in moderately active rheumatoid arthritis. Journal of musculoskeletal pain. (2010) 18 1 pp81-87', '10.3109/10582450903495866', '']\n",
      "['9739481', '. Use of hydroxychloroquine in rheumatoid arthritis. American family physician. (1995) 52 1 pp274+276', '10.1016/s0002-9343(99)80399-4', '']\n",
      "['9739482', 'Thorn J; Hollingworth W; Ambler N; Dures E; Kirwan J; Plummer Z; Pollock J; Hewlett S. COST-EFFECTIVENESS OF REDUCING ARTHRITIS FATIGUE BY CLINICAL TEAMS (RAFT) USING COGNITIVE‚ÄìBEHAVIOURAL APPROACHES: a RANDOMISED CONTROLLED TRIAL. Value in health. (2018) 21 Supplement 3 ppS298', '10.1016/j.jval.2018.09.1776', '']\n",
      "['9739483', 'Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Sharma S; Singh S. Randomized controlled trial comparing starting dose of 7.5 mg and 15 mg per week of methotrexate in rheumatoid arthritis. Internal medicine journal. (2013) 43  pp9-', '10.1136/annrheumdis-2013-eular.785', '']\n",
      "['9739484', 'Smolen JS; Choe J-Y; Prodanovic N; Niebrzydowski J; Staykov I; Dokoupilova E; Baranauskaite A; Yatsyshyn R; Mekic M; Porawska W; Ciferska H; Jedrychowicz-Rosiak K; Zielinska A; Choi J; Rho YH. Comparable safety and immunogenicity and sustained efficacy after transition to SB2 (an infliximab biosimilar) vs ongoing infliximab reference product in patients with rheumatoid arthritis: results of phase III transition study. Annals of the rheumatic diseases. (2016) 75  pp488-', '10.1136/annrheumdis-2016-eular.3122', '']\n",
      "['9739485', 'Weinblatt M; McInnes I; Kremer J; Miranda P; Vencovsky J; Godwood A; Albulescu M; Close D; Burmester G. Earth explorer 2, a phase IIB exploratory study evaluating efficacy and safety of mavrilimumab, a fully human granulocyte-macrophage colony-stimulating factor receptor-alpha monoclonal antibody, and the tumor necrosis factor antagonist golimumab in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp717-718', '10.1136/annrheumdis-2016-eular.3453', '']\n",
      "['9739487', 'Choy E; Marshall D; Gabriel Z; Mitchell S; Gylee E; Dakin HA. A systematic review and mixed treatment comparison (MTC) of the efficacy of pharmacological treatments for fibromyalgia. Value in health. (2009) 12 7 ppA434-', '10.1016/s1098-3015(10)75145-7', '']\n",
      "['9739489', 'Kavanaugh A; Gladman DD; Edwards CJ; Poder A; Liote F; Bird P; Nguyen D; Teng L; Mease PJ. Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: pooled results from 3 phase III, randomized, controlled trials. Journal of the American Academy of Dermatology. (2017) 76 6 ppAB47', '10.1136/annrheumdis-2016-eular.1487', '']\n",
      "['9739491', 'Salomon S; Guignant C; Brault C; Flahaut G; Gubler B; Fardellone P; Marolleau J; Goeb V. Evolution of regulatory B cells under treatment by biologics in rheumatoid arthritis. Annals of the rheumatic diseases. (2016) 75  pp905-', '10.1136/annrheumdis-2016-eular.3118', '']\n",
      "['9739492', '. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator. Drugs in r and d. (2008) 9 3 pp197-202', '10.2165/00126839-200809030-00008', '']\n",
      "['9739493', 'Ding C; Xu S; Li C. A randomized, controlled clinical trial of nimesulide in the treatment of 171 cases of rheumatoid anthritis. Chinese pharmaceutical journal. (1998) 33 12 pp752-755', '10.1016/s0254-6272(13)60142-9', '']\n",
      "['9739495', 'Schanberg LE. Clinical research in pediatric SLE: the APPLE experience. Lupus. (2010) 19  pp23-', '10.1177/0961203310373937', 'https://journals.sagepub.com/doi/pdf/10.1177/0961203310373937']\n",
      "['9739496', 'Farahani P; Levine M; Goeree R. A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics. Journal of evaluation in clinical practice. (2006) 12 4 pp463-470', '10.1111/j.1365-2753.2006.00731.x', '']\n",
      "['9739497', 'Manheim LM; Dunlop DD; Chang RW. Utility differences in RA and knee OA patients. Arthritis and rheumatism. (2009) 60  pp1383-', '10.1002/1529-0131(200101)44:1<212::aid-anr28>3.0.co;2-q', '']\n",
      "['9739498', 'Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC. Lefunomide in combination therapy. Journal of rheumatology. Supplement. (2004) 71  pp25-30', '10.1093/rheumatology/keg072', 'http://academic.oup.com/rheumatology/article-pdf/42/2/244/18095765/420244.pdf']\n",
      "['9739499', 'Saito K; Tanaka Y. Recent topics on new biological agents for treatment of rheumatoid arthritis. Nihon Naika Gakkai zasshi [The Journal of the Japanese Society of Internal Medicine]. (2008) 97 10 pp2418-2423', '10.2169/naika.97.2418', '']\n",
      "['9739501', 'Finckh A; Iversen M; Liang MH. The exercise prescription in rheumatoid arthritis: primum non nocere. Arthritis and rheumatism. (2003) 48 9 pp2393-2395', '10.1002/art.11217', '']\n",
      "['9739502', '. Etanercept for psoriatic rheumatoid arthritis?. Pharmaceutical journal. (2000) 265 7108 pp188-', '10.2165/00063030-200317020-00006', '']\n",
      "['9739503', '. ‚ñºEtanercept and ‚ñºinfliximab for rheumatoid arthritis. Drug and therapeutics bulletin. (2001) 39 7 pp49-51', '10.1136/dtb.2001.39749', '']\n",
      "['9739505', 'Chow V; Kaliyaperumal A; Miller J; Mytych D; Starcevic Manning M; Wala I; Wang H; Zhang N; Krishnan E. Development of anti-drug antibodies among those treated with adalimumab and ABP 501 and its impact on serum drug concentration in randomised. United european gastroenterology journal. (2018) 6 8 Supplement ppA451', '10.1093/ecco-jcc/jjx180.531', 'http://academic.oup.com/ecco-jcc/article-pdf/12/supplement_1/S309/23744382/jjx180.531.pdf']\n",
      "['9739506', 'Zuidema RM; Van Dulmen S; Nijhuis-van der Sanden MWG; Fransen J; Van Gaal BGI. qLessons learned from patients with access to an online self-management enhancing program for RA patients: qualitative analysis of interviews alongside a randomized clinical trial. Patient education and counseling. (2019)   pp', '10.1016/j.pec.2019.01.005', '']\n",
      "['9739510', 'Brilman EG; Van Der Pol JA; De Jong PHP; Weel AEAM; Hazes JMW; Huizinga TWJ; Allaart CF. Corticosteroid bridging strategies with methotrexate monotherapy in early rheumatoid and undifferentiated arthritis; a comparison of efficacy and toxicity in 2 clinical trials. Arthritis and rheumatology. (2018) 70  pp590-591', '10.1136/annrheumdis-2018-eular.1912', '']\n",
      "['9739511', 'Kume K; Amano K; Yamada S; Kanazawa T; Hatta K. Combination of intra-articular steroid injection and tofacitinib more effective than tofacitinib in rapid radiographic progression patients with rheumatoid arthritis. Arthritis and rheumatology. (2018) 70  pp647-', '10.1136/annrheumdis-2013-eular.739', '']\n",
      "['9739513', 'Almeida GJ; Khoja SS; Piva SR. Dose-response relationship between neuromuscular electrical stimulation and muscle function in patients with rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp443-444', '10.1093/ptj/pzz079', 'http://academic.oup.com/ptj/advance-article-pdf/doi/10.1093/ptj/pzz079/28815196/pzz079.pdf']\n",
      "['9739514', 'Alivernini S; Tolusso B; Elmesmari A; Bui L; Peluso G; Gigante MR; Finlay S; Petricca L; Di Mario C; Perniola S; Fedele AL; Federico F; McInnes IB; Ferraccioli G; Kurowska-Stolarska M; Gremese E. Histological features and tissue-macrophage phenotype of synovial biopsies identify ra patients in sustained remission at risk of disease flare after treatment tapering or discontinuation. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2159-', '10.1136/annrheumdis-2022-eular.4018', '']\n",
      "['9739515', \"Tambiah J; Kennedy S; Ghandehari H; Swearingen C; Hochberg MC. Treatment of knee osteoarthritis with SM04690 improved WOMAC a1 'pain on walking'-results from a 52-week, randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, WNT pathway inhibitor. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1492-1493\", '10.1136/annrheumdis-2018-eular.5547', '']\n",
      "['9739516', \"Rezaieyazdi Z; Farooqi A; Soleymani-Salehabadi H; Ahmadzadeh A; Aslani M; Omidian S; Sadoughi A; Vahidi Z; Khodashahi M; Zamurrad S; Mortazavi-Jahromi SS; Fallahzadeh H; Hosseini M; Aghazadeh Z; Ekhtiari P; Matsuo H; Rehm BHA; Cuzzocrea S; D'Aniello A; Mirshafiey A. International multicenter randomized, placebo-controlled phase III clinical trial of Œ≤-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology. (2019)   pp\", '10.1007/s10787-018-00557-2', 'http://link.springer.com/article/10.1007/s10787-018-00557-2/fulltext.html']\n",
      "['9739517', 'Miyamoto Samira Tatiyama; Valim Valeria; Carletti Luciana; Ng Wan-Fai; Perez Anselmo Jose; Lendrem Dennis William; Trennel Michael; Giovelli Raquel Altoe; Dias Laiza Hombre; Serrano Erica Vieira; Subtil Alice Mendonca; Abreu Vanessa Candido; Natour Jamil. Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sj√∂gren‚Äôs syndrome: a randomized-controlled trial. Rheumatology international. (2019) 39 2 pp227-238', '10.1007/s00296-018-4213-z', 'http://link.springer.com/article/10.1007/s00296-018-4213-z/fulltext.html']\n",
      "['9739518', 'Dawson JK; Roychowdhury B; Tunn EJ. Cyclosporin can be used in early rheumatoid arthritis. British medical journal. (1997) 314 7097 pp1828-', '10.1136/bmj.314.7097.1828a', '']\n",
      "['9739519', 'Pope JE; Rampakakis E; Vaillancourt J; Grant E; Bessette L; Lazovskis J; Haraoui B; Sampalis JS. Dmard withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs: results from a canadian randomized study. Arthritis and rheumatology. (2018) 70 Supplement 9 pp677-678', '10.1093/rheumatology/kez470', 'http://academic.oup.com/rheumatology/article-pdf/59/7/1522/33420397/kez470.pdf']\n",
      "['9739520', 'Soriano ER; Madariaga H; Castaneda O; Citera G; Schneeberger EE; Cardiel MH; Hendrikx T; Graham D; Shi H; De Leon DP. Liver enzyme abnormalities after tofacitinib treatment in patients with hepatic steatosis from the rheumatoid arthritis, psoriatic arthritis, and psoriasis clinical programs. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2707-2709', '10.1136/annrheumdis-2018-eular.2517', '']\n",
      "['9739521', 'McLeod C; Olayemi G; Bhatia N; Migliore F; Quinet R. The impact of metformin on disease activity in systemic lupus erythematosus. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2969-2970', '10.1002/art.40571', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40571']\n",
      "['9739523', 'Moller-Bisgaard S; Horslev-Petersen K; Ejbjerg BJ; Glinatsi D; Hetland ML; ornbjerg L; Moller JM; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge E-M; Bennett P; Hendricks O; Asmussen K; Kowalski MR; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen A; Balding L; Jurik AG; Thomsen HS; Ostergaard M. An MRI guided treat-to-target strategy in rheumatoid arthritis patients in clinical remission improved MRI inflammation but not damage progression-results from the imagine-RA randomized controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp960-961', '10.1136/annrheumdis-2018-eular.3074', '']\n",
      "['9739524', 'Lahiri M; Cheung PPM; Dhanasekaran P; Wong SR; Yap A; Tan D; Santosa A; Phan PHC. Does care by a multidisciplinary team improve outcomes in rheumatoid arthritis? a randomized controlled study. Arthritis and rheumatology. (2018) 70 Supplement 9 pp310-311', '10.1007/s11136-021-03029-3', 'https://link.springer.com/article/10.1007/s11136-021-03029-3/fulltext.html']\n",
      "['9739525', \"Hickey G; Hunt C; Keebler M; Carpenter DM; Solow EB; Reyna V; Nowell WB; Edmonds C; O'Neill K; Blalock SJ. Enhancing patient ability to process and use information about medication risks and benefits. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1697-1698\", '10.1002/acr.24421', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.24421']\n",
      "['9739526', 'Kirchgesner T; Vande Berg B; Sokolova T; De Bellefon LM; Toukap AN; Stoenoiu M; Durez P. Evaluation of MRI ramris score and clinical response in patients with ACPA positive undifferentiated arthritis treated with infliximab versus placebo. Arthritis and rheumatology. (2018) 70  pp642-', '10.1136/annrheumdis-2018-eular.3504', '']\n",
      "['9739527', 'Singh JA. Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?. Annals of the rheumatic diseases. (2019) 78 2 pp153-154', '10.1136/annrheumdis-2018-213694', '']\n",
      "['9739528', 'Fenton SAM; Veldhuijzen Van Zanten JJCS; Metsios GS; Rouse PC; Ntoumanis N; Yu C-A; Kitas GD; Duda JL. A self-determination theory based intervention to promote autonomous motivation for, and engagement in physical activity in rheumatoid arthritis: theoretical process evaluation of a randomised controlled trial. Arthritis and rheumatology. (2018) 70 Supplement 9 pp686-688', '10.1136/annrheumdis-2015-eular.4764', '']\n",
      "['9739529', 'Murthy MNK; Gundagani S; Nutalapati C; Pingali U. Evaluation of analgesic activity of standardised aqueous extract of withania somnifera in healthy human volunteers using mechanical pain model. Journal of clinical and diagnostic research. (2019) 13 1 ppFC01-FC04', '10.7860/jcdr/2019/37590.12441', '']\n",
      "['9739531', 'Colmegna I; Useche M; Rodriguez K; Hudson M; Bernatsky S; Nedjar H; Rahme E; Ward B. Efficacy of high-dose versus standard-dose influenza vaccine in seropositive rheumatoid arthritis patients. Arthritis and rheumatology. (2018) 70 Supplement 9 pp927-928', '10.1016/s2665-9913(19)30094-3', '']\n",
      "['9739532', 'Rigby WFC; Burmester GR; Fitz-Gerald O; Azevedo VF; Nash P; Hendrikx T; Graham D; Wang C; Jones T. Changes in key laboratory values with tofacitinib 5mg bid treatment in patients with psoriatic arthritis and rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp753-755', '10.1136/annrheumdis-2019-eular.1290', '']\n",
      "['9739533', '. Efficacy of etanercept in the treatment of children with polyarticular juvenile rheumatoid arthritis. European journal of pediatrics. (2000) 159 10 pp785-', '10.1186/ar-2000-66814', 'http://link.springer.com/article/10.1186/ar-2000-66814/fulltext.html']\n",
      "['9739535', 'Van Felius L; Voskuyl A. Treatment of rheumatoid arthritis by the root Tripterygium wilfordii Hook F (TwHF) seems better than sulfasalazine. Nederlands tijdschrift voor geneeskunde. (2009) 153 48 pp2362-', '10.3410/f.1164904.626764', '']\n",
      "['9739536', 'Heinzl S. Tocilizumab: first interleukin-6 receptor blocker for the therapy of rheumatoid arthritis. Arzneimitteltherapie. (2009) 27 5 pp185-187', '10.4137/cmt.s2048', 'https://journals.sagepub.com/doi/pdf/10.4137/CMT.S2048']\n",
      "['9739538', 'Yarwood A; Viatte S; Okada Y; Plenge R; Barton A; Symmons DP; Worthington J; Eyre S. Loci associated with n-glycosylation of human immunoglobulin G are not associated with rheumatoid arthritis susceptibility, treatment response or outcome: a Mendelian randomization study. Rheumatology (united kingdom). (2015) 54 Supplement 1 ppi150', '10.1136/annrheumdis-2014-207210', '']\n",
      "['9739539', 'Dincses E; Guzelant G; Hatemi G; Yazici H. Acknowledged biostatistical help and the quality of statistical analyses in randomized controlled trials in rheumatology. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1274', '10.1136/annrheumdis-2018-eular.6561', '']\n",
      "['9739540', \"Giacovelli G; Barbetta B; Vitalini C; Brambilla N; D'Amato M; Girolami F; Rovati LC. Comparison of clinical features of seronegative and seropositive early rheumatoid arthritis: blinded data from the ongoing phase IIb trial with the EP4 receptor antagonist CR6086 in DMARD-na√Øve patients. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1634\", '10.1136/annrheumdis-2020-eular.5636', '']\n",
      "['9739541', 'Fraenkel L; Nowell WB; Wiedmeyer C; Wei Z; Michaud K; Neogi T; Ramsey C; Broniatowski D. Development of a rheumatoid arthritis global outcome measure to enable comparisons of patient experiences across treatment arms in randomized clinical trials. Arthritis and rheumatology. (2018) 70 Supplement 9 pp3279-3281', '10.1371/journal.pone.0245598', '']\n",
      "['9739542', 'Cohen S; Samad A; Karis E; Stolshek BS; Trivedi M; Zhang H; Aras GA; Kricorian G; Chung J. Decreased injection site pain associated with new etanercept formulation in patients with rheumatoid arthritis or psoriatic arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1525-1526', '10.1007/s40744-019-0152-8', 'https://link.springer.com/article/10.1007/s40744-019-0152-8/fulltext.html']\n",
      "['9739543', \"Vitalini C; Barbetta B; Giacovelli G; Brambilla N; D'Amato M; Girolami F; Rovati LC. ACR hybrid analysis: blinded data from the ongoing phase IIb trial with the EP4 receptor antagonist CR6086 in DMARD-na√Øve patients with early rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp638-639\", '10.1136/annrheumdis-2020-eular.5636', '']\n",
      "['9739544', \"Vitalini C; Barbetta B; Giacovelli G; Brambilla N; D'Amato M; Girolami F; Rovati LC. DAS28-CRP versus DAS28-ESR and thresholds for disease activity category: blinded data from the ongoing phase IIb trial with the EP4 receptor antagonist CR6086 in DMARD-na√Øve patients with early rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp639-640\", '10.1093/rheumatology/kew121.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i61/5076109/kew121.005.pdf']\n",
      "['9739545', 'Best JH; Pei J. Comparative cost per response for four clinical outcomes of tocilizumab monotherapy versus adalimumab monotherapy in a head-to-head randomized double-blind superiority trial in patients with rheumatoid arthritis. Arthritis and rheumatology. (2018) 70 Supplement 9 pp1291', '10.1016/j.jval.2018.04.1323', '']\n",
      "['9739548', 'Forman M; Leatherwood C; Xu C; Ko E; Lu B; Iversen MD; Solomon D; Desai S. Implementation of a treat-to-target quality improvement program for rheumatoid arthritis management using real-time patient reported outcome measures. Arthritis and rheumatology. (2018) 70 Supplement 9 pp343-344', '10.1002/acr.24114', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24114']\n",
      "['9739549', 'Gupta A; Zecchin C; Fisheleva E; Layton M; Zamuner S. Exposure-efficacy analysis in DMARD inadequate response rheumatoid arthritis patients treated with GSK3196165 along with methotrexate. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2799-', '10.31525/ct1-nct03980483', '']\n",
      "['9739551', 'Fleischmann R; Furst DE; Brasington R; Connolly-Strong E; Liu J; Barton ME. A multicenter study assessing the efficacy and safety of repository corticotropin injection in patients with rheumatoid arthritis: preliminary interim data from the open-label treatment period. Arthritis and rheumatology. (2018) 70 Supplement 9 pp2811-', '10.1136/annrheumdis-2018-eular.5768', '']\n",
      "['9739554', 'NCT03736161. Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis. Https://clinicaltrials.gov/show/nct03736161. (2018)   pp', '10.3410/f.740807180.793588644', '']\n",
      "['9739555', 'NCT03737708. A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA). Https://clinicaltrials.gov/show/nct03737708. (2018)   pp', '10.1093/rheumatology/key075.311', 'http://academic.oup.com/rheumatology/article-pdf/57/suppl_3/key075.311/24768095/key075.311.pdf']\n",
      "['9739557', 'Tukmachi ES. Acupuncture for rheumatoid arthritis. Acupuncture in medicine. (2000) 18 1 pp70-72', '10.1136/aim.18.1.70-b', 'https://journals.sagepub.com/doi/pdf/10.1136/aim.18.1.70-b']\n",
      "['9739558', 'NCT03771989. Treatment of Osteoarthritis With Autologous, Microfragmented Adipose Tissue. Https://clinicaltrials.gov/show/nct03771989. (2018)   pp', '10.1007/978-3-030-73299-8_43', '']\n",
      "['9739559', 'NCT03772717. Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Https://clinicaltrials.gov/show/nct03772717. (2018)   pp', '10.53347/rid-75221', '']\n",
      "['9739560', 'NCT03773471. A Multi-Center Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making. Https://clinicaltrials.gov/show/nct03773471. (2018)   pp', '10.1016/s0016-5085(18)32792-6', '']\n",
      "['9739562', 'NCT03798028. The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03798028. (2019)   pp', '10.1021/acsami.4c09080.s001', '']\n",
      "['9739563', 'NCT03802448. Myofascial Release on Electrophysiological Measures of Pregnant Women With CTS. Https://clinicaltrials.gov/show/nct03802448. (2019)   pp', '10.5114/pq.2019.83057', 'https://physioquart.awf.wroc.pl/pdf-103465-103582']\n",
      "['9739564', \"NCT03817424. A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis. Https://clinicaltrials.gov/show/nct03817424. (2019)   pp\", '10.22541/au.172311540.08854141/v1', '']\n",
      "['9739565', 'NCT03827148. Impact of Pharmacist Intervention on Disease Knowledge, Rehabilitation and Medication Adherence, Treatment Induced Direct Cost, Health-related Quality of Life and Satisfaction in Patients With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03827148. (2019)   pp', '10.1186/s13063-019-3540-z', 'http://link.springer.com/article/10.1186/s13063-019-3540-z/fulltext.html']\n",
      "['9739566', 'NCT03836820. Effects of Clinical Pilates Exercises in Patients With Rheumatoid Arthritis. Https://clinicaltrials.gov/show/nct03836820. (2019)   pp', '10.31525/ct1-nct03836820', '']\n",
      "['9739567', \"Liu Xia; Li Xiaomei; Li Xiangpei; Li Zhijun; Zhao Dongbao; Liu Shengyun; Zhang Miaojia; Zhang Fengxiao; Zhu Ping; Chen Jinwei; Wei Wei; Lin Bing; Zhou Yingbo; Chen Jing; Pang Yafei; Zhang Lei; Sun Xiaoxuan; Yu Zhibo; Jia Yun; Wang Jia; Sun Wenwen; Chiu Frank; Pang Liping; Wang Guochun. The efficacy and safety of total glucosides of peony in the treatment of primary Sjogren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial. Clinical rheumatology. (2019) 38 3 pp657-664\", '10.1007/s10067-018-4315-8', 'http://link.springer.com/article/10.1007/s10067-018-4315-8/fulltext.html']\n",
      "['9739568', \"Mariette X; Seror R; Quartuccio L; Baron G; Salvin S; Fabris M; Desmoulins F; Nocturne G; Ravaud P; Vita SD. Efficacy and safety of belimumab in primary Sj√∂gren's syndrome: results of the BELISS open-label phase II study. Annals of the rheumatic diseases. (2013)   pp\", '10.1136/annrheumdis-2013-203991', '']\n",
      "['9739571', 'EUCTR2009-011593-15-NL. A 24 week randomized double-blind, placebo controlled withdrawal trial with a 16 week open label lead-in phase, and 64 week open label follow-up, to evaluate the efficacy and safety of tocilizumab in patients with active polyarticular-course juvenile idiopathic arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011593-15-NL. (2009)   pp', '10.1111/dom.14642/v1/review5', '']\n",
      "['9739572', 'UMIN000011032. The effects of physical/occupational therapy after operations of the upper extremities on RA patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011032. (2013)   pp', '10.1186/isrctn36516369', '']\n",
      "['9739573', 'UMIN000011181. Continuous epidural infusion versus periarticular multimodal drug injection in bilateral simultaneous total knee arthroplasty: a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011181. (2013)   pp', '10.58837/chula.the.2023.579', '']\n",
      "['9739575', 'IRCT201302174251N9. Comparing the effect of corticosteroid injections and platelet rich plasma on the treatment of shoulder tendinopathy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201302174251N9. (2013)   pp', '10.1186/isrctn16755281', '']\n",
      "['9739577', 'ACTRN12615000891527. A First in Human study assessing the safety, tolerability and pharmacokinetics (blood levels) of gerilimzumab against placebo. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12615000891527. (2015)   pp', '10.1186/isrctn38693215', '']\n",
      "['9739578', 'UMIN000004646. Comparison Between Resection and Arthrodesis of the First MTP Joint for Rheumatoid Forefoot. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004646. (2010)   pp', '10.1007/s10165-008-0086-4', '']\n",
      "['9739579', 'EUCTR2010-018696-21-FR. Etude de l‚Äô√©volution de la r√©ponse immunitaire Th17 chez des patients atteints de polyarthrite rhumato√Øde et trait√©s par tocilizumab apr√®s √©chec des autres th√©rapies - TOCI 17. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-018696-21-FR. (2010)   pp', '10.1051/kmae:1998049', '']\n",
      "['9739580', 'EUCTR2004-003771-37-HU. A double-blind, randomized, placebo controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with active rheumatoid arthritis who have previously failed one or more disease modifying anti-rheumatic drugs. - HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003771-37-HU. (2005)   pp', '10.2165/00128413-200515060-00023', '']\n",
      "['9739581', 'EUCTR2014-003307-30-SK. Multiple dose study of UCB4940 as add-on to Certolizumab Pegol in subjects with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-003307-30-SK. (2015)   pp', '10.2399/raed.15.s1s1', '']\n",
      "['9739584', 'CTRI/2016/08/007152. Bio equivalent study of Methotrexate tablet 2.5 mg of Eugia Pharma specialites Limited, India with Methotrexate tablets 2.5 mg of Dava Pharmaceuticals Inc, USA in adult patients with mild to severe Psoriasis or Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/08/007152. (2016)   pp', '10.31525/cmr-d7cc27', '']\n",
      "['9739585', 'ACTRN12609000961246. Magnetic Resonance Imaging (MRI) assessment of the short external rotators post total hip replacement ‚Äì a randomized trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12609000961246. (2009)   pp', '10.1302/3114-220795', '']\n",
      "['9739586', 'EUCTR2016-001064-11-ES. Efficacy and safety study of Remicade¬¨√Ü (infliximab) and NI-071 (a proposed infliximab biosimilar) for the treatment of patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-001064-11-ES. (2017)   pp', '10.1093/rheumatology/kex062.055', 'http://academic.oup.com/rheumatology/article-pdf/56/suppl_2/kex062.055/19705537/kex062.055.pdf']\n",
      "['9739587', 'IRCT2015092024103N1. The effect of probiotics on oesteopenia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015092024103N1. (2016)   pp', '10.1186/isrctn16359093', '']\n",
      "['9739588', 'CTRI/2015/09/006187. Comparison of between two steroid injections given in swollen knee joints. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/09/006187. (2015)   pp', '10.18810/clinical-trial-registry-india', '']\n",
      "['9739589', 'ISRCTN43167547. Role of myofascial trigger points in fibromyalgia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN43167547. (2011)   pp', '10.1186/isrctn43167547', '']\n",
      "['9739590', 'Norton H; Sibbitt WL; Bankhurst A; Delea S; Chavez-Chiang N; Band P. A randomized controlled trial of cost-effectiveness of ultrasound-guided intraarticular injection of inflammatory arthritis. Journal of investigative medicine. (2011) 59 1 pp188-', '10.3899/jrheum.100866', '']\n",
      "['9739592', \"UMIN000004237. Efficacy and safety of mizoribine for  patients with Sjogren's syndrome in pediatric age. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004237. (2010)   pp\", '10.1186/isrctn34571027', '']\n",
      "['9739593', 'EUCTR2012-003057-29-SK. A multi-centre, randomised, double-blind multiple dose study of increasing doses of XmAb5871 in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003057-29-SK. (2012)   pp', '10.1186/isrctn76859006', '']\n",
      "['9739594', 'IRCT2015041921847N1. Effectiveness of  group exercise therapy  with the  instructional pack in improvement of patients with low back pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015041921847N1. (2015)   pp', '10.1186/isrctn31946666', '']\n",
      "['9739595', 'UMIN000004413. The effects of modified surgical instrument on bone remodeling and bone mass after artificial toe implants. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000004413. (2010)   pp', '10.1016/j.bone.2012.02.501', '']\n",
      "['9739598', 'EUCTR2010-020839-39-GB. Efficacy and safety of CDP6038 in patients with rheumatoid arthritis with an unsuccessful response to anti-TNF therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020839-39-GB. (2010)   pp', '10.5772/intechopen.76684', '']\n",
      "['9739600', 'UMIN000010902. A randomized controlled trial comparing epidural anesthesia and periarticular multimodal drug injection for total knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010902. (2013)   pp', '10.58837/chula.the.2023.579', '']\n",
      "['9739601', 'UMIN000010710. Effective treatment of rebamipide on xerostomia in Sjogrens  syndrome patients: a pilot study -a double-blind placebo-controlled trial-. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010710. (2013)   pp', '10.1186/isrctn23032339', '']\n",
      "['9739602', 'EUCTR2004-000074-31-BE. A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of L-000124467 in Rheumatoid Arthritis Patients - Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000074-31-BE. (2004)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739604', 'Dischereit G; Goronzy J-E; Muller-Ladner U; Fetaj S; Lange U. Effects of serial mud baths on inflammatory rheumatic and degenerative diseases. Zeitschrift fur Rheumatologie. (2019)   pp', '10.1007/s00393-018-0582-7', 'http://link.springer.com/article/10.1007/s00393-018-0582-7/fulltext.html']\n",
      "['9739605', 'Suh Chang-Hee; Yoo Dae Hyun; Berrocal Kasay Alfredo; Chalouhi El-Khouri Elia; Cons Molina Francisco Fidenci; Shesternya Pavel; Miranda Pedro; Medina-Rodriguez Francisco G; Wiland Piotr; Jeka Slawomir; Chavez-Corrales Jose; Linde Thomas; Hrycaj Pawel; Abello-Banfi Mauricio; Hospodarskyy Ihor; Jaworski Janusz; Piotrowski Mariusz; Brzosko Marek; Krogulec Marek; Shevchuk Sergii; Calvo Armando; Andersone Daina; Park Won; Shim Seung Cheol; Lee Sang Joon; Lee Sung Young. Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial. BioDrugs. (2019) 33 1 pp79-91', '10.1007/s40259-018-00331-4', 'http://link.springer.com/article/10.1007/s40259-018-00331-4/fulltext.html']\n",
      "['9739606', 'Cao W-Z; Zhao W-X; Guo H-M; Zhang X-M; Zhang M-F; Zhang X-L; Wei L-N. Rheumatoid arthritis treated with the triple strong-stimulation technique of acupuncture and moxibustion at specific acupoints: a randomized controlled trial. World journal of acupuncture - moxibustion. (2018) 28 4 pp251-256', '10.1016/j.wjam.2019.01.003', '']\n",
      "['9739607', 'Peng Kun; Wang Yehong; Siradze Ketevan; Erickson Rich; Fischer Saloumeh K; Staton Tracy L. Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352A. AAPS journal. (2019) 21 1 pp9', '10.1208/s12248-018-0280-z', 'http://link.springer.com/article/10.1208/s12248-018-0280-z/fulltext.html']\n",
      "['9739608', 'Gay F; Rota Scalabrini D; Belotti A; Oliva S; Rambaldi A; Zamagni E; Offidani M; Omede P; Cerrato C; Troia R; Gozzetti A; Pietrantuono G; Pavone V; De Rosa L; Palmieri S; Narni F; Pascarella A; Zambello R; Montefusco V; Palumbo A; Musto P; Cavo M; Boccadoro M. Updated efficacy and MRD data according to risk-status in newly diagnosed myeloma patients treated with carfilzomib plus lenalidomide or cyclophosphamide: results from the forte trial. Hemasphere. (2018) 2  pp6-', '10.1097/01.hs9.0000561768.53887.ff', '']\n",
      "['9739609', 'Zhao Liming; Nie Wenbo; Li Bin; Zhang Chengdong; Ye Fagang. A clinical study on the combined therapy of methotrexate and immuno adsorption in the treatment of rheumatoid arthritis disease. Pakistan journal of pharmaceutical sciences. (2018) 31 6(Special) pp2827-2830', '10.1186/ar3661', 'http://link.springer.com/article/10.1186/ar3661/fulltext.html']\n",
      "['9739611', 'ACTRN12612000774820. A Rheumatoid Arthritis Study to Test the Safety, Tolerability, and Efficacy of MK-8457 in Patients with an Inadequate Response or Intolerance to Anti-TNF-alpha Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12612000774820. (2012)   pp', '10.1186/s13075-019-1879-x', 'http://link.springer.com/article/10.1186/s13075-019-1879-x/fulltext.html']\n",
      "['9739614', 'UMIN000012844. The examination of the usefulness of anti-Sm antibody mesuremant with SmD peptide. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012844. (2014)   pp', '10.1111/1756-185x.12544', '']\n",
      "['9739615', 'UMIN000012841. The safety and usability assessment of sunscreen agents (cosmetics) for light-sensitive patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012841. (2014)   pp', '10.1186/isrctn41695172', '']\n",
      "['9739618', 'UMIN000012650. In vivo kinematic analysis of total knee arthroplasty with 3-dimensional registration technique. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012650. (2013)   pp', '10.1007/3-540-27658-0_5', 'http://link.springer.com/content/pdf/10.1007/3-540-27658-0_5.pdf']\n",
      "['9739619', 'UMIN000012647. Assessment of cardiac involvements in rheumatoid arthritis using a cardiac magnetic resonance approach. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012647. (2013)   pp', '10.1136/annrheumdis-2013-eular.518', '']\n",
      "['9739620', 'UMIN000012379. Functional analysis of macrophage and natural killer cells in inflammatory and hematologic diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012379. (2013)   pp', '10.1097/mib.0b013e318280b1e3', '']\n",
      "['9739621', 'UMIN000012364. Drug registry study to evaluate the effectiveness of tramadol / acetaminophen combination tablets as pain management for patient with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012364. (2013)   pp', '10.1016/s0149-2918(01)80118-1', '']\n",
      "['9739622', 'ISRCTN29199098. Efficacy of a topical cannabinoid preparation in decreasing symptoms of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN29199098. (2014)   pp', '10.1186/isrctn29199098', '']\n",
      "['9739623', 'EUCTR2011-005036-26-GB. A study to investigate what effects FX125L (taken by mouth) has on adults with chronic inflammatory diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005036-26-GB. (2011)   pp', '10.1093/ww/9780199540884.013.u185924', '']\n",
      "['9739624', 'IRCT201111088034N1. Ginger effect on pain in knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201111088034N1. (2012)   pp', '10.1186/isrctn48110500', '']\n",
      "['9739625', 'EUCTR2010-023956-99-ES. Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in subjects who are not responding to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-023956-99-ES. (2011)   pp', '10.1007/s00296-011-2041-5', 'http://link.springer.com/article/10.1007/s00296-011-2041-5/fulltext.html']\n",
      "['9739626', 'CTRI/2012/12/003205. A clinical trial to study the effect of drug, CF101 Administered Orally as Monotherapy for 12 Weeks in Patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/12/003205. (2012)   pp', '10.4103/2229-3485.103592', '']\n",
      "['9739627', 'UMIN000012257. Impact of corticosteroid on periarticular injection for pain control following total knee arthroplasty: a double-blind randomized trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012257. (2013)   pp', '10.1302/0301-620x.98b2.36596', 'https://online.boneandjoint.org.uk/doi/pdf/10.1302/0301-620X.98B2.36596']\n",
      "['9739628', 'EUCTR2006-004062-13-IT. Randomised, open label, no profit, clinical, multicenter study of phase II and IIIB to assess efficacy and tolerability of oxycodone/paracetamol compared to anti-inflammatory non-steroidal drugs  FANS  and corticosteroid, in patients suffering moderate to severe chronic pain due to rheumatoid arthritis. - Do.R.A. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-004062-13-IT. (2006)   pp', '10.1016/j.jaad.2004.10.789', '']\n",
      "['9739629', 'EUCTR2008-006256-22-FR. Evaluation by high resolution micro computerized tomography of bone microarchitecture changes in patients with rheumatoid arthritis under anti-TNF therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006256-22-FR. (2008)   pp', '10.2147/btt.s2338', '']\n",
      "['9739630', 'EUCTR2004-003298-10-DE. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Psoriatic Arthritis - NA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-003298-10-DE. (2005)   pp', '10.3410/f.718325312.793492806', '']\n",
      "['9739632', 'CTRI/2011/05/001724. A clinical trial to study the effects of Zenotechs Etanercept 50 mg injection in comparison with Wyeth?s Enbrel¬¨√Ü injection in patients with moderate to severe rheumatoid arthritis with inadequate response to methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2011/05/001724. (2011)   pp', '10.1002/art.30372', '']\n",
      "['9739634', 'UMIN000003807. A study for comparison of triple combination therapy (bucillamine, salazosulphapiridine and methotrexate) with TNF-blocking biologics and methotrexate combination therapy concerning efficacy and tolerability for rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003807. (2010)   pp', '10.1186/s41927-025-00489-9', 'https://link.springer.com/article/10.1186/s41927-025-00489-9/fulltext.html']\n",
      "['9739636', 'EUCTR2015-002809-12-CZ. A Study to Compare YLB113 and Enbrel for the Treatment of Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-002809-12-CZ. (2015)   pp', '10.15199/8.2015.3.1', '']\n",
      "['9739637', 'EUCTR2007-002945-18-CZ. A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy and safety in adult patients with active rheumatoid arthritis receiving non-biologic background disease-modifying antirheumatic drugs - Clinical efficacy and safety of ofatumumab in RA patients receiving background nonbiologic DMARDs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-002945-18-CZ. (2007)   pp', '10.1016/j.clinthera.2009.08.014', '']\n",
      "['9739639', 'EUCTR2008-006936-37-BE. A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ILV-094 Administered Subcutaneously to Subjects with Active Rheumatoid Arthritis on a Stable Background of Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006936-37-BE. (2009)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9739640', 'IRCT2015021015932N10. the effect of taping on men football players with chronic lateral ankle sprain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015021015932N10. (2015)   pp', '10.1186/isrctn53463752', '']\n",
      "['9739641', 'UMIN000003615. Evaluation of the effectiveness of three nonbiologic DMARDs [salazosulfapyridine(SSZ), bucillamine(BUC), methotrexate(MTX)] combination therapy for early RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003615. (2010)   pp', '10.1016/s1098-3015(10)67228-2', '']\n",
      "['9739642', 'UMIN000003643. Therapeutic efficacy and safety of chronotherapy of methotrexate in patients with rheumatic arthritis: double-blind randomized trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003643. (2010)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739643', 'McKendry RJR. Is rheumatoid arthritis caused by an infection?. Lancet. (1995) 345 8961 pp1319-1320', '10.1016/s0140-6736(95)92533-3', '']\n",
      "['9739645', 'Emery P; Foster W; Suarez-Almazor M. Rheumatoid arthritis. Clinical evidence. (2002)  7 pp1101-1121', '10.1002/9781444315844.ch9', '']\n",
      "['9739646', 'Arico M; Conter V; Valsecchi MG; Masera G. Importance of minimal residual disease testing during the second year of disease: still no answer?. Journal of clinical oncology. (2003) 21 23 pp4463-4464; author reply 4464-4465', '10.1200/jco.2003.99.093', '']\n",
      "['9739650', 'John H; Hale ED; Treharne GJ; Kitas GD; Carroll D. A randomized controlled trial of a cognitive behavioural patient education intervention versus a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (united kingdom). (2012) 51  ppiii77-', '10.1093/rheumatology/kes237', 'http://academic.oup.com/rheumatology/article-pdf/52/1/81/5176981/kes237.pdf']\n",
      "['9739651', 'Yang J; Yao H H; Mo X D; Luo Z; Baima Yangjin. Clinical and immunological characteristics of patients with systemic lupus erythematosus in Tibet plateau, China. Beijing da xue xue bao [Journal of Peking University. Health sciences]. (2018) 50 6 pp1004-1008', '10.52768/2766-7820/1963', '']\n",
      "['9739652', 'Weisman MH. TNF and anti-TNF treatment in rheumatoid arthritis (RA). What we know and what we still need to know. Ry≈´machi. [rheumatism]. (1997) 37 2 pp142-143', '10.4324/9781138609877-ree176-1', '']\n",
      "['9739653', 'ISRCTN78142229. Active management of rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN78142229. (2004)   pp', '10.1186/isrctn78142229', '']\n",
      "['9739654', 'CTRI/2016/02/006625. A clinical Trial to evaluate efficacy and safety of BMO-2 and Adalimumab in patient with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/02/006625. (2016)   pp', '10.4172/2329-6887.1000127', '']\n",
      "['9739656', 'EUCTR2009-012705-19-BG. A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects with Active Rheumatoid Arthritis (RA) on Stable Methotrexate (MTX) Therapy - LX3305.201. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012705-19-BG. (2009)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739657', 'CTRI/2014/12/005233. Outcome of Rheumatoid Arthritits patients following adjunct statin therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/12/005233. (2014)   pp', '10.4103/0253-7613.169585', '']\n",
      "['9739658', 'ISRCTN22703067. The use of an interactive self-management care booklet by patients with rheumatoid arthritis: a comparison of two distribution strategies. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN22703067. (2017)   pp', '10.1186/isrctn22703067', '']\n",
      "['9739659', 'ISRCTN02138359. Efficacy and cost effectiveness of day surgery for knee replacement: a randomised controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN02138359. (2004)   pp', '10.1186/isrctn02138359', '']\n",
      "['9739660', 'IRCT2016010425816N1. Evaluation of the Anti-inflammatory Effect of Atorvastatin on Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016010425816N1. (2016)   pp', '10.19082/2700', '']\n",
      "['9739661', 'UMIN000010315. Prediction of the recurrence after adalimumab discontinuation by using ultrasound assessment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010315. (2013)   pp', '10.1136/annrheumdis-2019-eular.4315', '']\n",
      "['9739662', 'EUCTR2009-012264-14-AT. A Phase 3 Multicenter, Randomized, Double-blind, Placebo controlled trial of Ustekinumab, a Fully Human anti-IL 12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psoriatic Arthritis. - PSUMMIT I. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012264-14-AT. (2009)   pp', '10.3410/f.718283036.793491904', '']\n",
      "['9739663', 'EUCTR2010-023782-22-HU. A TRIAL TO TEST THE EFFICACY AND SAFETY OF STUDY DRUG PF-04171327(1,5,10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY FOR SUBJECTS WITH RHEUMATOID ARHTRITIS OVER A PERIOD OF  8 WEEKS FOLLOWED BY 4 WEEKS OF TAPERING OF STUDY DRUG. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-023782-22-HU. (2011)   pp', '10.58837/chula.the.2009.850', '']\n",
      "['9739664', 'NCT03747354. Assessment of Disease Activity in Behcet by Complete Blood Count. Https://clinicaltrials.gov/show/nct03747354. (2018)   pp', '10.1097/00006454-199104000-00014', '']\n",
      "['9739665', 'NCT03753360. Online Mindfulness Program for Stress Management. Https://clinicaltrials.gov/show/nct03753360. (2018)   pp', '10.4135/9781526443380', '']\n",
      "['9739667', 'EUCTR2011-005649-10-CZ. An exploratory clinical study to investigate mavrilimumab, an antibody being developed for the treatment of moderate to severe rheumatoid arthritis, an inflammatory condition that affects the joints versus a different antibody whose mechanism works by inhibiting tumor necrosis factor. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005649-10-CZ. (2012)   pp', '10.1016/j.jval.2015.09.679', '']\n",
      "['9739668', 'EUCTR2006-005330-20-BE. anti TNF-IR phase III. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005330-20-BE. (2007)   pp', '10.1093/ww/9780199540884.013.u217337', '']\n",
      "['9739669', 'IRCT2015120125317N1. the effects of Scaphoid and Hamate mobilization in patients with carpal tunnel syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015120125317N1. (2016)   pp', '10.1016/j.rehab.2018.05.616', '']\n",
      "['9739670', 'UMIN000003128. Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003128. (2010)   pp', '10.1186/1475-2891-10-2', 'http://link.springer.com/article/10.1186/1475-2891-10-2/fulltext.html']\n",
      "['9739671', 'UMIN000003069. Hip stability in total hip arthroplasty by the change of the femoral head sizes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000003069. (2010)   pp', '10.3928/01477447-20090527-09', '']\n",
      "['9739672', 'ISRCTN71084664. Applicability of an educational-behavioural joint protection programme in practice. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN71084664. (2002)   pp', '10.1186/isrctn71084664', '']\n",
      "['9739673', 'ChiCTR-INC-16009960. Nerve block anesthesia and general anesthesia influnce postoperative on cognitive dysfunction after hip athroplasty of aged fracture of neck of femur patients: randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INC-16009960. (2016)   pp', '10.1101/2021.03.14.21253545', '']\n",
      "['9739674', 'EUCTR2015-002466-22-Outside-EU/EEA. A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Openlabel Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuiL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-002466-22-Outside-EU/EEA. (2015)   pp', '10.31525/ct1-nct03925194', '']\n",
      "['9739675', 'ISRCTN52709998. Reducing Arthritis Fatigue - clinical Teams using cognitive behavioural approaches (RAFT). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN52709998. (2013)   pp', '10.1186/isrctn52709998', '']\n",
      "['9739676', 'EUCTR2005-003750-10-SE. Growth hormone and androgens in the treatment of glucocorticoid induced protein catabolism - GH and androgens in protein catabolism. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003750-10-SE. (2005)   pp', '10.1210/jc.82.8.2528', '']\n",
      "['9739677', 'CTRI/2013/10/004040. A study to evaluate efficacy, tolerability and safety of Adalimumab (Zydus) and Adalimumab (Reference) in patients with Rheumatoid Arthritis.‚àö¬¢??. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2013/10/004040. (2013)   pp', '10.1186/isrctn90051516', '']\n",
      "['9739678', 'ACTRN12615001141538. The second healthy volunteer study assessing the safety, tolerability, and pharmacokinetics (blood levels) of gerilimzumab against placebo. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12615001141538. (2015)   pp', '10.1186/isrctn80267019', '']\n",
      "['9739679', 'EUCTR2007-006129-29-PL. A multicentre, randomized, double-blind, placebo-controlled study to  evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to patients with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006129-29-PL. (2010)   pp', '10.1002/art.27348', '']\n",
      "['9739680', 'IRCT201202219104N1. Effect of phase one of periodontal treatment on improvement of clinical signs of Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201202219104N1. (2012)   pp', '10.1186/isrctn27093749', '']\n",
      "['9739681', 'EUCTR2016-001532-35-BG. A Phase II, Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-001532-35-BG. (2016)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739682', 'IRCT2015072123270N1. Effect of local corticosteroid injection on prevertebral soft tissue swelling in cervical disc surgery. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015072123270N1. (2015)   pp', '10.53347/rid-40823', '']\n",
      "['9739685', 'EUCTR2008-007346-63-GB. Reumap: an Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients - REUMAP. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-007346-63-GB. (2010)   pp', '10.1186/isrctn64619216', '']\n",
      "['9739686', 'JMA-IIA00100. Effect of the feedback of life-log information using a smartphone on disease activity of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JMA-IIA00100. (2012)   pp', '10.1186/isrctn96372677', '']\n",
      "['9739687', 'ISRCTN81810979. Pre admission for patients undergoing total knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN81810979. (2004)   pp', '10.1186/isrctn81810979', '']\n",
      "['9739689', 'UMIN000011891. Multicenter study of the effect of GoLimumab On the Remission Induction rate and bio-free remission maintenance rate in early rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011891. (2013)   pp', '10.1186/isrctn75505683', '']\n",
      "['9739691', 'EUCTR2012-004090-16-CZ. Safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effects of multiple rising subcutaneous doses of BI655064 in healthy volunteers and in rheumatoid arthritis patients with prior inadequate response to methotrexate therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-004090-16-CZ. (2013)   pp', '10.1186/isrctn11659633', '']\n",
      "['9739692', 'UMIN000011789. Usefulness of intravenous abatacept at an increased dose in rheumatoid arthritis patients with a poor prognosis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000011789. (2013)   pp', '10.1186/isrctn89222125', '']\n",
      "['9739693', 'EUCTR2006-001359-36. Effects of low-dose aspirin taken at bedtime on pathophysiologic mechanisms underlying hypertension in subjects with grade 1 essential hypertension: the Aspirin In Reduction of Tension (ASPIRETENSION) study - ASPIRETENSION. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-001359-36-NL. (2006)   pp', '10.1097/00004872-201106001-00735', '']\n",
      "['9739694', 'EUCTR2010-024516-34-BG. Compare the efficacy and assess the safety of secukinumab given as 3 intravenous (i.v.) loading doses or weekly sub-cutaneous (s.c.) loading doses, compared to placebo, followed by monthly s.c. injections in patients with active Rheumatoid Arthritis despite treatment with methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-024516-34-BG. (2011)   pp', '10.37766/inplasy2021.12.0071', '']\n",
      "['9739695', 'ISRCTN92180550. Forefoot arthroplasty in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN92180550. (2002)   pp', '10.1186/isrctn92180550', '']\n",
      "['9739696', 'IRCT2013100513442N3. Study of the long term effects of local Platelet-rich plasma (PRP) injection versus Autologous blood injection in patients with Lateral Epicondylitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013100513442N3. (2013)   pp', '10.16965/ijims.2018.132', 'https://imedsciences.com/wp-content/uploads/2018/10/IJIMS.2018.132.pdf']\n",
      "['9739697', 'CTRI/2016/12/007569. Efficacy of castor oil in the management of Rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/12/007569. (2016)   pp', '10.36422//23076348-2023-11-4-35-42', '']\n",
      "['9739698', 'ACTRN12608000644369. A Phase 2a, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of BG00012 when given with methotrexate to subjects with active rheumatoid arthritis who have had an inadequate response to conventional disease-modifying anti-rheumatic drug therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12608000644369. (2008)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739699', 'IRCT2016022926846N1. The effect of interventions based of  psychological on the severity of insomnia and pain in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016022926846N1. (2016)   pp', '10.1093/rheumatology/kew133', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i121/5077934/kew133.pdf']\n",
      "['9739700', 'ISRCTN96372677. Treatment intensification based on disease activity parameters or on cartilage breakdown markers in early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN96372677. (2005)   pp', '10.1186/isrctn96372677', '']\n",
      "['9739701', 'EUCTR2013-003486-34-DK. Treatment of Tenosynovitis among rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003486-34-DK. (2013)   pp', '10.18057/ijasc.2010.6.1.1', '']\n",
      "['9739702', \"ISRCTN80708834. Assessment of controlled release buccal inserts containing pilocarpine hydrochloride: a multi-centre, double-blind, placebo-controlled, randomised, cross-over study in patients diagnosed with Sj√∂gren's Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN80708834. (2002)   pp\", '10.1186/isrctn80708834', '']\n",
      "['9739703', 'ISRCTN68585617. The effect of patient education on compliance with drug therapy for rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN68585617. (2002)   pp', '10.1186/isrctn68585617', '']\n",
      "['9739705', 'ChiCTR-IPR-15005787. The effect of food on the pharmacokinetics of Ginsenoside C-K. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15005787. (2015)   pp', '10.18810/chictr', '']\n",
      "['9739706', \"ChiCTR-ICR-15005877. Study on mechanism of Chinese Herbal Medicine for Nourishing Yin, Strengthening Qi and activating blood on the Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-ICR-15005877. (2015)   pp\", '10.4268/cjcmm20132332', '']\n",
      "['9739707', 'UMIN000002554. Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in patients with rheumatoid arthritis (Investigation by capsule endoscopy and measurement of biomarkers for rheumatoid arthritis). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002554. (2009)   pp', '10.1016/s0016-5085(11)61592-8', '']\n",
      "['9739708', 'IRCT201402207494N8. Honey on healing of foot ulcer in diabetic patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201402207494N8. (2014)   pp', '10.1007/978-981-15-7639-3_19', '']\n",
      "['9739711', 'EUCTR2006-002645-37-HU. A Phase II randomized double-blind placebo-controlled Study of KC706 in patients with rheumatoid arthritis inadequately controlled with a stable dose of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-002645-37-HU. (2006)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739712', 'EUCTR2004-004893-96-GB. Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-004893-96-GB. (2005)   pp', '10.1186/isrctn51459023', '']\n",
      "['9739713', 'EUCTR2015-004386-91-PL. Study to explore and compare the effects of a new drug in combination with methotrexate therapy in people with early and established rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-004386-91-PL. (2016)   pp', '10.1093/rheumatology/kep331', 'http://academic.oup.com/rheumatology/article-pdf/49/1/91/17386543/kep331.pdf']\n",
      "['9739714', 'EUCTR2005-002660-29-ES. A Phase 1b/2 Multiple-Dose Safety and Pharmacokinetic/Pharmacodynamic Study of  LY2189102 in Patients with Rheumatoid Arthritis Estudio fase 1b/II de dosis m√∫ltiples, para evaluar seguridad y farmacocin√©tica/farmacodin√°mica de LY2189102 en pacientes con artritis reumatoide. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002660-29-ES. (2005)   pp', '10.1016/j.rcreu.2018.10.001', '']\n",
      "['9739715', 'IRCT201106016675N1. Survey of Tranexamic acid affect on reduction of secondary hemorrhage in the traumatic hyphema. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201106016675N1. (2011)   pp', '10.1016/s0161-6420(94)31134-1', '']\n",
      "['9739716', 'UMIN000013234. Effect of the dual treatment of diquafosol sodium and rebamipide on dry eye syndrome related to chronic graft versus host disease and Sjogrens syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013234. (2014)   pp', '10.1186/isrctn44290046', '']\n",
      "['9739717', 'UMIN000002175. Comparison of the clinical responses by the dosage of once or triple a week of MTX in patients with rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000002175. (2009)   pp', '10.1002/cca.2940', '']\n",
      "['9739719', 'IRCT2016061728502N1. The effect of family-centered empowerment model on elderlies with diabetes who are at falling risk in Bojnourd city. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016061728502N1. (2016)   pp', '10.1111/pedi.13116/v1/review1', '']\n",
      "['9739720', 'EUCTR2008-002623-85-FR. A 3-PHASE STUDY TO EVALUATE SUSTAINED REMISSION AND PRODUCTIVITY OUTCOMES IN SUBJECTS WITH EARLY RHEUMATOID ARTHRITIS INITIATED ON TREATMENT WITH ETANERCEPT PLUS METHOTREXATE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-002623-85-FR. (2009)   pp', '10.1186/isrctn49682259', '']\n",
      "['9739721', 'UMIN000013362. Examination of the remission maintenance effect by low dose etanercept after clinical remission in the rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013362. (2014)   pp', '10.1186/s13075-019-1937-4', 'http://link.springer.com/article/10.1186/s13075-019-1937-4/fulltext.html']\n",
      "['9739722', 'UMIN000013305. Efficacy of once every four week oral minodronate in patients with glucocorticoid-induced osteoporosis after switching from weekly oral bisphosphonate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013305. (2014)   pp', '10.1530/endoabs.32.p96', '']\n",
      "['9739724', 'EUCTR2007-004399-38-EE. A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER, 1-YEAR EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFECTIVENESS OF CRx-102 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-004399-38-EE. (2008)   pp', '10.26226/morressier.5cdbe0aa618793e647b12aea', '']\n",
      "['9739725', \"EUCTR2011-001027-20-DE. A Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's disease (AOSD) including an open-label long term extension. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001027-20-DE. (2011)   pp\", '10.2139/ssrn.3491904', '']\n",
      "['9739726', 'EUCTR2004-000012-13-EE. A Double-Blind, Placebo-Controlled, Parallel, Randomized Study To Evaluate The Efficacy And Safety Of 3 Oral Dose Levels Of TMI-005 In Subjects With Active Rheumatoid Arthritis On A Background Of Methotrexate -. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000012-13-EE. (2005)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9739727', 'DRKS00004774. Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis: a randomized, placebo controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00004774. (2013)   pp', '10.1186/1745-6215-15-344', 'http://link.springer.com/article/10.1186/1745-6215-15-344/fulltext.html']\n",
      "['9739728', 'ChiCTR-IPR-15005990. Cyclosporine A in the Treatment of Interstitial Pneumonitis associated with Sjogren‚Äôs syndrome(CTRIPS): a Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15005990. (2015)   pp', '10.1016/j.urols.2015.06.277', '']\n",
      "['9739729', 'DRKS00004940. Wireless capsule endoscopy in diagnostics of enteropathy induced by nonsteroidal anti-inflammatory drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00004940. (2013)   pp', '10.1007/s10620-009-1066-z', 'http://link.springer.com/article/10.1007/s10620-009-1066-z/fulltext.html']\n",
      "['9739730', 'IRCT138903154104N1. Comparison of physical therapy treatment with or without treatment of trigger points in patients with knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138903154104N1. (2011)   pp', '10.1186/isrctn75722066', '']\n",
      "['9739731', 'EUCTR2005-002219-26-SE. A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-reactive protein (CRP) in subjects with rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002219-26-SE. (2005)   pp', '10.1186/isrctn04296019', '']\n",
      "['9739732', 'UMIN000012916. Analysis of immune status in autoimmune diseases treated with Biologics. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000012916. (2014)   pp', '10.1093/intimm/dxq199', 'http://academic.oup.com/intimm/article-pdf/22/Suppl_1_Pt_4/iv153/9958295/dxq199.pdf']\n",
      "['9739733', 'CTRI/2014/09/004954. A clinical trial  to study the effects of Three Anti-CD20 Monoclonal Antibodies in Patients with Moderate to Severe Active, Seropositive Rheumatoid Arthritis with an Inadequate Response to Methotrexate Based Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/09/004954. (2014)   pp', '10.1136/annrheumdis-2014-eular.3754', '']\n",
      "['9739735', 'EUCTR2014-004868-38-ES. A study comparing the use of etanercept and methotrexate, used either alone or in combination, for maintaining remission in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004868-38-ES. (2016)   pp', '10.2165/00128413-200816240-00044', '']\n",
      "['9739736', 'IRCT138811161778N2. Statins and rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138811161778N2. (2010)   pp', '10.2165/00128415-201013300-00011', '']\n",
      "['9739737', 'IRCT201206266302N3. Comparative analysis of Altebrel¬¨√Ü (Aryogen) with Enbrel¬¨√Ü. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201206266302N3. (2012)   pp', '10.24058/tki.176', '']\n",
      "['9739739', 'ChiCTR-IIR-16008461. Multimodal blood management in perioperative total knee arthroplasty: a randomized, double-blind, controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IIR-16008461. (2016)   pp', '10.1016/j.arth.2017.05.013', '']\n",
      "['9739740', 'EUCTR2004-000482-35-LT. A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arthritis. - HM2004/00255/03. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000482-35-LT. (2005)   pp', '10.1186/isrctn48638981', '']\n",
      "['9739741', 'EUCTR2008-004894-16-PL. Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-004894-16-PL. (2008)   pp', '10.1136/annrheumdis-2012-eular.2065', '']\n",
      "['9739742', 'ChiCTR-IIR-16008693. Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IIR-16008693. (2016)   pp', '10.1186/isrctn67656669', '']\n",
      "['9739743', 'ChiCTR-IIR-16008794. Tourniquet versus no tourniquet on rehabilitation after fast-track total knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IIR-16008794. (2016)   pp', '10.1016/j.knee.2014.12.010', '']\n",
      "['9739744', 'ISRCTN42355303. A controlled trial of shared care for chronic rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN42355303. (2004)   pp', '10.1186/isrctn42355303', '']\n",
      "['9739745', 'EUCTR2009-015740-42-DE. A PHASE 3, MULTICENTER, RANDOMIZED, OPEN, PROSPECTIVE, CONTROLLED, PARALLEL-GROUP STUDY OF REDUCTION OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ONGOING REMISSION RETRO ‚Äì REduction of Therapy in RA patients in Ongoing remission, Reduzierung der Therapie bei RA-Patienten in Remission - RETRO. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015740-42-DE. (2010)   pp', '10.35465/27.1.2019.pp16-23', '']\n",
      "['9739746', 'ISRCTN30748308. A prospective randomised controlled trial of thiopurine methyltransferase (TPMT) genotyping in the management of patients, prior to commencement of azathioprine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN30748308. (2005)   pp', '10.1186/isrctn30748308', '']\n",
      "['9739747', 'ISRCTN14909030. Rituximab in rheumatoid arthritis: is a reduced dose every 6 months equally effective as the regular dose if the patient has low or very low disease activity?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN14909030. (2015)   pp', '10.1186/isrctn14909030', '']\n",
      "['9739749', 'EUCTR2007-006150-25-FR. A Randomized, Parallel, Double-Blind, Placebo-Controlled Dose Regimen Finding Study to Evaluate the Safety and Efficacy of TRU-015 in Subjects With Active Seropositive Rheumatoid Arthritis on a Stable Background of Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-006150-25-FR. (2008)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9739750', 'EUCTR2008-008954-22-NL. Non Steroidal Anti-Inflammatory Drugs and the antiplatelet effects of acetylsalicylic acid - NSAIDs and ASA research. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-008954-22-NL. (2009)   pp', '10.1007/springerreference_122846', '']\n",
      "['9739751', \"UMIN000001460. The efficacy and safety of pirocarpine hydrochloride for juvenile Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000001460. (2008)   pp\", '10.1358/dot.2008.44.9.1256003', '']\n",
      "['9739753', 'CTRI/2012/05/002660. A clinical study to demonstrate safety and efficacy data to support the development of R-TPR-015 (1422015) in Patients with active rheumatoid arthritis on stable dose of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/05/002660. (2012)   pp', '10.1186/isrctn24868111', '']\n",
      "['9739754', 'CTRI/2015/10/006309. effect of Amavatari Rasa in Rheumatoid arthritis(Amavata). http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/10/006309. (2015)   pp', '10.18810/clinical-trial-registry-india', '']\n",
      "['9739756', 'ChiCTR-TRC-13002981. Effectiveness and safety of Chinese herbal medicine in low responders in patient population of rheumatoid arthritis under MTX-based conventional therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-13002981. (2013)   pp', '10.1142/9789811260377_0005', '']\n",
      "['9739758', 'EUCTR2005-001889-13-PT. Randomised controlled trial evaluating strategies to optimize disease activity control in RA patients treated with infliximab in clinical practice. - Re3. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001889-13-PT. (2006)   pp', '10.1186/isrctn99038914', '']\n",
      "['9739759', 'ISRCTN91412460. A 3-month study of the efficacy and safety of SVS20 in patients with bilateral moderate dry eye syndrome: a prospective, double-masked, randomised, controlled, parallel-group, 3 arm, multicentre, phase III trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN91412460. (2007)   pp', '10.1186/isrctn91412460', '']\n",
      "['9739760', 'DRKS00005323. Trichuris suis ova (TSO) as an additional therapy for rheumatoid arthritis patients with insufficient response to methotrexate. A prospective, double-blind, randomized, controlled monocenter study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00005323. (2013)   pp', '10.3410/f.2611957.2270055', '']\n",
      "['9739763', 'EUCTR2010-019438-28-SE. Vaccination against TBE in patients who use immunosuppressive drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019438-28-SE. (2010)   pp', '10.1093/ww/9780199540884.013.u188535', '']\n",
      "['9739764', 'ACTRN12609000960257. Cruciate Retaining vs Posterior Stabilised Total Knee Replacement: a Randomised Clinical Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12609000960257. (2009)   pp', '10.1016/b978-1-4160-4984-5.50008-5', '']\n",
      "['9739765', 'ChiCTR-IIR-16008226. Effectiveness of four different strategies of preoperative using rivaroxaban in patients undergoing fast-tract total  knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IIR-16008226. (2016)   pp', '10.1186/isrctn81810979', '']\n",
      "['9739766', 'EUCTR2009-015895-87-NL. Application of zileuton (Zyflo CR) in patients with Sj√∂gren Larsson Syndrome - Zileuton in Sj√∂gren Larsson Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015895-87-NL. (2009)   pp', '10.1007/springerreference_176989', '']\n",
      "['9739767', 'CTRI/2017/01/007713. A clinical trial to study the effect of periodontal treatment on rheumatoid arthritis disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/01/007713. (2017)   pp', '10.1016/j.hpb.2018.06.258', '']\n",
      "['9739768', 'IRCT201110247877N1. Comparison between effect of low-power laser therapy versus local methylprednisolone injection on plantar fascitis in patients refer to rheumatology clinic. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201110247877N1. (2011)   pp', '10.1186/isrctn57762240', '']\n",
      "['9739770', 'CTRI/2014/09/005044. multicenter, randomized, double-blind, controlled,  Phase 2b/3 study to compare efficacy and safety of AB1010 at 3 and 6 mg/kg/day in treatment of patients which active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/09/005044. (2014)   pp', '10.21236/ada622071', '']\n",
      "['9739771', 'IRCT2014020416485N1. Therapeutic Effect of Ultrasound-Guided Local Steroid Injection with Hydro-dissection in Carpal Tunnel Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014020416485N1. (2014)   pp', '10.1186/isrctn26264638', '']\n",
      "['9739772', 'EUCTR2010-019694-15-BE. Act-Alone : an open-label, single-arm study to describe glucocorticoid use in rheumatoid arthritis patients treated with Tocilizumab in daily clinical practice and to evaluate systematic glucocorticoid dose reduction once low disease activity is reached - ACT-Alone. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019694-15-BE. (2010)   pp', '10.1136/annrheumdis-2014-eular.1992', '']\n",
      "['9739774', 'EUCTR2009-012041-35-FR. A phase II, randomized, partially double blind, controlled study to evaluate the immunogenicity, safety, and clinical efficacy of three doses of Neovacs‚Äô TNF-Kinoid in adult patients with rheumatoid arthritis (RA) who have relapsed despite use of an anti-TNFa biological drug, due to anti-drug antibodies. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012041-35-FR. (2009)   pp', '10.1186/isrctn96199656', '']\n",
      "['9739775', \"IRCT2015020816830N2. Effect of sensory motor training on the upper limb function of patients with Parkinson's disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015020816830N2. (2015)   pp\", '10.1016/j.jht.2017.08.001', '']\n",
      "['9739776', 'EUCTR2004-001490-26-EE. A MULTI-CENTER, RANDOMIZED, BLINDED STUDY COMPARING THE EFFECT OF CRx-150 PLUS DMARD THERAPY TO THAT OF PLACEBO PLUS DMARD THERAPY ON SERUM C-REACTIVE PROTEIN (CRP) AND CYTOKINES IN SUBJECTS WITH RHEUMATOID ARTHRITIS. - CRx-150-RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-001490-26-EE. (2006)   pp', '10.1186/isrctn74570187', '']\n",
      "['9739777', 'EUCTR2009-011397-14-DE. Effect of anti-TNF-alpha therapy on endothelial progenitor cells and endothelial dysfunction in patients with psoriasis without risk factors for atherosclerosis - EPPSOR-Studie. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-011397-14-DE. (2009)   pp', '10.1016/j.atherosclerosis.2018.06.358', '']\n",
      "['9739778', 'ChiCTR-IPR-16009029. Clinical Study of the Bone Protection Effect of Biqi Capsule for Treatment of Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-16009029. (2016)   pp', '10.3109/03009748809096780', '']\n",
      "['9739779', 'EUCTR2016-000912-13-DE. A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with moderate to severe rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000912-13-DE. (2016)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739780', 'IRCT201407121552N2. Comparison of the effect of two types of exercise therapy in the treatment of shortening of posterior muscles of thigh. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201407121552N2. (2014)   pp', '10.1186/isrctn85595810', '']\n",
      "['9739782', 'EUCTR2010-022205-17-HU. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients with Moderate to Severe Rheumatoid Arthritis (RA) who had an Inadequate Response to Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-022205-17-HU. (2010)   pp', '10.1007/s12688-018-0181-3', 'http://link.springer.com/article/10.1007/s12688-018-0181-3/fulltext.html']\n",
      "['9739783', \"ACTRN12614000903684. A Randomized, Single-blind, Single-dose, 3-arm, Parallel Group Study to Determine the Pharmacokinetic Similarity of ABP 710 and Infliximab (Remicade 'Registered Trademark') in Healthy Adult Subjects. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12614000903684. (2014)   pp\", '10.26226/morressier.59a6b348d462b80290b54f0a', '']\n",
      "['9739784', 'IRCT2015111425031N1. The effect of pioglitason on  rheumatoid arthritis disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015111425031N1. (2016)   pp', '10.1186/isrctn04121489', '']\n",
      "['9739785', 'EUCTR2011-002363-15-IS. A clinical trial with the aim to explore infusion reactions from Tocilizumab given either in 31 or 60 minutes to patients with moderate to severe rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002363-15-IS. (2011)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9739786', 'IRCT2015061112257N3. The effect of  therapeutic touch on pain and physiological variables of patients undergoing of mechanical ventilation in intensive care units. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061112257N3. (2015)   pp', '10.1186/isrctn85308779', '']\n",
      "['9739787', 'IRCT2014081118762N1. The effect of traction on cervical osteoarthritis symptoms. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014081118762N1. (2014)   pp', '10.1186/isrctn10096951', '']\n",
      "['9739788', 'EUCTR2004-000612-54-SE. A Multicenter, Randomized, Parallel-Group, Active-Controlled Double-Blind Study Conducted Under In-House Blinding Conditions to Determine the Incidence of Gastroduodenal Ulcers in Patients With Osteoarthritis or Rheumatoid Arthritis After 12 Weeks of Treatment With L-001069957 21 mg Plus Low-Dose Aspirin, L- 01069957 42 mg Plus Low-Dose Aspirin, Celecoxib 400 mg Plus Low-Dose Aspirin, or Low-Dose Aspirin Alone - 12-Week NO-Rofecoxib Plus Aspirin Endoscopy Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-000612-54-SE. (2004)   pp', '10.1186/isrctn81818945', '']\n",
      "['9739789', 'CTRI/2012/09/003022. Benefits of Naturopathy and Yoga in the Treatment of Rheumatoid Arthritis Patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/09/003022. (2012)   pp', '10.4103/2229-3485.103592', '']\n",
      "['9739790', 'UMIN000000928. Chronotherapy of methotrexate in patients with rheumatic arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000000928. (2007)   pp', '10.1136/annrheumdis-2019-eular.4992', '']\n",
      "['9739791', 'IRCT2013052313442N1. Study of the effects of local platelet-rich plasma (PRP) injection versus autologous blood injection in patients with lateral epicondylitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013052313442N1. (2013)   pp', '10.16965/ijims.2018.132', 'https://imedsciences.com/wp-content/uploads/2018/10/IJIMS.2018.132.pdf']\n",
      "['9739792', 'ChiCTR-TRC-12002656. Total Glucosides Of Paeony in the treatment of early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-12002656. (2012)   pp', '10.1016/j.intimp.2013.01.021', '']\n",
      "['9739794', 'ISRCTN52892553. The use of a randomised controlled trial of autologous stem cell transplantation (ASCT) versus mobilisation alone to investigate the pathogenic role of T-cells in patients with severe rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN52892553. (2003)   pp', '10.1186/isrctn52892553', '']\n",
      "['9739797', 'EUCTR2007-000012-90-NL. The Standard care versus Celecoxib Outcome Trial (SCOT): a Large Streamlined Safety Study  - SCOT Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000012-90-NL. (2010)   pp', '10.1136/bmjopen-2012-002295', '']\n",
      "['9739798', 'EUCTR2011-001122-18-CZ. A Study of the Effectiveness and Safety of Ustekinumab (STELARA¬¨√Ü) and CNTO 1959 Administered Under the Skin of Patients with Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001122-18-CZ. (2012)   pp', '10.1186/isrctn28468355', '']\n",
      "['9739799', 'ACTRN12608000208303. Evaluate the effectiveness and safety of Cpn10 in subjects with moderate to severe rheumatoid arthritis despite treatment with methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12608000208303. (2008)   pp', '10.31525/ct1-nct04204603', '']\n",
      "['9739800', 'EUCTR2006-005391-40-IT. Study on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients - ND. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005391-40-IT. (2007)   pp', '10.1186/isrctn97686858', '']\n",
      "['9739803', 'EUCTR2012-005733-37-GB. A Study Comparing SB2 to Remicade¬¨√Ü in Subjects with Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-005733-37-GB. (2013)   pp', '10.1002/psb.1920', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1920']\n",
      "['9739804', 'IRCT2016091229795N1. Evaluation of the effectiveness of prolotherapy on patients with knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016091229795N1. (2016)   pp', '10.19082/5663', 'http://www.ephysician.ir/2017/5663.pdf']\n",
      "['9739805', 'IRCT201105131485N3. The effect of low-carbohydrate diet on inflammation. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201105131485N3. (2011)   pp', '10.1186/isrctn48034106', '']\n",
      "['9739806', 'IRCT201612051165N15. Evaluation of the efficacy of Spinal-Z on patients with gastrointestinal cancer. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201612051165N15. (2017)   pp', '10.1186/isrctn13119162', '']\n",
      "['9739807', 'UMIN000009088. Bio Logic MateTM clinical performance test for IFX Efficacy prediction. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009088. (2012)   pp', '10.1186/isrctn52392534', '']\n",
      "['9739808', 'CTRI/2017/02/007869. management of rheumatoid arthritis with Ayurvedic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2017/02/007869. (2017)   pp', '10.7897/2277-4343.084230', '']\n",
      "['9739809', 'ISRCTN21613721. Self monitoring of methotrexate by patients with arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN21613721. (2011)   pp', '10.1186/isrctn21613721', '']\n",
      "['9739811', 'ChiCTR-IPR-15007415. Study of Sinomenine Hydrochloride in the treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007415. (2015)   pp', '10.3109/03009748809096780', '']\n",
      "['9739812', 'JapicCTI-080565. A Long Term Study to Investigate the Efficacy and Safety Study of D961H (20 mg Once Daily) for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-Inflammatory Drug (NSAID) Use. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-080565. (2008)   pp', '10.1016/s0016-5085(15)30306-1', '']\n",
      "['9739813', 'UMIN000009260. Randomized controlled trial of integrative medicine program for self management on fibromyalgia. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009260. (2012)   pp', '10.1186/isrctn10824225', '']\n",
      "['9739814', 'IRCT2016020624149N3. Comparison of manual therapy and taping in patients with knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016020624149N3. (2016)   pp', '10.29070/13/57567', 'http://www.ignited.in/File_upload/93040_87253929.pdf']\n",
      "['9739815', 'ChiCTR-IPR-15007368. Clinical Research for the Effect of Chinese and Western Medicine on Treating Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-15007368. (2015)   pp', '10.18810/chictr', '']\n",
      "['9739816', 'ACTRN12612000113853. Surfactant for Obstructive Sleep Apnea in Patients with Primary Sjogren‚Äôs Syndrome: a randomised, placebo controlled study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12612000113853. (2012)   pp', '10.1542/peds.2012-0310d', '']\n",
      "['9739817', 'UMIN000008164. Restart for sustaining remission of rheumatoid arthritis in use of etanercept. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008164. (2012)   pp', '10.1136/annrheumdis-2014-eular.1098', '']\n",
      "['9739818', 'EUCTR2010-022378-15-DE. A clinical study to explore the therapeutic effects of different doses of the new drug veltuzumab,  a drug of biologic origin, and placebo, in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-022378-15-DE. (2011)   pp', '10.1097/00007691-199304000-00015', '']\n",
      "['9739820', 'CTRI/2010/091/006069. A clinical trial to study the effects of two drugs, Tolperisone and Diclofenac in patients suffering from acute muscle spasms. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2010/091/006069. (2010)   pp', '10.1037/e566792012-091', '']\n",
      "['9739822', 'ACTRN12613000579796. Fish oil in recent onset rheumatoid arthritis: high versus low dose fish oil on a background of dose-responsive combination disease-modifying anti-rheumatic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12613000579796. (2013)   pp', '10.1016/j.semarthrit.2020.09.017', '']\n",
      "['9739823', \"UMIN000008427. Evaluation of efficacy of rebamipide ophthalmic suspension in patients with dry eye associated with Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008427. (2012)   pp\", '10.2147/opth.s40798', '']\n",
      "['9739824', 'UMIN000008572. The Kitasato institute Non-inferiorty trial of Etanercept and Tacrolimus ,the combined therapy with Methotrexate in rhumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000008572. (2012)   pp', '10.1186/isrctn55428162', '']\n",
      "['9739825', 'EUCTR2009-015037-78-IT. PERI-OPERATIVE PROPHYLAXIS FOR CATARCT SURGERY IN UVEITIC PATIENTS: a  MULTICENTRIC, PROSPECTIVE, RANDOMISED STUDY - SAFE SURGERY IN UVEITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015037-78-IT. (2009)   pp', '10.1186/isrctn41154297', '']\n",
      "['9739826', \"IRCT2013031212797N1. The effect of follow-up care by telephone and short massage services on patients' quality of life after cardiac valve replacement surgery. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013031212797N1. (2013)   pp\", '10.17918/etd-7615', '']\n",
      "['9739827', 'IRCT2013120915723N1. Ginger effect on salivary secretion. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013120915723N1. (2014)   pp', '10.12677/qre.2014.11004', '']\n",
      "['9739828', 'ISRCTN24868111. Clinical and ultrasonographic efficacy of low-dose prednisone co-treatment versus methotrexate alone in early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN24868111. (2010)   pp', '10.1186/isrctn24868111', '']\n",
      "['9739829', 'IRCT201008293812N4. Comparison of the effect of knee injection of Dexamethasone and Triamcinolone hexacetonide on knee pain in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201008293812N4. (2015)   pp', '10.1186/isrctn15077843', '']\n",
      "['9739830', 'ISRCTN48722734. The feasibility of assessing rheumatoid arthritis activity and disability by touch screen questionnaire in clinic. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN48722734. (2006)   pp', '10.1186/isrctn48722734', '']\n",
      "['9739831', 'ACTRN12607000386437. Effectiveness of Sensorimotor Training in patients with rheumatoid arthritis ‚Äì a randomised controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12607000386437. (2007)   pp', '10.1186/isrctn18282428', '']\n",
      "['9739834', 'ACTRN12612001019897. Yoga for rheumatoid arthritis ‚Äì A pilot randomised controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12612001019897. (2012)   pp', '10.1186/isrctn71100165', '']\n",
      "['9739835', 'PER-108-12. A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY OF CNTO 136 (SIRUKUMAB) A HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY, ADMINISTERED SUBCUTANEOUSLY, IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE DMARD THERAPY. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-108-12. (2013)   pp', '10.1136/annrheumdis-2012-eular.1708', '']\n",
      "['9739836', 'TCTR20160417002. The Short Termed Efficacy of Ultrasound-Guided Hyaluronic Acid Injection into a Rheumatoid Ankle and Foot Joint: a Randomized Controlled Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160417002. (2016)   pp', '10.1016/j.ultrasmedbio.2017.08.1679', '']\n",
      "['9739837', 'UMIN000013546. The effect ofgrepefruit juice on the patients with autoimmune diseases taking tacrolimus. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013546. (2014)   pp', '10.1186/isrctn15030282', '']\n",
      "['9739838', 'UMIN000013592. Utility of Xiralite Fluorescence Imaging System *4in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013592. (2014)   pp', '10.1136/annrheumdis-2019-eular.6694', '']\n",
      "['9739839', 'UMIN000013614. Inhibitory effects on bone marrow edema and rapid radiographic progression by short term uage of biologics with  early rheumatoid arthritis patients inadequate response to non biological disease modifying antirheumatic drugs with extensive bone marrow edema in hand magnetc resonance imaging. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013614. (2014)   pp', '10.1136/annrheumdis-2020-eular.3187', '']\n",
      "['9739840', 'UMIN000013936. Autotransplantation and culture of cryopreserved ovarian tissue in patients with cancer or immunologic diseases to preserve fertility. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000013936. (2014)   pp', '10.1017/cbo9780511730207.029', '']\n",
      "['9739841', 'NTR1879. A phase I/II, double blind, cross-over design, placebo controlled, pilot study to assess the effect and tolerability of multiple oral doses of phytosphingosine in Sj√∂gren‚Äôs patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1879. (2009)   pp', '10.1186/isrctn86632774', '']\n",
      "['9739842', 'NTR1737. Chronic disease selfmanagement program for employees with a chronic disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1737. (2009)   pp', '10.1186/isrctn77240155', '']\n",
      "['9739843', 'UMIN000025873. Evaluation of educational program of clinical pharmacology on rheumatoid arthritis patients for nurse. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000025873. (2017)   pp', '10.1186/isrctn27093749', '']\n",
      "['9739844', 'UMIN000025768. Open-label, non-controlled study of patient specific femoral guide (PSG) for total hip arthroplasty (THA), linked with 3D surgical support software. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000025768. (2017)   pp', '10.2739/kurumemedj.ms652002', '']\n",
      "['9739845', 'NTR1520. Is there a difference in outcome between the Hoffman procedure and MTP-soft tissue-release in correcting reumatoid MTP-deformities?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1520. (2008)   pp', '10.1007/978-3-540-74986-8_10', '']\n",
      "['9739847', 'NTR1005. The Effects of SCH 351125 on Mononuclear Cell Trafficking to Joints, Synovial Inflammation and Expression of Chemokines in Subjects With Rheumatoid Arthritis (Protocol No. P03653). http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1005. (2007)   pp', '10.1186/isrctn87502236', '']\n",
      "['9739848', 'NTR1193. Psychophysiological stress mechanisms in chronic inflammatory diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR1193. (2007)   pp', '10.1002/ibd.20174', '']\n",
      "['9739849', 'NTR642. The efficacy of wrist working splints in patients with non-destructive wrist arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR642. (2006)   pp', '10.1186/isrctn22172654', '']\n",
      "['9739850', 'UMIN000026431. Analysis of molecular mechanism of systemic bone metabolism abnormality in systemic autoimmune diseases. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000026431. (2017)   pp', '10.1016/b978-0-12-803997-7.00007-7', '']\n",
      "['9739851', \"UMIN000014881. Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki University. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014881. (2014)   pp\", '10.1186/isrctn46017566', '']\n",
      "['9739852', 'NTR816. Conform and non conform glenoid components in total shoulder replacements. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR816. (2006)   pp', '10.1186/isrctn42881741', '']\n",
      "['9739853', 'UMIN000014624. Effects of postoperative administration of celecoxib on postoperative pain management in patients after total knee arthroplasty. A randomized controlled study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014624. (2014)   pp', '10.1186/s13063-015-1106-2', 'http://link.springer.com/article/10.1186/s13063-015-1106-2/fulltext.html']\n",
      "['9739854', 'UMIN000014423. Study of Matrix Metalloproteinase (MMP)-9 expressions in ocular surface disorders using dry eye diagnostic kit InflammaDry. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014423. (2014)   pp', '10.1201/b14144-17', '']\n",
      "['9739855', 'UMIN000014486. Efficacy and security of certolizumab pegol treatment in patients with reumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014486. (2014)   pp', '10.5114/reum.2014.44088', 'https://reu.termedia.pl/pdf-57250-86570']\n",
      "['9739856', 'UMIN000014485. Golimumab study for development of tight control and biologics-free condition. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000014485. (2014)   pp', '10.1186/isrctn89812075', '']\n",
      "['9739857', 'NTR144. Strategies in early arthritis management. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR144. (2005)   pp', '10.1186/isrctn56637846', '']\n",
      "['9739858', 'PER-080-12. A TWO-PART, PHASE I RANDOMIZED, DOUBLE-BLIND, ACTIVE-COMPARATOR CONTROLLED PARALLEL GROUP STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY. AND TOLERABILITY OF MK-8808 AND TO COMPARE THE PHARMACOKINETICS OF MK-8808 WITH RITUXIMUB (MAB THERA TM AND RITUXAN TM) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-080-12. (2013)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739859', 'PER-104-11. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SECUKINUMAB TO DEMONSTRATE THE EFFICACY AT 24 WEEKS AND TO ASSES THE SAFETY, TOLERABILITY AND LONG TERM EFFICACY UP TO 2 YEARS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE AN INADEQUATE RESPONSE TO ANTI-FNTa  AGENTS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-104-11. (2012)   pp', '10.1007/s12688-018-0181-3', 'http://link.springer.com/article/10.1007/s12688-018-0181-3/fulltext.html']\n",
      "['9739862', 'IRCT201306264105N14. The effect of probiotic supplementation on lipid profile and arylesterase activity of paraoxonase enzyme in women with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201306264105N14. (2013)   pp', '10.3390/antiox11122317', '']\n",
      "['9739863', 'CTRI/2014/04/004531. Effect of shiva guggulu tablets and kottam chukkadi taila in management of Amavata (one type of joint disorder). http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/04/004531. (2014)   pp', '10.7897/2277-4343.05102', '']\n",
      "['9739864', 'EUCTR2010-019262-86-AT. Long term evaluation of sarilumab in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019262-86-AT. (2012)   pp', '10.1186/isrctn25539102', '']\n",
      "['9739865', 'EUCTR2010-019926-15-CZ. A Phase 2 placebo-controlled study to compare the effectiveness and safety of two doses of apremilast (CC-10004) in subjects with active rheumatoid arthritis, who have not responded to methotrexate treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019926-15-CZ. (2010)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739866', \"UMIN000007019. Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007019. (2012)   pp\", '10.1186/isrctn21216199', '']\n",
      "['9739868', 'EUCTR2007-000733-19-HU. A Phase 2B, Blinded Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects with Rheumatoid Arthritis Who Previously Participated in Study 104RA202. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000733-19-HU. (2007)   pp', '10.31525/ct1-nct04064060', '']\n",
      "['9739869', 'EUCTR2007-000760-24-CZ. Activity and safety of oral administration of SSR150106XB for the reduction of inflammation in patients with active rheumatoid arthritis (RA): a 4-week, multi-center, randomized, double-blind, placebo-controlled parallel group study of 90 ¬µg administrered once daily and 90¬µg once every other day - ACCORD-RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-000760-24-CZ. (2007)   pp', '10.1186/isrctn71794661', '']\n",
      "['9739870', 'EUCTR2006-003054-26-HU. A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms of in Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003054-26-HU. (2007)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739871', 'UMIN000007205. The efficacy and safety of adding tacrolimus to methotrexate in elderly patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007205. (2012)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739872', 'ISRCTN59145515. Rheumatoid patients with wrist synovitis, if prescribed wrist splints do better in terms of grip strength, than if not prescribed. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN59145515. (2006)   pp', '10.1186/isrctn59145515', '']\n",
      "['9739873', 'UMIN000007806. The feasibility study of accelated infliximab infusion during maintenance phase. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007806. (2012)   pp', '10.1111/j.1365-2036.2011.04699.x', '']\n",
      "['9739874', 'EUCTR2009-012615-18-FR. Efficacy and safety of cholecalciferol on rheumatoid arthritis activity in patients with vitamin D deficiency - SCORPION. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-012615-18-FR. (2010)   pp', '10.1186/isrctn13331870', '']\n",
      "['9739875', 'IRCT201011015062N1. The effect of quercetin supplementation in women with type 2 diabetes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201011015062N1. (2011)   pp', '10.1186/isrctn30703970', '']\n",
      "['9739877', 'EUCTR2015-003289-97-AT. A study to determine the safety and efficacy of LY3337641 in Adult Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003289-97-AT. (2016)   pp', '10.1186/isrctn13331870', '']\n",
      "['9739878', 'DRKS00003328. Is there an increased risk for adverse pregnancy outcome after exposure to low-dose methotrexate (MTX) during early pregnancy? A prospective multicenter cohort study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00003328. (2012)   pp', '10.1093/rheumatology/ket390', 'http://academic.oup.com/rheumatology/article-pdf/53/4/757/5212969/ket390.pdf']\n",
      "['9739879', 'EUCTR2004-002846-36-SK. A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  DMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS - N/A. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-002846-36-SK. (2005)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739880', 'EUCTR2006-001428-38-GB. Remission Induction in Very Early Rheumatoid Arthritis (RIVERA): a comparison of etanercept plus methotrexate plus steroid with standard therapy  - RIVERA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-001428-38-GB. (2006)   pp', '10.1186/isrctn49682259', '']\n",
      "['9739881', 'IRCT201412165667N4. The effect of sexual skills training on intimacy and sexual satisfaction in women. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201412165667N4. (2016)   pp', '10.4069/kjwhn.2016.22.1.30', 'http://synapse.koreamed.org/pdf/10.4069/kjwhn.2016.22.1.30']\n",
      "['9739882', 'ChiCTR-TRC-10000849. Phase II clinical trial of Iguratimod in treatment of rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10000849. (2010)   pp', '10.18810/chictr', '']\n",
      "['9739883', 'EUCTR2010-020745-27-IT. A Phase III, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with Inadequate Response to a TNF-alpha antagonist. D4300C00003 - OSKIRA-3. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-020745-27-IT. (2010)   pp', '10.3899/jrheum.140238', '']\n",
      "['9739884', 'ISRCTN45993953. Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients after more than 4 years of treatment with bisphosphonates or bisphosphonates with pitavastatin. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN45993953. (2012)   pp', '10.1186/isrctn45993953', '']\n",
      "['9739885', 'IRCT201410187984N20. The effects of adding  ozone to the dextrose and uotropin intraarticular ln knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201410187984N20. (2015)   pp', '10.5812/aapm.27585', '']\n",
      "['9739886', 'EUCTR2006-002216-10-CZ. A Multicenter, Double-blind, Randomized, Parallel, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG 760564 in Adult Patients with Rheumatoid Arthritis Receiving Methotrexate - RACER. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-002216-10-CZ. (2006)   pp', '10.1002/art.27694', '']\n",
      "['9739887', 'ISRCTN70160382. Improving outcomes for patients with rheumatoid arthritis with intermediate disease - is intensive management more effective than standard care?. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN70160382. (2014)   pp', '10.1186/isrctn70160382', '']\n",
      "['9739889', 'EUCTR2015-002887-17-NL. Efficacy and Safety Study of BMS-986142 in Patients with Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-002887-17-NL. (2016)   pp', '10.31525/ct1-nct04049448', '']\n",
      "['9739890', 'IRCT201210313664N8. Comparing the effect of  probiotic and conventional yoghurt consumption in patients with non-alcoholic fatty liver disease (NAFLD). http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201210313664N8. (2012)   pp', '10.31525/ct1-nct04147195', '']\n",
      "['9739891', 'EUCTR2014-001114-26-IT. A study of subjects with rheumatoid arthritis who are in clinical remission  to investigate patient and disease characteristics that could help identify which subjects could reduce their adalimumab dose without flaring. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-001114-26-IT. (2014)   pp', '10.1093/rheumatology/keu096.026', 'http://academic.oup.com/rheumatology/article-pdf/53/suppl_1/i65/9578299/keu096.026.pdf']\n",
      "['9739892', 'ISRCTN44344800. A pragmatic randomised controlled trial of hydrotherapy and land exercises on global well-being in patients with rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN44344800. (2004)   pp', '10.1186/isrctn44344800', '']\n",
      "['9739893', 'EUCTR2010-019883-36-DE. A 24 week, randomized, double blind, multicenter, placebo-controlled efficacy, safety, tolerability and PK trial of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-019883-36-DE. (2011)   pp', '10.1016/j.amjhyper.2005.03.260', 'http://academic.oup.com/ajh/article-pdf/18/S4/93A/333712/18_S4_93Aa.pdf']\n",
      "['9739894', 'EUCTR2013-003780-65-IT. Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003780-65-IT. (2013)   pp', '10.1002/art.39249', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39249']\n",
      "['9739895', 'IRCT201110134519N3. The effectiveness of olive oil on controlling of morning inflammatory pain of phalanges and knees among women with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201110134519N3. (2013)   pp', '10.1097/rnj.0000000000000162', '']\n",
      "['9739897', 'IRCT2015042021872N1. the effectiveness of  corticosteroid injection in impingment syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015042021872N1. (2015)   pp', '10.1093/rheumatology/kev089.120', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i140/5181113/kev089.120.pdf']\n",
      "['9739898', 'RPCEC00000230. ESAR-814 Study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RPCEC00000230. (2017)   pp', '10.29199/esar.101', '']\n",
      "['9739899', 'JapicCTI-111620. A Randomized, Double-Blind, Phase I/II Study of CT-P13 Compared with Remicade in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-111620. (2011)   pp', '10.4172/1745-7580.1000087', '']\n",
      "['9739900', 'ISRCTN69908361. Intramuscular depomedrone in very early inflammatory polyarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN69908361. (2002)   pp', '10.1186/isrctn69908361', '']\n",
      "['9739901', 'RPCEC00000035. Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes  with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RPCEC00000035. (2010)   pp', '10.5455/medscience.2015.04.8350', '']\n",
      "['9739902', 'EUCTR2005-006165-14-CZ. A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study of the Efficacy, Safety, and Pharmacokinetics of MLN3897 in Patients with Rheumatoid Arthritis Taking Methotrexate - NA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-006165-14-CZ. (2006)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739903', \"UMIN000020224. Study on the effectiveness of the combination of cepharanthin and low-intensity pulsed ultrasound for Sjogren's syndrome patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000020224. (2015)   pp\", '10.26226/morressier.5ac383182afeeb00097a47f9', '']\n",
      "['9739904', 'EUCTR2016-000064-42-BG. Safety and Efficacy study of M2951 in Subjects with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-000064-42-BG. (2016)   pp', '10.1186/isrctn50655730', '']\n",
      "['9739906', 'EUCTR2009-015898-12-BE. Randomized, Double-Blind, Placebo-Controlled, Multicenter, Exploratory Phase II Study to Compare Three Dose Regimens of GLPG0259 vs Placebo, in Combination with Methotrexate, Administered for 12 Weeks to Subjects with Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015898-12-BE. (2010)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739907', 'IRCT201403109472N6. The effect of Ginger powder consumption on some genes expression that are mediators of immunity and inflammation in adult with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201403109472N6. (2014)   pp', '10.1016/j.gene.2019.01.048', '']\n",
      "['9739908', 'ISRCTN79105828. Can monthly low dose intramuscular (IM) steroids prevent erosive damage in established rheumatoid arthritis? A randomised placebo controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN79105828. (2002)   pp', '10.1186/isrctn79105828', '']\n",
      "['9739909', 'IRCT2016062728668N1. The success rate of intubation in patients with neck injury. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016062728668N1. (2016)   pp', '10.21275/sr23606214619', '']\n",
      "['9739910', 'EUCTR2006-001553-10-IT. A 26-week, phase II, multi-center, randomized, doubleblind,  placebo-controlled study to assess the response to  treatment (ACR50) and to determine a biomarker profile in  responders to ACZ885 (anti-interleukin-1beta monoclonal  antibody) plus MTX as compared to MTX alone in early  rheumatoid arthritis patients - ND. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-001553-10-IT. (2007)   pp', '10.1016/s0084-3873(09)79333-2', '']\n",
      "['9739911', 'EUCTR2008-001105-42-PL. A Phase 2 Study of Multiple Intravenous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Rheumatoid Arthritis on Concomitant Methotrexate and an Inadequate Response to TNFa Inhibitor Therapy - BCDG. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-001105-42-PL. (2009)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739912', 'EUCTR2005-003495-38-IE. A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (MTX) therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003495-38-IE. (2005)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n",
      "['9739914', 'CTRI/2014/05/004641. A clinical trial to study the effects of two drugs, Methotrexate / Imeth‚àö√á¬¨√Ü in Patients with Rheumatoid Arthritis under fasting condition. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/05/004641. (2014)   pp', '10.1002/cca.371', '']\n",
      "['9739917', 'ChiCTR-ONRC-13003578. Agkistrodon different formulations inflammatory and analgesic effects on rheumatoid arthritis clinical study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-ONRC-13003578. (2013)   pp', '10.1111/j.1742-1241.1973.tb09038.x', '']\n",
      "['9739918', \"UMIN000005878. Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005878. (2011)   pp\", '10.21276/ijcmr.2018.5.5.41', '']\n",
      "['9739919', 'EUCTR2012-004605-27-IT. Study that will compare a tear substitute (Siccafluid) with autologous serum (from the blood of the subject) in the pathology of dry eye, according to a plan that neither the doctor nor the patient will know which treatment the patient is assigned. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-004605-27-IT. (2012)   pp', '10.1186/isrctn94958652', '']\n",
      "['9739920', 'IRCT2015032011335N5. Effects of brewed tea of poulk in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015032011335N5. (2015)   pp', '10.1186/isrctn70800019', '']\n",
      "['9739921', 'ChiCTR-IPR-14005441. A double blind randomized study of Jiedu Tongluo Shengjin Decoction in treatment of primary Sjogren syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-14005441. (2014)   pp', '10.5665/sleep/32.2.159', '']\n",
      "['9739922', \"ISRCTN18282428. A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomised controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18282428. (2008)   pp\", '10.1186/isrctn18282428', '']\n",
      "['9739923', 'EUCTR2013-000114-38-HU. A 24-week, placebo-controlled, multicenter study to investigate the efficacy and safety of tregalizumab (BT061) in combination with methotrexate in the treatment of subjects with active rheumatoid arthritis who have had an insufficient response to methotrexate alone, followed by a 24-week extension phase: t cell REgulating Arthritis Trial 2b (TREAT 2b). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-000114-38-HU. (2013)   pp', '10.3410/f.14174.471676', '']\n",
      "['9739924', 'ChiCTR-TRC-10001014. Randomized Controlled Study to Evaluate the Clinical Outcomes of Rheumatoid Arthritis Treated with Method of Activating Blood Circulation by Removing Blood Stasis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10001014. (2010)   pp', '10.4268/cjcmm20132033', '']\n",
      "['9739927', 'ChiCTR-TRC-10001147. Treatment of rheumatoid arthritis by arthroscopic synovectomy combined with disease-modifying antirheumatic drugs. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-10001147. (2011)   pp', '10.1002/psb.773', '']\n",
      "['9739928', 'EUCTR2004-002157-30-DK. A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-002157-30-DK. (2004)   pp', '10.1186/isrctn57843703', '']\n",
      "['9739929', 'ChiCTR-IPR-14005684. Compare with methotrexate tablets to evaluate the randomized double-blind, multicenter clinical trial to trial the efficacy and safety of the injection technetium \"99Tc\" methylene diphosphonate treatment for active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-14005684. (2014)   pp', '10.1016/s0084-3873(09)79348-4', '']\n",
      "['9739930', 'UMIN000007432. Prospective research of infliximab treatment in active RA patients refractry to anti-interleukin six receptor monoclonal antibody. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007432. (2012)   pp', '10.1186/isrctn29665463', '']\n",
      "['9739931', 'UMIN000007404. Open-label, multicenter, randomized controlled trials, for comparing  remission induction rate of a dose-escalation therapy of methotrexate and  an additional combination therapy with  bucillamine for naive patients to over 8 mg/weekly of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007404. (2012)   pp', '10.1186/isrctn36745608', '']\n",
      "['9739932', 'IRCT201308064409N3. Exercise therapy and Platelet Rich Plasma injection in shoulder pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201308064409N3. (2013)   pp', '10.1186/isrctn66528592', '']\n",
      "['9739933', 'UMIN000007380. Comparison of the effects of single high-dose methotrexate and methotrexate-tocilizumab therapy on rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000007380. (2012)   pp', '10.1186/isrctn49682259', '']\n",
      "['9739934', 'UMIN000010105. Postoperative quadriceps strength of continuous or patient-controlled femoral nerve block: a prospective, randomized double-blind trial after total knee arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010105. (2013)   pp', '10.2147/tcrm.s33544', '']\n",
      "['9739935', 'ISRCTN01982076. RheumAFooT (Rheumatoid Arthritis Foot Trial). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN01982076. (2003)   pp', '10.1186/isrctn01982076', '']\n",
      "['9739936', 'UMIN000010033. To investigate the efficacy of tocilizumab in RA patients with moderate disease activity under biologic therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010033. (2013)   pp', '10.1136/annrheumdis-2013-eular.2632', '']\n",
      "['9739937', 'IRCT201305254105N12. The Effect of coenzyme Q10 on serum concentrations of pentraxin 3 and metabolic parameters in non-alcoholic fatty liver disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201305254105N12. (2013)   pp', '10.3390/obesities4020011', '']\n",
      "['9739938', 'EUCTR2012-003686-17-LT. A Phase 3 Study in Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003686-17-LT. (2013)   pp', '10.1093/ww/9780199540884.013.u237827', '']\n",
      "['9739942', 'IRCT201105106431N1. Effects of probiotic yogurt ingestion on inflammation and intestinal function in patients with inflammatory bowel disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201105106431N1. (2012)   pp', '10.1111/j.1365-2249.2007.03434.x', 'https://academic.oup.com/cei/article-pdf/149/3/470/42037899/j.1365-2249.2007.03434.x.pdf']\n",
      "['9739943', 'PER-060-14. Reflections B537-02. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-060-14. (2015)   pp', '10.35699/2317-6377.2006.58310', 'https://periodicos.ufmg.br/index.php/permusi/article/download/58310/47899']\n",
      "['9739946', 'UMIN000021910. The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021910. (2016)   pp', '10.58837/chula.the.2023.579', '']\n",
      "['9739947', 'UMIN000021929. Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021929. (2016)   pp', '10.1186/isrctn13142685', '']\n",
      "['9739948', 'EUCTR2011-001626-15-ES. A study of RoActemra/Actemra (tocilizumab) in combination with methotrexate in patients with rheumatoid arthritis with inadequate response to prior treatment with methotrexate and low disease activity with the combination de RoActemra/Actemra y methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-001626-15-ES. (2011)   pp', '10.2165/00128413-200716000-00015', '']\n",
      "['9739950', 'IRCT138807252394N2. Effects of Quercetin on plasma total antioxidant capacity, lipid peroxidation, blood pressure, inflammatory markers and disease activity in patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138807252394N2. (2010)   pp', '10.47750/pnr.2022.13.03.037', '']\n",
      "['9739951', 'IRCT201301167274N6. Evaluation of efficacy of Platelet-rich plasma injection plus oral celecoxib to treat knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201301167274N6. (2013)   pp', '10.47583/ijpsrr.2024.v84i04.014', '']\n",
      "['9739952', 'ChiCTR-TRC-08000093. Phase ?clinical trial of chicken type II collagen in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-08000093. (2008)   pp', '10.18810/chictr', '']\n",
      "['9739954', 'UMIN000021974. Precision comparison analysis of the navigation system in the total hip arthroplasty. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021974. (2016)   pp', '10.29007/9mwf', '']\n",
      "['9739955', 'EUCTR2013-005001-31-ES. Study on the ability of zoledronic acid to prevent worsening of radiographs of hands and feet of patients with rheumatoid arthritis diagnosed less than 2 years ago and who have few symptoms in their joints by making treatment with the drugs commonly used for the management of disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-005001-31-ES. (2014)   pp', '10.1186/isrctn15403905', '']\n",
      "['9739956', 'UMIN000021633. Study for theraputic effect of soy been peptide on arthritis in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021633. (2016)   pp', '10.1186/isrctn28793839', '']\n",
      "['9739957', 'UMIN000021640. Study for laser therapy against arthritis in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021640. (2016)   pp', '10.1186/isrctn60187959', '']\n",
      "['9739958', 'UMIN000021736. To measure the variation of the RFC activity in lymphocytes by MTX administration. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021736. (2016)   pp', '10.1186/isrctn33202080', '']\n",
      "['9739960', 'UMIN000005747. Comparison of 3 ELISA kits for anti-neutrophil cytoplasmic antibody (ANCA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005747. (2011)   pp', '10.1111/j.1365-2249.2011.04359.x', 'https://academic.oup.com/cei/article-pdf/164/Supplement_1/14/41909334/j.1365-2249.2011.04359.x.pdf']\n",
      "['9739961', 'UMIN000005773. Magnetic resonance image analysis for quantification of knee articular cartilage verified response to etanercept(ETN) in subjects with active rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005773. (2011)   pp', '10.1136/annrheumdis-2012-eular.2551', '']\n",
      "['9739962', 'UMIN000005362. Clinical study for the efficacy of mesalazine for the treatment of small bowel injury caused by non-steroidal anti-inflammatory drugs(NSAIDs). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005362. (2011)   pp', '10.1186/isrctn91790322', '']\n",
      "['9739963', 'ISRCTN32398235. Assessment of safety, pharmacokinetics and efficacy in a combination treatment with SMP-114. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN32398235. (2006)   pp', '10.1186/isrctn32398235', '']\n",
      "['9739964', 'ISRCTN74129767. A randomised controlled trial investigating the effect of debridement of painful and disabling forefoot plantar callosities and corns in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN74129767. (2004)   pp', '10.1186/isrctn74129767', '']\n",
      "['9739965', 'UMIN000021492. To investigate the safety of switch from infliximab biosimilar 1 in rheumatoid arthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021492. (2016)   pp', '10.1136/annrheumdis-2021-eular.477', '']\n",
      "['9739967', 'EUCTR2009-013223-37-CZ. A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-013223-37-CZ. (2009)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739968', 'EUCTR2008-000327-25-PL. A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF CE-224,535, AN ANTAGONIST OF THE P2X7 RECEPTOR, IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN SUBJECTS WHO ARE INADEQUATELY CONTROLLED ON METHOTREXATE. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000327-25-PL. (2008)   pp', '10.1186/isrctn49455679', '']\n",
      "['9739969', 'CTRI/2014/04/004571. A clinical trial to study the effects of two drugs, R-TPR-021 / Humira‚àö√á¬¨√Ü in Patients with Active Rheumatoid Arthritis on a stable dose of Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/04/004571. (2014)   pp', '10.4172/2161-1165.1000173', '']\n",
      "['9739970', 'IRCT138811093220N1. The effect of laser on planter fasciitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138811093220N1. (2011)   pp', '10.23937/ijfa-2017/1710002', '']\n",
      "['9739971', 'IRCT201403138286N4. Comparative the  effect of white noise, earplug and Instrumental  music on sleep in Cardiac patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201403138286N4. (2014)   pp', '10.1186/isrctn29988120', '']\n",
      "['9739972', 'ISRCTN48092875. N3 fatty acids as adjuvant therapy in rheumatoid arthritis (N3-fetts√§uren als adjuvante therapie bei rheumatoider arthritis). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN48092875. (2008)   pp', '10.1186/isrctn48092875', '']\n",
      "['9739973', 'UMIN000024507. Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000024507. (2016)   pp', '10.1186/s40780-017-0073-z', 'http://link.springer.com/content/pdf/10.1186/s40780-017-0073-z.pdf']\n",
      "['9739974', 'PER-063-14. REFLEXIONS B538-02. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-063-14. (2015)   pp', '10.35699/2317-6377.2006.58310', 'https://periodicos.ufmg.br/index.php/permusi/article/download/58310/47899']\n",
      "['9739975', 'UMIN000024143. efficacy of aterosclerosis of tofacitinib in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000024143. (2016)   pp', '10.1007/s40278-024-54853-6', 'https://link.springer.com/article/10.1007/s40278-024-54853-6/fulltext.html']\n",
      "['9739979', 'ChiCTR-TRC-12002269. The research of immue state and current treatment in early rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-TRC-12002269. (2012)   pp', '10.1186/isrctn28793839', '']\n",
      "['9739980', 'ISRCTN60834248. The Fixed Bearing Lateral Stabilised DJO 3D Knee‚Ñ¢ versus the Finsbury Medial Rotation Knee‚Ñ¢ System versus the Stryker Triathlon¬Æ knee in primary total knee replacement for osteoarthritis and rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN60834248. (2011)   pp', '10.1186/isrctn60834248', '']\n",
      "['9739981', 'ChiCTR-IPR-14005722. Study on telephone follow-up for health education in discharged patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-14005722. (2014)   pp', '10.1111/jocn.15002', 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocn.15002']\n",
      "['9739984', 'IRCT2014051817738N1. Effect of Atorvastatin in  patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014051817738N1. (2014)   pp', '10.1186/isrctn41829447', '']\n",
      "['9739985', \"ISRCTN14030412. Prediction and prevention of preeclampsia, intrauterine growth restriction, prenatal stress and fetal programming of child's psychological development. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN14030412. (2007)   pp\", '10.1186/isrctn14030412', '']\n",
      "['9739986', 'UMIN000006702. A parallel group, randomized clinical trial on the efficacy and safety of intensive treatment strategy with MTX as the anchor-drug in patients with active early rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000006702. (2011)   pp', '10.1186/isrctn13142685', '']\n",
      "['9739987', 'IRCT201606173220N7. The effect of electroacupuncture and laser on knee osteoarthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201606173220N7. (2016)   pp', '10.31525/ct1-nct04188925', '']\n",
      "['9739988', 'ISRCTN62025354. Minimal interventions to improve medication adherence in people with multiple long-term conditions (MINIMA) study. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN62025354. (2014)   pp', '10.1186/isrctn62025354', '']\n",
      "['9739989', 'EUCTR2005-001977-82-GB. A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001977-82-GB. (2005)   pp', '10.1186/isrctn50665418', '']\n",
      "['9739990', 'IRCT138808182685N1. The effect of low-dose oral Theophylline drug on active c serum protein level in patients with stable chronic obstructive pulmonary disease. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138808182685N1. (2009)   pp', '10.12816/0023358', '']\n",
      "['9739992', 'IRCT2016020414680N3. Effects of oral administration of cinnamon on rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016020414680N3. (2016)   pp', '10.1186/isrctn98945627', '']\n",
      "['9739993', 'UMIN000021247. Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-state. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000021247. (2016)   pp', '10.1136/annrheumdis-2012-eular.565', '']\n",
      "['9739995', 'EUCTR2012-003629-40-CZ. An Efficacy And Safety Study of CNTO6785 In Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003629-40-CZ. (2012)   pp', '10.1007/s00296-011-1944-5', 'http://link.springer.com/article/10.1007/s00296-011-1944-5/fulltext.html']\n",
      "['9739996', 'ISRCTN98945627. Control of Rheumatoid Arthritis (RA) by oral tolerance. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN98945627. (2002)   pp', '10.1186/isrctn98945627', '']\n",
      "['9740003', 'PER-020-13. A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK 0663/Etoricoxib in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=PER-020-13. (2013)   pp', '10.1186/isrctn04296019', '']\n",
      "['9740004', 'EUCTR2005-003525-92-DK. A Phase 2, Multicenter, Randomized, Double-blind, Placebo controlled Trial of CNTO 1275, a Fully Human Anti IL 12 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psoriatic Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-003525-92-DK. (2005)   pp', '10.1093/rheumatology/kev089.115', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i137/5181070/kev089.115.pdf']\n",
      "['9740005', \"UMIN000019009. The multicenter randomized open controlled trials of impact on clinical effect and oxidative stress markers of Mucosta ophthalmic solution that targets the dry eye patients complicated with Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000019009. (2015)   pp\", '10.21203/rs.2.487/v4', 'https://www.researchsquare.com/article/rs-486/v4']\n",
      "['9740006', 'IRCT2012102110603N1. The effects of designed educational program on health related quality of life of  knee osteoarthritis patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012102110603N1. (2012)   pp', '10.5297/ser.1403.012', '']\n",
      "['9740007', 'EUCTR2015-004476-30-DE. A Study to Evaluate the Efficacy of RO5459072 in Participants With Primary Sj√∂gren‚Äôs Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-004476-30-DE. (2016)   pp', '10.2147/opth.s35685', '']\n",
      "['9740008', 'EUCTR2004-004995-35-GB. A PHASE II MULTI-CENTER, RANDOMIZED, BLINDED STUDY OF 14 WEEKS DURATION COMPARING THE EFFECT OF CRx-139 PLUS DMARD THERAPY TO THAT OF STEROID PLUS DMARD THERAPY USING ACR-20 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS PARTIALLY RESPONSIVE TO THE DMARD. - CRx-139-RA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-004995-35-GB. (2005)   pp', '10.3410/f.717748061.793153315', '']\n",
      "['9740009', 'ISRCTN61158084. BIOmarker-driven DEcision Study with Adalimumab (BIODESA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN61158084. (2008)   pp', '10.1186/isrctn61158084', '']\n",
      "['9740010', 'IRCT2015091924080N1. Effect of vitamin C and omega-3 on the incidence of AF after surgery, length of stay in the ICU, and fatigue in patients with open heart surgery. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015091924080N1. (2016)   pp', '10.1186/isrctn98572043', '']\n",
      "['9740011', 'EUCTR2010-021577-37-DE. A PHASE II, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MLTA3698A IN COMBINATION WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG (DMARD) COMPARED WITH ADALIMUMAB IN COMBINATION WITH A DMARD IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021577-37-DE. (2010)   pp', '10.1007/978-3-211-79280-3_256', 'http://link.springer.com/content/pdf/10.1007/978-3-211-79280-3_256.pdf']\n",
      "['9740012', 'CTRI/2015/05/005737. To compare bioavailibility of Methotrexate Tablets 2.5 mg( Actavis LLC) with Methotrexate Tablets USP 2.5 mg (DAVA Pharmaceuticals, Inc.USA) in patients with mild to severe psoriasis or rheumatoid arthritis, who are already on established regimens of 2.5 mg every 12 hours under fasting condition. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/05/005737. (2015)   pp', '10.31525/ct1-nct03898193', '']\n",
      "['9740013', 'ISRCTN49672274. Foot disease in Juvenile Idiopathic Arthritis: foot care trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN49672274. (2012)   pp', '10.1186/isrctn49672274', '']\n",
      "['9740015', 'EUCTR2007-005218-38-FR. Essai prospectif Randomis√© contre placebo  en double aveugle de l‚ÄôhydroxychloroQUine dans le traitement du syndrome de sJOgren primitif (JOQUER) - JOQUER. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-005218-38-FR. (2007)   pp', '10.1016/s0151-9638(04)93745-3', '']\n",
      "['9740017', 'ISRCTN21272423. A double blind, randomised, placebo controlled, multicentre trial of Anti-Tumour Necrotising Factor alpha (Anti-TNFa) chimeric monoclonal antibody (infliximab, Remicade¬Æ) in combination with methotrexate in patients with very early inflammatory arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN21272423. (2007)   pp', '10.1186/isrctn21272423', '']\n",
      "['9740019', 'EUCTR2005-001319-23-IT. A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 3 Oral Doses of ERB-041 in Subjects With Rheumatoid Arthritis on a Background of Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-001319-23-IT. (2005)   pp', '10.3899/jrheum.150613.c1', '']\n",
      "['9740020', 'IRCT2015041121686N1. The self-care education and stabilizing exercise in pain, disability and muscle activities in mothers with chronic low back pain having children with cerebral palsy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015041121686N1. (2015)   pp', '10.1097/phm.0000000000001315', '']\n",
      "['9740021', 'EUCTR2013-005418-37-IT. A multicenter, placebo-controlled phase II study to evaluate safety and clinical efficacy of two different doses of F8IL10 administered subcutaneously to patients with active rheumatoid arthritis receiving Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-005418-37-IT. (2014)   pp', '10.1186/isrctn49455679', '']\n",
      "['9740022', 'EUCTR2008-006443-39-ES. Estudio piloto de fase II multic‚àö¬©ntrico, aleatorizado, en grupos paralelos para comparar la incidencia de las reacciones a la infusi‚àö‚â•n de Tocilizumab en pacientes con AR moderada a grave cuando la infusi‚àö‚â•n se realiza en 1 hora frente a 31 minutos. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-006443-39-ES. (2008)   pp', '10.35376/10324/39343', '']\n",
      "['9740023', 'IRCT2017010531711N2. Effect of Group Psychotherapy in Patients With Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017010531711N2. (2017)   pp', '10.1186/isrctn36516369', '']\n",
      "['9740024', 'JapicCTI-060259. A randomized, double-blind, multicenter, placebo-controlled study to determine the efficacy and safety of BTDS compared to placebo in subjects with moderate to severe osteoarthritic pain of the hip or knee. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-060259. (2006)   pp', '10.1186/isrctn75684296', '']\n",
      "['9740025', 'ISRCTN22788282. Effect of folic acid supplementation and allopurinol on blood vessel health in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN22788282. (2008)   pp', '10.1186/isrctn22788282', '']\n",
      "['9740026', 'EUCTR2005-002189-12-SI. A randomized, multicenter, international, open-label study of infliximab plus methotrexate versus methotrexate (MTX) alone for the treatment of MTX na√Øve subjects with Active Psoriatic Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005-002189-12-SI. (2005)   pp', '10.1016/s1098-3015(10)68898-5', '']\n",
      "['9740027', 'ChiCTR-INR-16009629. A double blinded Stratified sampling study of Jiedu Tongluo Shengjin prescription in treatment of primary Sjogren syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16009629. (2016)   pp', '10.1002/lary.26002', 'https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flary.26002']\n",
      "['9740028', 'IRCT2015012520795N1. \"BURP\" maneuver and intubation conditions. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015012520795N1. (2016)   pp', '10.34172/mj.2019.026', 'https://mj.tbzmed.ac.ir/Article/27118']\n",
      "['9740030', 'ISRCTN72443728. Febuxostat versus allopurinol streamlined trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN72443728. (2011)   pp', '10.1186/isrctn72443728', '']\n",
      "['9740032', 'ChiCTR-INR-16009481. Nerve block anesthesia and general anesthesia influnce postoperative on cognitive dysfunction after hip athroplasty of aged fracture of neck of femur patients: randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16009481. (2016)   pp', '10.1101/2021.03.14.21253545', '']\n",
      "['9740033', 'IRCT201605215520N8. A comparison between the effects of two types of orthosis in hallux valgus. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201605215520N8. (2016)   pp', '10.30707/etd2014.kelly.a', '']\n",
      "['9740034', 'ChiCTR-INR-16009274. The multi-center clinical research in TCM diagnosis and treatment norms on Rheumatoid arthritis of piweikuixu-shirezuluo symptoms. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16009274. (2016)   pp', '10.1186/isrctn27093749', '']\n",
      "['9740035', 'EUCTR2011-002849-36-LV. A study of multiple different dosages of JNJ 39758979 and placebo in patients with active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002849-36-LV. (2011)   pp', '10.1186/isrctn31164692', '']\n",
      "['9740036', 'IRCT2014051717716N1. The effect of orthosis in patient with chronic plantar fasciitis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014051717716N1. (2014)   pp', '10.1186/isrctn51246098', '']\n",
      "['9740038', 'DRKS00011083. Clinical study of an anthroposophic treatment strategy for early rheumatoid arthritis, compared to conventional long-term therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011083. (2016)   pp', '10.1186/isrctn13142685', '']\n",
      "['9740039', 'CTRI/2010/091/000127. A clinical study to evaluate the efficacy and safety of FDC of Tolperisone and Paracetamol in patients suffering from acute muscle spasms. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2010/091/000127. (2010)   pp', '10.22159/ajpcr.2021.v14i12.43295', 'https://innovareacademics.in/journals/index.php/ajpcr/article/download/43295/25779']\n",
      "['9740041', 'EUCTR2008-007185-33-HU. A Seamless, Phase 1/2, Multiple Ascending Dose, Proof of Concept Study of ATN-103 Administered to Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-007185-33-HU. (2009)   pp', '10.1186/isrctn13784998', '']\n",
      "['9740042', 'DRKS00011113. NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the knee joint. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011113. (2016)   pp', '10.1186/isrctn72633488', '']\n",
      "['9740043', 'EUCTR2008-004875-23-PL. An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-004875-23-PL. (2009)   pp', '10.1093/rheumatology/kew144.001', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i90/5078829/kew144.001.pdf']\n",
      "['9740045', 'IRCT2014071218453N1. Effect of Saffron on Rheumatoid Arthritis treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014071218453N1. (2015)   pp', '10.1093/rheumatology/kev139', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/kev139/5182107/kev139.pdf']\n",
      "['9740046', 'RBR-4h97rb. Low Level Laser Therapy and exercise to patients with chronic pain and rheumatic diseases: randomized clinical trials with pain , quality of life, functionality assessments and biomechanical aspects. http://www.who.int/trialsearch/Trial2.aspx?TrialID=RBR-4h97rb. (2016)   pp', '10.17504/protocols.io.bi6gkhbw', '']\n",
      "['9740047', 'EUCTR2011-002275-41-CZ. A Study of Two Different Adalimumab Formulations in Adults with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-002275-41-CZ. (2011)   pp', '10.1007/s12513-012-0658-0', 'http://link.springer.com/article/10.1007/s12513-012-0658-0/fulltext.html']\n",
      "['9740048', 'EUCTR2011-006058-94-PT. Secukinumab efficacy and safety study in patients with active Rheumatoid Arthritis (RA) and an Inadequate response to anti-TNFa agents. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-006058-94-PT. (2012)   pp', '10.1093/rheumatology/kew144.005', 'http://academic.oup.com/rheumatology/article-pdf/55/suppl_1/i93/5078864/kew144.005.pdf']\n",
      "['9740049', 'IRCT2014031517017N1. Effects of pomegranate juice on osteoarthritis of the knee. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014031517017N1. (2014)   pp', '10.1186/isrctn68475405', '']\n",
      "['9740050', 'CTRI/2016/05/006899. A study to compare the biosimilar of Etanercept (coded as YLB113) made by YLBiologics with Enbrel (originator‚àö¬¢??s Etanercept) in patients suffering from rheumatoid arthritis with respect to its efficacy, safety and antibody formation. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2016/05/006899. (2016)   pp', '10.1007/s40744-016-0045-z', 'http://link.springer.com/content/pdf/10.1007/s40744-016-0045-z.pdf']\n",
      "['9740052', 'IRCT2013092612450N1. Tendon/Nerve gliding exercises in carpal tunnel syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2013092612450N1. (2014)   pp', '10.51559/ptji.v5i1.173', 'https://ptji.org/index.php/ptji/article/download/173/105']\n",
      "['9740053', 'EUCTR2006-006373-25-SK. A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE LONG TERM SAFETY AND FUNCTIONAL STATUS OF SUBJECTS WITH RHEUMATOID ARTHRITIS PREVIOUSLY ENROLLED IN STUDIES OF cp 690,550 - N/A. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006373-25-SK. (2007)   pp', '10.1186/isrctn14123846', '']\n",
      "['9740054', 'DRKS00010909. Structured assessment of the risk Profile of RA patients by the rheumatology nurse. http://www.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010909. (2016)   pp', '10.1186/isrctn29803766', '']\n",
      "['9740055', 'CTRI/2015/01/005398. A study to determine pharmacodynamics (effect of drug in the body) and to compare pharmacokinetics (how drug behaves in the body), Safety and tolerability of single dose of Lupin‚àö¬¢??s Rituximab with Roche‚àö¬¢??s Rituximab following I.V. infusion in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/01/005398. (2015)   pp', '10.1093/rheumatology/kev088.092', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i86/5180170/kev088.092.pdf']\n",
      "['9740056', 'CTRI/2011/091/000150. Clinical trial to evaluate the efficacy and safety of the  fixed dose combination of Tramadol 50 mg IR + Diclofenac 75 mg SR  vs fixed dose combination of Tramadol 37.5 mg + Paracetamol 325 mg in treatment of patients with moderate to severe pain due to acute musculoskeletal conditions , acute flare of osteoarthritis , acute flare of rheumatoid arthritis and post operative pain. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2011/091/000150. (2011)   pp', '10.2147/jpr.s67817', '']\n",
      "['9740057', 'EUCTR2013-003493-27-HU. Study with the aim to evaluate the safety, tolerability and efficacy of QAL964 in patients with Rheumatoid Arthritis who are treated with anti-rheumatic drug methotrexate but where the treatment does not sufficiently work. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2013-003493-27-HU. (2014)   pp', '10.1136/annrheumdis-2023-eular.5991', '']\n",
      "['9740058', 'EUCTR2008-000742-30-PL. A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of Two Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2008-000742-30-PL. (2008)   pp', '10.1002/art.23964', '']\n",
      "['9740059', 'EUCTR2014-005418-45-SE. Are risk factors factors of  pertaining to or involving the heart and blood vessels and markers characterized or caused by inflammation in  Rheumatoid Arthritis (a chronic, systemic inflammatory disorder that primarily affects joints) and Systemic Lupus Erythematosus (systemic disease in which the body‚Äôs immune system mistakenly attacks healthy tissue)improved? New aspects of Hydroxychloroquine ‚Äì an interventional study (HCQCVDRASLE). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-005418-45-SE. (2015)   pp', '10.1007/978-3-319-24535-5_4', '']\n",
      "['9740063', 'EUCTR2004-004022-27-ES. Phase IIa, multicenter, randomised, double-blind, placebo controlled study of the efficacy and safety of RO0506997, an a4 integrin antagonist, in combination with methotrexate, versus methotrexate alone, in patients with mild/moderate active rheumatoid arthritis (RA) who have had a partial response to a stable dose of methotrexate. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2004-004022-27-ES. (2005)   pp', '10.3410/f.14174.471676', '']\n",
      "['9740066', 'EUCTR2014-001299-79-DK. Pnemococcal vaccination of rheumatoid arthritis patients in biological treatment. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-001299-79-DK. (2014)   pp', '10.1002/asna.18981450406', '']\n",
      "['9740067', 'EUCTR2016-002126-36-DE. A Study to Evaluate the Safety and Efficacy of RO7123520 as Adjunct Treatment in Patients With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to TNF-a Inhibitors. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002126-36-DE. (2016)   pp', '10.31525/ct1-nct03980483', '']\n",
      "['9740068', 'IRCT2016061828510N1. The effect of ulnar styloid fracture fixation in treatment of radius fracture. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016061828510N1. (2016)   pp', '10.53347/rid-165067', '']\n",
      "['9740069', 'IRCT201112066975N2. A randomized clinical trial comparing the effect of methylprednisolone and dexamethasone pulse in the control of rheumatoid arthritis flare up. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112066975N2. (2011)   pp', '10.1111/1756-185x.12278', '']\n",
      "['9740070', 'EUCTR2010-021449-28-FR. Valeur pr√©dictive de la concentration s√©rique d‚ÄôAdalimumab (Humira) sur la r√©ponse clinique dans la polyarthrite rhumato√Øde - AFORA. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2010-021449-28-FR. (2010)   pp', '10.4267/2042/20409', '']\n",
      "['9740071', \"UMIN000019242. Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000019242. (2015)   pp\", '10.1101/2023.01.23.23284918', '']\n",
      "['9740072', 'UMIN000019216. The evaluation of hydroxychoroquine (HCQ) for cutaneous lupus erythematosus (LE) including LE and Sjogren syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000019216. (2016)   pp', '10.33140/ijced.05.02.02', '']\n",
      "['9740073', 'EUCTR2014-004719-36-BG. Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-004719-36-BG. (2016)   pp', '10.1136/annrheumdis-2020-eular.1688', '']\n",
      "['9740074', 'ISRCTN12245727. Four year follow-up of a randomised controlled trial of joint protection for people with rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN12245727. (2002)   pp', '10.1186/isrctn12245727', '']\n",
      "['9740075', 'ChiCTR-INR-16009031. Evaluation of the Effect of Huayu Qiangshen Tongbi Fomular Combined with MTX on Treating Rheumatoid Arthritis and Study of the mechanism through gut microbiomes. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-INR-16009031. (2016)   pp', '10.1155/2022/2836128', 'http://downloads.hindawi.com/journals/jir/2022/2836128.pdf']\n",
      "['9740076', \"ISRCTN58887461. Effectiveness of an electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN58887461. (2012)   pp\", '10.1186/isrctn58887461', '']\n",
      "['9740077', \"EUCTR2006-003391-35-NL. Evaluation of the efficacy and safety of unpreserved dexamethasone phosphate 0.1% eye drops (T1910) versus placebo in patients with bilateral treated severe keratoconjunctivitis sicca due to Sj√∂grens' syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-003391-35-NL. (2006)   pp\", '10.1111/j.1755-3768.2010.330.x', '']\n",
      "['9740078', 'IRCT138803232027N1. Effect of Bromocriptine in rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT138803232027N1. (1900)   pp', '10.1186/isrctn36516369', '']\n",
      "['9740079', 'IRCT2017011231906N1. The effect of ketorolac in the treatment of shoulder impingement syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2017011231906N1. (2017)   pp', '10.5040/9781350969179', '']\n",
      "['9740081', 'CTRI/2010/091/000077. A clinical trial to study the effects of Eperisone SR in patients suffering from acute muscle spasms. http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2010/091/000077. (2010)   pp', '10.1037/e566792012-091', '']\n",
      "['9740082', 'EUCTR2011-004529-28-BG. A Study of the Efect of JNJ-40346527 and Placebo in Patients with Active Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-004529-28-BG. (2012)   pp', '10.1186/isrctn76859006', '']\n",
      "['9740083', 'EUCTR2012-003194-25-HR. Bioequivalence trial of MabionCD20¬¨√Ü (Mabion SA) compared to reference product: mabThera¬¨√Ü (rituximab, Roche) in Patients with Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2012-003194-25-HR. (2014)   pp', '10.3899/jrheum.131279', '']\n",
      "['9740084', 'EUCTR2009-015019-42-Outside-EU/EEA. Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children with Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015019-42-Outside-EU/EEA. (2012)   pp', '10.15690/vsp.v16i6.1823', 'http://vsp.spr-journal.ru:80/jour/article/viewFile/1837/752']\n",
      "['9740085', 'IRCT2012062610114N1. The effect of tomato juice on concentration of antioxidant enzymes and total antioxidant capacity of blood in over-weight and obese female student. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012062610114N1. (2012)   pp', '10.1016/s0271-5317(03)00131-3', '']\n",
      "['9740086', 'ACTRN12606000072516. Evaluation of an interactive audiovisual computer program educating patients with rheumatoid arthritis starting treatment with methotrexate: a randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000072516. (2006)   pp', '10.3410/f.14174.471676', '']\n",
      "['9740089', 'IRCT2015071722965N2. Effect of  N-acetyl cysteine  on controling clinical symtoms and  inflammatory biomarkers  in rhumatoid arthritis Patients. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015071722965N2. (2015)   pp', '10.2174/1573403x14666180926100811', '']\n",
      "['9740091', 'ISRCTN36667085. Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition - an early phase trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN36667085. (2014)   pp', '10.1186/isrctn36667085', '']\n",
      "['9740092', 'EUCTR2015-002523-26-HU. Effects of JAK inhibition on rheumatoid arthritis-related comorbidities: link between bone and vascular effects (investigator-initiated grant proposal). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-002523-26-HU. (2015)   pp', '10.1016/j.intimp.2022.109095', '']\n",
      "['9740093', 'IRCT2016071328903N1. Clinical evaluation of the efficacy of a novel wound dressing on treatment of wagner ulcer grade II. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2016071328903N1. (2016)   pp', '10.36948/ijfmr.2023.v05i03.3784', 'https://www.ijfmr.com/papers/2023/3/3784.pdf']\n",
      "['9740094', 'NTR80. Treatment Intensification Based on Disease Activity Parameters or on Cartilage Breakdown Markers in Early Rheumatoid Arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR80. (2005)   pp', '10.1186/isrctn96372677', '']\n",
      "['9740095', 'EUCTR2006-006380-22-DE. Biological dosimetry in radiation synovectomy of small finger joints with Erbium [169Er] citrate - ER-MM1 biological dosimetry. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-006380-22-DE. (2006)   pp', '10.1093/oxfordjournals.rpd.a033235', 'http://academic.oup.com/rpd/article-pdf/91/1-3/57/9932333/57.pdf']\n",
      "['9740096', 'ACTRN12606000248561. A phase 1 randomised double blind, placebo-controlled, single dose, dose escalation study of KB002, a chimeric monoclonal antibody which binds to granulocyte macrophage-colony stimulating factor (GM-CSF), in patients with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12606000248561. (2006)   pp', '10.1186/isrctn27114642', '']\n",
      "['9740097', 'UMIN000009425. A validity inspection study of the treat-to-target strategy with golimumab for the treatment of rheumatoid arthritis patient. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009425. (2012)   pp', '10.1093/rheumatology/kev089.005', 'http://academic.oup.com/rheumatology/article-pdf/54/suppl_1/i97/5180340/kev089.005.pdf']\n",
      "['9740098', 'ChiCTR-IPR-17010307. The efficacy and safety of rapamycin in refractory rheumatoid arthritis: a multi-center randomized controlled trial in China. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-17010307. (2017)   pp', '10.1186/isrctn81391471', '']\n",
      "['9740099', 'ChiCTR-IPR-17010325. The efficacy and safety of  Metformin combined with coenzyme Q10 in refractory rheumatoid arthritis: a multi-center randomized controlled trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IPR-17010325. (2017)   pp', '10.1111/dom.14163/v1/review2', '']\n",
      "['9740100', 'JapicCTI-132277. AMG 162 Phase III study (DESIRABLE study). http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-JapicCTI-132277. (2013)   pp', '10.1016/j.conbuildmat.2023.132277', '']\n",
      "['9740101', 'ISRCTN87704142. Rehabilitation of Patients with Rheumatoid Arthritis (RA): changes in Muscle, Functional and Biochemical Parameters. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN87704142. (2004)   pp', '10.1186/isrctn87704142', '']\n",
      "['9740102', \"EUCTR2014-003140-12-NL. Leflunomide and Hydroxychloroquine combination therapy for primary Sjogren's Syndrome. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-003140-12-NL. (2015)   pp\", '10.33540/204', '']\n",
      "['9740103', 'ChiCTR-IOR-16008869. Optimized using of drainage tube in ERAS total knee arthroplasty: a Prospective Randomized Controlled Trial. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-16008869. (2016)   pp', '10.31525/ct1-nct03869203', '']\n",
      "['9740104', 'UMIN000009566. Randomized controlled study for patients with RA using 23-valent pneumococcal polysaccharide vaccine. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009566. (2012)   pp', '10.1016/j.vaccine.2014.01.009', '']\n",
      "['9740105', 'EUCTR2014-001471-31-HU. This is a Phase 2, multicenter, 24-week, open-label extension (OLE) study to assess the safety and tolerability of ABT-122 in rheumatoid arthritis (RA) subjects who have completed Study M12-963. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-001471-31-HU. (2015)   pp', '10.31525/ct1-nct03909295', '']\n",
      "['9740106', 'EUCTR2011-006196-19-DK. Clinical Trials with lozenge as local anaesthesia as treatment for oral pain of patients with burning mouth syndrome and Sj√∂grens syndrom. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-006196-19-DK. (2012)   pp', '10.14476/jomp.2023.48.1.11', 'http://pdf.medrang.co.kr/JOMP/2023/048/jomp-48-1-11.pdf']\n",
      "['9740107', 'UMIN000009887. Associations between the initial concentration of serum TNF alpha and effects due to increasing a dose of Infliximab, and between effects of infliximab and the concentration of serum IL-6. http://www.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000009887. (2013)   pp', '10.7717/peerj.13024/fig-3', '']\n",
      "['9740108', 'IRCT2015092624201N1. Pilates exercise on symptoms of rheumatoid arthritis patients and lower extremity function. http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015092624201N1. (2016)   pp', '10.1002/art.1790040207', '']\n",
      "['9740111', 'EUCTR2011-006020-20-BG. A clinical study of ASP015K in patients with moderate to severe rheumatoid arthritis (RA). http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-006020-20-BG. (2013)   pp', '10.1186/isrctn75505683', '']\n",
      "['9740112', 'EUCTR2011-005634-19-PL. A Phase 2b to investigate the effectiveness of mavrilimumab, an antibody being developed for the treatment of moderate to severe rheumatoid arthritis, an inflammatory condition that affects the joints. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2011-005634-19-PL. (2012)   pp', '10.3410/f.727317664.793564270', '']\n",
      "['9740113', 'EUCTR2007-003647-75-SE. A randomised, double-blind, placebo controlled, multi-centre, exploratory, pilot, phase II trial of 150 mg atacicept given subcutaneously in combination with rituximab in subjects with rheumatoid arthritis. - Atacicept in combination with rituximab in subjects with rheumatoid arthritis. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2007-003647-75-SE. (2007)   pp', '10.1002/art.39262', 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39262']\n",
      "['9740114', 'EUCTR2006-005466-39-GB. A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Finding Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BG9924 When Given in Combination With Methotrexate to Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional DMARD Therapy. http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2006-005466-39-GB. (2007)   pp', '10.1007/s00108-017-0345-6', 'http://link.springer.com/article/10.1007/s00108-017-0345-6/fulltext.html']\n"
     ]
    }
   ],
   "source": [
    "import csv\n",
    "with open(paper_journal_info, \"r\") as f:\n",
    "    lines = csv.reader(f)\n",
    "    next(lines)  # skip header\n",
    "    for row in lines:\n",
    "        paper_id = row[0]\n",
    "        paper_title = row[1]\n",
    "        paper_doi = row[2]\n",
    "        paper_link = row[3]\n",
    "        print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "robust_py311",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
